PRODUCTID	PRODUCTNDC	PRODUCTTYPENAME	PROPRIETARYNAME	PROPRIETARYNAMESUFFIX	NONPROPRIETARYNAME	DOSAGEFORMNAME	ROUTENAME	STARTMARKETINGDATE	ENDMARKETINGDATE	MARKETINGCATEGORYNAME	APPLICATIONNUMBER	LABELERNAME	SUBSTANCENAME	ACTIVE_NUMERATOR_STRENGTH	ACTIVE_INGRED_UNIT	PHARM_CLASSES	DEASCHEDULE	NDC_EXCLUDE_FLAG	LISTING_RECORD_CERTIFIED_THROUGH
0002-0213_458ef2aa-cd5f-48bc-8829-82420cfed33b	0002-0213	HUMAN OTC DRUG	Humulin	R	Insulin human	INJECTION, SOLUTION	PARENTERAL	19830627		BLA	BLA018780	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-0800_dec32ead-837e-4331-ab55-f3bbccea5b38	0002-0800	HUMAN OTC DRUG	Sterile Diluent		diluent	INJECTION, SOLUTION	SUBCUTANEOUS	19870710		BLA	BLA018781	Eli Lilly and Company	WATER	1	mL/mL			N	20241231
0002-1152_b597917f-9673-4331-809d-79a538bb943c	0002-1152	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	2.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-1200_c2f899b5-287a-4002-ae37-f69418174eb4	0002-1200	HUMAN PRESCRIPTION DRUG	Amyvid		Florbetapir F 18	INJECTION, SOLUTION	INTRAVENOUS	20120601		NDA	NDA202008	Eli Lilly and Company	FLORBETAPIR F-18	51	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
0002-1220_e82b7e9c-6569-415d-9498-084612225c12	0002-1220	HUMAN PRESCRIPTION DRUG	TAUVID		Flortaucipir F-18	INJECTION, SOLUTION	INTRAVENOUS	20220701		NDA	NDA212123	Eli Lilly and Company	FLORTAUCIPIR F-18	100	mCi/mL			N	20241231
0002-1243_b597917f-9673-4331-809d-79a538bb943c	0002-1243	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-1433_d89b25b3-0f8d-4cbd-b58b-44d112cd7fe6	0002-1433	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918		BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	.75	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0002-1434_d89b25b3-0f8d-4cbd-b58b-44d112cd7fe6	0002-1434	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918		BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	1.5	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0002-1436_bec46346-20b5-4dbe-bac3-b8564e906941	0002-1436	HUMAN PRESCRIPTION DRUG	EMGALITY		galcanezumab-gnlm	INJECTION, SOLUTION	SUBCUTANEOUS	20180927		BLA	BLA761063	Eli Lilly and Company	GALCANEZUMAB	120	mg/mL			N	20241231
0002-1445_39e9a0c8-fced-467c-a773-4c07d7ba060c	0002-1445	HUMAN PRESCRIPTION DRUG	TALTZ		ixekizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20160322		BLA	BLA125521	Eli Lilly and Company	IXEKIZUMAB	80	mg/mL	Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]		N	20241231
0002-1457_b597917f-9673-4331-809d-79a538bb943c	0002-1457	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20220513		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	15	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-1460_b597917f-9673-4331-809d-79a538bb943c	0002-1460	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20220513		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	12.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-1471_b597917f-9673-4331-809d-79a538bb943c	0002-1471	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20220513		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	10	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-1484_b597917f-9673-4331-809d-79a538bb943c	0002-1484	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20220513		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	7.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-1495_b597917f-9673-4331-809d-79a538bb943c	0002-1495	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20220513		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-1506_b597917f-9673-4331-809d-79a538bb943c	0002-1506	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20220513		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	2.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2214_b597917f-9673-4331-809d-79a538bb943c	0002-2214	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	7.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2236_d89b25b3-0f8d-4cbd-b58b-44d112cd7fe6	0002-2236	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20200903		BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	3	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0002-2340_b597917f-9673-4331-809d-79a538bb943c	0002-2340	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	10	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2377_bec46346-20b5-4dbe-bac3-b8564e906941	0002-2377	HUMAN PRESCRIPTION DRUG	EMGALITY		galcanezumab-gnlm	INJECTION, SOLUTION	SUBCUTANEOUS	20180927		BLA	BLA761063	Eli Lilly and Company	GALCANEZUMAB	120	mg/mL			N	20241231
0002-2423_b597917f-9673-4331-809d-79a538bb943c	0002-2423	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	12.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2457_dcabc03d-6a72-467a-8043-9eb12ce9c856	0002-2457	HUMAN PRESCRIPTION DRUG	ZEPBOUND		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231108		NDA	NDA217806	Eli Lilly and Company	TIRZEPATIDE	15	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2460_dcabc03d-6a72-467a-8043-9eb12ce9c856	0002-2460	HUMAN PRESCRIPTION DRUG	ZEPBOUND		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231108		NDA	NDA217806	Eli Lilly and Company	TIRZEPATIDE	12.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2471_dcabc03d-6a72-467a-8043-9eb12ce9c856	0002-2471	HUMAN PRESCRIPTION DRUG	ZEPBOUND		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231108		NDA	NDA217806	Eli Lilly and Company	TIRZEPATIDE	10	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2484_dcabc03d-6a72-467a-8043-9eb12ce9c856	0002-2484	HUMAN PRESCRIPTION DRUG	ZEPBOUND		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231108		NDA	NDA217806	Eli Lilly and Company	TIRZEPATIDE	7.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2495_dcabc03d-6a72-467a-8043-9eb12ce9c856	0002-2495	HUMAN PRESCRIPTION DRUG	ZEPBOUND		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231108		NDA	NDA217806	Eli Lilly and Company	TIRZEPATIDE	5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2506_dcabc03d-6a72-467a-8043-9eb12ce9c856	0002-2506	HUMAN PRESCRIPTION DRUG	ZEPBOUND		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231108		NDA	NDA217806	Eli Lilly and Company	TIRZEPATIDE	2.5	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-2980_b0f8f174-6de2-4231-94c7-ae860ba286d8	0002-2980	HUMAN PRESCRIPTION DRUG	RETEVMO		selpercatinib	CAPSULE	ORAL	20200508		NDA	NDA213246	Eli Lilly and Company	SELPERCATINIB	80	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Rearranged during Transfection (RET) Inhibitors [MoA]		N	20241231
0002-3002_b597917f-9673-4331-809d-79a538bb943c	0002-3002	HUMAN PRESCRIPTION DRUG	MOUNJARO		tirzepatide	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		NDA	NDA215866	Eli Lilly and Company	TIRZEPATIDE	15	mg/.5mL	G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]		N	20241231
0002-3115_bec46346-20b5-4dbe-bac3-b8564e906941	0002-3115	HUMAN PRESCRIPTION DRUG	EMGALITY		galcanezumab-gnlm	INJECTION, SOLUTION	SUBCUTANEOUS	20190604		BLA	BLA761063	Eli Lilly and Company	GALCANEZUMAB	100	mg/mL			N	20241231
0002-3182_d89b25b3-0f8d-4cbd-b58b-44d112cd7fe6	0002-3182	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20200903		BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	4.5	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0002-3227_6963b20c-fce1-414e-90b6-5d0730f93191	0002-3227	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20021126		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0002-3228_6963b20c-fce1-414e-90b6-5d0730f93191	0002-3228	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20021126		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0002-3229_6963b20c-fce1-414e-90b6-5d0730f93191	0002-3229	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20021126		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0002-3230_c0e0ab8a-6a1e-4361-b8c6-00163eaa0f7b	0002-3230	HUMAN PRESCRIPTION DRUG	Symbyax		Olanzapine and Fluoxetine hydrochloride	CAPSULE	ORAL	20070409		NDA	NDA021520	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 3	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0002-3231_c0e0ab8a-6a1e-4361-b8c6-00163eaa0f7b	0002-3231	HUMAN PRESCRIPTION DRUG	Symbyax		Olanzapine and Fluoxetine hydrochloride	CAPSULE	ORAL	20031224		NDA	NDA021520	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 6	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0002-3235_9b59611f-2b1b-46d7-8d7e-9d0779811309	0002-3235	HUMAN PRESCRIPTION DRUG	Cymbalta		Duloxetine hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20040824		NDA	NDA021427	Eli Lilly and Company	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0002-3238_6963b20c-fce1-414e-90b6-5d0730f93191	0002-3238	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20021126		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0002-3239_6963b20c-fce1-414e-90b6-5d0730f93191	0002-3239	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20021126		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0002-3240_9b59611f-2b1b-46d7-8d7e-9d0779811309	0002-3240	HUMAN PRESCRIPTION DRUG	Cymbalta		Duloxetine hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20040824		NDA	NDA021427	Eli Lilly and Company	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0002-3250_6963b20c-fce1-414e-90b6-5d0730f93191	0002-3250	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20050214		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0002-3251_6963b20c-fce1-414e-90b6-5d0730f93191	0002-3251	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20050214		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0002-3270_9b59611f-2b1b-46d7-8d7e-9d0779811309	0002-3270	HUMAN PRESCRIPTION DRUG	Cymbalta		Duloxetine hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20100115		NDA	NDA021427	Eli Lilly and Company	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0002-3977_b0f8f174-6de2-4231-94c7-ae860ba286d8	0002-3977	HUMAN PRESCRIPTION DRUG	RETEVMO		selpercatinib	CAPSULE	ORAL	20200508		NDA	NDA213246	Eli Lilly and Company	SELPERCATINIB	40	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Rearranged during Transfection (RET) Inhibitors [MoA]		N	20241231
0002-4112_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4112	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19970623		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4115_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4115	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4116_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4116	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4117_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4117	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4182_44ded0f7-8c82-4875-ad44-db5b0354a094	0002-4182	HUMAN PRESCRIPTION DRUG	Olumiant		baricitinib	TABLET, FILM COATED	ORAL	20180531		NDA	NDA207924	Eli Lilly and Company	BARICITINIB	2	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0002-4184_736ef754-5dd5-422b-81fa-bf12e9ee8afb	0002-4184	HUMAN PRESCRIPTION DRUG	Evista		Raloxifene hydrochloride	TABLET	ORAL	19980106		NDA	NDA020815	Eli Lilly and Company	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0002-4312_5ef14cf2-d634-4a7b-9254-4cc480e8a48d	0002-4312	HUMAN PRESCRIPTION DRUG	Reyvow		lasmiditan	TABLET	ORAL	20191011		NDA	NDA211280	Eli Lilly and Company	LASMIDITAN	50	mg/1		CV	N	20241231
0002-4415_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4415	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	20000110		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4420_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4420	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	20010301		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4453_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4453	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20000601		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4454_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4454	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20000601		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4455_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4455	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20010901		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4456_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-4456	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20010901		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0002-4462_21516130-0eb4-48d3-ba98-80465523793a	0002-4462	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20031126		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0002-4463_21516130-0eb4-48d3-ba98-80465523793a	0002-4463	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20031126		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0002-4464_21516130-0eb4-48d3-ba98-80465523793a	0002-4464	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20031126		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0002-4465_21516130-0eb4-48d3-ba98-80465523793a	0002-4465	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20080107		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0002-4479_44ded0f7-8c82-4875-ad44-db5b0354a094	0002-4479	HUMAN PRESCRIPTION DRUG	Olumiant		baricitinib	TABLET, FILM COATED	ORAL	20220510		NDA	NDA207924	Eli Lilly and Company	BARICITINIB	4	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0002-4483_1bfe414d-380c-400b-8ae2-7caa0877dcad	0002-4483	HUMAN PRESCRIPTION DRUG	Verzenio		abemaciclib	TABLET	ORAL	20170928		NDA	NDA208716	Eli Lilly and Company	ABEMACICLIB	50	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20251231
0002-4491_5ef14cf2-d634-4a7b-9254-4cc480e8a48d	0002-4491	HUMAN PRESCRIPTION DRUG	Reyvow		lasmiditan	TABLET	ORAL	20191011		NDA	NDA211280	Eli Lilly and Company	LASMIDITAN	100	mg/1		CV	N	20241231
0002-4732_44ded0f7-8c82-4875-ad44-db5b0354a094	0002-4732	HUMAN PRESCRIPTION DRUG	Olumiant		baricitinib	TABLET, FILM COATED	ORAL	20191008		NDA	NDA207924	Eli Lilly and Company	BARICITINIB	1	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0002-4815_1bfe414d-380c-400b-8ae2-7caa0877dcad	0002-4815	HUMAN PRESCRIPTION DRUG	Verzenio		abemaciclib	TABLET	ORAL	20170928		NDA	NDA208716	Eli Lilly and Company	ABEMACICLIB	100	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20251231
0002-5337_1bfe414d-380c-400b-8ae2-7caa0877dcad	0002-5337	HUMAN PRESCRIPTION DRUG	Verzenio		abemaciclib	TABLET	ORAL	20170928		NDA	NDA208716	Eli Lilly and Company	ABEMACICLIB	150	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20251231
0002-6145_f88837b4-7c0d-4200-aba0-e92561310058	0002-6145	HUMAN PRESCRIPTION DRUG	Baqsimi		glucagon	POWDER	NASAL	20190724		NDA	NDA210134	Eli Lilly and Company	GLUCAGON	3	mg/1	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20241231
0002-6216_1bfe414d-380c-400b-8ae2-7caa0877dcad	0002-6216	HUMAN PRESCRIPTION DRUG	Verzenio		abemaciclib	TABLET	ORAL	20170928		NDA	NDA208716	Eli Lilly and Company	ABEMACICLIB	200	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20251231
0002-6885_14a2ffe3-1d7e-4d1b-ac44-1698d5f92da4	0002-6885	HUMAN PRESCRIPTION DRUG	Baricitinib		baricitinib	TABLET, FILM COATED	ORAL	20211220		EMERGENCY USE AUTHORIZATION		Eli Lilly and Company	BARICITINIB	4	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0002-6902_7b7804fa-6603-4aac-a91b-e3f66c0bb98a	0002-6902	HUMAN PRESCRIPTION DRUG	JAYPIRCA		pirtobrutinib	TABLET, COATED	ORAL	20230127		NDA	NDA216059	Eli Lilly and Company	PIRTOBRUTINIB	50	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Bruton's Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA]		N	20241231
0002-7026_7b7804fa-6603-4aac-a91b-e3f66c0bb98a	0002-7026	HUMAN PRESCRIPTION DRUG	JAYPIRCA		pirtobrutinib	TABLET, COATED	ORAL	20230127		NDA	NDA216059	Eli Lilly and Company	PIRTOBRUTINIB	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Bruton's Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA]		N	20241231
0002-7510_e57e8ab9-295b-4fb7-b723-e7b008117e9a	0002-7510	HUMAN PRESCRIPTION DRUG	Humalog		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19960614		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7511_6159de02-43c9-4b4b-83be-41246382761e	0002-7511	HUMAN PRESCRIPTION DRUG	Humalog	Mix75/25	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	19991222		BLA	BLA021017	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7512_371bd208-8aba-405b-9ea8-a2e473da4bf5	0002-7512	HUMAN PRESCRIPTION DRUG	Humalog	Mix50/50	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	19991222	20240331	BLA	BLA021018	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	
0002-7516_e57e8ab9-295b-4fb7-b723-e7b008117e9a	0002-7516	HUMAN PRESCRIPTION DRUG	Humalog		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19980220		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7533_e57e8ab9-295b-4fb7-b723-e7b008117e9a	0002-7533	HUMAN PRESCRIPTION DRUG	Humalog		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230802		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7575_83c555b7-3807-4f0b-8812-63b6082d026c	0002-7575	HUMAN PRESCRIPTION DRUG	Omvoh		mirikizumab-mrkz	INJECTION, SOLUTION	INTRAVENOUS	20231026		BLA	BLA761279	Eli Lilly and Company	MIRIKIZUMAB	20	mg/mL	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20241231
0002-7589_0a45f258-0828-4a0c-b992-a8ba521b84d0	0002-7589	HUMAN PRESCRIPTION DRUG	Bebtelovimab		Bebtelovimab	INJECTION, SOLUTION	INTRAVENOUS	20220211		EMERGENCY USE AUTHORIZATION		Eli Lilly and Company	BEBTELOVIMAB	87.5	mg/mL			N	20241231
0002-7597_c5ba5946-0f0a-445b-b370-6b98a6dbf6a3	0002-7597	HUMAN PRESCRIPTION DRUG	ZYPREXA	Intramuscular	Olanzapine	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR	20040401		NDA	NDA021253	Eli Lilly and Company	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]		N	20241231
0002-7623_3af0bc84-13d6-46aa-a4c0-c62410b73bc6	0002-7623	HUMAN PRESCRIPTION DRUG	Alimta		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20040204		NDA	NDA021462	Eli Lilly and Company	PEMETREXED DISODIUM HEPTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0002-7635_41196744-bae3-4fee-86d2-2df9f7dc6a04	0002-7635	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20091211		NDA	NDA022173	Eli Lilly and Company						N	20241231
0002-7636_41196744-bae3-4fee-86d2-2df9f7dc6a04	0002-7636	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20091211		NDA	NDA022173	Eli Lilly and Company						N	20241231
0002-7637_41196744-bae3-4fee-86d2-2df9f7dc6a04	0002-7637	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20091211		NDA	NDA022173	Eli Lilly and Company						N	20241231
0002-7640_3af0bc84-13d6-46aa-a4c0-c62410b73bc6	0002-7640	HUMAN PRESCRIPTION DRUG	Alimta		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20070907		NDA	NDA021462	Eli Lilly and Company	PEMETREXED DISODIUM HEPTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0002-7669_7ba2dde4-bb6d-4c7b-af6a-361ed01bfdf6	0002-7669	HUMAN PRESCRIPTION DRUG	CYRAMZA		ramucirumab	SOLUTION	INTRAVENOUS	20140421		BLA	BLA125477	Eli Lilly and Company	RAMUCIRUMAB	10	mg/mL	VEGFR2 Inhibitors [MoA], Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]		N	20241231
0002-7678_7ba2dde4-bb6d-4c7b-af6a-361ed01bfdf6	0002-7678	HUMAN PRESCRIPTION DRUG	CYRAMZA		ramucirumab	SOLUTION	INTRAVENOUS	20140421		BLA	BLA125477	Eli Lilly and Company	RAMUCIRUMAB	10	mg/mL	VEGFR2 Inhibitors [MoA], Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]		N	20241231
0002-7712_e57e8ab9-295b-4fb7-b723-e7b008117e9a	0002-7712	HUMAN PRESCRIPTION DRUG	Humalog	KwikPen	Insulin lispro	INJECTION, SOLUTION	SUBCUTANEOUS	20150526		BLA	BLA205747	Eli Lilly and Company	INSULIN LISPRO	200	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7714_e57e8ab9-295b-4fb7-b723-e7b008117e9a	0002-7714	HUMAN PRESCRIPTION DRUG	Humalog	Junior KwikPen	Insulin lispro	INJECTION, SOLUTION	SUBCUTANEOUS	20170606		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7715_dbb5654d-96c0-4cce-adba-5ae8c36acf80	0002-7715	HUMAN PRESCRIPTION DRUG	BASAGLAR	KwikPen	Insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20151216		BLA	BLA205692	Eli Lilly and Company	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0002-7716_de61c9cb-64bb-475a-9b6a-dde617a87e4a	0002-7716	HUMAN PRESCRIPTION DRUG	Portrazza		necitumumab	SOLUTION	INTRAVENOUS	20151124		BLA	BLA125547	Eli Lilly and Company	NECITUMUMAB	16	mg/mL	Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]		N	20241231
0002-7724_39e9a0c8-fced-467c-a773-4c07d7ba060c	0002-7724	HUMAN PRESCRIPTION DRUG	TALTZ		ixekizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20160322		BLA	BLA125521	Eli Lilly and Company	IXEKIZUMAB	80	mg/mL	Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]		N	20241231
0002-7728_6f84ba56-a2a5-440e-9d3f-334655934a53	0002-7728	HUMAN PRESCRIPTION DRUG	LYUMJEV		Insulin lispro-aabc	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200615		BLA	BLA761109	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7737_eee13147-cd23-4ee6-876e-8267fa954b0e	0002-7737	HUMAN PRESCRIPTION DRUG	Insulin Lispro		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200212		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7752_eee13147-cd23-4ee6-876e-8267fa954b0e	0002-7752	HUMAN PRESCRIPTION DRUG	Insulin Lispro	Junior KwikPen	Insulin lispro	INJECTION, SOLUTION	SUBCUTANEOUS	20200212		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-7910_8aa4f3ff-a512-4826-b910-85ab6e89f466	0002-7910	HUMAN PRESCRIPTION DRUG	Bamlanivimab		Bamlanivimab	INJECTION, SOLUTION	INTRAVENOUS	20201109		EMERGENCY USE AUTHORIZATION		Eli Lilly and Company	BAMLANIVIMAB	35	mg/mL			N	20241231
0002-7950_26bc28c0-e8ff-470f-96c7-db44b1e690ab	0002-7950	HUMAN PRESCRIPTION DRUG	Etesevimab		Etesevimab	INJECTION, SOLUTION	INTRAVENOUS	20210209		EMERGENCY USE AUTHORIZATION		Eli Lilly and Company	ETESEVIMAB	35	mg/mL			N	20241231
0002-8011_83c555b7-3807-4f0b-8812-63b6082d026c	0002-8011	HUMAN PRESCRIPTION DRUG	Omvoh		mirikizumab-mrkz	INJECTION, SOLUTION	SUBCUTANEOUS	20231026		BLA	BLA761279	Eli Lilly and Company	MIRIKIZUMAB	100	mg/mL	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20241231
0002-8031_024e1f7b-37ec-406c-9cec-bfe491866399	0002-8031	HUMAN PRESCRIPTION DRUG	Glucagon		glucagon	KIT		19990301		NDA	NDA020928	Eli Lilly and Company						N	20241231
0002-8147_874d72c5-2ba2-409e-99c7-8e32f68b3dd4	0002-8147	HUMAN PRESCRIPTION DRUG	HUMATROPE		Somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20060127		BLA	BLA019640	Eli Lilly and Company						N	20241231
0002-8148_874d72c5-2ba2-409e-99c7-8e32f68b3dd4	0002-8148	HUMAN PRESCRIPTION DRUG	HUMATROPE		Somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20060127		BLA	BLA019640	Eli Lilly and Company						N	20241231
0002-8149_874d72c5-2ba2-409e-99c7-8e32f68b3dd4	0002-8149	HUMAN PRESCRIPTION DRUG	HUMATROPE		Somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20060127		BLA	BLA019640	Eli Lilly and Company						N	20241231
0002-8207_6f84ba56-a2a5-440e-9d3f-334655934a53	0002-8207	HUMAN PRESCRIPTION DRUG	LYUMJEV	KwikPen	Insulin lispro-aabc	INJECTION, SOLUTION	SUBCUTANEOUS	20200615		BLA	BLA761109	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8213_e57e8ab9-295b-4fb7-b723-e7b008117e9a	0002-8213	HUMAN PRESCRIPTION DRUG	Humalog	Tempo Pen	Insulin lispro	INJECTION, SOLUTION	SUBCUTANEOUS	20170606		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8214_dbb5654d-96c0-4cce-adba-5ae8c36acf80	0002-8214	HUMAN PRESCRIPTION DRUG	BASAGLAR	Tempo Pen	Insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20151216		BLA	BLA205692	Eli Lilly and Company	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0002-8215_458ef2aa-cd5f-48bc-8829-82420cfed33b	0002-8215	HUMAN OTC DRUG	Humulin	R	Insulin human	INJECTION, SOLUTION	PARENTERAL	19830627		BLA	BLA018780	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-8222_eee13147-cd23-4ee6-876e-8267fa954b0e	0002-8222	HUMAN PRESCRIPTION DRUG	Insulin Lispro	KwikPen	Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200212		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8228_6f84ba56-a2a5-440e-9d3f-334655934a53	0002-8228	HUMAN PRESCRIPTION DRUG	LYUMJEV	KwikPen	Insulin lispro-aabc	INJECTION, SOLUTION	SUBCUTANEOUS	20200615		BLA	BLA761109	Eli Lilly and Company	INSULIN LISPRO	200	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8233_7a32de8b-9b84-4dd7-829b-5a300cca8331	0002-8233	HUMAN PRESCRIPTION DRUG	Insulin Lispro Protamine and Insulin Lispro Injectable Suspension	Mix75/25 KwikPen	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	20200212		BLA	BLA021017	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8235_6f84ba56-a2a5-440e-9d3f-334655934a53	0002-8235	HUMAN PRESCRIPTION DRUG	LYUMJEV	Tempo Pen	Insulin lispro-aabc	INJECTION, SOLUTION	SUBCUTANEOUS	20200615		BLA	BLA761109	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8315_dec32ead-837e-4331-ab55-f3bbccea5b38	0002-8315	HUMAN OTC DRUG	Humulin	N	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	19830627		BLA	BLA018781	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-8400_ee8cffaa-b78b-4c3f-bcf5-ffc76bf515ca	0002-8400	HUMAN PRESCRIPTION DRUG	Forteo		Teriparatide	INJECTION, SOLUTION	SUBCUTANEOUS	20021126		NDA	NDA021318	Eli Lilly and Company	TERIPARATIDE	250	ug/mL	Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]		N	20241231
0002-8501_509bb036-7546-4909-b830-87699d1e8d0a	0002-8501	HUMAN PRESCRIPTION DRUG	Humulin	R U-500	Insulin human	INJECTION, SOLUTION	SUBCUTANEOUS	19940331		BLA	BLA018780	Eli Lilly and Company	INSULIN HUMAN	500	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-8715_5ee14259-fd18-46e4-ab7f-82de871dd214	0002-8715	HUMAN OTC DRUG	Humulin	70/30	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	19890626		BLA	BLA019717	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-8797_6159de02-43c9-4b4b-83be-41246382761e	0002-8797	HUMAN PRESCRIPTION DRUG	Humalog	Mix75/25 KwikPen	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	20070906		BLA	BLA021017	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8798_371bd208-8aba-405b-9ea8-a2e473da4bf5	0002-8798	HUMAN PRESCRIPTION DRUG	Humalog	Mix50/50 KwikPen	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	20070906		BLA	BLA021018	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8799_e57e8ab9-295b-4fb7-b723-e7b008117e9a	0002-8799	HUMAN PRESCRIPTION DRUG	Humalog	KwikPen	Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20070906		BLA	BLA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0002-8803_5ee14259-fd18-46e4-ab7f-82de871dd214	0002-8803	HUMAN OTC DRUG	Humulin	70/30 KwikPen	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	20131107		BLA	BLA019717	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-8805_dec32ead-837e-4331-ab55-f3bbccea5b38	0002-8805	HUMAN OTC DRUG	Humulin	N	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	20131107		BLA	BLA018781	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-8824_509bb036-7546-4909-b830-87699d1e8d0a	0002-8824	HUMAN PRESCRIPTION DRUG	Humulin	R U-500 KwikPen	Insulin human	INJECTION, SOLUTION	SUBCUTANEOUS	20151229		BLA	BLA018780	Eli Lilly and Company	INSULIN HUMAN	500	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0002-8980_615b8713-dfda-4f22-b544-51550aecee4b	0002-8980	HUMAN PRESCRIPTION DRUG	Rezvoglar	KwikPen	Insulin glargine-aglr	INJECTION, SOLUTION	SUBCUTANEOUS	20211217		BLA	BLA761215	Eli Lilly and Company	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0003-0249_7d355981-e4d6-4d06-a2b3-eb83edce221b	0003-0249	HUMAN PRESCRIPTION DRUG	HALOG		Halcinonide	SOLUTION	TOPICAL	20090101		NDA	NDA017823	E.R. Squibb & Sons, L.L.C.	HALCINONIDE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0003-0293_6ee2f005-a466-4a9f-806a-20452d109661	0003-0293	HUMAN PRESCRIPTION DRUG	KENALOG-40		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20090601		NDA	NDA014901	E.R. Squibb & Sons, L.L.C.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0003-0315_6ee2f005-a466-4a9f-806a-20452d109661	0003-0315	HUMAN PRESCRIPTION DRUG	KENALOG-80		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20190412		NDA	NDA014901	E.R. Squibb & Sons, L.L.C.	TRIAMCINOLONE ACETONIDE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab	0003-0371	HUMAN PRESCRIPTION DRUG	NULOJIX		BELATACEPT	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110615		BLA	BLA125288	E.R. Squibb & Sons, L.L.C.	BELATACEPT	250	mg/1	CD80-directed Antibody Interactions [MoA], CD86-directed Antibody Interactions [MoA], Selective T Cell Costimulation Blocker [EPC], T Lymphocyte Costimulation Activity Blockade [PE]		N	20241231
0003-0494_1df55c51-c951-4bf9-a8f2-174d3814cdfe	0003-0494	HUMAN PRESCRIPTION DRUG	KENALOG-10		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL	20090601		NDA	NDA012041	E.R. Squibb & Sons, L.L.C.	TRIAMCINOLONE ACETONIDE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0003-0524_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf	0003-0524	HUMAN PRESCRIPTION DRUG	SPRYCEL		dasatinib	TABLET	ORAL	20060627		NDA	NDA021986	E.R. Squibb & Sons, L.L.C.	DASATINIB	70	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0003-0527_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf	0003-0527	HUMAN PRESCRIPTION DRUG	SPRYCEL		dasatinib	TABLET	ORAL	20060627		NDA	NDA021986	E.R. Squibb & Sons, L.L.C.	DASATINIB	20	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0003-0528_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf	0003-0528	HUMAN PRESCRIPTION DRUG	SPRYCEL		dasatinib	TABLET	ORAL	20060627		NDA	NDA021986	E.R. Squibb & Sons, L.L.C.	DASATINIB	50	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0003-0830_ff7bec97-40a2-46a7-b441-8264c98cc1bf	0003-0830	HUMAN PRESCRIPTION DRUG	HYDREA		HYDROXYUREA	CAPSULE	ORAL	20090601	20250331	NDA	NDA016295	E.R. Squibb & Sons, L.L.C.	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	
0003-0852_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf	0003-0852	HUMAN PRESCRIPTION DRUG	SPRYCEL		dasatinib	TABLET	ORAL	20080530		NDA	NDA021986	E.R. Squibb & Sons, L.L.C.	DASATINIB	100	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0003-0855_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf	0003-0855	HUMAN PRESCRIPTION DRUG	SPRYCEL		dasatinib	TABLET	ORAL	20101028		NDA	NDA021986	E.R. Squibb & Sons, L.L.C.	DASATINIB	80	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0003-0857_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf	0003-0857	HUMAN PRESCRIPTION DRUG	SPRYCEL		dasatinib	TABLET	ORAL	20101028		NDA	NDA021986	E.R. Squibb & Sons, L.L.C.	DASATINIB	140	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0003-0893_a260aeff-75b6-4468-bc8a-c2f8d6ac66e3	0003-0893	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	E.R. Squibb & Sons, L.L.C.	APIXABAN	2.5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
0003-0894_a260aeff-75b6-4468-bc8a-c2f8d6ac66e3	0003-0894	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	E.R. Squibb & Sons, L.L.C.	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
0003-0895_ff4d7258-5068-4cdf-9692-8cae04c3198e	0003-0895	HUMAN PRESCRIPTION DRUG	SOTYKTU		deucravacitinib	TABLET, FILM COATED	ORAL	20220909		NDA	NDA214958	E.R. Squibb & Sons, L.L.C.	DEUCRAVACITINIB	6	mg/1			N	20241231
0003-1611_5ea9d52c-ff85-43a8-a663-73e4f77a43d1	0003-1611	HUMAN PRESCRIPTION DRUG	BARACLUDE		entecavir	TABLET, FILM COATED	ORAL	20050329		NDA	NDA021797	E.R. Squibb & Sons, L.L.C.	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0003-1612_5ea9d52c-ff85-43a8-a663-73e4f77a43d1	0003-1612	HUMAN PRESCRIPTION DRUG	BARACLUDE		entecavir	TABLET, FILM COATED	ORAL	20050329		NDA	NDA021797	E.R. Squibb & Sons, L.L.C.	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0003-1614_5ea9d52c-ff85-43a8-a663-73e4f77a43d1	0003-1614	HUMAN PRESCRIPTION DRUG	BARACLUDE		entecavir	SOLUTION	ORAL	20050329		NDA	NDA021798	E.R. Squibb & Sons, L.L.C.	ENTECAVIR	.05	mg/mL	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0003-2187_ca83b90c-3ec0-4803-bf69-18c035bc41f0	0003-2187	HUMAN PRESCRIPTION DRUG	ORENCIA		abatacept	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090101		BLA	BLA125118	E.R. Squibb & Sons, L.L.C.	ABATACEPT	250	mg/15mL	Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]		N	20241231
0003-2188_ca83b90c-3ec0-4803-bf69-18c035bc41f0	0003-2188	HUMAN PRESCRIPTION DRUG	ORENCIA		abatacept	INJECTION, SOLUTION	SUBCUTANEOUS	20110729		BLA	BLA125118	E.R. Squibb & Sons, L.L.C.	ABATACEPT	125	mg/mL	Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]		N	20241231
0003-2291_ef47282a-3cff-40ed-867f-36af14c8f99c	0003-2291	HUMAN PRESCRIPTION DRUG	EMPLICITI		elotuzumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151130		BLA	BLA761035	E.R. Squibb & Sons, L.L.C.	ELOTUZUMAB	300	mg/1	Antibodies, Monoclonal [CS], SLAMF7-directed Antibody Interactions [MoA], SLAMF7-directed Immunostimulatory Antibody [EPC]		N	20241231
0003-2327_839bc9a8-9583-41fa-beb6-728ef542fa72	0003-2327	HUMAN PRESCRIPTION DRUG	YERVOY		ipilimumab	INJECTION	INTRAVENOUS	20110325		BLA	BLA125377	E.R. Squibb & Sons, L.L.C.	IPILIMUMAB	5	mg/mL	CTLA-4-directed Antibody Interactions [MoA], CTLA-4-directed Blocking Antibody [EPC], Increased T Lymphocyte Activation [PE]		N	20241231
0003-2328_839bc9a8-9583-41fa-beb6-728ef542fa72	0003-2328	HUMAN PRESCRIPTION DRUG	YERVOY		ipilimumab	INJECTION	INTRAVENOUS	20110325		BLA	BLA125377	E.R. Squibb & Sons, L.L.C.	IPILIMUMAB	5	mg/mL	CTLA-4-directed Antibody Interactions [MoA], CTLA-4-directed Blocking Antibody [EPC], Increased T Lymphocyte Activation [PE]		N	20241231
0003-2560_475e5ee7-db46-4426-bb91-79d08ba6ece6	0003-2560	HUMAN PRESCRIPTION DRUG	AZACTAM		AZTREONAM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100401		NDA	NDA050580	E.R. Squibb & Sons, L.L.C.	AZTREONAM	1	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
0003-2570_475e5ee7-db46-4426-bb91-79d08ba6ece6	0003-2570	HUMAN PRESCRIPTION DRUG	AZACTAM		AZTREONAM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100401		NDA	NDA050580	E.R. Squibb & Sons, L.L.C.	AZTREONAM	2	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
0003-2814_ca83b90c-3ec0-4803-bf69-18c035bc41f0	0003-2814	HUMAN PRESCRIPTION DRUG	ORENCIA		abatacept	INJECTION, SOLUTION	SUBCUTANEOUS	20110729		BLA	BLA125118	E.R. Squibb & Sons, L.L.C.	ABATACEPT	50	mg/.4mL	Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]		N	20241231
0003-2818_ca83b90c-3ec0-4803-bf69-18c035bc41f0	0003-2818	HUMAN PRESCRIPTION DRUG	ORENCIA		abatacept	INJECTION, SOLUTION	SUBCUTANEOUS	20110729		BLA	BLA125118	E.R. Squibb & Sons, L.L.C.	ABATACEPT	87.5	mg/.7mL	Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]		N	20241231
0003-3622_aa7cebdf-1418-4bd0-9630-c1233ed09f3d	0003-3622	HUMAN PRESCRIPTION DRUG	REYATAZ		ATAZANAVIR	CAPSULE, GELATIN COATED	ORAL	20030624		NDA	NDA021567	E.R. Squibb & Sons, L.L.C.	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0003-3631_aa7cebdf-1418-4bd0-9630-c1233ed09f3d	0003-3631	HUMAN PRESCRIPTION DRUG	REYATAZ		ATAZANAVIR	CAPSULE, GELATIN COATED	ORAL	20030624		NDA	NDA021567	E.R. Squibb & Sons, L.L.C.	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0003-3638_aa7cebdf-1418-4bd0-9630-c1233ed09f3d	0003-3638	HUMAN PRESCRIPTION DRUG	REYATAZ		ATAZANAVIR	POWDER	ORAL	20141219		NDA	NDA206352	E.R. Squibb & Sons, L.L.C.	ATAZANAVIR SULFATE	50	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0003-3641_36598a63-353c-4b23-83a1-46f225ea6765	0003-3641	HUMAN PRESCRIPTION DRUG	EVOTAZ		atazanavir and cobicistat	TABLET	ORAL	20150129		NDA	NDA206353	E.R. Squibb & Sons, L.L.C.	ATAZANAVIR SULFATE; COBICISTAT	300; 150	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0003-3734_14db8181-5332-4374-8278-53b726994528	0003-3734	HUMAN PRESCRIPTION DRUG	OPDIVO		nivolumab	INJECTION	INTRAVENOUS	20171208		BLA	BLA125554	E.R. Squibb & Sons, L.L.C.	NIVOLUMAB	10	mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
0003-3756_14db8181-5332-4374-8278-53b726994528	0003-3756	HUMAN PRESCRIPTION DRUG	OPDIVO		nivolumab	INJECTION	INTRAVENOUS	20210830		BLA	BLA125554	E.R. Squibb & Sons, L.L.C.	NIVOLUMAB	10	mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
0003-3764_a260aeff-75b6-4468-bc8a-c2f8d6ac66e3	0003-3764	HUMAN PRESCRIPTION DRUG	ELIQUIS	30-Day Starter Pack	apixaban	KIT		20171129		NDA	NDA202155	E.R. Squibb & Sons, L.L.C.						N	20241231
0003-3772_14db8181-5332-4374-8278-53b726994528	0003-3772	HUMAN PRESCRIPTION DRUG	OPDIVO		nivolumab	INJECTION	INTRAVENOUS	20141222		BLA	BLA125554	E.R. Squibb & Sons, L.L.C.	NIVOLUMAB	10	mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
0003-3774_14db8181-5332-4374-8278-53b726994528	0003-3774	HUMAN PRESCRIPTION DRUG	OPDIVO		nivolumab	INJECTION	INTRAVENOUS	20141222		BLA	BLA125554	E.R. Squibb & Sons, L.L.C.	NIVOLUMAB	10	mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
0003-4040_fb526827-40ba-4462-94cf-179ae3b0cb8a	0003-4040	HUMAN PRESCRIPTION DRUG	Augtyro		repotrectinib	CAPSULE	ORAL	20231205		NDA	NDA218213	E.R. Squibb & Sons, L.L.C.	REPOTRECTINIB	40	mg/1			N	20241231
0003-4522_ef47282a-3cff-40ed-867f-36af14c8f99c	0003-4522	HUMAN PRESCRIPTION DRUG	EMPLICITI		elotuzumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151130		BLA	BLA761035	E.R. Squibb & Sons, L.L.C.	ELOTUZUMAB	400	mg/1	Antibodies, Monoclonal [CS], SLAMF7-directed Antibody Interactions [MoA], SLAMF7-directed Immunostimulatory Antibody [EPC]		N	20241231
0003-6335_4e5c3df1-3e9c-4eb1-959e-1ab30dbb84f2	0003-6335	HUMAN PRESCRIPTION DRUG	DROXIA		HYDROXYUREA	CAPSULE	ORAL	20090601	20250331	NDA	NDA016295	E.R. Squibb & Sons, L.L.C.	HYDROXYUREA	200	mg/1	Antimetabolite [EPC], Urea [CS]		N	
0003-6336_4e5c3df1-3e9c-4eb1-959e-1ab30dbb84f2	0003-6336	HUMAN PRESCRIPTION DRUG	DROXIA		HYDROXYUREA	CAPSULE	ORAL	20090601	20250531	NDA	NDA016295	E.R. Squibb & Sons, L.L.C.	HYDROXYUREA	300	mg/1	Antimetabolite [EPC], Urea [CS]		N	
0003-6337_4e5c3df1-3e9c-4eb1-959e-1ab30dbb84f2	0003-6337	HUMAN PRESCRIPTION DRUG	DROXIA		HYDROXYUREA	CAPSULE	ORAL	20090601	20250531	NDA	NDA016295	E.R. Squibb & Sons, L.L.C.	HYDROXYUREA	400	mg/1	Antimetabolite [EPC], Urea [CS]		N	
0003-7125_b22c9d83-3256-4e17-85f7-f331a504adc6	0003-7125	HUMAN PRESCRIPTION DRUG	OPDUALAG		nivolumab and relatlimab-rmbw	INJECTION	INTRAVENOUS	20220318		BLA	BLA761234	E.R. Squibb & Sons, L.L.C.	NIVOLUMAB; RELATLIMAB	12; 4	mg/mL; mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
0004-0038_489edd7b-59eb-40d9-83d5-abc96aaac2cb	0004-0038	HUMAN PRESCRIPTION DRUG	Valcyte		valganciclovir	TABLET, FILM COATED	ORAL	20010329		NDA	NDA021304	Genentech, Inc.	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20251231
0004-0039_489edd7b-59eb-40d9-83d5-abc96aaac2cb	0004-0039	HUMAN PRESCRIPTION DRUG	Valcyte		valganciclovir hydrochloride	POWDER, FOR SOLUTION	ORAL	20090828		NDA	NDA022257	Genentech, Inc.	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20251231
0004-0058_48e75245-3b80-4dec-8f33-6387737ede6d	0004-0058	HUMAN PRESCRIPTION DRUG	Klonopin		Clonazepam	TABLET	ORAL	19750602	20240228	NDA	NDA017533	Genentech, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
0004-0068_48e75245-3b80-4dec-8f33-6387737ede6d	0004-0068	HUMAN PRESCRIPTION DRUG	Klonopin		Clonazepam	TABLET	ORAL	19750602	20240131	NDA	NDA017533	Genentech, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
0004-0244_a9982b9f-49dc-474b-8179-da91897a7237	0004-0244	HUMAN PRESCRIPTION DRUG	Invirase		saquinavir mesylate	TABLET, FILM COATED	ORAL	20041217	20240430	NDA	NDA021785	Genentech, Inc.	SAQUINAVIR MESYLATE	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	
0004-0259_0ab859a2-aff9-4df4-bd01-3d687d27239a	0004-0259	HUMAN PRESCRIPTION DRUG	CellCept		Mycophenolate Mofetil	CAPSULE	ORAL	19950503		NDA	NDA050722	Genentech, Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0004-0260_0ab859a2-aff9-4df4-bd01-3d687d27239a	0004-0260	HUMAN PRESCRIPTION DRUG	CellCept		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	19970619		NDA	NDA050723	Genentech, Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0004-0261_0ab859a2-aff9-4df4-bd01-3d687d27239a	0004-0261	HUMAN PRESCRIPTION DRUG	CellCept		Mycophenolate Mofetil	POWDER, FOR SUSPENSION	ORAL	19981001		NDA	NDA050759	Genentech, Inc.	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
0004-0298_0ab859a2-aff9-4df4-bd01-3d687d27239a	0004-0298	HUMAN PRESCRIPTION DRUG	CellCept		Mycophenolate Mofetil hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19980812		NDA	NDA050758	Genentech, Inc.	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
0004-0350_cc1e24aa-6242-4429-bfeb-c92907641f3e	0004-0350	HUMAN PRESCRIPTION DRUG	Pegasys		peginterferon alfa-2a	INJECTION, SOLUTION	SUBCUTANEOUS	20021016	20250630	BLA	BLA103964	Genentech, Inc.	PEGINTERFERON ALFA-2A	180	ug/mL	Interferon alpha [EPC], Interferon-alpha [CS]		N	
0004-0357_cc1e24aa-6242-4429-bfeb-c92907641f3e	0004-0357	HUMAN PRESCRIPTION DRUG	Pegasys		peginterferon alfa-2a	INJECTION, SOLUTION	SUBCUTANEOUS	20110329	20240630	BLA	BLA103964	Genentech, Inc.	PEGINTERFERON ALFA-2A	180	ug/.5mL	Interferon alpha [EPC], Interferon-alpha [CS]		N	
0004-0381_c73e3929-f256-4abf-b2a5-5bec18dadf71	0004-0381	HUMAN PRESCRIPTION DRUG	FUZEON		Enfuvirtide	KIT		20120410		NDA	NDA021481	Genentech, Inc.						N	20241231
0004-0800_8d967e7e-51b5-44f5-b3fb-5b111ce4a9ec	0004-0800	HUMAN PRESCRIPTION DRUG	Tamiflu		oseltamivir phosphate	CAPSULE	ORAL	19991027		NDA	NDA021087	Genentech, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0004-0801_8d967e7e-51b5-44f5-b3fb-5b111ce4a9ec	0004-0801	HUMAN PRESCRIPTION DRUG	Tamiflu		oseltamivir phosphate	CAPSULE	ORAL	19991027		NDA	NDA021087	Genentech, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0004-0802_8d967e7e-51b5-44f5-b3fb-5b111ce4a9ec	0004-0802	HUMAN PRESCRIPTION DRUG	Tamiflu		oseltamivir phosphate	CAPSULE	ORAL	19991027		NDA	NDA021087	Genentech, Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0004-0822_8d967e7e-51b5-44f5-b3fb-5b111ce4a9ec	0004-0822	HUMAN PRESCRIPTION DRUG	Tamiflu		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20110321		NDA	NDA021246	Genentech, Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0004-1100_1187214d-f028-4db4-a59c-ab3bb029c46f	0004-1100	HUMAN PRESCRIPTION DRUG	Xeloda		capecitabine	TABLET, FILM COATED	ORAL	19980430		NDA	NDA020896	Genentech, Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0004-1101_1187214d-f028-4db4-a59c-ab3bb029c46f	0004-1101	HUMAN PRESCRIPTION DRUG	Xeloda		capecitabine	TABLET, FILM COATED	ORAL	19980430		NDA	NDA020896	Genentech, Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0005-0100_9eb46fff-908d-433d-bf28-bc896f6a0833	0005-0100	VACCINE	Trumenba		meningococcal group B vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20141105		BLA	BLA125549	Wyeth Pharmaceutical Division of Wyeth Holdings LLC	NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN	60; 60	ug/.5mL; ug/.5mL			N	20241231
0005-1971_c6d01d5e-3968-4485-8eee-e2ffe73bbffe	0005-1971	VACCINE	PREVNAR 13		pneumococcal 13-valent conjugate vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20100312		BLA	BLA125324	Wyeth Pharmaceutical Division of Wyeth Holdings LLC	STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN	2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Conjugate [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0005-2000_48ecccfb-5879-4dc7-8016-551e4e1dfec1	0005-2000	VACCINE	Prevnar 20		Pneumococcal 20-valent Conjugate Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20210810		BLA	BLA125731	Wyeth Pharmaceutical Division of Wyeth Holdings LLC	STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN	2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2; 2.2	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Conjugate [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-0005_18f09198-23e9-48c9-8426-e39828d75ad8	0006-0005	HUMAN PRESCRIPTION DRUG	BELSOMRA		suvorexant	TABLET, FILM COATED	ORAL	20140829		NDA	NDA204569	Merck Sharp & Dohme LLC	SUVOREXANT	5	mg/1	Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]	CIV	N	20241231
0006-0032_18baa032-5219-4c30-a76b-5b2c8e1174c5	0006-0032	HUMAN PRESCRIPTION DRUG	STROMECTOL		ivermectin	TABLET	ORAL	19961122		NDA	NDA050742	Merck Sharp & Dohme LLC	IVERMECTIN	3	mg/1	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
0006-0033_18f09198-23e9-48c9-8426-e39828d75ad8	0006-0033	HUMAN PRESCRIPTION DRUG	BELSOMRA		suvorexant	TABLET, FILM COATED	ORAL	20140829		NDA	NDA204569	Merck Sharp & Dohme LLC	SUVOREXANT	10	mg/1	Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]	CIV	N	20241231
0006-0078_40b87f24-8005-4ee7-b162-94690443fdb0	0006-0078	HUMAN PRESCRIPTION DRUG	JANUMET	XR	sitagliptin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120202		NDA	NDA202270	Merck Sharp & Dohme LLC	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	500; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-0080_40b87f24-8005-4ee7-b162-94690443fdb0	0006-0080	HUMAN PRESCRIPTION DRUG	JANUMET	XR	sitagliptin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120202		NDA	NDA202270	Merck Sharp & Dohme LLC	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	1000; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-0081_40b87f24-8005-4ee7-b162-94690443fdb0	0006-0081	HUMAN PRESCRIPTION DRUG	JANUMET	XR	sitagliptin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120202		NDA	NDA202270	Merck Sharp & Dohme LLC	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	1000; 100	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-0112_6970c5e9-bd40-4847-9321-ab5826b7b7e5	0006-0112	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	Merck Sharp & Dohme LLC	SITAGLIPTIN PHOSPHATE	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-0221_6970c5e9-bd40-4847-9321-ab5826b7b7e5	0006-0221	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	Merck Sharp & Dohme LLC	SITAGLIPTIN PHOSPHATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-0227_6898502e-696b-4ccc-aa35-f00e2f172c39	0006-0227	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, FILM COATED	ORAL	20071012		NDA	NDA022145	Merck Sharp & Dohme LLC	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
0006-0277_6970c5e9-bd40-4847-9321-ab5826b7b7e5	0006-0277	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	Merck Sharp & Dohme LLC	SITAGLIPTIN PHOSPHATE	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-0325_18f09198-23e9-48c9-8426-e39828d75ad8	0006-0325	HUMAN PRESCRIPTION DRUG	BELSOMRA		suvorexant	TABLET, FILM COATED	ORAL	20140829		NDA	NDA204569	Merck Sharp & Dohme LLC	SUVOREXANT	15	mg/1	Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]	CIV	N	20241231
0006-0335_18f09198-23e9-48c9-8426-e39828d75ad8	0006-0335	HUMAN PRESCRIPTION DRUG	BELSOMRA		suvorexant	TABLET, FILM COATED	ORAL	20140829		NDA	NDA204569	Merck Sharp & Dohme LLC	SUVOREXANT	20	mg/1	Cytochrome P450 3A Inhibitors [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]	CIV	N	20241231
0006-0461_40da276a-ade0-4306-a0ad-f812325c4399	0006-0461	HUMAN PRESCRIPTION DRUG	EMEND		aprepitant	CAPSULE	ORAL	20030326		NDA	NDA021549	Merck Sharp & Dohme LLC	APREPITANT	80	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0006-0462_40da276a-ade0-4306-a0ad-f812325c4399	0006-0462	HUMAN PRESCRIPTION DRUG	EMEND		aprepitant	CAPSULE	ORAL	20030326		NDA	NDA021549	Merck Sharp & Dohme LLC	APREPITANT	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0006-0464_40da276a-ade0-4306-a0ad-f812325c4399	0006-0464	HUMAN PRESCRIPTION DRUG	EMEND		aprepitant	CAPSULE	ORAL	20030326		NDA	NDA021549	Merck Sharp & Dohme LLC	APREPITANT	40	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0006-0473_6898502e-696b-4ccc-aa35-f00e2f172c39	0006-0473	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, CHEWABLE	ORAL	20111221		NDA	NDA203045	Merck Sharp & Dohme LLC	RALTEGRAVIR POTASSIUM	25	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
0006-0477_6898502e-696b-4ccc-aa35-f00e2f172c39	0006-0477	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, CHEWABLE	ORAL	20111221		NDA	NDA203045	Merck Sharp & Dohme LLC	RALTEGRAVIR POTASSIUM	100	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
0006-0568_255c6d3a-625e-43a7-ae67-ba5053f6e03f	0006-0568	HUMAN PRESCRIPTION DRUG	ZOLINZA		vorinostat	CAPSULE	ORAL	20061006		NDA	NDA021991	Merck Sharp & Dohme LLC	VORINOSTAT	100	mg/1	Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA]		N	20241231
0006-0575_57ef5ead-02e0-417d-b21f-8e41ff34b53f	0006-0575	HUMAN PRESCRIPTION DRUG	JANUMET		SITAGLIPTIN and METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20070330		NDA	NDA022044	Merck Sharp & Dohme LLC	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	500; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-0577_57ef5ead-02e0-417d-b21f-8e41ff34b53f	0006-0577	HUMAN PRESCRIPTION DRUG	JANUMET		SITAGLIPTIN and METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20070330		NDA	NDA022044	Merck Sharp & Dohme LLC	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	1000; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-3025_10a116c7-454f-42f0-8519-05ae60cc8791	0006-3025	HUMAN PRESCRIPTION DRUG	ZINPLAVA		bezlotoxumab	INJECTION, SOLUTION	INTRAVENOUS	20161021		BLA	BLA761046	Merck Sharp & Dohme LLC	BEZLOTOXUMAB	25	mg/mL			N	20241231
0006-3026_1780018b-86df-4a41-bf1c-2ea84d23621c	0006-3026	HUMAN PRESCRIPTION DRUG	KEYTRUDA		pembrolizumab	INJECTION, SOLUTION	INTRAVENOUS	20150115		BLA	BLA125514	Merck Sharp & Dohme LLC	PEMBROLIZUMAB	25	mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20251231
0006-3061_18eb4ec1-255e-4861-8dfd-747c0a982b49	0006-3061	HUMAN PRESCRIPTION DRUG	EMEND		FOSAPREPITANT DIMEGLUMINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170203		NDA	NDA022023	Merck Sharp & Dohme LLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20251231
0006-3066_40da276a-ade0-4306-a0ad-f812325c4399	0006-3066	HUMAN PRESCRIPTION DRUG	EMEND		aprepitant	POWDER, FOR SUSPENSION	ORAL	20151217		NDA	NDA207865	Merck Sharp & Dohme LLC	APREPITANT	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0006-3069_15d3431d-2abc-4a2a-ab4e-de1c5ed3a95b	0006-3069	HUMAN PRESCRIPTION DRUG	PIFELTRO		doravirine	TABLET, FILM COATED	ORAL	20180720		NDA	NDA210806	Merck Sharp & Dohme LLC	DORAVIRINE	100	mg/1	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0006-3074_194bbac3-2955-4d3f-ae5e-9da852e428fa	0006-3074	HUMAN PRESCRIPTION DRUG	ZEPATIER		elbasvir and grazoprevir	TABLET, FILM COATED	ORAL	20160128		NDA	NDA208261	Merck Sharp & Dohme LLC	ELBASVIR; GRAZOPREVIR ANHYDROUS	50; 100	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC]		N	20241231
0006-3075_21e739f3-f406-4bfe-8363-b8ee526a0a5e	0006-3075	HUMAN PRESCRIPTION DRUG	PREVYMIS		LETERMOVIR	TABLET, FILM COATED	ORAL	20171108		NDA	NDA209939	Merck Sharp & Dohme LLC	LETERMOVIR	240	mg/1	Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]		N	20241231
0006-3076_21e739f3-f406-4bfe-8363-b8ee526a0a5e	0006-3076	HUMAN PRESCRIPTION DRUG	PREVYMIS		LETERMOVIR	TABLET, FILM COATED	ORAL	20171108		NDA	NDA209939	Merck Sharp & Dohme LLC	LETERMOVIR	480	mg/1	Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]		N	20241231
0006-3080_6898502e-696b-4ccc-aa35-f00e2f172c39	0006-3080	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, FILM COATED	ORAL	20170526		NDA	NDA022145	Merck Sharp & Dohme LLC	RALTEGRAVIR POTASSIUM	600	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
0006-3516_32a4728f-dcf2-4008-9c8a-0706d2e1f97b	0006-3516	HUMAN PRESCRIPTION DRUG	PRIMAXIN	IV	imipenem and cilastatin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19851126		NDA	NDA050587	Merck Sharp & Dohme LLC	CILASTATIN SODIUM; IMIPENEM	500; 500	mg/100mL; mg/100mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
0006-3603_6898502e-696b-4ccc-aa35-f00e2f172c39	0006-3603	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	GRANULE, FOR SUSPENSION	ORAL	20131220		NDA	NDA205786	Merck Sharp & Dohme LLC	RALTEGRAVIR POTASSIUM	100	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
0006-3822_39327580-560c-4bab-a6a2-e7f042420e16	0006-3822	HUMAN PRESCRIPTION DRUG	CANCIDAS		CASPOFUNGIN ACETATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010126		NDA	NDA021227	Merck Sharp & Dohme LLC	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0006-3823_39327580-560c-4bab-a6a2-e7f042420e16	0006-3823	HUMAN PRESCRIPTION DRUG	CANCIDAS		CASPOFUNGIN ACETATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010126		NDA	NDA021227	Merck Sharp & Dohme LLC	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0006-3856_8a65f15d-ca70-46ce-b575-7a1b5092a243	0006-3856	HUMAN PRESCRIPTION DRUG	RECARBRIO		imipenem anhydrous, cilastatin, and relebactam anhydrous	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20200106		NDA	NDA212819	Merck Sharp & Dohme LLC	CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS	500; 500; 250	mg/100mL; mg/100mL; mg/100mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0006-3862_40da276a-ade0-4306-a0ad-f812325c4399	0006-3862	HUMAN PRESCRIPTION DRUG	EMEND		aprepitant	KIT		20030326		NDA	NDA021549	Merck Sharp & Dohme LLC						N	20241231
0006-4045_29df93f8-318f-4348-810f-3836352720ee	0006-4045	VACCINE	GARDASIL		Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant	INJECTION, SUSPENSION	INTRAMUSCULAR	20060608		BLA	BLA125126	Merck Sharp & Dohme LLC	HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN	40; 40; 20; 20	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-4047_41789cf7-08b5-43cc-b5ee-5e69ead21e01	0006-4047	VACCINE	RotaTeq		Rotavirus Vaccine, Live, Oral, Pentavalent	SOLUTION	ORAL	20060203		BLA	BLA125122	Merck Sharp & Dohme LLC	HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN	2200000; 2800000; 2200000; 2000000; 2300000	[iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Live Rotavirus Vaccine [EPC], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Rotavirus Vaccines [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS], Vaccines, Live, Unattenuated [CS]		N	20241231
0006-4093_30c061ac-552c-48bc-83fa-95b10e9fc1ee	0006-4093	VACCINE	RECOMBIVAX HB		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR; SUBCUTANEOUS	19860723		BLA	BLA101066	Merck Sharp & Dohme LLC	HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN	5	ug/.5mL	Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4094_30c061ac-552c-48bc-83fa-95b10e9fc1ee	0006-4094	VACCINE	RECOMBIVAX HB		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR; SUBCUTANEOUS	19860723		BLA	BLA101066	Merck Sharp & Dohme LLC	HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN	10	ug/mL	Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4095_261399ed-0541-4663-84c7-fef1bcd0bcf4	0006-4095	VACCINE	VAQTA		hepatitis A vaccine, inactivated	INJECTION, SUSPENSION	INTRAMUSCULAR	19960329		BLA	BLA103606	Merck Sharp & Dohme LLC	HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)	25	[iU]/.5mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4096_261399ed-0541-4663-84c7-fef1bcd0bcf4	0006-4096	VACCINE	VAQTA		hepatitis A vaccine, inactivated	INJECTION, SUSPENSION	INTRAMUSCULAR	19960329		BLA	BLA103606	Merck Sharp & Dohme LLC	HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)	50	[iU]/mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4109_29df93f8-318f-4348-810f-3836352720ee	0006-4109	VACCINE	GARDASIL		Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant	INJECTION, SUSPENSION	INTRAMUSCULAR	20060608		BLA	BLA125126	Merck Sharp & Dohme LLC	HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN	40; 40; 20; 20	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-4119_24b02bdc-d842-4667-93c5-b5ddfac71ab8	0006-4119	VACCINE	GARDASIL 9		Human Papillomavirus 9-valent Vaccine, Recombinant	INJECTION, SUSPENSION	INTRAMUSCULAR	20141210		BLA	BLA125508	Merck Sharp & Dohme LLC	HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN	40; 60; 40; 20; 20; 20; 20; 20; 30	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-4121_24b02bdc-d842-4667-93c5-b5ddfac71ab8	0006-4121	VACCINE	GARDASIL 9		Human Papillomavirus 9-valent Vaccine, Recombinant	INJECTION, SUSPENSION	INTRAMUSCULAR	20141210		BLA	BLA125508	Merck Sharp & Dohme LLC	HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN	40; 60; 40; 20; 20; 20; 20; 20; 30	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-4171_27112acd-05c6-4127-a963-8ed1f32a8bd8	0006-4171	VACCINE	ProQuad		Measles, Mumps, Rubella and Varicella Virus Vaccine Live	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	SUBCUTANEOUS	20150701		BLA	BLA125108	Merck Sharp & Dohme LLC	MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN; VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN	1000; 20000; 1000; 9772	[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL; [PFU]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Chickenpox Vaccine [CS], Herpes Zoster Vaccine [CS], Live Attenuated Herpes Zoster Virus Vaccine [EPC], Live Attenuated Measles Virus Vaccine [EPC], Live Attenuated Mumps Virus Vaccine [EPC], Live Attenuated Rubella Virus Vaccine [EPC], Live Attenuated Varicella Zoster Virus Vaccine [EPC], Measles Vaccine [CS], Mumps Vaccine [CS], Rubella Vaccine [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS]		N	20241231
0006-4175_36729163-fa66-4c6a-8f66-3b8b916e9fc7	0006-4175	VACCINE	STERILE DILUENT		Sterile Water	INJECTION	SUBCUTANEOUS	20230821		BLA	BLA101069	Merck Sharp & Dohme LLC	WATER	.7	mL/.7mL			N	20241231
0006-4293_14d5a05f-f95b-4fa5-af7e-db027a00a128	0006-4293	VACCINE	ERVEBO		ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN	INJECTION, SOLUTION	INTRAMUSCULAR	20191219		BLA	BLA125690	Merck Sharp & Dohme LLC	ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN	72000000	[PFU]/mL			N	20241231
0006-4305_fc8da8a3-76dd-4c0d-a987-236eec11b184	0006-4305	HUMAN PRESCRIPTION DRUG	Renflexis		infliximab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170701		BLA	BLA761054	Merck Sharp & Dohme LLC	INFLIXIMAB	100	mg/1	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
0006-4309_36729163-fa66-4c6a-8f66-3b8b916e9fc7	0006-4309	VACCINE	STERILE DILUENT		Sterile Water	INJECTION	SUBCUTANEOUS	20060525		BLA	BLA125123	Merck Sharp & Dohme LLC	WATER	.7	mL/.7mL			N	20241231
0006-4329_11e0576a-2056-4861-b200-1a0a8f14df1f	0006-4329	VACCINE	VAXNEUVANCE		Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed	INJECTION, SUSPENSION	INTRAMUSCULAR	20210716		BLA	BLA125741	Merck Sharp & Dohme LLC	CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN; STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN	30; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 4; 2; 2	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Conjugate [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-4681_36729163-fa66-4c6a-8f66-3b8b916e9fc7	0006-4681	VACCINE	M-M-R II		measles, mumps, and rubella virus vaccine live	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	SUBCUTANEOUS	19710421		BLA	BLA101069	Merck Sharp & Dohme LLC	MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN	1000; 12500; 1000	[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Attenuated Measles Virus Vaccine [EPC], Live Attenuated Mumps Virus Vaccine [EPC], Live Attenuated Rubella Virus Vaccine [EPC], Measles Vaccine [CS], Mumps Vaccine [CS], Rubella Vaccine [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS]		N	20241231
0006-4827_458c359d-8661-4b7e-8bef-e5a446a0cab6	0006-4827	VACCINE	VARIVAX		Varicella Virus Vaccine Live	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	SUBCUTANEOUS	19950317		BLA	BLA103552	Merck Sharp & Dohme LLC	VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN	1350	[PFU]/.5mL	Actively Acquired Immunity [PE], Chickenpox Vaccine [CS], Herpes Zoster Vaccine [CS], Live Attenuated Herpes Zoster Virus Vaccine [EPC], Live Attenuated Varicella Zoster Virus Vaccine [EPC], Vaccines, Attenuated [CS]		N	20241231
0006-4831_261399ed-0541-4663-84c7-fef1bcd0bcf4	0006-4831	VACCINE	VAQTA		hepatitis A vaccine, inactivated	INJECTION, SUSPENSION	INTRAMUSCULAR	19960329		BLA	BLA103606	Merck Sharp & Dohme LLC	HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)	25	[iU]/.5mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4837_327ad052-4941-44c2-9511-352a39e7834a	0006-4837	VACCINE	PNEUMOVAX 23		pneumococcal vaccine polyvalent	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20140721		BLA	BLA101094	Merck Sharp & Dohme LLC	STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN	25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-4841_261399ed-0541-4663-84c7-fef1bcd0bcf4	0006-4841	VACCINE	VAQTA		hepatitis A vaccine, inactivated	INJECTION, SUSPENSION	INTRAMUSCULAR	19960329		BLA	BLA103606	Merck Sharp & Dohme LLC	HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)	50	[iU]/mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4897_17369496-05fc-4164-9b99-9cf6c034d0ec	0006-4897	VACCINE	PedvaxHIB		Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)	INJECTION, SUSPENSION	INTRAMUSCULAR	19891220		BLA	BLA103237	Merck Sharp & Dohme LLC	HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN	7.5	ug/.5mL	Actively Acquired Immunity [PE], Haemophilus Vaccines [CS], Inactivated Haemophilus Influenzae B Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4943_327ad052-4941-44c2-9511-352a39e7834a	0006-4943	VACCINE	PNEUMOVAX 23		pneumococcal vaccine polyvalent	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	19830707		BLA	BLA101094	Merck Sharp & Dohme LLC	STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN	25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
0006-4981_30c061ac-552c-48bc-83fa-95b10e9fc1ee	0006-4981	VACCINE	RECOMBIVAX HB		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR; SUBCUTANEOUS	19860723		BLA	BLA101066	Merck Sharp & Dohme LLC	HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN	5	ug/.5mL	Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4992_30c061ac-552c-48bc-83fa-95b10e9fc1ee	0006-4992	VACCINE	RECOMBIVAX HB		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR; SUBCUTANEOUS	19860723		BLA	BLA101066	Merck Sharp & Dohme LLC	HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN	40	ug/mL	Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-4995_30c061ac-552c-48bc-83fa-95b10e9fc1ee	0006-4995	VACCINE	RECOMBIVAX HB		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR; SUBCUTANEOUS	19860723		BLA	BLA101066	Merck Sharp & Dohme LLC	HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN	10	ug/mL	Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
0006-5003_21e739f3-f406-4bfe-8363-b8ee526a0a5e	0006-5003	HUMAN PRESCRIPTION DRUG	PREVYMIS		LETERMOVIR	INJECTION, SOLUTION	INTRAVENOUS	20171108		NDA	NDA209940	Merck Sharp & Dohme LLC	LETERMOVIR	20	mg/mL	Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]		N	20241231
0006-5004_21e739f3-f406-4bfe-8363-b8ee526a0a5e	0006-5004	HUMAN PRESCRIPTION DRUG	PREVYMIS		LETERMOVIR	INJECTION, SOLUTION	INTRAVENOUS	20171108		NDA	NDA209940	Merck Sharp & Dohme LLC	LETERMOVIR	20	mg/mL	Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]		N	20241231
0006-5007_159c05bc-4bee-42d5-90a8-70da539ed1b5	0006-5007	HUMAN PRESCRIPTION DRUG	DELSTRIGO		doravirine, lamivudine, and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20180720		NDA	NDA210807	Merck Sharp & Dohme LLC	DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	100; 300; 300	mg/1; mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
0006-5028_9bdc3dc1-e1f4-435b-923a-86ab6d16cf15	0006-5028	HUMAN PRESCRIPTION DRUG	VERQUVO		vericiguat	TABLET, FILM COATED	ORAL	20210201		NDA	NDA214377	Merck Sharp & Dohme LLC	VERICIGUAT	2.5	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
0006-5029_9bdc3dc1-e1f4-435b-923a-86ab6d16cf15	0006-5029	HUMAN PRESCRIPTION DRUG	VERQUVO		vericiguat	TABLET, FILM COATED	ORAL	20210201		NDA	NDA214377	Merck Sharp & Dohme LLC	VERICIGUAT	5	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
0006-5030_9bdc3dc1-e1f4-435b-923a-86ab6d16cf15	0006-5030	HUMAN PRESCRIPTION DRUG	VERQUVO		vericiguat	TABLET, FILM COATED	ORAL	20210201		NDA	NDA214377	Merck Sharp & Dohme LLC	VERICIGUAT	10	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
0006-5055_21fee90e-92bf-464f-a998-e8482bd48ba3	0006-5055	HUMAN PRESCRIPTION DRUG	LAGEVRIO		molnupiravir	CAPSULE	ORAL	20211223		EMERGENCY USE AUTHORIZATION		Merck Sharp & Dohme LLC	MOLNUPIRAVIR	200	mg/1			N	20241231
0006-5331_609c65d7-4bcd-4d2d-bad5-63a38cdd1b16	0006-5331	HUMAN PRESCRIPTION DRUG	WELIREG		belzutifan	TABLET, FILM COATED	ORAL	20210813		NDA	NDA215383	Merck Sharp & Dohme LLC	BELZUTIFAN	40	mg/1	Cytochrome P450 3A4 Inducers [MoA], Hypoxia-inducible Factor 2 alpha Inhibitors [MoA], Hypoxia-inducible Factor Inhibitor [EPC]		N	20251231
0006-5363_14d838b4-511b-4585-aa0f-1d61249b5d04	0006-5363	HUMAN PRESCRIPTION DRUG	STEGLATRO		ertugliflozin	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209803	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE	5	mg/1			N	20241231
0006-5364_14d838b4-511b-4585-aa0f-1d61249b5d04	0006-5364	HUMAN PRESCRIPTION DRUG	STEGLATRO		ertugliflozin	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209803	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE	15	mg/1			N	20241231
0006-5367_21cf231e-a04e-4f5b-82ab-b872482550f9	0006-5367	HUMAN PRESCRIPTION DRUG	STEGLUJAN		ertugliflozin and sitagliptin	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209805	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATE	5; 100	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-5368_21cf231e-a04e-4f5b-82ab-b872482550f9	0006-5368	HUMAN PRESCRIPTION DRUG	STEGLUJAN		ertugliflozin and sitagliptin	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209805	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATE	15; 100	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0006-5369_1712582f-570b-4357-b604-8ebb154b33d6	0006-5369	HUMAN PRESCRIPTION DRUG	SEGLUROMET		ertugliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209806	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0006-5370_1712582f-570b-4357-b604-8ebb154b33d6	0006-5370	HUMAN PRESCRIPTION DRUG	SEGLUROMET		ertugliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209806	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE	7.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0006-5373_1712582f-570b-4357-b604-8ebb154b33d6	0006-5373	HUMAN PRESCRIPTION DRUG	SEGLUROMET		ertugliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209806	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE	2.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0006-5374_1712582f-570b-4357-b604-8ebb154b33d6	0006-5374	HUMAN PRESCRIPTION DRUG	SEGLUROMET		ertugliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209806	Merck Sharp & Dohme LLC	ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE	7.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0006-5423_211ec98d-ff44-4d5a-82a4-cb5c97552fcd	0006-5423	HUMAN PRESCRIPTION DRUG	BRIDION		sugammadex	INJECTION, SOLUTION	INTRAVENOUS	20151215		NDA	NDA022225	Merck Sharp & Dohme LLC	SUGAMMADEX SODIUM	100	mg/mL	gamma-Cyclodextrins [CS]		N	20241231
0006-5424_2465438b-63e4-4879-9031-4608d88ce046	0006-5424	PLASMA DERIVATIVE	ANTIVENIN		Latrodectus mactans	KIT		20141201		BLA	BLA101062	Merck Sharp & Dohme LLC						N	20241231
0006-5425_211ec98d-ff44-4d5a-82a4-cb5c97552fcd	0006-5425	HUMAN PRESCRIPTION DRUG	BRIDION		sugammadex	INJECTION, SOLUTION	INTRAVENOUS	20151215		NDA	NDA022225	Merck Sharp & Dohme LLC	SUGAMMADEX SODIUM	100	mg/mL	gamma-Cyclodextrins [CS]		N	20241231
0007-3383_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761	0007-3383	HUMAN PRESCRIPTION DRUG	COREG	CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20191101	20240731	NDA	NDA022012	GlaxoSmithKline LLC	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	
0007-3385_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761	0007-3385	HUMAN PRESCRIPTION DRUG	COREG	CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20191101	20250131	NDA	NDA022012	GlaxoSmithKline LLC	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	
0007-3387_d03bd95a-f9f1-4f4a-9ea5-bc972ad55761	0007-3387	HUMAN PRESCRIPTION DRUG	COREG	CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20191101	20250131	NDA	NDA022012	GlaxoSmithKline LLC	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	
0008-0100_46f22997-83ff-4ff3-bc6b-263767c792dc	0008-0100	HUMAN PRESCRIPTION DRUG	Besponsa		inotuzumab ozogamicin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170818		BLA	BLA761040	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	INOTUZUMAB OZOGAMICIN	.25	mg/mL	CD22-directed Antibody Interactions [MoA], CD22-directed Immunoconjugate [EPC], Decreased DNA Integrity [PE], Immunoconjugates [CS], Increased Cellular Death [PE]		N	20241231
0008-0423_7a16fb9b-c963-48d9-90f9-b428857ab5de	0008-0423	HUMAN PRESCRIPTION DRUG	North American Coral Snake Antivenin (Equine)		Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20161012		BLA	BLA101099	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)	250	[arb'U]/10mL			N	20241231
0008-0833_b736ba0d-415e-4d3f-bb94-543edc7a7007	0008-0833	HUMAN PRESCRIPTION DRUG	Effexor	XR	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	19971101		NDA	NDA020699	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0008-0836_b736ba0d-415e-4d3f-bb94-543edc7a7007	0008-0836	HUMAN PRESCRIPTION DRUG	Effexor	XR	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	19971101		NDA	NDA020699	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0008-0837_b736ba0d-415e-4d3f-bb94-543edc7a7007	0008-0837	HUMAN PRESCRIPTION DRUG	Effexor	XR	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	19971101		NDA	NDA020699	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0008-0841_515d5149-1442-4534-981e-b6770f2bf6c8	0008-0841	HUMAN PRESCRIPTION DRUG	Protonix	Delayed-Release	PANTOPRAZOLE SODIUM	TABLET, DELAYED RELEASE	ORAL	20000501		NDA	NDA020987	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0008-0843_515d5149-1442-4534-981e-b6770f2bf6c8	0008-0843	HUMAN PRESCRIPTION DRUG	Protonix	Delayed-Release	PANTOPRAZOLE SODIUM	TABLET, DELAYED RELEASE	ORAL	20000501		NDA	NDA020987	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0008-0844_515d5149-1442-4534-981e-b6770f2bf6c8	0008-0844	HUMAN PRESCRIPTION DRUG	Protonix	Delayed-Release	PANTOPRAZOLE SODIUM	GRANULE, DELAYED RELEASE	ORAL	20080229		NDA	NDA022020	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0008-0923_7d32a7f0-6a99-4f79-a57a-92305a85c727	0008-0923	HUMAN PRESCRIPTION DRUG	Protonix	I.V.	PANTOPRAZOLE SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20010501		NDA	NDA020988	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0008-1030_59172404-9534-45d4-90a6-1aa6c42f7898	0008-1030	HUMAN PRESCRIPTION DRUG	Rapamune		SIROLIMUS	SOLUTION	ORAL	19990901		NDA	NDA021083	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	SIROLIMUS	1	mg/mL	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0008-1040_59172404-9534-45d4-90a6-1aa6c42f7898	0008-1040	HUMAN PRESCRIPTION DRUG	Rapamune		SIROLIMUS	TABLET, SUGAR COATED	ORAL	20100301		NDA	NDA021110	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	SIROLIMUS	.5	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0008-1041_59172404-9534-45d4-90a6-1aa6c42f7898	0008-1041	HUMAN PRESCRIPTION DRUG	Rapamune		SIROLIMUS	TABLET, SUGAR COATED	ORAL	20010701		NDA	NDA021110	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0008-1042_59172404-9534-45d4-90a6-1aa6c42f7898	0008-1042	HUMAN PRESCRIPTION DRUG	Rapamune		SIROLIMUS	TABLET, SUGAR COATED	ORAL	20010701		NDA	NDA021110	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0008-1123_4446d2d6-3c89-4815-af03-bebcd1237cbd	0008-1123	HUMAN PRESCRIPTION DRUG	Duavee		conjugated estrogens/bazedoxifene	TABLET, FILM COATED	ORAL	20131003		NDA	NDA022247	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED	20; .45	mg/1; mg/1	Estrogen Agonist/Antagonist [EPC], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0008-1179_4d977232-9274-48a3-b947-59afee770514	0008-1179	HUMAN PRESCRIPTION DRUG	Torisel		temsirolimus	KIT		20070701		NDA	NDA022088	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.						N	20241231
0008-1210_2d58c489-3d71-4a13-8ef1-dc80788feec9	0008-1210	HUMAN PRESCRIPTION DRUG	Pristiq	Extended-Release	desvenlafaxine succinate	TABLET, EXTENDED RELEASE	ORAL	20150401		NDA	NDA021992	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0008-1211_2d58c489-3d71-4a13-8ef1-dc80788feec9	0008-1211	HUMAN PRESCRIPTION DRUG	Pristiq	Extended-Release	desvenlafaxine succinate	TABLET, EXTENDED RELEASE	ORAL	20080501		NDA	NDA021992	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0008-1222_2d58c489-3d71-4a13-8ef1-dc80788feec9	0008-1222	HUMAN PRESCRIPTION DRUG	Pristiq	Extended-Release	desvenlafaxine succinate	TABLET, EXTENDED RELEASE	ORAL	20080501		NDA	NDA021992	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0008-4001_4f8dcfd7-45c6-4afe-b9a5-72bc92cac60b	0008-4001	HUMAN PRESCRIPTION DRUG	Protonix	I.V.	PANTOPRAZOLE SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20130501		NDA	NDA020988	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0008-4117_a6bd660e-10be-47ff-9538-6e7752799214	0008-4117	HUMAN PRESCRIPTION DRUG	Trecator		ethionamide	TABLET, FILM COATED	ORAL	20041108		NDA	NDA013026	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ETHIONAMIDE	250	mg/1	Antimycobacterial [EPC]		N	20241231
0008-4510_8323fbb8-fc24-472f-b6a7-c9bd0af1acee	0008-4510	HUMAN PRESCRIPTION DRUG	Mylotarg		gemtuzumab ozogamicin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170907		BLA	BLA761060	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	GEMTUZUMAB OZOGAMICIN	5	mg/5mL	CD33-directed Antibody Interactions [MoA], CD33-directed Immunoconjugate [EPC]		N	20241231
0008-4990_a7bb7b27-e0f1-4be5-98f8-e20bd125cfaa	0008-4990	HUMAN PRESCRIPTION DRUG	Tygacil		TIGECYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20080615		NDA	NDA021821	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	TIGECYCLINE	50	mg/5mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
0008-4994_6f8f7843-f620-4077-b0be-929d04d22884	0008-4994	HUMAN PRESCRIPTION DRUG	Tygacil		TIGECYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170208		NDA	NDA021821	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	TIGECYCLINE	50	mg/5mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
0009-0003_33bc6e1d-ee99-4ba0-bfe5-e06ecdb2884b	0009-0003	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	500	mg/4mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0005_19af0443-b5c0-45bf-be08-1a5c06fd89f0	0009-0005	HUMAN PRESCRIPTION DRUG	Solu-Cortef		hydrocortisone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19550427		NDA	NDA009866	Pharmacia & Upjohn Company LLC	HYDROCORTISONE SODIUM SUCCINATE	1000	mg/8mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0011_19af0443-b5c0-45bf-be08-1a5c06fd89f0	0009-0011	HUMAN PRESCRIPTION DRUG	Solu-Cortef		hydrocortisone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19550427		NDA	NDA009866	Pharmacia & Upjohn Company LLC	HYDROCORTISONE SODIUM SUCCINATE	100	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0012_55b4fcf7-2ed5-4edc-8111-7d52eb200f95	0009-0012	HUMAN PRESCRIPTION DRUG	CORTEF		hydrocortisone	TABLET	ORAL	19521215		NDA	NDA008697	Pharmacia & Upjohn Company LLC	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0013_19af0443-b5c0-45bf-be08-1a5c06fd89f0	0009-0013	HUMAN PRESCRIPTION DRUG	Solu-Cortef		hydrocortisone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19550427		NDA	NDA009866	Pharmacia & Upjohn Company LLC	HYDROCORTISONE SODIUM SUCCINATE	250	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0016_19af0443-b5c0-45bf-be08-1a5c06fd89f0	0009-0016	HUMAN PRESCRIPTION DRUG	Solu-Cortef		hydrocortisone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19550427		NDA	NDA009866	Pharmacia & Upjohn Company LLC	HYDROCORTISONE SODIUM SUCCINATE	500	mg/4mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0017_95a061ce-50dd-4414-937e-87fcdd8a0edd	0009-0017	HUMAN PRESCRIPTION DRUG	Halcion		triazolam	TABLET	ORAL	19821115		NDA	NDA017892	Pharmacia & Upjohn Company LLC	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0018_33bc6e1d-ee99-4ba0-bfe5-e06ecdb2884b	0009-0018	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	1	g/8mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0020_9f1ff5b5-f68d-43cf-af32-3e0db5ec3eba	0009-0020	HUMAN PRESCRIPTION DRUG	Medrol		methylprednisolone	TABLET	ORAL	20130920		NDA	NDA011153	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0022_9f1ff5b5-f68d-43cf-af32-3e0db5ec3eba	0009-0022	HUMAN PRESCRIPTION DRUG	Medrol		methylprednisolone	TABLET	ORAL	19571024		NDA	NDA011153	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE	8	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0029_55e7b060-7007-45ce-8f09-d56b0bcc365e	0009-0029	HUMAN PRESCRIPTION DRUG	Xanax		alprazolam	TABLET	ORAL	19811016		NDA	NDA018276	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0031_55b4fcf7-2ed5-4edc-8111-7d52eb200f95	0009-0031	HUMAN PRESCRIPTION DRUG	CORTEF		hydrocortisone	TABLET	ORAL	19521215		NDA	NDA008697	Pharmacia & Upjohn Company LLC	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0039_33bc6e1d-ee99-4ba0-bfe5-e06ecdb2884b	0009-0039	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0039_411c816c-a44b-4366-bfb1-b89fd9c6cbdd	0009-0039	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0009-0044_55b4fcf7-2ed5-4edc-8111-7d52eb200f95	0009-0044	HUMAN PRESCRIPTION DRUG	CORTEF		hydrocortisone	TABLET	ORAL	19521215		NDA	NDA008697	Pharmacia & Upjohn Company LLC	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0047_33bc6e1d-ee99-4ba0-bfe5-e06ecdb2884b	0009-0047	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0047_411c816c-a44b-4366-bfb1-b89fd9c6cbdd	0009-0047	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0009-0051_c2de256d-0907-4f1d-8d42-2af51c241b71	0009-0051	HUMAN PRESCRIPTION DRUG	Provera		medroxyprogesterone acetate	TABLET	ORAL	20200720		NDA	NDA011839	Pharmacia and Upjohn Company	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0009-0055_55e7b060-7007-45ce-8f09-d56b0bcc365e	0009-0055	HUMAN PRESCRIPTION DRUG	Xanax		alprazolam	TABLET	ORAL	19811016		NDA	NDA018276	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0056_9f1ff5b5-f68d-43cf-af32-3e0db5ec3eba	0009-0056	HUMAN PRESCRIPTION DRUG	Medrol		methylprednisolone	TABLET	ORAL	19571024		NDA	NDA011153	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0057_07e7906e-b82b-4a85-9f41-b014864a6931	0009-0057	HUMAN PRESCRIPTION DRUG	Xanax	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA	NDA021434	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0059_07e7906e-b82b-4a85-9f41-b014864a6931	0009-0059	HUMAN PRESCRIPTION DRUG	Xanax	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA	NDA021434	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0065_c2de256d-0907-4f1d-8d42-2af51c241b71	0009-0065	HUMAN PRESCRIPTION DRUG	Provera		medroxyprogesterone acetate	TABLET	ORAL	20190903		NDA	NDA011839	Pharmacia and Upjohn Company	MEDROXYPROGESTERONE ACETATE	2.5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0009-0066_07e7906e-b82b-4a85-9f41-b014864a6931	0009-0066	HUMAN PRESCRIPTION DRUG	Xanax	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA	NDA021434	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0068_07e7906e-b82b-4a85-9f41-b014864a6931	0009-0068	HUMAN PRESCRIPTION DRUG	Xanax	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA	NDA021434	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	3	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0073_9f1ff5b5-f68d-43cf-af32-3e0db5ec3eba	0009-0073	HUMAN PRESCRIPTION DRUG	Medrol		methylprednisolone	TABLET	ORAL	19571024		NDA	NDA011153	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE	16	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0085_304a4928-e4fe-44ab-8219-81967dfe77e8	0009-0085	HUMAN PRESCRIPTION DRUG	Depo-Testosterone		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20140701		ANDA	ANDA085635	Pharmacia and Upjohn Company LLC	TESTOSTERONE CYPIONATE	100	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0009-0086_304a4928-e4fe-44ab-8219-81967dfe77e8	0009-0086	HUMAN PRESCRIPTION DRUG	Depo-Testosterone		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20140701		ANDA	ANDA085635	Pharmacia and Upjohn Company LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0009-0090_55e7b060-7007-45ce-8f09-d56b0bcc365e	0009-0090	HUMAN PRESCRIPTION DRUG	Xanax		alprazolam	TABLET	ORAL	19811016		NDA	NDA018276	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0094_55e7b060-7007-45ce-8f09-d56b0bcc365e	0009-0094	HUMAN PRESCRIPTION DRUG	Xanax		alprazolam	TABLET	ORAL	19811016		NDA	NDA018276	PHARMACIA & UPJOHN COMPANY LLC	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0009-0107_fb3f510e-c1a6-40b9-9543-e10bf7142065	0009-0107	HUMAN PRESCRIPTION DRUG	Lincocin		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20230418		NDA	NDA050317	Pharmacia & Upjohn Company LLC	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
0009-0215_68b1c5b9-b121-4cbc-8232-80f6f8b41e24	0009-0215	HUMAN PRESCRIPTION DRUG	PROSTIN	VR PEDIATRIC	alprostadil	INJECTION, SOLUTION	INTRAVASCULAR; INTRAVENOUS	20221003		NDA	NDA018484	Pharmacia & Upjohn Company LLC	ALPROSTADIL	500	ug/mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0009-0225_fe7c5eb1-3812-4765-8d6a-ec48ef3cd6b8	0009-0225	HUMAN PRESCRIPTION DRUG	Cleocin Hydrochloride		clindamycin hydrochloride	CAPSULE	ORAL	19700522		NDA	NDA050162	Pharmacia & Upjohn Company LLC	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-0260_ffbca6d0-651c-4eea-b69d-cdb250ee8d11	0009-0260	HUMAN PRESCRIPTION DRUG	Colestid		Colestipol Hydrochloride	GRANULE, FOR SUSPENSION	ORAL	19770601		NDA	NDA017563	Pharmacia & Upjohn Company LLC	COLESTIPOL HYDROCHLORIDE	5	g/5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0009-0271_5d5c29d1-9e18-4447-b158-dbc85490d29e	0009-0271	HUMAN PRESCRIPTION DRUG	Depo-Estradiol		estradiol cypionate	INJECTION	INTRAMUSCULAR	19790815		ANDA	ANDA085470	Pharmacia & Upjohn Company LLC	ESTRADIOL CYPIONATE	5	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0009-0274_608dc02f-aaf7-4777-be1d-46e24640021b	0009-0274	HUMAN PRESCRIPTION DRUG	Depo-Medrol		methylprednisolone acetate	INJECTION, SUSPENSION	INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	19590528		NDA	NDA011757	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE ACETATE	20	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0280_608dc02f-aaf7-4777-be1d-46e24640021b	0009-0280	HUMAN PRESCRIPTION DRUG	Depo-Medrol		methylprednisolone acetate	INJECTION, SUSPENSION	INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	19590528		NDA	NDA011757	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0286_c2de256d-0907-4f1d-8d42-2af51c241b71	0009-0286	HUMAN PRESCRIPTION DRUG	Provera		medroxyprogesterone acetate	TABLET	ORAL	19591201		NDA	NDA011839	Pharmacia and Upjohn Company	MEDROXYPROGESTERONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0009-0287_c2de256d-0907-4f1d-8d42-2af51c241b71	0009-0287	HUMAN PRESCRIPTION DRUG	Provera		medroxyprogesterone acetate	TABLET	ORAL	20181111		NDA	NDA011839	Pharmacia and Upjohn Company	MEDROXYPROGESTERONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0009-0306_608dc02f-aaf7-4777-be1d-46e24640021b	0009-0306	HUMAN PRESCRIPTION DRUG	Depo-Medrol		methylprednisolone acetate	INJECTION, SUSPENSION	INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	19590528		NDA	NDA011757	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0331_fe7c5eb1-3812-4765-8d6a-ec48ef3cd6b8	0009-0331	HUMAN PRESCRIPTION DRUG	Cleocin Hydrochloride		clindamycin hydrochloride	CAPSULE	ORAL	19700522		NDA	NDA050162	Pharmacia & Upjohn Company LLC	CLINDAMYCIN HYDROCHLORIDE	75	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-0347_98a2bd0b-76c9-4b4b-98ac-8743261b36b9	0009-0347	HUMAN PRESCRIPTION DRUG	Depo-Testosterone		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	19790725		ANDA	ANDA085635	Pharmacia & Upjohn Company LLC	TESTOSTERONE CYPIONATE	100	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
0009-0352_801180f1-adee-405e-a466-ee2052fcffd0	0009-0352	HUMAN PRESCRIPTION DRUG	Glynase		glyburide	TABLET	ORAL	19920304		NDA	NDA020051	Pharmacia & Upjohn Company LLC	GLYBURIDE	3	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0009-0370_ffbca6d0-651c-4eea-b69d-cdb250ee8d11	0009-0370	HUMAN PRESCRIPTION DRUG	Flavored Colestid		Colestipol Hydrochloride	GRANULE, FOR SUSPENSION	ORAL	19770601	20240430	NDA	NDA017563	Pharmacia & Upjohn Company LLC	COLESTIPOL HYDROCHLORIDE	5	g/7.5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	
0009-0395_fe7c5eb1-3812-4765-8d6a-ec48ef3cd6b8	0009-0395	HUMAN PRESCRIPTION DRUG	Cleocin Hydrochloride		clindamycin hydrochloride	CAPSULE	ORAL	19700522		NDA	NDA050162	Pharmacia & Upjohn Company LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-0417_98a2bd0b-76c9-4b4b-98ac-8743261b36b9	0009-0417	HUMAN PRESCRIPTION DRUG	Depo-Testosterone		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	19790725		ANDA	ANDA085635	Pharmacia & Upjohn Company LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
0009-0436_d4303b5a-5737-44bd-bd90-af3978cac73e	0009-0436	HUMAN PRESCRIPTION DRUG	R-Gene		Arginine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19760615		NDA	NDA016931	Pharmacia & Upjohn Company LLC	ARGININE HYDROCHLORIDE	10	g/100mL			N	20241231
0009-0450_69acf84f-8be2-484a-9c08-f0eb2f15f262	0009-0450	HUMAN PRESCRIPTION DRUG	Colestid		Colestipol Hydrochloride	TABLET	ORAL	19940719		NDA	NDA020222	Pharmacia & Upjohn Company LLC	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0009-0555_fb3f510e-c1a6-40b9-9543-e10bf7142065	0009-0555	HUMAN PRESCRIPTION DRUG	Lincocin		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	19641229		NDA	NDA050317	Pharmacia & Upjohn Company LLC	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
0009-0698_33bc6e1d-ee99-4ba0-bfe5-e06ecdb2884b	0009-0698	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	1	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0698_411c816c-a44b-4366-bfb1-b89fd9c6cbdd	0009-0698	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	1	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0009-0728_e1cef283-1e43-40ae-b892-093b539c3bf4	0009-0728	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19721002		NDA	NDA050441	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-0746_8088c906-ead8-4afb-965a-599ff3ae1919	0009-0746	HUMAN PRESCRIPTION DRUG	Depo-Provera		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	19921029		NDA	NDA020246	Pharmacia & Upjohn Company LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0009-0758_33bc6e1d-ee99-4ba0-bfe5-e06ecdb2884b	0009-0758	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	500	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0760_a8c91741-5b2f-4a9b-a8ad-b49a04b32747	0009-0760	HUMAN PRESCRIPTION DRUG	Cleocin Pediatric		clindamycin palmitate hydrochloride	GRANULE, FOR SOLUTION	ORAL	19860417		ANDA	ANDA062644	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-0775_e1cef283-1e43-40ae-b892-093b539c3bf4	0009-0775	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19721002		NDA	NDA050441	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-0825_19af0443-b5c0-45bf-be08-1a5c06fd89f0	0009-0825	HUMAN PRESCRIPTION DRUG	Solu-Cortef		hydrocortisone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19550427		NDA	NDA009866	Pharmacia & Upjohn Company LLC	HYDROCORTISONE SODIUM SUCCINATE	100	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0850_33bc6e1d-ee99-4ba0-bfe5-e06ecdb2884b	0009-0850	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	2	g/30.6mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-0856_244be587-b9ec-4072-8a6c-e1ed1165acc7	0009-0856	HUMAN PRESCRIPTION DRUG	Hemabate		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	19790109		NDA	NDA017989	Pharmacia & Upjohn Company LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0009-0870_e1cef283-1e43-40ae-b892-093b539c3bf4	0009-0870	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19721002		NDA	NDA050441	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-0902_e1cef283-1e43-40ae-b892-093b539c3bf4	0009-0902	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19721002		NDA	NDA050441	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-3051_92e62bb5-3fa1-4d85-a8dc-882c0d115f6d	0009-3051	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191118		NDA	NDA050441	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-3073_14b68a61-7d37-435d-8379-cc86b8d8f22d	0009-3073	HUMAN PRESCRIPTION DRUG	Depo-Medrol		methylprednisolone acetate	INJECTION, SUSPENSION	INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	19590528		NDA	NDA011757	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0009-3073_3b4b3a02-2c1f-4a34-82b3-da8f49c48637	0009-3073	HUMAN PRESCRIPTION DRUG	Depo-Medrol		methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	19590528		NDA	NDA011757	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-3169_b352eb18-5983-473a-a627-0271ef2ba4cf	0009-3169	HUMAN PRESCRIPTION DRUG	PROSTIN	VR PEDIATRIC	alprostadil	INJECTION, SOLUTION	INTRAVASCULAR; INTRAVENOUS	19811016		NDA	NDA018484	Pharmacia and Upjohn Company LLC	ALPROSTADIL	500	ug/mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0009-3329_ace3af2a-85d9-410f-8d4e-19f190b1e2ec	0009-3329	HUMAN PRESCRIPTION DRUG	Cleocin T		clindamycin phosphate	LOTION	TOPICAL	19890531		NDA	NDA050600	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-3359_b3ab31df-3b44-45f1-ae08-73542f13cd68	0009-3359	HUMAN PRESCRIPTION DRUG	Prepidil		dinoprostone	GEL	VAGINAL	19921209		NDA	NDA019617	Pharmacia and Upjohn Company LLC	DINOPROSTONE	.5	mg/3g	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0009-3448_4d9b3edd-e1d8-4007-ab69-c1411f489432	0009-3448	HUMAN PRESCRIPTION DRUG	Cleocin		clindamycin phosphate	CREAM	VAGINAL	19920811		NDA	NDA050680	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	20	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-3475_3b4b3a02-2c1f-4a34-82b3-da8f49c48637	0009-3475	HUMAN PRESCRIPTION DRUG	Depo-Medrol		methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	19590528		NDA	NDA011757	Pharmacia & Upjohn Company LLC	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0009-3701_b9809b81-2598-454c-9676-8d822786ce15	0009-3701	HUMAN PRESCRIPTION DRUG	Caverject		Alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	19950706		NDA	NDA020379	Pharmacia & Upjohn Company LLC	ALPROSTADIL	20.5	ug/mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0009-3794_b937121d-97e0-4581-8b38-c5c955dd3e44	0009-3794	HUMAN PRESCRIPTION DRUG	Corvert		ibutilide fumarate	INJECTION, SOLUTION	INTRAVENOUS	19951228		NDA	NDA020491	Pharmacia & Upjohn Company LLC	IBUTILIDE FUMARATE	.1	mg/mL	Antiarrhythmic [EPC]		N	20241231
0009-3794_ddf19050-1987-4589-ab01-2c4b00ad61bf	0009-3794	HUMAN PRESCRIPTION DRUG	Corvert		ibutilide fumarate	INJECTION, SOLUTION	INTRAVENOUS	19951228		NDA	NDA020491	Pharmacia & Upjohn Company LLC	IBUTILIDE FUMARATE	.1	mg/mL	Antiarrhythmic [EPC]		N	20241231
0009-4073_92e62bb5-3fa1-4d85-a8dc-882c0d115f6d	0009-4073	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191118		NDA	NDA050441	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-4541_bf08d786-0e54-423f-9e98-f7bbe89a27ab	0009-4541	HUMAN PRESCRIPTION DRUG	Detrol		tolterodine tartrate	TABLET, FILM COATED	ORAL	19980325		NDA	NDA020771	PHARMACIA & UPJOHN COMPANY LLC	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0009-4544_bf08d786-0e54-423f-9e98-f7bbe89a27ab	0009-4544	HUMAN PRESCRIPTION DRUG	Detrol		tolterodine tartrate	TABLET, FILM COATED	ORAL	19980325		NDA	NDA020771	PHARMACIA & UPJOHN COMPANY LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0009-4709_537374db-8865-4583-88b6-84d22b05736d	0009-4709	HUMAN PRESCRIPTION DRUG	Depo-SubQ Provera		medroxyprogesterone acetate	INJECTION, SUSPENSION	SUBCUTANEOUS	20050502		NDA	NDA021583	Pharmacia & Upjohn Company LLC	MEDROXYPROGESTERONE ACETATE	104	mg/.65mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0009-4992_dfe0cf93-a761-452d-878c-9203bd246ab9	0009-4992	HUMAN PRESCRIPTION DRUG	Zyvox		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20150706		NDA	NDA021131	Pharmacia & Upjohn Company LLC	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0009-5091_27ab0561-e4f8-4db3-b1c5-dc22ccfdc5c6	0009-5091	HUMAN PRESCRIPTION DRUG	Ellence		epirubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19990915		NDA	NDA050778	Pharmacia & Upjohn Company LLC	EPIRUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0009-5093_27ab0561-e4f8-4db3-b1c5-dc22ccfdc5c6	0009-5093	HUMAN PRESCRIPTION DRUG	Ellence		epirubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19990915		NDA	NDA050778	Pharmacia & Upjohn Company LLC	EPIRUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0009-5095_92e62bb5-3fa1-4d85-a8dc-882c0d115f6d	0009-5095	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191118		NDA	NDA050441	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-5136_9d42f2ad-3492-45c7-98b8-d4e2ffec1e37	0009-5136	HUMAN PRESCRIPTION DRUG	Zyvox		linezolid	GRANULE, FOR SUSPENSION	ORAL	20000418		NDA	NDA021132	Pharmacia & Upjohn Company LLC	LINEZOLID	100	mg/5mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0009-5137_9d42f2ad-3492-45c7-98b8-d4e2ffec1e37	0009-5137	HUMAN PRESCRIPTION DRUG	Zyvox		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20000418		NDA	NDA021131	Pharmacia & Upjohn Company LLC	LINEZOLID	200	mg/100mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0009-5138_9d42f2ad-3492-45c7-98b8-d4e2ffec1e37	0009-5138	HUMAN PRESCRIPTION DRUG	Zyvox		linezolid	TABLET, FILM COATED	ORAL	20151012		NDA	NDA021130	Pharmacia & Upjohn Company LLC	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0009-5140_9d42f2ad-3492-45c7-98b8-d4e2ffec1e37	0009-5140	HUMAN PRESCRIPTION DRUG	Zyvox		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20000418		NDA	NDA021131	Pharmacia & Upjohn Company LLC	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0009-5181_e8453e6e-3089-4f34-9834-9683179276cb	0009-5181	HUMAN PRESCRIPTION DRUG	Caverject Impulse		Alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	20020611		NDA	NDA021212	Pharmacia & Upjohn Company LLC	ALPROSTADIL	10	ug/.5mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0009-5182_e8453e6e-3089-4f34-9834-9683179276cb	0009-5182	HUMAN PRESCRIPTION DRUG	Caverject Impulse		Alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	20020611		NDA	NDA021212	Pharmacia & Upjohn Company LLC	ALPROSTADIL	20	ug/.5mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0009-5190_59d526b1-16f4-41b8-84da-5843d66551d6	0009-5190	HUMAN PRESCRIPTION DRUG	Detrol LA		tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20000222	20241231	NDA	NDA021228	Pharmacia and Upjohn Company LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
0009-5191_59d526b1-16f4-41b8-84da-5843d66551d6	0009-5191	HUMAN PRESCRIPTION DRUG	Detrol LA		tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20000222		NDA	NDA021228	Pharmacia and Upjohn Company LLC	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
0009-5400_00c25938-fb91-4e66-ac58-11b6e10d6d3a	0009-5400	HUMAN PRESCRIPTION DRUG	Nicotrol		nicotine	INHALANT	RESPIRATORY (INHALATION)	19970502		NDA	NDA020714	Pharmacia & Upjohn Company LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0009-5401_81c50c19-8c24-4258-9a63-7b01f42e7ff6	0009-5401	HUMAN PRESCRIPTION DRUG	Nicotrol		nicotine	SPRAY, METERED	NASAL	19960522		NDA	NDA020385	Pharmacia & Upjohn Company LLC	NICOTINE	10	mg/mL	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0009-7224_9c95f217-8fd9-45d6-bccf-46821cad14fa	0009-7224	PLASMA DERIVATIVE	Atgam		EQUINE THYMOCYTE IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAVENOUS	19811117		BLA	BLA103676	Pharmacia & Upjohn Company LLC	EQUINE THYMOCYTE IMMUNE GLOBULIN	50	mg/mL	Antibody-Surface Protein Interactions [MoA], Immunoglobulin G [EPC], Immunoglobulins [CS], Increased T Lymphocyte Destruction [PE], Lymphocyte Function Alteration [PE]		N	20241231
0009-7376_8088c906-ead8-4afb-965a-599ff3ae1919	0009-7376	HUMAN PRESCRIPTION DRUG	Depo-Provera		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	19921029		NDA	NDA020246	Pharmacia & Upjohn Company LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0009-7529_ece2f47a-8151-4f84-80ec-16cc3a7dec6a	0009-7529	HUMAN PRESCRIPTION DRUG	Camptosar		irinotecan hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960614		NDA	NDA020571	Pharmacia & Upjohn Company LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0009-7663_7e993740-efd8-4635-aed7-b535b6bbe092	0009-7663	HUMAN PRESCRIPTION DRUG	Aromasin		exemestane	TABLET	ORAL	19991021		NDA	NDA020753	Pharmacia & Upjohn Company LLC	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
0009-7667_2f2c2547-3d8d-4904-b155-23eff23b7ce9	0009-7667	HUMAN PRESCRIPTION DRUG	Cleocin		clindamycin phosphate	SUPPOSITORY	VAGINAL	19990813		NDA	NDA050767	Pharmacia & Upjohn Company LLC	CLINDAMYCIN PHOSPHATE	100	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0009-7686_b9809b81-2598-454c-9676-8d822786ce15	0009-7686	HUMAN PRESCRIPTION DRUG	Caverject		Alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	19950706		NDA	NDA020379	Pharmacia & Upjohn Company LLC	ALPROSTADIL	41.1	ug/mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0009-7807_c493bdb7-af56-4df8-8d5f-c755afca984b	0009-7807	HUMAN PRESCRIPTION DRUG	Zyvox		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20150218		NDA	NDA021131	Pharmacia & Upjohn Company LLC	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0013-0101_66df1e05-ac72-4c81-9ec8-281ca9fae8c5	0013-0101	HUMAN PRESCRIPTION DRUG	Azulfidine		Sulfasalazine	TABLET	ORAL	19500620		NDA	NDA007073	Pfizer Laboratories Div Pfizer Inc	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0013-0102_8da70297-7d35-4c91-85b2-cf938a8bb98f	0013-0102	HUMAN PRESCRIPTION DRUG	Azulfidine	EN-tabs	Sulfasalazine	TABLET, DELAYED RELEASE	ORAL	19500620		NDA	NDA007073	Pfizer Laboratories Div Pfizer Inc	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0013-0132_c92bfd1e-e378-4983-9597-21c0b4e8473a	0013-0132	HUMAN PRESCRIPTION DRUG	Emcyt		estramustine phosphate sodium	CAPSULE	ORAL	19920101		NDA	NDA018045	Pfizer Laboratories Div Pfizer Inc	ESTRAMUSTINE PHOSPHATE SODIUM	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC], Estradiol [CS], Nitrogen Mustard Compounds [CS]		N	20241231
0013-1042_95fcdfc7-e329-4b40-bb78-3230719dc2f8	0013-1042	HUMAN PRESCRIPTION DRUG	Estring		estradiol	SYSTEM	VAGINAL	20230605		NDA	NDA020472	Pfizer Laboratories Div Pfizer Inc	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0013-1114_6203322e-0dd7-4d18-be4a-4501357b0a5f	0013-1114	HUMAN PRESCRIPTION DRUG	Cyklokapron		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	19861230		NDA	NDA019281	Pfizer Laboratories Div Pfizer Inc	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20251231
0013-2150_ec0d8d00-c87b-483a-8c28-e97d46cf821b	0013-2150	HUMAN PRESCRIPTION DRUG	Estring		estradiol	RING	VAGINAL	19960426	20241231	NDA	NDA020472	Pfizer Laboratories Div Pfizer Inc	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	
0013-2576_25de0c4d-09a1-45b6-b829-ea608205dd0b	0013-2576	HUMAN PRESCRIPTION DRUG	Idamycin PFS		idarubicin hydrochloride	SOLUTION	INTRAVENOUS	19970217		NDA	NDA050734	Pfizer Laboratories Div Pfizer Inc	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20251231
0013-2586_25de0c4d-09a1-45b6-b829-ea608205dd0b	0013-2586	HUMAN PRESCRIPTION DRUG	Idamycin PFS		idarubicin hydrochloride	SOLUTION	INTRAVENOUS	19970217		NDA	NDA050734	Pfizer Laboratories Div Pfizer Inc	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20251231
0013-2596_25de0c4d-09a1-45b6-b829-ea608205dd0b	0013-2596	HUMAN PRESCRIPTION DRUG	Idamycin PFS		idarubicin hydrochloride	SOLUTION	INTRAVENOUS	19970217		NDA	NDA050734	Pfizer Laboratories Div Pfizer Inc	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20251231
0013-2626_eb199832-06a0-471f-af37-d279182b9807	0013-2626	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2646_eb199832-06a0-471f-af37-d279182b9807	0013-2646	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2649_eb199832-06a0-471f-af37-d279182b9807	0013-2649	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2650_eb199832-06a0-471f-af37-d279182b9807	0013-2650	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2651_eb199832-06a0-471f-af37-d279182b9807	0013-2651	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2652_eb199832-06a0-471f-af37-d279182b9807	0013-2652	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2653_eb199832-06a0-471f-af37-d279182b9807	0013-2653	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2654_eb199832-06a0-471f-af37-d279182b9807	0013-2654	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2655_eb199832-06a0-471f-af37-d279182b9807	0013-2655	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2656_eb199832-06a0-471f-af37-d279182b9807	0013-2656	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2657_eb199832-06a0-471f-af37-d279182b9807	0013-2657	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-2658_eb199832-06a0-471f-af37-d279182b9807	0013-2658	HUMAN PRESCRIPTION DRUG	GENOTROPIN		somatropin	KIT		19951220		BLA	BLA020280	Pfizer Laboratories Div Pfizer Inc						N	20241231
0013-5301_47f0a676-c541-4d24-8710-bef6180556e3	0013-5301	HUMAN PRESCRIPTION DRUG	Mycobutin		rifabutin	CAPSULE	ORAL	19921223		NDA	NDA050689	Pfizer Laboratories Div Pfizer Inc	RIFABUTIN	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
0013-8303_5d44a392-517e-44a8-99b2-c54db48bb63d	0013-8303	HUMAN PRESCRIPTION DRUG	Xalatan		latanoprost	SOLUTION	OPHTHALMIC	19950320		NDA	NDA020597	PFIZER LABORATORIES DIV PFIZER INC	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0019-0862_ff628e06-2cb5-4714-a741-1dec04bd5602	0019-0862	HUMAN PRESCRIPTION DRUG	Cysto-Conray II		Iothalamate meglumine	INJECTION	URETERAL	20101008		NDA	NDA017057	Liebel-Flarsheim Company LLC	IOTHALAMATE MEGLUMINE	172	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-0953_0ad12048-60f9-474e-b488-cb152456977f	0019-0953	HUMAN PRESCRIPTION DRUG	Conray		iothalamate meglumine	INJECTION	INTRAVASCULAR	20031014		NDA	NDA013295	Liebel-Flarsheim Company LLC	IOTHALAMATE MEGLUMINE	600	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1188_cdff7813-7b00-4f61-a017-18ab8910d49d	0019-1188	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION	INTRAVASCULAR	20120901		NDA	NDA021569	Liebel-Flarsheim Company LLC	SODIUM CHLORIDE	.9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0019-1323_1884aaeb-c174-4df7-a710-82d2b1869ad2	0019-1323	HUMAN PRESCRIPTION DRUG	Optiray	320	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20120304		NDA	NDA019710	Liebel-Flarsheim Company LLC	IOVERSOL	678	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1323_9861a367-76f0-4e91-8dcf-ffc30b35d276	0019-1323	HUMAN PRESCRIPTION DRUG	Optiray	320	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20201118		NDA	NDA020923	Liebel-Flarsheim Company LLC	IOVERSOL	678	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1323_abc7573e-aa40-4f9a-8025-0f7f488bf0c7	0019-1323	HUMAN PRESCRIPTION DRUG	Optiray	320	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20111017		NDA	NDA020923	Liebel-Flarsheim Company LLC	IOVERSOL	678	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1332_1884aaeb-c174-4df7-a710-82d2b1869ad2	0019-1332	HUMAN PRESCRIPTION DRUG	Optiray	300	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20120304		NDA	NDA019710	Liebel-Flarsheim Company LLC	IOVERSOL	636	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1332_9861a367-76f0-4e91-8dcf-ffc30b35d276	0019-1332	HUMAN PRESCRIPTION DRUG	Optiray	300	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20201118		NDA	NDA020923	Liebel-Flarsheim Company LLC	IOVERSOL	636	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1332_abc7573e-aa40-4f9a-8025-0f7f488bf0c7	0019-1332	HUMAN PRESCRIPTION DRUG	Optiray	300	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20111017		NDA	NDA020923	Liebel-Flarsheim Company LLC	IOVERSOL	636	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1333_1884aaeb-c174-4df7-a710-82d2b1869ad2	0019-1333	HUMAN PRESCRIPTION DRUG	Optiray	350	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20120304		NDA	NDA019710	Liebel-Flarsheim Company LLC	IOVERSOL	741	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1333_9861a367-76f0-4e91-8dcf-ffc30b35d276	0019-1333	HUMAN PRESCRIPTION DRUG	Optiray	350	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20201118		NDA	NDA020923	Liebel-Flarsheim Company LLC	IOVERSOL	741	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-1333_abc7573e-aa40-4f9a-8025-0f7f488bf0c7	0019-1333	HUMAN PRESCRIPTION DRUG	Optiray	350	Ioversol	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20111017		NDA	NDA020923	Liebel-Flarsheim Company LLC	IOVERSOL	741	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0019-4816_79425e73-456a-458a-986d-baf4291584a2	0019-4816	HUMAN PRESCRIPTION DRUG	MD GASTROVIEW		diatrizoate meglumine and diatrizoate sodium	SOLUTION	ORAL; RECTAL	20090831		ANDA	ANDA087388	Liebel-Flarsheim Company LLC	DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM	600; 100	mg/mL; mg/mL	Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA]		N	20241231
0023-0042_17efca2f-f818-43c0-bdac-8047c5fa4989	0023-0042	HUMAN PRESCRIPTION DRUG	TAZORAC		tazarotene	GEL	CUTANEOUS	19970801		NDA	NDA020600	Allergan, Inc.	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0023-0312_fcef5d58-db5e-4350-af53-2d664bb31211	0023-0312	HUMAN OTC DRUG	REFRESH LACRI-LUBE		mineral oil, petrolatum	OINTMENT	OPHTHALMIC	19771215		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	MINERAL OIL; PETROLATUM	425; 568	mg/g; mg/g			N	20241231
0023-0403_46382b58-5847-4984-a4d1-b91b832dbe4e	0023-0403	HUMAN OTC DRUG	REFRESH PLUS		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	19961009		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
0023-0506_41e51bd3-9d1e-4bd5-b748-0aaa6e558ae3	0023-0506	HUMAN OTC DRUG	REFRESH Classic		Polyvinyl Alcohol, Povidone	SOLUTION/ DROPS	OPHTHALMIC	19850912		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	14; 6	mg/mL; mg/mL			N	20241231
0023-1145_b1bbf0e3-3d1b-4b7b-89f4-d59c872f8585	0023-1145	HUMAN PRESCRIPTION DRUG	BOTOX		onabotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRADERMAL; INTRAMUSCULAR	19891215		BLA	BLA103000	Allergan, Inc.	BOTULINUM TOXIN TYPE A	100	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0023-2181_0cc5c7a6-d87f-48a8-bf26-b17eb18f06c5	0023-2181	HUMAN PRESCRIPTION DRUG	Acular		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	19921201		NDA	NDA019700	Allergan, Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0023-3205_157ec58b-058b-4a9f-988e-38d19ff72cab	0023-3205	HUMAN PRESCRIPTION DRUG	LUMIGAN		bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20100910		NDA	NDA022184	Allergan, Inc.	BIMATOPROST	.1	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0023-3240_d3ba620c-494b-4d6b-a1b1-e90ee87ba257	0023-3240	HUMAN OTC DRUG	REFRESH OPTIVE		carboxymethylcellulose sodium and glycerin	SOLUTION/ DROPS	OPHTHALMIC	20060906		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN	5; 9	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-3348_9aafcf18-c506-4bd7-9521-de261a37626e	0023-3348	HUMAN PRESCRIPTION DRUG	OZURDEX		dexamethasone	IMPLANT	INTRAVITREAL	20090901		NDA	NDA022315	Allergan, Inc.	DEXAMETHASONE	.7	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0023-3416_0bcf63da-f5a0-41e2-985a-3af8053120ed	0023-3416	HUMAN OTC DRUG	Refresh Optive		Carboxymethylcellulose Sodium, Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20080822		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN	5; 9	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-3507_29d890de-b348-4594-8f94-30dc1bc2e4d0	0023-3507	HUMAN PRESCRIPTION DRUG	ACUVAIL		ketorolac tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20090801		NDA	NDA022427	Allergan, Inc.	KETOROLAC TROMETHAMINE	4.5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0023-3615_9637ee2e-46de-4f8f-ae4f-b19139d57657	0023-3615	HUMAN PRESCRIPTION DRUG	ZYMAXID		gatifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20100519		NDA	NDA022548	Allergan, Inc.	GATIFLOXACIN	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0023-3616_2c93eda7-3ae0-4804-a557-3a19364f06e7	0023-3616	HUMAN PRESCRIPTION DRUG	LATISSE		bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20090126		NDA	NDA022369	Allergan, Inc.	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0023-3670_dfe068d3-6b3f-428a-9471-21287cada2a8	0023-3670	HUMAN PRESCRIPTION DRUG	ACZONE		dapsone	GEL	TOPICAL	20090624		NDA	NDA021794	Allergan, Inc.	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
0023-3919_55da57ed-9beb-4476-abf1-36cb380ac17f	0023-3919	HUMAN PRESCRIPTION DRUG	BOTOX Cosmetic		onabotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20080715		BLA	BLA103000	Allergan, Inc.	BOTULINUM TOXIN TYPE A	50	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0023-3921_b1bbf0e3-3d1b-4b7b-89f4-d59c872f8585	0023-3921	HUMAN PRESCRIPTION DRUG	BOTOX		onabotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRADERMAL; INTRAMUSCULAR	20100111		BLA	BLA103000	Allergan, Inc.	BOTULINUM TOXIN TYPE A	200	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0023-4290_3dec5ba5-65c8-46c3-b73d-b081a20899bd	0023-4290	HUMAN PRESCRIPTION DRUG	LASTACAFT		alcaftadine	SOLUTION/ DROPS	OPHTHALMIC	20101101		NDA	NDA022134	Allergan, Inc.	ALCAFTADINE	2.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0023-4291_3110f1f0-8f7d-425b-8ed5-99673f085be6	0023-4291	HUMAN OTC DRUG	LASTACAFT		alcaftadine	SOLUTION/ DROPS	OPHTHALMIC	20211201		NDA	NDA022134	Allergan, Inc.	ALCAFTADINE	2.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0023-4307_b6de74b4-5475-4572-8b07-2585e1fac94d	0023-4307	HUMAN OTC DRUG	REFRESH OPTIVE Advanced		carboxymethylcellulose sodium, glycerin, and polysorbate 80	SOLUTION/ DROPS	OPHTHALMIC	20111130		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80	5; 10; 5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-4491_5a4e6455-0ba5-4cc6-9c18-78c4f2b548ea	0023-4491	HUMAN OTC DRUG	REFRESH OPTIVE Advanced		carboxymethylcellulose sodium, glycerin, polysorbate 80	SOLUTION/ DROPS	OPHTHALMIC	20130115		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80	5; 10; 5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-4515_9f04116b-954c-46e0-b755-d6273db959cd	0023-4515	HUMAN OTC DRUG	Refresh RELIEVA PF		Carboxymethylcellulose sodium and Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20200925		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN	5; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-4554_134a5c66-403b-488d-ac11-e16f83ab130b	0023-4554	HUMAN OTC DRUG	REFRESH CELLUVISC		carboxymethylcellulose sodium	GEL	OPHTHALMIC	19891004		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	10	mg/mL			N	20241231
0023-4948_5b33bda9-8388-4b2c-baaa-efb3f206131b	0023-4948	HUMAN OTC DRUG	SKIN MEDICA Purifying Foaming Wash		salicylic acid	LIQUID	TOPICAL	20130101		OTC MONOGRAPH DRUG	M006	Allergan, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
0023-5301_884a1d8c-14e0-464c-a6b6-bfdd7009d514	0023-5301	HUMAN PRESCRIPTION DRUG	Restasis MultiDose		cyclosporine	EMULSION	OPHTHALMIC	20161110		NDA	NDA050790	Allergan, Inc.	CYCLOSPORINE	.5	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0023-5459_4fc2d31c-5670-4dc9-9148-b443c423e6a7	0023-5459	HUMAN OTC DRUG	REFRESH OPTIVE Drops		carboxymethylcellulose sodium and glycerin	SOLUTION/ DROPS	OPHTHALMIC	20150930		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN	10; 9	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-5494_93ab2b62-c9b0-4ed6-bc97-239cb2a59e12	0023-5494	HUMAN OTC DRUG	TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen		Octinoxate, Octisalate and Zinc Oxide	LOTION	TOPICAL	20150615		OTC MONOGRAPH DRUG	M020	Allergan, Inc.	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 30; 80	mg/g; mg/g; mg/g			N	20241231
0023-5497_55d82999-d09a-44fa-8692-f13b4c144402	0023-5497	HUMAN OTC DRUG	TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen (Tinted)		Octinoxate, Octisalate, Titanium dioxide and Zinc Oxide	LOTION	TOPICAL	20150615		OTC MONOGRAPH DRUG	M020	Allergan, Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 30; 35; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
0023-5675_8895bbf4-d277-43d1-9553-cb4e0e77f020	0023-5675	HUMAN OTC DRUG	Essential Defense Mineral Shield Broad Spectrum SPF 32 TINTED Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20160316		OTC MONOGRAPH DRUG	M020	Allergan, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	50; 60	mg/g; mg/g			N	20241231
0023-5703_bf4ff9d8-90aa-478a-9bb8-46ca1ddd14ee	0023-5703	HUMAN OTC DRUG	Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen		Titanium Dioxide and Zinc oxide	LOTION	TOPICAL	20160316		OTC MONOGRAPH DRUG	M020	Allergan, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	50; 60	mg/g; mg/g			N	20241231
0023-5738_b2aab83c-9d1b-4f34-a66b-fcb912796678	0023-5738	HUMAN OTC DRUG	Essential Defense Everyday Clear Broad Spectrum SPF 47 Sunscreen		Zinc Oxide and Octinoxate	LOTION	TOPICAL	20160316		OTC MONOGRAPH DRUG	M020	Allergan, Inc.	OCTINOXATE; ZINC OXIDE	75; 120	mg/g; mg/g			N	20241231
0023-5773_0880d5b4-a8c6-4bf1-be8f-933e68fa5130	0023-5773	HUMAN OTC DRUG	REFRESH Optive Mega-3		Carboxymethylcellulose sodium, Glycerin and Polysorbate 80	SOLUTION/ DROPS	OPHTHALMIC	20170530		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80	5; 10; 5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-5853_1c8e73a4-a025-4aee-a80a-376f29232566	0023-5853	HUMAN PRESCRIPTION DRUG	Delzicol		mesalamine	CAPSULE, DELAYED RELEASE	ORAL	20160516		NDA	NDA204412	Allergan, Inc.	MESALAMINE	400	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0023-5858_f36c1454-a028-4c09-9f34-96d734434be5	0023-5858	HUMAN PRESCRIPTION DRUG	LILETTA		Levonorgestrel	INTRAUTERINE DEVICE	INTRAUTERINE	20160531		NDA	NDA206229	Allergan, Inc.	LEVONORGESTREL	52	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
0023-5861_ffa5a0e3-0166-49da-bfca-09199c0cae3e	0023-5861	HUMAN PRESCRIPTION DRUG	GELNIQUE		oxybutynin chloride	GEL	TRANSDERMAL	20170401		NDA	NDA022204	Allergan, Inc.	OXYBUTYNIN CHLORIDE	100	mg/g	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0023-5862_fabb7a8c-1072-4a8f-9705-e04325364a24	0023-5862	HUMAN PRESCRIPTION DRUG	Taytulla		norethindrone acetate and ethinyl estradiol, and ferrous fumarate	KIT		20160501		NDA	NDA204426	Allergan, Inc.						N	20241231
0023-5990_cd69eaab-a8ad-412a-a56e-2feaa59c5639	0023-5990	HUMAN PRESCRIPTION DRUG	Androderm		Testosterone	PATCH	TRANSDERMAL	19950929	20240930	NDA	NDA020489	Allergan, Inc.	TESTOSTERONE	2	mg/d	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	
0023-5992_cd69eaab-a8ad-412a-a56e-2feaa59c5639	0023-5992	HUMAN PRESCRIPTION DRUG	Androderm		Testosterone	PATCH	TRANSDERMAL	19950929	20240930	NDA	NDA020489	Allergan, Inc.	TESTOSTERONE	4	mg/d	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	
0023-6082_b0adfe67-b4ca-41c8-aa45-689c1341849d	0023-6082	HUMAN PRESCRIPTION DRUG	INFeD		Iron Dextran	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19740429		NDA	NDA017441	Allergan, Inc.	IRON DEXTRAN	50	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0023-6118_80db0ad5-b20d-4c50-8d96-bb586488c832	0023-6118	HUMAN PRESCRIPTION DRUG	Condylox		podofilox	GEL	TOPICAL	19970313		NDA	NDA020529	Allergan, Inc.	PODOFILOX	5	mg/g	Decreased Mitosis [PE]		N	20241231
0023-6142_6cba0207-6e74-431e-9298-710b5fc592d4	0023-6142	HUMAN PRESCRIPTION DRUG	RAPAFLO		silodosin	CAPSULE	ORAL	20090323		NDA	NDA022206	Allergan, Inc.	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0023-6147_6cba0207-6e74-431e-9298-710b5fc592d4	0023-6147	HUMAN PRESCRIPTION DRUG	RAPAFLO		silodosin	CAPSULE	ORAL	20090323		NDA	NDA022206	Allergan, Inc.	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0023-6150_da3178d8-d328-4d13-8e3f-18acc75e54d4	0023-6150	HUMAN PRESCRIPTION DRUG	Crinone		progesterone	GEL	VAGINAL	19970513		NDA	NDA020701	Allergan, Inc.	PROGESTERONE	45	mg/1.125g	Progesterone [CS], Progesterone [EPC]		N	20241231
0023-6151_da3178d8-d328-4d13-8e3f-18acc75e54d4	0023-6151	HUMAN PRESCRIPTION DRUG	Crinone		progesterone	GEL	VAGINAL	19970513		NDA	NDA020701	Allergan, Inc.	PROGESTERONE	90	mg/1.125g	Progesterone [CS], Progesterone [EPC]		N	20241231
0023-6153_3919a14c-f563-4ae9-8774-fc2543f18d12	0023-6153	HUMAN PRESCRIPTION DRUG	OXYTROL		Oxybutynin	PATCH	TRANSDERMAL	20030226		NDA	NDA021351	Allergan, Inc.	OXYBUTYNIN	3.9	mg/d	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0023-6498_a2a2dac4-01bf-469c-be05-60bee5d4b117	0023-6498	HUMAN PRESCRIPTION DRUG	UBRELVY		ubrogepant	TABLET	ORAL	20191223		NDA	NDA211765	Allergan, Inc.	UBROGEPANT	50	mg/1	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
0023-6501_a2a2dac4-01bf-469c-be05-60bee5d4b117	0023-6501	HUMAN PRESCRIPTION DRUG	UBRELVY		ubrogepant	TABLET	ORAL	20191223		NDA	NDA211765	Allergan, Inc.	UBROGEPANT	100	mg/1	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
0023-6630_0cdd2598-7802-4f90-ba37-d8eb75d8332b	0023-6630	HUMAN OTC DRUG	Refresh Relieva		Carboxymethylcellulose sodium, Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20190722		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN	5; 9	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-6634_fcb7bb37-4d9a-420e-9f7e-1c1bd3b3a024	0023-6634	HUMAN OTC DRUG	Refresh Relieva Preservative Free		Carboxymethylcellulose sodium and Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20190726		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN	5; 9	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-6934_c610570f-3cee-4b6e-88eb-255e53d51e45	0023-6934	HUMAN OTC DRUG	OcuMend	Healing Gels	Arnica Montana and Ledum Palustre Twig	PATCH	TOPICAL	20200901		UNAPPROVED HOMEOPATHIC		Allergan, Inc.	ARNICA MONTANA; LEDUM PALUSTRE TWIG	50; 50	[hp_X]/1; [hp_X]/1			N	20241231
0023-6952_2304c8bb-2ad8-4b78-a37d-0ba3d6ed88cf	0023-6952	HUMAN OTC DRUG	Refresh Digital		Carboxymethylcellulose sodium, Glycerin, Polysorbate 80	SOLUTION/ DROPS	OPHTHALMIC	20200801		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80	5; 10; 5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-6954_0702ebf0-06fb-44a1-ba8b-21c00c4a288d	0023-6954	HUMAN OTC DRUG	Refresh Digital PF		Carboxymethylcellulose sodium, Glycerin and Polysorbate 80	SOLUTION/ DROPS	OPHTHALMIC	20200801		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80	5; 10; 5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-7151_0880d5b4-a8c6-4bf1-be8f-933e68fa5130	0023-7151	HUMAN OTC DRUG	REFRESH Optive Mega-3		Carboxymethylcellulose sodium, Glycerin and Polysorbate 80	SOLUTION/ DROPS	OPHTHALMIC	20210615		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80	5; 10; 5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-8335_17efca2f-f818-43c0-bdac-8047c5fa4989	0023-8335	HUMAN PRESCRIPTION DRUG	TAZORAC		tazarotene	GEL	CUTANEOUS	19970801		NDA	NDA020600	Allergan, Inc.	TAZAROTENE	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0023-8842_0aeb87da-f1d5-4a28-ad87-80fb3c31b3ea	0023-8842	HUMAN PRESCRIPTION DRUG	ALOCRIL		nedocromil sodium	SOLUTION/ DROPS	OPHTHALMIC	20000203		NDA	NDA021009	Allergan, Inc.	NEDOCROMIL SODIUM	20	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
0023-9163_9821a057-4b01-42fd-84ba-3e30e41c2249	0023-9163	HUMAN PRESCRIPTION DRUG	RESTASIS		cyclosporine	EMULSION	OPHTHALMIC	20030401		NDA	NDA050790	Allergan, Inc.	CYCLOSPORINE	.5	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0023-9177_d5a1e293-64ea-4870-b1bb-0afdf128fa2c	0023-9177	HUMAN PRESCRIPTION DRUG	ALPHAGAN P		brimonidine tartrate	SOLUTION/ DROPS	OPHTHALMIC	20010710		NDA	NDA021262	Allergan, Inc.	BRIMONIDINE TARTRATE	1.5	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0023-9205_7a6e5495-f68b-4007-917f-8a40c8404422	0023-9205	HUMAN OTC DRUG	REFRESH LIQUIGEL		Carboxymethylcellulose sodium	GEL	OPHTHALMIC	20011004		OTC MONOGRAPH FINAL	part349	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	10	mg/mL			N	20241231
0023-9211_c2946063-4406-44a4-9907-ca33438607b6	0023-9211	HUMAN PRESCRIPTION DRUG	COMBIGAN		brimonidine tartrate, timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20071114		NDA	NDA021398	Allergan, Inc.	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0023-9232_55da57ed-9beb-4476-abf1-36cb380ac17f	0023-9232	HUMAN PRESCRIPTION DRUG	BOTOX Cosmetic		onabotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20080520		BLA	BLA103000	Allergan, Inc.	BOTULINUM TOXIN TYPE A	100	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0023-9277_7b366f14-cdc3-4bd9-bc2b-eccddea325d0	0023-9277	HUMAN PRESCRIPTION DRUG	ACULAR LS		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20030819		NDA	NDA021528	Allergan, Inc.	KETOROLAC TROMETHAMINE	4	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0023-9321_d5a1e293-64ea-4870-b1bb-0afdf128fa2c	0023-9321	HUMAN PRESCRIPTION DRUG	ALPHAGAN P		brimonidine tartrate	SOLUTION/ DROPS	OPHTHALMIC	20060125		NDA	NDA021770	Allergan, Inc.	BRIMONIDINE TARTRATE	1	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0023-9537_9f04116b-954c-46e0-b755-d6273db959cd	0023-9537	HUMAN OTC DRUG	Refresh RELIEVA PF		Carboxymethylcellulose sodium and Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20200925		OTC MONOGRAPH DRUG	M018	Allergan, Inc.	CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN	5; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0023-9637_bfd95021-d60e-4842-be48-20cfab631ccd	0023-9637	HUMAN OTC DRUG	Oxytrol for Women		Oxybutynin	PATCH	TRANSDERMAL	20160101		NDA	NDA202211	Allergan, Inc.	OXYBUTYNIN	3.9	mg/d	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0023-9652_ebbce360-a6dd-423b-98da-f6a16f6153e7	0023-9652	HUMAN PRESCRIPTION DRUG	DURYSTA		bimatoprost	IMPLANT	INTRACAMERAL	20200304		NDA	NDA211911	Allergan, Inc.	BIMATOPROST	10	ug/1	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0024-0654_fb20a1b6-f85c-4ab8-9f68-eb5f27ffd781	0024-0654	HUMAN PRESCRIPTION DRUG	Sarclisa		isatuximab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200302		BLA	BLA761113	sanof-aventis U.S. LLC	ISATUXIMAB	100	mg/5mL	Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]		N	20241231
0024-0656_fb20a1b6-f85c-4ab8-9f68-eb5f27ffd781	0024-0656	HUMAN PRESCRIPTION DRUG	Sarclisa		isatuximab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200302		BLA	BLA761113	sanof-aventis U.S. LLC	ISATUXIMAB	500	mg/25mL	Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]		N	20241231
0024-1171_9720bfe8-9e1a-4ffd-b76b-cf96f280150f	0024-1171	HUMAN PRESCRIPTION DRUG	Plavix		clopidogrel	TABLET, FILM COATED	ORAL	19971117		NDA	NDA020839	sanofi-aventis U.S. LLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0024-1332_9720bfe8-9e1a-4ffd-b76b-cf96f280150f	0024-1332	HUMAN PRESCRIPTION DRUG	Plavix		clopidogrel	TABLET, FILM COATED	ORAL	20090509		NDA	NDA020839	sanofi-aventis U.S. LLC	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0024-1596_015ee43c-fbf1-4435-bb3d-ca97d6589037	0024-1596	HUMAN PRESCRIPTION DRUG	Primaquine Phosphate		Primaquine Phosphate	TABLET, FILM COATED	ORAL	20110415		NDA	NDA008316	Sanofi-Aventis U.S. LLC	PRIMAQUINE PHOSPHATE	15	mg/1	Antimalarial [EPC]		N	20241231
0024-2792_c13b28ee-c828-4b06-b2f4-3817c5cf38a1	0024-2792	HUMAN PRESCRIPTION DRUG	Ferrlecit		sodium ferric gluconate complex	INJECTION	INTRAVENOUS	20110301		NDA	NDA020955	sanofi-aventis U.S. LLC	SODIUM FERRIC GLUCONATE COMPLEX	12.5	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0024-2794_07ce6987-8136-40fd-8cab-84f8ac73a0d0	0024-2794	HUMAN PRESCRIPTION DRUG	Ferrlecit		sodium ferric gluconate complex	INJECTION	INTRAVENOUS	20140707		NDA	NDA020955	sanofi-aventis U.S. LLC	SODIUM FERRIC GLUCONATE COMPLEX	12.5	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0024-4142_81fb46df-86c1-4558-b52b-78d8deed1ab1	0024-4142	HUMAN PRESCRIPTION DRUG	Multaq		Dronedarone	TABLET, FILM COATED	ORAL	20090701		NDA	NDA022425	sanofi-aventis U.S. LLC	DRONEDARONE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0024-4512_f17ba6ea-25d5-23c3-e053-2a95a90ab2a6	0024-4512	HUMAN PRESCRIPTION DRUG	Fexinidazole		Fexinidazole	TABLET	ORAL	20210716		NDA	NDA214429	Sanofi-Aventis U.S. LLC	FEXINIDAZOLE	600	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0024-5150_619ea95d-54eb-4525-a7fa-7bfccc0cc80d	0024-5150	HUMAN PRESCRIPTION DRUG	Elitek		rasburicase	KIT		20020712		BLA	BLA103946	Sanofi-Aventis U.S. LLC						N	20241231
0024-5151_619ea95d-54eb-4525-a7fa-7bfccc0cc80d	0024-5151	HUMAN PRESCRIPTION DRUG	Elitek		rasburicase	KIT		20060601		BLA	BLA103946	Sanofi-Aventis U.S. LLC						N	20241231
0024-5401_c8f05d12-bc35-43cb-8b65-588bec02c73d	0024-5401	HUMAN PRESCRIPTION DRUG	Ambien		zolpidem tartrate	TABLET, FILM COATED	ORAL	19930401		NDA	NDA019908	sanofi-aventis U.S. LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0024-5421_c8f05d12-bc35-43cb-8b65-588bec02c73d	0024-5421	HUMAN PRESCRIPTION DRUG	Ambien		zolpidem tartrate	TABLET, FILM COATED	ORAL	19930401		NDA	NDA019908	sanofi-aventis U.S. LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0024-5501_8138a0a9-168c-46d2-b13e-e7e84f27eaee	0024-5501	HUMAN PRESCRIPTION DRUG	Ambien	CR	zolpidem tartrate	TABLET, COATED	ORAL	20050919		NDA	NDA021774	sanofi-aventis U.S. LLC	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0024-5521_8138a0a9-168c-46d2-b13e-e7e84f27eaee	0024-5521	HUMAN PRESCRIPTION DRUG	Ambien	CR	zolpidem tartrate	TABLET, COATED	ORAL	20050919		NDA	NDA021774	sanofi-aventis U.S. LLC	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0024-5745_082cf774-e9b2-fdbd-e063-6294a90a6d61	0024-5745	HUMAN PRESCRIPTION DRUG	ADLYXIN		Lixisenatide	KIT		20160727		BLA	BLA208471	sanofi-aventis U.S. LLC						N	20241231
0024-5747_082cf774-e9b2-fdbd-e063-6294a90a6d61	0024-5747	HUMAN PRESCRIPTION DRUG	ADLYXIN		Lixisenatide	INJECTION, SOLUTION	SUBCUTANEOUS	20160727		BLA	BLA208471	sanofi-aventis U.S. LLC	LIXISENATIDE	100	ug/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0024-5761_6c6933a6-cede-46c0-8140-7b59797b03d2	0024-5761	HUMAN PRESCRIPTION DRUG	Soliqua 100/33		insulin glargine and lixisenatide	INJECTION, SOLUTION	SUBCUTANEOUS	20161121		BLA	BLA208673	sanofi-aventis U.S. LLC	INSULIN GLARGINE; LIXISENATIDE	100; 33	U/mL; ug/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS]		N	20241231
0024-5824_a2143f39-0543-4e3d-bba8-4d21f4bb5efb	0024-5824	HUMAN PRESCRIPTION DRUG	Jevtana		cabazitaxel	KIT		20100617		NDA	NDA201023	Sanofi-Aventis U.S. LLC						N	20241231
0024-5837_f17b7d67-baa2-9958-e053-2a95a90a0662	0024-5837	HUMAN PRESCRIPTION DRUG	FLOMAX		tamsulosin hydrochloride	CAPSULE	ORAL	20190416		NDA	NDA020579	sanofi-aventis U.S. LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0024-5840_8e160898-1926-4079-963c-e447c17a2566	0024-5840	HUMAN PRESCRIPTION DRUG	ZALTRAP		ziv-aflibercept	SOLUTION, CONCENTRATE	INTRAVENOUS	20120803		BLA	BLA125418	sanofi-aventis U.S. LLC	AFLIBERCEPT	100	mg/4mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
0024-5841_8e160898-1926-4079-963c-e447c17a2566	0024-5841	HUMAN PRESCRIPTION DRUG	ZALTRAP		ziv-aflibercept	SOLUTION, CONCENTRATE	INTRAVENOUS	20120803		BLA	BLA125418	sanofi-aventis U.S. LLC	AFLIBERCEPT	200	mg/8mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
0024-5850_cf3ca8df-5a3f-413d-a895-65685cc17313	0024-5850	HUMAN PRESCRIPTION DRUG	Avapro		irbesartan	TABLET, FILM COATED	ORAL	20130101		NDA	NDA020757	Sanofi-Aventis U.S. LLC	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0024-5851_cf3ca8df-5a3f-413d-a895-65685cc17313	0024-5851	HUMAN PRESCRIPTION DRUG	Avapro		irbesartan	TABLET, FILM COATED	ORAL	20130101		NDA	NDA020757	Sanofi-Aventis U.S. LLC	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0024-5852_cf3ca8df-5a3f-413d-a895-65685cc17313	0024-5852	HUMAN PRESCRIPTION DRUG	Avapro		irbesartan	TABLET, FILM COATED	ORAL	20130101		NDA	NDA020757	Sanofi-Aventis U.S. LLC	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0024-5855_dda07a5c-1081-495d-a4ba-f2794baaa729	0024-5855	HUMAN PRESCRIPTION DRUG	Avalide		irbesartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130101		NDA	NDA020758	sanofi-aventis U.S. LLC	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0024-5856_dda07a5c-1081-495d-a4ba-f2794baaa729	0024-5856	HUMAN PRESCRIPTION DRUG	Avalide		irbesartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130101		NDA	NDA020758	sanofi-aventis U.S. LLC	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0024-5860_06aeff93-91f9-4ce6-ac41-173d56e34b1d	0024-5860	HUMAN PRESCRIPTION DRUG	Clolar		clofarabine	INJECTION	INTRAVENOUS	20130401		NDA	NDA021673	Sanofi-Aventis U.S. LLC	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0024-5862_0abe8d3a-2518-4581-b150-75f03ae30641	0024-5862	HUMAN PRESCRIPTION DRUG	Mozobil		PLERIXAFOR	INJECTION, SOLUTION	SUBCUTANEOUS	20130901		NDA	NDA022311	sanofi-aventis U.S. LLC	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
0024-5869_23d7263b-16d4-4b17-bc45-8e499861015d	0024-5869	HUMAN PRESCRIPTION DRUG	TOUJEO		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20150215		BLA	BLA206538	Sanofi-Aventis U.S. LLC	INSULIN GLARGINE	300	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0024-5871_23d7263b-16d4-4b17-bc45-8e499861015d	0024-5871	HUMAN PRESCRIPTION DRUG	TOUJEO Max		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20150215		BLA	BLA206538	Sanofi-Aventis U.S. LLC	INSULIN GLARGINE	300	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0024-5901_d6e3eeb8-c775-4382-85c3-3f3e8999c280	0024-5901	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724		BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	75	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
0024-5902_d6e3eeb8-c775-4382-85c3-3f3e8999c280	0024-5902	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724		BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	150	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
0024-5903_d6e3eeb8-c775-4382-85c3-3f3e8999c280	0024-5903	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724		BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	75	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
0024-5904_d6e3eeb8-c775-4382-85c3-3f3e8999c280	0024-5904	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150724		BLA	BLA125559	Sanofi-Aventis U.S. LLC	ALIROCUMAB	150	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
0024-5908_ca91dfdd-7d4f-4074-bbfd-d8fc21deac46	0024-5908	HUMAN PRESCRIPTION DRUG	KEVZARA		sarilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20170522		BLA	BLA761037	sanofi-aventis U.S. LLC	SARILUMAB	150	mg/1.14mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
0024-5910_ca91dfdd-7d4f-4074-bbfd-d8fc21deac46	0024-5910	HUMAN PRESCRIPTION DRUG	KEVZARA		sarilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20170522		BLA	BLA761037	sanofi-aventis U.S. LLC	SARILUMAB	200	mg/1.14mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
0024-5911_214be693-3f1d-42ee-b72a-f3f210a4ce43	0024-5911	HUMAN PRESCRIPTION DRUG	Dupixent		Dupilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20211020		BLA	BLA761055	sanofi-aventis U.S. LLC	DUPILUMAB	100	mg/.67mL	Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]		N	20241231
0024-5914_214be693-3f1d-42ee-b72a-f3f210a4ce43	0024-5914	HUMAN PRESCRIPTION DRUG	Dupixent		Dupilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20170328		BLA	BLA761055	sanofi-aventis U.S. LLC	DUPILUMAB	300	mg/2mL	Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]		N	20241231
0024-5915_214be693-3f1d-42ee-b72a-f3f210a4ce43	0024-5915	HUMAN PRESCRIPTION DRUG	Dupixent		Dupilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20200619		BLA	BLA761055	sanofi-aventis U.S. LLC	DUPILUMAB	300	mg/2mL	Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]		N	20241231
0024-5918_214be693-3f1d-42ee-b72a-f3f210a4ce43	0024-5918	HUMAN PRESCRIPTION DRUG	Dupixent		Dupilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20181019		BLA	BLA761055	sanofi-aventis U.S. LLC	DUPILUMAB	200	mg/1.14mL	Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]		N	20241231
0024-5919_214be693-3f1d-42ee-b72a-f3f210a4ce43	0024-5919	HUMAN PRESCRIPTION DRUG	Dupixent		Dupilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20210614		BLA	BLA761055	sanofi-aventis U.S. LLC	DUPILUMAB	200	mg/1.14mL	Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]		N	20241231
0024-5920_ca91dfdd-7d4f-4074-bbfd-d8fc21deac46	0024-5920	HUMAN PRESCRIPTION DRUG	KEVZARA		sarilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20170522		BLA	BLA761037	sanofi-aventis U.S. LLC	SARILUMAB	150	mg/1.14mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
0024-5922_ca91dfdd-7d4f-4074-bbfd-d8fc21deac46	0024-5922	HUMAN PRESCRIPTION DRUG	KEVZARA		sarilumab	INJECTION, SOLUTION	SUBCUTANEOUS	20170522		BLA	BLA761037	sanofi-aventis U.S. LLC	SARILUMAB	200	mg/1.14mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
0024-5924_5c8efb5f-4957-428e-ad2a-a2a9a28ca2fd	0024-5924	HUMAN PRESCRIPTION DRUG	ADMELOG		insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20171211		BLA	BLA209196	Sanofi-Aventis U.S. LLC	INSULIN LISPRO	100	U/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0024-5925_5c8efb5f-4957-428e-ad2a-a2a9a28ca2fd	0024-5925	HUMAN PRESCRIPTION DRUG	ADMELOG		insulin lispro	INJECTION, SOLUTION	SUBCUTANEOUS	20171211		BLA	BLA209196	Sanofi-Aventis U.S. LLC	INSULIN LISPRO	100	U/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0024-5926_5c8efb5f-4957-428e-ad2a-a2a9a28ca2fd	0024-5926	HUMAN PRESCRIPTION DRUG	ADMELOG		insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20181019		BLA	BLA209196	Sanofi-Aventis U.S. LLC	INSULIN LISPRO	100	U/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0025-0061_95594203-bf78-4e64-9bc1-0c39429cfc54	0025-0061	HUMAN PRESCRIPTION DRUG	Lomotil		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	19600915		NDA	NDA012462	Pfizer Laboratories Div Pfizer Inc	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
0025-0166_bbb3315f-c436-4ae0-8374-300bf31826ed	0025-0166	HUMAN PRESCRIPTION DRUG	Synarel		nafarelin acetate	SPRAY, METERED	NASAL	19900213		NDA	NDA019886	Pfizer Laboratories Div Pfizer Inc	NAFARELIN ACETATE	2	mg/mL	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
0025-0325_df88bbe6-cab6-49d0-af20-99bf61a03589	0025-0325	HUMAN PRESCRIPTION DRUG	ABRILADA		adalimumab-afzb	KIT		20231214		BLA	BLA761118	Pfizer Laboratories Div Pfizer Inc						N	20241231
0025-0328_df88bbe6-cab6-49d0-af20-99bf61a03589	0025-0328	HUMAN PRESCRIPTION DRUG	ABRILADA		adalimumab-afzb	KIT		20231214		BLA	BLA761118	Pfizer Laboratories Div Pfizer Inc						N	20241231
0025-0333_df88bbe6-cab6-49d0-af20-99bf61a03589	0025-0333	HUMAN PRESCRIPTION DRUG	ABRILADA		adalimumab-afzb	KIT		20231214		BLA	BLA761118	Pfizer Laboratories Div Pfizer Inc						N	20241231
0025-1001_db8685f3-a8da-43d4-bd89-8e630223887c	0025-1001	HUMAN PRESCRIPTION DRUG	Aldactone		spironolactone	TABLET, FILM COATED	ORAL	19600121		NDA	NDA012151	Pfizer Laboratories Div Pfizer Inc	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0025-1021_675ddb03-da87-4741-ad30-31653d578e39	0025-1021	HUMAN PRESCRIPTION DRUG	ALDACTAZIDE		spironolactone and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19780101		NDA	NDA012616	Pfizer Laboratories Div Pfizer Inc	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	50; 50	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0025-1031_db8685f3-a8da-43d4-bd89-8e630223887c	0025-1031	HUMAN PRESCRIPTION DRUG	Aldactone		spironolactone	TABLET, FILM COATED	ORAL	19600121		NDA	NDA012151	Pfizer Laboratories Div Pfizer Inc	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0025-1041_db8685f3-a8da-43d4-bd89-8e630223887c	0025-1041	HUMAN PRESCRIPTION DRUG	Aldactone		spironolactone	TABLET, FILM COATED	ORAL	19600121		NDA	NDA012151	Pfizer Laboratories Div Pfizer Inc	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0025-1381_b2dd3c39-1c89-470f-b43b-0c85ed1a2fe1	0025-1381	HUMAN PRESCRIPTION DRUG	Daypro		oxaprozin	TABLET, FILM COATED	ORAL	19921029		NDA	NDA018841	Pfizer Laboratories Div Pfizer Inc	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0025-1411_30c422b3-45d5-4ff1-b1aa-cbbcca40b716	0025-1411	HUMAN PRESCRIPTION DRUG	ARTHROTEC		diclofenac sodium and misoprostol	TABLET, FILM COATED	ORAL	19971224		NDA	NDA020607	Pfizer Laboratories Div Pfizer Inc	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
0025-1421_30c422b3-45d5-4ff1-b1aa-cbbcca40b716	0025-1421	HUMAN PRESCRIPTION DRUG	ARTHROTEC		diclofenac sodium and misoprostol	TABLET, FILM COATED	ORAL	19971224		NDA	NDA020607	Pfizer Laboratories Div Pfizer Inc	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
0025-1451_a84b3f70-cd54-4d4b-904e-c76719e8da24	0025-1451	HUMAN PRESCRIPTION DRUG	Cytotec		misoprostol	TABLET	ORAL	19861227		NDA	NDA019268	Pfizer Laboratories Div Pfizer Inc	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
0025-1461_a84b3f70-cd54-4d4b-904e-c76719e8da24	0025-1461	HUMAN PRESCRIPTION DRUG	Cytotec		misoprostol	TABLET	ORAL	19861227		NDA	NDA019268	Pfizer Laboratories Div Pfizer Inc	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
0025-1515_cc02a061-67c0-4db9-9073-ffcef45449fe	0025-1515	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	19981002	20240831	NDA	NDA020998	PFIZER LABORATORIES DIV PFIZER INC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0025-1520_cc02a061-67c0-4db9-9073-ffcef45449fe	0025-1520	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	19981002		NDA	NDA020998	PFIZER LABORATORIES DIV PFIZER INC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
0025-1525_cc02a061-67c0-4db9-9073-ffcef45449fe	0025-1525	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	19981002		NDA	NDA020998	PFIZER LABORATORIES DIV PFIZER INC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
0025-1530_cc02a061-67c0-4db9-9073-ffcef45449fe	0025-1530	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	19981002	20240831	NDA	NDA020998	PFIZER LABORATORIES DIV PFIZER INC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0025-1710_d9c94e3a-5db0-4cf4-be46-c9501930818b	0025-1710	HUMAN PRESCRIPTION DRUG	Inspra		eplerenone	TABLET, FILM COATED	ORAL	20020927		NDA	NDA021437	Pfizer Laboratories Div Pfizer Inc	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0025-1720_d9c94e3a-5db0-4cf4-be46-c9501930818b	0025-1720	HUMAN PRESCRIPTION DRUG	Inspra		eplerenone	TABLET, FILM COATED	ORAL	20020927		NDA	NDA021437	Pfizer Laboratories Div Pfizer Inc	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0025-1942_8a69e39f-2ee6-44ff-a54a-1c6f92e3dd51	0025-1942	HUMAN PRESCRIPTION DRUG	Flagyl		metronidazole	CAPSULE	ORAL	19950503		NDA	NDA020334	Pfizer Laboratories Div Pfizer Inc	METRONIDAZOLE	375	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0025-2732_bad34f2f-efbc-453a-b783-fba7a05ba580	0025-2732	HUMAN PRESCRIPTION DRUG	Norpace CR		disopyramide phosphate	CAPSULE, EXTENDED RELEASE	ORAL	19820720		NDA	NDA018655	Pfizer Laboratories Div Pfizer Inc	DISOPYRAMIDE PHOSPHATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
0025-2742_bad34f2f-efbc-453a-b783-fba7a05ba580	0025-2742	HUMAN PRESCRIPTION DRUG	Norpace CR		disopyramide phosphate	CAPSULE, EXTENDED RELEASE	ORAL	19820720		NDA	NDA018655	Pfizer Laboratories Div Pfizer Inc	DISOPYRAMIDE PHOSPHATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
0025-2752_bad34f2f-efbc-453a-b783-fba7a05ba580	0025-2752	HUMAN PRESCRIPTION DRUG	Norpace		disopyramide phosphate	CAPSULE, GELATIN COATED	ORAL	19770901		NDA	NDA017447	Pfizer Laboratories Div Pfizer Inc	DISOPYRAMIDE PHOSPHATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
0025-2762_bad34f2f-efbc-453a-b783-fba7a05ba580	0025-2762	HUMAN PRESCRIPTION DRUG	Norpace		disopyramide phosphate	CAPSULE, GELATIN COATED	ORAL	19770901		NDA	NDA017447	Pfizer Laboratories Div Pfizer Inc	DISOPYRAMIDE PHOSPHATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
0025-2818_f01a76e9-903f-4326-8eff-af7b09464b54	0025-2818	HUMAN PRESCRIPTION DRUG	CALAN SR		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201216		NDA	NDA019152	Pfizer Laboratories Div Pfizer Inc	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0026-3782_836b7a1a-f568-4814-9438-7d6414f14e09	0026-3782	PLASMA DERIVATIVE	Kogenate FS		Antihemophilic Factor (Recombinant)	KIT		20130626		BLA	BLA103332	Bayer HealthCare LLC						N	20241231
0026-3783_836b7a1a-f568-4814-9438-7d6414f14e09	0026-3783	PLASMA DERIVATIVE	Kogenate FS		Antihemophilic Factor (Recombinant)	KIT		20130626		BLA	BLA103332	Bayer HealthCare LLC						N	20241231
0026-3785_836b7a1a-f568-4814-9438-7d6414f14e09	0026-3785	PLASMA DERIVATIVE	Kogenate FS		Antihemophilic Factor (Recombinant)	KIT		20130626		BLA	BLA103332	Bayer HealthCare LLC						N	20241231
0026-3786_836b7a1a-f568-4814-9438-7d6414f14e09	0026-3786	PLASMA DERIVATIVE	Kogenate FS		Antihemophilic Factor (Recombinant)	KIT		20130626		BLA	BLA103332	Bayer HealthCare LLC						N	20241231
0026-3787_836b7a1a-f568-4814-9438-7d6414f14e09	0026-3787	PLASMA DERIVATIVE	Kogenate FS		Antihemophilic Factor (Recombinant)	KIT		20130626		BLA	BLA103332	Bayer HealthCare LLC						N	20241231
0026-3821_8d9498f7-77e5-4bf8-b68a-69464ada2790	0026-3821	PLASMA DERIVATIVE	Kovaltry		Antihemophilic Factor (Recombinant)	KIT		20160317		BLA	BLA125574	Bayer HealthCare LLC						N	20241231
0026-3822_8d9498f7-77e5-4bf8-b68a-69464ada2790	0026-3822	PLASMA DERIVATIVE	Kovaltry		Antihemophilic Factor (Recombinant)	KIT		20160317		BLA	BLA125574	Bayer HealthCare LLC						N	20241231
0026-3824_8d9498f7-77e5-4bf8-b68a-69464ada2790	0026-3824	PLASMA DERIVATIVE	Kovaltry		Antihemophilic Factor (Recombinant)	KIT		20160317		BLA	BLA125574	Bayer HealthCare LLC						N	20241231
0026-3826_8d9498f7-77e5-4bf8-b68a-69464ada2790	0026-3826	PLASMA DERIVATIVE	Kovaltry		Antihemophilic Factor (Recombinant)	KIT		20160317		BLA	BLA125574	Bayer HealthCare LLC						N	20241231
0026-3828_8d9498f7-77e5-4bf8-b68a-69464ada2790	0026-3828	PLASMA DERIVATIVE	Kovaltry		Antihemophilic Factor (Recombinant)	KIT		20160317		BLA	BLA125574	Bayer HealthCare LLC						N	20241231
0026-3942_7785a352-6c1a-4989-87bb-0630600c04db	0026-3942	PLASMA DERIVATIVE	Jivi		Antihemophilic Factor (Recombinant) Pegylated-aucl	KIT		20180830		BLA	BLA125661	Bayer HealthCare LLC						N	20241231
0026-3944_7785a352-6c1a-4989-87bb-0630600c04db	0026-3944	PLASMA DERIVATIVE	Jivi		Antihemophilic Factor (Recombinant) Pegylated-aucl	KIT		20180830		BLA	BLA125661	Bayer HealthCare LLC						N	20241231
0026-3946_7785a352-6c1a-4989-87bb-0630600c04db	0026-3946	PLASMA DERIVATIVE	Jivi		Antihemophilic Factor (Recombinant) Pegylated-aucl	KIT		20180830		BLA	BLA125661	Bayer HealthCare LLC						N	20241231
0026-3948_7785a352-6c1a-4989-87bb-0630600c04db	0026-3948	PLASMA DERIVATIVE	Jivi		Antihemophilic Factor (Recombinant) Pegylated-aucl	KIT		20180830		BLA	BLA125661	Bayer HealthCare LLC						N	20241231
0031-2097_0946ebde-5c4f-24a5-e063-6294a90ab66f	0031-2097	HUMAN OTC DRUG	Robitussin Elderberry Maximum Strength Cough plus Chest Congestion DM		dextromethorphan HBr, guaifenesin	SOLUTION	ORAL	20210614		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-2098_094a6186-10b3-ed17-e063-6394a90a601a	0031-2098	HUMAN OTC DRUG	Childrens Robitussin Elderberry Cough and Chest Congestion DM		dextromethorphan HBr, guaifenesin	SOLUTION	ORAL	20210614		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8655_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a	0031-8655	HUMAN OTC DRUG	Robitussin 12 Hour Cough Relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150701		ANDA	ANDA091135	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8692_7225da3f-32a7-4aa6-9e3e-0cd0dfbe4e53	0031-8692	HUMAN OTC DRUG	Childrens Robitussin Nighttime Cough Long-Acting DM		chlorpheniramine maleate, dextromethorphan hydrobromide	SOLUTION	ORAL	20140701		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8693_6f0fba24-5f21-40bf-868b-6e3c24854391	0031-8693	HUMAN OTC DRUG	CHILDRENS ROBITUSSIN COUGH AND COLD LONG-ACTING		chlorpheniramine maleate, dextrometrorphan HBr	LIQUID	ORAL	20040101		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8694_0eacf074-9134-66b8-e063-6294a90a9f46	0031-8694	HUMAN OTC DRUG	Childrens Robitussin Cough Long-Acting		dextromethorphan hydrobromide	LIQUID	ORAL	20040101		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	7.5	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
0031-8702_6dbc0a50-8ae8-4587-8e75-9e72bf47e00c	0031-8702	HUMAN OTC DRUG	Childrens Robitussin Cough and Chest Congestion DM		dextromethorphan hydrobromide and guaifenesin	LIQUID	ORAL	20200512		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8715_094a6186-10d7-ed17-e063-6394a90a601a	0031-8715	HUMAN OTC DRUG	Childrens Robitussin Cough and Chest Congestion DM		dextromethorphan hydrobromide, guaifenesin	LIQUID	ORAL	20140701		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8716_3bdaa205-01d4-453d-b351-cbcf2c5ef6f7	0031-8716	HUMAN OTC DRUG	Childrens Robitussin Cough and Cold CF		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20090901		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0031-8718_2843123a-4fe6-4872-92fd-85077e45c9ee	0031-8718	HUMAN OTC DRUG	Robitussin Maximum Strength Nighttime Cough DM		dextromethorphan hydrobromide, doxylamine succinate	SOLUTION	ORAL	20160601		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8719_09550dcf-e262-8cb9-e063-6294a90acbd2	0031-8719	HUMAN OTC DRUG	Robitussin Maximum Strength Cough Plus Chest Congestion DM		dextromethorphan hydrobromide and guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20130523		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8725_0eaf193e-7888-0b06-e063-6294a90a35f5	0031-8725	HUMAN OTC DRUG	Childrens Robitussin 12 Hour Cough Relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20160705		ANDA	ANDA091135	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
0031-8726_0eaf193e-7888-0b06-e063-6294a90a35f5	0031-8726	HUMAN OTC DRUG	Childrens Robitussin 12 Hour Cough Relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20160705		ANDA	ANDA091135	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
0031-8739_011d653e-0754-40bd-b4c8-2280bdd1953c	0031-8739	HUMAN OTC DRUG	ROBITUSSIN MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20160601		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8743_932a25d0-61e5-4215-9623-9db5e45bc244	0031-8743	HUMAN OTC DRUG	ROBITUSSIN LONG-ACTING COUGHGELS		dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20190104		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8750_90199483-457d-4f7b-915d-72250ec14390	0031-8750	HUMAN OTC DRUG	Robitussin Maximum Strength Severe Cough Plus Sore Throat		acetaminophen, dextromethorphan hydrobromide	LIQUID	ORAL	20170410		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8751_62ce8cd8-57d2-48a6-aaf1-d9b0cdb5753c	0031-8751	HUMAN OTC DRUG	Robitussin Severe Multi-Symptom Cough Cold Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20150501		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0031-8752_1d94c4de-0064-4f64-bbbb-b3123e6ba05d	0031-8752	HUMAN OTC DRUG	Robitussin Severe Multi-Symptom Cough Cold Flu Nighttime		acetaminophen, diphenhydramine hydrochloride, phenylephrine hydrochloride	SOLUTION	ORAL	20150701		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0031-8753_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a	0031-8753	HUMAN OTC DRUG	Robitussin 12 Hour Cough Relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150701		ANDA	ANDA091135	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8754_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a	0031-8754	HUMAN OTC DRUG	Robitussin 12 Hour Cough Relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20160705		ANDA	ANDA091135	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8755_76e2e2e1-5df8-45fc-b9d2-3e2155ecac5a	0031-8755	HUMAN OTC DRUG	Robitussin 12 Hour Cough Relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20160705		ANDA	ANDA091135	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8756_e8322a96-9e8e-4e9d-9d55-d5893f312f92	0031-8756	HUMAN OTC DRUG	Robitussin Honey Maximum Strength Cough and Chest Congestion DM		dextromethorphan HBr, guaifenesin	SOLUTION	ORAL	20180625		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8757_b82dd102-8850-4ce2-887f-2a45a3e74d6c	0031-8757	HUMAN OTC DRUG	ROBITUSSIN COUGH PLUS CHEST CONGESTION DM		dextromethorphan hydrobromide and guaifenesin	SOLUTION	ORAL	20180601		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8758_3caaba28-7abf-4a16-8f3b-a0490ae0bc23	0031-8758	HUMAN OTC DRUG	Robitussin Honey Maximum Strength Nighttime Cough DM		dextromethorphan HBr, doxylamine succinate	SOLUTION	ORAL	20180625		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8759_8e630a92-84b8-40e7-bcb9-7e3f608b17b1	0031-8759	HUMAN OTC DRUG	Robitussin Sugar-Free Dye-Free Cough Plus Chest Congestion DM		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20180216		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8760_f5952d8d-f142-460b-b6d3-96a21720396d	0031-8760	HUMAN OTC DRUG	Childrens Robitussin Honey Cough and Chest Congestion DM		dextromethorphan HBr, guaifenesin	SOLUTION	ORAL	20180625		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8762_af05cbe5-2843-4cd7-8205-cc35fc33efaf	0031-8762	HUMAN OTC DRUG	Childrens Robitussin Honey Nighttime Cough DM		dextromethorphan hbr, doxylamine succinate	SOLUTION	ORAL	20190527		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	15; 6.25	mg/10mL; mg/10mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8765_094ada80-3657-484d-e063-6294a90ac26c	0031-8765	HUMAN OTC DRUG	Robitussin Maximum Strength 12 Hour Cough and Mucus Relief		Dextromethorphan Hydrobromide, Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA207602	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-8770_0f6f1624-42d6-48d7-9a6b-9e4fbc48ee71	0031-8770	HUMAN OTC DRUG	Robitussin Honey Severe Cough, Flu Plus Sore Throat Nighttime		acetaminophen and diphenhydramine hydrochloride	SOLUTION	ORAL	20200615		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	650; 25	mg/20mL; mg/20mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0031-8771_d511de1c-8caa-49de-8742-a6922d31099c	0031-8771	HUMAN OTC DRUG	Robitussin Honey Severe Cough, Flu Plus Sore Throat		acetaminophen, dextromethorphan hbr	SOLUTION	ORAL	20200615		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-9301_094af31a-b79c-5e7b-e063-6294a90a72c2	0031-9301	HUMAN OTC DRUG	Robitussin Direct Sore Throat Pain		acetaminophen	TABLET, COATED	ORAL	20220715		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN	500	mg/1			N	20241231
0031-9302_581650cb-1fc3-4183-a8b0-02e0a1016ab5	0031-9302	HUMAN OTC DRUG	Robitussin Direct Cough		dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20220715		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-9303_094b6ec2-79cc-5869-e063-6294a90a749a	0031-9303	HUMAN OTC DRUG	Robitussin Direct Chest Congestion		guaifenesin	TABLET, COATED	ORAL	20220715		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0031-9304_094be948-02e8-85de-e063-6394a90a3935	0031-9304	HUMAN OTC DRUG	Robitussin Direct Runny Nose		diphenhydramine	TABLET, COATED	ORAL	20220715		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0031-9305_094bf9c4-bebb-96f1-e063-6394a90a7a67	0031-9305	HUMAN OTC DRUG	Robitussin Direct Stuffy Nose		Phenylephrine hcl	TABLET, COATED	ORAL	20220715		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0031-9306_6bec225e-a203-4866-b0db-b76f73a6ae25	0031-9306	HUMAN OTC DRUG	Robitussin Medi-Soothers		dextromethorphan hydrobromide, menthol	LOZENGE	ORAL	20230601		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL, UNSPECIFIED FORM	5; 5	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0031-9307_4c3d57e3-e40b-41ca-b44b-5f4c5f4dbae5	0031-9307	HUMAN OTC DRUG	Robitussin Medi-Soothers		dextromethorphan hydrobromide, menthol	LOZENGE	ORAL	20230601		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL, UNSPECIFIED FORM	5; 5	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0032-0045_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-0045	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE	ORAL	20231012		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	15000; 3000; 9500	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-0046_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-0046	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20231012		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	30000; 6000; 19000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-0047_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-0047	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20231012		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	60000; 12000; 38000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-1203_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-1203	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE	ORAL	20090430		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	15000; 3000; 9500	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-1206_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-1206	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20090430		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	30000; 6000; 19000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-1212_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-1212	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20090430		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	60000; 12000; 38000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-1224_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-1224	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20090430		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	120000; 24000; 76000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-2636_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-2636	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20231012		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	120000; 24000; 76000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-2637_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-2637	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20231012		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	180000; 36000; 114000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0032-3016_714758e2-9023-4d6b-bf05-2cb97ea27caa	0032-3016	HUMAN PRESCRIPTION DRUG	Creon		Pancrelipase	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130314		BLA	BLA020725	AbbVie Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	180000; 36000; 114000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
0037-0022_2a2f46f1-444c-4850-890c-487b36f87716	0037-0022	HUMAN PRESCRIPTION DRUG	sfRowasa	Sulfite-Free Formulation	mesalamine	SUSPENSION	RECTAL	20160324		NDA	NDA019618	Meda Pharmaceuticals Inc.	MESALAMINE	4	g/60mL	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0037-0066_28f60c73-ba42-4081-b2d3-c83b3298a92e	0037-0066	HUMAN PRESCRIPTION DRUG	Rowasa		mesalamine	SUSPENSION	RECTAL	20160324		NDA	NDA019618	Meda Pharmaceuticals Inc.	MESALAMINE	4	g/60mL	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0037-0245_4b104121-a698-414e-b0c1-8af6fb7f2a41	0037-0245	HUMAN PRESCRIPTION DRUG	DYMISTA		Azelastine Hydrochloride and Fluticasone Propionate	SPRAY, METERED	NASAL	20120501		NDA	NDA202236	Meda Pharmaceuticals Inc.	AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE	137; 50	ug/1; ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0037-0430_7bbea585-978a-44c8-be8f-48a7dfabaced	0037-0430	HUMAN PRESCRIPTION DRUG	Felbatol		felbamate	TABLET	ORAL	19930729		NDA	NDA020189	Meda Pharmaceuticals Inc.	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0037-0431_7bbea585-978a-44c8-be8f-48a7dfabaced	0037-0431	HUMAN PRESCRIPTION DRUG	Felbatol		felbamate	TABLET	ORAL	19930729		NDA	NDA020189	Meda Pharmaceuticals Inc.	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0037-0442_7bbea585-978a-44c8-be8f-48a7dfabaced	0037-0442	HUMAN PRESCRIPTION DRUG	Felbatol		felbamate	SUSPENSION	ORAL	19930729	20260331	NDA	NDA020189	Meda Pharmaceuticals Inc.	FELBAMATE	600	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0037-0678_6c00dfda-8bd6-4f4e-a2fc-8b544c8b38d4	0037-0678	HUMAN PRESCRIPTION DRUG	Gastrocrom		cromolyn sodium	LIQUID	ORAL	20150501		NDA	NDA020479	Meda Pharmaceuticals	CROMOLYN SODIUM	20	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
0037-2001_f39b043a-853c-4f8e-aeb7-9800e3af0c29	0037-2001	HUMAN PRESCRIPTION DRUG	Soma		Carisoprodol	TABLET	ORAL	19951101		NDA	NDA011792	Meda Pharmaceuticals Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
0037-2250_f39b043a-853c-4f8e-aeb7-9800e3af0c29	0037-2250	HUMAN PRESCRIPTION DRUG	Soma		Carisoprodol	TABLET	ORAL	20070908		NDA	NDA011792	Meda Pharmaceuticals Inc.	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
0037-4401_77c2159e-4fd8-4487-bd4d-67f5580b2106	0037-4401	HUMAN PRESCRIPTION DRUG	Depen		Penicillamine	TABLET	ORAL	19781130		NDA	NDA019854	Meda Pharmaceuticals Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
0037-4801_a22ae3bb-acd9-4438-b502-fdfe8e2ca5d6	0037-4801	HUMAN PRESCRIPTION DRUG	ELESTRIN		ESTRADIOL	GEL, METERED	TOPICAL	20140602		NDA	NDA021813	Meda Pharmaceuticals Inc.	ESTRADIOL	.52	mg/.87g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0037-6010_79fd5fd0-e6cf-49af-a632-8cc578fde3d8	0037-6010	HUMAN PRESCRIPTION DRUG	Edluar		Zolpidem Tartrate	TABLET	ORAL	20090724		NDA	NDA021997	Meda Pharmaceuticals Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0037-6050_79fd5fd0-e6cf-49af-a632-8cc578fde3d8	0037-6050	HUMAN PRESCRIPTION DRUG	Edluar		Zolpidem Tartrate	TABLET	ORAL	20090724		NDA	NDA021997	Meda Pharmaceuticals Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0037-6321_3c4ac6f5-f382-4cf7-aa0d-87959fa0c705	0037-6321	HUMAN PRESCRIPTION DRUG	URELLE		hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate	TABLET	ORAL	20150112		UNAPPROVED DRUG OTHER		Meda Pharmaceuticals	HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.12; 81; 10.8; 32.4; 40.8	mg/1; mg/1; mg/1; mg/1; mg/1	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0037-6822_ed540cbc-cfaa-4eee-ba7a-0f324c779df4	0037-6822	HUMAN PRESCRIPTION DRUG	PROCTOFOAM	HC	pramoxine hydrochloride hydrocortisone acetate	AEROSOL, FOAM	TOPICAL	20140815		ANDA	ANDA086195	Meda Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	100; 100	mg/10g; mg/10g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0037-6823_67f367b7-f7e8-466d-bd32-3e799d522aaf	0037-6823	HUMAN OTC DRUG	PROCTOFOAM	NS	pramoxine hydrochloride	AEROSOL, FOAM	RECTAL	20140818		OTC MONOGRAPH FINAL	part346	Meda Pharmaceuticals	PRAMOXINE HYDROCHLORIDE	150	mg/15g			N	20241231
0037-6824_74d3a7b5-1602-4861-a662-50fe63a9cdfe	0037-6824	HUMAN PRESCRIPTION DRUG	EPIFOAM		pramoxine hydrochloride and hydrocortisone acetate	AEROSOL, FOAM	TOPICAL	20140825		ANDA	ANDA086457	Meda Pharmaceuticals	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	100; 100	mg/10g; mg/10g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0037-6830_96e601d3-53ec-46d6-9f54-822ef75f5071	0037-6830	HUMAN PRESCRIPTION DRUG	Cortifoam		hydrocortisone acetate	AEROSOL, FOAM	TOPICAL	20150615		NDA	NDA017351	Meda Pharmaceuticals Inc.	HYDROCORTISONE ACETATE	1500	mg/15g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0037-6860_f463a4ea-ba23-47da-af7f-92c2d7367a82	0037-6860	HUMAN PRESCRIPTION DRUG	Dipentum		olsalazine sodium	CAPSULE, GELATIN COATED	ORAL	20150515		NDA	NDA019715	Meda Pharmaceuticals Inc.	OLSALAZINE SODIUM	250	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0037-8120_0209b68d-e74a-43a9-ad21-c9bca0293f0f	0037-8120	HUMAN PRESCRIPTION DRUG	MUSE		Alprostadil	SUPPOSITORY	URETHRAL	20110722		NDA	NDA020700	Meda Pharmaceuticals Inc.	ALPROSTADIL	250	ug/1	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0037-8130_0209b68d-e74a-43a9-ad21-c9bca0293f0f	0037-8130	HUMAN PRESCRIPTION DRUG	MUSE		Alprostadil	SUPPOSITORY	URETHRAL	20110722		NDA	NDA020700	Meda Pharmaceuticals Inc.	ALPROSTADIL	500	ug/1	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0037-8140_0209b68d-e74a-43a9-ad21-c9bca0293f0f	0037-8140	HUMAN PRESCRIPTION DRUG	MUSE		Alprostadil	SUPPOSITORY	URETHRAL	20110722		NDA	NDA020700	Meda Pharmaceuticals Inc.	ALPROSTADIL	1000	ug/1	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
0046-0749_f2e60564-2b7d-4a5f-bc81-226c2c8c43a9	0046-0749	HUMAN PRESCRIPTION DRUG	Premarin		CONJUGATED ESTROGENS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19561201		NDA	NDA010402	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED	25	mg/5mL	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
0046-0872_5a5b8cbf-a567-4438-bef4-a149a404e848	0046-0872	HUMAN PRESCRIPTION DRUG	Premarin	Vaginal	conjugated estrogens	CREAM	VAGINAL	19781101		NDA	NDA020216	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED	.625	mg/g	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
0046-1100_3e3a0f0c-d906-402d-b52e-a85aa069b183	0046-1100	HUMAN PRESCRIPTION DRUG	Premarin		estrogens, conjugated	TABLET, FILM COATED	ORAL	20060101		NDA	NDA004782	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED	.3	mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
0046-1101_3e3a0f0c-d906-402d-b52e-a85aa069b183	0046-1101	HUMAN PRESCRIPTION DRUG	Premarin		estrogens, conjugated	TABLET, FILM COATED	ORAL	20060101		NDA	NDA004782	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED	.45	mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
0046-1102_3e3a0f0c-d906-402d-b52e-a85aa069b183	0046-1102	HUMAN PRESCRIPTION DRUG	Premarin		estrogens, conjugated	TABLET, FILM COATED	ORAL	20060101		NDA	NDA004782	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED	.625	mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
0046-1103_3e3a0f0c-d906-402d-b52e-a85aa069b183	0046-1103	HUMAN PRESCRIPTION DRUG	Premarin		estrogens, conjugated	TABLET, FILM COATED	ORAL	20060101		NDA	NDA004782	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED	.9	mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
0046-1104_3e3a0f0c-d906-402d-b52e-a85aa069b183	0046-1104	HUMAN PRESCRIPTION DRUG	Premarin		estrogens, conjugated	TABLET, FILM COATED	ORAL	20040901		NDA	NDA004782	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED	1.25	mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
0046-1105_bec19a55-9af8-4a30-8c06-e51b896aea30	0046-1105	HUMAN PRESCRIPTION DRUG	Prempro		conjugated estrogens and medroxyprogesterone acetate	TABLET, SUGAR COATED	ORAL	20090921		NDA	NDA020527	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE	.3; 1.5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0046-1106_bec19a55-9af8-4a30-8c06-e51b896aea30	0046-1106	HUMAN PRESCRIPTION DRUG	Prempro		conjugated estrogens and medroxyprogesterone acetate	TABLET, SUGAR COATED	ORAL	20090921		NDA	NDA020527	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE	.45; 1.5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0046-1107_bec19a55-9af8-4a30-8c06-e51b896aea30	0046-1107	HUMAN PRESCRIPTION DRUG	Prempro		conjugated estrogens and medroxyprogesterone acetate	TABLET, SUGAR COATED	ORAL	20090921		NDA	NDA020527	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE	.625; 2.5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0046-1108_bec19a55-9af8-4a30-8c06-e51b896aea30	0046-1108	HUMAN PRESCRIPTION DRUG	Prempro		conjugated estrogens and medroxyprogesterone acetate	TABLET, SUGAR COATED	ORAL	20121203		NDA	NDA020527	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE	.625; 5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0046-2575_bec19a55-9af8-4a30-8c06-e51b896aea30	0046-2575	HUMAN PRESCRIPTION DRUG	Premphase		conjugated estrogens and medroxyprogesterone acetate	KIT		20120301		NDA	NDA020527	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.						N	20241231
0049-0013_a09386af-b482-41e0-a238-2102580792e0	0049-0013	HUMAN PRESCRIPTION DRUG	UNASYN		ampicillin sodium and sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19911122		NDA	NDA050608	Roerig	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0049-0014_a09386af-b482-41e0-a238-2102580792e0	0049-0014	HUMAN PRESCRIPTION DRUG	UNASYN		ampicillin sodium and sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19911122		NDA	NDA050608	Roerig	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0049-0024_014e4daf-a322-4733-b875-1190fd13beba	0049-0024	HUMAN PRESCRIPTION DRUG	UNASYN		ampicillin sodium and sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19911122		NDA	NDA050608	Roerig	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0049-0050_7e6deb58-5cba-493f-a22c-fa59b5c2f58a	0049-0050	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	SOLUTION, CONCENTRATE	ORAL	20170106		NDA	NDA020990	ROERIG	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0049-0054_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-0054	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone hydrochloride	CAPSULE	ORAL	20190319	20240131	NDA	NDA020825	ROERIG	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	
0049-0056_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-0056	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone hydrochloride	CAPSULE	ORAL	20190801		NDA	NDA020825	ROERIG	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0049-0058_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-0058	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone hydrochloride	CAPSULE	ORAL	20190801		NDA	NDA020825	ROERIG	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0049-0114_fa6cff94-4d7e-4240-b7e1-7fd3e573ed47	0049-0114	HUMAN PRESCRIPTION DRUG	ERAXIS		anidulafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060217		NDA	NDA021632	Roerig	ANIDULAFUNGIN	50	mg/15mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0049-0116_fa6cff94-4d7e-4240-b7e1-7fd3e573ed47	0049-0116	HUMAN PRESCRIPTION DRUG	ERAXIS		anidulafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060217		NDA	NDA021632	Roerig	ANIDULAFUNGIN	100	mg/30mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0049-0170_1fdfc3b7-b578-4c68-896e-b8cf38d10fa1	0049-0170	HUMAN PRESCRIPTION DRUG	Glucotrol	XL	glipizide	TABLET, EXTENDED RELEASE	ORAL	20130715		NDA	NDA020329	Roerig	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0049-0174_1fdfc3b7-b578-4c68-896e-b8cf38d10fa1	0049-0174	HUMAN PRESCRIPTION DRUG	Glucotrol	XL	glipizide	TABLET, EXTENDED RELEASE	ORAL	20130509		NDA	NDA020329	Roerig	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0049-0178_1fdfc3b7-b578-4c68-896e-b8cf38d10fa1	0049-0178	HUMAN PRESCRIPTION DRUG	Glucotrol	XL	glipizide	TABLET, EXTENDED RELEASE	ORAL	20130509		NDA	NDA020329	Roerig	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0049-0352_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-0352	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone	CAPSULE	ORAL	20211108		NDA	NDA020825	ROERIG	ZIPRASIDONE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0049-0354_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-0354	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone	CAPSULE	ORAL	20230714		NDA	NDA020825	ROERIG	ZIPRASIDONE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0049-0356_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-0356	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone	CAPSULE	ORAL	20211108		NDA	NDA020825	ROERIG	ZIPRASIDONE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0049-0358_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-0358	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone	CAPSULE	ORAL	20211108		NDA	NDA020825	ROERIG	ZIPRASIDONE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0049-0420_5e86bc2b-252a-4e70-99cb-1358431a3be2	0049-0420	HUMAN PRESCRIPTION DRUG	Pfizerpen		penicillin G potassium	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRATHECAL; INTRAVENOUS	20100601		ANDA	ANDA060657	Roerig	PENICILLIN G POTASSIUM	5000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0049-0430_5e86bc2b-252a-4e70-99cb-1358431a3be2	0049-0430	HUMAN PRESCRIPTION DRUG	Pfizerpen		penicillin G potassium	POWDER, FOR SOLUTION	INTRAVENOUS	20100601		ANDA	ANDA060657	Roerig	PENICILLIN G POTASSIUM	20000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0049-0520_ab28cc25-b99f-48d8-b6a7-add7c51bf52d	0049-0520	HUMAN PRESCRIPTION DRUG	Pfizerpen		penicillin G potassium	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRATHECAL; INTRAVENOUS	20100601		ANDA	ANDA060657	Roerig	PENICILLIN G POTASSIUM	5000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0049-0520_ed6120cf-aa30-4570-b772-ad380e77cfe1	0049-0520	HUMAN PRESCRIPTION DRUG	Pfizerpen		penicillin G potassium	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRATHECAL; INTRAVENOUS	20100601		ANDA	ANDA060657	Roerig	PENICILLIN G POTASSIUM	5000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0049-0530_ab28cc25-b99f-48d8-b6a7-add7c51bf52d	0049-0530	HUMAN PRESCRIPTION DRUG	Pfizerpen		penicillin G potassium	POWDER, FOR SOLUTION	INTRAVENOUS	20100601		ANDA	ANDA060657	Roerig	PENICILLIN G POTASSIUM	20000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0049-0530_ed6120cf-aa30-4570-b772-ad380e77cfe1	0049-0530	HUMAN PRESCRIPTION DRUG	Pfizerpen		penicillin G potassium	POWDER, FOR SOLUTION	INTRAVENOUS	20100601		ANDA	ANDA060657	Roerig	PENICILLIN G POTASSIUM	20000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0049-2040_1133046b-9788-40f7-8683-760dd9497067	0049-2040	HUMAN PRESCRIPTION DRUG	Cardura	XL	doxazosin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210121		NDA	NDA021269	Roerig	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0049-2080_1133046b-9788-40f7-8683-760dd9497067	0049-2080	HUMAN PRESCRIPTION DRUG	Cardura	XL	doxazosin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20220426	20250331	NDA	NDA021269	Roerig	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
0049-2330_20f8821b-f61b-4a2c-aeb8-8f723e3f7f8b	0049-2330	HUMAN PRESCRIPTION DRUG	Relpax		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20021226		NDA	NDA021016	ROERIG	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0049-2340_20f8821b-f61b-4a2c-aeb8-8f723e3f7f8b	0049-2340	HUMAN PRESCRIPTION DRUG	Relpax		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20021226		NDA	NDA021016	ROERIG	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0049-2410_86e7f4c5-4855-4568-a444-c1e810ab4614	0049-2410	HUMAN PRESCRIPTION DRUG	Cardura		doxazosin	TABLET	ORAL	20211019		NDA	NDA019668	ROERIG	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0049-2512_86e7f4c5-4855-4568-a444-c1e810ab4614	0049-2512	HUMAN PRESCRIPTION DRUG	Cardura		doxazosin	TABLET	ORAL	20211019		NDA	NDA019668	ROERIG	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0049-2614_86e7f4c5-4855-4568-a444-c1e810ab4614	0049-2614	HUMAN PRESCRIPTION DRUG	Cardura		doxazosin	TABLET	ORAL	20211019		NDA	NDA019668	ROERIG	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0049-2716_86e7f4c5-4855-4568-a444-c1e810ab4614	0049-2716	HUMAN PRESCRIPTION DRUG	Cardura		doxazosin	TABLET	ORAL	20230215		NDA	NDA019668	ROERIG	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0049-3160_d2d9cc9b-9859-4f59-8d06-05d2de5eb192	0049-3160	HUMAN PRESCRIPTION DRUG	VFEND		voriconazole	POWDER, FOR SUSPENSION	ORAL	20030328		NDA	NDA021630	Roerig	VORICONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3170_d2d9cc9b-9859-4f59-8d06-05d2de5eb192	0049-3170	HUMAN PRESCRIPTION DRUG	VFEND		voriconazole	TABLET, FILM COATED	ORAL	20030328		NDA	NDA021266	Roerig	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3180_d2d9cc9b-9859-4f59-8d06-05d2de5eb192	0049-3180	HUMAN PRESCRIPTION DRUG	VFEND		voriconazole	TABLET, FILM COATED	ORAL	20030328		NDA	NDA021266	Roerig	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3190_91925285-3037-4bf6-8f10-654c72bb0a57	0049-3190	HUMAN PRESCRIPTION DRUG	VFEND		voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20121024		NDA	NDA021267	Roerig	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3190_d2d9cc9b-9859-4f59-8d06-05d2de5eb192	0049-3190	HUMAN PRESCRIPTION DRUG	VFEND		voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20030328		NDA	NDA021267	Roerig	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3190_f098cc33-f6ee-4a49-9329-cbc1d1c31bd2	0049-3190	HUMAN PRESCRIPTION DRUG	VFEND		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20020524		NDA	NDA021267	Roerig	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3420_e4a1a4d9-aed8-4fc4-a66d-ec9bb4023a29	0049-3420	HUMAN PRESCRIPTION DRUG	Diflucan		fluconazole	TABLET	ORAL	19900129		NDA	NDA019949	Roerig	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3430_e4a1a4d9-aed8-4fc4-a66d-ec9bb4023a29	0049-3430	HUMAN PRESCRIPTION DRUG	Diflucan		fluconazole	TABLET	ORAL	19900129		NDA	NDA019949	Roerig	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3440_e4a1a4d9-aed8-4fc4-a66d-ec9bb4023a29	0049-3440	HUMAN PRESCRIPTION DRUG	Diflucan		fluconazole	POWDER, FOR SUSPENSION	ORAL	19931223		NDA	NDA020090	Roerig	FLUCONAZOLE	350	mg/35mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3450_e4a1a4d9-aed8-4fc4-a66d-ec9bb4023a29	0049-3450	HUMAN PRESCRIPTION DRUG	Diflucan		fluconazole	POWDER, FOR SUSPENSION	ORAL	19931223		NDA	NDA020090	Roerig	FLUCONAZOLE	1400	mg/35mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3500_e4a1a4d9-aed8-4fc4-a66d-ec9bb4023a29	0049-3500	HUMAN PRESCRIPTION DRUG	Diflucan		fluconazole	TABLET	ORAL	19940630		NDA	NDA019949	Roerig	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-3920_5b52c7ea-0f28-4231-8445-56d3e32311a0	0049-3920	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20031223		NDA	NDA020919	ROERIG	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
0049-4190_d827ff6f-9a87-4641-b400-497661924dde	0049-4190	HUMAN PRESCRIPTION DRUG	VFEND		VORICONAZOLE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20121024		NDA	NDA021267	Roerig	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0049-4900_7e6deb58-5cba-493f-a22c-fa59b5c2f58a	0049-4900	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	TABLET, FILM COATED	ORAL	19920211		NDA	NDA019839	ROERIG	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0049-4910_7e6deb58-5cba-493f-a22c-fa59b5c2f58a	0049-4910	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	TABLET, FILM COATED	ORAL	19920211		NDA	NDA019839	ROERIG	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0049-4960_7e6deb58-5cba-493f-a22c-fa59b5c2f58a	0049-4960	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	TABLET, FILM COATED	ORAL	19920211		NDA	NDA019839	ROERIG	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0051-8462_20e9e091-ab9f-4e48-a13d-fcbc93d94637	0051-8462	HUMAN PRESCRIPTION DRUG	Androgel		Testosterone	GEL	TRANSDERMAL	20110429	20250501	NDA	NDA022309	AbbVie Inc.	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	
0052-0313_24d5b4a2-b184-4c46-8bde-e0d4c7cc3f8b	0052-0313	HUMAN PRESCRIPTION DRUG	Follistim AQ		follitropin	INJECTION, SOLUTION	SUBCUTANEOUS	20040324		BLA	BLA021211	Merck Sharp & Dohme LLC	FOLLITROPIN	350	[iU]/.42mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
0052-0315_169aacc4-4598-4680-8bc4-37c09935677e	0052-0315	HUMAN PRESCRIPTION DRUG	Pregnyl		CHORIOGONADOTROPIN ALFA	KIT		19761020		BLA	BLA017692	Merck Sharp & Dohme LLC						N	20241231
0052-0316_24d5b4a2-b184-4c46-8bde-e0d4c7cc3f8b	0052-0316	HUMAN PRESCRIPTION DRUG	Follistim AQ		follitropin	INJECTION, SOLUTION	SUBCUTANEOUS	20040324		BLA	BLA021211	Merck Sharp & Dohme LLC	FOLLITROPIN	650	[iU]/.78mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
0052-0326_24d5b4a2-b184-4c46-8bde-e0d4c7cc3f8b	0052-0326	HUMAN PRESCRIPTION DRUG	Follistim AQ		follitropin	INJECTION, SOLUTION	SUBCUTANEOUS	20040324		BLA	BLA021211	Merck Sharp & Dohme LLC	FOLLITROPIN	975	[iU]/1.17mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
0052-0602_192772ac-a779-4cbb-a1ba-d69d84883736	0052-0602	HUMAN PRESCRIPTION DRUG	TICE BCG		BACILLUS CALMETTE-GUERIN	POWDER, FOR SUSPENSION	INTRAVESICAL	19900824		BLA	BLA102821	Merck Sharp & Dohme LLC	BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN	50	mg/50mL	Actively Acquired Immunity [PE], BCG Vaccine [CS], Increased Immunologically Active Molecule Activity [PE], Increased Macrophage Proliferation [PE], Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC], Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC], Vaccines, Attenuated [CS]		N	20241231
0052-0603_1859426f-1c17-4e9c-8ebe-28e1be203344	0052-0603	VACCINE	BCG VACCINE		BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS	19890621		BLA	BLA103050	Merck Sharp & Dohme LLC	BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN	50	mg/1	Actively Acquired Immunity [PE], BCG Vaccine [CS], Increased Immunologically Active Molecule Activity [PE], Increased Macrophage Proliferation [PE], Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC], Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC], Vaccines, Attenuated [CS]		N	20241231
0053-0100_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0100	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0110_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0110	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0120_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0120	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0130_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0130	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0140_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0140	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0150_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0150	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0160_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0160	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0170_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0170	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0180_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0180	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0190_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0190	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0200_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0200	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0210_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0210	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0220_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0220	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0230_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0230	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0240_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0240	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0250_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0250	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0260_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0260	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0270_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0270	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0280_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0280	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0290_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0290	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0300_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0300	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0310_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0310	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0320_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0320	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0330_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0330	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0340_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0340	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0350_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0350	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0360_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0360	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0370_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0370	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0380_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0380	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0390_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0390	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0400_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0400	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0410_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0410	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0420_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0420	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0430_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0430	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0440_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0440	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0450_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0450	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0460_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0460	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0470_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0470	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-0480_37461df8-e3a4-4052-bcf5-eb1e5cc56de1	0053-0480	HUMAN PRESCRIPTION DRUG	HEMGENIX		etranacogene dezaparvovec	KIT		20221122		BLA	BLA125772	CSL Behring						N	20241231
0053-7201_c2b6f34e-ac6e-42e8-86f2-63b8bf151b48	0053-7201	PLASMA DERIVATIVE	Zemaira		alpha-1-proteinase inhibitor human	KIT		20030708		BLA	BLA125078	CSL Behring LLC						N	20241231
0053-7202_c2b6f34e-ac6e-42e8-86f2-63b8bf151b48	0053-7202	PLASMA DERIVATIVE	ZEMAIRA		.ALPHA.1-PROTEINASE INHIBITOR HUMAN	KIT		20190424		BLA	BLA125078	CSL Behring LLC						N	20241231
0053-7203_c2b6f34e-ac6e-42e8-86f2-63b8bf151b48	0053-7203	PLASMA DERIVATIVE	ZEMAIRA		.ALPHA.1-PROTEINASE INHIBITOR HUMAN	KIT		20190424		BLA	BLA125078	CSL Behring LLC						N	20241231
0054-0007_5b41206d-3af7-4aea-83b5-fc7973c85353	0054-0007	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE	ORAL	20060327		ANDA	ANDA076917	Hikma Pharmaceuticals USA Inc.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20251231
0054-0010_d6c6bfea-c932-47cc-ae30-c1f59f8623f5	0054-0010	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20030114		ANDA	ANDA076278	Hikma Pharmaceuticals USA Inc.	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
0054-0011_d6c6bfea-c932-47cc-ae30-c1f59f8623f5	0054-0011	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20030114		ANDA	ANDA076278	Hikma Pharmaceuticals USA Inc.	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
0054-0012_d6c6bfea-c932-47cc-ae30-c1f59f8623f5	0054-0012	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20030114		ANDA	ANDA076278	Hikma Pharmaceuticals USA Inc.	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
0054-0017_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-0017	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030213		ANDA	ANDA084122	Hikma Pharmaceuticals USA Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-0018_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-0018	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030213		ANDA	ANDA087342	Hikma Pharmaceuticals USA Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-0019_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-0019	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030314		ANDA	ANDA084283	Hikma Pharmaceuticals USA Inc.	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-0020_17dfc90a-8988-4e63-aaa0-9c88c4a7d1bf	0054-0020	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20040113		ANDA	ANDA076691	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-0021_5e0351f3-360d-4044-a40a-a36f0008cf92	0054-0021	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20041028		ANDA	ANDA076832	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-0025_e6ca0066-8671-4719-8707-90b4121cba11	0054-0025	HUMAN PRESCRIPTION DRUG	Mefloquine Hydrochloride		mefloquine hydrochloride	TABLET	ORAL	20041001		ANDA	ANDA076523	Hikma Pharmaceuticals USA Inc.	MEFLOQUINE HYDROCHLORIDE	250	mg/1	Antimalarial [EPC]		N	20241231
0054-0028_d872300b-ff60-4709-a667-aab53462bfac	0054-0028	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20050517		ANDA	ANDA077024	West-Ward Pharmaceuticals Corp.	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0054-0044_d872300b-ff60-4709-a667-aab53462bfac	0054-0044	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20050517		ANDA	ANDA077024	West-Ward Pharmaceuticals Corp.	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0054-0045_b5392074-d029-4f71-adff-f2484b47671f	0054-0045	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY	NASAL	20031105		ANDA	ANDA076664	West-Ward Pharmaceuticals Corp.	IPRATROPIUM BROMIDE	21	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0054-0046_5523ec2e-969f-431d-8eb2-258fe8fe4160	0054-0046	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY	NASAL	20031105		ANDA	ANDA076598	West-Ward Pharmaceuticals Corp.	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0054-0057_7a1520a8-09f2-424a-a825-01156b57db5f	0054-0057	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	SOLUTION	ORAL	20040826		NDA	NDA021648	West-Ward Pharmaceuticals Corp.	DIGOXIN	.05	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0054-0062_6a701183-6c4f-448f-a05a-81ee7f5b734f	0054-0062	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	SOLUTION	ORAL	20040525		ANDA	ANDA077043	Hikma Pharmaceuticals USA Inc.	CITALOPRAM HYDROBROMIDE	10	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0054-0063_a2db7d9b-79ed-4768-9ef1-d3ea0dadb0fa	0054-0063	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	SOLUTION	ORAL	20090729		ANDA	ANDA076904	Hikma Pharmaceuticals USA Inc.	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
0054-0064_5888823c-c0e3-4b3b-ba2d-2054951af97a	0054-0064	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	SOLUTION	ORAL	20061226		ANDA	ANDA076960	Hikma Pharmaceuticals USA Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0054-0077_978f435d-eae6-49b7-80cd-6c951abce99f	0054-0077	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20050303		ANDA	ANDA076943	Hikma Pharmaceuticals USA Inc.	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-0079_70a5c5b6-174b-4974-992e-3b977f52a4e3	0054-0079	HUMAN PRESCRIPTION DRUG	Balsalazide Disodium		Balsalazide Disodium	CAPSULE	ORAL	20071228		ANDA	ANDA077806	Hikma Pharmaceuticals USA Inc.	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0054-0080_76ca55bd-c459-4de7-8f26-33349ceb2462	0054-0080	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET, FILM COATED	ORAL	20110401		ANDA	ANDA077431	Hikma Pharmaceuticals USA Inc	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
0054-0084_8ebd4014-d092-45c8-8c96-62713d44598d	0054-0084	HUMAN PRESCRIPTION DRUG	Zaleplon		Zaleplon	CAPSULE	ORAL	20080606		ANDA	ANDA077237	West-Ward Pharmaceuticals Corp.	ZALEPLON	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
0054-0085_8ebd4014-d092-45c8-8c96-62713d44598d	0054-0085	HUMAN PRESCRIPTION DRUG	Zaleplon		Zaleplon	CAPSULE	ORAL	20080606		ANDA	ANDA077237	West-Ward Pharmaceuticals Corp.	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
0054-0088_454bd52f-2207-47c9-95c0-d59fd38b87c7	0054-0088	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20080226		ANDA	ANDA077728	Hikma Pharmaceuticals USA Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0054-0106_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4	0054-0106	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Hikma Pharmaceuticals USA Inc.	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0054-0107_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4	0054-0107	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Hikma Pharmaceuticals USA Inc.	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0054-0108_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4	0054-0108	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Hikma Pharmaceuticals USA Inc.	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0054-0109_4019e596-dfb9-43a4-b027-a2bdf6d0f5b4	0054-0109	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Hikma Pharmaceuticals USA Inc.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0054-0137_b2bf3efc-7521-4ff7-b77c-6e312e34b3c4	0054-0137	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	SOLUTION	ORAL	20090814		ANDA	ANDA078185	Hikma Pharmaceuticals USA Inc.	GALANTAMINE HYDROBROMIDE	4	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
0054-0140_68881739-6edb-4c67-be06-14953f60a146	0054-0140	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20080507		ANDA	ANDA078470	Hikma Pharmaceuticals USA Inc.	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
0054-0141_68881739-6edb-4c67-be06-14953f60a146	0054-0141	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20080507		ANDA	ANDA078470	Hikma Pharmaceuticals USA Inc.	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
0054-0142_68881739-6edb-4c67-be06-14953f60a146	0054-0142	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20080507		ANDA	ANDA078470	Hikma Pharmaceuticals USA Inc.	ACARBOSE	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
0054-0163_26b454ba-2535-4aba-9199-782ebc1fefc8	0054-0163	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	CAPSULE	ORAL	20080729		ANDA	ANDA065410	Hikma Pharmaceuticals USA Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0054-0166_26b454ba-2535-4aba-9199-782ebc1fefc8	0054-0166	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	TABLET	ORAL	20080729		ANDA	ANDA065413	Hikma Pharmaceuticals USA Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0054-0176_befbc7ee-700d-4c0c-9b0d-7c6076b3aec4	0054-0176	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20091008		ANDA	ANDA078633	Hikma Pharmaceuticals USA Inc.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0054-0177_befbc7ee-700d-4c0c-9b0d-7c6076b3aec4	0054-0177	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20091008		ANDA	ANDA078633	Hikma Pharmaceuticals USA Inc.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0054-0188_1055d41b-9222-44ec-b732-024497a6269c	0054-0188	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride and naloxone hydrochloride dihydrate		buprenorphine hydrochloride and naloxone hydrochloride dihydrate	TABLET	SUBLINGUAL	20140627		ANDA	ANDA203326	Hikma Pharmaceuticals USA Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0054-0189_1055d41b-9222-44ec-b732-024497a6269c	0054-0189	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride and naloxone hydrochloride dihydrate		buprenorphine hydrochloride and naloxone hydrochloride dihydrate	TABLET	SUBLINGUAL	20140627		ANDA	ANDA203326	Hikma Pharmaceuticals USA Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0054-0199_84e5c5d4-55ab-4bbe-9d32-de0f65f3aedd	0054-0199	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	SUSPENSION	ORAL	20121003		ANDA	ANDA201193	Hikma Pharmaceuticals USA Inc.	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0054-0210_472157bf-1092-42ce-891c-80d59d11b168	0054-0210	HUMAN PRESCRIPTION DRUG	Protriptyline Hydrochloride		Protriptyline Hydrochloride	TABLET	ORAL	20080916		ANDA	ANDA078913	Hikma Pharmaceuticals USA Inc.	PROTRIPTYLINE HYDROCHLORIDE	5	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0054-0211_472157bf-1092-42ce-891c-80d59d11b168	0054-0211	HUMAN PRESCRIPTION DRUG	Protriptyline Hydrochloride		Protriptyline Hydrochloride	TABLET	ORAL	20080916		ANDA	ANDA078913	Hikma Pharmaceuticals USA Inc.	PROTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0054-0220_dba92d73-0329-4152-9add-7a53f2fe250b	0054-0220	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090120	West-Ward Pharmaceuticals Corp	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0054-0221_dba92d73-0329-4152-9add-7a53f2fe250b	0054-0221	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	West-Ward Pharmaceuticals Corp	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0054-0222_dba92d73-0329-4152-9add-7a53f2fe250b	0054-0222	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	West-Ward Pharmaceuticals Corp	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0054-0223_dba92d73-0329-4152-9add-7a53f2fe250b	0054-0223	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	West-Ward Pharmaceuticals Corp	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0054-0229_dba92d73-0329-4152-9add-7a53f2fe250b	0054-0229	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	West-Ward Pharmaceuticals Corp	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0054-0230_dba92d73-0329-4152-9add-7a53f2fe250b	0054-0230	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	West-Ward Pharmaceuticals Corp	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0054-0235_06d834e8-8080-43c7-81b7-eb1099140c56	0054-0235	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20080317		NDA	NDA022207	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0236_06d834e8-8080-43c7-81b7-eb1099140c56	0054-0236	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20080317		NDA	NDA022207	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0237_ea803a79-d08a-463e-acaf-9c5373b05eb5	0054-0237	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20080317		NDA	NDA022195	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0238_ea803a79-d08a-463e-acaf-9c5373b05eb5	0054-0238	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20080317		NDA	NDA022195	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	20	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0243_98a36372-b8c6-4717-8e49-ed62329404e6	0054-0243	HUMAN PRESCRIPTION DRUG	Codeine sulfate		codeine sulfate	TABLET	ORAL	20090716		NDA	NDA022402	Hikma Pharmaceuticals USA Inc.	CODEINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0244_98a36372-b8c6-4717-8e49-ed62329404e6	0054-0244	HUMAN PRESCRIPTION DRUG	Codeine sulfate		codeine sulfate	TABLET	ORAL	20090716		NDA	NDA022402	Hikma Pharmaceuticals USA Inc.	CODEINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0245_98a36372-b8c6-4717-8e49-ed62329404e6	0054-0245	HUMAN PRESCRIPTION DRUG	Codeine sulfate		codeine sulfate	TABLET	ORAL	20090716		NDA	NDA022402	Hikma Pharmaceuticals USA Inc.	CODEINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0254_1786e07d-ad22-4e8b-b999-3442da68882e	0054-0254	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20121015		ANDA	ANDA090351	Hikma Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0054-0255_1786e07d-ad22-4e8b-b999-3442da68882e	0054-0255	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20121015		ANDA	ANDA090351	Hikma Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0054-0264_2cc0f9e7-3ad5-43e8-9bce-cc64d12eb184	0054-0264	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		hydromorphone hydrochloride	TABLET	ORAL	20090729		ANDA	ANDA074597	Hikma Pharmaceuticals USA Inc.	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0265_2cc0f9e7-3ad5-43e8-9bce-cc64d12eb184	0054-0265	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		hydromorphone hydrochloride	TABLET	ORAL	20090729		ANDA	ANDA074597	Hikma Pharmaceuticals USA Inc.	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0271_603f67a5-f415-46d7-95ce-5168f26bd46b	0054-0271	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20160715		ANDA	ANDA200483	Hikma Pharmaceuticals USA Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0054-0272_603f67a5-f415-46d7-95ce-5168f26bd46b	0054-0272	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20160715		ANDA	ANDA200483	Hikma Pharmaceuticals USA Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0054-0273_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1	0054-0273	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100419		ANDA	ANDA091099	Hikma Pharmaceuticals USA Inc	IMIPRAMINE PAMOATE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0054-0274_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1	0054-0274	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100419		ANDA	ANDA091099	Hikma Pharmaceuticals USA Inc	IMIPRAMINE PAMOATE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0054-0275_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1	0054-0275	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100419		ANDA	ANDA091099	Hikma Pharmaceuticals USA Inc	IMIPRAMINE PAMOATE	125	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0054-0276_4f0700ec-c11f-4f9a-a99b-8f6c7c1186d1	0054-0276	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100419		ANDA	ANDA091099	Hikma Pharmaceuticals USA Inc	IMIPRAMINE PAMOATE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0054-0278_14eeba7d-700d-4ac1-a71e-d6a1fca8aaab	0054-0278	HUMAN PRESCRIPTION DRUG	Naratriptan		Naratriptan	TABLET	ORAL	20100707		ANDA	ANDA090381	Hikma Pharmaceuticals USA Inc.	NARATRIPTAN HYDROCHLORIDE	1	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0054-0279_14eeba7d-700d-4ac1-a71e-d6a1fca8aaab	0054-0279	HUMAN PRESCRIPTION DRUG	Naratriptan		Naratriptan	TABLET	ORAL	20100707		ANDA	ANDA090381	Hikma Pharmaceuticals USA Inc.	NARATRIPTAN HYDROCHLORIDE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0054-0282_850e217b-2c59-48c1-a7fc-92f991060186	0054-0282	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	SOLUTION	ORAL	20201030		ANDA	ANDA090520	Hikma Pharmaceuticals USA Inc.	ALENDRONATE SODIUM	70	mg/75mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0054-0283_0e7efe87-54a9-4643-8ee7-d43f597941fe	0054-0283	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		oxymorphone hydrochloride	TABLET	ORAL	20100927		ANDA	ANDA090964	Hikma Pharmaceuticals USA Inc.	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0284_0e7efe87-54a9-4643-8ee7-d43f597941fe	0054-0284	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		oxymorphone hydrochloride	TABLET	ORAL	20100927		ANDA	ANDA090964	Hikma Pharmaceuticals USA Inc.	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0293_420d7fc2-1aed-4a14-a6ce-db173115f1f2	0054-0293	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		Azelastine Hydrochloride	SPRAY, METERED	NASAL	20141027		ANDA	ANDA091444	West-Ward Pharmaceuticals Corp.	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0054-0319_54d662b1-db69-44cd-9bbf-b2d018aa43f6	0054-0319	HUMAN PRESCRIPTION DRUG	Linezolid		linezolid	POWDER, FOR SUSPENSION	ORAL	20150603		ANDA	ANDA200068	Hikma Pharmaceuticals USA Inc.	LINEZOLID	100	mg/5mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0054-0326_2af0cc77-a2bd-478e-b2e8-e9b125f564de	0054-0326	HUMAN PRESCRIPTION DRUG	fluticasone propionate and salmeterol		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20201217		ANDA	ANDA203433	Hikma Pharmaceuticals USA Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	100; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0054-0327_2af0cc77-a2bd-478e-b2e8-e9b125f564de	0054-0327	HUMAN PRESCRIPTION DRUG	fluticasone propionate and salmeterol		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20201217		ANDA	ANDA203433	Hikma Pharmaceuticals USA Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0054-0328_2af0cc77-a2bd-478e-b2e8-e9b125f564de	0054-0328	HUMAN PRESCRIPTION DRUG	fluticasone propionate and salmeterol		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20201217		ANDA	ANDA203433	Hikma Pharmaceuticals USA Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	500; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0054-0334_f6904d40-78ae-4f7a-ad6b-65d63902651c	0054-0334	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride		Cevimeline Hydrochloride	CAPSULE	ORAL	20130708		ANDA	ANDA091591	Hikma Pharmaceuticals USA Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0054-0349_b5316254-0082-4bab-8111-734af78f6576	0054-0349	HUMAN PRESCRIPTION DRUG	Phenoxybenzamine Hydrochloride		Phenoxybenzamine Hydrochloride	CAPSULE	ORAL	20150810		ANDA	ANDA201050	Hikma Pharmaceuticals USA Inc.	PHENOXYBENZAMINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0054-0357_e594ecbf-a6fe-4722-87db-b970a4639883	0054-0357	HUMAN PRESCRIPTION DRUG	Disulfiram		Disulfiram	TABLET	ORAL	20141104		ANDA	ANDA202652	Hikma Pharmaceuticals USA Inc.	DISULFIRAM	500	mg/1	Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]		N	20241231
0054-0370_aa48e74a-afca-4456-929e-2c40f1fa2d38	0054-0370	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0054-0371_aa48e74a-afca-4456-929e-2c40f1fa2d38	0054-0371	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0054-0372_aa48e74a-afca-4456-929e-2c40f1fa2d38	0054-0372	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0054-0373_aa48e74a-afca-4456-929e-2c40f1fa2d38	0054-0373	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0054-0374_aa48e74a-afca-4456-929e-2c40f1fa2d38	0054-0374	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0054-0375_aa48e74a-afca-4456-929e-2c40f1fa2d38	0054-0375	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0054-0382_aa018ad1-e8c6-44c9-a240-39615186b777	0054-0382	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20130916		NDA	NDA203856	Hikma Pharmaceuticals USA Inc.	CYCLOPHOSPHAMIDE	25	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0054-0383_aa018ad1-e8c6-44c9-a240-39615186b777	0054-0383	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20130916		NDA	NDA203856	Hikma Pharmaceuticals USA Inc.	CYCLOPHOSPHAMIDE	50	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0054-0386_2cc0f9e7-3ad5-43e8-9bce-cc64d12eb184	0054-0386	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		hydromorphone hydrochloride	SOLUTION	ORAL	20120301		ANDA	ANDA074653	Hikma Pharmaceuticals USA Inc.	HYDROMORPHONE HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0389_e3885555-8e95-4377-8583-99abc1f5b5f5	0054-0389	HUMAN PRESCRIPTION DRUG	Methamphetamine Hydrochloride		Methamphetamine Hydrochloride	TABLET	ORAL	20161206		ANDA	ANDA203846	Hikma Pharmaceuticals USA Inc.	METHAMPHETAMINE HYDROCHLORIDE	5	mg/1	Amphetamine Anorectic [EPC], Amphetamines [CS], Appetite Suppression [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE]	CII	N	20241231
0054-0390_0cb44981-167f-45c3-b2da-4a83f2c2b7d5	0054-0390	HUMAN PRESCRIPTION DRUG	oxycodone hydrochloride		oxycodone hydrochloride	SOLUTION	ORAL	20140904		ANDA	ANDA204037	Hikma Pharmceuticals USA Inc.	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0391_b9a70827-03b9-47c6-adc6-a785a407ae3b	0054-0391	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	CONCENTRATE	ORAL	20100623		ANDA	ANDA089897	Hikma Pharmaceuticals USA	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0392_b9a70827-03b9-47c6-adc6-a785a407ae3b	0054-0392	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	CONCENTRATE	ORAL	20100316		ANDA	ANDA040180	Hikma Pharmaceuticals USA	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0399_84e77a4e-27da-404f-8386-b9255d465b1d	0054-0399	HUMAN PRESCRIPTION DRUG	Bexarotene		bexarotene	CAPSULE, LIQUID FILLED	ORAL	20201111		ANDA	ANDA203663	Hikma Pharmaceuticals USA Inc.	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
0054-0400_60781e20-3d08-4162-b341-fa544f6a846e	0054-0400	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204082	Hikma Pharmaceuticals USA Inc.	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0054-0401_60781e20-3d08-4162-b341-fa544f6a846e	0054-0401	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204083	Hikma Pharmaceuticals USA Inc.	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0054-0407_e167f497-2f1b-42f7-b807-a3a117385238	0054-0407	HUMAN PRESCRIPTION DRUG	Ritonavir		Ritonavir	TABLET, FILM COATED	ORAL	20180320		ANDA	ANDA202573	West-Ward Pharmaceuticals Corp.	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0054-0413_bbddff32-f902-4e38-94fb-a1b903d69ee8	0054-0413	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20191111		ANDA	ANDA205414	Hikma Pharmaceuticals USA Inc	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0054-0414_bbddff32-f902-4e38-94fb-a1b903d69ee8	0054-0414	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20191111		ANDA	ANDA205414	Hikma Pharmaceuticals USA Inc	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0054-0425_72348f03-413e-4d00-be89-00c719af669b	0054-0425	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	TABLET, FILM COATED	ORAL	20210530		ANDA	ANDA204988	Hikma Pharmaceuticals USA Inc.	RUFINAMIDE	200	mg/1			N	20241231
0054-0426_72348f03-413e-4d00-be89-00c719af669b	0054-0426	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	TABLET, FILM COATED	ORAL	20210530		ANDA	ANDA204988	Hikma Pharmaceuticals USA Inc.	RUFINAMIDE	400	mg/1			N	20241231
0054-0427_8e4eba6c-6315-436c-a5de-f5e37418ccf9	0054-0427	HUMAN PRESCRIPTION DRUG	flucytosine		flucytosine	CAPSULE	ORAL	20171017		ANDA	ANDA206550	Hikma Pharmaceuticals USA Inc.	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
0054-0428_8e4eba6c-6315-436c-a5de-f5e37418ccf9	0054-0428	HUMAN PRESCRIPTION DRUG	flucytosine		flucytosine	CAPSULE	ORAL	20171017		ANDA	ANDA206550	Hikma Pharmaceuticals USA Inc.	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
0054-0438_b8de266f-b53d-4ae1-8c39-902508ee916b	0054-0438	HUMAN PRESCRIPTION DRUG	LEVORPHANOL TARTRATE		LEVORPHANOL TARTRATE	TABLET	ORAL	20000331		ANDA	ANDA074278	Hikma Pharmaceuticals USA Inc.	LEVORPHANOL TARTRATE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0449_556ea2e4-19af-4a7d-b0c3-72478c6a58f2	0054-0449	HUMAN PRESCRIPTION DRUG	posaconazole		posaconazole	SUSPENSION	ORAL	20230329		ANDA	ANDA208773	Hikma Pharmaceuticals USA Inc.	POSACONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0054-0470_9b85d4ee-2847-4f7b-ad84-8342e3e8b66f	0054-0470	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200310		ANDA	ANDA206133	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	.25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0471_9b85d4ee-2847-4f7b-ad84-8342e3e8b66f	0054-0471	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200310		ANDA	ANDA206133	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0472_9b85d4ee-2847-4f7b-ad84-8342e3e8b66f	0054-0472	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200310		ANDA	ANDA206133	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	.75	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0480_014da38d-f101-4816-8730-25040db4cf05	0054-0480	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200608		ANDA	ANDA207486	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0481_014da38d-f101-4816-8730-25040db4cf05	0054-0481	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200608		ANDA	ANDA207486	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0482_014da38d-f101-4816-8730-25040db4cf05	0054-0482	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200608		ANDA	ANDA207486	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0497_014da38d-f101-4816-8730-25040db4cf05	0054-0497	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200608		ANDA	ANDA207486	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0508_2417e4be-d579-4c3d-8ec0-a42dc51aabf5	0054-0508	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE	ORAL	20201104		ANDA	ANDA209457	Hikma Pharmaceuticals USA Inc.	ICOSAPENT ETHYL	1	g/1			N	20241231
0054-0517_ea803a79-d08a-463e-acaf-9c5373b05eb5	0054-0517	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20080317		NDA	NDA022195	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0528_eb1cdda2-10c1-4acc-ab6a-c6aba2c7db80	0054-0528	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	SUSPENSION	ORAL	20201101		ANDA	ANDA207363	Hikma Pharmaceuticals USA Inc.	RUFINAMIDE	40	mg/mL			N	20241231
0054-0532_32e24bbf-d284-4365-9aab-947496046910	0054-0532	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA212835	Hikma Pharmaceuticals USA Inc.	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
0054-0533_32e24bbf-d284-4365-9aab-947496046910	0054-0533	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA212835	Hikma Pharmaceuticals USA Inc.	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
0054-0534_32e24bbf-d284-4365-9aab-947496046910	0054-0534	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA212835	Hikma Pharmaceuticals USA Inc.	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
0054-0548_24b07b6f-e918-41cf-8db1-a72e33911118	0054-0548	HUMAN PRESCRIPTION DRUG	Lidocaine Viscous		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19850426		ANDA	ANDA088802	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0054-0576_f52c4949-6261-46d0-beda-5ceb8ce227a9	0054-0576	HUMAN PRESCRIPTION DRUG	Deferiprone		Deferiprone	TABLET, COATED	ORAL	20210603		ANDA	ANDA213239	Hikma Pharmaceuticals USA Inc.	DEFERIPRONE	500	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0054-0603_60781e20-3d08-4162-b341-fa544f6a846e	0054-0603	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170829		ANDA	ANDA204082	Hikma Pharmaceuticals USA Inc.	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0054-0604_9b85d4ee-2847-4f7b-ad84-8342e3e8b66f	0054-0604	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20211118		ANDA	ANDA206133	Hikma Pharmaceuticals USA Inc.	EVEROLIMUS	1	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0054-0621_2417e4be-d579-4c3d-8ec0-a42dc51aabf5	0054-0621	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE	ORAL	20201104		ANDA	ANDA209457	Hikma Pharmaceuticals USA Inc.	ICOSAPENT ETHYL	.5	g/1			N	20241231
0054-0622_8ad8c412-22d6-424f-9a52-48074ab28d4f	0054-0622	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	SOLUTION	ORAL	20200522		ANDA	ANDA212286	Hikma Pharmaceuticals USA Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0054-0639_f4e0883a-f280-7586-e053-2995a90abccd	0054-0639	HUMAN PRESCRIPTION DRUG	Methylergonovine Maleate		Methylergonovine Maleate	TABLET	ORAL	20180703		ANDA	ANDA210424	West-Ward Pharmaceuticals Corp	METHYLERGONOVINE MALEATE	.2	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
0054-0650_604e214c-d5fb-4061-9a88-b582d3a45f28	0054-0650	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20220509		ANDA	ANDA215138	Hikma Pharmaceuticals USA Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	300; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
0054-0652_5ed8d293-b7d8-4c66-9c31-8075e6f99092	0054-0652	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	TABLET	ORAL	20220909		ANDA	ANDA213104	Hikma Pharmaceuticals USA Inc	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
0054-0702_f4cea32f-ca86-ce64-e053-2995a90a3cd1	0054-0702	HUMAN PRESCRIPTION DRUG	Vigabatrin for oral solution USP, 500 mg		Vigabatrin	FOR SOLUTION	ORAL	20200710		ANDA	ANDA213469	Hikma Pharmaceuticals USA Inc.	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
0054-0709_7bcd7538-6d84-4238-8628-3206ac2015e4	0054-0709	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	19830308		ANDA	ANDA088108	Hikma Pharmaceuticals USA Inc.	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0710_7bcd7538-6d84-4238-8628-3206ac2015e4	0054-0710	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	19830308		ANDA	ANDA088109	Hikma Pharmaceuticals USA Inc.	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-0711_485546bd-0e6e-46e5-bdbb-02342cae49e2	0054-0711	HUMAN PRESCRIPTION DRUG	Deferiprone		Deferiprone	TABLET, COATED	ORAL	20220208		ANDA	ANDA213239	Hikma Pharmaceuticals USA Inc.	DEFERIPRONE	1000	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0054-0742_07a1b9ad-58cb-4c21-b8df-6854da990f85	0054-0742	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20211130		ANDA	ANDA207085	Hikma Pharmaceuticals USA Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0054-0748_99d7d1ce-47b5-4bbd-afe0-908505a9a51b	0054-0748	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	19970228		ANDA	ANDA040204	Hikma Pharmaceuticals USA Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0054-2526_a9e58e66-6569-4c3b-993f-b4236904296e	0054-2526	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19870128		NDA	NDA017812	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-2527_a9e58e66-6569-4c3b-993f-b4236904296e	0054-2527	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19801126		NDA	NDA017812	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-2531_a9e58e66-6569-4c3b-993f-b4236904296e	0054-2531	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19870128		NDA	NDA017812	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-3000_604e214c-d5fb-4061-9a88-b582d3a45f28	0054-3000	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20220509		ANDA	ANDA215138	Hikma Pharmaceuticals USA Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
0054-3068_f61b0308-0616-49ae-99f9-07b9fd62bc3d	0054-3068	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	SOLUTION, CONCENTRATE	ORAL	19931031		ANDA	ANDA074312	Hikma Pharmaceuticals USA Inc.	ALPRAZOLAM	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0054-3090_94a7a035-89fa-4607-9231-253e3a96a420	0054-3090	HUMAN PRESCRIPTION DRUG	Butorphanol Tartrate		Butorphanol Tartrate	SPRAY, METERED	NASAL	20020312		ANDA	ANDA075824	Hikma Pharmaceuticals USA Inc.	BUTORPHANOL TARTRATE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
0054-3117_8c0aefee-0ab5-4a1b-9a5f-0107ab3e0681	0054-3117	HUMAN OTC DRUG	Calcium Carbonate		Calcium Carbonate	SUSPENSION	ORAL	20041118	20240531	OTC MONOGRAPH FINAL	part331	Hikma Pharmaceuticals USA Inc.	CALCIUM CARBONATE	1250	mg/5mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
0054-3120_2b8745f3-5289-474e-bd44-48b59a40dd78	0054-3120	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	SOLUTION	ORAL	20030718		ANDA	ANDA076242	Hikma Pharmaceuticals USA Inc.	CALCITRIOL	1	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
0054-3176_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-3176	HUMAN PRESCRIPTION DRUG	Dexamethasone Intensol		Dexamethasone Intensol	SOLUTION, CONCENTRATE	ORAL	19830901		ANDA	ANDA088252	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-3177_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-3177	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	SOLUTION	ORAL	19830901		ANDA	ANDA088248	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	.5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-3185_26a8ed82-5cfc-4b3e-8a19-80b236c1ee0b	0054-3185	HUMAN PRESCRIPTION DRUG	Diazepam Intensol		Diazepam Intensol	SOLUTION, CONCENTRATE	ORAL	19870403		ANDA	ANDA071415	Hikma Pharmaceuticals USA Inc.	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0054-3188_864ad9d2-0438-458b-9238-1cbe07e6c835	0054-3188	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	SOLUTION	ORAL	19870403		ANDA	ANDA070928	Hikma Pharmaceuticals USA Inc.	DIAZEPAM	5	mg/5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0054-3194_ac0c72b1-8f3e-4f00-9388-a33945fb1971	0054-3194	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	SOLUTION	ORAL	19820503		ANDA	ANDA087708	Hikma Pharmaceuticals USA Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/5mL; mg/5mL	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
0054-3270_3a637546-f8af-4dd9-8966-06af1f3caf48	0054-3270	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20060222		ANDA	ANDA076504	Hikma Pharmaceuticals USA Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-3294_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-3294	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	SOLUTION	ORAL	19880712		ANDA	ANDA070434	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-3298_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-3298	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	SOLUTION	ORAL	19870422		ANDA	ANDA070433	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	40	mg/5mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-3500_24b07b6f-e918-41cf-8db1-a72e33911118	0054-3500	HUMAN PRESCRIPTION DRUG	Lidocaine Viscous		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19850426		ANDA	ANDA088802	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0054-3505_3996fa01-1f0c-41ab-8dc3-9a28246138c8	0054-3505	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	TOPICAL	19850403		ANDA	ANDA088803	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0054-3532_a0e90170-76ad-4493-991c-551903b42b09	0054-3532	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	SOLUTION, CONCENTRATE	ORAL	19910628		ANDA	ANDA072755	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0054-3545_ca69319b-0d47-4615-a8b6-eeb4b42e7d5c	0054-3545	HUMAN PRESCRIPTION DRUG	Meperidine Hydrochloride		Meperidine Hydrochloride	SOLUTION	ORAL	19850130		ANDA	ANDA088744	Hikma Pharmaceuticals USA Inc.	MEPERIDINE HYDROCHLORIDE	50	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-3553_92f6e14b-cfa0-4c55-bc9e-3dadbd80f598	0054-3553	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	CONCENTRATE	ORAL	19880906		ANDA	ANDA089897	Hikma Pharmaceuticals USA Inc.	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-3555_7505e1a8-3931-4d3c-ba74-303247d29265	0054-3555	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	19810522		ANDA	ANDA087393	Hikma Pharmaceuticals USA Inc.	METHADONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-3556_7505e1a8-3931-4d3c-ba74-303247d29265	0054-3556	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	19820830		ANDA	ANDA087997	Hikma Pharmaceuticals USA Inc.	METHADONE HYDROCHLORIDE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-3566_83e0ae08-f443-4c83-a995-5f2efd5b43ff	0054-3566	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20020430		ANDA	ANDA075873	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0054-3630_4f3ddcb9-fcec-404a-b2aa-90c5a281b794	0054-3630	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	SUSPENSION	ORAL	20210224		ANDA	ANDA074190	Hikma Pharmaceuticals USA Inc.	NAPROXEN	125	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0054-3721_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-3721	HUMAN PRESCRIPTION DRUG	PredniSONE Intensol		PredniSONE Intensol	SOLUTION, CONCENTRATE	ORAL	19850220		ANDA	ANDA088810	Hikma Pharmaceuticals USA Inc.	PREDNISONE	5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-3722_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-3722	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	SOLUTION	ORAL	19841108		ANDA	ANDA088703	Hikma Pharmaceuticals USA Inc.	PREDNISONE	5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-3727_09bbc997-1a8a-4e70-afbe-89971b48a7da	0054-3727	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	SOLUTION	ORAL	19870515		ANDA	ANDA070979	Hikma Pharmaceuticals USA Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0054-3730_09bbc997-1a8a-4e70-afbe-89971b48a7da	0054-3730	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	SOLUTION	ORAL	19870515		ANDA	ANDA070690	Hikma Pharmaceuticals USA Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0054-4146_4badcce8-f27a-44dd-87f1-2fd1375d39a0	0054-4146	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	LOZENGE	ORAL; TOPICAL	20040729		ANDA	ANDA076387	Hikma Pharmacuticals USA USA Inc.	CLOTRIMAZOLE	10	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0054-4179_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-4179	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750725		ANDA	ANDA084611	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4180_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-4180	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750603		ANDA	ANDA084613	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4181_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-4181	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19830915		ANDA	ANDA088306	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4182_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-4182	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750519		ANDA	ANDA084610	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4183_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-4183	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19820826		ANDA	ANDA087916	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4184_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-4184	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4186_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-4186	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19830915		ANDA	ANDA088316	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4297_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-4297	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-4299_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-4299	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-4301_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-4301	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19910313		ANDA	ANDA070086	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-4496_4aaa6078-c6f4-49ba-98aa-a4c460126eee	0054-4496	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19930222		ANDA	ANDA072733	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	5	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0054-4497_4aaa6078-c6f4-49ba-98aa-a4c460126eee	0054-4497	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19930222		ANDA	ANDA072734	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	10	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0054-4498_4aaa6078-c6f4-49ba-98aa-a4c460126eee	0054-4498	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19930222		ANDA	ANDA072735	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	15	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0054-4499_4aaa6078-c6f4-49ba-98aa-a4c460126eee	0054-4499	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19930222		ANDA	ANDA072736	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	25	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0054-4527_a9e58e66-6569-4c3b-993f-b4236904296e	0054-4527	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET	ORAL	19820129		NDA	NDA018558	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-4538_32cb861b-b785-4c9b-ab99-e99e177f5185	0054-4538	HUMAN PRESCRIPTION DRUG	DISKETS		Methadone Hydrochloride	TABLET	ORAL	19730314		NDA	NDA017058	Hikma Pharmaceuticals USA Inc.	METHADONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0054-4550_fd37b0f0-eb29-41d3-bb9a-9aff469f0fc4	0054-4550	HUMAN PRESCRIPTION DRUG	Methotrexate Sodium		Methotrexate Sodium	TABLET	ORAL	19940801		ANDA	ANDA040054	Hikma Pharmaceuticals USA Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0054-4581_0af63ac3-f9e8-4cba-8bb0-b42cec662c80	0054-4581	HUMAN PRESCRIPTION DRUG	Mercaptopurine		Mercaptopurine	TABLET	ORAL	20040213		ANDA	ANDA040528	Hikma Pharmaceuticals USA Inc.	MERCAPTOPURINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0054-4728_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-4728	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19720421		ANDA	ANDA080352	Hikma Pharmaceuticals USA Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4741_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-4741	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820422		ANDA	ANDA087800	Hikma Pharmaceuticals USA Inc.	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4742_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-4742	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820422		ANDA	ANDA087801	Hikma Pharmaceuticals USA Inc.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-4858_5f2e46af-164a-4ca1-a126-823e4a4fe3e7	0054-4858	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20181029		ANDA	ANDA074224	Hikma Pharmaceuticals USA Inc.	TRIAZOLAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0054-4859_5f2e46af-164a-4ca1-a126-823e4a4fe3e7	0054-4859	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20181029		ANDA	ANDA074224	Hikma Pharmaceuticals USA Inc.	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0054-8146_4badcce8-f27a-44dd-87f1-2fd1375d39a0	0054-8146	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	LOZENGE	ORAL; TOPICAL	20040729		ANDA	ANDA076387	Hikma Pharmacuticals USA USA Inc.	CLOTRIMAZOLE	10	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0054-8174_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-8174	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19830915		ANDA	ANDA088306	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8175_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-8175	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8176_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-8176	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19820826		ANDA	ANDA087916	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8179_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-8179	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750725		ANDA	ANDA084611	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8180_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-8180	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750603		ANDA	ANDA084613	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8181_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-8181	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750519		ANDA	ANDA084610	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8183_9b7151ad-5b52-4c1b-9b5d-efe3f1ac4e13	0054-8183	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19830915		ANDA	ANDA088316	Hikma Pharmaceuticals USA, Inc.	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8297_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-8297	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-8299_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-8299	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-8301_b3566916-0d7c-4243-abab-1eed1bc4bf69	0054-8301	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19910313		ANDA	ANDA070086	West-Ward Pharmaceuticals Corp.	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0054-8496_4aaa6078-c6f4-49ba-98aa-a4c460126eee	0054-8496	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19930222		ANDA	ANDA072733	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	5	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0054-8526_a9e58e66-6569-4c3b-993f-b4236904296e	0054-8526	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19870128		NDA	NDA017812	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-8527_a9e58e66-6569-4c3b-993f-b4236904296e	0054-8527	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19801126		NDA	NDA017812	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-8528_a9e58e66-6569-4c3b-993f-b4236904296e	0054-8528	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET	ORAL	19820614		NDA	NDA018558	Hikma Pharmaceuticals USA Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
0054-8550_fd37b0f0-eb29-41d3-bb9a-9aff469f0fc4	0054-8550	HUMAN PRESCRIPTION DRUG	Methotrexate Sodium		Methotrexate Sodium	TABLET	ORAL	19940801		ANDA	ANDA040054	Hikma Pharmaceuticals USA Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0054-8724_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-8724	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19720421		ANDA	ANDA080352	Hikma Pharmaceuticals USA Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8739_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-8739	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820422		ANDA	ANDA087800	Hikma Pharmaceuticals USA Inc.	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-8740_1cbd408d-9d88-4c28-b0f5-6045a3d2e1ae	0054-8740	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820422		ANDA	ANDA087801	Hikma Pharmaceuticals USA Inc.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-9628_d1edb735-8860-4240-8e24-d50f23222d31	0054-9628	HUMAN PRESCRIPTION DRUG	sodium oxybate		sodium oxybate	SOLUTION	ORAL	20230103		NDA AUTHORIZED GENERIC	NDA021196	Hikma Pharmaceuticals USA Inc.	SODIUM OXYBATE	.5	g/mL	Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
0054-9817_62ebfd2e-967b-42b9-b442-e33fdffa02a1	0054-9817	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200323		ANDA	ANDA084122	Hikma Pharmaceuticals USA Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-9818_62ebfd2e-967b-42b9-b442-e33fdffa02a1	0054-9818	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200323		ANDA	ANDA087342	Hikma Pharmaceuticals USA Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0054-9828_62ebfd2e-967b-42b9-b442-e33fdffa02a1	0054-9828	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200323		ANDA	ANDA080352	Hikma Pharmaceuticals USA Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0065-0023_a76a34d0-2e07-408d-a8c8-d00f2715cad7	0065-0023	HUMAN PRESCRIPTION DRUG	MIOSTAT		carbachol	SOLUTION	OPHTHALMIC	19740415		NDA	NDA016968	Alcon Laboratories, Inc.	CARBACHOL	.1	mg/mL	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0065-0085_af7dc605-2d55-45bd-b2d9-c9ef0b6e30e6	0065-0085	HUMAN OTC DRUG	Naphcon A		naphazoline hydrochloride and pheniramine maleate	SOLUTION/ DROPS	OPHTHALMIC	19940608		NDA	NDA020226	Alcon Laboratories, Inc.	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.25; 3	mg/mL; mg/mL			N	20241231
0065-0092_85861756-9727-4a43-8a4e-48564e341c48	0065-0092	HUMAN PRESCRIPTION DRUG	FLUORESCITE		fluorescein sodium	INJECTION, SOLUTION	OPHTHALMIC	19720915		NDA	NDA021980	Alcon, Inc.	FLUORESCEIN SODIUM	100	mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
0065-0246_35ea44d6-4fbe-4388-bd89-56db723454ec	0065-0246	HUMAN PRESCRIPTION DRUG	Betoptic S		betaxolol hydrochloride	SUSPENSION/ DROPS	OPHTHALMIC	19960115	20240831	NDA	NDA019845	Alcon Laboratories, Inc.	BETAXOLOL HYDROCHLORIDE	2.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
0065-0303_b3493429-e973-4c38-8e7b-23376075bd20	0065-0303	HUMAN PRESCRIPTION DRUG	Isopto Atropine		atropine sulfate	SOLUTION	OPHTHALMIC	20180801		NDA	NDA208151	Alcon Laboratories, Inc.	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0065-0355_3dd122a9-260c-4d25-9f18-38373ce1b07d	0065-0355	HUMAN PRESCRIPTION DRUG	Mydriacyl		tropicamide	SOLUTION/ DROPS	OPHTHALMIC	19590401		ANDA	ANDA084306	Alcon Laboratories, Inc.	TROPICAMIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0065-0359_6470e4d3-4917-416e-a6e6-3b2574b041a7	0065-0359	HUMAN PRESCRIPTION DRUG	Cyclomydril		cyclopentolate hydrochloride and phenylephrine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19580630		ANDA	ANDA084300	Alcon Laboratories, Inc.	CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10	mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0065-0395_0aa45ce5-d393-4030-aab5-ff5073c42381	0065-0395	HUMAN PRESCRIPTION DRUG	Cyclogyl		cyclopentolate hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19751015		ANDA	ANDA084109	Alcon Laboratories, Inc.	CYCLOPENTOLATE HYDROCHLORIDE	5	mg/mL			N	20241231
0065-0396_0aa45ce5-d393-4030-aab5-ff5073c42381	0065-0396	HUMAN PRESCRIPTION DRUG	Cyclogyl		cyclopentolate hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19751015		ANDA	ANDA084110	Alcon Laboratories, Inc.	CYCLOPENTOLATE HYDROCHLORIDE	10	mg/mL			N	20241231
0065-0397_0aa45ce5-d393-4030-aab5-ff5073c42381	0065-0397	HUMAN PRESCRIPTION DRUG	Cyclogyl		cyclopentolate hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19751015		ANDA	ANDA084108	Alcon Laboratories, Inc.	CYCLOPENTOLATE HYDROCHLORIDE	20	mg/mL			N	20241231
0065-0408_ea6245c6-1d3b-4fac-a0b5-b576f9f53af5	0065-0408	HUMAN OTC DRUG	Alcon Tears Lubricant Eye Drops		hypromellose 2910	SOLUTION/ DROPS	OPHTHALMIC	20220301		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	HYPROMELLOSE 2910 (4000 MPA.S)	5	mg/mL			N	20241231
0065-0411_45bf2066-cfd2-48ef-acf9-b590c69b83d8	0065-0411	HUMAN PRESCRIPTION DRUG	Betadine		povidone-iodine	SOLUTION	OPHTHALMIC	20000401		NDA	NDA018634	Alcon Laboratories, Inc.	POVIDONE-IODINE	5	mg/mL			N	20241231
0065-0419_34aa9128-4bc4-45a6-aeae-a8c1f7699183	0065-0419	HUMAN OTC DRUG	BION TEARS		Dextran, Hypromellose	SOLUTION/ DROPS	OPHTHALMIC	19921019		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)	1; 3	mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0065-0426_1a0c59b1-95e8-477f-9c56-26bcd3bd7470	0065-0426	HUMAN OTC DRUG	GenTeal Tears (Moderate)		Dextran 70, Glycerin, Hypromellose	SOLUTION/ DROPS	OPHTHALMIC	20160301		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	DEXTRAN 70; GLYCERIN; HYPROMELLOSES	1; 2; 3	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Intravascular Volume [PE], Non-Standardized Chemical Allergen [EPC], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0065-0429_bbb16c95-87ac-4e07-8060-5e33e6dae0a6	0065-0429	HUMAN OTC DRUG	Systane Lubricant		polyethylene glycol 400 and Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20030225		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-0431_5c7432b0-b4b8-49a1-89b7-6e3befa25917	0065-0431	HUMAN OTC DRUG	Systane		polyethylene glycol and propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20151030		OTC MONOGRAPH DRUG	M018	Alcon Research Ltd	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-0454_6c8fa8af-e9bf-49b3-9d5c-f1cb73de2fdd	0065-0454	HUMAN OTC DRUG	Systane		polyethylene glycol 400 and propylene glycol	GEL	OPHTHALMIC	20110209		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-0474_634b9bdb-004a-462e-ba48-1ab306157e02	0065-0474	HUMAN OTC DRUG	Systane		hypromellose	GEL	OPHTHALMIC	20121215		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	HYPROMELLOSE 2910 (4000 MPA.S)	3	mg/g			N	20241231
0065-0481_aad736dd-2475-4e97-9e45-cc892fbf67b1	0065-0481	HUMAN OTC DRUG	Systane COMPLETE		propylene glycol	EMULSION	OPHTHALMIC	20180118		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	PROPYLENE GLYCOL	.06	mg/mL			N	20241231
0065-0509_cddb7bf9-8ecf-4040-bdb0-37562d25d9b1	0065-0509	HUMAN OTC DRUG	Systane Nighttime		mineral oil and white petrolatum	OINTMENT	OPHTHALMIC	20080626		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	MINERAL OIL; PETROLATUM	30; 940	mg/g; mg/g			N	20241231
0065-0518_cb19f5ca-b66f-485b-a85f-8ed8bab8616a	0065-0518	HUMAN OTC DRUG	GenTeal	Tears NIGHT-TIME	mineral oil, white petrolatum	OINTMENT	OPHTHALMIC	20190905		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	MINERAL OIL; PETROLATUM	.03; .94	g/g; g/g			N	20241231
0065-0530_af74f51c-acab-42bd-8d05-0ba68eab4844	0065-0530	HUMAN OTC DRUG	Eye Stream		purified water	SOLUTION	OPHTHALMIC	19900930		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	WATER	986	mg/mL			N	20241231
0065-0543_f2ec8d15-d037-473a-8753-ca211c19e043	0065-0543	HUMAN PRESCRIPTION DRUG	TRIESENCE		triamcinolone acetonide	INJECTION, SUSPENSION	OPHTHALMIC	20071115		NDA	NDA022048	Alcon Laboratories, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0065-0631_7cafb7c6-1bf0-42d8-aa07-bc544149b50d	0065-0631	HUMAN PRESCRIPTION DRUG	MAXITROL		neomycin sulfate, polymyxin b sulfate and dexamethasone	OINTMENT	OPHTHALMIC	19720117	20240531	NDA	NDA050065	Alcon Laboratories, Inc.	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
0065-0741_802f5099-72db-43d7-96fd-ed59964a3348	0065-0741	HUMAN PRESCRIPTION DRUG	Tetracaine Hydrochloride		tetracaine hydrochloride	SOLUTION	OPHTHALMIC	20161102		NDA	NDA208135	Alcon Laboratories, Inc.	TETRACAINE HYDROCHLORIDE	5	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
0065-0795_6d152217-ad83-4a80-ad05-8792e6aa3240	0065-0795	HUMAN PRESCRIPTION DRUG	BSS		balanced salt solution	SOLUTION	OPHTHALMIC	19690328		NDA	NDA020742	Alcon Laboratories, Inc.	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE	.48; .3; .75; 3.9; 6.4; 1.7	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0065-0800_43bc81a5-9923-4f1f-be7e-4b34651f0322	0065-0800	HUMAN PRESCRIPTION DRUG	BSS PLUS		balanced salt solution enriched with bicarbonate, dextrose, and glutathione	KIT		19820628		NDA	NDA018469	Alcon Laboratories, Inc.						N	20241231
0065-0800_497b9a71-6e35-405b-a512-be4a0c11cc55	0065-0800	HUMAN PRESCRIPTION DRUG	BSS PLUS		balanced salt solution enriched with bicarbonate, dextrose, and glutathione	KIT		20130620		NDA	NDA018469	Alcon Laboratories, Inc.						N	20241231
0065-0816_c6eef41b-de2a-4461-9880-bc220176e886	0065-0816	HUMAN OTC DRUG	PATADAY ONCE DAILY RELIEF		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200901		NDA	NDA206276	Alcon Laboratories, Inc.	OLOPATADINE HYDROCHLORIDE	7	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
0065-0817_4da0512b-9d9f-4a23-a0da-4d4c80248e5d	0065-0817	HUMAN PRESCRIPTION DRUG	atropine sulfate		atropine sulfate	SOLUTION	OPHTHALMIC	20221101		NDA	NDA208151	Alcon Laboratories, Inc.	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0065-1431_e552d401-ec86-4cab-a8c7-1dc28068d26e	0065-1431	HUMAN OTC DRUG	Systane Ultra		Polyethylene Glycol 400 and Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20141001		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-1432_cce3e663-58ef-4ece-a6d2-c49ecc7ea9cb	0065-1432	HUMAN OTC DRUG	Systane	ULTRA	polyethylene glycol 400 and propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20090727		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-1433_02b220d8-3ef3-436a-9e9b-34532984d206	0065-1433	HUMAN OTC DRUG	Systane Balance		propylene glycol	EMULSION	OPHTHALMIC	20100625		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	PROPYLENE GLYCOL	.06	mg/mL			N	20241231
0065-1437_1eb226c4-8b11-4a92-ab95-5333e866ba13	0065-1437	HUMAN OTC DRUG	SYSTANE HYDRATION PF PRESERVATIVE FREE		Polyethylene Glycol 400 and Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20200201		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-1502_90134f50-ea64-4651-a2c0-afa48e09f129	0065-1502	HUMAN OTC DRUG	Systane Day and Night Value Pack		Polyethylene Glycol 400, Propylene Glycol 0.3%	KIT		20171024		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.						N	20241231
0065-1507_7d0a008c-25a7-432f-8e87-6738bd79a88c	0065-1507	HUMAN OTC DRUG	Systane Ultra Preservative Free		Polyethylene Glycol 400 and Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20220215		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-1509_001440c1-cd5a-4598-ae8a-a7a631a608ab	0065-1509	HUMAN OTC DRUG	Systane COMPLETE PF		propylene glycol	EMULSION	OPHTHALMIC	20220118		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	PROPYLENE GLYCOL	.06	mg/mL			N	20241231
0065-1510_abdc8950-e8b1-4d58-ae59-a666285b315a	0065-1510	HUMAN OTC DRUG	SYSTANE HYDRATION PF PRESERVATIVE FREE		Polyethylene Glycol 400 and Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20210201		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-1530_303d12ca-c965-4ba2-9723-6162f86fa351	0065-1530	HUMAN OTC DRUG	Systane COMPLETE PF		propylene glycol	EMULSION	OPHTHALMIC	20220201		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	PROPYLENE GLYCOL	.06	mg/mL			N	20241231
0065-1795_e84e5d87-f672-4e37-b65b-7f6a93db552a	0065-1795	HUMAN PRESCRIPTION DRUG	BSS		balanced salt solution	SOLUTION	OPHTHALMIC	19690328		NDA	NDA020742	Alcon Laboratories, Inc.	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE	.48; .3; .75; 3.9; 6.4; 1.7	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0065-4011_bed738a0-2943-46e7-a65e-2440dac7971b	0065-4011	HUMAN OTC DRUG	Zaditor		ketotifen fumarate	SOLUTION	OPHTHALMIC	20130108		ANDA	ANDA077200	Alcon Laboratories, Inc.	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
0065-4147_9ad71169-4b63-4405-bcab-ddfeb8131d9a	0065-4147	HUMAN PRESCRIPTION DRUG	SIMBRINZA		brinzolamide/brimonidine tartrate	SUSPENSION/ DROPS	OPHTHALMIC	20130506		NDA	NDA204251	Alcon Laboratories, Inc.	BRIMONIDINE TARTRATE; BRINZOLAMIDE	2; 10	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0065-4274_ac033450-8f36-4649-85c3-ddd5b5b7195f	0065-4274	HUMAN OTC DRUG	PATADAY TWICE A DAY RELIEF		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200225		NDA	NDA020688	Alcon Laboratories, Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
0065-8063_f7885429-659f-40b7-bbd7-d8680d1912f2	0065-8063	HUMAN OTC DRUG	GenTeal Tears Moderate Preservative Free		dextran 70, hypromellose 2910	SOLUTION/ DROPS	OPHTHALMIC	20180703		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)	1; 3	mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0065-8064_750c99c5-ade3-4759-870b-cb59248e9fa0	0065-8064	HUMAN OTC DRUG	GenTeal Tears	Severe	Hypromellose	GEL	OPHTHALMIC	20191231		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	HYPROMELLOSE 2910 (4000 MPA.S)	.003	g/g			N	20241231
0065-8067_b702ef77-f1ce-4064-9512-31098bd4479f	0065-8067	HUMAN OTC DRUG	GenTeal Tears Gel Drops		polyethylene glycol 400 and propylene glycol	GEL	OPHTHALMIC	20210204		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
0065-8150_30e4fc2d-7d06-477a-9160-aa231b83e642	0065-8150	HUMAN OTC DRUG	PATADAY ONCE DAILY RELIEF		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200228		NDA	NDA021545	Alcon Laboratories, Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
0065-9305_99e11df4-015e-41eb-804d-85a3e0e6c5be	0065-9305	HUMAN OTC DRUG	BION TEARS		Dextran, Hypromellose	SOLUTION/ DROPS	OPHTHALMIC	20230401		OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)	1; 3	mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0067-0100_0b9c5e7c-e0bc-845b-e063-6394a90a99e3	0067-0100	HUMAN OTC DRUG	Theraflu Severe Cold Relief Daytime		ACETAMINOPHEN, DEXTROMETHORPHAN HBr	POWDER, FOR SOLUTION	ORAL	20231201		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	500; 20	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0067-0101_0bba6b19-cbfe-553d-e063-6394a90aaef0	0067-0101	HUMAN OTC DRUG	Theraflu Severe Cold Relief Nighttime		ACETAMINOPHEN, DIPHENHYDRAMINE HCl	POWDER, FOR SOLUTION	ORAL	20231201		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	650; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0067-0103_0bdc6458-3976-85a4-e063-6394a90a5d41	0067-0103	HUMAN OTC DRUG	Theraflu Severe Cold Relief Daytime Honey Ginger		ACETAMINOPHEN, DEXTROMETHORPHAN HBr	POWDER, FOR SOLUTION	ORAL	20231201		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0067-0104_0f223b72-c9a1-444b-bca5-dcfcb7e33ddf	0067-0104	HUMAN OTC DRUG	Theraflu	Severe Cold Relief Chest Congestion Daytime	Acetaminophen, Dextromethorphan HBr, Guaifenesin	SYRUP	ORAL	20231201		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	650; 20; 400	mg/30mL; mg/30mL; mg/30mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0067-0105_c24b9489-208c-472b-8ae5-c6e86c12e04d	0067-0105	HUMAN OTC DRUG	Theraflu	Severe Cold Relief Nighttime	Acetaminophen, Diphenhydramine HCl	SYRUP	ORAL	20231201		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	650; 25	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0067-0106_0bbbc931-acd0-6e0c-e063-6294a90acd3e	0067-0106	HUMAN OTC DRUG	Theraflu Severe Cold Relief Daytime Berry Burst		ACETAMINOPHEN, DEXTROMETHORPHAN HBr	POWDER, FOR SOLUTION	ORAL	20231201		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0067-0117_93452d1f-a643-4402-b67e-364d1903996c	0067-0117	HUMAN OTC DRUG	Gas-X	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20120101		OTC MONOGRAPH FINAL	part332	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0067-0118_edb0f11a-bdb7-484d-9257-09ff47b0fca4	0067-0118	HUMAN OTC DRUG	Gas-X	Total Relief Maximum Strength	Calcium carbonate, Simethicone	TABLET, CHEWABLE	ORAL	20220203		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE; DIMETHICONE	750; 250	mg/1; mg/1	Skin Barrier Activity [PE]		N	20241231
0067-0119_62fc0a91-c44f-4546-a472-c183a2d95486	0067-0119	HUMAN OTC DRUG	Gas-X	Total Relief Maximum Strength	Calcium carbonate, Simethicone	TABLET, CHEWABLE	ORAL	20220203		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE; DIMETHICONE	750; 250	mg/1; mg/1	Skin Barrier Activity [PE]		N	20241231
0067-0129_a2b9dd33-249e-4128-9d57-5b0ff0f99414	0067-0129	HUMAN OTC DRUG	Gas-X	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20120101		OTC MONOGRAPH FINAL	part332	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0067-2000_6a5d7fad-847b-4201-b880-da378c333874	0067-2000	HUMAN OTC DRUG	Excedrin	Extra Strength Pain Reliever	Acetaminophen, Aspirin (NSAID), and Caffeine	TABLET, FILM COATED	ORAL	20060927		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-2001_a94552c2-4521-4e49-a759-ff664cdb5966	0067-2001	HUMAN OTC DRUG	Excedrin	Extra Strength Pain Reliever	Acetaminophen, Aspirin (NSAID), and Caffeine	TABLET, FILM COATED	ORAL	20190315		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-2021_7cb14fb8-1195-4da3-b9d7-7375d26fa029	0067-2021	HUMAN OTC DRUG	Excedrin	Extra Strength Geltabs	Acetaminophen, Asprin, Caffeine	TABLET, COATED	ORAL	20110913		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-2035_edbb64b9-f8ba-48db-8a36-d5837114f822	0067-2035	HUMAN OTC DRUG	Excedrin	Migraine Geltabs	Acetaminophen, Asprin, Caffeine	TABLET, COATED	ORAL	20110913		NDA	NDA020802	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-2039_06183414-a911-4a52-8f13-c78e3ec52956	0067-2039	HUMAN OTC DRUG	EXCEDRIN	MIGRAINE	Acetaminophen, Aspirin (NSAID) and Caffeine	TABLET, FILM COATED	ORAL	20100215		NDA	NDA020802	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-2040_f0e1a3a4-1ddd-4d82-8595-efc9d55df0df	0067-2040	HUMAN OTC DRUG	Excedrin	Migraine	Acetaminophen, Aspirin, and Caffeine	TABLET, FILM COATED	ORAL	20200930		NDA	NDA020802	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-2042_dd85f3a7-f4d2-4ea0-a7b6-18ebc0e993d8	0067-2042	HUMAN OTC DRUG	Excedrin	Migraine Relief	Acetaminophen, Aspirin (NSAID), Caffeine	TABLET, FILM COATED	ORAL	20240101		OTC MONOGRAPH DRUG	M013	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-2056_e8e54bff-666c-4f23-a5e6-85b98efe276a	0067-2056	HUMAN OTC DRUG	Excedrin PM Triple Action Caplets		Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate	TABLET, COATED	ORAL	20140924		OTC MONOGRAPH DRUG	M013	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE	250; 250; 38	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0067-2086_87d7b11c-4227-4073-95e2-1404bfe6d2f2	0067-2086	HUMAN OTC DRUG	4 Way	Fast Acting	Phenylephrine hydrochloride	SPRAY	NASAL	20100101		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-3998_f4438d90-0dcc-40ee-92a7-bdceb17ef010	0067-3998	HUMAN OTC DRUG	Lamisil	AT	TERBINAFINE HYDROCHLORIDE	CREAM	TOPICAL	20050810		NDA	NDA020980	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TERBINAFINE HYDROCHLORIDE	10	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0067-3999_331b6cb8-35ae-483d-be2e-350d6c565175	0067-3999	HUMAN OTC DRUG	Lamisil	AT Jock Itch	TERBINAFINE HYDROCHLORIDE	CREAM	TOPICAL	20061208		NDA	NDA020980	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TERBINAFINE HYDROCHLORIDE	10	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0067-6094_37cc655c-2189-46f0-9265-184c94e3c327	0067-6094	HUMAN OTC DRUG	Theraflu	PowerPods Daytime Severe Cold	ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20180728		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-6095_6aaf7108-4983-4951-901e-11bc65ccc933	0067-6095	HUMAN OTC DRUG	THERAFLU	POWERPODS NIGHTTIME SEVERE COLD	ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL	POWDER, FOR SOLUTION	ORAL	20180728		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-6274_a0c9b428-1d79-44ea-a82b-eb9328e32f92	0067-6274	HUMAN OTC DRUG	Gas-X	Ultra Strength AntiGas Softgels	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20070901		OTC MONOGRAPH FINAL	part332	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0067-6275_80fd869a-2099-4980-b214-a555cc17aec1	0067-6275	HUMAN OTC DRUG	Gas-X	Extra Strength Softgels	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20110912		OTC MONOGRAPH FINAL	part332	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0067-6283_bfbaaf31-a38c-48bf-9672-5df6d3006c5a	0067-6283	HUMAN OTC DRUG	Gas-X	Maximum Strength Softgels	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190310		OTC MONOGRAPH FINAL	part332	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
0067-6296_54dd4021-d70c-426b-9506-1d1f1819782f	0067-6296	HUMAN OTC DRUG	LAMISIL	AT	TERBINAFINE HYDROCHLORIDE	AEROSOL, SPRAY	TOPICAL	20180307		NDA	NDA021124	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TERBINAFINE HYDROCHLORIDE	.84	g/125mL	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0067-6297_1d96797c-7a93-40e9-8332-4aa2ccdcd129	0067-6297	HUMAN OTC DRUG	LAMISIL	AT	TERBINAFINE HYDROCHLORIDE	AEROSOL, SPRAY	TOPICAL	20180307		NDA	NDA021124	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TERBINAFINE HYDROCHLORIDE	.84	g/125mL	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0067-6426_098405eb-dfb7-dadd-e063-6294a90acb10	0067-6426	HUMAN OTC DRUG	THERAFLU	MULTI-SYMPTOM SEVERE COLD	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	POWDER, FOR SOLUTION	ORAL	20140701		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/237mL; mg/237mL; mg/237mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-6800_bac472da-7231-484e-aba2-41a0488df517	0067-6800	HUMAN OTC DRUG	Theraflu Severe Cold Relief Daytime Berry Burst		Acetaminophen, Dextromethorphan HBr, Phenylephrine Hydrochloride	POWDER	ORAL	20220120		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-6801_0d3b1bea-e2ca-4e07-8ae5-60627d230c96	0067-6801	HUMAN OTC DRUG	Theraflu Severe Cold relief Nighttime		Acetaminophen, Diphenhydramine Hydrochloride, Phenylephrine Hydrochloride	POWDER	ORAL	20220120		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-6804_e5ef7b85-feee-44a7-bd0e-ed91352c7434	0067-6804	HUMAN OTC DRUG	Theraflu Severe Cold Relief Daytime and Theraflu Severe Cold Relief Nighttime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl	KIT		20230120		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-7917_09859b07-46e5-fda9-e063-6394a90a6810	0067-7917	HUMAN OTC DRUG	Theraflu	Daytime Severe Cold and Cough	ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20120924		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-7918_098627cf-f89e-2a19-e063-6394a90ab53f	0067-7918	HUMAN OTC DRUG	THERAFLU	NIGHTTIME SEVERE COLD AND COUGH	ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL	POWDER, FOR SOLUTION	ORAL	20140701		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/237mL; mg/237mL; mg/237mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-7919_ee8780a7-ce6f-42fd-8918-61b2c5d984b5	0067-7919	HUMAN OTC DRUG	Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl	KIT		20160101		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-7923_667c7cca-7866-4f95-ab7f-22ae2eebcbcf	0067-7923	HUMAN OTC DRUG	Theraflu Flu Relief Max Strength	Daytime Nighttime Combo Pack	Acetaminophen, Dextromethorphan HBr, and Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	KIT		20220615		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8100_3831085f-f03b-4da1-823c-9574561dd92f	0067-8100	HUMAN OTC DRUG	Lamisil AT		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0067-8114_e076139d-60e6-4e93-81b0-aacebf68cbfb	0067-8114	HUMAN OTC DRUG	Lamisil AT	for Jock Itch	Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0067-8124_16be0a08-f1de-4da9-a689-c1e71bde4926	0067-8124	HUMAN OTC DRUG	Theraflu Nighttime Multi-Symptom Severe Cold Powder		Acetaminophen, Diphenhydramine Hydrochloride, Phenylephrine Hydrochloride	POWDER	ORAL	20150715		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8125_5752247a-a951-49c8-b52a-2b7f387e4fbe	0067-8125	HUMAN OTC DRUG	Theraflu ExpressMax	Daytime Nighttime Value Pack	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl and Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	KIT		20150715		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8127_83aacea7-68a1-494d-b36c-6d72a1e61584	0067-8127	HUMAN OTC DRUG	Theraflu ExpressMax	Daytime Severe Cold and Cough	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	SYRUP	ORAL	20150715		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8129_515a0df6-7148-4edc-bfb8-aa1a036d436b	0067-8129	HUMAN OTC DRUG	Theraflu ExpressMax	Nighttime Severe Cold and Cough	Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	SYRUP	ORAL	20150715		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8132_777d2ac7-e3cc-4513-8b6f-b90b2ff2c672	0067-8132	HUMAN OTC DRUG	Theraflu ExpressMax Severe Cold and Flu Syrup		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SYRUP	ORAL	20170707		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8136_0b77b02d-9a4a-4208-a291-c829d9655bba	0067-8136	HUMAN OTC DRUG	Theraflu ExpressMax	Daytime Severe Cold and Cough	acetaminophen, dextromethorphan HBr, phenylephrine HCl	TABLET, FILM COATED	ORAL	20160705		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8137_5201084d-a412-4c4f-b101-0432e97abd9f	0067-8137	HUMAN OTC DRUG	Theraflu ExpressMax	Nighttime Severe Cold and Cough	acetaminophen, diphenhydramine HCl, phenylephrine HCl	TABLET, FILM COATED	ORAL	20160705		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8138_493ffbab-355c-4ff5-ad9f-f70f4ae33a00	0067-8138	HUMAN OTC DRUG	Theraflu Expressmax Daytime Severe Cold and Cough and Theraflu Expressmax Nighttime Severe Cold and Cough		acetaminophen, dextromethorphan HBr, phenylephrine HCl, diphenhydramine HCl	KIT		20160705		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8139_5e057926-8baf-4283-ae59-91130e8ea0ca	0067-8139	HUMAN OTC DRUG	Excedrin	Tension Headache	Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20161215		OTC MONOGRAPH DRUG	M013	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0067-8140_a062e119-cea8-49b9-b957-f17cf49157f9	0067-8140	HUMAN OTC DRUG	EX-LAX	REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE	SENNOSIDES	TABLET, CHEWABLE	ORAL	20170801		OTC MONOGRAPH DRUG	M007	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SENNOSIDES	15	mg/1			N	20241231
0067-8141_7a0ee04e-9da2-40c8-81c6-29dd56c0ccf2	0067-8141	HUMAN OTC DRUG	EX-LAX	REGULAR STRENGTH STIMULANT LAXATIVE	SENNOSIDES	TABLET	ORAL	20170701		OTC MONOGRAPH NOT FINAL	part334	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SENNOSIDES	15	mg/1			N	20241231
0067-8142_c2602e10-2671-4a6d-912f-18503a75461a	0067-8142	HUMAN OTC DRUG	EX-LAX	MAXIMUM STRENGTH STIMULANT LAXATIVE	SENNOSIDES	PILL	ORAL	20170701		OTC MONOGRAPH NOT FINAL	part334	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SENNOSIDES	25	mg/1			N	20241231
0067-8143_099511f4-df04-725f-e063-6294a90a4695	0067-8143	HUMAN OTC DRUG	Perdiem		Sennosides, stimulant laxative	TABLET	ORAL	20170701		OTC MONOGRAPH DRUG	M007	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SENNOSIDES	15	mg/1			N	20241231
0067-8145_0995a0e7-dcd7-66d7-e063-6394a90ac7d0	0067-8145	HUMAN OTC DRUG	Theraflu ExpressMax Severe Cold and Flu Caplets		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, COATED	ORAL	20170717		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8147_09961321-a048-a0f7-e063-6394a90ab062	0067-8147	HUMAN OTC DRUG	Excedrin PM Triple Action Caplets and Excedrin Tension Headache		Acetaminophen, Aspirin (NSAID), Caffeine, and Diphenhydramine Citrate	KIT		20170601		OTC MONOGRAPH DRUG	M013	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8148_8e1b4c41-b51a-4183-99cb-91257c7247d0	0067-8148	HUMAN OTC DRUG	Excedrin PM Triple Action Caplets and Excedrin Extra Strength Pain Reliever		Acetaminophen, Aspirin (NSAID), Caffeine, and Diphenhydramine Citrate	KIT		20180501		OTC MONOGRAPH DRUG	M013	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8151_a1c4d6d6-dfd1-4ff5-a603-4b97145df1a5	0067-8151	HUMAN OTC DRUG	Excedrin Extra Strength and Excedrin Tension Headache		Acetaminophen, Aspirin (NSAID), and Caffeine	KIT		20180930		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8152_3005dd3b-5108-4990-9839-eb094b79263c	0067-8152	HUMAN OTC DRUG	Voltaren	Arthritis Pain	diclofenac sodium	GEL	TOPICAL	20200513		NDA	NDA022122	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0067-8153_3005dd3b-5108-4990-9839-eb094b79263c	0067-8153	HUMAN OTC DRUG	Voltaren	Arthritis Pain	diclofenac sodium	KIT		20200513		NDA	NDA022122	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8161_12a284e8-9d99-4273-89ec-f28df3301ed5	0067-8161	HUMAN OTC DRUG	Theraflu Flu Relief Maximum Strength	Daytime Nighttime Combo Pack	Acetaminophen, Dextromethorphan HBr and Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	KIT		20220627		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8200_ee8780a7-ce6f-42fd-8918-61b2c5d984b5	0067-8200	HUMAN OTC DRUG	Theraflu Multi-Symptom Severe Cold and Theraflu Nighttime Severe Cold and Cough		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl	KIT		20160101		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8201_029a0be5-dfe8-49a7-afc6-44235d5f9944	0067-8201	HUMAN OTC DRUG	EXCEDRIN	MIGRAINE	Acetaminophen, Aspirin (NSAID) and Caffeine	TABLET, FILM COATED	ORAL	20100215		NDA	NDA020802	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-8202_60acc110-03ee-44f1-9c51-f4bf0c92f688	0067-8202	HUMAN OTC DRUG	Excedrin	Extra Strength Pain Reliever	Acetaminophen, Aspirin (NSAID), and Caffeine	TABLET, FILM COATED	ORAL	20200309		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-8203_a6c98766-63c5-4376-9823-6a26a43646dc	0067-8203	HUMAN OTC DRUG	Excedrin	Extra Strength Pain Reliever	Acetaminophen, Aspirin (NSAID), and Caffeine	TABLET, FILM COATED	ORAL	20210115		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0067-8204_0324195f-506d-4747-990e-ad44e2a117d9	0067-8204	HUMAN OTC DRUG	Theraflu Flu Relief Max Strength	Daytime	Acetaminophen, Dextromethorphan HBr	SYRUP	ORAL	20220627		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	1000; 30	mg/30mL; mg/30mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0067-8205_61898c20-fbf7-4d08-bb32-9bc248da25d5	0067-8205	HUMAN OTC DRUG	Theraflu Flu Relief Max Strength	Nighttime	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	SYRUP	ORAL	20220627		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	1000; 4; 30	mg/30mL; mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0067-8206_bf1d87c4-4afa-42fc-9a61-b78afe65b476	0067-8206	HUMAN OTC DRUG	Theraflu Flu Relief Max Strength	Daytime Nighttime Value Pack	Acetaminophen, Dextromethorphan HBr, and Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	KIT		20220627		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0067-8211_a573b3c7-8499-4ebb-b24b-e17b36a8c508	0067-8211	HUMAN OTC DRUG	Theraflu	Severe Cold Relief Daytime with Honey Ginger Flavor	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	POWDER, FOR SOLUTION	ORAL	20230501		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0067-8212_d4ce06aa-776f-45e4-a1a6-9cf13797048f	0067-8212	HUMAN OTC DRUG	Theraflu	Severe Cold Relief Nighttime with Honey Elderberry Flavor	ACETAMINOPHEN, DIPHENHYDRAMINE HCl, PHENYLEPHRINE HCl	POWDER, FOR SOLUTION	ORAL	20230501		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0068-0597_c345f4af-20eb-490f-bead-a85af4718a82	0068-0597	HUMAN PRESCRIPTION DRUG	Rifadin IV		rifampin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19890525		NDA	NDA050627	Sanofi-Aventis U.S. LLC	RIFAMPIN	600	mg/10mL	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
0068-0599_cd3ffeea-a148-4196-bce1-18c0a38acd34	0068-0599	HUMAN PRESCRIPTION DRUG	Rifadin IV NOVAPLUS		rifampin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170201		NDA	NDA050627	Sanofi-Aventis U.S. LLC	RIFAMPIN	600	mg/10mL	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
0069-0043_402dbe94-888a-4e23-ba4b-b910f15c31e1	0069-0043	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20110721		NDA	NDA201370	Pfizer Laboratories Div Pfizer Inc	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0069-0058_402dbe94-888a-4e23-ba4b-b910f15c31e1	0069-0058	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20110721		NDA	NDA201370	Pfizer Laboratories Div Pfizer Inc	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0069-0059_402dbe94-888a-4e23-ba4b-b910f15c31e1	0069-0059	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20110721		NDA	NDA201370	Pfizer Laboratories Div Pfizer Inc	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0069-0106_6547b308-3f64-47d8-bbd7-b6ec447ba1d6	0069-0106	HUMAN PRESCRIPTION DRUG	ELELYSO		Taliglucerase alfa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120501		BLA	BLA022458	Pfizer Laboratories Div Pfizer Inc	TALIGLUCERASE ALFA	200	U/5mL	Glucosylceramidase [CS], Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]		N	20241231
0069-0135_291aeaa4-56f1-492a-bda9-bf98559a5c37	0069-0135	HUMAN PRESCRIPTION DRUG	BOSULIF		Bosutinib	TABLET, FILM COATED	ORAL	20120904		NDA	NDA203341	Pfizer Laboratories Div Pfizer Inc	BOSUTINIB MONOHYDRATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0069-0136_291aeaa4-56f1-492a-bda9-bf98559a5c37	0069-0136	HUMAN PRESCRIPTION DRUG	BOSULIF		Bosutinib	TABLET, FILM COATED	ORAL	20120904		NDA	NDA203341	Pfizer Laboratories Div Pfizer Inc	BOSUTINIB MONOHYDRATE	500	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0069-0137_402dbe94-888a-4e23-ba4b-b910f15c31e1	0069-0137	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20130311		NDA	NDA201370	Pfizer Laboratories Div Pfizer Inc	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0069-0145_fa886025-4464-4758-8f5e-1df1fc364097	0069-0145	HUMAN PRESCRIPTION DRUG	INLYTA		axitinib	TABLET, FILM COATED	ORAL	20120127		NDA	NDA202324	Pfizer Laboratories Div Pfizer Inc	AXITINIB	1	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-0151_fa886025-4464-4758-8f5e-1df1fc364097	0069-0151	HUMAN PRESCRIPTION DRUG	INLYTA		axitinib	TABLET, FILM COATED	ORAL	20120127		NDA	NDA202324	Pfizer Laboratories Div Pfizer Inc	AXITINIB	5	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-0187_cd87c86c-0c48-4f0d-8d03-a17989c5d4f5	0069-0187	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	CAPSULE	ORAL	20150203		NDA	NDA207103	Pfizer Laboratories Div Pfizer Inc	PALBOCICLIB	75	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0069-0188_cd87c86c-0c48-4f0d-8d03-a17989c5d4f5	0069-0188	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	CAPSULE	ORAL	20150203		NDA	NDA207103	Pfizer Laboratories Div Pfizer Inc	PALBOCICLIB	100	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0069-0189_cd87c86c-0c48-4f0d-8d03-a17989c5d4f5	0069-0189	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	CAPSULE	ORAL	20150203		NDA	NDA207103	Pfizer Laboratories Div Pfizer Inc	PALBOCICLIB	125	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0069-0193_291aeaa4-56f1-492a-bda9-bf98559a5c37	0069-0193	HUMAN PRESCRIPTION DRUG	BOSULIF		Bosutinib	TABLET, FILM COATED	ORAL	20171218		NDA	NDA203341	Pfizer Laboratories Div Pfizer Inc	BOSUTINIB MONOHYDRATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0069-0195_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0195	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	2500	[iU]/.2mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0196_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0196	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	5000	[iU]/.2mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0197_7a7e890e-6637-4aff-b4fd-96815d2f1f3f	0069-0197	HUMAN PRESCRIPTION DRUG	Vizimpro		dacomitinib	TABLET, FILM COATED	ORAL	20181004		NDA	NDA211288	Pfizer Laboratories Div Pfizer Inc	DACOMITINIB	15	mg/1			N	20241231
0069-0206_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0206	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	7500	[iU]/.3mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0209_e9209166-e3f7-4489-b67c-8adcd13c8e33	0069-0209	HUMAN PRESCRIPTION DRUG	Propofol		Propofol	INJECTION, EMULSION	INTRAVENOUS	20201005		ANDA	ANDA205576	Pfizer Laboratories Div Pfizer Inc	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0069-0217_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0217	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	10000	[iU]/mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0220_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0220	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	12500	[iU]/.5mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0223_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0223	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	15000	[iU]/.6mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0227_ea2ec3c5-caaa-4157-ac52-3c6adfff115e	0069-0227	HUMAN PRESCRIPTION DRUG	Lorbrena		lorlatinib	TABLET, FILM COATED	ORAL	20181119		NDA	NDA210868	Pfizer Laboratories Div Pfizer Inc	LORLATINIB	25	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Cation Transporter 1 Inhibitors [MoA], P-Glycoprotein Inducers [MoA]		N	20241231
0069-0228_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0228	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	18000	[iU]/.72mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0231_ea2ec3c5-caaa-4157-ac52-3c6adfff115e	0069-0231	HUMAN PRESCRIPTION DRUG	Lorbrena		lorlatinib	TABLET, FILM COATED	ORAL	20181119		NDA	NDA210868	Pfizer Laboratories Div Pfizer Inc	LORLATINIB	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Cation Transporter 1 Inhibitors [MoA], P-Glycoprotein Inducers [MoA]		N	20241231
0069-0232_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0232	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20150401		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	25000	[iU]/mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0234_e9209166-e3f7-4489-b67c-8adcd13c8e33	0069-0234	HUMAN PRESCRIPTION DRUG	Propofol		Propofol	INJECTION, EMULSION	INTRAVENOUS	20201005		ANDA	ANDA205576	Pfizer Laboratories Div Pfizer Inc	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0069-0235_9a98f605-9595-4c3e-a722-9cda77031e21	0069-0235	HUMAN PRESCRIPTION DRUG	Cibinqo		abrocitinib	TABLET, FILM COATED	ORAL	20220224		NDA	NDA213871	Pfizer Laboratories Div Pfizer Inc	ABROCITINIB	50	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0069-0238_7b46204f-1661-40a2-8926-3811582bebe0	0069-0238	HUMAN PRESCRIPTION DRUG	Ruxience		rituximab-pvvr	INJECTION, SOLUTION	INTRAVENOUS	20200123		BLA	BLA761103	Pfizer Laboratories Div Pfizer Inc	RITUXIMAB	100	mg/10mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20251231
0069-0242_29bbfba1-489b-4987-a3fc-e89c1575c709	0069-0242	HUMAN PRESCRIPTION DRUG	Toviaz		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081031		NDA	NDA022030	Pfizer Laboratories Div Pfizer Inc	FESOTERODINE FUMARATE	4	mg/1			N	20241231
0069-0244_29bbfba1-489b-4987-a3fc-e89c1575c709	0069-0244	HUMAN PRESCRIPTION DRUG	Toviaz		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081031		NDA	NDA022030	Pfizer Laboratories Div Pfizer Inc	FESOTERODINE FUMARATE	8	mg/1			N	20241231
0069-0248_e9209166-e3f7-4489-b67c-8adcd13c8e33	0069-0248	HUMAN PRESCRIPTION DRUG	Propofol		Propofol	INJECTION, EMULSION	INTRAVENOUS	20201005		ANDA	ANDA205576	Pfizer Laboratories Div Pfizer Inc	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0069-0249_7b46204f-1661-40a2-8926-3811582bebe0	0069-0249	HUMAN PRESCRIPTION DRUG	Ruxience		rituximab-pvvr	INJECTION, SOLUTION	INTRAVENOUS	20200123		BLA	BLA761103	Pfizer Laboratories Div Pfizer Inc	RITUXIMAB	500	mg/50mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20251231
0069-0251_e4384d2f-d204-468c-a2d4-23666e3a493f	0069-0251	HUMAN PRESCRIPTION DRUG	Xalkori		CRIZOTINIB	CAPSULE, COATED PELLETS	ORAL	20231120		NDA	NDA217581	Pfizer Laboratories Div Pfizer Inc	CRIZOTINIB	20	mg/1	Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-0253_f665f4ce-6b23-4aee-8a87-ab0ef532be5e	0069-0253	HUMAN PRESCRIPTION DRUG	Fragmin		Dalteparin Sodium	INJECTION	SUBCUTANEOUS	20221017		NDA	NDA020287	Pfizer Laboratories Div Pfizer Inc	DALTEPARIN SODIUM	2500	[iU]/mL	Anti-coagulant [EPC], Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0069-0274_d51313c5-d0f7-4324-830e-2a9ba2f48d4d	0069-0274	HUMAN PRESCRIPTION DRUG	Velsipity		etrasimod	TABLET, FILM COATED	ORAL	20231019		NDA	NDA216956	Pfizer Laboratories Div Pfizer Inc	ETRASIMOD ARGININE	2	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
0069-0284_6e5e2b14-bbfe-4f85-88ee-d516c6ac2536	0069-0284	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	TABLET, FILM COATED	ORAL	20200330		NDA	NDA212436	Pfizer Laboratories Div Pfizer Inc	PALBOCICLIB	75	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0069-0291_81738cc9-08b9-44d0-a8b0-d307ca93249e	0069-0291	HUMAN PRESCRIPTION DRUG	Nivestym		filgrastim-aafi	INJECTION, SOLUTION	SUBCUTANEOUS	20180924		BLA	BLA761080	Pfizer Laboratories Div Pfizer Inc	FILGRASTIM	300	ug/.5mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
0069-0292_81738cc9-08b9-44d0-a8b0-d307ca93249e	0069-0292	HUMAN PRESCRIPTION DRUG	Nivestym		filgrastim-aafi	INJECTION, SOLUTION	SUBCUTANEOUS	20180924		BLA	BLA761080	Pfizer Laboratories Div Pfizer Inc	FILGRASTIM	480	ug/.8mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
0069-0293_81738cc9-08b9-44d0-a8b0-d307ca93249e	0069-0293	HUMAN PRESCRIPTION DRUG	Nivestym		filgrastim-aafi	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190311		BLA	BLA761080	Pfizer Laboratories Div Pfizer Inc	FILGRASTIM	300	ug/mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
0069-0294_81738cc9-08b9-44d0-a8b0-d307ca93249e	0069-0294	HUMAN PRESCRIPTION DRUG	Nivestym		filgrastim-aafi	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190311		BLA	BLA761080	Pfizer Laboratories Div Pfizer Inc	FILGRASTIM	480	ug/1.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
0069-0296_207b4971-3031-45d7-b6a4-dfe66b37650c	0069-0296	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20181026		NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.25	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0069-0297_c646a966-5d4b-4921-8e37-74e6de0b95be	0069-0297	VACCINE	TicoVac		Tick-Borne Encephalitis Vaccine	INJECTION	INTRAMUSCULAR	20220627		BLA	BLA125740	Pfizer Laboratories Div Pfizer Inc	TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)	1.2	ug/.25mL			N	20241231
0069-0298_9695bbad-259b-4ac3-80af-36f1ca94d433	0069-0298	HUMAN PRESCRIPTION DRUG	Daurismo		glasdegib	TABLET, FILM COATED	ORAL	20181210		NDA	NDA210656	Pfizer Laboratories Div Pfizer Inc	GLASDEGIB	25	mg/1	Hedgehog Pathway Inhibitor [EPC], Smoothened Receptor Antagonists [MoA]		N	20241231
0069-0305_24399684-3818-4410-aecb-32b822817a4b	0069-0305	HUMAN PRESCRIPTION DRUG	Trazimera		trastuzumab-qyyp	KIT		20200224		BLA	BLA761081	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0308_24399684-3818-4410-aecb-32b822817a4b	0069-0308	HUMAN PRESCRIPTION DRUG	Trazimera		trastuzumab-qyyp	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210310		BLA	BLA761081	Pfizer Laboratories Div Pfizer Inc	TRASTUZUMAB	150	mg/7.15mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
0069-0315_ea88c0e2-d853-4382-89da-6661dae624a0	0069-0315	HUMAN PRESCRIPTION DRUG	Zirabev		bevacizumab-bvzr	INJECTION, SOLUTION	INTRAVENOUS	20200113		BLA	BLA761099	Pfizer Laboratories Div Pfizer Inc	BEVACIZUMAB	100	mg/4mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
0069-0324_a89f35d2-46e6-457b-a617-3c7537e6f709	0069-0324	HUMAN PRESCRIPTION DRUG	NYVEPRIA		pegfilgrastim-apgf	INJECTION, SOLUTION	SUBCUTANEOUS	20201215		BLA	BLA761111	Pfizer Laboratories Div Pfizer Inc	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
0069-0325_3984da11-0df7-446e-9b95-9d385e17e73c	0069-0325	HUMAN PRESCRIPTION DRUG	ABRILADA		adalimumab-afzb	KIT		20231018		BLA	BLA761118	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0328_3984da11-0df7-446e-9b95-9d385e17e73c	0069-0328	HUMAN PRESCRIPTION DRUG	ABRILADA		adalimumab-afzb	KIT		20231018		BLA	BLA761118	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0333_3984da11-0df7-446e-9b95-9d385e17e73c	0069-0333	HUMAN PRESCRIPTION DRUG	ABRILADA		adalimumab-afzb	KIT		20231018		BLA	BLA761118	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0334_4de417fe-fb93-4b56-84bc-20763a43b323	0069-0334	HUMAN PRESCRIPTION DRUG	Litfulo		ritlecitinib	CAPSULE	ORAL	20230706		NDA	NDA215830	Pfizer Laboratories Div Pfizer Inc	RITLECITINIB TOSYLATE	50	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Janus Kinase 3 Inhibitors [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-0335_9a98f605-9595-4c3e-a722-9cda77031e21	0069-0335	HUMAN PRESCRIPTION DRUG	Cibinqo		abrocitinib	TABLET, FILM COATED	ORAL	20220224		NDA	NDA213871	Pfizer Laboratories Div Pfizer Inc	ABROCITINIB	100	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0069-0336_c74907a0-9727-4683-8aef-d2312b3afa6b	0069-0336	HUMAN PRESCRIPTION DRUG	Revatio		sildenafil citrate	POWDER, FOR SUSPENSION	ORAL	20140602		NDA	NDA203109	PFIZER LABORATORIES DIV PFIZER INC	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0069-0338_c74907a0-9727-4683-8aef-d2312b3afa6b	0069-0338	HUMAN PRESCRIPTION DRUG	Revatio		sildenafil citrate	INJECTION, SOLUTION	INTRAVENOUS	20091118		NDA	NDA022473	PFIZER LABORATORIES DIV PFIZER INC	SILDENAFIL CITRATE	.8	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0069-0342_ea88c0e2-d853-4382-89da-6661dae624a0	0069-0342	HUMAN PRESCRIPTION DRUG	Zirabev		bevacizumab-bvzr	INJECTION, SOLUTION	INTRAVENOUS	20200113		BLA	BLA761099	Pfizer Laboratories Div Pfizer Inc	BEVACIZUMAB	400	mg/16mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
0069-0344_bac19b46-1505-4177-aaf2-616264deae24	0069-0344	VACCINE	Abrysvo		Respiratory Syncytial Virus Vaccine	KIT		20230712		BLA	BLA125769	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0345_a1690f5a-c047-4f60-a641-8c619d2ae12e	0069-0345	HUMAN PRESCRIPTION DRUG	Paxlovid		nirmatrelvir and ritonavir	KIT		20220418		EMERGENCY USE AUTHORIZATION		Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0400_9ed58343-d62a-4979-a3c3-07f784f3161b	0069-0400	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140307		NDA	NDA050733	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	500	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-0411_c646a966-5d4b-4921-8e37-74e6de0b95be	0069-0411	VACCINE	TicoVac		Tick-Borne Encephalitis Vaccine	INJECTION	INTRAMUSCULAR	20211025		BLA	BLA125740	Pfizer Laboratories Div Pfizer Inc	TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)	2.4	ug/.5mL			N	20241231
0069-0435_9a98f605-9595-4c3e-a722-9cda77031e21	0069-0435	HUMAN PRESCRIPTION DRUG	Cibinqo		abrocitinib	TABLET, FILM COATED	ORAL	20220224		NDA	NDA213871	Pfizer Laboratories Div Pfizer Inc	ABROCITINIB	200	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0069-0468_5d4a5db0-3c89-4851-8d3a-ad9b4f83c17a	0069-0468	HUMAN PRESCRIPTION DRUG	CHANTIX		varenicline tartrate	TABLET, FILM COATED	ORAL	20060510		NDA	NDA021928	Pfizer Laboratories Div Pfizer Inc	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
0069-0469_5d4a5db0-3c89-4851-8d3a-ad9b4f83c17a	0069-0469	HUMAN PRESCRIPTION DRUG	CHANTIX		varenicline tartrate	TABLET, FILM COATED	ORAL	20060510		NDA	NDA021928	Pfizer Laboratories Div Pfizer Inc	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
0069-0471_5d4a5db0-3c89-4851-8d3a-ad9b4f83c17a	0069-0471	HUMAN PRESCRIPTION DRUG	CHANTIX		varenicline tartrate	KIT		20060510		NDA	NDA021928	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0486_6e5e2b14-bbfe-4f85-88ee-d516c6ac2536	0069-0486	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	TABLET, FILM COATED	ORAL	20200330		NDA	NDA212436	Pfizer Laboratories Div Pfizer Inc	PALBOCICLIB	100	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0069-0501_b66d67c5-58ad-437e-a098-1e4a18d1104d	0069-0501	HUMAN PRESCRIPTION DRUG	XELJANZ	XR	tofacitinib	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160307		NDA	NDA208246	Pfizer Laboratories Div Pfizer Inc	TOFACITINIB CITRATE	11	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0069-0502_b66d67c5-58ad-437e-a098-1e4a18d1104d	0069-0502	HUMAN PRESCRIPTION DRUG	XELJANZ	XR	tofacitinib	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200121		NDA	NDA208246	Pfizer Laboratories Div Pfizer Inc	TOFACITINIB CITRATE	22	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0069-0504_291aeaa4-56f1-492a-bda9-bf98559a5c37	0069-0504	HUMAN PRESCRIPTION DRUG	BOSULIF		Bosutinib	CAPSULE	ORAL	20240102		NDA	NDA217729	Pfizer Laboratories Div Pfizer Inc	BOSUTINIB MONOHYDRATE	50	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0069-0505_7d29ea18-6a49-4219-bc89-e3ebce870551	0069-0505	HUMAN PRESCRIPTION DRUG	Ngenla		somatrogon-ghla	INJECTION, SOLUTION	SUBCUTANEOUS	20230814		BLA	BLA761184	Pfizer Laboratories Div Pfizer Inc	SOMATROGON	24	mg/1.2mL			N	20241231
0069-0507_e4384d2f-d204-468c-a2d4-23666e3a493f	0069-0507	HUMAN PRESCRIPTION DRUG	Xalkori		CRIZOTINIB	CAPSULE, COATED PELLETS	ORAL	20231120		NDA	NDA217581	Pfizer Laboratories Div Pfizer Inc	CRIZOTINIB	50	mg/1	Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-0520_7d29ea18-6a49-4219-bc89-e3ebce870551	0069-0520	HUMAN PRESCRIPTION DRUG	Ngenla		somatrogon-ghla	INJECTION, SOLUTION	SUBCUTANEOUS	20230814		BLA	BLA761184	Pfizer Laboratories Div Pfizer Inc	SOMATROGON	60	mg/1.2mL			N	20241231
0069-0550_98991164-3067-460c-8c8b-4ca0976ad736	0069-0550	HUMAN PRESCRIPTION DRUG	SUTENT		Sunitinib malate	CAPSULE	ORAL	20060126		NDA	NDA021938	Pfizer Laboratories Div Pfizer Inc	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0069-0600_fd5652b6-5ae4-437e-a456-47deaf500794	0069-0600	VACCINE	PENBRAYA		meningococcal groups a, b, c, w, and y vaccine	KIT		20231127		BLA	BLA125770	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-0688_6e5e2b14-bbfe-4f85-88ee-d516c6ac2536	0069-0688	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	TABLET, FILM COATED	ORAL	20200330		NDA	NDA212436	Pfizer Laboratories Div Pfizer Inc	PALBOCICLIB	125	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0069-0770_98991164-3067-460c-8c8b-4ca0976ad736	0069-0770	HUMAN PRESCRIPTION DRUG	SUTENT		Sunitinib malate	CAPSULE	ORAL	20060126		NDA	NDA021938	Pfizer Laboratories Div Pfizer Inc	SUNITINIB MALATE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0069-0809_4da60f4e-44ba-4880-b1df-8d16e5b86d1a	0069-0809	HUMAN PRESCRIPTION DRUG	INFLECTRA		infliximab-dyyb	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161121		BLA	BLA125544	Pfizer Laboratories Div Pfizer Inc	INFLIXIMAB	100	mg/10mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
0069-0830_98991164-3067-460c-8c8b-4ca0976ad736	0069-0830	HUMAN PRESCRIPTION DRUG	SUTENT		Sunitinib malate	CAPSULE	ORAL	20140712		NDA	NDA021938	Pfizer Laboratories Div Pfizer Inc	SUNITINIB MALATE	37.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0069-0950_5414f42d-cfc3-465c-9aaf-d34adcb2626e	0069-0950	HUMAN PRESCRIPTION DRUG	Vibramycin Hyclate		doxycycline hyclate	CAPSULE	ORAL	19671205		NDA	NDA050007	Pfizer Laboratories Div Pfizer Inc	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0069-0970_5414f42d-cfc3-465c-9aaf-d34adcb2626e	0069-0970	HUMAN PRESCRIPTION DRUG	Vibramycin Monohydrate		doxycycline	POWDER, FOR SUSPENSION	ORAL	19671206		NDA	NDA050006	Pfizer Laboratories Div Pfizer Inc	DOXYCYCLINE	25	mg/5mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0069-0971_5414f42d-cfc3-465c-9aaf-d34adcb2626e	0069-0971	HUMAN PRESCRIPTION DRUG	Vibramycin Calcium		doxycycline calcium	SYRUP	ORAL	19740923		NDA	NDA050480	Pfizer Laboratories Div Pfizer Inc	DOXYCYCLINE CALCIUM	50	mg/5mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0069-0980_98991164-3067-460c-8c8b-4ca0976ad736	0069-0980	HUMAN PRESCRIPTION DRUG	SUTENT		Sunitinib malate	CAPSULE	ORAL	20060126		NDA	NDA021938	Pfizer Laboratories Div Pfizer Inc	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0069-1001_b66d67c5-58ad-437e-a098-1e4a18d1104d	0069-1001	HUMAN PRESCRIPTION DRUG	XELJANZ		tofacitinib	TABLET, FILM COATED	ORAL	20121109		NDA	NDA203214	Pfizer Laboratories Div Pfizer Inc	TOFACITINIB CITRATE	5	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0069-1002_b66d67c5-58ad-437e-a098-1e4a18d1104d	0069-1002	HUMAN PRESCRIPTION DRUG	XELJANZ		tofacitinib	TABLET, FILM COATED	ORAL	20180702		NDA	NDA203214	Pfizer Laboratories Div Pfizer Inc	TOFACITINIB CITRATE	10	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0069-1011_070501cc-8328-4bc3-91c8-8688fba3f982	0069-1011	PLASMA DERIVATIVE	Panzyga		immune globulin intravenous (human)	SOLUTION	INTRAVENOUS	20190809		BLA	BLA125587	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1014_291aeaa4-56f1-492a-bda9-bf98559a5c37	0069-1014	HUMAN PRESCRIPTION DRUG	BOSULIF		Bosutinib	CAPSULE	ORAL	20240102		NDA	NDA217729	Pfizer Laboratories Div Pfizer Inc	BOSUTINIB MONOHYDRATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0069-1029_b66d67c5-58ad-437e-a098-1e4a18d1104d	0069-1029	HUMAN PRESCRIPTION DRUG	XELJANZ		tofacitinib	SOLUTION	ORAL	20210208		NDA	NDA213082	Pfizer Laboratories Div Pfizer Inc	TOFACITINIB CITRATE	1	mg/mL	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0069-1031_207b4971-3031-45d7-b6a4-dfe66b37650c	0069-1031	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20230621		NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.1	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0069-1061_40f980d3-2ca6-b207-d6ed-c04c24f70c66	0069-1061	PLASMA DERIVATIVE	Cutaquig		immunoglobulin G	SOLUTION	SUBCUTANEOUS	20190913		BLA	BLA125668	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	165	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1085_a1690f5a-c047-4f60-a641-8c619d2ae12e	0069-1085	HUMAN PRESCRIPTION DRUG	Paxlovid		nirmatrelvir and ritonavir	KIT		20211222		EMERGENCY USE AUTHORIZATION		Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-1101_a1690f5a-c047-4f60-a641-8c619d2ae12e	0069-1101	HUMAN PRESCRIPTION DRUG	Paxlovid		nirmatrelvir and ritonavir	KIT		20220317		EMERGENCY USE AUTHORIZATION		Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-1109_070501cc-8328-4bc3-91c8-8688fba3f982	0069-1109	PLASMA DERIVATIVE	Panzyga		immune globulin intravenous (human)	SOLUTION	INTRAVENOUS	20190809		BLA	BLA125587	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1195_207b4971-3031-45d7-b6a4-dfe66b37650c	0069-1195	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20181026		NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	1	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0069-1198_7a7e890e-6637-4aff-b4fd-96815d2f1f3f	0069-1198	HUMAN PRESCRIPTION DRUG	Vizimpro		dacomitinib	TABLET, FILM COATED	ORAL	20181004		NDA	NDA211288	Pfizer Laboratories Div Pfizer Inc	DACOMITINIB	30	mg/1			N	20241231
0069-1224_070501cc-8328-4bc3-91c8-8688fba3f982	0069-1224	PLASMA DERIVATIVE	Panzyga		immune globulin intravenous (human)	SOLUTION	INTRAVENOUS	20190809		BLA	BLA125587	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1235_207b4971-3031-45d7-b6a4-dfe66b37650c	0069-1235	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20230621		NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.35	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0069-1305_23aea279-5369-4735-9e43-7dfe3a38baf5	0069-1305	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Pfizer Laboratories Div Pfizer Inc	EPOETIN	2000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
0069-1306_23aea279-5369-4735-9e43-7dfe3a38baf5	0069-1306	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Pfizer Laboratories Div Pfizer Inc	EPOETIN	3000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
0069-1307_23aea279-5369-4735-9e43-7dfe3a38baf5	0069-1307	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Pfizer Laboratories Div Pfizer Inc	EPOETIN	4000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
0069-1308_23aea279-5369-4735-9e43-7dfe3a38baf5	0069-1308	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Pfizer Laboratories Div Pfizer Inc	EPOETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
0069-1309_23aea279-5369-4735-9e43-7dfe3a38baf5	0069-1309	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Pfizer Laboratories Div Pfizer Inc	EPOETIN	40000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
0069-1311_23aea279-5369-4735-9e43-7dfe3a38baf5	0069-1311	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20201109		BLA	BLA125545	Pfizer Laboratories Div Pfizer Inc	EPOETIN	20000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
0069-1312_070501cc-8328-4bc3-91c8-8688fba3f982	0069-1312	PLASMA DERIVATIVE	Panzyga		immune globulin intravenous (human)	SOLUTION	INTRAVENOUS	20190809		BLA	BLA125587	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1318_23aea279-5369-4735-9e43-7dfe3a38baf5	0069-1318	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20201109		BLA	BLA125545	Pfizer Laboratories Div Pfizer Inc	EPOETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
0069-1415_070501cc-8328-4bc3-91c8-8688fba3f982	0069-1415	PLASMA DERIVATIVE	Panzyga		immune globulin intravenous (human)	SOLUTION	INTRAVENOUS	20190809		BLA	BLA125587	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1476_40f980d3-2ca6-b207-d6ed-c04c24f70c66	0069-1476	PLASMA DERIVATIVE	Cutaquig		immunoglobulin G	SOLUTION	SUBCUTANEOUS	20190913		BLA	BLA125668	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	165	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1500_e4384d2f-d204-468c-a2d4-23666e3a493f	0069-1500	HUMAN PRESCRIPTION DRUG	Xalkori		CRIZOTINIB	CAPSULE, COATED PELLETS	ORAL	20231120		NDA	NDA217581	Pfizer Laboratories Div Pfizer Inc	CRIZOTINIB	150	mg/1	Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-1501_207b4971-3031-45d7-b6a4-dfe66b37650c	0069-1501	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20220131		NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.5	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0069-1509_40f980d3-2ca6-b207-d6ed-c04c24f70c66	0069-1509	PLASMA DERIVATIVE	Cutaquig		immunoglobulin G	SOLUTION	SUBCUTANEOUS	20190913		BLA	BLA125668	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	165	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1520_39954f0b-789f-439d-93e3-26dfa619780b	0069-1520	HUMAN PRESCRIPTION DRUG	Norvasc		amlodipine besylate	TABLET	ORAL	19920731		NDA	NDA019787	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0069-1530_39954f0b-789f-439d-93e3-26dfa619780b	0069-1530	HUMAN PRESCRIPTION DRUG	Norvasc		amlodipine besylate	TABLET	ORAL	19920731		NDA	NDA019787	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0069-1531_9695bbad-259b-4ac3-80af-36f1ca94d433	0069-1531	HUMAN PRESCRIPTION DRUG	Daurismo		glasdegib	TABLET, FILM COATED	ORAL	20181210		NDA	NDA210656	Pfizer Laboratories Div Pfizer Inc	GLASDEGIB	100	mg/1	Hedgehog Pathway Inhibitor [EPC], Smoothened Receptor Antagonists [MoA]		N	20241231
0069-1540_39954f0b-789f-439d-93e3-26dfa619780b	0069-1540	HUMAN PRESCRIPTION DRUG	Norvasc		amlodipine besylate	TABLET	ORAL	19920731		NDA	NDA019787	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0069-1558_070501cc-8328-4bc3-91c8-8688fba3f982	0069-1558	PLASMA DERIVATIVE	Panzyga		immune globulin intravenous (human)	SOLUTION	INTRAVENOUS	20190809		BLA	BLA125587	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1751_207b4971-3031-45d7-b6a4-dfe66b37650c	0069-1751	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20220131		NDA	NDA211651	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.75	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0069-1802_40f980d3-2ca6-b207-d6ed-c04c24f70c66	0069-1802	PLASMA DERIVATIVE	Cutaquig		immunoglobulin G	SOLUTION	SUBCUTANEOUS	20190913		BLA	BLA125668	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	165	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1960_40f980d3-2ca6-b207-d6ed-c04c24f70c66	0069-1960	PLASMA DERIVATIVE	Cutaquig		immunoglobulin G	SOLUTION	SUBCUTANEOUS	20190913		BLA	BLA125668	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	165	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1965_40f980d3-2ca6-b207-d6ed-c04c24f70c66	0069-1965	PLASMA DERIVATIVE	Cutaquig		immunoglobulin G	SOLUTION	SUBCUTANEOUS	20190913		BLA	BLA125668	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	165	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-1975_847e5e9a-9978-4804-b542-320eba1fb9ad	0069-1975	HUMAN PRESCRIPTION DRUG	Vyndaqel		tafamidis meglumine	CAPSULE, LIQUID FILLED	ORAL	20190516		NDA	NDA211996	Pfizer Laboratories Div Pfizer Inc	TAFAMIDIS MEGLUMINE	20	mg/1			N	20251231
0069-2025_a0e017dc-e076-48f3-9cb6-c2d3608b26f8	0069-2025	VACCINE	Comirnaty		COVID-19 Vaccine, mRNA	INJECTION, SUSPENSION	INTRAMUSCULAR	20220518	20240131	BLA	BLA125742	Pfizer Laboratories Div Pfizer Inc	TOZINAMERAN	.225	mg/2.25mL			N	
0069-2150_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2150	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2160_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2160	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2170_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2170	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2180_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2180	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2190_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2190	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2250_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2250	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2260_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2260	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2270_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-2270	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20040130		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-2299_7a7e890e-6637-4aff-b4fd-96815d2f1f3f	0069-2299	HUMAN PRESCRIPTION DRUG	Vizimpro		dacomitinib	TABLET, FILM COATED	ORAL	20181004		NDA	NDA211288	Pfizer Laboratories Div Pfizer Inc	DACOMITINIB	45	mg/1			N	20241231
0069-2362_a0e017dc-e076-48f3-9cb6-c2d3608b26f8	0069-2362	VACCINE	Comirnaty		COVID-19 Vaccine, mRNA	INJECTION, SUSPENSION	INTRAMUSCULAR	20230911		BLA	BLA125742	Pfizer Laboratories Div Pfizer Inc	RAXTOZINAMERAN	.048	mg/.48mL			N	20241231
0069-2377_a0e017dc-e076-48f3-9cb6-c2d3608b26f8	0069-2377	VACCINE	Comirnaty		COVID-19 Vaccine, mRNA	INJECTION, SUSPENSION	INTRAMUSCULAR	20231031		BLA	BLA125742	Pfizer Laboratories Div Pfizer Inc	RAXTOZINAMERAN	.042	mg/.418mL			N	20241231
0069-2392_a0e017dc-e076-48f3-9cb6-c2d3608b26f8	0069-2392	VACCINE	Comirnaty		COVID-19 Vaccine, mRNA	INJECTION, SUSPENSION	INTRAMUSCULAR	20230911		BLA	BLA125742	Pfizer Laboratories Div Pfizer Inc	RAXTOZINAMERAN	.043	mg/.432mL			N	20241231
0069-2522_f6fea598-ff58-4a20-b5e8-8a51f37d8beb	0069-2522	HUMAN PRESCRIPTION DRUG	Elrexfio		elranatamab-bcmm	INJECTION, SOLUTION	SUBCUTANEOUS	20230815		BLA	BLA761345	Pfizer Laboratories Div Pfizer Inc	ELRANATAMAB	44	mg/1.1mL			N	20241231
0069-2650_15bf1d0d-aade-438f-a415-b4f3e7c6fa91	0069-2650	HUMAN PRESCRIPTION DRUG	Procardia	XL	nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19890906		NDA	NDA019684	Pfizer Laboratories Div Pfizer Inc	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0069-2660_15bf1d0d-aade-438f-a415-b4f3e7c6fa91	0069-2660	HUMAN PRESCRIPTION DRUG	Procardia	XL	nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19890906		NDA	NDA019684	Pfizer Laboratories Div Pfizer Inc	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0069-2670_15bf1d0d-aade-438f-a415-b4f3e7c6fa91	0069-2670	HUMAN PRESCRIPTION DRUG	Procardia	XL	nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19890906		NDA	NDA019684	Pfizer Laboratories Div Pfizer Inc	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0069-3030_0979766c-fbf5-4a1e-a4bc-ea5643527f9a	0069-3030	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19871223		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-3031_0979766c-fbf5-4a1e-a4bc-ea5643527f9a	0069-3031	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19871223		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-3032_0979766c-fbf5-4a1e-a4bc-ea5643527f9a	0069-3032	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19871223		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-3033_0979766c-fbf5-4a1e-a4bc-ea5643527f9a	0069-3033	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19871223		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-3034_0979766c-fbf5-4a1e-a4bc-ea5643527f9a	0069-3034	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19871223		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-3051_e54d9511-3284-4264-b1b1-611386384208	0069-3051	HUMAN PRESCRIPTION DRUG	ZITHROMAX		AZITHROMYCIN DIHYDRATE	POWDER, FOR SUSPENSION	ORAL	19940928		NDA	NDA050693	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	1	g/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3060_58375b91-2484-47e3-8715-0672f87e2f0c	0069-3060	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	TABLET, FILM COATED	ORAL	19960718		NDA	NDA050711	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3070_58375b91-2484-47e3-8715-0672f87e2f0c	0069-3070	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	TABLET, FILM COATED	ORAL	20020524		NDA	NDA050784	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3110_58375b91-2484-47e3-8715-0672f87e2f0c	0069-3110	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	POWDER, FOR SUSPENSION	ORAL	19951019		NDA	NDA050710	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3120_58375b91-2484-47e3-8715-0672f87e2f0c	0069-3120	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	POWDER, FOR SUSPENSION	ORAL	19951019		NDA	NDA050710	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3130_58375b91-2484-47e3-8715-0672f87e2f0c	0069-3130	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	POWDER, FOR SUSPENSION	ORAL	19951019		NDA	NDA050710	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3140_58375b91-2484-47e3-8715-0672f87e2f0c	0069-3140	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	POWDER, FOR SUSPENSION	ORAL	19951019		NDA	NDA050710	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3150_baf6074e-2528-4dbe-8c95-1c47d6e8b36f	0069-3150	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19970130		NDA	NDA050733	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	500	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-3220_aec5f7f0-536e-41b9-a397-c392699a1695	0069-3220	HUMAN PRESCRIPTION DRUG	Feldene		piroxicam	CAPSULE	ORAL	19940525		NDA	NDA018147	Pfizer Laboratories Div Pfizer Inc	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0069-3230_aec5f7f0-536e-41b9-a397-c392699a1695	0069-3230	HUMAN PRESCRIPTION DRUG	Feldene		piroxicam	CAPSULE	ORAL	19940525		NDA	NDA018147	Pfizer Laboratories Div Pfizer Inc	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0069-3500_13080956-f883-468c-be4f-e8b503a7fbc1	0069-3500	HUMAN PRESCRIPTION DRUG	ZAVZPRET		zavegepant	SPRAY	NASAL	20230601		NDA	NDA216386	Pfizer Laboratories Div Pfizer Inc	ZAVEGEPANT HYDROCHLORIDE	10	mg/.1mL	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
0069-4004_3459fd85-3777-4890-92ad-9f7c95ca4231	0069-4004	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20130317		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-4015_3459fd85-3777-4890-92ad-9f7c95ca4231	0069-4015	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20140317		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-4026_3459fd85-3777-4890-92ad-9f7c95ca4231	0069-4026	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20140317		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-4037_3459fd85-3777-4890-92ad-9f7c95ca4231	0069-4037	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20140317		NDA	NDA050629	Pfizer Laboratories Div Pfizer Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0069-4061_58375b91-2484-47e3-8715-0672f87e2f0c	0069-4061	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	TABLET, FILM COATED	ORAL	20190517		NDA	NDA050711	Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0069-4190_c74907a0-9727-4683-8aef-d2312b3afa6b	0069-4190	HUMAN PRESCRIPTION DRUG	Revatio		sildenafil citrate	TABLET, FILM COATED	ORAL	20050603		NDA	NDA021845	PFIZER LABORATORIES DIV PFIZER INC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0069-4200_577d1bae-05bb-4377-9dd8-95dcc92da9b6	0069-4200	HUMAN PRESCRIPTION DRUG	Viagra		sildenafil citrate	TABLET, FILM COATED	ORAL	19980327		NDA	NDA020895	PFIZER LABORATORIES DIV PFIZER INC	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0069-4210_577d1bae-05bb-4377-9dd8-95dcc92da9b6	0069-4210	HUMAN PRESCRIPTION DRUG	Viagra		sildenafil citrate	TABLET, FILM COATED	ORAL	19980327		NDA	NDA020895	PFIZER LABORATORIES DIV PFIZER INC	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0069-4220_577d1bae-05bb-4377-9dd8-95dcc92da9b6	0069-4220	HUMAN PRESCRIPTION DRUG	Viagra		sildenafil citrate	TABLET, FILM COATED	ORAL	19980327		NDA	NDA020895	PFIZER LABORATORIES DIV PFIZER INC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0069-4310_3461845a-5608-4733-a1ff-232993a76648	0069-4310	HUMAN PRESCRIPTION DRUG	Minipress		prazosin hydrochloride	CAPSULE	ORAL	19940510		NDA	NDA017442	Pfizer Laboratories Div Pfizer Inc	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0069-4370_3461845a-5608-4733-a1ff-232993a76648	0069-4370	HUMAN PRESCRIPTION DRUG	Minipress		prazosin hydrochloride	CAPSULE	ORAL	19940510		NDA	NDA017442	Pfizer Laboratories Div Pfizer Inc	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0069-4380_3461845a-5608-4733-a1ff-232993a76648	0069-4380	HUMAN PRESCRIPTION DRUG	Minipress		prazosin hydrochloride	CAPSULE	ORAL	19940510		NDA	NDA017442	Pfizer Laboratories Div Pfizer Inc	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0069-4494_f6fea598-ff58-4a20-b5e8-8a51f37d8beb	0069-4494	HUMAN PRESCRIPTION DRUG	Elrexfio		elranatamab-bcmm	INJECTION, SOLUTION	SUBCUTANEOUS	20230815		BLA	BLA761345	Pfizer Laboratories Div Pfizer Inc	ELRANATAMAB	76	mg/1.9mL			N	20241231
0069-5317_5d665f18-f17c-4fad-a42c-af817bb5373a	0069-5317	HUMAN PRESCRIPTION DRUG	Paxlovid		nirmatrelvir and ritonavir	KIT		20231018		NDA	NDA217188	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-5321_5d665f18-f17c-4fad-a42c-af817bb5373a	0069-5321	HUMAN PRESCRIPTION DRUG	Paxlovid		nirmatrelvir and ritonavir	KIT		20231018		NDA	NDA217188	Pfizer Laboratories Div Pfizer Inc						N	20241231
0069-5410_0078bd09-54a0-41af-9116-7056c6d2491d	0069-5410	HUMAN PRESCRIPTION DRUG	Vistaril		hydroxyzine pamoate	CAPSULE	ORAL	19941128		NDA	NDA011459	Pfizer Laboratories Div Pfizer Inc	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0069-5420_0078bd09-54a0-41af-9116-7056c6d2491d	0069-5420	HUMAN PRESCRIPTION DRUG	Vistaril		hydroxyzine pamoate	CAPSULE	ORAL	19681115		NDA	NDA011459	Pfizer Laboratories Div Pfizer Inc	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0069-5471_3c7f9456-331d-4abd-a751-b47eafd68f38	0069-5471	HUMAN PRESCRIPTION DRUG	CEREBYX		Fosphenytoin Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131028		NDA	NDA020450	Pfizer Laboratories Div Pfizer Inc	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0069-5474_3c7f9456-331d-4abd-a751-b47eafd68f38	0069-5474	HUMAN PRESCRIPTION DRUG	CEREBYX		Fosphenytoin Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131028		NDA	NDA020450	Pfizer Laboratories Div Pfizer Inc	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0069-5800_a4df6111-f3d6-48d1-84d9-a7d4ee3175a3	0069-5800	HUMAN PRESCRIPTION DRUG	Tikosyn		dofetilide	CAPSULE	ORAL	19991001		NDA	NDA020931	Pfizer Laboratories Div Pfizer Inc	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
0069-5810_a4df6111-f3d6-48d1-84d9-a7d4ee3175a3	0069-5810	HUMAN PRESCRIPTION DRUG	Tikosyn		dofetilide	CAPSULE	ORAL	19991001		NDA	NDA020931	Pfizer Laboratories Div Pfizer Inc	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
0069-5820_a4df6111-f3d6-48d1-84d9-a7d4ee3175a3	0069-5820	HUMAN PRESCRIPTION DRUG	Tikosyn		dofetilide	CAPSULE	ORAL	19991001		NDA	NDA020931	Pfizer Laboratories Div Pfizer Inc	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
0069-6001_b6e28a06-abe9-4ee3-ab1e-85fdf36e7c22	0069-6001	HUMAN PRESCRIPTION DRUG	CEREBYX		Fosphenytoin Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131028		NDA	NDA020450	Pfizer Laboratories Div Pfizer Inc	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0069-6002_b2310968-f8ba-f022-39f2-52bacabbc35b	0069-6002	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-6111_b2310968-f8ba-f022-39f2-52bacabbc35b	0069-6111	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-6180_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-6180	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220831		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-6237_b2310968-f8ba-f022-39f2-52bacabbc35b	0069-6237	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-6323_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-6323	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220831		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-6339_b2310968-f8ba-f022-39f2-52bacabbc35b	0069-6339	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-6550_b2310968-f8ba-f022-39f2-52bacabbc35b	0069-6550	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-6565_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-6565	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220831		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-6747_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-6747	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220831		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-7232_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-7232	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220831		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-7476_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-7476	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220831		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-7654_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-7654	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220831		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-7810_9c800a70-9fd4-427c-b848-c65fff86f7e6	0069-7810	HUMAN PRESCRIPTION DRUG	Caduet		amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20220606		NDA	NDA021540	Pfizer Laboratories Div Pfizer Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0069-8140_e4384d2f-d204-468c-a2d4-23666e3a493f	0069-8140	HUMAN PRESCRIPTION DRUG	Xalkori		CRIZOTINIB	CAPSULE	ORAL	20110826		NDA	NDA202570	Pfizer Laboratories Div Pfizer Inc	CRIZOTINIB	250	mg/1	Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-8141_e4384d2f-d204-468c-a2d4-23666e3a493f	0069-8141	HUMAN PRESCRIPTION DRUG	Xalkori		CRIZOTINIB	CAPSULE	ORAL	20110826		NDA	NDA202570	Pfizer Laboratories Div Pfizer Inc	CRIZOTINIB	200	mg/1	Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0069-8400_6baea0c5-068c-ff76-8742-300979398c00	0069-8400	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	50	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-8425_6baea0c5-068c-ff76-8742-300979398c00	0069-8425	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	50	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-8451_6baea0c5-068c-ff76-8742-300979398c00	0069-8451	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	50	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-8476_6baea0c5-068c-ff76-8742-300979398c00	0069-8476	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20231113		BLA	BLA125062	Pfizer Laboratories Div Pfizer Inc	HUMAN IMMUNOGLOBULIN G	50	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0069-8730_847e5e9a-9978-4804-b542-320eba1fb9ad	0069-8730	HUMAN PRESCRIPTION DRUG	Vyndamax		tafamidis	CAPSULE, LIQUID FILLED	ORAL	20190827		NDA	NDA212161	Pfizer Laboratories Div Pfizer Inc	TAFAMIDIS	61	mg/1			N	20251231
0069-9500_20f4cb9d-a2d0-425c-858e-ba081b6cb033	0069-9500	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	TABLET, FILM COATED	ORAL	20200430		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Pfizer Laboratories Div Pfizer Inc	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0071-0007_93122552-894d-4578-8106-f6eb4bd256ef	0071-0007	HUMAN PRESCRIPTION DRUG	Dilantin Infatabs		Phenytoin	TABLET, CHEWABLE	ORAL	19790226		ANDA	ANDA084427	Parke-Davis Div of Pfizer Inc	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0155_b7cb94bf-e87b-4395-b634-27f3b4c1b2ee	0071-0155	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	19961217		NDA	NDA020702	Parke-Davis Div of Pfizer Inc	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0071-0156_b7cb94bf-e87b-4395-b634-27f3b4c1b2ee	0071-0156	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	19961217		NDA	NDA020702	Parke-Davis Div of Pfizer Inc	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0071-0157_b7cb94bf-e87b-4395-b634-27f3b4c1b2ee	0071-0157	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	19961217	20260331	NDA	NDA020702	Parke-Davis Div of Pfizer Inc	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
0071-0158_b7cb94bf-e87b-4395-b634-27f3b4c1b2ee	0071-0158	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	20000407		NDA	NDA020702	Parke-Davis Div of Pfizer Inc	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0071-0237_edbd0e03-32f6-4f34-9686-f63912bbe623	0071-0237	HUMAN PRESCRIPTION DRUG	Zarontin		Ethosuximide	CAPSULE	ORAL	20000922		NDA	NDA012380	Parke-Davis Div of Pfizer Inc	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0350_fb832db5-b964-43c1-b52f-c2b701b0ce94	0071-0350	HUMAN PRESCRIPTION DRUG	Nardil		Phenelzine Sulfate	TABLET, FILM COATED	ORAL	19610609		NDA	NDA011909	Parke-Davis Div of Pfizer Inc	PHENELZINE SULFATE	15	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
0071-0369_4f5488b4-78d4-4200-9fdf-506457478dea	0071-0369	HUMAN PRESCRIPTION DRUG	Dilantin		Extended Phenytoin Sodium	CAPSULE	ORAL	19760827		ANDA	ANDA084349	Parke-Davis Div of Pfizer Inc	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0401_9d661bad-5e98-43c8-81ce-29cd14ba829e	0071-0401	HUMAN PRESCRIPTION DRUG	Neurontin		gabapentin	TABLET, FILM COATED	ORAL	19981009		NDA	NDA020882	Parke-Davis Div of Pfizer Inc	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0417_234ddb0c-2f43-4819-a7e8-ee6056d8825e	0071-0417	HUMAN PRESCRIPTION DRUG	Nitrostat		nitroglycerin	TABLET	SUBLINGUAL	20000501		NDA	NDA021134	Parke-Davis Div of Pfizer Inc	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0071-0418_234ddb0c-2f43-4819-a7e8-ee6056d8825e	0071-0418	HUMAN PRESCRIPTION DRUG	Nitrostat		nitroglycerin	TABLET	SUBLINGUAL	20000501		NDA	NDA021134	Parke-Davis Div of Pfizer Inc	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0071-0419_234ddb0c-2f43-4819-a7e8-ee6056d8825e	0071-0419	HUMAN PRESCRIPTION DRUG	Nitrostat		nitroglycerin	TABLET	SUBLINGUAL	20000501		NDA	NDA021134	Parke-Davis Div of Pfizer Inc	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0071-0513_9d661bad-5e98-43c8-81ce-29cd14ba829e	0071-0513	HUMAN PRESCRIPTION DRUG	Neurontin		gabapentin	TABLET, FILM COATED	ORAL	19981009		NDA	NDA020882	Parke-Davis Div of Pfizer Inc	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0525_7125a267-65f7-40b7-88cb-fbfc4a750ef7	0071-0525	HUMAN PRESCRIPTION DRUG	Celontin		methsuximide	CAPSULE	ORAL	19570208		NDA	NDA010596	Parke-Davis Div of Pfizer Inc	METHSUXIMIDE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0527_5ff434c1-ca62-447d-b49c-31209efca983	0071-0527	HUMAN PRESCRIPTION DRUG	Accupril		quinapril hydrochloride	TABLET, FILM COATED	ORAL	19911119		NDA	NDA019885	Parke-Davis Div of Pfizer Inc	QUINAPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0071-0530_5ff434c1-ca62-447d-b49c-31209efca983	0071-0530	HUMAN PRESCRIPTION DRUG	Accupril		quinapril hydrochloride	TABLET, FILM COATED	ORAL	19911119		NDA	NDA019885	Parke-Davis Div of Pfizer Inc	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0071-0532_5ff434c1-ca62-447d-b49c-31209efca983	0071-0532	HUMAN PRESCRIPTION DRUG	Accupril		quinapril hydrochloride	TABLET, FILM COATED	ORAL	19911119		NDA	NDA019885	Parke-Davis Div of Pfizer Inc	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0071-0535_5ff434c1-ca62-447d-b49c-31209efca983	0071-0535	HUMAN PRESCRIPTION DRUG	Accupril		quinapril hydrochloride	TABLET, FILM COATED	ORAL	19911119		NDA	NDA019885	Parke-Davis Div of Pfizer Inc	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0071-0737_3ac037a2-68ec-4440-9de5-068666b343e6	0071-0737	HUMAN PRESCRIPTION DRUG	Lopid		gemfibrozil	TABLET, FILM COATED	ORAL	20040330		NDA	NDA018422	Parke-Davis Div of Pfizer Inc	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
0071-0803_9d661bad-5e98-43c8-81ce-29cd14ba829e	0071-0803	HUMAN PRESCRIPTION DRUG	Neurontin		gabapentin	CAPSULE	ORAL	19931230		NDA	NDA020235	Parke-Davis Div of Pfizer Inc	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0805_9d661bad-5e98-43c8-81ce-29cd14ba829e	0071-0805	HUMAN PRESCRIPTION DRUG	Neurontin		gabapentin	CAPSULE	ORAL	19931230		NDA	NDA020235	Parke-Davis Div of Pfizer Inc	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-0806_9d661bad-5e98-43c8-81ce-29cd14ba829e	0071-0806	HUMAN PRESCRIPTION DRUG	Neurontin		gabapentin	CAPSULE	ORAL	19931230		NDA	NDA020235	Parke-Davis Div of Pfizer Inc	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-1012_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1012	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	25	mg/1		CV	N	20241231
0071-1013_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1013	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	50	mg/1		CV	N	20241231
0071-1014_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1014	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	75	mg/1		CV	N	20241231
0071-1015_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1015	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	100	mg/1		CV	N	20241231
0071-1016_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1016	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	150	mg/1		CV	N	20241231
0071-1017_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1017	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	200	mg/1		CV	N	20241231
0071-1018_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1018	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	300	mg/1		CV	N	20241231
0071-1019_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1019	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Parke-Davis Div of Pfizer Inc	PREGABALIN	225	mg/1		CV	N	20241231
0071-1020_a0943da6-ba39-48b7-a89c-ec2942f6d0af	0071-1020	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	SOLUTION	ORAL	20100104		NDA	NDA022488	Parke-Davis Div of Pfizer Inc	PREGABALIN	20	mg/mL		CV	N	20241231
0071-1026_90915b8e-ad76-42c6-a07c-0b20cf2f603b	0071-1026	HUMAN PRESCRIPTION DRUG	Lyrica CR		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180101		NDA	NDA209501	Parke-Davis Div of Pfizer Inc	PREGABALIN	82.5	mg/1		CV	N	20241231
0071-1027_90915b8e-ad76-42c6-a07c-0b20cf2f603b	0071-1027	HUMAN PRESCRIPTION DRUG	Lyrica CR		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180101		NDA	NDA209501	Parke-Davis Div of Pfizer Inc	PREGABALIN	165	mg/1		CV	N	20241231
0071-1029_90915b8e-ad76-42c6-a07c-0b20cf2f603b	0071-1029	HUMAN PRESCRIPTION DRUG	Lyrica CR		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180101		NDA	NDA209501	Parke-Davis Div of Pfizer Inc	PREGABALIN	330	mg/1		CV	N	20241231
0071-2012_9d661bad-5e98-43c8-81ce-29cd14ba829e	0071-2012	HUMAN PRESCRIPTION DRUG	Neurontin		gabapentin	SOLUTION	ORAL	20000302		NDA	NDA021129	Parke-Davis Div of Pfizer Inc	GABAPENTIN	250	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-2214_2290658d-13e5-43f6-805f-614c8baa613c	0071-2214	HUMAN PRESCRIPTION DRUG	Dilantin-125		Phenytoin	SUSPENSION	ORAL	19530106		NDA	NDA008762	Parke-Davis Div of Pfizer Inc	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-2418_6afa95d3-162a-4fbb-ab47-561f4ee7771a	0071-2418	HUMAN PRESCRIPTION DRUG	Zarontin		Ethosuximide	SOLUTION	ORAL	20200310		ANDA	ANDA080258	Parke-Davis Div of Pfizer Inc	ETHOSUXIMIDE	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-3112_489727cb-429e-4f04-a973-ae4dc7898519	0071-3112	HUMAN PRESCRIPTION DRUG	ACCURETIC		quinapril and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211129		NDA	NDA020125	Parke-Davis Div of Pfizer Inc	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0071-3740_4f5488b4-78d4-4200-9fdf-506457478dea	0071-3740	HUMAN PRESCRIPTION DRUG	Dilantin		Extended Phenytoin Sodium	CAPSULE	ORAL	19760827		ANDA	ANDA084349	Parke-Davis Div of Pfizer Inc	PHENYTOIN SODIUM	30	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0071-5212_489727cb-429e-4f04-a973-ae4dc7898519	0071-5212	HUMAN PRESCRIPTION DRUG	ACCURETIC		quinapril and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211206		NDA	NDA020125	Parke-Davis Div of Pfizer Inc	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0074-0038_0c3c5812-03a4-4ff2-bc62-786488dc4cc4	0074-0038	HUMAN PRESCRIPTION DRUG	Orilissa		Elagolix	TABLET, FILM COATED	ORAL	20180723		NDA	NDA210450	AbbVie Inc.	ELAGOLIX SODIUM	150	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-0039_0c3c5812-03a4-4ff2-bc62-786488dc4cc4	0074-0039	HUMAN PRESCRIPTION DRUG	Orilissa		Elagolix	TABLET, FILM COATED	ORAL	20180723		NDA	NDA210450	AbbVie Inc.	ELAGOLIX SODIUM	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-0067_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-0067	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20161017	20240731	BLA	BLA125057	AbbVie Inc.						N	
0074-0124_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-0124	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20170421		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-0243_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-0243	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20151123		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-0522_d38d7a08-7c06-4262-961d-00e54cf20378	0074-0522	HUMAN PRESCRIPTION DRUG	Kaletra		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20100618		NDA	NDA021906	AbbVie Inc.	LOPINAVIR; RITONAVIR	100; 25	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0074-0554_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-0554	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20160309		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-0561_843d380a-6566-4045-bc90-1c3b633867ec	0074-0561	HUMAN PRESCRIPTION DRUG	Venclexta		Venetoclax	TABLET, FILM COATED	ORAL	20160411		NDA	NDA208573	AbbVie Inc.	VENETOCLAX	10	mg/1	BCL-2 Inhibitor [EPC], Increased Cellular Death [PE], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-0566_843d380a-6566-4045-bc90-1c3b633867ec	0074-0566	HUMAN PRESCRIPTION DRUG	Venclexta		Venetoclax	TABLET, FILM COATED	ORAL	20160411		NDA	NDA208573	AbbVie Inc.	VENETOCLAX	50	mg/1	BCL-2 Inhibitor [EPC], Increased Cellular Death [PE], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-0576_843d380a-6566-4045-bc90-1c3b633867ec	0074-0576	HUMAN PRESCRIPTION DRUG	Venclexta		Venetoclax	TABLET, FILM COATED	ORAL	20160411		NDA	NDA208573	AbbVie Inc.	VENETOCLAX	100	mg/1	BCL-2 Inhibitor [EPC], Increased Cellular Death [PE], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-0579_843d380a-6566-4045-bc90-1c3b633867ec	0074-0579	HUMAN PRESCRIPTION DRUG	Venclexta		Venetoclax	KIT		20160411		NDA	NDA208573	AbbVie Inc.						N	20241231
0074-0616_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-0616	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20170428		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-0817_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-0817	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20170428		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-1017_cc29473d-8559-4b6d-ab31-64c818e5d9df	0074-1017	HUMAN PRESCRIPTION DRUG	Oriahnn		Elagolix and Estradiol and Norethisterone	KIT		20200529		NDA	NDA213388	AbbVie Inc.						N	20241231
0074-1040_d7b22199-8b83-4205-b830-a6942b2249db	0074-1040	HUMAN PRESCRIPTION DRUG	Survanta		Beractant	SUSPENSION	ENDOTRACHEAL	19910701		BLA	BLA020032	AbbVie Inc.	BERACTANT	25	mg/mL			N	20241231
0074-1043_b3ed4d84-05b2-41f8-9664-2e2fff13effc	0074-1043	HUMAN PRESCRIPTION DRUG	Rinvoq		Upadacitinib	TABLET, EXTENDED RELEASE	ORAL	20190816		NDA	NDA211675	AbbVie Inc.	UPADACITINIB	45	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0074-1050_7718dd85-622c-478e-ae9b-91e14a1373c6	0074-1050	HUMAN PRESCRIPTION DRUG	Skyrizi		risankizumab-rzaa	INJECTION	SUBCUTANEOUS	20210426		BLA	BLA761105	AbbVie Inc.	RISANKIZUMAB	150	mg/mL	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20251231
0074-1065_7718dd85-622c-478e-ae9b-91e14a1373c6	0074-1065	HUMAN PRESCRIPTION DRUG	Skyrizi		Risankizumab-rzaa	KIT	INTRAVENOUS	20220923		BLA	BLA761105	AbbVie Inc.						N	20251231
0074-1070_7718dd85-622c-478e-ae9b-91e14a1373c6	0074-1070	HUMAN PRESCRIPTION DRUG	Skyrizi		Risankizumab-rzaa	KIT	INTRAVENOUS	20220616		BLA	BLA761105	AbbVie Inc.						N	20251231
0074-1539_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-1539	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20170421		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-1658_34ce3eec-a796-40f8-8902-127f8c47a980	0074-1658	HUMAN PRESCRIPTION DRUG	Zemplar		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	19980417		NDA	NDA020819	AbbVie Inc.	PARICALCITOL	5	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
0074-2100_7718dd85-622c-478e-ae9b-91e14a1373c6	0074-2100	HUMAN PRESCRIPTION DRUG	Skyrizi		risankizumab-rzaa	INJECTION	SUBCUTANEOUS	20210426		BLA	BLA761105	AbbVie Inc.	RISANKIZUMAB	150	mg/mL	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20251231
0074-2108_ffa75dac-b8cb-44fa-bcdb-2aa07d93d359	0074-2108	HUMAN PRESCRIPTION DRUG	Lupron Depot-PED		leuprolide acetate	KIT		19930416		NDA	NDA020263	AbbVie Inc.						N	20241231
0074-2282_ffa75dac-b8cb-44fa-bcdb-2aa07d93d359	0074-2282	HUMAN PRESCRIPTION DRUG	Lupron Depot-PED		leuprolide acetate	KIT		19930416		NDA	NDA020263	AbbVie Inc.						N	20241231
0074-2306_b3ed4d84-05b2-41f8-9664-2e2fff13effc	0074-2306	HUMAN PRESCRIPTION DRUG	Rinvoq		Upadacitinib	TABLET, EXTENDED RELEASE	ORAL	20190816		NDA	NDA211675	AbbVie Inc.	UPADACITINIB	15	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0074-2310_b3ed4d84-05b2-41f8-9664-2e2fff13effc	0074-2310	HUMAN PRESCRIPTION DRUG	Rinvoq		Upadacitinib	TABLET, EXTENDED RELEASE	ORAL	20190816		NDA	NDA211675	AbbVie Inc.	UPADACITINIB	30	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
0074-2340_4fac307e-e822-429d-9516-d95e86529dc9	0074-2340	HUMAN PRESCRIPTION DRUG	Norvir		Ritonavir	TABLET, FILM COATED	ORAL	20220816		NDA	NDA022417	AbbVie Inc.	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0074-2440_ffa75dac-b8cb-44fa-bcdb-2aa07d93d359	0074-2440	HUMAN PRESCRIPTION DRUG	Lupron Depot-PED		leuprolide acetate	KIT		19930416		NDA	NDA020263	AbbVie Inc.						N	20241231
0074-2540_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-2540	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20161017		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-2600_085d0018-b2f0-4da6-b528-a2866430599c	0074-2600	HUMAN PRESCRIPTION DRUG	Mavyret		Glecaprevir and Pibrentasvir	PELLET	ORAL	20210610		NDA	NDA215110	AbbVie Inc.	GLECAPREVIR; PIBRENTASVIR	50; 20	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0074-2625_085d0018-b2f0-4da6-b528-a2866430599c	0074-2625	HUMAN PRESCRIPTION DRUG	Mavyret		Glecaprevir and Pibrentasvir	TABLET, FILM COATED	ORAL	20170803		NDA	NDA209394	AbbVie Inc.	GLECAPREVIR; PIBRENTASVIR	100; 40	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0074-3008_d38d7a08-7c06-4262-961d-00e54cf20378	0074-3008	HUMAN PRESCRIPTION DRUG	Kaletra		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20200408		NDA	NDA021906	AbbVie Inc.	LOPINAVIR; RITONAVIR	100; 25	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0074-3012_6e98ea6e-244d-4901-9189-a04dd334d872	0074-3012	HUMAN PRESCRIPTION DRUG	Duopa		Carbidopa and Levodopa	SUSPENSION	ENTERAL	20150115		NDA	NDA203952	AbbVie Inc.	CARBIDOPA; LEVODOPA	4.63; 20	mg/mL; mg/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0074-3023_91a88355-2985-464a-ae70-f75e0ae09ae5	0074-3023	HUMAN PRESCRIPTION DRUG	K-Tab		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19800609	20250215	NDA	NDA018279	AbbVie Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
0074-3108_b4988e79-5738-42c0-b260-2fd071bb7a5d	0074-3108	HUMAN PRESCRIPTION DRUG	Gengraf		Cyclosporine	CAPSULE	ORAL	20151101		ANDA	ANDA065003	AbbVie Inc.	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-3109_b4988e79-5738-42c0-b260-2fd071bb7a5d	0074-3109	HUMAN PRESCRIPTION DRUG	Gengraf		Cyclosporine	CAPSULE	ORAL	20151101		ANDA	ANDA065003	AbbVie Inc.	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-3161_45d3b5e3-12f2-486c-87b6-d2e529e5017c	0074-3161	HUMAN PRESCRIPTION DRUG	Trilipix		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20160912		NDA	NDA022224	AbbVie Inc.	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0074-3162_45d3b5e3-12f2-486c-87b6-d2e529e5017c	0074-3162	HUMAN PRESCRIPTION DRUG	Trilipix		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20160912		NDA	NDA022224	AbbVie Inc.	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0074-3173_7d6fd4ec-c931-458a-8687-fd3a96dfda2c	0074-3173	HUMAN PRESCRIPTION DRUG	Tricor		Fenofibrate	TABLET	ORAL	20160205		NDA	NDA021656	AbbVie Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0074-3189_7d6fd4ec-c931-458a-8687-fd3a96dfda2c	0074-3189	HUMAN PRESCRIPTION DRUG	Tricor		Fenofibrate	TABLET	ORAL	20160205		NDA	NDA021656	AbbVie Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0074-3333_4fac307e-e822-429d-9516-d95e86529dc9	0074-3333	HUMAN PRESCRIPTION DRUG	Norvir		Ritonavir	TABLET, FILM COATED	ORAL	20100506	20240214	NDA	NDA022417	AbbVie Inc.	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	
0074-3346_2b547ade-c5d1-494f-956f-0b5703b1dadb	0074-3346	HUMAN PRESCRIPTION DRUG	Lupron Depot		leuprolide acetate	KIT		19951222		NDA	NDA020517	AbbVie Inc.						N	20241231
0074-3399_4fac307e-e822-429d-9516-d95e86529dc9	0074-3399	HUMAN PRESCRIPTION DRUG	Norvir		Ritonavir	POWDER	ORAL	20170607		NDA	NDA209512	AbbVie Inc.	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0074-3473_2b547ade-c5d1-494f-956f-0b5703b1dadb	0074-3473	HUMAN PRESCRIPTION DRUG	Lupron Depot		leuprolide acetate	KIT		19951222		NDA	NDA020517	AbbVie Inc.						N	20241231
0074-3575_ffa75dac-b8cb-44fa-bcdb-2aa07d93d359	0074-3575	HUMAN PRESCRIPTION DRUG	Lupron Depot-PED		leuprolide acetate	KIT		20230414		NDA	NDA020263	AbbVie Inc.						N	20241231
0074-3641_f8528649-0162-470f-9393-ea7fdfcaf11c	0074-3641	HUMAN PRESCRIPTION DRUG	Lupron Depot		leuprolide acetate	KIT		19901022		NDA	NDA020011	AbbVie Inc.						N	20241231
0074-3642_2b547ade-c5d1-494f-956f-0b5703b1dadb	0074-3642	HUMAN PRESCRIPTION DRUG	Lupron Depot		leuprolide acetate	KIT		19890126		NDA	NDA019732	AbbVie Inc.						N	20241231
0074-3663_b945574e-0130-44f2-b578-3815ce357939	0074-3663	HUMAN PRESCRIPTION DRUG	Lupron Depot		leuprolide acetate	KIT		20101108		NDA	NDA020708	AbbVie Inc.						N	20241231
0074-3683_2b547ade-c5d1-494f-956f-0b5703b1dadb	0074-3683	HUMAN PRESCRIPTION DRUG	Lupron Depot		leuprolide acetate	KIT		19951222		NDA	NDA020517	AbbVie Inc.						N	20241231
0074-3727_872c70fd-ed64-4f07-b811-5eaa08924982	0074-3727	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-3779_ffa75dac-b8cb-44fa-bcdb-2aa07d93d359	0074-3779	HUMAN PRESCRIPTION DRUG	Lupron Depot-PED		leuprolide acetate	KIT		19930416		NDA	NDA020263	AbbVie Inc.						N	20241231
0074-3799_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-3799	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20021231		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-3826_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e	0074-3826	HUMAN PRESCRIPTION DRUG	Depakote	ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20000804	20240621	NDA	NDA021168	AbbVie Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
0074-3956_d38d7a08-7c06-4262-961d-00e54cf20378	0074-3956	HUMAN PRESCRIPTION DRUG	Kaletra		Lopinavir and Ritonavir	SOLUTION	ORAL	20100618		NDA	NDA021251	AbbVie Inc.	LOPINAVIR; RITONAVIR	80; 20	mg/mL; mg/mL	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0074-4014_d38d7a08-7c06-4262-961d-00e54cf20378	0074-4014	HUMAN PRESCRIPTION DRUG	Kaletra		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20200408		NDA	NDA021906	AbbVie Inc.	LOPINAVIR; RITONAVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0074-4339_17d70a36-5bb6-43f0-add4-490aafac7ce3	0074-4339	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20060623		BLA	BLA125057	AbbVie Inc.						N	20241231
0074-4341_872c70fd-ed64-4f07-b811-5eaa08924982	0074-4341	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-4456_048607d6-77e3-4d40-83c2-d7e0a8dfdc60	0074-4456	HUMAN PRESCRIPTION DRUG	Ultane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	19950607		NDA	NDA020478	AbbVie Inc.	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0074-4456_acc4e05d-c8ef-4838-a942-792d6b98d286	0074-4456	HUMAN PRESCRIPTION DRUG	Ultane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	19950607		NDA	NDA020478	AbbVie Inc.	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0074-4552_872c70fd-ed64-4f07-b811-5eaa08924982	0074-4552	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-4637_34ce3eec-a796-40f8-8902-127f8c47a980	0074-4637	HUMAN PRESCRIPTION DRUG	Zemplar		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	19980417		NDA	NDA020819	AbbVie Inc.	PARICALCITOL	2	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
0074-5015_7718dd85-622c-478e-ae9b-91e14a1373c6	0074-5015	HUMAN PRESCRIPTION DRUG	Skyrizi		risankizumab-rzaa	INJECTION	INTRAVENOUS	20220616		BLA	BLA761262	AbbVie Inc.	RISANKIZUMAB	600	mg/10mL	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20251231
0074-5182_872c70fd-ed64-4f07-b811-5eaa08924982	0074-5182	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-6114_c4f87cf0-f300-479b-89ed-9234d530b574	0074-6114	HUMAN PRESCRIPTION DRUG	Depakote	Sprinkles	Divalproex Sodium	CAPSULE	ORAL	19890912		NDA	NDA019680	AbbVie Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0074-6214_2dd06ac2-bd8c-4c06-967e-09f649a0f971	0074-6214	HUMAN PRESCRIPTION DRUG	Depakote		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	19830310	20240301	NDA	NDA018723	AbbVie Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
0074-6215_2dd06ac2-bd8c-4c06-967e-09f649a0f971	0074-6215	HUMAN PRESCRIPTION DRUG	Depakote		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	19830310	20240225	NDA	NDA018723	AbbVie Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
0074-6594_872c70fd-ed64-4f07-b811-5eaa08924982	0074-6594	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-6624_872c70fd-ed64-4f07-b811-5eaa08924982	0074-6624	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-6799_d38d7a08-7c06-4262-961d-00e54cf20378	0074-6799	HUMAN PRESCRIPTION DRUG	Kaletra		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20100618		NDA	NDA021906	AbbVie Inc.	LOPINAVIR; RITONAVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0074-7034_7718dd85-622c-478e-ae9b-91e14a1373c6	0074-7034	HUMAN PRESCRIPTION DRUG	Skyrizi		Risankizumab-rzaa	KIT		20230322		BLA	BLA761105	AbbVie Inc.						N	20251231
0074-7036_7718dd85-622c-478e-ae9b-91e14a1373c6	0074-7036	HUMAN PRESCRIPTION DRUG	Skyrizi		Risankizumab-rzaa	KIT		20230322		BLA	BLA761105	AbbVie Inc.						N	20251231
0074-7068_872c70fd-ed64-4f07-b811-5eaa08924982	0074-7068	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-7069_872c70fd-ed64-4f07-b811-5eaa08924982	0074-7069	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-7070_872c70fd-ed64-4f07-b811-5eaa08924982	0074-7070	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-7094_a313e1c3-0edb-4e39-b069-0c538f0c9424	0074-7094	HUMAN PRESCRIPTION DRUG	Qulipta		Atogepant	TABLET	ORAL	20210930		NDA	NDA215206	AbbVie Inc.	ATOGEPANT	60	mg/1	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
0074-7095_a313e1c3-0edb-4e39-b069-0c538f0c9424	0074-7095	HUMAN PRESCRIPTION DRUG	Qulipta		Atogepant	TABLET	ORAL	20210930		NDA	NDA215206	AbbVie Inc.	ATOGEPANT	10	mg/1	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
0074-7096_a313e1c3-0edb-4e39-b069-0c538f0c9424	0074-7096	HUMAN PRESCRIPTION DRUG	Qulipta		Atogepant	TABLET	ORAL	20210930		NDA	NDA215206	AbbVie Inc.	ATOGEPANT	30	mg/1	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
0074-7098_84fc7fa1-fe20-4b58-9071-6f0f8f4debf8	0074-7098	HUMAN PRESCRIPTION DRUG	VUITY		Pilocarpine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20211028		NDA	NDA214028	AbbVie Inc.	PILOCARPINE HYDROCHLORIDE	12.5	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0074-7126_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e	0074-7126	HUMAN PRESCRIPTION DRUG	Depakote	ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20000804	20240326	NDA	NDA021168	AbbVie Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
0074-7148_872c70fd-ed64-4f07-b811-5eaa08924982	0074-7148	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020224		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-7149_872c70fd-ed64-4f07-b811-5eaa08924982	0074-7149	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-7269_58130bbd-f2d6-4dc8-a4e1-d00fa272fe2a	0074-7269	HUMAN PRESCRIPTION DRUG	Gengraf		Cyclosporine	SOLUTION	ORAL	20100525		ANDA	ANDA065025	AbbVie Inc.	CYCLOSPORINE	100	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0074-7325_2dd06ac2-bd8c-4c06-967e-09f649a0f971	0074-7325	HUMAN PRESCRIPTION DRUG	Depakote		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	19830310		NDA	NDA018723	AbbVie Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0074-7326_2dd06ac2-bd8c-4c06-967e-09f649a0f971	0074-7326	HUMAN PRESCRIPTION DRUG	Depakote		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20230630		NDA	NDA018723	AbbVie Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0074-7327_2dd06ac2-bd8c-4c06-967e-09f649a0f971	0074-7327	HUMAN PRESCRIPTION DRUG	Depakote		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	19830310		NDA	NDA018723	AbbVie Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0074-7401_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e	0074-7401	HUMAN PRESCRIPTION DRUG	Depakote	ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20000804		NDA	NDA021168	AbbVie Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0074-7402_c7f33a5e-be13-45a6-8edd-8f6cd7618e1e	0074-7402	HUMAN PRESCRIPTION DRUG	Depakote	ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20000804		NDA	NDA021168	AbbVie Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0074-9036_2a2432ff-542c-4fb4-aeba-2ece1d7cb8ad	0074-9036	HUMAN PRESCRIPTION DRUG	Zemplar		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20180420		NDA	NDA021606	AbbVie Inc.	PARICALCITOL	1	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
0074-9037_2a2432ff-542c-4fb4-aeba-2ece1d7cb8ad	0074-9037	HUMAN PRESCRIPTION DRUG	Zemplar		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20180420		NDA	NDA021606	AbbVie Inc.	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
0074-9296_872c70fd-ed64-4f07-b811-5eaa08924982	0074-9296	HUMAN PRESCRIPTION DRUG	Synthroid		Levothyroxine Sodium	TABLET	ORAL	20020724		NDA	NDA021402	AbbVie Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0074-9694_ffa75dac-b8cb-44fa-bcdb-2aa07d93d359	0074-9694	HUMAN PRESCRIPTION DRUG	Lupron Depot-PED		leuprolide acetate	KIT		19930416		NDA	NDA020263	AbbVie Inc.						N	20241231
0075-0620_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-0620	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-0621_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-0621	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-0622_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-0622	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-0623_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-0623	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-0624_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-0624	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-0626_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-0626	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-2912_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-2912	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-2915_3aafdd4d-7816-40f2-a675-af0e97fa0552	0075-2915	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8013_5651b020-2238-46af-9068-dd3b2795928d	0075-8013	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8014_5651b020-2238-46af-9068-dd3b2795928d	0075-8014	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8016_5651b020-2238-46af-9068-dd3b2795928d	0075-8016	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8018_5651b020-2238-46af-9068-dd3b2795928d	0075-8018	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8020_5651b020-2238-46af-9068-dd3b2795928d	0075-8020	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8022_5651b020-2238-46af-9068-dd3b2795928d	0075-8022	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8025_5651b020-2238-46af-9068-dd3b2795928d	0075-8025	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0075-8030_5651b020-2238-46af-9068-dd3b2795928d	0075-8030	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19930329		NDA	NDA020164	Sanofi-Aventis U.S. LLC	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0078-0109_5fd4ecdc-1dd9-4887-8817-d63e871d5c92	0078-0109	HUMAN PRESCRIPTION DRUG	Sandimmune		cyclosporine	INJECTION	INTRAVENOUS	19831114		NDA	NDA050573	Novartis Pharmaceuticals Corporation	CYCLOSPORINE	50	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0110_5fd4ecdc-1dd9-4887-8817-d63e871d5c92	0078-0110	HUMAN PRESCRIPTION DRUG	Sandimmune		cyclosporine	SOLUTION	ORAL	19831114		NDA	NDA050574	Novartis Pharmaceuticals Corporation	CYCLOSPORINE	100	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0180_d5dce034-2acf-46c3-afce-13b48bd73983	0078-0180	HUMAN PRESCRIPTION DRUG	Sandostatin		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19881021		NDA	NDA019667	Novartis Pharmaceuticals Corporation	OCTREOTIDE ACETATE	50	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0078-0181_d5dce034-2acf-46c3-afce-13b48bd73983	0078-0181	HUMAN PRESCRIPTION DRUG	Sandostatin		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19881021		NDA	NDA019667	Novartis Pharmaceuticals Corporation	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0078-0182_d5dce034-2acf-46c3-afce-13b48bd73983	0078-0182	HUMAN PRESCRIPTION DRUG	Sandostatin		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19881021		NDA	NDA019667	Novartis Pharmaceuticals Corporation	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0078-0240_5fd4ecdc-1dd9-4887-8817-d63e871d5c92	0078-0240	HUMAN PRESCRIPTION DRUG	Sandimmune		cyclosporine	CAPSULE, LIQUID FILLED	ORAL	19900302		NDA	NDA050625	Novartis Pharmaceuticals Corporation	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0241_5fd4ecdc-1dd9-4887-8817-d63e871d5c92	0078-0241	HUMAN PRESCRIPTION DRUG	Sandimmune		cyclosporine	CAPSULE, LIQUID FILLED	ORAL	19900302		NDA	NDA050625	Novartis Pharmaceuticals Corporation	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0246_2bc01154-2f23-4d1f-97c5-c83086800c76	0078-0246	HUMAN PRESCRIPTION DRUG	Neoral		cyclosporine	CAPSULE, LIQUID FILLED	ORAL	19950714		NDA	NDA050715	Novartis Pharmaceuticals Corporation	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0248_2bc01154-2f23-4d1f-97c5-c83086800c76	0078-0248	HUMAN PRESCRIPTION DRUG	Neoral		cyclosporine	CAPSULE, LIQUID FILLED	ORAL	19950714		NDA	NDA050715	Novartis Pharmaceuticals Corporation	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0249_9526bbe8-4e5c-4385-b8d5-6ba3493a70e6	0078-0249	HUMAN PRESCRIPTION DRUG	Femara		letrozole	TABLET, FILM COATED	ORAL	19970731		NDA	NDA020726	Novartis Pharmaceuticals Corporation	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20251231
0078-0274_2bc01154-2f23-4d1f-97c5-c83086800c76	0078-0274	HUMAN PRESCRIPTION DRUG	Neoral		cyclosporine	SOLUTION	ORAL	19950714		NDA	NDA050716	Novartis Pharmaceuticals Corporation	CYCLOSPORINE	100	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0314_f3791968-972c-4d43-9105-9b7c10fd764a	0078-0314	HUMAN PRESCRIPTION DRUG	Diovan HCT		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19980306		NDA	NDA020818	Novartis Pharmaceuticals Corporation	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0315_f3791968-972c-4d43-9105-9b7c10fd764a	0078-0315	HUMAN PRESCRIPTION DRUG	Diovan HCT		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19980306		NDA	NDA020818	Novartis Pharmaceuticals Corporation	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0331_d25af03e-66f5-4184-a769-cbe62de929f9	0078-0331	HUMAN PRESCRIPTION DRUG	Simulect		basiliximab	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19980512		BLA	BLA103764	Novartis Pharmaceuticals Corporation	BASILIXIMAB	20	mg/5mL	Interleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody [EPC]		N	20241231
0078-0337_2201beee-4887-43fa-9343-ac93936b0b90	0078-0337	HUMAN PRESCRIPTION DRUG	Trileptal		oxcarbazepine	TABLET, FILM COATED	ORAL	20000130		NDA	NDA021014	Novartis Pharmaceuticals Corporation	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0078-0343_2740040f-a14a-4b53-83f7-842dd443081f	0078-0343	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Novartis Pharmaceuticals Corporation	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0078-0344_2740040f-a14a-4b53-83f7-842dd443081f	0078-0344	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Novartis Pharmaceuticals Corporation	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0078-0345_2740040f-a14a-4b53-83f7-842dd443081f	0078-0345	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Novartis Pharmaceuticals Corporation	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0078-0346_2740040f-a14a-4b53-83f7-842dd443081f	0078-0346	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Novartis Pharmaceuticals Corporation	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0078-0354_11645911-2576-4b7c-b13f-bdbc4184a032	0078-0354	HUMAN PRESCRIPTION DRUG	Lescol	XL	fluvastatin sodium	TABLET, EXTENDED RELEASE	ORAL	20001006		NDA	NDA021192	Novartis Pharmaceuticals Corporation	FLUVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0078-0357_2201beee-4887-43fa-9343-ac93936b0b90	0078-0357	HUMAN PRESCRIPTION DRUG	Trileptal		oxcarbazepine	SUSPENSION	ORAL	20010530		NDA	NDA021285	Novartis Pharmaceuticals Corporation	OXCARBAZEPINE	60	mg/mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0078-0358_ec016c68-6ed6-4c53-8fbb-3472f03512db	0078-0358	HUMAN PRESCRIPTION DRUG	Diovan		valsartan	TABLET	ORAL	20010701		NDA	NDA021283	Novartis Pharmaceuticals Corporation	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0078-0359_ec016c68-6ed6-4c53-8fbb-3472f03512db	0078-0359	HUMAN PRESCRIPTION DRUG	Diovan		valsartan	TABLET	ORAL	20010701		NDA	NDA021283	Novartis Pharmaceuticals Corporation	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0078-0360_ec016c68-6ed6-4c53-8fbb-3472f03512db	0078-0360	HUMAN PRESCRIPTION DRUG	Diovan		valsartan	TABLET	ORAL	20010701		NDA	NDA021283	Novartis Pharmaceuticals Corporation	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0078-0364_218c693b-b915-4231-9d73-751898db6b72	0078-0364	HUMAN PRESCRIPTION DRUG	Lotrel		amlodipine besylate and benazepril hydrochloride	CAPSULE	ORAL	19950303		NDA	NDA020364	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0365_2740040f-a14a-4b53-83f7-842dd443081f	0078-0365	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Novartis Pharmaceuticals Corporation	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0078-0370_9532d8b4-56bf-4c8b-8e32-d1096188704c	0078-0370	HUMAN PRESCRIPTION DRUG	Ritalin	LA	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20020605		NDA	NDA021284	Novartis Pharmaceuticals Corporation	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0371_9532d8b4-56bf-4c8b-8e32-d1096188704c	0078-0371	HUMAN PRESCRIPTION DRUG	Ritalin	LA	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20020605		NDA	NDA021284	Novartis Pharmaceuticals Corporation	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0372_9532d8b4-56bf-4c8b-8e32-d1096188704c	0078-0372	HUMAN PRESCRIPTION DRUG	Ritalin	LA	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20020605		NDA	NDA021284	Novartis Pharmaceuticals Corporation	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0379_218c693b-b915-4231-9d73-751898db6b72	0078-0379	HUMAN PRESCRIPTION DRUG	Lotrel		amlodipine besylate and benazepril hydrochloride	CAPSULE	ORAL	19950303		NDA	NDA020364	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0380_9769b430-3ff8-4bfb-be61-e72104adbc88	0078-0380	HUMAN PRESCRIPTION DRUG	Focalin		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		NDA	NDA021278	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0381_9769b430-3ff8-4bfb-be61-e72104adbc88	0078-0381	HUMAN PRESCRIPTION DRUG	Focalin		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		NDA	NDA021278	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0382_9769b430-3ff8-4bfb-be61-e72104adbc88	0078-0382	HUMAN PRESCRIPTION DRUG	Focalin		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		NDA	NDA021278	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0383_f3791968-972c-4d43-9105-9b7c10fd764a	0078-0383	HUMAN PRESCRIPTION DRUG	Diovan HCT		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19980306		NDA	NDA020818	Novartis Pharmaceuticals Corporation	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0385_c42ba1b1-8510-46ff-8de5-e5aee86faaaf	0078-0385	HUMAN PRESCRIPTION DRUG	Myfortic		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20040227		NDA	NDA050791	Novartis Pharmaceuticals Corporation	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0078-0386_c42ba1b1-8510-46ff-8de5-e5aee86faaaf	0078-0386	HUMAN PRESCRIPTION DRUG	Myfortic		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20040227		NDA	NDA050791	Novartis Pharmaceuticals Corporation	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0078-0393_d25af03e-66f5-4184-a769-cbe62de929f9	0078-0393	HUMAN PRESCRIPTION DRUG	Simulect		basiliximab	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19980512		BLA	BLA103764	Novartis Pharmaceuticals Corporation	BASILIXIMAB	10	mg/2.5mL	Interleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody [EPC]		N	20241231
0078-0401_9d72c624-b4de-4771-8ab6-9f6e246a09ab	0078-0401	HUMAN PRESCRIPTION DRUG	Gleevec		imatinib mesylate	TABLET	ORAL	20010515		NDA	NDA021588	Novartis Pharmaceuticals Corporation	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0078-0405_218c693b-b915-4231-9d73-751898db6b72	0078-0405	HUMAN PRESCRIPTION DRUG	Lotrel		amlodipine besylate and benazepril hydrochloride	CAPSULE	ORAL	19950303		NDA	NDA020364	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0406_218c693b-b915-4231-9d73-751898db6b72	0078-0406	HUMAN PRESCRIPTION DRUG	Lotrel		amlodipine besylate and benazepril hydrochloride	CAPSULE	ORAL	19950303		NDA	NDA020364	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0414_c270a38b-dc3e-4c8e-85a5-77024e8d3f46	0078-0414	HUMAN PRESCRIPTION DRUG	Zortress		everolimus	TABLET	ORAL	20100422		NDA	NDA021560	Novartis Pharmaceuticals Corporation	EVEROLIMUS	.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0415_c270a38b-dc3e-4c8e-85a5-77024e8d3f46	0078-0415	HUMAN PRESCRIPTION DRUG	Zortress		everolimus	TABLET	ORAL	20100422		NDA	NDA021560	Novartis Pharmaceuticals Corporation	EVEROLIMUS	.75	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0417_c270a38b-dc3e-4c8e-85a5-77024e8d3f46	0078-0417	HUMAN PRESCRIPTION DRUG	Zortress		everolimus	TABLET	ORAL	20100422		NDA	NDA021560	Novartis Pharmaceuticals Corporation	EVEROLIMUS	.25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0422_c270a38b-dc3e-4c8e-85a5-77024e8d3f46	0078-0422	HUMAN PRESCRIPTION DRUG	Zortress		everolimus	TABLET	ORAL	20100422		NDA	NDA021560	Novartis Pharmaceuticals Corporation	EVEROLIMUS	1	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0423_ec016c68-6ed6-4c53-8fbb-3472f03512db	0078-0423	HUMAN PRESCRIPTION DRUG	Diovan		valsartan	TABLET	ORAL	20010701		NDA	NDA021283	Novartis Pharmaceuticals Corporation	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0078-0424_9532d8b4-56bf-4c8b-8e32-d1096188704c	0078-0424	HUMAN PRESCRIPTION DRUG	Ritalin	LA	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20020605		NDA	NDA021284	Novartis Pharmaceuticals Corporation	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0430_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0430	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0431_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0431	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0432_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0432	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0433_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0433	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0434_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0434	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0435_ae5a6cfc-93e8-4095-be3d-b4db71b57545	0078-0435	HUMAN PRESCRIPTION DRUG	Reclast		zoledronic acid	INJECTION, SOLUTION	INTRAVENOUS	20070401		NDA	NDA021817	Novartis Pharmaceuticals Corporation	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0078-0439_e5d5a5d8-1fab-4299-8263-68b0e872c6f8	0078-0439	HUMAN PRESCRIPTION DRUG	Ritalin		methylphenidate hydrochloride	TABLET	ORAL	19551231		NDA	NDA010187	Novartis Pharmaceuticals Corporation	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0440_e5d5a5d8-1fab-4299-8263-68b0e872c6f8	0078-0440	HUMAN PRESCRIPTION DRUG	Ritalin		methylphenidate hydrochloride	TABLET	ORAL	19551231		NDA	NDA010187	Novartis Pharmaceuticals Corporation	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0441_e5d5a5d8-1fab-4299-8263-68b0e872c6f8	0078-0441	HUMAN PRESCRIPTION DRUG	Ritalin		methylphenidate hydrochloride	TABLET	ORAL	19551231		NDA	NDA010187	Novartis Pharmaceuticals Corporation	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0456_2201beee-4887-43fa-9343-ac93936b0b90	0078-0456	HUMAN PRESCRIPTION DRUG	Trileptal		oxcarbazepine	TABLET, FILM COATED	ORAL	20000130		NDA	NDA021014	Novartis Pharmaceuticals Corporation	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0078-0457_2201beee-4887-43fa-9343-ac93936b0b90	0078-0457	HUMAN PRESCRIPTION DRUG	Trileptal		oxcarbazepine	TABLET, FILM COATED	ORAL	20000130		NDA	NDA021014	Novartis Pharmaceuticals Corporation	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0078-0467_1a76f5bb-28fe-4cbb-8735-2ce7b041a15e	0078-0467	HUMAN PRESCRIPTION DRUG	Desferal		deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19680402		NDA	NDA016267	Novartis Pharmaceuticals Corporation	DEFEROXAMINE MESYLATE	500	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0468_7dc3e0ba-efd7-4d96-99d5-199df65bcd0b	0078-0468	HUMAN PRESCRIPTION DRUG	Exjade		deferasirox	TABLET, FOR SUSPENSION	ORAL	20051130		NDA	NDA021882	Novartis Pharmaceuticals Corporation	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0469_7dc3e0ba-efd7-4d96-99d5-199df65bcd0b	0078-0469	HUMAN PRESCRIPTION DRUG	Exjade		deferasirox	TABLET, FOR SUSPENSION	ORAL	20051130		NDA	NDA021882	Novartis Pharmaceuticals Corporation	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0470_7dc3e0ba-efd7-4d96-99d5-199df65bcd0b	0078-0470	HUMAN PRESCRIPTION DRUG	Exjade		deferasirox	TABLET, FOR SUSPENSION	ORAL	20051130		NDA	NDA021882	Novartis Pharmaceuticals Corporation	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0471_f3791968-972c-4d43-9105-9b7c10fd764a	0078-0471	HUMAN PRESCRIPTION DRUG	Diovan HCT		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20060428		NDA	NDA020818	Novartis Pharmaceuticals Corporation	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0472_f3791968-972c-4d43-9105-9b7c10fd764a	0078-0472	HUMAN PRESCRIPTION DRUG	Diovan HCT		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20060428		NDA	NDA020818	Novartis Pharmaceuticals Corporation	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0488_23189575-6ec8-43d3-b630-f2ffcec0c236	0078-0488	HUMAN PRESCRIPTION DRUG	Exforge		amlodipine besylate and valsartan	TABLET, FILM COATED	ORAL	20070620		NDA	NDA021990	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0489_23189575-6ec8-43d3-b630-f2ffcec0c236	0078-0489	HUMAN PRESCRIPTION DRUG	Exforge		amlodipine besylate and valsartan	TABLET, FILM COATED	ORAL	20070620		NDA	NDA021990	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0490_23189575-6ec8-43d3-b630-f2ffcec0c236	0078-0490	HUMAN PRESCRIPTION DRUG	Exforge		amlodipine besylate and valsartan	TABLET, FILM COATED	ORAL	20070620		NDA	NDA021990	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0491_23189575-6ec8-43d3-b630-f2ffcec0c236	0078-0491	HUMAN PRESCRIPTION DRUG	Exforge		amlodipine besylate and valsartan	TABLET, FILM COATED	ORAL	20070620		NDA	NDA021990	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0078-0493_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0493	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0501_8e344120-8036-4d00-8b26-14ecea34d689	0078-0501	HUMAN PRESCRIPTION DRUG	Exelon		rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20070706		NDA	NDA022083	Novartis Pharmaceuticals Corporation	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0078-0502_8e344120-8036-4d00-8b26-14ecea34d689	0078-0502	HUMAN PRESCRIPTION DRUG	Exelon		rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20070706		NDA	NDA022083	Novartis Pharmaceuticals Corporation	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0078-0503_8e344120-8036-4d00-8b26-14ecea34d689	0078-0503	HUMAN PRESCRIPTION DRUG	Exelon		rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20070706		NDA	NDA022083	Novartis Pharmaceuticals Corporation	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0078-0508_73408f94-0a71-41b0-9955-9094225d914b	0078-0508	HUMAN PRESCRIPTION DRUG	Tegretol		carbamazepine	SUSPENSION	ORAL	19871218		NDA	NDA018927	Novartis Pharmaceuticals Corporation	CARBAMAZEPINE	100	mg/5mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0078-0509_73408f94-0a71-41b0-9955-9094225d914b	0078-0509	HUMAN PRESCRIPTION DRUG	Tegretol		carbamazepine	TABLET	ORAL	19680311		NDA	NDA016608	Novartis Pharmaceuticals Corporation	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0078-0510_73408f94-0a71-41b0-9955-9094225d914b	0078-0510	HUMAN PRESCRIPTION DRUG	Tegretol	XR	carbamazepine	TABLET, EXTENDED RELEASE	ORAL	19960325		NDA	NDA020234	Novartis Pharmaceuticals Corporation	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0078-0511_73408f94-0a71-41b0-9955-9094225d914b	0078-0511	HUMAN PRESCRIPTION DRUG	Tegretol	XR	carbamazepine	TABLET, EXTENDED RELEASE	ORAL	19960325		NDA	NDA020234	Novartis Pharmaceuticals Corporation	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0078-0512_73408f94-0a71-41b0-9955-9094225d914b	0078-0512	HUMAN PRESCRIPTION DRUG	Tegretol	XR	carbamazepine	TABLET, EXTENDED RELEASE	ORAL	19960325		NDA	NDA020234	Novartis Pharmaceuticals Corporation	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0078-0526_b230c25f-3612-4e55-a69d-9cd1bdfd69b9	0078-0526	HUMAN PRESCRIPTION DRUG	Tasigna		nilotinib	CAPSULE	ORAL	20071029		NDA	NDA022068	Novartis Pharmaceuticals Corporation	NILOTINIB	200	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0078-0559_27060f73-ac96-4d1a-96c1-1e9825a7590c	0078-0559	HUMAN PRESCRIPTION DRUG	Exforge HCT		amlodipine valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20090404		NDA	NDA022314	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0560_27060f73-ac96-4d1a-96c1-1e9825a7590c	0078-0560	HUMAN PRESCRIPTION DRUG	Exforge HCT		amlodipine valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20090404		NDA	NDA022314	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0561_27060f73-ac96-4d1a-96c1-1e9825a7590c	0078-0561	HUMAN PRESCRIPTION DRUG	Exforge HCT		amlodipine valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20090404		NDA	NDA022314	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0562_27060f73-ac96-4d1a-96c1-1e9825a7590c	0078-0562	HUMAN PRESCRIPTION DRUG	Exforge HCT		amlodipine valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20090404		NDA	NDA022314	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0563_27060f73-ac96-4d1a-96c1-1e9825a7590c	0078-0563	HUMAN PRESCRIPTION DRUG	Exforge HCT		amlodipine valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20090404		NDA	NDA022314	Novartis Pharmaceuticals Corporation	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 320	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0078-0566_a2136e71-186e-4bfc-901b-5ed9ca048a1f	0078-0566	HUMAN PRESCRIPTION DRUG	Afinitor		everolimus	TABLET	ORAL	20090331		NDA	NDA022334	Novartis Pharmaceuticals Corporation	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0567_a2136e71-186e-4bfc-901b-5ed9ca048a1f	0078-0567	HUMAN PRESCRIPTION DRUG	Afinitor		everolimus	TABLET	ORAL	20090331		NDA	NDA022334	Novartis Pharmaceuticals Corporation	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0568_d600e1b1-d1e7-44e9-98d7-4817fe2bf9e8	0078-0568	HUMAN PRESCRIPTION DRUG	COARTEM		artemether and lumefantrine	TABLET	ORAL	20090407		NDA	NDA022268	Novartis Pharmaceuticals Corporation	ARTEMETHER; LUMEFANTRINE	20; 120	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC]		N	20241231
0078-0569_21e70358-f7a8-4b98-8f6c-d2d4cf020a94	0078-0569	HUMAN PRESCRIPTION DRUG	EXTAVIA		Interferon beta-1b	KIT		20090814		BLA	BLA125290	Novartis Pharmaceuticals Corporation						N	20241231
0078-0592_b230c25f-3612-4e55-a69d-9cd1bdfd69b9	0078-0592	HUMAN PRESCRIPTION DRUG	Tasigna		nilotinib	CAPSULE	ORAL	20071029		NDA	NDA022068	Novartis Pharmaceuticals Corporation	NILOTINIB	150	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0078-0594_a2136e71-186e-4bfc-901b-5ed9ca048a1f	0078-0594	HUMAN PRESCRIPTION DRUG	Afinitor		everolimus	TABLET	ORAL	20100709		NDA	NDA022334	Novartis Pharmaceuticals Corporation	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0607_ca55becd-c1e3-439a-8563-d6a60b7806e9	0078-0607	HUMAN PRESCRIPTION DRUG	Gilenya		Fingolimod hcl	CAPSULE	ORAL	20100921		NDA	NDA022527	Novartis Pharmaceuticals Corporation	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
0078-0608_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0608	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0609_093870c1-4135-493a-b5b6-01a4c1be545a	0078-0609	HUMAN PRESCRIPTION DRUG	Focalin	XR	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20050531		NDA	NDA021802	Novartis Pharmaceuticals Corporation	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0078-0620_a2136e71-186e-4bfc-901b-5ed9ca048a1f	0078-0620	HUMAN PRESCRIPTION DRUG	Afinitor		everolimus	TABLET	ORAL	20110729		NDA	NDA022334	Novartis Pharmaceuticals Corporation	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0626_a2136e71-186e-4bfc-901b-5ed9ca048a1f	0078-0626	HUMAN PRESCRIPTION DRUG	Afinitor	Disperz	everolimus	TABLET, FOR SUSPENSION	ORAL	20120829		NDA	NDA203985	Novartis Pharmaceuticals Corporation	EVEROLIMUS	2	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0627_a2136e71-186e-4bfc-901b-5ed9ca048a1f	0078-0627	HUMAN PRESCRIPTION DRUG	Afinitor	Disperz	everolimus	TABLET, FOR SUSPENSION	ORAL	20120829		NDA	NDA203985	Novartis Pharmaceuticals Corporation	EVEROLIMUS	3	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0628_a2136e71-186e-4bfc-901b-5ed9ca048a1f	0078-0628	HUMAN PRESCRIPTION DRUG	Afinitor	Disperz	everolimus	TABLET, FOR SUSPENSION	ORAL	20120829		NDA	NDA203985	Novartis Pharmaceuticals Corporation	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0078-0639_3e03ef3f-f697-4301-acc3-f98c22c8ff6b	0078-0639	HUMAN PRESCRIPTION DRUG	COSENTYX		secukinumab	INJECTION	SUBCUTANEOUS	20150121		BLA	BLA125504	Novartis Pharmaceuticals Corporation	SECUKINUMAB	150	mg/mL	Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]		N	20241231
0078-0649_9d72c624-b4de-4771-8ab6-9f6e246a09ab	0078-0649	HUMAN PRESCRIPTION DRUG	Gleevec		imatinib mesylate	TABLET	ORAL	20141223		NDA	NDA021588	Novartis Pharmaceuticals Corporation	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0078-0654_d2bbabee-c3c6-4fda-8863-4418ad96d38e	0078-0654	HUMAN PRESCRIPTION DRUG	Jadenu		deferasirox	TABLET, FILM COATED	ORAL	20150330		NDA	NDA206910	Novartis Pharmaceuticals Corporation	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0655_d2bbabee-c3c6-4fda-8863-4418ad96d38e	0078-0655	HUMAN PRESCRIPTION DRUG	Jadenu		deferasirox	TABLET, FILM COATED	ORAL	20150330		NDA	NDA206910	Novartis Pharmaceuticals Corporation	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0656_d2bbabee-c3c6-4fda-8863-4418ad96d38e	0078-0656	HUMAN PRESCRIPTION DRUG	Jadenu		deferasirox	TABLET, FILM COATED	ORAL	20150330		NDA	NDA206910	Novartis Pharmaceuticals Corporation	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0659_d32b959b-b270-43bf-89de-639d833289d9	0078-0659	HUMAN PRESCRIPTION DRUG	ENTRESTO		Sacubitril and Valsartan	TABLET, FILM COATED	ORAL	20150707		NDA	NDA207620	Novartis Pharmaceuticals Corporation	SACUBITRIL; VALSARTAN	24; 26	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]		N	20241231
0078-0668_26a4b56c-c10d-4b34-97d2-e46d150f2043	0078-0668	HUMAN PRESCRIPTION DRUG	Mekinist		trametinib	TABLET, FILM COATED	ORAL	20160317	20240430	NDA	NDA204114	Novartis Pharmaceuticals Corporation	TRAMETINIB DIMETHYL SULFOXIDE	2	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	
0078-0669_1358cb68-5521-4de1-9749-5ed66f293d3b	0078-0669	HUMAN PRESCRIPTION DRUG	ARZERRA		ofatumumab	INJECTION, SOLUTION	INTRAVENOUS	20160201		BLA	BLA125326	Novartis Pharmaceuticals Corporation	OFATUMUMAB	20	mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
0078-0670_929749e3-ee9b-4550-b583-c78290919caf	0078-0670	HUMAN PRESCRIPTION DRUG	VOTRIENT		pazopanib hydrochloride	TABLET, FILM COATED	ORAL	20160712	20241031	NDA	NDA022465	Novartis Pharmaceuticals Corporation	PAZOPANIB HYDROCHLORIDE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	
0078-0671_3762f7f1-b9c3-4e9f-9249-01f87b0ec407	0078-0671	HUMAN PRESCRIPTION DRUG	TYKERB		lapatinib	TABLET	ORAL	20160803		NDA	NDA022059	Novartis Pharmaceuticals Corporation	LAPATINIB DITOSYLATE	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0078-0672_bf2754e4-bfee-452c-a095-3038c45d56c0	0078-0672	HUMAN PRESCRIPTION DRUG	HYCAMTIN		topotecan	CAPSULE	ORAL	20170707		NDA	NDA020981	Novartis Pharmaceuticals Corporation	TOPOTECAN HYDROCHLORIDE	.25	mg/1	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0078-0673_bf2754e4-bfee-452c-a095-3038c45d56c0	0078-0673	HUMAN PRESCRIPTION DRUG	HYCAMTIN		topotecan	CAPSULE	ORAL	20170224		NDA	NDA020981	Novartis Pharmaceuticals Corporation	TOPOTECAN HYDROCHLORIDE	1	mg/1	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0078-0674_e6e4f66b-e398-44d3-a832-e5a809f3e861	0078-0674	HUMAN PRESCRIPTION DRUG	HYCAMTIN		topotecan hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161221		NDA	NDA020671	Novartis Pharmaceuticals Corporation	TOPOTECAN HYDROCHLORIDE	4	mg/4mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0078-0681_23689dc5-f2a5-4475-bbc1-bd73107e51ba	0078-0681	HUMAN PRESCRIPTION DRUG	Tafinlar		dabrafenib	CAPSULE	ORAL	20160401		NDA	NDA202806	Novartis Pharmaceuticals Corporation	DABRAFENIB MESYLATE	75	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Protein Kinase Inhibitors [MoA]		N	20241231
0078-0682_23689dc5-f2a5-4475-bbc1-bd73107e51ba	0078-0682	HUMAN PRESCRIPTION DRUG	Tafinlar		dabrafenib	CAPSULE	ORAL	20160412		NDA	NDA202806	Novartis Pharmaceuticals Corporation	DABRAFENIB MESYLATE	50	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Protein Kinase Inhibitors [MoA]		N	20241231
0078-0683_6b71b057-dcb0-4ef0-8f20-887b870c4590	0078-0683	HUMAN PRESCRIPTION DRUG	Arranon		nelarabine	INJECTION	INTRAVENOUS	20161005		NDA	NDA021877	Novartis Pharmaceuticals Corporation	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0078-0684_ca81991b-b7af-4ee8-b1ca-fcc43c38550f	0078-0684	HUMAN PRESCRIPTION DRUG	PROMACTA		eltrombopag olamine	TABLET, FILM COATED	ORAL	20160822		NDA	NDA022291	Novartis Pharmaceuticals Corporation	ELTROMBOPAG OLAMINE	12.5	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20251231
0078-0685_ca81991b-b7af-4ee8-b1ca-fcc43c38550f	0078-0685	HUMAN PRESCRIPTION DRUG	PROMACTA		eltrombopag olamine	TABLET, FILM COATED	ORAL	20160524		NDA	NDA022291	Novartis Pharmaceuticals Corporation	ELTROMBOPAG OLAMINE	25	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20251231
0078-0686_ca81991b-b7af-4ee8-b1ca-fcc43c38550f	0078-0686	HUMAN PRESCRIPTION DRUG	PROMACTA		eltrombopag olamine	TABLET, FILM COATED	ORAL	20160407		NDA	NDA022291	Novartis Pharmaceuticals Corporation	ELTROMBOPAG OLAMINE	50	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20251231
0078-0687_ca81991b-b7af-4ee8-b1ca-fcc43c38550f	0078-0687	HUMAN PRESCRIPTION DRUG	PROMACTA		eltrombopag olamine	TABLET, FILM COATED	ORAL	20160401		NDA	NDA022291	Novartis Pharmaceuticals Corporation	ELTROMBOPAG OLAMINE	75	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20251231
0078-0690_1358cb68-5521-4de1-9749-5ed66f293d3b	0078-0690	HUMAN PRESCRIPTION DRUG	ARZERRA		ofatumumab	INJECTION, SOLUTION	INTRAVENOUS	20160201		BLA	BLA125326	Novartis Pharmaceuticals Corporation	OFATUMUMAB	20	mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
0078-0694_3db5cf0c-11a3-42f6-bfd0-2c7592470d1b	0078-0694	HUMAN PRESCRIPTION DRUG	ZYKADIA		ceritinib	TABLET, FILM COATED	ORAL	20190318		NDA	NDA211225	Novartis Pharmaceuticals Corporation	CERITINIB	150	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
0078-0696_d32b959b-b270-43bf-89de-639d833289d9	0078-0696	HUMAN PRESCRIPTION DRUG	ENTRESTO		Sacubitril and Valsartan	TABLET, FILM COATED	ORAL	20150707		NDA	NDA207620	Novartis Pharmaceuticals Corporation	SACUBITRIL; VALSARTAN	97; 103	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]		N	20241231
0078-0697_ca81991b-b7af-4ee8-b1ca-fcc43c38550f	0078-0697	HUMAN PRESCRIPTION DRUG	PROMACTA		eltrombopag olamine	POWDER, FOR SUSPENSION	ORAL	20180927		NDA	NDA207027	Novartis Pharmaceuticals Corporation	ELTROMBOPAG OLAMINE	25	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20251231
0078-0698_d33f12ce-c74d-487e-81db-86fd5c265c94	0078-0698	HUMAN PRESCRIPTION DRUG	RYDAPT		RYDAPT	CAPSULE, LIQUID FILLED	ORAL	20170428		NDA	NDA207997	Novartis Pharmaceuticals Corporation	MIDOSTAURIN	25	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
0078-0701_5794379a-4b10-4825-a07b-6d0e06fd657f	0078-0701	HUMAN PRESCRIPTION DRUG	PIQRAY		alpelisib	TABLET	ORAL	20190524		NDA	NDA212526	Novartis Pharmaceuticals Corporation	ALPELISIB	200	mg/1			N	20241231
0078-0708_5794379a-4b10-4825-a07b-6d0e06fd657f	0078-0708	HUMAN PRESCRIPTION DRUG	PIQRAY		alpelisib	TABLET	ORAL	20190524		NDA	NDA212526	Novartis Pharmaceuticals Corporation	ALPELISIB	150	mg/1			N	20241231
0078-0709_761d7399-fb73-455a-88de-c6ec4f13ba2c	0078-0709	HUMAN PRESCRIPTION DRUG	TABRECTA		capmatinib	TABLET, FILM COATED	ORAL	20200506		NDA	NDA213591	Novartis Pharmaceuticals Corporation	CAPMATINIB HYDROCHLORIDE	150	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor [EPC], Mesenchymal Epithelial Transition Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0713_d2bbabee-c3c6-4fda-8863-4418ad96d38e	0078-0713	HUMAN PRESCRIPTION DRUG	Jadenu		deferasirox	GRANULE	ORAL	20170518		NDA	NDA207968	Novartis Pharmaceuticals Corporation	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0715_5794379a-4b10-4825-a07b-6d0e06fd657f	0078-0715	HUMAN PRESCRIPTION DRUG	PIQRAY		alpelisib	KIT		20190524		NDA	NDA212526	Novartis Pharmaceuticals Corporation						N	20241231
0078-0716_761d7399-fb73-455a-88de-c6ec4f13ba2c	0078-0716	HUMAN PRESCRIPTION DRUG	TABRECTA		capmatinib	TABLET, FILM COATED	ORAL	20200506		NDA	NDA213591	Novartis Pharmaceuticals Corporation	CAPMATINIB HYDROCHLORIDE	200	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor [EPC], Mesenchymal Epithelial Transition Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
0078-0720_d2bbabee-c3c6-4fda-8863-4418ad96d38e	0078-0720	HUMAN PRESCRIPTION DRUG	Jadenu		deferasirox	GRANULE	ORAL	20170518		NDA	NDA207968	Novartis Pharmaceuticals Corporation	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0722_91c27dc2-2710-426a-90ba-35c8cf7972b9	0078-0722	HUMAN PRESCRIPTION DRUG	Azopt		brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	19980430		NDA	NDA020816	Novartis Pharmaceuticals Corporation	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
0078-0727_d2bbabee-c3c6-4fda-8863-4418ad96d38e	0078-0727	HUMAN PRESCRIPTION DRUG	Jadenu		deferasirox	GRANULE	ORAL	20170518		NDA	NDA207968	Novartis Pharmaceuticals Corporation	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0078-0729_44291b13-d51f-41cc-9395-0c8ab6432ec6	0078-0729	HUMAN PRESCRIPTION DRUG	Betoptic S		betaxolol hydrochloride	SUSPENSION/ DROPS	OPHTHALMIC	19960115		NDA	NDA019845	Novartis Pharmaceuticals Corporation	BETAXOLOL HYDROCHLORIDE	2.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0078-0734_05e186cc-0727-4347-abe9-a768f526d562	0078-0734	HUMAN PRESCRIPTION DRUG	Ilaris		canakinumab	INJECTION, SOLUTION	SUBCUTANEOUS	20161222		BLA	BLA125319	Novartis Pharmaceuticals Corporation	CANAKINUMAB	150	mg/mL			N	20241231
0078-0736_4e55e8fe-2c2c-4661-9713-cbcb6fa9ea7c	0078-0736	HUMAN PRESCRIPTION DRUG	ALOMIDE		lodoxamide tromethamine	SOLUTION/ DROPS	OPHTHALMIC	19930930		NDA	NDA020191	Novartis Pharmaceuticals Corporation	LODOXAMIDE TROMETHAMINE	1	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
0078-0743_436d5fa3-8223-49a8-8e65-09dac83281e3	0078-0743	HUMAN PRESCRIPTION DRUG	ILEVRO		nepafenac	SUSPENSION/ DROPS	OPHTHALMIC	20121220		NDA	NDA203491	Novartis Pharmaceuticals Corporation	NEPAFENAC	3	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0078-0771_06ba06c5-1c25-4f68-b1e9-cffcf0409c90	0078-0771	HUMAN PRESCRIPTION DRUG	MAXITROL		neomycin sulfate, polymyxin b sulfate and dexamethasone	OINTMENT	OPHTHALMIC	19720117		NDA	NDA050065	Novartis Pharmaceuticals Corporation	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0078-0777_d32b959b-b270-43bf-89de-639d833289d9	0078-0777	HUMAN PRESCRIPTION DRUG	ENTRESTO		Sacubitril and Valsartan	TABLET, FILM COATED	ORAL	20150707		NDA	NDA207620	Novartis Pharmaceuticals Corporation	SACUBITRIL; VALSARTAN	49; 51	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]		N	20241231
0078-0778_b60c701f-95ea-4053-b93e-90a1b23deb96	0078-0778	HUMAN PRESCRIPTION DRUG	NEVANAC		nepafenac	SUSPENSION/ DROPS	OPHTHALMIC	20050906		NDA	NDA021862	Novartis Pharmaceuticals Corporation	NEPAFENAC	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0078-0792_0ab4f06d-887e-afc2-e063-6394a90a4cb1	0078-0792	HUMAN PRESCRIPTION DRUG	Maxitrol		neomycin sulfate, polymyxin b sulfate and dexamethasone	SUSPENSION	OPHTHALMIC	19641115	20241031	NDA	NDA050023	Novartis Pharmaceuticals Corporation	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
0078-0799_ccd4ff25-82eb-44ec-9b4b-0a9cef26cecc	0078-0799	HUMAN PRESCRIPTION DRUG	CIPRODEX		ciprofloxacin and dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20030804		NDA	NDA021537	Novartis Pharmaceuticals Corporation	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0078-0811_d6ae5975-1926-427a-970d-0a369dd525f1	0078-0811	HUMAN PRESCRIPTION DRUG	Sandostatin LAR Depot		octreotide acetate	KIT		20160722		NDA	NDA021008	Novartis Pharmaceuticals Corporation						N	20241231
0078-0813_0d8f745a-51d2-4fdd-9463-1acf332e5acd	0078-0813	HUMAN PRESCRIPTION DRUG	TOBREX		tobramycin	OINTMENT	OPHTHALMIC	19810628		NDA	NDA050555	Novartis Pharmaceuticals Corporation	TOBRAMYCIN	3	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0078-0818_d6ae5975-1926-427a-970d-0a369dd525f1	0078-0818	HUMAN PRESCRIPTION DRUG	Sandostatin LAR Depot		octreotide acetate	KIT		20160722		NDA	NDA021008	Novartis Pharmaceuticals Corporation						N	20241231
0078-0825_d6ae5975-1926-427a-970d-0a369dd525f1	0078-0825	HUMAN PRESCRIPTION DRUG	Sandostatin LAR Depot		octreotide acetate	KIT		20160722		NDA	NDA021008	Novartis Pharmaceuticals Corporation						N	20241231
0078-0827_ae4eb3f7-4799-4d79-ac61-6bc5787f0b5e	0078-0827	HUMAN PRESCRIPTION DRUG	BEOVU		brolucizumab	INJECTION, SOLUTION	INTRAVITREAL	20191007		BLA	BLA761125	Novartis Pharmaceuticals Corporation	BROLUCIZUMAB	6	mg/.05mL			N	20241231
0078-0841_68f86590-69ca-495a-8edf-663ab2b3b68f	0078-0841	HUMAN PRESCRIPTION DRUG	CILOXAN		ciprofloxacin hydrochloride	OINTMENT	OPHTHALMIC	19980602		NDA	NDA020369	Novartis Pharmaceuticals Corporation	CIPROFLOXACIN HYDROCHLORIDE	3	mg/g	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0078-0846_08df395a-a319-42f9-b39b-2582b6644997	0078-0846	CELLULAR THERAPY	KYMRIAH		tisagenlecleucel	INJECTION, SUSPENSION	INTRAVENOUS	20170830		BLA	BLA125646	Novartis Pharmaceuticals Corporation	TISAGENLECLEUCEL	2000000	1/1	CD19 Receptor Interactions [MoA], CD19-directed Chimeric Antigen Receptor [EPC], CD19-specific Chimeric Antigen Receptor [CS], Genetically-modified Autologous T Cells [EPC], Increased T Lymphocyte Activation [PE], T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]		N	20241231
0078-0855_9e49e1c4-271b-4d37-a644-9065cda81ae7	0078-0855	HUMAN PRESCRIPTION DRUG	CIPRO	HC	ciprofloxacin hydrochloride and hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19990315		NDA	NDA020805	Novartis Pharmaceuticals Corporation	CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE	2; 10	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0078-0860_0916c545-7f68-439d-86f8-66b166eab6d0	0078-0860	HUMAN PRESCRIPTION DRUG	KISQALI		ribociclib	TABLET, FILM COATED	ORAL	20170313		NDA	NDA209092	Novartis Pharmaceuticals Corporation	RIBOCICLIB SUCCINATE	200	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0078-0862_fc48eb8f-ff3a-4919-bee4-8cc850834f2a	0078-0862	HUMAN PRESCRIPTION DRUG	DUREZOL		difluprednate	EMULSION	OPHTHALMIC	20110125		NDA	NDA022212	Novartis Pharmaceuticals Corporation	DIFLUPREDNATE	.5	mg/mL			N	20241231
0078-0867_0916c545-7f68-439d-86f8-66b166eab6d0	0078-0867	HUMAN PRESCRIPTION DRUG	KISQALI		ribociclib	TABLET, FILM COATED	ORAL	20170313		NDA	NDA209092	Novartis Pharmaceuticals Corporation	RIBOCICLIB SUCCINATE	200	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0078-0874_0916c545-7f68-439d-86f8-66b166eab6d0	0078-0874	HUMAN PRESCRIPTION DRUG	KISQALI		ribociclib	TABLET, FILM COATED	ORAL	20170313		NDA	NDA209092	Novartis Pharmaceuticals Corporation	RIBOCICLIB SUCCINATE	200	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0078-0876_4a23d1c4-6950-4172-86c9-89ed91a93ae8	0078-0876	HUMAN PRESCRIPTION DRUG	TobraDex		tobramycin and dexamethasone	OINTMENT	OPHTHALMIC	19881015		NDA	NDA050616	Novartis Pharmaceuticals Corporation	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0078-0883_9f1b7498-2769-40fb-8e5c-0fd7ac9ff177	0078-0883	HUMAN PRESCRIPTION DRUG	ADAKVEO		crizanlizumab	INJECTION	INTRAVENOUS	20191115		BLA	BLA761128	Novartis Pharmaceuticals Corporation	CRIZANLIZUMAB	10	mg/mL			N	20241231
0078-0909_5740112b-a7e5-47ec-955b-f25ad9c4344e	0078-0909	HUMAN PRESCRIPTION DRUG	KISQALI FEMARA CO-PACK		letrozole and ribociclib	KIT		20170504		NDA	NDA209935	Novartis Pharmaceuticals Corporation						N	20241231
0078-0911_d4d1ca2a-8c29-477e-bdd1-7e536daa28cf	0078-0911	HUMAN PRESCRIPTION DRUG	Xiidra		Lifitegrast	SOLUTION/ DROPS	OPHTHALMIC	20160711		NDA	NDA208073	Novartis Pharmaceuticals Corporation	LIFITEGRAST	50	mg/mL	Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]		N	20241231
0078-0916_5740112b-a7e5-47ec-955b-f25ad9c4344e	0078-0916	HUMAN PRESCRIPTION DRUG	KISQALI FEMARA CO-PACK		letrozole and ribociclib	KIT		20170504		NDA	NDA209935	Novartis Pharmaceuticals Corporation						N	20241231
0078-0923_5740112b-a7e5-47ec-955b-f25ad9c4344e	0078-0923	HUMAN PRESCRIPTION DRUG	KISQALI FEMARA CO-PACK		letrozole and ribociclib	KIT		20170504		NDA	NDA209935	Novartis Pharmaceuticals Corporation						N	20241231
0078-0925_eff2947a-9faa-4206-b11a-9ba2fbb7da43	0078-0925	HUMAN PRESCRIPTION DRUG	Maxidex		dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19660515		NDA	NDA013422	Novartis Pharmaceuticals Corporation	DEXAMETHASONE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0078-0937_9883f3fe-4881-47cc-a795-ce9245fe0645	0078-0937	HUMAN PRESCRIPTION DRUG	EGATEN		triclabendazole	TABLET	ORAL	20190213		NDA	NDA208711	Novartis Pharmaceuticals Corporation	TRICLABENDAZOLE	250	mg/1	Anthelmintic [EPC], Anthelmintics [CS], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2A6 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA]		N	20241231
0078-0939_c1ad2ede-ab1e-445a-bfa5-d4b984530f6d	0078-0939	HUMAN PRESCRIPTION DRUG	VIGAMOX		moxifloxacin hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20030507		NDA	NDA021598	Novartis Pharmaceuticals Corporation	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0078-0946_e070486d-9c3f-4f6a-8e99-1f99dcd1696a	0078-0946	HUMAN PRESCRIPTION DRUG	Travatan Z		travoprost	SOLUTION/ DROPS	OPHTHALMIC	20061020		NDA	NDA021994	Novartis Pharmaceuticals Corporation	TRAVOPROST	.04	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0078-0951_b230c25f-3612-4e55-a69d-9cd1bdfd69b9	0078-0951	HUMAN PRESCRIPTION DRUG	Tasigna		nilotinib	CAPSULE	ORAL	20071029		NDA	NDA022068	Novartis Pharmaceuticals Corporation	NILOTINIB	50	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0078-0953_3b30de62-e2a2-4609-9c58-26cb07135ffc	0078-0953	HUMAN PRESCRIPTION DRUG	TobraDex		tobramycin and dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19880915		NDA	NDA050592	Novartis Pharmaceuticals Corporation	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0078-0958_08df395a-a319-42f9-b39b-2582b6644997	0078-0958	CELLULAR THERAPY	KYMRIAH		tisagenlecleucel	INJECTION, SUSPENSION	INTRAVENOUS	20180501		BLA	BLA125646	Novartis Pharmaceuticals Corporation	TISAGENLECLEUCEL	60000000	1/1	CD19 Receptor Interactions [MoA], CD19-directed Chimeric Antigen Receptor [EPC], CD19-specific Chimeric Antigen Receptor [CS], Genetically-modified Autologous T Cells [EPC], Increased T Lymphocyte Activation [PE], T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]		N	20241231
0078-0965_ca55becd-c1e3-439a-8563-d6a60b7806e9	0078-0965	HUMAN PRESCRIPTION DRUG	Gilenya		Fingolimod hcl	CAPSULE	ORAL	20100921		NDA	NDA022527	Novartis Pharmaceuticals Corporation	FINGOLIMOD HYDROCHLORIDE	.25	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
0078-0972_ca81991b-b7af-4ee8-b1ca-fcc43c38550f	0078-0972	HUMAN PRESCRIPTION DRUG	PROMACTA		eltrombopag olamine	POWDER, FOR SUSPENSION	ORAL	20180927		NDA	NDA207027	Novartis Pharmaceuticals Corporation	ELTROMBOPAG OLAMINE	12.5	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20251231
0078-0979_27b099c3-3ed4-4b97-8fd2-90e6f914db61	0078-0979	HUMAN PRESCRIPTION DRUG	MAYZENT		siponimod	TABLET, FILM COATED	ORAL	20190326		NDA	NDA209884	Novartis Pharmaceuticals Corporation	SIPONIMOD	.25	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
0078-0986_27b099c3-3ed4-4b97-8fd2-90e6f914db61	0078-0986	HUMAN PRESCRIPTION DRUG	MAYZENT		siponimod	TABLET, FILM COATED	ORAL	20190326		NDA	NDA209884	Novartis Pharmaceuticals Corporation	SIPONIMOD	2	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
0078-1000_215a0563-1790-4250-adf5-687e82a9baec	0078-1000	HUMAN PRESCRIPTION DRUG	LEQVIO		inclisiran	INJECTION, SOLUTION	SUBCUTANEOUS	20211222		NDA	NDA214012	Novartis Pharmaceuticals Corporation	INCLISIRAN SODIUM	284	mg/1.5mL			N	20241231
0078-1007_8bab6c31-8f98-465b-abea-6146a88c8f83	0078-1007	HUMAN PRESCRIPTION DRUG	KESIMPTA		ofatumumab	INJECTION, SOLUTION	SUBCUTANEOUS	20091026		BLA	BLA125326	Novartis Pharmaceuticals Corporation	OFATUMUMAB	20	mg/.4mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
0078-1014_27b099c3-3ed4-4b97-8fd2-90e6f914db61	0078-1014	HUMAN PRESCRIPTION DRUG	MAYZENT		siponimod	TABLET, FILM COATED	ORAL	20190326		NDA	NDA209884	Novartis Pharmaceuticals Corporation	SIPONIMOD	1	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
0078-1021_caabacb2-ccb6-44b7-ae60-da86b804151a	0078-1021	HUMAN PRESCRIPTION DRUG	VIJOICE		alpelisib	TABLET	ORAL	20220405		NDA	NDA215039	Novartis Pharmaceuticals Corporation	ALPELISIB	50	mg/1			N	20241231
0078-1028_caabacb2-ccb6-44b7-ae60-da86b804151a	0078-1028	HUMAN PRESCRIPTION DRUG	VIJOICE		alpelisib	TABLET	ORAL	20220405		NDA	NDA215039	Novartis Pharmaceuticals Corporation	ALPELISIB	125	mg/1			N	20241231
0078-1035_caabacb2-ccb6-44b7-ae60-da86b804151a	0078-1035	HUMAN PRESCRIPTION DRUG	VIJOICE		alpelisib	KIT		20220405		NDA	NDA215039	Novartis Pharmaceuticals Corporation						N	20241231
0078-1056_3e03ef3f-f697-4301-acc3-f98c22c8ff6b	0078-1056	HUMAN PRESCRIPTION DRUG	COSENTYX		secukinumab	INJECTION	SUBCUTANEOUS	20150121		BLA	BLA125504	Novartis Pharmaceuticals Corporation	SECUKINUMAB	75	mg/.5mL	Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]		N	20241231
0078-1070_3e03ef3f-f697-4301-acc3-f98c22c8ff6b	0078-1070	HUMAN PRESCRIPTION DRUG	COSENTYX		secukinumab	INJECTION	SUBCUTANEOUS	20150121		BLA	BLA125504	Novartis Pharmaceuticals Corporation	SECUKINUMAB	300	mg/2mL	Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]		N	20241231
0078-1077_929749e3-ee9b-4550-b583-c78290919caf	0078-1077	HUMAN PRESCRIPTION DRUG	VOTRIENT		pazopanib hydrochloride	TABLET, FILM COATED	ORAL	20160712		NDA	NDA022465	Novartis Pharmaceuticals Corporation	PAZOPANIB HYDROCHLORIDE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0078-1091_4d9e643b-6588-4e86-9196-00daa5de5313	0078-1091	HUMAN PRESCRIPTION DRUG	SCEMBLIX		asciminib	TABLET, FILM COATED	ORAL	20211029		NDA	NDA215358	Novartis Pharmaceuticals Corporation	ASCIMINIB HYDROCHLORIDE	20	mg/1			N	20241231
0078-1098_4d9e643b-6588-4e86-9196-00daa5de5313	0078-1098	HUMAN PRESCRIPTION DRUG	SCEMBLIX		asciminib	TABLET, FILM COATED	ORAL	20211029		NDA	NDA215358	Novartis Pharmaceuticals Corporation	ASCIMINIB HYDROCHLORIDE	40	mg/1			N	20241231
0078-1105_26a4b56c-c10d-4b34-97d2-e46d150f2043	0078-1105	HUMAN PRESCRIPTION DRUG	Mekinist		trametinib	TABLET, FILM COATED	ORAL	20160317		NDA	NDA204114	Novartis Pharmaceuticals Corporation	TRAMETINIB DIMETHYL SULFOXIDE	.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0078-1112_26a4b56c-c10d-4b34-97d2-e46d150f2043	0078-1112	HUMAN PRESCRIPTION DRUG	Mekinist		trametinib	TABLET, FILM COATED	ORAL	20160317		NDA	NDA204114	Novartis Pharmaceuticals Corporation	TRAMETINIB DIMETHYL SULFOXIDE	2	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0078-1154_23689dc5-f2a5-4475-bbc1-bd73107e51ba	0078-1154	HUMAN PRESCRIPTION DRUG	Tafinlar		dabrafenib	TABLET, FOR SUSPENSION	ORAL	20230316		NDA	NDA217514	Novartis Pharmaceuticals Corporation	DABRAFENIB MESYLATE	10	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Protein Kinase Inhibitors [MoA]		N	20241231
0078-1161_26a4b56c-c10d-4b34-97d2-e46d150f2043	0078-1161	HUMAN PRESCRIPTION DRUG	Mekinist		trametinib	POWDER, FOR SOLUTION	ORAL	20230316		NDA	NDA217513	Novartis Pharmaceuticals Corporation	TRAMETINIB DIMETHYL SULFOXIDE	.05	mg/mL	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0078-1168_3e03ef3f-f697-4301-acc3-f98c22c8ff6b	0078-1168	HUMAN PRESCRIPTION DRUG	COSENTYX		secukinumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20231006		BLA	BLA761349	Novartis Pharmaceuticals Corporation	SECUKINUMAB	25	mg/mL	Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]		N	20241231
0078-1189_a76b5845-6e21-4d3b-ad07-cd8df1b60bee	0078-1189	HUMAN PRESCRIPTION DRUG	FABHALTA		iptacopan	CAPSULE	ORAL	20231205		NDA	NDA218276	Novartis Pharmaceuticals Corporation	IPTACOPAN HYDROCHLORIDE	200	mg/1			N	20241231
0078-9659_d32b959b-b270-43bf-89de-639d833289d9	0078-9659	HUMAN PRESCRIPTION DRUG	ENTRESTO		Sacubitril and Valsartan	TABLET, FILM COATED	ORAL	20150707		NDA	NDA207620	Novartis Pharmaceuticals Corporation	SACUBITRIL; VALSARTAN	24; 26	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]		N	20241231
0078-9777_d32b959b-b270-43bf-89de-639d833289d9	0078-9777	HUMAN PRESCRIPTION DRUG	ENTRESTO		Sacubitril and Valsartan	TABLET, FILM COATED	ORAL	20150707		NDA	NDA207620	Novartis Pharmaceuticals Corporation	SACUBITRIL; VALSARTAN	49; 51	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]		N	20241231
0085-1133_14b57151-dcc0-43f9-9b5b-eda8ddc5de22	0085-1133	HUMAN PRESCRIPTION DRUG	INTRON A		Interferon alfa-2b	INJECTION, SOLUTION	INTRALESIONAL; INTRAMUSCULAR; SUBCUTANEOUS	19860604		BLA	BLA103132	Merck Sharp & Dohme LLC	INTERFERON ALFA-2B	19.2	ug/.5mL	Interferon alpha [EPC], Interferon-alpha [CS], Interferon-alpha [CS]		N	20241231
0085-1168_14b57151-dcc0-43f9-9b5b-eda8ddc5de22	0085-1168	HUMAN PRESCRIPTION DRUG	INTRON A		Interferon alfa-2b	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	19860604		BLA	BLA103132	Merck Sharp & Dohme LLC	INTERFERON ALFA-2B	11.6	ug/.5mL	Interferon alpha [EPC], Interferon-alpha [CS], Interferon-alpha [CS]		N	20241231
0085-1328_50e517fb-4c04-4639-9359-e20907ca822e	0085-1328	HUMAN PRESCRIPTION DRUG	NOXAFIL		posaconazole	SUSPENSION	ORAL	20060915		NDA	NDA022003	Merck Sharp & Dohme LLC	POSACONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0085-1366_377e34ef-4f0a-4edc-8353-a9967683b580	0085-1366	HUMAN PRESCRIPTION DRUG	TEMODAR		Temozolomide	CAPSULE	ORAL	19990811		NDA	NDA021029	Merck Sharp & Dohme LLC	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0085-1381_377e34ef-4f0a-4edc-8353-a9967683b580	0085-1381	HUMAN PRESCRIPTION DRUG	TEMODAR		Temozolomide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090227		NDA	NDA022277	Merck Sharp & Dohme LLC	TEMOZOLOMIDE	2.5	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0085-1417_377e34ef-4f0a-4edc-8353-a9967683b580	0085-1417	HUMAN PRESCRIPTION DRUG	TEMODAR		Temozolomide	CAPSULE	ORAL	19990811		NDA	NDA021029	Merck Sharp & Dohme LLC	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0085-1425_377e34ef-4f0a-4edc-8353-a9967683b580	0085-1425	HUMAN PRESCRIPTION DRUG	TEMODAR		Temozolomide	CAPSULE	ORAL	19990811		NDA	NDA021029	Merck Sharp & Dohme LLC	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0085-1430_377e34ef-4f0a-4edc-8353-a9967683b580	0085-1430	HUMAN PRESCRIPTION DRUG	TEMODAR		Temozolomide	CAPSULE	ORAL	19990811		NDA	NDA021029	Merck Sharp & Dohme LLC	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0085-1519_377e34ef-4f0a-4edc-8353-a9967683b580	0085-1519	HUMAN PRESCRIPTION DRUG	TEMODAR		Temozolomide	CAPSULE	ORAL	19990811		NDA	NDA021029	Merck Sharp & Dohme LLC	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0085-2224_50e517fb-4c04-4639-9359-e20907ca822e	0085-2224	HUMAN PRESCRIPTION DRUG	NOXAFIL		posaconazole	POWDER, FOR SUSPENSION	ORAL	20210608		NDA	NDA214770	Merck Sharp & Dohme LLC	POSACONAZOLE	300	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0085-3004_377e34ef-4f0a-4edc-8353-a9967683b580	0085-3004	HUMAN PRESCRIPTION DRUG	TEMODAR		Temozolomide	CAPSULE	ORAL	19990811		NDA	NDA021029	Merck Sharp & Dohme LLC	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0085-4324_50e517fb-4c04-4639-9359-e20907ca822e	0085-4324	HUMAN PRESCRIPTION DRUG	NOXAFIL		posaconazole	TABLET, COATED	ORAL	20131125		NDA	NDA205053	Merck Sharp & Dohme LLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0085-4331_50e517fb-4c04-4639-9359-e20907ca822e	0085-4331	HUMAN PRESCRIPTION DRUG	NOXAFIL		posaconazole	SOLUTION	INTRAVENOUS	20140313		NDA	NDA205596	Merck Sharp & Dohme LLC	POSACONAZOLE	18	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0085-4350_14b57151-dcc0-43f9-9b5b-eda8ddc5de22	0085-4350	HUMAN PRESCRIPTION DRUG	INTRON A		interferon alfa-2b	KIT		20140811		BLA	BLA103132	Merck Sharp & Dohme LLC						N	20241231
0085-4351_14b57151-dcc0-43f9-9b5b-eda8ddc5de22	0085-4351	HUMAN PRESCRIPTION DRUG	INTRON A		interferon alfa-2b	KIT		20140811		BLA	BLA103132	Merck Sharp & Dohme LLC						N	20241231
0085-4352_14b57151-dcc0-43f9-9b5b-eda8ddc5de22	0085-4352	HUMAN PRESCRIPTION DRUG	INTRON A		interferon alfa-2b	KIT		20140811		BLA	BLA103132	Merck Sharp & Dohme LLC						N	20241231
0088-2102_2e1e7c6d-2c23-44fd-a775-cd89896f8b7d	0088-2102	HUMAN PRESCRIPTION DRUG	Priftin		rifapentine	TABLET, FILM COATED	ORAL	20170208		NDA	NDA021024	sanofi-aventis U.S. LLC	RIFAPENTINE	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
0088-2160_ea39cd13-cad1-3d69-e053-2995a90a7906	0088-2160	HUMAN PRESCRIPTION DRUG	Arava		leflunomide	TABLET, FILM COATED	ORAL	19980910		NDA	NDA020905	sanofi-aventis U.S. LLC	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
0088-2161_ea39cd13-cad1-3d69-e053-2995a90a7906	0088-2161	HUMAN PRESCRIPTION DRUG	Arava		leflunomide	TABLET, FILM COATED	ORAL	19980910		NDA	NDA020905	sanofi-aventis U.S. LLC	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
0088-2162_ea39cd13-cad1-3d69-e053-2995a90a7906	0088-2162	HUMAN PRESCRIPTION DRUG	Arava		leflunomide	TABLET, FILM COATED	ORAL	19980910		NDA	NDA020905	sanofi-aventis U.S. LLC	LEFLUNOMIDE	100	mg/1	Antirheumatic Agent [EPC]		N	20241231
0088-2219_5ba9a956-7c91-4f27-821a-1ddd54b70ffe	0088-2219	HUMAN PRESCRIPTION DRUG	Lantus Solostar		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20090923		BLA	BLA021081	sanofi-aventis U.S. LLC	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0088-2220_5ba9a956-7c91-4f27-821a-1ddd54b70ffe	0088-2220	HUMAN PRESCRIPTION DRUG	Lantus		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20090923		BLA	BLA021081	sanofi-aventis U.S. LLC	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0088-2500_3ad0d2f5-b5e2-4da9-8b4a-29ca1338eaad	0088-2500	HUMAN PRESCRIPTION DRUG	Apidra		insulin glulisine	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20090224		BLA	BLA021629	sanofi-aventis U.S. LLC	INSULIN GLULISINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0088-2502_3ad0d2f5-b5e2-4da9-8b4a-29ca1338eaad	0088-2502	HUMAN PRESCRIPTION DRUG	Apidra SoloStar		insulin glulisine	INJECTION, SOLUTION	SUBCUTANEOUS	20090224		BLA	BLA021629	sanofi-aventis U.S. LLC	INSULIN GLULISINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0088-5020_d0cf76a0-c9c8-4203-88ae-0c7259270dc0	0088-5020	HUMAN PRESCRIPTION DRUG	Lantus Solostar		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20170604		BLA	BLA021081	sanofi-aventis U.S. LLC	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0088-5021_d0cf76a0-c9c8-4203-88ae-0c7259270dc0	0088-5021	HUMAN PRESCRIPTION DRUG	Lantus		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20170604		BLA	BLA021081	sanofi-aventis U.S. LLC	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0093-0010_2f429822-d6d2-43c0-9aaf-1270b3e92a2f	0093-0010	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA077006	Teva Pharmaceuticals USA, Inc.	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0093-0017_47bb5b1f-0ee0-469f-9fcc-fc3087b2e865	0093-0017	HUMAN PRESCRIPTION DRUG	Moexipril Hydrochloride		Moexipril Hydrochloride	TABLET, FILM COATED	ORAL	20030508		ANDA	ANDA076204	Teva Pharmaceuticals USA, Inc.	MOEXIPRIL HYDROCHLORIDE	7.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0093-0018_2f429822-d6d2-43c0-9aaf-1270b3e92a2f	0093-0018	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA077006	Teva Pharmaceuticals USA, Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0093-0051_a369c0d5-8f93-4b0d-a5a0-8125af1309f7	0093-0051	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	Teva Pharmaceuticals USA, Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0093-0053_f2a05d58-ca70-4b89-aa19-6b63e85a57a5	0093-0053	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	Teva Pharmaceuticals USA, Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
0093-0054_f2a05d58-ca70-4b89-aa19-6b63e85a57a5	0093-0054	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	Teva Pharmaceuticals USA, Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
0093-0058_5c08c62b-8025-49c8-b330-1594bee4d523	0093-0058	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20020620		ANDA	ANDA075977	Teva Pharmaceuticals USA, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
0093-0073_2d5139eb-e369-43f7-951b-666cf006ba33	0093-0073	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070423		ANDA	ANDA076410	Teva Pharmaceuticals USA, Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0093-0074_2d5139eb-e369-43f7-951b-666cf006ba33	0093-0074	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070423		ANDA	ANDA076410	Teva Pharmaceuticals USA, Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0093-0090_6a0fed95-b700-4a24-aa68-e23578be7c91	0093-0090	HUMAN PRESCRIPTION DRUG	Epitol		Carbamazepine	TABLET	ORAL	19900930		ANDA	ANDA070541	Teva Pharmaceuticals USA, Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0093-0109_58b00f0d-faf9-43ee-8142-52bcb004fed3	0093-0109	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19900930		ANDA	ANDA070541	Teva Pharmaceuticals USA, Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0093-0135_a369c0d5-8f93-4b0d-a5a0-8125af1309f7	0093-0135	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	Teva Pharmaceuticals USA, Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0093-0262_248c7df2-0095-44f4-b8b5-124605487476	0093-0262	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	19900930		ANDA	ANDA072488	Teva Pharmaceuticals USA, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-0263_248c7df2-0095-44f4-b8b5-124605487476	0093-0263	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	19900930		ANDA	ANDA072490	Teva Pharmaceuticals USA, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-0264_248c7df2-0095-44f4-b8b5-124605487476	0093-0264	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	19920501		ANDA	ANDA073481	Teva Pharmaceuticals USA, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-0308_d4195d2d-40c5-4e06-8298-1ac90b0cbb3c	0093-0308	HUMAN PRESCRIPTION DRUG	Clemastine Fumarate		Clemastine Fumarate	TABLET	ORAL	19920401		ANDA	ANDA073283	Teva Pharmaceuticals USA, Inc.	CLEMASTINE FUMARATE	2.68	mg/1			N	20241231
0093-0311_863c19d4-c0cd-455e-9a93-5c5157762d02	0093-0311	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA073192	Teva Pharmaceuticals USA, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0093-0314_453df394-038f-40aa-af05-1d99fa5a5dd5	0093-0314	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	Teva Pharmaceuticals USA, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-0318_b5b12039-4294-42d8-a8a7-2c4b85f481df	0093-0318	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951222		ANDA	ANDA074185	Teva Pharmaceuticals USA, Inc.	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0093-0319_b5b12039-4294-42d8-a8a7-2c4b85f481df	0093-0319	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951222		ANDA	ANDA074185	Teva Pharmaceuticals USA, Inc.	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0093-0320_b5b12039-4294-42d8-a8a7-2c4b85f481df	0093-0320	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951222		ANDA	ANDA074185	Teva Pharmaceuticals USA, Inc.	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0093-0321_b5b12039-4294-42d8-a8a7-2c4b85f481df	0093-0321	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951226		ANDA	ANDA074185	Teva Pharmaceuticals USA, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0093-0576_ae2b21c6-efd3-42a8-aa6a-8ca2435030e9	0093-0576	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Teva Pharmaceuticals USA, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-0711_ea4b1dbf-08e4-442d-a281-4c51712494b1	0093-0711	HUMAN PRESCRIPTION DRUG	Flurbiprofen		Flurbiprofen	TABLET, FILM COATED	ORAL	19950602		ANDA	ANDA074431	Teva Pharmaceuticals USA, Inc.	FLURBIPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-0752_c09a6a57-535d-4ea9-b7e9-f59d62b6ebdb	0093-0752	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19950222		ANDA	ANDA074056	Teva Pharmaceuticals USA, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0093-0753_c09a6a57-535d-4ea9-b7e9-f59d62b6ebdb	0093-0753	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19950217		ANDA	ANDA074056	Teva Pharmaceuticals USA, Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0093-0756_389027d1-0d47-4715-b6c1-2747f4dae8e2	0093-0756	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	19941019		ANDA	ANDA074131	Teva Pharmaceuticals USA, Inc.	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-0757_389027d1-0d47-4715-b6c1-2747f4dae8e2	0093-0757	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	19940126		ANDA	ANDA074131	Teva Pharmaceuticals USA, Inc.	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-0771_00373263-a90a-474c-afe1-e515eb4b72bc	0093-0771	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20060425		ANDA	ANDA076056	Teva Pharmaceuticals USA, Inc.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0093-0778_58b00f0d-faf9-43ee-8142-52bcb004fed3	0093-0778	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	19950918		ANDA	ANDA073524	Teva Pharmaceuticals USA, Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0093-0787_c09a6a57-535d-4ea9-b7e9-f59d62b6ebdb	0093-0787	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20041116		ANDA	ANDA074056	Teva Pharmaceuticals USA, Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0093-0810_a8e5215a-8144-4227-914b-a7c92e4b4c36	0093-0810	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950405		ANDA	ANDA074132	Teva Pharmaceuticals USA, Inc.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0093-0811_a8e5215a-8144-4227-914b-a7c92e4b4c36	0093-0811	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950406		ANDA	ANDA074132	Teva Pharmaceuticals USA, Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0093-0812_a8e5215a-8144-4227-914b-a7c92e4b4c36	0093-0812	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950405		ANDA	ANDA074132	Teva Pharmaceuticals USA, Inc.	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0093-0813_a8e5215a-8144-4227-914b-a7c92e4b4c36	0093-0813	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950405		ANDA	ANDA074132	Teva Pharmaceuticals USA, Inc.	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0093-0832_d6abe4e3-7699-4ead-95f4-739a961b23ad	0093-0832	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960918		ANDA	ANDA074569	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-0926_ae2b21c6-efd3-42a8-aa6a-8ca2435030e9	0093-0926	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Teva Pharmaceuticals USA, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-0928_ae2b21c6-efd3-42a8-aa6a-8ca2435030e9	0093-0928	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Teva Pharmaceuticals USA, Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-0948_b6e73f02-96ee-4845-bc84-211ffeb53b7f	0093-0948	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	TABLET, FILM COATED	ORAL	19980811		ANDA	ANDA075219	Teva Pharmaceuticals USA, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-0983_2552fd84-f319-4ae2-903a-6eed1b16a017	0093-0983	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	TABLET, FILM COATED	ORAL	19900930		ANDA	ANDA062506	Teva Pharmaceuticals USA, Inc.	NYSTATIN	500000	[USP'U]/1	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0093-1003_f2a05d58-ca70-4b89-aa19-6b63e85a57a5	0093-1003	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020301		ANDA	ANDA075022	Teva Pharmaceuticals USA, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
0093-1005_f46220e2-0bea-4f74-b843-7d7e6f59aba7	0093-1005	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	19980731		ANDA	ANDA075227	Teva Pharmaceuticals USA, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-1006_f46220e2-0bea-4f74-b843-7d7e6f59aba7	0093-1006	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	19980729		ANDA	ANDA075227	Teva Pharmaceuticals USA, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-1010_fbef9813-87db-4aa3-90cf-c43c0587ec34	0093-1010	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20031107		ANDA	ANDA065085	Teva Pharmaceuticals USA, Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
0093-1024_810dfc46-2484-4215-83d7-c683495a18c5	0093-1024	HUMAN PRESCRIPTION DRUG	Nefazodone Hydrochloride		Nefazodone Hydrochloride	TABLET	ORAL	20030916		ANDA	ANDA076037	Teva Pharmaceuticals USA, Inc.	NEFAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0093-1025_810dfc46-2484-4215-83d7-c683495a18c5	0093-1025	HUMAN PRESCRIPTION DRUG	Nefazodone Hydrochloride		Nefazodone Hydrochloride	TABLET	ORAL	20030916		ANDA	ANDA076037	Teva Pharmaceuticals USA, Inc.	NEFAZODONE HYDROCHLORIDE	200	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0093-1026_810dfc46-2484-4215-83d7-c683495a18c5	0093-1026	HUMAN PRESCRIPTION DRUG	Nefazodone Hydrochloride		Nefazodone Hydrochloride	TABLET	ORAL	20030916		ANDA	ANDA076037	Teva Pharmaceuticals USA, Inc.	NEFAZODONE HYDROCHLORIDE	250	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0093-1060_e524b89d-4ddd-42f5-a0af-8b4945aec7b4	0093-1060	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20000505		ANDA	ANDA075429	Teva Pharmaceuticals USA, Inc.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
0093-1061_e524b89d-4ddd-42f5-a0af-8b4945aec7b4	0093-1061	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20000504		ANDA	ANDA075429	Teva Pharmaceuticals USA, Inc.	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
0093-1062_e524b89d-4ddd-42f5-a0af-8b4945aec7b4	0093-1062	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20000505		ANDA	ANDA075429	Teva Pharmaceuticals USA, Inc.	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
0093-1063_e524b89d-4ddd-42f5-a0af-8b4945aec7b4	0093-1063	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20000505		ANDA	ANDA075429	Teva Pharmaceuticals USA, Inc.	SOTALOL HYDROCHLORIDE	240	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
0093-1077_c226712f-00c2-407f-8b40-5ed1be54dfb8	0093-1077	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20051223		ANDA	ANDA065208	Teva Pharmaceuticals USA, Inc.	CEFPROZIL	250	mg/1			N	20241231
0093-1078_c226712f-00c2-407f-8b40-5ed1be54dfb8	0093-1078	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20051223		ANDA	ANDA065208	Teva Pharmaceuticals USA, Inc.	CEFPROZIL	500	mg/1			N	20241231
0093-1087_61ec00e0-d37d-4aa4-8f50-031ee7a37ecc	0093-1087	HUMAN PRESCRIPTION DRUG	Cefaclor		Cefaclor	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020926		ANDA	ANDA065058	Teva Pharmaceuticals USA, Inc.	CEFACLOR	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-1106_45bf9004-b62a-467f-b3a0-470dc868fba0	0093-1106	HUMAN PRESCRIPTION DRUG	Teriparatide		Teriparatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231218		ANDA	ANDA208569	Teva Pharmaceuticals USA, Inc.	TERIPARATIDE ACETATE	250	ug/mL	Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]		N	20241231
0093-1118_e96eb1a8-49e6-40e3-8e3f-66977e80e92d	0093-1118	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000817		ANDA	ANDA075665	Teva Pharmaceuticals USA, Inc.	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-1122_e96eb1a8-49e6-40e3-8e3f-66977e80e92d	0093-1122	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20010209		ANDA	ANDA075665	Teva Pharmaceuticals USA, Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-1125_81772086-cab1-4658-8132-d0650a06a4c7	0093-1125	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone Acetate	TABLET, FILM COATED	ORAL	20181121		ANDA	ANDA208432	Teva Pharmaceuticals USA, Inc.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
0093-1135_ba11783f-b2ad-49e8-b3a3-e96d29d1b369	0093-1135	HUMAN PRESCRIPTION DRUG	Acitretin		Acitretin	CAPSULE	ORAL	20130719		ANDA	ANDA091455	Teva Pharmaceuticals USA, Inc.	ACITRETIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0093-1136_ba11783f-b2ad-49e8-b3a3-e96d29d1b369	0093-1136	HUMAN PRESCRIPTION DRUG	Acitretin		Acitretin	CAPSULE	ORAL	20130719		ANDA	ANDA091455	Teva Pharmaceuticals USA, Inc.	ACITRETIN	25	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0093-1138_ba11783f-b2ad-49e8-b3a3-e96d29d1b369	0093-1138	HUMAN PRESCRIPTION DRUG	Acitretin		Acitretin	CAPSULE	ORAL	20130719		ANDA	ANDA202897	Teva Pharmaceuticals USA, Inc.	ACITRETIN	17.5	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0093-1172_165377dd-4272-4194-9d0b-36d213498f26	0093-1172	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET	ORAL	19900930		ANDA	ANDA060711	Teva Pharmaceuticals USA, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-1174_165377dd-4272-4194-9d0b-36d213498f26	0093-1174	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET	ORAL	19900930		ANDA	ANDA060711	Teva Pharmaceuticals USA, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-1177_18e9e5b7-e08c-445e-86bb-90bc0953eda9	0093-1177	HUMAN PRESCRIPTION DRUG	Neomycin Sulfate		Neomycin Sulfate	TABLET	ORAL	19900930		ANDA	ANDA060304	Teva Pharmaceuticals USA, Inc.	NEOMYCIN SULFATE	500	mg/1	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0093-1712_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1712	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20151019		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1713_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1713	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150505		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1714_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1714	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1715_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1715	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150714		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1716_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1716	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150609		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1718_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1718	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150722		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1720_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1720	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150512		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1721_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1721	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1723_0f94f9e0-7215-4b46-b12a-33eae411c533	0093-1723	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20180827		ANDA	ANDA040616	Teva Pharmaceuticals USA, Inc.	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0093-1920_a7cfb9fd-4417-4319-85c6-92c6fcad4085	0093-1920	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190304		NDA AUTHORIZED GENERIC	NDA021777	Teva Pharmaceuticals USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0093-1921_a7cfb9fd-4417-4319-85c6-92c6fcad4085	0093-1921	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190304		NDA AUTHORIZED GENERIC	NDA021777	Teva Pharmaceuticals USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	30	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0093-2013_b8128b50-7bfe-4ec9-8c1e-aa3141d8e917	0093-2013	HUMAN PRESCRIPTION DRUG	Sumatriptan		sumatriptan succinate	INJECTION	SUBCUTANEOUS	20160601	20240531	ANDA	ANDA078319	Teva Pharmaceuticals USA Inc	SUMATRIPTAN SUCCINATE	4	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	
0093-2026_44ec7e09-784b-41f7-a482-3be1d309e95b	0093-2026	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20101217		ANDA	ANDA065246	Teva Pharmaceuticals USA, Inc.	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0093-2027_44ec7e09-784b-41f7-a482-3be1d309e95b	0093-2027	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20101228		ANDA	ANDA065246	Teva Pharmaceuticals USA, Inc.	AZITHROMYCIN MONOHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0093-2063_c6af23d2-0b74-49fd-8c04-549988b0eb23	0093-2063	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20140312		ANDA	ANDA077745	Teva Pharmaceuticals USA, Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-2064_01457771-0b8c-4f1b-8513-01ad09ac97cc	0093-2064	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20121024		ANDA	ANDA077027	Teva Pharmaceuticals USA, Inc.	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0093-2065_01457771-0b8c-4f1b-8513-01ad09ac97cc	0093-2065	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20120424		ANDA	ANDA077027	Teva Pharmaceuticals USA, Inc.	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0093-2067_69a65fb3-443c-4b78-bb8b-9d8feff93fed	0093-2067	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20141205		ANDA	ANDA075536	Teva Pharmaceuticals USA, Inc.	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0093-2068_69a65fb3-443c-4b78-bb8b-9d8feff93fed	0093-2068	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20140909		ANDA	ANDA075536	Teva Pharmaceuticals USA, Inc.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0093-2069_69a65fb3-443c-4b78-bb8b-9d8feff93fed	0093-2069	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20140806		ANDA	ANDA075536	Teva Pharmaceuticals USA, Inc.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0093-2070_69a65fb3-443c-4b78-bb8b-9d8feff93fed	0093-2070	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20140806		ANDA	ANDA075536	Teva Pharmaceuticals USA, Inc.	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0093-2140_204ad27b-376e-4d07-bf27-1db57f446045	0093-2140	HUMAN PRESCRIPTION DRUG	Tri-Lo-Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20151230		ANDA	ANDA076784	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-2165_1712fc1d-aff1-4bd4-8f26-789fd7591786	0093-2165	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	SPRAY, METERED	NASAL	20211222		ANDA	ANDA209522	Teva Pharmaceuticals USA, Inc.	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0093-2178_22ed1e76-c20a-481e-bc00-2b531d14c3e4	0093-2178	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20210226		ANDA	ANDA211510	Teva Pharmaceuticals USA, Inc.	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
0093-2179_22ed1e76-c20a-481e-bc00-2b531d14c3e4	0093-2179	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20210226		ANDA	ANDA211510	Teva Pharmaceuticals USA, Inc.	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
0093-2180_22ed1e76-c20a-481e-bc00-2b531d14c3e4	0093-2180	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20210226		ANDA	ANDA211510	Teva Pharmaceuticals USA, Inc.	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
0093-2203_8f208d35-b19b-40a1-b363-f44ff08ec3d6	0093-2203	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	Teva Pharmaceuticals USA, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0093-2204_8f208d35-b19b-40a1-b363-f44ff08ec3d6	0093-2204	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19930701		ANDA	ANDA072801	Teva Pharmaceuticals USA, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0093-2210_5221c32c-714d-4d77-add6-36e2d414409e	0093-2210	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	19961111		ANDA	ANDA070848	Teva Pharmaceuticals USA, Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
0093-2238_53412318-db3b-446d-9b4f-2e5ddb74190a	0093-2238	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	TABLET	ORAL	19900930		ANDA	ANDA063023	Teva Pharmaceuticals USA, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-2240_53412318-db3b-446d-9b4f-2e5ddb74190a	0093-2240	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	TABLET	ORAL	19900930		ANDA	ANDA063024	Teva Pharmaceuticals USA, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-2263_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-2263	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20001121		ANDA	ANDA065056	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-2264_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-2264	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20000926		ANDA	ANDA065056	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-2267_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-2267	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, CHEWABLE	ORAL	19951001		ANDA	ANDA064013	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	125	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-2268_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-2268	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, CHEWABLE	ORAL	19930101		ANDA	ANDA064013	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-2270_f0d1a63e-3b4c-44d8-ad7a-af79463e7acf	0093-2270	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, CHEWABLE	ORAL	20050322		ANDA	ANDA065205	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0093-2272_f0d1a63e-3b4c-44d8-ad7a-af79463e7acf	0093-2272	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, CHEWABLE	ORAL	20050210		ANDA	ANDA065205	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0093-2274_f0d1a63e-3b4c-44d8-ad7a-af79463e7acf	0093-2274	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065101	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0093-2275_f0d1a63e-3b4c-44d8-ad7a-af79463e7acf	0093-2275	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065096	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0093-2277_f0d1a63e-3b4c-44d8-ad7a-af79463e7acf	0093-2277	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20050113		ANDA	ANDA065089	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0093-2279_f0d1a63e-3b4c-44d8-ad7a-af79463e7acf	0093-2279	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20050113		ANDA	ANDA065089	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0093-2401_a2897a74-f746-42aa-b752-ea4fc195d28d	0093-2401	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20201008		ANDA	ANDA040081	Teva Pharmaceuticals USA, Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
0093-3002_5a590f9a-a5ae-4c4a-9c0f-8742e7cceca2	0093-3002	HUMAN PRESCRIPTION DRUG	Quinine Sulfate		Quinine Sulfate	CAPSULE	ORAL	20120928		ANDA	ANDA091661	Teva Pharmaceuticals USA, Inc.	QUININE SULFATE	324	mg/1	Antimalarial [EPC]		N	20241231
0093-3008_eaa2693b-b9df-4cf3-b212-5de87110aa89	0093-3008	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180308		ANDA	ANDA208784	Teva Pharmaceuticals USA, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0093-3009_eaa2693b-b9df-4cf3-b212-5de87110aa89	0093-3009	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180308		ANDA	ANDA208784	Teva Pharmaceuticals USA, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0093-3016_08e8069b-c417-4cb8-8423-ffc540232a6a	0093-3016	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20180927		ANDA	ANDA090141	Teva Pharmaceuticals USA, Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-3017_08e8069b-c417-4cb8-8423-ffc540232a6a	0093-3017	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20180927		ANDA	ANDA090141	Teva Pharmaceuticals USA, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-3018_08e8069b-c417-4cb8-8423-ffc540232a6a	0093-3018	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20180927		ANDA	ANDA090141	Teva Pharmaceuticals USA, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-3019_08e8069b-c417-4cb8-8423-ffc540232a6a	0093-3019	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20180927		ANDA	ANDA090141	Teva Pharmaceuticals USA, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-3060_a133f4da-3384-4609-a7cd-be3ea506939c	0093-3060	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20170103		NDA AUTHORIZED GENERIC	NDA021641	Teva Pharmaceuticals USA, Inc.	RASAGILINE MESYLATE	.5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
0093-3061_a133f4da-3384-4609-a7cd-be3ea506939c	0093-3061	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20170103		NDA AUTHORIZED GENERIC	NDA021641	Teva Pharmaceuticals USA, Inc.	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
0093-3066_ea64720c-2b46-4ff1-9231-3f2b20968fcd	0093-3066	HUMAN PRESCRIPTION DRUG	Icatibant		Icatibant	INJECTION, SOLUTION	SUBCUTANEOUS	20190715		ANDA	ANDA210118	Teva Pharmaceuticals USA, Inc.	ICATIBANT ACETATE	10	mg/mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
0093-3090_e142bd35-7909-4c51-93dd-7b604f0f4ff3	0093-3090	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161129		NDA AUTHORIZED GENERIC	NDA021875	Teva Pharmaceuticals USA, Inc.	ARMODAFINIL	50	mg/1		CIV	N	20241231
0093-3092_e142bd35-7909-4c51-93dd-7b604f0f4ff3	0093-3092	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161129		NDA AUTHORIZED GENERIC	NDA021875	Teva Pharmaceuticals USA, Inc.	ARMODAFINIL	150	mg/1		CIV	N	20241231
0093-3093_e142bd35-7909-4c51-93dd-7b604f0f4ff3	0093-3093	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161129		NDA AUTHORIZED GENERIC	NDA021875	Teva Pharmaceuticals USA, Inc.	ARMODAFINIL	200	mg/1		CIV	N	20241231
0093-3094_e142bd35-7909-4c51-93dd-7b604f0f4ff3	0093-3094	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161129		NDA AUTHORIZED GENERIC	NDA021875	Teva Pharmaceuticals USA, Inc.	ARMODAFINIL	250	mg/1		CIV	N	20241231
0093-3098_fc389faf-d921-44b1-ab48-b0b14a2a47a5	0093-3098	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA077132	Teva Pharmaceuticals USA, Inc.	RISEDRONATE SODIUM MONOHYDRATE	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0093-3099_fc389faf-d921-44b1-ab48-b0b14a2a47a5	0093-3099	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA077132	Teva Pharmaceuticals USA, Inc.	RISEDRONATE SODIUM MONOHYDRATE	5	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0093-3100_fc389faf-d921-44b1-ab48-b0b14a2a47a5	0093-3100	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA077132	Teva Pharmaceuticals USA, Inc.	RISEDRONATE SODIUM MONOHYDRATE	30	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0093-3107_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-3107	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19900930		ANDA	ANDA061926	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-3109_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-3109	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19900930		ANDA	ANDA061926	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-3122_abd9820a-4a42-4700-bd5a-3da56ee2b252	0093-3122	HUMAN PRESCRIPTION DRUG	Jinteli		norethindrone acetate and ethinyl estradiol	TABLET	ORAL	20110217		ANDA	ANDA076221	Teva Pharmaceuticals USA, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	5; 1	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0093-3123_eafdab47-957b-44cb-88d5-7c1a428a5daf	0093-3123	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	Teva Pharmaceuticals USA, Inc.	DICLOXACILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-3125_eafdab47-957b-44cb-88d5-7c1a428a5daf	0093-3125	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	Teva Pharmaceuticals USA, Inc.	DICLOXACILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-3127_71a441c5-5c53-433e-84b9-f7b25818a077	0093-3127	HUMAN PRESCRIPTION DRUG	Disopyramide Phosphate		Disopyramide Phosphate	CAPSULE	ORAL	19900930		ANDA	ANDA070101	Teva Pharmaceuticals USA, Inc.	DISOPYRAMIDE PHOSPHATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
0093-3129_71a441c5-5c53-433e-84b9-f7b25818a077	0093-3129	HUMAN PRESCRIPTION DRUG	Disopyramide Phosphate		Disopyramide Phosphate	CAPSULE	ORAL	19900930		ANDA	ANDA070102	Teva Pharmaceuticals USA, Inc.	DISOPYRAMIDE PHOSPHATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
0093-3133_7393b310-0b4d-4558-a927-c81266bb73e5	0093-3133	HUMAN PRESCRIPTION DRUG	Imiquimod		imiquimod	CREAM	TOPICAL	20200730		NDA AUTHORIZED GENERIC	NDA022483	Teva Pharmaceuticals USA, Inc.	IMIQUIMOD	37.5	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
0093-3134_92a619ff-604b-4efa-881c-9649bc64fbe7	0093-3134	HUMAN PRESCRIPTION DRUG	Camrese		Levonorgestrel / Ethinyl Estradiol and Ethinyl Estradiol	KIT		20110728		NDA AUTHORIZED GENERIC	NDA021840	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-3145_c75c0bb6-fe3e-43c6-bdde-edd904731795	0093-3145	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	Teva Pharmaceuticals USA, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-3147_c75c0bb6-fe3e-43c6-bdde-edd904731795	0093-3147	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	Teva Pharmaceuticals USA, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-3160_d43379bc-861f-4f3f-9ddd-68eba5708143	0093-3160	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20070509		ANDA	ANDA065368	Teva Pharmaceuticals USA, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-3174_d9fc7dd4-8c8c-4c83-a6b7-02d984f4135b	0093-3174	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate	HFA	Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20190116		NDA AUTHORIZED GENERIC	NDA021457	Teva Pharmaceuticals USA, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-3186_e6116cf2-000d-461f-a8cb-47f4c4ec8d34	0093-3186	HUMAN PRESCRIPTION DRUG	Penciclovir		Penciclovir	CREAM	TOPICAL	20221114		ANDA	ANDA212710	Teva Pharmaceuticals USA, Inc.	PENCICLOVIR	10	mg/g	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0093-3196_b5585275-ba06-4ffd-9fa5-82e2603433ec	0093-3196	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070131		ANDA	ANDA065282	Teva Pharmaceuticals USA, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-3212_d6abe4e3-7699-4ead-95f4-739a961b23ad	0093-3212	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960917		ANDA	ANDA074569	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-3213_d6abe4e3-7699-4ead-95f4-739a961b23ad	0093-3213	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960918		ANDA	ANDA074569	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-3219_3027539e-261c-4ac2-a25d-c41fcce3da0f	0093-3219	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20190208		ANDA	ANDA075581	Teva Pharmaceuticals USA, Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0093-3223_12dbdb37-6b15-4e14-be86-e1a027918271	0093-3223	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	INSERT	VAGINAL	20170724		ANDA	ANDA206388	Teva Pharmaceuticals USA, Inc.	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0093-3234_6bb77fd9-0f19-4f91-8eb9-33d9c6b5c471	0093-3234	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20221215		ANDA	ANDA085828	Teva Pharmaceuticals USA, Inc.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0093-3239_6dcfd5c9-2e66-4157-b601-0a50d708a6cf	0093-3239	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20211227		ANDA	ANDA204937	Teva Pharmaceuticals USA, Inc.	BUPRENORPHINE	7.5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0093-3241_59305225-efd0-44df-aa80-acd404dc12a1	0093-3241	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190807		NDA AUTHORIZED GENERIC	NDA020186	Teva Pharmaceuticals USA, Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
0093-3242_59305225-efd0-44df-aa80-acd404dc12a1	0093-3242	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190807		NDA AUTHORIZED GENERIC	NDA020186	Teva Pharmaceuticals USA, Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
0093-3243_59305225-efd0-44df-aa80-acd404dc12a1	0093-3243	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190807		NDA AUTHORIZED GENERIC	NDA020186	Teva Pharmaceuticals USA, Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
0093-3304_6b24007e-0560-443d-9bca-894487c931af	0093-3304	HUMAN PRESCRIPTION DRUG	Reclipsen	28 Day	Desogestrel and Ethinyl Estradiol	KIT		20170101		ANDA	ANDA075256	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-3334_aff8cfda-2692-4975-af57-831a194d25d2	0093-3334	HUMAN PRESCRIPTION DRUG	ALYQ		Tadalafil	TABLET, FILM COATED	ORAL	20190206		ANDA	ANDA209942	Teva Pharmaceuticals USA, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-3420_e17eb9ef-7a98-4e37-8f13-62c870d6a767	0093-3420	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	Teva Pharmaceuticals USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0093-3421_e17eb9ef-7a98-4e37-8f13-62c870d6a767	0093-3421	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	Teva Pharmaceuticals USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0093-3422_e17eb9ef-7a98-4e37-8f13-62c870d6a767	0093-3422	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	Teva Pharmaceuticals USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0093-3425_d4025ada-2d5d-4e41-a891-b55dc5caa8c9	0093-3425	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211011		ANDA	ANDA072926	Teva Pharmaceuticals USA, Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-3426_d4025ada-2d5d-4e41-a891-b55dc5caa8c9	0093-3426	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211209		ANDA	ANDA072927	Teva Pharmaceuticals USA, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-3427_d4025ada-2d5d-4e41-a891-b55dc5caa8c9	0093-3427	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20210720		ANDA	ANDA072928	Teva Pharmaceuticals USA, Inc.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-3428_c54b0fe3-5125-406f-a7ac-c433b88cdee6	0093-3428	HUMAN PRESCRIPTION DRUG	Tacrolimus		tacrolimus	OINTMENT	TOPICAL	20220909		ANDA	ANDA200744	Teva Pharmaceuticals USA, Inc.	TACROLIMUS	.3	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0093-3429_c54b0fe3-5125-406f-a7ac-c433b88cdee6	0093-3429	HUMAN PRESCRIPTION DRUG	Tacrolimus		tacrolimus	OINTMENT	TOPICAL	20220909		ANDA	ANDA200744	Teva Pharmaceuticals USA, Inc.	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0093-3541_688192e9-df4b-41f9-8b0b-7ff1419475fe	0093-3541	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	CREAM	VAGINAL	20180102		ANDA	ANDA086069	Teva Pharmaceuticals USA, Inc.	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0093-3542_cc4ae863-6206-47b3-8bfa-37a2236504fd	0093-3542	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	Teva Pharmaceuticals USA, Inc.	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0093-3543_cc4ae863-6206-47b3-8bfa-37a2236504fd	0093-3543	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	Teva Pharmaceuticals USA, Inc.	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0093-3544_cc4ae863-6206-47b3-8bfa-37a2236504fd	0093-3544	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	Teva Pharmaceuticals USA, Inc.	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0093-3545_cc4ae863-6206-47b3-8bfa-37a2236504fd	0093-3545	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	Teva Pharmaceuticals USA, Inc.	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0093-3546_cc4ae863-6206-47b3-8bfa-37a2236504fd	0093-3546	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	Teva Pharmaceuticals USA, Inc.	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0093-3547_cc4ae863-6206-47b3-8bfa-37a2236504fd	0093-3547	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	Teva Pharmaceuticals USA, Inc.	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0093-3548_cc4ae863-6206-47b3-8bfa-37a2236504fd	0093-3548	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	Teva Pharmaceuticals USA, Inc.	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0093-3560_46e37694-3149-46b3-a949-fad3ccbb8052	0093-3560	HUMAN PRESCRIPTION DRUG	PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID		PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID	KIT		20200831		ANDA	ANDA090145	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-3607_0378204f-cc72-4a54-8ad7-ee9b93825261	0093-3607	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	Teva Pharmaceuticals USA, Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	55; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-3608_0378204f-cc72-4a54-8ad7-ee9b93825261	0093-3608	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	Teva Pharmaceuticals USA, Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	113; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-3609_0378204f-cc72-4a54-8ad7-ee9b93825261	0093-3609	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	Teva Pharmaceuticals USA, Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	232; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-3630_0a324dc2-0f76-9cd5-e063-6294a90a507c	0093-3630	HUMAN PRESCRIPTION DRUG	Acyclovir		acyclovir	CREAM	TOPICAL	20190829		NDA AUTHORIZED GENERIC	NDA021478	Teva Pharmaceuticals USA, Inc.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0093-3655_1c463f0a-7bee-4c90-871d-b69e85b0dc52	0093-3655	HUMAN PRESCRIPTION DRUG	Methylergonovine Maleate		Methylergonovine Maleate	TABLET	ORAL	20190326		ANDA	ANDA211455	Teva Pharmaceuticals USA, Inc.	METHYLERGONOVINE MALEATE	.2	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
0093-3656_6dcfd5c9-2e66-4157-b601-0a50d708a6cf	0093-3656	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20181126		ANDA	ANDA204937	Teva Pharmaceuticals USA, Inc.	BUPRENORPHINE	5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0093-3657_6dcfd5c9-2e66-4157-b601-0a50d708a6cf	0093-3657	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20181126		ANDA	ANDA204937	Teva Pharmaceuticals USA, Inc.	BUPRENORPHINE	10	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0093-3658_6dcfd5c9-2e66-4157-b601-0a50d708a6cf	0093-3658	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20181126		ANDA	ANDA204937	Teva Pharmaceuticals USA, Inc.	BUPRENORPHINE	15	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0093-3659_6dcfd5c9-2e66-4157-b601-0a50d708a6cf	0093-3659	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20181126		ANDA	ANDA204937	Teva Pharmaceuticals USA, Inc.	BUPRENORPHINE	20	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0093-3727_0b712273-bf2e-52ca-e063-6294a90aa935	0093-3727	HUMAN PRESCRIPTION DRUG	diclofenac epolamine		diclofenac epolamine	SYSTEM	TOPICAL	20200501		NDA AUTHORIZED GENERIC	NDA021234	Teva Pharmaceuticals USA Inc.	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-3750_7010c4fd-7c30-40f9-a8de-f69c40e55f30	0093-3750	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20200915		ANDA	ANDA210915	Teva Pharmaceuticals USA, Inc.	TOBRAMYCIN	300	mg/4mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0093-4000_1da64300-c1c5-442d-857c-a14a56b56128	0093-4000	HUMAN PRESCRIPTION DRUG	Vestura		Drospirenone and Ethinyl Estradiol	KIT		20210302		ANDA	ANDA078833	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-4059_2c394dcd-12d1-4f3d-9696-dc737687b0cb	0093-4059	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	TABLET	ORAL	20070131		ANDA	ANDA062774	Teva Pharmaceuticals USA, Inc.	CEFADROXIL	1000	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-4061_0ecd7fc0-7e29-4502-91ff-a0ead5a5a1f8	0093-4061	HUMAN PRESCRIPTION DRUG	Formoterol fumarate		Formoterol fumarate	SOLUTION	RESPIRATORY (INHALATION)	20210622		ANDA	ANDA091141	Teva Pharmaceuticals USA, Inc.	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-4067_d4823dac-88af-46cc-95f0-4944d17ffd9f	0093-4067	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20070222		ANDA	ANDA071745	Teva Pharmaceuticals USA, Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0093-4068_d4823dac-88af-46cc-95f0-4944d17ffd9f	0093-4068	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20070222		ANDA	ANDA071745	Teva Pharmaceuticals USA, Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0093-4069_d4823dac-88af-46cc-95f0-4944d17ffd9f	0093-4069	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20070118		ANDA	ANDA071745	Teva Pharmaceuticals USA, Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0093-4085_f1f2cab5-2399-4e1b-bcb7-e0e8abccaef3	0093-4085	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20131119		ANDA	ANDA091589	Teva Pharmaceuticals USA, Inc.	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0093-4125_165377dd-4272-4194-9d0b-36d213498f26	0093-4125	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	19900930		ANDA	ANDA060456	Teva Pharmaceuticals USA, Inc.	PENICILLIN V POTASSIUM	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-4127_165377dd-4272-4194-9d0b-36d213498f26	0093-4127	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	19900930		ANDA	ANDA060456	Teva Pharmaceuticals USA, Inc.	PENICILLIN V POTASSIUM	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-4136_d2c15629-9e81-4a12-9d90-50e1ca6013af	0093-4136	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070508		ANDA	ANDA065332	Teva Pharmaceuticals USA, Inc.	CEFDINIR MONOHYDRATE	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-4137_d2c15629-9e81-4a12-9d90-50e1ca6013af	0093-4137	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070508		ANDA	ANDA065332	Teva Pharmaceuticals USA, Inc.	CEFDINIR MONOHYDRATE	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-4145_c4bbe9ea-2824-4b67-8557-830bbb80ba5d	0093-4145	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20130429		ANDA	ANDA090297	Teva Pharmaceuticals USA, Inc.	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-4146_c4bbe9ea-2824-4b67-8557-830bbb80ba5d	0093-4146	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20130429		ANDA	ANDA090297	Teva Pharmaceuticals USA, Inc.	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-4147_9991cb94-c878-4ec9-aacd-8a2534ac60c8	0093-4147	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION, CONCENTRATE	RESPIRATORY (INHALATION)	20141216		ANDA	ANDA200875	Teva Pharmaceuticals USA, Inc.	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/.5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-4148_c4bbe9ea-2824-4b67-8557-830bbb80ba5d	0093-4148	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20130429		ANDA	ANDA090297	Teva Pharmaceuticals USA, Inc.	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-4155_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-4155	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-4160_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-4160	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20030402		ANDA	ANDA065119	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-4161_d352ea03-24be-4a9c-8ac9-de15e7aa94ff	0093-4161	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20030226		ANDA	ANDA065119	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0093-4175_c75c0bb6-fe3e-43c6-bdde-edd904731795	0093-4175	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA062703	Teva Pharmaceuticals USA, Inc.	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-4177_c75c0bb6-fe3e-43c6-bdde-edd904731795	0093-4177	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA062703	Teva Pharmaceuticals USA, Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0093-5002_8507a7e6-dd16-4064-8a4e-cb2d8fadea80	0093-5002	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA202491	Teva Pharmaceuticals USA, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-5003_8507a7e6-dd16-4064-8a4e-cb2d8fadea80	0093-5003	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA202491	Teva Pharmaceuticals USA, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-5004_8507a7e6-dd16-4064-8a4e-cb2d8fadea80	0093-5004	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA202491	Teva Pharmaceuticals USA, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-5005_8507a7e6-dd16-4064-8a4e-cb2d8fadea80	0093-5005	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA202491	Teva Pharmaceuticals USA, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-5006_8507a7e6-dd16-4064-8a4e-cb2d8fadea80	0093-5006	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA202491	Teva Pharmaceuticals USA, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-5030_774a4b2f-e96b-4d6a-a9ff-122279d46b6f	0093-5030	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20160603		NDA AUTHORIZED GENERIC	NDA020646	Teva Pharmaceuticals USA, Inc.	TIAGABINE HYDROCHLORIDE	2	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0093-5031_774a4b2f-e96b-4d6a-a9ff-122279d46b6f	0093-5031	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20160603		NDA AUTHORIZED GENERIC	NDA020646	Teva Pharmaceuticals USA, Inc.	TIAGABINE HYDROCHLORIDE	4	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0093-5045_a85e649d-b286-40a5-96ce-081db2b03505	0093-5045	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170705		ANDA	ANDA202731	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5046_a85e649d-b286-40a5-96ce-081db2b03505	0093-5046	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170705		ANDA	ANDA202731	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5056_52022cc0-0b9a-4afe-91b9-283b09c2a9ed	0093-5056	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	Teva Pharmaceuticals USA, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-5057_52022cc0-0b9a-4afe-91b9-283b09c2a9ed	0093-5057	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	Teva Pharmaceuticals USA, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-5058_52022cc0-0b9a-4afe-91b9-283b09c2a9ed	0093-5058	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	Teva Pharmaceuticals USA, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-5059_52022cc0-0b9a-4afe-91b9-283b09c2a9ed	0093-5059	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	Teva Pharmaceuticals USA, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-5060_cce6c295-d186-4bff-8b05-a9e941623257	0093-5060	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20130219		ANDA	ANDA088617	Teva Pharmaceuticals USA, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0093-5061_cce6c295-d186-4bff-8b05-a9e941623257	0093-5061	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121009		ANDA	ANDA088618	Teva Pharmaceuticals USA, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0093-5062_cce6c295-d186-4bff-8b05-a9e941623257	0093-5062	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121022		ANDA	ANDA088619	Teva Pharmaceuticals USA, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0093-5150_47bb5b1f-0ee0-469f-9fcc-fc3087b2e865	0093-5150	HUMAN PRESCRIPTION DRUG	Moexipril Hydrochloride		Moexipril Hydrochloride	TABLET, FILM COATED	ORAL	20030508		ANDA	ANDA076204	Teva Pharmaceuticals USA, Inc.	MOEXIPRIL HYDROCHLORIDE	15	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0093-5200_f2a05d58-ca70-4b89-aa19-6b63e85a57a5	0093-5200	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20040326		ANDA	ANDA075022	Teva Pharmaceuticals USA, Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
0093-5234_0f30b19a-e509-464e-a83e-4e1499fd060c	0093-5234	HUMAN PRESCRIPTION DRUG	Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate		Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA091215	Teva Pharmaceuticals USA, Inc.	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
0093-5245_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2	0093-5245	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20120217		ANDA	ANDA077243	Teva Pharmaceuticals USA, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5246_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2	0093-5246	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20120217		ANDA	ANDA077243	Teva Pharmaceuticals USA, Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5247_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2	0093-5247	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20120124		ANDA	ANDA077243	Teva Pharmaceuticals USA, Inc.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5248_a55a091b-2e1e-480a-aac1-3c9d9cc56dc2	0093-5248	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20120124		ANDA	ANDA077243	Teva Pharmaceuticals USA, Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5260_3c9afddb-516b-43a3-9a28-9a3b3aca6340	0093-5260	HUMAN PRESCRIPTION DRUG	Almotriptan Malate		Almotriptan Malate	TABLET, FILM COATED	ORAL	20150707		ANDA	ANDA078027	Teva Pharmaceuticals USA, Inc.	ALMOTRIPTAN MALATE	6.25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0093-5261_3c9afddb-516b-43a3-9a28-9a3b3aca6340	0093-5261	HUMAN PRESCRIPTION DRUG	Almotriptan Malate		Almotriptan Malate	TABLET, FILM COATED	ORAL	20150707		ANDA	ANDA078027	Teva Pharmaceuticals USA, Inc.	ALMOTRIPTAN MALATE	12.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0093-5292_e883a73f-7b17-4ef7-ba57-11f60a38017f	0093-5292	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(CD)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120927	20241031	ANDA	ANDA078873	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
0093-5293_e883a73f-7b17-4ef7-ba57-11f60a38017f	0093-5293	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(CD)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120927	20241031	ANDA	ANDA078873	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
0093-5295_e883a73f-7b17-4ef7-ba57-11f60a38017f	0093-5295	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(CD)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120927		ANDA	ANDA077707	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5296_e883a73f-7b17-4ef7-ba57-11f60a38017f	0093-5296	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(CD)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120927		ANDA	ANDA077707	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5297_e883a73f-7b17-4ef7-ba57-11f60a38017f	0093-5297	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(CD)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120927		ANDA	ANDA077707	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5298_e883a73f-7b17-4ef7-ba57-11f60a38017f	0093-5298	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(CD)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120927	20241031	ANDA	ANDA078873	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
0093-5328_8926360d-71a7-403d-bf86-608ffca92efb	0093-5328	HUMAN PRESCRIPTION DRUG	Junel Fe	24	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20150608		ANDA	ANDA090938	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-5341_0cc9f9b7-aece-4e31-b894-d878f26bd5a4	0093-5341	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA077342	Teva Pharmaceuticals USA, Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-5342_0cc9f9b7-aece-4e31-b894-d878f26bd5a4	0093-5342	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA077342	Teva Pharmaceuticals USA, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-5343_0cc9f9b7-aece-4e31-b894-d878f26bd5a4	0093-5343	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA077342	Teva Pharmaceuticals USA, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-5346_663ba889-95b5-45c2-af06-c90459d30d6d	0093-5346	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(LA)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120716		ANDA	ANDA079031	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5347_663ba889-95b5-45c2-af06-c90459d30d6d	0093-5347	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(LA)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120716		ANDA	ANDA079031	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5348_663ba889-95b5-45c2-af06-c90459d30d6d	0093-5348	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	(LA)	Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120716		ANDA	ANDA079031	Teva Pharmaceuticals USA, Inc.	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5376_247ca285-2a0e-4afc-af76-e0065e28d3f3	0093-5376	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20200730		ANDA	ANDA203039	Teva Pharmaceuticals USA, Inc.	CLOZAPINE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5377_247ca285-2a0e-4afc-af76-e0065e28d3f3	0093-5377	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20200730		ANDA	ANDA203039	Teva Pharmaceuticals USA, Inc.	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5416_c6e500d6-78be-4ef1-a102-4f1681aef7b3	0093-5416	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20180417		ANDA	ANDA090308	Teva Pharmaceuticals USA, Inc.	CLOZAPINE	12.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5417_c6e500d6-78be-4ef1-a102-4f1681aef7b3	0093-5417	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20170725		ANDA	ANDA090308	Teva Pharmaceuticals USA, Inc.	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5419_c6e500d6-78be-4ef1-a102-4f1681aef7b3	0093-5419	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20170725		ANDA	ANDA090308	Teva Pharmaceuticals USA, Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-5420_cb353e73-33cb-4c45-8770-2ee2205abc85	0093-5420	HUMAN PRESCRIPTION DRUG	Cabergoline		Cabergoline	TABLET	ORAL	20070307		ANDA	ANDA077750	Teva Pharmaceuticals USA, Inc.	CABERGOLINE	.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
0093-5455_eedfb5dd-653b-455f-86ec-93ab76f187fd	0093-5455	HUMAN PRESCRIPTION DRUG	Mimvey		Estradiol and Norethindrone Acetate	TABLET, FILM COATED	ORAL	20100602		ANDA	ANDA079193	Teva Pharmaceuticals USA, Inc.	ESTRADIOL; NORETHINDRONE ACETATE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0093-5503_35088d37-bd8c-49c4-8d1f-d3cb238f6ea0	0093-5503	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20130410		ANDA	ANDA202074	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 3	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0093-5504_35088d37-bd8c-49c4-8d1f-d3cb238f6ea0	0093-5504	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20120619		ANDA	ANDA077528	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 6	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0093-5505_35088d37-bd8c-49c4-8d1f-d3cb238f6ea0	0093-5505	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20120619		ANDA	ANDA077528	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 6	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0093-5506_35088d37-bd8c-49c4-8d1f-d3cb238f6ea0	0093-5506	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20120619		ANDA	ANDA077528	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 12	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0093-5507_35088d37-bd8c-49c4-8d1f-d3cb238f6ea0	0093-5507	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20120619		ANDA	ANDA077528	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 12	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0093-5517_249d0704-92f1-462e-badf-0594874f4fe1	0093-5517	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20130531		ANDA	ANDA078380	Teva Pharmaceuticals USA, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-5526_73941d8f-10d9-4e99-8a9b-e5cb9cd0d489	0093-5526	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir Sulfate	CAPSULE	ORAL	20171227		ANDA	ANDA091673	Teva Pharmaceuticals USA, Inc.	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0093-5527_73941d8f-10d9-4e99-8a9b-e5cb9cd0d489	0093-5527	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir Sulfate	CAPSULE	ORAL	20171227		ANDA	ANDA091673	Teva Pharmaceuticals USA, Inc.	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0093-5528_73941d8f-10d9-4e99-8a9b-e5cb9cd0d489	0093-5528	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir Sulfate	CAPSULE	ORAL	20171227		ANDA	ANDA091673	Teva Pharmaceuticals USA, Inc.	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
0093-5537_359cf2e6-4461-4ebf-a542-06736029d9d0	0093-5537	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140414		ANDA	ANDA091169	Teva Pharmaceuticals USA, Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
0093-5538_359cf2e6-4461-4ebf-a542-06736029d9d0	0093-5538	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140414		ANDA	ANDA091169	Teva Pharmaceuticals USA, Inc.	ESZOPICLONE	2	mg/1		CIV	N	20241231
0093-5539_359cf2e6-4461-4ebf-a542-06736029d9d0	0093-5539	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140414		ANDA	ANDA091169	Teva Pharmaceuticals USA, Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
0093-5550_a85e649d-b286-40a5-96ce-081db2b03505	0093-5550	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20141110		ANDA	ANDA078908	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5551_a85e649d-b286-40a5-96ce-081db2b03505	0093-5551	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150202		ANDA	ANDA078908	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5552_a85e649d-b286-40a5-96ce-081db2b03505	0093-5552	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140521		ANDA	ANDA078908	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5553_a85e649d-b286-40a5-96ce-081db2b03505	0093-5553	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150622		ANDA	ANDA078908	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5554_a85e649d-b286-40a5-96ce-081db2b03505	0093-5554	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140522		ANDA	ANDA202731	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5562_a85e649d-b286-40a5-96ce-081db2b03505	0093-5562	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20131121		ANDA	ANDA202731	Teva Pharmaceuticals USA, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0093-5571_ae45bc79-d364-47fb-ba1e-b6204757d7aa	0093-5571	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20210504		ANDA	ANDA214549	Teva Pharmaceuticals USA, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
0093-5572_ae45bc79-d364-47fb-ba1e-b6204757d7aa	0093-5572	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20210504		ANDA	ANDA214549	Teva Pharmaceuticals USA, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
0093-5731_7331dcb7-b48a-4c89-91fc-9119a4af0aa6	0093-5731	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151012	20241231	NDA AUTHORIZED GENERIC	NDA022272	Teva Pharmaceuticals USA, Inc.	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0093-5732_7331dcb7-b48a-4c89-91fc-9119a4af0aa6	0093-5732	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151012	20241231	NDA AUTHORIZED GENERIC	NDA022272	Teva Pharmaceuticals USA, Inc.	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0093-5733_7331dcb7-b48a-4c89-91fc-9119a4af0aa6	0093-5733	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151014	20250131	NDA AUTHORIZED GENERIC	NDA022272	Teva Pharmaceuticals USA, Inc.	OXYCODONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0093-5734_7331dcb7-b48a-4c89-91fc-9119a4af0aa6	0093-5734	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151014	20250131	NDA AUTHORIZED GENERIC	NDA022272	Teva Pharmaceuticals USA, Inc.	OXYCODONE HYDROCHLORIDE	80	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0093-5907_0926122d-8599-4cd1-b4e0-35c8d6763514	0093-5907	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, DELAYED RELEASE	ORAL	20190509		ANDA	ANDA207873	Teva Pharmaceuticals USA, Inc.	MESALAMINE	400	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0093-5938_c7a37d6c-c06f-440c-8c13-37508567f1fc	0093-5938	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		Lanthanum carbonate	TABLET, CHEWABLE	ORAL	20220525		ANDA	ANDA090977	Teva Pharmaceuticals USA, Inc.	LANTHANUM CARBONATE	500	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0093-5939_c7a37d6c-c06f-440c-8c13-37508567f1fc	0093-5939	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		Lanthanum carbonate	TABLET, CHEWABLE	ORAL	20220525		ANDA	ANDA090977	Teva Pharmaceuticals USA, Inc.	LANTHANUM CARBONATE	750	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0093-5940_c7a37d6c-c06f-440c-8c13-37508567f1fc	0093-5940	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		Lanthanum carbonate	TABLET, CHEWABLE	ORAL	20220525		ANDA	ANDA090977	Teva Pharmaceuticals USA, Inc.	LANTHANUM CARBONATE	1000	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0093-5955_98de9422-52ec-42d8-b4c4-f3ad3b11460f	0093-5955	HUMAN PRESCRIPTION DRUG	Arformoterol tartrate		Arformoterol tartrate	SOLUTION	RESPIRATORY (INHALATION)	20211206		ANDA	ANDA200293	Teva Pharmaceuticals USA, Inc.	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-5985_f96bd477-2239-4453-aaa4-e20d16c6e49e	0093-5985	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20190819		ANDA	ANDA090589	Teva Pharmaceuticals USA, Inc.	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0093-5986_f96bd477-2239-4453-aaa4-e20d16c6e49e	0093-5986	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20181127		ANDA	ANDA090589	Teva Pharmaceuticals USA, Inc.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0093-6031_8b3ea105-d75c-4b8c-817d-0424ed11cf22	0093-6031	HUMAN PRESCRIPTION DRUG	Rivelsa		Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol	KIT		20170403		NDA AUTHORIZED GENERIC	NDA204061	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-6148_04112bce-2705-4e59-8e28-d314684d9010	0093-6148	HUMAN PRESCRIPTION DRUG	camrese Lo		Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol	KIT		20111207		NDA AUTHORIZED GENERIC	NDA022262	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-6303_f82cf147-67cb-4716-a9a4-a5e9cd8fdbf9	0093-6303	HUMAN PRESCRIPTION DRUG	adapalene and benzoyl peroxide		adapalene and benzoyl peroxide	GEL	TOPICAL	20211201	20240131	NDA AUTHORIZED GENERIC	NDA207917	TEVA PHARMACEUTICALS USA, INC	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	
0093-6450_1f9c3fef-e926-4b18-9935-4df699ebb76e	0093-6450	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150217		ANDA	ANDA078003	Teva Pharmaceuticals USA, Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0093-6451_1f9c3fef-e926-4b18-9935-4df699ebb76e	0093-6451	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150217		ANDA	ANDA078003	Teva Pharmaceuticals USA, Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0093-6815_551a929a-3517-4e58-9df6-f9bfb0f2f3be	0093-6815	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20190111		ANDA	ANDA077519	Teva Pharmaceuticals USA, Inc.	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-6815_c51e584e-be7e-4807-aa09-ef3eca459a2f	0093-6815	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20081119		ANDA	ANDA077519	Teva Pharmaceuticals USA, Inc.	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-6816_551a929a-3517-4e58-9df6-f9bfb0f2f3be	0093-6816	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20190111		ANDA	ANDA077519	Teva Pharmaceuticals USA, Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-6816_c51e584e-be7e-4807-aa09-ef3eca459a2f	0093-6816	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20081119		ANDA	ANDA077519	Teva Pharmaceuticals USA, Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-6817_e505244f-d53f-4dc0-acd7-45dc98034b97	0093-6817	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20160311		ANDA	ANDA204548	Teva Pharmaceuticals USA, Inc.	BUDESONIDE	1	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0093-7113_810dfc46-2484-4215-83d7-c683495a18c5	0093-7113	HUMAN PRESCRIPTION DRUG	Nefazodone Hydrochloride		Nefazodone Hydrochloride	TABLET	ORAL	20030916		ANDA	ANDA076037	Teva Pharmaceuticals USA, Inc.	NEFAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0093-7163_52c595f5-a265-479b-a7bb-086703e2bbe7	0093-7163	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20170320		ANDA	ANDA079141	Teva Pharmaceuticals USA, Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0093-7164_52c595f5-a265-479b-a7bb-086703e2bbe7	0093-7164	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20170320		ANDA	ANDA079141	Teva Pharmaceuticals USA, Inc.	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0093-7165_08a4ffbf-1efc-4eaa-b2a2-a8f82cf3dd7b	0093-7165	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210	20240531	ANDA	ANDA076898	Teva Pharmaceuticals USA, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0093-7166_08a4ffbf-1efc-4eaa-b2a2-a8f82cf3dd7b	0093-7166	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210	20240229	ANDA	ANDA076898	Teva Pharmaceuticals USA, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0093-7170_08a4ffbf-1efc-4eaa-b2a2-a8f82cf3dd7b	0093-7170	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210	20240229	ANDA	ANDA076898	Teva Pharmaceuticals USA, Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0093-7172_e96eb1a8-49e6-40e3-8e3f-66977e80e92d	0093-7172	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000811		ANDA	ANDA075665	Teva Pharmaceuticals USA, Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-7178_810dfc46-2484-4215-83d7-c683495a18c5	0093-7178	HUMAN PRESCRIPTION DRUG	Nefazodone Hydrochloride		Nefazodone Hydrochloride	TABLET	ORAL	20030916		ANDA	ANDA076037	Teva Pharmaceuticals USA, Inc.	NEFAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0093-7198_41c1f88a-2a67-4130-830c-a3b1bf7aaf9a	0093-7198	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020130		ANDA	ANDA075452	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0093-7201_00373263-a90a-474c-afe1-e515eb4b72bc	0093-7201	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20060425		ANDA	ANDA076056	Teva Pharmaceuticals USA, Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0093-7202_00373263-a90a-474c-afe1-e515eb4b72bc	0093-7202	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20060425		ANDA	ANDA076056	Teva Pharmaceuticals USA, Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0093-7270_007743d1-588c-48df-b887-77a17b784543	0093-7270	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20080929	20240930	ANDA	ANDA077793	Teva Pharmaceuticals USA, Inc.	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
0093-7271_b5d757a4-7f61-4f9d-bd2a-0ebf9892398d	0093-7271	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20150204		ANDA	ANDA077210	Teva Pharmaceuticals USA, Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0093-7272_b5d757a4-7f61-4f9d-bd2a-0ebf9892398d	0093-7272	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20150204		ANDA	ANDA077210	Teva Pharmaceuticals USA, Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0093-7273_b5d757a4-7f61-4f9d-bd2a-0ebf9892398d	0093-7273	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20150522		ANDA	ANDA077210	Teva Pharmaceuticals USA, Inc.	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0093-7290_3641edbc-4bae-45d0-8afb-8db02f401f66	0093-7290	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20140328		ANDA	ANDA078193	Teva Pharmaceuticals USA, Inc.	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0093-7295_a369c0d5-8f93-4b0d-a5a0-8125af1309f7	0093-7295	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	Teva Pharmaceuticals USA, Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0093-7296_a369c0d5-8f93-4b0d-a5a0-8125af1309f7	0093-7296	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	Teva Pharmaceuticals USA, Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0093-7314_a9df5ba4-ab12-4f72-9264-a1f7f377e35b	0093-7314	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076999	Teva Pharmaceuticals USA, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0093-7334_144c0ffe-87ed-4c7e-bb7d-33e7008824db	0093-7334	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	CAPSULE	ORAL	20090506		ANDA	ANDA065491	Teva Pharmaceuticals USA, Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0093-7335_b71cda01-3219-4ac8-bc31-b5880fa61aad	0093-7335	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, COATED PELLETS	ORAL	20090417		ANDA	ANDA076575	Teva Pharmaceuticals USA, Inc.	TOPIRAMATE	15	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0093-7336_b71cda01-3219-4ac8-bc31-b5880fa61aad	0093-7336	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, COATED PELLETS	ORAL	20090417		ANDA	ANDA076575	Teva Pharmaceuticals USA, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0093-7350_cff4a734-b698-4be2-88f2-058914575919	0093-7350	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20091111		ANDA	ANDA077255	Teva Pharmaceuticals USA, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0093-7351_cff4a734-b698-4be2-88f2-058914575919	0093-7351	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20091111		ANDA	ANDA077255	Teva Pharmaceuticals USA, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0093-7352_ffd12b6d-fd6c-43df-9c30-e72ead74a903	0093-7352	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20160825		ANDA	ANDA075765	Teva Pharmaceuticals USA, Inc.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
0093-7353_ffd12b6d-fd6c-43df-9c30-e72ead74a903	0093-7353	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20160701		ANDA	ANDA075765	Teva Pharmaceuticals USA, Inc.	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
0093-7355_e0e9be8c-8610-4630-8676-8b2ab8d7ee3a	0093-7355	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20061215		ANDA	ANDA076511	Teva Pharmaceuticals USA, Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
0093-7367_0d21d46e-4738-4ac5-a2e0-36f8f6287743	0093-7367	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100406		ANDA	ANDA077157	Teva Pharmaceuticals USA, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-7368_0d21d46e-4738-4ac5-a2e0-36f8f6287743	0093-7368	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100406		ANDA	ANDA077157	Teva Pharmaceuticals USA, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-7369_0d21d46e-4738-4ac5-a2e0-36f8f6287743	0093-7369	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100406		ANDA	ANDA077157	Teva Pharmaceuticals USA, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-7384_79d62d73-0002-4826-8ef3-d9872d14aa4c	0093-7384	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-7385_79d62d73-0002-4826-8ef3-d9872d14aa4c	0093-7385	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-7386_79d62d73-0002-4826-8ef3-d9872d14aa4c	0093-7386	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-7387_4629423b-1b57-457c-8ae8-a8818389170b	0093-7387	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20140219		ANDA	ANDA077437	Teva Pharmaceuticals USA, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0093-7442_d188d01d-b6d2-4281-b7c3-2fc3479a5288	0093-7442	HUMAN PRESCRIPTION DRUG	Fluvastatin		Fluvastatin	CAPSULE	ORAL	20120705		ANDA	ANDA078407	Teva Pharmaceuticals USA, Inc.	FLUVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-7443_d188d01d-b6d2-4281-b7c3-2fc3479a5288	0093-7443	HUMAN PRESCRIPTION DRUG	Fluvastatin		Fluvastatin	CAPSULE	ORAL	20120705		ANDA	ANDA078407	Teva Pharmaceuticals USA, Inc.	FLUVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-7446_a962cd67-2b8a-4d30-aa2b-1ce0b2307346	0093-7446	HUMAN PRESCRIPTION DRUG	Fluvastatin Sodium		Fluvastatin Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160602		ANDA	ANDA079011	Teva Pharmaceuticals USA, Inc.	FLUVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0093-7455_50580ebe-be6b-439b-a39d-6536b9125fc1	0093-7455	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20051028		ANDA	ANDA077270	Teva Pharmaceuticals USA, Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-7456_50580ebe-be6b-439b-a39d-6536b9125fc1	0093-7456	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20051028		ANDA	ANDA077270	Teva Pharmaceuticals USA, Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-7457_50580ebe-be6b-439b-a39d-6536b9125fc1	0093-7457	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20051028		ANDA	ANDA077270	Teva Pharmaceuticals USA, Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-7471_63dc74cd-a3d8-496c-8a3d-ed686a4b4e14	0093-7471	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20130212		ANDA	ANDA077263	Teva Pharmaceuticals USA, Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0093-7472_63dc74cd-a3d8-496c-8a3d-ed686a4b4e14	0093-7472	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20130212		ANDA	ANDA077263	Teva Pharmaceuticals USA, Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0093-7473_a37697f4-c9a0-4309-a304-bf69c51d51b5	0093-7473	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20140307		ANDA	ANDA091649	Teva Pharmaceuticals USA, Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0093-7474_a37697f4-c9a0-4309-a304-bf69c51d51b5	0093-7474	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20140307		ANDA	ANDA091649	Teva Pharmaceuticals USA, Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0093-7516_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b	0093-7516	HUMAN PRESCRIPTION DRUG	fluticasone propionate and salmeterol		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20220323		ANDA	ANDA213948	Teva Pharmaceuticals USA, Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	500; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-7517_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b	0093-7517	HUMAN PRESCRIPTION DRUG	fluticasone propionate and salmeterol		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20220323		ANDA	ANDA213948	Teva Pharmaceuticals USA, Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	100; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-7518_2c0a7e7d-224f-4fd8-abf1-05f65fb12f5b	0093-7518	HUMAN PRESCRIPTION DRUG	fluticasone propionate and salmeterol		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20220323		ANDA	ANDA213948	Teva Pharmaceuticals USA, Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0093-7536_fa4a2a48-f3e9-4102-9f46-396b8e6f9535	0093-7536	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, FILM COATED	ORAL	20100628		ANDA	ANDA078058	Teva Pharmaceuticals USA, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
0093-7620_df8747c3-d774-467b-a861-6430ac1d568a	0093-7620	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole	TABLET, FILM COATED	ORAL	20110603		ANDA	ANDA090289	Teva Pharmaceuticals USA, Inc.	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
0093-7629_0f0cb35d-1de1-4031-bfbf-5773fe33ebbe	0093-7629	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA204285	Teva Pharmaceuticals USA, Inc.	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0093-7630_0f0cb35d-1de1-4031-bfbf-5773fe33ebbe	0093-7630	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA204285	Teva Pharmaceuticals USA, Inc.	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0093-7652_1e8c8eb3-da00-4bb0-b086-fefea38d2c58	0093-7652	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA091347	Teva Pharmaceuticals USA, Inc.	VARDENAFIL HYDROCHLORIDE	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-7653_1e8c8eb3-da00-4bb0-b086-fefea38d2c58	0093-7653	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA091347	Teva Pharmaceuticals USA, Inc.	VARDENAFIL HYDROCHLORIDE	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-7654_1e8c8eb3-da00-4bb0-b086-fefea38d2c58	0093-7654	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA091347	Teva Pharmaceuticals USA, Inc.	VARDENAFIL HYDROCHLORIDE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-7655_1e8c8eb3-da00-4bb0-b086-fefea38d2c58	0093-7655	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA091347	Teva Pharmaceuticals USA, Inc.	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0093-7662_4368f7b2-5bdb-4232-90b0-f6a769d71e9b	0093-7662	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20211208		ANDA	ANDA091059	Teva Pharmaceuticals USA, Inc.	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0093-7663_4368f7b2-5bdb-4232-90b0-f6a769d71e9b	0093-7663	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20190509		ANDA	ANDA091059	Teva Pharmaceuticals USA, Inc.	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0093-7664_4368f7b2-5bdb-4232-90b0-f6a769d71e9b	0093-7664	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20190509		ANDA	ANDA091059	Teva Pharmaceuticals USA, Inc.	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0093-7679_9d64a739-ee53-45dd-a534-89d933d08083	0093-7679	HUMAN PRESCRIPTION DRUG	Etonogestrel and Ethinyl Estradiol		Etonogestrel and Ethinyl Estradiol	INSERT, EXTENDED RELEASE	VAGINAL	20210119		ANDA	ANDA204305	Teva Pharmaceuticals USA, Inc.	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0093-7701_97f5e962-56ab-48e7-8b59-c38a44a5ada4	0093-7701	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20110906		ANDA	ANDA090199	Teva Pharmaceuticals USA, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0093-7704_639d6ae5-53c6-4b8c-88f0-dccdf9ddb526	0093-7704	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210120		ANDA	ANDA090894	Teva Pharmaceuticals USA, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
0093-7766_6595b273-ae65-4945-898d-f4c0d06991e5	0093-7766	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200610		ANDA	ANDA210050	Teva Pharmaceuticals USA, Inc.	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0093-7767_6595b273-ae65-4945-898d-f4c0d06991e5	0093-7767	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200610		ANDA	ANDA210050	Teva Pharmaceuticals USA, Inc.	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0093-7768_6595b273-ae65-4945-898d-f4c0d06991e5	0093-7768	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20200610		ANDA	ANDA210050	Teva Pharmaceuticals USA, Inc.	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0093-7769_6595b273-ae65-4945-898d-f4c0d06991e5	0093-7769	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20231023		ANDA	ANDA210050	Teva Pharmaceuticals USA, Inc.	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0093-7771_56853f43-4961-40ff-a5e8-d99b505380a1	0093-7771	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20161128		ANDA	ANDA079215	Teva Pharmaceuticals USA, Inc.	RISEDRONATE SODIUM MONOHYDRATE	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0093-7865_841d104f-e7c9-470f-9887-2533302348e4	0093-7865	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	20151208		NDA AUTHORIZED GENERIC	NDA020747	Teva Pharmaceuticals USA, Inc.	FENTANYL CITRATE	200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0093-7866_841d104f-e7c9-470f-9887-2533302348e4	0093-7866	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	20151208		NDA AUTHORIZED GENERIC	NDA020747	Teva Pharmaceuticals USA, Inc.	FENTANYL CITRATE	400	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0093-7867_841d104f-e7c9-470f-9887-2533302348e4	0093-7867	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	20151208		NDA AUTHORIZED GENERIC	NDA020747	Teva Pharmaceuticals USA, Inc.	FENTANYL CITRATE	600	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0093-7868_841d104f-e7c9-470f-9887-2533302348e4	0093-7868	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	20151208		NDA AUTHORIZED GENERIC	NDA020747	Teva Pharmaceuticals USA, Inc.	FENTANYL CITRATE	800	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0093-7869_841d104f-e7c9-470f-9887-2533302348e4	0093-7869	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	20151208		NDA AUTHORIZED GENERIC	NDA020747	Teva Pharmaceuticals USA, Inc.	FENTANYL CITRATE	1200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0093-7870_841d104f-e7c9-470f-9887-2533302348e4	0093-7870	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	20151208		NDA AUTHORIZED GENERIC	NDA020747	Teva Pharmaceuticals USA, Inc.	FENTANYL CITRATE	1600	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0093-7909_af883118-9b27-4cab-9a53-9d85c480bb99	0093-7909	HUMAN PRESCRIPTION DRUG	Tiopronin		Tiopronin	TABLET, SUGAR COATED	ORAL	20210517		ANDA	ANDA214326	Teva Pharmaceuticals USA, Inc.	TIOPRONIN	100	mg/1	Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]		N	20241231
0093-8034_00e55b1b-81b5-4df1-8a6d-4d54ac403e76	0093-8034	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19990511		ANDA	ANDA074686	Teva Pharmaceuticals USA, Inc.	GLYBURIDE	1.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-8035_00e55b1b-81b5-4df1-8a6d-4d54ac403e76	0093-8035	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19990511		ANDA	ANDA074686	Teva Pharmaceuticals USA, Inc.	GLYBURIDE	3	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-8036_00e55b1b-81b5-4df1-8a6d-4d54ac403e76	0093-8036	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19990512		ANDA	ANDA074686	Teva Pharmaceuticals USA, Inc.	GLYBURIDE	6	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-8072_774a4b2f-e96b-4d6a-a9ff-122279d46b6f	0093-8072	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20180309		NDA AUTHORIZED GENERIC	NDA020646	Teva Pharmaceuticals USA, Inc.	TIAGABINE HYDROCHLORIDE	12	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0093-8073_1c348c6c-a19b-4034-b3c5-f452fb80e140	0093-8073	HUMAN PRESCRIPTION DRUG	Kelnor 1/50		Ethynodiol Diacetate and Ethinyl Estradiol	KIT		20180301		ANDA	ANDA072723	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-8076_774a4b2f-e96b-4d6a-a9ff-122279d46b6f	0093-8076	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20180309		NDA AUTHORIZED GENERIC	NDA020646	Teva Pharmaceuticals USA, Inc.	TIAGABINE HYDROCHLORIDE	16	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0093-8107_103e496e-b449-4f27-800f-5059465f774a	0093-8107	HUMAN PRESCRIPTION DRUG	Ibuprofen and famotidine		Ibuprofen and famotidine	TABLET, FILM COATED	ORAL	20211215		ANDA	ANDA211278	Teva Pharmaceuticals USA, Inc.	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-8117_ce3075f6-1bcc-4cfa-a996-555cb87529ff	0093-8117	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077487	Teva Pharmaceuticals USA, Inc.	FAMCICLOVIR	125	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0093-8118_ce3075f6-1bcc-4cfa-a996-555cb87529ff	0093-8118	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077487	Teva Pharmaceuticals USA, Inc.	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0093-8119_ce3075f6-1bcc-4cfa-a996-555cb87529ff	0093-8119	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077487	Teva Pharmaceuticals USA, Inc.	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0093-8162_c6af23d2-0b74-49fd-8c04-549988b0eb23	0093-8162	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	Teva Pharmaceuticals USA, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-8163_c6af23d2-0b74-49fd-8c04-549988b0eb23	0093-8163	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	Teva Pharmaceuticals USA, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-8164_c6af23d2-0b74-49fd-8c04-549988b0eb23	0093-8164	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	Teva Pharmaceuticals USA, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-8165_c6af23d2-0b74-49fd-8c04-549988b0eb23	0093-8165	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	Teva Pharmaceuticals USA, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-8166_c6af23d2-0b74-49fd-8c04-549988b0eb23	0093-8166	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	Teva Pharmaceuticals USA, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0093-8180_bfd7c5ac-8914-4e26-a6f6-aa0c0462b1ca	0093-8180	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20190710		ANDA	ANDA211125	Teva Pharmaceuticals USA, Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0093-8192_e1f40596-aa5b-46a4-b2aa-add1150ac3a1	0093-8192	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20031124		ANDA	ANDA074151	Teva Pharmaceuticals USA, Inc.	CIMETIDINE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0093-8199_6e0b6eab-b0e5-4ef9-9e65-e28159258c67	0093-8199	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20211222		ANDA	ANDA213803	Teva Pharmaceuticals USA, Inc.	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0093-8204_e1f40596-aa5b-46a4-b2aa-add1150ac3a1	0093-8204	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20040202		ANDA	ANDA074151	Teva Pharmaceuticals USA, Inc.	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0093-8210_0beb6d3b-285e-41c8-86e3-eb1d14c83ffc	0093-8210	HUMAN PRESCRIPTION DRUG	Finzala		norethindrone acetate and ethinyl estradiol and ferrous fumarate	KIT		20220804		ANDA	ANDA210087	Teva Pharmaceuticals USA, Inc.						N	20241231
0093-8224_6e0b6eab-b0e5-4ef9-9e65-e28159258c67	0093-8224	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20211222		ANDA	ANDA213803	Teva Pharmaceuticals USA, Inc.	SUNITINIB MALATE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0093-8229_6e0b6eab-b0e5-4ef9-9e65-e28159258c67	0093-8229	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20211222		ANDA	ANDA213803	Teva Pharmaceuticals USA, Inc.	SUNITINIB MALATE	37.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0093-8231_6e0b6eab-b0e5-4ef9-9e65-e28159258c67	0093-8231	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20211222		ANDA	ANDA213803	Teva Pharmaceuticals USA, Inc.	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0093-8232_8413c0d9-41db-4717-8738-883964e26856	0093-8232	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130827		ANDA	ANDA077369	Teva Pharmaceuticals USA, Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-8238_8413c0d9-41db-4717-8738-883964e26856	0093-8238	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130124		ANDA	ANDA077369	Teva Pharmaceuticals USA, Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0093-8305_e1f40596-aa5b-46a4-b2aa-add1150ac3a1	0093-8305	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20031206		ANDA	ANDA074463	Teva Pharmaceuticals USA, Inc.	CIMETIDINE	800	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0093-8310_6b8e7aca-1ec4-445a-ac2e-87cfef15c6f4	0093-8310	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		Eletriptan Hydrobromide	TABLET, FILM COATED	ORAL	20170721		ANDA	ANDA202040	Teva Pharmaceuticals USA, Inc.	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0093-8311_6b8e7aca-1ec4-445a-ac2e-87cfef15c6f4	0093-8311	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		Eletriptan Hydrobromide	TABLET, FILM COATED	ORAL	20170721		ANDA	ANDA202040	Teva Pharmaceuticals USA, Inc.	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0093-8342_f4b5b433-1b6e-4af2-9d16-7194c2da041c	0093-8342	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19950830		ANDA	ANDA074388	Teva Pharmaceuticals USA, Inc.	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-8343_f4b5b433-1b6e-4af2-9d16-7194c2da041c	0093-8343	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19950830		ANDA	ANDA074388	Teva Pharmaceuticals USA, Inc.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-8344_f4b5b433-1b6e-4af2-9d16-7194c2da041c	0093-8344	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19950830		ANDA	ANDA074388	Teva Pharmaceuticals USA, Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-8675_b016bfaa-793c-49f9-bba1-67b9bb3f6ff2	0093-8675	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20040923		ANDA	ANDA065162	Teva Pharmaceuticals USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0093-8739_e7a9997c-4cf7-4cf1-94c0-ff60f15ae0f9	0093-8739	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	19950605		ANDA	ANDA074377	Teva Pharmaceuticals USA, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
0093-8740_e7a9997c-4cf7-4cf1-94c0-ff60f15ae0f9	0093-8740	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	19950605		ANDA	ANDA074377	Teva Pharmaceuticals USA, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
0093-8741_e7a9997c-4cf7-4cf1-94c0-ff60f15ae0f9	0093-8741	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	19950605		ANDA	ANDA074377	Teva Pharmaceuticals USA, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
0093-9018_0d006301-5ba4-46a1-a767-fbaa2a94bb75	0093-9018	HUMAN PRESCRIPTION DRUG	Cyclosporine	Modified	Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20210608		ANDA	ANDA065110	Teva Pharmaceuticals USA, Inc.	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0093-9019_0d006301-5ba4-46a1-a767-fbaa2a94bb75	0093-9019	HUMAN PRESCRIPTION DRUG	Cyclosporine	Modified	Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20210608		ANDA	ANDA065110	Teva Pharmaceuticals USA, Inc.	CYCLOSPORINE	50	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0093-9020_0d006301-5ba4-46a1-a767-fbaa2a94bb75	0093-9020	HUMAN PRESCRIPTION DRUG	Cyclosporine	Modified	Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20210608		ANDA	ANDA065110	Teva Pharmaceuticals USA, Inc.	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0093-9147_da23a2ab-f20e-4208-b72b-d50260b97923	0093-9147	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20060804		ANDA	ANDA076690	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-9148_da23a2ab-f20e-4208-b72b-d50260b97923	0093-9148	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20060804		ANDA	ANDA076690	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-9149_da23a2ab-f20e-4208-b72b-d50260b97923	0093-9149	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20060804		ANDA	ANDA076690	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-9157_da23a2ab-f20e-4208-b72b-d50260b97923	0093-9157	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20060804		ANDA	ANDA076690	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-9163_da23a2ab-f20e-4208-b72b-d50260b97923	0093-9163	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20060804		ANDA	ANDA076690	Teva Pharmaceuticals USA, Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0093-9219_9acda865-2177-4cdc-a314-75454c101c34	0093-9219	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE	ORAL	20200928	20240430	NDA AUTHORIZED GENERIC	NDA204063	TEVA PHARMACEUTICALS USA, INC.	DIMETHYL FUMARATE	240	mg/1			N	
0093-9222_1c3fbf36-5c3e-4b8c-8360-18135c230756	0093-9222	HUMAN PRESCRIPTION DRUG	Diflunisal		Diflunisal	TABLET, FILM COATED	ORAL	20210630		ANDA	ANDA073673	Teva Pharmaceuticals USA, Inc.	DIFLUNISAL	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0093-9224_0ce3f59e-e447-81a0-e063-6394a90ab0c3	0093-9224	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20210105		NDA AUTHORIZED GENERIC	NDA022301	Teva Pharmaceuticals USA, Inc.	MESALAMINE	375	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0093-9290_6ea2adb9-cbef-4571-9623-62c31394a162	0093-9290	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20220302		ANDA	ANDA077194	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-9291_6ea2adb9-cbef-4571-9623-62c31394a162	0093-9291	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20220302		ANDA	ANDA077194	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-9292_6ea2adb9-cbef-4571-9623-62c31394a162	0093-9292	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20220302		ANDA	ANDA077194	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-9293_6ea2adb9-cbef-4571-9623-62c31394a162	0093-9293	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20211122		ANDA	ANDA077194	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-9294_6ea2adb9-cbef-4571-9623-62c31394a162	0093-9294	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20220302		ANDA	ANDA077194	Teva Pharmaceuticals USA, Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0093-9364_84b83205-8813-494e-933e-a70697393744	0093-9364	HUMAN PRESCRIPTION DRUG	Glyburide		glyburide	TABLET	ORAL	19840501		NDA AUTHORIZED GENERIC	NDA017532	TEVA Pharmaceuticals USA Inc	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-9433_84b83205-8813-494e-933e-a70697393744	0093-9433	HUMAN PRESCRIPTION DRUG	Glyburide		glyburide	TABLET	ORAL	19840501		NDA AUTHORIZED GENERIC	NDA017532	TEVA Pharmaceuticals USA Inc	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-9477_84b83205-8813-494e-933e-a70697393744	0093-9477	HUMAN PRESCRIPTION DRUG	Glyburide		glyburide	TABLET	ORAL	19840501		NDA AUTHORIZED GENERIC	NDA017532	TEVA Pharmaceuticals USA Inc	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0093-9609_7d22a419-3d33-492c-b054-fb29a82ce643	0093-9609	HUMAN PRESCRIPTION DRUG	doxepin hydrochloride		doxepin hydrochloride	CREAM	TOPICAL	20230217		ANDA	ANDA215408	Teva Pharmaceuticals USA, Inc.	DOXEPIN HYDROCHLORIDE	50	mg/g	Tricyclic Antidepressant [EPC]		N	20241231
0093-9614_a661664e-57a8-4ef1-aa70-fa08e1c32a68	0093-9614	HUMAN PRESCRIPTION DRUG	Silver Nitrate		Silver Nitrate	SOLUTION	TOPICAL	19910101		UNAPPROVED DRUG OTHER		Teva Pharmaceuticals USA, Inc.	SILVER NITRATE	.005	g/mL			N	20241231
0093-9701_6989f93b-c2be-4026-89b3-5cb7c4a77b73	0093-9701	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20220118		ANDA	ANDA074260	Teva Pharmaceuticals USA, Inc.	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0093-9702_6989f93b-c2be-4026-89b3-5cb7c4a77b73	0093-9702	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20220118		ANDA	ANDA074260	Teva Pharmaceuticals USA, Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0093-9703_6989f93b-c2be-4026-89b3-5cb7c4a77b73	0093-9703	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20231215		ANDA	ANDA074260	Teva Pharmaceuticals USA, Inc.	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0095-3000_16609ec3-578a-4f92-83d4-85d58e23cd8d	0095-3000	HUMAN PRESCRIPTION DRUG	BUPAP		Butalbital and Acetaminophen Tablets	TABLET	ORAL	20130624		ANDA	ANDA090956	Bausch Health US, LLC	ACETAMINOPHEN; BUTALBITAL	300; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]		N	20241231
0096-0682_0cf9320b-27a0-70cd-e063-6394a90afa36	0096-0682	HUMAN OTC DRUG	Solbar Shield SPF40		Solbar Shield SPF40	CREAM	TOPICAL	19960601		OTC MONOGRAPH DRUG	M020	Person and Covey	TITANIUM DIOXIDE; ZINC OXIDE	.05; .075	g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20251231
0096-0685_0cf911a3-41f8-1dfe-e063-6294a90af393	0096-0685	HUMAN OTC DRUG	Solbar Thirty SPF 30		Solbar Thirty SPF30	CREAM	TOPICAL	19960601		OTC MONOGRAPH DRUG	M019	Person and Covey	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	.03; .12; .075; .015; .06	g/g; g/g; g/g; g/g; g/g			N	20251231
0096-0687_0cf91b40-9e49-6a45-e063-6394a90a73ae	0096-0687	HUMAN OTC DRUG	Solbar Avo SPF35		Solbar Avo SPF35	CREAM	TOPICAL	19960601		OTC MONOGRAPH DRUG	M020	Person and Covey	AVOBENZONE; HOMOSALATE; OCTINOXATE; OXYBENZONE	.03; .08; .075; .06	g/g; g/g; g/g; g/g			N	20251231
0096-0688_0cf901e1-366c-5d21-e063-6394a90af9af	0096-0688	HUMAN OTC DRUG	Solbar Zinc SPF38		Solbar Zinc SPF38	CREAM	TOPICAL	19960601		OTC MONOGRAPH DRUG	M020	Person and Covey	HOMOSALATE; OCTINOXATE; ZINC OXIDE	.1015; .077; .077	g/g; g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20251231
0096-0709_0cf901e1-366d-5d21-e063-6394a90af9af	0096-0709	HUMAN OTC DRUG	Xerac AC		Xerac AC	LIQUID	TOPICAL	19960601		OTC MONOGRAPH DRUG	M019	Person and Covey	ALUMINUM CHLORIDE	.0625	g/g			N	20251231
0096-0732_0cf91b03-89d7-7bd3-e063-6294a90a7fab	0096-0732	HUMAN OTC DRUG	Aquanil HC		Hydrocortisone	LOTION	TOPICAL	19950108		OTC MONOGRAPH DRUG	M015	Person and Covey	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0096-0736_0cf911a3-41f5-1dfe-e063-6294a90af393	0096-0736	HUMAN OTC DRUG	DHS tar gel		coal tar	SHAMPOO	TOPICAL	19960601		OTC MONOGRAPH DRUG	M032	Person and Covey	COAL TAR	.005	g/g			N	20251231
0096-0737_0cf935fd-4db0-8458-e063-6394a90a1c9f	0096-0737	HUMAN OTC DRUG	DHS TAR		coal tar	SHAMPOO	TOPICAL	19950601		OTC MONOGRAPH DRUG	M032	Person and Covey	COAL TAR	.005	g/g			N	20251231
0096-0738_0cf8f06a-cdad-5117-e063-6294a90a4dd1	0096-0738	HUMAN OTC DRUG	DHS SAL	4 oz.	DHS SAL	SHAMPOO	TOPICAL	19950601		OTC MONOGRAPH DRUG	M032	Person and Covey	SALICYLIC ACID	.035	g/g			N	20251231
0096-0741_0cf911a3-41f9-1dfe-e063-6294a90af393	0096-0741	HUMAN OTC DRUG	Solbar Fifty SPF50		Solbar Fifty SPF50	CREAM	TOPICAL	19960601		OTC MONOGRAPH DRUG	M020	Person and Covey	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	.011; .08; .1; .06	g/g; g/g; g/g; g/g			N	20251231
0113-0019_21fad873-3e4b-47ee-98d9-85f964bb9293	0113-0019	HUMAN OTC DRUG	Good Sense Severe NightTime		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20151021		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0020_fe2d2ffa-f511-4451-8911-4e1102c25ccc	0113-0020	HUMAN OTC DRUG	good sense childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20140320		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-0022_8a4c54d0-c24b-4e16-8a7b-67a3a0e3b727	0113-0022	HUMAN OTC DRUG	Good Sense Heartburn Relief		Cimetidine	TABLET, FILM COATED	ORAL	20021230		ANDA	ANDA075285	L. Perrigo Company	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0113-0023_9bf3f9f1-7ea0-498f-a0f9-9a2bf417356f	0113-0023	HUMAN OTC DRUG	good sense multi symptom flu and severe cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20161026		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0025_d27c221a-b40f-48d2-9de5-8575e18a5fcf	0113-0025	HUMAN OTC DRUG	Good Sense Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20151006		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-0028_92f51d8e-95ec-4777-aa82-dddbe5913c3c	0113-0028	HUMAN OTC DRUG	Good Sense 24 hour allergy nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160803		ANDA	ANDA207957	L. Perrigo Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-0029_078ff3ce-56ed-447f-a0fe-691a1cb96ba9	0113-0029	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050506		ANDA	ANDA076775	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0032_3668ac3e-d4be-493f-8f89-913ce34e0b54	0113-0032	HUMAN OTC DRUG	Good Sense Dual Action Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160106		ANDA	ANDA077355	L. Perrigo Company	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0113-0044_694143e8-301e-4825-91e7-716d1f9b3a14	0113-0044	HUMAN OTC DRUG	Good Sense Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170509	20240229	ANDA	ANDA075077	L. Perrigo Company	ACETAMINOPHEN	650	mg/1			N	
0113-0050_2ed7ed71-cbee-4272-8cab-e8e37153cbdc	0113-0050	HUMAN OTC DRUG	good sense ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20090305		ANDA	ANDA079113	L. Perrigo Company	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
0113-0052_e2346394-7edc-4922-89c5-6c9da56a8fec	0113-0052	HUMAN OTC DRUG	good sense sleep time		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20140206		OTC MONOGRAPH FINAL	part338	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0053_902860bf-7d0f-433b-95ea-fae6e953ab07	0113-0053	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170427		ANDA	ANDA206393	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0054_84b4baca-65a7-488d-ae42-8e4a03c04c58	0113-0054	HUMAN OTC DRUG	Good Sense Suphedrine	12 Hour	Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19991029		ANDA	ANDA075153	L. Perrigo Company	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0113-0056_63cddeaa-828c-442a-8f2a-91ce264126b2	0113-0056	HUMAN OTC DRUG	good sense night time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20140530		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0057_13cdf9f9-e7f0-4dbb-bd4e-7aac8d42292f	0113-0057	HUMAN OTC DRUG	Good Sense ibuprofen	infants	ibuprofen	SUSPENSION	ORAL	20000208		ANDA	ANDA075217	L. Perrigo Company	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0058_6916a481-6168-4c6f-8889-d8a207ce9d97	0113-0058	HUMAN OTC DRUG	Good Sense Omeprazole and Sodium Bicarbonate		Omeprazole, sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20170619		ANDA	ANDA201361	L. Perrigo Company	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-0061_ccbca601-b066-4332-8c93-cf3b00677365	0113-0061	HUMAN OTC DRUG	good sense tussin	mucus and chest congestion	Guaifenesin	SOLUTION	ORAL	19910115		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	GUAIFENESIN	200	mg/10mL			N	20241231
0113-0065_57806eef-5444-4241-ac28-3686d77ed637	0113-0065	HUMAN OTC DRUG	good sense nasal		Oxymetazoline HCl	SPRAY	NASAL	19940323		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0113-0074_673e46ce-81b7-4b19-a5fc-d3a05df97570	0113-0074	HUMAN OTC DRUG	Good Sense ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060310		ANDA	ANDA077349	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0081_717043cd-4457-4064-bb1b-2f2e64a2b461	0113-0081	HUMAN OTC DRUG	Good Sense Miconazole 3		Miconazole nitrate	KIT		20070402		ANDA	ANDA075329	L. Perrigo Company						N	20241231
0113-0084_c81ea0cc-2cdf-43f0-b6d2-3a3fe9b66b41	0113-0084	HUMAN OTC DRUG	Good Sense First Aid Antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20140428		OTC MONOGRAPH FINAL	part333B	L. Perrigo Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0113-0087_2969e412-6861-4d8e-bc16-b48bebf9ecec	0113-0087	HUMAN OTC DRUG	good sense anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181011		ANDA	ANDA209837	L. Perrigo Company	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
0113-0094_35fa9514-4f7e-4d29-a8c7-c5404bf4d6cb	0113-0094	HUMAN OTC DRUG	Good Sense Nasal Decongestant PE		Phenylephrine Hydrochloride	TABLET	ORAL	20050621		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0096_ab05b903-d505-456c-a87d-d4a1cac3088f	0113-0096	HUMAN OTC DRUG	good sense flu and severe cold and cough	daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20110131		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0101_5f638cc1-870f-4577-b2ef-0bce61a2a9f3	0113-0101	HUMAN OTC DRUG	Good Sense complete Lice Treatment		Piperonyl butoxide, pyrethrum extract	KIT		20160607		OTC MONOGRAPH FINAL	part358G	L. Perrigo Company						N	20241231
0113-0108_52ad31cb-c734-482d-90b1-54ad118288da	0113-0108	HUMAN OTC DRUG	Good Sense complete lice treatment kit		piperonyl butoxide, pyrethrum extract	KIT		20181120		OTC MONOGRAPH FINAL	part358G	L. Perrigo Company						N	20241231
0113-0112_df446886-2749-40b2-936c-698d7557cb76	0113-0112	HUMAN OTC DRUG	good sense nausea relief		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20141103		UNAPPROVED DRUG OTHER		L. Perrigo Company	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
0113-0116_f0a7cb93-46a4-412c-97e5-e66306eacdd6	0113-0116	HUMAN OTC DRUG	Good Sense Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20171128		NDA	NDA208025	L. Perrigo Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-0117_ab82ad1c-efcf-49f1-a225-63ced226528a	0113-0117	HUMAN OTC DRUG	Good Sense lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120524		ANDA	ANDA202319	L. Perrigo Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-0141_e61dbd67-a07d-46f5-90d8-0f4e56f2fa21	0113-0141	HUMAN OTC DRUG	good sense acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20091023		ANDA	ANDA075400	L. Perrigo Company	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0113-0147_c7154370-5d91-4dc4-90ed-1d07d9bc5943	0113-0147	HUMAN OTC DRUG	good sense all day allergy d		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201227		ANDA	ANDA210719	L. Perrigo Company	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0113-0161_b2ce8230-64a6-44d7-9866-95aad482299d	0113-0161	HUMAN OTC DRUG	Good Sense pain and fever		Acetaminophen	SUSPENSION	ORAL	20110921		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-0166_b7c7422f-ba00-4bb2-9b75-546d996a1785	0113-0166	HUMAN OTC DRUG	good sense ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20020504		ANDA	ANDA074937	L. Perrigo Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0170_dbbd9626-db04-4e8c-98c7-0cebbfb84c9d	0113-0170	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050506		ANDA	ANDA076789	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0186_2776f989-4118-4821-8dc1-0c35229294eb	0113-0186	HUMAN OTC DRUG	Good Sense Sleep Time		Diphenhydramine HCl	SOLUTION	ORAL	20130702		OTC MONOGRAPH FINAL	part338	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0188_217aa2e7-e2d3-443c-a173-228531846015	0113-0188	HUMAN OTC DRUG	Good Sense Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20131121		OTC MONOGRAPH FINAL	part346	L. Perrigo Company	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0189_462af1fb-e9bf-4e5f-a02e-df0399519a03	0113-0189	HUMAN OTC DRUG	Good Sense Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20140103		ANDA	ANDA204226	L. Perrigo Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0194_36010138-bad1-4eac-9a9f-05f629532ab9	0113-0194	HUMAN OTC DRUG	Good Sense Acid Reducer		Famotidine	TABLET, FILM COATED	ORAL	20070316		ANDA	ANDA077351	L. Perrigo Company	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0113-0206_4a2c1d77-3383-40df-9397-da3187e7b679	0113-0206	HUMAN OTC DRUG	good sense nicotine	mint	Nicotine Polacrilex	GUM, CHEWING	ORAL	19910415		ANDA	ANDA078325	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0212_5fe8820b-f08e-4584-ba6a-247e8372885d	0113-0212	HUMAN OTC DRUG	Good Sense Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	19930225		OTC MONOGRAPH DRUG	M013	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-0214_94cc97a6-7075-4e80-86de-71b32d366186	0113-0214	HUMAN OTC DRUG	Good Sense Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	19990730		ANDA	ANDA074760	L Perrigo Company	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0113-0224_db104321-d5d0-4e02-a542-f604bd486ba4	0113-0224	HUMAN OTC DRUG	Good Sense anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030225		ANDA	ANDA075232	L. Perrigo Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0113-0227_d1d3295c-be50-472d-b5e5-4157c9c422a5	0113-0227	HUMAN OTC DRUG	Good Sense Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20060213		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-0241_0b482364-a00a-4b95-975a-f403a3ae4d2e	0113-0241	HUMAN OTC DRUG	good sense levocetirizine		levocetirizine dihydrochloride	TABLET, FILM COATED	ORAL	20200911		ANDA	ANDA211983	L. Perrigo Company	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0274_bb21f974-49a0-49f1-b673-d3369831f488	0113-0274	HUMAN OTC DRUG	Good Sense aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19970808		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0113-0279_d0a3c9b6-0e55-4630-b76c-4b2de5e802f6	0113-0279	HUMAN OTC DRUG	Good Sense Hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140904		OTC MONOGRAPH FINAL	part346	L. Perrigo Company	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0285_7c10d357-5137-42f1-8abb-bd05ce9f9b9e	0113-0285	HUMAN OTC DRUG	Good Sense 24 hour allergy nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20171129		ANDA	ANDA207957	L. Perrigo Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-0296_a86a3699-a768-439e-90ef-fa49a4bddf5d	0113-0296	HUMAN OTC DRUG	good sense tussin	cf max	dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20130111		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0298_21e17c7f-2dae-4e91-97b1-f442488a720d	0113-0298	HUMAN OTC DRUG	good sense ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180220		ANDA	ANDA203599	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0304_3b8f4d52-14ec-4180-b431-aca505431b74	0113-0304	HUMAN OTC DRUG	Good Sense Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	19890915		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0113-0306_9c1c5c10-7fbd-4ec0-bfed-74fb474f8416	0113-0306	HUMAN OTC DRUG	Good Sense Clear Lax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	L. Perrigo Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0113-0323_c9d1ee54-8184-4ad7-a9f6-7936d2c2ddc0	0113-0323	HUMAN OTC DRUG	Good Sense Lubricating Plus		carboxymethylcellulose sodium	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20131111		OTC MONOGRAPH FINAL	part349	L. Perrigo Company	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
0113-0325_21d817c7-887b-4e6d-a22b-0a9dc15bc822	0113-0325	HUMAN OTC DRUG	Good Sense Mucus ER		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20170919		ANDA	ANDA091009	L. Perrigo Company	GUAIFENESIN	1200	mg/1			N	20241231
0113-0335_1f405688-3488-44d3-90a1-4436b8cbe3d3	0113-0335	HUMAN OTC DRUG	good sense night time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110819		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0344_dabc8be3-57d6-408d-83f6-b77b6f558b0d	0113-0344	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060725		ANDA	ANDA077007	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0359_e345de02-43e2-45f9-af6a-6085cd33ccbc	0113-0359	HUMAN OTC DRUG	good sense tussin dm		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19910918		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0374_caed078a-263c-49b9-8653-3c6aab20fefe	0113-0374	HUMAN OTC DRUG	good sense migraine formula		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020417		ANDA	ANDA075794	L. Perrigo Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0113-0379_466179f1-5a47-4402-95fc-bdb03c990209	0113-0379	HUMAN OTC DRUG	good sense allergy		Diphenhydramine HCl	SOLUTION	ORAL	19890915		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0384_dbc57b22-16cb-45b2-8f36-1fcc7c5a0093	0113-0384	HUMAN OTC DRUG	good sense cough dm		dextromethorphan polistirex	SUSPENSION	ORAL	20130201		ANDA	ANDA091135	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0388_244eff85-348f-42a5-a26e-aaaee89bfc69	0113-0388	HUMAN OTC DRUG	good sense nasal		Oxymetazoline HCl	SPRAY	NASAL	20020513		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0113-0401_ad24e53e-53b1-46e5-a135-1d35d6601ef0	0113-0401	HUMAN OTC DRUG	Zephrex D		pseudoephedrine hydrochloride	CAPSULE, GELATIN COATED	ORAL	20161104		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0113-0403_a6be230d-93ee-406b-8eba-b8dadf41e0f2	0113-0403	HUMAN OTC DRUG	good sense pain relief		Acetaminophen	TABLET	ORAL	19890815		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	325	mg/1			N	20241231
0113-0416_5631f047-211a-4f65-8d2c-5276adffc0d9	0113-0416	HUMAN OTC DRUG	good sense aspirin		Aspirin	TABLET, FILM COATED	ORAL	19910415		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0113-0419_0a2cee63-5cc7-452c-a183-1dd337e557cf	0113-0419	HUMAN OTC DRUG	Good Sense Childrens Mucus Relief Cough		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20071127		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0422_4a1988e4-44f8-4f67-b9c0-410f09e4a865	0113-0422	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050422		ANDA	ANDA078326	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0426_d8396310-fd7a-46be-b31c-41f0006605f2	0113-0426	HUMAN OTC DRUG	good sense tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20191022		ANDA	ANDA075915	L. Perrigo Company	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0113-0428_4bb9659c-b4d0-44f5-93e8-307fc4964351	0113-0428	HUMAN OTC DRUG	Good Sense Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	19990209		OTC MONOGRAPH FINAL	part332	L. Perrigo Company	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0113-0431_a20fd99d-d764-4152-a503-d5a4562a1196	0113-0431	HUMAN OTC DRUG	good sense nighttime sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20010425		OTC MONOGRAPH FINAL	part338	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0432_44b5fcf0-1cc1-48be-804b-b732482d5caa	0113-0432	HUMAN OTC DRUG	Good Sense Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19890915		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0113-0437_fb1e6733-84d0-491f-badb-974a5e720c19	0113-0437	HUMAN OTC DRUG	good sense pain relief pm	extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19920723		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0441_109a2834-9fdd-4e6e-bce9-5639acc6b3ed	0113-0441	HUMAN OTC DRUG	Good sense sleep aid		Doxylamine succinate	TABLET	ORAL	19970414		ANDA	ANDA040167	L. Perrigo Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0113-0443_164f6aaa-f280-4eeb-8837-606b8ff7283b	0113-0443	HUMAN OTC DRUG	Good Sense Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170209		ANDA	ANDA078104	L. Perrigo Company	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-0456_06546e70-d3e8-4e86-94d0-c19a899ad463	0113-0456	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20070307		ANDA	ANDA076777	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0459_11b498aa-3219-4a29-8dd4-62b6a3d294af	0113-0459	HUMAN OTC DRUG	good sense nighttime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110822		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0467_f975afad-02ce-4488-be1c-9c36ecf1d704	0113-0467	HUMAN OTC DRUG	good sense aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19921104		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0113-0471_ecd6d841-40b9-42c9-825d-d172cd04824d	0113-0471	HUMAN OTC DRUG	Good Sense Anti Itch		hydrocortisone	OINTMENT	TOPICAL	20210123		OTC MONOGRAPH NOT FINAL	part348	L. Perrigo Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-0479_5f3e3a49-a963-4b29-a1d1-7894d5ff9646	0113-0479	HUMAN OTC DRUG	good sense allergy relief		Diphenhydramine Hydrochloride	TABLET	ORAL	19910820		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0484_7688cfd4-2efa-4a56-8443-591e36ebc809	0113-0484	HUMAN OTC DRUG	Good Sense Pain Relief		Acetaminophen	TABLET	ORAL	19890915		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-0486_91c7df63-441e-4435-9e76-fa0521a48af4	0113-0486	HUMAN OTC DRUG	good sense stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	19911029		OTC MONOGRAPH NOT FINAL	part334	L. Perrigo Company	DOCUSATE SODIUM	100	mg/1			N	20241231
0113-0503_f3c1d41a-1538-4dca-912c-d7e787f48ff4	0113-0503	HUMAN OTC DRUG	Good Sense Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20160111		ANDA	ANDA204226	L. Perrigo Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0517_5cdbfc17-2b55-4c98-b31c-b3a57587c29d	0113-0517	HUMAN OTC DRUG	Good Sense ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060427		ANDA	ANDA077349	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0518_4f67bf99-e703-422d-baf5-b24b33634ea9	0113-0518	HUMAN OTC DRUG	good sense pain relief		Acetaminophen	TABLET, FILM COATED	ORAL	20180928		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-0520_a4b86766-3372-492a-9065-2c2dcb9cfcc5	0113-0520	HUMAN OTC DRUG	good sense omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180619		NDA	NDA209400	L. Perrigo Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-0532_248438c4-dbf0-49d2-8682-54dd4ac4d523	0113-0532	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	19900715		ANDA	ANDA076779	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0541_3a4751c0-676e-4875-8331-f701e905ebd1	0113-0541	HUMAN OTC DRUG	good sense anti itch		Hydrocortisone	CREAM	TOPICAL	20060224		OTC MONOGRAPH NOT FINAL	part348	L. Perrigo Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-0544_45da619d-b51a-4363-8246-fff1f60ff34b	0113-0544	HUMAN OTC DRUG	good sense pain relief	arthritis pain	Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA075077	L. Perrigo Company	ACETAMINOPHEN	650	mg/1			N	20241231
0113-0571_a6f6ab69-e633-43ec-8064-734b73529c88	0113-0571	HUMAN OTC DRUG	good sense aller ease		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110414		ANDA	ANDA076447	L. Perrigo Company	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0578_603a3551-d2fc-4861-9a62-34caa2324def	0113-0578	HUMAN OTC DRUG	good sense tussin dm	cough and chest congestion	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19940920		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0590_6b0cd804-6ccf-47b9-b233-a58ba4a8ed6b	0113-0590	HUMAN OTC DRUG	Good Sense Pain and Fever		acetaminophen	SUSPENSION	ORAL	20111108		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-0603_a08c5fee-fd6e-48e6-aab0-13df2043c29a	0113-0603	HUMAN OTC DRUG	Good Sense Severe Daytime Cold and Flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20131119		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0604_074d7013-4258-4d32-af1f-2fd7e9d1f292	0113-0604	HUMAN OTC DRUG	good sense ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19890915		ANDA	ANDA072096	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0608_417939ae-0b75-4972-956e-2da0d99a2501	0113-0608	HUMAN OTC DRUG	good sense childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19931008		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-0612_e82216ed-9b74-4ab6-a3c8-2aa7d87362c7	0113-0612	HUMAN OTC DRUG	good sense allergy relief		Loratadine	TABLET	ORAL	20040921		ANDA	ANDA076301	L. Perrigo Company	LORATADINE	10	mg/1			N	20241231
0113-0622_c8bb8bb3-88c8-432e-80b7-a9a803f22010	0113-0622	HUMAN OTC DRUG	good sense itch relief		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20060718		OTC MONOGRAPH NOT FINAL	part348	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0647_1937bbd6-c841-4ee5-82b4-615b46abaf48	0113-0647	HUMAN OTC DRUG	good sense ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19910215		ANDA	ANDA072096	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0648_579b5597-9b70-4cdb-9cc4-c0e25460d126	0113-0648	HUMAN OTC DRUG	Good Sense Nasal Four		Phenylephrine hydrochloride	SPRAY	NASAL	20020809		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0651_e54f2cc9-1d5f-4f0a-8bcf-bd5b917d98ec	0113-0651	HUMAN OTC DRUG	good sense esomeprazole magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200405		ANDA	ANDA207193	L. Perrigo Company	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-0656_202a8237-76aa-4649-b199-da62997ef4f3	0113-0656	HUMAN OTC DRUG	Good Sense Daytime	non drowsy cold and flu	acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20060725		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0657_a0077466-24bc-435a-a768-7651aa920c23	0113-0657	HUMAN OTC DRUG	good sense gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20020405		OTC MONOGRAPH FINAL	part332	L. Perrigo Company	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0113-0660_18236c8b-21ee-46eb-b0f2-2c5649d6736c	0113-0660	HUMAN OTC DRUG	Good Sense Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20020409		ANDA	ANDA074937	L. Perrigo Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0668_af835fdd-d4e1-44d6-9cda-c46eb57ca086	0113-0668	HUMAN OTC DRUG	Good Sense Nighttime Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20021103		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0671_637e309d-9846-45a1-ad11-f67ea85c87b8	0113-0671	HUMAN OTC DRUG	Good Sense childrens allergy relief		Loratadine	SOLUTION	ORAL	20200802		ANDA	ANDA075728	L. Perrigo Company	LORATADINE	5	mg/5mL			N	20241231
0113-0679_9bd1956f-ece5-4324-a7b9-4083f5db7937	0113-0679	HUMAN OTC DRUG	Good Sense Triple Antibiotic	and Pain Relief	Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20060214		OTC MONOGRAPH FINAL	part333B	L. Perrigo Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0113-0685_1fda427d-2145-4653-ad35-e78f2100c5c7	0113-0685	HUMAN OTC DRUG	Good Sense Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20110428		ANDA	ANDA074937	L. Perrigo Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0703_b99aa597-e032-4240-83d6-3d207ea0f1de	0113-0703	HUMAN OTC DRUG	Good Sense Tussin CF		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20140729		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0734_b33212e7-8e2d-4742-a88b-b776557d06c2	0113-0734	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130422		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0749_3ca879a9-5094-4e5d-92a2-ba3be96329e0	0113-0749	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20171227		ANDA	ANDA078326	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0763_cd46dc38-4135-4a54-86b8-5229f607f910	0113-0763	HUMAN OTC DRUG	Good Sense Severe NightTime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20131119		OTC MONOGRAPH DRUG	M004	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0773_be8c6949-8378-4af2-b18e-9134c8826652	0113-0773	HUMAN OTC DRUG	Basic Care Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20171219		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0113-0793_8d133c5e-a2d8-4d30-9bd4-5474491b3173	0113-0793	HUMAN OTC DRUG	basic care hydrocortisone		hydrocortisone	CREAM	TOPICAL	20180202		OTC MONOGRAPH NOT FINAL	part348	L. Perrigo Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-0798_7f33f95b-eb15-4134-bdca-6150d6d2e873	0113-0798	HUMAN OTC DRUG	Good Sense Hair Regrowth Treatment	for Men	Minoxidil	SOLUTION	TOPICAL	20100210		ANDA	ANDA075598	L. Perrigo Company	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0113-0808_6f51e788-012d-41d6-94cd-b752c4e01325	0113-0808	HUMAN OTC DRUG	Childrens Night Time Cold and Cough		Diphenhydramine HCl, Phenylephrine HCl	SOLUTION	ORAL	20220112		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0812_3310344d-dabf-4f1b-900f-f85ff30524b0	0113-0812	HUMAN OTC DRUG	good sense mucus dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180621		ANDA	ANDA207602	L Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0817_bbbfb1cd-55c6-4b35-8c3d-48f9ad1ba7d3	0113-0817	HUMAN OTC DRUG	Good Sense Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	19960418		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0113-0825_684d5988-5cf7-45ca-9918-612c7de46fce	0113-0825	HUMAN OTC DRUG	good sense miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20000222		ANDA	ANDA074760	L. Perrigo Company	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0113-0839_fd178374-704c-4e22-ab38-4db738c35a17	0113-0839	HUMAN OTC DRUG	Good Sense Childrens Mucus Relief		dextromethorphan HBr, guaifenesin, phenylephrine HCl	LIQUID	ORAL	20140325		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0847_e533a008-b437-401e-ab50-bda31e6662d3	0113-0847	HUMAN OTC DRUG	good sense aller ease		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20210910		ANDA	ANDA212971	L. Perrigo Company	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0854_1a70768d-b4f6-4a32-9d1a-24022f7184fe	0113-0854	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20130514		ANDA	ANDA078546	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0857_5ff06e61-512b-45a5-9a29-82c5ccdf75c2	0113-0857	HUMAN OTC DRUG	Good Sense Athletes Foot	antifungal	Clotrimazole	CREAM	TOPICAL	20060409		OTC MONOGRAPH FINAL	part333C	L. Perrigo Company	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0113-0866_2b64e417-83e4-4faf-9da8-9c0b504fac59	0113-0866	HUMAN OTC DRUG	good sense lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20071208		OTC MONOGRAPH FINAL	part358G	L. Perrigo Company	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
0113-0873_b5fea7eb-e206-4175-b719-8ca44c32c879	0113-0873	HUMAN OTC DRUG	good sense nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20061227		ANDA	ANDA077007	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0897_0ce3c522-4b65-4cd5-b4a8-092714a0c4c4	0113-0897	HUMAN OTC DRUG	good sense ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19990107		ANDA	ANDA074937	L. Perrigo Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0898_eaf22ec0-4bd2-434a-8a3a-3617279feb36	0113-0898	HUMAN OTC DRUG	Good Sense Esomeprazole Magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	L. Perrigo Company	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-0901_c87f166e-aff7-41b7-9286-1360653967af	0113-0901	HUMAN OTC DRUG	Good Sense Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140423		ANDA	ANDA074661	L. Perrigo Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-0903_55e64f41-8cee-4a92-a313-fee6d327fa54	0113-0903	HUMAN OTC DRUG	good sense cold		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SUSPENSION	ORAL	20101222		OTC MONOGRAPH DRUG	M012	L. Perrigo Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0915_1a6d4adc-376d-4439-a292-24799b886cca	0113-0915	HUMAN OTC DRUG	Good Sense Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080228		NDA	NDA022032	L. Perrigo Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-0927_05990fb7-dadd-4df2-b6c3-4187022d3980	0113-0927	HUMAN OTC DRUG	Good Sense Tussin DM Max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180801		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0944_3a1500cd-56c3-4751-9370-0d101543c7e6	0113-0944	HUMAN OTC DRUG	Good Sense Hemorrhoidal	Maximum Strength Pain Relief	glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20080228		OTC MONOGRAPH FINAL	part346	L. Perrigo Company	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0946_549e04b4-c925-4b9c-9b4c-fea1df778676	0113-0946	HUMAN OTC DRUG	good sense pain and fever	infants	Acetaminophen	SUSPENSION	ORAL	20111108		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-0957_dbb85c5f-031c-4cd3-8791-3ec14cc49baf	0113-0957	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130427		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-0958_79797a69-3564-46c2-b358-3aba1f986334	0113-0958	HUMAN OTC DRUG	Good Sense Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20130620		ANDA	ANDA091135	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-0964_1645dc0a-e818-4a23-8277-5cf48283ba78	0113-0964	HUMAN OTC DRUG	good sense flu and severe cold and cough	nighttime	Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20100917		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0973_db7c35fa-99b2-4e94-93e5-f859af8e0bb9	0113-0973	HUMAN OTC DRUG	Good Sense Anti Itch		hydrocortisone	CREAM	TOPICAL	20060307		OTC MONOGRAPH NOT FINAL	part348	L. Perrigo Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-0981_5b1203c7-9678-4cee-9d7b-6510da295561	0113-0981	HUMAN OTC DRUG	Good Sense All Day Allergy		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220901		ANDA	ANDA213105	L. Perrigo Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-0987_3bcb30cd-9bac-4974-bc3a-11908735e30a	0113-0987	HUMAN OTC DRUG	Good Sense Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20070224		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0994_7c7709dc-7868-427a-b69c-d85c729ee362	0113-0994	HUMAN OTC DRUG	good sense daytime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20070118		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-0998_39f34cb8-b1ee-406e-93d5-fbcaf0afde1e	0113-0998	HUMAN OTC DRUG	Good Sense Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20100729		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-1011_a1e210f8-cf2b-43cc-93c5-6eb2f811a0ee	0113-1011	HUMAN OTC DRUG	good sense tussin cf max		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230331		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-1019_bf0ac006-ed30-4f8b-89ed-e71464f7e951	0113-1019	HUMAN OTC DRUG	good sense childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20190731		ANDA	ANDA210033	L. Perrigo Company	LORATADINE	5	mg/1			N	20241231
0113-1023_6ef82ee5-bac5-4a80-8513-52265a66a3ed	0113-1023	HUMAN OTC DRUG	good sense clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20221227		ANDA	ANDA090685	L. Perrigo Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0113-1032_6894a246-c514-4166-907b-7797ffa61cd3	0113-1032	HUMAN OTC DRUG	Good Sense Hair Regrowth Treatment		minoxidil	SOLUTION	TOPICAL	20210525		ANDA	ANDA075598	L. Perrigo Company	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0113-1087_fcfd0b64-6876-4e6f-8a7b-ca1da9e03f00	0113-1087	HUMAN OTC DRUG	Good Sense Anti Diarrheal Anti Gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20190129		ANDA	ANDA209837	L. Perrigo Company	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
0113-1114_88c06799-f966-4f56-86af-2d29c3448671	0113-1114	HUMAN OTC DRUG	Good Sense Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20211122		ANDA	ANDA202319	L. Perrigo Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-1125_dd334b2c-bbae-48e7-8f3d-2706d325f600	0113-1125	HUMAN OTC DRUG	Good Sense Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200707		ANDA	ANDA090711	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-1129_e591d9e0-87d9-475f-8958-5f5c32fdaa83	0113-1129	HUMAN OTC DRUG	Good Sense Hair Regrowth Treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20190129		ANDA	ANDA091344	L. Perrigo Company	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0113-1140_e9e913d8-8ec8-4465-ad3a-b524f6710a0f	0113-1140	HUMAN OTC DRUG	good sense triple antibiotic		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20181229		OTC MONOGRAPH FINAL	part333B	L. Perrigo Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0113-1189_6e5aa684-f3be-4a0f-82d5-9259d6bb0d19	0113-1189	HUMAN OTC DRUG	good sense arthritis pain		diclofenac sodium	GEL	TOPICAL	20200822		ANDA	ANDA211253	L. Perrigo Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-1190_69c7b6f8-7200-4b9e-ac85-2e2c5c5eeda7	0113-1190	HUMAN OTC DRUG	good sense nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190227		ANDA	ANDA090711	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-1191_288efba1-b795-4272-a8b6-259c70be2f40	0113-1191	HUMAN OTC DRUG	good sense allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200806		ANDA	ANDA076011	L. Perrigo Company	LORATADINE	10	mg/1			N	20241231
0113-1212_772fd900-3833-4bf9-bbb3-e85d47e90998	0113-1212	HUMAN OTC DRUG	Good Sense Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20201019		ANDA	ANDA072096	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-1352_32658477-e904-48ff-87f2-ec21ddb28df9	0113-1352	HUMAN OTC DRUG	good sense nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20181129		ANDA	ANDA078547	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-1369_fe2be0f9-f563-4254-9a2c-b8d99f6b8ff1	0113-1369	HUMAN OTC DRUG	good sense anti itch		Hydrocortisone	CREAM	TOPICAL	20190604		OTC MONOGRAPH NOT FINAL	part348	L. Perrigo Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-1412_a980b939-f74d-4e95-87a8-65ad5a783ac5	0113-1412	HUMAN OTC DRUG	good sense naproxen sodium		naproxen sodium	TABLET, FILM COATED	ORAL	20211109		ANDA	ANDA074661	L. Perrigo Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-1612_bf838a8e-a12d-4970-8613-56a8b1864f33	0113-1612	HUMAN OTC DRUG	good sense allergy relief		Loratadine	TABLET	ORAL	20180926		ANDA	ANDA076301	L. Perrigo Company	LORATADINE	10	mg/1			N	20241231
0113-1619_93e7ba56-5682-4184-9a93-3b4b972b0e72	0113-1619	HUMAN OTC DRUG	good sense migraine formula		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220624		ANDA	ANDA075794	L. Perrigo Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0113-1645_d87b5c7e-a791-426b-a60e-fae9b46e2495	0113-1645	HUMAN OTC DRUG	Good Sense antidiarrheal		loperamide HCl	SOLUTION	ORAL	20180521		ANDA	ANDA091292	L. Perrigo Company	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0113-1719_4ce244e2-9fbc-4371-8806-789fd3a61a09	0113-1719	HUMAN OTC DRUG	good sense childrens allergy relief		Loratadine	SOLUTION	ORAL	20190530		ANDA	ANDA075728	L. Perrigo Company	LORATADINE	5	mg/5mL			N	20241231
0113-1720_695ed773-4a7f-462e-9352-13c000e06e4e	0113-1720	HUMAN OTC DRUG	Nasonex		mometasone furoate	SPRAY	NASAL	20220629		NDA	NDA215712	L. Perrigo Company	MOMETASONE FUROATE MONOHYDRATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-1723_2726e5fd-0cd1-45b8-900b-1c296e9a794e	0113-1723	HUMAN OTC DRUG	Good Sense Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20190522		NDA	NDA022032	L. Perrigo Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-1725_75272209-4a3d-45b1-a131-a8d52e479641	0113-1725	HUMAN OTC DRUG	good sense tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220416		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-1803_38082e59-c509-4be5-b29c-33a97565df1c	0113-1803	HUMAN OTC DRUG	good sense omeprazole delayed release		omeprazole	TABLET, DELAYED RELEASE	ORAL	20211221		NDA	NDA022032	L. Perrigo Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-1855_4cae0580-7ee3-4f38-8d13-79c7d7615f8f	0113-1855	HUMAN OTC DRUG	good sense headache relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220218		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0113-1889_d244abe3-6be3-4f25-8016-8c2ebc766152	0113-1889	HUMAN OTC DRUG	good sense pain relief		acetaminophen	TABLET, FILM COATED	ORAL	20200122		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-1909_97d65237-0aa3-4a53-9b0b-d5fb5533f69b	0113-1909	HUMAN OTC DRUG	good sense sleep aid		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20190530		OTC MONOGRAPH FINAL	part338	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-1910_16e69f99-ef67-4d31-8f52-e792c0d73ca8	0113-1910	HUMAN OTC DRUG	good sense lice killing creme rinse		Permethrin	LOTION	TOPICAL	20190724		ANDA	ANDA076090	L. Perrigo Company	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
0113-1913_ecabb6b9-e23b-45f9-9ff0-d9e4e2617e89	0113-1913	HUMAN OTC DRUG	good sense mucus relief cold flu and sore throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20201003		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-1919_0e94ef2d-e608-4af5-bce2-729ef4dc2427	0113-1919	HUMAN OTC DRUG	Good Sense Aspirin		aspirin	TABLET, FILM COATED	ORAL	20210310		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0113-1975_7f2038d3-9c95-4d83-b459-49ba8a3cd0ad	0113-1975	HUMAN OTC DRUG	Good Sense Pain Relief		Acetaminophen	TABLET	ORAL	20220123		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-1999_e15d055e-9a25-46b4-8724-3609cf2dc062	0113-1999	HUMAN OTC DRUG	Childrens Nasonex		mometasone furoate	SPRAY	NASAL	20230207		NDA	NDA215712	L. Perrigo Company	MOMETASONE FUROATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-2003_81d8cf01-db5e-44c9-842b-eec3f3793ea1	0113-2003	HUMAN OTC DRUG	Option 2		levonorgestrel	TABLET	ORAL	20160129		ANDA	ANDA202334	L. Perrigo Company	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
0113-2004_ba075037-be24-4620-8359-a9576de43e97	0113-2004	HUMAN OTC DRUG	sinus PE		Phenylephrine Hydrochloride	TABLET	ORAL	20150918		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-2007_e37599d0-af3e-4951-8790-e15aeac23603	0113-2007	HUMAN OTC DRUG	Allergy and Congestion Relief		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180412		ANDA	ANDA076050	L. Perrigo Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0113-2008_84ba172c-07a9-4153-8e4a-c2027bda8dc9	0113-2008	HUMAN OTC DRUG	sinus congestion		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20161004		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0113-2023_5eece352-cb88-42a4-9e3f-751c7c05756f	0113-2023	HUMAN OTC DRUG	good sense mucus er		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20200704		ANDA	ANDA078912	L. Perrigo Company	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0113-2061_3b84e130-b3b9-4b5b-9e43-cef52e1ab513	0113-2061	HUMAN OTC DRUG	tussin	mucus plus chest congestion	Guaifenesin	SOLUTION	ORAL	19870715		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	GUAIFENESIN	200	mg/10mL			N	20241231
0113-2219_34940dd4-01c8-47a1-ab0c-6a2246b1e6a1	0113-2219	HUMAN OTC DRUG	Good Sense Mucus DM		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190710		ANDA	ANDA207602	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-2224_e47631c6-5e8d-48ce-a5f3-4482e9a7463c	0113-2224	HUMAN OTC DRUG	anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20180625		ANDA	ANDA075232	L. Perrigo Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0113-2299_4ac6b64a-8214-4b03-8aa5-0d3199cf0b72	0113-2299	HUMAN OTC DRUG	good sense day time cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230705		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-2461_a8fc1b0c-dd69-4567-8eea-de4d9b0c7740	0113-2461	HUMAN OTC DRUG	Good Sense Childrens Ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20191009		ANDA	ANDA076359	L. Perrigo Company	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-2501_89dc1423-d097-47a8-9025-eab5381cca26	0113-2501	HUMAN OTC DRUG	good sense night time cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230705		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-3650_159d4955-7b43-442f-9d80-918cc7f6546b	0113-3650	HUMAN OTC DRUG	Good Sense Mucus ER		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210320		ANDA	ANDA213420	L. Perrigo Company	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0113-4368_e36e9148-2c01-4874-807a-84297259f3c4	0113-4368	HUMAN OTC DRUG	Good Sense Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140331		ANDA	ANDA074661	L. Perrigo Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-4500_7437e114-489b-4423-84a1-afe660921a5a	0113-4500	HUMAN OTC DRUG	good sense severe day time cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20191202		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-4501_3bc065d0-8c21-4097-ab30-6ddc38f161c4	0113-4501	HUMAN OTC DRUG	good sense ibuprofen		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20220123		ANDA	ANDA203599	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-5300_b117358c-f4ca-4ea8-95ee-88a42cc05040	0113-5300	HUMAN OTC DRUG	good sense dual action		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA214836	L Perrigo Company	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-6002_a42786d8-7a3f-4383-a3a6-f662afde73f5	0113-6002	HUMAN OTC DRUG	Prevacid 24 HR		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20201105		NDA	NDA022327	L. Perrigo Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-6004_cf5ccdf8-ab27-429f-a1b4-c51ced021046	0113-6004	HUMAN OTC DRUG	injoy diarrhea relief		Loperamide HCl	TABLET, FILM COATED	ORAL	20220809		ANDA	ANDA075232	L. Perrigo Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0113-6011_9d87da79-e681-444b-b7a1-a1587577c9f2	0113-6011	HUMAN OTC DRUG	injoy gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20220809		OTC MONOGRAPH FINAL	part332	L. Perrigo Company	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0113-6023_aca1b9e5-a35e-4eef-b55a-4189cd1b2a02	0113-6023	HUMAN OTC DRUG	injoy heartburn relief		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20220809		ANDA	ANDA077355	L. Perrigo Company	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0113-6044_6907ffd1-39cb-4cc5-9c8a-bd975a5b06bd	0113-6044	HUMAN OTC DRUG	good sense sleep aid ultra		Doxylamine Succinate	TABLET	ORAL	20220806		ANDA	ANDA040167	L. Perrigo Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0113-6117_205c9c1e-b422-4e86-a4b0-714b608adc19	0113-6117	HUMAN OTC DRUG	Prevacid 24 HR		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20230330		NDA	NDA022327	L. Perrigo Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-6900_6923ff1e-b81b-46bb-a5ca-43038eef6984	0113-6900	HUMAN OTC DRUG	injoy constipation relief		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20220809		ANDA	ANDA090685	L. Perrigo Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0113-7000_7ae8ac2b-9214-4341-b6bd-53f1742b4668	0113-7000	HUMAN OTC DRUG	Basic Care acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20170810		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-7002_8a4a8453-7dea-4e4a-8536-cdc4d08fed5f	0113-7002	HUMAN OTC DRUG	Basic Care All Day Allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20170808		ANDA	ANDA078336	L. Perrigo Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-7003_41207e47-b4d7-411d-9ba9-ed3c12849bf1	0113-7003	HUMAN OTC DRUG	Basic Care Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20170903		ANDA	ANDA202319	L. Perrigo Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-7006_0cadf2cf-84a9-43bb-a9fb-e15c2bdc6f9f	0113-7006	HUMAN OTC DRUG	Basic Case Hydrocortisone Anti-Itch		hydrocortisone	CREAM	TOPICAL	20190522		OTC MONOGRAPH NOT FINAL	part348	L. Perrigo Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-7007_a627391d-3692-46d2-b7b5-252a1778f382	0113-7007	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190522		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7008_5ff9bec6-0935-4076-a64a-37b9e4feaba1	0113-7008	HUMAN OTC DRUG	basic care nicotine		nicotine polacrilex	LOZENGE	ORAL	20200221		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7032_9e8d4d3e-44cd-4e46-b3d9-c8b4e6fe108d	0113-7032	HUMAN OTC DRUG	basic care hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20210826		ANDA	ANDA075598	L. Perrigo Company	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0113-7033_b12355d8-c36f-4af9-b981-e382cf0cff49	0113-7033	HUMAN OTC DRUG	basic care naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190123		ANDA	ANDA074661	L. Perrigo Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-7101_600696d0-d111-44b6-9ab4-68f4d99af195	0113-7101	HUMAN OTC DRUG	Basic Care childrens cold and cough and sore throat		acetaminophen, dextromethorphan hydrobromide	SUSPENSION	ORAL	20190116		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	160; 5	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0113-7116_9b09acc9-656c-4764-a2d1-5606f1e10e4d	0113-7116	HUMAN OTC DRUG	basic care lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20181229		NDA	NDA208025	L. Perrigo Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-7117_37451c78-0305-42f0-a2bc-a6aae002d75b	0113-7117	HUMAN OTC DRUG	basic care allergy relief nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20180320		ANDA	ANDA207957	L. Perrigo Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0113-7124_ecec36bb-87d6-416f-8e44-928d885c52b6	0113-7124	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20181011		ANDA	ANDA090711	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7201_2f6e282a-8bfe-46b6-9053-7caa2065f2b8	0113-7201	HUMAN OTC DRUG	Basic Care nicotine		nicotine polacrilex	LOZENGE	ORAL	20190522		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7203_400d181c-fba5-4e32-aa09-8e1d59bdbc58	0113-7203	HUMAN OTC DRUG	Basic Care nicotine		nicotine polacrilex	LOZENGE	ORAL	20200221		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7223_17e3ceac-18cd-48fa-a7f6-515050ff7769	0113-7223	HUMAN OTC DRUG	basic care childrens cold plus flu		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SUSPENSION	ORAL	20181212		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-7280_4fe17fff-543f-401b-b1fc-f668a85ac7c0	0113-7280	HUMAN OTC DRUG	basic care daytime nighttime cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride,Guaifenesin	KIT		20200225		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7301_74179600-f7c5-4872-9b71-548f63ea6666	0113-7301	HUMAN OTC DRUG	basic care daytime nighttime severe cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Guaifenesin, Phenylephrine Hydrochloride	KIT		20190116		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7303_21eeb451-1c58-4023-99bf-c429df433156	0113-7303	HUMAN OTC DRUG	basic care mucus relief cold flu and sore throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20181229		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-7400_1bb3aeea-2d49-40fb-a64b-b9df5240d9b1	0113-7400	HUMAN OTC DRUG	basic care mucus relief severe congestion and cough		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20190204		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-7401_ef9e606e-87b6-4468-92a4-52c0a3c870f5	0113-7401	HUMAN OTC DRUG	Basic Care Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20170808		NDA	NDA022032	L. Perrigo Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-7425_b7c1c103-38a3-4a59-95e9-be7b10f046ff	0113-7425	HUMAN OTC DRUG	basic care allergy		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20190410		ANDA	ANDA076447	L. Perrigo Company	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-7437_00b9cd41-52de-4338-9b96-38d86b4f1235	0113-7437	HUMAN OTC DRUG	basic care acetaminophen PM		Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20171011		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-7442_0602287a-381c-496a-9c56-0e2e6767b4dc	0113-7442	HUMAN OTC DRUG	basic care nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20190123		ANDA	ANDA091354	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7456_53b5007b-e760-4f1d-9e22-75a3c7c1d758	0113-7456	HUMAN OTC DRUG	Basic Care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170808		ANDA	ANDA076777	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7469_ae971ed2-8230-4198-a6c1-5ec61b7ae6b5	0113-7469	HUMAN OTC DRUG	basic care stomach relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20190111		OTC MONOGRAPH FINAL	part335	L. Perrigo Company	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
0113-7475_21778a8c-862b-4775-b56e-dd7fddb80124	0113-7475	HUMAN OTC DRUG	basic care childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20170829		ANDA	ANDA204226	L. Perrigo Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-7479_5edf3a94-01a5-49e9-97ff-e3df062eae64	0113-7479	HUMAN OTC DRUG	basic care allergy relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20170810		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-7484_f66aaf61-cb1a-4179-b292-99ab6451c321	0113-7484	HUMAN OTC DRUG	basic care acetaminophen		Acetaminophen	TABLET	ORAL	20170808		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	500	mg/1			N	20241231
0113-7499_75370a22-a18e-44b2-aad9-199a40b89db4	0113-7499	HUMAN OTC DRUG	Basic Care daytime nighttime severe cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20190116		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7501_3d876814-f1e8-499a-9c57-8bf33a8ab337	0113-7501	HUMAN OTC DRUG	basic care nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20200225		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-7511_7ae62588-43b3-4a4b-90fe-c8b886bebc28	0113-7511	HUMAN OTC DRUG	basic care daytime nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20200220		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7520_1abb9b6b-1b11-4fc9-beeb-3985edc5cf61	0113-7520	HUMAN OTC DRUG	basic care omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180830		NDA	NDA209400	L. Perrigo Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-7523_aced793a-2951-4fb5-9465-6bbed427349e	0113-7523	HUMAN OTC DRUG	basic care daytime nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20191015		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7532_145e0c83-1ccf-42c5-8668-7fa62c60e88a	0113-7532	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170808		ANDA	ANDA076779	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7571_20af7774-94ee-4bec-bb26-b728a096bc95	0113-7571	HUMAN OTC DRUG	basic care allergy		fexofenadine hcl	TABLET, FILM COATED	ORAL	20180509		ANDA	ANDA076447	L. Perrigo Company	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-7580_eae8b198-7415-4815-ac4a-12f16837546b	0113-7580	HUMAN OTC DRUG	basic care daytime nighttime cold and flu		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20180425		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7603_97931806-1720-47ad-9764-381d0991f1c1	0113-7603	HUMAN OTC DRUG	Basic Care Daytime Cold and Flu Severe		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20190225		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-7604_0df8a078-f04e-42a1-a677-c38c1c6e5ef5	0113-7604	HUMAN OTC DRUG	Basic Care Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20170810		ANDA	ANDA072096	L. Perrigo Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-7612_522d055e-b52b-4554-b332-bbaebc481638	0113-7612	HUMAN OTC DRUG	Basic Care allergy relief		Loratadine	TABLET	ORAL	20170824		ANDA	ANDA076301	L. Perrigo Company	LORATADINE	10	mg/1			N	20241231
0113-7619_05299d22-7241-4767-9fe0-97f84a1dc05e	0113-7619	HUMAN OTC DRUG	basic care childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190219		ANDA	ANDA076359	L. Perrigo Company	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-7656_f12806b8-abdd-4d89-a5b3-40e4e6c1fc59	0113-7656	HUMAN OTC DRUG	basic care daytime cold and flu		acetaminophen, dextromethorphan hydrobromide, Phenylephrine hydrochloride	SOLUTION	ORAL	20190314		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-7660_d4fa5121-507c-402b-bca7-1c437003b8db	0113-7660	HUMAN OTC DRUG	basic care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20190410		ANDA	ANDA074937	L. Perrigo Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-7671_faf22fb1-75ee-460c-b433-2c50302b92d8	0113-7671	HUMAN OTC DRUG	Basic Care Childrens Allergy Relief		Loratadine	SOLUTION	ORAL	20180823		ANDA	ANDA075728	L. Perrigo Company	LORATADINE	5	mg/5mL			N	20241231
0113-7679_7fef39aa-cd70-4075-8f1d-6720b9e240e7	0113-7679	HUMAN OTC DRUG	Basic Care First Aid Antibiotic Plus Pain Relief		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20190612		OTC MONOGRAPH FINAL	part333B	L. Perrigo Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0113-7734_596ae549-09ce-45c1-8589-79cb6d7cf3c2	0113-7734	HUMAN OTC DRUG	basic care nicotine mini		Nicotine Polacrilex	LOZENGE	ORAL	20180306		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7777_955c9f49-38af-4b48-b325-60fa94bfe60b	0113-7777	HUMAN OTC DRUG	perrigo allergy d		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211008		ANDA	ANDA076050	L. Perrigo Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0113-7798_f8dace4a-a95b-4a75-a797-adf02e87f88c	0113-7798	HUMAN OTC DRUG	Basic Care Hair Regrowth		Minoxidil	SOLUTION	TOPICAL	20170810		ANDA	ANDA075598	L. Perrigo Company	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0113-7801_632a19af-5069-4e1e-8c94-72b61457794f	0113-7801	HUMAN OTC DRUG	basic care day time night time cold and flu		Acetaminophen, dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20190314		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7825_a1238e85-81d5-4220-b245-622ff7cdab2f	0113-7825	HUMAN OTC DRUG	basic care miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20190522		ANDA	ANDA074760	L. Perrigo Company	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0113-7897_3aeab4eb-7bb9-4447-8809-dbcbf2c7d8b3	0113-7897	HUMAN OTC DRUG	Basic Care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170810		ANDA	ANDA074937	L Perrigo Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-7901_ec3997fc-6246-44cf-b835-d1207c43fec5	0113-7901	HUMAN OTC DRUG	basic care naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190410		ANDA	ANDA074661	L. Perrigo Company	NAPROXEN SODIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-7902_6fc27ed0-1f3b-4095-8fe5-be39446cac1f	0113-7902	HUMAN OTC DRUG	basic care daytime cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20200225		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-7911_f6aee0ed-00f8-4505-9fd5-019736d9dfea	0113-7911	HUMAN OTC DRUG	basic care daytime severe cold and flu nighttime severe cold, cough and flu		acetaminophen, dextromethorphan hydrobrmide, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20190513		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7915_3f8dd174-2e24-40b6-ae02-41061abe609e	0113-7915	HUMAN OTC DRUG	Basic Care Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20170808		NDA	NDA022032	L. Perrigo Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0113-7951_070a5866-97cc-43a7-b1e1-547fc5a9bf91	0113-7951	HUMAN OTC DRUG	basic care daytime severe cold nighttime cold and flu		Acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20190124		OTC MONOGRAPH FINAL	part341	L. Perrigo Company						N	20241231
0113-7957_9accdafd-abf2-482f-b77d-8927a7b63f7b	0113-7957	HUMAN OTC DRUG	basic care nicotine mini		Nicotine Polacrilex	LOZENGE	ORAL	20180306		ANDA	ANDA203690	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-7994_75d97b8e-6c30-4ad0-ada1-ceaa91a2c333	0113-7994	HUMAN OTC DRUG	basic care daytime cold and flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20181129		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-8002_b6d74a34-f128-4b00-83fa-35cafc2092f3	0113-8002	HUMAN OTC DRUG	burts bees throat soothing		pectin	LOZENGE	ORAL	20210606		OTC MONOGRAPH NOT FINAL	part356	L. Perrigo Company	PECTIN	10.5	mg/1			N	20241231
0113-8004_84db6862-de85-44a5-9872-bcedb67a1fde	0113-8004	HUMAN OTC DRUG	burts bees throat soothing		pectin	LOZENGE	ORAL	20210606		OTC MONOGRAPH NOT FINAL	part356	L. Perrigo Company	PECTIN	10.5	mg/1			N	20241231
0113-8100_ba373c62-65eb-43ad-88e3-bb2c13df588c	0113-8100	HUMAN OTC DRUG	good sense nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230621		ANDA	ANDA206394	L. Perrigo Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-8264_71e8a536-14c6-4865-8d07-51fd9c80f31f	0113-8264	HUMAN OTC DRUG	good sense naproxen sodium		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20181228		ANDA	ANDA208499	L. Perrigo Company	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0113-8442_89d35289-0b16-4d15-9b90-591a56db802f	0113-8442	HUMAN OTC DRUG	Good Sense Nicotine	Stop Smoking Aid	Nicotine polacrilex	GUM, CHEWING	ORAL	20120119		ANDA	ANDA091354	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-8600_eefcb8f8-4334-4e75-8e52-ef1ffbf3f0a9	0113-8600	HUMAN OTC DRUG	good sense nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230823		ANDA	ANDA206393	L. Perrigo Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0113-8959_8247de1f-26ab-4f77-8999-09bb18ad2778	0113-8959	HUMAN OTC DRUG	Good Sense Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20120322		OTC MONOGRAPH NOT FINAL	part343	L. Perrigo Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0113-9007_987b2abc-adc8-4383-87dc-52392dd8af47	0113-9007	HUMAN OTC DRUG	Good Sense Severe Tussin CF Max		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20211111		OTC MONOGRAPH FINAL	part341	L. Perrigo Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0113-9458_365965f1-200f-42d8-8030-d2c8fffffc5d	0113-9458	HUMAN OTC DRUG	Good Sense all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080116		ANDA	ANDA078336	L. Perrigo Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0113-9755_3ef968b8-6732-4c80-b385-f471ed407817	0113-9755	HUMAN OTC DRUG	good sense allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200911		ANDA	ANDA076011	L. Perrigo Company	LORATADINE	10	mg/1			N	20241231
0115-1010_e73c54db-d445-4784-9553-4e04fe9163ca	0115-1010	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20071027		ANDA	ANDA077971	Amneal Pharmaceuticals of New York LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0115-1011_e73c54db-d445-4784-9553-4e04fe9163ca	0115-1011	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210601		ANDA	ANDA077971	Amneal Pharmaceuticals of New York LLC	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0115-1012_e73c54db-d445-4784-9553-4e04fe9163ca	0115-1012	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20071027		ANDA	ANDA077971	Amneal Pharmaceuticals of New York LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0115-1070_3b2695c5-2844-487a-a3fa-640c7a89e5c6	0115-1070	HUMAN PRESCRIPTION DRUG	Dipyridamole		DIPYRIDAMOLE	TABLET	ORAL	20210830		ANDA	ANDA040782	Amneal Pharmaceuticals of New York LLC	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0115-1071_3b2695c5-2844-487a-a3fa-640c7a89e5c6	0115-1071	HUMAN PRESCRIPTION DRUG	Dipyridamole		DIPYRIDAMOLE	TABLET	ORAL	20210830		ANDA	ANDA040782	Amneal Pharmaceuticals of New York LLC	DIPYRIDAMOLE	50	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0115-1072_3b2695c5-2844-487a-a3fa-640c7a89e5c6	0115-1072	HUMAN PRESCRIPTION DRUG	Dipyridamole		DIPYRIDAMOLE	TABLET	ORAL	20210830		ANDA	ANDA040782	Amneal Pharmaceuticals of New York LLC	DIPYRIDAMOLE	75	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0115-1248_4318aae0-cda7-4f2d-a89d-0af7c08ef61f	0115-1248	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		CARVEDILOL PHOSPHATE	CAPSULE, EXTENDED RELEASE	ORAL	20240101		ANDA	ANDA204717	Amneal Pharmaceuticals of New York LLC	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
0115-1249_4318aae0-cda7-4f2d-a89d-0af7c08ef61f	0115-1249	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		CARVEDILOL PHOSPHATE	CAPSULE, EXTENDED RELEASE	ORAL	20240101		ANDA	ANDA204717	Amneal Pharmaceuticals of New York LLC	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
0115-1250_4318aae0-cda7-4f2d-a89d-0af7c08ef61f	0115-1250	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		CARVEDILOL PHOSPHATE	CAPSULE, EXTENDED RELEASE	ORAL	20240101		ANDA	ANDA204717	Amneal Pharmaceuticals of New York LLC	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
0115-1251_4318aae0-cda7-4f2d-a89d-0af7c08ef61f	0115-1251	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		CARVEDILOL PHOSPHATE	CAPSULE, EXTENDED RELEASE	ORAL	20240101		ANDA	ANDA204717	Amneal Pharmaceuticals of New York LLC	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
0115-1277_7df1a13c-b091-42b4-b66b-670f9e9fdf5f	0115-1277	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20160412		ANDA	ANDA200411	Amneal Pharmaceuticals of New York LLC	MORPHINE SULFATE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0115-1278_7df1a13c-b091-42b4-b66b-670f9e9fdf5f	0115-1278	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20160412		ANDA	ANDA200411	Amneal Pharmaceuticals of New York LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0115-1279_7df1a13c-b091-42b4-b66b-670f9e9fdf5f	0115-1279	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20160412		ANDA	ANDA200411	Amneal Pharmaceuticals of New York LLC	MORPHINE SULFATE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0115-1280_7df1a13c-b091-42b4-b66b-670f9e9fdf5f	0115-1280	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20160412		ANDA	ANDA200411	Amneal Pharmaceuticals of New York LLC	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0115-1281_7df1a13c-b091-42b4-b66b-670f9e9fdf5f	0115-1281	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20160412		ANDA	ANDA200411	Amneal Pharmaceuticals of New York LLC	MORPHINE SULFATE	80	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0115-1282_7df1a13c-b091-42b4-b66b-670f9e9fdf5f	0115-1282	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20160412		ANDA	ANDA200411	Amneal Pharmaceuticals of New York LLC	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0115-1320_35e7bdf2-7512-4484-be57-94a48a4bc906	0115-1320	HUMAN PRESCRIPTION DRUG	Colesevelam Hydrochloride		COLESEVELAM HYDROCHLORIDE	TABLET, COATED	ORAL	20180517		ANDA	ANDA091600	Amneal Pharmaceuticals of New York LLC	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20251231
0115-1365_b673720f-b62b-4afc-ac25-cb2ac4cf326f	0115-1365	HUMAN PRESCRIPTION DRUG	sevelamer carbonate		sevelamer carbonate	POWDER, FOR SUSPENSION	ORAL	20201120		ANDA	ANDA211316	Amneal Pharmaceuticals of New York LLC	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0115-1366_b673720f-b62b-4afc-ac25-cb2ac4cf326f	0115-1366	HUMAN PRESCRIPTION DRUG	sevelamer carbonate		sevelamer carbonate	POWDER, FOR SUSPENSION	ORAL	20201120		ANDA	ANDA211316	Amneal Pharmaceuticals of New York LLC	SEVELAMER CARBONATE	2400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0115-1436_c581b1e6-115d-4c79-a8d0-fa353e86d7d5	0115-1436	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		NDA AUTHORIZED GENERIC	NDA021777	Amneal Pharmaceuticals of New York LLC	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0115-1437_c581b1e6-115d-4c79-a8d0-fa353e86d7d5	0115-1437	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		NDA AUTHORIZED GENERIC	NDA021777	Amneal Pharmaceuticals of New York LLC	CYCLOBENZAPRINE HYDROCHLORIDE	30	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0115-1468_ef0e52f0-eafb-4ccc-86f4-19672a142b3c	0115-1468	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		Lidocaine and Prilocaine	CREAM	TOPICAL	20030827		ANDA	ANDA076320	Amneal Pharmaceuticals of New York LLC	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
0115-1474_943c4651-3d73-4af2-b4b7-b7d9027f73f4	0115-1474	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20060713		ANDA	ANDA077547	Amneal Pharmaceuticals of New York LLC	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0115-1475_cfa7f830-7c38-4bfb-8454-6d4908302606	0115-1475	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	SOLUTION	TOPICAL	20091120		ANDA	ANDA077029	Amneal Pharmaceuticals of New York LLC	CALCIPOTRIENE	.05	mg/mL	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
0115-1479_7df1a13c-b091-42b4-b66b-670f9e9fdf5f	0115-1479	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20181005		ANDA	ANDA200411	Amneal Pharmaceuticals of New York LLC	MORPHINE SULFATE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0115-1483_787406cd-77d4-4a18-b9dc-991057763703	0115-1483	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20131121		ANDA	ANDA200936	Amneal Pharmaceuticals of New York LLC	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0115-1486_e886b0c4-a0fe-4370-af4f-b7d2f381ab24	0115-1486	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE	ORAL	20160216		ANDA	ANDA076852	Amneal Pharmaceuticals of New York LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
0115-1487_e886b0c4-a0fe-4370-af4f-b7d2f381ab24	0115-1487	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE	ORAL	20160216		ANDA	ANDA076852	Amneal Pharmaceuticals of New York LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
0115-1488_e886b0c4-a0fe-4370-af4f-b7d2f381ab24	0115-1488	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE	ORAL	20160216		ANDA	ANDA076852	Amneal Pharmaceuticals of New York LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
0115-1489_e886b0c4-a0fe-4370-af4f-b7d2f381ab24	0115-1489	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE	ORAL	20160216		ANDA	ANDA076852	Amneal Pharmaceuticals of New York LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
0115-1490_e886b0c4-a0fe-4370-af4f-b7d2f381ab24	0115-1490	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE	ORAL	20160216		ANDA	ANDA076852	Amneal Pharmaceuticals of New York LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
0115-1491_e886b0c4-a0fe-4370-af4f-b7d2f381ab24	0115-1491	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE	ORAL	20160216		ANDA	ANDA076852	Amneal Pharmaceuticals of New York LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
0115-1510_eaabbf9e-b49d-4d23-bd49-8bc5aaee3967	0115-1510	HUMAN PRESCRIPTION DRUG	NAFTIFINE HYDROCHLORIDE		NAFTIFINE HYDROCHLORIDE	GEL	TOPICAL	20190320		ANDA	ANDA206165	Amneal Pharmaceuticals of New York LLC	NAFTIFINE HYDROCHLORIDE	10	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0115-1512_6cf7b001-6ec3-4d9d-a6b0-7231ecbf3c2d	0115-1512	HUMAN PRESCRIPTION DRUG	NAFTIFINE HYDROCHLORIDE		NAFTIFINE HYDROCHLORIDE	CREAM	TOPICAL	20170510		ANDA	ANDA206960	Amneal Pharmaceuticals of New York LLC	NAFTIFINE HYDROCHLORIDE	20	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0115-1526_9611e358-6fe1-4f8d-99a2-250a7862a896	0115-1526	HUMAN PRESCRIPTION DRUG	Lamotrigine		LAMOTRIGINE	TABLET, ORALLY DISINTEGRATING	ORAL	20150109		ANDA	ANDA200828	Amneal Pharmaceuticals of New York LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0115-1527_9611e358-6fe1-4f8d-99a2-250a7862a896	0115-1527	HUMAN PRESCRIPTION DRUG	Lamotrigine		LAMOTRIGINE	TABLET, ORALLY DISINTEGRATING	ORAL	20150109		ANDA	ANDA200828	Amneal Pharmaceuticals of New York LLC	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0115-1528_9611e358-6fe1-4f8d-99a2-250a7862a896	0115-1528	HUMAN PRESCRIPTION DRUG	Lamotrigine		LAMOTRIGINE	TABLET, ORALLY DISINTEGRATING	ORAL	20150109		ANDA	ANDA200828	Amneal Pharmaceuticals of New York LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0115-1529_9611e358-6fe1-4f8d-99a2-250a7862a896	0115-1529	HUMAN PRESCRIPTION DRUG	Lamotrigine		LAMOTRIGINE	TABLET, ORALLY DISINTEGRATING	ORAL	20150109		ANDA	ANDA200828	Amneal Pharmaceuticals of New York LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0115-1554_99d5bca5-31f8-4f65-a448-ea40ac5f2206	0115-1554	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20160912		NDA AUTHORIZED GENERIC	NDA022224	Amneal Pharmaceuticals of New York LLC	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0115-1555_99d5bca5-31f8-4f65-a448-ea40ac5f2206	0115-1555	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20160912		NDA AUTHORIZED GENERIC	NDA022224	Amneal Pharmaceuticals of New York LLC	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0115-1624_8adcda98-4dc1-4379-84b8-c16b122c16d1	0115-1624	HUMAN PRESCRIPTION DRUG	Azelaic Acid		Azelaic Acid	GEL	TOPICAL	20181119		ANDA	ANDA208724	Amneal Pharmaceuticals of New York LLC	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
0115-1643_fa122415-d787-4019-85f0-3602f1892e8d	0115-1643	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20070308		ANDA	ANDA073671	Amneal Pharmaceuticals of New York LLC	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
0115-1645_fa122415-d787-4019-85f0-3602f1892e8d	0115-1645	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20070308		ANDA	ANDA073652	Amneal Pharmaceuticals of New York LLC	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
0115-1659_6f426f6a-1366-4752-b439-da9b82db3fdb	0115-1659	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070175	Amneal Pharmaceuticals of New York LLC	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0115-1660_6f426f6a-1366-4752-b439-da9b82db3fdb	0115-1660	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070176	Amneal Pharmaceuticals of New York LLC	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0115-1661_6f426f6a-1366-4752-b439-da9b82db3fdb	0115-1661	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070177	Amneal Pharmaceuticals of New York LLC	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0115-1662_6f426f6a-1366-4752-b439-da9b82db3fdb	0115-1662	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070178	Amneal Pharmaceuticals of New York LLC	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0115-1676_0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1	0115-1676	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080206		ANDA	ANDA075710	Amneal Pharmaceuticals of New York LLC	ALENDRONATE SODIUM	5	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0115-1678_0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1	0115-1678	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080206		ANDA	ANDA075710	Amneal Pharmaceuticals of New York LLC	ALENDRONATE SODIUM	10	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0115-1679_0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1	0115-1679	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080206		ANDA	ANDA075710	Amneal Pharmaceuticals of New York LLC	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0115-1680_0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1	0115-1680	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080206		ANDA	ANDA075710	Amneal Pharmaceuticals of New York LLC	ALENDRONATE SODIUM	40	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0115-1681_0bb7b70c-72e0-4bb8-9d3a-0fc8e4762dd1	0115-1681	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080206		ANDA	ANDA075710	Amneal Pharmaceuticals of New York LLC	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0115-1682_d431fe33-4a29-4d90-9d0d-38f146aedbd6	0115-1682	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150806		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1683_d431fe33-4a29-4d90-9d0d-38f146aedbd6	0115-1683	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150806		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1684_d431fe33-4a29-4d90-9d0d-38f146aedbd6	0115-1684	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20141111		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1685_d431fe33-4a29-4d90-9d0d-38f146aedbd6	0115-1685	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20151221		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1686_d431fe33-4a29-4d90-9d0d-38f146aedbd6	0115-1686	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140224		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1687_2404cb3e-b023-4709-a32e-3da5d7db731b	0115-1687	HUMAN PRESCRIPTION DRUG	Budesonide Inhalation		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20160804		ANDA	ANDA078404	Amneal Pharmaceuticals of New York LLC	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0115-1689_2404cb3e-b023-4709-a32e-3da5d7db731b	0115-1689	HUMAN PRESCRIPTION DRUG	Budesonide Inhalation		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20160804		ANDA	ANDA078404	Amneal Pharmaceuticals of New York LLC	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0115-1694_a7a3d178-ac73-4318-97aa-9ab84a4d5693	0115-1694	HUMAN PRESCRIPTION DRUG	epinephrine		epinephrine	INJECTION	SUBCUTANEOUS	20100401		NDA AUTHORIZED GENERIC	NDA020800	Amneal Pharmaceuticals of New York LLC	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0115-1695_a7a3d178-ac73-4318-97aa-9ab84a4d5693	0115-1695	HUMAN PRESCRIPTION DRUG	epinephrine		epinephrine	INJECTION	SUBCUTANEOUS	20100401		NDA AUTHORIZED GENERIC	NDA020800	Amneal Pharmaceuticals of New York LLC	EPINEPHRINE	.15	mg/.15mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0115-1696_00b59416-214b-4b15-9411-3a8aac4ec081	0115-1696	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20070330		ANDA	ANDA040646	Amneal Pharmaceuticals of New York LLC	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0115-1697_00b59416-214b-4b15-9411-3a8aac4ec081	0115-1697	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20070330		ANDA	ANDA040646	Amneal Pharmaceuticals of New York LLC	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0115-1700_00b59416-214b-4b15-9411-3a8aac4ec081	0115-1700	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20070330		ANDA	ANDA040646	Amneal Pharmaceuticals of New York LLC	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0115-1701_2da2a777-2835-429d-b73a-31b8e0bde571	0115-1701	HUMAN PRESCRIPTION DRUG	Albendazole		albendazole	TABLET, FILM COATED	ORAL	19960611		NDA	NDA020666	Amneal Pharmaceuticals of New York LLC	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20251231
0115-1709_bbb45493-00cf-46d7-91bf-50f3c27a0a5d	0115-1709	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170705		ANDA	ANDA203614	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1710_bbb45493-00cf-46d7-91bf-50f3c27a0a5d	0115-1710	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170705		ANDA	ANDA203614	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1724_4b54c9f5-4d73-4578-aa08-6d457c8cb664	0115-1724	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Ultramicrosize Griseofulvin Tablets	TABLET, COATED	ORAL	20140929		ANDA	ANDA204371	Amneal Pharmaceuticals of New York LLC	GRISEOFULVIN	125	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0115-1725_4b54c9f5-4d73-4578-aa08-6d457c8cb664	0115-1725	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Ultramicrosize Griseofulvin Tablets	TABLET, COATED	ORAL	20140929		ANDA	ANDA204371	Amneal Pharmaceuticals of New York LLC	GRISEOFULVIN	250	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0115-1736_5b60721d-5cb3-437a-a798-5b10ab89e80a	0115-1736	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20160920		ANDA	ANDA205105	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1737_5b60721d-5cb3-437a-a798-5b10ab89e80a	0115-1737	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20160920		ANDA	ANDA205105	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1738_5b60721d-5cb3-437a-a798-5b10ab89e80a	0115-1738	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20160920		ANDA	ANDA205105	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1739_5b60721d-5cb3-437a-a798-5b10ab89e80a	0115-1739	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20160920		ANDA	ANDA205105	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1740_5b60721d-5cb3-437a-a798-5b10ab89e80a	0115-1740	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20160920		ANDA	ANDA205105	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1741_5b60721d-5cb3-437a-a798-5b10ab89e80a	0115-1741	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20160920		ANDA	ANDA205105	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1745_2043aef4-e061-4ef7-978b-768f47e347a6	0115-1745	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20160526		ANDA	ANDA040486	Amneal Pharmaceuticals of New York LLC	METAXALONE	400	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0115-1750_80d24efe-d863-40f0-bd2b-85718f6ad568	0115-1750	HUMAN PRESCRIPTION DRUG	Acitretin		Acitretin	CAPSULE	ORAL	20160104		ANDA	ANDA202552	Amneal Pharmaceuticals of New York LLC	ACITRETIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0115-1751_80d24efe-d863-40f0-bd2b-85718f6ad568	0115-1751	HUMAN PRESCRIPTION DRUG	Acitretin		Acitretin	CAPSULE	ORAL	20160104		ANDA	ANDA202552	Amneal Pharmaceuticals of New York LLC	ACITRETIN	17.5	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0115-1752_80d24efe-d863-40f0-bd2b-85718f6ad568	0115-1752	HUMAN PRESCRIPTION DRUG	Acitretin		Acitretin	CAPSULE	ORAL	20160104		ANDA	ANDA202552	Amneal Pharmaceuticals of New York LLC	ACITRETIN	22.5	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0115-1753_80d24efe-d863-40f0-bd2b-85718f6ad568	0115-1753	HUMAN PRESCRIPTION DRUG	Acitretin		Acitretin	CAPSULE	ORAL	20160104		ANDA	ANDA202552	Amneal Pharmaceuticals of New York LLC	ACITRETIN	25	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0115-1757_dd0666c7-8d08-4a7d-9afa-11980af71d73	0115-1757	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20150729		ANDA	ANDA040537	Amneal Pharmaceuticals of New York LLC	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
0115-1800_a2843a37-aca2-41b1-813f-3883d407e76e	0115-1800	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20140407		ANDA	ANDA091159	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1801_a2843a37-aca2-41b1-813f-3883d407e76e	0115-1801	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20140407		ANDA	ANDA091159	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1802_a2843a37-aca2-41b1-813f-3883d407e76e	0115-1802	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20140407		ANDA	ANDA091159	Amneal Pharmaceuticals of New York LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-1864_83f79a9e-7658-4d89-a3aa-8c5ee39ac846	0115-1864	HUMAN PRESCRIPTION DRUG	Colesevelam hydrochloride		Colesevelam hydrochloride	FOR SUSPENSION	ORAL	20230120		ANDA	ANDA212886	Amneal Pharmaceuticals of New York LLC	COLESEVELAM HYDROCHLORIDE	3.75	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0115-1911_b5f5cd6c-3874-4507-bbd4-72e8c5bfe17f	0115-1911	HUMAN PRESCRIPTION DRUG	Rimantadine Hydrochloride		Rimantadine Hydrochloride	TABLET, FILM COATED	ORAL	20211116		ANDA	ANDA076132	Amneal Pharmaceuticals of New York LLC	RIMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559	0115-2134	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		PYRIDOSTIGMINE BROMIDE	TABLET	ORAL	20220808		ANDA	ANDA040502	Amneal Pharmaceuticals of New York LLC	PYRIDOSTIGMINE BROMIDE	30	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0115-2142_26d8ab00-5e93-4aa2-817f-8829074ae109	0115-2142	HUMAN PRESCRIPTION DRUG	COLESTIPOL HYDROCHLORIDE		COLESTIPOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210817	20241231	ANDA	ANDA077510	Amneal Pharmaceuticals of New York LLC	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	
0115-2790_efeb6a72-a5b1-4552-bfb0-6f247038574e	0115-2790	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		CHLOROQUINE PHOSPHATE	TABLET	ORAL	20220510		ANDA	ANDA080880	Amneal Pharmaceuticals of New York LLC	CHLOROQUINE PHOSPHATE	250	mg/1	Antimalarial [EPC]		N	20241231
0115-3511_88bac1cf-dbf8-41ce-9865-694e52286e51	0115-3511	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		PYRIDOSTIGMINE BROMIDE	TABLET	ORAL	20030424		ANDA	ANDA040502	Amneal Pharmaceuticals of New York LLC	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0115-4411_020cc0ba-19eb-4442-b55f-6820c32b4754	0115-4411	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		Dantrolene Sodium	CAPSULE	ORAL	20050301		ANDA	ANDA076856	Amneal Pharmaceuticals of New York LLC	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0115-4422_020cc0ba-19eb-4442-b55f-6820c32b4754	0115-4422	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		Dantrolene Sodium	CAPSULE	ORAL	20050301		ANDA	ANDA076856	Amneal Pharmaceuticals of New York LLC	DANTROLENE SODIUM	50	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0115-4433_020cc0ba-19eb-4442-b55f-6820c32b4754	0115-4433	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		Dantrolene Sodium	CAPSULE	ORAL	20050301		ANDA	ANDA076856	Amneal Pharmaceuticals of New York LLC	DANTROLENE SODIUM	100	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0115-5211_dcf6ced3-ffe4-48bb-af41-1d3bed3adfcd	0115-5211	HUMAN PRESCRIPTION DRUG	COLESTIPOL HYDROCHLORIDE		COLESTIPOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210817		ANDA	ANDA077510	Amneal Pharmaceuticals of New York LLC	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0115-5212_78f0e0f5-e61e-4c11-8e35-b65bcdfcfc06	0115-5212	HUMAN PRESCRIPTION DRUG	COLESTIPOL HYDROCHLORIDE		COLESTIPOL HYDROCHLORIDE	SUSPENSION	ORAL	20060502		ANDA	ANDA077277	Amneal Pharmaceuticals of New York LLC	COLESTIPOL HYDROCHLORIDE	5	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0115-5213_78f0e0f5-e61e-4c11-8e35-b65bcdfcfc06	0115-5213	HUMAN PRESCRIPTION DRUG	COLESTIPOL HYDROCHLORIDE		COLESTIPOL HYDROCHLORIDE	SUSPENSION	ORAL	20060502		ANDA	ANDA077277	Amneal Pharmaceuticals of New York LLC	COLESTIPOL HYDROCHLORIDE	5	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0115-5445_5fed6a81-828f-4e98-b001-a379b7551fb7	0115-5445	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		BUPROPION HYDROCHLORIDE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041203		ANDA	ANDA076711	Amneal Pharmaceuticals of New York LLC	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0115-5511_71bb776c-1208-4049-bba2-0f9eb1ea4efe	0115-5511	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20100201		ANDA	ANDA076509	Amneal Pharmaceuticals of New York LLC	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
0115-5522_71bb776c-1208-4049-bba2-0f9eb1ea4efe	0115-5522	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20100201		ANDA	ANDA076509	Amneal Pharmaceuticals of New York LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
0115-7010_e1a40cca-a829-4aab-a1e3-3971db2746d9	0115-7010	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		CHLOROQUINE PHOSPHATE	TABLET	ORAL	20220510		ANDA	ANDA040516	Amneal Pharmaceuticals of New York LLC	CHLOROQUINE PHOSPHATE	500	mg/1	Antimalarial [EPC]		N	20241231
0115-7033_b9f93364-6bf6-4e7a-a1ae-6bdefec50178	0115-7033	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		FLUDROCORTISONE ACETATE	TABLET	ORAL	20020318		ANDA	ANDA040431	Amneal Pharmaceuticals of New York LLC	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
0115-9811_5c54a7d0-84ae-4e23-9ba6-811380d18b3b	0115-9811	HUMAN PRESCRIPTION DRUG	Digoxin		DIGOXIN	TABLET	ORAL	20090720		ANDA	ANDA078556	Amneal Pharmaceuticals of New York LLC	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0115-9822_5c54a7d0-84ae-4e23-9ba6-811380d18b3b	0115-9822	HUMAN PRESCRIPTION DRUG	Digoxin		DIGOXIN	TABLET	ORAL	20090720		ANDA	ANDA078556	Amneal Pharmaceuticals of New York LLC	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0115-9918_a7c9e3cb-f8ce-4d71-b5ae-196f1ba52967	0115-9918	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150806		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9919_a7c9e3cb-f8ce-4d71-b5ae-196f1ba52967	0115-9919	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150806		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9920_a7c9e3cb-f8ce-4d71-b5ae-196f1ba52967	0115-9920	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20141111		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9921_a7c9e3cb-f8ce-4d71-b5ae-196f1ba52967	0115-9921	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20151221		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9922_a7c9e3cb-f8ce-4d71-b5ae-196f1ba52967	0115-9922	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140224		ANDA	ANDA079108	Amneal Pharmaceuticals of New York LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9927_42b19d09-cffd-4772-bc84-76c2066d6f00	0115-9927	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate	Extended-Release	Dextroamphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	19760802		NDA AUTHORIZED GENERIC	NDA017078	Amneal Pharmaceuticals of New York LLC	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9928_42b19d09-cffd-4772-bc84-76c2066d6f00	0115-9928	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate	Extended-Release	Dextroamphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	19760802		NDA AUTHORIZED GENERIC	NDA017078	Amneal Pharmaceuticals of New York LLC	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9929_42b19d09-cffd-4772-bc84-76c2066d6f00	0115-9929	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate	Extended-Release	Dextroamphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	19760802		NDA AUTHORIZED GENERIC	NDA017078	Amneal Pharmaceuticals of New York LLC	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0115-9930_be1c7c11-31c8-4e84-bf0a-e395f0a21485	0115-9930	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Amneal Pharmaceuticals of New York LLC	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0115-9931_be1c7c11-31c8-4e84-bf0a-e395f0a21485	0115-9931	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Amneal Pharmaceuticals of New York LLC	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0115-9932_be1c7c11-31c8-4e84-bf0a-e395f0a21485	0115-9932	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Amneal Pharmaceuticals of New York LLC	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0115-9935_891b3e74-8a1b-49f6-9621-8d6ce4628e37	0115-9935	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090723		NDA AUTHORIZED GENERIC	NDA050808	Amneal Pharmaceuticals of New York, LLC	MINOCYCLINE HYDROCHLORIDE	65	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0115-9936_891b3e74-8a1b-49f6-9621-8d6ce4628e37	0115-9936	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090723		NDA AUTHORIZED GENERIC	NDA050808	Amneal Pharmaceuticals of New York, LLC	MINOCYCLINE HYDROCHLORIDE	115	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0116-0003_a187f677-2f93-8f95-e053-2a95a90a4c59	0116-0003	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate 0.12% Oral Rinse		CHLORHEXIDINE GLUCONATE	LIQUID	BUCCAL	20140120		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	[iU]/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0038_f8103984-51d8-79c6-e053-6394a90a4fae	0116-0038	HUMAN OTC DRUG	Bactoshield CHG		Chlorhexidine Gluconate 2%	SOLUTION	TOPICAL	20221116		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	2	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0039_f80ba3b9-c810-c003-e053-6394a90aff16	0116-0039	HUMAN OTC DRUG	Bactoshield CHG		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20221121		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	2	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0039_f810a273-b607-9c66-e053-6294a90a18d3	0116-0039	HUMAN OTC DRUG	Bactoshield CHG		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20221122		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	2	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0061_bb2b6cd5-ec59-4142-e053-2a95a90a74df	0116-0061	HUMAN OTC DRUG	Cardinal Health		CHLORHEXIDINE GLUCONATE 4%	LIQUID	TOPICAL	20150724		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0101_a1895aa7-b2bc-dc71-e053-2995a90a2e4f	0116-0101	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	LIQUID	ORAL	20160122		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	.12	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0113_a0c0511b-f250-3c76-e053-2995a90a6b22	0116-0113	HUMAN OTC DRUG	Cardinal Health Antiseptic Skin Cleanser		CHLORHEXIDINE GLUCONATE 2%	SOLUTION	TOPICAL	20150501		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	2	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0115_a18a2708-24d5-1183-e053-2a95a90a24dc	0116-0115	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20140220		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0137_b14390d9-9a73-5a11-e053-2a95a90acfab	0116-0137	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20130401		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0161_b143c4c5-6666-9a9b-e053-2a95a90a7057	0116-0161	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20110501		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0162_b1448a61-1e20-dfb1-e053-2995a90a50b1	0116-0162	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20140101		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0175_0cf7569c-188e-e844-e063-6294a90a8e4f	0116-0175	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20090618		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0200_b17c8d6c-9d57-ab28-e053-2a95a90a9453	0116-0200	HUMAN PRESCRIPTION DRUG	BETASEPT		Antiseptic Surgical Scrub	SOLUTION	TOPICAL	19930601		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	.04	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0228_b17ca396-40c6-aae9-e053-2a95a90a36e6	0116-0228	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20121030		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0237_b17cea6b-d75a-2665-e053-2a95a90a9b78	0116-0237	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20140220		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0244_b17d2149-2713-07f7-e053-2995a90a8fba	0116-0244	HUMAN PRESCRIPTION DRUG	Denti-Care Denti-Rinse	Chlorhexidine Gluconate Oral Rinse	Chlorhexidine Gluconante	LIQUID	DENTAL	20060602		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0301_b17da9aa-afcb-7a7d-e053-2995a90a7cce	0116-0301	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20100805		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0401_b17dd463-5252-20ff-e053-2995a90ac95a	0116-0401	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20131101		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0407_0c7dba2f-352a-280d-e063-6394a90ad976	0116-0407	HUMAN PRESCRIPTION DRUG	ANTISEPTIC SKIN CLEANSER		CHLORHEXIDINE GLUCONATE	SOLUTION	TOPICAL	20120101		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0505_b17e4edc-c82c-85a7-e053-2995a90a8e36	0116-0505	HUMAN OTC DRUG	BD E-Z Scrub		chlorhexidine gluconate	SOLUTION	TOPICAL	20060101		NDA	NDA019127	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	40	g/1000mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0506_b17f807f-8272-5e52-e053-2995a90ac190	0116-0506	HUMAN OTC DRUG	BD E-Z Scrub		chlorhexidine gluconate	SOLUTION	TOPICAL	20010401		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0620_f0711fbf-b273-0705-e053-2a95a90a131a	0116-0620	HUMAN PRESCRIPTION DRUG	Peridex		chlorhexidine gluconate	RINSE	ORAL	19860813		NDA	NDA019028	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0767_0c7ed4df-8e3e-7b4f-e063-6294a90a494c	0116-0767	HUMAN OTC DRUG	Antiseptic Skin Cleanser		CHLORHEXIDINE GLUCONATE 4%	LIQUID	TOPICAL	20110831		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0800_0cf77b88-229d-b17c-e063-6394a90a7211	0116-0800	HUMAN PRESCRIPTION DRUG	NUPRO Chlorhexidine Gluconate		CHLORHEXIDINE GLUCONATE	RINSE	ORAL	20170117		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0901_0cdebd32-e88e-b4dd-e063-6394a90a8748	0116-0901	HUMAN OTC DRUG	CliniClean		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20230315		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0901_0cdec541-9881-b4db-e063-6394a90a44c2	0116-0901	HUMAN OTC DRUG	CliniClean		CHLORHEXIDINE GLUCONATE 4%	SOLUTION	TOPICAL	20230323		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-0901_f8254e60-4d4b-696e-e053-6294a90a0cf8	0116-0901	HUMAN OTC DRUG	CliniClean		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20230323		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1021_0ccfe45f-217e-27e3-e063-6294a90a984d	0116-1021	HUMAN OTC DRUG	DYNA-HEX	2	Chlorhexidine gluconate	LIQUID	TOPICAL	20140101		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	2	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1021_0cd05cb2-8939-df4d-e063-6294a90a43fd	0116-1021	HUMAN OTC DRUG	DYNA-HEX	2	Chlorhexidine Gluconate	LIQUID	TOPICAL	20140101		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	2	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1022_0c808ebd-1bf8-175d-e063-6294a90ae7df	0116-1022	HUMAN OTC DRUG	Dyna-Hex 2		Chlorhexidine Gluconate 2%	SOLUTION	TOPICAL	20231214		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1022_b18f1e18-04d5-ef27-e053-2995a90a7b09	0116-1022	HUMAN OTC DRUG	Dyna-Hex 2		Chlorhexidine Gluconate 2%	SOLUTION	TOPICAL	20160129		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1060_09bfde37-90b8-1319-e063-6294a90a8ffc	0116-1060	HUMAN OTC DRUG	DYNA-HEX 4		Chlorhexidine Gluconate	LIQUID	TOPICAL	20160101		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1060_0c7fd25e-6ad6-1a54-e063-6294a90af27d	0116-1060	HUMAN OTC DRUG	Dyna-Hex 4		Chlorhexidine Gluconate	LIQUID	TOPICAL	20231115		NDA	NDA019127	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1061_0c7ae60a-7f0c-45d0-e063-6394a90a9032	0116-1061	HUMAN OTC DRUG	ANTISEPTIC SKIN CLEANSER		CHLORHEXIDINE GLUCONATE	SOLUTION	TOPICAL	20110831		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1061_0c7b142b-4001-6cfb-e063-6294a90a345f	0116-1061	HUMAN OTC DRUG	ANTISEPTIC SKIN CLEANSER		Chlorhexidine Gluconate	SOLUTION	TOPICAL	20110831		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1061_6e62eb50-ebab-361e-e053-2991aa0aba6f	0116-1061	HUMAN OTC DRUG	ANTISEPTIC SKIN CLEANSER		Chlorhexidine Gluconate	SOLUTION	TOPICAL	20180801		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-1221_0ce1b132-1f2e-d344-e063-6394a90a57d7	0116-1221	HUMAN OTC DRUG	Foster and Thrive		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20231027		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-2001_0cf3f53a-1fe5-92d7-e063-6394a90a9e9d	0116-2001	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20100601		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-2800_b1bc2086-5f5f-29b5-e053-2995a90ad40f	0116-2800	HUMAN OTC DRUG	Antiseptic Skin Cleanser	Exidine-2 CHG	CHLORHEXIDINE GLUCONATE	SOLUTION	TOPICAL	20160701		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	2	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-3678_0c7cbe7f-5411-c3de-e063-6394a90a5e8c	0116-3678	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20130101		NDA	NDA019125	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-4005_f76adfa2-7250-3365-e053-6294a90a1bff	0116-4005	HUMAN PRESCRIPTION DRUG	Lactulose		Lactulose	SOLUTION	ORAL	20220701		ANDA	ANDA075911	Xttrium Laboratories, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0116-4075_e1a5afc7-1921-4bf1-e053-2995a90a8d60	0116-4075	HUMAN PRESCRIPTION DRUG	Acclean Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	LIQUID	ORAL	20091001		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-6000_0cf3bb60-8cd3-865c-e063-6394a90a4486	0116-6000	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20120418		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-6720_e807e9d4-9ee5-0f20-e053-2995a90a1d7c	0116-6720	HUMAN PRESCRIPTION DRUG	Acclean Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	LIQUID	ORAL	20130201		ANDA	ANDA077789	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0116-8500_973e0c34-8585-ba4d-e053-2995a90a8fb0	0116-8500	HUMAN OTC DRUG	Provon Antimicrobial Foam Handwash		Chlorhexidine Gluconate 2%	SOLUTION	TOPICAL	20160701		NDA	NDA019422	Xttrium Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0121-0431_330a01cb-6c41-47eb-ac21-d53be2849c15	0121-0431	HUMAN OTC DRUG	Milk of Magnesia		Magnesium Hydroxide	SUSPENSION	ORAL	19790904		OTC MONOGRAPH DRUG	M007	PAI Holdings, LLC	MAGNESIUM HYDROXIDE	400	mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-0489_e16d8ed2-bd4a-f5d4-e053-2995a90a153b	0121-0489	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	SOLUTION	ORAL	19820210		ANDA	ANDA087513	Pharmaceutical Associates, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0121-0504_6514a566-da45-4e96-a5f7-13aaf8246401	0121-0504	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		ACETAMINOPHEN and CODEINE PHOSPHATE	SOLUTION	ORAL	19810821		ANDA	ANDA087508	PAI Holdings, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	120; 12	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
0121-0531_d4dbd9ed-e7bc-038e-e053-2a95a90a8a27	0121-0531	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	SOLUTION	ORAL	20070219		UNAPPROVED DRUG OTHER		Pharmaceutical Associates, Inc.	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
0121-0576_49eecb65-9859-4e18-b6cb-55b971a4cec3	0121-0576	HUMAN PRESCRIPTION DRUG	Metoclopramide		metoclopramide hydrochloride	SOLUTION	ORAL	19910601		ANDA	ANDA072744	PAI Holdings, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0121-0577_fb1e9286-2489-4141-87b8-1039e49f0d83	0121-0577	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	19660730		ANDA	ANDA074623	PAI Holdings, LLC	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-0581_da2ea885-9583-4475-b0ae-6683825a7587	0121-0581	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	SOLUTION	ORAL	20091110		ANDA	ANDA073037	PAI Holdings, LLC	HALOPERIDOL	2	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0121-0595_efe0dd73-00d4-9223-e053-2a95a90a1bae	0121-0595	HUMAN PRESCRIPTION DRUG	Sodium Citrate and Citric Acid		SODIUM CITRATE and CITRIC ACID MONOHYDRATE	SOLUTION	ORAL	19690101		UNAPPROVED DRUG OTHER		Pharmaceutical Associates, Inc.	ANHYDROUS CITRIC ACID; SODIUM CITRATE	334; 500	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0121-0638_91dc8d9b-2cb4-4a03-a984-a8b921ddd967	0121-0638	HUMAN OTC DRUG	GUAIFENESIN DM		GUAIFENESIN and DEXTROMETHORPHAN	SYRUP	ORAL	19920701		OTC MONOGRAPH DRUG	M012	PAI Holdings, LLC	DEXTROMETHORPHAN; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0121-0646_0bb9609d-2d23-44e8-9134-03515a2f00a9	0121-0646	HUMAN PRESCRIPTION DRUG	AMANTADINE HYDROCHLORIDE		AMANTADINE HYDROCHLORIDE	SOLUTION	ORAL	19950717		ANDA	ANDA074509	PAI Holdings, LLC	AMANTADINE HYDROCHLORIDE	50	mg/5mL	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
0121-0649_e16a0b54-26b1-2426-e053-2995a90ac0be	0121-0649	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine Hydrochloride	SOLUTION	ORAL	20210212		ANDA	ANDA074553	Pharmaceutical Associates, Inc.	CIMETIDINE HYDROCHLORIDE	300	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0121-0653_d5534874-7649-31d6-e053-2995a90ad657	0121-0653	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	SOLUTION, CONCENTRATE	ORAL	20100901		ANDA	ANDA074725	Pharmaceutical Associates, Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0121-0654_76d46ed6-6f95-4232-8f57-83bc2d240142	0121-0654	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	ELIXIR	ORAL	20100831		ANDA	ANDA040146	PAI Holdings, LLC	FLUPHENAZINE HYDROCHLORIDE	.5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0121-0657_043c86f3-1ec6-4073-8a52-105fbe6caf6f	0121-0657	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20070801		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
0121-0658_1ebb3dcc-88c8-4ea6-88f2-0eaf9322d875	0121-0658	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	SOLUTION	ORAL	19970515		ANDA	ANDA040177	PAI Holdings, LLC	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/5mL			N	20241231
0121-0670_f17f56b2-f448-4fad-8501-1358c24fbfe0	0121-0670	HUMAN PRESCRIPTION DRUG	ETHOSUXIMIDE		ETHOSUXIMIDE	SOLUTION	ORAL	20001122		ANDA	ANDA040253	PAI Holdings, LLC	ETHOSUXIMIDE	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0121-0675_4eb69580-587f-49d9-bba5-de1a57302e0f	0121-0675	HUMAN PRESCRIPTION DRUG	VALPROIC ACID		VALPROIC ACID	SOLUTION	ORAL	20050411		ANDA	ANDA075379	PAI Holdings, LLC	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0121-0676_16ac3c3c-e9a4-454b-9d37-3733b7af84fa	0121-0676	HUMAN PRESCRIPTION DRUG	Potassium Citrate and Citric Acid		Potassium Citrate and Citric Acid Monohydrate	SOLUTION	ORAL	19971007		UNAPPROVED DRUG OTHER		PAI Holdings, LLC	CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE	334; 1100	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0121-0677_ef78d6ad-c6b3-4891-8728-910687da39b0	0121-0677	HUMAN PRESCRIPTION DRUG	TRICITRATES		POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE	SOLUTION	ORAL	20050525		UNAPPROVED DRUG OTHER		PAI Holdings, LLC	CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE	334; 550; 500	mg/5mL; mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0121-0678_8740931d-ff81-46f3-b955-83c5f91b265a	0121-0678	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	SOLUTION	ORAL	20000823		ANDA	ANDA075606	PAI Holdings, LLC	NORTRIPTYLINE HYDROCHLORIDE	10	mg/5mL	Tricyclic Antidepressant [EPC]		N	20241231
0121-0721_e16e3979-5182-33f4-e053-2995a90a7339	0121-0721	HUMAN PRESCRIPTION DRUG	Fluoxetine		FLUOXETINE HYDROCHLORIDE	SOLUTION	ORAL	20020130		ANDA	ANDA076015	Pharmaceutical Associates, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0121-0727_d56a22ea-5dab-e98a-e053-2a95a90a34c4	0121-0727	HUMAN PRESCRIPTION DRUG	Ranitidine		RANITIDINE	SYRUP	ORAL	20101101		ANDA	ANDA077405	Pharmaceutical Associates, Inc.	RANITIDINE	15	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0121-0744_c108ab37-931f-428b-b06d-ce2ba776be66	0121-0744	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	SOLUTION	ORAL	20020901		OTC MONOGRAPH DRUG	M012	PAI Holdings, LLC	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0121-0759_a1edb13f-edeb-4916-8aed-dc0b9d341030	0121-0759	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20050425		ANDA	ANDA076913	PAI Holdings, LLC	PREDNISOLONE SODIUM PHOSPHATE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0121-0766_8ff807ab-6224-42f0-b0bb-f28d518bbc52	0121-0766	HUMAN OTC DRUG	Calcium Carbonate		Calcium Carbonate	SUSPENSION	ORAL	20041201		OTC MONOGRAPH DRUG	M001	PAI Holdings, LLC	CALCIUM CARBONATE	1250	mg/5mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0121-0770_e5f67a93-3cca-391b-e053-2a95a90af637	0121-0770	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	LIQUID	ORAL	20101101		ANDA	ANDA090260	Pharmaceutical Associates, Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0121-0772_b29d4daa-3f27-4ff7-b5f2-d94569faf063	0121-0772	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		HYDROCODONE BITARTRATE and ACETAMINOPHEN	SOLUTION	ORAL	20130729		ANDA	ANDA040838	PAI Holdings, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0121-0773_cd3c2ec3-09c0-51d7-e053-2995a90aba82	0121-0773	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20170131		ANDA	ANDA078465	Pharmaceutical Associates, Inc.	PREDNISOLONE SODIUM PHOSPHATE	10	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0121-0775_e16f3d0c-f07b-3d84-e053-2a95a90a2789	0121-0775	HUMAN OTC DRUG	Guaifenesin and Codeine Phosphate		Guaifenesin and Codeine Phosphate	SOLUTION	ORAL	20061001		OTC MONOGRAPH FINAL	part341	Pharmaceutical Associates, Inc.	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
0121-0777_d5792e8c-ee14-64a5-e053-2a95a90ad2fb	0121-0777	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20170131		ANDA	ANDA078988	Pharmaceutical Associates, Inc.	PREDNISOLONE SODIUM PHOSPHATE	20	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0121-0781_3800f39b-4f7e-4727-8580-6e05b3d90542	0121-0781	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20220928		OTC MONOGRAPH NOT FINAL	part343	PAI Holdings, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
0121-0799_abe070cf-8f58-41df-8b24-572a80d0a128	0121-0799	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	SOLUTION	ORAL	20150604		ANDA	ANDA201157	PAI Holdings, LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0121-0810_d57cde69-0eb9-180d-e053-2995a90a33aa	0121-0810	HUMAN PRESCRIPTION DRUG	Nystatin		NYSTATIN	SUSPENSION	ORAL	20160201		ANDA	ANDA203621	Pharmaceutical Associates, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0121-0820_30282017-c9a7-4a0d-8c87-468e2feba567	0121-0820	HUMAN PRESCRIPTION DRUG	THEOPHYLLINE		THEOPHYLLINE	SOLUTION	ORAL	20161216		ANDA	ANDA206344	PAI Holdings, LLC	THEOPHYLLINE	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0121-0825_f0a376c5-7cdd-4243-81c1-0389b83c1ce0	0121-0825	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SOLUTION	ORAL	20161114		ANDA	ANDA206573	PAI Holdings, LLC	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0121-0826_e8095cba-a76f-24ef-e053-2a95a90a3450	0121-0826	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	SOLUTION	ORAL	20180604		ANDA	ANDA206822	Pharmaceutical Associates, Inc.	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0121-0827_81862aa3-6834-4ba9-affd-6376b10be351	0121-0827	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	SOLUTION	ORAL	20190408		ANDA	ANDA206914	PAI Holdings, LLC	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0121-0841_cd3a937e-3347-6368-e053-2a95a90abe56	0121-0841	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20190402		ANDA	ANDA210766	Pharmaceutical Associates, Inc.	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0121-0853_d78243e9-f204-909e-e053-2a95a90ac4b1	0121-0853	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	19830701		NDA	NDA018615	Pharmaceutical Associates, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0121-0854_c12524e1-2c97-49c2-b2d9-35366f72907c	0121-0854	HUMAN PRESCRIPTION DRUG	SULFATRIM		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	19830701		NDA	NDA018615	PAI Holdings, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0121-0865_c4e71fc9-c7e0-e4cd-e053-2995a90a4508	0121-0865	HUMAN OTC DRUG	Diphenhydramine HCl Oral Solution		diphenhydramine hydrochloride	SOLUTION	ORAL	20200618		OTC MONOGRAPH FINAL	part341	Pharmaceutical Associates, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0121-0867_10c31aed-0d69-49ba-9747-7c7119c87c5d	0121-0867	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20190725		ANDA	ANDA210729	PAI Holdings, LLC	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0121-0867_46c61b28-1b3a-4f06-bcba-bf1fba0a6287	0121-0867	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20190725		ANDA	ANDA210729	PAI Holdings, LLC	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0121-0868_dffe6584-ea26-48e3-bb20-ac2dab65d433	0121-0868	HUMAN PRESCRIPTION DRUG	Nystatin		NYSTATIN	SUSPENSION	ORAL	20200717		ANDA	ANDA203621	PAI Holdings, LLC	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0121-0873_f0597d2a-6162-74d7-e053-2995a90a9894	0121-0873	HUMAN PRESCRIPTION DRUG	LACTULOSE		Lactulose	SOLUTION	ORAL	20191203		ANDA	ANDA074623	Pharmaceutical Associates, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-0885_d62d7894-79cb-4aab-8c94-bff4e1312a1d	0121-0885	HUMAN PRESCRIPTION DRUG	Prednisolone		Prednisolone	SOLUTION	ORAL	20230912		ANDA	ANDA040571	PAI Holdings, LLC	PREDNISOLONE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0121-0890_10c31aed-0d69-49ba-9747-7c7119c87c5d	0121-0890	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20190725		ANDA	ANDA210729	PAI Holdings, LLC	VANCOMYCIN HYDROCHLORIDE	250	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0121-0890_46c61b28-1b3a-4f06-bcba-bf1fba0a6287	0121-0890	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20190725		ANDA	ANDA210729	PAI Holdings, LLC	VANCOMYCIN HYDROCHLORIDE	250	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0121-0892_598abf5c-cda1-4f2b-80a6-08244044c5ee	0121-0892	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20040408		ANDA	ANDA040521	PAI Holdings, LLC	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0121-0893_efe0b1c4-571c-e951-e053-2995a90a7883	0121-0893	HUMAN PRESCRIPTION DRUG	CHLORHEXIDINE GLUCONATE		CHLORHEXIDINE GLUCONATE	RINSE	ORAL	19951215		ANDA	ANDA074522	Pharmaceutical Associates, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0121-0898_9e2c72f3-ce14-4bcf-9fa6-b9533894d4dc	0121-0898	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20181011		ANDA	ANDA210692	PAI Holdings, LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
0121-0902_c2c5fb34-8e7e-4954-e053-2a95a90ad0ad	0121-0902	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20040525		ANDA	ANDA075988	Pharmaceutical Associates, Inc.	PREDNISOLONE SODIUM PHOSPHATE	5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0121-0903_d5c843b5-65cb-b0a4-e053-2995a90a29e6	0121-0903	HUMAN PRESCRIPTION DRUG	Lidocaine Viscous		Lidocaine Hydrochloride	SOLUTION	ORAL	19850426		ANDA	ANDA088802	Pharmaceutical Associates, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0121-0904_60135685-b14b-44bf-95a7-f64e951d6aef	0121-0904	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20170317		NDA	NDA022195	PAI Holdings, LLC	MORPHINE SULFATE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0121-0905_cc0d49f5-c681-9d48-e053-2a95a90a597b	0121-0905	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	SOLUTION	ORAL	19870403		ANDA	ANDA070928	Pharmaceutical Associates, Inc.	DIAZEPAM	5	mg/5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0121-0908_e20b8c76-152c-9fee-e053-2a95a90aa52d	0121-0908	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	SOLUTION	ORAL	20210903		ANDA	ANDA070979	Pharmaceutical Associates, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0121-0910_bf4391f3-878b-46e1-ae72-9c03e9f605dd	0121-0910	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20200717		OTC MONOGRAPH FINAL	part335	PAI Holdings, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0121-0914_e78c2544-9dfe-6399-e053-2995a90ac3d0	0121-0914	HUMAN OTC DRUG	Childrens Ibuprofen Oral Suspension		Ibuprofen	SUSPENSION	ORAL	19990430		ANDA	ANDA074916	Pharmaceutical Associates, Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0121-0917_e1e1b2a4-6261-ad42-e053-2995a90a3407	0121-0917	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	19990430		ANDA	ANDA074916	Pharmaceutical Associates, Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0121-0918_d30c087d-a4bf-d940-e053-2995a90a1588	0121-0918	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170623		ANDA	ANDA209204	Pharmaceutical Associates, Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0121-0925_6468c79b-ff80-4d93-ad5a-7a63f54b5c70	0121-0925	HUMAN PRESCRIPTION DRUG	Promethazine VC with Codeine Oral Solution		Promethazine and Phenylephrine Hydrochloride and Codeine Phosphate	SOLUTION	ORAL	20210318		ANDA	ANDA040660	PAI Holdings, LLC	CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE	10; 5; 6.25	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]	CV	N	20241231
0121-0926_ece63603-a56d-428f-83dd-c8833c079261	0121-0926	HUMAN PRESCRIPTION DRUG	Promethazine VC		Promethazine Hydrochloride and Phenylephrine Hydrochloride	SOLUTION	ORAL	20210311		ANDA	ANDA040654	PAI Holdings, LLC	PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE	5; 6.25	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0121-0935_c9acc4ea-adee-3c73-e053-2a95a90a9702	0121-0935	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium Liquid	LIQUID	ORAL	20210816		OTC MONOGRAPH NOT FINAL	part334	Pharmaceutical Associates, Inc.	DOCUSATE SODIUM	50	mg/5mL			N	20241231
0121-0940_e521d5c6-0af8-4dc2-875e-5112fea8a10f	0121-0940	HUMAN OTC DRUG	Milk of Magnesia Concentrate		MAGNESIUM HYDROXIDE	SUSPENSION	ORAL	20220118		OTC MONOGRAPH DRUG	M007	PAI Holdings, LLC	MAGNESIUM HYDROXIDE	2400	mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-0941_bb9f2724-a561-4f6f-99f4-5da289be4906	0121-0941	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20210903		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
0121-0942_bcf8792a-6df2-41d6-b10e-70525f6cec5e	0121-0942	HUMAN PRESCRIPTION DRUG	Phenobarbital Oral Solution		Phenobarbital Oral	SOLUTION	ORAL	20210820		UNAPPROVED DRUG OTHER		PAI Holdings, LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
0121-0945_d336fb0b-58c7-4d98-e053-2995a90a6cca	0121-0945	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20010725		ANDA	ANDA075671	Pharmaceutical Associates, Inc.	MEGESTROL ACETATE	400	mg/10mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0121-0946_dff1f086-659e-c701-e053-2995a90a4175	0121-0946	HUMAN OTC DRUG	Childrens Acetaminophen		Childrens Acetaminophen	SUSPENSION	ORAL	20210907		OTC MONOGRAPH NOT FINAL	part343	Pharmaceutical Associates, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
0121-0947_c64c38ed-d17b-47d3-9538-23663d4c4027	0121-0947	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	SUSPENSION	ORAL	20211007		ANDA	ANDA076729	PAI Holdings, LLC	CARBAMAZEPINE	100	mg/5mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0121-0948_e4270913-0970-4a5a-8f92-825b84a29ffc	0121-0948	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20230327		ANDA	ANDA210766	PAI Holdings, LLC	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0121-0966_e24e0f6b-f066-48ef-a477-da9db822e800	0121-0966	HUMAN OTC DRUG	Childrens Acetaminophen Oral Suspension		Acetaminophen	SUSPENSION	ORAL	20220309		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
0121-0970_66f585b5-28c3-4e0b-a631-a8c65bda0324	0121-0970	HUMAN OTC DRUG	Lidocaine Pain Relief		Lidocaine Pain Relief	PATCH	TOPICAL	20230403		OTC MONOGRAPH DRUG	505G(a)(3)	PAI Holdings, LLC	LIDOCAINE	560	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0121-0972_c3b999d0-6f71-405e-858b-5ad5cacd5c7d	0121-0972	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	TOPICAL	20230731		ANDA	ANDA204494	PAI Holdings, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0121-0974_cac2ff1f-650b-468d-b55c-f0e105f456c3	0121-0974	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20220315		ANDA	ANDA211884	PAI Holdings, LLC	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
0121-0978_e16d8ed2-bd4a-f5d4-e053-2995a90a153b	0121-0978	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	SOLUTION	ORAL	19820210		ANDA	ANDA087513	Pharmaceutical Associates, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0121-1008_6514a566-da45-4e96-a5f7-13aaf8246401	0121-1008	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		ACETAMINOPHEN and CODEINE PHOSPHATE	SOLUTION	ORAL	19810821		ANDA	ANDA087508	PAI Holdings, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/12.5mL; mg/12.5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
0121-1012_597d3a63-1ba4-4680-9329-dd60ef73fbaf	0121-1012	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20220826		ANDA	ANDA216151	PAI Holdings, LLC	LACOSAMIDE	50	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0121-1016_053210ad-3cd0-406a-bd66-05d866924ae7	0121-1016	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20240110		ANDA	ANDA214272	PAI Holdings, LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20251231
0121-1018_2716284d-460e-4e97-8a8b-5b0c0dcf2c91	0121-1018	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20230905		ANDA	ANDA204431	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0121-1019_a8612260-6b87-416e-be1e-23aef7b9c27e	0121-1019	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride		buprenorphine hydrochloride	TABLET	SUBLINGUAL	20231012		ANDA	ANDA090622	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0121-1022_23007273-636b-4875-9bc5-187a2082d027	0121-1022	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20231103		ANDA	ANDA210602	PAI Holdings, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0121-1154_fb1e9286-2489-4141-87b8-1039e49f0d83	0121-1154	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	19660730		ANDA	ANDA074623	PAI Holdings, LLC	LACTULOSE	20	g/30mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-1190_efe0dd73-00d4-9223-e053-2a95a90a1bae	0121-1190	HUMAN PRESCRIPTION DRUG	Sodium Citrate and Citric Acid		SODIUM CITRATE and CITRIC ACID MONOHYDRATE	SOLUTION	ORAL	19690101		UNAPPROVED DRUG OTHER		Pharmaceutical Associates, Inc.	ANHYDROUS CITRIC ACID; SODIUM CITRATE	334; 500	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0121-1276_91dc8d9b-2cb4-4a03-a984-a8b921ddd967	0121-1276	HUMAN OTC DRUG	GUAIFENESIN DM		GUAIFENESIN and DEXTROMETHORPHAN	SYRUP	ORAL	19920701		OTC MONOGRAPH DRUG	M012	PAI Holdings, LLC	DEXTROMETHORPHAN; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0121-1298_e16a0b54-26b1-2426-e053-2995a90ac0be	0121-1298	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine Hydrochloride	SOLUTION	ORAL	20210326		ANDA	ANDA074553	Pharmaceutical Associates, Inc.	CIMETIDINE HYDROCHLORIDE	400	mg/6.67mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0121-1314_043c86f3-1ec6-4073-8a52-105fbe6caf6f	0121-1314	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20070801		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	325	mg/10.15mL			N	20241231
0121-1350_4eb69580-587f-49d9-bba5-de1a57302e0f	0121-1350	HUMAN PRESCRIPTION DRUG	VALPROIC ACID		VALPROIC ACID	SOLUTION	ORAL	20050411		ANDA	ANDA075379	PAI Holdings, LLC	VALPROIC ACID	500	mg/10mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0121-1488_c108ab37-931f-428b-b06d-ce2ba776be66	0121-1488	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	SOLUTION	ORAL	20020901		OTC MONOGRAPH DRUG	M012	PAI Holdings, LLC	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0121-1544_b29d4daa-3f27-4ff7-b5f2-d94569faf063	0121-1544	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		HYDROCODONE BITARTRATE and ACETAMINOPHEN	SOLUTION	ORAL	20130729		ANDA	ANDA040838	PAI Holdings, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	217; 5	mg/10mL; mg/10mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0121-1550_e16f3d0c-f07b-3d84-e053-2a95a90a2789	0121-1550	HUMAN OTC DRUG	Guaifenesin and Codeine Phosphate		Guaifenesin and Codeine Phosphate	SOLUTION	ORAL	20061001		OTC MONOGRAPH FINAL	part341	Pharmaceutical Associates, Inc.	CODEINE PHOSPHATE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
0121-1576_49eecb65-9859-4e18-b6cb-55b971a4cec3	0121-1576	HUMAN PRESCRIPTION DRUG	Metoclopramide		metoclopramide hydrochloride	SOLUTION	ORAL	19910601		ANDA	ANDA072744	PAI Holdings, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0121-1598_abe070cf-8f58-41df-8b24-572a80d0a128	0121-1598	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	SOLUTION	ORAL	20150604		ANDA	ANDA201157	PAI Holdings, LLC	LEVETIRACETAM	1000	mg/10mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0121-1680_cd3a937e-3347-6368-e053-2a95a90abe56	0121-1680	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20190402		ANDA	ANDA210766	Pharmaceutical Associates, Inc.	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0121-1730_c4e71fc9-c7e0-e4cd-e053-2995a90a4508	0121-1730	HUMAN OTC DRUG	Diphenhydramine HCl Oral Solution		diphenhydramine hydrochloride	SOLUTION	ORAL	20200618		OTC MONOGRAPH FINAL	part341	Pharmaceutical Associates, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0121-1744_c108ab37-931f-428b-b06d-ce2ba776be66	0121-1744	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	SOLUTION	ORAL	20020901		OTC MONOGRAPH DRUG	M012	PAI Holdings, LLC	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0121-1746_f0597d2a-6162-74d7-e053-2995a90a9894	0121-1746	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	20191203		ANDA	ANDA074623	Pharmaceutical Associates, Inc.	LACTULOSE	20	g/30mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-1760_e499949c-ef7f-4dd3-927d-b069e0625e82	0121-1760	HUMAN OTC DRUG	Mag-AL Liquid		Aluminum Hydroxide and Magnesium Hydroxide	SUSPENSION	ORAL	20040114		OTC MONOGRAPH FINAL	part331	PAI Holdings, LLC	ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE	200; 200	mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-1761_0ea0464a-35c2-48c9-88c0-d598cbd887c3	0121-1761	HUMAN OTC DRUG	Mag-AL Plus		Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone	SUSPENSION	ORAL	20040114		OTC MONOGRAPH DRUG	M001	PAI Holdings, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-1762_26a1e1ff-f122-4a93-bd12-038ba262677b	0121-1762	HUMAN OTC DRUG	Mag-AL Plus	XS	Aluminum Hydroxide, Magnesium Hydroxide, and Dimethicone	SUSPENSION	ORAL	20040114		OTC MONOGRAPH DRUG	M002	PAI Holdings, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-1775_e16f3d0c-f07b-3d84-e053-2a95a90a2789	0121-1775	HUMAN OTC DRUG	Guaifenesin and Codeine Phosphate		Guaifenesin and Codeine Phosphate	SOLUTION	ORAL	20061001		OTC MONOGRAPH FINAL	part341	Pharmaceutical Associates, Inc.	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
0121-1781_86d6208e-7b1a-4837-8a92-61ea615cda32	0121-1781	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20070917		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
0121-1796_9e2c72f3-ce14-4bcf-9fa6-b9533894d4dc	0121-1796	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20181011		ANDA	ANDA210692	PAI Holdings, LLC	ATOVAQUONE	1500	mg/10mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
0121-1828_e78c2544-9dfe-6399-e053-2995a90ac3d0	0121-1828	HUMAN OTC DRUG	Childrens Ibuprofen Oral Suspension		Ibuprofen	SUSPENSION	ORAL	19990430		ANDA	ANDA074916	Pharmaceutical Associates, Inc.	IBUPROFEN	100	mg/10mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0121-1870_c9acc4ea-adee-3c73-e053-2a95a90a9702	0121-1870	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium Liquid	LIQUID	ORAL	20210816		OTC MONOGRAPH NOT FINAL	part334	Pharmaceutical Associates, Inc.	DOCUSATE SODIUM	100	mg/10mL			N	20241231
0121-1882_bb9f2724-a561-4f6f-99f4-5da289be4906	0121-1882	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20210903		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	325	mg/10.15mL			N	20241231
0121-1884_bcf8792a-6df2-41d6-b10e-70525f6cec5e	0121-1884	HUMAN PRESCRIPTION DRUG	Phenobarbital Oral Solution		Phenobarbital Oral	SOLUTION	ORAL	20210820		UNAPPROVED DRUG OTHER		PAI Holdings, LLC	PHENOBARBITAL	30	mg/7.5mL		CIV	N	20241231
0121-1894_c64c38ed-d17b-47d3-9538-23663d4c4027	0121-1894	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	SUSPENSION	ORAL	20211007		ANDA	ANDA076729	PAI Holdings, LLC	CARBAMAZEPINE	200	mg/10mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0121-1896_e4270913-0970-4a5a-8f92-825b84a29ffc	0121-1896	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20230327		ANDA	ANDA210766	PAI Holdings, LLC	POTASSIUM CHLORIDE	20	meq/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0121-1971_043c86f3-1ec6-4073-8a52-105fbe6caf6f	0121-1971	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20070801		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	650	mg/20.3mL			N	20241231
0121-2024_597d3a63-1ba4-4680-9329-dd60ef73fbaf	0121-2024	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20220826		ANDA	ANDA216151	PAI Holdings, LLC	LACOSAMIDE	100	mg/10mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0121-2036_2716284d-460e-4e97-8a8b-5b0c0dcf2c91	0121-2036	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20230905		ANDA	ANDA204431	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0121-2038_a8612260-6b87-416e-be1e-23aef7b9c27e	0121-2038	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride		buprenorphine hydrochloride	TABLET	SUBLINGUAL	20231012		ANDA	ANDA090622	PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0121-2232_c108ab37-931f-428b-b06d-ce2ba776be66	0121-2232	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	SOLUTION	ORAL	20020901		OTC MONOGRAPH DRUG	M012	PAI Holdings, LLC	GUAIFENESIN	300	mg/15mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0121-2316_b29d4daa-3f27-4ff7-b5f2-d94569faf063	0121-2316	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		HYDROCODONE BITARTRATE and ACETAMINOPHEN	SOLUTION	ORAL	20130729		ANDA	ANDA040838	PAI Holdings, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0121-2397_abe070cf-8f58-41df-8b24-572a80d0a128	0121-2397	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	SOLUTION	ORAL	20150604		ANDA	ANDA201157	PAI Holdings, LLC	LEVETIRACETAM	1500	mg/15mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0121-2520_cd3a937e-3347-6368-e053-2a95a90abe56	0121-2520	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20190402		ANDA	ANDA210766	Pharmaceutical Associates, Inc.	POTASSIUM CHLORIDE	40	meq/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0121-2823_bb9f2724-a561-4f6f-99f4-5da289be4906	0121-2823	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20210903		OTC MONOGRAPH DRUG	M013	PAI Holdings, LLC	ACETAMINOPHEN	650	mg/20.3mL			N	20241231
0121-2826_bcf8792a-6df2-41d6-b10e-70525f6cec5e	0121-2826	HUMAN PRESCRIPTION DRUG	Phenobarbital Oral Solution		Phenobarbital Oral	SOLUTION	ORAL	20210820		UNAPPROVED DRUG OTHER		PAI Holdings, LLC	PHENOBARBITAL	60	mg/15mL		CIV	N	20241231
0121-2847_e4270913-0970-4a5a-8f92-825b84a29ffc	0121-2847	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20230327		ANDA	ANDA210766	PAI Holdings, LLC	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0121-3036_597d3a63-1ba4-4680-9329-dd60ef73fbaf	0121-3036	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20220826		ANDA	ANDA216151	PAI Holdings, LLC	LACOSAMIDE	150	mg/15mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0121-4048_597d3a63-1ba4-4680-9329-dd60ef73fbaf	0121-4048	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20220826		ANDA	ANDA216151	PAI Holdings, LLC	LACOSAMIDE	200	mg/20mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0121-4577_fb1e9286-2489-4141-87b8-1039e49f0d83	0121-4577	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	19660730		ANDA	ANDA074623	PAI Holdings, LLC	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0121-4675_4eb69580-587f-49d9-bba5-de1a57302e0f	0121-4675	HUMAN PRESCRIPTION DRUG	VALPROIC ACID		VALPROIC ACID	SOLUTION	ORAL	20050411		ANDA	ANDA075379	PAI Holdings, LLC	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0121-4721_e16e3979-5182-33f4-e053-2995a90a7339	0121-4721	HUMAN PRESCRIPTION DRUG	Fluoxetine		FLUOXETINE HYDROCHLORIDE	SOLUTION	ORAL	20020201		ANDA	ANDA076015	Pharmaceutical Associates, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0121-4727_d56a22ea-5dab-e98a-e053-2a95a90a34c4	0121-4727	HUMAN PRESCRIPTION DRUG	Ranitidine		RANITIDINE	SYRUP	ORAL	20101101		ANDA	ANDA077405	Pharmaceutical Associates, Inc.	RANITIDINE	15	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0121-4766_8ff807ab-6224-42f0-b0bb-f28d518bbc52	0121-4766	HUMAN OTC DRUG	Calcium Carbonate		Calcium Carbonate	SUSPENSION	ORAL	20041201		OTC MONOGRAPH DRUG	M001	PAI Holdings, LLC	CALCIUM CARBONATE	1250	mg/5mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0121-4772_b29d4daa-3f27-4ff7-b5f2-d94569faf063	0121-4772	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		HYDROCODONE BITARTRATE and ACETAMINOPHEN	SOLUTION	ORAL	20130729		ANDA	ANDA040838	PAI Holdings, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	108; 2.5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0121-4799_abe070cf-8f58-41df-8b24-572a80d0a128	0121-4799	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	SOLUTION	ORAL	20150604		ANDA	ANDA201157	PAI Holdings, LLC	LEVETIRACETAM	500	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0121-4810_d57cde69-0eb9-180d-e053-2995a90a33aa	0121-4810	HUMAN PRESCRIPTION DRUG	Nystatin		NYSTATIN	SUSPENSION	ORAL	20160201		ANDA	ANDA203621	Pharmaceutical Associates, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0121-4811_d2bc7ada-7c23-34be-e053-2a95a90ac145	0121-4811	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		Hydrocodone Bitartrate and Homatropine Methylbromide	SYRUP	ORAL	20091228		ANDA	ANDA088008	Pharmaceutical Associates, Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0121-4820_30282017-c9a7-4a0d-8c87-468e2feba567	0121-4820	HUMAN PRESCRIPTION DRUG	THEOPHYLLINE		THEOPHYLLINE	SOLUTION	ORAL	20161216		ANDA	ANDA206344	PAI Holdings, LLC	THEOPHYLLINE	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0121-4827_81862aa3-6834-4ba9-affd-6376b10be351	0121-4827	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	SOLUTION	ORAL	20190408		ANDA	ANDA206914	PAI Holdings, LLC	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0121-4839_d57d9fd8-8252-3c89-e053-2995a90aa9f3	0121-4839	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20160516		ANDA	ANDA206456	Pharmaceutical Associates, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0121-4948_e4270913-0970-4a5a-8f92-825b84a29ffc	0121-4948	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20230327		ANDA	ANDA210766	PAI Holdings, LLC	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0121-4967_e79e9c91-c923-6c35-e053-2a95a90aa851	0121-4967	HUMAN OTC DRUG	Senna Syrup		sennosides	LIQUID	ORAL	20220322		OTC MONOGRAPH NOT FINAL	part334	Pharmaceutical Associates, Inc.	SENNOSIDES	8.8	mg/5mL			N	20241231
0126-0016_f4c2f476-bdd5-49d1-80f7-361be61e47e5	0126-0016	HUMAN PRESCRIPTION DRUG	PreviDent	5000 Dry Mouth	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20090706		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	6.1	mg/mL			N	20241231
0126-0022_6b3ab11f-e5c3-460b-8519-1214876dd629	0126-0022	HUMAN PRESCRIPTION DRUG	PreviDent 5000 Enamel Protect		SODIUM FLUORIDE and POTASSIUM NITRATE	GEL, DENTIFRICE	DENTAL	20110330		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	57.5; 5.8	mg/mL; mg/mL			N	20241231
0126-0032_7adda5d7-0176-42ab-8331-ae3deeb0c935	0126-0032	HUMAN OTC DRUG	Colgate Phos-Flur Ortho Defense Alcohol Free Anticavity Mint Fluoride		SODIUM FLUORIDE	RINSE	DENTAL	20110112		OTC MONOGRAPH FINAL	part355	Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	2	mg/10mL			N	20241231
0126-0033_228280d8-dad7-4a08-98f4-e9166df917e8	0126-0033	HUMAN PRESCRIPTION DRUG	PreviDent Alcohol Free		Sodium Fluoride	MOUTHWASH	DENTAL	20160613		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	.9	mg/mL			N	20241231
0126-0034_48c88d15-0f72-4adf-b918-1f183b64c6d5	0126-0034	HUMAN OTC DRUG	Colgate Phos-Flur Ortho Defense Alcohol Free Anticavity Gushing Grape Fluoride		SODIUM FLUORIDE	RINSE	DENTAL	20110215		OTC MONOGRAPH FINAL	part355	Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	2	mg/10mL			N	20241231
0126-0070_9d1b6e76-002b-49e4-b483-be15723a03d6	0126-0070	HUMAN PRESCRIPTION DRUG	PreviDent	5000 Sensitive	Sodium fluoride and Potassium nitrate	GEL, DENTIFRICE	DENTAL	20090706		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	57.5; 5.8	mg/mL; mg/mL			N	20241231
0126-0072_90367a2b-d35d-46dd-82cc-60c8dacc5f75	0126-0072	HUMAN PRESCRIPTION DRUG	PreviDent 5000 Booster Plus Fruitastic		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20150301		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	6	mg/mL			N	20241231
0126-0074_0225f351-5f0f-4edf-b2c9-417f05adb0b8	0126-0074	HUMAN PRESCRIPTION DRUG	PrevidDent 5000 Booster Plus Spearmint		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20150301		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	6	mg/mL			N	20241231
0126-0083_56331d75-a18b-434d-a26c-0ee9cf160d55	0126-0083	HUMAN OTC DRUG	Peroxyl Mouth Sore Mild Mint		Hydrogen Peroxide	RINSE	BUCCAL	20090101		OTC MONOGRAPH NOT FINAL	part356	Colgate Oral Pharmaceuticals, Inc.	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
0126-0088_e16a75ef-1e92-474e-8134-f9f3416a07ef	0126-0088	HUMAN PRESCRIPTION DRUG	PreviDent Fresh Mint		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20120829		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	5	mg/g			N	20241231
0126-0165_da8d4753-973b-4192-9f9a-70000bb9eaee	0126-0165	HUMAN OTC DRUG	Gel-Kam Fruit and Berry		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	19900101		OTC MONOGRAPH FINAL	part355	Colgate Oral Pharmaceuticals, Inc.	STANNOUS FLUORIDE	1	mg/g			N	20241231
0126-0192_da8d4753-973b-4192-9f9a-70000bb9eaee	0126-0192	HUMAN OTC DRUG	Gel-Kam Mint		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	19900101		OTC MONOGRAPH FINAL	part355	Colgate Oral Pharmaceuticals, Inc.	STANNOUS FLUORIDE	1	mg/g			N	20241231
0126-0272_95ea00bd-fed8-4cc0-84a4-f45c33d87094	0126-0272	HUMAN PRESCRIPTION DRUG	Periogard Alcohol Free		Chlorhexidine Gluconate	RINSE	BUCCAL	20201118		ANDA	ANDA203212	Colgate Oral Pharmaceuticals, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0126-0282_2eb30568-8cea-42ca-88f4-ca5add1c3d75	0126-0282	HUMAN PRESCRIPTION DRUG	Periogard Alcohol Free		Chlorhexidine Gluconate	RINSE	BUCCAL	20211004		ANDA	ANDA203212	Colgate Oral Pharmaceuticals, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0126-0286_5aa1cb04-ad2b-4675-a4bc-f6d8b04513d9	0126-0286	HUMAN PRESCRIPTION DRUG	PreviDent	5000 Plus Fruitastic	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20120829		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	11	mg/g			N	20241231
0126-0287_5aa1cb04-ad2b-4675-a4bc-f6d8b04513d9	0126-0287	HUMAN PRESCRIPTION DRUG	PreviDent	5000 Plus Spearmint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20120829		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	11	mg/g			N	20241231
0126-0288_e16a75ef-1e92-474e-8134-f9f3416a07ef	0126-0288	HUMAN PRESCRIPTION DRUG	PreviDent Very Berry		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20120829		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	5	mg/g			N	20241231
0126-0289_7614b377-1c90-4bce-a8d7-f439ec93ceb8	0126-0289	HUMAN PRESCRIPTION DRUG	PreviDent OrthoDefense		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20190304		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	6	mg/mL			N	20241231
0126-0311_ed64b7a2-0604-4737-8077-23622f46a4cb	0126-0311	HUMAN PRESCRIPTION DRUG	PreviDent 5000 Kids		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230701		UNAPPROVED DRUG OTHER		Colgate Oral Pharmaceuticals, Inc.	SODIUM FLUORIDE	6	mg/mL			N	20241231
0131-1810_a8023ff0-e06c-4d04-ad9f-a60d825c4df5	0131-1810	HUMAN PRESCRIPTION DRUG	Vimpat		lacosamide	INJECTION	INTRAVENOUS	20090526		NDA	NDA022254	UCB, Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0131-2477_a8023ff0-e06c-4d04-ad9f-a60d825c4df5	0131-2477	HUMAN PRESCRIPTION DRUG	Vimpat		lacosamide	TABLET, FILM COATED	ORAL	20090526		NDA	NDA022253	UCB, Inc.	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0131-2478_a8023ff0-e06c-4d04-ad9f-a60d825c4df5	0131-2478	HUMAN PRESCRIPTION DRUG	Vimpat		lacosamide	TABLET, FILM COATED	ORAL	20090526		NDA	NDA022253	UCB, Inc.	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0131-2479_a8023ff0-e06c-4d04-ad9f-a60d825c4df5	0131-2479	HUMAN PRESCRIPTION DRUG	Vimpat		lacosamide	TABLET, FILM COATED	ORAL	20090526		NDA	NDA022253	UCB, Inc.	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0131-2480_a8023ff0-e06c-4d04-ad9f-a60d825c4df5	0131-2480	HUMAN PRESCRIPTION DRUG	Vimpat		lacosamide	TABLET, FILM COATED	ORAL	20090526		NDA	NDA022253	UCB, Inc.	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0131-5410_a8023ff0-e06c-4d04-ad9f-a60d825c4df5	0131-5410	HUMAN PRESCRIPTION DRUG	Vimpat		lacosamide	SOLUTION	ORAL	20100420		NDA	NDA022255	UCB, Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0132-0075_0e63b576-c5bd-4a06-b012-08d885bbb816	0132-0075	HUMAN OTC DRUG	Fleet		Glycerin	SUPPOSITORY	RECTAL	19841101		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0132-0081_aefc01c3-9e8b-42df-85a8-bf8ce77334e4	0132-0081	HUMAN OTC DRUG	Pedia-Lax		Glycerin	SUPPOSITORY	RECTAL	20080301		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	GLYCERIN	1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0132-0106_e8816dce-8c24-4e27-9a41-b64eecb0497a	0132-0106	HUMAN OTC DRUG	Pedia-Lax		Docusate Sodium	LIQUID	ORAL	20080301		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	DOCUSATE SODIUM	50	mg/15mL			N	20241231
0132-0107_25b30df6-095c-4ed1-b695-26a7b56b8da0	0132-0107	HUMAN OTC DRUG	Pedia-Lax		Docusate Sodium	LIQUID	ORAL	20200201		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	DOCUSATE SODIUM	50	mg/15mL			N	20241231
0132-0119_5d796181-8d4f-4fb3-b0d2-89352cd9e282	0132-0119	HUMAN OTC DRUG	Fleet		Enema	ENEMA	RECTAL	20110526		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC	7; 19	g/133mL; g/133mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
0132-0185_a1746d99-1b91-47be-83ef-f6e9a1626c41	0132-0185	HUMAN OTC DRUG	Fleet		glycerin	LIQUID	RECTAL	20020603		OTC MONOGRAPH DRUG	M007	C.B. Fleet Company, Inc.	GLYCERIN	5.4	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0132-0190_3f2cb644-2271-42c1-a64b-6351c07e698e	0132-0190	HUMAN OTC DRUG	Pedia-Lax		Glycerin	LIQUID	RECTAL	20080301		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	GLYCERIN	2.8	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0132-0194_15079401-c9d2-49d2-86e4-7cb9b7e5c07d	0132-0194	HUMAN OTC DRUG	Boudreauxs		Zinc Oxide	PASTE	TOPICAL	20161001		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.	ZINC OXIDE	40	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0132-0195_2db5157b-2ca6-4160-bbf6-8fd37ba8bef5	0132-0195	HUMAN OTC DRUG	Pedia-Lax		Glycerin	LIQUID	RECTAL	20190201		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	GLYCERIN	2.8	g/4mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0132-0201_00c5b580-1fe5-49f0-bbca-25506c75cf6f	0132-0201	HUMAN OTC DRUG	Fleet		sodium phosphate, dibasic and sodium phosphate, monobasic	ENEMA	RECTAL	19530310		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC	7; 19	g/133mL; g/133mL			N	20241231
0132-0201_b574e93a-5c0b-4eaa-b8ce-2e5ffc539afe	0132-0201	HUMAN OTC DRUG	Fleet		sodium phosphate, dibasic and sodium phosphate, monobasic	ENEMA	RECTAL	20040625		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC	7; 19	g/230mL; g/230mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0132-0202_b5e01333-93ab-4725-b9b5-bb17c5968729	0132-0202	HUMAN OTC DRUG	Pedia-Lax		sodium phosphate, dibasic and sodium phosphate, monobasic	ENEMA	RECTAL	20020510		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC	3.5; 9.5	g/66mL; g/66mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0132-0208_fa4012b5-0ff1-4521-b066-0cac49f1486f	0132-0208	HUMAN OTC DRUG	PHAZYME		Simethicone	CAPSULE, GELATIN COATED	ORAL	20120201		OTC MONOGRAPH FINAL	part332	C.B. Fleet Company, Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0132-0211_f916cbab-92e9-46a7-aea1-df2dac2e05b2	0132-0211	HUMAN OTC DRUG	PHAZYME		Simethicone	CAPSULE, GELATIN COATED	ORAL	20140401		OTC MONOGRAPH FINAL	part332	C.B. Fleet Company, Inc.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
0132-0217_28126b40-bb23-4f17-920e-73d4d505b87a	0132-0217	HUMAN OTC DRUG	PHAZYME ULTIMATE		SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20210215		OTC MONOGRAPH FINAL	part332	C.B. Fleet Company, Inc.	DIMETHICONE	500	mg/1	Skin Barrier Activity [PE]		N	20241231
0132-0301_749b7e47-7344-44ec-a526-0c7dc18680f2	0132-0301	HUMAN OTC DRUG	FLEET		Mineral Oil	ENEMA	RECTAL	20020501		OTC MONOGRAPH DRUG	M007	C.B. Fleet Company, Inc.	MINERAL OIL	100	g/100mL			N	20241231
0132-0323_506a264b-66b3-4a01-840d-f40fde15cda6	0132-0323	HUMAN OTC DRUG	Boudreauxs		Zinc Oxide	CREAM	TOPICAL	20120201		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.	ZINC OXIDE	40	g/113g			N	20241231
0132-0324_797da4de-e86c-4406-b6e0-de5d4530ca77	0132-0324	HUMAN OTC DRUG	Boudreauxs		Zinc Oxide	OINTMENT	TOPICAL	20191202		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.	ZINC OXIDE	16	g/113g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0132-0325_61d49cc6-c567-4546-badb-e10bc6decf25	0132-0325	HUMAN OTC DRUG	Boudreauxs Rash Kicking Kit		Zinc oxide	KIT	TOPICAL	20180525		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.						N	20241231
0132-0326_4cc9575d-b9dc-4da0-bc07-a6618139eafc	0132-0326	HUMAN OTC DRUG	Boudreauxs Butt Barrier		Dimethicone	OINTMENT	TOPICAL	20220301		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.	DIMETHICONE	1	g/113g	Skin Barrier Activity [PE]		N	20241231
0132-0333_343d2ab8-551d-482a-a4f7-0f70b5a1f8ee	0132-0333	HUMAN OTC DRUG	Boudreauxs		Zinc Oxide	CREAM	TOPICAL	20120201		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.	ZINC OXIDE	16	g/113g			N	20241231
0132-0334_1855f24f-5645-4a73-868c-ae1098c1b99d	0132-0334	HUMAN OTC DRUG	Boudreauxs		Zinc Oxide	CREAM	TOPICAL	20120201		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.	ZINC OXIDE	16	g/113g			N	20241231
0132-0507_428c1326-85da-4bc5-a2ae-1f7e10e31ef0	0132-0507	HUMAN OTC DRUG	PHAZYME		Simethicone and Calcium Carbonate	TABLET, CHEWABLE	ORAL	20160301		OTC MONOGRAPH FINAL	part332	C.B. Fleet Company, Inc.	CALCIUM CARBONATE; DIMETHICONE	750; 250	mg/241; mg/241	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Skin Barrier Activity [PE]		N	20241231
0132-0556_0062c78d-6b52-44d9-8100-a1b0de74d660	0132-0556	HUMAN OTC DRUG	FLEET		Mineral Oil	ENEMA	RECTAL	20020501		OTC MONOGRAPH DRUG	M007	C.B. Fleet Company, Inc.	MINERAL OIL	100	g/100mL			N	20241231
0132-0655_efb807d6-fe33-4e99-8b0b-8bd9e2f09f7d	0132-0655	HUMAN OTC DRUG	Pedia-Lax		Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20080301		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	MAGNESIUM HYDROXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0132-0703_36be417e-8635-49a0-930e-12d1d4b86dcf	0132-0703	HUMAN OTC DRUG	Fleet		Bisacodyl	ENEMA	RECTAL	20020510		OTC MONOGRAPH NOT FINAL	part334	C.B. Fleet Company, Inc.	BISACODYL	10	mg/30mL	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0132-8743_ff494daa-87b9-a7a3-e053-6294a90a6b55	0132-8743	HUMAN OTC DRUG	SUMMERS EVE		povidone-iodine	DOUCHE	VAGINAL	20020510	20260331	OTC MONOGRAPH NOT FINAL	part333E	C.B. Fleet Company, Inc.	POVIDONE-IODINE	4	g/133mL			N	
0132-8744_f7005aae-bd72-43e2-b633-33eb2225507f	0132-8744	HUMAN OTC DRUG	Summers Eve Active Chafe		Dimethicone	GEL	TOPICAL	20210112		OTC MONOGRAPH FINAL	part347	C.B. Fleet Company, Inc.	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
0135-0070_2d63d3e8-3f40-4c05-949b-e38d970f94fd	0135-0070	HUMAN OTC DRUG	TUMS		calcium carbonate	TABLET	ORAL	20100310		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0071_2d63d3e8-3f40-4c05-949b-e38d970f94fd	0135-0071	HUMAN OTC DRUG	TUMS		calcium carbonate	TABLET	ORAL	20100310		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0074_2fefb025-c8e3-45d1-a119-042d4099f924	0135-0074	HUMAN OTC DRUG	TUMS	EX	calcium carbonate	TABLET	ORAL	20100118		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0076_2fefb025-c8e3-45d1-a119-042d4099f924	0135-0076	HUMAN OTC DRUG	TUMS	EX	calcium carbonate	TABLET	ORAL	20100118		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0089_dd3ef3a2-6a92-48b5-b701-fae027d75c57	0135-0089	HUMAN OTC DRUG	CITRUCEL		methylcellulose	POWDER, FOR SOLUTION	ORAL	20100916		OTC MONOGRAPH NOT FINAL	part334	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	METHYLCELLULOSE (4000 MPA.S)	2	g/19g			N	20241231
0135-0090_dd3ef3a2-6a92-48b5-b701-fae027d75c57	0135-0090	HUMAN OTC DRUG	CITRUCEL		methylcellulose	POWDER, FOR SOLUTION	ORAL	20100916		OTC MONOGRAPH NOT FINAL	part334	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	METHYLCELLULOSE (4000 MPA.S)	2	g/10.2g			N	20241231
0135-0094_0ab338be-56a6-284d-e063-6294a90a306f	0135-0094	HUMAN OTC DRUG	GAVISCON		aluminum hydroxide and magnesium carbonate	LIQUID	ORAL	20110114		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	95; 358	mg/15mL; mg/15mL			N	20241231
0135-0095_0ab338be-56a6-284d-e063-6294a90a306f	0135-0095	HUMAN OTC DRUG	GAVISCON		aluminum hydroxide and magnesium carbonate	LIQUID	ORAL	20110114		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
0135-0096_1f37dcea-c641-435b-9d54-efa7f283481a	0135-0096	HUMAN OTC DRUG	Gaviscon	Regular Strength	aluminum hydroxide and magnesium trisilicate	TABLET, CHEWABLE	ORAL	20110613		NDA	NDA018685	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE	80; 14.2	mg/1; mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0135-0098_1f37dcea-c641-435b-9d54-efa7f283481a	0135-0098	HUMAN OTC DRUG	Gaviscon	Extra Strength	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20110613		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
0135-0118_4618db68-f98f-42e1-ade3-23cc4fdad7d6	0135-0118	HUMAN OTC DRUG	TUMS	ULTRA	calcium carbonate	TABLET, CHEWABLE	ORAL	20100212		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
0135-0138_95c5aaa2-3852-4114-9c80-ef2619e36242	0135-0138	HUMAN OTC DRUG	Tums Chewy Bites	Mixed Fruit	calcium carbonate	TABLET, CHEWABLE	ORAL	20220626		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0140_2fefb025-c8e3-45d1-a119-042d4099f924	0135-0140	HUMAN OTC DRUG	TUMS	EX	calcium carbonate	TABLET	ORAL	20100118		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0154_2fefb025-c8e3-45d1-a119-042d4099f924	0135-0154	HUMAN OTC DRUG	TUMS	EX	calcium carbonate	TABLET	ORAL	20100118		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0155_c01ac048-a94e-494f-adbc-95bbf7497fc0	0135-0155	HUMAN OTC DRUG	TUMS	Extra Strength Sugar-Free	calcium carbonate	TABLET, CHEWABLE	ORAL	20180318		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0157_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0157	HUMAN OTC DRUG	Nicorette	Original	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA018612	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0158_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0158	HUMAN OTC DRUG	Nicorette	Original	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0178_2fefb025-c8e3-45d1-a119-042d4099f924	0135-0178	HUMAN OTC DRUG	TUMS	EX	calcium carbonate	TABLET	ORAL	20100118		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0180_4618db68-f98f-42e1-ade3-23cc4fdad7d6	0135-0180	HUMAN OTC DRUG	TUMS	ULTRA	calcium carbonate	TABLET, CHEWABLE	ORAL	20100212		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
0135-0181_4618db68-f98f-42e1-ade3-23cc4fdad7d6	0135-0181	HUMAN OTC DRUG	TUMS	ULTRA	calcium carbonate	TABLET, CHEWABLE	ORAL	20100212		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
0135-0183_b03b5245-b573-4817-8d66-ad1bc90dbe93	0135-0183	HUMAN OTC DRUG	Tums Chewy Bites		calcium carbonate	TABLET, CHEWABLE	ORAL	20190301		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0184_9043983c-7ee4-4971-8885-36f814bb570f	0135-0184	HUMAN OTC DRUG	Tums Chewy Bites	Berry Shake	calcium carbonate	TABLET, CHEWABLE	ORAL	20210305		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0194_09311107-a3c9-17ca-e063-6394a90aab8b	0135-0194	HUMAN OTC DRUG	NICODERM	CQ	nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110512		NDA	NDA020165	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0195_09311107-a3c9-17ca-e063-6394a90aab8b	0135-0195	HUMAN OTC DRUG	NICODERM	CQ	nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110512		NDA	NDA020165	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0196_09311107-a3c9-17ca-e063-6394a90aab8b	0135-0196	HUMAN OTC DRUG	NICODERM	CQ	nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110512		NDA	NDA020165	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0199_0b74c063-d5a8-3720-e063-6394a90adbe6	0135-0199	HUMAN OTC DRUG	CITRUCEL		methylcellulose	TABLET	ORAL	20100201		OTC MONOGRAPH DRUG	M013	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
0135-0200_bde8ef69-c7cf-48d6-b2f6-239e0e888be8	0135-0200	HUMAN OTC DRUG	ABREVA		docosanol	CREAM	TOPICAL	20100319		NDA	NDA020941	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DOCOSANOL	100	mg/g			N	20241231
0135-0225_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0225	HUMAN OTC DRUG	Nicorette	Fresh Mint	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA018612	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0226_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0226	HUMAN OTC DRUG	Nicorette	Fresh Mint	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0228_4618db68-f98f-42e1-ade3-23cc4fdad7d6	0135-0228	HUMAN OTC DRUG	TUMS	ULTRA	calcium carbonate	TABLET, CHEWABLE	ORAL	20100212		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
0135-0229_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0229	HUMAN OTC DRUG	Nicorette	Mint	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA018612	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0230_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0230	HUMAN OTC DRUG	Nicorette	Mint	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0234_0a1de8e8-7ce6-abb2-e063-6294a90acced	0135-0234	HUMAN OTC DRUG	AQUAFRESH	EXTREME CLEAN WHITENING ACTION	sodium fluoride	PASTE	DENTAL	20110325		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	1.13	mg/g			N	20241231
0135-0235_693a588b-5d27-437f-90ff-db8df704f3b7	0135-0235	HUMAN OTC DRUG	TUMS	ULTRA	calcium carbonate	TABLET, CHEWABLE	ORAL	20210621		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
0135-0241_0a511507-f719-5c17-e063-6294a90a9c7e	0135-0241	HUMAN OTC DRUG	Nicorette	Fruit Chill	nicotine polacrilex	GUM, CHEWING	ORAL	20090914		NDA	NDA018612	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0242_0a511507-f719-5c17-e063-6294a90a9c7e	0135-0242	HUMAN OTC DRUG	Nicorette	Fruit Chill	nicotine polacrilex	GUM, CHEWING	ORAL	20090914		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0243_06065f63-3c3b-43b0-ae01-18e1d7447b28	0135-0243	HUMAN OTC DRUG	TUMS	Smoothies	calcium carbonate	TABLET, CHEWABLE	ORAL	20100324		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0245_06065f63-3c3b-43b0-ae01-18e1d7447b28	0135-0245	HUMAN OTC DRUG	TUMS	Smoothies	calcium carbonate	TABLET, CHEWABLE	ORAL	20100324		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0246_06065f63-3c3b-43b0-ae01-18e1d7447b28	0135-0246	HUMAN OTC DRUG	TUMS	Smoothies	calcium carbonate	TABLET, CHEWABLE	ORAL	20100324		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0300_4dda4911-3030-4b69-acc3-fb231b5f2e66	0135-0300	HUMAN OTC DRUG	ABREVA		docosanol	CREAM	TOPICAL	20220325		ANDA	ANDA208754	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DOCOSANOL	100	mg/g			N	20241231
0135-0355_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0355	HUMAN OTC DRUG	Nicorette	Spearmint Burst	nicotine polacrilex	GUM, CHEWING	ORAL	20170913		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0400_65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d	0135-0400	HUMAN OTC DRUG	ABREVA	Rapid Pain Relief	glycerin, lidocaine	GEL	TOPICAL	20230601		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	GLYCERIN; LIDOCAINE HYDROCHLORIDE	200; 40	mg/g; mg/g	Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0135-0430_1f37dcea-c641-435b-9d54-efa7f283481a	0135-0430	HUMAN OTC DRUG	Gaviscon	Extra Strength	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20110613		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
0135-0449_817c0dad-d109-428e-adb5-3354604acc94	0135-0449	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Intensive Enamel Repair Clean Mint	sodium fluoride	LIQUID	ORAL	20240102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
0135-0450_b6b53ab0-82ee-459a-be1a-14e12c2582f5	0135-0450	HUMAN OTC DRUG	SENSODYNE PRONAMEL	mineral BOOST refreshing peppermint	potassium nitrate and sodium fluoride	PASTE	ORAL	20210104		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0451_817c0dad-d109-428e-adb5-3354604acc94	0135-0451	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Intensive Enamel Repair Extra Fresh	sodium fluoride	LIQUID	ORAL	20240102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
0135-0456_06065f63-3c3b-43b0-ae01-18e1d7447b28	0135-0456	HUMAN OTC DRUG	TUMS	Smoothies	calcium carbonate	TABLET, CHEWABLE	ORAL	20100324		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0460_09413dec-15c0-0ec8-e063-6294a90a191c	0135-0460	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Daily Protection	potassium nitrate and sodium fluoride	PASTE	ORAL	20101018		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0461_091e2b1e-3b1f-2a08-e063-6294a90aab80	0135-0461	HUMAN OTC DRUG	ALLI		orlistat	CAPSULE	ORAL	20070207		NDA	NDA021887	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ORLISTAT	60	mg/1	Intestinal Lipase Inhibitor [EPC], Lipase Inhibitors [MoA]		N	20241231
0135-0466_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0466	HUMAN OTC DRUG	Nicorette	Cinnamon Surge	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA018612	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0467_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0467	HUMAN OTC DRUG	Nicorette	Cinnamon Surge	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0474_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0474	HUMAN OTC DRUG	Nicorette	White Ice Mint	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA018612	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0475_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0475	HUMAN OTC DRUG	Nicorette	White Ice Mint	nicotine polacrilex	GUM, CHEWING	ORAL	20090629		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0479_d2804559-f2af-45f0-a232-63d01658be58	0135-0479	HUMAN OTC DRUG	SENSODYNE	Advanced Whitening	potassium nitrate	PASTE	ORAL	20201016		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0480_b6b53ab0-82ee-459a-be1a-14e12c2582f5	0135-0480	HUMAN OTC DRUG	SENSODYNE PRONAMEL	mineral BOOST whitening action	potassium nitrate and sodium fluoride	PASTE	ORAL	20210104		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0481_24e2535f-c480-433a-97ed-aee9e393cbc1	0135-0481	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Intensive Enamel Repair Whitening	potassium nitrate and sodium fluoride	PASTE	ORAL	20200106		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US)	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0484_09413dec-15c0-0ec8-e063-6294a90a191c	0135-0484	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Gentle Whitening	potassium nitrate and sodium fluoride	PASTE	ORAL	20101018		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0486_24e2535f-c480-433a-97ed-aee9e393cbc1	0135-0486	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Intensive Enamel Repair Extra Fresh	potassium nitrate and sodium fluoride	PASTE	ORAL	20181129		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US)	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0492_24e2535f-c480-433a-97ed-aee9e393cbc1	0135-0492	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Intensive Enamel Repair Clean Mint	potassium nitrate and sodium fluoride	PASTE	ORAL	20181129		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US)	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0508_092d288a-eb9a-2975-e063-6394a90a0669	0135-0508	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20100301		NDA	NDA022360	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0509_092d288a-eb9a-2975-e063-6394a90a0669	0135-0509	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20100301	20240831	NDA	NDA022360	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
0135-0510_091d7863-1277-dbcc-e063-6394a90a53a3	0135-0510	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20101019		NDA	NDA021330	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0511_091d7863-1277-dbcc-e063-6394a90a53a3	0135-0511	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20101019		NDA	NDA021330	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0520_09413dec-15c0-0ec8-e063-6294a90a191c	0135-0520	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Fresh Breath	potassium nitrate and sodium fluoride	PASTE	ORAL	20110414		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0521_2fefb025-c8e3-45d1-a119-042d4099f924	0135-0521	HUMAN OTC DRUG	TUMS	EX	calcium carbonate	TABLET	ORAL	20110323		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0525_0afdf34d-3474-47db-bbb1-faab1043ccac	0135-0525	HUMAN OTC DRUG	Sensodyne	Extra Whitening	potassium nitrate and sodium fluoride	PASTE	DENTAL	19900930		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.11	mg/g; mg/g			N	20241231
0135-0528_0afdf34d-3474-47db-bbb1-faab1043ccac	0135-0528	HUMAN OTC DRUG	Sensodyne	Fresh Impact	potassium nitrate and sodium fluoride	PASTE	DENTAL	20000701		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0529_0afdf34d-3474-47db-bbb1-faab1043ccac	0135-0529	HUMAN OTC DRUG	Sensodyne	Fresh Mint	potassium nitrate and sodium fluoride	PASTE	DENTAL	19900930		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0532_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0532	HUMAN OTC DRUG	Nicorette	Spearmint Burst	nicotine polacrilex	GUM, CHEWING	ORAL	20170913		NDA	NDA018612	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0533_76540e6a-4694-4b85-b461-ed57698a5d41	0135-0533	HUMAN OTC DRUG	Nicorette	Spearmint Burst	nicotine polacrilex	GUM, CHEWING	ORAL	20170913		NDA	NDA020066	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0537_7bad4144-ffbc-4d33-9a1d-95b4b39cd637	0135-0537	HUMAN OTC DRUG	PANADOL		acetaminophen	SUSPENSION	ORAL	20121015		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
0135-0539_be98c798-4afe-4975-9936-b3bca28e2bd7	0135-0539	HUMAN OTC DRUG	PANADOL		acetaminophen	SUSPENSION	ORAL	20121015		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
0135-0540_4618db68-f98f-42e1-ade3-23cc4fdad7d6	0135-0540	HUMAN OTC DRUG	TUMS	ULTRA	calcium carbonate	TABLET, CHEWABLE	ORAL	20100212		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
0135-0547_97e98aa7-128b-435a-83e7-cec1432fcfc7	0135-0547	HUMAN OTC DRUG	SENSODYNE	Repair and Protect Extra Fresh	stannous fluoride	PASTE	ORAL	20210628		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0548_97e98aa7-128b-435a-83e7-cec1432fcfc7	0135-0548	HUMAN OTC DRUG	SENSODYNE	Repair and Protect	stannous fluoride	PASTE	ORAL	20210628		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0550_995290d4-5d44-40ea-87f3-ceb4ff01bb36	0135-0550	HUMAN OTC DRUG	Sensodyne		potassium nitrate and sodium fluoride	PASTE	DENTAL	20040217		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
0135-0551_995290d4-5d44-40ea-87f3-ceb4ff01bb36	0135-0551	HUMAN OTC DRUG	Sensodyne		potassium nitrate and sodium fluoride	PASTE	DENTAL	20020102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
0135-0553_c544120f-15f0-48b5-88b2-d4820f180f50	0135-0553	HUMAN OTC DRUG	Tums	Ultra	Calcium carbonate	TABLET, CHEWABLE	ORAL	20230301		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
0135-0557_0a3dc8fe-4218-85fa-e063-6294a90ad359	0135-0557	HUMAN OTC DRUG	BIOTENE	Fresh Mint Original	sodium fluoride	PASTE	ORAL	20130715		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	1.5	mg/g			N	20241231
0135-0558_0a3dc8fe-4218-85fa-e063-6294a90ad359	0135-0558	HUMAN OTC DRUG	BIOTENE	Gentle Mint	sodium fluoride	PASTE	ORAL	20130715		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	1.5	mg/g			N	20241231
0135-0560_c34c21a0-b4b1-4c88-8b16-81ce8bb76490	0135-0560	HUMAN OTC DRUG	Tums	Chewy Delights	calcium carbonate	BAR, CHEWABLE	ORAL	20130801		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0561_c34c21a0-b4b1-4c88-8b16-81ce8bb76490	0135-0561	HUMAN OTC DRUG	Tums	Chewy Delights	calcium carbonate	BAR, CHEWABLE	ORAL	20130801		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0568_09413dec-15c0-0ec8-e063-6294a90a191c	0135-0568	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Multi Action	potassium nitrate and sodium fluoride	PASTE	ORAL	20131209		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0569_c34c21a0-b4b1-4c88-8b16-81ce8bb76490	0135-0569	HUMAN OTC DRUG	Tums	Chewy Delights	calcium carbonate	BAR, CHEWABLE	ORAL	20140815		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0572_af845242-6d1b-4d2b-94e5-414c3ae61a2f	0135-0572	HUMAN OTC DRUG	Sensodyne Complete Protection	Extra Fresh	stannous fluoride	PASTE	DENTAL	20140714		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0573_af845242-6d1b-4d2b-94e5-414c3ae61a2f	0135-0573	HUMAN OTC DRUG	Sensodyne Complete Protection		stannous fluoride	PASTE	DENTAL	20140714		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0574_0ab338be-56a6-284d-e063-6294a90a306f	0135-0574	HUMAN OTC DRUG	GAVISCON		aluminum hydroxide and magnesium carbonate	LIQUID	ORAL	20140801		OTC MONOGRAPH DRUG	M001	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
0135-0575_97e98aa7-128b-435a-83e7-cec1432fcfc7	0135-0575	HUMAN OTC DRUG	SENSODYNE	Repair and Protect Whitening	stannous fluoride	PASTE	ORAL	20210628		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0576_091ef4f1-b52b-6aae-e063-6394a90ad7ab	0135-0576	HUMAN OTC DRUG	FLONASE	ALLERGY RELIEF	fluticasone propionate	SPRAY, METERED	NASAL	20141204		NDA	NDA205434	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0135-0577_0a3dc8fe-422b-85fa-e063-6294a90ad359	0135-0577	HUMAN OTC DRUG	biotene		sodium monofluorophosphate	PASTE	ORAL	20160901		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
0135-0578_0a4a4e6d-9f4f-d55b-e063-6394a90ab7eb	0135-0578	HUMAN OTC DRUG	FLONASE	Headache and Allergy Relief	acetaminophen, chlorpheniramine maleate, phenylephrine hcl	TABLET	ORAL	20220310		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0135-0579_40e3fe1a-6f43-40ab-a98c-dc43bc266f52	0135-0579	HUMAN OTC DRUG	Sensodyne	True white	potassium nitrate and sodium fluoride	PASTE	DENTAL	20151221		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0580_61a8fb28-ca4d-4fe5-925a-b6689c0350d2	0135-0580	HUMAN OTC DRUG	Sensodyne Pronamel	Gentle Whitening Advanced	potassium nitrate and sodium fluoride	PASTE	DENTAL	20210315		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0581_40e3fe1a-6f43-40ab-a98c-dc43bc266f52	0135-0581	HUMAN OTC DRUG	Sensodyne	True white	potassium nitrate and sodium fluoride	PASTE	DENTAL	20151221		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0582_07ea454a-1e7d-9afd-e063-6294a90a42fe	0135-0582	HUMAN OTC DRUG	CHILDRENS FLONASE	ALLERGY RELIEF	fluticasone propionate	SPRAY, METERED	NASAL	20160229		NDA	NDA205434	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0135-0582_07ecb1dc-aafa-2862-e063-6394a90a3f2a	0135-0582	HUMAN OTC DRUG	CHILDRENS FLONASE	ALLERGY RELIEF	fluticasone propionate	SPRAY, METERED	NASAL	20160229		NDA	NDA205434	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0135-0590_406bcedb-ab48-4b75-8e0a-0fa02064deda	0135-0590	HUMAN OTC DRUG	AQUAFRESH	CAVITY PROTECTION	sodium fluoride	PASTE	DENTAL	20161001		OTC MONOGRAPH FINAL	part355	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	1.15	mg/g			N	20241231
0135-0591_406bcedb-ab48-4b75-8e0a-0fa02064deda	0135-0591	HUMAN OTC DRUG	AQUAFRESH	EXTRA FRESH PLUS WHITENING	sodium fluoride	PASTE	DENTAL	20140509		OTC MONOGRAPH FINAL	part355	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	1.15	mg/g			N	20241231
0135-0593_159aa41e-6d13-4521-89ca-db23d132a336	0135-0593	HUMAN OTC DRUG	sensodyne		potassium nitrate and sodium fluoride	PASTE	DENTAL	20161219		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0598_06b968d1-077f-43d1-8c64-123c591261de	0135-0598	HUMAN OTC DRUG	parodontax		stannous fluoride	PASTE	DENTAL	20161219		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0599_06b968d1-077f-43d1-8c64-123c591261de	0135-0599	HUMAN OTC DRUG	parodontax		stannous fluoride	PASTE	DENTAL	20161219		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0601_06b968d1-077f-43d1-8c64-123c591261de	0135-0601	HUMAN OTC DRUG	parodontax		stannous fluoride	PASTE	DENTAL	20161219		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0602_52cc971b-ced0-403f-bac5-95a4961ca02d	0135-0602	HUMAN OTC DRUG	Sensodyne Pronamel	Strong and Bright Enamel Mint	potassium nitrate and sodium fluoride	PASTE	ORAL	20161219		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0603_52cc971b-ced0-403f-bac5-95a4961ca02d	0135-0603	HUMAN OTC DRUG	Sensodyne Pronamel	Strong and Bright Enamel Extra Fresh	potassium nitrate and sodium fluoride	PASTE	ORAL	20161219		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0604_09bb5e57-041e-7c62-e063-6294a90ad884	0135-0604	HUMAN OTC DRUG	Aquafresh	Extreme Clean Pure Breath Action	sodium fluoride	PASTE	DENTAL	20160601		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	1.15	mg/g			N	20241231
0135-0605_2c831976-6b78-48b0-9c0f-64d8b453f36e	0135-0605	HUMAN OTC DRUG	AQUAFRESH	SENSITIVE MAXIMUM STRENGTH	potassium nitrate and sodium fluoride	PASTE	DENTAL	20170217		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
0135-0606_43e8c48e-40b9-4217-8323-70a6651b5fcf	0135-0606	HUMAN OTC DRUG	Tums Chewy Bites		calcium carbonate	TABLET, CHEWABLE	ORAL	20170301		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0607_a26625e4-000e-4e91-b538-4b4d3df55f3b	0135-0607	HUMAN OTC DRUG	Panadol	Cold and Flu NonDrowsy	acetaminophen and phenyleprine HCl	TABLET, FILM COATED	ORAL	20170601		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0135-0608_b26b54e1-fce0-4e33-9323-6360ff62963e	0135-0608	HUMAN OTC DRUG	PANADOL	PM	acetaminophen and diphenhydramine HCl	TABLET, FILM COATED	ORAL	20161201		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0135-0609_120d4df8-ef28-40eb-91ed-4fc67626fc2c	0135-0609	HUMAN OTC DRUG	PANADOL	Extra Strength	acetaminophen	TABLET, FILM COATED	ORAL	20170315		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN	500	mg/1			N	20241231
0135-0611_5274f4e0-ef15-4ff2-9cc1-7e3daa34b909	0135-0611	HUMAN OTC DRUG	Tums	Regular Strength	calcium carbonate	TABLET, CHEWABLE	ORAL	20160901		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0615_558c8eee-9902-4ec7-81c6-97141e3d2c6f	0135-0615	HUMAN OTC DRUG	FLONASE SENSIMIST	ALLERGY RELIEF	fluticasone furoate	SPRAY, METERED	NASAL	20170201		NDA	NDA022051	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	FLUTICASONE FUROATE	27.5	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0135-0616_7db2bb57-ba37-46d4-873e-f4960c5d10b3	0135-0616	HUMAN OTC DRUG	FLONASE SENSIMIST	ALLERGY RELIEF	fluticasone furoate	SPRAY, METERED	NASAL	20170701		NDA	NDA022051	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	FLUTICASONE FUROATE	27.5	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0135-0618_b5a85266-8e54-4276-93c8-3be1dc0e386b	0135-0618	HUMAN OTC DRUG	Tums Chewy Bites		calcium carbonate	TABLET, CHEWABLE	ORAL	20170518		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0619_6c21e9f9-9df7-42fd-994d-483d16d2caa5	0135-0619	HUMAN OTC DRUG	Aquafresh	Kids Cavity Protection	sodium monofluorophosphate	PASTE	DENTAL	20170901		OTC MONOGRAPH FINAL	part355	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
0135-0621_5923ffcc-aa0c-414b-9407-f495fc46bd72	0135-0621	HUMAN OTC DRUG	SENSODYNE	Rapid Relief	stannous fluoride	PASTE	ORAL	20180108		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0622_5923ffcc-aa0c-414b-9407-f495fc46bd72	0135-0622	HUMAN OTC DRUG	SENSODYNE	Rapid Relief	stannous fluoride	PASTE	ORAL	20180108		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0624_41047eed-6d6e-4ffa-bfd6-c82c9e490755	0135-0624	HUMAN OTC DRUG	Tums Chewy Bites with Gas Relief		calcium carbonate and simethicone	TABLET, CHEWABLE	ORAL	20180301		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Skin Barrier Activity [PE]		N	20241231
0135-0625_1dc126d5-ca50-43b7-97d7-4d4f30b7c7cd	0135-0625	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20190411		NDA	NDA021330	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0626_1dc126d5-ca50-43b7-97d7-4d4f30b7c7cd	0135-0626	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20190411		NDA	NDA021330	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0627_1150c2c7-e357-42f7-8d10-44e27aa258ae	0135-0627	HUMAN OTC DRUG	parodontax	Complete Protection	stannous fluoride	PASTE	DENTAL	20181101		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US)	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0630_b5a85266-8e54-4276-93c8-3be1dc0e386b	0135-0630	HUMAN OTC DRUG	Tums Chewy Bites		calcium carbonate	TABLET, CHEWABLE	ORAL	20190301		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0631_b5a85266-8e54-4276-93c8-3be1dc0e386b	0135-0631	HUMAN OTC DRUG	Tums Chewy Bites		calcium carbonate	TABLET, CHEWABLE	ORAL	20190301		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0632_5923ffcc-aa0c-414b-9407-f495fc46bd72	0135-0632	HUMAN OTC DRUG	SENSODYNE	Rapid Relief	stannous fluoride	PASTE	ORAL	20190708		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0633_b5a85266-8e54-4276-93c8-3be1dc0e386b	0135-0633	HUMAN OTC DRUG	Tums Chewy Bites		calcium carbonate	TABLET, CHEWABLE	ORAL	20190928		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0634_6b1793ec-85d5-4e53-b2b5-555cc3d764a9	0135-0634	HUMAN OTC DRUG	parodontax	Complete Protection	stannous fluoride	PASTE	DENTAL	20200106		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US)	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0635_ffeb8286-860d-49f5-8df3-724afb4aaad8	0135-0635	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20220601		NDA	NDA021330	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0636_ffeb8286-860d-49f5-8df3-724afb4aaad8	0135-0636	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20220601		NDA	NDA021330	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-0637_a6e5c14e-bd31-435c-bb8a-bfb506d72579	0135-0637	HUMAN OTC DRUG	parodontax	Active Gum Repair	stannous fluoride	PASTE	DENTAL	20210104		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0638_817e804c-e55e-4d77-9ab9-ff54ae794725	0135-0638	HUMAN OTC DRUG	parodontax	Active Gum Repair Whitening	stannous fluoride	PASTE	DENTAL	20220103		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-0641_95c5aaa2-3852-4114-9c80-ef2619e36242	0135-0641	HUMAN OTC DRUG	Tums Chewy Bites	Mixed Fruit	calcium carbonate	TABLET, CHEWABLE	ORAL	20210115		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-0642_97760d0b-c769-4bca-acfa-4680b3fba721	0135-0642	HUMAN OTC DRUG	Tums Chewy Bites	Orange and Cream ES	calcium carbonate	TABLET, CHEWABLE	ORAL	20210305		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-0643_c977f2c4-e0f3-44d2-aa7a-845f0583af3e	0135-0643	HUMAN OTC DRUG	Sensodyne	Extra Whitening Cool Mint	potassium nitrate and sodium fluoride	PASTE	DENTAL	20230403		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0644_3dfa6827-3aae-4f19-93f6-2ded2faf2ddd	0135-0644	HUMAN OTC DRUG	Sensodyne Pronamel	Gentle Whitening Fresh Mint	potassium nitrate and sodium fluoride	PASTE	DENTAL	20230403		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0650_d4956ce5-d348-4d4b-92ad-c39427617d27	0135-0650	HUMAN OTC DRUG	Parodontax	Active Gum Health Clear Mint	cetylpyridinium chloride	MOUTHWASH	ORAL	20220103		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
0135-0651_d4956ce5-d348-4d4b-92ad-c39427617d27	0135-0651	HUMAN OTC DRUG	Parodontax	Active Gum Health Mint	cetylpyridinium chloride	MOUTHWASH	ORAL	20220103		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CETYLPYRIDINIUM CHLORIDE	70	mg/mL			N	20241231
0135-0652_32b632bf-058d-447b-a7fb-a9dd05c1e2b8	0135-0652	HUMAN OTC DRUG	Parodontax	Active Gum Health Daily Mouthwash Breath Freshener	Cetylpyridinium chloride	LIQUID	ORAL	20240102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CETYLPYRIDINIUM CHLORIDE	70	mg/mL			N	20241231
0135-0700_ca098ebc-1550-4f98-8279-1617d6a7fdd0	0135-0700	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Active Shield Fresh Mint	potassium nitrate and sodium fluoride	PASTE	ORAL	20230102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US)	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0701_ca098ebc-1550-4f98-8279-1617d6a7fdd0	0135-0701	HUMAN OTC DRUG	SENSODYNE PRONAMEL	Active Shield Cool Mint	potassium nitrate and sodium fluoride	PASTE	ORAL	20230102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US)	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-0702_99037e59-53d6-492c-8fce-67641fc8efdd	0135-0702	HUMAN OTC DRUG	Sensodyne	Clinical White Stain Protector	Potassium nitrate, Sodium fluoride	PASTE	ORAL	20240102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.5	mg/g; mg/g			N	20241231
0135-0703_99037e59-53d6-492c-8fce-67641fc8efdd	0135-0703	HUMAN OTC DRUG	Sensodyne	Clinical White Enamel Strengthening	Potassium nitrate, Sodium fluoride	PASTE	ORAL	20240102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.5	mg/g; mg/g			N	20241231
0135-0710_557eeb32-64f4-41e8-ada4-91bd39ae2920	0135-0710	HUMAN OTC DRUG	Polident	ProPartial	stannous fluoride	PASTE	DENTAL	20210104		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
0135-0711_4c01ca1f-f991-491d-bfb8-61ad548373ea	0135-0711	HUMAN OTC DRUG	Polident	ProPartial	sodium fluoride	MOUTHWASH	ORAL	20210104		OTC MONOGRAPH FINAL	part355	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
0135-0737_7cc8d2d4-e4cc-482f-a900-d597692df3ca	0135-0737	HUMAN OTC DRUG	parodontax	Active Gum Repair Breath Freshener	stannous fluoride	PASTE	DENTAL	20240102		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-1000_594b43cb-d7b1-4a2e-a178-fdd269386b97	0135-1000	HUMAN OTC DRUG	TUMS		calcium carbonate	TABLET	ORAL	20211008		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-1001_594b43cb-d7b1-4a2e-a178-fdd269386b97	0135-1001	HUMAN OTC DRUG	TUMS		calcium carbonate	TABLET	ORAL	20211008		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-1002_11078d7c-373b-4c7b-b33b-f1deba613fc1	0135-1002	HUMAN OTC DRUG	TUMS	extra strength, smoothies	calcium carbonate	TABLET, CHEWABLE	ORAL	20211129		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0135-1200_71b95962-2693-49f5-94d2-f2a035b5e0c8	0135-1200	HUMAN OTC DRUG	NATEAN	Clean and Whiten	sodium fluoride	PASTE	ORAL	20220103		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	SODIUM FLUORIDE	1.5	mg/g			N	20241231
0135-1250_cea6f992-8a44-4eb8-baea-97b7b181b227	0135-1250	HUMAN OTC DRUG	NATEAN	Clean plus Sensitivity Relief	potassium nitrate, sodium fluoride	PASTE	ORAL	20220103		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.5	mg/g; mg/g			N	20241231
0135-1326_c150b180-8224-4b6d-92a9-6a8ee8dd4d04	0135-1326	HUMAN OTC DRUG	Tums	Naturals	calcium carbonate	TABLET, CHEWABLE	ORAL	20201015		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-1328_c150b180-8224-4b6d-92a9-6a8ee8dd4d04	0135-1328	HUMAN OTC DRUG	Tums	Naturals	calcium carbonate	TABLET, CHEWABLE	ORAL	20201015		OTC MONOGRAPH FINAL	part331	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0135-1329_0a4c81f2-a046-b552-e063-6394a90a4fd9	0135-1329	HUMAN OTC DRUG	FLONASE	Nighttime Allergy Relief	triprolidine hcl	TABLET	ORAL	20221215		OTC MONOGRAPH DRUG	M012	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	TRIPROLIDINE HYDROCHLORIDE	2.5	mg/1			N	20241231
0135-1500_0a51c51c-bf86-e9b5-e063-6294a90a979b	0135-1500	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20220601		NDA	NDA022360	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-2029_5d76e753-563d-4d55-b7bf-387580dbea4c	0135-2029	HUMAN OTC DRUG	Chapstick	12 Days of Christmas	white petrolatum	KIT		20210930		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0135-2800_0a51c51c-bf86-e9b5-e063-6294a90a979b	0135-2800	HUMAN OTC DRUG	NICORETTE		nicotine polacrilex	LOZENGE	ORAL	20220601		NDA	NDA022360	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0135-5022_078ff5e1-fb33-0385-e063-6294a90a82df	0135-5022	HUMAN OTC DRUG	SENSODYNE	Sensitivity Gum and Enamel Mint	stannous fluoride	PASTE	ORAL	20230102		OTC MONOGRAPH DRUG	M021	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-5023_b299b01f-dbce-471c-a01d-0e0c7e223b9b	0135-5023	HUMAN OTC DRUG	SENSODYNE	Sensitivity and Gum Mint	stannous fluoride	PASTE	ORAL	20200106		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-5024_b299b01f-dbce-471c-a01d-0e0c7e223b9b	0135-5024	HUMAN OTC DRUG	SENSODYNE	Sensitivity and Gum Whitening	stannous fluoride	PASTE	ORAL	20200106		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-5025_b299b01f-dbce-471c-a01d-0e0c7e223b9b	0135-5025	HUMAN OTC DRUG	SENSODYNE	SENSITIVITY AND GUM CLEAN AND FRESH	stannous fluoride	PASTE	ORAL	20210106		OTC MONOGRAPH DRUG	M022	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
0135-5026_d02580a5-d7e1-47a5-8fca-78ed88df2bc5	0135-5026	HUMAN OTC DRUG	Sensodyne	Nourish Gently Soothing	potassium nitrate and sodium fluoride	PASTE	DENTAL	20220103		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-5027_aca38560-2fd7-47be-9e93-2abc3214e856	0135-5027	HUMAN OTC DRUG	Sensodyne	Nourish Healthy White	potassium nitrate and sodium fluoride	PASTE	DENTAL	20220103		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-5028_1418cddb-6a90-4d0f-8787-ca988fd98fce	0135-5028	HUMAN OTC DRUG	Sensodyne	Natural white	potassium nitrate and sodium fluoride	PASTE	DENTAL	20220124		OTC MONOGRAPH NOT FINAL	part356	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.15	mg/g; mg/g			N	20241231
0135-7011_7964bb07-d1a4-46a9-8a41-657164358dc3	0135-7011	HUMAN OTC DRUG	PANADOL	Extra Strength	acetaminophen	TABLET, FILM COATED	ORAL	20210215		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN	500	mg/1			N	20241231
0135-7021_b9015bb7-f72e-4ab6-833e-82e5603986b2	0135-7021	HUMAN OTC DRUG	PANADOL	PM	acetaminophen and diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210625		OTC MONOGRAPH NOT FINAL	part343	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0135-7031_31ba233e-eeaf-4124-822c-87faffb98ca3	0135-7031	HUMAN OTC DRUG	Panadol	Cold and Flu NonDrowsy	acetaminophen and phenyleprine HCl	TABLET, FILM COATED	ORAL	20221220		OTC MONOGRAPH FINAL	part341	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0140-0005_d4fcb5d9-afe0-4a2f-a366-9a2ec670aa58	0140-0005	HUMAN PRESCRIPTION DRUG	Valium		diazepam	TABLET	ORAL	19631115	20271209	NDA	NDA013263	Roche Laboratories Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
0143-1171_d16c6cf5-bd90-4f2c-98fb-7357fbd2c76e	0143-1171	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Hikma Pharmaceuticals USA Inc.	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0143-1172_d16c6cf5-bd90-4f2c-98fb-7357fbd2c76e	0143-1172	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Hikma Pharmaceuticals USA Inc.	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0143-1173_d16c6cf5-bd90-4f2c-98fb-7357fbd2c76e	0143-1173	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Hikma Pharmaceuticals USA Inc.	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0143-1174_d16c6cf5-bd90-4f2c-98fb-7357fbd2c76e	0143-1174	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Hikma Pharmaceuticals USA Inc.	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0143-1227_ab1abd30-25fd-46ed-a992-925836112c98	0143-1227	HUMAN PRESCRIPTION DRUG	Dicyclomine		Dicyclomine hydrochloride	TABLET	ORAL	19961001		ANDA	ANDA040161	Hikma Pharmaceuticals USA Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-1240_5a0a08c5-50b3-4f66-b1b0-043220142ebf	0143-1240	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20071030		ANDA	ANDA077002	Hikma Pharmaceuticals USA Inc.	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0143-1241_5a0a08c5-50b3-4f66-b1b0-043220142ebf	0143-1241	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20071030		ANDA	ANDA077002	Hikma Pharmaceuticals USA Inc.	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0143-1455_a7dba651-e3d9-4e44-a139-83c1407c7d35	0143-1455	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	19990111		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	PHENOBARBITAL	60	mg/1		CIV	N	20241231
0143-1458_a7dba651-e3d9-4e44-a139-83c1407c7d35	0143-1458	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20000107		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	PHENOBARBITAL	100	mg/1		CIV	N	20241231
0143-1495_a7dba651-e3d9-4e44-a139-83c1407c7d35	0143-1495	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20200305		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	PHENOBARBITAL	15	mg/1		CIV	N	20241231
0143-1500_a7dba651-e3d9-4e44-a139-83c1407c7d35	0143-1500	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20200305		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	PHENOBARBITAL	30	mg/1		CIV	N	20241231
0143-1769_d0b0270b-40f2-45db-ad0d-5db910302456	0143-1769	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19781201		ANDA	ANDA086067	Hikma Pharmaceuticals USA Inc.	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0143-1771_d0b0270b-40f2-45db-ad0d-5db910302456	0143-1771	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19781201		ANDA	ANDA086066	Hikma Pharmaceuticals USA Inc.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0143-1772_d0b0270b-40f2-45db-ad0d-5db910302456	0143-1772	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19830426		ANDA	ANDA088088	Hikma Pharmaceuticals USA Inc.	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0143-2112_fbf091e9-f0a4-498a-a24c-cb01113adc13	0143-2112	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20030702		ANDA	ANDA065095	Hikma Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0143-3018_b841bc35-deee-4220-9638-9be05989e67d	0143-3018	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	CAPSULE	ORAL	20141001		NDA	NDA204820	Hikma Pharmaceuticals USA Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20241231
0143-3126_77bf1e26-7b9b-4265-970b-4b0e5c4a3685	0143-3126	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	19970228	20250228	ANDA	ANDA040204	Hikma Pharmaceuticals USA Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
0143-3141_d1d9f89b-90f6-4012-860d-fbc6eff39437	0143-3141	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE, GELATIN COATED	ORAL	19841107		ANDA	ANDA062396	Hikma Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0143-3142_d1d9f89b-90f6-4012-860d-fbc6eff39437	0143-3142	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE, GELATIN COATED	ORAL	19840507		ANDA	ANDA062396	Hikma Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0143-9005_8534291c-eeeb-4cfa-b703-1719a47eb534	0143-9005	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION	INTRAMUSCULAR	20211122		ANDA	ANDA091244	Hikma Pharmaceuticals USA Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0143-9006_6933faa5-ca70-4215-8f52-7055a688c287	0143-9006	HUMAN PRESCRIPTION DRUG	AcetaZOLAMIDE		Acetazolamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA040089	Hikma Pharmaceuticals USA Inc.	ACETAZOLAMIDE SODIUM	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
0143-9022_aaafdc34-8bf3-4671-a93b-b074879f8f1a	0143-9022	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20220210		ANDA	ANDA214682	Hikma Pharmaceuticals USA Inc.	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0143-9089_693136bd-63da-463d-bd80-9b4182d8b7a8	0143-9089	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9090_693136bd-63da-463d-bd80-9b4182d8b7a8	0143-9090	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9091_693136bd-63da-463d-bd80-9b4182d8b7a8	0143-9091	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA064097	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9092_e29e7a67-10c1-4368-bf19-bfa344198192	0143-9092	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA062921	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9093_e29e7a67-10c1-4368-bf19-bfa344198192	0143-9093	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA062921	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9098_e673dbf4-9d4e-4665-ac36-81c6537044fc	0143-9098	HUMAN PRESCRIPTION DRUG	bortezomib		bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220727		ANDA	ANDA215011	Hikma Pharmaceuticals USA Inc.	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
0143-9128_9908273d-c700-4036-82fe-312f25a8aacd	0143-9128	HUMAN PRESCRIPTION DRUG	Gentamicin		Gentamicin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220215		ANDA	ANDA062251	Hikma Pharmaceuticals USA Inc.	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0143-9129_9908273d-c700-4036-82fe-312f25a8aacd	0143-9129	HUMAN PRESCRIPTION DRUG	Gentamicin		Gentamicin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220215		ANDA	ANDA062251	Hikma Pharmaceuticals USA Inc.	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0143-9135_967161c6-2423-4ce9-b386-0a4855b1cb75	0143-9135	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221001		ANDA	ANDA064117	Hikma Pharmaceuticals USA Inc.	MITOMYCIN	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9136_967161c6-2423-4ce9-b386-0a4855b1cb75	0143-9136	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221001		ANDA	ANDA064117	Hikma Pharmaceuticals USA Inc.	MITOMYCIN	40	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9139_7c1ee339-cbdc-447b-be59-7611ef0552ad	0143-9139	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230301		NDA	NDA216109	Hikma Pharmaceuticals USA Inc.	CEFAZOLIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9140_7c1ee339-cbdc-447b-be59-7611ef0552ad	0143-9140	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20230301		NDA	NDA216109	Hikma Pharmaceuticals USA Inc.	CEFAZOLIN SODIUM	3	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9141_06e5d151-bd26-4c5e-b84a-1a11a3147327	0143-9141	HUMAN PRESCRIPTION DRUG	Dobutamine		Dobutamine	INJECTION, SOLUTION	INTRAVENOUS	20230503		ANDA	ANDA074277	Hikma Pharmaceuticals USA Inc.	DOBUTAMINE HYDROCHLORIDE	12.5	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0143-9151_d2a5e902-dbcc-4e9e-9963-aba4568e2835	0143-9151	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20230331		ANDA	ANDA040453	Hikma Pharmaceuticals USA Inc.	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
0143-9152_826034e2-fe81-4999-9064-5c05e761deb4	0143-9152	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230717		ANDA	ANDA217489	Hikma Pharmaceuticals USA Inc.	VANCOMYCIN HYDROCHLORIDE	1.25	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9153_826034e2-fe81-4999-9064-5c05e761deb4	0143-9153	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230717		ANDA	ANDA217489	Hikma Pharmaceuticals USA Inc.	VANCOMYCIN HYDROCHLORIDE	1.5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9161_34796168-c42b-4d4a-aa29-2ebb400456da	0143-9161	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20230202		NDA	NDA210274	HIKMA PHARMACEUTICALS USA INC.	VANCOMYCIN HYDROCHLORIDE	513	mg/mg	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9162_34796168-c42b-4d4a-aa29-2ebb400456da	0143-9162	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20230202		NDA	NDA210274	HIKMA PHARMACEUTICALS USA INC.	VANCOMYCIN HYDROCHLORIDE	1025	mg/mg	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9163_a312266f-9e98-4adc-971f-ed6fca885dbb	0143-9163	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20230203		NDA	NDA210274	HIKMA PHARMACEUTICALS USA INC.	VANCOMYCIN HYDROCHLORIDE	5.13	g/g	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9164_a312266f-9e98-4adc-971f-ed6fca885dbb	0143-9164	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20230202		NDA	NDA210274	HIKMA PHARMACEUTICALS USA INC.	VANCOMYCIN HYDROCHLORIDE	10.25	g/g	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9180_313a4ea9-178b-495e-9bc7-af1860fa6501	0143-9180	HUMAN PRESCRIPTION DRUG	calcium gluconate		calcium gluconate	INJECTION, SOLUTION	INTRAVENOUS	20231016		ANDA	ANDA213071	Hikma Pharmaceuticals USA Inc.	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0143-9184_ce7becd8-cf59-4470-aac8-82761a24ebd7	0143-9184	HUMAN PRESCRIPTION DRUG	calcium gluconate		calcium gluconate	INJECTION, SOLUTION	INTRAVENOUS	20231124		ANDA	ANDA213071	Hikma Pharmaceuticals USA Inc.	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0143-9202_a854383a-1d91-456c-baae-2e4011faf1a5	0143-9202	HUMAN PRESCRIPTION DRUG	Epirubicin Hydrochloride		Epirubicin Hydrochloride	INJECTION	INTRAVENOUS	20070807		ANDA	ANDA065289	Hikma Pharmaceuticals USA Inc.	EPIRUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9203_a854383a-1d91-456c-baae-2e4011faf1a5	0143-9203	HUMAN PRESCRIPTION DRUG	Epirubicin Hydrochloride		Epirubicin Hydrochloride	INJECTION	INTRAVENOUS	20070807		ANDA	ANDA065289	Hikma Pharmaceuticals USA Inc.	EPIRUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9209_a652f290-f8c6-4483-9fe4-b1fd50dec37d	0143-9209	HUMAN PRESCRIPTION DRUG	Chloroprocaine Hydrochloride		Chloroprocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	19981101		ANDA	ANDA040273	Hikma Pharmaceuticals USA Inc.	CHLOROPROCAINE HYDROCHLORIDE	20	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
0143-9210_a652f290-f8c6-4483-9fe4-b1fd50dec37d	0143-9210	HUMAN PRESCRIPTION DRUG	Chloroprocaine Hydrochloride		Chloroprocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	19981101		ANDA	ANDA040273	Hikma Pharmaceuticals USA Inc.	CHLOROPROCAINE HYDROCHLORIDE	30	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
0143-9217_894003f2-e5ea-430f-9450-aae8a493664e	0143-9217	HUMAN PRESCRIPTION DRUG	Idarubicin Hydrochloride		Idarubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20170130		ANDA	ANDA065275	Hikma Pharmaceuticals USA Inc.	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9218_894003f2-e5ea-430f-9450-aae8a493664e	0143-9218	HUMAN PRESCRIPTION DRUG	Idarubicin Hydrochloride		Idarubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20170130		ANDA	ANDA065275	Hikma Pharmaceuticals USA Inc.	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9219_894003f2-e5ea-430f-9450-aae8a493664e	0143-9219	HUMAN PRESCRIPTION DRUG	Idarubicin Hydrochloride		Idarubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20170130		ANDA	ANDA065275	Hikma Pharmaceuticals USA Inc.	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9230_1a816eb9-6de4-4751-831b-d183254f36af	0143-9230	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160303		ANDA	ANDA205039	Hikma Pharmaceuticals USA Inc.	RIFAMPIN	600	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
0143-9232_cb43d4f5-2c2a-4fca-94d2-429d92282fef	0143-9232	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA203725	Hikma Pharmaceuticals USA Inc.	VECURONIUM BROMIDE	20	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0143-9233_3fc27cbc-696e-4662-a7b2-82f82863e392	0143-9233	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211014		ANDA	ANDA209442	Hikma Pharmaceuticals USA Inc.	BENZTROPINE MESYLATE	1	mg/mL	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20251231
0143-9234_cb43d4f5-2c2a-4fca-94d2-429d92282fef	0143-9234	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA203725	Hikma Pharmaceuticals USA Inc.	VECURONIUM BROMIDE	10	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0143-9240_17a59fa2-9e0c-4be6-b9ef-8d1299352a0f	0143-9240	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20180109		ANDA	ANDA065042	Hikma Pharmaceuticals USA Inc.	BLEOMYCIN SULFATE	15	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
0143-9241_17a59fa2-9e0c-4be6-b9ef-8d1299352a0f	0143-9241	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20180109		ANDA	ANDA065042	Hikma Pharmaceuticals USA Inc.	BLEOMYCIN SULFATE	30	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
0143-9245_aac851c5-8ca2-4b13-87cb-f8f78b1f2cbc	0143-9245	HUMAN PRESCRIPTION DRUG	Dacarbazine		Dacarbazine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010808		ANDA	ANDA075812	Hikma Pharmaceuticals USA Inc.	DACARBAZINE	10	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9246_0c4e9254-1f64-45fb-acfd-2114a638262d	0143-9246	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride		Buprenorphine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20050525		ANDA	ANDA076931	Hikma Pharmaceuticals USA Inc.	BUPRENORPHINE HYDROCHLORIDE	.324	mg/mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0143-9247_2c71aef6-33cc-4f1d-acba-8a2c4c6bce95	0143-9247	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050331		ANDA	ANDA076068	Hikma Pharmaceuticals USA Inc.	DEXRAZOXANE HYDROCHLORIDE	10	mg/mL	Cytoprotective Agent [EPC]		N	20241231
0143-9248_2c71aef6-33cc-4f1d-acba-8a2c4c6bce95	0143-9248	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050331		ANDA	ANDA076068	Hikma Pharmaceuticals USA Inc.	DEXRAZOXANE HYDROCHLORIDE	10	mg/mL	Cytoprotective Agent [EPC]		N	20241231
0143-9249_599fb59d-4133-4036-b487-86cfb09c21ea	0143-9249	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20160823		ANDA	ANDA203824	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0143-9250_ca8258ee-96b5-4463-8ff5-a2e29acf7fe5	0143-9250	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20170430		ANDA	ANDA204679	Hikma Pharmaceuticals USA Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0143-9251_ca8258ee-96b5-4463-8ff5-a2e29acf7fe5	0143-9251	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20170430		ANDA	ANDA204679	Hikma Pharmaceuticals USA Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0143-9252_7345e945-864d-43bb-b418-470a6843b4c4	0143-9252	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride		Dopamine Hydrochloride	INJECTION	INTRAVENOUS	20180411		ANDA	ANDA207707	Hikma Pharmaceuticals USA Inc.	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0143-9253_7345e945-864d-43bb-b418-470a6843b4c4	0143-9253	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride		Dopamine Hydrochloride	INJECTION	INTRAVENOUS	20180411		ANDA	ANDA207707	Hikma Pharmaceuticals USA Inc.	DOPAMINE HYDROCHLORIDE	80	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0143-9254_7345e945-864d-43bb-b418-470a6843b4c4	0143-9254	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride		Dopamine Hydrochloride	INJECTION	INTRAVENOUS	20180411		ANDA	ANDA207707	Hikma Pharmaceuticals USA Inc.	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0143-9255_7345e945-864d-43bb-b418-470a6843b4c4	0143-9255	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride		Dopamine Hydrochloride	INJECTION	INTRAVENOUS	20180411		ANDA	ANDA207707	Hikma Pharmaceuticals USA Inc.	DOPAMINE HYDROCHLORIDE	80	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0143-9260_a8d40e08-983c-4377-ac75-a68199d8a4ab	0143-9260	HUMAN PRESCRIPTION DRUG	mesna		mesna	INJECTION, SOLUTION	INTRAVENOUS	20040223		ANDA	ANDA075739	Hikma Pharmaceuticals USA Inc.	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
0143-9261_ea333849-55d3-4257-94e5-d70ba608f8c5	0143-9261	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20041018		ANDA	ANDA065143	West-Ward Pharmaceuticals Corp	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9262_ec660da2-fc70-4a4c-830b-f514938768cc	0143-9262	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010918		ANDA	ANDA065047	Hikma Pharmaceuticals USA Inc.	CEFAZOLIN SODIUM	330	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9263_13db2593-44e9-44a1-95e5-a5010aa93423	0143-9263	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION	20200720		ANDA	ANDA214074	Hikma Pharmaceuticals USA Inc.	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9264_13db2593-44e9-44a1-95e5-a5010aa93423	0143-9264	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION	20200720		ANDA	ANDA214074	Hikma Pharmaceuticals USA Inc.	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9265_13db2593-44e9-44a1-95e5-a5010aa93423	0143-9265	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL	20200720		ANDA	ANDA214074	Hikma Pharmaceuticals USA Inc.	ROPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9266_13db2593-44e9-44a1-95e5-a5010aa93423	0143-9266	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL	20200720		ANDA	ANDA214074	Hikma Pharmaceuticals USA Inc.	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9270_0ee8505b-6680-410d-94bf-d55558a8c0e8	0143-9270	HUMAN PRESCRIPTION DRUG	Floxuridine		Floxuridine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRA-ARTERIAL	20180215		ANDA	ANDA075387	Hikma Pharmaceuticals USA Inc.	FLOXURIDINE	100	mg/mL	Antimetabolite [EPC], Deoxyuridine [CS]		N	20241231
0143-9273_896ee223-d027-4b0e-83de-d3a4d718b791	0143-9273	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170915		ANDA	ANDA206621	Hikma Pharmaceuticals USA Inc.	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
0143-9275_79560e42-fedf-48d0-b2f9-db8b1feacf0b	0143-9275	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA062921	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9277_79560e42-fedf-48d0-b2f9-db8b1feacf0b	0143-9277	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA062921	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9279_643836ac-d4dc-426c-96fa-44ef273198bc	0143-9279	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA064117	Hikma Pharmaceuticals USA Inc.	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9280_643836ac-d4dc-426c-96fa-44ef273198bc	0143-9280	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19990901		ANDA	ANDA064117	Hikma Pharmaceuticals USA Inc.	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9284_284915b9-082e-4c76-8998-13aff7221045	0143-9284	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170922		NDA	NDA209463	Hikma Pharmaceuticals USA Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0143-9285_b63e7196-6c1f-4d48-b80e-19f1dc98a7b4	0143-9285	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, COATED	ORAL	20060329		ANDA	ANDA065255	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9289_5402dd96-aec7-4cbf-b2a4-1a9eb86c8934	0143-9289	HUMAN PRESCRIPTION DRUG	Estradiol Valerate		Estradiol Valerate	INJECTION	INTRAMUSCULAR	20200421		ANDA	ANDA203723	Hikma Pharmaceuticals USA Inc.	ESTRADIOL VALERATE	10	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0143-9290_5402dd96-aec7-4cbf-b2a4-1a9eb86c8934	0143-9290	HUMAN PRESCRIPTION DRUG	Estradiol Valerate		Estradiol Valerate	INJECTION	INTRAMUSCULAR	20200421		ANDA	ANDA203723	Hikma Pharmaceuticals USA Inc.	ESTRADIOL VALERATE	20	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0143-9291_5402dd96-aec7-4cbf-b2a4-1a9eb86c8934	0143-9291	HUMAN PRESCRIPTION DRUG	Estradiol Valerate		Estradiol Valerate	INJECTION	INTRAMUSCULAR	20200421		ANDA	ANDA203723	Hikma Pharmaceuticals USA Inc.	ESTRADIOL VALERATE	40	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0143-9292_f18a13d2-83c0-42a1-8980-60b228c23ab9	0143-9292	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20230929		ANDA	ANDA211755	Hikma Pharmaceuticals USA Inc.	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9295_afe82a8f-f76a-401f-8b9f-977b4c2a3cd8	0143-9295	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	19981001		ANDA	ANDA075305	Hikma Pharmaceuticals USA Inc.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0143-9296_afe82a8f-f76a-401f-8b9f-977b4c2a3cd8	0143-9296	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	19981001		ANDA	ANDA075305	Hikma Pharmaceuticals USA Inc.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0143-9297_eafbaffa-64c7-4bee-9ad5-235399687f81	0143-9297	HUMAN PRESCRIPTION DRUG	Dantrolene		Dantrolene	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170619		ANDA	ANDA204762	Hikma Pharmaceuticals USA Inc.	DANTROLENE SODIUM	20	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0143-9298_4272216c-1e53-4180-a731-0592e772666f	0143-9298	HUMAN PRESCRIPTION DRUG	Sodium Ferric Gluconate Complex in Sucrose		Sodium Ferric Gluconate Complex in Sucrose	INJECTION	INTRAVENOUS	20110331		ANDA	ANDA078215	Hikma Pharmaceuticals USA Inc.	SODIUM FERRIC GLUCONATE COMPLEX	12.5	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0143-9299_0fff71bc-b705-4d81-ab82-83f218f3160d	0143-9299	HUMAN PRESCRIPTION DRUG	Ganciclovir		Ganciclovir sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210617		ANDA	ANDA076222	Hikma Pharmaceuticals USA Inc.	GANCICLOVIR SODIUM	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
0143-9300_673b147b-f117-4f86-b22c-e78ea92fb0e8	0143-9300	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170922		NDA	NDA209463	Hikma Pharmaceuticals USA Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0143-9306_c290c041-b554-4830-80a6-a4ad90d7d00d	0143-9306	HUMAN PRESCRIPTION DRUG	Idarubicin Hydrochloride		Idarubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180112		ANDA	ANDA065275	Hikma Pharmaceuticals USA Inc.	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9307_c290c041-b554-4830-80a6-a4ad90d7d00d	0143-9307	HUMAN PRESCRIPTION DRUG	Idarubicin Hydrochloride		Idarubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180112		ANDA	ANDA065275	Hikma Pharmaceuticals USA Inc.	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9308_c290c041-b554-4830-80a6-a4ad90d7d00d	0143-9308	HUMAN PRESCRIPTION DRUG	Idarubicin Hydrochloride		Idarubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180112		ANDA	ANDA065275	Hikma Pharmaceuticals USA Inc.	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9309_43ac39a1-a0e0-48e9-93e2-e7e754bc6038	0143-9309	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20010601		ANDA	ANDA075547	Hikma Pharmaceuticals USA Inc.	THIOTEPA	15	mg/1.5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9310_c15bd8c1-34e3-40f2-b31a-634136fe197c	0143-9310	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION	INTRAVENOUS	20160225		ANDA	ANDA202354	Hikma Pharmaceuticals USA Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0143-9311_c15bd8c1-34e3-40f2-b31a-634136fe197c	0143-9311	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION	INTRAVENOUS	20160225		ANDA	ANDA202354	Hikma Pharmaceuticals USA Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0143-9315_05cdb9d7-2bce-400d-8565-8a76c4a1a8e3	0143-9315	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20110916		ANDA	ANDA091375	Hikma Pharmaceuticals USA Inc.	LEVOFLOXACIN	250	mg/50mL			N	20241231
0143-9316_05cdb9d7-2bce-400d-8565-8a76c4a1a8e3	0143-9316	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20110916		ANDA	ANDA091375	Hikma Pharmaceuticals USA Inc.	LEVOFLOXACIN	500	mg/100mL			N	20241231
0143-9317_05cdb9d7-2bce-400d-8565-8a76c4a1a8e3	0143-9317	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20110916		ANDA	ANDA091375	Hikma Pharmaceuticals USA Inc.	LEVOFLOXACIN	750	mg/150mL			N	20241231
0143-9318_4e4bd5c7-3e4b-4e5f-9693-5d2f56d268bf	0143-9318	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		Norepinephrine Bitartrate	INJECTION	INTRAVENOUS	20180801		ANDA	ANDA203662	Hikma Pharmaceuticals USA Inc.	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0143-9319_b93ee0dc-a484-402b-8345-3d68ba0c689a	0143-9319	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol lactate	INJECTION	INTRAMUSCULAR	20180914		ANDA	ANDA075858	Hikma Pharmaceuticals USA Inc.	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0143-9320_6b69f581-9d97-4e63-9a84-b82d1a945d1c	0143-9320	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	19991129		ANDA	ANDA075303	West-Ward Pharmaceuticals Corp	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9326_181d0496-395b-420b-ae94-99921949fc16	0143-9326	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20101203		ANDA	ANDA077966	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9328_db94d1d6-2933-4aea-a7ed-b6dd80119360	0143-9328	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20210211		ANDA	ANDA205141	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9329_db94d1d6-2933-4aea-a7ed-b6dd80119360	0143-9329	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20210211		ANDA	ANDA205141	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9330_70fe2b6d-7eaf-4507-8ba0-b07e84b775cb	0143-9330	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20210211		ANDA	ANDA204842	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9331_70fe2b6d-7eaf-4507-8ba0-b07e84b775cb	0143-9331	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20210211		ANDA	ANDA204842	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9332_70fe2b6d-7eaf-4507-8ba0-b07e84b775cb	0143-9332	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20210211		ANDA	ANDA204842	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9333_70fe2b6d-7eaf-4507-8ba0-b07e84b775cb	0143-9333	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20210211		ANDA	ANDA204842	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9334_70fe2b6d-7eaf-4507-8ba0-b07e84b775cb	0143-9334	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20210211		ANDA	ANDA204842	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9335_70fe2b6d-7eaf-4507-8ba0-b07e84b775cb	0143-9335	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20210211		ANDA	ANDA204842	Hikma Pharmaceuticals USA Inc.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0143-9338_cd89b069-f299-47e8-b752-9bc093cf3b3f	0143-9338	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210426		ANDA	ANDA213229	Hikma Pharmaceuticals USA Inc.	SUCCINYLCHOLINE CHLORIDE DIHYDRATE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
0143-9339_2558c762-cdc9-4135-a83e-8d4c5c9d1afc	0143-9339	HUMAN PRESCRIPTION DRUG	Sterile Water		Sterile Water	INJECTION, SOLUTION	INTRAVENOUS	20230505		ANDA	ANDA212735	Hikma Pharmaceuticals USA Inc.	WATER	1	mL/mL			N	20241231
0143-9355_e298d434-6e7e-4a46-9744-a098386a89d6	0143-9355	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181003		ANDA	ANDA206616	Hikma Pharmaceuticals USA Inc.	VANCOMYCIN	750	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9356_431d7445-e798-40a7-a8aa-6a8b1ac5813f	0143-9356	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200811		ANDA	ANDA203300	Hikma Pharmaceuticals USA Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9357_431d7445-e798-40a7-a8aa-6a8b1ac5813f	0143-9357	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200811		ANDA	ANDA203300	Hikma Pharmaceuticals USA Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9358_fcd91c44-1388-4e34-8078-678c1a640c9c	0143-9358	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20181015		ANDA	ANDA204360	Hikma Pharmaceuticals USA Inc.	VANCOMYCIN HYDROCHLORIDE	5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9359_fcd91c44-1388-4e34-8078-678c1a640c9c	0143-9359	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20181015		ANDA	ANDA204360	Hikma Pharmaceuticals USA Inc.	VANCOMYCIN HYDROCHLORIDE	10	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0143-9361_cafa9061-bee0-48bf-938f-ba688ded1140	0143-9361	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210709		ANDA	ANDA213261	Hikma Pharmaceuticals USA Inc.	MICAFUNGIN	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0143-9362_cafa9061-bee0-48bf-938f-ba688ded1140	0143-9362	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210709		ANDA	ANDA213261	Hikma Pharmaceuticals USA Inc.	MICAFUNGIN	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0143-9363_922f21dc-0eb6-4beb-85ce-58fe4edb1b89	0143-9363	HUMAN PRESCRIPTION DRUG	Labetalol HCl in Sodium Chloride		LABETALOL HYDROCHLORIDE	INJECTION	INTRAVENOUS	20201109		NDA	NDA213330	Hikma Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9364_922f21dc-0eb6-4beb-85ce-58fe4edb1b89	0143-9364	HUMAN PRESCRIPTION DRUG	Labetalol HCl in Sodium Chloride		LABETALOL HYDROCHLORIDE	INJECTION	INTRAVENOUS	20201109		NDA	NDA213330	Hikma Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9365_922f21dc-0eb6-4beb-85ce-58fe4edb1b89	0143-9365	HUMAN PRESCRIPTION DRUG	Labetalol HCl in Sodium Chloride		LABETALOL HYDROCHLORIDE	INJECTION	INTRAVENOUS	20201109		NDA	NDA213330	Hikma Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9366_922f21dc-0eb6-4beb-85ce-58fe4edb1b89	0143-9366	HUMAN PRESCRIPTION DRUG	Labetalol HCl in Dextrose		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	20201109		NDA	NDA213330	Hikma Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9367_f8fa3869-95ff-42a2-9658-8641a30e9eec	0143-9367	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20050906		ANDA	ANDA040632	Hikma Pharmaceuticals USA Inc.	METHOTREXATE	1	g/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0143-9368_0000f768-a8cc-46ba-95a1-88b0ebd09be7	0143-9368	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19950523		ANDA	ANDA040056	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0143-9369_64517d03-d04d-40ed-8627-afcae0b156bd	0143-9369	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9370_64517d03-d04d-40ed-8627-afcae0b156bd	0143-9370	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9371_64517d03-d04d-40ed-8627-afcae0b156bd	0143-9371	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9372_64517d03-d04d-40ed-8627-afcae0b156bd	0143-9372	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA064097	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9373_fc4d5027-2c9b-42fb-9c74-1d65b26319c0	0143-9373	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20101203		ANDA	ANDA077966	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9374_fc4d5027-2c9b-42fb-9c74-1d65b26319c0	0143-9374	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20101203		ANDA	ANDA077966	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9375_c46b3216-1e79-4473-b4f3-951fd506ab92	0143-9375	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	INJECTION	SUBCUTANEOUS	20090520		ANDA	ANDA078630	Hikma Pharmaceuticals USA Inc.	TERBUTALINE SULFATE	1	mg/mL			N	20241231
0143-9376_59f81d09-9385-478e-a1d7-19588a08a239	0143-9376	HUMAN PRESCRIPTION DRUG	Etoposide		Etoposide	INJECTION	INTRAVENOUS	19960501		ANDA	ANDA074290	Hikma Pharmaceuticals USA Inc.	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9377_b40b10c5-7a46-45e7-a665-307512a3f2b9	0143-9377	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION	INTRAVENOUS	20200325		NDA	NDA203049	Hikma Pharmaceuticals USA Inc.	ARGATROBAN	50	mg/50mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0143-9378_806f1a3f-9c54-4a7d-9749-9e7348b5409b	0143-9378	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200101		ANDA	ANDA212022	Hikma Pharmaceuticals USA Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0143-9379_a6be32fe-dc3d-4ce0-b780-8ba6b4261acc	0143-9379	HUMAN PRESCRIPTION DRUG	Midazolam in Sodium Chloride		Midazolam in Sodium Chloride	INJECTION	INTRAVENOUS	20230519		ANDA	ANDA216159	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0143-9380_a6be32fe-dc3d-4ce0-b780-8ba6b4261acc	0143-9380	HUMAN PRESCRIPTION DRUG	Midazolam in Sodium Chloride		Midazolam in Sodium Chloride	INJECTION	INTRAVENOUS	20230519		ANDA	ANDA216159	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0143-9381_6339f3cd-e271-4cca-b8ad-e2676747a7c2	0143-9381	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210517		ANDA	ANDA062992	Hikma Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0143-9384_b1f3d842-7902-4887-bd41-819a54b19f64	0143-9384	HUMAN PRESCRIPTION DRUG	FOSAPREPITANT DIMEGLUMINE		FOSAPREPITANT DIMEGLUMINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200908		ANDA	ANDA213106	Hikma Pharmaceuticals USA Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0143-9386_1a8999ab-e911-47f2-b5a5-a0271f32c104	0143-9386	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION	INTRAVENOUS	20220603		NDA	NDA206968	Hikma Pharmaceuticals USA Inc.	ACETAMINOPHEN	1000	mg/100mL			N	20241231
0143-9391_76680bf5-083a-43d3-93c6-998cfbe321bb	0143-9391	HUMAN PRESCRIPTION DRUG	REMIFENTANIL HYDROCHLORIDE		REMIFENTANIL HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210515		ANDA	ANDA210594	Hikma Pharmaceuticals USA Inc.	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0143-9392_76680bf5-083a-43d3-93c6-998cfbe321bb	0143-9392	HUMAN PRESCRIPTION DRUG	REMIFENTANIL HYDROCHLORIDE		REMIFENTANIL HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210515		ANDA	ANDA210594	Hikma Pharmaceuticals USA Inc.	REMIFENTANIL HYDROCHLORIDE	2	mg/2mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0143-9393_76680bf5-083a-43d3-93c6-998cfbe321bb	0143-9393	HUMAN PRESCRIPTION DRUG	REMIFENTANIL HYDROCHLORIDE		REMIFENTANIL HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210515		ANDA	ANDA210594	Hikma Pharmaceuticals USA Inc.	REMIFENTANIL HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0143-9394_37afef8b-07d8-4857-934a-ddea3296e592	0143-9394	HUMAN PRESCRIPTION DRUG	Gemcitabine		Gemcitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210625		ANDA	ANDA206617	Hikma Pharmaceuticals USA Inc.	GEMCITABINE	200	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0143-9395_37afef8b-07d8-4857-934a-ddea3296e592	0143-9395	HUMAN PRESCRIPTION DRUG	Gemcitabine		Gemcitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210625		ANDA	ANDA206617	Hikma Pharmaceuticals USA Inc.	GEMCITABINE	1	g/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0143-9396_0965be29-e992-4375-8992-dbd4cd06cca7	0143-9396	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20230531		ANDA	ANDA203078	Hikma Pharmaceuticals USA Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0143-9397_05b1a996-542c-441e-823a-692f7d1ebf52	0143-9397	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20231107		ANDA	ANDA203079	Hikma Pharmaceuticals USA Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0143-9398_f854c51c-2c99-4168-81d4-c71769ae9c0f	0143-9398	HUMAN PRESCRIPTION DRUG	ertapenem sodium		ertapenem sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210802		ANDA	ANDA208790	Hikma Pharmaceuticals USA, Inc.	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0143-9428_8c0f31c8-d8b7-453f-9cd9-041942311040	0143-9428	HUMAN PRESCRIPTION DRUG	FOSAPREPITANT DIMEGLUMINE		FOSAPREPITANT DIMEGLUMINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210501		ANDA	ANDA213106	Hikma Pharmaceuticals USA Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0143-9501_d0f89618-8b8e-43f1-913f-7bc85628f02c	0143-9501	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol lactate	INJECTION	INTRAMUSCULAR	20010619		ANDA	ANDA075858	Hikma Pharmaceuticals USA Inc.	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0143-9502_d0f89618-8b8e-43f1-913f-7bc85628f02c	0143-9502	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol Lactate	INJECTION	INTRAMUSCULAR	20010619		ANDA	ANDA075858	Hikma Pharmaceuticals USA Inc.	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0143-9503_3ae6699a-f856-443c-8a20-4c58fb10811b	0143-9503	HUMAN PRESCRIPTION DRUG	AcetaZOLAMIDE		Acetazolamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA040089	Hikma Pharmaceuticals USA Inc.	ACETAZOLAMIDE SODIUM	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
0143-9504_2c569ef0-588f-4828-8b2d-03a2120c9b4c	0143-9504	HUMAN PRESCRIPTION DRUG	CISplatin		Cisplatin	INJECTION	INTRAVENOUS	20001107		ANDA	ANDA075036	West-Ward Pharmaceuticals Corp	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0143-9505_2c569ef0-588f-4828-8b2d-03a2120c9b4c	0143-9505	HUMAN PRESCRIPTION DRUG	CISplatin		Cisplatin	INJECTION	INTRAVENOUS	20001107		ANDA	ANDA075036	West-Ward Pharmaceuticals Corp	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0143-9506_98560882-bfdf-404e-ab8b-3ee2a6875830	0143-9506	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION	INTRAVENOUS	20160225		ANDA	ANDA202354	Hikma Pharmaceuticals USA Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0143-9507_98560882-bfdf-404e-ab8b-3ee2a6875830	0143-9507	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION	INTRAVENOUS	20160225		ANDA	ANDA202354	Hikma Pharmaceuticals USA Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0143-9508_3205b1e7-c233-4299-8c21-e34f7f897c97	0143-9508	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19960701		ANDA	ANDA074524	Hikma Pharmaceuticals USA Inc.	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0143-9509_3205b1e7-c233-4299-8c21-e34f7f897c97	0143-9509	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19960701		ANDA	ANDA074524	Hikma Pharmaceuticals USA Inc.	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0143-9510_15cf77cf-4207-463d-b6ef-16163db5afb9	0143-9510	HUMAN PRESCRIPTION DRUG	Etoposide		Etoposide	INJECTION	INTRAVENOUS	19960501		ANDA	ANDA074290	Hikma Pharmaceuticals USA Inc.	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9511_15cf77cf-4207-463d-b6ef-16163db5afb9	0143-9511	HUMAN PRESCRIPTION DRUG	Etoposide		Etoposide	INJECTION	INTRAVENOUS	19970201		ANDA	ANDA074290	Hikma Pharmaceuticals USA Inc.	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9512_15cf77cf-4207-463d-b6ef-16163db5afb9	0143-9512	HUMAN PRESCRIPTION DRUG	Etoposide		Etoposide	INJECTION	INTRAVENOUS	19970201		ANDA	ANDA074290	Hikma Pharmaceuticals USA Inc.	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9513_7dc05b1a-344a-410b-a7b3-171727713cf1	0143-9513	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		Palonosetron Hydrochloride	INJECTION	INTRAVENOUS	20170901		NDA	NDA207963	West-Ward Pharmaceuticals Corp	PALONOSETRON HYDROCHLORIDE	.25	mg/2mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0143-9514_a7e520ca-3213-4203-9a23-5295d82088e3	0143-9514	HUMAN PRESCRIPTION DRUG	DROPERIDOL		DROPERIDOL	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220601		ANDA	ANDA208197	Hikma Pharmaceuticals USA Inc.	DROPERIDOL	2.5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0143-9515_a7e520ca-3213-4203-9a23-5295d82088e3	0143-9515	HUMAN PRESCRIPTION DRUG	DROPERIDOL		DROPERIDOL	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220601		ANDA	ANDA208197	Hikma Pharmaceuticals USA Inc.	DROPERIDOL	2.5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0143-9516_3046ff78-3565-46d1-a88b-283e5ff6e7c3	0143-9516	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20180105		ANDA	ANDA089343	Hikma Pharmaceuticals USA Inc.	METHOTREXATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0143-9517_3046ff78-3565-46d1-a88b-283e5ff6e7c3	0143-9517	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20180105		ANDA	ANDA089342	Hikma Pharmaceuticals USA Inc.	METHOTREXATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0143-9518_3046ff78-3565-46d1-a88b-283e5ff6e7c3	0143-9518	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20180105		ANDA	ANDA089341	Hikma Pharmaceuticals USA Inc.	METHOTREXATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0143-9519_3046ff78-3565-46d1-a88b-283e5ff6e7c3	0143-9519	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20171010		ANDA	ANDA089340	Hikma Pharmaceuticals USA Inc.	METHOTREXATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0143-9525_b8414657-909e-4ddb-8dbd-e0c3d15ac9c0	0143-9525	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200130		ANDA	ANDA206407	Hikma Pharmaceuticals USA Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0143-9526_b8414657-909e-4ddb-8dbd-e0c3d15ac9c0	0143-9526	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200130		ANDA	ANDA206407	Hikma Pharmaceuticals USA Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0143-9529_b224759c-812e-4881-a641-bd823e5ca875	0143-9529	HUMAN PRESCRIPTION DRUG	Fluphenazine Decanoate		Fluphenazine Decanoate	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	19960830		ANDA	ANDA074531	Hikma Pharmaceuticals USA Inc.	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0143-9530_0511e667-7034-446c-975b-3d48b77ad86d	0143-9530	HUMAN PRESCRIPTION DRUG	Ifosfamide		Ifosfamide	INJECTION	INTRAVENOUS	20170610		ANDA	ANDA076619	Hikma Pharmaceuticals USA Inc.	IFOSFAMIDE	50	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9531_0511e667-7034-446c-975b-3d48b77ad86d	0143-9531	HUMAN PRESCRIPTION DRUG	Ifosfamide		Ifosfamide	INJECTION	INTRAVENOUS	20170610		ANDA	ANDA076619	Hikma Pharmaceuticals USA Inc.	IFOSFAMIDE	50	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9532_27ff2cf4-825d-4e29-bd8d-ffccffa13c74	0143-9532	HUMAN PRESCRIPTION DRUG	Dexmedetomidine HCl		Dexmedetomidine HCl	INJECTION	INTRAVENOUS	20170426		ANDA	ANDA205046	Hikma Pharmaceuticals USA Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0143-9533_5f7a1da9-2b25-46d2-8b6b-fdb44a4e1fd7	0143-9533	HUMAN PRESCRIPTION DRUG	Allopurinol sodium		Allopurinol sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20040901		ANDA	ANDA076870	Hikma Pharmaceuticals USA Inc.	ALLOPURINOL SODIUM	500	mg/25mL	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0143-9534_6a2522c4-4dbd-4330-872a-4d350a5f5749	0143-9534	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	INJECTION, SOLUTION	INTRAVENOUS	20221227		ANDA	ANDA206454	Hikma Pharmaceuticals USA Inc.	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0143-9542_b87038d9-8a91-428b-8d7f-6eef3a836742	0143-9542	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	INJECTION	INTRAVENOUS	20120302		NDA	NDA022276	Hikma Pharmaceuticals USA Inc.	NICARDIPINE HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0143-9546_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5	0143-9546	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA064097	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9547_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5	0143-9547	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9548_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5	0143-9548	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9549_7eb88b4b-34e3-4d47-80f4-f17bd690d3b5	0143-9549	HUMAN PRESCRIPTION DRUG	Adriamycin		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19960501		ANDA	ANDA062975	Hikma Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9550_b43c2345-599b-42c0-bd18-9e35f62eac5e	0143-9550	HUMAN PRESCRIPTION DRUG	Daunorubicin Hydrochloride		Daunorubicin Hydrochloride	INJECTION	INTRAVENOUS	20180102		NDA	NDA050731	Hikma Pharmaceuticals USA Inc.	DAUNORUBICIN HYDROCHLORIDE	5	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9551_b43c2345-599b-42c0-bd18-9e35f62eac5e	0143-9551	HUMAN PRESCRIPTION DRUG	Daunorubicin Hydrochloride		Daunorubicin Hydrochloride	INJECTION	INTRAVENOUS	20180102		NDA	NDA050731	Hikma Pharmaceuticals USA Inc.	DAUNORUBICIN HYDROCHLORIDE	5	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9552_e2d1484b-2920-45ab-9207-4caa5285fef4	0143-9552	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000420		ANDA	ANDA040335	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	350	mg/17.5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0143-9553_e2d1484b-2920-45ab-9207-4caa5285fef4	0143-9553	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19950523		ANDA	ANDA040056	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0143-9554_e2d1484b-2920-45ab-9207-4caa5285fef4	0143-9554	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19880328		ANDA	ANDA089717	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	100	mg/10mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0143-9555_e2d1484b-2920-45ab-9207-4caa5285fef4	0143-9555	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19870914		ANDA	ANDA089384	Hikma Pharmaceuticals USA Inc.	LEUCOVORIN CALCIUM	50	mg/5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0143-9558_d5427bbc-8598-4e79-9aeb-b0a9317e3433	0143-9558	HUMAN PRESCRIPTION DRUG	Levoleucovorin		Levoleucovorin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160707		ANDA	ANDA206263	Hikma Pharmaceuticals USA Inc.	LEVOLEUCOVORIN CALCIUM	50	mg/5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0143-9559_7fcb5097-ef38-4eae-80ef-871f3d842d13	0143-9559	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION	INTRAVENOUS	20161101		NDA	NDA203049	Hikma Pharmaceuticals USA Inc.	ARGATROBAN	50	mg/50mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0143-9564_b086317f-d4f5-40c1-bf4c-e56a3a941552	0143-9564	HUMAN PRESCRIPTION DRUG	Phentolamine Mesylate		Phentolamine Mesylate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19980515		ANDA	ANDA040235	West-Ward Pharmaceuticals Corp	PHENTOLAMINE MESYLATE	5	mg/mL	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0143-9565_74c9ff27-7c88-4dff-831d-eab4b8d9f1d7	0143-9565	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20010601		ANDA	ANDA075547	Hikma Pharmaceuticals USA Inc.	THIOTEPA	15	mg/1.5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0143-9566_c16b0808-bf65-41c1-857f-1667c0344401	0143-9566	HUMAN PRESCRIPTION DRUG	Azathioprine Sodium		Azathioprine Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19950501		ANDA	ANDA074419	Hikma Pharmaceuticals USA Inc.	AZATHIOPRINE SODIUM	100	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
0143-9567_e43d5edd-fd78-43d3-b8d2-4b22b7541042	0143-9567	HUMAN PRESCRIPTION DRUG	Cefuroxime		Cefuroxime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20040109		ANDA	ANDA065048	Hikma Pharmaceuticals USA Inc.	CEFUROXIME SODIUM	1.5	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9568_e43d5edd-fd78-43d3-b8d2-4b22b7541042	0143-9568	HUMAN PRESCRIPTION DRUG	Cefuroxime		Cefuroxime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20040109		ANDA	ANDA065048	Hikma Pharmaceuticals USA Inc.	CEFUROXIME SODIUM	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9569_a44c47cd-1104-4275-b859-d7ed2af78b8e	0143-9569	HUMAN PRESCRIPTION DRUG	Cefuroxime		Cefuroxime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20040109		ANDA	ANDA065046	Hikma Pharmaceuticals USA Inc.	CEFUROXIME SODIUM	7.5	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9570_e95793d1-ecbf-4137-9dcf-8359b3529f93	0143-9570	HUMAN PRESCRIPTION DRUG	Sodium Ferric Gluconate Complex in Sucrose		Sodium Ferric Gluconate Complex in Sucrose	INJECTION	INTRAVENOUS	20110331		ANDA	ANDA078215	Hikma Pharmaceuticals USA Inc.	SODIUM FERRIC GLUCONATE COMPLEX	12.5	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0143-9574_a4390688-6b9a-48a8-8186-459e8240436e	0143-9574	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20150601		ANDA	ANDA090981	Hikma Pharmaceuticals USA Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0143-9575_b190b9f2-9116-4f2b-9c5d-27dda59b150f	0143-9575	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	19720214		ANDA	ANDA080407	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0143-9576_b190b9f2-9116-4f2b-9c5d-27dda59b150f	0143-9576	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	19720214		ANDA	ANDA080407	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0143-9577_b190b9f2-9116-4f2b-9c5d-27dda59b150f	0143-9577	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	19720214		ANDA	ANDA080407	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0143-9578_b190b9f2-9116-4f2b-9c5d-27dda59b150f	0143-9578	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	19720214		ANDA	ANDA080407	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0143-9579_b190b9f2-9116-4f2b-9c5d-27dda59b150f	0143-9579	HUMAN PRESCRIPTION DRUG	Lidocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	19720214		ANDA	ANDA080407	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0143-9583_e36c07c2-a7ad-4d59-bdcc-fe16765b264b	0143-9583	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20101220		ANDA	ANDA091032	Hikma Pharmaceuticals USA Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9584_d0ab666e-f450-4de6-a324-9c45be693df0	0143-9584	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150601		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9585_d0ab666e-f450-4de6-a324-9c45be693df0	0143-9585	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150601		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9586_d0ab666e-f450-4de6-a324-9c45be693df0	0143-9586	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150601		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9587_d0ab666e-f450-4de6-a324-9c45be693df0	0143-9587	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150601		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9593_6d6e45d5-e6b1-402c-93c1-3106ff8145d4	0143-9593	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	INJECTION	INTRAVENOUS	20120302		NDA	NDA022276	West-Ward Pharmaceuticals Corp	NICARDIPINE HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0143-9594_87d4dd29-20a8-4fb5-913f-d057ad8094fd	0143-9594	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	19750616		ANDA	ANDA084625	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0143-9595_87d4dd29-20a8-4fb5-913f-d057ad8094fd	0143-9595	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	19750616		ANDA	ANDA084625	Hikma Pharmaceuticals USA Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0143-9596_5830f342-11e2-4859-98c8-fdcfd89d606d	0143-9596	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION	INTRAVENOUS	20141118		NDA	NDA205917	West-Ward Pharmaceuticals Corp	PARICALCITOL	5	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
0143-9597_33ef87d9-0b0c-43f6-8796-c7ffb8341e23	0143-9597	HUMAN PRESCRIPTION DRUG	Abiraterone		Abiraterone acetate	TABLET	ORAL	20181123		ANDA	ANDA208339	Hikma Pharmaceuticals USA Inc.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
0143-9606_73585766-7787-4196-810e-b50f7cc2f9dc	0143-9606	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200608		ANDA	ANDA209337	Hikma Pharmaceuticals USA Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0143-9619_e2346d7b-6756-4939-ab84-6a5dc1b493f5	0143-9619	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	19711020		ANDA	ANDA080515	Hikma Pharmaceuticals USA Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0143-9620_e2346d7b-6756-4939-ab84-6a5dc1b493f5	0143-9620	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	19711020		ANDA	ANDA080515	Hikma Pharmaceuticals USA Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0143-9621_e2346d7b-6756-4939-ab84-6a5dc1b493f5	0143-9621	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	19711020		ANDA	ANDA080515	Hikma Pharmaceuticals USA Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0143-9622_d04df94f-45bf-497f-9976-1df2182bdafb	0143-9622	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	19991129		ANDA	ANDA075303	West-Ward Pharmaceuticals Corp	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9623_d04df94f-45bf-497f-9976-1df2182bdafb	0143-9623	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	19991129		ANDA	ANDA075303	West-Ward Pharmaceuticals Corp	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9624_5830f342-11e2-4859-98c8-fdcfd89d606d	0143-9624	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION	INTRAVENOUS	20141118		NDA	NDA205917	West-Ward Pharmaceuticals Corp	PARICALCITOL	5	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
0143-9625_5830f342-11e2-4859-98c8-fdcfd89d606d	0143-9625	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION	INTRAVENOUS	20141118		NDA	NDA205917	West-Ward Pharmaceuticals Corp	PARICALCITOL	2	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
0143-9633_441a9565-d5ec-4727-9693-4d3112c07b3e	0143-9633	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	INJECTION	INTRAVENOUS	20160407		NDA	NDA022276	Hikma Pharmaceuticals USA Inc.	NICARDIPINE HYDROCHLORIDE	.2	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0143-9634_441a9565-d5ec-4727-9693-4d3112c07b3e	0143-9634	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	INJECTION	INTRAVENOUS	20160407		NDA	NDA022276	Hikma Pharmaceuticals USA Inc.	NICARDIPINE HYDROCHLORIDE	.1	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0143-9637_4b1e2230-e7d4-470f-9ec5-99d03e80e897	0143-9637	HUMAN PRESCRIPTION DRUG	Valproate Sodium		Valproate Sodium	INJECTION	INTRAVENOUS	20130415		ANDA	ANDA078523	Hikma Pharmaceuticals USA Inc.	VALPROATE SODIUM	100	mg/mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0143-9638_38f8761d-784e-407e-9dda-73fd78a829f4	0143-9638	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	INJECTION	SUBCUTANEOUS	20130916		ANDA	ANDA200183	Hikma Pharmaceuticals USA Inc.	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0143-9642_c3a41c1b-a9b0-4ad4-83b8-25e56e2c95fe	0143-9642	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20130603		ANDA	ANDA202182	Hikma Pharmaceuticals USA Inc.	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0143-9657_e29723d0-9bc3-445d-88c7-daae144ee78b	0143-9657	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160229		ANDA	ANDA205771	Hikma Pharmaceuticals USA Inc.	ACYCLOVIR SODIUM	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0143-9658_e29723d0-9bc3-445d-88c7-daae144ee78b	0143-9658	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160229		ANDA	ANDA205771	Hikma Pharmaceuticals USA Inc.	ACYCLOVIR SODIUM	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0143-9659_961359c5-4cb0-41e4-92b8-b25cae5e7ede	0143-9659	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION	INTRAMUSCULAR	20120501		ANDA	ANDA091244	Hikma Pharmaceuticals USA Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0143-9660_5e67823e-d4f6-4495-ae17-12b075244380	0143-9660	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoroprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20070530		ANDA	ANDA077761	Hikma Pharmaceuticals USA Inc.	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9665_77dfcbe1-b3b6-43de-8bc2-31a6873174df	0143-9665	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20041018		ANDA	ANDA065143	West-Ward Pharmaceuticals Corp	CEFAZOLIN SODIUM	20	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9666_fe7bbd7b-11c6-485b-bd80-f9fa2e5a58ea	0143-9666	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION	INTRAVENOUS	20120130		ANDA	ANDA078764	Hikma Pharmaceuticals USA Inc.	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0143-9667_fe7bbd7b-11c6-485b-bd80-f9fa2e5a58ea	0143-9667	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION	INTRAVENOUS	20120130		ANDA	ANDA078764	Hikma Pharmaceuticals USA Inc.	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0143-9668_fe7bbd7b-11c6-485b-bd80-f9fa2e5a58ea	0143-9668	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION	INTRAVENOUS	20120130		ANDA	ANDA078698	Hikma Pharmaceuticals USA Inc.	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0143-9669_fe7bbd7b-11c6-485b-bd80-f9fa2e5a58ea	0143-9669	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION	INTRAVENOUS	20120130		ANDA	ANDA078698	Hikma Pharmaceuticals USA Inc.	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0143-9670_2117fd87-7f18-4b28-a183-8876c0179d13	0143-9670	HUMAN PRESCRIPTION DRUG	Cefotetan		Cefotetan	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20111026		ANDA	ANDA091031	Hikma Pharmaceuticals USA Inc.	CEFOTETAN	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9671_2117fd87-7f18-4b28-a183-8876c0179d13	0143-9671	HUMAN PRESCRIPTION DRUG	Cefotetan		Cefotetan	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20111026		ANDA	ANDA091031	Hikma Pharmaceuticals USA Inc.	CEFOTETAN	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9673_228bbc07-b30c-47d0-b862-c4f0b1705230	0143-9673	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20111013		ANDA	ANDA090981	Hikma Pharmaceuticals USA Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0143-9674_7fcb5097-ef38-4eae-80ef-871f3d842d13	0143-9674	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION	INTRAVENOUS	20120105		NDA	NDA203049	Hikma Pharmaceuticals USA Inc.	ARGATROBAN	250	mg/2.5mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0143-9678_e9f12b84-2885-442d-b53c-0fd5a9946d38	0143-9678	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20171004		ANDA	ANDA090701	Hikma Pharmaceuticals USA Inc.	CEFTRIAXONE SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9679_8ed339c6-d65f-4b1c-8e23-301f75258c2e	0143-9679	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110921		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9680_8ed339c6-d65f-4b1c-8e23-301f75258c2e	0143-9680	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110921		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9681_8ed339c6-d65f-4b1c-8e23-301f75258c2e	0143-9681	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110921		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9682_8ed339c6-d65f-4b1c-8e23-301f75258c2e	0143-9682	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110921		ANDA	ANDA090963	Hikma Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0143-9683_4eb6d9a7-7d83-4c19-82d3-01605f907b22	0143-9683	HUMAN PRESCRIPTION DRUG	Flumazenil		Flumazenil	INJECTION, SOLUTION	INTRAVENOUS	20090323		ANDA	ANDA078527	Hikma Pharmaceuticals USA Inc.	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
0143-9684_4eb6d9a7-7d83-4c19-82d3-01605f907b22	0143-9684	HUMAN PRESCRIPTION DRUG	Flumazenil		Flumazenil	INJECTION, SOLUTION	INTRAVENOUS	20090323		ANDA	ANDA078527	Hikma Pharmaceuticals USA Inc.	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
0143-9689_441a9565-d5ec-4727-9693-4d3112c07b3e	0143-9689	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	INJECTION	INTRAVENOUS	20120302		NDA	NDA022276	Hikma Pharmaceuticals USA Inc.	NICARDIPINE HYDROCHLORIDE	25	mg/10mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0143-9701_204eb37a-642f-4321-9466-414c32a6bbce	0143-9701	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20101220		ANDA	ANDA091032	Hikma Pharmaceuticals USA Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9702_204eb37a-642f-4321-9466-414c32a6bbce	0143-9702	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20101220		ANDA	ANDA091032	Hikma Pharmaceuticals USA Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0143-9708_e27be05d-6f81-40a3-93db-4b942843cc63	0143-9708	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20101203		ANDA	ANDA077966	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9709_e27be05d-6f81-40a3-93db-4b942843cc63	0143-9709	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20101203		ANDA	ANDA077966	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9710_e27be05d-6f81-40a3-93db-4b942843cc63	0143-9710	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20101203		ANDA	ANDA077966	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9718_1396b776-d178-4afc-9066-b24f20e70bad	0143-9718	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		Milrinone Lactate in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20100121		ANDA	ANDA090038	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	200	ug/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9719_1396b776-d178-4afc-9066-b24f20e70bad	0143-9719	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		Milrinone Lactate in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20100121		ANDA	ANDA090038	Hikma Pharmaceuticals USA Inc.	MILRINONE LACTATE	200	ug/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0143-9720_27201c72-46ca-4507-8333-00e8ec582ba0	0143-9720	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20110916		ANDA	ANDA091375	Hikma Pharmaceuticals USA Inc.	LEVOFLOXACIN	750	mg/150mL			N	20241231
0143-9721_27201c72-46ca-4507-8333-00e8ec582ba0	0143-9721	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20110916		ANDA	ANDA091375	Hikma Pharmaceuticals USA Inc.	LEVOFLOXACIN	500	mg/100mL			N	20241231
0143-9722_27201c72-46ca-4507-8333-00e8ec582ba0	0143-9722	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20110916		ANDA	ANDA091375	Hikma Pharmaceuticals USA Inc.	LEVOFLOXACIN	250	mg/50mL			N	20241231
0143-9723_9d6244d1-5e85-4da3-b06c-f4fe8da1b6fa	0143-9723	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20110101		ANDA	ANDA200300	Hikma Pharmaceuticals USA Inc.	CLONIDINE HYDROCHLORIDE	500	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0143-9724_9d6244d1-5e85-4da3-b06c-f4fe8da1b6fa	0143-9724	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20110101		ANDA	ANDA200300	Hikma Pharmaceuticals USA Inc.	CLONIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0143-9725_19dbc1d7-32a0-42cd-8420-8017ccb58e35	0143-9725	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	INJECTION	INTRAMUSCULAR	20101028		ANDA	ANDA091033	West-Ward Pharmaceuticals Corp	PROGESTERONE	50	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
0143-9726_961359c5-4cb0-41e4-92b8-b25cae5e7ede	0143-9726	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION	INTRAMUSCULAR	20120501		ANDA	ANDA091244	Hikma Pharmaceuticals USA Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0143-9729_f9867ac1-d996-4b45-9526-47894571e941	0143-9729	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20090901		ANDA	ANDA090287	Hikma Pharmaceuticals USA Inc.	BENZTROPINE MESYLATE	1	mg/mL	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0143-9742_9a99920c-c630-487a-a1fc-5289eeaf451b	0143-9742	HUMAN PRESCRIPTION DRUG	Oxytocin		Oxytocin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130213		ANDA	ANDA200219	West-Ward Pharmaceuticals Corp	OXYTOCIN	10	[USP'U]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
0143-9743_9a99920c-c630-487a-a1fc-5289eeaf451b	0143-9743	HUMAN PRESCRIPTION DRUG	Oxytocin		Oxytocin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130213		ANDA	ANDA200219	West-Ward Pharmaceuticals Corp	OXYTOCIN	10	[USP'U]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
0143-9744_3b366664-32e3-4d5c-b75c-0b764ffa31f6	0143-9744	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	INJECTION	INTRAVENOUS	20091223		ANDA	ANDA078629	Hikma Pharmaceuticals USA Inc.	GRANISETRON HYDROCHLORIDE	1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
0143-9745_3b366664-32e3-4d5c-b75c-0b764ffa31f6	0143-9745	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	INJECTION	INTRAVENOUS	20091223		ANDA	ANDA078629	Hikma Pharmaceuticals USA Inc.	GRANISETRON HYDROCHLORIDE	1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
0143-9746_3e8736f7-de5c-4906-851f-6a10a53866ad	0143-9746	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	INJECTION	SUBCUTANEOUS	20090520		ANDA	ANDA078630	Hikma Pharmaceuticals USA Inc.	TERBUTALINE SULFATE	1	mg/mL			N	20251231
0143-9750_d56a5e5d-c88f-4f0d-84b4-1be06ca6ebba	0143-9750	HUMAN PRESCRIPTION DRUG	TESTOSTERONE ENANTHATE		TESTOSTERONE ENANTHATE	INJECTION, SOLUTION	INTRAMUSCULAR	20120918		ANDA	ANDA091120	Hikma Pharmaceuticals USA Inc.	TESTOSTERONE ENANTHATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0143-9753_bb761096-c2a1-435a-8eaf-a14d1211909a	0143-9753	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220926		ANDA	ANDA203125	Hikma Pharmaceuticals USA Inc.	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0143-9754_bb761096-c2a1-435a-8eaf-a14d1211909a	0143-9754	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220926		ANDA	ANDA203125	Hikma Pharmaceuticals USA Inc.	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0143-9782_6b56fe59-9fb1-410b-b57c-7ada1662136a	0143-9782	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091202		ANDA	ANDA078765	West-Ward Pharmaceuticals Corp	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0143-9783_34742dd6-a033-40cb-aac4-499ad2920676	0143-9783	HUMAN PRESCRIPTION DRUG	Flumazenil		flumazenil	INJECTION, SOLUTION	INTRAVENOUS	20070101		ANDA	ANDA078527	Hikma Pharmaceuticals USA Inc.	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
0143-9784_34742dd6-a033-40cb-aac4-499ad2920676	0143-9784	HUMAN PRESCRIPTION DRUG	Flumazenil		flumazenil	INJECTION, SOLUTION	INTRAVENOUS	20070101		ANDA	ANDA078527	Hikma Pharmaceuticals USA Inc.	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
0143-9785_0610e50d-6447-4a0e-bc36-dc0bffa95c7d	0143-9785	HUMAN PRESCRIPTION DRUG	Valproate Sodium		Valproate Sodium	INJECTION	INTRAVENOUS	20100217		ANDA	ANDA078523	Hikma Pharmaceuticals USA Inc.	VALPROATE SODIUM	500	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0143-9786_bde8c35d-1cf2-42ea-a2a7-c4eb165e6d0d	0143-9786	HUMAN PRESCRIPTION DRUG	Enalaprilat		enalaprilat	INJECTION	INTRAVENOUS	20081223		ANDA	ANDA078687	Hikma Pharmaceuticals USA Inc.	ENALAPRILAT DIHYDRATE	2.5	mg/2mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
0143-9787_bde8c35d-1cf2-42ea-a2a7-c4eb165e6d0d	0143-9787	HUMAN PRESCRIPTION DRUG	Enalaprilat		enalaprilat	INJECTION	INTRAVENOUS	20081223		ANDA	ANDA078687	Hikma Pharmaceuticals USA Inc.	ENALAPRILAT DIHYDRATE	1.25	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
0143-9788_6b56fe59-9fb1-410b-b57c-7ada1662136a	0143-9788	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091202		ANDA	ANDA078765	West-Ward Pharmaceuticals Corp	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0143-9802_697e89d1-2cc2-400b-ac78-fc0cb7d1f9c3	0143-9802	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19840507		ANDA	ANDA062396	Hikma Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0143-9803_697e89d1-2cc2-400b-ac78-fc0cb7d1f9c3	0143-9803	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19840507		ANDA	ANDA062396	Hikma Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0143-9830_d295fa12-63ca-4760-b291-44ba56ce1b59	0143-9830	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20050906		ANDA	ANDA040632	Hikma Pharmaceuticals USA Inc.	METHOTREXATE	1	g/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0143-9836_3bb75cb7-f691-4e31-9629-2c8b0f329780	0143-9836	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	Hikma Pharmaceuticals USA Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9837_3bb75cb7-f691-4e31-9629-2c8b0f329780	0143-9837	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	Hikma Pharmaceuticals USA Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9850_ed476c43-519c-4015-b659-230605dd7316	0143-9850	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160101		ANDA	ANDA202691	Hikma Pharmaceuticals USA Inc.	METHYLPREDNISOLONE SODIUM SUCCINATE	500	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0143-9851_ed476c43-519c-4015-b659-230605dd7316	0143-9851	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160101		ANDA	ANDA202691	Hikma Pharmaceuticals USA Inc.	METHYLPREDNISOLONE SODIUM SUCCINATE	1	g/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0143-9852_1bc5a420-8884-4b82-a39b-02064a59fde4	0143-9852	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine	INJECTION	INTRAVENOUS	20230601		ANDA	ANDA075567	Hikma Pharmaceuticals USA Inc.	LEVOCARNITINE	1	g/5mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
0143-9853_fd9c4e17-94c5-4181-b07a-b81b7bdec075	0143-9853	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	SUSPENSION	ORAL	20090803		ANDA	ANDA065373	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0143-9856_ff2e929e-05bc-4771-9af4-53b52acfd5bc	0143-9856	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080110		ANDA	ANDA065342	Hikma Pharmaceuticals USA Inc.	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9857_ff2e929e-05bc-4771-9af4-53b52acfd5bc	0143-9857	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080110		ANDA	ANDA065342	Hikma Pharmaceuticals USA Inc.	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9858_ff2e929e-05bc-4771-9af4-53b52acfd5bc	0143-9858	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080110		ANDA	ANDA065342	Hikma Pharmaceuticals USA Inc.	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9859_ff2e929e-05bc-4771-9af4-53b52acfd5bc	0143-9859	HUMAN PRESCRIPTION DRUG	Ceftriaxone		ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080110		ANDA	ANDA065342	Hikma Pharmaceuticals USA Inc.	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9864_f5e85289-9d8f-4370-b7c2-a7176319c818	0143-9864	HUMAN PRESCRIPTION DRUG	Butorphanol Tartrate		Butorphanol Tartrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20090501		ANDA	ANDA078400	Hikma Pharmaceuticals USA Inc.	BUTORPHANOL TARTRATE	1	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
0143-9867_f5e85289-9d8f-4370-b7c2-a7176319c818	0143-9867	HUMAN PRESCRIPTION DRUG	Butorphanol Tartrate		Butorphanol Tartrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20090501		ANDA	ANDA078400	Hikma Pharmaceuticals USA Inc.	BUTORPHANOL TARTRATE	2	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
0143-9871_5aef0cdc-fa27-47a1-8cce-2a3201aba276	0143-9871	HUMAN PRESCRIPTION DRUG	Cladribine		Cladribine	INJECTION	INTRAVENOUS	20000228		ANDA	ANDA075405	Hikma Pharmaceuticals USA Inc.	CLADRIBINE	1	mg/mL	Purine Antimetabolite [EPC]		N	20241231
0143-9872_e8fc99d6-98e1-4c9f-80e7-327fb2817f08	0143-9872	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	INJECTION	INTRAVENOUS	20080131		ANDA	ANDA077760	Hikma Pharmaceuticals USA Inc.	PROPRANOLOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9873_5e67823e-d4f6-4495-ae17-12b075244380	0143-9873	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20070530		ANDA	ANDA077761	Hikma Pharmaceuticals USA Inc.	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0143-9875_fb1da603-4eda-46d4-9ecb-748f768c639d	0143-9875	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20080225		ANDA	ANDA077234	Hikma Pharmaceuticals USA Inc.	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0143-9876_19a2e1e6-a647-4d7a-87ec-0c09e5506953	0143-9876	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20100226		ANDA	ANDA065239	Hikma Pharmaceuticals USA Inc.	CEFOXITIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9877_3192e4fd-4f01-443f-8a6e-3baed05ffcda	0143-9877	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20100312		ANDA	ANDA065238	Hikma Pharmaceuticals USA Inc.	CEFOXITIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9878_3192e4fd-4f01-443f-8a6e-3baed05ffcda	0143-9878	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20100312		ANDA	ANDA065238	Hikma Pharmaceuticals USA Inc.	CEFOXITIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9886_c3ce8a05-f88b-4ef4-a59f-33f45597b7a0	0143-9886	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9887_c3ce8a05-f88b-4ef4-a59f-33f45597b7a0	0143-9887	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9888_efb14922-8b9a-48c0-b4fe-fc259666731a	0143-9888	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9889_efb14922-8b9a-48c0-b4fe-fc259666731a	0143-9889	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9890_7dd1fe92-e406-4dde-a0e7-abfc496ccfc3	0143-9890	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA076781	West-Ward Pharmaceuticals Corp	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0143-9891_7dd1fe92-e406-4dde-a0e7-abfc496ccfc3	0143-9891	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA076780	West-Ward Pharmaceuticals Corp	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0143-9899_fe7bbd7b-11c6-485b-bd80-f9fa2e5a58ea	0143-9899	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION	INTRAVENOUS	20050823		ANDA	ANDA076736	Hikma Pharmaceuticals USA Inc.	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0143-9923_42f71480-c709-4637-bf1e-493e07a47f4e	0143-9923	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010918		ANDA	ANDA065047	Hikma Pharmaceuticals USA Inc.	CEFAZOLIN SODIUM	225	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9924_42f71480-c709-4637-bf1e-493e07a47f4e	0143-9924	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010918		ANDA	ANDA065047	Hikma Pharmaceuticals USA Inc.	CEFAZOLIN SODIUM	330	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9927_a37946a5-4f46-42db-a7df-d6311352290d	0143-9927	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Hikma Pharmaceuticals USA Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0143-9928_a37946a5-4f46-42db-a7df-d6311352290d	0143-9928	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Hikma Pharmaceuticals USA Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0143-9929_a37946a5-4f46-42db-a7df-d6311352290d	0143-9929	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Hikma Pharmaceuticals USA Inc.	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0143-9930_4c8a6a51-bd22-4e05-861a-fc5a56d71f4c	0143-9930	HUMAN PRESCRIPTION DRUG	Cefotaxime		Cefotaxime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20021120		ANDA	ANDA065072	Hikma Pharmaceuticals USA Inc.	CEFOTAXIME SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9931_4c8a6a51-bd22-4e05-861a-fc5a56d71f4c	0143-9931	HUMAN PRESCRIPTION DRUG	Cefotaxime		Cefotaxime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20021120		ANDA	ANDA065072	Hikma Pharmaceuticals USA Inc.	CEFOTAXIME SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9933_4c8a6a51-bd22-4e05-861a-fc5a56d71f4c	0143-9933	HUMAN PRESCRIPTION DRUG	Cefotaxime		Cefotaxime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20021120		ANDA	ANDA065072	Hikma Pharmaceuticals USA Inc.	CEFOTAXIME SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9935_e8783b78-0cd5-4f12-bcbc-be12631d4903	0143-9935	HUMAN PRESCRIPTION DRUG	Cefotaxime		Cefotaxime	INJECTION	INTRAVENOUS	20021120		ANDA	ANDA065071	West-Ward Pharmaceuticals Corp	CEFOTAXIME SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9939_b67223b9-5650-4932-9d1c-9d2027e7e678	0143-9939	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0143-9941_dc529b6b-bbf4-44da-a829-f506c41d47f6	0143-9941	HUMAN PRESCRIPTION DRUG	Polymyxin B		Polymyxin B sulfate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	19980601		ANDA	ANDA060716	Hikma Pharmaceuticals USA Inc.	POLYMYXIN B SULFATE	500000	[iU]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0143-9976_5621cde0-74c5-45b2-8f76-329eb22b4a0a	0143-9976	HUMAN PRESCRIPTION DRUG	Cefuroxime		Cefuroxime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20040109		ANDA	ANDA065046	Hikma Pharmaceuticals USA Inc.	CEFUROXIME SODIUM	750	mg/8mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9977_6341f645-bd5f-4d4f-a532-2c0740ab95f5	0143-9977	HUMAN PRESCRIPTION DRUG	Cefuroxime		Cefuroxime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20040109		ANDA	ANDA065048	Hikma Pharmaceuticals USA Inc.	CEFUROXIME SODIUM	1.5	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9979_6341f645-bd5f-4d4f-a532-2c0740ab95f5	0143-9979	HUMAN PRESCRIPTION DRUG	Cefuroxime		Cefuroxime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20040109		ANDA	ANDA065048	Hikma Pharmaceuticals USA Inc.	CEFUROXIME SODIUM	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0143-9981_468a44c3-5a58-48b0-88b1-4a9bbeec7f49	0143-9981	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20071201		ANDA	ANDA065191	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN; CLAVULANIC ACID	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0143-9982_468a44c3-5a58-48b0-88b1-4a9bbeec7f49	0143-9982	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20071201		ANDA	ANDA065191	Hikma Pharmaceuticals USA Inc.	AMOXICILLIN; CLAVULANIC ACID	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0143-9983_77dfcbe1-b3b6-43de-8bc2-31a6873174df	0143-9983	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20041018		ANDA	ANDA065143	West-Ward Pharmaceuticals Corp	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0168-0002_719f34d8-deb8-446f-a201-3f74fed4e831	0168-0002	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	CREAM	TOPICAL	19780309		ANDA	ANDA085692	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0003_719f34d8-deb8-446f-a201-3f74fed4e831	0168-0003	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	CREAM	TOPICAL	19780309		ANDA	ANDA085692	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0004_719f34d8-deb8-446f-a201-3f74fed4e831	0168-0004	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	CREAM	TOPICAL	19780309		ANDA	ANDA085692	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0005_7fc35083-b5f3-4de7-928b-5597fd983676	0168-0005	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	19780214		ANDA	ANDA085691	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0006_7fc35083-b5f3-4de7-928b-5597fd983676	0168-0006	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	19780214		ANDA	ANDA085691	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0007_2563e491-2277-4393-8632-8127fb983e1d	0168-0007	HUMAN PRESCRIPTION DRUG	Nystatin		nystatin	OINTMENT	TOPICAL	19820923		ANDA	ANDA062124	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0168-0015_5c4ea70e-1e8a-497e-8337-b0219b21b68d	0168-0015	HUMAN PRESCRIPTION DRUG	hydrocortisone		Hydrocortisone	CREAM	TOPICAL	19760430		ANDA	ANDA080693	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0020_f5301f00-a3ce-4ca4-a443-a3011b985e5b	0168-0020	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	19750416		ANDA	ANDA080692	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0033_86c00d5a-878a-4bb4-b793-aa89189a4a7c	0168-0033	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	OINTMENT	TOPICAL	19830831		NDA	NDA018865	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0040_86c00d5a-878a-4bb4-b793-aa89189a4a7c	0168-0040	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	CREAM	TOPICAL	19830831		NDA	NDA018861	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0041_86c00d5a-878a-4bb4-b793-aa89189a4a7c	0168-0041	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	LOTION	TOPICAL	19830831		NDA	NDA018866	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE VALERATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0054_556fa641-b529-4fdc-882b-82ca44d5f1a1	0168-0054	HUMAN PRESCRIPTION DRUG	nystatin		nystatin	CREAM	TOPICAL	19790201		ANDA	ANDA062129	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0168-0055_f50b2abb-1a2d-4509-b1fe-617d9a4556a4	0168-0055	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	19840626		NDA	NDA019137	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0056_f50b2abb-1a2d-4509-b1fe-617d9a4556a4	0168-0056	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	OINTMENT	TOPICAL	19840904		NDA	NDA019141	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0057_f50b2abb-1a2d-4509-b1fe-617d9a4556a4	0168-0057	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	LOTION	TOPICAL	19850812		ANDA	ANDA070275	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0059_b50fa288-16d4-4d37-a714-dad056510b2b	0168-0059	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		fluocinolone acetonide	SOLUTION	TOPICAL	19821216		ANDA	ANDA088167	Fougera Pharmaceuticals Inc.	FLUOCINOLONE ACETONIDE	.1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0064_3ceb8d3a-752a-4fce-9360-5e8ea65a6156	0168-0064	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		fluocinolone acetonide	OINTMENT	TOPICAL	19821216		ANDA	ANDA088168	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	FLUOCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0080_b70bed43-6eed-4355-90b5-9d0819c13ebd	0168-0080	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	19861216		ANDA	ANDA089414	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0081_e191c228-03e5-4f73-a1cb-3b93246123fc	0168-0081	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		nystatin and triamcinolone acetonide	CREAM	TOPICAL	19851008		ANDA	ANDA062599	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0168-0089_37cd4550-b77e-413e-a70b-5ca9eaf22f63	0168-0089	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		nystatin and triamcinolone acetonide	OINTMENT	TOPICAL	19851009		ANDA	ANDA062602	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0168-0099_b4ef7400-7e35-47f2-bd1c-3c5e15cc90ee	0168-0099	HUMAN PRESCRIPTION DRUG	ketoconazole		ketoconazole	CREAM	TOPICAL	20040428		ANDA	ANDA076294	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0168-0126_4592e208-4cec-4edb-a704-b1830126451b	0168-0126	HUMAN OTC DRUG	Swim-EAR		Swim-EAR	SOLUTION	AURICULAR (OTIC)	19700403		OTC MONOGRAPH FINAL	part344	Fougera Pharmaceuticals Inc.	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
0168-0133_41af1c38-dbb2-46ac-94da-64e4639825c8	0168-0133	HUMAN PRESCRIPTION DRUG	Clotrimazole		clotrimazole	CREAM	TOPICAL	20080902		ANDA	ANDA078338	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0168-0134_aa842484-50fb-44dc-b85f-b4a1191f571e	0168-0134	HUMAN PRESCRIPTION DRUG	fluocinonide		fluocinonide	SOLUTION	TOPICAL	19950227		ANDA	ANDA072934	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0135_ab8112d1-2b6e-4d6e-a5a7-470205dfa6ac	0168-0135	HUMAN PRESCRIPTION DRUG	Fluocinonide		fluocinonide	GEL	TOPICAL	19941230		ANDA	ANDA072933	Fougera Pharmaceuticals Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0146_b70bed43-6eed-4355-90b5-9d0819c13ebd	0168-0146	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	19930528		ANDA	ANDA081203	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0151_aa08bd10-2801-4f27-82f1-c69c6a72418d	0168-0151	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20120928		ANDA	ANDA078657	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0162_0cf6d94b-c90f-4dec-82e5-afec8cc84a19	0168-0162	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	OINTMENT	TOPICAL	19960223		ANDA	ANDA074407	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0163_0cf6d94b-c90f-4dec-82e5-afec8cc84a19	0168-0163	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	CREAM	TOPICAL	19960930		ANDA	ANDA074392	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0180_3e7ef6cc-659b-4f69-ac46-905fa237d2e8	0168-0180	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20100629		ANDA	ANDA078369	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0201_30743ed0-409c-4fec-bdd5-d113ef8ec838	0168-0201	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	SOLUTION	TOPICAL	19970605		ANDA	ANDA064159	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0168-0202_30743ed0-409c-4fec-bdd5-d113ef8ec838	0168-0202	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	GEL	TOPICAL	20000128		ANDA	ANDA064160	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0168-0203_30743ed0-409c-4fec-bdd5-d113ef8ec838	0168-0203	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	LOTION	TOPICAL	20020131		ANDA	ANDA065067	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0168-0204_9089dd18-87a0-42ab-8bd2-a3ea00f8aa43	0168-0204	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	19720630		ANDA	ANDA080198	Fougera Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0168-0258_49ee0b08-4d97-44e3-b506-48d9049c0526	0168-0258	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20010605		ANDA	ANDA075502	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0263_574f7b2a-667a-40fe-9728-58ef1ec8204d	0168-0263	HUMAN PRESCRIPTION DRUG	Alclometasone Dipropionate		alclometasone dipropionate	CREAM	TOPICAL	20050712		ANDA	ANDA076973	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	ALCLOMETASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0264_f4b24fb7-96bb-4c9a-b1a0-e66f909553f3	0168-0264	HUMAN PRESCRIPTION DRUG	Alclometasone Dipropionate		alclometasone dipropionate	OINTMENT	TOPICAL	20050718		ANDA	ANDA076884	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	ALCLOMETASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0265_98a5f88e-6ba5-4064-b851-17b63a13e883	0168-0265	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone dipropionate	CREAM, AUGMENTED	TOPICAL	20031209		ANDA	ANDA076215	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0267_25638201-0985-43a0-8282-a309b3f57248	0168-0267	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	LOTION, AUGMENTED	TOPICAL	20070521		ANDA	ANDA077111	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0268_379a5fbc-3abe-44e7-aff2-d4f2a0114239	0168-0268	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		betamethasone dipropionate	OINTMENT, AUGMENTED	TOPICAL	19990622		ANDA	ANDA075373	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0269_62937ca8-a3c6-4ce6-a630-eca10a1c8316	0168-0269	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SOLUTION	TOPICAL	19990208		ANDA	ANDA075391	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0270_e5e151c4-74f1-470a-a1cb-bde40891a5ee	0168-0270	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		mometasone furoate	CREAM	TOPICAL	20050408		ANDA	ANDA076171	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0271_0d50968f-7781-40df-a235-42ea6596be6e	0168-0271	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		mometasone furoate	OINTMENT	TOPICAL	20050328		ANDA	ANDA077061	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0272_4176545b-2cb3-44a3-839e-bb8c33e6a4b4	0168-0272	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		mometasone furoate	SOLUTION	TOPICAL	20071129		ANDA	ANDA075919	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	MOMETASONE FUROATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0275_b5c8edbe-eed2-40ef-8426-f128363aad58	0168-0275	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20060606		ANDA	ANDA077018	Fougera Pharmaceuticals Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0168-0277_fff399c8-a606-4ccf-9800-0bb3ccf6a71b	0168-0277	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	CREAM	VAGINAL	20041227		ANDA	ANDA065139	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLINDAMYCIN PHOSPHATE	20	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0168-0278_51093468-b64d-4b34-9627-8e6313c8265e	0168-0278	HUMAN PRESCRIPTION DRUG	Amcinonide		Amcinonide	CREAM	TOPICAL	20030515		ANDA	ANDA076065	Fougera Pharmaceuticals Inc.	AMCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0288_d2ede941-e346-4fb1-9e7c-43d85a4592a3	0168-0288	HUMAN PRESCRIPTION DRUG	Hydrocortisone		hydrocortisone	LOTION	TOPICAL	20000725		ANDA	ANDA040351	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	HYDROCORTISONE	25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0293_0cf6d94b-c90f-4dec-82e5-afec8cc84a19	0168-0293	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	GEL	TOPICAL	20000215		ANDA	ANDA075368	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0301_60e61fbb-1d01-46ee-8a23-c1af3211f23a	0168-0301	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate (emollient)		clobetasol propionate	CREAM	TOPICAL	19990526		ANDA	ANDA075430	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0309_928b257f-8a7f-45b1-a2f9-c1ba834cb465	0168-0309	HUMAN PRESCRIPTION DRUG	desonide		desonide	OINTMENT	TOPICAL	20010312		ANDA	ANDA075751	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0310_807659ea-f276-43d6-a187-0fe0f82493e8	0168-0310	HUMAN PRESCRIPTION DRUG	desonide		desonide	LOTION	TOPICAL	20020319		ANDA	ANDA075860	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	DESONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0323_bfe32c3b-9d0e-4438-8417-3f948262b37d	0168-0323	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	CREAM	TOPICAL	20040528		ANDA	ANDA076408	Fougera Pharmaceuticals Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0168-0332_7f1e80c7-aa1d-4d0d-a5a7-3cc3a46e6939	0168-0332	HUMAN PRESCRIPTION DRUG	FLUTICASONE PROPIONATE		fluticasone propionate	CREAM	TOPICAL	20040514		ANDA	ANDA076451	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0346_5107e247-7c98-46a7-94d7-4fbf4e1114cb	0168-0346	HUMAN PRESCRIPTION DRUG	Terconazole		terconazole	CREAM	VAGINAL	20050218		ANDA	ANDA076712	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TERCONAZOLE	4	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0168-0347_65cb53ae-7417-48e5-9bb6-ca401ac73831	0168-0347	HUMAN PRESCRIPTION DRUG	Terconazole	Vaginal Cream 0.8%	terconazole	CREAM	VAGINAL	20050201		NDA	NDA021735	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TERCONAZOLE	8	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0168-0352_edf46c09-0326-4bb1-90bb-0bd3715600c5	0168-0352	HUMAN PRESCRIPTION DRUG	Mupirocin		mupirocin	OINTMENT	TOPICAL	20051130		ANDA	ANDA065192	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
0168-0355_13b31048-e881-404d-8321-ee882fc4456c	0168-0355	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		halobetasol propionate	CREAM	TOPICAL	20041216		ANDA	ANDA077001	Fougera Pharmaceuticals Inc.	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0357_01ee03aa-5444-4e90-9d08-9c3506a3bae0	0168-0357	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		lidocaine and prilocaine	CREAM	TOPICAL	20030818		ANDA	ANDA076453	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
0168-0358_ced09ac9-d81c-4812-905e-80abec8141da	0168-0358	HUMAN PRESCRIPTION DRUG	Oxiconazole Nitrate		Oxiconazole Nitrate	CREAM	TOPICAL	20160309		NDA AUTHORIZED GENERIC	NDA019828	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	OXICONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0168-0370_9959fe30-5f39-44ca-ad36-907fcc204ced	0168-0370	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	LOTION	TOPICAL	20050616		ANDA	ANDA076516	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/mL; mg/mL	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0383_820d66fb-a1d0-4f01-b108-de3162c8a88e	0168-0383	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	LOTION	TOPICAL	20060524		ANDA	ANDA077197	Fougera Pharmaceuticals Inc.	METRONIDAZOLE	7.5	mg/mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0168-0400_774dd89d-ce05-4c00-8770-e89c23865a26	0168-0400	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	SOLUTION	TOPICAL	20080506		ANDA	ANDA078305	Fougera Pharmaceuticals Inc.	CALCIPOTRIENE	.05	mg/mL	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
0168-0410_4ca277bb-9139-4e1d-9886-2a04d1fb124a	0168-0410	HUMAN PRESCRIPTION DRUG	Prednicarbate		prednicarbate	OINTMENT	TOPICAL	20070309		ANDA	ANDA077236	Fougera Pharmaceuticals Inc.	PREDNICARBATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0416_7ea94e22-7c5a-4949-87dc-872bbecde0c4	0168-0416	HUMAN PRESCRIPTION DRUG	Tacrolimus		tacrolimus	OINTMENT	TOPICAL	20140909		ANDA	ANDA200744	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0168-0417_7ea94e22-7c5a-4949-87dc-872bbecde0c4	0168-0417	HUMAN PRESCRIPTION DRUG	Tacrolimus		tacrolimus	OINTMENT	TOPICAL	20140909		ANDA	ANDA200744	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	TACROLIMUS	.3	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0168-0424_b5b9540d-cee3-4c50-9ae0-a5ff388369ea	0168-0424	HUMAN PRESCRIPTION DRUG	Adapalene		adapalene	CREAM	TOPICAL	20100630		ANDA	ANDA090824	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0168-0432_fdbbf340-e87c-44ed-9274-148846ffd788	0168-0432	HUMAN PRESCRIPTION DRUG	imiquimod		imiquimod	CREAM	TOPICAL	20100225		ANDA	ANDA078548	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	IMIQUIMOD	50	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
0168-0457_9b2a6817-78e5-4437-9fb0-efcdce64c617	0168-0457	HUMAN PRESCRIPTION DRUG	fluocinonide		fluocinonide	CREAM	TOPICAL	20140714		ANDA	ANDA200735	Fougera Pharmaceuticals Inc.	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0168-0907_288add98-f2b9-44ba-9992-0cbc77bf7328	0168-0907	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20200515		OTC MONOGRAPH NOT FINAL	part333A	Fougera Pharmaceuticals Inc.	ISOPROPYL ALCOHOL	75	mL/60mL			N	20241231
0169-1401_73ad2bc1-353a-4b01-b81c-7b276a5670c9	0169-1401	HUMAN PRESCRIPTION DRUG	Macrilen		Macimorelin acetate	GRANULE, FOR SOLUTION	ORAL	20220131	20270228	NDA	NDA205598	Novo Nordisk	MACIMORELIN	60	mg/mg	Growth Hormone Secretagogue Receptor Agonist [EPC], Growth Hormone Secretagogue Receptor Agonists [MoA]		N	
0169-1833_46700b71-3f26-4aaa-8eb7-6ceeeb515c79	0169-1833	HUMAN OTC DRUG	Novolin	R	Human Insulin	INJECTION, SOLUTION	SUBCUTANEOUS	19910625		BLA	BLA019938	Novo Nordisk	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0169-1834_652d3fd6-809f-476e-9159-a1beffb9ea01	0169-1834	HUMAN OTC DRUG	Novolin	N	Human Insulin	INJECTION, SUSPENSION	SUBCUTANEOUS	19910701		BLA	BLA019959	Novo Nordisk	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0169-1837_c7164ea1-aa3e-4359-a3f0-a34c78e78398	0169-1837	HUMAN OTC DRUG	Novolin	70/30	Human Insulin	INJECTION, SUSPENSION	SUBCUTANEOUS	19910625		BLA	BLA019991	Novo Nordisk	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0169-1912_48d68219-2ba1-426f-a5a0-0cc35e69ff19	0169-1912	HUMAN PRESCRIPTION DRUG	Zegalogue		dasiglucagon	INJECTION, SOLUTION	SUBCUTANEOUS	20230626		NDA	NDA214231	Novo Nordisk	DASIGLUCAGON	.6	mg/.6mL	Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]		N	20241231
0169-1913_48d68219-2ba1-426f-a5a0-0cc35e69ff19	0169-1913	HUMAN PRESCRIPTION DRUG	Zegalogue		dasiglucagon	INJECTION, SOLUTION	SUBCUTANEOUS	20230626		NDA	NDA214231	Novo Nordisk	DASIGLUCAGON	.6	mg/.6mL	Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]		N	20241231
0169-2001_99351c0b-1c32-4eaf-8bc0-68079866d80c	0169-2001	HUMAN PRESCRIPTION DRUG	Insulin Diluting Medium for NovoLog		water injection	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	Novo Nordisk	WATER	1	mL/mL			N	20241231
0169-2030_49f6746f-c935-45c4-af35-02df5db71e87	0169-2030	HUMAN PRESCRIPTION DRUG	SOGROYA		somapacitan-beco	INJECTION, SOLUTION	SUBCUTANEOUS	20230501		BLA	BLA761156	Novo Nordisk	SOMAPACITAN	6.7	mg/mL			N	20241231
0169-2035_49f6746f-c935-45c4-af35-02df5db71e87	0169-2035	HUMAN PRESCRIPTION DRUG	SOGROYA		somapacitan-beco	INJECTION, SOLUTION	SUBCUTANEOUS	20230501		BLA	BLA761156	Novo Nordisk	SOMAPACITAN	3.3	mg/mL			N	20241231
0169-2037_49f6746f-c935-45c4-af35-02df5db71e87	0169-2037	HUMAN PRESCRIPTION DRUG	SOGROYA		somapacitan-beco	INJECTION, SOLUTION	SUBCUTANEOUS	20230501		BLA	BLA761156	Novo Nordisk	SOMAPACITAN	10	mg/mL			N	20241231
0169-2100_99351c0b-1c32-4eaf-8bc0-68079866d80c	0169-2100	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-2101_99351c0b-1c32-4eaf-8bc0-68079866d80c	0169-2101	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20030122		BLA	BLA020986	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-2200_ecfd53fb-5887-48df-bc66-c32f8ff0cf67	0169-2200	HUMAN PRESCRIPTION DRUG	NovoLog Mix 70/30		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20011101		BLA	BLA021172	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-2201_ecfd53fb-5887-48df-bc66-c32f8ff0cf67	0169-2201	HUMAN PRESCRIPTION DRUG	NovoLog Mix 70/30		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20020911		BLA	BLA021172	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-2550_e5571110-ca7e-4fcc-88a8-9f1d0104c508	0169-2550	HUMAN PRESCRIPTION DRUG	Tresiba		insulin degludec	INJECTION, SOLUTION	SUBCUTANEOUS	20150925		BLA	BLA203314	Novo Nordisk	INSULIN DEGLUDEC	200	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-2660_e5571110-ca7e-4fcc-88a8-9f1d0104c508	0169-2660	HUMAN PRESCRIPTION DRUG	Tresiba		insulin degludec	INJECTION, SOLUTION	SUBCUTANEOUS	20150925		BLA	BLA203314	Novo Nordisk	INSULIN DEGLUDEC	100	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-2662_e5571110-ca7e-4fcc-88a8-9f1d0104c508	0169-2662	HUMAN PRESCRIPTION DRUG	Tresiba		insulin degludec	INJECTION, SOLUTION	SUBCUTANEOUS	20181121		BLA	BLA203314	Novo Nordisk	INSULIN DEGLUDEC	100	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-2800_7bb9293e-2a23-4662-9174-01468567657d	0169-2800	HUMAN PRESCRIPTION DRUG	Saxenda		liraglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20141231		NDA	NDA206321	Novo Nordisk	LIRAGLUTIDE	6	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-2911_be581c25-3626-46b1-b1a7-41d7467b262e	0169-2911	HUMAN PRESCRIPTION DRUG	Xultophy 100/3.6		(insulin degludec and liraglutide)	INJECTION, SOLUTION	SUBCUTANEOUS	20161121		BLA	BLA208583	Novo Nordisk	INSULIN DEGLUDEC; LIRAGLUTIDE	100; 3.6	[iU]/mL; mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-3003_46700b71-3f26-4aaa-8eb7-6ceeeb515c79	0169-3003	HUMAN OTC DRUG	Novolin	R	Human Insulin	INJECTION, SOLUTION	SUBCUTANEOUS	20190906		BLA	BLA019938	Novo Nordisk	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0169-3004_652d3fd6-809f-476e-9159-a1beffb9ea01	0169-3004	HUMAN OTC DRUG	Novolin	N	Human Insulin	INJECTION, SUSPENSION	SUBCUTANEOUS	20190906		BLA	BLA019959	Novo Nordisk	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0169-3007_c7164ea1-aa3e-4359-a3f0-a34c78e78398	0169-3007	HUMAN OTC DRUG	Novolin	70/30	Human Insulin	INJECTION, SUSPENSION	SUBCUTANEOUS	20180601		BLA	BLA019991	Novo Nordisk	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0169-3201_133d5f6e-b40f-47b6-ab47-10dc37114d79	0169-3201	HUMAN PRESCRIPTION DRUG	Fiasp		insulin aspart injection	INJECTION, SOLUTION	SUBCUTANEOUS	20171020		BLA	BLA208751	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-3204_133d5f6e-b40f-47b6-ab47-10dc37114d79	0169-3204	HUMAN PRESCRIPTION DRUG	Fiasp		insulin aspart injection	INJECTION, SOLUTION	SUBCUTANEOUS	20171020		BLA	BLA208751	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-3205_133d5f6e-b40f-47b6-ab47-10dc37114d79	0169-3205	HUMAN PRESCRIPTION DRUG	Fiasp		insulin aspart injection	INJECTION, SOLUTION	SUBCUTANEOUS	20171020		BLA	BLA208751	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-3206_133d5f6e-b40f-47b6-ab47-10dc37114d79	0169-3206	HUMAN PRESCRIPTION DRUG	Fiasp		insulin aspart	INJECTION, SOLUTION	SUBCUTANEOUS	20171020		BLA	BLA208751	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-3303_99351c0b-1c32-4eaf-8bc0-68079866d80c	0169-3303	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-3685_ecfd53fb-5887-48df-bc66-c32f8ff0cf67	0169-3685	HUMAN PRESCRIPTION DRUG	NovoLog Mix 70/30		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20011101		BLA	BLA021172	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-3687_40c85e9f-5e3e-4f53-a642-1ee982273108	0169-3687	HUMAN PRESCRIPTION DRUG	Levemir		insulin detemir	INJECTION, SOLUTION	SUBCUTANEOUS	20060327		BLA	BLA021536	Novo Nordisk	INSULIN DETEMIR	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0169-3696_ecfd53fb-5887-48df-bc66-c32f8ff0cf67	0169-3696	HUMAN PRESCRIPTION DRUG	NovoLog Mix 70/30		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20020911		BLA	BLA021172	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-4060_fbacd7b4-2565-4292-b1f6-2aff4e467d47	0169-4060	HUMAN PRESCRIPTION DRUG	Victoza		liraglutide	INJECTION	SUBCUTANEOUS	20100125		NDA	NDA022341	Novo Nordisk	LIRAGLUTIDE	6	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4130_7f4b992f-d010-4e6a-a475-d7133df0ebff	0169-4130	HUMAN PRESCRIPTION DRUG	Ozempic		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20200930		NDA	NDA209637	Novo Nordisk	SEMAGLUTIDE	1.34	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4132_7f4b992f-d010-4e6a-a475-d7133df0ebff	0169-4132	HUMAN PRESCRIPTION DRUG	Ozempic		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20171206	20250930	NDA	NDA209637	Novo Nordisk	SEMAGLUTIDE	1.34	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	
0169-4181_7f4b992f-d010-4e6a-a475-d7133df0ebff	0169-4181	HUMAN PRESCRIPTION DRUG	Ozempic		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20221007		NDA	NDA209637	Novo Nordisk	SEMAGLUTIDE	.68	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4303_fa74bbc6-5386-425e-8d4a-6151795ba57b	0169-4303	HUMAN PRESCRIPTION DRUG	RYBELSUS		Oral Semaglutide	TABLET	ORAL	20190920		NDA	NDA213051	Novo Nordisk	SEMAGLUTIDE	3	mg/1	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4307_fa74bbc6-5386-425e-8d4a-6151795ba57b	0169-4307	HUMAN PRESCRIPTION DRUG	RYBELSUS		Oral Semaglutide	TABLET	ORAL	20190920		NDA	NDA213051	Novo Nordisk	SEMAGLUTIDE	7	mg/1	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4314_fa74bbc6-5386-425e-8d4a-6151795ba57b	0169-4314	HUMAN PRESCRIPTION DRUG	RYBELSUS		Oral Semaglutide	TABLET	ORAL	20190920		NDA	NDA213051	Novo Nordisk	SEMAGLUTIDE	14	mg/1	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4501_3a4f9f29-6860-4f16-9310-bea0726b2b0f	0169-4501	HUMAN PRESCRIPTION DRUG	WEGOVY		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20210605		NDA	NDA215256	Novo Nordisk	SEMAGLUTIDE	1	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4505_3a4f9f29-6860-4f16-9310-bea0726b2b0f	0169-4505	HUMAN PRESCRIPTION DRUG	WEGOVY		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20210605		NDA	NDA215256	Novo Nordisk	SEMAGLUTIDE	.5	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4517_3a4f9f29-6860-4f16-9310-bea0726b2b0f	0169-4517	HUMAN PRESCRIPTION DRUG	WEGOVY		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20210605		NDA	NDA215256	Novo Nordisk	SEMAGLUTIDE	1.7	mg/.75mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4524_3a4f9f29-6860-4f16-9310-bea0726b2b0f	0169-4524	HUMAN PRESCRIPTION DRUG	WEGOVY		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20210605		NDA	NDA215256	Novo Nordisk	SEMAGLUTIDE	2.4	mg/.75mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4525_3a4f9f29-6860-4f16-9310-bea0726b2b0f	0169-4525	HUMAN PRESCRIPTION DRUG	WEGOVY		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20210605		NDA	NDA215256	Novo Nordisk	SEMAGLUTIDE	.25	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-4772_7f4b992f-d010-4e6a-a475-d7133df0ebff	0169-4772	HUMAN PRESCRIPTION DRUG	Ozempic		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20220425		NDA	NDA209637	Novo Nordisk	SEMAGLUTIDE	2.68	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0169-5176_3f3eb506-32e2-497b-a6ea-71ff839b49f5	0169-5176	HUMAN PRESCRIPTION DRUG	Vagifem		estradiol	INSERT	VAGINAL	20100111		NDA	NDA020908	Novo Nordisk	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0169-6338_99351c0b-1c32-4eaf-8bc0-68079866d80c	0169-6338	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20131031		BLA	BLA020986	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-6339_99351c0b-1c32-4eaf-8bc0-68079866d80c	0169-6339	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20030122		BLA	BLA020986	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-6432_40c85e9f-5e3e-4f53-a642-1ee982273108	0169-6432	HUMAN PRESCRIPTION DRUG	Levemir		insulin detemir	INJECTION, SOLUTION	SUBCUTANEOUS	20131031		BLA	BLA021536	Novo Nordisk	INSULIN DETEMIR	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0169-6438_40c85e9f-5e3e-4f53-a642-1ee982273108	0169-6438	HUMAN PRESCRIPTION DRUG	Levemir		insulin detemir	INJECTION, SOLUTION	SUBCUTANEOUS	20131031		BLA	BLA021536	Novo Nordisk	INSULIN DETEMIR	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
0169-7010_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7010	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20080430		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7013_7e42c015-2e0e-4488-8b8a-3ab37035b2f3	0169-7013	PLASMA DERIVATIVE	TRETTEN		Coagulation Factor XIII A-Subunit (Recombinant)	KIT		20131223		BLA	BLA125398	Novo Nordisk						N	20241231
0169-7020_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7020	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20080430		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7040_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7040	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20100806		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7050_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7050	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20080430		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7065_f2d5b224-15b1-4678-84cc-f9e2927ea9b8	0169-7065	HUMAN PRESCRIPTION DRUG	GlucaGen HypoKit		glucagon hydrochloride	KIT		20050622		NDA	NDA020918	Novo Nordisk						N	20241231
0169-7201_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7201	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20121029		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7202_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7202	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20121029		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7205_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7205	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20121029		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7208_eeebef79-2f60-467f-b01f-58a34f0a8175	0169-7208	PLASMA DERIVATIVE	NovoSeven	RT	Coagulation Factor VIIa (Recombinant)	KIT		20121029		BLA	BLA103665	Novo Nordisk						N	20241231
0169-7501_99351c0b-1c32-4eaf-8bc0-68079866d80c	0169-7501	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	Novo Nordisk	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0169-7703_f29c93fa-6486-465b-88a9-6c2d984d17f9	0169-7703	HUMAN PRESCRIPTION DRUG	Norditropin		somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	20090330		BLA	BLA021148	Novo Nordisk	SOMATROPIN	30	mg/3mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
0169-7704_f29c93fa-6486-465b-88a9-6c2d984d17f9	0169-7704	HUMAN PRESCRIPTION DRUG	Norditropin		somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	20050103		BLA	BLA021148	Novo Nordisk	SOMATROPIN	5	mg/1.5mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
0169-7705_f29c93fa-6486-465b-88a9-6c2d984d17f9	0169-7705	HUMAN PRESCRIPTION DRUG	Norditropin		somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	20060102		BLA	BLA021148	Novo Nordisk	SOMATROPIN	10	mg/1.5mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
0169-7708_f29c93fa-6486-465b-88a9-6c2d984d17f9	0169-7708	HUMAN PRESCRIPTION DRUG	Norditropin		somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	20050103		BLA	BLA021148	Novo Nordisk	SOMATROPIN	15	mg/1.5mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
0169-7810_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884	0169-7810	PLASMA DERIVATIVE	NOVOEIGHT		(antihemophilic factor, recombinant)	KIT		20150401		BLA	BLA125466	Novo Nordisk						N	20241231
0169-7815_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884	0169-7815	PLASMA DERIVATIVE	NOVOEIGHT		(antihemophilic factor, recombinant)	KIT		20150401		BLA	BLA125466	Novo Nordisk						N	20241231
0169-7820_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884	0169-7820	PLASMA DERIVATIVE	NOVOEIGHT		(antihemophilic factor, recombinant)	KIT		20150401		BLA	BLA125466	Novo Nordisk						N	20241231
0169-7825_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884	0169-7825	PLASMA DERIVATIVE	NOVOEIGHT		(antihemophilic factor, recombinant)	KIT		20150401		BLA	BLA125466	Novo Nordisk						N	20241231
0169-7830_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884	0169-7830	PLASMA DERIVATIVE	NOVOEIGHT		(antihemophilic factor, recombinant)	KIT		20150401		BLA	BLA125466	Novo Nordisk						N	20241231
0169-7850_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884	0169-7850	PLASMA DERIVATIVE	NOVOEIGHT		(antihemophilic factor, recombinant)	KIT		20150401		BLA	BLA125466	Novo Nordisk						N	20241231
0169-7901_34422170-df50-4547-9a46-ecd0a03af07d	0169-7901	HUMAN PRESCRIPTION DRUG	REBINYN		(Coagulation Factor IX (Recombinant), GlycoPEGylated)	KIT		20171201		BLA	BLA125611	Novo Nordisk						N	20241231
0169-7902_34422170-df50-4547-9a46-ecd0a03af07d	0169-7902	HUMAN PRESCRIPTION DRUG	REBINYN		(Coagulation Factor IX (Recombinant), GlycoPEGylated)	KIT		20171201		BLA	BLA125611	Novo Nordisk						N	20241231
0169-7903_34422170-df50-4547-9a46-ecd0a03af07d	0169-7903	HUMAN PRESCRIPTION DRUG	REBINYN		(Coagulation Factor IX (Recombinant), GlycoPEGylated)	KIT		20220811		BLA	BLA125611	Novo Nordisk						N	20241231
0169-7905_34422170-df50-4547-9a46-ecd0a03af07d	0169-7905	HUMAN PRESCRIPTION DRUG	REBINYN		(Coagulation Factor IX (Recombinant), GlycoPEGylated)	KIT		20171201		BLA	BLA125611	Novo Nordisk						N	20241231
0169-8100_c061a2a3-1e72-4b7d-a7b5-895503037d88	0169-8100	PLASMA DERIVATIVE	ESPEROCT		antihemophilic factor (recombinant), glycopegylated-exei	KIT		20190219		BLA	BLA125671	Novo Nordisk						N	20241231
0169-8150_c061a2a3-1e72-4b7d-a7b5-895503037d88	0169-8150	PLASMA DERIVATIVE	ESPEROCT		antihemophilic factor (recombinant), glycopegylated-exei	KIT		20190219		BLA	BLA125671	Novo Nordisk						N	20241231
0169-8200_c061a2a3-1e72-4b7d-a7b5-895503037d88	0169-8200	PLASMA DERIVATIVE	ESPEROCT		antihemophilic factor (recombinant), glycopegylated-exei	KIT		20190219		BLA	BLA125671	Novo Nordisk						N	20241231
0169-8300_c061a2a3-1e72-4b7d-a7b5-895503037d88	0169-8300	PLASMA DERIVATIVE	ESPEROCT		antihemophilic factor (recombinant), glycopegylated-exei	KIT		20190219		BLA	BLA125671	Novo Nordisk						N	20241231
0169-8500_c061a2a3-1e72-4b7d-a7b5-895503037d88	0169-8500	PLASMA DERIVATIVE	ESPEROCT		antihemophilic factor (recombinant), glycopegylated-exei	KIT		20190219		BLA	BLA125671	Novo Nordisk						N	20241231
0172-2083_8d630cf5-4435-4517-bff1-6cc2eb076787	0172-2083	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19730112		ANDA	ANDA083177	Teva Pharmaceuticals USA, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0172-2089_8d630cf5-4435-4517-bff1-6cc2eb076787	0172-2089	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19800107		ANDA	ANDA083177	Teva Pharmaceuticals USA, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0172-3925_79da6623-a61b-4020-acb6-c8fee38473c3	0172-3925	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071307	Teva Pharmaceuticals USA, Inc.	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0172-3926_79da6623-a61b-4020-acb6-c8fee38473c3	0172-3926	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	Teva Pharmaceuticals USA, Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0172-3927_79da6623-a61b-4020-acb6-c8fee38473c3	0172-3927	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071322	Teva Pharmaceuticals USA, Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0172-4096_ba227be6-e946-423c-a9a6-e0626d889ea7	0172-4096	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	19880721		ANDA	ANDA072234	Teva Pharmaceuticals USA, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0172-4097_ba227be6-e946-423c-a9a6-e0626d889ea7	0172-4097	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	19880721		ANDA	ANDA072235	Teva Pharmaceuticals USA, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0172-5240_fc800314-47d7-41ca-af8a-9222fbf5631c	0172-5240	HUMAN PRESCRIPTION DRUG	Anagrelide Hydrochloride		Anagrelide Hydrochloride	CAPSULE	ORAL	20050418		ANDA	ANDA076468	Teva Pharmaceuticals USA, Inc.	ANAGRELIDE HYDROCHLORIDE	1	mg/1	Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]		N	20241231
0172-5241_fc800314-47d7-41ca-af8a-9222fbf5631c	0172-5241	HUMAN PRESCRIPTION DRUG	Anagrelide Hydrochloride		Anagrelide Hydrochloride	CAPSULE	ORAL	20050418		ANDA	ANDA076468	Teva Pharmaceuticals USA, Inc.	ANAGRELIDE HYDROCHLORIDE	.5	mg/1	Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]		N	20241231
0172-5728_782862f6-1722-418a-bc28-9a28a4238433	0172-5728	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	Teva Pharmaceuticals USA, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0172-5729_782862f6-1722-418a-bc28-9a28a4238433	0172-5729	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	Teva Pharmaceuticals USA, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0172-6406_08d0b08d-90e1-46e7-afe3-c11b638d65db	0172-6406	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION	INTRABRONCHIAL	20000118		ANDA	ANDA075271	Teva Pharmaceuticals USA, Inc.	CROMOLYN SODIUM	20	mg/2mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
0172-7313_b220d09f-a710-4dc5-a784-6e7ac15647f9	0172-7313	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	SOLUTION	ORAL	20050329		ANDA	ANDA065078	Teva Pharmaceuticals USA, Inc.	CYCLOSPORINE	100	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0173-0135_d3423427-a8fe-473b-ae18-305040d648b8	0173-0135	HUMAN PRESCRIPTION DRUG	WELLBUTRIN	SR	bupropion hydrochloride	TABLET, FILM COATED	ORAL	19961115		NDA	NDA020358	GlaxoSmithKline LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0173-0388_29265e11-dbd6-4061-96ad-17b4f239ce60	0173-0388	HUMAN PRESCRIPTION DRUG	BECONASE	AQ	beclomethasone dipropionate monohydrate	SPRAY, SUSPENSION	NASAL	19891001		NDA	NDA019389	GlaxoSmithKline LLC	BECLOMETHASONE DIPROPIONATE MONOHYDRATE	42	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0478_9aa62440-fca5-4d1b-a077-0955e7c7daeb	0173-0478	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	INJECTION	SUBCUTANEOUS	19970127		NDA	NDA020080	GlaxoSmithKline LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0479_9aa62440-fca5-4d1b-a077-0955e7c7daeb	0173-0479	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	INJECTION	SUBCUTANEOUS	19970123		NDA	NDA020080	GlaxoSmithKline LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0517_8e8254ca-dbad-41f0-9c02-922425061a91	0173-0517	HUMAN PRESCRIPTION DRUG	FLOLAN		epoprostenol sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19951208		NDA	NDA020444	GlaxoSmithKline LLC	EPOPROSTENOL SODIUM	.5	mg/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0173-0519_8e8254ca-dbad-41f0-9c02-922425061a91	0173-0519	HUMAN PRESCRIPTION DRUG	FLOLAN		epoprostenol sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19951208		NDA	NDA020444	GlaxoSmithKline LLC	EPOPROSTENOL SODIUM	1.5	mg/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0173-0521_a2d4003d-3b54-492d-a9d2-5236358bdf05	0173-0521	HUMAN PRESCRIPTION DRUG	SEREVENT	DISKUS	salmeterol xinafoate	POWDER, METERED	ORAL; RESPIRATORY (INHALATION)	19971125		NDA	NDA020692	GlaxoSmithKline LLC	SALMETEROL XINAFOATE	50	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0523_9cc089f2-eafa-47cb-8d41-be00fd3d55c3	0173-0523	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	SPRAY	NASAL	19970918		NDA	NDA020626	GlaxoSmithKline LLC	SUMATRIPTAN	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0524_9cc089f2-eafa-47cb-8d41-be00fd3d55c3	0173-0524	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	SPRAY	NASAL	19971010		NDA	NDA020626	GlaxoSmithKline LLC	SUMATRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0526_d15a5607-7757-4f62-9269-154d706b67e9	0173-0526	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	TABLET, FOR SUSPENSION	ORAL	19980904		NDA	NDA020764	GlaxoSmithKline LLC	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0527_d15a5607-7757-4f62-9269-154d706b67e9	0173-0527	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	TABLET, FOR SUSPENSION	ORAL	19980903		NDA	NDA020764	GlaxoSmithKline LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0547_a88a003d-2672-4782-8d24-62b2bf6e64ba	0173-0547	HUMAN PRESCRIPTION DRUG	MEPRON		atovaquone	SUSPENSION	ORAL	19980918		NDA	NDA020500	GlaxoSmithKline LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
0173-0565_f5ee9f6a-21ab-4fab-a318-cdf2d144e6a2	0173-0565	HUMAN PRESCRIPTION DRUG	VALTREX		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	20020812		NDA	NDA020487	GlaxoSmithKline LLC	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0173-0594_d15a5607-7757-4f62-9269-154d706b67e9	0173-0594	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	KIT		20030929		NDA	NDA020241	GlaxoSmithKline LLC						N	20241231
0173-0600_483512d0-11e0-4416-b9b4-44b640adf357	0173-0600	HUMAN PRESCRIPTION DRUG	FLOVENT	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20070508		NDA	NDA020833	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0601_483512d0-11e0-4416-b9b4-44b640adf357	0173-0601	HUMAN PRESCRIPTION DRUG	FLOVENT	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20081013		NDA	NDA020833	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE	250	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0602_483512d0-11e0-4416-b9b4-44b640adf357	0173-0602	HUMAN PRESCRIPTION DRUG	FLOVENT	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20081013		NDA	NDA020833	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE	100	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0633_d15a5607-7757-4f62-9269-154d706b67e9	0173-0633	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	TABLET	ORAL	19960815		NDA	NDA020241	GlaxoSmithKline LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0642_d15a5607-7757-4f62-9269-154d706b67e9	0173-0642	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	TABLET	ORAL	19950117		NDA	NDA020241	GlaxoSmithKline LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0643_d15a5607-7757-4f62-9269-154d706b67e9	0173-0643	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	TABLET	ORAL	19950117		NDA	NDA020241	GlaxoSmithKline LLC	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0644_d15a5607-7757-4f62-9269-154d706b67e9	0173-0644	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	TABLET	ORAL	19950118		NDA	NDA020241	GlaxoSmithKline LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0662_38a4724f-2f27-465b-a185-d26f4bb28d04	0173-0662	HUMAN PRESCRIPTION DRUG	EPIVIR	HBV	lamivudine	TABLET, FILM COATED	ORAL	19981217		NDA	NDA021003	GlaxoSmithKline LLC	LAMIVUDINE	100	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0173-0663_38a4724f-2f27-465b-a185-d26f4bb28d04	0173-0663	HUMAN PRESCRIPTION DRUG	EPIVIR	HBV	lamivudine	SOLUTION	ORAL	19981223		NDA	NDA021004	GlaxoSmithKline LLC	LAMIVUDINE	5	mg/mL	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0173-0665_a88a003d-2672-4782-8d24-62b2bf6e64ba	0173-0665	HUMAN PRESCRIPTION DRUG	MEPRON		atovaquone	SUSPENSION	ORAL	19950228		NDA	NDA020500	GlaxoSmithKline LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
0173-0675_a4544599-2e43-4fb8-b38d-84613dac6729	0173-0675	HUMAN PRESCRIPTION DRUG	MALARONE		atovaquone and proguanil hydrochloride	TABLET, FILM COATED	ORAL	20000726		NDA	NDA021078	GlaxoSmithKline LLC	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
0173-0676_a4544599-2e43-4fb8-b38d-84613dac6729	0173-0676	HUMAN PRESCRIPTION DRUG	MALARONE		atovaquone and proguanil hydrochloride	TABLET, FILM COATED	ORAL	20000726		NDA	NDA021078	GlaxoSmithKline LLC	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	62.5; 25	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
0173-0681_276882d0-98d8-4f65-a341-62953e316217	0173-0681	HUMAN PRESCRIPTION DRUG	RELENZA		zanamivir	POWDER	RESPIRATORY (INHALATION)	19990922		NDA	NDA021036	GlaxoSmithKline LLC	ZANAMIVIR	5	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0173-0682_782b50c3-3687-47e9-ab1e-901868d8a861	0173-0682	HUMAN PRESCRIPTION DRUG	VENTOLIN	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20060609		NDA	NDA020983	GlaxoSmithKline LLC	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0695_9026232e-4b1f-4826-b941-686d0a3be857	0173-0695	HUMAN PRESCRIPTION DRUG	ADVAIR	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20010228		NDA	NDA021077	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	100; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0696_9026232e-4b1f-4826-b941-686d0a3be857	0173-0696	HUMAN PRESCRIPTION DRUG	ADVAIR	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20010205		NDA	NDA021077	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0697_9026232e-4b1f-4826-b941-686d0a3be857	0173-0697	HUMAN PRESCRIPTION DRUG	ADVAIR	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20010305		NDA	NDA021077	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	500; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0699_d15a5607-7757-4f62-9269-154d706b67e9	0173-0699	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	TABLET, FOR SUSPENSION	ORAL	20001012		NDA	NDA020764	GlaxoSmithKline LLC	LAMOTRIGINE	2	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0715_70e875cd-b7be-45b2-b5aa-993a384e0dd5	0173-0715	HUMAN PRESCRIPTION DRUG	ADVAIR HFA		fluticasone propionate and salmeterol xinafoate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20080929		NDA	NDA021254	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	45; 21	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0716_70e875cd-b7be-45b2-b5aa-993a384e0dd5	0173-0716	HUMAN PRESCRIPTION DRUG	ADVAIR HFA		fluticasone propionate and salmeterol xinafoate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20080929		NDA	NDA021254	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	115; 21	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0717_70e875cd-b7be-45b2-b5aa-993a384e0dd5	0173-0717	HUMAN PRESCRIPTION DRUG	ADVAIR HFA		fluticasone propionate and salmeterol xinafoate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20090306		NDA	NDA021254	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	230; 21	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0718_0c541801-6f2e-4998-b38f-41e7530e1d0d	0173-0718	HUMAN PRESCRIPTION DRUG	FLOVENT	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20070406		NDA	NDA021433	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE	44	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0719_0c541801-6f2e-4998-b38f-41e7530e1d0d	0173-0719	HUMAN PRESCRIPTION DRUG	FLOVENT	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20070129		NDA	NDA021433	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE	110	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0720_0c541801-6f2e-4998-b38f-41e7530e1d0d	0173-0720	HUMAN PRESCRIPTION DRUG	FLOVENT	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20070125		NDA	NDA021433	GlaxoSmithKline LLC	FLUTICASONE PROPIONATE	220	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0722_d3423427-a8fe-473b-ae18-305040d648b8	0173-0722	HUMAN PRESCRIPTION DRUG	WELLBUTRIN	SR	bupropion hydrochloride	TABLET, FILM COATED	ORAL	20020625		NDA	NDA020358	GlaxoSmithKline LLC	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0173-0735_d11a0873-59af-493c-be1a-9c5adf68182c	0173-0735	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	TABLET, FILM COATED	ORAL	20031217		NDA	NDA020132	GlaxoSmithKline LLC	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0736_d11a0873-59af-493c-be1a-9c5adf68182c	0173-0736	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	TABLET, FILM COATED	ORAL	20031217		NDA	NDA020132	GlaxoSmithKline LLC	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0737_d11a0873-59af-493c-be1a-9c5adf68182c	0173-0737	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	TABLET, FILM COATED	ORAL	20031219		NDA	NDA020132	GlaxoSmithKline LLC	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0739_9aa62440-fca5-4d1b-a077-0955e7c7daeb	0173-0739	HUMAN PRESCRIPTION DRUG	IMITREX		sumatriptan	INJECTION	SUBCUTANEOUS	20060406		NDA	NDA020080	GlaxoSmithKline LLC	SUMATRIPTAN SUCCINATE	4	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0173-0754_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0754	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090706		NDA	NDA022115	GlaxoSmithKline LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0755_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0755	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090706		NDA	NDA022115	GlaxoSmithKline LLC	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0756_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0756	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090706		NDA	NDA022115	GlaxoSmithKline LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0757_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0757	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090706		NDA	NDA022115	GlaxoSmithKline LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0758_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0758	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	KIT		20090706		NDA	NDA022115	GlaxoSmithKline LLC						N	20241231
0173-0759_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0759	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	KIT		20090706		NDA	NDA022115	GlaxoSmithKline LLC						N	20241231
0173-0760_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0760	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	KIT		20090706		NDA	NDA022115	GlaxoSmithKline LLC						N	20241231
0173-0761_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0761	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110331		NDA	NDA022115	GlaxoSmithKline LLC	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0772_d15a5607-7757-4f62-9269-154d706b67e9	0173-0772	HUMAN PRESCRIPTION DRUG	LAMICTAL	ODT	lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20090605		NDA	NDA022251	GlaxoSmithKline LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0774_d15a5607-7757-4f62-9269-154d706b67e9	0173-0774	HUMAN PRESCRIPTION DRUG	LAMICTAL	ODT	lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20090605		NDA	NDA022251	GlaxoSmithKline LLC	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0776_d15a5607-7757-4f62-9269-154d706b67e9	0173-0776	HUMAN PRESCRIPTION DRUG	LAMICTAL	ODT	lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20090605		NDA	NDA022251	GlaxoSmithKline LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0777_d15a5607-7757-4f62-9269-154d706b67e9	0173-0777	HUMAN PRESCRIPTION DRUG	LAMICTAL	ODT	lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20090605		NDA	NDA022251	GlaxoSmithKline LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0778_d15a5607-7757-4f62-9269-154d706b67e9	0173-0778	HUMAN PRESCRIPTION DRUG	LAMICTAL	ODT	lamotrigine	KIT		20090605		NDA	NDA022251	GlaxoSmithKline LLC						N	20241231
0173-0779_d15a5607-7757-4f62-9269-154d706b67e9	0173-0779	HUMAN PRESCRIPTION DRUG	LAMICTAL	ODT	lamotrigine	KIT		20090605		NDA	NDA022251	GlaxoSmithKline LLC						N	20241231
0173-0780_d15a5607-7757-4f62-9269-154d706b67e9	0173-0780	HUMAN PRESCRIPTION DRUG	LAMICTAL	ODT	lamotrigine	KIT		20090605		NDA	NDA022251	GlaxoSmithKline LLC						N	20241231
0173-0781_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c	0173-0781	HUMAN PRESCRIPTION DRUG	LAMICTAL	XR	lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110815		NDA	NDA022115	GlaxoSmithKline LLC	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0173-0809_d4997425-dc8a-4f1d-9508-0fe326591fe9	0173-0809	HUMAN PRESCRIPTION DRUG	JALYN		dutasteride and tamsulosin hydrochloride	CAPSULE	ORAL	20100621	20240331	NDA	NDA022460	GlaxoSmithKline LLC	DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE	.5; .4	mg/1; mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA], Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
0173-0817_d15a5607-7757-4f62-9269-154d706b67e9	0173-0817	HUMAN PRESCRIPTION DRUG	LAMICTAL		lamotrigine	KIT		20030929		NDA	NDA020241	GlaxoSmithKline LLC						N	20241231
0173-0823_4e4c46d0-11df-4810-bf8a-14c392b33345	0173-0823	HUMAN PRESCRIPTION DRUG	RYTHMOL	SR	propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110317		NDA	NDA021416	GlaxoSmithKline LLC	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
0173-0824_4e4c46d0-11df-4810-bf8a-14c392b33345	0173-0824	HUMAN PRESCRIPTION DRUG	RYTHMOL	SR	propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110317		NDA	NDA021416	GlaxoSmithKline LLC	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
0173-0826_4e4c46d0-11df-4810-bf8a-14c392b33345	0173-0826	HUMAN PRESCRIPTION DRUG	RYTHMOL	SR	propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110317		NDA	NDA021416	GlaxoSmithKline LLC	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
0173-0857_8e8254ca-dbad-41f0-9c02-922425061a91	0173-0857	HUMAN PRESCRIPTION DRUG	Diluent		water	SOLUTION	INTRAVENOUS	20160401		NDA	NDA020444	GlaxoSmithKline LLC	WATER	1	mL/mL			N	20241231
0173-0859_58e62ebe-a977-4ab7-b932-a2e985360dfb	0173-0859	HUMAN PRESCRIPTION DRUG	Breo Ellipta		fluticasone furoate and vilanterol trifenatate	POWDER	RESPIRATORY (INHALATION)	20130826		NDA	NDA204275	GlaxoSmithKline LLC	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	100; 25	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0869_99500bf8-e1f7-4aff-8f8e-4d4d1a54fea0	0173-0869	HUMAN PRESCRIPTION DRUG	Anoro Ellipta		umeclidinium bromide and vilanterol trifenatate	POWDER	RESPIRATORY (INHALATION)	20140131		NDA	NDA203975	GlaxoSmithKline LLC	UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE	62.5; 25	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0873_e528d273-b49e-4095-be44-1ac2ff45252e	0173-0873	HUMAN PRESCRIPTION DRUG	Incruse Ellipta		umeclidinium	AEROSOL, POWDER	ORAL	20140430		NDA	NDA205382	GlaxoSmithKline LLC	UMECLIDINIUM BROMIDE	62.5	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0173-0874_424438a1-6362-4694-b20c-7d2fba714d20	0173-0874	HUMAN PRESCRIPTION DRUG	Arnuity Ellipta		fluticasone furoate	POWDER	RESPIRATORY (INHALATION)	20140820		NDA	NDA205625	GlaxoSmithKline LLC	FLUTICASONE FUROATE	100	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0876_424438a1-6362-4694-b20c-7d2fba714d20	0173-0876	HUMAN PRESCRIPTION DRUG	Arnuity Ellipta		fluticasone furoate	POWDER	RESPIRATORY (INHALATION)	20140820		NDA	NDA205625	GlaxoSmithKline LLC	FLUTICASONE FUROATE	200	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0881_6aaacdeb-43d4-4367-9d37-a9d6876344f1	0173-0881	HUMAN PRESCRIPTION DRUG	Nucala		mepolizumab	INJECTION, POWDER, FOR SOLUTION	SUBCUTANEOUS	20151104		BLA	BLA125526	GlaxoSmithKline LLC	MEPOLIZUMAB	100	mg/mL	Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]		N	20241231
0173-0882_58e62ebe-a977-4ab7-b932-a2e985360dfb	0173-0882	HUMAN PRESCRIPTION DRUG	Breo Ellipta		fluticasone furoate and vilanterol trifenatate	POWDER	RESPIRATORY (INHALATION)	20150430		NDA	NDA204275	GlaxoSmithKline LLC	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	200; 25	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0887_d6db0c6b-fa8c-4b68-9ce1-76cac0c042c5	0173-0887	HUMAN PRESCRIPTION DRUG	Trelegy Ellipta		fluticasone furoate, umeclidinium bromide and vilanterol trifenatate	POWDER	RESPIRATORY (INHALATION)	20170918		NDA	NDA209482	GlaxoSmithKline LLC	FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE	100; 62.5; 25	ug/1; ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0888_424438a1-6362-4694-b20c-7d2fba714d20	0173-0888	HUMAN PRESCRIPTION DRUG	Arnuity Ellipta		fluticasone furoate	POWDER	RESPIRATORY (INHALATION)	20180517		NDA	NDA205625	GlaxoSmithKline LLC	FLUTICASONE FUROATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0173-0889_1dd2f8a0-1100-4410-ad7a-37d769fc0c35	0173-0889	HUMAN PRESCRIPTION DRUG	Krintafel		tafenoquine succinate	TABLET, FILM COATED	ORAL	20190122		NDA	NDA210795	GlaxoSmithKline LLC	TAFENOQUINE SUCCINATE	150	mg/1			N	20241231
0173-0892_6aaacdeb-43d4-4367-9d37-a9d6876344f1	0173-0892	HUMAN PRESCRIPTION DRUG	Nucala		mepolizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20190606		BLA	BLA761122	GlaxoSmithKline LLC	MEPOLIZUMAB	100	mg/mL	Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]		N	20241231
0173-0893_d6db0c6b-fa8c-4b68-9ce1-76cac0c042c5	0173-0893	HUMAN PRESCRIPTION DRUG	Trelegy Ellipta		fluticasone furoate, umeclidinium bromide and vilanterol trifenatate	POWDER	RESPIRATORY (INHALATION)	20200909		NDA	NDA209482	GlaxoSmithKline LLC	FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE	200; 62.5; 25	ug/1; ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0896_eac12010-cb69-47a5-962e-6ae43c8f545c	0173-0896	HUMAN PRESCRIPTION DRUG	Blenrep		Belantamab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200805	20240630	BLA	BLA761158	GlaxoSmithKline LLC	BELANTAMAB MAFODOTIN	50	mg/mL			N	
0173-0897_c6714341-ff44-4178-8c1d-2ba8fc4d6be1	0173-0897	HUMAN PRESCRIPTION DRUG	Jesduvroq		daprodustat	TABLET, FILM COATED	ORAL	20230201		NDA	NDA216951	GlaxoSmithKline LLC	DAPRODUSTAT	1	mg/1			N	20241231
0173-0898_e98f1917-0956-4ed1-a7f5-30774d27ea8c	0173-0898	HUMAN PRESCRIPTION DRUG	Jemperli		dostarlimab	INJECTION	INTRAVENOUS	20210422		BLA	BLA761174	GlaxoSmithKline LLC	DOSTARLIMAB	50	mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
0173-0901_c9cb1c3e-09db-49c1-a7c1-bd99a61dfb51	0173-0901	HUMAN PRESCRIPTION DRUG	Sotrovimab		sotrovimab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210526		UNAPPROVED DRUG OTHER		GlaxoSmithKline LLC	SOTROVIMAB	62.5	mg/mL			N	20241231
0173-0903_c6714341-ff44-4178-8c1d-2ba8fc4d6be1	0173-0903	HUMAN PRESCRIPTION DRUG	Jesduvroq		daprodustat	TABLET, FILM COATED	ORAL	20230201		NDA	NDA216951	GlaxoSmithKline LLC	DAPRODUSTAT	2	mg/1			N	20241231
0173-0904_6aaacdeb-43d4-4367-9d37-a9d6876344f1	0173-0904	HUMAN PRESCRIPTION DRUG	Nucala		mepolizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20220122		BLA	BLA761122	GlaxoSmithKline LLC	MEPOLIZUMAB	40	mg/.4mL	Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]		N	20241231
0173-0906_c6714341-ff44-4178-8c1d-2ba8fc4d6be1	0173-0906	HUMAN PRESCRIPTION DRUG	Jesduvroq		daprodustat	TABLET, FILM COATED	ORAL	20230201		NDA	NDA216951	GlaxoSmithKline LLC	DAPRODUSTAT	4	mg/1			N	20241231
0173-0909_b680e033-3428-436a-9999-4f851ec717a9	0173-0909	HUMAN PRESCRIPTION DRUG	ZEJULA		niraparib	TABLET, FILM COATED	ORAL	20230627		NDA	NDA214876	GlaxoSmithKline LLC	NIRAPARIB TOSYLATE MONOHYDRATE	100	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20251231
0173-0911_c6714341-ff44-4178-8c1d-2ba8fc4d6be1	0173-0911	HUMAN PRESCRIPTION DRUG	Jesduvroq		daprodustat	TABLET, FILM COATED	ORAL	20230201		NDA	NDA216951	GlaxoSmithKline LLC	DAPRODUSTAT	6	mg/1			N	20241231
0173-0912_b680e033-3428-436a-9999-4f851ec717a9	0173-0912	HUMAN PRESCRIPTION DRUG	ZEJULA		niraparib	TABLET, FILM COATED	ORAL	20230627		NDA	NDA214876	GlaxoSmithKline LLC	NIRAPARIB TOSYLATE MONOHYDRATE	200	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20251231
0173-0914_c6714341-ff44-4178-8c1d-2ba8fc4d6be1	0173-0914	HUMAN PRESCRIPTION DRUG	Jesduvroq		daprodustat	TABLET, FILM COATED	ORAL	20230201		NDA	NDA216951	GlaxoSmithKline LLC	DAPRODUSTAT	8	mg/1			N	20241231
0173-0915_b680e033-3428-436a-9999-4f851ec717a9	0173-0915	HUMAN PRESCRIPTION DRUG	ZEJULA		niraparib	TABLET, FILM COATED	ORAL	20230627		NDA	NDA214876	GlaxoSmithKline LLC	NIRAPARIB TOSYLATE MONOHYDRATE	300	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20251231
0173-0916_58e62ebe-a977-4ab7-b932-a2e985360dfb	0173-0916	HUMAN PRESCRIPTION DRUG	Breo Ellipta		fluticasone furoate and vilanterol trifenatate	POWDER	RESPIRATORY (INHALATION)	20230512		NDA	NDA204275	GlaxoSmithKline LLC	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	50; 25	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0173-0933_f5ee9f6a-21ab-4fab-a318-cdf2d144e6a2	0173-0933	HUMAN PRESCRIPTION DRUG	VALTREX		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	19950801		NDA	NDA020487	GlaxoSmithKline LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0173-0947_d3423427-a8fe-473b-ae18-305040d648b8	0173-0947	HUMAN PRESCRIPTION DRUG	WELLBUTRIN	SR	bupropion hydrochloride	TABLET, FILM COATED	ORAL	19961115		NDA	NDA020358	GlaxoSmithKline LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0178-0089_0e765c65-dfe9-b0fa-e063-6294a90a4b51	0178-0089	HUMAN PRESCRIPTION DRUG	Ferralet 90		iron, folic acid, cyanocobalamin, ascorbic acid, and docusate sodium	TABLET, FILM COATED	ORAL	20100204		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	ASCORBIC ACID; CYANOCOBALAMIN; DOCUSATE SODIUM; FOLIC ACID; IRON	120; 12; 50; 1; 90	mg/1; ug/1; mg/1; mg/1; mg/1	Ascorbic Acid [CS], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC]		N	20251231
0178-0314_f1e9c718-f2ec-1124-e053-2995a90a06ea	0178-0314	HUMAN OTC DRUG	POTASSIUM IODIDE		POTASSIUM IODIDE	SOLUTION	ORAL	20160515		ANDA	ANDA206211	Mission Pharmacal Company	POTASSIUM IODIDE	65	mg/mL			N	20241231
0178-0320_04393d66-38c6-1d2e-e063-6294a90ae487	0178-0320	HUMAN OTC DRUG	Theragesic Creme		METHYL SALICYLATE	GEL	TOPICAL	19810101		OTC MONOGRAPH NOT FINAL	part348	Mission Pharmacal Company	MENTHOL; METHYL SALICYLATE	10; 150	mg/g; mg/g			N	20241231
0178-0330_06f91e45-38a3-235c-e063-6294a90afbe6	0178-0330	HUMAN OTC DRUG	DR SMITHS DIAPER		Zinc Oxide	OINTMENT	TOPICAL	20100301		OTC MONOGRAPH DRUG	M016	Mission Pharmacal	ZINC OXIDE	100	mg/g			N	20241231
0178-0455_0e7660ec-ac6a-78f8-e063-6394a90ae05a	0178-0455	HUMAN PRESCRIPTION DRUG	Texacort		Hydrocortisone	SOLUTION	TOPICAL	20111215		ANDA	ANDA081271	Mission Pharmacal Company	HYDROCORTISONE	25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
0178-0460_099223af-a429-c370-e063-6394a90aa17f	0178-0460	HUMAN PRESCRIPTION DRUG	Avar-e Green		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0465_f7843c0f-b7f8-0b30-e053-6294a90aeb6e	0178-0465	HUMAN PRESCRIPTION DRUG	Avar-e LS		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0470_f7844b5e-dd65-9baa-e053-6394a90a96e6	0178-0470	HUMAN PRESCRIPTION DRUG	Avar-e		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0475_f7845bcc-5b38-4e2c-e053-6294a90a51b1	0178-0475	HUMAN PRESCRIPTION DRUG	AVAR LS		SULFACETAMIDE SODIUM, SULFUR	EMULSION	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0480_f7846b0e-0157-76f7-e053-6294a90af394	0178-0480	HUMAN PRESCRIPTION DRUG	AVAR		SULFACETAMIDE SODIUM, SULFUR	EMULSION	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0485_f797ecc8-1b4d-d9be-e053-6294a90a7af5	0178-0485	HUMAN PRESCRIPTION DRUG	OVACE Plus		SULFACETAMIDE SODIUM	SHAMPOO	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0490_f79394ee-e1ad-a404-e053-6394a90a9910	0178-0490	HUMAN PRESCRIPTION DRUG	OVACE Plus		SULFACETAMIDE SODIUM	LIQUID	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0495_f78467ae-c40f-cbde-e053-6394a90acad2	0178-0495	HUMAN PRESCRIPTION DRUG	OvacePlus	Plus	SULFACETAMIDE SODIUM	CREAM	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0499_f797f681-1106-2396-e053-6394a90ab801	0178-0499	HUMAN PRESCRIPTION DRUG	OVACE		SULFACETAMIDE SODIUM	LIQUID	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0500_0e767659-f96a-7c88-e063-6294a90a0f64	0178-0500	HUMAN PRESCRIPTION DRUG	Lithostat		acetohydroxamic acid	TABLET	ORAL	19830531		NDA	NDA018749	Mission Pharmacal Company	ACETOHYDROXAMIC ACID	250	mg/1	Urease Inhibitor [EPC], Urease Inhibitors [MoA]		N	20251231
0178-0600_0e76684e-8d68-ba16-e063-6294a90a5409	0178-0600	HUMAN PRESCRIPTION DRUG	UROCIT-K		potassium citrate	TABLET, EXTENDED RELEASE	ORAL	19850901		NDA	NDA019071	Mission Pharmacal Company	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20251231
0178-0610_0e76684e-8d68-ba16-e063-6294a90a5409	0178-0610	HUMAN PRESCRIPTION DRUG	UROCIT-K		potassium citrate	TABLET, EXTENDED RELEASE	ORAL	19920901		NDA	NDA019071	Mission Pharmacal Company	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20251231
0178-0615_0e76684e-8d68-ba16-e063-6294a90a5409	0178-0615	HUMAN PRESCRIPTION DRUG	UROCIT-K		potassium citrate	TABLET, EXTENDED RELEASE	ORAL	20100127		NDA	NDA019071	Mission Pharmacal Company	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20251231
0178-0620_032507e2-c9f8-f285-e063-6394a90a0fbf	0178-0620	HUMAN PRESCRIPTION DRUG	Ovace	Plus	SULFACETAMIDE SODIUM	LOTION	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM	98	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0630_f7938654-e4f4-fb07-e053-6394a90a588a	0178-0630	HUMAN PRESCRIPTION DRUG	OVACE	PLUS	SODIUM SULFACETAMIDE	LIQUID	TOPICAL	20110907		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0178-0740_0ac09d94-fca6-483e-e063-6394a90a8446	0178-0740	HUMAN PRESCRIPTION DRUG	URIBEL		Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate	CAPSULE	ORAL	20190415	20241231	UNAPPROVED DRUG OTHER		Mission Pharmacal Company	HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.12; 118; 10; 36; 40.8	mg/1; mg/1; mg/1; mg/1; mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	
0178-0745_0b25f1da-cbe8-e206-e063-6394a90a4e2e	0178-0745	HUMAN PRESCRIPTION DRUG	URIBEL TABS		Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate	TABLET, COATED	ORAL	20231107		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	BENZOIC ACID; HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE	9; .12; 81.6; 10.8; 36.2	mg/1; mg/1; mg/1; mg/1; mg/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0178-0796_0e75f143-c795-4323-e063-6294a90a9cdb	0178-0796	HUMAN PRESCRIPTION DRUG	CitraNatal Harmony 3.0		Calcium citrate, Iron pentacarbonyl, Cholecalciferol, .Alpha.-Tocopherol, Dl-, Pyridoxine hydrochloride, Folic Acid, Docusate Sodium, and Doconexent	CAPSULE, GELATIN COATED	ORAL	20140321		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	.ALPHA.-TOCOPHEROL; CALCIUM CITRATE; CHOLECALCIFEROL; DOCONEXENT; DOCUSATE SODIUM; FOLIC ACID; IRON; PYRIDOXINE	30; 104; 400; 260; 50; 1; 27; 25	[iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20251231
0178-0813_0a0ce624-1a05-85f4-e063-6294a90ac29a	0178-0813	HUMAN PRESCRIPTION DRUG	CitraNatal Bloom		iron, folic acid, cyanocobalamin, ascorbic acid, and docusate sodium	TABLET, FILM COATED	ORAL	20170801	20240601	UNAPPROVED DRUG OTHER		Mission Pharmacal Company	ASCORBIC ACID; CYANOCOBALAMIN; DOCUSATE SODIUM; FERROUS GLUCONATE; FOLIC ACID; IRON PENTACARBONYL	138; 16.8; 55; 13.2; 1.4; 88.5	mg/1; ug/1; mg/1; mg/1; mg/1; mg/1	Ascorbic Acid [CS], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC]		N	
0178-0821_0e7688ae-79e5-7d4d-e063-6394a90a36a7	0178-0821	HUMAN PRESCRIPTION DRUG	CitraNatal 90 DHA		Vitamin C, Calcium, Iron, Vitamin D3, Vitamin E, Thiamin, Riboflavin, Niacinamide, Vitamin B6, Folic Acid, Iodine, Zinc, Copper, Docusate Sodium	TABLET	ORAL	20140411		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; CALCIUM CITRATE; CUPRIC OXIDE; DOCUSATE SODIUM; FERROUS GLUCONATE; FOLIC ACID; IRON; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE; THIAMINE MONONITRATE; VITAMIN D; ZINC OXIDE	30; 120; 159; 2; 50; 5; 1; 85; 20; 150; 20; 3.4; 3; 4.54; 400; 25	[iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20251231
0178-0832_0e7645b5-71a9-72fb-e063-6394a90ae398	0178-0832	HUMAN PRESCRIPTION DRUG	CITRANATAL B-CALM		ascorbic acid, calcium citrate, iron, cholecalciferol, pyridoxine hydrochloride, and folic acid	KIT		20120618		UNAPPROVED DRUG OTHER		Mission Pharmacal Company						N	20251231
0178-0891_0e764c29-02d8-6485-e063-6394a90a6a45	0178-0891	HUMAN PRESCRIPTION DRUG	CitraNatal Assure		ascorbic acid, calcium citrate, iron, vitamin d, dl- alpha- tocopherol acetate, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, iodine, zinc, copper, docusate sodium, doconexent and icosapent	KIT		20140430		UNAPPROVED DRUG OTHER		Mission Pharmacal Company						N	20251231
0178-0896_0e10ed7c-91b7-f234-e063-6394a90ac554	0178-0896	HUMAN PRESCRIPTION DRUG	CitraNatal Medley		Calcium citrate, Iron pentacarbonyl, Ferrous Fumarate, Cholecalciferol, .Alpha.-Tocopherol, Dl-, Pyridoxine hydrochloride, Folic Acid, and Doconexent	CAPSULE, GELATIN COATED	ORAL	20180320		UNAPPROVED DRUG OTHER		Mission Pharmacal Company	.ALPHA.-TOCOPHEROL; CALCIUM CITRATE; CHOLECALCIFEROL; DOCONEXENT; FERROUS FUMARATE; FOLIC ACID; IRON; PYRIDOXINE	15; 62; 200; 200; 2; 1; 27; 12.5	[iU]/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20251231
0178-0900_0e764c29-02df-6485-e063-6394a90a6a45	0178-0900	HUMAN PRESCRIPTION DRUG	Thiola		tiopronin	TABLET, SUGAR COATED	ORAL	19880811		NDA	NDA019569	Mission Pharmacal Company	TIOPRONIN	100	mg/1	Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]		N	20251231
0178-0901_0e760312-a05a-7c86-e063-6294a90a6a15	0178-0901	HUMAN PRESCRIPTION DRUG	Thiola EC		tiopronin	TABLET, DELAYED RELEASE	ORAL	20190628		NDA	NDA211843	Mission Pharmacal Company	TIOPRONIN	300	mg/1	Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]		N	20251231
0178-0902_0e760312-a05a-7c86-e063-6294a90a6a15	0178-0902	HUMAN PRESCRIPTION DRUG	Thiola EC		tiopronin	TABLET, DELAYED RELEASE	ORAL	20190628		NDA	NDA211843	Mission Pharmacal Company	TIOPRONIN	100	mg/1	Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]		N	20251231
0178-8250_d423971d-34c8-c7d2-e053-2a95a90abe74	0178-8250	HUMAN PRESCRIPTION DRUG	Tindamax		tinidazole	TABLET, FILM COATED	ORAL	20040517		NDA	NDA021618	Mission Pharmacal Company	TINIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0178-8500_d423971d-34c8-c7d2-e053-2a95a90abe74	0178-8500	HUMAN PRESCRIPTION DRUG	Tindamax		tinidazole	TABLET, FILM COATED	ORAL	20040517		NDA	NDA021618	Mission Pharmacal Company	TINIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0185-0022_846fc74f-77bb-480c-9921-3e17dea4377d	0185-0022	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	20000215		ANDA	ANDA040327	Eon Labs, Inc.	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0185-0055_d53f778f-f832-4061-b3db-5885bbef5718	0185-0055	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20031219		ANDA	ANDA076466	Eon Labs, Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0185-0122_7626a80c-83d9-45a6-b1bc-08705ae46bb5	0185-0122	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	Eon Labs, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
0185-0128_0541dab4-9ca2-4c8f-b70a-42f64547b808	0185-0128	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Eon Labs, Inc.	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0185-0129_0541dab4-9ca2-4c8f-b70a-42f64547b808	0185-0129	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Eon Labs, Inc.	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0185-0130_0541dab4-9ca2-4c8f-b70a-42f64547b808	0185-0130	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Eon Labs, Inc.	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0185-0141_60c0b5a0-847a-4ce7-b5ac-54d921323358	0185-0141	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20010131	20250630	ANDA	ANDA075845	Eon Labs, Inc.	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0185-0211_312b5f03-afed-4083-9d93-f9d8bf8ae649	0185-0211	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20040211		ANDA	ANDA076631	Eon Labs, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0185-0236_312b5f03-afed-4083-9d93-f9d8bf8ae649	0185-0236	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150317		ANDA	ANDA076631	Eon Labs, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0185-0277_312b5f03-afed-4083-9d93-f9d8bf8ae649	0185-0277	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20040211		ANDA	ANDA076631	Eon Labs, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0185-0325_312b5f03-afed-4083-9d93-f9d8bf8ae649	0185-0325	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20140404		ANDA	ANDA076631	Eon Labs, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0185-0410_93be4c14-9bab-40e5-884b-5d3cb377210f	0185-0410	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20031125	20250731	ANDA	ANDA075932	Eon Labs, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
0185-0415_93be4c14-9bab-40e5-884b-5d3cb377210f	0185-0415	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20040322	20250731	ANDA	ANDA075932	Eon Labs, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
0185-0448_9d5f834f-07e8-4b18-aeb7-d7034b100fc8	0185-0448	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20100331	20241231	ANDA	ANDA040445	Eon Labs, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
0185-0615_0461f935-ab6e-4fed-8178-41df0cc50eaa	0185-0615	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214	20260531	ANDA	ANDA086183	Eon Labs, Inc.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
0185-0674_0461f935-ab6e-4fed-8178-41df0cc50eaa	0185-0674	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	Eon Labs, Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0185-0675_dae8e40e-6203-45b5-8273-61594af39245	0185-0675	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, COATED	ORAL	20150420	20250731	ANDA	ANDA074903	Eon Labs, Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0185-0676_0461f935-ab6e-4fed-8178-41df0cc50eaa	0185-0676	HUMAN PRESCRIPTION DRUG	Hydroxyzine pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA086183	Eon Labs, Inc.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0185-0687_dae8e40e-6203-45b5-8273-61594af39245	0185-0687	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, COATED	ORAL	20150420	20250731	ANDA	ANDA074903	Eon Labs, Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0185-0757_4435aed7-872c-4439-b5d7-4abd212f4a1e	0185-0757	HUMAN PRESCRIPTION DRUG	Sulfadiazine		Sulfadiazine	TABLET	ORAL	19940729	20240531	ANDA	ANDA040091	Eon Labs, Inc.	SULFADIAZINE	500	mg/1	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	
0185-0799_b57ddd24-b8a3-4b5e-950b-4c5f772b91b1	0185-0799	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	19970528	20250630	ANDA	ANDA064150	Eon Labs, Inc.	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	
0185-0801_b57ddd24-b8a3-4b5e-950b-4c5f772b91b1	0185-0801	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	19980102	20250630	ANDA	ANDA064150	Eon Labs, Inc.	RIFAMPIN	150	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	
0185-0831_26929670-78cf-40be-bd88-d1c6eb782a03	0185-0831	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020614		ANDA	ANDA040439	Eon Labs, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0185-0842_26929670-78cf-40be-bd88-d1c6eb782a03	0185-0842	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020614		ANDA	ANDA040439	Eon Labs, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0185-0853_26929670-78cf-40be-bd88-d1c6eb782a03	0185-0853	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020614		ANDA	ANDA040439	Eon Labs, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0185-0864_26929670-78cf-40be-bd88-d1c6eb782a03	0185-0864	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020614		ANDA	ANDA040439	Eon Labs, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0185-0939_7139858f-852e-4fc6-8166-7c226775ad9d	0185-0939	HUMAN PRESCRIPTION DRUG	cholestyramine light		cholestyramine light	POWDER, FOR SUSPENSION	ORAL	19941104	20250731	ANDA	ANDA074558	Eon Labs, Inc.	CHOLESTYRAMINE	4	g/5.7g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	
0185-0940_26b5a422-6048-4b33-be55-680187a7b0f9	0185-0940	HUMAN PRESCRIPTION DRUG	Cholestyramine		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	19960815	20250930	ANDA	ANDA074557	Eon Labs, Inc.	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	
0185-1047_e297490d-c30d-48e2-a7b8-25c6429ddaef	0185-1047	HUMAN PRESCRIPTION DRUG	Quinidine Sulfate		Quinidine Sulfate	TABLET	ORAL	19830926	20250531	ANDA	ANDA088072	Eon Labs, Inc.	QUINIDINE SULFATE	300	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	
0185-1111_93be4c14-9bab-40e5-884b-5d3cb377210f	0185-1111	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20050622	20250731	ANDA	ANDA075932	Eon Labs, Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
0185-2098_26929670-78cf-40be-bd88-d1c6eb782a03	0185-2098	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020614		ANDA	ANDA040439	Eon Labs, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0185-2099_26929670-78cf-40be-bd88-d1c6eb782a03	0185-2099	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020614		ANDA	ANDA040439	Eon Labs, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0185-4057_17fbdc0f-dacb-43ec-a3b2-99c52dd2fe1a	0185-4057	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	19770819	20240131	ANDA	ANDA085588	Eon Labs, Inc.	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	
0185-4346_e297490d-c30d-48e2-a7b8-25c6429ddaef	0185-4346	HUMAN PRESCRIPTION DRUG	Quinidine Sulfate		Quinidine Sulfate	TABLET	ORAL	19761124	20250531	ANDA	ANDA088072	Eon Labs, Inc.	QUINIDINE SULFATE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	
0185-5050_d53f778f-f832-4061-b3db-5885bbef5718	0185-5050	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20031219		ANDA	ANDA076732	Eon Labs, Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0185-5368_c887d894-5fff-4b34-ac40-4c805cffa580	0185-5368	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET	ORAL	20080801	20240731	ANDA	ANDA078510	Eon Labs, Inc.	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	
0185-5369_c887d894-5fff-4b34-ac40-4c805cffa580	0185-5369	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET	ORAL	20080801	20240731	ANDA	ANDA078510	Eon Labs, Inc.	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	
0185-5600_d53f778f-f832-4061-b3db-5885bbef5718	0185-5600	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20031219		ANDA	ANDA076466	Eon Labs, Inc.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0186-0370_8dbc0210-6208-4895-b1fb-8304e5540f69	0186-0370	HUMAN PRESCRIPTION DRUG	SYMBICORT		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20070529		NDA	NDA021929	AstraZeneca Pharmaceuticals LP	BUDESONIDE; FORMOTEROL FUMARATE	160; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0186-0372_8dbc0210-6208-4895-b1fb-8304e5540f69	0186-0372	HUMAN PRESCRIPTION DRUG	SYMBICORT		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20070529		NDA	NDA021929	AstraZeneca Pharmaceuticals LP	BUDESONIDE; FORMOTEROL FUMARATE	80; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0186-0776_a0a0d886-ed09-4160-9bd5-f6fd51d99dd8	0186-0776	HUMAN PRESCRIPTION DRUG	BRILINTA		Ticagrelor	TABLET	ORAL	20150904		NDA	NDA022433	AstraZeneca Pharmaceuticals LP	TICAGRELOR	60	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0186-0777_a0a0d886-ed09-4160-9bd5-f6fd51d99dd8	0186-0777	HUMAN PRESCRIPTION DRUG	BRILINTA		Ticagrelor	TABLET	ORAL	20110805		NDA	NDA022433	AstraZeneca Pharmaceuticals LP	TICAGRELOR	90	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0186-0916_075afa4d-0e1b-483c-8ba6-f0d4587726f9	0186-0916	HUMAN PRESCRIPTION DRUG	PULMICORT	FLEXHALER	Budesonide	AEROSOL, POWDER	RESPIRATORY (INHALATION)	20070319	20251031	NDA	NDA021949	AstraZeneca Pharmaceuticals LP	BUDESONIDE	180	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0186-0917_075afa4d-0e1b-483c-8ba6-f0d4587726f9	0186-0917	HUMAN PRESCRIPTION DRUG	PULMICORT	FLEXHALER	Budesonide	AEROSOL, POWDER	RESPIRATORY (INHALATION)	20070319	20251031	NDA	NDA021949	AstraZeneca Pharmaceuticals LP	BUDESONIDE	90	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0186-1988_6d3dbe02-f474-402d-ae9a-a623d9303bcf	0186-1988	HUMAN PRESCRIPTION DRUG	PULMICORT RESPULES		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20000908		NDA	NDA020929	AstraZeneca Pharmaceuticals LP	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0186-1989_6d3dbe02-f474-402d-ae9a-a623d9303bcf	0186-1989	HUMAN PRESCRIPTION DRUG	PULMICORT RESPULES		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20000908		NDA	NDA020929	AstraZeneca Pharmaceuticals LP	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0186-1990_6d3dbe02-f474-402d-ae9a-a623d9303bcf	0186-1990	HUMAN PRESCRIPTION DRUG	PULMICORT RESPULES		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20070917		NDA	NDA020929	AstraZeneca Pharmaceuticals LP	BUDESONIDE	1	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0186-4010_23febb9c-68d9-4186-a6b6-b63bd6d9c136	0186-4010	HUMAN PRESCRIPTION DRUG	NEXIUM		Esomeprazole magnesium	GRANULE, DELAYED RELEASE	ORAL	20080707		NDA	NDA022101	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE MAGNESIUM	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0186-4020_23febb9c-68d9-4186-a6b6-b63bd6d9c136	0186-4020	HUMAN PRESCRIPTION DRUG	NEXIUM		Esomeprazole magnesium	GRANULE, DELAYED RELEASE	ORAL	20070319		NDA	NDA021957	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0186-4025_23febb9c-68d9-4186-a6b6-b63bd6d9c136	0186-4025	HUMAN PRESCRIPTION DRUG	NEXIUM		Esomeprazole magnesium	GRANULE, DELAYED RELEASE	ORAL	20120601		NDA	NDA021957	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE MAGNESIUM	2.5	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0186-4040_23febb9c-68d9-4186-a6b6-b63bd6d9c136	0186-4040	HUMAN PRESCRIPTION DRUG	NEXIUM		Esomeprazole magnesium	GRANULE, DELAYED RELEASE	ORAL	20070319		NDA	NDA021957	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0186-4050_23febb9c-68d9-4186-a6b6-b63bd6d9c136	0186-4050	HUMAN PRESCRIPTION DRUG	NEXIUM		Esomeprazole magnesium	GRANULE, DELAYED RELEASE	ORAL	20120601		NDA	NDA021957	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE MAGNESIUM	5	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0186-5020_23febb9c-68d9-4186-a6b6-b63bd6d9c136	0186-5020	HUMAN PRESCRIPTION DRUG	NEXIUM		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20010319		NDA	NDA021153	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0186-5040_23febb9c-68d9-4186-a6b6-b63bd6d9c136	0186-5040	HUMAN PRESCRIPTION DRUG	NEXIUM		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20010319		NDA	NDA021153	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0186-6040_1b52e226-d791-4714-968d-10057438875a	0186-6040	HUMAN PRESCRIPTION DRUG	NEXIUM	I.V.	Esomeprazole sodium	INJECTION	INTRAVENOUS	20050503		NDA	NDA021689	AstraZeneca Pharmaceuticals LP	ESOMEPRAZOLE SODIUM	40	mg/5mL	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0187-0002_e14757d5-86ff-41a8-8bde-14065af6899e	0187-0002	HUMAN PRESCRIPTION DRUG	Bryhali		halobetasol propionate	LOTION	TOPICAL	20181106		NDA	NDA209355	Bausch Health US, LLC	HALOBETASOL PROPIONATE	.1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0187-0004_044e3e17-7930-63ae-e063-6294a90acb9b	0187-0004	HUMAN PRESCRIPTION DRUG	Siliq		Brodalumab	INJECTION	SUBCUTANEOUS	20170215		BLA	BLA761032	Bausch Health US LLC	BRODALUMAB	210	mg/1	Antibodies, Monoclonal [CS], Interleukin 17 Receptor A Antagonists [MoA], Interleukin-17 Receptor A Antagonist [EPC]		N	20241231
0187-0005_f942f9b5-aa0b-4729-98c5-76f50afcac88	0187-0005	HUMAN PRESCRIPTION DRUG	Altreno		tretinoin	LOTION	TOPICAL	20180824		NDA	NDA209353	Bausch Health US, LLC	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-0006_0990acf9-6777-a127-e063-6294a90a3c93	0187-0006	HUMAN PRESCRIPTION DRUG	Cabtreo		clindamycin phosphate/benzoyl peroxide/adapalene	GEL	TOPICAL	20231020		NDA	NDA216632	Bausch Health US LLC	ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	1.5; 31; 12	mg/g; mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE], Retinoid [EPC], Retinoids [CS]		N	20241231
0187-0007_164da93c-e915-4164-b3d1-61b4075a01bd	0187-0007	HUMAN PRESCRIPTION DRUG	Virazole		Ribavirin	POWDER, FOR SOLUTION	RESPIRATORY (INHALATION)	19860101		NDA	NDA018859	Bausch Health US, LLC	RIBAVIRIN	6	g/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
0187-0010_de82ac73-cc5f-4e5d-8dfb-9cb98c625bdd	0187-0010	HUMAN PRESCRIPTION DRUG	Ammonul		sodium phenylacetate and sodium benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050217		NDA	NDA020645	Bausch Health US LLC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
0187-0063_68d14631-347b-4c86-9c31-9efac7cf4386	0187-0063	HUMAN PRESCRIPTION DRUG	Ativan		lorazepam	TABLET	ORAL	20130501		NDA	NDA017794	Bausch Health US LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0187-0064_68d14631-347b-4c86-9c31-9efac7cf4386	0187-0064	HUMAN PRESCRIPTION DRUG	Ativan		lorazepam	TABLET	ORAL	20130501		NDA	NDA017794	Bausch Health US LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0187-0065_68d14631-347b-4c86-9c31-9efac7cf4386	0187-0065	HUMAN PRESCRIPTION DRUG	Ativan		lorazepam	TABLET	ORAL	20130501		NDA	NDA017794	Bausch Health US LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0187-0140_18a458cc-976a-4019-bd85-18f55a224f45	0187-0140	HUMAN PRESCRIPTION DRUG	Vasotec		Enalapril Maleate	TABLET	ORAL	19880726		NDA	NDA018998	Bausch Health US LLC	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0187-0141_18a458cc-976a-4019-bd85-18f55a224f45	0187-0141	HUMAN PRESCRIPTION DRUG	Vasotec		Enalapril Maleate	TABLET	ORAL	19851224		NDA	NDA018998	Bausch Health US LLC	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0187-0142_18a458cc-976a-4019-bd85-18f55a224f45	0187-0142	HUMAN PRESCRIPTION DRUG	Vasotec		Enalapril Maleate	TABLET	ORAL	19851224		NDA	NDA018998	Bausch Health US LLC	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0187-0143_18a458cc-976a-4019-bd85-18f55a224f45	0187-0143	HUMAN PRESCRIPTION DRUG	Vasotec		Enalapril Maleate	TABLET	ORAL	19851224		NDA	NDA018998	Bausch Health US LLC	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0187-0146_b97cbaf1-3abe-4f23-b2a0-4ff43f8bf5cb	0187-0146	HUMAN PRESCRIPTION DRUG	Vaseretic		enalapril maleate and hydrochlorothiazide	TABLET	ORAL	19861031		NDA	NDA019221	Bausch Health US, LLC	ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE	10; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0187-0152_584b3956-bfa2-4b08-80c3-ff7de4516c40	0187-0152	HUMAN PRESCRIPTION DRUG	Isordil	Titradose	isosorbide dinitrate	TABLET	ORAL	20130401		NDA	NDA012093	Bausch Health US LLC	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0187-0192_584b3956-bfa2-4b08-80c3-ff7de4516c40	0187-0192	HUMAN PRESCRIPTION DRUG	Isordil	Titradose	isosorbide dinitrate	TABLET	ORAL	20130401		NDA	NDA012093	Bausch Health US LLC	ISOSORBIDE DINITRATE	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0187-0194_225799d1-e616-45e8-8074-6fa232b42cc9	0187-0194	HUMAN OTC DRUG	BenzEFoam		benzoyl peroxide	AEROSOL	TOPICAL	20200206		OTC MONOGRAPH FINAL	part333D	Bausch Health US, LLC	BENZOYL PEROXIDE	5.3	g/100g			N	20241231
0187-0201_adc4ed21-dfa8-4dad-8e03-e5f07fca03bc	0187-0201	HUMAN OTC DRUG	BenzEFoam Ultra		benzoyl peroxide	AEROSOL	TOPICAL	20200206		OTC MONOGRAPH FINAL	part333D	Bausch Health US, LLC	BENZOYL PEROXIDE	9.8	g/100g			N	20241231
0187-0245_a98c05bc-6520-4e79-ada5-bed743f5dc91	0187-0245	HUMAN PRESCRIPTION DRUG	Migranal		dihydroergotamine mesylate	SPRAY	NASAL	19971208		NDA	NDA020148	Bausch Health US, LLC	DIHYDROERGOTAMINE MESYLATE	4	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
0187-0453_f8d8f532-d8a6-4eff-baab-325fed820cdb	0187-0453	HUMAN PRESCRIPTION DRUG	ZELAPAR		SELEGILINE HYDROCHLORIDE	TABLET, ORALLY DISINTEGRATING	ORAL	20060614		NDA	NDA021479	Bausch Health US, LLC	SELEGILINE HYDROCHLORIDE	1.25	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
0187-0653_dbee276a-6a2e-4565-a106-09a5bcca8778	0187-0653	HUMAN PRESCRIPTION DRUG	Duobrii		halobetasol propionate and tazarotene	LOTION	TOPICAL	20190425		NDA	NDA209354	Bausch Health US, LLC	HALOBETASOL PROPIONATE; TAZAROTENE	.1; .45	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Retinoid [EPC], Retinoids [CS]		N	20241231
0187-0658_0dfc6eb7-788b-7224-e063-6394a90a8b8b	0187-0658	HUMAN PRESCRIPTION DRUG	Diastat		diazepam	GEL	RECTAL	19970729	20240831	NDA	NDA020648	Bausch Health US, LLC	DIAZEPAM	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
0187-0730_63046e0c-233f-4dc1-b3eb-f9d27872bd25	0187-0730	HUMAN PRESCRIPTION DRUG	WELLBUTRIN	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20030829		NDA	NDA021515	Bausch Health US LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0187-0731_63046e0c-233f-4dc1-b3eb-f9d27872bd25	0187-0731	HUMAN PRESCRIPTION DRUG	WELLBUTRIN	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20030829		NDA	NDA021515	Bausch Health US LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0187-0771_73b78511-8da0-42c4-bf53-1158d748bfbd	0187-0771	HUMAN PRESCRIPTION DRUG	Cardizem		Diltiazem Hydrochloride	TABLET, COATED	ORAL	20101225		NDA	NDA018602	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0772_73b78511-8da0-42c4-bf53-1158d748bfbd	0187-0772	HUMAN PRESCRIPTION DRUG	Cardizem		Diltiazem Hydrochloride	TABLET, COATED	ORAL	20101225		NDA	NDA018602	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0792_73b78511-8da0-42c4-bf53-1158d748bfbd	0187-0792	HUMAN PRESCRIPTION DRUG	Cardizem		Diltiazem Hydrochloride	TABLET, COATED	ORAL	20101225		NDA	NDA018602	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0795_2329929b-21b6-49a4-be2b-4d2026c732d8	0187-0795	HUMAN PRESCRIPTION DRUG	Cardizem CD		diltiazem hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20010411		NDA	NDA020062	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0796_2329929b-21b6-49a4-be2b-4d2026c732d8	0187-0796	HUMAN PRESCRIPTION DRUG	Cardizem CD		diltiazem hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20010411		NDA	NDA020062	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0797_2329929b-21b6-49a4-be2b-4d2026c732d8	0187-0797	HUMAN PRESCRIPTION DRUG	Cardizem CD		diltiazem hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20010411		NDA	NDA020062	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0798_2329929b-21b6-49a4-be2b-4d2026c732d8	0187-0798	HUMAN PRESCRIPTION DRUG	Cardizem CD		diltiazem hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20010411		NDA	NDA020062	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0799_2329929b-21b6-49a4-be2b-4d2026c732d8	0187-0799	HUMAN PRESCRIPTION DRUG	Cardizem CD		diltiazem hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20010411		NDA	NDA020062	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-0920_78404c9e-9c31-4b0a-90f4-04182e82e183	0187-0920	HUMAN PRESCRIPTION DRUG	Tetracaine Hydrochloride		Tetracaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20190627		NDA	NDA210821	Bausch Health US LLC	TETRACAINE HYDROCHLORIDE	5	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
0187-0938_b5c3a96c-28c4-40b3-8b44-e977c4ca2a9c	0187-0938	HUMAN PRESCRIPTION DRUG	Tasmar		Tolcapone	TABLET, FILM COATED	ORAL	20040727		NDA	NDA020697	Bausch Health US LLC	TOLCAPONE	100	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0187-0993_e880f5a1-cf2f-4ace-87b3-e79c59490440	0187-0993	HUMAN PRESCRIPTION DRUG	Zovirax		acyclovir	OINTMENT	TOPICAL	19820329		NDA	NDA018604	Bausch Health US, LLC	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0187-0994_beac4f87-cacc-4345-be9e-b105f6db7ee2	0187-0994	HUMAN PRESCRIPTION DRUG	Zovirax		acyclovir	CREAM	TOPICAL	20021230		NDA	NDA021478	Bausch Health US, LLC	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0187-1231_c8ba6520-445a-4934-85f4-6f706cb21585	0187-1231	HUMAN PRESCRIPTION DRUG	Cesamet		Nabilone	CAPSULE	ORAL	20200309		NDA	NDA018677	Bausch Health US LLC	NABILONE	1	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CII	N	20241231
0187-1496_c8e75822-985a-47a4-a5b2-baee3c6a7e22	0187-1496	HUMAN PRESCRIPTION DRUG	Timoptic in Ocudose		Timolol Maleate	SOLUTION	OPHTHALMIC	19861105		NDA	NDA019463	Bausch Health US LLC	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0187-1498_c8e75822-985a-47a4-a5b2-baee3c6a7e22	0187-1498	HUMAN PRESCRIPTION DRUG	Timoptic in Ocudose		Timolol Maleate	SOLUTION	OPHTHALMIC	19861105		NDA	NDA019463	Bausch Health US LLC	TIMOLOL MALEATE	3.4	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0187-1660_430356b8-84d8-42e0-b458-d2ea26d6f246	0187-1660	HUMAN OTC DRUG	TheraSeal		Dimethicone	CREAM	TOPICAL	20120101		OTC MONOGRAPH FINAL	part347	Bausch Health US, LLC	DIMETHICONE	1.7	g/170.1g	Skin Barrier Activity [PE]		N	20241231
0187-2045_b7a1919f-b62a-49ec-8608-b4f345fea35b	0187-2045	HUMAN PRESCRIPTION DRUG	Cardizem LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20101225		NDA	NDA021392	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-2046_b7a1919f-b62a-49ec-8608-b4f345fea35b	0187-2046	HUMAN PRESCRIPTION DRUG	Cardizem LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20101225		NDA	NDA021392	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-2047_b7a1919f-b62a-49ec-8608-b4f345fea35b	0187-2047	HUMAN PRESCRIPTION DRUG	Cardizem LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20101225		NDA	NDA021392	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-2048_b7a1919f-b62a-49ec-8608-b4f345fea35b	0187-2048	HUMAN PRESCRIPTION DRUG	Cardizem LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20101225		NDA	NDA021392	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-2049_b7a1919f-b62a-49ec-8608-b4f345fea35b	0187-2049	HUMAN PRESCRIPTION DRUG	Cardizem LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20101225		NDA	NDA021392	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-2050_b7a1919f-b62a-49ec-8608-b4f345fea35b	0187-2050	HUMAN PRESCRIPTION DRUG	Cardizem LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20101225		NDA	NDA021392	Bausch Health US LLC	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0187-2098_06456968-fe83-2c27-e063-6294a90af3ea	0187-2098	HUMAN PRESCRIPTION DRUG	Arazlo		tazarotene	LOTION	TOPICAL	20191219		NDA	NDA211882	Bausch Health US, LLC	TAZAROTENE	.45	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-2120_38dd4547-62ef-4e2f-afc2-bfe43eb86b8d	0187-2120	HUMAN PRESCRIPTION DRUG	Syprine		trientine hydrochloride	CAPSULE	ORAL	19851108		NDA	NDA019194	Bausch Health US LLC	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
0187-2612_8476cd05-c290-44e9-85a5-b62c853439f4	0187-2612	HUMAN PRESCRIPTION DRUG	TIAZAC	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA	NDA020401	Bausch Health US, LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0187-2613_8476cd05-c290-44e9-85a5-b62c853439f4	0187-2613	HUMAN PRESCRIPTION DRUG	TIAZAC	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA	NDA020401	Bausch Health US, LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0187-2614_8476cd05-c290-44e9-85a5-b62c853439f4	0187-2614	HUMAN PRESCRIPTION DRUG	TIAZAC	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA	NDA020401	Bausch Health US, LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0187-2615_8476cd05-c290-44e9-85a5-b62c853439f4	0187-2615	HUMAN PRESCRIPTION DRUG	TIAZAC	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA	NDA020401	Bausch Health US, LLC	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0187-2616_8476cd05-c290-44e9-85a5-b62c853439f4	0187-2616	HUMAN PRESCRIPTION DRUG	TIAZAC	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA	NDA020401	Bausch Health US, LLC	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0187-2617_8476cd05-c290-44e9-85a5-b62c853439f4	0187-2617	HUMAN PRESCRIPTION DRUG	TIAZAC	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA	NDA020401	Bausch Health US, LLC	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0187-3010_f6bf0102-bf43-4f3b-8667-39362bc9cfbb	0187-3010	HUMAN PRESCRIPTION DRUG	Mestinon		pyridostigmine bromide	TABLET	ORAL	19550406		NDA	NDA009829	Bausch Health US, LLC	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0187-3012_f6bf0102-bf43-4f3b-8667-39362bc9cfbb	0187-3012	HUMAN PRESCRIPTION DRUG	Mestinon		pyridostigmine bromide	SOLUTION	ORAL	19650125		NDA	NDA015193	Bausch Health US, LLC	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0187-3013_f6bf0102-bf43-4f3b-8667-39362bc9cfbb	0187-3013	HUMAN PRESCRIPTION DRUG	Mestinon		pyridostigmine bromide	TABLET, EXTENDED RELEASE	ORAL	19590112		NDA	NDA011665	Bausch Health US, LLC	PYRIDOSTIGMINE BROMIDE	180	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0187-3050_c1de59e9-2d05-42bf-9ed7-d744854db763	0187-3050	HUMAN PRESCRIPTION DRUG	ONEXTON		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20141124		NDA	NDA050819	Bausch Health US, LLC	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	37.5; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
0187-3204_2a683780-450d-4797-9d16-a2b8446e3b52	0187-3204	HUMAN PRESCRIPTION DRUG	Efudex		Fluorouracil	CREAM	TOPICAL	19700729		NDA	NDA016831	Bausch Health US, LLC	FLUOROURACIL	2	g/40g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0187-3554_2611b6d9-1f11-4c1d-a2b6-ae818d39d299	0187-3554	HUMAN PRESCRIPTION DRUG	ANCOBON		Flucytosine	CAPSULE	ORAL	19711126		NDA	NDA017001	Bausch Health US LLC	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
0187-3555_2611b6d9-1f11-4c1d-a2b6-ae818d39d299	0187-3555	HUMAN PRESCRIPTION DRUG	ANCOBON		Flucytosine	CAPSULE	ORAL	19711126		NDA	NDA017001	Bausch Health US LLC	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
0187-4100_98fd8b52-2fc3-4540-8333-75b5c853aee2	0187-4100	HUMAN PRESCRIPTION DRUG	Librax		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	19660901		NDA	NDA012750	Bausch Health US, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]		N	20241231
0187-4303_4140d717-a105-473d-a891-8c7cb40b70d9	0187-4303	HUMAN PRESCRIPTION DRUG	Amytal Sodium		amobarbital sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080925		UNAPPROVED DRUG OTHER		Bausch Health US, LLC	AMOBARBITAL SODIUM	.5	g/5mL		CII	N	20241231
0187-4420_0296ba80-1041-4444-bdc6-a2c3a1d8ea53	0187-4420	HUMAN PRESCRIPTION DRUG	Pepcid		famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075805	Bausch Health US LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0187-4440_0296ba80-1041-4444-bdc6-a2c3a1d8ea53	0187-4440	HUMAN PRESCRIPTION DRUG	Pepcid		famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075805	Bausch Health US LLC	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0187-5100_2f802a3f-c021-45c1-8693-5689c30c3fc6	0187-5100	HUMAN PRESCRIPTION DRUG	ELIDEL		Pimecrolimus	CREAM	TOPICAL	20011202		NDA	NDA021302	Bausch Health US, LLC	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0187-5101_2f802a3f-c021-45c1-8693-5689c30c3fc6	0187-5101	HUMAN PRESCRIPTION DRUG	ELIDEL		Pimecrolimus	CREAM	TOPICAL	20011202		NDA	NDA021302	Bausch Health US, LLC	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0187-5102_2f802a3f-c021-45c1-8693-5689c30c3fc6	0187-5102	HUMAN PRESCRIPTION DRUG	ELIDEL		Pimecrolimus	CREAM	TOPICAL	20011202		NDA	NDA021302	Bausch Health US, LLC	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0187-5103_2f802a3f-c021-45c1-8693-5689c30c3fc6	0187-5103	HUMAN PRESCRIPTION DRUG	ELIDEL		Pimecrolimus	CREAM	TOPICAL	20011202		NDA	NDA021302	Bausch Health US, LLC	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0187-5104_a4efb63c-e7bf-43da-bbfe-463f672cb1bc	0187-5104	HUMAN PRESCRIPTION DRUG	Xerese		Acyclovir and Hydrocortisone	CREAM	TOPICAL	20090731		NDA	NDA022436	Bausch Health US LLC	ACYCLOVIR; HYDROCORTISONE	50; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0187-5115_c5d11596-8c13-483a-93f9-f7016fb8c663	0187-5115	HUMAN PRESCRIPTION DRUG	Ertaczo		Sertaconazole Nitrate	CREAM	TOPICAL	20031210		NDA	NDA021385	Bausch Health US, LLC	SERTACONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0187-5140_4644254a-9ff4-44ae-b447-44cc1ea25088	0187-5140	HUMAN PRESCRIPTION DRUG	Retin-A MICRO		Tretinoin	GEL	TOPICAL	19970207		NDA	NDA020475	Bausch Health US LLC	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5144_4644254a-9ff4-44ae-b447-44cc1ea25088	0187-5144	HUMAN PRESCRIPTION DRUG	Retin-A MICRO		Tretinoin	GEL	TOPICAL	20020510		NDA	NDA020475	Bausch Health US LLC	TRETINOIN	.4	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5146_4644254a-9ff4-44ae-b447-44cc1ea25088	0187-5146	HUMAN PRESCRIPTION DRUG	Retin-A MICRO		Tretinoin	GEL	TOPICAL	20171023		NDA	NDA020475	Bausch Health US LLC	TRETINOIN	.6	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5148_4644254a-9ff4-44ae-b447-44cc1ea25088	0187-5148	HUMAN PRESCRIPTION DRUG	Retin-A MICRO		Tretinoin	GEL	TOPICAL	20140128		NDA	NDA020475	Bausch Health US LLC	TRETINOIN	.8	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5150_2868c4e2-0f79-46c7-abbf-38f2910b625b	0187-5150	HUMAN PRESCRIPTION DRUG	Renova		Tretinoin	CREAM	TOPICAL	20000831		NDA	NDA021108	Bausch Health US LLC	TRETINOIN	.2	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5160_6f752d3c-6368-444a-8ca6-6c937b04dfb8	0187-5160	HUMAN PRESCRIPTION DRUG	Retin-A		Tretinoin	CREAM	TOPICAL	19881030		NDA	NDA019049	Bausch Health US, LLC	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5162_6f752d3c-6368-444a-8ca6-6c937b04dfb8	0187-5162	HUMAN PRESCRIPTION DRUG	Retin-A		Tretinoin	CREAM	TOPICAL	19740730		NDA	NDA017522	Bausch Health US, LLC	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5164_6f752d3c-6368-444a-8ca6-6c937b04dfb8	0187-5164	HUMAN PRESCRIPTION DRUG	Retin-A		Tretinoin	CREAM	TOPICAL	19730430		NDA	NDA017340	Bausch Health US, LLC	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5170_6f752d3c-6368-444a-8ca6-6c937b04dfb8	0187-5170	HUMAN PRESCRIPTION DRUG	Retin-A		Tretinoin	GEL	TOPICAL	19750730		NDA	NDA017579	Bausch Health US, LLC	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5172_6f752d3c-6368-444a-8ca6-6c937b04dfb8	0187-5172	HUMAN PRESCRIPTION DRUG	Retin-A		Tretinoin	GEL	TOPICAL	19790730		NDA	NDA017955	Bausch Health US, LLC	TRETINOIN	.1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5190_523c6fed-ee46-43c5-9c1f-b3866c11cf1a	0187-5190	HUMAN PRESCRIPTION DRUG	Benzaclin		Clindamycin phosphate and benzoyl peroxide	GEL	TOPICAL	20001221		NDA	NDA050756	Bausch Health US LLC	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0187-5198_4dd0038b-2f5d-436c-8a6d-6db44760c37a	0187-5198	HUMAN PRESCRIPTION DRUG	Klaron		sulfacetamide sodium	LOTION	TOPICAL	19961223		NDA	NDA019931	Bausch Health US, LLC	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0187-5200_e2893139-8c8c-4af0-8022-b717e6eaa783	0187-5200	HUMAN PRESCRIPTION DRUG	Carac		fluorouracil	CREAM	TOPICAL	20130628		NDA	NDA020985	Bausch Health US, LLC	FLUOROURACIL	5	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0187-5202_453f532e-bb72-4ea7-b9e5-b9ac903ffafe	0187-5202	HUMAN PRESCRIPTION DRUG	Noritate		metronidazole	CREAM	TOPICAL	20130809		NDA	NDA020743	Bausch Health US, LLC	METRONIDAZOLE	10	mg/60g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0187-5205_4e79c358-715c-4406-8260-cb83efbc55ec	0187-5205	HUMAN PRESCRIPTION DRUG	Benzamycin		erythromycin and benzoyl peroxide	KIT		19841026		NDA	NDA050557	Bausch Health US, LLC						N	20241231
0187-5400_f3c0bfe9-3cdf-41df-8e6e-77901a8c8f3e	0187-5400	HUMAN PRESCRIPTION DRUG	JUBLIA		efinaconazole	SOLUTION	TOPICAL	20140606		NDA	NDA203567	Bausch Health US LLC	EFINACONAZOLE	100	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0187-5465_c2b35f23-4193-4877-a079-1405d88246b6	0187-5465	HUMAN OTC DRUG	Caladryl		Ferric Oxide Red, Zinc Oxide, and Pramoxine Hydrochloride	LOTION	TOPICAL	20130816		OTC MONOGRAPH FINAL	part347	Bausch Health US, LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	1.36; 10; 78.65	mg/mL; mg/mL; mg/mL			N	20241231
0187-5466_758f2471-4647-4aea-8034-d5cf18ff5dcb	0187-5466	HUMAN OTC DRUG	Caladryl Clear		PRAMOXINE HYDROCHLORIDE and ZINC ACETATE	LOTION	TOPICAL	20130816		OTC MONOGRAPH FINAL	part347	Bausch Health US, LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0187-5500_25ecf41f-85d3-4f2b-9e4d-8ec40d6474d1	0187-5500	HUMAN OTC DRUG	Purpose		Octinoxate, Octisalate and Oxybenzone	LOTION	TOPICAL	20131007		OTC MONOGRAPH NOT FINAL	part352	Bausch Health US LLC	OCTINOXATE; OCTISALATE; OXYBENZONE	76; 50; 30	mg/mL; mg/mL; mg/mL			N	20241231
0187-5525_0b3ebeef-832b-420e-8d6e-e48b2fc494c3	0187-5525	HUMAN PRESCRIPTION DRUG	Targretin		bexarotene	GEL	TOPICAL	20000628		NDA	NDA021056	Bausch Health US, LLC	BEXAROTENE	1	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5526_48a80386-cbef-4555-95fe-36bbfafcd760	0187-5526	HUMAN PRESCRIPTION DRUG	Targretin		bexarotene	CAPSULE, LIQUID FILLED	ORAL	19991229		NDA	NDA021055	Bausch Health US, LLC	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0187-5600_35863851-5acc-4ccc-8afb-212a00179bf9	0187-5600	HUMAN PRESCRIPTION DRUG	Visudyne		verteporfin for injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20000412		NDA	NDA021119	Bausch Health US LLC	VERTEPORFIN	15	mg/1	Photoabsorption [MoA], Photoenhancer [EPC], Photosensitizing Activity [PE]		N	20241231
0187-5810_98a1f7cf-d7d2-49c3-9110-20449ac55d1c	0187-5810	HUMAN PRESCRIPTION DRUG	Aplenzin		bupropion hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20080423		NDA	NDA022108	Bausch Health US, LLC	BUPROPION HYDROBROMIDE	174	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0187-5811_98a1f7cf-d7d2-49c3-9110-20449ac55d1c	0187-5811	HUMAN PRESCRIPTION DRUG	Aplenzin		bupropion hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20080423		NDA	NDA022108	Bausch Health US, LLC	BUPROPION HYDROBROMIDE	348	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0187-5812_98a1f7cf-d7d2-49c3-9110-20449ac55d1c	0187-5812	HUMAN PRESCRIPTION DRUG	Aplenzin		bupropion hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20080423		NDA	NDA022108	Bausch Health US, LLC	BUPROPION HYDROBROMIDE	522	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0206-8860_30496b61-307a-43af-8369-971593382a70	0206-8860	HUMAN PRESCRIPTION DRUG	Zosyn	in Galaxy Containers	TAZOBACTAM SODIUM and PIPERACILLIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	19980301		NDA	NDA050750	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; 250	g/50mL; mg/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0206-8861_30496b61-307a-43af-8369-971593382a70	0206-8861	HUMAN PRESCRIPTION DRUG	Zosyn	in Galaxy Containers	TAZOBACTAM SODIUM and PIPERACILLIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	19980301		NDA	NDA050750	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; 375	g/50mL; mg/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0206-8862_30496b61-307a-43af-8369-971593382a70	0206-8862	HUMAN PRESCRIPTION DRUG	Zosyn	in Galaxy Containers	TAZOBACTAM SODIUM and PIPERACILLIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	19980301		NDA	NDA050750	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; 500	g/100mL; mg/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0219-0203_d9506518-f00e-4668-a65a-22b870bf0881	0219-0203	HUMAN OTC DRUG	Humphreys Bendito Alcoholado		menthol	LIQUID	TOPICAL	19720111		OTC MONOGRAPH NOT FINAL	part348	Humphreys Pharmacal, Incorporated	MENTHOL, UNSPECIFIED FORM	12.5	mg/mL			N	20241231
0219-0204_7b8796fd-fb0d-4cf2-8895-94174b641d01	0219-0204	HUMAN OTC DRUG	Humphreys Maravilla		witch hazel	LIQUID	TOPICAL	19550111		OTC MONOGRAPH FINAL	part347	Humphreys Pharmacal, Incorporated	WITCH HAZEL	1	g/mL			N	20241231
0220-0002_ff98f29b-dd8e-61b6-e053-6294a90a0c5f	0220-0002	HUMAN OTC DRUG	ABELMOSCHUS		ABELMOSCHUS MOSCHATUS SEED	PELLET	ORAL	20171019		UNAPPROVED HOMEOPATHIC		BOIRON	ABELMOSCHUS MOSCHATUS SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-0003_079d9002-6f1c-efe6-e063-6394a90a70ba	0220-0003	HUMAN OTC DRUG	ABELMOSCHUS		ABELMOSCHUS MOSCHATUS SEED	PELLET	ORAL	20240101		UNAPPROVED HOMEOPATHIC		Boiron	ABELMOSCHUS MOSCHATUS SEED	200	[kp_C]/200[kp_C]			N	20241231
0220-0006_ff98f2f5-de29-d183-e053-6394a90a3267	0220-0006	HUMAN OTC DRUG	Abies canadensis		TSUGA CANADENSIS BARK TSUGA CANADENSIS FLOWER BUD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TSUGA CANADENSIS BARK; TSUGA CANADENSIS FLOWER BUD	9; 9	[hp_C]/9[hp_C]; [hp_C]/9[hp_C]			N	20241231
0220-0010_ff987d6c-5940-9a21-e053-6394a90a41b7	0220-0010	HUMAN OTC DRUG	Abies Nigra		PICEA MARIANA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PICEA MARIANA RESIN	5	[hp_C]/5[hp_C]			N	20241231
0220-0011_ff98f2f5-de2a-d183-e053-6394a90a3267	0220-0011	HUMAN OTC DRUG	Abies Nigra		PICEA MARIANA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PICEA MARIANA RESIN	30	[hp_C]/30[hp_C]			N	20241231
0220-0014_fe043103-6469-4b0c-e053-6294a90adc05	0220-0014	HUMAN OTC DRUG	Abrotanum		ARTEMISIA ABROTANUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA ABROTANUM FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-0018_ff987d6c-5941-9a21-e053-6394a90a41b7	0220-0018	HUMAN PRESCRIPTION DRUG	Absinthium		WORMWOOD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	WORMWOOD	30	[hp_C]/30[hp_C]			N	20241231
0220-0027_f52bb371-cee0-235f-e053-2995a90a6c83	0220-0027	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	6	[hp_C]/6[hp_C]			N	20241231
0220-0028_ff9a0e87-8572-a16c-e053-6394a90a067d	0220-0028	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	9	[hp_C]/9[hp_C]			N	20241231
0220-0030_ff987d6c-5942-9a21-e053-6394a90a41b7	0220-0030	HUMAN PRESCRIPTION DRUG	Aceticum acidum		ACETIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACETIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-0031_ff998d5d-b317-3f6c-e053-6294a90a9743	0220-0031	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	12	[hp_C]/12[hp_C]			N	20241231
0220-0032_ff99c57a-e065-69d3-e053-6394a90a6775	0220-0032	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	15	[hp_C]/15[hp_C]			N	20241231
0220-0035_fd66ab9c-943c-252b-e053-6294a90a1d8b	0220-0035	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	30	[hp_C]/30[hp_C]			N	20241231
0220-0036_f2b840eb-4400-fd81-e053-2995a90a1f4b	0220-0036	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	200	[kp_C]/200[kp_C]			N	20241231
0220-0039_f67d09fe-1dff-666b-e053-2a95a90a7125	0220-0039	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	1	[hp_M]/[hp_M]			N	20241231
0220-0040_fbd4e679-0b00-18f8-e053-6294a90a8726	0220-0040	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	10	[hp_M]/10[hp_M]			N	20241231
0220-0043_ff9952c9-1da8-82f0-e053-6294a90ae0c8	0220-0043	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	12	[hp_X]/12[hp_X]			N	20241231
0220-0045_ff998d5d-b319-3f6c-e053-6294a90a9743	0220-0045	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	30	[hp_X]/30[hp_X]			N	20241231
0220-0052_ff99c57a-e067-69d3-e053-6394a90a6775	0220-0052	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACONITUM NAPELLUS	6	[hp_X]/6[hp_X]			N	20241231
0220-0053_00509733-37c3-6d14-e063-6394a90acbde	0220-0053	HUMAN OTC DRUG	Actaea spicata		ACTAEA SPICATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTAEA SPICATA ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-0054_00509733-37c6-6d14-e063-6394a90acbde	0220-0054	HUMAN OTC DRUG	Actaea spicata		ACTAEA SPICATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTAEA SPICATA ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-0055_00508f23-f3d9-6b03-e063-6394a90a7803	0220-0055	HUMAN OTC DRUG	Actaea spicata		ACTAEA SPICATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTAEA SPICATA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0060_00506c2b-31dd-0d26-e063-6394a90a413d	0220-0060	HUMAN OTC DRUG	Actaea Spicata		ACTAEA SPICATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTAEA SPICATA ROOT	5	[hp_C]/5[hp_C]			N	20241231
0220-0076_0d081006-d1e1-0fc2-e063-6294a90acc43	0220-0076	HUMAN OTC DRUG	Adrenalinum		EPINEPHRINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EPINEPHRINE	30	[hp_C]/30[hp_C]	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0220-0078_00508f23-f3dd-6b03-e063-6394a90a7803	0220-0078	HUMAN PRESCRIPTION DRUG	Adrenalinum		EPINEPHRINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EPINEPHRINE	200	[kp_C]/200[kp_C]	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0220-0081_f2b863b5-33ca-4d2c-e053-2a95a90ae197	0220-0081	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HORSE CHESTNUT	6	[hp_C]/6[hp_C]			N	20241231
0220-0082_003a0d9f-65aa-319d-e063-6394a90a6a7e	0220-0082	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HORSE CHESTNUT	9	[hp_C]/9[hp_C]			N	20241231
0220-0085_0050b23e-4b72-9cfa-e063-6394a90a97c7	0220-0085	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HORSE CHESTNUT	12	[hp_C]/12[hp_C]			N	20241231
0220-0086_f2b856af-aaf7-0014-e053-2a95a90acf8c	0220-0086	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HORSE CHESTNUT	30	[hp_C]/30[hp_C]			N	20241231
0220-0089_fbd19f25-cfdf-5bb2-e053-6294a90aa616	0220-0089	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HORSE CHESTNUT	200	[kp_C]/200[kp_C]			N	20241231
0220-0092_f1874758-af76-2fe4-e053-2995a90a3b8d	0220-0092	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HORSE CHESTNUT	6	[hp_X]/1			N	20241231
0220-0098_fbd19f25-cfdd-5bb2-e053-6294a90aa616	0220-0098	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HORSE CHESTNUT	1	[hp_M]/[hp_M]			N	20241231
0220-0104_01915655-c7a0-81b3-e063-6394a90af328	0220-0104	HUMAN OTC DRUG	Aethusa cynapium		AETHUSA CYNAPIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AETHUSA CYNAPIUM	6	[hp_C]/6[hp_C]			N	20241231
0220-0105_01914ceb-6c89-65e9-e063-6294a90a9c21	0220-0105	HUMAN OTC DRUG	Aethusa cynapium		AETHUSA CYNAPIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AETHUSA CYNAPIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-0109_f2b863b5-33cb-4d2c-e053-2a95a90ae197	0220-0109	HUMAN OTC DRUG	Aethusa cynapium		AETHUSA CYNAPIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AETHUSA CYNAPIUM	200	[kp_C]/200[kp_C]			N	20241231
0220-0110_0191f68a-7f9c-e60d-e063-6294a90ab308	0220-0110	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA FRUITING BODY	6	[hp_C]/6[hp_C]			N	20241231
0220-0113_003bf988-e90a-8518-e063-6294a90ab86c	0220-0113	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA FRUITING BODY	9	[hp_C]/9[hp_C]			N	20241231
0220-0114_01916485-abbb-6bc2-e063-6294a90aecc8	0220-0114	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA FRUITING BODY	12	[hp_C]/12[hp_C]			N	20241231
0220-0117_01914ceb-6c91-65e9-e063-6294a90a9c21	0220-0117	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA FRUITING BODY	15	[hp_C]/15[hp_C]			N	20241231
0220-0118_f67d2063-3331-579f-e053-2995a90a3b2b	0220-0118	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA FRUITING BODY	30	[hp_C]/30[hp_C]			N	20241231
0220-0121_0191fcf7-ab89-e583-e063-6294a90a7854	0220-0121	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA FRUITING BODY	200	[kp_C]/200[kp_C]			N	20241231
0220-0122_003b64cb-732f-b46f-e063-6294a90acb05	0220-0122	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA FRUITING BODY	1	[hp_M]/[hp_M]			N	20241231
0220-0124_0191fcf7-abc0-e583-e063-6294a90a7854	0220-0124	HUMAN OTC DRUG	Agaricus muscarius		AMANITA MUSCARIA WHOLE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMANITA MUSCARIA WHOLE	6	[hp_X]/6[hp_X]			N	20241231
0220-0125_f7e55ad0-0a18-10e6-e053-6394a90a3698	0220-0125	HUMAN PRESCRIPTION DRUG	Agnus castus		CHASTE TREE FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHASTE TREE FRUIT	9	[hp_C]/9[hp_C]			N	20241231
0220-0126_079c582b-f7cb-9c83-e063-6394a90a68ec	0220-0126	HUMAN PRESCRIPTION DRUG	Agnus castus		CHASTE TREE FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHASTE TREE FRUIT	30	[hp_C]/30[hp_C]			N	20241231
0220-0129_079c90d4-1c74-a567-e063-6394a90a45d8	0220-0129	HUMAN PRESCRIPTION DRUG	Agnus castus		CHASTE TREE FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHASTE TREE FRUIT	200	[kp_C]/200[kp_C]			N	20241231
0220-0130_032593b9-9d2b-e137-e063-6394a90a2626	0220-0130	HUMAN PRESCRIPTION DRUG	Agnus castus		CHASTE TREE FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHASTE TREE FRUIT	10	[hp_M]/10[hp_M]			N	20241231
0220-0140_079c88e3-0769-b41c-e063-6394a90ae1e3	0220-0140	HUMAN PRESCRIPTION DRUG	Agnus castus		CHASTE TREE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHASTE TREE	6	[hp_C]/6[hp_C]			N	20241231
0220-0141_fe043103-646a-4b0c-e053-6294a90adc05	0220-0141	HUMAN OTC DRUG	Agraphis nutans		HYACINTHOIDES NON-SCRIPTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYACINTHOIDES NON-SCRIPTA	6	[hp_C]/6[hp_C]			N	20241231
0220-0142_f527cbc9-7dcb-15c6-e053-2995a90a4d82	0220-0142	HUMAN OTC DRUG	Agraphis nutans		HYACINTHOIDES NON-SCRIPTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYACINTHOIDES NON-SCRIPTA	30	[hp_C]/30[hp_C]			N	20241231
0220-0144_079c68e7-7fe0-9bb9-e063-6394a90a5f8e	0220-0144	HUMAN OTC DRUG	Agraphis nutans		HYACINTHOIDES NON SCRIPTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYACINTHOIDES NON-SCRIPTA	5	[hp_C]/5[hp_C]			N	20241231
0220-0156_0039e4f8-3fde-6269-e063-6294a90a92eb	0220-0156	HUMAN OTC DRUG	AILANTHUS GLANDULOSUS		AILANTHUS ALTISSIMA FLOWERING TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AILANTHUS ALTISSIMA FLOWERING TWIG	9	[hp_C]/9[hp_C]			N	20241231
0220-0157_079c6cbc-e4c3-a1f0-e063-6294a90aba14	0220-0157	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	5	[hp_C]/5[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0158_f2b854f3-076b-b7dc-e053-2a95a90a1a6e	0220-0158	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0160_079c6cbc-e4c4-a1f0-e063-6294a90aba14	0220-0160	HUMAN OTC DRUG	Aletris farinosa		ALETRIS FARINOSA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALETRIS FARINOSA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0161_079c88e3-076a-b41c-e063-6394a90ae1e3	0220-0161	HUMAN OTC DRUG	Alfalfa		ALFALFA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALFALFA	6	[hp_C]/6[hp_C]			N	20241231
0220-0164_079c8b50-d1d8-a2a2-e063-6294a90a7a60	0220-0164	HUMAN OTC DRUG	Alfalfa		ALFALFA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALFALFA	6	[hp_X]/6[hp_X]			N	20241231
0220-0165_003adc62-2030-085a-e063-6294a90a43b6	0220-0165	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0166_079c8b50-d1da-a2a2-e063-6294a90a7a60	0220-0166	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0169_079c8b50-d1db-a2a2-e063-6294a90a7a60	0220-0169	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0170_f2b86955-d1c8-7a39-e053-2995a90a6f7d	0220-0170	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0172_f527d8ba-5535-38ba-e053-2995a90a321c	0220-0172	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	6	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0174_079c8b50-d1dc-a2a2-e063-6294a90a7a60	0220-0174	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	30	[hp_X]/30[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0177_f913dacb-a438-afdb-e053-6294a90a735b	0220-0177	HUMAN OTC DRUG	Allium sativum		GARLIC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GARLIC	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-0178_0803f6f1-9d71-230d-e063-6294a90a6831	0220-0178	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0179_0803ff4c-33a7-3105-e063-6294a90a866b	0220-0179	HUMAN OTC DRUG	Allium cepa		ONION	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONION	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-0182_0803f939-2d8b-0fe6-e063-6294a90a1b7b	0220-0182	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	5	[hp_C]/5[hp_C]			N	20241231
0220-0183_0803ff4c-33a8-3105-e063-6294a90a866b	0220-0183	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0187_f7e5e7e2-efb8-6c9e-e053-6394a90aaa7c	0220-0187	HUMAN OTC DRUG	Aloe		ALOE FEROX LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALOE FEROX LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-0189_0051c7de-8a83-0905-e063-6294a90a0bec	0220-0189	HUMAN OTC DRUG	Aloe		ALOE FEROX LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALOE FEROX LEAF	5	[hp_C]/5[hp_C]			N	20241231
0220-0190_0051d268-8f32-5d6e-e063-6394a90a01e2	0220-0190	HUMAN OTC DRUG	Aloe		ALOE FEROX LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALOE FEROX LEAF	6	[hp_C]/6[hp_C]			N	20241231
0220-0191_fe04346f-7bd6-4db7-e053-6294a90a338b	0220-0191	HUMAN OTC DRUG	Aloe		ALOE FEROX LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALOE FEROX LEAF	9	[hp_C]/9[hp_C]			N	20241231
0220-0194_f9136aab-2110-1590-e053-6394a90a5b50	0220-0194	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-0195_0804016b-405b-0f5c-e063-6394a90abcfe	0220-0195	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-0198_f7e5a855-747b-9e07-e053-6394a90af185	0220-0198	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-0199_f7fb44a5-fe04-7189-e053-6394a90a6786	0220-0199	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0201_fbd38614-fda6-2a5e-e053-6394a90ad49e	0220-0201	HUMAN OTC DRUG	Alumen		POTASSIUM ALUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM ALUM	30	[hp_C]/30[hp_C]			N	20241231
0220-0205_ff09a56a-9e8e-44fc-e053-6394a90a4fb7	0220-0205	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	30	[hp_X]/1			N	20241231
0220-0209_07ebb1fe-5b49-f073-e063-6394a90a4c78	0220-0209	HUMAN OTC DRUG	Alumina silicata		KAOLIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KAOLIN	30	[hp_C]/30[hp_C]			N	20241231
0220-0211_003ad7b2-d151-4924-e063-6394a90a2232	0220-0211	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0213_0804117f-0cee-81c6-e063-6394a90a0e68	0220-0213	HUMAN OTC DRUG	Aluminum metallicum		ALUMINUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM	30	[hp_C]/30[hp_C]			N	20241231
0220-0215_0804157e-b0f2-5a52-e063-6394a90aaae1	0220-0215	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALUMINUM OXIDE	1	[hp_M]/[hp_M]			N	20241231
0220-0218_0803f426-846f-3651-e063-6294a90a4c71	0220-0218	HUMAN OTC DRUG	Ambrosia artemisiaefolia		AMBROSIA ARTEMISIIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMBROSIA ARTEMISIIFOLIA	6	[hp_C]/6[hp_C]			N	20241231
0220-0219_08041bb3-a001-a234-e063-6294a90a5e48	0220-0219	HUMAN OTC DRUG	Ambrosia artemisiaefolia		AMBROSIA ARTEMISIIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMBROSIA ARTEMISIIFOLIA	30	[hp_C]/30[hp_C]			N	20241231
0220-0230_0c069179-fc7d-cf6b-e063-6394a90aeaeb	0220-0230	HUMAN OTC DRUG	AMBROSIA ARTEMISIAEFOLIA		AMBROSIA ARTEMISIIFOLIA	PELLET	ORAL	20240101		UNAPPROVED HOMEOPATHIC		Boiron	AMBROSIA ARTEMISIIFOLIA	200	[kp_C]/200[kp_C]			N	20241231
0220-0241_08041278-322b-35d1-e063-6394a90a748b	0220-0241	HUMAN OTC DRUG	Ammonium carbonicum		AMMONIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMMONIUM CARBONATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0242_f2b863b5-33cd-4d2c-e053-2a95a90ae197	0220-0242	HUMAN OTC DRUG	Ammonium carbonicum		AMMONIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMMONIUM CARBONATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0248_080400f1-4cdb-30ff-e063-6294a90aa19a	0220-0248	HUMAN OTC DRUG	Ammonium carbonicum		AMMONIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMMONIUM CARBONATE	6	[hp_C]/6[hp_C]			N	20241231
0220-0249_fbd4d873-9bf2-cdcd-e053-6294a90af0dd	0220-0249	HUMAN OTC DRUG	Ammonium muriaticum		AMMONIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMMONIUM CHLORIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0250_0410a1fe-a4cb-1f65-e063-6294a90ac687	0220-0250	HUMAN OTC DRUG	Ammonium muriaticum		AMMONIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMMONIUM CHLORIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0260_07d90abf-0479-2917-e063-6294a90a61e9	0220-0260	HUMAN OTC DRUG	Ammonium muriaticum		AMMONIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMMONIUM CHLORIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0268_07ec388a-23b7-ffc1-e063-6394a90a9d01	0220-0268	HUMAN OTC DRUG	Ammonium phosphoricum		AMMONIUM PHOSPHATE DIBASIC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMMONIUM PHOSPHATE, DIBASIC	30	[hp_C]/30[hp_C]			N	20241231
0220-0285_0804117f-0cf0-81c6-e063-6394a90a0e68	0220-0285	HUMAN OTC DRUG	Anacardium orientale		SEMECARPUS ANACARDIUM JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMECARPUS ANACARDIUM JUICE	12	[hp_C]/12[hp_C]			N	20241231
0220-0286_08041278-322d-35d1-e063-6394a90a748b	0220-0286	HUMAN OTC DRUG	Anacardium orientale		SEMECARPUS ANACARDIUM JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMECARPUS ANACARDIUM JUICE	15	[hp_C]/15[hp_C]			N	20241231
0220-0289_00efd5d5-06c6-572f-e063-6294a90a9990	0220-0289	HUMAN OTC DRUG	Anacardium orientale		SEMECARPUS ANACARDIUM JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMECARPUS ANACARDIUM JUICE	30	[hp_C]/30[hp_C]			N	20241231
0220-0290_0804117f-0cf2-81c6-e063-6394a90a0e68	0220-0290	HUMAN OTC DRUG	Anacardium orientale		SEMECARPUS ANACARDIUM JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMECARPUS ANACARDIUM JUICE	200	[kp_C]/200[kp_C]			N	20241231
0220-0296_0804117f-0cf5-81c6-e063-6394a90a0e68	0220-0296	HUMAN PRESCRIPTION DRUG	Amygdalus persica		PRUNUS PERSICA FLOWER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PRUNUS PERSICA FLOWER	30	[hp_C]/30[hp_C]			N	20241231
0220-0297_080425f6-1530-cd9d-e063-6294a90a4249	0220-0297	HUMAN OTC DRUG	Anacardium orientale		SEMECARPUS ANACARDIUM JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMECARPUS ANACARDIUM JUICE	1	[hp_M]/[hp_M]			N	20241231
0220-0298_08041278-3230-35d1-e063-6394a90a748b	0220-0298	HUMAN OTC DRUG	Anacardium orientale		SEMECARPUS ANACARDIUM JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMECARPUS ANACARDIUM JUICE	10	[hp_M]/10[hp_M]			N	20241231
0220-0300_08041bb3-a003-a234-e063-6294a90a5e48	0220-0300	HUMAN OTC DRUG	Amyl nitrosum		AMYL NITRITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMYL NITRITE	5	[hp_C]/5[hp_C]			N	20241231
0220-0301_0804117f-0cf6-81c6-e063-6394a90a0e68	0220-0301	HUMAN OTC DRUG	Amyl nitrosum		AMYL NITRITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AMYL NITRITE	30	[hp_C]/30[hp_C]			N	20241231
0220-0304_080423a5-9567-828e-e063-6394a90aa422	0220-0304	HUMAN OTC DRUG	Anacardium occidentale		ANACARDIUM OCCIDENTALE FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANACARDIUM OCCIDENTALE FRUIT	30	[hp_C]/30[hp_C]			N	20241231
0220-0308_07ec78b7-6524-1281-e063-6394a90ae002	0220-0308	HUMAN OTC DRUG	Anacardium orientale		SEMECARPUS ANACARDIUM JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMECARPUS ANACARDIUM JUICE	6	[hp_C]/1			N	20241231
0220-0312_080425f6-1531-cd9d-e063-6294a90a4249	0220-0312	HUMAN OTC DRUG	Anagallis arvensis		ANAGALLIS ARVENSIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAGALLIS ARVENSIS	30	[hp_C]/30[hp_C]			N	20241231
0220-0320_0804236d-9494-cb3d-e063-6294a90ae431	0220-0320	HUMAN OTC DRUG	Anatherum muriaticum		CHRYSOPOGON ZIZANIOIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHRYSOPOGON ZIZANIOIDES ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0345_f7073f3e-4d1f-444e-e053-6294a90ac643	0220-0345	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0346_0d081a9b-d30e-0acc-e063-6394a90a9c0f	0220-0346	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-0349_0d080f65-ec7d-0315-e063-6394a90ad441	0220-0349	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-0350_f5292d85-3674-c5ac-e053-2a95a90a4ec2	0220-0350	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-0353_f527e40a-56a1-3df5-e053-2a95a90a2dd7	0220-0353	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0354_fbd19f25-cfde-5bb2-e053-6294a90aa616	0220-0354	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0357_fbd1bbd9-e008-1fe6-e053-6294a90a73b4	0220-0357	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	1	[hp_M]/[hp_M]			N	20241231
0220-0358_f9114f16-dad3-8bd1-e053-6294a90af09e	0220-0358	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-0365_003a0d9f-65ab-319d-e063-6394a90a6a7e	0220-0365	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	5	[hp_C]/5[hp_C]			N	20241231
0220-0366_0d084044-84a6-33bd-e063-6294a90a7666	0220-0366	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	6	[hp_C]/6[hp_C]			N	20241231
0220-0369_0d08439b-3e81-1798-e063-6394a90a1f52	0220-0369	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	5	[hp_C]/5[hp_C]			N	20241231
0220-0372_f9110e2b-30a5-4b58-e053-6294a90a6ce3	0220-0372	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE	8	[hp_X]/1			N	20241231
0220-0375_f911080f-2c49-2a92-e053-6294a90a6923	0220-0375	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	30	[hp_X]/30[hp_X]			N	20241231
0220-0377_003b57db-25ff-cea8-e063-6294a90a8d59	0220-0377	HUMAN OTC DRUG	Antimonium iodatum		ANTIMONY TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRIIODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0378_f1874165-9c3c-0aec-e053-2a95a90ac93d	0220-0378	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	9	[hp_C]/9[hp_C]			N	20241231
0220-0379_0d08468e-40e0-174c-e063-6394a90ac3f7	0220-0379	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	12	[hp_C]/12[hp_C]			N	20241231
0220-0382_0d083bbe-3378-25a6-e063-6294a90a09d9	0220-0382	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	15	[hp_C]/15[hp_C]			N	20241231
0220-0383_fbd38614-fda7-2a5e-e053-6394a90ad49e	0220-0383	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0386_0d08439b-3e82-1798-e063-6394a90a1f52	0220-0386	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0387_0d08468e-40e1-174c-e063-6394a90ac3f7	0220-0387	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	1	[hp_M]/[hp_M]			N	20241231
0220-0393_f9110e2b-30a3-4b58-e053-6294a90a6ce3	0220-0393	HUMAN OTC DRUG	Antimonium tartaricum		ANTIMONY POTASSIUM TARTRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE	6	[hp_X]/1			N	20241231
0220-0399_08041bb3-a008-a234-e063-6294a90a5e48	0220-0399	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	5	[hp_C]/5[hp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0400_f52a03e5-f030-0612-e053-2995a90a708f	0220-0400	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	6	[hp_C]/6[hp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0403_08042e57-d48d-9e04-e063-6294a90a95bd	0220-0403	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	9	[hp_C]/9[hp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0404_fd67fa5d-f990-c607-e053-6294a90aee2b	0220-0404	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	12	[hp_C]/12[hp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0406_0804569f-07d2-252e-e063-6294a90a5405	0220-0406	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	6	[hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0408_f529414c-36ef-5164-e053-2995a90acb80	0220-0408	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	15	[hp_C]/15[hp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0409_f39710fd-b37b-e145-e053-2a95a90a7fad	0220-0409	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	30	[hp_C]/30[hp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0410_f2b86955-d1c9-7a39-e053-2995a90a6f7d	0220-0410	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	200	[kp_C]/200[kp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0411_f52956fe-ef65-0357-e053-2a95a90a24a8	0220-0411	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	1	[hp_M]/[hp_M]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0412_080454b1-0a47-2c42-e063-6394a90a92c3	0220-0412	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	10	[hp_M]/10[hp_M]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0413_080439f8-b3f2-f871-e063-6294a90a6551	0220-0413	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	12	[hp_X]/12[hp_X]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0416_003b5ad0-5707-ea98-e063-6394a90a2b72	0220-0416	HUMAN OTC DRUG	Apis venenum purum		APIS MELLIFERA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA VENOM	30	[hp_C]/30[hp_C]			N	20241231
0220-0417_04115b93-77a9-711e-e063-6394a90af37e	0220-0417	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA	30	[hp_X]/30[hp_X]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0220-0421_0d084645-2209-2d8e-e063-6294a90ae5f0	0220-0421	HUMAN OTC DRUG	Apocynum cannabinum		APOCYNUM CANNABINUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APOCYNUM CANNABINUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0428_0d08439b-3e84-1798-e063-6394a90a1f52	0220-0428	HUMAN PRESCRIPTION DRUG	Apocynum cannabinum		APOCYNUM CANNABINUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	APOCYNUM CANNABINUM ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-0432_08541f82-a6a3-bffb-e063-6294a90a133f	0220-0432	HUMAN OTC DRUG	Aqua marina		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0441_085421a7-f2ef-b07f-e063-6394a90a11b9	0220-0441	HUMAN OTC DRUG	Aranea diadema		ARANEUS DIADEMATUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARANEUS DIADEMATUS	30	[hp_C]/30[hp_C]			N	20241231
0220-0442_0854248c-b18e-d8b1-e063-6394a90ac728	0220-0442	HUMAN OTC DRUG	Aralia racemosa		ARALIA RACEMOSA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARALIA RACEMOSA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0444_08541f82-a6a4-bffb-e063-6294a90a133f	0220-0444	HUMAN OTC DRUG	Aralia racemosa		ARALIA RACEMOSA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARALIA RACEMOSA ROOT	5	[hp_C]/5[hp_C]			N	20241231
0220-0448_08541f82-a6a5-bffb-e063-6294a90a133f	0220-0448	HUMAN OTC DRUG	Aranea diadema		ARANEUS DIADEMATUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARANEUS DIADEMATUS	9	[hp_C]/9[hp_C]			N	20241231
0220-0449_ff0914cb-1a37-7a0d-e053-6394a90adaeb	0220-0449	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	12	[hp_X]/12[hp_X]			N	20241231
0220-0450_f2f61698-6571-ac28-e053-2995a90ad2a8	0220-0450	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	30	[hp_X]/30[hp_X]			N	20241231
0220-0453_f2b86b77-a058-9cf1-e053-2a95a90a099a	0220-0453	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	200	[hp_X]/200[hp_X]			N	20241231
0220-0457_f7e5b836-a353-0626-e053-6394a90a0642	0220-0457	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	6	[hp_C]/6[hp_C]			N	20241231
0220-0458_f527e40a-56a3-3df5-e053-2a95a90a2dd7	0220-0458	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	9	[hp_C]/9[hp_C]			N	20241231
0220-0461_0d083cfc-7871-36ea-e063-6294a90a4098	0220-0461	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	12	[hp_C]/12[hp_C]			N	20241231
0220-0462_0d085590-996c-4388-e063-6294a90ab54b	0220-0462	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	15	[hp_C]/15[hp_C]			N	20241231
0220-0465_fd67b009-acb9-6c7b-e053-6294a90ad80e	0220-0465	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0466_f52c1f8f-8da0-6eb5-e053-2995a90a773f	0220-0466	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0469_0d085a47-978d-137e-e063-6394a90a1814	0220-0469	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	1	[hp_M]/[hp_M]			N	20241231
0220-0470_0d08468e-40e3-174c-e063-6394a90ac3f7	0220-0470	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	10	[hp_M]/10[hp_M]			N	20241231
0220-0473_ff08d268-e3a8-8405-e053-6394a90a34bd	0220-0473	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	30	[hp_X]/30[hp_X]			N	20241231
0220-0476_f7e5f3ae-ec62-8857-e053-6294a90a91cd	0220-0476	HUMAN OTC DRUG	Argentum metallicum		SILVER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER	6	[hp_C]/6[hp_C]			N	20241231
0220-0477_003ae69a-ccf3-f0d1-e063-6294a90a60a9	0220-0477	HUMAN OTC DRUG	Argentum metallicum		SILVER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER	30	[hp_C]/30[hp_C]			N	20241231
0220-0478_0039e564-0763-619b-e063-6394a90a886c	0220-0478	HUMAN OTC DRUG	Argentum metallicum		SILVER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER	200	[kp_C]/200[kp_C]			N	20241231
0220-0481_0d085a47-978e-137e-e063-6394a90a1814	0220-0481	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	5	[hp_C]/5[hp_C]			N	20241231
0220-0484_0d083bbe-3379-25a6-e063-6294a90a09d9	0220-0484	HUMAN OTC DRUG	Argentum nitricum		SILVER NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILVER NITRATE	6	[hp_X]/1			N	20241231
0220-0486_f528e7d1-1bcd-cce4-e053-2a95a90a00c1	0220-0486	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	3	[hp_C]/3[hp_C]			N	20241231
0220-0489_0854248c-b18f-d8b1-e063-6394a90ac728	0220-0489	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	5	[hp_C]/5[hp_C]			N	20241231
0220-0490_f212f808-9359-2b65-e053-2995a90a5775	0220-0490	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	6	[hp_C]/6[hp_C]			N	20241231
0220-0493_08542e05-b987-4451-e063-6294a90a394e	0220-0493	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	8	[hp_C]/8[hp_C]			N	20241231
0220-0496_0854314d-07fc-b02b-e063-6394a90adb85	0220-0496	HUMAN OTC DRUG	Aristolochia clematitis		ARISTOLOCHIA CLEMATITIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISTOLOCHIA CLEMATITIS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0497_f52bd221-3c6f-ac9c-e053-2995a90a87b7	0220-0497	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	9	[hp_C]/9[hp_C]			N	20241231
0220-0498_f19e9472-d565-171d-e053-2995a90a9fe4	0220-0498	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	12	[hp_C]/12[hp_C]			N	20241231
0220-0501_f7e5af77-c673-ea03-e053-6294a90ac025	0220-0501	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	15	[hp_C]/15[hp_C]			N	20241231
0220-0502_f212f00a-eb17-0d37-e053-2995a90a7bca	0220-0502	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	200	[kp_C]/200[kp_C]			N	20241231
0220-0505_f67d27a2-c1e8-8efd-e053-2995a90aa164	0220-0505	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	1	[hp_M]/[hp_M]			N	20241231
0220-0508_f187678d-78f1-2490-e053-2995a90a3d27	0220-0508	HUMAN OTC DRUG	Arnica		ARNICA MONTANA	PELLET	ORAL	20090501		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA	30	[hp_C]/1			N	20241231
0220-0514_f9139ecc-89fc-5848-e053-6394a90a0a43	0220-0514	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	10	[hp_M]/10[hp_M]			N	20241231
0220-0515_f527facb-9e47-5cb0-e053-2995a90adab1	0220-0515	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	3	[hp_X]/3[hp_X]			N	20241231
0220-0518_04112d72-5c41-b944-e063-6394a90aec0c	0220-0518	HUMAN OTC DRUG	Arnica montana radix		ARNICA MONTANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0519_f2f60f32-f9d8-5c4e-e053-2a95a90a4ab5	0220-0519	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	6	[hp_X]/6[hp_X]			N	20241231
0220-0522_0d0898e9-7030-710d-e063-6294a90a1b26	0220-0522	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	6	[hp_X]/1			N	20241231
0220-0525_f9136f83-3935-9eeb-e053-6294a90af255	0220-0525	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	5	[hp_C]/5[hp_C]			N	20241231
0220-0526_f915ba94-aaa0-95cb-e053-6294a90a70d1	0220-0526	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0527_0d089a4b-f1af-73ae-e063-6294a90a8bde	0220-0527	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-0528_0d088e34-c5ee-2ae5-e063-6394a90aae94	0220-0528	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-0529_0d088ccd-2d07-65bf-e063-6294a90a45a0	0220-0529	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-0530_016b4271-216b-0a63-e063-6294a90a3c58	0220-0530	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0532_f527fe86-7d8c-5cbe-e053-2995a90a4b35	0220-0532	HUMAN OTC DRUG	Arsenicum bromatum		ARSENIC TRIBROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIBROMIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0536_00edbc51-9a86-566f-e063-6294a90a81a7	0220-0536	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	6	[hp_X]/1			N	20241231
0220-0540_0854384f-e619-5083-e063-6394a90a974c	0220-0540	HUMAN OTC DRUG	Arsenicum metallicum		ARSENIC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC	30	[hp_C]/30[hp_C]			N	20241231
0220-0544_08543c79-f1ea-1f62-e063-6294a90ac812	0220-0544	HUMAN OTC DRUG	Arsenicum sulphuratum flavum		ARSENIC TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRISULFIDE	8	[hp_X]/8[hp_X]			N	20241231
0220-0545_0854314d-07fd-b02b-e063-6394a90adb85	0220-0545	HUMAN OTC DRUG	Arsenicum sulphuratum flavum		ARSENIC TRISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRISULFIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0548_0854415f-e955-feb3-e063-6394a90a940e	0220-0548	HUMAN OTC DRUG	Arsenicum sulphuratum rubrum		TETRAARSENIC TETRASULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TETRAARSENIC TETRASULFIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0549_f913a062-3414-58d2-e053-6294a90a752b	0220-0549	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0550_f52be90f-25c5-29aa-e053-2995a90ad4db	0220-0550	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	1	[hp_M]/[hp_M]			N	20241231
0220-0552_00edd7b8-7aba-2396-e063-6394a90a9e11	0220-0552	HUMAN OTC DRUG	Artemisia vulgaris		ARTEMISIA VULGARIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA VULGARIS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0553_0d088ccd-2d08-65bf-e063-6294a90a45a0	0220-0553	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	10	[hp_M]/10[hp_M]			N	20241231
0220-0554_f600abc4-e5aa-4a81-e053-2995a90a3260	0220-0554	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	12	[hp_X]/12[hp_X]			N	20241231
0220-0557_04112d72-5c4c-b944-e063-6394a90aec0c	0220-0557	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-0560_0854248c-b191-d8b1-e063-6394a90ac728	0220-0560	HUMAN OTC DRUG	Arum maculatum		ARUM MACULATUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARUM MACULATUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0561_08545765-b8aa-4e62-e063-6294a90a8b27	0220-0561	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	5	[hp_C]/5[hp_C]			N	20241231
0220-0562_003c1bd9-c0cd-867a-e063-6394a90a8423	0220-0562	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0564_0854415f-e956-feb3-e063-6394a90a940e	0220-0564	HUMAN OTC DRUG	Arum triphyllum		ARISAEMA TRIPHYLLUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT	6	[hp_X]/1			N	20241231
0220-0565_0854314d-07fe-b02b-e063-6394a90adb85	0220-0565	HUMAN OTC DRUG	Arum triphyllum		ARISAEMA TRIPHYLLUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT	30	[hp_X]/30[hp_X]			N	20241231
0220-0568_085421a7-f2f1-b07f-e063-6394a90a11b9	0220-0568	HUMAN OTC DRUG	Arundo mauritanica		ARUNDO PLINIANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARUNDO PLINIANA ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-0569_08542e05-b988-4451-e063-6294a90a394e	0220-0569	HUMAN OTC DRUG	Arundo mauritanica		ARUNDO PLINIANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARUNDO PLINIANA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0572_0854415f-e957-feb3-e063-6394a90a940e	0220-0572	HUMAN OTC DRUG	Asafoetida		FERULA ASSA-FOETIDA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERULA ASSA-FOETIDA RESIN	3	[hp_X]/3[hp_X]			N	20241231
0220-0573_08543c79-f1eb-1f62-e063-6294a90ac812	0220-0573	HUMAN OTC DRUG	Asafoetida		FERULA ASSA-FOETIDA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERULA ASSA-FOETIDA RESIN	5	[hp_C]/5[hp_C]			N	20241231
0220-0574_07d90bf0-8738-54b3-e063-6294a90a4a9f	0220-0574	HUMAN OTC DRUG	Asafoetida		FERULA ASSA-FOETIDA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERULA ASSA-FOETIDA RESIN	30	[hp_C]/30[hp_C]			N	20241231
0220-0577_0854415f-e958-feb3-e063-6394a90a940e	0220-0577	HUMAN OTC DRUG	Asarum europaeum		ASARUM EUROPAEUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ASARUM EUROPAEUM	30	[hp_C]/30[hp_C]			N	20241231
0220-0580_08548452-1253-50e4-e063-6394a90ac876	0220-0580	HUMAN OTC DRUG	Asarum europaeum		ASARUM EUROPAEUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ASARUM EUROPAEUM	15	[hp_C]/15[hp_C]			N	20241231
0220-0581_09ac6632-14a5-a202-e063-6394a90a691b	0220-0581	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-0582_07d90e90-0b06-555b-e063-6294a90a64fd	0220-0582	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-0585_09ac9914-3c14-9607-e063-6394a90aa067	0220-0585	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-0586_003b5ad0-570f-ea98-e063-6394a90a2b72	0220-0586	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0589_fbd1be15-8444-139d-e053-6394a90a0da9	0220-0589	HUMAN OTC DRUG	Arsenicum iodatum		ARSENIC TRIIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIIODIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0593_f52bb371-cede-235f-e053-2995a90a6c83	0220-0593	HUMAN OTC DRUG	Arum triphyllum		ARISAEMA TRIPHYLLUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-0594_07ebb1fe-5b4a-f073-e063-6394a90a4c78	0220-0594	HUMAN OTC DRUG	Arum triphyllum		ARISAEMA TRIPHYLLUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-0597_f18762f4-abd0-4d68-e053-2a95a90a701e	0220-0597	HUMAN OTC DRUG	Arum triphyllum		ARISAEMA TRIPHYLLUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-0598_f7e59aea-64cc-a69b-e053-6294a90af7b5	0220-0598	HUMAN OTC DRUG	Arum triphyllum		ARISAEMA TRIPHYLLUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0601_09ac8e4f-f8fe-b0b9-e063-6394a90a3309	0220-0601	HUMAN OTC DRUG	Arum triphyllum		ARISAEMA TRIPHYLLUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-0616_09ac8fbe-166b-c886-e063-6294a90a6209	0220-0616	HUMAN OTC DRUG	Asterias rubens		ASTERIAS RUBENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ASTERIAS RUBENS	6	[hp_C]/6[hp_C]			N	20241231
0220-0617_09ac9914-3c15-9607-e063-6394a90aa067	0220-0617	HUMAN OTC DRUG	Asterias rubens		ASTERIAS RUBENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ASTERIAS RUBENS	30	[hp_C]/30[hp_C]			N	20241231
0220-0630_fd666f5d-c471-f12f-e053-6394a90ac851	0220-0630	HUMAN OTC DRUG	Aurum iodatum		GOLD MONOIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD MONOIODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0632_09ac8fbe-166c-c886-e063-6294a90a6209	0220-0632	HUMAN OTC DRUG	Aurum iodatum		GOLD MONOIODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD MONOIODIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0636_09acadb7-c09f-d753-e063-6294a90af9a9	0220-0636	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	8	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0640_09acb03c-1112-b167-e063-6394a90aaee1	0220-0640	HUMAN OTC DRUG	Aurum muriaticum		GOLD TRICHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD TRICHLORIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0644_09ac80f8-325d-a443-e063-6394a90a1438	0220-0644	HUMAN PRESCRIPTION DRUG	Aurum muriaticum kalinatum		POTASSIUM TETRACHLOROAURATE DIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM TETRACHLOROAURATE DIHYDRATE	9	[hp_C]/9[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-0646_09acadb7-c0a0-d753-e063-6294a90af9a9	0220-0646	HUMAN OTC DRUG	Aurum muriaticum natronum		SODIUM TETRACHLOROAURATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM TETRACHLOROAURATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0648_09acb03c-1113-b167-e063-6394a90aaee1	0220-0648	HUMAN OTC DRUG	Aurum muriaticum natronatum		SODIUM TETRACHLOROAURATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM TETRACHLOROAURATE	4	[hp_C]/4[hp_C]			N	20241231
0220-0649_09acadb7-c0a1-d753-e063-6294a90af9a9	0220-0649	HUMAN OTC DRUG	Aurum muriaticum natronatum		SODIUM TETRACHLOROAURATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM TETRACHLOROAURATE	9	[hp_C]/9[hp_C]			N	20241231
0220-0650_09acb03c-1114-b167-e063-6394a90aaee1	0220-0650	HUMAN OTC DRUG	Aurum muriaticum natronatum		SODIUM TETRACHLOROAURATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM TETRACHLOROAURATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0656_00edbc64-9d34-5751-e063-6294a90a400b	0220-0656	HUMAN OTC DRUG	Avena sativa		AVENA SATIVA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AVENA SATIVA FLOWERING TOP	6	[hp_X]/6[hp_X]			N	20241231
0220-0657_09ac9273-240b-b149-e063-6394a90a20cb	0220-0657	HUMAN OTC DRUG	Avena sativa		AVENA SATIVA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AVENA SATIVA FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-0658_00f11bb4-c71b-301e-e063-6294a90ad384	0220-0658	HUMAN OTC DRUG	Avena sativa		AVENA SATIVA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AVENA SATIVA FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-0664_f52634d3-58d1-4611-e053-2995a90a40bf	0220-0664	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0665_09ac9273-240c-b149-e063-6394a90a20cb	0220-0665	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0666_09acbbb8-c2bf-e7b4-e063-6294a90afaac	0220-0666	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0667_09ac8fbe-166d-c886-e063-6294a90a6209	0220-0667	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0668_f52bad7f-ef23-2543-e053-2995a90a6925	0220-0668	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0669_fd668eff-5829-259d-e053-6394a90a1a1e	0220-0669	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0670_f7faff00-879e-b33f-e053-6294a90ab0b5	0220-0670	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0671_f527fe86-7d8d-5cbe-e053-2995a90a4b35	0220-0671	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	10	[hp_M]/10[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0672_09acbdf1-5190-ba8f-e063-6394a90a6f3e	0220-0672	HUMAN OTC DRUG	Aurum metallicum		GOLD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD	30	[hp_X]/30[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-0674_09acb03c-1115-b167-e063-6394a90aaee1	0220-0674	HUMAN OTC DRUG	Aurum muriaticum		GOLD TRICHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD TRICHLORIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-0675_09ac8fbe-166e-c886-e063-6294a90a6209	0220-0675	HUMAN OTC DRUG	Aurum muriaticum		GOLD TRICHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD TRICHLORIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-0676_09acc4f9-59a0-c504-e063-6394a90a5cc6	0220-0676	HUMAN OTC DRUG	Aurum muriaticum		GOLD TRICHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD TRICHLORIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0677_fbd19ef4-84b2-d058-e053-6294a90aa84c	0220-0677	HUMAN OTC DRUG	Aurum muriaticum		GOLD TRICHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLD TRICHLORIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0731_07d92a69-05d7-5394-e063-6294a90a4229	0220-0731	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BELLIS PERENNIS	12	[hp_C]/12[hp_C]			N	20241231
0220-0732_09ba54aa-8c50-2331-e063-6394a90a8089	0220-0732	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BELLIS PERENNIS	30	[hp_C]/30[hp_C]			N	20241231
0220-0733_f7faf93a-da02-cd48-e053-6394a90a5af4	0220-0733	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BELLIS PERENNIS	200	[kp_C]/200[kp_C]			N	20241231
0220-0734_09ba5e8f-735b-2a35-e063-6394a90a98d0	0220-0734	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BELLIS PERENNIS	1	[hp_M]/[hp_M]			N	20241231
0220-0738_f2f61a3b-d201-b356-e053-2995a90aa9d0	0220-0738	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	200	[kp_C]/200[kp_C]			N	20241231
0220-0739_f529ff66-f775-71a3-e053-2a95a90a776b	0220-0739	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	1	[hp_M]/[hp_M]			N	20241231
0220-0740_0410676a-d886-6119-e063-6294a90a12ad	0220-0740	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	10	[hp_M]/10[hp_M]			N	20241231
0220-0741_00ed5319-d0e8-d7cd-e063-6394a90a5668	0220-0741	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	6	[hp_X]/6[hp_X]			N	20241231
0220-0742_09ba4b09-2086-2f85-e063-6394a90a0f12	0220-0742	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	12	[hp_X]/12[hp_X]			N	20241231
0220-0743_f600936c-f5dd-db3f-e053-2995a90a7a63	0220-0743	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	30	[hp_X]/30[hp_X]			N	20241231
0220-0747_0410a1fe-a4cc-1f65-e063-6294a90ac687	0220-0747	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	6	[hp_C]/6[hp_C]			N	20241231
0220-0748_09ba7935-c8f6-d228-e063-6294a90a1e29	0220-0748	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	9	[hp_C]/9[hp_C]			N	20241231
0220-0749_09ba4db2-3e55-1367-e063-6394a90abb06	0220-0749	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	12	[hp_C]/12[hp_C]			N	20241231
0220-0750_09ba4b09-2087-2f85-e063-6394a90a0f12	0220-0750	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	15	[hp_C]/15[hp_C]			N	20241231
0220-0751_f7e59aea-64ca-a69b-e053-6294a90af7b5	0220-0751	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0752_f7e5a0db-e97b-e158-e053-6394a90a9fb4	0220-0752	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0753_09ba5762-6b47-3a9b-e063-6394a90a53e9	0220-0753	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	1	[hp_M]/[hp_M]			N	20241231
0220-0754_ff08d268-e396-8405-e053-6394a90a34bd	0220-0754	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	30	[hp_X]/30[hp_X]			N	20241231
0220-0755_09ba6d7c-6427-2dd3-e063-6394a90a5cc4	0220-0755	HUMAN OTC DRUG	Baryta muriatica		BARIUM CHLORIDE DIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CHLORIDE DIHYDRATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0756_09ba4b09-2088-2f85-e063-6394a90a0f12	0220-0756	HUMAN OTC DRUG	Baryta muriatica		BARIUM CHLORIDE DIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CHLORIDE DIHYDRATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0759_09ba4ccf-6732-af53-e063-6294a90af1a8	0220-0759	HUMAN OTC DRUG	Badiaga		SPONGILLA LACUSTRIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGILLA LACUSTRIS	9	[hp_C]/9[hp_C]			N	20241231
0220-0761_09ba54aa-8c51-2331-e063-6394a90a8089	0220-0761	HUMAN OTC DRUG	Badiaga		SPONGILLA LACUSTRIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGILLA LACUSTRIS	6	[hp_C]/6[hp_C]			N	20241231
0220-0770_09ba859c-0874-4ca0-e063-6394a90a14f4	0220-0770	HUMAN OTC DRUG	Baptisia tinctoria		BAPTISIA TINCTORIA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BAPTISIA TINCTORIA ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-0773_09ba859c-0875-4ca0-e063-6394a90a14f4	0220-0773	HUMAN OTC DRUG	Baptisia tinctoria		BAPTISIA TINCTORIA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BAPTISIA TINCTORIA ROOT	6	[hp_C]/1			N	20241231
0220-0774_09ba5762-6b48-3a9b-e063-6394a90a53e9	0220-0774	HUMAN OTC DRUG	Baptisia tinctoria		BAPTISIA TINCTORIA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BAPTISIA TINCTORIA ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-0775_09ba7935-c8f7-d228-e063-6294a90a1e29	0220-0775	HUMAN OTC DRUG	Baptisia tinctoria		BAPTISIA TINCTORIA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BAPTISIA TINCTORIA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0785_09ba5762-6b49-3a9b-e063-6394a90a53e9	0220-0785	HUMAN OTC DRUG	Baryta carbonica		BARIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CARBONATE	8	[hp_X]/1			N	20241231
0220-0789_09ba4b09-2089-2f85-e063-6394a90a0f12	0220-0789	HUMAN OTC DRUG	Baryta iodata		BARIUM IODIDE	PELLET	ORAL	19830503		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM IODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0793_09ba7935-c8fb-d228-e063-6294a90a1e29	0220-0793	HUMAN OTC DRUG	Baryta muriatica		BARIUM CHLORIDE DIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BARIUM CHLORIDE DIHYDRATE	5	[hp_C]/5[hp_C]			N	20241231
0220-0797_09ba859c-0876-4ca0-e063-6394a90a14f4	0220-0797	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	4	[hp_X]/1			N	20241231
0220-0800_f7faf93a-da01-cd48-e053-6394a90a5af4	0220-0800	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	3	[hp_C]/3[hp_C]			N	20241231
0220-0801_09ba54aa-8c55-2331-e063-6394a90a8089	0220-0801	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	5	[hp_C]/5[hp_C]			N	20241231
0220-0802_f528df03-168b-4289-e053-2995a90a4395	0220-0802	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	6	[hp_C]/6[hp_C]			N	20241231
0220-0803_f7e5968d-d28b-a0f2-e053-6394a90a42a4	0220-0803	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	9	[hp_C]/9[hp_C]			N	20241231
0220-0804_f52b8a6c-d254-11e0-e053-2995a90a48f1	0220-0804	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	12	[hp_C]/12[hp_C]			N	20241231
0220-0805_003b64cb-732e-b46f-e063-6294a90acb05	0220-0805	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	15	[hp_C]/15[hp_C]			N	20241231
0220-0808_f2134bbc-0344-0999-e053-2a95a90a6941	0220-0808	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA	30	[hp_C]/30[hp_C]			N	20241231
0220-0811_09ba859c-0877-4ca0-e063-6394a90a14f4	0220-0811	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BELLIS PERENNIS	5	[hp_C]/1			N	20241231
0220-0812_07d8f0e7-e5f8-1b82-e063-6394a90aa0e5	0220-0812	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BELLIS PERENNIS	6	[hp_C]/6[hp_C]			N	20241231
0220-0815_07ec78b7-6523-1281-e063-6394a90ae002	0220-0815	HUMAN OTC DRUG	Benzinum		BENZENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BENZENE	30	[hp_C]/30[hp_C]			N	20241231
0220-0816_f913c88b-91b9-2a5d-e053-6294a90a579b	0220-0816	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BELLIS PERENNIS	9	[hp_C]/9[hp_C]			N	20241231
0220-0823_f187678d-78f2-2490-e053-2995a90a3d27	0220-0823	HUMAN OTC DRUG	Benzoicum acidum		BENZOIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BENZOIC ACID	6	[hp_C]/6[hp_C]	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
0220-0824_07d9363d-14ed-a4f7-e063-6294a90ac420	0220-0824	HUMAN OTC DRUG	Benzoicum acidum		BENZOIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BENZOIC ACID	30	[hp_C]/30[hp_C]	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
0220-0825_09ba4db2-3e57-1367-e063-6394a90abb06	0220-0825	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	3	[hp_C]/3[hp_C]			N	20241231
0220-0828_09ba859c-0878-4ca0-e063-6394a90a14f4	0220-0828	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	5	[hp_C]/5[hp_C]			N	20241231
0220-0829_09bab28f-d72d-f2e7-e063-6294a90a1b79	0220-0829	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	6	[hp_C]/6[hp_C]			N	20241231
0220-0831_09bab3c8-75be-db5a-e063-6294a90a6d9c	0220-0831	HUMAN OTC DRUG	Berberis aquifolium		BERBERIS AQUIFOLIUM ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS AQUIFOLIUM ROOT BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-0832_09ba8d97-4f52-3bf1-e063-6394a90afa4b	0220-0832	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	9	[hp_C]/9[hp_C]			N	20241231
0220-0833_09bab5f5-59d9-5c85-e063-6394a90a7848	0220-0833	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	12	[hp_C]/12[hp_C]			N	20241231
0220-0835_09ba7935-c8fd-d228-e063-6294a90a1e29	0220-0835	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	4	[hp_X]/1			N	20241231
0220-0836_00f08b1d-e1a1-da06-e063-6394a90a4724	0220-0836	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-0837_f2f3a73d-5be6-36c6-e053-2995a90ac478	0220-0837	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	200	[kp_C]/200[kp_C]			N	20241231
0220-0839_09bab81a-261b-df3a-e063-6294a90a67dd	0220-0839	HUMAN OTC DRUG	Beryllium metallicum		BERYLLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERYLLIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-0841_f527914c-7997-a5c6-e053-2995a90a1aa6	0220-0841	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	1	[hp_M]/[hp_M]			N	20241231
0220-0844_09bab3c8-75c0-db5a-e063-6294a90a6d9c	0220-0844	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	6	[hp_X]/6[hp_X]			N	20241231
0220-0845_00edbc64-9d36-5751-e063-6294a90a400b	0220-0845	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERBERIS VULGARIS ROOT BARK	10	[hp_X]/10[hp_X]			N	20241231
0220-0848_09bac992-8027-5dee-e063-6394a90a7e0d	0220-0848	HUMAN OTC DRUG	Beryllium metallicum		BERYLLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BERYLLIUM	200	[kp_C]/200[kp_C]			N	20241231
0220-0851_07d93101-13df-5334-e063-6294a90af8d5	0220-0851	HUMAN OTC DRUG	Bismuthum metallicum		BISMUTH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BISMUTH	30	[hp_C]/30[hp_C]			N	20241231
0220-0859_07d93bfb-dc2d-65aa-e063-6394a90a3761	0220-0859	HUMAN OTC DRUG	Bismuthum subnitricum		BISMUTH SUBNITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BISMUTH SUBNITRATE	30	[hp_C]/30[hp_C]	Bismuth [CS], Bismuth [EPC]		N	20241231
0220-0865_0c0490ee-23f3-1cdb-e063-6394a90a8185	0220-0865	HUMAN OTC DRUG	BLATTA ORIENTALIS		BLATTA ORIENTALIS	PELLET	ORAL	20240101		UNAPPROVED HOMEOPATHIC		Boiron	BLATTA ORIENTALIS	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0220-0868_09bab28f-d781-f2e7-e063-6294a90a1b79	0220-0868	HUMAN OTC DRUG	Blatta orientalis		BLATTA ORIENTALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLATTA ORIENTALIS	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0220-0869_09bacb67-af5d-06fe-e063-6294a90acf35	0220-0869	HUMAN OTC DRUG	Blatta orientalis		BLATTA ORIENTALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLATTA ORIENTALIS	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0220-0871_09bac8ea-5e5c-66ef-e063-6394a90a1c62	0220-0871	HUMAN OTC DRUG	Blatta orientalis		BLATTA ORIENTALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLATTA ORIENTALIS	5	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0220-0872_09bad418-b4b9-6eca-e063-6394a90ae0be	0220-0872	HUMAN OTC DRUG	Blatta orientalis		BLATTA ORIENTALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLATTA ORIENTALIS	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0220-0873_07d9093c-117c-55e0-e063-6294a90a9b61	0220-0873	HUMAN OTC DRUG	Blatta orientalis		BLATTA ORIENTALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLATTA ORIENTALIS	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0220-0876_f2f6110c-de3a-8535-e053-2995a90a7622	0220-0876	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0877_09bab5f5-59db-5c85-e063-6394a90a7848	0220-0877	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	1	[hp_M]/[hp_M]			N	20241231
0220-0880_07ebb1fe-5b4b-f073-e063-6394a90a4c78	0220-0880	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	15	[hp_C]/15[hp_C]			N	20241231
0220-0881_f2f61a3b-d202-b356-e053-2995a90aa9d0	0220-0881	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0884_07d93101-13de-5334-e063-6294a90af8d5	0220-0884	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	9	[hp_C]/9[hp_C]			N	20241231
0220-0885_fbd4e679-0afd-18f8-e053-6294a90a8726	0220-0885	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	12	[hp_C]/12[hp_C]			N	20241231
0220-0887_04115ec1-ef2d-1746-e063-6394a90a0a52	0220-0887	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	6	[hp_X]/1			N	20241231
0220-0888_09bad418-b4ba-6eca-e063-6394a90ae0be	0220-0888	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	5	[hp_C]/5[hp_C]			N	20241231
0220-0889_f2f61f63-eea2-dc1f-e053-2995a90a5d7e	0220-0889	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	6	[hp_C]/6[hp_C]			N	20241231
0220-0892_09bab28f-d782-f2e7-e063-6294a90a1b79	0220-0892	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM BORATE	30	[hp_X]/30[hp_X]			N	20241231
0220-0895_09bacb67-af5e-06fe-e063-6294a90acf35	0220-0895	HUMAN OTC DRUG	Bovista		LYCOPERDON UTRIFORME FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPERDON UTRIFORME FRUITING BODY	6	[hp_C]/6[hp_C]			N	20241231
0220-0896_09bab81a-261d-df3a-e063-6294a90a67dd	0220-0896	HUMAN OTC DRUG	Bovista		LYCOPERDON UTRIFORME FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPERDON UTRIFORME FRUITING BODY	9	[hp_C]/9[hp_C]			N	20241231
0220-0897_f5279bd1-17a3-74ce-e053-2a95a90a3ffe	0220-0897	HUMAN OTC DRUG	Bovista		LYCOPERDON UTRIFORME FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPERDON UTRIFORME FRUITING BODY	30	[hp_C]/30[hp_C]			N	20241231
0220-0900_f228aef8-0681-206e-e053-2a95a90ace6a	0220-0900	HUMAN OTC DRUG	Bovista		LYCOPERDON UTRIFORME FRUITING BODY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPERDON UTRIFORME FRUITING BODY	200	[kp_C]/200[kp_C]			N	20241231
0220-0901_09bac8ea-5e5d-66ef-e063-6394a90a1c62	0220-0901	HUMAN OTC DRUG	Bromium		BROMINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BROMINE	30	[hp_C]/30[hp_C]			N	20241231
0220-0904_09bad418-b4bb-6eca-e063-6394a90ae0be	0220-0904	HUMAN OTC DRUG	Bromium		BROMINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BROMINE	6	[hp_X]/6[hp_X]			N	20241231
0220-0907_09bac992-8029-5dee-e063-6394a90a7e0d	0220-0907	HUMAN OTC DRUG	Bromium		Bromine	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BROMINE	6	[hp_X]/6[hp_X]			N	20241231
0220-0909_f52c0a91-ded8-8768-e053-2a95a90a23f4	0220-0909	HUMAN OTC DRUG	Bromium		BROMINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BROMINE	6	[hp_C]/6[hp_C]			N	20241231
0220-0915_09bade27-0412-72b0-e063-6394a90a9758	0220-0915	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	4	[hp_X]/1			N	20241231
0220-0925_09bac8ea-5e5e-66ef-e063-6394a90a1c62	0220-0925	HUMAN PRESCRIPTION DRUG	Bufo rana		BUFO BUFO CUTANEOUS GLAND	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BUFO BUFO CUTANEOUS GLAND	6	[hp_C]/6[hp_C]			N	20241231
0220-0939_09bab81a-261f-df3a-e063-6294a90a67dd	0220-0939	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	5	[hp_C]/5[hp_C]			N	20241231
0220-0940_f2f622d4-8f00-db6a-e053-2995a90aba8d	0220-0940	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-0941_fd67fa5d-f98d-c607-e053-6294a90aee2b	0220-0941	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-0942_07d8fd31-f004-ff7d-e063-6394a90a1ac2	0220-0942	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-0943_07ebf835-3a3a-6c8d-e063-6294a90ade90	0220-0943	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	15	[hp_C]/15[hp_C]			N	20241231
0220-0944_f913b60a-76a7-7f23-e053-6394a90a2f9a	0220-0944	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-0945_f2f6118a-6f22-b358-e053-2995a90ac0de	0220-0945	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-0946_044c9f68-c770-1910-e063-6394a90adb29	0220-0946	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-0947_09bab5f5-59de-5c85-e063-6394a90a7848	0220-0947	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	10	[hp_M]/10[hp_M]			N	20241231
0220-0948_09bade27-0415-72b0-e063-6394a90a9758	0220-0948	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	6	[hp_X]/6[hp_X]			N	20241231
0220-0949_09bac8ea-5e60-66ef-e063-6394a90a1c62	0220-0949	HUMAN OTC DRUG	Bryonia		BRYONIA ALBA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BRYONIA ALBA ROOT	30	[hp_X]/30[hp_X]			N	20241231
0220-0951_09bab28f-d785-f2e7-e063-6294a90a1b79	0220-0951	HUMAN PRESCRIPTION DRUG	Bufo rana		BUFO BUFO CUTANEOUS GLAND	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BUFO BUFO CUTANEOUS GLAND	9	[hp_C]/9[hp_C]			N	20241231
0220-0952_09bade27-0416-72b0-e063-6394a90a9758	0220-0952	HUMAN PRESCRIPTION DRUG	Bufo rana		BUFO BUFO CUTANEOUS GLAND	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BUFO BUFO CUTANEOUS GLAND	12	[hp_C]/12[hp_C]			N	20241231
0220-0953_09bab28f-d786-f2e7-e063-6294a90a1b79	0220-0953	HUMAN PRESCRIPTION DRUG	Bufo rana		BUFO BUFO CUTANEOUS GLAND	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BUFO BUFO CUTANEOUS GLAND	30	[hp_C]/30[hp_C]			N	20241231
0220-0954_09baeb3e-9bcb-696a-e063-6394a90a6497	0220-0954	HUMAN PRESCRIPTION DRUG	Bufo rana		BUFO BUFO CUTANEOUS GLAND	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BUFO BUFO CUTANEOUS GLAND	200	[kp_C]/200[kp_C]			N	20241231
0220-0956_09badbb9-8fa6-120a-e063-6294a90ad032	0220-0956	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	5	[hp_C]/5[hp_C]			N	20241231
0220-0957_f2b88a07-10b5-5b2a-e053-2a95a90a7aa0	0220-0957	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	6	[hp_C]/6[hp_C]			N	20241231
0220-0958_f5262a2b-6bd9-4615-e053-2995a90aaf58	0220-0958	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	9	[hp_C]/9[hp_C]			N	20241231
0220-0959_09badbb9-8fa7-120a-e063-6294a90ad032	0220-0959	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	12	[hp_C]/12[hp_C]			N	20241231
0220-0960_0868b8dd-841a-d7c8-e063-6294a90a6ac1	0220-0960	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	15	[hp_C]/15[hp_C]			N	20241231
0220-0961_f67d60dc-76fc-2e3d-e053-2a95a90ac3bf	0220-0961	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	30	[hp_C]/30[hp_C]			N	20241231
0220-0962_f2b8862b-2b5e-5d0a-e053-2995a90a52e3	0220-0962	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	200	[kp_C]/200[kp_C]			N	20241231
0220-0963_09bade27-0418-72b0-e063-6394a90a9758	0220-0963	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	1	[hp_M]/[hp_M]			N	20241231
0220-0964_09bac992-802a-5dee-e063-6394a90a7e0d	0220-0964	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	10	[hp_M]/10[hp_M]			N	20241231
0220-0965_09bad27c-7f16-679f-e063-6394a90a90e0	0220-0965	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	8	[hp_X]/8[hp_X]			N	20241231
0220-0966_09bac8ea-5e63-66ef-e063-6394a90a1c62	0220-0966	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	12	[hp_X]/12[hp_X]			N	20241231
0220-0967_00edb965-211b-d896-e063-6294a90a86ad	0220-0967	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	30	[hp_X]/30[hp_X]			N	20241231
0220-0970_09baf622-ce7b-3709-e063-6294a90a55d8	0220-0970	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	5	[hp_C]/5[hp_C]			N	20241231
0220-0971_f528df03-168c-4289-e053-2995a90a4395	0220-0971	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-0972_f7e5f0f4-48d3-6f3a-e053-6394a90abb82	0220-0972	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-0973_09bacb67-af63-06fe-e063-6294a90acf35	0220-0973	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-0974_f9136aab-2111-1590-e053-6394a90a5b50	0220-0974	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-0975_f2b87ea9-28dc-1edf-e053-2a95a90ab449	0220-0975	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0976_f9155453-4076-0fbd-e053-6294a90a8f38	0220-0976	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0977_09baeb3e-9bcf-696a-e063-6394a90a6497	0220-0977	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	1	[hp_M]/[hp_M]			N	20241231
0220-0978_09baf8ea-54af-79de-e063-6394a90ae5db	0220-0978	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	10	[hp_M]/10[hp_M]			N	20241231
0220-0979_f2f62640-92f1-a9c4-e053-2995a90ac842	0220-0979	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	12	[hp_X]/12[hp_X]			N	20241231
0220-0980_f5279f5e-0fb2-1d94-e053-2995a90a2158	0220-0980	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-0983_f2f61a3b-d203-b356-e053-2995a90aa9d0	0220-0983	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_C]/30[hp_C]			N	20241231
0220-0984_f529414c-36e7-5164-e053-2995a90acb80	0220-0984	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	200	[kp_C]/200[kp_C]			N	20241231
0220-0985_f67d48ad-3c41-1e77-e053-2995a90a6e55	0220-0985	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	1	[hp_M]/[hp_M]			N	20241231
0220-0986_09bade27-0419-72b0-e063-6394a90a9758	0220-0986	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	10	[hp_M]/10[hp_M]			N	20241231
0220-0987_09bad418-b4bf-6eca-e063-6394a90ae0be	0220-0987	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	12	[hp_X]/12[hp_X]			N	20241231
0220-0988_09bacb67-af64-06fe-e063-6294a90acf35	0220-0988	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_X]/30[hp_X]			N	20241231
0220-0991_09bb00df-abd6-37c7-e063-6294a90a1cd7	0220-0991	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	6	[hp_C]/6[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-0992_09baeb3e-9bd0-696a-e063-6394a90a6497	0220-0992	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	9	[hp_C]/9[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-0995_09badbb9-8fae-120a-e063-6294a90ad032	0220-0995	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	12	[hp_C]/12[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-0996_09bade27-041a-72b0-e063-6394a90a9758	0220-0996	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	15	[hp_C]/15[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-0999_f52a1474-11dd-c2b6-e053-2a95a90a44d9	0220-0999	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	30	[hp_C]/30[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0220-1000_09bacb67-af65-06fe-e063-6294a90acf35	0220-1000	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	200	[kp_C]/200[kp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-1003_09badbb9-8fb0-120a-e063-6294a90ad032	0220-1003	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	1	[hp_M]/[hp_M]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-1004_0762982e-561f-4595-e063-6394a90a58b3	0220-1004	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	30	[hp_X]/30[hp_X]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-1006_09bad418-b4c0-6eca-e063-6394a90ae0be	0220-1006	HUMAN OTC DRUG	Cadmium metallicum		CADMIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CADMIUM	15	[hp_C]/15[hp_C]			N	20241231
0220-1007_09bacb67-af66-06fe-e063-6294a90acf35	0220-1007	HUMAN OTC DRUG	Cadmium metalllicum		CADMIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CADMIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-1014_f1872d4a-d2fb-6930-e053-2a95a90a47f1	0220-1014	HUMAN OTC DRUG	Cadmium sulphuratum		CADMIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CADMIUM SULFIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-1018_09badbb9-8fb1-120a-e063-6294a90ad032	0220-1018	HUMAN OTC DRUG	Cadmium sulphuricum		CADMIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CADMIUM SULFATE	12	[hp_C]/12[hp_C]			N	20241231
0220-1023_f52bad7f-ef24-2543-e053-2995a90a6925	0220-1023	HUMAN OTC DRUG	Cadmium sulphuricum		CADMIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CADMIUM SULFATE	30	[hp_C]/30[hp_C]			N	20241231
0220-1024_09bad418-b4c2-6eca-e063-6394a90ae0be	0220-1024	HUMAN OTC DRUG	Cadmium sulphuricum		CADMIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CADMIUM SULFATE	200	[kp_C]/200[kp_C]			N	20241231
0220-1027_f527914c-799a-a5c6-e053-2995a90a1aa6	0220-1027	HUMAN OTC DRUG	Caladium seguinum		DIEFFENBACHIA SEGUINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIEFFENBACHIA SEGUINE	200	[kp_C]/200[kp_C]			N	20241231
0220-1030_09baf622-ce7d-3709-e063-6294a90a55d8	0220-1030	HUMAN OTC DRUG	Cajuputum		CAJUPUT OIL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAJUPUT OIL	30	[hp_C]/30[hp_C]			N	20241231
0220-1031_09bb0c2d-7b7a-6b80-e063-6394a90a2486	0220-1031	HUMAN OTC DRUG	Caladium seguinum		DIEFFENBACHIA SEGUINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIEFFENBACHIA SEGUINE	15	[hp_C]/15[hp_C]			N	20241231
0220-1032_f7e529f9-fc20-4e00-e053-6394a90a1045	0220-1032	HUMAN OTC DRUG	Caladium seguinum		DIEFFENBACHIA SEGUINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIEFFENBACHIA SEGUINE	30	[hp_C]/30[hp_C]			N	20241231
0220-1034_09baeb3e-9bd1-696a-e063-6394a90a6497	0220-1034	HUMAN OTC DRUG	Caladium seguinum		DIEFFENBACHIA SEGUINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIEFFENBACHIA SEGUINE	6	[hp_C]/6[hp_C]			N	20241231
0220-1035_07ecd10a-f601-2999-e063-6394a90acebd	0220-1035	HUMAN OTC DRUG	Caladium seguinum		DIEFFENBACHIA SEGUINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIEFFENBACHIA SEGUINE	9	[hp_C]/9[hp_C]			N	20241231
0220-1036_09bb00df-abd8-37c7-e063-6294a90a1cd7	0220-1036	HUMAN OTC DRUG	Caladium seguinum		DIEFFENBACHIA SEGUINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIEFFENBACHIA SEGUINE	12	[hp_C]/12[hp_C]			N	20241231
0220-1046_09bb00df-abda-37c7-e063-6294a90a1cd7	0220-1046	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	8	[hp_X]/1			N	20241231
0220-1050_f67d3f48-7631-b1a8-e053-2a95a90aac09	0220-1050	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	6	[hp_C]/6[hp_C]			N	20241231
0220-1051_09bad27c-7f19-679f-e063-6394a90a90e0	0220-1051	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	9	[hp_C]/9[hp_C]			N	20241231
0220-1052_003bb485-5510-f985-e063-6394a90ae18e	0220-1052	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	12	[hp_C]/12[hp_C]			N	20241231
0220-1053_09bb085f-c3e5-80dd-e063-6394a90a27eb	0220-1053	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OYSTER SHELL CALCIUM CARBONATE, CRUDE	15	[hp_C]/15[hp_C]			N	20241231
0220-1056_09be97f2-2760-2ea1-e063-6394a90a17b9	0220-1056	HUMAN OTC DRUG	Calcarea caustica		CALCIUM HYDROXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM HYDROXIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-1057_04112095-edd3-75e4-e063-6294a90a5b0d	0220-1057	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-1060_04110848-458d-646a-e063-6394a90a19a1	0220-1060	HUMAN OTC DRUG	Calcarea fluorica		CALCIUM FLUORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM FLUORIDE	8	[hp_X]/1			N	20241231
0220-1063_f5279f5e-0fb3-1d94-e053-2995a90a2158	0220-1063	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-1066_f913bb53-456d-755a-e053-6294a90a6216	0220-1066	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-1067_09beb76a-d3b4-3c1d-e063-6394a90a10b3	0220-1067	HUMAN OTC DRUG	Calcarea iodata		CALCIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM IODIDE	200	[kp_C]/200[kp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-1069_f9137203-d8e9-289f-e053-6394a90a06d9	0220-1069	HUMAN OTC DRUG	Calcarea iodata		CALCIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM IODIDE	30	[hp_C]/30[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0220-1071_f7fb0f16-5333-ff03-e053-6294a90aebae	0220-1071	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	200	[kp_C]/200[kp_C]			N	20241231
0220-1074_09be9d05-7ae9-34e6-e063-6394a90a632d	0220-1074	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_M]/[hp_M]			N	20241231
0220-1075_fd6463b2-87fd-2b9f-e053-6294a90a7cd8	0220-1075	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	10	[hp_M]/10[hp_M]			N	20241231
0220-1078_09bea267-99df-54a6-e063-6294a90a5674	0220-1078	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	30	[hp_X]/30[hp_X]			N	20241231
0220-1079_09be8cc8-b80a-4600-e063-6294a90a74a2	0220-1079	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	15	[hp_C]/15[hp_C]			N	20241231
0220-1082_09beb76a-d3b5-3c1d-e063-6394a90a10b3	0220-1082	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	5	[hp_C]/5[hp_C]			N	20241231
0220-1083_f2b88588-8e8b-43f8-e053-2a95a90a0ba6	0220-1083	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	6	[hp_C]/6[hp_C]			N	20241231
0220-1085_f2b88a07-10b6-5b2a-e053-2a95a90a7aa0	0220-1085	HUMAN OTC DRUG	Calcarea phosphorica		TRIBASIC CALCIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRIBASIC CALCIUM PHOSPHATE	6	[hp_X]/1			N	20241231
0220-1088_f67d5b96-c356-0f47-e053-2a95a90af1a2	0220-1088	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	30	[hp_C]/30[hp_C]			N	20241231
0220-1091_09beb76a-d3b6-3c1d-e063-6394a90a10b3	0220-1091	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	9	[hp_C]/9[hp_C]			N	20241231
0220-1092_09be97f2-2761-2ea1-e063-6394a90a17b9	0220-1092	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	12	[hp_C]/12[hp_C]			N	20241231
0220-1094_09be8cc8-b80b-4600-e063-6294a90a74a2	0220-1094	HUMAN OTC DRUG	Calcarea silicata		CALCIUM SILICATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SILICATE	6	[hp_C]/6[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-1095_09be8cc8-b80d-4600-e063-6294a90a74a2	0220-1095	HUMAN OTC DRUG	Calcarea silicata		CALCIUM SILICATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SILICATE	30	[hp_C]/30[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-1098_09beb76a-d3b9-3c1d-e063-6394a90a10b3	0220-1098	HUMAN OTC DRUG	Calcarea sulphurica		CALCIUM SULFATE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFATE ANHYDROUS	6	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-1103_09bed294-41b0-4800-e063-6394a90afef4	0220-1103	HUMAN OTC DRUG	Calendula officinalis		CALENDULA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	6	[hp_X]/1			N	20241231
0220-1104_f40b2d36-692c-5803-e053-2a95a90af542	0220-1104	HUMAN OTC DRUG	Calendula		CALENDULA OFFICINALIS FLOWERING TOP	OINTMENT	TOPICAL	19880717		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/g			N	20241231
0220-1105_f706dafb-bd9b-8e95-e053-6294a90ac332	0220-1105	HUMAN OTC DRUG	Calendula		CALENDULA OFFICINALIS FLOWERING TOP	GEL	TOPICAL	19930930		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/g			N	20241231
0220-1108_f706dc04-987c-ee0d-e053-6394a90a3629	0220-1108	HUMAN OTC DRUG	Calendula		CALENDULA OFFICINALIS FLOWERING TOP	GEL	TOPICAL	19900413		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/g			N	20241231
0220-1109_f2041d6b-be6c-7baa-e053-2a95a90a50e7	0220-1109	HUMAN OTC DRUG	Calendula		CALENDULA OFFICINALIS FLOWERING TOP	CREAM	TOPICAL	20060321		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/g			N	20241231
0220-1111_003a6ff4-44c7-0cb3-e063-6294a90a6f4a	0220-1111	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	200	[kp_C]/200[kp_C]			N	20241231
0220-1114_ff08d268-e3a9-8405-e053-6394a90a34bd	0220-1114	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	1	[hp_M]/[hp_M]			N	20241231
0220-1115_ff089a1b-b4c9-53e1-e053-6394a90a8875	0220-1115	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	10	[hp_M]/10[hp_M]			N	20241231
0220-1118_09bed410-d358-6d67-e063-6294a90ac397	0220-1118	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1119_f2f39e0a-efc9-5521-e053-2995a90a55dc	0220-1119	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	10	[hp_M]/10[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1121_09bed597-d1a8-703d-e063-6294a90a629a	0220-1121	HUMAN OTC DRUG	Camphora		CAMPHOR (NATURAL)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAMPHOR (NATURAL)	30	[hp_C]/30[hp_C]			N	20241231
0220-1122_09bed597-d1ac-703d-e063-6294a90a629a	0220-1122	HUMAN OTC DRUG	Camphora		CAMPHOR (NATURAL)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAMPHOR (NATURAL)	200	[kp_C]/200[kp_C]			N	20241231
0220-1123_09bed597-d1ad-703d-e063-6294a90a629a	0220-1123	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	12	[hp_X]/12[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1126_f2b88588-8e8a-43f8-e053-2a95a90a0ba6	0220-1126	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1127_f7e5728e-6676-788f-e053-6394a90a784a	0220-1127	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1130_f187a241-d5eb-f763-e053-2a95a90a6c04	0220-1130	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1131_f91397ae-0f0b-580b-e053-6394a90ad8c0	0220-1131	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1133_09bea96e-844b-35e1-e063-6394a90a5750	0220-1133	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	CANDIDA ALBICANS	8	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1134_003ae69a-ccf5-f0d1-e063-6294a90a60a9	0220-1134	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1135_f91397ae-0f0c-580b-e053-6394a90ad8c0	0220-1135	HUMAN OTC DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-1138_09beb76a-d3bb-3c1d-e063-6394a90a10b3	0220-1138	HUMAN OTC DRUG	Capsicum annuum		CAPSICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAPSICUM	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
0220-1139_09bedd58-5c75-44d9-e063-6394a90ab144	0220-1139	HUMAN OTC DRUG	Capsicum annuum		CAPSICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAPSICUM	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
0220-1142_09bed294-41b5-4800-e063-6394a90afef4	0220-1142	HUMAN OTC DRUG	Capsicum annuum		CAPSICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAPSICUM	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
0220-1145_09bed294-41b6-4800-e063-6394a90afef4	0220-1145	HUMAN OTC DRUG	Cantharis		LYTTA VESICATORIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYTTA VESICATORIA	30	[hp_X]/1			N	20241231
0220-1147_04102cb9-ea14-d953-e063-6394a90ab551	0220-1147	HUMAN OTC DRUG	Capsicum annuum		CAPSICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAPSICUM	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
0220-1150_09bed294-41b7-4800-e063-6394a90afef4	0220-1150	HUMAN OTC DRUG	Capsicum annuum		CAPSICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAPSICUM	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
0220-1151_09beda5a-60d7-4a10-e063-6394a90a843d	0220-1151	HUMAN OTC DRUG	Carbo animalis		CARBO ANIMALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBO ANIMALIS	6	[hp_C]/6[hp_C]			N	20241231
0220-1154_09bed597-d1af-703d-e063-6294a90a629a	0220-1154	HUMAN OTC DRUG	Carbo animalis		CARBO ANIMALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBO ANIMALIS	8	[hp_X]/8[hp_X]			N	20241231
0220-1156_09bed6d1-db41-47c4-e063-6394a90a88bf	0220-1156	HUMAN OTC DRUG	Carbo animalis		CARBO ANIMALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBO ANIMALIS	9	[hp_C]/9[hp_C]			N	20241231
0220-1158_f9117006-2bde-7570-e053-6394a90a9a4b	0220-1158	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	8	[hp_X]/1			N	20241231
0220-1161_09bed294-41ba-4800-e063-6394a90afef4	0220-1161	HUMAN OTC DRUG	Carbo animalis		CARBO ANIMALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBO ANIMALIS	30	[hp_C]/30[hp_C]			N	20241231
0220-1163_09bee97d-a8e2-7c9c-e063-6294a90a0412	0220-1163	HUMAN OTC DRUG	Carbolicum acidum		PHENOL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHENOL	30	[hp_C]/30[hp_C]			N	20241231
0220-1164_09beda5a-60d9-4a10-e063-6394a90a843d	0220-1164	HUMAN OTC DRUG	Carbo animalis		CARBO ANIMALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBO ANIMALIS	200	[kp_C]/200[kp_C]			N	20241231
0220-1168_09bed6d1-db44-47c4-e063-6394a90a88bf	0220-1168	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	5	[hp_C]/5[hp_C]			N	20241231
0220-1169_f52bd3ad-b0f9-af03-e053-2995a90ac1e9	0220-1169	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	6	[hp_C]/6[hp_C]			N	20241231
0220-1172_09bed294-41bb-4800-e063-6394a90afef4	0220-1172	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	9	[hp_C]/9[hp_C]			N	20241231
0220-1173_ff095814-8c15-e307-e053-6394a90a19af	0220-1173	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	12	[hp_C]/12[hp_C]			N	20241231
0220-1176_09bed410-d359-6d67-e063-6294a90ac397	0220-1176	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	15	[hp_C]/15[hp_C]			N	20241231
0220-1177_f67d60dc-76fe-2e3d-e053-2a95a90ac3bf	0220-1177	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	30	[hp_C]/30[hp_C]			N	20241231
0220-1183_09bed294-41bc-4800-e063-6394a90afef4	0220-1183	HUMAN OTC DRUG	Carboneum sulphuratum		CARBON DISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBON DISULFIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-1184_f527a8c5-b05b-5f3c-e053-2995a90aa1a3	0220-1184	HUMAN OTC DRUG	Carboneum sulphuratum		CARBON DISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBON DISULFIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-1185_09bed294-41bd-4800-e063-6394a90afef4	0220-1185	HUMAN OTC DRUG	Carboneum sulphuratum		CARBON DISULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CARBON DISULFIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-1191_09bed294-41ca-4800-e063-6394a90afef4	0220-1191	HUMAN OTC DRUG	Carduus Marianus		MILK THISTLE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MILK THISTLE	6	[hp_X]/6[hp_X]			N	20241231
0220-1192_09bedd58-5c7e-44d9-e063-6394a90ab144	0220-1192	HUMAN OTC DRUG	Carduus marianus		MILK THISTLE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MILK THISTLE	6	[hp_C]/6[hp_C]			N	20241231
0220-1193_044cdf38-b8eb-1978-e063-6394a90a2fe3	0220-1193	HUMAN OTC DRUG	Carduus marianus		MILK THISTLE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MILK THISTLE	30	[hp_C]/30[hp_C]			N	20241231
0220-1196_f2b88a07-10fa-5b2a-e053-2a95a90a7aa0	0220-1196	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	200	[kp_C]/200[kp_C]			N	20241231
0220-1197_09bed294-41cd-4800-e063-6394a90afef4	0220-1197	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	1	[hp_M]/[hp_M]			N	20241231
0220-1200_09bed6d1-db45-47c4-e063-6394a90a88bf	0220-1200	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	12	[hp_X]/12[hp_X]			N	20241231
0220-1201_09bee97d-a8e7-7c9c-e063-6294a90a0412	0220-1201	HUMAN OTC DRUG	Carbo vegetabilis		ACTIVATED CHARCOAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL	30	[hp_X]/30[hp_X]			N	20241231
0220-1204_f5295d2d-53ce-a1ee-e053-2a95a90a39ce	0220-1204	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAULOPHYLLUM THALICTROIDES ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-1205_09befbae-e044-520f-e063-6394a90af02d	0220-1205	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAULOPHYLLUM THALICTROIDES ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-1208_0868de30-b3c0-c278-e063-6394a90a48c4	0220-1208	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAULOPHYLLUM THALICTROIDES ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-1209_f2b88588-8e8c-43f8-e053-2a95a90a0ba6	0220-1209	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAULOPHYLLUM THALICTROIDES ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-1212_044ce0f5-cb47-0111-e063-6394a90a46b8	0220-1212	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAULOPHYLLUM THALICTROIDES ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-1213_09bf01a1-7a2e-609d-e063-6394a90a6408	0220-1213	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAULOPHYLLUM THALICTROIDES ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-1216_f5279f5e-0fb7-1d94-e053-2995a90a2158	0220-1216	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	5	[hp_C]/5[hp_C]			N	20241231
0220-1217_f2b89744-78c6-8a19-e053-2a95a90ab8c8	0220-1217	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	6	[hp_C]/6[hp_C]			N	20241231
0220-1220_f529414c-36e9-5164-e053-2995a90acb80	0220-1220	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	9	[hp_C]/9[hp_C]			N	20241231
0220-1223_09bed597-d1b5-703d-e063-6294a90a629a	0220-1223	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAULOPHYLLUM THALICTROIDES ROOT	30	[hp_X]/1			N	20241231
0220-1224_f52c47eb-a096-75aa-e053-2a95a90a4f3b	0220-1224	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	12	[hp_C]/12[hp_C]			N	20241231
0220-1227_09bf01a1-7a31-609d-e063-6394a90a6408	0220-1227	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	6	[hp_X]/1			N	20241231
0220-1229_f913cd0d-603a-a95d-e053-6294a90af09a	0220-1229	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	15	[hp_C]/15[hp_C]			N	20241231
0220-1231_09bef660-9f66-48d2-e063-6394a90a2104	0220-1231	HUMAN PRESCRIPTION DRUG	Ceanothus americanus		CEANOTHUS AMERICANUS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CEANOTHUS AMERICANUS LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-1233_f2b88a07-10fb-5b2a-e053-2a95a90a7aa0	0220-1233	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	30	[hp_C]/30[hp_C]			N	20241231
0220-1235_f9117006-2be0-7570-e053-6394a90a9a4b	0220-1235	HUMAN OTC DRUG	Cedron		SIMABA CEDRON SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SIMABA CEDRON SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-1236_f706d0c3-08fa-8b36-e053-6294a90ab5b3	0220-1236	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	200	[kp_C]/200[kp_C]			N	20241231
0220-1237_f528f337-1058-6e60-e053-2a95a90a2b5c	0220-1237	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	1	[hp_M]/[hp_M]			N	20241231
0220-1239_09bf0d69-c1a9-62bb-e063-6394a90abb26	0220-1239	HUMAN OTC DRUG	Cenchris contortrix		AGKISTRODON CONTORTRIX VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AGKISTRODON CONTORTRIX VENOM	6	[hp_C]/6[hp_C]			N	20241231
0220-1240_09bf0d69-c1ac-62bb-e063-6394a90abb26	0220-1240	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	10	[hp_M]/10[hp_M]			N	20241231
0220-1241_09bee97d-a8ea-7c9c-e063-6294a90a0412	0220-1241	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAUSTICUM	30	[hp_X]/30[hp_X]			N	20241231
0220-1244_09bee97d-a8eb-7c9c-e063-6294a90a0412	0220-1244	HUMAN OTC DRUG	Cenchris contortrix		AGKISTRODON CONTORTRIX VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AGKISTRODON CONTORTRIX VENOM	30	[hp_C]/30[hp_C]			N	20241231
0220-1245_f2f62a15-1102-28ac-e053-2995a90a5b29	0220-1245	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	6	[hp_C]/6[hp_C]			N	20241231
0220-1248_09bf1e5f-95ff-9b3b-e063-6294a90a3d92	0220-1248	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	9	[hp_C]/9[hp_C]			N	20241231
0220-1249_f913c88b-91b8-2a5d-e053-6294a90a579b	0220-1249	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	12	[hp_C]/12[hp_C]			N	20241231
0220-1252_f9117281-c430-c08d-e053-6294a90af4eb	0220-1252	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	15	[hp_C]/15[hp_C]			N	20241231
0220-1253_f67d6a70-c0f0-05a9-e053-2a95a90a09fb	0220-1253	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	30	[hp_C]/30[hp_C]			N	20241231
0220-1256_f2f61f63-eea3-dc1f-e053-2995a90a5d7e	0220-1256	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	200	[kp_C]/200[kp_C]			N	20241231
0220-1257_f527adf2-793f-be8b-e053-2a95a90a8d64	0220-1257	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	1	[hp_M]/[hp_M]			N	20241231
0220-1260_0410b28b-341f-8f5e-e063-6394a90aa894	0220-1260	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	10	[hp_M]/10[hp_M]			N	20241231
0220-1261_09bf17cd-040f-6512-e063-6394a90aa494	0220-1261	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	12	[hp_X]/12[hp_X]			N	20241231
0220-1264_00ed4dd6-3abd-9207-e063-6294a90ae243	0220-1264	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA CHAMOMILLA	30	[hp_X]/30[hp_X]			N	20241231
0220-1267_09bf01a1-7a36-609d-e063-6394a90a6408	0220-1267	HUMAN OTC DRUG	Chamomilla		MATRICARIA RECUTITA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MATRICARIA RECUTITA	6	[hp_X]/1			N	20241231
0220-1269_09bf21f6-567b-6110-e063-6394a90a0f54	0220-1269	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	5	[hp_C]/5[hp_C]			N	20241231
0220-1270_f2f62a15-1103-28ac-e053-2995a90a5b29	0220-1270	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	6	[hp_C]/6[hp_C]			N	20241231
0220-1271_09befbae-e049-520f-e063-6394a90af02d	0220-1271	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	9	[hp_C]/9[hp_C]			N	20241231
0220-1272_fe043103-646e-4b0c-e053-6294a90adc05	0220-1272	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	12	[hp_C]/12[hp_C]			N	20241231
0220-1273_fbd430b6-cf56-6532-e053-6294a90ac608	0220-1273	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	30	[hp_C]/30[hp_C]			N	20241231
0220-1274_fd64badf-0787-7fb1-e053-6294a90a3ab4	0220-1274	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	200	[kp_C]/200[kp_C]			N	20241231
0220-1277_09bf2450-da9a-ab38-e063-6294a90ab744	0220-1277	HUMAN OTC DRUG	Cheiranthus cheiri		ERYSIMUM CHEIRI	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ERYSIMUM CHEIRI	9	[hp_C]/1			N	20241231
0220-1278_fd648f67-cc3d-e661-e053-6394a90ae255	0220-1278	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	1	[hp_M]/[hp_M]			N	20241231
0220-1281_09bf1419-e39e-6585-e063-6394a90ad627	0220-1281	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	4	[hp_X]/1			N	20241231
0220-1282_f227c611-37c0-0ef5-e053-2995a90a4b74	0220-1282	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	6	[hp_X]/6[hp_X]			N	20241231
0220-1283_09bf2450-da9b-ab38-e063-6294a90ab744	0220-1283	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHELIDONIUM MAJUS	30	[hp_X]/30[hp_X]			N	20241231
0220-1293_09befbae-e04a-520f-e063-6394a90af02d	0220-1293	HUMAN OTC DRUG	Chenopodium anthelminticum		DYSPHANIA AMBROSIOIDES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DYSPHANIA AMBROSIOIDES	9	[hp_C]/9[hp_C]			N	20241231
0220-1301_09bf2450-da9c-ab38-e063-6294a90ab744	0220-1301	HUMAN PRESCRIPTION DRUG	Chimaphila umbellata		CHIMAPHILA UMBELLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHIMAPHILA UMBELLATA	30	[hp_C]/30[hp_C]			N	20241231
0220-1306_09bf1e5f-9600-9b3b-e063-6294a90a3d92	0220-1306	HUMAN OTC DRUG	Chininum sulphuricum		QUININE SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE SULFATE	9	[hp_C]/9[hp_C]	Antimalarial [EPC]		N	20241231
0220-1307_09bf2b7b-4a92-66b6-e063-6394a90a847f	0220-1307	HUMAN OTC DRUG	Chininum sulphuricum		QUININE SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE SULFATE	12	[hp_C]/12[hp_C]	Antimalarial [EPC]		N	20241231
0220-1309_09bf1e5f-9601-9b3b-e063-6294a90a3d92	0220-1309	HUMAN OTC DRUG	Chininum arsenicosum		QUININE ARSENITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE ARSENITE	30	[hp_C]/30[hp_C]	Antimalarial [EPC]		N	20241231
0220-1310_09bf1e5f-9602-9b3b-e063-6294a90a3d92	0220-1310	HUMAN OTC DRUG	Chininum sulphuricum		QUININE SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE SULFATE	15	[hp_C]/15[hp_C]	Antimalarial [EPC]		N	20241231
0220-1311_fd64badf-0788-7fb1-e053-6294a90a3ab4	0220-1311	HUMAN OTC DRUG	Chininum sulphuricum		QUININE SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE SULFATE	30	[hp_C]/30[hp_C]	Antimalarial [EPC]		N	20241231
0220-1314_09bf01a1-7a37-609d-e063-6394a90a6408	0220-1314	HUMAN OTC DRUG	Chininum sulphuricum		QUININE SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE SULFATE	200	[kp_C]/200[kp_C]	Antimalarial [EPC]		N	20241231
0220-1321_0868b8dd-841b-d7c8-e063-6294a90a6ac1	0220-1321	HUMAN OTC DRUG	Chininum salicylicum		QUININE SALICYLATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE SALICYLATE	30	[hp_C]/30[hp_C]	Antimalarial [EPC]		N	20241231
0220-1325_09bf2450-da9d-ab38-e063-6294a90ab744	0220-1325	HUMAN OTC DRUG	Chininum sulphuricum		QUININE SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	QUININE SULFATE	6	[hp_C]/1	Antimalarial [EPC]		N	20241231
0220-1329_09bf1e5f-9603-9b3b-e063-6294a90a3d92	0220-1329	HUMAN OTC DRUG	Chionanthus virginica		CHIONANTHUS VIRGINICUS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHIONANTHUS VIRGINICUS BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-1333_09bf3adf-99f7-6e40-e063-6394a90a1f45	0220-1333	HUMAN OTC DRUG	Chlorinum		CHLORINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHLORINE	30	[hp_C]/30[hp_C]			N	20241231
0220-1334_09bf17cd-0413-6512-e063-6394a90aa494	0220-1334	HUMAN PRESCRIPTION DRUG	Cholesterinum		CHOLESTEROL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHOLESTEROL	9	[hp_C]/9[hp_C]			N	20241231
0220-1335_09bf2450-daa0-ab38-e063-6294a90ab744	0220-1335	HUMAN PRESCRIPTION DRUG	Cholesterinum		CHOLESTEROL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHOLESTEROL	30	[hp_C]/30[hp_C]			N	20241231
0220-1339_09bf0d69-c1b0-62bb-e063-6394a90abb26	0220-1339	HUMAN PRESCRIPTION DRUG	Cholesterinum		CHOLESTEROL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHOLESTEROL	200	[kp_C]/200[kp_C]			N	20241231
0220-1341_09bf17cd-0414-6512-e063-6394a90aa494	0220-1341	HUMAN PRESCRIPTION DRUG	Cholesterinum		CHOLESTEROL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHOLESTEROL	5	[hp_C]/5[hp_C]			N	20241231
0220-1346_09bf3adf-99f8-6e40-e063-6394a90a1f45	0220-1346	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	5	[hp_C]/5[hp_C]			N	20241231
0220-1347_f18790e8-c62f-33a0-e053-2995a90ae547	0220-1347	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	6	[hp_C]/6[hp_C]			N	20241231
0220-1351_f527d0ab-d166-37bc-e053-2995a90a8974	0220-1351	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	1	[hp_M]/[hp_M]			N	20241231
0220-1354_09bf1419-e3a2-6585-e063-6394a90ad627	0220-1354	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	9	[hp_C]/9[hp_C]			N	20241231
0220-1355_09bf0d69-c1b1-62bb-e063-6394a90abb26	0220-1355	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	12	[hp_C]/12[hp_C]			N	20241231
0220-1358_09bf1419-e3a3-6585-e063-6394a90ad627	0220-1358	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	15	[hp_C]/15[hp_C]			N	20241231
0220-1359_00efd7eb-9e04-7fbe-e063-6294a90affe6	0220-1359	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	30	[hp_C]/30[hp_C]			N	20241231
0220-1362_f529ff66-f772-71a3-e053-2a95a90a776b	0220-1362	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	200	[kp_C]/200[kp_C]			N	20241231
0220-1363_09bf2450-daa1-ab38-e063-6294a90ab744	0220-1363	HUMAN OTC DRUG	Cimifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	1	[hp_M]/[hp_M]			N	20241231
0220-1367_09bf2b7b-4a93-66b6-e063-6394a90a847f	0220-1367	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-1370_09bf4eb3-4cbe-73e2-e063-6394a90ab924	0220-1370	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-1371_09bf1419-e3a4-6585-e063-6394a90ad627	0220-1371	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-1374_f2f61f63-eea4-dc1f-e053-2995a90a5d7e	0220-1374	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-1375_f7face7b-7232-5102-e053-6294a90affdd	0220-1375	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	200	[kp_C]/200[kp_C]			N	20241231
0220-1377_09bf515c-0c75-73d7-e063-6394a90ae47e	0220-1377	HUMAN OTC DRUG	Cicuta virosa		CICUTA VIROSA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CICUTA VIROSA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-1378_f7e5f3ae-ec5f-8857-e053-6294a90a91cd	0220-1378	HUMAN OTC DRUG	Cicuta virosa		CICUTA VIROSA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CICUTA VIROSA ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-1379_09bf2450-daa2-ab38-e063-6294a90ab744	0220-1379	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	15	[hp_C]/15[hp_C]			N	20241231
0220-1382_09bf3adf-99fa-6e40-e063-6394a90a1f45	0220-1382	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	5	[hp_C]/5[hp_C]			N	20241231
0220-1383_f2f632f1-0773-47d0-e053-2995a90a8d99	0220-1383	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	6	[hp_C]/6[hp_C]			N	20241231
0220-1385_f913e707-97ec-ac7c-e053-6394a90a4853	0220-1385	HUMAN OTC DRUG	Cimicifuga racemosa		BLACK COHOSH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK COHOSH	30	[hp_X]/1			N	20241231
0220-1386_09bf2450-daa3-ab38-e063-6294a90ab744	0220-1386	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	9	[hp_C]/9[hp_C]			N	20241231
0220-1389_09bf515c-0c76-73d7-e063-6394a90ae47e	0220-1389	HUMAN OTC DRUG	Cina		ARTEMISIA CINA PRE-FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARTEMISIA CINA PRE-FLOWERING TOP	30	[hp_X]/1			N	20241231
0220-1390_09bf5a88-3f3c-7a35-e063-6394a90a46b1	0220-1390	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	12	[hp_C]/12[hp_C]			N	20241231
0220-1393_09bf4eb3-4cbf-73e2-e063-6394a90ab924	0220-1393	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	6	[hp_X]/1			N	20241231
0220-1395_09bf2b7b-4a94-66b6-e063-6394a90a847f	0220-1395	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	15	[hp_C]/15[hp_C]			N	20241231
0220-1396_fd13b56e-c06c-8a59-e053-6294a90a82a3	0220-1396	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-1399_09bf515c-0c79-73d7-e063-6394a90ae47e	0220-1399	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	200	[kp_C]/200[kp_C]			N	20241231
0220-1400_0410c7a2-bb7d-aafd-e063-6394a90a92a5	0220-1400	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	1	[hp_M]/[hp_M]			N	20241231
0220-1402_09bf5f49-ae50-c6c2-e063-6294a90abe3f	0220-1402	HUMAN OTC DRUG	Cineraria maritima		JACOBAEA MARITIMA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JACOBAEA MARITIMA	30	[hp_C]/30[hp_C]			N	20241231
0220-1403_09bf3adf-99fb-6e40-e063-6394a90a1f45	0220-1403	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	10	[hp_M]/10[hp_M]			N	20241231
0220-1404_09bf4eb3-4cc2-73e2-e063-6394a90ab924	0220-1404	HUMAN OTC DRUG	Cinchona officinalis		CINCHONA OFFICINALIS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINCHONA OFFICINALIS BARK	30	[hp_X]/30[hp_X]			N	20241231
0220-1406_09bf3adf-99fc-6e40-e063-6394a90a1f45	0220-1406	HUMAN OTC DRUG	Cinnamomum		CINNAMON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CINNAMON	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0220-1411_09bf515c-0c7a-73d7-e063-6394a90ae47e	0220-1411	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	5	[hp_C]/5[hp_C]			N	20241231
0220-1412_f2f624a3-f271-4f82-e053-2a95a90a89e9	0220-1412	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-1415_09bf3adf-99fd-6e40-e063-6394a90a1f45	0220-1415	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	7	[hp_C]/7[hp_C]			N	20241231
0220-1416_f527cbc9-7dca-15c6-e053-2995a90a4d82	0220-1416	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	9	[hp_C]/9[hp_C]			N	20241231
0220-1419_09bf5f49-ae54-c6c2-e063-6294a90abe3f	0220-1419	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	12	[hp_C]/12[hp_C]			N	20241231
0220-1420_09bf56c4-6112-7aa8-e063-6394a90ad44b	0220-1420	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	15	[hp_C]/15[hp_C]			N	20241231
0220-1423_f2f632f1-0774-47d0-e053-2995a90a8d99	0220-1423	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-1424_f2f62a15-1104-28ac-e053-2995a90a5b29	0220-1424	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	200	[kp_C]/200[kp_C]			N	20241231
0220-1427_f2b8b3f7-3767-ea86-e053-2995a90a946f	0220-1427	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1430_09bf5f49-ae55-c6c2-e063-6294a90abe3f	0220-1430	HUMAN PRESCRIPTION DRUG	Clematis erecta		CLEMATIS RECTA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLEMATIS RECTA FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-1431_09bf4eb3-4cc4-73e2-e063-6394a90ab924	0220-1431	HUMAN PRESCRIPTION DRUG	Clematis erecta		CLEMATIS RECTA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLEMATIS RECTA FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-1432_f6003033-dd83-0c03-e053-2995a90a1da7	0220-1432	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1435_00edbc64-9d35-5751-e063-6294a90a400b	0220-1435	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	6	[hp_X]/6[hp_X]			N	20241231
0220-1436_00f160e6-b4bf-2bc6-e063-6294a90a35b4	0220-1436	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	30	[hp_X]/30[hp_X]			N	20241231
0220-1439_09bf4eb3-4cc5-73e2-e063-6394a90ab924	0220-1439	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1440_f70744a9-6d8a-4143-e053-6294a90a7b05	0220-1440	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1442_09bf7027-eae2-793f-e063-6394a90a01d6	0220-1442	HUMAN OTC DRUG	Cobaltum metallicum		COBALT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COBALT	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-1444_fd64e438-d65a-c531-e053-6294a90a703c	0220-1444	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1447_f2f622d4-8f01-db6a-e053-2995a90aba8d	0220-1447	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1448_04111956-ec99-62a1-e063-6294a90af2fd	0220-1448	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1451_f527a8c5-b05d-5f3c-e053-2995a90aa1a3	0220-1451	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	10	[hp_M]/10[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1452_00edb97e-614f-1534-e063-6294a90ab766	0220-1452	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	30	[hp_X]/30[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1455_09bf7129-d1ea-d446-e063-6294a90a2c2c	0220-1455	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	9	[hp_C]/9[hp_C]			N	20241231
0220-1458_09bf3adf-9a00-6e40-e063-6394a90a1f45	0220-1458	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED	4	[hp_X]/1			N	20241231
0220-1461_09bf4eb3-4cc6-73e2-e063-6394a90ab924	0220-1461	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	12	[hp_C]/12[hp_C]			N	20241231
0220-1463_09bf7129-d1eb-d446-e063-6294a90a2c2c	0220-1463	HUMAN OTC DRUG	Coccus cacti		PROTORTONIA CACTI	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PROTORTONIA CACTI	9	[hp_C]/9[hp_C]			N	20241231
0220-1464_f527d0ab-d167-37bc-e053-2995a90a8974	0220-1464	HUMAN OTC DRUG	Coccus cacti		PROTORTONIA CACTI	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PROTORTONIA CACTI	30	[hp_C]/30[hp_C]			N	20241231
0220-1465_09bf56c4-6115-7aa8-e063-6394a90ad44b	0220-1465	HUMAN OTC DRUG	Coccus cacti		PROTORTONIA CACTI	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PROTORTONIA CACTI	200	[kp_C]/200[kp_C]			N	20241231
0220-1468_09bf7027-eae3-793f-e063-6394a90a01d6	0220-1468	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	15	[hp_C]/15[hp_C]			N	20241231
0220-1469_fd66e822-f1fd-789d-e053-6294a90a960e	0220-1469	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	30	[hp_C]/30[hp_C]			N	20241231
0220-1472_f52bfcc5-b582-d229-e053-2995a90a1b56	0220-1472	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	200	[kp_C]/200[kp_C]			N	20241231
0220-1473_09bf788b-e4ce-86f8-e063-6394a90a6dd1	0220-1473	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	1	[hp_M]/[hp_M]			N	20241231
0220-1475_f527cbc9-7dc9-15c6-e053-2995a90a4d82	0220-1475	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARABICA COFFEE BEAN	6	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-1480_09bf56c4-6116-7aa8-e063-6394a90ad44b	0220-1480	HUMAN OTC DRUG	Coffea tosta		COFFEA ARABICA SEED, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COFFEA ARABICA SEED, ROASTED	9	[hp_C]/9[hp_C]			N	20241231
0220-1481_09bf7b4c-82cf-8777-e063-6394a90aa3f1	0220-1481	HUMAN OTC DRUG	Coffea tosta		COFFEA ARABICA SEED, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COFFEA ARABICA SEED, ROASTED	30	[hp_C]/30[hp_C]			N	20241231
0220-1482_09bf5f49-ae57-c6c2-e063-6294a90abe3f	0220-1482	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	10	[hp_M]/10[hp_M]			N	20241231
0220-1485_f6001d44-e57b-9267-e053-2a95a90aace2	0220-1485	HUMAN OTC DRUG	Collinsonia canadensis		COLLINSONIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLLINSONIA CANADENSIS ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-1488_09bf7d75-797f-85e0-e063-6394a90a0b43	0220-1488	HUMAN OTC DRUG	Colchicum autumnale		COLCHICUM AUTUMNALE BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLCHICUM AUTUMNALE BULB	6	[hp_C]/1			N	20241231
0220-1489_0a0c373a-4960-0591-e063-6294a90a8983	0220-1489	HUMAN OTC DRUG	Collinsonia canadensis		COLLINSONIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLLINSONIA CANADENSIS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-1492_0a0c4a4a-8537-98fc-e063-6394a90abef2	0220-1492	HUMAN OTC DRUG	Collinsonia canadensis		COLLINSONIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COLLINSONIA CANADENSIS ROOT	8	[hp_X]/8[hp_X]			N	20241231
0220-1496_0a0c4723-2ff9-0c05-e063-6294a90ac904	0220-1496	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	6	[hp_X]/1			N	20241231
0220-1498_0a0c4b92-d588-043f-e063-6294a90a8230	0220-1498	HUMAN OTC DRUG	Colcynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	5	[hp_C]/5[hp_C]			N	20241231
0220-1499_f2b8adcb-4cf2-daa1-e053-2995a90ae4c4	0220-1499	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	6	[hp_C]/6[hp_C]			N	20241231
0220-1502_0a0c4f2c-3f3d-9e22-e063-6394a90a3a27	0220-1502	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	9	[hp_C]/9[hp_C]			N	20241231
0220-1503_0a0c4f2c-3f3e-9e22-e063-6394a90a3a27	0220-1503	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	12	[hp_C]/12[hp_C]			N	20241231
0220-1506_f6002118-551f-9991-e053-2995a90a84be	0220-1506	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	15	[hp_C]/15[hp_C]			N	20241231
0220-1507_f2b86b77-a059-9cf1-e053-2a95a90a099a	0220-1507	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	30	[hp_C]/30[hp_C]			N	20241231
0220-1510_f67c5f8c-f9b7-6e92-e053-2995a90a0152	0220-1510	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	200	[kp_C]/200[kp_C]			N	20241231
0220-1513_f6002c71-2a52-b17b-e053-2995a90a0576	0220-1513	HUMAN OTC DRUG	Condurango		MARSDENIA CONDURANGO BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MARSDENIA CONDURANGO BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-1514_0a0c48f9-6f90-99a3-e063-6394a90a139c	0220-1514	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	1	[hp_M]/[hp_M]			N	20241231
0220-1515_04112095-edd2-75e4-e063-6294a90a5b0d	0220-1515	HUMAN OTC DRUG	Colocynthis		CITRULLUS COLOCYNTHIS FRUIT PULP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITRULLUS COLOCYNTHIS FRUIT PULP	10	[hp_M]/10[hp_M]			N	20241231
0220-1518_f187b4b5-0252-ce65-e053-2995a90aa344	0220-1518	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	3	[hp_C]/3[hp_C]			N	20241231
0220-1519_f2b8adcb-4d64-daa1-e053-2995a90ae4c4	0220-1519	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-1522_0a0c442b-38a6-8c00-e063-6394a90a47f2	0220-1522	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-1525_003bf2a1-9577-c4e8-e063-6294a90a692f	0220-1525	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	6	[hp_X]/1			N	20241231
0220-1526_0a0c4723-2ffc-0c05-e063-6294a90ac904	0220-1526	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-1527_f9117302-74aa-6131-e053-6394a90a36ce	0220-1527	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	15	[hp_C]/15[hp_C]			N	20241231
0220-1530_fbd44766-6da0-6da0-e053-6394a90ad309	0220-1530	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-1531_fd67bacb-1aac-61da-e053-6394a90afa4f	0220-1531	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	200	[kp_C]/200[kp_C]			N	20241231
0220-1534_0a0c2db2-7ef3-909c-e063-6394a90a7a90	0220-1534	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	1	[hp_M]/[hp_M]			N	20241231
0220-1535_0a0c4f2c-3f4c-9e22-e063-6394a90a3a27	0220-1535	HUMAN OTC DRUG	Conium maculatum		CONIUM MACULATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CONIUM MACULATUM FLOWERING TOP	10	[hp_M]/10[hp_M]			N	20241231
0220-1541_0a0c373a-4961-0591-e063-6294a90a8983	0220-1541	HUMAN OTC DRUG	Corallium rubrum		CORALLIUM RUBRUM EXOSKELETON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CORALLIUM RUBRUM EXOSKELETON	5	[hp_C]/5[hp_C]			N	20241231
0220-1550_0a0c482e-b19b-9bf6-e063-6394a90a70cf	0220-1550	HUMAN OTC DRUG	Cortisone aceticum		CORTISONE ACETATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CORTISONE ACETATE	12	[hp_C]/12[hp_C]	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0220-1553_0a0c4723-2ffd-0c05-e063-6294a90ac904	0220-1553	HUMAN OTC DRUG	Cortisone aceticum		CORTISONE ACETATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CORTISONE ACETATE	6	[hp_C]/6[hp_C]	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0220-1554_f9117302-74ab-6131-e053-6394a90a36ce	0220-1554	HUMAN OTC DRUG	Cortisone aceticum		CORTISONE ACETATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CORTISONE ACETATE	30	[hp_C]/30[hp_C]	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0220-1569_0a0c4a4a-8538-98fc-e063-6394a90abef2	0220-1569	HUMAN OTC DRUG	Crocus sativus		SAFFRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAFFRON	30	[hp_C]/30[hp_C]			N	20241231
0220-1573_0a0c5b6f-e354-a085-e063-6394a90af1fc	0220-1573	HUMAN PRESCRIPTION DRUG	Crotalus cascavella		CROTALUS DURISSUS TERRIFICUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CROTALUS DURISSUS TERRIFICUS VENOM	30	[hp_C]/30[hp_C]			N	20241231
0220-1574_0a0c48f9-6f94-99a3-e063-6394a90a139c	0220-1574	HUMAN OTC DRUG	Croton tiglium		CROTON TIGLIUM SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CROTON TIGLIUM SEED	9	[hp_C]/9[hp_C]			N	20241231
0220-1575_0a0c4a4a-8539-98fc-e063-6394a90abef2	0220-1575	HUMAN OTC DRUG	Croton tiglium		CROTON TIGLIUM SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CROTON TIGLIUM SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-1577_0a0c52da-c498-805b-e063-6394a90aaa78	0220-1577	HUMAN PRESCRIPTION DRUG	Crotalus horridus		CROTALUS HORRIDUS HORRIDUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CROTALUS HORRIDUS HORRIDUS VENOM	6	[hp_C]/6[hp_C]			N	20241231
0220-1578_0a0c4b92-d589-043f-e063-6294a90a8230	0220-1578	HUMAN PRESCRIPTION DRUG	Crotalus horridus		CROTALUS HORRIDUS HORRIDUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CROTALUS HORRIDUS HORRIDUS VENOM	30	[hp_C]/30[hp_C]			N	20241231
0220-1579_0a0c52da-c499-805b-e063-6394a90aaa78	0220-1579	HUMAN PRESCRIPTION DRUG	Crotalus horridus		CROTALUS HORRIDUS HORRIDUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CROTALUS HORRIDUS HORRIDUS VENOM	200	[kp_C]/200[kp_C]			N	20241231
0220-1581_0a0c48f9-6f96-99a3-e063-6394a90a139c	0220-1581	HUMAN OTC DRUG	Croton tiglium		CROTON TIGLIUM SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CROTON TIGLIUM SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-1601_0a0c4f2c-3f4d-9e22-e063-6394a90a3a27	0220-1601	HUMAN OTC DRUG	Cuprum aceticum		CUPRIC ACETATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CUPRIC ACETATE	30	[hp_C]/30[hp_C]			N	20241231
0220-1605_0a0c4723-3001-0c05-e063-6294a90ac904	0220-1605	HUMAN OTC DRUG	Cuprum arsenicosum		CUPRIC ARSENITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CUPRIC ARSENITE	9	[hp_C]/9[hp_C]			N	20241231
0220-1607_0a0c5f21-f058-08da-e063-6294a90a44c1	0220-1607	HUMAN OTC DRUG	Cuprum arsenicosum		CUPRIC ARSENITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CUPRIC ARSENITE	30	[hp_C]/30[hp_C]			N	20241231
0220-1613_0a0c482e-b1a0-9bf6-e063-6394a90a70cf	0220-1613	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	8	[hp_X]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1616_0a0c732a-320a-a40c-e063-6394a90aa6a2	0220-1616	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	5	[hp_C]/5[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1623_f2b8c165-7276-1977-e053-2a95a90a27ad	0220-1623	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	6	[hp_C]/6[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1624_0a0c7444-3a7d-a6ce-e063-6394a90a0422	0220-1624	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	7	[hp_C]/7[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1626_0039d56d-2aca-7a09-e063-6294a90a59a3	0220-1626	HUMAN OTC DRUG	Cuprum oxydatum nigrum		CUPRIC OXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CUPRIC OXIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-1627_0a0c5f21-f059-08da-e063-6294a90a44c1	0220-1627	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	9	[hp_C]/9[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1628_0a0c4f2c-3f4f-9e22-e063-6394a90a3a27	0220-1628	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	12	[hp_C]/12[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1631_0bf3b4b5-b5e1-4e22-e063-6394a90a56e7	0220-1631	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	15	[hp_C]/15[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1634_0a0c732a-320f-a40c-e063-6394a90aa6a2	0220-1634	HUMAN OTC DRUG	Curare		TUBOCURARINE CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBOCURARINE CHLORIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-1635_f2b8b894-d888-c4ee-e053-2995a90a0c0b	0220-1635	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	30	[hp_C]/30[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1636_f228fd4a-e34c-56df-e053-2a95a90a65d6	0220-1636	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	200	[kp_C]/200[kp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1638_0a0c732a-3211-a40c-e063-6394a90aa6a2	0220-1638	HUMAN OTC DRUG	Cyclamen europaeum		CYCLAMEN PURPURASCENS TUBER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CYCLAMEN PURPURASCENS TUBER	5	[hp_C]/5[hp_C]			N	20241231
0220-1639_0a0c8b71-52bc-4a19-e063-6294a90a7a59	0220-1639	HUMAN OTC DRUG	Cyclamen europaeum		CYCLAMEN PURPURASCENS TUBER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CYCLAMEN PURPURASCENS TUBER	6	[hp_C]/6[hp_C]			N	20241231
0220-1640_0a0c7b29-2202-3d6b-e063-6294a90a86d2	0220-1640	HUMAN OTC DRUG	Cyclamen europaeum		CYCLAMEN PURPURASCENS TUBER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CYCLAMEN PURPURASCENS TUBER	9	[hp_C]/9[hp_C]			N	20241231
0220-1643_0a0c7b29-2203-3d6b-e063-6294a90a86d2	0220-1643	HUMAN OTC DRUG	Cyclamen europaeum		CYCLAMEN PURPURASCENS TUBER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CYCLAMEN PURPURASCENS TUBER	15	[hp_C]/15[hp_C]			N	20241231
0220-1644_0a0c7444-3a82-a6ce-e063-6394a90a0422	0220-1644	HUMAN OTC DRUG	Cyclamen europaeum		CYCLAMEN PURPURASCENS TUBER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CYCLAMEN PURPURASCENS TUBER	30	[hp_C]/30[hp_C]			N	20241231
0220-1648_0a0c91f9-28af-3d6d-e063-6294a90aec12	0220-1648	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	1	[hp_M]/[hp_M]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1651_0a0c8b9e-1181-adab-e063-6394a90a94cd	0220-1651	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	10	[hp_M]/10[hp_M]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1652_0a0c7444-3a83-a6ce-e063-6394a90a0422	0220-1652	HUMAN OTC DRUG	Cuprum metallicum		COPPER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COPPER	30	[hp_X]/30[hp_X]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-1756_0a0c7949-ae92-a51a-e063-6394a90a8a56	0220-1756	HUMAN PRESCRIPTION DRUG	Digitalis purpurea		DIGITALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIGITALIS	6	[hp_C]/6[hp_C]			N	20241231
0220-1757_0a0c91f9-28b0-3d6d-e063-6294a90aec12	0220-1757	HUMAN PRESCRIPTION DRUG	Digitalis purpurea		DIGITALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIGITALIS	30	[hp_C]/30[hp_C]			N	20241231
0220-1761_f2f3b480-803e-331c-e053-2a95a90a745b	0220-1761	HUMAN PRESCRIPTION DRUG	Digitalis purpurea		DIGITALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIGITALIS	200	[kp_C]/200[kp_C]			N	20241231
0220-1764_0a0c7949-ae93-a51a-e063-6394a90a8a56	0220-1764	HUMAN PRESCRIPTION DRUG	Digitalis purpurea		DIGITALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIGITALIS	1	[hp_M]/[hp_M]			N	20241231
0220-1767_0a0c9b00-4174-3584-e063-6294a90ae21c	0220-1767	HUMAN PRESCRIPTION DRUG	Digitalis purpurea		DIGITALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIGITALIS PURPUREA WHOLE	6	[hp_X]/6[hp_X]			N	20241231
0220-1772_f529041d-4867-7a38-e053-2a95a90a48ca	0220-1772	HUMAN OTC DRUG	Dolichos pruriens		MUCUNA PRURIENS FRUIT TRICHOME	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MUCUNA PRURIENS FRUIT TRICHOME	30	[hp_C]/30[hp_C]			N	20241231
0220-1773_0a0c7444-3a86-a6ce-e063-6394a90a0422	0220-1773	HUMAN OTC DRUG	Dioscorea villosa		DIOSCOREA VILLOSA TUBER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIOSCOREA VILLOSA TUBER	30	[hp_C]/30[hp_C]			N	20241231
0220-1775_0a0c9e7f-6ddc-b628-e063-6394a90a5916	0220-1775	HUMAN OTC DRUG	Dioscorea villosa		DIOSCOREA VILLOSA TUBER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIOSCOREA VILLOSA TUBER	9	[hp_C]/9[hp_C]			N	20241231
0220-1776_f527b77a-f715-bcc8-e053-2a95a90ab9d3	0220-1776	HUMAN OTC DRUG	Dolichos pruriens		MUCUNA PRURIENS FRUIT TRICHOME	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MUCUNA PRURIENS FRUIT TRICHOME	6	[hp_C]/6[hp_C]			N	20241231
0220-1777_0a0c8b9e-1182-adab-e063-6394a90a94cd	0220-1777	HUMAN OTC DRUG	Dolichos pruriens		MUCUNA PRURIENS FRUIT TRICHOME	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MUCUNA PRURIENS FRUIT TRICHOME	9	[hp_C]/9[hp_C]			N	20241231
0220-1783_0a0c8b9e-1183-adab-e063-6394a90a94cd	0220-1783	HUMAN OTC DRUG	Dolichos pruriens		MUCUNA PRURIENS FRUIT TRICHOME	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MUCUNA PRURIENS FRUIT TRICHOME	5	[hp_C]/5[hp_C]			N	20241231
0220-1784_0a0c7b29-2207-3d6b-e063-6294a90a86d2	0220-1784	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	5	[hp_C]/5[hp_C]			N	20241231
0220-1785_0a0c9e7f-6ddd-b628-e063-6394a90a5916	0220-1785	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	6	[hp_C]/6[hp_C]			N	20241231
0220-1788_f52bbfe3-c870-9cea-e053-2a95a90af124	0220-1788	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	9	[hp_C]/9[hp_C]			N	20241231
0220-1791_0a0c9b00-4178-3584-e063-6294a90ae21c	0220-1791	HUMAN OTC DRUG	Drosera rotundifolia		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	6	[hp_X]/1			N	20241231
0220-1792_0a0ca58e-c4fb-ab5b-e063-6394a90ab630	0220-1792	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	12	[hp_C]/12[hp_C]			N	20241231
0220-1793_0a0c91f9-28b1-3d6d-e063-6294a90aec12	0220-1793	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	15	[hp_C]/15[hp_C]			N	20241231
0220-1796_f2b8c004-abc7-015b-e053-2a95a90a40e8	0220-1796	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	30	[hp_C]/30[hp_C]			N	20241231
0220-1797_0a0c91f9-28b2-3d6d-e063-6294a90aec12	0220-1797	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	200	[kp_C]/200[kp_C]			N	20241231
0220-1799_00ee2920-5846-ccbf-e063-6394a90aa6d6	0220-1799	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	6	[hp_X]/1			N	20241231
0220-1800_fbd151be-772f-e46c-e053-6394a90a4c3f	0220-1800	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	1	[hp_M]/[hp_M]			N	20241231
0220-1801_0a0c8b9e-1184-adab-e063-6394a90a94cd	0220-1801	HUMAN OTC DRUG	Drosera		DROSERA ROTUNDIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DROSERA ROTUNDIFOLIA	30	[hp_X]/30[hp_X]			N	20241231
0220-1803_0a0c9e7f-6dde-b628-e063-6394a90a5916	0220-1803	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	5	[hp_C]/5[hp_C]			N	20241231
0220-1804_f52c3790-90c4-be94-e053-2995a90aecdb	0220-1804	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-1805_0a0cabf1-aac5-6492-e063-6294a90a8464	0220-1805	HUMAN PRESCRIPTION DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-1806_f187b82e-e32e-d676-e053-2995a90a98e7	0220-1806	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-1807_0868de30-b3c3-c278-e063-6394a90a48c4	0220-1807	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	15	[hp_C]/15[hp_C]			N	20241231
0220-1808_f52b8ce0-aac5-2b6e-e053-2a95a90a2c5b	0220-1808	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-1809_f2b8c165-7277-1977-e053-2a95a90a27ad	0220-1809	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	200	[kp_C]/200[kp_C]			N	20241231
0220-1810_0410b28b-3422-8f5e-e063-6394a90aa894	0220-1810	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	1	[hp_M]/[hp_M]			N	20241231
0220-1811_0a0c9b00-417a-3584-e063-6294a90ae21c	0220-1811	HUMAN OTC DRUG	Dulcamara		SOLANUM DULCAMARA TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLANUM DULCAMARA TOP	30	[hp_X]/30[hp_X]			N	20241231
0220-1841_0a0ca58e-c4fc-ab5b-e063-6394a90ab630	0220-1841	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	6	[hp_C]/6[hp_C]			N	20241231
0220-1842_0a0cb0c4-e49e-b60e-e063-6394a90a1377	0220-1842	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	9	[hp_C]/9[hp_C]			N	20241231
0220-1843_0a0cb0c4-e49f-b60e-e063-6394a90a1377	0220-1843	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	12	[hp_C]/12[hp_C]			N	20241231
0220-1844_0a0ca58e-c4fd-ab5b-e063-6394a90ab630	0220-1844	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	30	[hp_C]/30[hp_C]			N	20241231
0220-1845_0a0cb0c4-e4a1-b60e-e063-6394a90a1377	0220-1845	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	200	[kp_C]/200[kp_C]			N	20241231
0220-1846_0a0cbae3-25c9-6d47-e063-6294a90a0431	0220-1846	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	1	[hp_M]/[hp_M]			N	20241231
0220-1847_0a0cabf1-aac8-6492-e063-6294a90a8464	0220-1847	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	6	[hp_X]/6[hp_X]			N	20241231
0220-1852_0a0ca58e-c4fe-ab5b-e063-6394a90ab630	0220-1852	HUMAN OTC DRUG	Echinacea angustifolia		ECHINACEA ANGUSTIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA	4	[hp_X]/1			N	20241231
0220-1856_0a0cbae3-25cb-6d47-e063-6294a90a0431	0220-1856	HUMAN OTC DRUG	Echinacea purpurea		ECHINACEA PURPUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA PURPUREA	30	[hp_C]/30[hp_C]			N	20241231
0220-1885_0a0cc828-8ad4-c06c-e063-6394a90a784e	0220-1885	HUMAN OTC DRUG	Equisetum hyemale		EQUISETUM HYEMALE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EQUISETUM HYEMALE	9	[hp_C]/9[hp_C]			N	20241231
0220-1886_f2f63de3-8175-614b-e053-2995a90a8f0f	0220-1886	HUMAN OTC DRUG	Equisetum hyemale		EQUISETUM HYEMALE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EQUISETUM HYEMALE	30	[hp_C]/30[hp_C]			N	20241231
0220-1889_0a0cc828-8ad5-c06c-e063-6394a90a784e	0220-1889	HUMAN OTC DRUG	Equisetum hyemale		EQUISETUM HYEMALE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EQUISETUM HYEMALE	5	[hp_C]/5[hp_C]			N	20241231
0220-1890_0a0cca60-17d1-b93d-e063-6394a90a0731	0220-1890	HUMAN OTC DRUG	Equisetum hyemale		EQUISETUM HYEMALE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EQUISETUM HYEMALE	6	[hp_C]/6[hp_C]			N	20241231
0220-1892_0868c03c-702a-738d-e063-6394a90a9933	0220-1892	HUMAN OTC DRUG	Equisetum arvense		EQUISETUM ARVENSE TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EQUISETUM ARVENSE TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-1893_0a0cbae3-25cc-6d47-e063-6294a90a0431	0220-1893	HUMAN OTC DRUG	Equisetum arvense		EQUISETUM ARVENSE TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EQUISETUM ARVENSE TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-1896_0a0c9e7f-6de2-b628-e063-6394a90a5916	0220-1896	HUMAN OTC DRUG	Equisetum hyemale		EQUISETUM HYEMALE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EQUISETUM HYEMALE	6	[hp_X]/6[hp_X]			N	20241231
0220-1900_0a0ca635-b306-af0f-e063-6394a90aafa1	0220-1900	HUMAN OTC DRUG	Erigeron canadensis		ERIGERON CANADENSIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ERIGERON CANADENSIS	30	[hp_C]/30[hp_C]			N	20241231
0220-1940_0a0af344-a8f6-0fb4-e063-6394a90acbf0	0220-1940	HUMAN OTC DRUG	Eucalyptus globulus		EUCALYPTUS GLOBULUS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUCALYPTUS GLOBULUS LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-1941_0a0cb0c4-e4a2-b60e-e063-6394a90a1377	0220-1941	HUMAN OTC DRUG	Eugenia jambosa		SYZYGIUM JAMBOS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYZYGIUM JAMBOS SEED	9	[hp_C]/9[hp_C]			N	20241231
0220-1942_0a0cd0a0-f2c2-c28b-e063-6394a90ac393	0220-1942	HUMAN OTC DRUG	Eugenia jambosa		SYZYGIUM JAMBOS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYZYGIUM JAMBOS SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-1945_0a0cbae3-25cd-6d47-e063-6294a90a0431	0220-1945	HUMAN OTC DRUG	Eugenia jambosa		SYZYGIUM JAMBOS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYZYGIUM JAMBOS SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-1948_0a0cd0a0-f2c3-c28b-e063-6394a90ac393	0220-1948	HUMAN OTC DRUG	Eugenia jambosa		SYZYGIUM JAMBOS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYZYGIUM JAMBOS SEED	5	[hp_C]/5[hp_C]			N	20241231
0220-1949_f2f63f6f-bf2a-d47c-e053-2a95a90abf5b	0220-1949	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-1950_0a0cd0a0-f2c4-c28b-e063-6394a90ac393	0220-1950	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-1953_0a0cca60-17d2-b93d-e063-6394a90a0731	0220-1953	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-1954_0a0cdff5-275e-8938-e063-6294a90ad4fb	0220-1954	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-1957_0a0cd0a0-f2c6-c28b-e063-6394a90ac393	0220-1957	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	6	[hp_X]/6[hp_X]			N	20241231
0220-1960_0a0cdff5-275f-8938-e063-6294a90ad4fb	0220-1960	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	200	[kp_C]/200[kp_C]			N	20241231
0220-1961_f7071dcd-7a5d-4062-e053-6394a90aad1d	0220-1961	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	1	[hp_M]/[hp_M]			N	20241231
0220-1967_0a0cabf1-aaca-6492-e063-6294a90a8464	0220-1967	HUMAN OTC DRUG	Eupatorium perfoliatum		EUPATORIUM PERFOLIATUM FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPATORIUM PERFOLIATUM FLOWERING TOP	4	[hp_X]/1			N	20241231
0220-1988_ff08d268-e3a7-8405-e053-6394a90a34bd	0220-1988	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	6	[hp_X]/1			N	20241231
0220-1989_f2135bd3-bc99-df80-e053-2995a90a66eb	0220-1989	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	6	[hp_C]/6[hp_C]			N	20241231
0220-1990_0868db47-f901-f92b-e063-6394a90a61f5	0220-1990	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	9	[hp_C]/9[hp_C]			N	20241231
0220-1994_f187bdef-88fc-f34d-e053-2995a90a095f	0220-1994	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	12	[hp_C]/12[hp_C]			N	20241231
0220-1995_f67ccd86-24c7-4663-e053-2a95a90acec2	0220-1995	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	30	[hp_C]/30[hp_C]			N	20241231
0220-1996_003aa46c-a15d-8c9e-e063-6294a90a4931	0220-1996	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	200	[kp_C]/200[kp_C]			N	20241231
0220-1997_0410c7a2-bb7e-aafd-e063-6394a90a92a5	0220-1997	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	1	[hp_M]/[hp_M]			N	20241231
0220-1998_f600a007-6e12-d39a-e053-2a95a90a178a	0220-1998	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	EUPHRASIA STRICTA	30	[hp_X]/30[hp_X]			N	20241231
0220-2045_0868de30-b3b6-c278-e063-6394a90a48c4	0220-2045	HUMAN OTC DRUG	Fagopyrum esculentum		FAGOPYRUM ESCULENTUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FAGOPYRUM ESCULENTUM	30	[hp_C]/30[hp_C]			N	20241231
0220-2046_0a0ce402-1802-62f2-e063-6294a90a9770	0220-2046	HUMAN OTC DRUG	Ferrum metallicum		IRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRON	6	[hp_C]/6[hp_C]			N	20241231
0220-2047_0a0cdff5-2760-8938-e063-6294a90ad4fb	0220-2047	HUMAN OTC DRUG	Ferrum metallicum		IRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRON	9	[hp_C]/9[hp_C]			N	20241231
0220-2050_0a0ce624-19fe-85f4-e063-6294a90ac29a	0220-2050	HUMAN OTC DRUG	Ferrum metallicum		IRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRON	12	[hp_C]/12[hp_C]			N	20241231
0220-2051_f6002c71-2a53-b17b-e053-2995a90a0576	0220-2051	HUMAN OTC DRUG	Ferrum metallicum		IRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRON	15	[hp_C]/15[hp_C]			N	20241231
0220-2054_f5294c54-6706-bc8d-e053-2a95a90a5567	0220-2054	HUMAN OTC DRUG	Ferrum metallicum		IRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRON	30	[hp_C]/30[hp_C]			N	20241231
0220-2055_0a0ce402-1803-62f2-e063-6294a90a9770	0220-2055	HUMAN OTC DRUG	Ferrum metallicum		IRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRON	200	[kp_C]/200[kp_C]			N	20241231
0220-2070_00f07e8b-fb4d-0777-e063-6294a90abff1	0220-2070	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	30	[hp_C]/30[hp_C]			N	20241231
0220-2071_f67cd2c6-311c-6509-e053-2a95a90a3788	0220-2071	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	200	[kp_C]/200[kp_C]			N	20241231
0220-2074_0a0cc828-8ad6-c06c-e063-6394a90a784e	0220-2074	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	15	[hp_C]/15[hp_C]			N	20241231
0220-2077_0a0ce624-19ff-85f4-e063-6294a90ac29a	0220-2077	HUMAN PRESCRIPTION DRUG	Ferrum iodatum		FERROUS IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROUS IODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-2079_0a0cca60-17d3-b93d-e063-6394a90a0731	0220-2079	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	12	[hp_C]/12[hp_C]			N	20241231
0220-2082_f187b15f-3b24-3e63-e053-2a95a90a0b97	0220-2082	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	9	[hp_C]/9[hp_C]			N	20241231
0220-2085_0a0ce624-1a00-85f4-e063-6294a90ac29a	0220-2085	HUMAN OTC DRUG	Ferrum metallicum		IRON	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRON	5	[hp_C]/5[hp_C]			N	20241231
0220-2087_0a0cd0a0-f2c8-c28b-e063-6394a90ac393	0220-2087	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	7	[hp_C]/7[hp_C]			N	20241231
0220-2090_0a0cdff5-2762-8938-e063-6294a90ad4fb	0220-2090	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	5	[hp_C]/5[hp_C]			N	20241231
0220-2091_f2f642f3-8040-5efb-e053-2995a90ab010	0220-2091	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	6	[hp_C]/6[hp_C]			N	20241231
0220-2094_0a0cc828-8ad8-c06c-e063-6394a90a784e	0220-2094	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	1	[hp_M]/[hp_M]			N	20241231
0220-2097_00edfde0-0396-2226-e063-6294a90af199	0220-2097	HUMAN OTC DRUG	Ferrum phosphoricum		FERRUM PHOSPHORICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	8	[hp_X]/1			N	20241231
0220-2100_0a0ce402-1804-62f2-e063-6294a90a9770	0220-2100	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	12	[hp_X]/12[hp_X]			N	20241231
0220-2101_0a0cbae3-25d1-6d47-e063-6294a90a0431	0220-2101	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROSOFERRIC PHOSPHATE	30	[hp_X]/30[hp_X]			N	20241231
0220-2104_f600394c-2424-69b0-e053-2a95a90ac827	0220-2104	HUMAN OTC DRUG	Ferrum picricum		FERRIC PICRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERRIC PICRATE	30	[hp_C]/30[hp_C]	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-2107_0a0cca60-17d4-b93d-e063-6394a90a0731	0220-2107	HUMAN OTC DRUG	Ferrum picricum		FERRIC PICRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERRIC PICRATE	9	[hp_C]/9[hp_C]	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0220-2111_0a0cbae3-25d2-6d47-e063-6294a90a0431	0220-2111	HUMAN OTC DRUG	Ferrum sulphuricum		FERROUS SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FERROUS SULFATE	30	[hp_C]/30[hp_C]			N	20241231
0220-2116_f911080f-2c4a-2a92-e053-6294a90a6923	0220-2116	HUMAN OTC DRUG	Folliculinum		ESTRONE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ESTRONE	15	[hp_C]/15[hp_C]			N	20241231
0220-2117_f2926614-452a-1942-e053-2a95a90aa292	0220-2117	HUMAN OTC DRUG	Folliculinum		ESTRONE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ESTRONE	30	[hp_C]/30[hp_C]			N	20241231
0220-2124_0a0cf5e8-3788-99bc-e063-6294a90a1694	0220-2124	HUMAN OTC DRUG	Folliculinum		ESTRONE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ESTRONE	200	[kp_C]/200[kp_C]			N	20241231
0220-2127_0a0cca60-17d6-b93d-e063-6394a90a0731	0220-2127	HUMAN OTC DRUG	Filix mas		DRYOPTERIS FILIX-MAS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DRYOPTERIS FILIX-MAS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2129_f19eb43e-675d-8fc1-e053-2995a90aa1f5	0220-2129	HUMAN OTC DRUG	Folliculinum		ESTRONE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ESTRONE	6	[hp_C]/6[hp_C]			N	20241231
0220-2133_08686b3a-f109-7d96-e063-6394a90a7c00	0220-2133	HUMAN OTC DRUG	Folliculinum		ESTRONE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ESTRONE	12	[hp_C]/1			N	20241231
0220-2135_0a0ce624-1a01-85f4-e063-6294a90ac29a	0220-2135	HUMAN OTC DRUG	Formalinum		FORMALDEHYDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FORMALDEHYDE	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-2139_f19eb662-8f05-69f9-e053-2a95a90a7939	0220-2139	HUMAN OTC DRUG	Formica rufa		FORMICA RUFA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FORMICA RUFA	30	[hp_C]/30[hp_C]			N	20241231
0220-2140_0a0cd0a0-f2ca-c28b-e063-6394a90ac393	0220-2140	HUMAN OTC DRUG	Formica rufa		FORMICA RUFA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FORMICA RUFA	200	[kp_C]/200[kp_C]			N	20241231
0220-2147_0a0cd0a0-f2cb-c28b-e063-6394a90ac393	0220-2147	HUMAN OTC DRUG	Fragaria vesca		ALPINE STRAWBERRY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALPINE STRAWBERRY	6	[hp_C]/6[hp_C]			N	20241231
0220-2148_f187c21d-6587-0629-e053-2995a90a80ea	0220-2148	HUMAN OTC DRUG	Fragaria vesca		ALPINE STRAWBERRY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALPINE STRAWBERRY	30	[hp_C]/30[hp_C]			N	20241231
0220-2155_0a0ce402-1805-62f2-e063-6294a90a9770	0220-2155	HUMAN PRESCRIPTION DRUG	Fraxinus americana		FRAXINUS AMERICANA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FRAXINUS AMERICANA BARK	6	[hp_C]/6[hp_C]			N	20241231
0220-2156_f52926bd-b7fb-8070-e053-2a95a90ac58d	0220-2156	HUMAN PRESCRIPTION DRUG	Fraxinus americana		FRAXINUS AMERICANA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FRAXINUS AMERICANA BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-2165_0a0cd0a0-f2cc-c28b-e063-6394a90ac393	0220-2165	HUMAN OTC DRUG	Fucus vesiculosus		FUCUS VESICULOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FUCUS VESICULOSUS	30	[hp_C]/30[hp_C]			N	20241231
0220-2167_0a0cf5e8-3789-99bc-e063-6294a90a1694	0220-2167	HUMAN OTC DRUG	Fucus vesiculosus		FUCUS VESICULOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FUCUS VESICULOSUS	6	[hp_C]/6[hp_C]			N	20241231
0220-2173_0a0cd0a0-f2cd-c28b-e063-6394a90ac393	0220-2173	HUMAN OTC DRUG	Fumaria officinalis		FUMARIA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FUMARIA OFFICINALIS FLOWERING TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-2176_00edbc64-9d31-5751-e063-6294a90a400b	0220-2176	HUMAN OTC DRUG	Fumaria officinalis		FUMARIA OFFICINALIS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	FUMARIA OFFICINALIS FLOWERING TOP	6	[hp_X]/6[hp_X]			N	20241231
0220-2228_f52c3790-90c5-be94-e053-2995a90aecdb	0220-2228	HUMAN OTC DRUG	GALIUM APARINE		GALIUM APARINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GALIUM APARINE	9	[hp_C]/9[hp_C]			N	20241231
0220-2231_0a0cca60-17d7-b93d-e063-6394a90a0731	0220-2231	HUMAN OTC DRUG	Gallicum acidum		GALLIC ACID MONOHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GALLIC ACID MONOHYDRATE	6	[hp_C]/6[hp_C]			N	20241231
0220-2235_07d8e230-b7b8-4016-e063-6294a90aa435	0220-2235	HUMAN OTC DRUG	Galphimia glauca		GALPHIMIA GLAUCA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GALPHIMIA GLAUCA FLOWERING TOP	6	[hp_C]/1			N	20241231
0220-2236_0a0ce624-1a02-85f4-e063-6294a90ac29a	0220-2236	HUMAN OTC DRUG	Galphimia glauca		GALPHIMIA GLAUCA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GALPHIMIA GLAUCA FLOWERING TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-2237_0a0d035c-c4fb-a8d2-e063-6294a90ad46e	0220-2237	HUMAN OTC DRUG	Galphimia glauca		GALPHIMIA GLAUCA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GALPHIMIA GLAUCA FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-2240_0a0ce624-1a03-85f4-e063-6294a90ac29a	0220-2240	HUMAN OTC DRUG	Galphimia glauca		GALPHIMIA GLAUCA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GALPHIMIA GLAUCA FLOWERING TOP	15	[hp_C]/15[hp_C]			N	20241231
0220-2241_f52c2b0f-8c93-8e55-e053-2995a90a8299	0220-2241	HUMAN OTC DRUG	Galphimia glauca		GALPHIMIA GLAUCA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GALPHIMIA GLAUCA FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-2247_0a0cf5e8-378a-99bc-e063-6294a90a1694	0220-2247	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	6	[hp_X]/1			N	20241231
0220-2249_0a0ce624-1a04-85f4-e063-6294a90ac29a	0220-2249	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-2250_00f0abf1-c538-e294-e063-6294a90a300d	0220-2250	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-2251_0a0ce402-1807-62f2-e063-6294a90a9770	0220-2251	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-2252_f7e594c0-9069-a31c-e053-6294a90a8cea	0220-2252	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	15	[hp_C]/15[hp_C]			N	20241231
0220-2253_00f13831-75a6-b63c-e063-6294a90a534b	0220-2253	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2254_f913a062-3412-58d2-e053-6294a90a752b	0220-2254	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-2255_0a0ce402-1808-62f2-e063-6294a90a9770	0220-2255	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-2258_0a0d08d7-e3d8-d98d-e063-6394a90af5e9	0220-2258	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_X]/30[hp_X]			N	20241231
0220-2259_0a0d08d7-e3d9-d98d-e063-6394a90af5e9	0220-2259	HUMAN OTC DRUG	Gelsemium sempervirens		GELSEMIUM SEMPERVIRENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GELSEMIUM SEMPERVIRENS ROOT	10	[hp_M]/10[hp_M]			N	20241231
0220-2269_0a0d0b63-29d8-cdc0-e063-6394a90a3c6a	0220-2269	HUMAN OTC DRUG	Geranium maculatum		GERANIUM MACULATUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GERANIUM MACULATUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2279_08f2df2f-bc04-c2d7-e063-6294a90ab3d3	0220-2279	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	200	[kp_C]/200[kp_C]	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2282_0a0d035c-c4fe-a8d2-e063-6294a90ad46e	0220-2282	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	15	[hp_C]/15[hp_C]	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2283_f5290ae4-6b48-8be3-e053-2995a90a9068	0220-2283	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	30	[hp_C]/30[hp_C]	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2286_0868e9dd-cc16-e809-e063-6394a90ac321	0220-2286	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	9	[hp_C]/9[hp_C]	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2287_0a0d563e-f71a-b11c-e063-6294a90ababb	0220-2287	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	12	[hp_C]/12[hp_C]	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2290_0a0d5748-6cea-0f47-e063-6294a90a154e	0220-2290	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	5	[hp_C]/5[hp_C]	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2291_f2f63de3-8176-614b-e053-2995a90a8f0f	0220-2291	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	6	[hp_C]/6[hp_C]	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2293_0a0d5ec6-d6ef-ee65-e063-6394a90a8639	0220-2293	HUMAN OTC DRUG	Glonoinum		NITROGLYCERIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITROGLYCERIN	6	[hp_X]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-2305_0a0d5748-6ceb-0f47-e063-6294a90a154e	0220-2305	HUMAN PRESCRIPTION DRUG	GLYCYRRHIZA GLABRA		GLYCYRRHIZA GLABRA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GLYCYRRHIZA GLABRA	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-2306_f187ae44-71bd-a682-e053-2995a90a6426	0220-2306	HUMAN OTC DRUG	Gnaphalium polycephalum		PSEUDOGNAPHALIUM OBTUSIFOLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PSEUDOGNAPHALIUM OBTUSIFOLIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-2307_0a0d563e-f71c-b11c-e063-6294a90ababb	0220-2307	HUMAN OTC DRUG	Gnaphalium polycephalum		PSEUDOGNAPHALIUM OBTUSIFOLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PSEUDOGNAPHALIUM OBTUSIFOLIUM	200	[kp_C]/200[kp_C]			N	20241231
0220-2310_f6003ca2-33ab-d388-e053-2995a90a8332	0220-2310	HUMAN OTC DRUG	Gnaphalium polycephalum		PSEUDOGNAPHALIUM OBTUSIFOLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PSEUDOGNAPHALIUM OBTUSIFOLIUM	9	[hp_C]/9[hp_C]			N	20241231
0220-2313_0a0d6462-bacb-faf6-e063-6294a90a02cc	0220-2313	HUMAN OTC DRUG	Gnaphalium polycephalum		PSEUDOGNAPHALIUM OBTUSIFOLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PSEUDOGNAPHALIUM OBTUSIFOLIUM	6	[hp_C]/6[hp_C]			N	20241231
0220-2317_0a0d657c-89f6-e2f0-e063-6394a90a7230	0220-2317	HUMAN OTC DRUG	GOSSYPIUM HERBACEUM		GOSSYPIUM HERBACEUM ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOSSYPIUM HERBACEUM ROOT BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-2321_0a0d5748-6cec-0f47-e063-6294a90a154e	0220-2321	HUMAN OTC DRUG	Granatum		PUNICA GRANATUM ROOT BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PUNICA GRANATUM ROOT BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-2325_0a0d5ec6-d6f1-ee65-e063-6394a90a8639	0220-2325	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	8	[hp_X]/1			N	20241231
0220-2329_0a0d5748-6cee-0f47-e063-6294a90a154e	0220-2329	HUMAN OTC DRUG	Gratiola officinalis		GRATIOLA OFFICINALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRATIOLA OFFICINALIS	30	[hp_C]/30[hp_C]			N	20241231
0220-2333_0a0d797d-0083-5811-e063-6394a90a4d82	0220-2333	HUMAN OTC DRUG	Grindelia		GRINDELIA HIRSUTULA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRINDELIA HIRSUTULA FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-2351_0a0d6462-bacc-faf6-e063-6294a90a02cc	0220-2351	HUMAN OTC DRUG	Gun powder		POTASSIUM NITRATE, ACTIVATED CHARCOAL, SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL; POTASSIUM NITRATE; SULFUR	30; 30; 30	[hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]			N	20241231
0220-2353_0a0d5ec6-d6f2-ee65-e063-6394a90a8639	0220-2353	HUMAN OTC DRUG	Gun powder		POTASSIUM NITRATE, ACTIVATED CHARCOAL, SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL; POTASSIUM NITRATE; SULFUR	8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
0220-2360_0868899a-c1d5-8471-e063-6294a90ad39c	0220-2360	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	5	[hp_C]/5[hp_C]			N	20241231
0220-2361_f5295d2d-53cf-a1ee-e053-2a95a90a39ce	0220-2361	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	6	[hp_C]/6[hp_C]			N	20241231
0220-2362_0a0b1f9e-167b-1b36-e063-6394a90abcac	0220-2362	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	9	[hp_C]/9[hp_C]			N	20241231
0220-2363_f527d3d0-8c4b-7abe-e053-2995a90a82a5	0220-2363	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	12	[hp_C]/12[hp_C]			N	20241231
0220-2364_0a0d5748-6cef-0f47-e063-6294a90a154e	0220-2364	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	15	[hp_C]/15[hp_C]			N	20241231
0220-2365_f2f632f1-0775-47d0-e053-2995a90a8d99	0220-2365	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	30	[hp_C]/30[hp_C]			N	20241231
0220-2366_f2f63f6f-bf2c-d47c-e053-2a95a90abf5b	0220-2366	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	200	[kp_C]/200[kp_C]			N	20241231
0220-2367_041157c3-c797-3390-e063-6394a90ac9d2	0220-2367	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	1	[hp_M]/[hp_M]			N	20241231
0220-2368_003a848f-c8d1-0cb1-e063-6294a90a6602	0220-2368	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	10	[hp_M]/10[hp_M]			N	20241231
0220-2369_0a0d643a-766c-135f-e063-6294a90a66d3	0220-2369	HUMAN OTC DRUG	Graphites		GRAPHITE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GRAPHITE	30	[hp_X]/30[hp_X]			N	20241231
0220-2374_0d09e624-a660-2b39-e063-6294a90a0e86	0220-2374	HUMAN OTC DRUG	HARPAGOPHYTUM		HARPAGOPHYTUM PROCUMBENS ROOT	PELLET	ORAL	20210122		UNAPPROVED HOMEOPATHIC		Boiron	HARPAGOPHYTUM PROCUMBENS ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-2375_0a0d643a-766d-135f-e063-6294a90a66d3	0220-2375	HUMAN OTC DRUG	HARPAGOPHYTUM		HARPAGOPHYTUM PROCUMBENS ROOT	PELLET	ORAL	20210430		UNAPPROVED HOMEOPATHIC		Boiron	HARPAGOPHYTUM PROCUMBENS ROOT	7	[hp_C]/7[hp_C]			N	20241231
0220-2376_0a0d5748-6cf0-0f47-e063-6294a90a154e	0220-2376	HUMAN OTC DRUG	HARPAGOPHYTUM		HARPAGOPHYTUM PROCUMBENS ROOT	PELLET	ORAL	20210430		UNAPPROVED HOMEOPATHIC		Boiron	HARPAGOPHYTUM PROCUMBENS ROOT	4	[hp_X]/4[hp_X]			N	20241231
0220-2391_f9153e41-24ef-f46e-e053-6294a90aa971	0220-2391	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	6	[hp_C]/6[hp_C]			N	20241231
0220-2392_0a0d797d-0084-5811-e063-6394a90a4d82	0220-2392	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	9	[hp_C]/9[hp_C]			N	20241231
0220-2393_f9117281-c432-c08d-e053-6294a90af4eb	0220-2393	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	12	[hp_C]/12[hp_C]			N	20241231
0220-2394_f52bf49e-2b34-4154-e053-2995a90a9181	0220-2394	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	30	[hp_C]/30[hp_C]			N	20241231
0220-2395_f2f38dd9-20d3-8a84-e053-2a95a90a7ed2	0220-2395	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	200	[kp_C]/200[kp_C]			N	20241231
0220-2396_f6003033-dd85-0c03-e053-2995a90a1da7	0220-2396	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	1	[hp_M]/[hp_M]			N	20241231
0220-2397_0a0d797d-0085-5811-e063-6394a90a4d82	0220-2397	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	10	[hp_M]/10[hp_M]			N	20241231
0220-2400_fd64e639-0e5b-941c-e053-6294a90af312	0220-2400	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	6	[hp_C]/6[hp_C]			N	20241231
0220-2401_0a0d9169-0372-3313-e063-6294a90ae007	0220-2401	HUMAN PRESCRIPTION DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	9	[hp_C]/9[hp_C]			N	20241231
0220-2402_f7e57c7d-0d57-f90f-e053-6294a90a85d3	0220-2402	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	12	[hp_C]/12[hp_C]			N	20241231
0220-2403_f7fb49d7-98ec-2ee3-e053-6294a90a139a	0220-2403	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-2404_f2f642f3-8041-5efb-e053-2995a90ab010	0220-2404	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	200	[kp_C]/200[kp_C]			N	20241231
0220-2405_0a0d926f-0b9a-581c-e063-6394a90a2c21	0220-2405	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	1	[hp_M]/[hp_M]			N	20241231
0220-2406_00edc4b9-66c8-497e-e063-6294a90acc2b	0220-2406	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	30	[hp_X]/30[hp_X]			N	20241231
0220-2407_0039e4f8-3fdc-6269-e063-6294a90a92eb	0220-2407	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	10	[hp_M]/10[hp_M]			N	20241231
0220-2408_0a0d9169-0373-3313-e063-6294a90ae007	0220-2408	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-2414_00edbed0-9989-a9fb-e063-6394a90ada4a	0220-2414	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	6	[hp_X]/1			N	20241231
0220-2416_f7e800b8-d2be-b8ae-e053-6394a90a44ab	0220-2416	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-2417_f7e5728e-6679-788f-e053-6394a90a784a	0220-2417	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-2418_00f0839b-294f-dd3d-e063-6294a90a64f1	0220-2418	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-2421_f7e5aff7-fc21-f99b-e053-6294a90aec2d	0220-2421	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-2422_f2b8e25c-5df8-5254-e053-2a95a90ab3b1	0220-2422	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-2425_f2b8c9c2-068c-23e9-e053-2995a90ab434	0220-2425	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-2426_0a0d94d8-aa76-8b9b-e063-6294a90a83e5	0220-2426	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	1	[hp_M]/[hp_M]			N	20241231
0220-2428_f9117302-74ac-6131-e053-6394a90a36ce	0220-2428	HUMAN OTC DRUG	Hekla lava		HEKLA LAVA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEKLA LAVA	8	[hp_X]/1			N	20241231
0220-2448_f527d8ba-5533-38ba-e053-2995a90a321c	0220-2448	HUMAN OTC DRUG	Helleborus niger		HELLEBORUS NIGER ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HELLEBORUS NIGER ROOT	6	[hp_C]/1			N	20241231
0220-2449_f19e9472-d562-171d-e053-2995a90a9fe4	0220-2449	HUMAN OTC DRUG	Helleborus niger		HELLEBORUS NIGER ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HELLEBORUS NIGER ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2450_003a848f-c8d0-0cb1-e063-6294a90a6602	0220-2450	HUMAN PRESCRIPTION DRUG	Helleborus niger		HELLEBORUS NIGER ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HELLEBORUS NIGER ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-2453_0a0d95f0-5c69-6afd-e063-6394a90a6ae6	0220-2453	HUMAN OTC DRUG	Helonias dioica		CHAMAELIRIUM LUTEUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHAMAELIRIUM LUTEUM ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-2454_0a0d9169-0374-3313-e063-6294a90ae007	0220-2454	HUMAN OTC DRUG	Helonias dioica		CHAMAELIRIUM LUTEUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHAMAELIRIUM LUTEUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2457_fd64f690-5307-40a3-e053-6394a90ac398	0220-2457	HUMAN OTC DRUG	Helonias dioica		CHAMAELIRIUM LUTEUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHAMAELIRIUM LUTEUM ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-2460_0a0d926f-0b9b-581c-e063-6394a90a2c21	0220-2460	HUMAN OTC DRUG	Helonias dioica		CHAMAELIRIUM LUTEUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHAMAELIRIUM LUTEUM ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-2464_086962c7-5cbf-d403-e063-6294a90a6d88	0220-2464	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM SULFIDE	8	[hp_X]/1			N	20241231
0220-2467_f2b8e25c-5e0b-5254-e053-2a95a90ab3b1	0220-2467	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-2468_fd661cef-a586-9df8-e053-6394a90a786c	0220-2468	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-2469_0a0d95f0-5c6a-6afd-e063-6394a90a6ae6	0220-2469	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-2470_f52bf49e-2b35-4154-e053-2995a90a9181	0220-2470	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-2471_f2b8e9d9-1276-22ca-e053-2a95a90a6f1a	0220-2471	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-2472_f52c0a91-ded7-8768-e053-2a95a90a23f4	0220-2472	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	1	[hp_M]/[hp_M]			N	20241231
0220-2478_0a0d9a8e-0d34-5f25-e063-6394a90add2c	0220-2478	HUMAN OTC DRUG	HEPATICA TRILOBA		ANEMONE HEPATICA VAR OBTUSA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE HEPATICA VAR. OBTUSA	30	[hp_C]/30[hp_C]			N	20241231
0220-2479_f527e40a-569f-3df5-e053-2a95a90a2dd7	0220-2479	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	10	[hp_M]/10[hp_M]			N	20241231
0220-2480_086887fb-e1b2-f895-e063-6394a90acdfd	0220-2480	HUMAN OTC DRUG	Histaminum hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HISTAMINE DIHYDROCHLORIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-2488_f212d8be-c461-489a-e053-2a95a90a2a75	0220-2488	HUMAN OTC DRUG	Histaminum 30C Allergy Relief		Histaminum Hydrochloricum	PELLET	ORAL	20160317		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	HISTAMINE DIHYDROCHLORIDE	30	[hp_C]/1			N	20241231
0220-2506_0a0d98fd-f812-3eaa-e063-6294a90ac42a	0220-2506	HUMAN OTC DRUG	Hura brasiliensis		HURA CREPITANS SAP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HURA CREPITANS SAP	30	[hp_C]/30[hp_C]			N	20241231
0220-2514_0a0d95f0-5c6b-6afd-e063-6394a90a6ae6	0220-2514	HUMAN OTC DRUG	Hydrangea arborescens		HYDRANGEA ARBORESCENS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDRANGEA ARBORESCENS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2522_00edbed0-9990-a9fb-e063-6394a90ada4a	0220-2522	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	6	[hp_X]/1			N	20241231
0220-2526_0a0da5ae-bdd3-3bf5-e063-6294a90a2a5e	0220-2526	HUMAN OTC DRUG	Hydrocotyle asiatica		CENTELLA ASIATICA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CENTELLA ASIATICA	6	[hp_C]/6[hp_C]			N	20241231
0220-2530_0a0d9169-0375-3313-e063-6294a90ae007	0220-2530	HUMAN OTC DRUG	Hydrocyanicum acidum		HYDROGEN CYANIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROGEN CYANIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-2531_0a0da814-a564-6cf5-e063-6394a90a80fa	0220-2531	HUMAN OTC DRUG	Hydrocotyle asiatica		CENTELLA ASIATICA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CENTELLA ASIATICA	9	[hp_C]/9[hp_C]			N	20241231
0220-2532_0a0da5ae-bdd4-3bf5-e063-6294a90a2a5e	0220-2532	HUMAN OTC DRUG	Hydrocotyle asiatica		CENTELLA ASIATICA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CENTELLA ASIATICA	30	[hp_C]/30[hp_C]			N	20241231
0220-2534_0a0d9169-0376-3313-e063-6294a90ae007	0220-2534	HUMAN OTC DRUG	Hydrofluoricum acidum		HYDROFLUORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROFLUORIC ACID	5	[hp_C]/5[hp_C]			N	20241231
0220-2542_f527e40a-56a2-3df5-e053-2a95a90a2dd7	0220-2542	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	6	[hp_X]/1			N	20241231
0220-2546_0a0db8e7-8470-3d08-e063-6294a90af3f5	0220-2546	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	6	[hp_X]/1			N	20241231
0220-2550_0d09e624-a661-2b39-e063-6294a90a0e86	0220-2550	HUMAN OTC DRUG	Hydrastis candadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	5	[hp_C]/5[hp_C]			N	20241231
0220-2551_f2b8e25c-5e0c-5254-e053-2a95a90ab3b1	0220-2551	HUMAN OTC DRUG	Hydrastis candadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	6	[hp_C]/6[hp_C]			N	20241231
0220-2552_04110848-458f-646a-e063-6394a90a19a1	0220-2552	HUMAN OTC DRUG	Hydrastis candadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	9	[hp_C]/9[hp_C]			N	20241231
0220-2553_0d09e624-a662-2b39-e063-6294a90a0e86	0220-2553	HUMAN OTC DRUG	Hydrastis candadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	12	[hp_C]/12[hp_C]			N	20241231
0220-2554_f7e594c0-90bd-a31c-e053-6294a90a8cea	0220-2554	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	15	[hp_C]/15[hp_C]			N	20241231
0220-2555_f913b60a-76a5-7f23-e053-6394a90a2f9a	0220-2555	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	30	[hp_C]/30[hp_C]			N	20241231
0220-2556_0d09c701-75d7-1f98-e063-6294a90ad44a	0220-2556	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	200	[kp_C]/200[kp_C]			N	20241231
0220-2557_0d09f780-d993-25f6-e063-6294a90a2f8f	0220-2557	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	1	[hp_M]/[hp_M]			N	20241231
0220-2558_0d09f924-46e4-a07f-e063-6394a90a7948	0220-2558	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	12	[hp_X]/12[hp_X]			N	20241231
0220-2559_f527e40a-56a0-3df5-e053-2a95a90a2dd7	0220-2559	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GOLDENSEAL	30	[hp_X]/30[hp_X]			N	20241231
0220-2561_0a0da814-a565-6cf5-e063-6394a90a80fa	0220-2561	HUMAN OTC DRUG	Hydrofluoricum acidum		HYDROFLUORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROFLUORIC ACID	6	[hp_C]/6[hp_C]			N	20241231
0220-2562_0a0d9ae0-6786-3114-e063-6294a90aa085	0220-2562	HUMAN OTC DRUG	Hydrofluoricum acidum		HYDROFLUORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROFLUORIC ACID	9	[hp_C]/9[hp_C]			N	20241231
0220-2563_0a0d926f-0b9c-581c-e063-6394a90a2c21	0220-2563	HUMAN OTC DRUG	Hydrofluoricum acidum		HYDROFLUORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROFLUORIC ACID	12	[hp_C]/12[hp_C]			N	20241231
0220-2564_f1ebae3e-6206-3609-e053-2995a90abfb8	0220-2564	HUMAN OTC DRUG	Hydrofluoricum acidum		HYDROFLUORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROFLUORIC ACID	15	[hp_C]/15[hp_C]			N	20241231
0220-2565_f19eb43e-6764-8fc1-e053-2995a90aa1f5	0220-2565	HUMAN OTC DRUG	Hydrofluoricum acidum		HYDROFLUORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROFLUORIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-2567_f7e57231-7521-479e-e053-6294a90a2a26	0220-2567	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	6	[hp_C]/6[hp_C]			N	20241231
0220-2568_0a0d9a8e-0d35-5f25-e063-6394a90add2c	0220-2568	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	9	[hp_C]/9[hp_C]			N	20241231
0220-2569_f19eb43e-6762-8fc1-e053-2995a90aa1f5	0220-2569	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	12	[hp_C]/12[hp_C]			N	20241231
0220-2570_0a0d9a8e-0d36-5f25-e063-6394a90add2c	0220-2570	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	15	[hp_C]/15[hp_C]			N	20241231
0220-2571_f52c2b0f-8c94-8e55-e053-2995a90a8299	0220-2571	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	30	[hp_C]/30[hp_C]			N	20241231
0220-2572_f7073067-50d1-e9dc-e053-6294a90afe9f	0220-2572	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	200	[kp_C]/200[kp_C]			N	20241231
0220-2573_0a0d9ae0-6787-3114-e063-6294a90aa085	0220-2573	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	1	[hp_M]/[hp_M]			N	20241231
0220-2574_097e24e9-3673-37b3-e063-6394a90ac6cc	0220-2574	HUMAN OTC DRUG	Hyoscyamus niger		HYOSCYAMUS NIGER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYOSCYAMUS NIGER	10	[hp_M]/10[hp_M]			N	20241231
0220-2576_0a0db8e7-8471-3d08-e063-6294a90af3f5	0220-2576	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	5	[hp_C]/5[hp_C]			N	20241231
0220-2577_f2b8f860-95b2-0994-e053-2995a90aa3db	0220-2577	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	6	[hp_C]/6[hp_C]			N	20241231
0220-2578_003ae69a-ccfa-f0d1-e063-6294a90a60a9	0220-2578	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	9	[hp_C]/9[hp_C]			N	20241231
0220-2579_0a0d9169-0378-3313-e063-6294a90ae007	0220-2579	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	12	[hp_C]/12[hp_C]			N	20241231
0220-2580_0a0dcff0-00cf-5e82-e063-6294a90a3a59	0220-2580	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	15	[hp_C]/15[hp_C]			N	20241231
0220-2581_f67d09fe-1dfe-666b-e053-2a95a90a7125	0220-2581	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	30	[hp_C]/30[hp_C]			N	20241231
0220-2582_f2b8f1e4-c7d5-62d6-e053-2995a90a6165	0220-2582	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	200	[kp_C]/200[kp_C]			N	20241231
0220-2583_003ae69a-ccf4-f0d1-e063-6294a90a60a9	0220-2583	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	1	[hp_M]/[hp_M]			N	20241231
0220-2584_f2b8f1e4-c7d4-62d6-e053-2995a90a6165	0220-2584	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	10	[hp_M]/10[hp_M]			N	20241231
0220-2585_0a0d9169-0379-3313-e063-6294a90ae007	0220-2585	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	12	[hp_X]/12[hp_X]			N	20241231
0220-2586_0a0d9ae0-6788-3114-e063-6294a90aa085	0220-2586	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYPERICUM PERFORATUM	30	[hp_X]/30[hp_X]			N	20241231
0220-2594_f2f62640-92f4-a9c4-e053-2995a90ac842	0220-2594	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-2595_f9117f36-2f0c-8d79-e053-6394a90a64af	0220-2595	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	9	[hp_C]/9[hp_C]			N	20241231
0220-2596_0a0d95f0-5c6c-6afd-e063-6394a90a6ae6	0220-2596	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	12	[hp_C]/12[hp_C]			N	20241231
0220-2597_f7e597d4-ad84-7893-e053-6394a90aee89	0220-2597	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	15	[hp_C]/15[hp_C]			N	20241231
0220-2598_f2f65b6a-172c-0f50-e053-2a95a90ac38e	0220-2598	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-2599_f212fdf7-7cb2-ed89-e053-2a95a90ac688	0220-2599	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	200	[kp_C]/200[kp_C]			N	20241231
0220-2600_f2f65520-a713-0ab3-e053-2a95a90ac054	0220-2600	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	1	[hp_M]/[hp_M]			N	20241231
0220-2601_0a0dcff0-00d0-5e82-e063-6294a90a3a59	0220-2601	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	10	[hp_M]/10[hp_M]			N	20241231
0220-2605_0a0dd0ec-c9a0-6add-e063-6394a90aac51	0220-2605	HUMAN OTC DRUG	Iberis amara		IBERIS AMARA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IBERIS AMARA SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-2613_f527eec7-8239-2ca8-e053-2995a90a93e0	0220-2613	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	6	[hp_X]/1			N	20241231
0220-2615_0a0da814-a566-6cf5-e063-6394a90a80fa	0220-2615	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	12	[hp_X]/12[hp_X]			N	20241231
0220-2616_0a0d95f0-5c6d-6afd-e063-6394a90a6ae6	0220-2616	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS IGNATII SEED	30	[hp_X]/30[hp_X]			N	20241231
0220-2656_f187ae44-71c0-a682-e053-2995a90a6426	0220-2656	HUMAN OTC DRUG	Iodium		IODINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IODINE	6	[hp_C]/6[hp_C]			N	20241231
0220-2657_0a0da5ae-bdd5-3bf5-e063-6294a90a2a5e	0220-2657	HUMAN OTC DRUG	Iodium		IODINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IODINE	9	[hp_C]/9[hp_C]			N	20241231
0220-2659_0a0dcff0-00d1-5e82-e063-6294a90a3a59	0220-2659	HUMAN OTC DRUG	Iodium		IODINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IODINE	6	[hp_X]/1			N	20241231
0220-2661_f2f38dd9-20d5-8a84-e053-2a95a90a7ed2	0220-2661	HUMAN OTC DRUG	Iodium		IODINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IODINE	200	[kp_C]/200[kp_C]			N	20241231
0220-2664_0a0d95f0-5c6e-6afd-e063-6394a90a6ae6	0220-2664	HUMAN OTC DRUG	Iodium		IODINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IODINE	1	[hp_M]/[hp_M]			N	20241231
0220-2667_0a0d95f0-5c6f-6afd-e063-6394a90a6ae6	0220-2667	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	6	[hp_X]/1			N	20241231
0220-2673_0a0d95f0-5c70-6afd-e063-6394a90a6ae6	0220-2673	HUMAN OTC DRUG	Iodium		IODINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IODINE	15	[hp_C]/15[hp_C]			N	20241231
0220-2674_f5293e5f-f78b-f59d-e053-2a95a90afd96	0220-2674	HUMAN OTC DRUG	Iodium		IODINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IODINE	30	[hp_C]/30[hp_C]			N	20241231
0220-2688_0a0d94d8-aa7a-8b9b-e063-6294a90a83e5	0220-2688	HUMAN PRESCRIPTION DRUG	Iris tenax		IRIS TENAX	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRIS TENAX	6	[hp_C]/6[hp_C]			N	20241231
0220-2692_0a0d98fd-f817-3eaa-e063-6294a90ac42a	0220-2692	HUMAN OTC DRUG	Iris versicolor		IRIS VERSICOLOR ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRIS VERSICOLOR ROOT	5	[hp_C]/1			N	20241231
0220-2693_0a0da814-a567-6cf5-e063-6394a90a80fa	0220-2693	HUMAN OTC DRUG	Iris versicolor		IRIS VERSICOLOR ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRIS VERSICOLOR ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-2694_f7e5ed88-969f-a127-e053-6294a90a795f	0220-2694	HUMAN OTC DRUG	Iris versicolor		IRIS VERSICOLOR ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRIS VERSICOLOR ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-2695_0a0d926f-0b9d-581c-e063-6394a90a2c21	0220-2695	HUMAN OTC DRUG	Iris versicolor		IRIS VERSICOLOR ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRIS VERSICOLOR ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-2696_0a0d95f0-5c71-6afd-e063-6394a90a6ae6	0220-2696	HUMAN OTC DRUG	Iris versicolor		IRIS VERSICOLOR ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRIS VERSICOLOR ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2697_fd66ee9b-5a09-776a-e053-6294a90a6559	0220-2697	HUMAN OTC DRUG	Iris versicolor		IRIS VERSICOLOR ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IRIS VERSICOLOR ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-2699_0a0da5ae-bdd6-3bf5-e063-6294a90a2a5e	0220-2699	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	5	[hp_C]/5[hp_C]			N	20241231
0220-2700_f2f62640-92f5-a9c4-e053-2995a90ac842	0220-2700	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	6	[hp_C]/6[hp_C]			N	20241231
0220-2701_fd67fa5d-f991-c607-e053-6294a90aee2b	0220-2701	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	9	[hp_C]/9[hp_C]			N	20241231
0220-2702_0a0da5ae-bdd7-3bf5-e063-6294a90a2a5e	0220-2702	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	12	[hp_C]/12[hp_C]			N	20241231
0220-2703_0a0da5ae-bdd8-3bf5-e063-6294a90a2a5e	0220-2703	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	15	[hp_C]/15[hp_C]			N	20241231
0220-2704_f7faf93a-da03-cd48-e053-6394a90a5af4	0220-2704	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	30	[hp_C]/30[hp_C]			N	20241231
0220-2705_0a0d926f-0b9e-581c-e063-6394a90a2c21	0220-2705	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	200	[kp_C]/200[kp_C]			N	20241231
0220-2706_097e30f5-59b3-b646-e063-6294a90a2320	0220-2706	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	1	[hp_M]/[hp_M]			N	20241231
0220-2707_f527f3bd-e7a8-00c0-e053-2995a90a50da	0220-2707	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPECAC	30	[hp_X]/30[hp_X]			N	20241231
0220-2727_e65e525b-a56c-bbd3-e053-2995a90a514a	0220-2727	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	6; 6; 6; 6	[hp_C]/6[hp_C]; [hp_C]/6[hp_C]; [hp_C]/6[hp_C]; [hp_C]/6[hp_C]			N	20241231
0220-2728_e65f188b-f075-3709-e053-2995a90a863e	0220-2728	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	9; 9; 9; 9	[hp_C]/9[hp_C]; [hp_C]/9[hp_C]; [hp_C]/9[hp_C]; [hp_C]/9[hp_C]			N	20241231
0220-2729_e65f54f7-4165-47f7-e053-2995a90a1552	0220-2729	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	12; 12; 12; 12	[hp_C]/12[hp_C]; [hp_C]/12[hp_C]; [hp_C]/12[hp_C]; [hp_C]/12[hp_C]			N	20241231
0220-2730_e66110f2-a844-19d6-e053-2995a90a39a1	0220-2730	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	[hp_C]/15[hp_C]; [hp_C]/15[hp_C]; [hp_C]/15[hp_C]; [hp_C]/15[hp_C]			N	20241231
0220-2731_e6618418-a510-30c2-e053-2a95a90a124a	0220-2731	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	30; 30; 30; 30	[hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]			N	20241231
0220-2732_00f11bb4-c71f-301e-e063-6294a90ad384	0220-2732	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	200; 200; 200; 200	[kp_C]/200[kp_C]; [kp_C]/200[kp_C]; [kp_C]/200[kp_C]; [kp_C]/200[kp_C]			N	20241231
0220-2733_e6626168-9e4d-0969-e053-2995a90a2e51	0220-2733	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	8; 8; 8; 8	[hp_X]/8[hp_X]; [hp_X]/8[hp_X]; [hp_X]/8[hp_X]; [hp_X]/8[hp_X]			N	20241231
0220-2734_e66294ea-928a-0f7c-e053-2995a90a8b20	0220-2734	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20220816		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	30; 30; 30; 30	[hp_X]/30[hp_X]; [hp_X]/30[hp_X]; [hp_X]/30[hp_X]; [hp_X]/30[hp_X]			N	20241231
0220-2749_0a0dd0ec-c9a1-6add-e063-6394a90aac51	0220-2749	HUMAN OTC DRUG	Jalapa		IPOMOEA PURGA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	IPOMOEA PURGA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-2777_0a0df4d3-fb86-8eea-e063-6394a90a2748	0220-2777	HUMAN OTC DRUG	Juglans regia		JUGLANS REGIA LEAF, JUGLANS REGIA FRUIT RIND, IMMATURE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF	30; 30	[hp_C]/30[hp_C]; [hp_C]/30[hp_C]			N	20241231
0220-2789_0a0dfe8a-78d4-8525-e063-6394a90aff46	0220-2789	HUMAN PRESCRIPTION DRUG	Juniperus virginiana		JUNIPERUS VIRGINIANA TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS VIRGINIANA TWIG	30	[hp_C]/30[hp_C]			N	20241231
0220-2798_0a0e1540-968c-93c6-e063-6294a90a6e77	0220-2798	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	5	[hp_C]/5[hp_C]			N	20241231
0220-2799_0a0e1685-b633-7e21-e063-6394a90a5324	0220-2799	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-2800_0a0df4d3-fb87-8eea-e063-6394a90a2748	0220-2800	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-2801_0a0e1894-0bea-949b-e063-6394a90a60a2	0220-2801	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-2802_f529227e-4142-fc0b-e053-2a95a90a8c50	0220-2802	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-2803_f52bd221-3c6d-ac9c-e053-2995a90a87b7	0220-2803	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-2804_0410a1fe-a4ce-1f65-e063-6294a90ac687	0220-2804	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	1	[hp_M]/[hp_M]			N	20241231
0220-2805_0a0e1685-b645-7e21-e063-6394a90a5324	0220-2805	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-2809_f2f66b96-f931-7454-e053-2a95a90a791a	0220-2809	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	6	[hp_C]/6[hp_C]			N	20241231
0220-2810_0a0e1894-0beb-949b-e063-6394a90a60a2	0220-2810	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	9	[hp_C]/9[hp_C]			N	20241231
0220-2811_f2f668b5-5046-5e26-e053-2a95a90a106d	0220-2811	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	12	[hp_C]/12[hp_C]			N	20241231
0220-2812_0a0dd0ec-c9a2-6add-e063-6394a90aac51	0220-2812	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	15	[hp_C]/15[hp_C]			N	20241231
0220-2813_f2f66b96-f933-7454-e053-2a95a90a791a	0220-2813	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	30	[hp_C]/30[hp_C]			N	20241231
0220-2814_f913b60a-76a8-7f23-e053-6394a90a2f9a	0220-2814	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	200	[kp_C]/200[kp_C]			N	20241231
0220-2815_0039e4f8-3fd9-6269-e063-6294a90a92eb	0220-2815	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	1	[hp_M]/[hp_M]			N	20241231
0220-2816_0a0e1685-b646-7e21-e063-6394a90a5324	0220-2816	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	10	[hp_M]/10[hp_M]			N	20241231
0220-2819_0a0e1d88-7fbd-8d1d-e063-6394a90a6398	0220-2819	HUMAN OTC DRUG	Kali bromatum		POTASSIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-2820_0a0e1efd-9eb4-83d7-e063-6294a90a9643	0220-2820	HUMAN OTC DRUG	Kali bromatum		POTASSIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-2821_0a0e1685-b647-7e21-e063-6394a90a5324	0220-2821	HUMAN OTC DRUG	Kali bromatum		POTASSIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-2822_08692954-9ccf-b338-e063-6394a90a4154	0220-2822	HUMAN OTC DRUG	Kali bromatum		POTASSIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-2823_f29293d0-8d4a-6fc8-e053-2995a90a0886	0220-2823	HUMAN OTC DRUG	Kali bromatum		POTASSIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-2824_0a0e1894-0bec-949b-e063-6394a90a60a2	0220-2824	HUMAN OTC DRUG	Kali bromatum		POTASSIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-2827_0a0e1d88-7fbe-8d1d-e063-6394a90a6398	0220-2827	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	5	[hp_C]/5[hp_C]			N	20241231
0220-2828_f307a559-aee6-fcdc-e053-2a95a90a5c1f	0220-2828	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	6	[hp_C]/6[hp_C]			N	20241231
0220-2829_0a0e1d88-7fbf-8d1d-e063-6394a90a6398	0220-2829	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	7	[hp_C]/7[hp_C]			N	20241231
0220-2830_f5292d85-3675-c5ac-e053-2a95a90a4ec2	0220-2830	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	9	[hp_C]/9[hp_C]			N	20241231
0220-2831_0a0df4d3-fb89-8eea-e063-6394a90a2748	0220-2831	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	12	[hp_C]/12[hp_C]			N	20241231
0220-2832_0a0e1685-b648-7e21-e063-6394a90a5324	0220-2832	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	15	[hp_C]/15[hp_C]			N	20241231
0220-2833_f2f62640-92f6-a9c4-e053-2995a90ac842	0220-2833	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	30	[hp_C]/30[hp_C]			N	20241231
0220-2834_f7e5aff7-fc24-f99b-e053-6294a90aec2d	0220-2834	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	200	[kp_C]/200[kp_C]			N	20241231
0220-2835_0a0dfe8a-78d5-8525-e063-6394a90aff46	0220-2835	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	1	[hp_M]/[hp_M]			N	20241231
0220-2836_0a0e1efd-9eb5-83d7-e063-6294a90a9643	0220-2836	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	10	[hp_M]/10[hp_M]			N	20241231
0220-2837_0a0dfe8a-78d6-8525-e063-6394a90aff46	0220-2837	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	30	[hp_X]/30[hp_X]			N	20241231
0220-2847_08f2df2f-bc05-c2d7-e063-6294a90ab3d3	0220-2847	HUMAN OTC DRUG	Kali arsenicosum		POTASSIUM ARSENITE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM ARSENITE ANHYDROUS	200	[kp_C]/200[kp_C]			N	20241231
0220-2850_0a0e1540-968d-93c6-e063-6294a90a6e77	0220-2850	HUMAN OTC DRUG	Kali arsenicosum		POTASSIUM ARSENITE ANHYDROUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM ARSENITE ANHYDROUS	30	[hp_C]/30[hp_C]			N	20241231
0220-2854_0a0e30cc-ad74-8cf3-e063-6394a90a974d	0220-2854	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM DICHROMATE	12	[hp_X]/1			N	20241231
0220-2859_0a0e1efd-9eb6-83d7-e063-6294a90a9643	0220-2859	HUMAN OTC DRUG	Kali bromatum		POTASSIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE	5	[hp_C]/5[hp_C]			N	20241231
0220-2863_0a0df4d3-fb8a-8eea-e063-6394a90a2748	0220-2863	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CARBONATE	6	[hp_X]/1			N	20241231
0220-2871_0a0e1efd-9eb7-83d7-e063-6294a90a9643	0220-2871	HUMAN OTC DRUG	Kali chloricum		POTASSIUM CHLORATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORATE	30	[hp_C]/30[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2887_0a0e1540-968e-93c6-e063-6294a90a6e77	0220-2887	HUMAN OTC DRUG	Kali iodatum		POTASSIUM IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM IODIDE	6	[hp_X]/1			N	20241231
0220-2891_07d90edc-88ec-06a4-e063-6294a90ae585	0220-2891	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2908_f67d2063-3334-579f-e053-2995a90a3b2b	0220-2908	HUMAN OTC DRUG	Kali phosphoricum		POTASSIUM PHOSPHATE, DIBASIC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	POTASSIUM PHOSPHATE, DIBASIC	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2921_0a0e390d-fe5d-9dc6-e063-6294a90a5f58	0220-2921	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM SULFATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2927_0a0dfe8a-78d8-8525-e063-6394a90aff46	0220-2927	HUMAN OTC DRUG	Kalmia latifolia		KALMIA LATIFOLIA LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KALMIA LATIFOLIA LEAF	9	[hp_C]/9[hp_C]			N	20241231
0220-2928_0a0e1894-0bed-949b-e063-6394a90a60a2	0220-2928	HUMAN OTC DRUG	Kalmia latifolia		KALMIA LATIFOLIA LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KALMIA LATIFOLIA LEAF	15	[hp_C]/15[hp_C]			N	20241231
0220-2931_f9155d23-35bf-0802-e053-6294a90a50af	0220-2931	HUMAN OTC DRUG	Kalmia latifolia		KALMIA LATIFOLIA LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KALMIA LATIFOLIA LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-2932_08f2d4aa-73aa-4165-e063-6394a90a747c	0220-2932	HUMAN OTC DRUG	Kalmia latifolia		KALMIA LATIFOLIA LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KALMIA LATIFOLIA LEAF	200	[kp_C]/200[kp_C]			N	20241231
0220-2934_0a0dfe8a-78d9-8525-e063-6394a90aff46	0220-2934	HUMAN OTC DRUG	Kalmia latifolia		KALMIA LATIFOLIA LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KALMIA LATIFOLIA LEAF	6	[hp_C]/6[hp_C]			N	20241231
0220-2940_0a0e390d-fe5e-9dc6-e063-6294a90a5f58	0220-2940	HUMAN OTC DRUG	Kreosotum		WOOD CREOSOTE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	WOOD CREOSOTE	1	[hp_M]/[hp_M]			N	20241231
0220-2943_f52c22b6-878a-deb8-e053-2a95a90a1aaa	0220-2943	HUMAN OTC DRUG	Kreosotum		WOOD CREOSOTE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	WOOD CREOSOTE	30	[hp_C]/30[hp_C]			N	20241231
0220-2944_fbd3a1c2-2474-ea9c-e053-6394a90a4bad	0220-2944	HUMAN OTC DRUG	Kreosotum		WOOD CREOSOTE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	WOOD CREOSOTE	200	[kp_C]/200[kp_C]			N	20241231
0220-2946_0a0e30cc-ad75-8cf3-e063-6394a90a974d	0220-2946	HUMAN OTC DRUG	Kreosotum		WOOD CREOSOTE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	WOOD CREOSOTE	12	[hp_C]/1			N	20241231
0220-2951_0a0e30cc-ad76-8cf3-e063-6394a90a974d	0220-2951	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	6	[hp_C]/6[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2952_0a0e1894-0bee-949b-e063-6394a90a60a2	0220-2952	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	9	[hp_C]/9[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2953_0a0e390d-fe5f-9dc6-e063-6294a90a5f58	0220-2953	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	12	[hp_C]/12[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2954_0a0e1685-b64a-7e21-e063-6394a90a5324	0220-2954	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	15	[hp_C]/15[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2955_f2f668b5-5047-5e26-e053-2a95a90a106d	0220-2955	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	30	[hp_C]/30[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2956_0a0e390d-fe60-9dc6-e063-6294a90a5f58	0220-2956	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	200	[kp_C]/200[kp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2957_0a0dfe8a-78da-8525-e063-6394a90aff46	0220-2957	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	1	[hp_M]/[hp_M]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2958_00f16275-94ad-cd71-e063-6394a90a88fa	0220-2958	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	12	[hp_X]/12[hp_X]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2959_0a0df4d3-fb8c-8eea-e063-6394a90a2748	0220-2959	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM CHLORIDE	30	[hp_X]/30[hp_X]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2962_f7e5b836-a352-0626-e053-6394a90a0642	0220-2962	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	6	[hp_C]/6[hp_C]			N	20241231
0220-2963_f9117f36-2f0d-8d79-e053-6394a90a64af	0220-2963	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	9	[hp_C]/9[hp_C]			N	20241231
0220-2964_0a0e1685-b64b-7e21-e063-6394a90a5324	0220-2964	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	12	[hp_C]/12[hp_C]			N	20241231
0220-2965_0a0e1d88-7fc4-8d1d-e063-6394a90a6398	0220-2965	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	15	[hp_C]/15[hp_C]			N	20241231
0220-2966_f2f3b480-803c-331c-e053-2a95a90a745b	0220-2966	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	200	[kp_C]/200[kp_C]			N	20241231
0220-2967_0a0e5f97-6e83-9892-e063-6294a90a1a7d	0220-2967	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	1	[hp_M]/[hp_M]			N	20241231
0220-2968_f19e9472-d564-171d-e053-2995a90a9fe4	0220-2968	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	6	[hp_X]/6[hp_X]			N	20241231
0220-2969_00ed2acb-b6f5-a982-e063-6394a90a7c7c	0220-2969	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	12	[hp_X]/12[hp_X]			N	20241231
0220-2970_0a0e60e6-7be0-acb9-e063-6394a90acb2f	0220-2970	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DIBASIC POTASSIUM PHOSPHATE	30	[hp_X]/30[hp_X]			N	20241231
0220-2973_003adc62-202c-085a-e063-6294a90a43b6	0220-2973	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM SULFATE	6	[hp_C]/6[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2974_0a0e1894-0bf1-949b-e063-6394a90a60a2	0220-2974	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM SULFATE	9	[hp_C]/9[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2975_0a0e1efd-9eb8-83d7-e063-6294a90a9643	0220-2975	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM SULFATE	12	[hp_C]/12[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2976_0a0e6b08-3f30-b3f7-e063-6394a90ae8e3	0220-2976	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM SULFATE	15	[hp_C]/15[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2977_f529227e-4143-fc0b-e053-2a95a90a8c50	0220-2977	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM SULFATE	30	[hp_C]/30[hp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2978_f2b90b86-d09e-7a52-e053-2995a90ab95b	0220-2978	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM SULFATE	200	[kp_C]/200[kp_C]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-2979_0a0e1efd-9eb9-83d7-e063-6294a90a9643	0220-2979	HUMAN OTC DRUG	Kali sulphuricum		POTASSIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED MEDICAL GAS		Boiron	POTASSIUM SULFATE	1	[hp_M]/[hp_M]	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0220-3000_0a0e390d-fe61-9dc6-e063-6294a90a5f58	0220-3000	HUMAN OTC DRUG	Lac caninum		CANIS LUPUS FAMILIARIS MILK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANIS LUPUS FAMILIARIS MILK	6	[hp_C]/6[hp_C]			N	20241231
0220-3003_0a0e6def-a7b2-d1cc-e063-6294a90a317b	0220-3003	HUMAN OTC DRUG	Lac caninum		CANIS LUPUS FAMILIARIS MILK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANIS LUPUS FAMILIARIS MILK	8	[hp_X]/8[hp_X]			N	20241231
0220-3004_0a0e1efd-9eba-83d7-e063-6294a90a9643	0220-3004	HUMAN OTC DRUG	Lac caninum		CANIS LUPUS FAMILIARIS MILK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANIS LUPUS FAMILIARIS MILK	9	[hp_C]/9[hp_C]			N	20241231
0220-3007_f7e58011-b748-749d-e053-6294a90a2da3	0220-3007	HUMAN OTC DRUG	LAC DEFLORATUM		SKIM MILK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SKIM MILK	30	[hp_C]/30[hp_C]			N	20241231
0220-3008_0a0e6fff-2da6-b307-e063-6394a90ad9ed	0220-3008	HUMAN OTC DRUG	Lac caninum		CANIS LUPUS FAMILIARIS MILK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANIS LUPUS FAMILIARIS MILK	30	[hp_C]/30[hp_C]			N	20241231
0220-3009_0a0e1efd-9ebb-83d7-e063-6294a90a9643	0220-3009	HUMAN OTC DRUG	Lac caninum		CANIS LUPUS FAMILIARIS MILK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANIS LUPUS FAMILIARIS MILK	200	[kp_C]/200[kp_C]			N	20241231
0220-3012_0a0e60e6-7be9-acb9-e063-6394a90acb2f	0220-3012	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	5	[hp_C]/5[hp_C]			N	20241231
0220-3013_f52bfe56-ceab-53ee-e053-2a95a90af5c4	0220-3013	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	6	[hp_C]/6[hp_C]			N	20241231
0220-3016_0a0e6fff-2da7-b307-e063-6394a90ad9ed	0220-3016	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	7	[hp_C]/7[hp_C]			N	20241231
0220-3017_0a0e1efd-9ebc-83d7-e063-6294a90a9643	0220-3017	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	9	[hp_C]/9[hp_C]			N	20241231
0220-3020_f2926614-4527-1942-e053-2a95a90aa292	0220-3020	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	12	[hp_C]/12[hp_C]			N	20241231
0220-3023_00f00ee1-2c0f-fd54-e063-6294a90a651b	0220-3023	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	8	[hp_X]/1			N	20241231
0220-3025_0a0e30cc-ad7c-8cf3-e063-6394a90a974d	0220-3025	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	15	[hp_C]/15[hp_C]			N	20241231
0220-3026_f7fb36d8-55f3-3b31-e053-6394a90a5155	0220-3026	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	30	[hp_C]/30[hp_C]			N	20241231
0220-3027_fe04346f-7bd5-4db7-e053-6294a90a338b	0220-3027	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	200	[kp_C]/200[kp_C]			N	20241231
0220-3028_f52c3790-90c3-be94-e053-2995a90aecdb	0220-3028	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	1	[hp_M]/[hp_M]			N	20241231
0220-3029_0a0e30cc-ad7d-8cf3-e063-6394a90a974d	0220-3029	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	10	[hp_M]/10[hp_M]			N	20241231
0220-3030_0a0e5f97-6e88-9892-e063-6294a90a1a7d	0220-3030	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHESIS MUTA VENOM	30	[hp_X]/30[hp_X]			N	20241231
0220-3033_f187ae44-71c1-a682-e053-2995a90a6426	0220-3033	HUMAN OTC DRUG	Lachnanthes tinctoria		LACHNANTHES CAROLINIANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHNANTHES CAROLINIANA	6	[hp_C]/6[hp_C]			N	20241231
0220-3034_0868b8dd-8417-d7c8-e063-6294a90a6ac1	0220-3034	HUMAN OTC DRUG	Lacticum acidum		LACTIC ACID, DL-	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACTIC ACID, DL-	30	[hp_C]/30[hp_C]			N	20241231
0220-3037_0a0e5f97-6e89-9892-e063-6294a90a1a7d	0220-3037	HUMAN OTC DRUG	Lacticum acidum		LACTIC ACID, DL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACTIC ACID, DL-	6	[hp_C]/6[hp_C]			N	20241231
0220-3038_f187cc92-7d1b-0627-e053-2995a90a71a1	0220-3038	HUMAN OTC DRUG	Lachnanthes tinctoria		LACHNANTHES CAROLINIANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHNANTHES CAROLINIANA	9	[hp_C]/9[hp_C]			N	20241231
0220-3039_0a0e1efd-9ebd-83d7-e063-6294a90a9643	0220-3039	HUMAN OTC DRUG	Lachnanthes tinctoria		LACHNANTHES CAROLINIANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACHNANTHES CAROLINIANA	30	[hp_C]/30[hp_C]			N	20241231
0220-3041_0a0e6de8-b7c0-af7e-e063-6394a90a3ee2	0220-3041	HUMAN OTC DRUG	Lactuca virosa		LACTUCA VIROSA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LACTUCA VIROSA	30	[hp_C]/30[hp_C]			N	20241231
0220-3043_0868fd44-d79a-652d-e063-6294a90ae3ce	0220-3043	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	5	[hp_C]/5[hp_C]			N	20241231
0220-3044_f2b920b2-f88b-1e6e-e053-2a95a90ae153	0220-3044	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	6	[hp_C]/6[hp_C]			N	20241231
0220-3045_0a0e6def-a7b4-d1cc-e063-6294a90a317b	0220-3045	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	9	[hp_C]/9[hp_C]			N	20241231
0220-3046_0a0e30cc-ad7e-8cf3-e063-6394a90a974d	0220-3046	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	12	[hp_C]/12[hp_C]			N	20241231
0220-3047_0b3cc92a-2317-f982-e063-6394a90a7072	0220-3047	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	15	[hp_C]/15[hp_C]			N	20241231
0220-3053_0a0e6b08-3f33-b3f7-e063-6394a90ae8e3	0220-3053	HUMAN PRESCRIPTION DRUG	Lapis albus		CALCIUM HEXAFLUOROSILICATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM HEXAFLUOROSILICATE	6	[hp_C]/6[hp_C]			N	20241231
0220-3055_0a0e30cc-ad7f-8cf3-e063-6394a90a974d	0220-3055	HUMAN PRESCRIPTION DRUG	Lapis albus		CALCIUM HEXAFLUOROSILICATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALCIUM HEXAFLUOROSILICATE	9	[hp_C]/9[hp_C]			N	20241231
0220-3061_0a0e6b08-3f34-b3f7-e063-6394a90ae8e3	0220-3061	HUMAN OTC DRUG	Lathyrus sativus		LATHYRUS SATIVAS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LATHYRUS SATIVAS SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-3065_0869848d-2d01-d58d-e063-6294a90a86b8	0220-3065	HUMAN PRESCRIPTION DRUG	Latrodectus mactans		LATRODECTUS MACTANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LATRODECTUS MACTANS	30	[hp_C]/30[hp_C]			N	20241231
0220-3066_0a0e60e6-7bea-acb9-e063-6394a90acb2f	0220-3066	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	30	[hp_X]/30[hp_X]			N	20241231
0220-3069_f2f3946c-1158-49b5-e053-2995a90a47cb	0220-3069	HUMAN OTC DRUG	Laurocerasus		PRUNUS LAUROCERASUS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PRUNUS LAUROCERASUS LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-3070_fd64f690-5308-40a3-e053-6394a90ac398	0220-3070	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	30	[hp_C]/30[hp_C]			N	20241231
0220-3071_f2b9195b-7929-c498-e053-2a95a90aa22e	0220-3071	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	200	[kp_C]/200[kp_C]			N	20241231
0220-3074_f7e5c187-283e-13e2-e053-6294a90a360b	0220-3074	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	1	[hp_M]/[hp_M]			N	20241231
0220-3075_08f2df2f-bc03-c2d7-e063-6294a90ab3d3	0220-3075	HUMAN OTC DRUG	Ledum palustre		RHODODENDRON TOMENTOSUM LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON TOMENTOSUM LEAFY TWIG	10	[hp_M]/10[hp_M]			N	20241231
0220-3077_00edd7b8-7abc-2396-e063-6394a90a9e11	0220-3077	HUMAN OTC DRUG	Ledum palustre		LEDUM PALUSTRE TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEDUM PALUSTRE TWIG	6	[hp_X]/1			N	20241231
0220-3081_f2b92056-ca3d-c5c6-e053-2995a90a9973	0220-3081	HUMAN OTC DRUG	Lemna minor		LEMNA MINOR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEMNA MINOR	30	[hp_C]/30[hp_C]			N	20241231
0220-3083_f9110e2b-30a4-4b58-e053-6294a90a6ce3	0220-3083	HUMAN OTC DRUG	Lemna minor		LEMNA MINOR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEMNA MINOR	6	[hp_C]/6[hp_C]			N	20241231
0220-3095_0a0e873a-4d86-e689-e063-6294a90a18a8	0220-3095	HUMAN OTC DRUG	Leptandra virginica		VERONICASTRUM VIRGINICUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERONICASTRUM VIRGINICUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-3104_fbd3a578-1c33-464b-e053-6294a90af2ef	0220-3104	HUMAN OTC DRUG	Lilium tigrinum		LILIUM LANCIFOLIUM WHOLE FLOWERING	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LILIUM LANCIFOLIUM WHOLE FLOWERING	30	[hp_C]/30[hp_C]			N	20241231
0220-3105_003aa46c-a158-8c9e-e063-6294a90a4931	0220-3105	HUMAN OTC DRUG	Lilium tigrinum		LILIUM LANCIFOLIUM WHOLE FLOWERING	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LILIUM LANCIFOLIUM WHOLE FLOWERING	200	[kp_C]/200[kp_C]			N	20241231
0220-3111_0a0e873a-4d87-e689-e063-6294a90a18a8	0220-3111	HUMAN OTC DRUG	Lilium tigrinum		LILIUM LANCIFOLIUM WHOLE FLOWERING	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LILIUM LANCIFOLIUM WHOLE FLOWERING	6	[hp_C]/6[hp_C]			N	20241231
0220-3128_0a0e6b08-3f35-b3f7-e063-6394a90ae8e3	0220-3128	HUMAN OTC DRUG	Lithium carbonicum		LITHIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LITHIUM CARBONATE	200	[kp_C]/200[kp_C]	Mood Stabilizer [EPC]		N	20241231
0220-3131_0a0e6def-a7b5-d1cc-e063-6294a90a317b	0220-3131	HUMAN OTC DRUG	Lithium carbonicum		LITHIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LITHIUM CARBONATE	30	[hp_C]/30[hp_C]	Mood Stabilizer [EPC]		N	20241231
0220-3132_0a0b1f9e-167c-1b36-e063-6394a90abcac	0220-3132	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	5	[hp_C]/5[hp_C]			N	20241231
0220-3133_f7e800b8-d2c0-b8ae-e053-6394a90a44ab	0220-3133	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	6	[hp_C]/6[hp_C]			N	20241231
0220-3136_0a0b302e-72fc-8b92-e063-6294a90abb0c	0220-3136	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	9	[hp_C]/9[hp_C]			N	20241231
0220-3137_0a0e8175-d83a-9557-e063-6294a90ac4dd	0220-3137	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	12	[hp_C]/12[hp_C]			N	20241231
0220-3140_f529414c-36e8-5164-e053-2995a90acb80	0220-3140	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	30	[hp_C]/30[hp_C]			N	20241231
0220-3141_0a0e8175-d83b-9557-e063-6294a90ac4dd	0220-3141	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	200	[kp_C]/200[kp_C]			N	20241231
0220-3144_003ad7b2-d15a-4924-e063-6394a90a2232	0220-3144	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	1	[hp_M]/[hp_M]			N	20241231
0220-3147_0a0e60e6-7beb-acb9-e063-6394a90acb2f	0220-3147	HUMAN OTC DRUG	Lobelia inflata		LOBELIA INFLATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA	30	[hp_X]/1			N	20241231
0220-3167_f6003ca2-33ac-d388-e053-2995a90a8332	0220-3167	HUMAN OTC DRUG	Luffa operculata		LUFFA OPERCULATA FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LUFFA OPERCULATA FRUIT	6	[hp_C]/6[hp_C]			N	20241231
0220-3176_08f30162-a0e3-c8f5-e063-6294a90addc8	0220-3176	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	10	[hp_M]/10[hp_M]			N	20241231
0220-3179_0a0e6def-a7b6-d1cc-e063-6294a90a317b	0220-3179	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	12	[hp_X]/1			N	20241231
0220-3181_0868de30-b3bf-c278-e063-6394a90a48c4	0220-3181	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	5	[hp_C]/5[hp_C]			N	20241231
0220-3182_fbd434c0-3a2a-6530-e053-6294a90aa824	0220-3182	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	6	[hp_C]/6[hp_C]			N	20241231
0220-3183_0a0e5f97-6e8a-9892-e063-6294a90a1a7d	0220-3183	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	7	[hp_C]/7[hp_C]			N	20241231
0220-3184_f9117f36-2f0e-8d79-e053-6394a90a64af	0220-3184	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	9	[hp_C]/9[hp_C]			N	20241231
0220-3185_f2b90b86-d09f-7a52-e053-2995a90ab95b	0220-3185	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	12	[hp_C]/12[hp_C]			N	20241231
0220-3186_f2926b37-e941-5f45-e053-2a95a90a46f1	0220-3186	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	15	[hp_C]/15[hp_C]			N	20241231
0220-3187_f7e80a83-1d5a-cf8d-e053-6394a90aeba6	0220-3187	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	30	[hp_C]/30[hp_C]			N	20241231
0220-3189_0a0e6def-a7b7-d1cc-e063-6294a90a317b	0220-3189	HUMAN PRESCRIPTION DRUG	Lycopus virginicus		LYCOPUS VIRGINICUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPUS VIRGINICUS	6	[hp_C]/6[hp_C]			N	20241231
0220-3190_fbd525b8-78ea-2797-e053-6394a90acdf5	0220-3190	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	200	[kp_C]/200[kp_C]			N	20241231
0220-3191_f52bf49e-2b36-4154-e053-2995a90a9181	0220-3191	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	1	[hp_M]/[hp_M]			N	20241231
0220-3194_0a0e9b39-9ce0-e788-e063-6294a90abf0b	0220-3194	HUMAN PRESCRIPTION DRUG	Lycopus virginicus		LYCOPUS VIRGINICUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPUS VIRGINICUS	30	[hp_C]/30[hp_C]			N	20241231
0220-3195_0a0e6fff-2daa-b307-e063-6394a90ad9ed	0220-3195	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOPODIUM CLAVATUM SPORE	30	[hp_X]/30[hp_X]			N	20241231
0220-3227_0868b8dd-8416-d7c8-e063-6294a90a6ac1	0220-3227	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	5	[hp_C]/5[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3228_f2b94137-2059-1c77-e053-2a95a90afc15	0220-3228	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_C]/6[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3229_0a1f3d5d-13cf-97b3-e063-6394a90aa250	0220-3229	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	9	[hp_C]/9[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3230_f911080f-2c48-2a92-e053-6294a90a6923	0220-3230	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	12	[hp_C]/12[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3231_f9114f16-dad4-8bd1-e053-6294a90af09e	0220-3231	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	15	[hp_C]/15[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3232_f67d3173-5216-aec2-e053-2995a90add0b	0220-3232	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_C]/30[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3233_f52c1f8f-8d9f-6eb5-e053-2995a90a773f	0220-3233	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	200	[kp_C]/200[kp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3234_0a1f29ea-f6ef-68a4-e063-6294a90adc40	0220-3234	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	1	[hp_M]/[hp_M]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3235_0a1f3256-dc5a-91b7-e063-6394a90a0de4	0220-3235	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	10	[hp_M]/10[hp_M]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3236_00edfde0-0394-2226-e063-6294a90af199	0220-3236	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	12	[hp_X]/12[hp_X]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3237_0a1f3d5d-13d0-97b3-e063-6394a90aa250	0220-3237	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_X]/30[hp_X]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3240_0a1f2eba-4117-82ae-e063-6394a90a4b27	0220-3240	HUMAN OTC DRUG	Magnesia carbonica		MAGNESIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CARBONATE	9	[hp_C]/9[hp_C]			N	20241231
0220-3241_fbd36e0e-3dac-d023-e053-6294a90abb04	0220-3241	HUMAN OTC DRUG	Magnesia carbonica		MAGNESIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CARBONATE	30	[hp_C]/30[hp_C]			N	20241231
0220-3242_0a1f2eba-4118-82ae-e063-6394a90a4b27	0220-3242	HUMAN OTC DRUG	Magnesia carbonica		MAGNESIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CARBONATE	200	[kp_C]/200[kp_C]			N	20241231
0220-3243_0a1f450e-cc76-a0cc-e063-6394a90aeb38	0220-3243	HUMAN OTC DRUG	Magnesia carbonica		MAGNESIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CARBONATE	1	[hp_M]/[hp_M]			N	20241231
0220-3250_0a1f4673-3e0d-976b-e063-6394a90a5eed	0220-3250	HUMAN OTC DRUG	Magnesia carbonica		MAGNESIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CARBONATE	6	[hp_C]/6[hp_C]			N	20241231
0220-3254_0a1f2f64-3b0c-5e5c-e063-6294a90a7185	0220-3254	HUMAN OTC DRUG	Magnesia muriatica		MAGNESIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CHLORIDE	5	[hp_C]/5[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3256_0a1f2eba-411a-82ae-e063-6394a90a4b27	0220-3256	HUMAN OTC DRUG	Magnesia muriatica		MAGNESIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CHLORIDE	9	[hp_C]/9[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3259_f187cc92-7d1c-0627-e053-2995a90a71a1	0220-3259	HUMAN OTC DRUG	Magnesia muriatica		MAGNESIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CHLORIDE	30	[hp_C]/30[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3260_0a1f49d4-a5f3-a666-e063-6394a90a16c0	0220-3260	HUMAN OTC DRUG	Magnesia muriatica		MAGNESIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM CHLORIDE	200	[kp_C]/200[kp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3262_0a1f450e-cc77-a0cc-e063-6394a90aeb38	0220-3262	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	8	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3267_0a1f2eba-411b-82ae-e063-6394a90a4b27	0220-3267	HUMAN OTC DRUG	Magnesia sulphurica		MAGNESIUM SULFATE HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MAGNESIUM SULFATE HEPTAHYDRATE	30	[hp_C]/30[hp_C]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-3283_0a1f49d4-a5f4-a666-e063-6394a90a16c0	0220-3283	HUMAN OTC DRUG	Mancinella		HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	30	[hp_C]/30[hp_C]			N	20241231
0220-3291_0a1f2074-d586-5fbc-e063-6294a90a2456	0220-3291	HUMAN OTC DRUG	Manganum aceticum		MANGANESE ACETATE TETRAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MANGANESE ACETATE TETRAHYDRATE	5	[hp_C]/5[hp_C]	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0220-3292_0a1f2f64-3b0d-5e5c-e063-6294a90a7185	0220-3292	HUMAN OTC DRUG	Manganum aceticum		MANGANESE ACETATE TETRAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MANGANESE ACETATE TETRAHYDRATE	9	[hp_C]/9[hp_C]	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0220-3293_f187d180-7c48-7912-e053-2a95a90a9321	0220-3293	HUMAN OTC DRUG	Manganum aceticum		MANGANESE ACETATE TETRAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MANGANESE ACETATE TETRAHYDRATE	30	[hp_C]/30[hp_C]	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0220-3299_0a1f29ea-f6f0-68a4-e063-6294a90adc40	0220-3299	HUMAN OTC DRUG	Manganum metallicum		MANGANESE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MANGANESE	30	[hp_C]/30[hp_C]			N	20241231
0220-3327_0a1f49d4-a5f5-a666-e063-6394a90a16c0	0220-3327	HUMAN OTC DRUG	Medusa		PHYSALIA PHYSALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYSALIA PHYSALIS	6	[hp_C]/6[hp_C]			N	20241231
0220-3328_0a1f531e-55e4-7573-e063-6294a90aaa48	0220-3328	HUMAN OTC DRUG	Medusa		PHYSALIA PHYSALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYSALIA PHYSALIS	30	[hp_C]/30[hp_C]			N	20241231
0220-3329_0a1f531e-55e6-7573-e063-6294a90aaa48	0220-3329	HUMAN OTC DRUG	MEDULLA OSSIS SUIS		SUS SCROFA BONE MARROW	PELLET	ORAL	20180108		UNAPPROVED HOMEOPATHIC		BOIRON	SUS SCROFA BONE MARROW	8	[hp_X]/8[hp_X]			N	20241231
0220-3335_0a1f3256-dc5d-91b7-e063-6394a90a0de4	0220-3335	HUMAN OTC DRUG	Melilotus officinalis		MELILOTUS OFFICINALIS TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MELILOTUS OFFICINALIS TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-3339_0a1f531e-55e7-7573-e063-6294a90aaa48	0220-3339	HUMAN OTC DRUG	Melissa officinalis		MELISSA OFFICINALIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MELISSA OFFICINALIS	30	[hp_C]/30[hp_C]			N	20241231
0220-3363_0a1f4673-3e0f-976b-e063-6394a90a5eed	0220-3363	HUMAN OTC DRUG	Menyanthes trifoliata		MENYANTHES TRIFOLIATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MENYANTHES TRIFOLIATA	6	[hp_C]/6[hp_C]			N	20241231
0220-3367_0a1f531e-55e8-7573-e063-6294a90aaa48	0220-3367	HUMAN OTC DRUG	Mephitis mephitica		MEPHITIS MEPHITIS ANAL GLAND FLUID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MEPHITIS MEPHITIS ANAL GLAND FLUID	6	[hp_C]/6[hp_C]			N	20241231
0220-3372_ff0914cb-1a38-7a0d-e053-6394a90adaeb	0220-3372	HUMAN OTC DRUG	Mercurius dulcis		CALOMEL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALOMEL	12	[hp_C]/12[hp_C]			N	20241231
0220-3373_0a1f4673-3e10-976b-e063-6394a90a5eed	0220-3373	HUMAN OTC DRUG	Mercurius dulcis		CALOMEL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALOMEL	30	[hp_C]/30[hp_C]			N	20241231
0220-3377_0a1f38b6-4e1b-9ba9-e063-6394a90ac482	0220-3377	HUMAN OTC DRUG	Mercurius corrosivus		MERCURIC CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC CHLORIDE	1	[hp_M]/[hp_M]			N	20241231
0220-3380_f19ebda3-2810-8fd9-e053-2995a90a85af	0220-3380	HUMAN OTC DRUG	Mercurius corrosivus		MERCURIC CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC CHLORIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-3381_097e67bf-c462-cbd8-e063-6294a90ab34f	0220-3381	HUMAN OTC DRUG	Mercurius corrosivus		MERCURIC CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC CHLORIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-3384_f187d890-3904-8614-e053-2a95a90ab91d	0220-3384	HUMAN OTC DRUG	Mercurius corrosivus		MERCURIC CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC CHLORIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-3385_0a1f450e-cc78-a0cc-e063-6394a90aeb38	0220-3385	HUMAN OTC DRUG	Mercurius corrosivus		MERCURIC CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC CHLORIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-3387_0a1f49d4-a5f6-a666-e063-6394a90a16c0	0220-3387	HUMAN OTC DRUG	Mercurius corrosivus		MERCURIC CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC CHLORIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-3391_f2927b24-040c-df7f-e053-2995a90ac453	0220-3391	HUMAN OTC DRUG	Mercurius cyanatus		MERCURIC CYANIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC CYANIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-3395_f7e57231-751e-479e-e053-6294a90a2a26	0220-3395	HUMAN OTC DRUG	Mercurius dulcis		CALOMEL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CALOMEL	9	[hp_C]/9[hp_C]			N	20241231
0220-3401_0c05e75e-4821-22e3-e063-6294a90a2a1e	0220-3401	HUMAN OTC DRUG	MERCURIUS IODATUS RUBER		MERCURIC IODIDE	PELLET	ORAL	20240101		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC IODIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-3403_f2927b24-040d-df7f-e053-2995a90ac453	0220-3403	HUMAN OTC DRUG	Mercurius iodatus ruber		MERCURIC IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC IODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-3405_f9138e8a-e4f5-4372-e053-6394a90a1370	0220-3405	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	30	[hp_C]/30[hp_C]			N	20241231
0220-3408_f528d6f0-8c0d-48a0-e053-2a95a90ad54f	0220-3408	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	6	[hp_C]/6[hp_C]			N	20241231
0220-3409_0a1f4673-3e12-976b-e063-6394a90a5eed	0220-3409	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	9	[hp_C]/9[hp_C]			N	20241231
0220-3413_0a1f531e-55e9-7573-e063-6294a90aaa48	0220-3413	HUMAN OTC DRUG	Mercurius sulphuratus ruber		MERCURIC SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC SULFIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-3416_0a1f49d4-a5f7-a666-e063-6394a90a16c0	0220-3416	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	12	[hp_C]/12[hp_C]			N	20241231
0220-3417_f187cc92-7d1d-0627-e053-2995a90a71a1	0220-3417	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	15	[hp_C]/15[hp_C]			N	20241231
0220-3419_0a1f49d4-a5f8-a666-e063-6394a90a16c0	0220-3419	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	30	[hp_X]/1			N	20241231
0220-3424_0a1f6431-7a1f-aa57-e063-6394a90a9687	0220-3424	HUMAN OTC DRUG	Mercurius sulphuratus ruber		MERCURIC SULFIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIC SULFIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-3426_f2b94137-205a-1c77-e053-2a95a90afc15	0220-3426	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	200	[kp_C]/200[kp_C]			N	20241231
0220-3429_0a1f4673-3e13-976b-e063-6394a90a5eed	0220-3429	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	1	[hp_M]/[hp_M]			N	20241231
0220-3430_f60007c0-9b0a-273c-e053-2995a90a77d9	0220-3430	HUMAN OTC DRUG	Mercurius solubilis		MERCURIUS SOLUBILIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURIUS SOLUBILIS	10	[hp_M]/10[hp_M]			N	20241231
0220-3432_0a1f38b6-4e1e-9ba9-e063-6394a90ac482	0220-3432	HUMAN OTC DRUG	Mercurius vivus		MERCURY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURY	12	[hp_C]/1			N	20241231
0220-3438_0a1f7394-bd4b-b627-e063-6394a90a0a90	0220-3438	HUMAN OTC DRUG	Mercurius vivus		MERCURY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURY	1	[hp_M]/[hp_M]			N	20241231
0220-3441_0a1f450e-cc7a-a0cc-e063-6394a90aeb38	0220-3441	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	6	[hp_X]/1			N	20241231
0220-3442_f528dca9-23d9-b822-e053-2a95a90ae583	0220-3442	HUMAN OTC DRUG	Mercurius vivus		MERCURY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURY	30	[hp_C]/30[hp_C]			N	20241231
0220-3443_f7073f3e-4d1c-444e-e053-6294a90ac643	0220-3443	HUMAN OTC DRUG	Mercurius vivus		MERCURY	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MERCURY	200	[kp_C]/200[kp_C]			N	20241231
0220-3445_f52935f8-31fc-f420-e053-2a95a90a3419	0220-3445	HUMAN OTC DRUG	Millefolium		ACHILLEA MILLEFOLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACHILLEA MILLEFOLIUM	6	[hp_C]/6[hp_C]			N	20241231
0220-3446_f52c0a91-ded9-8768-e053-2a95a90a23f4	0220-3446	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	6	[hp_C]/6[hp_C]			N	20241231
0220-3447_0868dae9-90b3-0265-e063-6294a90a7694	0220-3447	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	9	[hp_C]/9[hp_C]			N	20241231
0220-3450_0a1f75ea-3aad-9953-e063-6294a90a4323	0220-3450	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	12	[hp_C]/12[hp_C]			N	20241231
0220-3451_0a1f7394-bd4c-b627-e063-6394a90a0a90	0220-3451	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	15	[hp_C]/15[hp_C]			N	20241231
0220-3454_f52b8a6c-d251-11e0-e053-2995a90a48f1	0220-3454	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-3457_0a0b1f9e-1675-1b36-e063-6394a90abcac	0220-3457	HUMAN OTC DRUG	Momordica balsamina		MOMORDICA BALSAMINA IMMATURE FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MOMORDICA BALSAMINA IMMATURE FRUIT	30	[hp_C]/30[hp_C]			N	20241231
0220-3458_f70729a0-53f6-84c2-e053-6394a90a0dd4	0220-3458	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	200	[kp_C]/200[kp_C]			N	20241231
0220-3459_08f2f8ae-fa65-47c6-e063-6394a90a752f	0220-3459	HUMAN OTC DRUG	Mezereum		DAPHNE MEZEREUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DAPHNE MEZEREUM BARK	1	[hp_M]/[hp_M]			N	20241231
0220-3461_0a1f7d44-c337-a4dd-e063-6294a90ac0de	0220-3461	HUMAN PRESCRIPTION DRUG	Morbillinum		MEASLES VIRUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MEASLES VIRUS	30	[hp_C]/30[hp_C]			N	20241231
0220-3462_0a1f75ea-3ab2-9953-e063-6294a90a4323	0220-3462	HUMAN OTC DRUG	Millefolium		ACHILLEA MILLEFOLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACHILLEA MILLEFOLIUM	9	[hp_C]/9[hp_C]			N	20241231
0220-3463_0a1f75ea-3ab3-9953-e063-6294a90a4323	0220-3463	HUMAN OTC DRUG	Millefolium		ACHILLEA MILLEFOLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ACHILLEA MILLEFOLIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-3466_0a1f97b8-3909-bdf0-e063-6394a90aafe0	0220-3466	HUMAN OTC DRUG	Muriaticum acidum		HYDROCHLORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROCHLORIC ACID	9	[hp_C]/9[hp_C]			N	20241231
0220-3467_f9153e41-24f0-f46e-e053-6294a90aa971	0220-3467	HUMAN OTC DRUG	Muriaticum acidum		HYDROCHLORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROCHLORIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-3469_0a1f98bc-1f94-a898-e063-6294a90af5c7	0220-3469	HUMAN OTC DRUG	Murex purpurea		HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE	15	[hp_C]/15[hp_C]			N	20241231
0220-3470_0a1f895c-d34a-b78f-e063-6394a90a542b	0220-3470	HUMAN OTC DRUG	Murex purpurea		HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE	30	[hp_C]/30[hp_C]			N	20241231
0220-3473_0a1f98bc-1f95-a898-e063-6294a90af5c7	0220-3473	HUMAN OTC DRUG	Muriaticum acidum		HYDROCHLORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROCHLORIC ACID	6	[hp_C]/6[hp_C]			N	20241231
0220-3474_0a1f9be1-3bae-be83-e063-6394a90a8b2f	0220-3474	HUMAN OTC DRUG	Muriaticum acidum		HYDROCHLORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROCHLORIC ACID	200	[kp_C]/200[kp_C]			N	20241231
0220-3475_0a1f9be1-3baf-be83-e063-6394a90a8b2f	0220-3475	HUMAN OTC DRUG	Muriaticum acidum		HYDROCHLORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HYDROCHLORIC ACID	1	[hp_M]/[hp_M]			N	20241231
0220-3478_0a1f7d44-c338-a4dd-e063-6294a90ac0de	0220-3478	HUMAN OTC DRUG	Myristica sebifera		VIROLA SEBIFERA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIROLA SEBIFERA RESIN	6	[hp_C]/6[hp_C]			N	20241231
0220-3479_0a1fa1d1-0fcd-bbdd-e063-6394a90a80d1	0220-3479	HUMAN OTC DRUG	Myristica sebifera		VIROLA SEBIFERA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIROLA SEBIFERA RESIN	9	[hp_C]/9[hp_C]			N	20241231
0220-3481_0a1f7d44-c33a-a4dd-e063-6294a90ac0de	0220-3481	HUMAN OTC DRUG	Mygale		AVICULARIA AVICULARIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	AVICULARIA AVICULARIA	30	[hp_C]/30[hp_C]			N	20241231
0220-3489_0a1fa1d1-0fce-bbdd-e063-6394a90a80d1	0220-3489	HUMAN OTC DRUG	Myristica sebifera		VIROLA SEBIFERA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIROLA SEBIFERA RESIN	3	[hp_X]/3[hp_X]			N	20241231
0220-3490_f2b94137-205b-1c77-e053-2a95a90afc15	0220-3490	HUMAN OTC DRUG	Myristica sebifera		VIROLA SEBIFERA RESIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIROLA SEBIFERA RESIN	30	[hp_C]/30[hp_C]			N	20241231
0220-3531_f187c21d-6588-0629-e053-2995a90a80ea	0220-3531	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	5	[hp_C]/5[hp_C]			N	20241231
0220-3532_0a1facfa-d401-c646-e063-6394a90a9e80	0220-3532	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	6	[hp_C]/6[hp_C]			N	20241231
0220-3533_0a1fa998-dcd2-c181-e063-6294a90ad098	0220-3533	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	9	[hp_C]/9[hp_C]			N	20241231
0220-3534_0a1f9be1-3bb0-be83-e063-6394a90a8b2f	0220-3534	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	12	[hp_C]/12[hp_C]			N	20241231
0220-3535_0a1f97b8-394b-bdf0-e063-6394a90aafe0	0220-3535	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	15	[hp_C]/15[hp_C]			N	20241231
0220-3536_f187de4d-ba5a-9da2-e053-2a95a90a0a79	0220-3536	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	30	[hp_C]/30[hp_C]			N	20241231
0220-3537_0a1fa998-dcd3-c181-e063-6294a90ad098	0220-3537	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	200	[kp_C]/200[kp_C]			N	20241231
0220-3538_0a1fb6ac-606a-ca01-e063-6394a90a4df8	0220-3538	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	1	[hp_M]/[hp_M]			N	20241231
0220-3541_003a848f-c8d2-0cb1-e063-6294a90a6602	0220-3541	HUMAN OTC DRUG	Naja tripudians		NAJA NAJA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NAJA NAJA VENOM	9	[hp_C]/9[hp_C]			N	20241231
0220-3542_0a1fb81c-5f56-c27a-e063-6294a90a7dce	0220-3542	HUMAN OTC DRUG	Naja tripudians		NAJA NAJA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NAJA NAJA VENOM	30	[hp_C]/30[hp_C]			N	20241231
0220-3543_0410b28b-3421-8f5e-e063-6394a90aa894	0220-3543	HUMAN OTC DRUG	Naja tripudians		NAJA NAJA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NAJA NAJA VENOM	200	[kp_C]/200[kp_C]			N	20241231
0220-3544_00edbed0-9988-a9fb-e063-6394a90ada4a	0220-3544	HUMAN OTC DRUG	Naja tripudians		NAJA NAJA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NAJA NAJA VENOM	1	[hp_M]/[hp_M]			N	20241231
0220-3549_0869697d-5dd7-011a-e063-6294a90aa38e	0220-3549	HUMAN OTC DRUG	Naja tripudians		NAJA NAJA VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NAJA NAJA VENOM	6	[hp_C]/6[hp_C]			N	20241231
0220-3553_f2926b37-e943-5f45-e053-2a95a90a46f1	0220-3553	HUMAN OTC DRUG	Naphthalinum		NAPHTHALENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NAPHTHALENE	30	[hp_C]/30[hp_C]			N	20241231
0220-3577_0a1fb81c-5f57-c27a-e063-6294a90a7dce	0220-3577	HUMAN OTC DRUG	Natrum carbonicum		SODIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CARBONATE	6	[hp_X]/1			N	20241231
0220-3582_0a1fb6ac-606c-ca01-e063-6394a90a4df8	0220-3582	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	12	[hp_X]/12[hp_X]			N	20241231
0220-3583_0a1fa998-dcd6-c181-e063-6294a90ad098	0220-3583	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-3586_f2f67abe-f219-a19e-e053-2995a90a6b3f	0220-3586	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	6	[hp_X]/6[hp_X]			N	20241231
0220-3587_0a1fa998-dcd7-c181-e063-6294a90ad098	0220-3587	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	8	[hp_X]/8[hp_X]			N	20241231
0220-3590_f2f3ae88-0165-46cb-e053-2995a90aa3cb	0220-3590	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	10	[hp_M]/10[hp_M]			N	20241231
0220-3593_f527adf2-7940-be8b-e053-2a95a90a8d64	0220-3593	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	3	[hp_X]/1			N	20241231
0220-3595_f2f67ab8-49a3-23df-e053-2a95a90a4050	0220-3595	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-3596_08688808-a73e-f955-e063-6394a90a4f42	0220-3596	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-3597_ff091148-a5d4-6c9a-e053-6294a90a1c81	0220-3597	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-3598_f52b8a6c-d252-11e0-e053-2995a90a48f1	0220-3598	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-3599_f2f66b96-f934-7454-e053-2a95a90a791a	0220-3599	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-3600_f2f67ab8-49a2-23df-e053-2a95a90a4050	0220-3600	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-3601_0a1fb7cb-bb05-8467-e063-6394a90a93f3	0220-3601	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM CHLORIDE	1	[hp_M]/[hp_M]			N	20241231
0220-3604_0a1fa998-dcd9-c181-e063-6294a90ad098	0220-3604	HUMAN OTC DRUG	Natrum phosphoricum		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_C]/6[hp_C]			N	20241231
0220-3605_f9117302-74ad-6131-e053-6394a90a36ce	0220-3605	HUMAN OTC DRUG	Natrum phosphoricum		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	12	[hp_C]/12[hp_C]			N	20241231
0220-3608_0a1fbdfd-54f2-cbfd-e063-6394a90a2db8	0220-3608	HUMAN OTC DRUG	Natrum phosphoricum		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	30	[hp_C]/30[hp_C]			N	20241231
0220-3609_0410a57d-5332-7a32-e063-6394a90a6162	0220-3609	HUMAN OTC DRUG	Natrum phosphoricum		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	200	[kp_C]/200[kp_C]			N	20241231
0220-3611_f5281961-3ea2-18bf-e053-2995a90aa2f1	0220-3611	HUMAN OTC DRUG	Natrum phosphoricum		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_X]/1			N	20241231
0220-3617_0410afa8-1af3-f44b-e063-6294a90a67c7	0220-3617	HUMAN OTC DRUG	Natrum phosphoricum		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	1	[hp_M]/[hp_M]			N	20241231
0220-3626_0a0bc2e1-cc51-5dc1-e063-6394a90aadb1	0220-3626	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	5	[hp_C]/5[hp_C]			N	20241231
0220-3627_f2926b37-e942-5f45-e053-2a95a90a46f1	0220-3627	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	6	[hp_C]/6[hp_C]			N	20241231
0220-3629_f52c47eb-a095-75aa-e053-2a95a90a4f3b	0220-3629	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	6	[hp_X]/1			N	20241231
0220-3631_0a1fb6ac-606e-ca01-e063-6394a90a4df8	0220-3631	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	10	[hp_M]/10[hp_M]			N	20241231
0220-3634_003ad7b2-d153-4924-e063-6394a90a2232	0220-3634	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	9	[hp_C]/9[hp_C]			N	20241231
0220-3635_0a1f9be1-3bb3-be83-e063-6394a90a8b2f	0220-3635	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	12	[hp_C]/12[hp_C]			N	20241231
0220-3638_f19d3bef-676b-0c62-e053-2995a90affa5	0220-3638	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	15	[hp_C]/15[hp_C]			N	20241231
0220-3639_f913e22d-1f2f-b142-e053-6394a90a1659	0220-3639	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	30	[hp_C]/30[hp_C]			N	20241231
0220-3642_f2f67abe-f21b-a19e-e053-2995a90a6b3f	0220-3642	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	200	[kp_C]/200[kp_C]			N	20241231
0220-3643_0a1fbdfd-54f3-cbfd-e063-6394a90a2db8	0220-3643	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	1	[hp_M]/[hp_M]			N	20241231
0220-3646_00ee5460-4bbf-d276-e063-6294a90a88d0	0220-3646	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	12	[hp_X]/12[hp_X]			N	20241231
0220-3647_00ee5460-4bc1-d276-e063-6294a90a88d0	0220-3647	HUMAN OTC DRUG	Natrum sulphuricum		SODIUM SULFATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SODIUM SULFATE	30	[hp_X]/30[hp_X]			N	20241231
0220-3649_0a1fb7cb-bb06-8467-e063-6394a90a93f3	0220-3649	HUMAN OTC DRUG	Niccolum metallicum		NICKEL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NICKEL	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-3650_0a0b1eb8-f56a-0a67-e063-6394a90a6d44	0220-3650	HUMAN OTC DRUG	Niccolum metallicum		NICKEL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NICKEL	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0220-3657_0a1fa998-dcda-c181-e063-6294a90ad098	0220-3657	HUMAN OTC DRUG	Nicotinum		NICOTINE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NICOTINE	30	[hp_C]/30[hp_C]	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0220-3665_0a1fa998-dcdb-c181-e063-6294a90ad098	0220-3665	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	6	[hp_X]/1			N	20241231
0220-3677_0039e564-075e-619b-e063-6394a90a886c	0220-3677	HUMAN OTC DRUG	Nux moschata		NUTMEG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NUTMEG	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3681_09445992-8341-4bc7-e063-6394a90a4701	0220-3681	HUMAN OTC DRUG	Nux Vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20120101		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3683_0a1fbdfd-54f4-cbfd-e063-6394a90a2db8	0220-3683	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	3	[hp_C]/3[hp_C]			N	20241231
0220-3684_0a1fb81c-5f58-c27a-e063-6294a90a7dce	0220-3684	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	5	[hp_C]/5[hp_C]			N	20241231
0220-3685_f52b9a8c-ddb1-0f25-e053-2a95a90a3f7d	0220-3685	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	6	[hp_C]/6[hp_C]			N	20241231
0220-3686_f9117f36-2f0f-8d79-e053-6394a90a64af	0220-3686	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	9	[hp_C]/9[hp_C]			N	20241231
0220-3687_0a1fb7cb-bb08-8467-e063-6394a90a93f3	0220-3687	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	12	[hp_C]/12[hp_C]			N	20241231
0220-3688_0a1fb4b5-1483-c300-e063-6394a90a0779	0220-3688	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	15	[hp_C]/15[hp_C]			N	20241231
0220-3689_f2045e18-39f2-ed6b-e053-2a95a90a7294	0220-3689	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-3690_f7072bd0-b8e9-8692-e053-6394a90afd1f	0220-3690	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	200	[kp_C]/200[kp_C]			N	20241231
0220-3691_f60007c0-9b0b-273c-e053-2995a90a77d9	0220-3691	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	1	[hp_M]/[hp_M]			N	20241231
0220-3692_097dfa9e-8922-0796-e063-6394a90a3b87	0220-3692	HUMAN OTC DRUG	Nitricum acidum		NITRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NITRIC ACID	10	[hp_M]/10[hp_M]			N	20241231
0220-3695_0a1fb81c-5f5a-c27a-e063-6294a90a7dce	0220-3695	HUMAN OTC DRUG	Nux moschata		NUTMEG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NUTMEG	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3696_f7e57231-751f-479e-e053-6294a90a2a26	0220-3696	HUMAN OTC DRUG	Nux moschata		NUTMEG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NUTMEG	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3697_08695622-c17e-a9d2-e063-6294a90ad1fc	0220-3697	HUMAN OTC DRUG	Nux moschata		NUTMEG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NUTMEG	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3698_0a1fa998-dcdc-c181-e063-6294a90ad098	0220-3698	HUMAN OTC DRUG	Nux moschata		NUTMEG	PELLET	ORAL	19830303		UNAPPROVED MEDICAL GAS		Boiron	NUTMEG	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3699_0a1fb4b5-1484-c300-e063-6394a90a0779	0220-3699	HUMAN OTC DRUG	Nux moschata		NUTMEG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NUTMEG	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3702_0941d99b-60e3-e61a-e063-6394a90a54e3	0220-3702	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	5	[hp_C]/5[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3703_09420877-f476-98a1-e063-6294a90a05b8	0220-3703	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3704_0942185b-630b-193d-e063-6394a90a3437	0220-3704	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3705_09432f67-5c45-7510-e063-6394a90a1d5a	0220-3705	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3706_0943966b-1b28-b015-e063-6394a90a4267	0220-3706	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3707_0944a5d4-2cce-5f0d-e063-6394a90a8af9	0220-3707	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3708_093227d6-e122-8765-e063-6394a90aeef8	0220-3708	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3709_09431201-e7dd-7245-e063-6394a90ab555	0220-3709	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	10	[hp_M]/10[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3710_09441f78-7353-0cb3-e063-6394a90a46ab	0220-3710	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	4	[hp_X]/4[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3711_0942120a-b5ad-0ac3-e063-6394a90ae611	0220-3711	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	6	[hp_X]/6[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3712_0943894a-fe1a-66da-e063-6294a90aa6cf	0220-3712	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	12	[hp_X]/12[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3713_096f78cd-31ca-6262-e063-6394a90ab266	0220-3713	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRYCHNOS NUX-VOMICA SEED	30	[hp_X]/30[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-3744_f2f68cf0-d63b-6305-e053-2a95a90a5dc0	0220-3744	HUMAN OTC DRUG	Ocimum canum		OCIMUM AMERICANUM LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OCIMUM AMERICANUM LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-3752_0a20cdf1-400c-331f-e063-6394a90a04dc	0220-3752	HUMAN OTC DRUG	Oenanthe crocata		OENANTHE CROCATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OENANTHE CROCATA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-3757_0a21056c-3171-440e-e063-6294a90a75aa	0220-3757	HUMAN OTC DRUG	Oleander		NERIUM OLEANDER LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NERIUM OLEANDER LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-3760_0a2106c1-eb7d-4885-e063-6394a90a778e	0220-3760	HUMAN OTC DRUG	Oleander		NERIUM OLEANDER LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NERIUM OLEANDER LEAF	6	[hp_C]/6[hp_C]			N	20241231
0220-3796_0a2107cc-30c4-4bb8-e063-6394a90a9181	0220-3796	HUMAN OTC DRUG	Onosmodium virginianum		ONOSMODIUM VIRGINIANUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ONOSMODIUM VIRGINIANUM	30	[hp_C]/30[hp_C]			N	20241231
0220-3816_0a210914-9eb5-4244-e063-6394a90a9687	0220-3816	HUMAN PRESCRIPTION DRUG	Origanum marjorana		ORIGANUM MAJORANA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ORIGANUM MAJORANA	30	[hp_C]/30[hp_C]			N	20241231
0220-3820_0a210ac2-e5df-655f-e063-6294a90afb2d	0220-3820	HUMAN OTC DRUG	Ornithogalum umbellatum		ORNITHOGALUM UMBELLATUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ORNITHOGALUM UMBELLATUM	30	[hp_C]/30[hp_C]			N	20241231
0220-3840_0a2107cc-30cc-4bb8-e063-6394a90a9181	0220-3840	HUMAN OTC DRUG	Oxalicum acidum		OXALIC ACID DIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OXALIC ACID DIHYDRATE	6	[hp_C]/6[hp_C]			N	20241231
0220-3842_0a211521-c517-7c84-e063-6294a90a0a8a	0220-3842	HUMAN OTC DRUG	Oxalicum acidum		OXALIC ACID DIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OXALIC ACID DIHYDRATE	30	[hp_C]/30[hp_C]			N	20241231
0220-3900_0a0b34ba-2f56-27a4-e063-6394a90a0777	0220-3900	HUMAN OTC DRUG	Paeonia officinalis		PAEONIA OFFICINALIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PAEONIA OFFICINALIS ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-3901_0a21056c-3174-440e-e063-6294a90a75aa	0220-3901	HUMAN OTC DRUG	Paeonia officinalis		PAEONIA OFFICINALIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PAEONIA OFFICINALIS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-3904_0a2106c1-eb82-4885-e063-6394a90a778e	0220-3904	HUMAN OTC DRUG	Palladium metallicum		PALLADIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PALLADIUM	6	[hp_C]/6[hp_C]			N	20241231
0220-3905_f187d890-3906-8614-e053-2a95a90ab91d	0220-3905	HUMAN OTC DRUG	Palladium metallicum		PALLADIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PALLADIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-3920_0a2107cc-30cd-4bb8-e063-6394a90a9181	0220-3920	HUMAN OTC DRUG	Pareira brava		CHONDRODENDRON TOMENTOSUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHONDRODENDRON TOMENTOSUM ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-3921_0a213722-cf6b-8932-e063-6294a90a7550	0220-3921	HUMAN OTC DRUG	Pareira brava		CHONDRODENDRON TOMENTOSUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHONDRODENDRON TOMENTOSUM ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-3922_0039e564-075f-619b-e063-6394a90a886c	0220-3922	HUMAN OTC DRUG	Pareira brava		CHONDRODENDRON TOMENTOSUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CHONDRODENDRON TOMENTOSUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-3928_0a21088a-b735-4bbe-e063-6394a90a0c1a	0220-3928	HUMAN OTC DRUG	Paris quadrifolia		PARIS QUADRIFOLIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PARIS QUADRIFOLIA	30	[hp_C]/30[hp_C]			N	20241231
0220-3929_f187d890-3907-8614-e053-2a95a90ab91d	0220-3929	HUMAN OTC DRUG	Passiflora incarnata		PASSIFLORA INCARNATA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PASSIFLORA INCARNATA FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-3930_003abd8e-d4b4-fc69-e063-6394a90a381f	0220-3930	HUMAN OTC DRUG	Passiflora incarnata		PASSIFLORA INCARNATA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PASSIFLORA INCARNATA FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-3933_f600a30c-0576-2f36-e053-2a95a90a4da7	0220-3933	HUMAN OTC DRUG	Passiflora incarnata		PASSIFLORA INCARNATA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PASSIFLORA INCARNATA FLOWERING TOP	30	[hp_X]/30[hp_X]			N	20241231
0220-3936_00ee5368-11f3-a88e-e063-6294a90a87b0	0220-3936	HUMAN OTC DRUG	Passiflora incarnata		PASSIFLORA INCARNATA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PASSIFLORA INCARNATA FLOWERING TOP	4	[hp_X]/1			N	20241231
0220-3937_f19e943e-307f-0e8a-e053-2a95a90ae031	0220-3937	HUMAN OTC DRUG	Passiflora incarnata		PASSIFLORA INCARNATA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PASSIFLORA INCARNATA FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-3968_0a213597-7c17-54ba-e063-6394a90a301b	0220-3968	HUMAN PRESCRIPTION DRUG	Pertussinum		HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED	30	[hp_C]/30[hp_C]			N	20241231
0220-3969_f7e5968d-d28a-a0f2-e053-6394a90a42a4	0220-3969	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	5	[hp_C]/5[hp_C]			N	20241231
0220-3970_003a848f-c8d3-0cb1-e063-6294a90a6602	0220-3970	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	6	[hp_C]/6[hp_C]			N	20241231
0220-3973_fbd151be-7730-e46c-e053-6394a90a4c3f	0220-3973	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	1	[hp_M]/[hp_M]			N	20241231
0220-3976_f60067a6-1dea-3199-e053-2995a90a8f6f	0220-3976	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	30	[hp_X]/1			N	20241231
0220-3977_f52935f8-31fa-f420-e053-2a95a90a3419	0220-3977	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	9	[hp_C]/9[hp_C]			N	20241231
0220-3978_f7e594c0-9067-a31c-e053-6294a90a8cea	0220-3978	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	12	[hp_C]/12[hp_C]			N	20241231
0220-3980_0a0b1620-07c4-16fc-e063-6394a90ac9e8	0220-3980	HUMAN PRESCRIPTION DRUG	Petroselinum sativum		PETROSELINUM CRISPUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PETROSELINUM CRISPUM	30	[hp_C]/30[hp_C]			N	20241231
0220-3985_f2f67a5f-ff3c-23dd-e053-2a95a90a055d	0220-3985	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	30	[hp_C]/30[hp_C]			N	20241231
0220-3986_f2f68c92-2479-6aa4-e053-2a95a90a72a9	0220-3986	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KEROSENE	200	[kp_C]/200[kp_C]			N	20241231
0220-3988_0a0b0c23-8bf3-0efd-e063-6394a90ad797	0220-3988	HUMAN OTC DRUG	Phellandrium aquaticum		OENANTHE AQUATICA FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	OENANTHE AQUATICA FRUIT	30	[hp_C]/30[hp_C]			N	20241231
0220-3993_f5296adf-af66-a8cd-e053-2a95a90adcfc	0220-3993	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	6	[hp_C]/6[hp_C]			N	20241231
0220-3994_f911b3e3-f8f0-4ba2-e053-6294a90aaa97	0220-3994	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	9	[hp_C]/9[hp_C]			N	20241231
0220-4000_0a2132cb-07d3-8c92-e063-6294a90a97fd	0220-4000	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	6	[hp_X]/1			N	20241231
0220-4004_00f16de0-5e03-2f26-e063-6294a90ace7b	0220-4004	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	12	[hp_X]/1			N	20241231
0220-4007_0a0bdefc-0ba0-682e-e063-6394a90abfbb	0220-4007	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	12	[hp_C]/12[hp_C]			N	20241231
0220-4008_0a2107cc-30cf-4bb8-e063-6394a90a9181	0220-4008	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	15	[hp_C]/15[hp_C]			N	20241231
0220-4009_fbd53e5f-bbf2-75b4-e053-6394a90af028	0220-4009	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-4010_0a213597-7c1a-54ba-e063-6394a90a301b	0220-4010	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	200	[kp_C]/200[kp_C]			N	20241231
0220-4011_0a2132cb-07d4-8c92-e063-6294a90a97fd	0220-4011	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	1	[hp_M]/[hp_M]			N	20241231
0220-4012_0a2132cb-07d5-8c92-e063-6294a90a97fd	0220-4012	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORIC ACID	10	[hp_M]/10[hp_M]			N	20241231
0220-4015_00ed4c30-6918-d7b8-e063-6394a90a31dc	0220-4015	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	30	[hp_X]/30[hp_X]			N	20241231
0220-4018_0a2107cc-30d0-4bb8-e063-6394a90a9181	0220-4018	HUMAN OTC DRUG	Physostigma venenosum		PHYSOSTIGMA VENENOSUM SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYSOSTIGMA VENENOSUM SEED	6	[hp_X]/6[hp_X]			N	20241231
0220-4019_f2f5942b-af82-234c-e053-2a95a90ad689	0220-4019	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	10	[hp_M]/10[hp_M]			N	20241231
0220-4022_f913c6ad-148f-8fd8-e053-6294a90a6ab2	0220-4022	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	6	[hp_X]/1			N	20241231
0220-4023_0a2107cc-30d1-4bb8-e063-6394a90a9181	0220-4023	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	5	[hp_C]/5[hp_C]			N	20241231
0220-4024_f2f5949e-4480-2724-e053-2a95a90a9f9a	0220-4024	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	6	[hp_C]/6[hp_C]			N	20241231
0220-4027_003ad7b2-d14c-4924-e063-6394a90a2232	0220-4027	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	1	[hp_M]/[hp_M]			N	20241231
0220-4030_0a0b1620-07c1-16fc-e063-6394a90ac9e8	0220-4030	HUMAN OTC DRUG	Picricum acidum		PICRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PICRIC ACID	6	[hp_C]/6[hp_C]			N	20241231
0220-4031_f6003241-59ba-1c87-e053-2a95a90a7dbe	0220-4031	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	9	[hp_C]/9[hp_C]			N	20241231
0220-4032_0a215248-f2c4-8e1a-e063-6294a90a8ff3	0220-4032	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	12	[hp_C]/12[hp_C]			N	20241231
0220-4035_f7e5a410-72d2-b778-e053-6294a90a79a7	0220-4035	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	15	[hp_C]/15[hp_C]			N	20241231
0220-4036_fbd53dfa-92dd-c189-e053-6394a90ae1bf	0220-4036	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	30	[hp_C]/30[hp_C]			N	20241231
0220-4040_f2f59273-db6c-464f-e053-2a95a90ac16b	0220-4040	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHOSPHORUS	200	[kp_C]/200[kp_C]			N	20241231
0220-4043_f91123b7-f57e-6b11-e053-6294a90a9536	0220-4043	HUMAN OTC DRUG	Physostigma venenosum		PHYSOSTIGMA VENENOSUM SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYSOSTIGMA VENENOSUM SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-4044_0a213722-cf6f-8932-e063-6294a90a7550	0220-4044	HUMAN OTC DRUG	Physostigma venenosum		PHYSOSTIGMA VENENOSUM SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYSOSTIGMA VENENOSUM SEED	9	[hp_C]/9[hp_C]			N	20241231
0220-4050_0a2156c6-f8bf-4d37-e063-6394a90ae8d4	0220-4050	HUMAN OTC DRUG	Pilocarpus		PILOCARPUS JABORANDII LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PILOCARPUS JABORANDI LEAF	5	[hp_C]/5[hp_C]			N	20241231
0220-4051_0a213caf-a848-5d10-e063-6394a90a8658	0220-4051	HUMAN OTC DRUG	Physostigma venenosum		PHYSOSTIGMA VENENOSUM SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYSOSTIGMA VENENOSUM SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-4055_0a213722-cf70-8932-e063-6294a90a7550	0220-4055	HUMAN OTC DRUG	Picricum acidum		PICRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PICRIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-4056_0a213597-7c1c-54ba-e063-6394a90a301b	0220-4056	HUMAN OTC DRUG	Picricum acidum		PICRIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PICRIC ACID	200	[kp_C]/200[kp_C]			N	20241231
0220-4059_0a215c18-671e-6498-e063-6394a90a5b3a	0220-4059	HUMAN OTC DRUG	Pilocarpus		PILOCARPUS JABORANDII LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PILOCARPUS JABORANDII LEAF	6	[hp_C]/6[hp_C]			N	20241231
0220-4060_0a2156c6-f8c2-4d37-e063-6394a90ae8d4	0220-4060	HUMAN OTC DRUG	Pilocarpus		PILOCARPUS JABORANDII LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PILOCARPUS JABORANDII LEAF	9	[hp_C]/9[hp_C]			N	20241231
0220-4062_0a2151ce-82f0-629a-e063-6394a90a7e1b	0220-4062	HUMAN OTC DRUG	Piper methysticum		MACROPIPER METHYSTICUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	MACROPIPER METHYSTICUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4063_0a213597-7c1d-54ba-e063-6394a90a301b	0220-4063	HUMAN OTC DRUG	Pilocarpus		PILOCARPUS JABORANDII LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PILOCARPUS JABORANDII LEAF	15	[hp_C]/15[hp_C]			N	20241231
0220-4064_0a2156c6-f8c3-4d37-e063-6394a90ae8d4	0220-4064	HUMAN OTC DRUG	Pilocarpus		PILOCARPUS JABORANDII LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PILOCARPUS JABORANDII LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-4078_0a21619d-46bd-69a9-e063-6394a90a84ae	0220-4078	HUMAN PRESCRIPTION DRUG	Pituitarum posterium		SUS SCROFA PITUITARY GLAND, POSTERIOR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SUS SCROFA PITUITARY GLAND, POSTERIOR	30	[hp_C]/30[hp_C]			N	20241231
0220-4083_0a215248-f2c6-8e1a-e063-6294a90a8ff3	0220-4083	HUMAN OTC DRUG	Platinum metallicum		PLATINUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PLATINUM	12	[hp_C]/12[hp_C]			N	20241231
0220-4084_08688808-a743-f955-e063-6394a90a4f42	0220-4084	HUMAN OTC DRUG	Platinum metallicum		PLATINUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PLATINUM	30	[hp_C]/30[hp_C]			N	20241231
0220-4086_0a215248-f2c7-8e1a-e063-6294a90a8ff3	0220-4086	HUMAN OTC DRUG	Plantago major		PLANTAGO MAJOR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PLANTAGO MAJOR	6	[hp_C]/6[hp_C]			N	20241231
0220-4087_f2f59ef5-1ea8-0dca-e053-2a95a90a67a8	0220-4087	HUMAN OTC DRUG	Plantago major		PLANTAGO MAJOR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PLANTAGO MAJOR	30	[hp_C]/30[hp_C]			N	20241231
0220-4088_0a2151ce-82f1-629a-e063-6394a90a7e1b	0220-4088	HUMAN OTC DRUG	Plantago major		PLANTAGO MAJOR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PLANTAGO MAJOR	200	[kp_C]/200[kp_C]			N	20241231
0220-4094_0a213722-cf72-8932-e063-6294a90a7550	0220-4094	HUMAN OTC DRUG	Platinum metallicum		PLATINUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PLATINUM	6	[hp_C]/6[hp_C]			N	20241231
0220-4107_f52b8a6c-d253-11e0-e053-2995a90a48f1	0220-4107	HUMAN OTC DRUG	Plumbum metallicum		LEAD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEAD	200	[kp_C]/200[kp_C]			N	20241231
0220-4108_097e30f5-59b1-b646-e063-6294a90a2320	0220-4108	HUMAN OTC DRUG	Plumbum metallicum		LEAD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEAD	1	[hp_M]/[hp_M]			N	20241231
0220-4111_0a0c002f-48f3-df87-e063-6294a90a74b1	0220-4111	HUMAN OTC DRUG	Plumbum metallicum		LEAD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEAD	15	[hp_C]/15[hp_C]			N	20241231
0220-4112_003bd28b-f9f7-c9df-e063-6394a90a46e7	0220-4112	HUMAN OTC DRUG	Plumbum metallicum		LEAD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEAD	30	[hp_C]/30[hp_C]			N	20241231
0220-4115_0a213722-cf73-8932-e063-6294a90a7550	0220-4115	HUMAN OTC DRUG	Plumbum metallicum		LEAD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEAD	9	[hp_C]/9[hp_C]			N	20241231
0220-4116_0a2151ce-82f3-629a-e063-6394a90a7e1b	0220-4116	HUMAN OTC DRUG	Plumbum metallicum		LEAD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEAD	12	[hp_C]/12[hp_C]			N	20241231
0220-4122_0a2151ce-82f5-629a-e063-6394a90a7e1b	0220-4122	HUMAN OTC DRUG	Plumbum metallicum		LEAD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LEAD	6	[hp_C]/1			N	20241231
0220-4124_0a216e76-f636-e85e-e063-6294a90a0917	0220-4124	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	30	[hp_X]/30[hp_X]			N	20241231
0220-4127_f2f5949e-4482-2724-e053-2a95a90a9f9a	0220-4127	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	6	[hp_C]/6[hp_C]			N	20241231
0220-4128_f187c21d-6589-0629-e053-2995a90a80ea	0220-4128	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	9	[hp_C]/9[hp_C]			N	20241231
0220-4130_00ee5460-4bc0-d276-e063-6294a90a88d0	0220-4130	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	6	[hp_X]/1			N	20241231
0220-4131_0a213caf-a84a-5d10-e063-6394a90a8658	0220-4131	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	12	[hp_C]/12[hp_C]			N	20241231
0220-4134_f2f3634c-027b-6347-e053-2a95a90a2037	0220-4134	HUMAN OTC DRUG	Polygonum punctatum		PERSICARIA PUNCTATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PERSICARIA PUNCTATA	6	[hp_X]/6[hp_X]			N	20241231
0220-4135_0a2156c6-f8c4-4d37-e063-6394a90ae8d4	0220-4135	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	15	[hp_C]/15[hp_C]			N	20241231
0220-4136_f67d6f73-88d5-2031-e053-2995a90a3b09	0220-4136	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	30	[hp_C]/30[hp_C]			N	20241231
0220-4139_0a21710c-d93e-e85a-e063-6294a90a892b	0220-4139	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	200	[kp_C]/200[kp_C]			N	20241231
0220-4140_0a2156c6-f8c5-4d37-e063-6394a90ae8d4	0220-4140	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PODOPHYLLUM	1	[hp_M]/[hp_M]			N	20241231
0220-4163_0a218244-fdcf-699d-e063-6394a90aa4e9	0220-4163	HUMAN PRESCRIPTION DRUG	Proteus		Proteus inconstans,Proteus mirabilis,Proteus morgani,Proteus rettgeri,Proteus vulgaris	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PROTEUS INCONSTANS; PROTEUS MIRABILIS; PROTEUS MORGANII; PROTEUS RETTGERI; PROTEUS VULGARIS	8; 8; 8; 8; 8	[hp_X]/8[hp_X]; [hp_X]/8[hp_X]; [hp_X]/8[hp_X]; [hp_X]/8[hp_X]; [hp_X]/8[hp_X]			N	20241231
0220-4167_0a21619d-46be-69a9-e063-6394a90a84ae	0220-4167	HUMAN PRESCRIPTION DRUG	Proteus		PROTEUS INCONSTANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PROTEUS INCONSTANS	30	[hp_C]/30[hp_C]			N	20241231
0220-4170_0a0ad6a2-addf-08b9-e063-6394a90a116e	0220-4170	HUMAN PRESCRIPTION DRUG	Prunus spinosa		PRUNUS SPINOSA FLOWER BUD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PRUNUS SPINOSA FLOWER BUD	6	[hp_C]/6[hp_C]			N	20241231
0220-4174_0a215c18-6724-6498-e063-6394a90a5b3a	0220-4174	HUMAN OTC DRUG	Ptelea trifoliata		PTELEA TRIFOLIATA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PTELEA TRIFOLIATA BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-4175_0a21710c-d93f-e85a-e063-6294a90a892b	0220-4175	HUMAN PRESCRIPTION DRUG	Prunus spinosa		PRUNUS SPINOSA FLOWER BUD	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PRUNUS SPINOSA FLOWER BUD	30	[hp_C]/30[hp_C]			N	20241231
0220-4178_0258168b-039a-d994-e063-6294a90a1d8c	0220-4178	HUMAN OTC DRUG	Pulsatilla		ANEMONE PATENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PATENS WHOLE	6	[hp_X]/1			N	20241231
0220-4180_0a218244-fdd1-699d-e063-6394a90aa4e9	0220-4180	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	5	[hp_C]/5[hp_C]			N	20241231
0220-4181_f2f5a8df-2c3c-12a5-e053-2a95a90a9076	0220-4181	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	6	[hp_C]/6[hp_C]			N	20241231
0220-4182_0a0c1f37-14ec-8dd4-e063-6394a90aef88	0220-4182	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	9	[hp_C]/9[hp_C]			N	20241231
0220-4183_f52be90f-25c6-29aa-e053-2995a90ad4db	0220-4183	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	12	[hp_C]/12[hp_C]			N	20241231
0220-4184_f187d890-3908-8614-e053-2a95a90ab91d	0220-4184	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	15	[hp_C]/15[hp_C]			N	20241231
0220-4185_f213487a-bcb3-ee4c-e053-2a95a90a85c0	0220-4185	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	30	[hp_C]/30[hp_C]			N	20241231
0220-4186_f2f59f63-fcd7-2a80-e053-2995a90ab087	0220-4186	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	200	[kp_C]/200[kp_C]			N	20241231
0220-4190_f792c569-d726-a994-e053-6294a90a5331	0220-4190	HUMAN OTC DRUG	Pyrogenium		RANCID BEEF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	RANCID BEEF	6	[hp_C]/1			N	20241231
0220-4193_f52c0d73-6bda-6378-e053-2995a90aebc1	0220-4193	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	1	[hp_M]/[hp_M]			N	20241231
0220-4194_f70744a9-6d8b-4143-e053-6294a90a7b05	0220-4194	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	10	[hp_M]/10[hp_M]			N	20241231
0220-4197_0a218eb6-b1fd-fa33-e063-6294a90a57d4	0220-4197	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	12	[hp_X]/12[hp_X]			N	20241231
0220-4198_00edbc51-9a8c-566f-e063-6294a90a81a7	0220-4198	HUMAN OTC DRUG	Pulsatilla		ANEMONE PULSATILLA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ANEMONE PULSATILLA	30	[hp_X]/30[hp_X]			N	20241231
0220-4201_0a0c0c92-8fd2-7637-e063-6394a90a2995	0220-4201	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	5	[hp_C]/5[hp_C]			N	20241231
0220-4202_f913c202-3440-8e25-e053-6294a90a944d	0220-4202	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-4203_0a0b1eb8-f569-0a67-e063-6394a90a6d44	0220-4203	HUMAN OTC DRUG	PHYTOLACCA DECANDRA		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-4204_0a2181c5-414e-71fa-e063-6294a90a05c1	0220-4204	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-4205_0a216e76-f638-e85e-e063-6294a90a0917	0220-4205	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	15	[hp_C]/15[hp_C]			N	20241231
0220-4206_f2f5a4ac-8aaa-2301-e053-2a95a90a256e	0220-4206	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4207_f2f5a316-2435-cd5b-e053-2995a90a7362	0220-4207	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-4208_003aa46c-a15a-8c9e-e063-6294a90a4931	0220-4208	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-4209_00edbc51-9a85-566f-e063-6294a90a81a7	0220-4209	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PHYTOLACCA AMERICANA ROOT	30	[hp_X]/30[hp_X]			N	20241231
0220-4212_09aa5b10-da77-6d61-e063-6294a90a72b9	0220-4212	HUMAN OTC DRUG	Pyrogenium		RANCID BEEF	PELLET	ORAL	20231108		UNAPPROVED HOMEOPATHIC		Boiron	RANCID BEEF	9	[hp_C]/9[hp_C]			N	20241231
0220-4215_09aa14d9-4049-2f04-e063-6294a90af5ec	0220-4215	HUMAN OTC DRUG	Pyrogenium		RANCID BEEF	PELLET	ORAL	20231108		UNAPPROVED HOMEOPATHIC		Boiron	RANCID BEEF	30	[hp_C]/30[hp_C]			N	20241231
0220-4216_09a97a76-5cab-fcaf-e063-6294a90ab248	0220-4216	HUMAN OTC DRUG	PYROGENIUM		RANCID BEEF	PELLET	ORAL	20231108		UNAPPROVED HOMEOPATHIC		Boiron	RANCID BEEF	200	[kp_C]/200[kp_C]			N	20241231
0220-4252_f187c21d-658b-0629-e053-2995a90a80ea	0220-4252	HUMAN OTC DRUG	Quebracho		ASPIDOSPERMA QUEBRACHO-BLANCO BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ASPIDOSPERMA QUEBRACHO-BLANCO BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-4309_0a218eb6-b200-fa33-e063-6294a90a57d4	0220-4309	HUMAN OTC DRUG	Radium bromatum		RADIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RADIUM BROMIDE	9	[hp_C]/1			N	20241231
0220-4310_097e16d0-9f84-ba28-e063-6294a90af714	0220-4310	HUMAN OTC DRUG	Radium bromatum		RADIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RADIUM BROMIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-4311_f2f59f63-fcd9-2a80-e053-2995a90ab087	0220-4311	HUMAN OTC DRUG	Radium bromatum		RADIUM BROMIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RADIUM BROMIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-4314_0a21a3a5-2b02-d673-e063-6394a90ad91b	0220-4314	HUMAN OTC DRUG	Ranunculus bulbosus		RANUNCULUS BULBOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RANUNCULUS BULBOSUS	200	[kp_C]/200[kp_C]			N	20241231
0220-4317_0a2190a6-2883-db7d-e063-6394a90a639e	0220-4317	HUMAN OTC DRUG	Ranunculus bulbosus		RANUNCULUS BULBOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RANUNCULUS BULBOSUS	6	[hp_C]/1			N	20241231
0220-4318_0a2181c5-414f-71fa-e063-6294a90a05c1	0220-4318	HUMAN OTC DRUG	Ranunculus bulbosus		RANUNCULUS BULBOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RANUNCULUS BULBOSUS	9	[hp_C]/9[hp_C]			N	20241231
0220-4319_0a2190a6-2884-db7d-e063-6394a90a639e	0220-4319	HUMAN OTC DRUG	Ranunculus bulbosus		RANUNCULUS BULBOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RANUNCULUS BULBOSUS	12	[hp_C]/12[hp_C]			N	20241231
0220-4322_0a2198a0-8454-fcdf-e063-6294a90ab50c	0220-4322	HUMAN OTC DRUG	Ranunculus bulbosus		RANUNCULUS BULBOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RANUNCULUS BULBOSUS	15	[hp_C]/15[hp_C]			N	20241231
0220-4323_f67c50a3-3e0d-1f51-e053-2995a90a28af	0220-4323	HUMAN OTC DRUG	Ranunculus bulbosus		RANUNCULUS BULBOSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RANUNCULUS BULBOSUS	30	[hp_C]/30[hp_C]			N	20241231
0220-4327_0c05a4f3-1bc1-f41c-e063-6294a90ac64b	0220-4327	HUMAN OTC DRUG	RAPHANUS SATIVUS		RADISH	PELLET	ORAL	20240101		UNAPPROVED HOMEOPATHIC		Boiron	RADISH	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-4330_0a21a8f9-1a3a-0c0d-e063-6294a90aea88	0220-4330	HUMAN OTC DRUG	Raphanus sativus		RADISH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RADISH	8	[hp_X]/8[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-4333_0a21913f-4e61-f0ec-e063-6294a90ad9dd	0220-4333	HUMAN OTC DRUG	Raphanus sativus		RADISH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RADISH	6	[hp_X]/6[hp_X]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-4334_0a2190a6-2885-db7d-e063-6394a90a639e	0220-4334	HUMAN OTC DRUG	Raphanus sativus		RADISH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RADISH	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-4335_0a21913f-4e62-f0ec-e063-6294a90ad9dd	0220-4335	HUMAN OTC DRUG	Raphanus sativus		RADISH	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RADISH	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-4337_0a21a3a5-2b05-d673-e063-6394a90ad91b	0220-4337	HUMAN OTC DRUG	Ratanhia		KRAMERIA LAPPACEA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KRAMERIA LAPPACEA ROOT	8	[hp_X]/8[hp_X]			N	20241231
0220-4338_0a21ae0e-36f6-e4cd-e063-6394a90ae089	0220-4338	HUMAN OTC DRUG	Ratanhia		KRAMERIA LAPPACEA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KRAMERIA LAPPACEA ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-4339_0a218eb6-b202-fa33-e063-6294a90a57d4	0220-4339	HUMAN OTC DRUG	Ratanhia		KRAMERIA LAPPACEA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	KRAMERIA LAPPACEA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4369_0a2198a0-8455-fcdf-e063-6294a90ab50c	0220-4369	HUMAN OTC DRUG	Rheum officinale		RHEUM OFFICINALE ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHEUM OFFICINALE ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4377_fd68012d-814e-ac07-e053-6394a90afc68	0220-4377	HUMAN OTC DRUG	Rhododendron chrysanthum		RHODODENDRON AUREUM LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON AUREUM LEAF	6	[hp_C]/1			N	20241231
0220-4378_0a21913f-4e63-f0ec-e063-6294a90ad9dd	0220-4378	HUMAN OTC DRUG	Rhododendron chrysanthum		RHODODENDRON AUREUM LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON AUREUM LEAF	9	[hp_C]/9[hp_C]			N	20241231
0220-4379_0a218eb6-b203-fa33-e063-6294a90a57d4	0220-4379	HUMAN OTC DRUG	Rhododendron chrysanthum		RHODODENDRON AUREUM LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON AUREUM LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-4382_0a21ae0e-36f7-e4cd-e063-6394a90ae089	0220-4382	HUMAN OTC DRUG	Rhododendron chrysanthum		RHODODENDRON AUREUM LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RHODODENDRON AUREUM LEAF	200	[kp_C]/200[kp_C]			N	20241231
0220-4386_003abd8e-d4b5-fc69-e063-6394a90a381f	0220-4386	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	1	[hp_M]/[hp_M]			N	20241231
0220-4387_097e16d0-9f86-ba28-e063-6294a90af714	0220-4387	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	10	[hp_M]/10[hp_M]			N	20241231
0220-4393_003ad7b2-d157-4924-e063-6394a90a2232	0220-4393	HUMAN OTC DRUG	Rhus toxicodendron		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	7	[hp_X]/1			N	20241231
0220-4395_0a2198a0-8456-fcdf-e063-6294a90ab50c	0220-4395	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	5	[hp_C]/5[hp_C]			N	20241231
0220-4396_f67c5846-8e25-51b7-e053-2995a90aa875	0220-4396	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	6	[hp_C]/6[hp_C]			N	20241231
0220-4397_0a21ae0e-36f8-e4cd-e063-6394a90ae089	0220-4397	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	9	[hp_C]/9[hp_C]			N	20241231
0220-4398_0a21ae0e-36fb-e4cd-e063-6394a90ae089	0220-4398	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	12	[hp_C]/12[hp_C]			N	20241231
0220-4399_0a21a8f9-1a40-0c0d-e063-6294a90aea88	0220-4399	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	15	[hp_C]/15[hp_C]			N	20241231
0220-4400_fe916773-3d0c-6242-e053-6394a90ab4d7	0220-4400	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-4401_f2f68c92-247a-6aa4-e053-2a95a90a72a9	0220-4401	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	200	[kp_C]/200[kp_C]			N	20241231
0220-4403_0a21d620-da84-2bb5-e063-6294a90ae8f8	0220-4403	HUMAN OTC DRUG	Rhus venenata		TOXICODENDRON VERNIX LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON VERNIX LEAFY TWIG	9	[hp_C]/9[hp_C]			N	20241231
0220-4404_0a21e756-d27c-3182-e063-6294a90a2169	0220-4404	HUMAN OTC DRUG	Rhus venenata		TOXICODENDRON VERNIX LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON VERNIX LEAFY TWIG	30	[hp_C]/30[hp_C]			N	20241231
0220-4407_0a21eed8-7d38-3b24-e063-6294a90a3abb	0220-4407	HUMAN OTC DRUG	Ricinus communis		RICINUS COMMUNIS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RICINUS COMMUNIS SEED	5	[hp_C]/5[hp_C]			N	20241231
0220-4411_0a225714-ccb3-4676-e063-6294a90aeeb2	0220-4411	HUMAN OTC DRUG	Robinia pseudoacacia		ROBINIA PSEUDOACACIA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ROBINIA PSEUDOACACIA BARK	5	[hp_C]/5[hp_C]			N	20241231
0220-4416_0a225714-ccb4-4676-e063-6294a90aeeb2	0220-4416	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	12	[hp_X]/12[hp_X]			N	20241231
0220-4417_0a228c7b-a885-2255-e063-6394a90a8b95	0220-4417	HUMAN OTC DRUG	Rhus tox		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOXICODENDRON PUBESCENS LEAF	30	[hp_X]/30[hp_X]			N	20241231
0220-4420_0a225714-ccb5-4676-e063-6294a90aeeb2	0220-4420	HUMAN OTC DRUG	Ricinus communis		RICINUS COMMUNIS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RICINUS COMMUNIS SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-4421_0a228a8a-c50f-210b-e063-6394a90a2f97	0220-4421	HUMAN OTC DRUG	Ricinus communis		RICINUS COMMUNIS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RICINUS COMMUNIS SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-4435_0a22be10-c869-9522-e063-6294a90a6216	0220-4435	HUMAN OTC DRUG	Rumex crispus		RUMEX CRISPUS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUMEX CRISPUS ROOT	6	[hp_X]/1			N	20241231
0220-4443_0a22dc34-407d-ab14-e063-6294a90a966f	0220-4443	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	30	[hp_X]/1			N	20241231
0220-4448_0a22dd5e-4251-4c12-e063-6394a90a056a	0220-4448	HUMAN OTC DRUG	Robinia pseudoacacia		ROBINIA PSEUDOACACIA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ROBINIA PSEUDOACACIA BARK	6	[hp_C]/6[hp_C]			N	20241231
0220-4449_0a22d018-448e-8cf7-e063-6294a90a0de4	0220-4449	HUMAN OTC DRUG	Robinia pseudoacacia		ROBINIA PSEUDOACACIA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ROBINIA PSEUDOACACIA BARK	9	[hp_C]/9[hp_C]			N	20241231
0220-4450_0a22df7f-462c-30b0-e063-6394a90ab47d	0220-4450	HUMAN OTC DRUG	Robinia pseudoacacia		ROBINIA PSEUDOACACIA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ROBINIA PSEUDOACACIA BARK	12	[hp_C]/12[hp_C]			N	20241231
0220-4451_f7e58806-7611-7677-e053-6294a90a5f86	0220-4451	HUMAN OTC DRUG	Robinia pseudoacacia		ROBINIA PSEUDOACACIA BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ROBINIA PSEUDOACACIA BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-4454_0868c03c-702d-738d-e063-6394a90a9933	0220-4454	HUMAN OTC DRUG	Rumex crispus		RUMEX CRISPUS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUMEX CRISPUS ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-4455_0a240bec-4c22-3d68-e063-6294a90ad53d	0220-4455	HUMAN OTC DRUG	Rumex crispus		RUMEX CRISPUS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUMEX CRISPUS ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-4456_0a24187c-adef-c6aa-e063-6394a90ae86f	0220-4456	HUMAN OTC DRUG	Rumex crispus		RUMEX CRISPUS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUMEX CRISPUS ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-4457_f527facb-9e48-5cb0-e053-2995a90adab1	0220-4457	HUMAN OTC DRUG	Rumex crispus		RUMEX CRISPUS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUMEX CRISPUS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4458_f7073903-d494-3ff7-e053-6294a90a6902	0220-4458	HUMAN OTC DRUG	Rumex crispus		RUMEX CRISPUS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUMEX CRISPUS ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-4459_0a2428d1-ebaa-43dc-e063-6294a90abada	0220-4459	HUMAN OTC DRUG	Rumex crispus		RUMEX CRISPUS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUMEX CRISPUS ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-4462_0a2429f3-6917-cb4c-e063-6394a90acd23	0220-4462	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	5	[hp_C]/5[hp_C]			N	20241231
0220-4463_f2f6a569-9a1b-c3fa-e053-2a95a90aa1c8	0220-4463	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-4464_fd66ee9b-5a0a-776a-e053-6294a90a6559	0220-4464	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-4465_00efd5d5-06c8-572f-e063-6294a90a9990	0220-4465	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-4466_0a242afc-f84d-d388-e063-6394a90aecfc	0220-4466	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	15	[hp_C]/15[hp_C]			N	20241231
0220-4467_f2f68cf0-d67f-6305-e053-2a95a90a5dc0	0220-4467	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-4468_f9137623-f7e2-0cfe-e053-6294a90a676c	0220-4468	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	200	[kp_C]/200[kp_C]			N	20241231
0220-4469_f52634d3-58d4-4611-e053-2995a90a40bf	0220-4469	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	1	[hp_M]/[hp_M]			N	20241231
0220-4470_0a2424d8-2d00-cbc9-e063-6394a90acb06	0220-4470	HUMAN OTC DRUG	Ruta graveolens		RUTA GRAVEOLENS FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	RUTA GRAVEOLENS FLOWERING TOP	10	[hp_M]/10[hp_M]			N	20241231
0220-4474_0d09f5fa-45ae-9e0b-e063-6394a90a4ed7	0220-4474	HUMAN OTC DRUG	SARCOLACTICUM ACIDUM		LACTIC ACID, L-	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Boiron	LACTIC ACID, L-	3	[hp_C]/3[hp_C]			N	20241231
0220-4475_0d09fbec-72f2-3f01-e063-6294a90aa3b8	0220-4475	HUMAN OTC DRUG	SARCOLACTICUM ACIDUM		LACTIC ACID, L-	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Boiron	LACTIC ACID, L-	6	[hp_C]/6[hp_C]			N	20241231
0220-4476_0d09cff2-fd87-7a76-e063-6394a90a7df0	0220-4476	HUMAN OTC DRUG	SARCOLACTICUM ACIDUM		LACTIC ACID, L-	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Boiron	LACTIC ACID, L-	9	[hp_C]/9[hp_C]			N	20241231
0220-4477_fbd45a2a-2683-6a28-e053-6294a90a4b4f	0220-4477	HUMAN OTC DRUG	SARCOLACTICUM ACIDUM		LACTIC ACID, L-	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Boiron	LACTIC ACID, L-	30	[hp_C]/30[hp_C]			N	20241231
0220-4478_0c041754-793b-8aae-e063-6294a90ac248	0220-4478	HUMAN OTC DRUG	SARCOLACTICUM ACIDUM		LACTIC ACID, L-	PELLET	ORAL	20240101		UNAPPROVED HOMEOPATHIC		Borion	LACTIC ACID, L-	200	[kp_C]/200[kp_C]			N	20241231
0220-4481_f7e5728e-6677-788f-e053-6394a90a784a	0220-4481	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	5	[hp_C]/5[hp_C]			N	20241231
0220-4482_0a241b47-5ead-c98a-e063-6394a90a6e3d	0220-4482	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-4483_0a242afc-f84e-d388-e063-6394a90aecfc	0220-4483	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-4484_0a2431d5-75cc-386d-e063-6294a90a5be9	0220-4484	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-4485_f7e58806-7612-7677-e053-6294a90a5f86	0220-4485	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4486_07d8faf1-c28d-8f42-e063-6394a90a92f5	0220-4486	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-4487_08f2d4aa-73ab-4165-e063-6394a90a747c	0220-4487	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-4492_0a243947-734f-6792-e063-6294a90afbed	0220-4492	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	5	[hp_C]/5[hp_C]			N	20241231
0220-4493_f7e572e9-82a8-2127-e053-6394a90ab01a	0220-4493	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-4494_0a243e3e-8c93-d6b7-e063-6394a90af4b2	0220-4494	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	9	[hp_C]/9[hp_C]			N	20241231
0220-4495_0a2424d8-2d01-cbc9-e063-6394a90acb06	0220-4495	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	12	[hp_C]/12[hp_C]			N	20241231
0220-4496_0a242afc-f84f-d388-e063-6394a90aecfc	0220-4496	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	15	[hp_C]/15[hp_C]			N	20241231
0220-4497_f52c10e2-269c-2931-e053-2995a90ae8f4	0220-4497	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-4498_0a2424d8-2d02-cbc9-e063-6394a90acb06	0220-4498	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	200	[kp_C]/200[kp_C]			N	20241231
0220-4499_fbd1bead-de71-237c-e053-6294a90af82b	0220-4499	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	1	[hp_M]/[hp_M]			N	20241231
0220-4502_0a242686-c333-558d-e063-6294a90abff2	0220-4502	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCHOENOCAULON OFFICINALE SEED	6	[hp_X]/1			N	20241231
0220-4503_0a2424d8-2d03-cbc9-e063-6394a90acb06	0220-4503	HUMAN OTC DRUG	Sabal serrulata		SAW PALMETTO	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAW PALMETTO	200	[kp_C]/200[kp_C]			N	20241231
0220-4506_0410c66a-4ead-acca-e063-6394a90ad4bf	0220-4506	HUMAN OTC DRUG	Sabal serrualata		SAW PALMETTO	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAW PALMETTO	3	[hp_C]/3[hp_C]			N	20241231
0220-4507_0a243750-f866-60df-e063-6294a90acc61	0220-4507	HUMAN OTC DRUG	Sabal serrulata		SAW PALMETTO	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAW PALMETTO	6	[hp_C]/6[hp_C]			N	20241231
0220-4508_04102efe-2e18-db61-e063-6394a90a0461	0220-4508	HUMAN OTC DRUG	Sabal serrulata		SAW PALMETTO	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAW PALMETTO	30	[hp_C]/30[hp_C]			N	20241231
0220-4510_f527adf2-7941-be8b-e053-2a95a90a8d64	0220-4510	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	30	[hp_X]/1			N	20241231
0220-4511_0a244e71-f8d4-e51c-e063-6394a90ade98	0220-4511	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	5	[hp_C]/5[hp_C]			N	20241231
0220-4515_f529634c-2613-bd9c-e053-2a95a90ab2f9	0220-4515	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	6	[hp_C]/6[hp_C]			N	20241231
0220-4516_0a24308f-66f1-d501-e063-6394a90a17d4	0220-4516	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	9	[hp_C]/9[hp_C]			N	20241231
0220-4519_0a242686-c334-558d-e063-6294a90abff2	0220-4519	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	200	[kp_C]/200[kp_C]			N	20241231
0220-4520_0a244e71-f8d5-e51c-e063-6394a90ade98	0220-4520	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	1	[hp_M]/[hp_M]			N	20241231
0220-4522_f5279767-2407-3b9d-e053-2a95a90a85f1	0220-4522	HUMAN OTC DRUG	Saccharum officinale		SUCROSE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SUCROSE	6	[hp_X]/6[hp_X]			N	20241231
0220-4523_0a24308f-66f2-d501-e063-6394a90a17d4	0220-4523	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	12	[hp_C]/12[hp_C]			N	20241231
0220-4524_f915077b-bb34-9985-e053-6294a90a3736	0220-4524	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	JUNIPERUS SABINA LEAFY TWIG	30	[hp_C]/30[hp_C]			N	20241231
0220-4526_0a244e71-f8d7-e51c-e063-6394a90ade98	0220-4526	HUMAN OTC DRUG	Salicylicum acidum		SALICYLIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SALICYLIC ACID	6	[hp_C]/6[hp_C]			N	20241231
0220-4528_0a243947-7363-6792-e063-6294a90afbed	0220-4528	HUMAN OTC DRUG	Salicylicum acidum		SALICYLIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SALICYLIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-4531_0a24308f-66f3-d501-e063-6394a90a17d4	0220-4531	HUMAN OTC DRUG	Saccharum officinale		SUCROSE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SUCROSE	30	[hp_C]/30[hp_C]			N	20241231
0220-4532_0a246eae-0a39-80a8-e063-6294a90a4c39	0220-4532	HUMAN OTC DRUG	Saccharum officinale		SUCROSE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SUCROSE	200	[kp_C]/200[kp_C]			N	20241231
0220-4535_0a2499ec-8b97-9471-e063-6294a90abbd8	0220-4535	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	5	[hp_C]/5[hp_C]			N	20241231
0220-4536_00f13bb7-e676-890c-e063-6294a90a47b1	0220-4536	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-4539_0a24908f-0fd9-ee04-e063-6394a90a26a4	0220-4539	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	9	[hp_C]/9[hp_C]			N	20241231
0220-4540_0a248127-003d-f491-e063-6394a90af837	0220-4540	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	12	[hp_C]/12[hp_C]			N	20241231
0220-4543_f600936c-f5de-db3f-e053-2995a90a7a63	0220-4543	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	3	[hp_X]/3[hp_X]			N	20241231
0220-4546_0a24a01c-c520-774e-e063-6294a90a8923	0220-4546	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	8	[hp_X]/1			N	20241231
0220-4547_0a24a01c-c521-774e-e063-6294a90a8923	0220-4547	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	6	[hp_X]/6[hp_X]			N	20241231
0220-4550_0a24908f-0fda-ee04-e063-6394a90a26a4	0220-4550	HUMAN OTC DRUG	Sanguinaria canadensis		SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARIA CANADENSIS ROOT	4	[hp_X]/1			N	20241231
0220-4554_0d09cff2-fd88-7a76-e063-6394a90a7df0	0220-4554	HUMAN OTC DRUG	Sanguinarinum nitricum		SANGUINARINE NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARINE NITRATE	5	[hp_C]/5[hp_C]			N	20241231
0220-4555_0d09f780-d997-25f6-e063-6294a90a2f8f	0220-4555	HUMAN OTC DRUG	Sanguinarinum nitricum		SANGUINARINE NITRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANGUINARINE NITRATE	30	[hp_C]/30[hp_C]			N	20241231
0220-4558_0a249c74-b417-9dc2-e063-6294a90aaa45	0220-4558	HUMAN OTC DRUG	Santoninum		SANTONIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SANTONIN	30	[hp_C]/30[hp_C]			N	20241231
0220-4560_0a24b0cb-2898-9489-e063-6294a90a77c0	0220-4560	HUMAN OTC DRUG	SAPONARIA OFFICINALIS		SAPONARIA OFFICINALIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAPONARIA OFFICINALIS ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-4562_0a24b8af-5223-c47e-e063-6294a90a2787	0220-4562	HUMAN OTC DRUG	Saponaria officinalis		SAPONARIA OFFICINALIS ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	SAPONARIA OFFICINALIS ROOT	6	[hp_X]/1			N	20241231
0220-4564_0a24b2b9-701c-b19f-e063-6294a90a5370	0220-4564	HUMAN OTC DRUG	Sambucus nigra		SAMBUCUS NIGRA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SAMBUCUS NIGRA FLOWERING TOP	200	[kp_C]/200[kp_C]			N	20241231
0220-4567_0a249c74-b419-9dc2-e063-6294a90aaa45	0220-4567	HUMAN OTC DRUG	Sarsaparilla		SMILAX ORNATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SMILAX ORNATA ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-4568_003ad7b2-d14d-4924-e063-6394a90a2232	0220-4568	HUMAN OTC DRUG	Sarsaparilla		SMILAX ORNATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SMILAX ORNATA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4571_0a24bd61-5de0-9d79-e063-6294a90a9922	0220-4571	HUMAN OTC DRUG	Sarsaparilla		SMILAX ORNATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SMILAX ORNATA ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-4572_0a24908f-0fdb-ee04-e063-6394a90a26a4	0220-4572	HUMAN OTC DRUG	Sarsaparilla		SMILAX ORNATA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SMILAX ORNATA ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-4578_0a24908f-0fdc-ee04-e063-6394a90a26a4	0220-4578	HUMAN OTC DRUG	Sarsaparilla		SMILAX REGELII ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SMILAX ORNATA ROOT	6	[hp_C]/1			N	20241231
0220-4594_0a24bd61-5de1-9d79-e063-6294a90a9922	0220-4594	HUMAN OTC DRUG	Scilla maritima		DRIMIA MARITIMA BULB	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DRIMIA MARITIMA BULB	30	[hp_C]/30[hp_C]			N	20241231
0220-4606_0a249c74-b41a-9dc2-e063-6294a90aaa45	0220-4606	HUMAN OTC DRUG	Scrophularia nodosa		SCROPHULARIA NODOSA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCROPHULARIA NODOSA	6	[hp_C]/6[hp_C]			N	20241231
0220-4607_f7e5728e-6678-788f-e053-6394a90a784a	0220-4607	HUMAN OTC DRUG	Scrophularia nodosa		SCROPHULARIA NODOSA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCROPHULARIA NODOSA	30	[hp_C]/30[hp_C]			N	20241231
0220-4610_0a24b2b9-705b-b19f-e063-6294a90a5370	0220-4610	HUMAN OTC DRUG	Scutellaria lateriflora		SCUTELLARIA LATERIFLORA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCUTELLARIA LATERIFLORA	6	[hp_C]/6[hp_C]			N	20241231
0220-4611_0a24c4b8-4959-c2d4-e063-6294a90adfb2	0220-4611	HUMAN OTC DRUG	Scutellaria lateriflora		SCUTELLARIA LATERIFLORA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCUTELLARIA LATERIFLORA	30	[hp_C]/30[hp_C]			N	20241231
0220-4614_0a24c2c8-814b-9bf8-e063-6294a90a066e	0220-4614	HUMAN OTC DRUG	Secale cornutum		CLAVICEPS PURPUREA SCLEROTIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLAVICEPS PURPUREA SCLEROTIUM	6	[hp_C]/1			N	20241231
0220-4615_0a24b2b9-705c-b19f-e063-6294a90a5370	0220-4615	HUMAN OTC DRUG	Secale cornutum		CLAVICEPS PURPUREA SCLEROTIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLAVICEPS PURPUREA SCLEROTIUM	9	[hp_C]/9[hp_C]			N	20241231
0220-4616_0a24c2c8-814f-9bf8-e063-6294a90a066e	0220-4616	HUMAN OTC DRUG	Secale cornutum		CLAVICEPS PURPUREA SCLEROTIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLAVICEPS PURPUREA SCLEROTIUM	15	[hp_C]/15[hp_C]			N	20241231
0220-4619_0a24d63f-d926-1627-e063-6394a90a8701	0220-4619	HUMAN OTC DRUG	Secale cornutum		CLAVICEPS PURPUREA SCLEROTIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLAVICEPS PURPUREA SCLEROTIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-4620_0a24c2c8-8150-9bf8-e063-6294a90a066e	0220-4620	HUMAN OTC DRUG	Secale cornutum		CLAVICEPS PURPUREA SCLEROTIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLAVICEPS PURPUREA SCLEROTIUM	200	[kp_C]/200[kp_C]			N	20241231
0220-4622_0a24d63f-d927-1627-e063-6394a90a8701	0220-4622	HUMAN OTC DRUG	Selenium metallicum		SELENIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SELENIUM	6	[hp_C]/1			N	20241231
0220-4626_0a24d60a-7ed2-1d1b-e063-6394a90a60a0	0220-4626	HUMAN OTC DRUG	Sempervivum tectorum		SEMPERVIVUM TECTORUM LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEMPERVIVUM TECTORUM LEAF	6	[hp_C]/6[hp_C]			N	20241231
0220-4627_0a24d97b-9b61-cf58-e063-6294a90ad429	0220-4627	HUMAN OTC DRUG	Secale cornutum		CLAVICEPS PURPUREA SCLEROTIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CLAVICEPS PURPUREA SCLEROTIUM	1	[hp_M]/[hp_M]			N	20241231
0220-4628_0a24dc8b-b860-1d84-e063-6394a90a1c4a	0220-4628	HUMAN OTC DRUG	Selenium metallicum		SELENIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SELENIUM	9	[hp_C]/9[hp_C]			N	20241231
0220-4630_0a24cdf7-e450-1d70-e063-6394a90a8826	0220-4630	HUMAN OTC DRUG	Senecio aureus		PACKERA AUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	PACKERA AUREA	30	[hp_C]/30[hp_C]			N	20241231
0220-4631_0a24cdf7-e451-1d70-e063-6394a90a8826	0220-4631	HUMAN OTC DRUG	Selenium metallicum		SELENIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SELENIUM	12	[hp_C]/12[hp_C]			N	20241231
0220-4632_0a24c4b8-495d-c2d4-e063-6294a90adfb2	0220-4632	HUMAN OTC DRUG	Selenium metallicum		SELENIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SELENIUM	15	[hp_C]/15[hp_C]			N	20241231
0220-4635_0a24c2c8-8152-9bf8-e063-6294a90a066e	0220-4635	HUMAN OTC DRUG	Senega officinalis		POLYGALA SENEGA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POLYGALA SENEGA ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4638_0a33cf5e-4e8c-2184-e063-6394a90ab904	0220-4638	HUMAN OTC DRUG	Senega officinalis		POLYGALA SENEGA ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	POLYGALA SENEGA ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-4639_0a33cf5e-4e8d-2184-e063-6394a90ab904	0220-4639	HUMAN OTC DRUG	Selenium metallicum		SELENIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SELENIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-4640_0a33d1d0-9c7d-0f44-e063-6394a90a08a4	0220-4640	HUMAN OTC DRUG	Selenium metallicum		SELENIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SELENIUM	200	[kp_C]/200[kp_C]			N	20241231
0220-4642_0a33d2ce-d5a0-1f75-e063-6394a90a0d1b	0220-4642	HUMAN OTC DRUG	Senna		SENNA LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SENNA LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-4646_0a33c2ba-138a-127e-e063-6394a90a2848	0220-4646	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	8	[hp_X]/1			N	20241231
0220-4649_0a33d1d0-9c7e-0f44-e063-6394a90a08a4	0220-4649	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	5	[hp_C]/5[hp_C]			N	20241231
0220-4650_0a33d61a-0c20-451f-e063-6294a90a4c6d	0220-4650	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	6	[hp_C]/6[hp_C]			N	20241231
0220-4651_0a33c2ba-138b-127e-e063-6394a90a2848	0220-4651	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	9	[hp_C]/9[hp_C]			N	20241231
0220-4652_f529414c-36ec-5164-e053-2995a90acb80	0220-4652	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	12	[hp_C]/12[hp_C]			N	20241231
0220-4653_f9138e8a-e4f4-4372-e053-6394a90a1370	0220-4653	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	15	[hp_C]/15[hp_C]			N	20241231
0220-4654_00ef7f3f-06ab-add1-e063-6394a90ab4f5	0220-4654	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	30	[hp_C]/30[hp_C]			N	20241231
0220-4657_f2f6a6a4-9efb-25f4-e053-2995a90adfc3	0220-4657	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	200	[kp_C]/200[kp_C]			N	20241231
0220-4658_f52bad7f-ef26-2543-e053-2995a90a6925	0220-4658	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	1	[hp_M]/[hp_M]			N	20241231
0220-4660_0a33c52a-66b8-1d2d-e063-6294a90a7dbe	0220-4660	HUMAN OTC DRUG	Silica marina		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-4661_0a33e0f6-e284-5f8a-e063-6294a90ad2dc	0220-4661	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	10	[hp_M]/10[hp_M]			N	20241231
0220-4662_0a33c788-2062-5531-e063-6294a90a9598	0220-4662	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SEPIA OFFICINALIS JUICE	30	[hp_X]/30[hp_X]			N	20241231
0220-4664_003a6ff4-44c6-0cb3-e063-6294a90a6f4a	0220-4664	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	8	[hp_X]/1			N	20241231
0220-4667_f2f68cf0-d67e-6305-e053-2a95a90a5dc0	0220-4667	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	6	[hp_C]/6[hp_C]			N	20241231
0220-4668_0a33c788-2065-5531-e063-6294a90a9598	0220-4668	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-4669_0a33e794-1f0b-2717-e063-6394a90a2c0b	0220-4669	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-4670_f7e5a855-747c-9e07-e053-6394a90af185	0220-4670	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-4671_f213487a-bcb2-ee4c-e053-2a95a90a85c0	0220-4671	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-4672_f2f6a6a4-9efd-25f4-e053-2995a90adfc3	0220-4672	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-4675_0a33d3a4-ab85-561a-e063-6294a90a9b77	0220-4675	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	200	[hp_X]/200[hp_X]			N	20241231
0220-4678_0a33d2ce-d5a1-1f75-e063-6394a90a0d1b	0220-4678	HUMAN OTC DRUG	Sinapis nigra		BLACK MUSTARD SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	BLACK MUSTARD SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-4679_f2f6a569-9a1e-c3fa-e053-2a95a90aa1c8	0220-4679	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	1	[hp_M]/[hp_M]			N	20241231
0220-4680_0a33e794-1f0c-2717-e063-6394a90a2c0b	0220-4680	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	10	[hp_M]/10[hp_M]			N	20241231
0220-4683_f527a8c5-b05c-5f3c-e053-2995a90aa1a3	0220-4683	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	12	[hp_X]/12[hp_X]			N	20241231
0220-4684_0a33e0f6-e285-5f8a-e063-6294a90ad2dc	0220-4684	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SILICON DIOXIDE	30	[hp_X]/30[hp_X]			N	20241231
0220-4702_0a33d2ce-d5a2-1f75-e063-6394a90a0d1b	0220-4702	HUMAN OTC DRUG	Solidago virgaurea		SOLIDAGO VIRGAUREA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLIDAGO VIRGAUREA FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-4703_00edd7b8-7abb-2396-e063-6394a90a9e11	0220-4703	HUMAN OTC DRUG	SOLIDAGO VIRGAUREA		SOLIDAGO VIRGAUREA FLOWERING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SOLIDAGO VIRGAUREA FLOWERING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-4707_0a33e794-1f0e-2717-e063-6394a90a2c0b	0220-4707	HUMAN OTC DRUG	Spigelia anthelmia		SPIGELIA ANTHELMIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPIGELIA ANTHELMIA	1	[hp_M]/[hp_M]			N	20241231
0220-4710_0a33d61a-0c22-451f-e063-6294a90a4c6d	0220-4710	HUMAN OTC DRUG	Spigelia anthelmia		SPIGELIA ANTHELMIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPIGELIA ANTHELMIA	6	[hp_C]/1			N	20241231
0220-4711_f529634c-2612-bd9c-e053-2a95a90ab2f9	0220-4711	HUMAN OTC DRUG	Spigelia anthelmia		SPIGELIA ANTHELMIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPIGELIA ANTHELMIA	30	[hp_C]/30[hp_C]			N	20241231
0220-4712_f52be3ce-f891-03fa-e053-2a95a90a1969	0220-4712	HUMAN OTC DRUG	Spigelia anthelmia		SPIGELIA ANTHELMIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPIGELIA ANTHELMIA	200	[kp_C]/200[kp_C]			N	20241231
0220-4726_0a33e794-1f0f-2717-e063-6394a90a2c0b	0220-4726	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	8	[hp_X]/1			N	20241231
0220-4737_0a33e0f6-e286-5f8a-e063-6294a90ad2dc	0220-4737	HUMAN OTC DRUG	Stannum metallicum		TIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TIN	200	[kp_C]/200[kp_C]			N	20241231
0220-4739_f227d3b9-61e2-11e8-e053-2995a90a325e	0220-4739	HUMAN OTC DRUG	Stannum metallicum		TIN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TIN	30	[hp_C]/30[hp_C]			N	20241231
0220-4743_0a33d2ce-d5a4-1f75-e063-6394a90a0d1b	0220-4743	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	6	[hp_X]/1			N	20241231
0220-4744_0a33e0f6-e288-5f8a-e063-6294a90ad2dc	0220-4744	HUMAN OTC DRUG	Sticta pulmonaria		LOBARIA PULMONARIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBARIA PULMONARIA	6	[hp_C]/6[hp_C]			N	20241231
0220-4745_0a33fa8a-8adf-30ed-e063-6394a90a1808	0220-4745	HUMAN OTC DRUG	Sticta pulmonaria		LOBARIA PULMONARIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBARIA PULMONARIA	9	[hp_C]/9[hp_C]			N	20241231
0220-4748_0a33fee4-9989-7d53-e063-6294a90aa0b2	0220-4748	HUMAN OTC DRUG	Sticta pulmonaria		LOBARIA PULMONARIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBARIA PULMONARIA	15	[hp_C]/15[hp_C]			N	20241231
0220-4749_0a33fb78-6d1a-3344-e063-6394a90a1861	0220-4749	HUMAN OTC DRUG	Sticta pulmonaria		LOBARIA PULMONARIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBARIA PULMONARIA	30	[hp_C]/30[hp_C]			N	20241231
0220-4752_0a3400ec-70cb-340c-e063-6394a90ad39d	0220-4752	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	15	[hp_C]/15[hp_C]			N	20241231
0220-4753_f5296adf-af65-a8cd-e053-2a95a90adcfc	0220-4753	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-4756_0a33fa8a-8ae1-30ed-e063-6394a90a1808	0220-4756	HUMAN OTC DRUG	Sticta pulmonaria		LOBARIA PULMONARIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBARIA PULMONARIA	200	[kp_C]/200[kp_C]			N	20241231
0220-4759_f60007c0-9b0c-273c-e053-2995a90a77d9	0220-4759	HUMAN OTC DRUG	Sticta pulmonaria		LOBARIA PULMONARIA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LOBARIA PULMONARIA	5	[hp_C]/1			N	20241231
0220-4760_0a33e170-e8a9-25a8-e063-6394a90addf5	0220-4760	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	200	[kp_C]/200[kp_C]			N	20241231
0220-4761_0a33e170-e8aa-25a8-e063-6394a90addf5	0220-4761	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	1	[hp_M]/[hp_M]			N	20241231
0220-4768_0a33e170-e8ab-25a8-e063-6394a90addf5	0220-4768	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	10	[hp_M]/10[hp_M]			N	20241231
0220-4771_f2f59f63-fce0-2a80-e053-2995a90ab087	0220-4771	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	6	[hp_C]/1			N	20241231
0220-4772_f227d7e2-2e5c-0693-e053-2a95a90af4f8	0220-4772	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	9	[hp_C]/9[hp_C]			N	20241231
0220-4773_0a33e794-1f10-2717-e063-6394a90a2c0b	0220-4773	HUMAN OTC DRUG	Stramonium		DATURA STRAMONIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM	12	[hp_C]/12[hp_C]			N	20241231
0220-4779_0a33e0f6-e28e-5f8a-e063-6294a90ad2dc	0220-4779	HUMAN OTC DRUG	Strontium carbonicum		STRONTIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRONTIUM CARBONATE	30	[hp_C]/30[hp_C]			N	20241231
0220-4781_0a33fee4-998a-7d53-e063-6294a90aa0b2	0220-4781	HUMAN OTC DRUG	Strontium carbonicum		STRONTIUM CARBONATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STRONTIUM CARBONATE	200	[kp_C]/200[kp_C]			N	20241231
0220-4783_0a33fb78-6d1b-3344-e063-6394a90a1861	0220-4783	HUMAN PRESCRIPTION DRUG	Strophanthus hispidus		STROPHANTHUS HISPIDUS SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STROPHANTHUS HISPIDUS SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-4813_07ec81ae-f40a-15a2-e063-6394a90abacd	0220-4813	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	200	[hp_X]/200[hp_X]			N	20241231
0220-4816_0a33fb78-6d1c-3344-e063-6394a90a1861	0220-4816	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	12	[hp_X]/12[hp_X]			N	20241231
0220-4817_003abd8e-d4e1-fc69-e063-6394a90a381f	0220-4817	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	30	[hp_X]/30[hp_X]			N	20241231
0220-4820_f52c0d73-6bd9-6378-e053-2995a90aebc1	0220-4820	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	1	[hp_M]/[hp_M]			N	20241231
0220-4821_0a33fb78-6d1d-3344-e063-6394a90a1861	0220-4821	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	10	[hp_M]/10[hp_M]			N	20241231
0220-4823_0a33e170-e8ae-25a8-e063-6394a90addf5	0220-4823	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	6	[hp_X]/1			N	20241231
0220-4826_f2f5b6ce-2bac-4d5d-e053-2a95a90a5f77	0220-4826	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	6	[hp_C]/6[hp_C]			N	20241231
0220-4827_0a3400ec-70d0-340c-e063-6394a90ad39d	0220-4827	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	9	[hp_C]/9[hp_C]			N	20241231
0220-4828_f9156ad0-0d43-3c6e-e053-6294a90ab740	0220-4828	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	12	[hp_C]/12[hp_C]			N	20241231
0220-4829_0a33e170-e8af-25a8-e063-6394a90addf5	0220-4829	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	15	[hp_C]/15[hp_C]			N	20241231
0220-4830_f67ce46f-fe86-e06f-e053-2a95a90ae28d	0220-4830	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	30	[hp_C]/30[hp_C]			N	20241231
0220-4831_f67ce46f-fe85-e06f-e053-2a95a90ae28d	0220-4831	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR	200	[kp_C]/200[kp_C]			N	20241231
0220-4834_0a33fee4-998b-7d53-e063-6294a90aa0b2	0220-4834	HUMAN OTC DRUG	Sulphur iodatum		SULFUR IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR IODIDE	9	[hp_C]/9[hp_C]			N	20241231
0220-4835_0a3400ec-70d1-340c-e063-6394a90ad39d	0220-4835	HUMAN OTC DRUG	Sulphur iodatum		SULFUR IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR IODIDE	12	[hp_C]/12[hp_C]			N	20241231
0220-4837_f52bfcc5-b581-d229-e053-2995a90a1b56	0220-4837	HUMAN OTC DRUG	Sulphur iodatum		SULFUR IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR IODIDE	6	[hp_C]/1			N	20241231
0220-4839_0a3421ae-8d23-3d0b-e063-6394a90ad467	0220-4839	HUMAN OTC DRUG	SULPHUR IODATUM		SULFUR IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR IODIDE	200	[kp_C]/200[kp_C]			N	20241231
0220-4841_0a346452-bd6e-9347-e063-6294a90a8abe	0220-4841	HUMAN OTC DRUG	Sulphuricum acidum		SULFURIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFURIC ACID	5	[hp_C]/5[hp_C]			N	20241231
0220-4842_fbd3a132-a648-2a60-e053-6394a90af39f	0220-4842	HUMAN OTC DRUG	Sulphur iodatum		SULFUR IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR IODIDE	15	[hp_C]/15[hp_C]			N	20241231
0220-4843_fd663b0e-478f-7a45-e053-6294a90a8d11	0220-4843	HUMAN OTC DRUG	Sulphur iodatum		SULFUR IODIDE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFUR IODIDE	30	[hp_C]/30[hp_C]			N	20241231
0220-4846_f187ecaf-d672-2ce0-e053-2995a90a79af	0220-4846	HUMAN OTC DRUG	Sulphuricum acidum		SULFURIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFURIC ACID	6	[hp_C]/6[hp_C]			N	20241231
0220-4847_0a346084-bcec-9359-e063-6294a90a1930	0220-4847	HUMAN OTC DRUG	Sulphuricum acidum		SULFURIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFURIC ACID	9	[hp_C]/9[hp_C]			N	20241231
0220-4853_0a346de9-0afc-9276-e063-6294a90ae2fe	0220-4853	HUMAN OTC DRUG	Symphoricarpus racemosus		SYMPHORICARPOS ALBUS FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYMPHORICARPOS ALBUS FRUIT	6	[hp_C]/6[hp_C]			N	20241231
0220-4854_0a346db6-8fba-9351-e063-6294a90ab849	0220-4854	HUMAN OTC DRUG	Symphoricarpus racemosus		SYMPHORICARPOS ALBUS FRUIT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYMPHORICARPOS ALBUS FRUIT	30	[hp_C]/30[hp_C]			N	20241231
0220-4857_0a3462a4-63bf-9353-e063-6294a90aa211	0220-4857	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	6	[hp_X]/1			N	20241231
0220-4860_0a3462a4-63c0-9353-e063-6294a90aa211	0220-4860	HUMAN OTC DRUG	Sulphuricum acidum		SULFURIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFURIC ACID	30	[hp_C]/30[hp_C]			N	20241231
0220-4861_0a3470f2-50ca-b14b-e063-6294a90ad2ee	0220-4861	HUMAN OTC DRUG	Sulphuricum acidum		SULFURIC ACID	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SULFURIC ACID	200	[kp_C]/200[kp_C]			N	20241231
0220-4865_0a3443af-c2bc-3ddf-e063-6394a90a616c	0220-4865	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	5	[hp_C]/5[hp_C]			N	20241231
0220-4866_f5296adf-af64-a8cd-e053-2a95a90adcfc	0220-4866	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	6	[hp_C]/6[hp_C]			N	20241231
0220-4867_0a346452-bd72-9347-e063-6294a90a8abe	0220-4867	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	9	[hp_C]/9[hp_C]			N	20241231
0220-4868_0a346db6-8fbb-9351-e063-6294a90ab849	0220-4868	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	12	[hp_C]/12[hp_C]			N	20241231
0220-4869_0a346452-bd73-9347-e063-6294a90a8abe	0220-4869	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	15	[hp_C]/15[hp_C]			N	20241231
0220-4870_f2f6a6a4-9efe-25f4-e053-2995a90adfc3	0220-4870	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_C]/30[hp_C]			N	20241231
0220-4871_0a345bf9-6037-3de3-e063-6394a90a0584	0220-4871	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	200	[kp_C]/200[kp_C]			N	20241231
0220-4872_0410afa8-1af4-f44b-e063-6294a90a67c7	0220-4872	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	1	[hp_M]/[hp_M]			N	20241231
0220-4873_0a3470f2-50cc-b14b-e063-6294a90ad2ee	0220-4873	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	10	[hp_M]/10[hp_M]			N	20241231
0220-4874_0a34706b-1e32-3e15-e063-6394a90a0327	0220-4874	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_X]/30[hp_X]			N	20241231
0220-4877_0a346f01-3fca-3de1-e063-6394a90a164b	0220-4877	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-4878_fd66f136-ebe9-350d-e053-6294a90ab631	0220-4878	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	9	[hp_C]/9[hp_C]			N	20241231
0220-4879_0a346db6-8fbd-9351-e063-6294a90ab849	0220-4879	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	12	[hp_C]/12[hp_C]			N	20241231
0220-4880_0a348212-cf32-9343-e063-6294a90afbe4	0220-4880	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	15	[hp_C]/15[hp_C]			N	20241231
0220-4881_f2f59f63-fcdf-2a80-e053-2995a90ab087	0220-4881	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-4882_0a3482fb-8aa0-50c8-e063-6394a90a03af	0220-4882	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	200	[kp_C]/200[kp_C]			N	20241231
0220-4883_f529ff66-f774-71a3-e053-2a95a90a776b	0220-4883	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	1	[hp_M]/[hp_M]			N	20241231
0220-4884_0a346db6-8fbe-9351-e063-6294a90ab849	0220-4884	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	10	[hp_M]/10[hp_M]			N	20241231
0220-4885_0a348859-3b8d-69b9-e063-6394a90a47f8	0220-4885	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	DELPHINIUM STAPHISAGRIA SEED	30	[hp_X]/30[hp_X]			N	20241231
0220-4888_f2f5b6ce-2bb1-4d5d-e053-2a95a90a5f77	0220-4888	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-4889_0a346452-bd77-9347-e063-6294a90a8abe	0220-4889	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-4890_00efc613-7e4c-696d-e063-6394a90a6a50	0220-4890	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-4891_0a3470f2-50cd-b14b-e063-6294a90ad2ee	0220-4891	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	15	[hp_C]/15[hp_C]			N	20241231
0220-4892_f2f5a316-245b-cd5b-e053-2995a90a7362	0220-4892	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-4893_f2f5b6ce-2bad-4d5d-e053-2a95a90a5f77	0220-4893	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-4894_f600394c-2425-69b0-e053-2a95a90ac827	0220-4894	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-4895_0a34706b-1e35-3e15-e063-6394a90a0327	0220-4895	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	10	[hp_M]/10[hp_M]			N	20241231
0220-4896_f911aa31-1263-31dc-e053-6294a90a6931	0220-4896	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	12	[hp_X]/12[hp_X]			N	20241231
0220-4897_00ee4acc-fde0-5504-e063-6294a90aabd0	0220-4897	HUMAN OTC DRUG	Symphytum officinale		COMFREY ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	COMFREY ROOT	30	[hp_X]/30[hp_X]			N	20241231
0220-4906_f187ef5a-a876-733e-e053-2995a90a1b60	0220-4906	HUMAN OTC DRUG	Tabacum		TOBACCO LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOBACCO LEAF	9	[hp_C]/9[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-4907_0a346f01-3fcc-3de1-e063-6394a90a164b	0220-4907	HUMAN OTC DRUG	Tabacum		TOBACCO LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOBACCO LEAF	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-4908_0a346452-bd78-9347-e063-6294a90a8abe	0220-4908	HUMAN OTC DRUG	Tabacum		TOBACCO LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOBACCO LEAF	15	[hp_C]/15[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-4909_00f0839b-294e-dd3d-e063-6294a90a64f1	0220-4909	HUMAN OTC DRUG	Tabacum		TOBACCO LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOBACCO LEAF	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-4910_f2f5c1ee-892f-321c-e053-2995a90a2717	0220-4910	HUMAN OTC DRUG	Tabacum		TOBACCO LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOBACCO LEAF	200	[kp_C]/200[kp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-4911_0a3482fb-8aa2-50c8-e063-6394a90a03af	0220-4911	HUMAN OTC DRUG	Tabacum		TOBACCO LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOBACCO LEAF	1	[hp_M]/[hp_M]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-4916_f2f5c596-54d2-f981-e053-2995a90aeecd	0220-4916	HUMAN OTC DRUG	Tabacum		TOBACCO LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TOBACCO LEAF	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-4930_fd67fda2-9791-c5bb-e053-6294a90a7338	0220-4930	HUMAN OTC DRUG	Tarentula hispana		LYCOSA TARANTULA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOSA TARANTULA	30	[hp_C]/30[hp_C]			N	20241231
0220-4931_0a348212-cf39-9343-e063-6294a90afbe4	0220-4931	HUMAN OTC DRUG	Tarentula hispana		LYCOSA TARANTULA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOSA TARANTULA	200	[kp_C]/200[kp_C]			N	20241231
0220-4933_0a349001-5e7b-4ed1-e063-6394a90a6d24	0220-4933	HUMAN OTC DRUG	Taraxacum officinale		TARAXACUM OFFICINALE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TARAXACUM OFFICINALE	6	[hp_C]/6[hp_C]			N	20241231
0220-4934_f187f20e-7dda-dcef-e053-2a95a90a67d8	0220-4934	HUMAN OTC DRUG	Taraxacum officinale		TARAXACUM OFFICINALE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TARAXACUM OFFICINALE	30	[hp_C]/30[hp_C]			N	20241231
0220-4935_0a3470f2-50d0-b14b-e063-6294a90ad2ee	0220-4935	HUMAN OTC DRUG	Tarentula hispana		LYCOSA TARANTULA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOSA TARANTULA	1	[hp_M]/[hp_M]			N	20241231
0220-4937_0a349d0a-c677-726b-e063-6394a90a1b1d	0220-4937	HUMAN OTC DRUG	Tarentula cubensis		CITHARACANTHUS SPINICRUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITHARACANTHUS SPINICRUS	6	[hp_C]/6[hp_C]			N	20241231
0220-4938_0a349d0a-c67a-726b-e063-6394a90a1b1d	0220-4938	HUMAN OTC DRUG	Tarentula cubensis		CITHARACANTHUS SPINICRUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CITHARACANTHUS SPINICRUS	30	[hp_C]/30[hp_C]			N	20241231
0220-4939_f528df03-168a-4289-e053-2995a90a4395	0220-4939	HUMAN OTC DRUG	Tellurium metallicum		TELLURIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TELLURIUM	200	[kp_C]/200[kp_C]			N	20241231
0220-4941_0a349d0a-c67b-726b-e063-6394a90a1b1d	0220-4941	HUMAN OTC DRUG	Tarentula hispana		LYCOSA TARANTULA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOSA TARANTULA	6	[hp_C]/1			N	20241231
0220-4942_0a348859-3b94-69b9-e063-6394a90a47f8	0220-4942	HUMAN OTC DRUG	Tarentula hispana		LYCOSA TARANTULA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOSA TARANTULA	12	[hp_C]/12[hp_C]			N	20241231
0220-4943_f187f3ba-37de-8480-e053-2995a90ab996	0220-4943	HUMAN OTC DRUG	Tarentula hispana		LYCOSA TARANTULA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	LYCOSA TARANTULA	15	[hp_C]/15[hp_C]			N	20241231
0220-4953_f187f843-7a53-847e-e053-2995a90a2392	0220-4953	HUMAN OTC DRUG	Tellurium metallicum		TELLURIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TELLURIUM	30	[hp_C]/1			N	20241231
0220-4957_0a348212-cf3e-9343-e063-6294a90afbe4	0220-4957	HUMAN OTC DRUG	Terebinthina		TURPENTINE OIL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TURPENTINE OIL	9	[hp_C]/9[hp_C]			N	20241231
0220-4958_0039e564-0761-619b-e063-6394a90a886c	0220-4958	HUMAN OTC DRUG	Terebinthina		TURPENTINE OIL	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TURPENTINE OIL	30	[hp_C]/30[hp_C]			N	20241231
0220-4962_0a349a9b-19cb-770a-e063-6394a90a0e99	0220-4962	HUMAN OTC DRUG	Teucrium marum		TEUCRIUM MARUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TEUCRIUM MARUM	6	[hp_C]/6[hp_C]			N	20241231
0220-4963_0a3482fb-8aa4-50c8-e063-6394a90a03af	0220-4963	HUMAN OTC DRUG	Teucrium marum		TEUCRIUM MARUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TEUCRIUM MARUM	30	[hp_C]/30[hp_C]			N	20241231
0220-4964_0a348859-3b95-69b9-e063-6394a90a47f8	0220-4964	HUMAN OTC DRUG	Teucrium marum		TEUCRIUM MARUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TEUCRIUM MARUM	200	[kp_C]/200[kp_C]			N	20241231
0220-4970_0a3482fb-8aa5-50c8-e063-6394a90a03af	0220-4970	HUMAN PRESCRIPTION DRUG	Thallium metallicum		THALLIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THALLIUM	9	[hp_C]/9[hp_C]			N	20241231
0220-4971_f2f5c1ee-8932-321c-e053-2995a90a2717	0220-4971	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALLYLTHIOUREA	30	[hp_C]/30[hp_C]			N	20241231
0220-4972_0a34b653-86a5-787d-e063-6394a90a1970	0220-4972	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALLYLTHIOUREA	200	[kp_C]/200[kp_C]			N	20241231
0220-4978_0a349001-5e7e-4ed1-e063-6394a90a6d24	0220-4978	HUMAN OTC DRUG	Thea sinensis		GREEN TEA LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GREEN TEA LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-4979_0a34706b-1e3e-3e15-e063-6394a90a0327	0220-4979	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALLYLTHIOUREA	1	[hp_M]/[hp_M]			N	20241231
0220-4980_f2f5c903-5698-8e28-e053-2a95a90add6d	0220-4980	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALLYLTHIOUREA	30	[hp_X]/30[hp_X]			N	20241231
0220-4983_f528e4a2-d1a7-7c81-e053-2a95a90ae038	0220-4983	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALLYLTHIOUREA	6	[hp_C]/6[hp_C]			N	20241231
0220-4984_0a349d0a-c67c-726b-e063-6394a90a1b1d	0220-4984	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALLYLTHIOUREA	12	[hp_C]/12[hp_C]			N	20241231
0220-4986_0a34afcf-6d2d-d26e-e063-6294a90adfe6	0220-4986	HUMAN OTC DRUG	Theridion		THERIDION CURASSAVICUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THERIDION CURASSAVICUM	30	[hp_C]/30[hp_C]			N	20241231
0220-4990_0a349bfa-bb8a-ddb1-e063-6294a90a5772	0220-4990	HUMAN OTC DRUG	Thiosinominum		ALLYLTHIOUREA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALLYLTHIOUREA	6	[hp_X]/6[hp_X]			N	20241231
0220-4994_0a34706b-1e3f-3e15-e063-6394a90a0327	0220-4994	HUMAN OTC DRUG	Thlaspi bursa pastoris		CAPSELLA BURSA-PASTORIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAPSELLA BURSA-PASTORIS	30	[hp_C]/30[hp_C]			N	20241231
0220-4998_f938dfeb-4f69-cad0-e053-6294a90a029c	0220-4998	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/1			N	20241231
0220-5002_f938f1ee-ddd2-ffea-e053-6294a90ad187	0220-5002	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	5	[hp_C]/5[hp_C]			N	20241231
0220-5003_f938f309-d42e-fff9-e053-6294a90a83e6	0220-5003	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_C]/6[hp_C]			N	20241231
0220-5004_f938f309-d42f-fff9-e053-6294a90a83e6	0220-5004	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	7	[hp_C]/7[hp_C]			N	20241231
0220-5005_f938dfaa-58b3-e20e-e053-6394a90a3912	0220-5005	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	9	[hp_C]/9[hp_C]			N	20241231
0220-5006_f938e403-78c6-86e6-e053-6394a90a8115	0220-5006	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	12	[hp_C]/12[hp_C]			N	20241231
0220-5009_f938e403-78c8-86e6-e053-6394a90a8115	0220-5009	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	15	[hp_C]/15[hp_C]			N	20241231
0220-5010_f7a81cba-d21a-bd5b-e053-6294a90ab9ed	0220-5010	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/30[hp_C]			N	20241231
0220-5013_f938e403-78c7-86e6-e053-6394a90a8115	0220-5013	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	12	[hp_X]/12[hp_X]			N	20241231
0220-5016_00edfde0-0395-2226-e063-6294a90af199	0220-5016	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	8	[hp_X]/1			N	20241231
0220-5018_f2f5c596-54d7-f981-e053-2995a90aeecd	0220-5018	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	200	[kp_C]/200[kp_C]			N	20241231
0220-5019_f938dfeb-4f6d-cad0-e053-6294a90a029c	0220-5019	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	1	[hp_M]/[hp_M]			N	20241231
0220-5022_f938e403-78c5-86e6-e053-6394a90a8115	0220-5022	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	10	[hp_M]/10[hp_M]			N	20241231
0220-5025_0a35a826-f6ad-95df-e063-6294a90afc75	0220-5025	HUMAN OTC DRUG	Titanium metallicum		TITANIUM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TITANIUM	30	[hp_C]/30[hp_C]			N	20241231
0220-5027_f938f309-d42c-fff9-e053-6294a90a83e6	0220-5027	HUMAN OTC DRUG	Thuja occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_X]/30[hp_X]			N	20241231
0220-5034_0a35afa0-79bd-a098-e063-6294a90aa0a0	0220-5034	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	4	[hp_C]/4[hp_C]			N	20241231
0220-5035_f52b94f8-0c48-6fc1-e053-2a95a90a9802	0220-5035	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	6	[hp_C]/6[hp_C]			N	20241231
0220-5038_0a358999-33a4-cd9a-e063-6394a90a187c	0220-5038	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	9	[hp_C]/9[hp_C]			N	20241231
0220-5039_0a35a826-f6ae-95df-e063-6294a90afc75	0220-5039	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	12	[hp_C]/12[hp_C]			N	20241231
0220-5042_f528f39c-3069-41f3-e053-2995a90ab774	0220-5042	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	30	[hp_C]/30[hp_C]			N	20241231
0220-5043_f528f39c-3068-41f3-e053-2995a90ab774	0220-5043	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	200	[kp_C]/200[kp_C]			N	20241231
0220-5046_0a35c673-8bf7-b4ee-e063-6294a90a8f21	0220-5046	HUMAN OTC DRUG	Thyroidinum		THYROID, UNSPECIFIED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	THYROID, UNSPECIFIED	1	[hp_M]/[hp_M]			N	20241231
0220-5049_00edbc51-9a8b-566f-e063-6294a90a81a7	0220-5049	HUMAN OTC DRUG	Trillium pendulum		TRILLIUM ERECTUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TRILLIUM ERECTUM ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-5065_f2927b24-040e-df7f-e053-2995a90ac453	0220-5065	HUMAN OTC DRUG	TUBERCULINUM RESIDUUM		TUBERCULINUM RESIDUUM	PELLET	ORAL	20221014		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULINUM RESIDUUM	15	[hp_C]/15[hp_C]			N	20241231
0220-5066_f2926b37-e944-5f45-e053-2a95a90a46f1	0220-5066	HUMAN OTC DRUG	TUBERCULINUM RESIDUUM		TUBERCULINUM RESIDUUM	PELLET	ORAL	20221014		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULINUM RESIDUUM	30	[hp_C]/30[hp_C]			N	20241231
0220-5067_f80d8c5f-44be-5126-e053-6294a90a5e6b	0220-5067	HUMAN OTC DRUG	TUBERCULINUM RESIDUUM		TUBERCULINUM RESIDUUM	PELLET	ORAL	20221014		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULINUM RESIDUUM	200	[kp_C]/200[kp_C]			N	20241231
0220-5085_0590e5fd-6217-b75a-e063-6294a90acb86	0220-5085	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	12; 12; 12; 12	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-5086_05cdea44-c4fc-0437-e063-6294a90a156f	0220-5086	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-5087_05cec593-2b58-0564-e063-6394a90a77f4	0220-5087	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	200; 200; 200; 200	[kp_C]/1; [kp_C]/1; [kp_C]/1; [kp_C]/1			N	20241231
0220-5088_05cec593-2b60-0564-e063-6394a90a77f4	0220-5088	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-5089_0636383b-29e7-db7a-e063-6394a90a2aa6	0220-5089	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	30; 30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
0220-5090_0636383b-29f0-db7a-e063-6394a90a2aa6	0220-5090	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-5091_06368ea2-bdf3-c2ea-e063-6294a90a69b5	0220-5091	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
0220-5092_0636d9ae-f24d-6d93-e063-6394a90a5e73	0220-5092	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED),INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Boiron	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	9; 9; 9; 9	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-5115_0a35c9e5-6594-b78a-e063-6294a90a64b8	0220-5115	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	5	[hp_C]/5[hp_C]			N	20241231
0220-5116_f2f5e0bd-6541-1687-e053-2995a90a1cca	0220-5116	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	6	[hp_C]/6[hp_C]			N	20241231
0220-5117_0a35dd58-da88-2b28-e063-6394a90a02e6	0220-5117	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	9	[hp_C]/9[hp_C]			N	20241231
0220-5118_0a35cc13-45d7-a4b0-e063-6294a90a0773	0220-5118	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	12	[hp_C]/12[hp_C]			N	20241231
0220-5119_0a35df6b-5389-3a41-e063-6294a90a6846	0220-5119	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	15	[hp_C]/15[hp_C]			N	20241231
0220-5120_f2f5ddbe-e8ac-855d-e053-2a95a90a5b83	0220-5120	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	30	[hp_C]/30[hp_C]			N	20241231
0220-5121_f7fb78b0-c636-0007-e053-6294a90affab	0220-5121	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	200	[kp_C]/200[kp_C]			N	20241231
0220-5122_0a35c673-8bfb-b4ee-e063-6294a90a8f21	0220-5122	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	1	[hp_M]/[hp_M]			N	20241231
0220-5123_0a35e1d8-aed3-32e1-e063-6394a90a6055	0220-5123	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	30	[hp_X]/30[hp_X]			N	20241231
0220-5146_00ee4acc-fddc-5504-e063-6294a90aabd0	0220-5146	HUMAN OTC DRUG	Urtica urens		URTICA URENS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	URTICA URENS	6	[hp_X]/1			N	20241231
0220-5153_0a35c9e5-6595-b78a-e063-6294a90a64b8	0220-5153	HUMAN OTC DRUG	USTILAGO MAIDIS		USTILAGO MAYDIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	USTILAGO MAYDIS	30	[hp_C]/30[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-5156_0a35e565-6aee-27d2-e063-6394a90aae1e	0220-5156	HUMAN OTC DRUG	Ustilago maidis		USTILAGO MAYDIS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	USTILAGO MAYDIS	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-5160_0a35df43-5bf5-c58f-e063-6294a90aa4e0	0220-5160	HUMAN OTC DRUG	Uva ursi		ARCTOSTAPHYLOS UVA URSI LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARCTOSTAPHYLOS UVA-URSI LEAF	8	[hp_X]/8[hp_X]			N	20241231
0220-5161_0a35df43-5bf6-c58f-e063-6294a90aa4e0	0220-5161	HUMAN OTC DRUG	UVA URSI		ARCTOSTAPHYLOS UVA-URSI LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARCTOSTAPHYLOS UVA-URSI LEAF	6	[hp_C]/6[hp_C]			N	20241231
0220-5162_0a35df6b-538c-3a41-e063-6294a90a6846	0220-5162	HUMAN OTC DRUG	UVA URSI		ARCTOSTAPHYLOS UVA-URSI LEAF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ARCTOSTAPHYLOS UVA-URSI LEAF	30	[hp_C]/30[hp_C]			N	20241231
0220-5196_0a35e96a-e83d-306d-e063-6394a90ac710	0220-5196	HUMAN OTC DRUG	VERATRUM ALBUM		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	9	[hp_C]/9[hp_C]			N	20241231
0220-5197_0a35e565-6af0-27d2-e063-6394a90aae1e	0220-5197	HUMAN OTC DRUG	VERATRUM ALBUM		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	12	[hp_C]/12[hp_C]			N	20241231
0220-5198_0a35ec95-6aa4-333e-e063-6394a90a4b1b	0220-5198	HUMAN OTC DRUG	VERATRUM ALBUM		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	15	[hp_C]/15[hp_C]			N	20241231
0220-5199_00efda74-d430-04be-e063-6294a90a6d98	0220-5199	HUMAN OTC DRUG	VERATRUM ALBUM		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-5200_044c713e-bd2b-f64b-e063-6394a90a7699	0220-5200	HUMAN OTC DRUG	VERATRUM ALBUM		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	200	[kp_C]/200[kp_C]			N	20241231
0220-5201_0a35e96a-e83e-306d-e063-6394a90ac710	0220-5201	HUMAN OTC DRUG	VERATRUM ALBUM		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	1	[hp_M]/[hp_M]			N	20241231
0220-5202_0a35e96a-e83f-306d-e063-6394a90ac710	0220-5202	HUMAN OTC DRUG	VERATRUM ALBUM		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	10	[hp_M]/10[hp_M]			N	20241231
0220-5207_0a35df6b-538d-3a41-e063-6294a90a6846	0220-5207	HUMAN OTC DRUG	VALERIANA OFFICINALIS		VALERIAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VALERIAN	6	[hp_C]/6[hp_C]			N	20241231
0220-5208_0a35f0c9-695e-e38a-e063-6294a90afb5c	0220-5208	HUMAN OTC DRUG	VALERIANA OFFICINALIS		VALERIAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VALERIAN	9	[hp_C]/9[hp_C]			N	20241231
0220-5209_0a35f1c3-6c28-1ac0-e063-6394a90a2201	0220-5209	HUMAN OTC DRUG	VALERIANA OFFICINALIS		VALERIAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VALERIAN	30	[hp_C]/30[hp_C]			N	20241231
0220-5210_00f14e28-1ef3-a93c-e063-6394a90aa4b4	0220-5210	HUMAN OTC DRUG	VALERIANA OFFICINALIS		VALERIAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VALERIAN	30	[hp_X]/30[hp_X]			N	20241231
0220-5217_0a35df43-5bf7-c58f-e063-6294a90aa4e0	0220-5217	HUMAN OTC DRUG	Valeriana officinalis		VALERIAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VALERIAN	4	[hp_X]/1			N	20241231
0220-5225_0a0b260d-72fc-1d4e-e063-6394a90a11c4	0220-5225	HUMAN OTC DRUG	Venus mercenaria		NORTHERN QUAHOG	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	NORTHERN QUAHOG	12	[hp_C]/12[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
0220-5233_0a35f1c3-6c29-1ac0-e063-6394a90a2201	0220-5233	HUMAN OTC DRUG	Veratrum album		VERATRUM ALBUM ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM ALBUM ROOT	6	[hp_C]/1			N	20241231
0220-5238_00edb97e-6153-1534-e063-6294a90ab766	0220-5238	HUMAN OTC DRUG	Veratrum viride		VERATRUM VIRIDE ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM VIRIDE ROOT	6	[hp_C]/6[hp_C]			N	20241231
0220-5239_0a35e565-6af5-27d2-e063-6394a90aae1e	0220-5239	HUMAN OTC DRUG	VERATRUM VIRIDE		VERATRUM VIRIDE ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERATRUM VIRIDE ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-5242_0a0b1620-07c0-16fc-e063-6394a90ac9e8	0220-5242	HUMAN OTC DRUG	Verbascum thapsus		VERBASCUM THAPSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERBASCUM THAPSUS	6	[hp_C]/6[hp_C]			N	20241231
0220-5243_0a35fac4-43c9-f28b-e063-6294a90a4e6b	0220-5243	HUMAN OTC DRUG	VERBASCUM THAPSUS		VERBASCUM THAPSUS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VERBASCUM THAPSUS	30	[hp_C]/30[hp_C]			N	20241231
0220-5254_0a35df43-5bfa-c58f-e063-6294a90aa4e0	0220-5254	HUMAN OTC DRUG	Vespa crabro		VESPA CRABRO	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VESPA CRABRO	30	[hp_C]/30[hp_C]			N	20241231
0220-5258_0a35ec95-6aa5-333e-e063-6394a90a4b1b	0220-5258	HUMAN OTC DRUG	Viburnum opulus		VIBURNUM OPULUS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIBURNUM OPULUS BARK	5	[hp_C]/5[hp_C]			N	20241231
0220-5259_0a36799d-2e56-3100-e063-6294a90adf85	0220-5259	HUMAN OTC DRUG	VIBURNUM OPULUS		VIBURNUM OPULUS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIBURNUM OPULUS BARK	9	[hp_C]/9[hp_C]			N	20241231
0220-5260_0a369e28-5b95-4abb-e063-6294a90a2c07	0220-5260	HUMAN OTC DRUG	VIBURNUM OPULUS		VIBURNUM OPULUS BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIBURNUM OPULUS BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-5270_0a367b49-adcf-4974-e063-6394a90a66c3	0220-5270	HUMAN OTC DRUG	Viola odorata		VIOLA ODORATA	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIOLA ODORATA	30	[hp_C]/30[hp_C]			N	20241231
0220-5274_0a366d54-9794-3138-e063-6294a90a81aa	0220-5274	HUMAN OTC DRUG	Viola tricolor		VIOLA TRICOLOR	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIOLA TRICOLOR	6	[hp_C]/6[hp_C]			N	20241231
0220-5275_0c070987-c605-7b3b-e063-6294a90ad9de	0220-5275	HUMAN OTC DRUG	VIPERA BERUS		VIPERA BERUS VENOM	PELLET	ORAL	20240101		UNAPPROVED HOMEOPATHIC		Boiron	VIPERA BERUS VENOM	200	[kp_C]/200[kp_C]			N	20241231
0220-5278_0a366191-6c3a-1435-e063-6294a90ab694	0220-5278	HUMAN OTC DRUG	Vipera berus		VIPERA BERUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIPERA BERUS VENOM	6	[hp_C]/6[hp_C]			N	20241231
0220-5282_0a36a405-49c5-28d1-e063-6294a90ae102	0220-5282	HUMAN OTC DRUG	Viscum album		VISCUM ALBUM FRUITING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VISCUM ALBUM FRUITING TOP	4	[hp_X]/4[hp_X]			N	20241231
0220-5283_0a366191-6c3c-1435-e063-6294a90ab694	0220-5283	HUMAN OTC DRUG	VISCUM ALBUM		VISCUM ALBUM FRUITING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VISCUM ALBUM FRUITING TOP	6	[hp_C]/6[hp_C]			N	20241231
0220-5284_f7e5dacd-0bc2-4ac4-e053-6394a90a457a	0220-5284	HUMAN OTC DRUG	VISCUM ALBUM		VISCUM ALBUM FRUITING TOP	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VISCUM ALBUM FRUITING TOP	30	[hp_C]/30[hp_C]			N	20241231
0220-5286_0a36a405-49c6-28d1-e063-6294a90ae102	0220-5286	HUMAN OTC DRUG	VIPERA BERUS		VIPERA BERUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIPERA BERUS VENOM	9	[hp_C]/9[hp_C]			N	20241231
0220-5287_0a36799d-2e58-3100-e063-6294a90adf85	0220-5287	HUMAN OTC DRUG	VIPERA BERUS		VIPERA BERUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIPERA BERUS VENOM	12	[hp_C]/12[hp_C]			N	20241231
0220-5288_fbd41018-0366-4244-e053-6294a90ac3c5	0220-5288	HUMAN OTC DRUG	VIPERA BERUS		VIPERA BERUS VENOM	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	VIPERA BERUS VENOM	30	[hp_C]/30[hp_C]			N	20241231
0220-5307_0a365b0c-9349-6cb3-e063-6394a90aaa14	0220-5307	HUMAN OTC DRUG	Wyethia helenioides		WYETHIA HELENIOIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	WYETHIA HELENIOIDES ROOT	6	[hp_C]/1			N	20241231
0220-5308_0a36aba0-d574-46ba-e063-6294a90a238f	0220-5308	HUMAN OTC DRUG	WYETHIA HELENIOIDES		WYETHIA HELENIOIDES ROOT	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	WYETHIA HELENIOIDES ROOT	30	[hp_C]/30[hp_C]			N	20241231
0220-5335_00edb97e-6152-1534-e063-6294a90ab766	0220-5335	HUMAN OTC DRUG	Xanthoxylum fraxineum		ZANTHOXYLUM AMERICANUM BARK	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZANTHOXYLUM AMERICANUM BARK	30	[hp_C]/30[hp_C]			N	20241231
0220-5343_0a365b0c-934b-6cb3-e063-6394a90aaa14	0220-5343	HUMAN OTC DRUG	X-ray		ALCOHOL, X-RAY EXPOSED (1000 RAD)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALCOHOL, X-RAY EXPOSED (1000 RAD)	12	[hp_C]/1			N	20241231
0220-5344_0a36a405-49c7-28d1-e063-6294a90ae102	0220-5344	HUMAN OTC DRUG	X-RAY		ALCOHOL, X-RAY EXPOSED (1000 RAD)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALCOHOL, X-RAY EXPOSED (1000 RAD)	30	[hp_C]/30[hp_C]			N	20241231
0220-5345_0a36aba0-d575-46ba-e063-6294a90a238f	0220-5345	HUMAN OTC DRUG	X-RAY		ALCOHOL, X-RAY EXPOSED (1000 RAD)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALCOHOL, X-RAY EXPOSED (1000 RAD)	200	[kp_C]/200[kp_C]			N	20241231
0220-5346_0a36a405-49c8-28d1-e063-6294a90ae102	0220-5346	HUMAN OTC DRUG	X-RAY		ALCOHOL, X-RAY EXPOSED (1000 RAD)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ALCOHOL, X-RAY EXPOSED (1000 RAD)	10	[hp_M]/10[hp_M]			N	20241231
0220-5349_0a36aba0-d576-46ba-e063-6294a90a238f	0220-5349	HUMAN OTC DRUG	Camphora		CAMPHOR (NATURAL)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CAMPHOR (NATURAL)	1	[hp_M]/[hp_M]			N	20241231
0220-5433_f7e59aea-64cd-a69b-e053-6294a90af7b5	0220-5433	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	6	[hp_C]/6[hp_C]			N	20241231
0220-5434_0a367b49-add2-4974-e063-6394a90a66c3	0220-5434	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	9	[hp_C]/9[hp_C]			N	20241231
0220-5435_0a36c18a-5f88-8cd2-e063-6394a90a561e	0220-5435	HUMAN OTC DRUG	Zincum metallicum		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	12	[hp_C]/12[hp_C]			N	20241231
0220-5436_0a36cd60-0ab6-432f-e063-6294a90a6034	0220-5436	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	15	[hp_C]/15[hp_C]			N	20241231
0220-5437_f2f5a316-245c-cd5b-e053-2995a90a7362	0220-5437	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	30	[hp_C]/30[hp_C]			N	20241231
0220-5438_00f1b06e-2bea-566c-e063-6294a90a1734	0220-5438	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	200	[kp_C]/200[kp_C]			N	20241231
0220-5439_0a36aba0-d579-46ba-e063-6294a90a238f	0220-5439	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	1	[hp_M]/[hp_M]			N	20241231
0220-5440_0a36aba0-d57a-46ba-e063-6294a90a238f	0220-5440	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	30	[hp_X]/30[hp_X]			N	20241231
0220-5465_00edbed0-998e-a9fb-e063-6394a90ada4a	0220-5465	HUMAN OTC DRUG	Zincum metallicum		ZINC	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC	8	[hp_X]/1			N	20241231
0220-5485_0a36c585-782c-7493-e063-6394a90aecbb	0220-5485	HUMAN OTC DRUG	ZINCUM SULPHURICUM		ZINC SULFATE HEPTAHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC SULFATE HEPTAHYDRATE	30	[hp_C]/30[hp_C]	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0220-5489_0a35e96a-e842-306d-e063-6394a90ac710	0220-5489	HUMAN OTC DRUG	Zincum valerianicum		ZINC VALERATE DIHYDRATE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ZINC VALERATE DIHYDRATE	30	[hp_C]/30[hp_C]			N	20241231
0220-6413_0a35e565-6af7-27d2-e063-6394a90aae1e	0220-6413	HUMAN PRESCRIPTION DRUG	Candida albicans		CANDIDA ALBICANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	CANDIDA ALBICANS	8	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0220-6515_0a35e96a-e843-306d-e063-6394a90ac710	0220-6515	HUMAN PRESCRIPTION DRUG	Colibacillinum		ESCHERICHIA COLI	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ESCHERICHIA COLI	12	[hp_C]/12[hp_C]			N	20241231
0220-6517_0a35df43-5bfd-c58f-e063-6294a90aa4e0	0220-6517	HUMAN PRESCRIPTION DRUG	Colibacillinum		ESCHERICHIA COLI	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	ESCHERICHIA COLI	15	[hp_C]/15[hp_C]			N	20241231
0220-6529_0d09f924-46e5-a07f-e063-6394a90a7948	0220-6529	HUMAN PRESCRIPTION DRUG	Crataegus		HAWTHORN LEAF WITH FLOWER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAWTHORN LEAF WITH FLOWER	30	[hp_C]/30[hp_C]			N	20241231
0220-6530_04110848-45a8-646a-e063-6394a90a19a1	0220-6530	HUMAN PRESCRIPTION DRUG	Crataegus oxyacantha		HAWTHORN LEAF WITH FLOWER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAWTHORN LEAF WITH FLOWER	200	[kp_C]/200[kp_C]			N	20241231
0220-6532_086957b6-703d-4b1e-e063-6294a90a3848	0220-6532	HUMAN PRESCRIPTION DRUG	Crataegus		HAWTHORN LEAF WITH FLOWER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAWTHORN LEAF WITH FLOWER	6	[hp_C]/6[hp_C]			N	20241231
0220-6535_08693119-e5fa-6f91-e063-6394a90a3022	0220-6535	HUMAN PRESCRIPTION DRUG	Crataegus		HAWTHORN LEAF WITH FLOWER	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	HAWTHORN LEAF WITH FLOWER	6	[hp_X]/6[hp_X]			N	20241231
0220-7306_0869283b-57d8-6328-e063-6294a90a3fab	0220-7306	HUMAN PRESCRIPTION DRUG	Medorrhinum		GONORRHEAL URETHRAL SECRETION HUMAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GONORRHEAL URETHRAL SECRETION HUMAN	9	[hp_C]/9[hp_C]			N	20241231
0220-7307_0a35f0c9-6969-e38a-e063-6294a90afb5c	0220-7307	HUMAN PRESCRIPTION DRUG	Medorrhinum		GONORRHEAL URETHRAL SECRETION HUMAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GONORRHEAL URETHRAL SECRETION HUMAN	12	[hp_C]/12[hp_C]			N	20241231
0220-7309_0d09d981-2757-2a4f-e063-6294a90aaca1	0220-7309	HUMAN PRESCRIPTION DRUG	Medorrhinum		GONORRHEAL URETHRAL SECRETION HUMAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	GONORRHEAL URETHRAL SECRETION HUMAN	12	[hp_X]/1			N	20241231
0220-7310_0a35df43-5bfe-c58f-e063-6294a90aa4e0	0220-7310	HUMAN PRESCRIPTION DRUG	Medorrhinum		GONORRHEAL URETHRAL SECRETION HUMAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GONORRHEAL URETHRAL SECRETION HUMAN	15	[hp_C]/15[hp_C]			N	20241231
0220-7311_0a35f0c9-696a-e38a-e063-6294a90afb5c	0220-7311	HUMAN PRESCRIPTION DRUG	Medorrhinum		GONORRHEAL URETHRAL SECRETION HUMAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	GONORRHEAL URETHRAL SECRETION HUMAN	30	[hp_C]/30[hp_C]			N	20241231
0220-7604_0a35ec95-6aaa-333e-e063-6394a90a4b1b	0220-7604	HUMAN PRESCRIPTION DRUG	Psorinum		SCABIES LESION LYSATE (HUMAN)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCABIES LESION LYSATE (HUMAN)	7	[hp_X]/1			N	20241231
0220-7609_09a87fd2-d04e-0af8-e063-6294a90a8227	0220-7609	HUMAN PRESCRIPTION DRUG	Pyrogenium		RANCID BEEF	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	RANCID BEEF	8	[hp_X]/1			N	20241231
0220-7622_0a35f15c-c1cd-e9d4-e063-6294a90a333d	0220-7622	HUMAN PRESCRIPTION DRUG	Psorinum		SCABIES LESION LYSATE (HUMAN)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCABIES LESION LYSATE (HUMAN)	6	[hp_C]/6[hp_C]			N	20241231
0220-7623_0a360f87-76d1-e6a7-e063-6294a90a07fb	0220-7623	HUMAN PRESCRIPTION DRUG	Psorinum		SCABIES LESION LYSATE (HUMAN)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCABIES LESION LYSATE (HUMAN)	9	[hp_C]/9[hp_C]			N	20241231
0220-7624_0a35eea4-a456-c538-e063-6294a90a290f	0220-7624	HUMAN PRESCRIPTION DRUG	Psorinum		SCABIES LESION LYSATE (HUMAN)	PELLET	ORAL	19830303		UNAPPROVED MEDICAL GAS		Boiron	SCABIES LESION LYSATE (HUMAN)	12	[hp_C]/12[hp_C]			N	20241231
0220-7625_0a35f0c9-696e-e38a-e063-6294a90afb5c	0220-7625	HUMAN PRESCRIPTION DRUG	Psorinum		SCABIES LESION LYSATE (HUMAN)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCABIES LESION LYSATE (HUMAN)	15	[hp_C]/15[hp_C]			N	20241231
0220-7626_0a36226a-1254-4b3a-e063-6394a90a3e55	0220-7626	HUMAN PRESCRIPTION DRUG	Psorinum		SCABIES LESION LYSATE (HUMAN)	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SCABIES LESION LYSATE (HUMAN)	30	[hp_C]/30[hp_C]			N	20241231
0220-7791_0a35fac4-43cf-f28b-e063-6294a90a4e6b	0220-7791	HUMAN PRESCRIPTION DRUG	Staphylococcinum		STAPHYLOCOCCUS EPIDERMIDIS, STAPHYLOCOCCUS HAEMOLYTICUS, STAPHYLOCOCCUS SIMULANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS	30; 30; 30	[hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]			N	20241231
0220-7794_0a35f1c3-6c2e-1ac0-e063-6394a90a2201	0220-7794	HUMAN PRESCRIPTION DRUG	Staphylococcinum		STAPHYLOCOCCUS EPIDERMIDIS, STAPHYLOCOCCUS HAEMOLYTICUS, STAPHYLOCOCCUS SIMULANS	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS	8; 8; 8	[hp_X]/8[hp_X]; [hp_X]/8[hp_X]; [hp_X]/8[hp_X]			N	20241231
0220-7796_0a3622d0-76f7-48de-e063-6394a90a426a	0220-7796	HUMAN PRESCRIPTION DRUG	Streptococcinum		STREPTOCOCCUS PYOGENES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STREPTOCOCCUS PYOGENES	12	[hp_X]/1			N	20241231
0220-7799_0a35fac4-43d0-f28b-e063-6294a90a4e6b	0220-7799	HUMAN PRESCRIPTION DRUG	Streptococcinum		STREPTOCOCCUS PYOGENES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STREPTOCOCCUS PYOGENES	6	[hp_C]/6[hp_C]			N	20241231
0220-7800_0a35fac4-43d1-f28b-e063-6294a90a4e6b	0220-7800	HUMAN PRESCRIPTION DRUG	Streptococcinum		STREPTOCOCCUS PYOGENES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STREPTOCOCCUS PYOGENES	9	[hp_C]/9[hp_C]			N	20241231
0220-7802_0a362eed-459b-4865-e063-6394a90a470d	0220-7802	HUMAN PRESCRIPTION DRUG	Streptococcinum		STREPTOCOCCUS PYOGENES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STREPTOCOCCUS PYOGENES	15	[hp_C]/15[hp_C]			N	20241231
0220-7803_f228e06c-f17e-667a-e053-2995a90aa418	0220-7803	HUMAN PRESCRIPTION DRUG	Streptococcinum		STREPTOCOCCUS PYOGENES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STREPTOCOCCUS PYOGENES	30	[hp_C]/30[hp_C]			N	20241231
0220-7805_0a3622d0-76f9-48de-e063-6394a90a426a	0220-7805	HUMAN PRESCRIPTION DRUG	Streptococcinum		STREPTOCOCCUS PYOGENES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STREPTOCOCCUS PYOGENES	200	[kp_C]/200[kp_C]			N	20241231
0220-7806_0a362eed-459c-4865-e063-6394a90a470d	0220-7806	HUMAN PRESCRIPTION DRUG	Streptococcinum		STREPTOCOCCUS PYOGENES	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	STREPTOCOCCUS PYOGENES	1	[hp_M]/[hp_M]			N	20241231
0220-7838_0a361e9b-0cdf-f7c7-e063-6294a90a08b7	0220-7838	HUMAN PRESCRIPTION DRUG	Syphilinum		TREPONEMIC SKIN CANKER HUMAN	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TREPONEMIC SKIN CANKER HUMAN	30	[hp_C]/30[hp_C]			N	20241231
0220-7841_0a362fe6-6eb7-6020-e063-6394a90a7454	0220-7841	HUMAN PRESCRIPTION DRUG	Syzygium jambolanum		SYZYGIUM CUMINI SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYZYGIUM CUMINI SEED	6	[hp_C]/6[hp_C]			N	20241231
0220-7842_0a364a68-011b-5f71-e063-6394a90afc82	0220-7842	HUMAN PRESCRIPTION DRUG	Syzygium jambolanum		SYZYGIUM CUMINI SEED	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	SYZYGIUM CUMINI SEED	30	[hp_C]/30[hp_C]			N	20241231
0220-7935_0a363bae-0d76-632e-e063-6394a90ac9ea	0220-7935	HUMAN PRESCRIPTION DRUG	Tuberculinum		TUBERCULIN PURIFIED PROTEIN DERIVATIVE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	8	[hp_X]/1	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
0220-7944_0a362eed-45ae-4865-e063-6394a90a470d	0220-7944	HUMAN PRESCRIPTION DRUG	Tuberculinum		TUBERCULIN PURIFIED PROTEIN DERIVATIVE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	12	[hp_C]/12[hp_C]	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
0220-7945_0a362fe6-6eb8-6020-e063-6394a90a7454	0220-7945	HUMAN PRESCRIPTION DRUG	Tuberculinum		TUBERCULIN PURIFIED PROTEIN DERIVATIVE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	15	[hp_C]/15[hp_C]	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
0220-7946_0a362eed-45af-4865-e063-6394a90a470d	0220-7946	HUMAN PRESCRIPTION DRUG	Tuberculinum		TUBERCULIN PURIFIED PROTEIN DERIVATIVE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	30	[hp_C]/30[hp_C]	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
0220-7947_0a361e9b-0ce1-f7c7-e063-6294a90a08b7	0220-7947	HUMAN PRESCRIPTION DRUG	Tuberculinum		TUBERCULIN PURIFIED PROTEIN DERIVATIVE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	200	[kp_C]/200[kp_C]	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
0220-7948_0a36226a-1257-4b3a-e063-6394a90a3e55	0220-7948	HUMAN PRESCRIPTION DRUG	Tuberculinum		TUBERCULIN PURIFIED PROTEIN DERIVATIVE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	1	[hp_M]/[hp_M]	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
0220-7949_0a361874-75d7-480d-e063-6394a90a864b	0220-7949	HUMAN PRESCRIPTION DRUG	Tuberculinum		TUBERCULIN PURIFIED PROTEIN DERIVATIVE	PELLET	ORAL	19830303		UNAPPROVED HOMEOPATHIC		Boiron	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	10	[hp_M]/10[hp_M]	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
0220-9000_ff599824-85fe-0ed5-e053-6294a90a1c87	0220-9000	HUMAN OTC DRUG	Arnicare		ARNICA MONTANA	GEL	TOPICAL	20070109		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA	1	[hp_X]/g			N	20241231
0220-9004_fb46dcaf-ef71-4f45-e053-6294a90a7a98	0220-9004	HUMAN OTC DRUG	Acidil		PICEA MARIANA RESIN, ACTIVATED CHARCOAL, STRYCHNOS NUX-VOMICA SEED, ROBINIA PSEUDOACACIA BARK	TABLET	ORAL	19970805		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ACTIVATED CHARCOAL; PICEA MARIANA RESIN; ROBINIA PSEUDOACACIA BARK; STRYCHNOS NUX-VOMICA SEED	4; 4; 4; 4	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9010_06ea4068-3729-527c-e063-6394a90ac081	0220-9010	HUMAN OTC DRUG	Acidil		PICEA MARIANA RESIN, ACTIVATED CHARCOAL, STRYCHNOS NUX-VOMICA SEED, ROBINIA PSEUDOACACIA BARK	PELLET	ORAL	20220429		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL; PICEA MARIANA RESIN; ROBINIA PSEUDOACACIA BARK; STRYCHNOS NUX-VOMICA SEED	4; 4; 4; 4	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9013_0b508c1c-542f-5a82-e063-6294a90ab8c6	0220-9013	HUMAN OTC DRUG	Avenoc		HORSE CHESTNUT, COLLINSONIA CANADENSIS ROOT, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	OINTMENT	TOPICAL	20070602	20240630	UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	COLLINSONIA CANADENSIS ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT	1; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g			N	
0220-9021_f60007c0-9b09-273c-e053-2995a90a77d9	0220-9021	HUMAN OTC DRUG	ARNICARE		ARNICA MONTANA	CREAM	TOPICAL	20070301		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA	1	[hp_X]/g			N	20241231
0220-9023_f2923e63-4f88-a054-e053-2a95a90abddc	0220-9023	HUMAN OTC DRUG	Arnicare		ARNICA MONTANA	OINTMENT	CUTANEOUS	20070602		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA	1	[hp_X]/g			N	20241231
0220-9032_05173f5f-6763-be69-e063-6394a90a8852	0220-9032	HUMAN OTC DRUG	Chestal		ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA, IPECAC, PULSATILLA VULGARIS, RUMEX CRISPUS ROOT, PONGIA OFFICINALIS SKELETON, ROASTED, LOBARIA PULMONARIA	SYRUP	ORAL	19930201		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; LOBARIA PULMONARIA; PROTORTONIA CACTI; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 3; 3; 3; 3; 3; 6; 6; 3	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
0220-9033_00c80802-be3c-5fc8-e063-6394a90a7e86	0220-9033	HUMAN OTC DRUG	Chestal for Children		ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA, IPECAC, PULSATILLA VULGARIS, RUMEX CRISPUS ROOT, PONGIA OFFICINALIS SKELETON, ROASTED, LOBARIA PULMONARIA	SYRUP	ORAL	19960801		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; LOBARIA PULMONARIA; PROTORTONIA CACTI; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 3; 3; 3; 3; 3; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9042_0b294e1a-d6e5-e2fd-e063-6394a90a05c4	0220-9042	HUMAN OTC DRUG	Arnicare Value Pack		ARNICA MONTANA	KIT	ORAL; TOPICAL	20081101		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron						N	20241231
0220-9044_f539a8d6-2843-32de-e053-2a95a90a2b5a	0220-9044	HUMAN OTC DRUG	Arnicare Arthritis		ARNICA MONTANA, BENZOIC ACID, BRYONIA ALBA ROOT, MATRICARIA RECUTITA, SOLANUM DULCAMARA TOP, POTASSIUM IODIDE, PULSATILLA VULGARIS, RHODODENDRON AUREUM LEAF, TOXICODENDRON PUBESCENS LEAF	TABLET	ORAL	20071123		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA; BENZOIC ACID; BRYONIA ALBA ROOT; MATRICARIA RECUTITA; POTASSIUM IODIDE; PULSATILLA VULGARIS; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF	3; 6; 6; 12; 12; 3; 12; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
0220-9047_f28d6223-5ca5-4056-e053-2a95a90a6d3f	0220-9047	HUMAN OTC DRUG	Arnica Value Pack		ARNICA MONTANA	KIT		20081101		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron						N	20241231
0220-9048_faba59e5-ee23-5e16-e053-6394a90ac6ea	0220-9048	HUMAN OTC DRUG	Coldcalm		ONION, APIS MELLIFERA, ATROPA BELLADONNA, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, STRYCHNOS NUX-VOMICA SEED, PHYTOLACCA AMERICANA ROOT, PULSATILLA VULGARIS, DICHROMATE ION	TABLET	ORAL	19950101		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	APIS MELLIFERA; ATROPA BELLADONNA; DICHROMATE ION; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; ONION; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 3; 6; 3; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9049_f7e8ed4c-29c1-b08c-e053-6394a90ac8d9	0220-9049	HUMAN OTC DRUG	Children Coldcalm		ONION, APIS MELLIFERA, ATROPA BELLADONNA, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED, PHYTOLACCA AMERICANA ROOT, PULSATILLA VULGARIS	PELLET	ORAL	20080908		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	APIS MELLIFERA; ATROPA BELLADONNA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; ONION; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED	5; 6; 3; 6; 3; 6; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9050_f1875a4f-fc44-cb91-e053-2995a90addeb	0220-9050	HUMAN OTC DRUG	Arnicare Procedure Recovery		ARNICA MONTANA	KIT	ORAL	20071101		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron						N	20241231
0220-9053_06eaf8a7-52d5-3258-e063-6294a90abc7a	0220-9053	HUMAN OTC DRUG	Arnica montana 30X Bonus Pack		ARNICA MONTANA	PELLET	ORAL	20170701		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	30	[hp_X]/1			N	20241231
0220-9054_f5dd50b4-6666-d932-e053-2a95a90a085f	0220-9054	HUMAN OTC DRUG	Camilia		MATRICARIA RECUTITA, RHUBARB, PHYTOLACCA AMERICANA ROOT	LIQUID	ORAL	20101201		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	MATRICARIA RECUTITA; PHYTOLACCA AMERICANA ROOT; RHUBARB	9; 5; 5	[hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0220-9055_fc5e9b32-5730-bafb-e053-6294a90a8ea9	0220-9055	HUMAN OTC DRUG	Arnicare Foot Care		ARNICA MONTANA	CREAM	TOPICAL	20180601		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	1	[hp_X]/[hp_X]			N	20241231
0220-9057_0994a032-bd05-d389-e063-6294a90afbe0	0220-9057	HUMAN OTC DRUG	Coldcalm		ONION, APIS MELLIFERA, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED, PHYTOLACCA AMERICANA ROOT, PULSATILLA VULGARIS	LIQUID	ORAL	20170501		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	APIS MELLIFERA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; ONION; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED	15; 3; 6; 3; 6; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9059_00c2e4bc-356d-455b-e063-6294a90ae965	0220-9059	HUMAN OTC DRUG	Arnicare Arnica		ARNICA MONTANA	TABLET	ORAL	20110711		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA	9	[hp_C]/1			N	20241231
0220-9060_0a5f84a6-b629-1773-e063-6294a90a7640	0220-9060	HUMAN OTC DRUG	ColdCalm Kids		STRYCHNOS NUX-VOMICA SEED, PULSATILLA VULGARIS, ONION, PHYTOLACCA AMERICANA ROOT, POTASSIUM DICHROMATE, GELSEMIUM SEMPERVIRENS ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, APIS MELLIFERA,	LIQUID	ORAL	20180515		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; ONION; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED	15; 3; 6; 3; 6; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9065_0389abb0-7dda-eeb6-e063-6294a90ace85	0220-9065	HUMAN OTC DRUG	Chestal Adult Pellets		ANTIMONY POTASSIUM TARTRATE,BRYONIA ALBA ROOT, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA WHOLE, IPECAC, RUMEX CRISPUS ROOT, SPONGIA OFFICINALIS SKELETON, ROASTED, PULSATILLA VULGARIS WHOLE, LOBARIA PULMONARIA	PELLET	ORAL	20200619		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC; LOBARIA PULMONARIA; PROTORTONIA CACTI; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 3; 3; 3; 3; 3; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9066_0389c5de-dc1c-7ef5-e063-6394a90a9285	0220-9066	HUMAN OTC DRUG	Chestal Kids Pellets		ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, PROTORTONIA CACTI,DROSERA ROTUNDIFOLIA WHOLE, IPECAC, PULSATILLA VULGARIS WHOLE, RUMEX CRISPUS ROOT,SPONGIA OFFICINALIS SKELETON, ROASTED, LOBARIA PULMONARIA	PELLET	ORAL	20200727		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC; LOBARIA PULMONARIA; PROTORTONIA CACTI; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 3; 3; 3; 3; 3; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9067_f1ff76da-0ae0-536d-e053-2a95a90a2441	0220-9067	HUMAN OTC DRUG	Chestal Cough and Cold		SOLANUM DULCAMARA TOP, FERRUM PHOSPHORICUM, GOLDENSEAL, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED	SYRUP	ORAL	20130601		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	FERRUM PHOSPHORICUM; GOLDENSEAL; POTASSIUM DICHROMATE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED	9; 9; 9; 5; 9	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9068_f1f082bc-6e02-0681-e053-2995a90a50f7	0220-9068	HUMAN OTC DRUG	Chestal Childrens Cough and Cold		SOLANUM DULCAMARA TOP, FERRUM PHOSPHORICUM, GOLDENSEAL, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED	SYRUP	ORAL	20130601		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	FERRUM PHOSPHORICUM; GOLDENSEAL; POTASSIUM DICHROMATE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED	9; 9; 9; 5; 9	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9073_f40b2d36-692b-5803-e053-2a95a90af542	0220-9073	HUMAN OTC DRUG	Arnicare Leg Cramps		ARNICA MONTANA, LACTIC ACID, L-, ZINC OXIDE	TABLET	ORAL	20180615		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA; LACTIC ACID, L-; ZINC OXIDE	9; 3; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9077_00c6172d-4afe-1268-e063-6394a90a2cb4	0220-9077	HUMAN OTC DRUG	ARNICARE ARTHRITIS		ARNICA MONTANA, HARPAGOPHYTUM PROCUMBENS ROOT, HARPAGOPHYTUM ZEYHERI ROOT	CREAM	TOPICAL	20220317		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA; HARPAGOPHYTUM PROCUMBENS ROOT; HARPAGOPHYTUM ZEYHERI ROOT	1; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
0220-9078_f63ce25e-71a7-5139-e053-2a95a90af330	0220-9078	HUMAN OTC DRUG	Cyclease Cramps		BLACK COHOSH, CITRULLUS COLOCYNTHIS FRUIT PULP, ESIUM PHOSPHATE, DIBASIC TRIHYDRATE	TABLET	ORAL	19920708		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	BLACK COHOSH; CITRULLUS COLOCYNTHIS FRUIT PULP; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-9079_0995f09f-c345-a152-e063-6394a90aa945	0220-9079	HUMAN OTC DRUG	Arnicare Leg Cramps		ARNICA MONTANA WHOLE, COPPER, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, STRYCHNOS NUX-VOMICA SEED, PASSIFLORA INCARNATA TOP, CLAVICEPS PURPUREA SCLEROTIUM	TABLET	ORAL	20230911		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA; CLAVICEPS PURPUREA SCLEROTIUM; COPPER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PASSIFLORA INCARNATA TOP; STRYCHNOS NUX-VOMICA SEED	6; 9; 4; 6; 3; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0220-9081_fcea41e7-b1a6-8718-e053-6294a90a117a	0220-9081	HUMAN OTC DRUG	Cyclease PMS		ESTRONE, SODIUM CHLORIDE, SEPIA OFFICINALIS JUICE	TABLET	ORAL	20020812		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ESTRONE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE	15; 12; 12	[hp_C]/1; [hp_C]/1; [hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0220-9082_030b038f-d916-dc07-e063-6394a90a6e5e	0220-9082	HUMAN OTC DRUG	Cyclease Menopause		ARNICA MONTANA WHOLE, BLACK COHOSH, NITROGLYCERIN, LACHESIS MUTA VENOM, SANGUINARIA CANADENSIS ROOT	TABLET	ORAL	20200401		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA WHOLE; BLACK COHOSH; LACHESIS MUTA VENOM; NITROGLYCERIN; SANGUINARIA CANADENSIS ROOT	4; 4; 5; 4; 4	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0220-9083_06ea4068-372a-527c-e063-6394a90ac081	0220-9083	HUMAN OTC DRUG	Arnicare Bruise		ARNICA MONTANA	TABLET	ORAL	20220118		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	9	[hp_C]/1			N	20241231
0220-9084_f539ab4f-58df-0ed9-e053-2a95a90abbd1	0220-9084	HUMAN OTC DRUG	Arnicare Bruise		ARNICA MONTANA	GEL	TOPICAL	20160201		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARNICA MONTANA	1	[hp_X]/g			N	20241231
0220-9085_fc5e6f2a-e817-0666-e053-6394a90a66a7	0220-9085	HUMAN OTC DRUG	Arnicare Bruise		ARNICA MONTANA	CREAM	TOPICAL	20200121		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	1	[hp_X]/[hp_X]			N	20241231
0220-9086_f526b0db-d4fa-7281-e053-2995a90a6fa1	0220-9086	HUMAN OTC DRUG	CALENDULA		CALENDULA	OINTMENT	TOPICAL	20160129		UNAPPROVED HOMEOPATHIC		Boiron	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/g			N	20241231
0220-9087_0671385c-7371-03ac-e063-6394a90afc1c	0220-9087	HUMAN OTC DRUG	Arnica		ARNICA MONTANA	TABLET	ORAL	20231001		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	30	[hp_C]/1			N	20241231
0220-9089_0682b0ee-eebc-c149-e063-6294a90a6293	0220-9089	HUMAN OTC DRUG	ARNICA		ARNICA MONTANA	TABLET	ORAL	20231001		UNAPPROVED HOMEOPATHIC		Boiron	ARNICA MONTANA	30	[hp_X]/1			N	20241231
0220-9095_fb5a86ae-243a-f9a0-e053-6394a90a504b	0220-9095	HUMAN OTC DRUG	DIARALIA		ARSENIC TRIOXIDE,CINCHONA OFFICINALIS BARK, PODOPHYLLUM	TABLET	ORAL	20190801		UNAPPROVED HOMEOPATHIC		BOIRON	ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; PODOPHYLLUM	9; 5; 9	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9097_06ea4068-372b-527c-e063-6394a90ac081	0220-9097	HUMAN OTC DRUG	DIARALIA		ARSENIC TRIOXIDE, CINCHONA OFFICINALIS BARK, PODOPHYLLUM	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Boiron	ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; PODOPHYLLUM	9; 5; 9	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9098_fe91543e-a79e-6399-e053-6394a90af5e5	0220-9098	HUMAN OTC DRUG	COLDCALM		ONION, APIS MELLIFERA, ATROPA BELLADONNA, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, POTASSIUM DICHROMATE, STRYCHNOS NUX-VOMICA SEED, PHYTOLACCA AMERICANA ROOT, PULSATILLA VULGARIS WHOLE	PELLET	ORAL	20220315		UNAPPROVED HOMEOPATHIC		Boiron	APIS MELLIFERA; ATROPA BELLADONNA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; ONION; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED	6; 6; 3; 6; 3; 6; 6; 6; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9099_06c011fd-2815-2a57-e063-6394a90a8099	0220-9099	HUMAN OTC DRUG	Camilia Tummy		ACTIVATED CHARCOAL, MATRICARIA CHAMOMILLA, COPPER, CITRULLUS COLOCYNTHIS FRUIT PULP	LIQUID	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL; CITRULLUS COLOCYNTHIS FRUIT PULP; COPPER; MATRICARIA CHAMOMILLA	6; 9; 6; 15	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-9101_06ea67d8-b617-776b-e063-6294a90a3185	0220-9101	HUMAN OTC DRUG	ACNE RELIEF		POTASSIUM BROMIDE, SYZYGIUM JAMBOS SEED, SELENIUM	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Boiron	POTASSIUM BROMIDE; SELENIUM; SYZYGIUM JAMBOS SEED	30; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9134_fb5cf5e0-86d4-3f5a-e053-6294a90a2d38	0220-9134	HUMAN OTC DRUG	Gasalia		ACTIVATED CHARCOAL, LYCOPODIUM CLAVATUM SPORE, NUTMEG, DAIKON	TABLET	ORAL	19970805		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ACTIVATED CHARCOAL; DAIKON; LYCOPODIUM CLAVATUM SPORE; NUTMEG	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9135_06ea4a82-ecad-6320-e063-6394a90ab9a0	0220-9135	HUMAN OTC DRUG	GASALIA		ACTIVATED CHARCOAL, LYCOPODIUM CLAVATUM SPORE, NUTMEG, RADISH	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Boiron	ACTIVATED CHARCOAL; LYCOPODIUM CLAVATUM SPORE; NUTMEG; RADISH	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
0220-9178_f2042bfe-4da6-1f53-e053-2995a90aceb7	0220-9178	HUMAN OTC DRUG	HemCalm		HORSE CHESTNUT, COLLINSONIA CANADENSIS ROOT, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	OINTMENT	TOPICAL	20200101		UNAPPROVED HOMEOPATHIC		BOIRON	COLLINSONIA CANADENSIS ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT	1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
0220-9179_f204538e-0396-b450-e053-2a95a90a82b4	0220-9179	HUMAN OTC DRUG	HemCalm		HORSE CHESTNUT, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, PAEONIA OFFICINALIS ROOT, KRAMERIA LAPPACEA ROOT	SUPPOSITORY	RECTAL	20200101		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; KRAMERIA LAPPACEA ROOT; PAEONIA OFFICINALIS ROOT	2; 7; 7; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
0220-9180_fe03b9f5-90bb-b07c-e053-6394a90afac9	0220-9180	HUMAN OTC DRUG	HEMCALM		HORSE CHESTNUT, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, STRYCHNOS NUX-VOMICA SEED	TABLET	ORAL	20191201		UNAPPROVED HOMEOPATHIC		BOIRON	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; STRYCHNOS NUX-VOMICA SEED	6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9181_f495f64b-c0e2-6363-e053-2a95a90a78e0	0220-9181	HUMAN OTC DRUG	HEMCALM		HORSE CHESTNUT, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Boiron	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; STRYCHNOS NUX-VOMICA SEED	6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9214_06ea4a82-ecae-6320-e063-6394a90ab9a0	0220-9214	HUMAN OTC DRUG	Jet Lag Relief		ANAMIRTA COCCULUS SEED, ARNICA MONTANA, STRYCHNOS NUX-VOMICA WHOLE	PELLET	ORAL	20170101		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ANAMIRTA COCCULUS SEED; ARNICA MONTANA; STRYCHNOS NUX-VOMICA WHOLE	6; 6; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9228_06ea67d8-b619-776b-e063-6294a90a3185	0220-9228	HUMAN OTC DRUG	Leg Pain Relief		ZINC, COPPER, HYPERICUM PERFORATUM	PELLET	ORAL	20170101		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	COPPER; HYPERICUM PERFORATUM; ZINC	6; 30; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
0220-9234_fceda9b6-659b-43f8-e053-6294a90af01f	0220-9234	HUMAN OTC DRUG	MotionCalm		ANAMIRTA COCCULUS SEED, IPECAC,STRYCHNOS NUX-VOMICA SEED,TOBACCO LEAF, KEROSENE	TABLET	ORAL	20210723		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED; IPECAC; KEROSENE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	4; 4; 4; 4; 4	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9244_fd00be12-6095-1d4c-e053-6294a90aae87	0220-9244	HUMAN OTC DRUG	NauseaCalm		ANAMIRTA COCCULUS SEED, IPECAC, STRYCHNOS NUX-VOMICA SEED, TOBACCO LEAF, KEROSENE	TABLET	ORAL	20210729		UNAPPROVED HOMEOPATHIC		Boiron	ANAMIRTA COCCULUS SEED; IPECAC; KEROSENE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	4; 4; 4; 4; 4	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9280_017e89fd-3366-d223-e063-6394a90aedb1	0220-9280	HUMAN OTC DRUG	Oscillococcinum		CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	PELLET	ORAL	19980801		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
0220-9303_fe91543e-a796-6399-e053-6394a90af5e5	0220-9303	HUMAN OTC DRUG	ALLERGYCALM		SCHOENOCAULON OFFICINALE SEED, ONION, SOLIDAGO VIRGAUREA FLOWERING TOP, AMBROSIA ARTEMISIIFOLIA, EUPHRASIA STRICTA, HISTAMINE DIHYDROCHLORIDE	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Boiron	AMBROSIA ARTEMISIIFOLIA; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; SCHOENOCAULON OFFICINALE SEED; SOLIDAGO VIRGAUREA FLOWERING TOP	5; 5; 9; 5; 5; 5	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9305_06e98f5b-5a00-0b35-e063-6294a90aaa0d	0220-9305	HUMAN OTC DRUG	ALLERGYCALM		ONION, AMBROSIA ARTEMISIIFOLIA WHOLE, EUPHRASIA STRICTA, HISTAMINE DIHYDROCHLORIDE, SOLIDAGO VIRGAUREA FLOWERING TOP, SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	20220315		UNAPPROVED HOMEOPATHIC		Boiron	AMBROSIA ARTEMISIIFOLIA; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; SCHOENOCAULON OFFICINALE SEED; SOLIDAGO VIRGAUREA FLOWERING TOP	5; 5; 9; 5; 5; 5	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9306_fd791428-05d1-5c7b-e053-6294a90a2747	0220-9306	HUMAN OTC DRUG	AllergyCalm		ONION, AMBROSIA ARTEMISIIFOLIA, EUPHRASIA STRICTA, HISTAMINE DIHYDROCHLORIDE, SCHOENOCAULON OFFICINALE SEED, SOLIDAGO VIRGAUREA FLOWERING TOP	TABLET	ORAL	20220301		UNAPPROVED HOMEOPATHIC		Boiron	AMBROSIA ARTEMISIIFOLIA; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; SCHOENOCAULON OFFICINALE SEED; SOLIDAGO VIRGAUREA FLOWERING TOP	5; 5; 9; 5; 5; 5	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9307_f396daec-cb49-a8fc-e053-2995a90a0926	0220-9307	HUMAN OTC DRUG	AllergyCalm		ONION, AMBROSIA ARTEMISIIFOLIA, EUPHRASIA STRICTA, HISTAMINE DIHYDROCHLORIDE, SCHOENOCAULON OFFICINALE SEED, SOLIDAGO VIRGAUREA FLOWERING TOP	TABLET	ORAL	20220301		UNAPPROVED HOMEOPATHIC		Boiron	AMBROSIA ARTEMISIIFOLIA; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; SCHOENOCAULON OFFICINALE SEED; SOLIDAGO VIRGAUREA FLOWERING TOP	5; 5; 9; 5; 5; 5	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0220-9308_05b737df-3c6c-f84e-e063-6394a90a570d	0220-9308	HUMAN OTC DRUG	SleepCalm		MATRICARIA CHAMOMILLA WHOLE, GELSEMIUM SEMPERVIRENS ROOT, HYOSCYAMUS NIGER, POTASSIUM BROMIDE, PASSIFLORA INCARNATA FLOWERING TOP, DATURA STRAMONIUM	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM BROMIDE	9; 9; 9; 9; 3; 9	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9309_0992dcf6-0f08-c4e5-e063-6294a90a6bd1	0220-9309	HUMAN OTC DRUG	SleepCalm Kids		MATRICARIA CHAMOMILLA WHOLE, GELSEMIUM SEMPERVIRENS ROOT, HYOSCYAMUS NIGER, POTASSIUM BROMIDE, PASSIFLORA INCARNATA FLOWERING TOP, DATURA STRAMONIUM	LIQUID	ORAL	20200910		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM BROMIDE	9; 9; 9; 9; 3; 9	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9310_0981ee4b-1c96-d7a5-e063-6294a90ad203	0220-9310	HUMAN OTC DRUG	SleepCalm		HYOSCYAMUS NIGER, NUTMEG, PASSIFLORA INCARNATA TOP, DATURA STRAMONIUM	TABLET	ORAL	20200401		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	DATURA STRAMONIUM; HYOSCYAMUS NIGER; NUTMEG; PASSIFLORA INCARNATA TOP	6; 3; 4; 3	[hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9311_fe914a16-23f6-2909-e053-6294a90a3af6	0220-9311	HUMAN OTC DRUG	SleepCalm		HYOSCYAMUS NIGER, NUTMEG, PASSIFLORA INCARNATA FLOWERING TOP, DATURA STRAMONIUM	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Boiron	DATURA STRAMONIUM; HYOSCYAMUS NIGER; NUTMEG; PASSIFLORA INCARNATA TOP	6; 3; 4; 3	[hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9314_0b51dae5-fa5b-71d2-e063-6294a90a9a66	0220-9314	HUMAN OTC DRUG	Quietude		HYOSCYAMUS NIGER, NUTMEG, PASSIFLORA INCARNATA TOP, DATURA STRAMONIUM	TABLET	ORAL	20131001	20241031	UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	DATURA STRAMONIUM; HYOSCYAMUS NIGER; NUTMEG; PASSIFLORA INCARNATA TOP	6; 3; 4; 3	[hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
0220-9318_ffc34bc6-5de3-addb-e053-6294a90a25be	0220-9318	HUMAN OTC DRUG	Quit Smoking Symptom Relief		LOBELIA INFLATA WHOLE, STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Boiron	LOBELIA INFLATA; STRYCHNOS NUX-VOMICA SEED	6; 30	[hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0220-9325_fabac923-0c6d-e15b-e053-6394a90aa8db	0220-9325	HUMAN OTC DRUG	ThroatCalm		ARNICA MONTANA, ARISAEMA TRIPHYLLUM ROOT, BELLADONNA LEAF, BROMINE, BRYONIA ALBA ROOT, MERCURIUS SOLUBILIS, PHYTOLACCA AMERICANA ROOT, PULSATILLA VULGARIS, SPONGIA OFFICINALIS SKELETON, ROASTED	TABLET	ORAL	20170501		UNAPPROVED HOMEOPATHIC		Laboratoires Boiron	ARISAEMA TRIPHYLLUM ROOT; ARNICA MONTANA; BELLADONNA LEAF; BROMINE; BRYONIA ALBA ROOT; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; SPONGIA OFFICINALIS SKELETON, ROASTED	3; 3; 3; 3; 3; 4; 3; 3; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9327_f396a5be-36bb-d582-e053-2a95a90affaa	0220-9327	HUMAN OTC DRUG	THROATCALM		ARISAEMA TRIPHYLLUM ROOT, ATROPA BELLADONNA, MERCURIUS SOLUBILIS, BROMINE, BRYONIA ALBA ROOT, ARNICA MONTANA, PHYTOLACCA AMERICANA ROOT, PULSATILLA VULGARIS, SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Boiron	ARISAEMA TRIPHYLLUM ROOT; ARNICA MONTANA; ATROPA BELLADONNA; BROMINE; BRYONIA ALBA ROOT; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; SPONGIA OFFICINALIS SKELETON, ROASTED	3; 3; 3; 3; 3; 4; 3; 3; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9329_0e993cb8-ecca-240d-e063-6394a90a98e4	0220-9329	HUMAN OTC DRUG	THROATCALM		ECHINACEA ANGUSTIFOLIA WHOLE, PLANTAGO MAJOR WHOLE	SPRAY	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Boiron	ECHINACEA ANGUSTIFOLIA WHOLE; PLANTAGO MAJOR WHOLE	1; 1	[hp_X]/mL; [hp_X]/mL			N	20251231
0220-9333_f897099d-910a-3a25-e053-6294a90af62c	0220-9333	HUMAN OTC DRUG	StressCalm		ACONITUM NAPELLUS WHOLE, ATROPA BELLADONNA, CALENDULA OFFICINALIS FLOWERING TOP, CHELIDONIUM MAJUS WHOLE, ABRUS PRECATORIUS SEED, VIBURNUM OPULUS BARK	TABLET	ORAL	20200914		UNAPPROVED HOMEOPATHIC		Boiron	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS WHOLE; ATROPA BELLADONNA; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS WHOLE; VIBURNUM OPULUS BARK	6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9334_f89758d3-9391-56cc-e053-6394a90a94c6	0220-9334	HUMAN OTC DRUG	StressCalm		ACONITUM NAPELLUS, ATROPA BELLADONNA, CHELIDONIUM MAJUS, CALENDULA OFFICINALIS FLOWERING TOP, VIBURNUM OPULUS BARK, ABRUS PRECATORIUS SEED	PELLET	ORAL	20220429		UNAPPROVED HOMEOPATHIC		Boiron	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; ATROPA BELLADONNA; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; VIBURNUM OPULUS BARK	6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9338_f2041d6b-be6d-7baa-e053-2a95a90a50e7	0220-9338	HUMAN OTC DRUG	SINUSCALM		ATROPA BELLADONNA, SANGUINARIA CANADENSIS ROOT, SPIGELIA ANTHELMIA	TABLET	ORAL	20190601		UNAPPROVED HOMEOPATHIC		BOIRON	ATROPA BELLADONNA; SANGUINARIA CANADENSIS ROOT; SPIGELIA ANTHELMIA	3; 3; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9339_f29251a1-7d15-a1bf-e053-2a95a90a10c1	0220-9339	HUMAN OTC DRUG	SINUSCALM ALLERGY		ATROPA BELLADONNA, SANGUINARIA CANADENSIS ROOT,	TABLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA; SANGUINARIA CANADENSIS ROOT; SPIGELIA ANTHELMIA	3; 3; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9347_08f2e848-c96f-4947-e063-6394a90a7310	0220-9347	HUMAN OTC DRUG	SinusCalm		ATROPA BELLADONNA, SANGUINARIA CANADENSIS ROOT, SPIGELIA ANTHELMIA	PELLET	ORAL	20191201		UNAPPROVED HOMEOPATHIC		Boiron	ATROPA BELLADONNA; SANGUINARIA CANADENSIS ROOT; SPIGELIA ANTHELMIA	3; 3; 3	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9356_f938cca9-3228-57a7-e053-6394a90a2745	0220-9356	HUMAN OTC DRUG	Thuja occidentalis 30C		THUJA OCCIDENTALIS	PELLET	ORAL	20170315		UNAPPROVED HOMEOPATHIC		Boiron	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/30[hp_C]			N	20241231
0220-9372_f939070d-3c86-b635-e053-6394a90a58d4	0220-9372	HUMAN OTC DRUG	WartCalm		ANTIMONY TRISULFIDE, NITRIC ACID, THUJA OCCIDENTALIS LEAFY TWIG,	TABLET	ORAL	20211015		UNAPPROVED HOMEOPATHIC		Boiron	ANTIMONY TRISULFIDE; NITRIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	9; 9; 9	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
0220-9376_fa68ce46-cf03-f774-e053-6394a90af5c7	0220-9376	HUMAN OTC DRUG	YeastCalm		SODIUM BORATE,CALENDULA OFFICINALIS FLOWERING TOP,CANDIDA ALBICANS,GOLDENSEAL	SUPPOSITORY	VAGINAL	20211001		UNAPPROVED HOMEOPATHIC		Laboratoires Boirdon	CALENDULA OFFICINALIS FLOWERING TOP; CANDIDA ALBICANS; GOLDENSEAL; SODIUM BORATE	1; 30; 5; 14	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0224-1852_d455865c-148b-1a49-e053-2a95a90af656	0224-1852	HUMAN OTC DRUG	Konsyl Orange Flavor Psyllium Fiber - Smooth Texture		PSYLLIUM HUSK	GRANULE	ORAL	20110331	20240501	OTC MONOGRAPH NOT FINAL	part334	Konsyl Pharmaceuticals, Inc.	PSYLLIUM HUSK	3.4	g/12g			N	
0224-1884_d4558e44-9e24-bdc8-e053-2a95a90af1ef	0224-1884	HUMAN OTC DRUG	Konsyl Sugar free Orange With Stevia		PSYLLIUM HUSK	POWDER	TOPICAL	20181001	20240601	OTC MONOGRAPH NOT FINAL	part334	Konsyl Pharmaceuticals, Inc.	PSYLLIUM HUSK	3.5	g/5.8g			N	
0225-0295_5b5d2c46-5cd4-c6ef-e053-2991aa0adf32	0225-0295	HUMAN PRESCRIPTION DRUG	ANASPAZ		HYOSCYAMINE SULFATE	TABLET, ORALLY DISINTEGRATING	ORAL; SUBLINGUAL	19730102		UNAPPROVED DRUG OTHER		BF ASCHER AND CO INC	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
0225-0360_ec816efc-bf05-1fc4-e053-2995a90a8c3b	0225-0360	HUMAN OTC DRUG	MOBISYL		TROLAMINE SALICYLATE	CREAM	TOPICAL	20140919		OTC MONOGRAPH NOT FINAL	part348	BF ASCHER AND CO INC	TROLAMINE SALICYLATE	10	g/100g			N	20241231
0225-0495_ec8208ae-21d1-51d7-e053-2a95a90ad50d	0225-0495	HUMAN OTC DRUG	ITCH X		BENZYL ALCOHOL/PRAMOXINE HYDROCHLORIDE	GEL	TOPICAL	20140919		OTC MONOGRAPH NOT FINAL	part348	BF ASCHER AND CO INC	BENZYL ALCOHOL; PRAMOXINE HYDROCHLORIDE	10; 1	g/100g; g/100g	Pediculicide [EPC]		N	20241231
0225-0516_ec8208ae-21d5-51d7-e053-2a95a90ad50d	0225-0516	HUMAN OTC DRUG	ITCH-X		PRAMOXINE HCL/BENZYL ALCOHOL	SPRAY	TOPICAL	20140919	20251031	OTC MONOGRAPH NOT FINAL	part348	BF ASCHER AND CO INC	BENZYL ALCOHOL; PRAMOXINE HYDROCHLORIDE	10; 1	g/100mL; g/100mL	Pediculicide [EPC]		N	
0225-0610_00d95376-5745-3c48-e063-6394a90a7fbc	0225-0610	HUMAN OTC DRUG	BENZEDREX	09-19-2014	PROPYLHEXEDRINE	INHALANT	NASAL	20140919	20250228	OTC MONOGRAPH FINAL	M012	BF ASCHER AND CO INC	PROPYLHEXEDRINE	250	mg/1			N	
0225-0611_00d8bf32-aeae-22da-e063-6294a90a7567	0225-0611	HUMAN OTC DRUG	BENZEDREX		PROPYLHEXEDRINE	INHALANT	NASAL	20230623		OTC MONOGRAPH FINAL	M012	BF ASCHER AND CO INC	PROPYLHEXEDRINE	175	mg/1			N	20241231
0225-0800_0a49851d-972e-3326-e063-6394a90a5ad4	0225-0800	HUMAN OTC DRUG	Neo-Synephrine Mild		PHENYLEPHRINE HYDROCHLORIDE	SPRAY	NASAL	20200701		OTC MONOGRAPH DRUG	M012	BF ASCHER AND CO INC	PHENYLEPHRINE HYDROCHLORIDE	.25	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0225-0805_0a4959f4-48c2-1fab-e063-6394a90a41f8	0225-0805	HUMAN OTC DRUG	Neo-Synephrine Regular		PHENYLEPHRINE HYDROCHLORIDE	SPRAY	NASAL	20200701		OTC MONOGRAPH DRUG	M012	BF ASCHER AND CO INC	PHENYLEPHRINE HYDROCHLORIDE	.5	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0225-0810_0a49488a-841e-7937-e063-6294a90aeac8	0225-0810	HUMAN OTC DRUG	Neo-Synephrine Maximum		PHENYLEPHRINE HYDROCHLORIDE	SPRAY	NASAL	20200701		OTC MONOGRAPH DRUG	M012	BF ASCHER AND CO INC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0228-1410_b90472f4-fa00-41e4-adb5-0dd4c611e0a0	0228-1410	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160401		ANDA	ANDA200672	Actavis Pharma, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0228-1422_b90472f4-fa00-41e4-adb5-0dd4c611e0a0	0228-1422	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160401		ANDA	ANDA200672	Actavis Pharma, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0228-1435_b90472f4-fa00-41e4-adb5-0dd4c611e0a0	0228-1435	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160401		ANDA	ANDA200672	Actavis Pharma, Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0228-1453_b90472f4-fa00-41e4-adb5-0dd4c611e0a0	0228-1453	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160401		ANDA	ANDA200672	Actavis Pharma, Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0228-1580_b90472f4-fa00-41e4-adb5-0dd4c611e0a0	0228-1580	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160401		ANDA	ANDA200672	Actavis Pharma, Inc.	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0228-1638_b90472f4-fa00-41e4-adb5-0dd4c611e0a0	0228-1638	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160601		ANDA	ANDA200672	Actavis Pharma, Inc.	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0228-2027_17df721a-a91e-4313-b85e-29cc19a0d4fd	0228-2027	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Actavis Pharma, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2029_17df721a-a91e-4313-b85e-29cc19a0d4fd	0228-2029	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Actavis Pharma, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2031_17df721a-a91e-4313-b85e-29cc19a0d4fd	0228-2031	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Actavis Pharma, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2039_17df721a-a91e-4313-b85e-29cc19a0d4fd	0228-2039	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Actavis Pharma, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2067_402cac61-f3fb-46ea-88ed-3ce641406717	0228-2067	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE, GELATIN COATED	ORAL	20070102		ANDA	ANDA072253	Actavis Pharma, Inc.	OXAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2069_402cac61-f3fb-46ea-88ed-3ce641406717	0228-2069	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE, GELATIN COATED	ORAL	20070102		ANDA	ANDA072253	Actavis Pharma, Inc.	OXAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2073_402cac61-f3fb-46ea-88ed-3ce641406717	0228-2073	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE, GELATIN COATED	ORAL	20070102		ANDA	ANDA072253	Actavis Pharma, Inc.	OXAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2076_6e5063d3-25f1-44c8-83d5-0f3f0ea877fa	0228-2076	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	19900930		ANDA	ANDA071620	Actavis Pharma, Inc.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2077_6e5063d3-25f1-44c8-83d5-0f3f0ea877fa	0228-2077	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	19900930		ANDA	ANDA071620	Actavis Pharma, Inc.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-2127_2073adcf-e52c-4b2b-854e-4efb8ddc40f8	0228-2127	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070974	Actavis Pharma, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-2128_2073adcf-e52c-4b2b-854e-4efb8ddc40f8	0228-2128	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070975	Actavis Pharma, Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-2129_2073adcf-e52c-4b2b-854e-4efb8ddc40f8	0228-2129	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070976	Actavis Pharma, Inc.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-2348_c3e85c2b-3603-4993-a00d-b1cf61387b61	0228-2348	HUMAN PRESCRIPTION DRUG	Propylthiouracil		Propylthiouracil	TABLET	ORAL	20060115		ANDA	ANDA080172	Actavis Pharma, Inc.	PROPYLTHIOURACIL	50	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
0228-2497_f5799caf-c875-46f7-a23b-092a54872b30	0228-2497	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE, LIQUID FILLED	ORAL	19910101		ANDA	ANDA072579	Actavis Pharma, Inc.	NIFEDIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0228-2530_f5799caf-c875-46f7-a23b-092a54872b30	0228-2530	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE, LIQUID FILLED	ORAL	19900920		ANDA	ANDA072556	Actavis Pharma, Inc.	NIFEDIPINE	20	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0228-2538_fe0c1375-fa09-4fc4-919b-ac03a5c5ab82	0228-2538	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	19930901	20240930	ANDA	ANDA074260	Actavis Pharma, Inc.	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
0228-2539_fe0c1375-fa09-4fc4-919b-ac03a5c5ab82	0228-2539	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	19930901	20241130	ANDA	ANDA074260	Actavis Pharma, Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
0228-2540_fe0c1375-fa09-4fc4-919b-ac03a5c5ab82	0228-2540	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	19930901		ANDA	ANDA074260	Actavis Pharma, Inc.	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0228-2550_f1bfed87-11b0-4fe8-9e93-0e4b288d409d	0228-2550	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	Actavis Pharma, Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0228-2551_f1bfed87-11b0-4fe8-9e93-0e4b288d409d	0228-2551	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	Actavis Pharma, Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0228-2571_d3a5980b-afa6-4fc6-8c1b-3f9631dd1cba	0228-2571	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20070102		ANDA	ANDA074722	Actavis Pharma, Inc.	INDAPAMIDE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0228-2597_d3a5980b-afa6-4fc6-8c1b-3f9631dd1cba	0228-2597	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20070102		ANDA	ANDA074722	Actavis Pharma, Inc.	INDAPAMIDE	1.25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0228-2620_d5d4cdad-5d0a-4d50-8aea-dc0ec36c26e7	0228-2620	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET	ORAL	19981030		ANDA	ANDA075037	Actavis Pharma, Inc.	ISOSORBIDE MONONITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0228-2631_d5d4cdad-5d0a-4d50-8aea-dc0ec36c26e7	0228-2631	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET	ORAL	19981030		ANDA	ANDA075037	Actavis Pharma, Inc.	ISOSORBIDE MONONITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0228-2636_aea65b96-e213-4141-8c3f-3eb4650985f1	0228-2636	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20040214		ANDA	ANDA075694	Actavis Pharma, Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0228-2637_aea65b96-e213-4141-8c3f-3eb4650985f1	0228-2637	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20041004		ANDA	ANDA075694	Actavis Pharma, Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0228-2778_429abeed-5a01-4294-a05b-23d0632325ba	0228-2778	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20070810		ANDA	ANDA078494	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0228-2779_429abeed-5a01-4294-a05b-23d0632325ba	0228-2779	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20070810		ANDA	ANDA078494	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0228-2780_429abeed-5a01-4294-a05b-23d0632325ba	0228-2780	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20070810		ANDA	ANDA078494	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0228-2781_429abeed-5a01-4294-a05b-23d0632325ba	0228-2781	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20070810		ANDA	ANDA078494	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0228-2801_7db72b88-d664-4f26-901c-46c901b20d80	0228-2801	HUMAN PRESCRIPTION DRUG	Pilocarpine hydrochloride		Pilocarpine hydrochloride	TABLET, FILM COATED	ORAL	20110913		NDA AUTHORIZED GENERIC	NDA020237	Actavis Pharma, Inc.	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0228-2820_eb535009-05c2-4100-8f7d-b01308e13f47	0228-2820	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070312		ANDA	ANDA040707	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0228-2837_7db72b88-d664-4f26-901c-46c901b20d80	0228-2837	HUMAN PRESCRIPTION DRUG	Pilocarpine hydrochloride		Pilocarpine hydrochloride	TABLET, FILM COATED	ORAL	20110913		NDA AUTHORIZED GENERIC	NDA020237	Actavis Pharma, Inc.	PILOCARPINE HYDROCHLORIDE	7.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0228-2848_31345079-f1be-48c5-adc6-5b79b4c6542f	0228-2848	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	CAPSULE, EXTENDED RELEASE	ORAL	20140805		ANDA	ANDA091482	Actavis Pharma, Inc.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0228-2849_31345079-f1be-48c5-adc6-5b79b4c6542f	0228-2849	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	CAPSULE, EXTENDED RELEASE	ORAL	20140805		ANDA	ANDA091482	Actavis Pharma, Inc.	FLUVOXAMINE MALEATE	150	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0228-2850_16343763-c429-4a2e-9a78-09bbdb4fb08f	0228-2850	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20141201		ANDA	ANDA200881	Actavis Pharma, Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-2851_16343763-c429-4a2e-9a78-09bbdb4fb08f	0228-2851	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20141201		ANDA	ANDA200881	Actavis Pharma, Inc.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-2853_16343763-c429-4a2e-9a78-09bbdb4fb08f	0228-2853	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20141201		ANDA	ANDA200881	Actavis Pharma, Inc.	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-2855_16343763-c429-4a2e-9a78-09bbdb4fb08f	0228-2855	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20141201		ANDA	ANDA200881	Actavis Pharma, Inc.	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-2856_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd	0228-2856	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200910	20240531	ANDA	ANDA091025	Actavis Pharma, Inc.	PREGABALIN	25	mg/1		CV	N	
0228-2858_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd	0228-2858	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200910	20240531	ANDA	ANDA091025	Actavis Pharma, Inc.	PREGABALIN	75	mg/1		CV	N	
0228-2859_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd	0228-2859	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200910	20240131	ANDA	ANDA091025	Actavis Pharma, Inc.	PREGABALIN	100	mg/1		CV	N	
0228-2860_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd	0228-2860	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20201008	20240229	ANDA	ANDA091025	Actavis Pharma, Inc.	PREGABALIN	150	mg/1		CV	N	
0228-2861_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd	0228-2861	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20201008	20240331	ANDA	ANDA091025	Actavis Pharma, Inc.	PREGABALIN	200	mg/1		CV	N	
0228-2862_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd	0228-2862	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20201008	20240331	ANDA	ANDA091025	Actavis Pharma, Inc.	PREGABALIN	225	mg/1		CV	N	
0228-2863_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd	0228-2863	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20201008	20250331	ANDA	ANDA091025	Actavis Pharma, Inc.	PREGABALIN	300	mg/1		CV	N	
0228-2890_30d458c8-d191-4e8a-a93a-986081db7e27	0228-2890	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Actavis Pharma, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0228-2891_30d458c8-d191-4e8a-a93a-986081db7e27	0228-2891	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Actavis Pharma, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0228-2892_30d458c8-d191-4e8a-a93a-986081db7e27	0228-2892	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Actavis Pharma, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0228-2918_7a7000ce-5d72-4238-a363-a74c9f23f8d7	0228-2918	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20131125		ANDA	ANDA202463	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0228-2996_1540b199-f9ac-40c0-b949-0fb4e16daafc	0228-2996	HUMAN PRESCRIPTION DRUG	Tamsulosin hydrochloride		Tamsulosin hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078801	Actavis Pharma, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0228-3059_227465ee-0fce-4491-b0c2-9506d64df743	0228-3059	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate		Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20120622		ANDA	ANDA077302	Actavis Pharma, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0228-3060_227465ee-0fce-4491-b0c2-9506d64df743	0228-3060	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate		Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20120622		ANDA	ANDA077302	Actavis Pharma, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0228-3061_227465ee-0fce-4491-b0c2-9506d64df743	0228-3061	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate		Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20120622		ANDA	ANDA077302	Actavis Pharma, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0228-3062_227465ee-0fce-4491-b0c2-9506d64df743	0228-3062	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate		Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20120622		ANDA	ANDA077302	Actavis Pharma, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0228-3063_227465ee-0fce-4491-b0c2-9506d64df743	0228-3063	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate		Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20120622		ANDA	ANDA077302	Actavis Pharma, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0228-3064_227465ee-0fce-4491-b0c2-9506d64df743	0228-3064	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate		Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20120622		ANDA	ANDA077302	Actavis Pharma, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0228-3083_709318d6-1f0e-42b9-a8c1-fcec5eb5c5d1	0228-3083	HUMAN PRESCRIPTION DRUG	Alprazolam	Extended Release	Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20070312		ANDA	ANDA078056	Actavis Pharma, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-3084_709318d6-1f0e-42b9-a8c1-fcec5eb5c5d1	0228-3084	HUMAN PRESCRIPTION DRUG	Alprazolam	Extended Release	Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20070312		ANDA	ANDA078056	Actavis Pharma, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-3086_709318d6-1f0e-42b9-a8c1-fcec5eb5c5d1	0228-3086	HUMAN PRESCRIPTION DRUG	Alprazolam	Extended Release	Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20070312		ANDA	ANDA078056	Actavis Pharma, Inc.	ALPRAZOLAM	3	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-3087_709318d6-1f0e-42b9-a8c1-fcec5eb5c5d1	0228-3087	HUMAN PRESCRIPTION DRUG	Alprazolam	Extended Release	Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20070312		ANDA	ANDA078056	Actavis Pharma, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-3090_0c6cdd1a-2cea-4713-92f2-b5048eff9dda	0228-3090	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140204		ANDA	ANDA079040	Actavis Pharma, Inc.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-3091_0c6cdd1a-2cea-4713-92f2-b5048eff9dda	0228-3091	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140204		ANDA	ANDA079040	Actavis Pharma, Inc.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-3092_0c6cdd1a-2cea-4713-92f2-b5048eff9dda	0228-3092	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140204		ANDA	ANDA079040	Actavis Pharma, Inc.	MORPHINE SULFATE	90	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-3093_0c6cdd1a-2cea-4713-92f2-b5048eff9dda	0228-3093	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140204		ANDA	ANDA079040	Actavis Pharma, Inc.	MORPHINE SULFATE	120	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-3116_0c6cdd1a-2cea-4713-92f2-b5048eff9dda	0228-3116	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140204		ANDA	ANDA079040	Actavis Pharma, Inc.	MORPHINE SULFATE	45	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-3117_0c6cdd1a-2cea-4713-92f2-b5048eff9dda	0228-3117	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140204		ANDA	ANDA079040	Actavis Pharma, Inc.	MORPHINE SULFATE	75	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-3153_29a0049c-b49f-42e9-86cc-aa2c0ae00896	0228-3153	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	TABLET	SUBLINGUAL	20150219		ANDA	ANDA090819	Actavis Pharma, Inc.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0228-3154_d8006109-8655-4b3f-8601-7f025fbec47b	0228-3154	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20130304		ANDA	ANDA091422	Actavis Pharma, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0228-3155_d8006109-8655-4b3f-8601-7f025fbec47b	0228-3155	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20130304		ANDA	ANDA091422	Actavis Pharma, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0228-3156_29a0049c-b49f-42e9-86cc-aa2c0ae00896	0228-3156	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	TABLET	SUBLINGUAL	20150219		ANDA	ANDA090819	Actavis Pharma, Inc.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0228-3315_84c77416-5f71-4fc9-b00b-964960f27241	0228-3315	HUMAN PRESCRIPTION DRUG	Doxepin		Doxepin	TABLET, FILM COATED	ORAL	20200102		ANDA	ANDA201951	Actavis Pharma, Inc.	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0228-3316_84c77416-5f71-4fc9-b00b-964960f27241	0228-3316	HUMAN PRESCRIPTION DRUG	Doxepin		Doxepin	TABLET, FILM COATED	ORAL	20200102		ANDA	ANDA201951	Actavis Pharma, Inc.	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0228-3640_15b0eb29-60db-46a5-9da6-c4350c0ce726	0228-3640	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120823		ANDA	ANDA090869	Actavis Pharma, Inc.	ROPINIROLE HYDROCHLORIDE	6	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0228-3658_15b0eb29-60db-46a5-9da6-c4350c0ce726	0228-3658	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120823		ANDA	ANDA090869	Actavis Pharma, Inc.	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0228-3659_15b0eb29-60db-46a5-9da6-c4350c0ce726	0228-3659	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120823		ANDA	ANDA090869	Actavis Pharma, Inc.	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0228-3660_15b0eb29-60db-46a5-9da6-c4350c0ce726	0228-3660	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120823		ANDA	ANDA090869	Actavis Pharma, Inc.	ROPINIROLE HYDROCHLORIDE	8	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0228-3661_15b0eb29-60db-46a5-9da6-c4350c0ce726	0228-3661	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120823		ANDA	ANDA090869	Actavis Pharma, Inc.	ROPINIROLE HYDROCHLORIDE	12	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0228-4019_9c3b36b3-a624-452d-8152-4454a9880e9a	0228-4019	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20100317		ANDA	ANDA078561	Actavis Pharma, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-4022_9c3b36b3-a624-452d-8152-4454a9880e9a	0228-4022	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20100317		ANDA	ANDA078561	Actavis Pharma, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-4024_9c3b36b3-a624-452d-8152-4454a9880e9a	0228-4024	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20100317		ANDA	ANDA078561	Actavis Pharma, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-4025_9c3b36b3-a624-452d-8152-4454a9880e9a	0228-4025	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20100317		ANDA	ANDA078561	Actavis Pharma, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0228-4241_94559ea4-7bff-45d1-9661-e1a70e485fcf	0228-4241	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150617		ANDA	ANDA203320	Actavis Pharma, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0228-4270_b3ebf58d-9730-4a88-802c-5c27fb2b090f	0228-4270	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151026		ANDA	ANDA203849	Actavis Pharma, Inc.	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-4271_b3ebf58d-9730-4a88-802c-5c27fb2b090f	0228-4271	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151026		ANDA	ANDA203849	Actavis Pharma, Inc.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-4311_b3ebf58d-9730-4a88-802c-5c27fb2b090f	0228-4311	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151026		ANDA	ANDA203849	Actavis Pharma, Inc.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-4323_b3ebf58d-9730-4a88-802c-5c27fb2b090f	0228-4323	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151026		ANDA	ANDA203849	Actavis Pharma, Inc.	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0228-4347_b3ebf58d-9730-4a88-802c-5c27fb2b090f	0228-4347	HUMAN PRESCRIPTION DRUG	Morphine sulfate		Morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151026		ANDA	ANDA203849	Actavis Pharma, Inc.	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0245-0036_9b6744b4-a5bb-4b5c-a92e-c11b0329cba9	0245-0036	HUMAN PRESCRIPTION DRUG	Prevalite		cholestyramine	POWDER, FOR SUSPENSION	ORAL	19960201		ANDA	ANDA073263	Upsher-Smith Laboratories, LLC	CHOLESTYRAMINE	4	g/5.5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0245-0070_e5f8949f-ddb5-66ed-e053-2995a90adf54	0245-0070	HUMAN PRESCRIPTION DRUG	Potassium Citrate		potassium citrate	TABLET	ORAL	20060901		NDA	NDA019071	Upsher-Smith Laboratories, LLC	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0245-0071_e5f8949f-ddb5-66ed-e053-2995a90adf54	0245-0071	HUMAN PRESCRIPTION DRUG	Potassium Citrate		potassium citrate	TABLET	ORAL	20060901		NDA	NDA019071	Upsher-Smith Laboratories, LLC	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0245-0144_c6c66dbb-cc0b-4576-9248-e20255e83cf0	0245-0144	HUMAN PRESCRIPTION DRUG	Pacerone		Amiodarone Hydrochloride	TABLET	ORAL	20101115		ANDA	ANDA075135	Upsher-Smith Laboratories, LLC	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0245-0147_c6c66dbb-cc0b-4576-9248-e20255e83cf0	0245-0147	HUMAN PRESCRIPTION DRUG	Pacerone		Amiodarone Hydrochloride	TABLET	ORAL	20101115		ANDA	ANDA075135	Upsher-Smith Laboratories, LLC	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0245-0211_ae3c4938-5bb2-46f3-a054-13b1022dc5ce	0245-0211	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20041103		ANDA	ANDA076725	Upsher-Smith laboratories, LLC	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0245-0212_ae3c4938-5bb2-46f3-a054-13b1022dc5ce	0245-0212	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20041103		ANDA	ANDA076725	Upsher-Smith laboratories, LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0245-0213_ae3c4938-5bb2-46f3-a054-13b1022dc5ce	0245-0213	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20041103		ANDA	ANDA076725	Upsher-Smith laboratories, LLC	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0245-0271_e385707e-eb9d-4e4d-96f1-68769ce87d11	0245-0271	HUMAN PRESCRIPTION DRUG	Oxandrolone		Oxandrolone	TABLET	ORAL	20061201		ANDA	ANDA076761	Upsher-Smith Laboratories, LLC	OXANDROLONE	2.5	mg/1		CIII	N	20241231
0245-0272_07d23eea-3550-4eae-a5f2-557a81c1fd6f	0245-0272	HUMAN PRESCRIPTION DRUG	oxandrolone		oxandrolone	TABLET	ORAL	20070322		ANDA	ANDA078033	Upsher-Smith Laboratories, LLC	OXANDROLONE	10	mg/1		CIII	N	20241231
0245-0360_d9472735-27e8-4597-92f4-0b9afaaaa0a4	0245-0360	HUMAN PRESCRIPTION DRUG	KLOR-CON		potassium chloride	POWDER, FOR SOLUTION	ORAL	20171023		ANDA	ANDA209662	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	1.5	g/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-0410_590750e6-33b4-4c08-be30-7cb0ca2b4c63	0245-0410	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170327		ANDA	ANDA206484	Upsher-Smith Laboratories, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0245-0411_590750e6-33b4-4c08-be30-7cb0ca2b4c63	0245-0411	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170327		ANDA	ANDA206484	Upsher-Smith Laboratories, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0245-0412_590750e6-33b4-4c08-be30-7cb0ca2b4c63	0245-0412	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170327		ANDA	ANDA206484	Upsher-Smith Laboratories, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0245-0556_abecd8f0-e107-4976-84c9-9fdd6614c870	0245-0556	HUMAN PRESCRIPTION DRUG	VIGADRONE		vigabatrin	POWDER, FOR SOLUTION	ORAL	20180621		ANDA	ANDA210196	Upsher-Smith Laboratories, LLC	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
0245-0570_d6b9aca7-1565-4e98-acca-694593913cd4	0245-0570	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210921		ANDA	ANDA212333	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0245-0571_d6b9aca7-1565-4e98-acca-694593913cd4	0245-0571	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210921		ANDA	ANDA212333	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0245-0573_d6b9aca7-1565-4e98-acca-694593913cd4	0245-0573	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210921		ANDA	ANDA212333	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0245-0575_51287574-9a83-45db-9b8d-cc8bcb8a44db	0245-0575	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210412		ANDA	ANDA213571	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0245-0809_2af28380-02e8-4913-a1f6-60ad15310825	0245-0809	HUMAN PRESCRIPTION DRUG	ZEMBRACE SYMTOUCH		Sumatriptan Succinate	INJECTION, SOLUTION	SUBCUTANEOUS	20160222		NDA	NDA208223	Upsher-Smith laboratories, LLC	SUMATRIPTAN SUCCINATE	3	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0245-0812_cc19c8b4-3c96-494b-baa5-f02afdcfc0d7	0245-0812	HUMAN PRESCRIPTION DRUG	TOSYMRA		sumatriptan	SPRAY	NASAL	20190708		NDA	NDA210884	Upsher-Smith Laboratories, LLC	SUMATRIPTAN	10	mg/.1mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0245-0860_8b0284d3-2622-47d4-a6b4-4b736147c3de	0245-0860	HUMAN PRESCRIPTION DRUG	Vandazole		Metronidazole	GEL	VAGINAL	20051004		NDA	NDA021806	Upsher-Smith Laboratories, LLC	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0245-0871_cfc38697-d9c3-4b92-bcdd-dfe7f1f46d9b	0245-0871	HUMAN PRESCRIPTION DRUG	Vogelxo		Testosterone	GEL	TOPICAL	20140609		NDA	NDA204399	Upsher-Smith Laboratories, LLC	TESTOSTERONE	50	mg/5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0245-0872_cfc38697-d9c3-4b92-bcdd-dfe7f1f46d9b	0245-0872	HUMAN PRESCRIPTION DRUG	Vogelxo		Testosterone	GEL, METERED	TOPICAL	20140609		NDA	NDA204399	Upsher-Smith Laboratories, LLC	TESTOSTERONE	12.5	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0245-1071_b3424de5-f841-4d5c-81d3-f222b9b23526	0245-1071	HUMAN PRESCRIPTION DRUG	QUDEXY	XR	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140411		NDA	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0245-1072_b3424de5-f841-4d5c-81d3-f222b9b23526	0245-1072	HUMAN PRESCRIPTION DRUG	QUDEXY	XR	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140411		NDA	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0245-1073_b3424de5-f841-4d5c-81d3-f222b9b23526	0245-1073	HUMAN PRESCRIPTION DRUG	QUDEXY	XR	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140411		NDA	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0245-1074_b3424de5-f841-4d5c-81d3-f222b9b23526	0245-1074	HUMAN PRESCRIPTION DRUG	QUDEXY	XR	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140411		NDA	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0245-1075_b3424de5-f841-4d5c-81d3-f222b9b23526	0245-1075	HUMAN PRESCRIPTION DRUG	QUDEXY	XR	Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140411		NDA	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	150	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0245-1645_c6c66dbb-cc0b-4576-9248-e20255e83cf0	0245-1645	HUMAN PRESCRIPTION DRUG	Pacerone		Amiodarone Hydrochloride	TABLET	ORAL	20200702		ANDA	ANDA075135	Upsher-Smith Laboratories, LLC	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0245-5315_0907ea1c-82f3-4ba8-9d1b-3f4fa104d7a2	0245-5315	HUMAN PRESCRIPTION DRUG	KLOR-CON		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19860417		NDA	NDA019123	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-5316_0907ea1c-82f3-4ba8-9d1b-3f4fa104d7a2	0245-5316	HUMAN PRESCRIPTION DRUG	KLOR-CON		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19860417		NDA	NDA019123	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-5317_a069987e-0e79-4a49-859a-737d8dade617	0245-5317	HUMAN PRESCRIPTION DRUG	KLOR-CON M		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20110118		ANDA	ANDA074726	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-5318_a069987e-0e79-4a49-859a-737d8dade617	0245-5318	HUMAN PRESCRIPTION DRUG	KLOR-CON M		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20110118		ANDA	ANDA074726	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-5319_a069987e-0e79-4a49-859a-737d8dade617	0245-5319	HUMAN PRESCRIPTION DRUG	KLOR-CON M		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20110118		ANDA	ANDA074726	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-5320_53c08b4a-f00e-4c9c-a00b-21b87166fac5	0245-5320	HUMAN PRESCRIPTION DRUG	Klor-Con Sprinkle		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20150710		ANDA	ANDA203106	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-5321_53c08b4a-f00e-4c9c-a00b-21b87166fac5	0245-5321	HUMAN PRESCRIPTION DRUG	Klor-Con Sprinkle		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20150710		ANDA	ANDA203106	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-5326_42cf9a5d-81eb-42c5-a6ca-995e1e2690c2	0245-5326	HUMAN PRESCRIPTION DRUG	KLOR-Con/EF		Potassium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20140901		UNAPPROVED DRUG OTHER		Upsher-Smith Laboratories, Inc.	POTASSIUM BICARBONATE	978	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0245-6001_dfc2fa77-36d4-41d8-a5e5-4881a91a8497	0245-6001	HUMAN PRESCRIPTION DRUG	VIGADRONE		Vigabatrin	TABLET	ORAL	20230629		ANDA	ANDA214749	Upsher-Smith Laboratories, LLC	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
0254-0460_ace2251f-959d-4aab-94c3-b257cd337109	0254-0460	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	CAPSULE	ORAL	20231101		ANDA	ANDA208678	Par Pharmaceutical, Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
0254-1010_55016d64-95a3-490f-a4d5-3a8d104324f8	0254-1010	HUMAN PRESCRIPTION DRUG	Diazoxide		Diazoxide	SUSPENSION	ORAL	20200721		ANDA	ANDA210799	Par Pharmaceutical, Inc	DIAZOXIDE	50	mg/mL			N	20241231
0254-1011_afd960c2-2c06-4f64-b895-ff24401b5090	0254-1011	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20200127		NDA AUTHORIZED GENERIC	NDA019183	Par Pharmaceutical Inc.	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
0254-1016_120c8d44-0e83-4fe7-9af7-c87efb13567a	0254-1016	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		posaconazole	SUSPENSION	ORAL	20230329		NDA AUTHORIZED GENERIC	NDA022003	Par Pharmaceutical Inc.	POSACONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0254-2000_e690a422-5709-4fad-89d0-d3650d18f349	0254-2000	HUMAN PRESCRIPTION DRUG	penicillamine		penicillamine	TABLET, FILM COATED	ORAL	20200102		ANDA	ANDA211196	Par Pharmaceutical, Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
0254-2005_47bc5f3d-39d3-4336-84fb-3e279320e5e4	0254-2005	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20201104		ANDA	ANDA212743	Par Pharmaceutical, Inc.	CHLORZOXAZONE	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0254-2008_bd7a3243-fb43-40fa-8a57-81c063d79a8a	0254-2008	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20180701		NDA AUTHORIZED GENERIC	NDA022352	Par Pharmaceutical, Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
0254-2029_b5d0fa43-d4e0-415d-a14c-f0c1167a358d	0254-2029	HUMAN PRESCRIPTION DRUG	Previfem		Norgestimate and ethinyl estradiol	KIT		20190102		ANDA	ANDA090794	Par Pharmaceutical, Inc.						N	20241231
0254-2033_38c4c30c-a66c-494c-ae61-41c12456d905	0254-2033	HUMAN PRESCRIPTION DRUG	EMOQUETTE		desogestrel and ethinyl estradiol	KIT		20190408		ANDA	ANDA202789	Par Pharmaceutical, Inc.						N	20241231
0254-2034_2ec6751e-3479-4bef-a1fb-42b30c837186	0254-2034	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181005		ANDA	ANDA202935	Par Pharmaceutical, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0254-2035_2ec6751e-3479-4bef-a1fb-42b30c837186	0254-2035	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181005		ANDA	ANDA202935	Par Pharmaceutical, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0254-2036_2ec6751e-3479-4bef-a1fb-42b30c837186	0254-2036	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181005		ANDA	ANDA202935	Par Pharmaceutical, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0254-2045_120c8d44-0e83-4fe7-9af7-c87efb13567a	0254-2045	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		posaconazole	TABLET, COATED	ORAL	20190830		NDA AUTHORIZED GENERIC	NDA205053	Par Pharmaceutical Inc.	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0254-2053_47bc5f3d-39d3-4336-84fb-3e279320e5e4	0254-2053	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20210617		ANDA	ANDA212743	Par Pharmaceutical, Inc.	CHLORZOXAZONE	375	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0254-3010_9b349968-03b7-4a4f-ab40-976570f5e398	0254-3010	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE	ORAL	20170919		ANDA	ANDA203893	Par Pharmaceutical Inc.	OMEGA-3-ACID ETHYL ESTERS	900	mg/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
0254-3012_995ea3be-a86b-4dc7-ac69-fcc4af5fa781	0254-3012	HUMAN PRESCRIPTION DRUG	ALVIMOPAN		ALVIMOPAN	CAPSULE	ORAL	20230503		ANDA	ANDA216843	Par Pharmaceutical, Inc.	ALVIMOPAN	12	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0254-3020_75548bb0-fbf1-4ac5-86af-cd6dc30de589	0254-3020	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20191004		ANDA	ANDA211041	Par Pharmaceutical, Inc.	NITISINONE	2	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]		N	20241231
0254-3021_75548bb0-fbf1-4ac5-86af-cd6dc30de589	0254-3021	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20191004		ANDA	ANDA211041	Par Pharmaceutical, Inc.	NITISINONE	5	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]		N	20241231
0254-3022_75548bb0-fbf1-4ac5-86af-cd6dc30de589	0254-3022	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20191004		ANDA	ANDA211041	Par Pharmaceutical, Inc.	NITISINONE	10	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]		N	20241231
0254-3028_099472ee-b62a-4859-babd-69ba7f23eab9	0254-3028	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20210101		NDA AUTHORIZED GENERIC	NDA021908	Par Pharmaceutical Inc.	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
0254-3029_099472ee-b62a-4859-babd-69ba7f23eab9	0254-3029	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20210101		NDA AUTHORIZED GENERIC	NDA021908	Par Pharmaceutical Inc.	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
0259-0501_0ddcb06f-7039-4609-9ddf-d33fd484e9a8	0259-0501	HUMAN PRESCRIPTION DRUG	Cuvposa		glycopyrrolate	LIQUID	ORAL	20130101		NDA	NDA022571	Merz Pharmaceuticals, LLC	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0259-0502_2d1b0e12-b007-422b-8375-a9b48a24cea7	0259-0502	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	LIQUID	ORAL	20220104		NDA AUTHORIZED GENERIC	NDA022571	Merz Pharmaceuticals, LLC	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0259-1105_16b107d5-a7b0-4165-9dea-8b6f97371f17	0259-1105	HUMAN OTC DRUG	Mederma Advanced Scar		Allantoin	GEL	TOPICAL	20131101	20240531	OTC MONOGRAPH FINAL	part347	Merz Pharmaceuticals, LLC	ALLANTOIN	5	mg/g			N	
0259-1605_cebab8bd-7c0c-4a2f-bf9b-56feadb6dcc8	0259-1605	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20100901		BLA	BLA125360	Merz Pharmaceuticals, LLC	BOTULINUM TOXIN TYPE A	50	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0259-1610_cebab8bd-7c0c-4a2f-bf9b-56feadb6dcc8	0259-1610	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20100901		BLA	BLA125360	Merz Pharmaceuticals, LLC	BOTULINUM TOXIN TYPE A	100	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0259-1620_cebab8bd-7c0c-4a2f-bf9b-56feadb6dcc8	0259-1620	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20151120		BLA	BLA125360	Merz Pharmaceuticals, LLC	BOTULINUM TOXIN TYPE A	200	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0259-2102_e5d09ae0-5fc1-408a-9e8b-018143d25e2b	0259-2102	HUMAN OTC DRUG	Mederma Stretch Marks Therapy		dimethicone	CREAM	TOPICAL	20131201	20240630	OTC MONOGRAPH FINAL	part347	Merz Pharmaceuticals, LLC	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	
0259-2202_2988a54d-5ee7-47bd-a00a-6e43993c5894	0259-2202	HUMAN OTC DRUG	Mederma PM		Dimethicone	CREAM	TOPICAL	20131101	20240731	OTC MONOGRAPH FINAL	part347	Merz Pharmaceuticals, LLC	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	
0259-4110_cebab8bd-7c0c-4a2f-bf9b-56feadb6dcc8	0259-4110	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20100901		BLA	BLA125360	Merz Pharmaceuticals, LLC	BOTULINUM TOXIN TYPE A	100	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0259-4150_cebab8bd-7c0c-4a2f-bf9b-56feadb6dcc8	0259-4150	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20100901		BLA	BLA125360	Merz Pharmaceuticals, LLC	BOTULINUM TOXIN TYPE A	50	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0264-1510_0a144591-6cfa-4aed-a067-c95aebc29057	0264-1510	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose	INJECTION, SOLUTION	INTRAVENOUS	19731221		NDA	NDA016730	B. Braun Medical Inc.	DEXTROSE MONOHYDRATE	50	mg/mL			N	20251231
0264-1800_7d4ee37f-5016-422c-9f66-e675ae22c46a	0264-1800	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19780208		NDA	NDA017464	B. Braun Medical Inc.	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-1933_8f22257f-eaef-4f5a-a5ab-343914743651	0264-1933	HUMAN PRESCRIPTION DRUG	TrophAmine		ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, and TAURINE	SOLUTION	INTRAVENOUS	20201027		NDA	NDA019018	B. Braun Medical Inc.	ACETYL L-TYROSINE; ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE HYDROCHLORIDE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	.24; .54; 1.2; .32; .024; .5; .36; .48; .82; 1.4; 1.2; .34; .48; .68; .38; .025; .42; .2; .044; .78	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0264-1944_95c83840-ae78-4210-8b5f-cf4120989811	0264-1944	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	PARENTERAL	20220502		ANDA	ANDA085870	B. Braun Medical Inc.	POTASSIUM CHLORIDE	14.9	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-1945_9f9e76d7-d8b4-43c3-b5ef-c85aeb5dcd74	0264-1945	HUMAN PRESCRIPTION DRUG	Balanced Salt		Sodium Chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Acetate, and Sodium Citrate	SOLUTION	IRRIGATION	20220128		ANDA	ANDA091387	B. Braun Medical Inc.	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE	.48; .3; .75; 3.9; 6.4; 1.7	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-1965_47e5d437-857d-4328-bdda-e6ff01544d9d	0264-1965	HUMAN PRESCRIPTION DRUG	HESPAN		Hetastarch in Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19910404		NDA	BN890105	B. Braun Medical Inc.	HETASTARCH; SODIUM CHLORIDE	6; .9	g/100mL; g/100mL	Increased Intravascular Volume [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plasma Volume Expander [EPC], Starch [CS]		N	20241231
0264-2101_969bdf41-6565-42fb-8ac1-8661a928cc22	0264-2101	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	IRRIGANT	IRRIGATION	19700910		NDA	NDA016734	B. Braun Medical Inc.	WATER	1	mL/mL			N	20241231
0264-2201_35e26a6d-60d6-4388-84e9-c481a3b69ee7	0264-2201	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	IRRIGANT	IRRIGATION	20090914		NDA	NDA016733	B. Braun Medical Inc.	SODIUM CHLORIDE	.9	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-2202_e5a74370-8043-4fba-8540-6306fd69d34e	0264-2202	HUMAN PRESCRIPTION DRUG	Ringers		Sodium Chloride, Potassium Chloride, and Calcium Chloride	IRRIGANT	IRRIGATION	19790806		NDA	NDA018156	B. Braun Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	.033; .03; .86	g/100mL; g/100mL; g/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-2203_6275292e-2642-492a-bd56-0586cb6caf77	0264-2203	HUMAN PRESCRIPTION DRUG	Lactated Ringers		Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride	IRRIGANT	IRRIGATION	19821227		NDA	NDA018681	B. Braun Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	.02; .03; .6; .31	g/100mL; g/100mL; g/100mL; g/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-2205_03ced4e7-7317-45fb-8303-54a924c7d281	0264-2205	HUMAN PRESCRIPTION DRUG	Physiolyte		Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, and Magnesium Chloride	IRRIGANT	IRRIGATION	19840608		NDA	NDA019024	B. Braun Medical Inc.	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE	.03; .037; .37; .53; .5	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-2304_ab98b143-e9d6-4869-9abf-708ec1004f57	0264-2304	HUMAN PRESCRIPTION DRUG	Acetic Acid		Acetic Acid	IRRIGANT	IRRIGATION	19790806		NDA	NDA018161	B. Braun Medical Inc.	ACETIC ACID	.25	g/100mL			N	20241231
0264-2514_445be296-044a-4175-b52b-b98335ca5855	0264-2514	HUMAN PRESCRIPTION DRUG	Balanced Salt		Sodium Chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Acetate, and Sodium Citrate	SOLUTION	IRRIGATION	20100203		ANDA	ANDA091387	B. Braun Medical Inc.	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE	.48; .3; .75; 3.9; 6.4; 1.7	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-3103_ec3aaa31-2614-40b5-a968-6de27f86eb31	0264-3103	HUMAN PRESCRIPTION DRUG	Cefazolin Sodium		Cefazolin Sodium	SOLUTION	INTRAVENOUS	20000727		NDA	NDA050779	B. Braun Medical Inc.	CEFAZOLIN SODIUM	1	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
0264-3105_ec3aaa31-2614-40b5-a968-6de27f86eb31	0264-3105	HUMAN PRESCRIPTION DRUG	Cefazolin Sodium		Cefazolin Sodium	SOLUTION	INTRAVENOUS	20120113		NDA	NDA050779	B. Braun Medical Inc.	CEFAZOLIN SODIUM	2	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
0264-3112_6874a295-7ec7-4822-9d04-4dd9932b4546	0264-3112	HUMAN PRESCRIPTION DRUG	Cefuroxime and Dextrose		CEFUROXIME AND DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20010221		NDA	NDA050780	B. Braun Medical Inc.	CEFUROXIME SODIUM	750	mg/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-3114_6874a295-7ec7-4822-9d04-4dd9932b4546	0264-3114	HUMAN PRESCRIPTION DRUG	Cefuroxime and Dextrose		CEFUROXIME AND DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20010221		NDA	NDA050780	B. Braun Medical Inc.	CEFUROXIME SODIUM	1.5	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-3123_0cca0e6a-3047-4142-af33-d9b98efe85b1	0264-3123	HUMAN PRESCRIPTION DRUG	Cefoxitin and Dextrose		CEFOXITIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20060310		NDA	NDA065214	B. Braun Medical Inc.	CEFOXITIN SODIUM	1	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-3125_0cca0e6a-3047-4142-af33-d9b98efe85b1	0264-3125	HUMAN PRESCRIPTION DRUG	Cefoxitin and Dextrose		CEFOXITIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20060310		NDA	NDA065214	B. Braun Medical Inc.	CEFOXITIN SODIUM	2	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-3153_05bf8d04-202d-472f-94b5-4f5d9020f0c7	0264-3153	HUMAN PRESCRIPTION DRUG	CEFTRIAXONE AND DEXTROSE		CEFTRIAXONE	INJECTION, SOLUTION	INTRAVENOUS	20050420		NDA	NDA050796	B. Braun Medical Inc.	CEFTRIAXONE SODIUM	1	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-3155_05bf8d04-202d-472f-94b5-4f5d9020f0c7	0264-3155	HUMAN PRESCRIPTION DRUG	CEFTRIAXONE AND DEXTROSE		CEFTRIAXONE	INJECTION, SOLUTION	INTRAVENOUS	20050420		NDA	NDA050796	B. Braun Medical Inc.	CEFTRIAXONE SODIUM	2	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-3183_90d39190-b13b-449e-af61-b1fc61354665	0264-3183	HUMAN PRESCRIPTION DRUG	Meropenem and Sodium Chloride		Meropenem and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20150430		NDA	NDA202106	B. Braun Medical Inc.	MEROPENEM	500	mg/50mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0264-3185_90d39190-b13b-449e-af61-b1fc61354665	0264-3185	HUMAN PRESCRIPTION DRUG	Meropenem and Sodium Chloride		Meropenem and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20150430		NDA	NDA202106	B. Braun Medical Inc.	MEROPENEM	1	g/50mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0264-3193_afe666d5-84ec-45a7-ae00-c643b4eaeb35	0264-3193	HUMAN PRESCRIPTION DRUG	CEFEPIME HYDROCHLORIDE AND DEXTROSE		CEFEPIME HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20100506		NDA	NDA050821	B. Braun Medical Inc.	CEFEPIME HYDROCHLORIDE	1	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-3195_afe666d5-84ec-45a7-ae00-c643b4eaeb35	0264-3195	HUMAN PRESCRIPTION DRUG	CEFEPIME HYDROCHLORIDE AND DEXTROSE		CEFEPIME HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20100506		NDA	NDA050821	B. Braun Medical Inc.	CEFEPIME HYDROCHLORIDE	2	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0264-4050_011c0907-df72-4a78-9c37-0a65f9a48994	0264-4050	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION	INTRAVENOUS	20210218		NDA	NDA204957	B. Braun Medical Inc.	ACETAMINOPHEN	10	mg/mL			N	20241231
0264-4050_4cb0ada9-7859-4a2c-b114-6626ae84b757	0264-4050	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION	INTRAVENOUS	20231010		NDA	NDA204957	B. Braun Medical Inc.	ACETAMINOPHEN	10	mg/mL			N	20241231
0264-4100_011c0907-df72-4a78-9c37-0a65f9a48994	0264-4100	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION	INTRAVENOUS	20210218		NDA	NDA204957	B. Braun Medical Inc.	ACETAMINOPHEN	10	mg/mL			N	20241231
0264-4204_52933ed3-bb73-4aba-84a4-4b8f3467e25a	0264-4204	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		magnesium sulfate heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20210426		ANDA	ANDA207967	B. Braun Medical Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	2	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-4205_52933ed3-bb73-4aba-84a4-4b8f3467e25a	0264-4205	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		magnesium sulfate heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20210426		ANDA	ANDA207967	B. Braun Medical Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-4206_52933ed3-bb73-4aba-84a4-4b8f3467e25a	0264-4206	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		magnesium sulfate heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20210426		ANDA	ANDA207967	B. Braun Medical Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-4400_7f6b020e-0bf1-4b48-9f69-9771f4c819a8	0264-4400	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Dextrose		magnesium sulfate heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20201027		ANDA	ANDA207966	B. Braun Medical Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	10	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-4460_fc052277-22af-45d4-9a92-a8341033fc5f	0264-4460	HUMAN PRESCRIPTION DRUG	NutriLipid I.V. Fat Emulsion		Soybean Oil	INJECTION, SOLUTION	INTRAVENOUS	20140630		NDA	NDA019531	B. Braun Medical Inc.	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
0264-4500_e55957d3-67af-4b6d-9232-55b654e0076f	0264-4500	HUMAN PRESCRIPTION DRUG	Plenamine		LYSINE ACETATE, LEUCINE, PHENYLALANINE, VALINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, HISTIDINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, and TYROSINE	SOLUTION	INTRAVENOUS	20180928		ANDA	ANDA091112	B. Braun Medical Inc.	ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	2.17; 1.47; 434; 749; 1.04; 894; 749; 1.04; 1.18; 749; 1.04; 894; 592; 749; 250; 39; 960	g/100mL; g/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; g/100mL; g/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0264-5535_cec943a0-c83c-486c-bf73-86b66ccf4ae0	0264-5535	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	SOLUTION	INTRAVENOUS	19830929		NDA	NDA018900	B. Braun Medical Inc.	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0264-5600_c39effaa-a9b8-4430-a42a-c642b76550df	0264-5600	HUMAN PRESCRIPTION DRUG	Calcium Gluconate		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20231102		ANDA	ANDA216541	B. Braun Medical Inc.	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0264-5705_12d0886b-aa54-417e-a235-2dce060ea52d	0264-5705	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190408		ANDA	ANDA208827	B. Braun Medical Inc.	HEPARIN SODIUM	5000	[USP'U]/.5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0264-5802_d34ea9bc-a1f9-402a-97cf-894505cee75d	0264-5802	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19980309		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	.9	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-5804_d34ea9bc-a1f9-402a-97cf-894505cee75d	0264-5804	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880309		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	.45	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7055_fffbe142-9c62-4a45-af74-cfada0daf2a4	0264-7055	HUMAN PRESCRIPTION DRUG	Clorotekal		CHLOROPROCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRATHECAL	20180501		NDA	NDA208791	B. Braun Medical Inc.	CHLOROPROCAINE HYDROCHLORIDE	10	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
0264-7385_ed933e44-2560-495b-879c-99c6a0bf8ba0	0264-7385	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION	INTRAVENOUS	20140904		NDA	NDA019633	B. Braun Medical Inc.	WATER	1	mL/mL			N	20241231
0264-7386_5a720898-0d85-4a14-9507-d8835857bdc6	0264-7386	HUMAN PRESCRIPTION DRUG	Sterile Water		Sterile Water	IRRIGANT	IRRIGATION	20130913		NDA	NDA016734	B. Braun Medical Inc.	WATER	100	mL/100mL			N	20241231
0264-7387_2b059b77-28e3-4734-a781-0ca991de2ceb	0264-7387	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose	SOLUTION	INTRAVENOUS	20150219		NDA	NDA019626	B. Braun Medical Inc.	DEXTROSE	70	g/100mL			N	20241231
0264-7388_69f7d8f6-65cd-45bd-83f7-7249905a2e72	0264-7388	HUMAN PRESCRIPTION DRUG	Sodium Chloride for Irrigation		Sodium Chloride for Irrigation	SOLUTION	IRRIGATION	20130419		NDA	NDA016733	B. Braun Medical Inc.	SODIUM CHLORIDE	.9	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7389_4bf1e3a5-1742-4843-ad41-f4e7c9c2936e	0264-7389	HUMAN PRESCRIPTION DRUG	Lactated Ringers Irrigation		sodium chloride, sodium lactate, potassium chloride and calcium chloride	SOLUTION	IRRIGATION	20140902		NDA	NDA018681	B. Braun Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7390_520815fc-d305-4abb-87e8-41998801a624	0264-7390	HUMAN PRESCRIPTION DRUG	Glycine		Glycine	IRRIGANT	IRRIGATION	20131204		NDA	NDA016784	B. Braun Medical Inc.	GLYCINE	1.5	g/100mL			N	20241231
0264-7500_39ca9e18-9a9f-4dce-8176-558a8f1e6c17	0264-7500	HUMAN PRESCRIPTION DRUG	Lactated Ringers		Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20230301		NDA	NDA019632	B. Braun Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	.02; .03; .6; .31	g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7510_f8b0dae4-652b-4ff0-a4b8-26f177e1bf18	0264-7510	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE	SOLUTION	INTRAVENOUS	19880202		NDA	NDA019626	B. Braun Medical Inc.	DEXTROSE	5	g/100mL			N	20241231
0264-7520_f8b0dae4-652b-4ff0-a4b8-26f177e1bf18	0264-7520	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE	SOLUTION	INTRAVENOUS	19880202		NDA	NDA019626	B. Braun Medical Inc.	DEXTROSE	10	g/100mL			N	20241231
0264-7578_33171b62-3532-4eb1-b273-714d07b0e3f8	0264-7578	HUMAN PRESCRIPTION DRUG	Mannitol		MANNITOL	INJECTION, SOLUTION	INTRAVENOUS	19930726		NDA	NDA020006	B. Braun Medical Inc.	MANNITOL	20	g/100mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0264-7608_c488441b-de6f-412a-a12d-b9a3d5949ca2	0264-7608	HUMAN PRESCRIPTION DRUG	Dextrose And Sodium Chloride		DEXTROSE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019631	B. Braun Medical Inc.	DEXTROSE; SODIUM CHLORIDE	3.3; .3	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7610_c488441b-de6f-412a-a12d-b9a3d5949ca2	0264-7610	HUMAN PRESCRIPTION DRUG	Dextrose And Sodium Chloride		DEXTROSE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019631	B. Braun Medical Inc.	DEXTROSE; SODIUM CHLORIDE	5; .9	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7612_c488441b-de6f-412a-a12d-b9a3d5949ca2	0264-7612	HUMAN PRESCRIPTION DRUG	Dextrose And Sodium Chloride		DEXTROSE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019631	B. Braun Medical Inc.	DEXTROSE; SODIUM CHLORIDE	5; .45	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7614_c488441b-de6f-412a-a12d-b9a3d5949ca2	0264-7614	HUMAN PRESCRIPTION DRUG	Dextrose And Sodium Chloride		DEXTROSE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019631	B. Braun Medical Inc.	DEXTROSE; SODIUM CHLORIDE	5; .33	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7616_c488441b-de6f-412a-a12d-b9a3d5949ca2	0264-7616	HUMAN PRESCRIPTION DRUG	Dextrose And Sodium Chloride		DEXTROSE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019631	B. Braun Medical Inc.	DEXTROSE; SODIUM CHLORIDE	5; .2	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7622_c488441b-de6f-412a-a12d-b9a3d5949ca2	0264-7622	HUMAN PRESCRIPTION DRUG	Dextrose And Sodium Chloride		DEXTROSE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019631	B. Braun Medical Inc.	DEXTROSE; SODIUM CHLORIDE	10; .45	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7623_c488441b-de6f-412a-a12d-b9a3d5949ca2	0264-7623	HUMAN PRESCRIPTION DRUG	Dextrose And Sodium Chloride		DEXTROSE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019631	B. Braun Medical Inc.	DEXTROSE; SODIUM CHLORIDE	10; .2	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7625_e90be23e-0c01-4579-bd8c-4cf9d686ccbb	0264-7625	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE IN DEXTROSE		DEXTROSE and POTASSIUM CHLORIDE	SOLUTION	INTRAVENOUS	19890929		NDA	NDA019699	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE	5; .15	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7628_e90be23e-0c01-4579-bd8c-4cf9d686ccbb	0264-7628	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE IN DEXTROSE		DEXTROSE and POTASSIUM CHLORIDE	SOLUTION	INTRAVENOUS	19890929		NDA	NDA019699	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE	5; .3	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7634_f57a5fa9-b169-4cf9-8ec1-052812fb7191	0264-7634	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	19880217		NDA	NDA019630	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; .075; .45	g/100mL; g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7635_f57a5fa9-b169-4cf9-8ec1-052812fb7191	0264-7635	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	19880217		NDA	NDA019630	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; .15; .45	g/100mL; g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7636_f57a5fa9-b169-4cf9-8ec1-052812fb7191	0264-7636	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	19880217		NDA	NDA019630	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; .22; .45	g/100mL; g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7638_f57a5fa9-b169-4cf9-8ec1-052812fb7191	0264-7638	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	19880217		NDA	NDA019630	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; .3; .45	g/100mL; g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7645_f57a5fa9-b169-4cf9-8ec1-052812fb7191	0264-7645	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	19880217		NDA	NDA019630	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; .15; .2	g/100mL; g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7652_f57a5fa9-b169-4cf9-8ec1-052812fb7191	0264-7652	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	19880217		NDA	NDA019630	B. Braun Medical Inc.	DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; .15; .9	g/100mL; g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7703_e9350a07-ea60-46e4-9ed5-81cc371f9696	0264-7703	HUMAN PRESCRIPTION DRUG	Isolyte S		SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19890929		NDA	NDA019711	B. Braun Medical Inc.	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE	.03; .037; .37; .53; .5	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-7707_88c0041b-2b08-4ca1-b733-60f8b5723892	0264-7707	HUMAN PRESCRIPTION DRUG	Isolyte S pH 7.4		SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE	INJECTION, SOLUTION	INTRAVENOUS	19890929		NDA	NDA019696	B. Braun Medical Inc.	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC	.03; .037; .00082; .37; .53; .5; .012	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-7730_68a1b5ad-1949-4ef9-afa4-d2b592508a39	0264-7730	HUMAN PRESCRIPTION DRUG	Isolyte P in Dextrose		Dextrose, Sodium Acetate, Potassium Chloride, Magnesium Chloride, and Potassium Phosphate, Dibasic	INJECTION, SOLUTION	INTRAVENOUS	19930610		NDA	NDA019873	B. Braun Medical Inc.	DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE	5; .031; .13; .026; .32	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0264-7750_28116ed2-c692-42ea-8222-65eb14fbcd28	0264-7750	HUMAN PRESCRIPTION DRUG	Lactated Ringers		Sodium Chloride, Sodium Lactate, Potassium Chloride, and Calcium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19880229		NDA	NDA019632	B. Braun Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	.02; .03; .6; .31	g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7751_69e32273-ba17-479b-aa3c-9e1b0c0e6efd	0264-7751	HUMAN PRESCRIPTION DRUG	Dextrose in Lactated Ringers		DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, and CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880224		NDA	NDA019634	B. Braun Medical Inc.	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	.02; 5; .03; .6; .31	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-7780_f8ccf9ad-0426-4288-afc7-0cf99f12391f	0264-7780	HUMAN PRESCRIPTION DRUG	Ringers		Sodium Chloride, Calcium Chloride, and Potassium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19920417		NDA	NDA020002	B. Braun Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	.033; .03; .86	g/100mL; g/100mL; g/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0264-7800_3b32329d-4909-44c8-856d-3dbfce33378d	0264-7800	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20131231		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	.9	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7800_477396b5-90fd-4ea8-9103-bea49c77f180	0264-7800	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880309		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	.9	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7802_477396b5-90fd-4ea8-9103-bea49c77f180	0264-7802	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19880309		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	.45	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7805_e8a3dcb0-1f0c-435b-8e7b-8fedcb2f1be8	0264-7805	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19880319		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	3	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7806_e8a3dcb0-1f0c-435b-8e7b-8fedcb2f1be8	0264-7806	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19880309		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	5	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-7850_19946531-ef19-4933-bd74-c6d01c0ab5c0	0264-7850	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION	INTRAVENOUS	19880224		NDA	NDA019633	B. Braun Medical Inc.	WATER	1	mL/mL			N	20241231
0264-7865_f688240d-8193-41f3-a904-05a4bd766e39	0264-7865	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE IN SODIUM CHLORIDE		SODIUM CHLORIDE and POTASSIUM CHLORIDE	SOLUTION	INTRAVENOUS	19890929		NDA	NDA019708	B. Braun Medical Inc.	POTASSIUM CHLORIDE; SODIUM CHLORIDE	.15; .9	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0264-9375_7a6642e8-d304-47fc-acd9-0dcac4650f88	0264-9375	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	20160809		NDA	NDA019635	B. Braun Medical Inc.	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0264-9376_21658976-c912-45c1-9969-2fa865576b81	0264-9376	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		LIDOCAINE HYDROCHLORIDE	INJECTION	INFILTRATION	20180803		ANDA	ANDA208474	B. Braun Medical Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0264-9378_5f189f9b-1978-401e-8e5f-1969fe8c8ad7	0264-9378	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl and EPINEPHRINE		LIDOCAINE HCl and EPINEPHRINE	INJECTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20210908		ANDA	ANDA208475	B. Braun Medical Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 15	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0264-9379_0eb562f2-577f-4138-b0a7-c64c6624aefe	0264-9379	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride with Dextrose		Bupivacaine Hydrochloride with Dextrose	INJECTION	SUBARACHNOID	20190402		ANDA	ANDA209087	B. Braun Medical Inc.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0264-9567_c7b6af70-3ad5-4cd6-8124-6544e9a8ce03	0264-9567	HUMAN PRESCRIPTION DRUG	Heparin Sodium in Dextrose		Heparin Sodium and Dextrose	INJECTION	INTRAVENOUS	19920720		NDA	NDA019952	B. Braun Medical Inc.	DEXTROSE MONOHYDRATE; HEPARIN SODIUM	5; 4000	g/100mL; [USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0264-9577_c7b6af70-3ad5-4cd6-8124-6544e9a8ce03	0264-9577	HUMAN PRESCRIPTION DRUG	Heparin Sodium in Dextrose		Heparin Sodium and Dextrose	INJECTION	INTRAVENOUS	19920720		NDA	NDA019952	B. Braun Medical Inc.	DEXTROSE MONOHYDRATE; HEPARIN SODIUM	5; 5000	g/100mL; [USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0264-9587_c7b6af70-3ad5-4cd6-8124-6544e9a8ce03	0264-9587	HUMAN PRESCRIPTION DRUG	Heparin Sodium in Dextrose		Heparin Sodium and Dextrose	INJECTION	INTRAVENOUS	19920720		NDA	NDA019952	B. Braun Medical Inc.	DEXTROSE MONOHYDRATE; HEPARIN SODIUM	5; 10000	g/100mL; [USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0264-9594_68ae482a-115e-477d-8721-d10f15ea2afc	0264-9594	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Dextrose		LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	19920408		NDA	NDA019830	B. Braun Medical Inc.	DEXTROSE MONOHYDRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	5; .4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0264-9598_68ae482a-115e-477d-8721-d10f15ea2afc	0264-9598	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Dextrose		LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	19920408		NDA	NDA019830	B. Braun Medical Inc.	DEXTROSE MONOHYDRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	5; .8	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0264-9872_f2461766-cfeb-4b4b-8a44-5520e456d174	0264-9872	HUMAN PRESCRIPTION DRUG	Heparin Sodium in Sodium Chloride		Heparin Sodium in Sodium Chloride	INJECTION	INTRAVENOUS	19920720		NDA	NDA019953	B. Braun Medical Inc.	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0268-0021_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0021	NON-STANDARDIZED ALLERGENIC	CENTER-AL - ACACIA LONGIFOLIA POLLEN		ACACIA LONGIFOLIA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	ACACIA LONGIFOLIA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0024_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0024	NON-STANDARDIZED ALLERGENIC	CENTER-AL - ALNUS INCANA SSP. RUGOSA POLLEN		ALNUS INCANA SUBSP. RUGOSA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	ALNUS INCANA SUBSP. RUGOSA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0027_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0027	NON-STANDARDIZED ALLERGENIC	CENTER-AL - FRAXINUS AMERICANA POLLEN		FRAXINUS AMERICANA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	FRAXINUS AMERICANA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0031_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0031	NON-STANDARDIZED ALLERGENIC	CENTER-AL - PASPALUM NOTATUM POLLEN		PASPALUM NOTATUM POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	PASPALUM NOTATUM POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0037_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0037	NON-STANDARDIZED ALLERGENIC	CENTER-AL - CYNODON DACTYLON POLLEN		CYNODON DACTYLON POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	CYNODON DACTYLON POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0041_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0041	NON-STANDARDIZED ALLERGENIC	CENTER-AL - BETULA LENTA POLLEN		BETULA LENTA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	BETULA LENTA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0047_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0047	NON-STANDARDIZED ALLERGENIC	CENTER-AL - ACER NEGUNDO POLLEN		ACER NEGUNDO POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0053_32333cee-3883-450b-bd93-0c8ace0bad98	0268-0053	NON-STANDARDIZED ALLERGENIC	CENTER-AL - XANTHIUM STRUMARIUM POLLEN		XANTHIUM STRUMARIUM POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	XANTHIUM STRUMARIUM POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0063_69c27f1b-06eb-4f5f-aa13-bf6f142553df	0268-0063	NON-STANDARDIZED ALLERGENIC	CENTER-AL - RUMEX ACETOSELLA POLLEN		RUMEX ACETOSELLA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	RUMEX ACETOSELLA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0069_69c27f1b-06eb-4f5f-aa13-bf6f142553df	0268-0069	NON-STANDARDIZED ALLERGENIC	CENTER-AL - ULMUS AMERICANA POLLEN		ULMUS AMERICANA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	ULMUS AMERICANA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0078_69c27f1b-06eb-4f5f-aa13-bf6f142553df	0268-0078	NON-STANDARDIZED ALLERGENIC	CENTER-AL - CARYA OVATA POLLEN		CARYA OVATA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	CARYA OVATA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0087_69c27f1b-06eb-4f5f-aa13-bf6f142553df	0268-0087	NON-STANDARDIZED ALLERGENIC	CENTER-AL - SORGHUM HALEPENSE POLLEN		SORGHUM HALEPENSE POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	SORGHUM HALEPENSE POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0097_6d7a39b8-39cd-4256-a4ba-5978b391037e	0268-0097	NON-STANDARDIZED ALLERGENIC	CENTER-AL - CHENOPODIUM ALBUM POLLEN		CHENOPODIUM ALBUM POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	CHENOPODIUM ALBUM POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0100_6d7a39b8-39cd-4256-a4ba-5978b391037e	0268-0100	NON-STANDARDIZED ALLERGENIC	CENTER-AL - ACER SACCHARUM POLLEN		ACER SACCHARUM POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0110_6d7a39b8-39cd-4256-a4ba-5978b391037e	0268-0110	NON-STANDARDIZED ALLERGENIC	CENTER-AL - ARTEMISIA VULGARIS POLLEN		ARTEMISIA VULGARIS POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	ARTEMISIA VULGARIS POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0113_6d7a39b8-39cd-4256-a4ba-5978b391037e	0268-0113	NON-STANDARDIZED ALLERGENIC	CENTER-AL - MORUS RUBRA POLLEN		MORUS RUBRA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	MORUS RUBRA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0122_6d7a39b8-39cd-4256-a4ba-5978b391037e	0268-0122	NON-STANDARDIZED ALLERGENIC	CENTER-AL - QUERCUS ALBA POLLEN		QUERCUS ALBA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS ALBA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0128_6d7a39b8-39cd-4256-a4ba-5978b391037e	0268-0128	NON-STANDARDIZED ALLERGENIC	CENTER-AL - OLEA EUROPAEA POLLEN		OLEA EUROPAEA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	OLEA EUROPAEA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0134_070eea8d-3fd1-452d-89de-1dbf1c19efb2	0268-0134	NON-STANDARDIZED ALLERGENIC	CENTER-AL - DACTYLIS GLOMERATA POLLEN		DACTYLIS GLOMERATA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	DACTYLIS GLOMERATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0140_070eea8d-3fd1-452d-89de-1dbf1c19efb2	0268-0140	NON-STANDARDIZED ALLERGENIC	CENTER-AL - AMARANTHUS RETROFLEXUS POLLEN		AMARANTHUS RETROFLEXUS POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0146_070eea8d-3fd1-452d-89de-1dbf1c19efb2	0268-0146	NON-STANDARDIZED ALLERGENIC	CENTER-AL - PLANTAGO LANCEOLATA POLLEN		PLANTAGO LANCEOLATA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	PLANTAGO LANCEOLATA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0150_070eea8d-3fd1-452d-89de-1dbf1c19efb2	0268-0150	NON-STANDARDIZED ALLERGENIC	CENTER-AL - POPULUS ALBA POLLEN		POPULUS ALBA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	POPULUS ALBA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0156_070eea8d-3fd1-452d-89de-1dbf1c19efb2	0268-0156	NON-STANDARDIZED ALLERGENIC	CENTER-AL - AMBROSIA ARTEMISIIFOLIA POLLEN		AMBROSIA ARTEMISIIFOLIA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0164_070eea8d-3fd1-452d-89de-1dbf1c19efb2	0268-0164	NON-STANDARDIZED ALLERGENIC	CENTER-AL - AMBROSIA PSILOSTACHYA POLLEN		AMBROSIA PSILOSTACHYA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA PSILOSTACHYA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0170_92d8302b-b86a-43fb-b86e-a2021367d178	0268-0170	NON-STANDARDIZED ALLERGENIC	CENTER-AL - SALSOLA KALI POLLEN		SALSOLA KALI POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	SALSOLA KALI POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0173_92d8302b-b86a-43fb-b86e-a2021367d178	0268-0173	NON-STANDARDIZED ALLERGENIC	CENTER-AL - LOLIUM PERENNE POLLEN		LOLIUM PERENNE POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	LOLIUM PERENNE POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0186_92d8302b-b86a-43fb-b86e-a2021367d178	0268-0186	NON-STANDARDIZED ALLERGENIC	CENTER-AL - PLATANUS OCCIDENTALIS POLLEN		PLATANUS OCCIDENTALIS POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	PLATANUS OCCIDENTALIS POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0192_92d8302b-b86a-43fb-b86e-a2021367d178	0268-0192	NON-STANDARDIZED ALLERGENIC	CENTER-AL - PHLEUM PRATENSE POLLEN		PHLEUM PRATENSE POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	PHLEUM PRATENSE POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0193_92d8302b-b86a-43fb-b86e-a2021367d178	0268-0193	NON-STANDARDIZED ALLERGENIC	CENTER-AL - PHLEUM PRATENSE POLLEN		PHLEUM PRATENSE POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	PHLEUM PRATENSE POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0199_92d8302b-b86a-43fb-b86e-a2021367d178	0268-0199	NON-STANDARDIZED ALLERGENIC	CENTER-AL - JUGLANS NIGRA POLLEN		JUGLANS NIGRA POLLEN	INJECTION, SUSPENSION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	JUGLANS NIGRA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-0247_b405798b-4f02-4236-9b5d-00da85a2c6c4	0268-0247	HUMAN PRESCRIPTION DRUG	Histamine Positive	Skin Test Control	histamine phosphate	SOLUTION	PERCUTANEOUS	19891023		BLA	BLA103754	ALK-Abello, Inc.	HISTAMINE PHOSPHATE	2.75	mg/mL			N	20241231
0268-0248_b405798b-4f02-4236-9b5d-00da85a2c6c4	0268-0248	HUMAN PRESCRIPTION DRUG	histamine positive	skin test control	histamine phosphate	INJECTION, SOLUTION	INTRADERMAL	19891023		BLA	BLA103754	ALK-Abello, Inc.	HISTAMINE PHOSPHATE	.275	mg/mL			N	20241231
0268-0275_7641d225-ff95-44d4-9279-296d84b96b05	0268-0275	STANDARDIZED ALLERGENIC	Standardized Mite D. farinae		Standardized Mite D. farinae	INJECTION, SOLUTION	SUBCUTANEOUS	19910708		BLA	BLA103060	ALK-Abello, Inc.	DERMATOPHAGOIDES FARINAE	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-0277_7641d225-ff95-44d4-9279-296d84b96b05	0268-0277	STANDARDIZED ALLERGENIC	Standardized Mite D. pteronyssinus		Standardized Mite D. pteronyssinus	INJECTION, SOLUTION	SUBCUTANEOUS	19900814		BLA	BLA103752	ALK-Abello, Inc.	DERMATOPHAGOIDES PTERONYSSINUS	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-0279_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0279	STANDARDIZED ALLERGENIC	Timothy, Standardized		Timothy, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	PHLEUM PRATENSE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0281_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0281	STANDARDIZED ALLERGENIC	Orchard Grass, Standardized		Orchard Grass, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103054	ALK-Abello, Inc.	DACTYLIS GLOMERATA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0283_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0283	STANDARDIZED ALLERGENIC	Kentucky Bluegrass (June) Standardized		Kentucky Bluegrass June, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103052	ALK-Abello, Inc.	POA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0285_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0285	STANDARDIZED ALLERGENIC	Redtop Grass, Standardized		Redtop Grass, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103055	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0287_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0287	STANDARDIZED ALLERGENIC	Sweet Vernal Grass, Standardized		Sweet Vernal Grass, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103057	ALK-Abello, Inc.	ANTHOXANTHUM ODORATUM POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0289_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0289	STANDARDIZED ALLERGENIC	Rye Grass, Perennial Standardized		Rye Grass, Perennial Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103056	ALK-Abello, Inc.	LOLIUM PERENNE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0291_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0291	STANDARDIZED ALLERGENIC	Meadow Fescue Grass, Standardized		Meadow Fescue Grass, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103053	ALK-Abello, Inc.	FESTUCA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0293_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-0293	STANDARDIZED ALLERGENIC	Bermuda Grass, Standardized		Bermuda Grass, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103051	ALK-Abello, Inc.	CYNODON DACTYLON POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-0603_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0603	NON-STANDARDIZED ALLERGENIC	BOS TAURUS SKIN		CATTLE EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BOS TAURUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0615_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0615	NON-STANDARDIZED ALLERGENIC	CANIS LUPUS FAMILIARIS SKIN		DOG EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANIS LUPUS FAMILIARIS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0619_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0619	NON-STANDARDIZED ALLERGENIC	CANIS LUPUS FAMILIARIS SKIN		DOG EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANIS LUPUS FAMILIARIS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0620_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0620	NON-STANDARDIZED ALLERGENIC	CANIS LUPUS FAMILIARIS SKIN		DOG EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANIS LUPUS FAMILIARIS SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0621_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0621	NON-STANDARDIZED ALLERGENIC	CANIS LUPUS FAMILIARIS SKIN		DOG EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANIS LUPUS FAMILIARIS SKIN	.05	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0626_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0626	NON-STANDARDIZED ALLERGENIC	CANIS LUPUS FAMILIARIS SKIN		DOG EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANIS LUPUS FAMILIARIS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0628_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0628	NON-STANDARDIZED ALLERGENIC	EQUUS CABALLUS SKIN		HORSE EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EQUUS CABALLUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0631_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0631	NON-STANDARDIZED ALLERGENIC	EQUUS CABALLUS SKIN		HORSE EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EQUUS CABALLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0638_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0638	NON-STANDARDIZED ALLERGENIC	MUS MUSCULUS SKIN		MOUSE EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MUS MUSCULUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0650_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0650	NON-STANDARDIZED ALLERGENIC	RABBIT		RABBIT	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RABBIT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-0651_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0651	NON-STANDARDIZED ALLERGENIC	RABBIT		RABBIT	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RABBIT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-0653_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0653	NON-STANDARDIZED ALLERGENIC	CAVIA PORCELLUS SKIN		GUINEA PIG EPITHELIA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CAVIA PORCELLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-0707_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0707	NON-STANDARDIZED ALLERGENIC	PERIPLANETA AMERICANA		AMERICAN COCKROACH	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PERIPLANETA AMERICANA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-0714_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0714	NON-STANDARDIZED ALLERGENIC	BLATELLA GERMANICA		GERMAN COCKROACH	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BLATTELLA GERMANICA	.05	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-0722_028ad0ff-1a2d-4610-bf84-a0eaacaf599e	0268-0722	NON-STANDARDIZED ALLERGENIC	FIRE ANT		FIRE ANT	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SOLENOPSIS INVICTA	.05	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0268-0722_4d458dd3-8f4a-4fbc-bdab-1be92ad1a7f4	0268-0722	NON-STANDARDIZED ALLERGENIC	FIRE ANT		SOLENOPSIS INVICTA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SOLENOPSIS INVICTA	.05	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0268-0723_028ad0ff-1a2d-4610-bf84-a0eaacaf599e	0268-0723	NON-STANDARDIZED ALLERGENIC	MIXED FEATHERS		MIXED FEATHERS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.005; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
0268-0723_78f45cdb-937a-4516-b8b8-3e5095a98154	0268-0723	NON-STANDARDIZED ALLERGENIC	MIXED FEATHERS		GALLUS GALLUS FEATHER, ANAS PLATYRHYNCHOS FEATHER, ANSER ANSER FEATHER	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
0268-0724_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-0724	NON-STANDARDIZED ALLERGENIC	FIRE ANT		SOLENOPSIS INVICTA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SOLENOPSIS INVICTA	.1	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0268-0725_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-0725	NON-STANDARDIZED ALLERGENIC	MOSQUITO		CULIX PIPIENS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CULEX PIPIENS	.01	g/mL			N	20241231
0268-0725_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-0725	NON-STANDARDIZED ALLERGENIC	MOSQUITO		CULEX PIPIENS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CULEX PIPIENS	.01	g/mL			N	20241231
0268-0945_a3200b5f-95f3-43cf-a26f-27a503470956	0268-0945	NON-STANDARDIZED ALLERGENIC	USTILAGO MAYDIS		CORN SMUT	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	USTILAGO MAYDIS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-1001_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1001	NON-STANDARDIZED ALLERGENIC	ACACIA		Acacia	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACACIA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0268-1007_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1007	NON-STANDARDIZED ALLERGENIC	ALNUS INCANA SSP RUGOSA POLLEN		Alder White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALNUS INCANA SUBSP. RUGOSA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1008_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1008	NON-STANDARDIZED ALLERGENIC	ALNUS INCANA SSP RUGOSA POLLEN		Alder White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALNUS INCANA SUBSP. RUGOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1012_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1012	NON-STANDARDIZED ALLERGENIC	MEDICAGO SATIVA POLLEN		Alfalfa	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MEDICAGO SATIVA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1016_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1016	NON-STANDARDIZED ALLERGENIC	FRAXINUS VELUTINA POLLEN		Ash Arizona	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FRAXINUS VELUTINA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1022_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1022	NON-STANDARDIZED ALLERGENIC	FRAXINUS AMERICANA POLLEN		Ash White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FRAXINUS AMERICANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1023_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1023	NON-STANDARDIZED ALLERGENIC	FRAXINUS AMERICANA POLLEN		Ash White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FRAXINUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1024_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1024	NON-STANDARDIZED ALLERGENIC	FRAXINUS AMERICANA POLLEN		Ash White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FRAXINUS AMERICANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1034_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1034	NON-STANDARDIZED ALLERGENIC	PASPALUM NOTATUM POLLEN		Bahia Grass	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PASPALUM NOTATUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1035_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1035	NON-STANDARDIZED ALLERGENIC	PASPALUM NOTATUM POLLEN		Bahia Grass	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PASPALUM NOTATUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1041_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1041	NON-STANDARDIZED ALLERGENIC	MORELLA CERIFERA POLLEN		Bayberry Wax Myrtle	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORELLA CERIFERA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1042_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1042	NON-STANDARDIZED ALLERGENIC	MORELLA CERIFERA POLLEN		Bayberry Wax Myrtle	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORELLA CERIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1046_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1046	NON-STANDARDIZED ALLERGENIC	FAGUS GRANDIFOLIA POLLEN		Beech	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FAGUS GRANDIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1047_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1047	NON-STANDARDIZED ALLERGENIC	FAGUS GRANDIFOLIA POLLEN		Beech	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FAGUS GRANDIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1056_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1056	NON-STANDARDIZED ALLERGENIC	BETULA LENTA POLLEN		Birch Black	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA LENTA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1062_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1062	NON-STANDARDIZED ALLERGENIC	BETULA NIGRA POLLEN		Birch River Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1063_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1063	NON-STANDARDIZED ALLERGENIC	BETULA NIGRA POLLEN		Birch River Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1069_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1069	NON-STANDARDIZED ALLERGENIC	BETULA LENTA POLLEN		Birch White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA LENTA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1070_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1070	NON-STANDARDIZED ALLERGENIC	BETULA LENTA POLLEN		Birch White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA LENTA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1080_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1080	NON-STANDARDIZED ALLERGENIC	ACER NEGUNDO POLLEN		Box Elder Ash Leaf Maple	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1081_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1081	NON-STANDARDIZED ALLERGENIC	ACER NEGUNDO POLLEN		Box Elder Ash Leaf Maple	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1087_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1087	NON-STANDARDIZED ALLERGENIC	BROMUS INERMIS POLLEN		Brome Grass	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BROMUS INERMIS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-1092_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1092	NON-STANDARDIZED ALLERGENIC	AMARANTHUS PALMERI POLLEN		Carelessweed	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS PALMERI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1093_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1093	NON-STANDARDIZED ALLERGENIC	AMARANTHUS PALMERI POLLEN		Carelessweed	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS PALMERI POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1097_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1097	NON-STANDARDIZED ALLERGENIC	JUNIPERUS ASHEI POLLEN		Cedar Mountain	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS ASHEI POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1098_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1098	NON-STANDARDIZED ALLERGENIC	JUNIPERUS ASHEI POLLEN		Cedar Mountain	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS ASHEI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1102_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1102	NON-STANDARDIZED ALLERGENIC	JUNIPERUS VIRGINIANA POLLEN		Cedar Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS VIRGINIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1110_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1110	NON-STANDARDIZED ALLERGENIC	XANTHIUM STRUMARIUM VAR CANADENSE POLLEN		Cocklebur	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1111_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1111	NON-STANDARDIZED ALLERGENIC	XANTHIUM STRUMARIUM VAR CANADENSE POLLEN		Cocklebur	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1112_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1112	NON-STANDARDIZED ALLERGENIC	XANTHIUM STRUMARIUM VAR CANADENSE POLLEN		Cocklebur	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1121_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1121	NON-STANDARDIZED ALLERGENIC	ZEA MAYS POLLEN		Corn Pollen	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ZEA MAYS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1126_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1126	NON-STANDARDIZED ALLERGENIC	POPULUS DELTOIDES POLLEN		Cottonwood Eastern Common	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS DELTOIDES POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1127_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1127	NON-STANDARDIZED ALLERGENIC	POPULUS DELTOIDES POLLEN		Cottonwood Eastern Common	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS DELTOIDES POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1138_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1138	NON-STANDARDIZED ALLERGENIC	POPULUS DELTOIDES SSP MONILIFERA POLLEN		Cottonwood Western	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1139_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1139	NON-STANDARDIZED ALLERGENIC	POPULUS DELTOIDES SSP MONILIFERA POLLEN		Cottonwood Western	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1143_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1143	NON-STANDARDIZED ALLERGENIC	CUPRESSUS ARIZONICA POLLEN		Cypress Arizona	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CUPRESSUS ARIZONICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1147_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1147	NON-STANDARDIZED ALLERGENIC	TAXODIUM DISTICHUM POLLEN		Cypress Bald	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	TAXODIUM DISTICHUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1150_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-1150	NON-STANDARDIZED ALLERGENIC	MIXED COCKROACH		BLATTELLA GERMANICA AND PERIPLANETA AMERICANA	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-1150_91e6f082-b201-409a-9cab-95d4e0433468	0268-1150	NON-STANDARDIZED ALLERGENIC	MIXED COCKROACH		BLATELLA GERMANICA and PERIPLANETA AMERICANA	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-1151_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1151	NON-STANDARDIZED ALLERGENIC	RUMEX ACETOSELLA POLLEN		Dock Sour Sheep Sorrel	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RUMEX ACETOSELLA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1152_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1152	NON-STANDARDIZED ALLERGENIC	RUMEX ACETOSELLA POLLEN		Dock Sour Sheep Sorrel	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RUMEX ACETOSELLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1159_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1159	NON-STANDARDIZED ALLERGENIC	RUMEX CRISPUS POLLEN		Dock Yellow	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RUMEX CRISPUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1160_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1160	NON-STANDARDIZED ALLERGENIC	RUMEX CRISPUS POLLEN		Dock Yellow	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RUMEX CRISPUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1165_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1165	NON-STANDARDIZED ALLERGENIC	EUPATORIUM CAPILLIFOLIUM POLLEN		Dog Fennel Non Stock	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EUPATORIUM CAPILLIFOLIUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1168_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1168	NON-STANDARDIZED ALLERGENIC	ULMUS AMERICANA POLLEN		Elm American	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS AMERICANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1169_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1169	NON-STANDARDIZED ALLERGENIC	ULMUS AMERICANA POLLEN		Elm American	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1170_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1170	NON-STANDARDIZED ALLERGENIC	ULMUS AMERICANA POLLEN		Elm American	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS AMERICANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1177_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1177	NON-STANDARDIZED ALLERGENIC	ULMUS CRASSIFOLIA POLLEN		Elm Cedar	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS CRASSIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1178_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1178	NON-STANDARDIZED ALLERGENIC	ULMUS CRASSIFOLIA POLLEN		Elm Cedar	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS CRASSIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1182_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1182	NON-STANDARDIZED ALLERGENIC	ULMUS PUMILA POLLEN		Elm Chinese	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS PUMILA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1185_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1185	NON-STANDARDIZED ALLERGENIC	EUCALYPTUS GLOBULUS POLLEN		Eucalyptus	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EUCALYPTUS GLOBULUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1186_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1186	NON-STANDARDIZED ALLERGENIC	EUCALYPTUS GLOBULUS POLLEN		Eucalyptus	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EUCALYPTUS GLOBULUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1192_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1192	NON-STANDARDIZED ALLERGENIC	SOLIDAGO CANADENSIS POLLEN		Goldenrod	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SOLIDAGO CANADENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1198_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1198	NON-STANDARDIZED ALLERGENIC	CELTIS OCCIDENTALIS POLLEN		Hackberry	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CELTIS OCCIDENTALIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1199_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1199	NON-STANDARDIZED ALLERGENIC	CELTIS OCCIDENTALIS POLLEN		Hackberry	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CELTIS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1214_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1214	NON-STANDARDIZED ALLERGENIC	SORGHUM HALEPENSE POLLEN		Johnson Grass	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SORGHUM HALEPENSE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1215_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1215	NON-STANDARDIZED ALLERGENIC	SORGHUM HALEPENSE POLLEN		Johnson Grass	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SORGHUM HALEPENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1216_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1216	NON-STANDARDIZED ALLERGENIC	SORGHUM HALEPENSE POLLEN		Johnson Grass	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SORGHUM HALEPENSE POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1223_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1223	NON-STANDARDIZED ALLERGENIC	JUNIPERUS CALIFORNICA POLLEN		Juniper Western	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS CALIFORNICA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1224_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1224	NON-STANDARDIZED ALLERGENIC	JUNIPERUS CALIFORNICA POLLEN		Juniper Western	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS CALIFORNICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1232_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1232	NON-STANDARDIZED ALLERGENIC	KOCHIA SCOPARIA POLLEN		Kochia Firebush	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BASSIA SCOPARIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1233_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1233	NON-STANDARDIZED ALLERGENIC	KOCHIA SCOPARIA POLLEN		Kochia Firebush	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BASSIA SCOPARIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1234_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1234	NON-STANDARDIZED ALLERGENIC	KOCHIA SCOPARIA POLLEN		Kochia Firebush	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BASSIA SCOPARIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1238_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1238	NON-STANDARDIZED ALLERGENIC	CHENOPODIUM ALBUM POLLEN		Lambs Quarters	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CHENOPODIUM ALBUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1239_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1239	NON-STANDARDIZED ALLERGENIC	CHENOPODIUM ALBUM POLLEN		Lambs Quarters	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CHENOPODIUM ALBUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1240_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1240	NON-STANDARDIZED ALLERGENIC	CHENOPODIUM ALBUM POLLEN		Lambs Quarters	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CHENOPODIUM ALBUM POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1249_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1249	NON-STANDARDIZED ALLERGENIC	ACER RUBRUM POLLEN		Maple Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER RUBRUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1252_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1252	NON-STANDARDIZED ALLERGENIC	ACER SACCHARUM POLLEN		Maple Sugar	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1253_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1253	NON-STANDARDIZED ALLERGENIC	ACER SACCHARUM POLLEN		Maple Sugar	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1254_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1254	NON-STANDARDIZED ALLERGENIC	ACER SACCHARUM POLLEN		Maple Sugar	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1258_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1258	NON-STANDARDIZED ALLERGENIC	IVA XANTHIFOLIA POLLEN		Marshelder Burweed	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CYCLACHAENA XANTHIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1259_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1259	NON-STANDARDIZED ALLERGENIC	IVA XANTHIFOLIA POLLEN		Marshelder Burweed	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CYCLACHAENA XANTHIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1263_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1263	NON-STANDARDIZED ALLERGENIC	IVA ANNUA VAR ANNUA POLLEN		Marshelder Rough	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	IVA ANNUA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1264_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1264	NON-STANDARDIZED ALLERGENIC	IVA ANNUA VAR ANNUA POLLEN		Marshelder Rough	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	IVA ANNUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1265_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1265	NON-STANDARDIZED ALLERGENIC	IVA ANNUA VAR ANNUA POLLEN		Marshelder Rough	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	IVA ANNUA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1277_4d458dd3-8f4a-4fbc-bdab-1be92ad1a7f4	0268-1277	NON-STANDARDIZED ALLERGENIC	MELALEUCA		MELALEUCA QUINQUENERVIA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MELALEUCA QUINQUENERVIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1277_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-1277	NON-STANDARDIZED ALLERGENIC	MELALEUCA		MELALEUCA QUINQUENERVIA POLLEN	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MELALEUCA QUINQUENERVIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1279_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1279	NON-STANDARDIZED ALLERGENIC	PROSOPIS JULIFLORA POLLEN		Mesquite	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PROSOPIS JULIFLORA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1280_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1280	NON-STANDARDIZED ALLERGENIC	PROSOPIS JULIFLORA POLLEN		Mesquite	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PROSOPIS JULIFLORA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1297_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1297	NON-STANDARDIZED ALLERGENIC	ARTEMISIA VULGARIS POLLEN		Mugwort Common	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ARTEMISIA VULGARIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1298_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1298	NON-STANDARDIZED ALLERGENIC	ARTEMISIA VULGARIS POLLEN		Mugwort Common	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ARTEMISIA VULGARIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1302_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-1302	NON-STANDARDIZED ALLERGENIC	SORREL/DOCK MIX		RUMEX ACETOSELLA POLLEN AND RUMEX CRISPUS POLLEN	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-1302_739911f7-038e-48f0-a424-9b2c786a6c68	0268-1302	NON-STANDARDIZED ALLERGENIC	SORREL/DOCK MIX		RUMEX ACETOSELLA POLLEN and RUMEX CRISPUS POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-1302_91e6f082-b201-409a-9cab-95d4e0433468	0268-1302	NON-STANDARDIZED ALLERGENIC	SORREL/DOCK MIX		RUMEX ACETOSELLA POLLEN and RUMEX CRISPUS POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-1304_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1304	NON-STANDARDIZED ALLERGENIC	MORUS RUBRA POLLEN		Mulberry Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORUS RUBRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1305_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1305	NON-STANDARDIZED ALLERGENIC	MORUS RUBRA POLLEN		Mulberry Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1310_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1310	NON-STANDARDIZED ALLERGENIC	MORUS ALBA POLLEN		Mulberry White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORUS ALBA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1311_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1311	NON-STANDARDIZED ALLERGENIC	MORUS ALBA POLLEN		Mulberry White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1319_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1319	NON-STANDARDIZED ALLERGENIC	QUERCUS RUBRA POLLEN		Oak Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1322_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1322	NON-STANDARDIZED ALLERGENIC	QUERCUS VIRGINIANA POLLEN		Oak Virginia Live	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS VIRGINIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1323_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1323	NON-STANDARDIZED ALLERGENIC	QUERCUS VIRGINIANA POLLEN		Oak Virginia Live	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1327_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1327	NON-STANDARDIZED ALLERGENIC	QUERCUS ALBA POLLEN		Oak White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS ALBA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1328_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1328	NON-STANDARDIZED ALLERGENIC	QUERCUS ALBA POLLEN		Oak White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1329_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1329	NON-STANDARDIZED ALLERGENIC	QUERCUS ALBA POLLEN		Oak White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS ALBA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1340_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1340	NON-STANDARDIZED ALLERGENIC	OLEA EUROPAEA POLLEN		Olive Pollen	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	OLEA EUROPAEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1347_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1347	NON-STANDARDIZED ALLERGENIC	SYAGRUS ROMANZOFFIANA POLLEN		Palm Queen Coco Palm	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1348_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1348	NON-STANDARDIZED ALLERGENIC	SYAGRUS ROMANZOFFIANA POLLEN		Palm Queen Coco Palm	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1354_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1354	NON-STANDARDIZED ALLERGENIC	CARYA ILLINOINENSIS POLLEN		Pecan Pollen	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA ILLINOINENSIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1355_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1355	NON-STANDARDIZED ALLERGENIC	CARYA ILLINOINENSIS POLLEN		Pecan Pollen	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA ILLINOINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1361_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1361	NON-STANDARDIZED ALLERGENIC	SCHINUS MOLLE POLLEN		Pepper Tree California	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SCHINUS MOLLE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1364_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1364	NON-STANDARDIZED ALLERGENIC	AMARANTHUS RETROFLEXUS POLLEN		Pigweed Rough Redroot	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1365_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1365	NON-STANDARDIZED ALLERGENIC	AMARANTHUS RETROFLEXUS POLLEN		Pigweed Rough Redroot	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1371_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1371	NON-STANDARDIZED ALLERGENIC	AMARANTHUS SPINOSUS POLLEN		Pigweed Spiny	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS SPINOSUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1372_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1372	NON-STANDARDIZED ALLERGENIC	AMARANTHUS SPINOSUS POLLEN		Pigweed Spiny	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS SPINOSUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1376_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1376	NON-STANDARDIZED ALLERGENIC	CASUARINA EQUISETIFOLIA POLLEN		Pine Australian Beefwood	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CASUARINA EQUISETIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1382_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1382	NON-STANDARDIZED ALLERGENIC	PINUS STROBUS POLLEN		Pine White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PINUS STROBUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1383_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1383	NON-STANDARDIZED ALLERGENIC	PINUS STROBUS POLLEN		Pine White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PINUS STROBUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1390_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1390	NON-STANDARDIZED ALLERGENIC	PINUS ECHINATA POLLEN		Pine Yellow	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PINUS ECHINATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1394_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1394	NON-STANDARDIZED ALLERGENIC	PLANTAGO LANCEOLATA POLLEN		Plantain English	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PLANTAGO LANCEOLATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1395_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1395	NON-STANDARDIZED ALLERGENIC	PLANTAGO LANCEOLATA POLLEN		Plantain English	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PLANTAGO LANCEOLATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1400_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1400	NON-STANDARDIZED ALLERGENIC	PLANTAGO LANCEOLATA POLLEN		Plantain English	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PLANTAGO LANCEOLATA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1405_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1405	NON-STANDARDIZED ALLERGENIC	POPULUS ALBA POLLEN		Poplar White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS ALBA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1406_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1406	NON-STANDARDIZED ALLERGENIC	POPULUS ALBA POLLEN		Poplar White	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1412_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1412	NON-STANDARDIZED ALLERGENIC	LIGUSTRUM VULGARE POLLEN		Privet	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	LIGUSTRUM VULGARE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1413_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1413	NON-STANDARDIZED ALLERGENIC	LIGUSTRUM VULGARE POLLEN		Privet	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	LIGUSTRUM VULGARE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1415_028ad0ff-1a2d-4610-bf84-a0eaacaf599e	0268-1415	NON-STANDARDIZED ALLERGENIC	SHAGBARK HICKORY		SHAGBARK HICKORY	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA OVATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1415_4d458dd3-8f4a-4fbc-bdab-1be92ad1a7f4	0268-1415	NON-STANDARDIZED ALLERGENIC	SHAGBARK HICKORY		CARYA OVATA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA OVATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1417_028ad0ff-1a2d-4610-bf84-a0eaacaf599e	0268-1417	NON-STANDARDIZED ALLERGENIC	MIXED RAGWEED		MIXED RAGWEED	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	20150503		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-1418_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1418	NON-STANDARDIZED ALLERGENIC	ELYMUS REPENS POLLEN		Quack Grass	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ELYMUS REPENS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1421_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-1421	NON-STANDARDIZED ALLERGENIC	SHAGBARK, HICKORY		CARYA OVATA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA OVATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1424_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1424	NON-STANDARDIZED ALLERGENIC	AMBROSIA ACANTHICARPA POLLEN		Ragweed False Bur	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ACANTHICARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1439_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1439	NON-STANDARDIZED ALLERGENIC	AMBROSIA TRIFIDA POLLEN		Ragweed Tall Giant	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA TRIFIDA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1440_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1440	NON-STANDARDIZED ALLERGENIC	AMBROSIA TRIFIDA POLLEN		Ragweed Tall Giant	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA TRIFIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1445_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1445	NON-STANDARDIZED ALLERGENIC	AMBROSIA PSILOSTACHYA POLLEN		Ragweed Western	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA PSILOSTACHYA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1446_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1446	NON-STANDARDIZED ALLERGENIC	AMBROSIA PSILOSTACHYA POLLEN		Ragweed Western	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA PSILOSTACHYA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1453_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1453	NON-STANDARDIZED ALLERGENIC	SALSOLA KALI POLLEN		Russian Thistle	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SALSOLA KALI POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1454_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1454	NON-STANDARDIZED ALLERGENIC	SALSOLA KALI POLLEN		Russian Thistle	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SALSOLA KALI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1471_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1471	NON-STANDARDIZED ALLERGENIC	ARTEMISIA TRIDENTATA POLLEN		Sagebrush Common	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ARTEMISIA TRIDENTATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1472_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1472	NON-STANDARDIZED ALLERGENIC	ARTEMISIA TRIDENTATA POLLEN		Sagebrush Common	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ARTEMISIA TRIDENTATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1482_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-1482	NON-STANDARDIZED ALLERGENIC	LENSCALE		ATRIPLEX LENTIFORMIS POLLEN	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ATRIPLEX LENTIFORMIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1483_6c4e406a-5724-42a6-afbd-34e4971ec41f	0268-1483	NON-STANDARDIZED ALLERGENIC	MIXED RAGWEED		AMBROSIA ARTEMISIIFOLIA AND AMBROSIA TRIFIDA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1493_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1493	NON-STANDARDIZED ALLERGENIC	LIQUIDAMBAR STYRACIFLUA POLLEN		Sweetgum	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1494_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1494	NON-STANDARDIZED ALLERGENIC	LIQUIDAMBAR STYRACIFLUA POLLEN		Sweetgum	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1501_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1501	NON-STANDARDIZED ALLERGENIC	PLATANUS OCCIDENTALIS POLLEN		Sycamore American	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PLATANUS OCCIDENTALIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1502_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1502	NON-STANDARDIZED ALLERGENIC	PLATANUS OCCIDENTALIS POLLEN		Sycamore American	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PLATANUS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1512_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1512	NON-STANDARDIZED ALLERGENIC	JUGLANS NIGRA POLLEN		Walnut Black Pollen	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUGLANS NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1513_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1513	NON-STANDARDIZED ALLERGENIC	JUGLANS NIGRA POLLEN		Walnut Black Pollen	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUGLANS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1519_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1519	NON-STANDARDIZED ALLERGENIC	AMARANTHUS TUBERCULATUS POLLEN		Water Hemp	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS TUBERCULATUS POLLEN	.025	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-1524_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1524	NON-STANDARDIZED ALLERGENIC	SALIX NIGRA POLLEN		Willow Black	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SALIX NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1525_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-1525	NON-STANDARDIZED ALLERGENIC	SALIX NIGRA POLLEN		Willow Black	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SALIX NIGRA POLLEN	.05	g/mL			N	20241231
0268-1525_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1525	NON-STANDARDIZED ALLERGENIC	SALIX NIGRA POLLEN		Willow Black	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SALIX NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-1531_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1531	NON-STANDARDIZED ALLERGENIC	AMBROSIA ARTEMISIIFOLIA POLLEN		Ragweed Short	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-1532_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1532	NON-STANDARDIZED ALLERGENIC	AMBROSIA ARTEMISIIFOLIA POLLEN		Ragweed Short	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-1603_a3200b5f-95f3-43cf-a26f-27a503470956	0268-1603	NON-STANDARDIZED ALLERGENIC	JUNIPERUS VIRGINIANA POLLEN		Cedar Red	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-2000_72738311-74cc-4156-be7e-5e92ed20850c	0268-2000	STANDARDIZED ALLERGENIC	Cat Hair, Standardized		Cat Hair, Standardized	INJECTION, SOLUTION	SUBCUTANEOUS	20031128		BLA	BLA103810	ALK-Abello, Inc.	FELIS CATUS HAIR	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dander [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Salivary Proteins and Peptides [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
0268-2001_72738311-74cc-4156-be7e-5e92ed20850c	0268-2001	STANDARDIZED ALLERGENIC	Cat Hair, Standardized		Cat Hair, Standardized	SOLUTION	PERCUTANEOUS	20031128		BLA	BLA103810	ALK-Abello, Inc.	FELIS CATUS HAIR	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dander [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Salivary Proteins and Peptides [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
0268-3050_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3050	STANDARDIZED ALLERGENIC	Bermuda Grass, Standardized		Bermuda Grass, Standardized	SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103051	ALK-Abello, Inc.	CYNODON DACTYLON POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-3051_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3051	STANDARDIZED ALLERGENIC	Kentucky Bluegrass (June) Standardized		Kentucky Bluegrass June, Standardized	SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103052	ALK-Abello, Inc.	POA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-3053_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3053	STANDARDIZED ALLERGENIC	Meadow Fescue Grass, Standardized		Meadow Fescue Grass, Standardized	SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103053	ALK-Abello, Inc.	FESTUCA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-3055_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3055	STANDARDIZED ALLERGENIC	Orchard Grass, Standardized		Orchard Grass, Standardized	SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103054	ALK-Abello, Inc.	DACTYLIS GLOMERATA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-3057_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3057	STANDARDIZED ALLERGENIC	Redtop Grass, Standardized		Redtop Grass, Standardized	SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103055	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-3061_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3061	STANDARDIZED ALLERGENIC	Sweet Vernal Grass, Standardized		Sweet Vernal Grass, Standardized	SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103057	ALK-Abello, Inc.	ANTHOXANTHUM ODORATUM POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-3063_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3063	STANDARDIZED ALLERGENIC	Timothy, Standardized		Timothy, Standardized	SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	PHLEUM PRATENSE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-3509_2e2db5ce-9bd5-4ad3-94c0-45e59370fb28	0268-3509	STANDARDIZED ALLERGENIC	STANDARDIZED PERENNIAL RYE GRASS POLLEN		LOLIUM PERENNE POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103056	ALK-Abello, Inc.	LOLIUM PERENNE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-6100_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6100	NON-STANDARDIZED ALLERGENIC	ALMOND		PRUNUS DULCIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ALMOND	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
0268-6101_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6101	NON-STANDARDIZED ALLERGENIC	APPLE		MALUS DOMESTICA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	APPLE	.1	g/mL	Allergens [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6102_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6102	NON-STANDARDIZED ALLERGENIC	APRICOT		PRUNUS ARMENIACA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	APRICOT	.1	g/mL	Allergens [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6103_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6103	NON-STANDARDIZED ALLERGENIC	ASPARAGUS		ASPARAGUS OFFICINALIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ASPARAGUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6104_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6104	NON-STANDARDIZED ALLERGENIC	AVOCADO		PERSEA AMERICANA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AVOCADO	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6105_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6105	NON-STANDARDIZED ALLERGENIC	BANANA		MUSA SAPIENTUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BANANA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6106_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6106	NON-STANDARDIZED ALLERGENIC	BARLEY		HORDEUM VULGARE	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BARLEY	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6107_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6107	NON-STANDARDIZED ALLERGENIC	KIDNEY BEAN		PHASEOLUS VULGARIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	KIDNEY BEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
0268-6108_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6108	NON-STANDARDIZED ALLERGENIC	STRINGBEAN		PHASEOLUS VULGARIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	STRING BEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0268-6109_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6109	NON-STANDARDIZED ALLERGENIC	BEEF		BOS TAURUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BEEF	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6110_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6110	NON-STANDARDIZED ALLERGENIC	BRAZIL NUT		BERTHOLLETIA EXCELSA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BRAZIL NUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
0268-6112_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6112	NON-STANDARDIZED ALLERGENIC	BROCCOLI		BRASSICA OLERACEA VAR. BOTRYTIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BROCCOLI	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6113_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6113	NON-STANDARDIZED ALLERGENIC	BUCKWHEAT		FAGOPYRUM ESCULENTUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BUCKWHEAT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6114_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6114	NON-STANDARDIZED ALLERGENIC	CABBAGE		BRASSICA OLERACEA VAR. CAPITATA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CABBAGE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6115_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6115	NON-STANDARDIZED ALLERGENIC	CANTALOUPE		CUCUMIS MELO CANTALUPENSIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CANTALOUPE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6116_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6116	NON-STANDARDIZED ALLERGENIC	CARROT		DAUCUS CAROTA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CARROT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6118_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6118	NON-STANDARDIZED ALLERGENIC	CASEIN		BOS TAURUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CASEIN	.1	g/mL	Allergens [CS], Caseins [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6120_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6120	NON-STANDARDIZED ALLERGENIC	CELERY		APIUM GRAVEOLENS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CELERY	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6121_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6121	NON-STANDARDIZED ALLERGENIC	CHERRY		PRUNUS AVIUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	SWEET CHERRY	.1	g/mL			N	20241231
0268-6122_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6122	NON-STANDARDIZED ALLERGENIC	CHICKEN MEAT		GALLUS GALLUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CHICKEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
0268-6123_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6123	NON-STANDARDIZED ALLERGENIC	CINNAMON		CINNAMOMUM VERUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CINNAMON	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6124_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6124	NON-STANDARDIZED ALLERGENIC	CLAM		MERCENARIA MERCENARIA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	NORTHERN QUAHOG	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
0268-6125_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6125	NON-STANDARDIZED ALLERGENIC	COCOA BEAN		THEOBROMA CACAO	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	COCOA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0268-6127_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6127	NON-STANDARDIZED ALLERGENIC	COCONUT		COCOS NUCIFERA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	COCONUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6128_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6128	NON-STANDARDIZED ALLERGENIC	CODFISH		GADUS MORHUA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ATLANTIC COD	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6129_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6129	NON-STANDARDIZED ALLERGENIC	COFFEE		COFFEE ARABICA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ARABICA COFFEE BEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0268-6130_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6130	NON-STANDARDIZED ALLERGENIC	CRAB		PARALITHODES CAMTSCHATICUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	RED KING CRAB	.1	g/mL			N	20241231
0268-6132_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6132	NON-STANDARDIZED ALLERGENIC	CUCUMBER		CUCUMIS SATIVUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CUCUMBER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6133_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6133	NON-STANDARDIZED ALLERGENIC	EGG WHITE		GALLUS GALLUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	EGG WHITE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6135_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6135	NON-STANDARDIZED ALLERGENIC	EGG, WHOLE		GALLUS GALLUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	EGG	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6136_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6136	NON-STANDARDIZED ALLERGENIC	EGG YOLK		GALLUS GALLUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	EGG YOLK	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6137_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6137	NON-STANDARDIZED ALLERGENIC	FLOUNDER		PARALICHTHYS DENTATUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	SUMMER FLOUNDER	.1	g/mL			N	20241231
0268-6138_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6138	NON-STANDARDIZED ALLERGENIC	GARLIC		ALLIUM SATIVUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	GARLIC	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0268-6139_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6139	NON-STANDARDIZED ALLERGENIC	VITIS SPP		Vitis SPP	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	GRAPE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6141_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6141	NON-STANDARDIZED ALLERGENIC	GRAPEFRUIT		CITRUS X PARADISI	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	GRAPEFRUIT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6146_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6146	NON-STANDARDIZED ALLERGENIC	HONEYDEW		CUCUMIS MELO	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	HONEYDEW MELON	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6149_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6149	NON-STANDARDIZED ALLERGENIC	LAMB		OVIS ARIES	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	LAMB	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6170_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6170	NON-STANDARDIZED ALLERGENIC	LEMON		citrus limon	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	LEMON	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6171_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6171	NON-STANDARDIZED ALLERGENIC	LETTUCE		LACTUCA SATIVA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	LETTUCE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6173_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6173	NON-STANDARDIZED ALLERGENIC	LIMA BEAN		PHASEOLUS LUNATUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	LIMA BEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0268-6174_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6174	NON-STANDARDIZED ALLERGENIC	LOBSTER		HOMARUS AMERICANUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AMERICAN LOBSTER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
0268-6177_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6177	NON-STANDARDIZED ALLERGENIC	GOATS MILK		CAPRA AEGAGRUS HIRCUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	GOAT MILK	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6178_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6178	NON-STANDARDIZED ALLERGENIC	COWS MILK		BOS TAURUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	SKIM MILK	.1	g/mL			N	20241231
0268-6180_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6180	NON-STANDARDIZED ALLERGENIC	MUSHROOM		AGARICUS CAMPESTRIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CULTIVATED MUSHROOM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6181_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6181	NON-STANDARDIZED ALLERGENIC	MUSTARD		SINAPIS ALBA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	WHITE MUSTARD SEED	.1	g/mL			N	20241231
0268-6183_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6183	NON-STANDARDIZED ALLERGENIC	OAT GRAIN		AVENA SATIVA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AVENA SATIVA WHOLE	.1	g/mL			N	20241231
0268-6185_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6185	NON-STANDARDIZED ALLERGENIC	OLIVE		OLEA EUROPAEA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BLACK OLIVE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6186_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6186	NON-STANDARDIZED ALLERGENIC	ONION		ALLIUM CEPA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ONION	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6187_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6187	NON-STANDARDIZED ALLERGENIC	ORANGE		CITRUS X SINENSIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ORANGE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6189_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6189	NON-STANDARDIZED ALLERGENIC	OYSTER		CRASSOSTREA VIRGINICA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	EASTERN OYSTER	.1	g/mL			N	20241231
0268-6191_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6191	NON-STANDARDIZED ALLERGENIC	GREEN PEA		PISUM SATIVUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PEA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6192_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6192	NON-STANDARDIZED ALLERGENIC	PEACH		PRUNUS PERSICA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PEACH	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6193_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6193	NON-STANDARDIZED ALLERGENIC	PEANUT		ARACHIS HYPOGAEA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PEANUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
0268-6195_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6195	NON-STANDARDIZED ALLERGENIC	PEAR		PYRUS COMMUNIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PEAR	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6196_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6196	NON-STANDARDIZED ALLERGENIC	PECAN NUT		CARYA ILLINOINENSIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PECAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
0268-6197_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6197	NON-STANDARDIZED ALLERGENIC	BELL PEPPER		CAPSICUM ANNUUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	GREEN BELL PEPPER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6198_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6198	NON-STANDARDIZED ALLERGENIC	BLACK PEPPER		PIPER NIGRUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BLACK PEPPER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6200_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6200	NON-STANDARDIZED ALLERGENIC	PINEAPPLE		ANANAS COMOSUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PINEAPPLE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6202_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6202	NON-STANDARDIZED ALLERGENIC	PISTACHIO NUT		PISTACIA VERA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PISTACHIO	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
0268-6203_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6203	NON-STANDARDIZED ALLERGENIC	PLUM		PRUNUS DOMESTICA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PLUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6204_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6204	NON-STANDARDIZED ALLERGENIC	PORK		SUS SCROFA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	PORK	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6205_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6205	NON-STANDARDIZED ALLERGENIC	SWEET POTATO		IPOMOEA BATATAS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	SWEET POTATO	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6206_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6206	NON-STANDARDIZED ALLERGENIC	WHITE POTATO		SOLANUM TUBEROSUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	POTATO	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6208_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6208	NON-STANDARDIZED ALLERGENIC	RICE		ORYZA SATIVA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	WHITE RICE	.1	g/mL			N	20241231
0268-6210_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6210	NON-STANDARDIZED ALLERGENIC	RYE GRAIN		SECALE CEREALE	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	RYE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6212_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6212	NON-STANDARDIZED ALLERGENIC	SALMON		SALMO SALAR	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ATLANTIC SALMON	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6213_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6213	NON-STANDARDIZED ALLERGENIC	SESAME SEED		SESAMUM INDICUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	SESAME SEED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
0268-6214_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6214	NON-STANDARDIZED ALLERGENIC	SHRIMP		CRANGON CRANGON	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	COMMON SHRIMP	.1	g/mL			N	20241231
0268-6216_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6216	NON-STANDARDIZED ALLERGENIC	SOYBEAN		GLYCINE MAX	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	SOYBEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6218_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6218	NON-STANDARDIZED ALLERGENIC	SPINACH		SPINACIA OLERACEA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	SPINACH	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6219_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6219	NON-STANDARDIZED ALLERGENIC	SQUASH		CURCUBITA PEPO	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ZUCCHINI	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6220_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6220	NON-STANDARDIZED ALLERGENIC	STRAWBERRY		FRAGARIA X ANANASSA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	STRAWBERRY	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6221_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6221	NON-STANDARDIZED ALLERGENIC	SWEET CORN		ZEA MAYS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CORN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6224_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6224	NON-STANDARDIZED ALLERGENIC	TOMATO		SOLANUM LYCOPERSICUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	TOMATO	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
0268-6226_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6226	NON-STANDARDIZED ALLERGENIC	TUNA		THUNNUS THYNNUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	NORTHERN BLUEFIN TUNA	.1	g/mL			N	20241231
0268-6229_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6229	NON-STANDARDIZED ALLERGENIC	TURKEY		MELEAGRIS GALLOPAVO	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	TURKEY	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
0268-6230_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6230	NON-STANDARDIZED ALLERGENIC	VANILLA		VANILLA PLANIFOLIA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	VANILLA BEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6231_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6231	NON-STANDARDIZED ALLERGENIC	ENGLISH WALNUT		JUGLANS REGIA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ENGLISH WALNUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
0268-6233_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6233	NON-STANDARDIZED ALLERGENIC	WATERMELON		CITRULLUS LANATUS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	WATERMELON	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6234_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6234	NON-STANDARDIZED ALLERGENIC	WHEAT GRAIN		TRITICUM AESTIVUM	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	WHEAT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6235_05a11518-84fe-4206-b305-3a249d4d35e8	0268-6235	NON-STANDARDIZED ALLERGENIC	THEA SINENSIS		THEA SINENSIS	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	TEA LEAF	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0268-6300_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6300	NON-STANDARDIZED ALLERGENIC	BOS TAURUS SKIN		Cattle Epithelium	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BOS TAURUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-6306_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6306	NON-STANDARDIZED ALLERGENIC	CANIS LUPUS FAMILIARIS SKIN		Dog Epithelium	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANIS LUPUS FAMILIARIS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-6309_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6309	NON-STANDARDIZED ALLERGENIC	CAVIA PORCELLUS SKIN		Guinea Pig Epithelium	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CAVIA PORCELLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-6311_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6311	NON-STANDARDIZED ALLERGENIC	EQUUS CABALLUS SKIN		Horse Epithelium	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EQUUS CABALLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-6314_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6314	NON-STANDARDIZED ALLERGENIC	MUS MUSCULUS SKIN		Mouse Epithelium	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MUS MUSCULUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
0268-6320_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6320	NON-STANDARDIZED ALLERGENIC	RABBIT		Rabbit Epithelium	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RABBIT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-6400_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6400	NON-STANDARDIZED ALLERGENIC	SOLENOPSIS INVICTA		Fire Ant	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SOLENOPSIS INVICTA	.01	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0268-6403_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6403	NON-STANDARDIZED ALLERGENIC	PERIPLANETA AMERICANA		American Cockroach	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PERIPLANETA AMERICANA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-6405_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6405	NON-STANDARDIZED ALLERGENIC	BLATELLA GERMANICA		German Cockroach	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BLATTELLA GERMANICA	.05	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-6600_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6600	NON-STANDARDIZED ALLERGENIC	ACACIA		Acacia	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACACIA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0268-6601_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6601	NON-STANDARDIZED ALLERGENIC	ALNUS INCANA SSP RUGOSA POLLEN		White Alder	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALNUS INCANA SUBSP. RUGOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6602_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6602	NON-STANDARDIZED ALLERGENIC	MEDICAGO SATIVA POLLEN		Alfalfa	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MEDICAGO SATIVA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6603_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6603	NON-STANDARDIZED ALLERGENIC	FRAXINUS AMERICANA POLLEN		White Ash	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FRAXINUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6605_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6605	NON-STANDARDIZED ALLERGENIC	PASPALUM NOTATUM POLLEN		Bahia Grass	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PASPALUM NOTATUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6606_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6606	NON-STANDARDIZED ALLERGENIC	MORELLA CERIFERA POLLEN		Bayberry Wax Myrtle	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORELLA CERIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6607_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6607	NON-STANDARDIZED ALLERGENIC	FAGUS GRANDIFOLIA POLLEN		Beech	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	FAGUS GRANDIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6608_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6608	NON-STANDARDIZED ALLERGENIC	BETULA LENTA POLLEN		Black Birch	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA LENTA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6609_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6609	NON-STANDARDIZED ALLERGENIC	BETULA NIGRA POLLEN		River Birch Red	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6610_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6610	NON-STANDARDIZED ALLERGENIC	BETULA LENTA POLLEN		White Birch	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA LENTA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6612_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6612	NON-STANDARDIZED ALLERGENIC	ACER NEGUNDO POLLEN		Box Elder Ash Leaf Maple	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6613_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6613	NON-STANDARDIZED ALLERGENIC	AMARANTHUS PALMERI POLLEN		Carelessweed	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS PALMERI POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6614_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6614	NON-STANDARDIZED ALLERGENIC	JUNIPERUS ASHEI POLLEN		Mountain Cedar	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS ASHEI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6615_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6615	NON-STANDARDIZED ALLERGENIC	JUNIPERUS VIRGINIANA POLLEN		Red Cedar	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6616_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6616	NON-STANDARDIZED ALLERGENIC	XANTHIUM STRUMARIUM VAR CANADENSE POLLEN		Cocklebur	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6618_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6618	NON-STANDARDIZED ALLERGENIC	POPULUS DELTOIDES POLLEN		Eastern Cottonwood Common	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS DELTOIDES POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6619_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6619	NON-STANDARDIZED ALLERGENIC	CUPRESSUS ARIZONICA POLLEN		Arizona Cypress	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CUPRESSUS ARIZONICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6620_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6620	NON-STANDARDIZED ALLERGENIC	TAXODIUM DISTICHUM POLLEN		Bald Cypress	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	TAXODIUM DISTICHUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6621_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6621	NON-STANDARDIZED ALLERGENIC	RUMEX ACETOSELLA POLLEN		Sour Dock Sheep Sorrel	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RUMEX ACETOSELLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6622_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6622	NON-STANDARDIZED ALLERGENIC	RUMEX CRISPUS POLLEN		Yellow Dock	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RUMEX CRISPUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6623_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6623	NON-STANDARDIZED ALLERGENIC	ULMUS AMERICANA POLLEN		American Elm	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6625_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6625	NON-STANDARDIZED ALLERGENIC	SOLIDAGO CANADENSIS POLLEN		Goldenrod	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SOLIDAGO CANADENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6626_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6626	NON-STANDARDIZED ALLERGENIC	CELTIS OCCIDENTALIS POLLEN		Hackberry	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CELTIS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6627_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6627	NON-STANDARDIZED ALLERGENIC	CARYA OVATA POLLEN		Shagbark Hickory	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA OVATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6629_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6629	NON-STANDARDIZED ALLERGENIC	SORGHUM HALEPENSE POLLEN		Johnson Grass	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SORGHUM HALEPENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6630_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6630	NON-STANDARDIZED ALLERGENIC	JUNIPERUS CALIFORNICA POLLEN		Western Juniper	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUNIPERUS CALIFORNICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6631_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6631	NON-STANDARDIZED ALLERGENIC	KOCHIA SCOPARIA POLLEN		Kochia Firebush	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BASSIA SCOPARIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6632_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6632	NON-STANDARDIZED ALLERGENIC	CHENOPODIUM ALBUM POLLEN		Lambs Quarters	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CHENOPODIUM ALBUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6634_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6634	NON-STANDARDIZED ALLERGENIC	ACER RUBRUM POLLEN		Red Maple	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER RUBRUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6635_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6635	NON-STANDARDIZED ALLERGENIC	ACER SACCHARUM POLLEN		Sugar Maple	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6636_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6636	NON-STANDARDIZED ALLERGENIC	IVA XANTHIFOLIA POLLEN		Burweed Marshelder	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CYCLACHAENA XANTHIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6637_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6637	NON-STANDARDIZED ALLERGENIC	IVA ANNUA VAR ANNUA POLLEN		Rough Marshelder	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	IVA ANNUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6638_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6638	NON-STANDARDIZED ALLERGENIC	PROSOPIS JULIFLORA POLLEN		Mesquite	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PROSOPIS JULIFLORA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6639_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6639	NON-STANDARDIZED ALLERGENIC	ARTEMISIA VULGARIS POLLEN		Common Mugwort	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ARTEMISIA VULGARIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6640_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6640	NON-STANDARDIZED ALLERGENIC	MORUS RUBRA POLLEN		Red Mulberry	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6641_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6641	NON-STANDARDIZED ALLERGENIC	MORUS ALBA POLLEN		White Mulberry	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MORUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6642_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6642	NON-STANDARDIZED ALLERGENIC	QUERCUS RUBRA POLLEN		Red Oak	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6643_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6643	NON-STANDARDIZED ALLERGENIC	QUERCUS VIRGINIANA POLLEN		Virginia Live Oak	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6644_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6644	NON-STANDARDIZED ALLERGENIC	QUERCUS ALBA POLLEN		White Oak	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6646_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6646	NON-STANDARDIZED ALLERGENIC	OLEA EUROPAEA POLLEN		Olive Pollen	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	OLEA EUROPAEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6647_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6647	NON-STANDARDIZED ALLERGENIC	SYAGRUS ROMANZOFFIANA POLLEN		Queen Palm Coco Palm	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6648_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6648	NON-STANDARDIZED ALLERGENIC	CARYA ILLINOINENSIS POLLEN		Pecan Pollen	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA ILLINOINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6649_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6649	NON-STANDARDIZED ALLERGENIC	AMARANTHUS RETROFLEXUS POLLEN		Rough Pigweed	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6651_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6651	NON-STANDARDIZED ALLERGENIC	PINUS STROBUS POLLEN		White Pine	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PINUS STROBUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6652_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6652	NON-STANDARDIZED ALLERGENIC	PLANTAGO LANCEOLATA POLLEN		English Plantain	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PLANTAGO LANCEOLATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6654_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6654	NON-STANDARDIZED ALLERGENIC	POPULUS ALBA POLLEN		White Poplar	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6656_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6656	NON-STANDARDIZED ALLERGENIC	LIGUSTRUM VULGARE POLLEN		Privet	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	LIGUSTRUM VULGARE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6658_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6658	NON-STANDARDIZED ALLERGENIC	AMBROSIA TRIFIDA POLLEN		Tall Ragweed Giant	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA TRIFIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6659_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6659	NON-STANDARDIZED ALLERGENIC	SALSOLA KALI POLLEN		Russian Thistle	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SALSOLA KALI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6670_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6670	NON-STANDARDIZED ALLERGENIC	ARTEMISIA TRIDENTATA POLLEN		Common Sagebrush	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ARTEMISIA TRIDENTATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6671_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6671	NON-STANDARDIZED ALLERGENIC	LIQUIDAMBAR STYRACIFLUA POLLEN		Sweetgum	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6672_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6672	NON-STANDARDIZED ALLERGENIC	PLATANUS OCCIDENTALIS POLLEN		American Sycamore	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PLATANUS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6674_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6674	NON-STANDARDIZED ALLERGENIC	JUGLANS NIGRA POLLEN		Black Pollen Walnut	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	JUGLANS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6691_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6691	NON-STANDARDIZED ALLERGENIC	BROMUS INERMIS POLLEN		Brome Grass	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BROMUS INERMIS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-6697_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6697	NON-STANDARDIZED ALLERGENIC	ZEA MAYS POLLEN		Corn Pollen	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ZEA MAYS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6701_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6701	NON-STANDARDIZED ALLERGENIC	POPULUS DELTOIDES SSP MONILIFERA POLLEN		Western Cottonwood	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6706_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6706	NON-STANDARDIZED ALLERGENIC	EUPATORIUM CAPILLIFOLIUM POLLEN		Dog Fennel	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EUPATORIUM CAPILLIFOLIUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6709_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6709	NON-STANDARDIZED ALLERGENIC	ULMUS CRASSIFOLIA POLLEN		Cedar Elm	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS CRASSIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6710_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6710	NON-STANDARDIZED ALLERGENIC	ULMUS PUMILA POLLEN		Chinese Elm	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ULMUS PUMILA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6712_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6712	NON-STANDARDIZED ALLERGENIC	EUCALYPTUS GLOBULUS POLLEN		Eucalyptus	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EUCALYPTUS GLOBULUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6728_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6728	NON-STANDARDIZED ALLERGENIC	MELALEUCA QUINQUENERVIA POLLEN		Melaleuca Pollen	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MELALEUCA QUINQUENERVIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6743_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6743	NON-STANDARDIZED ALLERGENIC	SCHINUS MOLLE POLLEN		California Pepper Tree	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SCHINUS MOLLE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6744_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6744	NON-STANDARDIZED ALLERGENIC	AMARANTHUS SPINOSUS POLLEN		Spiny Pigweed	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS SPINOSUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6748_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6748	NON-STANDARDIZED ALLERGENIC	PINUS ECHINATA POLLEN		Yellow Pine	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PINUS ECHINATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6749_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6749	NON-STANDARDIZED ALLERGENIC	AMBROSIA ACANTHICARPA POLLEN		False Ragweed Bur	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ACANTHICARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6752_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6752	NON-STANDARDIZED ALLERGENIC	AMBROSIA PSILOSTACHYA POLLEN		Western Ragweed	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA PSILOSTACHYA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-6771_22a0440f-2b25-45c4-997a-ea67c4ccea74	0268-6771	NON-STANDARDIZED ALLERGENIC	AMARANTHUS TUBERCULATUS POLLEN		Water Hemp	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS TUBERCULATUS POLLEN	.025	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-7000_7641d225-ff95-44d4-9279-296d84b96b05	0268-7000	STANDARDIZED ALLERGENIC	Standardized Mite D. farinae		Standardized Mite D. farinae	SOLUTION	PERCUTANEOUS	19910708		BLA	BLA103060	ALK-Abello, Inc.	DERMATOPHAGOIDES FARINAE	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-7001_7641d225-ff95-44d4-9279-296d84b96b05	0268-7001	STANDARDIZED ALLERGENIC	Standardized Mite D. pteronyssinus		Standardized Mite D. pteronyssinus	SOLUTION	PERCUTANEOUS	19900814		BLA	BLA103752	ALK-Abello, Inc.	DERMATOPHAGOIDES PTERONYSSINUS	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-7002_0d272bb1-4853-4bef-a694-5aef113225e6	0268-7002	STANDARDIZED ALLERGENIC	Standardized Mite, Mixed		Standardized Mite, Mixed	INJECTION, SOLUTION	SUBCUTANEOUS	19910708		BLA	BLA103060	ALK-Abello, Inc.	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	10000; 10000	[AU]/mL; [AU]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-7003_0d272bb1-4853-4bef-a694-5aef113225e6	0268-7003	STANDARDIZED ALLERGENIC	Standardized Mite, Mixed		Standardized Mite, Mixed	INJECTION, SOLUTION	SUBCUTANEOUS	19910708		BLA	BLA103060	ALK-Abello, Inc.	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	5000; 5000	[AU]/mL; [AU]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-7100_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-7100	NON-STANDARDIZED ALLERGENIC	DANDELION		TARAXACUM OFFICINALE POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	TARAXACUM OFFICINALE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-7100_4d458dd3-8f4a-4fbc-bdab-1be92ad1a7f4	0268-7100	NON-STANDARDIZED ALLERGENIC	DANDELION		TARAXACUM OFFICINALE POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	TARAXACUM OFFICINALE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-7110_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-7110	NON-STANDARDIZED ALLERGENIC	NETTLE		URTICA DIOICA POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	URTICA DIOICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-7110_4d458dd3-8f4a-4fbc-bdab-1be92ad1a7f4	0268-7110	NON-STANDARDIZED ALLERGENIC	NETTLE		URTICA DIOICA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	URTICA DIOICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-7120_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-7120	NON-STANDARDIZED ALLERGENIC	SHORT RAGWEED		AMBROSIA ARTEMISIIFOLIA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103059	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-7130_05a11518-84fe-4206-b305-3a249d4d35e8	0268-7130	NON-STANDARDIZED ALLERGENIC	HALIBUT		HIPPOGLOSSUS HIPPOGLOSSUS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ATLANTIC HALIBUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-8000_78f45cdb-937a-4516-b8b8-3e5095a98154	0268-8000	NON-STANDARDIZED ALLERGENIC	10 TREE MIX		ACER NEGUNDO POLLEN, BETULA NIGRA POLLEN, BLACK WALNUT, CARYA OVATA POLLEN, FRAXINUS AMERICANA POLLEN, PLATANUS OCCIDENTALIS POLLEN, POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN, QUERCUS RUBRA POLLEN, SALIX NIGRA POLLEN and ULMUS AMERICANA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN; BETULA NIGRA POLLEN; BLACK WALNUT; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.05; .05; .05; .05; .05; .05; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Nut Proteins [EXT], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8002_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8002	NON-STANDARDIZED ALLERGENIC	4 WEED MIX		AMARANTHUS RETROFLEXUS POLLEN, CHENOPODIUM ALBUM POLLEN, PLANTAGO LANCEOLATA POLLEN and XANTHIUM STRUMARIUM POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; XANTHIUM STRUMARIUM POLLEN	.05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8002_78f45cdb-937a-4516-b8b8-3e5095a98154	0268-8002	NON-STANDARDIZED ALLERGENIC	4 WEED MIX		AMARANTHUS RETROFLEXUS POLLEN, CHENOPODIUM ALBUM POLLEN, PLANTAGO LANCEOLATA POLLEN, XANTHIUM STRUMARIUM POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; XANTHIUM STRUMARIUM POLLEN	.05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8003_8762013a-24c8-4dae-a319-789065564b34	0268-8003	NON-STANDARDIZED ALLERGENIC	4 WEED MIX		AMARANTHUS RETROFLEXUS POLLEN, CHENOPODIUM ALBUM POLLEN, PLANTAGO LANCEOLATA POLLEN and XANTHIUM STRUMARIUM POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; XANTHIUM STRUMARIUM POLLEN	40000; 40000; 40000; 40000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8004_3fd70615-c7a0-4144-a725-117e4579b25e	0268-8004	NON-STANDARDIZED ALLERGENIC	4 WEED MIX		AMARANTHUS RETROFLEXUS POLLEN, CHENOPODIUM ALBUM POLLEN, PLANTAGO LANCEOLATA POLLEN, XANTHIUM STRUMARIUM POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; XANTHIUM STRUMARIUM POLLEN	10000; 10000; 10000; 10000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8008_3fd70615-c7a0-4144-a725-117e4579b25e	0268-8008	NON-STANDARDIZED ALLERGENIC	5 GRASS MIX		AGROSTIS GIGANTEA POLLEN, ANTHOXANTHUM ODORATUM, DACTYLIS GLOMERATA, PHLEUM PRATENSE, POA PRATENSIS	INJECTION, SOLUTION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM; DACTYLIS GLOMERATA; PHLEUM PRATENSE; POA PRATENSIS	10000; 10000; 10000; 10000; 10000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-8019_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8019	NON-STANDARDIZED ALLERGENIC	9 TREE MIX		ACER SACCHARUM POLLEN, ALNUS RHOMBIFOLIA POLLEN, BETULA LENTA POLLEN, CARYA OVATA POLLEN, FRAXINUS AMERICANA POLLEN, PLATANUS OCCIDENTALIS POLLEN, POPULUS ALBA POLLEN, QUERCUS ALBA POLLEN and ULMUS CRASSIFOLIA POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN; ALNUS RHOMBIFOLIA POLLEN; BETULA LENTA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; QUERCUS ALBA POLLEN; ULMUS CRASSIFOLIA POLLEN	.05; .05; .05; .05; .05; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8020_8762013a-24c8-4dae-a319-789065564b34	0268-8020	NON-STANDARDIZED ALLERGENIC	9 TREE MIX		ACER SACCHARINUM POLLEN, ALNUS RHOMBIFOLIA POLLEN, BETULA LENTA WHOLE, CARYA OVATA POLLEN, FRAXINUS AMERICANA POLLEN, PLATANUS OCCIDENTALIS POLLEN, POPULUS ALBA POLLEN, QUERCUS ALBA POLLEN, ULMUS AMERICANA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARINUM POLLEN; ALNUS RHOMBIFOLIA POLLEN; BETULA LENTA WHOLE; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; QUERCUS ALBA POLLEN; ULMUS AMERICANA POLLEN	40000; 40000; 40000; 40000; 40000; 40000; 40000; 40000; 40000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8021_8762013a-24c8-4dae-a319-789065564b34	0268-8021	NON-STANDARDIZED ALLERGENIC	9 TREE MIX		ACER SACCHARINUM POLLEN, ALNUS RHOMBIFOLIA POLLEN, BETULA LENTA WHOLE, CARYA OVATA POLLEN, FRAXINUS AMERICANA POLLEN, PLATANUS OCCIDENTALIS POLLEN, POPULUS ALBA POLLEN, QUERCUS ALBA POLLEN, ULMUS CRASSIFOLIA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARINUM POLLEN; ALNUS RHOMBIFOLIA POLLEN; BETULA LENTA WHOLE; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; QUERCUS ALBA POLLEN; ULMUS CRASSIFOLIA POLLEN	.1; .1; .1; .1; .1; .1; .1; .1; .1	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8022_91e6f082-b201-409a-9cab-95d4e0433468	0268-8022	NON-STANDARDIZED ALLERGENIC	9 TREE MIX		ACER SACCHARUM POLLEN, ALNUS RHOMBIFOLIA POLLEN, BETULA LENTA POLLEN, CARYA OVATA POLLEN, FRAXINUS AMERICANA POLLEN, PLATANUS OCCIDENTALIS POLLEN, POPULUS ALBA POLLEN, QUERCUS ALBA POLLEN and ULMUS CRASSIFOLIA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN; ALNUS RHOMBIFOLIA POLLEN; BETULA LENTA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; QUERCUS ALBA POLLEN; ULMUS CRASSIFOLIA POLLEN	.05; .05; .05; .05; .05; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8023_3fd70615-c7a0-4144-a725-117e4579b25e	0268-8023	NON-STANDARDIZED ALLERGENIC	9 TREE MIX		ACER SACCHARUM POLLEN, ALNUS RHOMBIFOLIA POLLEN, BETULA LENTA POLLEN, CARYA OVATA POLLEN, FRAXINUS AMERICANA POLLEN, PLATANUS OCCIDENTALIS POLLEN, POPULUS ALBA POLLEN, QUERCUS ALBA POLLEN, ULMUS AMERICANA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	ACER SACCHARUM POLLEN; ALNUS RHOMBIFOLIA POLLEN; BETULA LENTA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; QUERCUS ALBA POLLEN; ULMUS AMERICANA POLLEN	10000; 10000; 10000; 10000; 10000; 10000; 10000; 10000; 10000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8024_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8024	NON-STANDARDIZED ALLERGENIC	BIRCH MIX		BETULA NIGRA POLLEN and BETULA POPULIFOLIA POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8024_78f45cdb-937a-4516-b8b8-3e5095a98154	0268-8024	NON-STANDARDIZED ALLERGENIC	BIRCH MIX		BETULA NIGRA, BETULA POPULIFOLIA	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8026_f4170117-0559-46bb-a4fb-66138c6a9874	0268-8026	STANDARDIZED ALLERGENIC	GRASS MIX Number 4-S		AGROSTIS GIGANTEA POLLEN, DACTYLIS GLOMERATA POLLEN, PHLEUM PRATENSE POLLEN and POA PRATENSIS POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	25000; 25000; 25000; 25000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-8027_f4170117-0559-46bb-a4fb-66138c6a9874	0268-8027	STANDARDIZED ALLERGENIC	GRASS MIX Number 4-S		AGROSTIS GIGANTEA POLLEN, DACTYLIS GLOMERATA POLLEN, PHLEUM PRATENSE POLLEN and POA PRATENSIS POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	25000; 25000; 25000; 25000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-8028_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8028	NON-STANDARDIZED ALLERGENIC	HICKORY/ PECAN MIX		CARYA ILLINOINENSIS POLLEN and CARYA OVATA POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8029_8762013a-24c8-4dae-a319-789065564b34	0268-8029	NON-STANDARDIZED ALLERGENIC	HICKORY PECAN MIX		CARYA ILLINOINENSIS POLLEN, CARYA OVATA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8030_91e6f082-b201-409a-9cab-95d4e0433468	0268-8030	NON-STANDARDIZED ALLERGENIC	HICKORY PECAN MIX		CARYA ILLINOINENSIS POLLEN and CARYA OVATA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8031_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8031	NON-STANDARDIZED ALLERGENIC	MAPLE/BOX ELDER		ACER NEGUNDO POLLEN and ACER SACCHARUM POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8032_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8032	NON-STANDARDIZED ALLERGENIC	MAPLE MIX		ACER NEGUNDO POLLEN and ACER RUBRUM POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8033_91e6f082-b201-409a-9cab-95d4e0433468	0268-8033	NON-STANDARDIZED ALLERGENIC	MAPLE MIX		ACER NEGUNDO POLLEN and ACER RUBRUM POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
0268-8038_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8038	NON-STANDARDIZED ALLERGENIC	MIXED COCKROACH		BLATELLA GERMANICA and PERIPLANETA AMERICANA	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
0268-8040_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8040	NON-STANDARDIZED ALLERGENIC	MIXED FEATHERS		ANAS PLATYRHYNCHOS FEATHER, ANSER ANSER FEATHER and GALLUS GALLUS FEATHER	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
0268-8042_78f45cdb-937a-4516-b8b8-3e5095a98154	0268-8042	NON-STANDARDIZED ALLERGENIC	MIXED FEATHERS		GALLUS GALLUS FEATHER, ANAS PLATYRHYNCHOS FEATHER, ANSER ANSER FEATHER	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
0268-8043_05a11518-84fe-4206-b305-3a249d4d35e8	0268-8043	NON-STANDARDIZED ALLERGENIC	MIXED FISH		PARALICHTHYS DENTATUS, GADUS MORHUA, HIPPOGLOSSUS HIPPOGLOSSUS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ATLANTIC COD; ATLANTIC HALIBUT; SUMMER FLOUNDER	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-8044_05a11518-84fe-4206-b305-3a249d4d35e8	0268-8044	NON-STANDARDIZED ALLERGENIC	MIXED FISH		PARALICHTHYS DENTATUS, GADUS MORHUA, HIPPOGLOSSUS HIPPOGLOSSUS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ATLANTIC COD; ATLANTIC HALIBUT; SUMMER FLOUNDER	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
0268-8056_739911f7-038e-48f0-a424-9b2c786a6c68	0268-8056	NON-STANDARDIZED ALLERGENIC	MIXED RAGWEED		AMBROSIA ARTEMISIIFOLIA and AMBROSIA TRIFIDA POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-8057_3fd70615-c7a0-4144-a725-117e4579b25e	0268-8057	NON-STANDARDIZED ALLERGENIC	MIXED RAGWEED		AMBROSIA ARTEMISIIFOLIA, AMBROSIA TRIFIDA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-8058_3fd70615-c7a0-4144-a725-117e4579b25e	0268-8058	NON-STANDARDIZED ALLERGENIC	MIXED RAGWEED		AMBROSIA ARTEMISIIFOLIA, AMBROSIA TRIFIDA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19750115		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-8059_8762013a-24c8-4dae-a319-789065564b34	0268-8059	NON-STANDARDIZED ALLERGENIC	MIXED RAGWEED		AMBROSIA ARTEMISIIFOLIA, AMBROSIA TRIFIDA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN	40000; 40000	[PNU]/mL; [PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-8060_8762013a-24c8-4dae-a319-789065564b34	0268-8060	NON-STANDARDIZED ALLERGENIC	MIXED RAGWEED		AMBROSIA ARTEMISIIFOLIA, AMBROSIA TRIFIDA POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AMBROSIA ARTEMISIIFOLIA; AMBROSIA TRIFIDA POLLEN	.1; .1	g/mL; g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
0268-8061_05a11518-84fe-4206-b305-3a249d4d35e8	0268-8061	NON-STANDARDIZED ALLERGENIC	MIXED SHELLFISH		PARALITHODES CAMTSCHATICUS, CRANGON CRANGON, HOMARUS AMERICANUS, CRASSOSTREA VIRGINICA	INJECTION, SOLUTION	PERCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AMERICAN LOBSTER; COMMON SHRIMP; EASTERN OYSTER; RED KING CRAB	.1; .1; .1; .1	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
0268-8062_05a11518-84fe-4206-b305-3a249d4d35e8	0268-8062	NON-STANDARDIZED ALLERGENIC	MIXED SHELLFISH		PARALITHODES CAMTSCHATICUS, CRANGON CRANGON, HOMARUS AMERICANUS, CRASSOSTREA VIRGINICA	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AMERICAN LOBSTER; COMMON SHRIMP; EASTERN OYSTER; RED KING CRAB	.1; .1; .1; .1	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
0268-8063_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8063	NON-STANDARDIZED ALLERGENIC	MIXED WEEDS		CHENOPODIUM ALBUM POLLEN, IVA ANNUA POLLEN, PLANTAGO LANCEOLATA POLLEN and XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CHENOPODIUM ALBUM POLLEN; IVA ANNUA POLLEN; PLANTAGO LANCEOLATA POLLEN; XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN	.05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8063_91e6f082-b201-409a-9cab-95d4e0433468	0268-8063	NON-STANDARDIZED ALLERGENIC	MIXED WEEDS		CHENOPODIUM ALBUM POLLEN, IVA ANNUA POLLEN, LANCEOLATA POLLEN and XANTHIUM STRUMARIUM POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	CHENOPODIUM ALBUM POLLEN; IVA ANNUA POLLEN; PLANTAGO LANCEOLATA POLLEN; XANTHIUM STRUMARIUM POLLEN	.05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8070_0521d788-9ddb-4e34-a990-62ccf60a4402	0268-8070	NON-STANDARDIZED ALLERGENIC	OAK MIX		QUERCUS ALBA POLLEN, QUERCUS RUBRA POLLEN and QUERCUS VIRGINIANA POLLEN	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8070_91e6f082-b201-409a-9cab-95d4e0433468	0268-8070	NON-STANDARDIZED ALLERGENIC	OAK MIX		QUERCUS RUBRA, QUERCUS ALBA, QUERCUS VIRGINIANA	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8073_f4170117-0559-46bb-a4fb-66138c6a9874	0268-8073	STANDARDIZED ALLERGENIC	MIX OF 5 STANDARDIZED GRASS POLLEN		AGROSTIS GIGANTEA POLLEN, ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, PHLEUM PRATENSE POLLEN and POA PRATENSIS POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	20000; 20000; 20000; 20000; 20000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-8074_f4170117-0559-46bb-a4fb-66138c6a9874	0268-8074	STANDARDIZED ALLERGENIC	MIX OF 6 STANDARDIZED GRASS POLLEN		AGROSTIS GIGANTEA POLLEN, DACTYLIS GLOMERATA POLLEN, FESTUCA PRATENSIS, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN and POA PRATENSIS POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN; DACTYLIS GLOMERATA POLLEN; FESTUCA PRATENSIS POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	16667; 16667; 16667; 16667; 16667; 16667	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-8076_f4170117-0559-46bb-a4fb-66138c6a9874	0268-8076	STANDARDIZED ALLERGENIC	MIX OF 7 STANDARDIZED GRASS POLLEN		AGROSTIS GIGANTEA POLLEN, DACTYLIS GLOMERATA POLLEN, FESTUCA PRATENSIS, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, POA PRATENSIS POLLEN and ANTHOXANTHUM ODORATUM POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; FESTUCA PRATENSIS POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	14286; 14286; 14286; 14286; 14286; 14286; 14286	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-8077_f4170117-0559-46bb-a4fb-66138c6a9874	0268-8077	STANDARDIZED ALLERGENIC	MIDWEST MIX OF STANDARDIZED GRASS		AGROSTIS GIGANTEA POLLEN, DACTYLIS GLOMERATA POLLEN, PHLEUM PRATENSE POLLEN and POA PRATENSIS POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19971218		BLA	BLA103058	ALK-Abello, Inc.	AGROSTIS GIGANTEA POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	20000; 20000; 40000; 20000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
0268-8078_91e6f082-b201-409a-9cab-95d4e0433468	0268-8078	NON-STANDARDIZED ALLERGENIC	WEED MIX Number 7B		AMARANTHUS RETROFLEXUS POLLEN, ARTEMISIA VULGARIS ROOT, CHENOPODIUM ALBUM POLLEN, PLANTAGO LANCEOLATA POLLEN, RUMEX ACETOSELLA POLLEN, RUMEX CRISPUS POLLEN and STRUMARIUM POLLEN	INJECTION, SOLUTION	SUBCUTANEOUS	19980223		BLA	BLA103753	ALK-Abello, Inc.	AMARANTHUS RETROFLEXUS POLLEN; ARTEMISIA VULGARIS ROOT; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; XANTHIUM STRUMARIUM POLLEN	.05; .05; .05; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
0268-8080_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8080	NON-STANDARDIZED ALLERGENIC	SAROCLADIUM STRICTUM		SAROCLADIUM STRICTUM	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SAROCLADIUM STRICTUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8081_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8081	NON-STANDARDIZED ALLERGENIC	SAROCLADIUM STRICTUM		SAROCLADIUM STRICTUM	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SAROCLADIUM STRICTUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8081_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8081	NON-STANDARDIZED ALLERGENIC	SAROCLADIUM STRICTUM		SAROCLADIUM STRICTUM	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SAROCLADIUM STRICTUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8082_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8082	NON-STANDARDIZED ALLERGENIC	ALTERNARIA ALTERNATA		ALTERNARIA ALTERNATA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALTERNARIA ALTERNATA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8083_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8083	NON-STANDARDIZED ALLERGENIC	ALTERNARIA ALTERNATA		ALTERNARIA ALTERNATA	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALTERNARIA ALTERNATA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8083_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8083	NON-STANDARDIZED ALLERGENIC	ALTERNARIA ALTERNATA		ALTERNARIA ALTERNATA	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALTERNARIA ALTERNATA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8084_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8084	NON-STANDARDIZED ALLERGENIC	ASPERGILLUS FUMIGATUS		ASPERGILLUS FUMIGATUS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ASPERGILLUS FUMIGATUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8085_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8085	NON-STANDARDIZED ALLERGENIC	ASPERGILLUS FUMIGATUS		ASPERGILLUS FUMIGATUS	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ASPERGILLUS FUMIGATUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8085_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8085	NON-STANDARDIZED ALLERGENIC	ASPERGILLUS FUMIGATUS		ASPERGILLUS FUMIGATUS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ASPERGILLUS FUMIGATUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8086_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8086	NON-STANDARDIZED ALLERGENIC	AUREOBASIDIUM PULLULANS		AUREOBASIDIUM PULLULANS VAR. PULLUTANS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8087_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8087	NON-STANDARDIZED ALLERGENIC	AUREOBASIDIUM PULLULANS		AUREOBASIDIUM PULLULANS VAR. PULLUTANS	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8087_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8087	NON-STANDARDIZED ALLERGENIC	AUREOBASIDIUM PULLULANS		AUREOBASIDIUM PULLULANS VAR. PULLUTANS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8088_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8088	NON-STANDARDIZED ALLERGENIC	BIPOLARIS SOROKINIANA		COCHLIOBOLUS SATIVUS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	COCHLIOBOLUS SATIVUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8089_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8089	NON-STANDARDIZED ALLERGENIC	BIPOLARIS SOROKINIANA		COCHLIOBOLUS SATIVUS	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	COCHLIOBOLUS SATIVUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8089_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8089	NON-STANDARDIZED ALLERGENIC	BIPOLARIS SOROKINIANA		COCHLIOBOLUS SATIVUS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	COCHLIOBOLUS SATIVUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8090_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8090	NON-STANDARDIZED ALLERGENIC	BOTRYTIS CINEREA		BOTRYTIS CINEREA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BOTRYTIS CINEREA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8091_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8091	NON-STANDARDIZED ALLERGENIC	BOTRYTIS CINEREA		BOTRYTIS CINEREA	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BOTRYTIS CINEREA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8091_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8091	NON-STANDARDIZED ALLERGENIC	BOTRYTIS CINEREA		BOTRYTIS CINEREA	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	BOTRYTIS CINEREA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8092_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8092	NON-STANDARDIZED ALLERGENIC	CANDIDA ALBICANS		CANDIDA ALBICANS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANDIDA ALBICANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8093_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8093	NON-STANDARDIZED ALLERGENIC	CANDIDA ALBICANS		CANDIDA ALBICANS	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANDIDA ALBICANS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8093_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8093	NON-STANDARDIZED ALLERGENIC	CANDIDA ALBICANS		CANDIDA ALBICANS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CANDIDA ALBICANS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8094_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8094	NON-STANDARDIZED ALLERGENIC	CLADOSPORIUM CLADOSPORIOIDES		CLADOSPORIUM CLADOSPORIOIDES	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CLADOSPORIUM CLADOSPORIOIDES	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8095_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8095	NON-STANDARDIZED ALLERGENIC	CLADOSPORIUM CLADOSPORIOIDES		CLADOSPORIUM CLADOSPORIOIDES	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CLADOSPORIUM CLADOSPORIOIDES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8095_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8095	NON-STANDARDIZED ALLERGENIC	CLADOSPORIUM CLADOSPORIOIDES		CLADOSPORIUM CLADOSPORIOIDES	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	CLADOSPORIUM CLADOSPORIOIDES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8096_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8096	NON-STANDARDIZED ALLERGENIC	EPICOCCUM NIGRUM		EPICOCCUM NIGRUM	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EPICOCCUM NIGRUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8097_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8097	NON-STANDARDIZED ALLERGENIC	EPICOCCUM NIGRUM		EPICOCCUM NIGRUM	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EPICOCCUM NIGRUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8097_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8097	NON-STANDARDIZED ALLERGENIC	EPICOCCUM NIGRUM		EPICOCCUM NIGRUM	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EPICOCCUM NIGRUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8098_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8098	NON-STANDARDIZED ALLERGENIC	GIBBERELLA PULICARIS		GIBBERELLA ZEAE	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	GIBBERELLA ZEAE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8099_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8099	NON-STANDARDIZED ALLERGENIC	GIBBERELLA PULICARIS		GIBBERELLA ZEAE	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	GIBBERELLA ZEAE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8099_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8099	NON-STANDARDIZED ALLERGENIC	GIBBERELLA PULICARIS		GIBBERELLA ZEAE	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	GIBBERELLA ZEAE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8100_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8100	NON-STANDARDIZED ALLERGENIC	MUCOR PLUMBEUS		MUCOR PLUMBEUS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MUCOR PLUMBEUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8101_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8101	NON-STANDARDIZED ALLERGENIC	MUCOR PLUMBEUS		MUCOR PLUMBEUS	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MUCOR PLUMBEUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8101_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8101	NON-STANDARDIZED ALLERGENIC	MUCOR PLUMBEUS		MUCOR PLUMBEUS	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	MUCOR PLUMBEUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8102_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8102	NON-STANDARDIZED ALLERGENIC	PENICILLIUM NOTATUM		PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8103_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8103	NON-STANDARDIZED ALLERGENIC	PENICILLIUM NOTATUM		PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8103_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8103	NON-STANDARDIZED ALLERGENIC	PENICILLIUM NOTATUM		PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8104_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8104	NON-STANDARDIZED ALLERGENIC	RHODOTORULA MUCILAGINOSA		RHODOTORULA MUCILAGINOSA	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RHODOTORULA MUCILAGINOSA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8105_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8105	NON-STANDARDIZED ALLERGENIC	RHODOTORULA MUCILAGINOSA		RHODOTORULA MUCILAGINOSA	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RHODOTORULA MUCILAGINOSA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8105_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8105	NON-STANDARDIZED ALLERGENIC	RHODOTORULA MUCILAGINOSA		RHODOTORULA MUCILAGINOSA	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	RHODOTORULA MUCILAGINOSA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8106_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8106	NON-STANDARDIZED ALLERGENIC	SACCHAROMYCES CEREVISIAE		SACCHAROMYCES CEREVISIAE	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SACCHAROMYCES CEREVISIAE	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8106_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8106	NON-STANDARDIZED ALLERGENIC	SACCHAROMYCES CEREVISIAE		SACCHAROMYCES CEREVISIAE	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	SACCHAROMYCES CEREVISIAE	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8107_85c04c83-76ad-4116-aeb7-bbb5a9ab23f3	0268-8107	NON-STANDARDIZED ALLERGENIC	TRICHOPHYTON MENTAGROPHYTES		TRICHOPHYTON MENTAGROPHYTES	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	TRICHOPHYTON MENTAGROPHYTES	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8108_8c93c301-de0c-466d-b914-7ec864c7c0a6	0268-8108	NON-STANDARDIZED ALLERGENIC	TRICHOPHYTON MENTAGROPHYTES		TRICHOPHYTON MENTAGROPHYTES	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	TRICHOPHYTON MENTAGROPHYTES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8108_a89220e1-1403-4b42-90d0-0bf3dc2192f7	0268-8108	NON-STANDARDIZED ALLERGENIC	TRICHOPHYTON MENTAGROPHYTES		TRICHOPHYTON MENTAGROPHYTES	INJECTION, SOLUTION	PERCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	TRICHOPHYTON MENTAGROPHYTES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8109_e013a85e-8896-42b7-b581-74695a9370b5	0268-8109	NON-STANDARDIZED ALLERGENIC	Mold Mix A		ALTERNARIA ALTERNATA, ASPERGILLUS FUMIGATUS, CLADOSPORIUM CLADOSPORIOIDES and PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; CLADOSPORIUM CLADOSPORIOIDES; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.1; .1; .1; .1	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8110_93fe3f8e-51cb-41f4-9b1c-f7c9733b24fb	0268-8110	NON-STANDARDIZED ALLERGENIC	Mold Mix A		ALTERNARIA ALTERNATA, ASPERGILLUS FUMIGATUS, CLADOSPORIUM CLADOSPORIOIDES and PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; CLADOSPORIUM CLADOSPORIOIDES; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8110_ace8770c-5ac7-49bc-8f95-22c8feda1624	0268-8110	NON-STANDARDIZED ALLERGENIC	Mold Mix A		ALTERNARIA ALTERNATA, ASPERGILLUS FUMIGATUS, CLADOSPORIUM CLADOSPORIOIDES and PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; CLADOSPORIUM CLADOSPORIOIDES; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8111_e013a85e-8896-42b7-b581-74695a9370b5	0268-8111	NON-STANDARDIZED ALLERGENIC	Mold Mix B		EPICOCCUM NIGRUM, GIBBERELLA ZEAE and MUCOR PLUMBEUS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EPICOCCUM NIGRUM; GIBBERELLA ZEAE; MUCOR PLUMBEUS	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8112_93fe3f8e-51cb-41f4-9b1c-f7c9733b24fb	0268-8112	NON-STANDARDIZED ALLERGENIC	Mold Mix B		EPICOCCUM NIGRUM, GIBBERELLA ZEAE and MUCOR PLUMBEUS	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EPICOCCUM NIGRUM; GIBBERELLA ZEAE; MUCOR PLUMBEUS	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8112_ace8770c-5ac7-49bc-8f95-22c8feda1624	0268-8112	NON-STANDARDIZED ALLERGENIC	Mold Mix B		EPICOCCUM NIGRUM, GIBBERELLA ZEAE and MUCOR PLUMBEUS	INJECTION, SOLUTION	SUBCUTANEOUS	19650101		BLA	BLA103753	ALK-Abello, Inc.	EPICOCCUM NIGRUM; GIBBERELLA ZEAE; MUCOR PLUMBEUS	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0268-8116_21755244-d667-402d-a88d-82537f735f23	0268-8116	STANDARDIZED ALLERGENIC	STANDARDIZED MITE, MIXED		DERMATOPHAGOIDES FARINAE and DERMATOPHAGOIDES PTERONYSSINUS	INJECTION, SOLUTION	PERCUTANEOUS	19910708		BLA	BLA103060	ALK-Abello, Inc.	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	5000; 5000	[AU]/mL; [AU]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
0270-0083_a6cc2855-ab95-6938-4785-73288a2f8b64	0270-0083	HUMAN PRESCRIPTION DRUG	Choletec		Mebrofenin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19870121		NDA	NDA018963	Bracco Diagnostics Inc	MEBROFENIN	45	mg/1			N	20241231
0270-0091_3971cc46-96d1-4051-97f1-92565880f1ac	0270-0091	HUMAN PRESCRIPTION DRUG	CardioGen-82		Rubidium Chloride RB-82	INJECTION, SOLUTION	INTRAVENOUS	19891230		NDA	NDA019414	Bracco Diagnostics Inc	RUBIDIUM CHLORIDE RB-82	150	mCi/1	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
0270-0149_e94f2e02-f897-48c4-f1f6-ad66d588819b	0270-0149	HUMAN PRESCRIPTION DRUG	Cystografin		diatrizoate meglumine	INJECTION, SOLUTION	INTRAVENOUS	19701103		NDA	NDA010040	BRACCO DIAGNOSTICS INC	DIATRIZOATE MEGLUMINE	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-0445_7c17ff73-033f-4c13-b31d-3f84a9f88768	0270-0445	HUMAN PRESCRIPTION DRUG	Gastrografin		diatrizoate meglumine and diatrizoate sodium	LIQUID	ORAL; RECTAL	19580226		NDA	NDA011245	Bracco Diagnostics Inc	DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM	660; 100	mg/mL; mg/mL	Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA]		N	20241231
0270-0556_0d2aa8b3-2d00-f50a-c4cc-92748288e6aa	0270-0556	HUMAN PRESCRIPTION DRUG	KINEVAC		sincalide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19760721		NDA	NDA017697	Bracco Diagnostics Inc.	SINCALIDE	5	ug/5mL	Cholecystokinin Analog [EPC], Cholecystokinin [CS]		N	20241231
0270-1111_09633ce5-0c24-479c-bc6d-4a7138abc1f2	0270-1111	HUMAN PRESCRIPTION DRUG	ProHance		gadoteridol	INJECTION, SOLUTION	INTRAVENOUS	19921116		NDA	NDA020131	BRACCO DIAGNOSTICS INC	GADOTERIDOL	279.3	mg/mL	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0270-1111_a4ad381d-2260-427d-925a-bb35c850e98c	0270-1111	HUMAN PRESCRIPTION DRUG	ProHance		gadoteridol	INJECTION, SOLUTION	INTRAVENOUS	20031009		NDA	NDA021489	Bracco Diagnostics Inc	GADOTERIDOL	279.3	mg/mL	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0270-1314_3fe8c249-a971-4527-a3e5-ddef4929b719	0270-1314	HUMAN PRESCRIPTION DRUG	ISOVUE	200	IOPAMIDOL	INJECTION, SOLUTION	INTRAVASCULAR	19851231		NDA	NDA018735	BRACCO DIAGNOSTICS INC	IOPAMIDOL	408	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1315_3fe8c249-a971-4527-a3e5-ddef4929b719	0270-1315	HUMAN PRESCRIPTION DRUG	ISOVUE	300	IOPAMIDOL	INJECTION, SOLUTION	INTRAVASCULAR	19851231		NDA	NDA018735	BRACCO DIAGNOSTICS INC	IOPAMIDOL	612	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1315_76846458-2ba4-4a3f-8be0-30aaa45be80d	0270-1315	HUMAN PRESCRIPTION DRUG	ISOVUE	300	IOPAMIDOL	INJECTION, SOLUTION	INTRAVENOUS	20140620		NDA	NDA020327	Bracco Diagnostics Inc	IOPAMIDOL	612	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1316_3fe8c249-a971-4527-a3e5-ddef4929b719	0270-1316	HUMAN PRESCRIPTION DRUG	ISOVUE	370	IOPAMIDOL	INJECTION, SOLUTION	INTRAVASCULAR	19851231		NDA	NDA018735	BRACCO DIAGNOSTICS INC	IOPAMIDOL	755	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1316_76846458-2ba4-4a3f-8be0-30aaa45be80d	0270-1316	HUMAN PRESCRIPTION DRUG	ISOVUE	370	IOPAMIDOL	INJECTION, SOLUTION	INTRAVENOUS	20140620		NDA	NDA020327	Bracco Diagnostics Inc	IOPAMIDOL	755	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1317_3fe8c249-a971-4527-a3e5-ddef4929b719	0270-1317	HUMAN PRESCRIPTION DRUG	ISOVUE	250	IOPAMIDOL	INJECTION, SOLUTION	INTRAVASCULAR	19851231		NDA	NDA018735	BRACCO DIAGNOSTICS INC	IOPAMIDOL	510	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1410_2ca3d703-43ee-8c20-fa77-109118c128e9	0270-1410	HUMAN PRESCRIPTION DRUG	Cystografin Dilute		diatrizoate meglumine	INJECTION, SOLUTION	INTRAVESICAL	19821109		NDA	NDA010040	BRACCO DIAGNOSTICS INC	DIATRIZOATE MEGLUMINE	180	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1411_5418c5cf-20c3-4f65-9c46-53b0d3a68df9	0270-1411	HUMAN PRESCRIPTION DRUG	ISOVUE-M		IOPAMIDOL	INJECTION, SOLUTION	INTRATHECAL	19851231		NDA	NDA018735	Bracco Diagnostics Inc	IOPAMIDOL	408	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-1412_5418c5cf-20c3-4f65-9c46-53b0d3a68df9	0270-1412	HUMAN PRESCRIPTION DRUG	ISOVUE-M		IOPAMIDOL	INJECTION, SOLUTION	INTRATHECAL	19851231		NDA	NDA018735	Bracco Diagnostics Inc	IOPAMIDOL	612	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0270-5164_98594439-f1f3-4063-96d4-14af2c82bc23	0270-5164	HUMAN PRESCRIPTION DRUG	MultiHance		gadobenate dimeglumine	INJECTION, SOLUTION	INTRAVENOUS	20041123		NDA	NDA021357	BRACCO DIAGNOSTICS INC	GADOBENATE DIMEGLUMINE	529	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
0270-5264_6a51bea3-c6b0-aace-271c-d44742de7341	0270-5264	HUMAN PRESCRIPTION DRUG	MultiHance		gadobenate dimeglumine	INJECTION, SOLUTION	INTRAVENOUS	20041123		NDA	NDA021358	BRACCO DIAGNOSTICS INC	GADOBENATE DIMEGLUMINE	529	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
0270-7015_26aa626c-965d-4587-9046-03e601ae57ba	0270-7015	HUMAN PRESCRIPTION DRUG	Vueway		Gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	BRACCO DIAGNOSTICS INC	GADOPICLENOL	485.1	mg/mL			N	20241231
0270-7020_26aa626c-965d-4587-9046-03e601ae57ba	0270-7020	HUMAN PRESCRIPTION DRUG	Vueway		Gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	BRACCO DIAGNOSTICS INC	GADOPICLENOL	485.1	mg/mL			N	20241231
0270-7025_26aa626c-965d-4587-9046-03e601ae57ba	0270-7025	HUMAN PRESCRIPTION DRUG	Vueway		Gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	BRACCO DIAGNOSTICS INC	GADOPICLENOL	485.1	mg/mL			N	20241231
0270-7030_26aa626c-965d-4587-9046-03e601ae57ba	0270-7030	HUMAN PRESCRIPTION DRUG	Vueway		Gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	BRACCO DIAGNOSTICS INC	GADOPICLENOL	485.1	mg/mL			N	20241231
0270-7035_26aa626c-965d-4587-9046-03e601ae57ba	0270-7035	HUMAN PRESCRIPTION DRUG	Vueway		Gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	BRACCO DIAGNOSTICS INC	GADOPICLENOL	485.1	mg/mL			N	20241231
0270-7097_9f55461e-0f28-fb88-578c-d5235a18466f	0270-7097	HUMAN PRESCRIPTION DRUG	Lumason		SULFUR HEXAFLUORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS; INTRAVESICAL	20210401		NDA	NDA203684	BRACCO DIAGNOSTICS INC	DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE	.19; .19; 60.7	mg/mg; mg/mg; mg/mg	Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA]		N	20241231
0270-7097_f2ac7c1e-74f0-9fb2-d158-5123798b89cc	0270-7097	HUMAN PRESCRIPTION DRUG	LumaSon		SULFUR HEXAFLUORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS; INTRAVESICAL	20210401		NDA	NDA203684	BRACCO DIAGNOSTICS INC	DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE	.19; .19; 60.7	mg/mg; mg/mg; mg/mg	Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA]		N	20241231
0270-7099_9f55461e-0f28-fb88-578c-d5235a18466f	0270-7099	HUMAN PRESCRIPTION DRUG	LumaSon		SULFUR HEXAFLUORIDE	KIT		20200115		NDA	NDA203684	BRACCO DIAGNOSTICS INC						N	20241231
0270-7099_f2ac7c1e-74f0-9fb2-d158-5123798b89cc	0270-7099	HUMAN PRESCRIPTION DRUG	LumaSon		SULFUR HEXAFLUORIDE	KIT		20150115		NDA	NDA203684	BRACCO DIAGNOSTICS INC						N	20241231
0270-7250_3d62233a-350b-48a4-9e2c-d20dfa0a30b3	0270-7250	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BRACCO DIAGNOSTICS INC	IOMEPROL	510	mg/mL			N	20241231
0270-7300_3d62233a-350b-48a4-9e2c-d20dfa0a30b3	0270-7300	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BRACCO DIAGNOSTICS INC	IOMEPROL	612	mg/mL			N	20241231
0270-7350_3d62233a-350b-48a4-9e2c-d20dfa0a30b3	0270-7350	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BRACCO DIAGNOSTICS INC	IOMEPROL	714	mg/mL			N	20241231
0270-7400_3d62233a-350b-48a4-9e2c-d20dfa0a30b3	0270-7400	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BRACCO DIAGNOSTICS INC	IOMEPROL	816	mg/mL			N	20241231
0270-9300_3d62233a-350b-48a4-9e2c-d20dfa0a30b3	0270-9300	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BRACCO DIAGNOSTICS INC	IOMEPROL	612	mg/mL			N	20241231
0270-9350_3d62233a-350b-48a4-9e2c-d20dfa0a30b3	0270-9350	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BRACCO DIAGNOSTICS INC	IOMEPROL	714	mg/mL			N	20241231
0270-9400_3d62233a-350b-48a4-9e2c-d20dfa0a30b3	0270-9400	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BRACCO DIAGNOSTICS INC	IOMEPROL	816	mg/mL			N	20241231
0273-0104_f1621e06-f87b-2afa-e053-2a95a90a90e4	0273-0104	HUMAN OTC DRUG	Ammonia Inhalants		Ammonia Inhalants	INHALANT	RESPIRATORY (INHALATION)	20180109		UNAPPROVED DRUG OTHER		YOUNG DENTAL MANUFACTURING CO 1, LLC	AMMONIA	.045	g/.3mL			N	20241231
0273-0241_f16222d2-3664-bd47-e053-2995a90abfed	0273-0241	HUMAN PRESCRIPTION DRUG	Oral B NeutraCare	Mint Menthe	Sodium Fluoride	SOLUTION	ORAL	20141123		UNAPPROVED DRUG OTHER		YOUNG DENTAL MANUFACTURING CO 1, LLC	SODIUM FLUORIDE	.5	mg/g			N	20241231
0273-0341_f1621bba-8cfa-26d6-e053-2a95a90ac1db	0273-0341	HUMAN PRESCRIPTION DRUG	Oral B Minute-Foam	Mellow Mint	Sodium Fluoride	SOLUTION	ORAL	20141123		UNAPPROVED DRUG OTHER		YOUNG DENTAL MANUFACTURING CO 1, LLC	SODIUM FLUORIDE	12.3	mg/g			N	20241231
0273-0342_f1621bba-8cfa-26d6-e053-2a95a90ac1db	0273-0342	HUMAN PRESCRIPTION DRUG	Oral B Minute-Foam	Orange-A-Tangy	Sodium Fluoride	SOLUTION	ORAL	20141123		UNAPPROVED DRUG OTHER		YOUNG DENTAL MANUFACTURING CO 1, LLC	SODIUM FLUORIDE	12.3	mg/g			N	20241231
0273-0345_f1621bba-8cfa-26d6-e053-2a95a90ac1db	0273-0345	HUMAN PRESCRIPTION DRUG	Oral B Minute-Foam	Bubble Gum	Sodium Fluoride	SOLUTION	ORAL	20141123		UNAPPROVED DRUG OTHER		YOUNG DENTAL MANUFACTURING CO 1, LLC	SODIUM FLUORIDE	12.3	mg/g			N	20241231
0273-0346_f1621bba-8cfa-26d6-e053-2a95a90ac1db	0273-0346	HUMAN PRESCRIPTION DRUG	Oral B Minute-Foam	Strawberry	Sodium Fluoride	SOLUTION	ORAL	20141123		UNAPPROVED DRUG OTHER		YOUNG DENTAL MANUFACTURING CO 1, LLC	SODIUM FLUORIDE	12.3	mg/g			N	20241231
0273-0348_f2271d36-b4a8-6b91-e053-2a95a90a9322	0273-0348	HUMAN PRESCRIPTION DRUG	Oral B Neutra Foam	Mint Menthe	Sodium Fluoride	SOLUTION	ORAL	20151008		UNAPPROVED DRUG OTHER		YOUNG DENTAL MANUFACTURING CO 1, LLC	SODIUM FLUORIDE	.5	mg/g			N	20241231
0273-0357_f1623deb-4a71-3e68-e053-2a95a90aec16	0273-0357	HUMAN PRESCRIPTION DRUG	ZOOBY	Spearmint Safari	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20100801		UNAPPROVED DRUG OTHER		Young Dental Manufacturing Co 1, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
0273-0358_f1623b8f-f95b-25b6-e053-2995a90a824e	0273-0358	HUMAN PRESCRIPTION DRUG	ZOOBY	Growlin Grrrape	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20100801		UNAPPROVED DRUG OTHER		Young Dental Manufacturing Co 1, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
0273-0370_f1623b8f-f964-25b6-e053-2995a90a824e	0273-0370	HUMAN PRESCRIPTION DRUG	ZOOBY	Gator Gum	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20100801		UNAPPROVED DRUG OTHER		Young Dental Manufacturing Co 1, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
0273-0393_f1623deb-4a7b-3e68-e053-2a95a90aec16	0273-0393	HUMAN PRESCRIPTION DRUG	ZOOBY	Happy Hippo Cake	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20100801		UNAPPROVED DRUG OTHER		Young Dental Manufacturing Co 1, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
0273-0394_f1623deb-4a84-3e68-e053-2a95a90aec16	0273-0394	HUMAN PRESCRIPTION DRUG	ZOOBY	Turtle Melon	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20100801		UNAPPROVED DRUG OTHER		Young Dental Manufacturing Co 1, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
0276-0508_d0276e7b-a1ca-61f3-e053-2a95a90ae3aa	0276-0508	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20211101		ANDA	ANDA207466	Misemer Pharmaceuticals, Inc.	METAXALONE	400	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
0276-0801_0d3842c0-149e-b681-e063-6394a90a52ed	0276-0801	HUMAN OTC DRUG	Glitch Advanced Relief Eye Drops		Polyethylene glycol 400, Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230821		OTC MONOGRAPH DRUG	M018	Misemer Pharmaceutical, Inc	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE	1; .05	g/100mL; g/100mL			N	20241231
0280-0001_0bb527d4-6ab9-a98b-e063-6394a90af3a0	0280-0001	HUMAN OTC DRUG	Alka-Seltzer Cool Action Heartburn Relief	Mint	Calcium Carbonate	GUM, CHEWING	ORAL	20200301		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0002_0bb54312-8ca7-15e8-e063-6294a90a2b31	0280-0002	HUMAN OTC DRUG	Alka-Seltzer Heartburn Relief	Peppermint	calcium carbonate	GUM, CHEWING	ORAL	20200302		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0020_030bc78e-6d7d-06cb-e063-6394a90afa70	0280-0020	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold PowerFast Fizz	Orange Zest	aspirin, chlorpheniramine maleate, phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20200701		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0021_0bb5cfdb-9b12-e451-e063-6394a90afefc	0280-0021	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold Powerfast Fizz Night		aspirin, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20200401		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ASPIRIN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE BITARTRATE	500; 10; 6.25; 7.8	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Antihistamine [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine Receptor Antagonists [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0022_f6412de0-6e3d-2179-e053-2995a90a35b4	0280-0022	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold and Flu PowerFast Fizz		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide	TABLET, EFFERVESCENT	ORAL	20200401		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0023_030bee36-f252-8fd4-e063-6294a90aef6c	0280-0023	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold and Cough PowerFast Fizz		aspirin, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20200401		OTC MONOGRAPH FINAL	part341	Bayer Healthcare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE BITARTRATE	325; 2; 10; 7.8	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0024_0c3debc9-8f1b-684a-e063-6394a90a5067	0280-0024	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold PowerFast Fizz Non Drowsy		asprin, dextromethorphan hydrobromide, phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20200401		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ASPIRIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE BITARTRATE	325; 10; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0025_0bb5a372-5e08-62e0-e063-6294a90ae8ef	0280-0025	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold PowerFast Fizz		aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate, doxylamine succinate	KIT	ORAL	20200401		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0030_0b61f92a-fb19-e13e-e063-6294a90a4924	0280-0030	HUMAN OTC DRUG	PHILLIPS ORIGINAL MILK OF MAGNESIA		PHILLIPS ORIGINAL MILK OF MAGNESIA	LIQUID	ORAL	20141216		OTC MONOGRAPH DRUG	M007	Bayer HealthCare LLC.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0280-0031_0b61f004-e108-c9e5-e063-6394a90aa6b3	0280-0031	HUMAN OTC DRUG	PHILLIPS FRESH MINT MILK OF MAGNESIA		PHILLIPS FRESH MINT MILK OF MAGNESIA	LIQUID	ORAL	20141216		OTC MONOGRAPH DRUG	M007	Bayer HealthCare LLC.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0280-0032_0b61f6a4-33dc-df0b-e063-6294a90ac9e2	0280-0032	HUMAN OTC DRUG	Phillips Milk Of Magnesia Wild Cherry		Phillips Milk Of Magnesia Wild Cherry	LIQUID	ORAL	20141217		OTC MONOGRAPH DRUG	M007	Bayer HealthCare LLC.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0280-0033_0b61f477-68a9-c739-e063-6394a90a4f22	0280-0033	HUMAN OTC DRUG	Phillips Milk of Magnesia Concentrated	Fresh Strawberry	Phillips Milk of Magnesia Concentrated Fresh Strawberry	LIQUID	ORAL	20141218		OTC MONOGRAPH DRUG	M007	Bayer HealthCare LLC.	MAGNESIUM HYDROXIDE	2400	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0280-0035_0bb5609f-8a11-c67e-e063-6394a90a1929	0280-0035	HUMAN OTC DRUG	Alka-Seltzer Plus Cough, Mucus and Congestion Day and Night Powermax		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT	ORAL	20200601		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0039_0b611f2d-bd72-258d-e063-6394a90af75b	0280-0039	HUMAN OTC DRUG	Aleve Arthritis Pain Gel		Diclofenac Sodium	GEL	TOPICAL	20210601		ANDA	ANDA211253	Bayer HealthCare LLC	DICLOFENAC SODIUM	1	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-0040_f5606ccd-c243-477b-e053-2a95a90a7521	0280-0040	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Day and Night Cold and Flu		dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride, doxylamine succinate	KIT	ORAL	20201026		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.						N	20241231
0280-0041_ea38d7f0-32a1-b31b-e053-2995a90a9a2a	0280-0041	HUMAN OTC DRUG	Aleve Headache Pain		Naproxen Sodium	TABLET	ORAL	20210601		NDA	NDA020204	Bayer HealthCare LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-0042_0bb521d3-b3bb-f576-e063-6294a90a3a18	0280-0042	HUMAN OTC DRUG	Alka-Seltzer Extra Strength Heartburn ReliefChews		Calcium carbonate	TABLET, CHEWABLE	ORAL	20160915		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0047_0bb521d3-b3bc-f576-e063-6294a90a3a18	0280-0047	HUMAN OTC DRUG	Alka-Seltzer Heartburn		Anhydrous citric acid, Sodium bicarbonate (heat-treated)	TABLET, EFFERVESCENT	ORAL	20100302		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE	1000; 1940	mg/1; mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0280-0049_0b612f59-f255-25e6-e063-6294a90ace77	0280-0049	HUMAN OTC DRUG	AleveX		camphor and menthol	SPRAY	TOPICAL	20210401		OTC MONOGRAPH DRUG	M017	Bayer HealthCare LLC	CAMPHOR (SYNTHETIC); MENTHOL	5.5; 16	mg/g; mg/g			N	20241231
0280-0050_0b612bb0-eb18-0068-e063-6294a90aa62a	0280-0050	HUMAN OTC DRUG	AleveX		camphor and menthol	LOTION	TOPICAL	20210401		OTC MONOGRAPH DRUG	M017	Bayer HealthCare LLC	CAMPHOR (SYNTHETIC); MENTHOL	5.5; 16	mg/g; mg/g			N	20241231
0280-0051_0bb5437c-f63d-10af-e063-6294a90ac0a8	0280-0051	HUMAN OTC DRUG	Alka-Seltzer Kids Tummy ReliefChews		calcium carbonate and dimethicone	TABLET, CHEWABLE	ORAL	20210301		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
0280-0055_030bc17f-be0d-798c-e063-6394a90af83b	0280-0055	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Sinus Congestion and Pain PowerFast Fizz		chlorpheniramine maleate, dextromethorphan hydrobromide, acetaminophen, phenylephrine hydrochloride	TABLET, EFFERVESCENT	ORAL	20210615		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0058_0bb521d3-b3b1-f576-e063-6294a90a3a18	0280-0058	HUMAN OTC DRUG	Alka-Seltzer Cool Action Extra Strength ReliefChews Mint		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190303		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0059_0bb5ea01-aecd-cffe-e063-6294a90aaaed	0280-0059	HUMAN OTC DRUG	Alka-Seltzer Ultra Strength Heartburn ReliefChews	Strawberry and Orange	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190303		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0060_030bdbcd-d372-5eeb-e063-6294a90ac765	0280-0060	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Sparkling Original PowerFast Fizz		aspirin, chlorpheniramine maleate, phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20210615		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0061_0bb57b3d-dbf4-c55d-e063-6394a90a064b	0280-0061	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Cough, Mucus and Congestion Powermax		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20200601		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0062_0bb583b7-5a7b-63ba-e063-6294a90a5cb4	0280-0062	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Cough, Mucus and Congestion Day and Night		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT	ORAL	20200601		OTC MONOGRAPH DRUG	M012	Bayer HealthCare, LLC.						N	20241231
0280-0063_0b613dc7-be90-33b8-e063-6394a90a2c4f	0280-0063	HUMAN OTC DRUG	AleveX		camphor and menthol	LOTION	TOPICAL	20210401		OTC MONOGRAPH DRUG	M017	Bayer HealthCare LLC	CAMPHOR (SYNTHETIC); MENTHOL	5.5; 16	mg/g; mg/g			N	20241231
0280-0064_0b615625-a207-36fd-e063-6394a90a17ff	0280-0064	HUMAN OTC DRUG	Bayer Headache		Aspirin and caffeine	TABLET	ORAL	20210428		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0280-0065_05e0474c-67eb-4d5a-e063-6394a90a22fc	0280-0065	HUMAN OTC DRUG	Astepro Allergy		Azelastine HCl	SPRAY, METERED	NASAL	20220627		NDA	NDA213872	Bayer HealthCare LLC.	AZELASTINE HYDROCHLORIDE	205.5	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0280-0066_0b618633-7379-6799-e063-6294a90a04f1	0280-0066	HUMAN OTC DRUG	Children Astepro Allergy		Azelastine HCl	SPRAY, METERED	NASAL	20220627		NDA	NDA213872	Bayer HealthCare LLC.	AZELASTINE HYDROCHLORIDE	205.5	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0280-0068_0bb5b6b0-7f99-d7a0-e063-6394a90aeafb	0280-0068	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold Night PowerFast Fizz		aspirin, doxylamine succinate, dextromethorphan hydrobromide, phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20210712		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ASPIRIN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE BITARTRATE	325; 10; 6.25; 7.8	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Antihistamine [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine Receptor Antagonists [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0069_0bb5c4a2-ea8c-a59e-e063-6294a90a449c	0280-0069	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night		aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate	KIT	ORAL	20210805		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0070_c1ad6073-63f7-669f-e053-2995a90aacee	0280-0070	HUMAN OTC DRUG	Midol Bloat Relief		pamabrom	TABLET	ORAL	20210428		OTC MONOGRAPH FINAL	M027	Bayer HealthCare LLC.	PAMABROM	50	mg/1			N	20241231
0280-0079_fc5ed909-37ad-3a60-e053-6394a90a9e17	0280-0079	HUMAN OTC DRUG	Alka-Seltzer Heartburn Relief Extra Strength		Anhydrous citric acid, Sodium bicarbonate (heat-treated)	TABLET, EFFERVESCENT	ORAL	20210921		OTC MONOGRAPH FINAL	part331	Bayer Healthcare LLC	CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE	1000; 1976	mg/1; mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0280-0083_df38e786-bb22-75d6-e053-2a95a90a86c0	0280-0083	HUMAN OTC DRUG	Alka-Seltzer Heartburn Relief Lemon Lime		Anhydrous citric acid, Sodium bicarbonate (heat-treated)	TABLET, EFFERVESCENT	ORAL	20220216		OTC MONOGRAPH DRUG	M001	Bayer Healthcare LLC	CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE	1000; 1650	mg/1; mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0280-0084_fbfaf8f3-ed73-bb51-e053-6294a90aab40	0280-0084	HUMAN OTC DRUG	Alka-Seltzer Hangover Relief		ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20220221		OTC MONOGRAPH FINAL	M013	Bayer HealthCare LLC.	ASPIRIN; CAFFEINE	500; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0280-0086_0bb5d52f-42cb-950d-e063-6294a90a2a64	0280-0086	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night		aspirin, dextromethorphan hydrobromide, phenylephrine bitartrate	KIT	ORAL	20220427		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0087_fa3e7823-58c2-ddc5-e053-6294a90a12c8	0280-0087	HUMAN OTC DRUG	Alka-Seltzer Original Flavor		Alka-Seltzer Original Flavor	TABLET, EFFERVESCENT	ORAL	20220303		OTC MONOGRAPH NOT FINAL	part343	Bayer HealthCare LLC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-0088_f654c140-89f0-f157-e053-2a95a90a2149	0280-0088	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold and Flu PowerFast Fizz		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide	TABLET, EFFERVESCENT	ORAL	20220405		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0089_030c071d-bfb4-0b7d-e063-6294a90ac908	0280-0089	HUMAN OTC DRUG	Alka Seltzer Plus Maximum Strength Cough Chest Congestion PowerFast Fizz		dextromethorphan hydrobromide, guaifenesin	TABLET, EFFERVESCENT	ORAL	20220405		OTC MONOGRAPH FINAL	part341	Bayer Healthcare LLC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0280-0092_0bb5609f-8a12-c67e-e063-6394a90a1929	0280-0092	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Cold and Cough Power Max Gels		Acetaminophen, Chlorpheniramine malaeate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20190701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0095_0c3debc9-8f1c-684a-e063-6394a90a5067	0280-0095	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Sinus, Congestion and Pain Power Max Gels		Acetaminophen, Dextromethorphan hydrobromide , Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210801		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0097_0c3de498-4e7d-6a1f-e063-6294a90a8c00	0280-0097	HUMAN OTC DRUG	Alka Seltzer Plus Maximum Strength Sinus, Allergy And Cough Power Max Gels		Acetaminophen, Dextromethorphan hydrobromide , Doxylamine Succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210525		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0098_0bb5609f-8a09-c67e-e063-6394a90a1929	0280-0098	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Day and Night PowerMax gels		Acetaminophen, Dextromethorphan hydrobromide, Phenylephrine bitartrate, Doxylamine succinate	KIT	ORAL	20180701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0099_0c3d891d-0f75-4fb8-e063-6294a90aad3a	0280-0099	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Day and Night PowerMax gels		Acetaminophen, Dextromethorphan hydrobromide, Phenylephrine bitartrate, Doxylamine succinate	KIT	ORAL	20180701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0103_f1ecbdc8-2bc6-79e7-e053-2995a90aab38	0280-0103	HUMAN OTC DRUG	Bayer Rapid Relief		Aspirin/Caffeine Oral Powder	POWDER	ORAL	20230113		OTC MONOGRAPH NOT FINAL	part343	Bayer HealthCare LLC.	ASPIRIN; CAFFEINE	650; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0280-0105_121ecb6f-4dd2-4856-a736-c5f1c8fc70c9	0280-0105	HUMAN OTC DRUG	Aleve liquid gels		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20231201		ANDA	ANDA214463	Bayer Healthcare LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-0109_0bb5d729-5108-e387-e063-6394a90a1fce	0280-0109	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night		aspirin, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine bitartrate	KIT	ORAL	20210805		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0110_0bb5d729-5108-e387-e063-6394a90a1fce	0280-0110	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold PowerFast Fizz Day and Night		aspirin, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine bitartrate	KIT		20210805		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0121_030c066e-c3cb-9c00-e063-6294a90a3d10	0280-0121	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold Night PowerFast Fizz		aspirin, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20230524		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE BITARTRATE	325; 2; 10; 7.8	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0211_0bb521d3-b3b5-f576-e063-6294a90a3a18	0280-0211	HUMAN OTC DRUG	Alka-Seltzer Extra Strength		Anhydrous Citric Acid, Sodium Bicarbonate, and Aspirin	GRANULE, EFFERVESCENT	ORAL	20110411		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 500; 1985	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-0221_02f8f5fa-ed93-c5be-e063-6294a90a5484	0280-0221	HUMAN OTC DRUG	Alka-Seltzer Heartburn ReliefChews		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20140315		OTC MONOGRAPH FINAL	part331	Bayer HealthCare LLC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0224_0bb527d4-6abd-a98b-e063-6394a90af3a0	0280-0224	HUMAN OTC DRUG	Alka-Seltzer Heartburn ReliefChews Strawberry and Orange		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20140315		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0225_0bb54312-8ca6-15e8-e063-6294a90a2b31	0280-0225	HUMAN OTC DRUG	Alka-Seltzer Heartburn Plus Gas ReliefChews Tropical Punch		CALCIUM CARBONATE AND SIMETHICONE	TABLET, CHEWABLE	ORAL	20140315		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
0280-0245_0bb5e7ce-127c-ab8a-e063-6294a90ac543	0280-0245	HUMAN OTC DRUG	Alka-Seltzer Ultra Strength Heartburn ReliefChews		Calcium carbonate	TABLET, CHEWABLE	ORAL	20170301		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0280-0505_0bb5d5e9-78d9-b1c2-e063-6294a90ad593	0280-0505	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cough Mucus and Congestion	Liquid Gels	Alka-Seltzer Plus Severe Cough Mucus and Congestion	CAPSULE, LIQUID FILLED	ORAL	20150107		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	250; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0506_0bb5d52f-42cc-950d-e063-6294a90a2a64	0280-0506	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cough Mucus and Congestion Day and Night		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride, Guaifenesin	KIT	ORAL	20170530		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-0507_0bb5eac8-e01e-e3bc-e063-6394a90aab19	0280-0507	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Sinus Cold and Cough	Liquid Gels	Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20150128		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	250; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-0921_0e885b70-a708-5d10-e063-6294a90a1a99	0280-0921	HUMAN OTC DRUG	Alka-Seltzer Plus Day Severe Cold Plus Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	POWDER, FOR SOLUTION	ORAL	20140417		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 400; 10	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
0280-0922_0e8855e7-13a2-59ca-e063-6294a90a9f4e	0280-0922	HUMAN OTC DRUG	Alka-Seltzer Plus Night Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, and PHENYLEPHRINE HYDROCHLORIDE	POWDER, FOR SOLUTION	ORAL	20140417		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
0280-0924_0e886b57-4fc8-12b2-e063-6294a90ac4b7	0280-0924	HUMAN OTC DRUG	Alka-Seltzer Plus Day and Night Severe Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride, and Doxylamine succinate	KIT		20140701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20251231
0280-1138_f1eb1cb9-848d-cdaf-e053-2995a90a9195	0280-1138	HUMAN OTC DRUG	Alka-Seltzer Plus Multi-Symptom Cold and Flu Day and Night	Liquid Gels	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT	ORAL	20160715		OTC MONOGRAPH FINAL	part343	Bayer HealthCare LLC.						N	20241231
0280-1200_ed85a3c4-5220-9051-e053-2a95a90a703b	0280-1200	HUMAN OTC DRUG	Aleve PM		DIPHENHYDRAMINE HYDROCHLORIDE and NAPROXEN SODIUM	TABLET, FILM COATED	ORAL	20140909		NDA	NDA205352	Bayer HealthCare LLC.	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-1400_0bb56517-7439-c1cc-e063-6394a90a9f69	0280-1400	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Medicine Sparkling Original		ASPIRIN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE BITARTRATE	TABLET, EFFERVESCENT	ORAL	20080410		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1510_0bb5689d-f18d-a296-e063-6394a90a3641	0280-1510	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Orange Zest		Aspirin, Chlorpheniramine Maleate, Phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20170715		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1520_0bb56bf3-5ab4-c36c-e063-6394a90a40ee	0280-1520	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Sparkling Original		Aspirin, Chlorpheniramine maleate, Phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20170703		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1545_0bb5689d-f18c-a296-e063-6394a90a3641	0280-1545	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Night		Aspirin, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20180914		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ASPIRIN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE BITARTRATE	500; 10; 6.25; 7.8	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Antihistamine [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine Receptor Antagonists [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1550_0bb5609f-8a07-c67e-e063-6394a90a1929	0280-1550	HUMAN OTC DRUG	Alka-Seltzer Plus Cold Day and Night		Aspirin, Dextromethorphan hydrobromide, Phenylephrine bitartrate, Doxylamine succinate	KIT	ORAL	20180914		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-1555_0bb527d4-6abe-a98b-e063-6394a90af3a0	0280-1555	HUMAN OTC DRUG	Alka-Seltzer Plus Cold and Cough		Aspirin, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20180914		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ASPIRIN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE BITARTRATE	325; 2; 10; 7.8	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1580_0bb582bb-acbf-5f58-e063-6294a90aa88d	0280-1580	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Day and Night Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	KIT	ORAL	20170522		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-1581_0bb59766-1bf4-d9e5-e063-6394a90a5c49	0280-1581	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Day and Night Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	KIT	ORAL	20170522		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-1590_0bb57b3d-dbf6-c55d-e063-6394a90a064b	0280-1590	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Day Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170619		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1600_0bb57b3d-dbf7-c55d-e063-6394a90a064b	0280-1600	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Night Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170619		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1610_0bb59575-7718-53ea-e063-6294a90a32e4	0280-1610	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Severe Sinus Congestion and Cough Day and Night		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	KIT	ORAL	20170612		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-1620_0bb5b6b0-7f94-d7a0-e063-6394a90aeafb	0280-1620	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Severe Sinus, Allergy and Cough		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170626		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1630_0bb5a372-5e05-62e0-e063-6294a90ae8ef	0280-1630	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Day Cold and Flu PowerMax Gels		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20180702		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1640_0bb59766-1bf6-d9e5-e063-6394a90a5c49	0280-1640	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Night Cold and Flu PowerMax Gels		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20180702		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0280-1650_0bb583b7-5a7d-63ba-e063-6294a90a5cb4	0280-1650	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Day and Night Cold and Flu PowerMax Gels		Acetaminophen, Dextromethorphan hydrobromide, Phenylephrine hydrochloride, Doxylamine succinate	KIT		20180702		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-1680_0bb56baf-de30-ca2a-e063-6394a90a98a9	0280-1680	HUMAN OTC DRUG	Alka-Seltzer Plus Maximum Strength Day and Night Cold and Flu PowerMax Gels		acetaminophen, dextrmethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20180702		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
0280-2000_ff1d9abc-592c-a14f-e053-6294a90a6fc0	0280-2000	HUMAN OTC DRUG	Bayer Genuine Aspirin		Aspirin	TABLET	ORAL	20140731		OTC MONOGRAPH NOT FINAL	part343	Bayer HealthCare LLC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-2020_0b618633-736e-6799-e063-6294a90a04f1	0280-2020	HUMAN OTC DRUG	BAYER Aspirin	Extra Strength Caplets	BAYER Aspirin Extra Strength	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ASPIRIN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-2080_0b613910-a566-cf56-e063-6294a90ab8af	0280-2080	HUMAN OTC DRUG	Bayer Aspirin Regimen Chewable	Low Dose Aspirin Orange	Aspirin	TABLET, CHEWABLE	ORAL	20150111		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-2090_0b613910-a569-cf56-e063-6294a90ab8af	0280-2090	HUMAN OTC DRUG	Bayer Chewable - Aspirin Regimen	Low Dose Aspirin Cherry Flavored	Aspirin	TABLET, CHEWABLE	ORAL	20020702		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-2100_0b616fce-d3b1-6c3e-e063-6394a90a61fa	0280-2100	HUMAN OTC DRUG	Bayer	Low Dose	Aspirin	TABLET	ORAL	20020712		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-2110_0b618633-736f-6799-e063-6294a90a04f1	0280-2110	HUMAN OTC DRUG	Bayer Aspirin Regimen	enteric coated	Aspirin	TABLET, COATED	ORAL	20150111		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-2150_ff31f892-68cf-3dc2-e053-6394a90ae9f0	0280-2150	HUMAN OTC DRUG	Bayer Back and Body	Extra Strength	Aspirin,Caffeine	TABLET	ORAL	20150112		OTC MONOGRAPH NOT FINAL	part343	Bayer HealthCare LLC.	ASPIRIN; CAFFEINE	500; 35.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0280-4000_0bb55660-27bb-c2ea-e063-6394a90a3a0e	0280-4000	HUMAN OTC DRUG	Alka-Seltzer Original		ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20100302		OTC MONOGRAPH DRUG	M013	Bayer HealthCare LLC.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0280-4100_0bb5329c-888f-9e66-e063-6394a90a3b9e	0280-4100	HUMAN OTC DRUG	Alka-Seltzer Gold		Alka-Seltzer Gold	TABLET, EFFERVESCENT	ORAL	20141119		OTC MONOGRAPH DRUG	M001	Bayer HealthCare LLC.	CITRIC ACID MONOHYDRATE; POTASSIUM BICARBONATE; SODIUM BICARBONATE	1000; 344; 1050	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0280-6000_ec568c97-25b1-5880-e053-2a95a90ab344	0280-6000	HUMAN OTC DRUG	Aleve	Caplets	NAPROXEN SODIUM	TABLET	ORAL	20140226		NDA	NDA020204	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6010_033526a5-1d79-3e78-e063-6394a90a2160	0280-6010	HUMAN OTC DRUG	Aleve		NAPROXEN SODIUM	TABLET	ORAL	20020726		NDA	NDA020204	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6020_0b612bb0-eb15-0068-e063-6294a90aa62a	0280-6020	HUMAN OTC DRUG	Aleve	Gelcaps	NAPROXEN SODIUM	TABLET, COATED	ORAL	20020801		NDA	NDA020204	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6045_0b612bb0-eb17-0068-e063-6294a90aa62a	0280-6045	HUMAN OTC DRUG	Aleve-D Sinus and Headache		naproxen sodium, pseudoephedrine hydrochloride	TABLET	ORAL	20140101		ANDA	ANDA076518	Bayer HealthCare LLC.	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0280-6050_ebcacd2a-5512-3763-e053-2995a90a328f	0280-6050	HUMAN OTC DRUG	Aleve	Caplets - Easy Open Arthritis Cap	NAPROXEN SODIUM	TABLET	ORAL	20131111		NDA	NDA020204	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6060_ebcaf0ca-b283-5de8-e053-2a95a90ae5fc	0280-6060	HUMAN OTC DRUG	Aleve	Easy Open Arthritis Cap	NAPROXEN SODIUM	TABLET	ORAL	20020726		NDA	NDA020204	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6070_0b6104ec-47d3-2b6c-e063-6394a90aa523	0280-6070	HUMAN OTC DRUG	Aleve	Gelcaps	NAPROXEN SODIUM	TABLET, COATED	ORAL	20020801		NDA	NDA020204	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6080_0b6134d3-00e5-3184-e063-6394a90a1ad1	0280-6080	HUMAN OTC DRUG	Aleve		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20070220		NDA	NDA021920	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6090_0b611f2d-bd73-258d-e063-6394a90af75b	0280-6090	HUMAN OTC DRUG	Aleve-D Sinus and Cold		naproxen sodium, pseudeoephedrine hydrochloride	TABLET	ORAL	20140101		ANDA	ANDA076518	Bayer HealthCare LLC.	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0280-6091_0b6134d3-00e6-3184-e063-6394a90a1ad1	0280-6091	HUMAN OTC DRUG	Aleve	Easy Open Arthritis Cap	Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20070228		NDA	NDA021920	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-6092_e9325493-7c3f-e9f2-e053-2995a90a89b6	0280-6092	HUMAN OTC DRUG	Aleve Back and Muscle Pain		Naproxen Sodium	TABLET	ORAL	20180126		NDA	NDA020204	Bayer HealthCare LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0280-8005_fa3ff071-7cb7-a1ee-e053-6394a90aff94	0280-8005	HUMAN OTC DRUG	Midol Complete		ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE	TABLET	ORAL	20140210		OTC MONOGRAPH NOT FINAL	part343	Bayer HealthCare LLC.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0280-8015_0b61ed6d-b860-c5fc-e063-6394a90ab2a6	0280-8015	HUMAN OTC DRUG	Midol Complete	Gelcaps	Midol Complete	TABLET, COATED	ORAL	20141215		OTC MONOGRAPH DRUG	M027	Bayer HealthCare LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0280-8090_0b61f06f-ec5a-c6db-e063-6394a90a724e	0280-8090	HUMAN OTC DRUG	Midol Long Lasting Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20170310		ANDA	ANDA075077	Bayer HealthCare LLC.	ACETAMINOPHEN	650	mg/1			N	20241231
0281-0326_d4bd3e47-88da-4f5a-a0eb-8e6cc0d4df79	0281-0326	HUMAN PRESCRIPTION DRUG	NITRO-BID		Nitroglycerin	OINTMENT	TOPICAL	20090815		ANDA	ANDA087355	Savage Laboratories a division of Fougera Pharmaceuticals Inc.	NITROGLYCERIN	20	mg/g	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0283-0220_043c323d-999f-076e-e063-6394a90a3b96	0283-0220	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20230831		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0220_0b7a1c43-b169-e48c-e063-6294a90a4517	0283-0220	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210131	20240630	OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
0283-0293_a1b4cb09-683e-48ad-9f6e-7e64873743de	0283-0293	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Gel	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	19930215		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0293_f345fdf6-bcf4-49c8-e053-2995a90ae73c	0283-0293	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Gel	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	19930215		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0293_f5eec054-6ebe-1ecc-e053-2995a90ab6b8	0283-0293	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Gel	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	19930215		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0520_043c255f-d5c5-0821-e063-6394a90a152f	0283-0520	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20230831		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0520_09a6a044-a5d3-3bc6-e063-6294a90a98d6	0283-0520	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210131		OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0520_0b51b686-79a1-5338-e063-6294a90ad887	0283-0520	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210131		OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0522_043c00b1-ba59-83b4-e063-6394a90a6ca4	0283-0522	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20230831		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0569_f5efadde-31d2-576c-e053-2a95a90a401c	0283-0569	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Liquid	Benzocaine	LIQUID	DENTAL; ORAL; PERIODONTAL	19690515		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0610_f5edeb16-7f62-da22-e053-2995a90a6534	0283-0610	HUMAN OTC DRUG	HurriCaine		Topical Anesthetic	SPRAY	DENTAL; PERIODONTAL	20100615		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0622_0b513cb2-2a00-0a1e-e063-6394a90a11af	0283-0622	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20221215		OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0679_0396eb4a-f109-16fb-e063-6394a90afdaf	0283-0679	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	SPRAY	DENTAL; ORAL; PERIODONTAL	19790615		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0808_087c799b-bb16-48ad-e063-6394a90a294c	0283-0808	HUMAN OTC DRUG	CEO-TWO		Laxative	SUPPOSITORY	RECTAL	20080815	20250930	OTC MONOGRAPH DRUG	M007	Beutlich Pharmaceuticals, LLC	POTASSIUM BITARTRATE; SODIUM BICARBONATE	927; 618	mg/3.7g; mg/3.7g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	
0283-0871_065d760b-7098-3e26-e063-6394a90a48cd	0283-0871	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	19710815		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0871_f1eb64e8-05c2-931b-e053-2995a90a2fe8	0283-0871	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	19710815		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0871_f5ee9ea9-8cb0-09fe-e053-2a95a90ad398	0283-0871	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210131		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0886_3afd751c-3d5c-4e54-a61a-de1eb6426dce	0283-0886	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Gel	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	19860815		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0886_f5eeaf37-33e5-2c0c-e053-2a95a90abcc0	0283-0886	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Gel	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	19860815		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0914_03969bcb-d82c-c510-e063-6394a90a14f2	0283-0914	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	SPRAY	DENTAL; ORAL; PERIODONTAL	20140901		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0920_043a110b-ea71-37f4-e063-6394a90af086	0283-0920	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20230831		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0920_09a6bf06-ea77-5aee-e063-6294a90a3bb2	0283-0920	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210131		OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0920_0b51732f-ec7c-3542-e063-6394a90a1a67	0283-0920	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210131		OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0998_03b69d07-2a1a-4572-9291-8cd5480ecc68	0283-0998	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; PERIODONTAL	19980915		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-0998_f5eeb8c7-671e-6d35-e053-2a95a90a30d9	0283-0998	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; PERIODONTAL	19980915		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-1016_7cfe03e5-2feb-4061-a71f-fd71239bc997	0283-1016	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	BENZOCAINE	GEL	DENTAL; ORAL; PERIODONTAL	20161015		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-1016_f5eec054-6eb0-1ecc-e053-2995a90ab6b8	0283-1016	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	BENZOCAINE	GEL	DENTAL; ORAL; PERIODONTAL	20161015		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-1023_0867303a-d32a-921f-e063-6394a90a3fbe	0283-1023	HUMAN OTC DRUG	CEO-TWO		Laxative	SUPPOSITORY	RECTAL	20231015		OTC MONOGRAPH DRUG	M007	Beutlich Pharmaceuticals, LLC	POTASSIUM BITARTRATE; SODIUM BICARBONATE	.9; .6	g/5.7g; g/5.7g	Alkalinizing Activity [MoA], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0283-1116_2545ef15-8b01-47a6-9190-f4c2a7d4d28a	0283-1116	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Liquid	Benzocaine	LIQUID	DENTAL; ORAL; PERIODONTAL	20161115		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-1820_043c00b1-ba5c-83b4-e063-6394a90a6ca4	0283-1820	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20230831		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-1820_fe921a82-8035-f0fd-e053-6394a90af4af	0283-1820	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210228		OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-1820_fe9270c0-bf72-f0ff-e053-6394a90ae8f1	0283-1820	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic	Benzocaine	GEL	DENTAL; ORAL; PERIODONTAL	20210131		OTC MONOGRAPH DRUG	M022	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0283-1886_457f28b3-7acd-42e3-87aa-99ffa5530631	0283-1886	HUMAN OTC DRUG	HurriCaine	Topical Anesthetic Liquid	Benzocaine	LIQUID	DENTAL; ORAL; PERIODONTAL	19860815		OTC MONOGRAPH NOT FINAL	part356	Beutlich Pharmaceuticals, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0295-9011_076a60f5-891f-df35-e063-6394a90a7a9b	0295-9011	HUMAN OTC DRUG	Hydrolatum		White Petrolatum	CREAM	TOPICAL	20200219		OTC MONOGRAPH DRUG	M016	Denison Pharmaceuticals, LLC	PETROLATUM	45	g/100g			N	20241231
0295-9049_a44b9fb7-87e4-2185-e053-2a95a90a5b6e	0295-9049	HUMAN OTC DRUG	Stay Safe Hand Sanitizer Alcohol Free		benzalkonium chloride	GEL	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part333A	Denison Pharmaceuticals, LLC	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
0299-2012_2026b117-e38f-4f4e-a232-a7374b64a323	0299-2012	HUMAN PRESCRIPTION DRUG	Vectical		calcitriol	OINTMENT	TOPICAL	20090201		NDA	NDA022087	Galderma Laboratories, L.P.	CALCITRIOL	3	ug/g	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
0299-3820_1972793f-cceb-4044-853c-a82db751f55d	0299-3820	HUMAN PRESCRIPTION DRUG	METROGEL		metronidazole	GEL	TOPICAL	20050630		NDA	NDA021789	Galderma Laboratories, L.P.	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0299-3822_a78ea97d-fa82-40b7-aa5c-0536b364cc69	0299-3822	HUMAN PRESCRIPTION DRUG	ORACEA		DOXYCYCLINE	CAPSULE	ORAL	20100514		NDA	NDA050805	Galderma Laboratories, L.P.	DOXYCYCLINE	40	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0299-3823_0e84e7ac-c8f4-40b5-917f-6dbfb22a046c	0299-3823	HUMAN PRESCRIPTION DRUG	SOOLANTRA		IVERMECTIN	CREAM	TOPICAL	20150101		NDA	NDA206255	Galderma Laboratories, L.P.	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
0299-3836_02c98a23-7923-4f37-b2e5-627e688f3e09	0299-3836	HUMAN PRESCRIPTION DRUG	MetroCream		metronidazole	CREAM	TOPICAL	19950920		NDA	NDA020531	Galderma Laboratories, L.P.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0299-3838_986498be-52fe-47ba-a639-5267a03e98bf	0299-3838	HUMAN PRESCRIPTION DRUG	MetroLotion		metronidazole	LOTION	TOPICAL	19981124		NDA	NDA020901	Galderma Laboratories, L.P.	METRONIDAZOLE	7.5	mg/mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0299-3847_e8158f90-cd55-4929-b440-fc3fc6ac344c	0299-3847	HUMAN PRESCRIPTION DRUG	Clobex		clobetasol propionate	SHAMPOO	TOPICAL	20040301		NDA	NDA021644	Galderma Laboratories, L.P.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0299-3848_b20424b0-0e9d-420a-b1f6-88abac9a4fa2	0299-3848	HUMAN PRESCRIPTION DRUG	Clobex		Clobetasol Propionate	LOTION	TOPICAL	20030801		NDA	NDA021535	Galderma Laboratories, L.P.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0299-3849_8bfd877e-3ed7-4ed7-b986-fd68aed8bd09	0299-3849	HUMAN PRESCRIPTION DRUG	CLOBEX		clobetasol propionate	SPRAY	TOPICAL	20051027		NDA	NDA021835	Galderma Laboratories, L.P.	CLOBETASOL PROPIONATE	.05	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0299-3928_7a88a774-4682-4bdf-a312-777ea118d4b9	0299-3928	HUMAN OTC DRUG	Cetaphil		octocrylene, avobenzone	LOTION	TOPICAL	20000401		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; OCTOCRYLENE	3; 10	g/100mL; g/100mL			N	20241231
0299-4103_01b1ef2f-f664-450b-9fc1-81c61d1ed6b1	0299-4103	HUMAN OTC DRUG	Cetaphil Baby Soothe and Protect Cream		allantoin	CREAM	TOPICAL	20200203		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	ALLANTOIN	5	mg/g			N	20241231
0299-4105_123cee2b-1cfd-4530-bce4-bd524177fcdd	0299-4105	HUMAN OTC DRUG	Cetaphil Soothing Gel Cream		allantoin	CREAM	TOPICAL	20200217		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	ALLANTOIN	5	mg/g			N	20241231
0299-4108_f7ba64ea-7792-4862-89ec-ca971634c2e0	0299-4108	HUMAN OTC DRUG	Cetaphil Sheer Mineral Sunscreen Stick SPF 50		titanium dioxide, zinc oxide	STICK	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	TITANIUM DIOXIDE; ZINC OXIDE	60; 47	mg/g; mg/g			N	20241231
0299-4110_c67dbf34-a2c7-4a8f-9d13-6e8841a055a4	0299-4110	HUMAN OTC DRUG	Cetaphil Sheer Mineral Face Liquid Sunscreen SPF 50		zinc oxide	LOTION	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	ZINC OXIDE	120	mg/mL			N	20241231
0299-4111_e9ad4fb6-9c57-442a-a98c-f8071d2baa2b	0299-4111	HUMAN OTC DRUG	Cetaphil Sheer Mineral Sunscreen SPF 30		titanium dioxide, zinc oxide	LOTION	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/mL; mg/mL			N	20241231
0299-4112_20c0c46d-72ba-425c-99de-a3548ef72de0	0299-4112	HUMAN OTC DRUG	Cetaphil Sheer Mineral Sunscreen SPF 50		titanium dioxide, zinc oxide	LOTION	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	TITANIUM DIOXIDE; ZINC OXIDE	49; 47	mg/mL; mg/mL			N	20241231
0299-4113_29eb06f0-f7a0-4e73-af39-57789e8c7f0c	0299-4113	HUMAN OTC DRUG	Cetaphil Daily Facial Moisturizer with suncreen SPF 35		avobenzone, homosalate, octisalate, octocrylene	LOTION	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28; 95; 48; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0299-4114_54f6994b-a5ad-4dd6-82ec-c2578b46c89e	0299-4114	HUMAN OTC DRUG	Cetaphil Cracked Skin Repair		Dimethicone	LOTION	TOPICAL	20210501		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	DIMETHICONE	20	mg/mL	Skin Barrier Activity [PE]		N	20241231
0299-4115_40277fde-372e-4ded-b7f8-15168d11582a	0299-4115	HUMAN OTC DRUG	Cetaphil Cracked Skin Repair Balm		Dimethicone	CREAM	TOPICAL	20210501		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	DIMETHICONE	10	mg/g	Skin Barrier Activity [PE]		N	20241231
0299-4116_919a94dd-695a-4b3c-ba11-7eb46471b49d	0299-4116	HUMAN OTC DRUG	Cetaphil Healing		petrolatum	OINTMENT	TOPICAL	20210501		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	PETROLATUM	715	mg/g			N	20241231
0299-4117_9fb6103e-9b61-481b-a089-836d5c0e213f	0299-4117	HUMAN OTC DRUG	Cetaphil Gentle Clear Mattifying Acne Moisturizer		Salicylic Acid	LOTION	TOPICAL	20210501		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	SALICYLIC ACID	5	mg/mL			N	20241231
0299-4118_3e98ff53-9e8c-4c6c-82d0-5bd17f83c665	0299-4118	HUMAN OTC DRUG	Cetaphil Healthy Radiance Whipped Day Cream Broad Spectrum SPF 30		avobenzone, homosalate, octisalate, octocrylene	LOTION	TOPICAL	20210501		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 125; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
0299-4119_98ce0d8c-0e2d-4254-b0be-435c7ee3c6f0	0299-4119	HUMAN OTC DRUG	Cetaphil Gentle Clear Clarifying Acne Cleanser		Salicylic Acid	CREAM	TOPICAL	20210501		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	SALICYLIC ACID	20	mg/mL			N	20241231
0299-4121_eaae77d5-6bd9-4582-8055-cccfb26197ad	0299-4121	HUMAN OTC DRUG	Cetaphil Acne Relief Body Wash		Salicylic Acid	GEL	TOPICAL	20220101		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	SALICYLIC ACID	20	mg/mL			N	20241231
0299-4122_ef0189b7-4c9c-4831-9441-622007e02ca4	0299-4122	HUMAN OTC DRUG	Cetaphil Sheer Mineral Sunscreen SPF 50		titanium dioxide, zinc oxide	LOTION	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	TITANIUM DIOXIDE; ZINC OXIDE	90; 70	mg/mL; mg/mL			N	20241231
0299-4123_3adb6e04-3e4c-4f82-9ae6-5eac610af0a6	0299-4123	HUMAN OTC DRUG	Cetaphil Oil Absorbing SPF 30		octocrylene, octisalate, avobenzone	LOTION	TOPICAL	20111201	20250901	OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 7	g/100mL; g/100mL; g/100mL			N	
0299-4124_695eeb38-ab0c-4437-91e2-5bf96f1c64ac	0299-4124	HUMAN OTC DRUG	Cetaphil Eczema Soothing Moisturizer		colloidal oatmeal	LOTION	TOPICAL	20180501	20240201	OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
0299-4125_b20c8c1a-9311-4ad9-a713-fa3451dc6f7e	0299-4125	HUMAN OTC DRUG	Cetaphil Gentle Clear BPO Acne Cleanser		benzoyl peroxide	CREAM	TOPICAL	20220501		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	BENZOYL PEROXIDE	2.6	g/100mL			N	20241231
0299-4127_1554ce57-1d3a-4472-9e1f-a75fa8403ab8	0299-4127	HUMAN OTC DRUG	Cetaphil Eczema Flare-Up Cream		colloidal oatmeal	CREAM	TOPICAL	20220501		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	OATMEAL	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0299-4128_65ff62b3-9b06-446e-8d40-dd447bde8a64	0299-4128	HUMAN OTC DRUG	Cetaphil Eczema Soothing Moisturizer		colloidal oatmeal	LOTION	TOPICAL	20220501		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0299-4129_cba9dbd5-9100-4a07-ac6e-620aff818641	0299-4129	HUMAN OTC DRUG	Cetaphil Eczema Itch Relief Gel		colloidal oatmeal	GEL	TOPICAL	20220501		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	OATMEAL	.5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0299-4131_a560db7f-bb8b-42e2-bbb4-b932e5cfa826	0299-4131	HUMAN OTC DRUG	Differin Acne Clearing Body Wash		Salicylic Acid	GEL	TOPICAL	20220601		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	SALICYLIC ACID	20	mg/mL			N	20241231
0299-4132_cdd1f28c-d497-47ce-b95c-d81902d0a3e2	0299-4132	HUMAN OTC DRUG	Differin Acne Clearing Body		Salicylic Acid	AEROSOL, SPRAY	TOPICAL	20220601		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	SALICYLIC ACID	2	g/100g			N	20241231
0299-4133_ff84bfe3-ec28-42dc-80e1-02cc7c2f6411	0299-4133	HUMAN OTC DRUG	Differin Oil Absorbing Moisturizer SPF 30		avobenzone, octisalate, octocrylene	LOTION	TOPICAL	20220601		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 7	g/100mL; g/100mL; g/100mL			N	20241231
0299-4134_ddf85907-2f48-4200-a50c-ac1c60215613	0299-4134	HUMAN OTC DRUG	Cetaphil Oil Absorbing SPF 30		avobenzone, octisalate, octocrylene	LOTION	TOPICAL	20220601		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 7	g/100mL; g/100mL; g/100mL			N	20241231
0299-4135_6ef04144-8863-42f8-8f29-b93a0a5ec996	0299-4135	HUMAN OTC DRUG	Cetaphil Gentle Clear Triple-Action Acne Serum		Salicylic Acid	SOLUTION	TOPICAL	20220501		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	SALICYLIC ACID	5	mg/mL			N	20241231
0299-4136_95ed6d89-b436-4197-a942-485d640990d2	0299-4136	HUMAN OTC DRUG	Cetaphil Healthy Renew Day Cream Broad Spectrum SPF 30		homosalate, octocrylene, octisalate, avobenzone	LOTION	TOPICAL	20230412		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28; 95; 48; 95	mg/g; mg/g; mg/g; mg/g			N	20241231
0299-4137_26e7eefc-c9dd-4ef3-b4ab-02be7bc22977	0299-4137	HUMAN OTC DRUG	Differin Max Strength Acne Foaming BPO Cleanser		benzoyl peroxide	SOLUTION	TOPICAL	20230411		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	BENZOYL PEROXIDE	10	g/100mL			N	20241231
0299-4138_6845e329-c3bf-46f4-b9c2-09e62064da19	0299-4138	HUMAN OTC DRUG	Cetaphil Redness Relieving Daily Facial Moisturizer with sunscreen SPF 40		titanium dioxide, zinc oxide	CREAM	TOPICAL	20230720		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	TITANIUM DIOXIDE; ZINC OXIDE	101; 78	mg/mL; mg/mL			N	20241231
0299-4139_b50a1238-3aa1-4511-a284-7afa9a45f603	0299-4139	HUMAN OTC DRUG	Cetaphil Eczema Flare-Up Cream		colloidal oatmeal	CREAM	TOPICAL	20230201		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0299-4140_bfe4854f-7c69-4d6a-8663-adc49f3bec83	0299-4140	HUMAN OTC DRUG	Cetaphil Baby Eczema Soothing		colloidal oatmeal	LOTION	TOPICAL	20180501		OTC MONOGRAPH DRUG	M016	Galderma Laboratories, L.P.	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0299-4142_6eb7c1fe-9c87-4330-a245-e20a0f66aa56	0299-4142	HUMAN OTC DRUG	Cetaphil Hydrating Face Sunscreen SPF 35		avobenzone, homosalate, octisalate, octocrylene	LOTION	TOPICAL	20231101		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28; 95; 48; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0299-4606_24a54860-8467-4a81-85c7-2d07b17be1fc	0299-4606	HUMAN OTC DRUG	Differin Daily Deep Cleanser with BPO		benzoyl peroxide	SOLUTION	TOPICAL	20171101		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	BENZOYL PEROXIDE	5	g/100mL			N	20241231
0299-4607_1911e5ec-f69f-41d3-8f55-bc15a605bc93	0299-4607	HUMAN OTC DRUG	Differin Oil Absorbing Moisturizer SPF 30		octocrylene, octisalate, avobenzone	LOTION	TOPICAL	20171101	20250401	OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 7	g/100mL; g/100mL; g/100mL			N	
0299-4609_4750442e-5497-4bd9-878c-fa064ca97e9d	0299-4609	HUMAN OTC DRUG	Differin Acne Clearing Body Scrub		Salicylic Acid	LIQUID	TOPICAL	20210601		OTC MONOGRAPH DRUG	M006	Galderma Laboratories, L.P.	SALICYLIC ACID	20	mg/mL			N	20241231
0299-4910_7d2ef345-753e-4f6c-bb76-15fae398a44d	0299-4910	HUMAN OTC DRUG	Differin		Adapalene	GEL	TOPICAL	20160708		NDA	NDA020380	Galderma Laboratories, L.P.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0299-4930_ae845dee-2080-4b21-abdc-d81a6fc105d8	0299-4930	HUMAN OTC DRUG	Cetaphil Daily Facial Moisturizer with suncreen SPF 50		octinoxate, octisalate, octocrylene, oxybenzone, titanium dioxide	LOTION	TOPICAL	20120101		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	75; 50; 70; 60; 57	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0299-5500_969aef09-57f8-4f14-8ad6-0dc69451adfd	0299-5500	HUMAN PRESCRIPTION DRUG	Capex		fluocinolone acetonide	KIT	TOPICAL	19841012		NDA	NDA020001	Galderma Laboratories, L.P.						N	20241231
0299-5765_5d3f519a-8957-4b8e-8525-88799e299f2a	0299-5765	HUMAN PRESCRIPTION DRUG	DesOwen		desonide	LOTION	TOPICAL	19880715		ANDA	ANDA072354	Galderma Laboratories, L.P.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0299-5770_5d3f519a-8957-4b8e-8525-88799e299f2a	0299-5770	HUMAN PRESCRIPTION DRUG	DesOwen		desonide	CREAM	TOPICAL	19841214		NDA	NDA019048	Galderma Laboratories, L.P.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0299-5889_47fbeff5-87c4-4614-8b8e-a7bff9f3df38	0299-5889	HUMAN OTC DRUG	Cetaphil Redness Relieving Daily Facial Moisturizer with sunscreen SPF 20		titanium dioxide, zinc oxide	CREAM	TOPICAL	20161209		OTC MONOGRAPH DRUG	M020	Galderma Laboratories, L.P.	TITANIUM DIOXIDE; ZINC OXIDE	101; 78	mg/mL; mg/mL			N	20241231
0299-5890_a15b4373-e951-4c25-be7e-a2538736b56f	0299-5890	HUMAN PRESCRIPTION DRUG	EPSOLAY		Benzoyl Peroxide	CREAM	TOPICAL	20220509		NDA	NDA214510	Galderma Laboratories, L.P.	BENZOYL PEROXIDE	50	mg/g			N	20241231
0299-5906_c1dc4ed4-4ac0-4e9b-8b0a-e9215d4761e2	0299-5906	HUMAN PRESCRIPTION DRUG	epiduo forte		adapalene and benzoyl peroxide	GEL	TOPICAL	20150701		NDA	NDA207917	Galderma Laboratories, L.P.	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0299-5908_35dbccc7-10bf-4f85-af37-b64708075af9	0299-5908	HUMAN PRESCRIPTION DRUG	EPIDUO		adapalene and benzoyl peroxide	GEL	TOPICAL	20081208		NDA	NDA022320	Galderma Laboratories, L.P.	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0299-5912_c1490598-6e85-494d-8852-66ac0cd2755d	0299-5912	HUMAN PRESCRIPTION DRUG	Differin		adapalene	LOTION	TOPICAL	20100331		NDA	NDA022502	Galderma Laboratories, L.P.	ADAPALENE	.1	g/100mL	Retinoid [EPC], Retinoids [CS]		N	20241231
0299-5915_387e53ec-96cc-48b4-89fb-9fadc8397d70	0299-5915	HUMAN PRESCRIPTION DRUG	Differin		Adapalene	CREAM	TOPICAL	20091124		NDA	NDA020748	GALDERMA LABORATORIES, L.P	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0299-5918_03b91d51-9c2e-4632-8cf0-332c56cf74f1	0299-5918	HUMAN PRESCRIPTION DRUG	DIFFERIN		adapalene	GEL	TOPICAL	20090915		NDA	NDA021753	Galderma Laboratories, L.P.	ADAPALENE	3	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0299-5935_a867cb7a-4d96-4e98-8a65-dd74ba71704f	0299-5935	HUMAN PRESCRIPTION DRUG	AKLIEF		trifarotene	CREAM	TOPICAL	20191004		NDA	NDA211527	Galderma Laboratories, L.P.	TRIFAROTENE	50	ug/g			N	20241231
0299-5945_f94fc0a5-8c01-4280-b9de-60a990de26a3	0299-5945	HUMAN PRESCRIPTION DRUG	TWYNEO		tretinoin and benzoyl peroxide	CREAM	TOPICAL	20220315		NDA	NDA214902	Galderma Laboratories, L.P.	BENZOYL PEROXIDE; TRETINOIN	30; 1	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0299-5950_dcbba72f-e5b7-4688-93b7-d06478f28556	0299-5950	HUMAN PRESCRIPTION DRUG	TRI-LUMA		fluocinolone acetonide, hydroquinone, and tretinoin	CREAM	TOPICAL	20020118		NDA	NDA021112	Galderma Laboratories, L.P.	FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN	.1; 40; .5	mg/g; mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Retinoid [EPC], Retinoids [CS]		N	20241231
0299-5962_11af31e7-1043-454a-9570-4b2e9cb79a23	0299-5962	HUMAN PRESCRIPTION DRUG	Dysport		Botulinum Toxin Type A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20091102		BLA	BLA125274	Galderma Laboratories, L.P.	BOTULINUM TOXIN TYPE A	300	U/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
0299-5980_fda53493-1917-4c14-988b-bec8814c37c8	0299-5980	HUMAN PRESCRIPTION DRUG	Mirvaso		brimonidine tartrate	GEL	TOPICAL	20130823		NDA	NDA204708	Galderma Laboratories, L.P.	BRIMONIDINE TARTRATE	5	mg/g	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0310-0088_e51336e0-095d-4700-908f-bdbefbc6bb6d	0310-0088	HUMAN PRESCRIPTION DRUG	Daliresp		roflumilast	TABLET	ORAL	20150701		NDA	NDA022522	AstraZeneca Pharmaceuticals LP	ROFLUMILAST	250	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
0310-0095_e51336e0-095d-4700-908f-bdbefbc6bb6d	0310-0095	HUMAN PRESCRIPTION DRUG	Daliresp		roflumilast	TABLET	ORAL	20150701		NDA	NDA022522	AstraZeneca Pharmaceuticals LP	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
0310-0271_37cb4cbf-8192-4921-b17c-e562467fc018	0310-0271	HUMAN PRESCRIPTION DRUG	SEROQUEL		quetiapine	TABLET, FILM COATED	ORAL	19971001		NDA	NDA020639	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0272_37cb4cbf-8192-4921-b17c-e562467fc018	0310-0272	HUMAN PRESCRIPTION DRUG	SEROQUEL		quetiapine	TABLET, FILM COATED	ORAL	19971001		NDA	NDA020639	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0274_37cb4cbf-8192-4921-b17c-e562467fc018	0310-0274	HUMAN PRESCRIPTION DRUG	SEROQUEL		quetiapine	TABLET, FILM COATED	ORAL	20001113		NDA	NDA020639	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0275_37cb4cbf-8192-4921-b17c-e562467fc018	0310-0275	HUMAN PRESCRIPTION DRUG	SEROQUEL		quetiapine	TABLET, FILM COATED	ORAL	19971001		NDA	NDA020639	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0278_37cb4cbf-8192-4921-b17c-e562467fc018	0310-0278	HUMAN PRESCRIPTION DRUG	SEROQUEL		quetiapine	TABLET, FILM COATED	ORAL	20060213		NDA	NDA020639	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0279_37cb4cbf-8192-4921-b17c-e562467fc018	0310-0279	HUMAN PRESCRIPTION DRUG	SEROQUEL		quetiapine	TABLET, FILM COATED	ORAL	20060213		NDA	NDA020639	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0280_c3b26ed5-6f3a-4ca5-80a5-b98380040294	0310-0280	HUMAN PRESCRIPTION DRUG	SEROQUEL	XR	quetiapine	TABLET, EXTENDED RELEASE	ORAL	20090201		NDA	NDA022047	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0281_c3b26ed5-6f3a-4ca5-80a5-b98380040294	0310-0281	HUMAN PRESCRIPTION DRUG	SEROQUEL	XR	quetiapine	TABLET, EXTENDED RELEASE	ORAL	20090201		NDA	NDA022047	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0282_c3b26ed5-6f3a-4ca5-80a5-b98380040294	0310-0282	HUMAN PRESCRIPTION DRUG	SEROQUEL	XR	quetiapine	TABLET, EXTENDED RELEASE	ORAL	20070716		NDA	NDA022047	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0283_c3b26ed5-6f3a-4ca5-80a5-b98380040294	0310-0283	HUMAN PRESCRIPTION DRUG	SEROQUEL	XR	quetiapine	TABLET, EXTENDED RELEASE	ORAL	20070716		NDA	NDA022047	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0284_c3b26ed5-6f3a-4ca5-80a5-b98380040294	0310-0284	HUMAN PRESCRIPTION DRUG	SEROQUEL	XR	quetiapine	TABLET, EXTENDED RELEASE	ORAL	20070716		NDA	NDA022047	AstraZeneca Pharmaceuticals LP	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0310-0482_e45a64d1-6585-4489-b601-db5b7e40ad5e	0310-0482	HUMAN PRESCRIPTION DRUG	IRESSA		Gefitinib	TABLET, COATED	ORAL	20150713		NDA	NDA206995	AstraZeneca Pharmaceuticals LP	GEFITINIB	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0310-0512_071b1175-2b58-47ea-80fd-395df43037a4	0310-0512	HUMAN PRESCRIPTION DRUG	CALQUENCE		Acalabrutinib	CAPSULE, GELATIN COATED	ORAL	20171031		NDA	NDA210259	AstraZeneca Pharmaceuticals LP	ACALABRUTINIB	100	mg/1	Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
0310-0610_6c8f682f-896f-4f33-9edc-97c152c1f452	0310-0610	HUMAN PRESCRIPTION DRUG	KOSELUGO		SELUMETINIB	CAPSULE	ORAL	20200416		NDA	NDA213756	AstraZeneca Pharmaceuticals LP	SELUMETINIB	10	mg/1	Kinase Inhibitor [EPC], Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]		N	20241231
0310-0625_6c8f682f-896f-4f33-9edc-97c152c1f452	0310-0625	HUMAN PRESCRIPTION DRUG	KOSELUGO		SELUMETINIB	CAPSULE	ORAL	20200416		NDA	NDA213756	AstraZeneca Pharmaceuticals LP	SELUMETINIB	25	mg/1	Kinase Inhibitor [EPC], Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]		N	20241231
0310-0668_5d1fb11d-00fa-48eb-b915-acf9ae26de79	0310-0668	HUMAN PRESCRIPTION DRUG	Lynparza		olaparib	TABLET, FILM COATED	ORAL	20170817		NDA	NDA208558	AstraZeneca Pharmaceuticals LP	OLAPARIB	100	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0310-0679_5d1fb11d-00fa-48eb-b915-acf9ae26de79	0310-0679	HUMAN PRESCRIPTION DRUG	Lynparza		olaparib	TABLET, FILM COATED	ORAL	20170817		NDA	NDA208558	AstraZeneca Pharmaceuticals LP	OLAPARIB	150	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
0310-0720_7e2ffac1-a46a-4e0b-b4cc-4b3cfdbfbee3	0310-0720	HUMAN PRESCRIPTION DRUG	FASLODEX		Fulvestrant	INJECTION	INTRAMUSCULAR	20101101		NDA	NDA021344	AstraZeneca Pharmaceuticals LP	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0310-0751_f3bf9a83-3da3-4e55-9fd2-afff19e2a6e6	0310-0751	HUMAN PRESCRIPTION DRUG	CRESTOR		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20030818	20240430	NDA	NDA021366	AstraZeneca Pharmaceuticals LP	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
0310-0755_f3bf9a83-3da3-4e55-9fd2-afff19e2a6e6	0310-0755	HUMAN PRESCRIPTION DRUG	CRESTOR		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20030818	20240430	NDA	NDA021366	AstraZeneca Pharmaceuticals LP	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
0310-0800_392d891f-7292-4fda-9f05-f1c21586e4d5	0310-0800	HUMAN PRESCRIPTION DRUG	Tudorza Pressair		aclidinium bromide	POWDER, METERED	RESPIRATORY (INHALATION)	20150701	20240731	NDA	NDA202450	AstraZeneca Pharmaceuticals LP	ACLIDINIUM BROMIDE	400	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
0310-0900_542906e1-4eb9-4718-a490-a3eb90975819	0310-0900	HUMAN PRESCRIPTION DRUG	DUAKLIR PRESSAIR		aclidinium bromide and formoterol fumarate	POWDER, METERED	RESPIRATORY (INHALATION)	20220817	20250430	NDA	NDA210595	AstraZeneca Pharmaceuticals LP	ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE	400; 12	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	
0310-1105_d9459fbd-9cb8-4eb1-ac2d-7cd44d8734fa	0310-1105	HUMAN PRESCRIPTION DRUG	LOKELMA		sodium zirconium cyclosilicate	POWDER, FOR SUSPENSION	ORAL	20180904		NDA	NDA207078	AstraZeneca Pharmaceuticals LP	SODIUM ZIRCONIUM CYCLOSILICATE	5	g/5g			N	20241231
0310-1110_d9459fbd-9cb8-4eb1-ac2d-7cd44d8734fa	0310-1110	HUMAN PRESCRIPTION DRUG	LOKELMA		sodium zirconium cyclosilicate	POWDER, FOR SUSPENSION	ORAL	20180904		NDA	NDA207078	AstraZeneca Pharmaceuticals LP	SODIUM ZIRCONIUM CYCLOSILICATE	10	g/10g			N	20241231
0310-1349_d413d9fe-c54c-4c40-9c73-796f96f3edb0	0310-1349	HUMAN PRESCRIPTION DRUG	TAGRISSO		osimertinib	TABLET, FILM COATED	ORAL	20151113		NDA	NDA208065	AstraZeneca Pharmaceuticals LP	OSIMERTINIB	40	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0310-1350_d413d9fe-c54c-4c40-9c73-796f96f3edb0	0310-1350	HUMAN PRESCRIPTION DRUG	TAGRISSO		osimertinib	TABLET, FILM COATED	ORAL	20151113		NDA	NDA208065	AstraZeneca Pharmaceuticals LP	OSIMERTINIB	80	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
0310-1730_ec74f450-77c9-4e72-9111-7169441ced13	0310-1730	HUMAN PRESCRIPTION DRUG	FASENRA		Benralizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20171114		BLA	BLA761070	AstraZeneca Pharmaceuticals LP	BENRALIZUMAB	30	mg/mL	Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA], Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]		N	20241231
0310-1830_ec74f450-77c9-4e72-9111-7169441ced13	0310-1830	HUMAN PRESCRIPTION DRUG	FASENRA		Benralizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20191004		BLA	BLA761070	AstraZeneca Pharmaceuticals LP	BENRALIZUMAB	30	mg/mL	Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA], Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]		N	20241231
0310-3040_3f2b76dd-4c0c-4d2c-ba03-762f92b00153	0310-3040	HUMAN PRESCRIPTION DRUG	SAPHNELO		Anifrolumab	INJECTION, SOLUTION	INTRAVENOUS	20210730		BLA	BLA761123	AstraZeneca Pharmaceuticals LP	ANIFROLUMAB	300	mg/2mL	Type I Interferon Receptor Antagonist [EPC], Type I Interferon Receptor Antagonists [MoA]		N	20241231
0310-3200_b603803b-80eb-4097-aa98-3bd692bce171	0310-3200	HUMAN PRESCRIPTION DRUG	ANDEXXA		andexanet alfa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220712		BLA	BLA125586	AstraZeneca Pharmaceuticals LP	ANDEXANET ALFA	200	mg/20mL			N	20241231
0310-3512_b1409184-3267-4d8c-8f17-4e01f69828b1	0310-3512	HUMAN PRESCRIPTION DRUG	CALQUENCE		acalabrutinib	TABLET, FILM COATED	ORAL	20220804		NDA	NDA216387	AstraZeneca Pharmaceuticals LP	ACALABRUTINIB	100	mg/1	Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
0310-4500_50f25f3d-31a5-40a5-a970-36b3429457b8	0310-4500	HUMAN PRESCRIPTION DRUG	IMFINZI		Durvalumab	INJECTION, SOLUTION	INTRAVENOUS	20170501		BLA	BLA761069	AstraZeneca Pharmaceuticals LP	DURVALUMAB	120	mg/2.4mL	Antibodies, Monoclonal [CS], Programmed Death Ligand-1 Antagonists [MoA], Programmed Death Ligand-1 Blocker [EPC], Programmed Death Ligand-1-directed Antibody Interactions [MoA]		N	20241231
0310-4505_4c293d27-b307-4b99-8ab0-904cf3d0353b	0310-4505	HUMAN PRESCRIPTION DRUG	IMJUDO		tremelimumab	INJECTION, SOLUTION	INTRAVENOUS	20221021		BLA	BLA761289	AstraZeneca Pharmaceuticals LP	TREMELIMUMAB	25	mg/1.25mL			N	20241231
0310-4535_4c293d27-b307-4b99-8ab0-904cf3d0353b	0310-4535	HUMAN PRESCRIPTION DRUG	IMJUDO		tremelimumab	INJECTION, SOLUTION	INTRAVENOUS	20221021		BLA	BLA761289	AstraZeneca Pharmaceuticals LP	TREMELIMUMAB	300	mg/15mL			N	20241231
0310-4600_4de58592-1f9d-4bf9-bf77-2356095c1745	0310-4600	HUMAN PRESCRIPTION DRUG	BEVESPI AEROSPHERE		Glycopyrrolate and formoterol fumarate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20161003		NDA	NDA208294	AstraZeneca Pharmaceuticals LP	FORMOTEROL FUMARATE; GLYCOPYRROLATE	4.8; 9	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0310-4611_50f25f3d-31a5-40a5-a970-36b3429457b8	0310-4611	HUMAN PRESCRIPTION DRUG	IMFINZI		Durvalumab	INJECTION, SOLUTION	INTRAVENOUS	20170501		BLA	BLA761069	AstraZeneca Pharmaceuticals LP	DURVALUMAB	500	mg/10mL	Antibodies, Monoclonal [CS], Programmed Death Ligand-1 Antagonists [MoA], Programmed Death Ligand-1 Blocker [EPC], Programmed Death Ligand-1-directed Antibody Interactions [MoA]		N	20241231
0310-4616_650ce9da-73d0-4335-b8f4-dabb12672108	0310-4616	HUMAN PRESCRIPTION DRUG	BREZTRI		budesonide, glycopyrrolate, and formoterol fumarate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200723		NDA	NDA212122	AstraZeneca Pharmaceuticals LP	BUDESONIDE; FORMOTEROL; GLYCOPYRROLATE	160; 4.8; 9	ug/1; ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0310-4700_bd80307f-5490-4eda-a787-423a7ca788cc	0310-4700	HUMAN PRESCRIPTION DRUG	LUMOXITI		moxetumomab pasudotox	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181024	20240930	BLA	BLA761104	AstraZeneca Pharmaceuticals LP	MOXETUMOMAB PASUDOTOX	1	mg/mL			N	
0310-4715_bd80307f-5490-4eda-a787-423a7ca788cc	0310-4715	HUMAN PRESCRIPTION DRUG	IV Solution Stabilizer		IV Solution Stabilizer	SOLUTION	INTRAVENOUS	20181024	20240229	BLA	BLA761104	AstraZeneca Pharmaceuticals LP	POLYSORBATE 80	6.5	mg/mL			N	
0310-6100_71dbfa65-f758-4352-82af-f6fedd8f2242	0310-6100	HUMAN PRESCRIPTION DRUG	ONGLYZA		SAXAGLIPTIN	TABLET, FILM COATED	ORAL	20141120		NDA	NDA022350	AstraZeneca Pharmaceuticals LP	SAXAGLIPTIN HYDROCHLORIDE	2.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0310-6105_71dbfa65-f758-4352-82af-f6fedd8f2242	0310-6105	HUMAN PRESCRIPTION DRUG	ONGLYZA		SAXAGLIPTIN	TABLET, FILM COATED	ORAL	20141120		NDA	NDA022350	AstraZeneca Pharmaceuticals LP	SAXAGLIPTIN HYDROCHLORIDE	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0310-6125_18325f97-e837-472a-9118-f1fb8b9b71e7	0310-6125	HUMAN PRESCRIPTION DRUG	KOMBIGLYZE	XR	SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141204		NDA	NDA200678	AstraZeneca Pharmaceuticals LP	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE	1000; 2.5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0310-6135_18325f97-e837-472a-9118-f1fb8b9b71e7	0310-6135	HUMAN PRESCRIPTION DRUG	KOMBIGLYZE	XR	SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141204		NDA	NDA200678	AstraZeneca Pharmaceuticals LP	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE	500; 5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0310-6145_18325f97-e837-472a-9118-f1fb8b9b71e7	0310-6145	HUMAN PRESCRIPTION DRUG	KOMBIGLYZE	XR	SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141204		NDA	NDA200678	AstraZeneca Pharmaceuticals LP	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE	1000; 5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0310-6205_129852e5-b1f1-488e-99fe-aa8d0d4fd07a	0310-6205	HUMAN PRESCRIPTION DRUG	FARXIGA		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20080114		NDA	NDA202293	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN PROPANEDIOL	5	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6210_129852e5-b1f1-488e-99fe-aa8d0d4fd07a	0310-6210	HUMAN PRESCRIPTION DRUG	FARXIGA		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20080114		NDA	NDA202293	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN PROPANEDIOL	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6225_7d19a7d8-7419-4bf1-8462-52894fe73902	0310-6225	HUMAN PRESCRIPTION DRUG	XIGDUO	XR	dapagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141029		NDA	NDA205649	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE	2.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6250_7d19a7d8-7419-4bf1-8462-52894fe73902	0310-6250	HUMAN PRESCRIPTION DRUG	XIGDUO	XR	dapagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141029		NDA	NDA205649	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6260_7d19a7d8-7419-4bf1-8462-52894fe73902	0310-6260	HUMAN PRESCRIPTION DRUG	XIGDUO	XR	dapagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141029		NDA	NDA205649	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE	5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6270_7d19a7d8-7419-4bf1-8462-52894fe73902	0310-6270	HUMAN PRESCRIPTION DRUG	XIGDUO	XR	dapagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141029		NDA	NDA205649	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE	10; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6280_7d19a7d8-7419-4bf1-8462-52894fe73902	0310-6280	HUMAN PRESCRIPTION DRUG	XIGDUO	XR	dapagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141029		NDA	NDA205649	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE	10; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6512_7d116557-6fe2-4179-af97-7e2fc5935d38	0310-6512	HUMAN PRESCRIPTION DRUG	Byetta		exenatide	INJECTION	SUBCUTANEOUS	20141210		NDA	NDA021773	AstraZeneca Pharmaceuticals LP	EXENATIDE	250	ug/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0310-6524_7d116557-6fe2-4179-af97-7e2fc5935d38	0310-6524	HUMAN PRESCRIPTION DRUG	Byetta		exenatide	INJECTION	SUBCUTANEOUS	20141212		NDA	NDA021773	AstraZeneca Pharmaceuticals LP	EXENATIDE	250	ug/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0310-6540_745b5938-8834-45c4-a5f0-ba7c9e6628c6	0310-6540	HUMAN PRESCRIPTION DRUG	BYDUREON BCise		exenatide	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20171201		NDA	NDA209210	AstraZeneca Pharmaceuticals LP	EXENATIDE	2	mg/.85mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
0310-6770_73713238-3794-4c37-be41-34e790e2111f	0310-6770	HUMAN PRESCRIPTION DRUG	QTERN		dapagliflozin and saxagliptin	TABLET, FILM COATED	ORAL	20171204		NDA	NDA209091	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE	5; 5	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-6780_73713238-3794-4c37-be41-34e790e2111f	0310-6780	HUMAN PRESCRIPTION DRUG	QTERN		dapagliflozin and saxagliptin	TABLET, FILM COATED	ORAL	20171204		NDA	NDA209091	AstraZeneca Pharmaceuticals LP	DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE	10; 5	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0310-7370_dd03d461-e832-4b70-a540-a70fbbfd87f9	0310-7370	HUMAN PRESCRIPTION DRUG	Budesonide and Formoterol Fumarate Dihydrate		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20200103		NDA AUTHORIZED GENERIC	NDA021929	AstraZeneca Pharmaceuticals LP	BUDESONIDE; FORMOTEROL FUMARATE	160; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0310-7372_dd03d461-e832-4b70-a540-a70fbbfd87f9	0310-7372	HUMAN PRESCRIPTION DRUG	Budesonide and Formoterol Fumarate Dihydrate		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20200103		NDA AUTHORIZED GENERIC	NDA021929	AstraZeneca Pharmaceuticals LP	BUDESONIDE; FORMOTEROL FUMARATE	80; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0310-7560_18053149-18b6-427b-b740-5541f6ed2000	0310-7560	HUMAN PRESCRIPTION DRUG	Crestor		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20220509		NDA	NDA021366	AstraZeneca Pharmaceuticals LP	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0310-7570_18053149-18b6-427b-b740-5541f6ed2000	0310-7570	HUMAN PRESCRIPTION DRUG	Crestor		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20220509		NDA	NDA021366	AstraZeneca Pharmaceuticals LP	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0310-7580_18053149-18b6-427b-b740-5541f6ed2000	0310-7580	HUMAN PRESCRIPTION DRUG	Crestor		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20220124		NDA	NDA021366	AstraZeneca Pharmaceuticals LP	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0310-7590_18053149-18b6-427b-b740-5541f6ed2000	0310-7590	HUMAN PRESCRIPTION DRUG	Crestor		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20220124		NDA	NDA021366	AstraZeneca Pharmaceuticals LP	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0310-9080_c840b36a-ccf6-4976-881c-0c2315ed03eb	0310-9080	HUMAN PRESCRIPTION DRUG	AIRSUPRA		Albuterol sulfate and budesonide	AEROSOL, METERED	RESPIRATORY (INHALATION)	20231002		NDA	NDA214070	AstraZeneca Pharmaceuticals LP	ALBUTEROL SULFATE; BUDESONIDE	90; 80	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0310-9400_d7dcb847-71dd-4fff-82d0-d43a465fc096	0310-9400	HUMAN PRESCRIPTION DRUG	WAINUA		EPLONTERSEN	INJECTION, SOLUTION	SUBCUTANEOUS	20231221		NDA	NDA217388	AstraZeneca Pharmaceuticals LP	EPLONTERSEN	45	mg/45mg			N	20241231
0310-9500_1f261e9d-095f-4472-85fc-690fc0e240cd	0310-9500	HUMAN PRESCRIPTION DRUG	TRUQAP		capivasertib	TABLET, FILM COATED	ORAL	20231116		NDA	NDA218197	AstraZeneca Pharmaceuticals LP	CAPIVASERTIB	160	mg/1			N	20241231
0310-9501_1f261e9d-095f-4472-85fc-690fc0e240cd	0310-9501	HUMAN PRESCRIPTION DRUG	TRUQAP		capivasertib	TABLET, FILM COATED	ORAL	20231116		NDA	NDA218197	AstraZeneca Pharmaceuticals LP	CAPIVASERTIB	200	mg/1			N	20241231
0311-0701_95852697-83b0-abbd-e053-2a95a90a9e69	0311-0701	HUMAN OTC DRUG	Almay Smart Shade Skintone Matching Makeup		Titanium Dioxide Zinc Oxide	LIQUID	TOPICAL	20160416		OTC MONOGRAPH FINAL	part352	Almay, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	4.8; 2.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0311-0706_9585cbfc-e6d9-312f-e053-2995a90a51fb	0311-0706	HUMAN OTC DRUG	Almay Age Smart Shade CC Luminous Primer SPF 15		Zinc Oxide, Titanium Dioxide Make-Up	LIQUID	TOPICAL	20131114		OTC MONOGRAPH FINAL	part352	Almay, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	4.3; 3.3	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0311-0709_9585b71f-eb7a-2563-e053-2995a90ad376	0311-0709	HUMAN OTC DRUG	Almay Anti Aging Lip Care SPF 20		Octinoxate, Octisalate, Homosalate, Oxybenzone, Avobenzone	LIPSTICK	TOPICAL	20160420		OTC MONOGRAPH FINAL	part352	Almay, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	3; 5; 7.5; 5; 5	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0311-0710_9586054e-7c80-da13-e053-2a95a90a96e5	0311-0710	HUMAN OTC DRUG	ALMAY SMART SHADE ANTI-AGING SKINTONE MATCHING MAKEUP SPF 20		Titanium Dioxide, Zinc Oxide	LIQUID	TOPICAL	20160416		OTC MONOGRAPH FINAL	part352	Almay, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	5.5; 2.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0311-0711_95860633-2b52-eb44-e053-2995a90afcc4	0311-0711	HUMAN OTC DRUG	Almay Health Glow 3-In-1 Makeup SPF 20		Octinoxate, Titanium Dioxide, Zinc Oxide	KIT	TOPICAL	20160120		OTC MONOGRAPH FINAL	part352	Almay, Inc.						N	20241231
0311-0712_95860c6c-5b48-f016-e053-2a95a90ae835	0311-0712	HUMAN OTC DRUG	Almay Clear Gel		ALUMINUM SESQUICHLOROHYDRATE	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Almay, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.25	g/mL			N	20241231
0311-0713_95860c6c-5b48-f016-e053-2a95a90ae835	0311-0713	HUMAN OTC DRUG	Almay Clear Gel		ALUMINUM SESQUICHLOROHYDRATE	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Almay, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.25	g/mL			N	20241231
0311-0714_95861a9b-00aa-3a44-e053-2995a90a1dfb	0311-0714	HUMAN OTC DRUG	Almay Roll-On For Sensitive Skin - Fragrance-Free		ALUMINUM SESQUICHLOROHYDRATE	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Almay, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.25	g/mL			N	20241231
0311-0720_715c53f0-2ace-1f24-e053-2995a90ad463	0311-0720	HUMAN OTC DRUG	Almay Clear Complexion Liquid Makeup		Salicylic Acid	LIQUID	TOPICAL	20180423		OTC MONOGRAPH FINAL	part358H	Almay	SALICYLIC ACID	2	mg/2mL			N	20241231
0311-0721_8980bb57-ada8-aaf3-e053-2a95a90aa40e	0311-0721	HUMAN OTC DRUG	Almay Clear Complexion Pressed Powder		Salicylic Acid	POWDER	TOPICAL	20190102		OTC MONOGRAPH FINAL	part358H	Almay, Inc.	SALICYLIC ACID	.002	g/g			N	20241231
0311-0723_ab20969a-8641-307d-e053-2a95a90a004d	0311-0723	HUMAN OTC DRUG	Almay Healthy Biome Makeup		Homosalate, Octisalate, Octocrylene, Titanium Dioxide, Zinc Oxide	EMULSION	TOPICAL	20200701		OTC MONOGRAPH FINAL	part352	Almay	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	5; 5; 5; 5.8; 3.94	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0311-0724_c3dea7dd-6023-112e-e053-2a95a90aab0c	0311-0724	HUMAN OTC DRUG	ALMAY CLEAR COMPLEXION MAKEUP		SALICYLIC ACID	EMULSION	TOPICAL	20210316		OTC MONOGRAPH FINAL	part358H	ALMAY	SALICYLIC ACID	1	mg/mL			N	20241231
0311-0725_c3b57024-120f-390f-e053-2a95a90a6d35	0311-0725	HUMAN OTC DRUG	ALMAY CLEAR COMPLEXION CONCEALER		SALICYLIC ACID	LIQUID	TOPICAL	20210305		OTC MONOGRAPH FINAL	part358H	ALMAY	SALICYLIC ACID	2	mg/2mL			N	20241231
0316-0100_0c9326fe-9396-a166-e063-6294a90a167e	0316-0100	HUMAN OTC DRUG	Ulcerease		phenol 0.6% anesthetic oral rinse	RINSE	ORAL	19770328	20250829	OTC MONOGRAPH DRUG	M022	Crown Laboratories	PHENOL	6	mg/mL			N	
0316-0118_0aacd913-975c-b6f8-e063-6294a90a5f3e	0316-0118	HUMAN OTC DRUG	Sulfo lo		Sulfur 3% Soap Bar	SOAP	TOPICAL	19651101		OTC MONOGRAPH DRUG	M006	Crown Laboratories	SULFUR	30	mg/g			N	20241231
0316-0126_087b94eb-d121-11d0-e063-6294a90a53fc	0316-0126	HUMAN PRESCRIPTION DRUG	Alacort		Hydrocortisone	CREAM	TOPICAL	19730309		ANDA	ANDA080706	Crown Laboratories	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0316-0128_087b94eb-d121-11d0-e063-6294a90a53fc	0316-0128	HUMAN PRESCRIPTION DRUG	Alacort		Hydrocortisone	CREAM	TOPICAL	20160106		ANDA	ANDA080706	Crown Laboratories	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0316-0143_0c93a2f8-8188-15fb-e063-6394a90a5521	0316-0143	HUMAN OTC DRUG	PanOxyl		Adapalene	GEL	TOPICAL	20230206		ANDA	ANDA215940	CROWN LABORATORIES	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0316-0165_087c46f5-119d-cdd3-e063-6294a90a58e5	0316-0165	HUMAN PRESCRIPTION DRUG	TRIDERM		Triamcinolone Acetonide	CREAM	TOPICAL	19840319		ANDA	ANDA088042	Crown Laboratories	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0316-0170_087c46f5-119d-cdd3-e063-6294a90a58e5	0316-0170	HUMAN PRESCRIPTION DRUG	TRIDERM		Triamcinolone Acetonide	CREAM	TOPICAL	19840319		ANDA	ANDA088042	Crown Laboratories	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0316-0175_087c46f5-119d-cdd3-e063-6294a90a58e5	0316-0175	HUMAN PRESCRIPTION DRUG	TRIDERM		Triamcinolone Acetonide	CREAM	TOPICAL	19840319		ANDA	ANDA088042	Crown Laboratories	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0316-0186_087b5751-4553-c71c-e063-6394a90ac98f	0316-0186	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	19730309		ANDA	ANDA080706	Crown Laboratories	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0316-0193_087b5751-4553-c71c-e063-6394a90ac98f	0316-0193	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160106		ANDA	ANDA080706	Crown Laboratories	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0316-0221_087c02ff-9dd7-4053-e063-6394a90a4937	0316-0221	HUMAN PRESCRIPTION DRUG	Nystatin Cream		Nystatin Cream	CREAM	TOPICAL	20171010		ANDA	ANDA207733	Crown Laboratories	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0316-0223_087be530-68c1-bfaa-e063-6294a90ae1d3	0316-0223	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20180102		ANDA	ANDA207730	Crown Laboratories	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0316-0225_09cd922d-258a-3903-e063-6394a90ae99a	0316-0225	HUMAN OTC DRUG	Desenex		MICONAZOLE NITRATE	POWDER	TOPICAL	20231019		OTC MONOGRAPH DRUG	M005	Crown Laboratories	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0316-0225_0c935646-fc62-0630-e063-6394a90acc57	0316-0225	HUMAN OTC DRUG	Desenex		MICONAZOLE NITRATE	POWDER	TOPICAL	20090803	20250724	OTC MONOGRAPH DRUG	M005	Crown Laboratories	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
0316-0226_0a5be3d9-8fe1-03c2-e063-6294a90a7d56	0316-0226	HUMAN OTC DRUG	Mineral Ice	Pain Relieving	Menthol	GEL	TOPICAL	20111101		OTC MONOGRAPH DRUG	M017	Crown Laboratories	MENTHOL	20	mg/g			N	20241231
0316-0227_0a0b34ba-2f57-27a4-e063-6394a90a0777	0316-0227	HUMAN OTC DRUG	PanOxyl		benzoyl peroxide	CREAM	TOPICAL	20110325		OTC MONOGRAPH DRUG	M006	Crown Laboratories	BENZOYL PEROXIDE	58.7	mg/g			N	20241231
0316-0228_0a0b34ba-2f57-27a4-e063-6394a90a0777	0316-0228	HUMAN OTC DRUG	PanOxyl		benzoyl peroxide	CREAM	TOPICAL	20110325		OTC MONOGRAPH DRUG	M006	Crown Laboratories	BENZOYL PEROXIDE	146.7	mg/g			N	20241231
0316-0229_0a5c7f7a-1090-128b-e063-6394a90a09ca	0316-0229	HUMAN OTC DRUG	Sarna		camphor and menthol	LOTION	TOPICAL	20110222		OTC MONOGRAPH DRUG	M017	Crown Laboratories	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	5; 5	mg/mL; mg/mL			N	20241231
0316-0230_0a5caaee-7f11-6e7b-e063-6294a90ab9b4	0316-0230	HUMAN OTC DRUG	Sarna		pramoxine hydrochloride	LOTION	TOPICAL	20110222		OTC MONOGRAPH DRUG	M017	Crown Laboratories	PRAMOXINE HYDROCHLORIDE	10	mg/mL			N	20241231
0316-0231_0c935646-fc64-0630-e063-6394a90acc57	0316-0231	HUMAN OTC DRUG	Zeasorb		miconazole nitrate	POWDER	TOPICAL	20110314	20250331	OTC MONOGRAPH DRUG	M005	Crown Laboratories	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
0316-0232_0c935646-fc64-0630-e063-6394a90acc57	0316-0232	HUMAN OTC DRUG	Zeasorb		miconazole nitrate	POWDER	TOPICAL	20110314	20250416	OTC MONOGRAPH DRUG	M005	Crown Laboratories	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
0316-0263_f49cf15f-5539-6fbd-e053-2a95a90a6bd8	0316-0263	HUMAN OTC DRUG	PanOxyl Oil Control Moisturizer		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20210309		OTC MONOGRAPH NOT FINAL	part352	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	10; 83.4	mg/g; mg/g			N	20241231
0316-0264_08b8bdab-ea9c-bc6b-e063-6394a90a0f3e	0316-0264	HUMAN OTC DRUG	PanOxyl		Benzoyl Peroxide	SOAP	TOPICAL	20230701		OTC MONOGRAPH DRUG	M006	Crown Laboratories	BENZOYL PEROXIDE	12.6	g/113g			N	20241231
0316-0269_0a4ae60a-db57-08dc-e063-6394a90a4056	0316-0269	HUMAN OTC DRUG	PanOxyl Oil AM Control Moisturizer		Zinc Oxide	LOTION	TOPICAL	20230113		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	170	mg/g			N	20241231
0316-0290_0c930b31-16fe-ef83-e063-6394a90af90d	0316-0290	HUMAN OTC DRUG	Mineral Ice Quick Dry Foam		Menthol	AEROSOL, FOAM	TOPICAL	20210430	20240731	OTC MONOGRAPH DRUG	M017	Crown Laboratories	MENTHOL	100	mg/g			N	
0316-0291_0c933e1b-c9c1-ab91-e063-6294a90aca64	0316-0291	HUMAN OTC DRUG	Sarna Whipped Foam		Hydrocortisone	AEROSOL, FOAM	TOPICAL	20210315	20240131	OTC MONOGRAPH DRUG	M017	Crown Laboratories	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0316-0296_08a44d1a-b01b-80bc-e063-6294a90af2bd	0316-0296	HUMAN OTC DRUG	PanOxyl Clarifying Exfoliant		salicylic acid	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	M006	Crown Laboratories, Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
0316-0300_0c92dfc3-782c-e11f-e063-6394a90a2f8a	0316-0300	HUMAN OTC DRUG	BIOJUVE Microbiome-Safe Sheer Finish SPF 50 Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20221025		OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	99.9; 66.6	mg/mL; mg/mL			N	20241231
0316-2011_0bc5ae14-3259-2b66-e063-6394a90a674c	0316-2011	HUMAN OTC DRUG	Blue Lizard Baby SPF 50		zinc oxide	STICK	TOPICAL	20191125		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	20	mg/g			N	20241231
0316-2012_0bc660be-6e64-6584-e063-6394a90a01fe	0316-2012	HUMAN OTC DRUG	Blue Lizard Kids SPF 50		zinc oxide	STICK	TOPICAL	20191125		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	20	mg/g			N	20241231
0316-2013_0bc6daea-0e95-ba61-e063-6294a90adb54	0316-2013	HUMAN OTC DRUG	Blue Lizard Sensitive SPF 50		zinc oxide	STICK	TOPICAL	20191125		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	20	mg/g			N	20241231
0316-2021_0bc58eff-d05f-fd74-e063-6394a90afce2	0316-2021	HUMAN OTC DRUG	Blue Lizard Sport Sunscreen		Octocrylene and Zinc Oxide	LOTION	TOPICAL	20190102		OTC MONOGRAPH DRUG	M020	Crown Laboratories	OCTOCRYLENE; ZINC OXIDE	41.8; 104.5	mg/mL; mg/mL			N	20241231
0316-2035_0bd864a0-cb35-8dbf-e063-6294a90a4adb	0316-2035	HUMAN OTC DRUG	Blue Lizard Baby		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20031208	20240229	OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	54; 108	mg/mL; mg/mL			N	
0316-2036_0bc7fab1-727e-d911-e063-6394a90a8174	0316-2036	HUMAN OTC DRUG	Blue Lizard Baby SPF 50 Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20200129		OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	89.6; 112	mg/mL; mg/mL			N	20241231
0316-2045_0bb3a503-8ba6-271e-e063-6394a90a0fd6	0316-2045	HUMAN OTC DRUG	Blue Lizard Sensitive Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20031208		OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	54; 108	mg/mL; mg/mL			N	20241231
0316-2046_0bc74f51-ac53-4b1b-e063-6294a90a6d30	0316-2046	HUMAN OTC DRUG	Blue Lizard Sensitive SPF 50 Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20200129		OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	89.6; 112	mg/mL; mg/mL			N	20241231
0316-2055_0bc824f9-7b49-09c1-e063-6294a90ae0f2	0316-2055	HUMAN OTC DRUG	Blue Lizard Face		Sunscreen	GEL	TOPICAL	20100406	20240331	OTC MONOGRAPH DRUG	M020	Crown Laboratories	OCTINOXATE; ZINC OXIDE	55; 80	mg/g; mg/g			N	
0316-2056_0bc550a7-098f-75e4-e063-6294a90a9fc1	0316-2056	HUMAN OTC DRUG	Blue Lizard Sensitive Face Sunscreen		Titanium Dioxide, Zinc Oxide	GEL	TOPICAL	20190130		OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	10; 83.4	mg/g; mg/g			N	20241231
0316-2057_0bc915c5-ecaf-e7f7-e063-6294a90a2e4f	0316-2057	HUMAN OTC DRUG	Blue Lizard Sheer Face SPF 50 Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20210513		OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	99.9; 66.6	mg/mL; mg/mL			N	20241231
0316-2062_0bc8fdf2-a52f-d218-e063-6294a90a031d	0316-2062	HUMAN OTC DRUG	Blue Lizard Kids SPF 50 Sunscreen		Octisalate and Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	Crown Laboratories	OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	55.5; 59.5; 111	mg/mL; mg/mL; mg/mL			N	20241231
0316-2064_0bca6995-8055-ab04-e063-6394a90a8f7f	0316-2064	HUMAN OTC DRUG	Blue Lizard Sheer SPF 50 Sunscreen		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210506		OTC MONOGRAPH DRUG	M020	Crown Laboratories	TITANIUM DIOXIDE; ZINC OXIDE	99.9; 66.6	mg/mL; mg/mL			N	20241231
0316-2071_0bb582bb-acd0-5f58-e063-6294a90aa88d	0316-2071	HUMAN OTC DRUG	Blue Lizard Active Sunscreen		Octocrylene and Zinc Oxide	LOTION	TOPICAL	20190102		OTC MONOGRAPH DRUG	M020	Crown Laboratories	OCTOCRYLENE; ZINC OXIDE	41.8; 104.5	mg/mL; mg/mL			N	20241231
0316-2072_0bb52e03-d658-ab38-e063-6394a90a72ba	0316-2072	HUMAN OTC DRUG	Blue Lizard Active SPF 50 Sunscreen		Octisalate and Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	Crown Laboratories	OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	55.5; 59.5; 111	mg/mL; mg/mL; mg/mL			N	20241231
0316-2075_0bb4c8af-8975-88cd-e063-6394a90a076c	0316-2075	HUMAN OTC DRUG	Blue Lizard Sport SPF 50 Sunscreen		Octisalate and Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	Crown Laboratories	OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	55.5; 59.5; 111	mg/mL; mg/mL; mg/mL			N	20241231
0316-2080_0bc99cab-0995-55ee-e063-6294a90a3dc5	0316-2080	HUMAN OTC DRUG	Blue Lizard Sport SPF 50		zinc oxide	SPRAY	TOPICAL	20210329		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	24	mg/g			N	20241231
0316-2081_0bca24fd-f0b9-9a53-e063-6394a90ae8c8	0316-2081	HUMAN OTC DRUG	Blue Lizard Kids SPF 50		zinc oxide	SPRAY	TOPICAL	20210329		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	24	mg/g			N	20241231
0316-2082_0bca51f3-854b-a465-e063-6394a90a481e	0316-2082	HUMAN OTC DRUG	Blue Lizard Active SPF 50		zinc oxide	SPRAY	TOPICAL	20210329		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	24	mg/g			N	20241231
0316-2083_0bc9324d-a961-45a2-e063-6394a90a4458	0316-2083	HUMAN OTC DRUG	Blue Lizard Sensitive SPF 50		zinc oxide	SPRAY	TOPICAL	20210329		OTC MONOGRAPH DRUG	M020	Crown Laboratories	ZINC OXIDE	24	mg/g			N	20241231
0316-8000_09bb313e-90cb-5629-e063-6294a90ac268	0316-8000	HUMAN OTC DRUG	Zeasorb Athletes Foot		MICONAZOLE NITRATE	POWDER	TOPICAL	20231019		OTC MONOGRAPH DRUG	M005	Crown Laboratories	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0316-8001_09d088ef-aab3-5565-e063-6394a90af263	0316-8001	HUMAN OTC DRUG	Zeasorb Jock Itch		MICONAZOLE NITRATE	POWDER	TOPICAL	20231019		OTC MONOGRAPH DRUG	M005	Crown Laboratories	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0322-2222_0c92744b-a2ad-3402-e063-6294a90aa674	0322-2222	HUMAN OTC DRUG	Percy Medicine		Bismuth Subsalicylate	LIQUID	ORAL	20190909		OTC MONOGRAPH DRUG	M008	Merrick Medicine Company, Inc	BISMUTH SUBSALICYLATE	1050	mg/10mL			N	20241231
0327-0001_cb389c70-6709-4f4d-93ce-5c152cb3754c	0327-0001	HUMAN OTC DRUG	Clorpactin WCS-90		chlorine	POWDER, FOR SOLUTION	TOPICAL	19550101		UNAPPROVED DRUG OTHER		United-Guardian, Inc.	CHLORINE	.16	g/2g			N	20241231
0327-0012_73bb8d15-8d5c-426c-b42f-504a5da9cb8e	0327-0012	HUMAN PRESCRIPTION DRUG	Renacidin		citric acid, gluconolactone and magnesium carbonate	SOLUTION	IRRIGATION	20160201		NDA	NDA019481	United-Guardian, Inc.	ANHYDROUS CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE	6.602; .198; 3.268	g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Irrigation [MoA]		N	20241231
0338-0003_fdceac9b-eb01-4c04-9a29-5ff50ed44090	0338-0003	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	IRRIGANT	IRRIGATION	19800530		NDA	NDA017866	Baxter Healthcare Corporation	WATER	100	mL/100mL			N	20241231
0338-0004_fdceac9b-eb01-4c04-9a29-5ff50ed44090	0338-0004	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	IRRIGANT	IRRIGATION	19741231		NDA	NDA017428	Baxter Healthcare Corporation	WATER	100	mL/100mL			N	20241231
0338-0008_32e40160-b01b-4ec7-bb5f-cc5f82d4f749	0338-0008	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant Dimeglumine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190905		ANDA	ANDA211860	Baxter Healthcare Corporation	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0338-0013_99ac5fd0-064f-4a9b-8e9b-1abe0a3b170d	0338-0013	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION, SOLUTION	INTRAVENOUS	19820630		NDA	NDA018632	Baxter Healthcare Company	WATER	100	mL/100mL			N	20241231
0338-0013_a6cc713d-1548-485a-8898-1045ad4bfd42	0338-0013	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION, SOLUTION	INTRAVENOUS	19820630		NDA	NDA018632	Baxter Healthcare Company	WATER	100	mL/100mL			N	20241231
0338-0017_99c477eb-8c99-4a13-928d-405f84a116dc	0338-0017	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	19710304		NDA	NDA016673	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	50	g/1000mL			N	20241231
0338-0023_99c477eb-8c99-4a13-928d-405f84a116dc	0338-0023	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	19710125		NDA	NDA016694	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	100	g/1000mL			N	20241231
0338-0043_3e1de52f-b27d-45e7-b84e-badb273620a9	0338-0043	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA018016	Baxter Healthcare Corporation	SODIUM CHLORIDE	4.5	g/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0047_de39184e-f033-4566-a07a-e27e33df9282	0338-0047	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	IRRIGANT	IRRIGATION	19800530		NDA	NDA017867	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0047_ebb175d8-e9bf-408c-a86e-c343ce000aa1	0338-0047	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	IRRIGANT	IRRIGATION	19800530		NDA	NDA017867	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0048_21d5c4cb-3c23-4352-aec2-f344efa3d45d	0338-0048	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	IRRIGANT	IRRIGATION	19741231		NDA	NDA017427	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0049_3e1de52f-b27d-45e7-b84e-badb273620a9	0338-0049	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19701209		NDA	NDA016677	Baxter Healthcare Corporation	SODIUM CHLORIDE	9	g/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0050_ba09e96a-1195-42c5-a009-e190c0d7a501	0338-0050	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	SOLUTION	EXTRACORPOREAL	19800530		NDA	NDA017867	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0051_307aee77-ffc9-495f-8f28-1cbac2894d49	0338-0051	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	IRRIGANT	IRRIGATION	19850517		NDA	NDA019319	Baxter Healthcare Corporation	SODIUM CHLORIDE	9	g/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0054_a414d388-f1ef-4db6-bda3-b9fbef047307	0338-0054	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19831101		NDA	NDA019022	Baxter Healthcare Corporation	SODIUM CHLORIDE	3	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0056_a414d388-f1ef-4db6-bda3-b9fbef047307	0338-0056	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19831101		NDA	NDA019022	Baxter Healthcare Corporation	SODIUM CHLORIDE	5	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0062_47f44292-e964-419b-895e-c588aee37a9e	0338-0062	HUMAN PRESCRIPTION DRUG	DEXTROSE		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19710304		NDA	NDA016673	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0063_4915523a-9314-41a6-8e48-540db0acf65a	0338-0063	HUMAN PRESCRIPTION DRUG	DOXIL		doxorubicin hydrochloride	INJECTION, SUSPENSION, LIPOSOMAL	INTRAVENOUS	20190813		NDA	NDA050718	Baxter Healthcare Corporation	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0338-0066_47f44292-e964-419b-895e-c588aee37a9e	0338-0066	HUMAN PRESCRIPTION DRUG	DEXTROSE		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19710304		NDA	NDA016673	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0067_4915523a-9314-41a6-8e48-540db0acf65a	0338-0067	HUMAN PRESCRIPTION DRUG	DOXIL		doxorubicin hydrochloride	INJECTION, SUSPENSION, LIPOSOMAL	INTRAVITREAL	20190813		NDA	NDA050718	Baxter Healthcare Corporation	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0338-0069_33797a65-2f9c-421c-918a-5a3223b2ed68	0338-0069	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181130		ANDA	ANDA209900	Baxter Healthcare Corporation	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0338-0070_47f44292-e964-419b-895e-c588aee37a9e	0338-0070	HUMAN PRESCRIPTION DRUG	DEXTROSE		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19710304		NDA	NDA016673	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0072_33797a65-2f9c-421c-918a-5a3223b2ed68	0338-0072	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181130		ANDA	ANDA209900	Baxter Healthcare Corporation	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0338-0073_cc51c42d-34d6-473a-9a67-a5224187c907	0338-0073	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		Dextrose and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19710322		NDA	NDA016697	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	2.5; 450	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0074_47f44292-e964-419b-895e-c588aee37a9e	0338-0074	HUMAN PRESCRIPTION DRUG	DEXTROSE		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19710304		NDA	NDA016673	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0076_33797a65-2f9c-421c-918a-5a3223b2ed68	0338-0076	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181130		ANDA	ANDA209900	Baxter Healthcare Corporation	KETOROLAC TROMETHAMINE	15	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0338-0077_cc51c42d-34d6-473a-9a67-a5224187c907	0338-0077	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		Dextrose and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19701208		NDA	NDA016689	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; 200	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0078_47f44292-e964-419b-895e-c588aee37a9e	0338-0078	HUMAN PRESCRIPTION DRUG	DEXTROSE		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19710304		NDA	NDA016673	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0080_5962766d-9826-4839-ba79-e21af641a72f	0338-0080	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride Liposome		Doxorubicin Hydrochloride Liposome	INJECTION, SUSPENSION, LIPOSOMAL	INTRAVENOUS	20190815		NDA AUTHORIZED GENERIC	NDA050718	Baxter Healthcare Corporation	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0338-0081_cc51c42d-34d6-473a-9a67-a5224187c907	0338-0081	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		Dextrose and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19710322		NDA	NDA016687	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; 330	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0082_47f44292-e964-419b-895e-c588aee37a9e	0338-0082	HUMAN PRESCRIPTION DRUG	DEXTROSE		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19710304		NDA	NDA016673	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0085_cc51c42d-34d6-473a-9a67-a5224187c907	0338-0085	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		Dextrose and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19710322		NDA	NDA016683	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; 450	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0086_5962766d-9826-4839-ba79-e21af641a72f	0338-0086	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride Liposome		Doxorubicin Hydrochloride Liposome	INJECTION, SUSPENSION, LIPOSOMAL	INTRAVENOUS	20190815		NDA AUTHORIZED GENERIC	NDA050718	Baxter Healthcare Corporation	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0338-0089_cc51c42d-34d6-473a-9a67-a5224187c907	0338-0089	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		Dextrose and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19701209		NDA	NDA016678	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; 900	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0104_36a1e6dd-9bf2-40d7-8879-9fa472a9efe9	0338-0104	HUMAN PRESCRIPTION DRUG	Ringers		sodium chloride, calcium chloride, potassium chloride,	IRRIGANT	IRRIGATION	19820219		NDA	NDA018495	Baxter Healthcare Corporation	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	33; 30; 860	mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0108_c35f2239-b566-442c-abd0-2a909cf930d5	0338-0108	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		norepinephrine bitartrate	INJECTION, SOLUTION	INTRAVENOUS	20210115		NDA	NDA214313	Baxter Healthcare Corporation	NOREPINEPHRINE BITARTRATE	8	mg/250mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0338-0112_c35f2239-b566-442c-abd0-2a909cf930d5	0338-0112	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		norepinephrine bitartrate	INJECTION, SOLUTION	INTRAVENOUS	20210115		NDA	NDA214313	Baxter Healthcare Corporation	NOREPINEPHRINE BITARTRATE	4	mg/250mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0338-0114_0fdf81e2-45e9-4cfc-b26a-7f581ca10fce	0338-0114	HUMAN PRESCRIPTION DRUG	Lactated Ringers		sodium chloride, sodium lactate, potassium chloride, calcium chloride	IRRIGANT	IRRIGATION	19820219		NDA	NDA018494	Baxter Healthcare Corporation	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0116_c35f2239-b566-442c-abd0-2a909cf930d5	0338-0116	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		norepinephrine bitartrate	INJECTION, SOLUTION	INTRAVENOUS	20231121		NDA	NDA214313	Baxter Healthcare Corporation	NOREPINEPHRINE BITARTRATE	16	mg/250mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0338-0117_93c6233c-8806-49d1-a795-7834b43ad3d5	0338-0117	HUMAN PRESCRIPTION DRUG	Lactated Ringers		Sodium chloride, potassium chloride, sodium lactate and calcium chloride	INJECTION, SOLUTION	INTRAVENOUS	19710322		NDA	NDA016682	Baxter Healthcare Corporation	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0125_f63912ec-66cd-4c53-9730-0344e8ceb352	0338-0125	HUMAN PRESCRIPTION DRUG	Lactated Ringers and Dextrose		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	19710322		NDA	NDA016679	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 5; 30; 600; 310	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0126_a81a584d-6d29-4dc6-b74a-8d4831c1bcb7	0338-0126	HUMAN PRESCRIPTION DRUG	MYXREDLIN		insulin human	INJECTION, SOLUTION	INTRAVENOUS	20190712		BLA	BLA208157	Baxter Healthcare Corporation	INSULIN HUMAN	1	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
0338-0137_4a5cd867-a6cd-45fc-8afd-9cc103a4d262	0338-0137	HUMAN PRESCRIPTION DRUG	Lactated Ringers		sodium chloride, soldium lactate, potassium chloride and calcium chloride	IRRIGANT	IRRIGATION	19840403		NDA	NDA018921	Baxter Healthcare Corporation	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	200; 300; 6; 3.1	mg/1000mL; mg/1000mL; g/1000mL; g/1000mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0143_16f0eb2d-53c0-41d1-b2e3-51de371a0be3	0338-0143	HUMAN PRESCRIPTION DRUG	Dextrose and Electrolyte No. 48		Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride and Dextrose monohydrate	INJECTION	INTRAVENOUS	19790202		NDA	NDA017484	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE	5; 31; 141; 20; 12; 260	g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0160_d9e9dd44-82bd-40f6-8ea0-fb17574ad06c	0338-0160	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0162_d9e9dd44-82bd-40f6-8ea0-fb17574ad06c	0338-0162	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0164_d9e9dd44-82bd-40f6-8ea0-fb17574ad06c	0338-0164	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0166_d9e9dd44-82bd-40f6-8ea0-fb17574ad06c	0338-0166	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0170_7197131a-10b2-45c5-8e64-6e5b573fe7ab	0338-0170	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	2.5	g/50mL			N	20241231
0338-0172_7197131a-10b2-45c5-8e64-6e5b573fe7ab	0338-0172	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0174_7197131a-10b2-45c5-8e64-6e5b573fe7ab	0338-0174	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	2.5	g/50mL			N	20241231
0338-0176_7197131a-10b2-45c5-8e64-6e5b573fe7ab	0338-0176	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0179_132f2e9f-735e-4e30-bb10-9c81330e2100	0338-0179	HUMAN PRESCRIPTION DRUG	Plasma-Lyte 148		SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA017378	Baxter Healthcare Corporation	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE	30; 37; 368; 526; 502	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0180_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-0180	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 14; 824; 384; 480; 584; 464; 320; 448; 544; 400; 336; 144; 32; 464	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0182_c944b085-b1da-47f3-9a39-01e339b122f4	0338-0182	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	450	mg/50mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0184_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-0184	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION, EMULSION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 14; 824; 384; 480; 584; 464; 320; 448; 544; 400; 336; 144; 32; 464	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0186_c944b085-b1da-47f3-9a39-01e339b122f4	0338-0186	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0188_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-0188	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 10; 515; 384; 480; 584; 464; 320; 448; 544; 400; 336; 144; 32; 464	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0190_5f7d8eae-8cde-4b08-89e8-7721c45c1036	0338-0190	HUMAN PRESCRIPTION DRUG	TIS-U-SOL		sodium chloride, potassium chloride, magnesium sulfate, sodium phosphate, and potassium phosphate	IRRIGANT	IRRIGATION	19820219		NDA	NDA018508	Baxter Healthcare Corporation	MAGNESIUM SULFATE HEPTAHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	20; 40; 6.25; 800; 8.75	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0192_c944b085-b1da-47f3-9a39-01e339b122f4	0338-0192	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	450	mg/50mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0194_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-0194	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 10; 824; 384; 480; 584; 464; 320; 448; 544; 400; 336; 144; 32; 464	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0196_c944b085-b1da-47f3-9a39-01e339b122f4	0338-0196	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0198_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-0198	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1242; 690; 5; 618; 288; 360; 438; 348; 200; 336; 408; 300; 252; 108; 24; 348	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0202_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-0202	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	20200921		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 33; 14; 824; 384; 480; 584; 464; 51; 320; 448; 261; 544; 400; 340; 205; 336; 144; 32; 464	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0204_eab39c66-8e4b-480a-891e-30f30bdf3580	0338-0204	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	2.5	g/50mL			N	20241231
0338-0206_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-0206	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	20200921		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 33; 14; 824; 384; 480; 584; 464; 51; 320; 448; 261; 544; 400; 340; 205; 336; 144; 32; 464	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0208_eab39c66-8e4b-480a-891e-30f30bdf3580	0338-0208	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0210_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-0210	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	20200921		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 33; 10; 824; 384; 480; 584; 464; 51; 320; 448; 261; 544; 400; 340; 205; 336; 144; 32; 464	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0211_eab39c66-8e4b-480a-891e-30f30bdf3580	0338-0211	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	2.5	g/50mL			N	20241231
0338-0214_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-0214	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	20200921		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1656; 920; 33; 10; 824; 384; 480; 584; 464; 51; 320; 448; 261; 544; 400; 340; 205; 336; 144; 32; 464	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0216_eab39c66-8e4b-480a-891e-30f30bdf3580	0338-0216	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0221_15e14ca4-cf1b-4445-8025-e97abacc228d	0338-0221	HUMAN PRESCRIPTION DRUG	Plasma-Lyte A		Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA017378	Baxter Healthcare Corporation	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE	30; 37; 368; 526; 502	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0289_7daa1386-10ac-42b8-b948-162370d08007	0338-0289	HUMAN PRESCRIPTION DRUG	Glycine		Glycine	SOLUTION	IRRIGATION	19800530		NDA	NDA017865	Baxter Healthcare Corporation	GLYCINE	1.5	g/100mL			N	20241231
0338-0295_2ea45388-9467-4a8f-9d88-6a2008a389a4	0338-0295	HUMAN PRESCRIPTION DRUG	Sorbitol		Sorbitol	IRRIGANT	IRRIGATION	19800530		NDA	NDA017863	Baxter Healthcare Corporation	SORBITOL	30	g/1000mL			N	20241231
0338-0322_11e93be9-a63f-4f96-9266-8a84ffb0ba38	0338-0322	HUMAN PRESCRIPTION DRUG	RECOTHROM		thrombin topical recombinant	KIT		20080129		BLA	BLA125248	Baxter Healthcare Corporation						N	20241231
0338-0326_11e93be9-a63f-4f96-9266-8a84ffb0ba38	0338-0326	HUMAN PRESCRIPTION DRUG	RECOTHROM		thrombin topical recombinant	KIT		20080609		BLA	BLA125248	Baxter Healthcare Corporation						N	20241231
0338-0330_11e93be9-a63f-4f96-9266-8a84ffb0ba38	0338-0330	HUMAN PRESCRIPTION DRUG	RECOTHROM		thrombin topical recombinant	KIT		20080609		BLA	BLA125248	Baxter Healthcare Corporation						N	20241231
0338-0341_96bad26f-90cf-4e05-83d8-6d227eb19395	0338-0341	HUMAN PRESCRIPTION DRUG	Cardioplegic		Calcium Chloride, Magnesium Chloride, Potassium Chloride and Sodium Chloride	SOLUTION	INTRA-ARTERIAL	20000421		ANDA	ANDA075323	Baxter Healthcare Corporation	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	17.6; 325.3; 119.3; 643	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-0353_5cb91724-aefd-40ef-8134-b3087e369a78	0338-0353	HUMAN PRESCRIPTION DRUG	Osmitrol		Mannitol	INJECTION, SOLUTION	INTRAVENOUS	19640608		NDA	NDA013684	Baxter Healthcare Corporation	MANNITOL	10	g/100mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0338-0355_5cb91724-aefd-40ef-8134-b3087e369a78	0338-0355	HUMAN PRESCRIPTION DRUG	Osmitrol		Mannitol	INJECTION, SOLUTION	INTRAVENOUS	19640608		NDA	NDA013684	Baxter Healthcare Corporation	MANNITOL	15	g/100mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0338-0357_5cb91724-aefd-40ef-8134-b3087e369a78	0338-0357	HUMAN PRESCRIPTION DRUG	Osmitrol		Mannitol	INJECTION, SOLUTION	INTRAVENOUS	19640608		NDA	NDA013684	Baxter Healthcare Corporation	MANNITOL	20	g/100mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0338-0409_ea052102-b3a3-422a-851c-512646352c78	0338-0409	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Dextrose		Lidocaine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19810422		NDA	NDA018461	Baxter Healthcare Corporation	LIDOCAINE HYDROCHLORIDE	4	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0338-0411_ea052102-b3a3-422a-851c-512646352c78	0338-0411	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Dextrose		Lidocaine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19810422		NDA	NDA018461	Baxter Healthcare Corporation	LIDOCAINE HYDROCHLORIDE	8	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0338-0424_751d833a-06dd-4b1d-a2fc-2174a717065c	0338-0424	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM IN SODIUM CHLORIDE		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	19820428		NDA	NDA018609	Baxter Healthcare Corporation	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0338-0428_751d833a-06dd-4b1d-a2fc-2174a717065c	0338-0428	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM IN SODIUM CHLORIDE		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	19820428		NDA	NDA018609	Baxter Healthcare Corporation	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0338-0431_751d833a-06dd-4b1d-a2fc-2174a717065c	0338-0431	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM IN SODIUM CHLORIDE		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	19820428		NDA	NDA018609	Baxter Healthcare Corporation	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0338-0433_751d833a-06dd-4b1d-a2fc-2174a717065c	0338-0433	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM IN SODIUM CHLORIDE		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	19820428		NDA	NDA018609	Baxter Healthcare Corporation	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0338-0499_11d8580d-073d-4220-a246-244ca79c3838	0338-0499	HUMAN PRESCRIPTION DRUG	ProSol		Valine, Lysine, Histidine, Isoleucine, Leucine, Phenylalanine, Threonine, Methionine, Tryptophan, Alanine, Glycine, Arginine, Proline, Glutamic Acid, Serine, Aspartic Acid and Tyrosine	INJECTION, SOLUTION	INTRAVENOUS	19980826		NDA	NDA020849	Baxter Healthcare Corporation	ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	2.76; 1.96; 600; 1.02; 2.06; 1.18; 1.08; 1.08; 1.35; 760; 1; 1.34; 1.02; 980; 320; 50; 1.44	g/100mL; g/100mL; mg/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; mg/100mL; g/100mL; g/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0502_7d4094c6-d6a1-435f-af48-1a9315c93696	0338-0502	HUMAN PRESCRIPTION DRUG	Clinisol		Lysine, Leucine, Phenylalanine, Valine, Histidine, Isoleucine, Methionine, Threonine, Tryptophan, Alanine, Arginine, Glycine, Proline, Glutamic Acid, Serine, Aspartic Acid, Tyrosine	INJECTION, SOLUTION	INTRAVENOUS	19960830		ANDA	ANDA020512	Baxter Healthcare Corporation	ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	2.17; 1.47; 434; 749; 1.04; 894; 749; 1.04; 1.18; 749; 1.04; 894; 592; 749; 250; 39; 960	g/100mL; g/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; g/100mL; g/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0503_8d447ef1-0cc4-4984-9e9a-4bc9217597cf	0338-0503	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate in Sodium Chloride		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAVENOUS	19820907		ANDA	ANDA062373	Baxter Healthcare Corporation	GENTAMICIN SULFATE	80	mg/100mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0338-0505_8d447ef1-0cc4-4984-9e9a-4bc9217597cf	0338-0505	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate in Sodium Chloride		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAVENOUS	19820907		ANDA	ANDA062373	Baxter Healthcare Corporation	GENTAMICIN SULFATE	100	mg/100mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0338-0507_8d447ef1-0cc4-4984-9e9a-4bc9217597cf	0338-0507	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate in Sodium Chloride		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAVENOUS	19820907		ANDA	ANDA062373	Baxter Healthcare Corporation	GENTAMICIN SULFATE	60	mg/50mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0338-0509_8d447ef1-0cc4-4984-9e9a-4bc9217597cf	0338-0509	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate in Sodium Chloride		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAVENOUS	19820907		ANDA	ANDA062373	Baxter Healthcare Corporation	GENTAMICIN SULFATE	80	mg/50mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0338-0511_8d447ef1-0cc4-4984-9e9a-4bc9217597cf	0338-0511	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate in Sodium Chloride		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAVENOUS	19820907		ANDA	ANDA062373	Baxter Healthcare Corporation	GENTAMICIN SULFATE	100	mg/50mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0338-0518_3044bcdc-50b3-437a-ad5e-6871defe1676	0338-0518	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20141212		NDA	NDA017643	Baxter Healthcare CORP	SOYBEAN OIL	10	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
0338-0519_75a235ef-1390-4ba5-abe5-27744d698537	0338-0519	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA020248	Baxter Healthcare Corporation	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
0338-0519_7f10161b-9f00-3f03-e053-2991aa0adcd4	0338-0519	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA020248	Baxter Healthcare Corporation	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
0338-0519_a34dffef-567f-47fe-9f33-3370819874c8	0338-0519	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA018449	Baxter Healthcare Corporation	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
0338-0520_b2f1f6aa-ceed-4246-95df-c3d3c1e0db3d	0338-0520	HUMAN PRESCRIPTION DRUG	Intralipid		I. V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA019942	Baxter Healthcare Corporation	SOYBEAN OIL	30	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
0338-0551_8b5173f8-9289-4cdc-a895-cebb2631fd57	0338-0551	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-0553_5f7d1a06-9e08-4b84-8252-1f8d08b59d9e	0338-0553	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-0603_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0603	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19820323		NDA	NDA018629	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 150; 330	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0644_b9d0470e-41ab-4151-84c4-a7b9defbcefd	0338-0644	HUMAN PRESCRIPTION DRUG	Travasol		Leucine, Phenylalanine, Lysine hydrochloride, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Tyrosine, Serine	INJECTION	INTRAVENOUS	19840823		NDA	NDA018931	Baxter Healthcare Corporation	ALANINE; ARGININE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	2.07; 1.15; 1.03; 480; 600; 730; 580; 400; 560; 680; 500; 420; 180; 40; 580	g/100mL; g/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-0656_dd2b0094-aaf5-47b2-9b91-74b063f15b2c	0338-0656	HUMAN PRESCRIPTION DRUG	Acetic Acid		Acetic Acid	IRRIGANT	IRRIGATION	19820219		NDA	NDA018523	Baxter Healthcare Corporation	ACETIC ACID	250	mg/100mL			N	20241231
0338-0663_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0663	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA018037	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 150; 200	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0669_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0669	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA018008	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 75; 450	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0671_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0671	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA018008	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 150; 450	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0673_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0673	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA018008	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 224; 450	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0675_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0675	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA018008	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 300; 450	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0683_f1a588f6-403d-40da-a135-a082007dfd3a	0338-0683	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose		Potassium Chloride and Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19790201		NDA	NDA017634	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE	5; 150	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0691_fea3418a-bd23-4b09-a318-c56c4c0eb31a	0338-0691	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		Potassium Chloride and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA017648	Baxter Healthcare Corporation	POTASSIUM CHLORIDE; SODIUM CHLORIDE	150; 900	mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0695_fea3418a-bd23-4b09-a318-c56c4c0eb31a	0338-0695	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		Potassium Chloride and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA017648	Baxter Healthcare Corporation	POTASSIUM CHLORIDE; SODIUM CHLORIDE	300; 900	mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0703_87460a3c-e3c1-4602-b2a3-dc19a356fc9a	0338-0703	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19891226		NDA	NDA019904	Baxter Healthcare Corporation	POTASSIUM CHLORIDE	29.8	g/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0704_fea3418a-bd23-4b09-a318-c56c4c0eb31a	0338-0704	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		Potassium Chloride and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19790202		NDA	NDA017648	Baxter Healthcare Corporation	POTASSIUM CHLORIDE; SODIUM CHLORIDE	150; 450	mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0705_87460a3c-e3c1-4602-b2a3-dc19a356fc9a	0338-0705	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19891226		NDA	NDA019904	Baxter Healthcare Corporation	POTASSIUM CHLORIDE	14.9	g/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0709_87460a3c-e3c1-4602-b2a3-dc19a356fc9a	0338-0709	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19891226		NDA	NDA019904	Baxter Healthcare Corporation	POTASSIUM CHLORIDE	7.46	g/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0712_25bd1f2e-c34c-41dd-957d-953a24c36b9b	0338-0712	HUMAN PRESCRIPTION DRUG	Daptomycin in Sodium Chloride		Daptomycin in Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20220125		NDA	NDA213645	Baxter Healthcare Corporation	DAPTOMYCIN	350	mg/50mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0338-0714_25bd1f2e-c34c-41dd-957d-953a24c36b9b	0338-0714	HUMAN PRESCRIPTION DRUG	Daptomycin in Sodium Chloride		Daptomycin in Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20220125		NDA	NDA213645	Baxter Healthcare Corporation	DAPTOMYCIN	500	mg/50mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0338-0716_25bd1f2e-c34c-41dd-957d-953a24c36b9b	0338-0716	HUMAN PRESCRIPTION DRUG	Daptomycin in Sodium Chloride		Daptomycin in Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20220125		NDA	NDA213645	Baxter Healthcare Corporation	DAPTOMYCIN	700	mg/100mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0338-0718_25bd1f2e-c34c-41dd-957d-953a24c36b9b	0338-0718	HUMAN PRESCRIPTION DRUG	Daptomycin in Sodium Chloride		Daptomycin in Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20220125		NDA	NDA213645	Baxter Healthcare Corporation	DAPTOMYCIN	1000	mg/100mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0338-0719_ca8bc0ea-3a9c-4716-a386-7f9d569fd16a	0338-0719	HUMAN PRESCRIPTION DRUG	DEXTROSE		Dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	19910702		NDA	NDA020047	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	70	g/100mL			N	20241231
0338-0720_49e02e19-8abb-4fa7-a69c-6df8bdb102f6	0338-0720	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220818		ANDA	ANDA214436	Baxter Healthcare Corporation	PEMETREXED DISODIUM HEPTAHYDRATE	100	mg/10mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0338-0722_49e02e19-8abb-4fa7-a69c-6df8bdb102f6	0338-0722	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENTRICULAR	20220818		ANDA	ANDA214436	Baxter Healthcare Corporation	PEMETREXED DISODIUM HEPTAHYDRATE	500	mg/50mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0338-0803_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0803	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19850405		NDA	NDA019308	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 150; 900	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0807_0c876b0e-8c37-40fc-9979-905e067e846d	0338-0807	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		Potassium Chloride, Dextrose Monohydrate and Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	19850405		NDA	NDA019308	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	5; 300; 900	g/100mL; mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-0811_af7d50b8-c1e7-44f1-8e2b-c7e8dba40603	0338-0811	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Lactated Ringers and Dextrose		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19850405		NDA	NDA019367	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 5; 179; 600; 310	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0338-1005_7b01149c-feae-46bd-94cb-207bcd24ae59	0338-1005	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride and Dextrose		Dopamine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19870327		NDA	NDA019615	Baxter Healthcare Corporation	DOPAMINE HYDROCHLORIDE	80	mg/100mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0338-1007_7b01149c-feae-46bd-94cb-207bcd24ae59	0338-1007	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride and Dextrose		Dopamine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19870327		NDA	NDA019615	Baxter Healthcare Corporation	DOPAMINE HYDROCHLORIDE	160	mg/100mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0338-1009_7b01149c-feae-46bd-94cb-207bcd24ae59	0338-1009	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride and Dextrose		Dopamine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19870327		NDA	NDA019615	Baxter Healthcare Corporation	DOPAMINE HYDROCHLORIDE	320	mg/100mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0338-1013_b0bcb6a6-0b97-46f7-bfd2-efa0122e11e2	0338-1013	HUMAN PRESCRIPTION DRUG	OXACILLIN		OXACILLIN	INJECTION, SOLUTION	INTRAVENOUS	19891026		NDA	NDA050640	Baxter Healthcare Corporation	OXACILLIN SODIUM	1	g/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0338-1015_b0bcb6a6-0b97-46f7-bfd2-efa0122e11e2	0338-1015	HUMAN PRESCRIPTION DRUG	OXACILLIN		OXACILLIN	INJECTION, SOLUTION	INTRAVENOUS	19891026		NDA	NDA050640	Baxter Healthcare Corporation	OXACILLIN SODIUM	2	g/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0338-1017_3fe6ffd5-4cc8-450b-8968-841f86097f29	0338-1017	HUMAN PRESCRIPTION DRUG	NAFCILLIN		NAFCILLIN	INJECTION, SOLUTION	INTRAVENOUS	19891031		NDA	NDA050655	Baxter Healthcare Corporation	NAFCILLIN SODIUM	1	g/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0338-1019_3fe6ffd5-4cc8-450b-8968-841f86097f29	0338-1019	HUMAN PRESCRIPTION DRUG	NAFCILLIN		NAFCILLIN	INJECTION, SOLUTION	INTRAVENOUS	19891031		NDA	NDA050655	Baxter Healthcare Corporation	NAFCILLIN SODIUM	2	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0338-1021_468e8659-0b43-437d-98c4-3da6773ab261	0338-1021	HUMAN PRESCRIPTION DRUG	PENICILLIN G POTASSIUM		PENICILLIN G	INJECTION, SOLUTION	INTRAVENOUS	19900625		NDA	NDA050638	Baxter Healthcare Corporation	PENICILLIN G POTASSIUM	1000000	[iU]/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0338-1023_468e8659-0b43-437d-98c4-3da6773ab261	0338-1023	HUMAN PRESCRIPTION DRUG	PENICILLIN G POTASSIUM		PENICILLIN G	INJECTION, SOLUTION	INTRAVENOUS	19900625		NDA	NDA050638	Baxter Healthcare Corporation	PENICILLIN G POTASSIUM	2000000	[iU]/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0338-1025_468e8659-0b43-437d-98c4-3da6773ab261	0338-1025	HUMAN PRESCRIPTION DRUG	PENICILLIN G POTASSIUM		PENICILLIN G	INJECTION, SOLUTION	INTRAVENOUS	19900625		NDA	NDA050638	Baxter Healthcare Corporation	PENICILLIN G POTASSIUM	3000000	[iU]/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0338-1047_c92e537d-41c9-4b47-b455-5fca8f91be97	0338-1047	HUMAN PRESCRIPTION DRUG	Nitroglycerin In Dextrose		Nitroglycerin	INJECTION	INTRAVENOUS	19891229		NDA	NDA019970	Baxter Healthcare Company	NITROGLYCERIN	10	mg/100mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0338-1049_c92e537d-41c9-4b47-b455-5fca8f91be97	0338-1049	HUMAN PRESCRIPTION DRUG	Nitroglycerin In Dextrose		Nitroglycerin	INJECTION	INTRAVENOUS	19891229		NDA	NDA019970	Baxter Healthcare Company	NITROGLYCERIN	20	mg/100mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0338-1051_c92e537d-41c9-4b47-b455-5fca8f91be97	0338-1051	HUMAN PRESCRIPTION DRUG	Nitroglycerin In Dextrose		Nitroglycerin	INJECTION	INTRAVENOUS	19891229		NDA	NDA019970	Baxter Healthcare Company	NITROGLYCERIN	40	mg/100mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0338-1055_b686b10a-1ec3-41bf-9be9-fb3d1187c7df	0338-1055	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	INJECTION, SOLUTION	INTRAVENOUS	19811224		NDA	NDA018657	Baxter Healthcare Corporation	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0338-1073_56b372ac-b2a4-4131-bc76-dc0eb036f5f2	0338-1073	HUMAN PRESCRIPTION DRUG	Dobutamine Hydrochloride in Dextrose		Dobutamine Hydrochloride	INJECTION	INTRAVENOUS	19930927		NDA	NDA020255	Baxter Healthcare Corporation	DOBUTAMINE HYDROCHLORIDE	100	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0338-1075_56b372ac-b2a4-4131-bc76-dc0eb036f5f2	0338-1075	HUMAN PRESCRIPTION DRUG	Dobutamine Hydrochloride in Dextrose		Dobutamine Hydrochloride	INJECTION	INTRAVENOUS	19930927		NDA	NDA020255	Baxter Healthcare Corporation	DOBUTAMINE HYDROCHLORIDE	200	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0338-1077_56b372ac-b2a4-4131-bc76-dc0eb036f5f2	0338-1077	HUMAN PRESCRIPTION DRUG	Dobutamine Hydrochloride in Dextrose		Dobutamine Hydrochloride	INJECTION	INTRAVENOUS	19930923		NDA	NDA020255	Baxter Healthcare Corporation	DOBUTAMINE HYDROCHLORIDE	400	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0338-1089_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1089	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 5; 438; 204; 255; 311; 247; 170; 238; 289; 213; 179; 77; 17; 247	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1091_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1091	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 10; 438; 204; 255; 311; 247; 170; 238; 289; 213; 179; 77; 17; 247	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1099_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1099	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 15; 515; 240; 300; 365; 290; 200; 280; 340; 250; 210; 90; 20; 290	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1101_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1101	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 20; 515; 240; 300; 365; 290; 200; 280; 340; 250; 210; 90; 20; 290	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1113_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1113	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 33; 5; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77; 17; 247	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1115_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1115	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 33; 10; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77; 17; 247	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1123_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1123	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 33; 15; 515; 240; 300; 365; 290; 51; 200; 280; 261; 340; 250; 340; 59; 210; 90; 20; 290	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1125_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1125	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 33; 20; 515; 240; 300; 365; 290; 51; 200; 280; 261; 340; 250; 340; 59; 210; 90; 20; 290	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1130_15389cc5-b934-41cf-81c6-b84a04b15f80	0338-1130	HUMAN PRESCRIPTION DRUG	Premasol - sulfite-free (Amino Acid)		LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20030619		ANDA	ANDA075880	Baxter Healthcare Corporation	ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE HYDROCHLORIDE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	.54; 1.2; .32; .016; .5; .36; .48; .82; 1.4; .82; .34; .48; .68; .38; 25; .42; .2; .24; .78	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; mg/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1133_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1133	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 5; 438; 204; 255; 311; 247; 170; 238; 289; 213; 179; 77; 17; 247	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1134_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1134	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	20120320		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 10; 438; 204; 255; 311; 247; 170; 238; 289; 213; 179; 77; 17; 247	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1137_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1137	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 15; 515; 240; 300; 365; 290; 200; 280; 340; 250; 210; 90; 20; 290	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1138_c6dd0ed5-c5bd-4f0d-b9f9-dd8d963f5bc8	0338-1138	HUMAN PRESCRIPTION DRUG	CLINIMIX		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dextrose	INJECTION	INTRAVENOUS	19970929		NDA	NDA020734	Baxter Healthcare Corporation	ALANINE; ARGININE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 20; 515; 240; 300; 365; 290; 200; 280; 340; 250; 210; 90; 20; 290	mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0338-1142_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1142	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	570; 316; 33; 5; 283; 132; 165; 201; 159; 51; 110; 154; 261; 187; 138; 217; 112; 116; 50; 11; 160	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1144_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1144	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 33; 5; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77; 17; 247	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1145_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1145	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	880; 489; 33; 10; 438; 204; 255; 311; 247; 51; 170; 238; 261; 289; 213; 297; 77; 179; 77; 17; 247	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1147_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1147	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 33; 15; 515; 240; 300; 365; 290; 51; 200; 280; 261; 340; 250; 340; 59; 210; 90; 20; 290	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1148_814fe2b3-f533-4ef2-912f-07b2baa55b99	0338-1148	HUMAN PRESCRIPTION DRUG	CLINIMIX E		Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose	INJECTION	INTRAVENOUS	19970326		NDA	NDA020678	Baxter Healthcare Corporation	ALANINE; ARGININE; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM CHLORIDE; METHIONINE; PHENYLALANINE; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; SERINE; SODIUM ACETATE; SODIUM CHLORIDE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	1035; 575; 33; 20; 515; 240; 300; 365; 290; 51; 200; 280; 261; 340; 250; 340; 59; 210; 90; 20; 290	mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1301_f286a7d3-fee7-42bb-b237-21769b9b39e1	0338-1301	HUMAN PRESCRIPTION DRUG	Cefepime		cefepime	INJECTION, SOLUTION	INTRAVENOUS	20080805		NDA	NDA050817	Baxter Healthcare Corporation	CEFEPIME HYDROCHLORIDE	1	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0338-1305_ad12f990-8af7-4708-b9ea-d2bc02379926	0338-1305	HUMAN PRESCRIPTION DRUG	MESNEX		mesna	INJECTION, SOLUTION	INTRAVENOUS	19881230		NDA	NDA019884	Baxter Healthcare Corporation	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
0338-1307_c7badc4e-476a-4745-a4ba-73c794a6ca19	0338-1307	HUMAN PRESCRIPTION DRUG	MESNEX		MESNA	INJECTION, SOLUTION	INTRAVENOUS	19881230		NDA	NDA019884	Baxter Healthcare Corporation	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
0338-1708_b5a8b04e-abe3-41fd-adb7-7f968118bf52	0338-1708	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20200601		ANDA	ANDA211966	Baxter Healthcare Corporation	MAGNESIUM SULFATE HEPTAHYDRATE	2	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1709_f21cee72-13a2-41e9-9410-3d6a1262a072	0338-1709	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE IN DEXTROSE		magnesium sulfate in dextrose	INJECTION, SOLUTION	INTRAVENOUS	20200811		ANDA	ANDA211965	Baxter Healthcare Corporation	MAGNESIUM SULFATE HEPTAHYDRATE	10	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1715_b5a8b04e-abe3-41fd-adb7-7f968118bf52	0338-1715	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20200601		ANDA	ANDA211966	Baxter Healthcare Corporation	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-1719_b5a8b04e-abe3-41fd-adb7-7f968118bf52	0338-1719	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20200601		ANDA	ANDA211966	Baxter Healthcare Corporation	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0338-3410_e4c83966-9baa-4b5b-a365-52e4da1a174a	0338-3410	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170628		ANDA	ANDA208084	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	300	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-3503_4d476b96-80d8-4ad8-af57-8747d2721485	0338-3503	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin Sodium	INJECTION, SOLUTION	INTRAVENOUS	20150807		NDA	NDA207131	Baxter Healthcare Corporation	CEFAZOLIN SODIUM	1	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0338-3508_4d476b96-80d8-4ad8-af57-8747d2721485	0338-3508	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin Sodium	INJECTION, SOLUTION	INTRAVENOUS	20150807		NDA	NDA207131	Baxter Healthcare Corporation	CEFAZOLIN SODIUM	2	g/100mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0338-3551_4fe67700-54d2-48af-9031-c8032c88a300	0338-3551	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19581114		NDA	NDA050671	Baxter Healthcare Corporation	VANCOMYCIN HYDROCHLORIDE	500	mg/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0338-3552_4fe67700-54d2-48af-9031-c8032c88a300	0338-3552	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19581114		NDA	NDA050671	Baxter Healthcare Corporation	VANCOMYCIN HYDROCHLORIDE	1	g/200mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0338-3580_4fe67700-54d2-48af-9031-c8032c88a300	0338-3580	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19581114		NDA	NDA050671	Baxter Healthcare Corporation	VANCOMYCIN HYDROCHLORIDE	750	mg/150mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0338-3581_4fe67700-54d2-48af-9031-c8032c88a300	0338-3581	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19581114		NDA	NDA050671	Baxter Healthcare Corporation	VANCOMYCIN HYDROCHLORIDE	500	mg/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0338-3582_4fe67700-54d2-48af-9031-c8032c88a300	0338-3582	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19581114		NDA	NDA050671	Baxter Healthcare Corporation	VANCOMYCIN HYDROCHLORIDE	750	mg/150mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0338-3583_4fe67700-54d2-48af-9031-c8032c88a300	0338-3583	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19581114		NDA	NDA050671	Baxter Healthcare Corporation	VANCOMYCIN HYDROCHLORIDE	1	g/200mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0338-3612_e4c83966-9baa-4b5b-a365-52e4da1a174a	0338-3612	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170628		ANDA	ANDA208084	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	600	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-3616_96bb0966-05c9-454c-a3bc-1f6ed382c1cf	0338-3616	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170628		ANDA	ANDA208084	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	600	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-3814_e4c83966-9baa-4b5b-a365-52e4da1a174a	0338-3814	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170628		ANDA	ANDA208084	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	900	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-3991_8f059d89-8848-4f29-aa9a-d14a4721df47	0338-3991	HUMAN PRESCRIPTION DRUG	IFEX		ifosfamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19881230		NDA	NDA019763	Baxter Healthcare Corporation	IFOSFAMIDE	1	g/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0338-3993_8f059d89-8848-4f29-aa9a-d14a4721df47	0338-3993	HUMAN PRESCRIPTION DRUG	IFEX		ifosfamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19881230		NDA	NDA019763	Baxter Healthcare Corporation	IFOSFAMIDE	3	g/60mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0338-4114_96bb0966-05c9-454c-a3bc-1f6ed382c1cf	0338-4114	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170628		ANDA	ANDA208084	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	900	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-4210_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-4210	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	KIT		19980501		BLA	BLA103980	Baxter Healthcare Corporation						N	20241231
0338-4211_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-4211	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	KIT		19980501		BLA	BLA103980	Baxter Healthcare Corporation						N	20241231
0338-4212_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-4212	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	KIT		19980501		BLA	BLA103980	Baxter Healthcare Corporation						N	20241231
0338-4301_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-4301	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	KIT		19980501		BLA	BLA103980	Baxter Healthcare Corporation						N	20241231
0338-4302_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-4302	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	KIT		19980501		BLA	BLA103980	Baxter Healthcare Corporation						N	20241231
0338-4303_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-4303	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	KIT		19980501		BLA	BLA103980	Baxter Healthcare Corporation						N	20241231
0338-5002_14402b7c-c5fe-4b57-9e2c-d6411bafa6b3	0338-5002	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone Sodium	INJECTION, SOLUTION	INTRAVENOUS	20050823		ANDA	ANDA065224	Baxter Healthcare Corporation	CEFTRIAXONE SODIUM	1	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0338-5003_14402b7c-c5fe-4b57-9e2c-d6411bafa6b3	0338-5003	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone Sodium	INJECTION, SOLUTION	INTRAVENOUS	20050823		ANDA	ANDA065224	Baxter Healthcare Corporation	CEFTRIAXONE SODIUM	2	g/50mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0338-5197_b84aeb9a-81e1-47f9-889a-38afa8deda14	0338-5197	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION, SOLUTION	INTRAVENOUS	20010510		ANDA	ANDA075591	Baxter Healthcare Corporation	FAMOTIDINE	20	mg/50mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0338-6010_70457950-9ae2-4df3-893d-fd0416e5099d	0338-6010	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		MILRINONE LACTATE	INJECTION, SOLUTION	INTRAVENOUS	20020528		ANDA	ANDA075834	Baxter Healthcare Corporation	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0338-6011_70457950-9ae2-4df3-893d-fd0416e5099d	0338-6011	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		MILRINONE LACTATE	INJECTION, SOLUTION	INTRAVENOUS	20020528		ANDA	ANDA075834	Baxter Healthcare Corporation	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0338-6045_3d6857d5-f305-48d0-95bf-442a3cb8fd45	0338-6045	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION, SOLUTION	INTRAVENOUS	20040729		ANDA	ANDA076766	Baxter Healthcare Corporation	FLUCONAZOLE	400	mg/200mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0338-6046_3d6857d5-f305-48d0-95bf-442a3cb8fd45	0338-6046	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION, SOLUTION	INTRAVENOUS	20040729		ANDA	ANDA076766	Baxter Healthcare Corporation	FLUCONAZOLE	200	mg/100mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0338-8402_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-8402	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	SOLUTION	TOPICAL	19980501		BLA	BLA103980	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	90; 500	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-8503_d49b844c-32d1-4c69-94fd-f4447c4bd409	0338-8503	PLASMA DERIVATIVE	ARTISS	Fibrin Sealant	Fibrinogen Human, Human Thrombin	SOLUTION	TOPICAL	20080319		BLA	BLA125266	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	86.5; 4	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-8701_da19ff1a-b194-4df8-9a7f-0ca120e15b9a	0338-8701	HUMAN PRESCRIPTION DRUG	TachoSil		THROMBIN HUMAN and FIBRINOGEN	PATCH	TOPICAL	20100405	20250206	BLA	BLA125351	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	5.5; 2	mg/1; [USP'U]/1	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	
0338-8702_da19ff1a-b194-4df8-9a7f-0ca120e15b9a	0338-8702	HUMAN PRESCRIPTION DRUG	TachoSil		THROMBIN HUMAN and FIBRINOGEN	PATCH	TOPICAL	20100405	20250206	BLA	BLA125351	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	5.5; 2	mg/1; [USP'U]/1	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	
0338-8704_da19ff1a-b194-4df8-9a7f-0ca120e15b9a	0338-8704	HUMAN PRESCRIPTION DRUG	TachoSil		THROMBIN HUMAN and FIBRINOGEN	PATCH	TOPICAL	20100405	20250206	BLA	BLA125351	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	5.5; 2	mg/1; [USP'U]/1	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	
0338-9051_a95f901e-0ac4-4ec0-9720-9c6a066cd06c	0338-9051	HUMAN PRESCRIPTION DRUG	Micafungin in Sodium Chloride		Micafungin in Sodium Chloride	INJECTION	INTRAVENOUS	20230929		NDA	NDA216142	Baxter Healthcare Corporation	MICAFUNGIN SODIUM	50	mg/50mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0338-9053_a95f901e-0ac4-4ec0-9720-9c6a066cd06c	0338-9053	HUMAN PRESCRIPTION DRUG	Micafungin in Sodium Chloride		Micafungin in Sodium Chloride	INJECTION	INTRAVENOUS	20230929		NDA	NDA216142	Baxter Healthcare Corporation	MICAFUNGIN SODIUM	100	mg/100mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0338-9055_a95f901e-0ac4-4ec0-9720-9c6a066cd06c	0338-9055	HUMAN PRESCRIPTION DRUG	Micafungin in Sodium Chloride		Micafungin in Sodium Chloride	INJECTION	INTRAVENOUS	20230929		NDA	NDA216142	Baxter Healthcare Corporation	MICAFUNGIN SODIUM	150	mg/150mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0338-9143_fc37d011-8460-47fa-8dd3-873ced312dcc	0338-9143	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	2.5	g/50mL			N	20241231
0338-9147_fc37d011-8460-47fa-8dd3-873ced312dcc	0338-9147	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION	INTRAVENOUS	19921207		NDA	NDA020179	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0338-9151_616e481c-4910-4f2a-807e-78a41da381d6	0338-9151	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-9159_616e481c-4910-4f2a-807e-78a41da381d6	0338-9159	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION	INTRAVENOUS	19921207		NDA	NDA020178	Baxter Healthcare Corporation	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-9540_30bf9567-4ae0-44fd-b53f-50e3bc3b185f	0338-9540	HUMAN PRESCRIPTION DRUG	Clinolipid		Olive Oil and Soybean Oil	INJECTION, EMULSION	INTRAVENOUS	20160101		NDA	NDA204508	Baxter Healthcare Corporation	OLIVE OIL; SOYBEAN OIL	16; 4	g/100mL; g/100mL	Lipid Emulsion [EPC], Lipid Emulsion [EPC], Lipids [CS], Lipids [CS]		N	20241231
0338-9541_1c833e1f-b99b-4f19-b59e-d4aa049c2427	0338-9541	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	INJECTION, SOLUTION	INTRAVENOUS	19811224		NDA	NDA018657	Baxter Healthcare Corporation	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0338-9543_d7d7d10d-5ef6-479e-a4f4-602f765dfc15	0338-9543	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION, SOLUTION	INTRAVENOUS	19701209		NDA	NDA016677	Baxter Healthcare Corporation	SODIUM CHLORIDE	9	g/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0338-9545_ed5b6988-2a59-4c71-93f1-53e2de0d4477	0338-9545	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170420		NDA	NDA208083	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	300	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-9549_ed5b6988-2a59-4c71-93f1-53e2de0d4477	0338-9549	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170420		NDA	NDA208083	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	600	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-9553_ed5b6988-2a59-4c71-93f1-53e2de0d4477	0338-9553	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170420		NDA	NDA208083	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	900	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0338-9555_d9037c6e-d0d0-45a2-8688-e2f231a9fcdc	0338-9555	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20180821		ANDA	ANDA208532	Baxter Healthcare Company	DEXMEDETOMIDINE HYDROCHLORIDE	200	ug/50mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0338-9557_d9037c6e-d0d0-45a2-8688-e2f231a9fcdc	0338-9557	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20180821		ANDA	ANDA208532	Baxter Healthcare Company	DEXMEDETOMIDINE HYDROCHLORIDE	400	ug/100mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0338-9558_adec2ba9-b744-4539-98c8-8c9b0be57abe	0338-9558	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION	INTRAVENOUS	20190201		ANDA	ANDA208554	Baxter Healthcare Corporation	EPTIFIBATIDE	75	mg/100mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0338-9560_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-9560	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	SOLUTION	TOPICAL	19980501		BLA	BLA103980	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	86.5; 500	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-9564_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-9564	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	SOLUTION	TOPICAL	19980501		BLA	BLA103980	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	86.5; 500	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-9568_ab3c245f-c0ae-42fb-97ac-5c0dd0f49879	0338-9568	PLASMA DERIVATIVE	TISSEEL	Fibrin Sealant	fibrinogen human, human thrombin	SOLUTION	TOPICAL	19980501		BLA	BLA103980	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	86.5; 500	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-9581_f713b9ab-9d6e-4390-ae8e-f116cf7691f4	0338-9581	HUMAN PRESCRIPTION DRUG	doxorubicin hydrochloride, Liposomal		doxorubicin hydrochloride	INJECTION, SUSPENSION, LIPOSOMAL	INTRAVENOUS	20231219		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Baxter Healthcare Corporation	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
0338-9632_8db6bd91-2106-4bfd-8cc8-38aaf1e18d17	0338-9632	HUMAN PRESCRIPTION DRUG	Zosyn		piperacillin sodium and tazobactam sodium	INJECTION, SOLUTION	INTRAVENOUS	20230401		NDA	NDA050750	Baxter Healthcare Corporation	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/50mL; g/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0338-9636_8db6bd91-2106-4bfd-8cc8-38aaf1e18d17	0338-9636	HUMAN PRESCRIPTION DRUG	Zosyn		piperacillin sodium and tazobactam sodium	INJECTION, SOLUTION	INTRAVENOUS	20230401		NDA	NDA050750	Baxter Healthcare Corporation	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/50mL; g/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0338-9637_d49b844c-32d1-4c69-94fd-f4447c4bd409	0338-9637	PLASMA DERIVATIVE	ARTISS	Fibrin Sealant	Fibrinogen Human, Human Thrombin	SOLUTION	TOPICAL	20080319		BLA	BLA125266	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	86.5; 4	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-9638_8db6bd91-2106-4bfd-8cc8-38aaf1e18d17	0338-9638	HUMAN PRESCRIPTION DRUG	Zosyn		piperacillin sodium and tazobactam sodium	INJECTION, SOLUTION	INTRAVENOUS	20230401		NDA	NDA050750	Baxter Healthcare Corporation	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/100mL; g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0338-9639_d49b844c-32d1-4c69-94fd-f4447c4bd409	0338-9639	PLASMA DERIVATIVE	ARTISS	Fibrin Sealant	Fibrinogen Human, Human Thrombin	SOLUTION	TOPICAL	20080319		BLA	BLA125266	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	86.5; 4	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-9640_b5b2c367-6b7e-40be-a296-c4632f3e783f	0338-9640	HUMAN PRESCRIPTION DRUG	Vasopressin in 0.9% Sodium Chloride		Vasopressin in 0.9% Sodium Chloride	INJECTION	INTRAVENOUS	20230929		NDA	NDA217569	Baxter Healthcare Corporation	VASOPRESSIN	20	[USP'U]/100mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
0338-9641_d49b844c-32d1-4c69-94fd-f4447c4bd409	0338-9641	PLASMA DERIVATIVE	ARTISS	Fibrin Sealant	Fibrinogen Human, Human Thrombin	SOLUTION	TOPICAL	20080319		BLA	BLA125266	Baxter Healthcare Corporation	FIBRINOGEN HUMAN; HUMAN THROMBIN	86.5; 4	mg/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
0338-9645_786fc4a2-bd97-42cd-89b5-dbe8eb80c064	0338-9645	HUMAN PRESCRIPTION DRUG	CYSTEINE HYDROCHLORIDE		cysteine hydrochloride	INJECTION	INTRAVENOUS	20220429		NDA	NDA212535	Baxter Healthcare Corporation	CYSTEINE HYDROCHLORIDE	34.5	mg/mL			N	20241231
0338-9647_b5b2c367-6b7e-40be-a296-c4632f3e783f	0338-9647	HUMAN PRESCRIPTION DRUG	Vasopressin in 0.9% Sodium Chloride		Vasopressin in 0.9% Sodium Chloride	INJECTION	INTRAVENOUS	20230929		NDA	NDA217569	Baxter Healthcare Corporation	VASOPRESSIN	40	[USP'U]/100mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
0360-0041_7df5700c-6216-1053-e053-2a91aa0a1d73	0360-0041	HUMAN OTC DRUG	ARNICA		ARNICA MONTANA	TABLET	SUBLINGUAL	19970217		UNAPPROVED HOMEOPATHIC		STANDARD HOMEOPATHIC COMPANY	ARNICA MONTANA	30	[hp_X]/g			N	20241231
0360-0182_7e1c4cde-2305-7637-e053-2991aa0a2856	0360-0182	HUMAN OTC DRUG	GELSEMIUM SEMPERVIRENS		Gelsemium Semp	TABLET	SUBLINGUAL	19970217		UNAPPROVED HOMEOPATHIC		STANDARD HOMEOPATHIC COMPANY	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_X]/g			N	20241231
0362-0101_f0465990-acce-46dc-9290-344dab1e4f2f	0362-0101	HUMAN PRESCRIPTION DRUG	Oraverse		Phentolamine Mesylate	INJECTION, SOLUTION	SUBMUCOSAL	20110601		NDA	NDA022159	Septodont, Inc.	PHENTOLAMINE MESYLATE	.235	mg/mL	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0362-0221_a87fa9a8-ad43-47dd-9509-47aa7c3a5157	0362-0221	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20150520		ANDA	ANDA040911	Septodont, Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0362-0262_79a7630d-b1ab-474d-8ee6-7b5e864e72cb	0362-0262	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20180810		ANDA	ANDA088389	Septodont, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.02; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-0557_f62f587d-3052-4af1-8810-37247759fb5e	0362-0557	HUMAN PRESCRIPTION DRUG	Marcaine		bupivacaine hydrochloride and epinephrine bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20180612		ANDA	ANDA077250	Septodont, Inc.	BUPIVACAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE BITARTRATE	5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-0753_baf6b0d1-e57c-40a0-9162-7b861e915759	0362-0753	HUMAN PRESCRIPTION DRUG	Carbocaine		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20180621		ANDA	ANDA088387	Septodont, Inc.	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0362-0830_9c472db9-adc1-414b-8388-95f602c7a901	0362-0830	HUMAN PRESCRIPTION DRUG	Zorcaine		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20190405		NDA AUTHORIZED GENERIC	NDA020971	Septodont, Inc.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .01	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-0898_d21d157c-7a44-4c0c-a109-8ab0ba97fc18	0362-0898	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20180718		ANDA	ANDA088390	Septodont, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-1095_68ef2658-de42-40f3-9c29-1640585200da	0362-1095	HUMAN PRESCRIPTION DRUG	Lignospan Standard		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20171128		ANDA	ANDA088390	Septodont, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-1096_da952f0d-b4e7-43d7-8fc9-8c27db77e5a6	0362-1096	HUMAN PRESCRIPTION DRUG	Lignospan Forte		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20171201		ANDA	ANDA088389	Septodont, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.02; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-1098_499e52c4-fba3-4898-a850-bbc745011ca0	0362-1098	HUMAN PRESCRIPTION DRUG	Scandonest 3% Plain		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20171222		ANDA	ANDA088387	Septodont, Inc.	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0362-3971_9d1148f3-0081-4574-ab81-8907cc61542b	0362-3971	HUMAN PRESCRIPTION DRUG	DycloPro		Dyclonine Hydrochloride	SOLUTION	TOPICAL	20190901		ANDA	ANDA200480	Septodont Inc	DYCLONINE HYDROCHLORIDE	5	mg/mL			N	20241231
0362-9011_79e3c6ef-9762-4afd-ace6-d6214d6a9c77	0362-9011	HUMAN PRESCRIPTION DRUG	Vivacaine		bupivacaine hydrochloride and epinephrine bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20130601		ANDA	ANDA077250	Septodont, Inc.	BUPIVACAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE BITARTRATE	5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-9048_8715e4f6-457a-440c-b7d3-44e672231e64	0362-9048	HUMAN PRESCRIPTION DRUG	Septocaine and Epinephrine		Articaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20110112		NDA	NDA020971	Septodont Inc.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0362-9049_8715e4f6-457a-440c-b7d3-44e672231e64	0362-9049	HUMAN PRESCRIPTION DRUG	Septocaine and Epinephrine		Articaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20110112		NDA	NDA020971	Septodont Inc.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .01	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0363-0005_7c2042b5-460a-4f8d-83f4-ee20a5770f23	0363-0005	HUMAN OTC DRUG	Saline Laxative		sodium phosphate	ENEMA	RECTAL	20120831		OTC MONOGRAPH NOT FINAL	part334	Walgreen Company	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
0363-0007_1c99dbb9-bed4-45fc-a390-44fb4b5ad387	0363-0007	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150325		NDA	NDA022032	Walgreen Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-0010_0a6a0a65-cd11-cd66-a92a-fcd7f7d7441e	0363-0010	HUMAN OTC DRUG	Wal-Zan		Ranitidine Hydrochloride Tablets 150mg	TABLET, COATED	ORAL	20110611		ANDA	ANDA078192	Walgreens Company	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-0014_7ef2f303-0c61-4231-b08d-9e390fff06ce	0363-0014	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20020627		OTC MONOGRAPH FINAL	part355	Walgreen Co	SODIUM FLUORIDE	.05	kg/100L			N	20241231
0363-0016_754284b8-6e9b-4438-a0f6-5551e92ffe21	0363-0016	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831	20251231	OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM	100	mg/1			N	
0363-0017_a6cf6163-4220-422e-b1e1-1433b5da9f19	0363-0017	HUMAN OTC DRUG	Salicylic acid		Salicylic acid	CREAM	TOPICAL	20151219		OTC MONOGRAPH FINAL	part333D	WALGREEN COMPANY	SALICYLIC ACID	5.05	mg/mL			N	20241231
0363-0018_b0b536c2-3f4b-4ec5-8dc5-daa464ab1bbf	0363-0018	HUMAN OTC DRUG	Antibiotic	Maximum Strength	Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	19980616		OTC MONOGRAPH FINAL	part333B	Walgreens	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	500; 3.5; 10000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-0019_3bed4a6b-3e6e-47f9-89cd-cd97e28eadf6	0363-0019	HUMAN OTC DRUG	Cough		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20140210		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0020_2809191c-3c9c-43a0-af40-d17a561886f5	0363-0020	HUMAN OTC DRUG	Wal-Sleep Z	Nighttime	Diphenhydramine HCl	SOLUTION	ORAL	20160912		OTC MONOGRAPH DRUG	M010	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0021_9af00e2c-7599-4bcf-e053-2995a90a96f9	0363-0021	HUMAN OTC DRUG	Extra Strength Headache Relief		Acetaminophen, Aspirin, and Caffeine	CAPSULE	ORAL	20160810		OTC MONOGRAPH NOT FINAL	part343	Walgreens	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-0022_876d2141-a51c-4055-a95d-3afdc7e57588	0363-0022	HUMAN OTC DRUG	cimetidine	acid reducer	Cimetidine	TABLET, FILM COATED	ORAL	20010327		ANDA	ANDA075285	Walgreen Company	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-0024_171e9f5a-4709-4225-b537-d5376625a4ef	0363-0024	HUMAN OTC DRUG	24 Hour Allergy Nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160527		ANDA	ANDA207957	Walgreen Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0025_a278646e-ea83-4440-bd1d-c39cb738dc75	0363-0025	HUMAN OTC DRUG	Soothe		Bismuth subsalicylate	LIQUID	ORAL	20150131		OTC MONOGRAPH DRUG	M008	Walgreens	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-0027_22337bee-8bbb-449b-b3f5-2db33d379f63	0363-0027	HUMAN OTC DRUG	Charcoal Blackhead Clearing Scrub		Salicylic Acid	CREAM	TOPICAL	20160301		OTC MONOGRAPH FINAL	part333D	Walgreen Co	SALICYLIC ACID	20.6	mg/mL			N	20241231
0363-0028_d5f723ec-3bb7-4d70-9010-418b994a19ac	0363-0028	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200508		ANDA	ANDA210453	WALGREEN CO.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-0032_96a0a17b-4a23-489b-b078-ab921b93661b	0363-0032	HUMAN OTC DRUG	hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20200601		ANDA	ANDA075598	Walgreen Company	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0363-0033_444d342a-dfc8-44ac-9be0-1e85b419d293	0363-0033	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200508		ANDA	ANDA210453	WALGREEN CO.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-0034_3e3b0ad9-f98d-4a04-9364-2785d5cbf816	0363-0034	HUMAN OTC DRUG	Childrens Plus Multi Symptom Cold		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	SUSPENSION	ORAL	20150430		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0035_e7167cfd-5325-f522-e053-2a95a90ac32c	0363-0035	HUMAN OTC DRUG	Walgreens SPF 70 Sport Continuous		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20191011		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0037_4187f27a-8126-542b-2b76-fdb6d4fc645f	0363-0037	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20230115		ANDA	ANDA202194	Walgreens company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-0038_bf649c66-1a18-4c11-98dc-922701ae4b17	0363-0038	HUMAN OTC DRUG	Eye Itch Relief		ketotifen fumarate	SOLUTION	OPHTHALMIC	20130903		NDA	NDA021996	Walgreen Company	KETOTIFEN FUMARATE	.35	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
0363-0042_7b0f13d6-2203-5376-977b-f227c12a6bd0	0363-0042	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150901		ANDA	ANDA078878	Walgreens Company	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-0044_b4dee645-711d-c843-e499-03c6cd879e57	0363-0044	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA215434	Walgreens Company	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0046_fd6b8e82-62fb-4b81-9814-f068e56d572b	0363-0046	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20200817		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ALCOHOL	62	mL/100mL			N	20241231
0363-0048_d63007e8-46d4-1733-85b6-2d63aae8e434	0363-0048	HUMAN OTC DRUG	Budesonide		Budesonide	SPRAY, METERED	NASAL	20160411		ANDA	ANDA078949	Walgreens	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0049_3e304c5e-8006-910e-a2fa-9765569363a8	0363-0049	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCl		Fexofenadine HCl and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20220713		ANDA	ANDA079043	Walgreens company	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0050_0f668c99-f879-470b-8c3e-3fe1fef10837	0363-0050	HUMAN OTC DRUG	Ibuprofen PM		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20090219		ANDA	ANDA079113	Walgreen Company	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0053_f05b53cb-09e9-13c5-e053-2a95a90adcb3	0363-0053	HUMAN OTC DRUG	Walgreens SPF 55 Sheer Face Mist Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220916		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	300; 1000; 500; 1000	mg/10mL; mg/10mL; mg/10mL; mg/10mL			N	20241231
0363-0055_8c1f793d-9f35-4857-aafc-95c40e124bc1	0363-0055	HUMAN OTC DRUG	Vaporizing		Camphor	INHALANT	RESPIRATORY (INHALATION)	20090601		OTC MONOGRAPH FINAL	part341	Walgreen Co	CAMPHOR (SYNTHETIC)	62	mg/mL			N	20241231
0363-0056_6244d725-6506-412f-abf7-8596986c92f3	0363-0056	HUMAN OTC DRUG	Nausea Relief		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20160803		UNAPPROVED DRUG OTHER		Walgreen Company	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
0363-0058_7febd3a1-07d3-4499-bd13-0b876e1c20f8	0363-0058	HUMAN OTC DRUG	Cold and Congestion	Childrens Nighttime	Diphenhydramine HCI, Phenylephrine HCl	LIQUID	ORAL	20160331		OTC MONOGRAPH DRUG	M012	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	12.5; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0061_29ca2837-275f-434a-8ea6-eb9c85e9949a	0363-0061	HUMAN OTC DRUG	walphed d	maximum strength non drowsy sinus	Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19990924		ANDA	ANDA075153	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0066_f07238df-4971-7759-e053-2a95a90a39f9	0363-0066	HUMAN OTC DRUG	Walgreens SPF 50 Clear Complexion Face Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210818		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27; 40; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0068_c74eb2ab-0bc7-475d-80dc-a569b2aaa3b8	0363-0068	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	CAPSULE	ORAL	20200608		ANDA	ANDA209107	WALGREEN CO.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0072_0b36da05-b6ea-4bc5-aa8e-bba63eae787e	0363-0072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL	MOUTHWASH	ORAL	20070330		OTC MONOGRAPH NOT FINAL	part348	Walgreens Co.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0073_1a6f578a-978f-49f7-aa6a-71264ec539f5	0363-0073	HUMAN OTC DRUG	Soothe		Bismuth subsalicylate	LIQUID	ORAL	20150131		OTC MONOGRAPH FINAL	part335	Walgreens	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-0075_5fe2079a-2e5d-4a55-8f26-3e94a3b32f88	0363-0075	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20161024		OTC MONOGRAPH FINAL	part333B	Walgreen Company	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
0363-0077_23bd928b-a15a-4da4-80c3-c599113f8376	0363-0077	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine Hydrochloride		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170801		NDA	NDA021585	WALGREEN COMPANY	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0078_173f78be-9002-426c-bc11-8a13e946a35d	0363-0078	HUMAN OTC DRUG	Well at Walgreens Castor Oil		Castor oil	OIL	ORAL	19921023		OTC MONOGRAPH NOT FINAL	part334	Walgreen Co	CASTOR OIL	1	g/mL			N	20241231
0363-0079_649f1580-89d1-4d14-a504-815bd2787137	0363-0079	HUMAN OTC DRUG	Walgreens Baby Healing		Petrolatum	OINTMENT	TOPICAL	20221201		OTC MONOGRAPH FINAL	part347	Walgreens Company	PETROLATUM	410	mg/g			N	20241231
0363-0081_1cebdec6-3529-41da-9e9d-3c727993c525	0363-0081	HUMAN OTC DRUG	Miconazole 3		Miconazole nitrate	KIT		20050701		ANDA	ANDA075329	Walgreen Company						N	20241231
0363-0082_3c977f36-bafa-4b0a-b4e6-018ce9ee2253	0363-0082	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
0363-0085_330648ef-5b1e-496b-b312-97f65439e561	0363-0085	HUMAN OTC DRUG	Sore Mouth Cleanser		Hydrogen Peroxide	MOUTHWASH	TOPICAL	20140502		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
0363-0086_6b11ef66-d41a-4d29-9927-fdc39f37c879	0363-0086	HUMAN OTC DRUG	Hemorrhoidal cooling		Phenylephrine HCl, Witch hazel	GEL	TOPICAL	20160730		OTC MONOGRAPH FINAL	part346	Walgreens	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	24.8; 497	g/g; g/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0087_f0cacc21-cd2d-a972-e053-2995a90a8d88	0363-0087	HUMAN OTC DRUG	Walgreens SPF 50 Sport Faces		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170911		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0088_e776927c-c0c7-46c7-bf3f-cfaa0b163309	0363-0088	HUMAN OTC DRUG	Iodine		Iodine	LIQUID	TOPICAL	20110311		OTC MONOGRAPH NOT FINAL	part333A	Walgreen Co	IODINE	20	mg/mL			N	20241231
0363-0090_f0cc0a6b-93ac-0e75-e053-2995a90a662d	0363-0090	HUMAN OTC DRUG	Walgreens SPF 50 Sport Faces		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210114		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 130; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0092_4ff14433-196d-49ba-ae49-0a0d828ad863	0363-0092	HUMAN OTC DRUG	Wal Dryl	Childrens Allergy	Diphenhydramine Hydrochloride	LIQUID	ORAL	20150430		OTC MONOGRAPH FINAL	part341	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0093_f12c976e-e1b8-5e98-e053-2a95a90ab6f5	0363-0093	HUMAN OTC DRUG	Walgreens SPF 30 Sport		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170911		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0094_682cc322-962f-4526-bddf-698c77017c50	0363-0094	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171030		ANDA	ANDA209116	WALGREEN CO.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0100_d4429698-b1c4-0624-e053-2a95a90a9ecd	0363-0100	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20211231		OTC MONOGRAPH FINAL	part341	WALGREENS	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0102_f0fb89d5-c3fd-0ff2-e053-2995a90a388d	0363-0102	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190802		NDA	NDA021920	WALGREEN COMPANY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0103_f0ea401f-66d1-96a5-e053-2995a90ac847	0363-0103	HUMAN OTC DRUG	Dye-Free Ibuprofen 200		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210305		ANDA	ANDA078682	WALGREEN COMPANY	IBUPROFEN	200	mg/1201	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0107_2c02e195-9c17-4ddc-80c2-52e51ae9eba0	0363-0107	HUMAN OTC DRUG	Heartburn Plus Gas Relief Chewable Multi Symptom		Calcium carbonate ,Magnesium hydroxide,Simethicone	TABLET, CHEWABLE	ORAL	20171218		OTC MONOGRAPH FINAL	part331	WALGREEN CO.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	675; 60; 135	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0109_e1da2d60-fa36-8486-e053-2a95a90a1bad	0363-0109	HUMAN OTC DRUG	DAYTIME COLD AND FLU	Maximum Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HBr,GUAIFENESIN, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20220623		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0111_50430dcd-e5ac-464e-aad8-5ce5ad6a3efd	0363-0111	HUMAN OTC DRUG	Wal-phed		Chlorpheniramine Maleate and Pseudoephedrine HCl	TABLET	ORAL	19921216	20240113	OTC MONOGRAPH FINAL	part341	Walgreen Company	CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	4; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	
0363-0112_50960681-a8cd-4e4f-87cf-34ea7c3b9ae4	0363-0112	HUMAN OTC DRUG	Wal-phed		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825	20241107	OTC MONOGRAPH FINAL	part341	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
0363-0115_0c068849-08ec-ca22-e063-6394a90ac04d	0363-0115	HUMAN OTC DRUG	MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM		Dextromethorphan Hydrobromide and Guaifenesin	CAPSULE, GELATIN COATED	ORAL	20160501		OTC MONOGRAPH DRUG	M012	WALGREENS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0116_f12d432e-3116-47ec-e053-2a95a90a69d3	0363-0116	HUMAN OTC DRUG	Walgreens Acne Spot Treatment		Benzoyl Peroxide	LOTION	TOPICAL	20190119		OTC MONOGRAPH FINAL	part333D	WALGREEN COMPANY	BENZOYL PEROXIDE	25	mg/g			N	20241231
0363-0118_8120a91c-c692-4bc2-815a-b15e6a024d45	0363-0118	HUMAN OTC DRUG	Walgreens	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH DRUG	M002	WALGREENS CO.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-0119_1ef6202f-f608-4a17-bd7b-575e5b1fb44f	0363-0119	HUMAN OTC DRUG	Extra Strength Gas Relief		Simethicone Antigas	TABLET, CHEWABLE	ORAL	20210128		OTC MONOGRAPH DRUG	M002	WALGREENS CO.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-0120_58addba8-a614-4b38-9cd4-9ddf3fc0122a	0363-0120	HUMAN OTC DRUG	Walgreen Fiber Lax		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20190521		OTC MONOGRAPH DRUG	M007	WALGREENS CO.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
0363-0121_b5a8d82f-4f8a-43e3-b1d6-5450255930be	0363-0121	HUMAN OTC DRUG	WAL- DRYL ITCH RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE and ZINC ACETATE	CREAM	TOPICAL	20201221		OTC MONOGRAPH NOT FINAL	part348	WALGREENS	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0124_cbcd9974-bd36-4a70-bb6a-7c709fd9599d	0363-0124	HUMAN OTC DRUG	nicotine		Nicotine polacrilex	LOZENGE	ORAL	20090915		ANDA	ANDA090711	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0128_f13ec3da-2dc3-04f7-e053-2995a90a198d	0363-0128	HUMAN OTC DRUG	Walgreens SPF 50 Sport Continuous Sunscreen		Avobenzone, Homosalat, Octisalate, Octocrylene	SPRAY	TOPICAL	20191011		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0131_5758229a-0414-20bb-97dc-d432e3643087	0363-0131	HUMAN OTC DRUG	Wal-Zan 75		Ranitidine Tablet USP, 75mg	TABLET	ORAL	20140106		ANDA	ANDA075294	Walgreens Company	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-0132_00cdb09e-0989-46b4-8ad1-4d3151239d7f	0363-0132	HUMAN OTC DRUG	Pain and Fever	Infants	Acetaminophen	LIQUID	ORAL	20140731		OTC MONOGRAPH DRUG	M013	Walgreens	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0134_f328fc61-c015-4a7d-8f28-5f7d6e80f326	0363-0134	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20200805		ANDA	ANDA213203	WALGREEN CO.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0135_f14bb0e9-5cfc-e51b-e053-2995a90ac293	0363-0135	HUMAN OTC DRUG	WALGREENS SPF 100 SHEER BODY SUNSCREEN MIST		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20220912		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0136_f347588d-8226-45a7-e053-2995a90ab688	0363-0136	HUMAN OTC DRUG	Walgreens SPF 50 Hydrating		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210209		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0138_2faa864f-13ae-4532-8452-4462984686ca	0363-0138	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH NOT FINAL	part334	Walgreens	SENNOSIDES	8.6	mg/1			N	20241231
0363-0139_c7171929-a9a4-5078-e053-2995a90a560e	0363-0139	HUMAN OTC DRUG	Arnica gel		Arnica	GEL	TOPICAL	20210715		UNAPPROVED HOMEOPATHIC		WALGREENS	ARNICA MONTANA	1	[hp_X]/g			N	20241231
0363-0140_fc3ff125-b7a0-4cd2-aed8-e0dfb6ca5f0b	0363-0140	HUMAN OTC DRUG	pain relief		Naproxen sodium	TABLET, FILM COATED	ORAL	20111022		ANDA	ANDA074661	Walgreen Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0141_ac3ec46b-1223-4756-8247-681d56df162d	0363-0141	HUMAN OTC DRUG	Acid Controller	Original Strength	Famotidine	TABLET, FILM COATED	ORAL	20090828		ANDA	ANDA075400	Walgreen Company	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-0144_90e998ef-67ac-4b24-9df7-86a5ddf9eff3	0363-0144	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin, pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA091071	Walgreen Company	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0146_f4156498-d1d3-5a92-e053-2995a90a0203	0363-0146	HUMAN OTC DRUG	Walgreens SPF 30 Hydrating		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27; 80; 50; 35	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0148_71fec87c-29fd-49b2-b825-a4b353a075ee	0363-0148	HUMAN OTC DRUG	Wal-Nadol	Extra Strength	Acetaminophen	TABLET	ORAL	19930121	20240310	OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	
0363-0153_f7933edc-0baa-6f4e-e053-6394a90a71fb	0363-0153	HUMAN OTC DRUG	Walgreens 3 Step Acne System		Benzoyl Peroxide	KIT		20190220		OTC MONOGRAPH FINAL	M006	WALGREEN COMPANY						N	20241231
0363-0155_e43e3288-f195-3486-e053-2995a90ad01b	0363-0155	HUMAN OTC DRUG	Walgreens Athletes Foot		Tolnaftate Spray	AEROSOL, SPRAY	TOPICAL	20220728		OTC MONOGRAPH FINAL	part333C	Walgreens	TOLNAFTATE	1	g/100g			N	20241231
0363-0157_abc6e272-3873-46c2-bcb2-858f44422b2b	0363-0157	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Walgreen Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0161_78bd9c0b-fbce-4995-86ca-4269b15f8016	0363-0161	HUMAN OTC DRUG	pain and fever		Acetaminophen	SUSPENSION	ORAL	20110916		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0163_cccf69a2-09cd-4445-a316-7a0c3b1ac322	0363-0163	HUMAN OTC DRUG	Mouth Rinse		sodium fluoride	MOUTHWASH	ORAL	20060315		OTC MONOGRAPH DRUG	M021	Walgreen	SODIUM FLUORIDE	.1	mg/mL			N	20241231
0363-0166_db200a1e-5b9c-4399-89eb-db7de76d57a6	0363-0166	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20020304		ANDA	ANDA074937	Walgreen Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0171_a6d6b351-2126-44d4-a33b-efe3cbde3e65	0363-0171	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20200811		OTC MONOGRAPH FINAL	part355	Walgreens	SODIUM FLUORIDE	.1	mg/mL			N	20241231
0363-0172_f906792b-083f-13e2-e053-6294a90ab4cf	0363-0172	HUMAN OTC DRUG	Walgreens Daily Facial Moisturizer with Broad Spectrum SPF 30 Sunscreen		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200724		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
0363-0175_70b7a982-35b7-41b9-a6ad-2b692a6e3ca1	0363-0175	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20251231
0363-0177_da638473-feb5-ccf1-e053-2a95a90a80d3	0363-0177	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190802		NDA	NDA021920	WALGREEN COMPANY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0178_68adb583-091b-43c8-8a78-b8b4b4d7971a	0363-0178	HUMAN OTC DRUG	Wal-Act		Pseudoephedrine HCl and Triprolidine HCl	TABLET, FILM COATED	ORAL	19930109	20240218	OTC MONOGRAPH FINAL	part341	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	60; 2.5	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
0363-0179_a2f2c92d-4d00-40e2-b6f8-2b3d3b05369b	0363-0179	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin-B Sulfate	OINTMENT	TOPICAL	20050119		OTC MONOGRAPH FINAL	part333B	Walgreens	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-0182_f9c84c3c-f2cc-193d-e053-6294a90aa3e5	0363-0182	HUMAN OTC DRUG	Walgreens Healing Petrolatum Skin Protectant		PETROLATUM	OINTMENT	TOPICAL	20190702		OTC MONOGRAPH FINAL	M016	WALGREEN COMPANY	PETROLATUM	465	mg/mL			N	20241231
0363-0184_8a77311a-f9ce-47c1-afdb-007968951c0f	0363-0184	HUMAN OTC DRUG	Antacid Extra Strength		Antacid	TABLET, CHEWABLE	ORAL	20171219		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	750	mg/1			N	20241231
0363-0186_f3827160-b08b-3400-e053-2995a90a4fa3	0363-0186	HUMAN OTC DRUG	Tolnaftate		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20210324		OTC MONOGRAPH FINAL	part333C	Walgreen Company	TOLNAFTATE	.3	g/30mL			N	20241231
0363-0187_f9c81d88-8e29-fa53-e053-6394a90ac5c4	0363-0187	HUMAN OTC DRUG	Walgreens Daytime Facial Moisturizer with Broad Spectrum SPF 30 Sunscreen		HOMOSALATE, OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20190626		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	HOMOSALATE; OCTOCRYLENE; ZINC OXIDE	150; 20; 63	mg/mL; mg/mL; mg/mL			N	20241231
0363-0189_bf8b00fc-0495-4577-ab5f-333ca9e07494	0363-0189	HUMAN OTC DRUG	Sleep II	Nighttime Sleep Aid	Diphenhydramine HCl	TABLET	ORAL	19900410		OTC MONOGRAPH DRUG	M010	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0190_1c97e18c-8088-4082-ba8d-153c24126b03	0363-0190	HUMAN OTC DRUG	Wal-Dryl		Diphenhydramine HCl	CAPSULE	ORAL	19900315	20240322	OTC MONOGRAPH FINAL	part341	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0193_faeb782d-9560-7324-e053-6394a90a22bf	0363-0193	HUMAN OTC DRUG	Sodium Chloride		Sodium Chloride	SOLUTION/ DROPS	OPHTHALMIC	20190401		OTC MONOGRAPH FINAL	part349	Walgreen Company	SODIUM CHLORIDE	50	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0363-0200_ee463951-4b99-4232-b427-25667231747e	0363-0200	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	WALGREEN CO.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
0363-0201_c1bedba9-50be-4682-9c82-89e4986fe65b	0363-0201	HUMAN OTC DRUG	nicotine		Nicotine polacrilex	LOZENGE	ORAL	20100112		ANDA	ANDA090821	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0203_f3811a6a-24d8-7ed5-e053-2a95a90aba6c	0363-0203	HUMAN OTC DRUG	Salicylic Acid		Wart Removers	PATCH	TOPICAL	20130726		OTC MONOGRAPH FINAL	part358B	Walgreen Company	SALICYLIC ACID	40	mg/181			N	20241231
0363-0204_d03cb6bb-f193-4cc7-807f-209cdea81efc	0363-0204	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0206_f38141b7-9c61-964f-e053-2995a90a46ab	0363-0206	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Pen	LIQUID	TOPICAL	20130730		OTC MONOGRAPH FINAL	part333C	Walgreen Company	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
0363-0207_0d86c3e7-2af8-812d-e063-6394a90a7257	0363-0207	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190802		ANDA	ANDA090397	WALGREEN COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0210_f3813747-0569-66a1-e053-2995a90a4313	0363-0210	HUMAN OTC DRUG	Benzethonium chloride and Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20120112		OTC MONOGRAPH NOT FINAL	part333A	Walgreen Company	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.06; .23	mg/29.6mL; mg/29.6mL			N	20241231
0363-0212_eebe2009-2985-4cf2-94f6-ecf53a23b60e	0363-0212	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19951013		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0215_f381387f-ffa3-975a-e053-2a95a90ac447	0363-0215	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief	SPRAY	TOPICAL	20120112		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0216_f3811c8d-9c08-2186-e053-2995a90a7f18	0363-0216	HUMAN OTC DRUG	Tolnaftate		Odor Control Powder Spray	AEROSOL, SPRAY	TOPICAL	20120120		OTC MONOGRAPH FINAL	part333C	Walgreen Company	TOLNAFTATE	1.3	g/113g			N	20241231
0363-0218_2d0de077-d1c5-4584-b697-e826685b4595	0363-0218	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	19900912		OTC MONOGRAPH DRUG	M013	Walgreen Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0219_f3811c8d-9c07-2186-e053-2995a90a7f18	0363-0219	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel	GEL	TOPICAL	20120824		OTC MONOGRAPH FINAL	part358B	Walgreen Company	SALICYLIC ACID	.17	g/7g			N	20241231
0363-0220_e7fded81-1545-4c35-a24d-82dbbb31ca24	0363-0220	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	19980901		ANDA	ANDA074165	Walgreens	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-0221_f0e93c45-051d-7362-e053-2a95a90a0cb2	0363-0221	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190802		ANDA	ANDA078682	WALGREEN COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0222_7fc8aec2-a16c-414b-af13-f5c918052c33	0363-0222	HUMAN OTC DRUG	Ibuprofen 200		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190802		ANDA	ANDA078682	WALGREEN COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0224_1c272ec5-05a8-4ec1-bf80-d07ea750b23d	0363-0224	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	19960105		OTC MONOGRAPH FINAL	part347	Walgreen Co.	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; mg/mL			N	20241231
0363-0225_f0ea196a-00a7-43aa-e053-2995a90aeff8	0363-0225	HUMAN OTC DRUG	Dye-Free Ibuprofen 200		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210128		ANDA	ANDA078682	WALGREEN COMPANY	IBUPROFEN	200	mg/1201	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0227_53192e17-ac0f-4665-ba66-e167de02634e	0363-0227	HUMAN OTC DRUG	Aspirin	Enteric Coated, Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	19921214		OTC MONOGRAPH DRUG	M013	Walgreen Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0228_fa17f996-e023-f934-e053-6294a90a03ac	0363-0228	HUMAN OTC DRUG	WALGREENS 100 SHEER BROAD SPECTRUM SPF 100		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220506		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0229_c837c445-209c-40bb-82e1-efa8c2966855	0363-0229	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20111202		OTC MONOGRAPH FINAL	part333D	Walgreens Co.	BENZOYL PEROXIDE	1	mg/g			N	20241231
0363-0231_f9cbbfb8-62ed-09bd-e053-6394a90a2584	0363-0231	HUMAN OTC DRUG	Walgreens Advanced 50 Clear Complexion Broad Spectrum SPF 50 Sunscreen		AVOBENZONE. HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20190808		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0232_f9cb3f54-a5eb-a48b-e053-6294a90a40dc	0363-0232	HUMAN OTC DRUG	WALGREENS 100 DRY TOUCH BROAD SPECTRUM SPF 100 FACE SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20151029		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0233_fa1c7aa9-3c90-e3b9-e053-6394a90abbb8	0363-0233	HUMAN OTC DRUG	Walgreens Advanced 50 Hydrating Broad Spectrum SPF 50 Sunscreen		AVOBENZONE. HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191016		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0234_fa1b1787-bf37-f51b-e053-6294a90ae5fc	0363-0234	HUMAN OTC DRUG	Walgreens 50 Sensitive Skin Broad Spectrum SPF 50 Sunscreen		OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20210209		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	OCTOCRYLENE; ZINC OXIDE	40; 50	mg/mL; mg/mL			N	20241231
0363-0235_a1acbbf5-4f76-4a4b-a7fe-48f3727fad55	0363-0235	HUMAN OTC DRUG	Wal-Nadol PM		Acetaminophen and Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19940515	20241228	OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0240_f0e99063-2b8f-af82-e053-2995a90a17e2	0363-0240	HUMAN OTC DRUG	Migraine Relief		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190313		ANDA	ANDA078682	WALGREENS	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0241_fa1ccb80-7af8-40fe-e053-6394a90a41eb	0363-0241	HUMAN OTC DRUG	Walgreens Advanced 50 Sport Broad Spectrum SPF 50 Sunscreen		AVOBENZONE. HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191016		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0242_ead9641b-4d31-da10-e053-2995a90a60e7	0363-0242	HUMAN OTC DRUG	Walgreen		Benzalkonium Chloride	SOAP	TOPICAL	20221014		OTC MONOGRAPH NOT FINAL	part333E	Walgreen	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
0363-0242_edc20f71-0290-1f15-e053-2a95a90a13a6	0363-0242	HUMAN OTC DRUG	Walgreen		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20210806		OTC MONOGRAPH NOT FINAL	part333E	Walgreen Co	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
0363-0245_fa2c2cff-2113-af95-e053-6294a90adaab	0363-0245	HUMAN OTC DRUG	Walgreens 50 Hydrating Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210818		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	TITANIUM DIOXIDE; ZINC OXIDE	90; 70	mg/mL; mg/mL			N	20241231
0363-0249_fa2d79fc-3184-c1f8-e053-6394a90afbaa	0363-0249	HUMAN OTC DRUG	Walgreens 90 Sport Continuous		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20091210		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0250_9608dc92-8d0f-49c3-ae59-268f7a69ef78	0363-0250	HUMAN OTC DRUG	Ibuprofen PM		Ibuprofen, Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210101		ANDA	ANDA210676	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0251_fa2d07aa-abad-b533-e053-6294a90a6c7c	0363-0251	HUMAN OTC DRUG	Walgreens 70 Hydrating Sport Broad Spectrum SPF 70 Sunscreen		AVOBENZONE. HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200917		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0252_65775907-b37e-42fd-8ca2-1f573fa82847	0363-0252	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength	Acetaminophen, Caffeine and Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-0253_55509de8-7edb-4dd1-bf7f-b07fa70aa019	0363-0253	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20160531		OTC MONOGRAPH FINAL	part358H	Walgreen Co	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-0254_fa2e5b1b-f392-11fe-e053-6394a90a4988	0363-0254	HUMAN OTC DRUG	Walgreens 90 Sport Continuous		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220725		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0256_fa3f480d-7d99-aac7-e053-6294a90af55c	0363-0256	HUMAN OTC DRUG	Walgreens Maximum Strength Tinted Acne Spot Treatment Cream		Benzoyl Peroxide	CREAM	TOPICAL	20200207		OTC MONOGRAPH FINAL	M006	WALGREEN COMPANY	BENZOYL PEROXIDE	100	mg/g			N	20241231
0363-0257_527c88da-027e-42e6-8e91-2b98222a4c94	0363-0257	HUMAN OTC DRUG	Stool Softener		DOCUSATE CALCIUM	CAPSULE, LIQUID FILLED	ORAL	20140731	20240223	OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE CALCIUM	240	mg/1			N	
0363-0258_fc502b0d-12d8-755b-e053-6394a90ae980	0363-0258	HUMAN OTC DRUG	WALGREENS ECZEMA		COLLOIDAL OATMEAL	LOTION	TOPICAL	20220603		OTC MONOGRAPH FINAL	M016	WALGREEN COMPANY	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0363-0261_fc634fe6-e124-713a-e053-6294a90ac9f4	0363-0261	HUMAN OTC DRUG	Walgreens 70 Sheer Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220907		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0262_5a41d162-b59b-4b11-a23c-7b650dd39ccc	0363-0262	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20190830		ANDA	ANDA207868	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0263_0c42feb9-5bfa-5289-e063-6394a90a02b9	0363-0263	HUMAN OTC DRUG	Walgreen Anti-Itch		Pramoxine HCL	LOTION	TOPICAL	20201208		OTC MONOGRAPH DRUG	M017	Walgreens	PRAMOXINE HYDROCHLORIDE	1	g/100g			N	20241231
0363-0264_9cb5e691-861b-4865-b441-cc7643436053	0363-0264	HUMAN OTC DRUG	Daily Acne Control Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20160301		OTC MONOGRAPH FINAL	part333D	Walgreen Co	BENZOYL PEROXIDE	100	mg/g			N	20241231
0363-0265_fc7294b5-6fe1-64ec-e053-6294a90a0cbc	0363-0265	HUMAN OTC DRUG	Walgreens Oil-Free Moisturizing Broad Spectrum SPF 15 Sunscreen		AVOBENZONE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20120531		OTC MONOGRAPH FINAL	M020	WALGREEN COMPANY	AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	15; 50; 30; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0266_02e5e856-8b6d-de38-e063-6394a90a93c7	0363-0266	HUMAN OTC DRUG	Walgreens Maximum Strength Acne Gel		Benzoyl Peroxide	GEL	TOPICAL	20230502		OTC MONOGRAPH FINAL	M006	WALGREEN COMPANY	BENZOYL PEROXIDE	100	mg/g			N	20241231
0363-0267_ce0749ab-e104-4082-8942-9b5c36159dd3	0363-0267	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20170630		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
0363-0268_cd2aaf26-f3ab-4113-af9a-7345ce699344	0363-0268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20150430		OTC MONOGRAPH DRUG	M022	Walgreens	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
0363-0269_ffc4cbf1-52ea-b168-e053-6394a90a3166	0363-0269	HUMAN OTC DRUG	Walgreens Acne Control Gel		SALICYLIC ACID	GEL	TOPICAL	20230502		OTC MONOGRAPH FINAL	M006	WALGREEN COMPANY	SALICYLIC ACID	20	mg/mL			N	20241231
0363-0273_099764cd-2080-3154-e063-6394a90a9de6	0363-0273	HUMAN OTC DRUG	Walgreens Advanced 50 Baby Broad Spectrum SPF 50 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20190808		OTC MONOGRAPH DRUG	M020	WALGREEN COMPANY	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-0274_09a9e53d-8b1e-2faa-e063-6394a90afbf6	0363-0274	HUMAN OTC DRUG	Walgreens Advanced 30 Hair and Scalp Mist Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190826		OTC MONOGRAPH DRUG	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 60; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0275_43591856-b68b-408a-a4db-8627dd908fbb	0363-0275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20170630		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0363-0277_d74112d5-2947-4ff9-acb6-9f388268eae3	0363-0277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20150430		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
0363-0278_9596606a-d83c-44a9-9cbf-89b27ed87e30	0363-0278	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	LIQUID	ORAL	20160131		OTC MONOGRAPH DRUG	M013	Walgreens	ACETAMINOPHEN	500	mg/15mL			N	20241231
0363-0280_0aaeb2ed-537a-5f43-e063-6294a90aeaa2	0363-0280	HUMAN OTC DRUG	Walgreens SPF 30 Premium Moisturizing Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0283_b8557c1e-56b5-4b15-b204-732e22da8fa0	0363-0283	HUMAN OTC DRUG	Dye Free Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20150331		OTC MONOGRAPH NOT FINAL	part343	Walgreens	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0285_66a552e1-ce49-40e3-aecb-f967493e02a3	0363-0285	HUMAN OTC DRUG	Dye Free Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20150331		OTC MONOGRAPH NOT FINAL	part343	Walgreens	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0286_0ab16998-3ba4-7e3e-e063-6394a90a55e7	0363-0286	HUMAN OTC DRUG	Walgreens SPF 50 Premium Moisturizing Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0287_332b24b6-629f-4df0-a2d7-b7b63fe45e83	0363-0287	HUMAN OTC DRUG	Cold and Allergy D		Pseudoephedrine HCl, Triprolidine HCl	TABLET, FILM COATED	ORAL	20221129		OTC MONOGRAPH DRUG	M012	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	60; 2.5	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0290_8875197e-6107-07d4-e053-2995a90a078b	0363-0290	HUMAN OTC DRUG	Walgreens Burn relief		Lidocaine Hydrochloride	GEL	TOPICAL	20180210		OTC MONOGRAPH NOT FINAL	part348	Walgreens	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-0291_9e446c8a-5b7e-47eb-8c45-4e6b59814c49	0363-0291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0292_6ec795cd-7d27-481e-8fbe-a49dc7907a60	0363-0292	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0293_e4dd456f-266e-48ac-9c85-337914fae153	0363-0293	HUMAN OTC DRUG	Dye Free Wal Dryl Allergy	childrens	Diphenhydramine Hydrochloride	LIQUID	ORAL	20150331		OTC MONOGRAPH FINAL	part341	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0295_ee0eab5e-9685-4e22-90c3-572b6fd2ccf2	0363-0295	HUMAN OTC DRUG	Anti-Itch Wal-Dryl		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20110708		OTC MONOGRAPH NOT FINAL	part348	Walgreen's Co	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	kg/100L; kg/100L	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0297_9f8f8635-6d0d-497b-b041-dc23d9ba884b	0363-0297	HUMAN OTC DRUG	Childrens Plus Cough and Runny Nose		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide	SUSPENSION	ORAL	20150731		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0298_0b24df43-b1e4-fb59-e063-6294a90a08c4	0363-0298	HUMAN OTC DRUG	Walgreens SPF 30 Premium Moisturizing Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 37.5	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0300_568b0af4-0c9f-4601-adf8-f453397bdc36	0363-0300	HUMAN OTC DRUG	Adult Wal Tussin	Cough Long Acting	Dextromethorphan Hydrobromide	SOLUTION	ORAL	20040903		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0304_653f9312-fcc6-4348-b72e-1c08a8619d0e	0363-0304	HUMAN OTC DRUG	Anefrin Nasal	Original	oxymetazoline hydrochloride	SPRAY	NASAL	19950928		OTC MONOGRAPH FINAL	part341	Walgreen Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0363-0306_fabc584e-5323-4f7c-9b65-3f96d2f7ecac	0363-0306	HUMAN OTC DRUG	smooth lax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA090685	Walgreen Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0310_74975388-34c0-4c4e-8368-8e375efe7908	0363-0310	HUMAN OTC DRUG	wal tussin	adult chest congestion	Guaifenesin	SOLUTION	ORAL	19951013		OTC MONOGRAPH FINAL	part341	Walgreen Company	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-0312_726c89d2-54c0-4bc7-8e2c-ecdd0ee6d77d	0363-0312	HUMAN OTC DRUG	Childrens Wal Tap Elixer	Cold and Allergy	Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20150331		OTC MONOGRAPH FINAL	part341	Walgreens	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0315_0b2b3298-8649-7c1b-e063-6294a90a3970	0363-0315	HUMAN OTC DRUG	Walgreens SPF 50 Premium Moisturizing Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0316_f214f16a-9fbf-845f-e053-2995a90a13e0	0363-0316	HUMAN OTC DRUG	NBE Anbesol		Benzocaine	GEL	ORAL	20220430		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-0317_83523e54-c08f-4112-ab25-2399a4756ecd	0363-0317	HUMAN OTC DRUG	Antacid Regular Strength		Antacid	TABLET, CHEWABLE	ORAL	20171218		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	500	mg/1			N	20241231
0363-0318_a7b4e95d-d732-4917-9ab0-4868e622ad67	0363-0318	HUMAN OTC DRUG	Rinse		Eucalyptol, menthol, Methyl salicylate, thymol	MOUTHWASH	ORAL	19900515		OTC MONOGRAPH NOT FINAL	part356	Walgreen Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0322_61af0cb4-d328-4256-8516-2cc5781dcbd5	0363-0322	HUMAN OTC DRUG	Childrens Pain and Fever Cherry flavor		ACETAMINOPHEN	SUSPENSION	ORAL	20201105		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0323_cab5509a-0c07-46f5-8f3d-eab1572e4c84	0363-0323	HUMAN OTC DRUG	Childrens Pain and Fever, Grape flavor		ACETAMINOPHEN	SUSPENSION	ORAL	20201105		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0327_e1052d14-bf01-42b0-bd31-38518f88e110	0363-0327	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Walgreen Company	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0329_a16d3a49-51e8-457d-9614-4ef71665b886	0363-0329	HUMAN OTC DRUG	WAL-DRYL ALLERGY		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302	20250808	OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0330_e03fb3aa-3155-4877-9b0f-91b686ee0a59	0363-0330	HUMAN OTC DRUG	infants dye free pain and fever		Acetaminophen	SUSPENSION	ORAL	20131022		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0331_6e90a856-b1f6-4a6e-bf4c-b341d3e1cee7	0363-0331	HUMAN OTC DRUG	Night Time Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCl	LIQUID	ORAL	20201113		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0334_c23a3a46-e36a-4bb9-ba9f-28e5474d11a5	0363-0334	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Walgreen Company	ACETAMINOPHEN	650	mg/1			N	20241231
0363-0336_6116df05-91b5-4f17-b6d7-bc5dcc693b21	0363-0336	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Walgreen Company	ACETAMINOPHEN	650	mg/1			N	20241231
0363-0337_997a9473-ccee-4cea-9df8-ba2f8d8c21a8	0363-0337	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20141230		OTC MONOGRAPH FINAL	part341	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0340_1bc5ce72-38f4-43f7-99cc-2b8b4725e15b	0363-0340	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20160501		ANDA	ANDA078569	Walgreen Company	ACETAMINOPHEN	650	mg/1			N	20241231
0363-0349_0c409c1c-818b-82ec-e063-6394a90a9d9b	0363-0349	HUMAN OTC DRUG	Walgreens 40 Invisible Facial Sunscreen Broad Spectrum SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20231019		OTC MONOGRAPH DRUG	M020	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0355_5f845434-d8db-4bfa-8fc0-8a9b9205f194	0363-0355	HUMAN OTC DRUG	Overnight Cold Therapy Pain Relief		Menthol, unspecified form	GEL	TOPICAL	20231204		OTC MONOGRAPH DRUG	M017	Walgreen Co.	MENTHOL, UNSPECIFIED FORM	36	mg/mL			N	20241231
0363-0365_3f364d1d-07d0-4b85-bda1-bc5edcac2652	0363-0365	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20130322		ANDA	ANDA091349	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0367_c1e50299-8887-4f1b-8139-dea4d4c6c7d8	0363-0367	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0368_2292586d-ca11-4adf-ba33-dd01ec7de588	0363-0368	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	19970114		ANDA	ANDA074661	Walgreen Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0370_dff9140e-023f-48b9-8ddc-974901ade921	0363-0370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20130208		OTC MONOGRAPH NOT FINAL	part333A	Walgreen CO	ALCOHOL	70	mL/100mL			N	20241231
0363-0374_e28c948b-41a9-4153-bcde-0068cda8b3c5	0363-0374	HUMAN OTC DRUG	migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020502		ANDA	ANDA075794	Walgreen Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-0375_af0d203d-6787-4dab-ad06-719c9be85744	0363-0375	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	Walgreen Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0363-0376_25efab59-409e-420f-a8ba-555060002acf	0363-0376	HUMAN OTC DRUG	Sore throat	cherry	Phenol	SPRAY	ORAL	20140831		OTC MONOGRAPH DRUG	M022	Walgreens	PHENOL	1.4	g/100mL			N	20241231
0363-0379_a678ffc5-84f9-4820-8f1d-20ed05d6f539	0363-0379	HUMAN OTC DRUG	wal dryl allergy	childrens	Diphenhydramine Hydrochloride	SOLUTION	ORAL	19890715		OTC MONOGRAPH FINAL	part341	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0384_4d041b9d-4324-41d7-a5c7-c46d90af4157	0363-0384	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120828		ANDA	ANDA091135	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0390_ed935d12-b874-4878-87da-8129ce0f2df2	0363-0390	HUMAN OTC DRUG	ephrine nose	extra strength	Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	19951020		OTC MONOGRAPH FINAL	part341	Walgreen Company	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0393_d01cceec-909d-4a84-8034-7229b15fcda2	0363-0393	HUMAN OTC DRUG	Ibuprofen 200		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0395_adcab0d5-0551-4ce7-a2a4-94adef0972f8	0363-0395	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20160430		OTC MONOGRAPH NOT FINAL	part334	Walgreens	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0396_ee385dff-e56d-46de-a5aa-a96847634941	0363-0396	HUMAN OTC DRUG	wal tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19951006		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0401_80a627db-860c-42d2-b5e7-b9550c2989e6	0363-0401	HUMAN OTC DRUG	Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110808		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0404_bcaad9f4-513b-483a-811e-af2e82169bb6	0363-0404	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, CHEWABLE	ORAL	20020529		OTC MONOGRAPH DRUG	M009	Walgreen Company	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0363-0411_4aba8ee5-d2b0-4f6d-ba98-03fb96877c50	0363-0411	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060223		ANDA	ANDA077007	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0415_f3813de4-9418-894e-e053-2995a90ac1f6	0363-0415	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230131		OTC MONOGRAPH NOT FINAL	part334	WALGREEN COMPANY	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0416_f3837b54-5b9a-35b4-e053-2a95a90a7ec7	0363-0416	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230131		OTC MONOGRAPH NOT FINAL	part334	WALGREEN COMPANY	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0418_6bb65c05-ac7a-4226-adae-58f5531e0ba4	0363-0418	HUMAN OTC DRUG	Wal-Dryl	Allergy	Diphenhydramine HCl	LIQUID	ORAL	20140831		OTC MONOGRAPH DRUG	M012	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0419_e18ebad8-a888-4400-b220-eb02cb6c5630	0363-0419	HUMAN OTC DRUG	Cough	Childrens	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19930409		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0421_f0466c5c-f3f8-e95e-e053-2a95a90ace9d	0363-0421	HUMAN OTC DRUG	Walgreens Effervescent Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20120507		OTC MONOGRAPH FINAL	part343	Walgreens	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0423_28d9145e-3aa3-4a6e-97d4-591a5ff16be9	0363-0423	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, COATED	ORAL	20170801		ANDA	ANDA074567	WALGREEN COMPANY	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0424_25ffadb3-a5e9-41a8-b788-97604f6b65d5	0363-0424	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	LOZENGE	ORAL	20100112		ANDA	ANDA090821	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0426_27c27bbc-c6f3-48c2-8f36-2fa7d9404694	0363-0426	HUMAN OTC DRUG	Tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20071219		ANDA	ANDA075915	Walgreen Company	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-0427_f383b21e-2320-32ac-e053-2995a90a0f77	0363-0427	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230131		OTC MONOGRAPH NOT FINAL	part334	WALGREEN COMPANY	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0430_760a75a6-df5e-47e1-8370-1b1f8bc64dc3	0363-0430	HUMAN OTC DRUG	Eye Allergy Relief		Pheniramine Maleate and Naphazoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20100831		NDA	NDA020065	Walgreen Company	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.2675; 3.15	mg/mL; mg/mL			N	20241231
0363-0432_1ffb530b-0302-469b-b058-8acdbfe1d83c	0363-0432	HUMAN OTC DRUG	Antacid Mint		Aluminum Hydroxide, Magnesium Hydroxide, Demithicone	SUSPENSION	ORAL	20180331	20241229	OTC MONOGRAPH FINAL	part332	Walgreens	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
0363-0437_de492825-7d3a-4f36-ab94-264470220abf	0363-0437	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets	Maximum Strength	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190101		ANDA	ANDA209692	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0438_d2681d42-1e43-4628-af4b-9c361397e357	0363-0438	HUMAN OTC DRUG	Dye Free Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0441_9cfe1589-c9d7-4076-be2c-27bcbd754b09	0363-0441	HUMAN OTC DRUG	WAL SOM	NIGHTTIME SLEEP AID	Doxylamine succinate	TABLET	ORAL	19990305		ANDA	ANDA040167	Walgreen Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0363-0451_7023ce13-c512-5f05-4c25-461c5b174a85	0363-0451	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150901		NDA	NDA020076	Walgreens Company	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0453_689d9ce4-091d-47c0-9c6b-25e82521bce5	0363-0453	HUMAN OTC DRUG	Wal-Phed PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Walgreen Company	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0455_7023ce13-c512-5f05-4c25-461c5b174a85	0363-0455	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150901		NDA	NDA020076	Walgreens Company	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0456_45ef5b64-95b0-4136-bfcf-399e14722b78	0363-0456	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20061027		ANDA	ANDA076777	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0457_7023ce13-c512-5f05-4c25-461c5b174a85	0363-0457	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150901		NDA	NDA020076	Walgreens Company	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0460_cf14688a-f532-493f-87c9-b662b4495d65	0363-0460	HUMAN OTC DRUG	Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0462_b384d62c-4f13-4a03-a446-f452a71dcc03	0363-0462	HUMAN OTC DRUG	Wal-Phed PE	Maximum Strength	Chlorpheniramine maleate and Phenylephrine HCl	TABLET	ORAL	20050609	20240216	OTC MONOGRAPH FINAL	part341	Walgreen Company	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
0363-0463_1ad0ce30-ad63-43bb-bb52-e94cf0eebc6f	0363-0463	HUMAN OTC DRUG	DayTime Mucus Relief Severe Cold and Nighttime Cold and Flu	Maximum Strength	Daytime Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, NightTime Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	KIT		20160331		OTC MONOGRAPH DRUG	M012	Walgreens						N	20241231
0363-0467_8e7a8e8a-18e5-4957-bbe9-493a8784c959	0363-0467	HUMAN OTC DRUG	Walgreens Acne Foaming Cleanser	Acne Treatment	Benzoyl Peroxide	CREAM	TOPICAL	20210629		OTC MONOGRAPH FINAL	part333D	Walgreen Company	BENZOYL PEROXIDE	40	mg/mL			N	20241231
0363-0469_c99a3528-3766-4f29-b806-f3fe410450d0	0363-0469	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20150126		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ALCOHOL	545	mg/mL			N	20241231
0363-0471_5203100d-35a4-4a56-a8e1-e1fd1ca5c2b9	0363-0471	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20200911		ANDA	ANDA213557	WALGREEN CO.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0472_4484b561-35c4-409f-8ff6-983085fa95ed	0363-0472	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20170630		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0363-0474_ba30d7fd-2984-4e14-b2d3-f3a6e04f98ff	0363-0474	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	WALGREEN CO.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0478_1c5fe1c3-f744-4234-bac0-fc9889a51024	0363-0478	HUMAN OTC DRUG	Sinus Relief Severe Congestion	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150831		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0481_ef3af371-66e5-4889-b3bb-e0f6ba34e438	0363-0481	HUMAN OTC DRUG	Childrens Allergy Dye-Free Wal Dryl		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20181010	20240627	OTC MONOGRAPH FINAL	part341	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0482_e58cd290-d8fe-46b9-a972-4faec0d0a8e4	0363-0482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20130601		OTC MONOGRAPH FINAL	part355	Walgreen Co	SODIUM FLUORIDE	.1	mg/mL			N	20241231
0363-0484_767ea90e-0273-4858-b1c4-404550c45163	0363-0484	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20090121		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20241231
0363-0486_2246c05d-0b74-4d56-b127-3ace24861b1a	0363-0486	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20151031	20250228	OTC MONOGRAPH DRUG	M007	Walgreens	SENNOSIDES	8.6	mg/1			N	
0363-0487_d6accafe-19ac-4c12-a9ef-68b6101645cd	0363-0487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160331	20250228	OTC MONOGRAPH DRUG	M016	Walgreens	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
0363-0491_3d4881c1-a58a-492d-ac18-be68826730e5	0363-0491	HUMAN OTC DRUG	Wal-Finate		Chlorpheniramine Maleate	TABLET	ORAL	19921219	20240124	OTC MONOGRAPH FINAL	part341	Walgreen Company	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0494_f3141d25-e1d7-4e53-a5f7-87145a9a8c82	0363-0494	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150701		ANDA	ANDA091135	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0495_b8222e44-dd58-41be-aefe-6367ae771a60	0363-0495	HUMAN OTC DRUG	Wal Zyr		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080109	20240301	ANDA	ANDA078336	Walgreen Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0504_effed7e4-def3-7322-e053-2995a90acc5f	0363-0504	HUMAN OTC DRUG	Well at Walgreens		SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20130401		UNAPPROVED DRUG OTHER		Walgreen Company						N	20241231
0363-0505_724a9ccc-0e58-47b3-ad10-cf7c48448362	0363-0505	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	dextromethorphan hydrobromide, guaifenesin	LIQUID	ORAL	20170831		OTC MONOGRAPH FINAL	part341	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0506_ecf14fb4-7b58-4fe3-919f-3c0538fbd9fc	0363-0506	HUMAN OTC DRUG	Cough and Chest Congestion DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160229		OTC MONOGRAPH FINAL	part341	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0508_29aed9f9-d2e5-4c4d-b76b-2673e7f12a92	0363-0508	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016		ANDA	ANDA209339	WALGREEN CO.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-0510_cec3fb6b-1c35-4869-b923-062b12e7e212	0363-0510	HUMAN OTC DRUG	Maximum Strength Mucus Relief DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	WALGREEN CO.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0511_246e504d-527a-481a-bb92-8489a7abf635	0363-0511	HUMAN OTC DRUG	Acid Reducer Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160129		ANDA	ANDA077355	Walgreen Company	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0512_08baa37a-3123-47b8-801a-8afb87a574b6	0363-0512	HUMAN OTC DRUG	Mucus Congestion and Cough Relief	Childrens	Dextromethorphan HBr, Guaifensin, Phenylephrine HCI	LIQUID	ORAL	20160430		OTC MONOGRAPH FINAL	part341	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0519_f1f51f6f-8f28-4ce8-a296-4be3f66d2b10	0363-0519	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20241231
0363-0524_b4af45c3-34ef-45c9-8696-61f238c9a32c	0363-0524	HUMAN OTC DRUG	Sinus Relief	Maximum Strength	Acetaminophen, Dextromethorphan HBR, Guaifenesin, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20170430	20240531	OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
0363-0531_678e13dd-1da2-49a5-9566-9e34d8f8cb0d	0363-0531	HUMAN OTC DRUG	Extra Strength Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20051211		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20241231
0363-0532_303a8b50-e7b3-48bd-93f8-f542413b5aad	0363-0532	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, FILM COATED	ORAL	20051222		OTC MONOGRAPH DRUG	M012	Walgreen Company	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-0533_d2910298-f2d6-4641-a8e0-e4fad2749ec4	0363-0533	HUMAN OTC DRUG	Mucus Relief DM		Dextromethorphan HBr, Guaifenesin	TABLET, FILM COATED	ORAL	20051231		OTC MONOGRAPH DRUG	M012	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0539_ce7ad9cf-3416-42f6-93b5-d9f18138d5b8	0363-0539	HUMAN OTC DRUG	triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20150507		OTC MONOGRAPH FINAL	part333B	Walgreen Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-0541_e054113d-bc9c-4763-e053-2995a90a3e4c	0363-0541	HUMAN OTC DRUG	Walgreens Antacid Pain Relief Extra Strength		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20210205		OTC MONOGRAPH FINAL	part343	Walgreens	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 500; 1985	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0542_1eae6300-66a1-4768-ae4c-ff286640c881	0363-0542	HUMAN OTC DRUG	Mucus Relief PE		Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20060415		OTC MONOGRAPH DRUG	M012	Walgreen Company	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0544_83543ced-27a8-442e-a883-4e7d18405179	0363-0544	HUMAN OTC DRUG	arthritis pain reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000526		ANDA	ANDA075077	Walgreen Company	ACETAMINOPHEN	650	mg/1			N	20241231
0363-0547_f23be068-50fe-4be3-9cf3-2a1093932ed5	0363-0547	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin, Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20070126		OTC MONOGRAPH DRUG	M012	Walgreen Company	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	400; 40	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0552_4807fb60-8d08-6e61-e054-00144ff8d46c	0363-0552	HUMAN OTC DRUG	Studio 35 External Analgesic Medicated Body		Menthol and Zinc Oxide	POWDER	TOPICAL	20170207		OTC MONOGRAPH NOT FINAL	part348	Walgreen Co	MENTHOL; ZINC OXIDE	1.5; 10	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-0556_ac56f68c-fddd-4736-b742-6de11bec565a	0363-0556	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0559_e058aead-6de2-492c-a5f0-a8c5c6138ce2	0363-0559	HUMAN OTC DRUG	Multi-Symptom Allergy		Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl	TABLET, COATED	ORAL	20080327		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0563_02aaaa06-eb38-4d40-8e23-8032edc71f1b	0363-0563	HUMAN OTC DRUG	Aspirin	enteric coated low dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Walgreen Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0564_9bc7210b-0935-4658-afee-fd045e87c745	0363-0564	HUMAN OTC DRUG	Vapor Inhaler		Levmetamfetamine Nasal Decongestant	INHALANT	NASAL	20160701		OTC MONOGRAPH FINAL	part341	Walgreens	LEVMETAMFETAMINE	50	mg/1			N	20241231
0363-0566_40780e12-bef1-4df0-b72f-5caa8414974d	0363-0566	HUMAN OTC DRUG	Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110816		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0567_0eb554bf-3601-4c7a-8b94-7e6eb3a55edd	0363-0567	HUMAN OTC DRUG	daytime nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20120906		OTC MONOGRAPH FINAL	part341	Walgreen Company						N	20241231
0363-0572_5aa9d2d0-8d9b-4fb0-ac1b-bc3e7f1ebfea	0363-0572	HUMAN OTC DRUG	Tension Headache Relief		Acetaminophen, Caffeine	TABLET, COATED	ORAL	20090209		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-0577_270dc262-55aa-44c2-90a4-9b966ce6642d	0363-0577	HUMAN OTC DRUG	daytime nighttime severe cold and flu		Acetaminophen, dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20150723		OTC MONOGRAPH FINAL	part341	Walgreen Company						N	20241231
0363-0578_8ac033e0-4b61-4611-adc2-bf03edfd711c	0363-0578	HUMAN OTC DRUG	wal tussin dm	adult cough and chest congestion	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19940729		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0579_00ca8084-a5af-4e64-b58a-e8806fe1f101	0363-0579	HUMAN OTC DRUG	pain reliever fever reducer	childrens	Acetaminophen	SUPPOSITORY	RECTAL	20100219		ANDA	ANDA070607	Walgreen Company	ACETAMINOPHEN	120	mg/1			N	20241231
0363-0581_a2c1c004-a355-4594-97bb-f7de3f9af157	0363-0581	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20170303		OTC MONOGRAPH FINAL	part355	Walgreens	SODIUM FLUORIDE	.2	mg/mL			N	20241231
0363-0584_7d40f49c-3bec-429c-9a1c-feea4eb216fb	0363-0584	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20151130	20250228	OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
0363-0586_5f474392-48ec-45d9-a1be-1953aeef3c83	0363-0586	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20190331		OTC MONOGRAPH NOT FINAL	part343	Walgreens	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-0587_09ad6729-b0c2-4d3f-a9c4-b80ef7560a29	0363-0587	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20090318		OTC MONOGRAPH DRUG	M013	Walgreen Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0589_e6c2450a-9e08-4b2d-b04e-35a7905e3725	0363-0589	HUMAN OTC DRUG	First Aid Antiseptic Wipes		Benzalkonium Chloride (0.13%)	CLOTH	TOPICAL	20170208		OTC MONOGRAPH NOT FINAL	part333A	Walgreen CO	BENZALKONIUM CHLORIDE	.0013	mg/100mg			N	20241231
0363-0590_4dc87da9-84ad-4e73-8b2c-b7457d21e7f4	0363-0590	HUMAN OTC DRUG	pain and fever		acetaminophen	SUSPENSION	ORAL	19930430		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0596_ae679464-54b8-4fe4-9a24-bdf4e2ba98df	0363-0596	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20150126		OTC MONOGRAPH NOT FINAL	part333A	Walgreen Co	ALCOHOL	63	mL/100mL			N	20241231
0363-0603_5775e31a-1333-4f37-9a95-0b1f4c4281a2	0363-0603	HUMAN OTC DRUG	Severe Cold and Flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20131121		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0604_f4381984-7353-4475-9882-fbb3b6af7f7c	0363-0604	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090121		ANDA	ANDA072096	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0606_c3200d50-e128-48db-be70-51f84f932b04	0363-0606	HUMAN OTC DRUG	Wal-Zyr		Cetirizine HCl	TABLET	ORAL	20180831		ANDA	ANDA209274	Walgreens	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0607_03354d89-62f9-36f2-e063-6394a90a8df0	0363-0607	HUMAN OTC DRUG	4x Medicated Toothache and Gum Cream		Benzocaine	CREAM	ORAL	20200602		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .26; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-0618_0f2c0980-e8dc-47b0-b41e-2083962deb7e	0363-0618	HUMAN OTC DRUG	Walgreens Pinworm Medicine		PYRANTEL PAMOATE	SUSPENSION	ORAL	20151116		OTC MONOGRAPH FINAL	part357B	Walgreens	PYRANTEL PAMOATE	144	mg/mL			N	20241231
0363-0619_46c01470-3f2d-49ae-9519-55cc048e6d6a	0363-0619	HUMAN OTC DRUG	Daily Moisturizing		Daily Moistruizing	LOTION	TOPICAL	20130206		OTC MONOGRAPH FINAL	part347	Walgreen, Co.	DIMETHICONE	13	mg/g	Skin Barrier Activity [PE]		N	20241231
0363-0623_8e016e89-0546-4f98-a274-92686c3decc7	0363-0623	HUMAN OTC DRUG	severe cold and flu		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20150723		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0625_a4393db3-d003-4965-903d-f4ac0409f441	0363-0625	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160630		OTC MONOGRAPH NOT FINAL	part343	Walgreens	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-0640_792a80a8-3e7d-404e-8fb4-1c668d76d1b2	0363-0640	HUMAN OTC DRUG	Cold and Flu	Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20140227		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0641_f035ec4b-f0f3-9c6a-e053-2a95a90aacba	0363-0641	HUMAN OTC DRUG	Hemorrhoidal Cream		Hemorrhoidal Cream	CREAM	TOPICAL	20180325		OTC MONOGRAPH NOT FINAL	part348	Walgreens	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0641_f035fb75-4609-eaf2-e053-2995a90a8070	0363-0641	HUMAN OTC DRUG	Hemorrhoidal Cream		Hemorrhoidal Cream	CREAM	TOPICAL	20180325		OTC MONOGRAPH NOT FINAL	part348	Walgreens	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0643_b71aa141-86c1-4667-a0e2-2ce8a8c4c1bb	0363-0643	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160310		OTC MONOGRAPH NOT FINAL	part333A	Walgreen Co	ALCOHOL	558	mg/mL			N	20241231
0363-0644_28932653-77a4-4988-bc46-9d4d942af8cb	0363-0644	HUMAN OTC DRUG	Hand wipes		Benzalkonium chloride	CLOTH	TOPICAL	20090105		OTC MONOGRAPH NOT FINAL	part333A	Walgreen Co	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
0363-0645_8aac3f97-448c-4bb9-a62e-0690071a48de	0363-0645	HUMAN OTC DRUG	loperamide hydrochloride		loperamide HCl	SUSPENSION	ORAL	20120518		ANDA	ANDA091292	Walgreen Company	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0363-0646_0cf96dfd-82db-9204-e063-6394a90a1019	0363-0646	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops Preservative Free		Dextran 70, Hypromellose	LIQUID	OPHTHALMIC	20200101		OTC MONOGRAPH DRUG	M018	Walgreen Company	DEXTRAN 70; HYPROMELLOSE, UNSPECIFIED	.1; .3	g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0363-0647_091c37a9-a031-584a-e063-6394a90ac4c4	0363-0647	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20141201		OTC MONOGRAPH DRUG	M007	WALGREEN COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0648_facc752f-bb8c-43b1-8cee-da9f498e41f4	0363-0648	HUMAN OTC DRUG	Wal Four		Phenylephrine hydrochloride	SPRAY	NASAL	20020920		OTC MONOGRAPH FINAL	part341	Walgreen Company	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0649_091c1959-4559-25e5-e063-6394a90adb9b	0363-0649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20170701		OTC MONOGRAPH DRUG	M007	WALGREEN COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0650_08303815-0b29-42fd-b83a-076c174a47f2	0363-0650	HUMAN OTC DRUG	All Day Sinus and Cold D		Naproxen sodium, Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130523		ANDA	ANDA076518	Walgreen Company	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0651_dfafde61-3865-4434-a530-667846e9c2ec	0363-0651	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20200105		OTC MONOGRAPH NOT FINAL	part333A	Walgreen	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
0363-0652_e79f9861-0591-b852-55af-1670d0c0477d	0363-0652	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20210202		ANDA	ANDA208150	Walgreens	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0660_c9eac4fb-01cb-4caa-a9a8-ebbe57963d32	0363-0660	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20020325		ANDA	ANDA074937	Walgreen Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0664_17ee4c13-d82c-43f6-9674-2fe261254d94	0363-0664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19930324		OTC MONOGRAPH NOT FINAL	part356	Walgreens Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0666_a62667d8-8433-461d-82ba-715800b8a071	0363-0666	HUMAN OTC DRUG	Cold and Flu		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20140207		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0669_d24f2856-6117-3ac5-e053-2a95a90a1a2c	0363-0669	HUMAN OTC DRUG	Extra Strength Pain Reliever		Acetaminophen tablets 500 mg	TABLET	ORAL	20211013		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ACETAMINOPHEN	500	mg/1			N	20241231
0363-0670_477234df-ba16-4e97-a96e-219034074af3	0363-0670	HUMAN OTC DRUG	Intensive Healing Eczema		Hydrocortisone	LOTION	TOPICAL	20180325		OTC MONOGRAPH NOT FINAL	part348	Walgreens	HYDROCORTISONE	1.02	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0672_c6572b5c-29a9-4202-9960-3ad73aac7c55	0363-0672	HUMAN OTC DRUG	Wal-Sleep Z		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20150724	20241014	OTC MONOGRAPH FINAL	part338	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0679_c0caa218-ec0f-47a0-be3e-f7acf6384eaf	0363-0679	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831	20250228	OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM	100	mg/1			N	
0363-0681_605cff31-c8aa-483f-ada7-9026e814a920	0363-0681	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20170531		OTC MONOGRAPH FINAL	part341	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0683_feefbd99-e8c6-4b76-af2c-baaefefd683d	0363-0683	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
0363-0684_d24f665b-2d5d-fcb8-e053-2995a90a7963	0363-0684	HUMAN OTC DRUG	Extra Strength Pain Reliever		Acetaminophen tablets 500 mg	TABLET	ORAL	20211013		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ACETAMINOPHEN	500	mg/1			N	20241231
0363-0686_d3517609-9665-ca77-e053-2995a90a73f2	0363-0686	HUMAN OTC DRUG	Low dose Aspirin		Aspirin 81 mg Delayed Release Tablets	TABLET	ORAL	20211008		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0688_2dfc9d6a-e8db-4b5e-8f28-e55a5822399e	0363-0688	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20190904		OTC MONOGRAPH FINAL	part358H	Walgreen Co	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-0690_df7fd50f-a3b4-6fe6-e053-2995a90ac4de	0363-0690	HUMAN OTC DRUG	Low dose Aspirin		Aspirin 81 mg Delayed Release Tablets	TABLET	ORAL	20211008		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0691_f18603d3-aead-4fff-90da-041f483e6576	0363-0691	HUMAN OTC DRUG	Aspirin 325		Aspirin	TABLET, DELAYED RELEASE	ORAL	20170701		OTC MONOGRAPH DRUG	M013	Walgreen Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-0695_ae539fc7-1fa6-48d3-8de8-88c30699d6b3	0363-0695	HUMAN OTC DRUG	jock itch		Tolnaftate	SPRAY	TOPICAL	20050608		OTC MONOGRAPH FINAL	part333C	Walgreen Company	TOLNAFTATE	1	g/100g			N	20241231
0363-0699_a64e51f8-49c5-4dcc-9157-c00e7c6d7399	0363-0699	HUMAN OTC DRUG	Wal itin		Loratadine	TABLET	ORAL	20090213		ANDA	ANDA076301	Walgreen Company	LORATADINE	10	mg/1			N	20241231
0363-0700_339d9edd-0e09-40de-944f-d2178d637556	0363-0700	HUMAN OTC DRUG	Walgreens Sterile Soothing Eye Wash		Purified water	LIQUID	OPHTHALMIC	20100831		OTC MONOGRAPH FINAL	part349	Walgreens	WATER	99.05	mL/100mL			N	20241231
0363-0701_b89f1014-8543-436f-8bd0-2cff55eef170	0363-0701	HUMAN OTC DRUG	Acid Controller		Famotidine	TABLET, FILM COATED	ORAL	20060926		ANDA	ANDA077351	Walgreen Company	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-0703_1498b956-9e44-42f7-8b79-878de4ebe33f	0363-0703	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20220217		ANDA	ANDA075357	Walgreen Company	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0363-0705_c56878b1-9f82-4d30-ac3a-3b5a15119e4a	0363-0705	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211031		ANDA	ANDA072096	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0708_4127be67-e3a5-4b52-9e06-3ec66998fd4f	0363-0708	HUMAN OTC DRUG	childrens wal tap	dm cough and cold	Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20070309		OTC MONOGRAPH FINAL	part341	Walgreen Company	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0709_6ab269f7-a2f2-4b6f-9798-02276b8b73f6	0363-0709	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20130322		ANDA	ANDA091354	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0710_3a4b702c-ce8a-40e8-a8a6-0b5579aedf23	0363-0710	HUMAN OTC DRUG	childrens Allergy Dye Free Wal Dryl		Diphenhydramine hydrochloride	LIQUID	ORAL	20170831		OTC MONOGRAPH DRUG	M012	WALGREEN CO.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0712_b72f6566-7c03-4f75-e053-2a95a90ac814	0363-0712	HUMAN OTC DRUG	Cocoa Butter Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20201224		OTC MONOGRAPH FINAL	part347	Walgreens	PETROLATUM	99	g/100g			N	20241231
0363-0713_02b59032-b352-4001-8be0-a2683fad38e7	0363-0713	HUMAN OTC DRUG	Acid Reducer Complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20160129		ANDA	ANDA077355	Walgreen Company	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0714_e3c367b5-da25-db6e-e053-2995a90a4dd7	0363-0714	HUMAN OTC DRUG	Extra Strength NiteTime Pain Relief		Acetaminophen 500 mg,Diphenhydramine Hydrochloride 25 mg Tablet	TABLET	ORAL	20211012		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0715_e3d6d795-4760-d460-e053-2995a90a9a25	0363-0715	HUMAN OTC DRUG	Extra Strength Nite-Time Pain Relief		430R WALGREENS Acetaminophen 500 mg,Diphenhydramine HCl 25 mg Tablet	TABLET	ORAL	20211012		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0717_e252ef5a-74ab-45e9-a364-36a5922f77cc	0363-0717	HUMAN OTC DRUG	nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20220131		OTC MONOGRAPH FINAL	part341	Walgreen Company	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0723_fb214941-f40e-440c-85c6-d2bff73120ed	0363-0723	HUMAN OTC DRUG	Daytime Nighttime Sinus Relief	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20160531	20250228	OTC MONOGRAPH DRUG	M012	Walgreens						N	
0363-0725_0c2d87ca-fff0-46d5-9800-756693969a77	0363-0725	HUMAN OTC DRUG	Loratadine and Pseudoephedrine		Loratadine and Pseudoephedrine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20131107		ANDA	ANDA076557	Walgreen Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0729_f0b6e8b4-6ef7-28d5-e053-2a95a90a3617	0363-0729	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl and Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	KIT		20211015		OTC MONOGRAPH FINAL	part341	WALGREENS						N	20241231
0363-0730_7fbc9a95-31f3-4b4e-8425-26c67545376f	0363-0730	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20001201		ANDA	ANDA074164	Walgreens	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-0731_acc1d75b-8661-6894-e053-2a95a90aceb4	0363-0731	HUMAN OTC DRUG	Baby Petroleum		Petrolatum	JELLY	TOPICAL	20140717		OTC MONOGRAPH FINAL	part347	Walgreen Company	PETROLATUM	100	g/100g			N	20241231
0363-0732_ba1e4088-1b21-47e9-b8a9-ac73cae8ebc4	0363-0732	HUMAN OTC DRUG	Omeprazole and sodium bicarbonate		Omeprazole, sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20160715		ANDA	ANDA201361	Walgreen Company	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-0733_bbbf7cf0-290d-4f5d-8fef-3d84ec368d86	0363-0733	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190101		ANDA	ANDA209692	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0734_cc25ea27-934e-4fdb-a806-77a8b5df2b89	0363-0734	HUMAN OTC DRUG	nicotine mini		Nicotine Polacrilex	LOZENGE	ORAL	20130119		ANDA	ANDA203690	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0736_97935ca6-ce8b-476f-9b8a-7840f9aec56b	0363-0736	HUMAN OTC DRUG	Soothe		Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH DRUG	M008	Walgreens	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-0739_feaadad7-0ff4-21b5-5ff5-ff8209636732	0363-0739	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120518		ANDA	ANDA202194	Walgreen Co	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-0740_ab1b1186-4abc-de83-e053-2995a90a77b8	0363-0740	HUMAN OTC DRUG	Shea Butter Petroleum Jelly		Petrolatum Jelly	JELLY	TOPICAL	20160614		OTC MONOGRAPH FINAL	part347	Walgreens	PETROLATUM	99.6	g/100g			N	20241231
0363-0741_6124ee28-5c3d-46f0-98c8-ccbc7d341f61	0363-0741	HUMAN OTC DRUG	Wal-Zyr		Cetirizine HCl	CAPSULE	ORAL	20180131	20241227	ANDA	ANDA207235	Walgreens	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-0743_204000ed-6d3c-4a1f-89c1-6d6ec9aa59b4	0363-0743	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190331		ANDA	ANDA206568	Walgreens	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0744_e0c0904c-f75f-21de-e053-2995a90a22cc	0363-0744	HUMAN OTC DRUG	Daytime Nighttime Sinus Relief	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl/Acetaminophen, Dextromethorphan HBr, Doxylamine succinate,Phenylephrine HCl	KIT	ORAL	20220601		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-0746_e0c48154-4442-56be-e053-2995a90ad58d	0363-0746	HUMAN OTC DRUG	DAYTIME NIGHTTIME SEVERE COLD AND FLU	Maximum Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HBr,GUAIFENESIN, PHENYLEPHRINE HCl / ACETAMINOPHEN, DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCl	KIT	ORAL	20220601		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-0747_5b9d40be-6fd3-4b63-be43-4d1b149c82c4	0363-0747	HUMAN OTC DRUG	Cough and Cold	Nighttime	Acetaminophen Diphenhydramine HCI phenylephrine HCI	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0748_68b7d201-4540-4370-8561-b06ca4483fbe	0363-0748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	Walgreens	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0749_1c50d1e4-dfe2-406c-b9ad-e69eb65bf093	0363-0749	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	Walgreens	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0752_67ced469-3068-49b4-988b-ac440ee968a4	0363-0752	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20190726		ANDA	ANDA210088	WALGREEN COMPANY	LORATADINE	5	mg/1			N	20241231
0363-0753_a4b98284-4419-4e8c-8b56-ddb95c19df0b	0363-0753	HUMAN OTC DRUG	Dye Free Wal Sleep Z		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20180724		OTC MONOGRAPH DRUG	M012	WALGREEN CO.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0754_819603c5-d0d2-4033-a5c7-3eecea442783	0363-0754	HUMAN OTC DRUG	Wal-itin		LORATADINE	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210088	Walgreens	LORATADINE	5	mg/1			N	20241231
0363-0755_e9c28b83-eeef-48a9-936c-6d11b830f8cf	0363-0755	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20171116		OTC MONOGRAPH FINAL	part358H	Walgreen Co	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-0756_92c3c561-28da-4f48-846c-1e1bdf7a4b3f	0363-0756	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20180731	20250831	ANDA	ANDA200888	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0363-0758_385a1e0b-09c5-4f2d-8404-086020e5c891	0363-0758	HUMAN OTC DRUG	Walgreens Adult Nighttime Wal Tussin DM Max Maximum Strength		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20170908		OTC MONOGRAPH FINAL	part341	WALGREEN CO.	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0760_f1460ae0-9753-4e68-a28a-953db855f56e	0363-0760	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20150831		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0763_0f9765e1-29b5-4fd5-8d23-c6ca2933c9ac	0363-0763	HUMAN OTC DRUG	Severe Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20131121		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0770_e3acc0ae-b992-671b-e053-2995a90a2d07	0363-0770	HUMAN OTC DRUG	HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET, COATED	ORAL	20210331		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-0771_06a0d5aa-cc25-4ef8-8157-10d519e96861	0363-0771	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20230419		ANDA	ANDA201865	WALGREEN COMPANY	LORATADINE	5	mg/5mL			N	20241231
0363-0775_e0c204a7-e41c-8352-e053-2a95a90a1520	0363-0775	HUMAN OTC DRUG	Daytime and Nighttime Cold and Flu	Maximum Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HBr,GUAIFENESIN, PHENYLEPHRINE HCl / ACETAMINOPHEN, DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCl	KIT	ORAL	20220601		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-0777_4d7293cd-9f80-444e-af91-483e8998ab79	0363-0777	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20160902		OTC MONOGRAPH NOT FINAL	part333E	Walgreens	POVIDONE-IODINE	10	mg/mL			N	20241231
0363-0782_7cfaed4f-8f79-4507-b44c-d92f51119173	0363-0782	HUMAN OTC DRUG	Mucus Relief	Maximum StrengthCold Flu and Sore Throat	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20170531		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0783_90bff7b8-9a61-b05c-2408-c08b1eb50c66	0363-0783	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20201214		ANDA	ANDA076502	Walgreens Company	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0784_7e7ffc3e-e6f3-18ec-ed27-f9268790597e	0363-0784	HUMAN OTC DRUG	Wal-Fex		Fexofenadine hydrochloride	TABLET	ORAL	20110413		ANDA	ANDA076502	Walgreens Company	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0785_a57761b7-8570-4e6b-b7b1-2fe221445f5e	0363-0785	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20151130	20250228	OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
0363-0790_09323865-ee2c-4c86-badc-672852e4e87e	0363-0790	HUMAN OTC DRUG	Walgreens Infants Dye Free Gas Relief		Simethicone	EMULSION	ORAL	20170830		OTC MONOGRAPH DRUG	M002	WALGREEN CO.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
0363-0791_63a21c0c-736f-4a5d-aca7-e9b2a49d19dc	0363-0791	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20170726		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0792_0bd294fa-29d6-dd5d-e063-6294a90aeb35	0363-0792	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET	ORAL	20200612		OTC MONOGRAPH DRUG	M013	WALGREEN CO.	ACETAMINOPHEN	500	mg/1			N	20241231
0363-0800_3a7e6310-9a80-4c48-9239-80cbfadd2cea	0363-0800	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19931008		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0801_effed7e4-def2-7322-e053-2995a90acc5f	0363-0801	HUMAN OTC DRUG	Well at Walgreens		SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20130401		UNAPPROVED DRUG OTHER		Walgreen Company	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
0363-0802_f45e1078-f4bb-0317-e053-2995a90ab88d	0363-0802	HUMAN OTC DRUG	Well at Walgreens		SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20130401		UNAPPROVED DRUG OTHER		Walgreen Company	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
0363-0803_425d16bb-2390-47aa-b395-63bbd90095ed	0363-0803	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20160623		OTC MONOGRAPH FINAL	part347	Walgreens Co	WITCH HAZEL	841	mg/mL			N	20241231
0363-0804_7d7f75af-7bad-4ab2-8185-367c54cdf64a	0363-0804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19910315		OTC MONOGRAPH NOT FINAL	part333A	Walgreen Co	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
0363-0806_62695561-e28b-418a-aacd-c27cf6587c0f	0363-0806	HUMAN OTC DRUG	Childrens Ibuprofen 100	Dye Free	Ibuprofen	SUSPENSION	ORAL	20140224		ANDA	ANDA074937	Walgreen Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0809_09a92bde-6450-ac59-e063-6294a90a8739	0363-0809	HUMAN OTC DRUG	Walgreen Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20110101		OTC MONOGRAPH DRUG	M003	Walgreens Company	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0363-0810_85f5f794-5f0a-4d91-b962-74125f396376	0363-0810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	19891015		OTC MONOGRAPH NOT FINAL	part333A	Walgreens, CO.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0363-0811_00bff0ff-d181-4fe2-a5af-203f6d435c7c	0363-0811	HUMAN OTC DRUG	Allergy Nasal		Triamcinolone acetonide	SPRAY, METERED	NASAL	20160410		ANDA	ANDA078104	Walgreen Company	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0816_a0e4ba62-12b5-4e6d-b738-8b40a588a81a	0363-0816	HUMAN OTC DRUG	Wal Som Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20191030		OTC MONOGRAPH DRUG	M010	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0819_f60495b2-2312-4d29-e053-2995a90a7076	0363-0819	HUMAN OTC DRUG	Walgreens Medicated Callus Removers		SALICYLIC ACID	DISC	TOPICAL	20130601		OTC MONOGRAPH FINAL	part358F	WALGREENS Co.	SALICYLIC ACID	17.67	mg/44.18mg			N	20241231
0363-0820_dead5e82-37ac-4313-bc3f-66ffa8832a29	0363-0820	HUMAN OTC DRUG	Daytime Mucus Relief Severe Cold Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20180930		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-0821_3daaaff1-6267-4a9b-a343-e557cfe18431	0363-0821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20200511		OTC MONOGRAPH FINAL	part333D	Walgreens	SALICYLIC ACID	21	mg/mL			N	20241231
0363-0827_7bc7424e-9b08-4375-9078-dd0978c60c29	0363-0827	HUMAN OTC DRUG	Stool Softener Laxative	Plus Stimulant	docusate sodium and sennosides	TABLET	ORAL	20180930		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0363-0830_93239cc7-b518-4ae8-bbce-79b1be81f8f4	0363-0830	HUMAN OTC DRUG	Well at Walgreens Blemish and Blackhead Control Apricot		Salicylic Acid	LIQUID	TOPICAL	20180105		OTC MONOGRAPH FINAL	part333D	Walgreen Company	SALICYLIC ACID	.02	g/g			N	20241231
0363-0831_260831d7-bd82-4613-9620-da3816e4238f	0363-0831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	19940616		OTC MONOGRAPH NOT FINAL	part334	Walgreen Co	MINERAL OIL	999	mg/mL			N	20241231
0363-0832_f8b25201-4a0d-4fe3-adfa-e2e42e11a793	0363-0832	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20180831		ANDA	ANDA207342	Walgreens	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-0833_edc8166f-63e2-4380-823e-4aa16ad20e87	0363-0833	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190131		OTC MONOGRAPH FINAL	part347	Walgreens	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-0837_752b10de-fa67-46a0-adf9-3c3900766f24	0363-0837	HUMAN OTC DRUG	Walgreens Arthritis Pain Relief Capsaicin Analgesic		Capsaicin	CREAM	TOPICAL	20100503		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	CAPSAICIN	1	mg/g			N	20241231
0363-0841_a429ffbf-c431-40c5-9f29-c016f7ea72e9	0363-0841	HUMAN OTC DRUG	First Aid Antibiotic		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20170216		OTC MONOGRAPH FINAL	part333B	Walgreen Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-0844_022bd9fe-6d43-4ca8-8dd8-4ecb2c198a85	0363-0844	HUMAN OTC DRUG	All Night Pain Relief PM		Naproxen Sodium	TABLET	ORAL	20181231		ANDA	ANDA209726	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0845_90c0c8c4-1712-4d7d-bfc9-4fe8e8d9a104	0363-0845	HUMAN OTC DRUG	70% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	20090511		OTC MONOGRAPH NOT FINAL	part333A	Walgreen CO	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
0363-0850_080cdc56-252a-ab05-e063-6394a90a4298	0363-0850	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20211015		OTC MONOGRAPH DRUG	M012	WALGREENS	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0853_ffcc6f5e-a04f-82f2-e053-6294a90a5d67	0363-0853	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophine Dextromethorphan HBr Phenylphrine HCl	CAPSULE, LIQUID FILLED	ORAL	20211015		OTC MONOGRAPH FINAL	part341	WALGREENS	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0855_ee55c98c-2b8d-4e3a-9786-c53237055a16	0363-0855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20140124		OTC MONOGRAPH NOT FINAL	part356	Walgreen Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0858_a69e70f5-0044-4834-b033-571f9c36caad	0363-0858	HUMAN OTC DRUG	Indoor Outdoor Allergy Relief		Loratadine	TABLET	ORAL	20180930		ANDA	ANDA075209	Walgreens	LORATADINE	10	mg/1			N	20241231
0363-0859_f53d9225-a51e-2ff1-e053-2a95a90ad3e3	0363-0859	HUMAN OTC DRUG	Walgreens		Ethyl Alcohol	GEL	TOPICAL	20230215		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ALCOHOL	700	mg/mL			N	20241231
0363-0860_ee322636-e2a7-4b74-9d9e-68ecf713d2e9	0363-0860	HUMAN OTC DRUG	Wal Som Nighttime Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20191030		OTC MONOGRAPH FINAL	part338	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0862_302a53a5-fd77-4d2c-be71-dd24244067f3	0363-0862	HUMAN OTC DRUG	Daytime Mucus Relief Severe Congestion and Cough and Nighttime Cold and Flu	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, Acetaminophen, Diphenhydramine HCI	KIT		20150731		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-0863_0d26be90-cc71-4bd0-b18a-1bf75c5836f2	0363-0863	HUMAN OTC DRUG	Pain Reliever PM	Extra strength	Acetaminophen, Diphenhydramine HCL	TABLET, COATED	ORAL	20191030		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0865_163fd699-b826-4f6a-b3ae-ffb3ca01ce49	0363-0865	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200529		OTC MONOGRAPH NOT FINAL	part343	Walgreens	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-0868_23e36b31-0c97-4c48-a84a-d6da25cb99be	0363-0868	HUMAN OTC DRUG	Stool Softener		DOCUSATE CALCIUM	CAPSULE, LIQUID FILLED	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE CALCIUM	240	mg/1			N	20241231
0363-0871_9e29ff09-4bbe-4f85-b7b8-252ed2003d8e	0363-0871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19960327		OTC MONOGRAPH NOT FINAL	part333A	Walgreens Co.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
0363-0873_055fe937-eaab-4f92-9930-ddd731517898	0363-0873	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060223		ANDA	ANDA077007	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0875_e0544e9f-93c0-62a1-e053-2995a90aa1a3	0363-0875	HUMAN OTC DRUG	Walgreens Effervescent Cold Relief Plus		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20141024		OTC MONOGRAPH FINAL	part341	Walgreens	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0876_fb77d4fe-fe4d-4480-98f5-88f8bff624cd	0363-0876	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20090518		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ALCOHOL	70	mL/100mL			N	20241231
0363-0881_2b9df61f-0901-4571-a7c2-e5e372112a5c	0363-0881	HUMAN OTC DRUG	Allergy Nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20160712		ANDA	ANDA207957	Walgreen Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0883_4d4b43ea-750d-45dd-9082-2e698db815b0	0363-0883	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0363-0886_8f566899-2c4d-4625-b0b3-91486b449917	0363-0886	HUMAN OTC DRUG	Mucus Relief All in One	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20210827		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0888_18378323-9af9-4766-938d-05d25a1eedcd	0363-0888	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20210430		ANDA	ANDA091314	Walgreens	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0363-0889_58cc06be-be75-4233-9617-160f4267f78f	0363-0889	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	19891215		OTC MONOGRAPH FINAL	part347	Walgreen Co	PETROLATUM	1	mg/g			N	20241231
0363-0890_da985544-5cbf-4210-a0db-746014eff3b2	0363-0890	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20190308		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ALCOHOL	567	mg/mL			N	20241231
0363-0897_4895240a-a40d-4e4b-b024-35113a4df790	0363-0897	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19990311		ANDA	ANDA074937	Walgreen Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0898_afcb1c69-5580-4cf8-b31d-1d859f9e6c58	0363-0898	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160404		OTC MONOGRAPH NOT FINAL	part333A	Walgreen	ALCOHOL	567	mg/mL			N	20241231
0363-0899_05cf5c16-3fb4-4c1c-8630-ebd493252494	0363-0899	HUMAN OTC DRUG	childrens cough dm		Dextromethorphan polistirex	SUSPENSION	ORAL	20150612		ANDA	ANDA091135	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-0900_c5ebc3e3-f7c6-9ea6-e053-2995a90a3a30	0363-0900	HUMAN OTC DRUG	WALGREEN SPORT SPF 70 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20180125		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0901_acc1c925-ee1b-71ca-e053-2a95a90a1544	0363-0901	HUMAN OTC DRUG	Baby		TALC	POWDER	TOPICAL	20140717		OTC MONOGRAPH NOT FINAL	part347	Walgreen Company	TALC	100	g/100g			N	20241231
0363-0904_fc9bf3ac-52f7-4fa2-ae8e-6ff6304bc2ee	0363-0904	HUMAN OTC DRUG	Indoor Outdoor Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20180831		ANDA	ANDA204507	Walgreens	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0905_a9e00927-5bc3-c6da-e053-2a95a90afa5a	0363-0905	HUMAN OTC DRUG	WALGREENS ALL PURPOSE PSORIASIS WASH		SALICYLIC ACID	LIQUID	TOPICAL	20200212		OTC MONOGRAPH FINAL	part358B	WALGREEN COMPANY	SALICYLIC ACID	30	mg/mL			N	20241231
0363-0907_f2030f1c-999a-4b65-e053-2995a90ac5eb	0363-0907	HUMAN OTC DRUG	Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
0363-0911_de3f5cee-0bb7-ddbb-e053-2995a90a7db1	0363-0911	HUMAN OTC DRUG	Pure Cornstarch Baby		Corn Starch	POWDER	TOPICAL	20140717		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	STARCH, CORN	99	g/100g			N	20241231
0363-0913_d7a00a92-7d41-4a6e-b84c-9e20514cbc4a	0363-0913	HUMAN OTC DRUG	wal tussin dm max nighttime wal tussin dm max		dextromethorphan hbr, doxylamine succinate, guaifenesin	KIT		20181027		OTC MONOGRAPH FINAL	part341	Walgreen Company						N	20241231
0363-0914_f2031ee0-99fa-fe4e-e053-2a95a90adfe7	0363-0914	HUMAN OTC DRUG	Cold and Heat Lidocaine Patch Plus Menthol		Lidocaine, Menthol	PATCH	TOPICAL	20180701		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-0915_2072485d-a8e0-41b7-827f-4f6d22d19911	0363-0915	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080227		NDA	NDA022032	Walgreen Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-0919_e49e88a5-07f5-4c8f-b630-1ace1da11b84	0363-0919	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20140318		ANDA	ANDA076779	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0920_a9e07cd1-b789-b9bc-e053-2995a90a897d	0363-0920	HUMAN OTC DRUG	WALGREENS DAILY REPAIR PSORIASIS MOISTURIZER		SALICYLIC ACID	LOTION	TOPICAL	20200214		OTC MONOGRAPH FINAL	part358B	WALGREEN COMPANY	SALICYLIC ACID	30	mg/mL			N	20241231
0363-0924_f0c91357-0562-adfe-e053-2a95a90a71cd	0363-0924	HUMAN OTC DRUG	WALGREENS SPORT SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20141204		OTC MONOGRAPH NOT FINAL	part352	Walgreen Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0926_f41e7969-646b-3e3b-e053-2995a90a9b68	0363-0926	HUMAN OTC DRUG	Walgreens Chap Aid Cherry Lip Balm		Padimate O, Petrolatum	STICK	TOPICAL	20010424		OTC MONOGRAPH NOT FINAL	part352	Walgreen Company	PADIMATE O; PETROLATUM	15; 450	mg/g; mg/g			N	20241231
0363-0927_f41e8d4b-3b0b-763c-e053-2a95a90a6afd	0363-0927	HUMAN OTC DRUG	Walgreens Chap Aid Regular Lip Balm		Padimate O, Petrolatum	STICK	TOPICAL	20000815		OTC MONOGRAPH NOT FINAL	part352	Walgreen Company	PADIMATE O; PETROLATUM	15; 450	mg/g; mg/g			N	20241231
0363-0930_f41e7232-fac5-035e-e053-2995a90a9d18	0363-0930	HUMAN OTC DRUG	Walgreens Chap Aid Lip Balm Strawberry		Padimate O, Petrolatum	STICK	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	Walgreen Company	PADIMATE O; PETROLATUM	15; 450	mg/g; mg/g			N	20241231
0363-0931_1f23481e-89df-4c62-9712-6c9ace91bcbf	0363-0931	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180831		ANDA	ANDA207342	Walgreens	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-0932_076d2c9c-216e-4407-885a-254ff2cbb2db	0363-0932	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20181231		OTC MONOGRAPH FINAL	part332	Walgreens	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-0933_c8d46cc9-1a7c-12f6-e053-2995a90a2ff9	0363-0933	HUMAN OTC DRUG	WALGREENS BROAD SPECTRUM SPF 110 AGE PROTECTION SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20180604		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0936_c72ddd27-ee50-11e3-e053-2a95a90afb77	0363-0936	HUMAN OTC DRUG	WALGREENS BROAD SPECTRUM SPF 70 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	STICK	TOPICAL	20190308		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0938_020d7f84-045c-47f3-88f9-b153a6d43ab2	0363-0938	HUMAN OTC DRUG	all day pain relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA074661	Walgreen Company	NAPROXEN SODIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0940_fa4976a7-8213-450a-b69f-eae0946956cb	0363-0940	HUMAN OTC DRUG	WALGREENS BROAD SPECTRUM SPF 30 DRY TOUCH SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OXYBENZONE	LOTION	TOPICAL	20151112		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 70; 75; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0941_43508101-de78-487a-aed3-79866c907078	0363-0941	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20080328		OTC MONOGRAPH FINAL	part347	Walgreen Co	PETROLATUM	.34	g/g			N	20241231
0363-0942_059fe7a8-aede-414e-b3a7-fdf9e73edcaa	0363-0942	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20150713		OTC MONOGRAPH NOT FINAL	part334	Walgreens	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-0943_c55c13f7-5222-2cdc-e053-2995a90a493c	0363-0943	HUMAN OTC DRUG	WALGREENS BROAD SPECTRUM SPORT SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20171030		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0945_fafa750f-5cc0-4f13-a808-d63b3d6e7008	0363-0945	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	Walgreens	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-0947_c780cc7f-2112-45a5-babc-3a6e3a751bdb	0363-0947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20141120		OTC MONOGRAPH FINAL	part333D	Walgreen Co	SALICYLIC ACID	20.6	mg/mL			N	20241231
0363-0948_baef3b1c-a100-46a1-e053-2995a90abc87	0363-0948	HUMAN OTC DRUG	WALGREENS FOAMING BODY WASH ACNE TREATMENT		SALICYLIC ACID	LIQUID	TOPICAL	20200514		OTC MONOGRAPH FINAL	part358B	WALGREEN COMPANY	SALICYLIC ACID	20	mg/mL			N	20241231
0363-0951_c68caf17-6add-5ce2-e053-2995a90a5655	0363-0951	HUMAN OTC DRUG	WALGREENS APRICOT SCRUB ACNE TREATMENT		SALICYLIC ACID	EMULSION	TOPICAL	20200403		OTC MONOGRAPH FINAL	part333D	WALGREEN COMPANY	SALICYLIC ACID	20	mg/g			N	20241231
0363-0952_1493a2b0-f001-4485-ac97-639234d190e7	0363-0952	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130321		OTC MONOGRAPH NOT FINAL	part333A	Walgreen Co	ALCOHOL	700	mg/mL			N	20241231
0363-0953_4941081e-0a65-4401-a06d-732c7d901545	0363-0953	HUMAN OTC DRUG	Childrens Dye Free Wal Zyr		Cetirizine HCl	SOLUTION	ORAL	20171019		ANDA	ANDA204226	Walgreen Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-0954_baffb272-436d-4ad8-e053-2a95a90a56fb	0363-0954	HUMAN OTC DRUG	Walgreens Cooling		Lidocaine Hydrochloride	GEL	TOPICAL	20210210		OTC MONOGRAPH NOT FINAL	part348	WALGREEN COMPANY	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-0955_19c7d21d-1f71-4392-9a91-a85dde7e3fa6	0363-0955	HUMAN OTC DRUG	lice treatment		Permethrin	LOTION	TOPICAL	20100715		ANDA	ANDA076090	Walgreen Company	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
0363-0956_bc443b6e-09c4-47d4-e053-2995a90a18ad	0363-0956	HUMAN OTC DRUG	Walgreens Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0957_2c8269f8-b61c-41e0-9f2e-2a53aadd0e06	0363-0957	HUMAN OTC DRUG	Nicotine mini		Nicotine Polacrilex	LOZENGE	ORAL	20130119		ANDA	ANDA203690	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0959_43da39b5-b915-4c50-a127-c0380e884ad4	0363-0959	HUMAN OTC DRUG	childrens dye free pain and fever		Acetaminophen	SUSPENSION	ORAL	20180126		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0960_6c8cab15-c118-4c32-acc9-baa9ecbcf4b1	0363-0960	HUMAN OTC DRUG	Maxi Nicotine		nicotine polacrilex	LOZENGE	ORAL	20201030		ANDA	ANDA210712	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0961_bd0db273-e2a1-5670-e053-2995a90a489e	0363-0961	HUMAN OTC DRUG	Walgreens SPF55 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	STICK	TOPICAL	20140625		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0962_c50cf225-c894-b0af-e053-2995a90a62e3	0363-0962	HUMAN OTC DRUG	WALGREENS KIDS BABY SPF 50		Titanium Dioxide, Zinc oxide	LOTION	TOPICAL	20210521		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	TITANIUM DIOXIDE; ZINC OXIDE	31; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-0963_c616ebb0-591b-492e-e053-2995a90a2315	0363-0963	HUMAN OTC DRUG	Walgreens SPF 55 Dry Touch		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20120323		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0964_b7edb0e0-abc4-4a5a-ada3-a93e809017ea	0363-0964	HUMAN OTC DRUG	wal flu severe cold and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20151105		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-0965_c628b273-b3c6-fa5e-e053-2a95a90afe04	0363-0965	HUMAN OTC DRUG	Walgreens Dry Touch Broad Spectrum SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210129		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0966_c8966b17-a8e1-79b3-e053-2a95a90af086	0363-0966	HUMAN OTC DRUG	Walgreens Sunburn Relief		Menthol	GEL	TOPICAL	20170911		OTC MONOGRAPH NOT FINAL	part348	WALGREEN COMPANY	MENTHOL	5	mg/g			N	20241231
0363-0967_c89b160d-5a9e-39b7-e053-2a95a90a0f6b	0363-0967	HUMAN OTC DRUG	WALGREENS ADVANCED HAND SANITIZER WITH FRESH SCENT		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333A	WALGREEN COMPANY	ALCOHOL	70	mg/100g			N	20241231
0363-0968_e935691a-0079-4333-9cfb-4356eadebb8c	0363-0968	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LOTION	TOPICAL	20190711		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ALCOHOL	558	mg/mL			N	20241231
0363-0969_c8abb39d-9716-ed0d-e053-2995a90a4687	0363-0969	HUMAN OTC DRUG	Walgreens Advanced Hand Sanitizer Citrus Scent		Alcohol	AEROSOL, SPRAY	TOPICAL	20200929		OTC MONOGRAPH NOT FINAL	part333A	WALGREEN COMPANY	ALCOHOL	70	mg/100g			N	20241231
0363-0970_f0c9fc9d-c154-fabb-e053-2a95a90aceb0	0363-0970	HUMAN OTC DRUG	Walgreens SPF 30 Hydrating Continuous		Avobenzone, Homosalate, Octocrylene,	AEROSOL, SPRAY	TOPICAL	20191114		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
0363-0971_71f5487a-643f-4918-b98f-11e00eaf27a1	0363-0971	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20100215		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-0972_0c412816-2cb8-e4e1-e063-6294a90add95	0363-0972	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone Acetate	CREAM	TOPICAL	20181026		OTC MONOGRAPH DRUG	M017	Walgreen Company	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-0976_cfeaf245-41b0-644d-e053-2995a90a4a34	0363-0976	HUMAN OTC DRUG	Walgreens SPF55 Sunscreen Reef-Conscious Formula		Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20210528		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0977_d4c7f668-2ff6-4672-e053-2995a90ae528	0363-0977	HUMAN OTC DRUG	Well at Walgreens Spot Acne Treatment		SALICYLIC ACID	GEL	TOPICAL	20130923		OTC MONOGRAPH FINAL	part333D	WALGREEN COMPANY	SALICYLIC ACID	20	mg/mL			N	20241231
0363-0978_d4c98756-b7e1-f2fc-e053-2a95a90a7f5e	0363-0978	HUMAN OTC DRUG	Walgreens Sunburn Relief		Lidocaine Hydrochloride	SPRAY	TOPICAL	20210224		OTC MONOGRAPH NOT FINAL	part348	WALGREEN COMPANY	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-0979_eaaf4474-12f1-483b-8f48-faaf7907ca91	0363-0979	HUMAN OTC DRUG	Nicotine	Mini	Nicotine Polacrilex	LOZENGE	ORAL	20210625		ANDA	ANDA210711	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-0981_d4ded96a-45ea-2df1-e053-2995a90a602a	0363-0981	HUMAN OTC DRUG	Walgreens SPF 50 Clear Complexion For Face		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20210518		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 40; 45; 60; 45	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0983_d4edc31c-82f7-eab5-e053-2995a90a4161	0363-0983	HUMAN OTC DRUG	Walgreens Acne Spot Treatment		SALICYLIC ACID	GEL	TOPICAL	20200206		OTC MONOGRAPH FINAL	part333D	WALGREEN COMPANY	SALICYLIC ACID	20	mg/mL			N	20241231
0363-0985_d506e2b2-5396-043d-e053-2995a90ae77e	0363-0985	HUMAN OTC DRUG	Walgreens Sunburn Relief		Lidocaine	GEL	TOPICAL	20171003		OTC MONOGRAPH NOT FINAL	part348	WALGREEN COMPANY	LIDOCAINE	8	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-0986_7c283709-8907-4623-97cb-291c0ea31b3b	0363-0986	HUMAN OTC DRUG	Baby Eczema Therapy		Colloidal oatmeal	CREAM	TOPICAL	20191228		OTC MONOGRAPH FINAL	part347	Walgreen Co	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0363-0988_d507cdb8-eaba-0afb-e053-2a95a90acacf	0363-0988	HUMAN OTC DRUG	Walgreens SPF 50 Mineral Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20210818		OTC MONOGRAPH FINAL	part346	WALGREEN COMPANY	ZINC OXIDE	216	mg/mL			N	20241231
0363-0989_cefefe10-2f8d-4e93-a525-b4ea59f81ffb	0363-0989	HUMAN OTC DRUG	Wal-Zyr D		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181101		ANDA	ANDA090922	Walgreen Company	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-0991_d56771ff-a49a-5277-e053-2a95a90a7da7	0363-0991	HUMAN OTC DRUG	Walgreens Sport SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20120427		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0363-0992_d61dcf3f-7ef6-e941-e053-2995a90a6dc0	0363-0992	HUMAN OTC DRUG	Well at Walgreens Kids Sunscreen Broad Spectrum SPF 50		Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	SPRAY	TOPICAL	20150407		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0363-0993_db277190-a5cc-1156-e053-2a95a90ae21c	0363-0993	HUMAN OTC DRUG	WALGREENS ECZEMA		COLLOIDAL OATMEAL	LOTION	TOPICAL	20210224		OTC MONOGRAPH FINAL	part347	WALGREEN COMPANY	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0363-0994_dbee6094-e106-6d14-e053-2995a90a1528	0363-0994	HUMAN OTC DRUG	Walgreens 50 Baby Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210820		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-0996_dfc64c7b-ee5a-62a3-e053-2995a90a14a1	0363-0996	HUMAN OTC DRUG	Well at Walgreens Mist Sheer Broad Spectrum Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20150407		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	300; 800; 400; 235; 500	mg/10g; mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
0363-0997_e4b84304-6054-0cfe-e053-2a95a90a124a	0363-0997	HUMAN OTC DRUG	WALGREENS SPORT CONTINUOUS SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20191024		OTC MONOGRAPH NOT FINAL	part352	WALGREEN COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
0363-1001_f94d0715-4452-3d44-e053-6394a90a9e2b	0363-1001	HUMAN OTC DRUG	Walgreens Chest Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20150301		OTC MONOGRAPH FINAL	part341	Walgreen Company	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
0363-1008_8e0192ff-e38f-45f8-bb13-7cdca9aa0780	0363-1008	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20210506		ANDA	ANDA206877	WALGREEN CO.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-1010_6609d6be-959d-4bea-9e54-2e19f459c5fa	0363-1010	HUMAN OTC DRUG	anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20210911		ANDA	ANDA075232	Walgreen Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0363-1011_e1da33c7-5578-51fa-e053-2a95a90a7b4f	0363-1011	HUMAN OTC DRUG	NIGHTTIME COLD AND FLU	Maximum Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20220623		OTC MONOGRAPH FINAL	part341	WALGREENS	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1012_5912a6e2-3b62-4dc6-94c6-f4e85dd14e26	0363-1012	HUMAN OTC DRUG	nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20180202		ANDA	ANDA206394	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1020_80f5fc76-4df7-4ff4-b457-4ff16adfb429	0363-1020	HUMAN OTC DRUG	Zinc Oxide		ZINC OXIDE	PASTE	TOPICAL	20080324		OTC MONOGRAPH FINAL	part347	Walgreen Co	ZINC OXIDE	532	mg/g			N	20241231
0363-1023_762ad88a-52c0-4afe-96eb-515a9a5f3fd1	0363-1023	HUMAN OTC DRUG	wal tussin dm max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180809		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-1045_0b413dfe-ee12-4204-8ff7-f10d693860f4	0363-1045	HUMAN OTC DRUG	Oral Sore Antiseptic		Hydrogen Peroxide, Menthol	LIQUID	ORAL	20200315		OTC MONOGRAPH NOT FINAL	part356	Walgreens	HYDROGEN PEROXIDE; MENTHOL	1.5; 1	mg/mL; mg/mL			N	20241231
0363-1056_1f55759f-a51a-4ade-b5c5-a6920ecf100d	0363-1056	HUMAN OTC DRUG	Childrens Mucus Cough and Congestion Relief		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20230512		OTC MONOGRAPH DRUG	M012	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1061_b8a57f84-d80b-23bb-e053-2a95a90adbbb	0363-1061	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20110501		NDA	NDA019125	Walgreen Co.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
0363-1070_06d3e07b-c4f4-8637-e063-6394a90ac8cb	0363-1070	HUMAN OTC DRUG	Menthol Cough Drop		menthol	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreens	MENTHOL	5.4	mg/1			N	20241231
0363-1071_06d3dd71-ab82-9582-e063-6394a90ab203	0363-1071	HUMAN OTC DRUG	Cherry Cough Drop		Menthol	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreen Co.	MENTHOL	5.8	mg/1			N	20241231
0363-1072_06d42b0c-a794-49b3-e063-6294a90a6292	0363-1072	HUMAN OTC DRUG	Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreens Co,	MENTHOL	7.5	mg/1			N	20241231
0363-1073_06d3cef9-0659-0d83-e063-6294a90a1593	0363-1073	HUMAN OTC DRUG	Strawberry Cough Drop		Menthol 2.7 mg	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreen Co.	MENTHOL	2.7	mg/1			N	20241231
0363-1077_06d40bec-8d16-c9ab-e063-6394a90aeda0	0363-1077	HUMAN OTC DRUG	SF Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreen Co.	MENTHOL	7.6	mg/1			N	20241231
0363-1079_06d43270-4cef-c91e-e063-6394a90a7224	0363-1079	HUMAN OTC DRUG	Cherry Sore Throat Lozenge		Benzocaine	LOZENGE	ORAL	20160415		OTC MONOGRAPH NOT FINAL	part356	Walgreens Co.	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-1081_06d40ba8-79e4-969a-e063-6394a90a754b	0363-1081	HUMAN OTC DRUG	Antacid Soft Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20150105		OTC MONOGRAPH FINAL	part331	Walgreen Co.	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-1082_06d43525-86d3-f2d9-e063-6394a90afc81	0363-1082	HUMAN OTC DRUG	Antacid Flavor Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20150615		OTC MONOGRAPH FINAL	part331	Walgreen Co.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-1083_06d4324d-2cf3-ee31-e063-6394a90ab1d2	0363-1083	HUMAN OTC DRUG	Antacid Flavor Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20151130		OTC MONOGRAPH FINAL	part331	Walgreen Co.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-1085_06d42f39-2487-7b3d-e063-6294a90ab05c	0363-1085	HUMAN OTC DRUG	SF Menthol Cough Drop		Menthol	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreen Co.	MENTHOL	5.8	mg/1			N	20241231
0363-1086_06d3cef9-0642-0d83-e063-6294a90a1593	0363-1086	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreen Co.	MENTHOL	5.8	mg/1			N	20241231
0363-1087_06d42c95-c8c7-7972-e063-6294a90aab3b	0363-1087	HUMAN OTC DRUG	Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20160605		OTC MONOGRAPH FINAL	part341	Walgreen Co.	MENTHOL	7.5	mg/1			N	20241231
0363-1093_097e7118-bed9-d82d-e063-6294a90a58b5	0363-1093	HUMAN OTC DRUG	Antacid Berry Bites		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190218		OTC MONOGRAPH DRUG	M001	Walgreen	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-1094_06d40bec-8d17-c9ab-e063-6394a90aeda0	0363-1094	HUMAN OTC DRUG	Sugar Free Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20190305		OTC MONOGRAPH FINAL	part341	Walgreen	MENTHOL	7.6	mg/1			N	20241231
0363-1099_06d4324d-2cf4-ee31-e063-6394a90ab1d2	0363-1099	HUMAN OTC DRUG	Walgreens Blueberry Raspberry Gentle Laxative		Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20211217		OTC MONOGRAPH NOT FINAL	part334	Walgreen	MAGNESIUM HYDROXIDE	1200	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-1106_06d66abd-d234-4a0b-a915-354d2ae24537	0363-1106	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine HCl		Ibuprofen and Pseudoephedrine HCl	CAPSULE, LIQUID FILLED	ORAL	20171201		ANDA	ANDA209235	WALGREEN CO.	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-1110_3835c8d5-f1c0-4d06-8ec9-794f124d1e48	0363-1110	HUMAN OTC DRUG	Allergy Relief D		Chlorpheniramine maleate, Pseudoephedrine HCl	TABLET	ORAL	20210824		OTC MONOGRAPH DRUG	M012	Walgreen Company	CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	4; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-1113_06d42c95-c8c8-7972-e063-6294a90aab3b	0363-1113	HUMAN OTC DRUG	Walgreens Mixed Berry Benz-Dex Lozenges		Benzocaine	LOZENGE	ORAL	20220609		OTC MONOGRAPH NOT FINAL	part356	Walgreen	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-1128_b4bd37dc-2423-442d-962b-f11ee9ecfe88	0363-1128	HUMAN OTC DRUG	Headache Relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220310		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-1130_0c05a84b-3193-4cc4-b640-dd8884311d46	0363-1130	HUMAN OTC DRUG	nicotine mini		Nicotine Polacrilex	LOZENGE	ORAL	20181120		ANDA	ANDA203690	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1144_77518927-df19-46c5-8e38-c3dd7304e083	0363-1144	HUMAN OTC DRUG	tussin dm max		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20220524		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-1147_b1c499d3-af2d-4e5a-a27f-c61e1221a215	0363-1147	HUMAN OTC DRUG	WAL ZYR D		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200326		ANDA	ANDA210719	Walgreen Company	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-1150_9f44c7f4-4edb-465f-be2d-699bcf737aad	0363-1150	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part343	Walgreens	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-1155_ddde9804-323f-4c2a-af5b-a92e9167757c	0363-1155	HUMAN OTC DRUG	FAST ACTING Heartburn Relief		aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20180105		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
0363-1170_0c0681f2-511c-c111-e063-6394a90ac765	0363-1170	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20200206		OTC MONOGRAPH DRUG	M012	WALGREENS	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-1172_0845c983-8fd7-29f0-e063-6394a90acf02	0363-1172	HUMAN OTC DRUG	Gentle Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20231021		OTC MONOGRAPH DRUG	M007	WALGREEN COMPANY	DOCUSATE SODIUM	100	mg/1			N	20241231
0363-1173_0845f244-6a91-4df1-e063-6294a90acfe9	0363-1173	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	CAPSULE, LIQUID FILLED	ORAL	20231020		OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0363-1174_0d8f7732-8fca-8634-e063-6394a90af021	0363-1174	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20231021		OTC MONOGRAPH DRUG	M010	WALGREEN COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
0363-1175_0859acb0-a294-a6b4-e063-6394a90afba9	0363-1175	HUMAN OTC DRUG	Free and Pure Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20231022		OTC MONOGRAPH DRUG	505G(a)(3)	WALGREEN COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-1176_f0fdd503-7741-146c-e053-2a95a90a7fa6	0363-1176	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180615		NDA	NDA021855	WALGREENS	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0363-1180_ca049acc-5587-43b3-872e-256a4eef349b	0363-1180	HUMAN OTC DRUG	Walgreen Cold Therapy	Cherry Flavor	Zincum Gluconicum	TABLET	ORAL	20190515		UNAPPROVED HOMEOPATHIC		WALGREENS CO.	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-1181_f6801e19-b8d3-4880-aa2f-65ca2076d632	0363-1181	HUMAN OTC DRUG	Walgreen Zinc Cold Therapy	Citrus Flavor	ZINCUM GLUCONICUM	TABLET, CHEWABLE	ORAL	20190516		UNAPPROVED HOMEOPATHIC		WALGREENS CO.	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-1188_b3d1ba8f-c9ee-4b7a-8fa8-fcc965f40877	0363-1188	HUMAN OTC DRUG	Ultra Zinc Cold Therapy		Zincum Gluconicum	TABLET, CHEWABLE	ORAL	20200120		UNAPPROVED HOMEOPATHIC		WALGREEN COMPANY	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-1199_ceee0bca-8019-4518-b82c-cee926f178c4	0363-1199	HUMAN OTC DRUG	Walgreens Pain Relieving	Analgesic	CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate	CREAM	TOPICAL	20200211		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
0363-1203_4f316782-0266-4770-8241-32845d2570a7	0363-1203	HUMAN OTC DRUG	acid controller		famotidine	TABLET, FILM COATED	ORAL	20220407		ANDA	ANDA077351	Walgreen Company	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-1205_b988f14d-7408-45ea-8867-1b1522d67346	0363-1205	HUMAN OTC DRUG	childrens nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20220808		ANDA	ANDA207957	Walgreen Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-1209_9f669f21-befd-4b71-be1a-e03eba590b88	0363-1209	HUMAN OTC DRUG	Cold Flu and Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20180804		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1210_a1eac59a-4813-4f46-ba32-9cf9557bf28d	0363-1210	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20210315		ANDA	ANDA208077	Walgreens	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-1213_43510210-c9f4-46ab-9724-eb44d27118b3	0363-1213	HUMAN OTC DRUG	Cold and Flu	Day, Night	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20221114		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-1214_82a8a1d4-0d02-44fe-8839-26b450677ef5	0363-1214	HUMAN OTC DRUG	Nasal Decongestant	D	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
0363-1217_fb71b613-79d7-4884-e053-6394a90a45d4	0363-1217	HUMAN OTC DRUG	Walgreens Hemorrhoidal Pain Relief		Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%	CREAM	TOPICAL	20230308		OTC MONOGRAPH FINAL	M015	Walgreens	GLYCERIN; LIDOCAINE; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14.4; 5; 15; .25	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1219_f0fe217f-23b0-72b5-e053-2995a90a4653	0363-1219	HUMAN OTC DRUG	24 HOUR ALLERGY		Cetirizine HCl	CAPSULE	ORAL	20180914		NDA	NDA022429	Walgreens	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-1220_13b6a35f-d141-4216-bf60-e3bf6c92ca85	0363-1220	HUMAN OTC DRUG	Walgreens	Fiber Therapy	Methylcellulose	TABLET	ORAL	20190514		OTC MONOGRAPH DRUG	M007	WALGREENS CO.	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
0363-1222_b6a5e2c7-83ec-4cc4-98ad-6e5c1dcca043	0363-1222	HUMAN OTC DRUG	Walgreens Pain Relieving with Turmeric	Analgesic	LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20220329		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-1223_6b6d115f-228f-488e-93eb-42c0ead43184	0363-1223	HUMAN OTC DRUG	infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20220809		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-1224_99296d87-dcab-406f-a7c8-c75d185a4c67	0363-1224	HUMAN OTC DRUG	Antacid Regular strength		Antacid Tablets	TABLET, CHEWABLE	ORAL	20171218		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-1225_52b91e76-28b4-4711-85bd-0594f9ae6d92	0363-1225	HUMAN OTC DRUG	Walgreens Pain Relieving with Lavender	Analgesic	LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20220329		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-1226_abd29500-44a8-4cc4-9f5d-8254d5995f4e	0363-1226	HUMAN OTC DRUG	Zinc oxide		Zinc oxide	CREAM	TOPICAL	19940131		OTC MONOGRAPH FINAL	part347	Walgreen Co	ZINC OXIDE	130	mg/g			N	20241231
0363-1233_f53b445a-e3b2-8dc6-e053-2a95a90a648a	0363-1233	HUMAN OTC DRUG	Walgreens		Ethyl Alcohol	GEL	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part333A	Walgreens	ALCOHOL	700	mg/mL			N	20241231
0363-1234_c9fd8b93-af72-42a0-846a-c6738cfa5e2c	0363-1234	HUMAN OTC DRUG	severe wal tussin cf max		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20171127		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1235_ed25c7fc-16c0-4db2-8e5f-459980aa5719	0363-1235	HUMAN OTC DRUG	migraine relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA075794	Walgreen Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-1239_862a6384-90fb-4d59-9b7f-bdfb1ebdddb0	0363-1239	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20230517		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-1243_005c2190-a0cd-1581-e063-6394a90a2e1b	0363-1243	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190401		ANDA	ANDA074612	Walgreens	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1244_005c2190-a0cd-1581-e063-6394a90a2e1b	0363-1244	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190401		ANDA	ANDA074612	Walgreens	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1245_005c2190-a0cd-1581-e063-6394a90a2e1b	0363-1245	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190401		ANDA	ANDA074612	Walgreens	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1253_0bf352b3-bb21-25d5-e063-6394a90a1e58	0363-1253	HUMAN OTC DRUG	Walgreens Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20190221		OTC MONOGRAPH DRUG	M031	Walgreens CO	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
0363-1298_3c227ac7-eef7-45c1-be8a-d6895dee43b5	0363-1298	HUMAN OTC DRUG	WALGREENS TOLNAFTATE		TOLNAFTATE	CREAM	TOPICAL	20110504		OTC MONOGRAPH FINAL	part333C	WALGREEN COMPANY	TOLNAFTATE	10	mg/g			N	20241231
0363-1301_06adf297-1844-4798-9995-520d6ac8815b	0363-1301	HUMAN OTC DRUG	sleep aid		Doxylamine succinate	TABLET	ORAL	20220809		ANDA	ANDA040167	Walgreen Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0363-1302_1d04bb72-cada-4dd3-be08-cb17fe6b3db0	0363-1302	HUMAN OTC DRUG	Ultra Strength digestive relief		Bismuth subsalicylate	TABLET	ORAL	20220926		OTC MONOGRAPH DRUG	M008	WALGREENS CO.	BISMUTH SUBSALICYLATE	525	mg/1			N	20241231
0363-1310_e0f253e4-5392-4c5d-bc75-b4f61b9739f4	0363-1310	HUMAN OTC DRUG	adult tussin chest congestion		Guaifenesin	SOLUTION	ORAL	20220607		OTC MONOGRAPH FINAL	part341	Walgreen Company	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-1319_aad0585e-4b12-4c6a-8458-46f8f74555ef	0363-1319	HUMAN OTC DRUG	wal flu severe		acetaminophen, dextromethorphan HBr, phenylephrine HCl, diphenhydramine HCl	KIT		20180919		OTC MONOGRAPH FINAL	part341	Walgreen Company						N	20241231
0363-1320_ee9e0c4a-7d63-497e-a9cc-52f5ebc76472	0363-1320	HUMAN OTC DRUG	Acetaminophen 250mg Aspirin 250mg Caffeine 65mg		Acetaminophen 250mg Aspirin 250mg Caffeine 65mg	TABLET	ORAL	20190924		OTC MONOGRAPH NOT FINAL	part343	WALGREENS CO.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-1323_a10e76dd-2ffd-4b30-a2bb-e16a5d065bc9	0363-1323	HUMAN OTC DRUG	smoothlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230210		ANDA	ANDA090685	Walgreen Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-1357_69edc038-d7b0-4ddf-a79b-036c1e10ae7a	0363-1357	HUMAN OTC DRUG	severe cold and flu		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20230531		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1401_c3c03ee7-2bf8-474b-9c6a-ba7923042a87	0363-1401	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20231025		ANDA	ANDA090962	Walgreens	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0363-1405_effed7e4-def1-7322-e053-2995a90acc5f	0363-1405	HUMAN OTC DRUG	Walgreens Sinus Wash Squeeze Bottle Kit		Sodium Chloride, Sodium Bicarbonate	KIT		20170414		UNAPPROVED DRUG OTHER		Walgreen Company						N	20241231
0363-1407_094a55ba-24fb-f519-e063-6294a90aca17	0363-1407	HUMAN OTC DRUG	Wal-Dram 2 Quick-Dissolving		meclizine hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20160301		OTC MONOGRAPH DRUG	M009	Walgreen Co.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0363-1419_3d9b0e95-13a6-4c6f-a8f9-ad13c74b380b	0363-1419	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20170525		NDA	NDA208025	Walgreen Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-1420_db099de1-e763-4011-a20e-cb292e72fab8	0363-1420	HUMAN OTC DRUG	Nicotine Polacrilex	MINT	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA076569	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1421_db099de1-e763-4011-a20e-cb292e72fab8	0363-1421	HUMAN OTC DRUG	Nicotine Polacrilex	MINT	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA076568	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1423_983bffcf-1acc-486e-b6c0-494a54d4989d	0363-1423	HUMAN OTC DRUG	Walgreen Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20231016		OTC MONOGRAPH DRUG	M008	WALGREENS CO.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
0363-1461_7fdc9565-e133-4702-93cb-03923334807c	0363-1461	HUMAN OTC DRUG	childrens ibuprofen 100		ibuprofen	TABLET, CHEWABLE	ORAL	20190606		ANDA	ANDA076359	Walgreen Company	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-1462_0cf9613b-2fae-88c0-e063-6394a90adac9	0363-1462	HUMAN OTC DRUG	Walgreens Multi-Symptom Relief Eye Drops		Glycerin, hypromellose, polyethylene glycol 400, tetrahydrozoline HCl, zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20200306		OTC MONOGRAPH DRUG	M018	Walgreen Co.	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.2; .36; 1; .05; .25	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0363-1474_0cf99668-f6c8-9154-e063-6394a90a1680	0363-1474	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops Restorative Performance		Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20190628		OTC MONOGRAPH DRUG	M018	Walgreen Company	PROPYLENE GLYCOL	.05	g/100mL			N	20241231
0363-1475_1ab4275d-fac8-45e8-93b7-fe7a9bb7dd39	0363-1475	HUMAN OTC DRUG	childrens dye free wal zyr		Cetirizine HCl	SOLUTION	ORAL	20171114		ANDA	ANDA204226	Walgreen Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-1480_ae4fef27-3cf9-41f6-9271-f8426d229599	0363-1480	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET	ORAL	20220119		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20251231
0363-1502_7ef2b176-50c0-4336-a2fc-354e324e5da5	0363-1502	HUMAN OTC DRUG	pain reliever		acetaminophen	TABLET, FILM COATED	ORAL	20220902		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20241231
0363-1505_90cbdf96-4ef2-5701-e053-2995a90a6373	0363-1505	HUMAN OTC DRUG	Walgreens Saline Mist	Extra Strength	Sodium Chloride	SPRAY	NASAL	20190822		UNAPPROVED DRUG OTHER		Walgreen's Corporation	SODIUM CHLORIDE	3	g/100g			N	20241231
0363-1507_0ac7ea18-a89c-bd04-e063-6294a90ae7c1	0363-1507	HUMAN OTC DRUG	Walgreens Antiseptic Wound Wash		BENZETHONIUM CHLORIDE	SOLUTION	TOPICAL	20190401		OTC MONOGRAPH DRUG	505G(a)(3)	Walgreen Company	BENZETHONIUM CHLORIDE	1.3	mg/g			N	20241231
0363-1510_af1076b5-46dd-4eb0-8be6-e1f31b88e186	0363-1510	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH DRUG	M002	Walgreens	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20251231
0363-1517_15fbfa65-d784-47d7-abb7-4cc2c5fe2235	0363-1517	HUMAN OTC DRUG	ibuprofen 200		Ibuprofen	TABLET, FILM COATED	ORAL	20211020		ANDA	ANDA077349	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-1521_066fa74d-f8a0-47ac-a65f-aef864c42c1c	0363-1521	HUMAN OTC DRUG	childrens ibuprofen 100		ibuprofen	TABLET, CHEWABLE	ORAL	20190610		ANDA	ANDA076359	Walgreen Company	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-1522_263041c9-2161-48fe-b8e7-f6ec303c45d2	0363-1522	HUMAN OTC DRUG	Walgreens Acne Foaming Wash	Acne Medication	Benzoyl Peroxide	LOTION	TOPICAL	20190315		OTC MONOGRAPH FINAL	part333D	Walgreen Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
0363-1550_3f27e042-c2cd-4079-bcb0-3160d0737b9f	0363-1550	HUMAN OTC DRUG	pain reliever		Acetaminophen	TABLET	ORAL	20220913		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20241231
0363-1567_0b65ad9c-a6d3-05aa-e063-6394a90adca3	0363-1567	HUMAN OTC DRUG	Lidocaine Hemorrhoid		Lidocaine 5%, Phenylephrine HCl 0.25%, Witch Hazel 50%	SPRAY	TOPICAL	20231130		OTC MONOGRAPH DRUG	M015	Walgreens Co	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	5; .25; 50	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1597_53b9c279-813f-471f-8978-b75c5d1d1475	0363-1597	HUMAN OTC DRUG	Severe Cold and Flu		acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20140908		OTC MONOGRAPH FINAL	part341	Walgreen Company						N	20241231
0363-1599_ec19308a-de67-f9fd-e053-2995a90acc50	0363-1599	HUMAN OTC DRUG	Walgreens Restore and Defend		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20221028		OTC MONOGRAPH FINAL	part355	Walgreens	STANNOUS FLUORIDE	.454	g/100g			N	20241231
0363-1603_b1000dea-9caf-4e72-be17-021afc527a5b	0363-1603	HUMAN OTC DRUG	adult tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220715		OTC MONOGRAPH FINAL	part341	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-1604_b31aa207-db57-bc99-1aa4-0cd830ccb160	0363-1604	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20190813		ANDA	ANDA208369	Walgreens Company	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-1605_f2150174-1bc0-465a-e053-2995a90ab273	0363-1605	HUMAN OTC DRUG	3x Medicated Mouth Sore Gel		Benzocaine	GEL	ORAL	20211020		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	20; .1; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-1606_22a37aee-5811-616b-a794-4c24bd940d73	0363-1606	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20190916		ANDA	ANDA076667	Walgreens Company	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-1607_17b95999-0e28-8b36-5173-1c26ab2ec1d1	0363-1607	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200115		ANDA	ANDA207740	Walgreens Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-1608_0cfb6dea-af2c-4c6d-ad77-5431b3357291	0363-1608	HUMAN OTC DRUG	Nicotine Polacrilex	original	Nicotine Polacrilex	GUM, CHEWING	ORAL	20140101		ANDA	ANDA074507	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1609_0cfb6dea-af2c-4c6d-ad77-5431b3357291	0363-1609	HUMAN OTC DRUG	Nicotine Polacrilex	original	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA074707	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1610_c5462932-9c8f-61ef-e053-2995a90aab78	0363-1610	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20160127		ANDA	ANDA079205	WALGREENS	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-1612_b8300a5e-3d18-4624-9427-cc96795f67fe	0363-1612	HUMAN OTC DRUG	allergy relief		Loratadine	TABLET	ORAL	20211021		ANDA	ANDA076301	Walgreen Company	LORATADINE	10	mg/1			N	20241231
0363-1623_ec04f7e2-a7ae-6886-e053-2995a90aa40f	0363-1623	HUMAN OTC DRUG	PM Toothache Relief		Benzocaine	PASTE	DENTAL	20221027		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL; ZINC CHLORIDE	.26; 20; .26; .242	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-1634_091c0eed-30ab-31ba-e063-6394a90afbd0	0363-1634	HUMAN OTC DRUG	Gentle Laxative		magnesium hydroxide	LIQUID	ORAL	20201201		OTC MONOGRAPH DRUG	M007	WALGREEN COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-1639_091c2496-6c95-2e4b-e063-6394a90a50ba	0363-1639	HUMAN OTC DRUG	ADVANCED REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20150101		OTC MONOGRAPH DRUG	M001	WALGREEN COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-1648_091c2496-6c96-2e4b-e063-6394a90a50ba	0363-1648	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M007	WALGREEN COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-1652_eff77965-dc80-49af-e053-2995a90a1a97	0363-1652	HUMAN OTC DRUG	Antibacterial Lidocaine Wound Gel		benzalkonium chloride, lidocaine hydrochloride	GEL	TOPICAL	20221205		OTC MONOGRAPH NOT FINAL	part333A	WALGREENS	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 2	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-1686_ed2fd264-8dba-e36d-e053-2a95a90aa08a	0363-1686	HUMAN OTC DRUG	WAL-ITIN		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20161021		ANDA	ANDA206214	WALGREENS	LORATADINE	10	mg/1			N	20241231
0363-1691_091bf671-be45-26fd-e063-6394a90afbc9	0363-1691	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20140901		OTC MONOGRAPH DRUG	M001	WALGREEN COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-1699_c83721ca-4f60-4436-8ce8-fbd546184754	0363-1699	HUMAN OTC DRUG	Esomeprazole Magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200322		ANDA	ANDA207193	Walgreen Company	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-1723_cd36eb67-903a-42ee-8391-013f561a9843	0363-1723	HUMAN OTC DRUG	tussin cf max		Acetaminophen, dextromethorphan Hydrobromide, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20220608		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1733_9d106fd2-e846-4e8e-9d12-01f9e74baba2	0363-1733	HUMAN OTC DRUG	daytime nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20170713		OTC MONOGRAPH FINAL	part341	Walgreen Company						N	20241231
0363-1739_0e138ee3-7e22-4b0f-9f1f-8c51b5ddf62b	0363-1739	HUMAN OTC DRUG	severe cold dm severe cold and flu		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20220524		OTC MONOGRAPH FINAL	part341	Walgreen Company						N	20241231
0363-1746_f37ff7a8-eb41-eddd-e053-2995a90a691a	0363-1746	HUMAN OTC DRUG	Tolnaftate		Tolnaftate Athletes Foot Powder Spray	SPRAY	TOPICAL	20211020		OTC MONOGRAPH FINAL	part333C	Walgreens Company	TOLNAFTATE	1.3	g/130g			N	20241231
0363-1747_f69205f1-a2fe-ad89-e053-2995a90a00c3	0363-1747	HUMAN OTC DRUG	Salicylic Acid		Clear Medicated Corn removers	PATCH	TOPICAL	20220222		OTC MONOGRAPH FINAL	part358F	Walgreens Company	SALICYLIC ACID	40	mg/121			N	20241231
0363-1750_2e73b0ec-a32d-4ec7-9f98-19dfb8152774	0363-1750	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	20241231
0363-1780_96c4f985-b2c5-4f70-bb1f-5f7436215eb9	0363-1780	HUMAN OTC DRUG	Cold and Allergy D		Pseudoephedrine HCl and Triprolidine HCl	TABLET, FILM COATED	ORAL	20220124		OTC MONOGRAPH DRUG	M012	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	60; 2.5	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-1794_08332210-6c16-be1e-e063-6394a90a0bbe	0363-1794	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET	ORAL	20231025		ANDA	ANDA078933	WALGREENS	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-1819_dea0bb95-63c8-4da5-b91f-72002cf403cd	0363-1819	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180301		NDA	NDA209400	Walgreen Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-1825_ee4e4e2b-9f71-4e03-a214-ffcaa9e0e78e	0363-1825	HUMAN OTC DRUG	nicotine		nicotine polacrilex	LOZENGE	ORAL	20181108		ANDA	ANDA203690	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-1830_93427104-fe3b-4858-a30b-08a09bf9f05c	0363-1830	HUMAN OTC DRUG	anti diarrheal and anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181010		ANDA	ANDA209837	Walgreen Company	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
0363-1857_3457e45d-12db-4ae7-9c27-48f93b93cdab	0363-1857	HUMAN OTC DRUG	athletes foot		Clotrimazole	CREAM	TOPICAL	20170929		OTC MONOGRAPH FINAL	part333C	Walgreen Company	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-1871_dffedb3c-62b7-41d7-9317-6150d1f8e45e	0363-1871	HUMAN OTC DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20200831		ANDA	ANDA211253	Walgreen Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-1898_2bf551ca-bd65-49a1-8340-143f3e4a0840	0363-1898	HUMAN OTC DRUG	esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Walgreen Company	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-1899_e82ab13e-530a-473e-b4c5-6f80e94df8c7	0363-1899	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220218		ANDA	ANDA206531	WALGREEN CO.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-1900_3292408a-7c5d-4173-a7f4-9aeb555156f7	0363-1900	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	20210917		OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-1919_318b0eeb-803f-48c9-bb71-347760d0c4d3	0363-1919	HUMAN OTC DRUG	Severe Cold DM		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20230601		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1940_bd61a7d8-bf6a-45d5-8adf-5e974d9c8c28	0363-1940	HUMAN OTC DRUG	severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20190629		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-1941_c0d200a5-df2b-4f7d-a028-7f633d0086a0	0363-1941	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	20210916		OTC MONOGRAPH DRUG	M012	Walgreen Company	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-1972_e9cce92a-438e-4c00-a685-7544610b131c	0363-1972	HUMAN OTC DRUG	Walgreens maximum strength ONE-STEP Corn Remover		Salicylic acid	STRIP	TOPICAL	20231018		OTC MONOGRAPH DRUG	M030	Walgreen Co.	SALICYLIC ACID	1.35	mg/1			N	20241231
0363-1973_1a5d89ca-8d98-44f3-b06b-4cf00dec9510	0363-1973	HUMAN OTC DRUG	Hydrocortisone		hydrocortisone	CREAM	TOPICAL	20180109		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-1980_04af85e0-8085-4ae0-a07d-34e06368e11f	0363-1980	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	20211022		OTC MONOGRAPH DRUG	M009	Walgreen Company	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-2020_090568cf-d90c-2f8a-e063-6394a90a0136	0363-2020	HUMAN OTC DRUG	WALGREENS BURN		lidocaine hydrochloride	GEL	TOPICAL	20210716		OTC MONOGRAPH DRUG	M017	WALGREENS	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-2021_bbb21ead-18db-b1bf-e053-2995a90a1bfc	0363-2021	HUMAN OTC DRUG	Severe Anefrin		OXYMETAZOLINE HYDROCHLORIDE	LIQUID	NASAL	20210208		OTC MONOGRAPH FINAL	part341	WALGREENS	OXYMETAZOLINE HYDROCHLORIDE	.05	g/15mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0363-2022_bebbb40e-ed27-490a-bbd9-111ad23dd04d	0363-2022	HUMAN OTC DRUG	Anti Diarrheal		loperamide HCl	SOLUTION	ORAL	20220321		ANDA	ANDA091292	Walgreen Company	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0363-2023_090570c3-7d64-5533-e063-6294a90a3d0e	0363-2023	HUMAN OTC DRUG	Ephrine Nose Drops		Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	20210715		OTC MONOGRAPH DRUG	M012	Walgreens	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-2025_cec75db8-3e68-41d3-9a34-bd9e18c01a04	0363-2025	HUMAN OTC DRUG	Walgreens Medicated Corn Removers		Salicylic acid	PATCH	TOPICAL	20231018		OTC MONOGRAPH DRUG	M030	Walgreen Co.	SALICYLIC ACID	.54	mg/1			N	20241231
0363-2029_6cf3267a-0305-4fe1-a13a-d970115f76cc	0363-2029	HUMAN OTC DRUG	nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230708		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-2035_119da751-8ffd-45ea-a3d5-32b9da5ffb55	0363-2035	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19940515		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-2052_09054ad6-1b26-1e77-e063-6394a90aa122	0363-2052	HUMAN OTC DRUG	Ichthammol		Ichthammol Ointment	OINTMENT	TOPICAL	20210728		UNAPPROVED DRUG OTHER		Walgreens	ICHTHAMMOL	100	mg/g			N	20241231
0363-2053_e1e54f3b-cd5c-4085-e053-2a95a90a2439	0363-2053	HUMAN OTC DRUG	Walgreens Pain Burn Itch Relief		Benzocaine 20%, Menthol 0.5%	SPRAY	TOPICAL	20220505		OTC MONOGRAPH NOT FINAL	part348	Walgreens	BENZOCAINE; MENTHOL	200; 5	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-2054_e29b5845-4587-08ac-e053-2995a90a77a6	0363-2054	HUMAN OTC DRUG	Walgreens Scar Cream w/SPF 30		Avobenzone3%,Octocrylene10%,Oxybenone 6%	CREAM	TOPICAL	20220429		OTC MONOGRAPH FINAL	part352	Walgreens	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	30; 100; 60	mg/g; mg/g; mg/g			N	20241231
0363-2060_6085f2e0-95ee-4d23-985f-1de9b1eb1ed9	0363-2060	HUMAN OTC DRUG	allergy nasal		mometasone furoate monohydrate	SPRAY	NASAL	20230330		NDA	NDA215712	Walgreen Company	MOMETASONE FUROATE MONOHYDRATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0363-2062_358d5d91-f6fe-42b3-9f0e-8dcc45512443	0363-2062	HUMAN OTC DRUG	Walgreens	Clotrimazole 3	Clotrimazole	CREAM	VAGINAL	20000412		NDA	NDA021143	Walgreen Company	CLOTRIMAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-2068_f2819e70-f156-427f-bfd3-fa7029637c6e	0363-2068	HUMAN OTC DRUG	Walgreens Ear Wax Remover		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20140428		OTC MONOGRAPH FINAL	part344	Walgreens Company	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
0363-2080_d8005a9c-424b-4d89-a6da-a64bfd04cbf5	0363-2080	HUMAN OTC DRUG	Walgreens	Athletes Foot	Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Walgreen Company	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0363-2083_aab4fe7d-4fa1-4751-b681-3d041dc116ce	0363-2083	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Walgreen Company	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0363-2100_9226e7dc-7881-4ce1-99d4-28c5a1019708	0363-2100	HUMAN OTC DRUG	Athletes Foot		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	Walgreen Company	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
0363-2101_4c018fd2-bfdc-4f58-b62a-d4c39ce5d6fa	0363-2101	HUMAN OTC DRUG	Jock Itch		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	Walgreen Company	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
0363-2102_4b885186-3ee5-418c-9ee9-04166c076f8b	0363-2102	HUMAN OTC DRUG	Wal-Zyr	Cetirizine Hydrochloride	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Walgreen Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-2103_c51ac00f-d544-4a36-9131-6bda2bde94f1	0363-2103	HUMAN OTC DRUG	Antacid Ultra Strength	Assorted Fruits	Antacid	TABLET, CHEWABLE	ORAL	20171218		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	1000	mg/1			N	20241231
0363-2103_dece97fa-366c-4e23-9ff9-07e2e4f7ba22	0363-2103	HUMAN OTC DRUG	Antacid Ultra Strength	Assorted Fruits	Antacid	TABLET, CHEWABLE	ORAL	20171218		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	1000	mg/1			N	20241231
0363-2105_6a9a3bef-33ec-4207-b231-3fbcce3fcb04	0363-2105	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Walgreen Company	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-2106_236ed4fb-cea6-468a-9a9c-10e346533690	0363-2106	HUMAN OTC DRUG	Wal-Zyr	All Day Allergy	Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	WALGREEN COMPANY	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-2107_d35e875e-96f5-4db6-b4fa-ca7c1467c2fa	0363-2107	HUMAN OTC DRUG	Ringworm		Clotrimazole	CREAM	TOPICAL	20210402		OTC MONOGRAPH DRUG	M005	Walgreen Company	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-2108_ebfab224-98d3-435a-9812-1f16b9b1e8d9	0363-2108	HUMAN OTC DRUG	Childrens Walitin		Loratadine	SOLUTION	ORAL	20161212		ANDA	ANDA201865	Walgreen Company	LORATADINE	5	mg/5mL			N	20241231
0363-2109_e1a6fc36-5eb9-407b-a815-f703d51c1bd5	0363-2109	HUMAN OTC DRUG	Walgreens	Jock Itch	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH DRUG	M005	Walgreen Company	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-2111_f6e2b4c7-ed46-7ebe-e053-6294a90a9a1c	0363-2111	HUMAN OTC DRUG	Walgreens Complete Lubricant Eye Drops		propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20230301		OTC MONOGRAPH FINAL	part349	Walgreens	PROPYLENE GLYCOL	.06	mg/mL			N	20241231
0363-2112_fae6cc7f-7410-91e1-e053-6294a90ae3ce	0363-2112	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops		propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20230503		OTC MONOGRAPH FINAL	part349	WALGREEN COMPANY	PROPYLENE GLYCOL	.06	mg/mL			N	20241231
0363-2122_c7d68a01-445c-47c6-88f8-80d17c8f3a49	0363-2122	HUMAN OTC DRUG	Walgreens Kids Multi-Antibiotic with Pain Relief Cream		Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride	CREAM	TOPICAL	20221201		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-2123_44fdb48c-74df-47fa-a878-1fbc87b64adc	0363-2123	HUMAN OTC DRUG	Walgreens Multi-Antibiotic with Pain Relief Cream		Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride	CREAM	TOPICAL	20150715		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-2131_4e61386b-8f55-4be1-bc55-613ce9cf3331	0363-2131	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Walgreen Company	LORATADINE	5	mg/5mL			N	20241231
0363-2177_0d84aa1a-d8c6-aeb1-e063-6394a90ae2e0	0363-2177	HUMAN OTC DRUG	EXTRA STRENGTH WAL-DRYL ITCH RELIEF		DIPHENHYDRAMINE, ZINC ACETATE	SPRAY	TOPICAL	20110103		OTC MONOGRAPH DRUG	M017	WALGREEN CO	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-2247_64210f2c-a100-4231-a040-47dd1c2731ea	0363-2247	HUMAN OTC DRUG	Daily Baby		Dimethicone	LOTION	TOPICAL	20181113		OTC MONOGRAPH FINAL	part347	WALGREEN CO	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
0363-2294_770eb3c4-2e18-4eee-8b41-aa0ee28e7237	0363-2294	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20181119		ANDA	ANDA091344	Walgreen Company	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0363-2303_8e1fa901-0b6b-4181-b4ad-d703abb36300	0363-2303	HUMAN OTC DRUG	No Drip Nasal Mist		Oxymetazoline Spray	LIQUID	NASAL	20180830		OTC MONOGRAPH DRUG	M012	Walgreens Company	OXYMETAZOLINE HYDROCHLORIDE	50	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0363-2307_7741f87c-5391-4482-a41c-b284112835f3	0363-2307	HUMAN OTC DRUG	No Drip Nasal Mist		Oxymetazoline Spray	LIQUID	NASAL	20181008		OTC MONOGRAPH FINAL	part341	Walgreens Company	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0363-2309_080df8fa-1c0a-413f-98e8-e923d9fb54b9	0363-2309	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20180104		ANDA	ANDA206393	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-2310_5009d58e-346c-4cf9-8fc0-1648a0c3a115	0363-2310	HUMAN OTC DRUG	Acetaminophen 500mg Caffeine 60mg Pyrilamine maleate 15mg		Acetaminophen 500mg Caffeine 60mg Pyrilamine maleate 15mg	TABLET	ORAL	20190705		OTC MONOGRAPH NOT FINAL	part343	WALGREENS CO.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-2311_877ce040-c6d7-4d61-97f2-4ddf0a5094a9	0363-2311	HUMAN OTC DRUG	Anti-Itch Medicated Maximum Strength		Benzocaine and Resorcinol	CREAM	TOPICAL	20180716		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	BENZOCAINE; RESORCINOL	200; 30	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-2312_bfa7f5e4-221d-4034-a8c3-22507517d37d	0363-2312	HUMAN OTC DRUG	Walgreens Advanced Scar Gel		Advanced Scar Gel	GEL	TOPICAL	20190326		OTC MONOGRAPH FINAL	part347	Walgreens Company	ALLANTOIN	5	mg/g			N	20241231
0363-2315_2495d04d-14be-4707-b3d3-a57e5f3845f3	0363-2315	HUMAN OTC DRUG	Walgreens Anti Itch Cream		Anti Itch Cream	CREAM	TOPICAL	20140505		OTC MONOGRAPH FINAL	part347	Walgreens Company	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-2390_b27ff45e-0de3-4e94-9004-39b3e5cf13d5	0363-2390	HUMAN OTC DRUG	Wal-itin D	24 Hour	Loratadine and Pseudoephedrine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20160301	20240223	ANDA	ANDA075706	Walgreens	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
0363-2570_469af381-3641-4095-990d-d95e1241ffec	0363-2570	HUMAN OTC DRUG	Stool Softener		Docusate Calcium	CAPSULE, LIQUID FILLED	ORAL	20190131		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE CALCIUM	240	mg/1			N	20241231
0363-2600_34fcbd70-2358-4b3b-a633-e74808f47182	0363-2600	HUMAN OTC DRUG	Children Allergy		Fexofenadine HCL	SUSPENSION	ORAL	20231031		ANDA	ANDA203330	Walgreens	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-2628_091c3ffa-21d3-4fb3-e063-6394a90a98a6	0363-2628	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20140801		OTC MONOGRAPH DRUG	M001	WALGREEN COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-2640_48bef5a7-e7fe-482b-8bdc-d6e5dfc47746	0363-2640	HUMAN OTC DRUG	Mini Nicotine		nicotine polacrilex	LOZENGE	ORAL	20190901		ANDA	ANDA207868	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-2730_d34dc909-a95b-43f1-9138-b2527ab72bc8	0363-2730	HUMAN OTC DRUG	ULTRA STRENGTH Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200128		OTC MONOGRAPH DRUG	M001	WALGREEN CO	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-2801_6f1b5bcc-1000-4a7a-9849-6eaca9fef36c	0363-2801	HUMAN OTC DRUG	tussin cf max		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230526		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-2900_6d4e8feb-f1b7-4502-8686-bf9deafbae1e	0363-2900	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin-B Sulfate, Pramoxine hydrochloride	OINTMENT	TOPICAL	20201127		OTC MONOGRAPH FINAL	part333B	Walgreens	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-2981_5bfdb9e5-cd23-412e-999d-ceabc291a08b	0363-2981	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20190411		ANDA	ANDA208754	Walgreens	DOCOSANOL	100	mg/g			N	20241231
0363-3001_fd9b1b64-8b9d-40c0-9ec3-e8855f51f09a	0363-3001	HUMAN OTC DRUG	Pain and Itch Relief	4% Lidocaine	Lidocaine	CREAM	TOPICAL	20160115		OTC MONOGRAPH NOT FINAL	part348	Walgreens	LIDOCAINE	.04	g/40g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-3010_0c064eef-0699-bbcb-e063-6394a90a6184	0363-3010	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM and SENNOSIDES	CAPSULE, GELATIN COATED	ORAL	20160301		OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0363-3011_0c06378c-f95f-cf60-e063-6294a90a6d95	0363-3011	HUMAN OTC DRUG	WOMENS GENTLE LAXATIVE		BISACODYL	CAPSULE, GELATIN COATED	ORAL	20160301		OTC MONOGRAPH DRUG	M007	Walgreens	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-3031_f5765723-7cd2-b4fe-e053-2a95a90ae648	0363-3031	HUMAN OTC DRUG	Walgreens Cool and Heat		Menthol 16%	AEROSOL, SPRAY	TOPICAL	20230224		OTC MONOGRAPH NOT FINAL	part348	Walgreens	MENTHOL	16	g/100g			N	20241231
0363-3033_09057727-891e-28f7-e063-6394a90abb66	0363-3033	HUMAN OTC DRUG	Walgreens Cool n heat		Lidocaine 4% Menthol 1%	AEROSOL, SPRAY	TOPICAL	20220719		OTC MONOGRAPH DRUG	M017	Walgreens	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-3034_eea1704f-9bb8-9f9e-e053-2a95a90a1d57	0363-3034	HUMAN OTC DRUG	Walgreens Arnica		Arnica Montana 7%	AEROSOL, SPRAY	TOPICAL	20221101		UNAPPROVED HOMEOPATHIC		Walgreens	ARNICA MONTANA	1	[hp_X]/g			N	20241231
0363-3035_eea1704f-9baa-9f9e-e053-2a95a90a1d57	0363-3035	HUMAN OTC DRUG	Arthritis Pain Relief		Histamine Dihydrochloride .025%	CREAM	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part348	Walgreens	HISTAMINE DIHYDROCHLORIDE	.025	g/100g			N	20241231
0363-3037_09054540-3265-3a15-e063-6294a90aef65	0363-3037	HUMAN OTC DRUG	Walgreens Pain Relieving Cream		Lidocaine 4%	CREAM	TOPICAL	20220310		OTC MONOGRAPH DRUG	M017	Walgreens	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-3038_09057091-4886-4fae-e063-6294a90a95e5	0363-3038	HUMAN OTC DRUG	Walgreens pain relieving		Lidocaine 4%	AEROSOL, SPRAY	TOPICAL	20220802		OTC MONOGRAPH DRUG	M017	Walgreens	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-3100_09056983-cf95-4f82-e063-6294a90a858e	0363-3100	HUMAN OTC DRUG	Walgreens Skin Tag Treatment		Thuja Occidentalis	LIQUID	TOPICAL	20230430		UNAPPROVED HOMEOPATHIC		Walgreens	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/10mL			N	20241231
0363-3103_0a84ecce-fdd3-47cb-a55c-8870d1bae57a	0363-3103	HUMAN OTC DRUG	Antacid Extra Strength	Wintergreen	Antacid	TABLET, CHEWABLE	ORAL	20171219		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	750	mg/1			N	20241231
0363-3113_51227f98-6c4a-442c-a421-cadc657b0c67	0363-3113	HUMAN OTC DRUG	Antacid Ultra Strength		Antacid	TABLET, CHEWABLE	ORAL	20171218		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-3115_f380023b-fe0b-06d4-e053-2995a90a44d7	0363-3115	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20180601		OTC MONOGRAPH FINAL	part333C	Walgreens Company	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-3233_f53cff10-3738-0b30-e053-2995a90aaf2b	0363-3233	HUMAN OTC DRUG	WALGREENS EARACHE DROPS		belladonna leaf, calcium carbonate, chamomile, lycopodium clavatum spore, anemone patens, and sulfur	LIQUID	AURICULAR (OTIC)	20210622		UNAPPROVED HOMEOPATHIC		Walgreen Company	ANEMONE PATENS WHOLE; BELLADONNA LEAF; CALCIUM CARBONATE; CHAMOMILE; LYCOPODIUM CLAVATUM SPORE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0363-3255_0c052564-0a39-b1f2-e063-6294a90a8a65	0363-3255	HUMAN OTC DRUG	Walgreens Lice Elimination		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20131028		OTC MONOGRAPH DRUG	M031	Walgreens						N	20241231
0363-3290_7b338585-60dd-4a2b-aca6-d578ee618886	0363-3290	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201030		ANDA	ANDA204833	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-3291_18ac210c-3dab-4941-98a6-702f648d429b	0363-3291	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210927		OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-3298_6fe77186-25aa-e9cb-b69f-576f2456dc4e	0363-3298	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20181231		ANDA	ANDA207673	Walgreens Company	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-3301_0c060566-54b0-4fd9-9040-a7cc8917909d	0363-3301	HUMAN OTC DRUG	Nasal Decongestant D		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220406		ANDA	ANDA075153	Walgreen Company	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-3311_eaddd761-9658-42cd-bcef-e9cad43632d1	0363-3311	HUMAN OTC DRUG	childrens allergy relief		Cetirizine Hydrochloride	SOLUTION	ORAL	20220805		ANDA	ANDA204226	Walgreen Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-3355_90ddb88a-e1a2-4c6e-8acb-66c48b1f6212	0363-3355	HUMAN OTC DRUG	Antacid Extra Strength		Antacid Calcium carbonate	TABLET, CHEWABLE	ORAL	20171219		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	750	mg/1			N	20241231
0363-3361_d2a74fe7-742f-41a6-8ceb-2a5c9c60c6b9	0363-3361	HUMAN OTC DRUG	Mucus Relief Cold Flu Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20200730		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-3390_7fd5dc78-16e5-46b4-8475-753d2c77c6a3	0363-3390	HUMAN OTC DRUG	Antacid Extra Strength		Antacid	TABLET, CHEWABLE	ORAL	20171218		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	CALCIUM CARBONATE	750	mg/1			N	20241231
0363-3393_cd2cbb41-ac07-4ef1-9455-2fbacd81d8d1	0363-3393	HUMAN OTC DRUG	childrens allergy relief		Cetirizine Hydrochloride	SOLUTION	ORAL	20220809		ANDA	ANDA204226	Walgreen Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-3430_9e6ffcdc-5be2-42d9-8fe8-59e74b5ee9b9	0363-3430	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20200730		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-3440_f1cc9bc9-12fe-4679-a71d-04c215023a94	0363-3440	HUMAN OTC DRUG	Awake	Maximum Strength	Caffeine	TABLET, FILM COATED	ORAL	19980414		OTC MONOGRAPH DRUG	M011	Walgreen Company	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-3480_5eab839a-b31d-497d-874f-5f347c749440	0363-3480	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, SUGAR COATED	ORAL	20030102	20250512	OTC MONOGRAPH DRUG	505G(a)(3)	Walgreen Company	SENNOSIDES	25	mg/1			N	
0363-3602_efbb1f57-a144-4f6e-8ac5-c4b97faecaa6	0363-3602	HUMAN OTC DRUG	Walgreens Acne Control Cleanser	Acne Medication	Benzoyl Peroxide	LOTION	TOPICAL	20230303		OTC MONOGRAPH FINAL	part333D	Walgreen Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
0363-3630_d6aabff4-1370-4219-8314-e3fd99d4172d	0363-3630	HUMAN OTC DRUG	Walgreens Pain Relieving Plus Turmeric	Analgesic	Trolamine Salicylate	CREAM	TOPICAL	20210622		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	TROLAMINE SALICYLATE	100	mg/g			N	20241231
0363-3791_97520002-47b8-4958-acd0-be672b1cb3d2	0363-3791	HUMAN OTC DRUG	Walgreens Nerve Pain Relieving	Topical Analgesic	Lidocaine Hydrochloride and Menthol, Unspecified Form	LIQUID	TOPICAL	20230221		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-3890_293e408f-37f0-4e32-8f69-a3805dea0e0b	0363-3890	HUMAN OTC DRUG	Walgreens Sport Faces SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160608		OTC MONOGRAPH NOT FINAL	part352	Walgreen Co.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 13; 5; 1; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
0363-3900_47929d00-0e80-4463-aa89-51bfb4e7ddf4	0363-3900	HUMAN OTC DRUG	Menstrual Pain Relief		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-3901_8a6b5465-cde0-49e1-b2ed-ca34c3638cfa	0363-3901	HUMAN OTC DRUG	allergy relief		levocetirizine dihydrochloride	TABLET, FILM COATED	ORAL	20210923		ANDA	ANDA211983	Walgreen Company	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-3911_c6eab86c-99d8-424c-b4a2-6be56cf6d603	0363-3911	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201030		ANDA	ANDA079219	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-4020_18ac8158-eb8c-4d44-a102-8a4dfdd5299d	0363-4020	HUMAN OTC DRUG	CHILDRENS LORATADINE ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	WALGREEN CO.	LORATADINE	10	mg/1			N	20241231
0363-4025_5bfdffce-a721-49b3-b7c7-620fdf6ad9f2	0363-4025	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20200911		ANDA	ANDA213557	WALGREEN CO.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-4030_d2bb52dd-72ae-4ab8-b845-75e1c2b9d920	0363-4030	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20211021		OTC MONOGRAPH DRUG	M009	Walgreen Company	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0363-4050_c1b95f3b-e9e7-4c17-a09d-dedff0b80bfe	0363-4050	HUMAN OTC DRUG	Cough Cold and Sore Throat	Childrens	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141031		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-4063_fe1e6368-39db-4c01-821f-6482c57451f4	0363-4063	HUMAN OTC DRUG	Severe Congestion and Cough, Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, Triprolidine HCl	KIT		20231023		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-4066_67bc3c8e-c095-4296-9bea-a6265407495f	0363-4066	HUMAN OTC DRUG	Sinus and Headache		Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-4100_f888b78d-6b0d-46e5-8e8f-7564b7c48858	0363-4100	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM	100	mg/1			N	20241231
0363-4101_ef81c4ff-f4d0-43f2-880f-3fa272e646ec	0363-4101	HUMAN OTC DRUG	allergy relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA078336	Walgreen Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-4115_c333512f-e44c-4caf-b675-db2ea3a93daa	0363-4115	HUMAN OTC DRUG	Walgreens Original Strength Anti Itch		Diphenhydramine hydrochloride, zinc acetate	CREAM	TOPICAL	20130927		OTC MONOGRAPH DRUG	M017	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-4121_77dabfa4-1151-48a7-b42a-10466094d223	0363-4121	HUMAN OTC DRUG	Wal-Phed HEAD CONGESTION AND MUCUS	PE	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210412	20240210	OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
0363-4136_69fd3c37-b9e7-4899-af7a-73d998b7082e	0363-4136	HUMAN OTC DRUG	Walgreens Dandruff and Conditioner Cleansing and Conditioning	Anti-dandruff	Selenium Sulfide	SHAMPOO	TOPICAL	20230103		OTC MONOGRAPH FINAL	part358H	Walgreen Company	SELENIUM SULFIDE	10	mg/mL			N	20241231
0363-4137_616416bc-427a-4495-b173-e8c61ece8df9	0363-4137	HUMAN OTC DRUG	Walgreens Dandruff Itchy Dry Scalp Defense Plus Vitamins and Botanicals	Anti-dandruff	Salicylic Acid	SHAMPOO	TOPICAL	20230105		OTC MONOGRAPH FINAL	part358H	Walgreen Company	SALICYLIC ACID	30	mg/mL			N	20241231
0363-4138_bb529807-9620-4c18-8997-f545a97534b4	0363-4138	HUMAN OTC DRUG	Walgreens Dandruff Itchy Dry Scalp Defense	Anti-dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20221219		OTC MONOGRAPH FINAL	part358H	Walgreen Company	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-4139_ea848721-74b9-45bd-96ef-6bc120dcae69	0363-4139	HUMAN OTC DRUG	Walgreens Dandruff Maximum Strength	Anti-dandruff	Selenium Sulfide	SHAMPOO	TOPICAL	20221219		OTC MONOGRAPH FINAL	part358H	Walgreen Company	SELENIUM SULFIDE	10	mg/mL			N	20241231
0363-4150_6963a3b5-d61d-43e2-ab68-7a9574a61d4a	0363-4150	HUMAN OTC DRUG	Severe Cold and Flu Relief	Daytime	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20200730		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-4190_54d315da-5353-4198-85fb-9c59552d4b0c	0363-4190	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20141105		ANDA	ANDA090711	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-4200_dc8ce560-728e-44f8-8a6e-82d9d487f68a	0363-4200	HUMAN OTC DRUG	Daytime Nighttime Multi Symptom Cold	Childrens	Dextromethorphan HBr,Guaifenesin,Phenylephrine HCl,Acetaminophen,Diphenhydramine HCl, Phenylephrine HCl	KIT		20141231		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-4202_d8945528-dae5-4cb6-ba1e-b32c073f9339	0363-4202	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM	100	mg/1			N	20241231
0363-4208_f3827160-b08c-3400-e053-2995a90a4fa3	0363-4208	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Liquid	SPRAY	TOPICAL	20100518		OTC MONOGRAPH FINAL	part333C	Walgreens Company	MICONAZOLE NITRATE	3	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-4230_45704375-b8e9-482f-ae1c-43d6abebad67	0363-4230	HUMAN OTC DRUG	Ivermectin		Ivermectin	LOTION	TOPICAL	20200506		ANDA	ANDA210720	Walgreen Company	IVERMECTIN	5	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
0363-4262_0c427e12-a539-ad93-e063-6294a90ae134	0363-4262	HUMAN OTC DRUG	Walgreen Anti Itch		Camphor, Menthol	LOTION	TOPICAL	20201125		OTC MONOGRAPH DRUG	M017	Walgreens	CAMPHOR (SYNTHETIC); MENTHOL	.5; .5	g/100g; g/100g			N	20241231
0363-4278_d68c44f8-2ac5-49f0-9051-2535279a140c	0363-4278	HUMAN OTC DRUG	Cold and Flu	Daytime Nighttime Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, Triprolidine HCl	KIT		20231021		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-4288_6d803d99-b94e-4feb-a0da-455877d5fc07	0363-4288	HUMAN OTC DRUG	Walgreens Dandruff Conditioner 2 in 1 Itchy Scalp	Anti-dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20221222		OTC MONOGRAPH FINAL	part358H	Walgreen Company	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-4289_ce1057fe-0ea8-4433-b54c-d5d8b58f13ad	0363-4289	HUMAN OTC DRUG	Walgreens Dandruff Conditioner 2 in 1 Itchy Scalp	Anti-dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20230115		OTC MONOGRAPH FINAL	part358H	Walgreen Company	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-4381_5afd11b6-3d05-4c21-9eef-233b2f5e8660	0363-4381	HUMAN OTC DRUG	Dye Free Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Walgreen Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-4385_94233c3d-919a-4364-94cb-9e57a1b16166	0363-4385	HUMAN OTC DRUG	Wal-Phed PE	Daytime / Nighttime	Phenylephrine HCl, Diphenhydramine HCl	KIT		20180831	20240318	OTC MONOGRAPH FINAL	part341	Walgreen Company						N	
0363-4400_31ea38c1-c3ed-44f6-a72f-3d1efeb16018	0363-4400	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	WALGREEN CO.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-4404_46ed576a-2800-474c-8306-a91d93941a69	0363-4404	HUMAN OTC DRUG	Walgreens Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		Walgreen Company	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
0363-4411_f1dab11d-ef44-599d-e053-2995a90a96c4	0363-4411	HUMAN OTC DRUG	Cold Therapy Pain Relief	Walgreens	Menthol 10.5%	SPRAY	TOPICAL	20220109		OTC MONOGRAPH NOT FINAL	part348	WALGREEN COMPANY	MENTHOL	10.5	g/100g			N	20241231
0363-4470_0c6c72d1-07fc-44c0-94b5-c17caf0c8969	0363-4470	HUMAN OTC DRUG	Pain Reliever PM	Extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20141230	20251130	OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-4501_9ff73927-156a-4142-923b-3026cd4c07ff	0363-4501	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	160	mg/1			N	20241231
0363-4502_0bdec9de-f1c4-47c1-83a6-ff46ebd97112	0363-4502	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20231025		ANDA	ANDA077511	WALGREEN COMPANY	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
0363-4510_b1ba7634-3fbd-9522-e053-2a95a90a4059	0363-4510	HUMAN OTC DRUG	Lidocaine HCl 4%		Lidocaine HCl 4%	OINTMENT	TOPICAL	20190104		OTC MONOGRAPH NOT FINAL	part348	WALGREENS CO.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-4520_b1b90421-48de-2298-e053-2995a90ae9b7	0363-4520	HUMAN OTC DRUG	Lidocaine HCl 4% Menthol 1%		Lidocaine HCl 4% Menthol 1%	OINTMENT	TOPICAL	20190104		OTC MONOGRAPH NOT FINAL	part348	WALGREENS CO.	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-4530_b1baafb1-ad97-14f8-e053-2995a90a6341	0363-4530	HUMAN OTC DRUG	Lidocaine 5%		Lidocaine 5%	OINTMENT	TOPICAL	20190115		OTC MONOGRAPH FINAL	part346	WALGREENS CO.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-4531_1ecfec6d-2bf2-4960-8ec2-bb7d539478f0	0363-4531	HUMAN OTC DRUG	Nasal Decongestant	PE	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220121		OTC MONOGRAPH DRUG	M012	Walgreen Company	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
0363-4534_05d5ea08-575a-4ac2-af64-0547d09947cd	0363-4534	HUMAN OTC DRUG	Sinus PE Congestion		Diphenhydramine HCl, Phenylephrine HCl	KIT		20220119		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-4545_0cf99668-f6ca-9154-e063-6394a90a1680	0363-4545	HUMAN OTC DRUG	Walgreens Eye Drops Seasonal Relief 15mL		Tetrahydrozoline HCI, Zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20191009		OTC MONOGRAPH DRUG	M018	Walgreen Co.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-4546_0cf96ebf-f735-9152-e063-6394a90acad8	0363-4546	HUMAN OTC DRUG	Walgreens Eye Drops Maximum Redness Relief 15mL		Glycerin, Naphazoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20191010		OTC MONOGRAPH DRUG	M018	Walgreen Company	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0363-4547_0cf9a93e-0755-a2f2-e063-6394a90aec81	0363-4547	HUMAN OTC DRUG	Walgreens Eye Drops Advanced Relief 15mL		Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20191011		OTC MONOGRAPH DRUG	M018	Walgreen Company	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0363-4548_0cf9acd6-ec1e-a38e-e063-6394a90a8b91	0363-4548	HUMAN OTC DRUG	Walgreens Redness Relief Eye Drops 15mL		Glycerin, Naphazoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20191011		OTC MONOGRAPH DRUG	M018	Walgreen Company	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0363-4549_0cf9ab9d-6afb-a03f-e063-6394a90aba15	0363-4549	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops High Performance 15mL and twin pack		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20191015		OTC MONOGRAPH DRUG	M018	Walgreen Company	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
0363-4550_0cf9acd6-ec24-a38e-e063-6394a90a8b91	0363-4550	HUMAN OTC DRUG	Walgreens Eye Drops Original 15mL and twin pack		Tetrahydrozoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20191014		OTC MONOGRAPH DRUG	M018	Walgreens Company	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
0363-4551_0cf9c381-f52d-a547-e063-6394a90af8bd	0363-4551	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops Dry Eye 15mL and twin pack		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20191015		OTC MONOGRAPH DRUG	M018	Walgreen Company	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
0363-4560_eadec476-7e46-44bd-903d-af585da4ebbd	0363-4560	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20191031	20250228	ANDA	ANDA074916	Walgreens	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0363-4590_d6143a90-ba0f-44d7-aa18-2f6288b48ba0	0363-4590	HUMAN OTC DRUG	Daytime Cold and Cough and NightTime Cold and Congestion	Childrens	Brompheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl, Phenylephrine HCl	KIT		20220304		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-4621_cd43c454-9056-452d-8230-540b142708a2	0363-4621	HUMAN OTC DRUG	Sinus PE plus Allergy		Chlorpheniramine maleate and Phenylephrine HCl	TABLET	ORAL	20220125		OTC MONOGRAPH DRUG	M012	Walgreen Company	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-4661_ac664835-d695-44a4-af25-05717e23ce7d	0363-4661	HUMAN OTC DRUG	Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20200730		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-4663_f38120aa-6062-ddd6-e053-2a95a90aab4b	0363-4663	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel Pen	GEL	TOPICAL	20140315		OTC MONOGRAPH FINAL	part358B	Walgreen Company	SALICYLIC ACID	.17	g/g			N	20241231
0363-4666_517bfc3f-8b1c-4e79-9fdc-d9c43fb6091c	0363-4666	HUMAN OTC DRUG	Walgreens Dandruff Plus Conditioner 2 in 1 Dry Scalp	Anti-dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20230113		OTC MONOGRAPH FINAL	part358H	Walgreen Company	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-4670_3b88800d-71d0-4f52-8a7d-63ed85a920ce	0363-4670	HUMAN OTC DRUG	Daytime Nighttime Cold and Cough		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Doxylamine succinate	KIT		20200730		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-4673_bc4ad7db-6b86-47c1-9121-7a4d89079e70	0363-4673	HUMAN OTC DRUG	Walgreens Dandruff Plus Conditioner 2 in 1	Anti-dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20221205		OTC MONOGRAPH FINAL	part358H	Walgreen Company	PYRITHIONE ZINC	10	mg/mL			N	20241231
0363-4735_3cf982e2-4f3e-4414-8c1f-39fbd0415b0b	0363-4735	HUMAN OTC DRUG	Walgreens Zinc SPF 50		OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20160106		OTC MONOGRAPH NOT FINAL	part352	Walgreens	OCTOCRYLENE; ZINC OXIDE	4; 5	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-4801_07e3384a-4651-41f5-87ea-62661147c721	0363-4801	HUMAN OTC DRUG	Childrens Allergy Dye Free Wal-Dryl		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20181001	20240621	OTC MONOGRAPH FINAL	part341	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-4808_1fe60cec-c6c3-44ae-85cc-312c9c21e28f	0363-4808	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20220513		OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-4810_c9483cb0-249e-4b85-a1f3-ea36c07f1668	0363-4810	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20220513		OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-4816_efe55d57-b237-78f5-e053-2995a90a946a	0363-4816	HUMAN OTC DRUG	Walgreen Sterile Lubricant Drops 30 Count		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20140325		OTC MONOGRAPH FINAL	part349	Walgreen Company	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
0363-4837_c963ee69-2151-4f68-85f7-1be1b7f16b45	0363-4837	HUMAN OTC DRUG	Walgreen Cool n Heat Maximum Strength Pain Relieving		MENTHOL, UNSPECIFIED FORM	LIQUID	TOPICAL	20140109		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	MENTHOL, UNSPECIFIED FORM	160	mg/mL			N	20241231
0363-4851_d956d791-bd34-4768-b401-787e3966f20f	0363-4851	HUMAN OTC DRUG	Allergy Relief	Plus Congestion	Diphenhydramine HCl, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20211101		OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	25; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-4870_cc3b1341-eda4-47a3-a78e-2b17da7fc442	0363-4870	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190131	20240223	OTC MONOGRAPH FINAL	part347	Walgreens	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
0363-4923_c005ce51-9b89-46bd-bc3f-713bff7719cc	0363-4923	HUMAN OTC DRUG	allergy relief D12		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211020		ANDA	ANDA210719	Walgreen Company	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-5000_746ba792-d407-4730-8a4c-d48a9233e2f0	0363-5000	HUMAN OTC DRUG	Chocolated Laxative		Sennosides Stimulant Laxative	TABLET, CHEWABLE	ORAL	20140410		OTC MONOGRAPH NOT FINAL	part334	Walgreens	SENNOSIDES	15	mg/1			N	20241231
0363-5001_b9a3bbb2-6354-4e76-8c72-20d418dfd94b	0363-5001	HUMAN OTC DRUG	daytime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230708		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5009_e41b264b-d463-71fd-e053-2a95a90a615a	0363-5009	HUMAN OTC DRUG	Caffeine		Caffeine	TABLET	ORAL	20210928		OTC MONOGRAPH FINAL	part340	Walgreen Company	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-5012_e5dd5bd2-02bf-6c8b-881e-c8283a9021eb	0363-5012	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20180713	20240210	ANDA	ANDA208150	Walgreens	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0363-5027_c37001cb-e9e8-46dd-81e8-6fb6c446fd7e	0363-5027	HUMAN OTC DRUG	Severe Sinus	Daytime, Non-Drowsy	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5061_0b6911c4-4f97-4f29-8b31-d948626f133a	0363-5061	HUMAN OTC DRUG	Walgreens Pain Relief		BENZOCAINE	GEL	ORAL	20130319		OTC MONOGRAPH NOT FINAL	part356	Walgreens Company	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-5100_4eaa8aac-c731-4ee3-afa2-72985b6b41a0	0363-5100	HUMAN OTC DRUG	Infants Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20201204		ANDA	ANDA079058	Walgreens	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-5101_74633e85-a25b-45f5-af20-fd99fac760b1	0363-5101	HUMAN OTC DRUG	Childrens Pain and Fever	Dissolve Packs	Acetaminophen	POWDER	ORAL	20200129		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN	160	mg/1			N	20241231
0363-5123_659b4871-c763-4898-8b21-9ef22018be39	0363-5123	HUMAN OTC DRUG	arthritis pain relieving		diclofenac sodium	GEL	TOPICAL	20230201		ANDA	ANDA211253	Walgreen Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-5150_dc793108-68db-1323-e053-2995a90af598	0363-5150	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	GEL	TOPICAL	20190620		UNAPPROVED HOMEOPATHIC		WALGREENS CO.	ARNICA MONTANA	1	[hp_X]/g			N	20241231
0363-5220_6712cedb-9c09-4858-8fc4-63942ace1c2b	0363-5220	HUMAN OTC DRUG	dual pain reliever		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230310		ANDA	ANDA214836	Walgreen Company	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
0363-5260_1f3382f1-d67b-45a7-9b5a-2a7f8aee68ef	0363-5260	HUMAN OTC DRUG	Walgreens		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230301		NDA	NDA022015	WALGREEN COMPANY	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-5279_a4d94026-4682-4907-8dc3-77019ed07d12	0363-5279	HUMAN OTC DRUG	Sinus PE Pressure, Pain and Mucus		Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5300_51c7e6bc-bc52-447b-a6a4-92b474ad1119	0363-5300	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	WALGREEN CO.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-5301_07a99cc9-cf5b-4f2e-a857-396699d62024	0363-5301	HUMAN OTC DRUG	Walgreens Arthritis Pain Relief Cream		Histamine Dihydrochloride	CREAM	TOPICAL	20220430		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	HISTAMINE DIHYDROCHLORIDE	.00025	g/g			N	20241231
0363-5335_f1ffc068-9953-5382-e053-2995a90a1cd1	0363-5335	HUMAN OTC DRUG	Walgreens	Severe Oral Pain Reliever	Benzocaine	LIQUID	ORAL	20120110		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-5337_f1ffd08b-41db-5af5-e053-2995a90a63bc	0363-5337	HUMAN OTC DRUG	Walgreens	Maximum Strength	Benzocaine	PASTE, DENTIFRICE	TOPICAL	20130801		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-5350_f1ffbc60-13b6-2b82-e053-2995a90a9111	0363-5350	HUMAN OTC DRUG	Walgreens Instant Toothache and Gum Relief	Triple Medicated	Benzocaine, Menthol, Zinc chloride	CREAM	TOPICAL	20190306		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZOCAINE; MENTHOL; ZINC CHLORIDE	20; .25; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-5351_f1ffd54f-186c-32e0-e053-2a95a90a2e09	0363-5351	HUMAN OTC DRUG	Walgreens Instant Toothache and Gum Relief	Triple Medicated	Benzocaine, Menthol, Zinc chloride	GEL	TOPICAL	20190306		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZOCAINE; MENTHOL; ZINC CHLORIDE	20; .5; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-5353_f37fe401-300d-7846-e053-2995a90a92a9	0363-5353	HUMAN OTC DRUG	Miconazole Nitrate 2%		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20211028		OTC MONOGRAPH FINAL	part333C	Walgreens Company	MICONAZOLE NITRATE	1.3	g/131g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-5410_a54dfd1f-39f0-4e3b-87a6-43e20f72a8c3	0363-5410	HUMAN OTC DRUG	Nighttime Wal Flu Severe Cold and Cough		ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20180529		OTC MONOGRAPH DRUG	M010	WALGREEN CO.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5430_949b3a6f-6e20-490a-ae09-e6e476f98c3e	0363-5430	HUMAN OTC DRUG	Allergy Relief		ACETAMINOPHEN, DIPHENHYDRAMINE HCl, PHENYLEPHRINE HCl	TABLET, FILM COATED	ORAL	20211104		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5470_efb28a18-83d4-4e83-a76c-e231485a629e	0363-5470	HUMAN OTC DRUG	Multi Symptom Wal Flu Severe Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	POWDER, FOR SOLUTION	ORAL	20180531		OTC MONOGRAPH DRUG	M012	WALGREEN CO.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5480_88037b66-95b2-4b25-ac8e-07c77bbe50fe	0363-5480	HUMAN OTC DRUG	Multi Symptom Severe Cold and Nighttime Severe Cold and Cough		Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Phenylephrine HCl	KIT		20180622		OTC MONOGRAPH DRUG	M013	WALGREEN CO.						N	20241231
0363-5523_f3811a6a-24dc-7ed5-e053-2a95a90aba6c	0363-5523	HUMAN OTC DRUG	Salicylic Acid		Ultra Thin Corn Removers	PATCH	TOPICAL	20130730		OTC MONOGRAPH FINAL	part358F	Walgreens Company	SALICYLIC ACID	40	mg/91			N	20241231
0363-5527_a5dff2ea-b028-44dd-b97c-952d67195776	0363-5527	HUMAN OTC DRUG	Mucus Relief Cough	Childrens	Dextromethorphan HBr, Guaifensin	LIQUID	ORAL	20220225		OTC MONOGRAPH FINAL	part341	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-5528_b7005adf-dd26-7b08-d3e6-71e8440e5f90	0363-5528	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180312		ANDA	ANDA210375	Walgreens Company	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-5529_5086f31a-7713-8b78-cd39-4943b99d20c8	0363-5529	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180326		ANDA	ANDA210375	Walgreens Company	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-5557_d6bce8d9-dcdc-4800-e053-2995a90a65c1	0363-5557	HUMAN OTC DRUG	Saline Nasal moisturizing	Walgreens	Sodium Chloride	GEL	NASAL	20220113		UNAPPROVED DRUG OTHER		WALGREENS COMPANY	SODIUM CHLORIDE	.9	g/100mL			N	20241231
0363-5558_d6b9d517-d616-2b12-e053-2a95a90a97c3	0363-5558	HUMAN OTC DRUG	Sterile Saline Mist	Walgreens	Sodium Chloride	SPRAY	NASAL	20220113		UNAPPROVED DRUG OTHER		WALGREEN COMPANY	SODIUM CHLORIDE	.9	g/100g			N	20241231
0363-5580_1cc1011a-d72e-4619-9ffa-edde0571dfc5	0363-5580	HUMAN OTC DRUG	Sinus and Headache	Daytime, Non-Drowsy	Acetaminophen, Phenylephrine HCl	TABLET, COATED	ORAL	20080317		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5721_eb67dad9-2f92-d848-e053-2995a90a4a73	0363-5721	HUMAN OTC DRUG	Walgreens		Ethyl Alcohol	GEL	TOPICAL	20221019		OTC MONOGRAPH NOT FINAL	part333A	Walgreen	ALCOHOL	700	mg/mL			N	20241231
0363-5721_ec8139b3-2c89-2adc-e053-2a95a90ac7dc	0363-5721	HUMAN OTC DRUG	Walgreens		Ethyl Alcohol	GEL	TOPICAL	20221102		OTC MONOGRAPH NOT FINAL	part333A	walgreens	ALCOHOL	700	mg/mL			N	20241231
0363-5721_ecf7baaf-be61-820c-e053-2a95a90a5887	0363-5721	HUMAN OTC DRUG	Walgreens		Ethyl Alcohol	GEL	TOPICAL	20221019		OTC MONOGRAPH NOT FINAL	part333A	walgreens	ALCOHOL	700	mg/mL			N	20241231
0363-5722_28c17bee-81d7-4570-bbe8-a20c37c55935	0363-5722	HUMAN OTC DRUG	Walgreens Anorectal Lidocaine Cream		5% Lidocaine	CREAM	TOPICAL	20220430		OTC MONOGRAPH FINAL	part346	Walgreens Company	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-5760_d08ce335-fbe7-4136-b00a-473f9758df52	0363-5760	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210326		ANDA	ANDA210711	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-5770_f4d5f096-877d-4b1e-bf4b-ab1fc3763494	0363-5770	HUMAN OTC DRUG	Nicotine	Mini	Nicotine Polacrilex	LOZENGE	ORAL	20210820		ANDA	ANDA210711	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-5789_e33a37b0-9407-909f-e053-2a95a90aa493	0363-5789	HUMAN OTC DRUG	Ephedrine Sulfate		Ephedrine Sulfate	TABLET, FILM COATED	ORAL	20220722		OTC MONOGRAPH FINAL	part341	Walgreen Company	EPHEDRINE SULFATE	25	mg/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0363-5790_d4f196e0-1e7b-4b9e-93cb-3a2357705ebe	0363-5790	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20190131	20250228	OTC MONOGRAPH DRUG	M007	Walgreens	DOCUSATE SODIUM	100	mg/1			N	
0363-5820_f3bc66f4-4c05-6500-e053-2a95a90a5025	0363-5820	HUMAN OTC DRUG	Walgreens	Maximum Strength	Benzocaine	LIQUID	ORAL	20150101		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-5834_05ade52c-a184-087f-e063-6394a90ad7ae	0363-5834	HUMAN OTC DRUG	Acne Control		Cream	CREAM	TOPICAL	20230911		OTC MONOGRAPH FINAL	M006	Walgreen	SALICYLIC ACID	2000	mg/100mL			N	20241231
0363-5885_05c0fb6a-50c5-4ce9-e063-6294a90a8557	0363-5885	HUMAN OTC DRUG	Dry Skin Healing		Petrolatum	LOTION	TOPICAL	20230911		OTC MONOGRAPH FINAL	M016	Walgreen	PETROLATUM	41	g/100g			N	20241231
0363-5900_fc8db03a-48a4-4f23-a1cb-1ec70b0edc46	0363-5900	HUMAN OTC DRUG	nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20190629		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-5934_05c26712-dff9-49cf-e063-6394a90a6a87	0363-5934	HUMAN OTC DRUG	Daily Moisturizer		Lotion	LOTION	TOPICAL	20230911		OTC MONOGRAPH FINAL	M016	Walgreen	DIMETHICONE	1200	mg/100mL	Skin Barrier Activity [PE]		N	20241231
0363-5960_42f6b76f-21c4-4a29-8b7f-81885f2b1190	0363-5960	HUMAN OTC DRUG	Soothe	childrens	Calcium carbonate	TABLET, CHEWABLE	ORAL	20180801		OTC MONOGRAPH DRUG	M001	Walgreen Company	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-5990_05c25955-5c35-43eb-e063-6294a90aad2e	0363-5990	HUMAN OTC DRUG	Daily Moisturizer		Lotion	LOTION	TOPICAL	20230911		OTC MONOGRAPH FINAL	M016	Walgreen	DIMETHICONE	1200	mg/100mL	Skin Barrier Activity [PE]		N	20241231
0363-5995_05c1e8f0-68ca-4432-e063-6294a90a4c0e	0363-5995	HUMAN OTC DRUG	Skin Relief		Lotion	LOTION	TOPICAL	20230911		OTC MONOGRAPH FINAL	M016	Walgreen	DIMETHICONE	1200	mg/100mL	Skin Barrier Activity [PE]		N	20241231
0363-6005_cdd3cce3-ed2f-45bf-8e97-8923a76ac71f	0363-6005	HUMAN OTC DRUG	Mucus Relief DM Honey and Berry Flavor		Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20210202		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-6008_f214fb90-c3bf-3dc6-e053-2995a90a96b1	0363-6008	HUMAN OTC DRUG	4x Medicated Toothache and Gum Gel		Benzocaine	GEL	ORAL	20200602		OTC MONOGRAPH NOT FINAL	part356	Walgreens	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .5; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0363-6028_8d8146d3-8801-4f59-951e-394e656e3842	0363-6028	HUMAN OTC DRUG	Sinus Pressure and Pain		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20130503		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6045_9d129bb6-61dd-47ee-a51a-5762ae87fdd9	0363-6045	HUMAN OTC DRUG	Walgreens EXTRA THICK Callus Removers		Salicylic acid	PATCH	TOPICAL	20231018		OTC MONOGRAPH DRUG	M030	Walgreen Co.	SALICYLIC ACID	.23	g/1			N	20241231
0363-6048_48e901f0-1632-4832-9b7b-25e4fb22a80a	0363-6048	HUMAN OTC DRUG	Severe Congestion and Cough		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20150720		OTC MONOGRAPH DRUG	M012	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6099_fa1203e6-566b-b989-e053-6294a90ac8aa	0363-6099	HUMAN OTC DRUG	ALL DAY PAIN RELIEF		NAPROXEN SODIUM	TABLET, COATED	ORAL	20190630		ANDA	ANDA090545	WALGREENS	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-6101_ef7892f0-4389-4c7a-bc74-dabebce4b128	0363-6101	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20230309		NDA	NDA022032	Walgreen Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-6105_1f5a930b-880a-46e6-bcbc-d08ddc314ba6	0363-6105	HUMAN OTC DRUG	Walgreen Day Time NightTime Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride,Guaifenesin	KIT		20210210		OTC MONOGRAPH FINAL	part341	WALGREENS CO.						N	20241231
0363-6141_3f638040-4e55-40af-b8e0-7195095eb9f4	0363-6141	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210923		OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-6142_ae6d08e2-f3e8-4120-bbec-ba3d5a7459e3	0363-6142	HUMAN OTC DRUG	Walgreen NightTime	Cold and Flu relief	acetaminophen, dextromethorphan HBr, doxylamine succinate, and phenylephrine hydrochloride	SOLUTION	ORAL	20230417		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6150_950afd37-8770-4672-9cd3-68ea01610a87	0363-6150	HUMAN OTC DRUG	Severe Sinus Congestion		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20130630		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6156_9a1e661a-8a88-477a-91d4-b40978aab2b9	0363-6156	HUMAN OTC DRUG	Sinus Pressure and Pain	Daytime Nighttime Maximum Strength	Acetaminophen, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20180602		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-6156_9c11e4ac-912d-408f-b4ea-6d9d5db5da70	0363-6156	HUMAN OTC DRUG	Sinus Pressure and Pain	Daytime Nighttime Maximum Strength	Acetaminophen, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20180602		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-6171_a4945b85-e23b-4cba-9783-9ed21894213a	0363-6171	HUMAN OTC DRUG	Sinus Pressure, Pain and Cough		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220414		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6190_c6c307b4-a034-40f1-a9a3-b0c024c7951b	0363-6190	HUMAN OTC DRUG	Walgreens High Blood Pressure	Cold and Flu	Acetaminophen, Dextromethorphan	LIQUID	ORAL	20230303		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/30mL; mg/30mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-6210_48a90ca9-6300-4351-b47a-6087880d6e16	0363-6210	HUMAN OTC DRUG	Walgreen High Blood Pressure Nighttime	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate	LIQUID	ORAL	20230303		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-6220_084460e4-0a1f-4b83-93c2-79caf434af31	0363-6220	HUMAN OTC DRUG	WAG HBP Daytime and Nighttime	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	KIT		20230310		OTC MONOGRAPH DRUG	M013	WALGREENS CO.						N	20241231
0363-6238_a7df9577-d092-4107-a403-16525269b390	0363-6238	HUMAN OTC DRUG	Walgreen Daytimel Kids	Cold Cough plus Mucus	GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	LIQUID	ORAL	20230301		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6248_f28cbe36-000c-4d09-979d-02fd3ce47862	0363-6248	HUMAN OTC DRUG	Walgreens Nighttime Kids	Honey Cold Cough Congestion	Doxylamine Succinate, Phenylephrine Hydrochloride and Dextromethorphan Hydrobromide	LIQUID	ORAL	20230301		OTC MONOGRAPH DRUG	M012	WALGREENS CO	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6300_a5922f2c-2a19-4f6e-a5ad-d124c95800c4	0363-6300	HUMAN OTC DRUG	Walgreen Severe Multi-Symptom Cough Cold Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20221101		OTC MONOGRAPH DRUG	M013	WALGREENS	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-6330_52ec4298-44ef-4440-b625-8bf16ed11e86	0363-6330	HUMAN OTC DRUG	Walgreens Ice Blue Pain Relieving	Topical Analgesic	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20151118		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	MENTHOL, UNSPECIFIED FORM	20	mg/g			N	20241231
0363-6406_06b30f35-0bb5-460e-a3ef-3e89bd11d5d1	0363-6406	HUMAN OTC DRUG	Cold and Flu	Daytime, Nighttime, Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Guaifenesin, Phenylephrine HCl	KIT		20150801		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-6406_f76f518f-40ff-4cf2-a473-49c8724b9796	0363-6406	HUMAN OTC DRUG	Cold and Flu	Daytime, Nighttime, Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Guaifenesin, Phenylephrine HCl	KIT		20150801		OTC MONOGRAPH DRUG	M012	Walgreen Company						N	20241231
0363-6450_03fe828f-e674-40ad-88c7-a32a41f8544c	0363-6450	HUMAN OTC DRUG	Aspirin	Enteric Coated Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20140725		OTC MONOGRAPH DRUG	M013	Walgreen Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-6452_dfa538f5-88a4-f138-e053-2995a90acb92	0363-6452	HUMAN OTC DRUG	Aspirin 81		Aspirin	TABLET	ORAL	20220615		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-6453_dfa65626-0d4d-b7df-e053-2a95a90ac1d5	0363-6453	HUMAN OTC DRUG	Aspirin 325 mg		Aspirin	TABLET	ORAL	20220615		OTC MONOGRAPH NOT FINAL	part343	WALGREENS	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-6455_0c86d49a-27b4-7f18-e063-6394a90ad534	0363-6455	HUMAN OTC DRUG	Dye-Free Aspirin 81		Aspirin	TABLET	ORAL	20220615		OTC MONOGRAPH DRUG	M013	WALGREENS	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0363-6500_d2064ddd-4a37-6d87-e053-2995a90a5d84	0363-6500	HUMAN OTC DRUG	Homeopathic Medicine Yeast Relief Plus		Candida Albicans, Wood Creosote, Sodium Chloride, and Sulfur	TABLET	ORAL	20170518		UNAPPROVED HOMEOPATHIC		WALGREEN CO.	CANDIDA ALBICANS; SODIUM CHLORIDE; SULFUR; WOOD CREOSOTE	30; 12; 12; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
0363-6501_d6c006cd-b3f5-13a9-e053-2a95a90a7ca4	0363-6501	HUMAN OTC DRUG	WALGREENS NATURAL YEAST TREATMENT		Calendula, Melaleuca	OINTMENT	VAGINAL	20211230		UNAPPROVED HOMEOPATHIC		WALGREENS	CALENDULA OFFICINALIS FLOWERING TOP; CHAMOMILE; MELALEUCA CAJUPUTI WHOLE; OLIVE OIL	3; 3; 3; 3	[hp_X]/14g; [hp_X]/14g; [hp_X]/14g; [hp_X]/14g	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
0363-6504_6a833ff4-6a49-45a6-9c6d-6e1105011c3c	0363-6504	HUMAN OTC DRUG	Walgreen Childrens	COLD PLUS COUGH PLUS SORE THROAT	Acetaminophen and Dextromethorphan Hydrobromide	SUSPENSION	ORAL	20230224		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	160; 5	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-6510_6714201a-c99e-4a79-9e9a-60235bdae515	0363-6510	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230707		ANDA	ANDA212385	Walgreens	DOCOSANOL	100	mg/g			N	20241231
0363-6720_d984a83d-ff4e-440c-9d84-76b9d4308840	0363-6720	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20220318		OTC MONOGRAPH DRUG	M010	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-6760_c060151f-6dbd-4e01-bfbf-9cc084a380c1	0363-6760	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	Walgreen Company	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-6770_10c2adaa-d068-44d6-a683-16243128a1a0	0363-6770	HUMAN OTC DRUG	Cold and Flu	Severe, Nighttime, Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20150801	20240209	OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
0363-6812_ba200f15-56dd-4b4d-9f3f-1340f3cb73a5	0363-6812	HUMAN OTC DRUG	mucus relief dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20181221		ANDA	ANDA207602	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-6855_f53cff10-373a-0b30-e053-2995a90aaf2b	0363-6855	HUMAN OTC DRUG	Walgreens PM Lubricant Eye		mineral oil and white petrolatum	OINTMENT	OPHTHALMIC	20210615		OTC MONOGRAPH FINAL	part349	Walgreen Company	MINERAL OIL; PETROLATUM	30; 940	mg/g; mg/g			N	20241231
0363-6890_17dba440-3130-4bac-888c-e79778f16a23	0363-6890	HUMAN OTC DRUG	Cough and Cold HBP	Maximum Strength	Chlorpheniramine Maleate, Dextromethorphan Hbr	TABLET, COATED	ORAL	20170515	20240609	OTC MONOGRAPH FINAL	part341	Walgreen Company	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
0363-6950_3800032d-554d-4bdf-9dfa-4a4b914c8e55	0363-6950	HUMAN OTC DRUG	WalgreenChildrens Pain Fever		Acetaminophen	SUSPENSION	ORAL	20230217		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-6958_b8d35a73-8553-4687-a2b6-e41466a03100	0363-6958	HUMAN OTC DRUG	Walgreen Childrens Pain plus Fever		Acetaminophen	SUSPENSION	ORAL	20230224		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-6980_71a68394-b974-4d30-b5ba-e9812f1f592a	0363-6980	HUMAN OTC DRUG	Overnight Cold and Flu		Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20200128		OTC MONOGRAPH DRUG	M010	WALGREENS CO	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7020_44a2e79e-606d-4cd2-ac13-eccfa3b2f678	0363-7020	HUMAN OTC DRUG	Walgreen Maximum strength	pain relieving cleansing	benzalkonium chloride and lidocaine hydrochloride	LIQUID	TOPICAL	20210930		OTC MONOGRAPH DRUG	M015	WALGREENS CO.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-7023_3bade7ab-c107-49e8-afc4-a6d1d9dbb9d2	0363-7023	HUMAN OTC DRUG	allergy relief d 12		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211020		ANDA	ANDA076050	Walgreen Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-7024_5df3574e-49d8-4ef4-b06e-e1f072f695dc	0363-7024	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20231130		OTC MONOGRAPH FINAL	part335	Walgreens	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-7030_edf48f83-bc56-4011-b327-a1d030b3873d	0363-7030	HUMAN OTC DRUG	Walgreens Sore Throat	Cherry Flavor	Phenol	SPRAY	ORAL	20230301		OTC MONOGRAPH DRUG	M022	WALGREEN COMPANY	PHENOL	1.4	g/100mL			N	20241231
0363-7040_64a3c34a-b794-427e-bc0b-ce9b837be10d	0363-7040	HUMAN OTC DRUG	Walgreens Saline		Nasal	SPRAY	NASAL	20221101		OTC MONOGRAPH DRUG	M022	WALGREEN COMPANY	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
0363-7043_c3852740-5ea1-4e6e-89d6-dbdde4b482de	0363-7043	HUMAN OTC DRUG	Walgreen	Cherry	Guaifenesin	SYRUP	ORAL	20221101		OTC MONOGRAPH DRUG	M012	WALGREEN COMPANY	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-7064_f026e443-547b-ebee-2f66-7cabf4a56b1e	0363-7064	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20190710		ANDA	ANDA208369	Walgreens Company	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-7065_c1691d67-c0aa-69eb-9583-de5a8be6bd88	0363-7065	HUMAN OTC DRUG	Diclofenac Sodium Topical Gel 1%		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20200914		ANDA	ANDA210986	Walgreens Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-7071_2df15f1f-412f-457d-b176-e3103ca9f0a2	0363-7071	HUMAN OTC DRUG	Walgreen Stomach Relief	Ultra Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20231016		OTC MONOGRAPH DRUG	M008	WALGREENS CO.	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-7080_490cc206-9dc5-450b-ac28-15575a6615fc	0363-7080	HUMAN OTC DRUG	Walgreen Anti Nausea	Cherry Flavor	phosphorated carbohydrate	SOLUTION	ORAL	20231016		UNAPPROVED DRUG OTHER		WALGREENS CO.	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
0363-7100_0d8d3cd3-ac33-4385-bb0e-ffebbb011d03	0363-7100	HUMAN OTC DRUG	Adult Allergy Relief	Dye Free	Diphenhydramine Hydrochloride	SOLUTION	ORAL	20200130		OTC MONOGRAPH DRUG	M012	WALGREEN COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-7103_7688e15d-81e0-4cf1-93d2-0c419a0adf13	0363-7103	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230611		ANDA	ANDA206393	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-7120_44312f5a-1d22-4e14-9ee2-38c7743c98e1	0363-7120	HUMAN OTC DRUG	Walgreens Senna Laxative		SENNOSIDES	LIQUID	ORAL	20190409		OTC MONOGRAPH DRUG	M007	WALGREENS CO.	SENNOSIDES	25	mg/15mL			N	20241231
0363-7130_d64477d0-facf-4347-d194-24651e6e9f2d	0363-7130	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200915		ANDA	ANDA209619	Walgreens Company	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
0363-7131_05dbf20e-0a5e-29c4-03b9-bbef3511296f	0363-7131	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20201001		ANDA	ANDA209752	Walgreens Company	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
0363-7140_00eb8e8c-8030-43ee-8197-b8599b01bedd	0363-7140	HUMAN OTC DRUG	Walgreens Stool Softener	Fruit Punch	Docusate sodium	LIQUID	ORAL	20190425		OTC MONOGRAPH DRUG	M007	WALGREENS CO.	DOCUSATE SODIUM	50	mg/5mL			N	20241231
0363-7151_dbd02b7f-fc62-42f9-b25b-8befd6a839bd	0363-7151	HUMAN OTC DRUG	Walgreen		Nasal	SPRAY	NASAL	20200129		OTC MONOGRAPH DRUG	M012	WALGREENS CO	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0363-7162_6b7aeea6-04b3-40a1-8da7-8cce05706528	0363-7162	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Walgreen Co	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-7174_fea42376-8bbc-55c2-e053-6294a90ae2c5	0363-7174	HUMAN OTC DRUG	LEG CRAMPS PM		oyster shell calcium carbonate, crude, causticum, matricaria recutita, cinchona officinalis bark, copper, lycopodium clavatum spore, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, silicon dioxide, and sulfur	TABLET	ORAL	20230521		UNAPPROVED HOMEOPATHIC		Walgreen Company	CAUSTICUM; CINCHONA OFFICINALIS BARK; COPPER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; SULFUR; TOXICODENDRON PUBESCENS LEAF	12; 3; 12; 12; 6; 6; 12; 12; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-7213_0c0623fb-df1a-a4da-e063-6294a90a41d2	0363-7213	HUMAN OTC DRUG	TENSION HEADACHE RELIEF		ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20201117		OTC MONOGRAPH DRUG	M013	WALGREENS	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-7214_0c060dc6-7ccb-92be-e063-6294a90a2b27	0363-7214	HUMAN OTC DRUG	EXTRA STRENGTH HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20201117		OTC MONOGRAPH DRUG	M013	WALGREENS	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-7240_41e152f6-d756-4258-9605-dff9af0932a7	0363-7240	HUMAN OTC DRUG	Soothe		Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH DRUG	M008	Walgreens	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-7269_35160037-d1b6-464f-88eb-af9ffe83ef54	0363-7269	HUMAN OTC DRUG	NICOTINE		nicotine polacrilex	GUM, CHEWING	ORAL	20190524		ANDA	ANDA206394	Walgreen Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-7270_4384c3c3-b566-43a4-a799-ca85a1f354c4	0363-7270	HUMAN OTC DRUG	Daytime Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, GUAIFENESIN PHENYLEPHRINE HCL	LIQUID	ORAL	20210202		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-7296_97d98d43-fc2a-4ac5-9524-b577826c7185	0363-7296	HUMAN OTC DRUG	Walgreen	Cough and Chest Congestion	Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20220310		OTC MONOGRAPH DRUG	M012	WALGREEN COMPANY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7300_c088615f-d9d6-4f17-bf65-f879a828a3ed	0363-7300	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	SOLUTION	ORAL	20200125		OTC MONOGRAPH DRUG	M010	WALGREEN COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-7370_8dc6838c-7f9e-41cc-9c9d-4f92bdf00856	0363-7370	HUMAN OTC DRUG	Soothe	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20200131		OTC MONOGRAPH DRUG	M008	Walgreens	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-7380_67a79f65-7b7b-4da2-aeb5-d0e42ad6a3de	0363-7380	HUMAN OTC DRUG	Flu HBP	Maximum Strength	Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20200319		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7390_4742eb5b-18c7-4f64-a743-7e6bdd57fb68	0363-7390	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr and Guaifenesin	SOLUTION	ORAL	20200129		OTC MONOGRAPH DRUG	M012	WALGREENS CO	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7400_76c63b31-bc3a-46e1-a301-8bb2598f7ba4	0363-7400	HUMAN OTC DRUG	Wal-Sleep Z Pain Relief		ACETAMINOPHEN, DIPHENHYDRAMINE HCl	SOLUTION	ORAL	20210602	20240215	OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0363-7418_f3829015-9d04-4882-e053-2a95a90ac381	0363-7418	HUMAN OTC DRUG	Miconazole Nitrate		Antifungal Miconazole Powder Spray	AEROSOL, SPRAY	TOPICAL	20211014		OTC MONOGRAPH FINAL	part333C	Walgreens Company	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-7440_04f92dbf-fbf9-4d53-8de1-ef0d524b5225	0363-7440	HUMAN OTC DRUG	WALGREEN ADULT COUGH PLUS CHEST CONGESTION DM		dextromethorphan hydrobromide and guaifenesin	SOLUTION	ORAL	20221101		OTC MONOGRAPH DRUG	M012	WALGREEN COMPANY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7470_788327a0-723c-4b80-b281-5873de0b6905	0363-7470	HUMAN OTC DRUG	Walgreens	Grape Flavor	Children Cough and Chest Congestion	LIQUID	ORAL	20190515		OTC MONOGRAPH DRUG	M012	WALGREENS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7480_48de1a3f-9b76-482f-8a4b-f5cc59508b8a	0363-7480	HUMAN OTC DRUG	Walgreens		Childrens Stuffy Nose and Cold	SOLUTION	ORAL	20190515		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	100; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-7500_f54b327c-f2e3-229e-e053-2995a90ac85c	0363-7500	HUMAN OTC DRUG	Walgreens Sodium Chloride Ophthalmic 5 Percent Hypertonicity Eye		Sodium Chloride	OINTMENT	OPHTHALMIC	20190401		OTC MONOGRAPH FINAL	part349	Walgreen Company	SODIUM CHLORIDE	50	mg/g			N	20241231
0363-7504_af084134-84a3-4ec7-9a2b-19694fd3e98f	0363-7504	HUMAN OTC DRUG	Childrens Chest Congestion Relief		Guaifenesin	SOLUTION	ORAL	20200129		OTC MONOGRAPH DRUG	M012	WALGREENS COMPANY	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0363-7510_e5a5fe51-e1a2-4103-b1f5-2a2d33e79307	0363-7510	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20200131		ANDA	ANDA202807	Walgreens	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-7550_9e4ea31a-f035-4aa0-a91f-bad31a6f30a5	0363-7550	HUMAN OTC DRUG	Walgreens Daytime	Childrens	Cough and Chest Congestion	LIQUID	ORAL	20190716		OTC MONOGRAPH DRUG	M012	WALGREENS CO.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7560_f1772a01-e992-4797-8a5e-3f4a2770b397	0363-7560	HUMAN OTC DRUG	Walgreens Childrens		Nighttime Cough	LIQUID	ORAL	20190716		OTC MONOGRAPH DRUG	M010	WALGREENS CO.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7590_0e2862aa-fda5-4b01-b279-342afb7b9703	0363-7590	HUMAN OTC DRUG	Walgreen Saline		Nasal	SPRAY	NASAL	20210222		OTC MONOGRAPH DRUG	M022	WALGREENS CO.	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
0363-7630_ea4c3063-0eae-452a-bcab-b33c58f3c237	0363-7630	HUMAN OTC DRUG	Walgreens Fast Acting Heartburn Relief Extra Strength		aluminum hydroxide and magnesium carbonate	LIQUID	ORAL	20180115		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
0363-7730_f3812d0d-f85b-0d90-e053-2a95a90aa5bc	0363-7730	HUMAN OTC DRUG	Salicylic Acid		Extra Thick Callus Removers	PATCH	TOPICAL	20120816		OTC MONOGRAPH FINAL	part358F	Walgreen Company	SALICYLIC ACID	40	mg/41			N	20241231
0363-7731_f3825e9a-aef6-728d-e053-2995a90a850e	0363-7731	HUMAN OTC DRUG	Undecylenic Acid		Anti-Fungal Liquid	LIQUID	TOPICAL	20120816		OTC MONOGRAPH FINAL	part333C	Walgreen Company	UNDECYLENIC ACID	.25	g/g			N	20241231
0363-7760_15aea922-ecbc-4059-a9ae-d0aec98f3e5f	0363-7760	HUMAN OTC DRUG	Walgreens Maximum Strength Severe Congestion and Cough		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20230301		OTC MONOGRAPH DRUG	M012	WALGREEN COMPANY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-7775_d535d8dc-56ba-45b9-b809-971dd5b61890	0363-7775	HUMAN OTC DRUG	Walgreens Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Walgreens Co.	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
0363-7776_23490017-a59a-415b-b402-02fbc44e2fda	0363-7776	HUMAN OTC DRUG	Walgreens Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20150115		UNAPPROVED DRUG OTHER		Walgreens	PHENAZOPYRIDINE HYDROCHLORIDE	97.5	mg/1			N	20241231
0363-7790_630de116-4838-462e-9abb-cdbb1f7a834d	0363-7790	HUMAN OTC DRUG	Walgreen Pain Relieving	Fragrance Free	Lidocaine Hydrochloride	LIQUID	TOPICAL	20190516		OTC MONOGRAPH DRUG	M015	WALGREENS CO.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-7801_0d82d9c4-814c-ed9b-e063-6294a90a6522	0363-7801	HUMAN OTC DRUG	Walgreens Cool n Heat Lidocaine		Lidocaine HCl 4%	GEL	TOPICAL	20231227		OTC MONOGRAPH DRUG	M017	Walgreens Co	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-7920_d65d7127-20cc-40a9-ba19-29ce4ee39d18	0363-7920	HUMAN OTC DRUG	Walgreens Childrens	Cold plus Cough plus Runny Nose	Acetaminophen, Chlorpheniramine Maleate, and Dextromethorphan Hydrobromide	SUSPENSION	ORAL	20230224		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-7950_e1434957-eda4-4599-908f-e0392110f815	0363-7950	HUMAN OTC DRUG	Walgreens		First Aid Antiseptic	SPRAY	TOPICAL	20190516		OTC MONOGRAPH DRUG	M015	Walgreens	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 25	g/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-7971_89ed1949-2eae-4886-a8d2-4f0ce3ad9285	0363-7971	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190524		ANDA	ANDA206393	Walgreen Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-8004_441f8893-fdcd-4986-92a0-0a8fc9990c72	0363-8004	HUMAN OTC DRUG	Severe Congestion and Cough		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20231004		OTC MONOGRAPH DRUG	M012	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-8005_db74748b-cdff-4a3d-bd8a-455b2d20f55a	0363-8005	HUMAN OTC DRUG	Cold, Flu and Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20231004		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-8010_333707e7-77d5-4836-a77c-92f23f6fb85c	0363-8010	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20210917		ANDA	ANDA211075	Walgreens	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-8018_b5b3606f-f66c-482e-b612-9f1b0427416b	0363-8018	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20230518		OTC MONOGRAPH DRUG	M012	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-8020_8494109f-165f-450c-baaf-517c683f5c22	0363-8020	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20220310		OTC MONOGRAPH DRUG	M010	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-8022_05bd85c5-75a0-43d2-9273-578eec5e00d3	0363-8022	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	WALGREEN CO.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
0363-8031_3fcc3e52-6972-44e3-93d8-4cff3f36b1a5	0363-8031	HUMAN OTC DRUG	DM Max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20231003		OTC MONOGRAPH DRUG	M012	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-8042_f3813de4-9413-894e-e053-2995a90ac1f6	0363-8042	HUMAN OTC DRUG	Tolnaftate		Athletes Foot Liquid	SPRAY	TOPICAL	20090311		OTC MONOGRAPH FINAL	part333C	Walgreens Company	TOLNAFTATE	1.5	g/150g			N	20241231
0363-8063_503e841c-4de9-457c-85d3-53a765f2cc82	0363-8063	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20231023		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-8078_585bee94-4df8-419e-b336-968fd36b3424	0363-8078	HUMAN OTC DRUG	Cold and Flu	Severe	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Triprolidine HCl	SOLUTION	ORAL	20231021		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-8079_feac2f15-fbc2-4b08-8739-fe2b0967b815	0363-8079	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20221229		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
0363-8164_0503905b-17eb-4071-b82c-e3a7c2fe65e4	0363-8164	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Walgreens	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-8166_e5e15c94-10d5-45e0-88bf-5eb273faacb9	0363-8166	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Walgreen Co	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-8190_f41e72d0-72db-fb20-e053-2a95a90ac700	0363-8190	HUMAN OTC DRUG	Walgreens Chap Aid Moisturizer		octinoxate, oxybenzone, white petrolatum	STICK	TOPICAL	20150701		OTC MONOGRAPH FINAL	part352	Walgreen Company	OCTINOXATE; OXYBENZONE; PETROLATUM	75; 35; 407	mg/g; mg/g; mg/g			N	20241231
0363-8217_f3812d0d-f859-0d90-e053-2a95a90aa5bc	0363-8217	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20080623		OTC MONOGRAPH FINAL	part358F	Walgreen Company	SALICYLIC ACID	.17	g/g			N	20241231
0363-8319_a6d952b3-3479-44c8-bcd9-44c155fc8c6a	0363-8319	HUMAN OTC DRUG	wal flu severe cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20180916		OTC MONOGRAPH FINAL	part341	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-8350_f4ad7573-55d0-14fb-e053-2a95a90a1013	0363-8350	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220812		OTC MONOGRAPH FINAL	part341	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-8395_8ce69fbe-f516-4a68-8272-8dd3872ac0e9	0363-8395	HUMAN OTC DRUG	Walgreens Eczema Relief Body	Skin Protectant	Oatmeal	CREAM	TOPICAL	20210806		OTC MONOGRAPH FINAL	part347	Walgreen Company	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0363-8455_25724e65-d70c-4e0f-bead-ab06e70b36c9	0363-8455	HUMAN OTC DRUG	Wallgreens Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20191010		UNAPPROVED DRUG OTHER		Walgreens Co.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
0363-8530_5e55b927-377c-41ee-840f-83ff0a844b0e	0363-8530	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM	100	mg/1			N	20241231
0363-8540_1b4d178c-86e5-4784-a50b-7a3f4be7e52a	0363-8540	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM	100	mg/1			N	20241231
0363-8550_6a699f4a-bb20-4d52-9df8-2d6cab82142a	0363-8550	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0363-8588_f381387f-ffa4-975a-e053-2a95a90ac447	0363-8588	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus No-Touch	AEROSOL, SPRAY	TOPICAL	20130312		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/177mL; mg/177mL; mg/177mL			N	20241231
0363-8712_78103d75-c0fe-4a9b-856f-48f6f8f57426	0363-8712	HUMAN OTC DRUG	Walgreens Pain Relief Powder		Aspirin and Caffeine	POWDER	ORAL	20210325		OTC MONOGRAPH NOT FINAL	part343	Walgreens Co.	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-8730_1290c791-e840-48c4-a860-d547fd658a00	0363-8730	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200430		OTC MONOGRAPH FINAL	part332	Walgreens	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-8740_bd326ef5-40e8-4d7d-bff8-9bf76c290038	0363-8740	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH FINAL	part332	Walgreens	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-8750_c822ab55-2fbc-4b9c-9908-802e8a99648c	0363-8750	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20210930		OTC MONOGRAPH DRUG	M007	Walgreens	SENNOSIDES	8.6	mg/1			N	20241231
0363-8760_a36b377d-a52e-439a-9fc1-110fddc1cc45	0363-8760	HUMAN OTC DRUG	Senna S		Docusate Sodium, Sennosides	TABLET	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0363-8780_9293d8f3-9775-40ae-bbc0-cdb00ac31c61	0363-8780	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part334	Walgreens	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0363-8800_0cf9a93e-075b-a2f2-e063-6394a90aec81	0363-8800	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops Preservative Free		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20191201		OTC MONOGRAPH DRUG	M018	Walgreen Company	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
0363-8820_096ee142-658c-42fa-aae2-e9bf570c9533	0363-8820	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20210930		OTC MONOGRAPH DRUG	M007	Walgreens	SENNOSIDES	8.6	mg/1			N	20241231
0363-8832_f53d23d5-6412-1e52-e053-2a95a90a253e	0363-8832	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20200411		OTC MONOGRAPH FINAL	part349	Walgreen Company	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
0363-8833_f53d367e-68e3-1ae0-e053-2995a90a24f5	0363-8833	HUMAN OTC DRUG	Walgreens Lubricant Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20200411		OTC MONOGRAPH FINAL	part349	Walgreen Company	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
0363-8877_05820cd5-ba73-4d93-b6f6-2465de0fa44b	0363-8877	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230707		ANDA	ANDA208754	Walgreens	DOCOSANOL	100	mg/g			N	20241231
0363-8888_40ffa0b9-e6fa-43d0-904d-dae4477e6c40	0363-8888	HUMAN OTC DRUG	Triple Antibiotic	Plus Pain Relief	bacitracin zinc, neomycin sulfate, polymyxin B sulfate, and pramoxine hydrochloride	OINTMENT	TOPICAL	20120331		OTC MONOGRAPH FINAL	part333B	Walgreen Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0363-8970_f54b706e-5fcf-4c86-b624-b675b6c411b5	0363-8970	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH FINAL	part347	Walgreens	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-8980_63b239ad-26a5-4374-82a3-3bc3f6cf0f55	0363-8980	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Walgreens	DOCOSANOL	100	mg/g			N	20251231
0363-8989_0c05e2a4-2660-76f1-e063-6294a90a8eb5	0363-8989	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20201222		OTC MONOGRAPH DRUG	M010	WALGREEN COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-8990_0c060dc6-7cca-92be-e063-6294a90a2b27	0363-8990	HUMAN OTC DRUG	Cough Relief		DEXTROMETHORPHAN HBr	CAPSULE, LIQUID FILLED	ORAL	20201222		OTC MONOGRAPH DRUG	M012	WALGREEN COMPANY	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-8991_0c05e920-ffa4-7bd4-e063-6294a90aad3e	0363-8991	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20201222		OTC MONOGRAPH DRUG	M007	WALGREEN COMPANY	DOCUSATE SODIUM	100	mg/1			N	20241231
0363-8992_0c05d68c-0fde-50d9-e063-6294a90a1b4c	0363-8992	HUMAN OTC DRUG	EXTRA STRENGTH HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20210205		OTC MONOGRAPH DRUG	M013	WALGREENS	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0363-8996_0c7fe76a-62d3-0321-e063-6394a90a0b3f	0363-8996	HUMAN OTC DRUG	SEVERE DAYTIME COLD and FLU	DAYTIME MAXIMUM STRENGTH NON-DROWSY SEVERE	ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210823		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-8997_0c068aaa-8e01-fed6-e063-6294a90a28ca	0363-8997	HUMAN OTC DRUG	SEVERE NIGHTTIME COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20210823		OTC MONOGRAPH DRUG	M012	WALGREENS	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-8998_0c06b40e-a070-3feb-e063-6294a90a6f9f	0363-8998	HUMAN OTC DRUG	Daytime Non-Drowsy Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210823		OTC MONOGRAPH DRUG	M012	Walgreens Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-8999_0c06c239-c4d6-d107-e063-6394a90af381	0363-8999	HUMAN OTC DRUG	Walgreens NightTime Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20210823		OTC MONOGRAPH DRUG	M012	WALGREEN COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-9011_0c7eceaf-ae69-7003-e063-6294a90ab81a	0363-9011	HUMAN OTC DRUG	Cold and Flu	Daytime, Nighttime, Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	KIT		20210824		OTC MONOGRAPH DRUG	M012	Walgreens						N	20241231
0363-9012_0c40c3d0-b833-850d-e063-6394a90abd9f	0363-9012	HUMAN OTC DRUG	Cold and Flu	Daytime, Nighttime, Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	KIT		20210824		OTC MONOGRAPH DRUG	M012	Walgreens						N	20241231
0363-9013_0c06882b-a4e4-edb6-e063-6294a90ac15d	0363-9013	HUMAN OTC DRUG	MUCUS RELIEF DM		GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20210824		OTC MONOGRAPH DRUG	M012	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-9016_0c068849-08f0-ca22-e063-6394a90ac04d	0363-9016	HUMAN OTC DRUG	COLD, Flu and Sore Throat		ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210824		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9017_0c069179-fc79-cf6b-e063-6394a90aeaeb	0363-9017	HUMAN OTC DRUG	Maximum Strength Cold and Flu		ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210824		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9018_0c064a69-ed9b-bc0e-e063-6394a90a3650	0363-9018	HUMAN OTC DRUG	Severe Congestion Relief		ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210824		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9019_0c06534b-c688-b838-e063-6394a90ac405	0363-9019	HUMAN OTC DRUG	Maximum Strength Congestion and Headache		Acetaminophen, Dextromethorphan hydrobromide, and Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210824		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9023_0c05e1f7-a3d8-8e69-e063-6394a90aecc3	0363-9023	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20220531		OTC MONOGRAPH DRUG	M012	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-9024_0c05e6cf-b974-2ace-e063-6294a90a6cc0	0363-9024	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20220614		OTC MONOGRAPH DRUG	M012	Walgreens	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-9025_0926bf49-ee73-4baa-be12-ac4c7994f610	0363-9025	HUMAN OTC DRUG	Earache Drops		Chamomilla, Mercurius Solubilis and Sulphur	SOLUTION/ DROPS	AURICULAR (OTIC)	20210908		UNAPPROVED HOMEOPATHIC		Walgreen Company	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
0363-9026_0c05e920-ffa1-7bd4-e063-6294a90aad3e	0363-9026	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20220719		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN	325	mg/1			N	20241231
0363-9042_66343764-0589-4af5-af77-6de37880138f	0363-9042	HUMAN OTC DRUG	Cold and Flu		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20231021		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9051_97eef903-9b0b-42f0-a2e3-1565af2b531a	0363-9051	HUMAN OTC DRUG	Walgreens Stye Eye Relief		CONIUM MACULATUM, GRAPHITE, SULFUR	SOLUTION/ DROPS	OPHTHALMIC	20190601		UNAPPROVED HOMEOPATHIC		Walgreen Company	CONIUM MACULATUM FLOWERING TOP; GRAPHITE; SULFUR	6; 12; 12	[hp_C]/10mL; [hp_C]/10mL; [hp_C]/10mL			N	20241231
0363-9074_b828ed5f-af37-4288-906e-373827b31c56	0363-9074	HUMAN OTC DRUG	Sleep Aid Plus Pain Relief		Acetaminophen, Diphenhydramine HCl	SOLUTION	ORAL	20220827		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-9077_0c05d68c-0fda-50d9-e063-6294a90a1b4c	0363-9077	HUMAN OTC DRUG	Walgreens Maximum Strength Non Drowsy Day and Night Cold and Flu		Walgreens Maximum Strength Non Drowsy Day and Night Cold and Flu	KIT		20220920		OTC MONOGRAPH DRUG	M012	Walgreens						N	20241231
0363-9080_0c05e2a4-265b-76f1-e063-6294a90a8eb5	0363-9080	HUMAN OTC DRUG	Walgreens Maximum Strength Non-Drowsy Day and Night Sinus and Cold		Walgreens Maximum Strength Non-Drowsy Day and Night Sinus and Cold	KIT		20220920		OTC MONOGRAPH DRUG	M012	Walgreens						N	20241231
0363-9084_0c05d68c-0fd7-50d9-e063-6294a90a1b4c	0363-9084	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20230413		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN	500	mg/1			N	20241231
0363-9085_0c05c904-d3b0-37d2-e063-6294a90af2d4	0363-9085	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEVER PM		ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20230413		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-9089_0f18e6bf-2077-4bfa-8634-230024ad6d60	0363-9089	HUMAN OTC DRUG	Miconazole 3 Combination Pack		miconazole nitrate	KIT	VAGINAL	20220610		ANDA	ANDA074926	Walgreens						N	20241231
0363-9090_5076e3b7-04a0-40ce-91f9-dc63e9f14b9f	0363-9090	HUMAN OTC DRUG	Minoxidil	(For Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20220819		ANDA	ANDA209074	Walgreen Company	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0363-9091_60644c86-9dd0-422d-a4a9-262e3e5c7231	0363-9091	HUMAN OTC DRUG	Minoxidil	(For Women)	Minoxidil	AEROSOL, FOAM	TOPICAL	20220829		ANDA	ANDA209074	Walgreen Company	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0363-9110_f202be86-c821-0b7b-e053-2a95a90a9081	0363-9110	HUMAN OTC DRUG	PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20180301		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-9114_f256efe4-c5bf-4a59-b2db-7908d3411f75	0363-9114	HUMAN OTC DRUG	Calamine		Calamine, Pramoxind HCl	LOTION	TOPICAL	20170307		OTC MONOGRAPH FINAL	part347	Walgreen CO	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
0363-9115_2ad02e01-a8b9-4ce0-b87c-b4cab7bb9087	0363-9115	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20170307		OTC MONOGRAPH FINAL	part347	Walgreen CO	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-9116_f203111c-17d3-dcad-e053-2a95a90a2184	0363-9116	HUMAN OTC DRUG	PAIN RELIEF PATCHES		LIDOCAINE	KIT	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company						N	20241231
0363-9124_f01a9878-90a6-407a-a4d3-9eeb89ed8ddb	0363-9124	HUMAN OTC DRUG	Walgreen		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20190305		OTC MONOGRAPH DRUG	M008	WALGREEN COMPANY	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-9125_6fc6a14a-90cb-493a-91a7-7a071479ca5d	0363-9125	HUMAN OTC DRUG	Walgreen		Bismuth Subsalicylate	TABLET, FILM COATED	ORAL	20190514		OTC MONOGRAPH DRUG	M008	WALGREEN CO.	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
0363-9129_b9a3dacd-ffe7-4535-8b86-1e9e887332d0	0363-9129	HUMAN OTC DRUG	Walgreens Childrens	Saline Laxative	Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH DRUG	M001	WALGREEN CO.	MAGNESIUM HYDROXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-9130_77bb2566-dd92-4d40-8841-dd7d7c609499	0363-9130	HUMAN OTC DRUG	Mucus Relief All in One	Maximum Strength	Acetaminophen, Diphenhydramine HCl Phenylephrine HCl	LIQUID	ORAL	20210827		OTC MONOGRAPH DRUG	M012	Walgreens	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9131_0dfde746-f041-c8fe-e063-6294a90ab9fc	0363-9131	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET	ORAL	20230719		ANDA	ANDA216592	WALGREENS	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
0363-9140_3e572123-93b1-45ce-868b-35cc62593c51	0363-9140	HUMAN OTC DRUG	Mucus Relief All In One Daytime Nighttime Cold Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL, Acetaminophen, Diphenhydramine HCL Phenylephrine HCL	KIT		20190930		OTC MONOGRAPH FINAL	part341	Walgreens						N	20241231
0363-9150_e0b1325a-1d58-4555-a7dd-3ec3369dd437	0363-9150	HUMAN OTC DRUG	Wal-itin		Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	Walgreens	LORATADINE	10	mg/1			N	20241231
0363-9175_fc22303f-1ae2-4147-a269-5404db7eb0c3	0363-9175	HUMAN OTC DRUG	Wal-Nadol	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402	20240310	OTC MONOGRAPH NOT FINAL	part343	Walgreen Company	ACETAMINOPHEN	500	mg/1			N	
0363-9201_a2dcd8a8-5039-4e8b-a835-7cd9a68ef367	0363-9201	HUMAN OTC DRUG	Extra Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200128		OTC MONOGRAPH DRUG	M001	WALGREEN COMPANY	CALCIUM CARBONATE	750	mg/1			N	20241231
0363-9220_5233c125-56b3-4983-a860-11cb263bcd5e	0363-9220	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20200701		ANDA	ANDA208754	Walgreens	DOCOSANOL	100	mg/g			N	20241231
0363-9221_f381154b-d6f4-6d8a-e053-2995a90aa68a	0363-9221	HUMAN OTC DRUG	Witch Hazel		Witch Hazel Spray	SPRAY	TOPICAL	20170301		OTC MONOGRAPH FINAL	part347	Walgreens Company	WITCH HAZEL	146	g/170g			N	20241231
0363-9222_0ae438ab-ed38-47af-b23f-dd3010443a1b	0363-9222	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20210601		ANDA	ANDA208754	Walgreens	DOCOSANOL	100	mg/g			N	20241231
0363-9223_06d2f36c-8616-af08-e063-6394a90aa424	0363-9223	HUMAN OTC DRUG	Jock Itch Powder		Miconazole Nitrate	POWDER	TOPICAL	20231003		OTC MONOGRAPH DRUG	M005	Walgreens Company	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0363-9230_6d1d8516-9621-4edf-9c85-57a6da60dfba	0363-9230	HUMAN OTC DRUG	Dye Free Wal Fex	childrens allergy	Fexofenadine HCL	SUSPENSION	ORAL	20200601		ANDA	ANDA203330	Walgreens	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-9240_48a9a02c-91b9-4507-9410-e6ffbe5006ad	0363-9240	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201030		ANDA	ANDA079216	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9247_56016e92-bdb1-42b7-a5a3-5c0de287529b	0363-9247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20130827		OTC MONOGRAPH FINAL	part347	Walgreen Co	PETROLATUM	410	mg/g			N	20241231
0363-9250_e3a741b5-63c6-4ec1-8091-2564f2e3dd19	0363-9250	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20210129		ANDA	ANDA079044	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9260_eab58841-1644-423e-8b76-68fa89f6df9b	0363-9260	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20200131		ANDA	ANDA204794	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9263_059c5365-d97a-4f6e-9d2b-a4871e8b51bc	0363-9263	HUMAN OTC DRUG	Soothing Moisturizing		Colloidal oatmeal	CREAM	TOPICAL	20140422		OTC MONOGRAPH FINAL	part347	WALGREENS CO.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0363-9264_fb76f5f9-9a4d-b650-e053-6394a90a996e	0363-9264	HUMAN OTC DRUG	Dry Skin Healing		Petrolatum	LOTION	TOPICAL	20230324		OTC MONOGRAPH FINAL	M016	Walgreens	PETROLATUM	20.5	g/50g			N	20241231
0363-9270_3b08890b-cc3b-444d-aacd-6adad5646b1d	0363-9270	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210430		ANDA	ANDA078699	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9290_0c9927b7-ff40-49c2-b64e-a8176ed08d91	0363-9290	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20191227		ANDA	ANDA074507	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9310_80587e54-4b06-4e85-b31b-fc68a5081fb9	0363-9310	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201030		ANDA	ANDA079038	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9330_4a1a8207-d832-4d94-b239-f9e9ef17e72b	0363-9330	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201030		ANDA	ANDA078697	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9336_3ea25cd5-6586-4131-856a-6602e245b5c2	0363-9336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20170307		OTC MONOGRAPH FINAL	part347	Walgreen CO	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
0363-9350_aa3c7034-0395-41ff-812f-eedd7328bc0e	0363-9350	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20191227		ANDA	ANDA074707	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9368_06eac696-e8f7-ac50-e063-6394a90a2ed6	0363-9368	HUMAN OTC DRUG	Walgreens Flu Relief		CAIRINA MOSCHATA HEART/LIVER	PELLET	ORAL	20200301		UNAPPROVED HOMEOPATHIC		Walgreens Co.	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[kp_C]/200[kp_C]			N	20241231
0363-9369_fab62dcf-585f-de5b-e053-6294a90a5a0a	0363-9369	HUMAN OTC DRUG	Flu Symptom Relief		CAIRINA MOSCHATA HEART/LIVER	PELLET	ORAL	20200820		UNAPPROVED HOMEOPATHIC		Walgreens Co.	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[kp_C]/200[kp_C]			N	20241231
0363-9370_10262123-7c07-443d-90a9-bffc1701d8c8	0363-9370	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20191024		ANDA	ANDA074916	Walgreens	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9379_01362c0a-9a59-434c-8a99-80446f9f0166	0363-9379	HUMAN OTC DRUG	Walgreens Pain Relieving Foot	Pain Relief	Apis Mellifera, Gelsemium Sempervirens Whole, and Pseudognaphalium Luteoalbum Leaf	CREAM	TOPICAL	20230215		UNAPPROVED HOMEOPATHIC		Walgreen Company	APIS MELLIFERA; GELSEMIUM SEMPERVIRENS WHOLE; PSEUDOGNAPHALIUM LUTEOALBUM LEAF	3; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
0363-9390_25f1fc4a-14d0-4583-90bf-00b037ae8faa	0363-9390	HUMAN OTC DRUG	Menstrual Complete Pain Relief		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20220125		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0363-9410_07614d66-6c5e-57df-e063-6294a90a5bb1	0363-9410	HUMAN OTC DRUG	calamine		Calamine and Zinc oxide	LOTION	TOPICAL	20231016		OTC MONOGRAPH DRUG	M016	WALGREEN COMPANY	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-9411_079d3e20-150d-ce65-e063-6294a90af07f	0363-9411	HUMAN OTC DRUG	calahist		Calamine and Pramoxine Hydrochloride	LOTION	TOPICAL	20231016		OTC MONOGRAPH DRUG	M016	WALGREEN COMPANY	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-9412_07cc6f4e-56d6-fa89-e063-6294a90abcad	0363-9412	HUMAN OTC DRUG	calahist clear		Pramoxine hydrochloride and Zinc acetate	LOTION	TOPICAL	20231016		OTC MONOGRAPH DRUG	M016	WALGREEN COMPANY	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-9417_0833784b-16aa-75f4-e063-6394a90a47d6	0363-9417	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET	ORAL	20230915		OTC MONOGRAPH DRUG	M013	WALGREENS	ACETAMINOPHEN	500	mg/1			N	20241231
0363-9425_8e992180-ca87-4aba-9689-82263561b392	0363-9425	HUMAN OTC DRUG	Walgreens Camphor Phenol Gel		Camphor, Phenol	GEL	TOPICAL	20170831		OTC MONOGRAPH NOT FINAL	part348	Walgreens	CAMPHOR (SYNTHETIC); PHENOL	10.8; 4.7	mg/g; mg/g			N	20241231
0363-9440_f5f53c7b-ee68-44e0-a4be-e71e6f154ebe	0363-9440	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	Walgreen Company	ACETAMINOPHEN	160	mg/1			N	20241231
0363-9520_f2031ee0-9a0b-fe4e-e053-2a95a90adfe7	0363-9520	HUMAN OTC DRUG	Hot and Cold Medicated Patch		MENTHOL	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	MENTHOL	5	g/100g			N	20241231
0363-9536_ec843ad6-9203-9523-e053-2a95a90a361c	0363-9536	HUMAN OTC DRUG	Walgreens		Salicylic Acid	LOTION/SHAMPOO	TOPICAL	20221102		OTC MONOGRAPH FINAL	M032	Walgreens	SALICYLIC ACID	30	mg/mL			N	20241231
0363-9537_fd67bf60-7e11-6e0c-e053-6294a90a82ce	0363-9537	HUMAN OTC DRUG	Walgreens		Salicylic Acid	LOTION/SHAMPOO	TOPICAL	20221102		OTC MONOGRAPH FINAL	M032	Walgreens	SALICYLIC ACID	30	mg/mL			N	20241231
0363-9538_0dfdd469-81b4-cdda-e063-6394a90a27c5	0363-9538	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230303		OTC MONOGRAPH DRUG	M013	WALGREENS	ACETAMINOPHEN	500	mg/1			N	20251231
0363-9570_92654685-2198-47ba-8c9a-24dfa7fe741f	0363-9570	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20201030		ANDA	ANDA209206	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9580_85872882-a084-458f-899c-16a6e474c852	0363-9580	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210528		ANDA	ANDA209206	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9590_75f24332-29f6-444e-b5b4-fa0a88f6d4a0	0363-9590	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210528		ANDA	ANDA210712	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9594_0dfe2706-b5e5-257a-e063-6394a90a316b	0363-9594	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET	ORAL	20211015		ANDA	ANDA079174	WALGREENS CO.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
0363-9595_0dfe5faa-4196-6c4b-e063-6294a90a75e7	0363-9595	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20211015		OTC MONOGRAPH DRUG	M013	WALGREEN CO.	ACETAMINOPHEN	500	mg/1			N	20251231
0363-9600_e0d5aeba-3c87-f002-e053-2995a90aa1ae	0363-9600	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET	ORAL	20181211		ANDA	ANDA091239	WALGREENS	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9601_f77aa326-263d-1019-e053-6294a90aa65a	0363-9601	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET	ORAL	20181211		ANDA	ANDA091239	WALGREENS	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9602_7f752fde-e10a-4cbc-84bb-cd42849484c7	0363-9602	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20210705		ANDA	ANDA090760	WALGREEN CO.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-9603_d482e895-7a7b-4322-ae14-6c35613d8c2e	0363-9603	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210703		ANDA	ANDA208314	WALGREEN CO.	LORATADINE	10	mg/1			N	20241231
0363-9604_98cd819a-85c1-4339-bbd0-a08ee1c50363	0363-9604	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20210707		ANDA	ANDA207229	WALGREEN CO.	ACETAMINOPHEN	650	mg/1			N	20241231
0363-9605_0bfa94dc-1f27-efa5-e063-6394a90aa629	0363-9605	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20210705		OTC MONOGRAPH DRUG	M013	WALGREEN CO.	ACETAMINOPHEN	160	mg/1			N	20241231
0363-9606_4e182dc2-0248-420d-9bde-dc1a251d57e9	0363-9606	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20220803		ANDA	ANDA211059	WALGREEN CO.	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
0363-9607_813bb3a2-3938-4c61-a45f-7fce06f940fe	0363-9607	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20221130		ANDA	ANDA206531	WALGREEN CO.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0363-9608_fa0ff53a-0e3a-2857-e053-6294a90a99c0	0363-9608	HUMAN OTC DRUG	ALL DAY PAIN RELIEF		NAPROXEN SODIUM	TABLET, COATED	ORAL	20190626		ANDA	ANDA090545	WALGREENS	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9609_fa11cfe3-89e9-aefc-e053-6394a90a815c	0363-9609	HUMAN OTC DRUG	BACK AND MUSCLE PAIN		NAPROXEN	TABLET, COATED	ORAL	20190603		ANDA	ANDA090545	WALGREENS	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9610_42e03971-374f-4997-a019-edd779063c8f	0363-9610	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210528		ANDA	ANDA212056	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9611_e17b8b33-fb47-94ef-e053-2a95a90a14d4	0363-9611	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET	ORAL	20181211		ANDA	ANDA091237	WALGREENS	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9612_e17a47be-75d7-0a83-e053-2995a90a89ea	0363-9612	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET	ORAL	20181211		ANDA	ANDA091237	WALGREENS	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9617_ff1b08ae-2a15-1a6c-e053-6294a90a6efc	0363-9617	HUMAN OTC DRUG	Mucus DM Fast Max Day Cold and Flu and Night Cold and Flu		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Triprolidine HCl	KIT	ORAL	20230626		OTC MONOGRAPH FINAL	part341	WALGREENS						N	20241231
0363-9620_9eeb9062-7c01-47a9-87c7-330de72927be	0363-9620	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210131		ANDA	ANDA212056	Walgreens	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9621_dd4120c9-dec0-704e-e053-2995a90acc23	0363-9621	HUMAN OTC DRUG	Walgreens Ice Blue Gel		Menthol	GEL	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	MENTHOL	2	g/100g			N	20241231
0363-9664_0dfdeec1-f320-cced-e063-6294a90a54e4	0363-9664	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCL		Acetaminophen Diphenhydramine HCL	TABLET	ORAL	20220930		OTC MONOGRAPH DRUG	M013	WALGREENS CO.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
0363-9680_0dfdeba1-8e65-9dc2-e063-6294a90a161a	0363-9680	HUMAN OTC DRUG	Acetaminophen Aspirin Caffeine		Acetaminophen Aspirin Caffeine	TABLET	ORAL	20210816		ANDA	ANDA214039	WALGREEN CO	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20251231
0363-9689_5c1673c3-5c4d-46cd-b07f-d7a896063998	0363-9689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine Maleate, Dextromethorphan Hbr	TABLET, FILM COATED	ORAL	20220125		OTC MONOGRAPH DRUG	M012	Walgreen Company	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-9757_f3813de4-9412-894e-e053-2995a90ac1f6	0363-9757	HUMAN OTC DRUG	Salicylic Acid		Corn Removers	PATCH	TOPICAL	20080722		OTC MONOGRAPH FINAL	part358F	Walgreen Company	SALICYLIC ACID	40	mg/91			N	20241231
0363-9766_f5f03364-e721-9bcd-e053-2995a90a8ada	0363-9766	HUMAN OTC DRUG	Naproxen Sodium Diphenhydramine HCl		Naproxen Sodium Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210619		ANDA	ANDA213663	WALGREEN CO.	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0363-9776_9bb0c88f-8118-48db-bc60-561582038867	0363-9776	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20150127		OTC MONOGRAPH NOT FINAL	part333A	WALGREENS CO.	ALCOHOL	70	mL/100mL			N	20241231
0363-9780_bc9d2da7-f19d-4ac7-afa8-b6fa10c41911	0363-9780	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210101		ANDA	ANDA210711	Walgreens	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0363-9781_ea711187-c79b-1b72-e053-2995a90a3665	0363-9781	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20220928		ANDA	ANDA215486	WALGREENS	ACETAMINOPHEN	650	mg/1			N	20241231
0363-9791_0dd7dc9e-2c9c-5279-e063-6394a90ae799	0363-9791	HUMAN OTC DRUG	Walgreens Black Elderberry Cold and Flu Relief		Bryonia alba, Gelsemium sempervirens, Sambucus nigra, Sulphur, Zincum gluconicum	TABLET, ORALLY DISINTEGRATING	ORAL	20220513		UNAPPROVED HOMEOPATHIC		Walgreen Co.	BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SULFUR; ZINC GLUCONATE	6; 6; 3; 12; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0363-9798_0dfdddac-8e49-e297-e063-6394a90adbad	0363-9798	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20210924		OTC MONOGRAPH DRUG	M013	WALGREEN CO.	ACETAMINOPHEN	500	mg/1			N	20251231
0363-9799_0dfe5179-fe01-7c96-e063-6294a90ad9d4	0363-9799	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCL		Acetaminophen Diphenhydramine HCL	TABLET	ORAL	20230303		OTC MONOGRAPH DRUG	M013	WALGREEN CO.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
0363-9812_0c7a4c32-0af5-8e0d-e063-6294a90aebf7	0363-9812	HUMAN OTC DRUG	Ephedrine Hydrochloride		Ephedrine Hydrochloride	TABLET	ORAL	20211202		OTC MONOGRAPH DRUG	M012	Walgreen Company	EPHEDRINE HYDROCHLORIDE	12.5	mg/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0363-9820_fa230984-1361-f78a-e053-6294a90a8a2d	0363-9820	HUMAN OTC DRUG	WG 110 Walgreens Foamer		MAGNESIUM SULFATE HEPTAHYDRATE	SOLUTION	TOPICAL	20200301		UNAPPROVED HOMEOPATHIC		Walgreen Company	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0363-9835_ddcf7565-95af-39cc-e053-2995a90ac76c	0363-9835	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20210907		OTC MONOGRAPH FINAL	part341	Walgreen Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0363-9839_66d18d11-ca61-4864-85aa-c76ed77c577d	0363-9839	HUMAN OTC DRUG	childrens multi symptom cold		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20150627		OTC MONOGRAPH DRUG	M012	Walgreen Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9889_f380f63f-4d68-dd2d-e053-2995a90a5283	0363-9889	HUMAN OTC DRUG	Salicylic Acid		Liquid corn and Callus remover	LIQUID	TOPICAL	20080709		OTC MONOGRAPH FINAL	part358F	Walgreen Company	SALICYLIC ACID	.17	g/g			N	20241231
0363-9897_0c069065-d8c2-1d0e-e063-6294a90ab407	0363-9897	HUMAN OTC DRUG	MUCUS RELIEF DM		GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20150815		OTC MONOGRAPH DRUG	M012	Walgreens	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-9902_fbd53e5f-bbf4-75b4-e053-6394a90af028	0363-9902	HUMAN OTC DRUG	CAPSAICIN HEAT PATCHES BACK AND LARGE AREAS		CAPSAICIN	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	CAPSAICIN	.025	g/100g			N	20241231
0363-9903_f202e802-273e-496b-e053-2a95a90a16b4	0363-9903	HUMAN OTC DRUG	Pain Relieving Patches		CAMPHOR MENTHOL METHYL SALICYTATE	PATCH	TOPICAL	20191115		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	1.2; 5.7; 6.3	g/100g; g/100g; g/100g			N	20241231
0363-9904_f2036723-df2b-e7a0-e053-2a95a90a7f43	0363-9904	HUMAN OTC DRUG	Large Pain Relieving		CAMPHOR MENTHOL METHYL SALICYTATE	PATCH	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
0363-9905_f2033ba9-1bd5-a446-e053-2995a90a0762	0363-9905	HUMAN OTC DRUG	Extra Large Cool and Heat Patch		MENTHOL	PATCH	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part348	Walgreen Company	MENTHOL	5	g/100g			N	20241231
0363-9912_1ca046d2-a535-4728-8496-ca706372d63b	0363-9912	HUMAN OTC DRUG	Cold and Flu	Day	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20221114		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9913_cafe7e53-3e5e-4d95-a52b-f4d77a3df32c	0363-9913	HUMAN OTC DRUG	Cold and Flu	Night	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20221114		OTC MONOGRAPH DRUG	M012	Walgreen Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-9930_a170c33d-402e-447f-ad46-402c60045461	0363-9930	HUMAN OTC DRUG	Guaifenesin D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210506		ANDA	ANDA212542	Walgreen Company	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-9937_894e6dbc-c6b9-45fc-8288-376f538c954e	0363-9937	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	WALGREEN CO.	LORATADINE	10	mg/1			N	20241231
0363-9938_d12fc93c-9e10-4137-a203-9975eff2d325	0363-9938	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180327		OTC MONOGRAPH FINAL	part332	Walgreen Co.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-9941_8b9b1286-ad4b-40ed-a86b-f5c0af3df929	0363-9941	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180327		OTC MONOGRAPH FINAL	part332	Walgreen Co.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-9942_5a14f76b-f3b1-4659-ac91-b15b0e790a8f	0363-9942	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180327		OTC MONOGRAPH FINAL	part332	Walgreen Co.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-9943_ef2ff798-db87-34ee-e053-2a95a90a4f98	0363-9943	HUMAN OTC DRUG	Walgreens 24-Hour Lidocaine Patch		Lidocaine 4%	PATCH	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0363-9944_9acd7425-6450-42d7-a5a9-51a106bb92bf	0363-9944	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180329		OTC MONOGRAPH NOT FINAL	part334	Walgreen Co.	DOCUSATE SODIUM	100	mg/1			N	20241231
0363-9945_ca2e91d3-dd20-40ff-8fa0-f325728deac2	0363-9945	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190415		OTC MONOGRAPH FINAL	part332	WALGREEN CO.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
0363-9946_d4c1a405-1f10-49fc-b85d-c452cf23347c	0363-9946	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20220507		ANDA	ANDA213203	WALGREEN CO.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0363-9947_0bd295c7-906d-634f-e063-6394a90a8f3e	0363-9947	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET	ORAL	20211102		OTC MONOGRAPH DRUG	M013	WALGREEN CO.	ACETAMINOPHEN	500	mg/1			N	20241231
0363-9950_e67522f2-86a5-281d-e053-2995a90adb39	0363-9950	HUMAN OTC DRUG	Walgreens Cold Therapy Pain Relief Patch		Menthol 5%	PATCH	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part348	Walgreens Company	MENTHOL	5	g/100g			N	20241231
0363-9952_00b17a8e-9d35-a8d4-e063-6294a90a153e	0363-9952	HUMAN OTC DRUG	Walgreens Wild Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20221018		OTC MONOGRAPH FINAL	part331	Walgreens Company	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-9952_09cf38c2-0b46-eca1-e063-6294a90a72d8	0363-9952	HUMAN OTC DRUG	Walgreens Wild Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20231110		OTC MONOGRAPH DRUG	M001	Walgreens	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0363-9955_c3c18e2a-3dba-eeae-c893-0b3ab6a512c0	0363-9955	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210519		ANDA	ANDA212795	Walgreens Company	LORATADINE	5	mg/1			N	20241231
0363-9970_a9dc1403-3a12-47b7-b80e-ebd4a55e8976	0363-9970	HUMAN OTC DRUG	Minoxidil		Minoxidil	SOLUTION	TOPICAL	20221014		ANDA	ANDA074588	Walgreens	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0363-9971_0c014c67-f385-433b-bb96-1a0dd133d832	0363-9971	HUMAN OTC DRUG	Minoxidil		Minoxidil	SOLUTION	TOPICAL	20221014		ANDA	ANDA075518	Walgreens	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0363-9972_0a0a2cee-7082-488f-8593-540ac7e83047	0363-9972	HUMAN OTC DRUG	Minoxidil		Minoxidil	SOLUTION	TOPICAL	20221014	20250228	ANDA	ANDA074588	Walgreens	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
0363-9973_bc251a8f-4052-40b0-bb9c-702d2d8ed04e	0363-9973	HUMAN OTC DRUG	Minoxidil		Minoxidil	SOLUTION	TOPICAL	20221014	20250228	ANDA	ANDA075518	Walgreens	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
0363-9974_780c08b2-2814-4249-819c-a53f9a8edd76	0363-9974	HUMAN OTC DRUG	Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20220930		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0363-9975_01f7bed0-1883-401c-98b4-6fd620effde6	0363-9975	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20220930		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-9976_f3879e17-04d1-4711-80f0-0d1687b427ba	0363-9976	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20220930		OTC MONOGRAPH FINAL	part341	Walgreens	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0363-9977_6a3e27a9-1987-420c-8a14-34f8e8a9cc75	0363-9977	HUMAN OTC DRUG	Acid Reducer		Esomeprazole magnesium	TABLET	ORAL	20221104		ANDA	ANDA212088	Walgreens	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-9978_f9b1342d-b871-46ff-e053-6394a90a0576	0363-9978	HUMAN OTC DRUG	Laxative		Sennosides	TABLET	ORAL	20230415		OTC MONOGRAPH NOT FINAL	part334	WALGREENS	SENNOSIDES	25	mg/1			N	20241231
0363-9980_8add376a-81a3-41e0-ba8d-037f7f56165a	0363-9980	HUMAN OTC DRUG	Omeprazole		OMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20210105		ANDA	ANDA210593	Walgreen Company	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0363-9990_0dfde746-f040-c8fe-e063-6294a90ab9fc	0363-9990	HUMAN OTC DRUG	Sennosides		Sennosides	CAPSULE, LIQUID FILLED	ORAL	20190529		OTC MONOGRAPH DRUG	M007	Walgreens Co	SENNOSIDES	17.2	mg/17.21			N	20251231
0363-9992_0dfdeba1-8e62-9dc2-e063-6294a90a161a	0363-9992	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190928		ANDA	ANDA211544	WALGREENS	ACETAMINOPHEN	650	mg/1			N	20251231
0363-9993_0dfdd70c-e414-afcd-e063-6294a90a87bb	0363-9993	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190928		ANDA	ANDA211544	WALGREENS CO.	ACETAMINOPHEN	650	mg/1			N	20251231
0363-9994_7aeb3f5b-33c7-4cf8-b6ab-5f3d211ea27c	0363-9994	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20200801		ANDA	ANDA210088	WALGREENS CO.	LORATADINE	5	mg/1			N	20241231
0363-9995_73be4396-fd75-4e22-a850-3079d85eb72b	0363-9995	HUMAN OTC DRUG	Wal-itin		LORATADINE	TABLET, CHEWABLE	ORAL	20200801		ANDA	ANDA210088	WALGREENS CO.	LORATADINE	5	mg/1			N	20241231
0363-9996_efe0ec6b-9901-858f-e053-2a95a90aec59	0363-9996	HUMAN OTC DRUG	Childrens Cold and Cough Nighttime		onion, calcium sulfide, sodium chloride, anemone pulsatilla, arabica coffee bean, matricaria chamomilla, sulfur, phosphorus and goldenseal	LIQUID	ORAL	20190201		UNAPPROVED HOMEOPATHIC		Walgreen Company	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; CALCIUM SULFIDE; GOLDENSEAL; MATRICARIA CHAMOMILLA; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 6; 12; 6; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
0363-9997_efe10045-6c43-b698-e053-2995a90a641c	0363-9997	HUMAN OTC DRUG	Childrens Cold and Cough		onion, calcium sulfide, sodium chloride, phosphorus, pulsatilla vulgaris, sulfur, and goldenseal	LIQUID	ORAL	20190201		UNAPPROVED HOMEOPATHIC		Walgreen Company	ANEMONE PULSATILLA; CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 12; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
0363-9998_efe1832a-c43f-5a22-e053-2a95a90a8b6c	0363-9998	HUMAN OTC DRUG	Childrens Cold and Cough Day and Night Value Pack		onion, calcium sulfide, sodium chloride, anemone pulsatilla, arabica coffee bean, matricaria chamomilla, sulfur, phosphorus and goldenseal	KIT		20190201		UNAPPROVED HOMEOPATHIC		Walgreen Company						N	20241231
0363-9999_d3b08833-181d-9e6e-e053-2995a90a1e73	0363-9999	HUMAN OTC DRUG	Childrens Cold and Cough Grape Flavor		onion, calcium sulfide, goldenseal, sodium chloride, phosphorus, anemone pulsatilla, and sulfur	LIQUID	ORAL	20181214		UNAPPROVED HOMEOPATHIC		Walgreen Company	ANEMONE PULSATILLA; CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 12; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
0374-5080_7e7b458d-c301-5055-e053-2a91aa0aa93b	0374-5080	HUMAN PRESCRIPTION DRUG	CHLORHEXIDINE GLUCONATE		chlorhexidine gluconate	RINSE	ORAL	20171101		ANDA	ANDA074291	Lyne Laboratories, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0378-0005_129ab1eb-61df-49de-953c-fca0f0a28eee	0378-0005	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET, FOR SUSPENSION	ORAL	20211001		ANDA	ANDA210130	Mylan Pharmaceuticals Inc.	EVEROLIMUS	2	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0378-0006_129ab1eb-61df-49de-953c-fca0f0a28eee	0378-0006	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET, FOR SUSPENSION	ORAL	20211001		ANDA	ANDA210130	Mylan Pharmaceuticals Inc.	EVEROLIMUS	3	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0378-0007_129ab1eb-61df-49de-953c-fca0f0a28eee	0378-0007	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET, FOR SUSPENSION	ORAL	20211001		ANDA	ANDA210130	Mylan Pharmaceuticals Inc.	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0378-0014_22d23d93-bacd-49a2-8835-352379a71767	0378-0014	HUMAN PRESCRIPTION DRUG	Methotrexate		methotrexate	TABLET	ORAL	19920518		ANDA	ANDA081235	Mylan Pharmaceuticals Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
0378-0018_086a9f64-2ffe-46b5-b165-f6451c29ae47	0378-0018	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040223		ANDA	ANDA076704	Mylan Pharmaceuticals Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0032_086a9f64-2ffe-46b5-b165-f6451c29ae47	0378-0032	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	19931223		ANDA	ANDA076704	Mylan Pharmaceuticals Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0042_89bf8d20-6dd5-413b-a6cd-930715065d28	0378-0042	HUMAN PRESCRIPTION DRUG	Perphenazine and Amitriptyline Hydrochloride		perphenazine and amitriptyline hydrochloride	TABLET, FILM COATED	ORAL	19881110		ANDA	ANDA071443	Mylan Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE	10; 4	mg/1; mg/1	Phenothiazine [EPC], Phenothiazines [CS], Tricyclic Antidepressant [EPC]		N	20241231
0378-0047_086a9f64-2ffe-46b5-b165-f6451c29ae47	0378-0047	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	19931223		ANDA	ANDA076704	Mylan Pharmaceuticals Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0052_e622596a-a6c2-4054-bac0-02e5f19716b6	0378-0052	HUMAN PRESCRIPTION DRUG	Pindolol		pindolol	TABLET	ORAL	19920903	20250430	ANDA	ANDA074019	Mylan Pharmaceuticals Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
0378-0053_14717870-5f24-4002-ada5-1c5a44cc2be9	0378-0053	HUMAN PRESCRIPTION DRUG	Cimetidine		cimetidine	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074246	Mylan Pharmaceuticals Inc.	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
0378-0055_96dd25ab-c0a7-47e6-b056-c53813615d36	0378-0055	HUMAN PRESCRIPTION DRUG	Timolol Maleate		timolol maleate	TABLET	ORAL	19900608		ANDA	ANDA072668	Mylan Pharmaceuticals Inc.	TIMOLOL MALEATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0073_89bf8d20-6dd5-413b-a6cd-930715065d28	0378-0073	HUMAN PRESCRIPTION DRUG	Perphenazine and Amitriptyline Hydrochloride		perphenazine and amitriptyline hydrochloride	TABLET, FILM COATED	ORAL	19881110		ANDA	ANDA071443	Mylan Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE	50; 4	mg/1; mg/1	Phenothiazine [EPC], Phenothiazines [CS], Tricyclic Antidepressant [EPC]		N	20241231
0378-0078_26fe1be4-3d62-438c-a3d3-21999097cbae	0378-0078	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		carbidopa and levodopa	TABLET	ORAL	20110516		ANDA	ANDA090324	Mylan Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0378-0085_26fe1be4-3d62-438c-a3d3-21999097cbae	0378-0085	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		carbidopa and levodopa	TABLET	ORAL	20110516		ANDA	ANDA090324	Mylan Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0378-0088_040cbae3-06af-4478-b9fb-73562828fc3c	0378-0088	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		carbidopa and levodopa	TABLET, EXTENDED RELEASE	ORAL	20000426		ANDA	ANDA075091	Mylan Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0378-0094_040cbae3-06af-4478-b9fb-73562828fc3c	0378-0094	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		carbidopa and levodopa	TABLET, EXTENDED RELEASE	ORAL	19991006		ANDA	ANDA075091	Mylan Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0378-0127_e622596a-a6c2-4054-bac0-02e5f19716b6	0378-0127	HUMAN PRESCRIPTION DRUG	Pindolol		pindolol	TABLET	ORAL	19920903	20250430	ANDA	ANDA074019	Mylan Pharmaceuticals Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
0378-0137_fd6445a1-b5a8-4eff-964a-27c1403c90d5	0378-0137	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	19861024		ANDA	ANDA018659	Mylan Pharmaceuticals Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0378-0144_a18ae721-cd2b-4fd9-af68-610b3b65c7e2	0378-0144	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20030220		ANDA	ANDA074732	Mylan Pharmaceuticals Inc.	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0378-0181_fd6445a1-b5a8-4eff-964a-27c1403c90d5	0378-0181	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	19861024		ANDA	ANDA018659	Mylan Pharmaceuticals Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0378-0182_b4aed68a-03da-4925-8e9f-d2dba6db9e8d	0378-0182	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Mylan Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0183_b4aed68a-03da-4925-8e9f-d2dba6db9e8d	0378-0183	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Mylan Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0184_b4aed68a-03da-4925-8e9f-d2dba6db9e8d	0378-0184	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Mylan Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0185_b4aed68a-03da-4925-8e9f-d2dba6db9e8d	0378-0185	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Mylan Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0187_b4aed68a-03da-4925-8e9f-d2dba6db9e8d	0378-0187	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Mylan Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0208_0d7d06e2-2804-4a02-b9d6-2f70d9d45c4e	0378-0208	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	Mylan Pharmaceuticals Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0378-0211_7dec5311-2e37-4730-a8f2-574641d6c2e8	0378-0211	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide and Amitriptyline Hydrochloride		chlordiazepoxide and amitriptyline hydrochloride	TABLET, FILM COATED	ORAL	19861210		ANDA	ANDA071297	Mylan Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE	14; 5	mg/1; mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Tricyclic Antidepressant [EPC]	CIV	N	20241231
0378-0213_0ffb0719-40b0-4fc8-b6a8-cc07d97cca29	0378-0213	HUMAN PRESCRIPTION DRUG	Chlorthalidone		chlorthalidone	TABLET	ORAL	19810226		ANDA	ANDA086831	Mylan Pharmaceuticals Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20251231
0378-0214_746dbc60-6679-4e9a-bc8f-c573c693be32	0378-0214	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	19860610		ANDA	ANDA070278	Mylan Pharmaceuticals Inc.	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
0378-0216_0d7d06e2-2804-4a02-b9d6-2f70d9d45c4e	0378-0216	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	Mylan Pharmaceuticals Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0378-0218_25b4b9e7-65f3-42ef-9e59-e1eeaf39b5fe	0378-0218	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19990617		ANDA	ANDA073457	Mylan Pharmaceuticals Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0221_96dd25ab-c0a7-47e6-b056-c53813615d36	0378-0221	HUMAN PRESCRIPTION DRUG	Timolol Maleate		timolol maleate	TABLET	ORAL	19900608		ANDA	ANDA072668	Mylan Pharmaceuticals Inc.	TIMOLOL MALEATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0222_0ffb0719-40b0-4fc8-b6a8-cc07d97cca29	0378-0222	HUMAN PRESCRIPTION DRUG	Chlorthalidone		chlorthalidone	TABLET	ORAL	19810226		ANDA	ANDA086831	Mylan Pharmaceuticals Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20251231
0378-0231_25b4b9e7-65f3-42ef-9e59-e1eeaf39b5fe	0378-0231	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19920124		ANDA	ANDA073457	Mylan Pharmaceuticals Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0232_0d7d06e2-2804-4a02-b9d6-2f70d9d45c4e	0378-0232	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19861029		ANDA	ANDA070082	Mylan Pharmaceuticals Inc.	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0378-0243_bf19b6ac-2432-49fe-ac8f-df759e9fe884	0378-0243	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20020122		ANDA	ANDA040424	Mylan Pharmaceuticals Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0378-0257_746dbc60-6679-4e9a-bc8f-c573c693be32	0378-0257	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	19860610		ANDA	ANDA070278	Mylan Pharmaceuticals Inc.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
0378-0271_110aec36-9754-41af-9770-42949a300952	0378-0271	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	Mylan Pharmaceuticals Inc.	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0378-0274_a18ae721-cd2b-4fd9-af68-610b3b65c7e2	0378-0274	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20030220		ANDA	ANDA074732	Mylan Pharmaceuticals Inc.	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0378-0277_7dec5311-2e37-4730-a8f2-574641d6c2e8	0378-0277	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide and Amitriptyline Hydrochloride		chlordiazepoxide and amitriptyline hydrochloride	TABLET, FILM COATED	ORAL	19861210		ANDA	ANDA071297	Mylan Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE	27.98; 10	mg/1; mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Tricyclic Antidepressant [EPC]	CIV	N	20241231
0378-0317_14717870-5f24-4002-ada5-1c5a44cc2be9	0378-0317	HUMAN PRESCRIPTION DRUG	Cimetidine		cimetidine	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074246	Mylan Pharmaceuticals Inc.	CIMETIDINE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
0378-0327_746dbc60-6679-4e9a-bc8f-c573c693be32	0378-0327	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	19860610		ANDA	ANDA070278	Mylan Pharmaceuticals Inc.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0378-0330_89bf8d20-6dd5-413b-a6cd-930715065d28	0378-0330	HUMAN PRESCRIPTION DRUG	Perphenazine and Amitriptyline Hydrochloride		perphenazine and amitriptyline hydrochloride	TABLET, FILM COATED	ORAL	19881110		ANDA	ANDA071443	Mylan Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE	10; 2	mg/1; mg/1	Phenothiazine [EPC], Phenothiazines [CS], Tricyclic Antidepressant [EPC]		N	20241231
0378-0334_746dbc60-6679-4e9a-bc8f-c573c693be32	0378-0334	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20090717		ANDA	ANDA070278	Mylan Pharmaceuticals Inc.	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
0378-0335_746dbc60-6679-4e9a-bc8f-c573c693be32	0378-0335	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20090717	20250531	ANDA	ANDA070278	Mylan Pharmaceuticals Inc.	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	
0378-0345_110aec36-9754-41af-9770-42949a300952	0378-0345	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	Mylan Pharmaceuticals Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0378-0351_746dbc60-6679-4e9a-bc8f-c573c693be32	0378-0351	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	19860610		ANDA	ANDA070278	Mylan Pharmaceuticals Inc.	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0378-0372_14717870-5f24-4002-ada5-1c5a44cc2be9	0378-0372	HUMAN PRESCRIPTION DRUG	Cimetidine		cimetidine	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074246	Mylan Pharmaceuticals Inc.	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
0378-0396_7aef99fa-76ed-4750-a283-99cdf7ccc4de	0378-0396	HUMAN PRESCRIPTION DRUG	Dimethyl fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200818		ANDA	ANDA210531	Mylan Pharmaceuticals Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
0378-0399_7aef99fa-76ed-4750-a283-99cdf7ccc4de	0378-0399	HUMAN PRESCRIPTION DRUG	Dimethyl fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200818		ANDA	ANDA210531	Mylan Pharmaceuticals Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
0378-0403_a7e73fee-cca8-4726-b50b-1c2dfc5e870f	0378-0403	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		spironolactone and hydrochlorothiazide	TABLET	ORAL	19790803		ANDA	ANDA086513	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-0415_70e22ff5-bb2b-4a03-b0c3-63148f56f22b	0378-0415	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	19771117	20240331	ANDA	ANDA085762	Mylan Pharmaceuticals Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	
0378-0424_30a7e036-f161-4393-a646-beeacc72e1f0	0378-0424	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		metoprolol tartrate and hydrochlorothiazide	TABLET	ORAL	20040820		ANDA	ANDA076792	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 50	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0434_30a7e036-f161-4393-a646-beeacc72e1f0	0378-0434	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		metoprolol tartrate and hydrochlorothiazide	TABLET	ORAL	20040820		ANDA	ANDA076792	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0437_bf19b6ac-2432-49fe-ac8f-df759e9fe884	0378-0437	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20020122		ANDA	ANDA040424	Mylan Pharmaceuticals Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0378-0442_89bf8d20-6dd5-413b-a6cd-930715065d28	0378-0442	HUMAN PRESCRIPTION DRUG	Perphenazine and Amitriptyline Hydrochloride		perphenazine and amitriptyline hydrochloride	TABLET, FILM COATED	ORAL	19881110		ANDA	ANDA071443	Mylan Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE	25; 2	mg/1; mg/1	Phenothiazine [EPC], Phenothiazines [CS], Tricyclic Antidepressant [EPC]		N	20241231
0378-0445_30a7e036-f161-4393-a646-beeacc72e1f0	0378-0445	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		metoprolol tartrate and hydrochlorothiazide	TABLET	ORAL	20040820		ANDA	ANDA076792	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	50; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0460_0e54ebec-df86-4205-9434-315913b56a94	0378-0460	HUMAN PRESCRIPTION DRUG	MAXZIDE		maxzide	TABLET	ORAL	19880513	20240430	NDA	NDA019129	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	
0378-0464_0e54ebec-df86-4205-9434-315913b56a94	0378-0464	HUMAN PRESCRIPTION DRUG	MAXZIDE-25		maxzide	TABLET	ORAL	19880513	20240331	NDA	NDA019129	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	
0378-0472_86f5b65e-91ef-4def-87bb-aad6b82aad00	0378-0472	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090129		ANDA	ANDA077567	Mylan Pharmaceuticals Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0378-0473_86f5b65e-91ef-4def-87bb-aad6b82aad00	0378-0473	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090202		ANDA	ANDA077567	Mylan Pharmaceuticals Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0378-0477_110aec36-9754-41af-9770-42949a300952	0378-0477	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	Mylan Pharmaceuticals Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0378-0501_72972113-2cf1-4d8f-a9c8-8bbe80b75dc9	0378-0501	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210222		ANDA	ANDA075768	Mylan Pharmaceuticals Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0503_72972113-2cf1-4d8f-a9c8-8bbe80b75dc9	0378-0503	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210222		ANDA	ANDA075768	Mylan Pharmaceuticals Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0505_72972113-2cf1-4d8f-a9c8-8bbe80b75dc9	0378-0505	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210222		ANDA	ANDA075768	Mylan Pharmaceuticals Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0541_14717870-5f24-4002-ada5-1c5a44cc2be9	0378-0541	HUMAN PRESCRIPTION DRUG	Cimetidine		cimetidine	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074246	Mylan Pharmaceuticals Inc.	CIMETIDINE	800	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
0378-0574_89bf8d20-6dd5-413b-a6cd-930715065d28	0378-0574	HUMAN PRESCRIPTION DRUG	Perphenazine and Amitriptyline Hydrochloride		perphenazine and amitriptyline hydrochloride	TABLET, FILM COATED	ORAL	19881110		ANDA	ANDA071443	Mylan Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE	25; 4	mg/1; mg/1	Phenothiazine [EPC], Phenothiazines [CS], Tricyclic Antidepressant [EPC]		N	20241231
0378-0612_a6069a83-96d8-437b-a4e3-2a0a40611153	0378-0612	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19830315		ANDA	ANDA088004	Mylan Pharmaceuticals Inc.	THIORIDAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-0614_a6069a83-96d8-437b-a4e3-2a0a40611153	0378-0614	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19830315		ANDA	ANDA088004	Mylan Pharmaceuticals Inc.	THIORIDAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-0616_a6069a83-96d8-437b-a4e3-2a0a40611153	0378-0616	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19830315		ANDA	ANDA088004	Mylan Pharmaceuticals Inc.	THIORIDAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-0618_a6069a83-96d8-437b-a4e3-2a0a40611153	0378-0618	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19831118		ANDA	ANDA088004	Mylan Pharmaceuticals Inc.	THIORIDAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-0627_1824aae5-58af-43da-8231-435c8f118bc0	0378-0627	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209702	Mylan Pharmaceuticals Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
0378-0628_1824aae5-58af-43da-8231-435c8f118bc0	0378-0628	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209702	Mylan Pharmaceuticals Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
0378-0630_dcf849c7-acfc-4b32-ab2e-2e3d30c636f2	0378-0630	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20170320		ANDA	ANDA207231	Mylan Pharmaceuticals Inc.	ILOPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0631_dcf849c7-acfc-4b32-ab2e-2e3d30c636f2	0378-0631	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20170320		ANDA	ANDA207231	Mylan Pharmaceuticals Inc.	ILOPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0632_dcf849c7-acfc-4b32-ab2e-2e3d30c636f2	0378-0632	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20170320		ANDA	ANDA207231	Mylan Pharmaceuticals Inc.	ILOPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0633_dcf849c7-acfc-4b32-ab2e-2e3d30c636f2	0378-0633	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20170320		ANDA	ANDA207231	Mylan Pharmaceuticals Inc.	ILOPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0634_dcf849c7-acfc-4b32-ab2e-2e3d30c636f2	0378-0634	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20170320		ANDA	ANDA207231	Mylan Pharmaceuticals Inc.	ILOPERIDONE	8	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0635_dcf849c7-acfc-4b32-ab2e-2e3d30c636f2	0378-0635	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20170320		ANDA	ANDA207231	Mylan Pharmaceuticals Inc.	ILOPERIDONE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0636_dcf849c7-acfc-4b32-ab2e-2e3d30c636f2	0378-0636	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20170320		ANDA	ANDA207231	Mylan Pharmaceuticals Inc.	ILOPERIDONE	12	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0640_87140917-4e99-46da-bfab-f5dba297e9c1	0378-0640	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20190307		ANDA	ANDA080292	Mylan Pharmaceuticals Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0378-0641_87140917-4e99-46da-bfab-f5dba297e9c1	0378-0641	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20190403		ANDA	ANDA088832	Mylan Pharmaceuticals Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0378-0642_87140917-4e99-46da-bfab-f5dba297e9c1	0378-0642	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200206		ANDA	ANDA083677	Mylan Pharmaceuticals Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0378-0715_96dd25ab-c0a7-47e6-b056-c53813615d36	0378-0715	HUMAN PRESCRIPTION DRUG	Timolol Maleate		timolol maleate	TABLET	ORAL	19900608		ANDA	ANDA072668	Mylan Pharmaceuticals Inc.	TIMOLOL MALEATE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0757_25b4b9e7-65f3-42ef-9e59-e1eeaf39b5fe	0378-0757	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19920124		ANDA	ANDA073457	Mylan Pharmaceuticals Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-0825_2db70c4a-a95a-49b5-a515-55cab6dc0156	0378-0825	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	19990708		ANDA	ANDA075417	Mylan Pharmaceuticals Inc.	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0860_2db70c4a-a95a-49b5-a515-55cab6dc0156	0378-0860	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	19990708		ANDA	ANDA075417	Mylan Pharmaceuticals Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0871_9979db75-b038-418e-b527-724d23c65932	0378-0871	HUMAN PRESCRIPTION DRUG	Clonidine		clonidine	PATCH	TRANSDERMAL	20130225		ANDA	ANDA076166	Mylan Pharmaceuticals Inc.	CLONIDINE	.1	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0378-0872_9979db75-b038-418e-b527-724d23c65932	0378-0872	HUMAN PRESCRIPTION DRUG	Clonidine		clonidine	PATCH	TRANSDERMAL	20130304		ANDA	ANDA076166	Mylan Pharmaceuticals Inc.	CLONIDINE	.2	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0378-0873_9979db75-b038-418e-b527-724d23c65932	0378-0873	HUMAN PRESCRIPTION DRUG	Clonidine		clonidine	PATCH	TRANSDERMAL	20130301		ANDA	ANDA076166	Mylan Pharmaceuticals Inc.	CLONIDINE	.3	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0378-0896_9cb88c28-d9c9-45e3-b4fe-083327f122de	0378-0896	HUMAN PRESCRIPTION DRUG	Penciclovir		penciclovir	CREAM	TOPICAL	20221116		NDA AUTHORIZED GENERIC	NDA020629	Mylan Pharmaceuticals Inc.	PENCICLOVIR	10	mg/g	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0378-0972_2db70c4a-a95a-49b5-a515-55cab6dc0156	0378-0972	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	20100420		ANDA	ANDA075417	Mylan Pharmaceuticals Inc.	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-0973_2db70c4a-a95a-49b5-a515-55cab6dc0156	0378-0973	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	20100420		ANDA	ANDA075417	Mylan Pharmaceuticals Inc.	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-1049_528d1ddf-62f6-451f-a3af-8649e486282c	0378-1049	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0378-1075_71ff682d-8dfd-496b-a983-035d60b186be	0378-1075	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		telmisartan and amlodipine	TABLET	ORAL	20140919		ANDA	ANDA202516	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; TELMISARTAN	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1076_71ff682d-8dfd-496b-a983-035d60b186be	0378-1076	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		telmisartan and amlodipine	TABLET	ORAL	20140919		ANDA	ANDA202516	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; TELMISARTAN	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1077_71ff682d-8dfd-496b-a983-035d60b186be	0378-1077	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		telmisartan and amlodipine	TABLET	ORAL	20140919		ANDA	ANDA202516	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; TELMISARTAN	5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1078_71ff682d-8dfd-496b-a983-035d60b186be	0378-1078	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		telmisartan and amlodipine	TABLET	ORAL	20140919		ANDA	ANDA202516	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; TELMISARTAN	10; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1086_235977e7-e2e9-48db-a01f-2c8fc187a630	0378-1086	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20191125	20240331	ANDA	ANDA209470	Mylan Pharmaceuticals Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	
0378-1101_d34df403-6e07-4fc2-bba7-ec34bd20b4d7	0378-1101	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890228		ANDA	ANDA072575	Mylan Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0378-1110_e7c9f6a0-504a-4f2b-afaf-2fa93b442b86	0378-1110	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	19940510	20240831	ANDA	ANDA074226	Mylan Pharmaceuticals Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
0378-1133_26fe1be4-3d62-438c-a3d3-21999097cbae	0378-1133	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		carbidopa and levodopa	TABLET	ORAL	20110516		ANDA	ANDA090324	Mylan Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0378-1134_d9caf771-b764-4efd-8fe0-bd340cec23e6	0378-1134	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20130516		ANDA	ANDA074761	Mylan Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0378-1140_d6848975-7bf9-4227-a73c-2631d8b050be	0378-1140	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20020301		ANDA	ANDA076008	Mylan Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
0378-1145_d6848975-7bf9-4227-a73c-2631d8b050be	0378-1145	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20130708		ANDA	ANDA076008	Mylan Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
0378-1150_d6848975-7bf9-4227-a73c-2631d8b050be	0378-1150	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20020301		ANDA	ANDA076008	Mylan Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
0378-1165_d6848975-7bf9-4227-a73c-2631d8b050be	0378-1165	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20010328		ANDA	ANDA076008	Mylan Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
0378-1175_d6848975-7bf9-4227-a73c-2631d8b050be	0378-1175	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20010628		ANDA	ANDA076008	Mylan Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
0378-1201_3e7827a0-be39-4acf-a638-b7386a501516	0378-1201	HUMAN PRESCRIPTION DRUG	Sorafenib Tosylate		Sorafenib	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA207012	Mylan Pharmaceuticals Inc.	SORAFENIB TOSYLATE	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0378-1300_56f8de96-6c32-4b64-ac2e-efccec5f9751	0378-1300	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		lithium carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120702		ANDA	ANDA202288	Mylan Pharmaceuticals Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
0378-1375_74ab5fdd-ccdd-403d-af79-fd34a1cc939f	0378-1375	HUMAN PRESCRIPTION DRUG	Mesalamine		mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20191126		ANDA	ANDA207271	Mylan Pharmaceuticals Inc.	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0378-1403_884b2f91-8db1-4ea6-9332-acbae2ef2191	0378-1403	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		rizatriptan benzoate	TABLET	ORAL	20121231		ANDA	ANDA201993	Mylan Pharmaceuticals Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-1404_884b2f91-8db1-4ea6-9332-acbae2ef2191	0378-1404	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		rizatriptan benzoate	TABLET	ORAL	20121231		ANDA	ANDA201993	Mylan Pharmaceuticals Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-1450_040425a0-c697-4c16-810a-87df799807b6	0378-1450	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		lithium carbonate	TABLET, EXTENDED RELEASE	ORAL	20120809		ANDA	ANDA202219	Mylan Pharmaceuticals Inc.	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20241231
0378-1626_7ffb72ac-3633-4a8e-b724-88afedd22d30	0378-1626	HUMAN PRESCRIPTION DRUG	Voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20110215	20241231	ANDA	ANDA090547	Mylan Pharmaceuticals Inc.	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	
0378-1631_273877a4-ac76-4640-b05c-d56b0d70484d	0378-1631	HUMAN PRESCRIPTION DRUG	FORMOTEROL FUMARATE		formoterol fumarate dihydrate	SOLUTION	RESPIRATORY (INHALATION)	20210622		NDA AUTHORIZED GENERIC	NDA022007	Mylan Pharmaceuticals Inc.	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-1640_7ffb72ac-3633-4a8e-b724-88afedd22d30	0378-1640	HUMAN PRESCRIPTION DRUG	Voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20110215	20241231	ANDA	ANDA090547	Mylan Pharmaceuticals Inc.	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	
0378-1657_5338b580-6f06-444b-9571-200bca851a5d	0378-1657	HUMAN PRESCRIPTION DRUG	Sildenafil		sildinafil	TABLET, FILM COATED	ORAL	20121109	20240229	ANDA	ANDA201150	Mylan Pharmaceuticals Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
0378-1658_1d0e6262-2e9e-43ca-8f44-5f7e202a662c	0378-1658	HUMAN PRESCRIPTION DRUG	Sildenafil		sildenafil	TABLET, FILM COATED	ORAL	20190404		ANDA	ANDA201171	Mylan Pharmaceuticals Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0378-1659_1d0e6262-2e9e-43ca-8f44-5f7e202a662c	0378-1659	HUMAN PRESCRIPTION DRUG	Sildenafil		sildenafil	TABLET, FILM COATED	ORAL	20190404		ANDA	ANDA201171	Mylan Pharmaceuticals Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0378-1660_1d0e6262-2e9e-43ca-8f44-5f7e202a662c	0378-1660	HUMAN PRESCRIPTION DRUG	Sildenafil		sildenafil	TABLET, FILM COATED	ORAL	20190404		ANDA	ANDA201171	Mylan Pharmaceuticals Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0378-1721_ac1d0b4c-cd47-48f3-9343-6876fab71daf	0378-1721	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		AMLODIPINE AND VALSARTAN	TABLET, FILM COATED	ORAL	20150330		ANDA	ANDA090483	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1722_ac1d0b4c-cd47-48f3-9343-6876fab71daf	0378-1722	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		AMLODIPINE AND VALSARTAN	TABLET, FILM COATED	ORAL	20150330		ANDA	ANDA090483	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1723_ac1d0b4c-cd47-48f3-9343-6876fab71daf	0378-1723	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		AMLODIPINE AND VALSARTAN	TABLET, FILM COATED	ORAL	20150330		ANDA	ANDA090483	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1724_ac1d0b4c-cd47-48f3-9343-6876fab71daf	0378-1724	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		AMLODIPINE AND VALSARTAN	TABLET, FILM COATED	ORAL	20150330		ANDA	ANDA090483	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-1800_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1800	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1803_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1803	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1805_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1805	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1807_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1807	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1809_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1809	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1811_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1811	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1813_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1813	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1815_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1815	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1817_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1817	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1819_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1819	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1821_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1821	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1823_078efe5b-34d5-4505-b652-2aa5b519d418	0378-1823	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20061215		ANDA	ANDA076187	Mylan Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0378-1901_e92f278e-0a58-49e3-8fc0-3a16b8474d3b	0378-1901	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20030911		ANDA	ANDA076577	Mylan Pharmaceuticals Inc.	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0378-1902_e92f278e-0a58-49e3-8fc0-3a16b8474d3b	0378-1902	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20030911		ANDA	ANDA076577	Mylan Pharmaceuticals Inc.	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0378-1903_e92f278e-0a58-49e3-8fc0-3a16b8474d3b	0378-1903	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20030911		ANDA	ANDA076577	Mylan Pharmaceuticals Inc.	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0378-1905_60c7587f-e0db-41b8-94e2-67da4544c997	0378-1905	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20221019		ANDA	ANDA208257	Mylan Pharmaceuticals Inc.	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
0378-1930_d21888d6-d5a8-49fe-9e07-e854cf78b712	0378-1930	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA206436	Mylan Pharmaceuticals Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
0378-1935_c46c02e1-8159-4ab8-b6ab-3da52e4eb13e	0378-1935	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA213912	Mylan Pharmaceuticals Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
0378-1936_c46c02e1-8159-4ab8-b6ab-3da52e4eb13e	0378-1936	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA213912	Mylan Pharmaceuticals Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
0378-1937_c46c02e1-8159-4ab8-b6ab-3da52e4eb13e	0378-1937	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA213912	Mylan Pharmaceuticals Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
0378-1940_c46c02e1-8159-4ab8-b6ab-3da52e4eb13e	0378-1940	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA213912	Mylan Pharmaceuticals Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
0378-1941_c46c02e1-8159-4ab8-b6ab-3da52e4eb13e	0378-1941	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA213912	Mylan Pharmaceuticals Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
0378-1942_c46c02e1-8159-4ab8-b6ab-3da52e4eb13e	0378-1942	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA213912	Mylan Pharmaceuticals Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
0378-2045_a613c09f-71cb-465f-9033-7b0dd74b54e3	0378-2045	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100917		ANDA	ANDA090596	Mylan Pharmaceuticals Inc.	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
0378-2046_a613c09f-71cb-465f-9033-7b0dd74b54e3	0378-2046	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100917		ANDA	ANDA090596	Mylan Pharmaceuticals Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
0378-2047_a613c09f-71cb-465f-9033-7b0dd74b54e3	0378-2047	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100917		ANDA	ANDA090596	Mylan Pharmaceuticals Inc.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
0378-2096_18276df2-9ea6-4560-b8fc-18b0d8025342	0378-2096	HUMAN PRESCRIPTION DRUG	Nisoldipine		nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110128		ANDA	ANDA091001	Mylan Pharmaceuticals Inc.	NISOLDIPINE	8.5	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-2097_18276df2-9ea6-4560-b8fc-18b0d8025342	0378-2097	HUMAN PRESCRIPTION DRUG	Nisoldipine		nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110128		ANDA	ANDA091001	Mylan Pharmaceuticals Inc.	NISOLDIPINE	17	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-2098_18276df2-9ea6-4560-b8fc-18b0d8025342	0378-2098	HUMAN PRESCRIPTION DRUG	Nisoldipine		nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110128		ANDA	ANDA091001	Mylan Pharmaceuticals Inc.	NISOLDIPINE	25.5	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-2099_18276df2-9ea6-4560-b8fc-18b0d8025342	0378-2099	HUMAN PRESCRIPTION DRUG	Nisoldipine		nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110128		ANDA	ANDA091001	Mylan Pharmaceuticals Inc.	NISOLDIPINE	34	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0378-2100_84c39323-d4c3-452c-b89d-d104dcac4346	0378-2100	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	19910918		ANDA	ANDA072741	Mylan Pharmaceuticals Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
0378-2146_bf19b6ac-2432-49fe-ac8f-df759e9fe884	0378-2146	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	19810203		ANDA	ANDA040424	Mylan Pharmaceuticals Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0378-2150_2a2ba83c-8465-4d4e-8bd1-9bc73b50a3ab	0378-2150	HUMAN PRESCRIPTION DRUG	Meclofenamate Sodium		meclofenamate sodium	CAPSULE	ORAL	19860903		ANDA	ANDA071081	Mylan Pharmaceuticals Inc.	MECLOFENAMATE SODIUM	50	mg/1			N	20241231
0378-2222_f912a9d3-3306-477c-b868-a78c40f5809a	0378-2222	HUMAN PRESCRIPTION DRUG	Nisoldipine		Nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080725	20300101	ANDA	ANDA079051	Mylan Pharmaceuticals Inc.	NISOLDIPINE	20	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
0378-2223_f912a9d3-3306-477c-b868-a78c40f5809a	0378-2223	HUMAN PRESCRIPTION DRUG	Nisoldipine		Nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080725	20300101	ANDA	ANDA079051	Mylan Pharmaceuticals Inc.	NISOLDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
0378-2224_f912a9d3-3306-477c-b868-a78c40f5809a	0378-2224	HUMAN PRESCRIPTION DRUG	Nisoldipine		Nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080725	20300101	ANDA	ANDA079051	Mylan Pharmaceuticals Inc.	NISOLDIPINE	40	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
0378-2245_012fca57-d8e1-46dc-bfff-a3184f4de599	0378-2245	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		imatinib	TABLET, FILM COATED	ORAL	20170928		ANDA	ANDA204644	Mylan Pharmaceuticals Inc.	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0378-2246_012fca57-d8e1-46dc-bfff-a3184f4de599	0378-2246	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		imatinib	TABLET, FILM COATED	ORAL	20170928		ANDA	ANDA204644	Mylan Pharmaceuticals Inc.	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0378-2250_6731052a-6bc8-443f-a500-485fe06ea822	0378-2250	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	CAPSULE	ORAL	20090504		ANDA	ANDA065520	Mylan Pharmaceuticals Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0378-2302_d34df403-6e07-4fc2-bba7-ec34bd20b4d7	0378-2302	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890228		ANDA	ANDA072575	Mylan Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0378-2330_9e06d86c-b2bd-4afa-95f8-58622d83fd65	0378-2330	HUMAN PRESCRIPTION DRUG	Rufinamide		rufinamide	TABLET, FILM COATED	ORAL	20210601		ANDA	ANDA205095	Mylan Pharmaceuticals Inc.	RUFINAMIDE	200	mg/1			N	20241231
0378-2331_9e06d86c-b2bd-4afa-95f8-58622d83fd65	0378-2331	HUMAN PRESCRIPTION DRUG	Rufinamide		rufinamide	TABLET, FILM COATED	ORAL	20210601		ANDA	ANDA205095	Mylan Pharmaceuticals Inc.	RUFINAMIDE	400	mg/1			N	20241231
0378-2350_55a08066-56c9-4fd7-a64d-94e8994e100a	0378-2350	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20150803		ANDA	ANDA078936	Mylan Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-2351_55a08066-56c9-4fd7-a64d-94e8994e100a	0378-2351	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20150803		ANDA	ANDA078936	Mylan Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-2401_410bca3b-f13c-43f9-a16b-5e0e450917d2	0378-2401	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19970829		ANDA	ANDA040209	Mylan Pharmaceuticals Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-2402_410bca3b-f13c-43f9-a16b-5e0e450917d2	0378-2402	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19970829		ANDA	ANDA040209	Mylan Pharmaceuticals Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-2405_410bca3b-f13c-43f9-a16b-5e0e450917d2	0378-2405	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19970829		ANDA	ANDA040209	Mylan Pharmaceuticals Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-2410_410bca3b-f13c-43f9-a16b-5e0e450917d2	0378-2410	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19970829		ANDA	ANDA040209	Mylan Pharmaceuticals Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0378-2474_29742e42-c31f-497a-b8df-4efc6346c4e6	0378-2474	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	19990917	20240229	ANDA	ANDA075463	Mylan Pharmaceuticals Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0378-2670_ef0ae0b6-fe8b-4aa7-bd37-5414db9069cf	0378-2670	HUMAN PRESCRIPTION DRUG	Phenytek		extended phenytoin sodium	CAPSULE, EXTENDED RELEASE	ORAL	20011210		ANDA	ANDA040298	Mylan Pharmaceuticals Inc.	PHENYTOIN SODIUM	200	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0378-2920_3990ab06-c65c-4e19-9139-c05e46345c72	0378-2920	HUMAN PRESCRIPTION DRUG	Telmisartan		telmisartan	TABLET	ORAL	20140707		ANDA	ANDA202397	Mylan Pharmaceuticals Inc.	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-2921_3990ab06-c65c-4e19-9139-c05e46345c72	0378-2921	HUMAN PRESCRIPTION DRUG	Telmisartan		telmisartan	TABLET	ORAL	20140707		ANDA	ANDA202397	Mylan Pharmaceuticals Inc.	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-2922_3990ab06-c65c-4e19-9139-c05e46345c72	0378-2922	HUMAN PRESCRIPTION DRUG	Telmisartan		telmisartan	TABLET	ORAL	20140707		ANDA	ANDA202397	Mylan Pharmaceuticals Inc.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-3000_2a2ba83c-8465-4d4e-8bd1-9bc73b50a3ab	0378-3000	HUMAN PRESCRIPTION DRUG	Meclofenamate Sodium		meclofenamate sodium	CAPSULE	ORAL	19860903		ANDA	ANDA071081	Mylan Pharmaceuticals Inc.	MECLOFENAMATE SODIUM	100	mg/1			N	20241231
0378-3001_0cc4e1bb-e78c-4a7a-9aee-999399ea5a45	0378-3001	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20121204		ANDA	ANDA090704	Mylan Pharmaceuticals Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-3002_0cc4e1bb-e78c-4a7a-9aee-999399ea5a45	0378-3002	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20121204		ANDA	ANDA090704	Mylan Pharmaceuticals Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-3003_0cc4e1bb-e78c-4a7a-9aee-999399ea5a45	0378-3003	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20121204		ANDA	ANDA090704	Mylan Pharmaceuticals Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 25	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-3025_c53d1f25-6b7a-4559-90fc-e6e46bb2e0b8	0378-3025	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	19980511	20240430	ANDA	ANDA074947	Mylan Pharmaceuticals Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
0378-3050_c53d1f25-6b7a-4559-90fc-e6e46bb2e0b8	0378-3050	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	19980511	20240430	ANDA	ANDA074947	Mylan Pharmaceuticals Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
0378-3065_0994a7ae-8316-4ed4-bb42-b0ccdad9f1a9	0378-3065	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20130514		ANDA	ANDA202856	Mylan Pharmaceuticals Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0378-3066_0994a7ae-8316-4ed4-bb42-b0ccdad9f1a9	0378-3066	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20130514		ANDA	ANDA202856	Mylan Pharmaceuticals Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0378-3075_c53d1f25-6b7a-4559-90fc-e6e46bb2e0b8	0378-3075	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	19980511	20240430	ANDA	ANDA074947	Mylan Pharmaceuticals Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	
0378-3096_3b66e028-99fb-44e4-9c15-288f30b64708	0378-3096	HUMAN PRESCRIPTION DRUG	everolimus		everolimus	TABLET	ORAL	20221215		ANDA	ANDA212936	Mylan Pharmaceuticals Inc.	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0378-3097_3b66e028-99fb-44e4-9c15-288f30b64708	0378-3097	HUMAN PRESCRIPTION DRUG	everolimus		everolimus	TABLET	ORAL	20221215		ANDA	ANDA212936	Mylan Pharmaceuticals Inc.	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0378-3098_3b66e028-99fb-44e4-9c15-288f30b64708	0378-3098	HUMAN PRESCRIPTION DRUG	everolimus		everolimus	TABLET	ORAL	20221215		ANDA	ANDA212936	Mylan Pharmaceuticals Inc.	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0378-3099_3b66e028-99fb-44e4-9c15-288f30b64708	0378-3099	HUMAN PRESCRIPTION DRUG	everolimus		everolimus	TABLET	ORAL	20221215		ANDA	ANDA212936	Mylan Pharmaceuticals Inc.	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0378-3125_528d1ddf-62f6-451f-a3af-8649e486282c	0378-3125	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0378-3205_d34df403-6e07-4fc2-bba7-ec34bd20b4d7	0378-3205	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890228		ANDA	ANDA072575	Mylan Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0378-3224_1ef1afb2-a661-49d5-ab80-4b41e2369c63	0378-3224	HUMAN PRESCRIPTION DRUG	candesartan cilexetil		candesartan cilexetil	TABLET	ORAL	20200106		ANDA	ANDA078702	Mylan Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-3225_1ef1afb2-a661-49d5-ab80-4b41e2369c63	0378-3225	HUMAN PRESCRIPTION DRUG	candesartan cilexetil		candesartan cilexetil	TABLET	ORAL	20200106		ANDA	ANDA078702	Mylan Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-3231_1ef1afb2-a661-49d5-ab80-4b41e2369c63	0378-3231	HUMAN PRESCRIPTION DRUG	candesartan cilexetil		candesartan cilexetil	TABLET	ORAL	20200106		ANDA	ANDA078702	Mylan Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-3232_1ef1afb2-a661-49d5-ab80-4b41e2369c63	0378-3232	HUMAN PRESCRIPTION DRUG	candesartan cilexetil		candesartan cilexetil	TABLET	ORAL	20200106		ANDA	ANDA078702	Mylan Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-3266_a591eea6-af04-4207-b0f7-61fbada4719c	0378-3266	HUMAN PRESCRIPTION DRUG	Etoposide		etoposide	CAPSULE	ORAL	20011022		ANDA	ANDA075635	Mylan Pharmaceuticals Inc.	ETOPOSIDE	50	mg/1	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0378-3340_5cf2e689-da68-4a6a-8761-267a63244360	0378-3340	HUMAN PRESCRIPTION DRUG	XULANE		norelgestromin and ethinyl estradiol	PATCH	TRANSDERMAL	20140416		ANDA	ANDA200910	Mylan Pharmaceuticals Inc.	ETHINYL ESTRADIOL; NORELGESTROMIN	35; 150	ug/d; ug/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-3349_ea2e5496-f2cf-4031-a572-2b0b834556f3	0378-3349	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20050407		ANDA	ANDA075182	Mylan Pharmaceuticals Inc.	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-3350_ea2e5496-f2cf-4031-a572-2b0b834556f3	0378-3350	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20000301		ANDA	ANDA075182	Mylan Pharmaceuticals Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-3351_ea2e5496-f2cf-4031-a572-2b0b834556f3	0378-3351	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20050407		ANDA	ANDA075182	Mylan Pharmaceuticals Inc.	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-3352_ea2e5496-f2cf-4031-a572-2b0b834556f3	0378-3352	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20000301		ANDA	ANDA075182	Mylan Pharmaceuticals Inc.	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-3360_ea2e5496-f2cf-4031-a572-2b0b834556f3	0378-3360	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20060809		ANDA	ANDA075182	Mylan Pharmaceuticals Inc.	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-3361_ea2e5496-f2cf-4031-a572-2b0b834556f3	0378-3361	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20060809		ANDA	ANDA075182	Mylan Pharmaceuticals Inc.	ESTRADIOL	.06	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-3431_2c12075d-4a65-47d0-931a-644bb189ae04	0378-3431	HUMAN PRESCRIPTION DRUG	Armodafinil		armodafinil	TABLET	ORAL	20160601		ANDA	ANDA200043	Mylan Pharmaceuticals Inc.	ARMODAFINIL	50	mg/1		CIV	N	20241231
0378-3432_2c12075d-4a65-47d0-931a-644bb189ae04	0378-3432	HUMAN PRESCRIPTION DRUG	Armodafinil		armodafinil	TABLET	ORAL	20160601		ANDA	ANDA200043	Mylan Pharmaceuticals Inc.	ARMODAFINIL	150	mg/1		CIV	N	20241231
0378-3433_2c12075d-4a65-47d0-931a-644bb189ae04	0378-3433	HUMAN PRESCRIPTION DRUG	Armodafinil		armodafinil	TABLET	ORAL	20160601		ANDA	ANDA200043	Mylan Pharmaceuticals Inc.	ARMODAFINIL	250	mg/1		CIV	N	20241231
0378-3458_01e2dbc0-78d5-46da-afad-9610e42ed3ee	0378-3458	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride and Fluticasone Propionate		Azelastine Hydrochloride and Fluticasone Propionate	SPRAY, METERED	NASAL	20200414		NDA AUTHORIZED GENERIC	NDA202236	Mylan Pharmaceuticals Inc.	AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE	137; 50	ug/1; ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0378-3515_681d9ec4-046b-4c0e-b85f-2468620c724b	0378-3515	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030620		ANDA	ANDA076122	Mylan Pharmaceuticals Inc.	MIRTAZAPINE	15	mg/1			N	20241231
0378-3520_88dccf91-6e62-4f5f-849d-1ffa8bf8df9d	0378-3520	HUMAN PRESCRIPTION DRUG	Fosamprenavir Calcium		fosamprenavir calcium	TABLET, FILM COATED	ORAL	20170918		ANDA	ANDA204060	Mylan Pharmaceuticals Inc.	FOSAMPRENAVIR CALCIUM	700	mg/1	Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inducers [MoA], Protease Inhibitor [EPC]		N	20241231
0378-3530_681d9ec4-046b-4c0e-b85f-2468620c724b	0378-3530	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030620		ANDA	ANDA076122	Mylan Pharmaceuticals Inc.	MIRTAZAPINE	30	mg/1			N	20241231
0378-3545_681d9ec4-046b-4c0e-b85f-2468620c724b	0378-3545	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030620		ANDA	ANDA076122	Mylan Pharmaceuticals Inc.	MIRTAZAPINE	45	mg/1			N	20241231
0378-3547_f294e82d-4fbd-422b-b5fe-f77f0d6192ef	0378-3547	HUMAN PRESCRIPTION DRUG	Mercaptopurine		mercaptopurine	TABLET	ORAL	20050701		ANDA	ANDA040594	Mylan Pharmaceuticals Inc.	MERCAPTOPURINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0378-3631_d9fae816-e0d4-4baa-b0cd-e61669badea7	0378-3631	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070905	20240331	ANDA	ANDA077316	Mylan Pharmaceuticals Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	
0378-3632_d9fae816-e0d4-4baa-b0cd-e61669badea7	0378-3632	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070905	20250228	ANDA	ANDA077316	Mylan Pharmaceuticals Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	
0378-3633_d9fae816-e0d4-4baa-b0cd-e61669badea7	0378-3633	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070905	20250331	ANDA	ANDA077316	Mylan Pharmaceuticals Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	
0378-3634_d9fae816-e0d4-4baa-b0cd-e61669badea7	0378-3634	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077316	Mylan Pharmaceuticals Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0378-3635_5670c6c3-a4ab-4268-917a-99e0579f3079	0378-3635	HUMAN OTC DRUG	Cetirizine Hydrochloride		cetirizine hydrochloride	TABLET, FILM COATED	ORAL	20071227		ANDA	ANDA076677	Mylan Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0378-3637_5670c6c3-a4ab-4268-917a-99e0579f3079	0378-3637	HUMAN OTC DRUG	Cetirizine Hydrochloride		cetirizine hydrochloride	TABLET, FILM COATED	ORAL	20071227		ANDA	ANDA076677	Mylan Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0378-3750_ef0ae0b6-fe8b-4aa7-bd37-5414db9069cf	0378-3750	HUMAN PRESCRIPTION DRUG	Phenytek		phenytoin sodium	CAPSULE, EXTENDED RELEASE	ORAL	20011210		ANDA	ANDA040298	Mylan Pharmaceuticals Inc.	PHENYTOIN SODIUM	300	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0378-3813_47227a5a-7480-4106-9051-b3dac7de31f4	0378-3813	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20151102		ANDA	ANDA201824	Mylan Pharmaceuticals Inc.	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-3815_47227a5a-7480-4106-9051-b3dac7de31f4	0378-3815	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20151102		ANDA	ANDA201824	Mylan Pharmaceuticals Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-3816_47227a5a-7480-4106-9051-b3dac7de31f4	0378-3816	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20230816		ANDA	ANDA201824	Mylan Pharmaceuticals Inc.	CLOZAPINE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-3817_47227a5a-7480-4106-9051-b3dac7de31f4	0378-3817	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20230816		ANDA	ANDA201824	Mylan Pharmaceuticals Inc.	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-3950_ba547410-eb89-4d3a-a755-21a8ec43b871	0378-3950	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20130919		ANDA	ANDA091226	Mylan Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-3951_ba547410-eb89-4d3a-a755-21a8ec43b871	0378-3951	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20130919		ANDA	ANDA091226	Mylan Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-3952_ba547410-eb89-4d3a-a755-21a8ec43b871	0378-3952	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA091226	Mylan Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-3953_ba547410-eb89-4d3a-a755-21a8ec43b871	0378-3953	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20130919		ANDA	ANDA091226	Mylan Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-3980_b9bab77b-f3c2-425e-a160-37ad5ac7e80c	0378-3980	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150924	20240430	ANDA	ANDA203802	Mylan Pharmaceuticals Inc.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	
0378-3981_b9bab77b-f3c2-425e-a160-37ad5ac7e80c	0378-3981	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150924	20240131	ANDA	ANDA203802	Mylan Pharmaceuticals Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	
0378-4050_7bd83a74-71cc-472e-bfac-2f721b866905	0378-4050	HUMAN PRESCRIPTION DRUG	Nevirapine		nevirapine	TABLET	ORAL	20120522		ANDA	ANDA202523	Mylan Pharmaceuticals Inc.	NEVIRAPINE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0378-4105_2b1700b3-c2fe-4e96-a849-403d17b5fa2e	0378-4105	HUMAN PRESCRIPTION DRUG	Abacavir Sulfate		abacavir sulfate	TABLET, FILM COATED	ORAL	20120619		ANDA	ANDA091294	Mylan Pharmaceuticals Inc.	ABACAVIR SULFATE	300	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0378-4145_75a73f3c-36f0-482c-87fc-c5bab212d4e5	0378-4145	HUMAN PRESCRIPTION DRUG	Riluzole		riluzole	TABLET, FILM COATED	ORAL	20130722		ANDA	ANDA203042	Mylan Pharmaceuticals Inc.	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20241231
0378-4160_542f2f4d-84aa-416d-9d85-3dab8dca5cc8	0378-4160	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		atovaquone and proguanil hydrochloride	TABLET, FILM COATED	ORAL	20140528		ANDA	ANDA202362	Mylan Pharmaceuticals Inc.	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	62.5; 25	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
0378-4162_542f2f4d-84aa-416d-9d85-3dab8dca5cc8	0378-4162	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		atovaquone and proguanil hydrochloride	TABLET, FILM COATED	ORAL	20140528		ANDA	ANDA202362	Mylan Pharmaceuticals Inc.	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
0378-4250_528d1ddf-62f6-451f-a3af-8649e486282c	0378-4250	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0378-4270_e4e5f29a-5586-43d0-b80d-3277908b75a9	0378-4270	HUMAN PRESCRIPTION DRUG	Ambrisentan		ambrisentan	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA208441	Mylan Pharmaceuticals Inc.	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
0378-4271_e4e5f29a-5586-43d0-b80d-3277908b75a9	0378-4271	HUMAN PRESCRIPTION DRUG	Ambrisentan		ambrisentan	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA208441	Mylan Pharmaceuticals Inc.	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
0378-4275_6c899997-4cc1-40e2-a3cb-696c2566ae94	0378-4275	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		valacyclovir	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA078518	Mylan Pharmaceuticals Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0378-4276_6c899997-4cc1-40e2-a3cb-696c2566ae94	0378-4276	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		valacyclovir	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA078518	Mylan Pharmaceuticals Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0378-4287_cba8e2c4-eb4b-49c7-83be-d5cfb58b23d9	0378-4287	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170815		ANDA	ANDA205152	Mylan Pharmaceuticals Inc.	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-4288_cba8e2c4-eb4b-49c7-83be-d5cfb58b23d9	0378-4288	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170815		ANDA	ANDA205152	Mylan Pharmaceuticals Inc.	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-4390_0861e52e-72f0-489e-8b25-e545620ac26a	0378-4390	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET	ORAL	20160623		ANDA	ANDA204475	Mylan Pharmaceuticals Inc.	FENOFIBRATE	40	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0378-4391_0861e52e-72f0-489e-8b25-e545620ac26a	0378-4391	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET	ORAL	20160623		ANDA	ANDA204475	Mylan Pharmaceuticals Inc.	FENOFIBRATE	120	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0378-4472_6731052a-6bc8-443f-a500-485fe06ea822	0378-4472	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	TABLET, FILM COATED	ORAL	20090504		ANDA	ANDA065521	Mylan Pharmaceuticals Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0378-4500_ee7dda25-e215-414a-8fa3-1020fda9026b	0378-4500	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201020	20240430	ANDA	ANDA208851	Mylan Pharmaceuticals Inc.	BUDESONIDE	9	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0378-4513_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4513	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20150402		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4514_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4514	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20140521		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4515_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4515	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20141016		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4516_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4516	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20141010		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4517_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4517	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20141106		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4518_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4518	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20140211		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4519_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4519	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20140211		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4520_f478482e-05f2-46d6-87d2-8f36c5146d85	0378-4520	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20140521		ANDA	ANDA200465	Mylan Pharmaceuticals Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-4525_be2a4901-e292-45c3-b868-3da06d16a791	0378-4525	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod	CAPSULE	ORAL	20220922		ANDA	ANDA208005	Mylan Pharmaceuticals Inc.	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
0378-4560_975ccdcc-b4a6-40ef-8668-27989498db7f	0378-4560	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161109		ANDA	ANDA204662	Mylan Pharmaceuticals Inc.	POTASSIUM CHLORIDE	8	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0378-4561_975ccdcc-b4a6-40ef-8668-27989498db7f	0378-4561	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161109		ANDA	ANDA204662	Mylan Pharmaceuticals Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0378-4593_086a9f64-2ffe-46b5-b165-f6451c29ae47	0378-4593	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20160329		ANDA	ANDA076704	Mylan Pharmaceuticals Inc.	METOPROLOL TARTRATE	37.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-4594_086a9f64-2ffe-46b5-b165-f6451c29ae47	0378-4594	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20160329		ANDA	ANDA076704	Mylan Pharmaceuticals Inc.	METOPROLOL TARTRATE	75	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-4595_97ce83ca-6fd4-46be-877b-ed1f9ea533ba	0378-4595	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190102		ANDA	ANDA202033	Mylan Pharmaceuticals Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-4596_97ce83ca-6fd4-46be-877b-ed1f9ea533ba	0378-4596	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190102		ANDA	ANDA202033	Mylan Pharmaceuticals Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-4597_97ce83ca-6fd4-46be-877b-ed1f9ea533ba	0378-4597	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190102		ANDA	ANDA202033	Mylan Pharmaceuticals Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-4598_97ce83ca-6fd4-46be-877b-ed1f9ea533ba	0378-4598	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190102		ANDA	ANDA202033	Mylan Pharmaceuticals Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0378-4615_cb6d7357-e5e8-469b-9cc6-24afed78d00b	0378-4615	HUMAN PRESCRIPTION DRUG	Doxylamine Succinate and Pyridoxine Hydrochloride		doxylamine succinate and pyridoxine hydrochloride	TABLET, DELAYED RELEASE	ORAL	20200721		ANDA	ANDA207825	Mylan Pharmaceuticals Inc.	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
0378-4619_29e6312d-bb17-4958-87fb-ef5912bb3c2e	0378-4619	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20181101		ANDA	ANDA206685	Mylan Pharmaceuticals Inc.	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4620_29e6312d-bb17-4958-87fb-ef5912bb3c2e	0378-4620	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20181101		ANDA	ANDA206685	Mylan Pharmaceuticals Inc.	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4621_29e6312d-bb17-4958-87fb-ef5912bb3c2e	0378-4621	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20181101		ANDA	ANDA206685	Mylan Pharmaceuticals Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4622_29e6312d-bb17-4958-87fb-ef5912bb3c2e	0378-4622	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20181101		ANDA	ANDA206685	Mylan Pharmaceuticals Inc.	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4623_29e6312d-bb17-4958-87fb-ef5912bb3c2e	0378-4623	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20181101		ANDA	ANDA206685	Mylan Pharmaceuticals Inc.	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4640_80015fb2-2356-499b-890d-386dacfb383e	0378-4640	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20141219		ANDA	ANDA201675	Mylan Pharmaceuticals Inc.	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4641_80015fb2-2356-499b-890d-386dacfb383e	0378-4641	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20141219		ANDA	ANDA201675	Mylan Pharmaceuticals Inc.	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4642_80015fb2-2356-499b-890d-386dacfb383e	0378-4642	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20141219		ANDA	ANDA201675	Mylan Pharmaceuticals Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4643_80015fb2-2356-499b-890d-386dacfb383e	0378-4643	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20141219		ANDA	ANDA201675	Mylan Pharmaceuticals Inc.	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4644_80015fb2-2356-499b-890d-386dacfb383e	0378-4644	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH	TRANSDERMAL	20141219		ANDA	ANDA201675	Mylan Pharmaceuticals Inc.	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-4705_532191af-6300-4246-b459-734e49f21c86	0378-4705	HUMAN PRESCRIPTION DRUG	Saxagliptin		saxagliptin	TABLET, FILM COATED	ORAL	20230804		ANDA	ANDA205980	Mylan Pharmaceuticals Inc.	SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE	2.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0378-4706_532191af-6300-4246-b459-734e49f21c86	0378-4706	HUMAN PRESCRIPTION DRUG	Saxagliptin		saxagliptin	TABLET, FILM COATED	ORAL	20230804		ANDA	ANDA205980	Mylan Pharmaceuticals Inc.	SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0378-4791_1ff72539-1af5-41bf-8720-1ba12df35abc	0378-4791	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	CREAM	TOPICAL	20130919		NDA AUTHORIZED GENERIC	NDA016831	Mylan Pharmaceuticals Inc.	FLUOROURACIL	5	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0378-4810_cdca2aa8-76d9-4d8d-b163-b08da2c482c5	0378-4810	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	TABLET	ORAL	20200102	20240430	NDA AUTHORIZED GENERIC	NDA022036	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	
0378-4811_cdca2aa8-76d9-4d8d-b163-b08da2c482c5	0378-4811	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	TABLET	ORAL	20200102	20240430	NDA AUTHORIZED GENERIC	NDA022036	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	
0378-4830_e04da0a1-d02a-487d-a931-a31034738fdd	0378-4830	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20220520		ANDA	ANDA213847	Mylan Pharmaceuticals Inc.	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
0378-4890_efe32b99-275f-4979-91a0-c7d7ec594455	0378-4890	HUMAN PRESCRIPTION DRUG	Nevirapine		nevirapine	TABLET, EXTENDED RELEASE	ORAL	20141029		ANDA	ANDA205651	Mylan Pharmaceuticals Inc.	NEVIRAPINE	400	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0378-5055_b3cd7a77-9856-4bfe-9807-ade14a3c15f4	0378-5055	HUMAN PRESCRIPTION DRUG	Pitavastatin Calcium		pitavastatin	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA206070	Mylan Pharmaceuticals Inc.	PITAVASTATIN CALCIUM	1	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-5056_b3cd7a77-9856-4bfe-9807-ade14a3c15f4	0378-5056	HUMAN PRESCRIPTION DRUG	Pitavastatin Calcium		pitavastatin	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA206070	Mylan Pharmaceuticals Inc.	PITAVASTATIN CALCIUM	2	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-5057_b3cd7a77-9856-4bfe-9807-ade14a3c15f4	0378-5057	HUMAN PRESCRIPTION DRUG	Pitavastatin Calcium		pitavastatin	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA206070	Mylan Pharmaceuticals Inc.	PITAVASTATIN CALCIUM	4	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-5185_7ec7f053-c7f5-4626-b8b4-3d3247f0845b	0378-5185	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20170816		ANDA	ANDA205927	Mylan Pharmaceuticals Inc.	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0378-5186_7ec7f053-c7f5-4626-b8b4-3d3247f0845b	0378-5186	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20170815		ANDA	ANDA205927	Mylan Pharmaceuticals Inc.	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0378-5245_24da4379-1283-4c66-97bd-643b27a15368	0378-5245	HUMAN PRESCRIPTION DRUG	Almotriptan Malate		Almotriptan	TABLET, FILM COATED	ORAL	20151110		ANDA	ANDA205171	Mylan Pharmaceuticals Inc.	ALMOTRIPTAN MALATE	6.25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-5246_24da4379-1283-4c66-97bd-643b27a15368	0378-5246	HUMAN PRESCRIPTION DRUG	Almotriptan Malate		Almotriptan	TABLET, FILM COATED	ORAL	20151110		ANDA	ANDA205171	Mylan Pharmaceuticals Inc.	ALMOTRIPTAN MALATE	12.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-5270_850bc29d-2353-4e1f-bfe4-0811eb79000f	0378-5270	HUMAN PRESCRIPTION DRUG	Eszopiclone		eszopiclone	TABLET, FILM COATED	ORAL	20130326		ANDA	ANDA091151	Mylan Pharmaceuticals Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
0378-5271_850bc29d-2353-4e1f-bfe4-0811eb79000f	0378-5271	HUMAN PRESCRIPTION DRUG	Eszopiclone		eszopiclone	TABLET, FILM COATED	ORAL	20130326		ANDA	ANDA091151	Mylan Pharmaceuticals Inc.	ESZOPICLONE	2	mg/1		CIV	N	20241231
0378-5272_850bc29d-2353-4e1f-bfe4-0811eb79000f	0378-5272	HUMAN PRESCRIPTION DRUG	Eszopiclone		eszopiclone	TABLET, FILM COATED	ORAL	20130326		ANDA	ANDA091151	Mylan Pharmaceuticals Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
0378-5375_528d1ddf-62f6-451f-a3af-8649e486282c	0378-5375	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0378-5430_2d7654c7-9466-4647-9e54-570a69e1bb28	0378-5430	HUMAN PRESCRIPTION DRUG	Moxifloxacin		moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20200528	20241031	ANDA	ANDA206447	Mylan Pharmaceuticals Inc.	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	
0378-5510_c390b023-dcf1-4cb1-951b-cc305c7da309	0378-5510	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140512		ANDA	ANDA202285	Mylan Pharmaceuticals Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-5511_c390b023-dcf1-4cb1-951b-cc305c7da309	0378-5511	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140512		ANDA	ANDA202285	Mylan Pharmaceuticals Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-5512_c390b023-dcf1-4cb1-951b-cc305c7da309	0378-5512	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140512		ANDA	ANDA202285	Mylan Pharmaceuticals Inc.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-5513_c390b023-dcf1-4cb1-951b-cc305c7da309	0378-5513	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140512		ANDA	ANDA202285	Mylan Pharmaceuticals Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0378-5615_5c6f87fe-aabf-4349-9f1b-a280256dce5e	0378-5615	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20081104		ANDA	ANDA076919	Mylan Pharmaceuticals Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0378-5617_5c6f87fe-aabf-4349-9f1b-a280256dce5e	0378-5617	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20081104		ANDA	ANDA076919	Mylan Pharmaceuticals Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0378-5619_5c6f87fe-aabf-4349-9f1b-a280256dce5e	0378-5619	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20091210		ANDA	ANDA090261	Mylan Pharmaceuticals Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0378-5630_39d42545-ae9e-45e4-8b7a-aee017fb524e	0378-5630	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA077744	Mylan Pharmaceuticals Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-5631_39d42545-ae9e-45e4-8b7a-aee017fb524e	0378-5631	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA077744	Mylan Pharmaceuticals Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-5632_39d42545-ae9e-45e4-8b7a-aee017fb524e	0378-5632	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA077744	Mylan Pharmaceuticals Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0378-5807_dfa42353-61ed-4419-baea-724bb3b79f30	0378-5807	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA090866	Mylan Pharmaceuticals Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-5813_dfa42353-61ed-4419-baea-724bb3b79f30	0378-5813	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA090866	Mylan Pharmaceuticals Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-5814_dfa42353-61ed-4419-baea-724bb3b79f30	0378-5814	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA090866	Mylan Pharmaceuticals Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-5815_dfa42353-61ed-4419-baea-724bb3b79f30	0378-5815	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA090866	Mylan Pharmaceuticals Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0378-6001_b1d71739-26c3-43d3-9088-60bef3689e74	0378-6001	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160823		ANDA	ANDA200690	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0378-6002_b1d71739-26c3-43d3-9088-60bef3689e74	0378-6002	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160823		ANDA	ANDA200690	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0378-6060_1208426a-202a-49d5-aa98-b1f100df1b21	0378-6060	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19970502		ANDA	ANDA074910	Mylan Pharmaceuticals Inc.	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0378-6090_1208426a-202a-49d5-aa98-b1f100df1b21	0378-6090	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19970502		ANDA	ANDA074910	Mylan Pharmaceuticals Inc.	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0378-6120_1208426a-202a-49d5-aa98-b1f100df1b21	0378-6120	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19970502		ANDA	ANDA074910	Mylan Pharmaceuticals Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0378-6172_295d066f-8bdf-4c33-a1d4-4f768eececc2	0378-6172	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	20040106		ANDA	ANDA076698	Mylan Pharmaceuticals Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0378-6173_295d066f-8bdf-4c33-a1d4-4f768eececc2	0378-6173	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	20041019		ANDA	ANDA076698	Mylan Pharmaceuticals Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0378-6174_295d066f-8bdf-4c33-a1d4-4f768eececc2	0378-6174	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	20041019		ANDA	ANDA076698	Mylan Pharmaceuticals Inc.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0378-6231_18ca0ac9-56b4-473d-a3e8-94c29b58f506	0378-6231	HUMAN PRESCRIPTION DRUG	Citalopram		citalopram	TABLET, FILM COATED	ORAL	20080728		ANDA	ANDA077042	Mylan Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0378-6232_18ca0ac9-56b4-473d-a3e8-94c29b58f506	0378-6232	HUMAN PRESCRIPTION DRUG	Citalopram		citalopram	TABLET, FILM COATED	ORAL	20080728		ANDA	ANDA077042	Mylan Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0378-6233_18ca0ac9-56b4-473d-a3e8-94c29b58f506	0378-6233	HUMAN PRESCRIPTION DRUG	Citalopram		citalopram	TABLET, FILM COATED	ORAL	20080728		ANDA	ANDA077042	Mylan Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0378-6320_0c50b77a-0685-4db4-8311-bd4d7deffbe3	0378-6320	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19990520		ANDA	ANDA075138	Mylan Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0378-6321_cb98bd38-cbdb-4d73-8bed-6e25e226909f	0378-6321	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120921		ANDA	ANDA078020	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-6322_cb98bd38-cbdb-4d73-8bed-6e25e226909f	0378-6322	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120921		ANDA	ANDA078020	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-6323_cb98bd38-cbdb-4d73-8bed-6e25e226909f	0378-6323	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120921		ANDA	ANDA078020	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-6324_cb98bd38-cbdb-4d73-8bed-6e25e226909f	0378-6324	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120921		ANDA	ANDA078020	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-6325_cb98bd38-cbdb-4d73-8bed-6e25e226909f	0378-6325	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120921		ANDA	ANDA078020	Mylan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0378-6333_2708a3db-e987-4dd8-9c47-db3aa8a7010e	0378-6333	HUMAN PRESCRIPTION DRUG	Acamprosate Calcium		acamprosate calcium enteric-coated	TABLET, DELAYED RELEASE	ORAL	20140924		ANDA	ANDA200142	Mylan Pharmaceuticals Inc.	ACAMPROSATE CALCIUM	333	mg/1			N	20241231
0378-6380_0c50b77a-0685-4db4-8311-bd4d7deffbe3	0378-6380	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19990520		ANDA	ANDA075138	Mylan Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0378-6410_528d1ddf-62f6-451f-a3af-8649e486282c	0378-6410	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0378-6440_0c50b77a-0685-4db4-8311-bd4d7deffbe3	0378-6440	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19990520		ANDA	ANDA075138	Mylan Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0378-6470_163accb7-45e6-4d97-844d-72b606677008	0378-6470	HUMAN PRESCRIPTION DRUG	Scopolamine		scopolamine	PATCH	TRANSDERMAL	20190619		ANDA	ANDA203753	Mylan Pharmaceuticals Inc.	SCOPOLAMINE	1	mg/3d	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0378-6550_a668d9c7-2208-4aa5-8e53-ce2c3c8fcdb3	0378-6550	HUMAN PRESCRIPTION DRUG	LEVONORGESTREL AND ETHINYL ESTRADIOL		levonorgestrel and ethinyl estradiol	KIT		20130816		ANDA	ANDA091663	Mylan Pharmaceuticals Inc.						N	20241231
0378-6611_1b5bde7e-86a5-452e-a5da-ea8b6f3c0382	0378-6611	HUMAN PRESCRIPTION DRUG	Amnesteem		isotretinoin	CAPSULE	ORAL	20021111		ANDA	ANDA075945	Mylan Pharmaceuticals Inc.	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-6612_1b5bde7e-86a5-452e-a5da-ea8b6f3c0382	0378-6612	HUMAN PRESCRIPTION DRUG	Amnesteem		isotretinoin	CAPSULE	ORAL	20021111		ANDA	ANDA075945	Mylan Pharmaceuticals Inc.	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-6614_1b5bde7e-86a5-452e-a5da-ea8b6f3c0382	0378-6614	HUMAN PRESCRIPTION DRUG	Amnesteem		isotretinoin	CAPSULE	ORAL	20021111		ANDA	ANDA075945	Mylan Pharmaceuticals Inc.	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-6678_d34e742f-2268-4754-80e3-3dd5346c19b7	0378-6678	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		sunitinib malate	CAPSULE	ORAL	20220104		ANDA	ANDA201275	Mylan Pharmaceuticals Inc.	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0378-6679_d34e742f-2268-4754-80e3-3dd5346c19b7	0378-6679	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		sunitinib malate	CAPSULE	ORAL	20220104		ANDA	ANDA201275	Mylan Pharmaceuticals Inc.	SUNITINIB MALATE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0378-6680_d34e742f-2268-4754-80e3-3dd5346c19b7	0378-6680	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		sunitinib malate	CAPSULE	ORAL	20220104		ANDA	ANDA201275	Mylan Pharmaceuticals Inc.	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0378-6681_d34e742f-2268-4754-80e3-3dd5346c19b7	0378-6681	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		sunitinib malate	CAPSULE	ORAL	20220104		ANDA	ANDA201275	Mylan Pharmaceuticals Inc.	SUNITINIB MALATE	37.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0378-6688_38896560-f523-4d0b-8113-5ff7f5f38c81	0378-6688	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA090970	Mylan Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-6689_38896560-f523-4d0b-8113-5ff7f5f38c81	0378-6689	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA090970	Mylan Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-6854_efbde0f6-b848-4664-b741-c6c630e66108	0378-6854	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine	CAPSULE	ORAL	20230825		ANDA	ANDA202835	Mylan Pharmaceuticals Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-6855_efbde0f6-b848-4664-b741-c6c630e66108	0378-6855	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine	CAPSULE	ORAL	20230825		ANDA	ANDA202835	Mylan Pharmaceuticals Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-6856_efbde0f6-b848-4664-b741-c6c630e66108	0378-6856	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine	CAPSULE	ORAL	20230825		ANDA	ANDA202835	Mylan Pharmaceuticals Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-6857_efbde0f6-b848-4664-b741-c6c630e66108	0378-6857	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine	CAPSULE	ORAL	20230825		ANDA	ANDA202835	Mylan Pharmaceuticals Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-6858_efbde0f6-b848-4664-b741-c6c630e66108	0378-6858	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine	CAPSULE	ORAL	20230825		ANDA	ANDA202835	Mylan Pharmaceuticals Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-6859_efbde0f6-b848-4664-b741-c6c630e66108	0378-6859	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine	CAPSULE	ORAL	20230825		ANDA	ANDA202835	Mylan Pharmaceuticals Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-6860_efbde0f6-b848-4664-b741-c6c630e66108	0378-6860	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		lisdexamfetamine	CAPSULE	ORAL	20230825		ANDA	ANDA202835	Mylan Pharmaceuticals Inc.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-6920_e39ca16a-879e-414c-956f-c064e8de3261	0378-6920	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		abiraterone acetate	TABLET	ORAL	20181121		ANDA	ANDA208446	Mylan Pharmaceuticals Inc.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
0378-6921_e39ca16a-879e-414c-956f-c064e8de3261	0378-6921	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		abiraterone acetate	TABLET, FILM COATED	ORAL	20201214		ANDA	ANDA208446	Mylan Pharmaceuticals Inc.	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
0378-6955_43459ab6-17fd-4c77-b269-4a97780af170	0378-6955	HUMAN PRESCRIPTION DRUG	Bexarotene		Bexarotene	CAPSULE, LIQUID FILLED	ORAL	20150709		ANDA	ANDA203174	Mylan Pharmaceuticals Inc.	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-6960_49d064cb-b301-4ca9-b346-428e1b0c87f5	0378-6960	HUMAN PRESCRIPTION DRUG	Glatiramer Acetate		glatiramer acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20171004		ANDA	ANDA091646	Mylan Pharmaceuticals Inc.	GLATIRAMER ACETATE	20	mg/mL			N	20241231
0378-6961_8ec038d7-e115-4532-b2f1-0c6fe8608ab9	0378-6961	HUMAN PRESCRIPTION DRUG	Glatiramer Acetate		Glatiramer	INJECTION, SOLUTION	SUBCUTANEOUS	20171004		ANDA	ANDA206936	Mylan Pharmaceuticals Inc.	GLATIRAMER ACETATE	40	mg/mL			N	20241231
0378-6981_04746705-5055-4f28-bb1f-4c95495ca025	0378-6981	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20181129		ANDA	ANDA202396	Mylan Pharmaceuticals Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-6982_04746705-5055-4f28-bb1f-4c95495ca025	0378-6982	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20181129		ANDA	ANDA202396	Mylan Pharmaceuticals Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-6993_0aa39730-fc51-4088-8955-b11aac3025d0	0378-6993	HUMAN PRESCRIPTION DRUG	Levalbuterol		levalbuterol	SOLUTION, CONCENTRATE	RESPIRATORY (INHALATION)	20090828		ANDA	ANDA078309	Mylan Pharmaceuticals Inc.	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/.5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-7001_978687e7-c591-424e-95aa-a46f73370f10	0378-7001	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Mylan Pharmaceuticals Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
0378-7002_978687e7-c591-424e-95aa-a46f73370f10	0378-7002	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Mylan Pharmaceuticals Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
0378-7003_978687e7-c591-424e-95aa-a46f73370f10	0378-7003	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Mylan Pharmaceuticals Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
0378-7004_978687e7-c591-424e-95aa-a46f73370f10	0378-7004	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Mylan Pharmaceuticals Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
0378-7020_84fece18-4977-4faa-86c7-ef558429d40e	0378-7020	HUMAN PRESCRIPTION DRUG	Acitretin		acitretin	CAPSULE	ORAL	20160310		ANDA	ANDA202148	Mylan Pharmaceuticals Inc.	ACITRETIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-7023_84fece18-4977-4faa-86c7-ef558429d40e	0378-7023	HUMAN PRESCRIPTION DRUG	Acitretin		acitretin	CAPSULE	ORAL	20160310		ANDA	ANDA202148	Mylan Pharmaceuticals Inc.	ACITRETIN	25	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-7055_875ce162-0cc2-4572-b9e6-5d30c696018b	0378-7055	HUMAN PRESCRIPTION DRUG	Bepotastine Besilate		Bepotastine Besilate	SOLUTION/ DROPS	OPHTHALMIC	20210528		ANDA	ANDA206220	Mylan Pharmaceuticals Inc.	BEPOTASTINE BESILATE	15	mg/mL	Histamine-1 Receptor Antagonist [EPC]		N	20241231
0378-7057_de8e18d1-bd6b-484a-a7b4-3c286c8ae917	0378-7057	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20221007		ANDA	ANDA214531	Mylan Pharmaceuticals Inc.	ALBUTEROL SULFATE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-7058_de8e18d1-bd6b-484a-a7b4-3c286c8ae917	0378-7058	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20221007		ANDA	ANDA214531	Mylan Pharmaceuticals Inc.	ALBUTEROL SULFATE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-7096_caaa8c54-ee5c-47a9-8455-1f49fab45143	0378-7096	HUMAN PRESCRIPTION DRUG	Bromocriptine Mesylate		bromocriptine mesylate	CAPSULE	ORAL	20130617		ANDA	ANDA077226	Mylan Pharmaceuticals Inc.	BROMOCRIPTINE MESYLATE	5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
0378-7100_7a2b1694-b5f5-4e1b-b14e-c7abb1e76545	0378-7100	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20091222		ANDA	ANDA076520	Mylan Pharmaceuticals Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0378-7101_7a2b1694-b5f5-4e1b-b14e-c7abb1e76545	0378-7101	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20091222		ANDA	ANDA076520	Mylan Pharmaceuticals Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0378-7185_97ee674b-0f17-4b57-b49f-b41fa7b1ca82	0378-7185	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin hydrochloride	TABLET, FILM COATED	ORAL	20100603		ANDA	ANDA075973	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0378-7186_97ee674b-0f17-4b57-b49f-b41fa7b1ca82	0378-7186	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin hydrochloride	TABLET, FILM COATED	ORAL	20100603		ANDA	ANDA075973	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0378-7187_97ee674b-0f17-4b57-b49f-b41fa7b1ca82	0378-7187	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin hydrochloride	TABLET, FILM COATED	ORAL	20100603		ANDA	ANDA075973	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0378-7272_d777aa70-3657-4537-aa33-f4d93dcfc7bc	0378-7272	HUMAN PRESCRIPTION DRUG	Norethindrone		Norethindrone	TABLET	ORAL	20130624		ANDA	ANDA200980	Mylan Pharmaceuticals Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-7274_4f97f589-8308-46f5-b4cb-24fb5e391969	0378-7274	HUMAN PRESCRIPTION DRUG	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL		norethindrone acetate and ethinyl estradiol	TABLET	ORAL	20190925		ANDA	ANDA202770	Mylan Pharmaceuticals Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.03; 1.5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-7280_9ab64c35-6a7a-4752-bfd6-e4747d520069	0378-7280	HUMAN PRESCRIPTION DRUG	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL		norethindrone acetate and ethinyl estradiol	TABLET	ORAL	20140711		ANDA	ANDA202771	Mylan Pharmaceuticals Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.02; 1	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-7281_5465712c-3e47-4053-8ef7-ae2a81f1d239	0378-7281	HUMAN PRESCRIPTION DRUG	LEVONORGESTREL AND ETHINYL ESTRADIOL		Levonorgestrel and Ethinyl Estradiol	KIT		20150427		ANDA	ANDA200490	Mylan Pharmaceuticals Inc.						N	20241231
0378-7283_aafa22c5-b476-44e2-9825-da7b96bac650	0378-7283	HUMAN PRESCRIPTION DRUG	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL		norethindrone acetate and ethinyl estradiol	KIT		20140716		ANDA	ANDA202772	Mylan Pharmaceuticals Inc.						N	20241231
0378-7284_0929dad2-dcfc-4721-be70-27e6c4fa8621	0378-7284	HUMAN PRESCRIPTION DRUG	LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL		Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol	KIT		20161107		ANDA	ANDA200493	Mylan Pharmaceuticals Inc.						N	20241231
0378-7285_29f407c5-994b-4e31-ac91-20497cf7b3cd	0378-7285	HUMAN PRESCRIPTION DRUG	LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL		levonorgestrel and ethinyl estradiol and ethinyl estradiol	KIT		20150528		ANDA	ANDA200492	Mylan Pharmaceuticals Inc.						N	20241231
0378-7287_11a76b26-93f8-4d9e-a286-06ce95d28240	0378-7287	HUMAN PRESCRIPTION DRUG	LEVONORGESTREL AND ETHINYL ESTRADIOL		Levonorgestrel and Ethinyl Estradiol	KIT		20140626		ANDA	ANDA200245	Mylan Pharmaceuticals Inc.						N	20241231
0378-7288_35758b77-0cd8-479b-b66b-aa9cbc15b786	0378-7288	HUMAN PRESCRIPTION DRUG	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL		norethindrone acetate and ethinyl estradiol	KIT		20191216		ANDA	ANDA202741	Mylan Pharmaceuticals Inc.						N	20241231
0378-7291_f6ab678f-03e6-43a2-a20a-e22a6fd485c1	0378-7291	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate		Norethindrone Acetate	TABLET	ORAL	20190719		ANDA	ANDA205278	Mylan Pharmaceuticals Inc.	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-7292_bfc423bd-80d3-452e-b6f5-0a76ab0767e8	0378-7292	HUMAN PRESCRIPTION DRUG	NORETHINDRONE		norethindrone	TABLET	ORAL	20130712		ANDA	ANDA201483	Mylan Pharmaceuticals Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-7294_b24d133a-50ee-4fd6-926d-cac8f34e8ebd	0378-7294	HUMAN PRESCRIPTION DRUG	ESTRADIOL AND NORETHINDRONE ACETATE		estradiol and norethindrone acetate	TABLET	ORAL	20180724		ANDA	ANDA207261	Mylan Pharmaceuticals Inc.	ESTRADIOL; NORETHINDRONE ACETATE	.5; .1	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-7295_b24d133a-50ee-4fd6-926d-cac8f34e8ebd	0378-7295	HUMAN PRESCRIPTION DRUG	ESTRADIOL AND NORETHINDRONE ACETATE		estradiol and norethindrone acetate	TABLET	ORAL	20180724		ANDA	ANDA207261	Mylan Pharmaceuticals Inc.	ESTRADIOL; NORETHINDRONE ACETATE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0378-7296_6d21242f-a7b8-442a-b872-10e17ab784ff	0378-7296	HUMAN PRESCRIPTION DRUG	DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL		desogestrel and ethinyl estradiol and ethinyl estradiol	KIT		20140716		ANDA	ANDA202296	Mylan Pharmaceuticals Inc.						N	20241231
0378-7297_6cf853f7-1111-4216-aafb-2ce731ad5629	0378-7297	HUMAN PRESCRIPTION DRUG	NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE		norethindrone and ethinyl estradiol and ferrous fumarate	KIT		20161028		ANDA	ANDA202086	Mylan Pharmaceuticals Inc.						N	20241231
0378-7299_1748f34f-2cb9-4981-ba58-3084c100ac58	0378-7299	HUMAN PRESCRIPTION DRUG	DROSPIRENONE AND ETHINYL ESTRADIOL		drospirenone and ethinyl estradiol	KIT		20180423		ANDA	ANDA202594	Mylan Pharmaceuticals Inc.						N	20241231
0378-7300_c541380a-0a35-4efa-87f2-788a37f18b5e	0378-7300	HUMAN PRESCRIPTION DRUG	DROSPIRENONE AND ETHINYL ESTRADIOL		drospirenone and ethinyl estradiol	KIT		20150828		ANDA	ANDA202131	Mylan Pharmaceuticals Inc.						N	20241231
0378-7303_054917fa-573b-4b16-a719-ece6c0909656	0378-7303	HUMAN PRESCRIPTION DRUG	NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE		norethindrone acetate and ethinyl estradiol and ferrous fumarate	KIT		20220727		ANDA	ANDA205069	Mylan Pharmaceuticals Inc.						N	20241231
0378-7306_99a57312-5cf8-41c9-926d-1ce45f9f9b17	0378-7306	HUMAN PRESCRIPTION DRUG	ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL		ethynodiol diacetate and ethinyl estradiol	KIT		20161130		ANDA	ANDA204704	Mylan Pharmaceuticals Inc.						N	20241231
0378-7307_ba9224e4-13a6-48fe-bf94-6cfceba8a7d2	0378-7307	HUMAN PRESCRIPTION DRUG	ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL		ethynodiol diacetate and ethinyl estradiol	KIT		20170919		ANDA	ANDA204703	Mylan Pharmaceuticals Inc.						N	20241231
0378-7308_ee2b63d1-39aa-4d09-809a-592c69682b91	0378-7308	HUMAN PRESCRIPTION DRUG	NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE		norethindrone and ethinyl estradiol and ferrous fumarate	KIT		20150401		ANDA	ANDA203371	Mylan Pharmaceuticals Inc.						N	20251231
0378-7316_0700dfed-9414-4c76-9d06-f63dd75a8ab2	0378-7316	HUMAN PRESCRIPTION DRUG	LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL		levonorgestrel and ethinyl estradiol and ethinyl estradiol	KIT		20171002		ANDA	ANDA206053	Mylan Pharmaceuticals Inc.						N	20241231
0378-7502_4719c6e2-7ebe-43ee-9617-df57a6f4707c	0378-7502	HUMAN PRESCRIPTION DRUG	BREYNA		Budesonide and Formoterol Fumarate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20230731		ANDA	ANDA211699	Mylan Pharmaceuticals Inc.	BUDESONIDE; FORMOTEROL FUMARATE	80; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-7503_4719c6e2-7ebe-43ee-9617-df57a6f4707c	0378-7503	HUMAN PRESCRIPTION DRUG	BREYNA		Budesonide and Formoterol Fumarate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20230731		ANDA	ANDA211699	Mylan Pharmaceuticals Inc.	BUDESONIDE; FORMOTEROL FUMARATE	160; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-7732_59558f91-d670-4df2-969c-0beca659cf0d	0378-7732	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070625	20240531	ANDA	ANDA078139	Mylan Pharmaceuticals Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
0378-7734_59558f91-d670-4df2-969c-0beca659cf0d	0378-7734	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070625	20240531	ANDA	ANDA078139	Mylan Pharmaceuticals Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
0378-7970_2c5fc3b9-e3f3-4120-947a-815d30502a3a	0378-7970	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20101109		ANDA	ANDA075693	Mylan Pharmaceuticals Inc.	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0378-8015_bda3a6fc-98bb-4c98-9c2e-600b1d589a5a	0378-8015	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20091110		ANDA	ANDA090763	Mylan Pharmaceuticals Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-8020_da3501cc-6f71-4592-8b80-ad74ebe0cd30	0378-8020	HUMAN PRESCRIPTION DRUG	Fluvastatin Sodium		fluvastatin	CAPSULE	ORAL	20130319		ANDA	ANDA090595	Mylan Pharmaceuticals Inc.	FLUVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-8021_da3501cc-6f71-4592-8b80-ad74ebe0cd30	0378-8021	HUMAN PRESCRIPTION DRUG	Fluvastatin Sodium		fluvastatin	CAPSULE	ORAL	20130319		ANDA	ANDA090595	Mylan Pharmaceuticals Inc.	FLUVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0378-8030_bda3a6fc-98bb-4c98-9c2e-600b1d589a5a	0378-8030	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20091110		ANDA	ANDA090763	Mylan Pharmaceuticals Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0378-8056_09b49bcc-a3cf-4281-a753-65866b2b8c3b	0378-8056	HUMAN PRESCRIPTION DRUG	Halcinonide		Halcinonide	CREAM	TOPICAL	20190815		ANDA	ANDA211027	Mylan Pharmaceuticals Inc.	HALCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0378-8075_dce86476-c427-48a9-ad60-e4fe26063028	0378-8075	HUMAN PRESCRIPTION DRUG	ERYGEL		erythromycin	GEL	TOPICAL	20190307		NDA	NDA050617	Mylan Pharmaceuticals Inc.	ERYTHROMYCIN	20	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
0378-8078_8c0b453a-7e42-4edf-9e86-7cc2297a2354	0378-8078	HUMAN PRESCRIPTION DRUG	Fluorouracil Cream		fluorouracil	CREAM	TOPICAL	20200828		NDA AUTHORIZED GENERIC	NDA020985	Mylan Pharmaceuticals Inc.	FLUOROURACIL	5	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0378-8082_bbd26d3a-4571-4274-97e9-a64b9a46767c	0378-8082	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CREAM	TOPICAL	20190403		NDA AUTHORIZED GENERIC	NDA019049	Mylan Pharmaceuticals Inc.	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8083_bbd26d3a-4571-4274-97e9-a64b9a46767c	0378-8083	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CREAM	TOPICAL	20181105		NDA AUTHORIZED GENERIC	NDA017522	Mylan Pharmaceuticals Inc.	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8084_bbd26d3a-4571-4274-97e9-a64b9a46767c	0378-8084	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CREAM	TOPICAL	20190227		NDA AUTHORIZED GENERIC	NDA017340	Mylan Pharmaceuticals Inc.	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8085_bbd26d3a-4571-4274-97e9-a64b9a46767c	0378-8085	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20190812		NDA AUTHORIZED GENERIC	NDA017955	Mylan Pharmaceuticals Inc.	TRETINOIN	.1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8086_bbd26d3a-4571-4274-97e9-a64b9a46767c	0378-8086	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20190712		NDA AUTHORIZED GENERIC	NDA017579	Mylan Pharmaceuticals Inc.	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8090_7f967c10-776a-4b9c-aeda-70276ff2747f	0378-8090	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20181114		ANDA	ANDA207955	Mylan Pharmaceuticals Inc.	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8092_0eee5219-ac85-4f0b-a185-668e9eb2b739	0378-8092	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20190812		NDA AUTHORIZED GENERIC	NDA020475	Mylan Pharmaceuticals Inc.	TRETINOIN	.4	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8093_0eee5219-ac85-4f0b-a185-668e9eb2b739	0378-8093	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20181217		NDA AUTHORIZED GENERIC	NDA020475	Mylan Pharmaceuticals Inc.	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0378-8117_b4771ea7-c19b-4182-bb23-c1473ab583fa	0378-8117	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CREAM	TOPICAL	20190104		NDA AUTHORIZED GENERIC	NDA020126	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	50	mg/g	Tricyclic Antidepressant [EPC]		N	20241231
0378-8123_d08db934-a9ce-4b1a-9ca1-5c6705b227a1	0378-8123	HUMAN PRESCRIPTION DRUG	Zonalon		doxepin hydrochloride	CREAM	TOPICAL	20181114		NDA	NDA020126	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	50	mg/g	Tricyclic Antidepressant [EPC]		N	20241231
0378-8130_dc5b7069-dc63-4393-bd87-2828328103b0	0378-8130	HUMAN PRESCRIPTION DRUG	PRUDOXIN		doxepin hydrochloride	CREAM	TOPICAL	20180801		NDA	NDA020126	Mylan Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	50	mg/g	Tricyclic Antidepressant [EPC]		N	20241231
0378-8175_0db8da29-f062-47cd-958f-6b64a6da1d84	0378-8175	HUMAN PRESCRIPTION DRUG	Saxagliptin and Metformin		saxagliptin and metformin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA205981	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE	500; 5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0378-8176_0db8da29-f062-47cd-958f-6b64a6da1d84	0378-8176	HUMAN PRESCRIPTION DRUG	Saxagliptin and Metformin		saxagliptin and metformin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA205981	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE	1000; 2.5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0378-8177_0db8da29-f062-47cd-958f-6b64a6da1d84	0378-8177	HUMAN PRESCRIPTION DRUG	Saxagliptin and Metformin		saxagliptin and metformin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA205981	Mylan Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE	1000; 5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0378-8200_3faf3996-75bd-4f76-b5f4-9a8d2e5958cc	0378-8200	HUMAN PRESCRIPTION DRUG	Ketoprofen		ketoprofen	CAPSULE, EXTENDED RELEASE	ORAL	20030904		ANDA	ANDA075679	Mylan Pharmaceuticals Inc.	KETOPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0378-8212_09b16a2d-825a-4d08-b86e-076548926916	0378-8212	HUMAN PRESCRIPTION DRUG	Erythromycin		erythromycin	GEL	TOPICAL	20181019		NDA AUTHORIZED GENERIC	NDA050617	Mylan Pharmaceuticals Inc.	ERYTHROMYCIN	20	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
0378-8222_938703ee-e66f-474f-bc60-98afe38ece68	0378-8222	HUMAN PRESCRIPTION DRUG	VUSION		miconazole nitrate, zinc oxide, white petrolatum	OINTMENT	TOPICAL	20181106		NDA AUTHORIZED GENERIC	NDA021026	Mylan Pharmaceuticals Inc.	MICONAZOLE NITRATE; PETROLATUM; ZINC OXIDE	2.5; 813.5; 150	mg/g; mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0378-8260_1643b6a5-80da-4d4f-8c5f-feb907875702	0378-8260	HUMAN PRESCRIPTION DRUG	Methylphenidate		Methylphenidate	PATCH	TRANSDERMAL	20220627		ANDA	ANDA206497	Mylan Pharmaceuticals Inc.	METHYLPHENIDATE	1.1	mg/h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-8261_1643b6a5-80da-4d4f-8c5f-feb907875702	0378-8261	HUMAN PRESCRIPTION DRUG	Methylphenidate		Methylphenidate	PATCH	TRANSDERMAL	20220627		ANDA	ANDA206497	Mylan Pharmaceuticals Inc.	METHYLPHENIDATE	1.6	mg/h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-8262_1643b6a5-80da-4d4f-8c5f-feb907875702	0378-8262	HUMAN PRESCRIPTION DRUG	Methylphenidate		Methylphenidate	PATCH	TRANSDERMAL	20220627		ANDA	ANDA206497	Mylan Pharmaceuticals Inc.	METHYLPHENIDATE	2.2	mg/h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-8263_1643b6a5-80da-4d4f-8c5f-feb907875702	0378-8263	HUMAN PRESCRIPTION DRUG	Methylphenidate		Methylphenidate	PATCH	TRANSDERMAL	20220627		ANDA	ANDA206497	Mylan Pharmaceuticals Inc.	METHYLPHENIDATE	3.3	mg/h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0378-8270_6c181118-680f-4e62-b0d3-057a14803a4f	0378-8270	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20121015		ANDA	ANDA077839	Mylan Pharmaceuticals Inc.	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-8688_7b724238-fd5e-47ce-8994-267e807f76e8	0378-8688	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		clindamycin phosphate and benzoyl peroxide	KIT		20090825		ANDA	ANDA065443	Mylan Pharmaceuticals Inc.						N	20241231
0378-8688_9ef8f863-e4b5-4269-b4d9-e11079be2e9e	0378-8688	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		clindamycin phosphate and benzoyl peroxide	KIT		20140919		ANDA	ANDA065443	Mylan Pharmaceuticals Inc.						N	20241231
0378-8700_488199b6-1cb8-4f74-9e0e-cd599dd5b576	0378-8700	HUMAN PRESCRIPTION DRUG	Acyclovir		acyclovir	OINTMENT	TOPICAL	20130403		ANDA	ANDA202459	Mylan Pharmaceuticals Inc.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0378-8760_da3fa070-b512-4568-871a-dc8d5a949d13	0378-8760	HUMAN PRESCRIPTION DRUG	Cyclosporine		cyclosporine	EMULSION	OPHTHALMIC	20220203		ANDA	ANDA205894	Mylan Pharmaceuticals Inc.	CYCLOSPORINE	.5	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0378-8765_c7243e18-0425-4883-ae65-48d90b31c4fa	0378-8765	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20200417		ANDA	ANDA211785	Mylan Pharmaceuticals Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0378-8766_c7243e18-0425-4883-ae65-48d90b31c4fa	0378-8766	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20200417		ANDA	ANDA211785	Mylan Pharmaceuticals Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	4; 1	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0378-8767_c7243e18-0425-4883-ae65-48d90b31c4fa	0378-8767	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20190220		ANDA	ANDA207607	Mylan Pharmaceuticals Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0378-8768_c7243e18-0425-4883-ae65-48d90b31c4fa	0378-8768	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20190220		ANDA	ANDA207607	Mylan Pharmaceuticals Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	12; 3	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0378-8770_982b2667-6b0f-4287-b72c-4616754ec37a	0378-8770	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	CREAM	VAGINAL	20171229		ANDA	ANDA208788	Mylan Pharmaceuticals Inc.	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0378-8880_1392dd15-842c-4689-87ba-caafc0503bca	0378-8880	HUMAN OTC DRUG	Loratadine		loratadine	TABLET	ORAL	20110601		ANDA	ANDA076154	Mylan Pharmaceuticals Inc.	LORATADINE	10	mg/1			N	20241231
0378-9040_3152f70b-070d-47e0-80b2-6bb826793ee1	0378-9040	HUMAN PRESCRIPTION DRUG	Cystagon		cysteamine bitartrate	CAPSULE	ORAL	20050411		NDA	NDA020392	Mylan Pharmaceuticals Inc.	CYSTEAMINE BITARTRATE	50	mg/1	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
0378-9045_3152f70b-070d-47e0-80b2-6bb826793ee1	0378-9045	HUMAN PRESCRIPTION DRUG	Cystagon		cysteamine bitartrate	CAPSULE	ORAL	20050411		NDA	NDA020392	Mylan Pharmaceuticals Inc.	CYSTEAMINE BITARTRATE	150	mg/1	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
0378-9055_99a8db07-5d64-4bc4-9fa7-3fd44ca73d27	0378-9055	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20150807		ANDA	ANDA202346	Mylan Pharmaceuticals Inc.	LIDOCAINE	140	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0378-9070_08bdf58d-ec6d-4158-bdba-92fde5add107	0378-9070	HUMAN PRESCRIPTION DRUG	Rivastigmine		rivastigmine	PATCH	TRANSDERMAL	20180620		ANDA	ANDA205622	Mylan Pharmaceuticals Inc.	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0378-9071_08bdf58d-ec6d-4158-bdba-92fde5add107	0378-9071	HUMAN PRESCRIPTION DRUG	Rivastigmine		rivastigmine	PATCH	TRANSDERMAL	20180620		ANDA	ANDA205622	Mylan Pharmaceuticals Inc.	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0378-9072_08bdf58d-ec6d-4158-bdba-92fde5add107	0378-9072	HUMAN PRESCRIPTION DRUG	Rivastigmine		rivastigmine	PATCH	TRANSDERMAL	20180620		ANDA	ANDA205622	Mylan Pharmaceuticals Inc.	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0378-9102_68d53366-0e2b-4370-a084-af17a1a88681	0378-9102	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	PATCH	TRANSDERMAL	19980618		ANDA	ANDA074559	Mylan Pharmaceuticals Inc.	NITROGLYCERIN	.1	mg/h	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0378-9104_68d53366-0e2b-4370-a084-af17a1a88681	0378-9104	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	PATCH	TRANSDERMAL	19960830		ANDA	ANDA074559	Mylan Pharmaceuticals Inc.	NITROGLYCERIN	.2	mg/h	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0378-9112_68d53366-0e2b-4370-a084-af17a1a88681	0378-9112	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	PATCH	TRANSDERMAL	19960830		ANDA	ANDA074559	Mylan Pharmaceuticals Inc.	NITROGLYCERIN	.4	mg/h	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0378-9116_68d53366-0e2b-4370-a084-af17a1a88681	0378-9116	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	PATCH	TRANSDERMAL	19960830		ANDA	ANDA074559	Mylan Pharmaceuticals Inc.	NITROGLYCERIN	.6	mg/h	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0378-9119_87f6e135-d908-4279-b38c-d05597f3e882	0378-9119	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20050131		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	12	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9121_87f6e135-d908-4279-b38c-d05597f3e882	0378-9121	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20050131		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	25	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9122_87f6e135-d908-4279-b38c-d05597f3e882	0378-9122	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20050131		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	50	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9123_87f6e135-d908-4279-b38c-d05597f3e882	0378-9123	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20050131		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	75	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9124_87f6e135-d908-4279-b38c-d05597f3e882	0378-9124	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20050131		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	100	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9125_87f6e135-d908-4279-b38c-d05597f3e882	0378-9125	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20150226		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	37.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9126_87f6e135-d908-4279-b38c-d05597f3e882	0378-9126	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20150226		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	62.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9127_87f6e135-d908-4279-b38c-d05597f3e882	0378-9127	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH	TRANSDERMAL	20150226		ANDA	ANDA076258	Mylan Pharmaceuticals Inc.	FENTANYL	87.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0378-9205_107f926c-dcf7-4a04-a44a-e22ff1534f97	0378-9205	HUMAN PRESCRIPTION DRUG	sucralfate		sucralfate	SUSPENSION	ORAL	20220922		ANDA	ANDA212913	Mylan Pharmaceuticals Inc.	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
0378-9320_03d33612-03b4-4a2c-ba86-47816db363ce	0378-9320	HUMAN PRESCRIPTION DRUG	Wixela Inhub		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190211		ANDA	ANDA208891	Mylan Pharmaceuticals Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	100; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-9321_03d33612-03b4-4a2c-ba86-47816db363ce	0378-9321	HUMAN PRESCRIPTION DRUG	Wixela Inhub		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190211		ANDA	ANDA208891	Mylan Pharmaceuticals Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-9322_03d33612-03b4-4a2c-ba86-47816db363ce	0378-9322	HUMAN PRESCRIPTION DRUG	Wixela Inhub		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190211		ANDA	ANDA208891	Mylan Pharmaceuticals Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	500; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-9651_266ef74b-0524-47fd-b71d-d762fa45b145	0378-9651	HUMAN PRESCRIPTION DRUG	Travoprost Ophthalmic Solution, 0.004%		Travoprost Ophthalmic Solution, 0.004%	SOLUTION/ DROPS	OPHTHALMIC	20191218		ANDA	ANDA205050	Mylan Pharmaceuticals Inc.	TRAVOPROST	.04	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0378-9671_96603d2c-6783-4f6c-8b3e-de3eaabcc6aa	0378-9671	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20130301		ANDA	ANDA202496	Mylan Pharmaceuticals Inc.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-9690_2f82efe7-5a39-44e6-a7c0-840a60c6246f	0378-9690	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20180723		ANDA	ANDA203653	Mylan Pharmaceuticals Inc.	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-9691_2f82efe7-5a39-44e6-a7c0-840a60c6246f	0378-9691	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20180723		ANDA	ANDA203653	Mylan Pharmaceuticals Inc.	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-9692_2f82efe7-5a39-44e6-a7c0-840a60c6246f	0378-9692	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20180910		ANDA	ANDA203653	Mylan Pharmaceuticals Inc.	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0378-9720_ed286bc3-dda6-4f75-9338-3eb0987a2a7d	0378-9720	HUMAN PRESCRIPTION DRUG	Denavir		penciclovir	CREAM	TOPICAL	20180924		NDA	NDA020629	Mylan Pharmaceuticals Inc.	PENCICLOVIR	10	mg/g	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0378-9730_ef8a249b-a7e8-441f-be59-e8fd2d168627	0378-9730	HUMAN PRESCRIPTION DRUG	VUSION		miconazole nitrate, zinc oxide, white petrolatum	OINTMENT	TOPICAL	20200206		NDA	NDA021026	Mylan Pharmaceuticals Inc.	MICONAZOLE NITRATE; PETROLATUM; ZINC OXIDE	2.5; 813.5; 150	mg/g; mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0394-0859_2be72297-e06d-479b-815d-3c4305765335	0394-0859	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	LOTION	TOPICAL	20230612		OTC MONOGRAPH NOT FINAL	part348	Mericon Industries	HYDROCORTISONE	1.14	g/114g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0395-0040_0c92880c-76b6-b96f-e063-6394a90a7c31	0395-0040	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Alcohol	LIQUID	TOPICAL	19970101		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	ALCOHOL	700	mg/mL			N	20241231
0395-0073_da6eaf23-7416-4307-e053-2995a90a142a	0395-0073	HUMAN OTC DRUG	Humco Aromatic Ammonia Spirit		Ammonia 2%	LIQUID	TOPICAL	20080101	20250531	UNAPPROVED DRUG OTHER		Humco Holding Group, Inc.	AMMONIA	20	mg/mL			N	
0395-0098_0c929c77-c697-a582-e063-6394a90aeab1	0395-0098	HUMAN OTC DRUG	HUMCO Ear Drops for Swimmers		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20080101		OTC MONOGRAPH DRUG	M014	Humco Holding Group, Inc.	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
0395-0243_0c929c77-c698-a582-e063-6394a90aeab1	0395-0243	HUMAN OTC DRUG	Benzoin Compound Tincture		Benzoin Resin	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M022	Humco Holding Group, Inc.	BENZOIN RESIN	1000	mg/mL			N	20241231
0395-0247_0c929258-b192-bc2f-e063-6394a90a8e47	0395-0247	HUMAN OTC DRUG	Benzoin Tincture		Benzoin Resin	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M022	Humco Holding Group, Inc.	BENZOIN RESIN	1000	mg/mL			N	20241231
0395-0400_0c929258-b193-bc2f-e063-6394a90a8e47	0395-0400	HUMAN OTC DRUG	Humco Calaclear		Pramoxine Hydrochloride and Zinc Acetate	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Humco Holding Group, Inc.	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0395-0407_0c92d58b-b1c7-dc2c-e063-6394a90a4d7a	0395-0407	HUMAN OTC DRUG	Calamine Phenolated Topical Suspension		Calamine and Zinc Oxide and Phenol	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Humco Holding Group, Inc	PHENOL; ZINC OXIDE	10; 160	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0395-0413_0c92bf65-23cc-3a92-e063-6294a90a39a7	0395-0413	HUMAN OTC DRUG	Humco Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Humco holding Group, Inc.	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0395-0420_0c92bb26-904f-5952-e063-6294a90a481c	0395-0420	HUMAN OTC DRUG	Humco Calagesic		Calamine and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Humco Holding Group, Inc.	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0395-0431_0c92bb26-9051-5952-e063-6294a90a481c	0395-0431	HUMAN OTC DRUG	Calcium Carbonate		Calcium Carbonate	POWDER	ORAL	20080101		OTC MONOGRAPH DRUG	M001	Humco Holding Group, Inc.	CALCIUM CARBONATE	1	g/g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0395-0467_0c92eeea-202f-e81a-e063-6394a90a48eb	0395-0467	HUMAN OTC DRUG	HUMCO Camphor Spirit		Camphor 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Humco Holding Group, Inc.	CAMPHOR (NATURAL)	100	mg/mL			N	20241231
0395-0513_0c92eeea-2030-e81a-e063-6394a90a48eb	0395-0513	HUMAN OTC DRUG	Humco Castor Oil (Regular)		Castor Oil	LIQUID	ORAL	20130101		OTC MONOGRAPH DRUG	M007	Humco Holding Group, Inc.	CASTOR OIL	1	mg/mL			N	20241231
0395-0515_0c92bf65-23d1-3a92-e063-6294a90a39a7	0395-0515	HUMAN OTC DRUG	Humco Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Humco holding Group, Inc.	CASTOR OIL	1	mg/mL			N	20241231
0395-0527_0c92d58b-b1c6-dc2c-e063-6394a90a4d7a	0395-0527	HUMAN OTC DRUG	Humco Charcoal Activated		Activated Charcoal	POWDER	ORAL	20080101		OTC MONOGRAPH DRUG	M023	Humco Holding Group. Inc.	ACTIVATED CHARCOAL	1000	mg/g			N	20241231
0395-0713_0c92d0b3-1768-de2d-e063-6394a90a34d1	0395-0713	HUMAN OTC DRUG	Humco Dewees Carminative		Magnesium Carbonate	SUSPENSION	ORAL	19980325		OTC MONOGRAPH DRUG	M001	Humco Holding Group, inc.	MAGNESIUM CARBONATE	50	mg/mL			N	20241231
0395-0807_0c9325b5-94b3-f74e-e063-6394a90ab2ee	0395-0807	HUMAN OTC DRUG	Humco Epson Salt		Magnesium Sulfate	POWDER, FOR SOLUTION	ORAL	19980325		OTC MONOGRAPH DRUG	M007	Humco Holding Group, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	1000	mg/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0395-1003_0c933e1b-c9bf-ab91-e063-6294a90aca64	0395-1003	HUMAN OTC DRUG	Humco Gentian Violet 1%		Gentian Violet 1%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	GENTIAN VIOLET	10	mg/mL			N	20241231
0395-1005_0c933e1b-c9c0-ab91-e063-6294a90aca64	0395-1005	HUMAN OTC DRUG	Humco Gentian Violet 2%		Gentian Violet 2%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	GENTIAN VIOLET	20	mg/mL			N	20241231
0395-1113_0c9326fe-9394-a166-e063-6294a90a167e	0395-1113	HUMAN OTC DRUG	Humco Hydrogen Peroxide		Hydrogen Peroxide 3%	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
0395-1207_0c931a56-b7e0-c70e-e063-6394a90a2c4a	0395-1207	HUMAN OTC DRUG	Humco Iodides Tincture		Ethyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	ALCOHOL	.45	mL/mL			N	20241231
0395-1213_0c9325b5-94b7-f74e-e063-6394a90ab2ee	0395-1213	HUMAN OTC DRUG	Iodine Tincture Mild		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	19790101		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
0395-1249_0c93390b-bca1-9c43-e063-6294a90aeffb	0395-1249	HUMAN OTC DRUG	HUMCO Isopropyl Rubbing Alcohol 70%		Isopropyl Alcohol	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
0395-1672_0c93390b-bca2-9c43-e063-6294a90aeffb	0395-1672	HUMAN OTC DRUG	Humco Milk of Magnesia		Magnesium Hydroxide	SUSPENSION	ORAL	20190131		OTC MONOGRAPH DRUG	M001	Humco Holding Group, Inc.	MAGNESIUM HYDROXIDE	80	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0395-1673_0c935521-4e85-0605-e063-6394a90a0bbc	0395-1673	HUMAN OTC DRUG	Humco Mineral Oil Light		Mineral Oil	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Humco Holding Group, Inc.	MINERAL OIL	1000	mg/mL			N	20241231
0395-1685_0c93390b-bca4-9c43-e063-6294a90aeffb	0395-1685	HUMAN OTC DRUG	Humco Mineral Oil Heavy		Mineral Oil	LIQUID	ORAL	19980325		OTC MONOGRAPH DRUG	M007	Humco Holding Group, Inc.	MINERAL OIL	1000	mg/mL			N	20241231
0395-2325_0c935f5b-f253-0386-e063-6394a90a6880	0395-2325	HUMAN OTC DRUG	Humco Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	POVIDONE-IODINE	100	mg/mL			N	20241231
0395-2685_0c9364b5-e35e-068e-e063-6394a90a3386	0395-2685	HUMAN OTC DRUG	Humco Sodium Bicarbonate		Sodium Bicarbonate	POWDER	ORAL	19980325		OTC MONOGRAPH DRUG	M001	Humco Holding Group, Inc.	SODIUM BICARBONATE	1000	mg/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0395-3213_0c936cb3-838f-0603-e063-6394a90a0640	0395-3213	HUMAN OTC DRUG	Humco Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20120201		OTC MONOGRAPH DRUG	M016	Humco Holding Group, Inc.	WITCH HAZEL	884	mg/mL			N	20241231
0395-4202_0c935521-4e8a-0605-e063-6394a90a0bbc	0395-4202	HUMAN OTC DRUG	HUMCO Isopropyl Rubbing Alcohol 70% Professional Pack		Isopropyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
0395-8010_0c9364b5-e361-068e-e063-6394a90a3386	0395-8010	HUMAN OTC DRUG	HUMCO Merthiolate		Benzalkonium Chloride	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
0395-9123_0c936cb3-8393-0603-e063-6394a90a0640	0395-9123	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	POVIDONE-IODINE	100	mg/mL			N	20241231
0395-9126_0c9368f8-3985-07dd-e063-6394a90ac66a	0395-9126	HUMAN OTC DRUG	Father Johns Medicine		Dextromethorphan HBr	LIQUID	ORAL	20190617		OTC MONOGRAPH DRUG	M012	Humco Holding Group, Inc	DEXTROMETHORPHAN HYDROBROMIDE	10	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0395-9128_0c9380d5-c284-0902-e063-6394a90ac157	0395-9128	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine Gargle 0.5%	LIQUID	TOPICAL	20200610		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	POVIDONE-IODINE	5	mg/mL			N	20241231
0395-9129_0c9368f8-3986-07dd-e063-6394a90ac66a	0395-9129	HUMAN OTC DRUG	Povidone Iodine		Povidone-Iodine Spray 5%	LIQUID	TOPICAL	20200123		OTC MONOGRAPH DRUG	M003	Humco Holding Group, Inc.	POVIDONE-IODINE	50	mg/mL			N	20241231
0395-9130_0c9380d5-c285-0902-e063-6394a90ac157	0395-9130	HUMAN OTC DRUG	Lidocaine Pain Relief Roll-On		Lidocaine 4%	LIQUID	TOPICAL	20190605		OTC MONOGRAPH DRUG	M017	Humco Holding Group, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0395-9131_0c93883b-eed9-0f96-e063-6394a90ae9aa	0395-9131	HUMAN OTC DRUG	Hot/Cold Menthol 16% Roll-On		Hot/Cold Menthol 16% Roll-On	LIQUID	TOPICAL	20181221		OTC MONOGRAPH DRUG	M017	Humco Holding Group, Inc	MENTHOL	16	mg/100mL			N	20241231
0395-9132_0d99ad33-6033-1d16-e063-6294a90a1ee2	0395-9132	HUMAN OTC DRUG	Earwax Removal Drops		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20190605	20240531	OTC MONOGRAPH DRUG	M014	Humco Holding Group, Inc	CARBAMIDE PEROXIDE	.065	mg/mL			N	
0395-9133_0c93a2f8-8199-15fb-e063-6394a90a5521	0395-9133	HUMAN OTC DRUG	Earwax Removal Drops		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20190604		OTC MONOGRAPH DRUG	M014	Humco Holding Group, Inc	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
0395-9136_0c93bae9-c6ed-1fc7-e063-6394a90adea9	0395-9136	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine Oral Rinse 0.5%	LIQUID	TOPICAL	20210106		OTC MONOGRAPH DRUG	M022	Humco Holding Group, Inc.	POVIDONE-IODINE	5	mg/mL			N	20241231
0404-0001_08b8428c-300b-647e-e063-6394a90a3920	0404-0001	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20140601		OTC MONOGRAPH DRUG	M003	Henry Schein Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
0404-0002_08b88675-a150-e62b-e063-6394a90a2249	0404-0002	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20140601		OTC MONOGRAPH DRUG	M003	Henry Schein Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
0404-0007_0a53292c-2128-46cd-e063-6394a90a726d	0404-0007	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20151027		OTC MONOGRAPH DRUG	M003	Henry Schein, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0404-0012_0a0d643a-766e-135f-e063-6294a90a66d3	0404-0012	HUMAN OTC DRUG	Henry Schein Mouth		1.5% Hydrogen Peroxide	RINSE	ORAL	20210630		OTC MONOGRAPH DRUG	M022	Henry Schein Inc.	HYDROGEN PEROXIDE	1.5	mL/100mL			N	20241231
0404-0017_dee5b919-5ac5-d882-e053-2995a90a8742	0404-0017	HUMAN OTC DRUG	Henry Schein Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151215		ANDA	ANDA075010	Henry Schein Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0404-0032_d58f5f06-aab4-6a15-e053-2a95a90a8b7f	0404-0032	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0033_d58f69a7-0970-d84b-e053-2a95a90a4cc7	0404-0033	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0034_d58f69a7-0989-d84b-e053-2a95a90a4cc7	0404-0034	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0035_d58f6f95-25fd-1e7a-e053-2a95a90a7491	0404-0035	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0036_d58f7954-eccb-df20-e053-2a95a90a1015	0404-0036	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0037_d58f7913-7cc1-14f4-e053-2995a90a3dae	0404-0037	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0038_d58f7a00-49c1-682a-e053-2995a90a28b4	0404-0038	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0039_d58f89da-8f7d-3cd8-e053-2995a90aecaf	0404-0039	HUMAN OTC DRUG	Benzo-Jel		Benzocaine	GEL	DENTAL	20160501		OTC MONOGRAPH NOT FINAL	part356	Henry Schein Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0404-0042_f1628b72-eb7b-1590-e053-2a95a90ad4e9	0404-0042	HUMAN OTC DRUG	Petrolatum		petrolatum	OINTMENT	TOPICAL	20110405	20250401	OTC MONOGRAPH FINAL	M016	Henry Schein, Inc.	PETROLATUM	1	g/g			N	
0404-0103_0a53292c-2127-46cd-e063-6394a90a726d	0404-0103	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20210101		OTC MONOGRAPH DRUG	M003	Henry Schein, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0404-0119_07a00946-6185-f6ba-e063-6394a90af19c	0404-0119	HUMAN OTC DRUG	Henry Schein Povidone-Iodine Swabsticks		POVIDONE-IODINE	SWAB	TOPICAL	20191022		OTC MONOGRAPH DRUG	M003	Henry Schein, Inc.	POVIDONE-IODINE	1	g/100mL			N	20241231
0404-0120_07a02b63-fcac-97c6-e063-6294a90a0351	0404-0120	HUMAN OTC DRUG	Henry Schein Povidone-Iodine Swabsticks		POVIDONE-IODINE	SWAB	TOPICAL	20191022		OTC MONOGRAPH DRUG	M003	Henry Schein, Inc.	POVIDONE-IODINE	1	g/100mL			N	20241231
0404-0121_079feab5-a3f3-8896-e063-6294a90a8838	0404-0121	HUMAN OTC DRUG	Henry Schein Povidone-Iodine Prep Pad		POVIDONE-IODINE	SWAB	TOPICAL	20191022		OTC MONOGRAPH DRUG	M003	Henry Schein, Inc.	POVIDONE-IODINE	1	g/100mL			N	20241231
0404-0122_8cfdaf0d-3486-41d4-9a33-d6bc7b272a60	0404-0122	HUMAN OTC DRUG	Antibacterial		alcohol	LIQUID	TOPICAL	20191111		OTC MONOGRAPH NOT FINAL	part333A	Henry Schein Inc.	ALCOHOL	665	mL/L			N	20241231
0404-0164_da2ead93-f9b5-6d01-e053-2995a90aa046	0404-0164	HUMAN OTC DRUG	Henry Schein Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200720		OTC MONOGRAPH NOT FINAL	part343	Henry Schein, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0404-0168_f2f12ccc-6e53-0a67-e053-2995a90a22bc	0404-0168	HUMAN OTC DRUG	Vitamin A D		Vitamin A D	OINTMENT	TOPICAL	20221107		OTC MONOGRAPH FINAL	M016	Henry Schein	WHITE PETROLATUM	93	g/100g			N	20241231
0404-0169_f2f138c8-776e-40f9-e053-2a95a90a6c93	0404-0169	HUMAN OTC DRUG	White Petrolatum		White Petrolatum	OINTMENT	TOPICAL	20221117		OTC MONOGRAPH FINAL	M016	Henry Schein	WHITE PETROLATUM	1	g/g			N	20241231
0404-0175_f5cf0e60-9e0b-75b0-e053-2a95a90aeba3	0404-0175	HUMAN OTC DRUG	Maxiclens Chlorhexidine gluconate Liquid Solution, 4%		Chlorhexidine Gluconate	SOLUTION	TOPICAL	20211117		NDA	NDA019258	Henry Schein, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0404-0176_f5d02e04-dbe1-3e87-e053-2995a90a18bc	0404-0176	HUMAN OTC DRUG	Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%		Chlorhexidine Gluconate	SOLUTION	TOPICAL	20211117		NDA	NDA019258	Henry Schein, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0404-0177_f5cd93ab-a950-23d9-e053-2a95a90ab4da	0404-0177	HUMAN PRESCRIPTION DRUG	Acclean Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate	SOLUTION	DENTAL	20211117		ANDA	ANDA075561	Henry Schein, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0404-0178_f5ceb5ee-ba00-456f-e053-2a95a90afafd	0404-0178	HUMAN PRESCRIPTION DRUG	Acclean Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate	SOLUTION	DENTAL	20211117		ANDA	ANDA075561	Henry Schein, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0404-0360_f1635e9d-d190-883f-e053-2a95a90a54a8	0404-0360	HUMAN OTC DRUG	Schein Triple Antibiotic		neomycin sulfate, polymyxin b Sulfate, bacitracin zinc	OINTMENT	TOPICAL	20150421	20240301	OTC MONOGRAPH FINAL	M004	Henry Schein, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
0404-0375_f1628c66-5650-fa92-e053-2995a90a601f	0404-0375	HUMAN OTC DRUG	A and D		Petrolatum	OINTMENT	TOPICAL	20111204	20240901	OTC MONOGRAPH FINAL	M016	Henry Schein, Inc.	PETROLATUM	937.5	mg/g			N	
0404-0714_dee72182-b3c7-42c5-e053-2995a90a83ce	0404-0714	HUMAN OTC DRUG	Henry Schein Acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Henry Schein, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
0404-0716_da431097-9d76-dfe0-e053-2a95a90ad917	0404-0716	HUMAN OTC DRUG	Henry Schein Acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Henry Schein, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
0404-1000_c8af694a-3717-4b64-935a-3dd762bb5579	0404-1000	HUMAN PRESCRIPTION DRUG	STYPTSTIX		SILVER NITRATE APPLICATOR	STICK	TOPICAL	20140601		UNAPPROVED DRUG OTHER		Henry Schein Inc.	POTASSIUM NITRATE; SILVER NITRATE	12.74; 38.21	mg/1; mg/1			N	20241231
0404-1061_7abc4c4c-8ab1-fa25-e053-2991aa0a766b	0404-1061	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20030402		NDA	NDA019125	Henry Schein, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0404-1701_06d4de64-6d8f-6bfb-e063-6294a90a40eb	0404-1701	HUMAN PRESCRIPTION DRUG	Acclean Foam Fluoride 60 Second Application		Sodium Fluoride	AEROSOL, FOAM	DENTAL	20210428		UNAPPROVED DRUG OTHER		Henry Schein	SODIUM FLUORIDE	.0272	g/g			N	20241231
0404-1711_06d4de64-6d8f-6bfb-e063-6294a90a40eb	0404-1711	HUMAN PRESCRIPTION DRUG	Acclean Foam Fluoride 60 Second Application		Sodium Fluoride	AEROSOL, FOAM	DENTAL	20210428		UNAPPROVED DRUG OTHER		Henry Schein	SODIUM FLUORIDE	.0272	g/g			N	20241231
0404-1721_06d4de64-6d8f-6bfb-e063-6294a90a40eb	0404-1721	HUMAN PRESCRIPTION DRUG	Acclean Foam Fluoride 60 Second Application		Sodium Fluoride	AEROSOL, FOAM	DENTAL	20210428		UNAPPROVED DRUG OTHER		Henry Schein	SODIUM FLUORIDE	.0272	g/g			N	20241231
0404-1731_06d4de64-6d8f-6bfb-e063-6294a90a40eb	0404-1731	HUMAN PRESCRIPTION DRUG	Acclean Foam Fluoride 60 Second Application		Sodium Fluoride	AEROSOL, FOAM	DENTAL	20210428		UNAPPROVED DRUG OTHER		Henry Schein	SODIUM FLUORIDE	.0272	g/g			N	20241231
0404-4075_e1a7a426-4bf2-1ac1-e053-2a95a90a14c3	0404-4075	HUMAN PRESCRIPTION DRUG	Acclean Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	LIQUID	ORAL	20091001		ANDA	ANDA077789	Henry Schein, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0404-4438_da334b32-778e-4089-a566-576910a194b2	0404-4438	HUMAN OTC DRUG	Antibacterial Hand		chloroxylenol	SOAP	TOPICAL	20130130		OTC MONOGRAPH NOT FINAL	part333A	Henry Schein, Inc.	CHLOROXYLENOL	6.1	g/L			N	20241231
0404-4441_97b82369-22e3-472d-9765-a8814ac40411	0404-4441	HUMAN OTC DRUG	Antibacterial		chloroxylenol	LIQUID	TOPICAL	20130131		OTC MONOGRAPH NOT FINAL	part333A	Henry Schein, Inc.	CHLOROXYLENOL	6.046	g/L			N	20241231
0404-5987_46177116-56b5-4d6a-aaa7-d32954b4270c	0404-5987	HUMAN OTC DRUG	Antimicrobial Hand Wash		Chloroxylenol	SOAP	TOPICAL	20120207		OTC MONOGRAPH NOT FINAL	part333A	Henry Schein, Inc.	CHLOROXYLENOL	6	mg/1000mL			N	20241231
0404-5988_26a74a3b-86ca-45c1-bad9-faea264329b2	0404-5988	HUMAN OTC DRUG	Instant Hand Sanitizer		alcohol	GEL	TOPICAL	20120207		OTC MONOGRAPH NOT FINAL	part333E	Henry Schein, Inc.	ALCOHOL	665	mL/1000mL			N	20241231
0404-5990_2175033d-2201-4e33-86ee-600fac438d58	0404-5990	HUMAN OTC DRUG	Antimicrobial Hand Wash		Chloroxylenol	SOAP	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part333A	Henry Schein, Inc.	CHLOROXYLENOL	6	mg/1000mL			N	20241231
0404-5991_d483d4b6-6fd8-4efa-ae66-ed740bb5e7eb	0404-5991	HUMAN OTC DRUG	Instant Hand Sanitizer		alcohol	GEL	TOPICAL	20120201		OTC MONOGRAPH NOT FINAL	part333E	Henry Schein, Inc.	ALCOHOL	665	mL/1000mL			N	20241231
0404-6500_0e663407-dbef-4e15-af0b-215dd43031c9	0404-6500	HUMAN PRESCRIPTION DRUG	LIDOCAINE		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111107		ANDA	ANDA088389	Henry Schein Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.02; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-6512_2420c114-52c7-436b-b149-c27b74163cc9	0404-6512	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111107		ANDA	ANDA088390	Henry Schein Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-6620_c8064500-6748-4615-954a-8c1be02ddc66	0404-6620	HUMAN PRESCRIPTION DRUG	Articaine Hydrochloride and Epinephrine		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20150128		NDA AUTHORIZED GENERIC	NDA020971	Henry Schein	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .01	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-6625_c8064500-6748-4615-954a-8c1be02ddc66	0404-6625	HUMAN PRESCRIPTION DRUG	Articaine Hydrochloride and Epinephrine		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20140128		NDA AUTHORIZED GENERIC	NDA020971	Henry Schein	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-6720_81e29617-b415-3fcd-e053-2a91aa0acdf3	0404-6720	HUMAN PRESCRIPTION DRUG	Acclean Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	LIQUID	ORAL	20130201		ANDA	ANDA077789	Henry Schein, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0404-6730_8bd05674-a4a7-4f6d-9067-5446c40e96ed	0404-6730	HUMAN PRESCRIPTION DRUG	Mepivacaine Hydrochloride		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20110101		ANDA	ANDA088387	Henry Schein Inc.	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-6735_07a02b63-fcab-97c6-e063-6294a90a0351	0404-6735	HUMAN OTC DRUG	BZK		benzalkonium chloride	LIQUID	TOPICAL	20130107		OTC MONOGRAPH DRUG	M003	Henry Schein Inc.	BENZALKONIUM CHLORIDE	.0013	g/g			N	20241231
0404-9406_085ef7e6-7133-e42f-e063-6294a90abb43	0404-9406	HUMAN OTC DRUG	Alcohol Prep Pad Large Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20210101		OTC MONOGRAPH DRUG	505G(a)(3)	Henry Schein Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
0404-9407_085ef4b1-5a91-20a5-e063-6294a90a6130	0404-9407	HUMAN OTC DRUG	Alcohol Prep Pad Medium Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20210101		OTC MONOGRAPH DRUG	505G(a)(3)	Henry Schein Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
0404-9408_085ef4b1-5a83-20a5-e063-6294a90a6130	0404-9408	HUMAN OTC DRUG	Alcohol Prep Pad Medium Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20210401		OTC MONOGRAPH DRUG	505G(a)(3)	Henry Schein Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0404-9809_f2d99a20-78fa-44a5-b908-d73da7e14257	0404-9809	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20220106	20241130	ANDA	ANDA078076	Henry Schein, Inc.	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	
0404-9810_0509a6a0-3467-4f56-a8b0-33734ad86df6	0404-9810	HUMAN PRESCRIPTION DRUG	Adrenalin		epineprine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220107		NDA	NDA204200	Henry Schein, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9811_b1961c6a-ae4a-4aaf-b95b-eb9df8faf38f	0404-9811	HUMAN PRESCRIPTION DRUG	Amidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20220106		NDA	NDA018227	Henry Schein, Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0404-9812_91a59d2e-8171-46c4-98cf-b2680b6f2e78	0404-9812	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	INJECTION, SOLUTION	INTRAVENOUS	20211026		ANDA	ANDA070010	Henry Schein, Inc.	AMINOCAPROIC ACID	250	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
0404-9813_4991962f-38bb-4eec-ae30-e07f18cc4dbe	0404-9813	HUMAN PRESCRIPTION DRUG	Aminophylline		Aminophylline	INJECTION, SOLUTION	INTRAVENOUS	20220108		ANDA	ANDA087242	Henry Schein, Inc.	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0404-9814_af2db801-7398-47d2-9c52-b5f99845c08a	0404-9814	HUMAN PRESCRIPTION DRUG	Aminophylline		Aminophylline	INJECTION, SOLUTION	INTRAVENOUS	20220108		ANDA	ANDA087242	Henry Schein, Inc.	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0404-9815_789f4921-6032-4b9d-a40b-3097c60a308c	0404-9815	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220108		ANDA	ANDA076217	Henry Schein, Inc	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0404-9816_574b3c3b-1d88-4e30-8d50-5bc272926855	0404-9816	HUMAN PRESCRIPTION DRUG	AMPICILLIN		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220108		ANDA	ANDA065499	Henry Schein, Inc.	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0404-9818_124d4462-f505-4426-89e0-855412c603b2	0404-9818	HUMAN PRESCRIPTION DRUG	AMPICILLIN		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220117		ANDA	ANDA065499	Henry Schein, Inc.	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0404-9821_7789b041-454a-4dab-ab66-142dc41f727d	0404-9821	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220109		UNAPPROVED DRUG OTHER		Henry Schein, Inc.	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0404-9822_214b053d-e596-445a-b982-87959c19a822	0404-9822	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220109		UNAPPROVED DRUG OTHER		Henry Schein, Inc.	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0404-9825_2e72b161-d531-4190-ae4f-6db182e14494	0404-9825	HUMAN PRESCRIPTION DRUG	Brevibloc		esmolol hydrochloride	INJECTION	INTRAVENOUS	20220109		NDA	NDA019386	Henry Schein, Inc	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0404-9826_9bd98677-4965-44f9-a52e-4dad8c504117	0404-9826	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20211203		ANDA	ANDA070590	Henry Schein, Inc	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-9827_d1f0b6d5-b603-4fd1-969b-acd75fe410ad	0404-9827	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20220109		ANDA	ANDA070597	Henry Schein, Inc	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-9828_3b0e121e-9a96-4f2f-b315-61a51505db84	0404-9828	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride and Epinephrine		Bupivacaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220109		ANDA	ANDA071165	Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9829_54b2bf1b-1bf4-4810-8f4e-da86d759ef8c	0404-9829	HUMAN PRESCRIPTION DRUG	Calcium Chloride		Calcium Choride	INJECTION, SOLUTION	INTRAVENOUS; INTRAVENTRICULAR	20220117		UNAPPROVED DRUG OTHER		Henry Schein, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0404-9830_310dacb7-7b6a-4e9a-8654-57d428249770	0404-9830	HUMAN PRESCRIPTION DRUG	Calcium Chloride		Calcium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20220109		NDA	NDA021117	Henry Schein, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0404-9831_8430940c-d5cf-40c9-8313-08a93069c791	0404-9831	HUMAN PRESCRIPTION DRUG	Calcium Gluconate		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20220109		NDA	NDA208418	Henry Schein, Inc.	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0404-9833_295024d7-118c-4e05-a7af-736eafccbcff	0404-9833	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220109		ANDA	ANDA203661	Henry Schein, Inc.	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0404-9834_a9de94ec-f0a9-443b-b9c8-d1a3ee5bfd45	0404-9834	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220109		ANDA	ANDA065047	Henry Schein, Inc.	CEFAZOLIN SODIUM	330	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0404-9835_311eb782-5855-44ff-b567-5b39a76b588d	0404-9835	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220109		ANDA	ANDA065047	Henry Schein Inc.	CEFAZOLIN SODIUM	225	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0404-9836_9356e152-4904-4fa7-812f-53a4b0445be7	0404-9836	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR	20220109		ANDA	ANDA083329	Henry Schein, Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0404-9837_2e84b8e5-5fa5-4dbf-a7bd-5f4f888fcc21	0404-9837	HUMAN PRESCRIPTION DRUG	CLEOCIN PHOSPHATE		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220109		NDA	NDA050441	Henry Schein, Inc.	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0404-9838_85585920-2c7b-4838-9503-0f65c21305df	0404-9838	HUMAN PRESCRIPTION DRUG	Clindamycin		Clindamycin Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220109		ANDA	ANDA090108	Henry Schein, Inc.	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0404-9839_f10b7d59-c43f-4460-8002-2ccb2ab2c787	0404-9839	HUMAN PRESCRIPTION DRUG	Cortrosyn		Cortrosyn	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	20220109		NDA	NDA016750	Henry Schein, Inc.	COSYNTROPIN	.25	mg/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
0404-9840_1f03517d-bee7-43d7-b307-3878ecb43e01	0404-9840	HUMAN PRESCRIPTION DRUG	CYANOCOBALAMIN		CYANOCOBALAMIN	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20220109		ANDA	ANDA204829	Henry Schein, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0404-9841_57391e26-1c6e-4df2-bdd4-aa3843ef6a01	0404-9841	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20220109		ANDA	ANDA040803	Henry Schein, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0404-9842_990c131b-ed15-4c9d-8046-f8332d4708ee	0404-9842	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220109		ANDA	ANDA040802	Henry Schein, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0404-9843_73327485-790a-4972-9a08-b89976f05254	0404-9843	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		dexamethasone sodium phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20220110		ANDA	ANDA206781	Henry Schein, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0404-9844_a5a86841-e185-4112-a77d-e2996b58c1b8	0404-9844	HUMAN PRESCRIPTION DRUG	Infant Dextrose		Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20220110		NDA	NDA019445	Henry Schein, Inc.	DEXTROSE MONOHYDRATE	250	mg/mL			N	20241231
0404-9845_70cbd349-21b5-4635-b79a-9ef7eeae4ff4	0404-9845	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20220110		NDA	NDA019445	Henry Schein, Inc.	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
0404-9846_0e8c54d2-bb93-4cf4-8ffb-90dad14beb39	0404-9846	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20220110		UNAPPROVED DRUG OTHER		Henry Schein, Inc.	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
0404-9847_4ca86009-3d17-4016-86b5-e3bb4dfba21a	0404-9847	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20220110		NDA	NDA019445	Henry Schein, Inc.	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
0404-9848_cdd85be1-597f-4f02-ba27-b0bcb7f49339	0404-9848	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA071583	Henry Schein, Inc.	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0404-9849_0eb06d75-873f-440c-babf-296673bcc2cd	0404-9849	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220118		ANDA	ANDA072079	Henry Schein, Inc.	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0404-9850_91885534-5154-4bb9-9716-510ecd2ea223	0404-9850	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA083391	Henry Schein, Inc.	DIGOXIN	.25	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0404-9851_30a2722f-7fdf-486c-b2ae-96bf27351b15	0404-9851	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220117		ANDA	ANDA080817	Henry Schein, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0404-9852_775dd8d8-6441-46ef-a482-9b1211941793	0404-9852	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	INJECTION	INTRAVENOUS	20220110		ANDA	ANDA074521	Henry Schein, Inc.	DIPYRIDAMOLE	5	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0404-9855_4635a3c9-de47-4d71-8768-473f394bbfba	0404-9855	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220110		ANDA	ANDA091406	Henry Schein, Inc	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0404-9857_2aefb5bc-d55f-459f-b235-4519f3c8c578	0404-9857	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220110		NDA	NDA205029	Henry Schein, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9858_e6202d6e-595c-4fb9-a363-934e40fc0c5d	0404-9858	HUMAN PRESCRIPTION DRUG	ESMOLOL HYDROCHLORIDE		ESMOLOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220110		ANDA	ANDA205520	Henry Schein, Inc.	ESMOLOL HYDROCHLORIDE	100	mg/10mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0404-9859_a2c4868f-55a0-4619-8512-8f3ccb6ca7a1	0404-9859	HUMAN PRESCRIPTION DRUG	Flumazenil		flumazenil	INJECTION	INTRAVENOUS	20220110		ANDA	ANDA076755	Henry Schein, Inc	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
0404-9860_a2c218c1-551b-4fb5-9950-ffe7fd8bbb54	0404-9860	HUMAN PRESCRIPTION DRUG	Flumazenil		flumazenil	INJECTION	INTRAVENOUS	20220110		ANDA	ANDA076755	Henry Schein, Inc	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
0404-9862_586a8ec7-8a07-4098-8305-43c30e0594f6	0404-9862	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20220110		ANDA	ANDA202747	Henry Schein, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0404-9863_cc40e1a9-d2a0-46a8-b8ef-21e865fe1f9f	0404-9863	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAVENOUS	20220110		ANDA	ANDA202747	Henry Schein, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0404-9864_4282e281-7368-4f6f-9c7c-fba8b7b68c24	0404-9864	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA212174	Henry Schein, Inc.	FUROSEMIDE	20	mg/2mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0404-9865_abbc37c7-f160-4d0e-a734-b3550f934054	0404-9865	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA062420	Henry Schein, Inc.	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0404-9866_36855996-9aa1-4441-ac52-10bd442b59cb	0404-9866	HUMAN PRESCRIPTION DRUG	Gentamicin		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA062366	Henry Schein, Inc	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0404-9867_0c2f7873-8c4a-4116-a4ca-48353a337f93	0404-9867	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA090963	Henry Schein, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0404-9868_a62f8ca2-1653-424d-81a9-0769a4e73329	0404-9868	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA090963	Henry Schein, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0404-9869_9f762481-34d1-44dd-ac5d-76a168f732c2	0404-9869	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA090963	Henry Schein, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0404-9870_c8c5f85d-11c6-4abd-8505-924f261f63c1	0404-9870	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220111		ANDA	ANDA208973	Henry Schein, Inc.	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0404-9871_23fc3dfa-3101-43b8-b6f0-716f98ae8007	0404-9871	HUMAN PRESCRIPTION DRUG	Haloperidol Lactate		Haloperidol	INJECTION, SOLUTION	INTRAMUSCULAR	20220111		ANDA	ANDA078347	Henry Schein, Inc.	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0404-9872_b2f9c0ce-de2e-47d2-8720-24db551d6847	0404-9872	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220111		ANDA	ANDA090808	Henry Schein, Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0404-9873_00d8d6df-3220-47a1-93f9-9600f9921bd3	0404-9873	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM		heparin sodium injection	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20220111		ANDA	ANDA203851	Henry Schein, Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0404-9877_4f82a0b4-c54f-4da8-83c7-11715052993f	0404-9877	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	20220117		ANDA	ANDA087408	Henry Schein, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0404-9878_16519e8a-1a89-4d03-801c-4a1c13c61d93	0404-9878	HUMAN PRESCRIPTION DRUG	Hydroxyzine		Hydroxyzine	INJECTION, SOLUTION	INTRAMUSCULAR	20220117		ANDA	ANDA087408	Henry Schein, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0404-9879_b4f93688-378a-45f2-a3d4-55de85322895	0404-9879	HUMAN PRESCRIPTION DRUG	INFED		iron dextran	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220111		NDA	NDA017441	Henry Schein, Inc.	IRON DEXTRAN	50	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0404-9880_12b3c48f-5635-46cf-b332-47e3bf485a61	0404-9880	HUMAN PRESCRIPTION DRUG	KETALAR		ketamine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220111		NDA	NDA016812	Henry Schein, Inc	KETAMINE HYDROCHLORIDE	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0404-9881_a6cde232-e573-461f-a55c-80d24ac3d3fe	0404-9881	HUMAN PRESCRIPTION DRUG	KETAMINE HYDROCHLORIDE		ketamine hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAMUSCULAR; INTRAVENOUS	20220111		ANDA	ANDA074549	Henry Schein, Inc.	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0404-9882_defda130-5d21-4888-b78d-17f1ca07d66e	0404-9882	HUMAN PRESCRIPTION DRUG	KETAMINE HYDROCHLORIDE		ketamine hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAMUSCULAR; INTRAVENOUS	20220111		ANDA	ANDA074549	Henry Schein, Inc.	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0404-9883_2615451f-49af-4ec7-bd09-0fc9c462acaa	0404-9883	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220111	20241130	ANDA	ANDA204216	Henry Schein, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0404-9884_45918389-10fe-48e3-8f24-a778fc466cc7	0404-9884	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20220111	20240930	ANDA	ANDA204216	Henry Schein, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0404-9885_65e22427-6bf9-4289-90b1-7cc36fa331d5	0404-9885	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; INTRAVENOUS	20220111		ANDA	ANDA088328	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9886_74f8caf7-ac17-4a66-97da-d4a7d91ecc03	0404-9886	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220111		ANDA	ANDA089635	Henry Schein, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	5; 5	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9887_c36f41b1-cd58-43d2-90e7-31d3c1526cca	0404-9887	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride Anhydrous	INJECTION, SOLUTION	INFILTRATION	20220112		ANDA	ANDA080408	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9888_7ffd1d65-141e-4deb-83b2-f0e0ce0ce91e	0404-9888	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride Anhydrous	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220112		ANDA	ANDA088299	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9889_3e7b6ca4-4eb0-4c8b-9887-8aa6a4702c4c	0404-9889	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220112		ANDA	ANDA040302	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9890_9524dc6b-1af0-4add-ba1c-67b653fd5796	0404-9890	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine	INJECTION, SOLUTION	INTRAVENOUS	20220112		ANDA	ANDA083158	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9891_e87d325a-8fad-43e9-b031-7e89133065ce	0404-9891	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	INFILTRATION	20220112		ANDA	ANDA089644	Henry Schein, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 10	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9892_b9facdfa-b600-43bd-8b23-aa7fff385174	0404-9892	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220112		ANDA	ANDA083158	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9893_474d164a-5573-4118-acd8-6d8096af6f33	0404-9893	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20220112		ANDA	ANDA088294	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9894_fb1ca6c9-db24-4b6f-bdb5-80cffa25b557	0404-9894	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220112		ANDA	ANDA040302	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9895_4b51775a-7a32-4251-b6a5-8c3241f28c8b	0404-9895	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride Anhydrous	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220112		ANDA	ANDA088327	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9896_c1eda316-3fc1-4fcf-8583-19dbda606b94	0404-9896	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220112		ANDA	ANDA089646	Henry Schein, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9897_86a4bc17-817b-4943-8a99-65fe575a58c0	0404-9897	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		lidocaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220112		ANDA	ANDA203082	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9898_dc3e5022-a6ea-4750-acaf-ccf1ee57f897	0404-9898	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	20220112		ANDA	ANDA086283	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9899_d640e2f3-dd49-459f-9d62-7b0905aca9cf	0404-9899	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		lidocaine hydrochloride	JELLY	TOPICAL	20220112		ANDA	ANDA086283	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9900_d9cc1b4f-63a5-4724-aaa3-6c2eedf9e969	0404-9900	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	20220112		ANDA	ANDA086283	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9901_3ef0abd5-5a02-4b5a-9654-2c1dd37034a9	0404-9901	HUMAN PRESCRIPTION DRUG	LINCOMYCIN		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20220112		ANDA	ANDA201746	Henry Schein, Inc.	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
0404-9902_b887bb5f-2d74-480c-bc4f-8f6198e7d9b7	0404-9902	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220112		NDA	NDA019316	Henry Schein, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0404-9903_be393ea2-169a-4e77-a7ea-911c368b3d20	0404-9903	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220112		ANDA	ANDA075151	Henry Schein, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0404-9904_3574184e-d7ee-415a-82e5-92e3ba9e0333	0404-9904	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220118		NDA	NDA019316	Henry Schein, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0404-9905_2b70d3af-2277-40a3-90cb-a18871da49fe	0404-9905	HUMAN PRESCRIPTION DRUG	Mannitol		Mannitol	INJECTION, SOLUTION	INTRAVENOUS	20220112		NDA	NDA016269	Henry Schein, Inc.	MANNITOL	12.5	g/50mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0404-9906_7d28a235-dab2-4bf2-a29b-f0c693029d3a	0404-9906	HUMAN PRESCRIPTION DRUG	Marcaine		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220118		NDA	NDA016964	Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-9907_041f7ed9-25e1-419b-a1eb-421a510b823b	0404-9907	HUMAN PRESCRIPTION DRUG	Marcaine		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20220119		NDA	NDA016964	Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
0404-9908_c4709f3e-40ad-4cae-a255-fa0bb7dd5d3f	0404-9908	HUMAN PRESCRIPTION DRUG	MARCAINE WITH EPINEPHRINE		bupivacaine hydrochloride and epinephrine bitartrate	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220113		NDA	NDA016964	Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9910_1e83bd42-c1dc-4a27-864c-d79a701d8d1c	0404-9910	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA073118	Henry Schein, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0404-9912_429b6c3e-c7bb-455e-acb8-483ee4c29d5c	0404-9912	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA075154	Henry Schein, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0404-9913_0be5d579-aaad-4441-8245-545afb7d89ba	0404-9913	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA075243	Henry Schein, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0404-9914_3fbd8d19-77df-4cf6-8b2c-58194b2969eb	0404-9914	HUMAN PRESCRIPTION DRUG	MIDAZOLAM		midazoalm	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA090850	Henry Schein, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0404-9915_8581eb98-4d8c-48d1-a530-d4ae63b2e4b4	0404-9915	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA075293	Henry Schein, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0404-9916_bdd50e1d-b951-44dd-b735-6372892c85a4	0404-9916	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220117		ANDA	ANDA075857	Henry Schein, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0404-9917_1ad21c31-ebc4-4188-b8c8-4db6d32e0121	0404-9917	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		nalbuphine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220113		ANDA	ANDA070918	Henry Schein, Inc.	NALBUPHINE HYDROCHLORIDE	20	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0404-9918_20a9b995-8c2d-4af3-9cfb-f12f73d4cceb	0404-9918	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		Nalbuphine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220113		ANDA	ANDA070914	Henry Schein, Inc.	NALBUPHINE HYDROCHLORIDE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0404-9919_307f05a4-dbea-4e10-a837-40e34c90f370	0404-9919	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		nalbuphine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220113		ANDA	ANDA070915	Henry Schein, Inc.	NALBUPHINE HYDROCHLORIDE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0404-9920_56cc180c-5a2a-4ea9-a295-e4fc5b9ae06e	0404-9920	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220113		ANDA	ANDA070172	Henry Schein, Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0404-9921_434a854f-8704-4045-886b-d0236ed9ee5b	0404-9921	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	INJECTION	PARENTERAL	20220118		ANDA	ANDA072076	Henry Schein, Inc.	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0404-9922_5ce82dd5-e414-417f-bd28-ad77e2365b38	0404-9922	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	INJECTION	PARENTERAL	20220113		ANDA	ANDA072076	Henry Schein, Inc	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0404-9923_24e7a08e-2829-41f7-a1ba-0d0753bbe27e	0404-9923	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220113		ANDA	ANDA207633	Henry Schein, Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0404-9924_657ada64-56b2-4a29-8b36-6fbf034bc669	0404-9924	HUMAN PRESCRIPTION DRUG	NAROPIN		ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20220113		NDA	NDA020533	Henry Schein, Inc.	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-9925_e21f98d9-62e9-4a1e-bc7c-c567de6d8650	0404-9925	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20220113		ANDA	ANDA209933	Henry Schein, Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0404-9926_7596aa3c-0b70-493a-b791-5b92bd6ca922	0404-9926	HUMAN PRESCRIPTION DRUG	Nesacaine		Chloroprocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220113		NDA	NDA009435	Henry Schein, Inc.	CHLOROPROCAINE HYDROCHLORIDE	10	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
0404-9927_e0a69696-2947-4540-8499-384b7546fbd1	0404-9927	HUMAN PRESCRIPTION DRUG	NESACAINE		chloroprocaine hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220113		NDA	NDA009435	Henry Schein, Inc.	CHLOROPROCAINE HYDROCHLORIDE	20	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
0404-9928_be36f1f6-d307-41dc-a9a4-523c30928b97	0404-9928	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	INJECTION, SOLUTION	INTRAVENOUS	20220113		ANDA	ANDA072034	Henry Schein, Inc.	NITROGLYCERIN	5	mg/mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0404-9929_18025d80-8404-4a16-9b53-639bc410806c	0404-9929	HUMAN PRESCRIPTION DRUG	NITROSTAT		nitroglycerin	TABLET	SUBLINGUAL	20230223		NDA	NDA021134	Henry Schein, Inc.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0404-9930_998e0c60-e94d-46b6-8702-6f61bfee3bc5	0404-9930	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA203711	Henry Schein, Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0404-9931_9417b336-d7a5-4826-a7e7-0f1ef068ed68	0404-9931	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20220113		ANDA	ANDA211079	Henry Schein, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0404-9932_8b60d04b-23ce-45b8-ae3d-bfcd243595bd	0404-9932	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220117		ANDA	ANDA084307	Henry Schein, Inc.	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0404-9933_b9b5e216-a9fa-46e3-bf80-92cc083891a8	0404-9933	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA084307	Henry Schein, Inc.	PHENYTOIN SODIUM	250	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0404-9935_be9954f6-b11f-447a-ac84-8ca26013ba65	0404-9935	HUMAN PRESCRIPTION DRUG	PHYTONADIONE		phytonadione	INJECTION, EMULSION	PARENTERAL	20220113		ANDA	ANDA083722	Henry Schein, Inc.	PHYTONADIONE	1	mg/.5mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
0404-9936_4d8904c9-b0a5-4936-af4b-b5ee6033d17a	0404-9936	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220113		ANDA	ANDA088901	Henry Schein, Inc.	POTASSIUM CHLORIDE	2	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0404-9937_3e28569f-b662-4bc1-b281-068abaf22649	0404-9937	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220113		ANDA	ANDA080205	Henry Schein, Inc.	POTASSIUM CHLORIDE	149	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0404-9938_8231fcbf-1fab-41d6-a9c6-8e048bde272f	0404-9938	HUMAN PRESCRIPTION DRUG	PRECEDEX		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220113		NDA	NDA021038	Henry Schein, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0404-9940_fe487cf0-6fd7-4d62-a01e-5d0291e1119f	0404-9940	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220113		ANDA	ANDA083312	Henry Schein, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0404-9941_eff315c0-6d81-4f45-b211-27a03abf5be3	0404-9941	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220117		ANDA	ANDA083312	Henry Schein, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0404-9942_1cece6e1-79d2-4c30-8986-cbed8b50d761	0404-9942	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	20220117		ANDA	ANDA083312	Henry Schein, Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0404-9944_b0fe06c0-be68-4b6d-8d15-563fc55f90e5	0404-9944	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		propranolol hydrochloride	INJECTION	INTRAVENOUS	20220112		ANDA	ANDA077760	Henry Schein, Inc.	PROPRANOLOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0404-9945_a5d4f529-6359-4c6d-9789-4208aa5c0b03	0404-9945	HUMAN PRESCRIPTION DRUG	Sensorcaine		Bupivacaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220112		NDA	NDA018304	Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-9946_b0cc0453-2ece-4d85-85b9-61ca9c627437	0404-9946	HUMAN PRESCRIPTION DRUG	Sensorcaine MPF		bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20220112		ANDA	ANDA070553	Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-9947_6b9c5db9-3a48-4b38-8767-6461f4c4c446	0404-9947	HUMAN PRESCRIPTION DRUG	Sensorcaine		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20220112		NDA	NDA018304	Henry Schein, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0404-9950_9aa82955-103c-45e4-a36b-4be9933a6be0	0404-9950	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20220117		ANDA	ANDA202495	Henry Schein, Inc.	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
0404-9951_f490a8de-e239-4f52-b426-0c83379d9d62	0404-9951	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		sodium bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20220112		ANDA	ANDA202981	Henry Schein, Inc.	SODIUM BICARBONATE	42	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0404-9952_ef76d0b4-3b44-44bd-b251-c8c837e0f5da	0404-9952	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220111	20240731	ANDA	ANDA204216	Henry Schein, Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0404-9953_5c336dcb-ce46-4898-bb5e-5f47a64db169	0404-9953	HUMAN PRESCRIPTION DRUG	Bacteriostatic Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220112		NDA	NDA018800	Henry Schein, Inc.	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0404-9954_085433f7-2490-43c0-8e78-a4c67903c931	0404-9954	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220112		NDA	NDA018803	Henry Schein, Inc.	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0404-9955_e51cc749-3dd2-4576-8c14-09bcfeddf0cc	0404-9955	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	20220112		ANDA	ANDA088912	Henry Schein, Inc.	SODIUM CHLORIDE	9	mg/mL			N	20241231
0404-9957_2b1d9c22-c022-4b74-bd07-cb40446d11b4	0404-9957	HUMAN PRESCRIPTION DRUG	Solu-Medrol		Methylprednisolone Sodium Succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220112		NDA	NDA011856	Henry Schein, Inc.	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0404-9958_617d1dd1-3a51-47a4-b69c-02cc001002e5	0404-9958	HUMAN PRESCRIPTION DRUG	Solu-Medrol		Methylprednisolone Sodium Succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220112		NDA	NDA011856	Henry Schein, Inc.	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0404-9959_83ab9a61-5dfb-42b5-bdea-3b0f432844ee	0404-9959	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220112		NDA	NDA018801	Henry Schein, Inc.	WATER	1	mL/mL			N	20241231
0404-9961_e7452255-acfa-4c01-b162-12165d11255a	0404-9961	HUMAN PRESCRIPTION DRUG	Suprane		Desflurane	LIQUID	RESPIRATORY (INHALATION)	20220112		NDA	NDA020118	Henry Schein, Inc.	DESFLURANE	240	mL/240mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0404-9962_57fb4ea2-2aec-4c81-9864-69d7148db36f	0404-9962	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	INJECTION, SOLUTION	SUBCUTANEOUS	20220112		ANDA	ANDA076887	Henry Schein, Inc.	TERBUTALINE SULFATE	1	mg/mL			N	20241231
0404-9963_b864c55a-0dd6-44ae-a249-665fc4618c1e	0404-9963	HUMAN PRESCRIPTION DRUG	THIAMINE HYDROCHLORIDE		thiamine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220112		ANDA	ANDA091623	Henry Schein, Inc.	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
0404-9964_57f1a9eb-47ed-40e1-a087-4b7bf2389411	0404-9964	HUMAN PRESCRIPTION DRUG	Tigan		Trimethobenzamide Hydrochloride	INJECTION	INTRAMUSCULAR	20220111		NDA	NDA017530	Henry Schein, Inc	TRIMETHOBENZAMIDE HYDROCHLORIDE	100	mg/mL	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0404-9965_10eeda4b-63b0-45dc-b28f-03db9d591277	0404-9965	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220111		ANDA	ANDA062911	Henry Schein, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0404-9966_5ebf59d0-1088-4655-a153-c2bede8ee6ee	0404-9966	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220111		ANDA	ANDA211015	Henry Schein, Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0404-9967_56e00c1a-c79e-4a45-a2a1-39eefbbce34a	0404-9967	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		verapamil hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220110		ANDA	ANDA211015	Henry Schein, Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0404-9968_1b86fe1b-7b9b-4903-b75a-6bc2a9b4c795	0404-9968	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220110		ANDA	ANDA075136	Henry Schein, Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0404-9969_63291e02-e135-449b-8f9c-50b8ce3c14f8	0404-9969	HUMAN PRESCRIPTION DRUG	PHYTONADIONE		phytonadione	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220110		ANDA	ANDA207719	Henry Schein, Inc.	PHYTONADIONE	10	mg/mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
0404-9970_45a11537-b92a-4743-9b53-f3423bebd394	0404-9970	HUMAN PRESCRIPTION DRUG	Bacteriostatic Water		Water	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220117		NDA	NDA018802	Henry Schein, Inc.	WATER	1	mL/mL			N	20241231
0404-9971_7e3ba953-bd16-49bc-a87c-8be71241111f	0404-9971	HUMAN PRESCRIPTION DRUG	STERILE WATER		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220110		NDA	NDA018801	Henry Schein, Inc.	WATER	1	mL/mL			N	20241231
0404-9972_27434ccd-be3a-439a-bc10-02a799ac9b9d	0404-9972	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride and epinephrine	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220110		NDA	NDA006488	Henry Schein, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9973_8b51312c-03a5-45c4-8447-3944fb840bdc	0404-9973	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220110		NDA	NDA006488	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9974_ed78eab6-80e8-4af9-bb25-d8602b77608b	0404-9974	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine HCl	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220117		NDA	NDA006488	Henry Schein, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0404-9975_8020eb22-18dd-44fb-b751-f4e1291c3b11	0404-9975	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine hydrochloride, epinephrine bitartrate injection, solution	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220110		NDA	NDA006488	Henry Schein, Inc	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9976_892865f5-41da-48f3-9fa4-fdfc74031509	0404-9976	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride and epinephrine	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220110		NDA	NDA006488	Henry Schein, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9977_4bec9662-8e1f-4e9c-9ea9-c67fd4bf11be	0404-9977	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220110		NDA	NDA006488	Henry Schein, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 10	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0404-9978_21d791a8-7d43-4ee6-96af-1822427c222e	0404-9978	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220112		ANDA	ANDA212248	Henry Schein, Inc.	SODIUM CHLORIDE	4	meq/mL			N	20241231
0404-9979_c7a21c1e-13e8-49a2-b084-bf52cbebe114	0404-9979	HUMAN PRESCRIPTION DRUG	Heparin Sodium		heparin sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220117		NDA	NDA017029	Henry Schein, Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0404-9980_ac0ede57-6bb6-4a61-a358-a6b09e90a7cd	0404-9980	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		sodium bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20220112		UNAPPROVED DRUG OTHER		Henry Schein, Inc.	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0404-9981_13565697-fcb0-4df5-806e-35b1be22ce87	0404-9981	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride		Dopamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220217		NDA	NDA018132	Henry Schein, Inc.	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0404-9982_89ad3844-2f1b-4f6e-9958-644f31d219a4	0404-9982	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride		Dopamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220218		NDA	NDA018132	Henry Schein, Inc.	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0404-9983_aec46247-2c2a-4fb7-997b-5f7f7424adbc	0404-9983	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		succinylcholine chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220722		ANDA	ANDA213810	Henry Schein, Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
0404-9984_d7901dd7-c109-4c9a-8e6b-bc7763552b23	0404-9984	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		sodium bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20220913		ANDA	ANDA202494	Henry Schein, Inc.	SODIUM BICARBONATE	75	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0404-9985_15aa8422-3c82-4a51-89a3-63b36ac3ad82	0404-9985	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		sodium bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20230508		ANDA	ANDA202679	Henry Schein, Inc.	SODIUM BICARBONATE	42	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0404-9986_e4f7eabb-2d33-4c3d-be71-c216ddddd9c4	0404-9986	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221014	20240430	ANDA	ANDA040730	Henry Schein, Inc.	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
0404-9988_486f2196-2281-4ebc-961b-51043e5e425b	0404-9988	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20230905		NDA	NDA214652	Henry Schein, Inc.	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0404-9989_953811b7-e3d7-4463-b601-be4704b81619	0404-9989	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20230905		NDA	NDA214652	Henry Schein, Inc.	ATROPINE SULFATE	1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0404-9990_3fbc391e-8c26-4b3a-9de6-aa1c4689161a	0404-9990	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		atropine sulfate injection	INJECTION	ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20221221		ANDA	ANDA213561	Henry Schein, Inc.	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0404-9991_5f2b2477-422d-4eda-a8d8-557a395e8bd8	0404-9991	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		metronidazole	INJECTION, SOLUTION	INTRAVENOUS	20230224		ANDA	ANDA206191	Henry Schein, Inc.	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0404-9992_440f227a-7815-4b74-989b-528cd4a0a567	0404-9992	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		methocarbamol	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230406		ANDA	ANDA206128	Henry Schein, Inc	METHOCARBAMOL	1000	mg/10mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0404-9993_ee202dbf-63f9-4ca9-8131-c88b6b374ff1	0404-9993	HUMAN PRESCRIPTION DRUG	ADENOSINE		adenosine injection, solution	INJECTION, SOLUTION	INTRAVENOUS	20230628		ANDA	ANDA077133	Henry Schein, Inc.	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
0404-9994_e659da2e-e330-4ec5-a3ba-547451ccd276	0404-9994	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230717		ANDA	ANDA213667	Henry Schein, Inc.	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0404-9995_ba3dcfdf-bc4d-4eb5-99f7-035b333842e4	0404-9995	HUMAN PRESCRIPTION DRUG	CYANOCOBALAMINE		cyanocobalamine injection	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20230609		ANDA	ANDA204829	Henry Schein, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0404-9996_a5d2ebee-81a8-4480-a375-5fb77a8f943e	0404-9996	HUMAN PRESCRIPTION DRUG	Ketorolac tromethamine		Ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230825		ANDA	ANDA204216	Henry Schein, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0404-9997_900caab4-d678-4b80-801d-85e07c0e24dd	0404-9997	HUMAN PRESCRIPTION DRUG	Ketorolac tromethamine		Ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230825		ANDA	ANDA204216	Henry Schein, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0406-0123_d8235792-ff67-48ec-b06f-0a6fafdd15dd	0406-0123	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20001020		ANDA	ANDA040409	SpecGx LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0406-0124_d8235792-ff67-48ec-b06f-0a6fafdd15dd	0406-0124	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20000908		ANDA	ANDA040405	SpecGx LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0406-0125_d8235792-ff67-48ec-b06f-0a6fafdd15dd	0406-0125	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20000726		ANDA	ANDA040400	SpecGx LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0406-0127_40f2d4de-2581-403a-a612-4afeae8f7a89	0406-0127	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20121228		ANDA	ANDA202608	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-0136_40f2d4de-2581-403a-a612-4afeae8f7a89	0406-0136	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20121228		ANDA	ANDA202608	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-0154_40f2d4de-2581-403a-a612-4afeae8f7a89	0406-0154	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20121228		ANDA	ANDA202608	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-0376_bbad3e7a-fdaa-4c79-b7e5-0fca81b7f02f	0406-0376	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170331		ANDA	ANDA206718	SpecGx LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
0406-0377_bbad3e7a-fdaa-4c79-b7e5-0fca81b7f02f	0406-0377	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170331		ANDA	ANDA206718	SpecGx LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
0406-0378_bbad3e7a-fdaa-4c79-b7e5-0fca81b7f02f	0406-0378	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170331		ANDA	ANDA206718	SpecGx LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
0406-0483_b91690e1-0616-449c-82da-f8568b4f7da6	0406-0483	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	SpecGx LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 15	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
0406-0484_b91690e1-0616-449c-82da-f8568b4f7da6	0406-0484	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	SpecGx LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
0406-0485_b91690e1-0616-449c-82da-f8568b4f7da6	0406-0485	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	SpecGx LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
0406-0512_a2cb3498-ca57-429c-861a-bf77f8487297	0406-0512	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	19831207		ANDA	ANDA087463	SpecGx LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0406-0522_a2cb3498-ca57-429c-861a-bf77f8487297	0406-0522	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	20040630		ANDA	ANDA040545	SpecGx LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0406-0523_a2cb3498-ca57-429c-861a-bf77f8487297	0406-0523	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	20040630		ANDA	ANDA040545	SpecGx LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0406-0527_90605203-cf8b-4cc7-8c94-8ce877854757	0406-0527	HUMAN PRESCRIPTION DRUG	METHADOSE		methadone hydrochloride	CONCENTRATE	ORAL	19730314		NDA	NDA017116	SpecGx LLC	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-0540_157e1beb-b460-456c-a45e-67f5c7d962e2	0406-0540	HUMAN PRESCRIPTION DRUG	METHADOSE DISPERSIBLE		Methadone Hydrochloride	TABLET	ORAL	19930429		ANDA	ANDA074184	SpecGx LLC	METHADONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-0552_89996466-29eb-4543-9653-23983ae3309f	0406-0552	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		oxycodone hydrochloride	TABLET	ORAL	20040630		ANDA	ANDA076758	SpecGx LLC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-0803_f08614e5-8d0b-4d51-a315-851b6e18db35	0406-0803	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-0804_f08614e5-8d0b-4d51-a315-851b6e18db35	0406-0804	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	12.5; 12.5; 12.5; 12.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-0805_f08614e5-8d0b-4d51-a315-851b6e18db35	0406-0805	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-0807_f08614e5-8d0b-4d51-a315-851b6e18db35	0406-0807	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single-Entity Amphetamine Product		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA211546	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	9.375; 9.375; 9.375; 9.375	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1142_6d75b224-bdfa-4f2b-9165-83a4e1a342e2	0406-1142	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	19981127		ANDA	ANDA040300	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1144_6d75b224-bdfa-4f2b-9165-83a4e1a342e2	0406-1144	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	19981127		ANDA	ANDA040300	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1146_6d75b224-bdfa-4f2b-9165-83a4e1a342e2	0406-1146	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	19981127		ANDA	ANDA040300	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1170_e584f90b-2dab-450b-8968-f736af25e412	0406-1170	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		naltrexone hydrochloride	TABLET, FILM COATED	ORAL	20020322		ANDA	ANDA076264	SpecGx LLC	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0406-1219_39839d7b-5a2f-415b-843d-6d67d27a95e4	0406-1219	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20210228		ANDA	ANDA213583	SpecGx LLC	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1220_39839d7b-5a2f-415b-843d-6d67d27a95e4	0406-1220	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20210228		ANDA	ANDA213583	SpecGx LLC	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1236_49af8523-a00b-4821-a0a2-fd0b35bf4649	0406-1236	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20201030		ANDA	ANDA213335	SpecGx LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
0406-1445_6d75b224-bdfa-4f2b-9165-83a4e1a342e2	0406-1445	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20000509		ANDA	ANDA075629	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1473_6d75b224-bdfa-4f2b-9165-83a4e1a342e2	0406-1473	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20000509		ANDA	ANDA075629	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1810_0e9d337e-ddbb-4312-a279-65ddc4adde53	0406-1810	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150929		ANDA	ANDA203583	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1820_0e9d337e-ddbb-4312-a279-65ddc4adde53	0406-1820	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150929		ANDA	ANDA203583	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1830_0e9d337e-ddbb-4312-a279-65ddc4adde53	0406-1830	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150929		ANDA	ANDA203583	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1840_0e9d337e-ddbb-4312-a279-65ddc4adde53	0406-1840	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150929		ANDA	ANDA203583	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1850_0e9d337e-ddbb-4312-a279-65ddc4adde53	0406-1850	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150929		ANDA	ANDA203583	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-1860_0e9d337e-ddbb-4312-a279-65ddc4adde53	0406-1860	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride	Extended-Release	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150929		ANDA	ANDA203583	SpecGx LLC	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-2224_9814f610-7c4a-4199-8d10-4c89e0639467	0406-2224	HUMAN PRESCRIPTION DRUG	Levorphanol Tartrate		Levorphanol Tartrate	TABLET	ORAL	20191213		ANDA	ANDA212024	SpecGx LLC	LEVORPHANOL TARTRATE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-2540_157e1beb-b460-456c-a45e-67f5c7d962e2	0406-2540	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20050712		ANDA	ANDA077142	SpecGx LLC	METHADONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-3243_7e45dda7-15dc-48f1-892e-eee90b06d0f9	0406-3243	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		hydromorphone hydrochloride	TABLET	ORAL	20041223		ANDA	ANDA076855	SpecGx LLC	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-3244_7e45dda7-15dc-48f1-892e-eee90b06d0f9	0406-3244	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		hydromorphone hydrochloride	TABLET	ORAL	20041223		ANDA	ANDA076855	SpecGx LLC	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-3249_7e45dda7-15dc-48f1-892e-eee90b06d0f9	0406-3249	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		hydromorphone hydrochloride	TABLET	ORAL	20041223		ANDA	ANDA076855	SpecGx LLC	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-4123_0230807f-9a3a-4bc5-a4ca-12120abc2682	0406-4123	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	CONCENTRATE	ORAL	20210618		ANDA	ANDA207368	SpecGx LLC	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-5111_96510b78-eff8-4355-bf7f-c5b8e47ce1c9	0406-5111	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA211840	SpecGx LLC	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-5112_96510b78-eff8-4355-bf7f-c5b8e47ce1c9	0406-5112	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA211840	SpecGx LLC	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-5113_96510b78-eff8-4355-bf7f-c5b8e47ce1c9	0406-5113	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA211840	SpecGx LLC	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-5114_96510b78-eff8-4355-bf7f-c5b8e47ce1c9	0406-5114	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA211840	SpecGx LLC	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-5115_96510b78-eff8-4355-bf7f-c5b8e47ce1c9	0406-5115	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA211840	SpecGx LLC	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-5116_96510b78-eff8-4355-bf7f-c5b8e47ce1c9	0406-5116	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA211840	SpecGx LLC	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-5117_96510b78-eff8-4355-bf7f-c5b8e47ce1c9	0406-5117	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA211840	SpecGx LLC	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-5118_a1eb08b0-df4f-490b-8181-b3f5e4a3586a	0406-5118	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20230901		ANDA	ANDA215194	SpecGx LLC	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-5119_a1eb08b0-df4f-490b-8181-b3f5e4a3586a	0406-5119	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20230901		ANDA	ANDA215194	SpecGx LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-5755_cf32d94d-88ef-4130-9919-6bb6e309c58f	0406-5755	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20040427		ANDA	ANDA040517	SpecGx LLC	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-5771_cf32d94d-88ef-4130-9919-6bb6e309c58f	0406-5771	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20040427		ANDA	ANDA040517	SpecGx LLC	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-6221_028f6347-241a-4804-92c6-50a3623ca066	0406-6221	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	SOLUTION	ORAL	20210618		ANDA	ANDA207537	SpecGx LLC	METHADONE HYDROCHLORIDE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-6225_028f6347-241a-4804-92c6-50a3623ca066	0406-6225	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	SOLUTION	ORAL	20210618		ANDA	ANDA207537	SpecGx LLC	METHADONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-7711_699a51ed-842d-412d-b794-8ffe5056d4a4	0406-7711	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		posaconazole	TABLET, DELAYED RELEASE	ORAL	20220510		ANDA	ANDA212226	SpecGx LLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0406-8003_3db9d08a-e981-471c-bab4-d3f33fdd9a1f	0406-8003	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	SOLUTION	ORAL	20110715		ANDA	ANDA202348	SpecGx LLC	MORPHINE SULFATE	20	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8005_92844814-7e03-41a7-bc69-335a837e3f32	0406-8005	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate		Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate	TABLET	SUBLINGUAL	20171213		ANDA	ANDA207000	SpecGx LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
0406-8020_92844814-7e03-41a7-bc69-335a837e3f32	0406-8020	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate		Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate	TABLET	SUBLINGUAL	20171213		ANDA	ANDA207000	SpecGx LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
0406-8315_5ef1a457-8aa6-42eb-ac36-6e8ecd6d77db	0406-8315	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET, EXTENDED RELEASE	ORAL	20030731		ANDA	ANDA076412	SpecGx LLC	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8320_5ef1a457-8aa6-42eb-ac36-6e8ecd6d77db	0406-8320	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET, EXTENDED RELEASE	ORAL	20030703		ANDA	ANDA076438	SpecGx LLC	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8330_5ef1a457-8aa6-42eb-ac36-6e8ecd6d77db	0406-8330	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET, EXTENDED RELEASE	ORAL	20030731		ANDA	ANDA076412	SpecGx LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8380_5ef1a457-8aa6-42eb-ac36-6e8ecd6d77db	0406-8380	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET, EXTENDED RELEASE	ORAL	20030731		ANDA	ANDA076412	SpecGx LLC	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8390_5ef1a457-8aa6-42eb-ac36-6e8ecd6d77db	0406-8390	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET, EXTENDED RELEASE	ORAL	20030703		ANDA	ANDA076438	SpecGx LLC	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8510_89996466-29eb-4543-9653-23983ae3309f	0406-8510	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		oxycodone hydrochloride	TABLET	ORAL	20211012		ANDA	ANDA076758	SpecGx LLC	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8515_89996466-29eb-4543-9653-23983ae3309f	0406-8515	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		oxycodone hydrochloride	TABLET	ORAL	20040630		ANDA	ANDA076758	SpecGx LLC	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8520_89996466-29eb-4543-9653-23983ae3309f	0406-8520	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		oxycodone hydrochloride	TABLET	ORAL	20211012		ANDA	ANDA076758	SpecGx LLC	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8530_89996466-29eb-4543-9653-23983ae3309f	0406-8530	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		oxycodone hydrochloride	TABLET	ORAL	20040630		ANDA	ANDA076758	SpecGx LLC	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8556_acda01b0-6e54-4e4f-801e-850713a861d2	0406-8556	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20180430		ANDA	ANDA210758	SpecGx LLC	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8557_acda01b0-6e54-4e4f-801e-850713a861d2	0406-8557	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20180430		ANDA	ANDA210758	SpecGx LLC	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8725_90605203-cf8b-4cc7-8c94-8ce877854757	0406-8725	HUMAN PRESCRIPTION DRUG	METHADOSE	SUGAR-FREE	methadone hydrochloride	CONCENTRATE	ORAL	19730314		NDA	NDA017116	SpecGx LLC	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-8806_a6e2bb83-27f6-4f38-a554-a89165c5c3d3	0406-8806	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		clomipramine hydrochloride	CAPSULE	ORAL	20150601		NDA	NDA019906	SpecGx LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-8807_a6e2bb83-27f6-4f38-a554-a89165c5c3d3	0406-8807	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		clomipramine hydrochloride	CAPSULE	ORAL	20150601		NDA	NDA019906	SpecGx LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-8808_a6e2bb83-27f6-4f38-a554-a89165c5c3d3	0406-8808	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		clomipramine hydrochloride	CAPSULE	ORAL	20150601		NDA	NDA019906	SpecGx LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-8884_b25a2f3f-ee3a-44c0-a475-f371025c767b	0406-8884	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20031007		ANDA	ANDA040440	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8885_b25a2f3f-ee3a-44c0-a475-f371025c767b	0406-8885	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20031007		ANDA	ANDA040440	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8891_b25a2f3f-ee3a-44c0-a475-f371025c767b	0406-8891	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate		dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20031007		ANDA	ANDA040440	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8892_b25a2f3f-ee3a-44c0-a475-f371025c767b	0406-8892	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20031007		ANDA	ANDA040440	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8893_b25a2f3f-ee3a-44c0-a475-f371025c767b	0406-8893	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20031007		ANDA	ANDA040440	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8894_b25a2f3f-ee3a-44c0-a475-f371025c767b	0406-8894	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20031007		ANDA	ANDA040440	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8951_9bf7ad00-2b81-4472-a0b8-d4ac6e77d334	0406-8951	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single Entity Amphetamine Product	XR	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20190422		ANDA	ANDA211547	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8952_9bf7ad00-2b81-4472-a0b8-d4ac6e77d334	0406-8952	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single Entity Amphetamine Product	XR	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20190422		ANDA	ANDA211547	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8953_9bf7ad00-2b81-4472-a0b8-d4ac6e77d334	0406-8953	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single Entity Amphetamine Product	XR	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20190422		ANDA	ANDA211547	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8954_9bf7ad00-2b81-4472-a0b8-d4ac6e77d334	0406-8954	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single Entity Amphetamine Product	XR	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20190422		ANDA	ANDA211547	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8955_9bf7ad00-2b81-4472-a0b8-d4ac6e77d334	0406-8955	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single Entity Amphetamine Product	XR	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20190422		ANDA	ANDA211547	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8956_9bf7ad00-2b81-4472-a0b8-d4ac6e77d334	0406-8956	HUMAN PRESCRIPTION DRUG	Mixed Salts of a Single Entity Amphetamine Product	XR	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20190422		ANDA	ANDA211547	SpecGx LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8958_0062f409-85c6-4e8f-b300-68e39d2fd4c0	0406-8958	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20020129		ANDA	ANDA040436	SpecGx LLC	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8959_0062f409-85c6-4e8f-b300-68e39d2fd4c0	0406-8959	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20020129		ANDA	ANDA040436	SpecGx LLC	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8960_ed3d3ea0-2f3e-4dbd-a220-c40046a58a23	0406-8960	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate	Extended-Release	dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20030506		ANDA	ANDA076353	SpecGx LLC	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8961_ed3d3ea0-2f3e-4dbd-a220-c40046a58a23	0406-8961	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate	Extended-Release	dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20030506		ANDA	ANDA076353	SpecGx LLC	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-8962_ed3d3ea0-2f3e-4dbd-a220-c40046a58a23	0406-8962	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate	Extended-Release	dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20030506		ANDA	ANDA076353	SpecGx LLC	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0406-9037_cf625b15-abc9-464c-af66-5cad02a4c502	0406-9037	HUMAN PRESCRIPTION DRUG	FENTANYL TRANSDERMAL		fentanyl transdermal	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200228		ANDA	ANDA077154	SpecGx LLC	FENTANYL	37.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-9062_cf625b15-abc9-464c-af66-5cad02a4c502	0406-9062	HUMAN PRESCRIPTION DRUG	FENTANYL TRANSDERMAL		fentanyl transdermal	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200228		ANDA	ANDA077154	SpecGx LLC	FENTANYL	62.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-9100_cf625b15-abc9-464c-af66-5cad02a4c502	0406-9100	HUMAN PRESCRIPTION DRUG	FENTANYL TRANSDERMAL		fentanyl transdermal	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200506		ANDA	ANDA077154	SpecGx LLC	FENTANYL	100	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-9112_cf625b15-abc9-464c-af66-5cad02a4c502	0406-9112	HUMAN PRESCRIPTION DRUG	FENTANYL TRANSDERMAL		fentanyl transdermal	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200506		ANDA	ANDA077154	SpecGx LLC	FENTANYL	12.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-9125_cf625b15-abc9-464c-af66-5cad02a4c502	0406-9125	HUMAN PRESCRIPTION DRUG	FENTANYL TRANSDERMAL		fentanyl transdermal	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200506		ANDA	ANDA077154	SpecGx LLC	FENTANYL	25	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-9150_cf625b15-abc9-464c-af66-5cad02a4c502	0406-9150	HUMAN PRESCRIPTION DRUG	FENTANYL TRANSDERMAL		fentanyl transdermal	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200506		ANDA	ANDA077154	SpecGx LLC	FENTANYL	50	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-9175_cf625b15-abc9-464c-af66-5cad02a4c502	0406-9175	HUMAN PRESCRIPTION DRUG	FENTANYL TRANSDERMAL		fentanyl transdermal	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200506		ANDA	ANDA077154	SpecGx LLC	FENTANYL	75	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0406-9202_55344414-3e7d-4ef5-ad58-c003051ad440	0406-9202	HUMAN PRESCRIPTION DRUG	FENTANYL CITRATE		FENTANYL CITRATE	LOZENGE	TRANSMUCOSAL	20091030	20250131	ANDA	ANDA078907	SpecGx LLC	FENTANYL CITRATE	200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0406-9204_55344414-3e7d-4ef5-ad58-c003051ad440	0406-9204	HUMAN PRESCRIPTION DRUG	FENTANYL CITRATE		FENTANYL CITRATE	LOZENGE	TRANSMUCOSAL	20091030	20241231	ANDA	ANDA078907	SpecGx LLC	FENTANYL CITRATE	400	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0406-9206_55344414-3e7d-4ef5-ad58-c003051ad440	0406-9206	HUMAN PRESCRIPTION DRUG	FENTANYL CITRATE		FENTANYL CITRATE	LOZENGE	TRANSMUCOSAL	20091030	20241231	ANDA	ANDA078907	SpecGx LLC	FENTANYL CITRATE	600	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0406-9208_55344414-3e7d-4ef5-ad58-c003051ad440	0406-9208	HUMAN PRESCRIPTION DRUG	FENTANYL CITRATE		FENTANYL CITRATE	LOZENGE	TRANSMUCOSAL	20091030	20250228	ANDA	ANDA078907	SpecGx LLC	FENTANYL CITRATE	800	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0406-9212_55344414-3e7d-4ef5-ad58-c003051ad440	0406-9212	HUMAN PRESCRIPTION DRUG	FENTANYL CITRATE		FENTANYL CITRATE	LOZENGE	TRANSMUCOSAL	20091030	20241031	ANDA	ANDA078907	SpecGx LLC	FENTANYL CITRATE	1200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0406-9216_55344414-3e7d-4ef5-ad58-c003051ad440	0406-9216	HUMAN PRESCRIPTION DRUG	FENTANYL CITRATE		FENTANYL CITRATE	LOZENGE	TRANSMUCOSAL	20091030	20250228	ANDA	ANDA078907	SpecGx LLC	FENTANYL CITRATE	1600	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
0406-9906_1077b306-9dea-41fe-a7ff-bec91679be14	0406-9906	HUMAN PRESCRIPTION DRUG	ANAFRANIL		clomipramine hydrochloride	CAPSULE	ORAL	19891229		NDA	NDA019906	SpecGx LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-9907_1077b306-9dea-41fe-a7ff-bec91679be14	0406-9907	HUMAN PRESCRIPTION DRUG	ANAFRANIL		clomipramine hydrochloride	CAPSULE	ORAL	19891229		NDA	NDA019906	SpecGx LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-9908_1077b306-9dea-41fe-a7ff-bec91679be14	0406-9908	HUMAN PRESCRIPTION DRUG	ANAFRANIL		clomipramine hydrochloride	CAPSULE	ORAL	19891229		NDA	NDA019906	SpecGx LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-9910_ad133e62-40fe-496f-8bb4-575c5102e781	0406-9910	HUMAN PRESCRIPTION DRUG	PAMELOR		nortriptyline hydrochloride	CAPSULE	ORAL	19770801		NDA	NDA018013	SpecGx LLC	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-9911_ad133e62-40fe-496f-8bb4-575c5102e781	0406-9911	HUMAN PRESCRIPTION DRUG	PAMELOR		nortriptyline hydrochloride	CAPSULE	ORAL	19770801		NDA	NDA018013	SpecGx LLC	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-9912_ad133e62-40fe-496f-8bb4-575c5102e781	0406-9912	HUMAN PRESCRIPTION DRUG	PAMELOR		nortriptyline hydrochloride	CAPSULE	ORAL	19770801		NDA	NDA018013	SpecGx LLC	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-9913_ad133e62-40fe-496f-8bb4-575c5102e781	0406-9913	HUMAN PRESCRIPTION DRUG	PAMELOR		nortriptyline hydrochloride	CAPSULE	ORAL	19770801		NDA	NDA018013	SpecGx LLC	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0406-9914_a7bb175a-d42e-4f19-8931-6410b120cb39	0406-9914	HUMAN PRESCRIPTION DRUG	RESTORIL		temazepam	CAPSULE	ORAL	19810227		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0406-9915_a7bb175a-d42e-4f19-8931-6410b120cb39	0406-9915	HUMAN PRESCRIPTION DRUG	RESTORIL		temazepam	CAPSULE	ORAL	19810227		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0406-9916_a7bb175a-d42e-4f19-8931-6410b120cb39	0406-9916	HUMAN PRESCRIPTION DRUG	RESTORIL		temazepam	CAPSULE	ORAL	19810227		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0406-9917_a7bb175a-d42e-4f19-8931-6410b120cb39	0406-9917	HUMAN PRESCRIPTION DRUG	RESTORIL		temazepam	CAPSULE	ORAL	19810227		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0406-9959_c3efd031-500e-4d4c-a75e-87d2197d2858	0406-9959	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		temazepam	CAPSULE	ORAL	20100223		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0406-9960_c3efd031-500e-4d4c-a75e-87d2197d2858	0406-9960	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		temazepam	CAPSULE	ORAL	20100223		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0406-9961_c3efd031-500e-4d4c-a75e-87d2197d2858	0406-9961	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		temazepam	CAPSULE	ORAL	20100223		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0406-9962_c3efd031-500e-4d4c-a75e-87d2197d2858	0406-9962	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		temazepam	CAPSULE	ORAL	20100223		NDA	NDA018163	SpecGx LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0407-0690_2ea47a94-9d97-4e66-9f58-d78dfa4d010e	0407-0690	HUMAN PRESCRIPTION DRUG	OMNISCAN		gadodiamide	INJECTION	INTRAVENOUS	20100601		NDA	NDA020123	GE Healthcare Inc.	GADODIAMIDE	287	mg/mL	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20251231
0407-0690_5ca2b122-b409-4e66-9378-b8b5e0ea999e	0407-0690	HUMAN PRESCRIPTION DRUG	OMNISCAN		gadodiamide	INJECTION	INTRAVENOUS	20020419		NDA	NDA020123	GE Healthcare Inc.	GADODIAMIDE	287	mg/mL	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0407-1401_9b00a600-5fce-4dd5-8db4-26248d46f0d9	0407-1401	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRAVASCULAR; INTRAVENOUS	20040525		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	140	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1411_9b00a600-5fce-4dd5-8db4-26248d46f0d9	0407-1411	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRATHECAL; ORAL; RECTAL	20040715		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	180	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1412_9b00a600-5fce-4dd5-8db4-26248d46f0d9	0407-1412	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL	19851226		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	240	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1412_e0d32b8f-012d-494a-95e7-427da2b59fd9	0407-1412	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL	20050811		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	240	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20251231
0407-1413_6e0325c6-740f-48c4-b25e-d4145d6b4aed	0407-1413	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRAVENOUS	20161221		NDA	NDA020608	GE Healthcare	IOHEXOL	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1413_96c4adb3-6b11-40bd-a86e-d259ce109199	0407-1413	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL	20040903		NDA	NDA020608	GE Healthcare Inc.	IOHEXOL	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1413_9b00a600-5fce-4dd5-8db4-26248d46f0d9	0407-1413	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL	19851226		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1413_e0d32b8f-012d-494a-95e7-427da2b59fd9	0407-1413	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL	20060921		NDA	NDA020608	GE Healthcare Inc.	IOHEXOL	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20251231
0407-1413_fc61eee9-ee13-9078-e053-6394a90a22f4	0407-1413	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL	20050803		NDA	NDA020608	GE Healthcare Inc.	IOHEXOL	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1413_fc780ae9-6fd6-f433-e053-6394a90a1d9e	0407-1413	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRAVENOUS	20161221		NDA	NDA020608	GE Healthcare	IOHEXOL	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1414_6e0325c6-740f-48c4-b25e-d4145d6b4aed	0407-1414	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRAVENOUS	20161221		NDA	NDA020608	GE Healthcare	IOHEXOL	350	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1414_96c4adb3-6b11-40bd-a86e-d259ce109199	0407-1414	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL	20040903		NDA	NDA020608	GE Healthcare Inc.	IOHEXOL	350	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1414_9b00a600-5fce-4dd5-8db4-26248d46f0d9	0407-1414	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRAVASCULAR; INTRAVENOUS; ORAL	19851226		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	350	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1414_e0d32b8f-012d-494a-95e7-427da2b59fd9	0407-1414	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	INJECTION, SOLUTION	INTRAVASCULAR; INTRAVENOUS; ORAL	20060721		NDA	NDA020608	GE Healthcare Inc.	IOHEXOL	350	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20251231
0407-1414_fc61eee9-ee13-9078-e053-6394a90a22f4	0407-1414	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL	20050803		NDA	NDA020608	GE Healthcare Inc.	IOHEXOL	350	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1414_fc780ae9-6fd6-f433-e053-6394a90a1d9e	0407-1414	HUMAN PRESCRIPTION DRUG	Omnipaque		Iohexol	INJECTION, SOLUTION	INTRAVENOUS	20161221		NDA	NDA020608	GE Healthcare	IOHEXOL	350	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1415_9b00a600-5fce-4dd5-8db4-26248d46f0d9	0407-1415	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	SOLUTION	ORAL	20180427		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	9	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-1416_9b00a600-5fce-4dd5-8db4-26248d46f0d9	0407-1416	HUMAN PRESCRIPTION DRUG	OMNIPAQUE		Iohexol	SOLUTION	ORAL	20180427		NDA	NDA018956	GE Healthcare Inc.	IOHEXOL	12	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-2222_c2c4d356-1532-47f9-b142-d3a7300917c9	0407-2222	HUMAN PRESCRIPTION DRUG	Visipaque		Iodixanol	INJECTION, SOLUTION	INTRAVASCULAR	20021213		NDA	NDA020351	GE Healthcare Inc.	IODIXANOL	270	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-2223_7af7ff0d-0a77-49ce-b144-eafaa8d53df0	0407-2223	HUMAN PRESCRIPTION DRUG	Visipaque		Iodixanol	INJECTION, SOLUTION	INTRAVASCULAR	20100601		NDA	NDA020808	GE Healthcare Inc.	IODIXANOL	320	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20251231
0407-2223_87c07046-2bcc-416d-8133-98ba7c046779	0407-2223	HUMAN PRESCRIPTION DRUG	Visipaque		Iodixanol	INJECTION, SOLUTION	INTRAVASCULAR	20060501		NDA	NDA020808	GE Healthcare Inc.	IODIXANOL	320	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-2223_c2c4d356-1532-47f9-b142-d3a7300917c9	0407-2223	HUMAN PRESCRIPTION DRUG	Visipaque		Iodixanol	INJECTION, SOLUTION	INTRAVASCULAR	20030909		NDA	NDA020351	GE Healthcare Inc.	IODIXANOL	320	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
0407-2707_63524386-08e9-49e4-aafd-91057f33ebf4	0407-2707	HUMAN PRESCRIPTION DRUG	Optison	Perflutren Protein-Type A Microspheres	Human Albumin Microspheres and Perflutren	INJECTION, SOLUTION	INTRAVENOUS	20020102		NDA	NDA020899	GE Healthcare Inc.	HUMAN ALBUMIN MICROSPHERES; PERFLUTREN	10; .22	mg/mL; mg/mL	Contrast Agent for Ultrasound Imaging [EPC], Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA], Ultrasound Contrast Activity [MoA]		N	20251231
0407-2943_26a1619b-ae92-41c3-83ff-4b5d6b3316a1	0407-2943	HUMAN PRESCRIPTION DRUG	CLARISCAN		gadoterate meglumine	INJECTION, SOLUTION	INTRAVENOUS	20191101		ANDA	ANDA210016	GE Healthcare	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20251231
0407-2943_d1cff6d2-eaf9-4e9f-9615-6ed0ceb7cd3a	0407-2943	HUMAN PRESCRIPTION DRUG	CLARISCAN		gadoterate meglumine	INJECTION, SOLUTION	INTRAVENOUS	20191101		ANDA	ANDA210016	GE Healthcare	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20251231
0409-0004_3e087418-69ff-47fa-93c2-f28699309433	0409-0004	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230201		NDA	NDA214218	Hospira, Inc.	PEMETREXED DISODIUM	1	g/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-0012_3cc352ef-503a-44bf-a0f0-c20400da885a	0409-0012	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20230227		NDA	NDA018916	Hospira, Inc.	HEPARIN SODIUM	5000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-0016_ec1cf311-020a-4a35-9a70-954b012d804e	0409-0016	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20220110		NDA	NDA022234	Hospira, Inc.	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-0020_3e087418-69ff-47fa-93c2-f28699309433	0409-0020	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230201		NDA	NDA214218	Hospira, Inc.	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-0021_3e087418-69ff-47fa-93c2-f28699309433	0409-0021	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230201		NDA	NDA214218	Hospira, Inc.	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-0040_e39017e3-e3bc-419e-af25-ada813b72e18	0409-0040	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		KETAMINE HYDROCHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAMUSCULAR; INTRAVENOUS	20221010		ANDA	ANDA074549	Hospira, Inc.	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0409-0120_38e8f402-3c58-4173-a589-b38049e837d8	0409-0120	HUMAN PRESCRIPTION DRUG	Daptomycin		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210802		NDA	NDA210282	Hospira, Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0409-0122_38e8f402-3c58-4173-a589-b38049e837d8	0409-0122	HUMAN PRESCRIPTION DRUG	Daptomycin		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210802		NDA	NDA210282	Hospira, Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0409-0125_2ea8704a-ff7d-4724-9e92-751141d9e43f	0409-0125	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230807		ANDA	ANDA075240	Hospira, Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0409-0144_6e8555fe-02a3-4434-be63-f7c26d308d0c	0409-0144	HUMAN PRESCRIPTION DRUG	Azithromycin		AZITHROMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090626		ANDA	ANDA065500	Hospira, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0409-0144_85545574-c9c9-499c-9830-d94a24eb3b15	0409-0144	HUMAN PRESCRIPTION DRUG	Azithromycin		AZITHROMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20111230		ANDA	ANDA065511	Hospira, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0409-0152_3dc29403-f807-4e6a-835b-e6f26272fd6c	0409-0152	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	INJECTION, SOLUTION	INTRAVENOUS	20211213		ANDA	ANDA206191	Hospira, Inc.	METRONIDAZOLE	5	mg/mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0409-0155_b5e7a125-4e03-403d-8fd1-435103ef3f20	0409-0155	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20230103		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-0181_1acb16a1-f6c4-43ce-93ea-1a2a329fe85f	0409-0181	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20130709		NDA	NDA200795	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0181_ab7f353a-7621-4be6-a100-dd816f4e4c92	0409-0181	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20110826		NDA	NDA200795	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0182_1acb16a1-f6c4-43ce-93ea-1a2a329fe85f	0409-0182	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20130729		NDA	NDA200795	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0182_ab7f353a-7621-4be6-a100-dd816f4e4c92	0409-0182	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20110822		NDA	NDA200795	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0183_1acb16a1-f6c4-43ce-93ea-1a2a329fe85f	0409-0183	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20130709		NDA	NDA200795	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0183_ab7f353a-7621-4be6-a100-dd816f4e4c92	0409-0183	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20110824		NDA	NDA200795	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0185_a1e3c76f-316c-499e-a272-392ea249308d	0409-0185	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110726		ANDA	ANDA078339	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0186_a1e3c76f-316c-499e-a272-392ea249308d	0409-0186	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110726		ANDA	ANDA078339	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0187_2c70f324-2f1a-42e4-9135-4b8bf09392d8	0409-0187	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20101115		ANDA	ANDA079183	Hospira, Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0201_5c53a6cf-b941-4b81-a7c5-2759aa0587d6	0409-0201	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20110317		NDA	NDA022234	Hospira, Inc.	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-0212_9fb3d66d-4fb8-427b-9a8d-9b2a5e2574a7	0409-0212	HUMAN PRESCRIPTION DRUG	MILRINONE LACTATE		MILRINONE LACTATE	INJECTION, SOLUTION	INTRAVENOUS	20150331		ANDA	ANDA203280	Hospira, Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0409-0222_c3a6b536-a7c6-4a2b-9ac6-94e1c3eef1d7	0409-0222	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20221206		ANDA	ANDA091404	Hospira, Inc.	MEROPENEM	500	mg/10mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0409-0302_293334d4-88f2-4ec2-9eed-20975ff65c0a	0409-0302	HUMAN PRESCRIPTION DRUG	Topotecan		TOPOTECAN	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20110221		NDA	NDA200582	Hospira, Inc.	TOPOTECAN HYDROCHLORIDE	1	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
0409-0323_d9e9c332-1b3f-469c-83b8-41e15183e635	0409-0323	HUMAN PRESCRIPTION DRUG	Bleomycin		BLEOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20180425		ANDA	ANDA065031	Hospira, Inc.	BLEOMYCIN SULFATE	30	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
0409-0332_d9e9c332-1b3f-469c-83b8-41e15183e635	0409-0332	HUMAN PRESCRIPTION DRUG	Bleomycin		BLEOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20150425		ANDA	ANDA065031	Hospira, Inc.	BLEOMYCIN SULFATE	15	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
0409-0365_826fc035-ecfc-4dcc-84ba-b813a844f57e	0409-0365	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL	INJECTION, SOLUTION	INTRAVENOUS	20210628		NDA	NDA022234	Hospira, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-0366_42d94b85-933d-4174-a927-651a6a8fd96b	0409-0366	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL	INJECTION, SOLUTION	INTRAVENOUS	20160824		NDA	NDA022234	Hospira, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-0367_42d94b85-933d-4174-a927-651a6a8fd96b	0409-0367	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL	INJECTION, SOLUTION	INTRAVENOUS	20160824		NDA	NDA022234	Hospira, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-0368_42d94b85-933d-4174-a927-651a6a8fd96b	0409-0368	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL	INJECTION, SOLUTION	INTRAVENOUS	20180109		NDA	NDA022234	Hospira, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-0528_5ab673d0-89b8-410e-81ac-d18df31b6819	0409-0528	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	INJECTION, SOLUTION	INTRAVENOUS	20170612		ANDA	ANDA078579	Hospira, Inc.	LEVOFLOXACIN	5	mg/mL			N	20241231
0409-0801_d0a07732-fd08-4f3e-bbc8-cb039f6b9026	0409-0801	HUMAN PRESCRIPTION DRUG	Nipent		PENTOSTATIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20070815		NDA	NDA020122	Hospira, Inc.	PENTOSTATIN	2	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0409-0829_cbefea63-fdf4-45f7-9dae-3059a0394feb	0409-0829	HUMAN PRESCRIPTION DRUG	Aztreonam		Aztreonam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220124		ANDA	ANDA206517	Hospira, Inc.	AZTREONAM	1	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20251231
0409-0830_cbefea63-fdf4-45f7-9dae-3059a0394feb	0409-0830	HUMAN PRESCRIPTION DRUG	Aztreonam		Aztreonam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220124		ANDA	ANDA206517	Hospira, Inc.	AZTREONAM	2	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20251231
0409-1005_4d8d8c73-8f39-46e7-bc32-d1065a70522f	0409-1005	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20230227		NDA	NDA018916	Hospira, Inc.	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-1045_f9317d20-80ef-4c2d-8c7b-bad954f8b7f4	0409-1045	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220627		NDA	NDA214218	Hospira, Inc.	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-1060_ecccc885-df16-4182-a36c-57da74a2d973	0409-1060	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220620		NDA	NDA208746	Hospira, Inc.	PEMETREXED TROMETHAMINE ANHYDROUS	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-1061_ecccc885-df16-4182-a36c-57da74a2d973	0409-1061	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220620		NDA	NDA208746	Hospira, Inc.	PEMETREXED TROMETHAMINE ANHYDROUS	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-1098_e3daa782-20f5-4560-bad0-a28c6e47b761	0409-1098	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20200317		ANDA	ANDA203236	Hospira, Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-1103_e3daa782-20f5-4560-bad0-a28c6e47b761	0409-1103	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20191202		ANDA	ANDA203236	Hospira, Inc.	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-1105_926d60c7-8585-42f2-a9fc-02fcb51dc2ae	0409-1105	HUMAN PRESCRIPTION DRUG	Atracurium Besylate		ATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20130529		ANDA	ANDA090761	Hospira, Inc.	ATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-1109_926d60c7-8585-42f2-a9fc-02fcb51dc2ae	0409-1109	HUMAN PRESCRIPTION DRUG	Atracurium Besylate		ATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20130225		ANDA	ANDA090782	Hospira, Inc.	ATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-1112_1e2080b5-8c77-4eb1-95bf-4cbd86c27995	0409-1112	HUMAN PRESCRIPTION DRUG	BUSULFAN		BUSULFAN	INJECTION, SOLUTION	INTRAVENOUS	20190228		ANDA	ANDA205672	Hospira, Inc.	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0409-1134_a641ae70-f6ba-4f49-b5fc-b2895ef3408f	0409-1134	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050811		UNAPPROVED DRUG OTHER		Hospira, Inc.	MORPHINE SULFATE	50	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1140_05c82537-afbb-4435-bd3f-7343b31bbead	0409-1140	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION, SOLUTION	INTRAVENOUS	20170306		ANDA	ANDA204120	Hospira, Inc.	ARGATROBAN	100	mg/mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0409-1141_56999619-4f6a-47fe-90ae-f813aa96c94d	0409-1141	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050430		NDA	NDA018897	Hospira, Inc.	SODIUM CHLORIDE	234	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-1144_1975dcaa-94b4-4af2-b95d-41463e1db00c	0409-1144	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050331		ANDA	ANDA070737	Hospira, Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0409-1144_3e68ac3f-7a92-4199-b631-c4ab05bdf6cb	0409-1144	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180620		ANDA	ANDA070737	Hospira, Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0409-1159_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-1159	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050506		ANDA	ANDA070583	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1159_a33878a1-9d68-4a46-9913-c7be85f1d1ff	0409-1159	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HYDROCHLORIDE		bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20150811		ANDA	ANDA070583	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1160_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-1160	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050430		ANDA	ANDA070590	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1162_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-1162	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20051122		ANDA	ANDA070584	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1162_a33878a1-9d68-4a46-9913-c7be85f1d1ff	0409-1162	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HYDROCHLORIDE		bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20170207		ANDA	ANDA070584	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1163_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-1163	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	PERINEURAL	20050331		ANDA	ANDA070597	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1165_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-1165	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20050608		ANDA	ANDA070585	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1174_900fc04d-df7d-47e5-a1a0-53fe5d2bd10b	0409-1174	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220307		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-1176_8f4a5305-31a6-40f6-8acd-f6f160ffcf77	0409-1176	HUMAN PRESCRIPTION DRUG	DEMEROL		MEPERIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050825		NDA	NDA021171	Hospira, Inc.	MEPERIDINE HYDROCHLORIDE	25	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1178_8f4a5305-31a6-40f6-8acd-f6f160ffcf77	0409-1178	HUMAN PRESCRIPTION DRUG	DEMEROL		MEPERIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050913		NDA	NDA021171	Hospira, Inc.	MEPERIDINE HYDROCHLORIDE	50	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1179_8f4a5305-31a6-40f6-8acd-f6f160ffcf77	0409-1179	HUMAN PRESCRIPTION DRUG	DEMEROL		MEPERIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20051012		NDA	NDA021171	Hospira, Inc.	MEPERIDINE HYDROCHLORIDE	75	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1180_8f4a5305-31a6-40f6-8acd-f6f160ffcf77	0409-1180	HUMAN PRESCRIPTION DRUG	DEMEROL		MEPERIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050915		NDA	NDA021171	Hospira, Inc.	MEPERIDINE HYDROCHLORIDE	100	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1181_8f4a5305-31a6-40f6-8acd-f6f160ffcf77	0409-1181	HUMAN PRESCRIPTION DRUG	DEMEROL		MEPERIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20060224		NDA	NDA021171	Hospira, Inc.	MEPERIDINE HYDROCHLORIDE	50	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1207_54038252-b0e3-4f67-9473-22725fd055f8	0409-1207	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050829		ANDA	ANDA062420	Hospira, Inc.	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0409-1208_e3daa782-20f5-4560-bad0-a28c6e47b761	0409-1208	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20200324		ANDA	ANDA203238	Hospira, Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-1209_1bb10d36-88d2-4a53-94fe-4881d0497dbd	0409-1209	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		LIDOCAINE HYDROCHLORIDE and EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL	19850913		ANDA	ANDA088571	Hospira, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	5; 15	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-1215_b5c11830-ea6b-4448-9772-0d45e592735b	0409-1215	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050712		ANDA	ANDA070256	Hospira, Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
0409-1219_b5c11830-ea6b-4448-9772-0d45e592735b	0409-1219	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050902		ANDA	ANDA070257	Hospira, Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
0409-1273_88590f46-0e4c-4a4b-97de-05a1344514b7	0409-1273	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050823		ANDA	ANDA072079	Hospira, Inc.	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
0409-1283_92f27fad-d7ea-468b-8b67-259e73520efe	0409-1283	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210111		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0409-1283_f699ac2c-1705-496e-a8ee-5802d2c2515b	0409-1283	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20111201		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1304_f699ac2c-1705-496e-a8ee-5802d2c2515b	0409-1304	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20111201		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1312_92f27fad-d7ea-468b-8b67-259e73520efe	0409-1312	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210201		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0409-1312_f699ac2c-1705-496e-a8ee-5802d2c2515b	0409-1312	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20111201		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1316_e616e4ae-b6f6-4769-b770-c03f1198c1b3	0409-1316	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20050331		ANDA	ANDA089522	Hospira, Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-1319_c96bb5b9-18bb-4c0c-a1af-c885d3dd06d7	0409-1319	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211102		ANDA	ANDA063076	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-1323_3a6e4402-7b97-4d62-8239-16c2ff17009d	0409-1323	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20051209		ANDA	ANDA040302	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-1362_8f4a5305-31a6-40f6-8acd-f6f160ffcf77	0409-1362	HUMAN PRESCRIPTION DRUG	DEMEROL		MEPERIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210416		NDA	NDA021171	Hospira, Inc.	MEPERIDINE HYDROCHLORIDE	25	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1390_8e148e1d-80e7-4a8c-9456-d949181b229c	0409-1390	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20191009		ANDA	ANDA091404	Hospira, Inc.	MEROPENEM	500	mg/10mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0409-1391_8e148e1d-80e7-4a8c-9456-d949181b229c	0409-1391	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20191009		ANDA	ANDA091404	Hospira, Inc.	MEROPENEM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0409-1401_5216c6a9-392e-4f73-8d03-3defdffcff10	0409-1401	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20230301		ANDA	ANDA214349	Hospira, Inc.	REGADENOSON ANHYDROUS	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
0409-1402_e616e4ae-b6f6-4769-b770-c03f1198c1b3	0409-1402	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20110218		ANDA	ANDA088100	Hospira, Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-1403_f01f9986-43f9-40e8-9506-11bfe78f9242	0409-1403	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20230828		ANDA	ANDA205656	Hospira, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-1412_5d5a1e32-3392-489f-98c3-29f1f87711bc	0409-1412	HUMAN PRESCRIPTION DRUG	Bumetanide		BUMETANIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060706		ANDA	ANDA074332	Hospira, Inc.	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0409-1418_8f4a5305-31a6-40f6-8acd-f6f160ffcf77	0409-1418	HUMAN PRESCRIPTION DRUG	DEMEROL		MEPERIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210416		NDA	NDA021171	Hospira, Inc.	MEPERIDINE HYDROCHLORIDE	50	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1434_ffeff440-1322-4851-921f-e5b74e675fbf	0409-1434	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200928		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-1454_900fc04d-df7d-47e5-a1a0-53fe5d2bd10b	0409-1454	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220307		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-1463_b2cf8534-434d-4f63-9328-6e4ac06f3e71	0409-1463	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		NALBUPHINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20080627		ANDA	ANDA070914	Hospira, Inc.	NALBUPHINE HYDROCHLORIDE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0409-1463_c6be438f-eb10-48bd-bcdb-2b58569850b8	0409-1463	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		NALBUPHINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050331		ANDA	ANDA070914	Hospira, Inc.	NALBUPHINE HYDROCHLORIDE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0409-1464_c6be438f-eb10-48bd-bcdb-2b58569850b8	0409-1464	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		NALBUPHINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050719		ANDA	ANDA070915	Hospira, Inc.	NALBUPHINE HYDROCHLORIDE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0409-1465_c6be438f-eb10-48bd-bcdb-2b58569850b8	0409-1465	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		NALBUPHINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20041231		ANDA	ANDA070916	Hospira, Inc.	NALBUPHINE HYDROCHLORIDE	20	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0409-1467_c6be438f-eb10-48bd-bcdb-2b58569850b8	0409-1467	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		NALBUPHINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050516		ANDA	ANDA070918	Hospira, Inc.	NALBUPHINE HYDROCHLORIDE	20	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
0409-1541_8bed8b7f-9c71-40fb-9312-8e5e0ab6680f	0409-1541	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220906		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-1555_0f69105e-ffcf-4806-a11d-c9cb88c1c436	0409-1555	HUMAN PRESCRIPTION DRUG	Hextend		HETASTARCH	INJECTION, SOLUTION	INTRAVENOUS	20050202		NDA	BN200952	Hospira, Inc.	HETASTARCH	6	g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC], Starch [CS]		N	20241231
0409-1559_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1559	HUMAN PRESCRIPTION DRUG	Marcaine		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050823		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
0409-1560_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1560	HUMAN PRESCRIPTION DRUG	Marcaine		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20050816		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
0409-1582_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1582	HUMAN PRESCRIPTION DRUG	Marcaine		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20050727		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
0409-1587_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1587	HUMAN PRESCRIPTION DRUG	Marcaine		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20060117		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
0409-1593_51cdbf24-2361-48d8-91c6-77f2eeb94f87	0409-1593	HUMAN PRESCRIPTION DRUG	THAM		TROMETHAMINE	INJECTION, SOLUTION	INTRAVENOUS	20200624		NDA	NDA013025	Hospira, Inc.	TROMETHAMINE	3.6	g/100mL			N	20241231
0409-1596_ffeff440-1322-4851-921f-e5b74e675fbf	0409-1596	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20231113		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-1610_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1610	HUMAN PRESCRIPTION DRUG	Marcaine		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	PERINEURAL	20051130		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
0409-1623_e889573a-2745-485a-878b-8b9a3fff682e	0409-1623	HUMAN PRESCRIPTION DRUG	Butorphanol Tartrate		Butorphanol Tartrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050923		ANDA	ANDA074626	Hospira, Inc.	BUTORPHANOL TARTRATE	1	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20251231
0409-1626_e889573a-2745-485a-878b-8b9a3fff682e	0409-1626	HUMAN PRESCRIPTION DRUG	Butorphanol Tartrate		Butorphanol Tartrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051220		ANDA	ANDA074626	Hospira, Inc.	BUTORPHANOL TARTRATE	2	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20251231
0409-1630_77d2cecb-001f-4b7b-b8ee-94c8b6d89be5	0409-1630	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20060119		NDA	NDA021146	Hospira, Inc.	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0409-1631_ffe34ef3-7abe-40fc-89d7-15cb8bceadc2	0409-1631	HUMAN PRESCRIPTION DRUG	Calcium Chloride		CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050914		NDA	NDA021117	Hospira, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0409-1632_a842348f-f29c-4387-9125-7cca44d69ae5	0409-1632	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060228		ANDA	ANDA075164	Hospira, Inc.	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-1638_ffeff440-1322-4851-921f-e5b74e675fbf	0409-1638	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20041130		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-1660_ffeff440-1322-4851-921f-e5b74e675fbf	0409-1660	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20130408		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-1700_f2323114-35c2-40d0-8d41-f50fa574581d	0409-1700	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220727		ANDA	ANDA208460	Hospira, Inc.	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
0409-1703_e7c31651-e301-43f9-bc81-e0fd5dcb828c	0409-1703	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		BORTEZOMIB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220516		NDA	NDA209191	Hospira, Inc.	BORTEZOMIB	2.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
0409-1704_e7c31651-e301-43f9-bc81-e0fd5dcb828c	0409-1704	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		BORTEZOMIB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220516		NDA	NDA209191	Hospira, Inc.	BORTEZOMIB	1	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
0409-1732_7211b3d4-f1cb-4d9f-87c3-5476c625782f	0409-1732	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20210628		NDA	NDA022234	Hospira, Inc.	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-1746_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1746	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050912		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-1749_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1749	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20050912		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-1752_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1752	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20060206		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-1754_c4b61b4d-095a-4878-bb38-130efb1926c4	0409-1754	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		magnesium sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20061128		ANDA	ANDA075151	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-1755_472fc5b8-7d75-4466-812e-2a3f58281d28	0409-1755	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	PERINEURAL	20060322		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-1761_f16150a3-6fc7-443f-909c-688fdd99b1ab	0409-1761	HUMAN PRESCRIPTION DRUG	Marcaine Spinal		Bupivacaine Hydrochloride in Dextrose	INJECTION, SOLUTION	SUBARACHNOID	20050519		NDA	NDA018692	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-1775_35a74bc2-fce3-46d2-a42d-645d19eb2e80	0409-1775	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20060222		NDA	NDA019445	Hospira, Inc.	DEXTROSE MONOHYDRATE	250	mg/mL			N	20251231
0409-1778_87b8f512-1fc6-42fd-9a64-185b182eccce	0409-1778	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		METOPROLOL TARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20080724		ANDA	ANDA078085	Hospira, Inc.	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0409-1782_568bacb5-8e96-46d9-8717-23951594a9fb	0409-1782	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050923		ANDA	ANDA070172	Hospira, Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0409-1886_03a8a31c-be90-4503-924e-da1c93aa5a89	0409-1886	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	INJECTION, SOLUTION	INTRAVENOUS	20121102		ANDA	ANDA202869	Hospira, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0409-1886_1baacbe6-d522-49c9-ac43-cf862a88f28f	0409-1886	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	INJECTION, SOLUTION	INTRAVENOUS	20180301		ANDA	ANDA202869	Hospira, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0409-1890_d3f09ce9-4b4c-4861-8573-d41229ebb0fa	0409-1890	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20120823		NDA	NDA202515	Hospira, Inc.	MORPHINE SULFATE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0409-1891_d3f09ce9-4b4c-4861-8573-d41229ebb0fa	0409-1891	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20120807		NDA	NDA202515	Hospira, Inc.	MORPHINE SULFATE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0409-1892_d3f09ce9-4b4c-4861-8573-d41229ebb0fa	0409-1892	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20120924		NDA	NDA202515	Hospira, Inc.	MORPHINE SULFATE	8	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0409-1893_d3f09ce9-4b4c-4861-8573-d41229ebb0fa	0409-1893	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20120820		NDA	NDA202515	Hospira, Inc.	MORPHINE SULFATE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0409-1896_0bc79f18-1d6b-4e50-a88a-97ed530163da	0409-1896	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20231120		NDA	NDA202515	Hospira, Inc.	MORPHINE SULFATE	50	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-1902_71239e14-ba00-4819-bc9f-d802e09fcab3	0409-1902	HUMAN PRESCRIPTION DRUG	Procainamide Hydrochloride		PROCAINAMIDE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060308		ANDA	ANDA089069	Hospira, Inc.	PROCAINAMIDE HYDROCHLORIDE	100	mg/mL	Antiarrhythmic [EPC]		N	20241231
0409-1932_af4ef593-85c4-472a-9d07-5cd821e25715	0409-1932	HUMAN PRESCRIPTION DRUG	Adenosine		ADENOSINE	INJECTION, SOLUTION	INTRAVENOUS	20140402		ANDA	ANDA203883	Hospira, Inc.	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
0409-1966_406379a1-45c1-4582-a504-19fd0e5a99bd	0409-1966	HUMAN PRESCRIPTION DRUG	BACTERIOSTATIC SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050430		NDA	NDA018800	Hospira, Inc.	SODIUM CHLORIDE	9	mg/mL			N	20241231
0409-1983_41afad76-bea1-46c5-ab31-84a54b157410	0409-1983	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		Milrinone Lactate in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20211004		ANDA	ANDA213585	Hospira, Inc.	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0409-1985_e90a536c-421f-4774-8f88-013e18a8163e	0409-1985	HUMAN PRESCRIPTION DRUG	Lorazepam		LORAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050606		ANDA	ANDA074243	Hospira, Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-2011_56fc4fed-e482-4259-8253-8c5b3f603e9f	0409-2011	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	INJECTION, SOLUTION	INTRAVENOUS	20211101		ANDA	ANDA202869	Hospira, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0409-2012_f94f73a3-1a9f-4ace-82fb-2a6721485e31	0409-2012	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride		Buprenorphine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050614		ANDA	ANDA074137	Hospira, Inc.	BUPRENORPHINE HYDROCHLORIDE	.3	mg/mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0409-2016_a60b0c88-2c92-452a-a45a-79b52c466c47	0409-2016	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		METOPROLOL TARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20220613		ANDA	ANDA078085	Hospira, Inc.	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0409-2026_ec1cf311-020a-4a35-9a70-954b012d804e	0409-2026	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20220110		NDA	NDA022234	Hospira, Inc.	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-2045_41afad76-bea1-46c5-ab31-84a54b157410	0409-2045	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		Milrinone Lactate in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20220404		ANDA	ANDA213585	Hospira, Inc.	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
0409-2050_0fbee92b-14b5-4eba-93d7-3bee3b2aca80	0409-2050	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		MAGNESIUM SULFATE IN WATER	INJECTION, SOLUTION	INTRAVENOUS	20221114		NDA	NDA020309	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	20	g/500mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-2051_f45f79db-6570-4f97-aeab-f1219b283882	0409-2051	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAMUSCULAR; INTRAVENOUS	20041130		ANDA	ANDA074549	Hospira, Inc.	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0409-2053_f45f79db-6570-4f97-aeab-f1219b283882	0409-2053	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAMUSCULAR; INTRAVENOUS	20041130		ANDA	ANDA074549	Hospira, Inc.	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
0409-2066_7ec189f1-7357-4bc2-b1d3-57cbb695252d	0409-2066	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050907		ANDA	ANDA040078	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-2168_8d7db5ea-52c4-49dc-851e-33f02e751c8f	0409-2168	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050331		ANDA	ANDA202411	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-2188_f9317d20-80ef-4c2d-8c7b-bad954f8b7f4	0409-2188	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220627		NDA	NDA214218	Hospira, Inc.	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-2222_4d8d8c73-8f39-46e7-bc32-d1065a70522f	0409-2222	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20230227		NDA	NDA018916	Hospira, Inc.	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-2267_2ea8704a-ff7d-4724-9e92-751141d9e43f	0409-2267	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20051230		ANDA	ANDA075240	Hospira, Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0409-2300_6f4bacb9-10fd-4e44-9037-dae6c583f708	0409-2300	HUMAN PRESCRIPTION DRUG	Ciprofloxacin in Dextrose		ciprofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20230630		ANDA	ANDA078252	Hospira, Inc.	CIPROFLOXACIN	200	mg/100mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0409-2305_76f21870-33d5-45a1-9e0a-9713da5bf2f9	0409-2305	HUMAN PRESCRIPTION DRUG	MIDAZOLAM HYDROCHLORIDE		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050803		ANDA	ANDA075857	Hospira, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-2305_ba875654-83b4-4ecf-80fb-6b9e1f3c75a6	0409-2305	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050817		ANDA	ANDA075857	Hospira, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-2308_76f21870-33d5-45a1-9e0a-9713da5bf2f9	0409-2308	HUMAN PRESCRIPTION DRUG	MIDAZOLAM HYDROCHLORIDE		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051121		ANDA	ANDA075857	Hospira, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-2308_ba875654-83b4-4ecf-80fb-6b9e1f3c75a6	0409-2308	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050614		ANDA	ANDA075857	Hospira, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-2337_a1126531-9102-4c43-9192-87d6943e19f0	0409-2337	HUMAN PRESCRIPTION DRUG	Deferoxamine Mesylate		Deferoxamine Mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050331		ANDA	ANDA076019	Hospira, Inc.	DEFEROXAMINE MESYLATE	2	g/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0409-2339_7ba44762-b760-4a8f-adce-65bf78cc5d98	0409-2339	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20051018		ANDA	ANDA075239	Hospira, Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0409-2344_05ad3ad4-86b3-416d-9218-bd6b7f6efea1	0409-2344	HUMAN PRESCRIPTION DRUG	DOBUTAMINE		DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050430		ANDA	ANDA074086	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	12.5	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0409-2344_987f02ca-ce1d-4afd-87f7-b34bbb90c294	0409-2344	HUMAN PRESCRIPTION DRUG	DOBUTAMINE		DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050629		ANDA	ANDA074086	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	12.5	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0409-2346_03a39c90-e78b-4864-8d4c-b11ea1af9fc5	0409-2346	HUMAN PRESCRIPTION DRUG	Dobutamine in Dextrose		Dobutamine in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20050812		NDA	NDA020201	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	100	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0409-2347_03a39c90-e78b-4864-8d4c-b11ea1af9fc5	0409-2347	HUMAN PRESCRIPTION DRUG	Dobutamine in Dextrose		Dobutamine in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20060120		NDA	NDA020201	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	200	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0409-2504_91412b10-62b2-446b-9459-725e1ae7bcaa	0409-2504	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		PALONOSETRON HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181114		ANDA	ANDA207005	Hospira, Inc.	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0409-2552_f699ac2c-1705-496e-a8ee-5802d2c2515b	0409-2552	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20111201		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-2585_24419190-91d0-4ec9-9ee6-478b5775af1d	0409-2585	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20070509		ANDA	ANDA065345	Hospira, Inc	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-2587_195a2732-7cc2-432f-be09-97c771a43c2c	0409-2587	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060202		ANDA	ANDA075293	Hospira, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-2596_195a2732-7cc2-432f-be09-97c771a43c2c	0409-2596	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051103		ANDA	ANDA075293	Hospira, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-2634_50fc66e7-b555-4725-abc5-014506cc98e7	0409-2634	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20080731		ANDA	ANDA078591	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-2689_36379fb6-184f-4aef-90e3-292c7f71766b	0409-2689	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin sodium and Sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20060725		ANDA	ANDA065310	Hospira, Inc	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-2720_91eee322-7805-4992-854c-b9d6b17684a4	0409-2720	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20090831		ANDA	ANDA090571	Hospira, Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-2721_91eee322-7805-4992-854c-b9d6b17684a4	0409-2721	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20090831		ANDA	ANDA090571	Hospira, Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-2723_91eee322-7805-4992-854c-b9d6b17684a4	0409-2723	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20090831		ANDA	ANDA090571	Hospira, Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-2757_14409528-2a66-418b-a94e-2f507e91b203	0409-2757	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201005		ANDA	ANDA206005	Hospira Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0409-2815_900fc04d-df7d-47e5-a1a0-53fe5d2bd10b	0409-2815	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20230117		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-2987_36379fb6-184f-4aef-90e3-292c7f71766b	0409-2987	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin sodium and Sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20060725		ANDA	ANDA065310	Hospira, Inc	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-2999_7bcecbdf-1a6d-4691-8c1b-e596c516a7ba	0409-2999	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20161214		ANDA	ANDA203557	Hospira, Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	12; 1.5	g/60mL; g/60mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-3150_3cc352ef-503a-44bf-a0f0-c20400da885a	0409-3150	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20230103		NDA	NDA018916	Hospira, Inc.	HEPARIN SODIUM	5000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-3164_0fbee92b-14b5-4eba-93d7-3bee3b2aca80	0409-3164	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		MAGNESIUM SULFATE IN WATER	INJECTION, SOLUTION	INTRAVENOUS	20230619		NDA	NDA020309	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	40	g/1000mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-3177_1bb10d36-88d2-4a53-94fe-4881d0497dbd	0409-3177	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		LIDOCAINE HYDROCHLORIDE and EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20051101		ANDA	ANDA089635	Hospira, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	5; 5	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-3178_1bb10d36-88d2-4a53-94fe-4881d0497dbd	0409-3178	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		LIDOCAINE HYDROCHLORIDE and EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050916		ANDA	ANDA089644	Hospira, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 10	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-3181_1bb10d36-88d2-4a53-94fe-4881d0497dbd	0409-3181	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		LIDOCAINE HYDROCHLORIDE and EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050131		ANDA	ANDA089645	Hospira, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	5; 15	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-3182_1bb10d36-88d2-4a53-94fe-4881d0497dbd	0409-3182	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		LIDOCAINE HYDROCHLORIDE and EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050623		ANDA	ANDA089646	Hospira, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-3183_1bb10d36-88d2-4a53-94fe-4881d0497dbd	0409-3183	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		LIDOCAINE HYDROCHLORIDE and EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050706		ANDA	ANDA089651	Hospira, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	5; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-3189_c96726ef-f1fa-4ebb-ba33-3479c3902a8e	0409-3189	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20230717		ANDA	ANDA205656	Hospira, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-3213_1bf7a9b5-8085-4e46-aa92-57516790ea78	0409-3213	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20071005		ANDA	ANDA071583	Hospira, Inc.	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-3294_500bb334-6d33-4bb1-b081-f505423f2872	0409-3294	HUMAN PRESCRIPTION DRUG	Potassium Acetate		POTASSIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050705		NDA	NDA018896	Hospira, Inc.	POTASSIUM ACETATE	196.3	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-3294_cc6c07c8-e3a6-429d-8820-2a85a3c3a740	0409-3294	HUMAN PRESCRIPTION DRUG	Potassium Acetate		POTASSIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20131223		NDA	NDA018896	Hospira, Inc.	POTASSIUM ACETATE	196.3	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-3299_416a7d2a-271d-4b08-a491-1e8a13650b86	0409-3299	HUMAN PRESCRIPTION DRUG	Sodium Acetate		sodium acetate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20131119		NDA	NDA018893	Hospira, Inc.	SODIUM ACETATE ANHYDROUS	164	mg/mL			N	20241231
0409-3299_6604fcb2-3e30-497e-92c8-dbbb236d46a5	0409-3299	HUMAN PRESCRIPTION DRUG	Sodium Acetate		sodium acetate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050430		NDA	NDA018893	Hospira, Inc.	SODIUM ACETATE ANHYDROUS	164	mg/mL			N	20241231
0409-3300_6f4bacb9-10fd-4e44-9037-dae6c583f708	0409-3300	HUMAN PRESCRIPTION DRUG	Ciprofloxacin in Dextrose		ciprofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20221201		ANDA	ANDA078252	Hospira, Inc.	CIPROFLOXACIN	400	mg/200mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0409-3301_900fc04d-df7d-47e5-a1a0-53fe5d2bd10b	0409-3301	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220307		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-3307_7691b1e4-b6a3-4a20-aa62-48da78d412a9	0409-3307	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20050430		ANDA	ANDA073664	Hospira, Inc.	ACETYLCYSTEINE	100	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0409-3308_7691b1e4-b6a3-4a20-aa62-48da78d412a9	0409-3308	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20050601		ANDA	ANDA074037	Hospira, Inc.	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0409-3365_f699ac2c-1705-496e-a8ee-5802d2c2515b	0409-3365	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20111201		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-3373_8631bdd7-d667-42fe-878e-d7d146f3d5e8	0409-3373	HUMAN PRESCRIPTION DRUG	Corlopam		fenoldopam mesylate	INJECTION, SOLUTION	INTRAVENOUS	20080314		NDA	NDA019922	Hospira, Inc.	FENOLDOPAM MESYLATE	10	mg/mL	Dopamine Agonists [MoA], Dopaminergic Agonist [EPC]		N	20241231
0409-3374_1636d91c-747c-4092-ab0c-88717fb8c20b	0409-3374	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065363	Hospira, Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-3375_c8ec5d58-0b51-43d9-97c0-c22a41a86d1a	0409-3375	HUMAN PRESCRIPTION DRUG	LEVOPHED		NOREPINEPHRINE BITARTRATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20090427		NDA	NDA007513	Hospira, Inc.	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0409-3378_1636d91c-747c-4092-ab0c-88717fb8c20b	0409-3378	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065363	Hospira, Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-3379_1636d91c-747c-4092-ab0c-88717fb8c20b	0409-3379	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065363	Hospira, Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-3382_4f948c10-c423-451b-af5c-29fafa52c987	0409-3382	HUMAN PRESCRIPTION DRUG	Sufentanil Citrate		SUFENTANIL CITRATE	INJECTION, SOLUTION	EPIDURAL; INTRAVENOUS	20050726		ANDA	ANDA074534	Hospira, Inc.	SUFENTANIL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-3383_d0218154-03cc-4242-b7ae-5667fe3d848e	0409-3383	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Hospira, Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-3385_d0218154-03cc-4242-b7ae-5667fe3d848e	0409-3385	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Hospira, Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-3390_d0218154-03cc-4242-b7ae-5667fe3d848e	0409-3390	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Hospira, Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0409-3412_c3a6b536-a7c6-4a2b-9ac6-94e1c3eef1d7	0409-3412	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20221206		ANDA	ANDA091404	Hospira, Inc.	MEROPENEM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0409-3414_450f0260-3b90-46ab-b655-eb50aaa5ec0a	0409-3414	HUMAN PRESCRIPTION DRUG	Metoclopramide		metoclopramide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060202		ANDA	ANDA073118	Hospira, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0409-3510_3b435e53-f4bc-44d5-8995-797afb41c1ae	0409-3510	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201019		ANDA	ANDA208790	Hospira, Inc.	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0409-3515_890943d5-1a46-42af-a24b-775d26f2ba6a	0409-3515	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210528		ANDA	ANDA062912	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	1.5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-3532_f9317d20-80ef-4c2d-8c7b-bad954f8b7f4	0409-3532	HUMAN PRESCRIPTION DRUG	PEMETREXED		PEMETREXED	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220627		NDA	NDA214218	Hospira, Inc.	PEMETREXED DISODIUM	1	g/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0409-3578_ce014193-d7cb-48ba-ab31-c120aa8c4dfe	0409-3578	HUMAN PRESCRIPTION DRUG	TOBRAMYCIN		TOBRAMYCIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050505		ANDA	ANDA063111	Hospira, Inc.	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0409-3613_cd32bbaa-7714-458e-8855-50ae146cfcaa	0409-3613	HUMAN PRESCRIPTION DRUG	Bupivacaine	Spinal	BUPIVACAINE HYDROCHLORIDE IN DEXTROSE	INJECTION, SOLUTION	SUBARACHNOID	20050131		ANDA	ANDA071810	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-3670_6728ba52-e751-44ec-a19b-3045eaf02342	0409-3670	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20210601		ANDA	ANDA203236	Hospira, Inc.	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-3718_c94b9c81-8266-4b5a-85f6-9c6d7a4e1393	0409-3718	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170801		ANDA	ANDA061395	Hospira, Inc	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0409-3720_c94b9c81-8266-4b5a-85f6-9c6d7a4e1393	0409-3720	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170801	20240229	ANDA	ANDA061395	Hospira, Inc	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	
0409-3724_03a39c90-e78b-4864-8d4c-b11ea1af9fc5	0409-3724	HUMAN PRESCRIPTION DRUG	Dobutamine in Dextrose		Dobutamine in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20051012		NDA	NDA020201	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	400	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0409-3725_4510a92f-2731-4959-a36f-0c659278707c	0409-3725	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19710303		ANDA	ANDA061395	Hospira, Inc	AMPICILLIN SODIUM	10	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0409-3726_c94b9c81-8266-4b5a-85f6-9c6d7a4e1393	0409-3726	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170801		ANDA	ANDA061395	Hospira, Inc	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0409-3793_be3c3d59-deb5-4116-a5a9-155df6c495c4	0409-3793	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050606		ANDA	ANDA074802	Hospira, Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0409-3795_be3c3d59-deb5-4116-a5a9-155df6c495c4	0409-3795	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060119		ANDA	ANDA074802	Hospira, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0409-3796_be3c3d59-deb5-4116-a5a9-155df6c495c4	0409-3796	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20151030		ANDA	ANDA074802	Hospira, Inc.	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0409-3812_8bed8b7f-9c71-40fb-9312-8e5e0ab6680f	0409-3812	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220906		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-3814_23e7cff5-2c55-440f-a17e-65125e0389ac	0409-3814	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	EPIDURAL; INTRATHECAL; INTRAVENOUS	20050810		ANDA	ANDA073509	Hospira, Inc.	MORPHINE SULFATE	.5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-3815_23e7cff5-2c55-440f-a17e-65125e0389ac	0409-3815	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	EPIDURAL; INTRATHECAL; INTRAVENOUS	20050629		ANDA	ANDA073510	Hospira, Inc.	MORPHINE SULFATE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-3977_1038cc12-a011-4d6b-89b7-6fca5e2f9105	0409-3977	HUMAN PRESCRIPTION DRUG	Bacteriostatic Water		Bacteriostatic Water	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050430		NDA	NDA018802	Hospira, Inc.	WATER	1	mL/mL			N	20241231
0409-4011_1975dcaa-94b4-4af2-b95d-41463e1db00c	0409-4011	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050228		ANDA	ANDA070738	Hospira, Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0409-4031_ede97765-4775-4579-952b-ea1bb5d4eaf1	0409-4031	HUMAN PRESCRIPTION DRUG	Mannitol		MANNITOL	INJECTION, SOLUTION	INTRAVENOUS	20041130		NDA	NDA016269	Hospira, Inc.	MANNITOL	12.5	g/50mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0409-4090_243bd351-e37d-430e-8ff7-2610aa8eb5a3	0409-4090	HUMAN PRESCRIPTION DRUG	ZINC		ZINC CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	19900930		NDA	NDA018959	Hospira, Inc.	ZINC CHLORIDE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0409-4091_1b45a603-e0d9-46bb-8aed-349ce8fe980a	0409-4091	HUMAN PRESCRIPTION DRUG	MANGANESE		MANGANESE CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050131		NDA	NDA018962	Hospira, Inc.	MANGANESE CHLORIDE	.1	mg/mL	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0409-4092_2d6f2467-41e3-49fe-bfc2-f9c56e80c1cc	0409-4092	HUMAN PRESCRIPTION DRUG	COPPER		CUPRIC CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050228		NDA	NDA018960	Hospira, Inc.	CUPRIC CHLORIDE	.4	mg/mL			N	20241231
0409-4093_80d5ebf7-fcb9-4c94-9efd-15a87faf3133	0409-4093	HUMAN PRESCRIPTION DRUG	Chromium		Chromic Chloride	INJECTION, SOLUTION	INTRAVENOUS	20160427		NDA	NDA018961	Hospira, Inc.	CHROMIC CHLORIDE	4	ug/mL			N	20241231
0409-4093_e08f7829-70fe-4f24-bf74-44b4774c9103	0409-4093	HUMAN PRESCRIPTION DRUG	CHROMIUM		CHROMIC CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050630		NDA	NDA018961	Hospira, Inc.	CHROMIC CHLORIDE	4	ug/mL			N	20241231
0409-4121_0fbee92b-14b5-4eba-93d7-3bee3b2aca80	0409-4121	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		MAGNESIUM SULFATE IN WATER	INJECTION, SOLUTION	INTRAVENOUS	20221227		NDA	NDA020309	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-4208_8bed8b7f-9c71-40fb-9312-8e5e0ab6680f	0409-4208	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20220926		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-4215_db0dfbdb-32dc-485a-beeb-e5faeaef7e8c	0409-4215	HUMAN PRESCRIPTION DRUG	ZOLEDRONIC ACID		ZOLEDRONIC ACID	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20171019		ANDA	ANDA090621	Hospira, Inc.	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
0409-4235_826fc035-ecfc-4dcc-84ba-b813a844f57e	0409-4235	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL	INJECTION, SOLUTION	INTRAVENOUS	20210628		NDA	NDA022234	Hospira, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-4264_92f27fad-d7ea-468b-8b67-259e73520efe	0409-4264	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220527		NDA	NDA200403	Hospira, Inc.	HYDROMORPHONE HYDROCHLORIDE	.5	mg/.5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0409-4275_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4275	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20060104		ANDA	ANDA088325	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4276_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4276	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050712		ANDA	ANDA088299	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4277_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4277	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050615		ANDA	ANDA088327	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4278_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4278	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; INTRAVENOUS	20050630		ANDA	ANDA088328	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4279_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4279	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050830		ANDA	ANDA088329	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4282_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4282	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050914		ANDA	ANDA088294	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4283_684219c8-9e63-4922-8090-6c1b30a0aa3a	0409-4283	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	RETROBULBAR; TOPICAL; TRANSTRACHEAL	20050609		ANDA	ANDA088295	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4332_890943d5-1a46-42af-a24b-775d26f2ba6a	0409-4332	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050430		ANDA	ANDA062911	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-4346_549114bf-19dc-4781-a7f0-190c775d5817	0409-4346	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		AMINOCAPROIC ACID	INJECTION, SOLUTION	INTRAVENOUS	20100512		ANDA	ANDA070010	Hospira, Inc.	AMINOCAPROIC ACID	250	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
0409-4350_18648c0d-5f60-4195-92f0-1dffc1452d4c	0409-4350	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		DILTIAZEM HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050430		ANDA	ANDA075853	Hospira, Inc.	DILTIAZEM HYDROCHLORIDE	100	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0409-4520_02f84fa1-2ffd-4ca8-8e64-3563f630d311	0409-4520	HUMAN PRESCRIPTION DRUG	Heparin Sodium and Dextrose		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20221212		NDA	NDA019339	Hospira, Inc.	HEPARIN SODIUM	10000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-4596_b5e7a125-4e03-403d-8fd1-435103ef3f20	0409-4596	HUMAN PRESCRIPTION DRUG	Precedex		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20230103		NDA	NDA021038	Hospira, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0409-4688_19102cde-a846-4d12-a480-f3d0c0fff7ae	0409-4688	HUMAN PRESCRIPTION DRUG	Fluconazole in Sodium Chloride		Fluconazole in Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20060417		ANDA	ANDA076303	Hospira, Inc.	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0409-4699_5eef33b6-0f69-4bf2-ae0e-e2db8417e163	0409-4699	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20060403		ANDA	ANDA077908	Hospira, Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0409-4713_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4713	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050708		ANDA	ANDA080408	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4755_7fe1d355-dc6e-443b-9b19-4dc27e115375	0409-4755	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20081016		ANDA	ANDA077548	Hospira, Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0409-4759_7fe1d355-dc6e-443b-9b19-4dc27e115375	0409-4759	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20061107		ANDA	ANDA077473	Hospira, Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0409-4776_1d346dc9-3408-4971-8cd5-79c2527eee5f	0409-4776	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20060106		ANDA	ANDA080408	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	15	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4777_2dc48387-9ad4-477a-9eee-5dae4f9e11c9	0409-4777	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	INJECTION, SOLUTION	INTRAVENOUS	20080319		ANDA	ANDA077753	Hospira, Inc.	CIPROFLOXACIN	2	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0409-4883_f00d4862-363b-4d8a-a99d-cbf753aad2c7	0409-4883	HUMAN PRESCRIPTION DRUG	Linezolid		LINEZOLID	INJECTION, SOLUTION	INTRAVENOUS	20150618		NDA	NDA206473	Hospira, Inc.	LINEZOLID	2	mg/mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0409-4887_900859c0-a075-4fb1-98ce-0e329acc009a	0409-4887	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050616		NDA	NDA018801	Hospira, Inc.	WATER	1	mL/mL			N	20251231
0409-4888_a2e039d7-f931-4356-8ce6-f40241617b2c	0409-4888	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050228		NDA	NDA018803	Hospira, Inc.	SODIUM CHLORIDE	9	mg/mL			N	20241231
0409-4902_fa05af43-a986-4206-aa80-62988b03c019	0409-4902	HUMAN PRESCRIPTION DRUG	Dextrose		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20051207		NDA	NDA019445	Hospira, Inc.	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
0409-4903_3a6e4402-7b97-4d62-8239-16c2ff17009d	0409-4903	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20051201		ANDA	ANDA083158	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4904_3a6e4402-7b97-4d62-8239-16c2ff17009d	0409-4904	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050830		ANDA	ANDA083158	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-4910_77d2cecb-001f-4b7b-b8ee-94c8b6d89be5	0409-4910	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20050825		NDA	NDA021146	Hospira, Inc.	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0409-4911_77d2cecb-001f-4b7b-b8ee-94c8b6d89be5	0409-4911	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20051025		NDA	NDA021146	Hospira, Inc.	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0409-4916_5026b367-27f6-4bf3-bfe8-c36c5fde401c	0409-4916	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20200723		ANDA	ANDA202494	Hospira, Inc.	SODIUM BICARBONATE	75	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-4928_ffe34ef3-7abe-40fc-89d7-15cb8bceadc2	0409-4928	HUMAN PRESCRIPTION DRUG	Calcium Chloride		CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS; INTRAVENTRICULAR	20060124		UNAPPROVED DRUG OTHER		Hospira, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0409-4933_71438da7-e738-466f-a75e-61ee56d73e2a	0409-4933	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		epinephrine	INJECTION, SOLUTION	INTRAVENOUS	20210310		NDA	NDA209359	Hospira, Inc.	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-5017_a9c73d4d-b023-4d1c-99c4-ffea71f36d8e	0409-5017	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211102		ANDA	ANDA063076	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-5068_826fc035-ecfc-4dcc-84ba-b813a844f57e	0409-5068	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL	INJECTION, SOLUTION	INTRAVENOUS	20210628		NDA	NDA022234	Hospira, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-5082_5e926814-530f-49b4-a2a5-7209e5010d33	0409-5082	HUMAN PRESCRIPTION DRUG	TAZICEF		CEFTAZIDIME	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051102		ANDA	ANDA062662	Hospira, Inc.	CEFTAZIDIME	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-5084_5e926814-530f-49b4-a2a5-7209e5010d33	0409-5084	HUMAN PRESCRIPTION DRUG	TAZICEF		CEFTAZIDIME	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20051216		ANDA	ANDA062662	Hospira, Inc.	CEFTAZIDIME	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-5086_a40ef4d6-68d4-42e3-9ed2-7ab5e324c6e4	0409-5086	HUMAN PRESCRIPTION DRUG	TAZICEF		CEFTAZIDIME	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20060420		ANDA	ANDA062662	Hospira, Inc.	CEFTAZIDIME	6	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b	0409-5092	HUMAN PRESCRIPTION DRUG	TAZICEF		CEFTAZIDIME	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20060508		ANDA	ANDA064032	Hospira, Inc.	CEFTAZIDIME	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-5093_3f749ee0-db14-4ed0-9056-d545a38bbe3b	0409-5093	HUMAN PRESCRIPTION DRUG	TAZICEF		CEFTAZIDIME	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20060405		ANDA	ANDA064032	Hospira, Inc.	CEFTAZIDIME	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-5160_f01f9986-43f9-40e8-9506-11bfe78f9242	0409-5160	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20230828		ANDA	ANDA205656	Hospira, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-5239_0fbee92b-14b5-4eba-93d7-3bee3b2aca80	0409-5239	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		MAGNESIUM SULFATE IN WATER	INJECTION, SOLUTION	INTRAVENOUS	20221227		NDA	NDA020309	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	2	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-5255_7552bd4f-55d2-42d2-8bf7-c0781b98fc67	0409-5255	HUMAN PRESCRIPTION DRUG	Metoclopramide		metoclopramide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20221114		ANDA	ANDA073118	Hospira, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0409-5534_84dd5f18-5b16-4181-87c5-fd6cf4df147c	0409-5534	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20200817		ANDA	ANDA202679	Hospira, Inc.	SODIUM BICARBONATE	42	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-5547_6728ba52-e751-44ec-a19b-3045eaf02342	0409-5547	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20210601		ANDA	ANDA203236	Hospira, Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-5555_ac34e4ae-d08f-482a-be08-cfe3c82bf0fd	0409-5555	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20191021		ANDA	ANDA202981	Hospira, Inc.	SODIUM BICARBONATE	42	mg/mL	Alkalinizing Activity [MoA]		N	20251231
0409-5555_b81f60cb-9cb1-45d5-b27c-424ac1c846b6	0409-5555	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20200826		ANDA	ANDA202981	Hospira, Inc.	SODIUM BICARBONATE	42	mg/mL	Alkalinizing Activity [MoA]		N	20251231
0409-5738_8bed8b7f-9c71-40fb-9312-8e5e0ab6680f	0409-5738	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220906		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-5820_20d35934-b56f-4ce6-a897-fc25414f25aa	0409-5820	HUMAN PRESCRIPTION DRUG	DOPamine Hydrochloride		Dopamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050825		NDA	NDA018132	Hospira, Inc.	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0409-5921_210ec8ae-dc4c-4919-b3e0-39be81ac8132	0409-5921	HUMAN PRESCRIPTION DRUG	Aminophylline		Aminophylline	INJECTION, SOLUTION	INTRAVENOUS	20050510		ANDA	ANDA087242	Hospira, Inc.	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0409-5922_210ec8ae-dc4c-4919-b3e0-39be81ac8132	0409-5922	HUMAN PRESCRIPTION DRUG	Aminophylline		Aminophylline	INJECTION, SOLUTION	INTRAVENOUS	20050228		ANDA	ANDA087242	Hospira, Inc.	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0409-5933_33dd79f7-7a85-4ce1-b663-bf5700aeaf94	0409-5933	HUMAN PRESCRIPTION DRUG	Daptomycin		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201028		NDA	NDA209949	Hospira Inc.	DAPTOMYCIN	350	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
0409-6010_5eef33b6-0f69-4bf2-ae0e-e2db8417e163	0409-6010	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20220522		ANDA	ANDA077908	Hospira, Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0409-6102_7f76ad27-02dc-48c4-95ff-ec6e762707c3	0409-6102	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131119		NDA	NDA018667	Hospira, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0409-6102_e4f70352-f05a-4d06-b1fd-69a036177b97	0409-6102	HUMAN PRESCRIPTION DRUG	Furosemide		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050228		NDA	NDA018667	Hospira, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0409-6476_ffa36ce2-7c68-4981-860c-f1538a2f9a63	0409-6476	HUMAN PRESCRIPTION DRUG	Erythrocin Lactobionate		ERYTHROMYCIN LACTOBIONATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060316		ANDA	ANDA062638	Hospira, Inc.	ERYTHROMYCIN LACTOBIONATE	500	mg/100mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
0409-6482_94c8bf36-909a-49ad-8b24-53101c3c41c0	0409-6482	HUMAN PRESCRIPTION DRUG	Erythrocin Lactobionate		ERYTHROMYCIN LACTOBIONATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050525		NDA	NDA050609	Hospira, Inc.	ERYTHROMYCIN LACTOBIONATE	500	mg/10mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
0409-6509_a9c73d4d-b023-4d1c-99c4-ffea71f36d8e	0409-6509	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190115		ANDA	ANDA063076	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6509_c96bb5b9-18bb-4c0c-a1af-c885d3dd06d7	0409-6509	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050606		ANDA	ANDA063076	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6531_3adba283-02f8-45a2-b191-873ca5b99364	0409-6531	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120323		ANDA	ANDA062933	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	750	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6531_890943d5-1a46-42af-a24b-775d26f2ba6a	0409-6531	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090327		ANDA	ANDA062912	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	750	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6533_890943d5-1a46-42af-a24b-775d26f2ba6a	0409-6533	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050331		ANDA	ANDA062912	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6533_90137a5e-8216-4b09-8e53-988cfebbf290	0409-6533	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200218		ANDA	ANDA062912	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6534_3adba283-02f8-45a2-b191-873ca5b99364	0409-6534	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050616		ANDA	ANDA062931	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6535_3adba283-02f8-45a2-b191-873ca5b99364	0409-6535	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050430		ANDA	ANDA062933	Hospira, Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
0409-6557_32e992a5-f4e4-4741-b8c4-ef7d468055a0	0409-6557	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20160801		ANDA	ANDA085635	Hospira, Inc.	TESTOSTERONE CYPIONATE	100	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0409-6562_32e992a5-f4e4-4741-b8c4-ef7d468055a0	0409-6562	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20160801		ANDA	ANDA085635	Hospira, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0409-6562_7ba1cd1f-cd53-4b7a-b8f4-87dd77ef9f4a	0409-6562	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20180117		ANDA	ANDA085635	Hospira, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0409-6581_8bed8b7f-9c71-40fb-9312-8e5e0ab6680f	0409-6581	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	PERINEURAL	20220926		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-6625_74c6bade-39d4-42cf-90b0-033afe7e7ed1	0409-6625	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA202432	Hospira, Inc.	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-6625_f63086fb-43c2-4ccd-901c-6035ae47f905	0409-6625	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20201015		ANDA	ANDA202432	Hospira, Inc.	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-6629_85396a53-f320-4200-a3fe-acbabcee1b6d	0409-6629	HUMAN PRESCRIPTION DRUG	QUELICIN		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050430		NDA	NDA008845	Hospira, Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
0409-6635_1a35de1a-eb30-4770-9744-8c85dde56ac9	0409-6635	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050919		ANDA	ANDA080205	Hospira, Inc.	POTASSIUM CHLORIDE	149	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-6637_5026b367-27f6-4bf3-bfe8-c36c5fde401c	0409-6637	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20200723		ANDA	ANDA202494	Hospira, Inc.	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-6648_fa05af43-a986-4206-aa80-62988b03c019	0409-6648	HUMAN PRESCRIPTION DRUG	Dextrose		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20050331		NDA	NDA019445	Hospira, Inc.	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
0409-6651_1a35de1a-eb30-4770-9744-8c85dde56ac9	0409-6651	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20051110		ANDA	ANDA080205	Hospira, Inc.	POTASSIUM CHLORIDE	149	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-6653_1a35de1a-eb30-4770-9744-8c85dde56ac9	0409-6653	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050808		ANDA	ANDA080205	Hospira, Inc.	POTASSIUM CHLORIDE	149	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-6695_9501506c-b453-4d74-b7e9-1cfded2bcf89	0409-6695	HUMAN PRESCRIPTION DRUG	Amidate		ETOMIDATE	INJECTION, SOLUTION	INTRAVENOUS	20050726		NDA	NDA018227	Hospira, Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0409-6727_7c690dc0-a5dd-415b-9c97-12f367c13bc9	0409-6727	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Dextrose		Magnesium Sulfate in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20050927		NDA	NDA020488	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	10	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-6729_0fbee92b-14b5-4eba-93d7-3bee3b2aca80	0409-6729	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		MAGNESIUM SULFATE IN WATER	INJECTION, SOLUTION	INTRAVENOUS	20050822		NDA	NDA020309	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-6730_0fbee92b-14b5-4eba-93d7-3bee3b2aca80	0409-6730	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Water		MAGNESIUM SULFATE IN WATER	INJECTION, SOLUTION	INTRAVENOUS	20060331		NDA	NDA020309	Hospira, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	80	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-6778_2d57bb95-a84e-42ea-bc7c-371cc15be95e	0409-6778	HUMAN PRESCRIPTION DRUG	Lorazepam		LORAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060131		ANDA	ANDA074282	Hospira, Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0409-7037_c96726ef-f1fa-4ebb-ba33-3479c3902a8e	0409-7037	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20230717		ANDA	ANDA205656	Hospira, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-7083_6728ba52-e751-44ec-a19b-3045eaf02342	0409-7083	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20210601		ANDA	ANDA203238	Hospira, Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-7100_4fb2acb9-ec11-4cfd-b820-0e68dc8df673	0409-7100	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20050627		NDA	NDA019466	Hospira, Inc.	DEXTROSE MONOHYDRATE	50	mg/mL			N	20241231
0409-7101_bee16468-f227-4840-bdf5-c48114dd88b3	0409-7101	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20050630		NDA	NDA019465	Hospira, Inc.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
0409-7248_24a50f10-cd05-4e76-8de9-d4defaa620be	0409-7248	HUMAN PRESCRIPTION DRUG	Hetastarch in Sodium Chloride		HETASTARCH	INJECTION, SOLUTION	INTRAVENOUS	20050228		ANDA	BA740193	Hospira, Inc.	HETASTARCH	6	g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC], Starch [CS]		N	20241231
0409-7295_1a84d005-2f27-4677-989c-9d975a6fa8bd	0409-7295	HUMAN PRESCRIPTION DRUG	Potassium Phosphates		POTASSIUM PHOSPHATE, MONOBASIC and POTASSIUM PHOSPHATE, DIBASIC	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050826		UNAPPROVED DRUG OTHER		Hospira, Inc.	DIBASIC POTASSIUM PHOSPHATE; MONOBASIC POTASSIUM PHOSPHATE	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-7299_72b7bb61-297e-4b65-8ffe-f5e1b47feafc	0409-7299	HUMAN PRESCRIPTION DRUG	Sodium Acetate		SODIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140305		NDA	NDA018893	Hospira, Inc.	SODIUM ACETATE ANHYDROUS	3.28	g/20mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-7299_fb234b3d-59d0-4e47-9eba-07a814f8752e	0409-7299	HUMAN PRESCRIPTION DRUG	Sodium Acetate		SODIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050331		NDA	NDA018893	Hospira, Inc.	SODIUM ACETATE ANHYDROUS	3.28	g/20mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0409-7333_06236b06-80b0-471a-9c01-df439ec643aa	0409-7333	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20050720		ANDA	ANDA065204	Hospira, Inc	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7333_7aff2ede-5fac-4ad5-89c2-2de9c781bbde	0409-7333	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20050714		ANDA	ANDA065204	Hospira, Inc	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7334_8e4e37f3-759b-407b-b5d7-1dfbff1c2e88	0409-7334	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20050517		ANDA	ANDA065168	Hospira, Inc	CEFTRIAXONE SODIUM	10	g/100mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7334_c67a6eae-905e-4b8f-a65c-5c8cc2134516	0409-7334	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20050517		ANDA	ANDA065168	Hospira, Inc	CEFTRIAXONE SODIUM	10	g/100mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7337_06cbc906-85d6-45a5-98f2-fd6152b8cdb5	0409-7337	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Hospira, Inc	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7337_2a8e54f3-90ea-4cd7-9d5d-663665a6ccee	0409-7337	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Hospira, Inc	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7338_06cbc906-85d6-45a5-98f2-fd6152b8cdb5	0409-7338	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Hospira, Inc	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7338_2a8e54f3-90ea-4cd7-9d5d-663665a6ccee	0409-7338	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Hospira, Inc	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-7391_6c1b8eb9-c01e-4f9f-b12b-ccf64b5f5da1	0409-7391	HUMAN PRESCRIPTION DRUG	Sodium Phosphates		SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE and SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20050602		NDA	NDA018892	Hospira, Inc.	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	142; 276	mg/mL; mg/mL			N	20241231
0409-7418_a3f88ff2-6295-4943-add8-193a1a74de10	0409-7418	HUMAN PRESCRIPTION DRUG	LMD in Dextrose		DEXTRAN 40	INJECTION, SOLUTION	INTRAVENOUS	20060214		ANDA	BA720563	Hospira, Inc.	DEXTRAN 40	10	g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0409-7419_a3f88ff2-6295-4943-add8-193a1a74de10	0409-7419	HUMAN PRESCRIPTION DRUG	LMD in Sodium Chloride		DEXTRAN 40	INJECTION, SOLUTION	INTRAVENOUS	20050812		ANDA	BA720562	Hospira, Inc.	DEXTRAN 40	10	g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
0409-7517_fa05af43-a986-4206-aa80-62988b03c019	0409-7517	HUMAN PRESCRIPTION DRUG	Dextrose		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20051202		NDA	NDA019445	Hospira, Inc.	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
0409-7620_4d8d8c73-8f39-46e7-bc32-d1065a70522f	0409-7620	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20050331		NDA	NDA018916	Hospira, Inc.	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-7650_3cc352ef-503a-44bf-a0f0-c20400da885a	0409-7650	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20050630		NDA	NDA018916	Hospira, Inc.	HEPARIN SODIUM	10000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-7651_3cc352ef-503a-44bf-a0f0-c20400da885a	0409-7651	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20050621		NDA	NDA018916	Hospira, Inc.	HEPARIN SODIUM	5000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-7793_02f84fa1-2ffd-4ca8-8e64-3563f630d311	0409-7793	HUMAN PRESCRIPTION DRUG	Heparin Sodium and Dextrose		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20051025		NDA	NDA019339	Hospira, Inc.	HEPARIN SODIUM	10000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0409-7809_9465439f-8efd-4586-96dd-91cf4e63bb5f	0409-7809	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride in Dextrose		Dopamine Hydrochloride in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20050430		NDA	NDA018826	Hospira, Inc.	DOPAMINE HYDROCHLORIDE	1.6	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0409-7810_9465439f-8efd-4586-96dd-91cf4e63bb5f	0409-7810	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride in Dextrose		Dopamine Hydrochloride in Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20050808		NDA	NDA018826	Hospira, Inc.	DOPAMINE HYDROCHLORIDE	3.2	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0409-7811_a576d6bc-6490-413b-8101-75d44e951c2f	0409-7811	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	INJECTION, SOLUTION	INTRAVENOUS	20050907		NDA	NDA018890	Hospira, Inc.	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0409-7870_7211b3d4-f1cb-4d9f-87c3-5476c625782f	0409-7870	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20210628		NDA	NDA022234	Hospira, Inc.	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0409-7969_ba5cec1a-f5a4-44fb-be56-b5de27980c78	0409-7969	HUMAN PRESCRIPTION DRUG	Plegisol		POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, and MAGNESIUM CHLORIDE	INJECTION, SOLUTION	INTRA-ARTERIAL	20050728		NDA	NDA018608	Hospira, Inc.	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	17.6; 325.3; 119.3; 643	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0409-8126_8bed8b7f-9c71-40fb-9312-8e5e0ab6680f	0409-8126	HUMAN PRESCRIPTION DRUG	Marcaine with Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20220906		NDA	NDA016964	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .0091	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
0409-8183_28f98aef-8865-4faf-b491-a77b56513d5d	0409-8183	HUMAN PRESCRIPTION DRUG	Potassium Acetate		POTASSIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140327		NDA	NDA018896	Hospira, Inc.	POTASSIUM ACETATE	3.93	g/20mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-8183_bc52e608-540d-4a9a-9c38-7d7b3d926abd	0409-8183	HUMAN PRESCRIPTION DRUG	Potassium Acetate		POTASSIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050707		NDA	NDA018896	Hospira, Inc.	POTASSIUM ACETATE	3.93	g/20mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0409-8300_92d76052-3ebd-4ea7-b041-4ba649373c27	0409-8300	HUMAN PRESCRIPTION DRUG	Bivalirudin		BIVALIRUDIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150730		ANDA	ANDA090811	Hospira, Inc.	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0409-8300_cf21ebf8-98ae-4e4d-81d7-cd9886b438fa	0409-8300	HUMAN PRESCRIPTION DRUG	Bivalirudin		BIVALIRUDIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151005		ANDA	ANDA090816	Hospira, Inc.	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0409-9042_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-9042	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride and Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050615		ANDA	ANDA071165	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-9043_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-9043	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride and Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20051129		ANDA	ANDA071167	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-9045_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-9045	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride and Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20050518		ANDA	ANDA071168	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-9046_832b49a9-8fed-4b1b-bf60-c330520ef46a	0409-9046	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride and Epinephrine		BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE	INJECTION, SOLUTION	PERINEURAL	20050726		ANDA	ANDA071170	Hospira, Inc.	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0409-9093_0bf7127b-b5db-4cf8-a28f-a5fc530fa196	0409-9093	HUMAN PRESCRIPTION DRUG	FENTANYL CITRATE		fentanyl citrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20161206		NDA	NDA019115	Hospira, Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-9093_dd044413-7ca2-42d5-8d0d-781d2db4982c	0409-9093	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		FENTANYL CITRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051115		NDA	NDA019115	Hospira, Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-9094_dd044413-7ca2-42d5-8d0d-781d2db4982c	0409-9094	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		FENTANYL CITRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050927		NDA	NDA019115	Hospira, Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0409-9104_20d35934-b56f-4ce6-a897-fc25414f25aa	0409-9104	HUMAN PRESCRIPTION DRUG	DOPamine Hydrochloride		Dopamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050630		NDA	NDA018132	Hospira, Inc.	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0409-9137_3a6e4402-7b97-4d62-8239-16c2ff17009d	0409-9137	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050706		ANDA	ANDA040302	Hospira, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0409-9157_e809fff2-8dd2-4436-b31a-5b2890f86576	0409-9157	HUMAN PRESCRIPTION DRUG	Vitamin K1		PHYTONADIONE	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050622		ANDA	ANDA087954	Hospira, Inc.	PHYTONADIONE	2	mg/mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
0409-9158_e809fff2-8dd2-4436-b31a-5b2890f86576	0409-9158	HUMAN PRESCRIPTION DRUG	Vitamin K1		PHYTONADIONE	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050727		ANDA	ANDA087955	Hospira, Inc.	PHYTONADIONE	10	mg/mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
0409-9300_f5cd7992-66a9-410a-a486-110cd85228a2	0409-9300	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20141107		ANDA	ANDA090194	Hospira, Inc.	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-9301_f5cd7992-66a9-410a-a486-110cd85228a2	0409-9301	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20140923		ANDA	ANDA090194	Hospira, Inc.	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-9302_f5cd7992-66a9-410a-a486-110cd85228a2	0409-9302	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; PERINEURAL	20140923		ANDA	ANDA090194	Hospira, Inc.	ROPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-9303_f5cd7992-66a9-410a-a486-110cd85228a2	0409-9303	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL	20140923		ANDA	ANDA090194	Hospira, Inc.	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
0409-9558_0070ffe7-60d3-4940-8b9a-57ae692d9440	0409-9558	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20081215		ANDA	ANDA078519	Hospira, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-9558_da526c7d-a72b-4a7b-ae0a-3231245b211a	0409-9558	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION, SOLUTION	INTRAVENOUS	20081201		ANDA	ANDA078519	Hospira, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0409-9566_30250d5e-0271-45fb-abbf-3addf8dcdb53	0409-9566	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200824		ANDA	ANDA065441	Hospira, Inc.	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0409-9630_77d2cecb-001f-4b7b-b8ee-94c8b6d89be5	0409-9630	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20041231		NDA	NDA021146	Hospira, Inc.	ATROPINE SULFATE	.05	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0409-9633_1975dcaa-94b4-4af2-b95d-41463e1db00c	0409-9633	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20051202		ANDA	ANDA075136	Hospira, Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0409-9735_30250d5e-0271-45fb-abbf-3addf8dcdb53	0409-9735	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20200824		ANDA	ANDA065441	Hospira, Inc.	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0430-0420_9d46a77b-7a76-4e8c-baac-2b12fc535dfd	0430-0420	HUMAN PRESCRIPTION DRUG	Lo Loestrin Fe		norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate	KIT		20101201		NDA	NDA022501	Allergan, Inc.						N	20241231
0430-0472_7d8b4cf5-8395-4a5e-8def-feaaf742fb21	0430-0472	HUMAN PRESCRIPTION DRUG	Actonel		Risedronate Sodium	TABLET, FILM COATED	ORAL	20020517		NDA	NDA020835	Allergan, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE	30.1; 4.9	mg/1; mg/1	Bisphosphonate [EPC], Bisphosphonate [EPC], Diphosphonates [CS], Diphosphonates [CS]		N	20241231
0430-0478_7d8b4cf5-8395-4a5e-8def-feaaf742fb21	0430-0478	HUMAN PRESCRIPTION DRUG	Actonel		Risedronate Sodium	TABLET, FILM COATED	ORAL	20080422		NDA	NDA020835	Allergan, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE	129; 21	mg/1; mg/1	Bisphosphonate [EPC], Bisphosphonate [EPC], Diphosphonates [CS], Diphosphonates [CS]		N	20241231
0430-0540_650af72a-ce4e-4f7f-8a8a-e122818f6eb5	0430-0540	HUMAN PRESCRIPTION DRUG	Minastrin 24 Fe		norethindrone acetate and ethinyl estradiol and ferrous fumarate	KIT		20130614		NDA	NDA203667	Allergan, Inc.						N	20241231
0430-0720_7d28252e-6605-4939-8d94-b2287d66fd98	0430-0720	HUMAN PRESCRIPTION DRUG	Estrace		Estradiol	TABLET	ORAL	20111226		ANDA	ANDA040197	Allergan, Inc.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0430-0721_7d28252e-6605-4939-8d94-b2287d66fd98	0430-0721	HUMAN PRESCRIPTION DRUG	Estrace		Estradiol	TABLET	ORAL	20111226		ANDA	ANDA040197	Allergan, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0430-0722_7d28252e-6605-4939-8d94-b2287d66fd98	0430-0722	HUMAN PRESCRIPTION DRUG	Estrace		Estradiol	TABLET	ORAL	20111226		ANDA	ANDA040197	Allergan, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0430-0979_b02fe687-a8b8-43c1-84d3-b9a35f6b0043	0430-0979	HUMAN PRESCRIPTION DRUG	Atelvia		risedronate sodium	TABLET, DELAYED RELEASE	ORAL	20101201		NDA	NDA022560	Allergan, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE	30.1; 4.9	mg/1; mg/1	Bisphosphonate [EPC], Bisphosphonate [EPC], Diphosphonates [CS], Diphosphonates [CS]		N	20241231
0430-3754_969d7e63-8266-4e46-b572-69170fee8f94	0430-3754	HUMAN PRESCRIPTION DRUG	ESTRACE		estradiol	CREAM	VAGINAL	20010701		ANDA	ANDA086069	Allergan, Inc.	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0456-0400_4b8d8d5d-fb56-4c99-8d55-6c6c6cbbd88b	0456-0400	HUMAN PRESCRIPTION DRUG	Teflaro		ceftaroline fosamil	POWDER, FOR SOLUTION	INTRAVENOUS	20101029		NDA	NDA200327	Allergan, Inc.	CEFTAROLINE FOSAMIL	400	mg/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0456-0457_60b71cb9-842c-4241-9c6e-af222923d505	0456-0457	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	15	mg/1			N	20241231
0456-0458_60b71cb9-842c-4241-9c6e-af222923d505	0456-0458	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	30	mg/1			N	20241231
0456-0459_60b71cb9-842c-4241-9c6e-af222923d505	0456-0459	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	60	mg/1			N	20241231
0456-0460_60b71cb9-842c-4241-9c6e-af222923d505	0456-0460	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	90	mg/1			N	20241231
0456-0461_60b71cb9-842c-4241-9c6e-af222923d505	0456-0461	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	120	mg/1			N	20241231
0456-0462_60b71cb9-842c-4241-9c6e-af222923d505	0456-0462	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	180	mg/1			N	20241231
0456-0463_60b71cb9-842c-4241-9c6e-af222923d505	0456-0463	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	240	mg/1			N	20241231
0456-0464_60b71cb9-842c-4241-9c6e-af222923d505	0456-0464	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Allergan, Inc.	SUS SCROFA THYROID	300	mg/1			N	20241231
0456-0600_4b8d8d5d-fb56-4c99-8d55-6c6c6cbbd88b	0456-0600	HUMAN PRESCRIPTION DRUG	Teflaro		ceftaroline fosamil	POWDER, FOR SOLUTION	INTRAVENOUS	20101029		NDA	NDA200327	Allergan, Inc.	CEFTAROLINE FOSAMIL	600	mg/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0456-1110_fb184b54-bc19-4f4f-bfa8-936cf79dd79f	0456-1110	HUMAN PRESCRIPTION DRUG	VIIBRYD		vilazodone hydrochloride	TABLET	ORAL	20110429		NDA	NDA022567	Allergan, Inc.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
0456-1120_fb184b54-bc19-4f4f-bfa8-936cf79dd79f	0456-1120	HUMAN PRESCRIPTION DRUG	VIIBRYD		vilazodone hydrochloride	TABLET	ORAL	20110429		NDA	NDA022567	Allergan, Inc.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
0456-1140_fb184b54-bc19-4f4f-bfa8-936cf79dd79f	0456-1140	HUMAN PRESCRIPTION DRUG	VIIBRYD		vilazodone hydrochloride	TABLET	ORAL	20110429		NDA	NDA022567	Allergan, Inc.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
0456-1201_e471953e-5cf7-45b5-ae6f-e6e8a75087ea	0456-1201	HUMAN PRESCRIPTION DRUG	Linzess		linaclotide	CAPSULE, GELATIN COATED	ORAL	20120908		NDA	NDA202811	Allergan, Inc.	LINACLOTIDE	145	ug/1	Guanylate Cyclase Activators [MoA], Guanylate Cyclase-C Agonist [EPC]		N	20241231
0456-1202_e471953e-5cf7-45b5-ae6f-e6e8a75087ea	0456-1202	HUMAN PRESCRIPTION DRUG	Linzess		linaclotide	CAPSULE, GELATIN COATED	ORAL	20120908		NDA	NDA202811	Allergan, Inc.	LINACLOTIDE	290	ug/1	Guanylate Cyclase Activators [MoA], Guanylate Cyclase-C Agonist [EPC]		N	20241231
0456-1203_e471953e-5cf7-45b5-ae6f-e6e8a75087ea	0456-1203	HUMAN PRESCRIPTION DRUG	Linzess		linaclotide	CAPSULE, GELATIN COATED	ORAL	20170130		NDA	NDA202811	Allergan, Inc.	LINACLOTIDE	72	ug/1	Guanylate Cyclase Activators [MoA], Guanylate Cyclase-C Agonist [EPC]		N	20241231
0456-1207_0b0a604f-041e-43f0-98ad-566f1dcb13df	0456-1207	HUMAN PRESCRIPTION DRUG	Namzaric		memantine hydrochloride and donepezil hydrochloride	CAPSULE	ORAL	20160718		NDA	NDA206439	Allergan, Inc.	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 7	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-1214_0b0a604f-041e-43f0-98ad-566f1dcb13df	0456-1214	HUMAN PRESCRIPTION DRUG	Namzaric		memantine hydrochloride and donepezil hydrochloride	CAPSULE	ORAL	20141224		NDA	NDA206439	Allergan, Inc.	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 14	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-1221_0b0a604f-041e-43f0-98ad-566f1dcb13df	0456-1221	HUMAN PRESCRIPTION DRUG	Namzaric		memantine hydrochloride and donepezil hydrochloride	CAPSULE	ORAL	20160718		NDA	NDA206439	Allergan, Inc.	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 21	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-1228_0b0a604f-041e-43f0-98ad-566f1dcb13df	0456-1228	HUMAN PRESCRIPTION DRUG	Namzaric		memantine hydrochloride and donepezil hydrochloride	CAPSULE	ORAL	20141224		NDA	NDA206439	Allergan, Inc.	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 28	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-1229_0b0a604f-041e-43f0-98ad-566f1dcb13df	0456-1229	HUMAN PRESCRIPTION DRUG	Namzaric		memantine hydrochloride and donepezil hydrochloride	KIT	ORAL	20161128		NDA	NDA206439	Allergan, Inc.						N	20241231
0456-1402_fc045f7d-469a-4504-9bdc-3a836349b684	0456-1402	HUMAN PRESCRIPTION DRUG	Bystolic		nebivolol hydrochloride	TABLET	ORAL	20080122		NDA	NDA021742	Allergan, Inc.	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0456-1405_fc045f7d-469a-4504-9bdc-3a836349b684	0456-1405	HUMAN PRESCRIPTION DRUG	Bystolic		nebivolol hydrochloride	TABLET	ORAL	20080122		NDA	NDA021742	Allergan, Inc.	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0456-1410_fc045f7d-469a-4504-9bdc-3a836349b684	0456-1410	HUMAN PRESCRIPTION DRUG	Bystolic		nebivolol hydrochloride	TABLET	ORAL	20080122		NDA	NDA021742	Allergan, Inc.	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0456-1420_fc045f7d-469a-4504-9bdc-3a836349b684	0456-1420	HUMAN PRESCRIPTION DRUG	Bystolic		nebivolol hydrochloride	TABLET	ORAL	20080122		NDA	NDA021742	Allergan, Inc.	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0456-1500_997e5533-a689-48d2-83ff-46ad62ffee61	0456-1500	HUMAN PRESCRIPTION DRUG	Savella		milnacipran hydrochloride	KIT	ORAL	20090417		NDA	NDA022256	Allergan, Inc.						N	20241231
0456-1510_997e5533-a689-48d2-83ff-46ad62ffee61	0456-1510	HUMAN PRESCRIPTION DRUG	Savella		milnacipran hydrochloride	TABLET, FILM COATED	ORAL	20090417		NDA	NDA022256	Allergan, Inc.	MILNACIPRAN HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-1512_997e5533-a689-48d2-83ff-46ad62ffee61	0456-1512	HUMAN PRESCRIPTION DRUG	Savella		milnacipran hydrochloride	TABLET, FILM COATED	ORAL	20090417		NDA	NDA022256	Allergan, Inc.	MILNACIPRAN HYDROCHLORIDE	12.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-1525_997e5533-a689-48d2-83ff-46ad62ffee61	0456-1525	HUMAN PRESCRIPTION DRUG	Savella		milnacipran hydrochloride	TABLET, FILM COATED	ORAL	20090417		NDA	NDA022256	Allergan, Inc.	MILNACIPRAN HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-1550_997e5533-a689-48d2-83ff-46ad62ffee61	0456-1550	HUMAN PRESCRIPTION DRUG	Savella		milnacipran hydrochloride	TABLET, FILM COATED	ORAL	20090417		NDA	NDA022256	Allergan, Inc.	MILNACIPRAN HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-2005_4bf626c4-fe19-41f1-8928-effced9f8003	0456-2005	HUMAN PRESCRIPTION DRUG	Lexapro		ESCITALOPRAM	TABLET, FILM COATED	ORAL	20020814		NDA	NDA021323	Allergan, Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0456-2010_4bf626c4-fe19-41f1-8928-effced9f8003	0456-2010	HUMAN PRESCRIPTION DRUG	Lexapro		ESCITALOPRAM	TABLET, FILM COATED	ORAL	20020814		NDA	NDA021323	Allergan, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0456-2020_4bf626c4-fe19-41f1-8928-effced9f8003	0456-2020	HUMAN PRESCRIPTION DRUG	Lexapro		ESCITALOPRAM	TABLET, FILM COATED	ORAL	20020814		NDA	NDA021323	Allergan, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0456-2200_7b3b300a-81f4-4b72-ad88-71e95d182456	0456-2200	HUMAN PRESCRIPTION DRUG	Fetzima		LEVOMILNACIPRAN HYDROCHLORIDE	KIT	ORAL	20230324		NDA	NDA204168	Allergan, Inc.						N	20241231
0456-2202_7b3b300a-81f4-4b72-ad88-71e95d182456	0456-2202	HUMAN PRESCRIPTION DRUG	Fetzima		LEVOMILNACIPRAN HYDROCHLORIDE	KIT	ORAL	20130725		NDA	NDA204168	Allergan, Inc.						N	20241231
0456-2212_7b3b300a-81f4-4b72-ad88-71e95d182456	0456-2212	HUMAN PRESCRIPTION DRUG	Fetzima		LEVOMILNACIPRAN HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20130725		NDA	NDA204168	Allergan, Inc.	LEVOMILNACIPRAN HYDROCHLORIDE	120	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-2220_7b3b300a-81f4-4b72-ad88-71e95d182456	0456-2220	HUMAN PRESCRIPTION DRUG	Fetzima		LEVOMILNACIPRAN HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20130725		NDA	NDA204168	Allergan, Inc.	LEVOMILNACIPRAN HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-2240_7b3b300a-81f4-4b72-ad88-71e95d182456	0456-2240	HUMAN PRESCRIPTION DRUG	Fetzima		LEVOMILNACIPRAN HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20130725		NDA	NDA204168	Allergan, Inc.	LEVOMILNACIPRAN HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-2280_7b3b300a-81f4-4b72-ad88-71e95d182456	0456-2280	HUMAN PRESCRIPTION DRUG	Fetzima		LEVOMILNACIPRAN HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20130725		NDA	NDA204168	Allergan, Inc.	LEVOMILNACIPRAN HYDROCHLORIDE	80	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0456-2402_251a0ca6-0449-472c-871c-2c3f3be60d92	0456-2402	HUMAN PRESCRIPTION DRUG	SAPHRIS		Asenapine Maleate	TABLET	SUBLINGUAL	20141230		NDA	NDA022117	Allergan, Inc.	ASENAPINE MALEATE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0456-2405_251a0ca6-0449-472c-871c-2c3f3be60d92	0456-2405	HUMAN PRESCRIPTION DRUG	SAPHRIS		Asenapine Maleate	TABLET	SUBLINGUAL	20130930		NDA	NDA022117	Allergan, Inc.	ASENAPINE MALEATE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0456-2410_251a0ca6-0449-472c-871c-2c3f3be60d92	0456-2410	HUMAN PRESCRIPTION DRUG	SAPHRIS		Asenapine Maleate	TABLET	SUBLINGUAL	20130930		NDA	NDA022117	Allergan, Inc.	ASENAPINE MALEATE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0456-2700_3873fe44-7870-4d3e-9a4f-e94b402d7762	0456-2700	HUMAN PRESCRIPTION DRUG	AVYCAZ		ceftazidime, avibactam	POWDER, FOR SOLUTION	INTRAVENOUS	20141226		NDA	NDA206494	Allergan, Inc.	AVIBACTAM SODIUM; CEFTAZIDIME	.5; 2	g/1; g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0456-3200_8bb8ac09-8fd2-4cb6-bad0-bc4f9b48a708	0456-3200	HUMAN PRESCRIPTION DRUG	Namenda		Memantine Hydrochloride	KIT	ORAL	20031016		NDA	NDA021487	Allergan, Inc.						N	20241231
0456-3205_8bb8ac09-8fd2-4cb6-bad0-bc4f9b48a708	0456-3205	HUMAN PRESCRIPTION DRUG	Namenda		memantine hydrochloride	TABLET	ORAL	20031016		NDA	NDA021487	Allergan, Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-3210_8bb8ac09-8fd2-4cb6-bad0-bc4f9b48a708	0456-3210	HUMAN PRESCRIPTION DRUG	Namenda		memantine hydrochloride	TABLET	ORAL	20031016		NDA	NDA021487	Allergan, Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-3414_ba05f457-602d-4eff-8897-0358c50202d2	0456-3414	HUMAN PRESCRIPTION DRUG	Namenda	XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		NDA	NDA022525	Allergan, Inc.	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-3421_ba05f457-602d-4eff-8897-0358c50202d2	0456-3421	HUMAN PRESCRIPTION DRUG	Namenda	XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		NDA	NDA022525	Allergan, Inc.	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-3428_ba05f457-602d-4eff-8897-0358c50202d2	0456-3428	HUMAN PRESCRIPTION DRUG	Namenda	XR	memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		NDA	NDA022525	Allergan, Inc.	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0456-4010_a6e5794d-438d-4fb9-8303-6a57d7b64da6	0456-4010	HUMAN PRESCRIPTION DRUG	Celexa		citalopram	TABLET, FILM COATED	ORAL	19980717		NDA	NDA020822	Allergan, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0456-4020_a6e5794d-438d-4fb9-8303-6a57d7b64da6	0456-4020	HUMAN PRESCRIPTION DRUG	Celexa		citalopram	TABLET, FILM COATED	ORAL	19980717		NDA	NDA020822	Allergan, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0456-4040_a6e5794d-438d-4fb9-8303-6a57d7b64da6	0456-4040	HUMAN PRESCRIPTION DRUG	Celexa		citalopram	TABLET, FILM COATED	ORAL	19980717		NDA	NDA020822	Allergan, Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0469-0125_bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb	0469-0125	HUMAN PRESCRIPTION DRUG	Xtandi		enzalutamide	CAPSULE	ORAL	20120831		NDA	NDA203415	Astellas Pharma US, Inc.	ENZALUTAMIDE	40	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]		N	20241231
0469-0420_a91d60a8-2fa7-4f5c-b10b-852309428863	0469-0420	HUMAN PRESCRIPTION DRUG	CRESEMBA		isavuconazonium sulfate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150306		NDA	NDA207501	Astellas Pharma US, Inc.	ISAVUCONAZONIUM SULFATE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0469-0520_a91d60a8-2fa7-4f5c-b10b-852309428863	0469-0520	HUMAN PRESCRIPTION DRUG	CRESEMBA		isavuconazonium sulfate	CAPSULE	ORAL	20151104		NDA	NDA207500	Astellas Pharma US, Inc.	ISAVUCONAZONIUM SULFATE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0469-0607_32e10bd8-7464-4967-bdc5-1a5ee660bfb3	0469-0607	HUMAN PRESCRIPTION DRUG	Prograf		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	19980824		NDA	NDA050708	Astellas Pharma US, Inc.	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-0617_32e10bd8-7464-4967-bdc5-1a5ee660bfb3	0469-0617	HUMAN PRESCRIPTION DRUG	Prograf		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	19940408		NDA	NDA050708	Astellas Pharma US, Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-0625_bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb	0469-0625	HUMAN PRESCRIPTION DRUG	Xtandi		enzalutamide	TABLET	ORAL	20200804		NDA	NDA213674	Astellas Pharma US, Inc.	ENZALUTAMIDE	40	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]		N	20241231
0469-0647_15be9383-263f-4080-bda4-2ab0bdfbf239	0469-0647	HUMAN PRESCRIPTION DRUG	ASTAGRAF XL		tacrolimus extended-release capsules	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20130719		NDA	NDA204096	Astellas Pharma US, Inc.	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-0657_32e10bd8-7464-4967-bdc5-1a5ee660bfb3	0469-0657	HUMAN PRESCRIPTION DRUG	Prograf		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	19940408		NDA	NDA050708	Astellas Pharma US, Inc.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-0677_15be9383-263f-4080-bda4-2ab0bdfbf239	0469-0677	HUMAN PRESCRIPTION DRUG	ASTAGRAF XL		tacrolimus extended-release capsules	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20130719		NDA	NDA204096	Astellas Pharma US, Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-0687_15be9383-263f-4080-bda4-2ab0bdfbf239	0469-0687	HUMAN PRESCRIPTION DRUG	ASTAGRAF XL		tacrolimus extended-release capsules	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20130719		NDA	NDA204096	Astellas Pharma US, Inc.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-0725_bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb	0469-0725	HUMAN PRESCRIPTION DRUG	Xtandi		enzalutamide	TABLET	ORAL	20200804		NDA	NDA213674	Astellas Pharma US, Inc.	ENZALUTAMIDE	80	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]		N	20241231
0469-1125_bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb	0469-1125	HUMAN PRESCRIPTION DRUG	Xtandi		enzalutamide	CAPSULE	ORAL	20120831		NDA	NDA203415	Astellas Pharma US, Inc.	ENZALUTAMIDE	40	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]		N	20241231
0469-1230_32e10bd8-7464-4967-bdc5-1a5ee660bfb3	0469-1230	HUMAN PRESCRIPTION DRUG	Prograf		Tacrolimus	GRANULE, FOR SUSPENSION	ORAL	20180524		NDA	NDA210115	Astellas Pharma US, Inc.	TACROLIMUS	.2	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-1330_32e10bd8-7464-4967-bdc5-1a5ee660bfb3	0469-1330	HUMAN PRESCRIPTION DRUG	Prograf		Tacrolimus	GRANULE, FOR SUSPENSION	ORAL	20180524		NDA	NDA210115	Astellas Pharma US, Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-1425_92b78198-99b0-4895-aa24-ce776f9c5842	0469-1425	HUMAN PRESCRIPTION DRUG	Xospata		gilteritinib	TABLET	ORAL	20181129		NDA	NDA211349	Astellas Pharma US, Inc.	GILTERITINIB FUMARATE	40	mg/1			N	20241231
0469-1725_bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb	0469-1725	HUMAN PRESCRIPTION DRUG	Xtandi		enzalutamide	TABLET	ORAL	20200804		NDA	NDA213674	Astellas Pharma US, Inc.	ENZALUTAMIDE	40	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA]		N	20241231
0469-2460_dd7b6095-12cc-43e0-be7f-b53a0a0794f3	0469-2460	HUMAN PRESCRIPTION DRUG	VEOZAH		fezolinetant	TABLET, FILM COATED	ORAL	20230516		NDA	NDA216578	Astellas Pharma US, Inc.	FEZOLINETANT	45	mg/1			N	20241231
0469-2601_fc13cf38-3baf-44e6-8cfb-d55cc769ee29	0469-2601	HUMAN PRESCRIPTION DRUG	Myrbetriq		mirabegron	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120628		NDA	NDA202611	Astellas Pharma US, Inc.	MIRABEGRON	25	mg/1	Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]		N	20241231
0469-2602_fc13cf38-3baf-44e6-8cfb-d55cc769ee29	0469-2602	HUMAN PRESCRIPTION DRUG	Myrbetriq		mirabegron	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120628		NDA	NDA202611	Astellas Pharma US, Inc.	MIRABEGRON	50	mg/1	Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]		N	20241231
0469-2660_dd7b6095-12cc-43e0-be7f-b53a0a0794f3	0469-2660	HUMAN PRESCRIPTION DRUG	VEOZAH		fezolinetant	TABLET, FILM COATED	ORAL	20230512		NDA	NDA216578	Astellas Pharma US, Inc.	FEZOLINETANT	45	mg/1			N	20241231
0469-2760_dd7b6095-12cc-43e0-be7f-b53a0a0794f3	0469-2760	HUMAN PRESCRIPTION DRUG	VEOZAH		fezolinetant	TABLET, FILM COATED	ORAL	20230512		NDA	NDA216578	Astellas Pharma US, Inc.	FEZOLINETANT	45	mg/1			N	20241231
0469-2860_a91d60a8-2fa7-4f5c-b10b-852309428863	0469-2860	HUMAN PRESCRIPTION DRUG	CRESEMBA		isavuconazonium sulfate	CAPSULE	ORAL	20221122		NDA	NDA207500	Astellas Pharma US, Inc.	ISAVUCONAZONIUM SULFATE	40	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0469-3016_32e10bd8-7464-4967-bdc5-1a5ee660bfb3	0469-3016	HUMAN PRESCRIPTION DRUG	Prograf		Tacrolimus	INJECTION, SOLUTION	INTRAVENOUS	19940408		NDA	NDA050709	Astellas Pharma US, Inc.	TACROLIMUS	5	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0469-3051_26d0ac07-3801-4595-86e6-f14f1435b82f	0469-3051	HUMAN PRESCRIPTION DRUG	AmBisome		amphotericin B	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19970811		NDA	NDA050740	Astellas Pharma US, Inc.	AMPHOTERICIN B	50	mg/12.5mL	Lipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0469-3211_de0abc7f-313f-4bf5-a3b8-d0d142711ca1	0469-3211	HUMAN PRESCRIPTION DRUG	Mycamine		Micafungin sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060627		NDA	NDA021506	Astellas Pharma US, Inc.	MICAFUNGIN SODIUM	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0469-3250_de0abc7f-313f-4bf5-a3b8-d0d142711ca1	0469-3250	HUMAN PRESCRIPTION DRUG	Mycamine		Micafungin sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20050316		NDA	NDA021506	Astellas Pharma US, Inc.	MICAFUNGIN SODIUM	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0469-5020_fc13cf38-3baf-44e6-8cfb-d55cc769ee29	0469-5020	HUMAN PRESCRIPTION DRUG	Myrbetriq		mirabegron	GRANULE, FOR SUSPENSION, EXTENDED RELEASE	ORAL	20210325		NDA	NDA213801	Astellas Pharma US, Inc.	MIRABEGRON	8	mg/mL	Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]		N	20241231
0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10	0469-6501	HUMAN PRESCRIPTION DRUG	LEXISCAN		regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20080410		NDA	NDA022161	Astellas Pharma US, Inc.	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
0472-0013_53b365ad-ba82-485e-a1bb-aa604d0f3af7	0472-0013	HUMAN PRESCRIPTION DRUG	Griseofulvin		Griseofulvin	SUSPENSION	ORAL	20070726		ANDA	ANDA065394	Actavis Pharma, Inc.	GRISEOFULVIN	125	mg/5mL	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0472-0082_e5856f1b-d203-436d-91bb-9f22f2965cab	0472-0082	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	SUSPENSION	ORAL	20020903		ANDA	ANDA074738	Actavis Pharma, Inc.	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0472-0117_6fbd891b-df67-43b7-b500-8662e047a86d	0472-0117	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CREAM	TOPICAL	19980420		NDA AUTHORIZED GENERIC	NDA020404	Actavis Pharma, Inc.	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0472-0126_67f45522-41a2-42a3-a09e-6c2d9b247f87	0472-0126	HUMAN PRESCRIPTION DRUG	adapalene		adapalene	GEL	TOPICAL	20141027		ANDA	ANDA201000	Actavis Pharma, Inc.	ADAPALENE	3	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0472-0166_d16825d2-4dc4-4237-a7d3-42db8766cf1a	0472-0166	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20020903		ANDA	ANDA062840	Actavis Pharma, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0472-0235_bf019c51-1a31-4d54-8a3d-d9c57697ac3c	0472-0235	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20090115		ANDA	ANDA078976	Actavis Pharma, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0472-0242_0e6e649c-112a-4a7e-acc3-f7ca477f8aa7	0472-0242	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin	CREAM	TOPICAL	20041130		ANDA	ANDA074806	Actavis Pharma, Inc.	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
0472-0321_d74b9b48-0a47-43d1-a89a-f294c4ca1297	0472-0321	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20020103		ANDA	ANDA087795	Actavis Pharma, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0337_527a8d09-450b-4b8e-ad19-78fbba9732c5	0472-0337	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20020930		ANDA	ANDA089682	Actavis Pharma, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0370_af0fcb94-9e3b-4b1f-8229-060508617b20	0472-0370	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	19970901		ANDA	ANDA070050	Actavis Pharma, Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0371_af0fcb94-9e3b-4b1f-8229-060508617b20	0472-0371	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	OINTMENT	TOPICAL	19971001		ANDA	ANDA070051	Actavis Pharma, Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0379_2ec9b37c-e1fe-46d3-addd-4eba66eb14bd	0472-0379	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20031216		ANDA	ANDA076002	Actavis Pharma, Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0380_cc47e18b-f404-4d43-9ec8-2e3644fbea82	0472-0380	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20020903		ANDA	ANDA070885	Actavis Pharma, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0381_e8e8285a-02b1-4e44-baf1-459545f7a631	0472-0381	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	OINTMENT	TOPICAL	19970201		ANDA	ANDA071012	Actavis Pharma, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0382_2f2016cb-8b63-40ef-ad6d-4850179ec8cd	0472-0382	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	OINTMENT, AUGMENTED	TOPICAL	19950901		ANDA	ANDA074304	Actavis Pharma, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0403_69a83d92-46be-4387-9d1c-f36e640f56ff	0472-0403	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SHAMPOO	TOPICAL	20120103		ANDA	ANDA078854	Actavis Pharma, Inc.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0404_7dc00a2f-fcdd-46e8-b0f1-c2a050f81e8a	0472-0404	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	LOTION	TOPICAL	20120102		ANDA	ANDA078223	Actavis Pharma, Inc.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0478_9835ac91-ee1c-48e3-b1c4-518a920a51a9	0472-0478	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20160331		ANDA	ANDA205082	Actavis Pharma, Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0479_80ac8db4-cda6-4495-a31b-eb4ae0e578c7	0472-0479	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20161121		ANDA	ANDA204965	Actavis Pharma, Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0803_8d3633e6-80d9-4779-862a-b608180e202a	0472-0803	HUMAN PRESCRIPTION DRUG	Desonide		desonide	LOTION	TOPICAL	20090528		ANDA	ANDA072354	Actavis Pharma, Inc.	DESONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0804_8d3633e6-80d9-4779-862a-b608180e202a	0472-0804	HUMAN PRESCRIPTION DRUG	Desonide		desonide	CREAM	TOPICAL	20130801		NDA AUTHORIZED GENERIC	NDA019048	Actavis Pharma, Inc.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0472-0825_d129e8b6-6957-7b79-e053-2995a90a94e2	0472-0825	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SYRUP	ORAL	20160219		ANDA	ANDA074454	Actavis Pharma, Inc.	ALBUTEROL SULFATE	2	mg/5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0472-1030_13833a04-8f2d-4ac7-bc72-b661457fec56	0472-1030	HUMAN PRESCRIPTION DRUG	Hydromet		hydrocodone bitartrate and homatropine methylbromide	SOLUTION	ORAL	20020930		ANDA	ANDA088017	Actavis Pharma, Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0472-1738_bb1aad58-4ca7-4be9-8649-0f29e22b81f5	0472-1738	HUMAN PRESCRIPTION DRUG	Miconazole Nitrate		Miconazole Nitrate	SUPPOSITORY	VAGINAL	19950118		ANDA	ANDA073508	Actavis Pharma, Inc.	MICONAZOLE NITRATE	200	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0472-1783_49ccabb7-2501-49e5-8683-ef71f98b0c67	0472-1783	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20160519		ANDA	ANDA206493	Actavis Pharma, Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0472-1790_1096af81-44dd-40fd-8f12-7bcc1d43ba54	0472-1790	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Tretinoin		Clindamycin Phosphate and Tretinoin	GEL	TOPICAL	20160705		ANDA	ANDA202564	Actavis Pharma, Inc.	CLINDAMYCIN PHOSPHATE; TRETINOIN	12; .25	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Retinoid [EPC], Retinoids [CS]		N	20241231
0472-1915_8cc40b3e-ebb9-4c3d-96cb-a8cb1aa95b18	0472-1915	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUPPOSITORY	RECTAL	20210423		ANDA	ANDA205654	Actavis Pharma, Inc.	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0472-1992_daa2705a-a5a4-407a-9333-8693d3afe00b	0472-1992	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20161007		ANDA	ANDA205180	Actavis Pharma, Inc.	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
0472-2002_1770ba2a-d7df-4237-adc7-ba1226e702ff	0472-2002	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20180716		ANDA	ANDA074978	Actavis Pharma, Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0480-0083_08f6fedf-b483-4bfd-b768-b95e3c54bc7f	0480-0083	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20221001		ANDA	ANDA076846	Teva Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0480-0126_a1df4757-8d08-49a7-ac6a-f4cc9cf8f481	0480-0126	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE, LIQUID FILLED	ORAL	20220909		ANDA	ANDA209525	Teva Pharmaceuticals, Inc.	ICOSAPENT ETHYL	500	mg/1			N	20241231
0480-0127_a1df4757-8d08-49a7-ac6a-f4cc9cf8f481	0480-0127	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE, LIQUID FILLED	ORAL	20221215		ANDA	ANDA209525	Teva Pharmaceuticals, Inc.	ICOSAPENT ETHYL	1	g/1			N	20241231
0480-0951_7bb36843-17db-4442-a31f-9a2637d3e85f	0480-0951	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		naproxen sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221101		ANDA	ANDA075416	Teva Pharmaceuticals, Inc.	NAPROXEN SODIUM	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0480-0952_7bb36843-17db-4442-a31f-9a2637d3e85f	0480-0952	HUMAN PRESCRIPTION DRUG	Naproxen sodium		naproxen sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221101		ANDA	ANDA075416	Teva Pharmaceuticals, Inc.	NAPROXEN SODIUM	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0480-0953_7bb36843-17db-4442-a31f-9a2637d3e85f	0480-0953	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		naproxen sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221101		ANDA	ANDA075416	Teva Pharmaceuticals, Inc.	NAPROXEN SODIUM	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0480-1175_20a5af71-3262-40b1-91a5-3d87ace1978f	0480-1175	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	POWDER, FOR SUSPENSION	ORAL	20220602		ANDA	ANDA211272	Teva Pharmaceuticals, Inc.	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
0480-1232_044b1827-cfa0-4a2f-9e69-cac15ad6163c	0480-1232	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	KIT		20231211		ANDA	ANDA214068	Teva Pharmaceuticals, Inc.						N	20241231
0480-1241_96d22409-3421-421e-93cd-6ba3d29e796d	0480-1241	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230308		ANDA	ANDA201452	Teva Pharmaceuticals, Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
0480-1242_4bad502a-b6a5-4513-8f15-bc05df94cce3	0480-1242	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220303		ANDA	ANDA201452	Teva Pharmaceuticals, Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
0480-1243_4bad502a-b6a5-4513-8f15-bc05df94cce3	0480-1243	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220303		ANDA	ANDA201452	Teva Pharmaceuticals, Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
0480-1244_4bad502a-b6a5-4513-8f15-bc05df94cce3	0480-1244	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220303		ANDA	ANDA201452	Teva Pharmaceuticals, Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
0480-1245_96d22409-3421-421e-93cd-6ba3d29e796d	0480-1245	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230308		ANDA	ANDA201452	Teva Pharmaceuticals, Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
0480-1246_4bad502a-b6a5-4513-8f15-bc05df94cce3	0480-1246	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220303		ANDA	ANDA201452	Teva Pharmaceuticals, Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
0480-1342_044b1827-cfa0-4a2f-9e69-cac15ad6163c	0480-1342	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	KIT		20231211		ANDA	ANDA214068	Teva Pharmaceuticals, Inc.						N	20241231
0480-1453_044b1827-cfa0-4a2f-9e69-cac15ad6163c	0480-1453	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	KIT		20231211		ANDA	ANDA214068	Teva Pharmaceuticals, Inc.						N	20241231
0480-1554_044b1827-cfa0-4a2f-9e69-cac15ad6163c	0480-1554	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	KIT		20231211		ANDA	ANDA214068	Teva Pharmaceuticals, Inc.						N	20241231
0480-2043_6980ccc8-3944-4470-a9b7-f55afb144224	0480-2043	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA208212	Teva Pharmaceuticals, Inc.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
0480-2044_6980ccc8-3944-4470-a9b7-f55afb144224	0480-2044	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA208212	Teva Pharmaceuticals, Inc.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
0480-2045_6980ccc8-3944-4470-a9b7-f55afb144224	0480-2045	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA208212	Teva Pharmaceuticals, Inc.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
0480-2356_ac4bb36b-9980-4e39-b938-9370fe21c781	0480-2356	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230503		ANDA	ANDA206210	Teva Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0480-2357_ac4bb36b-9980-4e39-b938-9370fe21c781	0480-2357	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230503		ANDA	ANDA206210	Teva Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0480-2358_ac4bb36b-9980-4e39-b938-9370fe21c781	0480-2358	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230503		ANDA	ANDA206210	Teva Pharmaceuticals, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0480-2359_ac4bb36b-9980-4e39-b938-9370fe21c781	0480-2359	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230331		ANDA	ANDA206210	Teva Pharmaceuticals, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0480-3154_eb73b5d8-9b36-413d-9cdc-596d789d6e69	0480-3154	HUMAN PRESCRIPTION DRUG	Adapalene and benzoyl peroxide		Adapalene and benzoyl peroxide	GEL	TOPICAL	20221128		ANDA	ANDA209641	Teva Pharmaceuticals, Inc.	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0480-3156_97ace8fc-4e47-4cb4-84a0-ca2cfb38293c	0480-3156	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209700	Teva Pharmaceuticals, Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
0480-3157_97ace8fc-4e47-4cb4-84a0-ca2cfb38293c	0480-3157	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209700	Teva Pharmaceuticals, Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
0480-3309_287dcdda-ce6b-4949-bf12-4316f1f4fe00	0480-3309	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230127		ANDA	ANDA216961	Teva Pharmaceuticals, Inc.	THEOPHYLLINE	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0480-3310_287dcdda-ce6b-4949-bf12-4316f1f4fe00	0480-3310	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230127		ANDA	ANDA216961	Teva Pharmaceuticals, Inc.	THEOPHYLLINE	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
0480-3470_8af65514-f556-48d7-bbfb-07d01c2f9b5c	0480-3470	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20220909	20240731	ANDA	ANDA077066	Teva Pharmaceuticals USA, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	
0480-3472_f3b1a714-262c-4ba2-9fc7-d9a5d4b27483	0480-3472	HUMAN PRESCRIPTION DRUG	Amethyst		Levonorgestrel and Ethinyl Estradiol	TABLET	ORAL	20230301		ANDA	ANDA079218	Teva Pharmaceuticals, Inc.	ETHINYL ESTRADIOL; LEVONORGESTREL	20; 90	ug/1; ug/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
0480-3475_7b3bbaea-94d7-4b5a-a45c-0723c32764ac	0480-3475	HUMAN PRESCRIPTION DRUG	Nora BE		Norethindrone	TABLET	ORAL	20231201		NDA AUTHORIZED GENERIC	NDA017060	Teva Pharmaceuticals, Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0480-3479_22f53da2-2fb9-411d-baad-fef011383f6f	0480-3479	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230103		ANDA	ANDA209920	Teva Pharmaceuticals, Inc.	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
0480-3571_7011c865-1b49-4b8e-9ade-99c1fc2105a5	0480-3571	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	20220909		ANDA	ANDA065451	Teva Pharmaceuticals USA, Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0480-3610_6a2b1a0f-9a23-47c8-b0d1-f352d343fff2	0480-3610	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220511		ANDA	ANDA212759	Teva Pharmaceuticals, Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
0480-3611_6a2b1a0f-9a23-47c8-b0d1-f352d343fff2	0480-3611	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220511		ANDA	ANDA212759	Teva Pharmaceuticals, Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
0480-3631_0c32cfe2-d0ca-3315-e063-6294a90a9c53	0480-3631	HUMAN PRESCRIPTION DRUG	Pitavastatin		pitavastatin calcium	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA205932	Teva Pharmaceuticals, Inc.	PITAVASTATIN CALCIUM	1.045	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0480-3632_0c32cfe2-d0ca-3315-e063-6294a90a9c53	0480-3632	HUMAN PRESCRIPTION DRUG	Pitavastatin		pitavastatin calcium	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA205932	Teva Pharmaceuticals, Inc.	PITAVASTATIN CALCIUM	2.09	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0480-3633_0c32cfe2-d0ca-3315-e063-6294a90a9c53	0480-3633	HUMAN PRESCRIPTION DRUG	Pitavastatin		pitavastatin calcium	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA205932	Teva Pharmaceuticals, Inc.	PITAVASTATIN CALCIUM	4.18	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0480-3683_474c1435-76cc-4db0-872d-e6c20aea41a9	0480-3683	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20231010		ANDA	ANDA210876	Teva Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0480-3684_474c1435-76cc-4db0-872d-e6c20aea41a9	0480-3684	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20231010		ANDA	ANDA210876	Teva Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0480-3685_474c1435-76cc-4db0-872d-e6c20aea41a9	0480-3685	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20231010		ANDA	ANDA210876	Teva Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	9.375; 9.375; 9.375; 9.375	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0480-3686_474c1435-76cc-4db0-872d-e6c20aea41a9	0480-3686	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20231010		ANDA	ANDA210876	Teva Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	12.5; 12.5; 12.5; 12.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0480-3720_90ea4054-7c0a-4971-be57-d72e482491b8	0480-3720	HUMAN PRESCRIPTION DRUG	Pyrimethamine		Pyrimethamine	TABLET	ORAL	20211215		ANDA	ANDA215506	Teva Pharmaceuticals, Inc.	PYRIMETHAMINE	25	mg/1	Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
0480-4053_be3e39b7-b109-4695-a427-587556f472a3	0480-4053	HUMAN PRESCRIPTION DRUG	Gefitinib		Gefitinib	TABLET, FILM COATED	ORAL	20230621		ANDA	ANDA208913	Teva Pharmaceuticals, Inc.	GEFITINIB	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0480-4111_99639a92-36fa-4e5c-b2d9-ebce91c37df8	0480-4111	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220909		ANDA	ANDA090296	Teva Pharmaceuticals USA, Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0480-4138_22f53da2-2fb9-411d-baad-fef011383f6f	0480-4138	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230103		ANDA	ANDA209920	Teva Pharmaceuticals, Inc.	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
0480-4184_2a1d6a3c-edb4-4c03-9684-749cf50cd32a	0480-4184	HUMAN PRESCRIPTION DRUG	Pazopanib		Pazopanib	TABLET, FILM COATED	ORAL	20231020		ANDA	ANDA217517	Teva Pharmaceuticals, Inc.	PAZOPANIB HYDROCHLORIDE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0480-4320_584ee231-d0e9-43e5-9973-477c5f9791ae	0480-4320	HUMAN PRESCRIPTION DRUG	Plerixafor		Plerixafor	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		ANDA	ANDA205197	Teva Pharmaceuticals, Inc.	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
0480-4490_64e7208e-cb62-44ec-b4bf-6b39f2500259	0480-4490	HUMAN PRESCRIPTION DRUG	Tasimelteon		Tasimelteon	CAPSULE, GELATIN COATED	ORAL	20221229		ANDA	ANDA211601	Teva Pharmaceuticals, Inc.	TASIMELTEON	20	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
0480-4514_358c3982-007b-43db-8cb6-9777f9488510	0480-4514	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	SOLUTION, CONCENTRATE	INTRAVENOUS	20220531		NDA	NDA208419	Teva Pharmaceuticals, Inc.	PEMETREXED MONOHYDRATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0480-4515_358c3982-007b-43db-8cb6-9777f9488510	0480-4515	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	SOLUTION, CONCENTRATE	INTRAVENOUS	20220531		NDA	NDA208419	Teva Pharmaceuticals, Inc.	PEMETREXED MONOHYDRATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0480-4516_358c3982-007b-43db-8cb6-9777f9488510	0480-4516	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	SOLUTION, CONCENTRATE	INTRAVENOUS	20220601		NDA	NDA208419	Teva Pharmaceuticals, Inc.	PEMETREXED MONOHYDRATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0480-5425_213b5f06-be1f-4bc1-b09d-86c12f83d3b9	0480-5425	HUMAN PRESCRIPTION DRUG	Sorafenib		Sorafenib	TABLET, FILM COATED	ORAL	20230103		ANDA	ANDA209567	Teva Pharmaceuticals, Inc.	SORAFENIB TOSYLATE	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0480-5795_bbc4b58f-86fc-4d82-b0ac-98ae4051c982	0480-5795	HUMAN PRESCRIPTION DRUG	Cetrorelix		Cetrorelix Acetate	KIT	SUBCUTANEOUS	20231214		ANDA	ANDA215737	Teva Pharmaceuticals, Inc.						N	20241231
0480-7167_08f6fedf-b483-4bfd-b768-b95e3c54bc7f	0480-7167	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20221001		ANDA	ANDA076846	Teva Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0480-7168_08f6fedf-b483-4bfd-b768-b95e3c54bc7f	0480-7168	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20221001		ANDA	ANDA076846	Teva Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0480-7270_f206c736-837b-419f-90fc-abfae6c67a0a	0480-7270	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20230209		ANDA	ANDA077793	Teva Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0480-7736_dda9cb99-4dee-4966-a60a-a70b97e0ed13	0480-7736	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA202118	Teva Pharmaceuticals, Inc.	DARUNAVIR HYDRATE	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
0480-8682_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8682	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8687_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8687	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8690_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8690	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8693_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8693	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8701_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8701	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8704_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8704	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8707_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8707	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8710_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8710	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8715_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8715	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8718_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8718	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8722_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8722	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-8725_b7b0021f-f2a3-47a2-9860-0787d9965b77	0480-8725	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20220921		ANDA	ANDA207588	Teva Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0480-9435_d96858a2-fc29-1421-e053-2a95a90ac06d	0480-9435	HUMAN PRESCRIPTION DRUG	Diclofenac potassium		diclofenac potassium	CAPSULE, LIQUID FILLED	ORAL	20220324		ANDA	ANDA204648	TEVA PHARMACEUTICALS, INC.	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0480-9772_7344b0e1-5990-4038-a331-6586fe8a474f	0480-9772	HUMAN PRESCRIPTION DRUG	Fludarabine Phosphate		Fludarabine Phosphate	INJECTION, SOLUTION	INTRAVENOUS	20230831		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Teva Pharmaceuticals, Inc.	FLUDARABINE PHOSPHATE	25	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0485-0057_02932f00-fd92-2a18-e063-6294a90a591c	0485-0057	HUMAN OTC DRUG	ED APAP		ACETAMINOPHEN	LIQUID	ORAL	20120307		OTC MONOGRAPH NOT FINAL	part343	EDWARDS PHARMACEUTICALS, INC.	ACETAMINOPHEN	160	mg/5mL			N	20241231
0485-0080_0293f337-e4d4-e77a-e063-6394a90a9040	0485-0080	HUMAN OTC DRUG	RYMED		DEXCHLORPHENIRAMINE MALEATE and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20111115		OTC MONOGRAPH FINAL	part341	EDWARDS PHARMACEUTICALS, INC.	DEXCHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0485-0151_efbc4c78-6c40-2a0a-e053-2995a90abffb	0485-0151	HUMAN PRESCRIPTION DRUG	UROGESIC BLUE		METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, and HYOSCYAMINE SULFATE	TABLET, COATED	ORAL	20101119		UNAPPROVED DRUG OTHER		EDWARDS PHARMACEUTICALS, INC.	HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; SODIUM PHOSPHATE, MONOBASIC	.12; 81.6; 10.8; 40.8	mg/1; mg/1; mg/1; mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0485-0151_f2270d35-31e3-1017-e053-2a95a90a170b	0485-0151	HUMAN PRESCRIPTION DRUG	UROGESIC BLUE		METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, and HYOSCYAMINE SULFATE	TABLET, COATED	ORAL	20101119		UNAPPROVED DRUG OTHER		EDWARDS PHARMACEUTICALS, INC.	HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; SODIUM PHOSPHATE, MONOBASIC	.12; 81.6; 10.8; 40.8	mg/1; mg/1; mg/1; mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0485-0202_efbada87-3472-ed2a-e053-2a95a90a08eb	0485-0202	HUMAN OTC DRUG	RYNEX PE		BROMPHENIRAMINE MALEATE and Phenylephrine HCL	LIQUID	ORAL	20110307		OTC MONOGRAPH FINAL	part341	EDWARDS PHARMACEUTICALS, INC.	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	1; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0485-0204_02940f28-7dcf-f7cd-e063-6294a90af857	0485-0204	HUMAN OTC DRUG	Rynex	DM	Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20110314		OTC MONOGRAPH FINAL	part341	Edwards Pharmaceuticals, Inc	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0485-0240_02941928-1289-2c88-e063-6294a90ac6ba	0485-0240	HUMAN OTC DRUG	ED-A-HIST DM		CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141027		OTC MONOGRAPH FINAL	part341	EDWARDS PHARMACEUTICALS, INC.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 10; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0486-1111_5cdb4128-66e9-4e90-936b-38dd8b5b8688	0486-1111	HUMAN PRESCRIPTION DRUG	K Phos	Original	Potassium Phosphate, Monobasic	TABLET, SOLUBLE	ORAL	19770329		UNAPPROVED DRUG OTHER		Beach Products, Inc.	POTASSIUM PHOSPHATE, MONOBASIC	500	mg/1			N	20241231
0486-1125_669a0245-d995-4e93-8d10-d01dec029b0b	0486-1125	HUMAN PRESCRIPTION DRUG	K Phos	Neutral	Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, and Sodium Phosphate, Monobasic, Monohydrate	TABLET, COATED	ORAL	19770411		UNAPPROVED DRUG OTHER		Beach Products, Inc.	POTASSIUM PHOSPHATE, MONOBASIC; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	155; 852; 130	mg/1; mg/1; mg/1			N	20241231
0486-1134_5199cfb1-2514-4d76-910e-a8a7616a8ef9	0486-1134	HUMAN PRESCRIPTION DRUG	K-Phos	No. 2	Potassium Phosphate, Monobasic and Sodium Phosphate, Monobasic, Anhydrous	TABLET, COATED	ORAL	19780509		UNAPPROVED DRUG OTHER		Beach Products, Inc.	POTASSIUM PHOSPHATE, MONOBASIC; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	305; 700	mg/1; mg/1			N	20241231
0487-0201_b8a6d33d-d642-4615-e053-2a95a90ace8e	0487-0201	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20071231		ANDA	ANDA076749	Nephron Pharmaceuticals Corporation	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	3; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0487-0301_b8a6cb0d-0000-5734-e053-2995a90abd12	0487-0301	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20100331		ANDA	ANDA076355	Nephron Pharmaceuticals Corporation	ALBUTEROL SULFATE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0487-2784_b8a6aed9-a173-f172-e053-2995a90a17a0	0487-2784	HUMAN OTC DRUG	Asthmanefrin		racepinephrine hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20120801		OTC MONOGRAPH FINAL	part341	Nephron Pharmaceuticals Corporation	RACEPINEPHRINE HYDROCHLORIDE	11.25	mg/.5mL			N	20241231
0487-4301_c3e073a5-e0e4-c908-e053-2a95a90a0bd0	0487-4301	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	20200604		ANDA	ANDA211968	Nephron SC Inc.	SODIUM CHLORIDE	9	mg/mL			N	20241231
0487-5901_b8a789aa-55e6-6497-e053-2a95a90a4169	0487-5901	HUMAN OTC DRUG	S2		racepinephrine hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20000101		OTC MONOGRAPH FINAL	part341	Nephron SC, Inc.	RACEPINEPHRINE HYDROCHLORIDE	11.25	mg/.5mL			N	20241231
0487-6105_c3f4ecb1-53e1-5894-e053-2995a90ade2e	0487-6105	HUMAN PRESCRIPTION DRUG	Sterile Water		Sterile Water	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210607		ANDA	ANDA211222	Nephron Pharmaceuticals Corporation	WATER	1	mL/mL			N	20241231
0487-6232_cf6e2f84-03b0-7f12-e053-2995a90aac06	0487-6232	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR	20200908		ANDA	ANDA211445	Nephron SC Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0487-9501_b8a75428-95af-d867-e053-2a95a90a6509	0487-9501	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	19970917		ANDA	ANDA074880	Nephron Pharmaceuticals Corporation	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0487-9601_b8a6d890-656e-40e9-e053-2a95a90a0d61	0487-9601	HUMAN PRESCRIPTION DRUG	Budesonide		BUDESONIDE	INHALANT	RESPIRATORY (INHALATION)	20131001		ANDA	ANDA078202	Nephron Pharmaceuticals Corporation	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0487-9701_b8a6d890-656e-40e9-e053-2a95a90a0d61	0487-9701	HUMAN PRESCRIPTION DRUG	Budesonide		BUDESONIDE	INHALANT	RESPIRATORY (INHALATION)	20131001		ANDA	ANDA078202	Nephron Pharmaceuticals Corporation	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0487-9801_b8a6d890-6561-40e9-e053-2a95a90a0d61	0487-9801	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20010927		ANDA	ANDA075562	Nephron Pharmaceuticals Corporation	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0487-9901_b8a6cb0d-0001-5734-e053-2995a90abd12	0487-9901	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20010626		ANDA	ANDA075664	Nephron Pharmaceuticals Corporation	ALBUTEROL SULFATE	2.5	mg/.5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0487-9904_b8a6cb0d-0000-5734-e053-2995a90abd12	0487-9904	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20040628		ANDA	ANDA076355	Nephron Pharmaceuticals Corporation	ALBUTEROL SULFATE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0496-0586_48814a87-ee9c-2e5b-e054-00144ff8d46c	0496-0586	HUMAN OTC DRUG	DerMend Moisturizing Anti-Itch		pramoxine hydrochloride	LOTION	TOPICAL	20170301		OTC MONOGRAPH NOT FINAL	part348	Ferndale Laboratories, Inc.	PRAMOXINE HYDROCHLORIDE	10	mg/mL			N	20241231
0496-0590_ec06f1fd-c3e2-5dfc-e053-2a95a90a7cdd	0496-0590	HUMAN OTC DRUG	Dr. Mom Butt Balm		dimethicone petrolatum	OINTMENT	TOPICAL	20221107		OTC MONOGRAPH FINAL	M016	Ferndale Laboratories, Inc.	DIMETHICONE; WHITE PETROLATUM	.28; .48	g/g; g/g	Skin Barrier Activity [PE]		N	20241231
0496-0748_97a2d217-11a5-fd4c-e053-2a95a90ab4de	0496-0748	HUMAN OTC DRUG	PRAX		pramoxine hydrochloride	LOTION	TOPICAL	20120401		OTC MONOGRAPH FINAL	part346	Ferndale Laboratories, Inc.	PRAMOXINE HYDROCHLORIDE	10	mg/mL			N	20241231
0496-0882_a58a2e97-9b55-3b5a-e053-2995a90acb5a	0496-0882	HUMAN OTC DRUG	LMX4		lidocaine	CREAM	TOPICAL	20110103		OTC MONOGRAPH NOT FINAL	part348	Ferndale Laboratories, Inc.	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0496-0883_7974c929-ea52-91a4-e053-2a91aa0a3157	0496-0883	HUMAN OTC DRUG	LMX5		lidocaine	CREAM	TOPICAL	20031001		OTC MONOGRAPH FINAL	part346	Ferndale Laboratories, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0496-0892_c10b35cd-6a2c-381e-e053-2995a90afe09	0496-0892	HUMAN OTC DRUG	RECTICARE		lidocaine	CREAM	TOPICAL	20120309		OTC MONOGRAPH FINAL	part346	Ferndale Laboratories, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0496-0978_bfc88525-566d-9dcd-e053-2995a90a94bc	0496-0978	HUMAN OTC DRUG	Recticare Advanced		lidocaine and mineral oil and phenylephrine HCl and white petrolatum	CREAM	TOPICAL	20160401		OTC MONOGRAPH FINAL	part346	Ferndale Laboratories, Inc.	LIDOCAINE; MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	50; 170; 390; 2.5	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0496-0980_97a52156-d456-c339-e053-2a95a90a0334	0496-0980	HUMAN OTC DRUG	RECTICARE		lidocaine and glycerin	CLOTH	TOPICAL	20160101		OTC MONOGRAPH FINAL	part346	Ferndale Laboratories, Inc.	GLYCERIN; LIDOCAINE	200; 50	mg/g; mg/g	Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
0498-0100_0e3b75ae-b37e-d586-e063-6394a90ac2e9	0498-0100	HUMAN OTC DRUG	Eyesaline Emergency Eyewash		Purified water	LIQUID	OPHTHALMIC	20181215		OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, Inc.	WATER	98.6	mL/100mL			N	20251231
0498-0101_0e3cd297-a996-4c42-e063-6294a90a4621	0498-0101	HUMAN OTC DRUG	Eyesaline Emergency Eyewash Concentrate		Water	CONCENTRATE	OPHTHALMIC	20200305		OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, Inc	WATER	70	mL/100mL			N	20251231
0498-0161_0e23b510-8247-a4c7-e063-6294a90a55b4	0498-0161	HUMAN OTC DRUG	Eye Drops		Tetrahydrozoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20180704	20241231	OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, INC	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	
0498-0162_0e23c0a8-e97d-27e1-e063-6394a90ae5db	0498-0162	HUMAN OTC DRUG	Industrial Strength Eye Drops		Tetrahydrozoline hydrochloride, polyethylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20180704	20241231	OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, INC	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE	1; .05	g/100mL; g/100mL			N	
0498-0601_0e4a1837-d1c3-cddd-e063-6294a90af240	0498-0601	HUMAN OTC DRUG	Eyesaline Concentrate		Water	LIQUID	OPHTHALMIC	20200901		OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, Inc	WATER	92.2	L/100L			N	20251231
0498-0620_0e3dc725-452f-899b-e063-6394a90a86f9	0498-0620	HUMAN OTC DRUG	Eyesaline Emergency Eyewash		Purified water	LIQUID	OPHTHALMIC	20181215		OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, Inc.	WATER	98.6	L/100L			N	20251231
0498-0630_0e3b22ec-4ec5-484f-e063-6294a90a9284	0498-0630	HUMAN OTC DRUG	Fendall Pure Flow		Purified water	LIQUID	OPHTHALMIC	20181215		OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, Inc.	WATER	98.6	L/100L			N	20251231
0498-0631_0e4a17cb-beaf-6525-e063-6394a90a16b0	0498-0631	HUMAN OTC DRUG	Fendall 2000 Pure Flow		Purified water	LIQUID	OPHTHALMIC	20181215		OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, Inc.	WATER	98.6	L/100L			N	20251231
0498-0640_0e246ca1-ce32-584a-e063-6394a90a1212	0498-0640	HUMAN OTC DRUG	Sperian Water Additive Concentrate		Purified water	LIQUID	OPHTHALMIC	20181215	20241231	OTC MONOGRAPH DRUG	M018	Honeywell Safety Products USA, Inc.	WATER	95	mL/100mL			N	
0498-1071_f0ec2740-9a35-1880-e053-2995a90a0bef	0498-1071	HUMAN OTC DRUG	Antidiarrheal Relief		Loperamide HCl	TABLET	ORAL	20130429		ANDA	ANDA074091	Honeywell Safety Products USA, Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0498-4128_0e901544-2f8c-ce0f-e063-6294a90ae5a1	0498-4128	HUMAN OTC DRUG	4128 First Aid Kit		4128 First Aid Kit	KIT		20181018	20240131	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4130_0e902405-2b15-fc76-e063-6394a90ad984	0498-4130	HUMAN OTC DRUG	4130 First Aid Kit		4130 First Aid Kit	KIT		20181018	20240131	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4131_0e99de37-5e6c-85f0-e063-6394a90a4457	0498-4131	HUMAN OTC DRUG	4131 First Aid Kit		4131 First Aid Kit	KIT		20181018	20240331	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4132_0e9b56a3-f6f2-fccf-e063-6394a90aade0	0498-4132	HUMAN OTC DRUG	4132 First Aid Kit		4132 First Aid Kit	KIT	OPHTHALMIC; ORAL; TOPICAL	20181018	20240229	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4134_0e9b8215-cc6d-062b-e063-6394a90a3910	0498-4134	HUMAN OTC DRUG	4134 First Aid Kit		4134 First Aid Kit	KIT		20181018	20240229	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4136_0e9baada-98dc-0ea2-e063-6394a90a5aae	0498-4136	HUMAN OTC DRUG	4136 First Aid Kit		4136 first aid	KIT		20180913	20240331	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4137_0e9bd757-a856-2067-e063-6394a90a7042	0498-4137	HUMAN OTC DRUG	4137 First Aid Kit		4137 first aid	KIT		20180913	20240229	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4138_0e9be7a9-4e09-25e8-e063-6394a90abb86	0498-4138	HUMAN OTC DRUG	4138 First Aid Kit		4138 first aid	KIT		20180913	20240331	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4140_0e9bcca8-ceb5-a99b-e063-6294a90a70bc	0498-4140	HUMAN OTC DRUG	4140 First Aid Kit		4140 first aid	KIT		20180913	20240430	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4141_0e9c4cc5-1869-fdd9-e063-6294a90a46af	0498-4141	HUMAN OTC DRUG	4141 First Aid Kit		4141 First Aid Kit	KIT		20181018	20240331	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4143_0e9ca51a-6ea2-67a2-e063-6394a90ab375	0498-4143	HUMAN OTC DRUG	4143 First Aid Kit		4143 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4144_0e9c8e92-0ab0-6217-e063-6394a90a2bd4	0498-4144	HUMAN OTC DRUG	4144 First Aid Kit		4144 First Aid Kit	KIT		20181018	20240731	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4145_0e9cb2cf-9a0d-48f6-e063-6294a90a3acc	0498-4145	HUMAN OTC DRUG	4145 First Aid Kit		4145 First Aid Kit	KIT		20181018	20241031	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4146_0e9cd3e5-cff9-7594-e063-6394a90aad90	0498-4146	HUMAN OTC DRUG	4146 First Aid Kit		4146 first aid	KIT		20180913	20240831	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4147_0e99de37-5e6c-85f0-e063-6394a90a4457	0498-4147	HUMAN OTC DRUG	4147 First Aid Kit		4147 First Aid Kit	KIT		20181018	20240131	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4148_0e9cd40a-a270-402b-e063-6294a90aebbd	0498-4148	HUMAN OTC DRUG	4148 First Aid Kit		4148 first aid	KIT		20180913	20240731	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4149_0e9cebc6-ad26-6fe3-e063-6394a90acc9f	0498-4149	HUMAN OTC DRUG	4149 First Aid Kit		4149 first aid	KIT		20180913	20240830	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4150_0e9d116b-6e2e-874e-e063-6394a90adf4d	0498-4150	HUMAN OTC DRUG	4150 First Aid Kit		4150 First Aid Kit	KIT		20181018	20240531	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4151_0e9d1d81-eaf9-6c83-e063-6394a90a3b05	0498-4151	HUMAN OTC DRUG	4151 First Aid Kit		4151 First Aid Kit	KIT		20181018	20240830	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4152_0e9ec490-b7a4-0765-e063-6394a90a9171	0498-4152	HUMAN OTC DRUG	4152 First Aid Kit		4152 first aid	KIT		20180913	20240531	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4153_0e9e6a57-0c67-075f-e063-6394a90a883a	0498-4153	HUMAN OTC DRUG	4153 First Aid Kit		4153 First Aid Kit	KIT		20181018	20240630	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4155_0e9eb110-531f-82f8-e063-6294a90a5234	0498-4155	HUMAN OTC DRUG	4155 First Aid Kit		4155 first aid	KIT		20180913	20240930	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4156_0ea0bede-58b0-eb0c-e063-6394a90a1575	0498-4156	HUMAN OTC DRUG	4156 First Aid Kit		4156 First Aid Kit	KIT		20181018	20240731	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4157_0ea0cf88-bc9f-fb47-e063-6394a90ada77	0498-4157	HUMAN OTC DRUG	4157 First Aid Kit		4157 first aid	KIT		20180913	20240630	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4158_0ea11038-21a7-0ac0-e063-6394a90acb6e	0498-4158	HUMAN OTC DRUG	4158 First Aid Kit		4158 First Aid Kit	KIT	TOPICAL	20181013	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4161_0ea11038-21a7-0ac0-e063-6394a90acb6e	0498-4161	HUMAN OTC DRUG	4161 First Aid Kit		4161 First Aid Kit	KIT	TOPICAL	20181013	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4162_0e9bcca8-ceb5-a99b-e063-6294a90a70bc	0498-4162	HUMAN OTC DRUG	4162 First Aid Kit		4162 first aid	KIT		20180913	20240331	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4163_0ea11038-21a6-0ac0-e063-6394a90acb6e	0498-4163	HUMAN OTC DRUG	4163 First Aid Kit		4163 First Aid Kit	KIT		20181018	20241031	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4165_0ea13ef4-3557-1824-e063-6394a90ab77b	0498-4165	HUMAN OTC DRUG	4165 First Aid Kit		4165 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4166_0ea14e03-8a4b-50ab-e063-6294a90a83e0	0498-4166	HUMAN OTC DRUG	4166 First Aid Kit		4166 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4167_0ea151da-9679-1cbf-e063-6394a90a05e8	0498-4167	HUMAN OTC DRUG	4167 First Aid Kit		4167 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4168_0ea177ee-ba66-636d-e063-6294a90a6ef5	0498-4168	HUMAN OTC DRUG	4168 First Aid Kit		4168 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4169_0ea2598c-7245-e41a-e063-6294a90a8904	0498-4169	HUMAN OTC DRUG	4169 First Aid Kit		4169 First Aid Kit	KIT	OPHTHALMIC; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4171_0ea24dde-f92d-dde8-e063-6294a90af34d	0498-4171	HUMAN OTC DRUG	4171 First Aid Kit		4171 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4172_0ea2ccf8-33b7-f929-e063-6294a90a21fb	0498-4172	HUMAN OTC DRUG	4172 First Aid Kit		4172 First Aid Kit	KIT	OPHTHALMIC; ORAL; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4174_0ea11038-21a7-0ac0-e063-6394a90acb6e	0498-4174	HUMAN OTC DRUG	4174 First Aid Kit		4174 First Aid Kit	KIT	TOPICAL	20181013	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4175_0ea286c4-d787-8eaa-e063-6394a90ad9d3	0498-4175	HUMAN OTC DRUG	4175 First Aid Kit		4175 first aid kit	KIT		20171222	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc						N	
0498-4176_0ea11038-21a7-0ac0-e063-6394a90acb6e	0498-4176	HUMAN OTC DRUG	4176 First Aid Kit		4176 First Aid Kit	KIT	TOPICAL	20181013	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4178_0ea11038-21a7-0ac0-e063-6394a90acb6e	0498-4178	HUMAN OTC DRUG	4178 First Aid Kit		4178 First Aid Kit	KIT	TOPICAL	20181013	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4183_0ea286c4-d788-8eaa-e063-6394a90ad9d3	0498-4183	HUMAN OTC DRUG	4183 First Aid Kit		4183 First Aid Kit	KIT		20181124	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc						N	
0498-4184_0ea2b234-d015-1378-e063-6294a90af809	0498-4184	HUMAN OTC DRUG	4184 First Aid Kit		4184 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4185_0ea2ccf8-33b4-f929-e063-6294a90a21fb	0498-4185	HUMAN OTC DRUG	4185 First Aid Kit		4185 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4186_0ea2e938-4377-1b75-e063-6294a90a5ade	0498-4186	HUMAN OTC DRUG	4186 First Aid Kit		4186 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4189_0ea3146f-f264-41ec-e063-6294a90a12cb	0498-4189	HUMAN OTC DRUG	4189 First Aid Kit		4189 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4191_0ea31597-f021-2b49-e063-6294a90a4fb0	0498-4191	HUMAN OTC DRUG	4191 First Aid Kit		4191 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4195_0ea3f2d7-50e8-1d72-e063-6394a90a680c	0498-4195	HUMAN OTC DRUG	4195 First Aid Kit		4195 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4196_0ea40e74-800f-2b2d-e063-6294a90a7962	0498-4196	HUMAN OTC DRUG	4196 First Aid Kit		4196 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4197_0ea458bc-da45-4972-e063-6294a90a0dc7	0498-4197	HUMAN OTC DRUG	4197 First Aid Kit		4197 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4198_0ea458bc-da45-4972-e063-6294a90a0dc7	0498-4198	HUMAN OTC DRUG	4198 First Aid Kit		4198 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4199_0ea458bc-da45-4972-e063-6294a90a0dc7	0498-4199	HUMAN OTC DRUG	4199 First Aid Kit		4199 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4200_0eae3e75-788d-e1bb-e063-6394a90a0d10	0498-4200	HUMAN OTC DRUG	4200 First Aid Kit		4200 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4201_0eae3e75-788d-e1bb-e063-6394a90a0d10	0498-4201	HUMAN OTC DRUG	4201 First Aid Kit		4201 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4202_0eae3e75-788d-e1bb-e063-6394a90a0d10	0498-4202	HUMAN OTC DRUG	4202 First Aid Kit		4202 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4203_0eae8d8e-4fe8-aa3f-e063-6294a90abce0	0498-4203	HUMAN OTC DRUG	4203 First Aid Kit		4203 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4204_0eaebab2-2fbf-e88c-e063-6294a90ae4c3	0498-4204	HUMAN OTC DRUG	4204 First Aid Kit		4204 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4210_0eaebab2-2fbf-e88c-e063-6294a90ae4c3	0498-4210	HUMAN OTC DRUG	4210 First Aid Kit		4210 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4214_0eaf63e2-9922-4408-e063-6394a90a9035	0498-4214	HUMAN OTC DRUG	4214 First Aid Kit		4214 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4218_0eb0640d-ff18-e2fd-e063-6294a90aa6d7	0498-4218	HUMAN OTC DRUG	4218 First Aid Kit		4218 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4219_0eb06fd8-aaa9-9b29-e063-6394a90a2f7d	0498-4219	HUMAN OTC DRUG	4219 First Aid Kit		4219 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4220_0eb06bdb-c85a-98c0-e063-6394a90ab3d6	0498-4220	HUMAN OTC DRUG	4220 First Aid Kit		4220 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4223_0eb0c861-cd8c-aff7-e063-6394a90afdf8	0498-4223	HUMAN OTC DRUG	4223 First Aid Kit		4223 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4227_0eb0da5e-0fa6-b442-e063-6394a90a08f4	0498-4227	HUMAN OTC DRUG	4227 First Aid Kit		4227 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4231_0eb1bd93-68d4-05a4-e063-6394a90a1050	0498-4231	HUMAN OTC DRUG	4231First Aid Kit		4231 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4232_0eb0a622-5e97-ab28-e063-6394a90a1e1b	0498-4232	HUMAN OTC DRUG	4232 First Aid Kit		4232 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4233_0eb1bade-a2fc-0586-e063-6394a90a3318	0498-4233	HUMAN OTC DRUG	4233 First Aid Kit		4233 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4235_0eb1e018-6230-0a66-e063-6394a90ac2a9	0498-4235	HUMAN OTC DRUG	4235 First Aid Kit		4235 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4236_0eb1e5a2-b315-0fad-e063-6394a90a8735	0498-4236	HUMAN OTC DRUG	4236 First Aid Kit		4236 first aid kit	KIT		20180912	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4237_0eb1f1d7-7534-0f4c-e063-6394a90af22b	0498-4237	HUMAN OTC DRUG	4237 First Aid Kit		4237 first aid kit	KIT		20180912	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4238_0eb1f906-3349-14d6-e063-6394a90a70f5	0498-4238	HUMAN OTC DRUG	4238 First Aid Kit		4238 First Aid Kit	KIT		20190314	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4239_0eb1f158-ee7d-f172-e063-6294a90ab87d	0498-4239	HUMAN OTC DRUG	4239 First Aid Kit		4239 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4242_0eb20598-9439-0029-e063-6294a90aaebb	0498-4242	HUMAN OTC DRUG	4242 First Aid Kit		4242 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4247_0eb2473c-bb10-2be5-e063-6394a90a4a40	0498-4247	HUMAN OTC DRUG	4247 First Aid Kit		4247 First Aid Kit	KIT		20190314	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4249_0eb29983-250f-41a5-e063-6394a90a7058	0498-4249	HUMAN OTC DRUG	4249 First Aid Kit		4249 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4250_0eb2acb8-5c63-5ed8-e063-6294a90ac802	0498-4250	HUMAN OTC DRUG	4250 First Aid Kit		4250 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4252_0eb2bd0e-7f2f-6539-e063-6294a90a3941	0498-4252	HUMAN OTC DRUG	4252 First Aid Kit		4252 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4253_0ea458bc-da45-4972-e063-6294a90a0dc7	0498-4253	HUMAN OTC DRUG	4253 First Aid Kit		4253 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4254_0ea458bc-da45-4972-e063-6294a90a0dc7	0498-4254	HUMAN OTC DRUG	4254 First Aid Kit		4254 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4255_0eae3e75-788d-e1bb-e063-6394a90a0d10	0498-4255	HUMAN OTC DRUG	4255 First Aid Kit		4255 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4256_0eae8d8e-4fe8-aa3f-e063-6294a90abce0	0498-4256	HUMAN OTC DRUG	4256 First Aid Kit		4256 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4257_0eaebab2-2fbf-e88c-e063-6294a90ae4c3	0498-4257	HUMAN OTC DRUG	4257 First Aid Kit		4257 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4261_0eb2c0fe-dc53-4b76-e063-6394a90a5e76	0498-4261	HUMAN OTC DRUG	4261 First Aid Kit		4261 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4263_0eb2da3a-17cd-6e3c-e063-6294a90a2467	0498-4263	HUMAN OTC DRUG	4263 First Aid Kit		4263 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4264_0eb3020c-81c5-9af9-e063-6294a90a5371	0498-4264	HUMAN OTC DRUG	4264 First Aid Kit		4264 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4265_0eb3020c-81c5-9af9-e063-6294a90a5371	0498-4265	HUMAN OTC DRUG	4265 First Aid Kit		4265 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4266_0eb3020c-81c5-9af9-e063-6294a90a5371	0498-4266	HUMAN OTC DRUG	4266 First Aid Kit		4266 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4267_0eb30ff6-8719-8b65-e063-6394a90acbfe	0498-4267	HUMAN OTC DRUG	4267 First Aid Kit		4267 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4268_0eb3f6b3-21ff-e282-e063-6394a90aaec6	0498-4268	HUMAN OTC DRUG	4268 First Aid Kit		4268 First Aid Kit	KIT	TOPICAL	20181013	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4269_0ea2ccf8-33b4-f929-e063-6294a90a21fb	0498-4269	HUMAN OTC DRUG	4269 First Aid Kit		4269 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4273_0eb40b81-c2e8-a5d9-e063-6294a90abadf	0498-4273	HUMAN OTC DRUG	4273 First Aid Kit		4273 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4274_0eb41d0d-21f0-ec2b-e063-6394a90a0ce4	0498-4274	HUMAN OTC DRUG	4274 First Aid Kit		4274 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4275_0eb0c861-cd8c-aff7-e063-6394a90afdf8	0498-4275	HUMAN OTC DRUG	4275 First Aid Kit		4275 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4276_0eb45193-29fc-cd56-e063-6294a90a21f9	0498-4276	HUMAN OTC DRUG	4276 First Aid Kit		4276 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4277_0eb447a9-efbc-c9f9-e063-6294a90ae08e	0498-4277	HUMAN OTC DRUG	4277 First Aid Kit		4277 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4278_0eb45191-509b-cb7d-e063-6294a90a597e	0498-4278	HUMAN OTC DRUG	4278 First Aid Kit		4278 First Aid Kit	KIT	OPHTHALMIC; ORAL; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4280_0eb450f8-7af4-c9f6-e063-6294a90a1ca4	0498-4280	HUMAN OTC DRUG	4280 First Aid Kit		4280 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4281_0ea177ee-ba66-636d-e063-6294a90a6ef5	0498-4281	HUMAN OTC DRUG	4281 First Aid Kit		4281 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4282_0eb4776d-5057-02d8-e063-6394a90a2177	0498-4282	HUMAN OTC DRUG	4282 First Aid Kit		4282 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4283_0eb4776d-5057-02d8-e063-6394a90a2177	0498-4283	HUMAN OTC DRUG	4283 First Aid Kit		4283 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4284_0ea458bc-da45-4972-e063-6294a90a0dc7	0498-4284	HUMAN OTC DRUG	4284 First Aid Kit		4284 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4285_0eb2c0fe-dc53-4b76-e063-6394a90a5e76	0498-4285	HUMAN OTC DRUG	4285 First Aid Kit		4285 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4287_0eb4776d-5059-02d8-e063-6394a90a2177	0498-4287	HUMAN OTC DRUG	4287 First Aid Kit		4287 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4288_0eb48351-5135-f600-e063-6294a90a1696	0498-4288	HUMAN OTC DRUG	4288 First Aid Kit		4288 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4289_0eb1e018-6230-0a66-e063-6394a90ac2a9	0498-4289	HUMAN OTC DRUG	4289 First Aid Kit		4289 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4292_0eb4a8fe-3b14-122f-e063-6394a90a5154	0498-4292	HUMAN OTC DRUG	4292 First Aid Kit		4292 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4294_0e902405-2b15-fc76-e063-6394a90ad984	0498-4294	HUMAN OTC DRUG	4294 First Aid Kit		4294 First Aid Kit	KIT		20181018	20240129	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4295_0eb4bc7b-ebd5-1897-e063-6294a90a6acd	0498-4295	HUMAN OTC DRUG	4295 First Aid Kit		4295 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4298_0eb4b88b-98f9-18a0-e063-6394a90aad72	0498-4298	HUMAN OTC DRUG	4298 First Aid Kit		4298 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4299_0eb4d0c8-8a9a-2825-e063-6294a90af43a	0498-4299	HUMAN OTC DRUG	4299 First Aid Kit		4299 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4300_0eb4ddbd-4236-1f69-e063-6394a90a5108	0498-4300	HUMAN OTC DRUG	4300 First Aid Kit		4300 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4302_0eb4e943-669d-34a8-e063-6294a90a2889	0498-4302	HUMAN OTC DRUG	4302 First Aid Kit		4302 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4306_0eb4e364-2d99-27dc-e063-6394a90a1ea2	0498-4306	HUMAN OTC DRUG	4306 First Aid Kit		4306 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4309_0eb5172d-2e4f-48a5-e063-6294a90a9694	0498-4309	HUMAN OTC DRUG	4309 First Aid Kit		4309 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4310_0eb3020c-81c5-9af9-e063-6294a90a5371	0498-4310	HUMAN OTC DRUG	4310 First Aid Kit		4310 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4311_0eb52229-6911-3e4a-e063-6394a90a4541	0498-4311	HUMAN OTC DRUG	4311 First Aid Kit		4311 first aid	KIT		20180913	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4312_0eb53468-70c5-3f04-e063-6394a90a6e25	0498-4312	HUMAN OTC DRUG	4312 First Aid Kit		4312 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4316_0eb53fa1-864f-610e-e063-6294a90a5f6e	0498-4316	HUMAN OTC DRUG	4316 First Aid Kit		4316 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4321_0eb5172d-2e4f-48a5-e063-6294a90a9694	0498-4321	HUMAN OTC DRUG	4321 First Aid Kit		4321 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4322_0e9baada-98dc-0ea2-e063-6394a90a5aae	0498-4322	HUMAN OTC DRUG	4322 First Aid Kit		4322 first aid	KIT		20180913	20240331	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4324_0e9bd757-a856-2067-e063-6394a90a7042	0498-4324	HUMAN OTC DRUG	4324 First Aid Kit		4324 first aid	KIT		20180913	20240430	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4325_0e9bd757-a856-2067-e063-6394a90a7042	0498-4325	HUMAN OTC DRUG	4325 First Aid Kit		4325 first aid	KIT		20180913	20240330	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4336_0ea458bc-da45-4972-e063-6294a90a0dc7	0498-4336	HUMAN OTC DRUG	4336 First Aid Kit		4336 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4337_0eb2c0fe-dc53-4b76-e063-6394a90a5e76	0498-4337	HUMAN OTC DRUG	4337 First Aid Kit		4337 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4344_0ea2ccf8-33b7-f929-e063-6294a90a21fb	0498-4344	HUMAN OTC DRUG	4344 First Aid Kit		4344 First Aid Kit	KIT	OPHTHALMIC; ORAL; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4350_0ea11038-21a6-0ac0-e063-6394a90acb6e	0498-4350	HUMAN OTC DRUG	4350 First Aid Kit		4350 First Aid Kit	KIT		20181018	20240930	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4353_0ea2ccf8-33b7-f929-e063-6294a90a21fb	0498-4353	HUMAN OTC DRUG	4353 First Aid Kit		4353 First Aid Kit	KIT	OPHTHALMIC; ORAL; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4354_0e9bd757-a856-2067-e063-6394a90a7042	0498-4354	HUMAN OTC DRUG	4354 First Aid Kit		4354 first aid	KIT		20180913	20240331	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, Inc.						N	
0498-4366_0ea2598c-7245-e41a-e063-6294a90a8904	0498-4366	HUMAN OTC DRUG	4366 First Aid Kit		4366 First Aid Kit	KIT	OPHTHALMIC; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4368_0ea2598c-7245-e41a-e063-6294a90a8904	0498-4368	HUMAN OTC DRUG	4368 First Aid Kit		4368 First Aid Kit	KIT	OPHTHALMIC; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4372_0ea2ccf8-33b7-f929-e063-6294a90a21fb	0498-4372	HUMAN OTC DRUG	4372 First Aid Kit		4372 First Aid Kit	KIT	OPHTHALMIC; ORAL; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4373_0ea2ccf8-33b7-f929-e063-6294a90a21fb	0498-4373	HUMAN OTC DRUG	4373 First Aid Kit		4373 First Aid Kit	KIT	OPHTHALMIC; ORAL; TOPICAL	20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4375_0ea11038-21a6-0ac0-e063-6394a90acb6e	0498-4375	HUMAN OTC DRUG	4375 First Aid Kit		4375 First Aid Kit	KIT		20181018	20241130	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4397_0eb4ddbd-4236-1f69-e063-6394a90a5108	0498-4397	HUMAN OTC DRUG	4397 First Aid Kit		4397 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4400_0eb3020c-81c5-9af9-e063-6294a90a5371	0498-4400	HUMAN OTC DRUG	4400 First Aid Kit		4400 First Aid Kit	KIT		20181018	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0498-4401_0eb3fe42-4ed4-8fe9-e063-6294a90a5032	0498-4401	HUMAN OTC DRUG	4401 First Aid Kit		4401 First Aid Kit	KIT		20190314	20241231	UNAPPROVED DRUG OTHER		Honeywell Safety Products USA, INC						N	
0517-0020_7daa7474-b04e-4ffe-a75d-30ee0a83baaa	0517-0020	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		Caffeine Citrate	INJECTION, SOLUTION	INTRAVENOUS	20070910		ANDA	ANDA077906	American Regent, Inc.	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0517-0031_28421ba1-7e37-429c-9c66-62cc36f5847c	0517-0031	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	19900930		ANDA	ANDA080737	American Regent, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0517-0032_28421ba1-7e37-429c-9c66-62cc36f5847c	0517-0032	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	19961107		ANDA	ANDA080737	American Regent, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0517-0125_a525d7db-e893-45c9-a844-ec936339c8ae	0517-0125	HUMAN PRESCRIPTION DRUG	PROVAYBLUE		methylene blue	INJECTION	INTRAVENOUS	20200408		NDA	NDA204630	American Regent, Inc.	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0517-0130_28421ba1-7e37-429c-9c66-62cc36f5847c	0517-0130	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20030529		ANDA	ANDA080737	American Regent, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
0517-0371_a525d7db-e893-45c9-a844-ec936339c8ae	0517-0371	HUMAN PRESCRIPTION DRUG	PROVAYBLUE		methylene blue	INJECTION	INTRAVENOUS	20200408		NDA	NDA204630	American Regent, Inc.	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0517-0374_a525d7db-e893-45c9-a844-ec936339c8ae	0517-0374	HUMAN PRESCRIPTION DRUG	PROVAYBLUE		methylene blue	INJECTION	INTRAVENOUS	20160408		NDA	NDA204630	American Regent, Inc.	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0517-0381_a525d7db-e893-45c9-a844-ec936339c8ae	0517-0381	HUMAN PRESCRIPTION DRUG	PROVAYBLUE		methylene blue	INJECTION	INTRAVENOUS	20160408		NDA	NDA204630	American Regent, Inc.	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
0517-0420_34294770-179c-4b76-b20f-9e842e156851	0517-0420	HUMAN PRESCRIPTION DRUG	ESTRADIOL VALERATE		ESTRADIOL VALERATE	INJECTION, SOLUTION	INTRAMUSCULAR	20200301		ANDA	ANDA090920	American Regent, Inc.	ESTRADIOL VALERATE	20	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0517-0440_34294770-179c-4b76-b20f-9e842e156851	0517-0440	HUMAN PRESCRIPTION DRUG	ESTRADIOL VALERATE		ESTRADIOL VALERATE	INJECTION, SOLUTION	INTRAMUSCULAR	20200301		ANDA	ANDA090920	American Regent, Inc.	ESTRADIOL VALERATE	40	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0517-0602_72f9297d-5eb4-4e10-9545-c4d6f686c2c5	0517-0602	HUMAN PRESCRIPTION DRUG	Injectafer		Ferric Carboxymaltose Injection	INJECTION, SOLUTION	INTRAVENOUS	20220601		NDA	NDA203565	American Regent, Inc.	FERRIC CARBOXYMALTOSE	50	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0517-0620_72f9297d-5eb4-4e10-9545-c4d6f686c2c5	0517-0620	HUMAN PRESCRIPTION DRUG	Injectafer		Ferric Carboxymaltose	INJECTION, SOLUTION	INTRAVENOUS	20210601		NDA	NDA203565	American Regent, Inc.	FERRIC CARBOXYMALTOSE	50	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0517-0650_72f9297d-5eb4-4e10-9545-c4d6f686c2c5	0517-0650	HUMAN PRESCRIPTION DRUG	Injectafer		Ferric Carboxymaltose Injection	INJECTION, SOLUTION	INTRAVENOUS	20130812		NDA	NDA203565	American Regent, Inc.	FERRIC CARBOXYMALTOSE	50	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0517-0710_aac796de-58f6-49e5-b959-f95b0c7b8889	0517-0710	HUMAN PRESCRIPTION DRUG	fomepizole		fomepizole	INJECTION, SOLUTION	INTRAVENOUS	20200731		ANDA	ANDA078368	American Regent, Inc.	FOMEPIZOLE	1	g/mL	Antidote [EPC]		N	20241231
0517-0710_fe5cc52b-7f4b-405a-a8d7-d52fd63289db	0517-0710	HUMAN PRESCRIPTION DRUG	fomepizole		fomepizole	INJECTION, SOLUTION	INTRAVENOUS	20180716		ANDA	ANDA078368	American Regent, Inc.	FOMEPIZOLE	1	g/mL	Antidote [EPC]		N	20241231
0517-0720_6b2d548a-9e98-41f5-bc8b-a47bccb73183	0517-0720	HUMAN PRESCRIPTION DRUG	Betamethasone Sodium Phosphate and Betamethasone Acetate		Betamethasone Sodium Phosphate and Betamethasone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR	20100428		ANDA	ANDA090747	American Regent, Inc.	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
0517-0735_92ab3adc-2097-490a-a0b3-fa3fac098a2a	0517-0735	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200508		ANDA	ANDA090534	American Regent, Inc.	NICARDIPINE HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0517-0740_fd646b72-2c28-406e-91a1-e1026551fc2d	0517-0740	HUMAN PRESCRIPTION DRUG	Methylergonovine Maleate		Methylergonovine Maleate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100621		ANDA	ANDA090193	American Regent, Inc.	METHYLERGONOVINE MALEATE	.2	mg/mL	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
0517-0791_963c2f51-4a65-43f7-99a6-9dffc301d875	0517-0791	HUMAN PRESCRIPTION DRUG	Betamethasone Sodium Phosphate and Betamethasone Acetate		Betamethasone Sodium Phosphate and Betamethasone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR	20191101		ANDA	ANDA090747	American Regent, Inc.	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
0517-0799_2a0aeb19-8f87-4317-9d1d-694e8404efc4	0517-0799	HUMAN PRESCRIPTION DRUG	Betamethasone Sodium Phosphate and Betamethasone Acetate		Betamethasone Sodium Phosphate and Betamethasone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR	20191101		ANDA	ANDA090747	American Regent, Inc.	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
0517-0901_5aca9ccd-3ac3-48b6-9372-34ee0eb4b7f9	0517-0901	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19970630		ANDA	ANDA040136	American Regent, Inc.	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0517-0955_b8891afa-918e-47f6-9beb-f0dbd68ebfd3	0517-0955	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20120627		ANDA	ANDA201741	American Regent, Inc.	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]		N	20241231
0517-0960_1a8db732-66d1-443c-9664-08f9e84903f1	0517-0960	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20111115		ANDA	ANDA201885	American Regent, Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
0517-1001_1c500ed9-94a9-472c-bfb7-50e1fcfc31fb	0517-1001	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20220802		ANDA	ANDA216120	American Regent, Inc.	ATROPINE SULFATE	1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0517-1004_1c500ed9-94a9-472c-bfb7-50e1fcfc31fb	0517-1004	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20220802		ANDA	ANDA216120	American Regent, Inc.	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0517-1020_2db53144-cf24-490d-9a1c-54febc3ed1b8	0517-1020	HUMAN PRESCRIPTION DRUG	Vasopressin		Vasopressin	INJECTION, SOLUTION	INTRAVENOUS	20220203		NDA	NDA212593	American Regent, Inc.	VASOPRESSIN	20	[USP'U]/mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
0517-1030_2db53144-cf24-490d-9a1c-54febc3ed1b8	0517-1030	HUMAN PRESCRIPTION DRUG	Vasopressin		Vasopressin	INJECTION, SOLUTION	INTRAVENOUS	20230621		NDA	NDA212593	American Regent, Inc.	VASOPRESSIN	20	[USP'U]/mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
0517-1045_6da188f1-f972-4949-9764-da02eb63d113	0517-1045	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine	INJECTION, SOLUTION	INTRAVENOUS	20230401		ANDA	ANDA075861	American Regent, Inc.	LEVOCARNITINE	200	mg/mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
0517-1171_b44e1fe9-df03-4a0a-8e8b-deceb6d32357	0517-1171	HUMAN PRESCRIPTION DRUG	epinephrine		epinephrine	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20230131		ANDA	ANDA207568	American Regent, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0517-1767_4207c2b1-a227-4a27-9768-557a02ec4791	0517-1767	HUMAN PRESCRIPTION DRUG	Hydroxyprogesterone Caproate		Hydroxyprogesterone Caproate	INJECTION	INTRAMUSCULAR	20180628		ANDA	ANDA210723	American Regent, Inc.	HYDROXYPROGESTERONE CAPROATE	250	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0517-1791_abe2312b-bc06-497b-835e-b9526fbe09bf	0517-1791	HUMAN PRESCRIPTION DRUG	Hydroxyprogesterone Caproate		Hydroxyprogesterone Caproate	INJECTION	INTRAMUSCULAR	20190301		ANDA	ANDA210723	American Regent, Inc.	HYDROXYPROGESTERONE CAPROATE	250	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0517-1820_2c97dd4f-150c-4fc0-9400-2d8305bb21b0	0517-1820	HUMAN PRESCRIPTION DRUG	Chlorothiazide Sodium		Chlorothiazide Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150401		ANDA	ANDA202561	American Regent, Inc.	CHLOROTHIAZIDE SODIUM	500	mg/18mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0517-1830_110449a6-1353-41e1-a41e-cb4cb4f0a5ae	0517-1830	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20190719		ANDA	ANDA207742	American Regent, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0517-1980_c937bc30-3d00-4367-87f9-49cfc5766fbd	0517-1980	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	20170901		ANDA	ANDA208353	American Regent, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0517-2051_90a23cc9-db2b-4f24-b2cf-ea7abf6c9944	0517-2051	HUMAN PRESCRIPTION DRUG	Potassium Phosphates		potassium phosphates	INJECTION, SOLUTION	INTRAVENOUS	20231013		ANDA	ANDA216274	American Regent, Inc.	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
0517-2102_90a23cc9-db2b-4f24-b2cf-ea7abf6c9944	0517-2102	HUMAN PRESCRIPTION DRUG	Potassium Phosphates		Potassium Phosphate	INJECTION, SOLUTION	INTRAVENOUS	20231013		ANDA	ANDA216274	American Regent, Inc.	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
0517-2310_0d23fc3d-925b-489a-833d-ccd1a49881c7	0517-2310	HUMAN PRESCRIPTION DRUG	Venofer		iron sucrose	INJECTION, SOLUTION	INTRAVENOUS	20070612		NDA	NDA021135	American Regent, Inc.	IRON SUCROSE	20	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0517-2325_0d23fc3d-925b-489a-833d-ccd1a49881c7	0517-2325	HUMAN PRESCRIPTION DRUG	Venofer		iron sucrose	INJECTION, SOLUTION	INTRAVENOUS	20110127		NDA	NDA021135	American Regent, Inc.	IRON SUCROSE	20	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0517-2340_0d23fc3d-925b-489a-833d-ccd1a49881c7	0517-2340	HUMAN PRESCRIPTION DRUG	Venofer		iron sucrose	INJECTION, SOLUTION	INTRAVENOUS	20001110		NDA	NDA021135	American Regent, Inc.	IRON SUCROSE	20	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0517-2340_dc0d986a-05da-4659-ad5a-26ec57cac899	0517-2340	HUMAN PRESCRIPTION DRUG	Venofer		iron sucrose	INJECTION, SOLUTION	INTRAVENOUS	20140714		NDA	NDA021135	American Regent, Inc.	IRON SUCROSE	20	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0517-2502_53245845-b446-46f8-bbe8-3323c58e10e5	0517-2502	HUMAN PRESCRIPTION DRUG	Caffeine and Sodium Benzoate		Caffeine and Sodium Benzoate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19930201		UNAPPROVED DRUG OTHER		American Regent, Inc.	CAFFEINE	125	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0517-2505_90a23cc9-db2b-4f24-b2cf-ea7abf6c9944	0517-2505	HUMAN PRESCRIPTION DRUG	Potassium Phosphates		Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic	INJECTION, SOLUTION	INTRAVENOUS	20231013		ANDA	ANDA216274	American Regent, Inc.	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
0517-3010_b885fb92-786e-49bf-aed2-17b430e4743e	0517-3010	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION, SOLUTION	INTRAVENOUS	20220422		UNAPPROVED DRUG OTHER		American Regent, Inc.	WATER	1	mL/mL			N	20241231
0517-3020_b885fb92-786e-49bf-aed2-17b430e4743e	0517-3020	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION, SOLUTION	INTRAVENOUS	20220422		UNAPPROVED DRUG OTHER		American Regent, Inc.	WATER	1	mL/mL			N	20241231
0517-4002_0a4f7219-b60d-46ff-9c63-e21271569771	0517-4002	HUMAN PRESCRIPTION DRUG	Papaverine Hydrochloride		Papaverine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19950901		UNAPPROVED DRUG OTHER		American Regent, Inc.	PAPAVERINE HYDROCHLORIDE	30	mg/mL			N	20241231
0517-4201_6d7bbb1a-0613-4ed8-8896-40c07c2b64df	0517-4201	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	19900930		ANDA	ANDA087408	American Regent, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0517-4300_2af4cfae-b569-4445-86f4-b11aba1a4538	0517-4300	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20230502		NDA	NDA211875	American Regent, Inc.	PACLITAXEL	100	mg/20mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0517-4601_0ac91c4c-256f-48ea-83c5-f23c56f5428f	0517-4601	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19900930		ANDA	ANDA089335	American Regent, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0517-4602_0ac91c4c-256f-48ea-83c5-f23c56f5428f	0517-4602	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19900930		ANDA	ANDA089335	American Regent, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0517-4605_0ac91c4c-256f-48ea-83c5-f23c56f5428f	0517-4605	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19900930		ANDA	ANDA089335	American Regent, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0517-4620_0ac91c4c-256f-48ea-83c5-f23c56f5428f	0517-4620	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19900930		ANDA	ANDA089335	American Regent, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0517-4810_ee83c8b9-c31a-4f32-9e9d-0370545204cb	0517-4810	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	INJECTION, SOLUTION	INTRAVENOUS	20030304		ANDA	ANDA072034	American Regent, Inc.	NITROGLYCERIN	5	mg/mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0517-5601_6d7bbb1a-0613-4ed8-8896-40c07c2b64df	0517-5601	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	19900930		ANDA	ANDA087408	American Regent, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0517-5602_6d7bbb1a-0613-4ed8-8896-40c07c2b64df	0517-5602	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	19900930		ANDA	ANDA087408	American Regent, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0517-6101_e5d2004c-bb47-42a6-aa17-e6e4cae3246f	0517-6101	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20200518		NDA	NDA209377	American Regent, Inc.	ZINC SULFATE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0517-6103_e5d2004c-bb47-42a6-aa17-e6e4cae3246f	0517-6103	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA209377	American Regent, Inc.	ZINC SULFATE	3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0517-6502_4f6657ea-8dfd-4a74-8a36-9855ca7fd34a	0517-6502	HUMAN PRESCRIPTION DRUG	Selenious Acid		Selenious Acid	INJECTION, SOLUTION	INTRAVENOUS	20220328		NDA	NDA209379	American Regent, Inc.	SELENIUM	6	ug/mL			N	20251231
0517-6560_4f6657ea-8dfd-4a74-8a36-9855ca7fd34a	0517-6560	HUMAN PRESCRIPTION DRUG	Selenious Acid		Selenious Acid	INJECTION, SOLUTION	INTRAVENOUS	20190701		NDA	NDA209379	American Regent, Inc.	SELENIUM	60	ug/mL			N	20251231
0517-6710_c7e0f31e-f9cd-4f8f-afd8-170c7a66ba46	0517-6710	HUMAN PRESCRIPTION DRUG	Calcium Chloride		CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180206		ANDA	ANDA209088	American Regent, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0517-7504_d8c54054-153b-4e3a-9446-700b6f80bd6e	0517-7504	HUMAN PRESCRIPTION DRUG	Acetylcysteine		acetylcysteine	INHALANT	RESPIRATORY (INHALATION)	19951001		ANDA	ANDA072489	American Regent, Inc.	ACETYLCYSTEINE	100	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0517-7510_d8c54054-153b-4e3a-9446-700b6f80bd6e	0517-7510	HUMAN PRESCRIPTION DRUG	Acetylcysteine		acetylcysteine	INHALANT	RESPIRATORY (INHALATION)	19951001		ANDA	ANDA072489	American Regent, Inc.	ACETYLCYSTEINE	100	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0517-7604_d8c54054-153b-4e3a-9446-700b6f80bd6e	0517-7604	HUMAN PRESCRIPTION DRUG	Acetylcysteine		acetylcysteine	INHALANT	RESPIRATORY (INHALATION)	19951001		ANDA	ANDA072547	American Regent, Inc.	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0517-7610_d8c54054-153b-4e3a-9446-700b6f80bd6e	0517-7610	HUMAN PRESCRIPTION DRUG	Acetylcysteine		acetylcysteine	INHALANT	RESPIRATORY (INHALATION)	19951001		ANDA	ANDA072547	American Regent, Inc.	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0517-7630_d8c54054-153b-4e3a-9446-700b6f80bd6e	0517-7630	HUMAN PRESCRIPTION DRUG	Acetylcysteine		acetylcysteine	INHALANT	RESPIRATORY (INHALATION)	19951001		ANDA	ANDA072547	American Regent, Inc.	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0517-8005_e5d2004c-bb47-42a6-aa17-e6e4cae3246f	0517-8005	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA209377	American Regent, Inc.	ZINC SULFATE	5	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0517-8510_db92fb2d-610d-427e-ab62-0a0bb07e6cc0	0517-8510	HUMAN PRESCRIPTION DRUG	Multitrace-5		Trace Elements 5	INJECTION, SOLUTION	INTRAVENOUS	19940217		UNAPPROVED DRUG OTHER		American Regent, Inc.	CHROMIC CHLORIDE; CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE HEPTAHYDRATE	20.5; 1.57; .308; 32.7; 4.39	ug/mL; mg/mL; mg/mL; ug/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0517-9120_c62d23ae-6f20-4a53-94e4-4ba5d25b7231	0517-9120	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	INJECTION, SOLUTION	INTRAVENOUS	19900930		ANDA	ANDA071192	American Regent, Inc.	AMINOCAPROIC ACID	250	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
0517-9191_eea945f2-15ce-4ac9-b786-90f68f6e634c	0517-9191	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	INJECTION, SOLUTION	INTRAVENOUS	20190201		ANDA	ANDA071192	American Regent, Inc.	AMINOCAPROIC ACID	250	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
0517-9203_8e5be3e5-1916-4d19-87ab-e2092f5d4c5a	0517-9203	HUMAN PRESCRIPTION DRUG	Multitrace -4 Pediatric		Trace Elements 4	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	19931209		UNAPPROVED DRUG OTHER		American Regent, Inc.	CHROMIC CHLORIDE; CUPRIC SULFATE; MANGANESE SULFATE; ZINC SULFATE HEPTAHYDRATE	5.12; .4; 77; 4.39	ug/mL; mg/mL; ug/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0517-9302_d1c398ef-f162-49b3-89ff-59adff04ed27	0517-9302	HUMAN PRESCRIPTION DRUG	Multrys		Trace Elements Injection 4	INJECTION, SOLUTION	INTRAVENOUS	20210901		NDA	NDA209376	American Regent, Inc.	CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE	150; 8.22; 9.8; 2470	ug/mL; ug/mL; ug/mL; ug/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0517-9305_deeb1a5b-de13-4b67-b7c3-7503ca79926f	0517-9305	HUMAN PRESCRIPTION DRUG	Tralement		Trace Elements Injection 4	INJECTION, SOLUTION	INTRAVENOUS	20200929		NDA	NDA209376	American Regent, Inc.	CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE	.3; 55; 60; 3	mg/mL; ug/mL; ug/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
0517-9702_8bcdfec0-1df7-413d-82c1-ac564d18aaa0	0517-9702	HUMAN PRESCRIPTION DRUG	Droperidol		Droperidol	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19900930		ANDA	ANDA072123	American Regent, Inc.	DROPERIDOL	2.5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0519-6257_4d87d890-73c8-4d33-9469-e1451ed363d6	0519-6257	HUMAN OTC DRUG	Septihol Hand Sanitizer		Alcohol	AEROSOL, FOAM	TOPICAL	20210501		OTC MONOGRAPH DRUG	M003	STERIS Corporation	ALCOHOL	62	mL/100mL			N	20241231
0519-8802_9218fd1d-74ec-450a-b798-7e332fe724ff	0519-8802	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140908		OTC MONOGRAPH NOT FINAL	part333A	Steris Corporation	ALCOHOL	578	mg/mL			N	20241231
0527-0586_d8e70a41-d906-4ddd-b4d3-3850281f986e	0527-0586	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Lannett Company, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0527-0597_13517af4-9eee-422d-ae02-2a0f09101d74	0527-0597	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20071201		ANDA	ANDA087022	Lannett Company, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-0760_ac601486-681e-4068-bc88-01e1212c6c08	0527-0760	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20220708		ANDA	ANDA215565	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0761_ac601486-681e-4068-bc88-01e1212c6c08	0527-0761	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20220708		ANDA	ANDA215565	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0762_ac601486-681e-4068-bc88-01e1212c6c08	0527-0762	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20220708		ANDA	ANDA215565	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0763_ac601486-681e-4068-bc88-01e1212c6c08	0527-0763	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20220708		ANDA	ANDA215565	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0764_ac601486-681e-4068-bc88-01e1212c6c08	0527-0764	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20220708		ANDA	ANDA215565	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0765_ac601486-681e-4068-bc88-01e1212c6c08	0527-0765	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20220708		ANDA	ANDA215565	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0766_ac601486-681e-4068-bc88-01e1212c6c08	0527-0766	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20220708		ANDA	ANDA215565	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0790_bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9	0527-0790	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0791_bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9	0527-0791	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0792_bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9	0527-0792	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0793_bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9	0527-0793	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0794_bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9	0527-0794	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-0795_bcd83dbd-5f90-45d7-b85d-6e4cbd62e1e9	0527-0795	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1170_7d6498f1-eb15-4601-861d-5cc81862292a	0527-1170	HUMAN PRESCRIPTION DRUG	DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE		DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE	TABLET	ORAL	19780221		ANDA	ANDA085372	Lannett Company, Inc.	ATROPINE; DIPHENOXYLATE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
0527-1221_5931403d-152d-43b3-b6df-941c580affa8	0527-1221	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20161110		ANDA	ANDA207236	Lannett Company, Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0527-1222_5931403d-152d-43b3-b6df-941c580affa8	0527-1222	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20161110		ANDA	ANDA207236	Lannett Company, Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0527-1231_5825879a-e77d-4416-b031-ad6c9515b802	0527-1231	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	19781201		ANDA	ANDA084903	Lannett Company, Inc.	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0527-1242_1b10ebb9-8a76-41c8-bf18-166e54471b0d	0527-1242	HUMAN PRESCRIPTION DRUG	Fludarabine Phosphate		Fludarabine Phosphate	INJECTION	INTRAVENOUS	20191231		ANDA	ANDA090724	Lannett Company, Inc.	FLUDARABINE PHOSPHATE	25	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0527-1282_d8e70a41-d906-4ddd-b4d3-3850281f986e	0527-1282	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	Lannett Company, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0527-1301_5825879a-e77d-4416-b031-ad6c9515b802	0527-1301	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20010524		ANDA	ANDA084903	Lannett Company, Inc.	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0527-1308_13517af4-9eee-422d-ae02-2a0f09101d74	0527-1308	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20071201		ANDA	ANDA087022	Lannett Company, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1310_13517af4-9eee-422d-ae02-2a0f09101d74	0527-1310	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20071201		ANDA	ANDA087022	Lannett Company, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1311_f2e6055d-7a43-403a-8787-75259d9f7af7	0527-1311	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20050325		ANDA	ANDA077152	Lannett Company, Inc.	TERBUTALINE SULFATE	5	mg/1			N	20241231
0527-1312_b040a6d6-8f3b-4f09-825f-cf2a2fec2499	0527-1312	HUMAN PRESCRIPTION DRUG	Butalbital, Aspirin, Caffeine and Codeine Phosphate		Butalbital, Aspirin, Caffeine and Codeine Phosphate	CAPSULE	ORAL	19980831		ANDA	ANDA074951	Lannett Company, Inc.	ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	20241231
0527-1313_b10fcdbb-cba7-45d5-9476-a45cb857caaf	0527-1313	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20051014		ANDA	ANDA077220	Lannett Company, Inc.	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0527-1318_f2e6055d-7a43-403a-8787-75259d9f7af7	0527-1318	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20050325		ANDA	ANDA077152	Lannett Company, Inc.	TERBUTALINE SULFATE	2.5	mg/1			N	20241231
0527-1326_c2f5fb91-e93d-430f-bc5e-bbba09b508f5	0527-1326	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20090101		ANDA	ANDA079082	Lannett Company, Inc.	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
0527-1329_747a1dfb-7e27-4592-8816-b2d91caa9012	0527-1329	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20080327		ANDA	ANDA040677	Lannett Company, Inc.	BETHANECHOL CHLORIDE	50	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0527-1330_153f6bd7-9462-4d92-b738-48e7807c5919	0527-1330	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Lannett Company, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0527-1332_747a1dfb-7e27-4592-8816-b2d91caa9012	0527-1332	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20080327		ANDA	ANDA040677	Lannett Company, Inc.	BETHANECHOL CHLORIDE	5	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0527-1333_153f6bd7-9462-4d92-b738-48e7807c5919	0527-1333	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20210922		ANDA	ANDA077241	Lannett Company, Inc.	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0527-1335_b7dcf9c9-643e-4db7-9531-9c39a102df95	0527-1335	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20051208		ANDA	ANDA065285	Lannett Company, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0527-1337_153f6bd7-9462-4d92-b738-48e7807c5919	0527-1337	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	Lannett Company, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0527-1338_b7dcf9c9-643e-4db7-9531-9c39a102df95	0527-1338	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20051208		ANDA	ANDA065285	Lannett Company, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0527-1340_747a1dfb-7e27-4592-8816-b2d91caa9012	0527-1340	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20080327		ANDA	ANDA040677	Lannett Company, Inc.	BETHANECHOL CHLORIDE	10	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0527-1353_96651dd3-483d-41c4-b179-e7e05470d205	0527-1353	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Lannett Company, Inc.	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1354_96651dd3-483d-41c4-b179-e7e05470d205	0527-1354	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Lannett Company, Inc.	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1355_96651dd3-483d-41c4-b179-e7e05470d205	0527-1355	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Lannett Company, Inc.	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1356_747a1dfb-7e27-4592-8816-b2d91caa9012	0527-1356	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20080327		ANDA	ANDA040677	Lannett Company, Inc.	BETHANECHOL CHLORIDE	25	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0527-1367_64677a67-fc89-4480-a02c-edb65c0b5e28	0527-1367	HUMAN PRESCRIPTION DRUG	Probenecid		Probenecid	TABLET, FILM COATED	ORAL	19760729		ANDA	ANDA080966	Lannett Company, Inc.	PROBENECID	500	mg/1			N	20241231
0527-1368_399a377e-237d-4939-ad70-805ebd30a1c9	0527-1368	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20070419		ANDA	ANDA078214	Lannett Company, Inc.	DANAZOL	100	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
0527-1369_399a377e-237d-4939-ad70-805ebd30a1c9	0527-1369	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20050928		ANDA	ANDA077246	Lannett Company, Inc.	DANAZOL	200	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
0527-1392_399a377e-237d-4939-ad70-805ebd30a1c9	0527-1392	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20070419		ANDA	ANDA078214	Lannett Company, Inc.	DANAZOL	50	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
0527-1394_d3cf2be5-8c99-4a5a-85ec-be5aa26ac928	0527-1394	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20110926		ANDA	ANDA090695	Lannett Company, Inc.	LOXAPINE SUCCINATE	5	mg/1			N	20241231
0527-1395_d3cf2be5-8c99-4a5a-85ec-be5aa26ac928	0527-1395	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20110926		ANDA	ANDA090695	Lannett Company, Inc.	LOXAPINE SUCCINATE	10	mg/1			N	20241231
0527-1396_d3cf2be5-8c99-4a5a-85ec-be5aa26ac928	0527-1396	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20110926		ANDA	ANDA090695	Lannett Company, Inc.	LOXAPINE SUCCINATE	25	mg/1			N	20241231
0527-1397_d3cf2be5-8c99-4a5a-85ec-be5aa26ac928	0527-1397	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20110926		ANDA	ANDA090695	Lannett Company, Inc.	LOXAPINE SUCCINATE	50	mg/1			N	20241231
0527-1407_b10fcdbb-cba7-45d5-9476-a45cb857caaf	0527-1407	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20051014		ANDA	ANDA077220	Lannett Company, Inc.	PILOCARPINE HYDROCHLORIDE	7.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0527-1413_7ab02f2a-c630-488e-8395-cd83da05e565	0527-1413	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070501		ANDA	ANDA084325	Lannett Company, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0527-1414_7ab02f2a-c630-488e-8395-cd83da05e565	0527-1414	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070501		ANDA	ANDA084324	Lannett Company, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0527-1435_12cd3176-5d6e-43bb-9a0b-41f6ff17d8aa	0527-1435	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Lannett Company, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
0527-1438_13517af4-9eee-422d-ae02-2a0f09101d74	0527-1438	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20100719		ANDA	ANDA091359	Lannett Company, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1445_71a5941a-3831-4042-989d-1c47e1b65bab	0527-1445	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20050415		ANDA	ANDA040555	Lannett Company, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1450_87de6548-70dd-4efd-b3c5-8f5a1749e395	0527-1450	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20180518		ANDA	ANDA201463	Lannett Company, Inc.	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
0527-1451_87de6548-70dd-4efd-b3c5-8f5a1749e395	0527-1451	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20180518		ANDA	ANDA201463	Lannett Company, Inc.	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
0527-1452_87de6548-70dd-4efd-b3c5-8f5a1749e395	0527-1452	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20180518		ANDA	ANDA201463	Lannett Company, Inc.	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
0527-1461_c8c9bc23-afe1-4cde-aed0-64f3d21b94f8	0527-1461	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080423		ANDA	ANDA040898	Lannett Company, Inc.	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0527-1462_c8c9bc23-afe1-4cde-aed0-64f3d21b94f8	0527-1462	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080423		ANDA	ANDA040898	Lannett Company, Inc.	DIPYRIDAMOLE	50	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0527-1463_c8c9bc23-afe1-4cde-aed0-64f3d21b94f8	0527-1463	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080423		ANDA	ANDA040898	Lannett Company, Inc.	DIPYRIDAMOLE	75	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0527-1475_7188e0f4-81a7-47ca-9eb8-da2a1d5cdcd3	0527-1475	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride		Diethylpropion Hydrochloride	TABLET	ORAL	20110718		ANDA	ANDA200177	Lannett Company, Inc.	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1477_d3d06946-dd79-43e6-bdc0-02e29d9da026	0527-1477	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride	ER	Diethylpropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111024		ANDA	ANDA091680	Lannett Company, Inc.	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1500_c8e3e12d-63f1-451f-ab4e-51c7ec63cecf	0527-1500	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20181212		ANDA	ANDA211352	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1501_c8e3e12d-63f1-451f-ab4e-51c7ec63cecf	0527-1501	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20181212		ANDA	ANDA211352	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1502_c8e3e12d-63f1-451f-ab4e-51c7ec63cecf	0527-1502	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20181212		ANDA	ANDA211352	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1503_c8e3e12d-63f1-451f-ab4e-51c7ec63cecf	0527-1503	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20181212		ANDA	ANDA211352	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1504_c8e3e12d-63f1-451f-ab4e-51c7ec63cecf	0527-1504	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20181212		ANDA	ANDA211352	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1505_c8e3e12d-63f1-451f-ab4e-51c7ec63cecf	0527-1505	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20181212		ANDA	ANDA211352	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1506_c8e3e12d-63f1-451f-ab4e-51c7ec63cecf	0527-1506	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20181212		ANDA	ANDA211352	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1535_b7dcf9c9-643e-4db7-9531-9c39a102df95	0527-1535	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20080825		ANDA	ANDA065285	Lannett Company, Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0527-1537_b7dcf9c9-643e-4db7-9531-9c39a102df95	0527-1537	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20080825		ANDA	ANDA065285	Lannett Company, Inc.	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0527-1552_04d698c2-dd59-4d9e-b8eb-8f45030d4cdd	0527-1552	HUMAN PRESCRIPTION DRUG	Butalbital, aspirin, and caffeine		Butalbital, aspirin, and caffeine	CAPSULE	ORAL	19851011	20260831	ANDA	ANDA086996	Lannett Company, Inc.	ASPIRIN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	
0527-1632_4d422902-e50b-4596-a753-5d5a9b29b209	0527-1632	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20111209		ANDA	ANDA201407	Lannett Company, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0527-1646_546e215e-32fd-4fed-9532-059860eecd62	0527-1646	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170620		ANDA	ANDA207171	Lannett Company, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
0527-1647_546e215e-32fd-4fed-9532-059860eecd62	0527-1647	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170620		ANDA	ANDA207171	Lannett Company, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
0527-1648_546e215e-32fd-4fed-9532-059860eecd62	0527-1648	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170620		ANDA	ANDA207171	Lannett Company, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
0527-1649_7fbc3f0d-0b5f-4057-8cd9-731c3e5b8a33	0527-1649	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA207172	Lannett Company, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0527-1650_7fbc3f0d-0b5f-4057-8cd9-731c3e5b8a33	0527-1650	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA207172	Lannett Company, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0527-1651_7fbc3f0d-0b5f-4057-8cd9-731c3e5b8a33	0527-1651	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA207172	Lannett Company, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0527-1669_eeba5087-0da5-476e-9efc-e6e24a231629	0527-1669	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170925		ANDA	ANDA207333	Lannett Company, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1671_eeba5087-0da5-476e-9efc-e6e24a231629	0527-1671	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170925		ANDA	ANDA207333	Lannett Company, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1695_09ee20d4-6ac0-4069-8270-0581e323bb12	0527-1695	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20120913		ANDA	ANDA200243	Lannett Company, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0527-1698_3db82243-1649-4470-91af-af12a932f456	0527-1698	HUMAN PRESCRIPTION DRUG	Codeine Sulfate		Codeine Sulfate	TABLET	ORAL	20140613		ANDA	ANDA203046	Lannett Company, Inc.	CODEINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1699_3db82243-1649-4470-91af-af12a932f456	0527-1699	HUMAN PRESCRIPTION DRUG	Codeine Sulfate		Codeine Sulfate	TABLET	ORAL	20140613		ANDA	ANDA203046	Lannett Company, Inc.	CODEINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1742_13517af4-9eee-422d-ae02-2a0f09101d74	0527-1742	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120120		ANDA	ANDA087022	Lannett Company, Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1743_fa4eafdd-0a89-46fd-aedf-7ccd5776c42a	0527-1743	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20110720		ANDA	ANDA201961	Lannett Company, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
0527-1774_854d438c-9766-4ab7-b280-9c276153529a	0527-1774	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	CAPSULE	ORAL	20140801		ANDA	ANDA203823	Lannett Company, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1788_daa47c80-1e79-4bc6-b560-b22e80c5f952	0527-1788	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Lannett Company, Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-1789_daa47c80-1e79-4bc6-b560-b22e80c5f952	0527-1789	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Lannett Company, Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-1790_daa47c80-1e79-4bc6-b560-b22e80c5f952	0527-1790	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Lannett Company, Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-1791_daa47c80-1e79-4bc6-b560-b22e80c5f952	0527-1791	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Lannett Company, Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-1818_e1729091-ed76-43f7-a710-afacba56bb0f	0527-1818	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	SPRAY	NASAL	20160219		ANDA	ANDA204841	Lannett Company, Inc.	SUMATRIPTAN	5	mg/.1mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0527-1830_071b5720-d208-9e0e-e063-6294a90a0513	0527-1830	HUMAN PRESCRIPTION DRUG	Entacapone		entacapone	TABLET, FILM COATED	ORAL	20181220		ANDA	ANDA206669	Lannett Company, Inc.	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0527-1859_e1729091-ed76-43f7-a710-afacba56bb0f	0527-1859	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	SPRAY	NASAL	20160219		ANDA	ANDA204841	Lannett Company, Inc.	SUMATRIPTAN	20	mg/.1mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0527-1899_4edb2085-e7e1-4f52-a8fe-dd3bc175c052	0527-1899	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20170925		ANDA	ANDA209468	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1900_4edb2085-e7e1-4f52-a8fe-dd3bc175c052	0527-1900	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20170925		ANDA	ANDA209468	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1901_4edb2085-e7e1-4f52-a8fe-dd3bc175c052	0527-1901	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		dexmethylphenidate hydrochloride	TABLET	ORAL	20170925		ANDA	ANDA209468	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-1926_6714ab49-287c-460f-84c6-4a2eb909b896	0527-1926	HUMAN PRESCRIPTION DRUG	Methadone Hydrocloride		methadone hydrochloride	CONCENTRATE	ORAL	20210303		ANDA	ANDA212094	Lannett Company, Inc.	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1927_6f18816c-0d2a-41d0-95ef-7db0a2bb2bbe	0527-1927	HUMAN PRESCRIPTION DRUG	Methadone Hydrocloride	dye-free, sugar-free, unflavored	methadone hydrochloride	CONCENTRATE	ORAL	20201102		ANDA	ANDA212093	Lannett Company, Inc.	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-1930_05ef280b-60a9-77ec-e063-6394a90a7821	0527-1930	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA208987	Lannett Company, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0527-1931_0a136962-d1f1-f728-e063-6394a90a01b0	0527-1931	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20191123		ANDA	ANDA203584	Lannett Company, Inc.	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0527-1932_0a136962-d1f1-f728-e063-6394a90a01b0	0527-1932	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20191123		ANDA	ANDA203584	Lannett Company, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0527-1933_ee4e17cc-e1c9-419e-838d-f21313e021d4	0527-1933	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20230606		ANDA	ANDA211622	Lannett Company, Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0527-1934_ee4e17cc-e1c9-419e-838d-f21313e021d4	0527-1934	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20230606		ANDA	ANDA211622	Lannett Company, Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0527-1943_bd33c8de-5194-4b37-8a5f-c2b691d6aa5d	0527-1943	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	SOLUTION	ORAL	20151013	20240531	ANDA	ANDA204033	Lannett Company, Inc.	MEMANTINE HYDROCHLORIDE	2	mg/mL	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	
0527-1947_751545a0-3b8c-4486-821d-94eb6383dc52	0527-1947	HUMAN PRESCRIPTION DRUG	Lopinavir-Ritonavir		Lopinavir-Ritonavir	SOLUTION	ORAL	20161227		ANDA	ANDA207407	Lannett Company, Inc.	LOPINAVIR; RITONAVIR	80; 20	mg/mL; mg/mL	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
0527-1948_d9ed9779-ac7b-4cc8-a663-f2326cacf4b7	0527-1948	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	SOLUTION	ORAL	20180525		ANDA	ANDA205222	Lannett Company, Inc.	LEVOFLOXACIN	25	mg/mL			N	20241231
0527-1949_06a06ff1-54cb-427a-b208-7e3cce78d398	0527-1949	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	SOLUTION	ORAL	20170713	20240131	ANDA	ANDA203191	Lannett Company, Inc.	CYPROHEPTADINE HYDROCHLORIDE	2	mg/5mL			N	
0527-1971_97ccac10-e64a-405d-a886-e622a5a97d0b	0527-1971	HUMAN PRESCRIPTION DRUG	cocaine hydrochloride nasal		cocaine hydrochloride nasal	SOLUTION	TOPICAL	20200110	20240831	NDA AUTHORIZED GENERIC	NDA209575	Lannett Company, Inc.	COCAINE HYDROCHLORIDE	40	mg/mL		CII	N	
0527-2133_b2ab1917-7791-4a0c-8e11-9c03b3ef01e1	0527-2133	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20190828		ANDA	ANDA212411	Lannett Company Inc.	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0527-2170_8b211626-6778-4ce8-b390-155373005da6	0527-2170	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, EXTENDED RELEASE	ORAL	20021106		ANDA	ANDA076201	Lannett Company, Inc.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0527-2215_fa932ec2-1e68-4e48-a492-ddf5bda15eb2	0527-2215	HUMAN PRESCRIPTION DRUG	metolazone		metolazone	TABLET	ORAL	19731127	20240131	NDA AUTHORIZED GENERIC	NDA017386	Lannett Company, Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	
0527-2216_fa932ec2-1e68-4e48-a492-ddf5bda15eb2	0527-2216	HUMAN PRESCRIPTION DRUG	metolazone		metolazone	TABLET	ORAL	19731127	20240131	NDA AUTHORIZED GENERIC	NDA017386	Lannett Company, Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	
0527-2217_fa932ec2-1e68-4e48-a492-ddf5bda15eb2	0527-2217	HUMAN PRESCRIPTION DRUG	metolazone		metolazone	TABLET	ORAL	19731127	20240131	NDA AUTHORIZED GENERIC	NDA017386	Lannett Company, Inc.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	
0527-2244_e37eb896-8c23-7687-e053-2995a90af016	0527-2244	HUMAN PRESCRIPTION DRUG	FEBUXOSTAT		febuxostat	TABLET	ORAL	20200602		ANDA	ANDA213069	Lannett Company, Inc.	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0527-2248_e37eb896-8c23-7687-e053-2995a90af016	0527-2248	HUMAN PRESCRIPTION DRUG	FEBUXOSTAT		febuxostat	TABLET	ORAL	20200602		ANDA	ANDA213069	Lannett Company, Inc.	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0527-2370_006e8c30-31d7-1039-e063-6394a90a7444	0527-2370	HUMAN PRESCRIPTION DRUG	azithromycin		AZITHROMYCIN MONOHYDRATE	TABLET, FILM COATED	ORAL	20190704		ANDA	ANDA209045	Lannett Company, Inc.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0527-2395_006e8c30-31d7-1039-e063-6394a90a7444	0527-2395	HUMAN PRESCRIPTION DRUG	azithromycin		AZITHROMYCIN MONOHYDRATE	TABLET, FILM COATED	ORAL	20190704		ANDA	ANDA209044	Lannett Company, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0527-2425_dc0e3a14-55e1-706b-e053-2995a90acead	0527-2425	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		Olmesartan medoxomil	TABLET, FILM COATED	ORAL	20190305		ANDA	ANDA211049	Lannett Company, Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0527-2426_dc0e3a14-55e1-706b-e053-2995a90acead	0527-2426	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		Olmesartan medoxomil	TABLET, FILM COATED	ORAL	20190305		ANDA	ANDA211049	Lannett Company, Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0527-2427_dc0e3a14-55e1-706b-e053-2995a90acead	0527-2427	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		Olmesartan medoxomil	TABLET, FILM COATED	ORAL	20190305		ANDA	ANDA211049	Lannett Company, Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0527-2524_e02abc41-2428-4c48-ab5e-5c5fa0e91cea	0527-2524	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200525		ANDA	ANDA212901	Lannett Company, Inc.	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-2525_e02abc41-2428-4c48-ab5e-5c5fa0e91cea	0527-2525	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200525		ANDA	ANDA212901	Lannett Company, Inc.	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-2580_0ead960b-0e48-cf8a-e063-6294a90aa925	0527-2580	HUMAN PRESCRIPTION DRUG	Fluvastatin Sodium		Fluvastatin Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210507		ANDA	ANDA209397	Lannett Company, Inc.	FLUVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
0527-2604_22da933d-33b2-43fa-b30f-bc0e599e99ac	0527-2604	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20191226		ANDA	ANDA209193	Lannett Company, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0527-2605_22da933d-33b2-43fa-b30f-bc0e599e99ac	0527-2605	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20191226		ANDA	ANDA209193	Lannett Company, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0527-2606_b296ebac-8124-4376-8b0b-3acd719df847	0527-2606	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20210406		ANDA	ANDA213927	Lannett Company, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0527-2616_b296ebac-8124-4376-8b0b-3acd719df847	0527-2616	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20221231		ANDA	ANDA213927	Lannett Company, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0527-2800_c9c7a4ac-41c5-4754-8933-ebb0354e8ddd	0527-2800	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA209057	Lannett Company, Inc.	VARDENAFIL HYDROCHLORIDE	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0527-2801_c9c7a4ac-41c5-4754-8933-ebb0354e8ddd	0527-2801	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA209057	Lannett Company, Inc.	VARDENAFIL HYDROCHLORIDE	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0527-2802_c9c7a4ac-41c5-4754-8933-ebb0354e8ddd	0527-2802	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA209057	Lannett Company, Inc.	VARDENAFIL HYDROCHLORIDE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0527-2803_c9c7a4ac-41c5-4754-8933-ebb0354e8ddd	0527-2803	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA209057	Lannett Company, Inc.	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0527-2961_0d66289f-ce61-4b6b-b717-8a0b0b0da496	0527-2961	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Lannett Company, Inc.	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-2962_0d66289f-ce61-4b6b-b717-8a0b0b0da496	0527-2962	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Lannett Company, Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-2963_0d66289f-ce61-4b6b-b717-8a0b0b0da496	0527-2963	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Lannett Company, Inc.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-2964_0d66289f-ce61-4b6b-b717-8a0b0b0da496	0527-2964	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Lannett Company, Inc.	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-2965_0d66289f-ce61-4b6b-b717-8a0b0b0da496	0527-2965	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Lannett Company, Inc.	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0527-3012_d734cd63-d4d9-4199-95d4-5e53cd1f5231	0527-3012	HUMAN PRESCRIPTION DRUG	MESALAMINE		mesalamine	TABLET, DELAYED RELEASE	ORAL	20230603		ANDA	ANDA217337	Lannett Company Inc.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0527-3161_002da62b-aec3-8e2a-e063-6294a90a5efc	0527-3161	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20230530		ANDA	ANDA208146	Lannett Company, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0527-3162_002da62b-aec3-8e2a-e063-6294a90a5efc	0527-3162	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20230530		ANDA	ANDA208146	Lannett Company, Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0527-3163_002da62b-aec3-8e2a-e063-6294a90a5efc	0527-3163	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20230530		ANDA	ANDA208146	Lannett Company, Inc.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0527-3164_002da62b-aec3-8e2a-e063-6294a90a5efc	0527-3164	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20230530		ANDA	ANDA208146	Lannett Company, Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0527-3219_aa8a58a9-7696-4c26-b277-6b4f74cd020e	0527-3219	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Lannett Company, Inc.	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0527-3220_aa8a58a9-7696-4c26-b277-6b4f74cd020e	0527-3220	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Lannett Company, Inc.	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0527-3221_aa8a58a9-7696-4c26-b277-6b4f74cd020e	0527-3221	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Lannett Company, Inc.	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0527-3236_95a5197a-6305-45c3-bea9-e50b334a9e32	0527-3236	HUMAN PRESCRIPTION DRUG	Levorphanol Tartrate		Levorphanol Tartrate	TABLET	ORAL	20190520		ANDA	ANDA213479	Lannett Company, Inc.	LEVORPHANOL TARTRATE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-3237_95a5197a-6305-45c3-bea9-e50b334a9e32	0527-3237	HUMAN PRESCRIPTION DRUG	Levorphanol Tartrate		Levorphanol Tartrate	TABLET	ORAL	20200112		ANDA	ANDA213479	Lannett Company, Inc.	LEVORPHANOL TARTRATE	3	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0527-3280_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3280	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3281_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3281	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3282_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3282	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3283_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3283	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3284_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3284	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3285_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3285	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3286_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3286	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3287_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3287	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3288_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3288	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3289_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3289	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3290_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3290	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-3291_0dfc6488-2bcb-6e01-e063-6394a90a8b2c	0527-3291	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Lannett Company, Inc	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
0527-4062_deea4759-8189-4dd3-8d07-99b569e2206b	0527-4062	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200724		ANDA	ANDA212997	Lannett Company, Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0527-4063_deea4759-8189-4dd3-8d07-99b569e2206b	0527-4063	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200724		ANDA	ANDA212997	Lannett Company, Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0527-4064_deea4759-8189-4dd3-8d07-99b569e2206b	0527-4064	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200724		ANDA	ANDA212997	Lannett Company, Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0527-4065_deea4759-8189-4dd3-8d07-99b569e2206b	0527-4065	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200724		ANDA	ANDA212997	Lannett Company, Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0527-4066_deea4759-8189-4dd3-8d07-99b569e2206b	0527-4066	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200724		ANDA	ANDA212997	Lannett Company, Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0527-4068_0090a2e0-927a-4284-a88b-b3c4cb7dbbdb	0527-4068	HUMAN PRESCRIPTION DRUG	TRIENTINE HYDROCHLORIDE		TRIENTINE HYDROCHLORIDE	CAPSULE	ORAL	20201222		ANDA	ANDA211251	Lannett Company Inc.	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
0527-4094_e505b8df-b401-4967-b4d5-c0717a6a1d08	0527-4094	HUMAN PRESCRIPTION DRUG	butalbital, acetaminophen and caffeine		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20191217		ANDA	ANDA212083	Lannett Company, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0527-4095_146b5639-6699-471c-ae28-1f576bbead9f	0527-4095	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine Capsules	CAPSULE	ORAL	20191217		ANDA	ANDA212082	Lannett Company, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0527-4107_328667a9-1180-4924-aef5-c23c738af939	0527-4107	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200723		ANDA	ANDA213500	Lannett Company, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
0527-4108_328667a9-1180-4924-aef5-c23c738af939	0527-4108	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200723		ANDA	ANDA213500	Lannett Company, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
0527-4109_328667a9-1180-4924-aef5-c23c738af939	0527-4109	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200723		ANDA	ANDA213500	Lannett Company, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
0527-4116_69e6688b-88a4-4305-91da-391e407f4f84	0527-4116	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200106		ANDA	ANDA212026	Lannett Company, Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0527-4117_69e6688b-88a4-4305-91da-391e407f4f84	0527-4117	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200106		ANDA	ANDA212026	Lannett Company, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0527-4118_69e6688b-88a4-4305-91da-391e407f4f84	0527-4118	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200106		ANDA	ANDA212026	Lannett Company, Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0527-4119_69e6688b-88a4-4305-91da-391e407f4f84	0527-4119	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200106		ANDA	ANDA212026	Lannett Company, Inc.	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0527-4125_aac4561c-b9ba-4d3a-b86c-be120e4593dc	0527-4125	HUMAN PRESCRIPTION DRUG	DRONABINOL		dronabinol	CAPSULE	ORAL	20200210		ANDA	ANDA207421	Lannett Company, Inc.	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
0527-4180_c83184cf-25bc-46f0-b29b-ea16e6f00fac	0527-4180	HUMAN PRESCRIPTION DRUG	Prazosin		Prazosin	CAPSULE	ORAL	20240103		ANDA	ANDA214083	Lannett Company, Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0527-4181_c83184cf-25bc-46f0-b29b-ea16e6f00fac	0527-4181	HUMAN PRESCRIPTION DRUG	Prazosin		Prazosin	CAPSULE	ORAL	20240103		ANDA	ANDA214083	Lannett Company, Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0527-4182_c83184cf-25bc-46f0-b29b-ea16e6f00fac	0527-4182	HUMAN PRESCRIPTION DRUG	Prazosin		Prazosin	CAPSULE	ORAL	20240103		ANDA	ANDA214083	Lannett Company, Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
0527-4579_72b41a0f-09a7-482c-8f0c-7712246087aa	0527-4579	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride CD		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030812		NDA AUTHORIZED GENERIC	NDA021259	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4580_72b41a0f-09a7-482c-8f0c-7712246087aa	0527-4580	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride CD		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030218		NDA AUTHORIZED GENERIC	NDA021259	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4581_72b41a0f-09a7-482c-8f0c-7712246087aa	0527-4581	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride CD		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030722		NDA AUTHORIZED GENERIC	NDA021259	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4582_72b41a0f-09a7-482c-8f0c-7712246087aa	0527-4582	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride CD		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20060321		NDA AUTHORIZED GENERIC	NDA021259	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4583_72b41a0f-09a7-482c-8f0c-7712246087aa	0527-4583	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride CD		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20060321		NDA AUTHORIZED GENERIC	NDA021259	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4584_72b41a0f-09a7-482c-8f0c-7712246087aa	0527-4584	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride CD		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20060321		NDA AUTHORIZED GENERIC	NDA021259	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4591_00e310fb-2460-a1bf-e063-6394a90a2457	0527-4591	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		oseltamivir phosphate	CAPSULE	ORAL	20230515		ANDA	ANDA212739	Lannett Company, Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0527-4592_00e310fb-2460-a1bf-e063-6394a90a2457	0527-4592	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		oseltamivir phosphate	CAPSULE	ORAL	20230515		ANDA	ANDA212739	Lannett Company, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0527-4593_00e310fb-2460-a1bf-e063-6394a90a2457	0527-4593	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		oseltamivir phosphate	CAPSULE	ORAL	20230515		ANDA	ANDA212739	Lannett Company, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0527-4661_981ca74f-737d-45e5-a3b2-b25256263768	0527-4661	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA215802	Lannett Company, Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4662_981ca74f-737d-45e5-a3b2-b25256263768	0527-4662	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA215802	Lannett Company, Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4663_981ca74f-737d-45e5-a3b2-b25256263768	0527-4663	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA215802	Lannett Company, Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4664_981ca74f-737d-45e5-a3b2-b25256263768	0527-4664	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA215802	Lannett Company, Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4665_981ca74f-737d-45e5-a3b2-b25256263768	0527-4665	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA215802	Lannett Company, Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4666_981ca74f-737d-45e5-a3b2-b25256263768	0527-4666	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA215802	Lannett Company, Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4667_981ca74f-737d-45e5-a3b2-b25256263768	0527-4667	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA215802	Lannett Company, Inc.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-4951_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4951	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	13	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4952_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4952	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4953_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4953	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4954_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4954	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4955_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4955	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4956_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4956	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4957_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4957	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4958_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4958	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4959_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4959	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4960_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4960	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4961_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4961	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-4962_0b273fe1-0b63-ec03-e063-6294a90a5ab6	0527-4962	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20201102		NDA AUTHORIZED GENERIC	NDA021924	Lannett Company, Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0527-5120_bfb6944f-ad8c-4bcf-98bf-b0eb806e9172	0527-5120	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	19960730		ANDA	ANDA074623	Lannett Company, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0527-5121_ecee61db-4b5c-4d8a-8c31-e02d15fbece1	0527-5121	HUMAN PRESCRIPTION DRUG	Nystatin Oral Suspension		Nystatin Oral Suspension	SOLUTION	ORAL	20050628		ANDA	ANDA065148	Lannett Company, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0527-5125_1b869904-b3c5-4f81-a333-1f26b6b2c7bf	0527-5125	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	20010726		ANDA	ANDA075993	Lannett Company, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0527-5137_0070049a-785f-56da-e063-6394a90adb25	0527-5137	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		oseltamivir phosphate	SUSPENSION	ORAL	20230713		ANDA	ANDA213594	Lannett Company, Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
0527-5160_cf98576e-03d7-46f1-a7fc-6caef50ac8df	0527-5160	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	POWDER, FOR SUSPENSION	ORAL	20210729		ANDA	ANDA214525	Lannett Company, Inc.	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
0527-5180_014233b6-20bc-4004-a83a-3e8ece36ea97	0527-5180	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20070124	20240331	ANDA	ANDA077785	Lannett Company, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	
0527-5181_014233b6-20bc-4004-a83a-3e8ece36ea97	0527-5181	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20070124	20240331	ANDA	ANDA077785	Lannett Company, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	
0527-5250_c72bdbdd-4aac-46ad-95a7-4d79690e9031	0527-5250	HUMAN PRESCRIPTION DRUG	VALPROIC ACID		VALPROIC ACID	SOLUTION	ORAL	20061013		ANDA	ANDA077960	Lannett Company, Inc.	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0527-5406_92ae73c9-e1d5-4de0-94c2-781e7ace5834	0527-5406	HUMAN PRESCRIPTION DRUG	PrednisoLONE		Prednisolone	SYRUP	ORAL	20070921		ANDA	ANDA040775	Lannett Company, Inc.	PREDNISOLONE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0527-5510_2f5fae05-6e77-4992-8c87-264b98ccf84d	0527-5510	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191218		ANDA	ANDA212037	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-5511_2f5fae05-6e77-4992-8c87-264b98ccf84d	0527-5511	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191218		ANDA	ANDA212037	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-5512_2f5fae05-6e77-4992-8c87-264b98ccf84d	0527-5512	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191218		ANDA	ANDA212037	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-5513_2f5fae05-6e77-4992-8c87-264b98ccf84d	0527-5513	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191218		ANDA	ANDA212037	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-5514_2f5fae05-6e77-4992-8c87-264b98ccf84d	0527-5514	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191218		ANDA	ANDA212037	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-5515_2f5fae05-6e77-4992-8c87-264b98ccf84d	0527-5515	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191218		ANDA	ANDA212037	Lannett Company, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-6002_f2b2b472-fa86-4459-8795-cf9e0a45eecd	0527-6002	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	OROPHARYNGEAL	20070227	20240531	ANDA	ANDA040708	Lannett Company, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
0527-6004_57338904-9362-4312-8b58-cc19e3f89d38	0527-6004	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL	20070227		ANDA	ANDA040710	Lannett Company, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0527-6123_f3d34dea-e901-46b9-80f8-b314ca57020c	0527-6123	HUMAN PRESCRIPTION DRUG	Sevoflurane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20230818		ANDA	ANDA214382	Lannett Company, Inc.	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0527-8106_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8106	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-8107_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8107	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-8108_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8108	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-8109_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8109	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-8110_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8110	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-8111_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8111	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-8112_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8112	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0527-8113_e4c11747-213b-4b92-9490-c33f4e3a2721	0527-8113	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181009		ANDA	ANDA210279	Lannett Company, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0536-0015_09306334-8341-db28-e063-6394a90a376f	0536-0015	HUMAN OTC DRUG	ALMACONE DOUBLE STRENGTH		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20110105		OTC MONOGRAPH DRUG	M001	RUGBY LABORATORIES	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0536-0091_092ffeee-3ae1-a123-e063-6294a90a4b32	0536-0091	HUMAN OTC DRUG	Aluminum Hydroxide		aluminum hydroxide	LIQUID	ORAL	20050201		OTC MONOGRAPH DRUG	M001	Rugby Laboratories	ALUMINUM HYDROXIDE	320	mg/5mL			N	20241231
0536-1006_68b03150-22a3-408c-a6b1-1220d543b3ed	0536-1006	HUMAN OTC DRUG	Aller-chlor		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	Rugby Laboratories	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0536-1007_138e5f9e-5159-47fe-8688-284c196fbaf3	0536-1007	HUMAN OTC DRUG	Rugby Cal-Gest Antacid	Assorted Flavors	Antacid Tablets	TABLET, CHEWABLE	ORAL	20191030		OTC MONOGRAPH DRUG	M001	Rugby Laboratories, Inc.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0536-1008_63f65a45-3454-4171-8f98-e78600a8a84f	0536-1008	HUMAN OTC DRUG	Rugby Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20140321		OTC MONOGRAPH NOT FINAL	part343	Rugby Laboratories	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0536-1010_0eaf12c0-ca13-1396-e063-6294a90aa5c8	0536-1010	HUMAN OTC DRUG	Diphenhist		Diphenhydramine HCl	CAPSULE	ORAL	20140317	20250430	OTC MONOGRAPH DRUG	M012	Rugby Laboratories	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0536-1021_429ee2d1-2c5c-4967-bf7d-0e1e8ebd2768	0536-1021	HUMAN OTC DRUG	Peptic Relief		Peptic Relief	TABLET	ORAL	20140220		OTC MONOGRAPH FINAL	part335	Rugby Laboratories	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
0536-1046_0bde3e63-1c4c-3d9c-e063-6394a90ac09c	0536-1046	HUMAN OTC DRUG	Sodium Bicarbonate Antacid		Sodium Bicarbonate	TABLET	ORAL	20150325		OTC MONOGRAPH DRUG	M001	Rugby Laboratories	SODIUM BICARBONATE	325	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0536-1047_0eaf2d90-d844-3881-e063-6394a90a2742	0536-1047	HUMAN OTC DRUG	Sodium Bicarbonate Antacid		Sodium Bicarbonate	TABLET	ORAL	20150325		OTC MONOGRAPH DRUG	M001	Rugby Laboratories	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
0536-1048_610cc6c8-a4c6-40ac-bca5-5eb7be8642f6	0536-1048	HUMAN OTC DRUG	Rugby		Antacid Tablets	TABLET, CHEWABLE	ORAL	20121224		OTC MONOGRAPH DRUG	M001	Rugby Laboratories	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0536-1050_b4d15be9-ce86-455e-af7b-c0ad8d42fb24	0536-1050	HUMAN OTC DRUG	Rugby	Extra Strength Assorted Berries	Antacid Tablets	TABLET, CHEWABLE	ORAL	20191118		OTC MONOGRAPH DRUG	M001	Rugby Laboratories	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0536-1052_205ec3d7-ce33-49ea-bdc2-f2c78a94bb58	0536-1052	HUMAN OTC DRUG	rugby PEG 3350		POLYETHYLENE GLYCOL 3350	POWDER, FOR SOLUTION	ORAL	20150105		ANDA	ANDA090685	Rugby Laboratories	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0536-1054_3285c564-3ec2-4ddd-9010-27307fc56a3c	0536-1054	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Rugby Laboratories	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0536-1055_7dd13a35-c9e7-4a4c-a562-a79cf5b66aeb	0536-1055	HUMAN OTC DRUG	Rugby Benzoyl Peroxide	Acne Medication	Benzoyl Peroxide	GEL	TOPICAL	20150120		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories, Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
0536-1056_9d484819-3d46-43be-b3ee-fea6be3d3076	0536-1056	HUMAN OTC DRUG	Rugby Benzoyl Peroxide	Acne Medication	Benzoyl Peroxide	GEL	TOPICAL	20150120		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories, Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
0536-1057_edc7795f-60db-4d90-b4c6-aa586ca12f51	0536-1057	HUMAN OTC DRUG	Rugby Benzoyl Peroxide	Acne Medication	Benzoyl Peroxide	LOTION	TOPICAL	20150120		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories, Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
0536-1058_522d963d-b1df-4e6e-b3aa-582380458434	0536-1058	HUMAN OTC DRUG	Rugby Benzoyl Peroxide	Acne Medication	Benzoyl Peroxide	LOTION	TOPICAL	20150120		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories, Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
0536-1061_7e58d9a5-8cda-4366-b96f-cb15d12aded0	0536-1061	HUMAN OTC DRUG	Rugby Ice Blue	External Analgesic	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20150120		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories, Inc.	MENTHOL, UNSPECIFIED FORM	20	mg/g			N	20241231
0536-1065_85bad6d2-5e32-470d-9f58-7285b90c454e	0536-1065	HUMAN OTC DRUG	Stool Softener		Docusate calcium	CAPSULE, LIQUID FILLED	ORAL	20150131	20240223	OTC MONOGRAPH NOT FINAL	part334	Rugby Laboratories, Inc.	DOCUSATE CALCIUM	240	mg/1			N	
0536-1093_c46d1b38-5c25-473f-ac16-35a65902b416	0536-1093	HUMAN OTC DRUG	Rugby All Day Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20150902		ANDA	ANDA074661	Rugby Laboratories	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0536-1094_f63bc468-7973-4893-9e22-9eb397bd6773	0536-1094	HUMAN OTC DRUG	rugby all day relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20150902		ANDA	ANDA074661	Rugby Laboratories	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0536-1101_e8092960-4cb7-4a03-9f72-74dc4731f88f	0536-1101	HUMAN OTC DRUG	Rugby Pain Relieving	Analgesic	Menthol, Unspecified Form and Methyl Salicylate	CREAM	TOPICAL	20160511		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 150	mg/mL; mg/mL			N	20241231
0536-1103_0a532499-a5ff-a333-e063-6394a90a19fd	0536-1103	HUMAN OTC DRUG	Alcohol Prep Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20170405		OTC MONOGRAPH DRUG	M003	Rugby Laboratories	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
0536-1106_fccc46b5-cfc9-8eb6-30c1-a11319c12034	0536-1106	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160401		NDA	NDA020076	Rugby Laboratories	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1107_fccc46b5-cfc9-8eb6-30c1-a11319c12034	0536-1107	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160401		NDA	NDA020076	Rugby Laboratories	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1108_fccc46b5-cfc9-8eb6-30c1-a11319c12034	0536-1108	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160401		NDA	NDA020076	Rugby Laboratories	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1112_005a7a28-1bb7-13cf-bf60-baefc96e0927	0536-1112	HUMAN OTC DRUG	Budesonide		Budesonide	SPRAY, METERED	NASAL	20160713		ANDA	ANDA078949	Rugby Laboratories	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0536-1118_c221c55e-8bb6-41bf-b31e-a6bb7527811b	0536-1118	HUMAN OTC DRUG	Rugby Arthritis Pain Relieving	Topical Analgesic	Capsaicin	CREAM	TOPICAL	20170524		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories	CAPSAICIN	.75	mg/g			N	20241231
0536-1129_f406d10b-3f23-405e-ab46-f5ca29af9862	0536-1129	HUMAN OTC DRUG	Rugby Acne Medication Benzoyl Peroxide		Benzoyl Peroxide	GEL	TOPICAL	20191031		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories	BENZOYL PEROXIDE	25	mg/g			N	20241231
0536-1134_bbac48c4-ed9c-4713-ae82-def7e66d1316	0536-1134	HUMAN OTC DRUG	Miconazole Nitrate		MICONAZOLE NITRATE	CREAM	TOPICAL	19911001		OTC MONOGRAPH FINAL	part333C	Rugby Laboratories, Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0536-1137_a0c55dff-f90c-4af5-ac04-6f09bbcb5827	0536-1137	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180301		NDA	NDA021585	Rugby Laboratories	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0536-1139_b20041bc-3ba5-46c3-9f4c-c290d6b9567c	0536-1139	HUMAN OTC DRUG	Rugby Lidocaine		Lidocaine	CREAM	TOPICAL	20180921		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0536-1142_bea85d01-936e-46f6-8037-b60d0e39dd05	0536-1142	HUMAN OTC DRUG	Levonorgestrel		Levonorgestrel	TABLET	ORAL	20171101		ANDA	ANDA202635	Rugby Laboratories	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
0536-1143_6b94c8ae-a806-4822-99ac-7d40f0d3b2e5	0536-1143	HUMAN OTC DRUG	Rugby Petrolatum Hydrating	Skin Protectant	Petrolatum	OINTMENT	TOPICAL	20180531		OTC MONOGRAPH FINAL	part347	Rugby Laboratories	PETROLATUM	420	mg/g			N	20241231
0536-1144_daf74664-b2c9-5aed-96a9-acf815abdc43	0536-1144	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180420		ANDA	ANDA210375	RUGBY LABORATORIES	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0536-1147_ad0c2d7b-c9b8-4575-95cc-4626552b5ace	0536-1147	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228		ANDA	ANDA206568	Rugby Laboratories, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0536-1161_065e9247-fa6a-4a64-9c83-5f76702f5288	0536-1161	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20181213		ANDA	ANDA209692	Rugby Laboratories, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0536-1163_20890674-dbb0-47f1-b4b7-cd955790a101	0536-1163	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180831		ANDA	ANDA207342	Rugby Laboratories, Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0536-1164_7d71d000-d68f-41e0-a746-c5fe9114d160	0536-1164	HUMAN OTC DRUG	Rugby Acetaminophen		Acetaminophen	TABLET	ORAL	20190116		OTC MONOGRAPH NOT FINAL	part343	Rugby Laboratories	ACETAMINOPHEN	325	mg/1			N	20241231
0536-1168_0eafc535-7f23-7eab-e063-6294a90a07c8	0536-1168	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, FILM COATED	ORAL	20190123	20251130	OTC MONOGRAPH DRUG	M007	Rugby Laboratories	SENNOSIDES	8.6	mg/1			N	
0536-1172_0eaf3569-5e07-f353-e063-6294a90a4150	0536-1172	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20181001		OTC MONOGRAPH DRUG	M013	Rugby Laboratories	ACETAMINOPHEN	500	mg/1			N	20251231
0536-1181_0dfe9697-9682-58db-e063-6394a90a407a	0536-1181	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	20180820		OTC MONOGRAPH DRUG	M005	RUGBY LABORATORIES	CLOTRIMAZOLE	1	g/mL	Azole Antifungal [EPC], Azoles [CS]		N	20251231
0536-1182_b12e5b65-50c4-41c8-9a78-c1bde82b547f	0536-1182	HUMAN OTC DRUG	rugby mucus and chest congestion		Guaifenesin	SOLUTION	ORAL	20181126		OTC MONOGRAPH FINAL	part341	Rugby Laboratories	GUAIFENESIN	200	mg/10mL			N	20241231
0536-1183_92d0c678-c76d-4939-97d7-0939638e2492	0536-1183	HUMAN OTC DRUG	RUGBY FLUTICASONE PROPIONATE NASAL		Fluticasone propionate	SPRAY, METERED	NASAL	20181218		ANDA	ANDA207957	Rugby Laboratories	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0536-1184_180a814e-e68a-4280-8518-cacc3ff382c0	0536-1184	HUMAN OTC DRUG	rugby cough		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180822		OTC MONOGRAPH FINAL	part341	Rugby Laboratories	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0536-1185_7f06d5b8-e781-416a-bcec-44d9650cac0c	0536-1185	HUMAN OTC DRUG	rugby almacone		Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20181219		OTC MONOGRAPH FINAL	part331	Rugby Laboratories	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0536-1186_c1a126b5-0d34-437f-a7ef-8d5cbeb7b03b	0536-1186	HUMAN OTC DRUG	rugby hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20180822		OTC MONOGRAPH FINAL	part346	Rugby Laboratories	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0536-1206_21bbf3fa-871c-4621-a48e-07fe6ee3b3ce	0536-1206	HUMAN OTC DRUG	Calcium Carbonate 10 gr (648 mg)	(Antacid)	Calcium Carbonate 10gr (648 mg)	TABLET	ORAL	20190228		OTC MONOGRAPH FINAL	part331	RUGBY LABORATORIES	CALCIUM CARBONATE	648	mg/1			N	20241231
0536-1207_a8229dc3-975f-4b10-b713-725bf0835828	0536-1207	HUMAN OTC DRUG	Rugby Gas relief		Simethicone	TABLET, CHEWABLE	ORAL	20190425		OTC MONOGRAPH FINAL	part332	Rugby Laboratories	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
0536-1211_08833e99-3ddc-97e6-e063-6294a90abc6e	0536-1211	HUMAN OTC DRUG	Dibucaine Topical Anesthetic 1% Hemorrhoidal		DIBUCAINE	OINTMENT	TOPICAL	20190819		OTC MONOGRAPH DRUG	M015	Rugby Laboratories Inc.	DIBUCAINE	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0536-1212_175aca2f-a88b-4b2d-9806-984ed0e49ff7	0536-1212	HUMAN OTC DRUG	rugby acetaminophen		Acetaminophen	SUSPENSION	ORAL	20181116		OTC MONOGRAPH NOT FINAL	part343	Rugby Laboratories	ACETAMINOPHEN	160	mg/5mL			N	20241231
0536-1213_bf302ec2-82d7-43e1-b18f-959c8cdec6f9	0536-1213	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20181105		ANDA	ANDA209692	Rugby Laboratories, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0536-1214_e087f0f2-d5f5-4751-9913-dfa4aab1c547	0536-1214	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20190328		OTC MONOGRAPH DRUG	M012	Rugby Laboratories	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0536-1217_0cf9c0f6-3ef9-a74f-e063-6394a90aa22f	0536-1217	HUMAN OTC DRUG	Rugby Tetrahydrozoline Ophthalmic Solution		Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20190608		OTC MONOGRAPH DRUG	M018	Rugby Laboratories	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
0536-1219_0cf9f63b-8237-af5c-e063-6394a90a9c9d	0536-1219	HUMAN OTC DRUG	Rugby Lubricating Eye Drops		Polyethylene glycol, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190219		OTC MONOGRAPH DRUG	M018	Rugby Laboratories	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
0536-1223_df6aa060-9f28-4d72-860c-497339bbcd19	0536-1223	HUMAN OTC DRUG	Rugby Gas relief		Simethicone	TABLET, CHEWABLE	ORAL	20190429		OTC MONOGRAPH FINAL	part332	Rugby Laboratories	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0536-1224_0cf9fa54-554a-a8c8-e063-6394a90a9333	0536-1224	HUMAN OTC DRUG	Rugby Eye Wash		Water, purified	SOLUTION	OPHTHALMIC	20190222		OTC MONOGRAPH DRUG	M018	Rugby Laboratories	WATER	99.05	g/100mL			N	20241231
0536-1225_1fd077b4-dd12-4605-908c-f58480639b63	0536-1225	HUMAN OTC DRUG	Rugby Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190314		OTC MONOGRAPH FINAL	part331	Rugby Laboratories	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0536-1228_8032488b-5f74-4fb1-a3ca-bacb675acf4f	0536-1228	HUMAN OTC DRUG	Rugby	Cherry Flavor	Phenol	SPRAY	ORAL	20190405		OTC MONOGRAPH DRUG	M022	RUGBY LABORATORIES	PHENOL	1.4	g/100mL			N	20241231
0536-1229_39822079-a3d2-460a-b94e-19e9e22d4f1e	0536-1229	HUMAN OTC DRUG	Rugby Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190414		OTC MONOGRAPH FINAL	part331	Rugby Laboratories	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0536-1230_7fab98d8-9601-c0ed-38c9-802bdd4013af	0536-1230	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190528		ANDA	ANDA207673	RUGBY LABORATORIES	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0536-1232_d3ac6dfe-991d-41b9-96a8-897361cc2b2f	0536-1232	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190601		OTC MONOGRAPH DRUG	M013	Rugby Laboratories	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0536-1234_19dad4bc-c980-45c0-9eb5-a8f47184e08e	0536-1234	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190701		OTC MONOGRAPH DRUG	M013	Rugby Laboratories	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0536-1239_46ecd7b0-5b26-42c7-bc21-cc5d6b80777c	0536-1239	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20190731		ANDA	ANDA207868	Rugby Laboratories, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1241_e5251669-82d9-4e1e-9018-e76480349971	0536-1241	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190731		ANDA	ANDA207868	Rugby Laboratories, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20251231
0536-1242_35d5bdde-cb43-ed3c-3a7c-075b259523dd	0536-1242	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20190826		ANDA	ANDA076667	RUGBY LABORATORIES	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0536-1247_60e8c404-4bd9-4183-aefe-880d49774eee	0536-1247	HUMAN OTC DRUG	Senexon-S		Docusate Sodium 50mg and Sennosides 8.6mg	TABLET, FILM COATED	ORAL	20191002		OTC MONOGRAPH NOT FINAL	part334	RUGBY LABORATORIES	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0536-1248_46553c5e-85d5-491a-8e23-0cd9b7451bb8	0536-1248	HUMAN OTC DRUG	Stimulant Laxative Plus Stool Softener		Docusate Sodium 50 mg and Sennosides 8.6 mg	TABLET, FILM COATED	ORAL	20191022		OTC MONOGRAPH NOT FINAL	part334	RUGBY LABORATORIES	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0536-1252_d4082ec4-f5c5-4f0d-be97-89f44f6aa52c	0536-1252	HUMAN OTC DRUG	Ketotifen Fumarate		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20200918		NDA AUTHORIZED GENERIC	NDA021996	Rugby Laboratories	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
0536-1253_d67c8b34-5245-49ab-925d-dc95629156d9	0536-1253	HUMAN OTC DRUG	Sodium Chloride Hypertonicity Ophthalmic		sodium chloride	OINTMENT	OPHTHALMIC	20201106		OTC MONOGRAPH FINAL	part349	Rugby Laboratories	SODIUM CHLORIDE	50	mg/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0536-1254_822d25c0-71b3-421d-b702-4cded0c4ca32	0536-1254	HUMAN OTC DRUG	Sodium Chlorode Hypertonicity Ophthalmic Solution		sodium chloride	SOLUTION	OPHTHALMIC	20200917		OTC MONOGRAPH FINAL	part349	Rugby Laboratories	SODIUM CHLORIDE	50	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0536-1256_08834c9b-68a7-91e4-e063-6394a90ad45d	0536-1256	HUMAN OTC DRUG	Bacitracin		BACITRACIN	OINTMENT	TOPICAL	20200430		OTC MONOGRAPH DRUG	M004	RUGBY LABORATORIES	BACITRACIN	500	U/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
0536-1257_0e9b56a3-f6ee-fccf-e063-6394a90aade0	0536-1257	HUMAN OTC DRUG	TRIPROLIDINE HYDROCHLORIDE		TRIPROLIDINE HYDROCHLORIDE	LIQUID	ORAL	20191109	20241031	OTC MONOGRAPH DRUG	M012	Rugby Laboratories	TRIPROLIDINE HYDROCHLORIDE	.938	mg/mL			N	
0536-1259_616058e8-4702-4af5-b6e1-f158ccd7ff66	0536-1259	HUMAN OTC DRUG	Rugby Benzoyl Peroxide Wash	Acne Medication	BENZOYL PEROXIDE	LOTION	TOPICAL	20191217		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories	BENZOYL PEROXIDE	50	mg/mL			N	20241231
0536-1261_5bb2d899-8018-43eb-87b7-dc5a11b62583	0536-1261	HUMAN OTC DRUG	Rugby Benzoyl Peroxide Wash	Acne Medication	Benzoyl Peroxide	LOTION	TOPICAL	20191217		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories	BENZOYL PEROXIDE	100	mg/mL			N	20241231
0536-1263_004e078b-ff10-c177-e063-6394a90a3654	0536-1263	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20200415		OTC MONOGRAPH FINAL	part333B	Rugby Laboratories	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
0536-1264_ff4b6054-8db3-b96f-e053-6294a90a5698	0536-1264	HUMAN OTC DRUG	Rugby Capsaicin Cream		Capsaicin	CREAM	TOPICAL	20200217		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories	CAPSAICIN	.1	g/100g			N	20241231
0536-1265_0984d76b-63cb-319f-e063-6294a90a5208	0536-1265	HUMAN OTC DRUG	Rugby Clotrimazole Antifungal Cream		Clotrimazole	CREAM	TOPICAL	20200319		OTC MONOGRAPH DRUG	M005	Rugby Laboratories	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0536-1266_1d12935c-0e5e-4d8a-bff3-3c965b514f7b	0536-1266	HUMAN OTC DRUG	Senna Liquid		Sennosides	LIQUID	ORAL	20190501		OTC MONOGRAPH NOT FINAL	part334	RUGBY LABORATORIES	SENNOSIDES	8.8	mg/5mL			N	20241231
0536-1267_0883340e-4a26-6eb2-e063-6294a90aabe0	0536-1267	HUMAN OTC DRUG	4 Lidocaine Topical Anesthetic		LIDOCAINE	CREAM	TOPICAL	20200430		OTC MONOGRAPH DRUG	M017	RUGBY LABORATORIES	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0536-1268_99d8a53f-8b88-033d-e053-2995a90ad4b0	0536-1268	HUMAN OTC DRUG	Rugby Anti-Itch		Camphor, Menthol	LOTION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part348	RUGBY LABORATORIES	CAMPHOR (SYNTHETIC); MENTHOL	.5; .5	g/100g; g/100g			N	20241231
0536-1269_0c7d1e80-0b68-d543-e063-6394a90ae76e	0536-1269	HUMAN OTC DRUG	Rugby Caldyphen Clear		pramoxine hydrochloride and zinc acetate lotion	LOTION	TOPICAL	20191230		OTC MONOGRAPH DRUG	M016	Rugby Laboratories	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0536-1271_0e87fc65-a55c-da85-e063-6394a90a1ae5	0536-1271	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	OINTMENT	TOPICAL	20201103		OTC MONOGRAPH DRUG	M003	Rugby Laboratories	POVIDONE-IODINE	100	mg/g			N	20251231
0536-1272_f527f10a-1543-4594-aa2f-c08bc2292a4f	0536-1272	HUMAN OTC DRUG	RUGBY ANTIFUNGAL CLOTRIMAZOLE		CLOTRIMAZOLE	CREAM	TOPICAL	20200114		OTC MONOGRAPH FINAL	part333C	RUGBY	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0536-1277_8f428539-3797-4a6a-8a11-d6f26a2019dc	0536-1277	HUMAN OTC DRUG	RUGBY HYDROCORTISONE WITH ALOE		HYDROCORTISONE	CREAM	TOPICAL	20200114		OTC MONOGRAPH NOT FINAL	part348	RUGBY	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0536-1278_923ea6ed-c59f-4fd4-ade6-9a5f3b64490d	0536-1278	HUMAN OTC DRUG	RUGBY LIDOCAINE		LIDOCAINE	CREAM	TOPICAL	20200117		OTC MONOGRAPH NOT FINAL	part348	RUGBY	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0536-1279_3e66138c-cf57-46f7-a402-b58bafb3c3b1	0536-1279	HUMAN OTC DRUG	Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200309		ANDA	ANDA210719	Rugby Laboratories	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0536-1284_ee4ce25f-ac6a-4bb8-8eb7-62c4ae98b64c	0536-1284	HUMAN OTC DRUG	rugby adult aspirin		aspirin	TABLET, FILM COATED	ORAL	20200309		OTC MONOGRAPH NOT FINAL	part343	Rugby Laboratories	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0536-1286_d7b5d01c-bbe4-4732-b710-b230f6f90a47	0536-1286	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20200329		OTC MONOGRAPH FINAL	part335	Rugby Laboratories, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0536-1287_411aba59-10c3-4c48-9f84-ac87dba3770e	0536-1287	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20200329		OTC MONOGRAPH FINAL	part335	Rugby Laboratories, Inc.	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
0536-1288_0c900ca8-01a2-fa04-e063-6394a90a28fa	0536-1288	HUMAN OTC DRUG	Hemorrhoidal		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20200514		OTC MONOGRAPH DRUG	M015	Rugby	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0536-1289_760ca2df-9a7b-4fc9-9456-a023240d30d8	0536-1289	HUMAN OTC DRUG	Sinus Congestion and Pain	Maximum Strength	Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20200521		OTC MONOGRAPH DRUG	M012	Rugby Laboratories	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0536-1291_750547dc-c722-4d17-b58f-146fc6fd0dd1	0536-1291	HUMAN OTC DRUG	Phenylephrine HCl	Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200409		OTC MONOGRAPH DRUG	M012	Rugby Laboratories	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0536-1292_51b67650-0093-4088-aa8d-073bc87cc55d	0536-1292	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20200513		OTC MONOGRAPH DRUG	M013	Rugby Laboratories	ACETAMINOPHEN	500	mg/1			N	20241231
0536-1293_ec4ea84e-ce4c-4acd-b306-75df725abd6d	0536-1293	HUMAN OTC DRUG	Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20210602		OTC MONOGRAPH FINAL	part331	Rugby Laboratories	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0536-1294_958908f7-98d7-4b77-97fb-34106b11abd5	0536-1294	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20200914		ANDA	ANDA208077	Rugby Laboratories, Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0536-1297_d3b8b142-4601-45c5-bde1-9c302956ddb6	0536-1297	HUMAN OTC DRUG	MECLIZINE		Meclizine HCl 12.5 mg	TABLET	ORAL	20200521		OTC MONOGRAPH FINAL	part336	RUGBY LABORATORIES	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0536-1298_75ff96f5-4e9a-4352-a331-076f922cfb7d	0536-1298	HUMAN OTC DRUG	Rugby Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20200914		ANDA	ANDA077351	Rugby Laboratories	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0536-1299_0eafa87d-ba74-5faa-e063-6294a90a79c1	0536-1299	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20201030		OTC MONOGRAPH DRUG	M009	Rugby Laboratories	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20251231
0536-1302_1a1eca4b-fa2d-4216-8ab8-0682ee6316bf	0536-1302	HUMAN OTC DRUG	Anti Nausea		dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20200909		UNAPPROVED DRUG OTHER		RUGBY LABORATORIES	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
0536-1303_1daf79b5-59ab-49a7-92bd-41af0bedc1d0	0536-1303	HUMAN OTC DRUG	Infants		Simethicone	SUSPENSION/ DROPS	ORAL	20200901		OTC MONOGRAPH DRUG	M002	RUGBY LABORATORIES	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
0536-1304_9fb4915f-1685-4ad0-8957-f764f1689157	0536-1304	HUMAN OTC DRUG	Docusate Sodium Liquid		Docusate Sodium	LIQUID	ORAL	20201001		OTC MONOGRAPH NOT FINAL	part334	RUGBY LABORATORIES	DOCUSATE SODIUM	50	mg/5mL			N	20241231
0536-1306_aa0ecd91-5bab-4d48-a296-9a8442181561	0536-1306	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200724		OTC MONOGRAPH FINAL	part332	Rugby Laboratories, Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
0536-1307_5a23873b-2d97-1b0a-1e50-475bad78be13	0536-1307	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210115		ANDA	ANDA209752	Rugby Laboratories	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
0536-1308_2634b4fc-71ba-e5db-76ad-6ebdc52ae2d3	0536-1308	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20210105		ANDA	ANDA209619	Rugby Laboratories	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
0536-1309_465a62c5-b8d6-47ee-99b2-aafb23563774	0536-1309	HUMAN OTC DRUG	Rugby Chest Congestion Relief	PE	Guaifenesin/phenylephrine	TABLET	ORAL	20200909		OTC MONOGRAPH FINAL	part341	Rugby Laboratories	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0536-1311_2122999c-58f1-4620-852b-e0e3acc48620	0536-1311	HUMAN OTC DRUG	Rugby Chest Congestion Relief	G450	Guaifenesin	TABLET	ORAL	20200901		OTC MONOGRAPH FINAL	part341	Rugby Laboratories	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0536-1312_d2cdbd54-6a96-48dc-8870-8e9d8fbd9585	0536-1312	HUMAN OTC DRUG	Rugby Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20200901		OTC MONOGRAPH FINAL	part341	Rugby Laboratories	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0536-1313_332f30a5-7cd9-4b2b-9938-bb2eb87ed021	0536-1313	HUMAN OTC DRUG	Chest Congestion Relief	DM	Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20201001		OTC MONOGRAPH FINAL	part341	RUGBY LABORATORIES	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0536-1314_f78f166a-24ff-429a-b043-daa72a2be9f6	0536-1314	HUMAN OTC DRUG	Chest Congestion Relief		Guaifenesin	LIQUID	ORAL	20201001		OTC MONOGRAPH FINAL	part341	RUGBY LABORATORIES	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0536-1315_0b39a617-72d2-513e-e063-6394a90a7192	0536-1315	HUMAN OTC DRUG	CR-371059 Tolnaftate 1% Cream		CR-371059 Tolnaftate 1% Cream	CREAM	TOPICAL	20210301		OTC MONOGRAPH DRUG	M005	Rugby Laboratories	TOLNAFTATE	1	g/100g			N	20241231
0536-1316_0b3a3e45-9da6-b662-e063-6394a90ad48e	0536-1316	HUMAN OTC DRUG	Rugby Zinc Oxide 20%		Rugby Zinc Oxide 20%	OINTMENT	TOPICAL	20210301		OTC MONOGRAPH DRUG	M016	Rugby Laboratories	ZINC OXIDE	20	g/100g			N	20241231
0536-1317_093024c1-5b32-b803-e063-6394a90a9b57	0536-1317	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID/ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200801		OTC MONOGRAPH DRUG	M001	RUGBY LABORATORIES	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0536-1319_09300ae4-d9a4-5d12-e063-6294a90a2cb8	0536-1319	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	LIQUID	ORAL	20200901		OTC MONOGRAPH DRUG	M007	RUGBY LABORATORIES	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0536-1321_304a9aa2-9198-44ca-8627-d41b84ec6cbf	0536-1321	HUMAN OTC DRUG	Rugby Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20201021		OTC MONOGRAPH NOT FINAL	part343	Rugby Laboratories	ACETAMINOPHEN	160	mg/5mL			N	20241231
0536-1322_cc1710a6-25a0-4478-b1a8-89ac1f85f89e	0536-1322	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200915		ANDA	ANDA206877	Rugby Laboratories	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0536-1324_6a7f83ee-82b4-ca7d-1d7b-876a48c73fee	0536-1324	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20201112		ANDA	ANDA202194	Rugby Laboratories	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0536-1326_0eafb814-3caf-5a4f-e063-6394a90a7773	0536-1326	HUMAN OTC DRUG	Acetaminophen, Aspirin, Caffeine		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210603		OTC MONOGRAPH DRUG	M013	Rugby Laboratories	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20251231
0536-1327_83c8ae16-4462-4ba5-a91f-c52a5853e8c1	0536-1327	HUMAN OTC DRUG	Rugby Regular Strength Acetaminophen		Acetaminophen	TABLET	ORAL	20210311		OTC MONOGRAPH NOT FINAL	part343	RUGBY LABORATORIES	ACETAMINOPHEN	325	mg/1			N	20241231
0536-1329_0b39a617-72d7-513e-e063-6394a90a7192	0536-1329	HUMAN OTC DRUG	Rugby Tolnaftate 1% Powder		Rugby Tolnaftate 1% Powder	POWDER	TOPICAL	20210510		OTC MONOGRAPH DRUG	M005	Rugby Laboratories	TOLNAFTATE	1	g/100g			N	20241231
0536-1333_4f4c9058-ec1c-48d5-81df-56188b7ae803	0536-1333	HUMAN OTC DRUG	Guaifenesin D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220404		ANDA	ANDA212542	RUGBY LABORATORIES, INC.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
0536-1334_50320858-6b9c-416f-b677-3f242cfd305c	0536-1334	HUMAN OTC DRUG	Dextromethorphan HBr 15 mg Liquid Gels		Dextromethorphan HBr	CAPSULE, LIQUID FILLED	ORAL	20210904		OTC MONOGRAPH FINAL	part341	RUGBY LABORATORIES	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0536-1337_25d43731-1a15-4687-9af9-441d7921d448	0536-1337	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210917		ANDA	ANDA209206	Rugby Laboratories, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1338_a06034db-9fc0-4ba2-a030-a57cb513f2da	0536-1338	HUMAN OTC DRUG	Maxi Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210917		ANDA	ANDA209206	Rugby Laboratories, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1339_c98bfc2d-abb3-4bc3-b824-83e52f1bf0d8	0536-1339	HUMAN OTC DRUG	ANORECTAL Lidocaine Cream		Lidocaine	CREAM	TOPICAL	20210904		OTC MONOGRAPH FINAL	part346	RUGBY LABORATORIES	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0536-1348_89752c69-25c8-45e3-9021-f81b35b52d36	0536-1348	HUMAN OTC DRUG	rugby cough syrup		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220107		OTC MONOGRAPH FINAL	part341	Rugby Laboratories	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0536-1349_0062d73b-5a92-4535-97fd-785902139c15	0536-1349	HUMAN OTC DRUG	Rugby Muscle Rub Cream		Muscle Rub Cream	CREAM	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories	MENTHOL; METHYL SALICYLATE	100; 150	mg/g; mg/g			N	20241231
0536-1351_4a1682bd-ff15-4b67-83fb-c4e9fe1f78b8	0536-1351	HUMAN OTC DRUG	Rugby Benzoyl Peroxide Wash	Acne Medication	Benzoyl Peroxide	LOTION	TOPICAL	20220307		OTC MONOGRAPH FINAL	part333D	Rugby Laboratories	BENZOYL PEROXIDE	100	mg/g			N	20241231
0536-1357_d94292f7-10fd-48bf-e053-2995a90a8472	0536-1357	HUMAN OTC DRUG	Rugby Lidocaine		Lidocaine 4%	CREAM	TOPICAL	20220302		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0536-1362_43bd4eaa-9d28-483c-9163-d786cd9039a8	0536-1362	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Mint Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20040729		ANDA	ANDA076569	Rugby Laboratories, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1367_f59f3400-da77-4eb7-be02-842071d87fae	0536-1367	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20221006		ANDA	ANDA208477	Rugby Laboratories	LORATADINE	10	mg/1			N	20241231
0536-1368_b0b97aa7-c1a1-7cf6-1005-d2a639819c01	0536-1368	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221026		ANDA	ANDA202194	Rugby Laboratories, Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0536-1372_43bd4eaa-9d28-483c-9163-d786cd9039a8	0536-1372	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Mint Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20040729		ANDA	ANDA076568	Rugby Laboratories, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-1373_66ede09a-41a4-4e14-a007-31de53efec8f	0536-1373	HUMAN OTC DRUG	Allergy Relief		fluticasone propionate	SPRAY, METERED	NASAL	20220915	20241231	ANDA	ANDA208024	Rugby Laboratories, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0536-1375_f420da03-f88e-7cf3-e053-2a95a90a4824	0536-1375	HUMAN OTC DRUG	MICONAZOLE Nitrate 2% Cream ANTIFUNGAL		MICONAZOLE NITRATE	CREAM	TOPICAL	20230207		OTC MONOGRAPH FINAL	part333C	Rugby	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0536-1376_0c02af9c-cc21-8147-e063-6394a90ac3f8	0536-1376	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET	ORAL	20230715		ANDA	ANDA216592	RUGBY LABORATORIES	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0536-1379_2d766360-3ed9-4c32-8709-3f65f9ba05ee	0536-1379	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230101		ANDA	ANDA208754	Rugby Laboratories, Inc.	DOCOSANOL	100	mg/g			N	20241231
0536-1381_b4c43535-ad22-44c2-b04f-df4348a6c485	0536-1381	HUMAN OTC DRUG	Rugby mometasone furoate nasal		mometasone furoate	SPRAY	NASAL	20231011		NDA	NDA215712	Rugby Laboratories	MOMETASONE FUROATE MONOHYDRATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0536-1383_f5b42952-7aad-0af1-e053-2a95a90ac31d	0536-1383	HUMAN OTC DRUG	Mineral Oil with Petroleum		mineral oil and white petrolatum	OINTMENT	OPHTHALMIC	20230227		OTC MONOGRAPH FINAL	part349	Rugby Laboratories	MINERAL OIL; PETROLATUM	30; 940	mg/g; mg/g			N	20241231
0536-1384_3e628c0e-311d-2ab0-8a9a-504f2b153f40	0536-1384	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA215434	RUGBY LABORATORIES	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0536-1386_0d38267e-cdfb-a2c0-e063-6394a90ab84c	0536-1386	HUMAN OTC DRUG	Rugby Carboxymethylcellulose Sodium 0.5% Eye Drops		Carboxymethylcellulose Sodium	SOLUTION/ DROPS	OPHTHALMIC	20230511		OTC MONOGRAPH DRUG	M018	Rugby Laboratories	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
0536-1387_0cf9f932-b521-ab8b-e063-6394a90a4620	0536-1387	HUMAN OTC DRUG	Rugby Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20230323		OTC MONOGRAPH DRUG	M018	Rugby Laboratories	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
0536-1390_0c565eaf-dafc-7154-e063-6394a90a4ddb	0536-1390	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230825		ANDA	ANDA079174	Rugby Laboratories	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0536-1391_517847c9-c477-41b3-9d46-e26edbbf9038	0536-1391	HUMAN OTC DRUG	Emergency Contraceptive		Levonorgestrel	TABLET	ORAL	20230801		ANDA	ANDA205329	Rugby Laboratories, Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
0536-1392_67c00599-a7cb-4791-aab4-02fc190f5bc6	0536-1392	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230701		ANDA	ANDA207342	Rugby Laboratories, Inc.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0536-1394_02a75f42-64c1-f115-a7ac-d6c0e665df59	0536-1394	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCl		Fexofenadine HCl and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20221130		ANDA	ANDA079043	RUGBY LABORATORIES	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0536-1398_0c019d2f-d32f-8978-e063-6294a90a9cf6	0536-1398	HUMAN OTC DRUG	Carboxymethylcellulose Sodium 1%		carboxymethylcellulose sodium	LIQUID	OPHTHALMIC	20230919		OTC MONOGRAPH DRUG	M018	RUGBY LABORATORIES	CARBOXYMETHYLCELLULOSE SODIUM	10	mg/mL			N	20241231
0536-1399_0dd882fb-f0de-8ec0-e063-6394a90a4de6	0536-1399	HUMAN OTC DRUG	Polyvinyl Alcohol w/Povidon1.4-0.6%		Polyvinyl Alcohol, Povidon	LIQUID	OPHTHALMIC	20230919		OTC MONOGRAPH DRUG	M018	RUGBY LABORATORIES	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	14; 6	mg/mL; mg/mL			N	20241231
0536-1408_081673b2-5c75-1200-e063-6394a90ae363	0536-1408	HUMAN OTC DRUG	Rugby Polyvinyl Alcohol 1.4% Lubricating Eye Drops		Polyvinyl alcohol	SOLUTION/ DROPS	OPHTHALMIC	20231019		OTC MONOGRAPH DRUG	M018	Rugby Laboratories	POLYVINYL ALCOHOL, UNSPECIFIED	1.4	g/100mL			N	20241231
0536-1411_49cd5456-fae0-4e17-80fd-75d4e191385e	0536-1411	HUMAN OTC DRUG	Rugby Phenazopyridine HCl Urinary Tract Analgesic		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20231207		UNAPPROVED DRUG OTHER		Rugby Laboratories	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
0536-1421_a7354a30-0e1c-47ac-a865-2612280901a0	0536-1421	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20240101		OTC MONOGRAPH DRUG	M002	Rugby Laboratories, Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20251231
0536-1962_ccd4e61e-a839-4a49-a6d5-d9c4b9afd118	0536-1962	HUMAN OTC DRUG	Sebex	Antidandruff, anti-seborrheic dermatitis, anti-psoriasis	Salicylic Acid, Sulfur	SHAMPOO	TOPICAL	20121029		OTC MONOGRAPH FINAL	part358H	Rugby Laboratories	SALICYLIC ACID; SULFUR	20; 20	mg/1000mL; mg/1000mL			N	20241231
0536-1995_67ec8bd0-3c51-431a-912e-e1f948108820	0536-1995	HUMAN OTC DRUG	Rugby Anti-Dandruff		Selenium Sulfide	SHAMPOO	TOPICAL	20120501		OTC MONOGRAPH FINAL	part358H	Rugby Laboratories	SELENIUM SULFIDE	10	mg/mL			N	20241231
0536-2470_09300ae4-d9a2-5d12-e063-6294a90a2cb8	0536-2470	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	LIQUID	ORAL	20110128		OTC MONOGRAPH DRUG	M007	Rugby Laboratories	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0536-2525_1590893b-54bd-4035-a5d2-993263848a1d	0536-2525	HUMAN OTC DRUG	Rugby Capsaicin	External Analgesic	Capsaicin	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part348	Rugby Laboratories	CAPSAICIN	.25	mg/g			N	20241231
0536-3029_4b241650-30a2-4a25-9c43-0c1d3c45b58e	0536-3029	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Original Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	19990315		ANDA	ANDA074507	Rugby Laboratories, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3030_4b241650-30a2-4a25-9c43-0c1d3c45b58e	0536-3030	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Original Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	19990319		ANDA	ANDA074707	Rugby Laboratories, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3112_226455b9-f0cc-4777-afc3-d0196ed860f9	0536-3112	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Coated Mint Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20081229		ANDA	ANDA078699	Rugby Laboratories, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3113_226455b9-f0cc-4777-afc3-d0196ed860f9	0536-3113	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Coated Mint Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20081229		ANDA	ANDA078697	Rugby Laboratories, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3386_55135f1a-1748-432c-bde4-9e1214a1a708	0536-3386	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Coated Fruit Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20090708		ANDA	ANDA079044	Rugby Laboratories, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3387_55135f1a-1748-432c-bde4-9e1214a1a708	0536-3387	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Coated Fruit Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20090708		ANDA	ANDA079038	Rugby Laboratories, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3404_31646ed3-e82c-4db9-9ff1-a75e5e036d61	0536-3404	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20090708		ANDA	ANDA079216	Rugby Laboratories, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3405_31646ed3-e82c-4db9-9ff1-a75e5e036d61	0536-3405	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20090708		ANDA	ANDA079219	Rugby Laboratories, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
0536-3607_0eafac67-d7aa-5b86-e063-6394a90a2184	0536-3607	HUMAN OTC DRUG	Nasal Decongestant		Pseudoephedrine HCl	TABLET	ORAL	20121029		OTC MONOGRAPH DRUG	M012	Rugby Laboratories	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
0536-4306_0bb2f3d6-f972-07d8-e063-6294a90abfb8	0536-4306	HUMAN OTC DRUG	Fiber Lax		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20100901		OTC MONOGRAPH DRUG	M007	Rugby Laboratories	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
0536-5700_88c1fe46-7976-4671-b1df-045b2b6d72f5	0536-5700	HUMAN OTC DRUG	Rugby Zinc Oxide		Zinc Oxide	OINTMENT	TOPICAL	20040323		OTC MONOGRAPH FINAL	part347	Rugby Laboratories	ZINC OXIDE	200	mg/g			N	20241231
0536-7415_35d076a9-29a3-4c29-b82e-8148336e7016	0536-7415	HUMAN OTC DRUG	Ready-to-Use		Sodium Phosphate	ENEMA	RECTAL	20110901		OTC MONOGRAPH NOT FINAL	part334	Rugby Laboratories, Inc.	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
0548-5001_0e71b74d-723d-46a4-b2e5-7c7157949ad4	0548-5001	HUMAN PRESCRIPTION DRUG	Ganirelix Acetate		Ganirelix Acetate	INJECTION	SUBCUTANEOUS	20220620		ANDA	ANDA212613	Amphastar Pharmaceuticals, Inc.	GANIRELIX ACETATE	250	ug/.5mL	Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]		N	20241231
0548-5400_fe3eb29d-0024-4834-a1af-81661804f532	0548-5400	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20171128		ANDA	ANDA077235	Amphastar Pharmaceuticals, Inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0548-5410_24f666b3-e168-4860-87d3-bd6c02617ede	0548-5410	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20171128		ANDA	ANDA077235	Amphastar Pharmaceuticals, Inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0548-5601_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5601	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20110919		ANDA	ANDA076684	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5602_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5602	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20110919		ANDA	ANDA076684	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5603_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5603	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20110919		ANDA	ANDA076684	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5604_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5604	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20110919		ANDA	ANDA076684	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5605_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5605	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20110919		ANDA	ANDA076684	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5606_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5606	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20110919		ANDA	ANDA076684	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5607_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5607	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20110919		ANDA	ANDA076684	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5608_26be8717-95ce-4c2c-ad2f-3e58d202afde	0548-5608	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20191111		ANDA	ANDA208600	Amphastar Pharmaceuticals, Inc.	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0548-5701_fe3eb29d-0024-4834-a1af-81661804f532	0548-5701	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20171128		ANDA	ANDA077334	Amphastar Pharmaceuticals, Inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0548-5711_24f666b3-e168-4860-87d3-bd6c02617ede	0548-5711	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20171128		ANDA	ANDA077334	Amphastar Pharmaceuticals, Inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0548-5850_7b1b15a9-4632-4749-b4ad-95dd0c5d3966	0548-5850	HUMAN PRESCRIPTION DRUG	Glucagon		Glucagon	KIT		20210210		ANDA	ANDA208086	Amphastar Pharmaceuticals, Inc.						N	20241231
0548-5900_0c6ca51b-eaa6-4604-8f31-389c6e034dd2	0548-5900	HUMAN PRESCRIPTION DRUG	Cortrosyn		Cosyntropin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20030801		NDA	NDA016750	Amphastar Pharmaceuticals, Inc.	COSYNTROPIN	.25	mg/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20251231
0548-9090_c8b90610-c372-4908-9861-8a628f7e0773	0548-9090	HUMAN PRESCRIPTION DRUG	AMPHADASE		hyaluronidase	INJECTION	SUBCUTANEOUS	20041026		BLA	BLA021665	Amphastar Pharmaceuticals, Inc.	HYALURONIDASE	150	[USP'U]/mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
0548-9501_03384075-bc26-4df6-b1e3-0e20e8808d65	0548-9501	HUMAN PRESCRIPTION DRUG	ISOPROTERENOL HYDROCHLORIDE		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180716		ANDA	ANDA210106	Amphastar Pharmaceuticals, Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0548-9502_03384075-bc26-4df6-b1e3-0e20e8808d65	0548-9502	HUMAN PRESCRIPTION DRUG	ISOPROTERENOL HYDROCHLORIDE		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180716		ANDA	ANDA210106	Amphastar Pharmaceuticals, Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
0548-9601_32069cca-ad21-4afc-9c23-5ab376b0237a	0548-9601	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20170925		ANDA	ANDA209933	Amphastar Pharmaceuticals, Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0548-9602_32069cca-ad21-4afc-9c23-5ab376b0237a	0548-9602	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20170925		ANDA	ANDA209933	Amphastar Pharmaceuticals, Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0548-9701_93e40d97-9476-44dc-80dc-4c9d33062d63	0548-9701	HUMAN PRESCRIPTION DRUG	Vasopressin		Vasopressin	INJECTION	INTRAVENOUS	20220822		ANDA	ANDA211857	Amphastar Pharmaceuticals, Inc.	VASOPRESSIN	20	[USP'U]/mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
0555-0033_598ba8a6-a1d5-4a09-b3e6-14404f68f30c	0555-0033	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19900930		ANDA	ANDA083116	Teva Pharmaceuticals USA, Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0555-0066_05da038d-6763-49c3-b3ac-c2cc76155af4	0555-0066	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080936	Teva Pharmaceuticals USA, Inc.	ISONIAZID	100	mg/1	Antimycobacterial [EPC]		N	20241231
0555-0071_05da038d-6763-49c3-b3ac-c2cc76155af4	0555-0071	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080937	Teva Pharmaceuticals USA, Inc.	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
0555-0158_598ba8a6-a1d5-4a09-b3e6-14404f68f30c	0555-0158	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760701		ANDA	ANDA084768	Teva Pharmaceuticals USA, Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0555-0159_598ba8a6-a1d5-4a09-b3e6-14404f68f30c	0555-0159	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760701		ANDA	ANDA084769	Teva Pharmaceuticals USA, Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0555-0171_33a105c5-0e51-4759-857b-6ca8dfae1d13	0555-0171	HUMAN PRESCRIPTION DRUG	Mefloquine Hydrochloride		Mefloquine Hydrochloride	TABLET	ORAL	20040106		ANDA	ANDA076392	Teva Pharmaceuticals USA, Inc.	MEFLOQUINE HYDROCHLORIDE	250	mg/1	Antimalarial [EPC]		N	20241231
0555-0211_3fc82f76-249d-47fd-b598-678fb98b7ec7	0555-0211	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate		Norethindrone Acetate	TABLET	ORAL	20010629		ANDA	ANDA075951	Teva Pharmaceuticals USA, Inc.	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-0302_eaa80f18-ac88-4b1d-9506-ff7d665e1c95	0555-0302	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19840701		ANDA	ANDA088487	Teva Pharmaceuticals USA, Inc.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0555-0323_eaa80f18-ac88-4b1d-9506-ff7d665e1c95	0555-0323	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19840701		ANDA	ANDA088496	Teva Pharmaceuticals USA, Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0555-0324_eaa80f18-ac88-4b1d-9506-ff7d665e1c95	0555-0324	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19840701		ANDA	ANDA088488	Teva Pharmaceuticals USA, Inc.	HYDROXYZINE PAMOATE	100	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0555-0483_3c6d3a11-6d0b-4109-89cd-658827847fea	0555-0483	HUMAN PRESCRIPTION DRUG	Amiloride Hydrochloride and Hydrochlorothiazide		Amiloride Hydrochloride and Hydrochlorothiazide	TABLET	ORAL	19891201		ANDA	ANDA071111	Teva Pharmaceuticals USA, Inc.	AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	5; 50	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0555-0484_3aaaf34b-95c1-4388-8eab-510e693024e8	0555-0484	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19900630		ANDA	ANDA071198	Teva Pharmaceuticals USA, Inc.	LEUCOVORIN CALCIUM	5	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0555-0485_3aaaf34b-95c1-4388-8eab-510e693024e8	0555-0485	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19900630		ANDA	ANDA071199	Teva Pharmaceuticals USA, Inc.	LEUCOVORIN CALCIUM	25	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0555-0572_b37f40c2-08e0-4d9c-9243-4a02133a0d8d	0555-0572	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	19901101		ANDA	ANDA081099	Teva Pharmaceuticals USA, Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0555-0606_f3030cc3-88e9-48d4-9771-d313b6b87b35	0555-0606	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	19961025		ANDA	ANDA074621	Teva Pharmaceuticals USA, Inc.	MEGESTROL ACETATE	20	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-0607_f3030cc3-88e9-48d4-9771-d313b6b87b35	0555-0607	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	19951130		ANDA	ANDA074621	Teva Pharmaceuticals USA, Inc.	MEGESTROL ACETATE	40	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-0633_bf7b8fa5-f864-440f-bf44-333b3714678f	0555-0633	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	19980625		ANDA	ANDA074582	Teva Pharmaceuticals USA, Inc.	DANAZOL	50	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
0555-0634_bf7b8fa5-f864-440f-bf44-333b3714678f	0555-0634	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	19980625		ANDA	ANDA074582	Teva Pharmaceuticals USA, Inc.	DANAZOL	100	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
0555-0635_bf7b8fa5-f864-440f-bf44-333b3714678f	0555-0635	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	19960809		ANDA	ANDA074582	Teva Pharmaceuticals USA, Inc.	DANAZOL	200	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
0555-0711_3902eb87-aa22-4775-b56a-7cb86c5f920e	0555-0711	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20211209		ANDA	ANDA071196	Teva Pharmaceuticals USA, Inc.	TRAZODONE HYDROCHLORIDE	300	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0555-0775_34b99d97-5d73-4eb8-b3e4-7721b9e8726c	0555-0775	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20030319		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0776_34b99d97-5d73-4eb8-b3e4-7721b9e8726c	0555-0776	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20030319		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0777_34b99d97-5d73-4eb8-b3e4-7721b9e8726c	0555-0777	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20030319		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0779_12e9b52f-a3dc-4cb6-9e1c-0e02765402e6	0555-0779	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	Teva Pharmaceuticals USA, Inc.	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-0808_48f08c97-20c2-404a-a05f-84dada1ec42d	0555-0808	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE, LIQUID FILLED	ORAL	20070626		ANDA	ANDA077684	Teva Pharmaceuticals USA, Inc.	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0555-0872_12e9b52f-a3dc-4cb6-9e1c-0e02765402e6	0555-0872	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	Teva Pharmaceuticals USA, Inc.	MEDROXYPROGESTERONE ACETATE	2.5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-0873_12e9b52f-a3dc-4cb6-9e1c-0e02765402e6	0555-0873	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961203		ANDA	ANDA040159	Teva Pharmaceuticals USA, Inc.	MEDROXYPROGESTERONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-0882_28568498-1bd4-4312-9faf-3bcf89824189	0555-0882	HUMAN PRESCRIPTION DRUG	HYDROXYUREA		Hydroxyurea	CAPSULE	ORAL	19981019		ANDA	ANDA075143	Teva Pharmaceuticals USA, Inc.	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
0555-0886_80d8c060-3bbd-4010-9402-b191ec10717e	0555-0886	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	Teva Pharmaceuticals USA, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0555-0887_80d8c060-3bbd-4010-9402-b191ec10717e	0555-0887	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	Teva Pharmaceuticals USA, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0555-0899_80d8c060-3bbd-4010-9402-b191ec10717e	0555-0899	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	Teva Pharmaceuticals USA, Inc.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0555-0952_e339af0f-084a-4d19-8013-3ccb826816d0	0555-0952	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20010212		ANDA	ANDA040361	Teva Pharmaceuticals USA, Inc.	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0953_e339af0f-084a-4d19-8013-3ccb826816d0	0555-0953	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20010212		ANDA	ANDA040361	Teva Pharmaceuticals USA, Inc.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0971_34b99d97-5d73-4eb8-b3e4-7721b9e8726c	0555-0971	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020211		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0972_34b99d97-5d73-4eb8-b3e4-7721b9e8726c	0555-0972	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020211		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0973_34b99d97-5d73-4eb8-b3e4-7721b9e8726c	0555-0973	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020211		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0974_34b99d97-5d73-4eb8-b3e4-7721b9e8726c	0555-0974	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20020211		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0555-0997_85d41b6a-4c27-475e-9d87-dc647962239c	0555-0997	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		Fludrocortisone Acetate	TABLET	ORAL	20030214		ANDA	ANDA040425	Teva Pharmaceuticals USA, Inc.	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
0555-1054_a69dde5d-5585-4313-be43-02d11fec4c9f	0555-1054	HUMAN PRESCRIPTION DRUG	Claravis		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20030509		ANDA	ANDA076356	Teva Pharmaceuticals USA, Inc.	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0555-1055_a69dde5d-5585-4313-be43-02d11fec4c9f	0555-1055	HUMAN PRESCRIPTION DRUG	Claravis		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20030509		ANDA	ANDA076135	Teva Pharmaceuticals USA, Inc.	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0555-1056_a69dde5d-5585-4313-be43-02d11fec4c9f	0555-1056	HUMAN PRESCRIPTION DRUG	Claravis		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20060518		ANDA	ANDA076135	Teva Pharmaceuticals USA, Inc.	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0555-1057_a69dde5d-5585-4313-be43-02d11fec4c9f	0555-1057	HUMAN PRESCRIPTION DRUG	Claravis		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20030509		ANDA	ANDA076135	Teva Pharmaceuticals USA, Inc.	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0555-9008_76509f88-35fd-458f-be86-65c5c1e828bc	0555-9008	HUMAN PRESCRIPTION DRUG	Nortrel	28 Day	Norethindrone and Ethinyl Estradiol	KIT		20010606		ANDA	ANDA072695	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9009_76509f88-35fd-458f-be86-65c5c1e828bc	0555-9009	HUMAN PRESCRIPTION DRUG	Nortrel	21 Day	Norethindrone and Ethinyl Estradiol	TABLET	ORAL	20010613		ANDA	ANDA072693	Teva Pharmaceuticals USA, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE	.035; 1	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-9010_76509f88-35fd-458f-be86-65c5c1e828bc	0555-9010	HUMAN PRESCRIPTION DRUG	Nortrel	28 Day	Norethindrone and Ethinyl Estradiol	KIT		20010606		ANDA	ANDA072696	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9012_ddd9ebd7-bd21-4247-a158-95c5fc757aef	0555-9012	HUMAN PRESCRIPTION DRUG	Nortrel 7/7/7	(28 Day Regimen)	Norethindrone and Ethinyl Estradiol	KIT		20030102		ANDA	ANDA075478	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9014_02883b10-2ca4-4a70-a1c6-4bfc1604a15e	0555-9014	HUMAN PRESCRIPTION DRUG	Lessina		Levonorgestrel and Ethinyl Estradiol	KIT		20020422		ANDA	ANDA075803	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9016_a37e47fa-1919-47aa-983c-2bdb9e428cd5	0555-9016	HUMAN PRESCRIPTION DRUG	Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20020926		ANDA	ANDA075804	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9018_e599171b-f4b9-46fc-9ed7-3335374e1d5f	0555-9018	HUMAN PRESCRIPTION DRUG	Tri-Sprintec		norgestimate and ethinyl estradiol	KIT		20031229		ANDA	ANDA075808	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9020_8c284934-29a3-4dc3-8400-f90baf63a2b6	0555-9020	HUMAN PRESCRIPTION DRUG	Portia		Levonorgestrel and Ethinyl Estradiol	KIT		20020627		ANDA	ANDA075866	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9025_d29dbb49-908f-451a-9379-21a96a1d7bb1	0555-9025	HUMAN PRESCRIPTION DRUG	Junel	21 Day	Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20030918		ANDA	ANDA076380	Teva Pharmaceuticals USA, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	20; 1	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-9026_d29dbb49-908f-451a-9379-21a96a1d7bb1	0555-9026	HUMAN PRESCRIPTION DRUG	Junel	Fe 28 Day	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20030918		ANDA	ANDA076081	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9027_d29dbb49-908f-451a-9379-21a96a1d7bb1	0555-9027	HUMAN PRESCRIPTION DRUG	Junel	21 Day	Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20030918		ANDA	ANDA076381	Teva Pharmaceuticals USA, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	30; 1.5	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0555-9028_d29dbb49-908f-451a-9379-21a96a1d7bb1	0555-9028	HUMAN PRESCRIPTION DRUG	Junel	Fe 28 Day	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20030918		ANDA	ANDA076064	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9032_d7c6f988-bb93-48d0-90e3-9074a5185999	0555-9032	HUMAN PRESCRIPTION DRUG	Tri-Legest Fe	28 Day	Norethindrone Acetate and Ethinyl Estradiol	KIT		20071026		ANDA	ANDA076105	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9034_e954d96a-4a26-42db-a129-1f8d4b646507	0555-9034	HUMAN PRESCRIPTION DRUG	Balziva		Norethindrone and Ethinyl Estradiol	KIT		20061016		ANDA	ANDA076238	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9043_06176d8d-c9e2-4912-ab6d-ecb3d5e514d8	0555-9043	HUMAN PRESCRIPTION DRUG	Apri	28 Day	Desogestrel and Ethinyl Estradiol	KIT		19991022		ANDA	ANDA075256	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9045_42920a37-eba1-45ea-9cbc-30642955719f	0555-9045	HUMAN PRESCRIPTION DRUG	Aviane		Levonorgestrel and Ethinyl Estradiol	KIT		20010402		ANDA	ANDA075796	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9047_5f1d4816-8608-4f95-b62f-6ef55f4f03a8	0555-9047	HUMAN PRESCRIPTION DRUG	Enpresse		Levonorgestrel and Ethinyl Estradiol	KIT		20020627		ANDA	ANDA075809	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9049_554c9974-1f3d-4959-bbf0-1bebfadbfdbe	0555-9049	HUMAN PRESCRIPTION DRUG	Cryselle		Norgestrel and Ethinyl Estradiol	KIT		20020724		ANDA	ANDA075840	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9050_1c2d2392-d1cb-4a23-919e-406e5a99853b	0555-9050	HUMAN PRESCRIPTION DRUG	Kariva		Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol	KIT		20020408		ANDA	ANDA075863	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9051_855af598-bfc0-4f0b-ab61-d3cb414b86d5	0555-9051	HUMAN PRESCRIPTION DRUG	Velivet	Triphasic Regimen	Desogestrel and Ethinyl Estradiol	KIT		20040301		ANDA	ANDA076455	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9064_a579e715-cf4d-4d28-9bb7-3b4e2d4dc4d3	0555-9064	HUMAN PRESCRIPTION DRUG	Kelnor 1/35		Ethynodiol Diacetate and Ethinyl Estradiol	KIT		20050620		ANDA	ANDA076785	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9066_2ac158f0-30db-4d93-8387-ad314cabaa66	0555-9066	HUMAN PRESCRIPTION DRUG	Aranelle		norethindrone and ethinyl estradiol	KIT		20041004		ANDA	ANDA076783	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9123_4826f86c-89b6-4172-b0da-39688d5c511e	0555-9123	HUMAN PRESCRIPTION DRUG	Jolessa		Levonorgestrel / Ethinyl Estradiol	KIT		20031013		NDA AUTHORIZED GENERIC	NDA021544	Teva Pharmaceuticals USA, Inc.						N	20241231
0555-9131_121ea8dd-1108-4c1d-a41e-657648522be3	0555-9131	HUMAN PRESCRIPTION DRUG	OCELLA		drospirenone and ethinyl estradiol	KIT		20010611		NDA AUTHORIZED GENERIC	NDA021098	TEVA PHARMACEUTICALS USA, INC.						N	20241231
0562-7805_658ecb5b-660d-411b-ae83-50af5b3b9302	0562-7805	PLASMA DERIVATIVE	RhoGAM Ultra-Filtered PLUS		HUMAN RHO(D) IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR	20070309		BLA	BLA103777	Kedrion Biopharma Inc	HUMAN RHO(D) IMMUNE GLOBULIN	300	ug/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0562-7806_658ecb5b-660d-411b-ae83-50af5b3b9302	0562-7806	PLASMA DERIVATIVE	MICRhoGAM Ultra-Filtered PLUS		HUMAN RHO(D) IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR	20070309		BLA	BLA103777	Kedrion Biopharma Inc	HUMAN RHO(D) IMMUNE GLOBULIN	50	ug/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0573-0133_4e46a19d-ca33-44b9-bf35-a1da6a4be764	0573-0133	HUMAN OTC DRUG	Advil		ibuprofen sodium	TABLET, COATED	ORAL	20130708		NDA	NDA201803	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN SODIUM	256	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0134_4e46a19d-ca33-44b9-bf35-a1da6a4be764	0573-0134	HUMAN OTC DRUG	Advil		ibuprofen sodium	TABLET, COATED	ORAL	20130708		NDA	NDA201803	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN SODIUM	256	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0145_acaa9806-e552-44f2-a680-b8bb64c49e1f	0573-0145	HUMAN OTC DRUG	ADVIL DUAL ACTION WITH ACETAMINOPHEN	Back Pain	Ibuprofen, Acetaminophen	TABLET, FILM COATED	ORAL	20230116		NDA	NDA211733	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0147_37acdfb0-6dd1-438d-8727-96e33ccbccce	0573-0147	HUMAN OTC DRUG	ADVIL DUAL ACTION WITH ACETAMINOPHEN		Ibuprofen, Acetaminophen	TABLET, FILM COATED	ORAL	20200727		NDA	NDA211733	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0149_ab51d278-0fcc-4882-ba04-5e045a976db6	0573-0149	HUMAN OTC DRUG	Advil		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	19950410		NDA	NDA020402	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0150_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-0150	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0151_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-0151	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0154_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-0154	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0160_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-0160	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0161_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-0161	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0164_84782dbd-48de-47fc-96c0-bb9834d8c966	0573-0164	HUMAN OTC DRUG	ADVIL PM		diphenhydramine citrate and ibuprofen	TABLET, COATED	ORAL	20051221		NDA	NDA021394	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0165_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-0165	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0166_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-0166	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0167_10a1d025-f010-4cf1-b09a-b590d054afd8	0573-0167	HUMAN OTC DRUG	ADVIL PM		diphenhydramine HCl, ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20051220		NDA	NDA021393	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0168_2c23a210-0709-450e-8433-ad69b88ae3c7	0573-0168	HUMAN OTC DRUG	ADVIL MIGRAINE		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20000316		NDA	NDA020402	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0169_ab51d278-0fcc-4882-ba04-5e045a976db6	0573-0169	HUMAN OTC DRUG	Advil		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	19950410		NDA	NDA020402	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0170_bf8d401c-b1fe-4638-966b-8a0f6a83d325	0573-0170	HUMAN OTC DRUG	CHILDRENS ADVIL		ibuprofen	SUSPENSION	ORAL	19960627		NDA	NDA020589	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0171_bf8d401c-b1fe-4638-966b-8a0f6a83d325	0573-0171	HUMAN OTC DRUG	CHILDRENS ADVIL		ibuprofen	SUSPENSION	ORAL	19960627		NDA	NDA020589	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0174_bf8d401c-b1fe-4638-966b-8a0f6a83d325	0573-0174	HUMAN OTC DRUG	CHILDRENS ADVIL		ibuprofen	SUSPENSION	ORAL	19960627		NDA	NDA020589	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0175_0782baf2-5129-4456-a538-20d89d4be659	0573-0175	HUMAN OTC DRUG	JUNIOR STRENGTH ADVIL		ibuprofen	TABLET, COATED	ORAL	20110621		NDA	NDA020267	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0179_4898214f-e425-4ca8-b8e1-c865cd131ed2	0573-0179	HUMAN OTC DRUG	JUNIOR STRENGTH ADVIL		ibuprofen	TABLET, CHEWABLE	ORAL	20110601		NDA	NDA020944	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0180_02bb30f1-68de-47ef-b37c-7829b552e81b	0573-0180	HUMAN OTC DRUG	ADVIL COLD AND SINUS		ibuprofen and pseudoephedrine hydrochloride	TABLET, COATED	ORAL	19890919		NDA	NDA019771	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0573-0188_57a31fd0-310d-4ca1-bead-d449d79a0ae4	0573-0188	HUMAN OTC DRUG	ADVIL ALLERGY SINUS		chlorpheniramine maleate, ibuprofen, pseudoephedrine HCl	TABLET, COATED	ORAL	20021220		NDA	NDA021441	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 200; 30	mg/1; mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0573-0190_2b02a49b-750d-4ea3-b51f-8e799c09bcd0	0573-0190	HUMAN OTC DRUG	Advil Multi-Symptom Cold and Flu		chlorpheniramine maleate, ibuprofen, phenylephrine HCl	TABLET, COATED	ORAL	20180625		NDA	NDA022113	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	4; 200; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-0191_0150e96e-74ba-48b1-997d-5fdb75b98556	0573-0191	HUMAN OTC DRUG	INFANTS ADVIL		ibuprofen	SUSPENSION/ DROPS	ORAL	19980130		NDA	NDA020812	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0196_b0d2dd9a-b905-47cc-88f1-0114b210e7ab	0573-0196	HUMAN OTC DRUG	Advil Allergy and Congestion Relief		chlorpheniramine maleate, ibuprofen, and phenylephrine hydrochloride	TABLET, COATED	ORAL	20120723		NDA	NDA022113	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	4; 200; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-0199_77bc957b-4c40-4bca-b4fc-ce28defb867f	0573-0199	HUMAN OTC DRUG	ADVIL SINUS CONGESTION AND PAIN		ibuprofen, phenylephrine hydrochloride	TABLET, COATED	ORAL	20150701		NDA	NDA022565	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	200; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-0207_bf8d401c-b1fe-4638-966b-8a0f6a83d325	0573-0207	HUMAN OTC DRUG	CHILDRENS ADVIL		ibuprofen	SUSPENSION	ORAL	20120904		NDA	NDA020589	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0230_0573f2d1-0762-4a1e-9ac2-f9ebc5746431	0573-0230	HUMAN OTC DRUG	Advil Menstrual Pain		ibuprofen sodium	TABLET, COATED	ORAL	20160630		NDA	NDA201803	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN SODIUM	256	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0232_bf8d401c-b1fe-4638-966b-8a0f6a83d325	0573-0232	HUMAN OTC DRUG	CHILDRENS ADVIL		ibuprofen	SUSPENSION	ORAL	20131220		NDA	NDA020589	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0290_bf8d401c-b1fe-4638-966b-8a0f6a83d325	0573-0290	HUMAN OTC DRUG	CHILDRENS ADVIL		ibuprofen	SUSPENSION	ORAL	20101201		NDA	NDA020589	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-0552_1e8b9043-b6ab-4bfc-b23b-935e2bd64b52	0573-0552	HUMAN OTC DRUG	PREPARATION H SOOTHING RELIEF ANTI-ITCH		hydrocortisone	CREAM	TOPICAL	20200228		OTC MONOGRAPH NOT FINAL	part348	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0573-0553_0d7692dc-06b5-468a-9882-42d9f773bc33	0573-0553	HUMAN OTC DRUG	PREPARATION H SOOTHING RELIEF CLEANSING AND COOLING WIPES		witch hazel	CLOTH	TOPICAL	20200304		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	WITCH HAZEL	200	mg/1			N	20241231
0573-0554_867fdf95-0d1e-487e-a17f-95a246f2abe9	0573-0554	HUMAN OTC DRUG	Preparation H Rapid Relief		Glycerin, Lidocaine, Phenylephrine Hydrochloride	CLOTH	TOPICAL	20190301		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	GLYCERIN; LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	200; 50; 2.5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-0556_01a3b602-0d23-4230-b264-20bed3efc369	0573-0556	HUMAN OTC DRUG	PREPARATION H MEDICATED WIPES		witch hazel	CLOTH	TOPICAL	20040202		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	WITCH HAZEL	5	g/1			N	20241231
0573-0557_3b1cfa8a-942f-471e-b7c0-744f83b687a0	0573-0557	HUMAN OTC DRUG	PREPARATION H MEDICATED WIPES		witch hazel	CLOTH	TOPICAL	20220801		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	WITCH HAZEL	5	g/1			N	20241231
0573-0558_1ca0200f-0bf5-43ce-b230-9c142dd174e3	0573-0558	HUMAN OTC DRUG	PREPARATION H TOTABLES IRRITATION RELIEF WIPES		witch hazel	CLOTH	TOPICAL	20101121		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	WITCH HAZEL	5	g/1			N	20241231
0573-0559_f2380eed-b9dc-4c6f-b3d6-415b72e2ed2c	0573-0559	HUMAN OTC DRUG	PREPARATION H FOR WOMEN		witch hazel	CLOTH	TOPICAL	20140401		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	WITCH HAZEL	2	g/1			N	20241231
0573-0701_4e8b0ef6-edf4-47cf-bf56-e9e57e7da2b0	0573-0701	HUMAN OTC DRUG	ChapStick Classic Original		white petrolatum	STICK	TOPICAL	20180528		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PETROLATUM	450	mg/g			N	20241231
0573-0705_e985a231-913f-4b56-a879-5c3790c85e72	0573-0705	HUMAN OTC DRUG	ChapStick Classic Cherry		white petrolatum	STICK	TOPICAL	20180610		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PETROLATUM	450	mg/g			N	20241231
0573-0711_214349bc-7ab2-4f6b-872b-a5e5700e7bb7	0573-0711	HUMAN OTC DRUG	ChapStick Classic Spearmint		white petrolatum	STICK	TOPICAL	20180611		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PETROLATUM	450	mg/g			N	20241231
0573-0725_e04236b8-9094-4554-84ce-6a15555f57b9	0573-0725	HUMAN OTC DRUG	Chapstick Moisturizer Original		avobenzone, octinoxate, and white petrolatum	STICK	TOPICAL	20180628		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 423	mg/g; mg/g; mg/g			N	20241231
0573-0803_d1998a9e-d61f-4b4c-91b0-5e66754bcc4a	0573-0803	HUMAN OTC DRUG	Chapstick Active 2in1	Variety Pack	zinc oxide	KIT		20230531		OTC MONOGRAPH FINAL	part352	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0573-0804_d6eb2ea6-27c7-40a6-a1f0-789ea2131de3	0573-0804	HUMAN OTC DRUG	Chapstick	12 Days of Christmas	white petrolatum	KIT		20230901		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0573-0805_6df216dc-c03d-463a-8029-5e54c1dc3d27	0573-0805	HUMAN OTC DRUG	Chapstick Holiday Classics Kit		white petrolatum	KIT		20230801		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0573-0871_5c03f887-60de-460f-acfe-5b7b7192ec51	0573-0871	HUMAN OTC DRUG	Chapstick Total Hydration Moisture Tint Peachy Keen		zinc oxide	STICK	TOPICAL	20200225		OTC MONOGRAPH FINAL	part352	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ZINC OXIDE	101	mg/g			N	20241231
0573-0872_e6d0a0d2-28c8-4eb0-a142-b166bb930d0f	0573-0872	HUMAN OTC DRUG	Chapstick Total Hydration Moisture Tint Very Berry		zinc oxide	STICK	TOPICAL	20200225		OTC MONOGRAPH FINAL	part352	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ZINC OXIDE	101	mg/g			N	20241231
0573-0873_f5ef20d2-f97d-4d5b-82e2-8862cca5e7b0	0573-0873	HUMAN OTC DRUG	Chapstick Total Hydration Moisture Tint Pretty in Pink		zinc oxide	STICK	TOPICAL	20200225		OTC MONOGRAPH FINAL	part352	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ZINC OXIDE	101	mg/g			N	20241231
0573-1174_e5972cc2-c3f6-44f7-8417-1247205d238d	0573-1174	HUMAN OTC DRUG	CHILDRENS ADVIL		ibuprofen	SUSPENSION	ORAL	19960627		NDA	NDA020589	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-1378_3bdbd61e-bc4f-4804-8c1d-651fe3ceb6d8	0573-1378	HUMAN OTC DRUG	PREPARATION H		Phenylephrine hydrochloride	SUPPOSITORY	RECTAL	20221216		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PHENYLEPHRINE HYDROCHLORIDE	6.25	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-1711_50ff83c8-c41f-4a9c-adb1-cb060bf21bc3	0573-1711	HUMAN OTC DRUG	ADVIL		ibuprofen	TABLET, COATED	ORAL	19840518		NDA	NDA018989	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-1769_ab51d278-0fcc-4882-ba04-5e045a976db6	0573-1769	HUMAN OTC DRUG	Advil		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170308		NDA	NDA020402	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0573-1912_f001228f-ab50-4120-af45-492d7c6dc100	0573-1912	HUMAN OTC DRUG	ChapStick Classic Spearmint		PETROLATUM	STICK	TOPICAL	20120801		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PETROLATUM	450	mg/g			N	20241231
0573-1921_84d8cc38-83e3-49be-b180-d01820525b60	0573-1921	HUMAN OTC DRUG	ChapStick Supreme Classic Cherry		white petrolatum	STICK	TOPICAL	20220301		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PETROLATUM	450	mg/g			N	20241231
0573-1957_33497c07-ad6e-4c50-bc23-a55725b2eae1	0573-1957	HUMAN OTC DRUG	Chapstick Moisturizer Cool Mint		avobenzone, homosalate, octisalate, octocrylene, white petrolatum	STICK	TOPICAL	20220401		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; PETROLATUM	30; 40; 45; 26; 369	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0573-1958_de250ae9-6e4a-46ca-bcc9-5bb07dbb70c5	0573-1958	HUMAN OTC DRUG	Chapstick Moisturizer Original		avobenzone, homosalate, octisalate, octocrylene, white petrolatum	STICK	TOPICAL	20220401		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; PETROLATUM	30; 40; 45; 26; 384	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0573-1959_bfb9a2d5-1ad2-45b8-a215-9d1370af5337	0573-1959	HUMAN OTC DRUG	Chapstick Moisturizer Variety Pack		avobenzone, homosalate, octisalate, octocrylene, white petrolatum	KIT		20220401		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0573-2027_7f2f81fa-9e09-4713-8214-5651db553db3	0573-2027	HUMAN OTC DRUG	Chapstick		avobenzone, octinoxate, and white petrolatum	KIT		20210428		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0573-2031_3d6d49f5-556a-4af0-a411-dfd0d2aee840	0573-2031	HUMAN OTC DRUG	CHAPSTICK CLASSIC MEDICATED		camphor, menthol, petrolatum	STICK	TOPICAL	20220315		OTC MONOGRAPH NOT FINAL	part348	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM	16; 6; 410	mg/g; mg/g; mg/g			N	20241231
0573-2062_f0adf4a4-c8db-47c7-b553-89331cfb9258	0573-2062	HUMAN OTC DRUG	Chapstick		White petrolatum	KIT		20210328		OTC MONOGRAPH FINAL	part347	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0573-2161_b0d2dd9a-b905-47cc-88f1-0114b210e7ab	0573-2161	HUMAN OTC DRUG	Advil Allergy and Congestion Relief		chlorpheniramine maleate, ibuprofen, and phenylephrine hydrochloride	TABLET, COATED	ORAL	20120723		NDA	NDA022113	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	4; 200; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-2450_d6b37184-f02c-4d98-82e0-32fb73d0879d	0573-2450	HUMAN OTC DRUG	Nexium 24HR		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20140527		NDA	NDA204655	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0573-2451_9802a702-5da3-4952-9c13-7a5f9b7b2d95	0573-2451	HUMAN OTC DRUG	Nexium 24HR		esomeprazole magnesium	TABLET	ORAL	20160206		NDA	NDA207920	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0573-2452_d6b37184-f02c-4d98-82e0-32fb73d0879d	0573-2452	HUMAN OTC DRUG	Nexium 24HR ClearMinis		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20170301		NDA	NDA204655	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0573-2660_60d4d282-c9fb-4d77-b832-80d9d4841eec	0573-2660	HUMAN OTC DRUG	ALAVERT ALLERGY SINUS D-12		loratadine, pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20040130		ANDA	ANDA076050	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0573-2840_3e24784a-7d44-43a0-ac39-55bd22f09c5b	0573-2840	HUMAN OTC DRUG	Preparation H Cooling Gel		phenylephrine hcl, witch hazel	GEL	TOPICAL	20040101		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	2.5; 500	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-2843_c82b8c3d-8ee0-44ee-9a58-a15f3d89d482	0573-2843	HUMAN OTC DRUG	Preparation H Rapid Relief		Glycerin, Lidocaine, Petrolatum, and Phenylephrine Hydrochloride	CREAM	TOPICAL	20181101		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	GLYCERIN; LIDOCAINE; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	144; 50; 150; 2.5	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-2868_0a5d6aa5-e99a-e028-e063-6294a90afde6	0573-2868	HUMAN OTC DRUG	PREPARATION H	Maximum Strength	glycerin, petrolatum, phenylephrine HCl, pramoxine HCl	CREAM	TOPICAL	20040701		OTC MONOGRAPH DRUG	M015	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	144; 150; 2.5; 10	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-2871_0a5daa94-6921-01a4-e063-6294a90aed0f	0573-2871	HUMAN OTC DRUG	PREPARATION H		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	TOPICAL	20040301		OTC MONOGRAPH DRUG	M015	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-2880_0b129af7-c02b-4952-acf5-9a337895b9e1	0573-2880	HUMAN OTC DRUG	PREPARATION H		cocoa butter, phenylephrine hydrochloride	SUPPOSITORY	RECTAL	20040105		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.25	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-2883_0b129af7-c02b-4952-acf5-9a337895b9e1	0573-2883	HUMAN OTC DRUG	PREPARATION H		cocoa butter, phenylephrine hydrochloride	SUPPOSITORY	RECTAL	20040105		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.25	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0573-2884_26c89aab-afd1-4fff-a857-8a366e470877	0573-2884	HUMAN OTC DRUG	Preparation H		cocoa butter, phenylephrine hydrochloride, and witch hazel	KIT		20150701		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC						N	20241231
0573-2889_0a5e9bd8-9556-b20b-e063-6294a90ad540	0573-2889	HUMAN OTC DRUG	Preparation H	Soothing Relief Cooling	witch hazel	AEROSOL, SPRAY	TOPICAL	20210412		OTC MONOGRAPH DRUG	M015	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	WITCH HAZEL	200	mg/g			N	20241231
0573-2890_27db1d58-4609-4a80-af2f-9e36f10482e1	0573-2890	HUMAN OTC DRUG	Preparation H Rapid Relief		Lidocaine, Phenylephrine Hydrochloride	SPRAY	TOPICAL	20220201		OTC MONOGRAPH FINAL	part346	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	50; 2.5	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0574-0067_9f5d1cea-be7a-440b-afc9-2dd5c3021634	0574-0067	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20140414		OTC MONOGRAPH NOT FINAL	part333A	Paddock Laboratories LLC	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
0574-0106_fcaf4b62-a6de-4ffc-ac2b-1cc275efc130	0574-0106	HUMAN PRESCRIPTION DRUG	Bromocriptine mesylate		Bromocriptine mesylate	TABLET	ORAL	20140401		ANDA	ANDA077646	Padagis US LLC	BROMOCRIPTINE MESYLATE	2.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
0574-0107_c3d8e3ce-0429-4979-a91d-58dd19bbe996	0574-0107	HUMAN PRESCRIPTION DRUG	Clotrimazole		clotrimazole	LOZENGE	ORAL	20051201		ANDA	ANDA076763	Padagis US LLC	CLOTRIMAZOLE	10	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0574-0115_9e259d4a-07b9-491f-8afe-85de77ac3e8f	0574-0115	HUMAN PRESCRIPTION DRUG	FLAVOXATE HYDROCHLORIDE		FLAVOXATE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20041222		ANDA	ANDA076831	Padagis US LLC	FLAVOXATE HYDROCHLORIDE	100	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0574-0118_8a1e6330-2aa2-4e32-bbfe-369709d024c7	0574-0118	HUMAN PRESCRIPTION DRUG	Trospium Chloride	ER	Trospium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20130607		ANDA	ANDA201291	Padagis US LLC	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0574-0122_076638ec-85bd-4665-afc4-0af0c73076be	0574-0122	HUMAN OTC DRUG	EZ Char		Activated charcoal	PELLET	ORAL	20020114	20251130	OTC MONOGRAPH NOT FINAL	part357	Padagis US LLC	ACTIVATED CHARCOAL	25	g/25g			N	
0574-0129_3afce752-ba2e-4643-9104-e28c55dbdc53	0574-0129	HUMAN PRESCRIPTION DRUG	Clindamycin Palmitate Hydrochloride		Clindamycin Palmitate Hydrochloride	GRANULE, FOR SOLUTION	ORAL	20100121		ANDA	ANDA090902	Padagis US LLC	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0574-0145_04283a5f-817d-4ad9-a946-e73b5fcb4f4c	0574-0145	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	TABLET, FILM COATED	ORAL	20101117		ANDA	ANDA091573	Padagis US LLC	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0574-0147_833284dd-bd16-444c-a965-6f70359fc19d	0574-0147	HUMAN PRESCRIPTION DRUG	famotidine		famotidine	POWDER, FOR SUSPENSION	ORAL	20100528		NDA AUTHORIZED GENERIC	NDA019527	Padagis US LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0574-0150_d7b8dd9f-1acd-4d10-afbf-a57a93154a6b	0574-0150	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20050502		ANDA	ANDA076379	Padagis US LLC	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0574-0157_4657bbc6-2013-4fe8-9e91-bb201c3e61a7	0574-0157	HUMAN PRESCRIPTION DRUG	Tavaborole		Tavaborole	SOLUTION	TOPICAL	20210110		ANDA	ANDA211848	Padagis US LLC	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
0574-0167_9e86e2de-4a4d-4e0c-a003-843f0064afc4	0574-0167	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	SOLUTION	TOPICAL	20221122	20240930	NDA AUTHORIZED GENERIC	NDA204623	Padagis US LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
0574-0227_1d6c07ee-7f41-4184-8dc5-aca58cb2eb78	0574-0227	HUMAN PRESCRIPTION DRUG	benazepril hydrochloride and hydrochlorothiazide		benazepril hydrochloride and hydrochlorothiazide	TABLET	ORAL	20190407		NDA AUTHORIZED GENERIC	NDA020033	Padagis US LLC	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0574-0228_1d6c07ee-7f41-4184-8dc5-aca58cb2eb78	0574-0228	HUMAN PRESCRIPTION DRUG	benazepril hydrochloride and hydrochlorothiazide		benazepril hydrochloride and hydrochlorothiazide	TABLET	ORAL	20190407		NDA AUTHORIZED GENERIC	NDA020033	Padagis US LLC	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0574-0229_1d6c07ee-7f41-4184-8dc5-aca58cb2eb78	0574-0229	HUMAN PRESCRIPTION DRUG	benazepril hydrochloride and hydrochlorothiazide		benazepril hydrochloride and hydrochlorothiazide	TABLET	ORAL	20190407		NDA AUTHORIZED GENERIC	NDA020033	Padagis US LLC	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0574-0240_d49adc4a-7bb7-4794-8355-210325b08ff5	0574-0240	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20130809		ANDA	ANDA201189	Padagis US LLC	REPAGLINIDE	.5	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
0574-0241_d49adc4a-7bb7-4794-8355-210325b08ff5	0574-0241	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20140122	20250131	ANDA	ANDA201189	Padagis US LLC	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	
0574-0242_d49adc4a-7bb7-4794-8355-210325b08ff5	0574-0242	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20140122	20240531	ANDA	ANDA201189	Padagis US LLC	REPAGLINIDE	2	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	
0574-0275_8107e2a7-f286-46f3-b502-dce8e66f6a8f	0574-0275	HUMAN PRESCRIPTION DRUG	Potassium chloride extended release		Potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20151211		ANDA	ANDA205993	Padagis US LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
0574-0279_2da9c1a5-7b6c-4990-b6a5-1b06e1dd85cd	0574-0279	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine	CAPSULE	ORAL	20171003		NDA AUTHORIZED GENERIC	NDA204516	Padagis US LLC	PAROXETINE MESYLATE	7.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0574-0292_8fcb7492-3943-4a51-ba0d-81a37c4bd04d	0574-0292	HUMAN PRESCRIPTION DRUG	amiloride hydrochloride		amiloride hydrochloride	TABLET	ORAL	20090406		NDA AUTHORIZED GENERIC	NDA018200	Padagis US LLC	AMILORIDE HYDROCHLORIDE	5	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
0574-0293_185636e1-ed9d-4a36-bac9-1ea7026d2b42	0574-0293	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150522		ANDA	ANDA204278	Padagis US LLC	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-0294_185636e1-ed9d-4a36-bac9-1ea7026d2b42	0574-0294	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150522		ANDA	ANDA204278	Padagis US LLC	HYDROMORPHONE HYDROCHLORIDE	12	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-0295_185636e1-ed9d-4a36-bac9-1ea7026d2b42	0574-0295	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150522		ANDA	ANDA204278	Padagis US LLC	HYDROMORPHONE HYDROCHLORIDE	16	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-0297_185636e1-ed9d-4a36-bac9-1ea7026d2b42	0574-0297	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150522		ANDA	ANDA204278	Padagis US LLC	HYDROMORPHONE HYDROCHLORIDE	32	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-0520_25f1d299-8fda-4342-93e0-8965c9dd506c	0574-0520	HUMAN OTC DRUG	ACTIDOSE		activated charcoal	SUSPENSION	ORAL	20201205		OTC MONOGRAPH NOT FINAL	part357	Padagis US LLC	ACTIVATED CHARCOAL	208	mg/mL			N	20241231
0574-0521_472de6a4-9ecb-4be4-afe0-6a3673e9d6f4	0574-0521	HUMAN OTC DRUG	ACTIDOSE AQUA		activated charcoal	SUSPENSION	ORAL	20201110		OTC MONOGRAPH NOT FINAL	part357	Padagis US LLC	ACTIVATED CHARCOAL	208	mg/mL			N	20241231
0574-0601_2da57a29-5c89-4641-881c-176cb576c89e	0574-0601	HUMAN PRESCRIPTION DRUG	Podocon 25		Podophyllum resin	TINCTURE	TOPICAL	19900901		UNAPPROVED DRUG OTHER		Padagis US LLC	PODOPHYLLUM RESIN	1	mg/4mL			N	20241231
0574-0611_a9e73e11-abbe-43a3-8ec4-48c9eca20329	0574-0611	HUMAN PRESCRIPTION DRUG	PODOFILOX		PODOFILOX	SOLUTION	TOPICAL	20020129		ANDA	ANDA075600	Padagis US LLC	PODOFILOX	5	mg/mL	Decreased Mitosis [PE]		N	20241231
0574-0618_fd06c678-6ab0-4c52-82df-083a98292f18	0574-0618	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20041222		OTC MONOGRAPH NOT FINAL	part334	Paddock Laboratories, LLC	MINERAL OIL	99.9	mg/mL			N	20241231
0574-0621_d2e70c5e-d4a9-4295-9eff-517ffb974e61	0574-0621	HUMAN PRESCRIPTION DRUG	Podofilox		Podofilox	GEL	TOPICAL	20231213		ANDA	ANDA211871	Padagis US LLC	PODOFILOX	5	mg/g	Decreased Mitosis [PE]		N	20241231
0574-0790_d78d4629-2b29-42b4-8880-ec292270ae7f	0574-0790	HUMAN PRESCRIPTION DRUG	methazolamide		methazolamide	TABLET	ORAL	20140930		ANDA	ANDA040062	Padagis US LLC	METHAZOLAMIDE	25	mg/1			N	20241231
0574-0791_d78d4629-2b29-42b4-8880-ec292270ae7f	0574-0791	HUMAN PRESCRIPTION DRUG	methazolamide		methazolamide	TABLET	ORAL	20140930		ANDA	ANDA040062	Padagis US LLC	METHAZOLAMIDE	50	mg/1			N	20241231
0574-0792_d695f741-5439-413a-b092-3f78e73ad85b	0574-0792	HUMAN PRESCRIPTION DRUG	pilocarpine hydrchloride		pilocarpine hydrchloride	TABLET, FILM COATED	ORAL	20200824		ANDA	ANDA076746	Padagis US LLC	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0574-0805_ec58883f-f7ea-4bed-b9dd-724849a999b9	0574-0805	HUMAN PRESCRIPTION DRUG	acetylcysteine		Acetylcysteine	INJECTION	INTRAVENOUS	20121220		NDA AUTHORIZED GENERIC	NDA021539	Padagis US LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
0574-0820_95aaac2f-c71e-4833-9ce2-8a1e59bf398b	0574-0820	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20071221		ANDA	ANDA040530	Padagis US LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0574-0827_38c7c236-651b-490f-9e33-3608692550d8	0574-0827	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20140501		ANDA	ANDA091244	Padagis US LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0574-0850_457877f9-c530-440c-a903-c87a497b5b0d	0574-0850	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20030429		ANDA	ANDA040475	Padagis US LLC	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
0574-0866_14c2c066-efee-4b5d-b987-507cb2b4ac68	0574-0866	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	INJECTION, SOLUTION	INTRAVENOUS	20031007	20240801	ANDA	ANDA065151	Padagis US LLC	CYCLOSPORINE	50	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	
0574-0930_5f3b11e3-6fd0-4115-b42b-6d29f6dcf93b	0574-0930	HUMAN PRESCRIPTION DRUG	doxorubicin hydrochloride		doxorubicin hydrochloride	INJECTION, SUSPENSION, LIPOSOMAL	INTRAVENOUS	20211025	20240430	ANDA	ANDA207228	Padagis US LLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	
0574-0931_5f3b11e3-6fd0-4115-b42b-6d29f6dcf93b	0574-0931	HUMAN PRESCRIPTION DRUG	doxorubicin hydrochloride		doxorubicin hydrochloride	INJECTION, SUSPENSION, LIPOSOMAL	INTRAVENOUS	20211025	20240430	ANDA	ANDA207228	Padagis US LLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	
0574-1104_5560c2eb-6257-4654-a05f-5f79fa1b88b3	0574-1104	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide	SYRUP	ORAL	20150206		ANDA	ANDA205292	Padagis US LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0574-1133_522bd365-ddcc-48f4-8a98-66dc4c3bb314	0574-1133	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		spironolactone	SUSPENSION	ORAL	20231031		NDA AUTHORIZED GENERIC	NDA209478	Padagis US LLC	SPIRONOLACTONE	25	mg/5mL	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0574-2008_b164d1c9-e720-49f6-8bd3-fa767fb2179e	0574-2008	HUMAN PRESCRIPTION DRUG	Nystop		Nystatin	POWDER	TOPICAL	19960816		ANDA	ANDA064118	Padagis US LLC	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0574-2042_31d53fc5-3004-41e1-a5af-cf6b8f4285a6	0574-2042	HUMAN PRESCRIPTION DRUG	LIDOCAINE AND PRILOCAINE		Lidocaine and Prilocaine	CREAM	TOPICAL	20221220		ANDA	ANDA212482	Padagis US LLC	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
0574-2061_c152d6a1-9dd6-4d79-9e6a-590df574f361	0574-2061	HUMAN PRESCRIPTION DRUG	CICLOPIROX		CICLOPIROX	GEL	TOPICAL	20090107		ANDA	ANDA078266	Padagis US LLC	CICLOPIROX	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
0574-2067_0235e42a-c9e1-4e19-848f-7d760f242493	0574-2067	HUMAN PRESCRIPTION DRUG	Evamist		Estradiol	SPRAY	TRANSDERMAL	20150411		NDA	NDA022014	Padagis US LLC	ESTRADIOL	1.53	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0574-2107_e12e16c8-a58f-4dc7-90f3-78c9b803f28b	0574-2107	HUMAN PRESCRIPTION DRUG	Ivermectin		IVERMECTIN	CREAM	TOPICAL	20210607		NDA AUTHORIZED GENERIC	NDA206255	Padagis US LLC	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
0574-2201_6794b201-8cb8-46de-9126-8d30f78c24fe	0574-2201	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	CREAM	TOPICAL	20170330		ANDA	ANDA075213	Padagis US LLC	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0574-2205_6794b201-8cb8-46de-9126-8d30f78c24fe	0574-2205	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	CREAM	TOPICAL	20170426		ANDA	ANDA075265	Padagis US LLC	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0574-2225_6794b201-8cb8-46de-9126-8d30f78c24fe	0574-2225	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	CREAM	TOPICAL	20170615		ANDA	ANDA075264	Padagis US LLC	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0574-2301_6794b201-8cb8-46de-9126-8d30f78c24fe	0574-2301	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	GEL	TOPICAL	20170330		ANDA	ANDA075589	Padagis US LLC	TRETINOIN	.1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0574-2325_6794b201-8cb8-46de-9126-8d30f78c24fe	0574-2325	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	GEL	TOPICAL	20170307		ANDA	ANDA075529	Padagis US LLC	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0574-2410_134a3034-e670-488c-99d1-a482109b0a2d	0574-2410	HUMAN PRESCRIPTION DRUG	Methylphenidate Transdermal System		methylphenidate	PATCH	TRANSDERMAL	20230605		NDA AUTHORIZED GENERIC	NDA021514	PADAGIS US LLC	METHYLPHENIDATE	27.5	mg/mg	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0574-2415_134a3034-e670-488c-99d1-a482109b0a2d	0574-2415	HUMAN PRESCRIPTION DRUG	Methylphenidate Transdermal System		methylphenidate	PATCH	TRANSDERMAL	20230605		NDA AUTHORIZED GENERIC	NDA021514	PADAGIS US LLC	METHYLPHENIDATE	41.3	mg/mg	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0574-2420_134a3034-e670-488c-99d1-a482109b0a2d	0574-2420	HUMAN PRESCRIPTION DRUG	Methylphenidate Transdermal System		methylphenidate	PATCH	TRANSDERMAL	20230605		NDA AUTHORIZED GENERIC	NDA021514	PADAGIS US LLC	METHYLPHENIDATE	55	mg/mg	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0574-2430_134a3034-e670-488c-99d1-a482109b0a2d	0574-2430	HUMAN PRESCRIPTION DRUG	Methylphenidate Transdermal System		methylphenidate	PATCH	TRANSDERMAL	20230605		NDA AUTHORIZED GENERIC	NDA021514	PADAGIS US LLC	METHYLPHENIDATE	82.5	mg/mg	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0574-4012_92c14301-6ca9-48f6-aabc-df7b1656a778	0574-4012	HUMAN PRESCRIPTION DRUG	BRINZOLAMIDE		brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	20231010		ANDA	ANDA211914	Padagis US LLC	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
0574-4021_c304d2f8-68d7-4199-90b5-fb5b14e9b45c	0574-4021	HUMAN PRESCRIPTION DRUG	polycin		bacitracin zinc and polymyxin b sulfates	OINTMENT	OPHTHALMIC	20141112		ANDA	ANDA065022	Padagis US LLC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0574-4022_6b07949f-2ca2-4a23-a0a4-a36abd1f565c	0574-4022	HUMAN PRESCRIPTION DRUG	Bacitracin		Bacitracin	OINTMENT	OPHTHALMIC	20140310		ANDA	ANDA061212	Padagis US LLC	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
0574-4024_e5de2c54-b0ab-4466-8102-74d7da5ac337	0574-4024	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	OINTMENT	OPHTHALMIC	20140508		ANDA	ANDA062447	Padagis US LLC	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
0574-4031_15adc2a4-b735-430b-a4cd-8dc1ce158b96	0574-4031	HUMAN PRESCRIPTION DRUG	TOBRAMYCIN AND DEXAMETHASONE		tobramycin and dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20220317		ANDA	ANDA212715	Padagis US LLC	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0574-4144_68f44956-2ea6-4137-8a0a-945d784d471d	0574-4144	HUMAN PRESCRIPTION DRUG	Neo Polycin HC		neomycin and polymyxin b sulfates, bacitracin zinc and hydrocortisone acetate	OINTMENT	OPHTHALMIC	20150107		ANDA	ANDA062166	Padagis US LLC	BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 10; 3.5; 10000	[USP'U]/g; mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0574-4160_300ff594-23be-4bdd-9bf4-d5e71bc5a782	0574-4160	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin, Polymyxin B Sulfates, Dexamethasone	OINTMENT	OPHTHALMIC	20140703		ANDA	ANDA062938	Padagis US LLC	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0574-4190_b50202dd-c913-4ae7-afbb-74be0db2ef80	0574-4190	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		Sulfacetamide Sodium	OINTMENT	OPHTHALMIC	20140813		ANDA	ANDA080029	Padagis US LLC	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
0574-4250_05ca8739-5108-426f-b235-a8c92a0243a1	0574-4250	HUMAN PRESCRIPTION DRUG	Neo Polycin		neomycin and polymyxin B sulfates and bacitracin zinc	OINTMENT	OPHTHALMIC	20150105		ANDA	ANDA060764	Padagis US LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 10000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0574-7034_1fde5a34-6494-43b5-a12a-c3ef3964d882	0574-7034	HUMAN OTC DRUG	aspirin		aspirin	SUPPOSITORY	RECTAL	19900901		OTC MONOGRAPH NOT FINAL	part343	Padagis US LLC	ASPIRIN	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0574-7040_1b4faa37-bd21-411b-ba78-6cbb82a91d13	0574-7040	HUMAN PRESCRIPTION DRUG	Belladonna and Opium		ATROPA BELLADONNA and OPIUM	SUPPOSITORY	RECTAL	19970422		UNAPPROVED DRUG OTHER		Padagis US LLC	ATROPA BELLADONNA; OPIUM	16.2; 60	mg/1; mg/1		CII	N	20241231
0574-7045_1b4faa37-bd21-411b-ba78-6cbb82a91d13	0574-7045	HUMAN PRESCRIPTION DRUG	Belladonna and Opium		ATROPA BELLADONNA and OPIUM	SUPPOSITORY	RECTAL	19940501		UNAPPROVED DRUG OTHER		Padagis US LLC	ATROPA BELLADONNA; OPIUM	16.2; 30	mg/1; mg/1		CII	N	20241231
0574-7050_06214150-2221-462b-a0ac-5a5a8a257c13	0574-7050	HUMAN OTC DRUG	Bisacodyl		bisacodyl	SUPPOSITORY	RECTAL	19900901		OTC MONOGRAPH NOT FINAL	part334	Padagis US LLC	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0574-7090_48172e27-c972-4926-94d5-1c297b33b711	0574-7090	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	19900701		UNAPPROVED DRUG OTHER		Padagis US LLC	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0574-7093_48172e27-c972-4926-94d5-1c297b33b711	0574-7093	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	19900701		UNAPPROVED DRUG OTHER		Padagis US LLC	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0574-7110_877e20c2-b5ef-45ee-95f2-d6ad3a4057e5	0574-7110	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Padagis US LLC	MORPHINE SULFATE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-7112_877e20c2-b5ef-45ee-95f2-d6ad3a4057e5	0574-7112	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Padagis US LLC	MORPHINE SULFATE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-7114_877e20c2-b5ef-45ee-95f2-d6ad3a4057e5	0574-7114	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Padagis US LLC	MORPHINE SULFATE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-7116_877e20c2-b5ef-45ee-95f2-d6ad3a4057e5	0574-7116	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Padagis US LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-7224_b7bbd723-9b3b-4ad7-8b61-37ce6da2983a	0574-7224	HUMAN PRESCRIPTION DRUG	HYDROMORPHONE HYDROCHLORIDE		HYDROMORPHONE HYDROCHLORIDE	SUPPOSITORY	RECTAL	19960131		UNAPPROVED DRUG OTHER		Padagis US LLC	HYDROMORPHONE HYDROCHLORIDE	3	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0574-7226_a7245ba0-8a1f-42ca-a05b-19dbc333bc53	0574-7226	HUMAN PRESCRIPTION DRUG	Compro		PROCHLORPERAZINE	SUPPOSITORY	RECTAL	20000901		ANDA	ANDA040246	Padagis US LLC	PROCHLORPERAZINE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0574-9855_9cdd000d-9ee0-4429-99b5-2671ee564286	0574-9855	HUMAN PRESCRIPTION DRUG	budesonide		budesonide	CAPSULE	ORAL	20180629		NDA	NDA021324	Padagis US LLC	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0575-6200_feeca3aa-0bb3-4873-8887-e1c53accf956	0575-6200	HUMAN PRESCRIPTION DRUG	Proglycem		diazoxide	SUSPENSION	ORAL	19900930		NDA	NDA017453	Teva Pharmaceuticals USA, Inc.	DIAZOXIDE	50	mg/mL			N	20241231
0591-0343_6fa625d9-b02d-4905-8e72-eecf0d6aaf8e	0591-0343	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED	ORAL	19861001		ANDA	ANDA070995	Actavis Pharma, Inc.	VERAPAMIL HYDROCHLORIDE	80	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-0345_6fa625d9-b02d-4905-8e72-eecf0d6aaf8e	0591-0345	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED	ORAL	19861001		ANDA	ANDA070994	Actavis Pharma, Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-0347_f89c4d9c-1c79-4d7d-9a47-4126600a2c6d	0591-0347	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE, GELATIN COATED	ORAL	19961227		NDA AUTHORIZED GENERIC	NDA020504	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0591-0348_dbdda9e3-ef48-431d-8463-2ba91f48d5b8	0591-0348	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA071851	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0591-0369_a75db571-2e63-4796-a741-29f6c0337d5f	0591-0369	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	19880615		ANDA	ANDA072204	Actavis Pharma, Inc.	LOXAPINE SUCCINATE	5	mg/1			N	20241231
0591-0370_a75db571-2e63-4796-a741-29f6c0337d5f	0591-0370	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	19880615		ANDA	ANDA072205	Actavis Pharma, Inc.	LOXAPINE SUCCINATE	10	mg/1			N	20241231
0591-0371_a75db571-2e63-4796-a741-29f6c0337d5f	0591-0371	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	19880615		ANDA	ANDA072206	Actavis Pharma, Inc.	LOXAPINE SUCCINATE	25	mg/1			N	20241231
0591-0372_a75db571-2e63-4796-a741-29f6c0337d5f	0591-0372	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	19880615		ANDA	ANDA072062	Actavis Pharma, Inc.	LOXAPINE SUCCINATE	50	mg/1			N	20241231
0591-0395_512a6163-1239-4cb7-b968-1695c9b9618f	0591-0395	HUMAN PRESCRIPTION DRUG	Pentazocine and naloxone		Pentazocine hydrochloride and naloxone hydrochloride	TABLET	ORAL	19970521		ANDA	ANDA074736	Actavis Pharma, Inc.	NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE	.5; 50	mg/1; mg/1	Competitive Opioid Antagonists [MoA], Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
0591-0397_5151188a-c6d7-4842-86a8-c1ac42375176	0591-0397	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20121101		ANDA	ANDA201089	Actavis Pharma, Inc.	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
0591-0398_5151188a-c6d7-4842-86a8-c1ac42375176	0591-0398	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20121101		ANDA	ANDA201089	Actavis Pharma, Inc.	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
0591-0404_6fa625d9-b02d-4905-8e72-eecf0d6aaf8e	0591-0404	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED	ORAL	19930629		ANDA	ANDA072924	Actavis Pharma, Inc.	VERAPAMIL HYDROCHLORIDE	40	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-0405_01764c1d-aebe-4a46-920c-4b5f8cca8acb	0591-0405	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Actavis Pharma, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0591-0406_01764c1d-aebe-4a46-920c-4b5f8cca8acb	0591-0406	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Actavis Pharma, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0591-0407_01764c1d-aebe-4a46-920c-4b5f8cca8acb	0591-0407	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Actavis Pharma, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0591-0408_01764c1d-aebe-4a46-920c-4b5f8cca8acb	0591-0408	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Actavis Pharma, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0591-0409_01764c1d-aebe-4a46-920c-4b5f8cca8acb	0591-0409	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Actavis Pharma, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0591-0424_dbdda9e3-ef48-431d-8463-2ba91f48d5b8	0591-0424	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA073449	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0591-0444_22c8af60-3cdf-48a6-9477-c9fee1607cf8	0591-0444	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	19951017		ANDA	ANDA074145	Actavis Pharma, Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-0453_22c8af60-3cdf-48a6-9477-c9fee1607cf8	0591-0453	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	19951017		ANDA	ANDA074145	Actavis Pharma, Inc.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-0460_ca217d5e-9725-4b1b-be12-e678ae699d30	0591-0460	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	Actavis Pharma, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0591-0461_ca217d5e-9725-4b1b-be12-e678ae699d30	0591-0461	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	Actavis Pharma, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0591-0582_71d5cee6-245f-4d4a-8a59-e555c3ca4573	0591-0582	HUMAN PRESCRIPTION DRUG	Propafenone HCl		Propafenone hydrochloride	TABLET, FILM COATED	ORAL	20001024		ANDA	ANDA075203	Actavis Pharma, Inc.	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
0591-0583_71d5cee6-245f-4d4a-8a59-e555c3ca4573	0591-0583	HUMAN PRESCRIPTION DRUG	Propafenone HCl		Propafenone hydrochloride	TABLET, FILM COATED	ORAL	20001024		ANDA	ANDA075203	Actavis Pharma, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
0591-0605_f542c90d-8e54-46f7-947b-772d46f74a87	0591-0605	HUMAN PRESCRIPTION DRUG	Labetalol hydrochloride		Labetalol hydrochloride	TABLET, FILM COATED	ORAL	19980803		ANDA	ANDA075133	Actavis Pharma, Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0591-0606_f542c90d-8e54-46f7-947b-772d46f74a87	0591-0606	HUMAN PRESCRIPTION DRUG	Labetalol hydrochloride		Labetalol hydrochloride	TABLET, FILM COATED	ORAL	19980803		ANDA	ANDA075133	Actavis Pharma, Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0591-0607_f542c90d-8e54-46f7-947b-772d46f74a87	0591-0607	HUMAN PRESCRIPTION DRUG	Labetalol hydrochloride		Labetalol hydrochloride	TABLET, FILM COATED	ORAL	19980803		ANDA	ANDA075133	Actavis Pharma, Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0591-0744_b25f02d6-4a96-479e-9399-30dde39b1f03	0591-0744	HUMAN PRESCRIPTION DRUG	Estazolam		Estazolam	TABLET	ORAL	19971001		ANDA	ANDA074818	Actavis Pharma, Inc.	ESTAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0591-0745_b25f02d6-4a96-479e-9399-30dde39b1f03	0591-0745	HUMAN PRESCRIPTION DRUG	Estazolam		Estazolam	TABLET	ORAL	19971001		ANDA	ANDA074818	Actavis Pharma, Inc.	ESTAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0591-0794_09f2241a-f68c-4c22-97de-79f8234c418f	0591-0794	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	Actavis Pharma, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0591-0795_09f2241a-f68c-4c22-97de-79f8234c418f	0591-0795	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19860730		ANDA	ANDA085223	Actavis Pharma, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0591-0796_5b043885-3305-46b1-96dd-da2c71641165	0591-0796	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	19821001	20241130	ANDA	ANDA085828	Actavis Pharma, Inc.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	
0591-0844_84db3537-cb18-4bb5-8cd9-05a9da26ec90	0591-0844	HUMAN PRESCRIPTION DRUG	Glipizide	ER	Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20031119		ANDA	ANDA076467	Actavis Pharma, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0591-0845_84db3537-cb18-4bb5-8cd9-05a9da26ec90	0591-0845	HUMAN PRESCRIPTION DRUG	Glipizide	ER	Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20031119		ANDA	ANDA076467	Actavis Pharma, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0591-0860_ff5e5610-775f-48a9-a410-e8d8b547b958	0591-0860	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20020701		ANDA	ANDA076194	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0591-0861_ff5e5610-775f-48a9-a410-e8d8b547b958	0591-0861	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20030304		ANDA	ANDA076194	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0591-0862_ff5e5610-775f-48a9-a410-e8d8b547b958	0591-0862	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20030304		ANDA	ANDA076194	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0591-0885_01764c1d-aebe-4a46-920c-4b5f8cca8acb	0591-0885	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Actavis Pharma, Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0591-0900_84db3537-cb18-4bb5-8cd9-05a9da26ec90	0591-0900	HUMAN PRESCRIPTION DRUG	Glipizide	ER	Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060403		ANDA	ANDA076467	Actavis Pharma, Inc.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0591-1159_9a0c599a-742a-48f5-ae69-cd9e8cbaa604	0591-1159	HUMAN PRESCRIPTION DRUG	Acyclovir		acyclovir	OINTMENT	TOPICAL	20140411		NDA AUTHORIZED GENERIC	NDA018604	ACTAVIS PHARMA, INC.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0591-2070_1c722202-fd7d-471b-a5a1-9d9366b4b0aa	0591-2070	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		lidocaine and prilocaine	CREAM	TOPICAL	20150403	20240430	NDA AUTHORIZED GENERIC	NDA019941	Actavis Pharma, Inc.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	
0591-2114_5ab3bf39-162f-49d1-bfc2-208356829151	0591-2114	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	SOLUTION	TOPICAL	20170818		ANDA	ANDA205328	Actavis Pharma, Inc.	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-2127_2edebc83-c08f-47fc-a7b1-3639cf627404	0591-2127	HUMAN PRESCRIPTION DRUG	Brinzolamide		Brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	20210308		ANDA	ANDA209406	Actavis Pharma, Inc.	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
0591-2131_38d8c966-bb27-4b39-b436-4e7ffbd2d134	0591-2131	HUMAN PRESCRIPTION DRUG	azelaic acid		azelaic acid	GEL	TOPICAL	20181119		ANDA	ANDA208011	Actavis Pharma, Inc.	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
0591-2132_ebdef315-cb4d-4b45-8599-6cff8ecf3755	0591-2132	HUMAN PRESCRIPTION DRUG	Doxylamine succinate and pyridoxine hydrochloride		Doxylamine succinate and pyridoxine hydrochloride	TABLET, DELAYED RELEASE	ORAL	20190621		ANDA	ANDA205811	Actavis Pharma, Inc.	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
0591-2159_078b9c81-4a91-497c-8657-54703da31bb3	0591-2159	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SHAMPOO	TOPICAL	20121212		ANDA	ANDA090490	Actavis Pharma, Inc.	CICLOPIROX	10	mg/.96mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
0591-2191_e74e2bb6-6aec-41ff-a434-c34f53728f17	0591-2191	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20190722		ANDA	ANDA091610	Actavis Pharma, Inc.	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
0591-2245_282ca8a0-1d7c-4658-ac70-04c9fe8ec69d	0591-2245	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	TABLET, DELAYED RELEASE	ORAL	20180326		ANDA	ANDA203817	Actavis Pharma, Inc.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0591-2258_668e3706-c7fe-4649-b508-2b44a388718c	0591-2258	HUMAN PRESCRIPTION DRUG	scopolamine		scopolamine	SYSTEM	TRANSDERMAL	20220512		ANDA	ANDA208769	Actavis Pharma, Inc.	SCOPOLAMINE	1	mg/3d	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0591-2285_c41f1e43-d6a0-4de1-b622-b2c2ce4b9836	0591-2285	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20151015		ANDA	ANDA202688	Actavis Pharma, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
0591-2286_c41f1e43-d6a0-4de1-b622-b2c2ce4b9836	0591-2286	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20151015		ANDA	ANDA202688	Actavis Pharma, Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
0591-2287_c41f1e43-d6a0-4de1-b622-b2c2ce4b9836	0591-2287	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20151015		ANDA	ANDA202688	Actavis Pharma, Inc.	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
0591-2312_5b5b2646-f328-4a7f-b83c-cae8e2720404	0591-2312	HUMAN PRESCRIPTION DRUG	Alvimopan		Alvimopan	CAPSULE	ORAL	20201201		ANDA	ANDA208295	Actavis Pharma, Inc.	ALVIMOPAN	12	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0591-2341_ab04be92-0dba-4dc2-be97-60fc403add2b	0591-2341	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170619		ANDA	ANDA203695	Actavis Pharma, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
0591-2363_a4201616-9b08-42e3-b0de-bf8354152d3b	0591-2363	HUMAN PRESCRIPTION DRUG	Testosterone		testosterone	GEL, METERED	TOPICAL	20150601		ANDA	ANDA204571	Actavis Pharma, Inc.	TESTOSTERONE	10	mg/.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-2405_2642df14-b8bc-4f7f-8290-495ae31a279d	0591-2405	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA208252	Actavis Pharma, Inc.	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
0591-2406_2642df14-b8bc-4f7f-8290-495ae31a279d	0591-2406	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA208252	Actavis Pharma, Inc.	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
0591-2411_1ee5baf7-7aab-473d-bebc-056eb09f5b9d	0591-2411	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		ANDA	ANDA203755	Actavis Pharma, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0591-2412_1ee5baf7-7aab-473d-bebc-056eb09f5b9d	0591-2412	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		ANDA	ANDA203755	Actavis Pharma, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0591-2422_1d48bdb8-e47a-4716-a13a-49482fd45b5e	0591-2422	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate/Timolol Maleate		Brimonidine Tartrate and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20221007		ANDA	ANDA201949	Actavis Pharma, Inc.	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0591-2433_ff870db3-ca93-4f91-a0ed-e529d83c16d4	0591-2433	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20210429		ANDA	ANDA205063	Actavis Pharma, Inc.	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0591-2434_ff870db3-ca93-4f91-a0ed-e529d83c16d4	0591-2434	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20210429		ANDA	ANDA205063	Actavis Pharma, Inc.	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0591-2435_ff870db3-ca93-4f91-a0ed-e529d83c16d4	0591-2435	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20210429		ANDA	ANDA205063	Actavis Pharma, Inc.	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0591-2436_ff870db3-ca93-4f91-a0ed-e529d83c16d4	0591-2436	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20210429		ANDA	ANDA205063	Actavis Pharma, Inc.	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0591-2451_ff870db3-ca93-4f91-a0ed-e529d83c16d4	0591-2451	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20210429		ANDA	ANDA205063	Actavis Pharma, Inc.	ISOTRETINOIN	25	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0591-2465_cb70ad7d-a4bc-4e6a-aa87-62dc8394f830	0591-2465	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20110815	20240131	ANDA	ANDA076470	Actavis Pharma, Inc.	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
0591-2472_3fe33f22-acfc-44cd-9b89-cf7166cf5a8b	0591-2472	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20110815		ANDA	ANDA070929	Actavis Pharma, Inc.	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0591-2473_3fe33f22-acfc-44cd-9b89-cf7166cf5a8b	0591-2473	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20110815		ANDA	ANDA070929	Actavis Pharma, Inc.	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0591-2474_d0e12e41-2e25-4843-a120-915d3cfaa22e	0591-2474	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20110815		ANDA	ANDA061837	Actavis Pharma, Inc.	TETRACYCLINE HYDROCHLORIDE	250	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
0591-2475_d0e12e41-2e25-4843-a120-915d3cfaa22e	0591-2475	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20110815		ANDA	ANDA061837	Actavis Pharma, Inc.	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
0591-2501_ff870db3-ca93-4f91-a0ed-e529d83c16d4	0591-2501	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20210429		ANDA	ANDA205063	Actavis Pharma, Inc.	ISOTRETINOIN	35	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0591-2510_29146990-42bc-43d6-8b61-717df1c7e054	0591-2510	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180705		ANDA	ANDA205457	Actavis Pharma, Inc.	BUDESONIDE	9	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0591-2511_b2fcbca4-83a2-45c2-bced-eed50865af00	0591-2511	HUMAN PRESCRIPTION DRUG	bosentan		bosentan	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA207110	Actavis Pharma, Inc.	BOSENTAN	62.5	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
0591-2512_b2fcbca4-83a2-45c2-bced-eed50865af00	0591-2512	HUMAN PRESCRIPTION DRUG	bosentan		bosentan	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA207110	Actavis Pharma, Inc.	BOSENTAN	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
0591-2520_17a93150-15ec-4d0e-a911-e8626b487817	0591-2520	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	Actavis Pharma, Inc.	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0591-2533_f2d33c82-a69f-4f6a-bd74-2c91efd6cab8	0591-2533	HUMAN PRESCRIPTION DRUG	Dalfampridine		Dalfampridine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220531		ANDA	ANDA206836	Actavis Pharma, Inc.	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
0591-2562_1a2cbb1f-af4c-4f84-83aa-3e59d5859758	0591-2562	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20201202		ANDA	ANDA204461	Actavis Pharma, Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
0591-2579_9f669f81-9b46-440d-bb4f-0696098da2cc	0591-2579	HUMAN PRESCRIPTION DRUG	Valganciclovir hydrochloride for Oral		Valganciclovir hydrochloride	POWDER, FOR SOLUTION	ORAL	20160826		ANDA	ANDA205220	Actavis Pharma, Inc.	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
0591-2640_0a7ba157-5ce2-4b49-bdce-0e9b997e05fc	0591-2640	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	CAPSULE	ORAL	20130729		ANDA	ANDA040885	Actavis Pharma, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0591-2641_477f2826-8c19-4d10-b279-41d64328d23d	0591-2641	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate	CAPSULE	ORAL	20130729		ANDA	ANDA076560	Actavis Pharma, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	300; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
0591-2679_7c543a73-d389-4382-9376-07deb206bbc7	0591-2679	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20140701		ANDA	ANDA200675	Actavis Pharma, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0591-2682_12b79848-390c-4639-adf4-bea10021eecf	0591-2682	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20180530		ANDA	ANDA209758	Actavis Pharma, Inc.	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0591-2712_071a50e4-8606-40a7-b09c-e7281ccac80b	0591-2712	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET, FILM COATED	ORAL	20190613		ANDA	ANDA208094	Actavis Pharma, Inc.	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
0591-2719_ba0272a1-f364-42bf-a536-f3fdd4caee48	0591-2719	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120418		NDA AUTHORIZED GENERIC	NDA021574	Actavis Pharma, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0591-2720_ba0272a1-f364-42bf-a536-f3fdd4caee48	0591-2720	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120418		NDA AUTHORIZED GENERIC	NDA021574	Actavis Pharma, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0591-2729_12b79848-390c-4639-adf4-bea10021eecf	0591-2729	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20180530		ANDA	ANDA209758	Actavis Pharma, Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0591-2742_12b79848-390c-4639-adf4-bea10021eecf	0591-2742	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20180530		ANDA	ANDA209758	Actavis Pharma, Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0591-2788_3058ee98-254e-4b0a-b253-d18621b6abd8	0591-2788	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE, GELATIN COATED	ORAL	20120206		NDA AUTHORIZED GENERIC	NDA021447	Actavis Pharma, Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-2789_3058ee98-254e-4b0a-b253-d18621b6abd8	0591-2789	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE, GELATIN COATED	ORAL	20120206		NDA AUTHORIZED GENERIC	NDA021447	Actavis Pharma, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-2790_3058ee98-254e-4b0a-b253-d18621b6abd8	0591-2790	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE, GELATIN COATED	ORAL	20120206		NDA AUTHORIZED GENERIC	NDA021447	Actavis Pharma, Inc.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-2805_0f500bad-5401-4f34-aebe-42c1ec4ea45c	0591-2805	HUMAN PRESCRIPTION DRUG	clarithromycin		clarithromycin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140227		ANDA	ANDA065145	Actavis Pharma, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-2832_66571927-4b7a-4141-9d0b-05aafb9b5db6	0591-2832	HUMAN PRESCRIPTION DRUG	bexarotene		bexarotene	CAPSULE, LIQUID FILLED	ORAL	20211111		ANDA	ANDA209931	Actavis Pharma, Inc.	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0591-2880_0afac0f7-3b38-4330-9e34-622223d84df7	0591-2880	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Teva Pharmaceuticals Inc	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-2882_0afac0f7-3b38-4330-9e34-622223d84df7	0591-2882	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Teva Pharmaceuticals Inc	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-2884_0afac0f7-3b38-4330-9e34-622223d84df7	0591-2884	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Teva Pharmaceuticals Inc	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-2886_0afac0f7-3b38-4330-9e34-622223d84df7	0591-2886	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Teva Pharmaceuticals Inc	VERAPAMIL HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0591-2888_8aba3d27-2891-4595-85be-87a2cf1c5dd9	0591-2888	HUMAN PRESCRIPTION DRUG	Hydroxocobalamin		Hydroxocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR	20101112		ANDA	ANDA085998	Actavis Pharma, Inc.	HYDROXOCOBALAMIN ACETATE	1000	ug/mL	Antidote [EPC]		N	20241231
0591-2921_02602360-e544-4c4c-aa35-49448ec72d63	0591-2921	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TOPICAL	20151214		ANDA	ANDA076737	Actavis Pharma, Inc.	TESTOSTERONE	10	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-2924_1fffebb2-aabf-4d05-b9c0-5ce61b4cb345	0591-2924	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20190410		ANDA	ANDA204570	Actavis Pharma, Inc.	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-2925_1fffebb2-aabf-4d05-b9c0-5ce61b4cb345	0591-2925	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20210212		ANDA	ANDA204570	Actavis Pharma, Inc.	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-2926_1fffebb2-aabf-4d05-b9c0-5ce61b4cb345	0591-2926	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20210212		ANDA	ANDA204570	Actavis Pharma, Inc.	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-2927_f9039b6c-2ae3-416b-bc2a-ab6e06e830bf	0591-2927	HUMAN PRESCRIPTION DRUG	Levalbuterol tartrate HFA inhalation		levalbuterol tartrate	AEROSOL, METERED	ORAL	20161003		NDA AUTHORIZED GENERIC	NDA021730	Actavis Pharma, Inc.	LEVALBUTEROL TARTRATE	45	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0591-2944_a3f0bc92-796c-4f74-8c7a-63001b4e9e43	0591-2944	HUMAN PRESCRIPTION DRUG	pimecrolimus		pimecrolimus	CREAM	TOPICAL	20181227		ANDA	ANDA209345	Actavis Pharma, Inc.	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0591-2971_eaa6c32e-87f4-404f-a55e-fccae46392d3	0591-2971	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	SPRAY, METERED	NASAL	20230120		ANDA	ANDA209522	Actavis Pharma, Inc.	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0591-2990_8c1b96a1-47e6-4fac-9bda-0b299ac25800	0591-2990	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide Topical		Fluocinolone Acetonide Topical	SOLUTION	TOPICAL	20161207		ANDA	ANDA208386	Actavis Pharma, Inc.	FLUOCINOLONE ACETONIDE	.1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0591-2998_aabd2b91-d52c-4ff6-980e-492458e81d75	0591-2998	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	19971210		NDA AUTHORIZED GENERIC	NDA020675	Actavis Pharma, Inc.	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
0591-3005_aabd2b91-d52c-4ff6-980e-492458e81d75	0591-3005	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	19971210		NDA AUTHORIZED GENERIC	NDA020675	Actavis Pharma, Inc.	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
0591-3128_aacccc63-aa7d-435e-bec5-0aab0e04153f	0591-3128	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	INJECTION, SOLUTION	INTRAMUSCULAR	19780511		NDA	NDA017362	Actavis Pharma, Inc.	PROGESTERONE	50	mg/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
0591-3137_ee020b14-5c0d-4178-ac4d-6243945eef5e	0591-3137	HUMAN PRESCRIPTION DRUG	Nizatidine		Nizatidine	CAPSULE	ORAL	20020709		ANDA	ANDA075616	Actavis Pharma, Inc.	NIZATIDINE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0591-3138_ee020b14-5c0d-4178-ac4d-6243945eef5e	0591-3138	HUMAN PRESCRIPTION DRUG	Nizatidine		Nizatidine	CAPSULE	ORAL	20020709		ANDA	ANDA075616	Actavis Pharma, Inc.	NIZATIDINE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0591-3153_5d892333-6f78-4190-9bce-93d3a864913b	0591-3153	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20020917		ANDA	ANDA063065	Actavis Pharma, Inc.	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0591-3159_3155bbdf-c01e-478f-a51b-0b9e7df33019	0591-3159	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	19871231		NDA AUTHORIZED GENERIC	NDA019594	Actavis Pharma, Inc.	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
0591-3204_21f4b05f-2bd6-4298-adb8-b8eae52ffadf	0591-3204	HUMAN PRESCRIPTION DRUG	Podofilox		Podofilox	SOLUTION	TOPICAL	19901213	20241031	NDA AUTHORIZED GENERIC	NDA019795	Actavis Pharma, Inc.	PODOFILOX	5	mg/mL	Decreased Mitosis [PE]		N	
0591-3216_02602360-e544-4c4c-aa35-49448ec72d63	0591-3216	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TOPICAL	20151204		ANDA	ANDA076737	Actavis Pharma, Inc.	TESTOSTERONE	10	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-3217_02602360-e544-4c4c-aa35-49448ec72d63	0591-3217	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TOPICAL	20151204		ANDA	ANDA076737	Actavis Pharma, Inc.	TESTOSTERONE	10	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-3220_95f94b0d-61d0-48de-9f7f-90077c4f6825	0591-3220	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate	CAPSULE	ORAL	20030918		NDA AUTHORIZED GENERIC	NDA020232	Actavis Pharma, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
0591-3222_76bd2057-e1ac-4529-9663-f6139218eeab	0591-3222	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20100708		ANDA	ANDA084779	Actavis Pharma, Inc.	ORPHENADRINE CITRATE	30	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0591-3331_c401095c-8fac-43ea-8396-8efc466ff3e0	0591-3331	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081126		ANDA	ANDA077715	Actavis Pharma, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0591-3354_573675b0-8d66-4d58-85f2-428dda7c166c	0591-3354	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET	ORAL	20110518		ANDA	ANDA077462	Actavis Pharma, Inc.	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
0591-3355_573675b0-8d66-4d58-85f2-428dda7c166c	0591-3355	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET	ORAL	20110518		ANDA	ANDA077462	Actavis Pharma, Inc.	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
0591-3369_546cb1c8-df90-426b-9794-aff3ed2cd407	0591-3369	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20071213		ANDA	ANDA088616	Actavis Pharma, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0591-3467_822389a6-a2ba-498a-bf4e-ba76319ea127	0591-3467	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	INTRABRONCHIAL	20070925		ANDA	ANDA077772	Actavis Pharma, Inc.	ALBUTEROL SULFATE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0591-3468_822389a6-a2ba-498a-bf4e-ba76319ea127	0591-3468	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	INTRABRONCHIAL	20070925		ANDA	ANDA077772	Actavis Pharma, Inc.	ALBUTEROL SULFATE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0591-3508_996f475b-4f8b-4487-b5c1-6e5c4f284045	0591-3508	HUMAN PRESCRIPTION DRUG	Clonidine transdermal system		Clonidine	PATCH	TRANSDERMAL	20140506		ANDA	ANDA090873	Actavis Pharma, Inc.	CLONIDINE	.1	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-3509_996f475b-4f8b-4487-b5c1-6e5c4f284045	0591-3509	HUMAN PRESCRIPTION DRUG	Clonidine transdermal system		Clonidine	PATCH	TRANSDERMAL	20140506		ANDA	ANDA090873	Actavis Pharma, Inc.	CLONIDINE	.2	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-3510_996f475b-4f8b-4487-b5c1-6e5c4f284045	0591-3510	HUMAN PRESCRIPTION DRUG	Clonidine transdermal system		Clonidine	PATCH	TRANSDERMAL	20140506		ANDA	ANDA090873	Actavis Pharma, Inc.	CLONIDINE	.3	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0591-3524_e8f9d374-366f-496f-8856-65a3c2767d21	0591-3524	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20171012		ANDA	ANDA091073	Actavis Pharma, Inc.	TESTOSTERONE	50	mg/5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0591-3525_5a1284cc-8ddb-438b-9441-b874a05af467	0591-3525	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20130915		ANDA	ANDA200675	Actavis Pharma, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0591-3540_561a0063-806c-49e1-9978-c9cbea5aadfe	0591-3540	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	Actavis Pharma, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0591-3541_561a0063-806c-49e1-9978-c9cbea5aadfe	0591-3541	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	Actavis Pharma, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0591-3542_561a0063-806c-49e1-9978-c9cbea5aadfe	0591-3542	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	Actavis Pharma, Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0591-3543_8617a073-1628-4c21-9eef-c9b474e23124	0591-3543	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090611		ANDA	ANDA079094	Actavis Pharma, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0591-3636_fdd6a50e-bcdf-4f99-b74d-e1bbd2bba111	0591-3636	HUMAN PRESCRIPTION DRUG	Trospium Chloride		Trospium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20121012		ANDA	ANDA091289	Actavis Pharma, Inc.	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0591-3659_02da0e43-e346-47ea-840f-b951aafe335c	0591-3659	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204065	Actavis Pharma, Inc.	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0591-3660_02da0e43-e346-47ea-840f-b951aafe335c	0591-3660	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204065	Actavis Pharma, Inc.	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0591-3670_f9050539-cd58-4641-a6ce-e643dcc00866	0591-3670	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20110613		ANDA	ANDA091083	Actavis Pharma, Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-3671_f9050539-cd58-4641-a6ce-e643dcc00866	0591-3671	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20110613		ANDA	ANDA091083	Actavis Pharma, Inc.	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-3692_75ae369f-ef01-426b-8e2d-3959fca835e7	0591-3692	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150924		ANDA	ANDA202645	Actavis Pharma, Inc.	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0591-3693_75ae369f-ef01-426b-8e2d-3959fca835e7	0591-3693	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150924		ANDA	ANDA202645	Actavis Pharma, Inc.	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0591-3694_75ae369f-ef01-426b-8e2d-3959fca835e7	0591-3694	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150924		ANDA	ANDA202645	Actavis Pharma, Inc.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0591-3695_75ae369f-ef01-426b-8e2d-3959fca835e7	0591-3695	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150924		ANDA	ANDA202645	Actavis Pharma, Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0591-3713_acd303ed-782a-4e39-8280-b583a22fa321	0591-3713	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA200831	Actavis Pharma, Inc.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
0591-3720_7cb915c7-37a1-4eea-aac7-84031e1c821e	0591-3720	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET, FILM COATED	ORAL	20130103		ANDA	ANDA202093	Actavis Pharma, Inc.	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
0591-3795_58f3a941-bb03-4590-b541-60cea4629a05	0591-3795	HUMAN PRESCRIPTION DRUG	Solifenacin succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA202551	Actavis Pharma, Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0591-3796_58f3a941-bb03-4590-b541-60cea4629a05	0591-3796	HUMAN PRESCRIPTION DRUG	Solifenacin succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20200409		ANDA	ANDA202551	Actavis Pharma, Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0591-3851_c137a609-d5bf-406a-81ce-57120af459f2	0591-3851	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	TABLET, FILM COATED	ORAL	20190206		ANDA	ANDA209822	Actavis Pharma, Inc.	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
0591-3854_7c0c2088-0639-4093-8f56-e6a82710c3c3	0591-3854	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA208861	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0591-3862_7c0c2088-0639-4093-8f56-e6a82710c3c3	0591-3862	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA208861	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0591-3869_7c0c2088-0639-4093-8f56-e6a82710c3c3	0591-3869	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA208861	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0591-3870_0b1165b5-71ba-45d3-bede-28dfa18c2d9a	0591-3870	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20150401		NDA AUTHORIZED GENERIC	NDA021487	Actavis Pharma, Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0591-3873_7c0c2088-0639-4093-8f56-e6a82710c3c3	0591-3873	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA208861	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0591-3875_0b1165b5-71ba-45d3-bede-28dfa18c2d9a	0591-3875	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20150401		NDA AUTHORIZED GENERIC	NDA021487	Actavis Pharma, Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0591-3891_7c0c2088-0639-4093-8f56-e6a82710c3c3	0591-3891	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA208861	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0591-3895_7c0c2088-0639-4093-8f56-e6a82710c3c3	0591-3895	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA208861	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0591-3900_0b1165b5-71ba-45d3-bede-28dfa18c2d9a	0591-3900	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	KIT	ORAL	20150401		NDA AUTHORIZED GENERIC	NDA021487	Actavis Pharma, Inc.						N	20241231
0591-3902_7c0c2088-0639-4093-8f56-e6a82710c3c3	0591-3902	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA208861	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0591-3916_2b55073d-8fae-4f44-a955-8e328af88638	0591-3916	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate and benzoyl peroxide		Clindamycin phosphate and benzoyl peroxide	GEL	TOPICAL	20190219		ANDA	ANDA205128	Actavis Pharma, Inc.	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	25; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0591-3955_c388a7b2-5b58-40c3-9949-2cdcf8b57f87	0591-3955	HUMAN PRESCRIPTION DRUG	vigabatrin		vigabatrin	POWDER, FOR SOLUTION	ORAL	20200514		ANDA	ANDA209824	Actavis Pharma, Inc.	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
0591-3982_77e5bedf-7c7a-4f62-bef7-b7d797e6d0b8	0591-3982	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150312		ANDA	ANDA200562	Actavis Pharma, Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-3983_77e5bedf-7c7a-4f62-bef7-b7d797e6d0b8	0591-3983	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150312		ANDA	ANDA200562	Actavis Pharma, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-3984_77e5bedf-7c7a-4f62-bef7-b7d797e6d0b8	0591-3984	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150312		ANDA	ANDA200562	Actavis Pharma, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-3985_77e5bedf-7c7a-4f62-bef7-b7d797e6d0b8	0591-3985	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150312		ANDA	ANDA200562	Actavis Pharma, Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-4012_e34decca-ef07-4fc4-8ef2-74563e237244	0591-4012	HUMAN PRESCRIPTION DRUG	Valproic		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20090908		ANDA	ANDA073229	Actavis Pharma, Inc.	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0591-4039_ce444a9f-09ab-4065-a434-553f9660ca2a	0591-4039	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	SPRAY	TOPICAL	20150828		NDA AUTHORIZED GENERIC	NDA021835	Actavis Pharma, Inc.	CLOBETASOL PROPIONATE	.05	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0591-4050_61d61568-db4c-41be-a776-c51fc2eeda2f	0591-4050	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	POWDER, FOR SUSPENSION	ORAL	20200817		ANDA	ANDA211534	Actavis Pharma, Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0591-4052_3da0bd88-42bd-40e7-8705-554881c5340f	0591-4052	HUMAN PRESCRIPTION DRUG	Ivermectin		Ivermectin	CREAM	TOPICAL	20191014		ANDA	ANDA210019	Actavis Pharma, Inc.	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
0591-4060_02da0e43-e346-47ea-840f-b951aafe335c	0591-4060	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204065	Actavis Pharma, Inc.	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0591-4101_83f2251f-6b15-464c-be34-dd0a84db16e1	0591-4101	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20170530		ANDA	ANDA207582	Actavis Pharma, Inc.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0591-4102_83f2251f-6b15-464c-be34-dd0a84db16e1	0591-4102	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20170530		ANDA	ANDA207582	Actavis Pharma, Inc.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0591-4103_83f2251f-6b15-464c-be34-dd0a84db16e1	0591-4103	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20170530		ANDA	ANDA207582	Actavis Pharma, Inc.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0591-4104_83f2251f-6b15-464c-be34-dd0a84db16e1	0591-4104	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20170530		ANDA	ANDA207582	Actavis Pharma, Inc.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0591-4128_3e791493-07af-4824-83cd-f41b193e0fd8	0591-4128	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION	INTRAMUSCULAR	20150305	20250531	ANDA	ANDA091244	Actavis Pharma, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	
0591-4171_b7e1730b-faa2-4324-b7ad-d73641f652e8	0591-4171	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20190625		ANDA	ANDA210976	Actavis Pharma, Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
0591-4365_4333e903-cbd7-4f97-a190-8b2433833f28	0591-4365	HUMAN PRESCRIPTION DRUG	Abiraterone acetate		Abiraterone acetate	TABLET, FILM COATED	ORAL	20230713		ANDA	ANDA210726	Actavis Pharma, Inc.	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
0591-4385_89783971-3346-4ff8-ac47-d824a7ddf75d	0591-4385	HUMAN PRESCRIPTION DRUG	Fosaprepitant		fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190919		NDA	NDA210064	Actavis Pharma, Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0591-4550_97685c63-ce6a-4a86-bd19-55f58e6b5f24	0591-4550	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20190814		ANDA	ANDA090134	Actavis Pharma, Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0591-4575_97685c63-ce6a-4a86-bd19-55f58e6b5f24	0591-4575	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20190814		ANDA	ANDA090134	Actavis Pharma, Inc.	DOXYCYCLINE HYCLATE	200	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0591-4730_5a3a827b-be6c-4d85-8cae-2e974101d7f2	0591-4730	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	GRANULE	ORAL	20231110		ANDA	ANDA214180	Actavis Pharma, Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0591-4735_5a3a827b-be6c-4d85-8cae-2e974101d7f2	0591-4735	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	GRANULE	ORAL	20231110		ANDA	ANDA214180	Actavis Pharma, Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0591-4740_5a3a827b-be6c-4d85-8cae-2e974101d7f2	0591-4740	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	GRANULE	ORAL	20231110		ANDA	ANDA214180	Actavis Pharma, Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
0591-4910_5d9a34dd-179f-4599-8912-1714e063def6	0591-4910	HUMAN PRESCRIPTION DRUG	Trientine Hydrochloride		Trientine Hydrochloride	CAPSULE	ORAL	20180208		ANDA	ANDA207567	Actavis Pharma, Inc.	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
0591-4920_eeee154a-d52b-4078-ad88-569aa53440a5	0591-4920	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	TABLET	ORAL	20170103		ANDA	ANDA208096	Actavis Pharma, Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
0591-5019_fa2113fa-a281-498e-a127-4feab0e4d481	0591-5019	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20190822	20240630	NDA	NDA210063	Actavis Pharma, Inc.	FULVESTRANT	250	mg/5mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	
0591-5052_330e28d0-0ab6-4f31-8a76-afd1c2512a89	0591-5052	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA080356	Actavis Pharma, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0591-5307_aeb50160-20c6-4d2c-b77b-f17ff0cfd6a5	0591-5307	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	19730919		ANDA	ANDA083426	Actavis Pharma, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0591-5319_aeb50160-20c6-4d2c-b77b-f17ff0cfd6a5	0591-5319	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	19730921		ANDA	ANDA083711	Actavis Pharma, Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0591-5321_ea3729e4-be9a-454f-aca7-7b13869a6076	0591-5321	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20100619		ANDA	ANDA083551	Actavis Pharma, Inc.	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0591-5325_1d32f188-a4e0-4ff5-bdb3-78709fca8b5f	0591-5325	HUMAN PRESCRIPTION DRUG	Probenecid and Colchicine		Probenecid and Colchicine	TABLET	ORAL	19821001		ANDA	ANDA084279	Actavis Pharma, Inc.	COLCHICINE; PROBENECID	.5; 500	mg/1; mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20241231
0591-5335_ddc89b6c-1652-4fff-971c-9d8d0596e69f	0591-5335	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	19871101		ANDA	ANDA084363	Actavis Pharma, Inc.	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
0591-5337_ddc89b6c-1652-4fff-971c-9d8d0596e69f	0591-5337	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	19871101		ANDA	ANDA084364	Actavis Pharma, Inc.	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
0591-5347_5fca24d7-5052-45fb-9a9e-23812a484b4f	0591-5347	HUMAN PRESCRIPTION DRUG	Probenecid		Probenecid	TABLET, FILM COATED	ORAL	19830701		ANDA	ANDA084442	Actavis Pharma, Inc.	PROBENECID	500	mg/1			N	20241231
0591-5442_330e28d0-0ab6-4f31-8a76-afd1c2512a89	0591-5442	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085162	Actavis Pharma, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0591-5443_330e28d0-0ab6-4f31-8a76-afd1c2512a89	0591-5443	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085161	Actavis Pharma, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0591-5513_93954d60-cc97-48ac-ad9d-2e9c32be6bc5	0591-5513	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	19871101		ANDA	ANDA087499	Actavis Pharma, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
0591-5543_1ee17dd3-d553-4f09-a302-259546a4a568	0591-5543	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20090406		NDA	NDA018832	Actavis Pharma, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0591-5544_1ee17dd3-d553-4f09-a302-259546a4a568	0591-5544	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20090406		NDA	NDA018877	Actavis Pharma, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0591-5553_5ff8b94b-d80d-4c39-ad05-82425183cc03	0591-5553	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	19900101		ANDA	ANDA062421	Actavis Pharma, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0591-5554_c9eb1f85-2694-465e-9bca-17793419256c	0591-5554	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070175	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0591-5555_c9eb1f85-2694-465e-9bca-17793419256c	0591-5555	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070176	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0591-5556_c9eb1f85-2694-465e-9bca-17793419256c	0591-5556	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070177	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0591-5557_c9eb1f85-2694-465e-9bca-17793419256c	0591-5557	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070178	Actavis Pharma, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0591-5590_2fa717d1-ea07-4d1e-b4f8-766df8ef735d	0591-5590	HUMAN PRESCRIPTION DRUG	Tranylcypromine Sulfate		tranylcypromine sulfate	TABLET, FILM COATED	ORAL	20160205		NDA AUTHORIZED GENERIC	NDA012342	Actavis Pharma, Inc.	TRANYLCYPROMINE SULFATE	10	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
0591-5642_ccbe99ca-e1da-4a05-9e81-917afb30d434	0591-5642	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	20091026		ANDA	ANDA071344	Actavis Pharma, Inc.	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0591-5643_ccbe99ca-e1da-4a05-9e81-917afb30d434	0591-5643	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	20091026		ANDA	ANDA071345	Actavis Pharma, Inc.	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0591-5660_8727ec0e-b601-422a-a335-778e319a84be	0591-5660	HUMAN PRESCRIPTION DRUG	Sulindac		Sulindac	TABLET	ORAL	19900403		ANDA	ANDA071795	Actavis Pharma, Inc.	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-5661_8727ec0e-b601-422a-a335-778e319a84be	0591-5661	HUMAN PRESCRIPTION DRUG	Sulindac		Sulindac	TABLET	ORAL	19900403		ANDA	ANDA071891	Actavis Pharma, Inc.	SULINDAC	150	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0591-5694_5d892333-6f78-4190-9bce-93d3a864913b	0591-5694	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19920201		ANDA	ANDA063181	Actavis Pharma, Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0591-5695_5d892333-6f78-4190-9bce-93d3a864913b	0591-5695	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA063065	Actavis Pharma, Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0591-5713_031890ec-0687-47cd-8046-6cdae8943311	0591-5713	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19920828		ANDA	ANDA072691	Actavis Pharma, Inc.	AMOXAPINE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0591-5714_031890ec-0687-47cd-8046-6cdae8943311	0591-5714	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19920828		ANDA	ANDA072691	Actavis Pharma, Inc.	AMOXAPINE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0591-5715_031890ec-0687-47cd-8046-6cdae8943311	0591-5715	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19920828		ANDA	ANDA072691	Actavis Pharma, Inc.	AMOXAPINE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0591-5716_031890ec-0687-47cd-8046-6cdae8943311	0591-5716	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19920828		ANDA	ANDA072691	Actavis Pharma, Inc.	AMOXAPINE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0591-5782_d5ffd19b-ec6c-42df-a9fd-f152693830ad	0591-5782	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	19920801		ANDA	ANDA073665	Actavis Pharma, Inc.	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0591-5783_d5ffd19b-ec6c-42df-a9fd-f152693830ad	0591-5783	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	19920801		ANDA	ANDA073665	Actavis Pharma, Inc.	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0597-0003_895618dd-a613-4d06-b20b-c2e92e472a7c	0597-0003	HUMAN PRESCRIPTION DRUG	Aptivus		tipranavir	CAPSULE, LIQUID FILLED	ORAL	20050701		NDA	NDA021814	Boehringer Ingelheim Pharmaceuticals, Inc.	TIPRANAVIR	250	mg/1	HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
0597-0024_e5596ca1-fa08-4d03-a745-c0bca1af38f9	0597-0024	HUMAN PRESCRIPTION DRUG	Combivent Respimat		ipratropium bromide and albuterol	SPRAY, METERED	RESPIRATORY (INHALATION)	20120701		NDA	NDA021747	Boehringer Ingelheim Pharmaceuticals Inc.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	100; 20	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0597-0035_d5c9f2bd-76f9-42f4-aa3c-1a20c6c313d6	0597-0035	HUMAN PRESCRIPTION DRUG	SPEVIGO		spesolimab-sbzo	INJECTION	INTRAVENOUS	20220901		BLA	BLA761244	Boehringer Ingelheim Pharmaceuticals, Inc.	SPESOLIMAB	60	mg/mL			N	20241231
0597-0039_dfe75352-d19d-4a1b-bf6f-973404ef2b34	0597-0039	HUMAN PRESCRIPTION DRUG	Micardis		telmisartan	TABLET	ORAL	20001201	20250430	NDA	NDA020850	Boehringer Ingelheim Pharmaceuticals, Inc.	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
0597-0040_dfe75352-d19d-4a1b-bf6f-973404ef2b34	0597-0040	HUMAN PRESCRIPTION DRUG	Micardis		telmisartan	TABLET	ORAL	20001201	20250630	NDA	NDA020850	Boehringer Ingelheim Pharmaceuticals, Inc.	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
0597-0041_dfe75352-d19d-4a1b-bf6f-973404ef2b34	0597-0041	HUMAN PRESCRIPTION DRUG	Micardis		telmisartan	TABLET	ORAL	20001201	20250630	NDA	NDA020850	Boehringer Ingelheim Pharmaceuticals, Inc.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
0597-0042_c58fc0c9-d4dc-4fc5-9cb5-bfd7f6fe5636	0597-0042	HUMAN PRESCRIPTION DRUG	Micardis HCT		telmisartan and hydrochlorothiazide	TABLET	ORAL	20001201		NDA	NDA021162	Boehringer Ingelheim Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0597-0043_c58fc0c9-d4dc-4fc5-9cb5-bfd7f6fe5636	0597-0043	HUMAN PRESCRIPTION DRUG	Micardis HCT		telmisartan and hydrochlorothiazide	TABLET	ORAL	20001201		NDA	NDA021162	Boehringer Ingelheim Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0597-0044_c58fc0c9-d4dc-4fc5-9cb5-bfd7f6fe5636	0597-0044	HUMAN PRESCRIPTION DRUG	Micardis HCT		telmisartan and hydrochlorothiazide	TABLET	ORAL	20001201		NDA	NDA021162	Boehringer Ingelheim Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0597-0047_a917a77c-34d3-a4ba-c2f9-e0b084a14827	0597-0047	HUMAN PRESCRIPTION DRUG	Viramune		nevirapine	SUSPENSION	ORAL	20011001		NDA	NDA020933	Boehringer Ingelheim Pharmaceuticals Inc.	NEVIRAPINE	50	mg/5mL	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0597-0053_6f81fe64-66cb-4532-8fd0-932979b89b84	0597-0053	HUMAN PRESCRIPTION DRUG	GlucaGen		glucagon hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050622		NDA	NDA020918	Boehringer Ingelheim Pharmaceuticals, Inc.	GLUCAGON HYDROCHLORIDE	1	mg/mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20241231
0597-0075_74c01ed6-9299-467e-bda9-8043c8d887fb	0597-0075	HUMAN PRESCRIPTION DRUG	Spiriva	HandiHaler	TIOTROPIUM BROMIDE	CAPSULE	ORAL; RESPIRATORY (INHALATION)	20051011		NDA	NDA021395	Boehringer Ingelheim Pharmaceuticals, Inc.	TIOTROPIUM BROMIDE MONOHYDRATE	18	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0597-0087_62d1b7f6-bdf8-45c9-b295-667db2991d6c	0597-0087	HUMAN PRESCRIPTION DRUG	Atrovent	HFA	ipratropium bromide	AEROSOL, METERED	RESPIRATORY (INHALATION)	20050501		NDA	NDA021527	Boehringer Ingelheim Pharmaceuticals, Inc.	IPRATROPIUM BROMIDE	17	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0597-0100_bf4399ac-101f-486b-8c8f-d48dffe32d63	0597-0100	HUMAN PRESCRIPTION DRUG	Spiriva Respimat		tiotropium bromide inhalation spray	SPRAY, METERED	RESPIRATORY (INHALATION)	20140930		NDA	NDA021936	Boehringer Ingelheim Pharmaceuticals, Inc.	TIOTROPIUM BROMIDE ANHYDROUS	3.124	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0597-0108_00778be6-a0f3-4092-9023-4c4bdcdb7286	0597-0108	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate mesylate	CAPSULE	ORAL	20151123		NDA	NDA022512	Boehringer Ingelheim Pharmaceuticals Inc.	DABIGATRAN ETEXILATE MESYLATE	110	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0109_60ae1a38-d77c-49ae-82fc-8c246276352b	0597-0109	HUMAN PRESCRIPTION DRUG	Mirapex	ER	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100222	20240731	NDA	NDA022421	Boehringer Ingelheim Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	
0597-0115_60ae1a38-d77c-49ae-82fc-8c246276352b	0597-0115	HUMAN PRESCRIPTION DRUG	Mirapex	ER	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100222	20240831	NDA	NDA022421	Boehringer Ingelheim Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	
0597-0116_60ae1a38-d77c-49ae-82fc-8c246276352b	0597-0116	HUMAN PRESCRIPTION DRUG	Mirapex	ER	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100222	20240630	NDA	NDA022421	Boehringer Ingelheim Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	
0597-0137_c5839d3f-c4f1-4791-8804-ba8da8a39d9d	0597-0137	HUMAN PRESCRIPTION DRUG	Gilotrif		afatinib	TABLET, FILM COATED	ORAL	20130712		NDA	NDA201292	Boehringer Ingelheim Pharmaceuticals, Inc.	AFATINIB	30	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0597-0138_c5839d3f-c4f1-4791-8804-ba8da8a39d9d	0597-0138	HUMAN PRESCRIPTION DRUG	Gilotrif		afatinib	TABLET, FILM COATED	ORAL	20130712		NDA	NDA201292	Boehringer Ingelheim Pharmaceuticals, Inc.	AFATINIB	40	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0597-0140_af239154-d1de-4c5c-9a24-32910117d8fd	0597-0140	HUMAN PRESCRIPTION DRUG	Tradjenta		linagliptin	TABLET, FILM COATED	ORAL	20110509		NDA	NDA201280	Boehringer Ingelheim Pharmaceuticals, Inc.	LINAGLIPTIN	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0597-0141_c5839d3f-c4f1-4791-8804-ba8da8a39d9d	0597-0141	HUMAN PRESCRIPTION DRUG	Gilotrif		afatinib	TABLET, FILM COATED	ORAL	20130712		NDA	NDA201292	Boehringer Ingelheim Pharmaceuticals, Inc.	AFATINIB	20	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0597-0143_9de10615-5f26-453a-9c56-a0b844b479f9	0597-0143	HUMAN PRESCRIPTION DRUG	Ofev		nintedanib	CAPSULE	ORAL	20141015		NDA	NDA205832	Boehringer Ingelheim Pharmaceuticals, Inc.	NINTEDANIB ESYLATE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0597-0145_9de10615-5f26-453a-9c56-a0b844b479f9	0597-0145	HUMAN PRESCRIPTION DRUG	Ofev		nintedanib	CAPSULE	ORAL	20141015		NDA	NDA205832	Boehringer Ingelheim Pharmaceuticals, Inc.	NINTEDANIB ESYLATE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
0597-0146_a3daffd5-03f9-4a2d-8905-b175e7562a40	0597-0146	HUMAN PRESCRIPTION DRUG	Jentadueto		linagliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20120213		NDA	NDA201281	Boehringer Ingelheim Pharmaceuticals, Inc.	LINAGLIPTIN; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0597-0147_a3daffd5-03f9-4a2d-8905-b175e7562a40	0597-0147	HUMAN PRESCRIPTION DRUG	Jentadueto		linagliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20120213		NDA	NDA201281	Boehringer Ingelheim Pharmaceuticals, Inc.	LINAGLIPTIN; METFORMIN HYDROCHLORIDE	2.5; 850	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0597-0148_a3daffd5-03f9-4a2d-8905-b175e7562a40	0597-0148	HUMAN PRESCRIPTION DRUG	Jentadueto		linagliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20120213		NDA	NDA201281	Boehringer Ingelheim Pharmaceuticals, Inc.	LINAGLIPTIN; METFORMIN HYDROCHLORIDE	2.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0597-0152_efe87772-1fbc-4457-b369-2bf724f9d62b	0597-0152	HUMAN PRESCRIPTION DRUG	Jardiance		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0153_efe87772-1fbc-4457-b369-2bf724f9d62b	0597-0153	HUMAN PRESCRIPTION DRUG	Jardiance		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN	25	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0155_dd969dec-1e23-4cac-a42b-2f7f06a07f13	0597-0155	HUMAN PRESCRIPTION DRUG	Stiolto Respimat		tiotropium bromide and olodaterol	SPRAY, METERED	RESPIRATORY (INHALATION)	20150521		NDA	NDA206756	Boehringer Ingelheim Pharmaceuticals Inc.	OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE MONOHYDRATE	2.736; 3.124	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0597-0159_5e0b91aa-b43b-4e0f-b3ad-9b69b47433b2	0597-0159	HUMAN PRESCRIPTION DRUG	Synjardy		empagliflozin and metformin hydrochloride	TABLET	ORAL	20150826		NDA	NDA206111	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0160_bf4399ac-101f-486b-8c8f-d48dffe32d63	0597-0160	HUMAN PRESCRIPTION DRUG	Spiriva Respimat		tiotropium bromide inhalation spray	SPRAY, METERED	RESPIRATORY (INHALATION)	20150915		NDA	NDA207070	Boehringer Ingelheim Pharmaceuticals, Inc.	TIOTROPIUM BROMIDE ANHYDROUS	1.562	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0597-0164_c00ed17d-86f6-4d4d-a26a-0cf2e7315a85	0597-0164	HUMAN PRESCRIPTION DRUG	Glyxambi		empagliflozin and linagliptin	TABLET, FILM COATED	ORAL	20150130		NDA	NDA206073	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN	25; 5	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0168_5e0b91aa-b43b-4e0f-b3ad-9b69b47433b2	0597-0168	HUMAN PRESCRIPTION DRUG	Synjardy		empagliflozin and metformin hydrochloride	TABLET	ORAL	20150826		NDA	NDA206111	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	12.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0175_5e0b91aa-b43b-4e0f-b3ad-9b69b47433b2	0597-0175	HUMAN PRESCRIPTION DRUG	Synjardy		empagliflozin and metformin hydrochloride	TABLET	ORAL	20150826		NDA	NDA206111	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0180_5e0b91aa-b43b-4e0f-b3ad-9b69b47433b2	0597-0180	HUMAN PRESCRIPTION DRUG	Synjardy		empagliflozin and metformin hydrochloride	TABLET	ORAL	20150826		NDA	NDA206111	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	12.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0182_c00ed17d-86f6-4d4d-a26a-0cf2e7315a85	0597-0182	HUMAN PRESCRIPTION DRUG	Glyxambi		empagliflozin and linagliptin	TABLET, FILM COATED	ORAL	20150130		NDA	NDA206073	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN	10; 5	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0192_95406558-30c2-422e-a10a-c1b3d78ff40a	0597-0192	HUMAN PRESCRIPTION DRUG	Striverdi Respimat		olodaterol respimat inhalation spray	SPRAY, METERED	RESPIRATORY (INHALATION)	20140801		NDA	NDA203108	Boehringer Ingelheim Pharmaceuticals, Inc.	OLODATEROL HYDROCHLORIDE	2.5	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0597-0197_541f6df1-3562-43c1-8064-6fddb11c1ad1	0597-0197	HUMAN PRESCRIPTION DRUG	Praxbind		idarucizumab	INJECTION	INTRAVENOUS	20151021		BLA	BLA761025	Boehringer Ingelheim Pharmaceuticals, Inc.	IDARUCIZUMAB	50	mg/mL	Antibodies, Monoclonal, Humanized [CS], Humanized Monoclonal Antibody Fragment [EPC]		N	20241231
0597-0260_6f81fe64-66cb-4532-8fd0-932979b89b84	0597-0260	HUMAN PRESCRIPTION DRUG	GlucaGen		glucagon hydrochloride	KIT		20050622		NDA	NDA020918	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0270_d3b76cb1-ca66-412d-b028-41ab7ee3f92f	0597-0270	HUMAN PRESCRIPTION DRUG	Jentadueto XR		linagliptin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160527		NDA	NDA208026	Boehringer Ingelheim Pharmaceuticals, Inc.	LINAGLIPTIN; METFORMIN HYDROCHLORIDE	2.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0597-0275_d3b76cb1-ca66-412d-b028-41ab7ee3f92f	0597-0275	HUMAN PRESCRIPTION DRUG	Jentadueto XR		linagliptin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160527		NDA	NDA208026	Boehringer Ingelheim Pharmaceuticals, Inc.	LINAGLIPTIN; METFORMIN HYDROCHLORIDE	5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
0597-0280_f81d39d1-538b-491d-94a7-8d0c788e5bcf	0597-0280	HUMAN PRESCRIPTION DRUG	Synjardy	XR	empagliflozin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20161210		NDA	NDA208658	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	10; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0285_60ae1a38-d77c-49ae-82fc-8c246276352b	0597-0285	HUMAN PRESCRIPTION DRUG	Mirapex	ER	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100222	20240731	NDA	NDA022421	Boehringer Ingelheim Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	
0597-0286_60ae1a38-d77c-49ae-82fc-8c246276352b	0597-0286	HUMAN PRESCRIPTION DRUG	Mirapex	ER	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110618	20240831	NDA	NDA022421	Boehringer Ingelheim Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	
0597-0287_60ae1a38-d77c-49ae-82fc-8c246276352b	0597-0287	HUMAN PRESCRIPTION DRUG	Mirapex	ER	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110618	20240831	NDA	NDA022421	Boehringer Ingelheim Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	3.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	
0597-0290_f81d39d1-538b-491d-94a7-8d0c788e5bcf	0597-0290	HUMAN PRESCRIPTION DRUG	Synjardy	XR	empagliflozin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20161210		NDA	NDA208658	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0295_f81d39d1-538b-491d-94a7-8d0c788e5bcf	0597-0295	HUMAN PRESCRIPTION DRUG	Synjardy	XR	empagliflozin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20161210		NDA	NDA208658	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	25; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0300_f81d39d1-538b-491d-94a7-8d0c788e5bcf	0597-0300	HUMAN PRESCRIPTION DRUG	Synjardy	XR	empagliflozin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20161210		NDA	NDA208658	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	12.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0355_00778be6-a0f3-4092-9023-4c4bdcdb7286	0597-0355	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate mesylate	CAPSULE	ORAL	20110808		NDA	NDA022512	Boehringer Ingelheim Pharmaceuticals Inc.	DABIGATRAN ETEXILATE MESYLATE	75	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0360_00778be6-a0f3-4092-9023-4c4bdcdb7286	0597-0360	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate mesylate	CAPSULE	ORAL	20170728		NDA	NDA022512	Boehringer Ingelheim Pharmaceuticals Inc.	DABIGATRAN ETEXILATE MESYLATE	150	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0370_58f63d1a-fe43-4db7-b4e5-2ff15f7c07b8	0597-0370	HUMAN PRESCRIPTION DRUG	Cyltezo		adalimumab-adbm	KIT		20230701		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0375_58f63d1a-fe43-4db7-b4e5-2ff15f7c07b8	0597-0375	HUMAN PRESCRIPTION DRUG	Cyltezo		adalimumab-adbm	KIT		20230701		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0380_0cc7f716-30ec-497c-9aa0-4bfbf8b88d3e	0597-0380	HUMAN PRESCRIPTION DRUG	Trijardy XR		empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423		NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	10; 5; 1000	mg/1; mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0385_0cc7f716-30ec-497c-9aa0-4bfbf8b88d3e	0597-0385	HUMAN PRESCRIPTION DRUG	Trijardy XR		empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423		NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	12.5; 2.5; 1000	mg/1; mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0390_0cc7f716-30ec-497c-9aa0-4bfbf8b88d3e	0597-0390	HUMAN PRESCRIPTION DRUG	Trijardy XR		empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423		NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	25; 5; 1000	mg/1; mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0395_0cc7f716-30ec-497c-9aa0-4bfbf8b88d3e	0597-0395	HUMAN PRESCRIPTION DRUG	Trijardy XR		empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423		NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	5; 2.5; 1000	mg/1; mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
0597-0400_58f63d1a-fe43-4db7-b4e5-2ff15f7c07b8	0597-0400	HUMAN PRESCRIPTION DRUG	Cyltezo		adalimumab-adbm	KIT		20230701		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0405_58f63d1a-fe43-4db7-b4e5-2ff15f7c07b8	0597-0405	HUMAN PRESCRIPTION DRUG	Cyltezo		adalimumab-adbm	KIT		20230701		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0425_e80e64c0-c622-4e33-86b7-66f8c2ae3722	0597-0425	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate	PELLET	ORAL	20220316		NDA	NDA214358	Boehringer Ingelheim Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	20	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0430_e80e64c0-c622-4e33-86b7-66f8c2ae3722	0597-0430	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate	PELLET	ORAL	20220316		NDA	NDA214358	Boehringer Ingelheim Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	30	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0435_e80e64c0-c622-4e33-86b7-66f8c2ae3722	0597-0435	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate	PELLET	ORAL	20220316		NDA	NDA214358	Boehringer Ingelheim Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	40	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0440_e80e64c0-c622-4e33-86b7-66f8c2ae3722	0597-0440	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate	PELLET	ORAL	20220316		NDA	NDA214358	Boehringer Ingelheim Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	50	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0445_e80e64c0-c622-4e33-86b7-66f8c2ae3722	0597-0445	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate	PELLET	ORAL	20220316		NDA	NDA214358	Boehringer Ingelheim Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	110	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0450_e80e64c0-c622-4e33-86b7-66f8c2ae3722	0597-0450	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate	PELLET	ORAL	20220316		NDA	NDA214358	Boehringer Ingelheim Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	150	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0597-0545_91b92321-8a46-4cdf-b124-746adc907a19	0597-0545	HUMAN PRESCRIPTION DRUG	Adalimumab-adbm		Adalimumab-adbm	KIT		20231001		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0555_91b92321-8a46-4cdf-b124-746adc907a19	0597-0555	HUMAN PRESCRIPTION DRUG	Adalimumab-adbm		Adalimumab-adbm	KIT		20231001		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0585_91b92321-8a46-4cdf-b124-746adc907a19	0597-0585	HUMAN PRESCRIPTION DRUG	Adalimumab-adbm		Adalimumab-adbm	KIT		20231001		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0597-0595_91b92321-8a46-4cdf-b124-746adc907a19	0597-0595	HUMAN PRESCRIPTION DRUG	Adalimumab-adbm		Adalimumab-adbm	KIT		20231001		BLA	BLA761058	Boehringer Ingelheim Pharmaceuticals, Inc.						N	20241231
0603-0209_bdb053c5-7d83-43e4-aeac-bcdbd0d048c6	0603-0209	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20140701		OTC MONOGRAPH DRUG	M001	PAR Pharmaceuticals	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0603-0213_b40d866b-76d8-4522-bf1b-0ad137cedb42	0603-0213	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20201110		OTC MONOGRAPH DRUG	M001	PAR Pharmaceuticals	MAGNESIUM OXIDE	253	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0603-1161_2538f870-515e-47ba-ba3b-a39aa02cd849	0603-1161	HUMAN PRESCRIPTION DRUG	dicyclomine hydrochloride		dicyclomine hydrochloride	SOLUTION	ORAL	20050623		ANDA	ANDA040169	Par Pharmaceutical, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0603-1508_65e7e1ed-5a7c-4e01-9d97-5286b531eb29	0603-1508	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	ELIXIR	ORAL	19970101	20240229	UNAPPROVED DRUG OTHER		Par Pharmaceutical	PHENOBARBITAL	20	mg/5mL		CIV	N	
0603-1542_7cf9c3e6-66c5-4a4c-aa11-83b2d317fc9e	0603-1542	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20150504		NDA	NDA206814	Par Pharmaceutical	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0603-1543_7cf9c3e6-66c5-4a4c-aa11-83b2d317fc9e	0603-1543	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20150504		NDA	NDA206814	Par Pharmaceutical	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0603-1554_93f33512-04a6-4ec9-b8e6-eed49d7b6af8	0603-1554	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20150918		NDA	NDA208019	Par Pharmaceutical	POTASSIUM CHLORIDE	1.5	g/1.58g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0603-1880_8730a197-a228-4913-815c-c135b1097fd7	0603-1880	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20140502		NDA AUTHORIZED GENERIC	NDA020612	Par Pharmaceutical	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0603-2115_f45eb9cd-3e30-40a9-b4c8-b6fea8789ce7	0603-2115	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Par Pharmaceutical, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0603-2116_f45eb9cd-3e30-40a9-b4c8-b6fea8789ce7	0603-2116	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Par Pharmaceutical, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0603-2406_9a8ca50c-56f5-48f5-bb1f-8cb13d96f228	0603-2406	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077156	Par Pharmaceutical, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0603-2407_9a8ca50c-56f5-48f5-bb1f-8cb13d96f228	0603-2407	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077068	Par Pharmaceutical, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0603-2433_e15f528d-1dcf-46ef-97f9-ee53c5a8d89b	0603-2433	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	Par Pharmaceutical, Inc.	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0603-2434_e15f528d-1dcf-46ef-97f9-ee53c5a8d89b	0603-2434	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	Par Pharmaceutical, Inc.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0603-2435_e15f528d-1dcf-46ef-97f9-ee53c5a8d89b	0603-2435	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	Par Pharmaceutical, Inc.	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0603-2437_d8b9d4bf-340a-4a87-80a9-4bc0606ab60f	0603-2437	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515	20240531	ANDA	ANDA204713	Par Pharmaceutical, Inc.	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
0603-2438_d8b9d4bf-340a-4a87-80a9-4bc0606ab60f	0603-2438	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515	20240630	ANDA	ANDA204713	Par Pharmaceutical, Inc.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
0603-2439_d8b9d4bf-340a-4a87-80a9-4bc0606ab60f	0603-2439	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515	20240630	ANDA	ANDA204713	Par Pharmaceutical, Inc.	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
0603-2540_0e85235d-3789-9f6c-e063-6294a90ad320	0603-2540	HUMAN PRESCRIPTION DRUG	butalbital and acetaminophen		butalbital and acetaminophen	TABLET	ORAL	19990603		ANDA	ANDA089987	Par Pharmaceutical	ACETAMINOPHEN; BUTALBITAL	325; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]		N	20251231
0603-2544_644ecb93-aa80-41fa-8e95-143d74e5ba02	0603-2544	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20030827	20240331	ANDA	ANDA040511	Par Pharmaceutical, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
0603-3581_1c67ab14-ed68-41e1-ae18-3fc76cd030de	0603-3581	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20090331		ANDA	ANDA200815	Par Pharmaceutical, Inc.	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0603-3582_1c67ab14-ed68-41e1-ae18-3fc76cd030de	0603-3582	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Par Pharmaceutical, Inc.	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0603-3583_1c67ab14-ed68-41e1-ae18-3fc76cd030de	0603-3583	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Par Pharmaceutical, Inc.	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0603-3718_bf47e955-8af1-43f6-9972-aab0329a9765	0603-3718	HUMAN PRESCRIPTION DRUG	Frovatriptan Succinate		frovatriptan succinate	TABLET, FILM COATED	ORAL	20151005		NDA	NDA021006	Par Pharmaceutical	FROVATRIPTAN SUCCINATE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
0603-4593_92696a21-5fc7-40ff-8f7d-efa4deb8349d	0603-4593	HUMAN PRESCRIPTION DRUG	MethylPREDNISolone		methylprednisolone	TABLET	ORAL	19981222		ANDA	ANDA040183	Par Pharmaceutical, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0603-5060_458090e5-1db5-42c1-88f5-3251bca27d4c	0603-5060	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Par Pharmaceutical, Inc.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0603-5061_458090e5-1db5-42c1-88f5-3251bca27d4c	0603-5061	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Par Pharmaceutical, Inc.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0603-5062_458090e5-1db5-42c1-88f5-3251bca27d4c	0603-5062	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Par Pharmaceutical, Inc.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0603-5063_458090e5-1db5-42c1-88f5-3251bca27d4c	0603-5063	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Par Pharmaceutical, Inc.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0603-5165_79f79901-ddd2-450a-bea8-1103c0d90198	0603-5165	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20020301		UNAPPROVED DRUG OTHER		Par Pharmaceutical, Inc.	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
0603-5166_79f79901-ddd2-450a-bea8-1103c0d90198	0603-5166	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20030201		UNAPPROVED DRUG OTHER		Par Pharmaceutical, Inc.	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
0603-5167_79f79901-ddd2-450a-bea8-1103c0d90198	0603-5167	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20011201		UNAPPROVED DRUG OTHER		Par Pharmaceutical, Inc.	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
0603-5168_79f79901-ddd2-450a-bea8-1103c0d90198	0603-5168	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20011201		UNAPPROVED DRUG OTHER		Par Pharmaceutical, Inc.	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
0603-5335_2be8fc69-d222-45a2-867e-6e369356937b	0603-5335	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20041221		ANDA	ANDA040584	Par Pharmaceutical, Inc.	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0603-5336_2be8fc69-d222-45a2-867e-6e369356937b	0603-5336	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20041221		ANDA	ANDA040581	Par Pharmaceutical, Inc.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0603-5337_2be8fc69-d222-45a2-867e-6e369356937b	0603-5337	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Par Pharmaceutical, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0603-5338_2be8fc69-d222-45a2-867e-6e369356937b	0603-5338	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Par Pharmaceutical, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0603-5339_2be8fc69-d222-45a2-867e-6e369356937b	0603-5339	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20030212		ANDA	ANDA040392	Par Pharmaceutical, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0603-5449_b375fca8-7731-4563-a237-2b066af75310	0603-5449	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, FILM COATED	ORAL	20021017	20240430	ANDA	ANDA075938	Par Pharmaceutical, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	
0603-5450_b375fca8-7731-4563-a237-2b066af75310	0603-5450	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, FILM COATED	ORAL	20021017	20240331	ANDA	ANDA075938	Par Pharmaceutical, Inc.	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	
0603-5482_20df09cb-5669-4f9f-9161-a2958e0650a4	0603-5482	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Par Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0603-5483_20df09cb-5669-4f9f-9161-a2958e0650a4	0603-5483	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Par Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0603-5484_20df09cb-5669-4f9f-9161-a2958e0650a4	0603-5484	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Par Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0603-5485_20df09cb-5669-4f9f-9161-a2958e0650a4	0603-5485	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Par Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0603-5486_20df09cb-5669-4f9f-9161-a2958e0650a4	0603-5486	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Par Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0603-6330_2ef2c711-9b0e-42fa-aa3e-58797bc86a33	0603-6330	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir hydrochloride	TABLET, FILM COATED	ORAL	20141104		ANDA	ANDA200790	Par Pharmaceutical	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
0603-7831_c9469c53-cb9f-4a98-a091-c29b7afcbac5	0603-7831	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL, METERED	TOPICAL	20140825	20240228	NDA AUTHORIZED GENERIC	NDA021463	Par Pharmaceutical, Inc.	TESTOSTERONE	10	mg/.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	
0615-2572_f2d29ac8-4dcc-4b65-a683-5d840c324eb2	0615-2572	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070974	NCS HealthCare of KY, LLC dba Vangard Labs	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0615-2574_790db004-f84d-4e3c-b09f-fdc96f2b0f51	0615-2574	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070976	NCS HealthCare of KY, LLC dba Vangard Labs	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0615-3505_5c7ae16b-0cbf-4f47-b00d-aab31dc18bbf	0615-3505	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19900930	20240430	ANDA	ANDA070541	NCS HealthCare of KY, LLC dba Vangard Labs	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
0615-3512_6905c0e0-8272-4436-97ea-6ed581c9e533	0615-3512	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20121030	20240430	ANDA	ANDA075079	NCS HealthCare of KY, LLC dba Vangard Labs	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
0615-4517_8ee62c16-abf6-426e-953e-dc06600b8deb	0615-4517	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20100108		ANDA	ANDA070848	NCS HealthCare of KY, Inc dba Vangard Labs	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
0615-4582_b936bdb0-9b96-4f47-9f5d-53f363a6a2ca	0615-4582	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20100430		ANDA	ANDA075511	NCS HealthCare of KY, LLC dba Vangard Labs	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0615-6562_8207940f-4048-4cee-a735-a74e00058296	0615-6562	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		FLUDROCORTISONE ACETATE	TABLET	ORAL	20020318		ANDA	ANDA040431	NCS HealthCare of KY, Inc dba Vangard Labs	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
0615-7621_f2e88e80-f6fa-472a-a595-aed7d9c6f478	0615-7621	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701	20240531	ANDA	ANDA076565	NCS HealthCare of KY, LLC dba Vangard Labs	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
0615-7622_f2e88e80-f6fa-472a-a595-aed7d9c6f478	0615-7622	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701	20240531	ANDA	ANDA076565	NCS HealthCare of KY, LLC dba Vangard Labs	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
0615-7625_2647ab30-f02e-46bd-8cf5-bcf1f83a6548	0615-7625	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	NCS HealthCare of KY, LLC dba Vangard Labs	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-7629_84e19224-509d-45b9-b926-5482601b9f95	0615-7629	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20220406		ANDA	ANDA090970	NCS HealthCare of KY, LLC dba Vangard Labs	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0615-7689_6c110ec8-9544-4e3a-acb7-ac4f8ebbbeb2	0615-7689	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20101223		ANDA	ANDA075022	NCS HealthCare of KY, LLC dba Vangard Labs	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
0615-7698_287dcd9d-85eb-4001-8c8a-e688d51e03de	0615-7698	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20111118		ANDA	ANDA072801	NCS HealthCare of KY, LLC dba Vangard Labs	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0615-7714_6c110ec8-9544-4e3a-acb7-ac4f8ebbbeb2	0615-7714	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120423		ANDA	ANDA075022	NCS HealthCare of KY, LLC dba Vangard Labs	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
0615-7718_6c110ec8-9544-4e3a-acb7-ac4f8ebbbeb2	0615-7718	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	NCS HealthCare of KY, LLC dba Vangard Labs	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
0615-7767_9af3aa38-8eec-416b-8581-89f5e1509a33	0615-7767	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20110603		ANDA	ANDA200270	NCS HealthCare of KY, LLC dba Vangard Labs	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0615-7768_20b1a496-6d77-4d91-afaf-b8c3bf4b2e15	0615-7768	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20110603		ANDA	ANDA200495	NCS HealthCare of KY, LLC dba Vangard Labs	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0615-7814_7490d9d7-4635-4e75-b91c-96feb3d1c579	0615-7814	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20091202	20240331	ANDA	ANDA040625	NCS HealthCare of KY, LLC dba Vangard Labs	FOLIC ACID	1	mg/1			N	
0615-7823_981232fd-da9e-4eda-a2fb-8a299089b6d4	0615-7823	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	NCS HealthCare of KY, LLC dba Vangard Labs	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-7824_981232fd-da9e-4eda-a2fb-8a299089b6d4	0615-7824	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	NCS HealthCare of KY, LLC dba Vangard Labs	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-7825_63f01591-ca92-4ddc-bdbf-8b7fd9da9c55	0615-7825	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	NCS HealthCare of KY, Inc dba Vangard Labs	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-7951_63934e61-64ba-4b94-9075-f2a60cbcf5fb	0615-7951	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	NCS HealthCare of KY, LLC dba Vangard Labs	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0615-7958_03fe4525-9972-47bc-a193-8eb445fbc22c	0615-7958	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	NCS HealthCare of KY, Inc dba Vangard Labs	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0615-7959_03fe4525-9972-47bc-a193-8eb445fbc22c	0615-7959	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	NCS HealthCare of KY, Inc dba Vangard Labs	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0615-7960_03fe4525-9972-47bc-a193-8eb445fbc22c	0615-7960	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	NCS HealthCare of KY, Inc dba Vangard Labs	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0615-7964_22545957-98d2-4f38-afdf-04711262196c	0615-7964	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	NCS HealthCare of KY, Inc dba Vangard Labs	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-7973_836cffbd-37d4-441f-8c7d-febf0dac6ee5	0615-7973	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	NCS HealthCare of KY, LLC dba Vangard Labs	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0615-7974_36982f97-09bd-40b8-ac24-00e211b5212d	0615-7974	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410	20241231	ANDA	ANDA202556	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
0615-7975_22545957-98d2-4f38-afdf-04711262196c	0615-7975	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	NCS HealthCare of KY, Inc dba Vangard Labs	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-7976_06a52f37-359e-43e4-bc82-b5405b2c9747	0615-7976	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120109	20240930	ANDA	ANDA090515	NCS HealthCare of KY, LLC dba Vangard Labs	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-7977_2e62eb6f-1706-4fcc-94bd-44ffcfe1b08f	0615-7977	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120109	20240930	ANDA	ANDA090515	NCS HealthCare of KY, LLC dba Vangard Labs	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-7978_06a52f37-359e-43e4-bc82-b5405b2c9747	0615-7978	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120109	20241031	ANDA	ANDA090515	NCS HealthCare of KY, LLC dba Vangard Labs	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-7979_2d6ed9e4-c9d0-4d18-b364-64bd9511b7b1	0615-7979	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115	20241031	ANDA	ANDA090025	NCS HealthCare of KY, LLC dba Vangard Labs	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-7982_02d72da7-3128-4811-b337-f22354d03d90	0615-7982	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	NCS HealthCare of KY, LLC dba Vangard Labs	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0615-7985_34c4cb21-d274-4d85-90f4-df09a9beffd8	0615-7985	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	NCS HealthCare of KY, LLC dba Vangard Labs	PAROXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-7986_71b5ea63-5ca4-433f-b542-166638e12380	0615-7986	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328	20250131	ANDA	ANDA202152	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	
0615-7987_71b5ea63-5ca4-433f-b542-166638e12380	0615-7987	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328	20241231	ANDA	ANDA202152	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	
0615-7988_71b5ea63-5ca4-433f-b542-166638e12380	0615-7988	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328	20250131	ANDA	ANDA202152	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	
0615-7989_a1a77fb6-83bf-4760-9170-2b5f34fb312d	0615-7989	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206	20240630	ANDA	ANDA077670	NCS HealthCare of KY, LLC dba Vangard Labs	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
0615-7990_a1a77fb6-83bf-4760-9170-2b5f34fb312d	0615-7990	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206	20240531	ANDA	ANDA077670	NCS HealthCare of KY, LLC dba Vangard Labs	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
0615-7991_a1a77fb6-83bf-4760-9170-2b5f34fb312d	0615-7991	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206	20240630	ANDA	ANDA077670	NCS HealthCare of KY, LLC dba Vangard Labs	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
0615-7992_2b632b51-abb9-424c-9cd0-0eba67cc4d73	0615-7992	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	NCS HealthCare of KY, LLC dba Vangard Labs	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-7993_2b632b51-abb9-424c-9cd0-0eba67cc4d73	0615-7993	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	NCS HealthCare of KY, LLC dba Vangard Labs	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-7997_d1cc10b3-6c92-444e-a12d-314c9c92f13c	0615-7997	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	NCS HealthCare of KY, LLC dba Vangard Labs	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0615-8005_66e5e891-13bd-48eb-972a-641c6482c8b7	0615-8005	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20101115	20240228	ANDA	ANDA076003	NCS HealthCare of KY, LLC dba Vangard Labs	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	
0615-8006_32feeb97-2416-4d73-b976-e1b80159d6ca	0615-8006	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	NCS HealthCare of KY, LLC dba Vangard Labs	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8007_8793aa37-6d01-438e-93d3-9bf804b6a2d6	0615-8007	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	NCS HealthCare of KY, LLC dba Vangard Labs	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8008_d4439c29-d053-4f2c-aa06-7899db099f49	0615-8008	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	NCS HealthCare of KY, LLC dba Vangard Labs	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8009_8793aa37-6d01-438e-93d3-9bf804b6a2d6	0615-8009	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	NCS HealthCare of KY, LLC dba Vangard Labs	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8014_9163e003-4d05-493a-abd1-ce7597dd8224	0615-8014	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076274	NCS HealthCare of KY, LLC dba Vangard Labs	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0615-8015_02d72da7-3128-4811-b337-f22354d03d90	0615-8015	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	NCS HealthCare of KY, LLC dba Vangard Labs	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0615-8020_75b615c9-bf3f-4cb2-8664-89ef15f2ff8d	0615-8020	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20060905		ANDA	ANDA040684	NCS HealthCare of KY, LLC dba Vangard Labs	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8022_aec16083-ac47-4a94-83ca-412b543f477e	0615-8022	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	NCS HealthCare of KY, LLC dba Vangard Labs	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8023_aec16083-ac47-4a94-83ca-412b543f477e	0615-8023	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	NCS HealthCare of KY, LLC dba Vangard Labs	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8029_16e8c2ab-0669-4f92-a799-3700677af85b	0615-8029	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	NCS HealthCare of KY, LLC dba Vangard Labs	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8030_16e8c2ab-0669-4f92-a799-3700677af85b	0615-8030	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	NCS HealthCare of KY, LLC dba Vangard Labs	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8032_23de032e-65c7-4081-bf7f-a6f266d874ac	0615-8032	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951222		ANDA	ANDA074185	NCS HealthCare of KY, LLC dba Vangard Labs	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0615-8033_23de032e-65c7-4081-bf7f-a6f266d874ac	0615-8033	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951222		ANDA	ANDA074185	NCS HealthCare of KY, LLC dba Vangard Labs	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0615-8040_c6eed972-9c7c-44b8-a5f5-1a012abdef88	0615-8040	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	NCS HealthCare of KY, LLC dba Vangard Labs	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0615-8041_9f0945c8-b3cf-469c-8d86-5aa62df384d3	0615-8041	HUMAN OTC DRUG	Docusate Sodium		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20081028		OTC MONOGRAPH DRUG	505G(a)(3)	NCS HealthCare of KY, LLC dba Vangard Labs	DOCUSATE SODIUM	100	mg/1			N	20241231
0615-8055_99d9ac0a-1ffb-4bbc-9ba6-543cde4ad9ef	0615-8055	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	NCS HealthCare of KY, LLC dba Vangard Labs	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0615-8056_d4f96add-3a0f-4a00-9fa5-d73852230543	0615-8056	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20151202		ANDA	ANDA078103	NCS HealthCare of KY, LLC dba Vangard Labs	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8078_34cc58b7-ab62-42dc-ac84-55b0ece426f7	0615-8078	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422	20240630	ANDA	ANDA076541	NCS HealthCare of KY, LLC dba Vangard Labs	MIRTAZAPINE	7.5	mg/1			N	
0615-8079_c428d2a7-34b0-484f-8c44-91827d2e5901	0615-8079	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	NCS HealthCare of KY, LLC dba Vangard Labs	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0615-8082_ac405e41-4f23-462e-bb34-19c499750ad1	0615-8082	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20120324		ANDA	ANDA204279	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0615-8084_f627b337-88b1-40f5-a677-e2b546bfcdf8	0615-8084	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA090478	NCS HealthCare of KY, LLC dba Vangard Labs	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0615-8087_23845e22-60ca-4487-a6e9-1a47a3536bd7	0615-8087	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	19910918	20241031	ANDA	ANDA072741	NCS HealthCare of KY, LLC dba Vangard Labs	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	
0615-8093_2647ab30-f02e-46bd-8cf5-bcf1f83a6548	0615-8093	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	NCS HealthCare of KY, LLC dba Vangard Labs	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8094_0aa460fe-3ac9-4b38-8e2b-8a59e5cb3563	0615-8094	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	NCS HealthCare of KY, Inc dba Vangard Labs	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0615-8105_02d72da7-3128-4811-b337-f22354d03d90	0615-8105	HUMAN PRESCRIPTION DRUG	Metformin Hydrochoride		Metformin	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	NCS HealthCare of KY, LLC dba Vangard Labs	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0615-8113_6acc7e9a-ac10-45d4-b0d7-4253d848e108	0615-8113	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	NCS HealthCare of KY, LLC dba Vangard Labs	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0615-8118_39428a95-1100-4878-b5f0-df178c450b69	0615-8118	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328	20250131	ANDA	ANDA202152	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	
0615-8119_39428a95-1100-4878-b5f0-df178c450b69	0615-8119	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328	20241231	ANDA	ANDA202152	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	
0615-8121_20e1f91c-ddc9-432c-b698-761ee42134cf	0615-8121	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	NCS HealthCare of KY, Inc dba Vangard Labs	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0615-8124_c6eed972-9c7c-44b8-a5f5-1a012abdef88	0615-8124	HUMAN PRESCRIPTION DRUG	MELOXICAM		Meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	NCS HealthCare of KY, LLC dba Vangard Labs	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0615-8125_f8c0c630-dec1-4c2b-9925-39f6a3c86909	0615-8125	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	20001024		ANDA	ANDA075687	NCS HealthCare of KY, LLC dba Vangard Labs	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8130_7df47383-03df-4a15-b021-a1d066291c15	0615-8130	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	NCS HealthCare of KY, Inc dba Vangard Labs	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8131_7df47383-03df-4a15-b021-a1d066291c15	0615-8131	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	NCS HealthCare of KY, Inc dba Vangard Labs	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8132_ac440846-dd75-4c42-8178-6f788ca7837e	0615-8132	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401	20240531	ANDA	ANDA077662	NCS HealthCare of KY, LLC dba Vangard Labs	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-8138_848d3095-00b2-4f4e-aec8-88ac7ffa0d28	0615-8138	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	NCS HealthCare of KY, LLC dba Vangard Labs	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8139_848d3095-00b2-4f4e-aec8-88ac7ffa0d28	0615-8139	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	NCS HealthCare of KY, LLC dba Vangard Labs	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8140_848d3095-00b2-4f4e-aec8-88ac7ffa0d28	0615-8140	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	NCS HealthCare of KY, LLC dba Vangard Labs	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8141_aec16083-ac47-4a94-83ca-412b543f477e	0615-8141	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	NCS HealthCare of KY, LLC dba Vangard Labs	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8149_36982f97-09bd-40b8-ac24-00e211b5212d	0615-8149	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20180710	20240731	ANDA	ANDA202556	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
0615-8150_22545957-98d2-4f38-afdf-04711262196c	0615-8150	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	NCS HealthCare of KY, Inc dba Vangard Labs	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8151_e3e44841-fbef-4ac5-a7c2-b9ac79c68298	0615-8151	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20180709		ANDA	ANDA078296	NCS HealthCare of KY, LLC dba Vangard Labs	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8152_e3e44841-fbef-4ac5-a7c2-b9ac79c68298	0615-8152	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20180710		ANDA	ANDA078296	NCS HealthCare of KY, LLC dba Vangard Labs	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8153_dbdc7bbb-bc4d-46f9-829f-0c5444abb915	0615-8153	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009	20240430	ANDA	ANDA077794	NCS HealthCare of KY, LLC dba Vangard Labs	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-8154_7ba834b5-8d04-429c-bd83-71e895634521	0615-8154	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20180702		ANDA	ANDA040596	NCS HealthCare of KY, Inc dba Vangard Labs	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0615-8158_16e8c2ab-0669-4f92-a799-3700677af85b	0615-8158	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravatatin	TABLET	ORAL	20180710		ANDA	ANDA077987	NCS HealthCare of KY, LLC dba Vangard Labs	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8173_34c4cb21-d274-4d85-90f4-df09a9beffd8	0615-8173	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	NCS HealthCare of KY, LLC dba Vangard Labs	PAROXETINE HYDROCHLORIDE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8174_34c4cb21-d274-4d85-90f4-df09a9beffd8	0615-8174	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	NCS HealthCare of KY, LLC dba Vangard Labs	PAROXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8178_8877ef02-1d51-4692-8895-2a1784fcb5d5	0615-8178	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602	20241231	ANDA	ANDA203512	NCS HealthCare of KY, LLC dba Vangard Labs	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	
0615-8180_c0148274-b49f-4b30-8035-5397b6abe26f	0615-8180	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20070823	20240731	ANDA	ANDA077828	NCS HealthCare of KY, LLC dba Vangard Labs	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
0615-8181_c0148274-b49f-4b30-8035-5397b6abe26f	0615-8181	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20070823	20240731	ANDA	ANDA077828	NCS HealthCare of KY, LLC dba Vangard Labs	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
0615-8182_cb3fa04f-0ca1-4350-a29a-2ebe86233f64	0615-8182	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	NCS HealthCare of KY, Inc dba Vangard Labs	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0615-8183_f26a90de-3933-4a0f-89ad-d4a4d26c4fe0	0615-8183	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	NCS HealthCare of KY, LLC dba Vangard Labs	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8185_e9e5d263-002f-4d77-ab9f-d9a924aefbee	0615-8185	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	NCS HealthCare of KY, LLC dba Vangard Labs	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0615-8188_da62766f-17f7-42a4-9e04-0553b0c7a011	0615-8188	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	NCS HealthCare of KY, Inc dba Vangard Labs	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0615-8189_da62766f-17f7-42a4-9e04-0553b0c7a011	0615-8189	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	NCS HealthCare of KY, Inc dba Vangard Labs	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0615-8190_da62766f-17f7-42a4-9e04-0553b0c7a011	0615-8190	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	NCS HealthCare of KY, Inc dba Vangard Labs	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0615-8191_da62766f-17f7-42a4-9e04-0553b0c7a011	0615-8191	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	NCS HealthCare of KY, Inc dba Vangard Labs	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0615-8192_a788d2b2-f529-400d-842e-93b2556b5d80	0615-8192	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150711		ANDA	ANDA090048	NCS HealthCare of KY, Inc dba Vangard Labs	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0615-8196_102140c8-c00e-4498-8e1a-322d5de68198	0615-8196	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20150601		ANDA	ANDA077493	NCS HealthCare of KY, LLC dba Vangard Labs	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8197_102140c8-c00e-4498-8e1a-322d5de68198	0615-8197	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20150601		ANDA	ANDA077493	NCS HealthCare of KY, LLC dba Vangard Labs	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8198_102140c8-c00e-4498-8e1a-322d5de68198	0615-8198	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20150601		ANDA	ANDA077493	NCS HealthCare of KY, LLC dba Vangard Labs	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8202_08fa935c-6b30-4967-8e29-8fa39d7af332	0615-8202	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20071030		ANDA	ANDA077002	NCS HealthCare of KY, LLC dba Vangard Labs	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0615-8203_f9414a60-51fc-472d-ac97-0ccedd9e1015	0615-8203	HUMAN PRESCRIPTION DRUG	Duloxetine hydrochloride		Duloxetin hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211	20240930	ANDA	ANDA090774	NCS HealthCare of KY, LLC dba Vangard Labs	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
0615-8204_f9414a60-51fc-472d-ac97-0ccedd9e1015	0615-8204	HUMAN PRESCRIPTION DRUG	Duloxetine hydrochloride		Duloxetin hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211	20240930	ANDA	ANDA090774	NCS HealthCare of KY, LLC dba Vangard Labs	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
0615-8205_5fb753a4-19c2-46f9-b66a-2fac5263c026	0615-8205	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20160715		ANDA	ANDA073484	NCS HealthCare of KY, Inc dba Vangard Labs	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8206_f55d60a8-a938-4bbf-9410-87107696ad16	0615-8206	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20091224		ANDA	ANDA040866	NCS HealthCare of KY, LLC dba Vangard Labs	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8212_345064b7-35e4-435b-8c30-fb30033437a6	0615-8212	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20160118	20240731	ANDA	ANDA203002	NCS HealthCare of KY, LLC dba Vangard Labs	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
0615-8217_c05b1bc1-2c46-4f50-b66a-cf84d1eaa2a8	0615-8217	HUMAN OTC DRUG	Loratadine	antihistamine	Loratadine	TABLET	ORAL	20180711		ANDA	ANDA076301	NCS HealthCare of KY, LLC dba Vangard Labs	LORATADINE	10	mg/1			N	20241231
0615-8219_c67ff637-e959-4a8f-be1d-c1f73f0434b6	0615-8219	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180702		ANDA	ANDA202332	NCS HealthCare of KY, Inc dba Vangard Labs	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0615-8220_14ea75ea-9afc-44c8-95f4-d08aef313e45	0615-8220	HUMAN PRESCRIPTION DRUG	Oxybutynin		Oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	NCS HealthCare of KY, Inc dba Vangard Labs	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0615-8221_f45dbfc3-4ddd-4c82-b175-9f2c8bdee4ba	0615-8221	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20180910	20241231	ANDA	ANDA203512	NCS HealthCare of KY, LLC dba Vangard Labs	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	
0615-8222_0d81c7ee-5cc1-43bb-a980-191feac4ccfc	0615-8222	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	NCS HealthCare of KY, LLC dba Vangard Labs	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0615-8223_d9240af9-8ac7-4b12-8746-d1b261b634d3	0615-8223	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	NCS HealthCare of KY, LLC dba Vangard Labs	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0615-8233_ec2102c6-c800-4b3b-b4e6-4029fb6077bb	0615-8233	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401	20240831	ANDA	ANDA077662	NCS HealthCare of KY, LLC dba Vangard Labs	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-8237_a1184716-3614-423b-902c-968790b7ab68	0615-8237	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	CAPSULE	ORAL	20180827		ANDA	ANDA078979	NCS HealthCare of KY, LLC dba Vangard Labs	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8239_73bf1774-26ec-4fee-a1db-8d7ae42e2721	0615-8239	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20170717		ANDA	ANDA207179	NCS HealthCare of KY, Inc dba Vangard Labs	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0615-8240_e71f4041-eec2-4fe3-b9bd-a112c0dc17d0	0615-8240	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227	20240229	ANDA	ANDA078336	NCS HealthCare of KY, LLC dba Vangard Labs	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
0615-8243_425e7b87-7c9f-43d7-b89f-dfb30f8ee57b	0615-8243	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	NCS HealthCare of KY, Inc dba Vangard Labs	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8244_425e7b87-7c9f-43d7-b89f-dfb30f8ee57b	0615-8244	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	NCS HealthCare of KY, Inc dba Vangard Labs	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8245_425e7b87-7c9f-43d7-b89f-dfb30f8ee57b	0615-8245	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	NCS HealthCare of KY, Inc dba Vangard Labs	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8246_425e7b87-7c9f-43d7-b89f-dfb30f8ee57b	0615-8246	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	NCS HealthCare of KY, Inc dba Vangard Labs	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8251_bc1cbf1d-80c9-4c44-aa46-9847834c3b4d	0615-8251	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20180716		ANDA	ANDA073589	NCS HealthCare of KY, Inc dba Vangard Labs	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0615-8252_9ee93e97-bf33-4d59-b1fb-31c7abe60ff3	0615-8252	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	NCS HealthCare of KY, LLC dba Vangard Labs	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0615-8253_9ee93e97-bf33-4d59-b1fb-31c7abe60ff3	0615-8253	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	NCS HealthCare of KY, LLC dba Vangard Labs	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0615-8254_9ee93e97-bf33-4d59-b1fb-31c7abe60ff3	0615-8254	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	NCS HealthCare of KY, LLC dba Vangard Labs	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0615-8255_9ee93e97-bf33-4d59-b1fb-31c7abe60ff3	0615-8255	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	NCS HealthCare of KY, LLC dba Vangard Labs	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0615-8257_e010b721-a233-4093-b0d0-2d2400a8c872	0615-8257	HUMAN OTC DRUG	Aspirin Low Dose Chewable Orange		Aspirin	TABLET, CHEWABLE	ORAL	20180927		OTC MONOGRAPH FINAL	part343	NCS HealthCare of KY, LLC dba Vangard Labs	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0615-8258_3a306c3f-4cb0-40e7-b2a7-aeea3f918913	0615-8258	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20160603		ANDA	ANDA204742	NCS HealthCare of KY, LLC dba Vangard Labs	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0615-8261_204c61a5-77c4-4f33-b31c-2e3416b16209	0615-8261	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20160819		ANDA	ANDA206975	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0615-8262_1af6083f-90f2-4f46-b537-469a57827266	0615-8262	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA202304	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0615-8263_5d7866ea-8cc7-4208-87d7-95e7b72c5a1b	0615-8263	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20170101		ANDA	ANDA209171	NCS HealthCare of KY, Inc dba Vangard Labs	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
0615-8264_90d36b6e-23bb-4e06-9cc3-cc92c6408219	0615-8264	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	NCS HealthCare of KY, Inc dba Vangard Labs	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0615-8265_102140c8-c00e-4498-8e1a-322d5de68198	0615-8265	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20150601		ANDA	ANDA077493	NCS HealthCare of KY, LLC dba Vangard Labs	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8266_a420bf73-8572-47cc-ae35-4e3a51d6611e	0615-8266	HUMAN PRESCRIPTION DRUG	zonisamide		zonisamide	CAPSULE	ORAL	20160713		ANDA	ANDA077869	NCS HealthCare of KY, LLC dba Vangard Labs	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
0615-8267_22545957-98d2-4f38-afdf-04711262196c	0615-8267	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	NCS HealthCare of KY, Inc dba Vangard Labs	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8268_bc6ac7f8-bb01-4a98-b809-cdf6964d415d	0615-8268	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	NCS HealthCare of KY, Inc dba Vangard Labs	MIRTAZAPINE	15	mg/1			N	20241231
0615-8269_bc6ac7f8-bb01-4a98-b809-cdf6964d415d	0615-8269	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	NCS HealthCare of KY, Inc dba Vangard Labs	MIRTAZAPINE	30	mg/1			N	20241231
0615-8270_ba5a6f15-4de9-446b-9cb2-16b58a3d207d	0615-8270	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20180720		ANDA	ANDA210138	NCS HealthCare of KY, Inc dba Vangard Labs	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0615-8272_d7ba45f6-6388-4005-aeef-1737a65026c9	0615-8272	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070975	NCS HealthCare of KY, LLC dba Vangard Labs	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0615-8274_a83694d8-60a8-4386-9196-6c73e17e3ed9	0615-8274	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211	20240131	ANDA	ANDA076416	NCS HealthCare of KY, LLC dba Vangard Labs	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	
0615-8275_bc1cbf1d-80c9-4c44-aa46-9847834c3b4d	0615-8275	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20180716		ANDA	ANDA073607	NCS HealthCare of KY, Inc dba Vangard Labs	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0615-8282_88f5a456-f60e-49ce-92fa-cb7e82f7624b	0615-8282	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110415	20240430	ANDA	ANDA077516	NCS HealthCare of KY, LLC dba Vangard Labs	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
0615-8283_88f5a456-f60e-49ce-92fa-cb7e82f7624b	0615-8283	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110415	20240430	ANDA	ANDA077516	NCS HealthCare of KY, LLC dba Vangard Labs	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
0615-8284_88f5a456-f60e-49ce-92fa-cb7e82f7624b	0615-8284	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110415	20240430	ANDA	ANDA077516	NCS HealthCare of KY, LLC dba Vangard Labs	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
0615-8285_287dcd9d-85eb-4001-8c8a-e688d51e03de	0615-8285	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	NCS HealthCare of KY, LLC dba Vangard Labs	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0615-8288_102140c8-c00e-4498-8e1a-322d5de68198	0615-8288	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20150601		ANDA	ANDA077493	NCS HealthCare of KY, LLC dba Vangard Labs	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8289_4fcd1c71-b491-43ab-97e4-25943ea94f9e	0615-8289	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20130301		ANDA	ANDA201991	NCS HealthCare of KY, LLC dba Vangard Labs	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0615-8290_9cf38d6b-a7e3-4a20-b936-6758f5d2abe4	0615-8290	HUMAN PRESCRIPTION DRUG	Duloxetine hydrochloride		Duloxetin hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211	20240930	ANDA	ANDA090774	NCS HealthCare of KY, LLC dba Vangard Labs	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
0615-8292_dbdc7bbb-bc4d-46f9-829f-0c5444abb915	0615-8292	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009	20240331	ANDA	ANDA077794	NCS HealthCare of KY, LLC dba Vangard Labs	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-8296_ea682f4e-8dce-4696-9931-02a1fd783593	0615-8296	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20160819		ANDA	ANDA206975	NCS HealthCare of KY, Inc dba Vangard Labs	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0615-8298_56e45e90-b2b1-4867-bae8-b913be3c78e1	0615-8298	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET	ORAL	20170606		ANDA	ANDA207210	NCS HealthCare of KY, Inc dba Vangard Labs	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0615-8300_dbab9de3-65c0-404c-9782-3eecc24fd750	0615-8300	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170825		ANDA	ANDA209838	NCS HealthCare of KY, LLC dba Vangard Labs	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
0615-8301_6fd7f190-01fc-450b-a28d-f0e2adefd061	0615-8301	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	NCS HealthCare of KY, LLC dba Vangard Labs	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0615-8302_31aad90c-dab3-4f4d-870d-dab7ab34c9b3	0615-8302	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20091215	20240531	ANDA	ANDA090702	NCS HealthCare of KY, LLC dba Vangard Labs	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	
0615-8303_638f543b-427c-4ab4-83bb-a6782ef09d5b	0615-8303	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine	TABLET	ORAL	20100212	20240331	ANDA	ANDA201451	NCS HealthCare of KY, LLC dba Vangard Labs	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
0615-8305_834b9079-0207-47f4-b520-e0b8071c8f9a	0615-8305	HUMAN PRESCRIPTION DRUG	PENTOXIFYLLINE		PENTOXIFYLLINE	TABLET, EXTENDED RELEASE	ORAL	19990610		ANDA	ANDA075191	NCS HealthCare of KY, LLC dba Vangard Labs	PENTOXIFYLLINE	400	mg/1	Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]		N	20241231
0615-8306_864eb7ba-7f13-4a36-bdad-163d656d115f	0615-8306	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820422	20240731	ANDA	ANDA087800	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0615-8307_0d4f8c24-4daa-4881-81da-0502deba0fd2	0615-8307	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030213	20240731	ANDA	ANDA087342	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0615-8309_cb17d0fb-eb6b-4c47-bdf4-9c125b409027	0615-8309	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA078329	NCS HealthCare of KY, Inc dba Vangard Labs	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0615-8310_4828886c-223e-4642-afdf-68edce25a94f	0615-8310	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA078329	NCS HealthCare of KY, Inc dba Vangard Labs	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0615-8311_4828886c-223e-4642-afdf-68edce25a94f	0615-8311	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	NCS HealthCare of KY, Inc dba Vangard Labs	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0615-8313_bfb616f1-9747-4cb6-9702-0594725c608f	0615-8313	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	NCS HealthCare of KY, Inc dba Vangard Labs	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0615-8318_32979e9e-e084-4693-abdd-adb178c19da6	0615-8318	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19860417		NDA	NDA019123	NCS HealthCare of KY, Inc dba Vangard Labs	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0615-8319_43b61a6b-626f-417c-86ca-043e7bc0e808	0615-8319	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150711		ANDA	ANDA090048	NCS HealthCare of KY, Inc dba Vangard Labs	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0615-8324_cfc90580-5962-48ea-99a0-1dee1d3ea68e	0615-8324	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190601	20240930	OTC MONOGRAPH NOT FINAL	part343	NCS HealthCare of KY, LLC dba Vangard Labs	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
0615-8326_63550e56-a677-40c2-8a06-5e51277c5beb	0615-8326	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	NCS HealthCare of KY, LLC dba Vangard Labs	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8327_63550e56-a677-40c2-8a06-5e51277c5beb	0615-8327	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078182	NCS HealthCare of KY, LLC dba Vangard Labs	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8328_63550e56-a677-40c2-8a06-5e51277c5beb	0615-8328	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	NCS HealthCare of KY, LLC dba Vangard Labs	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8331_24d4d218-b59e-42b3-bd8b-b16d50977ec7	0615-8331	HUMAN OTC DRUG	Senexon-S		Docusate Sodium 50mg and Sennosides 8.6mg	TABLET, FILM COATED	ORAL	20191002		OTC MONOGRAPH NOT FINAL	part334	NCS HealthCare of KY, LLC dba Vangard Labs	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0615-8332_18f8ad9b-20d5-47ea-ad3a-9b2a7e3a4dd8	0615-8332	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	NCS HealthCare of KY, Inc dba Vangard Labs	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0615-8333_18f8ad9b-20d5-47ea-ad3a-9b2a7e3a4dd8	0615-8333	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	NCS HealthCare of KY, Inc dba Vangard Labs	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0615-8334_18f8ad9b-20d5-47ea-ad3a-9b2a7e3a4dd8	0615-8334	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	NCS HealthCare of KY, Inc dba Vangard Labs	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0615-8338_efff08d1-657d-453a-96e9-08ca5a05288c	0615-8338	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20191209		ANDA	ANDA202240	NCS HealthCare of KY, Inc dba Vangard Labs	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0615-8339_d28f23b8-dd17-480a-b961-1db8a2c0ac2b	0615-8339	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200311		ANDA	ANDA071525	NCS HealthCare of KY, LLC dba Vangard Labs	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0615-8340_d113f5d6-35ad-4e03-8ccd-04db9aa7a418	0615-8340	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124	20240531	ANDA	ANDA078428	NCS HealthCare of KY, LLC dba Vangard Labs	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-8341_d113f5d6-35ad-4e03-8ccd-04db9aa7a418	0615-8341	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124	20240430	ANDA	ANDA078428	NCS HealthCare of KY, LLC dba Vangard Labs	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-8342_d113f5d6-35ad-4e03-8ccd-04db9aa7a418	0615-8342	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124	20240531	ANDA	ANDA078428	NCS HealthCare of KY, LLC dba Vangard Labs	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
0615-8344_15a34378-fa04-4f29-9e10-19312c2b2761	0615-8344	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0615-8346_41a6941d-eb7b-4a2c-a46c-90e6e7b0aa2a	0615-8346	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20060804		ANDA	ANDA076690	NCS HealthCare of KY, LLC dba Vangard Labs	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0615-8354_41a6e05c-7bec-43e1-803c-e600dce780fc	0615-8354	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	NCS HealthCare of KY, LLC dba Vangard Labs	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
0615-8355_b8ec203d-2574-4472-88ed-4aefbbeb15e2	0615-8355	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	NCS HealthCare of KY, Inc dba Vangard Labs	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0615-8359_d04ea3ee-ed50-48ca-8226-fb2d029053f3	0615-8359	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	NCS HealthCare of KY, LLC dba Vangard Labs	PAROXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8360_a83694d8-60a8-4386-9196-6c73e17e3ed9	0615-8360	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211	20240131	ANDA	ANDA076416	NCS HealthCare of KY, LLC dba Vangard Labs	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	
0615-8364_346569cd-c999-4cab-9e4f-fb010f411a7d	0615-8364	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20160726		ANDA	ANDA203135	NCS HealthCare of KY, Inc dba Vangard Labs	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0615-8368_57f53f08-21a6-4f83-8f93-4f779ffda358	0615-8368	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	NCS HealthCare of KY, LLC dba Vangard Labs	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0615-8369_57f53f08-21a6-4f83-8f93-4f779ffda358	0615-8369	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	NCS HealthCare of KY, LLC dba Vangard Labs	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0615-8370_57f53f08-21a6-4f83-8f93-4f779ffda358	0615-8370	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	NCS HealthCare of KY, LLC dba Vangard Labs	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0615-8371_d28f23b8-dd17-480a-b961-1db8a2c0ac2b	0615-8371	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA071523	NCS HealthCare of KY, LLC dba Vangard Labs	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0615-8372_df64fdd3-c7fc-46aa-9691-ae2a44453280	0615-8372	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	NCS HealthCare of KY, LLC dba Vangard Labs	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8373_df64fdd3-c7fc-46aa-9691-ae2a44453280	0615-8373	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	NCS HealthCare of KY, LLC dba Vangard Labs	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8375_e8de660c-3ea9-489c-aca4-8b7c6e3f428f	0615-8375	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200316		ANDA	ANDA206383	NCS HealthCare of KY, LLC dba Vangard Labs	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8376_bef8ceca-9764-458c-988c-66cbb318b011	0615-8376	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20200918		ANDA	ANDA209286	NCS HealthCare of KY, LLC dba Vangard Labs	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8377_bef8ceca-9764-458c-988c-66cbb318b011	0615-8377	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20200918		ANDA	ANDA209286	NCS HealthCare of KY, LLC dba Vangard Labs	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8379_29e2c555-ccf6-43ff-a3f1-88a03ac8d3a4	0615-8379	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	NCS HealthCare of KY, LLC dba Vangard Labs	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0615-8380_29e2c555-ccf6-43ff-a3f1-88a03ac8d3a4	0615-8380	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	NCS HealthCare of KY, LLC dba Vangard Labs	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0615-8381_29e2c555-ccf6-43ff-a3f1-88a03ac8d3a4	0615-8381	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	NCS HealthCare of KY, LLC dba Vangard Labs	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0615-8382_c4131825-9146-4295-b501-ba62e3804b80	0615-8382	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200810	20240430	ANDA	ANDA212774	NCS HealthCare of KY, LLC dba Vangard Labs	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
0615-8383_c4131825-9146-4295-b501-ba62e3804b80	0615-8383	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200810	20240430	ANDA	ANDA212774	NCS HealthCare of KY, LLC dba Vangard Labs	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
0615-8384_c4131825-9146-4295-b501-ba62e3804b80	0615-8384	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200810	20240228	ANDA	ANDA212774	NCS HealthCare of KY, LLC dba Vangard Labs	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
0615-8385_1d731934-d867-499f-bfd6-e155e9aa1ec1	0615-8385	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	NCS HealthCare of KY, LLC dba Vangard Labs	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0615-8386_2ea4d9fc-8447-4b24-91f0-2ebfd0044781	0615-8386	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		trazodone hydrochloride	TABLET	ORAL	20201008		ANDA	ANDA071524	NCS HealthCare of KY, LLC dba Vangard Labs	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0615-8387_4956de7d-1edf-4386-bb70-6a6f5ae5926d	0615-8387	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	NCS HealthCare of KY, LLC dba Vangard Labs	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8388_4956de7d-1edf-4386-bb70-6a6f5ae5926d	0615-8388	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	NCS HealthCare of KY, LLC dba Vangard Labs	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8389_4956de7d-1edf-4386-bb70-6a6f5ae5926d	0615-8389	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	NCS HealthCare of KY, LLC dba Vangard Labs	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8390_4956de7d-1edf-4386-bb70-6a6f5ae5926d	0615-8390	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	NCS HealthCare of KY, LLC dba Vangard Labs	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8391_cf6fd1f9-5c11-40a4-96de-0172ad61d7e7	0615-8391	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200323	20240630	ANDA	ANDA084122	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0615-8393_c668c601-2ff2-44e3-be29-c3193902b91c	0615-8393	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	NCS HealthCare of KY, LLC dba Vangard Labs	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0615-8394_c668c601-2ff2-44e3-be29-c3193902b91c	0615-8394	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	NCS HealthCare of KY, LLC dba Vangard Labs	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0615-8395_cf6fd1f9-5c11-40a4-96de-0172ad61d7e7	0615-8395	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200323	20240731	ANDA	ANDA080352	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0615-8396_9390ea89-da4b-4f8d-a51d-b36174723a66	0615-8396	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160421		ANDA	ANDA205606	NCS HealthCare of KY, LLC dba Vangard Labs	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0615-8397_224b3b3d-1dc4-457c-b6a8-6ee82498daf6	0615-8397	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20111215		OTC MONOGRAPH NOT FINAL	part343	NCS HealthCare of KY, LLC dba Vangard Labs	ACETAMINOPHEN	325	mg/1			N	20241231
0615-8398_bee08ab5-e196-44f5-af0c-f94848b9114e	0615-8398	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20111215		OTC MONOGRAPH NOT FINAL	part343	NCS HealthCare of KY, LLC dba Vangard Labs	ACETAMINOPHEN	325	mg/1			N	20241231
0615-8399_8b6f8895-cd05-476f-9f83-a2a559c38910	0615-8399	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	NCS HealthCare of KY, LLC dba Vangard Labs	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0615-8400_8b6f8895-cd05-476f-9f83-a2a559c38910	0615-8400	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	NCS HealthCare of KY, LLC dba Vangard Labs	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0615-8402_d0a866cf-38b7-4b64-ae5d-426236f3e148	0615-8402	HUMAN OTC DRUG	SENNA TIME		SENNOSIDES	TABLET, COATED	ORAL	20120514		OTC MONOGRAPH NOT FINAL	part334	NCS HealthCare of KY, LLC dba Vangard Labs	SENNOSIDES A AND B	8.6	mg/1			N	20241231
0615-8403_4de09bb9-93bd-4b64-8742-7123a821bb01	0615-8403	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20161210		ANDA	ANDA091133	NCS HealthCare of KY, LLC dba Vangard Labs	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
0615-8405_c00edbc4-4747-4419-816f-a54b91970a08	0615-8405	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210601		ANDA	ANDA077321	NCS HealthCare of KY, LLC dba Vangard Labs	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0615-8406_964d2c33-7da1-4120-aefe-0787a6880fca	0615-8406	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190220		ANDA	ANDA212977	NCS HealthCare of KY, LLC dba Vangard Labs	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0615-8407_7d1ee79a-1187-4d20-a572-15989eddfe78	0615-8407	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	NCS HealthCare of KY, LLC dba Vangard Labs	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0615-8408_7d1ee79a-1187-4d20-a572-15989eddfe78	0615-8408	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	NCS HealthCare of KY, LLC dba Vangard Labs	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0615-8409_9b225569-29ee-47e6-9303-c90b3620258a	0615-8409	HUMAN OTC DRUG	ACETAMINOPHEN	Extra Strength	ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20110718		OTC MONOGRAPH DRUG	M013	NCS HealthCare of KY, LLC dba Vangard Labs	ACETAMINOPHEN	500	mg/1			N	20241231
0615-8410_3179a670-fe5e-47bc-b1ce-db4be693131f	0615-8410	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20071228		ANDA	ANDA077987	NCS HealthCare of KY, LLC dba Vangard Labs	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0615-8411_5ad6a02a-c00e-4e42-956e-1829f76a5f67	0615-8411	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20071026	20240131	ANDA	ANDA077971	NCS HealthCare of KY, LLC dba Vangard Labs	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
0615-8412_5ad6a02a-c00e-4e42-956e-1829f76a5f67	0615-8412	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20071027	20240131	ANDA	ANDA077971	NCS HealthCare of KY, LLC dba Vangard Labs	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
0615-8413_9d2969f1-7728-4607-8295-905db53454f4	0615-8413	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071972	NCS HealthCare of KY, LLC dba Vangard Labs	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8414_7c47b349-b0f2-45c0-a6f5-68ea5375c676	0615-8414	HUMAN OTC DRUG	LOW DOSE ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20150619		OTC MONOGRAPH NOT FINAL	part343	NCS HealthCare of KY, LLC dba Vangard Labs	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0615-8416_468ff122-2757-4fa7-a726-4ff2bf52bf17	0615-8416	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA210015	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0615-8417_9d2969f1-7728-4607-8295-905db53454f4	0615-8417	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071972	NCS HealthCare of KY, LLC dba Vangard Labs	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8418_468ff122-2757-4fa7-a726-4ff2bf52bf17	0615-8418	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA210015	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0615-8419_b805a16f-99e8-4e22-902a-6eed48d51d4d	0615-8419	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0615-8420_b805a16f-99e8-4e22-902a-6eed48d51d4d	0615-8420	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960615		ANDA	ANDA040156	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0615-8421_9005604c-ad83-4ac9-af01-6a6f8d7310dd	0615-8421	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20160731		ANDA	ANDA202871	NCS HealthCare of KY, LLC dba Vangard Labs	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8422_9005604c-ad83-4ac9-af01-6a6f8d7310dd	0615-8422	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20160731		ANDA	ANDA202871	NCS HealthCare of KY, LLC dba Vangard Labs	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8423_9005604c-ad83-4ac9-af01-6a6f8d7310dd	0615-8423	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20160731		ANDA	ANDA202871	NCS HealthCare of KY, LLC dba Vangard Labs	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8424_f85591e3-60f7-46b4-b12d-f0c53e726d3f	0615-8424	HUMAN PRESCRIPTION DRUG	Phenytoin Infatabs		Phenytoin	TABLET, CHEWABLE	ORAL	20211123		ANDA	ANDA084427	NCS HealthCare of KY, LLC dba Vangard Labs	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8425_44247293-9cac-4af2-b6f0-ed7f4be4b706	0615-8425	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20211004		ANDA	ANDA215486	NCS HealthCare of KY, LLC dba Vangard Labs	ACETAMINOPHEN	650	mg/1			N	20241231
0615-8426_7d962a47-0d3b-4687-b78b-23683fc1dc25	0615-8426	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071972	NCS HealthCare of KY, LLC dba Vangard Labs	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0615-8427_51997f6c-1b2c-4294-b4e7-776cc2fc0c4d	0615-8427	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20220307	20241031	ANDA	ANDA040625	NCS HealthCare of KY, LLC dba Vangard Labs	FOLIC ACID	1	mg/1			N	
0615-8428_975f2a30-bec6-4376-945a-e166a93557a0	0615-8428	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		oxybutynin chloride	TABLET	ORAL	20220404	20240131	ANDA	ANDA075079	NCS HealthCare of KY, LLC dba Vangard Labs	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
0615-8429_7919604c-a649-44d5-b948-a28937e36981	0615-8429	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	NCS HealthCare of KY, LLC dba Vangard Labs	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0615-8430_7919604c-a649-44d5-b948-a28937e36981	0615-8430	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	NCS HealthCare of KY, LLC dba Vangard Labs	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0615-8431_7919604c-a649-44d5-b948-a28937e36981	0615-8431	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	NCS HealthCare of KY, LLC dba Vangard Labs	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0615-8434_472fe641-6d11-4487-984f-2dc6a8f2678f	0615-8434	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170217		ANDA	ANDA202330	NCS HealthCare of KY, LLC dba Vangard Labs	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20251231
0615-8435_0e59d5f1-51d3-4d80-98e1-99345cd00d16	0615-8435	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET, FILM COATED	ORAL	20170208		ANDA	ANDA203550	NCS HealthCare of KY, LLC dba Vangard Labs	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0615-8436_b3267e03-8d59-4b8c-97e1-194b034eec49	0615-8436	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET, FILM COATED	ORAL	20170208		ANDA	ANDA203550	NCS HealthCare of KY, LLC dba Vangard Labs	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0615-8438_747ce29b-7a16-4275-9462-105f49545e89	0615-8438	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA210785	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0615-8439_cdfb3f3c-f9c8-402c-933d-c2bf6600b213	0615-8439	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20210804		ANDA	ANDA213385	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0615-8440_ba9b376d-3732-4446-9fa2-8a5a94123f0f	0615-8440	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0615-8441_ba9b376d-3732-4446-9fa2-8a5a94123f0f	0615-8441	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	NCS HealthCare of KY, LLC dba Vangard Labs	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0615-8442_25feb98a-94bb-49d8-a8ba-dbeff49383d3	0615-8442	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20210301		ANDA	ANDA214686	NCS HealthCare of KY, LLC dba Vangard Labs	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0615-8443_fe30f79c-2f8b-4411-872a-977c2726eee0	0615-8443	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	NCS HealthCare of KY, LLC dba Vangard Labs	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0615-8444_fe30f79c-2f8b-4411-872a-977c2726eee0	0615-8444	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	NCS HealthCare of KY, LLC dba Vangard Labs	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0615-8445_fe30f79c-2f8b-4411-872a-977c2726eee0	0615-8445	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	NCS HealthCare of KY, LLC dba Vangard Labs	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0615-8447_73e5a4f5-ce06-4fe7-a531-fd2739d12967	0615-8447	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20220111		ANDA	ANDA215939	NCS HealthCare of KY, LLC dba Vangard Labs	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8448_73e5a4f5-ce06-4fe7-a531-fd2739d12967	0615-8448	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20220111		ANDA	ANDA215939	NCS HealthCare of KY, LLC dba Vangard Labs	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0615-8449_b64d794a-1066-4f51-bea8-e9d7aa4fb5da	0615-8449	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20191101		ANDA	ANDA040702	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0615-8450_dffa477a-6ab3-4c52-aa0a-f11b90a00d0d	0615-8450	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0615-8451_29045e68-ef37-4fbe-b405-0978e18fb7af	0615-8451	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20191213		ANDA	ANDA202187	NCS HealthCare of KY, LLC dba Vangard Labs	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0615-8452_29045e68-ef37-4fbe-b405-0978e18fb7af	0615-8452	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	NCS HealthCare of KY, LLC dba Vangard Labs	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0615-8459_bad86613-5c66-450f-9145-52355cbd3f31	0615-8459	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	NCS HealthCare of KY, LLC dba Vangard Labs	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
0615-8460_2bb3a6de-4059-4d9c-b671-04b0a8230189	0615-8460	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20211005		ANDA	ANDA214091	NCS HealthCare of KY, LLC dba Vangard Labs	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0615-8461_2bb3a6de-4059-4d9c-b671-04b0a8230189	0615-8461	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20211005		ANDA	ANDA214091	NCS HealthCare of KY, LLC dba Vangard Labs	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0615-8462_115da2dd-0807-44a8-a1b1-ebeb7aa1dd72	0615-8462	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220422		ANDA	ANDA201451	NCS HealthCare of KY, LLC dba Vangard Labs	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0615-8463_e52655b8-2c52-4534-9f86-bb70ebff3321	0615-8463	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	NCS HealthCare of KY, LLC dba Vangard Labs	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0615-8464_e52655b8-2c52-4534-9f86-bb70ebff3321	0615-8464	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	NCS HealthCare of KY, LLC dba Vangard Labs	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0615-8465_e52655b8-2c52-4534-9f86-bb70ebff3321	0615-8465	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	NCS HealthCare of KY, LLC dba Vangard Labs	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0615-8466_9c2e25e4-823f-4ac2-82f4-674049807af5	0615-8466	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	NCS HealthCare of KY, LLC dba Vangard Labs	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0615-8467_9c2e25e4-823f-4ac2-82f4-674049807af5	0615-8467	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	NCS HealthCare of KY, LLC dba Vangard Labs	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0615-8468_316614ae-5121-4c42-ba7c-12f097241926	0615-8468	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20210304		ANDA	ANDA208187	NCS HealthCare of KY, LLC dba Vangard Labs	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0615-8469_316614ae-5121-4c42-ba7c-12f097241926	0615-8469	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20210304		ANDA	ANDA208187	NCS HealthCare of KY, LLC dba Vangard Labs	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0615-8470_85a1fb6b-f51d-4273-bd83-a35c032b0985	0615-8470	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8471_85a1fb6b-f51d-4273-bd83-a35c032b0985	0615-8471	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8472_85a1fb6b-f51d-4273-bd83-a35c032b0985	0615-8472	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8473_85a1fb6b-f51d-4273-bd83-a35c032b0985	0615-8473	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8474_85a1fb6b-f51d-4273-bd83-a35c032b0985	0615-8474	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	NCS HealthCare of KY, LLC dba Vangard Labs	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0615-8475_4fe53d91-8138-4a08-8cd2-b7d7aa30d300	0615-8475	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	NCS HealthCare of KY, LLC dba Vangard Labs	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8476_4fe53d91-8138-4a08-8cd2-b7d7aa30d300	0615-8476	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	NCS HealthCare of KY, LLC dba Vangard Labs	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8477_356b8a10-241f-41e7-96fe-57590f373800	0615-8477	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	NCS HealthCare of KY, LLC dba Vangard Labs	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8478_d9240af9-8ac7-4b12-8746-d1b261b634d3	0615-8478	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	NCS HealthCare of KY, LLC dba Vangard Labs	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0615-8479_7547cc87-e90e-4b66-ae51-a2e6ed325e33	0615-8479	HUMAN OTC DRUG	Cetirizine hydrochloride		Cetirizine hydrochloride	TABLET, COATED	ORAL	20220113		ANDA	ANDA209274	NCS HealthCare of KY, LLC dba Vangard Labs	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0615-8480_01fffc2d-591d-4a52-b659-7837eabd163a	0615-8480	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20090203		ANDA	ANDA079139	NCS HealthCare of KY, LLC dba Vangard Labs	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
0615-8482_4bccc188-4819-41c1-9d49-4fdc45d9dd36	0615-8482	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	NCS HealthCare of KY, LLC dba Vangard Labs	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0615-8483_8ff07322-ec3d-42fd-b615-50d8fc52ec8d	0615-8483	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	19970228		ANDA	ANDA040204	NCS HealthCare of KY, LLC dba Vangard Labs	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0615-8485_f508fbff-6588-4edf-9a94-bc1e8713a305	0615-8485	HUMAN PRESCRIPTION DRUG	Sertraline hydrochloride		Sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA078403	NCS HealthCare of KY, LLC dba Vangard Labs	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8486_f508fbff-6588-4edf-9a94-bc1e8713a305	0615-8486	HUMAN PRESCRIPTION DRUG	Sertraline hydrochloride		Sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA078403	NCS HealthCare of KY, LLC dba Vangard Labs	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8487_f508fbff-6588-4edf-9a94-bc1e8713a305	0615-8487	HUMAN PRESCRIPTION DRUG	Sertraline hydrochloride		Sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA078403	NCS HealthCare of KY, LLC dba Vangard Labs	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0615-8488_0082e5c3-40e5-49ba-b6cd-9bb9058f66a2	0615-8488	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220422		ANDA	ANDA201451	NCS HealthCare of KY, LLC dba Vangard Labs	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0615-8489_638be761-770a-4310-9296-00aa4a184425	0615-8489	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	NCS HealthCare of KY, LLC dba Vangard Labs	MIRTAZAPINE	7.5	mg/1			N	20241231
0615-8490_60d0d388-28b7-4144-bf00-9a06456de7d1	0615-8490	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220907		ANDA	ANDA214654	NCS HealthCare of KY, LLC dba Vangard Labs	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0615-8491_60d0d388-28b7-4144-bf00-9a06456de7d1	0615-8491	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220907		ANDA	ANDA214654	NCS HealthCare of KY, LLC dba Vangard Labs	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0615-8492_126741bf-877c-4f91-a0e0-a2378747e33b	0615-8492	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20191101		ANDA	ANDA212798	NCS HealthCare of KY, LLC dba Vangard Labs	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0615-8493_c51a051a-1c3d-4ff7-ae15-d95b553f19af	0615-8493	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20200421		ANDA	ANDA207798	NCS HealthCare of KY, LLC dba Vangard Labs	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0615-8494_556bdb20-19a9-49b0-9c5b-6cd6e56465e1	0615-8494	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	NCS HealthCare of KY, LLC dba Vangard Labs	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
0615-8495_556bdb20-19a9-49b0-9c5b-6cd6e56465e1	0615-8495	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	NCS HealthCare of KY, LLC dba Vangard Labs	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
0615-8496_556bdb20-19a9-49b0-9c5b-6cd6e56465e1	0615-8496	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	NCS HealthCare of KY, LLC dba Vangard Labs	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
0641-0121_b58ab10f-f9d0-4cea-966d-9fe9acf49b03	0641-0121	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19720101		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-0367_170a32e9-fea2-4e2b-95f2-bdd9b78cb615	0641-0367	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19820907		ANDA	ANDA087702	Hikma Pharmaceuticals USA Inc.	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0641-0376_bb796e58-4ee5-4fa7-9e48-6cb8bd7856f4	0641-0376	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		diphenhydramine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19721127		ANDA	ANDA080817	Hikma Pharmaceuticals USA Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0641-0391_9102e900-98b0-4afa-b6af-e1908e81f08f	0641-0391	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19720322		NDA	NDA017037	Hikma Pharmaceuticals USA Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0641-0400_9102e900-98b0-4afa-b6af-e1908e81f08f	0641-0400	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19720322		NDA	NDA017037	Hikma Pharmaceuticals USA Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0641-0410_9102e900-98b0-4afa-b6af-e1908e81f08f	0641-0410	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19720322		NDA	NDA017037	Hikma Pharmaceuticals USA Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0641-0476_333131f0-ddec-453b-96ed-63eadb2f0785	0641-0476	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19710101		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
0641-0477_333131f0-ddec-453b-96ed-63eadb2f0785	0641-0477	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19710101		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
0641-0493_55067035-de2c-4f9f-966f-ec808d91bb44	0641-0493	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750716		ANDA	ANDA084307	Hikma Pharmaceuticals USA Inc.	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0641-0497_4f9d3415-3574-4534-bf30-3790e69ae94a	0641-0497	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20130924		ANDA	ANDA201833	Hikma Pharmaceuticals USA Inc.	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0641-0928_5509eac1-ecc4-4054-86cd-3adb966b525c	0641-0928	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-0929_5509eac1-ecc4-4054-86cd-3adb966b525c	0641-0929	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-0948_9faeadf4-f725-4824-ba09-0f62d9e56d29	0641-0948	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-0949_9faeadf4-f725-4824-ba09-0f62d9e56d29	0641-0949	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-0955_b23fbdf9-8e5a-4fde-af63-acc133fa0324	0641-0955	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-0956_b23fbdf9-8e5a-4fde-af63-acc133fa0324	0641-0956	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-1397_57bd8481-79f8-4abb-afd6-188dabe98e0e	0641-1397	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	INJECTION	INTRAMUSCULAR	19740725		ANDA	ANDA083329	Hikma Pharmaceuticals USA Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-1398_57bd8481-79f8-4abb-afd6-188dabe98e0e	0641-1398	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	INJECTION	INTRAMUSCULAR	19740725		ANDA	ANDA083329	Hikma Pharmaceuticals USA Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-1410_af8ee3fb-f285-444c-9b7a-460ab74186f6	0641-1410	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19751024		ANDA	ANDA083391	Hikma Pharmaceuticals USA Inc.	DIGOXIN	.25	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0641-1495_4d1021e8-da0c-4762-ac7a-b964b1dc697e	0641-1495	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-1496_4d1021e8-da0c-4762-ac7a-b964b1dc697e	0641-1496	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-1512_90d2e8c2-7688-4a7d-9a1c-009f4a7e159c	0641-1512	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20120120		ANDA	ANDA201850	Hikma Pharmaceuticals USA Inc.	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0641-2341_b58ab10f-f9d0-4cea-966d-9fe9acf49b03	0641-2341	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19720101		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-2450_9102e900-98b0-4afa-b6af-e1908e81f08f	0641-2450	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19720322		NDA	NDA017037	Hikma Pharmaceuticals USA Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0641-2460_9102e900-98b0-4afa-b6af-e1908e81f08f	0641-2460	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19720322		NDA	NDA017037	Hikma Pharmaceuticals USA Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0641-2555_55067035-de2c-4f9f-966f-ec808d91bb44	0641-2555	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750716		ANDA	ANDA084307	Hikma Pharmaceuticals USA Inc.	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0641-2569_efbdae4d-b42f-4264-99b6-c4c14e4ed219	0641-2569	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	INJECTION	INTRAVENOUS	19961018		ANDA	ANDA074521	Hikma Pharmaceuticals USA Inc.	DIPYRIDAMOLE	5	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
0641-6000_209b0091-c890-4f69-a693-d0594c2606fe	0641-6000	HUMAN PRESCRIPTION DRUG	Ativan		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6001_209b0091-c890-4f69-a693-d0594c2606fe	0641-6001	HUMAN PRESCRIPTION DRUG	Ativan		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6002_209b0091-c890-4f69-a693-d0594c2606fe	0641-6002	HUMAN PRESCRIPTION DRUG	Ativan		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	4	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6003_209b0091-c890-4f69-a693-d0594c2606fe	0641-6003	HUMAN PRESCRIPTION DRUG	Ativan		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	4	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6006_ae95ec35-b992-4aa2-9fca-8e0ddc537fbc	0641-6006	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19710101		UNAPPROVED DRUG OTHER		Hikma Pharmaceuticals USA Inc.	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0641-6007_8d47d604-ae67-409c-b7f1-2ee204ea8cdd	0641-6007	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20080430		ANDA	ANDA079196	Hikma Pharmaceuticals USA Inc.	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0641-6008_8d47d604-ae67-409c-b7f1-2ee204ea8cdd	0641-6008	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20080430		ANDA	ANDA079196	Hikma Pharmaceuticals USA Inc.	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0641-6013_8c9d43bf-227c-4498-897b-c4deb1d49fd9	0641-6013	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	INJECTION	INTRAVENOUS	20081217		ANDA	ANDA078538	Hikma Pharmaceuticals USA Inc.	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0641-6014_8c9d43bf-227c-4498-897b-c4deb1d49fd9	0641-6014	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	INJECTION	INTRAVENOUS	20081217		ANDA	ANDA078538	Hikma Pharmaceuticals USA Inc.	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0641-6015_8c9d43bf-227c-4498-897b-c4deb1d49fd9	0641-6015	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	INJECTION	INTRAVENOUS	20081217		ANDA	ANDA078538	Hikma Pharmaceuticals USA Inc.	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0641-6018_3860168c-32e9-4151-b08e-25d4bbac75b6	0641-6018	HUMAN PRESCRIPTION DRUG	Dopram		Doxapram hydrochloride	INJECTION	INTRAVENOUS	19650623		NDA	NDA014879	Hikma Pharmaceuticals USA Inc.	DOXAPRAM HYDROCHLORIDE	20	mg/mL	Increased Medullary Respiratory Drive [PE], Respiratory Stimulant [EPC]		N	20241231
0641-6019_423b55d6-92db-4e29-a31b-279a6bafbd12	0641-6019	HUMAN PRESCRIPTION DRUG	Duramorph		morphine sulfate	INJECTION	EPIDURAL; INTRATHECAL; INTRAVENOUS	19840918		NDA	NDA018565	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6020_423b55d6-92db-4e29-a31b-279a6bafbd12	0641-6020	HUMAN PRESCRIPTION DRUG	Duramorph		morphine sulfate	INJECTION	EPIDURAL; INTRATHECAL; INTRAVENOUS	19840918		NDA	NDA018565	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	.5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6021_4a84b9ad-8be0-4b70-b5a5-dda3dd3cb934	0641-6021	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20010416		ANDA	ANDA075488	Hikma Pharmaceuticals USA Inc.	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0641-6022_4a84b9ad-8be0-4b70-b5a5-dda3dd3cb934	0641-6022	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20010416		ANDA	ANDA075486	Hikma Pharmaceuticals USA Inc.	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0641-6023_4a84b9ad-8be0-4b70-b5a5-dda3dd3cb934	0641-6023	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20010416		ANDA	ANDA075488	Hikma Pharmaceuticals USA Inc.	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0641-6024_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6024	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19840711		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6025_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6025	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19840711		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6026_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6026	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAVENOUS	19840711		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6027_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6027	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19840711		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6028_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6028	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19840711		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6029_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6029	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAVENOUS	19840711		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6030_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6030	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAVENOUS	19840711		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6039_0887deed-4775-4cb6-9721-40966a7d0e0e	0641-6039	HUMAN PRESCRIPTION DRUG	INFUMORPH 200		morphine sulfate	INJECTION, SOLUTION	EPIDURAL; INTRATHECAL	19840918		NDA	NDA018565	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6040_0887deed-4775-4cb6-9721-40966a7d0e0e	0641-6040	HUMAN PRESCRIPTION DRUG	INFUMORPH 500		morphine sulfate	INJECTION, SOLUTION	EPIDURAL; INTRATHECAL	19840918		NDA	NDA018565	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	25	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6041_042c80ac-42f9-4f7a-bc40-f61d8e65449c	0641-6041	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20040721		ANDA	ANDA075772	Hikma Pharmaceuticals USA Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0641-6042_042c80ac-42f9-4f7a-bc40-f61d8e65449c	0641-6042	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20040721		ANDA	ANDA075772	Hikma Pharmaceuticals USA Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0641-6043_042c80ac-42f9-4f7a-bc40-f61d8e65449c	0641-6043	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR	20040721		ANDA	ANDA075772	Hikma Pharmaceuticals USA Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0641-6044_2297cbcd-0026-412e-8186-1816b34c1d67	0641-6044	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6045_2297cbcd-0026-412e-8186-1816b34c1d67	0641-6045	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	4	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6046_2297cbcd-0026-412e-8186-1816b34c1d67	0641-6046	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6047_2297cbcd-0026-412e-8186-1816b34c1d67	0641-6047	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	4	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6048_a9ea858c-17d9-4847-b06b-f7137f43c555	0641-6048	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6049_a9ea858c-17d9-4847-b06b-f7137f43c555	0641-6049	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	4	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6050_a9ea858c-17d9-4847-b06b-f7137f43c555	0641-6050	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6051_a9ea858c-17d9-4847-b06b-f7137f43c555	0641-6051	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	4	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6052_00ed6237-13d3-4b65-9c85-2150da384655	0641-6052	HUMAN PRESCRIPTION DRUG	MEPERIDINE HYDROCHLORIDE		MEPERIDINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19750122		ANDA	ANDA080445	Hikma Pharmaceuticals USA Inc.	MEPERIDINE HYDROCHLORIDE	25	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6053_00ed6237-13d3-4b65-9c85-2150da384655	0641-6053	HUMAN PRESCRIPTION DRUG	MEPERIDINE HYDROCHLORIDE		MEPERIDINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19750122		ANDA	ANDA080445	Hikma Pharmaceuticals USA Inc.	MEPERIDINE HYDROCHLORIDE	50	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6054_00ed6237-13d3-4b65-9c85-2150da384655	0641-6054	HUMAN PRESCRIPTION DRUG	MEPERIDINE HYDROCHLORIDE		MEPERIDINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19750122		ANDA	ANDA080445	Hikma Pharmaceuticals USA Inc.	MEPERIDINE HYDROCHLORIDE	100	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6056_8f27f4cd-9fb6-40e7-9a09-b0d71b78f3f1	0641-6056	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6057_8f27f4cd-9fb6-40e7-9a09-b0d71b78f3f1	0641-6057	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6059_8f27f4cd-9fb6-40e7-9a09-b0d71b78f3f1	0641-6059	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6060_8f27f4cd-9fb6-40e7-9a09-b0d71b78f3f1	0641-6060	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6061_8f27f4cd-9fb6-40e7-9a09-b0d71b78f3f1	0641-6061	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6063_8f27f4cd-9fb6-40e7-9a09-b0d71b78f3f1	0641-6063	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6078_fadd37e8-7644-4e9e-a0a5-98624aeb27af	0641-6078	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA077541	Hikma Pharmaceuticals USA Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0641-6079_fadd37e8-7644-4e9e-a0a5-98624aeb27af	0641-6079	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA077365	Hikma Pharmaceuticals USA Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0641-6080_087786a1-41da-456d-9980-8eb737b89646	0641-6080	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA077541	Hikma Pharmaceuticals USA Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0641-6082_e134cda8-8ad2-4863-906b-83e57303806c	0641-6082	HUMAN PRESCRIPTION DRUG	PHENERGAN		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-6083_e134cda8-8ad2-4863-906b-83e57303806c	0641-6083	HUMAN PRESCRIPTION DRUG	PHENERGAN		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-6084_bc2d8f01-1268-4bb2-8db9-793866d32782	0641-6084	HUMAN PRESCRIPTION DRUG	PHENERGAN		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-6085_bc2d8f01-1268-4bb2-8db9-793866d32782	0641-6085	HUMAN PRESCRIPTION DRUG	PHENERGAN		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-6103_efa673f6-8613-4883-ac78-22aa123928ee	0641-6103	HUMAN PRESCRIPTION DRUG	ROBAXIN		methocarbamol	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19590616		NDA	NDA011790	Hikma Pharmaceuticals USA Inc.	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0641-6104_e4a973a8-5fc7-43d8-9bbe-14ce4cb7ded2	0641-6104	HUMAN PRESCRIPTION DRUG	Robinul		Robinul	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750206		NDA	NDA017558	West-Ward Pharmaceuticals Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0641-6105_e4a973a8-5fc7-43d8-9bbe-14ce4cb7ded2	0641-6105	HUMAN PRESCRIPTION DRUG	Robinul		Robinul	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750206		NDA	NDA017558	West-Ward Pharmaceuticals Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0641-6106_e4a973a8-5fc7-43d8-9bbe-14ce4cb7ded2	0641-6106	HUMAN PRESCRIPTION DRUG	Robinul		Robinul	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750206		NDA	NDA017558	West-Ward Pharmaceuticals Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0641-6107_e4a973a8-5fc7-43d8-9bbe-14ce4cb7ded2	0641-6107	HUMAN PRESCRIPTION DRUG	Robinul		Robinul	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750206		NDA	NDA017558	West-Ward Pharmaceuticals Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0641-6110_469744fe-e76e-488f-acb4-57a75ecb4f59	0641-6110	HUMAN PRESCRIPTION DRUG	Sufentanil Citrate		Sufentanil Citrate	INJECTION	EPIDURAL; INTRAVENOUS	19951215		ANDA	ANDA074413	West-Ward Pharmaceuticals Corp.	SUFENTANIL CITRATE	.05	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6111_469744fe-e76e-488f-acb4-57a75ecb4f59	0641-6111	HUMAN PRESCRIPTION DRUG	Sufentanil Citrate		Sufentanil Citrate	INJECTION	EPIDURAL; INTRAVENOUS	19951215		ANDA	ANDA074413	West-Ward Pharmaceuticals Corp.	SUFENTANIL CITRATE	.05	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6112_469744fe-e76e-488f-acb4-57a75ecb4f59	0641-6112	HUMAN PRESCRIPTION DRUG	Sufentanil Citrate		Sufentanil Citrate	INJECTION	EPIDURAL; INTRAVENOUS	19951215		ANDA	ANDA074413	West-Ward Pharmaceuticals Corp.	SUFENTANIL CITRATE	.05	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6114_43bde17d-d249-4ad7-9136-a4ecd9dc648d	0641-6114	HUMAN PRESCRIPTION DRUG	Oxytocin		Oxytocin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800429		NDA	NDA018243	Hikma Pharmaceuticals USA Inc.	OXYTOCIN	10	[USP'U]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
0641-6115_43bde17d-d249-4ad7-9136-a4ecd9dc648d	0641-6115	HUMAN PRESCRIPTION DRUG	Oxytocin		Oxytocin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800429		NDA	NDA018243	Hikma Pharmaceuticals USA Inc.	OXYTOCIN	10	[USP'U]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
0641-6116_74a61772-ac1f-44e3-a90f-85f776dc9ea7	0641-6116	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091222		ANDA	ANDA065406	Hikma Pharmaceuticals USA Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1.5g; g/1.5g	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6117_74a61772-ac1f-44e3-a90f-85f776dc9ea7	0641-6117	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091222		ANDA	ANDA065406	Hikma Pharmaceuticals USA Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/3g; g/3g	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6118_877f1410-8224-49a0-bd4e-e888b2ebe05f	0641-6118	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091203		ANDA	ANDA065403	Hikma Pharmaceuticals USA Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6119_92aca661-65af-4b86-a95c-ca9e2f7afd4a	0641-6119	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091222		ANDA	ANDA065406	Hikma Pharmaceuticals USA Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1.5g; g/1.5g	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6120_92aca661-65af-4b86-a95c-ca9e2f7afd4a	0641-6120	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091222		ANDA	ANDA065406	Hikma Pharmaceuticals USA Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/3g; g/3g	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6121_68fc19c6-3431-4c1d-bd50-b685aae800d6	0641-6121	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091203		ANDA	ANDA065403	West-Ward Pharmaceuticals Corp.	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6122_6ababc9a-b6ac-4fe9-8d69-d94eab27ac24	0641-6122	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091222		ANDA	ANDA065406	Hikma Pharmaceuticals USA Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	250; 125	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6123_6ababc9a-b6ac-4fe9-8d69-d94eab27ac24	0641-6123	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091222		ANDA	ANDA065406	Hikma Pharmaceuticals USA Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	250; 125	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0641-6125_eb8604d8-770a-443a-b5b4-14f7c30f4d64	0641-6125	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION	INTRAVENOUS	20150603		ANDA	ANDA205758	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6126_eb8604d8-770a-443a-b5b4-14f7c30f4d64	0641-6126	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION	INTRAVENOUS	20150603		ANDA	ANDA205758	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	8	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6127_eb8604d8-770a-443a-b5b4-14f7c30f4d64	0641-6127	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION	INTRAVENOUS	20150603		ANDA	ANDA205758	Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6132_4e1f7a9c-93dd-4e8e-b31d-ff9ea869995c	0641-6132	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Nalxone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19860924		ANDA	ANDA070299	Hikma Pharmaceuticals USA Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0641-6135_0ee79478-7b54-4b31-af4e-f927a996e18c	0641-6135	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19890829		ANDA	ANDA089903	Hikma Pharmaceuticals USA Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-6136_5fe5d597-7e6d-4fb3-8dff-8e9af00e6202	0641-6136	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20070806		ANDA	ANDA077989	Hikma Pharmaceuticals USA Inc.	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0641-6137_5fe5d597-7e6d-4fb3-8dff-8e9af00e6202	0641-6137	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20070806		ANDA	ANDA077989	Hikma Pharmaceuticals USA Inc.	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0641-6138_f5296c06-aa87-4f8f-ac34-06bdad7ffa51	0641-6138	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750716		ANDA	ANDA084307	Hikma Pharmaceuticals USA Inc.	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0641-6139_f5296c06-aa87-4f8f-ac34-06bdad7ffa51	0641-6139	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750716		ANDA	ANDA084307	Hikma Pharmaceuticals USA Inc.	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0641-6142_9861867e-7680-4bad-9740-fdb1b9c5c242	0641-6142	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20121218		NDA	NDA203826	Hikma Pharmaceuticals USA Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0641-6144_4f9d3415-3574-4534-bf30-3790e69ae94a	0641-6144	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20130924		ANDA	ANDA201833	Hikma Pharmaceuticals USA Inc.	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0641-6145_170a32e9-fea2-4e2b-95f2-bdd9b78cb615	0641-6145	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	19750715		ANDA	ANDA084282	Hikma Pharmaceuticals USA Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0641-6146_170a32e9-fea2-4e2b-95f2-bdd9b78cb615	0641-6146	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	19750715		ANDA	ANDA084282	Hikma Pharmaceuticals USA Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0641-6147_ff973eea-019f-4448-8175-0a13fb8839fc	0641-6147	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20150903		ANDA	ANDA206369	Hikma Pharmaceuticals USA Inc.	WATER	1	mL/mL			N	20241231
0641-6149_96273a3a-996b-4efa-9289-594fcc41c85f	0641-6149	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20151228		ANDA	ANDA207042	Hikma Pharmaceuticals USA Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0641-6150_96273a3a-996b-4efa-9289-594fcc41c85f	0641-6150	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20151228		ANDA	ANDA207042	Hikma Pharmaceuticals USA Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0641-6151_ab0205a1-df5f-499e-812c-01b34f4b4aea	0641-6151	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180701		ANDA	ANDA202159	Hikma Pharmaceuticals USA Inc.	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6154_1de15826-5859-4ea1-a0c0-c26ff3698861	0641-6154	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION	INTRAVENOUS	20130830		ANDA	ANDA091101	Hikma Pharmaceuticals USA Inc.	DOXERCALCIFEROL	2	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
0641-6161_3f316caf-5130-468d-958e-255b7d03bf2d	0641-6161	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20080430		ANDA	ANDA079196	Hikma Pharmaceuticals USA Inc.	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0641-6162_3f316caf-5130-468d-958e-255b7d03bf2d	0641-6162	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20080430		ANDA	ANDA079196	Hikma Pharmaceuticals USA Inc.	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0641-6166_c33d2645-5b58-4c87-9f7b-ed2267ff9030	0641-6166	HUMAN PRESCRIPTION DRUG	Amikacin Sulfate		Amikacin Sulfate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150801		ANDA	ANDA063315	Hikma Pharmaceuticals USA Inc.	AMIKACIN SULFATE	250	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0641-6167_c33d2645-5b58-4c87-9f7b-ed2267ff9030	0641-6167	HUMAN PRESCRIPTION DRUG	Amikacin Sulfate		Amikacin Sulfate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150801		ANDA	ANDA063315	Hikma Pharmaceuticals USA Inc.	AMIKACIN SULFATE	250	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0641-6173_3597e798-a7ee-4823-ba11-002eb0d185d8	0641-6173	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	INJECTION	INTRAMUSCULAR	20151230		ANDA	ANDA040465	Hikma Pharmaceuticals USA Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0641-6174_bf0946f5-1b95-494a-809c-558a01cd30c2	0641-6174	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20050404		ANDA	ANDA076313	Hikma Pharmaceuticals USA Inc.	OCTREOTIDE ACETATE	50	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0641-6175_bf0946f5-1b95-494a-809c-558a01cd30c2	0641-6175	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20050404		ANDA	ANDA076313	Hikma Pharmaceuticals USA Inc.	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0641-6176_bf0946f5-1b95-494a-809c-558a01cd30c2	0641-6176	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20050404		ANDA	ANDA076313	Hikma Pharmaceuticals USA Inc.	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0641-6177_bf0946f5-1b95-494a-809c-558a01cd30c2	0641-6177	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20050408		ANDA	ANDA076330	Hikma Pharmaceuticals USA Inc.	OCTREOTIDE ACETATE	200	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0641-6178_bf0946f5-1b95-494a-809c-558a01cd30c2	0641-6178	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20050408		ANDA	ANDA076330	Hikma Pharmaceuticals USA Inc.	OCTREOTIDE ACETATE	1000	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
0641-6182_2954443d-81a6-49d2-8786-92a175c0bb58	0641-6182	HUMAN PRESCRIPTION DRUG	Orphenadrine citrate		Orphenadrine citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20030428		ANDA	ANDA040463	Hikma Pharmaceuticals USA Inc.	ORPHENADRINE CITRATE	60	mg/2mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0641-6184_4526c189-9141-4d77-91b3-256048f01a17	0641-6184	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19751024		ANDA	ANDA083391	Hikma Pharmaceuticals USA Inc.	DIGOXIN	.25	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0641-6188_9861867e-7680-4bad-9740-fdb1b9c5c242	0641-6188	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20190619		NDA	NDA203826	Hikma Pharmaceuticals USA Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0641-6189_9861867e-7680-4bad-9740-fdb1b9c5c242	0641-6189	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20190619		NDA	NDA203826	Hikma Pharmaceuticals USA Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0641-6190_dfc3f55d-d0ae-4d7d-8e0e-0df40c15cf47	0641-6190	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6194_113ac304-ef02-4891-ac8b-8788f4ea041c	0641-6194	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20200501		ANDA	ANDA074848	Hikma Pharmaceuticals USA Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0641-6195_113ac304-ef02-4891-ac8b-8788f4ea041c	0641-6195	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20200501		ANDA	ANDA074848	Hikma Pharmaceuticals USA Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0641-6196_113ac304-ef02-4891-ac8b-8788f4ea041c	0641-6196	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20200501		ANDA	ANDA074848	Hikma Pharmaceuticals USA Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0641-6199_9102e900-98b0-4afa-b6af-e1908e81f08f	0641-6199	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190518		NDA	NDA017037	Hikma Pharmaceuticals USA Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0641-6204_9102e900-98b0-4afa-b6af-e1908e81f08f	0641-6204	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20200114		NDA	NDA017037	Hikma Pharmaceuticals USA Inc.	HEPARIN SODIUM	5000	[USP'U]/.5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
0641-6205_4ba40214-a15b-42d2-839c-85f5c260ed37	0641-6205	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220610		ANDA	ANDA212300	Hikma Pharmaceuticals USA Inc.	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0641-6207_4f2988b1-2854-4051-962f-07cc925608ab	0641-6207	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19800725		NDA	NDA018140	Hikma Pharmaceuticals USA Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6208_20551794-2758-4f53-a0bd-6e3e6ea4bc87	0641-6208	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Hikma Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-6209_1139ce09-dd54-4641-9dc0-2939f956fee7	0641-6209	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6210_1139ce09-dd54-4641-9dc0-2939f956fee7	0641-6210	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6211_1139ce09-dd54-4641-9dc0-2939f956fee7	0641-6211	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20000620		ANDA	ANDA075243	Hikma Pharmaceuticals USA Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6217_039931a2-6569-49bd-8b75-a08891a8a13b	0641-6217	HUMAN PRESCRIPTION DRUG	ROBAXIN		methocarbamol	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20171017		NDA	NDA011790	Hikma Pharmaceuticals USA Inc.	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0641-6225_55a9ca66-9bc3-4617-8ce5-7ecdd4a56bb4	0641-6225	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230102		ANDA	ANDA213630	Hikma Pharmaceuticals USA Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0641-6228_687b290b-a06b-4ea7-8060-9a3bb8571c6f	0641-6228	HUMAN PRESCRIPTION DRUG	Thiamine Hydrochloride		Thiamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210212		ANDA	ANDA080575	Hikma Pharmaceuticals USA Inc.	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
0641-6229_260e2347-35fc-4094-b488-4350cbd83546	0641-6229	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20121218		NDA	NDA203826	Hikma Pharmaceuticals USA Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0641-6231_6c90c508-2713-4e5c-bc86-af17480d1896	0641-6231	HUMAN PRESCRIPTION DRUG	HydrALAZINE hydrochloride		HydrALAZINE hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201218		ANDA	ANDA213667	Hikma Pharmaceuticals USA Inc.	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0641-6234_5270b37b-026b-499f-b33c-140f5262bc8d	0641-6234	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220317		NDA	NDA215143	Hikma Pharmaceuticals USA Inc.	SUCCINYLCHOLINE CHLORIDE DIHYDRATE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20251231
0641-6238_16fb818f-80b8-4776-84a8-84cc3f0ed05f	0641-6238	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20201215		ANDA	ANDA214334	Hikma Pharmaceuticals USA Inc.	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0641-6240_521e4ee9-7150-4513-b9d5-7fc5cc9efd0a	0641-6240	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20220713		ANDA	ANDA216206	Hikma Pharmaceuticals USA Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0641-6243_81c666ce-8a2d-48bd-9656-ffa3de4f9e00	0641-6243	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19851216		ANDA	ANDA070311	Hikma Pharmaceuticals USA Inc.	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6244_19eda095-0a17-4c01-a98e-27989c3ebffd	0641-6244	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210518		ANDA	ANDA070313	Hikma Pharmaceuticals USA Inc.	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0641-6245_9861867e-7680-4bad-9740-fdb1b9c5c242	0641-6245	HUMAN PRESCRIPTION DRUG	IMMPHENTIV		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20230309		NDA	NDA203826	Hikma Pharmaceuticals USA Inc.	PHENYLEPHRINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0641-6246_9861867e-7680-4bad-9740-fdb1b9c5c242	0641-6246	HUMAN PRESCRIPTION DRUG	IMMPHENTIV		Phenylephrine Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20230309		NDA	NDA203826	Hikma Pharmaceuticals USA Inc.	PHENYLEPHRINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0641-6247_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6247	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210318		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6248_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6248	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230201		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6249_90765191-e0c4-4ab2-a1e9-7a6a178fcee5	0641-6249	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230201		NDA	NDA019101	Hikma Pharmaceuticals USA Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0641-6251_99b7fe60-7b78-4d2e-83c3-384ea63f5e97	0641-6251	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20211201		ANDA	ANDA213561	Hikma Pharmaceuticals USA Inc.	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0641-6252_fa0062c6-f563-4d33-a540-fc2c7e91315d	0641-6252	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	20220318		NDA	NDA213330	Hikma Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0641-6253_0f68f5ee-f4c5-4306-b779-5d283742807d	0641-6253	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20230403		ANDA	ANDA215827	Hikma Pharmaceuticals USA Inc.	REGADENOSON ANHYDROUS	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
0641-6260_ddec76a9-dc04-4727-acf7-0482abfcf9e3	0641-6260	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Nalxone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220301		ANDA	ANDA070299	Hikma Pharmaceuticals USA Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0641-6264_a4e343d7-eb35-45fd-8c9d-be4b428f3637	0641-6264	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20151228		ANDA	ANDA207042	Hikma Pharmaceuticals USA Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0641-6265_a4e343d7-eb35-45fd-8c9d-be4b428f3637	0641-6265	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20151228		ANDA	ANDA207042	Hikma Pharmaceuticals USA Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0641-6267_e962ce5c-d8f4-4fe1-9190-344c9b0fa966	0641-6267	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		caffeine citrate	INJECTION	INTRAVENOUS	20081104		NDA	NDA020793	Hikma Pharmaceuticals USA Inc.	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0641-6282_6d0ee887-d248-42c8-9c80-747bb98ff37b	0641-6282	HUMAN PRESCRIPTION DRUG	Diphenhydramine hydrochloride		diphenhydramine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19721127		ANDA	ANDA080817	Hikma Pharmaceuticals USA Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0641-9217_0e067aab-ea5a-48da-8125-c09977b656d2	0641-9217	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	INJECTION	INTRAVENOUS	20081217		ANDA	ANDA078538	Hikma Pharmaceuticals USA Inc.	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0641-9218_0e067aab-ea5a-48da-8125-c09977b656d2	0641-9218	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	INJECTION	INTRAVENOUS	20081217		ANDA	ANDA078538	Hikma Pharmaceuticals USA Inc.	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0641-9219_0e067aab-ea5a-48da-8125-c09977b656d2	0641-9219	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	INJECTION	INTRAVENOUS	20081217		ANDA	ANDA078538	Hikma Pharmaceuticals USA Inc.	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0642-0076_f12bf665-1bc2-7760-e053-2995a90ae0e7	0642-0076	HUMAN PRESCRIPTION DRUG	Vitafol-OB Plus DHA	Prenatal Supplement Plus DHA	Vitamin A, Ascorbic Acid, Vitamin D, .Alpha.-Tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium, Iron, Magnesium, Zinc, Copper, and Doconexent	KIT		20070216		UNAPPROVED DRUG OTHER		Exeltis USA, Inc						N	20241231
0642-0079_f12aec60-46b4-6b23-e053-2995a90acb08	0642-0079	HUMAN PRESCRIPTION DRUG	Vitafol OB	Caplet	Vitamin A, Ascorbic Acid, Vitamin D, .Alpha.-Tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium, Iron, Magnesium, Zinc, and Copper	TABLET	ORAL	20021202		UNAPPROVED DRUG OTHER		Exeltis USA, Inc.	.ALPHA.-TOCOPHEROL; ASCORBIC ACID; CALCIUM; COPPER; CYANOCOBALAMIN; FOLIC ACID; IRON; MAGNESIUM; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D; ZINC	30; 70; 100; 2; 12; 1; 65; 25; 18; 2.5; 1.8; 1.6; 2700; 400; 25	[iU]/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calcium [CS], Calcium [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
0642-0093_f6df2d91-9721-c396-e053-6394a90a48b0	0642-0093	HUMAN PRESCRIPTION DRUG	Vitafol	Ultra	Doconexent, Niacinamide, .Alpha.-Tocopherol Acetate, DL-, Cholecalciferol, .Beta.-Carotene, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Cyanocobalamin, Iron, Zinc Oxide, Cupric Oxide, Potassium Iodide, Magnesium Oxide, Folic Acid, and Levomefolate Calcium	CAPSULE, LIQUID FILLED	ORAL	20130923		UNAPPROVED DRUG OTHER		Exeltis USA, Inc.	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; BETA CAROTENE; CHOLECALCIFEROL; CUPRIC OXIDE; CYANOCOBALAMIN; DOCONEXENT; FOLIC ACID; IRON; LEVOMEFOLATE CALCIUM; MAGNESIUM OXIDE; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC OXIDE	9; 30; 330; 25; 2; 12; 200; 680; 29; 1020; 20; 15; 150; 2.5; 1.8; 1.6; 25	mg/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
0642-0094_f4ab6922-697c-107d-e053-2a95a90ad0f7	0642-0094	HUMAN PRESCRIPTION DRUG	Vitafol	Nano	CHOLECALCIFEROL, Pyridoxine Hydrochloride, Folic Acid, Levomefolate Calcium, Cyanocobalamin, Iron, and Iodine	TABLET, COATED	ORAL	20140714		UNAPPROVED DRUG OTHER		Exeltis USA, Inc.	CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; IODINE; IRON; LEVOMEFOLATE CALCIUM; PYRIDOXINE HYDROCHLORIDE	25; 12; 680; 150; 18; 1020; 2.5	ug/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
0642-0207_f15344bc-5c57-427d-e053-2995a90aaad3	0642-0207	HUMAN PRESCRIPTION DRUG	Strovite One	Caplets	Vitamin A, Calcium Pantothenate, Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Succinate, D-, Thiamine, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Biotin, Cyanocobalamin, Selenium, Magnesium Oxide, Zinc Oxide, Cupric Sulfate, Manganese, Chromium, .Alpha.-Lipoic Acid, and Lutein	TABLET	ORAL	20010504		UNAPPROVED DRUG OTHER		Exeltis USA, Inc.	.ALPHA.-TOCOPHEROL SUCCINATE, D-; ALPHA LIPOIC ACID; ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; CHOLECALCIFEROL; CHROMIUM; CUPRIC SULFATE; CYANOCOBALAMIN; FOLIC ACID; LUTEIN; MAGNESIUM OXIDE; MANGANESE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE; VITAMIN A; ZINC OXIDE	45; 15; 300; 100; 7.5; 25; 50; 1.5; 50; 1700; 5; 50; 1.5; 25; 25; 5; 100; 20; 900; 25	ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
0642-7463_09d1317f-8e95-b708-e063-6394a90a1ef5	0642-7463	HUMAN PRESCRIPTION DRUG	Benznidazole		benznidazole	TABLET	ORAL	20180330		NDA	NDA209570	Exeltis USA, Inc.	BENZNIDAZOLE	12.5	mg/1			N	20241231
0642-7464_09d1317f-8e95-b708-e063-6394a90a1ef5	0642-7464	HUMAN PRESCRIPTION DRUG	Benznidazole		benznidazole	TABLET	ORAL	20180330		NDA	NDA209570	Exeltis USA, Inc.	BENZNIDAZOLE	100	mg/1			N	20241231
0642-7466_09d13114-f228-f0bc-e063-6394a90a84f5	0642-7466	HUMAN PRESCRIPTION DRUG	Nuvessa		metronidazole	GEL	TOPICAL	20180310		NDA	NDA205223	Exeltis USA, Inc.	METRONIDAZOLE	65	mg/5g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0642-7470_ee104043-d35c-7876-e053-2995a90a5eed	0642-7470	HUMAN PRESCRIPTION DRUG	SLYND		Drospirenone	KIT		20190606		NDA	NDA211367	Exeltis USA, Inc.						N	20241231
0642-7471_f48a4726-8731-6fcb-e053-2995a90a6bea	0642-7471	HUMAN PRESCRIPTION DRUG	Tyblume		Levonorgestrel and Ethinyl Estradiol	KIT		20201026		NDA	NDA209405	Exeltis USA, Inc.						N	20241231
0682-0051_074b53d0-d9da-8d24-e063-6294a90a9fda	0682-0051	HUMAN PRESCRIPTION DRUG	Crotan		Crotamiton	LOTION	TOPICAL	20220115		ANDA	ANDA087204	Marnel Pharmaceuticals, Inc.	CROTAMITON	100	mg/g			N	20241231
0699-0701_19f58a0c-1a10-40a3-9d0c-e85d60d2232e	0699-0701	HUMAN PRESCRIPTION DRUG	Topex Neutral pH Fluoride Gel	Mint	sodium fluoride	GEL	DENTAL	19740101		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "Sultan Healthcare"	FLUORIDE ION	9	mg/g			N	20241231
0699-7011_73179c7e-74c8-4db6-b5e9-7d1e9d905fe1	0699-7011	HUMAN PRESCRIPTION DRUG	Topex	Mint	Benzocaine	GEL, DENTIFRICE	DENTAL	19630219		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "Sultan Healthcare"	BENZOCAINE	220	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0699-7021_73179c7e-74c8-4db6-b5e9-7d1e9d905fe1	0699-7021	HUMAN PRESCRIPTION DRUG	Topex	Cherry	Benzocaine	GEL, DENTIFRICE	DENTAL	19630219		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "Sultan Healthcare"	BENZOCAINE	220	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0699-7031_73179c7e-74c8-4db6-b5e9-7d1e9d905fe1	0699-7031	HUMAN PRESCRIPTION DRUG	Topex	Bubble Gum	Benzocaine	GEL, DENTIFRICE	DENTAL	19630219		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "Sultan Healthcare"	BENZOCAINE	220	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0699-7051_73179c7e-74c8-4db6-b5e9-7d1e9d905fe1	0699-7051	HUMAN PRESCRIPTION DRUG	Topex	Strawberry	Benzocaine	GEL, DENTIFRICE	DENTAL	19630219		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "Sultan Healthcare"	BENZOCAINE	220	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0699-7071_73179c7e-74c8-4db6-b5e9-7d1e9d905fe1	0699-7071	HUMAN PRESCRIPTION DRUG	Topex	Cherry	Benzocaine	GEL, DENTIFRICE	DENTAL	19630219		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "Sultan Healthcare"	BENZOCAINE	220	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0699-7081_73179c7e-74c8-4db6-b5e9-7d1e9d905fe1	0699-7081	HUMAN PRESCRIPTION DRUG	Topex	Mint	Benzocaine	GEL, DENTIFRICE	DENTAL	19630219		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "Sultan Healthcare"	BENZOCAINE	220	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0703-0018_0d8c5d56-ca80-43b5-ae8e-526f6424bb0d	0703-0018	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20110118		ANDA	ANDA078591	Teva Parenteral Medicines, Inc.	HYDROMORPHONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0703-0110_0d8c5d56-ca80-43b5-ae8e-526f6424bb0d	0703-0110	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20110118		ANDA	ANDA078591	Teva Parenteral Medicines, Inc.	HYDROMORPHONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0703-0113_0d8c5d56-ca80-43b5-ae8e-526f6424bb0d	0703-0113	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		HYDROMORPHONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20110118		ANDA	ANDA078591	Teva Parenteral Medicines, Inc.	HYDROMORPHONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0703-0241_e4c05e17-cc24-4e45-a42d-eaff2e9db337	0703-0241	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20190829		ANDA	ANDA209852	Teva Parenteral Medicines, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0703-0243_e4c05e17-cc24-4e45-a42d-eaff2e9db337	0703-0243	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20190829		ANDA	ANDA209852	Teva Parenteral Medicines, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0703-0245_e4c05e17-cc24-4e45-a42d-eaff2e9db337	0703-0245	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20190829		ANDA	ANDA209852	Teva Parenteral Medicines, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0703-0666_c7be0baa-694d-498d-a474-3611f7773954	0703-0666	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190930		ANDA	ANDA206648	Teva Parenteral Medicines, Inc.	TREPROSTINIL	20	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0703-0676_c7be0baa-694d-498d-a474-3611f7773954	0703-0676	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190930		ANDA	ANDA206648	Teva Parenteral Medicines, Inc.	TREPROSTINIL	50	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0703-0686_c7be0baa-694d-498d-a474-3611f7773954	0703-0686	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190930		ANDA	ANDA206648	Teva Parenteral Medicines, Inc.	TREPROSTINIL	100	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0703-0696_c7be0baa-694d-498d-a474-3611f7773954	0703-0696	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190930		ANDA	ANDA206648	Teva Parenteral Medicines, Inc.	TREPROSTINIL	200	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0703-2033_88278881-51ac-48a1-9559-fba537a4f5c5	0703-2033	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA204960	Teva Parenteral Medicines, Inc.	CISATRACURIUM BESYLATE	10	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0703-2045_88278881-51ac-48a1-9559-fba537a4f5c5	0703-2045	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA204960	Teva Parenteral Medicines, Inc.	CISATRACURIUM BESYLATE	200	mg/20mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0703-2056_88278881-51ac-48a1-9559-fba537a4f5c5	0703-2056	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA209334	Teva Parenteral Medicines, Inc.	CISATRACURIUM BESYLATE	20	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0703-3213_18eeda76-581a-46fe-9105-40fb1f67f1ae	0703-3213	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200707		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-3213_27d6ca2d-5a77-4428-a899-a599902db6c6	0703-3213	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200707		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-3216_18eeda76-581a-46fe-9105-40fb1f67f1ae	0703-3216	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200305		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-3216_27d6ca2d-5a77-4428-a899-a599902db6c6	0703-3216	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200325		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-3217_27d6ca2d-5a77-4428-a899-a599902db6c6	0703-3217	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200305		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-3218_18eeda76-581a-46fe-9105-40fb1f67f1ae	0703-3218	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200305		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-3218_27d6ca2d-5a77-4428-a899-a599902db6c6	0703-3218	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200305		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-3671_ec97aad6-8397-459f-a29e-9fa3a9bb9bd4	0703-3671	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20120731		ANDA	ANDA040843	Teva Parenteral Medicines, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0703-3675_ec97aad6-8397-459f-a29e-9fa3a9bb9bd4	0703-3675	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20120801		ANDA	ANDA040843	Teva Parenteral Medicines, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0703-3678_ebf6403a-1af8-413a-83b9-fb5ea8307238	0703-3678	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20151214		ANDA	ANDA040843	Teva Parenteral Medicines, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0703-3678_ec97aad6-8397-459f-a29e-9fa3a9bb9bd4	0703-3678	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20120801		ANDA	ANDA040843	Teva Parenteral Medicines, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0703-3985_ef9edd2b-00c3-4faf-8083-354d0f363357	0703-3985	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20090811		NDA	NDA022160	Teva Parenteral Medicines, Inc.	OXALIPLATIN	50	mg/10mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-3986_ef9edd2b-00c3-4faf-8083-354d0f363357	0703-3986	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20090811		NDA	NDA022160	Teva Parenteral Medicines, Inc.	OXALIPLATIN	100	mg/20mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4004_bc6afb1c-b9c9-4ea2-baac-433a24b0300d	0703-4004	HUMAN PRESCRIPTION DRUG	Romidepsin		Romidepsin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200414		NDA	NDA208574	Teva Parenteral Medicines, Inc.	ROMIDEPSIN	5	mg/mL	Bile Salt Export Pump Inhibitors [MoA], Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0703-4094_a9cbc770-f406-4296-994d-afc3b49e68a8	0703-4094	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		Palonosetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180323		ANDA	ANDA090713	Teva Parenteral Medicines, Inc.	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0703-4156_524bd02a-686f-4a67-806f-9a07edcac457	0703-4156	HUMAN PRESCRIPTION DRUG	Idarubicin Hydrochloride		Idarubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20021001	20240131	ANDA	ANDA065036	Teva Parenteral Medicines, Inc.	IDARUBICIN HYDROCHLORIDE	1	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	
0703-4239_b943761e-6a46-45a0-bdb4-1fec1e101f8c	0703-4239	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20160119		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4239_bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df	0703-4239	HUMAN PRESCRIPTION DRUG	CARBOplatin		CARBOplatin	INJECTION, SOLUTION	INTRAVENOUS	20141023		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4244_b943761e-6a46-45a0-bdb4-1fec1e101f8c	0703-4244	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20160115		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4244_bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df	0703-4244	HUMAN PRESCRIPTION DRUG	CARBOplatin		CARBOplatin	INJECTION, SOLUTION	INTRAVENOUS	20060504		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4246_b943761e-6a46-45a0-bdb4-1fec1e101f8c	0703-4246	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20151125		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4246_bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df	0703-4246	HUMAN PRESCRIPTION DRUG	CARBOplatin		CARBOplatin	INJECTION, SOLUTION	INTRAVENOUS	20060501		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4248_b943761e-6a46-45a0-bdb4-1fec1e101f8c	0703-4248	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20151209		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4248_bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df	0703-4248	HUMAN PRESCRIPTION DRUG	CARBOplatin		CARBOplatin	INJECTION, SOLUTION	INTRAVENOUS	20060201		ANDA	ANDA077269	Teva Parenteral Medicines, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-4502_e640a87c-7ee3-4ca2-9808-3916bfd1a54b	0703-4502	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19911201		ANDA	ANDA073135	Teva Parenteral Medicines, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
0703-4636_086af066-2d97-4c11-9f8d-68eb4f7c29f3	0703-4636	HUMAN PRESCRIPTION DRUG	Zanosar		streptozocin	POWDER, FOR SOLUTION	INTRAVENOUS	20031203		NDA	NDA050577	Teva Parenteral Medicines, Inc.	STREPTOZOCIN	100	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0703-4764_0b02547e-0b69-4044-9495-f5b7f287e2c6	0703-4764	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160303		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-4768_0b02547e-0b69-4044-9495-f5b7f287e2c6	0703-4768	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160303		ANDA	ANDA075184	Teva Parenteral Medicines, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0703-5075_46f32b94-ccdf-42ce-a41c-60f929479db8	0703-5075	HUMAN PRESCRIPTION DRUG	Dacarbazine		Dacarbazine	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19980827	20240531	ANDA	ANDA075259	Teva Parenteral Medicines, Inc.	DACARBAZINE	200	mg/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	
0703-5656_57a9f2aa-e5c5-4bd2-856b-4ced775e2faa	0703-5656	HUMAN PRESCRIPTION DRUG	Toposar		Etoposide	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	19960801	20240131	ANDA	ANDA074529	Teva Parenteral Medicines, Inc.	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	
0703-5747_adf5773e-9095-4cb4-a90f-72cbf82f4493	0703-5747	HUMAN PRESCRIPTION DRUG	Cisplatin		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20000601		ANDA	ANDA074656	Teva Parenteral Medicines, Inc.	CISPLATIN	50	mg/50mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-5748_adf5773e-9095-4cb4-a90f-72cbf82f4493	0703-5748	HUMAN PRESCRIPTION DRUG	Cisplatin		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20000601		ANDA	ANDA074656	Teva Parenteral Medicines, Inc.	CISPLATIN	100	mg/100mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0703-9503_07b4c18c-4daa-40da-8abd-013adbb9920c	0703-9503	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	19911101		ANDA	ANDA073303	Teva Parenteral Medicines, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0703-9514_07b4c18c-4daa-40da-8abd-013adbb9920c	0703-9514	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	19911101		ANDA	ANDA073303	Teva Parenteral Medicines, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0703-9514_4f95c6e0-5888-4e8d-a0d6-3525dc2174c7	0703-9514	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	19911101		ANDA	ANDA073303	Teva Parenteral Medicines, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0703-9526_07b4c18c-4daa-40da-8abd-013adbb9920c	0703-9526	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	19911101		ANDA	ANDA073303	Teva Parenteral Medicines, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0713-0132_0b625ebc-4f41-49d9-e063-6294a90a56ef	0713-0132	HUMAN PRESCRIPTION DRUG	PROMETHEGAN		promethazine hydrochloride	SUPPOSITORY	RECTAL	19870831		ANDA	ANDA087165	Cosette Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0713-0135_0b4881d9-a9bd-b7a0-e063-6394a90aa028	0713-0135	HUMAN PRESCRIPTION DRUG	Prochlorperazine		Prochlorperazine	SUPPOSITORY	RECTAL	19931130		ANDA	ANDA040058	Cosette Pharmaceuticals, Inc.	PROCHLORPERAZINE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0713-0166_ee9c58f6-c353-2cf3-e053-2a95a90a3f5e	0713-0166	HUMAN PRESCRIPTION DRUG	MIGERGOT		Ergotamine Tartrate and Caffeine	SUPPOSITORY	RECTAL	19831030		ANDA	ANDA086557	Cosette Pharmaceuticals, Inc.	CAFFEINE; ERGOTAMINE TARTRATE	100; 2	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Ergotamine Derivative [EPC], Ergotamines [CS], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0713-0223_0abbbbe6-b694-1260-e063-6294a90a6f81	0713-0223	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	CREAM	TOPICAL	19880726		ANDA	ANDA089526	Cosette Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0224_0abbbbe6-b694-1260-e063-6294a90a6f81	0713-0224	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	OINTMENT	TOPICAL	19880726		ANDA	ANDA089524	Cosette Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0225_edbdc68d-056b-6aab-e053-2995a90a3fab	0713-0225	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20150414		ANDA	ANDA089798	Cosette Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0226_edbdc68d-056b-6aab-e053-2995a90a3fab	0713-0226	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20150414		ANDA	ANDA089797	Cosette Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0228_24fce155-9434-4aee-8c47-9cd3d1d50c5a	0713-0228	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20150910		ANDA	ANDA089796	Cosette Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0229_24fce155-9434-4aee-8c47-9cd3d1d50c5a	0713-0229	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20150910		ANDA	ANDA089795	Cosette Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0268_0cf1cf3a-c318-a32a-e063-6394a90a884d	0713-0268	HUMAN OTC DRUG	Triple Antibiotic		Polymyxin B Sulfate, Bacitracin Zinc and Neomycin Sulfate	OINTMENT	TOPICAL	19950111		OTC MONOGRAPH DRUG	M004	Cosette Pharmaceuticals, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0713-0280_0cee4d1f-c118-adbd-e063-6294a90a74d8	0713-0280	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	19950110		OTC MONOGRAPH DRUG	M004	Cosette Pharmaceuticals, Inc.	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
0713-0317_de0c0ab2-9e23-a0b7-e053-2995a90acdd4	0713-0317	HUMAN PRESCRIPTION DRUG	Ciclopirox		CICLOPIROX	SOLUTION	TOPICAL	20070522	20240630	ANDA	ANDA078233	Cosette Pharmaceuticals, Inc.	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	
0713-0318_ed81406a-8c10-5c33-e053-2a95a90a941f	0713-0318	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	SOLUTION	TOPICAL	20110324		ANDA	ANDA078468	Cosette Pharmaceuticals, Inc.	CALCIPOTRIENE	.05	mg/mL	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
0713-0326_de48a395-89de-07a5-e053-2a95a90abdf7	0713-0326	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	19830324		NDA	NDA018642	Cosette Pharmaceuticals, Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0327_de48a395-89de-07a5-e053-2a95a90abdf7	0713-0327	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	OINTMENT	TOPICAL	19851219		ANDA	ANDA070069	Cosette Pharmaceuticals, Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0339_0acd5050-82df-37f0-e063-6394a90a9e34	0713-0339	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	OINTMENT	TOPICAL	20050614		ANDA	ANDA077109	Cosette Pharmaceuticals, Inc.	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0351_da466ec4-5acf-189c-e053-2995a90af2a4	0713-0351	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220211		ANDA	ANDA213626	Cosette Pharmaceuticals, Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0713-0352_99b667fa-b00c-465b-bbed-36f317078115	0713-0352	HUMAN PRESCRIPTION DRUG	Betaine		Betaine	POWDER, FOR SOLUTION	ORAL	20221104		ANDA	ANDA214864	Cosette Pharmaceuticals, Inc.	BETAINE	1	g/g	Methylating Activity [MoA], Methylating Agent [EPC]		N	20241231
0713-0353_e4d903b2-6585-4e80-a58e-128fe69cf1d4	0713-0353	HUMAN OTC DRUG	DOCOSANOL		Docosanol	CREAM	TOPICAL	20240104		ANDA	ANDA215839	Cosette Pharmaceuticals, Inc.	DOCOSANOL	100	mg/g			N	20251231
0713-0493_0acd8136-06dc-4ea4-e063-6394a90a5b51	0713-0493	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	20210809		UNAPPROVED DRUG OTHER		Cosette Pharmaceuticals, Inc.	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0503_0abb41a1-447c-5565-e063-6294a90a6414	0713-0503	HUMAN PRESCRIPTION DRUG	ANUCORT-HC		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	19900115		UNAPPROVED DRUG OTHER		Cosette Pharmaceuticals, Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0526_0b622b7b-a45f-eab0-e063-6394a90a0c0a	0713-0526	HUMAN PRESCRIPTION DRUG	PROMETHEGAN		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20020228		ANDA	ANDA040428	Cosette Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0713-0536_0b622b7b-a45f-eab0-e063-6394a90a0c0a	0713-0536	HUMAN PRESCRIPTION DRUG	PROMETHEGAN		promethazine hydrochloride	SUPPOSITORY	RECTAL	20040228		ANDA	ANDA040428	Cosette Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0713-0552_ee20ae91-d9b6-6f7f-e053-2a95a90a3171	0713-0552	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	SUPPOSITORY	VAGINAL	20150925		ANDA	ANDA077553	Cosette Pharmaceuticals, Inc.	TERCONAZOLE	80	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0713-0560_0b46d11e-449c-315b-e063-6294a90a6e2a	0713-0560	HUMAN PRESCRIPTION DRUG	Hydrocortisone Valerate		HYDROCORTISONE VALERATE	OINTMENT	TOPICAL	20210503		ANDA	ANDA211764	Cosette Pharmaceuticals, Inc.	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0570_7603372c-888b-43c2-9753-aa38ce0b0ee3	0713-0570	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Cosette Pharmaceuticals, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0713-0571_7603372c-888b-43c2-9753-aa38ce0b0ee3	0713-0571	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Cosette Pharmaceuticals, Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0713-0572_7603372c-888b-43c2-9753-aa38ce0b0ee3	0713-0572	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Cosette Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0713-0574_f38e0e45-e6e7-84f3-e053-2995a90a197c	0713-0574	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	GEL	TOPICAL	20230201		ANDA	ANDA216692	Cosette Pharmaceuticals, Inc.	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0713-0575_00beeda9-9cf9-730b-e063-6294a90a8ad0	0713-0575	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	GEL	VAGINAL	20230712		ANDA	ANDA216323	Cosette Pharmaceuticals, Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0713-0622_bbe9b82b-867d-4f19-8948-bcc36695092c	0713-0622	HUMAN OTC DRUG	Triple Antibiotic Plus		Polymyxin B Sulfate, Bacitracin Zinc, Neomycin Sulfate, Pramoxine HCl	OINTMENT	TOPICAL	19980228		OTC MONOGRAPH DRUG	M004	Cosette Pharmaceuticals, Inc.	BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0713-0631_de485a69-2992-143b-e053-2a95a90a4b89	0713-0631	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	CREAM	TOPICAL	20060630		ANDA	ANDA077055	Cosette Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0632_0abc4bef-4b22-8a3f-e063-6394a90ae599	0713-0632	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	OINTMENT	TOPICAL	20060531		ANDA	ANDA077168	Cosette Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0633_0b47088a-fa40-b41e-e063-6394a90acfb1	0713-0633	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	CREAM	TOPICAL	20080313		ANDA	ANDA077549	Cosette Pharmaceuticals, Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0713-0634_0b473eaf-fbda-c8ed-e063-6394a90ab80a	0713-0634	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20060823		ANDA	ANDA077447	Cosette Pharmaceuticals, Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0635_0b4770a7-60b1-f27f-e063-6394a90a16a6	0713-0635	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20140304		ANDA	ANDA077401	Cosette Pharmaceuticals, Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0637_edf61c59-f083-6b15-e053-2995a90a675b	0713-0637	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20110401		ANDA	ANDA078178	Cosette Pharmaceuticals, Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0713-0638_ed9669ad-fa01-5788-e053-2995a90a5897	0713-0638	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	CREAM	TOPICAL	20070522		ANDA	ANDA078463	Cosette Pharmaceuticals, Inc.	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
0713-0640_0acd2432-98e5-018e-e063-6294a90ad373	0713-0640	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	CREAM	TOPICAL	20070716		ANDA	ANDA078162	Cosette Pharmaceuticals, Inc.	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0655_ee9c5cfd-2bcc-eee9-e053-2a95a90aeef9	0713-0655	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	PASTE	DENTAL	20170113		ANDA	ANDA205592	Cosette Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0656_0b383db5-a99b-f222-e063-6294a90adc09	0713-0656	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	OINTMENT	TOPICAL	20160104		ANDA	ANDA074089	Cosette Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0659_0abb502d-643e-bbfc-e063-6294a90a8f61	0713-0659	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20181012		ANDA	ANDA210217	Cosette Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0661_ee0cb97f-162c-0dc0-e053-2995a90a8db3	0713-0661	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20160819		ANDA	ANDA074027	Cosette Pharmaceuticals, Inc.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0663_f0d2ff2b-732c-ae99-e053-2995a90a1ee7	0713-0663	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20221116		ANDA	ANDA073085	Cosette Pharmaceuticals, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0664_0abbc18e-8f87-0e6b-e063-6294a90a3685	0713-0664	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20160321		ANDA	ANDA074204	Cosette Pharmaceuticals, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0670_0b49129a-56be-fb05-e063-6394a90a4f5e	0713-0670	HUMAN PRESCRIPTION DRUG	Tazarotene		Tazarotene	CREAM	TOPICAL	20171222		ANDA	ANDA208662	Cosette Pharmaceuticals, Inc.	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0713-0676_eeaf2d1b-9102-e008-e053-2995a90ae1b8	0713-0676	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	LOTION	TOPICAL	20160913		ANDA	ANDA089129	Cosette Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0678_ee0cb97f-1642-0dc0-e053-2995a90a8db3	0713-0678	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin Cream	CREAM	TOPICAL	20150401		ANDA	ANDA061966	Cosette Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0713-0682_0acd2432-98da-018e-e063-6294a90ad373	0713-0682	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	OINTMENT	TOPICAL	20141128		ANDA	ANDA064054	Cosette Pharmaceuticals, Inc.	GENTAMICIN SULFATE	1	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0713-0683_0abc5db4-9344-8946-e063-6394a90abf1c	0713-0683	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	CREAM	TOPICAL	20161111		ANDA	ANDA064056	Cosette Pharmaceuticals, Inc.	GENTAMICIN SULFATE	1	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0713-0686_0b479d47-d58c-1457-e063-6394a90a1256	0713-0686	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin Ointment	OINTMENT	TOPICAL	20171006		ANDA	ANDA209114	Cosette Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0713-0709_ed968281-cd0d-65e8-e053-2a95a90a7054	0713-0709	HUMAN PRESCRIPTION DRUG	FLUOCINOLONE ACETONIDE		FLUOCINOLONE ACETONIDE	CREAM	TOPICAL	20181105		ANDA	ANDA210747	Cosette Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0720_0b469afc-621e-133a-e063-6294a90a6344	0713-0720	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE VALERATE		HYDROCORTISONE VALERATE	CREAM	TOPICAL	20210701		ANDA	ANDA213724	Cosette Pharmaceuticals, Inc.	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0804_0b4b0b29-a411-44a4-e063-6294a90ab3ba	0713-0804	HUMAN PRESCRIPTION DRUG	TAZAROTENE		tazarotene	GEL	TOPICAL	20220914		ANDA	ANDA214136	Cosette Pharmaceuticals, Inc.	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0713-0805_0b4ad65c-1d55-3e68-e063-6294a90a8e54	0713-0805	HUMAN PRESCRIPTION DRUG	TAZAROTENE		tazarotene	GEL	TOPICAL	20220914		ANDA	ANDA215433	Cosette Pharmaceuticals, Inc.	TAZAROTENE	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0713-0807_ed81406a-8c03-5c33-e053-2a95a90a941f	0713-0807	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	LOTION	TOPICAL	20160905		ANDA	ANDA071467	Cosette Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0713-0850_0d7c5376-a309-d8de-e063-6394a90af379	0713-0850	HUMAN PRESCRIPTION DRUG	Griseofulvin		Griseofulvin	SUSPENSION	ORAL	20221101		ANDA	ANDA065438	Cosette Pharmaceuticals, Inc.	GRISEOFULVIN	125	mg/5mL	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0713-0860_00494313-514a-b3b5-e063-6294a90a5ad5	0713-0860	HUMAN PRESCRIPTION DRUG	Benicar		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20220901		NDA	NDA021286	Cosette Pharmaceuticals, Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0713-0861_00494313-514a-b3b5-e063-6294a90a5ad5	0713-0861	HUMAN PRESCRIPTION DRUG	Benicar		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20220901		NDA	NDA021286	Cosette Pharmaceuticals, Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0713-0862_00494313-514a-b3b5-e063-6294a90a5ad5	0713-0862	HUMAN PRESCRIPTION DRUG	Benicar		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20220901		NDA	NDA021286	Cosette Pharmaceuticals, Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0713-0863_004953ba-fde0-03eb-e063-6394a90a638c	0713-0863	HUMAN PRESCRIPTION DRUG	Benicar HCT		olmesartan medoxomil-hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA021532	Cosette Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0864_004953ba-fde0-03eb-e063-6394a90a638c	0713-0864	HUMAN PRESCRIPTION DRUG	Benicar HCT		olmesartan medoxomil-hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA021532	Cosette Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0865_004953ba-fde0-03eb-e063-6394a90a638c	0713-0865	HUMAN PRESCRIPTION DRUG	Benicar HCT		olmesartan medoxomil-hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA021532	Cosette Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0870_00491aef-cf0c-eeb3-e063-6394a90a716d	0713-0870	HUMAN PRESCRIPTION DRUG	Azor		amlodipine besylate and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20220901		NDA	NDA022100	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0713-0871_00491aef-cf0c-eeb3-e063-6394a90a716d	0713-0871	HUMAN PRESCRIPTION DRUG	Azor		amlodipine besylate and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20220901		NDA	NDA022100	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0713-0872_00491aef-cf0c-eeb3-e063-6394a90a716d	0713-0872	HUMAN PRESCRIPTION DRUG	Azor		amlodipine besylate and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20220901		NDA	NDA022100	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0713-0873_00491aef-cf0c-eeb3-e063-6394a90a716d	0713-0873	HUMAN PRESCRIPTION DRUG	Azor		amlodipine besylate and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20220901		NDA	NDA022100	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0713-0874_004953ba-fe11-03eb-e063-6394a90a638c	0713-0874	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA200175	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0875_004953ba-fe11-03eb-e063-6394a90a638c	0713-0875	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA200175	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0876_004953ba-fe11-03eb-e063-6394a90a638c	0713-0876	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA200175	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0877_004953ba-fe11-03eb-e063-6394a90a638c	0713-0877	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA200175	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0878_004953ba-fe11-03eb-e063-6394a90a638c	0713-0878	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220901		NDA	NDA200175	Cosette Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0713-0879_e81774fc-7dd0-a628-e053-2995a90a1397	0713-0879	HUMAN PRESCRIPTION DRUG	Welchol		colesevelam hydrochloride	TABLET, FILM COATED	ORAL	20220901		NDA	NDA021176	Cosette Pharmaceuticals, Inc.	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0713-0880_e81774fc-7dd0-a628-e053-2995a90a1397	0713-0880	HUMAN PRESCRIPTION DRUG	Welchol		colesevelam hydrochloride	FOR SUSPENSION	ORAL	20220901		NDA	NDA022362	Cosette Pharmaceuticals, Inc.	COLESEVELAM HYDROCHLORIDE	3.75	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0713-0881_e8172297-af81-4c37-e053-2995a90ad4e5	0713-0881	HUMAN PRESCRIPTION DRUG	Effient		Prasugrel Hydrochloride	TABLET, COATED	ORAL	20220901		NDA	NDA022307	Cosette Pharmaceuticals, Inc.	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0713-0882_e8172297-af81-4c37-e053-2995a90ad4e5	0713-0882	HUMAN PRESCRIPTION DRUG	Effient		Prasugrel Hydrochloride	TABLET, COATED	ORAL	20220901		NDA	NDA022307	Cosette Pharmaceuticals, Inc.	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0713-0883_e816e1db-d4e5-425f-e053-2995a90a27c5	0713-0883	HUMAN PRESCRIPTION DRUG	Evoxac		cevimeline hydrochloride	CAPSULE	ORAL	20220901		NDA	NDA020989	Cosette Pharmaceuticals, Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0713-0885_e95633fa-e337-6112-e053-2a95a90ae826	0713-0885	HUMAN PRESCRIPTION DRUG	Clomid		Clomiphene Citrate	TABLET	ORAL	20220909		ANDA	ANDA075528	Cosette Pharmaceuticals, Inc.	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0713-0886_fb368415-d58a-0601-e053-6394a90a92af	0713-0886	HUMAN PRESCRIPTION DRUG	DAPSONE		dapsone	GEL	TOPICAL	20230508		ANDA	ANDA210178	Cosette Pharmaceuticals, Inc.	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
0713-0935_e87948c2-aa81-abb0-e053-2995a90a5c30	0713-0935	HUMAN PRESCRIPTION DRUG	COLESEVELAM HYDROCHLORIDE		COLESEVELAM HYDROCHLORIDE	FOR SUSPENSION	ORAL	20220801		NDA	NDA022362	Cosette Pharmaceuticals, Inc.	COLESEVELAM HYDROCHLORIDE	3.75	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0713-0936_e87948c2-aa81-abb0-e053-2995a90a5c30	0713-0936	HUMAN PRESCRIPTION DRUG	COLESEVELAM HYDROCHLORIDE		COLESEVELAM HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220801		NDA	NDA021176	Cosette Pharmaceuticals, Inc.	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0713-0937_f183f958-57f5-ea10-e053-2995a90a5ead	0713-0937	HUMAN PRESCRIPTION DRUG	cevimeline hydrochloride		cevimeline hydrochloride	CAPSULE	ORAL	20230103		NDA	NDA020989	Cosette Pharmaceuticals, Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
0761-0434_081719c1-49e6-825f-e063-6294a90a70d3	0761-0434	HUMAN OTC DRUG	Laxa-basic 100		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210101		OTC MONOGRAPH DRUG	M007	BASIC DRUGS, INC.	DOCUSATE SODIUM	100	mg/1			N	20241231
0761-0790_f27edbae-3cc3-80c6-e053-2a95a90a0bdc	0761-0790	HUMAN OTC DRUG	NATURAL SENNA LAXATIVE		SENNOSIDES	TABLET	ORAL	20211214		OTC MONOGRAPH NOT FINAL	part334	Basic Drugs, Inc.	SENNOSIDES	8.6	mg/1			N	20241231
0761-0908_0e12b3c6-3579-b0dc-e063-6394a90a8ea4	0761-0908	HUMAN OTC DRUG	IBUPROFEN	200 MG	IBUPROFEN	TABLET	ORAL	20211214		ANDA	ANDA079174	Basic Drugs, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
0761-0910_fe7fc44e-1cc2-713b-e053-6394a90a64c6	0761-0910	HUMAN OTC DRUG	SENNA-S	LAXATIVE WITH STOOL SOFTENER	SENNOSIDES	TABLET	ORAL	20211215		OTC MONOGRAPH NOT FINAL	part334	Basic Drugs, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
0777-3104_5c5ab2bb-463a-4a47-ba50-a47a6daee339	0777-3104	HUMAN PRESCRIPTION DRUG	Prozac		Fluoxetine hydrochloride	CAPSULE	ORAL	19930113		NDA	NDA018936	Dista Products Company	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0777-3105_5c5ab2bb-463a-4a47-ba50-a47a6daee339	0777-3105	HUMAN PRESCRIPTION DRUG	Prozac		Fluoxetine hydrochloride	CAPSULE	ORAL	19880201		NDA	NDA018936	Dista Products Company	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0777-3107_5c5ab2bb-463a-4a47-ba50-a47a6daee339	0777-3107	HUMAN PRESCRIPTION DRUG	Prozac		Fluoxetine hydrochloride	CAPSULE	ORAL	19990615		NDA	NDA018936	Dista Products Company	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0781-1061_d4bd9efd-efb8-4840-89d1-b92007dc8da0	0781-1061	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Sandoz Inc	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0781-1077_d4bd9efd-efb8-4840-89d1-b92007dc8da0	0781-1077	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Sandoz Inc	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0781-1079_d4bd9efd-efb8-4840-89d1-b92007dc8da0	0781-1079	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Sandoz Inc	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0781-1089_d4bd9efd-efb8-4840-89d1-b92007dc8da0	0781-1089	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19980325		ANDA	ANDA074909	Sandoz Inc	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0781-1486_870a9f3e-7329-4043-8992-56948475f2b6	0781-1486	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085968	Sandoz Inc	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0781-1487_870a9f3e-7329-4043-8992-56948475f2b6	0781-1487	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085968	Sandoz Inc	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0781-1488_870a9f3e-7329-4043-8992-56948475f2b6	0781-1488	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771129		ANDA	ANDA085968	Sandoz Inc	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0781-1489_870a9f3e-7329-4043-8992-56948475f2b6	0781-1489	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771129		ANDA	ANDA085968	Sandoz Inc	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0781-1490_870a9f3e-7329-4043-8992-56948475f2b6	0781-1490	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085968	Sandoz Inc	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0781-1491_870a9f3e-7329-4043-8992-56948475f2b6	0781-1491	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085968	Sandoz Inc	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0781-1556_cbb707d7-7200-4be8-9e5a-805282cbf84d	0781-1556	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19880107		ANDA	ANDA086223	Sandoz Inc.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0781-1635_cbb707d7-7200-4be8-9e5a-805282cbf84d	0781-1635	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19880107		ANDA	ANDA086221	Sandoz Inc.	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0781-1683_1f37dec7-beb5-4add-84de-b49b69766b3e	0781-1683	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077946	Sandoz Inc	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0781-1684_2ca4b053-0031-4a34-a1b1-8eaadb0879c6	0781-1684	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077946	Sandoz Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0781-1695_cbb707d7-7200-4be8-9e5a-805282cbf84d	0781-1695	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19880107		ANDA	ANDA089367	Sandoz Inc.	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0781-1830_ad9bf0d1-0ab6-4e90-b47e-b197dab2b7e0	0781-1830	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	19751219	20240930	ANDA	ANDA084176	Sandoz Inc	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	
0781-1831_8bf6f9da-59d1-4b50-8664-880feaf0b4c0	0781-1831	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020315		ANDA	ANDA065064	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-1832_ad9bf0d1-0ab6-4e90-b47e-b197dab2b7e0	0781-1832	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	19750218	20240930	ANDA	ANDA084176	Sandoz Inc	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	
0781-1852_8bf6f9da-59d1-4b50-8664-880feaf0b4c0	0781-1852	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020314		ANDA	ANDA065063	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-1874_8bf6f9da-59d1-4b50-8664-880feaf0b4c0	0781-1874	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20050823		ANDA	ANDA065189	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-1943_5bd7896b-a564-4774-8149-e82ee34b988d	0781-1943	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20100421		ANDA	ANDA090227	Sandoz Inc	AMOXICILLIN; AMOXICILLIN SODIUM; CLAVULANATE POTASSIUM	562.5; 437.5; 62.5	mg/1; mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillin-class Antibacterial [EPC], Penicillins [CS], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-1961_a18fa357-b294-48b9-aabe-dad7d6259ba3	0781-1961	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20051018		ANDA	ANDA065144	Sandoz Inc	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0781-1962_a18fa357-b294-48b9-aabe-dad7d6259ba3	0781-1962	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20050825		ANDA	ANDA065136	Sandoz Inc	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0781-2020_c06b394a-21ce-4b4b-bca8-76a7db74335e	0781-2020	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	Sandoz Inc	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-2027_c557ec0a-af3a-4970-a937-6d2a3c6ee313	0781-2027	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	19960329	20240229	ANDA	ANDA074364	Sandoz Inc	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-2037_c557ec0a-af3a-4970-a937-6d2a3c6ee313	0781-2037	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	19960329	20240229	ANDA	ANDA074364	Sandoz Inc	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-2067_f52a65f0-268c-4f88-b6fd-b963ba8eae83	0781-2067	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	CAPSULE	ORAL	20081015		ANDA	ANDA065379	Sandoz Inc	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0781-2074_dc3acdb0-252d-4366-acd9-36487e64c344	0781-2074	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	19970605		ANDA	ANDA074821	Sandoz Inc	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0781-2076_8bb520cd-935f-42b8-87c7-19928c2ad696	0781-2076	HUMAN PRESCRIPTION DRUG	tamsulosin hydrochloride		tamsulosin hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078015	Sandoz Inc	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0781-2081_07ffc7b1-97bd-09ba-e063-6294a90a521c	0781-2081	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20120314	20240331	NDA AUTHORIZED GENERIC	NDA021160	Sandoz Inc	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
0781-2102_aeff451c-a626-48ec-96dc-91856beed049	0781-2102	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Sandoz Inc	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0781-2103_aeff451c-a626-48ec-96dc-91856beed049	0781-2103	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Sandoz Inc	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0781-2104_aeff451c-a626-48ec-96dc-91856beed049	0781-2104	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Sandoz Inc	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0781-2144_e8f470a8-ec75-4c1e-84d8-766372f61cf3	0781-2144	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	CAPSULE	ORAL	19950829		ANDA	ANDA064082	Sandoz Inc	AMPICILLIN TRIHYDRATE	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-2145_e8f470a8-ec75-4c1e-84d8-766372f61cf3	0781-2145	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	CAPSULE	ORAL	19950829		ANDA	ANDA064082	Sandoz Inc	AMPICILLIN TRIHYDRATE	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-2158_32529e77-3c54-4bee-ab7b-086e73d6a9af	0781-2158	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	CAPSULE	ORAL	20230109		ANDA	ANDA212600	Sandoz Inc	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
0781-2164_7df70d10-a688-4718-9364-ac4915dec366	0781-2164	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20130213		ANDA	ANDA077562	Sandoz Inc	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0781-2166_7df70d10-a688-4718-9364-ac4915dec366	0781-2166	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20130213		ANDA	ANDA077562	Sandoz Inc	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0781-2167_7df70d10-a688-4718-9364-ac4915dec366	0781-2167	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20130213		ANDA	ANDA077562	Sandoz Inc	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0781-2168_7df70d10-a688-4718-9364-ac4915dec366	0781-2168	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20130213		ANDA	ANDA077562	Sandoz Inc	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0781-2176_977d4566-20b3-4909-ad00-6cbea017798d	0781-2176	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20070406		ANDA	ANDA065330	Sandoz Inc	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-2234_a7952460-51d0-4188-b3e0-ec8e81e19585	0781-2234	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA076515	Sandoz Inc	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0781-2321_d95f0773-c69e-4b70-923a-bac29b2ca662	0781-2321	HUMAN PRESCRIPTION DRUG	Aprepitant		aprepitant	CAPSULE	ORAL	20161227		ANDA	ANDA090999	Sandoz Inc	APREPITANT	40	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0781-2322_d95f0773-c69e-4b70-923a-bac29b2ca662	0781-2322	HUMAN PRESCRIPTION DRUG	Aprepitant		aprepitant	CAPSULE	ORAL	20161227		ANDA	ANDA090999	Sandoz Inc	APREPITANT	80	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0781-2323_d95f0773-c69e-4b70-923a-bac29b2ca662	0781-2323	HUMAN PRESCRIPTION DRUG	Aprepitant		aprepitant	CAPSULE	ORAL	20161227		ANDA	ANDA090999	Sandoz Inc	APREPITANT	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0781-2329_2b154cf2-cde1-4c73-8823-9b8c162606b7	0781-2329	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Sandoz Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2335_2b154cf2-cde1-4c73-8823-9b8c162606b7	0781-2335	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Sandoz Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2343_2b154cf2-cde1-4c73-8823-9b8c162606b7	0781-2343	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Sandoz Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2352_2b154cf2-cde1-4c73-8823-9b8c162606b7	0781-2352	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Sandoz Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2361_d6f0b53d-f881-45d4-9b67-156ac55d5a26	0781-2361	HUMAN PRESCRIPTION DRUG	Methylphenidate		methylphenidate	CAPSULE, EXTENDED RELEASE	ORAL	20151124		NDA AUTHORIZED GENERIC	NDA021284	Sandoz Inc	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2362_d6f0b53d-f881-45d4-9b67-156ac55d5a26	0781-2362	HUMAN PRESCRIPTION DRUG	Methylphenidate		methylphenidate	CAPSULE, EXTENDED RELEASE	ORAL	20151124		NDA AUTHORIZED GENERIC	NDA021284	Sandoz Inc	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2363_d6f0b53d-f881-45d4-9b67-156ac55d5a26	0781-2363	HUMAN PRESCRIPTION DRUG	Methylphenidate		methylphenidate	CAPSULE, EXTENDED RELEASE	ORAL	20151124		NDA AUTHORIZED GENERIC	NDA021284	Sandoz Inc	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2364_d6f0b53d-f881-45d4-9b67-156ac55d5a26	0781-2364	HUMAN PRESCRIPTION DRUG	Methylphenidate		methylphenidate	CAPSULE, EXTENDED RELEASE	ORAL	20151124		NDA AUTHORIZED GENERIC	NDA021284	Sandoz Inc	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2368_2b154cf2-cde1-4c73-8823-9b8c162606b7	0781-2368	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Sandoz Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2371_2b154cf2-cde1-4c73-8823-9b8c162606b7	0781-2371	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Sandoz Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2613_c06b394a-21ce-4b4b-bca8-76a7db74335e	0781-2613	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	Sandoz Inc	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-2672_07ffc7b1-97bd-09ba-e063-6294a90a521c	0781-2672	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20120314	20240331	NDA AUTHORIZED GENERIC	NDA021160	Sandoz Inc	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
0781-2682_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2682	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20141112		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2683_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2683	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150203		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2684_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2684	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140128		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2685_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2685	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150622		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2686_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2686	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2687_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2687	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140102		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2688_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2688	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2689_f2976909-5df3-4d53-b2f9-e49a840b4cf7	0781-2689	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140304		NDA AUTHORIZED GENERIC	NDA021802	Sandoz Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
0781-2785_24a57c2e-eda8-4c3f-9c81-a28a5b9a9229	0781-2785	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20030128		ANDA	ANDA075757	Sandoz Inc	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0781-2790_24a57c2e-eda8-4c3f-9c81-a28a5b9a9229	0781-2790	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20030128		ANDA	ANDA075757	Sandoz Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0781-2855_ed4bcd49-22fa-4c8d-834a-4b6085889b4b	0781-2855	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	CAPSULE	ORAL	19971022		ANDA	ANDA074655	Sandoz Inc	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0781-2859_6a54ba13-eeb3-4c8c-800b-dc9aaf961c3f	0781-2859	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190701		ANDA	ANDA075757	Sandoz Inc	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0781-2865_ed4bcd49-22fa-4c8d-834a-4b6085889b4b	0781-2865	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	CAPSULE	ORAL	19971022		ANDA	ANDA074655	Sandoz Inc	RANITIDINE HYDROCHLORIDE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0781-2868_6a54ba13-eeb3-4c8c-800b-dc9aaf961c3f	0781-2868	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190701		ANDA	ANDA075757	Sandoz Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0781-3000_0b211cb8-b5db-f170-e063-6394a90a370f	0781-3000	HUMAN PRESCRIPTION DRUG	MEROPENEM		MEROPENEM	INJECTION	INTRAVENOUS	20160829		ANDA	ANDA206086	Sandoz Inc	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0781-3001_3d887ce0-f7f1-4b49-adb7-b70eb707a67e	0781-3001	HUMAN PRESCRIPTION DRUG	Omnitrope		Somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	20060530		BLA	BLA021426	Sandoz Inc	SOMATROPIN	5	mg/1.5mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
0781-3004_3d887ce0-f7f1-4b49-adb7-b70eb707a67e	0781-3004	HUMAN PRESCRIPTION DRUG	Omnitrope		Somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	20060530		BLA	BLA021426	Sandoz Inc	SOMATROPIN	10	mg/1.5mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
0781-3040_eaf2bbb9-562b-0e4e-e053-2a95a90abdea	0781-3040	HUMAN PRESCRIPTION DRUG	Regonol		Pyridostigmine Bromide	INJECTION, SOLUTION	INTRAVENOUS; PARENTERAL	20050510		NDA	NDA017398	Sandoz Inc	PYRIDOSTIGMINE BROMIDE	5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0781-3056_eac68d8a-8ef3-5301-e053-2a95a90a4fd0	0781-3056	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	INJECTION, SOLUTION	INTRAMUSCULAR	20060119		ANDA	ANDA040648	Sandoz Inc	ISONIAZID	100	mg/mL	Antimycobacterial [EPC]		N	20241231
0781-3059_27614ed2-aab9-4ceb-a780-36f0e84f186b	0781-3059	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	20030821		ANDA	ANDA040481	Sandoz Inc	DIGOXIN	250	ug/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0781-3079_005e02bd-7b42-4f50-b3f9-1155bc6467b5	0781-3079	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20190529		ANDA	ANDA205935	Sandoz Inc	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0781-3098_0b211cb8-b5db-f170-e063-6394a90a370f	0781-3098	HUMAN PRESCRIPTION DRUG	MEROPENEM		MEROPENEM	INJECTION	INTRAVENOUS	20160829		ANDA	ANDA206086	Sandoz Inc	MEROPENEM	1	g/30mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
0781-3110_86a475fb-ae53-49bb-9600-e9703a0f0a8b	0781-3110	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-3113_86a475fb-ae53-49bb-9600-e9703a0f0a8b	0781-3113	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-3114_86a475fb-ae53-49bb-9600-e9703a0f0a8b	0781-3114	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-3117_383f85cb-a660-498b-96b3-44e6b909520e	0781-3117	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20141029		ANDA	ANDA203557	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	12; 1.5	g/100mL; g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-3150_7cd4aad1-5953-4007-a209-df6dadd9c4e3	0781-3150	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20120716		ANDA	ANDA200154	Sandoz Inc	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0781-3152_6597eb5b-91cd-4100-a59f-f493447828b6	0781-3152	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20120716		ANDA	ANDA200159	Sandoz Inc	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0781-3153_7cd4aad1-5953-4007-a209-df6dadd9c4e3	0781-3153	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20120716		ANDA	ANDA200154	Sandoz Inc	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0781-3154_d175dab8-4ddf-49e0-855a-5af1ac6dec2d	0781-3154	HUMAN PRESCRIPTION DRUG	Ferumoxytol		ferumoxytol	INJECTION	INTRAVENOUS	20210715		ANDA	ANDA206604	Sandoz Inc	FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE	510	mg/17mL	Iron [CS], Parenteral Iron Replacement [EPC]		N	20241231
0781-3156_a309db84-6691-4628-85f9-750bba002be9	0781-3156	HUMAN PRESCRIPTION DRUG	Acetaminophen		acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20201206		ANDA	ANDA204052	Sandoz Inc	ACETAMINOPHEN	10	mg/mL			N	20241231
0781-3158_6260b3ba-2bf2-4196-a9f6-4e7e159be5a6	0781-3158	HUMAN PRESCRIPTION DRUG	bivalirudin		bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150615		NDA AUTHORIZED GENERIC	NDA020873	Sandoz Inc	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0781-3159_4258561a-b7ad-45e7-b722-a9f1767f0bff	0781-3159	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR	20111024		ANDA	ANDA201588	Sandoz Inc	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]		N	20241231
0781-3180_383f85cb-a660-498b-96b3-44e6b909520e	0781-3180	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20211025		ANDA	ANDA203557	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/250mL; g/250mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-3206_b235a3e4-c61a-4bd7-88c4-05aacac2df44	0781-3206	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Sandoz Inc	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3207_b235a3e4-c61a-4bd7-88c4-05aacac2df44	0781-3207	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Sandoz Inc	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3208_b235a3e4-c61a-4bd7-88c4-05aacac2df44	0781-3208	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Sandoz Inc	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3209_b235a3e4-c61a-4bd7-88c4-05aacac2df44	0781-3209	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Sandoz Inc	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3210_9b2c3afc-ccd7-44e6-875d-62176d5215ec	0781-3210	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20050517		ANDA	ANDA065168	Sandoz Inc	CEFTRIAXONE SODIUM	10	g/100mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3220_eaf32464-7950-434a-e053-2a95a90aa2dc	0781-3220	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION, SOLUTION	INTRAVENOUS	20081205		ANDA	ANDA079195	Sandoz Inc	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
0781-3232_86481823-7f41-4f48-8a41-9288ae512b1b	0781-3232	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20200330		ANDA	ANDA090296	Sandoz Inc	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0781-3233_d3c1a983-d2ee-1d8e-e053-2a95a90a87cd	0781-3233	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20141031		ANDA	ANDA204555	Sandoz Inc.	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0781-3234_fe78c284-c0a7-4860-a18d-16398de95e9f	0781-3234	HUMAN PRESCRIPTION DRUG	Glatopa		Glatiramer Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20150618		ANDA	ANDA090218	Sandoz Inc	GLATIRAMER ACETATE	20	mg/mL			N	20241231
0781-3238_f4e78371-47e9-4512-a435-de184591fbb7	0781-3238	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Sandoz Inc	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0781-3244_d3c1a983-d2ee-1d8e-e053-2a95a90a87cd	0781-3244	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20141031		ANDA	ANDA204555	Sandoz Inc.	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0781-3246_f4e78371-47e9-4512-a435-de184591fbb7	0781-3246	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Sandoz Inc	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0781-3250_fe78c284-c0a7-4860-a18d-16398de95e9f	0781-3250	HUMAN PRESCRIPTION DRUG	Glatopa		Glatiramer Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20180212		ANDA	ANDA206921	Sandoz Inc	GLATIRAMER ACETATE	40	mg/mL			N	20241231
0781-3253_0185bc36-7e60-42b3-b270-3b02ab0ae425	0781-3253	HUMAN PRESCRIPTION DRUG	Azacitidine		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20130916	20250228	NDA AUTHORIZED GENERIC	NDA050794	Sandoz Inc	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	
0781-3255_d3c1a983-d2ee-1d8e-e053-2a95a90a87cd	0781-3255	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20141031		ANDA	ANDA204555	Sandoz Inc.	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
0781-3256_f4e78371-47e9-4512-a435-de184591fbb7	0781-3256	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Sandoz Inc	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0781-3258_af4b1a62-3aa9-45bd-bc00-7f8276676cf2	0781-3258	HUMAN PRESCRIPTION DRUG	bortezomib		bortezomib for injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220531		ANDA	ANDA203654	Sandoz Inc	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
0781-3262_f4e78371-47e9-4512-a435-de184591fbb7	0781-3262	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Sandoz Inc	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0781-3268_f4e78371-47e9-4512-a435-de184591fbb7	0781-3268	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Sandoz Inc	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0781-3269_107cfcd6-4c40-404b-8483-7b08c9020c6a	0781-3269	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20171001		ANDA	ANDA209784	Sandoz Inc	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
0781-3288_e9ea55df-4c10-43a8-97f1-02e6fce12f2b	0781-3288	HUMAN PRESCRIPTION DRUG	Clindamycin in 5 Percent Dextrose		Clindamycin in 5 Percent Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20130207		ANDA	ANDA201692	Sandoz Inc	CLINDAMYCIN	6	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0781-3289_e9ea55df-4c10-43a8-97f1-02e6fce12f2b	0781-3289	HUMAN PRESCRIPTION DRUG	Clindamycin in 5 Percent Dextrose		Clindamycin in 5 Percent Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20130207		ANDA	ANDA201692	Sandoz Inc	CLINDAMYCIN	12	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0781-3290_e9ea55df-4c10-43a8-97f1-02e6fce12f2b	0781-3290	HUMAN PRESCRIPTION DRUG	Clindamycin in 5 Percent Dextrose		Clindamycin in 5 Percent Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20130207		ANDA	ANDA201692	Sandoz Inc	CLINDAMYCIN	18	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0781-3298_f4e78371-47e9-4512-a435-de184591fbb7	0781-3298	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Sandoz Inc	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0781-3299_f4e78371-47e9-4512-a435-de184591fbb7	0781-3299	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Sandoz Inc	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0781-3312_eaf2e7ed-02aa-ebab-e053-2a95a90a4d2b	0781-3312	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		Palonosetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180323		ANDA	ANDA202521	Sandoz Inc	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0781-3315_d65e5aba-65a6-4d70-ae9f-98dc57e0fdc0	0781-3315	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20150301		ANDA	ANDA078817	Sandoz Inc	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0781-3317_d65e5aba-65a6-4d70-ae9f-98dc57e0fdc0	0781-3317	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20150301		ANDA	ANDA078817	Sandoz Inc	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0781-3400_bb1d4c82-3c12-44a0-85f6-53a7b8d84116	0781-3400	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	125	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3402_bb1d4c82-3c12-44a0-85f6-53a7b8d84116	0781-3402	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3404_bb1d4c82-3c12-44a0-85f6-53a7b8d84116	0781-3404	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3407_bb1d4c82-3c12-44a0-85f6-53a7b8d84116	0781-3407	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3408_bb1d4c82-3c12-44a0-85f6-53a7b8d84116	0781-3408	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3409_5c2a04b5-bef6-4298-8a5a-4b766d3f8584	0781-3409	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	10	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3411_1608ee20-304e-4f78-a9ba-4d067836cdb5	0781-3411	HUMAN PRESCRIPTION DRUG	Anectine		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	20170622		NDA	NDA008453	Sandoz Inc	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
0781-3412_7f2ab7cf-8912-4f0e-881c-edce623ba39f	0781-3412	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19870219		ANDA	ANDA062738	Sandoz Inc	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3413_7f2ab7cf-8912-4f0e-881c-edce623ba39f	0781-3413	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19870219		ANDA	ANDA062738	Sandoz Inc	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-3415_eaf2e413-df5b-a9e4-e053-2995a90af1f1	0781-3415	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		Palonosetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180323		ANDA	ANDA202521	Sandoz Inc	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0781-3416_61eee1bb-bffc-4bf6-b3f7-421636e833db	0781-3416	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120530		ANDA	ANDA090862	Sandoz Inc	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0781-3420_fe80d00e-9eba-4192-9515-f9a5ad686a53	0781-3420	HUMAN PRESCRIPTION DRUG	Treprostinil		treprostinil	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190325		ANDA	ANDA203649	Sandoz Inc	TREPROSTINIL	20	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0781-3421_d70d52c0-6601-f632-e053-2995a90a9291	0781-3421	HUMAN PRESCRIPTION DRUG	CASPOFUNGIN ACETATE		CASPOFUNGIN ACETATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180904		ANDA	ANDA200833	Sandoz Inc	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0781-3422_eb406850-2047-b431-e053-2a95a90a78da	0781-3422	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20190905		ANDA	ANDA208905	Sandoz Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0781-3423_d70d52c0-6601-f632-e053-2995a90a9291	0781-3423	HUMAN PRESCRIPTION DRUG	CASPOFUNGIN ACETATE		CASPOFUNGIN ACETATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180904		ANDA	ANDA200833	Sandoz Inc	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
0781-3425_fe80d00e-9eba-4192-9515-f9a5ad686a53	0781-3425	HUMAN PRESCRIPTION DRUG	Treprostinil		treprostinil	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190325		ANDA	ANDA203649	Sandoz Inc	TREPROSTINIL	50	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0781-3427_fe80d00e-9eba-4192-9515-f9a5ad686a53	0781-3427	HUMAN PRESCRIPTION DRUG	Treprostinil		treprostinil	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190325		ANDA	ANDA203649	Sandoz Inc	TREPROSTINIL	100	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0781-3430_fe80d00e-9eba-4192-9515-f9a5ad686a53	0781-3430	HUMAN PRESCRIPTION DRUG	Treprostinil		treprostinil	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190325		ANDA	ANDA203649	Sandoz Inc	TREPROSTINIL	200	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
0781-3431_69427822-65b5-4d23-ae45-82dc703208f5	0781-3431	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	INJECTION, SOLUTION	INTRAVENOUS	20160615		ANDA	ANDA200904	Sandoz Inc	LINEZOLID	200	mg/100mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0781-3433_69427822-65b5-4d23-ae45-82dc703208f5	0781-3433	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	INJECTION, SOLUTION	INTRAVENOUS	20160615		ANDA	ANDA200904	Sandoz Inc	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0781-3440_4d4fe66b-4495-4421-94b8-800f34eda2e3	0781-3440	HUMAN PRESCRIPTION DRUG	Cosyntropin		Cosyntropin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120629		ANDA	ANDA202147	Sandoz Inc	COSYNTROPIN	.25	mg/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
0781-3443_d34eabc6-140f-7b11-e053-2a95a90aa069	0781-3443	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20190618		ANDA	ANDA206812	Sandoz Inc.	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
0781-3447_eddac8ab-ef06-4517-bbed-7ac30cc73df3	0781-3447	HUMAN PRESCRIPTION DRUG	Angiomax		bivalirudin	INJECTION	INTRAVENOUS	20190801		NDA	NDA020873	Sandoz Inc	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0781-3450_f59d0e26-9dc1-4229-82a0-0b787d5301dd	0781-3450	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	19881209		ANDA	ANDA062831	Sandoz Inc	CEFAZOLIN SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3451_f59d0e26-9dc1-4229-82a0-0b787d5301dd	0781-3451	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	19881209		ANDA	ANDA062831	Sandoz Inc	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3452_3f470704-ad01-49b0-bddf-d22e1a33941d	0781-3452	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; PARENTERAL	19881209		ANDA	ANDA062831	Sandoz Inc	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-3454_d34eabc6-140f-7b11-e053-2a95a90aa069	0781-3454	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20190618		ANDA	ANDA206812	Sandoz Inc.	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
0781-3458_eb406850-2047-b431-e053-2a95a90a78da	0781-3458	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA208905	Sandoz Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0781-3465_d34eabc6-140f-7b11-e053-2a95a90aa069	0781-3465	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20190618		ANDA	ANDA206812	Sandoz Inc.	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
0781-3466_eb406850-2047-b431-e053-2a95a90a78da	0781-3466	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA208905	Sandoz Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0781-3474_d34c110e-afec-0ef0-e053-2995a90a6e3e	0781-3474	HUMAN PRESCRIPTION DRUG	CARMUSTINE		CARMUSTINE	KIT		20210526		ANDA	ANDA211202	Sandoz Inc.						N	20241231
0781-3476_d34eabc6-140f-7b11-e053-2a95a90aa069	0781-3476	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20190618		ANDA	ANDA206812	Sandoz Inc.	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
0781-3481_6cf55dda-55df-48ee-9fe1-944ce41f93a0	0781-3481	HUMAN PRESCRIPTION DRUG	Tigecycline		Tigecycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20171130		ANDA	ANDA091620	Sandoz Inc	TIGECYCLINE	50	mg/10mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
0781-3484_e8055dfe-f5cd-4784-84e6-2d105b0d4c91	0781-3484	HUMAN PRESCRIPTION DRUG	fosaprepitant dimeglumine		fosaprepitant dimeglumine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220216		ANDA	ANDA203939	Sandoz Inc	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
0781-3492_505df3f5-1119-4d76-969f-a0a2ededd51f	0781-3492	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20190529		ANDA	ANDA205935	Sandoz Inc	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0781-3493_fdf227d9-008e-60f8-e053-6294a90af5c4	0781-3493	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	INJECTION	INTRAVENOUS	20200612		ANDA	ANDA209065	Sandoz Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0781-3494_fdf227d9-008e-60f8-e053-6294a90af5c4	0781-3494	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	INJECTION	INTRAVENOUS	20200612		ANDA	ANDA209065	Sandoz Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0781-3495_fdf227d9-008e-60f8-e053-6294a90af5c4	0781-3495	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	INJECTION	INTRAVENOUS	20200612		ANDA	ANDA209065	Sandoz Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
0781-3497_629d5f84-1866-4c98-b163-33ba0137a108	0781-3497	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200902	20240229	ANDA	ANDA212309	Sandoz Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	
0781-3498_ca1ecb72-cf90-41f4-874d-ca0d640f639d	0781-3498	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION, SOLUTION	INTRAVENOUS	20220519		ANDA	ANDA215359	Sandoz Inc	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
0781-3516_83d9f077-7a63-44d3-b86d-610ea0d83635	0781-3516	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE ACETATE		METHYLPREDNISOLONE ACETATE	INJECTION, SUSPENSION	INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20230208		ANDA	ANDA214870	Sandoz Inc.	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0781-3518_6f33b740-1984-4cb1-94f2-f618c529522d	0781-3518	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, SOLUTION	INTRAVENOUS	20220608		NDA	NDA214657	Sandoz Inc.	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0781-3519_6f33b740-1984-4cb1-94f2-f618c529522d	0781-3519	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, SOLUTION	INTRAVENOUS	20220608		NDA	NDA214657	Sandoz Inc.	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0781-3520_6f33b740-1984-4cb1-94f2-f618c529522d	0781-3520	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, SOLUTION	INTRAVENOUS	20220608		NDA	NDA214657	Sandoz Inc.	PEMETREXED DISODIUM	1000	mg/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0781-3522_83d9f077-7a63-44d3-b86d-610ea0d83635	0781-3522	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE ACETATE		METHYLPREDNISOLONE ACETATE	INJECTION, SUSPENSION	INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20231206		ANDA	ANDA214870	Sandoz Inc.	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0781-3532_141f439e-078c-4a59-acff-ebf7685f55b8	0781-3532	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20231101		ANDA	ANDA205935	Sandoz Inc	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0781-3755_eaf2eebc-d694-f15a-e053-2995a90a81b6	0781-3755	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		Norepinephrine Bitartrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20190423		ANDA	ANDA211359	Sandoz Inc	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
0781-3825_eaf4151c-b7ea-4b3a-e053-2995a90adf17	0781-3825	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190722		ANDA	ANDA211334	Sandoz Inc	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0781-3827_eaf4151c-b7ea-4b3a-e053-2995a90adf17	0781-3827	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190722		ANDA	ANDA211334	Sandoz Inc	GLYCOPYRROLATE	.4	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0781-3829_eaf4151c-b7ea-4b3a-e053-2995a90adf17	0781-3829	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190722		ANDA	ANDA211334	Sandoz Inc	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0781-3831_eaf4151c-b7ea-4b3a-e053-2995a90adf17	0781-3831	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190722		ANDA	ANDA211334	Sandoz Inc	GLYCOPYRROLATE	4	mg/20mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0781-4003_f4ad53f4-59ab-4405-b79d-2d7de920a383	0781-4003	HUMAN PRESCRIPTION DRUG	Leuprolide Acetate		Leuprolide Acetate	KIT		19980804		ANDA	ANDA074728	Sandoz Inc						N	20241231
0781-4004_3d887ce0-f7f1-4b49-adb7-b70eb707a67e	0781-4004	HUMAN PRESCRIPTION DRUG	Omnitrope		Somatropin	KIT		20060530		BLA	BLA021426	Sandoz Inc						N	20241231
0781-4027_e93866b2-8d8b-4eba-9651-5a8ff19d5860	0781-4027	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	CONCENTRATE	ORAL	20230331		ANDA	ANDA214542	Sandoz, Inc.	CHLORPROMAZINE HYDROCHLORIDE	30	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-4028_e93866b2-8d8b-4eba-9651-5a8ff19d5860	0781-4028	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	CONCENTRATE	ORAL	20230331		ANDA	ANDA214542	Sandoz, Inc.	CHLORPROMAZINE HYDROCHLORIDE	100	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-4063_d95f0773-c69e-4b70-923a-bac29b2ca662	0781-4063	HUMAN PRESCRIPTION DRUG	Aprepitant		aprepitant	KIT		20161227		ANDA	ANDA090999	Sandoz Inc						N	20241231
0781-4075_e0847494-9c83-446b-b999-706bcbf9c8d3	0781-4075	HUMAN PRESCRIPTION DRUG	Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium		Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium	KIT		20161012		NDA AUTHORIZED GENERIC	NDA022532	Sandoz Inc						N	20241231
0781-4103_d93e8f3e-2b9d-4512-ac14-61efb6db90d9	0781-4103	HUMAN PRESCRIPTION DRUG	Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium		Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium	KIT		20150801		NDA	NDA022574	Sandoz Inc						N	20241231
0781-4110_e911eff9-abfc-42b0-847c-e14d165604ee	0781-4110	HUMAN PRESCRIPTION DRUG	Estradiol Valerate and Estradiol Valerate/Dienogest		estradiol valerate and estradiol valerate/dienogest	KIT		20150805		NDA AUTHORIZED GENERIC	NDA022252	Sandoz Inc						N	20241231
0781-5022_9ea2987c-02ef-4032-8ddb-faba09203e15	0781-5022	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031	20240131	ANDA	ANDA040194	Sandoz Inc	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0781-5061_c06b394a-21ce-4b4b-bca8-76a7db74335e	0781-5061	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20050713		ANDA	ANDA065228	Sandoz Inc	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-5175_f52a65f0-268c-4f88-b6fd-b963ba8eae83	0781-5175	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	20081015		ANDA	ANDA065451	Sandoz Inc	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0781-5208_7ad950ff-aaff-4da0-b1ae-403d86fb06a2	0781-5208	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077478	Sandoz Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0781-5209_7ad950ff-aaff-4da0-b1ae-403d86fb06a2	0781-5209	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077478	Sandoz Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0781-5221_d3397c48-c061-4f60-800c-bf7564ac816b	0781-5221	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078227	Sandoz Inc	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0781-5222_d3397c48-c061-4f60-800c-bf7564ac816b	0781-5222	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078227	Sandoz Inc	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0781-5223_d3397c48-c061-4f60-800c-bf7564ac816b	0781-5223	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078227	Sandoz Inc	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0781-5224_d3397c48-c061-4f60-800c-bf7564ac816b	0781-5224	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078227	Sandoz Inc	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0781-5276_ba3b76a0-19e3-4b09-abef-bdcf3649a127	0781-5276	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20110510		ANDA	ANDA091198	Sandoz Inc	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0781-5277_ba3b76a0-19e3-4b09-abef-bdcf3649a127	0781-5277	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20110510		ANDA	ANDA091198	Sandoz Inc	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0781-5283_e783d7e9-6988-4872-8d56-91b651c26d58	0781-5283	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20080214		ANDA	ANDA078692	Sandoz Inc	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0781-5284_19a2fdfc-fc49-4226-8c8a-b428135ec4f7	0781-5284	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20080214		ANDA	ANDA078692	Sandoz Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0781-5315_a9697200-6b5e-4ce9-a653-6fb4b24f4854	0781-5315	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090107	Sandoz Inc	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0781-5316_a9697200-6b5e-4ce9-a653-6fb4b24f4854	0781-5316	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090107	Sandoz Inc	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0781-5317_7d2d2739-e084-4010-971a-b052bc8160f8	0781-5317	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20070423		ANDA	ANDA077322	Sandoz Inc	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0781-5318_7d2d2739-e084-4010-971a-b052bc8160f8	0781-5318	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20070423		ANDA	ANDA077322	Sandoz Inc	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0781-5325_ed58abc4-1571-46be-8190-29dcaed68fef	0781-5325	HUMAN PRESCRIPTION DRUG	Bromocriptine mesylate		Bromocriptine mesylate	TABLET	ORAL	19980113		ANDA	ANDA074631	Sandoz Inc	BROMOCRIPTINE MESYLATE	2.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
0781-5385_b2dfcb1c-526b-4678-8a71-e6fc12b6db5a	0781-5385	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20090813		ANDA	ANDA090422	Sandoz Inc	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0781-5386_b2dfcb1c-526b-4678-8a71-e6fc12b6db5a	0781-5386	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20090813		ANDA	ANDA090422	Sandoz Inc	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0781-5387_b2dfcb1c-526b-4678-8a71-e6fc12b6db5a	0781-5387	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20090813		ANDA	ANDA090422	Sandoz Inc	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0781-5420_114a7af7-cc48-4535-8b56-589941e5f521	0781-5420	HUMAN PRESCRIPTION DRUG	Pioglitazone		pioglitazone	TABLET	ORAL	20130301		ANDA	ANDA078670	Sandoz Inc	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0781-5421_114a7af7-cc48-4535-8b56-589941e5f521	0781-5421	HUMAN PRESCRIPTION DRUG	Pioglitazone		pioglitazone	TABLET	ORAL	20130301		ANDA	ANDA078670	Sandoz Inc	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0781-5422_114a7af7-cc48-4535-8b56-589941e5f521	0781-5422	HUMAN PRESCRIPTION DRUG	Pioglitazone		pioglitazone	TABLET	ORAL	20130301		ANDA	ANDA078670	Sandoz Inc	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0781-5438_6878b572-5711-43a8-9972-1410927f1f14	0781-5438	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20080528		ANDA	ANDA065462	Sandoz Inc	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-5439_6878b572-5711-43a8-9972-1410927f1f14	0781-5439	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20080528		ANDA	ANDA065462	Sandoz Inc	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0781-5514_d4ebe202-2232-4415-82ad-e73488b09757	0781-5514	HUMAN PRESCRIPTION DRUG	Griseofulvin		Griseofulvin	TABLET	ORAL	20130807		ANDA	ANDA091592	Sandoz Inc	GRISEOFULVIN	250	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0781-5515_d4ebe202-2232-4415-82ad-e73488b09757	0781-5515	HUMAN PRESCRIPTION DRUG	Griseofulvin		Griseofulvin	TABLET	ORAL	20130807		ANDA	ANDA091592	Sandoz Inc	GRISEOFULVIN	500	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0781-5554_b0e6f41c-217f-4203-a8dc-ecd2bceb069f	0781-5554	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA091414	Sandoz Inc	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
0781-5555_b0e6f41c-217f-4203-a8dc-ecd2bceb069f	0781-5555	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA091414	Sandoz Inc	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
0781-5560_b0e6f41c-217f-4203-a8dc-ecd2bceb069f	0781-5560	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA200889	Sandoz Inc	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
0781-5578_de04bffa-9751-4530-a742-add6331edf6b	0781-5578	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET, FILM COATED	ORAL	20140604		NDA AUTHORIZED GENERIC	NDA020796	Sandoz Inc	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0781-5613_1f90ca2f-e5b3-44a4-94a3-71b701abeb45	0781-5613	HUMAN PRESCRIPTION DRUG	Carbidopa, Levodopa, and Entacapone		Carbidopa, Levodopa, and Entacapone	TABLET, FILM COATED	ORAL	20140618		NDA AUTHORIZED GENERIC	NDA021485	Sandoz Inc	CARBIDOPA; ENTACAPONE; LEVODOPA	12.5; 200; 50	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0781-5625_1f90ca2f-e5b3-44a4-94a3-71b701abeb45	0781-5625	HUMAN PRESCRIPTION DRUG	Carbidopa, Levodopa, and Entacapone		Carbidopa, Levodopa, and Entacapone	TABLET, FILM COATED	ORAL	20140618		NDA AUTHORIZED GENERIC	NDA021485	Sandoz Inc	CARBIDOPA; ENTACAPONE; LEVODOPA	18.75; 200; 75	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0781-5626_b7db37b9-778e-4835-809c-13a65f7e1d8d	0781-5626	HUMAN PRESCRIPTION DRUG	Pioglitazone and metformin		Pioglitazone and metformin	TABLET, FILM COATED	ORAL	20130502		ANDA	ANDA091273	Sandoz Inc	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	500; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0781-5627_b7db37b9-778e-4835-809c-13a65f7e1d8d	0781-5627	HUMAN PRESCRIPTION DRUG	Pioglitazone and metformin		Pioglitazone and metformin	TABLET, FILM COATED	ORAL	20130502		ANDA	ANDA091273	Sandoz Inc	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	850; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0781-5634_724cb72e-023e-409c-8979-3a380a2fdc0a	0781-5634	HUMAN PRESCRIPTION DRUG	Pioglitazone hydrochloride and glimepiride		Pioglitazone hydrochloride and glimepiride	TABLET	ORAL	20130108		ANDA	ANDA201049	Sandoz Inc	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	2; 30	mg/1; mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0781-5635_724cb72e-023e-409c-8979-3a380a2fdc0a	0781-5635	HUMAN PRESCRIPTION DRUG	Pioglitazone hydrochloride and glimepiride		Pioglitazone hydrochloride and glimepiride	TABLET	ORAL	20130108		ANDA	ANDA201049	Sandoz Inc	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	4; 30	mg/1; mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0781-5637_1f90ca2f-e5b3-44a4-94a3-71b701abeb45	0781-5637	HUMAN PRESCRIPTION DRUG	Carbidopa, Levodopa, and Entacapone		Carbidopa, Levodopa, and Entacapone	TABLET, FILM COATED	ORAL	20140618		NDA AUTHORIZED GENERIC	NDA021485	Sandoz Inc	CARBIDOPA; ENTACAPONE; LEVODOPA	25; 200; 100	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0781-5641_1f90ca2f-e5b3-44a4-94a3-71b701abeb45	0781-5641	HUMAN PRESCRIPTION DRUG	Carbidopa, Levodopa, and Entacapone		Carbidopa, Levodopa, and Entacapone	TABLET, FILM COATED	ORAL	20140618		NDA AUTHORIZED GENERIC	NDA021485	Sandoz Inc	CARBIDOPA; ENTACAPONE; LEVODOPA	31.25; 200; 125	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0781-5654_1f90ca2f-e5b3-44a4-94a3-71b701abeb45	0781-5654	HUMAN PRESCRIPTION DRUG	Carbidopa, Levodopa, and Entacapone		Carbidopa, Levodopa, and Entacapone	TABLET, FILM COATED	ORAL	20140618		NDA AUTHORIZED GENERIC	NDA021485	Sandoz Inc	CARBIDOPA; ENTACAPONE; LEVODOPA	37.5; 200; 150	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0781-5667_a663ed16-1d0a-4ba7-a5df-dac789735767	0781-5667	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20111212		ANDA	ANDA200265	Sandoz Inc	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0781-5668_a663ed16-1d0a-4ba7-a5df-dac789735767	0781-5668	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20111212		ANDA	ANDA200265	Sandoz Inc	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0781-5669_1f90ca2f-e5b3-44a4-94a3-71b701abeb45	0781-5669	HUMAN PRESCRIPTION DRUG	Carbidopa, Levodopa, and Entacapone		Carbidopa, Levodopa, and Entacapone	TABLET, FILM COATED	ORAL	20140618		NDA AUTHORIZED GENERIC	NDA021485	Sandoz Inc	CARBIDOPA; ENTACAPONE; LEVODOPA	50; 200; 200	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
0781-5690_89afbf88-88a6-4de9-8f12-5804dadb83d6	0781-5690	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA203931	Sandoz Inc	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
0781-5747_97563214-8fa8-4eab-aa82-4151a9f6f722	0781-5747	HUMAN PRESCRIPTION DRUG	Teriflunomide		teriflunomide	TABLET, FILM COATED	ORAL	20230221		ANDA	ANDA209710	Sandoz Inc	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
0781-5755_97563214-8fa8-4eab-aa82-4151a9f6f722	0781-5755	HUMAN PRESCRIPTION DRUG	Teriflunomide		teriflunomide	TABLET, FILM COATED	ORAL	20230221		ANDA	ANDA209710	Sandoz Inc	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
0781-5780_d3bd26df-86a8-405a-ba67-5702cd8e089d	0781-5780	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120901		ANDA	ANDA201047	Sandoz Inc	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0781-5782_d3bd26df-86a8-405a-ba67-5702cd8e089d	0781-5782	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120901		ANDA	ANDA201047	Sandoz Inc	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0781-5784_d3bd26df-86a8-405a-ba67-5702cd8e089d	0781-5784	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120901		ANDA	ANDA201047	Sandoz Inc	ROPINIROLE HYDROCHLORIDE	6	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0781-5786_d3bd26df-86a8-405a-ba67-5702cd8e089d	0781-5786	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120901		ANDA	ANDA201047	Sandoz Inc	ROPINIROLE HYDROCHLORIDE	8	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0781-5788_d3bd26df-86a8-405a-ba67-5702cd8e089d	0781-5788	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120901		ANDA	ANDA201047	Sandoz Inc	ROPINIROLE HYDROCHLORIDE	12	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0781-5790_f03e9691-8fbe-4175-bc2e-5c627895bb71	0781-5790	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA077438	Sandoz Inc	LEVOFLOXACIN	250	mg/1			N	20241231
0781-5791_f03e9691-8fbe-4175-bc2e-5c627895bb71	0781-5791	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA077438	Sandoz Inc	LEVOFLOXACIN	500	mg/1			N	20241231
0781-5792_f03e9691-8fbe-4175-bc2e-5c627895bb71	0781-5792	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA077438	Sandoz Inc	LEVOFLOXACIN	750	mg/1			N	20241231
0781-5827_3361b60b-c6a2-422a-863c-c1ee80beb757	0781-5827	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Ultramicrosize Griseofulvin	TABLET, COATED	ORAL	20200401		ANDA	ANDA202805	Sandoz Inc	GRISEOFULVIN	125	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0781-5828_3361b60b-c6a2-422a-863c-c1ee80beb757	0781-5828	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Ultramicrosize Griseofulvin	TABLET, COATED	ORAL	20200401		ANDA	ANDA202805	Sandoz Inc	GRISEOFULVIN	250	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
0781-5987_7a606a30-c4f8-4694-9642-edb8e3cf5eee	0781-5987	HUMAN PRESCRIPTION DRUG	Carbamazepine	ER	Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	19960325		NDA AUTHORIZED GENERIC	NDA020234	Sandoz Inc	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0781-5988_7a606a30-c4f8-4694-9642-edb8e3cf5eee	0781-5988	HUMAN PRESCRIPTION DRUG	Carbamazepine	ER	Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	19960325		NDA AUTHORIZED GENERIC	NDA020234	Sandoz Inc	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0781-5994_e84ad77e-6737-44a6-a8f9-623dee31be05	0781-5994	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	19951130	20240229	ANDA	ANDA040104	Sandoz Inc	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	
0781-6000_bea0882b-df20-45e5-bbf9-410f54398313	0781-6000	HUMAN PRESCRIPTION DRUG	Difluprednate Ophthalmic		Difluprednate Ophthalmic	EMULSION	OPHTHALMIC	20130515		NDA AUTHORIZED GENERIC	NDA022212	Sandoz Inc	DIFLUPREDNATE	.5	mg/mL			N	20241231
0781-6014_9fc22b67-1ddb-4b7f-bbf8-f8ddf1d9554a	0781-6014	HUMAN PRESCRIPTION DRUG	Brinzolamide		Brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	20210308		NDA AUTHORIZED GENERIC	NDA020816	Sandoz Inc	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
0781-6021_fe80d00e-9eba-4192-9515-f9a5ad686a53	0781-6021	HUMAN PRESCRIPTION DRUG	DILUENT		water solution	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190325		ANDA	ANDA203649	Sandoz Inc	WATER	1	mL/mL			N	20241231
0781-6022_fcbab0c3-9fdb-40aa-9a17-e53f88a19bbc	0781-6022	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	FOR SUSPENSION	ORAL	20070904		ANDA	ANDA065283	Sandoz Inc	CLARITHROMYCIN	125	mg/5mL	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0781-6023_fcbab0c3-9fdb-40aa-9a17-e53f88a19bbc	0781-6023	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	FOR SUSPENSION	ORAL	20070904		ANDA	ANDA065283	Sandoz Inc	CLARITHROMYCIN	250	mg/5mL	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0781-6039_c06b394a-21ce-4b4b-bca8-76a7db74335e	0781-6039	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065387	Sandoz Inc	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-6041_c06b394a-21ce-4b4b-bca8-76a7db74335e	0781-6041	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065387	Sandoz Inc	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-6102_8bf6f9da-59d1-4b50-8664-880feaf0b4c0	0781-6102	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20020605		ANDA	ANDA065066	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-6104_8bf6f9da-59d1-4b50-8664-880feaf0b4c0	0781-6104	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20020605		ANDA	ANDA065066	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-6135_e76e56d8-13b5-4520-8aa3-9202ceef1a03	0781-6135	HUMAN PRESCRIPTION DRUG	Penicillin G Potassium		Penicillin G Potassium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010830		ANDA	ANDA065079	Sandoz Inc	PENICILLIN G POTASSIUM	5000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-6136_e76e56d8-13b5-4520-8aa3-9202ceef1a03	0781-6136	HUMAN PRESCRIPTION DRUG	Penicillin G Potassium		Penicillin G Potassium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010830		ANDA	ANDA065079	Sandoz Inc	PENICILLIN G POTASSIUM	20000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-6139_1a5e8fc9-d230-4b5d-bfb3-c93e33c65cf5	0781-6139	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	SUSPENSION	ORAL	20070813		ANDA	ANDA065358	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-6153_0e84343e-8796-4c54-8dcc-8448a231fcfa	0781-6153	HUMAN PRESCRIPTION DRUG	Penicillin G Sodium		Penicillin G Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010226		ANDA	ANDA065068	Sandoz Inc	PENICILLIN G SODIUM	5000000	[USP'U]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-6156_c06b394a-21ce-4b4b-bca8-76a7db74335e	0781-6156	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065378	Sandoz Inc	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-6157_c06b394a-21ce-4b4b-bca8-76a7db74335e	0781-6157	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065378	Sandoz Inc	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-6160_ecf89ead-16b2-91cf-e053-2995a90adc93	0781-6160	HUMAN PRESCRIPTION DRUG	Sevoflurane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20170125		ANDA	ANDA203793	Sandoz Inc.	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0781-6172_ecf9968e-58b0-4792-e053-2995a90aef25	0781-6172	HUMAN PRESCRIPTION DRUG	Desflurane		desflurane	LIQUID	RESPIRATORY (INHALATION)	20180226		ANDA	ANDA208234	Sandoz Inc.	DESFLURANE	240	mL/240mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
0781-6184_bfffa484-4105-45ec-ab1d-124e96639f35	0781-6184	HUMAN PRESCRIPTION DRUG	Tafluprost		Tafluprost	SOLUTION/ DROPS	OPHTHALMIC	20221205		ANDA	ANDA209040	Sandoz Inc	TAFLUPROST	.0045	mg/.3mL	Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]		N	20241231
0781-6185_85482fff-ce5d-449c-9bee-883e52713d6e	0781-6185	HUMAN PRESCRIPTION DRUG	Travoprost Ophthalmic Solution		travoprost	SOLUTION/ DROPS	OPHTHALMIC	20191218		NDA AUTHORIZED GENERIC	NDA021994	Sandoz Inc	TRAVOPROST	.04	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0781-6186_68fde9d5-fc6e-4693-89e6-79ccbabeb52e	0781-6186	HUMAN PRESCRIPTION DRUG	Ciprofloxacin and Dexamethasone		ciprofloxacin and dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20200810		NDA AUTHORIZED GENERIC	NDA021537	Sandoz Inc	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0781-6206_0badf913-d17f-4a9b-b440-d1fdef1f7819	0781-6206	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20161206		ANDA	ANDA202719	Sandoz Inc	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
0781-6270_84eef65d-7572-4d9e-9b77-b3aaa837f883	0781-6270	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		oxcarbazepine	SUSPENSION	ORAL	20010530		NDA AUTHORIZED GENERIC	NDA021285	Sandoz Inc	OXCARBAZEPINE	60	mg/mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0781-7054_b660ec42-fe99-4681-b7ed-167f41978710	0781-7054	HUMAN PRESCRIPTION DRUG	Erythromycin and Benzoyl Peroxide		Erythromycin and Benzoyl Peroxide	KIT	TOPICAL	20040329		ANDA	ANDA065112	Sandoz Inc.						N	20241231
0781-7077_5945b2c1-def7-4364-b716-bf633f6b6ce4	0781-7077	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	VAGINAL	20061031	20241130	ANDA	ANDA077264	Sandoz Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	
0781-7080_327f4ef7-b4c7-4e46-8ee4-e4a78f95ff76	0781-7080	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20130701		ANDA	ANDA090903	Sandoz Inc.	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0781-7094_b660ec42-fe99-4681-b7ed-167f41978710	0781-7094	HUMAN PRESCRIPTION DRUG	Erythromycin and Benzoyl Peroxide		Erythromycin and Benzoyl Peroxide	KIT	TOPICAL	20040329		ANDA	ANDA065112	Sandoz Inc.						N	20241231
0781-7104_eae28053-9c1d-4779-b322-6ed262879640	0781-7104	HUMAN PRESCRIPTION DRUG	Estradiol Transdermal System		Estradiol	PATCH	TRANSDERMAL	19941222		NDA AUTHORIZED GENERIC	NDA020375	Sandoz Inc	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7117_5a50e59c-d0f6-468e-9cff-4a85472dbb97	0781-7117	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	CREAM	TOPICAL	20120727		ANDA	ANDA200935	Sandoz Inc.	CALCIPOTRIENE	.05	mg/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
0781-7119_eae28053-9c1d-4779-b322-6ed262879640	0781-7119	HUMAN PRESCRIPTION DRUG	Estradiol Transdermal System		Estradiol	PATCH	TRANSDERMAL	19990305		NDA AUTHORIZED GENERIC	NDA020375	Sandoz Inc	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7122_eae28053-9c1d-4779-b322-6ed262879640	0781-7122	HUMAN PRESCRIPTION DRUG	Estradiol Transdermal System		Estradiol	PATCH	TRANSDERMAL	20030527		NDA AUTHORIZED GENERIC	NDA020375	Sandoz Inc	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7129_9a1c6881-b6bc-45b9-ac5c-c5912e30d921	0781-7129	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20141222		NDA AUTHORIZED GENERIC	NDA020538	Sandoz Inc	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7133_eae28053-9c1d-4779-b322-6ed262879640	0781-7133	HUMAN PRESCRIPTION DRUG	Estradiol Transdermal System		Estradiol	PATCH	TRANSDERMAL	19941222		NDA AUTHORIZED GENERIC	NDA020375	Sandoz Inc	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7134_eae28053-9c1d-4779-b322-6ed262879640	0781-7134	HUMAN PRESCRIPTION DRUG	Estradiol Transdermal System		Estradiol	PATCH	TRANSDERMAL	20080103		NDA AUTHORIZED GENERIC	NDA020375	Sandoz Inc	ESTRADIOL	.06	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7135_fe09f635-c4f0-4698-8468-d226257b6d58	0781-7135	HUMAN PRESCRIPTION DRUG	Moxifloxacin Ophthalmic Solution		moxifloxacin hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20030507		NDA AUTHORIZED GENERIC	NDA021598	Sandoz Inc	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0781-7136_eae28053-9c1d-4779-b322-6ed262879640	0781-7136	HUMAN PRESCRIPTION DRUG	Estradiol Transdermal System		Estradiol	PATCH	TRANSDERMAL	19980323		NDA AUTHORIZED GENERIC	NDA020375	Sandoz Inc	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7138_9a1c6881-b6bc-45b9-ac5c-c5912e30d921	0781-7138	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20141222		NDA AUTHORIZED GENERIC	NDA020538	Sandoz Inc	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7144_9a1c6881-b6bc-45b9-ac5c-c5912e30d921	0781-7144	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20141222		NDA AUTHORIZED GENERIC	NDA020538	Sandoz Inc	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7156_9a1c6881-b6bc-45b9-ac5c-c5912e30d921	0781-7156	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20141222		NDA AUTHORIZED GENERIC	NDA020538	Sandoz Inc	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7161_b5c8681b-5513-4d3e-90dc-9d11d8c1799c	0781-7161	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20160825		ANDA	ANDA203688	Sandoz Inc.	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 12	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
0781-7165_b85f9bc8-280a-4fb8-9094-a0a30545fc08	0781-7165	HUMAN PRESCRIPTION DRUG	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE		calcipotriene and betamethasone dipropionate	OINTMENT	TOPICAL	20140331		ANDA	ANDA201615	Sandoz Inc.	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
0781-7167_9a1c6881-b6bc-45b9-ac5c-c5912e30d921	0781-7167	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20141222		NDA AUTHORIZED GENERIC	NDA020538	Sandoz Inc	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
0781-7172_d6c8343f-d169-4924-9fa2-4fbf097a32a7	0781-7172	HUMAN PRESCRIPTION DRUG	Azelaic Acid Gel		azelaic acid	GEL	TOPICAL	20181001		NDA AUTHORIZED GENERIC	NDA021470	Sandoz Inc.	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
0781-7182_12b7a31c-65a0-46d4-a655-3015c95b6386	0781-7182	HUMAN PRESCRIPTION DRUG	Adapalene and Benzoyl Peroxide		Adapalene and Benzoyl Peroxide	GEL	TOPICAL	20180523		ANDA	ANDA206164	Sandoz Inc.	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
0781-7186_1f07e7ec-85b8-4b21-b17e-90c75b7f7906	0781-7186	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate and Timolol Maleate		Brimonidine Tartrate and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20220413		ANDA	ANDA091087	Sandoz Inc	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0781-7296_e994ce04-c737-6dc4-e053-2a95a90abd58	0781-7296	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20210315		NDA AUTHORIZED GENERIC	NDA020503	Sandoz Inc	ALBUTEROL SULFATE	108	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
0781-7304_74c49cb6-c091-4989-b36f-f327e22d73bc	0781-7304	HUMAN PRESCRIPTION DRUG	Rivastigmine		rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150902		NDA AUTHORIZED GENERIC	NDA022083	Sandoz Inc	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0781-7309_74c49cb6-c091-4989-b36f-f327e22d73bc	0781-7309	HUMAN PRESCRIPTION DRUG	Rivastigmine		rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150902		NDA AUTHORIZED GENERIC	NDA022083	Sandoz Inc	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0781-7313_74c49cb6-c091-4989-b36f-f327e22d73bc	0781-7313	HUMAN PRESCRIPTION DRUG	Rivastigmine		rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150902		NDA AUTHORIZED GENERIC	NDA022083	Sandoz Inc	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0781-7515_12e4cbdd-c6a9-4681-83b5-d40c9be009ef	0781-7515	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20150724		ANDA	ANDA201966	Sandoz Inc	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0781-7516_12e4cbdd-c6a9-4681-83b5-d40c9be009ef	0781-7516	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20150724		ANDA	ANDA201966	Sandoz Inc	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0781-7517_12e4cbdd-c6a9-4681-83b5-d40c9be009ef	0781-7517	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20150724		ANDA	ANDA201966	Sandoz Inc	BUDESONIDE	1	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0781-8004_4ea4be37-c7b1-4035-85d1-4a7cb4e2be40	0781-8004	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20081001		ANDA	ANDA074501	Sandoz Inc	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0781-8005_4ea4be37-c7b1-4035-85d1-4a7cb4e2be40	0781-8005	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20081001		ANDA	ANDA074501	Sandoz Inc	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0781-8006_4ea4be37-c7b1-4035-85d1-4a7cb4e2be40	0781-8006	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20081001		ANDA	ANDA074501	Sandoz Inc	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0781-8013_a538029f-6387-4ea1-aa62-ecd14f31e0b6	0781-8013	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181023		ANDA	ANDA209808	Sandoz Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
0781-8014_a538029f-6387-4ea1-aa62-ecd14f31e0b6	0781-8014	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181023		ANDA	ANDA209808	Sandoz Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
0781-8016_7a606a30-c4f8-4694-9642-edb8e3cf5eee	0781-8016	HUMAN PRESCRIPTION DRUG	Carbamazepine	ER	Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	19960325		NDA AUTHORIZED GENERIC	NDA020234	Sandoz Inc	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0781-8017_77459ca9-18bd-48ad-8cb4-7ce49bd0e7b6	0781-8017	HUMAN PRESCRIPTION DRUG	FLUVASTATIN SODIUM	ER	fluvastatin sodium	TABLET, EXTENDED RELEASE	ORAL	20151016		NDA AUTHORIZED GENERIC	NDA021192	Sandoz Inc	FLUVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0781-8028_3d0c73c1-bcda-4df6-b240-8d826cb6e65b	0781-8028	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085785	Sandoz Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8029_abab7b59-4411-4f8c-81b8-d03ed7cfa9b2	0781-8029	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161201		NDA AUTHORIZED GENERIC	NDA021875	Sandoz Inc	ARMODAFINIL	50	mg/1		CIV	N	20241231
0781-8032_3d0c73c1-bcda-4df6-b240-8d826cb6e65b	0781-8032	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085786	Sandoz Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8034_3d0c73c1-bcda-4df6-b240-8d826cb6e65b	0781-8034	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085789	Sandoz Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8036_3d0c73c1-bcda-4df6-b240-8d826cb6e65b	0781-8036	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085788	Sandoz Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8037_abab7b59-4411-4f8c-81b8-d03ed7cfa9b2	0781-8037	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161201		NDA AUTHORIZED GENERIC	NDA021875	Sandoz Inc	ARMODAFINIL	150	mg/1		CIV	N	20241231
0781-8045_abab7b59-4411-4f8c-81b8-d03ed7cfa9b2	0781-8045	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161201		NDA AUTHORIZED GENERIC	NDA021875	Sandoz Inc	ARMODAFINIL	200	mg/1		CIV	N	20241231
0781-8046_5dd6b06f-cc54-4370-8665-f428049ffe2e	0781-8046	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	19881208		ANDA	ANDA089685	Sandoz Inc	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8047_5dd6b06f-cc54-4370-8665-f428049ffe2e	0781-8047	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	19881208		ANDA	ANDA089685	Sandoz Inc	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8048_5dd6b06f-cc54-4370-8665-f428049ffe2e	0781-8048	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	19881208		ANDA	ANDA089685	Sandoz Inc	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8049_5dd6b06f-cc54-4370-8665-f428049ffe2e	0781-8049	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	19881208		ANDA	ANDA089685	Sandoz Inc	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0781-8052_d3b1f9c2-fa3b-4326-8561-507a20256520	0781-8052	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	SANDOZ INC.	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0781-8053_abab7b59-4411-4f8c-81b8-d03ed7cfa9b2	0781-8053	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161201		NDA AUTHORIZED GENERIC	NDA021875	Sandoz Inc	ARMODAFINIL	250	mg/1		CIV	N	20241231
0781-8061_d3b1f9c2-fa3b-4326-8561-507a20256520	0781-8061	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	SANDOZ INC.	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0781-8075_d3b1f9c2-fa3b-4326-8561-507a20256520	0781-8075	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	SANDOZ INC.	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0781-8080_d3b1f9c2-fa3b-4326-8561-507a20256520	0781-8080	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	SANDOZ INC.	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0781-8085_b22f432a-14bf-44b2-bb86-63dc277ce7ed	0781-8085	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220502		ANDA	ANDA212560	Sandoz Inc	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
0781-8086_b22f432a-14bf-44b2-bb86-63dc277ce7ed	0781-8086	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220502		ANDA	ANDA212560	Sandoz Inc	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
0781-8089_a43a036c-9af9-4429-b0c0-731001003fea	0781-8089	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065211	Sandoz Inc	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0781-8090_a43a036c-9af9-4429-b0c0-731001003fea	0781-8090	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065212	Sandoz Inc	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0781-8091_5cec3961-a2a4-4f61-a73e-1656021b4195	0781-8091	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065209	Sandoz Inc	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0781-8218_b04d3bbb-6154-41f7-bc95-318ae2e9a800	0781-8218	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	19880524	20240229	ANDA	ANDA072099	Sandoz Inc	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-8972_b04d3bbb-6154-41f7-bc95-318ae2e9a800	0781-8972	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	19880524	20240229	ANDA	ANDA072100	Sandoz Inc	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-8973_b04d3bbb-6154-41f7-bc95-318ae2e9a800	0781-8973	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	19880524	20240229	ANDA	ANDA072101	Sandoz Inc	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-8974_b04d3bbb-6154-41f7-bc95-318ae2e9a800	0781-8974	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	19880620	20240229	ANDA	ANDA072102	Sandoz Inc	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-8975_b04d3bbb-6154-41f7-bc95-318ae2e9a800	0781-8975	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	19880620	20240229	ANDA	ANDA072103	Sandoz Inc	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-8976_b04d3bbb-6154-41f7-bc95-318ae2e9a800	0781-8976	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	19880620	20240229	ANDA	ANDA072104	Sandoz Inc	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	
0781-9053_ee6b25ed-2fcd-43bc-b914-cfff37b82c19	0781-9053	HUMAN PRESCRIPTION DRUG	Anectine		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	20190612		NDA	NDA008453	Sandoz Inc	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
0781-9055_7a03f714-b109-4256-80a6-78c82127d624	0781-9055	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20230701		ANDA	ANDA205935	Sandoz Inc	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0781-9105_7d385062-ffa8-47c0-b139-8a1cb47a5452	0781-9105	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR	20111024		ANDA	ANDA201588	Sandoz Inc	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]		N	20241231
0781-9158_77e2ae87-3dbd-46dd-b745-9eea5fb9b2f1	0781-9158	HUMAN PRESCRIPTION DRUG	bivalirudin		bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151023		NDA AUTHORIZED GENERIC	NDA020873	Sandoz Inc	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
0781-9210_3097c42f-2a39-4387-ac52-d42f26c4eeca	0781-9210	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-9213_3097c42f-2a39-4387-ac52-d42f26c4eeca	0781-9213	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-9214_3097c42f-2a39-4387-ac52-d42f26c4eeca	0781-9214	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20101021		ANDA	ANDA065362	Sandoz Inc	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
0781-9226_eb4076c0-0b18-332f-e053-2a95a90aae13	0781-9226	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210217		ANDA	ANDA208905	Sandoz Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0781-9227_eb4076c0-0b18-332f-e053-2a95a90aae13	0781-9227	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210217		ANDA	ANDA208905	Sandoz Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0781-9228_eb4076c0-0b18-332f-e053-2a95a90aae13	0781-9228	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210217		ANDA	ANDA208905	Sandoz Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0781-9242_cb846971-32be-437a-a10c-c8d5dbc33989	0781-9242	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9250_cb846971-32be-437a-a10c-c8d5dbc33989	0781-9250	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9253_f7cb6926-a333-41dc-8700-b181ba7250dd	0781-9253	HUMAN PRESCRIPTION DRUG	Azacitidine		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140327	20240930	NDA AUTHORIZED GENERIC	NDA050794	Sandoz Inc	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	
0781-9261_cb846971-32be-437a-a10c-c8d5dbc33989	0781-9261	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9273_cb846971-32be-437a-a10c-c8d5dbc33989	0781-9273	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9274_2884e523-5f12-48d6-98dc-3a80cde524f8	0781-9274	HUMAN PRESCRIPTION DRUG	Acetaminophen		acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20201206		ANDA	ANDA204052	Sandoz Inc	ACETAMINOPHEN	10	mg/mL			N	20241231
0781-9315_01167ee3-8eca-428d-a822-7a7e41c40f60	0781-9315	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20160701		ANDA	ANDA078817	Sandoz Inc	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0781-9317_01167ee3-8eca-428d-a822-7a7e41c40f60	0781-9317	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20160701		ANDA	ANDA078817	Sandoz Inc	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0781-9401_1df09c62-4880-4d1c-be75-d8e721d5a74b	0781-9401	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	125	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9402_1df09c62-4880-4d1c-be75-d8e721d5a74b	0781-9402	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9404_1df09c62-4880-4d1c-be75-d8e721d5a74b	0781-9404	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9407_1df09c62-4880-4d1c-be75-d8e721d5a74b	0781-9407	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9408_1df09c62-4880-4d1c-be75-d8e721d5a74b	0781-9408	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9409_7cf3693c-1b10-4a21-8108-5215c49008a7	0781-9409	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19710303		ANDA	ANDA061395	Sandoz Inc	AMPICILLIN SODIUM	10	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9412_533ea477-1f9e-41d8-af25-9b7779103545	0781-9412	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19870219		ANDA	ANDA062738	Sandoz Inc	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0781-9413_533ea477-1f9e-41d8-af25-9b7779103545	0781-9413	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19870219		ANDA	ANDA062738	Sandoz Inc	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
0792-0002_a2b45d6a-4268-b586-e053-2995a90a3e84	0792-0002	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	LIQUID	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part333A	Siegfried USA, LLC	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
0799-0001_58f828af-7e71-4d87-b0d3-6e4174fb6293	0799-0001	HUMAN OTC DRUG	Calmoseptine		Anorectal Ointment	OINTMENT	TOPICAL	19500801		OTC MONOGRAPH FINAL	part346	Calmoseptine Inc.	LANOLIN; MENTHOL; PETROLATUM; ZINC OXIDE	15.7; .44; 24; 20.6	g/100g; g/100g; g/100g; g/100g			N	20241231
0802-2685_0c93bbb5-cb2d-1f6e-e063-6394a90a39f5	0802-2685	HUMAN OTC DRUG	Medis Sodium Bicarbonate		Sodium Bicarbonate	POWDER	ORAL	20171109		OTC MONOGRAPH DRUG	M001	Humco Holding Group, Inc	SODIUM BICARBONATE	1000	mg/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0813-0799_f28f9319-1a5b-276b-e053-2995a90a99bc	0813-0799	HUMAN PRESCRIPTION DRUG	Fem pH		Acetic Acid and Oxyquinoline sulfate	JELLY	VAGINAL	19990715		UNAPPROVED DRUG OTHER		Pharmics, Inc.	ACETIC ACID; OXYQUINOLINE SULFATE	.009; .00025	g/g; g/g			N	20241231
0832-0038_1b6f2fb5-4c01-4bde-9495-09b43861327f	0832-0038	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20111107		ANDA	ANDA074625	Upsher-Smith Laboratories, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0832-0111_a797175b-354e-477c-8bc0-345b5dd2bb2a	0832-0111	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		amantadine hydrochloride	TABLET	ORAL	20111215		ANDA	ANDA076186	Upsher-Smith Laboratories, LLC	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
0832-0225_7bf2aa48-883a-40f5-b1b8-5571ec335736	0832-0225	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0226_7bf2aa48-883a-40f5-b1b8-5571ec335736	0832-0226	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0227_7bf2aa48-883a-40f5-b1b8-5571ec335736	0832-0227	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0228_7bf2aa48-883a-40f5-b1b8-5571ec335736	0832-0228	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0229_7bf2aa48-883a-40f5-b1b8-5571ec335736	0832-0229	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0230_7bf2aa48-883a-40f5-b1b8-5571ec335736	0832-0230	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	80	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0233_7bf2aa48-883a-40f5-b1b8-5571ec335736	0832-0233	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0273_8fc9cdfb-07b2-4eda-b0e3-c1b030c35bb5	0832-0273	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	TABLET	ORAL	20190722		ANDA	ANDA210610	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0274_8fc9cdfb-07b2-4eda-b0e3-c1b030c35bb5	0832-0274	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	TABLET	ORAL	20190722		ANDA	ANDA210610	Upsher-Smith Laboratories, LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0832-0285_0392c67b-a83c-4e6c-95d6-09604953652d	0832-0285	HUMAN PRESCRIPTION DRUG	Bexarotene		Bexarotene	CAPSULE	ORAL	20180725		ANDA	ANDA209886	Upsher-Smith Laboratories, Inc.	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0832-0310_e7fcd602-83b9-48ad-b3e1-87e9310a59fc	0832-0310	HUMAN PRESCRIPTION DRUG	valproic acid		valproic acid	CAPSULE	ORAL	20111029		ANDA	ANDA073229	Upsher-Smith Laboratories, LLC	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0832-0356_2d8d4412-557f-4c2f-9dbb-936d16817f36	0832-0356	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20180417		ANDA	ANDA209013	Upsher-Smith laboratories, LLC	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0832-0357_2d8d4412-557f-4c2f-9dbb-936d16817f36	0832-0357	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20180417		ANDA	ANDA209013	Upsher-Smith laboratories, LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0832-0402_be725074-1864-4727-b820-6cabf1b58148	0832-0402	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET	ORAL	20190130		ANDA	ANDA211696	Upsher-Smith Laboratories, LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0832-0403_be725074-1864-4727-b820-6cabf1b58148	0832-0403	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET	ORAL	20190130		ANDA	ANDA211696	Upsher-Smith Laboratories, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0832-0465_7b84e67d-ec0d-4067-ba8b-6a85edd1cb99	0832-0465	HUMAN PRESCRIPTION DRUG	Nyamyc		Nystatin	POWDER	TOPICAL	20050503		ANDA	ANDA065183	Upsher-Smith Laboratories, LLC	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
0832-0510_723d911f-14f1-4039-9f30-889ef6cd93de	0832-0510	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20100124		ANDA	ANDA040633	Upsher-Smith Laboratories, LLC	BETHANECHOL CHLORIDE	5	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0832-0511_723d911f-14f1-4039-9f30-889ef6cd93de	0832-0511	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20100124		ANDA	ANDA040634	Upsher-Smith Laboratories, LLC	BETHANECHOL CHLORIDE	10	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0832-0512_723d911f-14f1-4039-9f30-889ef6cd93de	0832-0512	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20100124		ANDA	ANDA040635	Upsher-Smith Laboratories, LLC	BETHANECHOL CHLORIDE	25	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0832-0513_723d911f-14f1-4039-9f30-889ef6cd93de	0832-0513	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20100124		ANDA	ANDA040636	Upsher-Smith Laboratories, LLC	BETHANECHOL CHLORIDE	50	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0832-0536_18b1f8a0-4efa-41db-99e9-f836a17176ad	0832-0536	HUMAN PRESCRIPTION DRUG	Cholestyramine		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20220121		ANDA	ANDA214877	Upsher-Smith Laboratories,LLC	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
0832-0540_0c33dc02-8c80-408e-867c-cf49549f4a68	0832-0540	HUMAN PRESCRIPTION DRUG	Bumetanide		BUMETANIDE	TABLET	ORAL	20180130		ANDA	ANDA209916	Upsher-Smith Laboratories, LLC	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0832-0541_0c33dc02-8c80-408e-867c-cf49549f4a68	0832-0541	HUMAN PRESCRIPTION DRUG	Bumetanide		BUMETANIDE	TABLET	ORAL	20180130		ANDA	ANDA209916	Upsher-Smith Laboratories, LLC	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0832-0542_0c33dc02-8c80-408e-867c-cf49549f4a68	0832-0542	HUMAN PRESCRIPTION DRUG	Bumetanide		BUMETANIDE	TABLET	ORAL	20180130		ANDA	ANDA209916	Upsher-Smith Laboratories, LLC	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0832-0580_de3c3251-40dc-46ba-b6a1-5692fe01bf3a	0832-0580	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181022		ANDA	ANDA209687	Upsher-Smith Laboratories, LLC	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
0832-0581_de3c3251-40dc-46ba-b6a1-5692fe01bf3a	0832-0581	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181022		ANDA	ANDA209687	Upsher-Smith Laboratories, LLC	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
0832-0595_0896e18a-378e-4981-85cb-6ecd29f3475b	0832-0595	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET	ORAL	20170727		ANDA	ANDA209208	Upsher-Smith Laboratories, Inc.	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
0832-0630_e0475db2-c87f-4c1d-a619-e288451b0d73	0832-0630	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20170321		ANDA	ANDA074953	Upsher-Smith Laboratories, LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0832-0631_e0475db2-c87f-4c1d-a619-e288451b0d73	0832-0631	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20170321		ANDA	ANDA074953	Upsher-Smith Laboratories, LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0832-0632_e0475db2-c87f-4c1d-a619-e288451b0d73	0832-0632	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20170321		ANDA	ANDA074953	Upsher-Smith Laboratories, LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0832-0720_bfd15b0e-e34b-4f33-aeaf-4280c8c6c649	0832-0720	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA213661	Upsher-Smith Laboratories, LLC	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
0832-0721_bfd15b0e-e34b-4f33-aeaf-4280c8c6c649	0832-0721	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA213661	Upsher-Smith Laboratories, LLC	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
0832-0722_bfd15b0e-e34b-4f33-aeaf-4280c8c6c649	0832-0722	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA213661	Upsher-Smith Laboratories, LLC	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
0832-0740_38dfeb26-ff08-45c2-9f6f-57be81c204ac	0832-0740	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200625		ANDA	ANDA212744	Upsher-Smith Laboratories, LLC	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
0832-0741_38dfeb26-ff08-45c2-9f6f-57be81c204ac	0832-0741	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200625		ANDA	ANDA212744	Upsher-Smith Laboratories, LLC	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
0832-0742_38dfeb26-ff08-45c2-9f6f-57be81c204ac	0832-0742	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200625		ANDA	ANDA212744	Upsher-Smith Laboratories, LLC	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
0832-1015_41d066f0-524f-40a2-a154-bda550a8f41c	0832-1015	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		amantadine hydrochloride	CAPSULE, GELATIN COATED	ORAL	20110915		ANDA	ANDA070589	Upsher-Smith Laboratories, LLC	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
0832-1054_d8e8de4f-292a-4826-9219-0c7978de4672	0832-1054	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20101020		ANDA	ANDA074584	Upsher-Smith Laboratories, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0832-1055_d8e8de4f-292a-4826-9219-0c7978de4672	0832-1055	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20101020		ANDA	ANDA074584	Upsher-Smith Laboratories, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0832-1071_0b6b5600-c64c-405e-8fb2-bcd3a380e204	0832-1071	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0832-1072_0b6b5600-c64c-405e-8fb2-bcd3a380e204	0832-1072	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0832-1073_0b6b5600-c64c-405e-8fb2-bcd3a380e204	0832-1073	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0832-1074_0b6b5600-c64c-405e-8fb2-bcd3a380e204	0832-1074	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0832-1075_0b6b5600-c64c-405e-8fb2-bcd3a380e204	0832-1075	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA205122	Upsher-Smith Laboratories, LLC	TOPIRAMATE	150	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0832-1112_3db4220f-98af-40bf-9c52-cbbc7750179c	0832-1112	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20150731		ANDA	ANDA090043	Upsher-Smith Laboratories, LLC	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0832-1113_3db4220f-98af-40bf-9c52-cbbc7750179c	0832-1113	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20150731		ANDA	ANDA090043	Upsher-Smith Laboratories, LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0832-1120_2690f962-cb46-4e43-a41d-5d4a19126dd3	0832-1120	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TOPICAL	20140616		NDA AUTHORIZED GENERIC	NDA204399	Upsher-Smith Laboratories, LLC	TESTOSTERONE	50	mg/5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0832-1121_2690f962-cb46-4e43-a41d-5d4a19126dd3	0832-1121	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL, METERED	TOPICAL	20140616		NDA AUTHORIZED GENERIC	NDA204399	Upsher-Smith Laboratories, LLC	TESTOSTERONE	12.5	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
0832-1211_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1211	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1212_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1212	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1213_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1213	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1214_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1214	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1215_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1215	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1216_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1216	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1217_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1217	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1218_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1218	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1219_6bf07384-92a7-4543-9797-2edc079a9cbe	0832-1219	HUMAN PRESCRIPTION DRUG	Jantoven		Warfarin Sodium	TABLET	ORAL	20100223		ANDA	ANDA040416	Upsher-Smith Laboratories, LLC	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
0832-1250_d91c6a0a-5477-492a-a4a2-ebc71e068c16	0832-1250	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20201026		ANDA	ANDA213815	Upsher-Smith Laboratories, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
0832-1358_2d8d4412-557f-4c2f-9dbb-936d16817f36	0832-1358	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20180417		ANDA	ANDA209013	Upsher-Smith laboratories, LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0832-1359_2d8d4412-557f-4c2f-9dbb-936d16817f36	0832-1359	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20180417		ANDA	ANDA209013	Upsher-Smith laboratories, LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0832-1410_b740604e-1d7a-4382-90ca-26b0186f7a93	0832-1410	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	SOLUTION	OPHTHALMIC	20210210		ANDA	ANDA212616	Upsher-Smith Laboratories, LLC	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
0832-1425_7aa410f8-a849-49e1-a670-11114d7c003e	0832-1425	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate and Timolol Maleate		Brimonidine Tartrate and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20221215		ANDA	ANDA215598	Upsher-Smith Laboratories, LLC	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0832-1510_33081f36-a4b6-436b-bd33-05d08e734650	0832-1510	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	Upsher-Smith Laboratories, LLC	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0832-1520_33081f36-a4b6-436b-bd33-05d08e734650	0832-1520	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	Upsher-Smith Laboratories, LLC	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
0832-1530_33081f36-a4b6-436b-bd33-05d08e734650	0832-1530	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	Upsher-Smith Laboratories, LLC	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
0832-1540_33081f36-a4b6-436b-bd33-05d08e734650	0832-1540	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	Upsher-Smith Laboratories, LLC	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0832-1550_33081f36-a4b6-436b-bd33-05d08e734650	0832-1550	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	Upsher-Smith Laboratories, LLC	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
0832-1560_33081f36-a4b6-436b-bd33-05d08e734650	0832-1560	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	Upsher-Smith Laboratories, LLC	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
0832-1670_f21c8ec6-c05e-4d09-9421-db9ca33db605	0832-1670	HUMAN PRESCRIPTION DRUG	Fluvoxamine maleate		Fluvoxamine maleate	TABLET, FILM COATED	ORAL	20001129		ANDA	ANDA075888	Upsher-Smith Laboratories, LLC	FLUVOXAMINE MALEATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0832-1671_f21c8ec6-c05e-4d09-9421-db9ca33db605	0832-1671	HUMAN PRESCRIPTION DRUG	Fluvoxamine maleate		Fluvoxamine maleate	TABLET, FILM COATED	ORAL	20001129		ANDA	ANDA075888	Upsher-Smith Laboratories, LLC	FLUVOXAMINE MALEATE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0832-1672_f21c8ec6-c05e-4d09-9421-db9ca33db605	0832-1672	HUMAN PRESCRIPTION DRUG	Fluvoxamine maleate		Fluvoxamine maleate	TABLET, FILM COATED	ORAL	20001129		ANDA	ANDA075888	Upsher-Smith Laboratories, LLC	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0832-1690_1aad20d6-3c40-442c-b86d-e7a84973954b	0832-1690	HUMAN PRESCRIPTION DRUG	Ethacrynic Acid		Ethacrynic Acid	TABLET	ORAL	20200219		ANDA	ANDA212417	Upsher-Smith Laboratories, LLC	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0832-5322_a1cc3a02-f6a1-4a21-9507-c8cc66f2769f	0832-5322	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19860417		NDA	NDA019123	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0832-5323_a1cc3a02-f6a1-4a21-9507-c8cc66f2769f	0832-5323	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19860417		NDA	NDA019123	Upsher-Smith Laboratories, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0832-5324_0c4ca165-fb2d-406f-9e18-a54e67d94528	0832-5324	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	19981120		ANDA	ANDA074726	Upsher-SmithLaboratories, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0832-5325_0c4ca165-fb2d-406f-9e18-a54e67d94528	0832-5325	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	19981120		ANDA	ANDA074726	Upsher-SmithLaboratories, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0832-6003_94deeaea-6913-49ac-bdae-7f45419d17f5	0832-6003	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20221122		ANDA	ANDA213784	Upsher-Smith Laboratories,LLC	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6004_94deeaea-6913-49ac-bdae-7f45419d17f5	0832-6004	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20221122		ANDA	ANDA213784	Upsher-Smith Laboratories,LLC	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6005_94deeaea-6913-49ac-bdae-7f45419d17f5	0832-6005	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20221122		ANDA	ANDA213784	Upsher-Smith Laboratories,LLC	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6006_94deeaea-6913-49ac-bdae-7f45419d17f5	0832-6006	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20221122		ANDA	ANDA213784	Upsher-Smith Laboratories,LLC	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6017_c62b0702-358a-4b01-a908-c82dcae530da	0832-6017	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20110808		ANDA	ANDA083386	Upsher-Smith Laboratories, LLC	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6018_c62b0702-358a-4b01-a908-c82dcae530da	0832-6018	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20110803		ANDA	ANDA084112	Upsher-Smith Laboratories, LLC	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6019_c62b0702-358a-4b01-a908-c82dcae530da	0832-6019	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20110803		ANDA	ANDA084113	Upsher-Smith Laboratories, LLC	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6020_c62b0702-358a-4b01-a908-c82dcae530da	0832-6020	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20110803		ANDA	ANDA084114	Upsher-Smith Laboratories, LLC	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6021_c62b0702-358a-4b01-a908-c82dcae530da	0832-6021	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20110803		ANDA	ANDA084115	Upsher-Smith Laboratories, LLC	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0832-6022_8bbf550a-a827-45cc-85a5-4795ec14e2e5	0832-6022	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213311	Upsher-Smith Laboratories, LLC	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0832-6023_8bbf550a-a827-45cc-85a5-4795ec14e2e5	0832-6023	HUMAN PRESCRIPTION DRUG	Carbamazepin		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213311	Upsher-Smith Laboratories, LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0832-6024_8bbf550a-a827-45cc-85a5-4795ec14e2e5	0832-6024	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213311	Upsher-Smith Laboratories, LLC	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0832-6032_178bf3b7-fdee-454e-9446-822a1077d985	0832-6032	HUMAN PRESCRIPTION DRUG	Fluoxetine hydrochloride		Fluoxetine hydrochloride	FOR SOLUTION	ORAL	20221115		ANDA	ANDA216953	Upsher-Smith Laboratories, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0832-6045_287ca32d-6a1d-4b97-bb64-0e147b33af57	0832-6045	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SUSPENSION	ORAL	20230616		ANDA	ANDA217655	Upsher-Smith Laboratories, LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0832-6048_87f96927-31fd-4ca5-93d6-6ec6a861b28a	0832-6048	HUMAN PRESCRIPTION DRUG	Pitavastatin		Pitavastatin Calcium	TABLET	ORAL	20231102		ANDA	ANDA205955	Upsher-Smith Laboratories, LLC	PITAVASTATIN CALCIUM	1	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0832-6049_87f96927-31fd-4ca5-93d6-6ec6a861b28a	0832-6049	HUMAN PRESCRIPTION DRUG	Pitavastatin		Pitavastatin Calcium	TABLET	ORAL	20231102		ANDA	ANDA205955	Upsher-Smith Laboratories, LLC	PITAVASTATIN CALCIUM	2	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0832-6050_87f96927-31fd-4ca5-93d6-6ec6a861b28a	0832-6050	HUMAN PRESCRIPTION DRUG	Pitavastatin		Pitavastatin Calcium	TABLET	ORAL	20231102		ANDA	ANDA205955	Upsher-Smith Laboratories, LLC	PITAVASTATIN CALCIUM	4	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0832-6052_4626b909-5795-4eab-96b6-109c9fec9271	0832-6052	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	TABLET	ORAL	20221128		ANDA	ANDA216760	Upsher-Smith Laboratories, LLC	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0832-6053_12039f66-c368-4689-9aee-446e1305e92f	0832-6053	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	20230324		ANDA	ANDA216639	Upsher-Smith Laboratories, LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0832-6056_fd80b8da-62ca-47a5-8888-7c5906603203	0832-6056	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20230606		ANDA	ANDA217533	Upsher-Smith Laboratories, LLC	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0832-7122_ee84f30f-92ce-4c2a-a033-46b790196a77	0832-7122	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	Upsher-Smith Laboratories, LLC	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0832-7123_ee84f30f-92ce-4c2a-a033-46b790196a77	0832-7123	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	Upsher-Smith Laboratories, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0832-7124_ee84f30f-92ce-4c2a-a033-46b790196a77	0832-7124	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	Upsher-Smith Laboratories, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0832-8301_2828b839-a73c-43a2-a19f-08e7b7843426	0832-8301	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20120501		ANDA	ANDA076485	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0832-8302_2828b839-a73c-43a2-a19f-08e7b7843426	0832-8302	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20120501		ANDA	ANDA076485	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0832-8303_2828b839-a73c-43a2-a19f-08e7b7843426	0832-8303	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20150826		ANDA	ANDA076485	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0832-8304_2828b839-a73c-43a2-a19f-08e7b7843426	0832-8304	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20120501		ANDA	ANDA076485	Upsher-Smith Laboratories, LLC	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0869-0004_7a139bcd-8671-4b62-beee-3b513ef173e6	0869-0004	HUMAN OTC DRUG	Kids Anticavity		Kids Anticavity	MOUTHWASH	ORAL	20040406		OTC MONOGRAPH FINAL	part355	Vi Jon, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
0869-0005_255a10f2-802f-45f7-ad62-bc5329415176	0869-0005	HUMAN OTC DRUG	Sunburn Relief Gel		Lidocaine HCl	GEL	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part348	Vi-Jon, LLC	LIDOCAINE HYDROCHLORIDE	5.05	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0869-0020_0ff9aaa4-95eb-41c1-b53d-a441e10b017e	0869-0020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	PASTE	TOPICAL	20120510		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	ZINC OXIDE	532	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0869-0041_79229853-8adf-49d3-811d-f1f428e1dfe0	0869-0041	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20150113		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	19.8	mg/g			N	20241231
0869-0041_7e5cf9b1-8c2d-4387-bf4a-012bf219b578	0869-0041	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20080917		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	19.8	mg/g			N	20241231
0869-0050_e3aa664c-cb4d-4aea-bb9c-33aad154d056	0869-0050	HUMAN OTC DRUG	Povidone Iodine Solution First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20090507		OTC MONOGRAPH NOT FINAL	part333E	Vi Jon, LLC	POVIDONE-IODINE	10.34	mg/mL			N	20241231
0869-0055_4d602138-b469-42a8-ab40-5851e28bf0aa	0869-0055	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220919		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
0869-0059_9a336b5e-5a7a-46a1-aa70-bbe5f3672505	0869-0059	HUMAN OTC DRUG	Sunscreen		Sunscreen	LOTION	TOPICAL	20220817		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0063_c899d97b-094b-45bf-a5db-6bc90d918f3a	0869-0063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	19890715		OTC MONOGRAPH FINAL	part347	Vi Jon, LLC	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL			N	20241231
0869-0072_70668961-a5bb-4fd5-a5cb-d7da4f36c003	0869-0072	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl salicylate, thymol	MOUTHWASH	ORAL	19880720		OTC MONOGRAPH NOT FINAL	part356	Vi Jon, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0078_6fedd977-3944-44e7-a99c-f6488c933707	0869-0078	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	19890715		OTC MONOGRAPH NOT FINAL	part334	Vi-Jon, LLC	CASTOR OIL	1	g/mL			N	20241231
0869-0088_c191f146-c7e5-48aa-a692-8b127d13e335	0869-0088	HUMAN OTC DRUG	Iodine		Iodine	LIQUID	TOPICAL	20170807		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	IODINE	20	mg/mL			N	20241231
0869-0104_148dd832-fd9e-4a96-be9b-4a64982e0d49	0869-0104	HUMAN OTC DRUG	Oil-Free Astringent		Salicylic acid	LIQUID	TOPICAL	20160803		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	18	mg/mL			N	20241231
0869-0107_5f98cc57-b022-4dd8-a969-824147229a09	0869-0107	HUMAN OTC DRUG	Lanolin, Petrolatum		Lanolin, Petrolatum	OINTMENT	TOPICAL	20201230		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
0869-0109_05f2e865-825d-4d12-ba31-18f96ffa88b9	0869-0109	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220817		OTC MONOGRAPH NOT FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0153_d28e95be-eebd-46d9-8809-3aeb5fd0e443	0869-0153	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20090113		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
0869-0162_957a3eb3-6652-4d94-86a8-91c947af47f4	0869-0162	HUMAN OTC DRUG	Citroma		Magnesium Citrate	LIQUID	ORAL	20210908		OTC MONOGRAPH NOT FINAL	part334	Vi-Jon, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0869-0163_1dbcfb4f-244d-49a2-8171-1e2f85c9d93b	0869-0163	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20060513		OTC MONOGRAPH DRUG	M021	Vi-Jon, LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
0869-0164_74f5c93f-f503-4425-8189-8e772bdd26fb	0869-0164	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Vi-Jon, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0869-0166_99d0826f-0404-40ec-a46d-7c79210a11ec	0869-0166	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Vi-Jon, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0869-0180_368dec05-5b6d-4a92-a236-67c9bf9230a9	0869-0180	HUMAN OTC DRUG	Petrolatum		Petrolatum	OINTMENT	TOPICAL; TOPICAL	20080328		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	PETROLATUM	.34	g/g			N	20241231
0869-0205_0b6f63e7-e8a7-40a0-b7e9-c58ff87849ee	0869-0205	HUMAN OTC DRUG	Therapeutic Dandruff		Coal Tar	SHAMPOO	TOPICAL	20090513		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	COAL TAR	25	mg/mL			N	20241231
0869-0211_d53ec498-8cdb-42bb-823c-392df13844d1	0869-0211	HUMAN OTC DRUG	Isopropyl		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20040930		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ISOPROPYL ALCOHOL	924	mg/mL			N	20241231
0869-0213_7ebcf70d-bac3-41b3-a483-ded5ea619d2f	0869-0213	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20010621		OTC MONOGRAPH FINAL	part355	Vi Jon, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
0869-0218_84f5b367-e079-4e3d-ba97-8ade37bb2605	0869-0218	HUMAN OTC DRUG	Clear Anti Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	19940507		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0869-0247_b2fa150b-057b-46ac-9d71-eed8bd1fe7c5	0869-0247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20170320		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	PETROLATUM	340	mg/100g			N	20241231
0869-0248_d8561350-0ac6-446c-83df-c0bec188c187	0869-0248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	CREAM	TOPICAL	20210628		OTC MONOGRAPH FINAL	part341	Vi-Jon, LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	kg/100g; kg/100g; kg/100g			N	20241231
0869-0264_8e295586-c4e4-4d2e-8608-76d9b00077d4	0869-0264	HUMAN OTC DRUG	Acne Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20140218		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	BENZOYL PEROXIDE	104	mg/10g			N	20241231
0869-0295_f80ff737-021f-41bd-bfec-3ae3f9eafd85	0869-0295	HUMAN OTC DRUG	Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20100714		OTC MONOGRAPH NOT FINAL	part348	Vi-Jon, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	18; 882	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0869-0299_0553f228-8e8c-46b1-9837-cd8ac42cadbb	0869-0299	HUMAN OTC DRUG	Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	19950105		OTC MONOGRAPH NOT FINAL	part356	Vi-Jon, LLC	CETYLPYRIDINIUM CHLORIDE	.07	kg/100L			N	20241231
0869-0318_f6db5c3a-fb6c-4e23-9428-e3bd3bf09ae2	0869-0318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	19890715		OTC MONOGRAPH NOT FINAL	part356	Vi-Jon, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0336_1dff9f39-bfd4-43ae-81bf-bbef2fd9de33	0869-0336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL; TOPICAL	20170307		OTC MONOGRAPH NOT FINAL	part347	Vi-Jon, LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	8.6; 10; 20	mg/mL; mg/mL; mg/mL			N	20241231
0869-0338_d031f222-ddbd-406b-87c3-6fc3d56c1fcc	0869-0338	HUMAN OTC DRUG	daily moisturizer		Avobenzone, Octinoxate, Octisalate	LOTION	TOPICAL	20170806		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
0869-0353_42ff03e4-f74b-4694-9f2a-775bec18a660	0869-0353	HUMAN OTC DRUG	Body Wash		Salicylic Acid	GEL	TOPICAL	20150115		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	25	mg/mL			N	20241231
0869-0354_8b9e4f9e-6309-424f-bb91-3b117e2ebf45	0869-0354	HUMAN OTC DRUG	Daily Baby		Dimethicone	LOTION	TOPICAL	20170915		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	DIMETHICONE	13.1	mg/g	Skin Barrier Activity [PE]		N	20241231
0869-0370_48f05515-c19b-4ef7-aea5-452364926d3a	0869-0370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20140804		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
0869-0434_8d028d53-0c0b-46ca-bffb-41582c880432	0869-0434	HUMAN OTC DRUG	Tartar Control Plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130610		OTC MONOGRAPH NOT FINAL	part356	Vi-Jon, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0435_dc74b634-04b0-43bf-b5c2-f1a235760a4a	0869-0435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150909		OTC MONOGRAPH FINAL	part355	Vi-Jon, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
0869-0462_65e04542-7d7e-4f34-a1b0-70382a7e30aa	0869-0462	HUMAN OTC DRUG	Sore Mouth Cleanser		Hydrogen Peroxide	MOUTHWASH	TOPICAL	20170502		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	HYDROGEN PEROXIDE	1588	mg/mL			N	20241231
0869-0482_fd7d9e41-4888-494a-8660-509ac61201b8	0869-0482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20130201		OTC MONOGRAPH FINAL	part355	Vi-Jon, LLC	SODIUM FLUORIDE	219	mg/mL			N	20241231
0869-0496_15838609-ed3f-447d-81ca-ba394d1f1b6c	0869-0496	HUMAN OTC DRUG	Daily Baby		Dimethicone	LOTION	TOPICAL	20160428		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	DIMETHICONE	12.12	mg/mL	Skin Barrier Activity [PE]		N	20241231
0869-0503_9d1b27ec-99b8-4d64-8bfd-8568b97971e9	0869-0503	HUMAN OTC DRUG	Complete Beauty		Octinoxate	LOTION	TOPICAL	20060228		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	OCTINOXATE; ZINC OXIDE	60; 30	mg/mL; mg/mL			N	20241231
0869-0576_eac6e467-91f9-4804-a15b-843949bf8691	0869-0576	HUMAN OTC DRUG	Alcohol Free Refreshing Mint		Sodium fluoride	MOUTHWASH	ORAL	20170315		OTC MONOGRAPH FINAL	part355	Vi-Jon, LLC	SODIUM FLUORIDE	10.41	mg/mL			N	20241231
0869-0602_8148f7ac-c3ae-4de2-be9e-764ca8b8ddd4	0869-0602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	19980715		OTC MONOGRAPH NOT FINAL	part334	Vi-Jon, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0869-0619_45767d5f-a635-4664-8ea4-506525cf78bb	0869-0619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20150601		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
0869-0664_74c106cd-6f41-458e-8a2b-fc3957ba760e	0869-0664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19920715		OTC MONOGRAPH NOT FINAL	part356	Vi-Jon, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0711_431337d7-2173-4dac-86e2-03a7d6b02a2d	0869-0711	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.9; 133.9; 51.5; 72.1; 41.2	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0714_6c5ddf32-e5e3-478b-a6ee-1434f61d2c45	0869-0714	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate, Octocrylene		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20161128		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.3; 101; 50.5; 101	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0722_fcd2e007-cb98-414f-82fd-b25ef69ca79e	0869-0722	HUMAN OTC DRUG	Sheer Touch Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20170920		OTC MONOGRAPH NOT FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0727_bd242d9d-3569-47ce-854a-acf9dcb422aa	0869-0727	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	26.49; 132.45; 44.15; 52.98	mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0729_fe7d4689-08f9-4563-90f8-3a1e9c9f6049	0869-0729	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	26.49; 132.45; 43.45; 52.98	mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0730_d8c58e17-4c4b-44bd-801f-c359d4bbbd3e	0869-0730	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 150; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0752_c8d24d9a-a943-4707-8230-44920f1988eb	0869-0752	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.9; 133.9; 51.5; 72.1; 41.2	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0760_a643abf6-b299-4fca-a7b4-781d2b4ead19	0869-0760	HUMAN OTC DRUG	Sheer Touch Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20170920		OTC MONOGRAPH NOT FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 28; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0769_f116b709-221d-45f7-bd70-8a37abb694e9	0869-0769	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate, Octocrylene		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30.3; 101; 30.3	mg/mL; mg/mL; mg/mL			N	20241231
0869-0787_4424257f-643b-4b7f-95b0-2457d52172b0	0869-0787	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	26.49; 132.45; 44.15; 52.98	mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0788_57b05ae8-4ac3-43fc-875f-5aabe60372ba	0869-0788	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27.03; 135.15; 45.05; 90.1; 54.06	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0789_38e644e8-bec0-4b8e-abcc-2fc1b4b496ba	0869-0789	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	26.07; 86.9; 43.45; 34.76; 43.45	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0790_293e211c-cb28-4791-bace-53817f58c44d	0869-0790	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	25.95; 86.5; 43.25; 17.3; 34.6	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
0869-0792_1400ecda-d4f7-4fc4-b1ec-1eadd2ca873b	0869-0792	HUMAN OTC DRUG	Sheer Touch Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20170920		OTC MONOGRAPH NOT FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 80; 50; 40; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0793_77bf8553-d29e-47ff-99d2-8e04e5b090ac	0869-0793	HUMAN OTC DRUG	Active Sport		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20121201		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.6; 30.6; 45.9; 45.9; 55.08	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0804_68cc1f63-99f3-41f6-95ae-65333e82086c	0869-0804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH DRUG	M003	Vi-Jon, LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
0869-0810_b5a0a6a4-e043-442b-8c9e-3920728de1d9	0869-0810	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0869-0816_5666c6f1-ea5c-45a8-b8f2-2a3289638d2f	0869-0816	HUMAN OTC DRUG	Dandruff		Selenium sulfide	SHAMPOO	TOPICAL	20160925		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	SELENIUM SULFIDE	10	mg/mL			N	20241231
0869-0821_ea2ff7b6-3f4f-4320-a2ad-f6d508b436bb	0869-0821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20171214		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
0869-0822_a01b6af2-4ec0-4d43-9dcd-38b627ee6125	0869-0822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	19980129		OTC MONOGRAPH FINAL	part347	Vi-Jon	WITCH HAZEL	86	kg/100L			N	20241231
0869-0831_893c1e2a-4e28-4d0c-8e57-1acdfe590e13	0869-0831	HUMAN OTC DRUG	oil		Mineral Oil	OIL	ORAL	19890715		OTC MONOGRAPH NOT FINAL	part334	Vi-Jon, LLC	MINERAL OIL	1	mg/mL			N	20241231
0869-0845_dedb53ab-f129-4ea0-b858-acf106a92416	0869-0845	HUMAN OTC DRUG	70% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
0869-0850_8a48677f-8c7b-4df5-bf34-3f2cb9f2385d	0869-0850	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20171201		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	COAL TAR	1.02	mg/mL			N	20241231
0869-0855_57b643f2-2e6b-4020-9d93-c080a190113b	0869-0855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20221102		OTC MONOGRAPH NOT FINAL	part356	Vi-Jon, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0861_2b99bd26-4db3-4f1e-8ddd-7ee543df9971	0869-0861	HUMAN OTC DRUG	Oil Free Moisturizer		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20160225		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30.6; 76.5; 51	mg/mL; mg/mL; mg/mL			N	20241231
0869-0864_b41e3674-d723-4a6e-92fd-286340e251d4	0869-0864	HUMAN OTC DRUG	50% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
0869-0871_8e264ac5-4254-486b-8568-816bee70cf5a	0869-0871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20170709		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
0869-0875_df3aa8f1-1636-4fce-8202-ad1db0589c8e	0869-0875	HUMAN OTC DRUG	Salicylic Acid		Astringent	LIQUID	TOPICAL	20170318		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	5	mg/mL			N	20241231
0869-0876_b105e59a-676b-40cc-8a1e-32a90cbac2fc	0869-0876	HUMAN OTC DRUG	Rubbing		Ethyl Alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
0869-0894_aa193f90-f7b9-44aa-8da5-2b2e9b326705	0869-0894	HUMAN OTC DRUG	Gel Cooling Pain Relief		Menthol	GEL	TOPICAL	20210113		OTC MONOGRAPH NOT FINAL	part348	Vi-Jon, LLC	MENTHOL	160	mg/mL			N	20241231
0869-0909_e13dc711-69cc-4349-80a9-80098e13ccd8	0869-0909	HUMAN OTC DRUG	Octinoxate, Zinc Oxide		Octinoxate, Zinc Oxide	LOTION	TOPICAL	20160317		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
0869-0910_049645e7-a68f-4b6c-96bf-de0d403678f2	0869-0910	HUMAN OTC DRUG	Salicylic Acid		Salicylic Acid	CREAM	TOPICAL	20160301		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	20.6	mg/mL			N	20241231
0869-0940_c4ebda60-d0d6-464d-b55d-43713bd96854	0869-0940	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
0869-0947_d856066e-55ff-4c88-9ee8-0630aae9d843	0869-0947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic acid 2%	LOTION	TOPICAL	20170320		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	20.6	mg/mL			N	20241231
0869-0948_894af424-9ad0-4ef2-af9e-0531c2da9232	0869-0948	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231002		OTC MONOGRAPH NOT FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
0869-0949_8d857874-3ea0-44df-9193-50d11109d978	0869-0949	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230929		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
0869-0950_afc1012b-2950-41ec-a962-0437213f77ba	0869-0950	HUMAN OTC DRUG	Moisturizing Sunscreen SPF 50		Sunscreen	LOTION	TOPICAL	20230929		OTC MONOGRAPH DRUG	M020	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
0869-0965_31334826-f01f-4c96-9ea9-a9ce345bab19	0869-0965	HUMAN OTC DRUG	Colloidal oatmeal		Colloidal oatmeal	CREAM	TOPICAL	20140422		OTC MONOGRAPH FINAL	part347	Vi-Jon	OATMEAL	10.4	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
0869-0995_098f76d7-dfeb-433e-9422-011b93dfee9d	0869-0995	HUMAN OTC DRUG	Octinoxate, Octisalate, Avobenzone		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20160225		OTC MONOGRAPH FINAL	part352	Vi-Jon	AVOBENZONE; OCTINOXATE; OCTISALATE	30.6; 76.5; 51	mg/mL; mg/mL; mg/mL			N	20241231
0869-9054_60c0428f-7af6-4bea-b3e7-312eb98aa810	0869-9054	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230503		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
0869-9055_fca93c61-f47c-4cc4-8b50-31885a2f6ad0	0869-9055	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230503		OTC MONOGRAPH FINAL	part352	Vi-Jon, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
0884-0293_5a414cfc-14d4-453a-8cef-ebe675f0153b	0884-0293	HUMAN OTC DRUG	fungoid tincture		miconazole nitrate	TINCTURE	TOPICAL	20120411		OTC MONOGRAPH FINAL	part333C	Pedinol Pharmacal, Inc.	MICONAZOLE NITRATE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0904-0012_c8f5dd09-fd34-4558-ac27-a9e64ff503a9	0904-0012	HUMAN OTC DRUG	Allergy		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-0049_b4acb76b-96a9-4e3b-a615-f40c75949c85	0904-0049	HUMAN OTC DRUG	formula em		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	19940415		UNAPPROVED DRUG OTHER		Major Pharmaceuticals	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
0904-0201_2c82268e-1a92-4551-a3dd-5f5cdefee692	0904-0201	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20090610		ANDA	ANDA085968	Major Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-0202_2c82268e-1a92-4551-a3dd-5f5cdefee692	0904-0202	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20090610		ANDA	ANDA085968	Major Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-0250_a86ef9a4-8bbf-4be5-83a9-df374c7c1576	0904-0250	HUMAN OTC DRUG	Aprodine		Pseudoephedrine HCl and Triprolidine HCl	TABLET, FILM COATED	ORAL	19930109	20240505	OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	60; 2.5	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
0904-0358_8c97b943-1051-4d87-84f5-8b0cc0602ffd	0904-0358	HUMAN PRESCRIPTION DRUG	Hydroxyzine		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20070320		ANDA	ANDA040787	Major Pharmaceuticals	HYDROXYZINE HYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-0359_8c97b943-1051-4d87-84f5-8b0cc0602ffd	0904-0359	HUMAN PRESCRIPTION DRUG	Hydroxyzine		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20070320		ANDA	ANDA040788	Major Pharmaceuticals	HYDROXYZINE HYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-0428_da4320ee-cf2e-419a-867a-4b4086815c4e	0904-0428	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20080805		ANDA	ANDA062396	Major Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0904-0430_a43d088c-e5b1-4bff-ac7e-e4641f0dabba	0904-0430	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20030702		ANDA	ANDA065095	Major Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0904-0722_d4c0d927-7a7a-4b89-ba8e-5f05659586bf	0904-0722	HUMAN OTC DRUG	Tolnaftate		TOLNAFTATE	CREAM	TOPICAL	20100211		OTC MONOGRAPH FINAL	part333C	Major Pharmaceuticals	TOLNAFTATE	10	mg/g			N	20241231
0904-0734_498a98ce-16d9-4997-b6a1-8275d2b18bd2	0904-0734	HUMAN OTC DRUG	TRIPLE ANTIBIOTIC		Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate	OINTMENT	TOPICAL	20110601		OTC MONOGRAPH FINAL	part333B	Major Pharmaceuticals	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0904-0788_092fd18b-633d-484d-e063-6394a90ac521	0904-0788	HUMAN OTC DRUG	MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	LIQUID	ORAL	20101208		OTC MONOGRAPH DRUG	M007	MAJOR Pharmaceuticals Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-1102_931d28a6-d1d1-49f0-b58b-53492e35d817	0904-1102	HUMAN OTC DRUG	Major Povidone Iodine		POVIDONE-IODINE	OINTMENT	TOPICAL	20060814		OTC MONOGRAPH FINAL	part333C	Major Pharmaceuticals	POVIDONE-IODINE	100	mg/g			N	20241231
0904-1103_0ac2bc01-90a6-7492-e063-6294a90a4532	0904-1103	HUMAN OTC DRUG	povidone iodine		povidone iodine	SOLUTION	TOPICAL	20111221		OTC MONOGRAPH DRUG	M003	Major Pharmaceuticals	POVIDONE-IODINE	100	mg/mL			N	20241231
0904-1987_a60078f1-193f-9ed2-e053-2995a90abcb3	0904-1987	HUMAN OTC DRUG	MAPAP	Extra Strength	Acetaminophen	CAPSULE	ORAL	19971222		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	500	mg/1			N	20241231
0904-2015_61d9afec-c0ff-428d-88c0-1ec66ecb694c	0904-2015	HUMAN OTC DRUG	Tri-Buffered Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19900330		OTC MONOGRAPH DRUG	M013	Major Pharmaceuticals	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-2035_a2a395d4-45f9-9db7-e053-2995a90a6412	0904-2035	HUMAN OTC DRUG	Banophen		Diphenhydramine HCl	CAPSULE	ORAL	20090102		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-2051_b9315992-bfda-427a-9397-1d3d3f0c0db7	0904-2051	HUMAN OTC DRUG	Driminate		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	Major Pharmaceuticals	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-2056_a2a395d4-45f9-9db7-e053-2995a90a6412	0904-2056	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20090102		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-2500_0bb2ee47-8a0d-00ff-e063-6394a90a1a40	0904-2500	HUMAN OTC DRUG	FIBER TABS		calcium polycarbophil	TABLET, FILM COATED	ORAL	20100901		OTC MONOGRAPH DRUG	M007	Major Pharmaceuticals	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
0904-2528_e48b8846-df0d-43f7-bb36-e10bb9d9692c	0904-2528	HUMAN OTC DRUG	lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070816		OTC MONOGRAPH FINAL	part358G	Major Pharmaceuticals	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
0904-2533_8a532bb2-117d-4b42-a4a9-768af4e44e45	0904-2533	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20130107		OTC MONOGRAPH FINAL	part347	Major Pharmaceuticals	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; mg/mL			N	20241231
0904-2725_ab6c95db-cd6d-4646-830a-d8474ccb3a2a	0904-2725	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20090811		ANDA	ANDA076899	Major Pharmaceuticals	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
0904-3854_e138c248-7101-4d8f-8387-2c3e57cd36e0	0904-3854	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, CHEWABLE	ORAL	20100322		ANDA	ANDA075712	Major Pharmaceuticals	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-4040_dc0a44c3-e6fb-4897-b74b-0f752f452e9e	0904-4040	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20071212		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-4274_90a11c7b-68d5-4855-b4a1-5a3486e7af2a	0904-4274	HUMAN OTC DRUG	Sleep Tabs		Diphenhydramine HCl	TABLET	ORAL	19900410		OTC MONOGRAPH DRUG	M010	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-5053_af076662-07f8-4cfa-ae25-5a9ad08ee6b0	0904-5053	HUMAN OTC DRUG	SudoGest		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-5135_ff100b38-67f4-4d87-9136-ddefa33e36f3	0904-5135	HUMAN OTC DRUG	Pain Reliever Plus		Acetaminophen, Aspirin and caffeine	TABLET, FILM COATED	ORAL	19921117		OTC MONOGRAPH DRUG	M013	Major Pharmaceuticals	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
0904-5154_cba0084f-ce10-40e4-948b-42fc7622440f	0904-5154	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20091005		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	GUAIFENESIN	200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0904-5259_b1367f00-0447-485c-8504-3dabe0bc95f1	0904-5259	HUMAN OTC DRUG	Major Thera-Gel Therapeutic	Anti-Dandruff	Coal Tar	SHAMPOO	TOPICAL	20070901		OTC MONOGRAPH FINAL	part358H	Major Pharmaceuticals	COAL TAR	5	mg/mL			N	20241231
0904-5306_a2a395d4-45f9-9db7-e053-2995a90a6412	0904-5306	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20090102		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-5307_a61584fa-4f2c-207f-e053-2a95a90a6db5	0904-5307	HUMAN OTC DRUG	Banophen		diphenhydramine hcl	CAPSULE	ORAL	20091102		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-5309_79a46f8f-e792-448e-8dd6-2b9eee6303c0	0904-5309	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	19990207		ANDA	ANDA074937	Major Pharmaceuticals	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-5351_0392b11a-e04e-4ce0-b4ce-4f86701090ee	0904-5351	HUMAN OTC DRUG	SudoGest		Chlorpheniramine maleate, pseudoephedrine HCl	TABLET	ORAL	19921216		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	4; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-5354_fea40969-7f10-4f6a-b4e7-8afa9d24e661	0904-5354	HUMAN OTC DRUG	Banophen		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20090619		OTC MONOGRAPH NOT FINAL	part348	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-5365_22ed4b8a-3b98-44b1-8375-ee871f863d7c	0904-5365	HUMAN OTC DRUG	Acid Gone Antacid	Extra Strength	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20140606		OTC MONOGRAPH DRUG	M001	Major Pharmaceuticals	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
0904-5415_93c58543-e10e-4ff9-82d9-09b3be152677	0904-5415	HUMAN OTC DRUG	Miconazole 3 Combination Pack		miconazole nitrate	KIT	VAGINAL	20021202		ANDA	ANDA074926	Major Pharmaceuticals						N	20241231
0904-5448_32d8aca0-ea31-46f6-a5e9-f730cb7346b3	0904-5448	HUMAN PRESCRIPTION DRUG	PENTOXIFYLLINE		PENTOXIFYLLINE	TABLET, EXTENDED RELEASE	ORAL	19990610		ANDA	ANDA075191	Major Pharmaceuticals	PENTOXIFYLLINE	400	mg/1	Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]		N	20241231
0904-5463_30293465-3322-46e1-b3e1-b1d0055624e6	0904-5463	HUMAN OTC DRUG	ibuprofen		ibuprofen	SUSPENSION	ORAL	20000108		ANDA	ANDA075217	Major Pharmaceuticals	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-5502_6002936e-3077-42f4-8e89-81259bbfbfb7	0904-5502	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Major Pharmaceuticals	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0904-5522_17cf30fb-edf2-442a-a743-5a731ca1c1ab	0904-5522	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Major Pharmaceuticals	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-5523_17cf30fb-edf2-442a-a743-5a731ca1c1ab	0904-5523	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Major Pharmaceuticals	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-5524_17cf30fb-edf2-442a-a743-5a731ca1c1ab	0904-5524	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Major Pharmaceuticals	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-5529_170a7abb-2877-4286-9888-77c3671195f4	0904-5529	HUMAN OTC DRUG	heartburn relief	original strength	Famotidine	TABLET	ORAL	20090909		ANDA	ANDA075400	Major Pharmaceuticals	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0904-5551_3fdd1d21-b241-4357-9d8f-01dd16bb4a87	0904-5551	HUMAN OTC DRUG	Banophen		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-5577_6b883ef7-cb66-414a-81ae-8c2587240eeb	0904-5577	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20020403		ANDA	ANDA074937	Major Pharmaceuticals	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-5609_6002936e-3077-42f4-8e89-81259bbfbfb7	0904-5609	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Major Pharmaceuticals	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0904-5610_6002936e-3077-42f4-8e89-81259bbfbfb7	0904-5610	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Major Pharmaceuticals	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0904-5611_6002936e-3077-42f4-8e89-81259bbfbfb7	0904-5611	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Major Pharmaceuticals	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
0904-5675_30635d66-a6f0-4b15-b007-526f56c1afd0	0904-5675	HUMAN OTC DRUG	FIBER THERAPY		methylcellulose	POWDER, FOR SOLUTION	ORAL	20080418		OTC MONOGRAPH DRUG	M007	Major Pharmaceuticals	METHYLCELLULOSE (4000 MPA.S)	2	g/19g			N	20241231
0904-5676_1610a394-8fdd-44ec-8da0-78d4b56bee39	0904-5676	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Major Pharmaceuticals	PAROXETINE HYDROCHLORIDE ANHYDROUS	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-5677_1610a394-8fdd-44ec-8da0-78d4b56bee39	0904-5677	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Major Pharmaceuticals	PAROXETINE HYDROCHLORIDE ANHYDROUS	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-5725_092ff042-828f-4851-e063-6394a90aade4	0904-5725	HUMAN OTC DRUG	MINTOX MAXIMUM STRENGTH		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20110201		OTC MONOGRAPH DRUG	M001	MAJOR Pharmaceuticals Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-5731_1fa4acf1-582d-4241-9de9-6f9873d73af4	0904-5731	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20070711		OTC MONOGRAPH FINAL	part347	Major	PETROLATUM	1	g/g			N	20241231
0904-5769_21078c0d-76b8-4596-9c4e-a9c1f8a84958	0904-5769	HUMAN OTC DRUG	mapap arthritis pain		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060216		ANDA	ANDA075077	Major Pharmaceuticals	ACETAMINOPHEN	650	mg/1			N	20241231
0904-5780_71a76a25-c5a5-4efd-a26f-3f1630968310	0904-5780	HUMAN OTC DRUG	Major Heartburn Relief	Maximum Strength	Famotidine	TABLET, FILM COATED	ORAL	20060929		ANDA	ANDA077351	Major Pharmaceuticals	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0904-5784_7eb87c3e-6bbc-4e57-a560-0d439a4e102b	0904-5784	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20070216		ANDA	ANDA076001	Major Pharmaceuticals	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-5785_7eb87c3e-6bbc-4e57-a560-0d439a4e102b	0904-5785	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20070216		ANDA	ANDA076001	Major Pharmaceuticals	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-5786_c16d294c-961b-4661-9d4b-7be23688a0a5	0904-5786	HUMAN OTC DRUG	Multi-Symptom Mapap Cold Formula		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050715		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-5789_4e7fa878-ba99-4a54-ab4d-954fbb194e5b	0904-5789	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20060320		ANDA	ANDA075677	Major Pharmaceuticals	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0904-5790_af7044ff-8bde-4859-ba31-9297002857a3	0904-5790	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20070209		ANDA	ANDA077309	Major Pharmaceuticals	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0904-5791_51f45d92-03f2-4cd3-8b08-d2aa1b6b4de5	0904-5791	HUMAN OTC DRUG	Childrens Mapap		Acetaminophen	TABLET, CHEWABLE	ORAL	20041206		OTC MONOGRAPH DRUG	M013	Major Pharmaceuticals	ACETAMINOPHEN	80	mg/1			N	20241231
0904-5792_f47bc7d5-ac13-437d-8dbd-24f962a1175f	0904-5792	HUMAN OTC DRUG	Mucus Relief Sinus		Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20060415		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-5833_be7d6dd8-6b4c-47c2-9f23-da06169b1c3f	0904-5833	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Major Pharmaceuticals	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-5847_0daed283-d409-480d-9245-2077223e6e1d	0904-5847	HUMAN OTC DRUG	Extra Strength Acetaminohpen	Adult Rapid Burst Cherry	Acetaminophen	LIQUID	ORAL	20090702	20240426	OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	500	mg/15mL			N	
0904-5853_05b0dbbf-0ef7-4c0d-8be9-c5536f23e4e7	0904-5853	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20090610		ANDA	ANDA075682	Major Pharmaceuticals	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-5854_05b0dbbf-0ef7-4c0d-8be9-c5536f23e4e7	0904-5854	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20090610		ANDA	ANDA075682	Major Pharmaceuticals	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-5855_05b0dbbf-0ef7-4c0d-8be9-c5536f23e4e7	0904-5855	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20090610		ANDA	ANDA075682	Major Pharmaceuticals	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-5891_e3b5fc1e-8901-4f13-883f-70970c6aa4d0	0904-5891	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Major Pharmaceuticals	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-5892_e3b5fc1e-8901-4f13-883f-70970c6aa4d0	0904-5892	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Major Pharmaceuticals	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-5893_e3b5fc1e-8901-4f13-883f-70970c6aa4d0	0904-5893	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Major Pharmaceuticals	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-5921_0294d7e5-def0-455d-a9b7-74d345221ff3	0904-5921	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20090610		ANDA	ANDA077002	Major Pharmaceuticals	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0904-5922_0294d7e5-def0-455d-a9b7-74d345221ff3	0904-5922	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20090610		ANDA	ANDA077002	Major Pharmaceuticals	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
0904-5959_405fa004-dcfe-4248-b742-58dc0dd64840	0904-5959	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20090410		ANDA	ANDA065061	Major Pharmaceuticals	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
0904-6007_fac971ce-af4a-403e-9df6-f3fcf180f2b1	0904-6007	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Major Pharmaceuticals	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-6008_fac971ce-af4a-403e-9df6-f3fcf180f2b1	0904-6008	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Major Pharmaceuticals	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-6009_fac971ce-af4a-403e-9df6-f3fcf180f2b1	0904-6009	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Major Pharmaceuticals	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-6019_ca1ad8ef-c41f-4ad8-b451-75cd9068bbdd	0904-6019	HUMAN PRESCRIPTION DRUG	Bicalutamide		Bicalutamide	TABLET	ORAL	20100511		ANDA	ANDA078917	Major Pharmaceuticals	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
0904-6082_a69bc411-4712-4ee8-8485-304a97499658	0904-6082	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Major Pharmaceuticals	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0904-6084_ad203122-a689-40e1-aa11-97291b6bf0ef	0904-6084	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20091102		ANDA	ANDA078216	Major Pharmaceuticals	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-6085_ad203122-a689-40e1-aa11-97291b6bf0ef	0904-6085	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20091102		ANDA	ANDA078216	Major Pharmaceuticals	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-6172_e138c248-7101-4d8f-8387-2c3e57cd36e0	0904-6172	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20100920		ANDA	ANDA077272	Major Pharmaceuticals	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-6178_9f559183-7e74-47c5-9922-1373948abaca	0904-6178	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20100401		ANDA	ANDA040855	Major Pharmaceuticals	BETHANECHOL CHLORIDE	25	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
0904-6187_8a71ec29-abd6-4c6c-bda3-7fa45a7ad9b0	0904-6187	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20091216		ANDA	ANDA040765	Major Pharmaceuticals	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-6195_1bbc43c4-ae3a-4514-9d30-389da6c27da4	0904-6195	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100615		ANDA	ANDA090568	Major Pharmaceuticals	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
0904-6237_dde744df-ff6f-4123-b94e-3549e1e27865	0904-6237	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20110211	20241130	ANDA	ANDA074260	Major Pharmaceuticals	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
0904-6238_dde744df-ff6f-4123-b94e-3549e1e27865	0904-6238	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20110211		ANDA	ANDA074260	Major Pharmaceuticals	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0904-6255_09bcb3ce-0646-291e-e063-6294a90aef73	0904-6255	HUMAN OTC DRUG	Sore Throat Logenzes	Sore Throat	Benzocaine and Menthol	LOZENGE	ORAL	20121228		OTC MONOGRAPH DRUG	M013	Major Pharmaceuticals	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0904-6269_f7d93df5-b367-4cb6-8918-14a43c5ff83b	0904-6269	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20120315		ANDA	ANDA077565	Major Pharmaceuticals	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6270_f7d93df5-b367-4cb6-8918-14a43c5ff83b	0904-6270	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20120315		ANDA	ANDA077565	Major Pharmaceuticals	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6271_f7d93df5-b367-4cb6-8918-14a43c5ff83b	0904-6271	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20120315		ANDA	ANDA077565	Major Pharmaceuticals	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6272_f7d93df5-b367-4cb6-8918-14a43c5ff83b	0904-6272	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20120315		ANDA	ANDA077565	Major Pharmaceuticals	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6283_4a0e8cdb-f3fa-4d97-8aac-f30a3f9c1545	0904-6283	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076255	Major Pharmaceuticals	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6286_7314c880-539e-4daf-9e26-1bab174ca717	0904-6286	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076133	Major Pharmaceuticals	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6287_7314c880-539e-4daf-9e26-1bab174ca717	0904-6287	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076133	Major Pharmaceuticals	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6290_5a11bf64-da71-4c17-80ed-c77de80b41a3	0904-6290	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Major Pharmaceuticals	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6291_5a11bf64-da71-4c17-80ed-c77de80b41a3	0904-6291	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Major Pharmaceuticals	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6292_17b6124e-f0a4-479c-bcf7-74847f720714	0904-6292	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20141031		ANDA	ANDA090548	Major Pharmaceuticals	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6293_17b6124e-f0a4-479c-bcf7-74847f720714	0904-6293	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20141031		ANDA	ANDA090548	Major Pharmaceuticals	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6294_c55b83a2-a7e7-407b-ae9d-fdfc2f86e384	0904-6294	HUMAN PRESCRIPTION DRUG	Clopidogrel Bisulfate		Clopidogrel Bisulfate	TABLET	ORAL	20120517		ANDA	ANDA090844	Major Pharmaceuticals	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0904-6300_c519a97b-5893-4a94-9923-1f867d08bdf1	0904-6300	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20121114		ANDA	ANDA078227	Major Pharmaceuticals	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6301_c519a97b-5893-4a94-9923-1f867d08bdf1	0904-6301	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20121114		ANDA	ANDA078227	Major Pharmaceuticals	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6302_c519a97b-5893-4a94-9923-1f867d08bdf1	0904-6302	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20121114		ANDA	ANDA078227	Major Pharmaceuticals	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6303_c519a97b-5893-4a94-9923-1f867d08bdf1	0904-6303	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20121114		ANDA	ANDA078227	Major Pharmaceuticals	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6305_ae698eb1-307d-4c8a-b417-35ea4c51a30b	0904-6305	HUMAN OTC DRUG	Sore Throat Cherry		Phenol	LIQUID	ORAL	20120901		OTC MONOGRAPH DRUG	M013	Major Pharmaceuticals	PHENOL	1.5	g/100mL			N	20241231
0904-6312_e5fb89d1-6bfa-4b05-9159-46483f132c40	0904-6312	HUMAN OTC DRUG	cough dm		dextromethorphan polistirex	SUSPENSION	ORAL	20120906		ANDA	ANDA091135	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6320_c4fb146c-fbdd-460e-8d33-d8f36fb39077	0904-6320	HUMAN OTC DRUG	Saline Laxative		Saline Laxative	ENEMA	RECTAL	20130711		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/133mL; g/133mL			N	20241231
0904-6322_d029afe1-2d7a-43a5-9838-c8ae443ce66a	0904-6322	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Major Pharmaceuticals	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6323_d029afe1-2d7a-43a5-9838-c8ae443ce66a	0904-6323	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Major Pharmaceuticals	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6324_22cef51c-b14b-4d06-a9e4-a9b608ada151	0904-6324	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Major Pharmaceuticals	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6329_15de6fee-b0fa-4deb-8265-7bb71ba94c62	0904-6329	HUMAN OTC DRUG	lubricating plus		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20130509		OTC MONOGRAPH FINAL	part349	Major Pharmaceuticals	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
0904-6337_8bf24642-97e0-4ad1-8156-2142a1267eda	0904-6337	HUMAN OTC DRUG	SudoGest Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19910910		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6351_fd353596-a7b5-4720-83fb-b21c6bb481eb	0904-6351	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20131201		ANDA	ANDA076710	Major Pharmaceuticals	LEVOFLOXACIN	250	mg/1			N	20241231
0904-6352_fd353596-a7b5-4720-83fb-b21c6bb481eb	0904-6352	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20131201		ANDA	ANDA076710	Major Pharmaceuticals	LEVOFLOXACIN	500	mg/1			N	20241231
0904-6353_fd353596-a7b5-4720-83fb-b21c6bb481eb	0904-6353	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20131201		ANDA	ANDA076710	Major Pharmaceuticals	LEVOFLOXACIN	750	mg/1			N	20241231
0904-6357_bf688909-a66f-4f99-bd20-ff7269a6c6b0	0904-6357	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Major Pharmaceuticals	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6358_bf688909-a66f-4f99-bd20-ff7269a6c6b0	0904-6358	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Major Pharmaceuticals	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6359_bf688909-a66f-4f99-bd20-ff7269a6c6b0	0904-6359	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Major Pharmaceuticals	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6360_bf688909-a66f-4f99-bd20-ff7269a6c6b0	0904-6360	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Major Pharmaceuticals	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6361_bf688909-a66f-4f99-bd20-ff7269a6c6b0	0904-6361	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Major Pharmaceuticals	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6362_bf688909-a66f-4f99-bd20-ff7269a6c6b0	0904-6362	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Major Pharmaceuticals	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6363_38300d64-12b1-4579-9745-657f9f0bff2d	0904-6363	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20130811		ANDA	ANDA090161	Major Pharmaceuticals	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-6364_49d57ed2-069c-4b57-9ef7-8d69a6730f11	0904-6364	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20130811		ANDA	ANDA090070	Major Pharmaceuticals	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-6369_35565947-d434-49d3-b3db-b119d0cf4b20	0904-6369	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20130120		ANDA	ANDA078226	Major Pharmaceuticals	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0904-6370_35565947-d434-49d3-b3db-b119d0cf4b20	0904-6370	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20130120		ANDA	ANDA078226	Major Pharmaceuticals	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0904-6371_35565947-d434-49d3-b3db-b119d0cf4b20	0904-6371	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20130120		ANDA	ANDA078226	Major Pharmaceuticals	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0904-6373_3c2a6a36-196a-4ca3-9e9a-ef62272333ba	0904-6373	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141001		ANDA	ANDA090429	Major Pharmaceuticals	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0904-6374_3c2a6a36-196a-4ca3-9e9a-ef62272333ba	0904-6374	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141001		ANDA	ANDA090429	Major Pharmaceuticals	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0904-6376_3dd0be68-e71b-4a74-9899-71de1d6b50d1	0904-6376	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076255	Major Pharmaceuticals	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6377_3dd0be68-e71b-4a74-9899-71de1d6b50d1	0904-6377	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076255	Major Pharmaceuticals	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6378_241be998-3009-4715-a4b3-f226e669f304	0904-6378	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		ciprofloxacin	TABLET, FILM COATED	ORAL	20140609		ANDA	ANDA075593	Major Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0904-6401_4c7c59b5-fc0d-4bce-81b5-5b1ca798359b	0904-6401	HUMAN PRESCRIPTION DRUG	tamsulosin hydrochloride		tamsulosin hydrochloride	CAPSULE	ORAL	20150105		ANDA	ANDA078015	Major Pharmaceuticals	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-6406_5347c7e3-120f-408d-9cb3-b8f42fed655d	0904-6406	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA076938	Major Pharmaceuticals	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0904-6407_dc58fa70-d2e4-4e72-953a-4119fa1f787f	0904-6407	HUMAN OTC DRUG	Unit Dose Bisacodyl		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Major Pharmaceuticals	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6412_2f7a1565-647e-45d6-b9c3-50667e776628	0904-6412	HUMAN OTC DRUG	Major Regular Strength	Assorted Flavors	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140812		OTC MONOGRAPH DRUG	M001	Major Pharmaceuticals	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0904-6418_a9c5751e-bd60-46ea-a2ed-5c7c50bd6c8b	0904-6418	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20141001		ANDA	ANDA076533	Major Pharmaceuticals	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0904-6420_24c08ad8-be13-44d0-ad85-169db27d9b8e	0904-6420	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20130314		ANDA	ANDA040148	Major Pharmaceuticals	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0904-6421_24c08ad8-be13-44d0-ad85-169db27d9b8e	0904-6421	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20130307		ANDA	ANDA040148	Major Pharmaceuticals	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0904-6423_ba79644c-c89d-41e9-9851-6dbde712564a	0904-6423	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20130403		ANDA	ANDA076715	Major Pharmaceuticals	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
0904-6424_ba79644c-c89d-41e9-9851-6dbde712564a	0904-6424	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20130403		ANDA	ANDA076715	Major Pharmaceuticals	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
0904-6426_29cb1d9e-bdf3-42fd-ac05-9f3e4ddaa7b0	0904-6426	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20141015		ANDA	ANDA090939	Major Pharmaceuticals	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-6427_29cb1d9e-bdf3-42fd-ac05-9f3e4ddaa7b0	0904-6427	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20141015		ANDA	ANDA090939	Major Pharmaceuticals	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-6436_54e8b018-e003-4c61-aa54-33ceb260fb73	0904-6436	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20150325		ANDA	ANDA071457	Major Pharmaceuticals	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-6440_512fa4b6-6ff4-4eb6-a4e5-8a7d55fda758	0904-6440	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20150514		ANDA	ANDA086242	Major Pharmaceuticals	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0904-6441_512fa4b6-6ff4-4eb6-a4e5-8a7d55fda758	0904-6441	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20150514		ANDA	ANDA086242	Major Pharmaceuticals	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0904-6442_512fa4b6-6ff4-4eb6-a4e5-8a7d55fda758	0904-6442	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20150514		ANDA	ANDA086242	Major Pharmaceuticals	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0904-6443_512fa4b6-6ff4-4eb6-a4e5-8a7d55fda758	0904-6443	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20150514		ANDA	ANDA086242	Major Pharmaceuticals	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
0904-6449_55fc0865-43d3-4bbd-8e6b-75a004127730	0904-6449	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20150105		ANDA	ANDA200270	Major Pharmaceuticals	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0904-6450_55fc0865-43d3-4bbd-8e6b-75a004127730	0904-6450	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20150105		ANDA	ANDA200495	Major Pharmaceuticals	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0904-6459_a0e641cb-6838-48cd-b0f2-cae12ab70382	0904-6459	HUMAN OTC DRUG	Kao Tin		Docusate calcium	CAPSULE, LIQUID FILLED	ORAL	20150228	20250228	OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE CALCIUM	240	mg/1			N	
0904-6461_85e0d628-0315-4ea2-b604-2b86a31ac2ce	0904-6461	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20150315		ANDA	ANDA084176	Major Pharmaceuticals	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-6463_f915e1f8-ea35-4e6f-8b68-68c74af2954f	0904-6463	HUMAN OTC DRUG	dimaphen dm		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060911		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-6464_83295f24-f1cd-4c56-a593-b95a932b070a	0904-6464	HUMAN OTC DRUG	robafen		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19910315		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6465_1ad4ae89-6ad3-40df-ab3f-aef83d8d7235	0904-6465	HUMAN OTC DRUG	all nite		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20121119		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6467_3c214bf9-8d09-44aa-bc10-3b7d07f4581e	0904-6467	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20150406		ANDA	ANDA076274	Major Pharmaceuticals	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
0904-6468_2f13e60d-a9f8-472c-b7b1-25c7805143af	0904-6468	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150406		ANDA	ANDA090899	Major Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-6469_2f13e60d-a9f8-472c-b7b1-25c7805143af	0904-6469	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150406		ANDA	ANDA090899	Major Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-6470_2f13e60d-a9f8-472c-b7b1-25c7805143af	0904-6470	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150406		ANDA	ANDA090899	Major Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-6474_192245f2-bbce-41c6-b827-5b3aedc30a2c	0904-6474	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20150601		ANDA	ANDA090074	Major Pharmaceuticals	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0904-6475_28957cdc-a9bb-4caa-8b97-96b800a7a327	0904-6475	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20150715		ANDA	ANDA078220	Major Pharmaceuticals	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0904-6476_28957cdc-a9bb-4caa-8b97-96b800a7a327	0904-6476	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20150715		ANDA	ANDA077241	Major Pharmaceuticals	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0904-6477_55e6bcd7-fa52-45d5-a3a6-f094c5c17486	0904-6477	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110528		ANDA	ANDA090686	Major Pharmaceuticals	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0904-6478_55e6bcd7-fa52-45d5-a3a6-f094c5c17486	0904-6478	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110528		ANDA	ANDA090686	Major Pharmaceuticals	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0904-6488_0c017b10-29be-e30f-e063-6294a90a8a3c	0904-6488	HUMAN OTC DRUG	Major LubriFresh PM		Mineral oil and White petrolatum	OINTMENT	OPHTHALMIC	20150911		OTC MONOGRAPH DRUG	M018	Major Pharmaceuticals	MINERAL OIL; PETROLATUM	150; 830	mg/g; mg/g			N	20241231
0904-6500_43c95296-87be-4176-aaec-753dae9a3e75	0904-6500	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20150625		ANDA	ANDA076658	Major Pharmaceuticals	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0904-6501_43c95296-87be-4176-aaec-753dae9a3e75	0904-6501	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20150625		ANDA	ANDA076658	Major Pharmaceuticals	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0904-6502_f5e293dd-b257-4a9a-b5a4-0cd62e7fc066	0904-6502	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150625		ANDA	ANDA204197	Major Pharmaceuticals	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-6503_f5e293dd-b257-4a9a-b5a4-0cd62e7fc066	0904-6503	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150625		ANDA	ANDA204197	Major Pharmaceuticals	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-6505_55ce4cf8-3c92-4064-8fcc-747b79e19bb1	0904-6505	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150720		ANDA	ANDA090048	Major Pharmaceuticals	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0904-6506_55ce4cf8-3c92-4064-8fcc-747b79e19bb1	0904-6506	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150720		ANDA	ANDA090048	Major Pharmaceuticals	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0904-6509_b57698aa-42fb-43eb-84bc-8c20a358a946	0904-6509	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150825		ANDA	ANDA078583	Major Pharmaceuticals	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6510_b57698aa-42fb-43eb-84bc-8c20a358a946	0904-6510	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150825		ANDA	ANDA078583	Major Pharmaceuticals	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6511_b57698aa-42fb-43eb-84bc-8c20a358a946	0904-6511	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150825		ANDA	ANDA078583	Major Pharmaceuticals	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6512_b57698aa-42fb-43eb-84bc-8c20a358a946	0904-6512	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150825		ANDA	ANDA078583	Major Pharmaceuticals	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6513_b57698aa-42fb-43eb-84bc-8c20a358a946	0904-6513	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150825		ANDA	ANDA078583	Major Pharmaceuticals	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6514_b57698aa-42fb-43eb-84bc-8c20a358a946	0904-6514	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150825		ANDA	ANDA078583	Major Pharmaceuticals	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6516_f7ceaf71-c39a-45fa-aa42-e77a707b11a5	0904-6516	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine	TABLET	ORAL	20100212		ANDA	ANDA201451	Major Pharmaceuticals	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0904-6517_f7ceaf71-c39a-45fa-aa42-e77a707b11a5	0904-6517	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20100212		ANDA	ANDA201451	Major Pharmaceuticals	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0904-6519_dbfa1528-7a85-4bfd-980e-38facdd88583	0904-6519	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Major Pharmaceuticals	MIRTAZAPINE	15	mg/1			N	20241231
0904-6522_b61d2106-f380-2f9f-e053-2995a90ae468	0904-6522	HUMAN OTC DRUG	Senna-Lax		Sennosides	TABLET, FILM COATED	ORAL	20160307		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	SENNOSIDES	8.6	mg/1			N	20241231
0904-6530_9f353aee-c752-4c68-a915-60d987c85c57	0904-6530	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20120116		ANDA	ANDA090635	Major Pharmaceuticals	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6537_7601fd8e-b074-4286-b26d-ff53f07284bc	0904-6537	HUMAN OTC DRUG	Tussin Multi Symptom Cold CF	Adult	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20151130		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-6550_887c75bb-6386-4fd8-bbee-f8f3dcd5f8c3	0904-6550	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070217	Major Pharmaceuticals	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6551_9a75d65d-b3e8-4fe9-89ea-e5419e37360c	0904-6551	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	Major Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0904-6552_9a75d65d-b3e8-4fe9-89ea-e5419e37360c	0904-6552	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	Major Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0904-6553_8f9c2435-37ea-42ad-ad5c-efd312223bb0	0904-6553	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA205517	Major Pharmaceuticals	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
0904-6557_1d09145e-68dc-483a-a967-5481bc5a8dec	0904-6557	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074862	Major Pharmaceuticals	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6558_1d09145e-68dc-483a-a967-5481bc5a8dec	0904-6558	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074862	Major Pharmaceuticals	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6559_1d09145e-68dc-483a-a967-5481bc5a8dec	0904-6559	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074862	Major Pharmaceuticals	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6560_1d09145e-68dc-483a-a967-5481bc5a8dec	0904-6560	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074769	Major Pharmaceuticals	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6564_b84d327b-91f1-4896-93a0-c9f207feb700	0904-6564	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070904		ANDA	ANDA040597	Major Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
0904-6565_b31846b6-0134-4877-85a7-720921f76a27	0904-6565	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Major Pharmaceuticals	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
0904-6570_0390265b-0192-492d-a434-547c52721357	0904-6570	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20151102		ANDA	ANDA204010	Major Pharmaceuticals	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0904-6572_b32dae95-729d-4b50-a0d9-bc764cf5f0af	0904-6572	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Major Pharmaceuticals	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0904-6573_6a8a96ee-b20f-4a8f-8b35-8c15ae1ce29f	0904-6573	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612		ANDA	ANDA077284	Major Pharmaceuticals	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-6575_9af410da-5e4f-4be6-985f-30f447e02b53	0904-6575	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20030201		UNAPPROVED DRUG OTHER		Major Pharmaceuticals	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
0904-6581_bdd5e6d8-f0e8-421d-8e30-0079e890ebb9	0904-6581	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20151210		ANDA	ANDA078279	Major Pharmaceuticals	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0904-6583_7c395299-3d86-4c50-8cc2-423bc75cb424	0904-6583	HUMAN PRESCRIPTION DRUG	LAMIVUDINE		lamivudine	TABLET, FILM COATED	ORAL	20111202		ANDA	ANDA091606	Major Pharmaceuticals	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0904-6585_1e0ea26d-24ab-40c5-b9ec-1a816a8d0da1	0904-6585	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20040322		ANDA	ANDA075932	Major Pharmaceuticals	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-6592_51952461-8eb1-453b-b923-4fcaf6b78b83	0904-6592	HUMAN PRESCRIPTION DRUG	TOLTERODINE TARTRATE		TOLTERODINE	CAPSULE, EXTENDED RELEASE	ORAL	20150811		ANDA	ANDA203016	Major Pharmaceuticals	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0904-6593_51952461-8eb1-453b-b923-4fcaf6b78b83	0904-6593	HUMAN PRESCRIPTION DRUG	TOLTERODINE TARTRATE		TOLTERODINE	CAPSULE, EXTENDED RELEASE	ORAL	20150811		ANDA	ANDA203016	Major Pharmaceuticals	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0904-6596_e2767a52-a648-4fa4-b3cf-c73e9ad9fc63	0904-6596	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET	ORAL	20160525		ANDA	ANDA206747	Major Pharmaceuticals	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0904-6599_36ce4c05-08fa-4b0f-8d1f-bf8ac4ccba63	0904-6599	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Major Pharmaceuticals	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-6600_36ce4c05-08fa-4b0f-8d1f-bf8ac4ccba63	0904-6600	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Major Pharmaceuticals	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-6601_36ce4c05-08fa-4b0f-8d1f-bf8ac4ccba63	0904-6601	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Major Pharmaceuticals	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-6615_21ba54b4-dd8f-45a7-b4a1-90e9de5b7f56	0904-6615	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	CAPSULE	ORAL	20090123		ANDA	ANDA078979	Major Pharmaceuticals	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-6617_e3312d1a-af18-467c-8d93-a55bd4daa4f8	0904-6617	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040604	Major Pharmaceuticals	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-6618_e3312d1a-af18-467c-8d93-a55bd4daa4f8	0904-6618	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040604	Major Pharmaceuticals	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-6619_d3a941c3-9b72-40d4-9130-e1ccef0779d0	0904-6619	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19781201		ANDA	ANDA086066	Major Pharmaceuticals	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0904-6620_d3a941c3-9b72-40d4-9130-e1ccef0779d0	0904-6620	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19830426		ANDA	ANDA088088	Major Pharmaceuticals	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
0904-6621_8b34da8f-4d25-4206-a2e8-e84af4836518	0904-6621	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA079179	Major Pharmaceuticals	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0904-6622_4c6fd785-399a-4ce9-bbe3-a040411e955f	0904-6622	HUMAN PRESCRIPTION DRUG	pyridostigmine bromide		pyridostigmine bromide	TABLET	ORAL	20150807		ANDA	ANDA205650	Major Pharmaceuticals	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0904-6623_45062d26-ca2e-4935-86c4-8ea83944c19b	0904-6623	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100514		ANDA	ANDA090509	Major Pharmaceuticals	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0904-6624_45062d26-ca2e-4935-86c4-8ea83944c19b	0904-6624	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100514		ANDA	ANDA090509	Major Pharmaceuticals	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0904-6627_0c7d0e65-8c41-66a5-e063-6294a90ab40a	0904-6627	HUMAN OTC DRUG	Ear Drops	Major	Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20191010		OTC MONOGRAPH DRUG	M014	Major Pharmaceuticals	CARBAMIDE PEROXIDE	6.5	g/100mL			N	20241231
0904-6634_1c745ff9-528a-4901-88d5-aa4c909a6e1e	0904-6634	HUMAN OTC DRUG	Cough and Cold		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, COATED	ORAL	20170331		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6635_a5e2004f-e901-407e-9aae-9ae2ff4f2a48	0904-6635	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Major Pharmaceuticals	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-6636_a5e2004f-e901-407e-9aae-9ae2ff4f2a48	0904-6636	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Major Pharmaceuticals	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-6637_54fbf23f-ea09-480d-9f22-e40db60389d2	0904-6637	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Major Pharmaceuticals	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
0904-6638_501b0152-fb42-4060-8402-dfe63746099e	0904-6638	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Major Pharmaceuticals	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6639_501b0152-fb42-4060-8402-dfe63746099e	0904-6639	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Major Pharmaceuticals	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6640_501b0152-fb42-4060-8402-dfe63746099e	0904-6640	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Major Pharmaceuticals	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6641_501b0152-fb42-4060-8402-dfe63746099e	0904-6641	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Major Pharmaceuticals	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6642_501b0152-fb42-4060-8402-dfe63746099e	0904-6642	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Major Pharmaceuticals	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6643_501b0152-fb42-4060-8402-dfe63746099e	0904-6643	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Major Pharmaceuticals	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6645_52d43c93-62f1-42a4-bd1d-00fbaee1ca37	0904-6645	HUMAN OTC DRUG	childrens mapap		Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	Major Pharmaceuticals	ACETAMINOPHEN	160	mg/1			N	20241231
0904-6656_e4db63f7-360f-43ee-bd34-1e304d7c9d1c	0904-6656	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Major Pharmaceuticals	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6661_7f9d54e9-3101-4396-b38d-5f76311f74fe	0904-6661	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Major Pharmaceuticals	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-6662_613b7e58-07ee-4da0-b930-3788889ae59f	0904-6662	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	Major Pharmaceuticals	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0904-6663_7dea9b77-57ea-456c-a8ff-93689ce10647	0904-6663	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	TABLET	ORAL	20130315		ANDA	ANDA205530	Major Pharmaceuticals	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
0904-6665_436716b6-158c-4ae6-92a7-5098545a4764	0904-6665	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Major Pharmaceuticals	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-6666_436716b6-158c-4ae6-92a7-5098545a4764	0904-6666	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Major Pharmaceuticals	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-6667_436716b6-158c-4ae6-92a7-5098545a4764	0904-6667	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Major Pharmaceuticals	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-6671_0d224a38-857b-4a16-ada3-5fe6e5ac9762	0904-6671	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20121106		ANDA	ANDA091479	Major Pharmaceuticals	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
0904-6678_9270610b-9fc6-4d1d-86e6-68df6dfada28	0904-6678	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20161123		ANDA	ANDA207511	MAJOR PHARMACEUTICALS	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6679_c74b8735-2476-4d17-a8c8-a9a0db7e69d3	0904-6679	HUMAN OTC DRUG	Major Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20180928		OTC MONOGRAPH FINAL	part333B	Major Pharmaceuticals	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
0904-6680_789e49e8-03f4-42d4-866d-8ef534ba8fb4	0904-6680	HUMAN OTC DRUG	Major Triple Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate	OINTMENT	TOPICAL	20181004		OTC MONOGRAPH FINAL	part333B	Major Pharmaceuticals	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0904-6681_878263a5-b2a1-4aa0-84cc-7fc165ee86c9	0904-6681	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20160607		ANDA	ANDA207058	Major Pharmaceuticals	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
0904-6682_878263a5-b2a1-4aa0-84cc-7fc165ee86c9	0904-6682	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20160607		ANDA	ANDA207058	Major Pharmaceuticals	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
0904-6683_878263a5-b2a1-4aa0-84cc-7fc165ee86c9	0904-6683	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20160607		ANDA	ANDA207058	Major Pharmaceuticals	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
0904-6700_3b658217-1a2f-4b03-b26e-1089680e114a	0904-6700	HUMAN OTC DRUG	Mintox Plus Tabs		Aluminum hydroxide, Magnesium hydroxide, Simethicone	TABLET, CHEWABLE	ORAL	20180802		OTC MONOGRAPH DRUG	M001	Major Pharmaceuticals	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 25; 200	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6703_17638b77-384b-4746-8626-92924e1ad9da	0904-6703	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	19930222		ANDA	ANDA072736	Major Pharmaceuticals	LEUCOVORIN CALCIUM	25	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
0904-6704_a25159b6-8f95-468a-8b57-b07022fdba9d	0904-6704	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Major Pharmaceuticals	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
0904-6705_887c75bb-6386-4fd8-bbee-f8f3dcd5f8c3	0904-6705	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070218	Major Pharmaceuticals	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-6706_df45a33c-6079-47f4-bed9-f0cfdc65ab86	0904-6706	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20140930		ANDA	ANDA090973	Major Pharmaceuticals	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
0904-6707_520e94ed-edcf-4533-91b8-f2bb765f3f7b	0904-6707	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20170929		ANDA	ANDA206094	Major Pharmaceuticals	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0904-6708_d4258698-37c7-427c-8b3c-c73028891242	0904-6708	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818	20240731	ANDA	ANDA065398	Major Pharmaceuticals	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
0904-6709_63129698-150d-47d9-8e79-e0ec8c1cae45	0904-6709	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20170227		ANDA	ANDA207201	Major Pharmaceuticals	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0904-6711_a1429ace-51e7-2616-efed-8c1972e3f479	0904-6711	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20180427		ANDA	ANDA076502	MAJOR PHARMACEUTICALS	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-6712_1c3089f5-f643-40f1-b346-6a1fa5fc4755	0904-6712	HUMAN OTC DRUG	Aspirin	regular strength	Aspirin	TABLET, COATED	ORAL	20180331	20241227	OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
0904-6713_935dd945-de27-4847-bfe4-b112c076544e	0904-6713	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20180228	20250228	OTC MONOGRAPH FINAL	part343	Major Pharmaceuticals	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
0904-6714_dd019a22-9e88-4fb4-addd-61904a6ab056	0904-6714	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20180331	20250331	OTC MONOGRAPH FINAL	part332	Major Pharmaceuticals	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
0904-6717_1ff34910-6290-4727-babd-f30423a48088	0904-6717	HUMAN OTC DRUG	Cetirizine		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA078336	Major Pharmaceuticals	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-6717_961f9ea8-4fe5-4e14-a638-e7a5b1df236b	0904-6717	HUMAN OTC DRUG	Cetirizine		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA078336	Major Pharmaceuticals	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-6718_ac37e50c-c12d-4a2f-8f14-082276a7b050	0904-6718	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180930		ANDA	ANDA207342	Major Pharmaceuticals	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0904-6719_4612b5f6-4120-4364-a6f8-b43d15d0caf8	0904-6719	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20181018		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	325	mg/1			N	20241231
0904-6720_a78b3b02-2157-4a79-8392-a457097521f7	0904-6720	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20180726		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	500	mg/1			N	20241231
0904-6725_b61d2106-f380-2f9f-e053-2995a90ae468	0904-6725	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, FILM COATED	ORAL	20181220		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	SENNOSIDES	8.6	mg/1			N	20241231
0904-6726_11d2b2b0-85b5-4a66-9ddb-73944cb3591a	0904-6726	HUMAN OTC DRUG	major prep hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20180906		OTC MONOGRAPH FINAL	part346	Major Pharmaceuticals	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-6727_efb9a1d4-50d4-5b2d-e053-2a95a90a733f	0904-6727	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET	ORAL	20190131		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6728_b61d6e2e-18dc-37d2-e053-2a95a90af57b	0904-6728	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET	ORAL	20190826		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE	60	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6730_a822fa87-eb1a-cd3a-e053-2a95a90ae01d	0904-6730	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180912		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	500	mg/1			N	20241231
0904-6731_d1151d77-f72b-5dfa-e053-2a95a90a90cd	0904-6731	HUMAN OTC DRUG	Acetaminophen, Diphenhydramine Hydrochloride		Acetaminophen, Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20181226		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-6732_1abdc08c-c1e0-45ce-aeea-632a623d9895	0904-6732	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	CAPSULE	ORAL	20141001		NDA	NDA204820	Major Pharmaceuticals	COLCHICINE	.6	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
0904-6733_7f9d54e9-3101-4396-b38d-5f76311f74fe	0904-6733	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Major Pharmaceuticals	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-6734_cbe75266-38f8-452f-82aa-38409630ff71	0904-6734	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Major Pharmaceuticals	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0904-6735_cbe75266-38f8-452f-82aa-38409630ff71	0904-6735	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Major Pharmaceuticals	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0904-6736_cbe75266-38f8-452f-82aa-38409630ff71	0904-6736	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Major Pharmaceuticals	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0904-6737_cbe75266-38f8-452f-82aa-38409630ff71	0904-6737	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Major Pharmaceuticals	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
0904-6744_36b8ff76-16ac-40e0-b6f6-fdecd6d69b94	0904-6744	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, FILM COATED	ORAL	19891015		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-6747_f095763a-fa57-4c89-92fb-1e0674233f44	0904-6747	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180920		ANDA	ANDA072096	Major Pharmaceuticals	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-6748_f1fb6ece-49f9-4c39-8c38-50100f2b1131	0904-6748	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20181201		OTC MONOGRAPH DRUG	505G(a)(3)	Major Pharmaceuticals	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6750_08649f2e-5f6c-5ba0-e063-6294a90a5fd1	0904-6750	HUMAN OTC DRUG	DOK		docusate sodium	TABLET	ORAL	20180601		OTC MONOGRAPH DRUG	M007	MAJOR PHARMACEUTICALS	DOCUSATE SODIUM	100	mg/1			N	20241231
0904-6751_41e0cedf-5f77-4626-9ebe-b5e0c7744ed4	0904-6751	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Major Pharmaceuticals	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-6753_2079d3af-32b3-414b-9f13-8b53497a1f9e	0904-6753	HUMAN OTC DRUG	sudogest pe		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20190212		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-6754_a962b916-f01f-439c-9098-9c0e3d839e7d	0904-6754	HUMAN OTC DRUG	SudoGest 12 Hour		Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190212		ANDA	ANDA075153	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6756_35de3bdb-d476-4bd2-9d36-666f6c6ecb53	0904-6756	HUMAN OTC DRUG	milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20190212		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6757_8c27cc9c-22c9-4518-90c9-1c5008d597aa	0904-6757	HUMAN OTC DRUG	milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	19910415		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6758_e0860161-f303-4c4a-871c-68131e2be221	0904-6758	HUMAN OTC DRUG	robafen		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180813		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6759_7057ef34-acd9-48e7-ba9f-3446dbc4dc56	0904-6759	HUMAN OTC DRUG	robafen dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20181129		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6760_c90f3d54-12b7-4bab-8af9-05e848414633	0904-6760	HUMAN OTC DRUG	acetaminophen congestion and pain		Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20070115		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-6761_30ac6c99-1384-49e2-84d1-8e52757568a4	0904-6761	HUMAN OTC DRUG	nasal decongestant		Oxymetazoline HCl	SPRAY	NASAL	20181012		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0904-6763_2c946d4b-760f-49e7-a3ec-367b24fbeb22	0904-6763	HUMAN OTC DRUG	robafen		Guaifenesin	SOLUTION	ORAL	20180813		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	GUAIFENESIN	200	mg/10mL			N	20241231
0904-6765_6a59e630-2a83-4093-bc3b-1f15a12d359e	0904-6765	HUMAN OTC DRUG	childrens cetirizine hydrochloride		Cetirizine HCl	SOLUTION	ORAL	20180822		ANDA	ANDA204226	Major Pharmaceuticals	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-6766_05bea71d-876d-4a9f-bcb1-12367b7ea2dc	0904-6766	HUMAN OTC DRUG	childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20180813		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	160	mg/5mL			N	20241231
0904-6767_c1d82e33-5de9-40b0-8e03-be47e98c466c	0904-6767	HUMAN OTC DRUG	Childrens Loratadine Oral		Loratadine	SOLUTION	ORAL	20190212		ANDA	ANDA075728	Major Pharmaceuticals	LORATADINE	5	mg/5mL			N	20241231
0904-6772_b4043aed-f29f-c266-e053-2995a90a1c58	0904-6772	HUMAN OTC DRUG	Dimenhydrinate		Dimenhydrinate	TABLET	ORAL	20190214		OTC MONOGRAPH FINAL	part336	Major Pharmaceuticals	DIMENHYDRINATE	50	mg/1			N	20241231
0904-6773_a49aada7-a48b-48c4-e053-2a95a90ab53c	0904-6773	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20181023		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	325	mg/1			N	20241231
0904-6778_49bddf59-d42a-40d7-80f2-1f5dcd1db8dc	0904-6778	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Major Pharmaceuticals	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6779_49bddf59-d42a-40d7-80f2-1f5dcd1db8dc	0904-6779	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Major Pharmaceuticals	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6780_49bddf59-d42a-40d7-80f2-1f5dcd1db8dc	0904-6780	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Major Pharmaceuticals	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6781_49bddf59-d42a-40d7-80f2-1f5dcd1db8dc	0904-6781	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Major Pharmaceuticals	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
0904-6782_7f9d54e9-3101-4396-b38d-5f76311f74fe	0904-6782	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Major Pharmaceuticals	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-6783_08f1f37a-725b-e50c-e063-6394a90a72f1	0904-6783	HUMAN OTC DRUG	ASPIRIN LOW DOSE		Aspirin	TABLET, COATED	ORAL	20180901		OTC MONOGRAPH DRUG	M013	MAJOR PHARMACEUTICALS	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-6785_b192505c-ae0f-47ce-aced-0c303e802e83	0904-6785	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20120821		ANDA	ANDA091558	Major Pharmaceuticals	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0904-6786_b192505c-ae0f-47ce-aced-0c303e802e83	0904-6786	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20140819		ANDA	ANDA091558	Major Pharmaceuticals	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0904-6787_1234ebe2-b47c-4fd6-adb7-d7eb8985e48b	0904-6787	HUMAN OTC DRUG	Saline Laxative		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6788_c00ab670-2d95-44fb-9f4c-c12441a52057	0904-6788	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515		ANDA	ANDA204713	Major Pharmaceuticals	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0904-6789_c00ab670-2d95-44fb-9f4c-c12441a52057	0904-6789	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515		ANDA	ANDA204713	Major Pharmaceuticals	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0904-6790_c00ab670-2d95-44fb-9f4c-c12441a52057	0904-6790	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515		ANDA	ANDA204713	Major Pharmaceuticals	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0904-6791_06371e69-999b-4b54-9338-63b030b51a16	0904-6791	HUMAN PRESCRIPTION DRUG	Modafinil		modafinil	TABLET	ORAL	20140203		ANDA	ANDA077667	Major Pharmaceuticals	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
0904-6792_06371e69-999b-4b54-9338-63b030b51a16	0904-6792	HUMAN PRESCRIPTION DRUG	Modafinil		modafinil	TABLET	ORAL	20140203		ANDA	ANDA077667	Major Pharmaceuticals	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
0904-6793_659a707f-583c-4bd1-b7dc-282411188563	0904-6793	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20180831	20241227	OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
0904-6794_04500e52-a644-4de5-befc-8d721a1fe148	0904-6794	HUMAN OTC DRUG	Aspirin Low Dose Chewable Orange		Aspirin	TABLET, CHEWABLE	ORAL	20180927		OTC MONOGRAPH FINAL	part343	MAJOR PHARMACEUTICALS	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-6796_3d50ba95-55b5-4bc8-b626-adc5f0c5e0cf	0904-6796	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET, FILM COATED	ORAL	20160318		ANDA	ANDA205166	Major Pharmaceuticals	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
0904-6797_aac4145e-02a2-4e44-b8bc-a5eac8ad1108	0904-6797	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Major Pharmaceuticals	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0904-6798_aac4145e-02a2-4e44-b8bc-a5eac8ad1108	0904-6798	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	Major Pharmaceuticals	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0904-6799_aac4145e-02a2-4e44-b8bc-a5eac8ad1108	0904-6799	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	Major Pharmaceuticals	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0904-6800_aac4145e-02a2-4e44-b8bc-a5eac8ad1108	0904-6800	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Major Pharmaceuticals	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0904-6801_a61c4f32-8b2a-48f6-bd1d-9417a55bca5c	0904-6801	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Major Pharmaceuticals	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6802_a61c4f32-8b2a-48f6-bd1d-9417a55bca5c	0904-6802	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Major Pharmaceuticals	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6803_a61c4f32-8b2a-48f6-bd1d-9417a55bca5c	0904-6803	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Major Pharmaceuticals	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6804_a61c4f32-8b2a-48f6-bd1d-9417a55bca5c	0904-6804	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Major Pharmaceuticals	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6805_a61c4f32-8b2a-48f6-bd1d-9417a55bca5c	0904-6805	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Major Pharmaceuticals	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6808_e09b66fe-31a4-44c4-8682-df0f626f98bd	0904-6808	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	Major Pharmaceuticals	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
0904-6809_67303a86-9501-42e3-88e2-b64a33977275	0904-6809	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, FILM COATED	ORAL	20181227		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-6815_c8d2a23d-2313-477e-99d6-fd44c1fbd1f5	0904-6815	HUMAN OTC DRUG	Mucus Relief Chest Congestion		Guaifenesin	TABLET, FILM COATED	ORAL	20181031		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0904-6816_c849a677-2998-4af3-b533-2863dbe5513a	0904-6816	HUMAN OTC DRUG	Mucus Relief DM Cough		Dextromethorphan HBr, Guaifenesin	TABLET, FILM COATED	ORAL	20181219		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6817_04b4dc98-4401-4e7d-9eec-07030d5f1daf	0904-6817	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Major Pharmaceuticals	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6818_04b4dc98-4401-4e7d-9eec-07030d5f1daf	0904-6818	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Major Pharmaceuticals	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6819_04b4dc98-4401-4e7d-9eec-07030d5f1daf	0904-6819	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Major Pharmaceuticals	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6821_da78a5d3-f5c6-47fe-b593-3252704c225d	0904-6821	HUMAN PRESCRIPTION DRUG	tenofovir disproxil fumarate		tenofovir disproxil fumarate	TABLET	ORAL	20180126		ANDA	ANDA203232	Major Pharmaceuticals	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
0904-6823_e4dba0e2-e43e-4334-83e7-3db4fcd7f659	0904-6823	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Major Pharmaceuticals	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-6824_0671ed02-4c4c-4403-b616-3dd8fbdd052b	0904-6824	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Major Pharmaceuticals	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0904-6825_0671ed02-4c4c-4403-b616-3dd8fbdd052b	0904-6825	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Major Pharmaceuticals	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0904-6826_0671ed02-4c4c-4403-b616-3dd8fbdd052b	0904-6826	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Major Pharmaceuticals	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
0904-6828_a9b56482-cd32-4e0d-89bb-855345e378e0	0904-6828	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20161123		ANDA	ANDA207511	MAJOR PHARMACEUTICALS	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6829_eea1093b-2878-5c58-e053-2995a90aca20	0904-6829	HUMAN OTC DRUG	Major Medi-Pads		WITCH HAZEL	CLOTH	TOPICAL	20190125		OTC MONOGRAPH FINAL	part346	Major Pharmaceuticals	WITCH HAZEL	50	g/100g			N	20241231
0904-6830_7e3f1c65-9669-4dcb-a2e8-bc220e19dda2	0904-6830	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150613		ANDA	ANDA090061	Major Pharmaceuticals	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
0904-6831_68caa82e-928f-4f1b-8e9f-40b0cdbe812a	0904-6831	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170831		ANDA	ANDA207466	Major Pharmaceuticals	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
0904-6832_3d897e4c-1c41-43eb-a72f-e4cd16aeff41	0904-6832	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	TABLET, DELAYED RELEASE	ORAL	20170619		ANDA	ANDA091640	Major Pharmaceuticals	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
0904-6833_082edb23-8cc9-4ada-93f5-61f6b6b050e8	0904-6833	HUMAN OTC DRUG	Mi Acid		Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20181228		OTC MONOGRAPH FINAL	part331	Major Pharmaceuticals	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6834_0d4706ca-f1bc-4aac-a0d0-ce427e429965	0904-6834	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170707		ANDA	ANDA204652	Major Pharmaceuticals	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
0904-6835_0d4706ca-f1bc-4aac-a0d0-ce427e429965	0904-6835	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170707		ANDA	ANDA204652	Major Pharmaceuticals	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
0904-6836_1a0d783a-64e8-4e3d-85c0-4e8c2c1ef41e	0904-6836	HUMAN OTC DRUG	loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20181129		ANDA	ANDA091292	Major Pharmaceuticals	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0904-6848_0cf9f932-b522-ab8b-e063-6394a90a4620	0904-6848	HUMAN OTC DRUG	Major Lubricating Eye Drops		Carboxymethylcellulose Sodium	SOLUTION/ DROPS	OPHTHALMIC	20200623		OTC MONOGRAPH DRUG	M018	Harvard Drug Group L L C	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	.5	g/100mL			N	20241231
0904-6852_5cd57b40-f9a6-4598-93a5-385ce32030bb	0904-6852	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20181206		ANDA	ANDA076301	Major Pharmaceuticals	LORATADINE	10	mg/1			N	20241231
0904-6852_b91498b6-3bf0-411a-a3bf-c82801ad2e8e	0904-6852	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20050221		ANDA	ANDA076301	Major Pharmaceuticals	LORATADINE	10	mg/1			N	20241231
0904-6860_cfd66ec0-37c3-4651-b949-397b390c588c	0904-6860	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Major Pharmaceuticals	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-6861_cfd66ec0-37c3-4651-b949-397b390c588c	0904-6861	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Major Pharmaceuticals	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-6867_40c8a635-489e-4bc7-840a-9a6b22b655d4	0904-6867	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE	ORAL	20121024		ANDA	ANDA201687	Major Pharmaceuticals	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
0904-6868_1ee7551a-83ee-4710-87c1-bd75a7c967e5	0904-6868	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Major Pharmaceuticals	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0904-6869_1ee7551a-83ee-4710-87c1-bd75a7c967e5	0904-6869	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Major Pharmaceuticals	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0904-6870_3ed3291e-43c2-4517-916f-6663bdf90d88	0904-6870	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	Major Pharmaceuticals	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0904-6872_7cd9e19e-8846-41e0-9441-ae67cd29e79f	0904-6872	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	Major Pharmaceuticals	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
0904-6874_0e90adf2-8931-4df2-b501-0217ca0b822a	0904-6874	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET, FILM COATED	ORAL	20121217		ANDA	ANDA077844	Major Pharmaceuticals	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
0904-6882_1e25add8-d5b6-4342-b7cd-3074d7ee994c	0904-6882	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20180515		ANDA	ANDA209373	Major Pharmaceuticals	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
0904-6883_69ef9f35-add0-44cf-944d-fc69d1a7dd02	0904-6883	HUMAN OTC DRUG	major acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190304		ANDA	ANDA075077	Major Pharmaceuticals	ACETAMINOPHEN	650	mg/1			N	20241231
0904-6885_10cec58a-6060-403f-a451-c44c36316153	0904-6885	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20120323		ANDA	ANDA078986	Major Pharmaceuticals	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-6888_c22106f2-d06d-46ca-930a-979ec9a7f877	0904-6888	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Major Pharamceuticals	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
0904-6890_f426c03d-f7f5-4bff-9fea-b758f8049b7f	0904-6890	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Major Pharmaceuticals	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
0904-6899_a13e39d0-7b1b-40a2-945c-d624bfabe568	0904-6899	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Major Pharmaceuticals	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
0904-6900_f3fe5224-dbc7-4577-99ce-ea97003cc317	0904-6900	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20160212		ANDA	ANDA089286	Major Pharmaceuticals	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0904-6901_8b34da8f-4d25-4206-a2e8-e84af4836518	0904-6901	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA079179	Major Pharmaceuticals	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
0904-6902_50569dcc-367d-4203-940f-7043e61e6571	0904-6902	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, FILM COATED	ORAL	20161012		ANDA	ANDA206384	Major Pharmaceuticals	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
0904-6907_b61d6e2e-18dc-37d2-e053-2a95a90af57b	0904-6907	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET	ORAL	20190131		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE	60	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6908_fb49e22a-be13-4304-a079-4a3ceccae11b	0904-6908	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Major Pharmaceuticals	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-6909_d4258698-37c7-427c-8b3c-c73028891242	0904-6909	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818		ANDA	ANDA065399	Major Pharmaceuticals	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0904-6914_1684b688-dbb2-46e1-99c2-547a5515e63f	0904-6914	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Major Pharmaceuticals	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0904-6916_9313ea09-2608-4e4f-bd8a-eeba86d12cfa	0904-6916	HUMAN PRESCRIPTION DRUG	metolazone		metolazone	TABLET	ORAL	19731127		NDA AUTHORIZED GENERIC	NDA017386	Major Pharmaceuticals	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0904-6917_18b8a304-b1db-4bb6-b183-0a107cf95676	0904-6917	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Major Pharmaceuticals	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
0904-6920_09ce39b5-3df2-80d6-e063-6294a90afef4	0904-6920	HUMAN OTC DRUG	Docusate Mini Enema		docusate sodium	LIQUID	RECTAL	20190826		OTC MONOGRAPH DRUG	M007	Major Pharmaceuticals	DOCUSATE SODIUM	283	mg/5mL			N	20241231
0904-6921_f2d75d05-d8ce-4166-19a9-e9b0265c99a7	0904-6921	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20190528		ANDA	ANDA075294	MAJOR PHARMACEUTICALS	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0904-6923_bd500efc-1efc-48b3-be6b-41e1167ee72d	0904-6923	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Major Pharmaceuticals	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0904-6924_4cf8d5c8-842b-4e7c-9a99-3f41ef8abbdb	0904-6924	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Major Pharmaceuticals	SERTRALINE HYDROCHLORIDE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-6925_4cf8d5c8-842b-4e7c-9a99-3f41ef8abbdb	0904-6925	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Major Pharmaceuticals	SERTRALINE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-6926_4cf8d5c8-842b-4e7c-9a99-3f41ef8abbdb	0904-6926	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Major Pharmaceuticals	SERTRALINE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-6927_43803dbc-7b9f-42c3-8341-40e0759970b4	0904-6927	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Major Pharmaceuticals	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
0904-6928_56087942-5260-428d-ac86-b72bacfd199c	0904-6928	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Major Pharmaceuticals	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-6929_56087942-5260-428d-ac86-b72bacfd199c	0904-6929	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Major Pharmaceuticals	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-6930_4eda7e05-fbe6-4a4a-be1e-41bb73d50c43	0904-6930	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20160118		ANDA	ANDA203002	Major Pharmaceuticals	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-6931_68d97727-ab56-4a2a-9c46-52febf90e258	0904-6931	HUMAN OTC DRUG	Polyethylene glycol 3350		Polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190630		ANDA	ANDA203928	Major Pharmaceuticals	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-6935_ea0d63fc-69e1-4447-b98f-62197f385aaa	0904-6935	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA205618	Major Pharmaceuticals	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6936_ea0d63fc-69e1-4447-b98f-62197f385aaa	0904-6936	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA205618	Major Pharmaceuticals	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6937_ea0d63fc-69e1-4447-b98f-62197f385aaa	0904-6937	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA205618	Major Pharmaceuticals	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-6938_f8747497-9dc5-414f-adb8-d19c5e396034	0904-6938	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20120913		ANDA	ANDA200243	Major Pharmaceuticals	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
0904-6939_4cc543f0-459f-407a-8d4e-f57117c1b12b	0904-6939	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	19990224		ANDA	ANDA075340	Major Pharmaceuticals	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
0904-6948_e41d44e6-5df2-4117-bf83-582c5eb509ca	0904-6948	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone Acetate	TABLET	ORAL	20181123		ANDA	ANDA208453	Major Pharmaceuticals	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
0904-6949_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6949	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6950_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6950	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190502		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6951_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6951	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6952_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6952	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6953_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6953	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6954_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6954	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6955_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6955	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6956_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6956	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6957_f1f46064-ba8b-43b4-b986-2fae060a9a7a	0904-6957	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Major Pharmaceuticals	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
0904-6966_292cb621-2098-4788-a137-07f04c160275	0904-6966	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Major Pharmaceuticals	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-6977_0c00876c-0452-7827-e063-6294a90a78bc	0904-6977	HUMAN OTC DRUG	Hemorrhoidal		Hard Fat, Phenylephrine HCl	SUPPOSITORY	RECTAL	20191218		OTC MONOGRAPH DRUG	M015	Major Pharmaceuticals	HARD FAT; PHENYLEPHRINE HYDROCHLORIDE	1.77; 5	g/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-6985_5e2bea25-9aad-45e0-b506-6d999247a566	0904-6985	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	SOLUTION	ORAL	20190827		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-6986_1a5eb713-5acb-4e0e-89a8-eae3e9c2841e	0904-6986	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190923		ANDA	ANDA209215	Major Pharmaceuticals	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
0904-6987_9420a67a-ff7e-4c8f-97cd-df048d337ab4	0904-6987	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Major Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0904-6988_9420a67a-ff7e-4c8f-97cd-df048d337ab4	0904-6988	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	Major Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0904-6990_201b8688-1357-46ed-9304-c88c9db63a0b	0904-6990	HUMAN OTC DRUG	Pseudoephedrine HCl	Unit Dose	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20190812		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-6991_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-6991	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	25	mg/1		CV	N	20241231
0904-6992_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-6992	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	50	mg/1		CV	N	20241231
0904-6993_d8d7f793-a660-4227-b425-6a3875d2f83d	0904-6993	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20010330		ANDA	ANDA075424	Major Pharmaceuticals	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
0904-6994_27678486-5a24-4a43-b53a-2baacc85df8b	0904-6994	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190630		OTC MONOGRAPH FINAL	part347	Major Pharmaceuticals	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
0904-6995_b225d11c-6b5a-4c83-8fd8-e8bb985c92ae	0904-6995	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190731		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0904-6996_7e4b53b0-9743-4af6-a725-2faff601d76a	0904-6996	HUMAN OTC DRUG	Night Time Cold and Flu Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-6997_1ad9a5e9-bcbc-4fd6-b092-b92cf50e0ea9	0904-6997	HUMAN OTC DRUG	Stool Softener Laxative		Docusate calcium	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE CALCIUM	240	mg/1			N	20241231
0904-6998_7d52bdde-d69a-495e-af21-d39b5d4edeb2	0904-6998	HUMAN OTC DRUG	Docusate Sodium		DOCUSATE SODIUM	CAPSULE	ORAL	20200228		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE SODIUM	100	mg/1			N	20241231
0904-6999_d843827d-caa0-4b07-8436-1f20da9d847a	0904-6999	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE SODIUM	250	mg/1			N	20241231
0904-7000_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-7000	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	75	mg/1		CV	N	20241231
0904-7001_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-7001	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	100	mg/1		CV	N	20241231
0904-7002_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-7002	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	150	mg/1		CV	N	20241231
0904-7003_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-7003	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	200	mg/1		CV	N	20241231
0904-7004_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-7004	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	225	mg/1		CV	N	20241231
0904-7005_451eb2bb-8ad9-45df-97ab-230a9014ca30	0904-7005	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Major Pharmaceuticals	PREGABALIN	300	mg/1		CV	N	20241231
0904-7006_6a56ab1b-a541-4802-98ce-b47b39307049	0904-7006	HUMAN OTC DRUG	Major		Nasal Decongestant	SPRAY	NASAL	20190516		OTC MONOGRAPH DRUG	M012	MAJOR PHARMACEUTICALS	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0904-7007_7cec2cda-d931-4fe2-9036-deedf84226bf	0904-7007	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Major Pharmaceuticals	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0904-7008_7cec2cda-d931-4fe2-9036-deedf84226bf	0904-7008	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Major Pharmaceuticals	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
0904-7009_fbb6d4ef-0845-4645-ba07-4a51c1740dde	0904-7009	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride and naloxone hydrochloride dihydrate		buprenorphine hydrochloride and naloxone hydrochloride dihydrate	TABLET	SUBLINGUAL	20140627		ANDA	ANDA203326	Major Pharmaceuticals	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0904-7010_fbb6d4ef-0845-4645-ba07-4a51c1740dde	0904-7010	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride and naloxone hydrochloride dihydrate		buprenorphine hydrochloride and naloxone hydrochloride dihydrate	TABLET	SUBLINGUAL	20140627		ANDA	ANDA203326	Major Pharmaceuticals	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0904-7014_5cc2440e-0bee-4d48-9dc7-c4c517838536	0904-7014	HUMAN OTC DRUG	Children Acetaminophen Oral Solution		Acetaminophen	LIQUID	ORAL	20191001		OTC MONOGRAPH NOT FINAL	part343	MAJOR PHARMACEUTICALS	ACETAMINOPHEN	160	mg/5mL			N	20241231
0904-7016_e469934b-cc11-44da-99c9-b267b11ea320	0904-7016	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	Major Pharmaceuticals	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0904-7020_cf133f86-6334-4897-9e6c-e19e2d23d234	0904-7020	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Major Pharmaceuticals	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-7021_cf133f86-6334-4897-9e6c-e19e2d23d234	0904-7021	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Major Pharmaceuticals	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-7022_cf133f86-6334-4897-9e6c-e19e2d23d234	0904-7022	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Major Pharmaceuticals	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-7023_0c8fe61a-098c-a256-e063-6294a90a0664	0904-7023	HUMAN OTC DRUG	Major Bacitracin		Bacitracin Zinc	OINTMENT	TOPICAL	20200401		OTC MONOGRAPH DRUG	M004	Major Pharmaceuticals	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
0904-7024_32f1874d-6280-4894-ac06-33df37374d00	0904-7024	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET	ORAL	20160531		ANDA	ANDA206181	Major Pharmaceuticals	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
0904-7026_4e33ea73-0521-4572-957d-c3eb677c0cba	0904-7026	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20180215		ANDA	ANDA205005	Major Pharmaceuticals	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
0904-7027_7769ad3d-6228-4b2d-8f44-4efe990d3fad	0904-7027	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171115		ANDA	ANDA209823	Major Pharmaceuticals	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0904-7035_ee25a2bb-3878-5afd-e053-2a95a90a30a6	0904-7035	HUMAN PRESCRIPTION DRUG	Major Oral Rinse		0.12% Chlorhexidine Gluconate	RINSE	ORAL	20201120		ANDA	ANDA077789	Major Pharmaceuticals	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
0904-7036_71806820-b0c9-4d19-91a0-54056540c4c1	0904-7036	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		NALTREXONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120229		ANDA	ANDA090356	Major Pharmaceuticals	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
0904-7038_5d10b625-46ad-4d77-9ec8-d80fe176da3f	0904-7038	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Major Pharmaceuticals	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7039_5d10b625-46ad-4d77-9ec8-d80fe176da3f	0904-7039	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Major Pharmaceuticals	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7041_1bcfcec6-8a44-4245-a55b-b72206f2acd9	0904-7041	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20180208		ANDA	ANDA210117	Major Pharmaceuticals	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0904-7042_2a4bc60c-feef-49e4-9619-577cbb398287	0904-7042	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20170612		ANDA	ANDA209171	Major Pharmaceuticals	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
0904-7043_abd32cc2-e506-412d-9e59-01219830bba8	0904-7043	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Major Pharmaceuticals	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-7044_abd32cc2-e506-412d-9e59-01219830bba8	0904-7044	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Major Pharmaceuticals	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-7045_abd32cc2-e506-412d-9e59-01219830bba8	0904-7045	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Major Pharmaceuticals	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-7046_8da19a55-d8b8-40ae-bba4-8ce77e9a6c66	0904-7046	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20180501		ANDA	ANDA210441	Major Pharmaceuticals	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
0904-7047_3c527d7f-d617-459b-8a51-05b8dfaeac50	0904-7047	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Major Pharmaceuticals	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0904-7048_3c527d7f-d617-459b-8a51-05b8dfaeac50	0904-7048	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Major Pharmaceuticals	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0904-7049_3c527d7f-d617-459b-8a51-05b8dfaeac50	0904-7049	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Major Pharmaceuticals	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0904-7050_261b707f-0b54-411e-9c75-e3555f88668b	0904-7050	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine HCl	TABLET	ORAL	20191129		ANDA	ANDA204507	Major Pharmaceuticals	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-7052_5d3e99fa-c8a4-4d57-b652-c651181afd5f	0904-7052	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Major Pharmaceuticals	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7053_5d3e99fa-c8a4-4d57-b652-c651181afd5f	0904-7053	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Major Pharmaceuticals	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7054_5d3e99fa-c8a4-4d57-b652-c651181afd5f	0904-7054	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Major Pharmaceuticals	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7055_5d3e99fa-c8a4-4d57-b652-c651181afd5f	0904-7055	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Major Pharmaceuticals	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7056_a6e652e1-b2e4-47ba-bed2-c5e902f8b8f1	0904-7056	HUMAN PRESCRIPTION DRUG	Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg		Aspirin and Extended - Release Dipyridamole	CAPSULE	ORAL	20170130		ANDA	ANDA207944	Major Pharmaceuticals	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0904-7057_f76fe2ed-3e77-4340-928f-d6489b3da883	0904-7057	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20171215		ANDA	ANDA086989	Major Pharmaceuticals	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0904-7058_f76fe2ed-3e77-4340-928f-d6489b3da883	0904-7058	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130115		ANDA	ANDA086988	Major Pharmaceuticals	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
0904-7059_e885fca9-a9e5-45b7-9a7a-344b1b968dd3	0904-7059	HUMAN PRESCRIPTION DRUG	Trospium Chloride		Trospium Chloride	TABLET, FILM COATED	ORAL	20151116		ANDA	ANDA204945	Major Pharmaceuticals	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
0904-7061_bce700c8-e6ca-4c69-8b22-691726f2ffe7	0904-7061	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20180829		ANDA	ANDA211067	Major Pharmaceuticals	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-7062_7ea33928-b4b5-4c2c-bc92-80ddc59ac414	0904-7062	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20180829		ANDA	ANDA211067	Major Pharmaceuticals	POTASSIUM CHLORIDE	40	meq/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-7064_9b34e195-4e9c-4bed-8586-bf68c81873e9	0904-7064	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20181011		ANDA	ANDA210692	Major Pharmaceuticals	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
0904-7065_b0b4e716-88b1-4e04-a461-cc75841671cd	0904-7065	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	Major Pharmaceuticals	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-7067_ee387b38-ced2-437a-867a-bce3fb187065	0904-7067	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Major Pharmaceuticals	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
0904-7070_fc852b15-5479-4623-a911-95583bcb0089	0904-7070	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	Major Pharmaceuticals	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7071_fc852b15-5479-4623-a911-95583bcb0089	0904-7071	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	Major Pharmaceuticals	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7072_4c3f5466-d935-4063-8dbc-14480d1a4187	0904-7072	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20010725		ANDA	ANDA075671	Major Pharmaceuticals	MEGESTROL ACETATE	40	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0904-7073_fa2e1ce8-e4c2-4b85-bdc8-532ad510d5b3	0904-7073	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	SOLUTION	ORAL	20101217		ANDA	ANDA091483	Major Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
0904-7074_d5342771-def9-4108-bb5b-4e866847affc	0904-7074	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	CAPSULE	ORAL	20090504		ANDA	ANDA090253	Major Pharmaceuticals	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0904-7075_ff1ddeb2-9129-4c02-9757-964662dcd0ad	0904-7075	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Major Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-7076_ff1ddeb2-9129-4c02-9757-964662dcd0ad	0904-7076	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Major Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-7077_ff1ddeb2-9129-4c02-9757-964662dcd0ad	0904-7077	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Major Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
0904-7078_69d750fe-af4f-40a5-b4fb-ea574797ec50	0904-7078	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	TABLET, FILM COATED	ORAL	20101106		ANDA	ANDA090456	Major Pharmaceuticals	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
0904-7079_070e56f4-db77-4ead-aad9-054a1dad8507	0904-7079	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20040408		ANDA	ANDA040521	Major Pharmaceuticals	PHENYTOIN	100	mg/4mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7081_104876d9-0312-4f12-9324-76da4a8663a3	0904-7081	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Major Pharmaceuticals	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0904-7082_104876d9-0312-4f12-9324-76da4a8663a3	0904-7082	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Major Pharmaceuticals	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0904-7083_221a02bc-9da3-4a75-b42b-b34b6ea11013	0904-7083	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Major Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0904-7084_817668bf-0adf-42e9-ad65-d2f28fcdd09b	0904-7084	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA210015	Major Pharmaceuticals	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-7085_6ae34cdf-4f32-4719-b52a-e2a7612f5f40	0904-7085	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20160121		ANDA	ANDA206347	Major Pharmaceuticals	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-7086_6ae34cdf-4f32-4719-b52a-e2a7612f5f40	0904-7086	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20160121		ANDA	ANDA206347	Major Pharmaceuticals	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-7087_d93645f2-a1ec-4ce3-b554-6abd85965779	0904-7087	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Major Pharmaceuticals	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7088_d93645f2-a1ec-4ce3-b554-6abd85965779	0904-7088	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Major Pharmaceuticals	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7089_d93645f2-a1ec-4ce3-b554-6abd85965779	0904-7089	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Major Pharmaceuticals	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7090_b681f4d7-a2c1-4e80-ad6b-10f93e9c54c8	0904-7090	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Major Pharmaceuticals	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0904-7093_ccc62b6f-3554-46f2-a204-f0a286454024	0904-7093	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Major Pharmaceuticals	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-7094_ccc62b6f-3554-46f2-a204-f0a286454024	0904-7094	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Major Pharmaceuticals	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-7095_ccc62b6f-3554-46f2-a204-f0a286454024	0904-7095	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Major Pharmaceuticals	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-7096_b681f4d7-a2c1-4e80-ad6b-10f93e9c54c8	0904-7096	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Major Pharmaceuticals	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
0904-7097_aef1cd64-76b2-478c-8854-b772319fbda9	0904-7097	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20140813		ANDA	ANDA090687	Major Pharmaceuticals	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
0904-7103_067a6c29-522c-4fb3-ab5f-277351f9f3d8	0904-7103	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20171223		ANDA	ANDA209234	Major Pharmaceuticals	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
0904-7104_47dec5b0-d625-46f9-9363-4a0274035eaf	0904-7104	HUMAN PRESCRIPTION DRUG	Galantamine		galantamine	TABLET, FILM COATED	ORAL	20170802		ANDA	ANDA077604	Major Pharmaceuticals	GALANTAMINE HYDROBROMIDE	4	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0904-7105_a43a5373-ded9-4912-8c98-edaec8352836	0904-7105	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20191213		ANDA	ANDA212809	Major Pharmaceuticals	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0904-7106_a43a5373-ded9-4912-8c98-edaec8352836	0904-7106	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20191213		ANDA	ANDA212809	Major Pharmaceuticals	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0904-7107_785d6c15-62da-4cba-9234-961b52a2b677	0904-7107	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20160325		ANDA	ANDA204572	Major Pharmaceuticals	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
0904-7108_e4dba0e2-e43e-4334-83e7-3db4fcd7f659	0904-7108	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Major Pharmaceuticals	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7109_5eb2199a-cd19-48fa-9451-1c7940a0c8ef	0904-7109	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Major Pharmaceuticals	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7110_5eb2199a-cd19-48fa-9451-1c7940a0c8ef	0904-7110	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Major Pharmaceuticals	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7111_5eb2199a-cd19-48fa-9451-1c7940a0c8ef	0904-7111	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Major Pharmaceuticals	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7112_eadcea92-7ca6-4bd8-b4e5-f59bf44f3385	0904-7112	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	SOLUTION	ORAL	19930928		ANDA	ANDA073364	Major Pharmaceuticals	HALOPERIDOL LACTATE	2	mg/mL	Typical Antipsychotic [EPC]		N	20241231
0904-7113_d6010d83-ed41-47eb-af6e-44d9da6a30f9	0904-7113	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20020430		ANDA	ANDA075873	Major Pharmaceuticals	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-7114_2a9d7bfe-a757-4c5a-849d-b5ae1d2033e4	0904-7114	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20020430		ANDA	ANDA075873	Major Pharmaceuticals	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-7116_9e970e7f-4af3-43cf-91fa-409c08dc4719	0904-7116	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	SUSPENSION	ORAL	20040920		ANDA	ANDA076729	Major Pharmaceuticals	CARBAMAZEPINE	100	mg/5mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-7117_0a512abe-88ed-49f6-99b2-246f6d18681b	0904-7117	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	SOLUTION	ORAL	19870403		ANDA	ANDA070928	Major Pharmaceuticals	DIAZEPAM	5	mg/5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-7118_08989357-f611-4e49-a5be-729c2af7bc55	0904-7118	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	Major Pharmaceuticals	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7119_9a731cdf-6488-44ca-b97f-512a0e9deab1	0904-7119	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20080226		ANDA	ANDA077728	Major Pharmaceuticals	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0904-7120_1857a1f0-b6b1-41c4-8e5f-16342baefe23	0904-7120	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20200513		ANDA	ANDA210425	Major Pharmaceuticals	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
0904-7121_8dc1ee33-e5aa-4462-8fb9-9bbdf5463488	0904-7121	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Major Pharmaceuticals	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
0904-7122_8dc1ee33-e5aa-4462-8fb9-9bbdf5463488	0904-7122	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Major Pharmaceuticals	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
0904-7123_c4b27429-50a3-467c-a5ff-7e49a01a1088	0904-7123	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Major Pharmaceuticals	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7124_c4b27429-50a3-467c-a5ff-7e49a01a1088	0904-7124	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Major Pharmaceuticals	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7125_c4b27429-50a3-467c-a5ff-7e49a01a1088	0904-7125	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Major Pharmaceuticals	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7126_d18f5b70-c8e3-4309-b426-1bb04b1af348	0904-7126	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20171129		ANDA	ANDA205245	Major Pharmaceuticals	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0904-7127_5d2181be-c5ac-4c11-b680-66f3710801c2	0904-7127	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Major Pharmaceuticals	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0904-7128_0a333de0-9c71-41f4-8ae2-e1fcf42253e0	0904-7128	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20200701		ANDA	ANDA204019	Major Pharmaceuticals	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0904-7129_0d2308a2-da8e-48cf-8cb1-60e7cf29e7d1	0904-7129	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Major Pharmaceuticals	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7130_0d2308a2-da8e-48cf-8cb1-60e7cf29e7d1	0904-7130	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Major Pharmaceuticals	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7131_0d2308a2-da8e-48cf-8cb1-60e7cf29e7d1	0904-7131	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Major Pharmaceuticals	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7132_0d2308a2-da8e-48cf-8cb1-60e7cf29e7d1	0904-7132	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Major Pharmaceuticals	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7133_0d2308a2-da8e-48cf-8cb1-60e7cf29e7d1	0904-7133	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Major Pharmaceuticals	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7134_9191f6c3-0add-4116-a3d5-7199279aa77e	0904-7134	HUMAN OTC DRUG	Chest Congestion Relief	DM	Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20201001		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-7135_ea6fc95c-e5e0-4e75-ba13-afb7bc674f8c	0904-7135	HUMAN OTC DRUG	Chest Congestion Relief	DM	Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20201001		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-7136_79546ad3-b144-4eb2-848b-2fe7280f6e2b	0904-7136	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Major Pharmaceuticals	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
0904-7137_b2c95493-7bd7-414c-8ea8-61d55c5cedca	0904-7137	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	Major Pharmaceuticals	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
0904-7138_822bb0ac-1b6c-4132-afca-d0d0633d1843	0904-7138	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Major Pharmaceuticals	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0904-7139_822bb0ac-1b6c-4132-afca-d0d0633d1843	0904-7139	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Major Pharmaceuticals	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0904-7140_d82520e4-5c32-4072-bdd2-f7594d4de7c0	0904-7140	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20131202		ANDA	ANDA074673	Major Pharmaceuticals	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
0904-7141_64fee367-9e11-45c9-811c-e2a1e3b9dce5	0904-7141	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20170209		ANDA	ANDA207812	Major Pharmaceuticals	METHOTREXATE	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
0904-7142_0bffd511-cbd4-3dcf-e063-6294a90a540f	0904-7142	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	SUPPOSITORY	RECTAL	20210505		OTC MONOGRAPH DRUG	M007	Major Pharmaceuticals	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-7143_866e5717-3de2-4f19-b7c7-2275caeef78b	0904-7143	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Major Pharmaceuticals	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
0904-7144_adefab2b-167d-4b87-a57d-f8165de1f61b	0904-7144	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	Major Pharmaceuticals	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
0904-7145_adefab2b-167d-4b87-a57d-f8165de1f61b	0904-7145	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	Major Pharmaceuticals	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
0904-7149_c205a28d-ab21-4a1e-92ec-00093939dc01	0904-7149	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		POSACONAZOLE	TABLET, DELAYED RELEASE	ORAL	20210203		ANDA	ANDA213454	Major Pharmaceuticals	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0904-7153_324f65ae-09d1-4bd6-9d2b-593035201ecd	0904-7153	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Major Pharmaceuticals	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
0904-7154_18414e03-9dcb-4665-820e-c8d082834879	0904-7154	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20091008		ANDA	ANDA078633	Major Pharmaceuticals	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0904-7155_18414e03-9dcb-4665-820e-c8d082834879	0904-7155	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20091008		ANDA	ANDA078633	Major Pharmaceuticals	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
0904-7156_d18f5b70-c8e3-4309-b426-1bb04b1af348	0904-7156	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20171129		ANDA	ANDA205245	Major Pharmaceuticals	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
0904-7157_e8d4065a-45fc-4adf-9406-2122ca131d99	0904-7157	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Major Pharmaceuticals	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7158_e8d4065a-45fc-4adf-9406-2122ca131d99	0904-7158	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Major Pharmaceuticals	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7159_e8d4065a-45fc-4adf-9406-2122ca131d99	0904-7159	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Major Pharmaceuticals	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7160_e8d4065a-45fc-4adf-9406-2122ca131d99	0904-7160	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	19880825		ANDA	ANDA089743	Major Pharmaceuticals	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7161_bbffd586-f63a-4a84-bdfb-3e4a1df6449e	0904-7161	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20161215		ANDA	ANDA208709	Major Pharmaceuticals	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
0904-7162_5e783025-bf6d-465e-bf58-bcd253afad2c	0904-7162	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Major Pharmaceuticals	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0904-7163_5e783025-bf6d-465e-bf58-bcd253afad2c	0904-7163	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Major Pharmaceuticals	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0904-7164_5e783025-bf6d-465e-bf58-bcd253afad2c	0904-7164	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Major Pharmaceuticals	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
0904-7165_2612ee97-1723-40f2-99e6-3a736f63200f	0904-7165	HUMAN PRESCRIPTION DRUG	Aminocaproic acid		Aminocaproic acid	TABLET	ORAL	20191130		ANDA	ANDA212492	Major Pharmaceuticals	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
0904-7166_89fd0294-0cf9-4f9e-91d6-6771e390822b	0904-7166	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	CAPSULE, DELAYED RELEASE	ORAL	20170915		ANDA	ANDA206200	Major Pharmaceuticals	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0904-7167_0703558e-769a-b3c3-e063-6394a90a5f25	0904-7167	HUMAN PRESCRIPTION DRUG	Urea Cream 40%		Urea	CREAM	TOPICAL	20210706		UNAPPROVED DRUG OTHER		Major Pharmaceuticals	UREA	400	mg/g			N	20241231
0904-7168_27238e3b-937e-4d18-85b7-0f69bc9e8761	0904-7168	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20181022		ANDA	ANDA211301	Major Pharmaceuticals	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
0904-7172_afa76344-4349-4a9e-b83d-724900e50961	0904-7172	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA212114	Major Pharmaceuticals	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
0904-7177_6be1addd-a811-47fc-8650-6870d661c234	0904-7177	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Major Pharmaceuticals	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0904-7178_6be1addd-a811-47fc-8650-6870d661c234	0904-7178	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Major Pharmaceuticals	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0904-7179_0742ec44-f8b4-45c5-a36e-2638bdaa2e44	0904-7179	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Major Pharmaceuticals	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
0904-7180_292cb621-2098-4788-a137-07f04c160275	0904-7180	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Major Pharmaceuticals	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
0904-7181_19793f37-9dcd-430f-8693-07daed27086b	0904-7181	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20150601		ANDA	ANDA203730	Major Pharmaceuticals	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-7182_19793f37-9dcd-430f-8693-07daed27086b	0904-7182	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20150601		ANDA	ANDA203730	Major Pharmaceuticals	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
0904-7183_ca84ae13-c056-4f57-845b-fd26f2ebd3aa	0904-7183	HUMAN OTC DRUG	Docusate Sodium - Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210904		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE SODIUM	100	mg/1			N	20241231
0904-7184_c08db8a2-4b64-47b6-96b5-dd70d89d8a95	0904-7184	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Major Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7185_c08db8a2-4b64-47b6-96b5-dd70d89d8a95	0904-7185	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Major Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
0904-7187_4555261d-a997-4aa5-aba8-81aac7033787	0904-7187	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071031		ANDA	ANDA078512	Major Pharmaceuticals	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7188_91885fc8-876f-4a4d-8ae5-eb246a335808	0904-7188	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20070330		ANDA	ANDA040646	Major Pharmaceuticals	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0904-7189_a6a10785-cdf1-498c-8a92-d01bbd222af7	0904-7189	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Major Pharmaceuticals	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7190_a6a10785-cdf1-498c-8a92-d01bbd222af7	0904-7190	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Major Pharmaceuticals	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7192_0774a5b6-a30a-989b-e063-6294a90a40e4	0904-7192	HUMAN OTC DRUG	fexofenadine hcl		fexofenadine hcl	TABLET, FILM COATED	ORAL	20210826		ANDA	ANDA204507	Major Pharmaceuticals	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-7193_8c5ea5d0-41d3-496f-81ed-8c495441f03e	0904-7193	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075718	Major Pharmaceuticals	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
0904-7194_d53a66bf-fdbd-4a12-8d8c-4e3ab94e9ef5	0904-7194	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20090826		ANDA	ANDA065442	Major Pharmaceuticals	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
0904-7195_5b30a7b2-2587-451f-9906-9b7abb7c4ccc	0904-7195	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	SOLUTION	ORAL	20090319		ANDA	ANDA079209	Major Pharmaceuticals	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
0904-7199_08a9d26b-4419-43ec-98f3-43d4534c2e76	0904-7199	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	TABLET, CHEWABLE	ORAL	20140417		ANDA	ANDA200565	Major Pharmaceuticals	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7200_aac4145e-02a2-4e44-b8bc-a5eac8ad1108	0904-7200	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210601		ANDA	ANDA077321	Major Pharmaceuticals	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
0904-7205_dc48073a-6812-43c0-a679-478073e7c8da	0904-7205	HUMAN OTC DRUG	Major Bismuth Subsalicylate		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20211011		OTC MONOGRAPH FINAL	part335	Major Pharmaceuticals	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
0904-7206_019a85b2-f07a-4f5d-ae1f-4473fc4fe267	0904-7206	HUMAN OTC DRUG	Antiflatulent		Simethicone	TABLET, CHEWABLE	ORAL	20211004		OTC MONOGRAPH FINAL	part332	Major Pharmaceuticals	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
0904-7208_7c460c1d-9729-44b3-be9c-76ce9ab33f3a	0904-7208	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Major Pharmaceuticals	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0904-7211_90414d2f-7b2c-47f9-a096-2e7b7dd052de	0904-7211	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		Dantrolene Sodium	CAPSULE	ORAL	20050301		ANDA	ANDA076856	Major Pharmaceuticals	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
0904-7212_1ee7551a-83ee-4710-87c1-bd75a7c967e5	0904-7212	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Major Pharmaceuticals	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
0904-7213_ae6e79c0-a307-4888-b647-1b7be4cb9127	0904-7213	HUMAN PRESCRIPTION DRUG	Acamprosate Calcium		Acamprosate Calcium	TABLET, DELAYED RELEASE	ORAL	20130716		ANDA	ANDA202229	Major Pharmaceuticals	ACAMPROSATE CALCIUM	333	mg/1			N	20241231
0904-7214_088173b7-a948-41aa-bf26-7ca117a2ac93	0904-7214	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220707		ANDA	ANDA211347	Major Pharmaceuticals	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-7216_a9d68a40-75e3-4c5c-b5d7-1d6160527fa7	0904-7216	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181219		ANDA	ANDA210921	Major Pharmaceuticals	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-7217_e7476adc-a940-4e76-a1dd-c418de493bc0	0904-7217	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220809		ANDA	ANDA205231	Major Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0904-7218_e7476adc-a940-4e76-a1dd-c418de493bc0	0904-7218	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220809		ANDA	ANDA205231	Major Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0904-7219_e7476adc-a940-4e76-a1dd-c418de493bc0	0904-7219	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220809		ANDA	ANDA205231	Major Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0904-7220_e7476adc-a940-4e76-a1dd-c418de493bc0	0904-7220	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220809		ANDA	ANDA205231	Major Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
0904-7223_db18295f-456d-478f-b7fb-dd27aab153be	0904-7223	HUMAN OTC DRUG	robafen dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220107		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
0904-7224_7778ac96-7817-455a-a177-22ecb276c67f	0904-7224	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20220307		ANDA	ANDA040625	Major Pharmaceuticals	FOLIC ACID	1	mg/1			N	20241231
0904-7225_a6a10785-cdf1-498c-8a92-d01bbd222af7	0904-7225	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Major Pharmaceuticals	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7226_a6a10785-cdf1-498c-8a92-d01bbd222af7	0904-7226	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Major Pharmaceuticals	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
0904-7227_ba2c0192-900b-4722-8651-4edd816fc09c	0904-7227	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20220823		ANDA	ANDA077856	Major Pharmaceuticals	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-7229_acb493a3-b8f2-41a9-8ab2-550d97c4592a	0904-7229	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE	ORAL	20220823		ANDA	ANDA202644	Major Pharmaceuticals	NIFEDIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
0904-7236_2c755c6b-32e9-4029-8b70-855007f7375b	0904-7236	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	20220404		ANDA	ANDA072423	Major Pharmaceuticals	MEGESTROL ACETATE	40	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
0904-7237_dca04d80-e782-40b1-e053-2995a90a7010	0904-7237	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH FINAL	part341	Major Pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0904-7240_39607d71-0463-4c9b-bf6f-b39eaa006e85	0904-7240	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Major Pharmaceuticals	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-7241_39607d71-0463-4c9b-bf6f-b39eaa006e85	0904-7241	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Major Pharmaceuticals	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-7242_39607d71-0463-4c9b-bf6f-b39eaa006e85	0904-7242	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Major Pharmaceuticals	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-7243_f818ed31-c746-4171-afdf-57a75434e5f1	0904-7243	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20220823		ANDA	ANDA076639	Major Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
0904-7244_c83d2156-4dde-4316-98f1-b3dc751f3eac	0904-7244	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Major Pharmaceuticals	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0904-7245_c83d2156-4dde-4316-98f1-b3dc751f3eac	0904-7245	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Major Pharmaceuticals	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0904-7246_c83d2156-4dde-4316-98f1-b3dc751f3eac	0904-7246	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Major Pharmaceuticals	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0904-7247_c83d2156-4dde-4316-98f1-b3dc751f3eac	0904-7247	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Major Pharmaceuticals	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
0904-7248_1bef7d8f-524b-4218-8fef-6c3f3628d33e	0904-7248	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20210313		ANDA	ANDA214753	Major Pharmaceuticals	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
0904-7252_df3b431b-a1ae-91dd-e053-2995a90aa02f	0904-7252	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, FILM COATED	ORAL	20220517		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	SENNOSIDES	8.6	mg/1			N	20241231
0904-7257_a6c68d7d-d535-4dcd-a0e2-499ac8884dc6	0904-7257	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20220118		ANDA	ANDA074260	Major Pharmaceuticals	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0904-7261_ebf340c9-0b6e-13d2-e053-2995a90ae338	0904-7261	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	TABLET	ORAL	20221026		OTC MONOGRAPH FINAL	part331	Major Pharmaceuticals	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0904-7262_b1d54def-057d-4608-bc8f-1d967ac3ec91	0904-7262	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20221107		ANDA	ANDA078069	Major Pharmaceuticals	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7263_b1d54def-057d-4608-bc8f-1d967ac3ec91	0904-7263	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20221107		ANDA	ANDA078069	Major Pharmaceuticals	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7264_b1d54def-057d-4608-bc8f-1d967ac3ec91	0904-7264	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20221107		ANDA	ANDA078069	Major Pharmaceuticals	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
0904-7266_64b46398-9b97-45e8-b1ba-1a202d574448	0904-7266	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20210901		ANDA	ANDA215106	Major Pharmaceuticals	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0904-7270_088173b7-a948-41aa-bf26-7ca117a2ac93	0904-7270	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA211347	Major Pharmaceuticals	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
0904-7278_7e52855c-5d09-4731-b312-ced4f99e4113	0904-7278	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20230602		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	160	mg/5mL			N	20241231
0904-7279_ef54be19-9474-7555-e053-2995a90af217	0904-7279	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	LIQUID	ORAL	20210816		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE SODIUM	50	mg/5mL			N	20241231
0904-7280_e73cca4b-1d0d-4a89-b7af-702cfb30dadc	0904-7280	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20221115		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE SODIUM	100	mg/1			N	20241231
0904-7281_a18097c1-5618-4aa6-8870-72ceb367ec6b	0904-7281	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20221014		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	DOCUSATE SODIUM	250	mg/1			N	20241231
0904-7283_09305350-e317-419c-96f5-aa8fbeb4044d	0904-7283	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	Major Pharmaceuticals	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
0904-7284_f7eafae0-c9cc-e6d5-e053-6394a90a1859	0904-7284	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20230327		ANDA	ANDA065170	MAJOR PHARMACEUTICALS	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
0904-7288_8b18b66c-2935-4304-8e20-ebf68dee5a1a	0904-7288	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20230711		ANDA	ANDA040715	Major Pharmaceuticals	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0904-7289_8b18b66c-2935-4304-8e20-ebf68dee5a1a	0904-7289	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20230711		ANDA	ANDA040715	Major Pharmaceuticals	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0904-7290_8b18b66c-2935-4304-8e20-ebf68dee5a1a	0904-7290	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20230711		ANDA	ANDA040715	Major Pharmaceuticals	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
0904-7291_f71fb741-238f-fd7e-e053-6394a90a84d9	0904-7291	HUMAN OTC DRUG	Major	Saline Laxative - Lemon	Magnesium Citrate	LIQUID	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part334	Major Pharmaceuticals	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-7292_7c2274f2-5a7f-4a4a-8b7b-44f6ef9a84a4	0904-7292	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA212861	Major Pharmaceuticals	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-7293_7c2274f2-5a7f-4a4a-8b7b-44f6ef9a84a4	0904-7293	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA212861	Major Pharmaceuticals	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0904-7302_09143c3a-8817-4130-905b-5bb7af20f84c	0904-7302	HUMAN OTC DRUG	Aprodine		Pseudoephedrine HCl, Triprolidine HCl	TABLET, FILM COATED	ORAL	20221111		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	60; 2.5	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
0904-7304_4cee8622-7d59-4794-8e32-54f7aac1d923	0904-7304	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20230417		ANDA	ANDA091179	Major Pharmaceuticals	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7314_0c55ed8a-0925-6021-e063-6394a90afa82	0904-7314	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230303		ANDA	ANDA211544	MAJOR PHARMACEUTICALS	ACETAMINOPHEN	650	mg/1			N	20241231
0904-7316_0274e839-cc8b-ad1c-e063-6394a90ad56c	0904-7316	HUMAN PRESCRIPTION DRUG	Sodium Citrate and Citric Acid		SODIUM CITRATE and CITRIC ACID MONOHYDRATE	SOLUTION	ORAL	20230801		UNAPPROVED DRUG OTHER		MAJOR PHARMACEUTICALS	ANHYDROUS CITRIC ACID; SODIUM CITRATE	334; 500	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0904-7319_634a56fd-ad5a-4a3f-a9d0-c73beb8f9cec	0904-7319	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20230605		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	160	mg/5mL			N	20241231
0904-7320_634a56fd-ad5a-4a3f-a9d0-c73beb8f9cec	0904-7320	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20230605		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	325	mg/10.15mL			N	20241231
0904-7321_634a56fd-ad5a-4a3f-a9d0-c73beb8f9cec	0904-7321	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20230605		OTC MONOGRAPH NOT FINAL	part343	Major Pharmaceuticals	ACETAMINOPHEN	650	mg/20.3mL			N	20241231
0904-7325_027676c5-bd0b-ca4a-e063-6394a90ae75c	0904-7325	HUMAN OTC DRUG	Aluminum Hydroxide, Magnesium Hydroxide and Simethicone Suspension		Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone	SUSPENSION	ORAL	20230705		OTC MONOGRAPH FINAL	part331	MAJOR PHARMACEUTICALS	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	1200; 120; 1200	mg/30mL; mg/30mL; mg/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-7326_027676c5-bd0b-ca4a-e063-6394a90ae75c	0904-7326	HUMAN OTC DRUG	Aluminum Hydroxide, Magnesium Hydroxide and Simethicone Suspension Maximum Strength		Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone	SUSPENSION	ORAL	20230801		OTC MONOGRAPH FINAL	part331	MAJOR PHARMACEUTICALS	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	2400; 240; 2400	mg/30mL; mg/30mL; mg/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-7328_8e8bbe58-0845-40d1-9831-82435f01c7be	0904-7328	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20230830		ANDA	ANDA213827	Major Pharmaceuticals	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0904-7329_8e8bbe58-0845-40d1-9831-82435f01c7be	0904-7329	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20230830		ANDA	ANDA213827	Major Pharmaceuticals	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
0904-7334_41c7882e-530a-4ac1-8de4-8d1e7b391467	0904-7334	HUMAN PRESCRIPTION DRUG	SULINDAC		sulindac	TABLET	ORAL	20230727		ANDA	ANDA072050	Major Pharmaceuticals	SULINDAC	150	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-7335_41c7882e-530a-4ac1-8de4-8d1e7b391467	0904-7335	HUMAN PRESCRIPTION DRUG	SULINDAC		sulindac	TABLET	ORAL	20230727		ANDA	ANDA072051	Major Pharmaceuticals	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-7336_1c1fbad7-bef4-42a0-a8c9-b35168f5d533	0904-7336	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20231106		ANDA	ANDA090836	Major Pharmaceuticals	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0904-7337_1c1fbad7-bef4-42a0-a8c9-b35168f5d533	0904-7337	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20231106		ANDA	ANDA090836	Major Pharmaceuticals	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
0904-7341_135620a6-a3ef-4a83-a435-daabc909c579	0904-7341	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20230501		ANDA	ANDA211555	Major Pharmaceuticals	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
0904-7347_835b7875-e912-49b6-9574-d82797cdf76b	0904-7347	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20231009		ANDA	ANDA073589	Major Pharmaceuticals	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
0904-7349_0bc969fb-9868-509b-e063-6394a90a93e6	0904-7349	HUMAN OTC DRUG	Major Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	Major Pharmaceuticals	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
0904-7350_814abe38-da4a-48af-bf4b-2ce04a5aabd1	0904-7350	HUMAN PRESCRIPTION DRUG	azithromycin dihydrate		azithromycin dihydrate	TABLET	ORAL	20230501		ANDA	ANDA065398	Major Pharmaceuticals	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0904-7351_814abe38-da4a-48af-bf4b-2ce04a5aabd1	0904-7351	HUMAN PRESCRIPTION DRUG	azithromycin dihydrate		azithromycin dihydrate	TABLET	ORAL	20230501		ANDA	ANDA065399	Major Pharmaceuticals	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
0904-7355_0c1e8103-3019-4fe6-a998-ca8b82c8547f	0904-7355	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Major Pharmaceuticals	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7356_0c1e8103-3019-4fe6-a998-ca8b82c8547f	0904-7356	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Major Pharmaceuticals	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7357_0c1e8103-3019-4fe6-a998-ca8b82c8547f	0904-7357	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Major Pharmaceuticals	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7358_0c1e8103-3019-4fe6-a998-ca8b82c8547f	0904-7358	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Major Pharmaceuticals	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7359_0c1e8103-3019-4fe6-a998-ca8b82c8547f	0904-7359	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Major Pharmaceuticals	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7360_d5abd75f-7f4a-4a7d-b849-82fce88f5ff7	0904-7360	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Major Pharmaceuticals	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7361_d5abd75f-7f4a-4a7d-b849-82fce88f5ff7	0904-7361	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Major Pharmaceuticals	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7362_d5abd75f-7f4a-4a7d-b849-82fce88f5ff7	0904-7362	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Major Pharmaceuticals	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7363_d5abd75f-7f4a-4a7d-b849-82fce88f5ff7	0904-7363	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Major Pharmaceuticals	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7364_d5abd75f-7f4a-4a7d-b849-82fce88f5ff7	0904-7364	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Major Pharmaceuticals	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7365_d5abd75f-7f4a-4a7d-b849-82fce88f5ff7	0904-7365	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Major Pharmaceuticals	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7366_573c6bb6-941f-4413-8c23-826025385864	0904-7366	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Major Pharmaceuticals	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7367_573c6bb6-941f-4413-8c23-826025385864	0904-7367	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Major Pharmaceuticals	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7368_573c6bb6-941f-4413-8c23-826025385864	0904-7368	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Major Pharmaceuticals	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7369_573c6bb6-941f-4413-8c23-826025385864	0904-7369	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Major Pharmaceuticals	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7370_573c6bb6-941f-4413-8c23-826025385864	0904-7370	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Major Pharmaceuticals	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7371_573c6bb6-941f-4413-8c23-826025385864	0904-7371	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Major Pharmaceuticals	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
0904-7375_f99f13ab-33c0-4304-8dc5-3a75f3909377	0904-7375	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220422		ANDA	ANDA201451	Major Pharmaceuticals	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0904-7376_f99f13ab-33c0-4304-8dc5-3a75f3909377	0904-7376	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220422		ANDA	ANDA201451	Major Pharmaceuticals	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0904-7377_7f76580c-96a0-4b56-8986-ff5488bb9869	0904-7377	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20230801		ANDA	ANDA204279	Major Pharmaceuticals	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-7378_7f76580c-96a0-4b56-8986-ff5488bb9869	0904-7378	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20230801		ANDA	ANDA204279	Major Pharmaceuticals	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-7379_7f76580c-96a0-4b56-8986-ff5488bb9869	0904-7379	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20230801		ANDA	ANDA204279	Major Pharmaceuticals	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
0904-7381_d6fc83ad-9cce-4e60-854c-3825313ee60c	0904-7381	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220801		ANDA	ANDA216202	Major Pharmaceuticals	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7382_d6fc83ad-9cce-4e60-854c-3825313ee60c	0904-7382	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220801		ANDA	ANDA216202	Major Pharmaceuticals	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
0904-7383_f8302a6e-b8da-4931-a279-b49e37943816	0904-7383	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Major Pharmaceuticals	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
0904-7389_f5bfb3b9-0c6d-4f04-8bfc-d063cd8bb8ed	0904-7389	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230718		ANDA	ANDA071173	Major Pharmaceuticals	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-7390_f5bfb3b9-0c6d-4f04-8bfc-d063cd8bb8ed	0904-7390	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230718		ANDA	ANDA071173	Major Pharmaceuticals	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-7391_f5bfb3b9-0c6d-4f04-8bfc-d063cd8bb8ed	0904-7391	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230718		ANDA	ANDA071173	Major Pharmaceuticals	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
0904-7392_04b1f69d-ebba-43b9-8ecd-4f6be7c8a0a0	0904-7392	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	MAJOR PHARMACEUTICALS	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20251231
0904-7393_04b1f69d-ebba-43b9-8ecd-4f6be7c8a0a0	0904-7393	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	MAJOR PHARMACEUTICALS	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20251231
0904-7394_04b1f69d-ebba-43b9-8ecd-4f6be7c8a0a0	0904-7394	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	MAJOR PHARMACEUTICALS	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20251231
0904-7395_13a80059-46f7-4453-ab37-72744657a08a	0904-7395	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	MAJOR PHARMACEUTICALS	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0904-7396_13a80059-46f7-4453-ab37-72744657a08a	0904-7396	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	MAJOR PHARMACEUTICALS	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
0904-7399_c51b80f3-a591-4db9-81b4-b91603e35d7c	0904-7399	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20220907		ANDA	ANDA208256	MAJOR PHARMACEUTICALS	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
0904-7406_d93645f2-a1ec-4ce3-b554-6abd85965779	0904-7406	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Major Pharmaceuticals	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7413_1297c291-da28-4a73-9c28-d5adee36d7b7	0904-7413	HUMAN PRESCRIPTION DRUG	varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20231218		ANDA	ANDA214557	Major Pharmaceuticals	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
0904-7414_1297c291-da28-4a73-9c28-d5adee36d7b7	0904-7414	HUMAN PRESCRIPTION DRUG	varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20231218		ANDA	ANDA214557	Major Pharmaceuticals	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
0904-7415_1297c291-da28-4a73-9c28-d5adee36d7b7	0904-7415	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline tartrate	KIT		20231218		ANDA	ANDA214557	Major Pharmaceuticals						N	20241231
0904-7417_db52fdc0-765a-4fad-a8f9-ef98c6e4b898	0904-7417	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20240103		ANDA	ANDA088109	Major Pharmaceuticals	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
0904-7418_088e554c-e128-d52b-e063-6394a90ae8e8	0904-7418	HUMAN OTC DRUG	Magnesium Citrate		Major Magnesium Citrate Oral Solution - Lemon	LIQUID	ORAL	20231025		OTC MONOGRAPH DRUG	M007	Major Pharmaceuticals	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0904-7419_f656a741-7f9c-4173-8893-c259b0d96f5b	0904-7419	HUMAN PRESCRIPTION DRUG	valganciclovir hydrochloride		valganciclovir hydrochloride	FOR SOLUTION	ORAL	20220217		ANDA	ANDA210169	MAJOR PHARMACEUTICALS	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20251231
0904-7420_6913c611-4994-4501-8ed9-45161f90373e	0904-7420	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	SOLUTION	ORAL	20220716		ANDA	ANDA214757	MAJOR PHARMACEUTICALS	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
0904-7421_cecfd4c8-bff3-44fa-b360-b3e8a8e955f5	0904-7421	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	MAJOR PHARMACEUTICALS	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7422_cecfd4c8-bff3-44fa-b360-b3e8a8e955f5	0904-7422	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	MAJOR PHARMACEUTICALS	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7423_cecfd4c8-bff3-44fa-b360-b3e8a8e955f5	0904-7423	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	MAJOR PHARMACEUTICALS	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7424_cecfd4c8-bff3-44fa-b360-b3e8a8e955f5	0904-7424	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	MAJOR PHARMACEUTICALS	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7425_cecfd4c8-bff3-44fa-b360-b3e8a8e955f5	0904-7425	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	MAJOR PHARMACEUTICALS	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20251231
0904-7427_9a23ed6c-77ea-4647-b6d5-cba46283822b	0904-7427	HUMAN OTC DRUG	Major Nasal Decongestant		Oxymetazoline hydrochloride	SPRAY	NASAL	20231231		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0904-7435_22987538-bbaf-4dce-ba33-325abacdec70	0904-7435	HUMAN OTC DRUG	Major Nasal Decongestant		Oxymetazoline hydrochloride	SPRAY	NASAL	20231231		OTC MONOGRAPH DRUG	M012	Major Pharmaceuticals	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
0904-7456_b359992b-3e4a-4a05-9520-bb39a4923a42	0904-7456	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20240103		ANDA	ANDA214289	Major Pharmaceuticals	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
0904-7457_b359992b-3e4a-4a05-9520-bb39a4923a42	0904-7457	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20240103		ANDA	ANDA214289	Major Pharmaceuticals	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
0904-7623_3e805912-e5f4-4542-9c12-c4b2212683fa	0904-7623	HUMAN OTC DRUG	Hydrocortisone with Aloe	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20090421	20250131	OTC MONOGRAPH NOT FINAL	part348	Major Pharmaceuticals	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
0904-7725_565fad1c-be51-4c90-a6bd-b6c2ec137b43	0904-7725	HUMAN OTC DRUG	anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030224		ANDA	ANDA075232	Major Pharmaceuticals	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
0904-7727_092ff6db-b115-a2fe-e063-6294a90ae653	0904-7727	HUMAN OTC DRUG	ACID GONE ANTACID		aluminum hydroxide and magnesium carbonate	LIQUID	ORAL	20041230		OTC MONOGRAPH DRUG	M001	Major Pharmaceuticals	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	95; 358	mg/15mL; mg/15mL			N	20241231
0904-7728_ba2c0192-900b-4722-8651-4edd816fc09c	0904-7728	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20220823		ANDA	ANDA077856	Major Pharmaceuticals	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
0904-7734_90c5f56d-7a49-4f0c-9b5e-d00c81ecb4c9	0904-7734	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20090421		ANDA	ANDA074164	Major Pharmaceuticals	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0904-7822_9ee50c01-df42-42b6-9c36-a20b3f61504d	0904-7822	HUMAN OTC DRUG	Major Clotrimazole		CLOTRIMAZOLE	CREAM	TOPICAL	20041004		OTC MONOGRAPH FINAL	part333C	Major Pharmaceuticals	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
0904-7912_58e3a6ff-9e80-446e-a0df-8327050bcf4d	0904-7912	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19940816		ANDA	ANDA072096	Major Pharmaceuticals	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-7914_55b8dc80-acc3-4040-9a13-c05980770e9c	0904-7914	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Major Pharmaceuticals	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0904-8805_0c9007ab-62cf-f258-e063-6394a90ac613	0904-8805	HUMAN OTC DRUG	Major Triple Antibiotic		Bacitracin Zinc, Neomycin, Polymyxin B Sulfat	OINTMENT	TOPICAL	20200420		OTC MONOGRAPH DRUG	M004	Major Pharmaceuticals	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0924-0009_801168e9-ebef-fe3a-e053-2991aa0a1eb0	0924-0009	HUMAN OTC DRUG	First Aid Only Alcohol Antiseptic Pad		Alcohol Pad	SWAB	TOPICAL	20170726		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
0924-0015_ef3fdd30-e098-fd54-e053-2995a90a880c	0924-0015	HUMAN OTC DRUG	First Aid Only Alcohol Antiseptic Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20200306		OTC MONOGRAPH NOT FINAL	part333A	Acme United Coporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
0924-0017_a810e723-ad0d-8c71-e053-2995a90a0acc	0924-0017	HUMAN OTC DRUG	First Aid Only Alcohol Antiseptic		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0924-0036_5e31b1ff-2920-7b8c-e053-2a91aa0aedbc	0924-0036	HUMAN OTC DRUG	PhysiciansCare Allergy	Antihistamine	Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20171101		OTC MONOGRAPH FINAL	part341	Acme United Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0924-0056_5e31b1ff-2920-7b8c-e053-2a91aa0aedbc	0924-0056	HUMAN OTC DRUG	PhysiciansCare Allergy	Antihistamine	Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20171101		OTC MONOGRAPH FINAL	part341	Acme United Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
0924-0075_0d1bf02a-a833-514e-e063-6394a90a96e5	0924-0075	HUMAN OTC DRUG	Physicians Care Ibuprofen		Ibuprofen 200mg	TABLET, COATED	ORAL	20160201		ANDA	ANDA075010	Acme United Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0924-0076_0d1be2ff-a85d-dc80-e063-6294a90a2fc0	0924-0076	HUMAN OTC DRUG	Physicians Care Ibuprofen		Ibuprofen 200mg	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA079174	Acme United Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0924-0086_f6df2d91-9720-c396-e053-6394a90a48b0	0924-0086	HUMAN OTC DRUG	PhysiciansCare Antacid		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20111128		OTC MONOGRAPH FINAL	part331	Acme United Corporation	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0924-0091_e11d85d0-99e9-0b91-e053-2995a90a5766	0924-0091	HUMAN OTC DRUG	PhysiciansCare Allergy	Multi-Symptom Relief	Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20111223		OTC MONOGRAPH FINAL	part341	Acme United Corporation	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0924-0105_0c022a8b-a5de-04c7-e063-6294a90a1446	0924-0105	HUMAN OTC DRUG	Physicians Care Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200720		OTC MONOGRAPH DRUG	M013	Acme United Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0924-0123_f2a2ee93-3e6d-5627-e053-2a95a90af847	0924-0123	HUMAN OTC DRUG	PhysiciansCare Non Aspirin	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	20120120		OTC MONOGRAPH NOT FINAL	part343	Acme United Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
0924-0133_e3b3423a-4656-0575-e053-2995a90a77cc	0924-0133	HUMAN OTC DRUG	PhysiciansCare Sinus	Non-Drowsy	Phenylephrine HCL	TABLET, FILM COATED	ORAL	20120129		OTC MONOGRAPH FINAL	part341	Acme United Corporation	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
0924-0150_da45a371-ecfa-8dbd-e053-2995a90a8e58	0924-0150	HUMAN OTC DRUG	Physicians Care Cough and Sore Throat		Menthol	LOZENGE	ORAL	20150105		OTC MONOGRAPH FINAL	part341	Acme United Corporation	MENTHOL	7.6	mg/1			N	20241231
0924-0158_ef405f22-5bc5-5642-e053-2995a90a79be	0924-0158	HUMAN OTC DRUG	PhysiciansCare Ophthalmic Solution Eyewash	Purified Water, 98.3%	Purified Water 98.3%	SOLUTION	OPHTHALMIC	20191001		NDA	NDA022305	Acme United Corporation	WATER	465	mL/473mL			N	20241231
0924-0159_f19fbe45-b7a7-ddc1-e053-2a95a90abd3b	0924-0159	HUMAN OTC DRUG	Eyewash Station Additive Concentrate		Chlorhexidine gluconate and Propylene Glycol	LIQUID	OPHTHALMIC	20230109		OTC MONOGRAPH NOT FINAL	part349	Acme United Corporation	CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL	145.6; 280	kg/2800L; kg/2800L	Decreased Cell Wall Integrity [PE]		N	20241231
0924-0160_964ac97a-059d-ca4e-e053-2a95a90a36b6	0924-0160	HUMAN OTC DRUG	PhysiciansCare Ophthalmic Solution Eyewash		Purified Water 98.3%	SOLUTION	OPHTHALMIC	20130612		NDA	NDA022305	Acme United Corporation	WATER	929	g/946mL			N	20241231
0924-0162_964ac97a-05a1-ca4e-e053-2a95a90a36b6	0924-0162	HUMAN OTC DRUG	PhysiciansCare Ophthalmic Solution Eyewash		Purified Water 98.3%	SOLUTION	OPHTHALMIC	20130624		NDA	NDA022305	Acme United Corporation	WATER	929	g/946mL			N	20241231
0924-0165_29ca5d06-b6e2-4db0-e054-00144ff88e88	0924-0165	HUMAN OTC DRUG	PhysiciansCare Eye Wash		Water	SOLUTION	OPHTHALMIC	20141205		OTC MONOGRAPH FINAL	part349	Acme United Corporation	WATER	.98	mL/mL			N	20241231
0924-0204_6869dcc1-2407-4007-e053-2991aa0a4b2c	0924-0204	HUMAN OTC DRUG	First Aid Only Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH FINAL	part343	Acme United Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0924-0223_6891d57a-10a7-53de-e053-2a91aa0ac7c2	0924-0223	HUMAN OTC DRUG	First Aid Only Extra-Strength Non-Aspirin		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Acme United Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
0924-0228_6891f5ee-687a-7d10-e053-2a91aa0a3aae	0924-0228	HUMAN OTC DRUG	First Aid Only Extra-Strength Non-Aspirin		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Acme United Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
0924-0243_d92cb589-e2ad-4dac-e053-2995a90aa13c	0924-0243	HUMAN OTC DRUG	MED NAP Cleansing Towelette		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220302		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	BENZALKONIUM CHLORIDE	.0018	mg/1.35mL			N	20241231
0924-0244_d83d2fab-6973-9b18-e053-2995a90a5cb5	0924-0244	HUMAN OTC DRUG	MED NAP Obstetrical Towelette		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220225		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	BENZALKONIUM CHLORIDE	.0018	mg/1.35mL			N	20241231
0924-0246_f54f5472-4e35-80b8-e053-2995a90aee0c	0924-0246	HUMAN OTC DRUG	MED NAP Benzalkonium Chloride Antiseptic		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220211		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	BENZALKONIUM CHLORIDE	.0018	mg/1.35mL			N	20241231
0924-0252_f54e7c1e-f7a1-d92e-e053-2a95a90ad05a	0924-0252	HUMAN OTC DRUG	First Aid Only Hand Sanitizing Wipes		Isoprpoyl Alcohol	SWAB	TOPICAL	20230228		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0924-0276_968bf634-dc4e-39da-e053-2995a90a55fa	0924-0276	HUMAN OTC DRUG	First Aid Only Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170126		ANDA	ANDA079174	Acme United Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0924-0286_687dff3e-a350-1c88-e053-2991aa0a575c	0924-0286	HUMAN OTC DRUG	First Aid Only Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20081230		OTC MONOGRAPH FINAL	part331	Acme United Corporation	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0924-0287_68902dda-a13d-ff2e-e053-2991aa0a06b1	0924-0287	HUMAN OTC DRUG	First Aid Only Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20140615		OTC MONOGRAPH FINAL	part331	Acme United Corporation	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
0924-0301_03ec9021-8170-970c-e063-6294a90a6732	0924-0301	HUMAN OTC DRUG	First Aid Only Hand Sanitizing Wipe		Isopropyl Alcohol	SWAB	TOPICAL	20230831		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0924-0400_a7d6a7ae-2216-05d0-e053-2995a90ad06a	0924-0400	HUMAN OTC DRUG	GermiFree Antimicrobial Hand Gel		Ethyl alcohol	GEL	TOPICAL	20200611		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	ALCOHOL	67.7	mL/100mL			N	20241231
0924-0401_a7a8c72c-e81c-5688-e053-2995a90a1406	0924-0401	HUMAN OTC DRUG	First Aid Only Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200609		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	ALCOHOL	77	mL/100mL			N	20241231
0924-0450_02be4b36-80c6-e428-e063-6294a90a9cfd	0924-0450	HUMAN OTC DRUG	First Aid Only Instant Hand Sanitizer		alcohol	GEL	TOPICAL	20210811		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	ALCOHOL	665	mL/L			N	20241231
0924-0500_e39ff290-fb06-3329-e053-2995a90a2f61	0924-0500	HUMAN OTC DRUG	Med-Nap Sterile Alcohol Prep Pads		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
0924-0801_bba48cd2-9c2c-5623-e053-2995a90ad3d6	0924-0801	HUMAN OTC DRUG	First Aid Only SunX30 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Acme United Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
0924-0934_f1f051ad-7e83-9d1a-e053-2a95a90ac7d3	0924-0934	HUMAN OTC DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	LIQUID	TOPICAL	20230116		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0924-0935_f1db8929-9b96-0d6e-e053-2995a90a817f	0924-0935	HUMAN OTC DRUG	First Aid Only Hydrogen Peroxide 3%		Hydrogen Peroxide	SPRAY	TOPICAL	20230116		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporationn	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
0924-0936_f1ef592f-2567-f145-e053-2995a90a2de1	0924-0936	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SPRAY	TOPICAL	20230116		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
0924-1008_c4d3ea22-7c23-7311-e053-2a95a90a779c	0924-1008	HUMAN OTC DRUG	PhysiciansCare Motion Sickness		Meclizine HCl	TABLET	ORAL	20210618		OTC MONOGRAPH FINAL	part336	Acme United Corporation	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
0924-1133_fabc94c8-eb65-fc70-e053-6394a90af367	0924-1133	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0924-5010_9af39fcd-0a58-26d0-e053-2a95a90a99a0	0924-5010	HUMAN OTC DRUG	First Aid Only Burn		Lidocaine Hydrochloride	GEL	TOPICAL	20200102		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	LIDOCAINE HYDROCHLORIDE	20	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0924-5011_caa678ff-41a5-eaca-e053-2a95a90a159b	0924-5011	HUMAN OTC DRUG	First Aid Only First Aid/Burn		Lidocaine Hydrochloride and Benzalkonium Chloride	CREAM	TOPICAL	20210830		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0924-5201_5087cbbd-1bbf-62ed-e054-00144ff8d46c	0924-5201	HUMAN OTC DRUG	First Aid Only Sting Relief Pad		Benzocaine	PATCH	TOPICAL	20170731		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	BENZOCAINE	6	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0924-5202_6bb9f814-a368-d192-e053-2991aa0a7386	0924-5202	HUMAN OTC DRUG	Sting Relief Pad		BENZOCAINE, ISOPROPYL ALCOHOL	SWAB	TOPICAL	20180509		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	BENZOCAINE; ISOPROPYL ALCOHOL	60; 600	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0924-5203_85dec352-6cad-03fa-e053-2a91aa0a8715	0924-5203	HUMAN OTC DRUG	First Aid Only Sting Relief Pad		BENZOCAINE	SWAB	TOPICAL	20190408		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	BENZOCAINE; ISOPROPYL ALCOHOL	60; .6	mg/mL; mL/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0924-5204_d71047f6-1354-c758-e053-2995a90a962c	0924-5204	HUMAN OTC DRUG	First Aid Only Sting Relief Pad		BENZOCAINE, ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20220225		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	BENZOCAINE; ISOPROPYL ALCOHOL	60; 600	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0924-5250_697127d1-c02f-16d2-e053-2a91aa0a39fd	0924-5250	HUMAN OTC DRUG	First Aid Only Sting Relief		Benzocaine	SWAB	TOPICAL	20100201		UNAPPROVED DRUG OTHER		Acme United Corporation	BENZOCAINE; MENTHOL	.12; .006	g/.6mL; g/.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
0924-5401_6595bb25-5008-afdb-e053-2991aa0aac06	0924-5401	HUMAN OTC DRUG	First Aid Only Ammonia Inhalants		Ammonia Inhalants	INHALANT	RESPIRATORY (INHALATION)	20060101		UNAPPROVED DRUG OTHER		Acme United Corporation	AMMONIA	.045	g/.3mL			N	20241231
0924-5604_f9a48f73-aa13-cf68-e053-6294a90a8e53	0924-5604	HUMAN OTC DRUG	Triple Antibiotic		bacitracin zinc, neomycin sulfate, polymyxin b sulfate	OINTMENT	TOPICAL	20230424		OTC MONOGRAPH FINAL	part333B	Acme United Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0924-5607_85bc0e54-2b57-6201-e053-2a91aa0ac1fd	0924-5607	HUMAN OTC DRUG	First Aid Only Antibiotic	Neomycin Sulfate	Antibiotic Ointment	OINTMENT	TOPICAL	20171218		OTC MONOGRAPH FINAL	part333B	Acme United Corporation	NEOMYCIN SULFATE	3.5	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0924-5610_e55caa58-5df7-2dc3-e053-2a95a90af7f7	0924-5610	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20220804		OTC MONOGRAPH FINAL	part333B	Acme United Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0924-5618_fd8e36b3-b85e-d9cd-e053-6394a90a2916	0924-5618	HUMAN OTC DRUG	First Aid Only Triple Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20230224		OTC MONOGRAPH FINAL	part333B	Acme United Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	U/g; mg/g; U/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
0924-5620_fae5e2bf-c3b3-d474-e053-6394a90aaa08	0924-5620	HUMAN OTC DRUG	First Aid Only Neomycin Antibiotic		neomycin sulfate	OINTMENT	TOPICAL	20210716		OTC MONOGRAPH FINAL	part333B	Acme United Corporation	NEOMYCIN SULFATE	3.5	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
0924-5632_9a161629-eac9-f40f-e053-2a95a90a368d	0924-5632	HUMAN OTC DRUG	HYDROCORTISONE		Anti-itch cream	OINTMENT	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0924-5633_e5597b2b-8393-a11e-e053-2995a90a5929	0924-5633	HUMAN OTC DRUG	First Aid Only Hydrocortisone 1% Anti-Itch		Hydrocortisone	CREAM	TOPICAL	20120802		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
0924-5702_0258199c-b119-3b7e-e063-6394a90a31dc	0924-5702	HUMAN OTC DRUG	First Aid Only First Aid-Burn		Benzalkonium Chloride, Lidocaine Hydrochloride	CREAM	TOPICAL	20230130		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0924-5730_07247305-a6fe-50c3-e063-6294a90a6721	0924-5730	HUMAN OTC DRUG	First Aid Only First Aid/Burn		LIDOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE	CREAM	TOPICAL	20231016		OTC MONOGRAPH DRUG	M003	Acme United Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0924-5750_674e0a42-7a82-4fc2-e053-2991aa0ac69a	0924-5750	HUMAN OTC DRUG	First Aid Only Burn Mist		Lidocaine Hydrochloride	SPRAY	TOPICAL	20180301		OTC MONOGRAPH NOT FINAL	part348	Acme United Corporation	LIDOCAINE HYDROCHLORIDE	2	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
0924-6000_f7582032-efbd-5f5b-e053-6394a90a994e	0924-6000	HUMAN OTC DRUG	Bayer Aleve		Naproxen Sodium	TABLET	ORAL	20230324		NDA	NDA020204	Acme United Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
0924-6010_f7bf126d-a6f2-231a-e053-6294a90a04e1	0924-6010	HUMAN OTC DRUG	Midol Complete		ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE	TABLET	ORAL	20230330		OTC MONOGRAPH NOT FINAL	part343	Acme United Corporation	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
0924-6020_f7f9dc46-a946-7ae3-e053-6394a90a1192	0924-6020	HUMAN OTC DRUG	Bayer Genuine Aspirin		Aspirin	TABLET	ORAL	20230331		OTC MONOGRAPH NOT FINAL	part343	Acme United Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
0924-7019_8a96d919-4f11-9372-e053-2995a90a3102	0924-7019	HUMAN OTC DRUG	First Aid Only Alcohol Antiseptic Wipe		Alcohol Wipe	SWAB	TOPICAL	20190603		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
0924-7111_6ade7b54-dc0e-2c9b-e053-2a91aa0a34e9	0924-7111	HUMAN OTC DRUG	First Aid Only BZK Antiseptic Towelette		Benzalkonium Chloride	PATCH	TOPICAL	20170720		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
0924-7112_866f9e78-87a0-7919-e053-2a91aa0a4058	0924-7112	HUMAN OTC DRUG	BZK Towelette		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20190416		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
0924-7115_c927f845-1384-ae85-e053-2995a90a12fc	0924-7115	HUMAN OTC DRUG	First Aid Only BZK Antiseptic Towelettes		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210809		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
0924-7116_dbed78da-7f4b-657f-e053-2a95a90ac576	0924-7116	HUMAN OTC DRUG	First Aid Only BZK Antiseptic		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220415		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	BENZALKONIUM CHLORIDE	.0018	mg/1.35mL			N	20241231
0924-8110_509b6c8e-6aa0-2656-e054-00144ff8d46c	0924-8110	HUMAN OTC DRUG	First Aid Only Povidone-Iodine Prep Pad		Povidone-Iodine	PATCH	TOPICAL	20170724		OTC MONOGRAPH NOT FINAL	part333A	Acme United Corporation	POVIDONE-IODINE	10	g/100g			N	20241231
0924-8112_9b7f2580-0750-e1d3-e053-2995a90a2eef	0924-8112	HUMAN OTC DRUG	First Aid Only Povidone-Iodine Antiseptic		Povidone-iodine	SWAB	TOPICAL	20200107		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	POVIDONE-IODINE	1	g/100mL			N	20241231
0924-8113_e0052c81-0896-9409-e053-2a95a90ae9b3	0924-8113	HUMAN OTC DRUG	First Aid Only Povidone-Iodine Antiseptic		POVIDONE-IODINE	PATCH	TOPICAL	20220603		OTC MONOGRAPH NOT FINAL	part333E	Acme United Corporation	POVIDONE-IODINE	10	g/100g			N	20241231
0941-0409_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0409	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.3; 1.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0411_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0411	HUMAN PRESCRIPTION DRUG	DIANEAL PD-2 with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 1.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0413_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0413	HUMAN PRESCRIPTION DRUG	DIANEAL PD-2 with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 2.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0415_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0415	HUMAN PRESCRIPTION DRUG	DIANEAL PD-2 with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 4.25; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0424_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0424	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19921204		NDA	NDA020183	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.3; 1.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0426_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0426	HUMAN PRESCRIPTION DRUG	DIANEAL PD-2 with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19921204		NDA	NDA020163	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 1.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0427_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0427	HUMAN PRESCRIPTION DRUG	DIANEAL PD-2 with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19921204		NDA	NDA020163	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 2.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0429_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0429	HUMAN PRESCRIPTION DRUG	DIANEAL PD-2 with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19921204		NDA	NDA020163	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 4.25; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0430_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0430	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19921204		NDA	NDA020183	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.3; 2.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0433_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0433	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19921204		NDA	NDA020183	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.3; 4.25; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0457_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0457	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.3; 2.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0459_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0459	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.3; 4.25; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0484_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0484	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 1.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0487_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0487	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 2.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0490_03e63a94-f195-48ab-8ca9-76c76fea5a18	0941-0490	HUMAN PRESCRIPTION DRUG	DIANEAL Low Calcium with Dextrose		sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose	INJECTION, SOLUTION	INTRAPERITONEAL	19780927		NDA	NDA017512	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 4.25; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0941-0679_6c892436-ebb2-4b32-bfa3-25fc48c1a4b4	0941-0679	HUMAN PRESCRIPTION DRUG	EXTRANEAL		icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride	INJECTION, SOLUTION	INTRAPERITONEAL	20021220		NDA	NDA021321	Baxter Healthcare Corporation	CALCIUM CHLORIDE; ICODEXTRIN; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 7.5; 5.08; 535; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0942-0641_052fbb41-5092-4bdb-a356-cbf27ce5bf23	0942-0641	HUMAN PRESCRIPTION DRUG	ACD-A		Anticoagulant Citrate Dextrose Solution Formula A	SOLUTION	INTRAVENOUS	20070301		NDA	BN160918	Fenwal, Inc.	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM	7.3; 24.5; 22	g/1000mL; g/1000mL; g/1000mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-0641_fc8f1ca0-251a-493a-ad8e-defe2a5c7141	0942-0641	HUMAN PRESCRIPTION DRUG	ACD-A		Anticoagulant Citrate Dextrose Solution Formula A	SOLUTION	INTRAVENOUS	20070301		NDA	BN160918	Fenwal, Inc.	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM	3.65; 12.25; 11	g/500mL; g/500mL; g/500mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6305_fe034ff5-2f43-411e-b1b0-db05d801d2b6	0942-6305	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070301		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	17.3; 188; 2; 140; 1.66	mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6307_0c6dcb8d-530f-4435-bc72-85df13f44206	0942-6307	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070301		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	19.3; 209; 2.23; 155; 1.84	mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6308_24a1bb0c-2b88-4dd5-a20a-b803388e9954	0942-6308	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070301		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	19.3; 209; 2.23; 155; 1.84	mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6312_8361867d-d732-4c07-ab8e-980c63123afe	0942-6312	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070301		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	19.3; 209; 2.23; 155; 1.84	mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6316_c8666cbc-880c-41f5-8e96-0021e3408c3a	0942-6316	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070620		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	19.3; 209; 2.23; 155; 1.84	mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6320_1162003c-7a3a-4879-bd7a-0e418dc121ba	0942-6320	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070604		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	19.3; 209; 2.23; 155; 1.84	mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6322_f7b9be90-d870-40af-ae22-abf675d89784	0942-6322	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070624		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	17.3; 188; 2; 140; 1.66	mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6326_8c63953b-0989-499e-b724-dd32148df0a9	0942-6326	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20081215		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	19.3; 209; 2.23; 155; 1.84	mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-6430_5be4ca7b-f2b9-4042-bd6f-83e2bb7aebe0	0942-6430	HUMAN PRESCRIPTION DRUG	ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution	KIT		20070301		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6431_94e91fd1-9121-4554-98b7-d20447dbf6ca	0942-6431	HUMAN PRESCRIPTION DRUG	ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution	KIT		20070301		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6453_82cc2cde-873e-4634-8e03-1969691689f2	0942-6453	HUMAN PRESCRIPTION DRUG	ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution	KIT		20070301		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6459_30d1e4be-2af8-4046-a546-209e17f8ea73	0942-6459	HUMAN PRESCRIPTION DRUG	ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution	KIT		20070301		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6461_a76430ca-9fab-4781-a6ac-59a34fd459c3	0942-6461	HUMAN PRESCRIPTION DRUG	ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution	KIT		20070301		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6477_80bf3e06-78a0-462a-8800-c7f63475c457	0942-6477	HUMAN PRESCRIPTION DRUG	ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution	KIT		20071001		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6493_7f7a7602-0dde-4b35-af52-3147eb773397	0942-6493	HUMAN PRESCRIPTION DRUG	ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution and ADSOL Preservation Solution	KIT		20090515		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6504_8f0e68b0-7eba-4723-8c67-694679d2e621	0942-6504	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation kit	KIT		20170228		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6505_4bd5da7c-c894-476d-b4ab-0b7b09c6d88d	0942-6505	HUMAN PRESCRIPTION DRUG	CPD/ADSOL		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20170228		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6506_07c1fb7c-5992-4d08-b5a3-45a5d56f309a	0942-6506	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20170228		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6507_5f704205-56b5-483d-bdda-e7adc9199661	0942-6507	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20170228		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6508_0bec4955-7fdd-4a57-b0c1-f153c8619780	0942-6508	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20170228		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6514_9842aa52-f9ec-4ebc-a70a-c79f4f5d038a	0942-6514	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20211209		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6515_adf8dfd8-a5f6-4b6f-a96b-ba1bdccfe772	0942-6515	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20211209		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6516_bb0b7229-17a5-4c95-86f1-853a9e2e4d13	0942-6516	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20211209		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6517_82009c0f-2fb3-4564-b006-57aa35814dd1	0942-6517	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20211209		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6518_9365e352-13a0-43fc-bb9a-5ff93de28464	0942-6518	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20211209		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-6528_07ef7fc7-506e-4a04-8cee-2af3092f7013	0942-6528	HUMAN PRESCRIPTION DRUG	ADSOL RED CELL PRESERVATION		anticoagulant citrate phosphate dextrose (cpd) and adsol preservation	KIT		20220610		NDA	BN811104	Fenwal, Inc.						N	20241231
0942-9001_02a2ae7c-e324-4d5a-aa2a-4a4f7426fd06	0942-9001	HUMAN PRESCRIPTION DRUG	ACD Blood-Pack Units (PL 146 PLASTIC)		Anticoagulant Citrate Dextrose (ACD)	SOLUTION	INTRAVENOUS	20070301		NDA	BN160918	Fenwal, Inc.	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	493; 1.65; 1.48	mg/67.5mL; g/67.5mL; g/67.5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9005_26a93e4e-50c7-42d2-b169-c3ce9a89d106	0942-9005	HUMAN PRESCRIPTION DRUG	ACD-A		Antiocoagulant Citrate Dextrose Solution, Formula A	SOLUTION	INTRAVENOUS	20121024		NDA	BN160918	Fenwal, Inc.	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM	730; 2.45; 2.2	mg/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9201_1ee1e424-2028-4b58-b554-883d2e359c28	0942-9201	HUMAN PRESCRIPTION DRUG	Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic		Anticoagulant Citrate Phosphate Dextrose (CPD) Solution	SOLUTION	INTRAVENOUS	20070301		NDA	BN170401	Fenwal, Inc.	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	105; 893; 78; 921	mg/35mL; mg/35mL; mg/35mL; mg/35mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9202_d5d9902d-5b55-4a6e-88f1-293b1cf1ed75	0942-9202	HUMAN PRESCRIPTION DRUG	Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic		Anticoagulant Citrate Phosphate Dextrose (CPD)	SOLUTION	INTRAVENOUS	20070331		NDA	BN170401	Fenwal, Inc.	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	188; 1.61; 140; 1.66	mg/63mL; g/63mL; mg/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9393_e2fe6938-ea4c-490f-bee2-70a5d59a9c07	0942-9393	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070301		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	19.3; 209; 2.23; 155; 1.84	mg/70mL; mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9394_b12576d7-9bd9-48f6-bafb-865e35d1120b	0942-9394	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) Solution	SOLUTION	INTRAVENOUS	20070301		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	17.3; 188; 2; 140; 1.66	mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9398_fd410caf-3513-4688-ae7e-0cae94a0c2d7	0942-9398	HUMAN PRESCRIPTION DRUG	CPDA-1		Anticoagulant Citrate Phosphate Dextrose Adenine	SOLUTION	INTRAVENOUS	20070301		NDA	BN770420	Fenwal, Inc.	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	17.3; 188; 2; 140; 1.66	mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9504_f2b75651-90cf-4982-9762-76db5f0524d1	0942-9504	HUMAN PRESCRIPTION DRUG	Sodium Citrate Blood-Pack Units, (PL 146 Plastic)		Anticoagulant Sodium Citrate Solution	SOLUTION	INTRAVENOUS	20070301		NDA	BN770923	Fenwal, Inc.	TRISODIUM CITRATE DIHYDRATE	4	g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9505_a4ee4dcf-ebb9-4eaa-9630-293e8cd0655e	0942-9505	HUMAN PRESCRIPTION DRUG	Sodium Citrate Blood-Pack Units, (PL 146 Plastic)		Anticoagulant Sodium Citrate Solution	SOLUTION	INTRAVENOUS	20070301		NDA	BN770923	Fenwal, Inc.	TRISODIUM CITRATE DIHYDRATE	4	g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9506_9d256534-2088-4da9-b2cc-12dd4055e394	0942-9506	HUMAN PRESCRIPTION DRUG	Sodium Citrate Blood-Pack Units, (PL 146 Plastic)		Anticoagulant Sodium Citrate Solution	SOLUTION	INTRAVENOUS	20140929		NDA	BN770923	Fenwal, Inc.	TRISODIUM CITRATE DIHYDRATE	4	g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9601_e525571e-fef3-485f-a9af-858c14a7ec55	0942-9601	HUMAN PRESCRIPTION DRUG	InterSol		Platelet Additive 3	SOLUTION	INTRAVENOUS	20121025		NDA	BN080041	Fenwal, Inc.	SODIUM ACETATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	442; 452; 305; 93; 318	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9602_77e5b3e8-957f-4c2b-b528-e3b18b2cc70e	0942-9602	HUMAN PRESCRIPTION DRUG	InterSol		Platelet Additive 3	SOLUTION	INTRAVENOUS	20190605		NDA	BN080041	Fenwal, Inc.	SODIUM ACETATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	442; 452; 305; 93; 318	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0942-9603_71e5dcd0-4aa3-4cb6-89b3-8229f73c75fc	0942-9603	HUMAN PRESCRIPTION DRUG	Solucion InterSol		Solucion aditiva para plaquetas 3	SOLUTION	INTRAVENOUS	20121025		NDA	BN080041	Fenwal, Inc.	SODIUM ACETATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	442; 452; 305; 93; 318	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
0944-0493_4e8f07a8-250b-4a98-b830-3788aee6de7d	0944-0493	PLASMA DERIVATIVE	FLEXBUMIN		Albumin Human	SOLUTION	INTRAVENOUS	20020809		BLA	BLA101452	Takeda Pharmaceuticals America, Inc.	ALBUMIN HUMAN	.25	g/mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
0944-0495_08db62fa-8c10-475e-a9ea-380db06dd032	0944-0495	PLASMA DERIVATIVE	Flexbumin		Albumin Human	INJECTION, SOLUTION	INTRAVENOUS	20140731		BLA	BLA101452	Takeda Pharmaceuticals America, Inc.	ALBUMIN HUMAN	.05	g/mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
0944-2510_742fb840-cc18-4fdc-aa34-14fd52273dbf	0944-2510	PLASMA DERIVATIVE	HYQVIA		Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase	KIT		20140912		BLA	BLA125402	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2511_742fb840-cc18-4fdc-aa34-14fd52273dbf	0944-2511	PLASMA DERIVATIVE	HYQVIA		Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase	KIT		20140912		BLA	BLA125402	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2512_742fb840-cc18-4fdc-aa34-14fd52273dbf	0944-2512	PLASMA DERIVATIVE	HYQVIA		Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase	KIT		20140912		BLA	BLA125402	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2513_742fb840-cc18-4fdc-aa34-14fd52273dbf	0944-2513	PLASMA DERIVATIVE	HYQVIA		Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase	KIT		20140912		BLA	BLA125402	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2514_742fb840-cc18-4fdc-aa34-14fd52273dbf	0944-2514	PLASMA DERIVATIVE	HYQVIA		Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase	KIT		20140912		BLA	BLA125402	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2656_23aa5bda-ff70-444a-a115-ce92a1ac95cd	0944-2656	PLASMA DERIVATIVE	GAMMAGARD	S/D	Immune Globulin Intravenous (Human)	KIT		19940510		BLA	BLA103133	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2658_23aa5bda-ff70-444a-a115-ce92a1ac95cd	0944-2658	PLASMA DERIVATIVE	GAMMAGARD	S/D	Immune Globulin Intravenous (Human)	KIT		19940510		BLA	BLA103133	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2700_36196b6a-2e64-4f1b-96f9-5f5c7e84eebd	0944-2700	PLASMA DERIVATIVE	GAMMAGARD Liquid		Immune Globulin Infusion (Human)	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20050427		BLA	BLA125105	Takeda Pharmaceuticals America, Inc.	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0944-2814_33fe79d0-4db5-4fb2-b168-d46e2b182979	0944-2814	PLASMA DERIVATIVE	Aralast	NP	Alpha-1-Proteinase Inhibitor (Human)	KIT		20021223		BLA	BLA125039	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2815_33fe79d0-4db5-4fb2-b168-d46e2b182979	0944-2815	PLASMA DERIVATIVE	Aralast	NP	Alpha-1-Proteinase Inhibitor (Human)	KIT		20021223		BLA	BLA125039	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2841_cf5623f1-d12f-4960-a25c-695c975310d4	0944-2841	PLASMA DERIVATIVE	RECOMBINATE		antihemophilic factor recombinant	KIT		20090410		BLA	BLA103375	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2842_cf5623f1-d12f-4960-a25c-695c975310d4	0944-2842	PLASMA DERIVATIVE	RECOMBINATE		antihemophilic factor recombinant	KIT		20090410		BLA	BLA103375	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2843_cf5623f1-d12f-4960-a25c-695c975310d4	0944-2843	PLASMA DERIVATIVE	RECOMBINATE		antihemophilic factor recombinant	KIT		20090410		BLA	BLA103375	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2844_cf5623f1-d12f-4960-a25c-695c975310d4	0944-2844	PLASMA DERIVATIVE	RECOMBINATE		antihemophilic factor recombinant	KIT		20100315		BLA	BLA103375	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2845_cf5623f1-d12f-4960-a25c-695c975310d4	0944-2845	PLASMA DERIVATIVE	RECOMBINATE		antihemophilic factor recombinant	KIT		20100315		BLA	BLA103375	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-2850_396f9f8a-a6a3-44ee-8925-2ccb36cbc4fb	0944-2850	PLASMA DERIVATIVE	CUVITRU		Immune Globulin Subcutaneous (Human)	INJECTION, SOLUTION	SUBCUTANEOUS	20161018		BLA	BLA125596	Takeda Pharmaceuticals America, Inc.	HUMAN IMMUNOGLOBULIN G	200	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
0944-2884_27197b3c-6ded-41cc-bcdf-6796766468f9	0944-2884	PLASMA DERIVATIVE	GLASSIA		.ALPHA.1-PROTEINASE INHIBITOR HUMAN	INJECTION, SOLUTION	INTRAVENOUS	20100701		BLA	BLA125325	Takeda Pharmaceuticals America, Inc.	.ALPHA.1-PROTEINASE INHIBITOR HUMAN	1	g/50mL	Human alpha-1 Proteinase Inhibitor [EPC], Trypsin Inhibitors [MoA]		N	20241231
0944-3026_9deedd56-76ae-4eb7-b777-e3ae772306f4	0944-3026	PLASMA DERIVATIVE	RIXUBIS		COAGULATION FACTOR IX (RECOMBINANT)	KIT		20131004		BLA	BLA125446	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3028_9deedd56-76ae-4eb7-b777-e3ae772306f4	0944-3028	PLASMA DERIVATIVE	RIXUBIS		COAGULATION FACTOR IX (RECOMBINANT)	KIT		20131004		BLA	BLA125446	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3030_9deedd56-76ae-4eb7-b777-e3ae772306f4	0944-3030	PLASMA DERIVATIVE	RIXUBIS		COAGULATION FACTOR IX (RECOMBINANT)	KIT		20131004		BLA	BLA125446	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3032_9deedd56-76ae-4eb7-b777-e3ae772306f4	0944-3032	PLASMA DERIVATIVE	RIXUBIS		COAGULATION FACTOR IX (RECOMBINANT)	KIT		20131004		BLA	BLA125446	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3034_9deedd56-76ae-4eb7-b777-e3ae772306f4	0944-3034	PLASMA DERIVATIVE	RIXUBIS		COAGULATION FACTOR IX (RECOMBINANT)	KIT		20131004		BLA	BLA125446	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3045_e3808f08-3c70-4d96-81a9-519f9d384951	0944-3045	PLASMA DERIVATIVE	ADVATE		Antihemophilic Factor (Recombinant)	KIT		20060412		BLA	BLA125063	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3046_e3808f08-3c70-4d96-81a9-519f9d384951	0944-3046	PLASMA DERIVATIVE	ADVATE		Antihemophilic Factor (Recombinant)	KIT		20070703		BLA	BLA125063	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3047_e3808f08-3c70-4d96-81a9-519f9d384951	0944-3047	PLASMA DERIVATIVE	ADVATE		Antihemophilic Factor (Recombinant)	KIT		20120712		BLA	BLA125063	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3051_e3808f08-3c70-4d96-81a9-519f9d384951	0944-3051	PLASMA DERIVATIVE	ADVATE		Antihemophilic Factor (Recombinant)	KIT		20111215		BLA	BLA125063	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3052_e3808f08-3c70-4d96-81a9-519f9d384951	0944-3052	PLASMA DERIVATIVE	ADVATE		Antihemophilic Factor (Recombinant)	KIT		20111215		BLA	BLA125063	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3053_e3808f08-3c70-4d96-81a9-519f9d384951	0944-3053	PLASMA DERIVATIVE	ADVATE		Antihemophilic Factor (Recombinant)	KIT		20111215		BLA	BLA125063	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3054_e3808f08-3c70-4d96-81a9-519f9d384951	0944-3054	PLASMA DERIVATIVE	ADVATE		Antihemophilic Factor (Recombinant)	KIT		20111215		BLA	BLA125063	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3940_54833e6a-d1f3-4014-936d-9e679757c067	0944-3940	PLASMA DERIVATIVE	HEMOFIL M		antihemophilic factor human	KIT		19880223		BLA	BLA101448	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3942_54833e6a-d1f3-4014-936d-9e679757c067	0944-3942	PLASMA DERIVATIVE	HEMOFIL M		antihemophilic factor human	KIT		19880223		BLA	BLA101448	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3944_54833e6a-d1f3-4014-936d-9e679757c067	0944-3944	PLASMA DERIVATIVE	HEMOFIL M		antihemophilic factor human	KIT		19880223		BLA	BLA101448	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-3946_54833e6a-d1f3-4014-936d-9e679757c067	0944-3946	PLASMA DERIVATIVE	HEMOFIL M		antihemophilic factor human	KIT		19880223		BLA	BLA101448	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-4177_6580578e-c2a8-4619-b7fa-0554bc04514c	0944-4177	PLASMA DERIVATIVE	CEPROTIN		Protein C Concentrate Human	KIT		20100809		BLA	BLA125234	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-4179_6580578e-c2a8-4619-b7fa-0554bc04514c	0944-4179	PLASMA DERIVATIVE	CEPROTIN		Protein C Concentrate Human	KIT		20100809		BLA	BLA125234	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-4622_215d2368-3d55-4bf5-adce-cc4d43c566f6	0944-4622	PLASMA DERIVATIVE	ADYNOVATE		Antihemophilic Factor (Recombinant) PEGylated	KIT		20160728		BLA	BLA125566	Takeda Pharmaceuticals Amercia, Inc.						N	20251231
0944-4623_215d2368-3d55-4bf5-adce-cc4d43c566f6	0944-4623	PLASMA DERIVATIVE	ADYNOVATE		Antihemophilic Factor (Recombinant) PEGylated	KIT		20151113		BLA	BLA125566	Takeda Pharmaceuticals Amercia, Inc.						N	20251231
0944-4624_215d2368-3d55-4bf5-adce-cc4d43c566f6	0944-4624	PLASMA DERIVATIVE	ADYNOVATE		Antihemophilic Factor (Recombinant) PEGylated	KIT		20161025		BLA	BLA125566	Takeda Pharmaceuticals Amercia, Inc.						N	20251231
0944-4625_215d2368-3d55-4bf5-adce-cc4d43c566f6	0944-4625	PLASMA DERIVATIVE	ADYNOVATE		Antihemophilic Factor (Recombinant) PEGylated	KIT		20151113		BLA	BLA125566	Takeda Pharmaceuticals Amercia, Inc.						N	20251231
0944-4626_215d2368-3d55-4bf5-adce-cc4d43c566f6	0944-4626	PLASMA DERIVATIVE	ADYNOVATE		Antihemophilic Factor (Recombinant) PEGylated	KIT		20161025		BLA	BLA125566	Takeda Pharmaceuticals Amercia, Inc.						N	20251231
0944-4627_215d2368-3d55-4bf5-adce-cc4d43c566f6	0944-4627	PLASMA DERIVATIVE	ADYNOVATE		Antihemophilic Factor (Recombinant) PEGylated	KIT		20151113		BLA	BLA125566	Takeda Pharmaceuticals Amercia, Inc.						N	20251231
0944-4628_215d2368-3d55-4bf5-adce-cc4d43c566f6	0944-4628	PLASMA DERIVATIVE	ADYNOVATE		Antihemophilic Factor (Recombinant) PEGylated	KIT		20161025		BLA	BLA125566	Takeda Pharmaceuticals Amercia, Inc.						N	20251231
0944-5001_6bf6b16a-d0f3-4643-b491-e75fa0f98ac5	0944-5001	PLASMA DERIVATIVE	OBIZUR		Antihemophilic Factor (Recombinant), Porcine Sequence	KIT		20141023		BLA	BLA125512	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-7551_26db2aa3-9f54-4299-b6bf-e9168a55c5d0	0944-7551	PLASMA DERIVATIVE	VONVENDI		von Willebrand Factor (Recombinant)	KIT		20151208		BLA	BLA125577	Takeda Pharmaceuticals America, Inc.						N	20241231
0944-7553_26db2aa3-9f54-4299-b6bf-e9168a55c5d0	0944-7553	PLASMA DERIVATIVE	VONVENDI		von Willebrand Factor (Recombinant)	KIT		20151208		BLA	BLA125577	Takeda Pharmaceuticals America, Inc.						N	20241231
0955-1003_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1003	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1004_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1004	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1006_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1006	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1008_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1008	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1010_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1010	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1012_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1012	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1015_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1015	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1016_0bef24fe-4704-c7f3-e063-6294a90aeaef	0955-1016	HUMAN PRESCRIPTION DRUG	Enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20111003		NDA AUTHORIZED GENERIC	NDA020164	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
0955-1020_0beea4d6-76e2-c1d8-e063-6394a90ace94	0955-1020	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20101021		NDA AUTHORIZED GENERIC	NDA020449	Winthrop U.S, a business of sanofi-aventis U.S. LLC	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0955-1021_0beea4d6-76e2-c1d8-e063-6394a90ace94	0955-1021	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20101021		NDA AUTHORIZED GENERIC	NDA020449	Winthrop U.S, a business of sanofi-aventis U.S. LLC	DOCETAXEL	80	mg/4mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0955-1022_0beea4d6-76e2-c1d8-e063-6394a90ace94	0955-1022	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20161023		NDA AUTHORIZED GENERIC	NDA020449	Winthrop U.S, a business of sanofi-aventis U.S. LLC	DOCETAXEL	160	mg/8mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
0955-1040_0bef5b78-7793-e5cb-e063-6294a90aac50	0955-1040	HUMAN PRESCRIPTION DRUG	Irbesartan		irbesartan	TABLET, FILM COATED	ORAL	20190930		NDA AUTHORIZED GENERIC	NDA020757	Winthrop U.S, a business of sanofi-aventis U.S. LLC	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0955-1041_0bef5b78-7793-e5cb-e063-6294a90aac50	0955-1041	HUMAN PRESCRIPTION DRUG	Irbesartan		irbesartan	TABLET, FILM COATED	ORAL	20190930		NDA AUTHORIZED GENERIC	NDA020757	Winthrop U.S, a business of sanofi-aventis U.S. LLC	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0955-1042_0bef5b78-7793-e5cb-e063-6294a90aac50	0955-1042	HUMAN PRESCRIPTION DRUG	Irbesartan		irbesartan	TABLET, FILM COATED	ORAL	20190930		NDA AUTHORIZED GENERIC	NDA020757	Winthrop U.S, a business of sanofi-aventis U.S. LLC	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
0955-1045_0bef6b72-508e-ff17-e063-6394a90a3682	0955-1045	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		irbesartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190930		NDA AUTHORIZED GENERIC	NDA020758	Winthrop U.S, a business of sanofi-aventis U.S. LLC	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0955-1046_0bef6b72-508e-ff17-e063-6394a90a3682	0955-1046	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		irbesartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190930		NDA AUTHORIZED GENERIC	NDA020758	Winthrop U.S, a business of sanofi-aventis U.S. LLC	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
0955-1048_b5d5e078-07d1-41bd-90ae-581497782412	0955-1048	HUMAN PRESCRIPTION DRUG	Sevelamer Hydrochloride		Sevelamer Hydrochloride	TABLET, FILM COATED	ORAL	20190213		NDA AUTHORIZED GENERIC	NDA021179	Winthrop U.S, a business of sanofi-aventis U.S. LLC	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0955-1050_0bef7188-5f19-0981-e063-6294a90a1881	0955-1050	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20180201		NDA AUTHORIZED GENERIC	NDA022127	Winthrop U.S, a business of sanofi-aventis U.S. LLC	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0955-1052_0bef7188-5f19-0981-e063-6294a90a1881	0955-1052	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	POWDER, FOR SUSPENSION	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA022318	Winthrop U.S, a business of sanofi-aventis U.S. LLC	SEVELAMER CARBONATE	.8	g/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0955-1054_0bef7188-5f19-0981-e063-6294a90a1881	0955-1054	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	POWDER, FOR SUSPENSION	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA022318	Winthrop U.S, a business of sanofi-aventis U.S. LLC	SEVELAMER CARBONATE	2.4	g/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0955-1057_0bef7188-5f19-0981-e063-6294a90a1881	0955-1057	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20230714		NDA AUTHORIZED GENERIC	NDA022127	Winthrop U.S, a business of sanofi-aventis U.S. LLC	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
0955-1702_0bef6553-51ad-fba4-e063-6394a90aeb75	0955-1702	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		zolpidem tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101014		NDA AUTHORIZED GENERIC	NDA021774	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0955-1703_0bef6553-51ad-fba4-e063-6394a90aeb75	0955-1703	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		zolpidem tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101206		NDA AUTHORIZED GENERIC	NDA021774	Winthrop U.S, a business of sanofi-aventis U.S. LLC	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
0955-1725_0bef4471-e36c-83e6-e063-6294a90a6a5d	0955-1725	HUMAN PRESCRIPTION DRUG	OXALIPLATIN		oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140707		NDA AUTHORIZED GENERIC	NDA021759	Winthrop U.S, a business of sanofi-aventis U.S. LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0955-1727_0bef4471-e36c-83e6-e063-6294a90a6a5d	0955-1727	HUMAN PRESCRIPTION DRUG	OXALIPLATIN		oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140707		NDA AUTHORIZED GENERIC	NDA021759	Winthrop U.S, a business of sanofi-aventis U.S. LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0955-1728_81a7552c-6a2e-4c54-9bf7-56e15f7d166d	0955-1728	HUMAN PRESCRIPTION DRUG	Insulin Glargine Solostar		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20220502	20260331	BLA	BLA021081	Winthrop U.S.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	
0955-1729_81a7552c-6a2e-4c54-9bf7-56e15f7d166d	0955-1729	HUMAN PRESCRIPTION DRUG	Insulin Glargine		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20220502	20260331	BLA	BLA021081	Winthrop U.S.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	
0955-1731_0bef8406-8dab-0ad0-e063-6394a90a60d0	0955-1731	HUMAN PRESCRIPTION DRUG	OXALIPLATIN		oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20150901		NDA AUTHORIZED GENERIC	NDA021759	Winthrop U.S, a business of sanofi-aventis U.S. LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0955-1733_0bef8406-8dab-0ad0-e063-6394a90a60d0	0955-1733	HUMAN PRESCRIPTION DRUG	OXALIPLATIN		oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20150901		NDA AUTHORIZED GENERIC	NDA021759	Winthrop U.S, a business of sanofi-aventis U.S. LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
0955-1735_0bef8406-8d4b-0ad0-e063-6394a90a60d0	0955-1735	HUMAN PRESCRIPTION DRUG	Leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20150907		NDA AUTHORIZED GENERIC	NDA020905	Winthrop U.S, a business of sanofi-aventis U.S. LLC	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
0955-1737_0bef8406-8d4b-0ad0-e063-6394a90a60d0	0955-1737	HUMAN PRESCRIPTION DRUG	Leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20150907		NDA AUTHORIZED GENERIC	NDA020905	Winthrop U.S, a business of sanofi-aventis U.S. LLC	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
0955-1746_0bee9cd7-c848-bd0d-e063-6394a90ab294	0955-1746	HUMAN PRESCRIPTION DRUG	Clofarabine		clofarabine	INJECTION	INTRAVENOUS	20170511		NDA AUTHORIZED GENERIC	NDA021673	Winthrop U.S, a business of sanofi-aventis U.S. LLC	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
0955-2900_0bef2944-7ab5-e6bf-e063-6394a90af56a	0955-2900	HUMAN PRESCRIPTION DRUG	Insulin glargine U-300 Max		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20230118		BLA	BLA206538	Winthrop U.S, a business of sanofi-aventis U.S. LLC	INSULIN GLARGINE	300	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0955-3900_0bef2944-7ab5-e6bf-e063-6394a90af56a	0955-3900	HUMAN PRESCRIPTION DRUG	Insulin glargine U-300		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20230118		BLA	BLA206538	Winthrop U.S, a business of sanofi-aventis U.S. LLC	INSULIN GLARGINE	300	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
0990-4178_66a78f44-6cba-437f-bd01-d650bf913401	0990-4178	HUMAN PRESCRIPTION DRUG	Aminosyn-PF		ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, and TYROSINE	INJECTION, SOLUTION	INTRAVENOUS	20211001		NDA	NDA019398	ICU Medical Inc.	ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	490; 861; 370; 576; 270; 220; 534; 831; 475; 125; 300; 570; 347; 50; 360; 125; 44; 452	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0990-4179_016e2f08-9e3f-47e6-b7f3-cdaf9e720e9b	0990-4179	HUMAN PRESCRIPTION DRUG	Aminosyn-PF		ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, and TYROSINE	INJECTION, SOLUTION	INTRAVENOUS	20191101		NDA	NDA019492	ICU Medical Inc.	ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	698; 1227; 527; 820; 385; 312; 760; 1200; 677; 180; 427; 812; 495; 70; 512; 180; 44; 673	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0990-6138_8fe0bd51-0925-4ca4-a2b7-57d9335ace2d	0990-6138	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	IRRIGANT	IRRIGATION	20190801		NDA	NDA017514	ICU Medical Inc.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-6139_52f29318-9d59-4766-b7f4-cce37366a280	0990-6139	HUMAN PRESCRIPTION DRUG	Sterile Water		water	IRRIGANT	IRRIGATION	20190801		NDA	NDA017513	ICU Medical Inc.	WATER	1	mL/mL			N	20241231
0990-6140_e336f34b-8fb7-49ae-a8ad-335ad83d1567	0990-6140	HUMAN PRESCRIPTION DRUG	Ringers Irrigation		Sodium Chloride, Potassium Chloride, and Calcium Chloride Irrigant	INJECTION, SOLUTION	IRRIGATION	20210917		NDA	NDA017635	ICU Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	33; 30; 860	mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-6141_90b3f223-e559-43e5-8fc9-446f9c3d5e08	0990-6141	HUMAN PRESCRIPTION DRUG	Physiosol		SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE	IRRIGANT	IRRIGATION	20180701		NDA	NDA017637	ICU Medical Inc.	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM CHLORIDE; SODIUM GLUCONATE	30; 37; 222; 526; 502	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0990-6143_9cd42966-0cbb-4b9b-b5dc-a20b3a36275a	0990-6143	HUMAN PRESCRIPTION DRUG	Acetic Acid		Acetic Acid	IRRIGANT	IRRIGATION	20191125		NDA	NDA017656	ICU Medical Inc.	ACETIC ACID	250	mg/100mL			N	20241231
0990-7074_65335058-ed38-47fa-aeca-979356d58eb1	0990-7074	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190401		NDA	NDA020161	ICU Medical Inc.	POTASSIUM CHLORIDE	10	meq/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7075_65335058-ed38-47fa-aeca-979356d58eb1	0990-7075	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190401		NDA	NDA020161	ICU Medical Inc.	POTASSIUM CHLORIDE	200	meq/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7077_65335058-ed38-47fa-aeca-979356d58eb1	0990-7077	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190401		NDA	NDA020161	ICU Medical Inc.	POTASSIUM CHLORIDE	400	meq/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7107_4e244d74-868c-4a0e-be83-b30cdfd16eb3	0990-7107	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200125		NDA	NDA019691	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 1.49; 9	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7109_4e244d74-868c-4a0e-be83-b30cdfd16eb3	0990-7109	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200125		NDA	NDA019691	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 2.98; 9	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7111_ba6e9f8d-ec31-48d9-8b83-207d61158d11	0990-7111	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Lactated Ringers and Dextrose		POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20191125		NDA	NDA019685	ICU Medical Inc.	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	.2; 50; 1.79; 6; 3.1	g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7115_5b28bce5-609f-4e23-8d0f-0cbd2ada8ddf	0990-7115	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		SODIUM CHLORIDE and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20191101		NDA	NDA019686	ICU Medical Inc.	POTASSIUM CHLORIDE; SODIUM CHLORIDE	1.49; 9	g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7116_5b28bce5-609f-4e23-8d0f-0cbd2ada8ddf	0990-7116	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		SODIUM CHLORIDE and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20191201		NDA	NDA019686	ICU Medical Inc.	POTASSIUM CHLORIDE; SODIUM CHLORIDE	2.98; 9	g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7118_bdfb81ee-b06a-46d7-8efa-a8f7076476b3	0990-7118	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION, SOLUTION	INTRAVENOUS	20190601		NDA	NDA019869	ICU Medical Inc.	WATER	1	mL/mL			N	20241231
0990-7120_690f9cea-3d73-4985-a77d-195f621ce3e1	0990-7120	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20190701		NDA	NDA019893	ICU Medical Inc.	DEXTROSE MONOHYDRATE	70	g/100mL			N	20241231
0990-7138_8fe0bd51-0925-4ca4-a2b7-57d9335ace2d	0990-7138	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	IRRIGANT	IRRIGATION	20190801		NDA	NDA017514	ICU Medical Inc.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7139_52f29318-9d59-4766-b7f4-cce37366a280	0990-7139	HUMAN PRESCRIPTION DRUG	Sterile Water		water	IRRIGANT	IRRIGATION	20190801		NDA	NDA017513	ICU Medical Inc.	WATER	1	mL/mL			N	20241231
0990-7171_8e4121e2-89a0-4f4e-98b9-1530dec5972b	0990-7171	HUMAN PRESCRIPTION DRUG	Aminosyn II		ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, and GLYCINE	INJECTION, SOLUTION	INTRAVENOUS	20191101		NDA	NDA020041	ICU Medical Inc.	ACETYL L-TYROSINE; ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; VALINE	405; 1490; 1527; 1050; 1107; 750; 450; 990; 1500; 1575; 258; 447; 1083; 795; 600; 300; 750	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0990-7172_8e4121e2-89a0-4f4e-98b9-1530dec5972b	0990-7172	HUMAN PRESCRIPTION DRUG	Aminosyn II		ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, and GLYCINE	INJECTION, SOLUTION	INTRAVENOUS	20191101		NDA	NDA020015	ICU Medical Inc.	ACETYL L-TYROSINE; ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; VALINE	270; 993; 1018; 700; 738; 500; 300; 660; 1000; 1050; 172; 298; 722; 530; 400; 200; 500	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
0990-7372_a45a4764-7b27-447b-a835-3ac429351b85	0990-7372	HUMAN PRESCRIPTION DRUG	Ionosol MB and Dextrose		DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, and SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20190701		NDA	NDA019513	ICU Medical Inc.	DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; MONOBASIC POTASSIUM PHOSPHATE; POTASSIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	5; 30; 15; 141; 260; 25	g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0990-7670_b8e1836a-27af-4ef3-af65-121f8732bd6e	0990-7670	HUMAN PRESCRIPTION DRUG	Normosol-R		SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190901		NDA	NDA017586	ICU Medical Inc.	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM CHLORIDE; SODIUM GLUCONATE	30; 37; 222; 526; 502	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0990-7715_54394036-4417-408d-88c8-1b4b2f12ff33	0990-7715	HUMAN PRESCRIPTION DRUG	Mannitol		MANNITOL	INJECTION, SOLUTION	INTRAVENOUS	20190531		NDA	NDA019603	ICU Medical Inc.	MANNITOL	20	g/100mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0990-7730_4e92e246-09fd-4167-b5d6-517df56a46f2	0990-7730	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190401		NDA	NDA018090	ICU Medical Inc.	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7828_98c22aab-173e-4588-8999-c3b1c0b9c25c	0990-7828	HUMAN PRESCRIPTION DRUG	Lactated Ringers		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, and CALCIUM CHLORIDE	IRRIGANT	IRRIGATION	20190701		NDA	NDA019416	ICU Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7901_4e244d74-868c-4a0e-be83-b30cdfd16eb3	0990-7901	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200201		NDA	NDA018365	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 1.49; 2.25	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7902_4e244d74-868c-4a0e-be83-b30cdfd16eb3	0990-7902	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200201		NDA	NDA018362	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 1.49; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7903_4e244d74-868c-4a0e-be83-b30cdfd16eb3	0990-7903	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200201		NDA	NDA018362	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 2.24; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7904_4e244d74-868c-4a0e-be83-b30cdfd16eb3	0990-7904	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200201		NDA	NDA018362	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 2.98; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7905_b3ae67e4-0b52-42d0-8d2c-853ba64b2b22	0990-7905	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose		dextrose monohydrate and potassium chloride injection, solution	INJECTION, SOLUTION	INTRAVENOUS	20201120		NDA	NDA018371	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE	5; .149	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7918_8b5e0f3a-7f61-4ea2-a454-bf57d41e03ae	0990-7918	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA018561	ICU Medical Inc.	DEXTROSE MONOHYDRATE	70	g/100mL			N	20241231
0990-7922_23937f2d-9ed6-4ae8-aaeb-f76c4547ede3	0990-7922	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20190715		NDA	NDA016367	ICU Medical Inc.	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0990-7923_23937f2d-9ed6-4ae8-aaeb-f76c4547ede3	0990-7923	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20190715		NDA	NDA016367	ICU Medical Inc.	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
0990-7924_8aad724e-964b-4eac-a915-5f5013d983f5	0990-7924	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190901		NDA	NDA017606	ICU Medical Inc.	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .225	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7925_8aad724e-964b-4eac-a915-5f5013d983f5	0990-7925	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190901		NDA	NDA017799	ICU Medical Inc.	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .3	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7926_8aad724e-964b-4eac-a915-5f5013d983f5	0990-7926	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190901		NDA	NDA017607	ICU Medical Inc.	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .45	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7929_f0f79123-edc9-43ff-a696-0356b6f03952	0990-7929	HUMAN PRESCRIPTION DRUG	Lactated Ringers and Dextrose		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20190624		NDA	NDA017608	ICU Medical Inc.	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 5; 30; 600; 310	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7930_23937f2d-9ed6-4ae8-aaeb-f76c4547ede3	0990-7930	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20190715		NDA	NDA018080	ICU Medical Inc.	DEXTROSE MONOHYDRATE	10	g/100mL			N	20241231
0990-7935_8b5e0f3a-7f61-4ea2-a454-bf57d41e03ae	0990-7935	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA018564	ICU Medical Inc.	DEXTROSE MONOHYDRATE	20	g/100mL			N	20241231
0990-7936_8b5e0f3a-7f61-4ea2-a454-bf57d41e03ae	0990-7936	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA018563	ICU Medical Inc.	DEXTROSE MONOHYDRATE	50	g/100mL			N	20241231
0990-7937_8b5e0f3a-7f61-4ea2-a454-bf57d41e03ae	0990-7937	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA018562	ICU Medical Inc.	DEXTROSE MONOHYDRATE	40	g/100mL			N	20241231
0990-7938_6a549109-fb87-4490-b3f7-e11cb400b2fc	0990-7938	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose monohydrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20191120		NDA	NDA018080	ICU Medical Inc.	DEXTROSE MONOHYDRATE	10	g/100mL			N	20241231
0990-7941_8aad724e-964b-4eac-a915-5f5013d983f5	0990-7941	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190901		NDA	NDA017585	ICU Medical Inc.	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .9	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7953_f0f79123-edc9-43ff-a696-0356b6f03952	0990-7953	HUMAN PRESCRIPTION DRUG	Lactated Ringers		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, and CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190624		NDA	NDA017641	ICU Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7965_64d6879f-9673-4824-93c7-354e6f33d0a3	0990-7965	HUMAN PRESCRIPTION DRUG	NORMOSOL-M AND DEXTROSE		dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate	INJECTION, SOLUTION	INTRAVENOUS	20210208		NDA	NDA017610	ICU Medical Inc.	DEXTROSE MONOHYDRATE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE	5; 21; 128; 234	g/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0990-7967_c45fe05f-68f6-41b6-8a1a-448756d98e72	0990-7967	HUMAN PRESCRIPTION DRUG	Normosol-R		SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190918		NDA	NDA017586	ICU Medical Inc.	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM CHLORIDE; SODIUM GLUCONATE	30; 37; 222; 526; 502	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0990-7968_39a35d0e-fbf4-47be-a134-e35acaf4211d	0990-7968	HUMAN PRESCRIPTION DRUG	Normosol-R and Dextrose		Dextrose, Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, and Magnesium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20200514		NDA	NDA017609	ICU Medical Inc.	DEXTROSE, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM CHLORIDE; SODIUM GLUCONATE	5; 30; 37; 222; 526; 502	g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
0990-7972_1b3380e6-631b-48e7-bf53-2cc712b4778d	0990-7972	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	IRRIGANT	IRRIGATION	20190701		NDA	NDA018314	ICU Medical Inc.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7972_8fe0bd51-0925-4ca4-a2b7-57d9335ace2d	0990-7972	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	IRRIGANT	IRRIGATION	20190801		NDA	NDA018314	ICU Medical Inc.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7973_52f29318-9d59-4766-b7f4-cce37366a280	0990-7973	HUMAN PRESCRIPTION DRUG	Sterile Water		water	IRRIGANT	IRRIGATION	20190801		NDA	NDA018313	ICU Medical Inc.	WATER	1	mL/mL			N	20241231
0990-7974_95ed4b16-48cb-42f7-9f8a-99c3cf599b08	0990-7974	HUMAN PRESCRIPTION DRUG	Glycine		GLYCINE	IRRIGANT	IRRIGATION	20190701		NDA	NDA018315	ICU Medical Inc.	GLYCINE	1.5	g/100mL			N	20241231
0990-7981_750091b2-344c-461a-9f6a-0737e53041b2	0990-7981	HUMAN PRESCRIPTION DRUG	Sorbitol-Mannitol		SORBITOL and MANNITOL	IRRIGANT	URETHRAL	20191001		NDA	NDA018316	ICU Medical Inc.	MANNITOL; SORBITOL	.54; 2.7	g/100mL; g/100mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
0990-7982_5ced9253-c5e1-40d5-bf87-347e6470823b	0990-7982	HUMAN PRESCRIPTION DRUG	Ringers		SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200101		NDA	NDA018251	ICU Medical Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	33; 30; 860	mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-7983_4e92e246-09fd-4167-b5d6-517df56a46f2	0990-7983	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190401		NDA	NDA016366	ICU Medical Inc.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7984_4e92e246-09fd-4167-b5d6-517df56a46f2	0990-7984	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190401		NDA	NDA016366	ICU Medical Inc.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7985_4e92e246-09fd-4167-b5d6-517df56a46f2	0990-7985	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190401		NDA	NDA018090	ICU Medical Inc.	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
0990-7990_581f8aba-61d8-4835-a103-4f0ba20536ea	0990-7990	HUMAN PRESCRIPTION DRUG	Sterile Water		water	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA018233	ICU Medical Inc.	WATER	1000	mL/1000mL			N	20241231
0990-7993_4e244d74-868c-4a0e-be83-b30cdfd16eb3	0990-7993	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200201		NDA	NDA018362	ICU Medical Inc.	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; .745; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0990-8004_8b5e0f3a-7f61-4ea2-a454-bf57d41e03ae	0990-8004	HUMAN PRESCRIPTION DRUG	Dextrose		dextrose	INJECTION, SOLUTION	INTRAVENOUS	20191001		NDA	NDA019345	ICU Medical Inc.	DEXTROSE MONOHYDRATE	30	g/100mL			N	20241231
0990-9257_c84983c7-f279-443c-949f-f09a5a262358	0990-9257	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		SODIUM CHLORIDE and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200101		ANDA	ANDA078446	ICU Medical Inc.	POTASSIUM CHLORIDE; SODIUM CHLORIDE	1.49; 4.5	g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
0998-0016_68597ba4-c57a-4ad8-aa36-72cb77aef4a6	0998-0016	HUMAN PRESCRIPTION DRUG	Alcaine		proparacaine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19731019		ANDA	ANDA080027	Alcon Laboratories, Inc.	PROPARACAINE HYDROCHLORIDE	5	mg/mL	Local Anesthesia [PE], Local Anesthetic [EPC]		N	20241231
0998-0355_86af6085-d52b-4516-8234-64ae8baa98b4	0998-0355	HUMAN PRESCRIPTION DRUG	Mydriacyl		tropicamide	SOLUTION/ DROPS	OPHTHALMIC	19590401		ANDA	ANDA084306	Alcon Laboratories, Inc.	TROPICAMIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
0998-0408_087ce08b-8271-4eda-9ac0-3554dbe54dd1	0998-0408	HUMAN OTC DRUG	Isopto Tears		Hypromellose 2910	SOLUTION	OPHTHALMIC	19900930	20241231	OTC MONOGRAPH DRUG	M018	Alcon Laboratories, Inc.	HYPROMELLOSE 2910 (4000 MPA.S)	5	mg/mL			N	
10014-001_07eef313-2924-20ae-e063-6294a90a3180	10014-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19721006		NDA	NDA205840	Aero All Gas Company	OXYGEN	990	mL/L			N	20241231
10014-002_07ef001a-c64b-5639-e063-6294a90ab4d3	10014-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19721006		NDA	NDA205839	Aero All Gas Company	NITROGEN	990	mL/L			N	20241231
10014-003_07eef313-2923-20ae-e063-6294a90a3180	10014-003	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19721006		NDA	NDA206009	Aero All Gas Company	NITROUS OXIDE	990	mL/L			N	20241231
10014-004_07ef192f-b9ff-5644-e063-6394a90abcbd	10014-004	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	19721006		NDA	NDA206826	Aero All Gas Company	HELIUM	990	mL/L			N	20241231
10014-005_07eee3f4-8797-d062-e063-6294a90a2983	10014-005	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19721006		NDA	NDA205846	Aero All Gas Company	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
10018-8999_48d0d09a-35bd-4501-b481-5bb4aaaaacb2	10018-8999	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA205865	Air Products and Chemicals, Inc.	OXYGEN	990	mL/L			N	20241231
10018-9502_6eb4b61d-3ad6-45a6-8a3f-92ac48d5deb4	10018-9502	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA205866	Air Products and Chemicals, Inc.	NITROGEN	990	mL/L			N	20241231
10019-055_334bb1c1-23f4-4e19-ac28-950809bb3c7b	10019-055	HUMAN PRESCRIPTION DRUG	Brevibloc		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-075_334bb1c1-23f4-4e19-ac28-950809bb3c7b	10019-075	HUMAN PRESCRIPTION DRUG	Brevibloc		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-079_45fa3a63-1971-460a-ae3e-2b9f531c2218	10019-079	HUMAN PRESCRIPTION DRUG	BENDAMUSTINE HYDROCHLORIDE		bendamustine hydrochloride	INJECTION	INTRAVENOUS	20221215		NDA	NDA216078	Baxter Healthcare Corporation	BENDAMUSTINE HYDROCHLORIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-115_334bb1c1-23f4-4e19-ac28-950809bb3c7b	10019-115	HUMAN PRESCRIPTION DRUG	Brevibloc		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-120_f97c5b99-86e4-4bb9-bd78-2a051a7a0328	10019-120	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-360_6851d96f-d0d8-46af-983a-0e8714f84a62	10019-360	HUMAN PRESCRIPTION DRUG	FORANE		isoflurane	INHALANT	RESPIRATORY (INHALATION)	19791218		NDA	NDA017624	Baxter Healthcare Corporation	ISOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-553_c62c5c05-662c-4ef4-85c2-89dd21685ab4	10019-553	HUMAN PRESCRIPTION DRUG	Transderm Scop		Scopolamine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20161201	20250228	NDA	NDA017874	Baxter Healthcare Corporation	SCOPOLAMINE	1	mg/3d	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
10019-641_2fac2b47-dc48-40db-90b4-28c42617bc49	10019-641	HUMAN PRESCRIPTION DRUG	SUPRANE		desflurane	LIQUID	RESPIRATORY (INHALATION)	19920918		NDA	NDA020118	Baxter Healthcare Corporation	DESFLURANE	240	mL/240mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-644_ea93e280-7aa3-44a7-a415-17a0181867c5	10019-644	HUMAN PRESCRIPTION DRUG	Suprane		DESFLURANE	LIQUID	RESPIRATORY (INHALATION)	19920918		NDA	NDA020118	Baxter Healthcare Corporation	DESFLURANE	240	mL/240mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-646_9519a67c-bd7e-4d62-bf3f-73e7784837e6	10019-646	HUMAN PRESCRIPTION DRUG	SUPRANE		DESFLURANE	LIQUID	RESPIRATORY (INHALATION)	19920918		NDA	NDA020118	Baxter Healthcare Corporation	DESFLURANE	240	mL/240mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-651_94dadf82-9ad6-4588-8cee-3b529cb61e0a	10019-651	HUMAN PRESCRIPTION DRUG	Sevoflurane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20020702		ANDA	ANDA075895	Baxter Healthcare Corporation	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-653_8faf6015-7ba0-4f71-a0ed-9148f7be0a70	10019-653	HUMAN PRESCRIPTION DRUG	SEVOFLURANE		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20020707		ANDA	ANDA075895	Baxter Healthcare Corporation	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-655_94dadf82-9ad6-4588-8cee-3b529cb61e0a	10019-655	HUMAN PRESCRIPTION DRUG	Sevoflurane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20020702		ANDA	ANDA075895	Baxter Healthcare Corporation	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-657_8faf6015-7ba0-4f71-a0ed-9148f7be0a70	10019-657	HUMAN PRESCRIPTION DRUG	SEVOFLURANE		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20020707		ANDA	ANDA075895	Baxter Healthcare Corporation	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
10019-666_691927c7-8208-4e8d-b644-55e697bff359	10019-666	HUMAN PRESCRIPTION DRUG	BREVIBLOC		esmolol hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-668_44616775-cf16-4111-b069-fdaabf267791	10019-668	HUMAN PRESCRIPTION DRUG	BREVIBLOC		esmolol hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-670_691927c7-8208-4e8d-b644-55e697bff359	10019-670	HUMAN PRESCRIPTION DRUG	BREVIBLOC		esmolol hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-672_44616775-cf16-4111-b069-fdaabf267791	10019-672	HUMAN PRESCRIPTION DRUG	BREVIBLOC		esmolol hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Baxter Healthcare Corporation	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10019-925_4a719500-0f12-41cd-ac4c-5f50602d5b33	10019-925	HUMAN PRESCRIPTION DRUG	IFOSFAMIDE		IFOSFAMIDE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19881230		NDA	NDA019763	Baxter Healthcare Corporation	IFOSFAMIDE	1	g/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-926_4a719500-0f12-41cd-ac4c-5f50602d5b33	10019-926	HUMAN PRESCRIPTION DRUG	IFOSFAMIDE		IFOSFAMIDE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19881230		NDA	NDA019763	Baxter Healthcare Corporation	IFOSFAMIDE	3	g/60mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-927_2a660f99-4a19-4ffe-9c54-b41f76ffff3f	10019-927	HUMAN PRESCRIPTION DRUG	IFOSFAMIDE		ifosfamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19881230		NDA	NDA019763	Baxter Healthcare Corporation	IFOSFAMIDE	1	g/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-929_2a660f99-4a19-4ffe-9c54-b41f76ffff3f	10019-929	HUMAN PRESCRIPTION DRUG	IFOSFAMIDE		ifosfamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19881230		NDA	NDA019763	Baxter Healthcare Corporation	IFOSFAMIDE	3	g/60mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-935_180a493a-6821-4ef0-8589-a847d11e1834	10019-935	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-936_180a493a-6821-4ef0-8589-a847d11e1834	10019-936	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-937_180a493a-6821-4ef0-8589-a847d11e1834	10019-937	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-938_41308580-bee4-4301-8ed8-0fab327f41cc	10019-938	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-939_41308580-bee4-4301-8ed8-0fab327f41cc	10019-939	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-942_41308580-bee4-4301-8ed8-0fab327f41cc	10019-942	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-943_cda04fb2-e380-4236-bef0-e1a7d588d26b	10019-943	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-944_cda04fb2-e380-4236-bef0-e1a7d588d26b	10019-944	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-945_cda04fb2-e380-4236-bef0-e1a7d588d26b	10019-945	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-951_e169a25a-2549-462f-a54f-b175e02f14e0	10019-951	HUMAN PRESCRIPTION DRUG	MESNA		MESNA	INJECTION, SOLUTION	INTRAVENOUS	19881230		NDA	NDA019884	Baxter Healthcare Corporation	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
10019-953_9734a242-cbd5-4569-bb78-97d37769cbe7	10019-953	HUMAN PRESCRIPTION DRUG	MESNA		MESNA	INJECTION, SOLUTION	INTRAVENOUS	19881230		NDA	NDA019884	Baxter Healthcare Corporation	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
10019-955_4dc9578a-b1fb-4c0f-9ed5-99b442dbc8f2	10019-955	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-956_4dc9578a-b1fb-4c0f-9ed5-99b442dbc8f2	10019-956	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-957_4dc9578a-b1fb-4c0f-9ed5-99b442dbc8f2	10019-957	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-982_a62fd364-3f86-4d73-81f5-08025a32ce0d	10019-982	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	TABLET	ORAL	20200807		NDA AUTHORIZED GENERIC	NDA012141	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	25	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-984_a62fd364-3f86-4d73-81f5-08025a32ce0d	10019-984	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	TABLET	ORAL	20200807		NDA	NDA012141	Baxter Healthcare Corporation	CYCLOPHOSPHAMIDE	50	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
10019-991_70543c4c-f836-41c0-9b29-fd3d6bb8ed09	10019-991	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502		ANDA	ANDA213823	Baxter Healthcare Corporation	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
10028-020_f1d8ac07-2c86-0539-e053-2995a90a658d	10028-020	HUMAN OTC DRUG	Starter Set Oily/Normal Skin		Zinc Oxide	KIT	TOPICAL	20200301		OTC MONOGRAPH FINAL	part352	ULTRACEUTICALS PTY LIMITED						N	20241231
10028-022_f1d8ac07-2c85-0539-e053-2995a90a658d	10028-022	HUMAN OTC DRUG	Starter Set Dry/Normal Skin		Zinc Oxide	KIT	TOPICAL	20200304		OTC MONOGRAPH FINAL	part352	Ultraceuticals Pty Ltd						N	20241231
10028-050_0450dcc9-3fac-e2c2-e063-6294a90af60b	10028-050	HUMAN OTC DRUG	Ultra Clear Foaming Cleanser		Salicylic Acid	LOTION	TOPICAL	20191211		OTC MONOGRAPH FINAL	M006	ULTRACEUTICALS PTY LIMITED	SALICYLIC ACID	.5	g/100mL			N	20241231
10028-051_0450dcc9-3fb1-e2c2-e063-6294a90af60b	10028-051	HUMAN OTC DRUG	Ultra Clear Treatment		Salicylic Acid	LOTION	TOPICAL	20191215		OTC MONOGRAPH FINAL	M006	ULTRACEUTICALS PTY LIMITED	SALICYLIC ACID	2	g/100mL			N	20241231
10028-060_f653e8ad-7c4a-19fd-e053-2a95a90a9c45	10028-060	HUMAN OTC DRUG	Ultra UV Protective Mineral Defence		Zinc Oxide	LOTION	TOPICAL	20200110		OTC MONOGRAPH NOT FINAL	part352	Ultraceuticals Pty Ltd	ZINC OXIDE	127	mg/mL			N	20241231
10028-158_fc8a8f0a-55f2-4c98-e053-6294a90a3036	10028-158	HUMAN OTC DRUG	Ultraceuticals Ultra UV Protective Daily Moisturising		Zinc Oxide	LOTION	TOPICAL	20230522		OTC MONOGRAPH NOT FINAL	part352	Ultraceuticals	ZINC OXIDE	154	mg/mL			N	20241231
10056-006_085bb064-0a35-cb0d-e063-6294a90a16a1	10056-006	HUMAN OTC DRUG	Satinique Anti Dandruff		PYRITHIONE ZINC	CREAM	TOPICAL	20170329		OTC MONOGRAPH DRUG	M032	Access Business Group LLC	PYRITHIONE ZINC	9.5	mg/mL			N	20241231
10056-025_085bcc1d-8ef6-1348-e063-6394a90af6cf	10056-025	HUMAN OTC DRUG	g and h Protect Body		ENSULIZOLE, OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20230710		OTC MONOGRAPH DRUG	M020	Access Business Group LLC	ENSULIZOLE; OCTISALATE; ZINC OXIDE	17; 50; 165.55	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10056-026_085c311d-9905-e891-e063-6394a90aae95	10056-026	HUMAN OTC DRUG	g and h Protect Hand		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20230419		OTC MONOGRAPH DRUG	505G(a)(3)	Access Business Group LLC	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
10056-030_083752d6-b759-692f-e063-6294a90aa338	10056-030	HUMAN OTC DRUG	Artistry Ideal Radiance Illuminating CC SPF50 Broad Spectrum Sunscreen - Light		ENSULIZOLE,OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20151211		OTC MONOGRAPH DRUG	M020	Access Business Group LLC	ENSULIZOLE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	20; 55; 5; 8.8; 98	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10056-040_08370288-7303-b684-e063-6294a90ad541	10056-040	HUMAN OTC DRUG	Artistry Skin Nutrition BALANCING Matte Day		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210404		OTC MONOGRAPH DRUG	M020	Access Business Group LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 40	mg/g; mg/g; mg/g			N	20241231
10056-041_0837204a-9171-1842-e063-6394a90a18da	10056-041	HUMAN OTC DRUG	Artistry Skin Nutrition HYDRATING Day		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210404		OTC MONOGRAPH DRUG	M020	Access Business Group LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
10056-045_08372a75-e89d-3a6d-e063-6394a90a90a6	10056-045	HUMAN OTC DRUG	Artistry Studio Done With Zit Acne Treatment Clearing Gel		SALICYLIC ACID	GEL	TOPICAL	20210623		OTC MONOGRAPH DRUG	M006	Access Business Group LLC	SALICYLIC ACID	20	mg/mL			N	20241231
10056-048_085c4823-331f-c11e-e063-6394a90aa2be	10056-048	HUMAN OTC DRUG	Spectrum Health - Amway Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210601		OTC MONOGRAPH DRUG	505G(a)(3)	Access Business Group LLC	ALCOHOL	73	mL/100mL			N	20241231
10056-050_0837877c-606b-05ae-e063-6394a90a24b0	10056-050	HUMAN OTC DRUG	Artistry Skin Nutrition RENEWING Reactivation Day Cream SPF 30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20210922		OTC MONOGRAPH DRUG	M020	Access Business Group LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
10056-051_08373d36-699b-1800-e063-6394a90ab759	10056-051	HUMAN OTC DRUG	Artistry Skin Nutrition RENEWING Reactivation Day SPF 30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210414		OTC MONOGRAPH DRUG	M020	Access Business Group LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
10056-406_085c3cc5-cefc-e8e0-e063-6394a90a910c	10056-406	HUMAN OTC DRUG	G and H Protect Plus Advanced Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200624		OTC MONOGRAPH DRUG	505G(a)(3)	Access Business Group LLC	ALCOHOL	.73	mL/mL			N	20241231
10056-410_083600d9-206d-26f5-e063-6394a90a0685	10056-410	HUMAN OTC DRUG	ARTISTRY STUDiO Rose All Day Anti Acne Toner Pore Refresher		SALICYLIC ACID	LIQUID	TOPICAL	20200923		OTC MONOGRAPH DRUG	M006	Access Business Group LLC	SALICYLIC ACID	10	mg/mL			N	20241231
10056-415_085bbc1a-0302-ea11-e063-6394a90a3391	10056-415	HUMAN OTC DRUG	Glister Multi-Action		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20230322		OTC MONOGRAPH DRUG	M021	Access Business Group LLC	SODIUM FLUORIDE	2.1	mg/g			N	20241231
10056-530_08360dc3-2aff-9adb-e063-6394a90a996d	10056-530	HUMAN OTC DRUG	Glister Multi-Action Fluoride		SODIUM FLUORIDE	PASTE, DENTIFRICE	TOPICAL	20110411		OTC MONOGRAPH DRUG	M021	Access Business Group, LLC	SODIUM FLUORIDE	2.1	mg/g			N	20241231
10056-531_085c0563-2592-878d-e063-6394a90a43d3	10056-531	HUMAN OTC DRUG	Artistry Skin Nutrition Multi-Defense UV Protect		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20230808		OTC MONOGRAPH DRUG	M020	Access Business Group LLC	TITANIUM DIOXIDE; ZINC OXIDE	58.1; 145.9	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10056-532_085c29d8-81b0-59b1-e063-6394a90a9a85	10056-532	HUMAN OTC DRUG	G and H Protect Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20231111		OTC MONOGRAPH DRUG	505G(a)(3)	Access Business Group LLC	ALCOHOL	65.6	mL/100mL			N	20241231
10073-111_07618fd8-a43e-e56c-e063-6294a90ac336	10073-111	HUMAN PRESCRIPTION DRUG	oxygen		oxygen	GAS	RESPIRATORY (INHALATION)	19640101		NDA	NDA205767	Oz Arc/gas Equipment & Supply, Inc.	OXYGEN	992	mL/L			N	20241231
10094-205_f1ed6778-7598-432a-876e-e4b3d91c86a1	10094-205	HUMAN PRESCRIPTION DRUG	SYMPAZAN		clobazam	FILM	ORAL	20181101		NDA	NDA210833	Aquestive Therapeutics	CLOBAZAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
10094-210_f1ed6778-7598-432a-876e-e4b3d91c86a1	10094-210	HUMAN PRESCRIPTION DRUG	SYMPAZAN		clobazam	FILM	ORAL	20181101		NDA	NDA210833	Aquestive Therapeutics	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
10094-220_f1ed6778-7598-432a-876e-e4b3d91c86a1	10094-220	HUMAN PRESCRIPTION DRUG	SYMPAZAN		clobazam	FILM	ORAL	20181101		NDA	NDA210833	Aquestive Therapeutics	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
10095-100_f1eb4d3d-090c-7998-e053-2a95a90a871c	10095-100	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	POWDER	ORAL	20200205		OTC MONOGRAPH FINAL	part331	World Perfumes Inc	SODIUM BICARBONATE	2.6	g/2.6g	Alkalinizing Activity [MoA]		N	20241231
10107-240_87ef2a84-7556-42bc-91e9-76da095585be	10107-240	HUMAN OTC DRUG	CornStick		Salicylic Acid	STICK	TOPICAL	19670701		OTC MONOGRAPH FINAL	part358F	Balassa Laboratories Inc.	SALICYLIC ACID	.4	g/g			N	20241231
10107-250_d0c0f0ac-5e08-4ecc-a507-483ecdfde628	10107-250	HUMAN OTC DRUG	WartStick		Salicylic Acid	STICK	TOPICAL	19830601		OTC MONOGRAPH FINAL	part358B	Balassa Laboratories Inc.	SALICYLIC ACID	.4	g/g			N	20241231
10107-251_6ae1253c-31ab-40a7-8028-acfd0b2b88c3	10107-251	HUMAN OTC DRUG	WartStick Plantar		Salicylic Acid	STICK	TOPICAL	20200601		OTC MONOGRAPH FINAL	part358B	Balassa Laboratories Inc.	SALICYLIC ACID	.4	g/g			N	20241231
10107-420_9906eef3-faff-4262-a466-acad702195e6	10107-420	HUMAN OTC DRUG	Herb Street Sore Muscle Relief		Methyl Salicylate	STICK	TOPICAL	20210325		OTC MONOGRAPH NOT FINAL	part348	Balassa Laboratories Inc.	METHYL SALICYLATE	.25	g/g			N	20241231
10107-429_01709063-a8fb-410e-ba76-ad0d029fc9d0	10107-429	HUMAN OTC DRUG	Herb Street Anti-Itch Stick		Hydrocortisone	STICK	TOPICAL	20220501		OTC MONOGRAPH NOT FINAL	part348	Balassa Laboratories Inc.	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10107-431_647aeb2e-410c-4442-8394-dd2d59f868cf	10107-431	HUMAN OTC DRUG	Herb Street Arthritis Relief		Menthol/Camphor	STICK	TOPICAL	20220501		OTC MONOGRAPH NOT FINAL	part348	Balassa Laboratories Inc.	CAMPHOR (SYNTHETIC); MENTHOL	.11; .16	g/g; g/g			N	20241231
10107-432_087b2786-5cac-422d-9e2f-84001eb41c70	10107-432	HUMAN OTC DRUG	Herb Street Backache and Sore Muscle Relief		Menthol	STICK	TOPICAL	20210830		OTC MONOGRAPH NOT FINAL	part348	Balassa Laboratories Inc.	MENTHOL	.1	g/g			N	20241231
10122-100_4f6573ca-2d61-4602-8a51-f9e30af2e489	10122-100	HUMAN PRESCRIPTION DRUG	FERRIPROX		deferiprone	TABLET, FILM COATED	ORAL	20111125		NDA	NDA021825	Chiesi USA, Inc.	DEFERIPRONE	500	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
10122-101_ed8809cb-0122-4631-b9bb-148b20ecd49e	10122-101	HUMAN PRESCRIPTION DRUG	FERRIPROX		deferiprone	SOLUTION	ORAL	20150909		NDA	NDA208030	Chiesi USA, Inc.	DEFERIPRONE	100	mg/mL	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
10122-103_4f6573ca-2d61-4602-8a51-f9e30af2e489	10122-103	HUMAN PRESCRIPTION DRUG	FERRIPROX		DEFERIPRONE	TABLET, FILM COATED	ORAL	20190801		NDA	NDA021825	Chiesi USA, Inc.	DEFERIPRONE	1000	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
10122-104_4f6573ca-2d61-4602-8a51-f9e30af2e489	10122-104	HUMAN PRESCRIPTION DRUG	FERRIPROX		deferiprone	TABLET	ORAL	20200519		NDA	NDA212269	Chiesi USA, Inc.	DEFERIPRONE	1000	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
10122-141_91c28643-e5a8-49d2-af90-17fefeb5b827	10122-141	HUMAN PRESCRIPTION DRUG	Retavase		reteplase	KIT		19961030		BLA	BLA103786	Chiesi USA, Inc.						N	20241231
10122-143_91c28643-e5a8-49d2-af90-17fefeb5b827	10122-143	HUMAN PRESCRIPTION DRUG	Retavase		reteplase	KIT		19961030		BLA	BLA103786	Chiesi USA, Inc.						N	20241231
10122-160_87c2b108-9c81-4ddb-83d1-d61f88783c37	10122-160	HUMAN PRESCRIPTION DRUG	ELFABRIO		pegunigalsidase alfa	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230523		BLA	BLA761161	Chiesi USA, Inc.	PEGUNIGALSIDASE ALFA	20	mg/10mL			N	20241231
10122-180_27cf090b-196e-4330-8184-c72d9bb90660	10122-180	HUMAN PRESCRIPTION DRUG	Lamzede		Velmanase alfa-tycv	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230301		BLA	BLA761278	Chiesi USA, Inc.	VELMANASE ALFA-TYCV	10	mg/1			N	20241231
10122-502_964401e1-52e5-4c34-b5b5-d028ce092dd9	10122-502	HUMAN PRESCRIPTION DRUG	Revcovi		elapegademase-lvlr	INJECTION	INTRAMUSCULAR	20181005		BLA	BLA761092	Chiesi USA, Inc.	ELAPEGADEMASE	1.6	mg/mL			N	20241231
10122-510_c0cfc0b1-0f53-4f93-8d31-02c3711265a0	10122-510	HUMAN PRESCRIPTION DRUG	Curosurf		poractant alfa	SUSPENSION	ENDOTRACHEAL	19991118		BLA	BLA020744	Chiesi USA, Inc.	PORACTANT ALFA	80	mg/mL	Alveolar Surface Tension Reduction [PE], Surfactant Activity [MoA], Surfactant [EPC]		N	20241231
10122-610_e06eb245-362a-4a22-ad90-0d014944fbc1	10122-610	HUMAN PRESCRIPTION DRUG	Cleviprex		clevipidine	EMULSION	INTRAVENOUS	20080915		NDA	NDA022156	Chiesi USA, Inc.	CLEVIDIPINE	.5	mg/mL	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
10122-611_e06eb245-362a-4a22-ad90-0d014944fbc1	10122-611	HUMAN PRESCRIPTION DRUG	Cleviprex		clevipidine	EMULSION	INTRAVENOUS	20080915		NDA	NDA022156	Chiesi USA, Inc.	CLEVIDIPINE	.5	mg/mL	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
10122-620_c1800c52-71b7-4c51-8143-8fc0b853e814	10122-620	HUMAN PRESCRIPTION DRUG	KENGREAL		cangrelor	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150708		NDA	NDA204958	Chiesi USA, Inc.	CANGRELOR	50	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
10122-820_32442297-00c4-4800-b7c4-1e2e290f3162	10122-820	HUMAN PRESCRIPTION DRUG	BETHKIS		tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20130415		NDA	NDA201820	Chiesi USA, Inc.	TOBRAMYCIN	300	mg/4mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
10122-901_55ed6f7f-6b19-4ebb-926c-a21619b49e15	10122-901	HUMAN PRESCRIPTION DRUG	ZYFLO		zileuton	TABLET	ORAL	19961206		NDA	NDA020471	Chiesi USA, Inc.	ZILEUTON	600	mg/1	5-Lipoxygenase Inhibitor [EPC], 5-Lipoxygenase Inhibitors [MoA], Decreased Leukotriene Production [PE]		N	20241231
10129-001_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-001	HUMAN OTC DRUG	GINGI-PAK MAX SOFT-TWIST NO 1		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19870626		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-002_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-002	HUMAN OTC DRUG	GINGI-PAK MAX SOFT-TWIST NO 2		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19850111		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-003_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-003	HUMAN OTC DRUG	GINGI-PAK MAX SOFT-TWIST NO 3		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19850111		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-004_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-004	HUMAN OTC DRUG	GINGI-PAK MAX 2-PLY		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19840329		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-005_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-005	HUMAN OTC DRUG	CROWN-PAK MAX 4-PLY		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19840329		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-006_755005b8-165c-b667-e053-2991aa0a3651	10129-006	HUMAN OTC DRUG	Orostat 8%		EPINEPHRINE HYDROCHLORIDE	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19900404		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	1200	mg/15mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-007_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-007	HUMAN OTC DRUG	GINGI-PAK PELLETS		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19870626		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.7	mg/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-008_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-008	HUMAN OTC DRUG	GINGI-PAK COTTON COIL		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19870626		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	1.18	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-017_e441df80-39de-a39c-e053-2995a90ad9a2	10129-017	HUMAN OTC DRUG	Gingi-Aid Solution		Aluminum Chloride 25%	SOLUTION	DENTAL; ORAL; PERIODONTAL; SUBGINGIVAL	19900404		OTC MONOGRAPH FINAL	part350	Gingi-Pak a Division of the Belport	ALUMINUM CHLORIDE	3.75	g/15mL			N	20241231
10129-018_ec1cc8d2-9953-2f21-e053-2995a90acd6e	10129-018	HUMAN OTC DRUG	Perio Armor		1.7% Hydrogen Peroxide	GEL	DENTAL; PERIODONTAL	20220815		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	HYDROGEN PEROXIDE	17	g/100mL			N	20241231
10129-019_ec1cc8d2-9953-2f21-e053-2995a90acd6e	10129-019	HUMAN OTC DRUG	Perio Armor		1.7% Hydrogen Peroxide	GEL	DENTAL; PERIODONTAL	20220815		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	HYDROGEN PEROXIDE	17	g/100mL			N	20241231
10129-031_e41c0322-5721-3107-e053-2995a90aff8e	10129-031	HUMAN OTC DRUG	STASIS		Ferric Sulfate	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19870626		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	FERRIC SULFATE	3150	mg/15mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
10129-032_ec1cc8d2-9953-2f21-e053-2995a90acd6e	10129-032	HUMAN OTC DRUG	Perio Armor		1.7% Hydrogen Peroxide	GEL	DENTAL; PERIODONTAL	20221025		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	HYDROGEN PEROXIDE	17	g/100mL			N	20241231
10129-033_d2bb2e64-8fb9-62a4-e053-2995a90a1889	10129-033	HUMAN OTC DRUG	GingiCaine Gel, Pina Colada		GingiCaine Gel, Pina Colada Flavor	GEL	DENTAL; ORAL; PERIODONTAL	19930706		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-034_d2bb20bd-ec82-8d80-e053-2a95a90a2bba	10129-034	HUMAN OTC DRUG	GingiCaine Gel, Chocolate Mint		GingiCaine Gel, Chocolate Mint Flavor	GEL	DENTAL; ORAL; PERIODONTAL	19930706		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-035_d2abd1a4-1bed-7d2d-e053-2995a90aed9f	10129-035	HUMAN OTC DRUG	GingiCaine Gel		GingiCaine Gel Banana flavor	GEL	DENTAL; ORAL; PERIODONTAL	19930706		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-037_d2abe594-584b-4fe2-e053-2995a90af537	10129-037	HUMAN OTC DRUG	GingiCaine Gel, Cotton Candy Flavor		GingiCaine Gel, Cotton Candy Flavor	GEL	DENTAL; ORAL; PERIODONTAL	19930326		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-038_e77bc6e7-de68-3e91-e053-2a95a90a96b2	10129-038	HUMAN OTC DRUG	Perio Armor-X		1.7% Hydrogen Peroxide	GEL	DENTAL; PERIODONTAL	20220815		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	HYDROGEN PEROXIDE	1.7	g/100g			N	20241231
10129-039_e77bc6e7-de68-3e91-e053-2a95a90a96b2	10129-039	HUMAN OTC DRUG	Perio Armor-X		1.7% Hydrogen Peroxide	GEL	DENTAL; PERIODONTAL	20220815		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	HYDROGEN PEROXIDE	1.7	g/100g			N	20241231
10129-042_e77bc6e7-de68-3e91-e053-2a95a90a96b2	10129-042	HUMAN OTC DRUG	Perio Armor-X		1.7% Hydrogen Peroxide	GEL	DENTAL; PERIODONTAL	20220815		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	HYDROGEN PEROXIDE	1.7	g/100g			N	20241231
10129-044_ebe0fc4c-ba0c-79a2-e053-2995a90affec	10129-044	HUMAN OTC DRUG	Perio Max Plus		1.7% Hydrogen Peroxide	GEL	DENTAL; PERIODONTAL	20220815		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	HYDROGEN PEROXIDE	1.7	g/100g			N	20241231
10129-051_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-051	HUMAN OTC DRUG	GINGI-PAK MAX Z-TWIST NO 00		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19950524		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-052_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-052	HUMAN OTC DRUG	GINGI-PAK MAX Z-TWIST NO 1		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19950524		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-053_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-053	HUMAN OTC DRUG	GINGI-PAK MAX Z-TWIST NO 2		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19950524		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-054_7d855c49-3fb3-0059-e053-2a91aa0a40df	10129-054	HUMAN OTC DRUG	GINGI-PAK MAX Z-TWIST NO 3		dl EPINEPHRINE HCI	SOLUTION	DENTAL; PERIODONTAL; SUBGINGIVAL	19950524		UNAPPROVED DRUG OTHER		Gingi-Pak a Division of the Belport	EPINEPHRINE HYDROCHLORIDE	.197	mg/10mm	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
10129-059_638dbc25-481e-3d56-e053-2a91aa0a9554	10129-059	HUMAN OTC DRUG	Gingi-Aid MAX Z-Twist 00		Gingi-Aid MAX Z-Twist 00	SOLUTION	DENTAL; ORAL; PERIODONTAL; SUBGINGIVAL	19950113		OTC MONOGRAPH FINAL	part347	Gingi-Pak a Division of the Belport	ALUMINUM SULFATE	54	mg/1			N	20241231
10129-060_638dbc25-481e-3d56-e053-2a91aa0a9554	10129-060	HUMAN OTC DRUG	Gingi-Aid MAX Z-Twist 1		Gingi-Aid MAX Z-Twist 1	SOLUTION	DENTAL; ORAL; PERIODONTAL; SUBGINGIVAL	19950113		OTC MONOGRAPH FINAL	part347	Gingi-Pak a Division of the Belport	ALUMINUM SULFATE	54	mg/1			N	20241231
10129-061_638dbc25-481e-3d56-e053-2a91aa0a9554	10129-061	HUMAN OTC DRUG	Gingi-Aid MAX Z-Twist 2		Gingi-Aid MAX Z-Twist 2	SOLUTION	DENTAL; ORAL; PERIODONTAL; SUBGINGIVAL	19950113		OTC MONOGRAPH FINAL	part347	Gingi-Pak a Division of the Belport	ALUMINUM SULFATE	54	mg/1			N	20241231
10129-062_638dbc25-481e-3d56-e053-2a91aa0a9554	10129-062	HUMAN OTC DRUG	Gingi-Aid MAX Z-Twist 3		Gingi-Aid MAX Z-Twist 3	SOLUTION	DENTAL; ORAL; PERIODONTAL; SUBGINGIVAL	19980731		OTC MONOGRAPH FINAL	part347	Gingi-Pak a Division of the Belport	ALUMINUM SULFATE	54	mg/1			N	20241231
10129-063_d2aa34f8-d139-b3a6-e053-2a95a90aab6d	10129-063	HUMAN OTC DRUG	GingiCaine Gel, Mint Julep		GingiCaine Gel, Mint Julep Flabvor	GEL	DENTAL; ORAL; PERIODONTAL	19980713		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-070_62ed4ff3-18f7-5c67-e053-2991aa0a7792	10129-070	HUMAN OTC DRUG	Gingicaine Gel Variety Pak		Gingicaine Gel Variety Pak	GEL	DENTAL; ORAL; PERIODONTAL	20140609		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-071_f5dd8fa8-0b6b-5a30-e053-2995a90ad194	10129-071	HUMAN OTC DRUG	UltraCare Anesthetic Gel		Benzocaine	GEL	DENTAL; PERIODONTAL; TOPICAL	20230208		OTC MONOGRAPH FINAL	M022	The Bellport Company, Inc. dba Gingi-Pak	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-080_a21744dd-b5f7-0594-e053-2a95a90a19fb	10129-080	HUMAN OTC DRUG	iBrite Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	Gingi-Pak	ALCOHOL	70	mL/100mL			N	20241231
10129-081_ac8a52ca-20ef-aa77-e053-2995a90a8011	10129-081	HUMAN OTC DRUG	ProGuard Hand Sanitizer Gel		Ethyl Alcohol	GEL	TOPICAL	20200626		OTC MONOGRAPH NOT FINAL	part333A	Gingi-Pak, a division of Belport Co.	ALCOHOL	70	mL/100mL			N	20241231
10129-715_d2bb569e-6ed0-1f93-e053-2995a90ab6df	10129-715	HUMAN OTC DRUG	GingiCaine gel, Cherry		Gingicaine Gel, Cherry flavor	GEL	DENTAL; ORAL; PERIODONTAL	19990621		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10129-720_d2bb7b43-14a0-d9af-e053-2995a90af7ab	10129-720	HUMAN OTC DRUG	GingiCaine Liquid, Cherry		GingiCaine Liquid, Cherry flavor	LIQUID	DENTAL; ORAL; PERIODONTAL	19990719		OTC MONOGRAPH NOT FINAL	part356	Gingi-Pak a Division of the Belport	BENZOCAINE	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10135-146_09bc7968-f046-f8dd-e063-6294a90abbf4	10135-146	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20160301		ANDA	ANDA204071	Marlex Pharmaceuticals Inc	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
10135-173_555052ca-376e-4277-9c5c-4c76974f9447	10135-173	HUMAN OTC DRUG	Aspirin 81 mg Enteric Coated		Aspirin	TABLET	ORAL	20180801		OTC MONOGRAPH NOT FINAL	part343	Marlex Pharmaceuticals Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
10135-314_0a368d4d-f481-2519-e063-6294a90a2a0f	10135-314	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET	ORAL	20181001		OTC MONOGRAPH DRUG	M007	Marlex Pharmaceuticals Inc	SENNOSIDES	8.6	mg/1			N	20241231
10135-495_0ac13914-954c-5a36-e063-6294a90a36c9	10135-495	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		promethazine hydrochloride	TABLET	ORAL	20161001		ANDA	ANDA091179	Marlex Pharmaceuticals Inc	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
10135-532_088edfc9-4be1-3257-e063-6394a90a146f	10135-532	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20200501		ANDA	ANDA077241	Marlex Pharmaceuticals Inc	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
10135-533_088edfc9-4be1-3257-e063-6394a90a146f	10135-533	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20200501		ANDA	ANDA077241	Marlex Pharmaceuticals Inc	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
10135-541_0a37a2a4-a14d-cf40-e063-6394a90a736c	10135-541	HUMAN PRESCRIPTION DRUG	Probenecid		Probenecid	TABLET, FILM COATED	ORAL	19760729		ANDA	ANDA080966	Marlex Pharmaceuticals Inc	PROBENECID	500	mg/1			N	20241231
10135-639_f380ef7e-eece-412d-b50c-deae2f6098d5	10135-639	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20180901		ANDA	ANDA202046	Marlex Pharmaceuticals Inc	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10135-666_0a5d011d-308f-c100-e063-6294a90a9c6b	10135-666	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181001		ANDA	ANDA210971	Marlex Pharmaceuticals Inc	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
10135-667_0a5d011d-308f-c100-e063-6294a90a9c6b	10135-667	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181001		ANDA	ANDA210971	Marlex Pharmaceuticals Inc	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
10135-668_0a5d011d-308f-c100-e063-6294a90a9c6b	10135-668	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181001		ANDA	ANDA210971	Marlex Pharmaceuticals Inc	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
10135-669_0a3528b3-fa64-c187-e063-6294a90a81dd	10135-669	HUMAN OTC DRUG	Senna S		Docusate Sodium and Sennosides	TABLET	ORAL	20181001		OTC MONOGRAPH DRUG	M007	Marlex Pharmaceuticals Inc	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
10135-671_097f079e-aba9-bcac-e063-6394a90abb5c	10135-671	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	20181201		OTC MONOGRAPH DRUG	M005	Marlex Pharmaceuticals Inc	CLOTRIMAZOLE	1	g/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
10135-672_09ab51f5-ecf0-fe6f-e063-6394a90adbc6	10135-672	HUMAN OTC DRUG	Lidocaine		Lidocaine	CREAM	TOPICAL	20181201		OTC MONOGRAPH DRUG	M017	Marlex Pharmaceuticals Inc	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
10135-673_0a327fcc-a7c6-9d4c-e063-6394a90a0044	10135-673	HUMAN PRESCRIPTION DRUG	Ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA079165	Marlex Pharmaceuticals Inc	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
10135-674_0a327fcc-a7c6-9d4c-e063-6394a90a0044	10135-674	HUMAN PRESCRIPTION DRUG	Ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA079165	Marlex Pharmaceuticals Inc	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
10135-675_0a327fcc-a7c6-9d4c-e063-6394a90a0044	10135-675	HUMAN PRESCRIPTION DRUG	Ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA079165	Marlex Pharmaceuticals Inc	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
10135-676_0a327fcc-a7c6-9d4c-e063-6394a90a0044	10135-676	HUMAN PRESCRIPTION DRUG	Ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA079165	Marlex Pharmaceuticals Inc	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
10135-677_0a327fcc-a7c6-9d4c-e063-6394a90a0044	10135-677	HUMAN PRESCRIPTION DRUG	Ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA079165	Marlex Pharmaceuticals Inc	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
10135-678_0a327fcc-a7c6-9d4c-e063-6394a90a0044	10135-678	HUMAN PRESCRIPTION DRUG	Ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA079165	Marlex Pharmaceuticals Inc	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
10135-679_0a327fcc-a7c6-9d4c-e063-6394a90a0044	10135-679	HUMAN PRESCRIPTION DRUG	Ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA079165	Marlex Pharmaceuticals Inc	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
10135-681_093fc451-7ed3-2814-e063-6394a90afc4c	10135-681	HUMAN OTC DRUG	Guaifenesin 200mg		Guaifenesin	TABLET	ORAL	20190301		OTC MONOGRAPH DRUG	M012	Marlex Pharmaceuticals Inc	GUAIFENESIN	200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
10135-682_09400c44-c3ec-3caf-e063-6394a90a063d	10135-682	HUMAN OTC DRUG	Guaifenesin 400mg		Guaifenesin	TABLET	ORAL	20190301		OTC MONOGRAPH DRUG	M012	Marlex Pharmaceuticals Inc	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
10135-686_0bb52782-ca2e-03ce-e063-6294a90a0252	10135-686	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20200301		ANDA	ANDA210955	Marlex Pharmaceuticals Inc	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-687_0bb52782-ca2e-03ce-e063-6294a90a0252	10135-687	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20200301		ANDA	ANDA210955	Marlex Pharmaceuticals Inc	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-688_0bb52782-ca2e-03ce-e063-6294a90a0252	10135-688	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20200301		ANDA	ANDA210955	Marlex Pharmaceuticals Inc	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-692_08146f72-6a96-c85d-e063-6394a90a8cfb	10135-692	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	TABLET	ORAL	20200301		ANDA	ANDA210215	Marlex Pharmaceuticals Inc	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
10135-693_08146f72-6a96-c85d-e063-6394a90a8cfb	10135-693	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20200301		ANDA	ANDA210129	Marlex Pharmaceuticals Inc	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
10135-701_097dd427-7582-9987-e063-6294a90a8bed	10135-701	HUMAN OTC DRUG	Menthol and Zinc Oxide		Menthol and Zinc Oxide	OINTMENT	TOPICAL	20210501		OTC MONOGRAPH DRUG	M015	Marlex Pharmaceuticals, Inc.	MENTHOL; ZINC OXIDE	.44; 20.625	g/100g; g/100g			N	20241231
10135-702_09aa5d8b-76b1-85c6-e063-6394a90a9b32	10135-702	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	20220128		ANDA	ANDA213438	Marlex Pharmaceuticals, Inc.	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
10135-711_097eac26-5331-0f27-e063-6294a90ae0c5	10135-711	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA075215	Marlex Pharmaceuticals Inc	LABETALOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-712_097eac26-5331-0f27-e063-6294a90ae0c5	10135-712	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA075215	Marlex Pharmaceuticals Inc	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-713_097eac26-5331-0f27-e063-6294a90ae0c5	10135-713	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA075215	Marlex Pharmaceuticals Inc	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-718_07eb9ff0-8b18-3d0b-e063-6294a90a40e3	10135-718	HUMAN PRESCRIPTION DRUG	Alendronate		Alendronate sodium tablet	TABLET	ORAL	20201201		ANDA	ANDA090258	Marlex Pharmaceuticals, Inc.	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
10135-719_07eb9ff0-8b18-3d0b-e063-6294a90a40e3	10135-719	HUMAN PRESCRIPTION DRUG	Alendronate		Alendronate sodium tablet	TABLET	ORAL	20201201		ANDA	ANDA090258	Marlex Pharmaceuticals, Inc.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
10135-720_09bb906e-2e08-8afb-e063-6294a90af376	10135-720	HUMAN OTC DRUG	Miconazole Nitrate Antifungal Powder		Miconazole Nitrate Antifungal Powder	POWDER	TOPICAL	20220501		OTC MONOGRAPH DRUG	M005	Marlex Pharmaceuticals, Inc.	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
10135-721_0bb5d729-510b-e387-e063-6394a90a1fce	10135-721	HUMAN OTC DRUG	magnesium oxide		magnesium oxide	TABLET	ORAL	20231101		OTC MONOGRAPH DRUG	M001	Marlex Pharmaceuticals Inc.	MAGNESIUM OXIDE	420	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
10135-722_09ba039f-be59-08dc-e063-6394a90a68ae	10135-722	HUMAN PRESCRIPTION DRUG	Methocarbamol Tablets, USP, 500 mg		Methocarbamol	TABLET, FILM COATED	ORAL	20211209		ANDA	ANDA212623	Marlex Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
10135-723_09ba039f-be59-08dc-e063-6394a90a68ae	10135-723	HUMAN PRESCRIPTION DRUG	Methocarbamol Tablets, USP, 750 mg		Methocarbamol	TABLET, FILM COATED	ORAL	20211209		ANDA	ANDA212623	Marlex Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
10135-724_09aa75a2-3287-5f4a-e063-6394a90a94a2	10135-724	HUMAN PRESCRIPTION DRUG	hydroquinone		hydroquinone	CREAM	TOPICAL	20210301		UNAPPROVED DRUG OTHER		Marlex Pharmaceuticals, Inc.	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
10135-725_f5c45e2b-830b-b1ac-e053-2a95a90ac567	10135-725	HUMAN PRESCRIPTION DRUG	FLUPHENAZINE HYDROCHLORIDE		FLUPHENAZINE HYDROCHLORIDE	TABLET	ORAL	20210601		ANDA	ANDA214674	Marlex Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
10135-726_f5c45e2b-830b-b1ac-e053-2a95a90ac567	10135-726	HUMAN PRESCRIPTION DRUG	FLUPHENAZINE HYDROCHLORIDE		FLUPHENAZINE HYDROCHLORIDE	TABLET	ORAL	20210601		ANDA	ANDA214674	Marlex Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
10135-727_f5c45e2b-830b-b1ac-e053-2a95a90ac567	10135-727	HUMAN PRESCRIPTION DRUG	FLUPHENAZINE HYDROCHLORIDE		FLUPHENAZINE HYDROCHLORIDE	TABLET	ORAL	20210601		ANDA	ANDA214674	Marlex Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
10135-728_f5c45e2b-830b-b1ac-e053-2a95a90ac567	10135-728	HUMAN PRESCRIPTION DRUG	FLUPHENAZINE HYDROCHLORIDE		FLUPHENAZINE HYDROCHLORIDE	TABLET	ORAL	20210601		ANDA	ANDA214674	Marlex Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
10135-729_08164ff6-ecae-dedc-e063-6394a90add51	10135-729	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20210901		OTC MONOGRAPH DRUG	M013	Marlex Pharmaceuticals Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
10135-730_09bc0907-5c76-ce4f-e063-6294a90a5b6f	10135-730	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20220201		ANDA	ANDA213500	Marlex Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
10135-731_09bc0907-5c76-ce4f-e063-6294a90a5b6f	10135-731	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20220201		ANDA	ANDA213500	Marlex Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
10135-732_09bc0907-5c76-ce4f-e063-6294a90a5b6f	10135-732	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20220201		ANDA	ANDA213500	Marlex Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
10135-733_f5647029-c7b7-355c-e053-2995a90acb85	10135-733	HUMAN PRESCRIPTION DRUG	ATENOLOL AND CHLORTHALIDONE		atenolol and chlorthalidone tablet	TABLET	ORAL	20220301		ANDA	ANDA215560	MARLEX PHARMACEUTICALS, INC	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
10135-734_f5647029-c7b7-355c-e053-2995a90acb85	10135-734	HUMAN PRESCRIPTION DRUG	ATENOLOL AND CHLORTHALIDONE		atenolol and chlorthalidone tablet	TABLET	ORAL	20220301		ANDA	ANDA215560	MARLEX PHARMACEUTICALS, INC	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
10135-735_0bb4d596-372c-8d6f-e063-6394a90acbad	10135-735	HUMAN PRESCRIPTION DRUG	PYRAZINAMIDE		pyrazinamide tablet	TABLET	ORAL	20220301		ANDA	ANDA080157	MARLEX PHARMACEUTICALS, INC	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
10135-736_0a349bfa-bb74-ddb1-e063-6294a90a5772	10135-736	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	TOPICAL	20220601		ANDA	ANDA216250	Marlex Pharmaceuticals, Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
10135-737_f602e53a-57fd-20e1-e053-2a95a90a7812	10135-737	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA075352	Marlex Pharmaceuticals, Inc.	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
10135-738_f5f14f8b-5066-8471-e053-2995a90afce9	10135-738	HUMAN PRESCRIPTION DRUG	Rifabutin		Rifabutin	CAPSULE	ORAL	20220501		ANDA	ANDA215041	Marlex Pharmaceuticals, Inc.	RIFABUTIN	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
10135-739_f6035bc0-37e7-d517-e053-2a95a90aa03d	10135-739	HUMAN PRESCRIPTION DRUG	Tranylcypromine		Tranylcypromine	TABLET	ORAL	20220501		ANDA	ANDA206856	Marlex Pharmaceuticals, Inc.	TRANYLCYPROMINE SULFATE	10	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
10135-740_f573476f-731c-6b4e-e053-2995a90aff47	10135-740	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET	ORAL	20220501		ANDA	ANDA215562	Marlex Pharmaceuticals, Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
10135-741_f573476f-731c-6b4e-e053-2995a90aff47	10135-741	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET	ORAL	20220501		ANDA	ANDA215562	Marlex Pharmaceuticals, Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
10135-742_f573476f-731c-6b4e-e053-2995a90aff47	10135-742	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET	ORAL	20220501		ANDA	ANDA215562	Marlex Pharmaceuticals, Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
10135-743_ffd31d06-6014-34e2-e053-6394a90a437f	10135-743	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20220601		ANDA	ANDA073609	Marlex Pharmaceuticals, Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-744_ffd31d06-6014-34e2-e053-6394a90a437f	10135-744	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20220601		ANDA	ANDA073609	Marlex Pharmaceuticals, Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10135-745_f5f0e042-f033-4f3c-e053-2995a90a375f	10135-745	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220601		ANDA	ANDA076095	Marlex Pharmaceuticals, Inc.	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
10135-746_f5f0e042-f033-4f3c-e053-2995a90a375f	10135-746	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220601		ANDA	ANDA076095	Marlex Pharmaceuticals, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
10135-747_f5c3bd10-18a1-4e53-e053-2a95a90a1bfc	10135-747	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220601		ANDA	ANDA215307	Marlex Pharmaceuticals, Inc.	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
10135-748_f5c3bd10-18a1-4e53-e053-2a95a90a1bfc	10135-748	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220601		ANDA	ANDA215307	Marlex Pharmaceuticals, Inc.	DIGOXIN	.25	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
10135-751_0943e773-5f10-91f1-e063-6294a90a17f4	10135-751	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20220801		UNAPPROVED DRUG OTHER		Marlex Pharmaceuticals, Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10135-752_e7a6162b-35be-da65-e053-2a95a90a9c5a	10135-752	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220801		ANDA	ANDA071173	Marlex Pharmaceuticals, Inc.	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
10135-753_e7a6162b-35be-da65-e053-2a95a90a9c5a	10135-753	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220801		ANDA	ANDA071173	Marlex Pharmaceuticals, Inc.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
10135-754_e7a6162b-35be-da65-e053-2a95a90a9c5a	10135-754	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220801		ANDA	ANDA071173	Marlex Pharmaceuticals, Inc.	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
10135-755_e7a6162b-35be-da65-e053-2a95a90a9c5a	10135-755	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220801		ANDA	ANDA071173	Marlex Pharmaceuticals, Inc.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
10135-756_e7a6162b-35be-da65-e053-2a95a90a9c5a	10135-756	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220801		ANDA	ANDA071173	Marlex Pharmaceuticals, Inc.	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
10135-757_e7a6162b-35be-da65-e053-2a95a90a9c5a	10135-757	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220801		ANDA	ANDA071173	Marlex Pharmaceuticals, Inc.	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
10135-758_06e79465-1129-6806-e063-6394a90a2113	10135-758	HUMAN PRESCRIPTION DRUG	Doxepin		Doxepin	TABLET, FILM COATED	ORAL	20231001		ANDA	ANDA202337	Marlex Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
10135-762_08a1a524-4759-c7f7-e063-6294a90aa57f	10135-762	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20221001		ANDA	ANDA077498	Marlex Pharmaceuticals, Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10135-763_09bac992-802d-5dee-e063-6394a90a7e0d	10135-763	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20221001		ANDA	ANDA076134	Marlex Pharmaceuticals, Inc.	LORATADINE	10	mg/1			N	20241231
10135-764_06e79465-1129-6806-e063-6394a90a2113	10135-764	HUMAN PRESCRIPTION DRUG	Doxepin		Doxepin	TABLET, FILM COATED	ORAL	20231001		ANDA	ANDA202337	Marlex Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
10135-765_09bb313e-90cf-5629-e063-6294a90ac268	10135-765	HUMAN PRESCRIPTION DRUG	METOLAZONE		metolazone	TABLET	ORAL	20221201		ANDA	ANDA216216	Marlex Pharmaceuticals, Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
10135-766_09bb313e-90cf-5629-e063-6294a90ac268	10135-766	HUMAN PRESCRIPTION DRUG	METOLAZONE		metolazone	TABLET	ORAL	20221201		ANDA	ANDA216216	Marlex Pharmaceuticals, Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
10135-767_09bb313e-90cf-5629-e063-6294a90ac268	10135-767	HUMAN PRESCRIPTION DRUG	METOLAZONE		metolazone	TABLET	ORAL	20221201		ANDA	ANDA216216	Marlex Pharmaceuticals, Inc.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
10135-768_ffe781f1-cd81-3c62-e053-6394a90ad323	10135-768	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20221201		ANDA	ANDA205347	Marlex Pharmaceuticals, Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
10135-769_ffe781f1-cd81-3c62-e053-6394a90ad323	10135-769	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20221201		ANDA	ANDA205347	Marlex Pharmaceuticals, Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
10135-770_ffe781f1-cd81-3c62-e053-6394a90ad323	10135-770	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20221201		ANDA	ANDA205347	Marlex Pharmaceuticals, Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
10135-771_ffe781f1-cd81-3c62-e053-6394a90ad323	10135-771	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20221201		ANDA	ANDA205347	Marlex Pharmaceuticals, Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
10135-772_f5643d2a-b4f6-5b73-e053-2995a90a739d	10135-772	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20221201		ANDA	ANDA210588	Marlex Pharmaceuticals, Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
10135-773_f5643d2a-b4f6-5b73-e053-2995a90a739d	10135-773	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20221201		ANDA	ANDA210588	Marlex Pharmaceuticals, Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
10135-774_f45d31b8-5ba4-bf48-e053-2995a90a547b	10135-774	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230201		ANDA	ANDA215246	Marlex Pharmaceuticals, Inc.	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10135-775_f4991570-abe3-1515-e053-2a95a90a9e10	10135-775	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230201		ANDA	ANDA211575	Marlex Pharmaceuticals, Inc.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10135-776_f4991570-abe3-1515-e053-2a95a90a9e10	10135-776	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230201		ANDA	ANDA211575	Marlex Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10135-777_f4991570-abe3-1515-e053-2a95a90a9e10	10135-777	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230201		ANDA	ANDA211575	Marlex Pharmaceuticals, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10135-778_f4991570-abe3-1515-e053-2a95a90a9e10	10135-778	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230201		ANDA	ANDA211575	Marlex Pharmaceuticals, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10135-779_f4991570-abe3-1515-e053-2a95a90a9e10	10135-779	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230201		ANDA	ANDA211575	Marlex Pharmaceuticals, Inc.	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10135-780_09176b47-2c81-c8bb-e063-6394a90a70f0	10135-780	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20231001		ANDA	ANDA212378	Marlex Pharmaceuticals, Inc.	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
10135-781_09176b47-2c81-c8bb-e063-6394a90a70f0	10135-781	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20231001		ANDA	ANDA212378	Marlex Pharmaceuticals, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
10135-782_09176b47-2c81-c8bb-e063-6394a90a70f0	10135-782	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20231001		ANDA	ANDA212378	Marlex Pharmaceuticals, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
10135-783_0863f340-4c7f-379a-e063-6394a90a758d	10135-783	HUMAN OTC DRUG	Normal Salt		Sodium Chloride	TABLET	ORAL	20231001		OTC MONOGRAPH DRUG	505G(a)(3)	Marlex Pharmaceuticals, Inc.	SODIUM CHLORIDE	1	g/1			N	20241231
10135-786_0bb32ca5-c694-4f7a-e063-6294a90aa45b	10135-786	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20231101		OTC MONOGRAPH DRUG	M001	Marlex Pharmaceuticals Inc	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
10144-342_f2a3ac4a-132d-6200-e053-2995a90af649	10144-342	HUMAN PRESCRIPTION DRUG	Inbrija		levodopa	CAPSULE	RESPIRATORY (INHALATION)	20181222		NDA	NDA209184	Acorda Therapeutics, Inc.	LEVODOPA	42	mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
10144-427_f2f59273-db6b-464f-e053-2a95a90ac16b	10144-427	HUMAN PRESCRIPTION DRUG	AMPYRA		Dalfampridine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100301		NDA	NDA022250	Acorda Therapeutics, Inc.	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
10147-0150_0a474ead-d5be-5616-e063-6394a90ac05c	10147-0150	HUMAN PRESCRIPTION DRUG	itraconazole		itraconazole	SOLUTION	ORAL	19970221		NDA	NDA020657	Patriot Pharmaceuticals, LLC	ITRACONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
10147-0685_0b4ddbb9-76c9-d855-e063-6294a90aaacb	10147-0685	HUMAN PRESCRIPTION DRUG	methylphenidate Hydrochloride		methylphenidate hydrochloride	TABLET	ORAL	20000801	20250531	NDA	NDA021121	Patriot Pharmaceuticals, LLC.	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
10147-0686_0b4ddbb9-76c9-d855-e063-6294a90aaacb	10147-0686	HUMAN PRESCRIPTION DRUG	methylphenidate Hydrochloride		methylphenidate hydrochloride	TABLET	ORAL	20000801	20250831	NDA AUTHORIZED GENERIC	NDA021121	Patriot Pharmaceuticals, LLC.	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
10147-0687_0b4ddbb9-76c9-d855-e063-6294a90aaacb	10147-0687	HUMAN PRESCRIPTION DRUG	methylphenidate Hydrochloride		methylphenidate hydrochloride	TABLET	ORAL	20000801	20250430	NDA AUTHORIZED GENERIC	NDA021121	Patriot Pharmaceuticals, LLC.	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
10147-0688_0b4ddbb9-76c9-d855-e063-6294a90aaacb	10147-0688	HUMAN PRESCRIPTION DRUG	methylphenidate Hydrochloride		methylphenidate hydrochloride	TABLET	ORAL	20000801	20250430	NDA AUTHORIZED GENERIC	NDA021121	Patriot Pharmaceuticals, LLC.	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
10147-0921_a2f302b4-31f0-4192-bcf2-0ce0688379c1	10147-0921	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20110617		NDA AUTHORIZED GENERIC	NDA018701	Patriot Pharmaceuticals LLC	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
10147-0922_a2f302b4-31f0-4192-bcf2-0ce0688379c1	10147-0922	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20110617		NDA AUTHORIZED GENERIC	NDA018701	Patriot Pharmaceuticals LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
10147-0951_03226bfe-5d78-180f-e063-6294a90a5934	10147-0951	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20150924	20240831	NDA AUTHORIZED GENERIC	NDA021999	Patriot Pharmaceuticals, LLC	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	
10147-0952_03226bfe-5d78-180f-e063-6294a90a5934	10147-0952	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20150924	20240831	NDA AUTHORIZED GENERIC	NDA021999	Patriot Pharmaceuticals, LLC	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	
10147-0953_03226bfe-5d78-180f-e063-6294a90a5934	10147-0953	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20150924	20240831	NDA AUTHORIZED GENERIC	NDA021999	Patriot Pharmaceuticals, LLC	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	
10147-0954_03226bfe-5d78-180f-e063-6294a90a5934	10147-0954	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20150924	20240831	NDA AUTHORIZED GENERIC	NDA021999	Patriot Pharmaceuticals, LLC	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	
10147-1700_0a46f79c-9196-3aec-e063-6394a90a55d5	10147-1700	HUMAN PRESCRIPTION DRUG	itraconazole		ITRACONAZOLE	CAPSULE	ORAL	20050201		NDA	NDA020083	Patriot Pharmaceuticals	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
10148-201_fa2fce30-3172-6e10-e053-6294a90a1b5f	10148-201	HUMAN PRESCRIPTION DRUG	Miglustat		miglustat	CAPSULE	ORAL	20180425		NDA AUTHORIZED GENERIC	NDA021348	CoTherix, Inc.	MIGLUSTAT	100	mg/1	Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA]		N	20241231
10157-1006_bbb2a2ad-2f89-4a47-e053-2a95a90a1874	10157-1006	HUMAN OTC DRUG	Stridex	Maximum	Salicylic Acid	LIQUID	TOPICAL	20121201		OTC MONOGRAPH FINAL	part333D	Blistex Inc	SALICYLIC ACID	2	g/100mL			N	20241231
10157-1007_4e8874f9-4a83-4361-843b-196339d3821e	10157-1007	HUMAN OTC DRUG	Stridex	Sensitive	Salicylic Acid	LIQUID	TOPICAL	20121201		OTC MONOGRAPH FINAL	part333D	Blistex Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
10157-1119_ee878272-afcc-44fc-85d4-a4a450302f7c	10157-1119	HUMAN OTC DRUG	Blistex Medicated Lip Balm		DIMETHICONE, OCTINOXATE, and OCTISALATE	STICK	TOPICAL	20180115		OTC MONOGRAPH FINAL	part347	Blistex Inc	DIMETHICONE; OCTINOXATE; OCTISALATE	2; 6.6; 4.4	g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10157-1120_c59736f5-3b83-491b-94cb-bbec833fca92	10157-1120	HUMAN OTC DRUG	Blistex Medicated Mint Balm		DIMETHICONE, OCTINOXATE, and OCTISALATE	STICK	TOPICAL	20180115		OTC MONOGRAPH FINAL	part347	Blistex Inc	DIMETHICONE; OCTINOXATE; OCTISALATE	2; 6.6; 4.4	g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10157-1121_eee3e3bd-f924-4ad1-a6df-c3f4bab71c94	10157-1121	HUMAN OTC DRUG	Blistex Medicated Berry Balm		Dimethicone, Octinoxate, and Octisalate	STICK	TOPICAL	20180115		OTC MONOGRAPH FINAL	part347	Blistex Inc	DIMETHICONE; OCTINOXATE; OCTISALATE	2; 6.6; 4.4	g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10157-1170_b82f3bc5-e80d-41e2-9c47-33cd74655829	10157-1170	HUMAN OTC DRUG	Deep Renewal Broad Spectrum		dimethicone, avobenzone, homosalate, and octisalate	STICK	TOPICAL	20200909		OTC MONOGRAPH FINAL	part347	Blistex Inc	AVOBENZONE; DIMETHICONE; HOMOSALATE; OCTISALATE	3; 2; 9; 4.4	g/100g; g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10157-1171_7f00e804-2e2b-4dbf-8ceb-9e526785046a	10157-1171	HUMAN OTC DRUG	Blistex	Five Star Lip Protection Broad Spectrum	Homosalate, Octisalate, Avobenzone, and Dimethicone	STICK	TOPICAL	20200822		OTC MONOGRAPH FINAL	part352	Blistex Inc.	AVOBENZONE; DIMETHICONE; HOMOSALATE; OCTISALATE	3; 2; 15; 5	g/100g; g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10157-1189_fa68c43d-9947-4455-9182-380cdc9c8a77	10157-1189	HUMAN OTC DRUG	Repair and Protect		Petrolatum	STICK	TOPICAL	20230705		OTC MONOGRAPH FINAL	part347	Blistex Inc.	PETROLATUM	45	g/100g			N	20241231
10157-2100_e6d6628b-6f9f-42c6-9f8d-1513c1a186fe	10157-2100	HUMAN OTC DRUG	Blistex Ivarest Poison Ivy Itch		Zinc Acetate and PRAMOXINE HYDROCHLORIDE	SPRAY	TOPICAL	20150202		OTC MONOGRAPH FINAL	part347	Blistex Inc.	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	1; .12	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10157-2103_a6a8c255-ec4c-412b-8243-bccc63b231b2	10157-2103	HUMAN OTC DRUG	Tucks Medicated Cooling Pads		WITCH HAZEL	SOLUTION	TOPICAL	20160830		OTC MONOGRAPH FINAL	part346	Blistex Inc	WITCH HAZEL	500	mg/mL			N	20241231
10157-2106_63ce9e63-4c32-40c4-a18e-3daae1860150	10157-2106	HUMAN OTC DRUG	KANKA	SoftBrush	Benzocaine and ZINC CHLORIDE	GEL	ORAL	20190925		OTC MONOGRAPH NOT FINAL	part356	Blistex Inc	BENZOCAINE; ZINC CHLORIDE	20; .1	mg/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10157-2112_9c1667a8-e898-4da8-b09c-73bdbe2dcff5	10157-2112	HUMAN OTC DRUG	Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count)		GLYCERIN, LIDOCAINE, and WITCH HAZEL	KIT		20190215		OTC MONOGRAPH FINAL	part346	Blistex Inc						N	20241231
10157-2114_2b3549eb-298e-4ceb-8dfa-548596a03937	10157-2114	HUMAN OTC DRUG	Stridex XL Face and Body Pads		Salicylic Acid	LIQUID	TOPICAL	20200920		OTC MONOGRAPH FINAL	part333D	Blistex Inc	SALICYLIC ACID	2	g/100mL			N	20241231
10157-2119_653d0773-db3e-40d6-871f-896aa69577e4	10157-2119	HUMAN OTC DRUG	Stridex Essential		Salicylic Acid	LIQUID	TOPICAL	20221206		OTC MONOGRAPH FINAL	part333D	Blistex Inc	SALICYLIC ACID	1	g/100mL			N	20241231
10157-4645_0e7d57aa-4f70-48ce-8479-aff4d0c01833	10157-4645	HUMAN OTC DRUG	Blistex	Odor-Eaters Powder	Tolnaftate	SPRAY	TOPICAL	20131209		OTC MONOGRAPH FINAL	part333C	Blistex Inc	TOLNAFTATE	1	g/100g			N	20241231
10157-8407_b988c63d-b5c3-49ce-b87b-6a20fafb4b49	10157-8407	HUMAN OTC DRUG	Blistex Lip Medex		PETROLATUM, MENTHOL, UNSPECIFIED FORM, CAMPHOR (SYNTHETIC), and PHENOL	PASTE	TOPICAL	20170328		OTC MONOGRAPH NOT FINAL	part348	Blistex Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	1; 1; 59.14; .6	g/100g; g/100g; g/100g; g/100g			N	20241231
10157-9077_25cfcb6e-4432-4cbd-936e-0d0d3c39d0f5	10157-9077	HUMAN OTC DRUG	Ivarest		Zinc Oxide, Benzyl Alcohol, and Diphenhydramine Hydrochloride	CREAM	TOPICAL	20071231		OTC MONOGRAPH FINAL	part347	Blistex Inc	BENZYL ALCOHOL; DIPHENHYDRAMINE HYDROCHLORIDE; ZINC OXIDE	10.5; 2; 14	g/100g; g/100g; g/100g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Pediculicide [EPC]		N	20241231
10157-9302_3722476b-f75e-43af-b09b-afe4c28857fb	10157-9302	HUMAN OTC DRUG	Blistex	Foille Medicated First Aid	Benzocaine and Chloroxylenol	OINTMENT	TOPICAL	20130305		OTC MONOGRAPH NOT FINAL	part348	Blistex Inc.	BENZOCAINE; CHLOROXYLENOL	5; .1	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10157-9477_25efaeae-7405-47f6-9db1-9f15106ced37	10157-9477	HUMAN OTC DRUG	Kank-A	Mouth Pain	Benzocaine	LIQUID	BUCCAL	20111201		OTC MONOGRAPH FINAL	part346	Blistex Inc.	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10157-9908_7065c334-5edb-4040-8ec7-1ef4c192683f	10157-9908	HUMAN OTC DRUG	Blistex Medicated Lip Balm Variety Pack (Blistex Medicated Berry Lip Balm, Blistex Medicated Lip Balm, Blistex Medicated Mint Lip Balm)		Dimethicone, Octinoxate, and Octisalate	KIT		20200203		OTC MONOGRAPH FINAL	part347	Blistex Inc						N	20241231
10157-9910_8a5f40a4-cf7e-43b5-a08d-c9939294d57f	10157-9910	HUMAN OTC DRUG	Blistex Medicated Lip Balm Variety Pack (Blistex Medicated Berry Lip Balm, Blistex Medicated Lip Balm, Blistex Medicated Lip)		Dimethicone, Octinoxate, Octisalate, Camphor (Synthetic), Menthol, Unspecified Form, and Phenol	KIT		20200203		OTC MONOGRAPH FINAL	part347	Blistex Inc						N	20241231
10157-9951_9d89ac76-989e-43ee-9c2c-9da499cd4224	10157-9951	HUMAN OTC DRUG	Blistex	Medicated	Dimethicone, Camphor (synthetic), Menthol, and Phenol	OINTMENT	TOPICAL	20001201		OTC MONOGRAPH NOT FINAL	part348	Blistex Inc.	CAMPHOR (SYNTHETIC); DIMETHICONE; MENTHOL, UNSPECIFIED FORM; PHENOL	.5; 1.1; .625; .5	g/100g; g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10167-100_d0e7bc94-7c88-4c73-8cb9-60d4c8c7c38e	10167-100	HUMAN PRESCRIPTION DRUG	OXYGEN		0XYGEN	GAS	RESPIRATORY (INHALATION)	19920101		NDA	NDA205865	Air Source Industries Inc	OXYGEN	99	L/100L			N	20241231
10167-200_918eeadb-7863-42e4-a72e-295f9a1537e4	10167-200	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19920101		NDA	NDA206009	Air Source Industries	NITROUS OXIDE	99	L/100L			N	20241231
10167-300_d0dbdda5-fdd2-47fb-b332-ea5c38ef6b6c	10167-300	HUMAN PRESCRIPTION DRUG	HELIUM		HELIUM	GAS	RESPIRATORY (INHALATION)	19920101		NDA	NDA205843	Air Source Industries Inc	HELIUM	99	L/100L			N	20241231
10167-400_4b83e657-78e3-48a8-a468-b17993193b0f	10167-400	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19920101		NDA	NDA205866	Air Source Industries Inc	NITROGEN	99	L/100L			N	20241231
10167-500_d6a09707-43cc-448a-b6b8-9f45467dfc49	10167-500	HUMAN PRESCRIPTION DRUG	CARBON DIOXIDE		CARBON DIOXIDE	GAS	RESPIRATORY (INHALATION)	19920101		NDA	NDA205764	Air Source Industries Inc	CARBON DIOXIDE	99	L/100L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
10167-600_48776d7c-7085-4150-9856-7b4324dffb99	10167-600	HUMAN PRESCRIPTION DRUG	AIR COMPRESSED		AIR COMPRESSED	GAS	RESPIRATORY (INHALATION)	19920101		NDA	NDA205865	Air Source Industries	OXYGEN	20	L/100L			N	20241231
10189-001_0711e7af-5df6-3940-e063-6394a90a4816	10189-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19730601		NDA	NDA205767	Butler Gas Products Company	OXYGEN	990	mL/L			N	20241231
10191-1033_f65aab22-9b32-a09d-e053-2995a90a6456	10191-1033	HUMAN PRESCRIPTION DRUG	CODEINUM		CODEINE	PELLET	SUBLINGUAL	20150716		UNAPPROVED HOMEOPATHIC		Remedy Makers	CODEINE ANHYDROUS	3	[hp_X]/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10191-1034_f65ab6c0-1910-f6d5-e053-2995a90a34c2	10191-1034	HUMAN PRESCRIPTION DRUG	CODEINUM		CODEINE	PELLET	SUBLINGUAL	20150710		UNAPPROVED HOMEOPATHIC		Remedy Makers	CODEINE ANHYDROUS	6	[hp_X]/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10191-1035_f65aab22-9b36-a09d-e053-2995a90a6456	10191-1035	HUMAN PRESCRIPTION DRUG	CODEINUM		CODEINE	PELLET	SUBLINGUAL	20150714		UNAPPROVED HOMEOPATHIC		Remedy Makers	CODEINE ANHYDROUS	9	[hp_X]/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10191-1036_f65aab22-9b34-a09d-e053-2995a90a6456	10191-1036	HUMAN PRESCRIPTION DRUG	CODEINUM		CODEINE	PELLET	SUBLINGUAL	20150715		UNAPPROVED HOMEOPATHIC		Remedy Makers	CODEINE ANHYDROUS	12	[hp_X]/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10191-1037_f65aadda-613c-669f-e053-2a95a90a817a	10191-1037	HUMAN PRESCRIPTION DRUG	CODEINUM		CODEINE	PELLET	SUBLINGUAL	20150716		UNAPPROVED HOMEOPATHIC		Remedy Makers	CODEINE ANHYDROUS	15	[hp_X]/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10191-1038_f65aadda-613a-669f-e053-2a95a90a817a	10191-1038	HUMAN PRESCRIPTION DRUG	CODEINUM		CODEINE	PELLET	SUBLINGUAL	20150717		UNAPPROVED HOMEOPATHIC		Remedy Makers	CODEINE ANHYDROUS	30	[hp_X]/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10191-1081_f65aaf54-bcd1-50a9-e053-2995a90a9042	10191-1081	HUMAN PRESCRIPTION DRUG	OPIUM		Raw Opium Gum	PELLET	SUBLINGUAL	20150521		UNAPPROVED HOMEOPATHIC		Remedy Makers	OPIUM	3	[hp_X]/1		CII	N	20241231
10191-1082_f65aadda-613e-669f-e053-2a95a90a817a	10191-1082	HUMAN PRESCRIPTION DRUG	OPIUM		Raw Opium Gum	PELLET	SUBLINGUAL	20150706		UNAPPROVED HOMEOPATHIC		Remedy Makers	OPIUM	6	[hp_X]/1		CII	N	20241231
10191-1086_f65ab906-3671-631d-e053-2a95a90a7b05	10191-1086	HUMAN PRESCRIPTION DRUG	OPIUM		Raw Opium Gum	PELLET	SUBLINGUAL	20150708		UNAPPROVED HOMEOPATHIC		Remedy Makers	OPIUM	30	[hp_X]/1		CII	N	20241231
10191-1089_f65aadda-613d-669f-e053-2a95a90a817a	10191-1089	HUMAN PRESCRIPTION DRUG	OPIUM		Raw Opium Gum	PELLET	SUBLINGUAL	20150709		UNAPPROVED HOMEOPATHIC		Remedy Makers	OPIUM	6	[hp_C]/1		CII	N	20241231
10191-1242_f721c1ed-7d0b-5d7a-e053-6394a90a0bc3	10191-1242	HUMAN OTC DRUG	ARNICA MONTANA		WHOLE ARNICA PLANT	PELLET	SUBLINGUAL	20030806		UNAPPROVED HOMEOPATHIC		Remedy Makers	ARNICA MONTANA	6	[hp_X]/1			N	20241231
10191-1249_f72108d4-d5e3-2c4f-e053-6394a90a584b	10191-1249	HUMAN OTC DRUG	ARNICA MONTANA WHOLE PLANT		(WHOLE PLANT)	PELLET	SUBLINGUAL	20050824		UNAPPROVED HOMEOPATHIC		Remedy Makers	ARNICA MONTANA	6	[hp_C]/1			N	20241231
10191-1253_f70ab9d6-7a47-4fca-e053-6294a90ae18a	10191-1253	HUMAN OTC DRUG	ARNICA MONTANA WHOLE PLANT		WHOLE ARNICA PLANT	PELLET	SUBLINGUAL	20040706		UNAPPROVED HOMEOPATHIC		Remedy Makers	ARNICA MONTANA	30	[hp_C]/1			N	20241231
10191-1255_f7984dd0-4cdc-ef02-e053-6394a90a5a60	10191-1255	HUMAN OTC DRUG	ARNICA MONTANA (Whole Plant)		ARNICA WHOLE PLANT	PELLET	SUBLINGUAL	20020821		UNAPPROVED HOMEOPATHIC		Remedy Makers	ARNICA MONTANA	20	[hp_M]/1			N	20241231
10191-6374_f7844666-9d66-2c00-e053-6294a90aee29	10191-6374	HUMAN OTC DRUG	Cannabis Sativa		Cannabis Sativa	LIQUID	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Remedy Makers	CANNABIS SATIVA FLOWERING TOP	1	[hp_X]/30mL	Cannabinoids [CS], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20241231
10202-001_09453bf6-92ae-4aa6-e063-6294a90a62b2	10202-001	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20110223		OTC MONOGRAPH DRUG	505G(a)(3)	7-Eleven, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
10202-002_09453bf6-92bd-4aa6-e063-6294a90a62b2	10202-002	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20110203		OTC MONOGRAPH DRUG	505G(a)(3)	7-Eleven, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
10202-020_08f35d52-c2da-6184-e063-6394a90a05e4	10202-020	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20160728		OTC MONOGRAPH DRUG	M012	7-Eleven Inc.	MENTHOL	5.4	mg/1			N	20241231
10202-021_08f368a3-1c76-0bc3-e063-6294a90ad1a9	10202-021	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20150804		OTC MONOGRAPH DRUG	M012	7-Eleven Inc.	MENTHOL	5.8	mg/1			N	20241231
10202-022_08f386aa-23ae-5b18-e063-6294a90a2997	10202-022	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20150804		OTC MONOGRAPH DRUG	M012	7-Eleven Inc.	MENTHOL	7.5	mg/1			N	20241231
10202-069_b7c3909b-6d0c-410f-be2d-a096a3b88918	10202-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20211028		OTC MONOGRAPH FINAL	part347	7-Select	PETROLATUM	1	g/g			N	20241231
10202-107_2ed736e7-722d-2208-fb92-56067e451266	10202-107	HUMAN OTC DRUG	Allergy		Fexofenadine hydrochloride	TABLET	ORAL	20191115		ANDA	ANDA076502	7-Eleven	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10202-150_e9e24999-3c88-4bd0-9207-9852d79a173e	10202-150	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20220328		ANDA	ANDA209179	7-Eleven	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
10202-229_d5914c05-e8db-4c79-82d0-a279d1304118	10202-229	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20150115		ANDA	ANDA202039	7-eleven	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10202-400_eebacd0e-60aa-0dfe-e053-2995a90ac6c4	10202-400	HUMAN OTC DRUG	24 7 life by 7 Eleven	Instant Hand Sanitizer	ethyl alcohol	GEL	TOPICAL	20221117		OTC MONOGRAPH NOT FINAL	part333E	7-Eleven	ALCOHOL	70	mL/100mL			N	20241231
10202-401_f54e8507-00a7-8ac9-e053-2995a90a0a89	10202-401	HUMAN OTC DRUG	24 7 life by 7 Eleven	Hand Wipes	Benzalkonium chloride	CLOTH	TOPICAL	20230220		OTC MONOGRAPH NOT FINAL	part333E	7-Eleven	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
10202-664_3e348b70-863a-4278-9807-ea06753e0f6d	10202-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20160413		OTC MONOGRAPH NOT FINAL	part356	7-Eleven	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
10202-711_6d38fa0c-748e-4aba-8ce1-f9c6a750a8c1	10202-711	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20190506		ANDA	ANDA209179	7-Eleven	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
10202-722_d9c2719b-9650-41da-8ad4-085852934eeb	10202-722	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	7-Eleven	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
10202-740_ef8c1b84-ec9b-4353-8fc6-5ef50270ef5a	10202-740	HUMAN OTC DRUG	7 Select	Maximum Strength	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20190325		OTC MONOGRAPH FINAL	part341	7-ELEVEN	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
10202-850_efe55d57-b239-78f5-e053-2995a90a946a	10202-850	HUMAN OTC DRUG	7 Select Redness Relief		Glycerin and Naphazoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20170328		OTC MONOGRAPH FINAL	part349	7-Select, Inc	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.0025; .00012	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
10202-853_efceca57-21d7-6879-e053-2a95a90a8cbb	10202-853	HUMAN OTC DRUG	7 Select Oral Pain Maximum Strength Relief		Benzocaine	GEL	TOPICAL	20161208		OTC MONOGRAPH NOT FINAL	part356	7-ELEVEN, INC.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10202-939_868fafb5-277b-4231-b979-50909f19b943	10202-939	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20190731		ANDA	ANDA077498	7-ELEVEN	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10202-943_bc43a271-5218-103c-e053-2995a90add44	10202-943	HUMAN OTC DRUG	7-Select Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	7-11	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
10202-950_baffb55e-5253-d9bc-e053-2995a90a673c	10202-950	HUMAN OTC DRUG	7-Select After Sun Lidicaine HCl Pain-Relieving with Aloe Vera		Lidocaine Hydrochloride	GEL	TOPICAL	20190221		OTC MONOGRAPH NOT FINAL	part348	7-11	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
10202-951_d5660efc-8857-0560-e053-2995a90af7ca	10202-951	HUMAN OTC DRUG	7 Select Sport SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20181217		OTC MONOGRAPH NOT FINAL	part352	7-11	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
10210-0013_08883535-879b-c510-e063-6294a90a33ac	10210-0013	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Orange Dream SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	7.5; 4	g/100g; g/100g			N	20241231
10210-0014_088814d3-a2fe-3f58-e063-6294a90a14d3	10210-0014	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Tropical Colada SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	7.5; 4	g/100g; g/100g			N	20241231
10210-0015_08883535-87b9-c510-e063-6294a90a33ac	10210-0015	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Honey Dew Melon SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	7.5; 4	g/100g; g/100g			N	20241231
10210-0016_08883535-87aa-c510-e063-6294a90a33ac	10210-0016	HUMAN OTC DRUG	Carmex Daily Care moisturizing Lip Balm Winter Mint SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	7.5; 4	g/100g; g/100g			N	20241231
10210-0017_08883637-b87b-23dc-e063-6394a90ae9f7	10210-0017	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm SPF 15		OCTINOXATE, OXYBENZONE	KIT		20160926		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0022_03764137-c60e-71ae-e063-6294a90a8036	10210-0022	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated		CAMPHOR (SYNTHETIC), PETROLATUM	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M017	Carma Laboratories, Inc.	CAMPHOR (SYNTHETIC); WHITE PETROLATUM	1.7; 45.3	g/100g; g/100g			N	20241231
10210-0023_088825e1-7f9e-23b3-e063-6394a90a58db	10210-0023	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated SPF 15		OCTINOXATE, OXYBENZONE, PETROLATUM	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE; WHITE PETROLATUM	7.5; 4; 35	g/100g; g/100g; g/100g			N	20241231
10210-0027_08883b69-70eb-fc20-e063-6394a90a089b	10210-0027	HUMAN OTC DRUG	CARMEX COLD SORE treatment External Analgesic Skin Protectant		BENZOCAINE, WHITE PETROLATUM	CREAM	TOPICAL	20170302		OTC MONOGRAPH DRUG	M017	Carma Laboratories, Inc.	BENZOCAINE; WHITE PETROLATUM	100; 459	mg/g; mg/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
10210-0028_0888635b-1cfd-7902-e063-6394a90a339f	10210-0028	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Fresh Cherry SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20190131		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	75; 40	mg/g; mg/g			N	20241231
10210-0029_088814d3-a2d1-3f58-e063-6294a90a14d3	10210-0029	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Fresh Cherry SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20190520		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	75; 40	mg/g; mg/g			N	20241231
10210-0030_0885ed46-441d-fc87-e063-6294a90a383c	10210-0030	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Cupcake Batter SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20180620		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	75; 40	mg/g; mg/g			N	20241231
10210-0031_08881ca4-9f85-3c27-e063-6294a90a0233	10210-0031	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Strawberry SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20170705		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	75; 40	mg/g; mg/g			N	20241231
10210-0032_0888635b-1d0e-7902-e063-6394a90a339f	10210-0032	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Strawberry SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20170712		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	75; 40	mg/g; mg/g			N	20241231
10210-0033_0da943c7-e1e9-d090-e063-6294a90a07cc	10210-0033	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Wintergreen SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20180620		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	75; 40	mg/g; mg/g			N	20241231
10210-0037_0da9a869-4508-0128-e063-6294a90a79f5	10210-0037	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Wintergreen SPF 15		OCTINOXATE, OXYBENZONE	SALVE	TOPICAL	20200331		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	OCTINOXATE; OXYBENZONE	75; 40	mg/g; mg/g			N	20241231
10210-0038_0888635b-1d1f-7902-e063-6394a90a339f	10210-0038	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated		CAMPHOR (SYNTHETIC), WHITE PETROLATUM	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M017	Carma Laboratories, Inc.	CAMPHOR (SYNTHETIC); WHITE PETROLATUM	17; 453	mg/g; mg/g			N	20241231
10210-0039_088887f7-e00a-d47a-e063-6294a90a00df	10210-0039	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated		CAMPHOR (SYNTHETIC), WHITE PETROLATUM	SALVE	TOPICAL	20160926		OTC MONOGRAPH DRUG	M017	Carma Laboratories, Inc.	CAMPHOR (SYNTHETIC); WHITE PETROLATUM	17; 453	mg/g; mg/g			N	20241231
10210-0040_08886dde-ea9a-9dcb-e063-6394a90ad685	10210-0040	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm SPF 15 Minis		OCTINOXATE, OXYBENZONE	KIT		20201105		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0041_08883637-b88e-23dc-e063-6394a90ae9f7	10210-0041	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm SPF 15 Assorted		OCTINOXATE, OXYBENZONE	KIT		20190131		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0042_08883b69-70fa-fc20-e063-6394a90a089b	10210-0042	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm SPF 15 Assorted		OCTINOXATE, OXYBENZONE	KIT		20190131		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0043_088872f1-194d-a108-e063-6394a90adbfb	10210-0043	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Free Wintergreen and Fresh Cherry SPF 15		OCTINOXATE, OXYBENZONE	KIT		20190131		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0044_08887b7e-fe74-6a95-e063-6294a90a3140	10210-0044	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Favorites SPF 15		OCTINOXATE, OXYBENZONE	KIT		20190131		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0046_08883637-b8b8-23dc-e063-6394a90ae9f7	10210-0046	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Sweets SPF 15		OCTINOXATE, OXYBENZONE	KIT		20190131		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0047_0c054552-a2c8-d30b-e063-6294a90ac293	10210-0047	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Free Wintergreen Stick		OCTINOXATE, OXYBENZONE, CAMPHOR (SYNTHETIC), WHITE PETROLATUM	KIT		20180620		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0048_08883637-b8d6-23dc-e063-6394a90ae9f7	10210-0048	HUMAN OTC DRUG	CARMEX Multi-Symptom 3 in 1 COLD Sore treatment External Analgesic Skin Protectant		BENZOCAINE, WHITE PETROLATUM	CREAM	TOPICAL	20200701		OTC MONOGRAPH DRUG	M017	Carma Laboratories, Inc.	BENZOCAINE; WHITE PETROLATUM	100; 446.9	mg/g; mg/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
10210-0049_088887f7-e01a-d47a-e063-6294a90a00df	10210-0049	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Holiday SPF 15		OCTINOXATE, OXYBENZONE	KIT	TOPICAL	20190131		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0053_0975eb87-faa2-1621-e063-6394a90a9880	10210-0053	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Triple Force Formula		WHITE PETROLATUM	SALVE	TOPICAL	20230101		OTC MONOGRAPH DRUG	M016B	Carma Laboratories, Inc.	WHITE PETROLATUM	412.5	mg/g			N	20241231
10210-0054_09759b68-4c01-c41f-e063-6294a90a62a4	10210-0054	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Triple Force Formula		WHITE PETROLATUM	SALVE	TOPICAL	20230101		OTC MONOGRAPH DRUG	M016B	Carma Laboratories, Inc.	WHITE PETROLATUM	453	mg/g			N	20241231
10210-0055_0976085c-9b8a-3792-e063-6394a90a58c5	10210-0055	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Lip Protectant		WHITE PETROLATUM	SALVE	TOPICAL	20230101		OTC MONOGRAPH DRUG	M016B	Carma Laboratories, Inc.	WHITE PETROLATUM	453	mg/g			N	20241231
10210-0056_0885d6ac-3f56-dc8f-e063-6394a90a28de	10210-0056	HUMAN OTC DRUG	Carmex Weather Guard Moisturizing Lip Balm SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, WHITE PETROLATUM	SALVE	TOPICAL	20230223		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; WHITE PETROLATUM	30; 100; 50; 90; 310	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
10210-0057_088814d3-a2e3-3f58-e063-6294a90a14d3	10210-0057	HUMAN OTC DRUG	Carmex 10 Count Variety Pack SPF 15 Sunscreen		OCTINOXATE, OXYBENZONE, PETROLATUM	KIT		20230101		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0058_0375d681-7c20-2cc1-e063-6394a90ac82c	10210-0058	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Free Cupcake Batter Stick Sunscreen SPF 15		CAMPHOR (SYNTHETIC), PETROLATUM	KIT		20230101		OTC MONOGRAPH DRUG	M016	Carma Laboratories, Inc.						N	20241231
10210-0059_08881ca4-9f97-3c27-e063-6294a90a0233	10210-0059	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Free Cupcake Batter Stick Sunscreen SPF 15		OCTINOXATE, OXYBENZONE, WHITE PETROLATUM	KIT		20230101		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0060_0bc667c5-364c-6ba3-e063-6394a90a4ec3	10210-0060	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Free Cupcake Batter Stick Sunscreen SPF 15		CAMPHOR (SYNTHETIC), WHITE PETROLATUM, OCTINOXATE, OXYBENZONE	KIT		20230101		OTC MONOGRAPH DRUG	M016	Carma Laboratories, Inc.						N	20241231
10210-0061_0bc75804-ae89-3df1-e063-6294a90ac293	10210-0061	HUMAN OTC DRUG	Carmex Classic Lip Balm Medicated Free Strawberry Stick Sunscreen SPF 15		CAMPHOR (SYNTHETIC), WHITE PETROLATUM, OCTINOXATE, OXYBENZONE	KIT		20221022		OTC MONOGRAPH DRUG	M016	Carma Laboratories, Inc.						N	20241231
10210-0062_08883637-b85e-23dc-e063-6394a90ae9f7	10210-0062	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Free Cupcake Batter Stick Sunscreen SPF 15		OCTINOXATE, OXYBENZONE	KIT		20230101		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0063_08883b69-70dc-fc20-e063-6394a90a089b	10210-0063	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm Sunscreen SPF 15		OCTINOXATE, OXYBENZONE	KIT		20230101		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0064_08884106-3dfd-cf63-e063-6394a90ab094	10210-0064	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm with Free Cupcake Batter Stick Sunscreen SPF 15		OCTINOXATE, OXYBENZONE	KIT		20230825		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10210-0065_08883637-b86d-23dc-e063-6394a90ae9f7	10210-0065	HUMAN OTC DRUG	Carmex Daily Care Moisturizing Lip Balm SPF 15 Sunscreen Minis		OCTINOXATE, OXYBENZONE	KIT		20210811		OTC MONOGRAPH DRUG	M020	Carma Laboratories, Inc.						N	20241231
10218-001_0801db1a-6a28-c572-e063-6394a90a00a1	10218-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19970405		NDA	NDA205767	CEE-KAY SUPPLY, INC.	OXYGEN	995	mL/L			N	20241231
10218-003_0801cd99-a4b1-262a-e063-6394a90ae99a	10218-003	HUMAN PRESCRIPTION DRUG	Air		Breathing Air	GAS	RESPIRATORY (INHALATION)	20050801		NDA	NDA207036	Cee-Kay Supply, Inc.	AIR	100	L/100L			N	20241231
10218-102_0801ed0c-babe-8311-e063-6394a90adca7	10218-102	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19970405		NDA	NDA205766	CEE-KAY SUPPLY, INC.	NITROGEN	995	mL/L			N	20241231
10221-001_814525c4-46da-4a49-8d7e-b65914f0ab16	10221-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19690101		NDA	NDA205849	Central-McGowan, Inc.	OXYGEN	992	mL/L			N	20241231
10221-002_b394a746-41ea-48e8-8efa-f95c0aab323f	10221-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20140201		NDA	NDA205850	Central-McGowan, Inc.	NITROGEN	99	L/100L			N	20241231
10223-0201_ac4f8056-7c1b-461f-86c3-f5e44cbe4249	10223-0201	HUMAN PRESCRIPTION DRUG	Cetacaine Anesthetic		Benzocaine, Butamben, and Tetracaine Hydrochloride	AEROSOL, SPRAY	TOPICAL	19580101		UNAPPROVED DRUG OTHER		Cetylite Industries, Inc.	BENZOCAINE; BUTAMBEN; TETRACAINE HYDROCHLORIDE	.028; .004; .004	g/.2g; g/.2g; g/.2g	Allergens [CS], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
10223-0202_019d3010-af34-465c-b6b0-f89b5eaec099	10223-0202	HUMAN PRESCRIPTION DRUG	Cetacaine Anesthetic		Benzocaine, Butamben, and Tetracaine Hydrochloride	SOLUTION	TOPICAL	19600101		UNAPPROVED DRUG OTHER		Cetylite Industries, Inc.	BENZOCAINE; BUTAMBEN; TETRACAINE HYDROCHLORIDE	.028; .004; .004	g/.2g; g/.2g; g/.2g	Allergens [CS], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
10223-0217_5e116134-85fa-4b04-9795-d55a361b07de	10223-0217	HUMAN PRESCRIPTION DRUG	Cetacaine Topical Anesthetic		Benzocaine, Butamben, and Tetracaine Hydrochloride	GEL	TOPICAL	19600101		UNAPPROVED DRUG OTHER		Cetylite Industries, Inc.	BENZOCAINE; BUTAMBEN; TETRACAINE HYDROCHLORIDE	.028; .004; .004	g/.2g; g/.2g; g/.2g	Allergens [CS], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
10223-0221_5e116134-85fa-4b04-9795-d55a361b07de	10223-0221	HUMAN PRESCRIPTION DRUG	Cetacaine Topical Anesthetic		Benzocaine, Butamben, and Tetracaine Hydrochloride	GEL	TOPICAL	19600101		UNAPPROVED DRUG OTHER		Cetylite Industries, Inc.	BENZOCAINE; BUTAMBEN; TETRACAINE HYDROCHLORIDE	.028; .004; .004	g/.2g; g/.2g; g/.2g	Allergens [CS], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
10223-0225_019d3010-af34-465c-b6b0-f89b5eaec099	10223-0225	HUMAN PRESCRIPTION DRUG	Cetacaine Anesthetic		Benzocaine, Butamben, and Tetracaine Hydrochloride	SOLUTION	TOPICAL	19600101		UNAPPROVED DRUG OTHER		Cetylite Industries, Inc.	BENZOCAINE; BUTAMBEN; TETRACAINE HYDROCHLORIDE	.028; .004; .004	g/.2g; g/.2g; g/.2g	Allergens [CS], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
10223-0226_019d3010-af34-465c-b6b0-f89b5eaec099	10223-0226	HUMAN PRESCRIPTION DRUG	Cetacaine Anesthetic		Benzocaine, Butamben, and Tetracaine Hydrochloride	SOLUTION	TOPICAL	19600101		UNAPPROVED DRUG OTHER		Cetylite Industries, Inc.	BENZOCAINE; BUTAMBEN; TETRACAINE HYDROCHLORIDE	.028; .004; .004	g/.2g; g/.2g; g/.2g	Allergens [CS], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-001_2838de8c-99d6-4edc-9c67-891773b1352d	10237-001	HUMAN OTC DRUG	Hero Pore Release Blackhead Clearing		Salicylic Acid	LIQUID	TOPICAL	20230701		OTC MONOGRAPH FINAL	part333D	Church & Dwight Co., Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
10237-004_420a0687-9abf-4a80-9795-8617708ef487	10237-004	HUMAN OTC DRUG	Hero Force Shield Superbeam Sunscreen SPF 30 Apricot		Zinc Oxide	LOTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	Church & Dwight Co., Inc.	ZINC OXIDE	175.3	mg/mL			N	20241231
10237-200_16509103-3382-4a47-a041-16a1594af0a9	10237-200	HUMAN OTC DRUG	Trojan Extended Pleasure		Benzocaine	SPRAY	TOPICAL	20210427		OTC MONOGRAPH FINAL	part333B	Church and Dwight Co., Inc.	BENZOCAINE	4.5	g/60mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-255_8cc2573d-ab5c-465f-a943-ffd399450c80	10237-255	HUMAN OTC DRUG	TheraBreath for Kids Anticavity Wacky Watermelon		SODIUM FLUORIDE	RINSE	ORAL	20230101		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	.5	mg/mL			N	20241231
10237-256_8cc2573d-ab5c-465f-a943-ffd399450c80	10237-256	HUMAN OTC DRUG	TheraBreath for Kids Anticavity Strawberry Splash		SODIUM FLUORIDE	RINSE	ORAL	20230101		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	.5	mg/mL			N	20241231
10237-257_8cc2573d-ab5c-465f-a943-ffd399450c80	10237-257	HUMAN OTC DRUG	TheraBreath for Kids Anticavity Grapes Galore		SODIUM FLUORIDE	RINSE	ORAL	20230101		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	.5	mg/mL			N	20241231
10237-258_57d37572-2752-4253-92c9-affb9d56f82a	10237-258	HUMAN OTC DRUG	TheraBreath Healthy Gums		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20230104		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	CETYLPYRIDINIUM CHLORIDE	.01	mg/20mL			N	20241231
10237-259_f62c2212-b79f-421e-87c2-fb59afa9e71f	10237-259	HUMAN OTC DRUG	Therabreath Plaque Control		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20230425		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	CETYLPYRIDINIUM CHLORIDE	.015	mg/20mL			N	20241231
10237-260_4971b553-21be-42e2-843e-e595ecb195f4	10237-260	HUMAN OTC DRUG	Therabreath Anticavity		SODIUM FLUORIDE	RINSE	ORAL	20230213		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	.005	mg/10mL			N	20241231
10237-460_8cc254c9-22cc-4ea3-8ef6-fdac2f152afa	10237-460	HUMAN OTC DRUG	Zicam	Cold Remedy Rapidmelts Citrus	ZINC ACETATE ANHYDROUS and ZINC GLUCONATE	TABLET	ORAL	20210430		UNAPPROVED HOMEOPATHIC		Church & Dwight Co., Inc.	ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	2; 1	[hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
10237-464_47889eec-24d9-4fed-b9bd-cfd3465d9ee8	10237-464	HUMAN OTC DRUG	Zicam Extreme Congestion Relief		oxymetazoline hydrochloride	SPRAY	NASAL	20211001		OTC MONOGRAPH FINAL	part341	Church & Dwight Co., Inc.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
10237-471_9c49eed0-24cc-476a-8a39-4070a9e19740	10237-471	HUMAN OTC DRUG	Zicam Intense Sinus Relief		oxymetazoline hydrochloride	SPRAY	NASAL	20220228		OTC MONOGRAPH FINAL	part341	Church & Dwight Co., Inc.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
10237-472_d91738e5-1d2f-41d1-e053-2995a90a7aad	10237-472	HUMAN OTC DRUG	Zicam Cold Remedy		Galphimia Glauca Flowering Top, Luffa Operculata Fruit, and Schoenocaulon Officinale Seed	GEL	NASAL	20220228		UNAPPROVED HOMEOPATHIC		Church & Dwight Co., Inc.	GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED	4; 4; 4	[hp_X]/1.2mL; [hp_X]/1.2mL; [hp_X]/1.2mL			N	20241231
10237-473_db4c674c-967c-34fc-e053-2995a90a28e2	10237-473	HUMAN OTC DRUG	Zicam Cold Remedy		ZINC ACETATE ANHYDROUS and ZINC GLUCONATE	LOZENGE	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Church & Dwight Co., Inc.	ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	2; 2	[hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
10237-474_dc29d796-5854-6992-e053-2995a90ab6bd	10237-474	HUMAN OTC DRUG	Zicam Cold Remedy		galphimia glauca flowering top, luffa operculata fruit, and schoenocaulon officinale seed	SPRAY	NASAL	20220410		UNAPPROVED HOMEOPATHIC		Church & Dwight Co., Inc.	GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED	4; 4; 4	[hp_X]/.56mL; [hp_X]/.56mL; [hp_X]/.56mL			N	20241231
10237-477_331b27a5-2ad5-4baf-a96f-be048afb5e1d	10237-477	HUMAN OTC DRUG	Zicam	Cold Remedy Rapidmelts with Echinacea	ZINC ACETATE ANHYDROUS, ECHINACEA ANGUSTIFOLIA, and ZINC GLUCONATE	TABLET	ORAL	20220826		UNAPPROVED HOMEOPATHIC		CHURCH & DWIGHT CO., INC.	ECHINACEA ANGUSTIFOLIA WHOLE; ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	5; 2; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
10237-478_260fc4cb-553b-47c0-a356-e19c2e5f046a	10237-478	HUMAN OTC DRUG	Zicam Ultra Cold Remedy Rapidmelts		ZINC ACETATE ANHYDROUS and ZINC GLUCONATE	TABLET	ORAL	20220218		UNAPPROVED HOMEOPATHIC		CHURCH & DWIGHT CO., INC.	ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	2; 1	[hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
10237-479_4031fc72-9b93-41e6-a6c3-b930941f5026	10237-479	HUMAN OTC DRUG	zicam cold and flu-like symptoms	Echinacea plus Sambucus	zinc acetate anhydrous, zinc gluconate, echinacea angustifolia whole, and sambucus nigra flowering top	TABLET, MULTILAYER	ORAL	20230701		UNAPPROVED HOMEOPATHIC		CHURCH AND DWIGHT CO, INC.	ECHINACEA ANGUSTIFOLIA WHOLE; SAMBUCUS NIGRA FLOWERING TOP; ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	5; 5; 2; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
10237-505_c1fed667-bc81-4d31-832b-2575be278de2	10237-505	HUMAN OTC DRUG	Hero Force Shield Superlight Sunscreen SPF 30		Zinc Oxide	LOTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	Church & Dwight Co., Inc.	ZINC OXIDE	175.3	mg/mL			N	20241231
10237-506_0b4cc7ce-131b-42b7-a9c4-048d03fc83c6	10237-506	HUMAN OTC DRUG	Hero Force Shield Superlight Sunscreen SPF 30		Zinc Oxide	LOTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	Church & Dwight Co., Inc.	ZINC OXIDE	175.3	mg/mL			N	20241231
10237-591_26794395-761d-4776-b86e-0675bf3bdd3a	10237-591	HUMAN OTC DRUG	Arm and Hammer Baking Soda		Sodium Bicarbonate	POWDER, FOR SOLUTION	ORAL	20000101		OTC MONOGRAPH DRUG	M016	Church & Dwight Co., Inc.	SODIUM BICARBONATE	1	g/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
10237-625_561fd547-10d1-4beb-989b-5b0d3a6388a4	10237-625	HUMAN OTC DRUG	AIM	Bubble Berry	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20080101		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-633_0d248211-c531-4f9a-8852-677f1aaa0c5e	10237-633	HUMAN OTC DRUG	AIM CAVITY PROTECTION	Multi Benefit	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20040301		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-635_22c50775-129b-4272-be2f-3e37cd2a7096	10237-635	HUMAN OTC DRUG	AIM TARTAR CONTROL	Plus Mouthwash and Whitening	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20040301		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-637_e1a82b50-1c37-413f-adb1-6a01285f1db6	10237-637	HUMAN OTC DRUG	AIM	Cavity Protection with Whitening	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20101110		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-638_50951348-9d80-482d-be44-29e4f053e095	10237-638	HUMAN OTC DRUG	AIM Cavity Protection	Multi Benefit	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20110804		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-644_ac15bdf5-d20b-45c9-926d-777c1edd4117	10237-644	HUMAN OTC DRUG	CLOSE UP	Freshening with Mouthwash	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20010301		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-645_81fe3249-dd7c-40e6-9561-e8a76f51f192	10237-645	HUMAN OTC DRUG	CLOSE UP	Whitening with Mouthwash	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20101026		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-650_7b187625-a5b1-4fa3-a040-a120de43ec2e	10237-650	HUMAN OTC DRUG	Pepsodent Complete Care	Enamel-Safe WHITENING	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20040301		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-651_d5de3f85-adfc-4d6f-a2a2-a84f2499e6f3	10237-651	HUMAN OTC DRUG	Pepsodent Complete Care	Original	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20040301		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-652_3354275c-b671-4497-9ccd-6384b64c9555	10237-652	HUMAN OTC DRUG	Dental Care Advance Cleaning	Maximun Baking Soda	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20120129		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-653_d04dfdcc-f5f8-16aa-e053-2995a90a9fe1	10237-653	HUMAN OTC DRUG	Complete Care Tartar Control	Plus Whitening Baking Soda and Peroxide	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20120129	20241101	OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	
10237-655_02738ee0-ce53-4c56-ab12-7e38e4ef4516	10237-655	HUMAN OTC DRUG	Peroxie Care Tartar Control	Healthy Gums Baking Soda and Peroxide	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20120129		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-656_1883fc9b-d65f-49c6-bc70-07d162a3bdab	10237-656	HUMAN OTC DRUG	Advance White	Tartar Control Breath Freshening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20120129		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-658_92481651-3204-4441-865b-99439a35a970	10237-658	HUMAN OTC DRUG	Advance White Extreme Whitening	Tartar Control	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20120129		OTC MONOGRAPH DRUG	M021	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-664_6df29ae6-4436-4a26-9ccf-a54e63e974fb	10237-664	HUMAN OTC DRUG	Truly Radiant Rejuvenating	Whitening	Sodium Fluoride 0.243%	PASTE, DENTIFRICE	DENTAL	20150101		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	.243	mg/g			N	20241231
10237-666_b1099b3a-dad1-48f5-8648-b7e1c55f4488	10237-666	HUMAN OTC DRUG	Enamel Defense		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20200401		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	.24	mg/g			N	20241231
10237-668_cc4db83b-b11b-4f78-8ba4-77ad3496d3dd	10237-668	HUMAN OTC DRUG	Truly Radiant Clean and Fresh		Sodium Monofluorophosphate 0.833%	PASTE, DENTIFRICE	DENTAL	20151215		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM MONOFLUOROPHOSPHATE	.833	mg/g			N	20241231
10237-669_a8e201a4-3ca0-4713-89c8-cac4c2d52fa7	10237-669	HUMAN OTC DRUG	Sensitive Teeth and Gums		Potassium Nitrate, Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20171016		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.43	mg/g; mg/g			N	20241231
10237-670_b078ca38-7476-4336-b472-50104dc5f2ce	10237-670	HUMAN OTC DRUG	Essentials Healthy Teeth and Gums		Sodium fluoride 0.24%	PASTE, DENTIFRICE	DENTAL	20191201		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-672_371a8516-c231-40ac-8f92-4bb2cce27819	10237-672	HUMAN OTC DRUG	Essentials Whiten and Strengthen		Sodium Fluoride 0.24%	PASTE, DENTIFRICE	DENTAL	20191201		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
10237-673_63029c7c-6757-4e2e-ac04-90e276425737	10237-673	HUMAN OTC DRUG	Dude Perfect Fluoride Toothpastes and Spinbrush Combo Pack		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20211001		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
10237-674_d66eac56-a891-8f48-e053-2a95a90aa081	10237-674	HUMAN OTC DRUG	Kids Healthy Teeth		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20211231		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-675_d66eac56-a883-8f48-e053-2a95a90aa081	10237-675	HUMAN OTC DRUG	Complete Care Whole Mouth Protection		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20211231		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-676_0990ef3b-7f9a-45d0-89f1-2a3e30d8a404	10237-676	HUMAN OTC DRUG	A and H Plus Therabreath Breath Freshners		SODIUM FLUORIDE	PASTE, DENTIFRICE	ORAL	20240101		OTC MONOGRAPH DRUG	M021	Church & Dwight Co., Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
10237-677_cf70fcf8-7dbf-4ec2-bb5f-32a1b1d78632	10237-677	HUMAN OTC DRUG	Orajel Complete Protection		Sodium Fluoride	PASTE	ORAL	20240101		OTC MONOGRAPH DRUG	M021	Church & Dwight Co., Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .243	g/100g; g/100g			N	20241231
10237-700_6c802e91-b692-cdd0-e053-2991aa0aa781	10237-700	HUMAN OTC DRUG	Simply Saline	Wound Care	Benzethonium Chloride 0.13%	SPRAY	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part333A	Church & Dwight Co., Inc.	BENZETHONIUM CHLORIDE	1	mg/13mL			N	20241231
10237-723_ff0029f1-2730-4f9f-96ab-6fd9093d845b	10237-723	HUMAN OTC DRUG	Orajel 3X Medicated for Denture Pain		Benzocaine, Menthol, Zinc Chloride	GEL	TOPICAL	20181005		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	200; 5; 1.5	mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-745_fb0e5d38-d110-43cc-bc27-a1de6aeba29c	10237-745	HUMAN OTC DRUG	Orajel Instant Pain Relief	Regular	Benzocaine 10%	GEL	TOPICAL	20131201		OTC MONOGRAPH NOT FINAL	part356	Church Dwight Co., Inc.	BENZOCAINE	100	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-756_d7723392-c3a1-1bb4-e053-2995a90af3d6	10237-756	HUMAN OTC DRUG	Orajel for Cold Sores	Single Dose	Benzalkonium Chloride, Benzocaine	LIQUID	TOPICAL	20120701	20240930	OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	BENZALKONIUM CHLORIDE; BENZOCAINE	1.3; 50	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
10237-760_3c5c04cc-5c3e-4a6f-b1ea-1389afd57bd6	10237-760	HUMAN OTC DRUG	Orajel Antiseptic Rinse For All Mouth Sores		Hydrogen Peroxide and Menthol	LIQUID	ORAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	HYDROGEN PEROXIDE; MENTHOL, UNSPECIFIED FORM	15; 1	mg/mL; mg/mL			N	20241231
10237-761_d5785386-38bf-06d4-e053-2995a90abe5a	10237-761	HUMAN OTC DRUG	Orajel Cold Sore Moisturelock		Benzocaine	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	ALLANTOIN; BENZOCAINE; CAMPHOR (NATURAL); DIMETHICONE; MENTHOL; PETROLATUM	5; 200; 30; 20; 10; 640	mg/g; mg/g; mg/g; mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Skin Barrier Activity [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-763_9e05d17d-afe9-4f67-bcbc-fe02bb888a70	10237-763	HUMAN OTC DRUG	Orajel Fluoride		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20161210		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-764_c7b96c55-7c99-4d31-b631-5850d06801f6	10237-764	HUMAN OTC DRUG	Orajel Toothache Rinse		Benzyl Alcohol, Zinc Chloride	LIQUID	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	BENZYL ALCOHOL; ZINC CHLORIDE	2.7; 1.5	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Pediculicide [EPC]		N	20241231
10237-775_d773b056-3d17-c8f3-e053-2a95a90af889	10237-775	HUMAN OTC DRUG	Orajel		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20180720		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-783_d57d751d-7782-5b70-e053-2995a90a0934	10237-783	HUMAN OTC DRUG	Orajel 3X Medicated For All Mouth Sores		Benzocaine, Menthol, Zinc Chloride	GEL	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part348	Church & Dwight Co., Inc.	BENZOCAINE; MENTHOL; ZINC CHLORIDE	200; 1; 1.5	mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-784_cf529852-2a6e-4c86-b16b-ef30fe1211fb	10237-784	HUMAN OTC DRUG	Orajel Antiseptic Alcohol-Free Mouth Sore Rinse		Hydrogen peroxide, Menthol	LIQUID	ORAL	20191101		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	HYDROGEN PEROXIDE; MENTHOL, UNSPECIFIED FORM	15; 1	mg/mL; mg/mL			N	20241231
10237-785_05b305ef-8eda-480d-97df-17456966159d	10237-785	HUMAN OTC DRUG	Orajel KidsToothpaste		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20191101		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-786_fb2a3cf2-20d6-4b58-8081-8120e728ccac	10237-786	HUMAN OTC DRUG	Orajel Paw Patrol		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20191101		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-787_f95aca39-d0f0-4898-9815-4a943c73cd7f	10237-787	HUMAN OTC DRUG	Orajel 4X Medicated For Toothache and Gum		Benzalkonium chloride, Benzocaine, Menthol, Zinc chloride	GEL	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part333A	Church & Dwight Co., Inc.	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	1.3; 200; 5; 1.5	mg/g; mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-788_821f2e07-a85d-46dd-b11d-bd3c13376342	10237-788	HUMAN OTC DRUG	Orajel 4X Medicated For Toothache and Gum, Cream		Benzalkonium chloride, Benzocaine, Menthol, Zinc chloride	CREAM	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part333A	Church & Dwight Co., Inc.	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CATION	1.3; 200; 2.6; 1.5	mg/g; mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-789_a1ba29b5-e2b7-44cd-a2a5-cbdf292cff18	10237-789	HUMAN OTC DRUG	Orajel 4X Medicated PM For Toothache and Gum		Benzalkonium chloride, Benzocaine, Menthol, Zinc chloride	CREAM	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part333A	Church & Dwight Co., Inc.	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	1.3; 200; 2.6; 1.5	mg/g; mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-790_d57a744d-28c2-0098-e053-2a95a90abd8b	10237-790	HUMAN OTC DRUG	Orajel 3X Medicated For Toothache and Gum		Benzocaine, Menthol, Zinc chloride	GEL	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part348	Church & Dwight Co., Inc.	BENZOCAINE; MENTHOL; ZINC CHLORIDE	200; 2.6; 1.5	mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-792_2ed68d42-3eac-41aa-af15-786c4bf8136f	10237-792	HUMAN OTC DRUG	Orajel Gum Pain 3X Medicated		benzocaine, menthol, zinc chloride	GEL	TOPICAL	20191217		OTC MONOGRAPH NOT FINAL	part348	Church & Dwight Co., Inc.	BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	200; 2.6; 1.5	mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-794_33d8668f-9b0a-46e5-8e4c-d8c3e93b293f	10237-794	HUMAN OTC DRUG	Orajel JoJo Siwa		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20201001		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-795_7f889618-7428-40bb-be77-cf8ddc27e66e	10237-795	HUMAN OTC DRUG	Orajel Paw Patrol		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20201001		OTC MONOGRAPH FINAL	part355	Church & Dwight Co., Inc.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
10237-797_6a0df30a-700b-4f01-b60e-c79c4a4caf6b	10237-797	HUMAN OTC DRUG	Orajel for Cold Sores Double Medicated, Cream		Benzocaine and White Petrolatum	CREAM	TOPICAL	20210118		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	BENZOCAINE; PETROLATUM	200; 736.4	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10237-799_f5b6af5b-f7fe-4084-b184-965f049ece72	10237-799	HUMAN OTC DRUG	Orajel 2x Gum Pain	Alcohol-Free	Menthol and Hydrogen Peroxide	RINSE	ORAL	20230115		OTC MONOGRAPH NOT FINAL	part356	Church & Dwight Co., Inc.	HYDROGEN PEROXIDE; MENTHOL, UNSPECIFIED FORM	15; 1	mg/mL; mg/mL			N	20241231
10237-807_6ddf2b9c-382a-4fbd-9c27-dfeacede1946	10237-807	HUMAN OTC DRUG	UltraMax	Antiperspirant Deodorant Cool Blast	Aluminum Zirconium Tetrachlorohydrex Gly	GEL	TOPICAL	20031201	20241231	OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	
10237-814_2dcf3c56-b928-41aa-b802-0ce2933b464e	10237-814	HUMAN OTC DRUG	ARRID EXTRA DRY	Regular	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20110422		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	246	mg/g			N	20241231
10237-858_82eb49a3-da19-470c-8127-3452f3671757	10237-858	HUMAN OTC DRUG	ARRID EXTRA EXTRA DRY XX		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20110422		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	246	mg/g			N	20241231
10237-859_93bcbe06-79e0-49d6-9ce5-01691508479d	10237-859	HUMAN OTC DRUG	Arrid Extra Extra Dry Ultra Fresh		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151109		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	246	mg/g			N	20241231
10237-860_5e04fe9d-a821-4f32-b4f1-4ec4ed437db3	10237-860	HUMAN OTC DRUG	ARRID EXTRA EXTRA DRY XX	Morning Clean	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20110422		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	246	mg/g			N	20241231
10237-862_44b41f61-7397-4603-9b6a-400a93dfea0a	10237-862	HUMAN OTC DRUG	ARRID EXTRA DRY	Antiperspirant Deodorant Morning Clean	Aluminum Zirconium Tetrachlorohydrex Gly	GEL	TOPICAL	20040928		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
10237-863_5bcd68f2-aac2-4c9d-a528-d7c77b6c5c46	10237-863	HUMAN OTC DRUG	ARRID EXTRA DRY	Antiperspirant Deodorant Cool Shower	Aluminum Zirconium Tetrachlorohydrex Gly	GEL	TOPICAL	20040928		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
10237-865_02084ede-0040-4375-a961-6eef189902a0	10237-865	HUMAN OTC DRUG	Arrid Extra Extra Dry Regular Solid		Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-866_dc61ff52-22e5-44f3-914e-689a039bbfa5	10237-866	HUMAN OTC DRUG	Arrid Extra Extra Dry Unscented Solid		Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-867_631a397f-5ee2-47b8-a15a-b49d479b2491	10237-867	HUMAN OTC DRUG	Arrid Extra Extra Dry - Cool Shower		Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-868_4515b255-61a9-46e6-b2f6-805546c4e8be	10237-868	HUMAN OTC DRUG	Arrid Extra Extra Dry Ultra Fresh		Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-869_60a17334-c39a-41b9-96d2-11d8b10dc9d4	10237-869	HUMAN OTC DRUG	UltraMax Invisible Solid - Fresh	Antiperspirant Deodorant Fresh	Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-870_39237449-2cfc-41cb-977a-6e138b02ec89	10237-870	HUMAN OTC DRUG	UltraMax Invisible Solid - Powder Fresh	Antiperspirant Deodorant Powder Fresh	Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-871_43628d13-c84e-4e98-914c-802dc1bc0751	10237-871	HUMAN OTC DRUG	UltraMax Invisible Solid - Active Sport	Antiperspirant Deodorant Active Sport	Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-872_a0c29562-e1b3-4147-9325-d0cf0fddd559	10237-872	HUMAN OTC DRUG	UltraMax Invisible Solid - Cool Blast	Antiperspirant Deodorant Cool Blast	Aluminum Chlorohydrate	STICK	TOPICAL	20210201	20241231	OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	
10237-873_ae6df0d1-f9bd-4f21-9e98-92a40e2405c2	10237-873	HUMAN OTC DRUG	UltraMax Invisible Solid - Unscented	Antiperspirant Deodorant Unscented	Aluminum Chlorohydrate	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Church & Dwight Co., Inc.	ALUMINUM CHLOROHYDRATE	.19	g/g			N	20241231
10237-906_f1b4de1e-8f1c-2892-e053-2a95a90a10e9	10237-906	HUMAN OTC DRUG	Carters Little Pills	Sodium-Free	Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20110601		OTC MONOGRAPH NOT FINAL	part334	Church & Dwight Co., Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
10237-940_d9a20e59-9657-7032-e053-2a95a90a8b46	10237-940	HUMAN OTC DRUG	Gravol		Dimenhydrinate	CAPSULE, LIQUID FILLED	ORAL	20220302		OTC MONOGRAPH FINAL	part336	Church & Dwight Co., Inc.	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10237-941_d9582385-ba46-eebc-e053-2a95a90af9fe	10237-941	HUMAN OTC DRUG	Gravol		Dimenhydrinate	TABLET, COATED	ORAL	20220302		OTC MONOGRAPH FINAL	part336	Church & Dwight Co., Inc.	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10237-942_d955f3fa-a659-f7ef-e053-2a95a90aeb8f	10237-942	HUMAN OTC DRUG	Gravol		Dimenhydrinate	SYRUP	ORAL	20220302		OTC MONOGRAPH FINAL	part336	Church & Dwight Co., Inc.	DIMENHYDRINATE	15	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10258-101_0cd296d5-b4c5-28f8-e063-6394a90a3f67	10258-101	HUMAN OTC DRUG	OXYGENETIX OXYGENATING FOUNDATION	ACNE CONTROL	SALICYLIC ACID	LOTION	TOPICAL	20141221	20260816	OTC MONOGRAPH DRUG	M006	COLONIAL DAMES CO LTD	SALICYLIC ACID	2	g/100mL			N	
10258-103_0cd28fbd-519c-1fa8-e063-6294a90aa17a	10258-103	HUMAN OTC DRUG	OXYGENETIX - OXYGENATING HYDRO-MATRIX	ACNE CONTROL	SALICYLIC ACID	LOTION	TOPICAL	20200601	20250808	OTC MONOGRAPH DRUG	M006	COLONIAL DAMES CO LTD	SALICYLIC ACID	2	g/100mL			N	
10267-3846_77cf0092-7436-14ba-e053-2991aa0ac112	10267-3846	HUMAN OTC DRUG	ibuprofen		ibuprofen	TABLET	ORAL	20140115		ANDA	ANDA071265	Contract Pharmacal Corp.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
10267-3852_77cf0092-7436-14ba-e053-2991aa0ac112	10267-3852	HUMAN OTC DRUG	ibuprofen		ibuprofen	TABLET	ORAL	20140115		ANDA	ANDA071265	Contract Pharmacal Corp.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
10267-3909_77cf0092-7436-14ba-e053-2991aa0ac112	10267-3909	HUMAN OTC DRUG	ibuprofen		ibuprofen	TABLET	ORAL	20140115		ANDA	ANDA071265	Contract Pharmacal Corp.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
10267-5059_abbf7078-a013-4e1a-e053-2995a90a792d	10267-5059	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210124		ANDA	ANDA213474	Contract Pharmacal Corp.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
10267-5060_abbf7078-a013-4e1a-e053-2995a90a792d	10267-5060	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210124		ANDA	ANDA213474	Contract Pharmacal Corp.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
10267-5061_abbf7078-a013-4e1a-e053-2995a90a792d	10267-5061	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210124		ANDA	ANDA213474	Contract Pharmacal Corp.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
10267-5062_abbf7078-a013-4e1a-e053-2995a90a792d	10267-5062	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210124		ANDA	ANDA213474	Contract Pharmacal Corp.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
10267-5063_abbf7078-a013-4e1a-e053-2995a90a792d	10267-5063	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210124		ANDA	ANDA213474	Contract Pharmacal Corp.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
10297-006_07eef4a6-48c3-0c04-e063-6394a90abb0a	10297-006	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	20180601		NDA	NDA211781	A-OX WELDING SUPPLY CO., INC.	HELIUM	990	mL/L			N	20241231
10297-020_07ef001a-c649-5639-e063-6294a90ab4d3	10297-020	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20190617		NDA	NDA213507	A-OX WELDING SUPPLY CO., INC.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
10297-070_07eedc8b-adbb-52d9-e063-6394a90ae841	10297-070	HUMAN PRESCRIPTION DRUG	Heliox		Heliox	GAS	RESPIRATORY (INHALATION)	20180601		NDA	NDA205767	A-OX WELDING SUPPLY CO., INC.	OXYGEN	300	mL/L			N	20241231
10297-080_07eef313-2921-20ae-e063-6294a90a3180	10297-080	HUMAN PRESCRIPTION DRUG	Heliox		Heliox	GAS	RESPIRATORY (INHALATION)	20180601		NDA	NDA205767	A-OX WELDING SUPPLY CO., INC.	OXYGEN	200	mL/L			N	20241231
10297-100_07eef4a6-48c4-0c04-e063-6394a90abb0a	10297-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19780102		NDA	NDA205767	A OX Welding Supply Company Inc.	OXYGEN	995	mL/L			N	20241231
10297-103_07eef313-2920-20ae-e063-6294a90a3180	10297-103	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20150311		NDA	NDA205767	A-OX Welding Supply Co., Inc.	OXYGEN	210	mL/L			N	20241231
10297-200_07eef313-2922-20ae-e063-6294a90a3180	10297-200	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20120109		NDA	NDA205766	A OX Welding Supply Company Inc.	NITROGEN	990	mL/L			N	20241231
10304-463_0801db1a-6a2b-c572-e063-6394a90a00a1	10304-463	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000612		NDA	NDA205865	Delille Oxygen Company	OXYGEN	995	mL/L			N	20241231
10304-601_0801db1a-6a2c-c572-e063-6394a90a00a1	10304-601	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20000612		NDA	NDA205866	Delille Oxygen Company	NITROGEN	999	mL/L			N	20241231
10337-358_c31b3c09-29fc-45ca-a742-3b5a9f553517	10337-358	HUMAN PRESCRIPTION DRUG	Oxistat		oxiconazole nitrate	CREAM	TOPICAL	19881230		NDA	NDA019828	PharmaDerm a division of Fougera Pharmaceuticals Inc.	OXICONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
10337-359_c31b3c09-29fc-45ca-a742-3b5a9f553517	10337-359	HUMAN PRESCRIPTION DRUG	Oxistat		oxiconazole nitrate	LOTION	TOPICAL	19920930		NDA	NDA020209	PharmaDerm a division of Fougera Pharmaceuticals Inc.	OXICONAZOLE NITRATE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
10337-450_e25d94c3-0838-41c0-92cb-ec04bf8165b9	10337-450	HUMAN PRESCRIPTION DRUG	Veregen		sinecatechins	OINTMENT	TOPICAL	20071214	20241129	NDA	NDA021902	PharmaDerm a division of Fougera Pharmaceuticals Inc.	SINECATECHINS	150	mg/g			N	
10337-905_3d362b47-37c4-489d-91c6-a2b7ec99e207	10337-905	HUMAN PRESCRIPTION DRUG	Kerydin		Tavaborole	SOLUTION	TOPICAL	20140707		NDA	NDA204427	PharmaDerm, A division of Fougera Pharmaceuticals Inc.	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
10345-900_0bd096f2-8158-642a-e063-6394a90a647f	10345-900	HUMAN OTC DRUG	ERBORIAN - BB CREME AU GINSENG CLAIR SPF 20		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150206		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	30; 62.8; 19.2	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-901_0bd083a5-6e56-aefc-e063-6394a90a2c92	10345-901	HUMAN OTC DRUG	ERBORIAN - BB CREME AU GINSENG DORE SPF 20		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150206		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	30; 62.8; 19.2	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-902_0c99ba55-77d2-f62d-e063-6394a90a60c1	10345-902	HUMAN OTC DRUG	ERBORIAN - BB CREME NUDE SPF20		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20160817		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	30; 62.8; 19.2	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-903_0c1069d3-14b3-9959-e063-6294a90a7d85	10345-903	HUMAN OTC DRUG	ERBORIAN - BB CREME AU GINSENG CARAMEL SPF20		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20161216		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	30; 62.8; 19.2	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-904_0c10409e-5e30-9561-e063-6294a90a9c83	10345-904	HUMAN OTC DRUG	Erborian BB creme au Ginseng chocolate SPF 20		OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	40; 35.4; 29.4	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-910_0bd0c0ce-b9a4-c10e-e063-6394a90a3c77	10345-910	HUMAN OTC DRUG	ERBORIAN - CC CREME HIGH DEFINITION SPF 25		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150206		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	60; 20; 49.7; 19.2	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-911_0c3c1fef-eef8-ddbc-e063-6394a90a0447	10345-911	HUMAN OTC DRUG	ERBORIAN - CC CREME HIGH DEFINITION SPF25 CLAIR		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20160713		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	60; 20; 43.3; 19.2	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-912_089a2ea4-1b65-0bc6-e063-6394a90aa0df	10345-912	HUMAN OTC DRUG	ERBORIAN CC RED CORRECT SPF 25		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Laboratoires M&L	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	60; 20; 23.4; 38.4	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-913_0bd083a5-6e57-aefc-e063-6394a90a2c92	10345-913	HUMAN OTC DRUG	ERBORIAN CC CREME HIGH DEFINITION SPF 25 CARAMEL		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20180821		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	60; 20; 88.4; 38.4	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-914_0c106d71-8456-47eb-e063-6394a90adc19	10345-914	HUMAN OTC DRUG	Erborian CC Dull Correct SPF25		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190527		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	60; 20; 47; 38.4	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10345-921_0c99c835-0612-03be-e063-6394a90ad451	10345-921	HUMAN OTC DRUG	ERBORIAN DOUBLE SAMPLE CC CREME CLAIR and DORE SPF 25		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	KIT		20171203		OTC MONOGRAPH DRUG	M020	LABORATOIRES M&L						N	20241231
10348-018_0b77720a-f82e-266c-e063-6394a90a3135	10348-018	HUMAN OTC DRUG	SMASHBOX HALO HEALTHY GLOW ALL-IN-ONE TINTED MOISTURIZER BROAD SPECTRUM SPF 25		OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE	LIQUID	TOPICAL	20200402		OTC MONOGRAPH DRUG	M020	SMASHBOX BEAUTY COSMETICS, INC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	67; 31; 13	mg/mL; mg/mL; mg/mL			N	20241231
10356-100_074f24f9-ac93-3102-e063-6294a90a1c17	10356-100	HUMAN OTC DRUG	Aquaphor Original		Petrolatum	OINTMENT	TOPICAL	19750601		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	PETROLATUM	41	g/100g			N	20241231
10356-101_08779bfa-91eb-7672-e063-6394a90ac422	10356-101	HUMAN OTC DRUG	Aquaphor Healing		Petrolatum	OINTMENT	TOPICAL	19910101		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	PETROLATUM	41	g/100g			N	20241231
10356-105_0d96f86a-c8b9-7a18-e063-6394a90afd05	10356-105	HUMAN OTC DRUG	Aquaphor Healing Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20150130		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	ZINC OXIDE	15	g/100g			N	20241231
10356-111_0d97237e-eb4d-3f79-e063-6294a90ab27a	10356-111	HUMAN OTC DRUG	Aquaphor Lip Protectant and Sunscreen		Petrolatum, Avobenzone, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20150630		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; PETROLATUM	3; 6.75; 4.5; 2; 5.4; 31	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
10356-115_0d973f9d-a4ef-89d4-e063-6394a90a95d6	10356-115	HUMAN OTC DRUG	Aquaphor Healing Fast Relief Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	20170331		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	ZINC OXIDE	40	g/100g			N	20241231
10356-120_0d97633e-6dc5-9538-e063-6394a90a8001	10356-120	HUMAN OTC DRUG	Aquaphor Itch Relief		Hydrocortisone	OINTMENT	TOPICAL	20201101		OTC MONOGRAPH DRUG	M017	Beiersdorf Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10356-125_0d976866-81b4-5db8-e063-6294a90a39f9	10356-125	HUMAN OTC DRUG	Aquaphor Healing Balm Stick		Petrolatum	OINTMENT	TOPICAL	20210915		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	PETROLATUM	30	g/100g			N	20241231
10356-130_0d9761a2-91f6-8346-e063-6394a90a7517	10356-130	HUMAN OTC DRUG	Aquaphor Lip Repair Stick and Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene,	STICK	TOPICAL	20211115		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
10356-323_0dafb353-9109-729e-e063-6394a90a920c	10356-323	HUMAN OTC DRUG	Eucerin Daily Protection Face		Ensulizole, Octinoxate, Octisalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20150812		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	ENSULIZOLE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	2; 7.5; 4.5; 2.4; 4.8	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
10356-328_0dafe0d8-8f77-69d0-e063-6394a90ac4d2	10356-328	HUMAN OTC DRUG	Eucerin Daily Hydration		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20160801		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3.4; 3.4; 4.7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
10356-335_0daff09a-3313-a6be-e063-6294a90afa3b	10356-335	HUMAN OTC DRUG	Eucerin Daily Hydration		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20160801		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
10356-353_0dafe0d8-8f78-69d0-e063-6394a90ac4d2	10356-353	HUMAN OTC DRUG	Eucerin Redness Relief Daily Perfecting		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20170330		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3.5; 3.5; 4.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
10356-358_0db029b9-c222-f30f-e063-6294a90a6f5b	10356-358	HUMAN OTC DRUG	Eucerin Itch Relief Intensive Calming		Menthol	LOTION	TOPICAL	20200615		OTC MONOGRAPH DRUG	M017	Beiersdorf Inc	MENTHOL	.1	g/100mL			N	20241231
10356-365_0db04a5d-afc2-f290-e063-6294a90a57b7	10356-365	HUMAN OTC DRUG	Eucerin Eczema Relief Body		Oatmeal	CREAM	TOPICAL	20130715		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10356-371_0db01f99-4c08-ee38-e063-6294a90afba9	10356-371	HUMAN OTC DRUG	Eucerin Eczema Relief Flare Up Treatment		Oatmeal	CREAM	TOPICAL	20150608		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10356-375_0dbfcbf5-d784-835f-e063-6394a90a3b29	10356-375	HUMAN OTC DRUG	Eucerin Eczema Relief Hand		Oatmeal	CREAM	TOPICAL	20170601		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10356-381_0dc00586-77c4-0185-e063-6294a90aa19c	10356-381	HUMAN OTC DRUG	Eczema Relief Cream Body Wash		Oatmeal	LOTION	TOPICAL	20200615	20240701	OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	OATMEAL	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
10356-382_0dc00586-77c5-0185-e063-6294a90aa19c	10356-382	HUMAN OTC DRUG	Eczema Relief Cream Body Wash		Oatmeal	LOTION	TOPICAL	20220701		OTC MONOGRAPH DRUG	M016	Beiersdorf Inc	OATMEAL	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10356-385_fe0b372e-ab4a-b32d-e053-6294a90a992f	10356-385	HUMAN OTC DRUG	Eucerin Face immersive Hydration		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230615		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 4.5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
10356-566_0dc0b915-cad1-c424-e063-6394a90ae929	10356-566	HUMAN OTC DRUG	Nivea Men Protective		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20151101	20240701	OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 4.7; 8.4	g/100mL; g/100mL; g/100mL			N	
10356-567_0dc09de7-f314-474f-e063-6294a90abb54	10356-567	HUMAN OTC DRUG	Nivea Men Maximum Hydration Face		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20220701		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 4.7; 8.4	g/100mL; g/100mL; g/100mL			N	20241231
10356-575_0dc0b68c-1ade-4f8a-e063-6294a90af2a5	10356-575	HUMAN OTC DRUG	Nivea Men Sensitive Protective		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20140915		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 4.7; 8.4	g/100mL; g/100mL; g/100mL			N	20241231
10356-819_0dc0e346-a96c-dcca-e063-6394a90aa8c0	10356-819	HUMAN OTC DRUG	Nivea Smoothness Lip Care		Avobenzone,Octocrylene	STICK	TOPICAL	20210415		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; OCTOCRYLENE	2.5; 7	g/100g; g/100g			N	20241231
10361-778_fd85c750-4092-0c10-0b5e-7d80dbb29de2	10361-778	HUMAN PRESCRIPTION DRUG	E-Z-Disk		barium sulfate	TABLET	ORAL	20090201		UNAPPROVED DRUG OTHER		E-Z-EM, INC.	BARIUM SULFATE	700	mg/1	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
10361-793_f50e59ac-4ef0-b42f-dbd6-afd73ca1350a	10361-793	HUMAN OTC DRUG	E-Z-GAS	II	Antacid/AntiFlatulent	GRANULE, EFFERVESCENT	ORAL	19860501		OTC MONOGRAPH DRUG	M001	E-Z-EM, INC.	ANHYDROUS CITRIC ACID; DIMETHICONE; SILICON DIOXIDE; SODIUM BICARBONATE	380; 10; 10; 550	mg/g; mg/g; mg/g; mg/g	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Skin Barrier Activity [PE]		N	20241231
10370-101_7a6e7819-ba92-4ce9-b71e-47eeec2ab128	10370-101	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612	20250531	ANDA	ANDA077284	Par Pharmaceutical, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
10370-102_7a6e7819-ba92-4ce9-b71e-47eeec2ab128	10370-102	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612	20250228	ANDA	ANDA077284	Par Pharmaceutical, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
10370-175_66b909cc-033f-4c55-b7b5-7c45074ef474	10370-175	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	CAPSULE, EXTENDED RELEASE	ORAL	20130313		ANDA	ANDA091476	Par Pharmaceutical, Inc.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
10370-176_66b909cc-033f-4c55-b7b5-7c45074ef474	10370-176	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	CAPSULE, EXTENDED RELEASE	ORAL	20130313		ANDA	ANDA091476	Par Pharmaceutical, Inc.	FLUVOXAMINE MALEATE	150	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
10370-268_953ad085-d750-467c-9180-bec5bef40bb1	10370-268	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE	ORAL	20121024		ANDA	ANDA201687	Par Pharmaceutical, Inc.	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10370-280_0c8988b2-50dc-4ae2-9e5b-cd7eed19521d	10370-280	HUMAN PRESCRIPTION DRUG	Dutasteride and Tamsulosin Hydrochloride		Dutasteride and Tamsulosin Hydrochloride Capsules	CAPSULE	ORAL	20151118		ANDA	ANDA202509	Par Pharmaceutical, Inc.	DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE	.5; .4	mg/1; mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA], Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
10370-365_13d68059-c440-4fd7-a097-14c2d62973e3	10370-365	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230524		ANDA	ANDA205976	Par Pharmaceutical, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
10370-366_13d68059-c440-4fd7-a097-14c2d62973e3	10370-366	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230526		ANDA	ANDA205976	Par Pharmaceutical, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
10370-367_13d68059-c440-4fd7-a097-14c2d62973e3	10370-367	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230524		ANDA	ANDA205976	Par Pharmaceutical, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
10370-368_0bf76850-fef7-4a83-8308-2569dc557d85	10370-368	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230324		ANDA	ANDA205976	Par Pharmaceutical, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
10370-829_ed859b97-464c-4c30-9f55-395a33510288	10370-829	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Par Pharmaceutical, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
10370-830_ed859b97-464c-4c30-9f55-395a33510288	10370-830	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Par Pharmaceutical, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
10370-831_ed859b97-464c-4c30-9f55-395a33510288	10370-831	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Par Pharmaceutical, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
10370-832_ed859b97-464c-4c30-9f55-395a33510288	10370-832	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Par Pharmaceutical, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
10412-0001_0760d8f5-a1c1-06c4-e063-6394a90a217f	10412-0001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19650101		NDA	NDA206023	Flint Welding Supply Company	OXYGEN	99	L/100L			N	20241231
10412-0095_0760de99-143f-1c0e-e063-6394a90adef6	10412-0095	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19630101		NDA	NDA206024	Flint Welding Supply Company	NITROGEN	99.5	L/100L			N	20241231
10451-001_0761147f-1335-606e-e063-6394a90abd5d	10451-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19690101		NDA	NDA205889	General Distributing Co.	OXYGEN	992	mL/L			N	20241231
10451-003_07610a71-ea83-611b-e063-6394a90accbf	10451-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205891	General Distributing Company	NITROGEN	992	mL/L			N	20241231
10451-004_07610a71-ea82-611b-e063-6394a90accbf	10451-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205889	General Distributing Company	OXYGEN	210	mL/L			N	20241231
10454-710_0cf4ea12-0fa5-f469-e063-6394a90a8357	10454-710	HUMAN PRESCRIPTION DRUG	Myobloc		rimabotulinumtoxinB	INJECTION, SOLUTION	INTRAMUSCULAR	20001208		BLA	BLA103846	Solstice Neurosciences, LLC	RIMABOTULINUMTOXINB	2500	[USP'U]/.5mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA]		N	20241231
10454-711_0cf4ea12-0fa5-f469-e063-6394a90a8357	10454-711	HUMAN PRESCRIPTION DRUG	Myobloc		rimabotulinumtoxinB	INJECTION, SOLUTION	INTRAMUSCULAR	20001208		BLA	BLA103846	Solstice Neurosciences, LLC	RIMABOTULINUMTOXINB	5000	[USP'U]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA]		N	20241231
10454-712_0cf4ea12-0fa5-f469-e063-6394a90a8357	10454-712	HUMAN PRESCRIPTION DRUG	Myobloc		rimabotulinumtoxinB	INJECTION, SOLUTION	INTRAMUSCULAR	20001208		BLA	BLA103846	Solstice Neurosciences, LLC	RIMABOTULINUMTOXINB	10000	[USP'U]/2mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA]		N	20241231
10511-3001_09917e39-791a-9105-e063-6394a90ac7d8	10511-3001	HUMAN PRESCRIPTION DRUG	Cysview		Hexaminolevulinate hydrochloride	KIT		20180501		NDA	NDA022555	Photocure Inc.						N	20241231
10526-005_0aaf0811-077f-1625-e063-6394a90a9177	10526-005	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205767	Haun Welding Supply, Inc.	OXYGEN	990	mL/L			N	20241231
10526-006_0aaefeba-62ab-9845-e063-6294a90a03de	10526-006	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	LIQUID	RESPIRATORY (INHALATION)	19900101		NDA	NDA205766	Haun Welding Supply, Inc.	NITROGEN	990	mL/L			N	20241231
10542-009_1a659a3c-bd4f-4d8f-9d6e-43933b0cec5b	10542-009	HUMAN PRESCRIPTION DRUG	Dialyvite Supreme D		Ascorbic Acid, Cholecalciferol, Alpha-Tocopherol, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium	TABLET, COATED	ORAL	20100908		UNAPPROVED DRUG OTHER		Hillestad Pharmaceuticals USA	.ALPHA.-TOCOPHEROL SUCCINATE, D-; ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; CHOLECALCIFEROL; COBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENOCYSTEINE; THIAMINE MONONITRATE; ZINC CITRATE	30; 100; 300; 10; 2000; 1; 3; 20; 25; 1.7; 70; 1.5; 15	[iU]/1; mg/1; ug/1; mg/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
10542-010_5f304b64-cc7c-4744-853e-5341055612a3	10542-010	HUMAN PRESCRIPTION DRUG	Dialyvite		Ascorbic Acid, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid	TABLET, COATED	ORAL	19880801		UNAPPROVED DRUG OTHER		Hillestad Pharmaceuticals USA	ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; COBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE	100; 300; 10; 6; 1; 20; 10; 1.7; 1.5	mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
10542-011_88e23f86-93fa-4b8e-9804-c714f539727e	10542-011	HUMAN PRESCRIPTION DRUG	Dialyvite 5000		Ascorbic Acid, Tocopheryl Acid Succinate, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium	TABLET, COATED	ORAL	20080501		UNAPPROVED DRUG OTHER		Hillestad Pharmaceuticals USA	.ALPHA.-TOCOPHEROL SUCCINATE, D-; ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; COBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENOCYSTEINE; THIAMINE MONONITRATE; ZINC CITRATE	30; 100; 300; 10; 2; 5; 20; 50; 1.7; 70; 1.5; 25	[iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
10542-012_a4bb0842-ce2a-4f47-83f9-260d434a4c7c	10542-012	HUMAN PRESCRIPTION DRUG	Dialyvite with Zinc		Ascorbic Acid, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc	TABLET, COATED	ORAL	20021001		UNAPPROVED DRUG OTHER		Hillestad Pharmaceuticals USA	ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; COBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC CITRATE	100; 300; 10; 6; 1; 20; 10; 1.7; 1.5; 50	mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
10542-014_678d4ca4-b412-4904-8bb1-c58d54d2719b	10542-014	HUMAN PRESCRIPTION DRUG	Dialyvite 3000		Ascorbic Acid, Tocopheryl Acid Succinate, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium	TABLET, COATED	ORAL	20040201		UNAPPROVED DRUG OTHER		Hillestad Pharmaceuticals USA	.ALPHA.-TOCOPHEROL SUCCINATE, D-; ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; COBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENOCYSTEINE; THIAMINE MONONITRATE; ZINC CITRATE	30; 100; 300; 10; 1; 3; 20; 25; 1.7; 70; 1.5; 15	[iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
10546-100_082b1721-9122-222f-e063-6294a90a5ea7	10546-100	HUMAN OTC DRUG	NUMOTIZINE		MENTHOL	OINTMENT	TOPICAL	20111130		OTC MONOGRAPH DRUG	M017	Hobart Laboratories, Inc.	MENTHOL	1.25	g/100g			N	20241231
10565-001_08682393-4d76-fd5e-e063-6294a90a5bae	10565-001	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	19930901		OTC MONOGRAPH DRUG	M003	Hydrox Laboratories	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
10565-002_08a29e2e-8075-ad9d-e063-6294a90adf6b	10565-002	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20170505		OTC MONOGRAPH DRUG	M003	Hydrox Laboratories	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
10565-003_08688514-bb39-813c-e063-6294a90a3dba	10565-003	HUMAN OTC DRUG	Isopropyl Alcohol 50%		Isopropyl Alcohol 50%	SOLUTION	TOPICAL	20190611		OTC MONOGRAPH DRUG	M003	Hydrox Laboratories	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
10565-006_08a4a74e-6f1b-de1c-e063-6394a90a56a2	10565-006	HUMAN OTC DRUG	Isopropyl Alcohol with Wintergreen 70%		Isopropyl Alcohol with Wintergreen 70%	SOLUTION	TOPICAL	20190611		OTC MONOGRAPH DRUG	M003	Hydrox Laboratories	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
10565-007_08a50ea6-e201-b217-e063-6394a90a95c1	10565-007	HUMAN OTC DRUG	Isopropyl Alcohol with Wintergreen 50%		Isopropyl Alcohol with Wintergreen 50%	SOLUTION	TOPICAL	20190619		OTC MONOGRAPH DRUG	M003	Hydrox Laboratories	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
10565-040_08a2a30c-f0f4-7eae-e063-6394a90a3568	10565-040	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20111221		OTC MONOGRAPH DRUG	505G(a)(3)	Hydrox Laboratories	WITCH HAZEL	86	g/100mL			N	20241231
10565-066_08a3f519-2d7f-4c12-e063-6394a90a8b77	10565-066	HUMAN OTC DRUG	Roll On Anti Perspirant	Alcohol Free	ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20111026		OTC MONOGRAPH DRUG	M019	Hydrox Laboratories	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
10565-067_08a3f333-7b89-904b-e063-6294a90afc60	10565-067	HUMAN OTC DRUG	Anti-Perspirant Deodorant		ALUMINUM CHLOROHYDRATE	SPRAY	TOPICAL	20111111		OTC MONOGRAPH DRUG	M019	Hydrox Laboratories	ALUMINUM CHLOROHYDRATE	13	g/100mL			N	20241231
10565-071_08a29ed0-f337-aa57-e063-6394a90a43a2	10565-071	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20170519		OTC MONOGRAPH DRUG	M003	Hydrox Laboratories	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
10565-072_08a512f7-d1ef-b3d6-e063-6394a90a8312	10565-072	HUMAN OTC DRUG	Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20111129		OTC MONOGRAPH DRUG	505G(a)(3)	Hydrox Laboratories	ALCOHOL	70	mL/100mL			N	20241231
10565-074_08a3ed3e-5447-05ed-e063-6394a90a331e	10565-074	HUMAN OTC DRUG	Anti-Perspirant Deodorant Roll-On	Unscented	Aluminum Chlorohydrate	LIQUID	TOPICAL	20120320		OTC MONOGRAPH DRUG	M019	Hydrox Laboratories	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
10565-075_08a51d93-7c79-dbfe-e063-6394a90a412c	10565-075	HUMAN OTC DRUG	Instant Hand Sanitizer Unscented		Alcohol	GEL	TOPICAL	20120321		OTC MONOGRAPH DRUG	505G(a)(3)	Hydrox Laboratories	ALCOHOL	70	mL/100mL			N	20241231
10565-076_08a52381-d02b-c869-e063-6294a90a099b	10565-076	HUMAN OTC DRUG	Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20120109		OTC MONOGRAPH DRUG	505G(a)(3)	Hydrox Laboratories	ALCOHOL	70	mL/100mL			N	20241231
10572-012_e3110358-d2d4-e2b6-e053-2a95a90ad363	10572-012	HUMAN PRESCRIPTION DRUG	SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE		sodium sulfate, potassium sulfate, magnesium sulfate	SOLUTION, CONCENTRATE	ORAL	20100805		NDA	NDA022372	Affordable Pharmaceuticals, LLC	MAGNESIUM SULFATE, UNSPECIFIED FORM; POTASSIUM SULFATE; SODIUM SULFATE	1.6; 3.13; 17.5	g/mL; g/mL; g/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
10572-100_e9bdf1ea-2513-c298-e053-2a95a90a601e	10572-100	HUMAN PRESCRIPTION DRUG	PEG-3350 and Electrolytes		Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20090701		NDA AUTHORIZED GENERIC	NDA019011	Affordable Pharmaceuticals, LLC	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/4L; g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
10572-101_e9bdf1ea-2513-c298-e053-2a95a90a601e	10572-101	HUMAN PRESCRIPTION DRUG	PEG-3350 and Electrolytes		Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20090701	20240229	NDA AUTHORIZED GENERIC	NDA019011	Affordable Pharmaceuticals, LLC	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/4L; g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
10572-112_e3110358-d2d4-e2b6-e053-2a95a90ad363	10572-112	HUMAN PRESCRIPTION DRUG	SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE		sodium sulfate, potassium sulfate, magnesium sulfate	SOLUTION, CONCENTRATE	ORAL	20100805		NDA	NDA022372	Affordable Pharmaceuticals, LLC	MAGNESIUM SULFATE, UNSPECIFIED FORM; POTASSIUM SULFATE; SODIUM SULFATE	1.2; 2.35; 13.13	g/133.1mL; g/133.1mL; g/133.1mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
10572-302_d21af010-592c-bd05-e053-2995a90a3d39	10572-302	HUMAN PRESCRIPTION DRUG	PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride		polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride	POWDER, FOR SOLUTION	ORAL	20130208		NDA AUTHORIZED GENERIC	NDA019797	Affordable Pharmaceuticals, LLC	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	420; 1.48; 5.72; 11.2	g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
10578-001_eb8cf3f1-59d8-80cc-e053-2995a90a8f64	10578-001	HUMAN OTC DRUG	Eucamint		menthol, camphor	OINTMENT	TOPICAL	19950101		OTC MONOGRAPH FINAL	part341	Indiana Botanic Gardens	CAMPHOR (SYNTHETIC); MENTHOL	4.35; 2.61	g/100g; g/100g			N	20241231
10578-131_3b057467-ca8c-48c2-99ad-80a012b5f74b	10578-131	HUMAN OTC DRUG	Dr. Blue		menthol	GEL	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part348	Indiana Botanic Gardens	MENTHOL	4.58	g/100g			N	20241231
10578-135_dba1d268-ebac-0ac7-e053-2a95a90ad4b6	10578-135	HUMAN OTC DRUG	Painzaway Pain Relieving Gel		Menthol	GEL	TOPICAL	20220419		OTC MONOGRAPH NOT FINAL	part348	Indiana Botanic Gardens	MENTHOL	4.6	g/100g			N	20241231
10596-159_0b642bd3-ef22-c69d-e063-6294a90a1dd2	10596-159	HUMAN OTC DRUG	Biore	Blemish Fighting Ice Cleanser	SALICYLIC ACID	LIQUID	TOPICAL	20111228		OTC MONOGRAPH DRUG	M006	Kao USA Inc.	SALICYLIC ACID	4.3	g/200mL			N	20241231
10596-161_d22ace33-a03b-3ac3-e053-2a95a90a3e22	10596-161	HUMAN OTC DRUG	Biore	Pore Unclogging Scrub	SALICYLIC ACID	LIQUID	TOPICAL	20111228		OTC MONOGRAPH FINAL	part333D	Kao USA Inc.	SALICYLIC ACID	2.8	g/141g			N	20241231
10596-184_0c64f3d6-38ed-6b66-e063-6294a90a6555	10596-184	HUMAN OTC DRUG	Biore	Charcoal Acne Scrub	SALICYLIC ACID	GEL	TOPICAL	20161201	20240630	OTC MONOGRAPH DRUG	M006	Kao USA Inc.	SALICYLIC ACID	1.3	g/127g			N	
10596-185_b0b63981-1fe0-3eaa-e053-2a95a90ae4e1	10596-185	HUMAN OTC DRUG	Biore	Charcoal Acne Clearing Cleanser	SALICYLIC ACID	GEL	TOPICAL	20161201		OTC MONOGRAPH FINAL	part333D	Kao USA Inc.	SALICYLIC ACID	2	g/200mL			N	20241231
10596-187_f7f84c53-690b-21a4-e053-6294a90a9f40	10596-187	HUMAN OTC DRUG	Biore	Witch Hazel Pore Clarifying Toner	SALICYLIC ACID	LIQUID	TOPICAL	20180618		OTC MONOGRAPH FINAL	part333D	Kao USA Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
10596-188_bda8ad18-76ac-1ccb-e053-2a95a90a06e6	10596-188	HUMAN OTC DRUG	Biore	Witch Hazel Pore Clarifying Cleanser	SALICYLIC ACID	LIQUID	TOPICAL	20181201		OTC MONOGRAPH FINAL	part333D	Kao USA Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
10596-191_0ce45244-4a01-d4ce-e063-6394a90aa0a1	10596-191	HUMAN OTC DRUG	Biore	Anti Blemish Flash Treatment	SALICYLIC ACID	LIQUID	TOPICAL	20191001	20240630	OTC MONOGRAPH DRUG	505G(a)(3)	Kao USA Inc.	SALICYLIC ACID	2	g/100g			N	
10596-195_f900db18-5fe3-1d74-e053-6394a90a3ca2	10596-195	HUMAN OTC DRUG	Biore Aqua Rich UV		Octocrylene, Octisalate, Avobenzene, Homosalate	LIQUID	TOPICAL	20230410		OTC MONOGRAPH FINAL	M020	KAO USA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
10596-196_f6dfaa8f-1672-1460-e053-6394a90aa67c	10596-196	HUMAN OTC DRUG	Biore		salicyclic acid	LIQUID	TOPICAL	20230313		OTC MONOGRAPH FINAL	M006	KAO USA	SALICYLIC ACID	2	g/100mL			N	20241231
10596-197_f9024581-dbac-b7cb-e053-6294a90a8b9a	10596-197	HUMAN OTC DRUG	Biore Aqua Rich UV		OCTOCRYLENE, OCTISALATE, AVOBENZENE, HOMOSALATE	LIQUID	TOPICAL	20230410		OTC MONOGRAPH FINAL	M020	KAO USA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
10596-331_f7f84c9b-765f-21a2-e053-6294a90a93eb	10596-331	HUMAN OTC DRUG	Ban	Invisible Solid Antiperspirant Deodorant Powder Fresh	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20111229		OTC MONOGRAPH FINAL	part350	Kao USA Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	13.87	g/73g			N	20241231
10596-333_f7f84c9b-7660-21a2-e053-6294a90a93eb	10596-333	HUMAN OTC DRUG	Ban	Invisible Solid Antiperspirant Deodorant Shower Fresh	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20111229		OTC MONOGRAPH FINAL	part350	Kao USA Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	13.87	g/73g			N	20241231
10596-334_f7f869f9-ed77-80c7-e053-6394a90ad023	10596-334	HUMAN OTC DRUG	Ban	Invisible Solid Antiperspirant Deodorant Sweet Simplicity	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20111229		OTC MONOGRAPH FINAL	M019	Kao USA Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	13.87	g/73g			N	20241231
10596-335_f7f869f9-ed78-80c7-e053-6394a90ad023	10596-335	HUMAN OTC DRUG	Ban	Invisible Solid Antiperspirant Deodorant Unscented	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20111229		OTC MONOGRAPH FINAL	part350	Kao USA Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	13.87	g/73g			N	20241231
10596-336_0404bc4f-d496-b808-e063-6294a90a5cb6	10596-336	HUMAN OTC DRUG	Ban	Roll-On Antiperspirant Deodorant Regular	Aluminum Chlorohydrate	LIQUID	TOPICAL	20120101		OTC MONOGRAPH FINAL	part350	Kao USA Inc.	ALUMINUM CHLOROHYDRATE	20	g/103mL			N	20241231
10596-337_f7f82fb3-852e-f261-e053-6394a90af525	10596-337	HUMAN OTC DRUG	Ban	Roll-On Antiperspirant Deodorant Powder Fresh	Aluminum Chlorohydrate	LIQUID	TOPICAL	20120101		OTC MONOGRAPH FINAL	part350	Kao USA Inc.	ALUMINUM CHLOROHYDRATE	20	g/103mL			N	20241231
10596-338_f7f82fb3-852f-f261-e053-6394a90af525	10596-338	HUMAN OTC DRUG	Ban	Roll-On Antiperspirant Deodorant Unscented	Aluminum Chlorohydrate	LIQUID	TOPICAL	20120101		OTC MONOGRAPH FINAL	M026	Kao USA Inc.	ALUMINUM CHLOROHYDRATE	20	g/103mL			N	20241231
10596-339_f7f86938-80c2-7259-e053-6294a90a341e	10596-339	HUMAN OTC DRUG	Ban	Roll-On Antiperspirant Deodorant Satin Breeze	Aluminum Chlorohydrate	LIQUID	TOPICAL	20120101		OTC MONOGRAPH FINAL	part350	Kao USA Inc.	ALUMINUM CHLOROHYDRATE	20	g/103mL			N	20241231
10596-340_f7f87092-b394-2e89-e053-6394a90a8e77	10596-340	HUMAN OTC DRUG	Ban	Roll-On Antiperspirant Deodorant Fresh Cotton	Aluminum Chlorohydrate	LIQUID	TOPICAL	20120101		OTC MONOGRAPH FINAL	part350	Kao USA Inc.	ALUMINUM CHLOROHYDRATE	20	g/103mL			N	20241231
10596-400_f7f869f9-ed79-80c7-e053-6394a90ad023	10596-400	HUMAN OTC DRUG	Ban	Roll-On Antiperspirant Deodorant Simple Clean	Aluminum Chlorohydrate	LIQUID	TOPICAL	20111108		OTC MONOGRAPH FINAL	part350	Kao USA Inc	ALUMINUM CHLOROHYDRATE	20	g/103mL			N	20241231
10596-402_f7f87284-bef5-7464-e053-6294a90a1612	10596-402	HUMAN OTC DRUG	Ban Purely Gentle	Roll-On Antiperspirant Deodorant Unscented	Aluminum Chlorohydrate	LIQUID	TOPICAL	20180101		OTC MONOGRAPH FINAL	M019	Kao USA Inc.	ALUMINUM CHLOROHYDRATE	18	g/100mL			N	20241231
10596-714_0b645ab6-0693-3335-e063-6394a90a1f16	10596-714	HUMAN OTC DRUG	Jergens Natural Glow Face	Daily Moisturizer for Fair/Medium Skin	Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20150220		OTC MONOGRAPH DRUG	M020	Kao USA Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.74; 2.95; .65	g/59mL; g/59mL; g/59mL			N	20241231
10596-718_ff601f5c-b8ee-ee21-e053-6294a90aadba	10596-718	HUMAN OTC DRUG	Jergens Natural Glow Face	Moisturizer Medium to Deep Skin Tones	Avobenzone,Octisalate, Octocrylene	LOTION	TOPICAL	20230627		OTC MONOGRAPH NOT FINAL	part352	Kao USA Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.74; 2.95; .65	g/59mL; g/59mL; g/59mL			N	20241231
10596-901_038909c9-2c5b-d40b-e063-6294a90a1ec6	10596-901	HUMAN OTC DRUG	Re/Cover kit		COLLOIDAL OATMEAL	KIT	TOPICAL	20230821		UNAPPROVED DRUG OTHER		KAO USA						N	20241231
10599-003_508796b2-418c-402f-a33f-5766a8d4c18b	10599-003	HUMAN PRESCRIPTION DRUG	Sinuva		mometasone furoate	IMPLANT	INTRASINAL	20180201		NDA	NDA209310	Intersect ENT, Inc.	MOMETASONE FUROATE	1350	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10631-002_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-002	HUMAN PRESCRIPTION DRUG	Absorica LD		isotretinoin	CAPSULE	ORAL	20191120		NDA	NDA211913	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	8	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-003_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-003	HUMAN PRESCRIPTION DRUG	Absorica LD		isotretinoin	CAPSULE	ORAL	20191120		NDA	NDA211913	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	16	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-005_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-005	HUMAN PRESCRIPTION DRUG	Absorica LD		isotretinoin	CAPSULE	ORAL	20191120		NDA	NDA211913	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	24	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-007_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-007	HUMAN PRESCRIPTION DRUG	Absorica LD		isotretinoin	CAPSULE	ORAL	20191120		NDA	NDA211913	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	32	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-008_b982da20-735c-49d8-ad1f-6a831194db87	10631-008	HUMAN PRESCRIPTION DRUG	KAPSPARGO		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180315		NDA	NDA210428	Sun Pharmaceutical Industries, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10631-009_b982da20-735c-49d8-ad1f-6a831194db87	10631-009	HUMAN PRESCRIPTION DRUG	KAPSPARGO		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180315		NDA	NDA210428	Sun Pharmaceutical Industries, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10631-010_b982da20-735c-49d8-ad1f-6a831194db87	10631-010	HUMAN PRESCRIPTION DRUG	KAPSPARGO		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180315		NDA	NDA210428	Sun Pharmaceutical Industries, Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10631-011_b982da20-735c-49d8-ad1f-6a831194db87	10631-011	HUMAN PRESCRIPTION DRUG	KAPSPARGO		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180315		NDA	NDA210428	Sun Pharmaceutical Industries, Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
10631-093_eeb0548e-810f-4609-b3f0-fae397161fc8	10631-093	HUMAN PRESCRIPTION DRUG	Kenalog		Triamcinolone Acetonide	AEROSOL, SPRAY	TOPICAL	20090519		NDA	NDA012104	Sun Pharmaceutical Industries, Inc.	TRIAMCINOLONE ACETONIDE	.147	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10631-094_40cc929a-926f-4de0-871f-6d6395e6e28c	10631-094	HUMAN PRESCRIPTION DRUG	Halog		Halcinonide Cream	CREAM	TOPICAL	20090210		NDA	NDA017556	Sun Pharmaceutical Industries, Inc.	HALCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10631-095_b2cf0aaa-872e-49bf-89f3-27b54469d4fa	10631-095	HUMAN PRESCRIPTION DRUG	HALOG		Halcinonide Topical	SOLUTION	TOPICAL	20200318		NDA	NDA017823	Sun Pharmaceutical Industries, Inc.	HALCINONIDE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10631-096_98b84856-f204-469a-8808-044dcc45ae18	10631-096	HUMAN PRESCRIPTION DRUG	HALOG		HALCINONIDE	OINTMENT	TOPICAL	20090519		NDA	NDA017824	Sun Pharmaceutical Industries, Inc.	HALCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10631-115_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-115	HUMAN PRESCRIPTION DRUG	Absorica		isotretinoin	CAPSULE	ORAL	20120608		NDA	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-116_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-116	HUMAN PRESCRIPTION DRUG	Absorica		isotretinoin	CAPSULE	ORAL	20120608		NDA	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-117_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-117	HUMAN PRESCRIPTION DRUG	Absorica		isotretinoin	CAPSULE	ORAL	20120608		NDA	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-118_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-118	HUMAN PRESCRIPTION DRUG	Absorica		isotretinoin	CAPSULE	ORAL	20120608		NDA	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-122_8afe3d44-b60c-4ba2-ab6c-8da871fc62b0	10631-122	HUMAN PRESCRIPTION DRUG	Ultravate		halobetasol propionate	LOTION	TOPICAL	20160301		NDA	NDA208183	Sun Pharmaceutical Industries, Inc.	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10631-133_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-133	HUMAN PRESCRIPTION DRUG	Absorica		isotretinoin	CAPSULE	ORAL	20150217		NDA	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	25	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-134_fba81535-0761-42a7-b422-338f8bd2cfc6	10631-134	HUMAN PRESCRIPTION DRUG	Absorica		isotretinoin	CAPSULE	ORAL	20150217		NDA	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	35	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
10631-206_8ed86d67-8a49-4334-82c4-1dbf6a489d3b	10631-206	HUMAN PRESCRIPTION DRUG	Riomet		Metformin Hydrochloride	SOLUTION	ORAL	20040104		NDA	NDA021591	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	500	mg/5mL	Biguanide [EPC], Biguanides [CS]		N	20241231
10631-238_8ed86d67-8a49-4334-82c4-1dbf6a489d3b	10631-238	HUMAN PRESCRIPTION DRUG	Riomet		Metformin Hydrochloride	SOLUTION	ORAL	20040104		NDA	NDA021591	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	500	mg/5mL	Biguanide [EPC], Biguanides [CS]		N	20241231
10631-407_297a7b51-8e62-40c1-8691-0b6173918414	10631-407	HUMAN PRESCRIPTION DRUG	Proctosol-HC		Hydrocortisone	CREAM	TOPICAL	20050428		ANDA	ANDA088799	Sun Pharmaceutical Industries, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
10690-001_080200ff-2cfd-2dac-e063-6294a90a72dd	10690-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19780101		NDA	NDA205865	Depke Welding Supplies, Inc.	OXYGEN	995	mL/L			N	20241231
10690-002_0801d255-e0bb-9e59-e063-6394a90ad9a4	10690-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205866	Depke Welding Supplies, Inc.	NITROGEN	990	mL/L			N	20241231
10702-001_0ce01306-ef7f-563f-e063-6394a90a52b7	10702-001	HUMAN PRESCRIPTION DRUG	LOMAIRA		Phentermine Hydrochloride	TABLET	ORAL	20160912		ANDA	ANDA203495	KVK-TECH, INC.	PHENTERMINE HYDROCHLORIDE	8	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
10702-005_838e40fd-bd38-4b8d-abd4-45da435f1777	10702-005	HUMAN OTC DRUG	Dexbrompherniramine Maleate and Pseudoephedrine Sulfate	6mg/120mg	Dexbrompherniramine Maleate and Pseudoephedrine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20181217		ANDA	ANDA078648	KVK-TECH, INC.	DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE	6; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
10702-006_7d541fa9-d74b-5236-e053-2991aa0acc0e	10702-006	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	KVK-TECH, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
10702-007_7d541fa9-d74b-5236-e053-2991aa0acc0e	10702-007	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	KVK-TECH, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
10702-008_09ce8e17-96d3-9d49-e063-6294a90aa0f8	10702-008	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	KVK-TECH,INC	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-009_09ce8e17-96d3-9d49-e063-6294a90aa0f8	10702-009	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	KVK-TECH,INC	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-010_eff46bea-a884-5878-e053-2a95a90ae664	10702-010	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040786	KVK-Tech, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
10702-011_eff46bea-a884-5878-e053-2a95a90ae664	10702-011	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040786	KVK-Tech, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
10702-012_eff46bea-a884-5878-e053-2a95a90ae664	10702-012	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040786	KVK-Tech, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
10702-017_7d67f785-a25f-1819-e053-2991aa0a11d3	10702-017	HUMAN OTC DRUG	Chlorphen-12		Chlorpheniramine Maleate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100615		ANDA	ANDA040829	KVK-Tech, Inc.	CHLORPHENIRAMINE MALEATE	12	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
10702-018_09ce8e17-96d3-9d49-e063-6294a90aa0f8	10702-018	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	KVK-TECH,INC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-026_7d77cc21-8787-13bd-e053-2991aa0af08d	10702-026	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	KVK-Tech, Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
10702-027_7d77cc21-8787-13bd-e053-2991aa0af08d	10702-027	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	KVK-Tech, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
10702-028_7d77cc21-8787-13bd-e053-2991aa0af08d	10702-028	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	KVK-Tech, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
10702-036_7d78d917-2bde-6982-e053-2a91aa0ad631	10702-036	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		Sodium Polystyrene Sulfonate	POWDER	ORAL; RECTAL	20120725		ANDA	ANDA040905	KVK-Tech, Inc.	SODIUM POLYSTYRENE SULFONATE	1	g/g			N	20241231
10702-044_7d61a805-8dc5-4926-e053-2991aa0a49fa	10702-044	HUMAN PRESCRIPTION DRUG	DIETHYLPROPION HYDROCHLORIDE		DIETHYLPROPION HYDROCHLORIDE	TABLET	ORAL	20101227		ANDA	ANDA201212	KVK-TECH, INC	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
10702-045_99731537-82e4-cf08-e053-2995a90a94f2	10702-045	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	KVK-TECH, INC	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
10702-055_7d627eaa-683c-65e6-e053-2a91aa0a5833	10702-055	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		Hydrocodone Bitartrate and Homatropine Methylbromide	TABLET	ORAL	20170807		ANDA	ANDA207176	KVK-Tech, Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-056_09ce8e17-96d3-9d49-e063-6294a90aa0f8	10702-056	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	KVK-TECH,INC	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-057_09ce8e17-96d3-9d49-e063-6294a90aa0f8	10702-057	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	KVK-TECH,INC	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-065_09074cf3-f89a-db31-e063-6394a90a96b6	10702-065	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20151123		ANDA	ANDA203548	KVK-Tech, Inc.	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
10702-066_09074cf3-f89a-db31-e063-6394a90a96b6	10702-066	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20151123		ANDA	ANDA203548	KVK-Tech, Inc.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
10702-067_7d787b5e-b8c6-1ca4-e053-2991aa0a464b	10702-067	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20180329		ANDA	ANDA203436	KVK-TECH, Inc.	PHENTERMINE HYDROCHLORIDE	8	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
10702-070_0bef4471-e369-83e6-e063-6294a90a6a5d	10702-070	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		Oxymorphone Hydrochloride	TABLET	ORAL	20130211		ANDA	ANDA203601	KVK-Tech, Inc.	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-071_0bef4471-e369-83e6-e063-6294a90a6a5d	10702-071	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		Oxymorphone Hydrochloride	TABLET	ORAL	20130211		ANDA	ANDA203601	KVK-Tech, Inc.	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-077_99731537-82e4-cf08-e053-2995a90a94f2	10702-077	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	KVK-TECH, INC	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
10702-078_99731537-82e4-cf08-e053-2995a90a94f2	10702-078	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	KVK-TECH, INC	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
10702-150_7d627eaa-67ad-65e6-e053-2a91aa0a5833	10702-150	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		hydrocodone bitartrate and homatropine methylbromide oral solution	LIQUID	ORAL	20170221		ANDA	ANDA207487	KVK-Tech, Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-163_7d648f58-e026-2056-e053-2991aa0af885	10702-163	HUMAN PRESCRIPTION DRUG	Methylphenidate		Methylphenidate Hydrochloride	SOLUTION	ORAL	20161121		ANDA	ANDA207485	KVK-Tech, Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
10702-164_7d648f58-e026-2056-e053-2991aa0af885	10702-164	HUMAN PRESCRIPTION DRUG	Methylphenidate		Methylphenidate Hydrochloride	SOLUTION	ORAL	20161121		ANDA	ANDA207485	KVK-Tech, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
10702-171_9971bee1-a704-50f0-e053-2a95a90ab74b	10702-171	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		oxycodone hydrochloride	SOLUTION	ORAL	20170721		ANDA	ANDA208593	KVK-Tech, Inc.	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-183_9971bee1-a704-50f0-e053-2a95a90ab74b	10702-183	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20170721		ANDA	ANDA208593	KVK-Tech, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-184_0bf26a01-454e-9d8b-e063-6294a90a9602	10702-184	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180209		ANDA	ANDA210644	KVK-Tech, Inc.	ACETAMINOPHEN; OXYCODONE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-185_0bf26a01-454e-9d8b-e063-6294a90a9602	10702-185	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180209		ANDA	ANDA210644	KVK-Tech, Inc.	ACETAMINOPHEN; OXYCODONE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-186_0bf26a01-454e-9d8b-e063-6294a90a9602	10702-186	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180209		ANDA	ANDA210644	KVK-Tech, Inc.	ACETAMINOPHEN; OXYCODONE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-187_0bf26a01-454e-9d8b-e063-6294a90a9602	10702-187	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180209		ANDA	ANDA210644	KVK-Tech, Inc.	ACETAMINOPHEN; OXYCODONE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-189_0b4c1153-bdc7-8313-e063-6294a90a3765	10702-189	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA209037	KVK-Tech, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-190_0b4c1153-bdc7-8313-e063-6294a90a3765	10702-190	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA209037	KVK-Tech, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-191_0b4c1153-bdc7-8313-e063-6294a90a3765	10702-191	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA209037	KVK-Tech, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-192_0b4c1153-bdc7-8313-e063-6294a90a3765	10702-192	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA209036	KVK-Tech, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-193_0b4c1153-bdc7-8313-e063-6294a90a3765	10702-193	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA209036	KVK-Tech, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-194_0b4c1153-bdc7-8313-e063-6294a90a3765	10702-194	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20170622		ANDA	ANDA209036	KVK-Tech, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
10702-201_997064c9-24a1-7fb1-e053-2995a90ace7c	10702-201	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171222		ANDA	ANDA209335	KVK-Tech, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
10702-238_0b3e4839-4292-cae4-e063-6294a90ab2cf	10702-238	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	SOLUTION	ORAL	20191205		ANDA	ANDA211499	KVK-Tech, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
10702-364_051b2581-0874-9882-e063-6394a90ae12d	10702-364	HUMAN PRESCRIPTION DRUG	Isoproterenol hydrochloride		Isoproterenol hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230925		ANDA	ANDA215542	KVK-Tech, Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
10702-808_7ca0b8b7-21e5-4f26-8b0a-beca1638a662	10702-808	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	EMULSION	OPHTHALMIC	20220210		NDA AUTHORIZED GENERIC	NDA050790	KVK-TECH, INC.	CYCLOSPORINE	.5	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
10733-162_015475df-27f5-4371-e063-6294a90adddb	10733-162	HUMAN OTC DRUG	Topicale		Benzocaine	OINTMENT	ORAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	180	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-166_0155301b-ff8b-e06c-e063-6294a90a0b48	10733-166	HUMAN OTC DRUG	Topicale		Benzocaine	GEL	ORAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	180	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-167_01551860-dfd6-19aa-e063-6394a90a9d7b	10733-167	HUMAN OTC DRUG	Topicale		Benzocaine	GEL	ORAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	180	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-169_01551860-dfd6-19aa-e063-6394a90a9d7b	10733-169	HUMAN OTC DRUG	Topicale		Benzocaine	GEL	ORAL	20190401		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	180	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-170_01551860-dfd6-19aa-e063-6394a90a9d7b	10733-170	HUMAN OTC DRUG	Topicale		Benzocaine	GEL	ORAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	180	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-171_01551860-dfd6-19aa-e063-6394a90a9d7b	10733-171	HUMAN OTC DRUG	Topicale		Benzocaine	GEL	ORAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	180	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-173_01551b1e-fadb-ba1c-e063-6294a90a7224	10733-173	HUMAN OTC DRUG	Topicale		Benzocaine	PATCH	ORAL	20190506		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	180	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-174_01556923-4b0c-549b-e063-6294a90a18ad	10733-174	HUMAN OTC DRUG	Topicale Xtra		Benzocaine	GEL	ORAL	20220729		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories,Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-175_01558827-2fe8-2b63-e063-6294a90ac895	10733-175	HUMAN OTC DRUG	Topicale Xtra		Benzocaine	GEL	ORAL	20220822		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-176_01558d65-2f96-29e6-e063-6294a90a15f9	10733-176	HUMAN OTC DRUG	Topicale Xtra		Benzocaine	GEL	ORAL	20220817		OTC MONOGRAPH NOT FINAL	part356	Medical Products Laboratories,Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-412_b725dd26-c793-51a4-e053-2a95a90a573d	10733-412	HUMAN PRESCRIPTION DRUG	lumicain		Aluminium Chloride Hexahydrate	SOLUTION	TOPICAL	20100929		UNAPPROVED DRUG OTHER		Medical Products Laboratories, Inc.	ALUMINUM CHLORIDE	250	mg/g			N	20241231
10733-415_0168b7d1-41e3-38a6-e063-6294a90ad482	10733-415	HUMAN PRESCRIPTION DRUG	Salinocaine		salicylic acid and benzocaine	OINTMENT	TOPICAL	19380601		UNAPPROVED DRUG OTHER		Medical Products Laboratories, Inc.	BENZOCAINE; SALICYLIC ACID	20; 550	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10733-800_08a3fd47-154f-9dc5-e063-6294a90ac81a	10733-800	HUMAN OTC DRUG	HYDROGEN PEROXIDE		Hydrogen Peroxide	SOLUTION	ORAL; TOPICAL	20201116		OTC MONOGRAPH DRUG	M003	MEDICAL PRODUCTS LABORATORIES, INC.	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
10733-801_bb8db612-ee0c-0a3a-e053-2995a90a79cc	10733-801	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20210129		OTC MONOGRAPH FINAL	part346	Medical Products Laboratories, Inc.	WITCH HAZEL	86	g/100mL			N	20241231
10736-014_080297ff-a3dc-398b-e063-6394a90a2f28	10736-014	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19630101		NDA	NDA206025	MEDICAL-TECHNICAL GASES, INC.	CARBON DIOXIDE	995	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
10736-017_08028b08-3d94-6e5e-e063-6294a90a42e2	10736-017	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19630101		NDA	NDA209989	MEDICAL-TECHNICAL GASES, INC.	NITROUS OXIDE	995	mL/L			N	20241231
10736-020_08027ca7-3bbd-8f9b-e063-6294a90ac69c	10736-020	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	20210107		NDA	NDA205864	Medical-technical Gases, Inc.	HELIUM	990	mL/L			N	20241231
10736-202_0802760c-cc10-8290-e063-6294a90a71e9	10736-202	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19630101		NDA	NDA205767	MEDICAL-TECHNICAL GASES, INC.	OXYGEN	990	mL/L			N	20241231
10736-203_08028b08-3d95-6e5e-e063-6294a90a42e2	10736-203	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20120529		NDA	NDA205866	Medical-Technical Gases, Inc.	NITROGEN	990	mL/L			N	20241231
10738-020_f4224e76-39ce-09ee-e053-2995a90a1bbf	10738-020	HUMAN OTC DRUG	Triderma Lipsore Cream		CALENDULA OFFICINALIS	CREAM	TOPICAL	20210427		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	CALENDULA OFFICINALIS FLOWERING TOP	1.5	g/100g			N	20241231
10738-032_f395cdd3-a10c-1688-e053-2a95a90a896d	10738-032	HUMAN OTC DRUG	Healing All-Purpose Cream		CALENDULA OFFICINALIS	CREAM	TOPICAL	20200801		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	CALENDULA OFFICINALIS FLOWERING TOP	1.5	g/100g			N	20241231
10738-034_f3bd6bb6-6415-4215-e053-2995a90abf84	10738-034	HUMAN OTC DRUG	TRIDERMA Acne Spot Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20191230		OTC MONOGRAPH FINAL	part333D	Genuine Virgin Aloe Corporation	BENZOYL PEROXIDE	2.5	g/100g			N	20241231
10738-041_f3bd655c-44e6-1f1d-e053-2995a90a5390	10738-041	HUMAN OTC DRUG	TRIDERMA Acne Gel Face Wash		SALICYLIC ACID	GEL	TOPICAL	20200116		OTC MONOGRAPH FINAL	part333D	Genuine Virgin Aloe Corporation	SALICYLIC ACID	2	g/100mL			N	20241231
10738-054_f394e011-25f8-0783-e053-2995a90a60ed	10738-054	HUMAN OTC DRUG	TRIDERMA ECZEMA FAST HEALING FACE AND BODY		COLLOIDAL OATMEAL	CREAM	TOPICAL	20191001		OTC MONOGRAPH FINAL	part347	Genuine Virgin Aloe Corporation	OATMEAL	1.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10738-057_f3bd6141-c0da-218c-e053-2995a90a3233	10738-057	HUMAN OTC DRUG	TRIDERMA ULCER DEFENSE HEALING		Calendula Officinalis	CREAM	TOPICAL	20190830		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	CALENDULA OFFICINALIS FLOWERING TOP	1.5	g/100g			N	20241231
10738-059_f3bd655c-44f8-1f1d-e053-2995a90a5390	10738-059	HUMAN OTC DRUG	TRIDERMA EVERYDAY BRUISE RELIEF		ARNICA MONTANA	CREAM	TOPICAL	20190830		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	ARNICA MONTANA	1.6	g/100g			N	20241231
10738-060_f3bd79ab-be89-e676-e053-2a95a90ad560	10738-060	HUMAN OTC DRUG	TRIDERMA Intense Fast Healing Multi-Purpose Cream		Calendula Officinalis	CREAM	TOPICAL	20191230		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	CALENDULA OFFICINALIS FLOWER	1.5	g/100g			N	20241231
10738-061_f3bd7bf8-e277-6121-e053-2995a90aa3ef	10738-061	HUMAN OTC DRUG	TRIDERMA PROTECT AND HEAL NON- GREASY BARRIER		ALLANTOIN, DIMETHICONE	CREAM	TOPICAL	20190830		OTC MONOGRAPH FINAL	part347	Genuine Virgin Aloe Corporation	ALLANTOIN; DIMETHICONE	1.5; 2	g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10738-062_f395383a-0aed-22fe-e053-2995a90aae5c	10738-062	HUMAN OTC DRUG	TRIDERMA Psoriasis Control Face and Body Cream		Salicylic Acid	CREAM	TOPICAL	20191230		OTC MONOGRAPH FINAL	part358H	Genuine Virgin Aloe Corporation	SALICYLIC ACID	3	g/100g			N	20241231
10738-065_f3bd7bf8-e287-6121-e053-2995a90aa3ef	10738-065	HUMAN OTC DRUG	TRIDERMA BRUISE DEFENSE HEALING -DIABETICS		Arnica Montana Flower Extract	CREAM	TOPICAL	20190830		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	ARNICA MONTANA FLOWER	1.6	g/100g			N	20241231
10738-068_f3bd79ab-be99-e676-e053-2a95a90ad560	10738-068	HUMAN OTC DRUG	TriDerma Stubborn Diaper Rash Relief		Allantoin, Dimethicone	CREAM	TOPICAL	20191031		OTC MONOGRAPH FINAL	part347	Genuine Virgin Aloe Corporation	ALLANTOIN; DIMETHICONE	1.5; 2	g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
10738-069_f395ca14-610c-8d42-e053-2995a90a0736	10738-069	HUMAN OTC DRUG	TRIDERMA BABY STUBBORN ECZEMA ITCH RELIEF		Colloidal Oatmeal	CREAM	TOPICAL	20190830		OTC MONOGRAPH FINAL	part347	Genuine Aloe Virgin Corporation	OATMEAL	1.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10738-073_f3bd7bf8-e29e-6121-e053-2995a90aa3ef	10738-073	HUMAN OTC DRUG	TRIDERMA PAIN RELIEF		Lidocaine HCl, Menthol	CREAM	TOPICAL	20190830		OTC MONOGRAPH NOT FINAL	part348	Genuine Virgin Aloe Corporation	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
10738-090_f395b7a1-408d-3a53-e053-2995a90a44a6	10738-090	HUMAN OTC DRUG	TRIDERMA Intense Fast Healing Multi-Purpose Cream		Calendula Officinalis	CREAM	TOPICAL	20191230		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	CALENDULA OFFICINALIS FLOWER	1.5	g/100g			N	20241231
10738-162_f3951e7c-ea2e-c0b0-e053-2995a90afb0c	10738-162	HUMAN OTC DRUG	Eczema Itch Relief Wash and Shampo		Colloidal Oatmeal	SHAMPOO	TOPICAL	20200901		OTC MONOGRAPH FINAL	part347	Genuine Virgin Aloe Corporation	OATMEAL	15	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10738-173_f3bd6bb6-6424-4215-e053-2995a90abf84	10738-173	HUMAN OTC DRUG	Triderma Moisturizing Hand Sanitizer		Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333E	Genuine Virgin Aloe Corporation	ALCOHOL	.62	mL/mL			N	20241231
10738-205_f39580ef-c5aa-a7d9-e053-2995a90a2d33	10738-205	HUMAN OTC DRUG	Eczema Fast Healing Body Wash		Colloidal Oatmeal	LOTION/SHAMPOO	TOPICAL	20190101		OTC MONOGRAPH FINAL	part347	Genuine Virgin Aloe Corporation	OATMEAL	15	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
10738-210_f3bd8b5f-9c1b-7e2b-e053-2995a90a4cc6	10738-210	HUMAN OTC DRUG	TRIDERMA PRESSURE SORE RELIEF		CALENDULA OFFICINALIS	CREAM	TOPICAL	20190830		UNAPPROVED HOMEOPATHIC		Genuine Virgin Aloe Corporation	CALENDULA OFFICINALIS FLOWERING TOP	1.5	g/100g			N	20241231
10738-217_f3bd8ee2-841b-a4a2-e053-2995a90aca32	10738-217	HUMAN OTC DRUG	TRIDERMA PSORIASIS CONTROL BODY WASH		SALICYLIC ACID	GEL	TOPICAL	20190930		OTC MONOGRAPH FINAL	part358H	Genuine Virgin Aloe Corporation	SALICYLIC ACID	2	g/100mL			N	20241231
10738-980_f3bd8ee2-842c-a4a2-e053-2995a90aca32	10738-980	HUMAN OTC DRUG	TRIDERMA Psoriasis Control		SALICYLIC ACID	SHAMPOO	TOPICAL	20200115		OTC MONOGRAPH FINAL	part358H	Genuine Virgin Aloe Corporation	SALICYLIC ACID	3	g/100mL			N	20241231
10742-0002_f41f0b29-ed30-3e2d-e053-2a95a90a1b3e	10742-0002	HUMAN OTC DRUG	Mentholatum	Original	camphor, menthol	OINTMENT	TOPICAL	20141201		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	90; 13	mg/g; mg/g			N	20241231
10742-0003_f41f0e08-99cd-0f1b-e053-2995a90a6639	10742-0003	HUMAN OTC DRUG	Mentholatum Greaseless Vaporizing Cream		camphor, eucalyptus oil, menthol	CREAM	TOPICAL	20190715		OTC MONOGRAPH FINAL	part341	The Mentholatum Company	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	53; 13; 28	mg/g; mg/g; mg/g			N	20241231
10742-0004_f28ee215-1dcc-0062-e053-2995a90a6c14	10742-0004	HUMAN OTC DRUG	Mentholatum Moisturizing Hand Sanitizer		benzalkonium chloride	GEL	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333E	The Mentholatum Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
10742-0009_f42158cb-2412-3acb-e053-2995a90abce6	10742-0009	HUMAN OTC DRUG	Red Cross Toothache		eugenol	LIQUID	TOPICAL	19830621		OTC MONOGRAPH NOT FINAL	part356	The Mentholatum Company	EUGENOL	850	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10742-1000_f94d900f-ce6e-2fd9-e053-6394a90acc12	10742-1000	HUMAN OTC DRUG	OXY	ADVANCED CARE 3 in 1 RETEXTURIZING CLEANSING PADS	salicylic acid	SWAB	TOPICAL	20220615		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/1			N	20241231
10742-1048_f41f5bd4-d3ad-721b-e053-2995a90a9c11	10742-1048	HUMAN OTC DRUG	Mentholatum Natural Ice	Cherry	dimethicone, octinoxate, octisalate	STICK	TOPICAL	19990819		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE	10; 75; 50	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-1101_f94d7fda-d1bf-406b-e053-6294a90a1b98	10742-1101	HUMAN OTC DRUG	Oxy	Detox Care Invisible Healing Treatment Patches	salicylic acid	PATCH	TOPICAL	20220615		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	5	mg/1			N	20241231
10742-1112_f41f0e08-994f-0f1b-e053-2995a90a6639	10742-1112	HUMAN OTC DRUG	Mentholatum Childrens Nighttime Vaporizing Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20180801		OTC MONOGRAPH FINAL	part341	The Mentholatum Company	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	53; 13; 28	mg/g; mg/g; mg/g			N	20241231
10742-1117_f41ecf54-aacf-0e57-e053-2995a90acbbe	10742-1117	HUMAN OTC DRUG	Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	MENTHOL, UNSPECIFIED FORM	500	mg/1			N	20241231
10742-1118_f41ecf54-aacf-0e57-e053-2995a90acbbe	10742-1118	HUMAN OTC DRUG	Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20141201		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	MENTHOL, UNSPECIFIED FORM	240	mg/1			N	20241231
10742-1200_f41ff4fd-b1f4-2fa3-e053-2a95a90a0f38	10742-1200	HUMAN OTC DRUG	OXY	ADVANCED CARE MAXIMUM STRENGTH 3-in-1 ACNE PADS	salicylic acid	SWAB	TOPICAL	20211001		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/1			N	20241231
10742-1201_f94d7c0d-3966-17a8-e053-6394a90a52dc	10742-1201	HUMAN OTC DRUG	Oxy	Advanced Care Rapid Spot Treatment	benzoyl peroxide	GEL	TOPICAL	20210712		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
10742-1202_f41fb0d6-aa62-95da-e053-2995a90a433e	10742-1202	HUMAN OTC DRUG	OXY	Advanced Care Soothing Cream Acne Cleanser	benzoyl peroxide	GEL	TOPICAL	20210901		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/mL			N	20241231
10742-1203_f41fb0d6-aa52-95da-e053-2995a90a433e	10742-1203	HUMAN OTC DRUG	OXY	Advanced Care Sensitive Skin Acne Cleanser	Benzoyl Peroxide	GEL	TOPICAL	20210920		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	50	mg/mL			N	20241231
10742-1205_f94d7fda-d1ae-406b-e053-6294a90a1b98	10742-1205	HUMAN OTC DRUG	Oxy	Advanced Care Rapid Spot Treatment	benzoyl peroxide	GEL	TOPICAL	20220331		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
10742-1206_f94d7c0d-3956-17a8-e053-6394a90a52dc	10742-1206	HUMAN OTC DRUG	OXY	Advanced Care Soothing Cream Acne Cleanser	benzoyl peroxide	GEL	TOPICAL	20220331		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
10742-1233_f4212f4e-5baf-6570-e053-2a95a90a4029	10742-1233	HUMAN OTC DRUG	Phisoderm Clear Confidence Face Scrub		Salicylic acid	GEL	TOPICAL	20120501		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/g			N	20241231
10742-1234_f4212f4e-5ba0-6570-e053-2a95a90a4029	10742-1234	HUMAN OTC DRUG	pHisoderm	CLEAN ANTI-BLEMISH BODY WASH	Salicylic Acid	GEL	TOPICAL	20210702		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/mL			N	20241231
10742-1235_f42125d5-b3ef-1cc9-e053-2995a90abb44	10742-1235	HUMAN OTC DRUG	pHisoderm	CLEAN ANTI-BLEMISH FACIAL CLEANSER	Salicylic Acid	GEL	TOPICAL	20210702		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/mL			N	20241231
10742-1236_f94d27b4-0a7c-6bf4-e053-6294a90a125a	10742-1236	HUMAN OTC DRUG	pHisoderm	CLEAN ANTI-BLEMISH BODY WASH	Salicylic Acid	GEL	TOPICAL	20220331		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/g			N	20241231
10742-1301_f41f5df4-2827-35d3-e053-2995a90adcf4	10742-1301	HUMAN OTC DRUG	Oxy Rapid Spot Treatment	Maximum Action	benzoyl peroxide	CREAM	TOPICAL	20150101		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
10742-1313_f41fd90f-cb52-2c19-e053-2995a90a0a5f	10742-1313	HUMAN OTC DRUG	Oxy Sensitive Face Wash	Maximum Soothing	Benzoyl Peroxide	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	50	mg/mL			N	20241231
10742-1314_f41fa0d6-27fa-a8d8-e053-2a95a90a1422	10742-1314	HUMAN OTC DRUG	Oxy	Total Care Clarifying Moisturizer	benzoyl peroxide	LOTION	TOPICAL	20190930		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	25	mg/mL			N	20241231
10742-1315_ff376144-28a3-8811-e053-6394a90aa995	10742-1315	HUMAN OTC DRUG	Oxy	Total Care Vitamin C Serum	salicylic acid	SOLUTION	TOPICAL	20190930		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	5	mg/mL			N	20241231
10742-1316_f41f7de4-fbc3-2814-e053-2995a90a6e38	10742-1316	HUMAN OTC DRUG	Oxy	Total Care Creamy Facial Cleanser	salicylic acid	CREAM	TOPICAL	20190930		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/mL			N	20241231
10742-1338_f41fe09c-5f83-43e1-e053-2995a90a51ac	10742-1338	HUMAN OTC DRUG	OXY Volcanic Ash Detox Scrub		Salicylic acid	CREAM	TOPICAL	20181101		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/g			N	20241231
10742-1389_f41f560b-806e-f93a-e053-2a95a90a2ed6	10742-1389	HUMAN OTC DRUG	Mentholatum Lidocaine Ice		Lidocaine HCl, Menthol	GEL	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
10742-1397_f41fc590-5d39-a2d2-e053-2995a90ad3c9	10742-1397	HUMAN OTC DRUG	Oxy 10 Acne Cleanser		benzoyl peroxide	CREAM	TOPICAL	20180701		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/mL			N	20241231
10742-1412_f4213fe8-a58f-549d-e053-2995a90a8ce3	10742-1412	HUMAN OTC DRUG	Phisoderm Clear Confidence Daily Gel Face Wash		Salicylic acid	LIQUID	TOPICAL	20120501		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/mL			N	20241231
10742-1442_f4213d06-8335-da5d-e053-2995a90a5bdc	10742-1442	HUMAN OTC DRUG	Phisoderm Clear Confidence Body Wash		Salicylic Acid	LIQUID	TOPICAL	20120501		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/mL			N	20241231
10742-2002_f41f0e08-995d-0f1b-e053-2995a90a6639	10742-2002	HUMAN OTC DRUG	Mentholatum Deep Heating Rub	Extra Strength	menthol, methyl salicylate	CREAM	TOPICAL	19921215		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	80; 300	mg/g; mg/g			N	20241231
10742-2112_f41f1180-016a-5390-e053-2a95a90a9c56	10742-2112	HUMAN OTC DRUG	Mentholatum Lavender Vaporizing Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20180801		OTC MONOGRAPH FINAL	part341	The Mentholatum Company	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	53; 13; 28	mg/g; mg/g; mg/g			N	20241231
10742-3004_f41f3e6e-9047-90fe-e053-2a95a90ace9e	10742-3004	HUMAN OTC DRUG	Mentholatum Natural Ice	Original	dimethicone, octinoxate, octisalate	OINTMENT	TOPICAL	19990119		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE	10; 75; 50	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-3051_f4216d8c-6c3d-8d9a-e053-2a95a90ac1e6	10742-3051	HUMAN OTC DRUG	Softlips	Vanilla	dimethicone, octinoxate, octisalate, oxybenzone	OINTMENT	TOPICAL	19971119		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-3204_f4200b39-1703-4048-e053-2995a90a01e0	10742-3204	HUMAN OTC DRUG	OXY Cleansing Pads	Daily Defense	salicylic acid	SWAB	TOPICAL	20160801		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/1			N	20241231
10742-4204_f950bc1f-781a-e77b-e053-6394a90ac7ed	10742-4204	HUMAN OTC DRUG	OXY Deep Pore Cleansing Pads		salicylic acid	SWAB	TOPICAL	20180601		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/1			N	20241231
10742-4359_f4200390-f728-4921-e053-2995a90a4a38	10742-4359	HUMAN OTC DRUG	OXY 3 in 1 Acne Pads		salicylic acid	SWAB	TOPICAL	20180801		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/1			N	20241231
10742-6000_f420516b-84e0-5ea6-e053-2995a90acf31	10742-6000	HUMAN OTC DRUG	Ultra Strength Muscle Rub		Camphor, Menthol, Methyl salicylate	CREAM	TOPICAL	20210308		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
10742-7001_f4219310-240b-5ca1-e053-2995a90a04b0	10742-7001	HUMAN OTC DRUG	Softlips Cherry Cordial, Maple Butter, Frosted Berry		dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20181015		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; ug/g	Skin Barrier Activity [PE]		N	20241231
10742-7002_f420498a-bfbd-4549-e053-2995a90a7b09	10742-7002	HUMAN OTC DRUG	Softlips Cherry, Raspberry, Vanilla		dimethicone	STICK	TOPICAL	20181015		OTC MONOGRAPH FINAL	part347	The Mentholatum Company	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7003_f421b6aa-1450-d521-e053-2a95a90affb1	10742-7003	HUMAN OTC DRUG	Softlips Watermelon, Tropical Coconut, Peach Passion		dimethicone	STICK	TOPICAL	20181015		OTC MONOGRAPH FINAL	part347	The Mentholatum Company	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7004_f421a647-b109-5ea4-e053-2995a90a3d88	10742-7004	HUMAN OTC DRUG	Softlips Salted Caramel, Candy Apple, Marshmallow Ghost		dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20181015		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; ug/g	Skin Barrier Activity [PE]		N	20241231
10742-7005_f4216a89-8fb3-5211-e053-2995a90a6007	10742-7005	HUMAN OTC DRUG	Softlips	Tropical Coconut Peach Passion	dimethicone	STICK	TOPICAL	20200501		OTC MONOGRAPH FINAL	part347	The Mentholatum Company	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7006_f42189ba-c354-0844-e053-2995a90a5285	10742-7006	HUMAN OTC DRUG	Softlips	Peach Passion	dimethicone	STICK	TOPICAL	20190930		OTC MONOGRAPH FINAL	part347	The Mentholatum Company	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7007_f42186e9-988d-5c9d-e053-2995a90a00d1	10742-7007	HUMAN OTC DRUG	Softlips	Tropical Coconut	dimethicone	STICK	TOPICAL	20190930		OTC MONOGRAPH FINAL	part347	The Mentholatum Company	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7008_f4204cef-2391-50bc-e053-2995a90ac851	10742-7008	HUMAN OTC DRUG	Softlips	Watermelon	dimethicone	STICK	TOPICAL	20190930		OTC MONOGRAPH FINAL	part347	The Mentholatum Company	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7009_f42158cb-2421-3acb-e053-2995a90abce6	10742-7009	HUMAN OTC DRUG	Softlips	Vanilla, Watermelon, Cherry	dimethicone, octinoxate, octisalate, oxybenzone	OINTMENT	TOPICAL	20200403		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7010_f42152e4-d024-5cf6-e053-2a95a90a6304	10742-7010	HUMAN OTC DRUG	Softlips	Peppermint Mocha, Apple Chai Cider, Orange Cranberry	dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20201109		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-7011_f4216d8c-6c0a-8d9a-e053-2a95a90ac1e6	10742-7011	HUMAN OTC DRUG	Softlips	Pearl Plus Vanilla	dimethicone, octinoxate, octisalate, oxybenzone	KIT		20170102		OTC MONOGRAPH FINAL	part352	The Mentholatum Company						N	20241231
10742-8096_f94d27b4-0a89-6bf4-e053-6294a90a125a	10742-8096	HUMAN OTC DRUG	Mentholatum No Mess Vaporizing Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20160701		OTC MONOGRAPH FINAL	part341	The Mentholatum Company	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	53; 13; 28	mg/g; mg/g; mg/g			N	20241231
10742-8125_f420f705-58fe-4432-e053-2995a90aa99c	10742-8125	HUMAN OTC DRUG	WellPatch Cooling Pain Relief		menthol	PATCH	TOPICAL	20170206		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	MENTHOL, UNSPECIFIED FORM	50	mg/1			N	20241231
10742-8127_f4230c23-7cc4-5400-e053-2995a90a266d	10742-8127	HUMAN OTC DRUG	WellPatch Warming Pain Relief		capsaicin	PATCH	TOPICAL	20161205		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	CAPSAICIN	25	mg/1			N	20241231
10742-8140_f94d35cb-be00-88c3-e053-6294a90a51b0	10742-8140	HUMAN OTC DRUG	Rohto	Sun and Sport	hypromellose, povidone	LIQUID	OPHTHALMIC	20220701		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	HYPROMELLOSE, UNSPECIFIED; POVIDONE, UNSPECIFIED	3; 5	mg/mL; mg/mL			N	20241231
10742-8141_f43609cd-3292-6b21-e053-2995a90ac2a9	10742-8141	HUMAN OTC DRUG	Rohto	Cool Relief	Naphazoline hydrochloride, Polysorbate 80	LIQUID	OPHTHALMIC	20210621		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	NAPHAZOLINE HYDROCHLORIDE; POLYSORBATE 80	.12; 2	mg/mL; mg/mL			N	20241231
10742-8142_f43609cd-327c-6b21-e053-2995a90ac2a9	10742-8142	HUMAN OTC DRUG	Rohto	Cool	Naphazoline hydrochloride, Polysorbate 80	LIQUID	OPHTHALMIC	20010821		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	NAPHAZOLINE HYDROCHLORIDE; POLYSORBATE 80	.12; 2	mg/mL; mg/mL			N	20241231
10742-8143_f436048a-45c6-4885-e053-2a95a90aca84	10742-8143	HUMAN OTC DRUG	Rohto	Ice	Hypromellose, Tetrahydrozoline hydrochloride, Zinc sulfate	LIQUID	OPHTHALMIC	20050927		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	HYPROMELLOSE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM	2; .5; 2.5	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10742-8146_f435eabb-e9c9-fee3-e053-2995a90aa8b0	10742-8146	HUMAN OTC DRUG	Rohto	All-In-One	Hypromellose, Tetrahydrozoline hydrochloride, Zinc sulfate	LIQUID	OPHTHALMIC	20210621		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	HYPROMELLOSE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM	2; .5; 2.5	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10742-8158_f4337129-4080-1dee-e053-2a95a90abd96	10742-8158	HUMAN OTC DRUG	Rohto	Max Strength	Naphazoline hydrochloride, Polysorbate 80	LIQUID	OPHTHALMIC	20210512		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	NAPHAZOLINE HYDROCHLORIDE; POLYSORBATE 80	.3; 2	mg/mL; mg/mL			N	20241231
10742-8159_f4332b80-65aa-37a4-e053-2995a90a2375	10742-8159	HUMAN OTC DRUG	Rohto	Cool Max	Naphazoline hydrochloride, Polysorbate 80	LIQUID	OPHTHALMIC	20140505		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	NAPHAZOLINE HYDROCHLORIDE; POLYSORBATE 80	.3; 2	mg/mL; mg/mL			N	20241231
10742-8160_f4364bdb-05e8-1a4e-e053-2a95a90acc94	10742-8160	HUMAN OTC DRUG	Rohto Optic Glow		Naphazoline hydrochloride, Povidone, Propylene glycol	LIQUID	OPHTHALMIC	20210326		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	NAPHAZOLINE HYDROCHLORIDE; POVIDONE, UNSPECIFIED; PROPYLENE GLYCOL	.3; 5; 2	mg/mL; mg/mL; mg/mL			N	20241231
10742-8161_f94d3f12-ce4a-8dee-e053-6294a90aa0db	10742-8161	HUMAN OTC DRUG	Rohto	Preservative Free Dry Aid	povidone, propylene glycol	LIQUID	OPHTHALMIC	20220603		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	POVIDONE, UNSPECIFIED; PROPYLENE GLYCOL	6.8; 3	mg/mL; mg/mL			N	20241231
10742-8162_f422f710-5398-2061-e053-2a95a90ae494	10742-8162	HUMAN OTC DRUG	Rohto Dry-Aid		povidone, propylene glycol	LIQUID	OPHTHALMIC	20170101		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	POVIDONE, UNSPECIFIED; PROPYLENE GLYCOL	6.8; 3	mg/mL; mg/mL			N	20241231
10742-8168_ff376144-289f-8811-e053-6394a90aa995	10742-8168	HUMAN OTC DRUG	Mentholatum Nighttime Vaporizing Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20140714		OTC MONOGRAPH FINAL	part341	The Mentholatum Company	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	53; 13; 28	mg/g; mg/g; mg/g			N	20241231
10742-8169_f41f7f2f-5725-5c8b-e053-2a95a90a43db	10742-8169	HUMAN OTC DRUG	Mentholatum Pain Relieving		menthol, methyl salicylate	LOTION	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	60; 200	mg/mL; mg/mL			N	20241231
10742-8175_f43630ef-eb2e-076f-e053-2995a90a79ed	10742-8175	HUMAN OTC DRUG	Rohto Digi-Eye		Hypromellose, Tetrahydrozoline hydrochloride	LIQUID	OPHTHALMIC	20180301		OTC MONOGRAPH FINAL	part349	The Mentholatum Company	HYPROMELLOSE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE	3.5; .5	mg/mL; mg/mL			N	20241231
10742-8177_f42015a8-4f35-2147-e053-2a95a90a4f2f	10742-8177	HUMAN OTC DRUG	OXY Overnight Acne Reducing Patches		salicylic acid	PATCH	TOPICAL	20180101		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	5	mg/1			N	20241231
10742-8293_f421491b-e445-51be-e053-2995a90aeb1d	10742-8293	HUMAN OTC DRUG	Phisoderm Clear Confidence Spot Treatment		benzoyl peroxide	CREAM	TOPICAL	20130801		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	25	mg/g			N	20241231
10742-8304_f94d696f-5159-2115-e053-6294a90ab18e	10742-8304	HUMAN OTC DRUG	Oxy On-The-Go Acne Stick		benzoyl peroxide	STICK	TOPICAL	20161205		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	50	mg/g			N	20241231
10742-8334_f41fe09c-5f71-43e1-e053-2995a90a51ac	10742-8334	HUMAN OTC DRUG	OXY Volcanic Ash Acne Face Wash		Salicylic acid	LIQUID	TOPICAL	20181101		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/mL			N	20241231
10742-8338_f41feaa1-ffaa-83a3-e053-2a95a90a75ac	10742-8338	HUMAN OTC DRUG	OXY Volcanic Clay Acne Wash		Salicylic acid	CREAM	TOPICAL	20180101		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/g			N	20241231
10742-8353_f41fb0d6-aa73-95da-e053-2995a90a433e	10742-8353	HUMAN OTC DRUG	Oxy 10	Vanishing	benzoyl peroxide	LOTION	TOPICAL	20150701		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
10742-8354_f41fb0d6-aa81-95da-e053-2995a90a433e	10742-8354	HUMAN OTC DRUG	Oxy 10	Tinted	benzoyl peroxide	LOTION	TOPICAL	20150701		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/g			N	20241231
10742-8355_f41fc9b7-108f-d67f-e053-2995a90a8fa5	10742-8355	HUMAN OTC DRUG	Oxy 5	Vanishing	benzoyl peroxide	LOTION	TOPICAL	20150701		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	50	mg/g			N	20241231
10742-8356_f41fc590-5d49-a2d2-e053-2995a90ad3c9	10742-8356	HUMAN OTC DRUG	Oxy 5	Tinted	benzoyl peroxide	LOTION	TOPICAL	20150701		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	50	mg/g			N	20241231
10742-8386_f41f301d-d454-0cac-e053-2995a90ab741	10742-8386	HUMAN OTC DRUG	Mentholatum Lidocaine Heat		Lidocaine HCl	CREAM	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part348	The Mentholatum Company	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
10742-8397_f41fd33e-8f2e-14f8-e053-2995a90a5270	10742-8397	HUMAN OTC DRUG	Oxy Face Wash	Maximum Aciton	benzoyl peroxide	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	BENZOYL PEROXIDE	100	mg/mL			N	20241231
10742-8417_f42138a5-1655-d895-e053-2a95a90ac2fa	10742-8417	HUMAN OTC DRUG	Phisoderm Anti-Blemish Gel Cleanser		Salicylic acid	GEL	TOPICAL	20130901		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/g			N	20241231
10742-8451_f42133e8-4378-9ae2-e053-2995a90aa1d0	10742-8451	HUMAN OTC DRUG	Phisoderm Anti Blemish Body Wash		Salicylic Acid	LIQUID	TOPICAL	20130901		OTC MONOGRAPH FINAL	part333D	The Mentholatum Company	SALICYLIC ACID	20	mg/mL			N	20241231
10742-8470_f42186e9-98ae-5c9d-e053-2995a90a00d1	10742-8470	HUMAN OTC DRUG	Softlips	Raspberry	dimethicone, octinoxate, octisalate, oxybenzone	OINTMENT	TOPICAL	20070112		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8476_f4216d8c-6c2e-8d9a-e053-2a95a90ac1e6	10742-8476	HUMAN OTC DRUG	Softlips	Watermelon	dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20120416		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; ug/g	Skin Barrier Activity [PE]		N	20241231
10742-8477_f4216da2-2a5a-18ee-e053-2a95a90a12fd	10742-8477	HUMAN OTC DRUG	Softlips	Vanilla Watermelon	dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20191014		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8478_f4216a89-8fa0-5211-e053-2995a90a6007	10742-8478	HUMAN OTC DRUG	Softlips	Vanilla Watermelon	dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8508_f4204f8b-95c0-4b9f-e053-2995a90a2436	10742-8508	HUMAN OTC DRUG	Softlips Vanilla		dimethicone	STICK	TOPICAL	20161003		OTC MONOGRAPH FINAL	part347	The Mentholatum Company	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8510_f4218484-bde4-22af-e053-2995a90abc96	10742-8510	HUMAN OTC DRUG	Softlips	Marshmallow Ghost	dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20121001		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; ug/g	Skin Barrier Activity [PE]		N	20241231
10742-8512_f42186e9-989f-5c9d-e053-2995a90a00d1	10742-8512	HUMAN OTC DRUG	Softlips	Cherry	dimethicone, octinoxate, octisalate, oxybenzone	OINTMENT	TOPICAL	20000420		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8517_f421a647-b0f9-5ea4-e053-2995a90a3d88	10742-8517	HUMAN OTC DRUG	Softlips Peppermint		dimethicone, octinoxate, octisalate, oxybenzone	STICK	TOPICAL	20161107		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 75; 30; 30	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8573_f4204f8b-95b0-4b9f-e053-2995a90a2436	10742-8573	HUMAN OTC DRUG	Softlips Pearl		octinoxate, octisalate	STICK	TOPICAL	20100201		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	OCTINOXATE; OCTISALATE	75; 50	mg/g; mg/g			N	20241231
10742-8731_f41f1180-015a-5390-e053-2a95a90a9c56	10742-8731	HUMAN OTC DRUG	Mentholatum Cherry Vaporizing Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20150216		OTC MONOGRAPH FINAL	part341	The Mentholatum Company	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	47; 12; 26	mg/g; mg/g; mg/g			N	20241231
10742-8743_f421a2a4-1f63-7169-e053-2995a90a5a2e	10742-8743	HUMAN OTC DRUG	Softlips Oasis Peach Mango		dimethicone, oxybenzone, octinoxate	STICK	TOPICAL	20190501		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OXYBENZONE	20; 75; 40	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8744_f4204cef-23a0-50bc-e053-2995a90ac851	10742-8744	HUMAN OTC DRUG	Softlips	Oasis Pineapple Coconut, Peach Mango, Strawberry Kiwi	dimethicone, oxybenzone, octinoxate	STICK	TOPICAL	20190729		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OXYBENZONE	20; 75; 40	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8745_f421a647-b0dd-5ea4-e053-2995a90a3d88	10742-8745	HUMAN OTC DRUG	Softlips Oasis Pineapple Coconut		dimethicone, oxybenzone, octinoxate	STICK	TOPICAL	20190501		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OXYBENZONE	20; 75; 40	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8746_f421a2a4-1f71-7169-e053-2995a90a5a2e	10742-8746	HUMAN OTC DRUG	Softlips Oasis Strawberry Kiwi		dimethicone, oxybenzone, octinoxate	STICK	TOPICAL	20190501		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OXYBENZONE	20; 75; 40	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8747_f421a647-b0eb-5ea4-e053-2995a90a3d88	10742-8747	HUMAN OTC DRUG	Softlips Oasis Watermelon Blackberry		dimethicone, oxybenzone, octinoxate	STICK	TOPICAL	20190501		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OXYBENZONE	20; 75; 40	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8865_f41f7012-5358-5635-e053-2a95a90af021	10742-8865	HUMAN OTC DRUG	Mentholatum Medicated Lip Balm	Original	dimethicone, octinoxate, octisalate	OINTMENT	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE	10; 75; 50	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8893_f41f6a60-b20f-4c4c-e053-2995a90ae4e0	10742-8893	HUMAN OTC DRUG	Mentholatum Medicated Lip Balm	Cherry	dimethicone, octinoxate, octisalate	OINTMENT	TOPICAL	20160801		OTC MONOGRAPH FINAL	part352	The Mentholatum Company	DIMETHICONE; OCTINOXATE; OCTISALATE	10; 75; 50	mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10742-8902_f42152e4-d013-5cf6-e053-2a95a90a6304	10742-8902	HUMAN OTC DRUG	Red Cross Oral Pain Relief		benzocaine	LIQUID	TOPICAL	20130601		OTC MONOGRAPH NOT FINAL	part356	The Mentholatum Company	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10742-8915_f4214f3f-a2e7-550a-e053-2a95a90ac97e	10742-8915	HUMAN OTC DRUG	Red Cross Canker Sore		benzocaine	OINTMENT	TOPICAL	19980819		OTC MONOGRAPH NOT FINAL	part356	The Mentholatum Company	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
10742-8980_f41f7012-5367-5635-e053-2a95a90af021	10742-8980	HUMAN OTC DRUG	Mentholatum Natural Ice	Sport SPF 30	avobenzone, dimethicone, octinoxate, octisalate	OINTMENT	TOPICAL	20000329		OTC MONOGRAPH NOT FINAL	part352	The Mentholatum Company	AVOBENZONE; DIMETHICONE; OCTINOXATE; OCTISALATE	30; 10; 75; 50	mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
10812-198_f16c324c-bd3b-2c62-e053-2a95a90a44a4	10812-198	HUMAN OTC DRUG	Neutrogena MoistureShine Lip Soother	Sunscreen SPF20 - Gleam 40	Octinoxate and Oxybenzone	GEL	TOPICAL	20130611		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 20	mg/g; mg/g			N	20241231
10812-201_f16c324c-bd3b-2c62-e053-2a95a90a44a4	10812-201	HUMAN OTC DRUG	Neutrogena MoistureShine Lip Soother	Sunscreen SPF20 - Shine 30	Octinoxate and Oxybenzone	GEL	TOPICAL	20130611		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 20	mg/g; mg/g			N	20241231
10812-202_f16c324c-bd3b-2c62-e053-2a95a90a44a4	10812-202	HUMAN OTC DRUG	Neutrogena MoistureShine Lip Soother	Sunscreen SPF20 - Glaze 60	Octinoxate and Oxybenzone	GEL	TOPICAL	20130611		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 20	mg/g; mg/g			N	20241231
10812-204_f306bbcf-6b94-6280-e053-2a95a90ac132	10812-204	HUMAN OTC DRUG	Neutrogena Rapid Clear		Salicylic Acid	SWAB	TOPICAL	20100209	20240711	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/1			N	
10812-292_f16c324c-bd3b-2c62-e053-2a95a90a44a4	10812-292	HUMAN OTC DRUG	Neutrogena MoistureShine Lip Soother	Sunscreen SPF20 - Glow 70	Octinoxate and Oxybenzone	GEL	TOPICAL	20130611		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 20	mg/g; mg/g			N	20241231
10812-461_f306c550-0095-2706-e053-2a95a90aaee0	10812-461	HUMAN OTC DRUG	Neutrogena Cooldry Sport Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151019	20240308	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 90; 45; 60; 45	mg/g; mg/g; mg/g; mg/g; mg/g			N	
10812-519_ef4c7de4-1a3f-951e-e053-2995a90a5255	10812-519	HUMAN OTC DRUG	Neutrogena	Skin Clearing Blemish Concealer - Fair 05	Salicylic Acid	CREAM	TOPICAL	20100205		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5.5	mg/g			N	20241231
10812-520_ef4c7de4-1a3f-951e-e053-2995a90a5255	10812-520	HUMAN OTC DRUG	Neutrogena	Skin Clearing Blemish Concealer - Buff 09	Salicylic Acid	CREAM	TOPICAL	20100205		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5.5	mg/g			N	20241231
10812-521_ef4c7de4-1a3f-951e-e053-2995a90a5255	10812-521	HUMAN OTC DRUG	Neutrogena	Skin Clearing Blemish Concealer - Light 10	Salicylic Acid	CREAM	TOPICAL	20100205		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5.5	mg/g			N	20241231
10812-522_ef4c7de4-1a3f-951e-e053-2995a90a5255	10812-522	HUMAN OTC DRUG	Neutrogena	Skin Clearing Blemish Concealer - Medium 15	Salicylic Acid	CREAM	TOPICAL	20100205		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5.5	mg/g			N	20241231
10819-1080_078de79b-c16c-78f8-e063-6294a90a384a	10819-1080	HUMAN OTC DRUG	Prevantics Swab		Chlorhexidine Gluconate and Isopropyl Alcohol	SOLUTION	TOPICAL	20130115		NDA	NDA021524	Professional Disposables International, Inc.	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	31.5; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
10819-1080_079d6f47-65e3-2f14-e063-6394a90a444a	10819-1080	HUMAN OTC DRUG	Prevantics Swab		Chlorhexidine Gluconate and Isopropyl Alcohol	SOLUTION	TOPICAL	20130115		NDA	NDA021524	Professional Disposables International, Inc.	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	31.5; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
10819-3883_075f500a-3fc5-1e8d-e063-6394a90a4127	10819-3883	HUMAN OTC DRUG	PVP Iodine Prep Pad	Medium and Large	providone iodine	SWAB	TOPICAL	19780101		OTC MONOGRAPH DRUG	M003	Professional Disposables International, Inc.	POVIDONE-IODINE	10	mg/mL			N	20241231
10819-3885_075f500a-3fc5-1e8d-e063-6394a90a4127	10819-3885	HUMAN OTC DRUG	PVP Iodine Prep Swabstick	Ones and Threes	providone iodine	STICK	TOPICAL	19780101		OTC MONOGRAPH DRUG	M003	Professional Disposables International, Inc.	POVIDONE-IODINE	10	mg/mL			N	20241231
10819-3888_06be792e-12c0-9419-e063-6394a90a321f	10819-3888	HUMAN OTC DRUG	Profend Nasal Decolonization		Povidone Iodine USP, 10% w/w	SWAB	TOPICAL	20180216		OTC MONOGRAPH NOT FINAL	part333A	Professional Disposables International, Inc.	POVIDONE-IODINE	10	mg/mL			N	20241231
10819-3914_59293bb9-0cf1-995c-e053-2991aa0a6fff	10819-3914	HUMAN OTC DRUG	PDI Alcohol Prep Pad Sterile	Large and Medium	Alcohol	CLOTH	TOPICAL	19720101		OTC MONOGRAPH NOT FINAL	part333A	Professional Disposables International Inc	ALCOHOL	.7	mL/mL			N	20241231
10819-3916_eb7d6521-a7d6-3ec6-e053-2a95a90a58a7	10819-3916	HUMAN OTC DRUG	PDI Sani-Hands	Instant Hand Sanitizing Wipes	Alcohol	CLOTH	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part333A	Professional Disposables International, Inc.	ALCOHOL	.7	mL/mL			N	20241231
10819-3917_eb7db680-0361-b39c-e053-2a95a90ab40b	10819-3917	HUMAN OTC DRUG	PDI Sani-Hands	Instant Hand Sanitizing Wipes	Alcohol	CLOTH	TOPICAL	20140324		OTC MONOGRAPH NOT FINAL	part333A	Professional Disposables International, Inc.	ALCOHOL	.659	mL/mL			N	20241231
10819-3918_078de674-5347-8eb1-e063-6294a90a4bce	10819-3918	HUMAN OTC DRUG	PDI Sani Hands		Instant Hand Sanitizing Wipes	CLOTH	TOPICAL	20160401		OTC MONOGRAPH DRUG	M003	Professional Disposables International Inc	ALCOHOL	.7	mL/mL			N	20241231
10819-4076_f5aff4be-ddc9-63ad-e053-2a95a90a426b	10819-4076	HUMAN OTC DRUG	Prevantics Maxi Swabstick		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20200101		NDA	NDA021524	Professional Disposables International, Inc.	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	31.5; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
10819-4077_bd3387ac-3695-1fb0-e053-2a95a90a161f	10819-4077	HUMAN OTC DRUG	Prevantics Swabstick		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20200601		NDA	NDA021524	Professional Disposables International, Inc.	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	31.5; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
10819-6006_eb8bbe23-0fc3-0808-e053-2a95a90a4b63	10819-6006	HUMAN OTC DRUG	Sani Professional Hands Instant Sanitizing Wipes		Alcohol	CLOTH	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	Professional Disposables International, Inc.	ALCOHOL	.7	mL/mL			N	20241231
10819-6007_eb8bbe23-0fc3-0808-e053-2a95a90a4b63	10819-6007	HUMAN OTC DRUG	Sani Professional Hands Instant Sanitizing Wipes		Alcohol	CLOTH	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	Professional Disposables International, Inc.	ALCOHOL	.7	mL/mL			N	20241231
10819-6008_eb8bbe23-0fc3-0808-e053-2a95a90a4b63	10819-6008	HUMAN OTC DRUG	Sani Professional Hands Instant Sanitizing Wipes		Alcohol	CLOTH	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part333A	Professional Disposables International, Inc.	ALCOHOL	.7	mL/mL			N	20241231
10819-7014_074a2d40-1410-466f-e063-6294a90a296e	10819-7014	HUMAN OTC DRUG	Sani Pro Sani-Hands Antibacterial Wipe		Antibacterial wipe	SWAB	TOPICAL	20161001	20240630	OTC MONOGRAPH DRUG	M003	Professional Disposables International Inc	BENZALKONIUM CHLORIDE	.13	mg/mL			N	
10882-529_07289aba-63a2-a2c2-e063-6294a90ab1fa	10882-529	HUMAN OTC DRUG	LidoPatch Pain Relief		Lidocaine hcl, Menthol	PATCH	TOPICAL	20231007		OTC MONOGRAPH DRUG	M017	JAR Laboratories	LIDOCAINE; MENTHOL	100; 400	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
10893-100_f1efdb2b-6636-475d-a4a3-83e879407f80	10893-100	HUMAN OTC DRUG	Naturasil	Acne	PHOSPHORIC ACID	LIQUID	TOPICAL	20120111		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	PHOSPHORIC ACID	6	[hp_X]/10mL			N	20241231
10893-110_6a6e3055-223d-428b-a812-d87d50cd461c	10893-110	HUMAN OTC DRUG	Naturasil	Bite Relief	Phosphoricum Acidum	LIQUID	TOPICAL	20120113		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	PHOSPHORIC ACID	6	[hp_X]/10mL			N	20241231
10893-120_302fc1b1-e4a6-4b73-a485-d7d423a8eec9	10893-120	HUMAN OTC DRUG	Naturasil	Cherry Angiomas	Phosphoricum Acidum	LIQUID	TOPICAL	20111001		UNAPPROVED HOMEOPATHIC		Nature's Innovation	PHOSPHORIC ACID	6	[hp_X]/1			N	20241231
10893-200_53b4035d-249d-4c7a-92c3-eb916908ca90	10893-200	HUMAN OTC DRUG	Naturasil	Jock Itch	Sulfur	LIQUID	TOPICAL	20120202		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	6	[hp_X]/1			N	20241231
10893-220_cc8c0d59-28e8-416d-89e4-59f3471badb5	10893-220	HUMAN OTC DRUG	Naturasil	Ringworm	Sulfur	LIQUID	TOPICAL	20120202		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	6	[hp_X]/1			N	20241231
10893-240_2a02570a-35e8-4ef1-9e1a-ad8e86df286c	10893-240	HUMAN OTC DRUG	Naturasil	Tinea Versicolor	Sulfur	LIQUID	TOPICAL	20120101		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	6	[hp_X]/mL			N	20241231
10893-240_b82f6c3f-802e-46e3-ab7a-361620c6243f	10893-240	HUMAN OTC DRUG	Naturasil	Tinea Versicolor	Sulfur	LIQUID	TOPICAL	20120101		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	6	[hp_X]/mL			N	20241231
10893-260_5f33efa6-23d0-47af-aa4c-6f47a29d7d50	10893-260	HUMAN OTC DRUG	Naturasil	Athletes Foot	Sulfur	LIQUID	TOPICAL	20120202		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	6	[hp_X]/1			N	20241231
10893-270_8dd2bb29-2617-496c-a8a0-4d307ad5be1c	10893-270	HUMAN OTC DRUG	Naturasil	Internal Parasites	Sulfur	LIQUID	ORAL	20120111		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	6	[hp_X]/30mL			N	20241231
10893-300_80bd92f9-df76-456c-b77d-c9e237835f7f	10893-300	HUMAN OTC DRUG	Naturasil	Nail Fungus	Thuja Occidentalis	LIQUID	TOPICAL	20120202		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/1			N	20241231
10893-300_9a863208-29b5-42b5-a598-6624f53662f6	10893-300	HUMAN OTC DRUG	Naturasil	Nail Fungus	Thuja Occidentalis	LIQUID	TOPICAL	20111001		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/1			N	20241231
10893-350_09ec913a-5262-499f-a058-95dbf5f44034	10893-350	HUMAN OTC DRUG	Naturasil	Neuropathy Rub	Hypericum and Arnica Montana	LIQUID	TOPICAL	20120111		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	ARNICA MONTANA; ST. JOHN'S WORT	1; 6	[hp_X]/30mL; [hp_X]/30mL			N	20241231
10893-400_36463316-732c-437b-a4b2-32db24dc2a44	10893-400	HUMAN OTC DRUG	Naturasil	Scabies	Sulfur	LIQUID	TOPICAL	20120202		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	6	[hp_X]/1			N	20241231
10893-420_1eb2f2dc-ed15-4181-82df-056c840978a6	10893-420	HUMAN OTC DRUG	Naturasil	Scabies	Sulfur	CREAM	TOPICAL	20120111		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	1	[hp_X]/mL			N	20241231
10893-430_038bd10c-2d20-4978-adec-0d88c7ad8a49	10893-430	HUMAN OTC DRUG	Naturasil	Mite Be Gone	Sulfur	CREAM	TOPICAL	20200911		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc	SULFUR	.1	g/100mL			N	20241231
10893-440_97a4f952-c6c4-4b0b-b3c9-43a8c1410a48	10893-440	HUMAN OTC DRUG	Dr Berrys	Multi-purpose sulfur Creme	SULFUR	CREAM	TOPICAL	20201214		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR	1	[hp_X]/120mL			N	20241231
10893-500_319ee4b9-c24d-4787-8e8c-c63312c29a75	10893-500	HUMAN OTC DRUG	Naturasil	Molluscum	Thuja Occidentalis	LIQUID	TOPICAL	20120113		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/mL			N	20241231
10893-510_a206de09-906c-4d1e-941c-85a66dad16e9	10893-510	HUMAN OTC DRUG	Naturasil Molluscum Treatment Kit		Thuja occidentalis, Sulfur	KIT		20211019		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.						N	20241231
10893-520_d25ac220-7143-42de-9977-604cb5073ca1	10893-520	HUMAN OTC DRUG	Naturasil	Skin Tags	Thuja Occidentalis	LIQUID	TOPICAL	20111001		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/1			N	20241231
10893-520_e80f43e8-8286-4205-92bc-f06197d76c5f	10893-520	HUMAN OTC DRUG	Naturasil	Skin Tags	Thuja Occidentalis	LIQUID	TOPICAL	20111001		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/1			N	20241231
10893-540_b40dee2e-b950-4a68-a3a6-c208a7d6b5d9	10893-540	HUMAN OTC DRUG	Naturasil	Warts	Thuja Occidentalis	LIQUID	TOPICAL	20111001		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/mL			N	20241231
10893-600_b0bb79ee-6099-44ca-9fe7-aa1b0c40c699	10893-600	HUMAN OTC DRUG	Naturasil	Sulfur-Lavender	Sulfur	SOAP	TOPICAL	20120118		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	1; 6	[hp_X]/g; [hp_X]/g			N	20241231
10893-610_735323bf-c54f-4422-ad30-e5f15816b3d0	10893-610	HUMAN OTC DRUG	Naturasil	Molluscum Relief	SULFUR, THUJA OCCINDENTALIS	SOAP	TOPICAL	20201022		UNAPPROVED HOMEOPATHIC		Natures Innovation, Inc.	SULFUR; THUJA OCCIDENTALIS LEAF	1; 6	[hp_X]/113.3g; [hp_X]/113.3g			N	20241231
10893-620_5bdf09e0-03a1-4be9-a5f8-d7afb33c4245	10893-620	HUMAN OTC DRUG	Naturasil	Tinea Versicolor	Sulfur-Lavender	SOAP	TOPICAL	20120101		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	1; 6	[hp_X]/g; [hp_X]/g			N	20241231
10893-630_2f38c66c-fbc6-4af2-b427-65c23cad47ce	10893-630	HUMAN OTC DRUG	Naturasil	Nail Fungus	Sulfur and Thuja Occidentalis	SOAP	TOPICAL	20120113		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	1; 6	[hp_X]/127.6g; [hp_X]/127.6g			N	20241231
10893-640_dd1faaa7-a019-4a21-9a6a-e20310c666d0	10893-640	HUMAN OTC DRUG	Naturasil	Scabies Relief	SULFUR, THUJA OCCINDENTALIS	SOAP	TOPICAL	20201022		UNAPPROVED HOMEOPATHIC		Natures Innovation, Inc.	SULFUR; THUJA OCCIDENTALIS LEAF	1; 6	[hp_X]/113.3g; [hp_X]/113.3g			N	20241231
10893-660_7e46cc49-d3e6-4a84-816b-f0e3d4dad76c	10893-660	HUMAN OTC DRUG	Naturasil	Mite Be Gone	Sulfur, Thuja Occindentalis	SOAP	TOPICAL	20200911		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc	SULFUR; THUJA OCCIDENTALIS LEAF	1; 6	[hp_X]/113.3g; [hp_X]/113.3g			N	20241231
10893-710_c48478d1-44ff-42f7-b260-282c657dfced	10893-710	HUMAN OTC DRUG	Naturasil	Scars	Silicea	LIQUID	TOPICAL	20111001		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SILICON DIOXIDE	6	[hp_X]/mL			N	20241231
10893-730_af854498-9fbe-4d85-89fb-c96a3d9ed808	10893-730	HUMAN OTC DRUG	Naturasil	Stretch Marks	Silicea	LIQUID	TOPICAL	20120112		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SILICON DIOXIDE	6	[hp_X]/mL			N	20241231
10893-810_de93e02c-8a1c-48ee-81c5-a2b51ea511d4	10893-810	HUMAN OTC DRUG	Naturasil MollusCalm		Thuja Occidentalis	LIQUID	TOPICAL	20230821		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	THUJA OCCIDENTALIS LEAF	6	[hp_X]/15mL			N	20241231
10893-830_749ea771-003c-4940-bc36-303c1a7ccad6	10893-830	HUMAN OTC DRUG	Naturasil MollusCalm Relief		Sulfur, Thuja Occidentalis	SOAP	TOPICAL	20230821		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	SULFUR; THUJA OCCIDENTALIS LEAF	1; 6	[hp_X]/118.3g; [hp_X]/118.3g			N	20241231
10893-840_70d6c041-bec9-427f-8228-81099deb530e	10893-840	HUMAN OTC DRUG	Naturasil MollusCalm TREATMENT Kit		Sulfur, Thuja Occidentalis	KIT		20230821		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.						N	20241231
10893-900_f69d3d3e-612d-4758-8dea-844f8d98103d	10893-900	HUMAN OTC DRUG	CobraZol		Arnica montana, Capsicum annum, Crotalus horridus, Lachesis muta, Naja tripudians	GEL	TOPICAL	20130821		UNAPPROVED HOMEOPATHIC		Nature's Innovation, Inc.	ARNICA MONTANA; CAPSICUM; CROTALUS HORRIDUS HORRIDUS VENOM; LACHESIS MUTA VENOM; NAJA NAJA VENOM	1; 2; 6; 8; 5	[hp_X]/88.721mL; [hp_X]/88.721mL; [hp_X]/88.721mL; [hp_X]/88.721mL; [hp_X]/88.721mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
10927-003_0802c587-c0d6-4fc9-e063-6294a90a3d6c	10927-003	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19381020		NDA	NDA205767	PURITY CYLINDER GASES INC	OXYGEN	990	mL/L			N	20241231
10927-104_0802c587-c0d4-4fc9-e063-6294a90a3d6c	10927-104	HUMAN PRESCRIPTION DRUG	AIR		AIR	GAS	RESPIRATORY (INHALATION)	19381020		NDA	NDA205804	PURITY CYLINDER GASES INC	AIR	99	L/100L			N	20241231
10942-2001_0761b2dd-1b7b-2aa8-e063-6394a90a7784	10942-2001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19930512		NDA	NDA205865	Raimy Corporation	OXYGEN	996	mL/L			N	20241231
10942-2005_07618fd8-a43f-e56c-e063-6294a90ac336	10942-2005	HUMAN PRESCRIPTION DRUG	oxygen		oxygen	GAS	RESPIRATORY (INHALATION)	19930512		NDA	NDA205865	Raimy Corporation	OXYGEN	996	mL/L			N	20241231
10942-2010_0761b91e-5661-f275-e063-6294a90abcf0	10942-2010	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20180227		NDA	NDA205866	Raimy Corporation	NITROGEN	990	mL/L			N	20241231
10956-001_9144b215-79ea-43fe-a1d3-92b59f7f33f3	10956-001	HUMAN OTC DRUG	CVS Health Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Reese Pharmaceutical Co	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
10956-059_8d9ec74e-272a-4023-be41-e772cc13e7e0	10956-059	HUMAN OTC DRUG	DG Health Immediate Release Mucus Relief		Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Reese Pharmaceutical Co	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
10956-210_40284ba2-ade0-4183-bcd4-670a3426d211	10956-210	HUMAN OTC DRUG	Preferred Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190731		UNAPPROVED DRUG OTHER		Reese Pharmaceutical Co	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
10956-501_bb4a0a9a-cf8d-48a3-86ff-83cd65597125	10956-501	HUMAN OTC DRUG	Reese Headache Powders		Aspirin and Caffeine	POWDER	ORAL	20200722		OTC MONOGRAPH NOT FINAL	part343	Reese Pharmaceutical Co	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
10956-551_62b30a07-a130-4500-83ba-b57ffc091097	10956-551	HUMAN OTC DRUG	Preferred Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Reese Pharmaceutical Co	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
10956-621_204115cf-970b-4cd9-b2aa-a267cf9faeee	10956-621	HUMAN OTC DRUG	Preferred Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20230511		OTC MONOGRAPH NOT FINAL	part334	Reese Pharmaceutical Co	DOCUSATE SODIUM	100	mg/1			N	20241231
10956-703_aa176970-c7ab-428b-a77d-5c798c783db0	10956-703	HUMAN OTC DRUG	Vexia Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20230524		UNAPPROVED DRUG OTHER		Reese Pharmaceutical Co	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
10956-763_162f88ca-d492-4c85-9165-bfac4106eeb4	10956-763	HUMAN OTC DRUG	Preferred Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		Reese Pharmaceutical Co	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
10956-778_6c88dad3-dc41-4ece-a856-5c15a2f55cd3	10956-778	HUMAN OTC DRUG	Pinworm	Medicine	PYRANTEL PAMOATE	SUSPENSION	ORAL	20220928		OTC MONOGRAPH FINAL	part357B	REESE PHARMACEUTICAL CO.	PYRANTEL PAMOATE	144	mg/mL			N	20241231
10956-781_2f3d8fb3-4836-41af-80ab-9ef54f0986ca	10956-781	HUMAN OTC DRUG	Preferred Stool Softener	laxative	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20230511		OTC MONOGRAPH NOT FINAL	part334	Reese Pharmaceutical Co	DOCUSATE SODIUM	250	mg/1			N	20241231
10956-845_44cd160e-b7f7-468b-ab1f-be1c9d1917b3	10956-845	HUMAN OTC DRUG	Refenesen Mucus Relief		Guaifenesin	TABLET	ORAL	20210415		OTC MONOGRAPH FINAL	part341	Reese Pharmaceutical Co	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
10956-846_1bb7d730-5f81-4746-8da0-7e21b97ff2cf	10956-846	HUMAN OTC DRUG	Refenesen Mucus Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20210415		OTC MONOGRAPH FINAL	part341	Reese Pharmaceutical Co	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
10956-891_dc3a317b-f5e3-4109-b831-aee4a76d4308	10956-891	HUMAN OTC DRUG	Preferred Stool Softener		Docusate Calcium	CAPSULE, LIQUID FILLED	ORAL	20230511		OTC MONOGRAPH NOT FINAL	part334	Reese Pharmaceutical Co	DOCUSATE CALCIUM	240	mg/1			N	20241231
10967-601_97144888-8789-6587-e053-2995a90a6643	10967-601	HUMAN OTC DRUG	Mitchum Roll On		Aluminum Zirconium Tetrachlorohydrex Gly	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-613_97144fcd-9054-630b-e053-2995a90ae95c	10967-613	HUMAN OTC DRUG	Mitchum Smart Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20091201		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-617_97144fcd-905e-630b-e053-2995a90ae95c	10967-617	HUMAN OTC DRUG	Mitchum Advanced Control Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-618_97144fcd-905e-630b-e053-2995a90ae95c	10967-618	HUMAN OTC DRUG	Mitchum Advanced Control Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-619_97144fcd-905e-630b-e053-2995a90ae95c	10967-619	HUMAN OTC DRUG	Mitchum Advanced Control Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-620_97144fcd-905e-630b-e053-2995a90ae95c	10967-620	HUMAN OTC DRUG	Mitchum Advanced Control Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-623_995c631e-4c84-6d19-e053-2a95a90a8f39	10967-623	HUMAN OTC DRUG	Revlon PhotoReady BB Cream Skin Perfector		Octinoxate, Octisalate, Titanium Dioxide Make-Up	LIQUID	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part352	Revlon Consumer Products Corp	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 6.5	mg/mL; mg/mL; mg/mL			N	20241231
10967-629_97144fcd-905e-630b-e053-2995a90ae95c	10967-629	HUMAN OTC DRUG	Mitchum Advanced Control Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-631_9716f197-0d06-507d-e053-2a95a90a686d	10967-631	HUMAN OTC DRUG	REVLON PHOTOREADY INSTA-FIX MAKEUP		titanium dioxide, zinc oxide	STICK	TOPICAL	20140914		OTC MONOGRAPH FINAL	part352	Revlon Consumer Products Corp	TITANIUM DIOXIDE; ZINC OXIDE	4.7; 2.1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10967-632_9716f197-0d0d-507d-e053-2a95a90a686d	10967-632	HUMAN OTC DRUG	Revlon Mitchum Clinical Gel		Aluminum Zirconium Octachlorohydrex Gly liquid	LIQUID	TOPICAL	20151130		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-633_9716f197-0d0d-507d-e053-2a95a90a686d	10967-633	HUMAN OTC DRUG	Revlon Mitchum Clinical Gel		Aluminum Zirconium Octachlorohydrex Gly liquid	LIQUID	TOPICAL	20151130		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-635_43158fa6-9a5d-1c85-e054-00144ff88e88	10967-635	HUMAN OTC DRUG	Mitchum Advance Control		Aluminum Chlorohydrate	AEROSOL	TOPICAL	20151207		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM CHLOROHYDRATE	.25	g/mL			N	20241231
10967-636_43158fa6-9a5d-1c85-e054-00144ff88e88	10967-636	HUMAN OTC DRUG	Mitchum Advance Control Sport		Aluminum Chlorohydrate	AEROSOL	TOPICAL	20151207		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM CHLOROHYDRATE	.25	g/mL			N	20241231
10967-637_43158fa6-9a5d-1c85-e054-00144ff88e88	10967-637	HUMAN OTC DRUG	Mitchum Advance Control Powder Fresh		Aluminum Chlorohydrate	AEROSOL	TOPICAL	20151207		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM CHLOROHYDRATE	.25	g/mL			N	20241231
10967-638_43158fa6-9a5d-1c85-e054-00144ff88e88	10967-638	HUMAN OTC DRUG	Mitchum Advance Control		Aluminum Chlorohydrate	AEROSOL	TOPICAL	20151207		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM CHLOROHYDRATE	.25	g/mL			N	20241231
10967-639_97171128-96c3-64f3-e053-2995a90ab8fe	10967-639	HUMAN OTC DRUG	Revlon Youth FX		Zinc Oxide, Titanium Dioxide Make-Up	LIQUID	TOPICAL	20190919		OTC MONOGRAPH NOT FINAL	part352	Revlon Consumer Products Corp	TITANIUM DIOXIDE; ZINC OXIDE	4.3; 2.8	mg/30mL; mg/30mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10967-640_9716e569-93ee-5e04-e053-2995a90ab76c	10967-640	HUMAN OTC DRUG	Revlon Kiss Balm SPF 20		Avobenzone, Benzophenone-3, Octinoxate	STICK	TOPICAL	20160919		OTC MONOGRAPH FINAL	part352	Revlon Consumer Products Corp	AVOBENZONE; OCTINOXATE; OXYBENZONE	2; 7.5; 3	g/mL; g/mL; g/mL			N	20241231
10967-643_cee2fdc6-bc6f-ee82-e053-2a95a90a78d3	10967-643	HUMAN OTC DRUG	Revlon Colorstay Liquid Makeup for Normal to Dry Skin		Zinc Oxide, Titanium Dioxide Make-Up	LIQUID	TOPICAL	20120601		OTC MONOGRAPH FINAL	part352	Revlon Consumer Products Corp	TITANIUM DIOXIDE; ZINC OXIDE	4.3; 2.1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
10967-644_97144fcd-905e-630b-e053-2995a90ae95c	10967-644	HUMAN OTC DRUG	Mitchum Advanced Control Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-645_97144fcd-905e-630b-e053-2995a90ae95c	10967-645	HUMAN OTC DRUG	Mitchum Advanced Control Solid		Aluminum Zirconium Tetrachlorohydrex Gly liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/mL			N	20241231
10967-649_43158fa6-9a5d-1c85-e054-00144ff88e88	10967-649	HUMAN OTC DRUG	Mitchum Advance Control Pure Fresh		Aluminum Chlorohydrate	AEROSOL	TOPICAL	20151207		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp	ALUMINUM CHLOROHYDRATE	.25	g/mL			N	20241231
10967-650_9716d8d4-4a20-b376-e053-2a95a90a2b7a	10967-650	HUMAN OTC DRUG	American Crew		Pyrithione Zinc	SHAMPOO	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358H	Revlon Consumer Products Corp	PYRITHIONE ZINC	1	mg/mL			N	20241231
10967-651_9716d8d4-4a2e-b376-e053-2a95a90a2b7a	10967-651	HUMAN OTC DRUG	American Crew All In One Face Balm Broad Spectrum SPF 15		Octisalate,Homosalate,Avobenzone,Octocrylene	LIQUID	TOPICAL	20170401		OTC MONOGRAPH FINAL	part352	Revlon Consumer Products Corp	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5; 5; 2	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
10967-652_8eebf23e-7fcf-dfc0-e053-2995a90ae322	10967-652	HUMAN OTC DRUG	Revlon Colorstay Preo and Protect Primer		Titanium Dioxide, Zinc Oxide, Octinoxate Primer	LIQUID	TOPICAL	20190101		OTC MONOGRAPH FINAL	part352	Revlon Consumer Products Corp	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	7.5; 3.6; 9	mg/mL; mg/mL; mg/mL			N	20241231
10967-658_9065c31d-0bbe-05d2-e053-2995a90ab101	10967-658	HUMAN OTC DRUG	Mitchum Clinical Soft Solid		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20.0%	GEL	TOPICAL	20181001		OTC MONOGRAPH FINAL	part350	Revlon Consumer Products Corp.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/g			N	20241231
10967-676_f3a6fe29-7af8-bfb1-e053-2a95a90a0101	10967-676	HUMAN OTC DRUG	ELIZABETH ARDEN EIGHT HR PROTECTANT CLEAR		LIP PROTECTANT	LIPSTICK	TOPICAL	20230201		OTC MONOGRAPH FINAL	M016	REVLON CONSUMER PRODUCTS CORP	AVOBENZONE; OCTINOXATE; OXYBENZONE; PETROLATUM	.074; .2775; .111; 1.147	g/3.7g; g/3.7g; g/3.7g; g/3.7g			N	20241231
10967-689_d09b0a44-e699-f15b-e053-2995a90a5241	10967-689	HUMAN OTC DRUG	Advanced Ceramide Lift and Firm Day Cream	Broad Spectrum Sunscreen SPF 15	OCTISALATE, OCTOCRYLENE, AVOBENZONE, HOMOSALATE	EMULSION	TOPICAL	20210801		OTC MONOGRAPH FINAL	part352	REVLON	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
11043-001_08031467-57cc-f232-e063-6394a90a4092	11043-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA205767	S. J. Smith Co., Inc.	OXYGEN	992	mL/L			N	20241231
11043-002_080308f6-2f70-4f66-e063-6394a90a7b9d	11043-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA205766	S. J. Smith Co., Inc.	NITROGEN	990	mL/L			N	20241231
11045-0303_b389b6e6-9f4b-467d-9965-36736de8b533	11045-0303	HUMAN OTC DRUG	Soleo Organics Sunscreen		Zinc Oxide	CREAM	TOPICAL	20070120		OTC MONOGRAPH NOT FINAL	part352	SE Operations Pty Ltd	ZINC OXIDE	223	mg/g			N	20241231
11054-004_4e2daebf-fd56-441d-accb-7ff63b731aef	11054-004	HUMAN PRESCRIPTION DRUG	HELIUM		HELIUM	GAS	INTRACORONARY; RESPIRATORY (INHALATION)	19971106		NDA	NDA205843	AIRGAS USA, LLC	HELIUM	992	mL/L			N	20241231
11054-005_783d751b-d221-402d-a700-25efd65325ef	11054-005	HUMAN PRESCRIPTION DRUG	NITROGEN	Compressed, NF	NITROGEN	GAS	RESPIRATORY (INHALATION)	19971106		NDA	NDA205839	AIRGAS USA, LLC	NITROGEN	992	mL/L			N	20241231
11054-006_b9651d7f-16dc-48ec-8748-555cf7be8572	11054-006	HUMAN PRESCRIPTION DRUG	Nitrogen, Refrigerated		Nitrogen, Refrigerated	LIQUID	CUTANEOUS	19971106		NDA	NDA205839	Airgas Usa, LLC	NITROGEN	992	mL/L			N	20251231
11054-007_6881a5d6-9456-4ca4-8e7d-90a973703988	11054-007	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19971106		NDA	NDA206009	AIRGAS USA, LLC	NITROUS OXIDE	992	mL/L			N	20241231
11054-009_4fb17886-6bf7-492d-bcf8-ff3cc32aff03	11054-009	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	CUTANEOUS; RESPIRATORY (INHALATION)	19971014		NDA	NDA205840	Airgas Usa, LLC	OXYGEN	992	mL/L			N	20241231
11054-010_d2b21630-7138-45c5-a8b5-72113e854073	11054-010	HUMAN PRESCRIPTION DRUG	Oxygen, Refrigerated		Oxygen, Refrigerated	GAS	RESPIRATORY (INHALATION)	19971014		NDA	NDA205840	AIRGAS USA, LLC	OXYGEN	992	mL/L			N	20241231
11054-021_6e07a688-8499-444c-a596-2614f1ddd01f	11054-021	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20180102		NDA	NDA206025	Airgas Usa, LLC	CARBON DIOXIDE	1	g/g	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
11054-032_9923b29f-09e6-4666-a3b0-2e1f35ce9273	11054-032	HUMAN PRESCRIPTION DRUG	Helium Oxygen mixture		Helium Oxygen mixture	GAS	RESPIRATORY (INHALATION)	20120103		NDA AUTHORIZED GENERIC	NDA205843	Airgas Usa, LLC	HELIUM; OXYGEN	700; 300	mL/L; mL/L			N	20241231
11054-041_962be648-37ec-47f8-8a23-8ea4fa38e00e	11054-041	HUMAN PRESCRIPTION DRUG	Helium, Oxygen		Helium, Oxygen	GAS	RESPIRATORY (INHALATION)	19971014		NDA AUTHORIZED GENERIC	NDA205843	AIRGAS USA, LLC	HELIUM; OXYGEN	800; 200	mL/L; mL/L			N	20241231
11054-042_a9241aae-ebb4-4a1f-a0e5-bc8b93c6feb4	11054-042	HUMAN PRESCRIPTION DRUG	Helium, Oxygen		Helium, Oxygen	GAS	RESPIRATORY (INHALATION)	19971014		NDA AUTHORIZED GENERIC	NDA205843	AIRGAS USA, LLC	HELIUM; OXYGEN	600; 400	mL/L; mL/L			N	20241231
11054-110_2cc6e977-4934-476a-ba6b-ec35302b1c5a	11054-110	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19971106		NDA	NDA205845	AIRGAS USA, LLC	OXYGEN	210	mL/L			N	20241231
11054-114_d5aaa4e3-4212-4464-ae57-0662c8c59854	11054-114	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Oxygen Mix		Carbon Dioxide Oxygen Mix	GAS	RESPIRATORY (INHALATION)	19971014		NDA	NDA206023	Airgas Usa, LLC	OXYGEN	950	mL/L			N	20241231
11054-130_b16ca12f-3106-4843-ad9a-dad2b2950d50	11054-130	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20120102		NDA	NDA206025	Airgas Usa, LLC	CARBON DIOXIDE	992	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
11054-152_0588232e-329e-487d-8fb6-59602cfc8137	11054-152	HUMAN PRESCRIPTION DRUG	Nitrogen Oxygen Mix		Nitrogen Oxygen Mix	GAS	RESPIRATORY (INHALATION)	20170201		NDA	NDA206023	Airgas Usa, LLC	OXYGEN	400	mL/L			N	20241231
11056-001_aafe7c8b-36f2-476d-a6fe-01a2f29ea76a	11056-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19620101		NDA	NDA205849	South Jersey Welding Supply	OXYGEN	99	L/100L			N	20241231
11056-010_00eb5c59-18c7-4282-a323-9a5af63f290a	11056-010	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20100101		NDA	NDA205850	South Jersey Welding Supply	NITROGEN	99	L/100L			N	20241231
11084-006_42cf722d-f0bb-40a8-91e9-5b4eaff61f98	11084-006	HUMAN OTC DRUG	Alcare Extra Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20170301		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	80	mL/100mL			N	20241231
11084-010_063ce126-72c2-4dea-b846-b009a7105ba4	11084-010	HUMAN OTC DRUG	Refresh AntiBac FOAM		Benzalkonium Chloride	SOAP	TOPICAL	20170612		OTC MONOGRAPH NOT FINAL	part333A	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.13	g/L			N	20241231
11084-015_a1120e4f-ddcc-4b98-b6dd-024a8679261f	11084-015	HUMAN OTC DRUG	Appeal Antibacterial Hand Wash		Benzalkonium Chloride	SOLUTION	TOPICAL	20170612		OTC MONOGRAPH NOT FINAL	part333A	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
11084-021_c77fcba3-256c-42cd-a7bd-055cd4d1729b	11084-021	HUMAN OTC DRUG	Antibacterial Foam		Benzalkonium Chloride	SOLUTION	TOPICAL	20170801		OTC MONOGRAPH NOT FINAL	part333A	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	1.3	g/L			N	20241231
11084-024_5a434b26-85d5-4504-b717-165c67e737c0	11084-024	HUMAN OTC DRUG	AgroBac Pure FOAM		Benzalkonium Chloride	SOLUTION	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part333A	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
11084-025_51eca087-7e68-4f05-9222-3e7752626863	11084-025	HUMAN OTC DRUG	Clean Choice Foodservice Antibacterial Foam		Benzalkonium Chloride	SOLUTION	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part333A	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
11084-026_6636a770-ce5e-49e5-aa46-8fb3389b7163	11084-026	HUMAN OTC DRUG	Alcare Enhanced Foaming Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA Inc.	ALCOHOL	65	g/100mL			N	20241231
11084-032_ff0db40c-5714-47b7-89ce-9998ddf66ac1	11084-032	HUMAN OTC DRUG	Stokoderm Sunscreen PURE		Avobenzone, Octocrylene, Octisalate, and Homosalate	CREAM	TOPICAL	20210201		OTC MONOGRAPH FINAL	part352	SC Johnson Professional USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 3; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
11084-034_f25ddc01-c64e-4dfd-8877-206b1f7059ac	11084-034	HUMAN OTC DRUG	Alcare Elevate Antiseptic Handrub		ALCOHOL	LIQUID	TOPICAL	20201015		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
11084-035_37314799-7ab7-41da-9cd2-b92db28b4e5e	11084-035	HUMAN OTC DRUG	Alcare Antiseptic Handrub		ALCOHOL	LIQUID	TOPICAL	20210601		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	62.94	g/100mL			N	20241231
11084-036_f665a1a6-e134-4959-a43d-c033f206b33e	11084-036	HUMAN OTC DRUG	Kindest Kare Hand	Antimicrobial Handwash	CHLOROXYLENOL	SOAP	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	CHLOROXYLENOL	1	g/100mL			N	20241231
11084-038_d7388a34-0041-4a4b-85b1-60338d0351c4	11084-038	HUMAN OTC DRUG	Bactoshield CHG	Chlorhexidine Gluconate	Chlorhexidine Gluconate	SOLUTION	TOPICAL	20221201		NDA	NDA019422	SC Johnson Professional USA, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
11084-039_472d4ffd-4d5c-410e-9614-2bf169f22298	11084-039	HUMAN OTC DRUG	Bactoshield CHG		CHLORHEXIDINE GLUCONATE	SOLUTION	TOPICAL	20221201		NDA	NDA019125	SC Johnson Professional USA, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
11084-170_754e345a-4954-4713-8711-64b05cd17857	11084-170	HUMAN OTC DRUG	Deb InstantFOAM Complete		Alcohol	LIQUID	TOPICAL	20150818		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	.8	mL/mL			N	20241231
11084-300_809ee16e-3e33-4721-8c1f-f87888366436	11084-300	HUMAN OTC DRUG	Instant Foam Non-alcohol PURE Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
11084-301_5500da05-dbd4-440d-a602-5bddfa8f53a8	11084-301	HUMAN OTC DRUG	Instant Foam Non-alcohol Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
11084-303_bd3f3575-372f-4025-b620-86d30d041a77	11084-303	HUMAN OTC DRUG	InstantFoam Complete PURE		ALCOHOL	LIQUID	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA Inc.	ALCOHOL	80	g/100mL			N	20241231
11084-702_9dedfc3e-92be-447b-b627-f4855dd662f2	11084-702	HUMAN OTC DRUG	Appeal Alcohol Foaming Hand Sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	20120515		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
11084-703_f48f669b-a8af-474f-9dc8-537c0b0bf7db	11084-703	HUMAN OTC DRUG	Deb InstantFoam Alcohol Sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	20120515		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	70	L/100L			N	20241231
11084-704_118d053d-d141-423a-ab81-5988c0f00567	11084-704	HUMAN OTC DRUG	Clean Choice Alcohol Sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	20130915		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	70	L/100L			N	20241231
11084-800_82bc100a-dff5-4ce8-a1fc-055c61b32071	11084-800	HUMAN OTC DRUG	Acute-Kare	Healthcare Personnel Handwash	CHLOROXYLENOL	SOAP	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	CHLOROXYLENOL	1	g/100mL			N	20241231
11084-801_a259c6f8-8c51-4073-94f2-1577564fa590	11084-801	HUMAN OTC DRUG	Alcare Foamed Antiseptic Handrub		ALCOHOL	AEROSOL, FOAM	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	62	g/100g			N	20241231
11084-802_9058c66b-a0eb-42de-9b6a-eae7c8947d3b	11084-802	HUMAN OTC DRUG	Alcare OR Foamed Antiseptic Handrub		ALCOHOL	AEROSOL, FOAM	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	62	g/100g			N	20241231
11084-803_69fc3e1c-2257-4d33-a7ae-52f98a449f19	11084-803	HUMAN OTC DRUG	Alcare Plus Foamed Antiseptic Handrub		ALCOHOL	AEROSOL, FOAM	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	62	g/100g			N	20241231
11084-806_300b7246-339b-4918-b99a-a4dc9e3ec7ab	11084-806	HUMAN OTC DRUG	Kindest Kare Advanced Antimicrobial Handwash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.7	mg/100mL			N	20241231
11084-807_aa9e4904-f356-40dc-b380-6ad7e3d76273	11084-807	HUMAN OTC DRUG	Kindest Kare Advanced Antimicrobial Foam Handwash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	BENZALKONIUM CHLORIDE	.5	mg/100mL			N	20241231
11084-813_c191d5a9-f197-46c0-8308-aaef0a131413	11084-813	HUMAN OTC DRUG	Soft N Sure Foamed Antiseptic Handrub		Alcohol	AEROSOL, FOAM	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part333E	SC Johnson Professional USA, Inc.	ALCOHOL	62	g/100g			N	20241231
11086-011_074cfb96-7002-5f8d-e063-6394a90af30b	11086-011	HUMAN OTC DRUG	TARSUM PROFESSIONAL		COAL TAR	SHAMPOO	TOPICAL	20131030		OTC MONOGRAPH DRUG	M032	Summers Laboratories Inc	COAL TAR	2	g/100mL			N	20241231
11086-021_074d1c12-3cb5-292c-e063-6294a90a41f3	11086-021	HUMAN OTC DRUG	TRIPLE	MEDICATED FOR DIAPER RASH	ZINC OXIDE	PASTE	TOPICAL	20131030		OTC MONOGRAPH DRUG	M016	Summers Laboratories Inc	ZINC OXIDE	12.8	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11086-022_074cf888-7213-31ad-e063-6394a90a16d8	11086-022	HUMAN OTC DRUG	REZAMID		SULFUR AND RESORCINOL	LOTION	TOPICAL	20131030		OTC MONOGRAPH DRUG	M032	Summers Laboratories Inc	RESORCINOL; SULFUR	2; 5	g/100mL; g/100mL			N	20241231
11086-028_074cf154-7478-e203-e063-6294a90ab60e	11086-028	HUMAN OTC DRUG	LIQUIMAT	ACNE TREATMENT AND COVER-UP	SULFUR	LIQUID	TOPICAL	20131030		OTC MONOGRAPH DRUG	M006	Summers Laboratories Inc	SULFUR	3	g/100mL			N	20241231
11086-030_074cfb96-6fef-5f8d-e063-6394a90af30b	11086-030	HUMAN PRESCRIPTION DRUG	Keralyt		salicylic acid	GEL	TOPICAL	20091101		UNAPPROVED DRUG OTHER		Summers Laboratories Inc	SALICYLIC ACID	6	g/100g			N	20241231
11086-032_074cfc73-ce31-5fe4-e063-6394a90a307a	11086-032	HUMAN PRESCRIPTION DRUG	VANOXIDE	HC	BENZOYL PEROXIDE, HYDROCORTISONE	LOTION	TOPICAL	20091101		UNAPPROVED DRUG OTHER		Summers Laboratories Inc	BENZOYL PEROXIDE; HYDROCORTISONE	5; .5	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11086-038_074d1247-a817-29b6-e063-6294a90aa64e	11086-038	HUMAN OTC DRUG	Keralyt	3 PERCENT	salicylic acid	GEL	TOPICAL	20131030		OTC MONOGRAPH DRUG	M032	Summers Laboratories Inc	SALICYLIC ACID	3	g/100g			N	20241231
11086-040_074d2952-be4d-9e5c-e063-6394a90a0692	11086-040	HUMAN OTC DRUG	TRIPLE	AF	MICONAZOLE NITRATE	PASTE	TOPICAL	20131030		OTC MONOGRAPH DRUG	M005	Summers Laboratories Inc	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11086-043_074cf8c2-7740-0b9b-e063-6394a90a30a0	11086-043	HUMAN PRESCRIPTION DRUG	Keralyt		salicylic acid	SHAMPOO	TOPICAL	20091101		UNAPPROVED DRUG OTHER		Summers Laboratories Inc	SALICYLIC ACID	6	g/92.6mL			N	20241231
11086-047_074cf8c2-772c-0b9b-e063-6394a90a30a0	11086-047	HUMAN PRESCRIPTION DRUG	Keralyt		salicylic acid	KIT		20091101		UNAPPROVED DRUG OTHER		SUMMERS LABORATORIES INC						N	20241231
11086-105_074d03df-c1b0-1372-e063-6294a90a17ac	11086-105	HUMAN OTC DRUG	CUTAR		COAL TAR	LOTION	TOPICAL	20131029		OTC MONOGRAPH DRUG	M032	Summers Laboratories Inc	COAL TAR	1.5	g/100mL			N	20241231
11090-093_f7a8c3f8-9258-21fb-e053-6394a90a42a2	11090-093	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Color Correcting Full Coverage Antiaging Hydrating Serum Broad Spectrum SPF 50 Plus Clear Sunscreen-Deep		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
11090-094_f7a8c3f8-9258-21fb-e053-6394a90a42a2	11090-094	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Color Correcting Full Coverage Antiaging Hydrating Serum Broad Spectrum SPF 50 Plus Clear Sunscreen-Deep Honey		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
11090-095_f7a8c3f8-9258-21fb-e053-6394a90a42a2	11090-095	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Color Correcting Full Coverage Antiaging Hydrating Serum Broad Spectrum SPF 50 Plus Clear Sunscreen-Neutral Deep		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
11090-096_f7a8c3f8-9258-21fb-e053-6394a90a42a2	11090-096	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Color Correcting Full Coverage Antiaging Hydrating Serum Broad Spectrum SPF 50 Plus Clear Sunscreen-Neutral Rich		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
11090-097_f7a8c3f8-9258-21fb-e053-6394a90a42a2	11090-097	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Color Correcting Full Coverage Antiaging Hydrating Serum Broad Spectrum SPF 50 Plus Clear Sunscreen-Deep Bronze		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
11090-098_f7a8c3f8-9258-21fb-e053-6394a90a42a2	11090-098	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Color Correcting Full Coverage Antiaging Hydrating Serum Broad Spectrum SPF 50 Plus Clear Sunscreen-Deep Mocha		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
11090-099_ef2c1165-5555-1cce-e053-2a95a90a0f45	11090-099	HUMAN OTC DRUG	LOreal Paris Revitalift Derm Intensives Invisible UV Fluid Broad Spectrum SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	GEL	TOPICAL	20220930		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 150; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11090-103_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-103	HUMAN OTC DRUG	ITC CC Full Coverage Cream Fair		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-104_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-104	HUMAN OTC DRUG	ITC CC Full Coverage Cream Fair Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-105_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-105	HUMAN OTC DRUG	ITC CC Full Coverage Cream Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-106_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-106	HUMAN OTC DRUG	ITC CC Full Coverage Cream Light Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-107_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-107	HUMAN OTC DRUG	ITC CC Full Coverage Cream Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-108_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-108	HUMAN OTC DRUG	ITC CC Full Coverage Cream Neutral Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-109_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-109	HUMAN OTC DRUG	ITC CC Full Coverage Cream Medium Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-110_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-110	HUMAN OTC DRUG	ITC CC Full Coverage Cream Neutral Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-111_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-111	HUMAN OTC DRUG	ITC CC Full Coverage Cream Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-112_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-112	HUMAN OTC DRUG	ITC CC Full Coverage Cream Rich		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-113_d7c0fce8-715d-4a93-e053-2a95a90a86c6	11090-113	HUMAN OTC DRUG	ITC CC Full Coverage Cream Rich Honey		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-114_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-114	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Fair		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-115_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-115	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Fair Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-116_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-116	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-117_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-117	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Light Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-118_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-118	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-119_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-119	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Neutral Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-120_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-120	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Medium Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-121_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-121	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Neutral Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-122_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-122	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-123_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-123	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Rich		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-124_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-124	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Rich Honey		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-125_d8389555-2b2c-6026-e053-2a95a90a8a02	11090-125	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Deep		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
11090-126_d888be25-be1c-e92b-e053-2995a90aef82	11090-126	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Fair		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-127_d888be25-be1c-e92b-e053-2995a90aef82	11090-127	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Fair Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-128_d888be25-be1c-e92b-e053-2995a90aef82	11090-128	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-129_d888be25-be1c-e92b-e053-2995a90aef82	11090-129	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Light Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-130_d888be25-be1c-e92b-e053-2995a90aef82	11090-130	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-131_d888be25-be1c-e92b-e053-2995a90aef82	11090-131	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Neutral Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-132_d888be25-be1c-e92b-e053-2995a90aef82	11090-132	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Medium Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-133_d888be25-be1c-e92b-e053-2995a90aef82	11090-133	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Neutral Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-134_d888be25-be1c-e92b-e053-2995a90aef82	11090-134	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-135_d888be25-be1c-e92b-e053-2995a90aef82	11090-135	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Rich		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-136_d888be25-be1c-e92b-e053-2995a90aef82	11090-136	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Rich Honey		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-137_d888be25-be1c-e92b-e053-2995a90aef82	11090-137	HUMAN OTC DRUG	ITC Bye Bye Foundation Full Coverage Moisturizer Oil-Free Matte Deep		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 6.3	mg/mL; mg/mL			N	20241231
11090-223_d7c24ac7-e164-6907-e053-2a95a90a8d3d	11090-223	HUMAN OTC DRUG	La Roche-Posay Effaclar Duo Dual Action Acne Treatment		Benzoyl Peroxide	LOTION	TOPICAL	20120701		OTC MONOGRAPH FINAL	part333D	Beauty Manufacturing Solutions Corp	BENZOYL PEROXIDE	55	mg/mL			N	20241231
11090-251_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-251	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Fair		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.61; 6.30006	g/100g; g/100g			N	20241231
11090-252_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-252	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Fair Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.34; 6.30006	g/100g; g/100g			N	20241231
11090-253_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-253	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Light		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.61; 6.30006	g/100g; g/100g			N	20241231
11090-254_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-254	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Light Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.34; 6.30006	g/100g; g/100g			N	20241231
11090-255_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-255	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Neutral Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.34; 6.30006	g/100g; g/100g			N	20241231
11090-256_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-256	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Medium		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.34; 6.30006	g/100g; g/100g			N	20241231
11090-257_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-257	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Medium Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.61; 6.30006	g/100g; g/100g			N	20241231
11090-258_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-258	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Neutral Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.34; 6.30006	g/100g; g/100g			N	20241231
11090-259_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-259	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Tan		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	13.05; 6.30006	g/100g; g/100g			N	20241231
11090-260_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-260	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Rich		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	10.96; 6.30006	g/100g; g/100g			N	20241231
11090-261_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-261	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Rich Honey		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	9.98; 6.30006	g/100g; g/100g			N	20241231
11090-262_d7d69ce3-902c-5acd-e053-2995a90aaffe	11090-262	HUMAN OTC DRUG	ITC CC Illumination Full Coverage Cream Deep		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210830		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp	TITANIUM DIOXIDE; ZINC OXIDE	9.914; 6.30006	g/100g; g/100g			N	20241231
11090-263_d7c14c78-737f-5f38-e053-2a95a90a1ba0	11090-263	HUMAN OTC DRUG	Kate Summerville EradiKate		Sulfur	CREAM	TOPICAL	20220201		OTC MONOGRAPH FINAL	part333D	Beauty Manufacturing Solutions Corp.	SULFUR	3	g/100g			N	20241231
11090-264_d7c1e089-7ed7-c9b2-e053-2995a90ada4b	11090-264	HUMAN OTC DRUG	Murad Correct and Protect Serum		Zinc Oxide	EMULSION	TOPICAL	20220201		OTC MONOGRAPH FINAL	part352	Beauty Manufacturing Solutions Corp.	ZINC OXIDE	17	g/100g			N	20241231
11090-265_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-265	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Fair Porce		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-266_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-266	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Fair Ivory		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-267_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-267	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Fair Beige		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-268_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-268	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Fair		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-269_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-269	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Fair Light		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-270_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-270	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Light		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-271_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-271	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Light Medium		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-272_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-272	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Medium		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-273_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-273	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Neutral Medium		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-274_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-274	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Medium Tan		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-275_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-275	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Neutral Tan		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-276_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-276	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Tan		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-277_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-277	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Tan Warm		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-278_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-278	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Tan Rich		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-279_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-279	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Rich		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-280_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-280	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Rich Honey		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-281_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-281	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Neutral Rich		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-282_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-282	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Deep		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-283_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-283	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Deep Honey		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-284_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-284	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Neutral Deep		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-285_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-285	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Deep Bronze		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11090-286_fa2acee9-1a01-d81d-e053-6394a90aabb7	11090-286	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen - Deep Mocha		Octocrylene, Homosalate, Octisalate	LOTION	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part352	Beauty Manufacturing Solutions Corp.	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
11103-001_0760bb5f-85a8-c294-e063-6394a90aa71d	11103-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140101		NDA	NDA205849	Temple Industrial Welding Supply Co	OXYGEN	990	mL/L			N	20241231
11118-0264_fd285e1d-01d9-2409-e053-6294a90a7a2e	11118-0264	HUMAN OTC DRUG	Panoxyl		Benzoyl Peroxide	SOAP	TOPICAL	20230605		OTC MONOGRAPH FINAL	M006	The Original Bradford Soap Works Inc	BENZOYL PEROXIDE	12.6	g/113g			N	20241231
11291-070_dd1899a3-35f0-3b11-e053-2995a90ab6c5	11291-070	HUMAN OTC DRUG	Dr Tichenors	First Aid Antiseptic	Alcohol	GEL	TOPICAL	20121219		OTC MONOGRAPH NOT FINAL	part333E	Dr. G. H. Tichenor's Antiseptic Company	ALCOHOL	7	mL/10mL			N	20241231
11291-243_96ca9924-3d20-f3b4-e053-2a95a90a29d8	11291-243	HUMAN OTC DRUG	Dr Tichenors With Extra Whitening and Tartar Control		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20121024		OTC MONOGRAPH FINAL	part355	Dr. G. H. Tichenor's Antiseptic Company	SODIUM FLUORIDE	2.43	mg/g			N	20241231
11324-001_0d6b4bea-1df5-eaed-e063-6294a90a9743	11324-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20071001		UNAPPROVED MEDICAL GAS		Linde Puerto Rico B.V.	OXYGEN	990	mL/L			N	20241231
11324-002_0d6b3033-160f-6baf-e063-6394a90a43e2	11324-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20051001		UNAPPROVED MEDICAL GAS		Linde Puerto Rico B.V.	NITROGEN	990	mL/L			N	20241231
11324-003_0d6b3033-1609-6baf-e063-6394a90a43e2	11324-003	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20051001		UNAPPROVED MEDICAL GAS		Linde Puerto Rico B.V.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
11324-006_0d6abff2-552c-32c5-e063-6394a90aad70	11324-006	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20051001		UNAPPROVED MEDICAL GAS		Linde Puerto Rico B.V.	OXYGEN	210	mL/L			N	20241231
11324-499_0d6b4bea-1df7-eaed-e063-6294a90a9743	11324-499	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20130522		NDA	NDA205850	Linde Puerto Rico B.V.	NITROGEN	990	mL/L			N	20241231
11324-721_0d6b4bea-1df7-eaed-e063-6294a90a9743	11324-721	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130522		NDA	NDA205849	Linde Puerto Rico B.V.	OXYGEN	990	mL/L			N	20241231
11344-001_cbfdfd61-91d5-4555-8af2-cd1716a42407	11344-001	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20141010		OTC MONOGRAPH FINAL	part344	Sound Drug	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
11344-012_633b90ca-b8aa-450e-8f91-c622422e0ec1	11344-012	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20221012		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-014_f9c2344a-a801-4f3c-abbe-f3f9aabfa44a	11344-014	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20221012		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-015_784776d8-5df0-4dde-aaa7-1ef9f695dcf5	11344-015	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20221014		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-017_4b2a3617-44e8-421f-b666-9a849e7b566c	11344-017	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride	SOLUTION	TOPICAL	20170524		OTC MONOGRAPH NOT FINAL	part333A	VI-JON, LLC	BENZALKONIUM CHLORIDE	1.2	mg/mL			N	20241231
11344-031_05e17871-aac4-4794-a585-bb3de3d73986	11344-031	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20221012		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-053_da29f4be-daf1-4ca8-b0b3-e0576a41605a	11344-053	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20090105		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	545	mg/mL			N	20241231
11344-054_ffec0867-4cfa-4277-a552-5659170eee72	11344-054	HUMAN OTC DRUG	Blackhead scrub		Salicylic Acid (1%)	CREAM	TOPICAL	20200901		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	10	mg/g			N	20241231
11344-069_f14495ca-efda-4bf6-ab84-92dfbf59a099	11344-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	19890715		OTC MONOGRAPH FINAL	part347	Vi-Jon	PETROLATUM	1	g/g			N	20241231
11344-078_e5917a95-b315-4073-b6eb-cb574b068591	11344-078	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	20081209		OTC MONOGRAPH NOT FINAL	part334	Vi-Jon, LLC	CASTOR OIL	1	g/mL			N	20241231
11344-089_0f64e142-aa64-4675-82e6-6f0c637b40bf	11344-089	HUMAN OTC DRUG	Germ-X		Alcohol	LIQUID	TOPICAL	20160222		OTC MONOGRAPH NOT FINAL	part333A	Vi Jon, LLC	ALCOHOL	62	mg/mL			N	20241231
11344-098_7777de9d-c5f1-422f-b105-a3f89c4903e3	11344-098	HUMAN OTC DRUG	Germ-X		Alcohol	LIQUID	TOPICAL	20160222		OTC MONOGRAPH NOT FINAL	part333A	Vi Jon, LLC	ALCOHOL	62	mg/mL			N	20241231
11344-100_14d6794e-d7fc-4fae-8290-96560db45455	11344-100	HUMAN OTC DRUG	Hand Sanitizing Wipes		Ethyl Alcohol	CLOTH	TOPICAL	20180124		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	67	mL/100mL			N	20241231
11344-118_a289d381-4dac-4a97-a141-81db75c19dcb	11344-118	HUMAN OTC DRUG	Foaming Hand Sanitizer		Benzalkonium Chloride	LOTION	TOPICAL	20090105		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-199_2c7e19ab-7c26-48ab-a955-a35ae6e81aa9	11344-199	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	62	mL/100mL			N	20241231
11344-207_545951e2-35cd-47b5-a8b3-777a092b3f33	11344-207	HUMAN OTC DRUG	Foaming Hand		Benzalkonium Chloride	LOTION	TOPICAL	20180208		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-218_20c0aabe-e5d2-41c2-8bce-83a7f252e1e2	11344-218	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20080724		OTC MONOGRAPH NOT FINAL	part347	Vi-Jon, LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11344-224_14507d10-3398-4707-b8a5-38be09583427	11344-224	HUMAN OTC DRUG	Foaming Hand		Benzalkonium Chloride	LOTION	TOPICAL	20180208		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-231_86bd63fa-de2b-4ded-aa7c-f207b4b13bee	11344-231	HUMAN OTC DRUG	Hand Sanitizing Wipes		Ethyl Alcohol	CLOTH	TOPICAL	20090105		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	620	mg/mL			N	20241231
11344-234_52b68339-7b94-4851-9d24-aba011357e17	11344-234	HUMAN OTC DRUG	Germ-X		Alcohol	LIQUID	TOPICAL	19990712		OTC MONOGRAPH NOT FINAL	part333A	Vi Jon, LLC	ALCOHOL	63	mL/100mL			N	20241231
11344-235_dba466ee-3287-4b2a-b113-586ff650f3ad	11344-235	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20110126		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	PETROLATUM	99.8	g/100kg			N	20241231
11344-248_28162257-1429-4a44-9874-d9eef335dc8d	11344-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20170623		OTC MONOGRAPH FINAL	part341	Vi-Jon, LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	kg/g; kg/g; kg/g			N	20241231
11344-253_26961d7e-ba13-44bc-80e1-063759859d55	11344-253	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20160531		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
11344-279_6c08539a-5186-40c6-bf82-c6c8fbe26b7c	11344-279	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20170327		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-311_25d377aa-e9b2-436a-9d73-4c416bebdf3d	11344-311	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20050623		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
11344-336_dfc3ed13-fb7b-44fa-b722-bda4058a5a41	11344-336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxind HCl	LOTION	TOPICAL	20160908		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
11344-340_f45992a4-5fed-4e6b-a24a-4bc7b7fb47f3	11344-340	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20200105		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-370_9e8ffd4b-7ce6-48e2-b10d-a7c2b6def242	11344-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20210405		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
11344-391_6e89580a-4be5-4f2f-9255-05519e48dfe6	11344-391	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride 0.13%	LIQUID	TOPICAL	20160728		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.313	mg/mL			N	20241231
11344-396_fe53ce76-1380-47e7-b06a-337f36bbc66e	11344-396	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LOTION	TOPICAL	20150206		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	567	mg/mL			N	20241231
11344-397_05bd47bf-7824-45f4-8457-ec69c0b01cb5	11344-397	HUMAN OTC DRUG	Vaporizing		Camphor	INHALANT	RESPIRATORY (INHALATION)	20121003		OTC MONOGRAPH FINAL	part341	Vi-Jon, LLC	CAMPHOR (SYNTHETIC)	62	mg/mL			N	20241231
11344-403_cf73910f-dd01-4aff-851f-57aef9e64355	11344-403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20150123		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-416_9d997c0c-5c37-4d7b-84ad-0f104f501dd7	11344-416	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride 0.13%	LIQUID	TOPICAL	20170327		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.313	mg/mL			N	20241231
11344-437_9a08d57b-bd94-4afc-a5a2-ce53572306ab	11344-437	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20160613		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	63	mg/mL			N	20241231
11344-439_42cc03e0-087c-4945-bc44-b55ccc05e207	11344-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20120726		OTC MONOGRAPH DRUG	505G(a)(3)	Vi-Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
11344-443_d83a7407-d0a5-44f7-b1a3-33c0c6f5c84f	11344-443	HUMAN OTC DRUG	Dandruff		pyrthione zinc	SHAMPOO	TOPICAL	20160617		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	PYRITHIONE ZINC	10.4	mg/mL			N	20241231
11344-447_d0874eec-125e-4bb4-a874-ff6f2ebd13bd	11344-447	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		Ethyl Alcohol	LOTION	TOPICAL	20160503		OTC MONOGRAPH DRUG	M505(a)(3)	Vi-Jon, LLC	ALCOHOL	.62	mL/mL			N	20241231
11344-456_139915c1-a36f-4f34-b7b9-b44f22fa0819	11344-456	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20160610		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	.7	mL/mL			N	20241231
11344-460_c5a75809-e8ab-4ca0-b517-141351434597	11344-460	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride 0.13%	LIQUID	TOPICAL	20160527		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.313	mg/mL			N	20241231
11344-465_d91d5289-e913-499d-87ae-3f9c73d29d5e	11344-465	HUMAN OTC DRUG	Antibacterial Hand Wash		Ethyl Alcohol	LIQUID	TOPICAL	20160728		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	1.313	mg/mL			N	20241231
11344-466_b246a722-a2d1-4ad5-bf9c-d551d46a8838	11344-466	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160217		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-475_8daa38a3-6e13-4137-b6df-b11ce488a3d2	11344-475	HUMAN OTC DRUG	Dandruff		pyrthione zinc	SHAMPOO	TOPICAL	20160617		OTC MONOGRAPH FINAL	part358H	Vi-Jon, Inc	PYRITHIONE ZINC	1	mg/mL			N	20241231
11344-478_1f44dd9e-fddb-4ee8-b64e-798e44fa16de	11344-478	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		Benzethonium Chloride	LOTION	TOPICAL	20160503		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZETHONIUM CHLORIDE	1.98	mg/g			N	20241231
11344-488_9743e890-0934-46f8-bff0-21ae84b1c1a4	11344-488	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride 0.13%	LIQUID	TOPICAL	20160527		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.313	mg/mL			N	20241231
11344-529_88cb3add-6124-46dc-9a47-782ba06a6ef0	11344-529	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20221222		OTC MONOGRAPH DRUG	M505G(a)(3)	Vi-Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
11344-531_7e4db10c-34ea-4ca9-aa7a-c2e81dcb1579	11344-531	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO, SUSPENSION	TOPICAL	20160316		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	PYRITHIONE ZINC	958	mg/mL			N	20241231
11344-538_96e40efd-d647-411f-a12b-382f88e9f5a0	11344-538	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20090105		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	558	mg/mL			N	20241231
11344-544_a75ca083-af89-4594-a00d-7aa7784fdacc	11344-544	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140314		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	567	mg/mL			N	20241231
11344-566_914755c7-1595-4be8-81b8-2454d7b3a717	11344-566	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20100729		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	PETROLATUM	1	g/g			N	20241231
11344-570_0cfa83f7-d6e5-449e-ae3e-cc2c8c948bf1	11344-570	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20151122		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
11344-575_83caaf46-311b-426f-b93b-5c7cbc22aedd	11344-575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20170315		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
11344-603_fb79c6a6-7afd-4544-9b3b-74e2fb3e69a2	11344-603	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LOTION	TOPICAL	20050419		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	558	mg/mL			N	20241231
11344-612_679bb4b6-122f-4faa-8727-b29aed2f08fa	11344-612	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20161206		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	PYRITHIONE ZINC	1	g/mL			N	20241231
11344-633_9af2507f-0654-4586-9e51-365b85c75640	11344-633	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20170319		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
11344-644_c1609f87-5d43-4c36-8609-414b9e3015d6	11344-644	HUMAN OTC DRUG	Soft Wipes Alcohol Free Antibacterial		Benzalkonium Chloride (0.13%)	CLOTH	TOPICAL	20090105		OTC MONOGRAPH NOT FINAL	part333A	VI-JON, LLC	BENZALKONIUM CHLORIDE	.0013	mg/100mg			N	20241231
11344-646_52062152-8aa0-49f4-9dbe-e933a3dd7254	11344-646	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140729		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	558	mg/mL			N	20241231
11344-652_000f1c03-d5f3-4397-af55-12dd913abbe5	11344-652	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20221206		OTC MONOGRAPH DRUG	M505G(a)(3)	Vi-Jon, LLC	ALCOHOL	62	mL/100mL			N	20241231
11344-710_615b34d3-88c7-4724-967d-b8af305fbd9f	11344-710	HUMAN OTC DRUG	chloroxylenol		chloroxylenol	LIQUID	TOPICAL	20170114		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	CHLOROXYLENOL	3.09	mg/mL			N	20241231
11344-713_71108b59-d14f-4d45-93eb-76124387459e	11344-713	HUMAN OTC DRUG	antibacterial		chloroxylenol	LIQUID	TOPICAL	20170114		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	CHLOROXYLENOL	3	mg/mL			N	20241231
11344-721_e244f811-dc84-4665-acb6-1e2a8a0f20de	11344-721	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20160606		OTC MONOGRAPH NOT FINAL	part333A	Vi- Jon, LLC	ALCOHOL	.62	mL/mL			N	20241231
11344-746_685893cf-b761-45af-b15f-51d258af7472	11344-746	HUMAN OTC DRUG	Germ-X Advanced		Advanced Hand Sanitizer	GEL	TOPICAL	20170821		OTC MONOGRAPH NOT FINAL	part333A	Vi Jon, LLC	ALCOHOL	700	mg/mL			N	20241231
11344-747_ef5e3257-ad8f-4a1d-a9cb-bdd20c7c43a9	11344-747	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl, Menthol	GEL	TOPICAL	20170324		OTC MONOGRAPH NOT FINAL	part348	Vi-Jon, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	7; 2	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11344-766_1568d468-b0ee-45cf-bd26-54435009577a	11344-766	HUMAN OTC DRUG	Germ-X		Alcohol	LIQUID	TOPICAL	20170821		OTC MONOGRAPH NOT FINAL	part333A	Vi Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
11344-770_033d594f-f977-4368-a763-be6a6a9e712e	11344-770	HUMAN OTC DRUG	Germ-X Everywhere		Advanced Hand Sanitizer	GEL	TOPICAL	20160328		OTC MONOGRAPH NOT FINAL	part333A	Vi Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
11344-775_c726dd1c-f127-43a5-924b-d88543a5f560	11344-775	HUMAN OTC DRUG	Germ-X		Alcohol	LIQUID	TOPICAL	20160222		OTC MONOGRAPH NOT FINAL	part333A	Vi Jon, LLC	ALCOHOL	62	mg/mL			N	20241231
11344-801_100ecbd6-4625-407d-8f17-62d90ed8b9e3	11344-801	HUMAN OTC DRUG	germ-X Soft Wipes Alcohol Free Antibacterial		Benzalkonium Chloride (0.13%)	CLOTH	TOPICAL	20050401		OTC MONOGRAPH NOT FINAL	part333A	VI-JON	BENZALKONIUM CHLORIDE	.0013	mg/100mg			N	20241231
11344-815_a1416426-877f-4937-a108-bbc9bcfb9d10	11344-815	HUMAN OTC DRUG	Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20221102		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	620	mg/mL			N	20241231
11344-818_7a7c07ab-78dd-4918-a71a-a7d2e3fe1762	11344-818	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20220105		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
11344-821_5aa2f7f2-88e5-4b74-b313-73d14538f964	11344-821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20161027		OTC MONOGRAPH FINAL	part333D	Vi-Jon, LLC	SALICYLIC ACID	21	mg/mL			N	20241231
11344-826_bc70ea85-8965-459a-a9bd-b815f8d07e64	11344-826	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20170719		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	62	mL/100mL			N	20241231
11344-842_207841c7-6287-4eb3-a75f-f6dbcb15ff0b	11344-842	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20210405		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
11344-849_3da1e94d-a02b-4d28-8b2a-102ea0f63498	11344-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20200429		OTC MONOGRAPH DRUG	505G(a)(3)	Vi-Jon, LLC	ALCOHOL	62	mL/100mL			N	20241231
11344-858_aa694f6d-cdf1-44c5-83b3-8488acc937aa	11344-858	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20170710		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
11344-887_aa1b5401-a011-4d8f-839b-43f650efcd5f	11344-887	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20210405		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
11344-899_79fdb0a5-9b1c-428d-bd6e-836bf3ac853a	11344-899	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20160606		OTC MONOGRAPH NOT FINAL	part333A	Vi- Jon, LLC	ALCOHOL	.62	mL/mL			N	20241231
11344-938_0bca68fd-8613-1893-e063-6294a90a996d	11344-938	HUMAN OTC DRUG	Hand Sanitizing Wipes		Ethyl Alcohol	CLOTH	TOPICAL	20231121		OTC MONOGRAPH DRUG	505G(a)(3)	Vi-Jon, LLC	ALCOHOL	70	mL/100mL			N	20241231
11344-942_06f16b04-add2-4c2d-bbf1-dfda5286c031	11344-942	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20171101		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11344-951_cec1bddb-f9ee-47ac-8d09-cf7df0a4a3af	11344-951	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20140908		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	578	mg/mL			N	20241231
11344-960_69a9cc06-178e-422f-9b6e-83a0762483dd	11344-960	HUMAN OTC DRUG	White Petrolatum		White Petrolatum	JELLY	TOPICAL	20150715		OTC MONOGRAPH FINAL	part347	Vi-Jon, LLC	PETROLATUM	1	g/g			N	20241231
11344-975_70821a6b-24b9-4c47-8579-f344f4c77e65	11344-975	HUMAN OTC DRUG	Therapeutic Dandruff		Dandruff Shampoo	SHAMPOO	TOPICAL	20170801		OTC MONOGRAPH FINAL	part358H	Vi-Jon, LLC	SALICYLIC ACID	30	mg/mL			N	20241231
11344-996_cb62d6df-1d9d-42da-8de6-7e1ba686d607	11344-996	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20201202		OTC MONOGRAPH NOT FINAL	part333A	Vi-Jon, LLC	ALCOHOL	700	mg/mL			N	20241231
11365-001_0d8551c6-2f02-11a8-e063-6294a90aed01	11365-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100903		UNAPPROVED MEDICAL GAS		Medical Products Group LLC	OXYGEN	99	L/100L			N	20241231
11383-253_471758a2-9b34-29e8-e054-00144ff88e88	11383-253	HUMAN OTC DRUG	Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20110325		OTC MONOGRAPH FINAL	part358G	Weeks & Leo Co., Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
11383-255_0c1adbad-90bc-b402-e063-6294a90a5712	11383-255	HUMAN OTC DRUG	Weeks and Leo Complete Lice Treatment		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20101028		OTC MONOGRAPH DRUG	M031	Weeks & Leo Co., Inc.						N	20241231
11383-256_49c8da08-7be9-6b19-e054-00144ff8d46c	11383-256	HUMAN OTC DRUG	Weeks and Leo Medicated Vaporizing Steam		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20111102		OTC MONOGRAPH FINAL	part341	Weeks & Leo Co., Inc.	CAMPHOR (SYNTHETIC)	.623	g/10mL			N	20241231
11383-258_4b2a349b-93cf-5ef5-e054-00144ff8d46c	11383-258	HUMAN OTC DRUG	Weeks and Leo Extra Strength Itch Stopping		Diphenhydramine hydrochloride and Zinc acetate	CREAM	TOPICAL	20140317		OTC MONOGRAPH NOT FINAL	part348	Weeks & Leo Co., Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11383-268_0c5325e3-4797-856c-e063-6394a90a1f90	11383-268	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone 1%	OINTMENT	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	Weeks & Leo Co., Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11383-292_0c58634f-2474-3637-e063-6394a90a0704	11383-292	HUMAN OTC DRUG	Anti itch		HYDROCORTISONE	CREAM	TOPICAL	20130210		OTC MONOGRAPH DRUG	M017	Weeks & Leo Co., Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11383-308_0c43143e-c2f0-5a46-e063-6394a90a0644	11383-308	HUMAN OTC DRUG	AntiochPharma Hand Sanitizer		Alcohol	GEL	TOPICAL	20200324		OTC MONOGRAPH DRUG	M003	Weeks & Leo	ALCOHOL	70	mL/100mL			N	20241231
11383-309_0c57a011-6a1e-29d8-e063-6394a90a1e81	11383-309	HUMAN OTC DRUG	AntiochPharma Rapidgel Hand Sanitizer		Alcohol	GEL	TOPICAL	20200324		OTC MONOGRAPH DRUG	M003	Weeks & Leo	ALCOHOL	70	mL/100mL			N	20241231
11383-310_c44689ae-2a05-5ef6-e053-2995a90a9532	11383-310	HUMAN OTC DRUG	Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20210517		OTC MONOGRAPH FINAL	part358G	Weeks & Leo Co., Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
11383-311_0b606683-7d69-cca5-e063-6394a90a6f58	11383-311	HUMAN OTC DRUG	Carolina Crud Crusher		Dextromethorphan HBr, Guaifenesin	SYRUP	ORAL	20220601		OTC MONOGRAPH DRUG	M012	Weeks & Leo Co., Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11383-313_0c5419c5-0928-7ca6-e063-6294a90ac0a7	11383-313	HUMAN OTC DRUG	Anti-itch Paraben Free		HYDROCORTISONE	CREAM	TOPICAL	20230303		OTC MONOGRAPH DRUG	M017	Weeks & Leo Co., Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11401-6994_075f9001-085f-9f47-e063-6294a90af788	11401-6994	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100111		UNAPPROVED MEDICAL GAS		Hawaii Home Infusion Associates, Ltd.	OXYGEN	99	L/100L			N	20241231
11410-005_0b3db179-d0a4-abb2-e063-6394a90ac08d	11410-005	HUMAN OTC DRUG	Proactiv Renewing Cleanser		Benzoyl Peroxide	GEL	TOPICAL	20111021		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	BENZOYL PEROXIDE	2.5	g/100mL			N	20241231
11410-011_0b4cd209-ae20-5042-e063-6394a90a0891	11410-011	HUMAN OTC DRUG	Proactivplus Skin Smoothing Exfoliator		BENZOYL PEROXIDE	LOTION	TOPICAL	20130125		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	BENZOYL PEROXIDE	2.5	mg/100mL			N	20241231
11410-012_0b4c6ff6-b568-2387-e063-6394a90aa1b7	11410-012	HUMAN OTC DRUG	Proactiv Emergency Blemish Relief		Benzoyl Peroxide	CREAM	TOPICAL	20130215		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	BENZOYL PEROXIDE	5	g/100g			N	20241231
11410-013_0b4c71a3-93b3-165d-e063-6394a90af4fc	11410-013	HUMAN OTC DRUG	Proactiv Skin Purifying Mask		SULFUR	LOTION	TOPICAL	20121231		OTC MONOGRAPH DRUG	M006	THE PROACTIV COMPANY LLC	SULFUR	6	g/100g			N	20241231
11410-023_0b3d0b4f-dcc5-34db-e063-6394a90acf05	11410-023	HUMAN OTC DRUG	Proactiv Plus Complexion Perfecting Hydrator		SALICYLIC ACID	CREAM	TOPICAL	20130301		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	.5	g/100mL			N	20241231
11410-024_0b3dbe2f-5903-d99d-e063-6394a90ada00	11410-024	HUMAN OTC DRUG	Proactiv Blackhead Dissolving		SALICYLIC ACID	GEL	TOPICAL	20130501		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	.5	g/100mL			N	20241231
11410-030_0b3d19e4-0dc5-4a22-e063-6394a90a48d5	11410-030	HUMAN OTC DRUG	Proactiv Clarifying Night		Salicylic Acid	CREAM	TOPICAL	20150601		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	1	mg/100mL			N	20241231
11410-040_0bb27c2c-2a0f-b6af-e063-6294a90a0f90	11410-040	HUMAN OTC DRUG	Proactiv Repairing Treatment		Benzoyl Peroxide	GEL	TOPICAL	20111101		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	BENZOYL PEROXIDE	2.5	mg/100mL			N	20241231
11410-046_0b3d1724-7c1f-6341-e063-6394a90abb58	11410-046	HUMAN OTC DRUG	Proactiv plus Pore Targeting Treatment		BENZOYL PEROXIDE	GEL	TOPICAL	20130103		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	BENZOYL PEROXIDE	2.5	g/100mL			N	20241231
11410-048_0bb285b3-3939-9f59-e063-6294a90a5e36	11410-048	HUMAN OTC DRUG	Proactiv Deep Cleansing Wash		Salicylic Acid	LOTION/SHAMPOO	TOPICAL	20101001		OTC MONOGRAPH DRUG	M006	THE PROACTIV COMPANY LLC	SALICYLIC ACID	2	g/100mL			N	20241231
11410-051_0b4c7578-1ff0-dcc3-e063-6294a90ac305	11410-051	HUMAN OTC DRUG	Proactiv Plus Retexturizing Toner		SALICYLIC ACID	CREAM	TOPICAL	20140215		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
11410-055_0b3dd270-b0a1-cdec-e063-6394a90a607c	11410-055	HUMAN OTC DRUG	Proactiv Advanced Daily Oil Control		SALICYLIC ACID	LOTION	TOPICAL	20120301		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	.5	mg/100mL			N	20241231
11410-056_0b3cff3d-3551-3594-e063-6394a90a6e53	11410-056	HUMAN OTC DRUG	Proactiv CLEAR ZONE BODY PADS		salicylic acid	LIQUID	TOPICAL	20170103		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
11410-073_0bb28cba-477c-c1de-e063-6294a90a8a28	11410-073	HUMAN OTC DRUG	Proactiv Clear Skin SPF 30		Avobenzone, Octisalate, and Octocrylene	LOTION	TOPICAL	20211213		OTC MONOGRAPH DRUG	M020	Alchemee, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 7	mg/100mL; mg/100mL; mg/100mL			N	20241231
11410-074_0b3d986c-eeb4-adbe-e063-6294a90a0fb2	11410-074	HUMAN OTC DRUG	Proactiv Acne Body Wash		Salicylic Acid	LIQUID	TOPICAL	20200602		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
11410-400_2d78e229-f584-42b2-85d9-24e3256a7a52	11410-400	HUMAN OTC DRUG	Proactiv Acne Body Bar		SALICYLIC ACID	SOAP	TOPICAL	20220601	20240630	OTC MONOGRAPH FINAL	part333D	ALCHEMEE, LLC	SALICYLIC ACID	2	mg/100g			N	
11410-457_0b3cc92a-2308-f982-e063-6394a90a7072	11410-457	HUMAN OTC DRUG	Proactiv Clean Mineral Acne Cleanser		SULFUR	CREAM	TOPICAL	20220815		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SULFUR	3	g/100mL			N	20241231
11410-458_0b3cf5b2-9bd6-e1c6-e063-6294a90a8c21	11410-458	HUMAN OTC DRUG	Proactiv Clean Acne Clearing Hydrator		Salicylic Acid	GEL	TOPICAL	20230201		OTC MONOGRAPH DRUG	M006	Alchemee, LLC	SALICYLIC ACID	2	mg/100mL			N	20241231
11410-956_f1364b67-9750-4d0d-bc59-8b100c462376	11410-956	HUMAN OTC DRUG	Proactiv MD Adapalene	Acne Treatment	Adapalene	GEL	TOPICAL	20170327		NDA AUTHORIZED GENERIC	NDA020380	Alchemee, LLC	ADAPALENE	.1	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
11410-958_0a9b37b5-e067-4805-e063-6294a90ad703	11410-958	HUMAN OTC DRUG	Proactiv MD Adapalene	Acne Treatment	Adapalene	GEL	TOPICAL	20231116		ANDA	ANDA215940	Alchemee, LLC	ADAPALENE	.1	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
11429-1001_e1a57a3d-1109-2244-e053-2995a90abd14	11429-1001	HUMAN OTC DRUG	FoamFresh Alco-Free Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140416		OTC MONOGRAPH NOT FINAL	part333A	Woodbine Products Company	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
11429-1002_e1a588a6-5574-3a48-e053-2995a90a02e6	11429-1002	HUMAN OTC DRUG	FoamFresh E-2 Sanitizer Cleanser		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140226		OTC MONOGRAPH NOT FINAL	part333A	Woodbine Products Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11429-1003_e1a59825-ee52-62ff-e053-2a95a90a08cd	11429-1003	HUMAN OTC DRUG	Alco Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20140410		OTC MONOGRAPH NOT FINAL	part333A	Woodbine Products Company	ALCOHOL	70	mL/100mL			N	20241231
11429-1004_e1a5a6ff-8045-62fd-e053-2a95a90a160f	11429-1004	HUMAN OTC DRUG	FoamFresh Alco-Foam Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20140331		OTC MONOGRAPH NOT FINAL	part333A	Woodbine Products Company	ALCOHOL	62	mL/100mL			N	20241231
11429-1005_e1a5bc32-f994-6b33-e053-2995a90ab9ac	11429-1005	HUMAN OTC DRUG	FoamFresh Antibacterial Hand Wash		CHLOROXYLENOL	LIQUID	TOPICAL	20120928		OTC MONOGRAPH NOT FINAL	part333A	Woodbine Products Company	CHLOROXYLENOL	2.5	mg/mL			N	20241231
11429-1006_e26f5af3-0ef3-6d1f-e053-2995a90aea8d	11429-1006	HUMAN OTC DRUG	Lemon Drop Gentle Antiseptic		CHLOROXYLENOL	LIQUID	TOPICAL	20140416		OTC MONOGRAPH NOT FINAL	part333A	Woodbine Products Company	CHLOROXYLENOL	3	mg/mL			N	20241231
11429-1010_9fa71be6-bc0e-4179-9881-e611f4d0e2d8	11429-1010	HUMAN OTC DRUG	FoamFresh Dye Free Antibacterial Hand Wash		CHLOROXYLENOL	SOLUTION	TOPICAL	20181120		OTC MONOGRAPH NOT FINAL	part333A	Woodbine Products Company	CHLOROXYLENOL	2.5	mg/mL			N	20241231
11489-093_978eb2f0-0c94-4a17-a481-c2af89423c8e	11489-093	HUMAN OTC DRUG	Botanics All Bright Hydrating Day Cream Sunscreen Broad Spectrum SPF 15		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20160630		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 1.5; 2.5	g/50g; g/50g; g/50g			N	20241231
11489-095_dd69d898-2c37-465f-a5ca-a83625f70a7c	11489-095	HUMAN OTC DRUG	Botanics Triple Age Renewal Day Cream Sunscreen Broad Spectrum SPF 15		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20160630		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 1.5; 2.5	g/50g; g/50g; g/50g			N	20241231
11489-096_ed0ca160-8291-468b-a3ce-fd053d40cb17	11489-096	HUMAN OTC DRUG	Botanics Shine Away Mattifying Day Cream Sunscreen Broad Spectrum SPF 15		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20160630		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 1.5; 2.5	g/50g; g/50g; g/50g			N	20241231
11489-100_0af00430-c7de-462c-9696-a361a7f8e8b9	11489-100	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20160630		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-101_736671f1-9db6-44f4-836b-e6add9401257	11489-101	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20160630		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-112_88520cb3-8fb6-4e5e-aa96-e548683a1552	11489-112	HUMAN OTC DRUG	YourGoodSkin SPF 30 Anti-oxidant Day Sunscreen Broad Spectrum SPF 30		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20171016		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.25; .375; 3.75; 5.625	g/75g; g/75g; g/75g; g/75g			N	20241231
11489-113_f52a0947-bdfb-4f63-b643-4234fd5ff9bd	11489-113	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20161205		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-125_8eb3b637-1772-47a4-b326-a1754c523e94	11489-125	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20170731		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-126_b6baa02d-1e82-4ae7-9113-4f0f5ae4bb47	11489-126	HUMAN OTC DRUG	No7 Early Defence Day Cream		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20170808		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/g; g/g; g/g			N	20241231
11489-127_ae1136dd-85ca-41cb-8df0-f7058f6ae396	11489-127	HUMAN OTC DRUG	No7Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20180228		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 4	g/g; g/g; g/g			N	20241231
11489-128_969a390b-875b-48be-9c9c-760af4f93e4d	11489-128	HUMAN OTC DRUG	No7Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20180228		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 4	g/g; g/g; g/g			N	20241231
11489-136_71d3439b-6f65-489d-90e8-f1769efc61fc	11489-136	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20180802		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-137_cb22d3c9-41a3-44ce-9a82-9c6dae6d7015	11489-137	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20180427		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-138_f6ed4327-e278-4998-9975-f72e3aff941a	11489-138	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-139_6ed972ef-a335-4776-b32d-926025be0169	11489-139	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20181031		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-141_17e9ca03-7d6c-4af4-8bc4-8e53d5329a35	11489-141	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20181217		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 2	g/g; g/g; g/g			N	20241231
11489-145_ffdfe36c-7da1-4095-b915-4935564a8d4d	11489-145	HUMAN OTC DRUG	No7 Early Defence Glow Activating Day Cream		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20190924		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/g; g/g; g/g			N	20241231
11489-146_95f18020-3f77-4563-baaf-36cceeeff0d7	11489-146	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20190802		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-149_eee4ce58-3f74-4ebc-b3aa-8fa9b5625c6a	11489-149	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20190131		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 2	g/g; g/g; g/g			N	20241231
11489-154_afe6fbae-b5ef-49ef-976d-018db6772761	11489-154	HUMAN OTC DRUG	Urban Legend Antioxidant Day Cream with Green Tea and Vitamin C Sunscreen Broad Spectrum SPF 30		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.25; .375; 3.75; 5.625	g/75g; g/75g; g/75g; g/75g			N	20241231
11489-155_f85300a1-8573-4ae6-b3ee-99bdcdd283ab	11489-155	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20200203		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-156_59a54b10-94c4-4c4f-8f74-4de9fcd0f891	11489-156	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20200203		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-157_6083a2d4-122e-4b19-a246-faa2d010f1d3	11489-157	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20200203		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 2	g/g; g/g; g/g			N	20241231
11489-158_08046445-6a6d-4d65-aeb1-a575d5c5ed04	11489-158	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octocrylene, Octisalate	CREAM	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-159_6e13dbde-f5cf-4be5-a6f3-d3bfed57f066	11489-159	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octocrylene, Octisalate	CREAM	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-173_1848530b-a2c2-41a0-8210-fdade8305df8	11489-173	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octocrylene, Octisalate	CREAM	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-174_c685e137-941a-4e43-adf4-f94efc6840da	11489-174	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone, Octocrylene, Octisalate	CREAM	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-175_05d2a518-9399-4b04-8275-9400ce557cba	11489-175	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octocrylene, Octisalate	CREAM	TOPICAL	20200622		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 2	g/g; g/g; g/g			N	20241231
11489-176_4a09231a-44bc-4242-b49f-7e476c4b98d3	11489-176	HUMAN OTC DRUG	No7 Laboratories Acne Treatment		Salicylic Acid	LIQUID	TOPICAL	20201104		OTC MONOGRAPH FINAL	part333D	BCM Ltd	SALICYLIC ACID	1	g/50g			N	20241231
11489-177_d146d9f4-9141-47f2-95fd-070f60e1dbb4	11489-177	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Fragrance Free Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210326		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-178_acc1311b-40aa-44ee-a1b1-2f29680de652	11489-178	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Fragrance Free Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210326		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-179_b0c4a4cf-8bcb-42e8-bba8-bdffe4fe3bba	11489-179	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210326		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 4	g/g; g/g; g/g			N	20241231
11489-180_84317d24-c547-4b31-b871-b45ea86bb534	11489-180	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210809		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-181_c1d1cdab-69fd-4be3-ac8f-cbe51bfd4306	11489-181	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210817		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 4	g/50g; g/50g; g/50g			N	20241231
11489-182_163a445d-b416-4688-8938-ef03f976b7af	11489-182	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210817		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-183_fac45ee1-876f-4ed8-8278-cd273b011332	11489-183	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210914		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-184_236ab5a5-df16-4790-8552-ee1cb6b774d8	11489-184	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210915		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-185_641b6261-deb8-40b8-94d1-83527f5a4b84	11489-185	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210915		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 2	g/25g; g/25g; g/25g			N	20241231
11489-186_c414e049-8c48-4bcc-8ec7-7026df885a7c	11489-186	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210809		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-187_2a822855-f497-4a14-9d6d-4f9df3b4bd57	11489-187	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20210915		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-188_4da60c37-fd50-46dd-9502-72ce24e7ee16	11489-188	HUMAN OTC DRUG	No7 Menopause Skincare Protect and Hydrate Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.5; .25; 2.5; 3.75	g/g; g/g; g/g; g/g			N	20241231
11489-189_008196f8-7b05-469e-af5a-8ac532f9e6c8	11489-189	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20220624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-190_e7872673-770f-4515-b4fd-0bec098f47e0	11489-190	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20220624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-191_bffaf38a-6437-4ece-9270-a1a3d9506f5e	11489-191	HUMAN OTC DRUG	No7 Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20220624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 2	g/25g; g/25g; g/25g			N	20241231
11489-192_ae24287f-b534-4c2b-adf7-fb28967b0f08	11489-192	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20220624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-193_af13b3af-43ba-4e41-a563-32d8c0e2997c	11489-193	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20220624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-194_6c1ef4e7-0277-4eb1-87d8-5ebfab46635c	11489-194	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20220624		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.75; 1.25; 1.875	g/25g; g/25g; g/25g			N	20241231
11489-195_4096a6d4-6265-42e5-af3a-49b496d49c27	11489-195	HUMAN OTC DRUG	No7Restore and Renew Face and Neck Multi Action Day Cream Sunscreen Broad Spectrum SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20230814		OTC MONOGRAPH NOT FINAL	part352	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 4	g/g; g/g; g/g			N	20241231
11489-196_8debeec2-c074-447e-a627-75b780b0dc32	11489-196	HUMAN OTC DRUG	No7 Future Renew Damage Reversal Day Cream Sunscreen Broad Spectrum SPF 25		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.5; .25; 2.5; 3.75	g/50g; g/50g; g/50g; g/50g			N	20241231
11489-196_8e7bd9db-3567-48ee-8f02-b486b58cda1b	11489-196	HUMAN OTC DRUG	No7 Future Renew Damage Reversal Day Cream Sunscreen Broad Spectrum SPF 25		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.5; .25; 2.5; 3.75	g/50g; g/50g; g/50g; g/50g			N	20241231
11489-197_e1b10ced-a62b-4e43-893a-9d4f65e1e4b6	11489-197	HUMAN OTC DRUG	No7 Future Renew Damage Reversal Day Cream Sunscreen Broad Spectrum SPF 25		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.15; .025; .25; .375	g/5g; g/5g; g/5g; g/5g			N	20241231
11489-198_a02c10ae-c03a-4396-9bd4-5ed30fae56b8	11489-198	HUMAN OTC DRUG	No7 Future Renew Damage Reversal Day Cream Sunscreen Broad Spectrum SPF 25		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.45; .075; .75; 1.125	g/15g; g/15g; g/15g; g/15g			N	20241231
11489-199_d4a6aad9-7992-4d9b-a781-62e0ec3be5c9	11489-199	HUMAN OTC DRUG	No7 Future Renew Damage Reversal Day Cream Sunscreen Broad Spectrum SPF 25		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20230831		OTC MONOGRAPH DRUG	M020	BCM Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.5; .25; 2.5; 3.75	g/50g; g/50g; g/50g; g/50g			N	20241231
11489-200_29148cae-d8f0-47ea-8d29-81383851fef8	11489-200	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20160630		OTC MONOGRAPH DRUG	M020	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11489-201_63e22804-1547-41c0-a2e5-6e3225412eea	11489-201	HUMAN OTC DRUG	No7 Protect and Perfect Intense Advanced Fragrance Free Day Cream SPF 30		Avobenzone,Octisalate, Octocrylene	CREAM	TOPICAL	20160630		OTC MONOGRAPH DRUG	M020	BCM Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 2.5; 3.75	g/50g; g/50g; g/50g			N	20241231
11509-0081_f0688a1a-02b0-48af-a503-8de2f6ad52ae	11509-0081	HUMAN OTC DRUG	VAGISTAT 3		Miconazole nitrate	KIT		20180327		ANDA	ANDA075329	Combe Incorporated						N	20241231
11509-0426_63843066-38c3-4fd8-b774-cbac84de791c	11509-0426	HUMAN OTC DRUG	vagistat		Tioconazole	OINTMENT	VAGINAL	20200729		ANDA	ANDA075915	Combe Incorporated	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11509-0825_dce65992-7213-435c-b9a6-4479eb78054b	11509-0825	HUMAN OTC DRUG	vagisil brand vagistat		Miconazole nitrate	CREAM	VAGINAL	20201008		ANDA	ANDA074760	Combe Incorporated	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11509-4402_132b129e-9640-4a5b-9e4d-8f3d5b90331b	11509-4402	HUMAN OTC DRUG	VAGISIL Anti-Itch Medicated Creme Maximum Strength		Benzocaine and Resorcinol	CREAM	TOPICAL	19950301		OTC MONOGRAPH NOT FINAL	part348	Combe Incorporated	BENZOCAINE; RESORCINOL	200; 30	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11509-5035_2a24ec3c-4966-4804-aa26-4ddab397afaa	11509-5035	HUMAN OTC DRUG	VAGISIL Anti-Itch Medicated Wipes Maximum Strength		pramoxine hydrochloride	CLOTH	TOPICAL	20050628		OTC MONOGRAPH NOT FINAL	part348	Combe Incorporated	PRAMOXINE HYDROCHLORIDE	10	mg/g			N	20241231
11509-5058_2a24ec3c-4966-4804-aa26-4ddab397afaa	11509-5058	HUMAN OTC DRUG	VAGISIL Anti-Itch Medicated Wipes Maximum Strength		pramoxine hydrochloride	CLOTH	TOPICAL	20050628		OTC MONOGRAPH NOT FINAL	part348	Combe Incorporated	PRAMOXINE HYDROCHLORIDE	10	mg/g			N	20241231
11509-5101_d70e4063-6d69-489d-8052-fe5c311a717e	11509-5101	HUMAN OTC DRUG	Vagisil Anti-Itch Creme Maximum Strength Sensitive Skin Formula		Hydrocortisone Acetate	CREAM	TOPICAL	20160130		OTC MONOGRAPH NOT FINAL	part348	Combe Incorporated	HYDROCORTISONE ACETATE	280	mg/28g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11509-5103_7055b767-7eca-46af-8c64-56d74b6675ff	11509-5103	HUMAN OTC DRUG	VAGISIL Anti-Itch Creme Regular Strength		Benzocaine and Resorcinol	CREAM	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part348	Combe Incorporated	BENZOCAINE; RESORCINOL	50; 20	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11509-5225_f74cf487-de51-48ab-bda4-19e30856576a	11509-5225	HUMAN OTC DRUG	Just For Men Control GX Anti-Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20190101		OTC MONOGRAPH FINAL	part358H	Combe Incorporated	PYRITHIONE ZINC	10	mg/mL			N	20241231
11523-0006_0b61dc7d-8194-cbfe-e063-6294a90a62e1	11523-0006	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Cold, Cough and Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20200701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	325; 10; 200	mg/1; mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-0007_f7a4fd2d-6280-ee7f-e053-6394a90a6f36	11523-0007	HUMAN OTC DRUG	Claritin		loratadine	TABLET	ORAL	20201201		ANDA	ANDA075209	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-0008_fc749882-2e23-cad3-e053-6294a90a33ca	11523-0008	HUMAN OTC DRUG	Coricidin HBP Cough and Cold		chlorpheniramine maleate, dextromethorphan hydrochloride	TABLET	ORAL	20201023		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-0010_ffd3dbaf-b9e2-fd72-e053-6394a90a0549	11523-0010	HUMAN OTC DRUG	Lotrimin Daily Prevention Deo		Tolnaftate	AEROSOL, POWDER	TOPICAL	20200214		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	TOLNAFTATE	10	mg/g			N	20241231
11523-0011_05548b3f-79e2-24c2-e063-6394a90ad2d7	11523-0011	HUMAN OTC DRUG	Lotrimin Daily Prevention		tolnaftate	POWDER	TOPICAL	20200214		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	TOLNAFTATE	10	mg/g			N	20241231
11523-0012_05544b73-ea58-dc99-e063-6394a90a9ea3	11523-0012	HUMAN OTC DRUG	Lotrimin Daily Sweat and Odor Control		topical starch	POWDER	TOPICAL	20200217		OTC MONOGRAPH FINAL	part347	Bayer HealthCare LLC.	STARCH, CORN	837	mg/g			N	20241231
11523-0026_0b61d3ce-53be-8d52-e063-6294a90adecc	11523-0026	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Cold and Flu Day and Night		acetaminophen, dextromethorphan hydrobromide, guaifenesin, doxylamine succinate	KIT	ORAL	20200701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
11523-0034_0a373f1c-2e21-80b7-e063-6294a90af9bc	11523-0034	HUMAN OTC DRUG	Afrin NoDrip Allergy Sinus Night		oxymetazoline hydrochloride	SPRAY	NASAL	20201109		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-0038_f7a5ad35-f8fe-379f-e053-6394a90ac164	11523-0038	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Multi Symptom Flu		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide	TABLET	ORAL	20200701		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-0072_0553ed68-8c36-57e2-e063-6294a90a2a9a	11523-0072	HUMAN OTC DRUG	Tinactin		Tolnaftate	AEROSOL, POWDER	TOPICAL	19930923		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC	TOLNAFTATE	10	mg/g			N	20241231
11523-0073_0a3726cf-65f5-afbf-e063-6394a90adc4d	11523-0073	HUMAN OTC DRUG	Afrin Allergy Sinus Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20160826		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.5	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-0076_0b61dc1c-457f-ca87-e063-6294a90a9f3b	11523-0076	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Cold, Cough and Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin	LIQUID	ORAL	20210725		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	650; 20; 400	mg/30mL; mg/30mL; mg/30mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-0077_0b61e4f3-da41-ba44-e063-6394a90aec28	11523-0077	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Nighttime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	LIQUID	ORAL	20210725		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 20; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-0082_0b61ea71-e588-bff5-e063-6394a90a2e50	11523-0082	HUMAN OTC DRUG	Lotrimin Ultra		Butenafine hydrochloride	CREAM	TOPICAL	20211220		NDA	NDA021307	Bayer Healthcare LLC.	BUTENAFINE HYDROCHLORIDE	1	g/100g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
11523-0090_0b616d54-b825-0231-e063-6294a90a8f7e	11523-0090	HUMAN OTC DRUG	Children Afrin No Drip Extra Moisturizing Stuffy Nose Pump Mist	Stuffy Nose Pump Mist	Oxymetazoline hydrochloride	SPRAY, METERED	NASAL	20220706		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-0091_0b6162ac-babe-63bb-e063-6394a90a83bc	11523-0091	HUMAN OTC DRUG	Children Afrin Extra Moisturizing Stuffy Nose Pump Mist	Stuffy Nose Pump Mist	Oxymetazoline hydrochloride	SPRAY, METERED	NASAL	20220703		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.025	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-0093_0b61e1d7-3293-d486-e063-6294a90ad2b2	11523-0093	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Cold, Cough and Flu		acetaminophen, dextromethorphan hydrobromide	LIQUID	ORAL	20220427		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/30mL; mg/30mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-0094_0b61d8e9-2efc-c353-e063-6294a90a366c	11523-0094	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Cold Flu And Chest Congestion		Acetaminophen, Guaifenesin	CAPSULE, GELATIN COATED	ORAL	20220501		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; GUAIFENESIN	325; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11523-0096_077237ae-adad-af34-e063-6294a90acc5b	11523-0096	HUMAN OTC DRUG	A and D Original		Lanolin and Petrolatum	OINTMENT	TOPICAL	20030604		OTC MONOGRAPH DRUG	M016	Bayer HealthCare LLC.	LANOLIN; PETROLATUM	136.4; 469.9	mg/g; mg/g			N	20241231
11523-0096_07d71cdd-06d2-efd8-e063-6394a90ad13c	11523-0096	HUMAN OTC DRUG	A and D Original		Lanolin and Petrolatum	OINTMENT	TOPICAL	20091225		OTC MONOGRAPH DRUG	M016	Bayer HealthCare LLC.	LANOLIN; PETROLATUM	136.4; 469.9	mg/g; mg/g			N	20241231
11523-0100_0b61d664-6fa3-dba7-e063-6294a90a8c6d	11523-0100	HUMAN OTC DRUG	Coricidin HBP Maximum Strength Cold and Flu Day and Night		acetaminophen, dextromethorphan hydrobromide, guaifenesin, doxylamine succinate	KIT	ORAL	20200701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
11523-0102_0b61ba97-5340-90f2-e063-6394a90a4801	11523-0102	HUMAN OTC DRUG	Claritin-D	24 Hour	Loratadine pseudoephedrine sulfate	TABLET, EXTENDED RELEASE	ORAL	20221212		ANDA	ANDA075706	Bayer HealthCare LLC.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11523-0104_ff32a6fe-8783-64ae-e053-6394a90aa011	11523-0104	HUMAN OTC DRUG	Claritin		Loratadine	TABLET, CHEWABLE	ORAL	20230205		ANDA	ANDA210033	Bayer HealthCare LLC.	LORATADINE	5	mg/1			N	20241231
11523-0122_0a5b0131-5a12-60bb-e063-6394a90af922	11523-0122	HUMAN OTC DRUG	MiraLAX Orange Flavor		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230915		ANDA	ANDA090685	Bayer HealthCare LLC.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11523-0123_0322ef5c-632e-d1e6-e063-6294a90a417a	11523-0123	HUMAN OTC DRUG	Claritin Chewable Grape and Bubblegum		Loratadine	KIT	ORAL	20060823		NDA	NDA021891	Bayer HealthCare LLC.						N	20241231
11523-0165_0553ddb3-f760-21bf-e063-6294a90ad700	11523-0165	HUMAN OTC DRUG	Tinactin		Tolnaftate	AEROSOL, SPRAY	TOPICAL	19930923		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC	TOLNAFTATE	10	mg/g			N	20241231
11523-0259_ffd39f77-3ef2-2ac1-e053-6294a90a2582	11523-0259	HUMAN OTC DRUG	Mexsana	Medicated	Starch, Corn	POWDER	TOPICAL	19930923		OTC MONOGRAPH FINAL	part347	Bayer HealthCare LLC	STARCH, CORN	837	mg/g			N	20241231
11523-0404_07725856-ed6e-fba5-e063-6294a90a2f8d	11523-0404	HUMAN OTC DRUG	Solarcaine		Lidocaine	SPRAY	TOPICAL	20120406		OTC MONOGRAPH DRUG	M016	Bayer HealthCare LLC.	LIDOCAINE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11523-0544_0554d525-3e30-848e-e063-6394a90a55ee	11523-0544	HUMAN OTC DRUG	Lotrimin	Antifungal	Miconazole nitrate	AEROSOL, POWDER	TOPICAL	19930901		OTC MONOGRAPH FINAL	part333C	Bayer Healthcare LLC.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-0777_0553bb25-3831-042c-e063-6394a90a17ef	11523-0777	HUMAN OTC DRUG	Tinactin		Tolnaftate	AEROSOL, POWDER	TOPICAL	19930923		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	TOLNAFTATE	10	mg/g			N	20241231
11523-0800_f7a7b82b-4777-c19e-e053-6294a90aa0f5	11523-0800	HUMAN OTC DRUG	Claritin		loratadine	TABLET	ORAL	20201201		ANDA	ANDA075209	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-0919_05549748-1162-52ef-e063-6394a90a12c9	11523-0919	HUMAN OTC DRUG	Lotrimin	Antifungal	Miconazole nitrate	POWDER	TOPICAL	19930901		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-0934_0553c22b-8963-ee3c-e063-6394a90a34c0	11523-0934	HUMAN OTC DRUG	Tinactin		Tolnaftate	CREAM	TOPICAL	19930923		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	TOLNAFTATE	10	mg/g			N	20241231
11523-0963_0554a76c-95cd-b100-e063-6294a90a14fb	11523-0963	HUMAN OTC DRUG	Lotrimin		Clotrimazole	CREAM	TOPICAL	20020201		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-1125_05548829-e62a-2552-e063-6394a90ab265	11523-1125	HUMAN OTC DRUG	Lotrimin	Antifungal	Clotrimazole	CREAM	TOPICAL	20020201		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-1159_0a36ea8d-bd31-8b31-e063-6394a90a852f	11523-1159	HUMAN OTC DRUG	Afrin	Original Pump Mist	Oxymetazoline hydrochloride	SPRAY, METERED	NASAL	19750714		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-1160_0a372550-c686-9c34-e063-6294a90ab1e8	11523-1160	HUMAN OTC DRUG	Afrin No Drip Night	Chamomile	oxymetazoline hydrochloride	SPRAY, METERED	NASAL	20200701		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-1167_0a36f076-c6e5-7ea3-e063-6294a90a2ab6	11523-1167	HUMAN OTC DRUG	Afrin	Original	Oxymetazoline hydrochloride	SPRAY	NASAL	19750714		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-1168_09734a55-efc5-3b22-e063-6394a90ad2d2	11523-1168	HUMAN OTC DRUG	Afrin Original Nasal		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20201001		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-1190_0553a8f7-cd85-23aa-e063-6394a90ab3c0	11523-1190	HUMAN OTC DRUG	Tinactin		Tolnaftate	CREAM	TOPICAL	19930923		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	TOLNAFTATE	10	mg/g			N	20241231
11523-1272_05549748-1165-52ef-e063-6394a90a12c9	11523-1272	HUMAN OTC DRUG	Lotrimin	Antifungal	Miconazole nitrate	AEROSOL, POWDER	TOPICAL	19930901		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-1314_07725856-ed6d-fba5-e063-6294a90a2f8d	11523-1314	HUMAN OTC DRUG	A and D		Dimethicone and Zinc Oxide	CREAM	TOPICAL	20091225		OTC MONOGRAPH DRUG	M016	Bayer HealthCare LLC.	DIMETHICONE; ZINC OXIDE	11.09; 110.09	mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
11523-1350_0a370f72-3f23-8586-e063-6294a90a3a6f	11523-1350	HUMAN OTC DRUG	Afrin No Drip	Severe Congestion	Oxymetazoline hydrochloride	SPRAY, METERED	NASAL	20000831		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-1527_eaffeda1-d462-bb0b-e053-2995a90ab990	11523-1527	HUMAN OTC DRUG	Claritin		Loratadine	TABLET	ORAL	19930412		NDA	NDA019658	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-1783_0a370f72-3f20-8586-e063-6294a90a3a6f	11523-1783	HUMAN OTC DRUG	Afrin No Drip	Extra Moisturizing	Oxymetazoline hydrochloride	SPRAY, METERED	NASAL	20000831		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-3142_0a370f7b-5a42-a499-e063-6394a90af2ff	11523-3142	HUMAN OTC DRUG	Afrin No Drip	Original Pump Mist	Oxymetazoline hydrochloride	SPRAY, METERED	NASAL	19990831		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-3220_0a3726cf-65f9-afbf-e063-6394a90adc4d	11523-3220	HUMAN OTC DRUG	Afrin No-Drip	Allergy Sinus	Oxymetazoline hydrochloride	SPRAY, METERED	NASAL	20160830		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-4140_0554d4a9-28a2-9c08-e063-6394a90a52ef	11523-4140	HUMAN OTC DRUG	Lotrimin	Antifungal	Miconazole nitrate	AEROSOL, POWDER	TOPICAL	19930901		OTC MONOGRAPH FINAL	part333C	Bayer Healthcare LLC.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-4162_0553a56d-475c-e952-e063-6294a90abe3d	11523-4162	HUMAN OTC DRUG	Tinactin	Antifungal	Tolnaftate	AEROSOL, POWDER	TOPICAL	20140228		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	TOLNAFTATE	10	mg/g			N	20241231
11523-4325_f7a5ad35-f8ff-379f-e053-6394a90ac164	11523-4325	HUMAN OTC DRUG	Coricidin HBP	Cold and Flu	Acetaminophen and Chlorpheniramine maleate	TABLET, FILM COATED	ORAL	20131001		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	325; 2	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11523-4326_0b61cbe1-a785-95e2-e063-6394a90a8673	11523-4326	HUMAN OTC DRUG	Coricidin HBP Cough and Cold	Cough Suppressant, Antihistamine	Chlorpheniramine maleate and Dextromethorphan hydrobromide	TABLET, FILM COATED	ORAL	20130501		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-4327_0554c671-0715-3eb9-e063-6394a90ab956	11523-4327	HUMAN OTC DRUG	Lotrimin AF	Antifungal	Miconazole nitrate	SPRAY	TOPICAL	19930901		OTC MONOGRAPH FINAL	part333C	Bayer Healthcare LLC.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-4328_ff32e332-882f-e529-e053-6394a90acd5d	11523-4328	HUMAN OTC DRUG	Claritin		Loratadine	TABLET, CHEWABLE	ORAL	20060823		NDA	NDA021891	Bayer HealthCare LLC.	LORATADINE	5	mg/1			N	20241231
11523-4329_0b616d54-b827-0231-e063-6294a90a8f7e	11523-4329	HUMAN OTC DRUG	Claritin	Reditabs	Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20021127		NDA	NDA020704	Bayer Healthcare LLC.	LORATADINE	10	mg/1			N	20241231
11523-4330_eb00777b-2fef-e655-e053-2995a90a3846	11523-4330	HUMAN OTC DRUG	Claritin		loratadine	TABLET, CHEWABLE	ORAL	20150925		NDA	NDA021891	Bayer HealthCare LLC.	LORATADINE	5	mg/1			N	20241231
11523-4331_ff32e332-882f-e529-e053-6394a90acd5d	11523-4331	HUMAN OTC DRUG	Claritin		Loratadine	TABLET, CHEWABLE	ORAL	20060823		NDA	NDA021891	Bayer HealthCare LLC.	LORATADINE	5	mg/1			N	20241231
11523-4332_0b61c541-d060-9abf-e063-6294a90a7574	11523-4332	HUMAN OTC DRUG	Claritin-D	24 Hour	Loratadine and pseudoephedrine sulfate	TABLET, EXTENDED RELEASE	ORAL	20091201		NDA	NDA020470	Bayer HealthCare LLC.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11523-4338_055463b7-f46c-da94-e063-6394a90ad0a6	11523-4338	HUMAN OTC DRUG	Lotrimin Ultra	Athletes Foot	Butenafine hydrochloride	CREAM	TOPICAL	20020222		NDA	NDA021307	Bayer Healthcare LLC.	BUTENAFINE HYDROCHLORIDE	1	g/100g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
11523-4339_06444b26-dfe0-cb46-e063-6294a90adf2b	11523-4339	HUMAN OTC DRUG	Lotrimin Ultra	Jock Itch	Butenafine hydrochloride	CREAM	TOPICAL	20020222		NDA	NDA021307	Bayer Healthcare LLC.	BUTENAFINE HYDROCHLORIDE	1	g/100g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
11523-4357_0bb62586-406e-f7e0-e063-6394a90a2b74	11523-4357	HUMAN OTC DRUG	MiraLAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20070201		NDA	NDA022015	Bayer HealthCare LLC.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11523-4358_0b61dc7d-8196-cbfe-e063-6294a90a62e1	11523-4358	HUMAN OTC DRUG	Coricidin HBP Nighttime Multi-Symptom Cold		Acetaminophen,Dextromethorphan hydrobromide, doxylamine succinate	LIQUID	ORAL	20151120		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/15mL; mg/15mL; mg/15mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-4359_eaffeda1-d462-bb0b-e053-2995a90ab990	11523-4359	HUMAN OTC DRUG	Claritin		Loratadine	TABLET	ORAL	19930412		NDA	NDA019658	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-4360_0b61ba97-533d-90f2-e063-6394a90a4801	11523-4360	HUMAN OTC DRUG	Children Claritin	Allergy	loratadine	SOLUTION	ORAL	20150526		NDA	NDA020641	Bayer HealthCare LLC.	LORATADINE	5	mg/5mL			N	20241231
11523-4364_0c665726-d675-1d6f-e063-6294a90a71c3	11523-4364	HUMAN OTC DRUG	Claritin Chewable	Cool Mint Flavor	loratadine	TABLET, CHEWABLE	ORAL	20191209		NDA	NDA021891	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-4765_0b61cc05-e5e2-b42f-e063-6294a90a60ae	11523-4765	HUMAN OTC DRUG	Coricidin HBP	Day and Night	Dextromethorphan Hydrobromide, Guaifenesin, Acetaminophen, Chlorpheniramine maleate	KIT		20090828		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.						N	20241231
11523-6549_0554512f-74bb-f4ae-e063-6394a90a034a	11523-6549	HUMAN OTC DRUG	Lotrimin		Clotrimazole	CREAM	TOPICAL	20090102		OTC MONOGRAPH FINAL	part333C	Bayer HealthCare LLC.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11523-6655_eaebed1d-2b0f-3fe7-e053-2a95a90a2d89	11523-6655	HUMAN OTC DRUG	Claritin		Loratadine	TABLET	ORAL	19930412		NDA	NDA019658	Bayer HealthCare LLC	LORATADINE	10	mg/1			N	20241231
11523-7020_0a370f72-3f1d-8586-e063-6294a90a3a6f	11523-7020	HUMAN OTC DRUG	Afrin	Severe Congestion	Oxymetazoline hydrochloride	SPRAY	NASAL	20000831		OTC MONOGRAPH DRUG	M012	Bayer HealthCare LLC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11523-7094_04db8d76-be3f-7134-e063-6294a90ad966	11523-7094	HUMAN OTC DRUG	Bain de Soleil	Mega Tan SPF 4	Octinoxate and Octocrylene	LOTION	TOPICAL	19990521		OTC MONOGRAPH FINAL	part352	Bayer HealthCare LLC.	OCTINOXATE; OCTOCRYLENE	35; 10	mg/mL; mg/mL			N	20241231
11523-7154_47e50ab6-5028-0fe0-e054-00144ff8d46c	11523-7154	HUMAN OTC DRUG	Lotrimin Ultra	Antifungal	Butenafine Hydrochloride	CREAM	TOPICAL	19930923		NDA	NDA021307	Bayer HealthCare LLC.	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
11523-7155_47e50ab6-503b-0fe0-e054-00144ff8d46c	11523-7155	HUMAN OTC DRUG	Lotrimin Ultra Jock Itch	Antifungal	Butenafine Hydrochloride	CREAM	TOPICAL	19930923		NDA	NDA021307	Bayer HealthCare LLC.	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
11523-7157_0b616d54-b827-0231-e063-6294a90a8f7e	11523-7157	HUMAN OTC DRUG	Claritin	Reditabs	Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20021127		NDA	NDA020704	Bayer Healthcare LLC.	LORATADINE	10	mg/1			N	20241231
11523-7158_f7fb41c3-9c20-3844-e053-6394a90a7aa6	11523-7158	HUMAN OTC DRUG	Coricidin HBP Chest Congestion And Cough		Dextromethorphan hydrobromide and Guaifenesin	CAPSULE, GELATIN COATED	ORAL	20000831		OTC MONOGRAPH FINAL	part341	Bayer HealthCare LLC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11523-7160_eaffeda1-d462-bb0b-e053-2995a90ab990	11523-7160	HUMAN OTC DRUG	Claritin		Loratadine	TABLET	ORAL	19930412		NDA	NDA019658	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-7162_0b61c541-d061-9abf-e063-6294a90a7574	11523-7162	HUMAN OTC DRUG	Claritin-D	12 Hour	Loratadine and pseudoephedrine sulfate	TABLET, EXTENDED RELEASE	ORAL	20091201		NDA	NDA019670	Bayer HealthCare LLC.	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11523-7200_ff3231ef-1dea-883a-e053-6394a90a60ea	11523-7200	HUMAN OTC DRUG	Claritin	Liqui-Gels	Loratadine	CAPSULE, LIQUID FILLED	ORAL	20080616		NDA	NDA021952	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-7202_f1eb1cb9-848f-cdaf-e053-2995a90a9195	11523-7202	HUMAN OTC DRUG	Claritin	Reditabs	Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20061212		NDA	NDA021993	Bayer HealthCare LLC	LORATADINE	5	mg/1			N	20241231
11523-7204_07725dab-436e-03a2-e063-6294a90a25b4	11523-7204	HUMAN OTC DRUG	A and D First Aid		Lanolin and petrolatum	OINTMENT	TOPICAL	20030604		OTC MONOGRAPH DRUG	M016	Bayer HealthCare LLC	LANOLIN; PETROLATUM	136.4; 469.9	mg/g; mg/g			N	20241231
11523-7234_0bb62586-406e-f7e0-e063-6394a90a2b74	11523-7234	HUMAN OTC DRUG	MiraLAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20070201		NDA	NDA022015	Bayer HealthCare LLC.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11523-7237_eaffeda1-d462-bb0b-e053-2995a90ab990	11523-7237	HUMAN OTC DRUG	Claritin		Loratadine	TABLET	ORAL	19930412		NDA	NDA019658	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-7268_0bb62586-406e-f7e0-e063-6394a90a2b74	11523-7268	HUMAN OTC DRUG	MiraLAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20070201		NDA	NDA022015	Bayer HealthCare LLC.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11523-7276_0b6203da-eb03-f750-e063-6294a90abf51	11523-7276	HUMAN OTC DRUG	Zegerid OTC		omeprazole and sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20171001		ANDA	ANDA201361	Bayer HealthCare LLC.	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11523-7333_ff3231ef-1dea-883a-e053-6394a90a60ea	11523-7333	HUMAN OTC DRUG	Claritin	Liqui-Gels	Loratadine	CAPSULE, LIQUID FILLED	ORAL	20080616		NDA	NDA021952	Bayer HealthCare LLC.	LORATADINE	10	mg/1			N	20241231
11523-7341_0bb62586-406e-f7e0-e063-6394a90a2b74	11523-7341	HUMAN OTC DRUG	MiraLAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20070201		NDA	NDA022015	Bayer HealthCare LLC.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11527-044_bcbf11e0-6af0-4a4c-a43d-05cd09452a94	11527-044	HUMAN OTC DRUG	Tanners Tasty Cha Cha Chocolate		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20100826		OTC MONOGRAPH DRUG	M021	Sheffield Pharmaceuticals LLC	SODIUM FLUORIDE	2.43	mg/g			N	20241231
11527-045_56115203-3364-4196-b1be-6ed903284864	11527-045	HUMAN OTC DRUG	Tanners Tasty Ooh La La Orange		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20210325		OTC MONOGRAPH DRUG	M021	Sheffield Pharmaceuticals LLC	SODIUM FLUORIDE	2.43	mg/g			N	20241231
11527-051_aafc94b4-c410-4bdd-954c-861835e044ce	11527-051	HUMAN OTC DRUG	Tolnaftate		TOLNAFTATE	CREAM	TOPICAL	20091007		OTC MONOGRAPH DRUG	M005	Sheffield Pharmaceuticals LLC	TOLNAFTATE	10	mg/g			N	20241231
11527-052_73503439-5ce2-480b-bf3f-9362a31c8e29	11527-052	HUMAN OTC DRUG	Dr. Sheffield Hydrocortisone Anti itch		Hydrocortisone	CREAM	TOPICAL	20070710		OTC MONOGRAPH DRUG	M017	Sheffield Pharmaceuticals LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11527-057_d737e806-5edc-48c3-bd75-812f2d63a5de	11527-057	HUMAN OTC DRUG	Dr Sheffield Muscle Rub Cream		Muscle Rub Cream	CREAM	TOPICAL	20020424		OTC MONOGRAPH DRUG	M017	Sheffield Pharmaceuticals LLC	MENTHOL; METHYL SALICYLATE	100; 150	mg/g; mg/g			N	20241231
11527-058_569610c1-6c56-4437-a651-2004d621d8ac	11527-058	HUMAN OTC DRUG	Dr. Sheffield Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	20020109		OTC MONOGRAPH DRUG	M016	Sheffield Pharmaceuticals LLC	ZINC OXIDE	400	mg/g			N	20241231
11527-062_fbb18ede-0cb2-4a87-bffd-70abd04d8155	11527-062	HUMAN OTC DRUG	Sheffield Pain Relief		BENZOCAINE	GEL	ORAL	20060130		OTC MONOGRAPH DRUG	M022	Sheffield Pharmaceuticals LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11527-065_9dac2c01-6044-4c48-9d36-8e3e0bd764de	11527-065	HUMAN OTC DRUG	Sheffield Zinc Oxide		Zinc Oxide	OINTMENT	TOPICAL	20050111		OTC MONOGRAPH DRUG	M016	Sheffield Pharmaceuticals LLC	ZINC OXIDE	200	mg/g			N	20241231
11527-069_36f56c5a-15fe-4243-83a4-e9a54eca9a13	11527-069	HUMAN OTC DRUG	Dr. Sheffield Anti Itch Cream		Anti Itch Cream	CREAM	TOPICAL	20081111		OTC MONOGRAPH DRUG	M016	Sheffield Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11527-071_d62a5e4d-1d38-4903-b79d-31a9b312388f	11527-071	HUMAN OTC DRUG	Dr Sheffield Athletes Foot		CLOTRIMAZOLE	CREAM	TOPICAL	20041004		OTC MONOGRAPH DRUG	M005	Sheffield Pharmaceuticals LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11527-080_18f1103f-c3e6-4451-bc74-019bb6dc9bfe	11527-080	HUMAN OTC DRUG	Sheffield Arthritis and Muscle Pain Relief		CAPSICUM OLEORESIN	CREAM	TOPICAL	20201222		OTC MONOGRAPH DRUG	M017	Sheffield Pharmaceuticals LLC	CAPSICUM OLEORESIN	.075	g/100g			N	20241231
11527-089_2da891e7-c0bd-449a-baf6-37b235126d22	11527-089	HUMAN OTC DRUG	Sheffield Arthritis and Muscle Pain Relief		CAPSICUM OLEORESIN	CREAM	TOPICAL	20100414		OTC MONOGRAPH DRUG	M017	Sheffield Pharmaceuticals LLC	CAPSICUM OLEORESIN	.25	mg/g			N	20241231
11527-140_36eb3a35-be6c-4e5f-a189-2575f5dd142b	11527-140	HUMAN OTC DRUG	12 Hour Original Nasal Decongestant		Nasal Spray	LIQUID	NASAL	20140530		OTC MONOGRAPH DRUG	M012	Sheffield Pharmaceuticals LLC	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11527-145_d5834ab3-eab3-4e6f-b6af-e03bf13a8b7e	11527-145	HUMAN OTC DRUG	No Drip Severe Nasal Mist		Oxymetazoline Spray	LIQUID	NASAL	20201222		OTC MONOGRAPH DRUG	M012	Sheffield Pharmaceuticals LLC	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11527-152_c45b2ae3-b31c-4ac3-8f89-fc8a60d7fd99	11527-152	HUMAN OTC DRUG	Dr. Sayman Salve		Salve	OINTMENT	TOPICAL	20150116		OTC MONOGRAPH DRUG	M016	Sheffield Pharmaceuticals LLC	PETROLATUM; ZINC OXIDE	87.3; 8.8	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11527-161_d91f9d30-8d50-4e41-8ba5-38989db9180b	11527-161	HUMAN OTC DRUG	Sheffield Triple Antibiotic Plus Pain Relief		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride	OINTMENT	TOPICAL	20110123		OTC MONOGRAPH DRUG	M004	Sheffield Pharmaceuticals LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11527-162_3232162e-2200-4c52-b0d1-2424336733b2	11527-162	HUMAN OTC DRUG	Sheffield Triple Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate	OINTMENT	TOPICAL	20110123		OTC MONOGRAPH DRUG	M004	Sheffield Pharmaceuticals LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11527-163_9a273a49-de7b-4b60-9d38-b4b0a57c4eb3	11527-163	HUMAN OTC DRUG	Sheffield Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20120925		OTC MONOGRAPH DRUG	M004	Sheffield Pharmaceuticals LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
11527-180_14c58cc5-11ed-46c7-b21f-d67d9ce3be51	11527-180	HUMAN OTC DRUG	Tanners Tasty Vanilla Bling		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20120710		OTC MONOGRAPH DRUG	M021	Sheffield Pharmaceuticals LLC	SODIUM FLUORIDE	2.43	mg/g			N	20241231
11527-191_f954502b-f7c0-4f72-a9bc-32b11b28b053	11527-191	HUMAN OTC DRUG	Sheffield Lidocaine		Lidocaine	CREAM	TOPICAL	20201222		OTC MONOGRAPH DRUG	M017	Sheffield Pharmaceuticals LLC	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11527-325_c7f30424-fc84-4781-a2bf-3291ede35271	11527-325	HUMAN OTC DRUG	Theriac Advanced Healing		Lanolin	OINTMENT	TOPICAL	20210301		OTC MONOGRAPH DRUG	M016	Sheffield Pharmaceuticals LLC	LANOLIN	350.8	mg/g			N	20241231
11527-348_fbc55adf-389c-476a-bd0a-855f5eacd8ae	11527-348	HUMAN OTC DRUG	Dr. Sayman Wonder Cream		Colloidal Oatmeal	CREAM	TOPICAL	20190125		OTC MONOGRAPH DRUG	M016	Sheffield Pharmaceuticals LLC	OATMEAL	50	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
11527-384_06c7e123-d0fa-4bde-9ecd-f77e0e352b49	11527-384	HUMAN OTC DRUG	Dr Saymans Wonder Rub		Lidocaine	GEL	TOPICAL	20190221		OTC MONOGRAPH DRUG	M017	Sheffield Pharmaceuticals LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11527-420_1dbaf50f-34ac-4468-80c8-49e58ee2f07d	11527-420	HUMAN OTC DRUG	Dr. Sheffield Sensitive Care		Sensitive Tooth Paste	PASTE, DENTIFRICE	ORAL	20170515		OTC MONOGRAPH DRUG	M022	Sheffield Pharmaceuticals LLC	POTASSIUM NITRATE	50	mg/g			N	20241231
11527-478_3080c930-e87b-4340-81ee-4a246634f56e	11527-478	HUMAN OTC DRUG	Dr. Sheffield Psoriasis Medicated Moisturizer		Psoriasis Medicated Moisturizer	LOTION	TOPICAL	20130901		OTC MONOGRAPH DRUG	M032	Sheffield Pharmaceuticals LLC	SALICYLIC ACID	20	mg/g			N	20241231
11527-704_c850c90a-b9bc-44b7-b30c-3f297f3ae164	11527-704	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 ppm Sensitive		Sodium Fluoride1.1%, Potassium Nitrate 5%	GEL, DENTIFRICE	DENTAL	20200326		UNAPPROVED DRUG OTHER		Sheffield Pharmaceuticals LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	57.5; 5.8	mg/mL; mg/mL			N	20241231
11527-725_b6c2d6dd-7354-4573-b34c-bd22abc7f355	11527-725	HUMAN OTC DRUG	Sheffield Advanced Scar Gel		Advanced Scar Gel	GEL	TOPICAL	20211014		OTC MONOGRAPH DRUG	M016	Sheffield Pharmaceuticals LLC	ALLANTOIN	5	mg/g			N	20241231
11527-730_86c0981d-f4cc-4136-a38e-ef6f86a272e0	11527-730	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 ppm Fruit		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200326		UNAPPROVED DRUG OTHER		Sheffield Pharmaceuticals LLC	SODIUM FLUORIDE	6	mg/mL			N	20241231
11527-735_b2ef98a2-03e1-4db5-a35e-9820d5fddf6e	11527-735	HUMAN PRESCRIPTION DRUG	Wentworth Alcohol Free		Sodium Fluoride	MOUTHWASH	DENTAL	20210415		UNAPPROVED DRUG OTHER		Sheffield Pharmaceuticals LLC	SODIUM FLUORIDE	.9	mg/mL			N	20241231
11527-745_3fa71e96-0c84-4ce6-8aa8-6689b876c480	11527-745	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 ppm Enamel Protect		Sodium Fluoride1.1%, Potassium Nitrate 5%	GEL, DENTIFRICE	DENTAL	20210108		UNAPPROVED DRUG OTHER		Sheffield Pharmaceuticals LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	57.5; 5.8	mg/mL; mg/mL			N	20241231
11527-750_86c0981d-f4cc-4136-a38e-ef6f86a272e0	11527-750	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 ppm Spearmint		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200326		UNAPPROVED DRUG OTHER		Sheffield Pharmaceuticals LLC	SODIUM FLUORIDE	6	mg/mL			N	20241231
11527-755_6bf92fe3-34f9-4d29-8312-3f65639c05ae	11527-755	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 ppm Dry Mouth		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20210108		UNAPPROVED DRUG OTHER		Sheffield Pharmaceuticals LLC	SODIUM FLUORIDE	6.1	mg/mL			N	20241231
11534-157_cc17e1e3-ca71-4ae4-a1c2-2b90f3fb2405	11534-157	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	SUNRISE PHARMACEUTICAL, INC.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
11534-159_9eaf9f62-79f1-4c6c-ba8c-d70972a98496	11534-159	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205017	SUNRISE PHARMACEUTICAL, INC.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
11534-160_9eaf9f62-79f1-4c6c-ba8c-d70972a98496	11534-160	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20170124		ANDA	ANDA205008	SUNRISE PHARMACEUTICAL, INC.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
11534-165_7d9c951e-0299-46b0-8d4a-19b6b74984f9	11534-165	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20150804		ANDA	ANDA204418	SUNRISE PHARMACEUTICAL, INC.	FOLIC ACID	1	mg/1			N	20241231
11534-166_c5432731-23bc-44cf-bfcc-e59d16437db2	11534-166	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE		sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124		ANDA	ANDA204071	SUNRISE PHARMACEUTICAL, INC.	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
11534-176_cc17e1e3-ca71-4ae4-a1c2-2b90f3fb2405	11534-176	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	SUNRISE PHARMACEUTICAL, INC.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
11534-180_020b7f87-0f3a-4223-a402-dea12a6c53d2	11534-180	HUMAN OTC DRUG	POLYETHYLENE GLYCOL 3350 NF		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20170613		ANDA	ANDA206105	SUNRISE PHARMACEUTICAL, INC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11534-187_78de51f2-3446-4de5-9b97-f7d3caa3e18e	11534-187	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20170110		ANDA	ANDA207118	SUNRISE PHARMACEUTICAL, INC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
11534-188_c56f6cc9-f5de-49c1-9210-1ee874599443	11534-188	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA210059	SUNRISE PHARMACEUTICAL, INC.	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-189_c56f6cc9-f5de-49c1-9210-1ee874599443	11534-189	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA210059	SUNRISE PHARMACEUTICAL, INC.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-190_46e183c3-c017-4012-9474-83e7b5ee32f5	11534-190	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	SUNRISE PHARMACEUTICAL, INC.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-191_46e183c3-c017-4012-9474-83e7b5ee32f5	11534-191	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	SUNRISE PHARMACEUTICAL, INC.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-192_46e183c3-c017-4012-9474-83e7b5ee32f5	11534-192	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	SUNRISE PHARMACEUTICAL, INC.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-193_46e183c3-c017-4012-9474-83e7b5ee32f5	11534-193	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	SUNRISE PHARMACEUTICAL, INC.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-194_46e183c3-c017-4012-9474-83e7b5ee32f5	11534-194	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	SUNRISE PHARMACEUTICAL, INC.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-195_46e183c3-c017-4012-9474-83e7b5ee32f5	11534-195	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	SUNRISE PHARMACEUTICAL, INC.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-196_46e183c3-c017-4012-9474-83e7b5ee32f5	11534-196	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	SUNRISE PHARMACEUTICAL, INC.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
11534-197_3ecf4af2-f5a1-43f1-ac8b-bf88037950d5	11534-197	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20200709		ANDA	ANDA211421	Sunrise Pharmaceutical, Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
11559-001_038728e4-ef83-60c4-e063-6394a90a372c	11559-001	HUMAN OTC DRUG	YOUTH DEW ROLL-ON ANTIPERSPIRANT DEODORANT		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20201202		OTC MONOGRAPH DRUG	M019	ESTEE LAUDER INC	ALUMINUM CHLOROHYDRATE	200	mg/mL			N	20241231
11559-030_ffd4881f-5fbc-b684-e053-6394a90a7c16	11559-030	HUMAN OTC DRUG	DOUBLE WEAR MAXIMUM COVER CAMOUFLAGE MAKEUP FOR FACE AND BODY BROAD SPECTRUM SPF 15		titanium dioxide	CREAM	TOPICAL	20101001		OTC MONOGRAPH FINAL	M020	ESTEE LAUDER INC	TITANIUM DIOXIDE	14	mg/mL			N	20241231
11559-048_0cf5cd91-fa4f-f74d-e063-6294a90a911d	11559-048	HUMAN OTC DRUG	DOUBLE WEAR NUDE WATER FRESH MAKEUP BROAD SPECTRUM SPF 30		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LIQUID	TOPICAL	20170501	20250715	OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	50; 31; 22	mg/mL; mg/mL; mg/mL			N	
11559-049_04290ca5-16ad-fd6a-e063-6394a90a809d	11559-049	HUMAN OTC DRUG	DAYWEAR MULTI-PROTECTION ANTII-OXIDANT 24H-MOISTURE CREME BROAD SPECTRUM SPF 15 NORMAL/COMBINATION SKIN		AVOBENZONE and OCTISALATE	CREAM	TOPICAL	20171201		OTC MONOGRAPH FINAL	M020	ESTEE LAUDER INC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
11559-050_08a3fd47-154c-9dc5-e063-6294a90ac81a	11559-050	HUMAN OTC DRUG	PERFECTIONIST PRO MULTI-DEFENSE UV FLUID BROAD SPRECTRUM SPF 45		TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20181005		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	TITANIUM DIOXIDE; ZINC OXIDE	63; 40	mg/mL; mg/mL			N	20241231
11559-052_0d0dd13b-6b88-01f5-e063-6394a90a8399	11559-052	HUMAN OTC DRUG	RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15		AVOBENZONE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20181101		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 45; 27	mg/mL; mg/mL; mg/mL			N	20241231
11559-053_08b59bdc-3636-ee2d-e063-6294a90a088b	11559-053	HUMAN OTC DRUG	RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin		AVOBENZONE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20181201		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.03; .045; .027	g/mL; g/mL; g/mL			N	20241231
11559-055_0aab5401-e543-b836-e063-6394a90a576e	11559-055	HUMAN OTC DRUG	DAYWEAR ANTI OXIDANT 72H-HYDRATION SORBET CREME BROAD SPECTRUM SPF 15		AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20181201		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 45; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11559-056_043890a6-8360-8aea-e063-6294a90afd7e	11559-056	HUMAN OTC DRUG	REVITALIZING SUPREME PLUS GLOBAL ANTI-AGING CELL POWER CREME BROAD SPECTRUM SPF 15		AVOBENZONE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20190501		OTC MONOGRAPH FINAL	M020	ESTEE LAUDER INC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 45; 50	mg/mL; mg/mL; mg/mL			N	20241231
11559-057_0a0d98fd-f813-3eaa-e063-6294a90ac42a	11559-057	HUMAN OTC DRUG	RE-NUTRIV ULTRA RADIANCE MAKEUP BROAD SPECTRUM SPF 20		OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	OCTINOXATE; TITANIUM DIOXIDE	22; 14	mg/mL; mg/mL			N	20241231
11559-058_04393cdf-14ab-b445-e063-6294a90a7dc0	11559-058	HUMAN OTC DRUG	FUTURIST HYDRA RESCUE MOISTURIZING MAKEUP BROAD SPECTRUM SPF 45		ENSULIZOLE, OCTINOXATE, OCTISALATE, and ZINC OXIDE	LIQUID	TOPICAL	20191004		OTC MONOGRAPH FINAL	M020	ESTEE LAUDER INC	ENSULIZOLE; OCTINOXATE; OCTISALATE; ZINC OXIDE	27; 67; 45; 38	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11559-060_043971a7-1534-dfc7-e063-6394a90a1470	11559-060	HUMAN OTC DRUG	ESTEE LAUDER MULTI-DEFENSE AQUA UV gel BROAD SPECTRUM SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE	LOTION	TOPICAL	20200504		OTC MONOGRAPH FINAL	M020	ESTEE LAUDER INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 45; 28; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11559-061_0b773c58-061d-1b0b-e063-6394a90a708d	11559-061	HUMAN OTC DRUG	ESTEE LAUDER DOUBLE WEAR SHEER LONG-WEAR MAKEUP BROAD SPECTRUM SPF 19		OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20210107		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	OCTINOXATE; TITANIUM DIOXIDE	20; 23	mg/mL; mg/mL			N	20241231
11559-062_0d0702a8-6b93-7e75-e063-6394a90a1b4e	11559-062	HUMAN OTC DRUG	ESTEE LAUDER DOUBLE WEAR SOFT GLOW MATTE CUSHION MAKEUP BROAD SPECTRUM SPF 36		OCTINOXATE, TITANIUM DIOXIDE AND ZINC OXIDE	GEL	TOPICAL	20210707		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	68; 76; 36	mg/g; mg/g; mg/g			N	20241231
11559-063_06d055a4-c9d8-4f62-e063-6394a90a0aa8	11559-063	HUMAN OTC DRUG	FUTURIST SKIN TINT SERUM		OCTINOXATE,OCTISALATE,ZINC OXIDE	CREAM	TOPICAL	20221031		OTC MONOGRAPH FINAL	M020	ESTEE LAUDER INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	67; 45; 68	mg/mL; mg/mL; mg/mL			N	20241231
11559-064_0a0bfe4a-53b7-5b7c-e063-6394a90a23ec	11559-064	HUMAN OTC DRUG	DAYWEAR ADVANCED MULTI-PROTECTION ANTI-OXIDANT 24H-MOISTURE CREME BROAD SPECTRUM SPF15		AVOBENZONE, HOMOSALATE, OCTISALATE	CREAM	TOPICAL	20231113		OTC MONOGRAPH DRUG	M020	ESTEE LAUDER INC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 20; 50	mg/mL; mg/mL; mg/mL			N	20241231
11564-001_0760b982-d742-f9f2-e063-6394a90a3ac8	11564-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19830101		NDA	NDA205889	Fresno Oxygen & Welding Suppliers Inc	OXYGEN	992	mL/L			N	20241231
11564-002_0760dd72-2fe8-c8eb-e063-6294a90ad4be	11564-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA205891	Fresno Oxygen & Welding Suppliers Inc	NITROGEN	992	mL/L			N	20241231
11564-004_0760c404-9d41-a7cc-e063-6294a90a6c7e	11564-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA205889	Fresno Oxygen and Welding Suppliers, Inc.	OXYGEN	210	mL/L			N	20241231
11584-0030_0e852f9b-ed28-bc08-e063-6394a90a28db	11584-0030	HUMAN PRESCRIPTION DRUG	Tencon		butalbital and acetaminophen	TABLET	ORAL	20131010		ANDA	ANDA089987	El Dorado Distributors LLC	ACETAMINOPHEN; BUTALBITAL	325; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]		N	20251231
11673-003_0bd9a2db-1739-a097-e063-6294a90a3274	11673-003	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20120308		OTC MONOGRAPH DRUG	M003	Target Corporation	POVIDONE-IODINE	10	mg/mL			N	20241231
11673-004_0bd96cdb-fc70-b965-e063-6394a90a9373	11673-004	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20110826		OTC MONOGRAPH DRUG	M021	Target Corp	SODIUM FLUORIDE	.2	mg/mL			N	20241231
11673-007_331c742f-5dae-40cc-a064-5358a4494ea9	11673-007	HUMAN OTC DRUG	up and up famotidine complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20150427		ANDA	ANDA077355	Target Corporation	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-010_467d1aa6-b363-4314-9806-e4f4a495bdab	11673-010	HUMAN OTC DRUG	up and up famotidine complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20150506		ANDA	ANDA077355	Target Corporation	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-011_4df7ec73-81d8-4eac-b808-dcc41bda32c6	11673-011	HUMAN OTC DRUG	2 in 1		Pyrithione zinc	SHAMPOO	TOPICAL	20130516		OTC MONOGRAPH FINAL	part358H	Target Corporation	PYRITHIONE ZINC	10.4	mg/mL			N	20241231
11673-012_6169d155-d6e7-43bd-be65-b6ebd65a61e0	11673-012	HUMAN OTC DRUG	up and up childrens allergy melts		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20151101		OTC MONOGRAPH DRUG	M012	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-012_e55b8c17-8dc4-4b44-9a03-07b4aa51ab94	11673-012	HUMAN OTC DRUG	up and up severe cold and flu	nighttime	Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20150803		OTC MONOGRAPH FINAL	part341	Target Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-015_39454e7c-6838-4efb-85bb-b639fafe14aa	11673-015	HUMAN OTC DRUG	Healing		petrolatum	OINTMENT	TOPICAL	20100107		OTC MONOGRAPH FINAL	part347	Target Corporation	PETROLATUM	340	mg/g			N	20241231
11673-016_94be1235-907e-4419-9a7b-0c67f85daaae	11673-016	HUMAN OTC DRUG	Athletes Foot		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	Target Corporation	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
11673-018_2bfbbd75-23a8-4d89-b69e-fc476358c8ce	11673-018	HUMAN OTC DRUG	up and up omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150417		NDA	NDA022032	Target Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-019_716f6c58-99e6-4d50-ba0d-af0f332e161e	11673-019	HUMAN OTC DRUG	up and up nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20150310		OTC MONOGRAPH FINAL	part341	Target Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-020_12af880b-3cd3-4afe-94bb-ca177c16f36d	11673-020	HUMAN OTC DRUG	Diaper Rash		ZINC OXIDE	PASTE	TOPICAL	20080324		OTC MONOGRAPH FINAL	part347	Target Corporation	ZINC OXIDE	400	mg/g			N	20241231
11673-021_f2990be2-63ef-4766-94fc-ec1ac0cd162d	11673-021	HUMAN OTC DRUG	Up and Up Daytime Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20150313		OTC MONOGRAPH FINAL	part341	Target Corporation						N	20241231
11673-024_b4cdd0d2-cff8-51e0-e053-2995a90adebe	11673-024	HUMAN OTC DRUG	Up and Up	Acne Wash	SALICYLIC ACID	LIQUID	TOPICAL	20131025		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	SALICYLIC ACID	20	mg/mL			N	20241231
11673-025_d5c644d3-19de-4ab9-910c-c24acb3646c2	11673-025	HUMAN OTC DRUG	up and up antibiotic plus pain relief		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20150415		OTC MONOGRAPH FINAL	part333B	Target Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11673-029_d51e4337-40c8-46b6-9cb0-880f1906910e	11673-029	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20100311		ANDA	ANDA076775	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-031_763d7c0c-950b-42ea-96e1-745e8445bb65	11673-031	HUMAN OTC DRUG	up and up famotidine		Famotidine	TABLET, FILM COATED	ORAL	20150313		ANDA	ANDA075400	Target Corporation	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11673-040_06d27bcc-fba4-4884-e063-6294a90aa2fe	11673-040	HUMAN OTC DRUG	Assorted Fruit Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20151204		OTC MONOGRAPH FINAL	part331	Target Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-049_04ff74ff-4dd3-43c5-8997-d7d9c9deef6b	11673-049	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	19970113		ANDA	ANDA074444	TARGET Corporation	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-050_a7bb2e56-5bee-4872-8191-7821b0ac4859	11673-050	HUMAN OTC DRUG	up and up ibuprofen pm		diphenhydramine citrate and ibuprofen	TABLET, FILM COATED	ORAL	20090710		ANDA	ANDA079113	Target Corporation	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-051_06d27b10-f036-1471-e063-6394a90a4191	11673-051	HUMAN OTC DRUG	Target Antacid Fruit Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191101		OTC MONOGRAPH FINAL	part331	Target	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-052_06d27bcc-fba5-4884-e063-6294a90aa2fe	11673-052	HUMAN OTC DRUG	Target Antacid - Anti-Gas Relief Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191101		OTC MONOGRAPH FINAL	part331	Target	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
11673-057_37afe6da-17d6-4254-9e22-89db7de236fe	11673-057	HUMAN OTC DRUG	up and up hydrocortisone		hydrocortisone	CREAM	TOPICAL	20150407		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-059_d3a3c424-d16f-4b45-b181-0364345a3ee1	11673-059	HUMAN OTC DRUG	Daytime Cold and Cough and NightTime Cold and Congestion	Childrens	Brompheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl, Phenylephrine HCl	KIT		20150731		OTC MONOGRAPH FINAL	part341	TARGET Corporation						N	20241231
11673-060_08f410f4-fad2-a136-e063-6294a90a55d8	11673-060	HUMAN OTC DRUG	Target StrawberryLime Antacid Chews		Calcium carbonate	TABLET, CHEWABLE	ORAL	20200115		OTC MONOGRAPH DRUG	M001	Target	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-061_a6f8e898-b673-4cd5-a81d-726d9bdffc05	11673-061	HUMAN OTC DRUG	up and up famotidine		Famotidine	TABLET, FILM COATED	ORAL	20120503		ANDA	ANDA077351	Target Corporation	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11673-062_548504ca-cf9c-4316-9154-47fe51c42397	11673-062	HUMAN OTC DRUG	Jock Itch		Clotrimazole	CREAM	TOPICAL	20190427		OTC MONOGRAPH FINAL	part333C	TARGET Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-063_e5c586ac-15a9-4f43-8ec7-a0f8051bba9a	11673-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	19971126		OTC MONOGRAPH DRUG	M016	Target Corporation	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL			N	20241231
11673-064_38ac5bca-1643-4af3-8407-fa3b7f5757d9	11673-064	HUMAN OTC DRUG	Eye Itch Relief		ketotifen fumarate	SOLUTION	OPHTHALMIC	20140102		NDA	NDA021996	Target Corporation	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
11673-068_baec3bd1-37d7-bb07-e053-2a95a90a9b8c	11673-068	HUMAN OTC DRUG	Target Up and Up Oil Free Acne Wash Pink Grapefruit Foaming Scrub		Salicylic Acid	LOTION	TOPICAL	20160706		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	SALICYLIC ACID	20	mg/mL			N	20241231
11673-069_1b2d1a76-62d6-4d59-a5e4-9f0753c69c99	11673-069	HUMAN OTC DRUG	Pure petroleum		White Petrolatum	JELLY	TOPICAL	20050602		OTC MONOGRAPH DRUG	M016	Target Corp	PETROLATUM	1	g/g			N	20241231
11673-070_9cbe75fe-4586-5654-e053-2995a90a3de4	11673-070	HUMAN OTC DRUG	HEADACHE RELIEF		ACETAMINOPHEN-ASPIRIN-CAFFEINE	TABLET, COATED	ORAL	20191004		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11673-072_738541a2-ac02-4408-aff6-3372e9d71ee8	11673-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19960108		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corp	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11673-073_62e951c0-2ea8-4caa-b436-447a6532eef3	11673-073	HUMAN OTC DRUG	up and up first aid antibiotic		Bacitracin	OINTMENT	TOPICAL	20150406		OTC MONOGRAPH FINAL	part333B	Target Corporation	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
11673-074_0896ba3c-9eee-2fc2-e063-6394a90a2d29	11673-074	HUMAN OTC DRUG	candy cutie hand sanitizer		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-075_0896b8b4-1a3b-b396-e063-6394a90aa50b	11673-075	HUMAN OTC DRUG	cheerful choco orange hand sanitizer		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-076_0896c4d1-6ac3-2552-e063-6294a90a69b9	11673-076	HUMAN OTC DRUG	creamy cappuccino hand sanitizer		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-077_57be54a0-586c-489b-bd7e-8c489e102f40	11673-077	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20180111		OTC MONOGRAPH DRUG	M003	TARGET Corporation	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
11673-078_0898be5e-2a02-7c7f-e063-6294a90ac297	11673-078	HUMAN OTC DRUG	berry blitz hand sanitizer		ALCOHOL	GEL	TOPICAL	20200718		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-079_0898ae01-4b97-74ee-e063-6394a90a1e58	11673-079	HUMAN OTC DRUG	choco mallow melt hand sanitizer		ALCOHOL	GEL	TOPICAL	20200718		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-080_dc435d71-3536-4759-b63f-f42a7f8c3d19	11673-080	HUMAN OTC DRUG	Athletes Foot		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Target Corporation	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
11673-086_c1557e29-07ec-4532-b126-7df9afe531cd	11673-086	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140314		OTC MONOGRAPH NOT FINAL	part333A	Target Corp	ALCOHOL	567	mg/mL			N	20241231
11673-087_f907010c-6789-e51b-e053-6394a90a8f8a	11673-087	HUMAN OTC DRUG	Target Up and Up Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20090501		OTC MONOGRAPH FINAL	M016	TARGET CORPORATION	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
11673-088_badbdee2-4148-67f8-e053-2995a90ab5ee	11673-088	HUMAN OTC DRUG	TARGET UP AND UP ACNE MEDICATION		BENZOYL PEROXIDE	GEL	TOPICAL	20160715		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	BENZOYL PEROXIDE	100	mg/g			N	20241231
11673-089_baef8c1e-a57a-2042-e053-2a95a90aa08b	11673-089	HUMAN OTC DRUG	Target Up and Up Kids Mineral Sunscreen SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20140117		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	45; 65	mg/mL; mg/mL			N	20241231
11673-091_f396dd27-ef78-b6af-e053-2995a90a88c4	11673-091	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Maximum Strength	LIQUID	TOPICAL	20210215		OTC MONOGRAPH FINAL	part333C	Target Corporation	TOLNAFTATE	.3	g/30mL			N	20241231
11673-093_f37d0b49-5e7d-ec94-e053-2a95a90ae803	11673-093	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20210320		OTC MONOGRAPH FINAL	part333C	Target Corporation	TOLNAFTATE	1.5	g/150g			N	20241231
11673-097_baf02e7e-d414-1894-e053-2a95a90a4133	11673-097	HUMAN OTC DRUG	Target Up and Up Sport SPF 15 Clear		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170105		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11673-099_09e8c036-9fd3-41d0-9bac-5add2d128354	11673-099	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20140406		OTC MONOGRAPH NOT FINAL	part333A	Target Corporation	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
11673-100_0cfa0b71-d377-fa73-e063-6294a90a390e	11673-100	HUMAN OTC DRUG	Target Eye Drops Maximum Redness Relief Eye		Glycerin, Naphazoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20190208		OTC MONOGRAPH DRUG	M018	Target Corporation	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	500; 30	mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
11673-101_0cfa0ee5-f8cf-b0f9-e063-6294a90a2c90	11673-101	HUMAN OTC DRUG	Target Lubricant Eye Drops High Performance		Polyethylene glycol 400, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190211		OTC MONOGRAPH DRUG	M018	Target Corporation	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
11673-103_2a403a81-84bc-4ef2-8d68-05be66dfca6d	11673-103	HUMAN OTC DRUG	Up and Up Allergy Relief Nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160531		ANDA	ANDA207957	Target Corporation	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-104_c90451f9-0f9f-4fd7-af22-5f2f544f089e	11673-104	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20180111	20250530	ANDA	ANDA079112	TARGET Corporation	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
11673-105_15d75cba-6969-46c1-87c3-e7ae740b56e0	11673-105	HUMAN OTC DRUG	Up and Up childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20090708		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11673-110_0cfa209f-bdf5-84d2-e063-6294a90a756e	11673-110	HUMAN OTC DRUG	Target Lubricant Eye Drops High Performance		Polyethylene glycol 400, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190212		OTC MONOGRAPH DRUG	M018	Target Corporation	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
11673-111_b9e6809c-e0ce-4205-98c5-665af1716503	11673-111	HUMAN OTC DRUG	DYE-FREE CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20201117		ANDA	ANDA210088	UP & UP	LORATADINE	5	mg/1			N	20241231
11673-114_0c525e24-22f3-4609-9c2d-6c93bf83081a	11673-114	HUMAN OTC DRUG	up and up 12 hour cough relief		dextromethorphan polistirex	SUSPENSION	ORAL	20121023		ANDA	ANDA091135	Target Corporation	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-115_78f854b0-4172-4464-804d-a58e0648983c	11673-115	HUMAN OTC DRUG	Dye-Free Childrens Loratadine		LORATADINE	TABLET, CHEWABLE	ORAL	20201117		ANDA	ANDA210088	UP & UP	LORATADINE	5	mg/1			N	20241231
11673-116_308f8b0f-97ac-4087-8c5a-53971e67924b	11673-116	HUMAN OTC DRUG	up and up gentle laxative		Bisacodyl	TABLET, COATED	ORAL	20150914		OTC MONOGRAPH DRUG	M007	Target Corporation	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-117_e84a8913-1d96-445a-8058-e3c8b4a4b391	11673-117	HUMAN OTC DRUG	up and up lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120518		ANDA	ANDA202319	Target Corporation	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-118_c63069d1-f793-4d17-92f9-76b0fb51dd3e	11673-118	HUMAN OTC DRUG	Target Zinc Cold Therapy	Citrus Flavor	ZINC GLUCONATE	TABLET, CHEWABLE	ORAL	20190418		UNAPPROVED HOMEOPATHIC		TARGET CORPORATION	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11673-119_baf0edc3-5fc5-4ff8-e053-2a95a90a7309	11673-119	HUMAN OTC DRUG	TARGET UP AND UP MINERAL BASED SPF 30 SUNSCREEN		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20200922		OTC MONOGRAPH FINAL	part347	TARGET CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/mL; mg/mL			N	20241231
11673-122_579f2a07-41b3-4bb5-b145-f3c3de9cb034	11673-122	HUMAN OTC DRUG	up and up 5-symptom digestive relief		Bismuth subsalicylate	TABLET	ORAL	20190312		OTC MONOGRAPH DRUG	M008	Target Corporation	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
11673-124_f99c792f-2585-45ce-9a2b-08acdd267da3	11673-124	HUMAN OTC DRUG	up and up nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20110221		ANDA	ANDA090711	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-125_91551ad6-6a59-42aa-b25b-200f55e21856	11673-125	HUMAN OTC DRUG	up and up 5-symptom digestive relief		Bismuth subsalicylate	TABLET	ORAL	20150907		OTC MONOGRAPH DRUG	M008	Target Corporation	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
11673-126_efe55d57-b23a-78f5-e053-2995a90a946a	11673-126	HUMAN OTC DRUG	Up and Up Lubricant		Carboxymethylcellulose Sodium	SOLUTION/ DROPS	OPHTHALMIC	20210126		OTC MONOGRAPH FINAL	part349	Target Corporation	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
11673-128_bd0ecc3e-74f7-8ce6-e053-2995a90abbb1	11673-128	HUMAN OTC DRUG	Target Up and Up SPF55 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	STICK	TOPICAL	20140625		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
11673-129_c527cf83-afeb-a861-e053-2995a90aa140	11673-129	HUMAN OTC DRUG	Target Up and Up Mineral Sunscreen Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20200122		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
11673-130_9c5b052e-bf97-4d18-b427-c5a887095e7f	11673-130	HUMAN OTC DRUG	Up and Up Childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20090708		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11673-132_baeaf660-ac50-1ebc-e053-2995a90ac0c1	11673-132	HUMAN OTC DRUG	Target Up and Up Petroleum Jelly		WHITE PETROLATUM	JELLY	TOPICAL	20151029		OTC MONOGRAPH FINAL	part346	TARGET CORPORATION	PETROLATUM	100	g/100g			N	20241231
11673-133_1e8a539f-633e-44f2-b9e4-048db51dfe6b	11673-133	HUMAN OTC DRUG	up and up acetaminophen	infants	Acetaminophen	SUSPENSION	ORAL	20150422		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11673-134_cfd735d2-df3b-5ed0-e053-2995a90a9f26	11673-134	HUMAN OTC DRUG	Target Up and Up Mineral Sunscreen Broad Spectrum SPF 50 Reef-Conscious Formula		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
11673-135_f8c1d858-5675-7d88-e053-6294a90a74a8	11673-135	HUMAN OTC DRUG	Target Up and Up SPF55 Sunscreen Reef-Conscious Formula		Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20190115		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
11673-138_d4c714c7-0517-5b5b-e053-2a95a90aaea7	11673-138	HUMAN OTC DRUG	TARGET UP AND UP ACNE SPOT TREATMENT		SALICYLIC ACID	GEL	TOPICAL	20130923		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	SALICYLIC ACID	20	mg/mL			N	20241231
11673-142_f7eabecd-9065-4bba-b2b3-06ad6050cbc8	11673-142	HUMAN OTC DRUG	Up and up vagicaine		Benzocaine, Resorcinol	CREAM	TOPICAL	20090825		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	BENZOCAINE; RESORCINOL	20; 3	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11673-143_f1ebcae5-9ef7-8112-e053-2a95a90a44cd	11673-143	HUMAN OTC DRUG	Severe Throat Sore Drops		Menthol	PASTILLE	ORAL	20191012		OTC MONOGRAPH FINAL	part341	Target Corporation Inc.	MENTHOL	.69	mg/1			N	20241231
11673-144_a23de815-286b-884f-e053-2995a90ac884	11673-144	HUMAN OTC DRUG	Natural Herbal Cough Drops		Cough Drops	PASTILLE	ORAL	20200401		OTC MONOGRAPH FINAL	part341	Target Corporation Inc.	MENTHOL	4.8	mg/1			N	20241231
11673-146_d4dd5a09-a026-2346-e053-2a95a90aa6d9	11673-146	HUMAN OTC DRUG	Target Up and Up Broad Spectrum SPF 55 Oil-Free		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20140129		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 40; 45; 60; 45	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11673-147_e069c9e6-024e-5482-e053-2995a90a767d	11673-147	HUMAN OTC DRUG	Target Up and Up 2-in-1 Hand Sanitizer		BENZETHONIUM CHLORIDE	LOTION	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part333A	TARGET CORPORATION	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11673-149_f12efbdd-01a4-89fc-e053-2995a90a1e85	11673-149	HUMAN OTC DRUG	Target Up and Up Acne Spot Treatment		Benzoyl Peroxide	LOTION	TOPICAL	20160913		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	BENZOYL PEROXIDE	25	mg/g			N	20241231
11673-150_0cf9f63b-8238-af5c-e063-6394a90a9c9d	11673-150	HUMAN OTC DRUG	Lubricant Eye Drops Preservative Free		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20190212		OTC MONOGRAPH DRUG	M018	Target Corporation	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
11673-151_86a77991-3dc9-0e98-e053-2a91aa0a61b7	11673-151	HUMAN OTC DRUG	WOMENS GENTLE LAXATIVE		BISACODYL	TABLET	ORAL	20190401		OTC MONOGRAPH NOT FINAL	part334	TARGET CORPORATION	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-152_f784bda2-1181-574c-e053-6394a90a6d9f	11673-152	HUMAN OTC DRUG	Target Up and Up 3 Step Acne System		Benzoyl Peroxide	KIT		20160707		OTC MONOGRAPH FINAL	M006	TARGET CORPORATION						N	20241231
11673-153_b8c5ea3a-aa23-4efe-95d8-f0e7ee1882bf	11673-153	HUMAN OTC DRUG	Everyday Clean Dandruff		pyrithione zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH FINAL	part358H	Target Corporation	PYRITHIONE ZINC	10	mg/mL			N	20241231
11673-154_e830918d-77c5-46c4-ba39-3ff9271660aa	11673-154	HUMAN OTC DRUG	up and up antifungal		tolnaftate	SPRAY	TOPICAL	20170628		OTC MONOGRAPH FINAL	part333C	Target Corporation	TOLNAFTATE	1	g/100g			N	20241231
11673-155_0cfa2cc7-bb7d-af55-e063-6394a90a28f0	11673-155	HUMAN OTC DRUG	Target Lubricant Eye Drops Restorative Performance		propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190212		OTC MONOGRAPH DRUG	M018	Target Corporation	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
11673-156_06d27e26-9806-24e3-e063-6394a90a4260	11673-156	HUMAN OTC DRUG	Target Wild Berry Antacid Chews 60ct		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220216		OTC MONOGRAPH FINAL	part331	Target	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-157_f75739eb-2e71-45f8-9cc8-023400615f57	11673-157	HUMAN OTC DRUG	Minoxidil	(For Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20220816		ANDA	ANDA209074	TARGET Corporation	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-163_3ac6a308-88e6-49ac-af74-59665597207f	11673-163	HUMAN OTC DRUG	Anticavity Fluoride Rinse		SODIUM FLUORIDE	MOUTHWASH	ORAL	19940406		OTC MONOGRAPH DRUG	M021	Target Corporation	SODIUM FLUORIDE	.1	mg/mL			N	20241231
11673-164_446ae1ff-df53-49c8-aa83-3fd4f7247a64	11673-164	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Target	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-166_36d41169-095b-42d0-a08f-d9cf62668587	11673-166	HUMAN OTC DRUG	Up and Up childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20090612		ANDA	ANDA074937	Target Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-167_0c0282a2-a42b-4d8c-e063-6294a90ad248	11673-167	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230227		OTC MONOGRAPH DRUG	M013	TARGET CORPORATION	ACETAMINOPHEN	500	mg/1			N	20241231
11673-168_f8c10651-a995-07ee-e053-6394a90a694e	11673-168	HUMAN OTC DRUG	Target Up and Up SPF50 Sport Sunscreen Lip Balm Reef-Conscious Formula		Avobenzone, Homosalate, Octocrylene	STICK	TOPICAL	20181221		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 80; 100	mg/g; mg/g; mg/g			N	20241231
11673-170_c01aa9ad-27c6-4eb0-8c76-e1f3c30cefed	11673-170	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20100312		ANDA	ANDA076789	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-171_4e4806a9-f406-40e9-9ed0-c00577a7f851	11673-171	HUMAN OTC DRUG	up and up nighttime sleep aid		Doxylamine succinate	TABLET	ORAL	20220204		ANDA	ANDA040167	Target Corporation	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
11673-177_f0ffa192-f512-d149-e053-2995a90a6c5f	11673-177	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20191009		NDA	NDA021855	TARGET Corporation	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
11673-181_c9e8b8dc-139b-8c48-e053-2a95a90a0946	11673-181	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20200101		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11673-182_9cbeae92-020a-3931-e053-2995a90ac96b	11673-182	HUMAN OTC DRUG	BISACODYL		BISCODYL	TABLET, COATED	ORAL	20200204		OTC MONOGRAPH NOT FINAL	part334	TARGET CORPORATION	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-183_9a5ec1c1-4590-458c-8777-ab8bc16c53fd	11673-183	HUMAN OTC DRUG	up and up ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20100311		ANDA	ANDA077349	Target Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-185_f8c200b9-0e22-db7f-e053-6294a90aaafb	11673-185	HUMAN OTC DRUG	Target Up and Up Sport Sunscreen Lip Balm plus Stick		Avobenzone, Homosalate, Octisalate, Octocrylene	KIT		20210121		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION						N	20241231
11673-186_a2d146f9-2a18-4528-aeb3-74061bc95375	11673-186	HUMAN OTC DRUG	Up and Up Nighttime Sleep Aid		diphenhydramine hydrochloride	SOLUTION	ORAL	20200326		OTC MONOGRAPH FINAL	part338	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-187_f0468186-c3f9-2030-e053-2995a90af3f2	11673-187	HUMAN OTC DRUG	Up and Up Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20200624		OTC MONOGRAPH FINAL	part343	Target Corporation	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11673-188_eebd1378-e454-f931-e053-2a95a90a8298	11673-188	HUMAN OTC DRUG	Regular strength aspirin		Aspirin	TABLET	ORAL	20221205		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11673-189_10b49685-fc4d-489d-96ac-86e4baffbb90	11673-189	HUMAN OTC DRUG	up and up hair regrowth treatment for women		Minoxidil	SOLUTION	TOPICAL	20150831		ANDA	ANDA075357	Target Corporation	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-190_457a6868-cc46-483a-babc-e766ae69290d	11673-190	HUMAN OTC DRUG	up and up nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20110312		ANDA	ANDA090711	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-191_86a77a11-d8c6-0e65-e053-2a91aa0aa8cb	11673-191	HUMAN OTC DRUG	SENNA LAXATIVE		SENNOSIDES 8.6 MG	TABLET	ORAL	20190401		OTC MONOGRAPH NOT FINAL	part334	TARGET CORPORATION	SENNOSIDES A AND B	8.6	mg/1			N	20241231
11673-192_81f51705-1b12-f726-e053-2991aa0a8e02	11673-192	HUMAN OTC DRUG	STOOL SOFTENING SENNA LAXATIVE		SENNOSIDES 8.6 MG - DOCUSATE SODIUM 50 MG	TABLET	ORAL	20190329		OTC MONOGRAPH NOT FINAL	part334	TARGET CORPORATION	DOCUSATE SODIUM; SENNOSIDES A AND B	50; 8.6	mg/1; mg/1			N	20241231
11673-193_f9027e42-017b-07fd-e053-6294a90ab916	11673-193	HUMAN OTC DRUG	Target Up and Up Oil Free Facial Moisturizer with Sunscreen Broad Spectrum SPF 15		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20090804		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	AVOBENZONE; OCTISALATE; OCTOCRYLENE	15; 50; 60	mg/mL; mg/mL; mg/mL			N	20241231
11673-198_7004ff84-6692-4d1f-b50e-6cb4aafc1907	11673-198	HUMAN OTC DRUG	Motion Sickness		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	Target Corporation	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-199_3fbed7c8-eb37-484d-aa8c-1aca4a3765e7	11673-199	HUMAN OTC DRUG	up and up miconazole		Miconazole nitrate	KIT		20100708		ANDA	ANDA079114	Target Corporation						N	20241231
11673-200_bb037be4-9c2b-2604-e053-2a95a90a9e72	11673-200	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20190115		OTC MONOGRAPH NOT FINAL	part334	Target Corporation	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-202_16768538-ae65-415f-9fc6-489bb9fb80ba	11673-202	HUMAN OTC DRUG	up and up hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20150401		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-204_76c58d5f-5a28-4faf-89ba-e31c77d8b731	11673-204	HUMAN OTC DRUG	up and up sinus pe		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20150312		OTC MONOGRAPH FINAL	part341	Target Corporation	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-205_59102555-d1e7-499c-b4c1-73d4b7ed3398	11673-205	HUMAN OTC DRUG	Therapeutic T Plus		Coal Tar	SHAMPOO	TOPICAL	20070129		OTC MONOGRAPH FINAL	part358H	Target Corp	COAL TAR	25	mg/mL			N	20241231
11673-206_bd2bcc7f-d196-4f5b-84b1-31ec0dd22289	11673-206	HUMAN OTC DRUG	up and up nicotine polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20111006		ANDA	ANDA078325	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-209_86a71607-d6c4-28ff-e053-2991aa0a37e4	11673-209	HUMAN OTC DRUG	STOOL SOFTENER AND STIMULANT LAXATIVE		DOCUSATE SODIUM AND SENNOSIDES	TABLET	ORAL	20190410		OTC MONOGRAPH NOT FINAL	part334	TARGET CORPORATION	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
11673-212_3511d713-1cc2-4648-a070-695b2a89b9a2	11673-212	HUMAN OTC DRUG	up and up omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180509		NDA	NDA209400	Target Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-213_e8ba7397-20c6-4243-9ac9-96e83f54cd22	11673-213	HUMAN OTC DRUG	Fluoride Mouth Rinse Anticavity		Sodium Fluoride	MOUTHWASH	ORAL	20100817		OTC MONOGRAPH DRUG	M021	Target Corp.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
11673-216_b6f39212-f35b-4770-95d7-d478be5cb051	11673-216	HUMAN OTC DRUG	up and up nighttime sleep aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20211109		OTC MONOGRAPH FINAL	part338	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-218_99ee7340-b9e8-41fa-8fb2-dd01699fe037	11673-218	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	19960331		OTC MONOGRAPH NOT FINAL	part347	Target Cop	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11673-220_e4769d3b-3d21-7fbf-4380-b45a5f6c2504	11673-220	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20180226	20240321	ANDA	ANDA208150	Target Corporation	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
11673-224_848b0dac-7084-41b6-88fe-3a6f44a9a3d8	11673-224	HUMAN OTC DRUG	Up and Up anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20090720		ANDA	ANDA075232	Target Corporation	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
11673-225_f0e691ea-8e75-3925-e053-2a95a90a800a	11673-225	HUMAN OTC DRUG	IBUPROFEN, DIPHENHYDRAMINE HCL		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20191030		ANDA	ANDA090397	TARGET Corporation	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-226_eab8b0b5-7a9f-494e-b197-85901809002e	11673-226	HUMAN OTC DRUG	Diaper Rash		Zinc Oxide	CREAM	TOPICAL	19940808		OTC MONOGRAPH FINAL	part347	Target Corporation	ZINC OXIDE	130	mg/g			N	20241231
11673-231_f98ea706-5c11-6002-e053-6394a90a47c1	11673-231	HUMAN OTC DRUG	Target Up and Up SPF 15 Sport Sunscreen		Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20181101		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	AVOBENZONE; OCTISALATE; OCTOCRYLENE	20; 45; 70	mg/g; mg/g; mg/g			N	20241231
11673-232_f98eeb73-c750-5ce2-e053-6294a90ad83e	11673-232	HUMAN OTC DRUG	Target Goodfellow and Co SPF 30 Face Scent No. 05 Kelp and Sea Mineral		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200819		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11673-233_f9902a2a-6fbb-49e9-e053-6294a90a338c	11673-233	HUMAN OTC DRUG	Target Up and Up SPF 50 Mineral Sunscreen		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200922		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	30; 150	mg/mL; mg/mL			N	20241231
11673-234_f9b62ce2-37bc-2e5c-e053-6394a90a657b	11673-234	HUMAN OTC DRUG	Target Up and Up Healing Petrolatum Skin Protectant		PETROLATUM	OINTMENT	TOPICAL	20200730		OTC MONOGRAPH FINAL	M016	TARGET CORPORATION	PETROLATUM	410	mg/g			N	20241231
11673-235_617ebd8b-85db-4a79-a9b3-877f77ffa75b	11673-235	HUMAN OTC DRUG	up and up maximum strength mucus relief dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180927		ANDA	ANDA207602	Target Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-237_0073f083-1066-264f-e063-6294a90ad9aa	11673-237	HUMAN OTC DRUG	Target Sensitive Whitening TP		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20200729		OTC MONOGRAPH NOT FINAL	part356	Target	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
11673-239_f9b6a393-6ffa-d0b1-e053-6394a90ab5c8	11673-239	HUMAN OTC DRUG	Target Up and Up Morning Facial Moisturizing with Sunscreen Broad Spectrum SPF 30		HOMOSALATE, OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20151013		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	HOMOSALATE; OCTOCRYLENE; ZINC OXIDE	150; 20; 63	mg/mL; mg/mL; mg/mL			N	20241231
11673-240_36636fff-f566-496d-b4b7-0b120c7ca0d3	11673-240	HUMAN OTC DRUG	Children Pain and Fever Reliver		Acetaminophen	TABLET, CHEWABLE	ORAL	20191111		OTC MONOGRAPH DRUG	M013	Target Corporation	ACETAMINOPHEN	160	mg/1			N	20241231
11673-241_c698ac14-5036-40da-b0b3-9ad3c12e720b	11673-241	HUMAN OTC DRUG	Children Pain and Fever Reliever		Acetaminophen	TABLET, CHEWABLE	ORAL	20191111		OTC MONOGRAPH DRUG	M013	Target Corporation	ACETAMINOPHEN	160	mg/1			N	20241231
11673-242_f0ff913d-c276-80c6-e053-2995a90a6820	11673-242	HUMAN OTC DRUG	Cetirizine HCl		Cetirizine HCl	CAPSULE	ORAL	20191030		NDA	NDA022429	TARGET Corporation	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-244_fa2ef76e-2c9c-d632-e053-6294a90a0b78	11673-244	HUMAN OTC DRUG	Target Up and Up Mineral Sunscreen SPF 30		ZINC OXIDE	SPRAY	TOPICAL	20201014		OTC MONOGRAPH FINAL	M020	TARGET CORPORATION	ZINC OXIDE	150	mg/g			N	20241231
11673-253_bdcca7d0-10a7-4add-bcd7-634ed0b59bef	11673-253	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20141217		OTC MONOGRAPH FINAL	part358H	Target Corporation	PYRITHIONE ZINC	10	mg/mL			N	20241231
11673-255_08377114-ccaa-4c97-86eb-8079c1964de4	11673-255	HUMAN OTC DRUG	up and up dye free infants concentrated ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20090708		ANDA	ANDA075217	Target Corporation	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-262_ea05c748-9364-7a31-3d83-ff2e95d16d36	11673-262	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20210311		ANDA	ANDA208150	Target Corporation	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-266_5a817cce-55ab-4118-958a-9eed467dbe6d	11673-266	HUMAN OTC DRUG	up and up infants acetaminophen		Acetaminophen	SUSPENSION	ORAL	20150421		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11673-268_c1856129-47a3-40e3-9e92-2132192d9adc	11673-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20150831		OTC MONOGRAPH DRUG	M022	TARGET Corporation	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
11673-269_13055fc5-202d-4207-9cdd-4d33bac46746	11673-269	HUMAN OTC DRUG	up and up nicotine		nicotine	GUM, CHEWING	ORAL	20190314		ANDA	ANDA206394	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-270_c2f8dd16-e566-4056-8243-48f33917266b	11673-270	HUMAN OTC DRUG	Maximum Strength Urinary Pain Relief		Phenazopyridine Hydrochloride	TABLET	ORAL	20230125		UNAPPROVED DRUG OTHER		TARGET CORPORATION	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
11673-275_c296f123-721f-4866-b727-457d54e069eb	11673-275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20150831		OTC MONOGRAPH DRUG	M003	TARGET Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
11673-276_cee24809-240c-4e26-87c1-6f2b08cf33f7	11673-276	HUMAN OTC DRUG	Isopropyl alcohol	70 percent Wintergreen	Isopropyl alcohol	LIQUID	TOPICAL	20150831		OTC MONOGRAPH DRUG	M003	TARGET Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
11673-279_2d3dfcf9-3325-4833-81b5-de671c228904	11673-279	HUMAN OTC DRUG	up and up hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140523		OTC MONOGRAPH FINAL	part346	Target Corporation	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-280_f7815e3d-e97b-45b3-88b0-7c188766b0f6	11673-280	HUMAN OTC DRUG	up and up lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210618		ANDA	ANDA202319	Target Corporation	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-281_81d55380-9b5c-48e5-a8a8-50a9fdcf7b31	11673-281	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20020718		OTC MONOGRAPH FINAL	part358H	Target Corporation	PYRITHIONE ZINC	10	mg/mL			N	20241231
11673-299_0bb2c2fd-7a6c-ec40-e063-6294a90a8967	11673-299	HUMAN OTC DRUG	Antiseptic		Cetylpyridinium chloride	MOUTHWASH	ORAL	20080721		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
11673-300_ab518c06-2421-46e9-a981-d9ea47084d67	11673-300	HUMAN OTC DRUG	Vitamin A D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20070308		OTC MONOGRAPH DRUG	M016	Target Corp	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
11673-301_3ab05fce-0e89-4f7b-ab2f-882aab3abeb0	11673-301	HUMAN OTC DRUG	Up and Up Daytime Cold and Flu		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20150226		OTC MONOGRAPH FINAL	part341	Target Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-303_3b4b9c1e-1219-4590-b5bc-a8666e818ec0	11673-303	HUMAN OTC DRUG	up and up childrens allergy relief		Cetirizine HCl	SOLUTION	ORAL	20180307		ANDA	ANDA204226	Target Corporation	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-305_92d9fc39-f87d-92b5-e053-2995a90af65c	11673-305	HUMAN OTC DRUG	EXTRA STRENGTH HEADACHE RELIEF		ACETAMINOPHEN-ASPIRIN-CAFFEINE	TABLET, COATED	ORAL	20200101		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11673-306_1e9a1e70-e34c-4937-8670-23140aa5b511	11673-306	HUMAN OTC DRUG	up and up powderlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	Target Corporation	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-309_4ad3680c-f184-474d-914c-397aad146e82	11673-309	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170831		ANDA	ANDA206393	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-313_44abdee1-fe24-4da4-a843-da2faf95342b	11673-313	HUMAN OTC DRUG	up and up antibiotic plus pain relief		Neomycin, Polymyxin B, Pramoxine HCl	CREAM	TOPICAL	20150409		OTC MONOGRAPH FINAL	part333B	Target Corporation	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11673-314_7ffbb607-1dd7-432c-a747-f8474a154393	11673-314	HUMAN OTC DRUG	up and up ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA072096	Target Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-316_0bdc5a82-2d04-04d9-e063-6294a90a625a	11673-316	HUMAN OTC DRUG	maxumim strength gas relief simethicone softgel 250 mg		maxumim strength gas relief simethicone softgel 250 mg	CAPSULE, LIQUID FILLED	ORAL	20211117		OTC MONOGRAPH DRUG	M002	Target Corporation	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
11673-317_bb6ea10d-3167-4a2a-9546-109a6430eec7	11673-317	HUMAN OTC DRUG	up and up hair regrowth treatment for men		minoxidil	SOLUTION	TOPICAL	20211119		ANDA	ANDA075598	Target Corporation	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-318_c9df2c87-ef73-4d7b-a682-f35607a636ee	11673-318	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19960715		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11673-323_11ebdf97-4fe4-ad02-89ef-5f3e4514f39d	11673-323	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20181106		ANDA	ANDA207740	Target Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-324_b9f33d96-82ae-b61b-5325-a0761365e0cb	11673-324	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220412		ANDA	ANDA202194	Target Corporation	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-326_07e5643b-23f5-ed55-e063-6294a90a4761	11673-326	HUMAN OTC DRUG	Up and Up 70 Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20191215		OTC MONOGRAPH DRUG	M003	Target Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
11673-327_09d67be5-cf4f-1ce9-e063-6394a90a387e	11673-327	HUMAN OTC DRUG	Up and Up 3 Hydrogen Peroxide Wipes		HYDROGEN PEROXIDE	CLOTH	TOPICAL	20200901		OTC MONOGRAPH DRUG	M003	Target Corporation	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
11673-333_c2990351-3b66-41a8-b6e9-70c39986a4e4	11673-333	HUMAN OTC DRUG	ultra strength	Assorted Fruit	Calcium Carbonate Antacid	TABLET, CHEWABLE	ORAL	20191111		OTC MONOGRAPH DRUG	M001	Target Corporation	CALCIUM CARBONATE	1000	mg/1			N	20241231
11673-336_3b487b65-5a65-4a64-bd58-d681726ae997	11673-336	HUMAN OTC DRUG	Fast Mucus Relief Cold Flu and Sore Throat	Maximum Strength Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150228	20250228	OTC MONOGRAPH FINAL	part341	TARGET Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
11673-337_6d80f014-6c94-46e7-88cf-fa431fdb4cb6	11673-337	HUMAN OTC DRUG	Mucus Relief Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI	LIQUID	ORAL	20160731		OTC MONOGRAPH FINAL	part341	TARGET Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-341_3a193d6a-37ac-4a64-99bd-8938649adf4b	11673-341	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part334	TARGET Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11673-342_87753c0d-af22-2f6a-e053-2a95a90a0b45	11673-342	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20190601		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ACETAMINOPHEN	500	mg/1			N	20241231
11673-344_0614d4a9-e3e8-449f-bc39-91c58e77026d	11673-344	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20090616		ANDA	ANDA077007	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-346_af1c017b-e5a1-4e1a-8d1b-854d0bfebded	11673-346	HUMAN OTC DRUG	up and up omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220203		NDA	NDA022032	Target Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-349_69c951a6-e0b9-49be-a023-b4230b358aa4	11673-349	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170627		ANDA	ANDA209207	TARGET Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-353_233848bc-195e-4308-a7d0-db3c6e9616f8	11673-353	HUMAN OTC DRUG	up and up intensive healing		Hydrocortisone	LOTION	TOPICAL	20190123		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-360_b73a313e-65a8-4da6-90d5-f13b045b033f	11673-360	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20230801		OTC MONOGRAPH DRUG	M010	TARGET Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-365_4dabd87f-ffff-482d-8734-e87996262320	11673-365	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20130809		ANDA	ANDA091349	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-367_6f5a0e96-483b-4252-8b0c-9156638e0645	11673-367	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-368_774831af-e505-4072-bbdf-290b1633af4b	11673-368	HUMAN OTC DRUG	up and up naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20090624		ANDA	ANDA074661	Target Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-370_93e98c84-e678-4a73-ba6b-78a2f9830486	11673-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20121213		OTC MONOGRAPH NOT FINAL	part333A	Target Corp	ALCOHOL	70	mL/100mL			N	20241231
11673-372_f7875866-f0dd-4481-9324-18c90ba7072a	11673-372	HUMAN OTC DRUG	Digestive Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20180731		OTC MONOGRAPH FINAL	part335	TARGET Corporation	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11673-375_c9e6b82f-c816-41c6-aea9-83a4dc900d5f	11673-375	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	LIQUID	ORAL	20160731	20250731	OTC MONOGRAPH DRUG	M010	TARGET Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
11673-376_ae748513-77eb-4b67-8ed2-0545d779764c	11673-376	HUMAN OTC DRUG	Sore throat	cherry	Phenol	SPRAY	ORAL	20160630	20250630	OTC MONOGRAPH NOT FINAL	part356	TARGET Corporation	PHENOL	1.4	g/100mL			N	
11673-378_c5841915-a02c-4108-a0a8-b897084fda42	11673-378	HUMAN OTC DRUG	up and up aspirin		aspirin	TABLET, FILM COATED	ORAL	20210527		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11673-382_c92305f6-95e0-4762-b695-e1b8401bb1f4	11673-382	HUMAN OTC DRUG	up and up hair regrowth treatment for women		minoxidil	SOLUTION	TOPICAL	20210325		ANDA	ANDA075357	Target Corporation	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-388_ef48b4e5-65d3-4985-876c-7f385d887f7c	11673-388	HUMAN OTC DRUG	Up and Up allergy relief nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20161217		ANDA	ANDA207957	Target Corporation	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-390_d5571049-930f-4577-8af6-46795c523c79	11673-390	HUMAN OTC DRUG	Menstrual Relief		Acetaminophen, Caffeine and Pyrilamine maleate	TABLET, FILM COATED	ORAL	20190401		OTC MONOGRAPH DRUG	M013	Target Corporation	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20251231
11673-391_ad19abde-5cba-4cf6-8e37-d6a9ae3a84ff	11673-391	HUMAN OTC DRUG	Miconazole 3		Miconazole Nitrate	CREAM	VAGINAL	20050302		ANDA	ANDA076773	TARGET Corporation	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-392_c2df233f-cf65-436e-bfad-69e1decbd820	11673-392	HUMAN OTC DRUG	Hydrocortisone	with Aloe	Hydrocortisone	CREAM	TOPICAL	20201019		OTC MONOGRAPH NOT FINAL	part348	TARGET Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-393_48af14ab-f23b-4967-9a05-f4cd4fdd035c	11673-393	HUMAN OTC DRUG	Antibiotic Plus Pain Relief		Neomycin sulfate, Polymyxin B sulfate, and Pramoxine hydrochloride	CREAM	TOPICAL	20201016		OTC MONOGRAPH FINAL	part333B	TARGET Corporation	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11673-396_f6dde4d4-b09e-437a-a9f3-4abd7dd744f8	11673-396	HUMAN OTC DRUG	First Aid Antibiotic		Bacitracin Zinc	OINTMENT	TOPICAL	20201016		OTC MONOGRAPH FINAL	part333B	TARGET Corporation	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
11673-397_86d2fc65-c13e-6d7f-3e7e-dd15a610b8a7	11673-397	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium 20.6mg Capsules	CAPSULE, DELAYED RELEASE	ORAL	20160328		ANDA	ANDA078878	Target Corporation	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-398_b22fb4e2-7922-4056-b709-7160cf6748b8	11673-398	HUMAN OTC DRUG	Hydrocortisone	Intensive Healing Formula	Hydrocortisone	CREAM	TOPICAL	20201019		OTC MONOGRAPH NOT FINAL	part348	TARGET Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-399_f3635819-c9d7-4de3-b949-43ded2c6b8c9	11673-399	HUMAN OTC DRUG	Hydrocortisone	Plus 12 Moisturizers	Hydrocortisone	CREAM	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part348	TARGET Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-404_0152b374-4429-bacd-e063-6294a90afe35	11673-404	HUMAN OTC DRUG	up and up medicated wipes	manixim strength	gentle hemorrhoidal care	SWAB	TOPICAL	20150101		OTC MONOGRAPH FINAL	part346	Target Corporation	WITCH HAZEL	.5	g/g			N	20241231
11673-405_02de40e4-e6ba-4ff9-beee-3223fb893421	11673-405	HUMAN OTC DRUG	up and up antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20140608		OTC MONOGRAPH FINAL	part333B	Target Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11673-409_ec1d3c43-0046-7593-e053-2995a90afd8a	11673-409	HUMAN OTC DRUG	Up and up Oil-free Cleansing wipe	pink grapefruit	salicylic acid	CLOTH	TOPICAL	20170101		OTC MONOGRAPH FINAL	part333D	Target Corporation	SALICYLIC ACID	20	mg/mL			N	20241231
11673-410_d338d3a4-9d9f-4b13-829a-ba9a3cbd640b	11673-410	HUMAN OTC DRUG	Mucus Relief Severe Cold	Daytime Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20160831		OTC MONOGRAPH DRUG	M012	TARGET Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-411_9d5a6785-f69e-44cb-ac46-963116a3df79	11673-411	HUMAN OTC DRUG	up and up nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20170830		ANDA	ANDA206394	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-412_6a44e9ba-cb47-4cb7-a49f-f13c31398d25	11673-412	HUMAN OTC DRUG	Maximum Strength Cold Sore Treatment		camphor, menthol, phenol, white petrolatum	GEL	TOPICAL	20190627		OTC MONOGRAPH NOT FINAL	part333E	Target Corporation	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
11673-414_4ab1b57d-0782-4882-a144-3c96cfe05fad	11673-414	HUMAN OTC DRUG	up and up famotidine		famotidine	TABLET, FILM COATED	ORAL	20220125		ANDA	ANDA077351	Target Corporation	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11673-415_0c074f33-1142-c3d6-e063-6294a90aa992	11673-415	HUMAN OTC DRUG	extra strength gas relief simethicone 125 mg		extra strength gas relief simethicone 125 mg	CAPSULE, LIQUID FILLED	ORAL	20211118		OTC MONOGRAPH DRUG	M002	Target Corporation	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
11673-416_b9cb4738-56d5-499e-a622-d11a1b4ed53d	11673-416	HUMAN OTC DRUG	Up and Up aspirin		Aspirin	TABLET, FILM COATED	ORAL	20090610		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11673-420_0623f119-9ec6-4ec6-b834-fc54450f7ca6	11673-420	HUMAN OTC DRUG	Multi Symptom Cold and Multi Symptom Nighttime Cold	Childrens	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	KIT		20170228		OTC MONOGRAPH FINAL	part341	TARGET Corporation						N	20241231
11673-421_cfa9f9e7-abe4-4186-b86d-b3dbdc380b53	11673-421	HUMAN OTC DRUG	up and up mucus relief		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20200731		ANDA	ANDA078912	Target Corporation	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11673-422_bdb9c77a-e4d9-47ef-be15-9d385744fbe3	11673-422	HUMAN OTC DRUG	up and up nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20111006		ANDA	ANDA078326	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-424_2f7a7f71-b512-4e75-ac70-38fb9cc53ce8	11673-424	HUMAN OTC DRUG	Up and Up Nicotine		nicotine	LOZENGE	ORAL	20200507		ANDA	ANDA090821	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-426_68961590-7193-49d0-9084-a3482bd2123a	11673-426	HUMAN OTC DRUG	Up and up tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20090708		ANDA	ANDA075915	Target Corporation	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-430_27951c6f-9048-45ed-b304-768afaad35a1	11673-430	HUMAN OTC DRUG	Eye Allergy Relief		Pheniramine Maleate and Naphazoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20100831		NDA	NDA020065	Target Corporation	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.2675; 3.15	mg/mL; mg/mL			N	20241231
11673-431_2a3cf23f-f238-4722-8674-ac7e939de9d6	11673-431	HUMAN OTC DRUG	up and up hair regrowth treatment for women		Minoxidil	AEROSOL, FOAM	TOPICAL	20181230		ANDA	ANDA091344	Target Corporation	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-433_196901c0-9e01-4ee5-9482-68598faa87de	11673-433	HUMAN OTC DRUG	headache relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20190401		OTC MONOGRAPH DRUG	M013	Target Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11673-434_80dff5a1-d1b2-4c6b-a996-9409319e704e	11673-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Target Corporation	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11673-437_61f22a5a-85d6-4b69-9d08-6d97a6a2b07c	11673-437	HUMAN OTC DRUG	up and up acetaminophen pm	extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20090626		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-439_3d86d73e-f221-48b3-8de1-db464a099b26	11673-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20121213		OTC MONOGRAPH NOT FINAL	part333A	Target Corp	ALCOHOL	70	mL/100mL			N	20241231
11673-442_bf0c3842-c4d9-4f34-a425-17ed6832345a	11673-442	HUMAN OTC DRUG	Up and Up Nicotine Polacrilex		Nicotine polacrilex	GUM, CHEWING	ORAL	20130809		ANDA	ANDA091354	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-443_f39564d9-e244-799e-e053-2a95a90af3c3	11673-443	HUMAN OTC DRUG	Salicylic acid		Liquid Wart Remover	LIQUID	TOPICAL	20081231		OTC MONOGRAPH FINAL	part358B	Target Corporation	SALICYLIC ACID	2.1	g/14.7mL			N	20241231
11673-444_fadfceb0-2b86-4359-8a51-91473c8082b1	11673-444	HUMAN OTC DRUG	up and up acetaminophen		Acetaminophen	TABLET	ORAL	20140820		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	325	mg/1			N	20241231
11673-453_748e58cb-9367-4b7a-baa4-7545e138d707	11673-453	HUMAN OTC DRUG	sinus PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210617		OTC MONOGRAPH DRUG	M012	Target Corporation	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-456_71e79a44-f217-446f-b046-e02aca432e40	11673-456	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20090701		ANDA	ANDA076777	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-460_b6415d4e-7448-4a79-ba0f-af7aa244adfa	11673-460	HUMAN OTC DRUG	Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	LIQUID	ORAL	20160831	20250831	OTC MONOGRAPH DRUG	M012	TARGET Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
11673-462_e5d553df-3a06-4b9d-ba49-c5222d55f69f	11673-462	HUMAN OTC DRUG	up and up allergy relief		diphenhydramine hydrochloride	CAPSULE	ORAL	20090610		OTC MONOGRAPH FINAL	part341	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-463_73cd6cb6-e960-4ba4-b2b0-2cf6224a1e6e	11673-463	HUMAN OTC DRUG	DayTime Mucus Relief Severe Cold and Nighttime Cold and Flu	Maximum Strength	Daytime Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, NightTime Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	KIT		20180111		OTC MONOGRAPH FINAL	part341	TARGET Corporation						N	20241231
11673-466_b3045dfa-ae6b-4822-8ae4-a7b584f07103	11673-466	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160217		OTC MONOGRAPH NOT FINAL	part333A	Target Corp.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11673-475_253a97bc-9c03-4b7b-94d5-8362367e1c06	11673-475	HUMAN OTC DRUG	Up and Up Childrens Allergy Relief		Cetirizine HCl	SOLUTION	ORAL	20151015		ANDA	ANDA204226	Target Corporation	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-482_07a3fd78-779d-4a1b-a8e5-d2119592335a	11673-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20120309		OTC MONOGRAPH FINAL	part355	Target Corporation	SODIUM FLUORIDE	.1	mg/mL			N	20241231
11673-484_d1b0efb5-ef4f-48d9-bb7c-07d41d18bca4	11673-484	HUMAN OTC DRUG	up and up acetaminophen	extra strength	Acetaminophen	TABLET	ORAL	20091202		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
11673-487_ab40717d-0262-4e5e-8938-4a099781ab18	11673-487	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	TARGET CORPORATION	ALCOHOL	62	mL/100mL			N	20241231
11673-494_085d79ef-5e52-fac1-e063-6394a90a5f60	11673-494	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET	ORAL	20231020		OTC MONOGRAPH DRUG	M012	TARGET CORPORATION	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-495_ffcc6f5e-a051-82f2-e053-6294a90a5d67	11673-495	HUMAN OTC DRUG	Extra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230701		OTC MONOGRAPH FINAL	M002	TARGET CORPORATION	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
11673-500_8aebb3d7-77bc-42d0-80e0-876e73f36b90	11673-500	HUMAN OTC DRUG	up and up nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20150310		OTC MONOGRAPH FINAL	part341	Target Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-501_02b8d0fc-00f9-6dbf-e063-6294a90a7cee	11673-501	HUMAN OTC DRUG	Medicated Chest Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20230901		OTC MONOGRAPH FINAL	part341	TARGET CORPORATION	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
11673-502_06c28497-6be4-490e-88f8-8b2a4a1776d2	11673-502	HUMAN OTC DRUG	Up and Up Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20141217		ANDA	ANDA078336	Target Corporation	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-504_9b77d64e-6226-4251-baa4-21f0eade6c36	11673-504	HUMAN OTC DRUG	Up and Up Jock Itch Relief		Clotrimazole	CREAM	TOPICAL	20130917		OTC MONOGRAPH FINAL	part333C	Target Corporation	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-509_b9e82afd-633d-4038-a195-7b7794df4e6c	11673-509	HUMAN OTC DRUG	Target	Fiber Laxative	Psyllium Husk	CAPSULE	ORAL	20190416		OTC MONOGRAPH DRUG	M007	TARGET CORPORATION	PSYLLIUM HUSK	.52	g/1			N	20241231
11673-510_f37fea91-1dcd-5fef-e053-2a95a90a3fc6	11673-510	HUMAN OTC DRUG	Maximum Strength Medicated Foot Powder		Medicated Foot Powder	POWDER	TOPICAL	20130430		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	MENTHOL	.1	g/g			N	20241231
11673-511_f396dd27-ef79-b6af-e053-2995a90a88c4	11673-511	HUMAN OTC DRUG	Menthol		Maximum Strength Medicated Foot Powder Talc Free	POWDER	TOPICAL	20171127		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	MENTHOL	2.8	g/283g			N	20241231
11673-514_2eb3a00e-a0e2-4a19-bbf8-9d093a8a0b50	11673-514	HUMAN OTC DRUG	up and up ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20181228		ANDA	ANDA203599	Target Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-515_c28f2aa2-82d0-4fbe-8341-ab8a25526293	11673-515	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	TARGET CORPORATION	ALCOHOL	62	mL/100mL			N	20241231
11673-517_6b830c1a-68dd-47a7-b016-2ad5af900ecf	11673-517	HUMAN OTC DRUG	up and up ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090610		ANDA	ANDA077349	Target Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-518_91327cbb-e5e1-427e-85ac-e8ec87e7b4ff	11673-518	HUMAN OTC DRUG	Daytime Mucus Relief Severe Cold Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20180531	20250530	OTC MONOGRAPH FINAL	part341	TARGET Corporation						N	
11673-519_c1f8f256-31bd-4132-992d-1979b3c66fdc	11673-519	HUMAN OTC DRUG	acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	Target Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
11673-532_133cfe85-329a-471a-9632-375c9ed5a29e	11673-532	HUMAN OTC DRUG	Up and Up nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20090709		ANDA	ANDA076779	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-542_62eec235-431f-4429-b173-d4a9b45a4e36	11673-542	HUMAN OTC DRUG	daytime severe cold and cough and nighttime severe cold and cough		Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Phenylephrine HCl	KIT		20170731		OTC MONOGRAPH FINAL	part341	Target Corporation						N	20241231
11673-550_1423c49e-007d-409c-b8ff-6f883c6aebaa	11673-550	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20130830		OTC MONOGRAPH DRUG	M002	Target Corporation	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
11673-558_81234385-53e1-41a6-9d90-6127532cc61f	11673-558	HUMAN OTC DRUG	up and up childrens allergy relief		Loratadine	SOLUTION	ORAL	20180605		ANDA	ANDA075728	Target Corporation	LORATADINE	5	mg/5mL			N	20241231
11673-562_bc1dbe4c-8a41-4547-9915-21238a5914fe	11673-562	HUMAN OTC DRUG	Up and Up multi action antibiotic		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20170511		OTC MONOGRAPH FINAL	part333B	Target Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11673-569_e30d7c79-8ef9-44fb-9c2c-31ed738b73a6	11673-569	HUMAN OTC DRUG	up and up arthritis pain reliever		diclofenac sodium	GEL	TOPICAL	20200819		ANDA	ANDA211253	Target Corporation	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-573_25db2db7-6ccc-4625-8eb9-ff98cceb264d	11673-573	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	TARGET CORPORATION	ALCOHOL	62	mL/100mL			N	20241231
11673-577_d92970b8-25ac-451e-b705-b508ce849064	11673-577	HUMAN OTC DRUG	Antibacterial		Benzalkonium chloride	SOAP	TOPICAL	20180426		OTC MONOGRAPH NOT FINAL	part333A	TARGET CORPORATION	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11673-581_52543c33-56f1-4fea-a28f-869bb9ed8784	11673-581	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	19981208		OTC MONOGRAPH FINAL	part358H	Target Corporation	PYRITHIONE ZINC	14	mg/mL			N	20241231
11673-586_f31e50dd-a8af-0533-e053-2995a90a63c2	11673-586	HUMAN OTC DRUG	Tolnaftate		Antifungal Powder Spray with Baking Soda	AEROSOL, POWDER	TOPICAL	20081231		OTC MONOGRAPH FINAL	part333C	Target Corporation	TOLNAFTATE	1.1	g/113.3g			N	20241231
11673-593_68083817-8197-480f-871f-c7129dc1decb	11673-593	HUMAN OTC DRUG	Up and Up Childrens Ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190731		ANDA	ANDA076359	Target Corporation	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-597_cf587673-375f-46e8-82d2-db1f2c470e1f	11673-597	HUMAN OTC DRUG	Up and Up severe cold and flu		acetaminophen, dextromethorphan HBr, doxylamine succinate, guaifenesin, phenylephrine HCl	KIT		20160719		OTC MONOGRAPH FINAL	part341	Target Corporation						N	20241231
11673-602_15a18cee-9bad-42bf-aa4f-e954f667e010	11673-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	19961212		OTC MONOGRAPH NOT FINAL	part334	Target Corporation	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-604_61e428bf-96ad-4d79-8ad9-355232f7bcc4	11673-604	HUMAN OTC DRUG	up and up ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090528		ANDA	ANDA072096	Target Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-605_089948f1-8e84-3775-e063-6294a90a05e2	11673-605	HUMAN OTC DRUG	RASPBERRY SCENTED HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20191230		OTC MONOGRAPH DRUG	505G(a)(3)	Target Brands,Inc.	ALCOHOL	620	mg/g			N	20241231
11673-606_08996332-bbbd-0192-e063-6294a90a4692	11673-606	HUMAN OTC DRUG	ROSE SCENTED HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20191230		OTC MONOGRAPH DRUG	505G(a)(3)	Target Brands,Inc.	ALCOHOL	620	mg/g			N	20241231
11673-607_089971c6-98bd-a75b-e063-6394a90a6a84	11673-607	HUMAN OTC DRUG	WATERMELON MANGO SCENTED HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20191230		OTC MONOGRAPH DRUG	505G(a)(3)	Target Brands,Inc.	ALCOHOL	620	mg/g			N	20241231
11673-610_3e1c9724-9f3d-4cf1-9254-a53f43bb5c67	11673-610	HUMAN OTC DRUG	up and up extra strength gas relief chewables	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20150916		OTC MONOGRAPH DRUG	M002	Target Corporation	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
11673-612_a136b013-3a10-444a-8a58-36af71f0aa72	11673-612	HUMAN OTC DRUG	up and up allergy relief		Loratadine	TABLET	ORAL	20120326		ANDA	ANDA076301	Target Corporation	LORATADINE	10	mg/1			N	20241231
11673-617_642da0b5-69e6-4219-ae21-a5443b5fba2c	11673-617	HUMAN OTC DRUG	up and up allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20210917		ANDA	ANDA212971	Target Corporation	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-618_e2b53c29-79b0-4335-816e-653c133feb4e	11673-618	HUMAN OTC DRUG	Up and Up acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170302		ANDA	ANDA075077	Target Corporation	ACETAMINOPHEN	650	mg/1			N	20241231
11673-620_bbf7b984-6389-46c2-84c4-aa77ff605dd4	11673-620	HUMAN OTC DRUG	up and up fiber therapy		Calcium polycarbophil	TABLET	ORAL	20151014		OTC MONOGRAPH DRUG	M007	Target Corporation.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
11673-622_0230b483-85a1-4568-bfc3-cdf8f2541f5e	11673-622	HUMAN OTC DRUG	Up and Up itch relief		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20091130		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-624_f2c0f9e5-61bd-4fb0-a29e-d358609c9270	11673-624	HUMAN OTC DRUG	up and up extra strength smooth dissolving antacid	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20170710		OTC MONOGRAPH FINAL	part331	Target corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
11673-625_68690f91-d89c-42ce-b298-e96ab31b2641	11673-625	HUMAN OTC DRUG	up and up extra strength smooth dissolving antacid	Assorted berry	Antacid Tablets	TABLET, CHEWABLE	ORAL	20170612		OTC MONOGRAPH DRUG	M001	Target Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-627_ed02b906-c131-4b67-88a6-df22fbe16ae7	11673-627	HUMAN OTC DRUG	up and up cough plus chest congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180823		OTC MONOGRAPH FINAL	part341	Target Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-629_f31e5472-7f89-0f42-e053-2995a90a19b3	11673-629	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171201		OTC MONOGRAPH NOT FINAL	part333A	Target Corporation	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/10mL; mg/10mL			N	20241231
11673-630_f3953452-2bb3-9c96-e053-2a95a90aed50	11673-630	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20181014		OTC MONOGRAPH FINAL	part358F	Target Corporation	SALICYLIC ACID	40	mg/91			N	20241231
11673-632_c1dd127c-623a-4be3-b976-0099ab0ebe13	11673-632	HUMAN OTC DRUG	up and up hair regrowth treatment for men		Minoxidil	SOLUTION	TOPICAL	20150729		ANDA	ANDA075598	Target Corporation	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-633_96b5a73d-4b1c-4845-9577-6549ca50ea44	11673-633	HUMAN OTC DRUG	antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part333A	Target Corp	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
11673-635_f3969c77-94b1-c020-e053-2a95a90a6705	11673-635	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus Spray	AEROSOL, SPRAY	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11673-637_8a88acf7-bbd5-4faf-956d-bf62204c6eff	11673-637	HUMAN OTC DRUG	up and up antacid anti gas		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	20170831		OTC MONOGRAPH FINAL	part331	Target Corporation	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-646_162f774a-dcd5-4138-ad34-2eac58a32998	11673-646	HUMAN OTC DRUG	up and up anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20190314		ANDA	ANDA209837	Target Corporation	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
11673-647_d6eefb76-853a-48d5-ab95-68be4524dedd	11673-647	HUMAN OTC DRUG	up and up ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090528		ANDA	ANDA072096	Target Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-660_2c924511-2456-4c2f-acaa-0a2a92569f62	11673-660	HUMAN OTC DRUG	up and up childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20090708		ANDA	ANDA074937	Target Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-661_96ed0920-7937-41db-a7cb-72e66a4bc7d9	11673-661	HUMAN OTC DRUG	vapor chill cold and flu	daytime/nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Guaifenesin, Phenylephrine HCl	KIT		20201222	20240304	OTC MONOGRAPH FINAL	part341	Target Corporation						N	
11673-663_7128da29-d03b-43e5-a913-1c9f14f4f68f	11673-663	HUMAN OTC DRUG	Crisp Apple Hand Sani		Ethyl Alcohol	LIQUID	TOPICAL	20141005		OTC MONOGRAPH NOT FINAL	part333A	Target Corporation	ALCOHOL	65	mL/100mL			N	20241231
11673-664_7c9eb62a-e0c3-4b02-aafe-053ecc414f36	11673-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19930811		OTC MONOGRAPH DRUG	M505G(a)(3)	Target Corporation	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11673-667_6477a1d8-b18b-4b75-8624-15810bb34cae	11673-667	HUMAN OTC DRUG	cough suppressant and topical analgesic		Camphor, Eucalyptus oil, Menthol	OINTMENT	TOPICAL	20090127		OTC MONOGRAPH FINAL	part341	Target Corporation	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
11673-668_e2866c25-5833-4fca-9e1f-ed23f70fa8c6	11673-668	HUMAN OTC DRUG	up and up fiber therapy	Natural Fiber	Psyllium Husk	POWDER	ORAL	20151026		OTC MONOGRAPH DRUG	M007	Target Corporation	PSYLLIUM HUSK	3.4	g/12g			N	20241231
11673-669_848c410a-6252-4500-83b6-9d80ae8aeb3e	11673-669	HUMAN OTC DRUG	up and up fiber therapy		Psyllium Husk	POWDER	ORAL	20151026		OTC MONOGRAPH DRUG	M007	Target Corporation	PSYLLIUM HUSK	3.4	g/5.79g			N	20241231
11673-669_eddf2c21-03cb-43ad-a802-af3b81dbf4a4	11673-669	HUMAN OTC DRUG	up and up fiber therapy		Psyllium Husk	POWDER	ORAL	20180315		OTC MONOGRAPH DRUG	M007	TARGET CORPORATION	PSYLLIUM HUSK	3.4	g/5.79g			N	20241231
11673-673_ee861900-0c70-68e7-e053-2a95a90abd70	11673-673	HUMAN OTC DRUG	Arthritis Pain Acetaminophen		Acetaminophen	TABLET	ORAL	20211217		ANDA	ANDA215486	TARGET CORPORATION	ACETAMINOPHEN	650	mg/1			N	20241231
11673-678_33fb795a-b259-4f28-8637-d31d503ce758	11673-678	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831		OTC MONOGRAPH DRUG	M007	TARGET Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11673-683_0e082f03-459c-4639-e063-6294a90a6689	11673-683	HUMAN OTC DRUG	Ibuprofen Mini		Ibuprofen Mini 200 mg	CAPSULE, LIQUID FILLED	ORAL	20211217		ANDA	ANDA079205	TARGET CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
11673-685_b99f3447-0a91-4118-92f1-e6fd3f0c9a27	11673-685	HUMAN OTC DRUG	up and up ibuprofen		Ibuprofen	SUSPENSION	ORAL	20090710		ANDA	ANDA074937	Target Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-686_2e6b91c6-6181-4068-b19c-18518061e0ac	11673-686	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20180131		OTC MONOGRAPH NOT FINAL	part343	TARGET Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11673-687_acc73e3b-e73d-4de2-9eb2-f18d32e9d656	11673-687	HUMAN OTC DRUG	up and up naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20220125		ANDA	ANDA208499	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-688_2483d7cd-1ae5-7555-7d32-7561c07f163b	11673-688	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210916		ANDA	ANDA209752	Target Corporation	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
11673-689_e3ea579d-219f-c33e-5e0a-dceec29b41c7	11673-689	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic Solution	SOLUTION/ DROPS	OPHTHALMIC	20211022		ANDA	ANDA209619	Target Corporation	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
11673-690_74960e68-ce98-4953-a20b-fca03be56366	11673-690	HUMAN OTC DRUG	up and up allergy relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20090612		OTC MONOGRAPH FINAL	part341	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-694_830fbf3c-86ee-406b-8339-6158b70bfab5	11673-694	HUMAN OTC DRUG	Daytime Sinus Nighttime Sinus	Maximum Strength	acetaminophen, diphenhydramine HCl, guaifenesin, phenylephrine HCl	KIT		20170701		OTC MONOGRAPH DRUG	M012	Target Corporation						N	20241231
11673-698_d8c4205a-50fb-4b94-b066-e15c3f5deae0	11673-698	HUMAN OTC DRUG	Target Overnight Cold and Flu		Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20200401		OTC MONOGRAPH DRUG	M012	TARGET CORPORATION	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-699_8e567635-6c3e-4d39-a0b2-c92a0c39fac9	11673-699	HUMAN OTC DRUG	extra strength	Tropical Fruit	Antacid	TABLET, CHEWABLE	ORAL	20191111		OTC MONOGRAPH DRUG	M001	Target Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-702_0babd00a-7770-4b51-bba9-7f31c8366b7c	11673-702	HUMAN OTC DRUG	up and up chewable aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20150909		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11673-705_222512df-3f16-4cb5-ae1c-b554a7fc592e	11673-705	HUMAN OTC DRUG	up and up allergy relief		cetirizine Hydrochloride	SOLUTION	ORAL	20141223		ANDA	ANDA090254	Target Corporation	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-706_09d5231d-12d3-48bb-b464-aa602125232d	11673-706	HUMAN OTC DRUG	up and up digestive relief		Bismuth subsalicylate	SUSPENSION	ORAL	20180315		OTC MONOGRAPH DRUG	M008	Target Corporation	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11673-707_fdc22b16-1afd-4bbc-9ff7-aa85523fc07f	11673-707	HUMAN OTC DRUG	up and up hair regrowth treatment for men		Minoxidil	AEROSOL, FOAM	TOPICAL	20150814		ANDA	ANDA091344	Target Corporation	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-708_dbec5f46-bf91-48a7-b511-e26e2b92e0bd	11673-708	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Target Corp	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11673-713_d2470a60-6a7f-417f-aee7-9485bd1d6700	11673-713	HUMAN OTC DRUG	up and up nighttime sleep aid		diphenhydramine hcl	CAPSULE, LIQUID FILLED	ORAL	20180605		OTC MONOGRAPH FINAL	part338	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-715_31ed359d-468a-41bf-8bff-5384313d4f18	11673-715	HUMAN OTC DRUG	up and up extra strength smooth dissolving antacid	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190410		OTC MONOGRAPH DRUG	M001	Target corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-716_9548ce2c-36ff-47b0-b3e3-c07a6166724d	11673-716	HUMAN OTC DRUG	up and up mucus relief dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190715		ANDA	ANDA207602	Target Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-717_ee398bcc-791d-486e-bfe3-308988673241	11673-717	HUMAN OTC DRUG	Up and Up Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170118		ANDA	ANDA078104	Target Corporation	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-719_535f14ed-a8a1-4814-9e40-8d54a5c61680	11673-719	HUMAN OTC DRUG	up and up nighttime cough control dm max		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20180926		OTC MONOGRAPH FINAL	part341	Target Corporation	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-721_7764c389-89ca-481a-a21c-e77654a0998a	11673-721	HUMAN OTC DRUG	Target Vitamin A and D Diaper Rash		Vitamin A and D Ointment	OINTMENT	TOPICAL	20220531		OTC MONOGRAPH FINAL	part347	Target Corporation	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
11673-724_0f5dce04-cffd-4aea-bb51-2cce10719e37	11673-724	HUMAN OTC DRUG	Digestive Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20190930		OTC MONOGRAPH FINAL	part335	TARGET Corporation	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11673-725_50f4be79-6dda-4b5a-8966-ecf8b83f8094	11673-725	HUMAN OTC DRUG	Target Advanced Scar Gel		Advanced Scar Gel	GEL	TOPICAL	20200815		OTC MONOGRAPH FINAL	part347	Target Corporation	ALLANTOIN	5	mg/g			N	20241231
11673-727_166bb119-c8ff-4126-891c-45df30da4c8b	11673-727	HUMAN OTC DRUG	Up and Up Nicotine		nicotine	LOZENGE	ORAL	20200910		ANDA	ANDA090821	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-728_0fd3ac70-b2ee-4514-8dc1-dbf2c941009e	11673-728	HUMAN OTC DRUG	Target Maximum Strength Zinc Oxide Diaper Rash		Zinc Oxide Diaper Rash	PASTE	TOPICAL	20220531		OTC MONOGRAPH FINAL	part347	Target Corporation	ZINC OXIDE	400	mg/g			N	20241231
11673-729_dc2257df-3e12-4007-9071-8ef2d522c342	11673-729	HUMAN OTC DRUG	Target Baby Healing		Petrolatum	OINTMENT	TOPICAL	20220531		OTC MONOGRAPH FINAL	part347	Target Corporation	PETROLATUM	410	mg/g			N	20241231
11673-731_b1c80af5-0e18-4d85-bf7d-1933a1a03cc3	11673-731	HUMAN OTC DRUG	Mucus Relief Extended-Release		Guaifenesin	TABLET	ORAL	20180711		ANDA	ANDA207342	TARGET Corporation	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11673-732_0624fe9f-c5f8-4fd0-becf-0efde9821b5f	11673-732	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180711		ANDA	ANDA207342	TARGET Corporation	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11673-733_58885bdd-c17c-4bcc-bafe-d0cdb1ab4bb0	11673-733	HUMAN OTC DRUG	Up and Up Cold Flu Relief Day Night		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20140818		OTC MONOGRAPH FINAL	part341	Target Corporation						N	20241231
11673-734_09fba2cc-0082-4de3-9081-57feabcccffb	11673-734	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130313		ANDA	ANDA203690	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-737_9c9ac383-7da3-4d22-bf51-c1468a17443b	11673-737	HUMAN OTC DRUG	Up and Up Miconazole 1		Miconazole nitrate	KIT		20170125		ANDA	ANDA079114	Target Corporation						N	20241231
11673-738_6daebd2e-5054-42a9-8221-40b9cbd9bcbc	11673-738	HUMAN OTC DRUG	Up and Up maximum Strength fast mucus relief	Severe Congestion and Cough	dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20151110		OTC MONOGRAPH DRUG	M012	Target Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-741_547be9aa-cf0b-4d2f-96da-7629b3af2d35	11673-741	HUMAN OTC DRUG	Up and Up Childrens Ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190805		ANDA	ANDA076359	Target Corporation	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-744_4a05261b-af63-46d1-a8b5-ec176ca1eba8	11673-744	HUMAN OTC DRUG	up and up lidocaine pain relief		lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20190715		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	LIDOCAINE	560	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11673-745_b70a1066-9e72-45dc-b59e-c8ae881448f1	11673-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131	20250530	ANDA	ANDA206568	TARGET Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
11673-748_eb7741d5-45f4-4e2b-9ece-ad97b28e30e6	11673-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	TARGET Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-749_301c51dc-c546-46bc-828b-0fb99ab1b53f	11673-749	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131	20250530	ANDA	ANDA206568	TARGET Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
11673-750_978db20b-a19e-4f1f-b93a-21f210dc08a8	11673-750	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	LIQUID	ORAL	20231031		OTC MONOGRAPH DRUG	M010	TARGET Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-753_9da1f84a-01be-47b4-8ab6-e5b05aa2045e	11673-753	HUMAN OTC DRUG	Up and Up Esomeprazole Magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200313		ANDA	ANDA207193	Target Corporation	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-754_0e61a219-3f16-4693-b6a1-6957237c083d	11673-754	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20230801		OTC MONOGRAPH DRUG	M013	TARGET Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-756_895f988d-e624-440a-8863-9c4e060fa15b	11673-756	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20180331	20250331	ANDA	ANDA200888	TARGET Corporation	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
11673-759_a478f793-45a6-45fa-a505-10fdbda1c8f0	11673-759	HUMAN OTC DRUG	up and up childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20110716		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11673-761_507a908b-246f-4d59-a27c-69db98e0218a	11673-761	HUMAN OTC DRUG	Ear Wax Removal Drops	Up and Up	Carbamide Peroxide - 6.5%	SOLUTION/ DROPS	TOPICAL	20230101		OTC MONOGRAPH FINAL	part344	Target Corporation	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
11673-763_3eb8cd3a-6c86-4ef0-98a3-095375bd17a6	11673-763	HUMAN OTC DRUG	up and up nighttime severe cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride	SOLUTION	ORAL	20200317		OTC MONOGRAPH FINAL	part341	Target Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-768_089955fe-6f6d-fb63-e063-6294a90a84fa	11673-768	HUMAN OTC DRUG	Watermelon Wonder Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200206		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-769_435fa4c4-3a68-4fd5-a163-3b9e5f4bdb3a	11673-769	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	TARGET Corporation	DOCOSANOL	100	mg/g			N	20241231
11673-773_9910af2d-960e-47f8-933b-42498e130a5a	11673-773	HUMAN OTC DRUG	Target Maximum Strength Cold Flu and Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20200402		OTC MONOGRAPH DRUG	M012	TARGET CORPORATION	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-775_fa70cdcd-a028-4f66-af1f-4c485f6ab3ba	11673-775	HUMAN OTC DRUG	Target Cough plus Chest Congestion DM Max	with Honey	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20200330		OTC MONOGRAPH DRUG	M012	TARGET CORPORATION	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-779_f440fed3-da38-4c5a-a153-8af827c86607	11673-779	HUMAN OTC DRUG	Cold and Flu	Daytime Nighttime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, Triprolidine HCl	KIT		20220517		OTC MONOGRAPH DRUG	M012	Target Corporation						N	20241231
11673-780_0899084d-01cc-7d6c-e063-6294a90af73b	11673-780	HUMAN OTC DRUG	COCONUT MACAROON HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-781_0898fd2d-6e2e-2864-e063-6394a90ad685	11673-781	HUMAN OTC DRUG	PEPPERMINT TWIST HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-782_0899102b-2f94-acce-e063-6394a90a2256	11673-782	HUMAN OTC DRUG	SPARKLING CRANBERRY HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-783_0899084d-01db-7d6c-e063-6294a90af73b	11673-783	HUMAN OTC DRUG	SUGARED LEMON HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-784_089922f1-affd-4d5a-e063-6294a90ac757	11673-784	HUMAN OTC DRUG	VANILLA SUGAR COOKIE HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-785_089943fb-e995-3c59-e063-6294a90a2690	11673-785	HUMAN OTC DRUG	berries and cream hand sanitizer		ALCOHOL	GEL	TOPICAL	20201114		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	.62	mL/mL			N	20241231
11673-789_8f9abd42-2bb5-4fb8-9944-7524a941e7a4	11673-789	HUMAN OTC DRUG	up and up nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230719		OTC MONOGRAPH FINAL	part341	Target Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-793_9e7d903c-4d6f-4fa0-ad78-4812143e688a	11673-793	HUMAN OTC DRUG	Ear Wax Removal Aid Drops		Carbamide peroxide	LIQUID	AURICULAR (OTIC)	20190205		OTC MONOGRAPH DRUG	M022	Target Corporation	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
11673-795_ca38d674-f93c-489b-b4ff-6fd11fb23428	11673-795	HUMAN OTC DRUG	Pain Relieving Cleansing		Benzalkonium Chloride, Lidocaine HCl	SPRAY	TOPICAL	20200310		OTC MONOGRAPH DRUG	M015	TARGET CORPORATION	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 2.5	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11673-798_0603a8d1-b2e4-48e9-81e8-ad5563a3ef7e	11673-798	HUMAN OTC DRUG	up and up hair regrowth treatment for men		Minoxidil	SOLUTION	TOPICAL	20210603		ANDA	ANDA075598	Target Corporation	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-802_b4a22392-d189-4d66-a253-59256d6ec4cf	11673-802	HUMAN OTC DRUG	up and up acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20210805		OTC MONOGRAPH NOT FINAL	part343	Target Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
11673-804_c8238676-5161-4a47-ace9-1a6f131b9174	11673-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19961212		OTC MONOGRAPH NOT FINAL	part333A	Target Corp	ISOPROPYL ALCOHOL	.91	mg/mL			N	20241231
11673-810_919a36ec-0c7a-47dc-b927-c6ce2cafe8b9	11673-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Target Corp.,	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
11673-813_ac07a7ea-3696-4e06-92fa-243e767eedc4	11673-813	HUMAN OTC DRUG	ultra strength antacid	Peppermint Flavored	Calciium carbonate	TABLET, CHEWABLE	ORAL	20180315		OTC MONOGRAPH DRUG	M001	Target Corporation	CALCIUM CARBONATE	1000	mg/1			N	20241231
11673-814_0f53b51c-6a4e-4004-a53e-423606ec04df	11673-814	HUMAN OTC DRUG	Extra Strength	Antacid	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20190829		OTC MONOGRAPH DRUG	M001	TARGET CORPORATION	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
11673-817_7895d644-3420-47c7-a7c6-88ba8d03f769	11673-817	HUMAN OTC DRUG	childrens allergy relief	dye-free	Diphenhydramine HCl	SOLUTION	ORAL	20180311		OTC MONOGRAPH DRUG	M012	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-821_95abd6e7-cac3-4eff-8acb-2c580a62598f	11673-821	HUMAN OTC DRUG	up and up daytime vapor ice cold and flu nighttime vapor ice cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20190815		OTC MONOGRAPH FINAL	part341	Target Corporation						N	20241231
11673-822_b7b722bf-281e-47f8-a0bb-19fe8d6f0ff3	11673-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	19980129		OTC MONOGRAPH FINAL	part347	Target Corporation	WITCH HAZEL	86	kg/100L			N	20241231
11673-825_1a673c72-8de9-4061-9644-fdf46046699c	11673-825	HUMAN OTC DRUG	up and up miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20090826		ANDA	ANDA074760	Target Corporation	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-826_d0abe72f-e014-4306-ad9c-991f6e3d9e67	11673-826	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201013		OTC MONOGRAPH NOT FINAL	part333A	Target	ALCOHOL	62	mL/100mL			N	20241231
11673-827_03bce376-92ca-ad67-e063-6294a90af5d0	11673-827	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230823		OTC MONOGRAPH FINAL	M002	TARGET CORPORATION	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
11673-831_10103fda-1ef9-4fc1-8dc6-f91bec8dc4e3	11673-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	19961212		OTC MONOGRAPH NOT FINAL	part334	Target Corp	MINERAL OIL	999	mg/mL			N	20241231
11673-833_7f9325ab-5936-4883-b649-9748009f287f	11673-833	HUMAN OTC DRUG	Mucus Relief DM Extended Release		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190101	20250530	ANDA	ANDA209692	TARGET Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
11673-837_98aa0a3f-d3da-49bc-8a16-b323920dd00e	11673-837	HUMAN OTC DRUG	Up and Up Daytime Severe Cold Nighttime Cold and Flu		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl, diphenhydramine HCl	KIT		20150325		OTC MONOGRAPH FINAL	part341	Target Corporation						N	20241231
11673-838_926ea6df-786b-18bf-e053-2995a90a0ab2	11673-838	HUMAN OTC DRUG	acetaminophen		acetaminophen	TABLET, COATED	ORAL	20200101		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ACETAMINOPHEN	500	mg/1			N	20241231
11673-839_92adcc61-ef65-0ca8-e053-2995a90a06b2	11673-839	HUMAN OTC DRUG	TENSION HEADACHE RELIEF		ACETAMINOPHEN-CAFFEINE	TABLET, COATED	ORAL	20200204		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
11673-841_926fff4e-7315-67cd-e053-2a95a90a4ff3	11673-841	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, COATED	ORAL	20200101		OTC MONOGRAPH NOT FINAL	part343	TARGET CORPORATION	ACETAMINOPHEN	325	mg/1			N	20241231
11673-842_951f4aca-0254-46b9-af85-e1dd8c2efc02	11673-842	HUMAN OTC DRUG	up and up hydrocortisone anti itch		hydrocortisone	CREAM	TOPICAL	20200214		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11673-845_90e35dc5-4b05-4711-b764-ca30c5ce5f03	11673-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20070314		OTC MONOGRAPH FINAL	part344	Target Corporation	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
11673-846_27b35476-861d-4f31-8ba7-925ec4c8d935	11673-846	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20210701		ANDA	ANDA208754	TARGET Corporation	DOCOSANOL	100	mg/g			N	20241231
11673-847_2d580d41-e218-bd1d-84ab-244af7d3b5c3	11673-847	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20181231		ANDA	ANDA210375	Target Corporation	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-849_966ad0ca-b455-fe60-7fa5-e250d75e64ce	11673-849	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET, COATED	ORAL	20190315		ANDA	ANDA078192	Target Corporation	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11673-850_22817ae0-5ac4-4e69-9029-57e7429e1096	11673-850	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180731	20250731	ANDA	ANDA206999	TARGET Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
11673-853_5e6be22f-5159-43d8-969a-3a08534ad4f7	11673-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210129		OTC MONOGRAPH NOT FINAL	part334	TARGET Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11673-857_caaa6b79-98a1-4f9c-ba46-ff1474d09328	11673-857	HUMAN OTC DRUG	up and up athletes foot		Clotrimazole	CREAM	TOPICAL	20170606		OTC MONOGRAPH FINAL	part333C	Target Corporation	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-858_bd87fad3-ede7-4576-b8f8-6d67e89b93ba	11673-858	HUMAN OTC DRUG	up and up mini nicotine		nicotine polacrilex	LOZENGE	ORAL	20200829		ANDA	ANDA203690	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-860_08996332-bbca-0192-e063-6294a90a4692	11673-860	HUMAN OTC DRUG	black cherry champ hand sanitizer		ALCOHOL	GEL	TOPICAL	20190507		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-861_08996402-654d-a52c-e063-6294a90afcd7	11673-861	HUMAN OTC DRUG	lavender life hand sanitizer		ALCOHOL	GEL	TOPICAL	20190507		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-862_08997fee-21ae-58ff-e063-6294a90a66a3	11673-862	HUMAN OTC DRUG	lemon love hand sanitizer		ALCOHOL	GEL	TOPICAL	20190507		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-863_08996332-bbd9-0192-e063-6294a90a4692	11673-863	HUMAN OTC DRUG	melon mango melt hand sanitizer		ALCOHOL	GEL	TOPICAL	20190507		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/mL			N	20241231
11673-864_08997bd4-d6bc-fffc-e063-6294a90a77ae	11673-864	HUMAN OTC DRUG	sweet stardust hand sanitizer		ALCOHOL	GEL	TOPICAL	20190507		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-865_089971c6-98cb-a75b-e063-6394a90a6a84	11673-865	HUMAN OTC DRUG	rose rush hand sanitizer		ALCOHOL	GEL	TOPICAL	20190507		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-867_0899754e-fc23-0c22-e063-6394a90adf3b	11673-867	HUMAN OTC DRUG	blue raspberry radiance hand sanitizer		ALCOHOL	GEL	TOPICAL	20190507		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-868_089971c6-98d8-a75b-e063-6394a90a6a84	11673-868	HUMAN OTC DRUG	gumdrop glitz hand sanitizer		ALCOHOL	GEL	TOPICAL	20190815		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-869_08996332-bc02-0192-e063-6294a90a4692	11673-869	HUMAN OTC DRUG	cranberry chill hand sanitizer		ALCOHOL	GEL	TOPICAL	20190815		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-870_0899754e-fc3e-0c22-e063-6394a90adf3b	11673-870	HUMAN OTC DRUG	sugar cookie cheer hand sanitizer		ALCOHOL	GEL	TOPICAL	20190815		OTC MONOGRAPH DRUG	505G(a)(3)	Target Corporation	ALCOHOL	620	mg/g			N	20241231
11673-871_ff2494ba-ca14-470a-ae81-a3d3becc1321	11673-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Target Corp	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
11673-873_a5e09a6e-ae04-46fb-bea8-bbf007ee8822	11673-873	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20090701		ANDA	ANDA077007	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-877_bb15d62b-4078-401f-aa2d-600a48e91f70	11673-877	HUMAN OTC DRUG	Up and Up Daytime Multi Symptom Severe Cold Nighttime Severe Cold and Cough		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20210716		OTC MONOGRAPH FINAL	part341	Target Corporation						N	20241231
11673-879_73f1bb83-9cb0-4146-aff3-6ee7908fcdd6	11673-879	HUMAN OTC DRUG	up and up mini nicotine		nicotine	LOZENGE	ORAL	20200910		ANDA	ANDA203690	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-881_e78ea67a-40ba-4b6c-bbbb-085c89eb05f8	11673-881	HUMAN OTC DRUG	up and up mini nicotine polacrilex		nicotine	LOZENGE	ORAL	20200910		ANDA	ANDA203690	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-882_05047644-1956-4ed7-b40f-3b15331233f6	11673-882	HUMAN OTC DRUG	Up and Up Infants Gas Relief		Simethicone	EMULSION	ORAL	20090721		OTC MONOGRAPH FINAL	part332	Target Corporation	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
11673-887_efe61aa3-529b-ecdc-e053-2995a90aa3c7	11673-887	HUMAN OTC DRUG	Up and Up Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20210601		OTC MONOGRAPH NOT FINAL	part348	TARGET CORP	MENTHOL	50	mg/1			N	20241231
11673-898_6aa68203-3af3-4fd5-bfdb-2532ab556645	11673-898	HUMAN OTC DRUG	up and up esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Target Corporation	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-899_552803ab-fae8-4848-a632-40849cb14457	11673-899	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	LIQUID	ORAL	20181231		OTC MONOGRAPH FINAL	part338	TARGET Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-900_e17b693e-1b2a-45cd-8049-276fb2e17c65	11673-900	HUMAN OTC DRUG	Up and Up anti diarrheal		loperamide HCl	SUSPENSION	ORAL	20160226		ANDA	ANDA091292	Target Corporation	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
11673-902_520916f2-dc21-44ca-a402-ddf22340d4ab	11673-902	HUMAN OTC DRUG	up and up extra strength antacid 750	Assorted Berry	Antacid Tablets	TABLET, CHEWABLE	ORAL	20150928		OTC MONOGRAPH DRUG	M001	Target Corporation	CALCIUM CARBONATE	750	mg/1			N	20241231
11673-902_e83fefe8-7d2f-4fc1-b4ff-a80da54eb310	11673-902	HUMAN OTC DRUG	up and up extra strength antacid 750	Assorted Berry	Antacid Tablets	TABLET, CHEWABLE	ORAL	20151012		OTC MONOGRAPH DRUG	M001	Target Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-906_6879cd08-f755-4264-8777-8f35265d30b3	11673-906	HUMAN OTC DRUG	Mucus Relief Daytime Severe Cold Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL,Guaifenesin	KIT		20190930	20250829	OTC MONOGRAPH FINAL	part341	TARGET Corporation						N	
11673-907_ac2f30d8-5974-47fd-b99c-6b04044ab1eb	11673-907	HUMAN OTC DRUG	ULTRA STRENGHT PINK BISMUTH		Bismuth subsalicylate	SUSPENSION	ORAL	20191015		OTC MONOGRAPH DRUG	M008	TARGET CORPORATION	BISMUTH SUBSALICYLATE	525	mg/15mL			N	20241231
11673-909_2b57c682-87bc-430e-bacd-dfeabed565cb	11673-909	HUMAN OTC DRUG	up and up naproxen sodium		naproxen sodium	TABLET, FILM COATED	ORAL	20200214		ANDA	ANDA074661	Target Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-910_d0b925b5-eaca-4a75-bb5a-5fd6d8d9760b	11673-910	HUMAN OTC DRUG	UpandUp	Clotrimazole	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Target Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11673-912_acfb74f3-8fea-4d6f-ab44-53a51ad34b3b	11673-912	HUMAN OTC DRUG	Target	antifungal	Tolnaftate	CREAM	TOPICAL	20060217		OTC MONOGRAPH FINAL	part333C	Target Corporation	TOLNAFTATE	10	mg/g			N	20241231
11673-915_dfb1aa0e-5676-48c4-a961-9ba45c78374a	11673-915	HUMAN OTC DRUG	up and up omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20090714		NDA	NDA022032	Target Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-918_f75604fb-1ffd-40b7-abae-8073d52033f9	11673-918	HUMAN OTC DRUG	childrens allergy relief	dye-free	Diphenhydramine HCl	SOLUTION	ORAL	20180520		OTC MONOGRAPH DRUG	M012	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11673-919_e113127f-3ec7-4582-8f2f-9efee60cb68e	11673-919	HUMAN OTC DRUG	up and up hair regrowth treatment for women		Minoxidil	SOLUTION	TOPICAL	20220105		ANDA	ANDA075357	Target Corporation	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11673-920_93ced018-b41d-4f7d-bd6f-89ae816e2f7f	11673-920	HUMAN OTC DRUG	Daytime Mucus Relief Severe Cold Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20181231	20250829	OTC MONOGRAPH FINAL	part341	TARGET Corporation						N	
11673-924_fb9091cf-2b91-f683-e053-6394a90a0fea	11673-924	HUMAN OTC DRUG	Dual Action Pain Relief		Acetaminophen, Ibuprofen	TABLET	ORAL	20230711		ANDA	ANDA216994	TARGET CORPORATION	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11673-925_a9dd0199-03a5-885a-e053-2a95a90a2195	11673-925	HUMAN OTC DRUG	MAXIMUM STRENGTH DAYTIME - NIGHTTIME COLD AND FLU COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIENESIN, PHENYLEPHRINE HCL,DOXYLAMINE SUCCINATE	KIT	ORAL	20200707		OTC MONOGRAPH FINAL	part341	TARGET CORP						N	20241231
11673-926_b09504ab-4d00-471c-ac81-09a1d35090bf	11673-926	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20200701	20241231	ANDA	ANDA208754	TARGET Corporation	DOCOSANOL	100	mg/g			N	
11673-927_d203aa44-c21e-40af-9487-7a76a7ee6367	11673-927	HUMAN OTC DRUG	Sinus Severe		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20190801		OTC MONOGRAPH DRUG	M012	Target Corporation	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-928_ee871d0d-0008-6785-e053-2995a90ac4aa	11673-928	HUMAN OTC DRUG	8HR Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA215486	TARGET CORPORATION	ACETAMINOPHEN	650	mg/1			N	20241231
11673-930_c68cae27-4a3e-119e-e053-2a95a90adf42	11673-930	HUMAN OTC DRUG	Up and Up	Blemish Controlling Apricot Scrub	SALICYLIC ACID	EMULSION	TOPICAL	20130925		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	SALICYLIC ACID	20	mg/g			N	20241231
11673-931_ea2b2e08-0d80-6027-e053-2995a90a806c	11673-931	HUMAN OTC DRUG	Up and Up	Dual Effects Moisturizer	SALICYLIC ACID	LOTION	TOPICAL	20121011		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	SALICYLIC ACID	5	mg/mL			N	20241231
11673-933_fd5d030a-8b4f-47d1-ae66-99ec9d4e74fb	11673-933	HUMAN OTC DRUG	ultra strength antacid		Antacid	TABLET, CHEWABLE	ORAL	20180105		OTC MONOGRAPH DRUG	M001	Target Corporation	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11673-934_b4cdac55-12fb-4e72-e053-2995a90aab2b	11673-934	HUMAN OTC DRUG	Up and Up	Illuminating Daily Moisturizer with Sunscreen Broad Spectrum SPF 15	Avobenzone, Octinoxate, Octisalate	LOTION	TOPICAL	20130201		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
11673-935_1d26e664-cccd-4793-b32c-e76c200e0935	11673-935	HUMAN OTC DRUG	Up and Up nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20160711		OTC MONOGRAPH FINAL	part341	Target Corporation	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11673-936_ea2c5b35-c34a-7555-e053-2a95a90a969f	11673-936	HUMAN OTC DRUG	Up and Up	Deep Clean Toner	SALICYLIC ACID	LIQUID	TOPICAL	20140613		OTC MONOGRAPH FINAL	part333D	TARGET CORPORATION	SALICYLIC ACID	5	mg/mL			N	20241231
11673-937_ea2d1b1e-bd36-2bff-e053-2a95a90a6664	11673-937	HUMAN OTC DRUG	Up and Up	Sport Sunscreen Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20191009		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
11673-938_0a9d9110-2904-0c74-e063-6394a90a8e1d	11673-938	HUMAN OTC DRUG	Target Up and Up Reef Conscious Formula SPF 50 Sport Sunscreen		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20180301		OTC MONOGRAPH DRUG	M020	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/g; mg/g; mg/g			N	20241231
11673-939_f12ec1c7-ad13-96a3-e053-2995a90a4619	11673-939	HUMAN OTC DRUG	Target Up and Up Sport SPF 50		Avobenzone, Homosalat, Octisalate, Octocrylene	SPRAY	TOPICAL	20181210		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
11673-941_0a9e233e-8567-8e8b-e063-6294a90a354e	11673-941	HUMAN OTC DRUG	Target Up and Up Kids SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20181210		OTC MONOGRAPH DRUG	M020	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
11673-942_c1b51259-50fe-423c-8327-29af51175653	11673-942	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part333A	Target Corp	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
11673-943_bc315679-c011-b41c-e053-2a95a90ad144	11673-943	HUMAN OTC DRUG	Target Up and Up Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
11673-944_715b22e6-f4d1-4fa4-9cbb-9a9582916b46	11673-944	HUMAN OTC DRUG	Up and Up Hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20140604		OTC MONOGRAPH FINAL	part346	Target Corporation	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-945_b789ceb5-0fe9-5c7a-e053-2995a90a3aea	11673-945	HUMAN OTC DRUG	DAY COLD AND FLU RELIEF		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20210701		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-946_b78c42b5-35da-5e64-e053-2a95a90a4625	11673-946	HUMAN OTC DRUG	NIGHT COLD AND FLU RELIEF		ACETAMINOPHEN,	CAPSULE, LIQUID FILLED	ORAL	20210701		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-947_b79edda9-0367-f652-e053-2995a90a6f6c	11673-947	HUMAN OTC DRUG	DAY-NIGHT COLD AND FLU		DAY-NIGHT COLD FLU	KIT	ORAL	20210701		OTC MONOGRAPH FINAL	part341	TARGET CORP						N	20241231
11673-948_ef059a98-451b-4590-93b4-937b855d6595	11673-948	HUMAN OTC DRUG	Omeprazole		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180721		ANDA	ANDA210593	UP & UP	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11673-949_f4ee0484-d84e-9f24-e053-2a95a90a5fce	11673-949	HUMAN OTC DRUG	Target Up and Up Sunscreen SPF 50 KIDS	Broad Spectrum	Titanium Dioxide, Zinc oxide	LOTION	TOPICAL	20190123		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	31; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11673-952_24c26841-a3f4-4f3c-9c6c-4a7a791facac	11673-952	HUMAN OTC DRUG	Body		Menthol, zinc oxide	POWDER	TOPICAL	20130701		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	MENTHOL	1.5	mg/g			N	20241231
11673-953_c6a0aa2e-2adb-4654-ba53-eafdec2f0729	11673-953	HUMAN OTC DRUG	up and up mini nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200829		ANDA	ANDA203690	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-955_d555ee26-3789-fb34-e053-2a95a90af89f	11673-955	HUMAN OTC DRUG	Target Up and Up Sport SPF 30 Clear	Sport SPF 30 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20120427		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
11673-957_6656022d-c2d4-42fb-a9b2-ab299cf9e5f3	11673-957	HUMAN OTC DRUG	Up and Up Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130313		ANDA	ANDA203690	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-961_30ee95d8-17a7-488e-aa15-bda04dc73406	11673-961	HUMAN OTC DRUG	sinus pressure and pain and cough		acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	TABLET, FILM COATED	ORAL	20190830		OTC MONOGRAPH DRUG	M012	Target Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-965_d61a7f2d-0147-a01b-e053-2995a90aaeb0	11673-965	HUMAN OTC DRUG	Target Up and Up Kids SPF 50 Clear		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170427		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
11673-966_4b8472c3-8d40-41e5-8f4b-5f7615e4005c	11673-966	HUMAN OTC DRUG	up and up acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150318		ANDA	ANDA075077	Target Corporation	ACETAMINOPHEN	650	mg/1			N	20241231
11673-967_51974b4e-91c4-430c-bc23-89906f96f229	11673-967	HUMAN OTC DRUG	Menstrual Relief		acetaminophen, pamabrom, pyrilamine maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	Target Corporation	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
11673-968_f0e797e8-4630-b3a6-e053-2a95a90a6d3e	11673-968	HUMAN OTC DRUG	Target Up and Up Sunscreen Sport Broad Spectrum SPF 30		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20180724		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
11673-969_a9f2a410-808f-8e1a-e053-2995a90aeb32	11673-969	HUMAN OTC DRUG	DAYTIME- NIGHTTIME COLD AND FLU		DAYTIME NIGHTTIME COLD AND FLU	KIT	ORAL	20200708		OTC MONOGRAPH FINAL	part341	TARGET CORP						N	20241231
11673-970_f41e7969-6467-3e3b-e053-2995a90a9b68	11673-970	HUMAN OTC DRUG	Target Up and Up Sunscreen SPF 30 SPORT	Broad Spectrum	Avobenzone, Homosalate,Octisalate,Octocrylene	SPRAY	TOPICAL	20190128		OTC MONOGRAPH NOT FINAL	part352	TARGET CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
11673-971_8d3050d7-2923-4cd1-b69a-ed5893132ff8	11673-971	HUMAN OTC DRUG	up and up nicotine		nicotine	GUM, CHEWING	ORAL	20190329		ANDA	ANDA206393	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11673-972_a5b5b448-9752-fbe7-e053-2a95a90a1e68	11673-972	HUMAN OTC DRUG	COLD AND FLU DAYTIME SEVERE		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200518		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-975_f1fa37a0-194e-26d8-e053-2a95a90ad9f6	11673-975	HUMAN OTC DRUG	DAYTIME COLD AND FLU MULTI SYMPTOM		DAYTIME COLD AND FLU MULTI SYMPTOM	CAPSULE, LIQUID FILLED	ORAL	20200707		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-976_ed1a901b-f969-1400-e053-2a95a90a66ad	11673-976	HUMAN OTC DRUG	NIGHTIME COLD AND FLU		NIGHTIME COLD AND FLU	CAPSULE, LIQUID FILLED	ORAL	20200708		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11673-978_ed6d131e-91eb-e999-e053-2995a90ad39b	11673-978	HUMAN OTC DRUG	MAXIMUM STRENGTH COLD AND FLU		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	CAPSULE, LIQUID FILLED	ORAL	20200608		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-979_a9dbb030-1588-e396-e053-2a95a90ab814	11673-979	HUMAN OTC DRUG	MAXIMUM STRENGTH NIGHTTIME COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200713		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-981_baef33af-c9d8-786b-e053-2995a90a0015	11673-981	HUMAN OTC DRUG	TARGET UP AND UP FOAMING BODY WASH ACNE TREATMENT		SALICYLIC ACID	LIQUID	TOPICAL	20170809		OTC MONOGRAPH FINAL	part358B	TARGET CORPORATION	SALICYLIC ACID	20	mg/mL			N	20241231
11673-982_454a6f85-fdf4-45bf-8a11-025a6081d24b	11673-982	HUMAN OTC DRUG	Up and Up Miconazole 3		Miconazole nitrate	KIT		20090812		ANDA	ANDA076357	Target Corporation						N	20241231
11673-983_f184fe04-0f9f-d842-e053-2995a90a433b	11673-983	HUMAN OTC DRUG	COLD AND FLU NIGHTTIME SEVERE		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200601		OTC MONOGRAPH FINAL	part341	TARGET CORP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11673-984_a5ae753c-32cd-0d27-e053-2a95a90ad60e	11673-984	HUMAN OTC DRUG	COLD AND FLU DAYTIME-NIGHTTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL	KIT		20200603		OTC MONOGRAPH FINAL	part341	TARGET CORP						N	20241231
11673-985_d0626567-c807-45f7-99d1-4522080e81f8	11673-985	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20190401	20240524	OTC MONOGRAPH DRUG	M012	Target Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
11673-986_a50e1309-9ee6-f5ef-e053-2995a90a6e89	11673-986	HUMAN OTC DRUG	ALLERGY RELIEF		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20190410		ANDA	ANDA206214	TARGET CORPORATION	LORATADINE	10	mg/1			N	20241231
11673-988_527bb2fd-7506-4949-80b1-2f4aa365070b	11673-988	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20200429		OTC MONOGRAPH NOT FINAL	part333A	Target	ALCOHOL	62	mL/100mL			N	20241231
11673-989_f06e4d37-5f2f-d60c-e053-2995a90a4634	11673-989	HUMAN OTC DRUG	Target Up and Up After Sun Cooling		Lidocaine Hydrochloride	GEL	TOPICAL	20190221		OTC MONOGRAPH NOT FINAL	part348	TARGET CORPORATION	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11673-990_0e05da1f-2504-fd21-e063-6394a90a5ee8	11673-990	HUMAN OTC DRUG	IBUPROFEN CA		IBUPROFEN	TABLET, COATED	ORAL	20200101		ANDA	ANDA091239	TARGET CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
11673-991_0e071c42-0f7e-586e-e063-6394a90a9533	11673-991	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20200204		ANDA	ANDA091239	TARGET CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
11673-992_0e074882-f7f2-66d4-e063-6394a90ac937	11673-992	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20200101		ANDA	ANDA079205	TARGET CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
11673-993_0e07c84c-691d-97b3-e063-6394a90aa81d	11673-993	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20200101		ANDA	ANDA091237	TARGET CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
11673-995_86a73170-db6f-5b97-e053-2991aa0a7375	11673-995	HUMAN OTC DRUG	MAXIMUM STRENGTH LAXATIVE PILLS		SENNOSIDES	TABLET	ORAL	20190409		OTC MONOGRAPH NOT FINAL	part334	TARGET CORPORATION	SENNOSIDES	25	mg/1			N	20241231
11673-996_1424ac6c-dd17-49a5-81ca-f4450e970de4	11673-996	HUMAN OTC DRUG	Childrens Allergy		LORATADINE	TABLET, CHEWABLE	ORAL	20190331		ANDA	ANDA210088	TARGET CORPORATION	LORATADINE	5	mg/1			N	20241231
11673-997_2ac6f348-4b68-43ab-aa09-1e4210e29eb4	11673-997	HUMAN OTC DRUG	CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20190331		ANDA	ANDA210088	TARGET CORPORATION	LORATADINE	5	mg/1			N	20241231
11701-025_700f0ddd-e5ae-4223-b779-688b0adbb976	11701-025	HUMAN OTC DRUG	Isagel		Alcohol	GEL	TOPICAL	20090615		OTC MONOGRAPH DRUG	M003	Coloplast Manufacturing US, LLC	ALCOHOL	600	mL/1000mL			N	20241231
11701-025_b22de22e-e46c-445c-bb8a-533c6392b7e7	11701-025	HUMAN OTC DRUG	Isagel		Alcohol	GEL	TOPICAL	20090615		OTC MONOGRAPH DRUG	M003	Coloplast Manufacturing US, LLC	ALCOHOL	600	mL/1000mL			N	20241231
11701-038_a7737468-09a2-4153-a3a5-b60c2cf9676c	11701-038	HUMAN OTC DRUG	Micro-Guard	(AF)	Miconazole Nitrate	POWDER	TOPICAL	20090615		OTC MONOGRAPH DRUG	M005	Coloplast Manufacturing US, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11701-047_fce53fc1-41c3-42ab-ac1b-715d1f6a868b	11701-047	HUMAN OTC DRUG	Baza Cleanse and Protect		Dimethicone	LOTION	TOPICAL	20090615		OTC MONOGRAPH DRUG	M016	Coloplast Manufacturing US, LLC	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
11701-048_c3184a2e-f31c-4012-92de-7081c0f46db6	11701-048	HUMAN OTC DRUG	Baza Clear		Petrolatum	OINTMENT	TOPICAL	20090615		OTC MONOGRAPH DRUG	M016	Coloplast Manufacturing US, LLC	PETROLATUM	960	mg/g			N	20241231
11701-050_35a7a62c-e0e9-4635-8680-cb44bc8965a3	11701-050	HUMAN OTC DRUG	Critic Aid Skin		Zinc oxide	PASTE	TOPICAL	20090615		OTC MONOGRAPH DRUG	M015	Coloplast Manufacturing US, LLC	ZINC OXIDE	200	mg/g			N	20241231
11701-062_8c0f5407-304a-4f88-a43b-d17a1e50d152	11701-062	HUMAN OTC DRUG	Baza Cleanse and Protect Odor Control		Dimethicone	LOTION	TOPICAL	20090615		OTC MONOGRAPH DRUG	M016	Coloplast Manufacturing US, LLC	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
11701-063_49cacdf2-8886-4e1f-9e7b-69e4a415a70f	11701-063	HUMAN OTC DRUG	Sween 24		DIMETHICONE	CREAM	TOPICAL	20090615		OTC MONOGRAPH DRUG	M016	Coloplast Manufacturing US, LLC	DIMETHICONE	60	mg/g	Skin Barrier Activity [PE]		N	20241231
11701-066_cae3b046-d152-4c35-9103-4a239381bfde	11701-066	HUMAN OTC DRUG	Critic Aid Clear		Petrolatum	OINTMENT	TOPICAL	20090615		OTC MONOGRAPH DRUG	M016	Coloplast Manufacturing US, LLC	PETROLATUM	710	mg/g			N	20241231
11701-172_c4e4068b-5e5f-a571-e053-2995a90a98a5	11701-172	HUMAN OTC DRUG	Antiseptic Solution		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20210701		NDA	NDA019125	Coloplast Corp	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
11704-101_f1736bb6-219c-48dd-969d-f26f6fbad350	11704-101	HUMAN PRESCRIPTION DRUG	ATROPEN Auto-Injector		atropine	INJECTION	INTRAMUSCULAR	19730515		NDA	NDA017106	Meridian Medical Technologies LLC	ATROPINE	2	mg/.7mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
11704-104_f1736bb6-219c-48dd-969d-f26f6fbad350	11704-104	HUMAN PRESCRIPTION DRUG	ATROPEN Auto-Injector		atropine	INJECTION	INTRAMUSCULAR	20030619		NDA	NDA017106	Meridian Medical Technologies LLC	ATROPINE	.5	mg/.7mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
11704-105_f1736bb6-219c-48dd-969d-f26f6fbad350	11704-105	HUMAN PRESCRIPTION DRUG	ATROPEN Auto-Injector		atropine	INJECTION	INTRAMUSCULAR	20030619		NDA	NDA017106	Meridian Medical Technologies LLC	ATROPINE	1	mg/.7mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
11704-106_f1736bb6-219c-48dd-969d-f26f6fbad350	11704-106	HUMAN PRESCRIPTION DRUG	ATROPEN Auto-Injector		atropine	INJECTION	INTRAMUSCULAR	20030619		NDA	NDA017106	Meridian Medical Technologies LLC	ATROPINE	2	mg/.7mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
11704-107_f1736bb6-219c-48dd-969d-f26f6fbad350	11704-107	HUMAN PRESCRIPTION DRUG	ATROPEN Auto-Injector		atropine	INJECTION	INTRAMUSCULAR	20040917		NDA	NDA017106	Meridian Medical Technologies LLC	ATROPINE	.25	mg/.3mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
11704-370_6e16a4c1-525d-405e-8c76-c2aa1e6909a9	11704-370	HUMAN PRESCRIPTION DRUG	Cyanokit		Hydroxocobalamin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20111001	20240524	NDA	NDA022041	Meridian Medical Technologies, Inc.	HYDROXOCOBALAMIN	5	g/250mL	Antidote [EPC]		N	
11704-600_9e08d47f-b706-44b2-9e2f-9ca972592050	11704-600	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	INJECTION	INTRAMUSCULAR	19901205		NDA	NDA020124	Meridian Medical Technologies LLC	DIAZEPAM	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
11704-620_b301a110-424c-4a7d-9560-8fbfbbd1a557	11704-620	HUMAN PRESCRIPTION DRUG	DuoDote		atropine and pralidoxime chloride	KIT	INTRAMUSCULAR	20060928		NDA	NDA021983	Meridian Medical Technologies LLC						N	20241231
11704-650_92c0fde3-69f9-4af3-ad99-1e256be6b54a	11704-650	HUMAN PRESCRIPTION DRUG	Seizalam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	20180914		NDA	NDA209566	Meridian Medical Technologies LLC	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
11704-777_ad537254-90f8-4732-9f32-bee3e1cae81a	11704-777	HUMAN PRESCRIPTION DRUG	ATNAA atropine and pralidoxime chloride	Auto-Injector	atropine and pralidoxime chloride	KIT	INTRAMUSCULAR	20020117		NDA	NDA021175	Meridian Medical Technologies, LLC						N	20241231
11748-010_609fc23e-e040-4961-9d88-fabff54884c6	11748-010	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19880101		UNAPPROVED MEDICAL GAS		P and J Oxyfill, LLC	OXYGEN	99	L/100L			N	20241231
11788-046_9f4cfb5c-909c-4002-8bca-a770aaf94b03	11788-046	HUMAN PRESCRIPTION DRUG	MELOXICAM		Meloxicam	TABLET	ORAL	20230803		ANDA	ANDA217579	AiPing Pharmaceutical, Inc	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11788-047_9f4cfb5c-909c-4002-8bca-a770aaf94b03	11788-047	HUMAN PRESCRIPTION DRUG	MELOXICAM		Meloxicam	TABLET	ORAL	20230803		ANDA	ANDA217579	AiPing Pharmaceutical, Inc	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11797-154_714aaf0c-95ac-4de9-b8d2-5fdcd1365804	11797-154	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Italfarmaco S.p.A	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
11797-155_714aaf0c-95ac-4de9-b8d2-5fdcd1365804	11797-155	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Italfarmaco S.p.A	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
11797-156_714aaf0c-95ac-4de9-b8d2-5fdcd1365804	11797-156	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Italfarmaco S.p.A	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
11797-157_714aaf0c-95ac-4de9-b8d2-5fdcd1365804	11797-157	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Italfarmaco S.p.A	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
11797-757_3102514e-1702-4b7d-9d26-60e98488ffc3	11797-757	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Italfarmaco SpA	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
11797-758_3102514e-1702-4b7d-9d26-60e98488ffc3	11797-758	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Italfarmaco SpA	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
11797-759_3102514e-1702-4b7d-9d26-60e98488ffc3	11797-759	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Italfarmaco SpA	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
11797-760_3102514e-1702-4b7d-9d26-60e98488ffc3	11797-760	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Italfarmaco SpA	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
11797-761_3102514e-1702-4b7d-9d26-60e98488ffc3	11797-761	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Italfarmaco SpA	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
11797-762_3102514e-1702-4b7d-9d26-60e98488ffc3	11797-762	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Italfarmaco SpA	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
11797-763_3102514e-1702-4b7d-9d26-60e98488ffc3	11797-763	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Italfarmaco SpA	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
11822-0003_e9a94b23-5851-443f-a306-190a2687d29f	11822-0003	HUMAN OTC DRUG	Double Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate	OINTMENT	TOPICAL	20060616	20241231	OTC MONOGRAPH DRUG	M009	Rite Aid Corporation	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
11822-0005_c7ea22f0-9b85-4418-a7b6-08e019443219	11822-0005	HUMAN OTC DRUG	hemorrhoidal relief		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20150109		OTC MONOGRAPH FINAL	part346	Rite Aid Corporation	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0006_07e8a5ef-966c-4177-824c-78b7572bb590	11822-0006	HUMAN OTC DRUG	Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20200227		OTC MONOGRAPH FINAL	part346	Rite Aid Corporation	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0007_6cbc5459-d5f9-c6f1-d7ed-56ba58f1c432	11822-0007	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCl	24 Hour	Fexofenadine HCl and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20220722		ANDA	ANDA079043	Rite Aid Corporation	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-0009_a33c9055-b95b-4c97-8739-c11a699683cf	11822-0009	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150205		ANDA	ANDA090711	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0011_6d14ded0-27cb-49e4-b8d1-3860d1211675	11822-0011	HUMAN OTC DRUG	artificial tears		lubricant eye drops	SOLUTION/ DROPS	OPHTHALMIC	20170101		OTC MONOGRAPH FINAL	part349	RITE AID CORPORATION	GLYCERIN; PROPYLENE GLYCOL	3; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
11822-0014_f214f16a-9fc0-845f-e053-2995a90a13e0	11822-0014	HUMAN OTC DRUG	Sensitive Rapid Relief		Stannous fluoride	PASTE	DENTAL	20200602		OTC MONOGRAPH FINAL	part355	Rite Aid	STANNOUS FLUORIDE	.454	g/100g			N	20241231
11822-0015_b97eaf9b-3474-4a21-a234-fbed33ec2981	11822-0015	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201027		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	ALCOHOL	62	mL/100mL			N	20241231
11822-0016_0bf7ec52-86be-2940-06e3-84e6a615c3bd	11822-0016	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220901		ANDA	ANDA202194	Rite Aid Corporation	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-0017_c545553c-2f3a-442a-90f5-c42edee0f68e	11822-0017	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-0019_9daacc79-4b07-1816-f25d-163fd7de4b9c	11822-0019	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221001		ANDA	ANDA202194	Rite Aid Corporation	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-0020_8f909f1f-c9c5-49d3-b7fe-5c9ecb7c7da0	11822-0020	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine Hydrochloride	LIQUID	ORAL	20210129		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0021_ad131669-4896-793e-1785-dc704aac0a98	11822-0021	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA215434	Rite Aid Corporation	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-0023_9aedf1f6-42e0-4489-9a19-5addd5538db2	11822-0023	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130409		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	ALCOHOL	700	mg/mL			N	20241231
11822-0024_3d07491d-316f-475c-a146-57b49b3fe99d	11822-0024	HUMAN OTC DRUG	esomeprazole magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200626		ANDA	ANDA207193	Rite Aid Corporation	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-0026_0a380922-8c8c-f0cd-e063-6294a90a79fb	11822-0026	HUMAN OTC DRUG	Rite Aid Ryshi Facial Mist Sunscreen Broad Spectrum SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20230111		OTC MONOGRAPH DRUG	M020	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 25	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0027_0a393f39-b92b-7b4f-e063-6294a90a6bb4	11822-0027	HUMAN OTC DRUG	Rite Aid Ryshi Sunscreen with Hyaluronic Acid and Collagen Broad Spectrum SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
11822-0029_938e5d1a-838f-4fc4-9ca5-728ec28b8337	11822-0029	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20160730		ANDA	ANDA076775	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0030_08a4421b-9bc8-5b83-e063-6394a90aa3e4	11822-0030	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20130501		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	MENTHOL	5.4	mg/1			N	20241231
11822-0031_08a44d1a-b01d-80bc-e063-6294a90af2bd	11822-0031	HUMAN OTC DRUG	Cherry Cough Drop		Menthol	LOZENGE	ORAL	20130501		OTC MONOGRAPH DRUG	M012	Rite Aid	MENTHOL	5.8	mg/1			N	20241231
11822-0032_08a4421b-9bc9-5b83-e063-6394a90aa3e4	11822-0032	HUMAN OTC DRUG	Menthol Cough Drop		Menthol	LOZENGE	ORAL	20150424		OTC MONOGRAPH DRUG	M012	Rite Aid	MENTHOL	5.4	mg/1			N	20241231
11822-0033_08a45eb8-5be1-884d-e063-6394a90aeaa1	11822-0033	HUMAN OTC DRUG	Cherry Cough Drop		Menthol	LOZENGE	ORAL	20150424		OTC MONOGRAPH DRUG	M012	Rite Aid	MENTHOL	5.8	mg/1			N	20241231
11822-0034_08a44ba2-1b77-b55e-e063-6394a90aeac7	11822-0034	HUMAN OTC DRUG	Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20130501		OTC MONOGRAPH DRUG	M012	Rite Aid	MENTHOL	7.5	mg/1			N	20241231
11822-0035_08a465cf-6f46-1407-e063-6394a90abf97	11822-0035	HUMAN OTC DRUG	Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20150424		OTC MONOGRAPH DRUG	M012	Rite Aid	MENTHOL	7.5	mg/1			N	20241231
11822-0038_08a48083-e5de-5bd7-e063-6394a90a0daa	11822-0038	HUMAN OTC DRUG	SF Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20110728		OTC MONOGRAPH DRUG	M012	Rite Aid	MENTHOL	7.6	mg/1			N	20241231
11822-0040_00b14e55-eddd-653d-e063-6394a90a3258	11822-0040	HUMAN OTC DRUG	Cherry Antacid Relief Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20180927		OTC MONOGRAPH FINAL	part331	Rite Aid	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-0043_08a465cf-6f4a-1407-e063-6394a90abf97	11822-0043	HUMAN OTC DRUG	Rite Aid Mixed Berry Sore Throat and Cough Lozenge		Benzocaine	LOZENGE	ORAL	20190418		OTC MONOGRAPH DRUG	M012	Rite Aid	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0044_b1abe61f-5d01-46fe-9482-f803d1463048	11822-0044	HUMAN OTC DRUG	Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate	OINTMENT	TOPICAL	20220225		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[iU]/g; [iU]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-0046_df73a993-2189-a555-4670-bc9ee7ea63e2	11822-0046	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20220201		ANDA	ANDA208369	Rite Aid Corporation	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-0048_00b16174-463c-682b-e063-6394a90a7206	11822-0048	HUMAN OTC DRUG	Rite Aid Wild Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220510		OTC MONOGRAPH FINAL	part331	Rite Aid	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-0049_0a39afe9-de12-c89a-e063-6294a90aef40	11822-0049	HUMAN OTC DRUG	Rite Aid Ryshi Sunscreen Face Primer Shea Butter, Aloe, Mineral Oil, and Vitamin E Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20221220		OTC MONOGRAPH DRUG	M020	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 110; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0050_5f945338-3fd2-4b4d-87e2-2405830dd5f6	11822-0050	HUMAN OTC DRUG	ibuprofen pm		Diphenhydramine Citrate, Ibuprofen	TABLET, FILM COATED	ORAL	20090319		ANDA	ANDA079113	Rite Aid Corporation	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0051_51606dad-98fa-4967-8c39-4a8b3448d626	11822-0051	HUMAN OTC DRUG	Rite Aid Athletes Foot		TOLNAFTATE	CREAM	TOPICAL	20140422		OTC MONOGRAPH FINAL	part333C	RITE AID	TOLNAFTATE	10	mg/g			N	20241231
11822-0052_0a39f046-a2c9-bf39-e063-6394a90a12ec	11822-0052	HUMAN OTC DRUG	Rite Aid Mineral Sensitive Skin Zinc Oxide Sunscreen For Face SPF 50		Zinc Oxide	LOTION	TOPICAL	20221221		OTC MONOGRAPH DRUG	M020	Rite Aid	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-0053_0a4cc73a-1348-bab8-e063-6394a90a1060	11822-0053	HUMAN OTC DRUG	Rite Aid Mineral Sunscreen Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200922		OTC MONOGRAPH DRUG	M020	Rite Aid	TITANIUM DIOXIDE; ZINC OXIDE	30; 150	mg/mL; mg/mL			N	20241231
11822-0058_0a9c19bf-c119-d61f-e063-6294a90aeead	11822-0058	HUMAN OTC DRUG	Rite Aid Mineral Sunscreen Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20230110		OTC MONOGRAPH DRUG	M020	Rite Aid	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
11822-0059_6076a0ac-446c-49d6-8a9d-2d25a6bca539	11822-0059	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20160715		ANDA	ANDA091354	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0060_0a9c6804-1af5-5497-e063-6394a90a827e	11822-0060	HUMAN OTC DRUG	Rite Aid Mineral Zinc Oxide Sunscreen Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20230208		OTC MONOGRAPH DRUG	M020	Rite Aid	ZINC OXIDE	216	mg/g			N	20241231
11822-0061_67c3cfe2-ab40-4c32-b386-ad3c740e3f6f	11822-0061	HUMAN OTC DRUG	omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200805		ANDA	ANDA210593	Rite Aid	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-0065_e8eed231-6c5d-49dd-a337-d406e7226fda	11822-0065	HUMAN OTC DRUG	nasal		Oxymetazoline HCl	SPRAY	NASAL	19961205		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11822-0072_eac1f63e-b64b-40a1-a3bb-d76e7d0d5fc6	11822-0072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol	MOUTHWASH	ORAL	19970801		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0073_62ab182e-ed9e-4b9a-966c-7639125b6121	11822-0073	HUMAN OTC DRUG	triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20140625		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-0080_91eb290c-78f1-4a2c-be0d-c7229ebc1bb5	11822-0080	HUMAN OTC DRUG	Athletes Foot		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Rite Aid Corporation	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
11822-0084_61dd37ef-591d-42c8-9bdc-bd2a6073e63b	11822-0084	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, COATED	ORAL	20180201		ANDA	ANDA074567	Rite-Aid	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-0085_644dbe2b-83d6-4309-aa52-66b2cc07e904	11822-0085	HUMAN OTC DRUG	Sport		Avobenzone, Homosalate, Octisalate, Octisalate	SPRAY	TOPICAL	20211202		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 2250; 250; 8	g/g; g/g; g/g; g/g			N	20241231
11822-0086_075141bb-54df-41a2-b2a0-f6484d2031e9	11822-0086	HUMAN OTC DRUG	tussin severe multi symptom cough cold plus flu CF MAX		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20170922		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0093_92d2271a-5392-4f52-94c4-1fa96ac7802c	11822-0093	HUMAN OTC DRUG	RITE AID Double Antibiotic		Double Antibiotic	OINTMENT	TOPICAL	20221001		OTC MONOGRAPH FINAL	part333B	RITE AID	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-0096_127990bb-c4d9-4ff2-8012-c1129c2ec4a9	11822-0096	HUMAN OTC DRUG	severe cold cough and flu relief	daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20150805		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0103_3e258fbe-3e80-4352-8f62-9f8e1f17647b	11822-0103	HUMAN OTC DRUG	Lanolin, Petrolatum		Lanolin, Petrolatum	OINTMENT	TOPICAL	20220824		OTC MONOGRAPH FINAL	part347	Rite Aid	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
11822-0104_a8063e46-a334-47dc-93f5-b5943a1e22a0	11822-0104	HUMAN OTC DRUG	Pain Relief	Regular Strength	Acetaminophen	TABLET	ORAL	19900713		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	325	mg/1			N	20241231
11822-0107_18c71f46-dfdc-4a16-a69b-f1afd20e89a7	11822-0107	HUMAN OTC DRUG	childrens fever reducer and pain reliever		Acetaminophen	SUSPENSION	ORAL	19970226		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11822-0112_9706399f-0e04-49ab-b26c-1e3bcdd05b4f	11822-0112	HUMAN OTC DRUG	Sinus Pressure and Congestion Relief	Maximum Strength	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-0113_e27353b9-23b5-3801-e053-2a95a90a6045	11822-0113	HUMAN OTC DRUG	Rite Aid Cortisone		Hydrocortisone 1%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-0114_76b2a7a3-3b3d-4336-8272-67e51d21ec02	11822-0114	HUMAN OTC DRUG	Minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20230505		ANDA	ANDA208092	Rite Aid Corporation	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-0115_22a98b8f-813e-4364-b5d8-4f4778df822e	11822-0115	HUMAN OTC DRUG	Minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20230505		ANDA	ANDA208092	Rite Aid Corporation	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-0116_be5df410-f894-a68f-e053-2995a90a1858	11822-0116	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20210325		NDA	NDA019125	Rite Aid	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
11822-0118_f31d4248-2d53-d7fd-e053-2a95a90af900	11822-0118	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Solution	LIQUID	TOPICAL	20171222		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	UNDECYLENIC ACID	7.5	g/30g			N	20241231
11822-0119_f31d4248-2d52-d7fd-e053-2a95a90af900	11822-0119	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	RITE AID CORPORATION	SALICYLIC ACID	.17	g/9mL			N	20241231
11822-0120_f31d2e60-fa4d-88da-e053-2a95a90a6325	11822-0120	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover Liquid	LIQUID	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	Rite Aid Corporation	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
11822-0121_f31d2e60-fa4c-88da-e053-2a95a90a6325	11822-0121	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel	GEL	TOPICAL	20141007		OTC MONOGRAPH FINAL	part358B	Rite Aid Corporation	SALICYLIC ACID	.17	g/7g			N	20241231
11822-0123_f31d31a5-6aed-905f-e053-2995a90a4908	11822-0123	HUMAN OTC DRUG	Salicylic Acid		Ultra Thin Corn Removers	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	Rite Aid Corporation	SALICYLIC ACID	40	mg/181			N	20241231
11822-0124_2b31591e-2118-4873-8c08-e02d2d733b65	11822-0124	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150205		ANDA	ANDA090711	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0125_f31d489d-8def-d8f6-e053-2a95a90a80e8	11822-0125	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	Rite Aid Corporation	SALICYLIC ACID	40	mg/41			N	20241231
11822-0127_f3951fc1-faf6-8c92-e053-2a95a90a0bad	11822-0127	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	Rite Aid Corporation	SALICYLIC ACID	40	mg/91			N	20241231
11822-0128_f31d4b56-acfc-fd57-e053-2a95a90afd70	11822-0128	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171222		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid Corporation	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
11822-0131_3fd4732b-a2fc-43c1-9177-a23d944fa93b	11822-0131	HUMAN OTC DRUG	ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170616		ANDA	ANDA203599	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0132_f31d31a5-6ae9-905f-e053-2995a90a4908	11822-0132	HUMAN OTC DRUG	Salicylic Acid		Ultra Thin Corn Removers	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	Rite Aid Corporation	SALICYLIC ACID	40	mg/91			N	20241231
11822-0134_f31d181a-33ca-560f-e053-2995a90abbd9	11822-0134	HUMAN OTC DRUG	Salicylic acid		Wart Remover	PLASTER	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358B	Rite Aid Corporation	SALICYLIC ACID	.4	g/181			N	20241231
11822-0135_f31d08ee-f64a-2b42-e053-2995a90a4029	11822-0135	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Powder Spray Talc Free	AEROSOL, POWDER	TOPICAL	20171222		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-0140_d747b505-3939-4154-851e-cbd1b45a5c02	11822-0140	HUMAN OTC DRUG	Naproxen Sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA074661	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0141_ac9b167c-9705-471d-b127-153879ad3e26	11822-0141	HUMAN OTC DRUG	acid reducer	original strength	Famotidine	TABLET, FILM COATED	ORAL	20090910		ANDA	ANDA075400	Rite Aid Corporation	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11822-0147_6e29f944-db0d-4419-bc72-d345f0e84dc4	11822-0147	HUMAN OTC DRUG	allergy and congestion relief d		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200401		ANDA	ANDA210719	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-0154_f070a807-8374-4617-abbd-5d8e8c5c662d	11822-0154	HUMAN OTC DRUG	antifungal	foot care	tolnaftate	SPRAY	TOPICAL	20040924		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	TOLNAFTATE	1	g/100g			N	20241231
11822-0157_22888037-c322-41a8-b3ef-b04675c69fb5	11822-0157	HUMAN OTC DRUG	Pain Relief Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-0166_b89fecd4-b9d3-49f7-bd63-519fc67ace59	11822-0166	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020510		ANDA	ANDA074937	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0170_1d050316-aec5-4d6e-8f6a-1b6280f3aa03	11822-0170	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20160720		ANDA	ANDA076789	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0172_f31ce6f6-14bd-d806-e053-2a95a90a1d59	11822-0172	HUMAN OTC DRUG	Witch Hazel		Witch Hazel Spray	SPRAY	TOPICAL	20180212		OTC MONOGRAPH FINAL	part347	Rite Aid Corporation	WITCH HAZEL	146	g/170g			N	20241231
11822-0180_e40f675a-37f8-4fb0-b6a9-f39b1e72bb1b	11822-0180	HUMAN OTC DRUG	Healing for Babies		Petrolatum	OINTMENT	TOPICAL	20220428		OTC MONOGRAPH FINAL	part347	Rite Aid	PETROLATUM	41	kg/100kg			N	20241231
11822-0186_a042474c-a70b-47bc-9298-6463b5660e45	11822-0186	HUMAN OTC DRUG	sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20160707		OTC MONOGRAPH FINAL	part338	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0188_fd4aeb92-cf71-4294-ac80-273c8d250563	11822-0188	HUMAN OTC DRUG	hemorrhoidal relief		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20140320		OTC MONOGRAPH FINAL	part346	Rite Aid Corporation	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0190_4fb4be8a-0a0e-4b1d-ac2f-c55ad2971259	11822-0190	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	19900315		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0194_b032833a-1133-49cf-b798-0995217541eb	11822-0194	HUMAN OTC DRUG	acid reducer	maximum strength	Famotidine	TABLET, FILM COATED	ORAL	20060929		ANDA	ANDA077351	Rite Aid Corporation	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11822-0198_072ed882-0516-48c4-815c-f57b2d1f5f10	11822-0198	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	Rite Aid Corporation	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
11822-0199_e98eb413-6037-4483-a75b-025ca31ff1e5	11822-0199	HUMAN OTC DRUG	miconazole 1	feminine care	Miconazole nitrate	KIT		20100609		ANDA	ANDA079114	Rite Aid Corporation						N	20241231
11822-0200_a3d95e45-f71b-4153-81db-9e6f249401c6	11822-0200	HUMAN OTC DRUG	Childrens Fever Reducer and Pain Reliever		Acetaminophen	SUSPENSION	ORAL	19960105		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11822-0201_af7ead83-1934-44e3-9535-5205dab67118	11822-0201	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20201211		ANDA	ANDA090821	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0202_4cadc133-acc0-483d-82d3-838707f3ef55	11822-0202	HUMAN OTC DRUG	Minoxidil		minoxidil	SOLUTION	TOPICAL	20161014		ANDA	ANDA075357	Rite Aid Corporation	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-0203_0cfa30c4-2583-add0-e063-6394a90a0487	11822-0203	HUMAN OTC DRUG	Rite Aid Hydration Lubricant Eye Drops		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20230106		OTC MONOGRAPH DRUG	M018	Rite Aid Corporation	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
11822-0209_523852c0-3a16-4242-b867-d7db32e647a1	11822-0209	HUMAN OTC DRUG	miconazole 3		miconazole nitrate	KIT		20231109		ANDA	ANDA075329	Rite Aid Corporation						N	20241231
11822-0213_889b6d34-6dbb-49a5-adc5-e18ae2610c04	11822-0213	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20050225		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM FLUORIDE	.2	mg/mL			N	20241231
11822-0216_abe26828-886e-4700-9f28-af63c9a156b3	11822-0216	HUMAN OTC DRUG	Rite Aid Extra Strength	Tropical Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190314		OTC MONOGRAPH DRUG	M001	Rite Aid Corporation	CALCIUM CARBONATE	750	mg/1			N	20241231
11822-0219_ac162977-cbaf-4153-924d-cc743b73c305	11822-0219	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	19971016		OTC MONOGRAPH NOT FINAL	part347	Rite Aid	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-0220_070d68e3-ad80-45d6-965c-c34dc222c286	11822-0220	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	19961122		ANDA	ANDA074165	Rite Aid Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-0223_bb2a0e3a-ac9d-42a3-90e1-8b6195023b8b	11822-0223	HUMAN OTC DRUG	acid reducer plus antacid		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20100603		ANDA	ANDA077355	Rite Aid Corporation	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-0231_0b9b7f4a-201c-4bc0-b59c-435383b43b42	11822-0231	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200730		ANDA	ANDA078682	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0241_0ad6652d-dca0-47c8-bc08-ca47b9cb0e1a	11822-0241	HUMAN OTC DRUG	allergy relief		levocetirizine dihydrochloride	TABLET, FILM COATED	ORAL	20201005		ANDA	ANDA211983	Rite Aid Corporation	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0255_77f725b0-fbdd-4b3a-a133-9478ba17c036	11822-0255	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20050603		ANDA	ANDA075217	Rite Aid Corporation	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0265_e283e462-96e9-04cf-e053-2a95a90a1d00	11822-0265	HUMAN OTC DRUG	Rite Aid Rectal Care		Lidocaine 5%	CREAM	TOPICAL	20220302		OTC MONOGRAPH FINAL	M015	Rite Aid	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-0269_322ebd51-511d-48cc-a67a-c96fd921baf8	11822-0269	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201211		ANDA	ANDA206394	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0273_8b718dea-8040-4970-b7af-cfd71203adb4	11822-0273	HUMAN OTC DRUG	Stomach Relief	regular strength	Bismuth subsalicylate	LIQUID	ORAL	20190331		OTC MONOGRAPH FINAL	part335	Rite Aid Corporation	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-0277_0cfa30c4-2584-add0-e063-6394a90a0487	11822-0277	HUMAN OTC DRUG	Rite Aid Multi-Symptom Relief Eye Drops		Polyethylene glycol 400, Tetrahydrozoline HCl, Zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20230120		OTC MONOGRAPH DRUG	M018	Rite Aid Corporation	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	1; .05; .25	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-0280_d6ef4d73-72eb-415d-a0a9-c2fb263a69cf	11822-0280	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20210119		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11822-0281_0c5266bf-b6bb-4128-e063-6394a90a8c4d	11822-0281	HUMAN OTC DRUG	Simplify Antibacterial Hand	Apple Blossom Scent	Chloroxylenol	SOAP	TOPICAL	20230809		OTC MONOGRAPH DRUG	505G(a)(3)	Rite Aid Corporation	CHLOROXYLENOL	.3	g/100mL			N	20241231
11822-0283_0c5288db-7852-027a-e063-6294a90a5bee	11822-0283	HUMAN OTC DRUG	Simplify Antibacterial Hand Wipes		Benzalkonium chloride	CLOTH	TOPICAL	20230911		OTC MONOGRAPH DRUG	505G(a)(3)	Rite Aid Corporation	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
11822-0291_775d5c86-b579-4b1d-8420-280e5eba6fa7	11822-0291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0292_f58b1797-5244-4d98-8897-d651ce41357b	11822-0292	HUMAN OTC DRUG	Pain Relief Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0304_a0b28b20-2ee8-421c-96ef-796086076b69	11822-0304	HUMAN OTC DRUG	nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20131219		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11822-0306_4b381740-6e0a-4fe0-9f5e-a317a4a64029	11822-0306	HUMAN OTC DRUG	Laxative		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA090685	Rite Aid Corporation	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-0309_bb03c2aa-0638-4273-9886-d611c2e71396	11822-0309	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170124		ANDA	ANDA206393	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0312_8e436234-ea33-4676-8b35-074235daa5a3	11822-0312	HUMAN OTC DRUG	Rite Aid Ultra Strength	Peppermint Flavor	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190313		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-0316_f1ffdcb0-fc2c-96bc-e053-2a95a90a5f49	11822-0316	HUMAN OTC DRUG	Rite Aid	Maximum Strength	Benzocaine	GEL, DENTIFRICE	ORAL	20110120		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-0323_bd0ee4fb-11f8-4dfb-b08d-9a07e0a11060	11822-0323	HUMAN OTC DRUG	Lubricant Eye Plus		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20130916		OTC MONOGRAPH DRUG	M018	Rite Aid Corporation	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
11822-0327_6c14679c-f7ce-4f35-951c-9ae4bf4fa465	11822-0327	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325	20241013	OTC MONOGRAPH DRUG	505G(a)(3)	Rite Aid Corporation	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
11822-0328_d681a23e-9e54-4916-9b2d-e9724ca9d4f8	11822-0328	HUMAN OTC DRUG	daytime nighttime severe cold and flu relief		Acetaminophen, dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20150724		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-0329_ed68ea20-9383-4ba7-9652-695d6906201b	11822-0329	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0340_dd4d86a3-459a-4d5e-b4ef-5958c6668e0f	11822-0340	HUMAN OTC DRUG	Arthritis Creme		Trolamine Salicylate	CREAM	TOPICAL	20050723		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	TROLAMINE SALICYLATE	10	g/100g			N	20241231
11822-0342_97de3845-c5b0-4456-8328-e0414b5a4948	11822-0342	HUMAN OTC DRUG	tussin mucus and chest congestion		Guaifenesin	SOLUTION	ORAL	20140729		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	GUAIFENESIN	200	mg/10mL			N	20241231
11822-0344_21806b88-889d-4f5c-b414-fb6b95d902bb	11822-0344	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060224		ANDA	ANDA077007	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0345_f3bc885a-99ac-28c0-e053-2995a90aa729	11822-0345	HUMAN OTC DRUG	Rite Aid	Maximum Strength	Benzocaine	LIQUID	ORAL	20150101		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-0350_3dfee788-cf48-4865-b33d-29b11475d78b	11822-0350	HUMAN OTC DRUG	Foot Care Clotrimazole		Clotrimazole	CREAM	TOPICAL	20100312		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-0351_1a010dc1-ed4e-4ae6-96f7-d0e6abf0a9b5	11822-0351	HUMAN OTC DRUG	Antifungal		Clotrimazole	CREAM	TOPICAL	20110415		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-0352_bfcf8f85-6b9f-446c-b782-db507cab30c5	11822-0352	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20161007		ANDA	ANDA078547	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0353_23b3c287-063e-4df9-b056-be2f4dbf423f	11822-0353	HUMAN OTC DRUG	Body Wash		Salicylic Acid	GEL	TOPICAL	20150115		OTC MONOGRAPH FINAL	part333D	Rite Aid	SALICYLIC ACID	20	mg/mL			N	20241231
11822-0359_f3bbc8b3-f2f0-45b7-a28d-fc28ae1c2548	11822-0359	HUMAN OTC DRUG	Cough and Chest Congestion DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20130921	20240229	OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
11822-0365_387398fe-9806-4241-9554-b190740eb50b	11822-0365	HUMAN OTC DRUG	nicotine gum		Nicotine Polacrilex	GUM, CHEWING	ORAL	20160730		ANDA	ANDA091349	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0374_f56b1b76-8190-49f4-ab71-7a0879db71d4	11822-0374	HUMAN OTC DRUG	migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020514		ANDA	ANDA075794	Rite Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11822-0375_169f1425-2171-4742-927d-f4abd59b16c6	11822-0375	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	Rite Aid Corporation	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
11822-0384_2f3754c3-078f-479f-ba1b-5d006f9fcd2a	11822-0384	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120827		ANDA	ANDA091135	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0390_70cc0a83-4c15-440b-9860-fb693437506e	11822-0390	HUMAN OTC DRUG	Menstrual Complete	Maximum Strength	Acetaminophen, Caffeine and Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
11822-0392_8af15c62-b8ac-4aab-8457-46499d728950	11822-0392	HUMAN OTC DRUG	pain relief ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20020330		ANDA	ANDA075139	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0393_8102ec1d-bfcd-44a5-843a-352282411a43	11822-0393	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0397_65a0b8b6-72cd-44fc-931f-5b60b67932d6	11822-0397	HUMAN OTC DRUG	Pain Relief Aspirin	Chewable, Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	20010904		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-0399_092d4fca-947c-1c0d-e063-6294a90a4eee	11822-0399	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20140401		OTC MONOGRAPH DRUG	M007	RITE AID PHARMACY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-0401_adeba218-6fcd-454d-ab43-f1396cfde05a	11822-0401	HUMAN OTC DRUG	nausea relief		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20141104		UNAPPROVED DRUG OTHER		Rite Aid Corporation	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
11822-0404_93f25b48-53be-4e4f-8265-32f6476dfe2c	11822-0404	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, CHEWABLE	ORAL	20020529		OTC MONOGRAPH DRUG	M009	Rite Aid Corporation	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
11822-0416_64c4b5ee-963f-49b4-af9b-7f3a08640922	11822-0416	HUMAN OTC DRUG	Intensive Healing Anti Itch		Hydrocortisone	CREAM	TOPICAL	20140320		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-0419_cbe93643-8c47-4ba3-a8fa-f89a73a8020f	11822-0419	HUMAN OTC DRUG	Cough	childrens mucus relief	Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20070816		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0424_ebf57a4f-c030-4e25-b1c6-f1e8eacf29d3	11822-0424	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20201211		ANDA	ANDA090821	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0425_81352698-6cc8-49b6-ab9f-ddd62ff8d75e	11822-0425	HUMAN OTC DRUG	allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20200801		ANDA	ANDA076447	Rite Aid Corporation	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0426_26259cf6-79c4-479b-ac98-d0ac2a6a5722	11822-0426	HUMAN OTC DRUG	tioconazole 1	1 dose treatment	Tioconazole	OINTMENT	VAGINAL	20071213		ANDA	ANDA075915	Rite Aid Corporation	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-0427_d5b6535e-e825-38a2-e053-2995a90aabb8	11822-0427	HUMAN OTC DRUG	Soft Tip Neti Pot Sinus Wash	Rite Aid	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		RITE AID CORPORATION						N	20241231
11822-0428_448c6f58-a3f3-482c-8280-82a45dd188f7	11822-0428	HUMAN OTC DRUG	Tension Headache	Aspirin-Free	Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20070117		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
11822-0429_d65e1e93-9700-406a-e053-2a95a90a04fe	11822-0429	HUMAN OTC DRUG	Soft Tip Squeeze bottle Sinus Wash	Rite Aid	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220116		UNAPPROVED DRUG OTHER		RITE AID CORPORATION						N	20241231
11822-0434_6bcdf7b6-b48b-4c8a-a521-428f1d5cdec2	11822-0434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0441_620b9777-305b-4cc7-af36-bed0f13128be	11822-0441	HUMAN OTC DRUG	sleep aid		Doxylamine succinate	TABLET	ORAL	20230313		ANDA	ANDA040167	Rite Aid Corporation	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
11822-0443_1d3ee715-0fe5-489e-8af2-9fc4252a57d6	11822-0443	HUMAN OTC DRUG	Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170615		ANDA	ANDA078104	Rite Aid Corporation	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-0444_cd82bf3a-200d-4b94-83f5-699e895fa568	11822-0444	HUMAN OTC DRUG	antibiotic and pain relief		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20050817		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-0446_2e0dd8e9-5d58-4db3-8f37-376cee1ced3d	11822-0446	HUMAN OTC DRUG	allergy relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20200717		ANDA	ANDA202538	Rite Aid Corporation	LORATADINE	10	mg/1			N	20241231
11822-0453_8841afea-64b7-4a36-8f83-5fa5c9fe1243	11822-0453	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150326		NDA	NDA022032	Rite Aid Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-0456_a379b048-e70a-4f59-96f0-3b2e617b2831	11822-0456	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20061026		ANDA	ANDA076777	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0457_2dcd14ac-627c-477a-8479-825a3f05e4b5	11822-0457	HUMAN OTC DRUG	allergy relief		Cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20201130		ANDA	ANDA207235	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0462_f18ef6dd-cf37-448d-b379-12bea9b2aabd	11822-0462	HUMAN OTC DRUG	Sinus and Allergy Relief PE		Chlorpheniramine maleate and Phenylephrine HCl	TABLET	ORAL	20050609		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0469_d583067e-1134-7d7d-e053-2a95a90a1e36	11822-0469	HUMAN OTC DRUG	Sterile Saline Mist	Rite Aid	Sodium Chloride	SPRAY	NASAL	20220113		UNAPPROVED DRUG OTHER		RITE AID	SODIUM CHLORIDE	.9	g/100g			N	20241231
11822-0470_d5b309fd-08a7-f733-e053-2a95a90a7f73	11822-0470	HUMAN OTC DRUG	Extra Strenght Saline Mist	Rite Aid	Sodium Chloride	SPRAY	NASAL	20220116		UNAPPROVED DRUG OTHER		RITE AID CORPORATION	SODIUM CHLORIDE	3	g/100g			N	20241231
11822-0471_deed7581-b8c5-4591-b383-4f01a2165027	11822-0471	HUMAN OTC DRUG	anti itch		hydrocortisone	OINTMENT	TOPICAL	20050725		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-0472_d622939e-90e0-efd5-e053-2a95a90a58d2	11822-0472	HUMAN OTC DRUG	Sinus Wash Pre Mixed Ready to Use	Rite Aid	Sodium Chloride, Sodium Bicarbonate	KIT		20190116		UNAPPROVED DRUG OTHER		RITE AID CORPORATION						N	20241231
11822-0475_2f8ba9db-bbaf-4936-8e43-a1e42e21e069	11822-0475	HUMAN OTC DRUG	childrens allergy relief		Cetirizine HCl	SOLUTION	ORAL	20160323		ANDA	ANDA204226	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0484_d65dd717-ff85-9d99-e053-2995a90ada73	11822-0484	HUMAN OTC DRUG	Sinus Wash Packet		SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER	NASAL	20220116		UNAPPROVED DRUG OTHER		RITE AID CORPORATION	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
11822-0485_d0504a04-27e2-4320-9506-5635c6c9421c	11822-0485	HUMAN OTC DRUG	Allergy Plus Sinus Relief		Diphenhydramine HCl and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050810		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	25; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0490_1d3cd8bf-240a-4214-8856-97be8d37bf42	11822-0490	HUMAN OTC DRUG	naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20010516		ANDA	ANDA074661	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0494_f8b8266b-96c4-469d-8174-ce570334ed3b	11822-0494	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150706		ANDA	ANDA091135	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0499_0aa702b6-147d-4ff4-9cc7-cb3f809f5483	11822-0499	HUMAN OTC DRUG	Anti Itch		Hydrocortisone	CREAM	TOPICAL	20130911		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-0500_016e00e7-51ec-4867-8ba4-3b19125fcf1b	11822-0500	HUMAN OTC DRUG	Acid Reducer Plus Antacid		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20131108		ANDA	ANDA077355	Rite Aid Corporation	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-0507_54e97657-b9ef-48e4-9fd5-945a98d0b92a	11822-0507	HUMAN OTC DRUG	naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20010516		ANDA	ANDA074661	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0511_393be867-e25d-4ce9-be94-7b316febd4ad	11822-0511	HUMAN OTC DRUG	nighttime severe cold and flu relief		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20150723		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0519_97b0b668-f83b-4bf6-b7d2-1de2386f66e2	11822-0519	HUMAN OTC DRUG	pain relief acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
11822-0527_09b3b703-f57f-4b97-a96e-0a5d8049dd60	11822-0527	HUMAN OTC DRUG	Sinus Congestion and Pain Relief	Non-Drowsy/Daytime	Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0534_5ab3747e-cbb3-456d-94f7-41697d8e8b9b	11822-0534	HUMAN OTC DRUG	Zinc Oxide		ZINC OXIDE	OINTMENT	TOPICAL	20220824		OTC MONOGRAPH FINAL	part347	Rite Aid	ZINC OXIDE	400	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-0539_b43e4e9f-bbdb-4833-8265-358f31326d6f	11822-0539	HUMAN OTC DRUG	antifungal		Tolnaftate	SPRAY	TOPICAL	20160512		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	TOLNAFTATE	1	g/100g			N	20241231
11822-0549_fededd3d-42a5-4b86-af2f-0fa1a4601fc8	11822-0549	HUMAN OTC DRUG	lice treatment		Permethrin	LOTION	TOPICAL	20110126		ANDA	ANDA076090	Rite Aid Corporation	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
11822-0552_40ee79dc-d62a-4926-aa60-26130a694c30	11822-0552	HUMAN OTC DRUG	Eye Allergy Relief		Pheniramine Maleate and Naphazoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20150701		NDA	NDA020065	Rite Aid Corporation	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.2675; 3.15	mg/mL; mg/mL			N	20241231
11822-0556_3fa998aa-7dd2-4884-be57-86cdce60f840	11822-0556	HUMAN OTC DRUG	Pain Relief Acetaminophen PM		Acetaminophen and Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0558_63e2370f-747b-489f-95e9-e000aee12ae1	11822-0558	HUMAN OTC DRUG	loratadine		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200717		ANDA	ANDA076011	Rite Aid Corporation	LORATADINE	10	mg/1			N	20241231
11822-0571_69338bed-2052-4a94-bc8d-1f3bd4af725b	11822-0571	HUMAN OTC DRUG	allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110415		ANDA	ANDA076447	Rite Aid Corporation	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0584_1892b7d6-7bf3-487c-b69f-5aba40c5fc13	11822-0584	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE	ORAL	20190601		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-0588_b013d406-a931-4fe2-b66d-7a4b92d5eb44	11822-0588	HUMAN OTC DRUG	Sinus Congestion and Pain Relief	Non-Drowsy, Daytime	Acetaminophen and Phenylephrine HCl	TABLET, COATED	ORAL	20080317		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0589_f432d968-b55c-ad57-e053-2a95a90a2ef3	11822-0589	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200415		ANDA	ANDA078682	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0590_a6a0bc9e-14e1-4fdf-a6ad-cb886b469569	11822-0590	HUMAN OTC DRUG	infants fever reducer and pain reliever		acetaminophen	SUSPENSION	ORAL	19930908		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11822-0591_fb5bee01-76da-4fdf-a9b3-2c2a0ccf125e	11822-0591	HUMAN OTC DRUG	cold and flu relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20200422		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0595_423dc381-da6e-4417-ad8e-02f283f2641b	11822-0595	HUMAN OTC DRUG	childrens fever reducer and pain reliever		Acetaminophen	SUSPENSION	ORAL	19970923		OTC MONOGRAPH NOT FINAL	part343	Rite Aid Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11822-0596_dc10db94-b589-442a-bff3-aebaf321ad27	11822-0596	HUMAN OTC DRUG	Childrens Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220615		OTC MONOGRAPH DRUG	M001	Rite Aid Corporation	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-0599_9b5300c9-12a2-49b1-ae13-810705cd8a2f	11822-0599	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20110425		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0600_e0858050-8bf2-4549-8ef7-8cb6cabb62b4	11822-0600	HUMAN OTC DRUG	Pain Relief Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20080212		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-0604_0d9cc98c-7142-43ed-9cbd-4a3d22237ba7	11822-0604	HUMAN OTC DRUG	RITE AID LAXATIVE SALINE	LAXATIVE	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20191203		OTC MONOGRAPH NOT FINAL	part334	RITE AID	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
11822-0606_96aa1d88-c927-444a-a971-d06a51ea88ae	11822-0606	HUMAN OTC DRUG	Daylogic For Men		Minoxidil	AEROSOL, FOAM	TOPICAL	20160805		ANDA	ANDA091344	Rite Aid Corporation	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-0612_1ad72d1e-6a6d-45c6-92e9-164c124f6058	11822-0612	HUMAN OTC DRUG	allergy relief		Loratadine	TABLET	ORAL	20041021		ANDA	ANDA076301	Rite Aid Corporation	LORATADINE	10	mg/1			N	20241231
11822-0613_f214fd12-9e4d-a5c4-e053-2995a90aa8bb	11822-0613	HUMAN OTC DRUG	3X Medicated Toothache and Gum Gel		Benzocaine	GEL	ORAL	20200506		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE; MENTHOL; ZINC CHLORIDE	20; .26; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-0614_f1fff859-46e0-cebc-e053-2a95a90ad396	11822-0614	HUMAN OTC DRUG	4X Medicated Severe Toothache and Gum Cream		Benzocaine	CREAM	ORAL	20200506		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL; ZINC CHLORIDE	.13; 20; .26; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-0615_f2000136-02ee-19d3-e053-2995a90ab647	11822-0615	HUMAN OTC DRUG	4X Medicated Severe Toothache and Gum Gel		Benzocaine	GEL	ORAL	20200506		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL; ZINC CHLORIDE	.13; 20; .5; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-0619_ac43f6ac-d5f3-4eb8-a523-f2752eab97d5	11822-0619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20120423		OTC MONOGRAPH FINAL	part347	Rite Aid Corporation	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
11822-0620_aaab4ba6-0fc7-409b-b91c-b07041b6eb2b	11822-0620	HUMAN OTC DRUG	childrens allergy relief		Loratadine	SOLUTION	ORAL	20230410		ANDA	ANDA075728	Rite Aid Corporation	LORATADINE	5	mg/5mL			N	20241231
11822-0622_faede400-f13a-4e52-bcdf-b5ca1f86bf45	11822-0622	HUMAN OTC DRUG	anti itch and skin protectant		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20050730		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0637_356bfcb1-8c4c-4464-889f-f2e4dd322109	11822-0637	HUMAN OTC DRUG	antibiotic plus pain relief	maximum strength	Neomycin, Polymyxin B, Pramoxine HCl	CREAM	TOPICAL	20050714		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-0639_e2225259-70ed-52de-e053-2a95a90a73f8	11822-0639	HUMAN OTC DRUG	Rite Aid Cooling Pain Relief		Menthol 10.5%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	MENTHOL	10.5	g/100g			N	20241231
11822-0640_c1cd5c57-728b-495e-8845-510918c7ac1a	11822-0640	HUMAN OTC DRUG	Cold and Flu Relief	Severe Daytime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20191125		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0645_0c93bae9-c706-1fc7-e063-6394a90adea9	11822-0645	HUMAN OTC DRUG	Rite Aid Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Rite Aid Corporation.	CASTOR OIL	1	mg/mL			N	20241231
11822-0647_e3287ac8-0e45-143b-e053-2995a90acbff	11822-0647	HUMAN OTC DRUG	Rite Aid Itch Relief		Diphenhydramine HCl 2%, Zinc Acetate 0.1%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0650_fd0c9dad-76a4-411b-b358-2bfd3c181159	11822-0650	HUMAN OTC DRUG	sinus pressure and congestion relief	maximum strength	Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19990830		ANDA	ANDA075153	Rite Aid Corporation	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-0652_ef16f4da-8e3e-4772-b11e-126e9ee7407c	11822-0652	HUMAN OTC DRUG	Stool Softener Laxative	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	250	mg/1			N	20241231
11822-0660_04221d7a-42ef-47f0-bef4-467156a455d5	11822-0660	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020510		ANDA	ANDA074937	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0662_6381215c-63e3-4d34-a398-a0b0c1c84b04	11822-0662	HUMAN OTC DRUG	allergy relief		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0664_bac9a8a4-bb4b-43ab-b41b-2b107c88833e	11822-0664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19950721		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0672_49eb46c6-8e28-4a3d-b12d-dddda8f2c936	11822-0672	HUMAN OTC DRUG	sleep aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20150724		OTC MONOGRAPH FINAL	part338	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0676_6dfcbb27-e6d0-483d-9eda-5ea5b9b57368	11822-0676	HUMAN OTC DRUG	laxative for women		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	Rite Aid Corporation	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-0677_2f44b46a-cd78-4b7c-82e2-5a9382d734fd	11822-0677	HUMAN OTC DRUG	Severe Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20191210		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0680_74af5a5c-5825-410e-aadd-8cc1b036e778	11822-0680	HUMAN OTC DRUG	anti itch	maximum strength plus	hydrocortisone	CREAM	TOPICAL	20110216		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-0683_be28b90e-2529-4e0b-81a2-43be1fdd9697	11822-0683	HUMAN OTC DRUG	lice solution kit		piperonyl butoxide, pyrethrum extract	KIT		20181220		OTC MONOGRAPH FINAL	part358G	Rite Aid Corporation						N	20241231
11822-0685_96fee49c-6687-4c2a-a6dd-a2b69e83fbe9	11822-0685	HUMAN OTC DRUG	Sleep-Aid		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20210616		OTC MONOGRAPH DRUG	M010	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0689_56aa24cc-22c2-4034-9c7c-f15bc66a5b73	11822-0689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine Maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0699_bf00d2f2-2d51-4bb0-9a8a-f1fd800b7cf0	11822-0699	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20160728		ANDA	ANDA076779	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0702_5968744f-4812-4ba8-ad8e-5cf839673deb	11822-0702	HUMAN OTC DRUG	minoxidil		Minoxidil	SOLUTION	TOPICAL	20220307		ANDA	ANDA075357	Rite Aid Corporation	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-0703_f93a5f69-f2d6-40f8-a8f5-1eedd9586182	11822-0703	HUMAN OTC DRUG	first aid triple antibiotic pain and scar		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20170309		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-0710_f777d730-164e-4b07-83bf-4a4c61ffc08f	11822-0710	HUMAN OTC DRUG	Daytime Severe Cold and Flu Relief		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20140618		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0713_e0485499-fd12-3dc1-e053-2995a90acc09	11822-0713	HUMAN OTC DRUG	Allergy Relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20220615		ANDA	ANDA206214	RITE AID	LORATADINE	10	mg/1			N	20241231
11822-0714_b164a3fe-4df6-4bc3-90b7-f03aab024e1c	11822-0714	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211202		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.3; 101; 50.5; 101	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0717_54f3d47d-22f7-4622-a272-f4a270a7cb73	11822-0717	HUMAN OTC DRUG	day severe cold night cold and flu		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl, doxylamine succinate	KIT		20170628		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-0724_e9f0c0a7-ac1c-411b-b372-2823eef97c23	11822-0724	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20220121		OTC MONOGRAPH FINAL	part335	Rite Aid Corporation	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-0730_93e76751-0d7b-4524-bdc9-45d75ae21ed3	11822-0730	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20010301		ANDA	ANDA074164	Rite Aid Corporation	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-0731_485227b4-cd24-46e9-8807-7cebc9a51e39	11822-0731	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20190531		ANDA	ANDA207342	Rite Aid Corporation	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-0732_24df684d-dbc7-417b-9875-819e09bda72d	11822-0732	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20190531		ANDA	ANDA207342	Rite Aid Corporation	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-0733_f89b26fe-affe-4d12-b2e0-c66447754554	11822-0733	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190228		ANDA	ANDA209692	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0734_b941bfce-13df-4b70-b502-f23f1e17a5c7	11822-0734	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130119		ANDA	ANDA203690	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0736_3c8e3b20-d597-4370-9992-36fca4806445	11822-0736	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20220114		OTC MONOGRAPH FINAL	part335	Rite Aid Corporation	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-0738_97ecdad6-f67f-4093-85a6-df37ed74ef7b	11822-0738	HUMAN OTC DRUG	Flu HBP	Maximum Strength	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20200724		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0763_9e009172-1c45-480b-bf2b-8435c3f71a90	11822-0763	HUMAN OTC DRUG	severe cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20140627		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0766_e6b498fa-dd42-4e2d-8f89-ebe1b849b74d	11822-0766	HUMAN OTC DRUG	infants fever reducer and pain reliever		Acetaminophen	SUSPENSION	ORAL	20111207		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11822-0775_5de5ef73-f633-42cc-82df-1bce212e81f9	11822-0775	HUMAN OTC DRUG	Less Drowsy Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20190630		OTC MONOGRAPH DRUG	M009	Rite Aid Corporation	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
11822-0776_3e01f31a-3b76-4097-ba54-61cd2c62dc7c	11822-0776	HUMAN OTC DRUG	Sunburn Relief		Lidocaine HCl 0.5%	GEL	TOPICAL	20191230		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-0780_f31ce6f6-14bb-d806-e053-2a95a90a1d59	11822-0780	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20210201		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	TOLNAFTATE	1.5	g/150g			N	20241231
11822-0781_f31cce26-8156-448f-e053-2a95a90ad84b	11822-0781	HUMAN OTC DRUG	Tolnaftate		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20201115		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	TOLNAFTATE	.3	g/30mL			N	20241231
11822-0782_f395605b-f5f8-78d8-e053-2a95a90a317d	11822-0782	HUMAN OTC DRUG	Tolnaftate		Jock Itch Powder	AEROSOL, SPRAY	TOPICAL	20210315		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	TOLNAFTATE	1.3	g/130g			N	20241231
11822-0788_f6075fe4-84b6-3b21-e053-2a95a90a9f99	11822-0788	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20200415		NDA	NDA021920	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0789_a35f6b2b-8e67-dd2d-e053-2995a90a27e1	11822-0789	HUMAN OTC DRUG	IBUPROFEN, DIPHENHYDRAMINE HCL		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200415		ANDA	ANDA090397	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0790_c1f65989-651a-4ff0-8de6-e071c7e1ad89	11822-0790	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20221114		OTC MONOGRAPH DRUG	505G(a)(3)	Rite Aid Corporation	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-0798_7d7018c2-f65c-4284-98a5-a90e2f3bd479	11822-0798	HUMAN OTC DRUG	minoxidil		Minoxidil	SOLUTION	TOPICAL	20160818		ANDA	ANDA075598	Rite Aid Corporation	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-0800_a2cac1f6-5633-4f3b-91a3-231409e2cf97	11822-0800	HUMAN OTC DRUG	Miconazole 3		Miconazole nitrate	KIT		20140212		ANDA	ANDA076357	Rite Aid Corporation						N	20241231
11822-0801_b47c9bf7-a06e-438c-a1f1-586de030be5c	11822-0801	HUMAN OTC DRUG	childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20230407		ANDA	ANDA210033	Rite Aid Corporation	LORATADINE	5	mg/1			N	20241231
11822-0812_616ccb0b-0c37-4337-88f0-51810bb9da2c	11822-0812	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
11822-0817_0d178573-e0c6-488f-b1c1-844bf003d260	11822-0817	HUMAN OTC DRUG	Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20130930		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11822-0839_537633a0-cfae-46ba-8739-c7f926fa6b87	11822-0839	HUMAN OTC DRUG	childrens mucus relief multi symptom cold		dextromethorphan HBr, guaifenesin, phenylephrine HCl	LIQUID	ORAL	20140604		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0851_604b7eaa-d9ff-4992-a8b8-98d971bf4cb4	11822-0851	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20190830		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-0854_1d0e7562-06c6-4623-825f-423e06d6e7aa	11822-0854	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20071221		ANDA	ANDA078546	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0861_d6c0e031-66bd-4a15-a892-2880f85d5d00	11822-0861	HUMAN OTC DRUG	Oil Free Moisturizer		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20160225		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; OCTINOXATE; OCTISALATE	30.6; 76.5; 51	mg/mL; mg/mL; mg/mL			N	20241231
11822-0862_085fb318-8d45-447b-9694-73c3e6d2839d	11822-0862	HUMAN OTC DRUG	Stool Softener Laxative		Docusate sodium	CAPSULE	ORAL	20200430		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-0866_6b56acf1-4e3b-4ec5-a702-251acea30d22	11822-0866	HUMAN OTC DRUG	lice		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070725		OTC MONOGRAPH FINAL	part358G	Rite Aid Corporation	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
11822-0870_54f8fa3c-2ed3-4b04-8b92-8b996c279f49	11822-0870	HUMAN OTC DRUG	Diclofenac Sodium		diclofenac sodium	GEL	TOPICAL	20220823		ANDA	ANDA211253	Rite Aid Corporation	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0871_78f82c54-942a-4735-8e8a-aa73142df632	11822-0871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19930111		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	HYDROGEN PEROXIDE	.3	kg/100L			N	20241231
11822-0873_b0617b04-b98f-4879-9c37-6f6b3d6ec2d8	11822-0873	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060224		ANDA	ANDA077007	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0876_060aea1d-9048-42ae-b49f-0e98ed6476ef	11822-0876	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20090518		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	ALCOHOL	610	mg/mL			N	20241231
11822-0891_09bce019-f905-6ea0-e063-6294a90ac036	11822-0891	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20210414		NDA	NDA019125	Rite Aid	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
11822-0894_0c13c48d-fee7-40a9-81b2-8fbc4531d10b	11822-0894	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200131		ANDA	ANDA206999	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0895_ac187baa-596a-49ed-94d5-2ddac52d1ed1	11822-0895	HUMAN OTC DRUG	Severe Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20200608		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0897_535d523a-24ee-46d8-bf36-5f4a449f329d	11822-0897	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19990108		ANDA	ANDA074937	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-0898_42f3485a-615c-4f59-8159-5f6867f0b6f4	11822-0898	HUMAN OTC DRUG	esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Rite Aid Corporation	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-0901_357aca8f-cf23-4b4f-9291-f23e5b7af74a	11822-0901	HUMAN OTC DRUG	allergy nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20201119		ANDA	ANDA207957	Rite Aid Corporation	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-0903_dcf2348c-3f3e-40b5-a5a8-d3f5b0192c96	11822-0903	HUMAN OTC DRUG	Mini Nicotine		nicotine polacrilex	LOZENGE	ORAL	20200730		ANDA	ANDA210711	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0904_d168171f-c81d-46d6-937e-1fe6e8e71531	11822-0904	HUMAN OTC DRUG	nictoine gum		Nicotine polacrilex	GUM, CHEWING	ORAL	20170117		ANDA	ANDA206394	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0905_a90ff6d9-b45b-4ef7-974b-c004e4a114fc	11822-0905	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20200801		ANDA	ANDA212056	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0915_d6ea9fab-5820-401b-9ed1-a36b95afc717	11822-0915	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080225		NDA	NDA022032	Rite Aid Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-0918_eea30e0e-54de-48ef-b2c1-4b3a61f06542	11822-0918	HUMAN OTC DRUG	Childrens Dye Free Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20230501		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0919_754e27cd-8990-46b7-9325-16e1765c0807	11822-0919	HUMAN OTC DRUG	loratadine		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200925		ANDA	ANDA076011	Rite Aid Corporation	LORATADINE	10	mg/1			N	20241231
11822-0922_24546b94-3c70-4ff1-93ef-3f8be747b025	11822-0922	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalat, Octocrylene	LOTION	TOPICAL	20211130		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0924_3b2103d5-d386-4bf4-96a3-4442373a36ee	11822-0924	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211202		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-0926_ea363a4d-78ad-4fc1-86a0-7bf3bcd07685	11822-0926	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210521		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
11822-0929_dd5d6ad9-d7ed-4c15-bede-3acea529868e	11822-0929	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210302		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
11822-0938_fc7bd26b-7385-436c-8e0a-147a0b378a75	11822-0938	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210521		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
11822-0940_2585887a-7b00-4be2-96ae-efb11aec7061	11822-0940	HUMAN OTC DRUG	severe vapor ice cold and flu relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20200717		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0941_72a14fc7-092c-4914-8100-aa72b7eeaf21	11822-0941	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
11822-0942_5cd6eb99-fd0c-4e84-8311-411d9ac43ff2	11822-0942	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
11822-0943_e07b8535-5e1b-4e6a-b55e-566fc62f0c55	11822-0943	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
11822-0945_78fba815-862c-4672-b409-f69e235cffba	11822-0945	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
11822-0946_9f92d1cd-b335-4b8f-8272-51b9ff728edb	11822-0946	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
11822-0947_2223d1c1-2ffc-4224-b171-58f75231e5c0	11822-0947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20090512		OTC MONOGRAPH FINAL	part333D	Rite Aid	SALICYLIC ACID	20.6	mg/mL			N	20241231
11822-0949_7d2f8ff0-43a6-4682-ab2a-dfe5a1935173	11822-0949	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
11822-0951_bc34cf29-642d-40e1-82cd-c14b9afd615f	11822-0951	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20200701	20241231	ANDA	ANDA208754	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	
11822-0955_efc494f4-8180-4ff2-aa20-fc04bd1d922a	11822-0955	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130113		OTC MONOGRAPH NOT FINAL	part333A	RITE AID	ALCOHOL	70	mL/100mL			N	20241231
11822-0957_5d2391ab-a59e-4d4c-9d1a-49011965125a	11822-0957	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130119		ANDA	ANDA203690	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0958_0639cf29-2773-4768-8e66-1948d5e629aa	11822-0958	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20130724		ANDA	ANDA091135	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-0959_24a47c0a-d8a5-45f7-9a75-d75696fa2d9b	11822-0959	HUMAN OTC DRUG	childrens fever reducer and pain reliever		Acetaminophen	SUSPENSION	ORAL	20200717		OTC MONOGRAPH NOT FINAL	part343	Rite Aid Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
11822-0964_5fd4d298-25c4-4395-aaa4-315dac4622b8	11822-0964	HUMAN OTC DRUG	severe cold cough and flu relief	nighttime	Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20150724		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-0971_ec9b8844-ee54-47a1-90be-c7d93279eb94	11822-0971	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20201211		ANDA	ANDA206393	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-0980_af8c8355-7725-46d2-9cc3-84663d9749c4	11822-0980	HUMAN OTC DRUG	all day allergy		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220610		ANDA	ANDA213105	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-0990_94d69d41-b3e3-4395-a3d6-dec72233eb7f	11822-0990	HUMAN OTC DRUG	nose		Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	19890815		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-1001_a8fe109a-bd60-2fb3-e053-2a95a90ae7bd	11822-1001	HUMAN OTC DRUG	Daylogic Oil-free Cleansing wipe for acne-prone skin	pink grapefruit	salicylic acid	CLOTH	TOPICAL	20170101		OTC MONOGRAPH FINAL	part333D	Rite Aid	SALICYLIC ACID	20	mg/mL			N	20241231
11822-1002_6c4b2dd2-0897-4bcb-a570-6bc6f5332828	11822-1002	HUMAN OTC DRUG	all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20210914		ANDA	ANDA078336	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-1003_2c03f0e1-119f-402e-8443-f1938d504fde	11822-1003	HUMAN OTC DRUG	anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20190103		ANDA	ANDA209837	Rite Aid Corporation	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
11822-1007_e3ec7d1d-9699-4050-ab4d-811ba28d7c3b	11822-1007	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20201211		ANDA	ANDA203690	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-1013_7a2ae81f-03ee-4c21-8121-1f1d29240a2a	11822-1013	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate,Otisalate, Octocrylene	SPRAY	TOPICAL	20211206		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 225; 250; 1000	mg/g; mg/g; mg/g; mg/g			N	20241231
11822-1014_29a6dae5-4a6f-4a9a-b281-088340cf52a0	11822-1014	HUMAN OTC DRUG	acid relief		famotidine	TABLET, FILM COATED	ORAL	20220331		ANDA	ANDA077351	Rite Aid Corporation	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11822-1015_fc4b2635-280c-267f-e053-6294a90a5e22	11822-1015	HUMAN OTC DRUG	Rite Aid Hot and Cold Roll On		Menthol 16%	LIQUID	TOPICAL	20230522		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	MENTHOL	16	g/100g			N	20241231
11822-1019_04772dfa-6b49-4df3-9898-16c7d6738923	11822-1019	HUMAN OTC DRUG	allergy and congestion relief		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180606		ANDA	ANDA076050	Rite Aid Corporation	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-1029_ea92855f-15e7-4671-a9d9-0534cf034581	11822-1029	HUMAN OTC DRUG	Rite Aid Pharmacy Extra Strength	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190321		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	750	mg/1			N	20241231
11822-1033_695f63d4-820c-4b1b-bf8b-c7a2569d0fa3	11822-1033	HUMAN OTC DRUG	minoxidil		minoxidil	SOLUTION	TOPICAL	20210529		ANDA	ANDA075598	Rite Aid Corporation	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-1037_49c18a23-0e0f-4352-9723-f61e6bc40da9	11822-1037	HUMAN OTC DRUG	Rite Aid Ultra Strength	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190320		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-1039_6ffcd947-c8fb-4a4d-a37c-eaa45ef634c8	11822-1039	HUMAN OTC DRUG	Extra Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191118		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	750	mg/1			N	20241231
11822-1040_738fbe10-8961-49e1-b353-a3d4a1c03515	11822-1040	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180329		NDA	NDA209400	Rite Aid Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-1050_b53c0456-7486-401e-bcae-eafb2362ba68	11822-1050	HUMAN OTC DRUG	Rite Aid Extra Strength		Aluminum Hydroxide and Magnesium Carbonate	TABLET, CHEWABLE	ORAL	20221213		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
11822-1051_d4389ee4-792b-42dc-94a1-c51df17d8594	11822-1051	HUMAN OTC DRUG	Rite Aid Extra Strength		aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20190314		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
11822-1055_7eefe0d0-6dd0-4fce-bde2-78aa40484fbb	11822-1055	HUMAN OTC DRUG	Allergy Relief D		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200505		ANDA	ANDA076050	Rite Aid Corporation	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-1067_0d385aa4-0522-b4c5-e063-6294a90a65f8	11822-1067	HUMAN OTC DRUG	Rite Aid Eye Drops Dry Eye Relief		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION	OPHTHALMIC	20230421		OTC MONOGRAPH DRUG	M018	Rite Aid Corporation	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
11822-1070_e33898d8-1b8c-5c0b-e053-2995a90add08	11822-1070	HUMAN OTC DRUG	Rite Aid Anti-Itch		Diphenhydramine HCl 2%	GEL	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	DIPHENHYDRAMINE HYDROCHLORIDE	2	g/100mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-1083_0e6936cf-227e-4381-8c4d-0bf4b320037e	11822-1083	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211202		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 8	g/g; g/g; g/g; g/g			N	20241231
11822-1103_56b1c2dc-225e-4760-99a8-ae22075816b1	11822-1103	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230626		ANDA	ANDA206393	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-1105_435e716b-2ffa-4285-9e8a-1f61ffab20d3	11822-1105	HUMAN OTC DRUG	First Aid Bacitracin Zinc		bacitracin zinc	OINTMENT	TOPICAL	20120223		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
11822-1110_7a72665c-c0ed-44f0-91d2-43a2d7802804	11822-1110	HUMAN OTC DRUG	Rite Aid	antifungal ringworm	Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-1121_67aa3237-e4c1-4653-9e1f-735caf150f5f	11822-1121	HUMAN OTC DRUG	migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20220308		ANDA	ANDA075794	Rite Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11822-1131_0c669cd4-d49e-76d9-e063-6394a90a9304	11822-1131	HUMAN OTC DRUG	Acetaminophen and Ibuprofen (NSAID)		Acetaminophen and Ibuprofen (NSAID)	TABLET	ORAL	20230721		ANDA	ANDA216592	RITE AID	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
11822-1156_ffce6a8b-3ed3-45fa-9e51-9ea2a97edd92	11822-1156	HUMAN OTC DRUG	Rite Aid Extra Strength	Assorted Fruits	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190314		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-1166_c2fa9b99-8f97-4718-8411-e2d9d8b657a8	11822-1166	HUMAN OTC DRUG	Extra Strength Smooth	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191119		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-1173_19b4de08-d9f1-4a95-98f5-349799a1dcbf	11822-1173	HUMAN OTC DRUG	Tussin Cough and Chest Congestion DM	adult	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20211119		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-1177_f562cd36-c9ac-4952-9ab0-bfaa7b4a447e	11822-1177	HUMAN OTC DRUG	childrens allergy nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20210122		ANDA	ANDA207957	Rite Aid Corporation	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-1181_cf3b7248-a2b3-4eb5-9bf7-1b98369ecba1	11822-1181	HUMAN OTC DRUG	Rite Aid Ultra Zinc Cold Therapy		Zincum Gluconicum	TABLET, CHEWABLE	ORAL	20200415		UNAPPROVED HOMEOPATHIC		RITE AID CORPORATION	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-1182_5db029f1-6179-479c-9343-6ff23f191a7f	11822-1182	HUMAN OTC DRUG	Rite Aid Zinc Cold Therapy		ZINCUM GLUCONICUM	TABLET, CHEWABLE	ORAL	20200414		UNAPPROVED HOMEOPATHIC		RITE AID CORPORATION	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-1183_5ab660a5-e7f5-4475-a5d5-85df1526dc46	11822-1183	HUMAN OTC DRUG	Rite Aid Zinc Cold Therapy		Zincum Gluconicum	TABLET	ORAL	20200413		UNAPPROVED HOMEOPATHIC		RITE AID CORPORATION	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-1189_614896dc-f825-48ba-8e68-47a6a0bc553a	11822-1189	HUMAN OTC DRUG	childrens allergy relief		Cetirizine HCl	SOLUTION	ORAL	20220623		ANDA	ANDA204226	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-1190_70261321-bcb7-4369-a4e9-e693cff109f8	11822-1190	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220413		NDA	NDA022032	Rite Aid Corporation	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-1194_43596294-66ff-45df-a504-4d782505fa0f	11822-1194	HUMAN OTC DRUG	acid relief		Famotidine	TABLET, FILM COATED	ORAL	20230315		ANDA	ANDA077351	Rite Aid Corporation	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11822-1199_6f2cba14-d766-4d2a-8d9c-0463963d882f	11822-1199	HUMAN OTC DRUG	laxative		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230118		ANDA	ANDA090685	Rite Aid Corporation	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-1200_19889912-e242-45db-bdfd-919d124a1a60	11822-1200	HUMAN OTC DRUG	Tussin Cough and Chest Congestion DM Max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180802		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-1222_0c93ce87-317a-1617-e063-6394a90a618d	11822-1222	HUMAN OTC DRUG	EarWax Removal Kit	Rite Aid	Carbamide Peroxide 6.5%	KIT		20111004		OTC MONOGRAPH DRUG	M014	Rite Aid						N	20241231
11822-1224_0c93bf8d-eab3-1947-e063-6394a90acc0f	11822-1224	HUMAN OTC DRUG	EAR WAX RMVL	Rite Aid	Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20111004		OTC MONOGRAPH DRUG	M014	Rite Aid	CARBAMIDE PEROXIDE	6.5	g/100mL			N	20241231
11822-1233_0c93a4bc-8f42-0307-e063-6294a90acea4	11822-1233	HUMAN OTC DRUG	EAR DRYING AGENT		ISOPROPYL ALCOHOL 94.998% GLYCERIN 5%	LIQUID	AURICULAR (OTIC)	20111007		OTC MONOGRAPH DRUG	M014	Rite Aid	ISOPROPYL ALCOHOL	94.998	g/100mL			N	20241231
11822-1247_faefdc97-c628-4095-9236-f49fc3653400	11822-1247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20170827		OTC MONOGRAPH FINAL	part347	Rite Aid	PETROLATUM	410	mg/g			N	20241231
11822-1254_072620fd-09e5-400c-883c-a848d79f9749	11822-1254	HUMAN OTC DRUG	Rite Aid Digestive Relief		Bismuth Subsalicylate	TABLET, FILM COATED	ORAL	20200331		OTC MONOGRAPH DRUG	M008	RITE AID CORPORATION	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
11822-1260_e90c267c-5147-4588-9203-244d9056f581	11822-1260	HUMAN OTC DRUG	hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20220823		ANDA	ANDA075598	Rite Aid Corporation	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-1297_fd152c8f-6df6-1236-e053-6394a90a865d	11822-1297	HUMAN OTC DRUG	Rite Aid Scar		Allantoin 0.5%	GEL	TOPICAL	20220915		OTC MONOGRAPH FINAL	M016	Rite Aid	ALLANTOIN	.5	g/100g			N	20241231
11822-1323_e4746e27-c2e0-470d-b8ca-85a768c5a2a4	11822-1323	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20220307		ANDA	ANDA075357	Rite Aid Corporation	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
11822-1330_13a016c8-9c54-469b-bce7-336a89fa48fc	11822-1330	HUMAN OTC DRUG	back and muscle pain		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190606		ANDA	ANDA074661	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-1332_4b7795c3-342b-4eff-9f33-f0dbf65531b6	11822-1332	HUMAN OTC DRUG	tussin cough chest congestion		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20230302		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-1343_e2c09e85-be0b-4e6d-e053-2995a90ad756	11822-1343	HUMAN OTC DRUG	Rite Aid Pain Relieving		Benzocaine 20%, Menthol 0.5%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	BENZOCAINE; MENTHOL	20; .5	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-1372_08b46133-0d84-40b1-9597-a6e19d3de51d	11822-1372	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH DRUG	M007	Rite Aid Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-1400_42b3eaa1-69ca-4825-b93b-821e82bc478c	11822-1400	HUMAN OTC DRUG	tussin severe cough cold flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230405		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-1405_5593f822-8179-4f52-a9b3-2136be90c746	11822-1405	HUMAN OTC DRUG	Rite Aid Zinc SPF 50		OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20160107		OTC MONOGRAPH NOT FINAL	part352	Rite Aid	OCTOCRYLENE; ZINC OXIDE	4; 5	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-1462_a1487c32-cd92-43b5-8630-c41ae1ebfa00	11822-1462	HUMAN OTC DRUG	Sore Mouth Cleanser		Hydrogen Peroxide	MOUTHWASH	TOPICAL	20120203		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	HYDROGEN PEROXIDE	1588	mg/mL			N	20241231
11822-1512_642ae50a-b5a9-4c77-bedb-b4168b518510	11822-1512	HUMAN OTC DRUG	Kids Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191104		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
11822-1521_5414aa44-3cb9-4a85-a781-631929b4cede	11822-1521	HUMAN OTC DRUG	childrens ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20200403		ANDA	ANDA076359	Rite Aid Corporation	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-1536_efe61aa3-529c-ecdc-e053-2995a90aa3c7	11822-1536	HUMAN OTC DRUG	Rite Aid Original Sterile Eye		Tetrahydrozoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20160421		OTC MONOGRAPH FINAL	part349	Rite Aid Corporation	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
11822-1565_0c053d9f-ebef-61fc-e063-6394a90a2718	11822-1565	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210504		OTC MONOGRAPH DRUG	M010	RITE AID CORPORATION	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-1566_0c054552-a2c9-d30b-e063-6294a90ac293	11822-1566	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210603		OTC MONOGRAPH DRUG	M012	RITE AID CORPORATION	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-1569_0c055eef-1459-67a0-e063-6394a90aa2e7	11822-1569	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20211227		OTC MONOGRAPH DRUG	M002	RITE AID CORPORATION	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
11822-1570_0c055eef-145a-67a0-e063-6394a90aa2e7	11822-1570	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20211209		OTC MONOGRAPH DRUG	M002	RITE AID CORPORATION	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
11822-1571_0c05574c-f99f-5d92-e063-6394a90a9d00	11822-1571	HUMAN OTC DRUG	SENNA		Sennosides	CAPSULE, LIQUID FILLED	ORAL	20211227		OTC MONOGRAPH DRUG	M007	RITE AID CORPORATION	SENNOSIDES	8.6	mg/1			N	20241231
11822-1572_0c055e8b-a187-5f63-e063-6394a90ac75b	11822-1572	HUMAN OTC DRUG	LAXATIVE		Docusate sodium and Sennosides	CAPSULE, LIQUID FILLED	ORAL	20211227		OTC MONOGRAPH DRUG	M007	RITE AID CORPORATION	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
11822-1573_0c057139-0e1f-f234-e063-6294a90ab03f	11822-1573	HUMAN OTC DRUG	Gentle Stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20221107		OTC MONOGRAPH DRUG	M007	RITE AID CORPORATION	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-1574_0c05574c-f9a2-5d92-e063-6394a90a9d00	11822-1574	HUMAN OTC DRUG	Gentle Stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20221107		OTC MONOGRAPH DRUG	M007	RITE AID CORPORATION	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-1575_0c05770e-40d0-fb46-e063-6294a90a64ab	11822-1575	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20221213		OTC MONOGRAPH DRUG	M013	RITE AID CORPORATION	ACETAMINOPHEN	500	mg/1			N	20241231
11822-1576_0c058647-13d9-7566-e063-6394a90a855f	11822-1576	HUMAN OTC DRUG	Maximum Strength Severe Sinus Pressure, Pain and Cough Relief		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20221213		OTC MONOGRAPH DRUG	M012	RITE AID CORPORATION	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-1583_1cd1fa5d-2a9c-4348-b3ff-78050bbaeb4c	11822-1583	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20200131		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-1590_36bb3b5d-8f08-49d0-84f3-8ffe066ae5e2	11822-1590	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen, Aspirin and caffeine	TABLET, FILM COATED	ORAL	19921117		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11822-1591_32bbd792-f102-4e8e-8815-02355bfa76a6	11822-1591	HUMAN OTC DRUG	day cold and flu night cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20200129		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-1603_005c2190-a0bb-1581-e063-6394a90a2e1b	11822-1603	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	KIT	TRANSDERMAL	20210915		ANDA	ANDA074612	Rite Aid Corporation						N	20241231
11822-1616_f21502e4-7368-05c7-e053-2a95a90a9336	11822-1616	HUMAN OTC DRUG	Toothache and Gum Relief Cushions		Benzocaine	DRESSING	ORAL	20200626		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE; MENTHOL	10; .25	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-1630_12211e3c-a608-4668-b85c-db9a0bf55762	11822-1630	HUMAN OTC DRUG	tussin cough and chest congestion		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220608		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-1645_18471e7d-1097-45b9-b9a9-54786fe6097f	11822-1645	HUMAN OTC DRUG	loperamide hydrochloride		loperamide HCl	SUSPENSION	ORAL	20120523		ANDA	ANDA091292	Rite Aid Corporation	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
11822-1685_d8f7ad47-1017-4ccc-a63a-0e4b6d55865e	11822-1685	HUMAN OTC DRUG	childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20230407		ANDA	ANDA074937	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-1700_abfdc6d0-c6cf-a30c-c8f3-60d0ab7c3df2	11822-1700	HUMAN OTC DRUG	Budesonide		Budesonide	SPRAY, METERED	NASAL	20191010		ANDA	ANDA078949	Rite Aid	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-1761_776459c6-60b3-4ed4-b09d-d3703fa06f6c	11822-1761	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20180228	20241231	ANDA	ANDA074916	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
11822-1812_f61c91ea-be88-4994-9c34-4a794093dfa2	11822-1812	HUMAN OTC DRUG	mucus relief DM MAX		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230313		ANDA	ANDA207602	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-1879_0d866479-be7c-dea5-e063-6294a90a005d	11822-1879	HUMAN OTC DRUG	Dye-Free Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210430		ANDA	ANDA078682	RITE AID CORPORATION	IBUPROFEN	200	mg/1201	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-1914_89f38d89-d6f6-4932-b0b4-6af4ed4aa9de	11822-1914	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-1920_99b83d0b-60d4-4fb1-ae99-b562eeecbea9	11822-1920	HUMAN OTC DRUG	sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 120; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-1978_6779dd68-9994-49d8-9836-ee4dd3f2af09	11822-1978	HUMAN OTC DRUG	sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211013		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-1987_c9323799-3506-d6c1-e053-2995a90a6f43	11822-1987	HUMAN OTC DRUG	MULTI-SYMPTOM COLD AND FLU RELIEF NIGHTTIME		ACETAMINOPHEN 325 mg DEXTROMETHORPHAN HBr 15 mg DOXYLAMINE SUCCINATE 6.25 mg	CAPSULE, LIQUID FILLED	ORAL	20210915		OTC MONOGRAPH FINAL	part341	RITE AID	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-1988_f0b71e60-6bf0-5e2e-e053-2a95a90a3abd	11822-1988	HUMAN OTC DRUG	MULTI-SYMPTOM COLD AND FLU RELIEF DAYTIME NIGHTTIME		Acetaminophen Dextromethorphan HBr Phenylephrine HCl and Acetominophen Dextromethorphan HBr Doxylamine Succinate	KIT		20210915		OTC MONOGRAPH FINAL	part341	RITE AID						N	20241231
11822-1989_c92dbbbb-d14a-1e7e-e053-2a95a90a6f1a	11822-1989	HUMAN OTC DRUG	MULTI-SYMPTOM COLD AND FLU RELIEF DAYTIME		ACETAMINOPHEN 325 mg DEXTROMETHORPHAN HBr 10 mg PHENYLEPHRINE HCI 5 mg	CAPSULE, LIQUID FILLED	ORAL	20210915		OTC MONOGRAPH FINAL	part341	RITE AID	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-2019_e1b87215-1b9d-442b-a1c7-41311d39372c	11822-2019	HUMAN OTC DRUG	Rite Aid Extra Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190314		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	750	mg/1			N	20241231
11822-2022_c3413e54-489d-036f-e053-2995a90a8087	11822-2022	HUMAN OTC DRUG	ALLERGY RELIEF		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20210601		ANDA	ANDA202538	Rite Aid Corporation	LORATADINE	10	mg/1			N	20241231
11822-2025_8e023730-6d7d-408b-b844-e8e1f48472a8	11822-2025	HUMAN OTC DRUG	Rite Aid Fiber Caplets		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20200420		OTC MONOGRAPH DRUG	M007	RITE AID CORPORATION	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
11822-2039_8060090b-198e-4395-8a0d-025af380cac4	11822-2039	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-2050_671a6f4d-be97-4991-90a5-69eeb39592bf	11822-2050	HUMAN OTC DRUG	daytime nighttime severe cold cough and flu relief		acetaminophen, dextromethorphan HBr, phenylephrine HCl, diphenhydramine HCl	KIT		20190624		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-2055_53db7d8a-e284-4659-be33-3e6d3c54371b	11822-2055	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211208		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
11822-2061_793071a1-f6df-4b14-ba5b-5a1bdffa0d14	11822-2061	HUMAN OTC DRUG	daytime nighttime severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20230613		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-2069_5a9e2e75-d9cf-44dc-bb00-b9b0e8da641b	11822-2069	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone Acetate	CREAM	TOPICAL	20220128		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-2090_14b619e3-86c6-45eb-9341-c4869f3afd9f	11822-2090	HUMAN OTC DRUG	Hydrocortisone	Plus 12 Moisturizers	Hydrocortisone	CREAM	TOPICAL	20230721		OTC MONOGRAPH NOT FINAL	part348	RITE AID CORPORATION	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-2099_a6b14412-388e-4e22-8295-3d27af0ec6e8	11822-2099	HUMAN OTC DRUG	Rite Aid	anti-itch	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-2100_70b93a28-8be8-42d7-b6eb-8d162283b2a8	11822-2100	HUMAN OTC DRUG	Athletes Foot		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	Rite Aid Corporation	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
11822-2102_5d39f492-09a8-4d3d-a658-e34747b1188a	11822-2102	HUMAN OTC DRUG	Rite Aid	childrens allergy relief	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-2106_0ac042b2-2867-48a4-b96c-04a214e18af4	11822-2106	HUMAN OTC DRUG	Rite Aid	childrens allergy relief	Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-2119_ecc21e75-1265-43bf-93fc-79fcef4a0f96	11822-2119	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCL	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-2123_f1887ccc-2d2a-4c36-8cca-1d2f22199495	11822-2123	HUMAN OTC DRUG	mucus relief		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20221205		ANDA	ANDA078912	Rite Aid Corporation	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-2128_1a8844da-40e5-456b-966e-a01e8d0f9946	11822-2128	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200131		ANDA	ANDA079219	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-2131_dfebc06e-d648-4ae9-b16d-58e07b9f61dd	11822-2131	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Rite Aid Corporation	LORATADINE	5	mg/5mL			N	20241231
11822-2163_09467616-841f-4290-9576-0e6ab68f0617	11822-2163	HUMAN OTC DRUG	Rite Aid Pharmacy Antibiotic With Pain Relief		Antibiotic With Pain Relief	CREAM	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part348	RITE AID	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-2180_3fa52760-df69-4a15-a021-5c9b959c7528	11822-2180	HUMAN OTC DRUG	Pain Relief Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	19900912		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-2219_380c3b71-0cc2-4fa7-84e7-924d521392b8	11822-2219	HUMAN OTC DRUG	mucus relief DM		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230315		ANDA	ANDA207602	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-2221_90557ec6-d871-496a-86e0-9ff9cf08dedf	11822-2221	HUMAN OTC DRUG	Rite Aid Fiber Therapy		Methylcellulose	TABLET	ORAL	20190312		OTC MONOGRAPH DRUG	M007	RITE AID CORPORATION	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
11822-2252_c5c6f09f-4ea3-4f36-89ce-76f9c356be81	11822-2252	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20191227		ANDA	ANDA207342	Rite Aid Corporation	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-2260_f6fe68e5-f25e-409f-a1f0-eed7221ccf69	11822-2260	HUMAN OTC DRUG	stay awake		caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	Rite Aid Corporation	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
11822-2270_b3b3d34c-67ca-45f6-a6c5-30f764be18ec	11822-2270	HUMAN OTC DRUG	aspirin	pain relief	Aspirin	TABLET, DELAYED RELEASE	ORAL	19921214		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-2331_b49927e5-090f-42f9-8121-cc3ecd57b235	11822-2331	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200131		ANDA	ANDA079216	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-2350_8176ddd9-539d-4197-a5da-9c8d75c8173a	11822-2350	HUMAN OTC DRUG	Pain Relief Acetaminophen PM	Extra Strength	Acetaminophen and Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19940515		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-2430_4f467e47-0366-4ea1-a544-a552726d1c6e	11822-2430	HUMAN OTC DRUG	Rite Aid Stomach Relief	Original Flavor	Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20200330		OTC MONOGRAPH DRUG	M008	RITE AID CORPORATION	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
11822-2552_efe6e7e9-63d6-16b8-e053-2995a90a1885	11822-2552	HUMAN OTC DRUG	Rite Aid Advanced Sterile Eye		Dextran 70, Polyethylene Glycol 400, Povidones, and Tetrahydrozoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20160421		OTC MONOGRAPH FINAL	part349	Rite Aid Corporation	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
11822-2685_0c580310-c4c4-2e53-e063-6394a90a83da	11822-2685	HUMAN OTC DRUG	Rite Aid Hydrocortisone		Hydrocortisone 1%	OINTMENT	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	Rite Aid	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-2700_e557c287-952a-4aa0-8fb0-2adae1650e6f	11822-2700	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin-B Sulfate, Pramoxine hydrochloride	OINTMENT	TOPICAL	20220225		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-2900_db60b07a-29aa-4c22-9d28-57bec84563a0	11822-2900	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin-B Sulfate	OINTMENT	TOPICAL	20220225		OTC MONOGRAPH FINAL	part333B	Rite Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
11822-2910_ca6a20be-ce70-477e-8270-36605cde2935	11822-2910	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part335	Rite Aid Corporation	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-2944_9e22d841-0921-4297-97b0-2776b71d2e06	11822-2944	HUMAN OTC DRUG	Hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20200227		OTC MONOGRAPH FINAL	part346	Rite Aid Corporation	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-2985_dd756abf-1150-45f3-908f-fe23b7dd9899	11822-2985	HUMAN OTC DRUG	Sleep Aid	Night Time	Diphenhydramine HCl	CAPSULE	ORAL	20210430		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-3000_d5a90d8e-14ba-4744-adc0-fa624cbcc9d7	11822-3000	HUMAN OTC DRUG	sleep aid		Doxylamine Succinate	TABLET	ORAL	20230719		ANDA	ANDA040167	Rite Aid Corporation	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
11822-3009_68f657d4-6a6b-4c3d-a345-ba960e8f3237	11822-3009	HUMAN OTC DRUG	allergy relief-D		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA210719	Rite Aid Corporation	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-3016_9e70452a-ea42-4d13-adec-52abe82d0885	11822-3016	HUMAN OTC DRUG	RITE AID Pharmacy Ultra Strength	Assorted Fruits	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190313		OTC MONOGRAPH DRUG	M001	RITE AID CORPORATION	CALCIUM CARBONATE	1000	mg/1			N	20241231
11822-3024_5323c303-6e56-47a3-8a3d-31fdf63b840f	11822-3024	HUMAN OTC DRUG	Oral Sore Antiseptic		Hydrogen Peroxide, Menthol	LIQUID	ORAL	20211202		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	HYDROGEN PEROXIDE; MENTHOL	1.5; 1	mg/mL; mg/mL			N	20241231
11822-3061_df2294d0-ec80-45df-80fa-9c02abbd4e72	11822-3061	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20210604		ANDA	ANDA074916	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-3065_f9c1d61a-e514-8063-e053-6294a90a79ea	11822-3065	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM AND SENNOSIDES	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part334	RITE AID	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
11822-3078_0186cac6-8305-4b3e-8a59-114d623e33da	11822-3078	HUMAN OTC DRUG	Antifungal		Clotrimazole	CREAM	TOPICAL	20210226		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-3101_e29a9d59-4c7b-81aa-e053-2995a90a7056	11822-3101	HUMAN OTC DRUG	Rite Aid Cala Itch Relief		Pramoxine HCl 1%, Zinc Acetate 0.1%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	1; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-3108_ccc2777a-1394-4441-9c94-7b691f121fec	11822-3108	HUMAN OTC DRUG	Oral Care Antiseptic		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	19901015		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-3109_d2ebf8cd-4741-491d-abdb-63e62eddc40b	11822-3109	HUMAN OTC DRUG	Sore Throat		Phenol	SPRAY	ORAL	20211008		OTC MONOGRAPH DRUG	M022	Rite Aid Corporation	PHENOL	1.4	g/100mL			N	20241231
11822-3111_42339c71-757d-4926-94ac-f5fe81d2f49b	11822-3111	HUMAN OTC DRUG	Rite Aid Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20191125		UNAPPROVED DRUG OTHER		Rite Aid	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
11822-3115_e313350f-74da-370b-e053-2995a90aeeaf	11822-3115	HUMAN OTC DRUG	Ryshi SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	STICK	TOPICAL	20220705		OTC MONOGRAPH NOT FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 15; 5	g/100g; g/100g; g/100g			N	20241231
11822-3120_4f06f5e4-6a79-4941-b0fa-bf035e1ebdd3	11822-3120	HUMAN OTC DRUG	severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-3130_0c540422-1578-9217-e063-6294a90ad06a	11822-3130	HUMAN OTC DRUG	Rite Aid Anti-itch		HYDROCORTISONE	CREAM	TOPICAL	20230303		OTC MONOGRAPH DRUG	M017	Rite Aid	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11822-3135_dfa97a12-8d20-42f3-b9ac-fc8da4bf8c71	11822-3135	HUMAN OTC DRUG	Pure petroleum		White Petrolatum	JELLY	TOPICAL	20130710		OTC MONOGRAPH FINAL	part347	Rite Aid	PETROLATUM	1	g/g			N	20241231
11822-3138_c34948cf-b4db-4d9f-b6f4-0cbb12266afe	11822-3138	HUMAN OTC DRUG	Rite Aid Zinc Oxide		Zinc Oxide	OINTMENT	TOPICAL	20210915		OTC MONOGRAPH FINAL	part347	RITE AID	ZINC OXIDE	200	mg/g			N	20241231
11822-3155_fe1e2326-c776-4f70-bbd7-68ec8260930d	11822-3155	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20210430		OTC MONOGRAPH DRUG	M022	Rite Aid Corporation	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
11822-3165_262f7f2d-7f23-4336-b08d-4d49872bf50a	11822-3165	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	100	mg/1			N	20241231
11822-3197_40bc94e1-b0bf-4885-b925-adc8e9f05924	11822-3197	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20090112		OTC MONOGRAPH FINAL	part341	Rite Aid	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	kg/100kg; kg/100kg; kg/100kg			N	20241231
11822-3252_762bb7e6-4363-4dfc-af09-26e160456464	11822-3252	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20210924		ANDA	ANDA207342	Rite Aid Corporation	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-3276_28f026e0-9e49-40dd-b4e6-fc67c607b391	11822-3276	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	Rite Aid Corporation	LORATADINE	10	mg/1			N	20241231
11822-3307_06bc5fd1-cd5f-4914-afb2-825b660cb826	11822-3307	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200730		ANDA	ANDA078682	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-3310_c1b16cd1-8541-4c5d-89c9-9ad5d89a336c	11822-3310	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20210528		ANDA	ANDA074916	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-3311_cf693c9e-9b3e-44da-e053-2a95a90ad2e9	11822-3311	HUMAN OTC DRUG	SENNA		SENNOSIDES	TABLET, COATED	ORAL	20200818		OTC MONOGRAPH NOT FINAL	part334	RITE AID	SENNOSIDES A AND B	8.6	mg/1			N	20241231
11822-3312_0c004bf0-9027-5ffc-e063-6294a90a6c3c	11822-3312	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20111014		OTC MONOGRAPH DRUG	M007	Rite Aid Corporation	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
11822-3313_2d26a152-4e79-401e-900f-4b38bf5e040e	11822-3313	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20200131		ANDA	ANDA204794	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3314_0fa619a1-b6a7-4353-9cdf-5e3bc44755aa	11822-3314	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200131		ANDA	ANDA204833	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3315_53230591-2cd5-4b5a-a15b-dd69ad7b7c2a	11822-3315	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20191227		ANDA	ANDA207868	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3316_70087d90-52c1-4bfb-8d89-67f638d6daf1	11822-3316	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20191227		ANDA	ANDA209206	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3317_ed25aa6c-4135-4f85-af0b-fea22d07e1e7	11822-3317	HUMAN OTC DRUG	Maxi Nicotine		nicotine polacrilex	LOZENGE	ORAL	20191129		ANDA	ANDA209206	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3318_4d46a5c2-ab80-44b4-a09c-32f08b0a2443	11822-3318	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-3319_28a98fe8-38f9-4c2f-b80c-6154c89868d6	11822-3319	HUMAN OTC DRUG	Maxi Nicotine		nicotine polacrilex	LOZENGE	ORAL	20210709		ANDA	ANDA210712	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3321_0c00740b-aad6-e263-e063-6394a90a2d68	11822-3321	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20120216		OTC MONOGRAPH DRUG	M007	Rite Aid Corporation	GLYCERIN	1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
11822-3322_202f76af-0ef5-4e27-b194-b198c8379b13	11822-3322	HUMAN OTC DRUG	Nicotine Polacrilex Gum		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20200131		ANDA	ANDA079044	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3323_324bd921-4a43-4fff-9e61-541db729068f	11822-3323	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20200131		ANDA	ANDA074707	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3324_092d86c3-c9bb-70b8-e063-6394a90a82af	11822-3324	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID AND GAS RELIEF		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20140401		OTC MONOGRAPH DRUG	M001	RITE AID PHARMACY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-3325_c2a5ace7-7e54-460b-acf7-c1d387056115	11822-3325	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20191227		ANDA	ANDA078699	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3326_6c488d7a-8429-43d1-b80b-636114e99ab8	11822-3326	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20191227		ANDA	ANDA078697	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3328_8dec92c5-e8d6-4335-94a0-1d08a8b1702e	11822-3328	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20200131		ANDA	ANDA074507	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3329_092d7fb7-d4ed-69b2-e063-6394a90a0e18	11822-3329	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20140401		OTC MONOGRAPH DRUG	M007	RITE AID PHARMACY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-3335_c7af0f60-9659-4b8f-b1aa-b4817c704d48	11822-3335	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-3337_649d733d-8e2f-4f18-a2aa-bbaf366ca720	11822-3337	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200529		ANDA	ANDA079038	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3340_fd703aca-29c6-4f99-a7fc-258bbb236bc6	11822-3340	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	OIL	ORAL; TOPICAL	20190531		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	MINERAL OIL	100	mg/100mL			N	20241231
11822-3366_35fe05a8-0653-4856-bbe3-60b777336f77	11822-3366	HUMAN OTC DRUG	Mucus Relief Cold Flu Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL	LIQUID	ORAL	20190531		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-3370_2f06c1f9-adc3-4ef8-bd06-bb0ae9f089c3	11822-3370	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL	LIQUID	ORAL	20190531		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-3374_f913e5ab-44cd-4997-bda5-79d050165ebd	11822-3374	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20191129		ANDA	ANDA203187	Rite Aid Corporation	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-3379_2269ad84-797d-4191-9d6a-2def628b2669	11822-3379	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20200318		ANDA	ANDA210712	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3391_7f1d7deb-da6e-402f-94c6-9595f7164549	11822-3391	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20200430		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-3392_071b26fe-dcb6-41b3-b469-1d32228ae60b	11822-3392	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-3423_38e4f283-9311-49c0-91d5-880e8d29ebce	11822-3423	HUMAN OTC DRUG	Clotrimazole	Jock Itch	Clotrimazole	CREAM	TOPICAL	20230130		OTC MONOGRAPH FINAL	part333C	Rite Aid Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
11822-3450_3ae79d60-90d9-412b-b126-672b82ead813	11822-3450	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	20241231
11822-3451_f452ec0b-930b-4801-b905-aeda50db95c5	11822-3451	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20211231		ANDA	ANDA208754	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	20241231
11822-3489_73e94cce-a084-425b-89cd-8a4417f471d4	11822-3489	HUMAN OTC DRUG	Stool Softener	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	250	mg/1			N	20241231
11822-3500_06b78c29-8c57-c01a-e063-6294a90a555a	11822-3500	HUMAN OTC DRUG	First Aid Antiseptic Alcohol Pads Isopropyl Alcohol 70 Rite Aid		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20220201		OTC MONOGRAPH DRUG	M003	Rite Aid Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
11822-3622_8b2abd2a-247b-4fc6-9087-3cc9afc32616	11822-3622	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20191227		ANDA	ANDA207868	Rite Aid Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3627_6269d8bf-1c25-bf76-a7e6-adf42946c2b5	11822-3627	HUMAN OTC DRUG	NICOTINE	TRANSDERMAL	NICOTINE	KIT	TRANSDERMAL	20210331		NDA	NDA020076	Rite Aid Corporation						N	20241231
11822-3644_678c8e7e-1d5b-f12a-e053-2991aa0ab6cc	11822-3644	HUMAN OTC DRUG	EAR CARE EARACHE DROPS		ATROPA BELLADONNA, ANEMONE PULSATILLA, LYCOPODIUM CLAVATUM SPORE, MATRICARIA CHAMOMILLA, and SULFUR	LIQUID	AURICULAR (OTIC)	20170803		UNAPPROVED HOMEOPATHIC		Rite Aid Corporation	ANEMONE PULSATILLA; ATROPA BELLADONNA; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
11822-3670_cea428c7-692f-435e-ae7b-e79f9d5748d6	11822-3670	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-3678_098117db-ecc3-d9f3-e063-6394a90a05fc	11822-3678	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20130101		NDA	NDA019125	Rite Aid Corporation	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
11822-3689_a1ab6e69-e46b-471c-94ee-ada950fc7e46	11822-3689	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20220103		OTC MONOGRAPH FINAL	part347	Rite Aid Corporation	WITCH HAZEL	842	mg/mL			N	20241231
11822-3698_42d3992c-4055-a07b-1782-d0c716ef9d32	11822-3698	HUMAN OTC DRUG	Allergy Relief		Fexofenadine hydrochloride	TABLET	ORAL	20110103		ANDA	ANDA076502	Rite Aid Corporation	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-3700_5c8369d6-e4d6-476d-a26a-82508f029e65	11822-3700	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20150105		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	ALCOHOL	70	mL/100mL			N	20241231
11822-3702_cfb70659-31e8-48f3-e053-2995a90ae6df	11822-3702	HUMAN OTC DRUG	2 IN 1LAXATIVE STOOL SOFTENER AND STIULANT LAXATIVE		STOOL SOFTENER-STIMULANT LAXATIVE	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part334	RITE AID	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
11822-3709_09c37526-4fde-7bf6-e063-6394a90a6788	11822-3709	HUMAN OTC DRUG	Rite Aid Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20210301		OTC MONOGRAPH DRUG	M003	Rite Aid	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
11822-3722_aaf91d84-a854-495f-94c5-9315dfaa086b	11822-3722	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL	LIQUID	ORAL	20210917		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-3727_092e42a4-8df1-b92e-e063-6394a90a2fbd	11822-3727	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID AND GAS RELIEF		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20140401		OTC MONOGRAPH DRUG	M001	RITE AID PHARMACY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-3728_0cfa2cc7-bb7f-af55-e063-6394a90a28f0	11822-3728	HUMAN OTC DRUG	Rite Aid Lubricant Eye Drops Restorative Performance		propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190604		OTC MONOGRAPH DRUG	M018	Rite Aid Corporation	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
11822-3729_f41e9be4-153c-affe-e053-2a95a90a2d17	11822-3729	HUMAN OTC DRUG	Rite Aid Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20100629		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	MENTHOL, UNSPECIFIED FORM	50	g/1			N	20241231
11822-3775_0c93bbb5-cb31-1f6e-e063-6394a90a39f5	11822-3775	HUMAN OTC DRUG	Rite Aid Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Rite Aid Corporation	POVIDONE-IODINE	100	mg/mL			N	20241231
11822-3802_6617c17a-9b1a-4178-95ae-ecf50d417f19	11822-3802	HUMAN OTC DRUG	nicotine		nicotine polacrilex	LOZENGE	ORAL	20201211		ANDA	ANDA203690	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-3840_dcfb50ae-408a-4841-8ed4-eeaa49d2455c	11822-3840	HUMAN OTC DRUG	Tussin Cough DM	Sugar Free	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20190331		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-3927_3f959472-c555-431c-8d03-94cd8f083214	11822-3927	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20200701	20241231	ANDA	ANDA208754	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	
11822-3935_903f9878-8c37-4c1b-81f2-f29a90932d2e	11822-3935	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20200630		OTC MONOGRAPH DRUG	M003	Rite Aid Corporation	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
11822-3951_e9a2bd8d-a7f4-49cb-a434-eeb6cbf1c349	11822-3951	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20211231		ANDA	ANDA208754	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	20241231
11822-3977_7aa7224d-0584-4ee4-ae8a-e6c341e815eb	11822-3977	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20211231		ANDA	ANDA208754	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	20241231
11822-3990_0c769ff3-db68-4b22-8696-420fd931718c	11822-3990	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20200730		ANDA	ANDA212056	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-4004_cbb38220-c609-45c9-9a54-3ff732484d77	11822-4004	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20221205		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM FLUORIDE	.5	mg/mL			N	20241231
11822-4040_a1b09fd2-7536-43b7-a8a8-1d91fede936a	11822-4040	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, CHEWABLE	ORAL	20231110		OTC MONOGRAPH DRUG	M009	Rite Aid Corporation	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
11822-4099_071db018-ce1c-43c6-b99e-0ea1f9921ab4	11822-4099	HUMAN OTC DRUG	severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-4130_38c4c35d-81eb-4f77-9a9e-49e6442948f8	11822-4130	HUMAN OTC DRUG	pain relief back and body	EXTRA STRENGTH	Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20040412		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20251231
11822-4170_7835e45d-c45b-4d0c-804c-1d190b16e0d7	11822-4170	HUMAN OTC DRUG	Back and Muscle Pain		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220707		ANDA	ANDA204872	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-4171_25edb7a5-4217-4874-b690-317191a6144a	11822-4171	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220707		ANDA	ANDA204872	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-4210_e5819a56-e06e-cac9-e053-2995a90ac3ce	11822-4210	HUMAN OTC DRUG	CAPSAICIN HEAT PATCHES PAIN RELIEF		CAPSAICIN	PATCH	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	CAPSAICIN	.025	g/100g			N	20241231
11822-4212_ef6b81d1-0376-c812-e053-2995a90af0de	11822-4212	HUMAN OTC DRUG	Rite Aid Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20200316		OTC MONOGRAPH FINAL	part343	Rite Aid	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-4215_dfefd57b-2024-877c-e053-2a95a90a6502	11822-4215	HUMAN OTC DRUG	Rite Aid Pain Relief Cream with Lidocaine		Lidocaine Hydrochloride	CREAM	TOPICAL	20220501		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-4216_e08e67d9-8e88-63a5-e053-2995a90ae9ee	11822-4216	HUMAN OTC DRUG	Rite Aid Hot and Cold Pain Relief	Pain Relieving	Lidocaine HCl and Menthol	CREAM	TOPICAL	20220601		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	LIDOCAINE; MENTHOL	.4; .1	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-4228_e3c8a262-ed07-4ae0-be85-be55d3459695	11822-4228	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	CAPSULE	ORAL	20220624		ANDA	ANDA209107	RITE AID CORPORATION	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-4230_187ef5fa-2f21-4c8f-bec2-ccc880fce206	11822-4230	HUMAN OTC DRUG	Ivermectin		Ivermectin	LOTION	TOPICAL	20200506		ANDA	ANDA210720	Rite Aid Corporation	IVERMECTIN	5	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
11822-4258_cf674005-a266-40ec-86eb-8195d1f3ebce	11822-4258	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE	ORAL	20220624		ANDA	ANDA207753	RITE AID CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-4260_afdc12f3-6003-4da4-a148-2c7350e3b178	11822-4260	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220629		ANDA	ANDA210453	RITE AID CORPORATION	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-4300_64d870cd-3a5a-4e8e-90b1-51976f839910	11822-4300	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200131		OTC MONOGRAPH FINAL	part347	Rite Aid Corporation	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
11822-4301_f414ae4d-9bd3-43af-a6d7-c6fc24107f18	11822-4301	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190531		OTC MONOGRAPH FINAL	part332	Rite Aid Corporation	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
11822-4303_3819552f-a654-44f0-9401-1f038fb0d123	11822-4303	HUMAN OTC DRUG	citroma		Magesium Citrate	LIQUID	ORAL	20200922		OTC MONOGRAPH NOT FINAL	part334	Rite Aid	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-4320_68cfa88a-3b4f-4804-a46d-75d23f7b2523	11822-4320	HUMAN OTC DRUG	Rite Aid Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20200630		OTC MONOGRAPH DRUG	M008	RITE AID CORPORATION	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
11822-4330_e7422e3e-9afc-44c6-8be7-d036f1914643	11822-4330	HUMAN OTC DRUG	citroma		Magesium Citrate	LIQUID	ORAL	20200805		OTC MONOGRAPH NOT FINAL	part334	Rite Aid	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-4352_0c9402f4-357f-6421-e063-6394a90a6839	11822-4352	HUMAN OTC DRUG	Rite Aid Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Rite Aid Corporation	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
11822-4447_eca31f60-dd46-4eea-9e8d-17d8da3a7b6a	11822-4447	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20200529		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-4450_4f0af6b0-edd6-4568-bf3a-87f012cc18b5	11822-4450	HUMAN OTC DRUG	pain relief	childrens	acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	160	mg/1			N	20241231
11822-4454_9c3ac842-319b-4129-b37f-635666fd14b0	11822-4454	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20210528		OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-4461_7666ed58-ae08-46e9-bcbc-aa1c827956ae	11822-4461	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20200324		ANDA	ANDA076359	Rite Aid Corporation	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-4471_f4e9ba5f-379f-4f7a-9677-17edd4ff7f06	11822-4471	HUMAN OTC DRUG	Allergy Relief	childrens	Diphenhydramine HCl	LIQUID	ORAL	20220204		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-4484_bc03458c-885a-43f7-b05d-101a20aeb4ab	11822-4484	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20200904		OTC MONOGRAPH NOT FINAL	part343	Rite Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
11822-4530_dad354e5-bfe8-489c-9694-116b12b2c0a5	11822-4530	HUMAN OTC DRUG	Sinus Pressure and Congestion Relief PE	Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-4611_263773c8-556c-408a-b587-8b5235f2f96e	11822-4611	HUMAN OTC DRUG	headache relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220328		OTC MONOGRAPH NOT FINAL	part343	Rite Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11822-4763_49339a09-09cb-419a-9507-cb9f31db2d2a	11822-4763	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20211231	20241231	ANDA	ANDA208754	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	
11822-4892_8c0fe509-c127-410e-85f0-2fdabf5af31c	11822-4892	HUMAN OTC DRUG	Rite Aid Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		Rite Aid	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
11822-4894_d3431bf6-7115-470d-9aa6-214bc586a537	11822-4894	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20210129		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-4973_af9ef4aa-fceb-914e-8d8d-4908cc613556	11822-4973	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150514		NDA	NDA020076	Rite Aid Corporation	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-4974_af9ef4aa-fceb-914e-8d8d-4908cc613556	11822-4974	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150514		NDA	NDA020076	Rite Aid Corporation	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-4975_af9ef4aa-fceb-914e-8d8d-4908cc613556	11822-4975	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150514		NDA	NDA020076	Rite Aid Corporation	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-5005_f214f16a-9fc1-845f-e053-2995a90a13e0	11822-5005	HUMAN OTC DRUG	Complete Protection TP		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20211026		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	STANNOUS FLUORIDE	.454	g/100g			N	20241231
11822-5006_f215108e-7690-cf8f-e053-2995a90a1e29	11822-5006	HUMAN OTC DRUG	Gum Detoxify		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20211110		OTC MONOGRAPH FINAL	part355	Rite Aid	STANNOUS FLUORIDE	.454	g/100g			N	20241231
11822-5019_0c57061b-f042-53f1-e063-6294a90a766f	11822-5019	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211130		ANDA	ANDA211544	RITE AID	ACETAMINOPHEN	650	mg/1			N	20251231
11822-5020_f1ffe84f-0b9c-da3b-e053-2995a90a6ab3	11822-5020	HUMAN OTC DRUG	Rite Aid	Extra Whitening	Fluoride	PASTE, DENTIFRICE	DENTAL	20130603		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
11822-5022_704a7ead-8b19-4765-9a05-2bcd1947f509	11822-5022	HUMAN OTC DRUG	Sinus Pressure and Pain PE	Maximum Strength	Acetaminophen and Phenylephrine HCl	TABLET	ORAL	20050623		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-5031_a515fbb5-2114-4dd5-bdde-3ef87804afc9	11822-5031	HUMAN OTC DRUG	Cold and Flu	Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-5034_fdcb326e-6536-456b-b02e-0103ecb21b96	11822-5034	HUMAN OTC DRUG	Cold and Flu	Severe, Daytime, Nighttime	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	KIT		20210630		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation						N	20241231
11822-5050_8292508a-ee9f-45da-916c-44c938be7250	11822-5050	HUMAN OTC DRUG	Mucus DM		Dextromethorphan Hydrobromide Guaifenesin	LIQUID	ORAL	20190930		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-5059_1e5ded73-4fa9-4f5b-bb19-a5cf8f9852dc	11822-5059	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20200529		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-5060_ed362e9c-2dac-1102-e053-2a95a90a76f3	11822-5060	HUMAN OTC DRUG	Rite Aid Sensitivity and Gum		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20221111		OTC MONOGRAPH FINAL	part355	Rite Aid	STANNOUS FLUORIDE	.454	g/100g			N	20241231
11822-5061_ed3741bb-0b7f-5cec-e053-2995a90a6655	11822-5061	HUMAN OTC DRUG	Rite Aid Gum and Enamel Repair		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20221111		OTC MONOGRAPH FINAL	part355	Rite Aid	STANNOUS FLUORIDE	.454	dL/100g			N	20241231
11822-5074_0ac857cb-e589-343f-e063-6294a90a0e7f	11822-5074	HUMAN OTC DRUG	3 in 1 First Aid Wound Care		BENZETHONIUM CHLORIDE	SOLUTION	TOPICAL	20181201		OTC MONOGRAPH DRUG	505G(a)(3)	Rite Aid Corporation	BENZETHONIUM CHLORIDE	1.3	mg/g			N	20241231
11822-5091_0c570733-e32d-6dea-e063-6294a90a9e68	11822-5091	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211130		ANDA	ANDA211544	RITE AID	ACETAMINOPHEN	650	mg/1			N	20251231
11822-5122_4cd93176-69b3-47ea-a314-25f6e66df602	11822-5122	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20200630		OTC MONOGRAPH DRUG	M003	Rite Aid Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
11822-5156_08a4f550-50e5-3a0e-e063-6294a90ae809	11822-5156	HUMAN OTC DRUG	Alcohol		Isopropyl alcohol	SWAB	TOPICAL	20111201		OTC MONOGRAPH DRUG	M003	Rite Aid Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
11822-5158_968e5d8b-f2ba-484d-953f-f382762ad5cd	11822-5158	HUMAN OTC DRUG	sinus congestion and pain		Ibuprofen, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA203200	Rite Aid Corporation	IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	200; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-5160_0551d06f-db1b-4b9e-a29d-ca75c203b22c	11822-5160	HUMAN OTC DRUG	severe sinus congestion relief	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20130630		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-5252_433d0d05-e244-2abc-d24a-254163cfc3cf	11822-5252	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20200215		ANDA	ANDA210375	Rite Aid Corporation	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-5259_d952b635-04e6-4b41-9eeb-aa51e959ba90	11822-5259	HUMAN OTC DRUG	Cold and Cough	Childrens	Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20211105		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-5311_0d7eef06-ec5f-4683-93c2-150e7ab3237a	11822-5311	HUMAN OTC DRUG	Extra Strength pain relief		Acetaminophen	TABLET, FILM COATED	ORAL	20051211		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
11822-5340_fcff01ee-da84-bbd1-e053-6294a90a22e4	11822-5340	HUMAN OTC DRUG	Rite Aid	Professional Strength	Benzocaine	LIQUID	ORAL	20140101		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-5462_6f65d5f8-b8e5-45fc-9149-a648cfc84123	11822-5462	HUMAN OTC DRUG	Head Congestion and Flu Severe	Relief	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210505		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-5519_e9d18cc6-65a9-44b8-ba65-043e3ee25504	11822-5519	HUMAN OTC DRUG	loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20180618		ANDA	ANDA091292	Rite Aid Corporation	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
11822-5533_601e5214-bbb6-420f-8380-5000df012cbd	11822-5533	HUMAN OTC DRUG	Eye Itch Releif		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20220401		NDA	NDA021996	Rite Aid Corporation	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
11822-5567_25feb0d0-ebd8-4d07-8e26-5f17220bb136	11822-5567	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20131226		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM FLUORIDE	.1	mg/mL			N	20241231
11822-5600_2385e2e4-e70b-4aca-9db8-905fe4cd3971	11822-5600	HUMAN OTC DRUG	Acid Reducer		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210723		ANDA	ANDA212088	Rite Aid Corporation	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-5694_25940c33-fca9-4ab7-9840-59cdcd6f8364	11822-5694	HUMAN OTC DRUG	Sinus Relief	Daytime, Nighttime	Acetaminophen, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20170616		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation						N	20241231
11822-5742_092ef09f-aa0a-b603-e063-6394a90a79ea	11822-5742	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID AND ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20121201		OTC MONOGRAPH DRUG	M001	RITE AID PHARMACY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-5761_7160c15d-3e57-464b-8d63-f5f07e5c4224	11822-5761	HUMAN OTC DRUG	Alcohol Free Antiseptic		cetylpyridinium chloride	MOUTHWASH	ORAL	20191216		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
11822-5768_1859d114-a81f-4b61-8f0a-4a04de4d9135	11822-5768	HUMAN OTC DRUG	Oral Antivavity		Sodium fluoride	MOUTHWASH	ORAL	20221205		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM FLUORIDE	.2	mg/mL			N	20241231
11822-5777_eac20f81-d508-4d00-8618-02783f8d2384	11822-5777	HUMAN OTC DRUG	dual action		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230524		ANDA	ANDA214836	Rite Aid Corporation	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-5826_d0d5997f-61c5-4393-9e2e-cf582dd1996c	11822-5826	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20090513		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	ISOPROPYL ALCOHOL	.91	mg/mL			N	20241231
11822-5829_4f298817-239d-44e4-8eca-3a83441e6669	11822-5829	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20150209		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
11822-5832_622aa1c6-9e2c-4ac7-a791-cb3722e2b6c6	11822-5832	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-5880_816d925e-9eb4-496d-8b4f-3c498ba94c0d	11822-5880	HUMAN OTC DRUG	Vagicaine Medicated Maximum Strength		Benzocaine and Resorcinol	CREAM	TOPICAL	20210930		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	BENZOCAINE; RESORCINOL	200; 30	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-5905_42188ccc-9e88-4a6e-b64d-77f9e89c534d	11822-5905	HUMAN OTC DRUG	oil-free moisturizer		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20200315		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
11822-5927_ce2f8cbf-e609-4e39-8a79-b42b017609e9	11822-5927	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20090513		OTC MONOGRAPH DRUG	M021	Rite Aid	SODIUM FLUORIDE	.1	mg/mL			N	20241231
11822-6005_2ed2166e-0e87-4aa8-ba9a-3754085abb63	11822-6005	HUMAN OTC DRUG	tussin nighttime cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20230316		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-6019_4e644da9-0b52-40b0-bf83-6dd6eae9809c	11822-6019	HUMAN OTC DRUG	Muscle Pain Relief		Acetaminophen	TABLET	ORAL	20200730	20251231	ANDA	ANDA211544	Rite Aid Corporation	ACETAMINOPHEN	650	mg/1			N	
11822-6020_f20069dc-f963-2602-e053-2995a90a39e1	11822-6020	HUMAN OTC DRUG	Rite Aid	Enamel Guard	Fluoride	PASTE, DENTIFRICE	DENTAL	20130603		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	POTASSIUM NITRITE; SODIUM FLUORIDE	5; .15	g/100g; g/100g			N	20241231
11822-6031_f200755d-3c1a-638e-e053-2995a90a1397	11822-6031	HUMAN OTC DRUG	Rite Aid Sensitive	Rapid Protection	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190303		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	STANNOUS FLUORIDE	.454	g/100g			N	20241231
11822-6032_f200755d-3c29-638e-e053-2995a90a1397	11822-6032	HUMAN OTC DRUG	Rite Aid	Brilliant White	Sodium monoflourophosphate	PASTE, DENTIFRICE	DENTAL	20190303		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
11822-6033_f2007fca-0bf3-259b-e053-2a95a90ad2bf	11822-6033	HUMAN OTC DRUG	Rite Aid Radiant White	Arctic Mint	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190303		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM FLUORIDE	.243	g/100g			N	20241231
11822-6034_f2009f11-925b-2e6a-e053-2995a90ab63d	11822-6034	HUMAN OTC DRUG	Rite Aid Pro Defense	Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190303		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	STANNOUS FLUORIDE	.454	g/100g			N	20241231
11822-6035_f200babf-07cb-d922-e053-2a95a90a2179	11822-6035	HUMAN OTC DRUG	Rite Aid Tooth and Gum Pain Relief	Cushions	Benzocaine	STRIP	TOPICAL	20190304		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE	10	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-6036_f200c412-ae63-40a3-e053-2995a90a4e41	11822-6036	HUMAN OTC DRUG	Rite Aid	Maximum Toothache Reliever	Benzocaine, Menthol	GEL	TOPICAL	20190304		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE; MENTHOL	20; .26	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-6037_f200abf8-4200-7e0a-e053-2995a90a1285	11822-6037	HUMAN OTC DRUG	Rite Aid Severe Toothache and Gum Relief	Triple Medicated	Benzocaine, Menthol, Zinc chloride	CREAM	TOPICAL	20190304		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE; MENTHOL; ZINC CHLORIDE	20; .25; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-6038_f200babf-07da-d922-e053-2a95a90a2179	11822-6038	HUMAN OTC DRUG	Rite Aid Severe Toothache and Gum Relief	Triple Medicated	Benzocaine, Menthol, Zinc chloride	GEL	TOPICAL	20190304		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE; MENTHOL; ZINC CHLORIDE	20; .5; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-6040_d93c1cc1-7124-417d-a0a6-68806f645a1b	11822-6040	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220718		ANDA	ANDA204872	Rite Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-6080_7824eeaf-9e9c-40cf-8763-012a2b149fcb	11822-6080	HUMAN OTC DRUG	Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20210125		OTC MONOGRAPH DRUG	M002	Rite Aid Corporation	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
11822-6123_e53e617d-7619-49d4-8e1a-b0f7b3f04288	11822-6123	HUMAN OTC DRUG	acid relief		famotidine	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA077351	Rite Aid Corporation	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11822-6141_e35835af-556c-430f-b860-2df4183a1aad	11822-6141	HUMAN OTC DRUG	acid relief		Famotidine	TABLET, FILM COATED	ORAL	20230228		ANDA	ANDA075400	Rite Aid Corporation	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
11822-6159_99eeb4f3-54bf-4f65-9ba9-368fc32ccfce	11822-6159	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20211203		ANDA	ANDA074916	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-6160_d6e8bcd4-ca17-4b79-9973-f016a970d87f	11822-6160	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat Max	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20130407	20250110	OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
11822-6170_f2150aa9-99bb-0c64-e053-2a95a90a1fde	11822-6170	HUMAN OTC DRUG	3X Medicated Mouth Sore Gel		Benzocaine	GEL	ORAL	20200605		OTC MONOGRAPH NOT FINAL	part356	Rite Aid	BENZOCAINE; MENTHOL; ZINC CHLORIDE	20; .1; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
11822-6179_78d1ad74-bdff-4812-a171-76c04505db3e	11822-6179	HUMAN OTC DRUG	Cold and Flu	maximum strength	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PHENYLEPHRINE HCl	TABLET, FILM COATED	ORAL	20210916		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-6184_d57a209b-5942-476e-942f-8720275dacb6	11822-6184	HUMAN OTC DRUG	Acne Control Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20171207		OTC MONOGRAPH FINAL	part333D	Rite Aid	BENZOYL PEROXIDE	100	mg/g			N	20241231
11822-6304_fe2733e1-fb59-4f5e-a5da-8897b3e352ad	11822-6304	HUMAN OTC DRUG	Acetaminophen	Extended Release	Acetaminophen	TABLET	ORAL	20200529	20250529	ANDA	ANDA211544	Rite Aid Corporation	ACETAMINOPHEN	650	mg/1			N	
11822-6319_6c949602-e0c8-40ce-8fb3-5147f406fa04	11822-6319	HUMAN OTC DRUG	nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20181205		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11822-6328_9145d59f-059f-415d-a053-9b5648cd2ac6	11822-6328	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE	ORAL	20200529	20251231	OTC MONOGRAPH NOT FINAL	part334	Rite Aid Corporation	DOCUSATE SODIUM	100	mg/1			N	
11822-6338_92fc3343-4a91-46eb-a950-47ccfd616e5f	11822-6338	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20221028		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
11822-6378_71845bf9-8981-4ca0-a62c-dbef102b1b02	11822-6378	HUMAN OTC DRUG	nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20181205		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11822-6440_29d337d2-689e-442f-b876-9ea0ee920033	11822-6440	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	LIQUID	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part343	Rite Aid Corporation	ACETAMINOPHEN	500	mg/15mL			N	20241231
11822-6450_0c94060a-bdcf-6ceb-e063-6394a90a745f	11822-6450	HUMAN OTC DRUG	Rite Aid Decolorized Iodine		Ethyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Rite Aid Corporation	ALCOHOL	.45	mL/mL			N	20241231
11822-6451_eb358b42-e5ad-44e0-a9dc-04f11a899e62	11822-6451	HUMAN OTC DRUG	pain relief aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20140725		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-6500_d773af01-2fb8-4493-8c94-90e7cf5546b9	11822-6500	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230707		ANDA	ANDA212385	Rite Aid Corporation	DOCOSANOL	100	mg/g			N	20241231
11822-6513_f20494e3-24a0-ad8b-e053-2995a90a153d	11822-6513	HUMAN OTC DRUG	Extra Strength Cold and Hot Menthol Patch		MENTHOL	PATCH	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	MENTHOL, UNSPECIFIED FORM	5	g/100g			N	20241231
11822-6514_f2048b24-4341-98ba-e053-2995a90a5e85	11822-6514	HUMAN OTC DRUG	Maximum Strenght Lidocaine plus Menthol Pain Relief Patch		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	LEVOMENTHOL; LIDOCAINE	1; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-6523_d46c06cb-2f2e-3d70-e053-2995a90a9e71	11822-6523	HUMAN OTC DRUG	SENNA		SENNOSIDES	TABLET, COATED	ORAL	20200818		OTC MONOGRAPH NOT FINAL	part334	RITE AID	SENNOSIDES A AND B	8.6	mg/1			N	20241231
11822-6541_f2048d71-67a2-98f8-e053-2995a90a533a	11822-6541	HUMAN OTC DRUG	Maximum Strength Pain Relief Lidocaine Patch		LIDOCAINE	PATCH	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-6604_3826e59c-7b6a-4929-b803-bf87232092ea	11822-6604	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200904		ANDA	ANDA072096	Rite Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-6611_0bf426d3-fba5-5c92-e063-6394a90a52e6	11822-6611	HUMAN OTC DRUG	Rite Aid Complete Lice Elimination Kit		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20230829		OTC MONOGRAPH DRUG	M031	Rite Aid						N	20241231
11822-6614_0c4174c2-1bc7-d676-e063-6394a90ac085	11822-6614	HUMAN OTC DRUG	Rite Aid Extra Strength Itch Stopping		Diphenhydramine hydrochloride and Zinc acetate	CREAM	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	Rite Aid	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-6616_0bca89d6-8433-37b3-e063-6294a90a1e42	11822-6616	HUMAN OTC DRUG	Rite Aid Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	Rite Aid Corp	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
11822-6623_fac859a4-e23a-4879-af6c-26368455506d	11822-6623	HUMAN OTC DRUG	nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20181205		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
11822-6690_c6108d66-936f-4065-aafb-24e9b898b3ee	11822-6690	HUMAN OTC DRUG	Acetaminophen	Extended Release	Acetaminophen	TABLET	ORAL	20190812	20251231	ANDA	ANDA207035	Rite Aid Corporation	ACETAMINOPHEN	650	mg/1			N	
11822-6790_77a8633a-382e-4f93-b422-73f707f028aa	11822-6790	HUMAN OTC DRUG	menstrual pain relief	maximum strength	acetaminophen, pamabrom, pyrilamine maleate	TABLET, FILM COATED	ORAL	20150103		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
11822-6859_26d2f6e0-7686-461e-8150-33d26f3e3da7	11822-6859	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen Diphenhydramine HCl Phenylephrine HCl	LIQUID	ORAL	20211231		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
11822-6877_72625e87-f40c-482e-b2b2-9c9d580dee5a	11822-6877	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20171204		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM FLUORIDE	.2	mg/mL			N	20241231
11822-6910_71ad00e9-232b-448f-85de-26aeaab78b80	11822-6910	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20230306		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
11822-6960_65fd9baf-7878-47aa-965e-735a63968f48	11822-6960	HUMAN OTC DRUG	nighttime cough dm max		Dextromethorphan Hydrobromide, Doxylamine succinate	SOLUTION	ORAL	20190620	20241031	OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
11822-7001_b372c7fa-8db4-443e-b724-3977cd9627b0	11822-7001	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20111014		OTC MONOGRAPH FINAL	part333D	Rite Aid	SALICYLIC ACID	19.8	mg/g			N	20241231
11822-7016_917b9a30-b852-4052-942b-fbfc22502be9	11822-7016	HUMAN OTC DRUG	Rite Aid Regular Strngth	Pink Bismuth	Bismuth subsalicylate	SUSPENSION	ORAL	20230102		OTC MONOGRAPH DRUG	M008	RITE AID CORPORATION	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-7060_a94658e0-1876-48a2-8a3c-2c957b472620	11822-7060	HUMAN OTC DRUG	RITE AID Regular Strength	Pink Bismuth	Bismuth Subsalicylate	SUSPENSION	ORAL	20230102		OTC MONOGRAPH DRUG	M008	RITE AID CORPORATION	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-7070_6847910f-a69d-415e-a12f-f089ce88468a	11822-7070	HUMAN OTC DRUG	RITE AID Ultra Strnght	Pink Bismuth	Bismuth subsalicylate	SUSPENSION	ORAL	20230102		OTC MONOGRAPH DRUG	M008	RITE AID CORPORATION	BISMUTH SUBSALICYLATE	525	mg/15mL			N	20241231
11822-7220_0ace1d46-98d2-4af5-bfb1-533583451876	11822-7220	HUMAN OTC DRUG	RITE AID Maximum strength	pain relieving	benzalkonium chloride and lidocaine hydrochloride	LIQUID	TOPICAL	20200123		OTC MONOGRAPH DRUG	M003	RITE AID	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-7224_cab798c2-9876-4926-818a-2be006d77786	11822-7224	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20211126		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-7240_b93384f9-c93b-4ede-a8dc-c523c910bb2e	11822-7240	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20180401		ANDA	ANDA210088	Rite Aid	LORATADINE	5	mg/1			N	20241231
11822-7300_63192d12-6b6b-47bd-8905-66af8a50b259	11822-7300	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20211231		ANDA	ANDA208077	Rite Aid Corporation	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-7310_68bb3e9b-74bd-4305-a60a-515d4c2925b3	11822-7310	HUMAN OTC DRUG	Miconazole 3 Combination Pack		Miconazole Nitrate	KIT		20010301		ANDA	ANDA074926	Rite Aid Corporation						N	20241231
11822-7329_1fe481ca-1bea-41f6-8fdb-ee94df52e802	11822-7329	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20200131		ANDA	ANDA207342	Rite Aid Corporation	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-7340_e40d09d1-87b4-4581-b348-93d1a1549bf6	11822-7340	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190531		ANDA	ANDA209692	Rite Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-7370_e6ffd9ff-2b8f-43f4-b9ac-4a6ff6d8c03f	11822-7370	HUMAN OTC DRUG	Stomach Relief	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20220128		OTC MONOGRAPH FINAL	part335	Rite Aid Corporation	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-7380_7a32434e-bb1f-4271-bddf-6b1484c69f8b	11822-7380	HUMAN OTC DRUG	COLD AND FLU HBP		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20210625		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-7388_0855522f-2405-be3c-f917-1eee93ea396a	11822-7388	HUMAN OTC DRUG	Allergy and Congestion		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20190719		ANDA	ANDA076667	Rite Aid Corporation	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-7399_ef18b6ca-9222-6d4d-acd8-baa27f2eae02	11822-7399	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20200115		ANDA	ANDA208369	Rite Aid Corporation	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-7448_de381032-cb84-31b5-e053-2995a90aaca2	11822-7448	HUMAN OTC DRUG	RITE AID CAPSICUM HOT		CAPSAICIN	PATCH	TOPICAL	20121130		OTC MONOGRAPH NOT FINAL	part348	RITE AID CORPORATION	CAPSAICIN	.6	mg/1			N	20241231
11822-7530_c5d9c8e7-16a7-4bdb-98a3-084189019160	11822-7530	HUMAN OTC DRUG	Rite Aid Nighttime Sleep Aid	Non Habit Forming	DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20210324		OTC MONOGRAPH DRUG	M010	RITE AID CORPORATION	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-7701_33900e8f-1652-4b3e-a554-42e8d8b214b6	11822-7701	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20111202		OTC MONOGRAPH FINAL	part333D	Rite Aid	BENZOYL PEROXIDE	100	mg/g			N	20241231
11822-7810_5bfe184f-5b44-40e6-9692-e728b85cef5c	11822-7810	HUMAN OTC DRUG	Rite Aid Stool Softener		Docusate Calcium	CAPSULE, LIQUID FILLED	ORAL	20211122		OTC MONOGRAPH NOT FINAL	part334	Rite Aid	DOCUSATE CALCIUM	240	mg/1			N	20241231
11822-7821_0a73e2f5-7a4b-4f47-abf3-5c3ae8a9376d	11822-7821	HUMAN OTC DRUG	Stomach Relief	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH DRUG	M008	Rite Aid Corporation	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
11822-7834_dfc3cd50-392a-4d97-e053-2a95a90a4d71	11822-7834	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200124		NDA	NDA021855	Rite Aid Corporation	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
11822-7836_d1700952-d836-fa09-e053-2995a90ae617	11822-7836	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20211227		OTC MONOGRAPH FINAL	part341	RITE AID	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
11822-7850_d06eae47-f595-6168-e053-2995a90ac9f9	11822-7850	HUMAN OTC DRUG	DELAYED RELEASE LAXATIVE BISACODYL		BISACODYL	TABLET, DELAYED RELEASE	ORAL	20200803		OTC MONOGRAPH NOT FINAL	part334	RITE AID	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
11822-7851_cf6a35bb-7746-4bbe-e053-2a95a90a6fac	11822-7851	HUMAN OTC DRUG	SENNA		SENNOSIDES	TABLET, COATED	ORAL	20200818		OTC MONOGRAPH NOT FINAL	part334	RITE AID	SENNOSIDES A AND B	8.6	mg/1			N	20241231
11822-7859_ad2a9db3-5b90-0f48-e053-2995a90ac010	11822-7859	HUMAN OTC DRUG	FAST DISSOLVING DAYTIME - NIGHTTIME COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIENESIN, PHENYLEPHRINE HCL,DOXYLAMINE SUCCINATE	KIT	ORAL	20200707		OTC MONOGRAPH FINAL	part341	RITE AID						N	20241231
11822-7883_23fd8b45-e113-4f6e-aab5-bb072ec13d19	11822-7883	HUMAN OTC DRUG	Pain Relief Medicated		CAMPHOR MENTHOL METHYL SALICYTATE	PATCH	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part348	RITE AID CORPORATION	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
11822-7884_02e9c753-48e3-b898-e063-6394a90a5771	11822-7884	HUMAN OTC DRUG	Capsaicin		Arthritis Pain Relief	CREAM	TOPICAL	20200221		OTC MONOGRAPH NOT FINAL	part348	Rite Aid	CAPSAICIN	.001	g/g			N	20241231
11822-7888_92f5335e-64be-463c-970e-3b75d219e708	11822-7888	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200228		OTC MONOGRAPH NOT FINAL	part343	Rite Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11822-7891_d4c0db96-297e-6de5-e053-2995a90a7028	11822-7891	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20200601		ANDA	ANDA091239	RITE AID CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-7892_cf2caf6f-2192-2428-e053-2995a90aae6d	11822-7892	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20200601		ANDA	ANDA091239	RITE AID CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-7893_d4aaf07c-ae80-1fb3-e053-2a95a90a3f89	11822-7893	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20200601		ANDA	ANDA091237	RITE AID	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-7894_d46bcc0f-2ab6-9fa6-e053-2a95a90ae5a6	11822-7894	HUMAN OTC DRUG	MUCUS RELIEF DM		DEXTROMETHORPHAN HYDROBROMIDE/GUAIFENESIN	TABLET	ORAL	20220101		OTC MONOGRAPH FINAL	part341	RITE AID	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-7896_f4b7d4e3-858d-183c-e053-2a95a90a8ee9	11822-7896	HUMAN OTC DRUG	MAXIMUM STRENGTH LAXATIVE		SENNOSIDES	TABLET, COATED	ORAL	20200901		OTC MONOGRAPH NOT FINAL	part334	RITE AID	SENNOSIDES	25	mg/1			N	20241231
11822-7897_d4a83688-2c8c-f692-e053-2a95a90aa769	11822-7897	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF		ACETAMINOPHEN ASPIRIN CAFFEINE	TABLET, COATED	ORAL	20210531		OTC MONOGRAPH NOT FINAL	part343	RITE AID	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
11822-7957_f4215b6f-5f1a-4d93-e053-2995a90ae237	11822-7957	HUMAN OTC DRUG	Rite Aid Muscle Rub	Ultra Strength	Camphor, Menthol, Methyl salicylate	CREAM	TOPICAL	20200619		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
11822-7958_f94d460f-6050-b7a2-e053-6394a90a6c8e	11822-7958	HUMAN OTC DRUG	Rite Aid Hot and Cold	Extra Strength	Menthol, Methyl salicylate	CREAM	TOPICAL	20200619		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 300	mg/g; mg/g			N	20241231
11822-8002_0fca8e27-9a00-4297-8fbd-872f07d200ce	11822-8002	HUMAN OTC DRUG	Nighttime Sleep-Aid		Diphenhydramine HCl	SOLUTION	ORAL	20230519		OTC MONOGRAPH DRUG	M010	Rite Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-8003_c43e19b7-9997-4db5-b141-02ef42f4e95e	11822-8003	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	SOLUTION	ORAL	20230504		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	1000	mg/30mL			N	20241231
11822-8005_d4aa33c2-b83f-5479-e053-2995a90addba	11822-8005	HUMAN OTC DRUG	2 IN 1LAXATIVE STOOL SOFTENER AND STIULANT LAXATIVE		STOOL SOFTENER-STIMULANT LAXATIVE	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part334	RITE AID	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
11822-8120_7cf7ab9d-e964-401f-b796-eafe0fda2dc6	11822-8120	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20211001		ANDA	ANDA208077	Rite Aid Corporation	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-8214_4f3d4127-a43a-4ef3-a946-2293f1941f3c	11822-8214	HUMAN OTC DRUG	Rite Aid Advanced Scar Gel		Advanced Scar Gel	GEL	TOPICAL	20200924		OTC MONOGRAPH FINAL	part347	Rite Aid	ALLANTOIN	5	mg/g			N	20241231
11822-8329_b3c8fc11-787c-4a66-9ed7-df0e0e7e0b16	11822-8329	HUMAN OTC DRUG	DYE-FREE CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20200901		ANDA	ANDA210088	RITE AID	LORATADINE	5	mg/1			N	20241231
11822-8330_a7eed1c8-90d1-4b66-b1bf-347ccab62202	11822-8330	HUMAN OTC DRUG	Gas Relief	Ultra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20190331	20251231	OTC MONOGRAPH FINAL	part332	Rite Aid Corporation	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
11822-8545_f4215b6f-5f0a-4d93-e053-2995a90ae237	11822-8545	HUMAN OTC DRUG	Rite Aid Chest Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20200720		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
11822-8554_d4d36368-c2a5-df50-e053-2a95a90ab382	11822-8554	HUMAN OTC DRUG	DAY-NIGHT SEVERE COLD AND FLU		DAY -ACETAMINOPHEN, DEXTROMETHORHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL NIGHT- ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL,	KIT	ORAL	20200803		OTC MONOGRAPH FINAL	part341	RITE AID						N	20241231
11822-8555_e6526e8a-e40a-4253-a955-641b53eb5aa4	11822-8555	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Phenylephrine HCI DoxylamineSucinate	KIT		20210528		OTC MONOGRAPH FINAL	part341	Rite Aid Corporation						N	20241231
11822-8557_d4aab501-1e17-2e2f-e053-2a95a90a4721	11822-8557	HUMAN OTC DRUG	DAY MAXIMUM STRENGTH COLD AND FLU RELIEF		DAY -ACETAMINOPHEN, DEXTROMETHORHAN HBR, PHENYLEPHRINE HCL	KIT	ORAL	20200803		OTC MONOGRAPH FINAL	part341	RITE AID						N	20241231
11822-8791_4a6d3c45-9ab3-4c58-a28e-0f543ace8b73	11822-8791	HUMAN OTC DRUG	RiteAid Nighttime	Sleep Aid	Diphenhydramine Hydrochloride and Acetaminophen	LIQUID	ORAL	20210601		OTC MONOGRAPH DRUG	M010	RITE AID CORPORATION	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-8855_2c06d832-f607-48da-a2f9-266266142a01	11822-8855	HUMAN OTC DRUG	Rite Aid Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Rite Aid	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
11822-8862_097ee366-701f-1571-d7cd-b6af73e159dd	11822-8862	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200215		ANDA	ANDA207673	Rite Aid Corporation	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
11822-8925_d4acfd96-91d0-34e3-e053-2995a90a445c	11822-8925	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20200601		ANDA	ANDA091237	RITE AID	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-8977_5e0d7398-a63a-40ec-845a-4ceff26721d1	11822-8977	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20220114		OTC MONOGRAPH FINAL	part347	Rite Aid Corporation	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
11822-9024_2861d2a3-81cc-4a04-8518-bc9983451ce6	11822-9024	HUMAN OTC DRUG	Rite Aid SPF 50		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	LOTION	TOPICAL	20160525		OTC MONOGRAPH NOT FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 6	g/100g; g/100g; g/100g			N	20241231
11822-9028_7f7ab6e8-9956-4245-9f1f-b224e7119d73	11822-9028	HUMAN OTC DRUG	Rite Aid SPF 30		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	LOTION	TOPICAL	20160531		OTC MONOGRAPH NOT FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1.8; 7; 5	g/100g; g/100g; g/100g			N	20241231
11822-9044_ef43b7e6-7f00-45a7-8863-1dab36347b97	11822-9044	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
11822-9380_99984265-ee60-4b51-810e-614440e9d269	11822-9380	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20220204		ANDA	ANDA074916	Rite Aid Corporation	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
11822-9386_8b32f3b1-b432-475e-8083-2a6dbb618bd2	11822-9386	HUMAN OTC DRUG	sleep aid		doxylamine succinate	TABLET	ORAL	20190730	20240921	ANDA	ANDA040564	Rite Aid Corporation	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
11822-9393_8f8af79a-80b9-42a2-8c24-a0cc4c4f0bcf	11822-9393	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230706		OTC MONOGRAPH FINAL	part352	Rite Aid Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
11822-9403_357cb071-c670-4e05-9fd3-659d1973fd80	11822-9403	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230706		OTC MONOGRAPH FINAL	part352	Rite Aid Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
11822-9440_07bf6276-51b7-4fb0-bc87-7c02cc6b6f82	11822-9440	HUMAN OTC DRUG	pain relief	childrens	acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	Rite Aid Corporation	ACETAMINOPHEN	160	mg/1			N	20241231
11822-9471_d1185bce-bc9d-4147-92f4-de7ef5d04474	11822-9471	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	Rite Aid	ALCOHOL	62	mL/100mL			N	20241231
11822-9485_2adb4012-a210-4681-bc5b-d90dbbca152f	11822-9485	HUMAN OTC DRUG	Sinus Pressure and Congestion Relief		Diphenhydramine HCl, Phenylephrine HCl	KIT		20190702		OTC MONOGRAPH DRUG	M012	Rite Aid Corporation						N	20241231
11822-9718_f51befb2-de57-433f-b074-0d82c5f38598	11822-9718	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20221205		OTC MONOGRAPH FINAL	part355	Rite Aid	SODIUM FLUORIDE	.2	mg/mL			N	20241231
11822-9832_d0d7b347-7b37-4569-b673-b96040b66a44	11822-9832	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
11822-9833_197e93d5-b686-4a9b-88d0-891d09f13bf6	11822-9833	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
11822-9834_2b46515a-0878-430c-b479-dd31b313d71b	11822-9834	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
11822-9835_d07cbd0c-1a42-463e-bde8-de69a87a80f8	11822-9835	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Rite Aid	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
11822-9860_c7ac306a-b080-4b50-bde9-0f2ef7560e3a	11822-9860	HUMAN OTC DRUG	Eye Wash		water	SOLUTION	OPHTHALMIC	20100831		OTC MONOGRAPH FINAL	part349	Rite Aid Corporation	WATER	99.05	mL/100mL			N	20241231
11822-9902_88ec5795-36c0-46f1-94d9-5611cdd5d6c7	11822-9902	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20200730		ANDA	ANDA210711	Rite Aid Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
11822-9972_c56b6a71-d550-42e4-9f4e-4fecdef3627b	11822-9972	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20160502		OTC MONOGRAPH FINAL	part358H	Rite Aid	COAL TAR	1.02	mg/mL			N	20241231
11822-9975_ffdd7856-ff38-bd43-1b53-2ce647e48743	11822-9975	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20201008		ANDA	ANDA209752	Rite Aid Corporation	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
11822-9976_b6818b93-1a36-22ff-f4d2-19480f059234	11822-9976	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200915		ANDA	ANDA209619	Rite Aid Corporation	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
11822-9990_ccbdd53a-d690-4df0-ad4b-13806b44f1aa	11822-9990	HUMAN OTC DRUG	Loratadine and Pseudoephedrine		LORATADINE and PSEUDOEPHEDRINE SULFATE	TABLET, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Rite Aid	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-9991_f822c71b-ce25-9cbb-e053-6294a90a1161	11822-9991	HUMAN OTC DRUG	Rite Aid Hot and Cold Back Patch		Menthol	PATCH	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	MENTHOL	5	g/100g			N	20241231
11822-9992_f7f9db2c-5b28-8675-e053-6394a90a4e42	11822-9992	HUMAN OTC DRUG	Rite Aid Lidocaine Patch XLarge		Lidocaine	PATCH	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
11822-9993_f7e73279-261f-3705-e053-6294a90ae35b	11822-9993	HUMAN OTC DRUG	Rite Aid Ultra Strength Muscle Rub		Methyl Salicylate 30.0%, Camphor 4.0%, Menthol 10.0%	CREAM	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part348	Rite Aid Corporation	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
11822-9994_e8846461-81e5-4bbd-876c-79f7bf8eb96c	11822-9994	HUMAN OTC DRUG	Allergy relief-D		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230720		ANDA	ANDA090922	RITE AID	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
11822-9995_d85c3452-7492-6a5b-edcb-3334bbeb70f1	11822-9995	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride 60 mg	TABLET	ORAL	20211201		ANDA	ANDA076502	Rite Aid Corporation	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
11822-9996_3b1ee432-8657-4ef6-9b89-cf0127157e64	11822-9996	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan Hydrobromide HBR		guaifenesin and dextromethorphan hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20220628		ANDA	ANDA214781	RITE-AID	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
11822-9999_81de9bee-7e74-4198-9afb-8044b41c4814	11822-9999	HUMAN OTC DRUG	Dye-Free Childrens Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20220401		ANDA	ANDA210088	RITE AID	LORATADINE	5	mg/1			N	20241231
11853-013_9cb8b680-6962-47a0-88ed-a85d22291fd6	11853-013	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205737	Air Liquide Large Industries U.S. LP	OXYGEN	99	L/100L			N	20241231
11853-023_15980fc8-113f-4481-aaf6-462898b57750	11853-023	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205738	Air Liquide Large Industries U.S. LP	NITROGEN	99	L/100L			N	20241231
11928-002_d723768c-1406-d097-e053-2995a90aabd1	11928-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20040616		NDA	NDA205840	Mada Medical Products, Inc.	OXYGEN	1	L/L			N	20241231
11928-004_bd5d58b9-eb45-4688-970f-17175b2b14e9	11928-004	HUMAN OTC DRUG	Mada		Alcohol	GEL	TOPICAL	20040401		OTC MONOGRAPH NOT FINAL	part333E	Mada Medical Products, Inc.	ALCOHOL	62	mL/100mL			N	20241231
11928-005_d7d50cd0-663e-42b3-8105-437456656a8b	11928-005	HUMAN OTC DRUG	Mada 70% Alcohol		Alcohol	GEL	TOPICAL	20171012		OTC MONOGRAPH NOT FINAL	part333E	Mada Medical Products, Inc.	ALCOHOL	72	L/100L			N	20241231
11980-174_d66e4158-b7db-48c5-a3dc-e31b5c3a0511	11980-174	HUMAN PRESCRIPTION DRUG	PRED MILD		prednisolone acetate	SUSPENSION/ DROPS	OPHTHALMIC	19721201		NDA	NDA017100	Allergan, Inc.	PREDNISOLONE ACETATE	1.2	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11980-180_817efb12-c4ee-4b53-ba84-12f51626d023	11980-180	HUMAN PRESCRIPTION DRUG	PRED FORTE		prednisolone acetate	SUSPENSION/ DROPS	OPHTHALMIC	19730601		NDA	NDA017011	Allergan, Inc.	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11980-211_ebf38131-26ad-4dc0-a602-19f900d43004	11980-211	HUMAN PRESCRIPTION DRUG	FML		fluorometholone	SUSPENSION/ DROPS	OPHTHALMIC	19720201		NDA	NDA016851	Allergan, Inc.	FLUOROMETHOLONE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11980-228_594fb227-1276-4db8-aeee-858d47eafec8	11980-228	HUMAN PRESCRIPTION DRUG	FML FORTE		fluorometholone	SUSPENSION/ DROPS	OPHTHALMIC	19860501		NDA	NDA019216	Allergan, Inc.	FLUOROMETHOLONE	2.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
11980-779_477e40b6-93a5-45f9-be91-e6c90ee8607c	11980-779	HUMAN PRESCRIPTION DRUG	OCUFLOX		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	19930801		NDA	NDA019921	Allergan, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
11988-001_077149c9-6718-4a27-e063-6294a90a49c0	11988-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020130		UNAPPROVED MEDICAL GAS		Lubbock Welding Supply	OXYGEN	99	L/100L			N	20241231
11993-000_0dcd08db-d6da-fb0e-e063-6294a90ad581	11993-000	HUMAN OTC DRUG	ASTRAPHARM CHILLI BRAND		CAPSAICIN	PLASTER	TOPICAL	20200301		OTC MONOGRAPH DRUG	M017	Dersan Pharmaceutical Co., Ltd	CAPSAICIN	.25	g/100g			N	20241231
11993-001_dbc77d91-1795-45cb-95ee-f1dae0b20e9f	11993-001	HUMAN OTC DRUG	ASTRAPHARM CHILLI BRAND EXTERNAL MEDICATED		Capsaicin	PLASTER	TOPICAL	20070501		OTC MONOGRAPH NOT FINAL	part348	DERSAN PHARMACEUTICAL CO LTD	CAPSAICIN	70	mg/1			N	20241231
11994-001_d515f49a-8eb4-42f3-a7ee-1634a4804ca5	11994-001	HUMAN PRESCRIPTION DRUG	Cardiolite		TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19901220		NDA	NDA019785	Lantheus Medical Imaging, Inc.	TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE	1	mg/mL			N	20241231
11994-003_517b7337-3529-4948-8d02-b8e2cf97a161	11994-003	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc99m Sestamibi		TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19901220		NDA	NDA019785	Lantheus Medical Imaging, Inc.	TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE	1	mg/mL			N	20241231
11994-006_6a6da20d-b33c-4e9e-98da-8d9b7cc963ca	11994-006	HUMAN PRESCRIPTION DRUG	NEUROLITE		Bicisate dihydrochloride	KIT		19941123		NDA	NDA020256	Lantheus Medical Imaging, Inc.						N	20241231
11994-011_417c6c92-fc77-4b51-8f76-6618ebf81ae6	11994-011	HUMAN PRESCRIPTION DRUG	Definity		perflutren	INJECTION, SUSPENSION	INTRAVENOUS	20010731		NDA	NDA021064	Lantheus Medical Imaging, Inc.	PERFLUTREN	6.52	mg/mL	Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA]		N	20241231
11994-017_def5db2c-ae30-433f-849e-0c5c171ca277	11994-017	HUMAN PRESCRIPTION DRUG	DEFINITY RT		perflutren	INJECTION, SUSPENSION	INTRAVENOUS	20201001		NDA	NDA021064	Lantheus Medical Imaging, Inc.	PERFLUTREN	6.52	mg/mL	Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA]		N	20241231
11994-090_e76a206e-0b87-4764-84bf-659781ef93ed	11994-090	HUMAN PRESCRIPTION DRUG	TechneLite		Technetium Tc99m Generator	INJECTION, SOLUTION	INTRAVENOUS	19751101		NDA	NDA017771	Lantheus Medical Imaging, Inc.	TECHNETIUM TC-99M SODIUM PERTECHNETATE	250	mCi/mL			N	20241231
11994-091_e76a206e-0b87-4764-84bf-659781ef93ed	11994-091	HUMAN PRESCRIPTION DRUG	TechneLite		Technetium Tc99m Generator	INJECTION, SOLUTION	INTRAVENOUS	19751101		NDA	NDA017771	Lantheus Medical Imaging, Inc.	TECHNETIUM TC-99M SODIUM PERTECHNETATE	250	mCi/mL			N	20241231
11994-127_ed8bea93-8d9f-4442-98ad-af0fd909cc6b	11994-127	HUMAN PRESCRIPTION DRUG	Xenon		Xenon XE-133	GAS	RESPIRATORY (INHALATION)	19741010		NDA	NDA017284	Lantheus Medical Imaging, Inc.	XENON XE-133	10	mCi/1	Inhalation Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
11994-128_ed8bea93-8d9f-4442-98ad-af0fd909cc6b	11994-128	HUMAN PRESCRIPTION DRUG	Xenon		Xenon XE-133	GAS	RESPIRATORY (INHALATION)	19741010		NDA	NDA017284	Lantheus Medical Imaging, Inc.	XENON XE-133	20	mCi/1	Inhalation Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
11999-001_46742bfd-1d1d-4a75-922b-d5fb63e67f82	11999-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19730101		NDA	NDA205767	Welders Supply Company	OXYGEN	992	mL/L			N	20241231
11999-002_1ec4ae93-efd7-4e7b-88f6-355d5d723c34	11999-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19730101		NDA	NDA205766	Welders Supply Company	NITROGEN	990	mL/L			N	20241231
12022-004_083314e8-c36f-c686-e063-6294a90af8ba	12022-004	HUMAN OTC DRUG	Black and White Skin Protectant		Petrolatum	OINTMENT	TOPICAL	19901201		OTC MONOGRAPH DRUG	M016	J. Strickland & Co.	PETROLATUM	620	mg/g			N	20241231
12022-005_0909e89d-1f77-c20a-e063-6294a90a0b46	12022-005	HUMAN OTC DRUG	Doo Gro Anti-Dandruff Vitalizer		Pyrithione Zinc	CREAM	TOPICAL	20150115		OTC MONOGRAPH DRUG	M032	J. Strickland & Co. DBA Nature's Protein, Inc.	PYRITHIONE ZINC	1	mg/mL			N	20241231
12022-006_0909d661-e594-c2ac-e063-6294a90af1f8	12022-006	HUMAN OTC DRUG	Doo Gro Anti-Dandruff Vitalizer		Salicylic Acid	OINTMENT	TOPICAL	20150108		OTC MONOGRAPH DRUG	M032	J. Strickland & Co. DBA Nature's Protein, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
12022-007_08340897-23b3-f23b-e063-6294a90a4eb9	12022-007	HUMAN OTC DRUG	Glovers Dandruff Control Medicine, Regular		Sulfur	SUSPENSION	TOPICAL	20010924		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SULFUR	25	mg/mL			N	20241231
12022-008_0833dce8-d162-c283-e063-6294a90a984a	12022-008	HUMAN OTC DRUG	Glovers Dandruff Control Med., Floral		Sulfur	SUSPENSION	TOPICAL	20011105		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SULFUR	25	mg/mL			N	20241231
12022-009_083342a6-c300-f132-e063-6294a90a502e	12022-009	HUMAN OTC DRUG	Glovers Anti-Dandruff		Sulfur, Salicylic Acid	OINTMENT	TOPICAL	20010920		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SALICYLIC ACID; SULFUR	30; 50	mg/g; mg/g			N	20241231
12022-010_08335d03-fc29-47cb-e063-6294a90a4857	12022-010	HUMAN OTC DRUG	Glovers Medicated Anti-Dandruff		COAL TAR	SHAMPOO	TOPICAL	20011031		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	COAL TAR	25	mg/mL			N	20241231
12022-011_083412a9-8755-f3ac-e063-6294a90af46a	12022-011	HUMAN OTC DRUG	Glovers Medicated Anti-Dandruff Scalp		Salicylic Acid	SOLUTION	TOPICAL	20011105		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SALICYLIC ACID	30	mg/mL			N	20241231
12022-017_0834c116-5125-932d-e063-6394a90a13ac	12022-017	HUMAN OTC DRUG	Sulfur 8 Original Anti-Dandruff Hair and Scalp Conditioner		Sulfur	OINTMENT	TOPICAL	19901201		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SULFUR	20	mg/g			N	20241231
12022-018_0833fc64-f83f-f3b0-e063-6294a90aeec1	12022-018	HUMAN OTC DRUG	Sulfur 8 Light Anti-Dandruff Hair and Scalp Conditioner		Sulfur	OINTMENT	TOPICAL	19901201		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SULFUR	20	mg/g			N	20241231
12022-019_08337902-0bf4-a579-e063-6294a90afc67	12022-019	HUMAN OTC DRUG	Sulfur 8 Oil Moisturizer Anti-Dandruff		Pyrithione Zinc	LOTION	TOPICAL	20051007		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	PYRITHIONE ZINC	1	mg/mL			N	20241231
12022-020_0833a051-7107-ffa3-e063-6294a90a3bf9	12022-020	HUMAN OTC DRUG	Sulfur 8 Light Moisturizer Anti-Dandruff		Pyrithione Zinc	LOTION	TOPICAL	19901201		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	PYRITHIONE ZINC	1	mg/mL			N	20241231
12022-021_08338925-6bc7-d723-e063-6394a90acfc8	12022-021	HUMAN OTC DRUG	Sulfur 8 Anti-Dandruff Braid		Salicylic Acid	SOLUTION	TOPICAL	19940714		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SALICYLIC ACID	20	mg/mL			N	20241231
12022-022_0834d673-e102-b96b-e063-6394a90a4cb1	12022-022	HUMAN OTC DRUG	Sulur 8 Kids Anti-Dandruff Hair and Scalp Conditioner		Sulfur	OINTMENT	TOPICAL	19970820		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SULFUR	20	mg/g			N	20241231
12022-023_08339f10-1c35-0a07-e063-6294a90aa4de	12022-023	HUMAN OTC DRUG	Sulfur 8 Kids Anti-Dandruff		Pyrithione Zinc	SHAMPOO, SUSPENSION	TOPICAL	19950522		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	PYRITHIONE ZINC	10	mg/mL			N	20241231
12022-024_0833b754-8327-2549-e063-6394a90abb37	12022-024	HUMAN OTC DRUG	Sulfur 8 Aqua Blue		Pyrithione Zinc	SHAMPOO, SUSPENSION	TOPICAL	20020715		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	PYRITHIONE ZINC	10	mg/mL			N	20241231
12022-025_0834cc0a-a4d9-be61-e063-6294a90a456b	12022-025	HUMAN OTC DRUG	Sulfur 8 Loc Twist and Braid Scalp		Salicylic Acid	SOLUTION	TOPICAL	20030519		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SALICYLIC ACID	30	mg/mL			N	20241231
12022-026_0834cc0a-a4e6-be61-e063-6294a90a456b	12022-026	HUMAN OTC DRUG	Sulfur 8 Fresh Anti-Dandruff Hair and Scalp Conditioner		Salicylic Acid	OINTMENT	TOPICAL	20080206		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SALICYLIC ACID	20	mg/g			N	20241231
12022-027_0833b934-8bcd-3327-e063-6294a90aa995	12022-027	HUMAN OTC DRUG	Sulfur 8 Fresh Anti-Dandruff Moisturizing		Pyrithione Zinc	CREAM	TOPICAL	20080206		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	PYRITHIONE ZINC	1	mg/g			N	20241231
12022-028_0833ce8a-3b6d-7ca8-e063-6394a90afc4e	12022-028	HUMAN OTC DRUG	Sulfur 8 Fresh Anti-Dandruff		Salicylic Acid	SOLUTION	TOPICAL	20080206		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	SALICYLIC ACID	20	mg/mL			N	20241231
12022-029_0833dce8-d156-c283-e063-6294a90a984a	12022-029	HUMAN OTC DRUG	Sulfur 8 Fresh Anti-Dandruff Oil Moisturizing		Pyrithione Zinc	LOTION	TOPICAL	20080206		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	PYRITHIONE ZINC	1	mg/mL			N	20241231
12022-030_0833d389-a801-9d58-e063-6294a90a4fc9	12022-030	HUMAN OTC DRUG	Sulfur 8 Five Star Anti-Dandruff Hair Groom		Pyrithione Zinc	CREAM	TOPICAL	20100429		OTC MONOGRAPH DRUG	M032	J. Strickland & Co.	PYRITHIONE ZINC	1	mg/g			N	20241231
12022-031_08351b22-f899-22b1-e063-6394a90aca4c	12022-031	HUMAN OTC DRUG	White Rose Petroleum Jelly		Petrolatum	OINTMENT	TOPICAL	19380801		OTC MONOGRAPH DRUG	M016	J. Strickland & Co.	PETROLATUM	1000	mg/g			N	20241231
12022-032_0834eb14-2e95-ef47-e063-6294a90ad922	12022-032	HUMAN OTC DRUG	Sulfur 8 Scalp Therapy Medicated Dandruff Control		SALICYLIC ACID	SPRAY	TOPICAL	20200101		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	SALICYLIC ACID	20	mg/mL			N	20241231
12022-033_0834f4b7-cad7-182f-e063-6294a90a7faa	12022-033	HUMAN OTC DRUG	Sulfur 8 Scalp Therapy Medicated Dandruff Control Leave-In Soothing Treatment		SALICYLIC ACID	SOLUTION	TOPICAL	20200101		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	SALICYLIC ACID	30	mg/mL			N	20241231
12022-034_0834f4b7-cae4-182f-e063-6294a90a7faa	12022-034	HUMAN OTC DRUG	Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Oil Serum		SULFUR	SUSPENSION	TOPICAL	20200101		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	SULFUR	25	mg/mL			N	20241231
12022-035_08350821-c7ca-6b7e-e063-6294a90ae838	12022-035	HUMAN OTC DRUG	Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Butter Cream		SULFUR, SALICYLIC ACID	OINTMENT	TOPICAL	20200101		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	SALICYLIC ACID; SULFUR	30; 50	mg/g; mg/g			N	20241231
12022-036_083508f2-6bb3-46cc-e063-6294a90a0cbd	12022-036	HUMAN OTC DRUG	Sulfur 8 Scalp Therapy Medicated Dandruff Control		PYRITHIONE ZINC	SHAMPOO, SUSPENSION	TOPICAL	20200101		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	PYRITHIONE ZINC	10	mg/mL			N	20241231
12022-038_083524d9-552f-7c19-e063-6394a90af541	12022-038	HUMAN OTC DRUG	Glovers Clinical Care Seborrheic Dermatitis Antidandruff		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20230401		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	PYRITHIONE ZINC	10	mg/mL			N	20241231
12022-039_09735fbf-7789-ca3f-e063-6294a90a9f94	12022-039	HUMAN OTC DRUG	Sulfur 8 Medicated Dandruff with Salicylic Acid		SALICYLIC ACID	LIQUID	TOPICAL	20231001		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	SALICYLIC ACID	20	mg/mL			N	20241231
12022-040_09735173-2617-39fd-e063-6394a90aa6cf	12022-040	HUMAN OTC DRUG	Glovers Therapeutic Care		SALICYLIC ACID	LIQUID	TOPICAL	20231001		OTC MONOGRAPH DRUG	M032	J. Strickland and Co.	SALICYLIC ACID	20	mg/mL			N	20241231
12121-001_b4570888-dfc3-441b-a8dd-fa059862aa45	12121-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19550101		NDA	NDA205767	Badger Welding Supplies, Inc.	OXYGEN	99	L/100L			N	20241231
12121-002_cbb00d1b-3637-4c5a-81e6-14ae060f0c1a	12121-002	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19550101		NDA	NDA209989	Badger Welding Supplies, Inc.	NITROUS OXIDE	99	L/100L			N	20241231
12121-006_bef1931d-f9f6-40e3-862b-eaa478435d94	12121-006	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19550101		NDA	NDA205766	Badger Welding Supplies, Inc.	NITROGEN	99	L/100L			N	20241231
12164-005_54830f4b-efe4-44ff-937b-a37b4e49ce4a	12164-005	HUMAN PRESCRIPTION DRUG	Sevoflurane		sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20071119		ANDA	ANDA078650	Halocarbon Life Sciences, LLC	SEVOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
12164-012_dacc1be5-2e9e-4142-b9f0-66400efcc4f6	12164-012	HUMAN PRESCRIPTION DRUG	Isoflurane		Isoflurane	LIQUID	RESPIRATORY (INHALATION)	19991020		ANDA	ANDA075225	Halocarbon Life Sciences, LLC	ISOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
12165-100_2649734d-3624-4cf6-9fa7-b0cec914c214	12165-100	HUMAN PRESCRIPTION DRUG	GRAFCO	APPLICATOR 15 CM	Silver Nitrate	STICK	TOPICAL	19490419		UNAPPROVED DRUG OTHER		GF Health Products, Inc.	POTASSIUM NITRATE; SILVER NITRATE	12.74; 38.21	mg/1; mg/1			N	20241231
12165-200_91d77ae9-6d0f-4f0e-a7b2-b6a270ce90a4	12165-200	HUMAN PRESCRIPTION DRUG	GRAFCO	APPLICATOR 30 CM	Silver Nitrate	STICK	TOPICAL	19490419		UNAPPROVED DRUG OTHER		GF Health Products, Inc.	POTASSIUM NITRATE; SILVER NITRATE	17.486; 52.451	mg/1; mg/1			N	20241231
12165-300_5c6969b7-1472-487d-90d9-10283e527c64	12165-300	HUMAN PRESCRIPTION DRUG	GRAFCO	APPLICATOR 45 CM	Silver Nitrate	STICK	TOPICAL	19490419		UNAPPROVED DRUG OTHER		GF Health Products, Inc.	POTASSIUM NITRATE; SILVER NITRATE	24.4804; 73.4314	mg/1; mg/1			N	20241231
12213-200_0a4a1ea9-53c8-fcef-e063-6394a90aa7fb	12213-200	HUMAN PRESCRIPTION DRUG	40% Oxygen/Nitrogen Mix		40% Oxygen/Nitrogen Mix	GAS	RESPIRATORY (INHALATION)	20200409		NDA	NDA205865	NexAir LLC	OXYGEN	400	mL/L			N	20241231
12213-498_0a4a3484-d5cb-d476-e063-6394a90a1736	12213-498	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA205850	NexAir, LLC	NITROGEN	990	mL/L			N	20241231
12213-593_0a4a345a-e50d-d3de-e063-6394a90a2a98	12213-593	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA206009	NEXAIR, LLC	NITROUS OXIDE	990	mL/L			N	20241231
12213-700_0a4a4e6d-9f46-d55b-e063-6394a90ab7eb	12213-700	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA205859	NexAir, LLC	AIR	1000	mL/L			N	20241231
12213-710_0a4a345a-e50e-d3de-e063-6394a90a2a98	12213-710	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA205851	NexAir, LLC	HELIUM	999	mL/L			N	20241231
12213-720_0a4a4b43-c22f-3a20-e063-6294a90a739a	12213-720	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA205849	NexAir, LLC	OXYGEN	991	mL/L			N	20241231
12213-733_0a4a4e6d-9f47-d55b-e063-6394a90ab7eb	12213-733	HUMAN PRESCRIPTION DRUG	Nitrogen Oxygen Mix		Nitrogen Oxygen Mix	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA205849	NexAir, LLC	OXYGEN	210	mL/L			N	20241231
12213-800_0a4a4e6d-9f48-d55b-e063-6394a90ab7eb	12213-800	HUMAN PRESCRIPTION DRUG	Carbon Dioxide/Oxygen Mix		Carbon Dioxide/Oxygen Mix	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA205849	NEXAIR, LLC	OXYGEN	50	mL/L			N	20241231
12213-801_0a4a4ee0-ebb9-385c-e063-6294a90a117d	12213-801	HUMAN PRESCRIPTION DRUG	Helium/Oxygen Mix		Helium/Oxygen Mix	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA205849	NEXAIR, LLC	OXYGEN	200	mL/L			N	20241231
12213-900_0a4a1ea9-53c9-fcef-e063-6394a90aa7fb	12213-900	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19960601		NDA	NDA215007	NexAir, LLC	CARBON DIOXIDE	991	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
12258-223_b3493419-5f78-0390-e053-2995a90a8ac1	12258-223	HUMAN OTC DRUG	Curasore		Pramoxine Hydrochloride	LIQUID	TOPICAL	19950831		OTC MONOGRAPH NOT FINAL	part348	S.S.S. Company	PRAMOXINE HYDROCHLORIDE	1	g/100mL			N	20241231
12258-241_b3491b38-4149-8d77-e053-2a95a90a4d5b	12258-241	HUMAN OTC DRUG	Green Tetterine		Miconazole Nitrate	OINTMENT	TOPICAL	19940731		OTC MONOGRAPH FINAL	part333C	S.S.S. Company	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
12258-242_b3491b38-4148-8d77-e053-2a95a90a4d5b	12258-242	HUMAN OTC DRUG	White Tetterine		Miconazole Nitrate	OINTMENT	TOPICAL	19950228		OTC MONOGRAPH FINAL	part333C	S.S.S. Company	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
12496-0003_74d3ee90-30a9-4586-be30-e8093621593e	12496-0003	HUMAN PRESCRIPTION DRUG	OPVEE		nalmefene hydrochloride	SPRAY	NASAL	20231002		NDA	NDA217470	Indivior Inc.	NALMEFENE HYDROCHLORIDE	2.7	mg/100uL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
12496-0090_47e1df06-f128-4504-bea9-df41a58840b0	12496-0090	HUMAN PRESCRIPTION DRUG	PERSERIS		Risperidone	KIT	SUBCUTANEOUS	20181109		NDA	NDA210655	Indivior Inc.						N	20241231
12496-0100_73ae82ca-2145-481f-9787-eef712d1b4cc	12496-0100	HUMAN PRESCRIPTION DRUG	SUBLOCADE		buprenorphine	SOLUTION	SUBCUTANEOUS	20180226		NDA	NDA209819	Indivior Inc.	BUPRENORPHINE	100	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
12496-0120_47e1df06-f128-4504-bea9-df41a58840b0	12496-0120	HUMAN PRESCRIPTION DRUG	PERSERIS		Risperidone	KIT	SUBCUTANEOUS	20181109		NDA	NDA210655	Indivior Inc.						N	20241231
12496-0300_73ae82ca-2145-481f-9787-eef712d1b4cc	12496-0300	HUMAN PRESCRIPTION DRUG	SUBLOCADE		buprenorphine	SOLUTION	SUBCUTANEOUS	20180226		NDA	NDA209819	Indivior Inc.	BUPRENORPHINE	300	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
12496-1202_ed75e0d7-9ae6-462a-aab1-65d0991927ef	12496-1202	HUMAN PRESCRIPTION DRUG	Suboxone		buprenorphine hydrochloride, naloxone hydrochloride	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20100913		NDA	NDA022410	INDIVIOR INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
12496-1204_ed75e0d7-9ae6-462a-aab1-65d0991927ef	12496-1204	HUMAN PRESCRIPTION DRUG	Suboxone		buprenorphine hydrochloride, naloxone hydrochloride	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20120824		NDA	NDA022410	INDIVIOR INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	4; 1	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
12496-1208_ed75e0d7-9ae6-462a-aab1-65d0991927ef	12496-1208	HUMAN PRESCRIPTION DRUG	Suboxone		buprenorphine hydrochloride, naloxone hydrochloride	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20100913		NDA	NDA022410	INDIVIOR INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
12496-1212_ed75e0d7-9ae6-462a-aab1-65d0991927ef	12496-1212	HUMAN PRESCRIPTION DRUG	Suboxone		buprenorphine hydrochloride, naloxone hydrochloride	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20120824		NDA	NDA022410	INDIVIOR INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	12; 3	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
12546-104_ea3bfe4a-2b51-2a12-e053-2995a90af14f	12546-104	HUMAN OTC DRUG	Halls	Sugar Free Black Cherry	Menthol	LOZENGE	ORAL	20190610		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	5.8	mg/1			N	20241231
12546-109_00ee0350-b310-94b7-e063-6394a90a668f	12546-109	HUMAN OTC DRUG	Halls	Cherry	Menthol	LOZENGE	ORAL	20190331		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	5.8	mg/1			N	20241231
12546-110_00ed4b55-cedc-219d-e063-6294a90ac32d	12546-110	HUMAN OTC DRUG	Halls	Honey Lemon	Menthol	LOZENGE	ORAL	20190324		OTC MONOGRAPH FINAL	M012	Mondelez Global LLC	MENTHOL	7.5	mg/1			N	20241231
12546-112_00ed4c30-691f-d7b8-e063-6394a90a31dc	12546-112	HUMAN OTC DRUG	Halls	MENTHO-LYPTUS	Menthol	LOZENGE	ORAL	20190407		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	5.4	mg/1			N	20241231
12546-114_f75aaef1-8230-ad53-e053-6394a90a1ef7	12546-114	HUMAN OTC DRUG	Halls	Strawberry	Menthol	LOZENGE	ORAL	20190714		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	2.7	mg/1			N	20241231
12546-151_ea3ca133-520f-3207-e053-2995a90a04bb	12546-151	HUMAN OTC DRUG	Breezers	Cool Berry	Pectin	LOZENGE	ORAL	20190324		OTC MONOGRAPH NOT FINAL	part356	Mondelez Global LLC	PECTIN	7	mg/1			N	20241231
12546-219_35941c63-dfd5-4eeb-aed1-067e622c4d00	12546-219	HUMAN OTC DRUG	Halls	Strawberry	Menthol	LOZENGE	ORAL	20190616		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	3.2	mg/1			N	20241231
12546-241_00ed72f4-1896-336a-e063-6394a90ae922	12546-241	HUMAN OTC DRUG	HALLS	Honey	Menthol	LOZENGE	ORAL	20190125		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	1.8	mg/1			N	20241231
12546-320_136c72ba-e3b8-4e27-b327-ec73e55d483c	12546-320	HUMAN OTC DRUG	Halls	Honey Lemon	Menthol	LOZENGE	ORAL	20190324		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	8.8	mg/1			N	20241231
12546-333_e80a25a7-da5b-485e-b76a-1444205ed566	12546-333	HUMAN OTC DRUG	Halls	Cherry	Menthol	LOZENGE	ORAL	20161121		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	6.8	mg/1			N	20241231
12546-334_9a6aa7f5-c79c-4864-8a1d-463a65b3016f	12546-334	HUMAN OTC DRUG	Halls	Mentholyptus	Menthol	LOZENGE	ORAL	20190407		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	6.4	mg/1			N	20241231
12546-336_436f539c-96b7-4ee0-a3f6-3a3869466b64	12546-336	HUMAN OTC DRUG	Halls Kids	Cherry	Menthol	LOZENGE	ORAL	20190726		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	5	mg/1			N	20241231
12546-337_88324602-3abf-44aa-8a69-51da4f8968dd	12546-337	HUMAN OTC DRUG	Halls Kids	Strawberry	Menthol	LOZENGE	ORAL	20190726		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	5	mg/1			N	20241231
12546-338_f75c1f5a-4a1e-0e71-e053-6294a90a8122	12546-338	HUMAN OTC DRUG	Halls	Honey Vanilla	Menthol	LOZENGE	ORAL	20190305		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	2.5	mg/1			N	20241231
12546-341_c17476b6-8794-b079-e053-2995a90aa49c	12546-341	HUMAN OTC DRUG	HALLS	Extra Strong Menthol Menthol	Menthol	LOZENGE	ORAL	20190726		OTC MONOGRAPH NOT FINAL	part356	Mondelez Global LLC	MENTHOL	20	mg/1			N	20241231
12546-347_ea385197-fd8a-6e93-e053-2995a90a6b5c	12546-347	HUMAN OTC DRUG	Halls	Sugar Free Honey Lemon	Menthol	LOZENGE	ORAL	20201021		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	2.5	mg/1			N	20241231
12546-348_ea3856f6-fedd-ee88-e053-2a95a90a33ce	12546-348	HUMAN OTC DRUG	Halls	Sugar Free Cherry	Menthol	LOZENGE	ORAL	20201021		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	2.9	mg/1			N	20241231
12546-349_ea38450c-efbe-7b6a-e053-2995a90a37e4	12546-349	HUMAN OTC DRUG	Halls	Sugar Free Mentho-Lyptus	Menthol	LOZENGE	ORAL	20201021		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	2.7	mg/1			N	20241231
12546-350_d2088c9e-d518-a36d-e053-2995a90a08e7	12546-350	HUMAN OTC DRUG	Halls Kids	Honey Apple	Menthol	LOZENGE	ORAL	20200330		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	5	mg/1			N	20241231
12546-351_d2ffefea-cce5-8a29-e053-2995a90acd01	12546-351	HUMAN OTC DRUG	Halls	Sugar Free Watermelon	Menthol	LOZENGE	ORAL	20211213		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	2.5	mg/1			N	20241231
12546-352_ea3be7a5-f72b-22c0-e053-2995a90a9fc3	12546-352	HUMAN OTC DRUG	Breezers	Creamy Strawberry	Pectin	LOZENGE	ORAL	20160803		OTC MONOGRAPH NOT FINAL	part356	Mondelez Global LLC	PECTIN	7	mg/1			N	20241231
12546-613_e9c324a9-f38e-4896-e053-2a95a90a2cb9	12546-613	HUMAN OTC DRUG	Halls	Sugar Free Citrus Blend	Menthol	LOZENGE	ORAL	20190714		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	5	mg/1			N	20241231
12546-640_0c5c2834-7fd0-9a23-e063-6294a90a773a	12546-640	HUMAN OTC DRUG	Halls	Sugar Free Mountain Menthol	Menthol	LOZENGE	ORAL	20190603		OTC MONOGRAPH DRUG	M012	Mondelez Global LLC	MENTHOL	5.8	mg/1			N	20241231
12546-642_ea3cc5d1-453d-1e81-e053-2995a90a3509	12546-642	HUMAN OTC DRUG	Halls	Sugar Free Honey Lemon	Menthol	LOZENGE	ORAL	20190527		OTC MONOGRAPH FINAL	part341	Mondelez Global LLC	MENTHOL	7.6	mg/1			N	20241231
12546-720_f75c4b87-3007-a938-e053-6394a90ac4cb	12546-720	HUMAN OTC DRUG	Halls	Breezers Sugar Free Cool Berry	Pectin	LOZENGE	ORAL	20190527		OTC MONOGRAPH NOT FINAL	part356	Mondelez Global LLC	PECTIN	7	mg/1			N	20241231
12830-864_feaed0b9-94cc-eb9b-e053-6294a90a40d4	12830-864	HUMAN OTC DRUG	Chlo Hist		Chlophedianol Hydrochloride, Dexbrompheniramine Maleate	LIQUID	ORAL	20140915		OTC MONOGRAPH FINAL	part341	R. A. McNeil Company	CHLOPHEDIANOL HYDROCHLORIDE; DEXBROMPHENIRAMINE MALEATE	12.5; 1	mg/5mL; mg/5mL			N	20241231
12870-0001_06fcc643-ca2c-6857-e063-6394a90a67e1	12870-0001	HUMAN PRESCRIPTION DRUG	Silver Nitrate Applicators		Silver Nitrate Applicators	STICK	TOPICAL	19370101		UNAPPROVED DRUG OTHER		Arzol Chemical Company	POTASSIUM NITRATE; SILVER NITRATE	25; 75	mg/100mg; mg/100mg			N	20241231
13107-001_706337f2-7f7c-44b8-a554-6a601dadf621	13107-001	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Aurolife Pharma LLC	MIRTAZAPINE	7.5	mg/1			N	20241231
13107-003_706337f2-7f7c-44b8-a554-6a601dadf621	13107-003	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Aurolife Pharma LLC	MIRTAZAPINE	30	mg/1			N	20241231
13107-004_eddc885c-0d68-4447-88a4-a8f0767ff597	13107-004	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Ibuprofen		Hydrocodone Bitartrate and Ibuprofen	TABLET, FILM COATED	ORAL	20160602		ANDA	ANDA204575	Aurolife Pharma, LLC	HYDROCODONE BITARTRATE; IBUPROFEN	7.5; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
13107-014_ceb690df-82b4-4a15-8d74-3571d5cf16a5	13107-014	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20130415		ANDA	ANDA202675	Aurolife Pharma LLC	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
13107-015_ceb690df-82b4-4a15-8d74-3571d5cf16a5	13107-015	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20181030		ANDA	ANDA202675	Aurolife Pharma LLC	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
13107-019_016c4f9f-647b-4f27-823c-1eb73e111ffc	13107-019	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20120411		ANDA	ANDA201013	Aurolife Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
13107-020_016c4f9f-647b-4f27-823c-1eb73e111ffc	13107-020	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20120411		ANDA	ANDA201013	Aurolife Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
13107-021_016c4f9f-647b-4f27-823c-1eb73e111ffc	13107-021	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20120411		ANDA	ANDA201013	Aurolife Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
13107-031_706337f2-7f7c-44b8-a554-6a601dadf621	13107-031	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Aurolife Pharma LLC	MIRTAZAPINE	15	mg/1			N	20241231
13107-032_706337f2-7f7c-44b8-a554-6a601dadf621	13107-032	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Aurolife Pharma LLC	MIRTAZAPINE	45	mg/1			N	20241231
13107-043_cbf505ce-25fc-44cb-abfe-dcc33f399244	13107-043	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20130715		ANDA	ANDA201972	Aurolife Pharma, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-044_cbf505ce-25fc-44cb-abfe-dcc33f399244	13107-044	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20130715		ANDA	ANDA201972	Aurolife Pharma, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-045_cbf505ce-25fc-44cb-abfe-dcc33f399244	13107-045	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20130715		ANDA	ANDA201972	Aurolife Pharma, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-046_cbf505ce-25fc-44cb-abfe-dcc33f399244	13107-046	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20130715		ANDA	ANDA201972	Aurolife Pharma, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-055_98781e1a-85d0-4c1d-9f55-78735542e2e6	13107-055	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20120712		ANDA	ANDA202160	Aurolife Pharma, LLC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-056_98781e1a-85d0-4c1d-9f55-78735542e2e6	13107-056	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20120712		ANDA	ANDA202160	Aurolife Pharma, LLC	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-057_98781e1a-85d0-4c1d-9f55-78735542e2e6	13107-057	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20120712		ANDA	ANDA202160	Aurolife Pharma, LLC	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-058_57911bf7-78f8-4769-a257-6b12f6f69d3e	13107-058	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	Aurolife Pharma, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 15	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
13107-059_57911bf7-78f8-4769-a257-6b12f6f69d3e	13107-059	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	Aurolife Pharma, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
13107-060_57911bf7-78f8-4769-a257-6b12f6f69d3e	13107-060	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	Aurolife Pharma, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
13107-061_0add1627-bf2b-40ba-b5a4-1cf580496a38	13107-061	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20140806		ANDA	ANDA203068	Aurolife Pharma, LLC	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
13107-068_7519ffff-75f4-4ede-9ee9-b75870506b80	13107-068	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20131127		ANDA	ANDA202424	Aurolife Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
13107-069_7519ffff-75f4-4ede-9ee9-b75870506b80	13107-069	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20131127		ANDA	ANDA202424	Aurolife Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
13107-070_7519ffff-75f4-4ede-9ee9-b75870506b80	13107-070	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20131127		ANDA	ANDA202424	Aurolife Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
13107-071_7519ffff-75f4-4ede-9ee9-b75870506b80	13107-071	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20131127		ANDA	ANDA202424	Aurolife Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
13107-072_7519ffff-75f4-4ede-9ee9-b75870506b80	13107-072	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20131127		ANDA	ANDA202424	Aurolife Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
13107-073_7519ffff-75f4-4ede-9ee9-b75870506b80	13107-073	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20131127		ANDA	ANDA202424	Aurolife Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
13107-074_7519ffff-75f4-4ede-9ee9-b75870506b80	13107-074	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20131127		ANDA	ANDA202424	Aurolife Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
13107-079_1e82723e-d8ce-4105-8798-cc46c7a5dd85	13107-079	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20150915		ANDA	ANDA204852	Aurolife Pharma LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13107-080_1e82723e-d8ce-4105-8798-cc46c7a5dd85	13107-080	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20150915		ANDA	ANDA204852	Aurolife Pharma LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13107-081_1e82723e-d8ce-4105-8798-cc46c7a5dd85	13107-081	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20150915		ANDA	ANDA204852	Aurolife Pharma LLC	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13107-082_1e82723e-d8ce-4105-8798-cc46c7a5dd85	13107-082	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20150915		ANDA	ANDA204852	Aurolife Pharma LLC	TRAZODONE HYDROCHLORIDE	300	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13107-083_82f8b652-862a-4f3b-9d95-146b732dfccf	13107-083	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20170324		ANDA	ANDA203572	Aurolife Pharma LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
13107-084_82f8b652-862a-4f3b-9d95-146b732dfccf	13107-084	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20170324		ANDA	ANDA203572	Aurolife Pharma LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
13107-085_82f8b652-862a-4f3b-9d95-146b732dfccf	13107-085	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20170324		ANDA	ANDA203572	Aurolife Pharma LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
13107-088_823dd254-a6d4-405c-b9bf-4f02138b27fa	13107-088	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20150915		ANDA	ANDA203502	Aurolife Pharma, LLC	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-089_823dd254-a6d4-405c-b9bf-4f02138b27fa	13107-089	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20150915		ANDA	ANDA203502	Aurolife Pharma, LLC	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-103_fcf12572-8e17-438f-9290-7e453aa09704	13107-103	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		Oxymorphone Hydrochloride	TABLET	ORAL	20160426		ANDA	ANDA204459	Aurolife Pharma, LLC	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-104_fcf12572-8e17-438f-9290-7e453aa09704	13107-104	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		Oxymorphone Hydrochloride	TABLET	ORAL	20160426		ANDA	ANDA204459	Aurolife Pharma, LLC	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-105_53dd7857-41fb-4da1-88f7-5c68a509bfb0	13107-105	HUMAN PRESCRIPTION DRUG	Phentermine		Phentermine Hydrochloride	CAPSULE	ORAL	20170320		ANDA	ANDA204318	Aurolife Pharma, LLC	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
13107-106_53dd7857-41fb-4da1-88f7-5c68a509bfb0	13107-106	HUMAN PRESCRIPTION DRUG	Phentermine		Phentermine Hydrochloride	CAPSULE	ORAL	20170320		ANDA	ANDA204318	Aurolife Pharma, LLC	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
13107-107_6c358f23-c07d-4b3a-9844-5366d5fa158d	13107-107	HUMAN PRESCRIPTION DRUG	HYDROMORPHONE HYDROCHLORIDE		HYDROMORPHONE HYDROCHLORIDE	TABLET	ORAL	20160517		ANDA	ANDA205814	Aurolife Pharma, LLC	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-108_6c358f23-c07d-4b3a-9844-5366d5fa158d	13107-108	HUMAN PRESCRIPTION DRUG	HYDROMORPHONE HYDROCHLORIDE		HYDROMORPHONE HYDROCHLORIDE	TABLET	ORAL	20160517		ANDA	ANDA205814	Aurolife Pharma, LLC	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-109_6c358f23-c07d-4b3a-9844-5366d5fa158d	13107-109	HUMAN PRESCRIPTION DRUG	HYDROMORPHONE HYDROCHLORIDE		HYDROMORPHONE HYDROCHLORIDE	TABLET	ORAL	20160517		ANDA	ANDA205814	Aurolife Pharma, LLC	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13107-154_ab9c1dc7-253b-45be-86c8-4863fa3fc856	13107-154	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	Aurolife Pharma LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13107-155_ab9c1dc7-253b-45be-86c8-4863fa3fc856	13107-155	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	Aurolife Pharma LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13107-156_ab9c1dc7-253b-45be-86c8-4863fa3fc856	13107-156	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	Aurolife Pharma LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13107-157_ab9c1dc7-253b-45be-86c8-4863fa3fc856	13107-157	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	Aurolife Pharma LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13107-211_c41e5c06-bede-4ccc-b5d5-ebed1867077c	13107-211	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20150506		ANDA	ANDA207709	Aurolife Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
13107-212_c41e5c06-bede-4ccc-b5d5-ebed1867077c	13107-212	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20150506		ANDA	ANDA207709	Aurolife Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
13107-213_c41e5c06-bede-4ccc-b5d5-ebed1867077c	13107-213	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20150506		ANDA	ANDA207709	Aurolife Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
13107-269_dfb7afdf-5c05-4487-9044-936e151e5ba6	13107-269	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230203		ANDA	ANDA213040	Aurolife Pharma LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13107-319_07c3013a-a3fe-44e1-9d8b-ccee1d1f0042	13107-319	HUMAN PRESCRIPTION DRUG	CLORAZEPATE DIPOTASSIUM		CLORAZEPATE DIPOTASSIUM	TABLET	ORAL	19870717		ANDA	ANDA071858	Aurolife Pharma LLC	CLORAZEPATE DIPOTASSIUM	3.75	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
13107-320_07c3013a-a3fe-44e1-9d8b-ccee1d1f0042	13107-320	HUMAN PRESCRIPTION DRUG	CLORAZEPATE DIPOTASSIUM		CLORAZEPATE DIPOTASSIUM	TABLET	ORAL	19870717		ANDA	ANDA071858	Aurolife Pharma LLC	CLORAZEPATE DIPOTASSIUM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
13107-321_07c3013a-a3fe-44e1-9d8b-ccee1d1f0042	13107-321	HUMAN PRESCRIPTION DRUG	CLORAZEPATE DIPOTASSIUM		CLORAZEPATE DIPOTASSIUM	TABLET	ORAL	19870717		ANDA	ANDA071858	Aurolife Pharma LLC	CLORAZEPATE DIPOTASSIUM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
13267-234_6586ed67-0b87-4046-a7c1-274d39c10922	13267-234	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose	F18	Fludeoxyglucose F18	INJECTION	INTRAVENOUS	20050819		NDA	NDA021870	THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH	FLUDEOXYGLUCOSE F-18	400	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
13267-345_5494a263-4c20-4f8d-9ce1-21705c4a8534	13267-345	HUMAN PRESCRIPTION DRUG	Fluorodopa	F18	Fluorodopa F18	INJECTION	INTRAVENOUS	20191010		NDA	NDA200655	THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH	FLUORODOPA F-18	8.33	mCi/mL			N	20241231
13267-346_f8d69c66-d9aa-4bb8-bb56-5bebeef87af5	13267-346	HUMAN PRESCRIPTION DRUG	Fluorodopa	F18	Fluorodopa F18	INJECTION	INTRAVENOUS	20191010		NDA	NDA200655	THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH	FLUORODOPA F-18	40	mCi/mL			N	20241231
13267-456_0bd46b33-99e9-4989-8816-182d7d72babb	13267-456	HUMAN PRESCRIPTION DRUG	Ammonia N 13		NH3N13	INJECTION	INTRAVENOUS	20070823		NDA	NDA022119	THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
13267-542_2e4dae7b-58ec-4b60-bff5-a1ecf6147d18	13267-542	HUMAN PRESCRIPTION DRUG	Sodium Fluoride	F 18	Sodium Fluoride F 18	INJECTION	INTRAVENOUS	20141119		ANDA	ANDA204328	THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH	SODIUM FLUORIDE F-18	600	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
13302-457_eca65e41-2e03-c651-e053-2a95a90af077	13302-457	HUMAN OTC DRUG	QS Plus Instant Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20190702		OTC MONOGRAPH NOT FINAL	part333E	Romaine Companies	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
13517-100_bd61493d-f0d2-4c15-808b-7bb77f56b3a9	13517-100	HUMAN PRESCRIPTION DRUG	Diazoxide		diazoxide	SUSPENSION	ORAL	20191211		ANDA	ANDA211050	e5 Pharma, LLC	DIAZOXIDE	50	mg/mL			N	20241231
13517-107_07d632e3-2a83-e041-e063-6394a90ac2d5	13517-107	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	ELIXIR	ORAL	20171117		UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
13517-110_014230b1-b475-aa7b-e063-6394a90a290a	13517-110	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20170224	20250927	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	16.2	mg/1		CIV	N	
13517-111_014230b1-b475-aa7b-e063-6394a90a290a	13517-111	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20170224	20251109	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	
13517-112_014230b1-b475-aa7b-e063-6394a90a290a	13517-112	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20170224	20251222	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	64.8	mg/1		CIV	N	
13517-113_014230b1-b475-aa7b-e063-6394a90a290a	13517-113	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20170224	20251110	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	97.2	mg/1		CIV	N	
13517-207_4b272605-2b91-4f7f-9c19-dca2308f4c9b	13517-207	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	ELIXIR	ORAL	20231103		UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
13517-755_0142f2d2-df51-1cdf-e063-6294a90a1555	13517-755	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190321	20240721	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	15	mg/1		CIV	N	
13517-756_0142f2d2-df51-1cdf-e063-6294a90a1555	13517-756	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190321	20240929	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	30	mg/1		CIV	N	
13517-757_0142f2d2-df51-1cdf-e063-6294a90a1555	13517-757	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190321	20241110	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	60	mg/1		CIV	N	
13517-758_0142f2d2-df51-1cdf-e063-6294a90a1555	13517-758	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190321	20241111	UNAPPROVED DRUG OTHER		e5 Pharma, LLC	PHENOBARBITAL	100	mg/1		CIV	N	
13533-131_5865c299-a006-446f-b9ce-7361b679ad6a	13533-131	VACCINE	TDVAX		Tetanus and Diphtheria Toxoids Adsorbed	INJECTION	INTRAMUSCULAR	20150701		BLA	BLA101322	GRIFOLS USA, LLC	CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	2; 2	[Lf]/.5mL; [Lf]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
13533-318_e17482c9-3bbf-4f63-a026-e8826768864d	13533-318	PLASMA DERIVATIVE	HyperRAB		Rabies Immune Globulin (Human)	INJECTION, SOLUTION	INFILTRATION; INTRAMUSCULAR	19740612		BLA	BLA101144	GRIFOLS USA, LLC	HUMAN RABIES VIRUS IMMUNE GLOBULIN	300	[iU]/mL			N	20241231
13533-335_a87fc58d-1cd3-49c4-8e92-79dce6a20306	13533-335	PLASMA DERIVATIVE	GamaSTAN		immune globulin (human)	INJECTION, SOLUTION	INTRAMUSCULAR	20180205		BLA	BLA101134	GRIFOLS USA, LLC	HUMAN IMMUNOGLOBULIN G	.165	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
13533-602_80bce7c9-5ee7-4922-b76b-6bc4cd2ca43c	13533-602	PLASMA DERIVATIVE	THROMBATE III		ANTITHROMBIN III (HUMAN)	KIT		19911230		BLA	BLA103196	GRIFOLS USA, LLC						N	20241231
13533-603_80bce7c9-5ee7-4922-b76b-6bc4cd2ca43c	13533-603	PLASMA DERIVATIVE	THROMBATE III		ANTITHROMBIN III (HUMAN)	KIT		19911230		BLA	BLA103196	GRIFOLS USA, LLC						N	20241231
13533-606_80bce7c9-5ee7-4922-b76b-6bc4cd2ca43c	13533-606	PLASMA DERIVATIVE	THROMBATE III		ANTITHROMBIN III (HUMAN)	KIT		19911230		BLA	BLA103196	GRIFOLS USA, LLC						N	20241231
13533-613_f23b216a-fbd5-49f0-a60b-26847078fdc4	13533-613	PLASMA DERIVATIVE	Plasmanate		Plasma Protein Fraction (Human)	SOLUTION	INTRAVENOUS	19581002		BLA	BLA101140	GRIFOLS USA, LLC	ALBUMIN HUMAN	2.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
13533-618_58aefdbd-27e0-46a7-905e-aefb089a92b2	13533-618	PLASMA DERIVATIVE	HYPERRAB	S/D	RABIES IMMUNE GLOBULIN (HUMAN)	INJECTION	INTRAMUSCULAR	19960814		BLA	BLA101144	GRIFOLS USA, LLC	HUMAN RABIES VIRUS IMMUNE GLOBULIN	150	[iU]/mL			N	20241231
13533-631_8647b6ee-80d7-43e6-a488-ddf545009d9d	13533-631	PLASMA DERIVATIVE	HYPERRHO	S/D FULL DOSE	RHO(D) IMMUNE GLOBULIN (HUMAN)	SOLUTION	INTRAMUSCULAR	19960814		BLA	BLA101141	GRIFOLS USA, LLC	HUMAN RHO(D) IMMUNE GLOBULIN	1500	[iU]/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
13533-634_c35adc4a-1bb3-4816-936a-8a331c1cde5e	13533-634	PLASMA DERIVATIVE	HyperTET		Tetanus Immune Globulin (Human)	INJECTION	INTRAMUSCULAR	19960814		BLA	BLA101142	GRIFOLS USA, LLC	HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN	250	[iU]/mL			N	20241231
13533-635_a87fc58d-1cd3-49c4-8e92-79dce6a20306	13533-635	PLASMA DERIVATIVE	GAMASTAN		IMMUNE GLOBULIN (HUMAN)	INJECTION, SOLUTION	INTRAMUSCULAR	19960814		BLA	BLA101134	GRIFOLS USA, LLC	HUMAN IMMUNOGLOBULIN G	.165	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
13533-636_3ea7e745-0884-4447-89c0-b4f72d9909ea	13533-636	PLASMA DERIVATIVE	HYPERHEP B		HEPATITIS B IMMUNE GLOBULIN (HUMAN)	INJECTION	INTRAMUSCULAR	19961009		BLA	BLA101146	GRIFOLS USA, LLC	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	220	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
13533-661_dab53388-70f8-4f8d-aa71-d0dec38a17d9	13533-661	PLASMA DERIVATIVE	HYPERRHO	S/D MINI-DOSE	RHO(D) IMMUNE GLOBULIN (HUMAN)	SOLUTION	INTRAMUSCULAR	19960814		BLA	BLA101141	GRIFOLS USA, LLC	HUMAN RHO(D) IMMUNE GLOBULIN	250	[iU]/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
13533-690_21a20866-f2c2-4b6d-9a3f-acd2cc1b9f4a	13533-690	PLASMA DERIVATIVE	Plasbumin		Albumin (Human)	SOLUTION	INTRAVENOUS	19940926		BLA	BLA101138	GRIFOLS USA, LLC	ALBUMIN HUMAN	2.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
13533-691_089f1f75-35f2-4ff2-884a-95a1f46f369d	13533-691	PLASMA DERIVATIVE	Plasbumin		Albumin (Human)	SOLUTION	INTRAVENOUS	19940926		BLA	BLA101138	GRIFOLS USA, LLC	ALBUMIN HUMAN	10	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
13533-692_38864ce1-9eaf-4d04-bfca-39205b0f1504	13533-692	PLASMA DERIVATIVE	Plasbumin		Albumin (Human)	SOLUTION	INTRAVENOUS	19940926		BLA	BLA101138	GRIFOLS USA, LLC	ALBUMIN HUMAN	5	g/20mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
13533-700_6a2d2b1f-c8f1-4002-ba1e-925179974d95	13533-700	PLASMA DERIVATIVE	PROLASTIN-C		ALPHA-1-PROTEINASE INHIBITOR (HUMAN)	KIT		19871202		BLA	BLA103174	GRIFOLS USA, LLC						N	20241231
13533-703_6a2d2b1f-c8f1-4002-ba1e-925179974d95	13533-703	PLASMA DERIVATIVE	PROLASTIN-C		ALPHA-1-PROTEINASE INHIBITOR (HUMAN)	KIT		19871202		BLA	BLA103174	GRIFOLS USA, LLC						N	20241231
13533-705_f3f69bd6-df32-45c4-bbd9-b18b0d725382	13533-705	PLASMA DERIVATIVE	Prolastin-C Liquid		Alpha1-Proteinase Inhibitor (Human)	INJECTION, SOLUTION	INTRAVENOUS	19871202		BLA	BLA103174	GRIFOLS USA, LLC	.ALPHA.1-PROTEINASE INHIBITOR HUMAN	1000	mg/20mL	Human alpha-1 Proteinase Inhibitor [EPC], Trypsin Inhibitors [MoA]		N	20241231
13533-706_6a2d2b1f-c8f1-4002-ba1e-925179974d95	13533-706	PLASMA DERIVATIVE	PROLASTIN-C		ALPHA-1-PROTEINASE INHIBITOR (HUMAN)	KIT		19871202		BLA	BLA103174	GRIFOLS USA, LLC						N	20241231
13533-800_8d03bd99-9ea6-4e20-b103-6a0a1fbcdce2	13533-800	PLASMA DERIVATIVE	Gamunex-C		Immune Globulin (Human)	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20101013		BLA	BLA125046	GRIFOLS USA, LLC	HUMAN IMMUNOGLOBULIN G	10	g/100mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
13533-810_74d8dcfc-4a65-4920-9974-fee811e297e9	13533-810	PLASMA DERIVATIVE	XEMBIFY		immune globulin subcutaneous, human-klhw	SOLUTION	SUBCUTANEOUS	20190703		BLA	BLA125683	GRIFOLS USA, LLC	HUMAN IMMUNOGLOBULIN G	200	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
13548-070_962b4d5b-be66-4125-a632-8e2c142655e1	13548-070	HUMAN PRESCRIPTION DRUG	Atralin		Tretinoin	GEL	TOPICAL	20070726		NDA	NDA022070	Bausch Health US, LLC	TRETINOIN	.05	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
13548-132_110dde63-b7d7-49af-aa96-9daefccb84ff	13548-132	HUMAN PRESCRIPTION DRUG	Acanya		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20100726		NDA	NDA050819	Bausch Health US, LLC	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	25; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
13551-001_60d0294f-268e-49a7-9303-71469c4295cc	13551-001	HUMAN PRESCRIPTION DRUG	Lumryz		sodium oxybate	FOR SUSPENSION, EXTENDED RELEASE	ORAL	20230501		NDA	NDA214755	Avadel CNS Pharmaceuticals, LLC	SODIUM OXYBATE	4.5	g/1	Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
13551-002_60d0294f-268e-49a7-9303-71469c4295cc	13551-002	HUMAN PRESCRIPTION DRUG	Lumryz		sodium oxybate	FOR SUSPENSION, EXTENDED RELEASE	ORAL	20230501		NDA	NDA214755	Avadel CNS Pharmaceuticals, LLC	SODIUM OXYBATE	6	g/1	Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
13551-003_60d0294f-268e-49a7-9303-71469c4295cc	13551-003	HUMAN PRESCRIPTION DRUG	Lumryz		sodium oxybate	FOR SUSPENSION, EXTENDED RELEASE	ORAL	20230501		NDA	NDA214755	Avadel CNS Pharmaceuticals, LLC	SODIUM OXYBATE	7.5	g/1	Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
13551-004_60d0294f-268e-49a7-9303-71469c4295cc	13551-004	HUMAN PRESCRIPTION DRUG	Lumryz		sodium oxybate	FOR SUSPENSION, EXTENDED RELEASE	ORAL	20230501		NDA	NDA214755	Avadel CNS Pharmaceuticals, LLC	SODIUM OXYBATE	9	g/1	Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
13630-0137_b8a218f1-8cb0-79c9-e053-2a95a90a8c13	13630-0137	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190130		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	24.93; 62.325; 41.55; 41.55	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0140_e1f6d8d1-9181-16bc-e053-2a95a90a0cfb	13630-0140	HUMAN OTC DRUG	Australian Gold Botanical	Broad Spectrum SPF 70	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20181002	20250228	OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.83; 86.1; 43.05; 43.05	mg/mL; mg/mL; mg/mL; mg/mL			N	
13630-0141_cf6a727d-9ad6-1e18-e053-2995a90a974a	13630-0141	HUMAN OTC DRUG	Pamana Jack	Sport Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190129		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	26.55; 88.5; 44.25; 44.25	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0142_b8a2e83f-8d69-9d90-e053-2995a90a083f	13630-0142	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191031		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.38; 63.45; 42.3; 42.3	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0144_b8a35e4d-587c-8135-e053-2a95a90a8384	13630-0144	HUMAN OTC DRUG	Australian Gold	Instant Bronzer Broad Spectrum SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191031		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.98; 42.45; 16.98	mg/mL; mg/mL; mg/mL			N	20241231
13630-0145_b8a3d06d-c9cb-2110-e053-2995a90a0238	13630-0145	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191031		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.44; 41.1; 16.44	mg/mL; mg/mL; mg/mL			N	20241231
13630-0146_c9b40071-5728-3c58-e053-2995a90aa9c4	13630-0146	HUMAN OTC DRUG	Pamana Jack	Broad Spectrum SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20190125		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.08; 40.2; 16.08	mg/mL; mg/mL; mg/mL			N	20241231
13630-0147_b8a43416-0119-9b73-e053-2a95a90ac9f0	13630-0147	HUMAN OTC DRUG	Pamana Jack	Broad Spectrum SPF 100	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190314		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	26.01; 130.05; 43.35; 86.7	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0148_b8a47ec3-1ab6-e827-e053-2995a90a62a9	13630-0148	HUMAN OTC DRUG	Pamana Jack	Kids Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190329		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	26.55; 88.5; 44.25; 44.25	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0159_e9ba265a-7e81-d2d5-e053-2995a90a94be	13630-0159	HUMAN OTC DRUG	Hurley	Sunscreen Broad Spectrum SPF15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20190828	20240329	OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.2; 40.5; 16.2	mg/mL; mg/mL; mg/mL			N	
13630-0162_b00129f7-945f-1047-e053-2995a90a65e5	13630-0162	HUMAN OTC DRUG	Australian Gold	SPF 30 with insect repellent	Octinoxate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20190903		OTC MONOGRAPH NOT FINAL	part352	Prime Packaging, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	7.5; 5; 5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
13630-0168_b075df21-2e32-6d61-e053-2a95a90aabcf	13630-0168	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191107		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
13630-0169_b078736f-836b-1b48-e053-2a95a90a7859	13630-0169	HUMAN OTC DRUG	Australian Gold	Extreme Sport SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191105		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
13630-0170_b079f185-31ca-2991-e053-2a95a90a18eb	13630-0170	HUMAN OTC DRUG	Australian Gold	little joey SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191118		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
13630-0178_c573c00c-45d2-36aa-e053-2a95a90aa8da	13630-0178	HUMAN OTC DRUG	Hurley	Broad Spectrum SPF	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20200224		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
13630-0180_ca52411a-4d62-1311-e053-2995a90a4542	13630-0180	HUMAN OTC DRUG	Australian Gold	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201012		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.89; 86.3; 43.15; 43.15	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0181_cf599750-2ecc-6066-e053-2a95a90aacc9	13630-0181	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 50 Sunscreen	Homosalate, Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20160828		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 27.5	mg/g; mg/g; mg/g; mg/g			N	20241231
13630-0182_cf5a8d49-7929-56fd-e053-2995a90a0e65	13630-0182	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 30 Sunscreen	Homosalate, Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20150928		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 27.5	mg/g; mg/g; mg/g; mg/g			N	20241231
13630-0183_cf5a0dd6-bfc6-33cb-e053-2995a90a9c87	13630-0183	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 50 Sunscreen	Homosalate, Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20160828		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 27.5	mg/g; mg/g; mg/g; mg/g			N	20241231
13630-0189_d0898bca-0793-7825-e053-2a95a90a7098	13630-0189	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 8	Avobenzone, Octocrylene	SPRAY	TOPICAL	20190103		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; OCTOCRYLENE	19.4; 19.4	mg/mL; mg/mL			N	20241231
13630-0190_d0d5e5ba-f3c4-3195-e053-2a95a90a3840	13630-0190	HUMAN OTC DRUG	Aloe Up	Broad Spectrum SPF 15	Avobenzone, Octisalate, and Octocrylene	SPRAY	TOPICAL	20170809		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.3; 40.9; 15.1	mg/mL; mg/mL; mg/mL			N	20241231
13630-0196_d11256c7-60f1-1354-e053-2995a90a35bc	13630-0196	HUMAN OTC DRUG	United Spirit of America (Warrior)	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190128		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.6; 85.3; 42.7; 42.7	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0201_d203d371-307b-ca64-e053-2995a90a3cf4	13630-0201	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190403		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.11; 62.78; 41.85; 41.85	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0202_d204d3f4-dd6b-4ca8-e053-2995a90ae34a	13630-0202	HUMAN OTC DRUG	Pamana Jack	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20171213		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.32; 84.4; 44.2; 42.2	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0203_d2059e96-6405-7cd0-e053-2a95a90a2e4a	13630-0203	HUMAN OTC DRUG	Hurley	Sunscreen Broad Spectrum SPF50	Avobenzone, Homosalate,Octisalate, Octocrylene	SPRAY	TOPICAL	20200430		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	24.93; 83.1; 41.55; 41.55	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0204_d398eabc-9938-6507-e053-2a95a90aea59	13630-0204	HUMAN OTC DRUG	Bask Suncare	Broad Spectrum SPF	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211220		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
13630-0205_d5dd5964-28df-a14c-e053-2a95a90af15a	13630-0205	HUMAN OTC DRUG	Aloe Up	Broad Spectrum SPF 15	Avobenzone, Octisalate, and Octocrylene	SPRAY	TOPICAL	20210930		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.24; 40.6; 15.02	mg/mL; mg/mL; mg/mL			N	20241231
13630-0206_d5ddc9a0-2d22-22e6-e053-2995a90a00d5	13630-0206	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 30 Sunscreen	Homosalate, Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20161110		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.23; 84.1; 42.05; 23.13	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0207_d5de2423-24e9-600e-e053-2a95a90a94d3	13630-0207	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 50 Sunscreen	Homosalate, Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20161110		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.47; 127.35; 42.45; 23.35	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0208_d5de6a07-db8f-2317-e053-2a95a90a45a2	13630-0208	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 50 Sunscreen	Homosalate, Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20161110		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.47; 127.35; 42.45; 23.35	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0209_d5df10bc-16ff-7a97-e053-2a95a90ab15e	13630-0209	HUMAN OTC DRUG	Soleil Toujours	SPF 50 Sheer Sunscreen	Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20210426		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	25.2; 84; 42	mg/mL; mg/mL; mg/mL			N	20241231
13630-0210_d5e0e120-f532-6aac-e053-2a95a90aae37	13630-0210	HUMAN OTC DRUG	Soleil Toujours	SPF 30 Sheer Sunscreen Mist	Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20210426		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	24.9; 62.25; 41.5	mg/mL; mg/mL; mg/mL			N	20241231
13630-0211_d5e097c9-3428-78c1-e053-2a95a90a6a6d	13630-0211	HUMAN OTC DRUG	Soleil Toujours	SPF 30 Sheer Sunscreen Mist	Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20210428		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	24.9; 62.25; 41.5	mg/mL; mg/mL; mg/mL			N	20241231
13630-0213_d5e21513-94c7-4db6-e053-2995a90a6fe3	13630-0213	HUMAN OTC DRUG	Ulta Beauty	SPF 30 Broad Spectrum Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20210311		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.05; 62.63; 41.75; 41.75	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0215_d5e2e691-a133-718b-e053-2a95a90aeb0b	13630-0215	HUMAN OTC DRUG	Bullfrog	SPF 50 Sunscreen Insect Repellent	Avobenzone, Homosalate, Octisalate, and Octinoxate	SPRAY	TOPICAL	20211203		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	26.55; 88.5; 66.38; 44.25; 44.25	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0216_d5f0dad1-fcbe-73d8-e053-2995a90a6d69	13630-0216	HUMAN OTC DRUG	Ulta Beauty	SPF 50 Broad Spectrum Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20210311		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.05; 83.5; 41.75; 41.75	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0217_d6073b54-6e49-3706-e053-2a95a90a2502	13630-0217	HUMAN OTC DRUG	Suntone	Sunscreen Broad Spectrum SPF30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20180430		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.2; 63; 42; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0218_d607c61c-50ec-73ff-e053-2995a90ac624	13630-0218	HUMAN OTC DRUG	Suntone	Sunscreen Broad Spectrum SPF50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20180502		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.2; 84; 42; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0219_d60874f7-4dfc-4ba0-e053-2995a90a8d1a	13630-0219	HUMAN OTC DRUG	Suntone	Sunscreen Broad Spectrum SPF50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20171214		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.2; 84; 42; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0220_d608b22e-b4e0-59af-e053-2a95a90a3045	13630-0220	HUMAN OTC DRUG	Suntone	Sunscreen Broad Spectrum SPF70	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220118		OTC MONOGRAPH FINAL	part352	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	26.1; 130.5; 43.5; 87	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0224_d71f15fc-a866-6c3b-e053-2995a90a1ccf	13630-0224	HUMAN OTC DRUG	Aloe Up	SPF 30 C/S Sunscreen with Aloe Vera	avobenzone, homosalate, octisalate, and octocrylene	SPRAY	TOPICAL	20190520		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.17; 83.9; 41.95; 23.07	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0225_d71fd4b6-a84f-44fd-e053-2a95a90a0b60	13630-0225	HUMAN OTC DRUG	Aloe Up	SPF 50 C/S Sunscreen with Aloe Vera	avobenzone, homosalate, octisalate, and octocrylene	SPRAY	TOPICAL	20190522		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.41; 127.05; 42.35; 23.29	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0232_dc26c38b-dd62-3217-e053-2995a90a2b14	13630-0232	HUMAN OTC DRUG	Vacation World	Classic Whip SPF 30	Dimethicone	SPRAY	TOPICAL	20220408		OTC MONOGRAPH FINAL	part352	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	50.5; 75.8; 50.5; 50.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0238_e21fc63a-1fd9-1f22-e053-2995a90a3e1f	13630-0238	HUMAN OTC DRUG	24/7 Life by 7- Eleven	Sunscreen Broad Spectrum SPF50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220505		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.2; 84; 42; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0241_e6499340-785b-08a9-e053-2995a90a4796	13630-0241	HUMAN OTC DRUG	Australian Gold	SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20220803		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.16; 40.4; 16.16	g/mL; g/mL; g/mL			N	20241231
13630-0243_e64b24d4-ea53-4835-e053-2995a90a2c2c	13630-0243	HUMAN OTC DRUG	BASK	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220414		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 83.4; 41.7; 41.7	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0244_e64ca34f-71eb-b52a-e053-2995a90a0e3f	13630-0244	HUMAN OTC DRUG	24/7 Life by 7-Eleven	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220414		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 83.4; 41.7; 41.7	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0245_e64ddc03-42e7-4eb5-e053-2995a90a0440	13630-0245	HUMAN OTC DRUG	Summer Camp Enviro UV	SPF 50 Sunscreen Mist	Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20220608		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	25.8; 86; 43	mg/mL; mg/mL; mg/mL			N	20241231
13630-0246_e64ea74b-473f-cdba-e053-2995a90ad36d	13630-0246	HUMAN OTC DRUG	Summer Camp Enviro UV	SPF 30 Sunscreen Mist	Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20220608		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	25.5; 63.8; 42.5	mg/mL; mg/mL; mg/mL			N	20241231
13630-0247_e672cd1c-0717-3ee8-e053-2a95a90a9e55	13630-0247	HUMAN OTC DRUG	Sun Bum	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190211		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.1; 83.6; 41.8; 31.4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0248_e673e040-5941-f9dd-e053-2995a90a0917	13630-0248	HUMAN OTC DRUG	Sun Bum	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190220		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.8; 129; 43; 60.2	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0253_ece8069a-267c-916e-e053-2995a90a1ee9	13630-0253	HUMAN OTC DRUG	Hurley	Sunscreen Broad Spectrum SPF15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20200505		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.44; 41.1; 16.44	g/mL; g/mL; g/mL			N	20241231
13630-0254_ece8bf4d-b2a6-3a3e-e053-2995a90a334f	13630-0254	HUMAN OTC DRUG	24/7 life by 7-Eleven	Broad Spectrum SPF	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220517		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.11; 62.78; 41.85; 41.85	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0255_ece97025-156b-8ed3-e053-2995a90a3bff	13630-0255	HUMAN OTC DRUG	Australian Gold	Instant Bronzer Broad Spectrum SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191113		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	16.42; 41.03; 16.42	g/mL; g/mL; g/mL			N	20241231
13630-0258_ecf92ca9-f19f-2012-e053-2a95a90a7bdc	13630-0258	HUMAN OTC DRUG	Trump Golf	Broad Spectrum SPF 30 Sunscreen	Homosalate, Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20150928		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.1; 83.6; 41.8; 23	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0259_ecf9c4fb-d276-dc57-e053-2a95a90a0bf5	13630-0259	HUMAN OTC DRUG	Panama Jack	Sunscreen Broad Spectrum SPF75	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220321		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.89; 129.45; 43.15; 86.3	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0261_ed86d0bb-9bf2-0cd5-e053-2995a90a45c3	13630-0261	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191023		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.2; 84; 42; 42	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0262_ed9a2ff0-1c86-52e8-e053-2a95a90abeb4	13630-0262	HUMAN OTC DRUG	Australian Gold	Extreme Sport SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191022		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.23; 63.08; 42.05; 42.05	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0263_ed9bd8f2-efed-ad77-e053-2a95a90ae48e	13630-0263	HUMAN OTC DRUG	Australian Gold	Little Joey SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191118		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.26; 84.2; 42.1; 42.1	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0265_edc5d89e-b925-5eb9-e053-2995a90a782e	13630-0265	HUMAN OTC DRUG	Australian Gold	Instant Bronzer Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191211		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.8; 64.5; 43; 43	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0267_f047dfdb-705f-3802-e053-2a95a90a7bd8	13630-0267	HUMAN OTC DRUG	Australian Gold	Botanical SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20161018		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.2; 84; 42; 42	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0268_f5656152-4df0-4945-e053-2995a90a3095	13630-0268	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191107		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.17; 62.93; 41.95; 41.95	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0269_f5653201-87cd-3ec6-e053-2995a90ace5a	13630-0269	HUMAN OTC DRUG	Australian Gold	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191118		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.08; 83.6; 41.8; 41.8	g/mL; g/mL; g/mL; g/mL			N	20241231
13630-0270_f8abe25b-c24f-ec0b-e053-6394a90ac382	13630-0270	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL	TOPICAL	20230406		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
13630-0271_f8adbfde-4daf-31c9-e053-6294a90adabf	13630-0271	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL	TOPICAL	20230406		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
13630-0272_fa2c258c-63ba-6f94-e053-6294a90a892b	13630-0272	HUMAN OTC DRUG	Australian Gold	SPF 6 Bronzer Oxybenzone	Avobenzone, Octocrylene	SPRAY	TOPICAL	20191016		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; OCTOCRYLENE	9.81; 9.81	mg/mL; mg/mL			N	20241231
13630-0274_0074787a-c9bd-ae87-e063-6394a90a2b86	13630-0274	HUMAN OTC DRUG	Australian Gold	Botanical Sunscreen Broad Spectrum SPF 30 Natural	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230301		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.5; 85; 42.5; 23.38	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0275_00752720-1367-03ed-e063-6394a90abab5	13630-0275	HUMAN OTC DRUG	Australian Gold Botanical	Broad Spectrum SPF 70	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20221205		OTC MONOGRAPH FINAL	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.71; 85.7; 42.85; 42.85	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0276_021be469-7aa5-008e-e063-6394a90ab367	13630-0276	HUMAN OTC DRUG	Ponte Vedra Inn	SPF 50 C/S Sunscreen	avobenzone, homosalate, octisalate, octocrylene	AEROSOL	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .15; .05; .0275	g/g; g/g; g/g; g/g			N	20241231
13630-0277_021c9663-dede-b7e1-e063-6394a90a9a2c	13630-0277	HUMAN OTC DRUG	Sugared and Bronzed	SPF 30 C/S Sunscreen	avobenzone, homosalate, octisalate, and octocrylene	AEROSOL	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .1; .05; .0275	g/g; g/g; g/g; g/g			N	20241231
13630-0278_021cd689-70e0-6862-e063-6294a90a2f8b	13630-0278	HUMAN OTC DRUG	SNAP	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Packaging	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .15; .05; .1	g/g; g/g; g/g; g/g			N	20241231
13630-0279_021dabae-fd66-b5a6-e063-6294a90ac2aa	13630-0279	HUMAN OTC DRUG	SNAP	Broad Spectrum SPF 40	Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Packaging	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .15; .05; .1	g/g; g/g; g/g; g/g			N	20241231
13630-0280_04c79ee8-132a-7010-e063-6294a90a8560	13630-0280	HUMAN OTC DRUG	Carnival Adventures	Sport Sunscreen Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20220329		OTC MONOGRAPH FINAL	M020	Prime Packaging Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.2; 84; 42; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
13630-0281_0c90a4ac-5683-26dc-e063-6394a90a6580	13630-0281	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL	TOPICAL	20210917		OTC MONOGRAPH DRUG	M020	Prime Packaging Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.11; 83.7; 41.85; 41.85	mg/g; mg/g; mg/g; mg/g			N	20241231
13630-0282_0c92d58b-b1b3-dc2c-e063-6394a90a4d7a	13630-0282	HUMAN OTC DRUG	Oleander NO-AD	Broad Spectrum SPF	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20231026		OTC MONOGRAPH DRUG	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.47; 63.68; 42.45; 42.45	mg/g; mg/g; mg/g; mg/g			N	20241231
13630-0283_0c93ce87-3179-1617-e063-6394a90a618d	13630-0283	HUMAN OTC DRUG	Sol-Or Kids	Broad Spectrum SPF	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220920		OTC MONOGRAPH DRUG	M020	Prime Packaging, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25.35; 126.75; 42.25; 23.24	mg/g; mg/g; mg/g; mg/g			N	20241231
13633-001_07720f82-6e44-72d0-e063-6294a90aeffc	13633-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Mountaineer Home Medical LLC	OXYGEN	99	L/100L			N	20241231
13668-007_eac5f2df-11a1-1465-e053-2a95a90a03f9	13668-007	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Torrent Pharmaceuticals Limited	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
13668-008_eac5f2df-11a1-1465-e053-2a95a90a03f9	13668-008	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Torrent Pharmaceuticals Limited	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
13668-009_9db626a0-e7de-4024-90f0-d592fccb82cd	13668-009	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Torrent Pharmaceuticals Limited	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-010_9db626a0-e7de-4024-90f0-d592fccb82cd	13668-010	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Torrent Pharmaceuticals Limited	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-011_9db626a0-e7de-4024-90f0-d592fccb82cd	13668-011	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Torrent Pharmaceuticals Limited	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-014_d74acd5e-5ed2-4685-87e6-ef6f03105eed	13668-014	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078858	Torrent Pharmaceuticals Limited	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
13668-015_d74acd5e-5ed2-4685-87e6-ef6f03105eed	13668-015	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078858	Torrent Pharmaceuticals Limited	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
13668-016_d74acd5e-5ed2-4685-87e6-ef6f03105eed	13668-016	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078858	Torrent Pharmaceuticals Limited	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
13668-017_d74acd5e-5ed2-4685-87e6-ef6f03105eed	13668-017	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078858	Torrent Pharmaceuticals Limited	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
13668-018_537376ac-bcab-4e78-a3fb-6b3dd10099d8	13668-018	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20110106	20240831	ANDA	ANDA090899	Torrent Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
13668-019_537376ac-bcab-4e78-a3fb-6b3dd10099d8	13668-019	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20110106	20240831	ANDA	ANDA090899	Torrent Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
13668-020_537376ac-bcab-4e78-a3fb-6b3dd10099d8	13668-020	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20110106	20240430	ANDA	ANDA090899	Torrent Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
13668-035_ed763004-3530-f312-e053-2a95a90acc40	13668-035	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	Torrent Pharmaceuticals Limited	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-036_ed763004-3530-f312-e053-2a95a90acc40	13668-036	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	Torrent Pharmaceuticals Limited	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-037_ed763004-3530-f312-e053-2a95a90acc40	13668-037	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	Torrent Pharmaceuticals Limited	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-038_ed763004-3530-f312-e053-2a95a90acc40	13668-038	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	Torrent Pharmaceuticals Limited	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-039_ed763004-3530-f312-e053-2a95a90acc40	13668-039	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	Torrent Pharmaceuticals Limited	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-040_ed763004-3530-f312-e053-2a95a90acc40	13668-040	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	Torrent Pharmaceuticals Limited	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-045_f211eef9-b57f-7e78-e053-2a95a90ae80b	13668-045	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20090127		ANDA	ANDA078947	Torrent Pharmaceuticals Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
13668-047_f211eef9-b57f-7e78-e053-2a95a90ae80b	13668-047	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20090127		ANDA	ANDA078947	Torrent Pharmaceuticals Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
13668-048_f211eef9-b57f-7e78-e053-2a95a90ae80b	13668-048	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20090127		ANDA	ANDA078947	Torrent Pharmaceuticals Limited	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
13668-049_f211eef9-b57f-7e78-e053-2a95a90ae80b	13668-049	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20090127		ANDA	ANDA078947	Torrent Pharmaceuticals Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
13668-079_6274e83c-d9bf-4fbf-88e3-bce066eac8b3	13668-079	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA090984	Torrent Pharmaceuticals Limited	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
13668-080_6274e83c-d9bf-4fbf-88e3-bce066eac8b3	13668-080	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA090984	Torrent Pharmaceuticals Limited	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
13668-081_6274e83c-d9bf-4fbf-88e3-bce066eac8b3	13668-081	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET	ORAL	20120803		ANDA	ANDA201515	Torrent Pharmaceuticals Limited	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
13668-086_ef53caaf-ca68-a0fc-e053-2a95a90ace16	13668-086	HUMAN PRESCRIPTION DRUG	OLANZAPINE		OLANZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20111025		ANDA	ANDA091415	Torrent Pharmaceuticals Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-088_ef53caaf-ca68-a0fc-e053-2a95a90ace16	13668-088	HUMAN PRESCRIPTION DRUG	OLANZAPINE		OLANZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20111025		ANDA	ANDA091415	Torrent Pharmaceuticals Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-089_ef53caaf-ca68-a0fc-e053-2a95a90ace16	13668-089	HUMAN PRESCRIPTION DRUG	OLANZAPINE		OLANZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20111025		ANDA	ANDA091415	Torrent Pharmaceuticals Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-090_ef53caaf-ca68-a0fc-e053-2a95a90ace16	13668-090	HUMAN PRESCRIPTION DRUG	OLANZAPINE		OLANZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20111025		ANDA	ANDA091415	Torrent Pharmaceuticals Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-091_daeac75c-f5a8-4e77-bd3c-daf5b942abbb	13668-091	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Torrent Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
13668-092_daeac75c-f5a8-4e77-bd3c-daf5b942abbb	13668-092	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Torrent Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
13668-093_daeac75c-f5a8-4e77-bd3c-daf5b942abbb	13668-093	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Torrent Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
13668-094_daeac75c-f5a8-4e77-bd3c-daf5b942abbb	13668-094	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Torrent Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
13668-095_daeac75c-f5a8-4e77-bd3c-daf5b942abbb	13668-095	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Torrent Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
13668-096_ac03b4b3-5aae-4ea8-9af4-3b0fbdbe5d5b	13668-096	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA090074	Torrent Pharmaceuticals Limited	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
13668-102_e4a4357c-7343-50ea-e053-2a95a90ab258	13668-102	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA090686	Torrent Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
13668-103_e4a4357c-7343-50ea-e053-2a95a90ab258	13668-103	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA090686	Torrent Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
13668-104_e6fdd5bc-4bc8-a7aa-e053-2995a90a96f1	13668-104	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20110603		ANDA	ANDA200270	Torrent Pharmaceuticals Limited	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
13668-105_e6fdd5bc-4bc8-a7aa-e053-2995a90a96f1	13668-105	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20110603		ANDA	ANDA200495	Torrent Pharmaceuticals Limited	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
13668-106_e6fdd5bc-4bc8-a7aa-e053-2995a90a96f1	13668-106	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20110603		ANDA	ANDA200495	Torrent Pharmaceuticals Limited	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
13668-107_19dddbee-7d7c-4202-9594-23792734586b	13668-107	HUMAN PRESCRIPTION DRUG	Rabeprazole sodium		Rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA202376	Torrent Pharmaceuticals Limited	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
13668-109_f9f0ae3c-5e9f-427f-b445-122b028f2792	13668-109	HUMAN PRESCRIPTION DRUG	Duloxetine hydrochloride		Duloxetin hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090774	Torrent Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
13668-110_f9f0ae3c-5e9f-427f-b445-122b028f2792	13668-110	HUMAN PRESCRIPTION DRUG	Duloxetine hydrochloride		Duloxetin hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090774	Torrent Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
13668-111_f9f0ae3c-5e9f-427f-b445-122b028f2792	13668-111	HUMAN PRESCRIPTION DRUG	Duloxetine hydrochloride		Duloxetin hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090774	Torrent Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
13668-116_1793f476-8ff4-475a-b26c-94b7d0977bfe	13668-116	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20101006	20240531	ANDA	ANDA090528	Torrent Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
13668-117_1793f476-8ff4-475a-b26c-94b7d0977bfe	13668-117	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20100406	20240630	ANDA	ANDA090528	Torrent Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
13668-132_e8044919-28e8-520b-e053-2a95a90a88aa	13668-132	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20111128		ANDA	ANDA202170	Torrent Pharmaceuticals Limited	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
13668-133_e8044919-28e8-520b-e053-2a95a90a88aa	13668-133	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20111128		ANDA	ANDA202170	Torrent Pharmaceuticals Limited	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
13668-134_e8044919-28e8-520b-e053-2a95a90a88aa	13668-134	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20111128		ANDA	ANDA202170	Torrent Pharmaceuticals Limited	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
13668-135_04a0a619-97a8-4832-9e4a-e10085002c1a	13668-135	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	Torrent Pharmaceuticals Limited	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-136_04a0a619-97a8-4832-9e4a-e10085002c1a	13668-136	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	Torrent Pharmaceuticals Limited	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-137_04a0a619-97a8-4832-9e4a-e10085002c1a	13668-137	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	Torrent Pharmaceuticals Limited	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-141_9861b1f3-7fc7-42fa-9e5e-db53e5bc1c4c	13668-141	HUMAN PRESCRIPTION DRUG	Clopidogrel Bisulfate		Clopidogrel Bisulfate	TABLET	ORAL	20120517		ANDA	ANDA090844	Torrent Pharmaceuticals Limited	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
13668-154_4cf5868d-0483-459a-aec0-b1a090ade4c7	13668-154	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20151019	20240430	ANDA	ANDA203636	Torrent Pharmaceuticals Limited	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
13668-155_4cf5868d-0483-459a-aec0-b1a090ade4c7	13668-155	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20151019	20241031	ANDA	ANDA203636	Torrent Pharmaceuticals Limited	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
13668-179_48ffd436-86c5-4724-9b5f-e4761be5d9ef	13668-179	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Torrent Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13668-180_48ffd436-86c5-4724-9b5f-e4761be5d9ef	13668-180	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Torrent Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13668-181_48ffd436-86c5-4724-9b5f-e4761be5d9ef	13668-181	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Torrent Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13668-182_48ffd436-86c5-4724-9b5f-e4761be5d9ef	13668-182	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Torrent Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13668-184_daeac75c-f5a8-4e77-bd3c-daf5b942abbb	13668-184	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Torrent Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
13668-185_1da3b4ae-e6f9-47c1-b238-df841a225d2f	13668-185	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20121106		ANDA	ANDA091479	Torrent Pharmaceuticals Limited	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-186_ea4a74d6-ecfe-bd72-e053-2a95a90a6d20	13668-186	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA091448	Torrent Pharmaceuticals Limited	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-187_ea4a74d6-ecfe-bd72-e053-2a95a90a6d20	13668-187	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA091448	Torrent Pharmaceuticals Limited	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-188_ea4a74d6-ecfe-bd72-e053-2a95a90a6d20	13668-188	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA091448	Torrent Pharmaceuticals Limited	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-189_ec092e4d-1ede-1656-e053-2995a90ae38e	13668-189	HUMAN PRESCRIPTION DRUG	TOLTERODINE TARTRATE		TOLTERODINE	CAPSULE, EXTENDED RELEASE	ORAL	20150811		ANDA	ANDA203016	Torrent Pharmaceuticals Limited	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
13668-190_ec092e4d-1ede-1656-e053-2995a90ae38e	13668-190	HUMAN PRESCRIPTION DRUG	TOLTERODINE TARTRATE		TOLTERODINE	CAPSULE, EXTENDED RELEASE	ORAL	20150811		ANDA	ANDA203016	Torrent Pharmaceuticals Limited	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
13668-201_f86e9a64-52b0-24cb-e053-6294a90a2bc7	13668-201	HUMAN PRESCRIPTION DRUG	moxifloxacin hydrochloride		moxifloxacin hydrochloride	TABLET	ORAL	20140403	20240531	ANDA	ANDA200160	Torrent Pharmaceuticals Limited	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	
13668-202_f04522cb-640c-4788-816d-795e588806d2	13668-202	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118		ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
13668-203_f04522cb-640c-4788-816d-795e588806d2	13668-203	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20161118		ANDA	ANDA205209	Torrent Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
13668-216_a3146dba-872f-4813-ada2-285e91a545e9	13668-216	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Torrent Pharmaceuticals Limited	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-217_a3146dba-872f-4813-ada2-285e91a545e9	13668-217	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Torrent Pharmaceuticals Limited	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-218_a3146dba-872f-4813-ada2-285e91a545e9	13668-218	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Torrent Pharmaceuticals Limited	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-219_a3146dba-872f-4813-ada2-285e91a545e9	13668-219	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Torrent Pharmaceuticals Limited	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-220_a3146dba-872f-4813-ada2-285e91a545e9	13668-220	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Torrent Pharmaceuticals Limited	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-221_a3146dba-872f-4813-ada2-285e91a545e9	13668-221	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Torrent Pharmaceuticals Limited	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-251_59f9a4b5-5fca-4aa0-9fc4-6ae1ea1d560e	13668-251	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 20/12.5	TABLET	ORAL	20170424	20240531	ANDA	ANDA206515	Torrent Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
13668-252_59f9a4b5-5fca-4aa0-9fc4-6ae1ea1d560e	13668-252	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 40/12.5	TABLET	ORAL	20170424	20240531	ANDA	ANDA206515	Torrent Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
13668-253_59f9a4b5-5fca-4aa0-9fc4-6ae1ea1d560e	13668-253	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 40/25	TABLET	ORAL	20170424	20240531	ANDA	ANDA206515	Torrent Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
13668-266_f211eef9-b57f-7e78-e053-2a95a90ae80b	13668-266	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		lamotrigine	KIT		20090127		ANDA	ANDA078947	Torrent Pharmaceuticals Limited						N	20241231
13668-268_9b02cba5-6e06-4fd6-aefe-c9acfb817b15	13668-268	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20091023		ANDA	ANDA077272	Torrent Pharmaceuticals Limited	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
13668-271_9b02cba5-6e06-4fd6-aefe-c9acfb817b15	13668-271	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, CHEWABLE	ORAL	20090826		ANDA	ANDA075712	Torrent Pharmaceuticals Limited	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
13668-307_c51c437d-a4e6-4e94-8031-63bf74408fbd	13668-307	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20151223		ANDA	ANDA207677	Torrent Pharmaceuticals Limited	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13668-310_c51c437d-a4e6-4e94-8031-63bf74408fbd	13668-310	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20151223		ANDA	ANDA207677	Torrent Pharmaceuticals Limited	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13668-330_35d61b31-d37a-4e44-bcff-e1a9be9b76e5	13668-330	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Torrent Pharmaceuticals Limited	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13668-331_35d61b31-d37a-4e44-bcff-e1a9be9b76e5	13668-331	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Torrent Pharmaceuticals Limited	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13668-332_35d61b31-d37a-4e44-bcff-e1a9be9b76e5	13668-332	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Torrent Pharmaceuticals Limited	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13668-333_35d61b31-d37a-4e44-bcff-e1a9be9b76e5	13668-333	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Torrent Pharmaceuticals Limited	TRAZODONE HYDROCHLORIDE	300	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
13668-339_cd696ead-bb18-47da-91c4-6cb38dcf2872	13668-339	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20131223		ANDA	ANDA203370	Torrent Pharmaceuticals Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
13668-340_cd696ead-bb18-47da-91c4-6cb38dcf2872	13668-340	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20131223		ANDA	ANDA203370	Torrent Pharmaceuticals Limited	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
13668-341_cd696ead-bb18-47da-91c4-6cb38dcf2872	13668-341	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20131223		ANDA	ANDA203370	Torrent Pharmaceuticals Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
13668-353_cf542000-0bff-4f8f-bcf6-b721d582e0fa	13668-353	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Torrent Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
13668-354_cf542000-0bff-4f8f-bcf6-b721d582e0fa	13668-354	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Torrent Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
13668-355_cf542000-0bff-4f8f-bcf6-b721d582e0fa	13668-355	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Torrent Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
13668-356_cf542000-0bff-4f8f-bcf6-b721d582e0fa	13668-356	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol	TABLET	ORAL	20180302		ANDA	ANDA203966	Torrent Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
13668-382_1ae8e8eb-da85-4790-8b02-a34f95c122f0	13668-382	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/10/25 mg		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 40/10/25 mg	TABLET	ORAL	20161026		ANDA	ANDA203580	Torrent Pharmaceuticals Limited	AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
13668-383_1ae8e8eb-da85-4790-8b02-a34f95c122f0	13668-383	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/10/12.5 mg		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 40/10/12.5 mg	TABLET	ORAL	20161026		ANDA	ANDA203580	Torrent Pharmaceuticals Limited	AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
13668-385_1ae8e8eb-da85-4790-8b02-a34f95c122f0	13668-385	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/25 mg		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 40/5/25 mg	TABLET	ORAL	20161026		ANDA	ANDA203580	Torrent Pharmaceuticals Limited	AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
13668-386_1ae8e8eb-da85-4790-8b02-a34f95c122f0	13668-386	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/12.5 mg		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 40/5/12.5 mg	TABLET	ORAL	20161026		ANDA	ANDA203580	Torrent Pharmaceuticals Limited	AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
13668-397_1ae8e8eb-da85-4790-8b02-a34f95c122f0	13668-397	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg		Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 20/5/12.5 mg	TABLET	ORAL	20161026		ANDA	ANDA203580	Torrent Pharmaceuticals Limited	AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
13668-429_ac03b4b3-5aae-4ea8-9af4-3b0fbdbe5d5b	13668-429	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA090074	Torrent Pharmaceuticals Limited	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
13668-438_00688fe9-dc17-4324-a6b8-fe3ecebe3eed	13668-438	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180701		ANDA	ANDA210782	Torrent Pharmaceuticals Limited	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
13668-439_00688fe9-dc17-4324-a6b8-fe3ecebe3eed	13668-439	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180701		ANDA	ANDA210782	Torrent Pharmaceuticals Limited	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
13668-440_00688fe9-dc17-4324-a6b8-fe3ecebe3eed	13668-440	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180701		ANDA	ANDA210782	Torrent Pharmaceuticals Limited	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
13668-441_c51c437d-a4e6-4e94-8031-63bf74408fbd	13668-441	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20151223		ANDA	ANDA207677	Torrent Pharmaceuticals Limited	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13668-442_c51c437d-a4e6-4e94-8031-63bf74408fbd	13668-442	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20151223		ANDA	ANDA207677	Torrent Pharmaceuticals Limited	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13668-443_abee2cfb-5aa7-4c5b-8c7a-6b041522176c	13668-443	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET	ORAL	20161021		ANDA	ANDA206937	Torrent Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-453_eb8c7860-68fe-4e98-e053-2995a90ae09b	13668-453	HUMAN PRESCRIPTION DRUG	anagrelide		anagrelide	CAPSULE	ORAL	20170630		ANDA	ANDA209151	Torrent Pharmaceuticals Limited	ANAGRELIDE HYDROCHLORIDE ANHYDROUS	.5	mg/1	Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]		N	20241231
13668-462_eb8c7860-68fe-4e98-e053-2995a90ae09b	13668-462	HUMAN PRESCRIPTION DRUG	anagrelide		anagrelide	CAPSULE	ORAL	20170630		ANDA	ANDA209151	Torrent Pharmaceuticals Limited	ANAGRELIDE HYDROCHLORIDE ANHYDROUS	1	mg/1	Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]		N	20241231
13668-463_7c8c2315-1c52-4020-9ac2-e92646a7bab1	13668-463	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE	ORAL	20180824		ANDA	ANDA209460	Torrent Pharmaceuticals Limited	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
13668-464_f092d831-92d3-47f3-9dec-e39a62bc658a	13668-464	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA208055	Torrent Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-465_f092d831-92d3-47f3-9dec-e39a62bc658a	13668-465	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA208055	Torrent Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-466_f092d831-92d3-47f3-9dec-e39a62bc658a	13668-466	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA208055	Torrent Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-467_f092d831-92d3-47f3-9dec-e39a62bc658a	13668-467	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA208055	Torrent Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20251231
13668-473_abee2cfb-5aa7-4c5b-8c7a-6b041522176c	13668-473	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET	ORAL	20161021		ANDA	ANDA206937	Torrent Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
13668-482_774d2ab4-de78-4eca-a050-e55670713d3a	13668-482	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Torrent Pharmaceuticals Limited	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
13668-483_774d2ab4-de78-4eca-a050-e55670713d3a	13668-483	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Torrent Pharmaceuticals Limited	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
13668-484_774d2ab4-de78-4eca-a050-e55670713d3a	13668-484	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Torrent Pharmaceuticals Limited	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
13668-485_2885ddeb-596e-4171-afa0-3fa4cb484508	13668-485	HUMAN PRESCRIPTION DRUG	MINOCYCLINE HYDROCHLORIDE		MINOCYCLINE HYDROCHLORIDE	TABLET	ORAL	20150402		ANDA	ANDA065156	Torrent Pharmaceuticals Limited	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
13668-486_2885ddeb-596e-4171-afa0-3fa4cb484508	13668-486	HUMAN PRESCRIPTION DRUG	MINOCYCLINE HYDROCHLORIDE		MINOCYCLINE HYDROCHLORIDE	TABLET	ORAL	20150402		ANDA	ANDA065156	Torrent Pharmaceuticals Limited	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
13668-487_2885ddeb-596e-4171-afa0-3fa4cb484508	13668-487	HUMAN PRESCRIPTION DRUG	MINOCYCLINE HYDROCHLORIDE		MINOCYCLINE HYDROCHLORIDE	TABLET	ORAL	20150402		ANDA	ANDA065156	Torrent Pharmaceuticals Limited	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
13668-509_bbaa3b2c-4233-44cf-b046-65024778a757	13668-509	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230217		ANDA	ANDA208047	Torrent Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
13668-515_f52393c2-572c-4753-e053-2995a90ab336	13668-515	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	OINTMENT	TOPICAL	20190111		ANDA	ANDA209971	Torrent Pharmaceuticals Limited	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
13668-531_6274e83c-d9bf-4fbf-88e3-bce066eac8b3	13668-531	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	GRANULE	ORAL	20170330		ANDA	ANDA210431	Torrent Pharmaceuticals Limited	MONTELUKAST SODIUM	4	mg/500mg	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
13668-534_068894d4-f2a3-4ac1-b250-88fee39a62db	13668-534	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20190129		ANDA	ANDA211838	Torrent Pharmaceuticals Limited	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
13668-565_e19cba04-4ed4-4fba-8ced-d23666756c8b	13668-565	HUMAN PRESCRIPTION DRUG	TADALAFIL		TADALAFIL	TABLET	ORAL	20190326		ANDA	ANDA211839	Torrent Pharmaceuticals Limited	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-566_e19cba04-4ed4-4fba-8ced-d23666756c8b	13668-566	HUMAN PRESCRIPTION DRUG	TADALAFIL		TADALAFIL	TABLET	ORAL	20190326		ANDA	ANDA211839	Torrent Pharmaceuticals Limited	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-567_e19cba04-4ed4-4fba-8ced-d23666756c8b	13668-567	HUMAN PRESCRIPTION DRUG	TADALAFIL		TADALAFIL	TABLET	ORAL	20190326		ANDA	ANDA211839	Torrent Pharmaceuticals Limited	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-568_e19cba04-4ed4-4fba-8ced-d23666756c8b	13668-568	HUMAN PRESCRIPTION DRUG	TADALAFIL		TADALAFIL	TABLET	ORAL	20190326		ANDA	ANDA211839	Torrent Pharmaceuticals Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-569_f91539a4-6c02-7eff-e053-6394a90a1662	13668-569	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20191230	20240930	ANDA	ANDA211836	Torrent Pharmaceuticals Limited	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
13668-581_d96919a9-113a-470f-91b3-d7d14f7a4542	13668-581	HUMAN PRESCRIPTION DRUG	TADALAFIL		TADALAFIL	TABLET	ORAL	20190326		ANDA	ANDA212062	Torrent Pharmaceuticals Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
13668-586_cc85f940-8d50-72ad-e053-2a95a90a61d1	13668-586	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN		ERYTHROMYCIN	TABLET, DELAYED RELEASE	ORAL	20210726		ANDA	ANDA211975	Torrent Pharmaceuticals Limited	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
13668-588_cc85f940-8d50-72ad-e053-2a95a90a61d1	13668-588	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN		ERYTHROMYCIN	TABLET, DELAYED RELEASE	ORAL	20210726		ANDA	ANDA211975	Torrent Pharmaceuticals Limited	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
13668-591_c037abe0-0d82-4f8b-a77a-bd6fee196259	13668-591	HUMAN PRESCRIPTION DRUG	APREPITANT		APREPITANT	CAPSULE	ORAL	20201021		ANDA	ANDA211835	Torrent Pharmaceuticals Limited	APREPITANT	40	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
13668-592_c037abe0-0d82-4f8b-a77a-bd6fee196259	13668-592	HUMAN PRESCRIPTION DRUG	APREPITANT		APREPITANT	CAPSULE	ORAL	20201021		ANDA	ANDA211835	Torrent Pharmaceuticals Limited	APREPITANT	80	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
13668-593_c037abe0-0d82-4f8b-a77a-bd6fee196259	13668-593	HUMAN PRESCRIPTION DRUG	APREPITANT		APREPITANT	CAPSULE	ORAL	20201021		ANDA	ANDA211835	Torrent Pharmaceuticals Limited	APREPITANT	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
13668-594_c037abe0-0d82-4f8b-a77a-bd6fee196259	13668-594	HUMAN PRESCRIPTION DRUG	APREPITANT		APREPITANT	KIT		20201021		ANDA	ANDA211835	Torrent Pharmaceuticals Limited						N	20241231
13668-595_c62d0da1-7d06-4328-be21-9161ee27da7c	13668-595	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20190724		ANDA	ANDA212557	Torrent Pharmaceuticals Limited	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
13668-605_f86d9c93-0b42-4740-9cf0-86fc9a873fea	13668-605	HUMAN PRESCRIPTION DRUG	dapsone		dapsone	GEL	TOPICAL	20220210		ANDA	ANDA214722	Torrent Pharmaceuticals Limited	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
13668-606_ee8f24ec-95c9-25ce-e053-2a95a90aac60	13668-606	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, COATED	ORAL	20200706		ANDA	ANDA212015	Torrent Pharmaceuticals Limited	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
13668-607_ee8f24ec-95c9-25ce-e053-2a95a90aac60	13668-607	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, COATED	ORAL	20200706		ANDA	ANDA212015	Torrent Pharmaceuticals Limited	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
13668-610_bc17b856-f6f4-4f64-831c-1819811c0ecb	13668-610	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20200714		ANDA	ANDA213142	Torrent Pharmaceuticals Limited	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
13668-629_d1b0a505-c6cd-41eb-832e-84e6ae7923ed	13668-629	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20230109		ANDA	ANDA215908	Torrent pharmaceuticals limited	NITISINONE	2	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
13668-630_d1b0a505-c6cd-41eb-832e-84e6ae7923ed	13668-630	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20230109		ANDA	ANDA215908	Torrent pharmaceuticals limited	NITISINONE	5	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
13668-631_d1b0a505-c6cd-41eb-832e-84e6ae7923ed	13668-631	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20230109		ANDA	ANDA215908	Torrent pharmaceuticals limited	NITISINONE	10	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
13668-632_d1b0a505-c6cd-41eb-832e-84e6ae7923ed	13668-632	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20230109		ANDA	ANDA215908	Torrent pharmaceuticals limited	NITISINONE	20	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
13668-661_d6ca2afc-2273-498a-9288-73bc055c39bc	13668-661	HUMAN PRESCRIPTION DRUG	Penciclovir		penciclovir	CREAM	TOPICAL	20230807		ANDA	ANDA216981	Torrent Pharmaceuticals Limited	PENCICLOVIR	10	mg/g	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
13668-676_f187add0-3dad-5c68-e053-2995a90af0e1	13668-676	HUMAN PRESCRIPTION DRUG	Dichlorphenamide		Dichlorphenamide	TABLET	ORAL	20221229		ANDA	ANDA215924	Torrent pharmaceuticals limited	DICHLORPHENAMIDE	50	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
13668-682_ae432058-c17e-46cf-a560-c0aa41b9334c	13668-682	HUMAN PRESCRIPTION DRUG	Sorafenib		sorafenib	TABLET, FILM COATED	ORAL	20230412		ANDA	ANDA217095	Torrent Pharmaceuticals Limited	SORAFENIB	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
13668-720_0cf092f3-161b-5a2b-e063-6294a90ac2b0	13668-720	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	TORRENT PHARMACEUTICALS LIMITED	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13668-721_0cf092f3-161b-5a2b-e063-6294a90ac2b0	13668-721	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	TORRENT PHARMACEUTICALS LIMITED	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13668-722_0cf092f3-161b-5a2b-e063-6294a90ac2b0	13668-722	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	TORRENT PHARMACEUTICALS LIMITED	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13668-723_0cf092f3-161b-5a2b-e063-6294a90ac2b0	13668-723	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	TORRENT PHARMACEUTICALS LIMITED	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
13672-051_0a3f0afb-70b6-d550-e063-6294a90a7498	13672-051	HUMAN PRESCRIPTION DRUG	Betapace		sotalol HCl	TABLET	ORAL	19921030		NDA	NDA019865	Skyepharma Production SAS	SOTALOL HYDROCHLORIDE	80	mg/80mg	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
13672-052_0a3f0afb-70b6-d550-e063-6294a90a7498	13672-052	HUMAN PRESCRIPTION DRUG	Betapace		sotalol HCl	TABLET	ORAL	19921030		NDA	NDA019865	Skyepharma Production SAS	SOTALOL HYDROCHLORIDE	120	mg/120mg	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
13672-053_0a3f0afb-70b6-d550-e063-6294a90a7498	13672-053	HUMAN PRESCRIPTION DRUG	Betapace		sotalol HCl	TABLET	ORAL	19921030		NDA	NDA019865	Skyepharma Production SAS	SOTALOL HYDROCHLORIDE	160	mg/160mg	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
13672-054_0a3f0afb-70b6-d550-e063-6294a90a7498	13672-054	HUMAN PRESCRIPTION DRUG	Betapace AF		sotalol HCl	TABLET	ORAL	20000222		NDA	NDA021151	Skyepharma Production SAS	SOTALOL HYDROCHLORIDE	80	mg/80mg	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
13672-055_0a3f0afb-70b6-d550-e063-6294a90a7498	13672-055	HUMAN PRESCRIPTION DRUG	Betapace AF		sotalol HCl	TABLET	ORAL	20000222		NDA	NDA021151	Skyepharma Production SAS	SOTALOL HYDROCHLORIDE	120	mg/120mg	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
13672-056_0a3f0afb-70b6-d550-e063-6294a90a7498	13672-056	HUMAN PRESCRIPTION DRUG	Betapace AF		sotalol HCl	TABLET	ORAL	20000222		NDA	NDA021151	Skyepharma Production SAS	SOTALOL HYDROCHLORIDE	160	mg/160mg	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
13709-230_0eb0ea7e-e08e-b48e-e063-6394a90af874	13709-230	HUMAN OTC DRUG	ClearCanal Ear Wax Softerner Drops		Carbamide Peroxide	SOLUTION/ DROPS	AURICULAR (OTIC)	20110824		OTC MONOGRAPH DRUG	M014	NeilMed Pharmaceuticals, Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20251231
13709-231_0eb0d276-2eba-1c8d-e063-6294a90ae9ff	13709-231	HUMAN OTC DRUG	SinuFrin	NeilMed	Oxymetazoline Hydrochloride	SPRAY	NASAL	20120715		OTC MONOGRAPH DRUG	M012	NeilMed Pharmaceuticals Inc	OXYMETAZOLINE HYDROCHLORIDE	7.5	mg/15mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20251231
13709-232_0eb0fd3c-87e2-405d-e063-6294a90ae06f	13709-232	HUMAN OTC DRUG	SinuFrin Plus	NeilMed	Oxymetazoline Hydrochloride	SPRAY	NASAL	20120715		OTC MONOGRAPH DRUG	M012	NeilMed Pharmaceuticals, Inc.	OXYMETAZOLINE HYDROCHLORIDE	7.5	mg/15mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20251231
13709-234_0eb0a622-5e98-ab28-e063-6394a90a1e1b	13709-234	HUMAN OTC DRUG	Netimist		Homeopathic Sinus Spray	SPRAY	NASAL	20160429		UNAPPROVED HOMEOPATHIC		NeilMed Pharmaceuticals, Inc	POTASSIUM CHLORIDE	6	[hp_X]/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
13709-234_0eb0b5a1-b347-985e-e063-6394a90a3784	13709-234	HUMAN OTC DRUG	Netimist		Homeopathic Sinus Spray	SPRAY	NASAL	20160429		UNAPPROVED HOMEOPATHIC		Neilmed Pharmaceuticals Inc.	POTASSIUM CHLORIDE	6	[hp_X]/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
13709-235_0eb06bdb-c858-98c0-e063-6394a90ab3d6	13709-235	HUMAN OTC DRUG	Wound Wash Antiseptic Saline with Benzalkonium Chloride		Wound Wash Antiseptic Saline with Benzalkonium Chloride	AEROSOL, SPRAY	TOPICAL	20170102		OTC MONOGRAPH DRUG	M004	NeilMed Pharmaceuticals, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20251231
13709-238_0eb0c83d-d076-1c8f-e063-6294a90a1423	13709-238	HUMAN OTC DRUG	NeilMed Hot and Cold Pain Relief		Pain Relief Spray	SPRAY	TOPICAL	20201111		OTC MONOGRAPH DRUG	M017	NeilMed Pharmaceuticals Inc.	MENTHOL	.16	g/g			N	20251231
13709-239_0eb0a47d-4c98-a632-e063-6394a90a29dd	13709-239	HUMAN OTC DRUG	NeilMed Anti-Itch		Anti-Itch Spray	SPRAY	TOPICAL	20201111		OTC MONOGRAPH DRUG	M017	NeilMed Pharmaceuticals Inc.	HYDROCORTISONE	1	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
13709-310_0eb11e53-062d-3f3d-e063-6294a90a7e75	13709-310	HUMAN OTC DRUG	Cooling Itch Relief		Cooling Itch Relief	SPRAY	TOPICAL	20181108		OTC MONOGRAPH DRUG	M017	NeilMed Pharmaceuticals, Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
13709-311_0eb06bdb-c859-98c0-e063-6394a90ab3d6	13709-311	HUMAN OTC DRUG	Cool n Heat		Cool n Heat	SPRAY	TOPICAL	20181109		OTC MONOGRAPH DRUG	M017	NeilMed Pharmaceuticals, Inc.	MENTHOL	160	mg/mL			N	20251231
13709-312_0eb0ee15-bb9f-bd77-e063-6394a90a0df7	13709-312	HUMAN OTC DRUG	SuavEar Earwax Removal Aid		Earwax Removal Aid	SOLUTION/ DROPS	AURICULAR (OTIC)	20210422		OTC MONOGRAPH DRUG	M014	NEILMED PHARMACEUTICALS INC	CARBAMIDE PEROXIDE	65	mg/mL			N	20251231
13709-313_0eb0da5e-0fa4-b442-e063-6394a90a08f4	13709-313	HUMAN OTC DRUG	Wax Out Plus		Carbamide peroxide drops	SOLUTION/ DROPS	AURICULAR (OTIC)	20181105		OTC MONOGRAPH DRUG	M014	NEILMED PHARMACEUTICALS INC	CARBAMIDE PEROXIDE	65	mg/mL			N	20251231
13709-314_0eb0d3b3-1a54-1c93-e063-6294a90a6d13	13709-314	HUMAN OTC DRUG	NeilMed Clear Canal Earwax Removal kit		Carbamide peroxide	SOLUTION/ DROPS	AURICULAR (OTIC)	20211225		OTC MONOGRAPH DRUG	M014	NEILMED PHARMACEUTICALS INC	CARBAMIDE PEROXIDE	65	mg/mL			N	20251231
13709-315_0eb0265b-79a8-8489-e063-6394a90a1967	13709-315	HUMAN OTC DRUG	No Drip		Oxymetazoline Hydrochloride	SPRAY	NASAL	20221001		OTC MONOGRAPH DRUG	M012	NeilMed Pharmaceuticals Inc	OXYMETAZOLINE HYDROCHLORIDE	15	mg/30mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20251231
13709-316_031957e1-9b0d-1579-e063-6394a90aaee8	13709-316	HUMAN OTC DRUG	Hydrocortisone		Anti Itch	OINTMENT	TOPICAL	20230817		OTC MONOGRAPH NOT FINAL	part348	NeilMed Pharmaceuticals Inc	HYDROCORTISONE	.0102	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
13709-317_042cc80a-9341-551f-e063-6394a90a86c6	13709-317	HUMAN OTC DRUG	Hydrocortisone with aloe		hydrocortisone with Aloe Anti Itch	CREAM	TOPICAL	20230818		OTC MONOGRAPH NOT FINAL	part348	NeilMed Pharmaceuticals Inc.	HYDROCORTISONE	10.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
13709-318_032fedc7-16d4-aa9c-e063-6294a90aa445	13709-318	HUMAN OTC DRUG	Hydrocortisone		Cool Relief gel with Aloe	GEL	TOPICAL	20230821		OTC MONOGRAPH NOT FINAL	part348	NeilMed Pharmaceuticals Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
13709-319_038a2cf5-1b73-227b-e063-6394a90a84ad	13709-319	HUMAN OTC DRUG	Hemorrhoidal		Pain Relief	OINTMENT	RECTAL	20230822		OTC MONOGRAPH FINAL	M015	NeilMed Pharmaceuticals Inc.	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
13709-321_03b3733a-4d79-149f-e063-6294a90a6518	13709-321	HUMAN OTC DRUG	Gentle Laxative Bisacodyl		Gentle Laxative Bisacodyl	SUPPOSITORY	RECTAL	20230824		OTC MONOGRAPH NOT FINAL	part334	NeilMed Pharmaceuticals Inc	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
13709-322_03b4be69-6489-76be-e063-6394a90a7edf	13709-322	HUMAN OTC DRUG	Glycerin Laxative		Glycerin based Gentle and Effective Laxative Adult Constipation Relief	SUPPOSITORY	RECTAL	20230824		OTC MONOGRAPH NOT FINAL	part334	NeilMed Pharmaceuticals Inc.	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
13709-323_03b159b0-b961-b38d-e063-6394a90a9462	13709-323	HUMAN OTC DRUG	Hemorrhoidal cocoa butter		Hemorrhoidal	SUPPOSITORY	RECTAL	20230824		OTC MONOGRAPH FINAL	M015	NeilMed Pharmaceuticals Inc.	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	884.4; 2.5	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
13709-324_076b5021-8ba1-0204-e063-6294a90a3337	13709-324	HUMAN OTC DRUG	Hemorrhoidal Pain Relief with Aloe and VitaminE		Hemorrhoidal Pain Relief with Aloe and VitaminE	CREAM	RECTAL	20231011		OTC MONOGRAPH DRUG	M015	NeilMed pharmaceuticals Inc.	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	144; 150; 25; 10	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
13709-325_0c36a34e-462e-713c-e063-6294a90a1776	13709-325	HUMAN OTC DRUG	Sinufrin Quick Relief Decongestant		Sinufrin	SPRAY	NASAL	20231211		OTC MONOGRAPH DRUG	M012	Neilmed pharmaceuticals Inc.	OXYMETAZOLINE	6	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
13733-141_95846bd5-ca75-258c-e053-2a95a90a427d	13733-141	HUMAN OTC DRUG	MISSHA M Perfect Cover BB No 13		Zinc Oxide, Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.075; .0419; .07	g/g; g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
13733-151_9585d3d2-806d-36e3-e053-2a95a90a28fa	13733-151	HUMAN OTC DRUG	MISSHA M Perfect Cover BB No 21		Zinc Oxide, Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.075; .0419; .07	g/g; g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
13733-160_95817e29-fd60-909d-e053-2995a90aa879	13733-160	HUMAN OTC DRUG	MISSHA M Perfect Cover BB No 23		Zinc Oxide, Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20151201		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3.75; 2.09; 3.5	g/50mL; g/50mL; g/50mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
13733-165_95813763-d9b4-21a4-e053-2a95a90af401	13733-165	HUMAN OTC DRUG	MISSHA M Perfect Cover BB Cream SPF42 (No. 25)		Zinc Oxide, Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20171214		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3.75; 2.099; 3.5	g/50mL; g/50mL; g/50mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
13733-170_959c3774-18d3-1c12-e053-2995a90ad7b9	13733-170	HUMAN OTC DRUG	MISSHA M Perfect Cover BB No 27		Zinc Oxide, Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20151201		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3.75; 2.09; 3.5	g/50mL; g/50mL; g/50mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
13733-181_95862d15-d978-7276-e053-2995a90ab690	13733-181	HUMAN OTC DRUG	MISSHA M Perfect Cover BB No 31		Zinc Oxide, Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.075; .0419; .07	g/g; g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
13733-219_958502a7-4d2f-be5a-e053-2995a90a54ef	13733-219	HUMAN OTC DRUG	MISSHA M Perfect Cover BB SPF42 No21		Octinoxate, Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.075; .042; .07	g/g; g/g; g/g			N	20241231
13733-220_958502a7-4d2f-be5a-e053-2995a90a54ef	13733-220	HUMAN OTC DRUG	MISSHA M Perfect Cover BB SPF42 No23		Octinoxate, Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20160922		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.075; .042; .07	g/g; g/g; g/g			N	20241231
13733-245_958566be-c739-354b-e053-2a95a90acf6c	13733-245	HUMAN OTC DRUG	MISSHA M Perfect Cover BB SPF42 No29		Octinoxate, Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20161001		OTC MONOGRAPH NOT FINAL	part352	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.075; .042; .07	g/g; g/g; g/g			N	20241231
13733-246_c2674f6b-02e8-485b-b3b0-bfec2161bcc1	13733-246	HUMAN OTC DRUG	MISSHA M Perfect Cover BB Cream SPF42 No. 25		Zinc Oxide, Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20230102		OTC MONOGRAPH DRUG	M020	Able C&C Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	7.5; 4.19; 7	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
13734-157_35748dc1-2591-49b2-938d-047e210c0c7b	13734-157	HUMAN OTC DRUG	NARS SMOOTH and PROTECT PRIMER		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	741.7; 2967; 1483.5; 1483.5; 1483.5	mg/30mL; mg/30mL; mg/30mL; mg/30mL; mg/30mL			N	20241231
13734-158_5163a7bc-a664-4eb0-8e8a-90b4409425a2	13734-158	HUMAN OTC DRUG	NARS RADIANCE PRIMER		AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	602.4; 1807.2; 1506; 481.9	mg/30mL; mg/30mL; mg/30mL; mg/30mL			N	20241231
13734-160_751057c1-8bde-4d59-8b11-4a2d3c9d3e24	13734-160	HUMAN OTC DRUG	NARS AFTERGLOW LIP BALM CLEAN CUT		OCTINOXATE	STICK	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE	222	mg/3g			N	20241231
13734-161_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-161	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER GOTLAND		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-162_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-162	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER NORWICH		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-163_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-163	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER MYKONOS		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-164_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-164	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER SYDNEY		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-165_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-165	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER AUCKLAND		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-166_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-166	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER SANTIAGO		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-167_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-167	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER MARRAKESH		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-168_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-168	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER HAVANA		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-169_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-169	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER GUERNSEY		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-170_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-170	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER GRANADA		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-171_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-171	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER FINLAND		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-172_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-172	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER ALASKA		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-173_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-173	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER ST. MORITZ		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-174_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-174	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER TERRE-NEUVE		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-175_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-175	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER GROENLAND		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13734-176_4b1e5304-9be0-44ba-b52c-c193c2fef8e6	13734-176	HUMAN OTC DRUG	NARS PURE RADIANT TINTED MOISTURIZER CUZCO		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	NARS Cosmetics	OCTINOXATE; TITANIUM DIOXIDE	3.745; 3.125	g/50mL; g/50mL			N	20241231
13811-090_c1a4982f-e093-41d0-8413-778169d20b36	13811-090	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20221010		NDA	NDA022038	Trigen Laboratories, LLC	ESTRADIOL	.25	mg/.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
13811-091_c1a4982f-e093-41d0-8413-778169d20b36	13811-091	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20221010		NDA	NDA022038	Trigen Laboratories, LLC	ESTRADIOL	.5	mg/.5g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
13811-092_c1a4982f-e093-41d0-8413-778169d20b36	13811-092	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20221010		NDA	NDA022038	Trigen Laboratories, LLC	ESTRADIOL	.75	mg/.75g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
13811-093_c1a4982f-e093-41d0-8413-778169d20b36	13811-093	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20221010		NDA	NDA022038	Trigen Laboratories, LLC	ESTRADIOL	1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
13811-094_c1a4982f-e093-41d0-8413-778169d20b36	13811-094	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20221010		NDA	NDA022038	Trigen Laboratories, LLC	ESTRADIOL	1.25	mg/1.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
13811-689_99f87319-1628-4d43-aef3-8da77a1f0f93	13811-689	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride	Extended-Release	tramadol hydrochloride	CAPSULE	ORAL	20150622		NDA AUTHORIZED GENERIC	NDA022370	Trigen Laboratories, LLC	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
13811-690_99f87319-1628-4d43-aef3-8da77a1f0f93	13811-690	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride	Extended-Release	tramadol hydrochloride	CAPSULE	ORAL	20150622		NDA AUTHORIZED GENERIC	NDA022370	Trigen Laboratories, LLC	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
13811-691_99f87319-1628-4d43-aef3-8da77a1f0f93	13811-691	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride	Extended-Release	tramadol hydrochloride	CAPSULE	ORAL	20150622		NDA AUTHORIZED GENERIC	NDA022370	Trigen Laboratories, LLC	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
13811-700_bebdbc1e-371e-44c2-b961-e9bf5475d5b7	13811-700	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Trigen Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	63	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
13811-701_b5f52e98-b992-48ea-8558-af81c04d927b	13811-701	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160915		ANDA	ANDA205629	Trigen Laboratories, LLC	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13811-702_b5f52e98-b992-48ea-8558-af81c04d927b	13811-702	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160915		ANDA	ANDA205629	Trigen Laboratories, LLC	HYDROMORPHONE HYDROCHLORIDE	12	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13811-703_b5f52e98-b992-48ea-8558-af81c04d927b	13811-703	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160915		ANDA	ANDA205629	Trigen Laboratories, LLC	HYDROMORPHONE HYDROCHLORIDE	16	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13811-704_b5f52e98-b992-48ea-8558-af81c04d927b	13811-704	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160915		ANDA	ANDA205629	Trigen Laboratories, LLC	HYDROMORPHONE HYDROCHLORIDE	32	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
13811-706_e5ea0abe-0ad4-4c09-b256-ac23af375a4e	13811-706	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Trigen Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
13811-707_e5ea0abe-0ad4-4c09-b256-ac23af375a4e	13811-707	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Trigen Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
13811-708_e5ea0abe-0ad4-4c09-b256-ac23af375a4e	13811-708	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Trigen Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
13811-709_e5ea0abe-0ad4-4c09-b256-ac23af375a4e	13811-709	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Trigen Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
13811-710_e5ea0abe-0ad4-4c09-b256-ac23af375a4e	13811-710	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171229		ANDA	ANDA205327	Trigen Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	72	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
13811-711_bebdbc1e-371e-44c2-b961-e9bf5475d5b7	13811-711	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Trigen Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	45	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
13811-712_523ad354-6ca2-4a14-b09d-797abaa359a4	13811-712	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Trigen Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
13811-713_523ad354-6ca2-4a14-b09d-797abaa359a4	13811-713	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Trigen Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
13811-714_523ad354-6ca2-4a14-b09d-797abaa359a4	13811-714	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Trigen Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
13811-715_523ad354-6ca2-4a14-b09d-797abaa359a4	13811-715	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Trigen Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
13811-717_0684da2a-03e7-1e4b-e063-6394a90a970d	13811-717	HUMAN PRESCRIPTION DRUG	chlorzoxazone		chlorzoxazone	TABLET	ORAL	20190401	20241231	ANDA	ANDA040861	Trigen Laboratories, LLC	CHLORZOXAZONE	375	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
13811-718_0684da2a-03e7-1e4b-e063-6394a90a970d	13811-718	HUMAN PRESCRIPTION DRUG	chlorzoxazone		chlorzoxazone	TABLET	ORAL	20190401	20241231	ANDA	ANDA040861	Trigen Laboratories, LLC	CHLORZOXAZONE	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
13811-719_fb696b06-d8b4-81df-e053-6394a90af1e3	13811-719	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Trigen Laboratories, LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
13826-001_0760e2c7-5b17-31a1-e063-6394a90a0dc7	13826-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19850101		NDA	NDA205865	Gallup Welders Supply, Inc.	OXYGEN	990	mL/L			N	20241231
13845-1200_f2a0bd7c-881d-37ee-e053-2995a90abccb	13845-1200	HUMAN PRESCRIPTION DRUG	SEROMYCIN		CYCLOSERINE	CAPSULE	ORAL	20090301		ANDA	ANDA060593	Parsolex Gmp Center, Inc.	CYCLOSERINE	250	mg/250mg			N	20241231
13845-1201_f2a0c59a-f966-50f8-e053-2995a90a9cc1	13845-1201	HUMAN PRESCRIPTION DRUG	CYCLOSERINE		CYCLOSERINE	CAPSULE	ORAL	20090301		ANDA	ANDA060593	Parsolex Gmp Center, Inc.	CYCLOSERINE	250	mg/250mg			N	20241231
13845-1202_f2a0bd2c-bd4a-37f0-e053-2995a90a3c85	13845-1202	HUMAN PRESCRIPTION DRUG	Cycloserine		Cycloserine	CAPSULE	ORAL	20130912		ANDA	ANDA060593	Parsolex Gmp Center, Inc.	CYCLOSERINE	250	mg/1			N	20241231
13845-1203_f2a0c59a-f97b-50f8-e053-2995a90a9cc1	13845-1203	HUMAN PRESCRIPTION DRUG	Seromycin		CycloSERINE	CAPSULE	ORAL	20090301		ANDA	ANDA060593	Parsolex Gmp Center, Inc.	CYCLOSERINE	250	mg/1			N	20241231
13859-001_fb718f78-349a-ec0c-e053-6294a90a53aa	13859-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19850715		UNAPPROVED MEDICAL GAS		Craig's Drug Store, Inc.	OXYGEN	99	L/100L			N	20241231
13913-008_f0e64763-d7f7-4574-b7ab-43fb104b43a4	13913-008	HUMAN PRESCRIPTION DRUG	ZIPSOR		diclofenac potassium	CAPSULE, LIQUID FILLED	ORAL	20090616		NDA	NDA022202	Assertio Therapeutics, Inc.	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13913-011_90212a85-4b76-4a51-a22b-15016a491238	13913-011	HUMAN PRESCRIPTION DRUG	Cambia		diclofenac potassium	POWDER, FOR SOLUTION	ORAL	20100420		NDA	NDA022165	Assertio Therapeutics, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13913-012_e8123abd-304e-4001-8ff1-01f5619ba30f	13913-012	HUMAN PRESCRIPTION DRUG	Cambia		diclofenac potassium	POWDER, FOR SOLUTION	ORAL	20160310		NDA	NDA022165	Assertio Therapeutics, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
13925-166_1fab17bb-9557-46af-a588-bc865575ad70	13925-166	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20131018		NDA	NDA019157	Seton Pharmaceuticals, LLC	PREDNISOLONE SODIUM PHOSPHATE	5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
13925-515_8b18239a-6f0e-42ce-8411-d3d1819c131f	13925-515	HUMAN PRESCRIPTION DRUG	Pentamidine Isethionate		Pentamidine Isethionate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180401		ANDA	ANDA206666	Seton Pharmaceuticals	PENTAMIDINE ISETHIONATE	300	mg/300mg	Antiprotozoal [EPC]		N	20241231
13925-522_cfac4bb5-52dc-46ae-9a66-a47d745ed852	13925-522	HUMAN PRESCRIPTION DRUG	Pentamidine Isethionate		Pentamidine Isethionate	INHALANT	RESPIRATORY (INHALATION)	20191014		ANDA	ANDA206667	Seton Pharmaceuticals	PENTAMIDINE ISETHIONATE	300	mg/300mg	Antiprotozoal [EPC]		N	20241231
13925-535_aa03ed23-1bd2-4a68-bf13-67584147d953	13925-535	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20220302		ANDA	ANDA214087	Seton Pharmaceuticals LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
13925-536_aa03ed23-1bd2-4a68-bf13-67584147d953	13925-536	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20220302		ANDA	ANDA214087	Seton Pharmaceuticals LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
13925-540_2169d573-cb80-451b-926f-bcd46948f8c0	13925-540	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride Oral	SOLUTION	ORAL	20200831		ANDA	ANDA210319	Seton Pharmaceuticals	MEMANTINE HYDROCHLORIDE	2	mg/mL	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
13985-609_e98fc587-9a9e-48c0-beeb-6d30b027f0af	13985-609	HUMAN OTC DRUG	Eyewash		Water	SOLUTION	OPHTHALMIC	20150223		NDA	NDA022305	MWI	WATER	929	g/946mL			N	20241231
13985-706_be7751d6-036f-4f05-bbfb-58b674f6576f	13985-706	HUMAN PRESCRIPTION DRUG	Vet one		Silver Nitrate Applicator	STICK	TOPICAL	20100101		UNAPPROVED DRUG OTHER		MWI Veterinary Supply	POTASSIUM NITRATE; SILVER NITRATE	12.74; 38.21	mg/1; mg/1			N	20241231
13985-918_00f1ac7a-2ae0-665a-e063-6394a90aca9f	13985-918	HUMAN OTC DRUG	Pyrantel Pamoate		PinwormTreatment	SUSPENSION	ORAL	20170419		OTC MONOGRAPH FINAL	part357B	MWI Veterinary Supply, Inc.	PYRANTEL PAMOATE	50	mg/mL			N	20241231
13992-002_1954c1ef-535f-4764-b1ec-18a0ebc70d8b	13992-002	HUMAN OTC DRUG	Colic Calm Plus		Aloe, Asafoetida, Carbo Vegetabilis, Carum Carvi, Chamomilla, Cinchona Officinalis, Foeniculum Vulgare, Magnesia Phosphorica, Melissa Officinalis, Mentha Piperita, Prunus Spinosa, Zingiber Officinale	LIQUID	ORAL	20161213	20240211	UNAPPROVED HOMEOPATHIC		TJL Enterprises Inc.	ACTIVATED CHARCOAL; ALOE; CARAWAY OIL; CHAMOMILE; CINCHONA OFFICINALIS BARK; FENNEL SEED; FERULA ASSA-FOETIDA RESIN; GINGER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MELISSA OFFICINALIS; MENTHA PIPERITA; PRUNUS SPINOSA FLOWER BUD	1; 8; 3; 3; 3; 3; 3; 3; 8; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
13992-006_c172c75c-5241-44a3-8d8a-b9641bc67245	13992-006	HUMAN OTC DRUG	Tummy Calm		Aloe, Carbo Vegetabilis, Chamomilla, Lycopodium Clavatum, Nux Moschata, Passiflora Incarnata, Raphanus Sativus, Sarsaparilla, Zingiber Officinale	LIQUID	ORAL	20180809	20250812	UNAPPROVED HOMEOPATHIC		TJL Enterprises Inc.	ACTIVATED CHARCOAL; ALOE; CHAMOMILE; GINGER; LYCOPODIUM CLAVATUM SPORE; NUTMEG; PASSIFLORA INCARNATA FLOWERING TOP; RADISH; SMILAX ORNATA ROOT	1; 4; 3; 3; 3; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
13992-009_066a436f-0536-429d-824d-6356dfe87bfc	13992-009	HUMAN OTC DRUG	Colic Calm		Carbo Vegetabilis, Carum Carvi, Chamomilla, Foeniculum Vulgare, Melissa Officinalis, Mentha Piperita, Prunus Spinosa, Zingiber Officinale	LIQUID	ORAL	20170314	20240711	UNAPPROVED HOMEOPATHIC		TJL Enterprises Inc.	ACTIVATED CHARCOAL; CARAWAY SEED; CHAMOMILE; FENNEL SEED; GINGER; MELISSA OFFICINALIS; MENTHA PIPERITA; PRUNUS SPINOSA FLOWER BUD	1; 3; 3; 3; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
14051-221_1cd66ecc-2248-452f-9488-68394c733ef1	14051-221	HUMAN OTC DRUG	Care		ALCOHOL	GEL	TOPICAL	20051101		OTC MONOGRAPH NOT FINAL	part333E	Top Chemical Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
14080-001_0940ab1b-6652-d2cb-e063-6294a90af52f	14080-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141001		UNAPPROVED MEDICAL GAS		KTL&C LLC dba RX Positive Medical Supply	OXYGEN	99	L/100L			N	20241231
14141-017_d22fc092-714b-26c9-e053-2995a90a1854	14141-017	HUMAN OTC DRUG	LBEL NUDE SKIN ULTRA LIGHT MATTE FOUNDATION WITH VITAMINS SPF 20 ALMENDRA 230-N		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-018_d22fc092-714b-26c9-e053-2995a90a1854	14141-018	HUMAN OTC DRUG	LBEL NUDE SKIN ULTRA LIGHT MATTE FOUNDATION WITH VITAMINS SPF 20 BEIGE 220-C		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-019_d22fc092-714b-26c9-e053-2995a90a1854	14141-019	HUMAN OTC DRUG	LBEL NUDE SKIN ULTRA LIGHT MATTE FOUNDATION WITH VITAMINS SPF 20 CAPUCCINO 310-C		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-020_d22fc092-714b-26c9-e053-2995a90a1854	14141-020	HUMAN OTC DRUG	LBEL NUDE SKIN ULTRA LIGHT MATTE FOUNDATION WITH VITAMINS SPF 20 CHAMPAGNE 170-N		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-021_d22fc092-714b-26c9-e053-2995a90a1854	14141-021	HUMAN OTC DRUG	LBEL NUDE SKIN ULTRA LIGHT MATTE FOUNDATION WITH VITAMINS SPF 20 LATTE 180-F		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-022_d22fc092-714b-26c9-e053-2995a90a1854	14141-022	HUMAN OTC DRUG	LBEL NUDE SKIN ULTRA LIGHT MATTE FOUNDATION WITH VITAMINS SPF 20 MOKACCINO 390-N		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-023_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-023	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR BLANCA 110-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-024_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-024	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 CHANTILLY 130-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-025_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-025	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 VAINILLA 140-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-026_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-026	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AVENA 170-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-027_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-027	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 NUEZ 180-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-028_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-028	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 MIEL 200-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-029_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-029	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 CARAMELO 210-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-030_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-030	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 ALMENDRA 230-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-031_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-031	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 TOFFEE 240-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-032_066bc3ce-69d0-fba8-e063-6394a90ac463	14141-032	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 DULCE DE LECHE 260-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-033_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-033	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AVELLANA 270-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-034_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-034	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 CANELA 280-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-035_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-035	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 AZUCAR MORENO 300-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-036_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-036	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 PANELA 320-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-037_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-037	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 CHOCOCHIP 330-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-039_0cd48080-0d01-015d-e063-6294a90a9b1f	14141-039	HUMAN OTC DRUG	LBEL CONCENTRE TOTAL BASE SERUM ULTRA-FLUID FOUNDATION SPF 25	CLAIRE 2 - BEIGE	Octinoxate and Zinc Oxide	LIQUID	TOPICAL	20170127	20240403	OTC MONOGRAPH DRUG	M020	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	.07; .072	g/mL; g/mL			N	
14141-088_ddde359e-7d9c-4a8f-abb9-b67f037e704b	14141-088	HUMAN OTC DRUG	LBEL DERMO CLARITE BRIGHTENING AND MOISTURIZING FACIAL SPF 30		Avobenzone, Octisalate, and Octocrylene	LOTION	TOPICAL	20180808		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.018; .045; .045	g/mL; g/mL; g/mL			N	20241231
14141-138_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-138	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 CACAO 350-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-139_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-139	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 BROWNIE 380-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-140_fe9a8512-3d27-40e8-e053-6294a90a12db	14141-140	HUMAN OTC DRUG	Defense Total High Protection SPF 50 No Color Daily Non-Greasy Face Protection		Homosalate, Octocrylene, Avobenzone	LOTION	TOPICAL	20200629		OTC MONOGRAPH FINAL	M020	Bel Star S.A. (Colombia)	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 8	g/100mL; g/100mL; g/100mL			N	20241231
14141-141_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-141	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 CHOCOTRUFA 430-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-142_e4f77322-e0b3-15c4-e053-2995a90a6989	14141-142	HUMAN OTC DRUG	Bioresist reinforcing effect face moisturizer SPF 30		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20191221		OTC MONOGRAPH FINAL	M020	BEL STAR S A	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.8; 4.5; 4.5	g/100mL; g/100mL; g/100mL			N	20241231
14141-200_e19c01d9-8ab5-0b31-e053-2a95a90a8cf5	14141-200	HUMAN OTC DRUG	Esika Winner Sport Antiperspirant Roll-on Deodorant		Aluminum Sesquichlorohydrate	EMULSION	TOPICAL	20201007		OTC MONOGRAPH FINAL	M019	Bel Star S.A. (Colombia)	ALUMINUM SESQUICHLOROHYDRATE	13.6	g/100mL			N	20241231
14141-201_e19bfdf2-633d-56a4-e053-2995a90a09d5	14141-201	HUMAN OTC DRUG	Double Use Compact SPF 15 gold deluxe edition Claire 1-2-3		Octinoxate, Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20201112		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 6.24; 4.9	g/100g; g/100g; g/100g			N	20241231
14141-202_e19bfdf2-633d-56a4-e053-2995a90a09d5	14141-202	HUMAN OTC DRUG	Double Use Compact SPF 15 gold deluxe edition Claire 4		Octinoxate, Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20201112		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 6.24; 4.9	g/100g; g/100g; g/100g			N	20241231
14141-203_e19bfdf2-633d-56a4-e053-2995a90a09d5	14141-203	HUMAN OTC DRUG	Double Use Compact SPF 15 gold deluxe edition Medium 5		Octinoxate, Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20201112		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 6.24; 4.9	g/100g; g/100g; g/100g			N	20241231
14141-204_e19bfdf2-633d-56a4-e053-2995a90a09d5	14141-204	HUMAN OTC DRUG	Double Use Compact SPF 15 gold deluxe edition Medium 6		Octinoxate, Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20201112		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 6.24; 4.9	g/100g; g/100g; g/100g			N	20241231
14141-205_e19bfdf2-633d-56a4-e053-2995a90a09d5	14141-205	HUMAN OTC DRUG	Double Use Compact SPF 15 gold deluxe edition Medium 7		Octinoxate, Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20201112		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 6.24; 4.9	g/100g; g/100g; g/100g			N	20241231
14141-206_e4f7ddad-9929-f636-e053-2a95a90adc0e	14141-206	HUMAN OTC DRUG	LBEL DIVINE Double Use compact SPF 15 gold deluxe edition Obscure 8-9		Zinc oxide, Titantium dioxide, Octinoxate	POWDER	TOPICAL	20201112		OTC MONOGRAPH FINAL	M020	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 6.24; 4.9	g/100g; g/100g; g/100g			N	20241231
14141-207_b56f5883-be58-e0e5-e053-2a95a90adb0c	14141-207	HUMAN OTC DRUG	Clarite Makeup Foundation for a Clearer Appearance SPF 30 170-N		Octinoxate, Zinc oxide	PASTE	TOPICAL	20201109		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 7.84	g/100g; g/100g			N	20241231
14141-208_b56f5883-be58-e0e5-e053-2a95a90adb0c	14141-208	HUMAN OTC DRUG	Clarite Makeup Foundation for a Clearer Appearance SPF 30 180-F		Octinoxate, Zinc oxide	PASTE	TOPICAL	20201109		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 7.84	g/100g; g/100g			N	20241231
14141-209_b56f5883-be58-e0e5-e053-2a95a90adb0c	14141-209	HUMAN OTC DRUG	Clarite Makeup Foundation for a Clearer Appearance SPF 30 220-C		Octinoxate, Zinc oxide	PASTE	TOPICAL	20201109		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 7.84	g/100g; g/100g			N	20241231
14141-210_b56f5883-be58-e0e5-e053-2a95a90adb0c	14141-210	HUMAN OTC DRUG	Clarite Makeup Foundation for a Clearer Appearance SPF 30 230-N		Octinoxate, Zinc oxide	PASTE	TOPICAL	20201109		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 7.84	g/100g; g/100g			N	20241231
14141-211_b56f5883-be58-e0e5-e053-2a95a90adb0c	14141-211	HUMAN OTC DRUG	Clarite Makeup Foundation for a Clearer Appearance SPF 30 310-C		Octinoxate, Zinc oxide	PASTE	TOPICAL	20201109		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 7.84	g/100g; g/100g			N	20241231
14141-212_b56f5883-be58-e0e5-e053-2a95a90adb0c	14141-212	HUMAN OTC DRUG	Clarite Makeup Foundation for a Clearer Appearance SPF 30 390-N		Octinoxate, Zinc oxide	PASTE	TOPICAL	20201109		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 7.84	g/100g; g/100g			N	20241231
14141-213_e39d890c-9621-3e2c-e053-2a95a90aa3f3	14141-213	HUMAN OTC DRUG	Its you Antiperspirant Roll-on Deodorant		Aluminum Sesquichlorohydrate	EMULSION	TOPICAL	20210304		OTC MONOGRAPH FINAL	M019	BEL STAR S A	ALUMINUM SESQUICHLOROHYDRATE	13.6	g/100mL			N	20241231
14141-214_bd0a3679-1f7b-4c41-e053-2995a90a8fcb	14141-214	HUMAN OTC DRUG	Pulso Absolute Antiperspirant Roll-on Deodorant		Aluminum Sesquichlorohydrate	EMULSION	TOPICAL	20210303		OTC MONOGRAPH FINAL	part350	Bel Star S.A. (Colombia)	ALUMINUM SESQUICHLOROHYDRATE	13.6	g/100mL			N	20241231
14141-215_ec0f924b-728d-3453-e053-2a95a90ad706	14141-215	HUMAN OTC DRUG	CONCENTRE TOTAL BASE SERUM BASE DE MAQUILLAJE ULTRA-FLUID FOUNDATION SPF 25 CHAMPAGNE 170-N		Zinc Oxide,Octinoxate	EMULSION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	7; 7.2	g/100mL; g/100mL			N	20241231
14141-216_ec0f924b-728d-3453-e053-2a95a90ad706	14141-216	HUMAN OTC DRUG	CONCENTRE TOTAL BASE SERUM BASE DE MAQUILLAJE ULTRA-FLUID FOUNDATION SPF 25 LATTE 180-F		Zinc Oxide,Octinoxate	EMULSION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	7; 7.2	g/100mL; g/100mL			N	20241231
14141-217_ec0f924b-728d-3453-e053-2a95a90ad706	14141-217	HUMAN OTC DRUG	CONCENTRE TOTAL BASE SERUM BASE DE MAQUILLAJE ULTRA-FLUID FOUNDATION SPF 25 BEIGE 220-C		Zinc Oxide,Octinoxate	EMULSION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	7; 7.2	g/100mL; g/100mL			N	20241231
14141-218_ec0f924b-728d-3453-e053-2a95a90ad706	14141-218	HUMAN OTC DRUG	CONCENTRE TOTAL BASE SERUM BASE DE MAQUILLAJE ULTRA-FLUID FOUNDATION SPF 25 ALMENDRA 230-N		Zinc Oxide,Octinoxate	EMULSION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	7; 7.2	g/100mL; g/100mL			N	20241231
14141-219_ec0f924b-728d-3453-e053-2a95a90ad706	14141-219	HUMAN OTC DRUG	CONCENTRE TOTAL BASE SERUM BASE DE MAQUILLAJE ULTRA-FLUID FOUNDATION SPF 25 CAPUCCINO 310-C		Zinc Oxide,Octinoxate	EMULSION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	7; 7.2	g/100mL; g/100mL			N	20241231
14141-220_ec0f9932-7919-431e-e053-2995a90aa0a3	14141-220	HUMAN OTC DRUG	CONCENTRE TOTAL BASE SERUM BASE DE MAQUILLAJE ULTRA-FLUID FOUNDATION SPF 25 MOKACCINO 390-N		zinc oxide,octinoxate	EMULSION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	7; 7.2	g/100mL; g/100mL			N	20241231
14141-221_c0843363-a5db-7be7-e053-2a95a90ae0d5	14141-221	HUMAN OTC DRUG	MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 CHAMPAGNE 170-N		zinc oxide,octinoxate	EMULSION	TOPICAL	20210414		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	5; 4.2	g/100mL; g/100mL			N	20241231
14141-222_c0843363-a5db-7be7-e053-2a95a90ae0d5	14141-222	HUMAN OTC DRUG	MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 LATTE 180-F		zinc oxide,octinoxate	EMULSION	TOPICAL	20210414		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	5; 4.2	g/100mL; g/100mL			N	20241231
14141-223_c0843363-a5db-7be7-e053-2a95a90ae0d5	14141-223	HUMAN OTC DRUG	MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 BEIGE 220-C		zinc oxide,octinoxate	EMULSION	TOPICAL	20210414		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	5; 4.2	g/100mL; g/100mL			N	20241231
14141-224_c0843363-a5db-7be7-e053-2a95a90ae0d5	14141-224	HUMAN OTC DRUG	MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 ALMENDRA 230-N		zinc oxide,octinoxate	EMULSION	TOPICAL	20210414		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	5; 4.2	g/100mL; g/100mL			N	20241231
14141-225_c0843363-a5db-7be7-e053-2a95a90ae0d5	14141-225	HUMAN OTC DRUG	MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 CAPUCCINO 310-C		zinc oxide,octinoxate	EMULSION	TOPICAL	20210414		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	5; 4.2	g/100mL; g/100mL			N	20241231
14141-226_c13590c9-131c-733a-e053-2a95a90a77d7	14141-226	HUMAN OTC DRUG	MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 MOKACCINO 390-N		zinc oxide,octinoxate	EMULSION	TOPICAL	20210414		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	OCTINOXATE; ZINC OXIDE	5; 4.2	g/100mL; g/100mL			N	20241231
14141-240_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-240	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 BOMBON 400-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-242_066c10ae-f334-f3d6-e063-6294a90abfc1	14141-242	HUMAN OTC DRUG	CYZONE STUDIO LOOK BASE DE ALTA COBERTURA Y LARGA DURACION FPS 20 ESPRESSO 450-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	40; 24	mg/g; mg/g			N	20241231
14141-300_eaf04c1f-d29c-436d-e053-2995a90ad257	14141-300	HUMAN OTC DRUG	LBEL FOREVER STAY POLVOS COMPACTOS DE LARGA DURACION FPS 15 LONG LASTING COMPACT SPF 15 PERLA 100		TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20220803		OTC MONOGRAPH FINAL	M020	BEL STAR S A	TITANIUM DIOXIDE; ZINC OXIDE	57.5; 49	mg/g; mg/g			N	20241231
14141-301_eaf04c1f-d29c-436d-e053-2995a90ad257	14141-301	HUMAN OTC DRUG	LBEL FOREVER STAY POLVOS COMPACTOS DE LARGA DURACION FPS 15 LONG LASTING COMPACT SPF 15 ARENA 200		TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20220803		OTC MONOGRAPH FINAL	M020	BEL STAR S A	TITANIUM DIOXIDE; ZINC OXIDE	57.5; 49	mg/g; mg/g			N	20241231
14141-302_eaf04c1f-d29c-436d-e053-2995a90ad257	14141-302	HUMAN OTC DRUG	LBEL FOREVER STAY POLVOS COMPACTOS DE LARGA DURACION FPS 15 LONG LASTING COMPACT SPF 15 CARAMEL 200		TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20220803		OTC MONOGRAPH FINAL	M020	BEL STAR S A	TITANIUM DIOXIDE; ZINC OXIDE	57.5; 49	mg/g; mg/g			N	20241231
14141-303_eaf04c1f-d29c-436d-e053-2995a90ad257	14141-303	HUMAN OTC DRUG	LBEL FOREVER STAY POLVOS COMPACTOS DE LARGA DURACION FPS 15 LONG LASTING COMPACT SPF 15 SOLEI 200		TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20220803		OTC MONOGRAPH FINAL	M020	BEL STAR S A	TITANIUM DIOXIDE; ZINC OXIDE	57.5; 49	mg/g; mg/g			N	20241231
14141-304_eaf04c1f-d29c-436d-e053-2995a90ad257	14141-304	HUMAN OTC DRUG	LBEL FOREVER STAY POLVOS COMPACTOS DE LARGA DURACION FPS 15 LONG LASTING COMPACT SPF 15 AVELLANA 200		TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20220803		OTC MONOGRAPH FINAL	M020	BEL STAR S A	TITANIUM DIOXIDE; ZINC OXIDE	57.5; 49	mg/g; mg/g			N	20241231
14141-305_eaf04c1f-d29c-436d-e053-2995a90ad257	14141-305	HUMAN OTC DRUG	LBEL FOREVER STAY POLVOS COMPACTOS DE LARGA DURACION FPS 15 LONG LASTING COMPACT SPF 15 GOLDEN 300		TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20220803		OTC MONOGRAPH FINAL	M020	BEL STAR S A	TITANIUM DIOXIDE; ZINC OXIDE	57.5; 49	mg/g; mg/g			N	20241231
14141-306_eaf0c66d-590c-88fc-e053-2a95a90a8c92	14141-306	HUMAN OTC DRUG	CYZONE CY PLAY CREAMY LIP BALM HIDRATANTE EN BARRA PARA LABIOS 24H FPS 12 FUCHSIA CREAMY		OCTINOXATE, ZINC OXIDE	STICK	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	25; 39.2	mg/g; mg/g			N	20241231
14141-307_eaf0c66d-590c-88fc-e053-2a95a90a8c92	14141-307	HUMAN OTC DRUG	CYZONE CY PLAY CREAMY LIP BALM HIDRATANTE EN BARRA PARA LABIOS 24H FPS 12 PINK CREAMY		OCTINOXATE, ZINC OXIDE	STICK	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	25; 39.2	mg/g; mg/g			N	20241231
14141-308_eaf0c66d-590c-88fc-e053-2a95a90a8c92	14141-308	HUMAN OTC DRUG	CYZONE CY PLAY CREAMY LIP BALM HIDRATANTE EN BARRA PARA LABIOS 24H FPS 12 NUDE CREAMY		OCTINOXATE, ZINC OXIDE	STICK	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	25; 39.2	mg/g; mg/g			N	20241231
14141-309_eaf0c66d-590c-88fc-e053-2a95a90a8c92	14141-309	HUMAN OTC DRUG	CYZONE CY PLAY CREAMY LIP BALM HIDRATANTE EN BARRA PARA LABIOS 24H FPS 12 CORAL CREAMY		OCTINOXATE, ZINC OXIDE	STICK	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	25; 39.2	mg/g; mg/g			N	20241231
14141-310_ea3a0e07-a278-48c8-e053-2a95a90a172f	14141-310	HUMAN OTC DRUG	LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 LATTE 180-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	50; 29.4	mg/mL; mg/mL			N	20241231
14141-311_ea3a0e07-a278-48c8-e053-2a95a90a172f	14141-311	HUMAN OTC DRUG	LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 BEIGE 220-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	50; 29.4	mg/mL; mg/mL			N	20241231
14141-312_ea3a0e07-a278-48c8-e053-2a95a90a172f	14141-312	HUMAN OTC DRUG	LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 ALMENDRA 230-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	50; 29.4	mg/mL; mg/mL			N	20241231
14141-313_ea3a0e07-a278-48c8-e053-2a95a90a172f	14141-313	HUMAN OTC DRUG	LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 CAPUCCINO 310-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	50; 29.4	mg/mL; mg/mL			N	20241231
14141-314_ea3a0e07-a278-48c8-e053-2a95a90a172f	14141-314	HUMAN OTC DRUG	LBEL FOREVER HYDRA BASE HIDRATANTE DE LARGA DURACION FPS 15 HYDRATING LONGWEAR FOUNDATION SPF 15 CHAMPAGNE 170-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20221007		OTC MONOGRAPH FINAL	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	50; 29.4	mg/mL; mg/mL			N	20241231
14141-315_ea79d363-6762-0bac-e053-2a95a90af8bb	14141-315	HUMAN OTC DRUG	LBEL DERMO CLARITE LOCION FACIAL ILUMINADORA HIDRATANTE CON FPS 30 BRIGHTENING AND MOISTURIZING FACIAL SPF 30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	EMULSION	TOPICAL	20221013		OTC MONOGRAPH FINAL	M020	BEL STAR S A	AVOBENZONE; OCTISALATE; OCTOCRYLENE	18; 45; 45	mg/mL; mg/mL; mg/mL			N	20241231
14141-316_eea17271-e8c9-ab21-e053-2995a90a2fcc	14141-316	HUMAN OTC DRUG	LBEL FOREVER ULTRA MATTE BASE CONTROL BRILLO DE LARGA DURACION FPS 15 SHINE CONTROL LONGWEAR FOUNDATION SPF 15 LATTE 180-F		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20221130		OTC MONOGRAPH FINAL	M020	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-317_eea17271-e8c9-ab21-e053-2995a90a2fcc	14141-317	HUMAN OTC DRUG	LBEL FOREVER ULTRA MATTE BASE CONTROL BRILLO DE LARGA DURACION FPS 15 SHINE CONTROL LONGWEAR FOUNDATION SPF 15 CHAMPAGNE 170-N		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20221130		OTC MONOGRAPH FINAL	M020	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-318_eea17271-e8c9-ab21-e053-2995a90a2fcc	14141-318	HUMAN OTC DRUG	LBEL FOREVER ULTRA MATTE BASE CONTROL BRILLO DE LARGA DURACION FPS 15 SHINE CONTROL LONGWEAR FOUNDATION SPF 15 ALMENDRA 230-N		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20221130		OTC MONOGRAPH FINAL	M020	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-319_eea17271-e8c9-ab21-e053-2995a90a2fcc	14141-319	HUMAN OTC DRUG	LBEL FOREVER ULTRA MATTE BASE CONTROL BRILLO DE LARGA DURACION FPS 15 SHINE CONTROL LONGWEAR FOUNDATION SPF 15 BEIGE 220-C		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20221130		OTC MONOGRAPH FINAL	M020	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-320_eea17271-e8c9-ab21-e053-2995a90a2fcc	14141-320	HUMAN OTC DRUG	LBEL FOREVER ULTRA MATTE BASE CONTROL BRILLO DE LARGA DURACION FPS 15 SHINE CONTROL LONGWEAR FOUNDATION SPF 15 CAPUCCINO 310-C		Octinoxate, Zinc Oxide	EMULSION	TOPICAL	20221130		OTC MONOGRAPH FINAL	M020	Bel Star S.A.	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-321_f459c27e-e608-47ba-e053-2a95a90a901f	14141-321	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON ACIDO HIALURONICO FPS 20 SERUM FOUNDATION WITH HYALURONIC ACID SPF 20 CHAMPAGNE 170-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230220		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-322_f459c27e-e608-47ba-e053-2a95a90a901f	14141-322	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON ACIDO HIALURONICO FPS 20 SERUM FOUNDATION WITH HYALURONIC ACID SPF 20 CAPUCCINO 310-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230220		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-323_f459c27e-e608-47ba-e053-2a95a90a901f	14141-323	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON ACIDO HIALURONICO FPS 20 SERUM FOUNDATION WITH HYALURONIC ACID SPF 20 LATTE 180-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230220		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-324_f459c27e-e608-47ba-e053-2a95a90a901f	14141-324	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON ACIDO HIALURONICO FPS 20 SERUM FOUNDATION WITH HYALURONIC ACID SPF 20 BEIGE 220-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230220		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-325_f459c27e-e608-47ba-e053-2a95a90a901f	14141-325	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON ACIDO HIALURONICO FPS 20 SERUM FOUNDATION WITH HYALURONIC ACID SPF 20 ALMENDRA 230-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230220		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	50; 42	mg/mL; mg/mL			N	20241231
14141-326_f926665a-8d42-2aed-e053-6294a90a13e1	14141-326	HUMAN OTC DRUG	LBEL CONCENTRE BASE SERUM ANTIEDAD EFECTO LIFTING FPS 15 ANTI AGING LIFTING SERUM FOUNDATION SPF 15 CHAMPAGNE 170-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230419		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-327_f926665a-8d42-2aed-e053-6294a90a13e1	14141-327	HUMAN OTC DRUG	LBEL CONCENTRE BASE SERUM ANTIEDAD EFECTO LIFTING FPS 15 ANTI AGING LIFTING SERUM FOUNDATION SPF 15 LATTE 180-F		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230419		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-328_f926665a-8d42-2aed-e053-6294a90a13e1	14141-328	HUMAN OTC DRUG	LBEL CONCENTRE BASE SERUM ANTIEDAD EFECTO LIFTING FPS 15 ANTI AGING LIFTING SERUM FOUNDATION SPF 15 BEIGE 220-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230419		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-329_f926665a-8d42-2aed-e053-6294a90a13e1	14141-329	HUMAN OTC DRUG	LBEL CONCENTRE BASE SERUM ANTIEDAD EFECTO LIFTING FPS 15 ANTI AGING LIFTING SERUM FOUNDATION SPF 15 ALMENDRA 230-N		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230419		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-330_f926665a-8d42-2aed-e053-6294a90a13e1	14141-330	HUMAN OTC DRUG	LBEL CONCENTRE BASE SERUM ANTIEDAD EFECTO LIFTING FPS 15 ANTI AGING LIFTING SERUM FOUNDATION SPF 15 CAPUCCINO 310-C		OCTINOXATE, ZINC OXIDE	EMULSION	TOPICAL	20230419		OTC MONOGRAPH FINAL	M020	BEL STAR SA	OCTINOXATE; ZINC OXIDE	60; 29.4	mg/mL; mg/mL			N	20241231
14141-331_fd0529dd-2c84-6a02-e053-6294a90a2ae1	14141-331	HUMAN OTC DRUG	LBEL DEFENSE TOTAL SUNSCREEN FOR FACE AND BODY SPF 50		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	EMULSION	TOPICAL	20230612		OTC MONOGRAPH FINAL	M020	BEL STAR SA	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 80	mg/mL; mg/mL; mg/mL			N	20241231
14141-332_fd9201b2-d34d-1382-e053-6294a90a543e	14141-332	HUMAN OTC DRUG	LBEL SPECIALISTE DARK SPOT BRIGHTENING MOISTURIZING SPF 30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	EMULSION	TOPICAL	20230620		OTC MONOGRAPH FINAL	M020	BEL STAR SA	AVOBENZONE; OCTISALATE; OCTOCRYLENE	18; 45; 45	mg/mL; mg/mL; mg/mL			N	20241231
14141-333_0b782198-58e8-5343-e063-6294a90a3713	14141-333	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON EFECTO RELLENO DE ARRUGAS FPS 15 WRINKLE FILLER EFFECT SERUM FOUNDATION SPF 15 CHAMPAGNE 170-N		OCTINOXATE, ZINC OXIDE	LIQUID	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	BEL STAR S.A.	OCTINOXATE; ZINC OXIDE	45; 29.4	mg/mL; mg/mL			N	20241231
14141-334_0b782198-58e8-5343-e063-6294a90a3713	14141-334	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON EFECTO RELLENO DE ARRUGAS FPS 15 WRINKLE FILLER EFFECT SERUM FOUNDATION SPF 15 LATTE 180-F		OCTINOXATE, ZINC OXIDE	LIQUID	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	BEL STAR S.A.	OCTINOXATE; ZINC OXIDE	45; 29.4	mg/mL; mg/mL			N	20241231
14141-335_0b782198-58e8-5343-e063-6294a90a3713	14141-335	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON EFECTO RELLENO DE ARRUGAS FPS 15 WRINKLE FILLER EFFECT SERUM FOUNDATION SPF 15 BEIGE 220-C		OCTINOXATE, ZINC OXIDE	LIQUID	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	BEL STAR S.A.	OCTINOXATE; ZINC OXIDE	45; 29.4	mg/mL; mg/mL			N	20241231
14141-336_0b782198-58e8-5343-e063-6294a90a3713	14141-336	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON EFECTO RELLENO DE ARRUGAS FPS 15 WRINKLE FILLER EFFECT SERUM FOUNDATION SPF 15 ALMENDRA 230-N		OCTINOXATE, ZINC OXIDE	LIQUID	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	BEL STAR S.A.	OCTINOXATE; ZINC OXIDE	45; 29.4	mg/mL; mg/mL			N	20241231
14141-337_0b782198-58e8-5343-e063-6294a90a3713	14141-337	HUMAN OTC DRUG	LBEL SOLUTIONS PRO-HIALURON BASE SERUM CON EFECTO RELLENO DE ARRUGAS FPS 15 WRINKLE FILLER EFFECT SERUM FOUNDATION SPF 15 CAPUCCINO 310-C		OCTINOXATE, ZINC OXIDE	LIQUID	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	BEL STAR S.A.	OCTINOXATE; ZINC OXIDE	45; 29.4	mg/mL; mg/mL			N	20241231
14141-452_c8328d62-ce21-7c3a-e053-2a95a90ab7cf	14141-452	HUMAN OTC DRUG	Ultra Balm Moisturizing Protective Balm for lips SPF 20 Nude Translucide		Octinoxate, Zinc Oxide	STICK	TOPICAL	20210615		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 4.9	g/100g; g/100g			N	20241231
14141-453_c8328d62-ce21-7c3a-e053-2a95a90ab7cf	14141-453	HUMAN OTC DRUG	Ultra Balm Moisturizing Protective Balm for lips SPF 20 Coral Petale		Octinoxate, Zinc Oxide	STICK	TOPICAL	20210615		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 4.9	g/100g; g/100g			N	20241231
14141-454_c8328d62-ce21-7c3a-e053-2a95a90ab7cf	14141-454	HUMAN OTC DRUG	Ultra Balm Moisturizing Protective Balm for lips SPF 20 Rose Cotton		Octinoxate, Zinc Oxide	STICK	TOPICAL	20210615		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 4.9	g/100g; g/100g			N	20241231
14141-455_c8328d62-ce21-7c3a-e053-2a95a90ab7cf	14141-455	HUMAN OTC DRUG	Ultra Balm Moisturizing Protective Balm for lips SPF 20 Rose Paradise		Octinoxate, Zinc Oxide	STICK	TOPICAL	20210615		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 4.9	g/100g; g/100g			N	20241231
14141-456_c8328d62-ce21-7c3a-e053-2a95a90ab7cf	14141-456	HUMAN OTC DRUG	Ultra Balm Moisturizing Protective Balm for lips SPF 20 Cerise Brise		Octinoxate, Zinc Oxide	STICK	TOPICAL	20210615		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 4.9	g/100g; g/100g			N	20241231
14141-457_c4f95c1b-acbf-4bb7-e053-2995a90a9120	14141-457	HUMAN OTC DRUG	Ultra Balm Moisturizing Protective Balm for lips SPF 20 Nude Caramel		Octinoxate, Zinc Oxide	STICK	TOPICAL	20210616		OTC MONOGRAPH FINAL	part352	BEL STAR S A	OCTINOXATE; ZINC OXIDE	7.5; 4.9	g/100g; g/100g			N	20241231
14141-684_0cd4b5fc-0588-c169-e063-6394a90a3282	14141-684	HUMAN OTC DRUG	LBEL EFFET PARFAIT signs of age appearance minimizer foundation SPF 20 FM	CLAIRE 4 - BEIGE	Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20191202	20240317	OTC MONOGRAPH DRUG	M020	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE	.07; .0244	g/mL; g/mL			N	
14141-685_0cd4b5fc-0588-c169-e063-6394a90a3282	14141-685	HUMAN OTC DRUG	LBEL EFFET PARFAIT signs of age appearance minimizer foundation SPF 20 FM	MEDIUM 5 - BEIGE	Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20191202	20240315	OTC MONOGRAPH DRUG	M020	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE	.07; .0244	g/mL; g/mL			N	
14141-686_0cd4b5fc-0588-c169-e063-6394a90a3282	14141-686	HUMAN OTC DRUG	LBEL EFFET PARFAIT signs of age appearance minimizer foundation SPF 20 FM	MEDIUM 6 - BEIGE	Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20191202	20240315	OTC MONOGRAPH DRUG	M020	Bel Star S.A. (Colombia)	OCTINOXATE; TITANIUM DIOXIDE	.07; .0244	g/mL; g/mL			N	
14141-754_0cd52151-1039-6187-e063-6294a90a5186	14141-754	HUMAN OTC DRUG	LBEL LEDERM 55 plus JOUR Facial against advanced signs of aging		Avobenzone, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20161024	20240427	OTC MONOGRAPH DRUG	M020	Bel Star S.A. (Colombia)	AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.03; .05; .03; .05	g/mL; g/mL; g/mL; g/mL			N	
14141-854_0cd52151-104d-6187-e063-6294a90a5186	14141-854	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Crema		Octinoxate	POWDER	TOPICAL	20200401	20250209	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-855_0cd52151-104d-6187-e063-6294a90a5186	14141-855	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Flan		Octinoxate	POWDER	TOPICAL	20200401	20250208	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-856_0cd52151-104d-6187-e063-6294a90a5186	14141-856	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Alfajor		Octinoxate	POWDER	TOPICAL	20200401	20240716	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-857_0cd52151-104d-6187-e063-6294a90a5186	14141-857	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Waffle		Octinoxate	POWDER	TOPICAL	20200401	20240922	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-858_0cd52151-104d-6187-e063-6294a90a5186	14141-858	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 cocada		Octinoxate	POWDER	TOPICAL	20200401	20240920	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-859_0cd52151-104d-6187-e063-6294a90a5186	14141-859	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Capuccino		Octinoxate	POWDER	TOPICAL	20200401	20250614	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-860_0cd52151-104d-6187-e063-6294a90a5186	14141-860	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Manjar		Octinoxate	POWDER	TOPICAL	20200401	20250315	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-861_0cd52151-104d-6187-e063-6294a90a5186	14141-861	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Mocha		Octinoxate	POWDER	TOPICAL	20200401	20240920	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-862_0cd52151-104d-6187-e063-6294a90a5186	14141-862	HUMAN OTC DRUG	Polvos Compactos de alta cobertura con FPS 20 Cocoa		Octinoxate	POWDER	TOPICAL	20200401	20240921	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE	5	g/100g			N	
14141-863_0cddd0e2-e2de-6472-e063-6394a90a57c3	14141-863	HUMAN OTC DRUG	Studio Look Base de alta cobertura para el rostro con FPS 20 Azucar Blanca 110-C		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20200401	20241020	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	4; 2.4	g/100g; g/100g			N	
14141-867_0cddd0e2-e2de-6472-e063-6394a90a57c3	14141-867	HUMAN OTC DRUG	Studio Look Base de alta cobertura para el rostro con FPS 20 Nuez 180-F		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20200401	20240807	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	4; 2.4	g/100g; g/100g			N	
14141-869_0cddd0e2-e2de-6472-e063-6394a90a57c3	14141-869	HUMAN OTC DRUG	Studio Look Base de alta cobertura para el rostro con FPS 20 Caramelo 210-F		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20200401	20240926	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	4; 2.4	g/100g; g/100g			N	
14141-875_0cddd0e2-e2de-6472-e063-6394a90a57c3	14141-875	HUMAN OTC DRUG	Studio Look Base de alta cobertura para el rostro con FPS 20 Azucar Moreno 300-N		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20200401	20240725	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	4; 2.4	g/100g; g/100g			N	
14141-878_0cddd0e2-e2de-6472-e063-6394a90a57c3	14141-878	HUMAN OTC DRUG	Studio Look Base de alta cobertura para el rostro con FPS 20 Cacao 350-N		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20200401	20240713	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	4; 2.4	g/100g; g/100g			N	
14141-879_0cddd0e2-e2de-6472-e063-6394a90a57c3	14141-879	HUMAN OTC DRUG	Studio Look Base de alta cobertura para el rostro con FPS 20 Brownie 380-F		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20200401	20240717	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	4; 2.4	g/100g; g/100g			N	
14141-880_0cddd0e2-e2de-6472-e063-6394a90a57c3	14141-880	HUMAN OTC DRUG	Studio Look Base de alta cobertura para el rostro con FPS 20 Bombon 400-N		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20200401	20240718	OTC MONOGRAPH DRUG	M020	BEL STAR S A	OCTINOXATE; ZINC OXIDE	4; 2.4	g/100g; g/100g			N	
14141-961_c4586784-3b78-1376-e053-2a95a90a24f7	14141-961	HUMAN OTC DRUG	esika total sec DELICATE SKIN Antiperspirant and deodorant Womens roll-on All day extra effective protection		Aluminum Sesquichlorohydrate	EMULSION	TOPICAL	20210607		OTC MONOGRAPH FINAL	part350	BEL STAR S A	ALUMINUM SESQUICHLOROHYDRATE	15	g/100mL			N	20241231
14141-962_db89c497-bc28-adce-e053-2a95a90a7560	14141-962	HUMAN OTC DRUG	esika total sec NEUTRAL FRAGRANCE Antiperspirant and deodorant Unisex Roll-on All day extra effective protection		Aluminum Sesquichlorohydrate	EMULSION	TOPICAL	20210607		OTC MONOGRAPH FINAL	part350	BEL STAR S A	ALUMINUM SESQUICHLOROHYDRATE	15	g/100mL			N	20241231
14141-990_19ebd935-27ec-4a5e-b3c0-054e8df68aa1	14141-990	HUMAN OTC DRUG	LBEL DEFENSE TOTAL broad spectrum SPF 50plus sunscreen for face and body		Avobenzone, Homosalate, and Octocrylene	LOTION	TOPICAL	20160823		OTC MONOGRAPH FINAL	part352	Bel Star S.A. (Colombia)	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	.03; .1; .08	g/mL; g/mL; g/mL			N	20241231
14208-003_053e314d-c1ad-4b33-a3a2-6377d9b9e145	14208-003	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20170101		NDA	NDA205766	Ctws, LLC	NITROGEN	99	L/100L			N	20241231
14208-532_d84a96ec-f021-455a-b7c8-5e2891b274e0	14208-532	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19760101		NDA	NDA205767	Ctws, LLC	OXYGEN	99	L/100L			N	20241231
14214-0123_f3a6582c-9ed8-1adb-e053-2995a90a17db	14214-0123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20081204		UNAPPROVED MEDICAL GAS		Leading Respiratory Service Inc.	OXYGEN	99	L/100L			N	20241231
14222-0000_0c5af7db-48bf-d979-e063-6294a90af24e	14222-0000	HUMAN OTC DRUG	RODAN FIELDS SOOTHE 4 Mineral Sunscreen BROAD SPECTRUM SPF 30		TITANIUM DIOXIDE	CREAM	TOPICAL	20130603		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	20; 120	mg/mL; mg/mL			N	20241231
14222-0001_0c5b2855-6f3e-280e-e063-6394a90acadb	14222-0001	HUMAN OTC DRUG	RODAN - FIELDS ESSENTIALS Body Sunscreen BROAD SPECTRUM SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20130522		OTC MONOGRAPH DRUG	M020	Rodan & Fields	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 70; 40; 17	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
14222-0002_54c23103-18bf-4e79-aee0-f1d0864021df	14222-0002	HUMAN OTC DRUG	ESSENTIALS Face and Body Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200410		OTC MONOGRAPH DRUG	M020	Rodan & Fields	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.028; .096; .048; .096	g/mL; g/mL; g/mL; g/mL			N	20241231
14222-0420_0c5b3b82-94e5-169a-e063-6394a90aa73e	14222-0420	HUMAN OTC DRUG	RODAN AND FIELDS REVERSE 4 BROAD SPECTRUM SPF 50 PLUS SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20121116		OTC MONOGRAPH DRUG	M020	Rodan & Fields	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
14222-0425_0c5b602d-b958-ffad-e063-6294a90a4eee	14222-0425	HUMAN OTC DRUG	Rodan and Fields ESSENTIALS Lip Shield Broad Spectrum SPF 25		Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20170501		OTC MONOGRAPH DRUG	M020	Rodan & Fields	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.5; 8; 5; 2.2	g/100g; g/100g; g/100g; g/100g			N	20241231
14222-1600_8fe2204d-a8c9-4dc5-a983-1a35aee48668	14222-1600	HUMAN OTC DRUG	SPOTLESS Regimen for Acne, Blemishes and Breakouts		Benzoyl Peroxide	KIT	TOPICAL	20190213		OTC MONOGRAPH FINAL	part333D	Rodan & Fields						N	20241231
14222-1610_933270ff-f1f3-464d-bba4-a96ed99aa043	14222-1610	HUMAN OTC DRUG	SPOTLESS Daily Acne Wash		Benzoyl Peroxide	CREAM	TOPICAL	20190213		OTC MONOGRAPH DRUG	M006	Rodan & Fields	BENZOYL PEROXIDE	.05	g/mL			N	20241231
14222-1620_243456e9-1661-47ad-be7d-380e93de63bb	14222-1620	HUMAN OTC DRUG	SPOTLESS Acne Clearing Treatment		Benzoyl Peroxide	LOTION	TOPICAL	20190213		OTC MONOGRAPH FINAL	part333D	Rodan & Fields	BENZOYL PEROXIDE	.025	g/mL			N	20241231
14222-2030_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2030	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Shell		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2031_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2031	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2032_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2032	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Beige		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2033_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2033	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Sand		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2034_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2034	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Golden		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2035_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2035	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Honey		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2036_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2036	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Almond		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2037_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2037	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Caramel		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2038_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2038	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Espresso		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2039_624a21a9-4206-42a2-b105-8164ea525ac8	14222-2039	HUMAN OTC DRUG	Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Truffle		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	3.44; 4	g/100mL; g/100mL			N	20241231
14222-2111_07a668b9-b34b-405b-be4b-7c0d0f5cf420	14222-2111	HUMAN OTC DRUG	UNBLEMISH Refining Acne Wash		SALICYLIC ACID	CREAM	TOPICAL	20200310		OTC MONOGRAPH DRUG	M006	Rodan & Fields	SALICYLIC ACID	.005	g/mL			N	20241231
14222-2120_c99b4e34-310d-4b9f-a8f9-db6ac489c633	14222-2120	HUMAN OTC DRUG	UNBLEMISH Dual Intensive Acne Treatment		BENZOYL PEROXIDE	LOTION	TOPICAL	20190213		OTC MONOGRAPH FINAL	part333D	Rodan & Fields	BENZOYL PEROXIDE	.025	g/mL			N	20241231
14222-2131_e6fcc289-8076-4e3b-9eb6-0ec9b1ed4f5c	14222-2131	HUMAN OTC DRUG	UNBLEMISH Invisible Matte Defense		HOMOSALATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	GEL	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Rodan & Fields	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .1; .05; .1	g/mL; g/mL; g/mL; g/mL			N	20241231
14222-2140_7c8e3182-0232-40e0-b5c4-641eb078c356	14222-2140	HUMAN OTC DRUG	UNBLEMISH Clarifying Mask		SULFUR	CREAM	TOPICAL	20190515		OTC MONOGRAPH DRUG	M006	Rodan & Fields	SULFUR	.1	g/mL			N	20241231
14222-2251_e09ab92b-81ca-44ad-9949-cd3586ba147a	14222-2251	HUMAN OTC DRUG	REDEFINE Triple Defense		AVOBENZONE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20201018		OTC MONOGRAPH FINAL	part352	Rodan & Fields	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.03; .05; .07	g/mL; g/mL; g/mL			N	20241231
14222-2252_3efa9080-5667-4b9d-835b-8ee6157f305b	14222-2252	HUMAN OTC DRUG	REDEFINE Triple Defense		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	LOTION	TOPICAL	20201018		OTC MONOGRAPH DRUG	M020	Rodan & Fields	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.02; .068; .034; .044	g/mL; g/mL; g/mL; g/mL			N	20241231
14222-2300_0e1bd3b8-48f9-4e74-8685-d5ad2463a258	14222-2300	HUMAN OTC DRUG	REVERSE Brightening Defense Fluid		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	LOTION	TOPICAL	20210309		OTC MONOGRAPH DRUG	M020	Rodan & Fields	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.028; .093; .0467; .061	g/mL; g/mL; g/mL; g/mL			N	20241231
14222-2420_e5c3e6b2-c934-45e9-88e6-6b23423b0bcf	14222-2420	HUMAN OTC DRUG	SOOTHE Sensitive Skin Treatment		Allantoin, Dimethicone	LOTION	TOPICAL	20210309		OTC MONOGRAPH FINAL	part347	Rodan & Fields	ALLANTOIN; DIMETHICONE	.5; 2	g/100mL; g/100mL	Skin Barrier Activity [PE]		N	20241231
14222-2430_695fafcf-e87a-4e92-8e85-bb1a6b9429d9	14222-2430	HUMAN OTC DRUG	SOOTHE Moisturizing Rescue Cream		OATMEAL	CREAM	TOPICAL	20210309		OTC MONOGRAPH DRUG	M016	Rodan & Fields	OATMEAL	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
14222-2440_c84fcd08-13d4-4199-88d6-fb06f81a5b75	14222-2440	HUMAN OTC DRUG	SOOTHE Daily Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210309		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	.036; .0234	g/mL; g/mL			N	20241231
14222-8000_9b8583c2-2f60-4e5e-959d-ed712e1319cf	14222-8000	HUMAN OTC DRUG	RECHARGE Regimen for Balancing, Boosting and Defending Healthy-Looking skin		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190920		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	.032; .077	g/mL; g/mL			N	20241231
14222-8010_eb31f299-c288-4f67-b02b-7842752109ee	14222-8010	HUMAN OTC DRUG	RECHARGE Protect Blur		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190920		OTC MONOGRAPH DRUG	M020	Rodan & Fields	TITANIUM DIOXIDE; ZINC OXIDE	.032; .077	g/mL; g/mL			N	20241231
14268-017_0c5b5d59-a2e3-2550-e063-6394a90aa2bd	14268-017	HUMAN OTC DRUG	Dr. Perrys Day Thyme SPF 20 Broad Spectrum Sunscreen		ZINC OXIDE	GEL	TOPICAL	20160404		OTC MONOGRAPH DRUG	M020	Englewood Lab, Inc.	ZINC OXIDE	100	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
14268-025_0c5b5d59-a2f3-2550-e063-6394a90aa2bd	14268-025	HUMAN OTC DRUG	Youth Activating BB SPF30 Shade 3		ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20171122		OTC MONOGRAPH DRUG	M020	Englewood Lab, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	23.6; 63	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
14268-118_0c5be140-80f1-1501-e063-6294a90a3faf	14268-118	HUMAN OTC DRUG	BEET THE SUN LIGHTWEIGHT SUNSCREEN BROAD SPECTRUM SPF 40 PA		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230301		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
14268-119_0c5bef36-461b-4a81-e063-6294a90a7583	14268-119	HUMAN OTC DRUG	ESSENCE LIGHT SUNSCREEN SPF 50 PA		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230301		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 45; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
14268-120_0c5bef36-460c-4a81-e063-6294a90a7583	14268-120	HUMAN OTC DRUG	SUMMARY EVERYDAY MINERAL SUNSCREEN BROAD SPECTRUM SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230301		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	TITANIUM DIOXIDE; ZINC OXIDE	364; 298	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
14268-122_0c5b2855-6f2f-280e-e063-6394a90acadb	14268-122	HUMAN OTC DRUG	Aqua protection Sunscreen Broad Spectrum SPF50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230301		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 45; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
14268-123_0c5b602d-b985-ffad-e063-6294a90a4eee	14268-123	HUMAN OTC DRUG	Byoma Moisturizing Gel Sunscreen Broad Spectrum SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE	CREAM	TOPICAL	20230315		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
14268-124_0c5bef36-45fd-4a81-e063-6294a90a7583	14268-124	HUMAN OTC DRUG	Bass Pro Shops Bass P Sunscreen Broad Spectrum SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230419		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	TITANIUM DIOXIDE; ZINC OXIDE	20; 170	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
14268-125_0c5bad81-095c-4f66-e063-6294a90a48d9	14268-125	HUMAN OTC DRUG	Bass Pro Shops Mineral Sun Stick Sunscreen Broad Spec SPF 40		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230419		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	TITANIUM DIOXIDE; ZINC OXIDE	81; 60	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
14268-126_0c5b602d-b995-ffad-e063-6294a90a4eee	14268-126	HUMAN OTC DRUG	MD Mineral BB Creme Broad Spectrum SPF 50 Water Resistant 80 Min		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230419		OTC MONOGRAPH DRUG	M020	ENGLEWOOD LAB, INC.	TITANIUM DIOXIDE; ZINC OXIDE	20; 170	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
14269-001_06e9dc12-acc2-3d79-e063-6294a90ad7a6	14269-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20191121		UNAPPROVED MEDICAL GAS		Healthwise Pharmacy of Greenville, Inc. dba Healthwise Pharmacy	OXYGEN	99	L/100L			N	20241231
14324-011_0b41a486-6e39-a1a7-e063-6294a90ace21	14324-011	HUMAN OTC DRUG	UV PROTECT FACE SPF 50		ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20180131	20250930	OTC MONOGRAPH DRUG	M020	Naos USA, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	88.2; 200	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
14324-020_0b41a486-6e3a-a1a7-e063-6294a90ace21	14324-020	HUMAN OTC DRUG	SUN ULTIMATE FACE SPF 30		HOMOSALATE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20190401	20240930	OTC MONOGRAPH DRUG	M020	Naos USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	27; 90; 45	mg/mL; mg/mL; mg/mL			N	
14324-025_0b418862-df5d-e682-e063-6394a90a32be	14324-025	HUMAN OTC DRUG	Adaptasun Sea and Tropics Protective Face Care SPF 25		HOMOSALATE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20220401	20240930	OTC MONOGRAPH DRUG	M020	Naos USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	27; 90; 45	mg/mL; mg/mL; mg/mL			N	
14324-026_0b41d8d2-7efe-4f4e-e063-6394a90a09e7	14324-026	HUMAN OTC DRUG	Photo Regul Cream Unifying Protective Face Care SPF 25		HOMOSALATE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20220401	20240930	OTC MONOGRAPH DRUG	M020	Naos USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	27; 90; 45	mg/mL; mg/mL; mg/mL			N	
14324-027_0b419ba3-48d6-8df0-e063-6294a90a741c	14324-027	HUMAN OTC DRUG	Sun Sublime Protective Face Care SPF 30		HOMOSALATE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20220401	20240930	OTC MONOGRAPH DRUG	M020	Naos USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	27; 90; 45	mg/mL; mg/mL; mg/mL			N	
14324-028_0b41e4c6-3d51-2689-e063-6394a90a3f70	14324-028	HUMAN OTC DRUG	Adaptasun Sea and Tropics Protective Body SPF 30		HOMOSALATE, OCTISALATE, AVOBENZONE	LOTION	TOPICAL	20230401	20240930	OTC MONOGRAPH DRUG	M020	Naos USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	27; 90; 45	mg/mL; mg/mL; mg/mL			N	
14335-060_d8054c01-c776-3c25-e053-2a95a90a0998	14335-060	HUMAN PRESCRIPTION DRUG	Esomeprazole sodium		Esomeprazole sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210131		ANDA	ANDA215732	Hainan Poly Pharm. Co., Ltd.	ESOMEPRAZOLE SODIUM	40	mg/5mL	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
14335-120_0a1a4553-120c-b67d-e063-6294a90a0572	14335-120	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20231114		ANDA	ANDA215890	Hainan Poly Pharm., Co., Ltd.	DAPTOMYCIN	500	mg/20mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
14335-132_e826d769-c243-f0ac-e053-2995a90afcff	14335-132	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION, SOLUTION	INTRAVENOUS	20221231		ANDA	ANDA215846	Hainan Poly Pharm. Co., Ltd.	SODIUM NITROPRUSSIDE	.2	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
14335-133_e826d769-c243-f0ac-e053-2995a90afcff	14335-133	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION, SOLUTION	INTRAVENOUS	20221231		ANDA	ANDA215846	Hainan Poly Pharm. Co., Ltd.	SODIUM NITROPRUSSIDE	.2	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
14335-134_e826d769-c243-f0ac-e053-2995a90afcff	14335-134	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION, SOLUTION	INTRAVENOUS	20221231		ANDA	ANDA215846	Hainan Poly Pharm. Co., Ltd.	SODIUM NITROPRUSSIDE	.5	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
14335-171_f153e636-62ab-3b86-e053-2995a90a36c1	14335-171	HUMAN PRESCRIPTION DRUG	Dobutamine		Dobutamine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210601		ANDA	ANDA216131	Hainan Poly Pharm. Co., Ltd.	DOBUTAMINE HYDROCHLORIDE	12.5	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
14335-172_f153e636-62ab-3b86-e053-2995a90a36c1	14335-172	HUMAN PRESCRIPTION DRUG	Dobutamine		Dobutamine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210601		ANDA	ANDA216131	Hainan Poly Pharm. Co., Ltd.	DOBUTAMINE HYDROCHLORIDE	12.5	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
14335-180_071a4f3a-9ee4-cd9d-e063-6394a90ac697	14335-180	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	POWDER, FOR SUSPENSION	ORAL	20231201		ANDA	ANDA215738	Hainan Poly Pharm. Co., Ltd.	FLUCONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
14335-200_01ea059f-2a84-ec26-e063-6294a90a647d	14335-200	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20230811		ANDA	ANDA217036	Hainan Poly Pharm. Co., Ltd.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
14335-201_01ea059f-2a84-ec26-e063-6294a90a647d	14335-201	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20230811		ANDA	ANDA217036	Hainan Poly Pharm. Co., Ltd.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
14335-202_01ea059f-2a84-ec26-e063-6294a90a647d	14335-202	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20230811		ANDA	ANDA217036	Hainan Poly Pharm. Co., Ltd.	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
14335-340_fcf83646-5cb1-2844-e053-6294a90a8a92	14335-340	HUMAN PRESCRIPTION DRUG	LEVOLEUCOVORIN CALCIUM		levoleucovorin injection	INJECTION, SOLUTION	INTRAVENOUS	20230531		ANDA	ANDA217314	Hainan Poly Pharm. Co., Ltd.	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
14335-341_fcf83646-5cb1-2844-e053-6294a90a8a92	14335-341	HUMAN PRESCRIPTION DRUG	LEVOLEUCOVORIN CALCIUM		levoleucovorin injection	INJECTION, SOLUTION	INTRAVENOUS	20230531		ANDA	ANDA217314	Hainan Poly Pharm. Co., Ltd.	LEVOLEUCOVORIN CALCIUM	10	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
14335-380_0b4487ec-22e5-edae-e063-6394a90a41e7	14335-380	HUMAN PRESCRIPTION DRUG	oseltamivir phosphate		oseltamivir phosphate	CAPSULE	ORAL	20231129		ANDA	ANDA218009	Hainan Poly Pharm. Co., Ltd.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
14362-0111_06873f1f-4203-4697-a0ae-c2eaa8f6c668	14362-0111	VACCINE	TDVAX		Tetanus and Diphtheria Toxoids Adsorbed	INJECTION	INTRAMUSCULAR	19700727		BLA	BLA101322	MassBiologics	CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	2; 2	[Lf]/.5mL; [Lf]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
14445-106_5b7d091a-7e7a-46ac-ab13-49ef27b1b0a5	14445-106	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20200814		ANDA	ANDA206155	Indoco Remedies Limited	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
14445-107_5b7d091a-7e7a-46ac-ab13-49ef27b1b0a5	14445-107	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20200814		ANDA	ANDA206155	Indoco Remedies Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
14445-108_5b7d091a-7e7a-46ac-ab13-49ef27b1b0a5	14445-108	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20200814		ANDA	ANDA206155	Indoco Remedies Limited	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
14445-109_5b7d091a-7e7a-46ac-ab13-49ef27b1b0a5	14445-109	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20200814		ANDA	ANDA206155	Indoco Remedies Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
14445-110_5b7d091a-7e7a-46ac-ab13-49ef27b1b0a5	14445-110	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20200814		ANDA	ANDA206155	Indoco Remedies Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
14445-111_5b7d091a-7e7a-46ac-ab13-49ef27b1b0a5	14445-111	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20200814		ANDA	ANDA206155	Indoco Remedies Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
14445-129_c16a4d24-f5e3-40a3-b8d7-072494029396	14445-129	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220320		ANDA	ANDA208308	Indoco Remedies Limited	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
14445-130_c16a4d24-f5e3-40a3-b8d7-072494029396	14445-130	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220320		ANDA	ANDA208308	Indoco Remedies Limited	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
14445-131_c16a4d24-f5e3-40a3-b8d7-072494029396	14445-131	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220320		ANDA	ANDA208308	Indoco Remedies Limited	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
14445-132_c16a4d24-f5e3-40a3-b8d7-072494029396	14445-132	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220320		ANDA	ANDA208308	Indoco Remedies Limited	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
14445-149_6a6e421b-6ed3-403c-b07d-09dbbd6a487c	14445-149	HUMAN PRESCRIPTION DRUG	apixaban		apixaban	TABLET, FILM COATED	ORAL	20200916		ANDA	ANDA209898	Indoco Remedies Limited	APIXABAN	2.5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
14445-150_6a6e421b-6ed3-403c-b07d-09dbbd6a487c	14445-150	HUMAN PRESCRIPTION DRUG	apixaban		apixaban	TABLET, FILM COATED	ORAL	20200916		ANDA	ANDA209898	Indoco Remedies Limited	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
14445-156_60d6e78a-98f8-4968-ad5f-37689cc2c096	14445-156	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20170214		ANDA	ANDA210292	Indoco Remedies Limited	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
14445-157_60d6e78a-98f8-4968-ad5f-37689cc2c096	14445-157	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20170215		ANDA	ANDA210292	Indoco Remedies Limited	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
14445-400_383421a5-5d33-4f15-88f4-8b66fcbfac71	14445-400	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION/ DROPS	OPHTHALMIC	20150101		ANDA	ANDA091691	Indoco Remedies Limited	BRIMONIDINE TARTRATE	2	mg/mg	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
14445-404_52429fcd-2961-412d-ae83-df3c6c9b5398	14445-404	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride		Dorzolamide	SOLUTION/ DROPS	OPHTHALMIC	20210514		ANDA	ANDA202053	Indoco Remedies Limited	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
14445-405_ad0940ba-ad02-47eb-9cc6-d974c211c538	14445-405	HUMAN PRESCRIPTION DRUG	DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE		ddorzolamide hydrochloride timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20210514		ANDA	ANDA202054	Indoco Remedies Limited	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
14445-406_03cd17c3-5f32-40a3-84a4-a2675a978208	14445-406	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	INJECTION	INTRAVENOUS	20220409		ANDA	ANDA214301	Indoco Remedies Limited	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
14445-407_428b0584-92f8-4485-b2ff-2d5c27891b51	14445-407	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191231		ANDA	ANDA214308	Indoco Remedies Limited	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
14445-412_2b8da336-9b90-466e-9ac2-6f6cbb999f9f	14445-412	HUMAN PRESCRIPTION DRUG	ACETYLCYSTEINE		ACETYLCYSTEINE	INJECTION	INTRAVENOUS	20220301		ANDA	ANDA215620	Indoco Remedies Limited	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
14445-413_f9c38a0e-9c8a-4a0f-ad9c-85cd06670af1	14445-413	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20211126		ANDA	ANDA210652	Indoco Remedies Limited	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
14445-414_f9c38a0e-9c8a-4a0f-ad9c-85cd06670af1	14445-414	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20211026		ANDA	ANDA210652	Indoco Remedies Limited	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
14448-302_09d7052e-ec40-ef60-e063-6294a90af214	14448-302	HUMAN OTC DRUG	SUPER WHITE STUFF Pain Relief		MENTHOL	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M017	BLUE SPRING WELLNESS, L.L.C.	MENTHOL	14	mg/mL			N	20241231
14448-306_09d6fabb-0d18-222e-e063-6294a90a95b6	14448-306	HUMAN OTC DRUG	SUPER WHITE STUFF Pain Relief		MENTHOL	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M017	BLUE SPRING WELLNESS, L.L.C.	MENTHOL	14	mg/mL			N	20241231
14448-307_09d7052e-ec52-ef60-e063-6294a90af214	14448-307	HUMAN OTC DRUG	SUPER WHITE Stuff Pain Relief		MENTHOL	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M017	BLUE SPRING WELLNESS, L.L.C.	MENTHOL	14	mg/mL			N	20241231
14448-314_09d70e71-d1aa-2749-e063-6294a90abd05	14448-314	HUMAN OTC DRUG	SUPER BLUE STUFF Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20201122		OTC MONOGRAPH DRUG	M017	BLUE SPRING WELLNESS, L.L.C.	MENTHOL	14	mg/mL			N	20241231
14448-315_09d6fabb-0d2a-222e-e063-6294a90a95b6	14448-315	HUMAN OTC DRUG	SUPER WHITE STUFF PAIN RELIEF		MENTHOL	CREAM	TOPICAL	20210419		OTC MONOGRAPH DRUG	M017	BLUE SPRING WELLNESS, L.L.C.	MENTHOL	14	mg/mL			N	20241231
14448-316_09d6fabb-0d3a-222e-e063-6294a90a95b6	14448-316	HUMAN OTC DRUG	BLUE SPRING Foot and Leg Comfort Cream with Pain Relief		MENTHOL, CAPSAICIN	CREAM	TOPICAL	20211025		OTC MONOGRAPH DRUG	M017	BLUE SPRING WELLNESS, L.L.C.	CAPSAICIN; MENTHOL	.25; 15	mg/g; mg/g			N	20241231
14498-001_09d31994-f9dc-1f75-e063-6294a90a89bb	14498-001	HUMAN PRESCRIPTION DRUG	MTL1 Leucoflex		Anticoagulant Citrate Phosphate Dextrose Solution with AS-1	KIT	INTRAVENOUS	20051121		NDA	BN040083	Maco Productions						N	20241231
14498-002_d0a932ad-0a0c-4b77-8d4b-46fcc08e8f2b	14498-002	HUMAN PRESCRIPTION DRUG	Leucoflex CGP		Anticoagulant Citrate Phosphate Dextrose Solution with Additive Solution AS-1	KIT		20130531		NDA	BN040083	Maco Productions						N	20241231
14498-003_034e4d21-9b5d-4316-b465-c7d89148729a	14498-003	HUMAN PRESCRIPTION DRUG	Sterile Cord Blood Collection Unit (MSC127D)		Anticoagulant Citrate Phosphate Dextrose Solution	INJECTION, SOLUTION	INTRAVENOUS	20161221		NDA	BN125552	Maco Productions	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	114.5; .89; .92; 87.9	mg/35mL; g/35mL; g/35mL; mg/35mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14498-004_c62f5860-90d4-4312-ade7-eb22e55910b9	14498-004	HUMAN PRESCRIPTION DRUG	Sterile Cord Blood Collection Unit (MSC128D)		Anticoagulant Citrate Phosphate Dextrose Solution	INJECTION, SOLUTION	INTRAVENOUS	20161221		NDA	BN125552	Maco Productions	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	94.8; .74; .76; 72.8	mg/29mL; g/29mL; g/29mL; mg/29mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-408_18d184d6-1606-4e5c-a25f-6a4acf283358	14537-408	HUMAN PRESCRIPTION DRUG	Isoplate		SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE, MONOBASIC	SOLUTION	INTRAVENOUS	20130305		NDA	BN090067	Terumo BCT Ltd.	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM	.03; .037; .00082; .37; .53; .5; .008	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
14537-815_9a552ffd-acf0-4816-a775-48b261784950	14537-815	HUMAN PRESCRIPTION DRUG	ACD	A	Citric Acid Monohydrate, Dextrose Monohydrate, and Trisodium Citrate Dihydrate	INJECTION, SOLUTION	INTRAVENOUS	20020225		ANDA	BA010228	Terumo BCT, Ltd.	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.8; 2.45; 2.2	g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-817_9a552ffd-acf0-4816-a775-48b261784950	14537-817	HUMAN PRESCRIPTION DRUG	ACD	A	Citric Acid Monohydrate, Dextrose Monohydrate, and Trisodium Citrate Dihydrate	INJECTION, SOLUTION	INTRAVENOUS	20020225		ANDA	BA010228	Terumo BCT, Ltd.	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.8; 2.45; 2.2	g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-820_45c01c61-c4a0-4b2f-9848-964a3fbd9615	14537-820	HUMAN PRESCRIPTION DRUG	Anticoagulant Citrate Dextrose (ACD-A)		Dextrose Monohydrate, sodium citrate, unspecified form, and Citric Acid Monohydrate	SOLUTION	INTRAVENOUS	20230718		ANDA	BA110057	Terumo BCT, Ltd	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM	.08; .245; .22	g/10mL; g/10mL; g/10mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
14537-824_3973708b-e5a7-47f5-829c-5e3ae9620dd8	14537-824	HUMAN PRESCRIPTION DRUG	Additive Formula 3		Dextrose Monohydrate, Trisodium Citrate Dihydrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate, and Adenine	SOLUTION	INTRAVENOUS	20020529		NDA	BN001214	Terumo BCT, Ltd	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.03; .042; 1.1; .41; .28; .59	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-826_3973708b-e5a7-47f5-829c-5e3ae9620dd8	14537-826	HUMAN PRESCRIPTION DRUG	Additive Formula 3		Dextrose Monohydrate, Trisodium Citrate Dihydrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate, and Adenine	SOLUTION	INTRAVENOUS	20020529		NDA	BN001214	Terumo BCT, Ltd	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.03; .042; 1.1; .41; .28; .59	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-828_3973708b-e5a7-47f5-829c-5e3ae9620dd8	14537-828	HUMAN PRESCRIPTION DRUG	Additive Formula 3		Dextrose Monohydrate, Trisodium Citrate Dihydrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate, and Adenine	SOLUTION	INTRAVENOUS	20020529		NDA	BN001214	Terumo BCT, Ltd	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.03; .042; 1.1; .41; .28; .59	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-832_a7c8359b-69ef-497d-85f9-205ffdec83cb	14537-832	HUMAN PRESCRIPTION DRUG	Additive Formula 3		Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, Citric Acid Monohydrate, and Adenine	SOLUTION	INTRAVENOUS	20020529		NDA	BN001214	Terumo BCT, Ltd	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.03; .042; 1.1; .41; .28; .59	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-833_a7c8359b-69ef-497d-85f9-205ffdec83cb	14537-833	HUMAN PRESCRIPTION DRUG	Additive Formula 3		Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, Citric Acid Monohydrate, and Adenine	SOLUTION	INTRAVENOUS	20020529		NDA	BN001214	Terumo BCT, Ltd	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.03; .042; 1.1; .41; .28; .59	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-834_a7c8359b-69ef-497d-85f9-205ffdec83cb	14537-834	HUMAN PRESCRIPTION DRUG	Additive Formula 3		Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, Citric Acid Monohydrate, and Adenine	SOLUTION	INTRAVENOUS	20020529		NDA	BN001214	Terumo BCT, Ltd	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.03; .042; 1.1; .41; .28; .59	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-881_abcdb978-0595-45a6-a7ae-326015afea8e	14537-881	HUMAN PRESCRIPTION DRUG	Sodium Citrate 4% w/v Anticoagulant		TRISODIUM CITRATE DIHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20180626		ANDA	BA125608	Terumo BCT, Ltd	TRISODIUM CITRATE DIHYDRATE	4	g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-883_4719aad5-3448-413e-ba12-7026b3330731	14537-883	HUMAN PRESCRIPTION DRUG	Sodium Citrate w/v Anticoagulant		TRISODIUM CITRATE DIHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20180626		ANDA	BA125608	Terumo BCT, Ltd	TRISODIUM CITRATE DIHYDRATE	4	g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-966_1f7b74b9-e7df-41fc-9af6-cf7c340300f5	14537-966	HUMAN PRESCRIPTION DRUG	AS	3	Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine	INJECTION, SOLUTION	INTRAVENOUS	20020529		NDA	BN001214	Terumo BCT Ltd	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM CITRATE, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.03; .042; 1.1; .41; .588; .276	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
14537-967_75f7d630-1735-4761-a42a-5c5687a021bd	14537-967	HUMAN PRESCRIPTION DRUG	ACD	A	Dextrose Monohydrate, Sodium Citrate, and Citric Acid Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20020225		ANDA	BA010228	Terumo BCT Ltd	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM	.8; 2.45; 2.2	g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
14539-673_dce209d8-8259-4673-80ff-88cdbbb26fb9	14539-673	HUMAN PRESCRIPTION DRUG	diflunisal		diflunisal	TABLET, FILM COATED	ORAL	20120308		ANDA	ANDA202845	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DIFLUNISAL	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
14539-674_bdb22fcc-b768-493e-a8e0-09975b3aba6a	14539-674	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
14539-675_bdb22fcc-b768-493e-a8e0-09975b3aba6a	14539-675	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
14539-700_138f8bdd-34a5-49c6-832f-0d343aa95c7b	14539-700	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20190601		ANDA	ANDA074225	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
14539-701_138f8bdd-34a5-49c6-832f-0d343aa95c7b	14539-701	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20190601		ANDA	ANDA074225	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
14539-702_138f8bdd-34a5-49c6-832f-0d343aa95c7b	14539-702	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20190601		ANDA	ANDA074225	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
14784-001_0bb72449-6369-b526-e063-6294a90a4b27	14784-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020130		UNAPPROVED MEDICAL GAS		Quick-Fill Mobile Oxygen LLC	OXYGEN	99	L/100L			N	20241231
14789-010_31201bb4-7d37-4ef5-bd88-209f44693e81	14789-010	HUMAN PRESCRIPTION DRUG	Dicyclomine HCl		Dicyclomine Hydrochloride	INJECTION	INTRAMUSCULAR	20190218		ANDA	ANDA206468	Nexus Pharmaceuticals LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
14789-011_b95042e4-c7dc-49ed-8433-18fc3f3a8e89	14789-011	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170803		ANDA	ANDA206961	Nexus Pharmaceuticals Inc	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
14789-012_f3a91a00-5e2f-4bcb-a11f-9458cced50c7	14789-012	HUMAN PRESCRIPTION DRUG	sodium nitroprusside		sodium nitroprusside	INJECTION	INTRAVENOUS	20170529		ANDA	ANDA207499	Nexus Pharmaceuticals Inc	SODIUM NITROPRUSSIDE	25	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
14789-013_aab333f1-a02c-462a-bb87-d6270f8b46b9	14789-013	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION	INTRAVENOUS	20230915		ANDA	ANDA207794	Nexus Pharmaceuticals LLC	BUSULFAN	60	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
14789-015_b95042e4-c7dc-49ed-8433-18fc3f3a8e89	14789-015	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170803		ANDA	ANDA206961	Nexus Pharmaceuticals Inc	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
14789-101_24bc52a7-a600-4896-b726-fe91e43e3f1e	14789-101	HUMAN PRESCRIPTION DRUG	Tirofiban Hydrochloride		Tirofiban Hydrochloride	INJECTION	INTRAVENOUS	20230925		ANDA	ANDA213947	Nexus Pharmaceuticals Inc.	TIROFIBAN HYDROCHLORIDE	50	ug/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
14789-102_24bc52a7-a600-4896-b726-fe91e43e3f1e	14789-102	HUMAN PRESCRIPTION DRUG	Tirofiban Hydrochloride		Tirofiban Hydrochloride	INJECTION	INTRAVENOUS	20230925		ANDA	ANDA213947	Nexus Pharmaceuticals Inc.	TIROFIBAN HYDROCHLORIDE	50	ug/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
14789-104_9ac95860-0b70-41cf-b646-14798d7a0f22	14789-104	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210111		ANDA	ANDA213552	Nexus Pharmaceuticals Inc	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
14789-107_fd507baf-f17a-4294-af56-ca6a5052cb1e	14789-107	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	INJECTION	INTRAVENOUS	20210228		ANDA	ANDA214727	Nexus Pharamaceuticals Inc.	POTASSIUM CHLORIDE	29.8	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
14789-108_fd507baf-f17a-4294-af56-ca6a5052cb1e	14789-108	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	INJECTION	INTRAVENOUS	20210228		ANDA	ANDA214727	Nexus Pharamaceuticals Inc.	POTASSIUM CHLORIDE	14.9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
14789-109_fd507baf-f17a-4294-af56-ca6a5052cb1e	14789-109	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	INJECTION	INTRAVENOUS	20210228		ANDA	ANDA214727	Nexus Pharamaceuticals Inc.	POTASSIUM CHLORIDE	7.45	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
14789-110_8879dc10-080c-4736-b66a-44f2ad84e778	14789-110	HUMAN PRESCRIPTION DRUG	Levetiracetam in Sodium Chloride		Levetiracetam	INJECTION	INTRAVENOUS	20200720		ANDA	ANDA213532	Nexus Pharamaceuticals Inc.	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
14789-114_7041521b-fb97-4c9c-ad5a-eceb73caf209	14789-114	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20231226		ANDA	ANDA215057	Nexus Pharmaceuticals LLC	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
14789-116_f62e4489-4e7b-4347-9c6a-3f132f10b2d2	14789-116	HUMAN PRESCRIPTION DRUG	Erythromycin Lactobionate		Erythromycin Lactobionate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210801		ANDA	ANDA215290	Nexus Pharmaceuticals Inc.	ERYTHROMYCIN LACTOBIONATE	500	mg/10mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
14789-121_aba550fb-6e45-49f8-80c9-9b7fad02fce3	14789-121	HUMAN PRESCRIPTION DRUG	Papaverine Hydrochloride		Papaverine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210628		UNAPPROVED DRUG OTHER		Nexus Pharamaceuticals Inc.	PAPAVERINE HYDROCHLORIDE	30	mg/mL			N	20241231
14789-122_b66b331e-c90a-48e0-9d9d-961c1cb5c9e2	14789-122	HUMAN PRESCRIPTION DRUG	Fluorescein		Fluorescein	INJECTION	INTRAVENOUS	20231024		ANDA	ANDA215709	Nexus Pharmaceuticals LLC	FLUORESCEIN	500	mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
14789-123_b66b331e-c90a-48e0-9d9d-961c1cb5c9e2	14789-123	HUMAN PRESCRIPTION DRUG	Fluorescein		Fluorescein	INJECTION	INTRAVENOUS	20231024		ANDA	ANDA215709	Nexus Pharmaceuticals LLC	FLUORESCEIN	250	mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
14789-127_2ee2da3e-027b-467b-be5e-b6744f45cb85	14789-127	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231206		UNAPPROVED DRUG OTHER		Nexus Pharmaceuticals, LLC	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
14789-128_2ee2da3e-027b-467b-be5e-b6744f45cb85	14789-128	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231206		UNAPPROVED DRUG OTHER		Nexus Pharmaceuticals, LLC	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
14789-131_734c4ca7-dc47-40ea-b40c-93589ec21aff	14789-131	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20230925		ANDA	ANDA217536	Nexus Pharmaceuticals Inc	WATER	10	mL/10mL			N	20241231
14789-132_734c4ca7-dc47-40ea-b40c-93589ec21aff	14789-132	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20230925		ANDA	ANDA217536	Nexus Pharmaceuticals Inc	WATER	20	mL/20mL			N	20241231
14789-133_1aef24d7-52a9-4342-b08c-cd87ad7d7fcc	14789-133	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20231031		ANDA	ANDA217535	Nexus Pharmaceuticals LLC	SODIUM CHLORIDE	9	mg/mL			N	20241231
14789-134_1aef24d7-52a9-4342-b08c-cd87ad7d7fcc	14789-134	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20231031		ANDA	ANDA217535	Nexus Pharmaceuticals LLC	SODIUM CHLORIDE	9	mg/mL			N	20241231
14789-136_dfdb8b17-8766-4d7c-a41f-242349b58ea8	14789-136	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	INJECTION	INTRAVENOUS	20230912		ANDA	ANDA217704	Nexus Pharamaceuticals Inc.	POTASSIUM CHLORIDE	29.8	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
14789-137_dfdb8b17-8766-4d7c-a41f-242349b58ea8	14789-137	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	INJECTION	INTRAVENOUS	20230912		ANDA	ANDA217704	Nexus Pharamaceuticals Inc.	POTASSIUM CHLORIDE	29.8	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
14789-201_7792cc09-02f8-47a4-a948-79ff051bff71	14789-201	HUMAN PRESCRIPTION DRUG	Colistimethate Sodium		Colistimethate Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20211206		ANDA	ANDA065177	Nexus Pharmaceuticals Inc	COLISTIMETHATE SODIUM	150	mg/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
14789-220_8879dc10-080c-4736-b66a-44f2ad84e778	14789-220	HUMAN PRESCRIPTION DRUG	Levetiracetam in Sodium Chloride		Levetiracetam	INJECTION	INTRAVENOUS	20200720		ANDA	ANDA213532	Nexus Pharamaceuticals Inc.	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
14789-250_54276f21-7800-44f4-ae51-0060fb1c43ad	14789-250	HUMAN PRESCRIPTION DRUG	Emerphed		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20200515		NDA	NDA213407	Nexus Pharamaceuticals Inc.	EPHEDRINE SULFATE	5	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
14789-330_8879dc10-080c-4736-b66a-44f2ad84e778	14789-330	HUMAN PRESCRIPTION DRUG	Levetiracetam in Sodium Chloride		Levetiracetam	INJECTION	INTRAVENOUS	20200720		ANDA	ANDA213532	Nexus Pharamaceuticals Inc.	LEVETIRACETAM	15	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
14789-600_d71a4638-e560-470d-9cc9-0a7819da7c8a	14789-600	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION	INTRAVENOUS	20181119		ANDA	ANDA209780	Nexus Pharmaceuticals Inc	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
14789-700_6abe6979-1fee-47d6-a8c1-0943adcd2b10	14789-700	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190225		ANDA	ANDA204860	Nexus Pharmaceuticals Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
14789-900_db2cc3c6-3473-4c22-a21d-d1ef5d8bd84b	14789-900	HUMAN PRESCRIPTION DRUG	Procainamide Hydrochloride		Procainamide Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20071014		ANDA	ANDA206332	Nexus Pharmaceuticals LLC	PROCAINAMIDE HYDROCHLORIDE	500	mg/mL	Antiarrhythmic [EPC]		N	20241231
14789-901_db2cc3c6-3473-4c22-a21d-d1ef5d8bd84b	14789-901	HUMAN PRESCRIPTION DRUG	Procainamide Hydrochloride		Procainamide Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20071014		ANDA	ANDA206332	Nexus Pharmaceuticals LLC	PROCAINAMIDE HYDROCHLORIDE	100	mg/mL	Antiarrhythmic [EPC]		N	20241231
14961-004_0aaefeba-62a9-9845-e063-6294a90a03de	14961-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20050104		NDA	NDA205767	Haun Specialty Gases, Inc.	OXYGEN	210	mL/L			N	20241231
14961-005_0aaef715-8e43-0617-e063-6394a90a4898	14961-005	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	20050104		NDA	NDA206826	Haun Specialty Gases, Inc.	HELIUM	990	mL/L			N	20241231
14961-006_0aaee474-cf46-8b39-e063-6294a90a815c	14961-006	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA205767	Haun Specialty Gases, Inc.	OXYGEN	990	mL/L			N	20241231
14961-007_0aaedfb3-c09b-ff5a-e063-6394a90aa9d0	14961-007	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	LIQUID	RESPIRATORY (INHALATION)	20050101		NDA	NDA205766	Haun Specialty Gases, Inc.	NITROGEN	990	mL/L			N	20241231
14961-008_0aaefc8a-a369-0e89-e063-6394a90af8f3	14961-008	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20211018		NDA	NDA205764	Haun Specialty Gases, Inc.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
15013-002_f45ca692-927f-6cb1-e053-2995a90a3356	15013-002	HUMAN OTC DRUG	SinolM Fast Allergy and Sinus Relief	All-Natural	CAPSICUM	SPRAY	NASAL	20050301		UNAPPROVED HOMEOPATHIC		Sinol USA, Inc.	CAPSICUM	4	[hp_X]/.263mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
15013-003_f45c8437-7371-e43a-e053-2995a90a85c2	15013-003	HUMAN OTC DRUG	SinolM Fast Headache Pain Relief	All-Natural Nasal	CAPSICUM	SPRAY	NASAL	20050301		UNAPPROVED HOMEOPATHIC		Sinol USA, Inc.	CAPSICUM	4	[hp_X]/.263mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
15013-004_f45cc5c4-2471-1c07-e053-2995a90a8244	15013-004	HUMAN OTC DRUG	SinolM Cold and Flu	All-Natural	CAPSICUM	SPRAY	NASAL	20050301		UNAPPROVED HOMEOPATHIC		Sinol USA, Inc.	CAPSICUM	4	[hp_X]/.263mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
15013-016_f45cbf13-ddfd-51eb-e053-2995a90a7a55	15013-016	HUMAN OTC DRUG	SinolD	All-Natural Nasal Decongestant	CAPSICUM	SPRAY	NASAL	20050301		UNAPPROVED HOMEOPATHIC		Sinol USA, Inc.	CAPSICUM	4	[hp_X]/.263mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
15014-400_079db405-aab1-a400-e063-6294a90a1489	15014-400	HUMAN PRESCRIPTION DRUG	Fenoprofen Calcium		fenoprofen calcium	CAPSULE	ORAL	20160519		NDA AUTHORIZED GENERIC	NDA017604	Gentex Pharma	FENOPROFEN CALCIUM	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
15054-0010_a370c8c8-9a5f-47df-b230-6ecbcc6dfa88	15054-0010	HUMAN PRESCRIPTION DRUG	SOHONOS		palovarotene	CAPSULE	ORAL	20230816		NDA	NDA215559	Ipsen Biopharmaceuticals, Inc.	PALOVAROTENE	1	mg/1			N	20241231
15054-0015_a370c8c8-9a5f-47df-b230-6ecbcc6dfa88	15054-0015	HUMAN PRESCRIPTION DRUG	SOHONOS		palovarotene	CAPSULE	ORAL	20230816		NDA	NDA215559	Ipsen Biopharmaceuticals, Inc.	PALOVAROTENE	1.5	mg/1			N	20241231
15054-0025_a370c8c8-9a5f-47df-b230-6ecbcc6dfa88	15054-0025	HUMAN PRESCRIPTION DRUG	SOHONOS		palovarotene	CAPSULE	ORAL	20230816		NDA	NDA215559	Ipsen Biopharmaceuticals, Inc.	PALOVAROTENE	2.5	mg/1			N	20241231
15054-0043_5ecd8e9a-b782-47f8-b5de-f19d3f14ebdc	15054-0043	HUMAN PRESCRIPTION DRUG	Onivyde		IRINOTECAN HYDROCHLORIDE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20151022		NDA	NDA207793	Ipsen Biopharmaceuticals, Inc.	IRINOTECAN HYDROCHLORIDE	4.3	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
15054-0050_a370c8c8-9a5f-47df-b230-6ecbcc6dfa88	15054-0050	HUMAN PRESCRIPTION DRUG	SOHONOS		palovarotene	CAPSULE	ORAL	20230816		NDA	NDA215559	Ipsen Biopharmaceuticals, Inc.	PALOVAROTENE	5	mg/1			N	20241231
15054-0100_a370c8c8-9a5f-47df-b230-6ecbcc6dfa88	15054-0100	HUMAN PRESCRIPTION DRUG	SOHONOS		palovarotene	CAPSULE	ORAL	20230816		NDA	NDA215559	Ipsen Biopharmaceuticals, Inc.	PALOVAROTENE	10	mg/1			N	20241231
15054-0500_44512f6b-6a35-4db5-ba17-fe2fe3ec5170	15054-0500	HUMAN PRESCRIPTION DRUG	Dysport		Botulinum Toxin Type A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20091102		BLA	BLA125274	Ipsen Biopharmaceuticals, Inc.	BOTULINUM TOXIN TYPE A	500	U/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
15054-0530_44512f6b-6a35-4db5-ba17-fe2fe3ec5170	15054-0530	HUMAN PRESCRIPTION DRUG	Dysport		Botulinum Toxin Type A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20091102		BLA	BLA125274	Ipsen Biopharmaceuticals, Inc.	BOTULINUM TOXIN TYPE A	300	U/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
15054-1040_f03c94cc-db9b-4da7-838a-ead7711d4fa3	15054-1040	HUMAN PRESCRIPTION DRUG	Increlex		mecasermin	INJECTION, SOLUTION	SUBCUTANEOUS	20060103		BLA	BLA021839	Ipsen Biopharmaceuticals, Inc.	MECASERMIN	40	mg/4mL			N	20241231
15054-1060_3cbf9cb7-cf01-4062-9e57-43e0f1c267a1	15054-1060	HUMAN PRESCRIPTION DRUG	SOMATULINE DEPOT		lanreotide acetate	INJECTION	SUBCUTANEOUS	20071114		NDA	NDA022074	Ipsen Biopharmaceuticals, Inc.	LANREOTIDE ACETATE	60	mg/.2mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
15054-1090_3cbf9cb7-cf01-4062-9e57-43e0f1c267a1	15054-1090	HUMAN PRESCRIPTION DRUG	SOMATULINE DEPOT		lanreotide acetate	INJECTION	SUBCUTANEOUS	20071114		NDA	NDA022074	Ipsen Biopharmaceuticals, Inc.	LANREOTIDE ACETATE	90	mg/.3mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
15054-1120_3cbf9cb7-cf01-4062-9e57-43e0f1c267a1	15054-1120	HUMAN PRESCRIPTION DRUG	SOMATULINE DEPOT		lanreotide acetate	INJECTION	SUBCUTANEOUS	20071114		NDA	NDA022074	Ipsen Biopharmaceuticals, Inc.	LANREOTIDE ACETATE	120	mg/.5mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
15127-007_e3787663-9b0a-4e1e-b5fa-2aad97e4738f	15127-007	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part333A	Select Brand Distributors	ALCOHOL	70	mL/100mL			N	20241231
15127-069_b0dd5352-bc15-48bd-9fa3-4aed2e297241	15127-069	HUMAN OTC DRUG	Petrolatum		White Petrolatum	JELLY	TOPICAL	20090313		OTC MONOGRAPH FINAL	part347	Select Brand Distributors	PETROLATUM	1	g/g			N	20241231
15127-804_74e1a606-0f40-45eb-96ac-d28e0108415e	15127-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20110310		OTC MONOGRAPH NOT FINAL	part333A	Select Brand Distributors	ISOPROPYL ALCOHOL	.91	mg/mL			N	20241231
15127-871_0c3f3bd6-5987-4d48-88ca-8c28549c38e8	15127-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20110921		OTC MONOGRAPH NOT FINAL	part333A	Select Brand Distributors	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
15370-103_0ad40f28-c81d-440a-8c07-d59f667487ed	15370-103	HUMAN PRESCRIPTION DRUG	Quflora Pediatric		VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, and SODIUM FLUORIDE	TABLET, CHEWABLE	ORAL	20140106		UNAPPROVED DRUG OTHER		CarWin Pharmaceutical Associates, LLC	.ALPHA.-TOCOPHEROL, DL-; ASCORBIC ACID; CHOLECALCIFEROL; CUPRIC SULFATE; CYANOCOBALAMIN; FOLIC ACID; LEVOMEFOLIC ACID; MAGNESIUM OXIDE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A ACETATE	15; 60; 400; 1; 4; 100; 108; 15; 5; 1.5; 1.3; .25; 1.2; 1200	[iU]/1; mg/1; [iU]/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20251231
15370-104_0ad40f28-c81d-440a-8c07-d59f667487ed	15370-104	HUMAN PRESCRIPTION DRUG	Quflora Pediatric		VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, and SODIUM FLUORIDE	TABLET, CHEWABLE	ORAL	20140106		UNAPPROVED DRUG OTHER		CarWin Pharmaceutical Associates, LLC	.ALPHA.-TOCOPHEROL, DL-; ASCORBIC ACID; CHOLECALCIFEROL; CUPRIC SULFATE; CYANOCOBALAMIN; FOLIC ACID; LEVOMEFOLIC ACID; MAGNESIUM OXIDE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A ACETATE	15; 60; 400; 1; 4; 100; 108; 15; 5; 1.5; 1.3; .5; 1.2; 1200	[iU]/1; mg/1; [iU]/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20251231
15370-105_0ad40f28-c81d-440a-8c07-d59f667487ed	15370-105	HUMAN PRESCRIPTION DRUG	Quflora Pediatric		VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, and SODIUM FLUORIDE	TABLET, CHEWABLE	ORAL	20140106		UNAPPROVED DRUG OTHER		CarWin Pharmaceutical Associates, LLC	.ALPHA.-TOCOPHEROL, DL-; ASCORBIC ACID; CHOLECALCIFEROL; CUPRIC SULFATE; CYANOCOBALAMIN; FOLIC ACID; LEVOMEFOLIC ACID; MAGNESIUM OXIDE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A ACETATE	15; 60; 400; 1; 4; 100; 108; 15; 5; 1.5; 1.3; 1; 1.2; 1200	[iU]/1; mg/1; [iU]/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20251231
15370-130_0e84f4a5-7637-6b55-e063-6294a90a4d55	15370-130	HUMAN PRESCRIPTION DRUG	RyVent		carbinoxamine maleate	TABLET	ORAL	20170217		ANDA	ANDA207484	Carwin Pharmaceutical Associates, LLC	CARBINOXAMINE MALEATE	6	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
15370-150_3affdd03-252d-443c-9966-e3aec314fb98	15370-150	HUMAN PRESCRIPTION DRUG	RYCLORA		Dexchlorpheniramine Maleate	LIQUID	ORAL	20181007		ANDA	ANDA202520	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	DEXCHLORPHENIRAMINE MALEATE	2	mg/5mL			N	20251231
15370-170_48aa3640-1dd2-4693-9b0d-a99595b97a0e	15370-170	HUMAN PRESCRIPTION DRUG	RELAFEN DS		NABUMETONE	TABLET	ORAL	20190920		ANDA	ANDA203166	Carwin Pharmaceutical Associates, LLC	NABUMETONE	1000	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
15370-180_5b6fd6af-5eb5-4977-889c-f91058302ff8	15370-180	HUMAN PRESCRIPTION DRUG	LOFENA		DICLOFENAC POTASSIUM	TABLET, FILM COATED	ORAL	20211025		ANDA	ANDA076561	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
15370-185_1b1312d0-033d-464a-9868-ba44da1505c8	15370-185	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		DICLOFENAC POTASSIUM	TABLET, FILM COATED	ORAL	20231101		ANDA	ANDA076561	CARWIN PHARMACEUTICAL ASSOCIATES, LLC	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
15370-250_4889480e-2d59-4dbd-a808-ea7fce24f922	15370-250	HUMAN PRESCRIPTION DRUG	TriStart DHA		ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACIN, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE MAGNESIUM, FOLIC ACID, CYANOCOBALAMIN, IRON PENTACARBONYL, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT, and ICOSAPENT	CAPSULE, LIQUID FILLED	ORAL	20150601		UNAPPROVED DRUG OTHER		CarWin Pharmaceutical Associates, LLC	.ALPHA.-TOCOPHEROL ACETATE, D-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; DOCONEXENT; FOLIC ACID; ICOSAPENT; IRON PENTACARBONYL; LEVOMEFOLATE MAGNESIUM; MAGNESIUM OXIDE; NIACIN; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE	15; 55; 1000; 14; 200; 400; 15; 31; 600; 30; 5; 200; 35; 1.8; 1.3	[iU]/1; mg/1; [iU]/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20251231
15370-305_aaccd6e8-7c06-409f-be77-2b1384ec63b3	15370-305	HUMAN PRESCRIPTION DRUG	POKONZA		Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20230919		NDA	NDA208019	Carwin Pharmaceutical Associates, LLC	POTASSIUM CHLORIDE	.75	g/.79g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
15435-300_0a2790b7-08f8-7c14-e063-6394a90a8b30	15435-300	HUMAN OTC DRUG	Suzanne Organics Tinted Mineral Sunscreen Broad Spectrum SPF 25 - Sand		ZINC OXIDE	CREAM	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	SLC Skincare	ZINC OXIDE	220	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
15435-310_0a279616-8604-7c1a-e063-6394a90abc28	15435-310	HUMAN OTC DRUG	Suzanne Organics Tinted Mineral Sunscreen Broad Spectrum SPF 25 - Bronze		ZINC OXIDE	CREAM	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	SLC Skincare	ZINC OXIDE	220	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
15547-001_08f4af81-9082-3d06-e063-6394a90ab2ac	15547-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20101028		UNAPPROVED MEDICAL GAS		Tri State Medical Supply	OXYGEN	99	L/100L			N	20241231
15579-105_f5739d68-cfd7-dbfd-e053-2995a90a05be	15579-105	HUMAN OTC DRUG	Otix Ear Relief Ear Drops		CHAMOMILE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	TOPICAL	20210816		UNAPPROVED HOMEOPATHIC		Bell Pharmaceuticals, Inc.	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
15579-200_0c864236-9d6a-38e4-e063-6394a90aa4ec	15579-200	HUMAN OTC DRUG	JET ALERT Double Strength		Caffine	TABLET, COATED	ORAL	20141126		OTC MONOGRAPH DRUG	M011	Bell Pharmaceuticals, Inc	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
15579-201_0c86777f-3cf7-5e1d-e063-6294a90a2369	15579-201	HUMAN OTC DRUG	JET ALERT Regular Strength		CAFFEINE	TABLET, COATED	ORAL	20160727		OTC MONOGRAPH DRUG	M011	Bell Pharmaceuticals, Inc	CAFFEINE	100	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
15579-828_0c868adb-9986-5c7a-e063-6394a90a6638	15579-828	HUMAN OTC DRUG	Jet-Asleep Double Strength Night Time Sleep Aid		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20171007		OTC MONOGRAPH DRUG	M010	Bell Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
15579-837_0c86777f-3d08-5e1d-e063-6294a90a2369	15579-837	HUMAN OTC DRUG	Jet-Avert Motion Sickness Aid		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20171007		OTC MONOGRAPH DRUG	M009	Bell Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
15579-838_0c7fd25e-6acd-1a54-e063-6294a90af27d	15579-838	HUMAN OTC DRUG	Otix Ear wax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20211001		OTC MONOGRAPH DRUG	M014	Bell Pharmaceuticals, Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
15579-839_0c7fb23c-2434-ee25-e063-6394a90a9f53	15579-839	HUMAN OTC DRUG	Otix Ear wax Removal System Ear wax and Bulb		CARBAMIDE PEROXIDE	KIT		20211001		OTC MONOGRAPH DRUG	M014	Bell Pharmaceuticals, Inc.						N	20241231
15584-0101_a618c51f-5e21-4c41-9607-417fd04ee8ba	15584-0101	HUMAN PRESCRIPTION DRUG	Atripla		efavirenz, emtricitabine, and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20060720		NDA	NDA021937	Gilead Sciences, LLC	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
15631-0005_ca51af6c-a197-e3ff-e053-2a95a90a7076	15631-0005	HUMAN OTC DRUG	ACONITUM NAPELLUS		ACONITUM NAPELLUS	PELLET	ORAL	20150902		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ACONITUM NAPELLUS	3	[hp_X]/1			N	20241231
15631-0008_cd9e4834-3de7-7b55-e053-2995a90a70d9	15631-0008	HUMAN OTC DRUG	AESCULUS HIPPOCASTANUM		AESCULUS HIPPOCASTANUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	HORSE CHESTNUT	2	[hp_X]/1			N	20241231
15631-0010_cd76f70f-e8a1-356e-e053-2995a90a9949	15631-0010	HUMAN OTC DRUG	AGARICUS MUSCARIUS		AGARICUS MUSCARIUS	PELLET	ORAL	20150903		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	AMANITA MUSCARIA FRUITING BODY	2	[hp_X]/1			N	20241231
15631-0011_cd769881-d37c-5df6-e053-2a95a90a63d1	15631-0011	HUMAN OTC DRUG	AGNUS CASTUS		AGNUS CASTUS	PELLET	ORAL	20150903		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CHASTE TREE	1	[hp_X]/1			N	20241231
15631-0015_ccf9daf4-0bdf-2610-e053-2a95a90a3f07	15631-0015	HUMAN OTC DRUG	ALLIUM CEPA		ALLIUM CEPA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ONION	1	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
15631-0018_cd273c77-4bc2-0dda-e053-2995a90ab1a8	15631-0018	HUMAN OTC DRUG	ALOE SOCOTRINA		ALOE SOCOTRINA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ALOE	1	[hp_X]/1			N	20241231
15631-0022_cce82172-a3b2-9aae-e053-2995a90a8771	15631-0022	HUMAN OTC DRUG	ALUMINA		ALUMINA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ALUMINUM OXIDE	3	[hp_X]/1			N	20241231
15631-0027_cdd97dbb-69ae-f153-e053-2995a90a3917	15631-0027	HUMAN OTC DRUG	AMMONIUM CARBONICUM		AMMONIUM CARBONICUM	PELLET	ORAL	20150906		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	AMMONIUM CARBONATE	3	[hp_X]/1			N	20241231
15631-0033_cd26fc86-569c-a64c-e053-2a95a90a4d98	15631-0033	HUMAN OTC DRUG	ANACARDIUM ORIENTALE		ANACARDIUM ORIENTALE	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SEMECARPUS ANACARDIUM JUICE	3	[hp_X]/1			N	20241231
15631-0036_ccf98196-0fe2-dcdf-e053-2995a90aab03	15631-0036	HUMAN OTC DRUG	ANTIMONIUM CRUDUM		ANTIMONIUM CRUDUM	PELLET	ORAL	20150906		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ANTIMONY TRISULFIDE	3	[hp_X]/1			N	20241231
15631-0038_ccf41de8-f7c8-20a7-e053-2995a90ac195	15631-0038	HUMAN OTC DRUG	ANTIMONIUM TARTARICUM		ANTIMONIUM TARTARICUM	PELLET	ORAL	20150906		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ANTIMONY POTASSIUM TARTRATE	3	[hp_X]/1			N	20241231
15631-0039_ca98a3ba-5c57-1bdd-e053-2995a90ac75c	15631-0039	HUMAN OTC DRUG	APIS MELLIFICA		APIS MELLIFICA	PELLET	ORAL	20150906		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	APIS MELLIFERA	1	[hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
15631-0045_caa0cdd5-e940-7ece-e053-2995a90a030b	15631-0045	HUMAN OTC DRUG	ARGENTUM NITRICUM		ARGENTUM NITRICUM	PELLET	ORAL	20150907		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SILVER NITRATE	6	[hp_X]/1			N	20241231
15631-0049_ca3a76f4-9778-f398-e053-2995a90a240e	15631-0049	HUMAN OTC DRUG	ARNICA MONTANA		ARNICA MONTANA	PELLET	ORAL	20150907		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ARNICA MONTANA	3	[hp_X]/1			N	20241231
15631-0050_ca3b88a2-0bb7-668d-e053-2995a90a2577	15631-0050	HUMAN OTC DRUG	ARSENICUM ALBUM		ARSENICUM ALBUM	PELLET	ORAL	20150907		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ARSENIC TRIOXIDE	6	[hp_X]/1			N	20241231
15631-0065_ca9b014e-f36e-505f-e053-2a95a90a1cdb	15631-0065	HUMAN OTC DRUG	AURUM METALLICUM		AURUM METALLICUM	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	GOLD	3	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
15631-0069_cf05b059-b374-6204-e053-2a95a90a273d	15631-0069	HUMAN OTC DRUG	AVENA SATIVA		AVENA SATIVA	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	AVENA SATIVA FLOWERING TOP	1	[hp_X]/1			N	20241231
15631-0073_caa0e143-1041-a109-e053-2995a90a9310	15631-0073	HUMAN OTC DRUG	BARYTA CARBONICA		BARYTA CARBONICA	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	BARIUM CARBONATE	6	[hp_X]/1			N	20241231
15631-0076_ca3b507f-45ab-f61f-e053-2995a90abb4b	15631-0076	HUMAN OTC DRUG	BELLADONNA		BELLADONNA	PELLET	ORAL	20150903		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ATROPA BELLADONNA	3	[hp_X]/1			N	20241231
15631-0077_ccf8ef09-bce5-730e-e053-2995a90a74e3	15631-0077	HUMAN OTC DRUG	BELLIS PERENNIS		BELLIS PERENNIS	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	BELLIS PERENNIS	1	[hp_X]/1			N	20241231
15631-0080_ccf94739-bd26-31a5-e053-2a95a90a393b	15631-0080	HUMAN OTC DRUG	BERBERIS VULGARIS		BERBERIS VULGARIS	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	BERBERIS VULGARIS ROOT BARK	1	[hp_X]/1			N	20241231
15631-0084_cd134645-8fef-c941-e053-2a95a90af7fe	15631-0084	HUMAN OTC DRUG	BORAX		BORAX	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SODIUM BORATE	1	[hp_X]/1			N	20241231
15631-0087_ca787fd0-fdec-8961-e053-2a95a90a9d88	15631-0087	HUMAN OTC DRUG	BRYONIA ALBA		BRYONIA ALBA	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	BRYONIA ALBA ROOT	3	[hp_X]/1			N	20241231
15631-0088_ce1627e3-1cef-1100-e053-2995a90a7a91	15631-0088	HUMAN OTC DRUG	CACTUS GRANDIFLORUS		CACTUS GRANDIFLORUS	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SELENICEREUS GRANDIFLORUS STEM	3	[hp_X]/1			N	20241231
15631-0090_cd76264c-fa5c-877e-e053-2a95a90ab3da	15631-0090	HUMAN OTC DRUG	CALADIUM SEGUINUM		CALADIUM SEGUINUM	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	DIEFFENBACHIA SEGUINE	3	[hp_X]/1			N	20241231
15631-0093_ca3c7505-8a61-26ed-e053-2995a90a508c	15631-0093	HUMAN OTC DRUG	CALCAREA CARBONICA		CALCAREA CARBONICA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	OYSTER SHELL CALCIUM CARBONATE, CRUDE	1	[hp_X]/1			N	20241231
15631-0095_ccf9568a-7946-14ee-e053-2995a90a21d3	15631-0095	HUMAN OTC DRUG	CALCAREA FLUORICA		CALCAREA FLUORICA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CALCIUM FLUORIDE	3	[hp_X]/1			N	20241231
15631-0099_cd4e900a-48ec-d923-e053-2a95a90ae893	15631-0099	HUMAN OTC DRUG	CALCAREA PHOSPHORICA		CALCAREA PHOSPHORICA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	TRIBASIC CALCIUM PHOSPHATE	1	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
15631-0100_ce16ada7-6d6a-c045-e053-2995a90a0809	15631-0100	HUMAN OTC DRUG	CALCAREA SULPHURICA		CALCAREA SULPHURICA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CALCIUM SULFATE ANHYDROUS	1	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
15631-0101_cd1303d5-e3db-c53c-e053-2995a90a5c50	15631-0101	HUMAN OTC DRUG	CALENDULA OFFICINALIS		CALENDULA OFFICINALIS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/1			N	20241231
15631-0105_caa1398e-ab39-4ae6-e053-2995a90a0c18	15631-0105	HUMAN OTC DRUG	CANTHARIS		CANTHARIS	PELLET	ORAL	20151006		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	LYTTA VESICATORIA	3	[hp_X]/1			N	20241231
15631-0108_ca98532a-d5fb-b7e2-e053-2995a90ac243	15631-0108	HUMAN OTC DRUG	CARBO VEGETABILIS		CARBO VEGETABILIS	PELLET	ORAL	20151006		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ACTIVATED CHARCOAL	1	[hp_X]/1			N	20241231
15631-0118_ca5143a4-77c7-d745-e053-2995a90a06bb	15631-0118	HUMAN OTC DRUG	CAUSTICUM		CAUSTICUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CAUSTICUM	2	[hp_X]/1			N	20241231
15631-0123_ca98d94d-efe0-1824-e053-2a95a90ad693	15631-0123	HUMAN OTC DRUG	CHAMOMILLA		CHAMOMILLA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	MATRICARIA RECUTITA	1	[hp_X]/1			N	20241231
15631-0124_cdd9c6d1-cff8-8257-e053-2a95a90ab1d1	15631-0124	HUMAN OTC DRUG	CHELIDONIUM MAJUS		CHELIDONIUM MAJUS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CHELIDONIUM MAJUS	1	[hp_X]/1			N	20241231
15631-0136_cde5f736-a5a7-527c-e053-2995a90adbca	15631-0136	HUMAN OTC DRUG	CIMICIFUGA RACEMOSA		CIMICIFUGA RACEMOSA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	BLACK COHOSH	1	[hp_X]/1			N	20241231
15631-0137_cdb383c8-8ecc-07e1-e053-2995a90adabb	15631-0137	HUMAN OTC DRUG	CINA		CINA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ARTEMISIA CINA PRE-FLOWERING TOP	1	[hp_X]/1			N	20241231
15631-0138_cd73e159-aa9e-2aa5-e053-2995a90a6610	15631-0138	HUMAN OTC DRUG	CINCHONA OFFICINALIS		CINCHONA OFFICINALIS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CINCHONA OFFICINALIS BARK	2	[hp_X]/1			N	20241231
15631-0143_cdd96e36-7d9f-b927-e053-2a95a90ac88c	15631-0143	HUMAN OTC DRUG	CLEMATIS ERECTA		CLEMATIS ERECTA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CLEMATIS RECTA FLOWERING TOP	3	[hp_X]/1			N	20241231
15631-0145_ccf3f6ff-1fe8-2555-e053-2995a90af36b	15631-0145	HUMAN OTC DRUG	COCCULUS INDICUS		COCCULUS INDICUS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ANAMIRTA COCCULUS SEED	3	[hp_X]/1			N	20241231
15631-0147_ccd1ae11-5b28-73b1-e053-2995a90a6a55	15631-0147	HUMAN OTC DRUG	COFFEA CRUDA		COFFEA CRUDA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ARABICA COFFEE BEAN	1	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
15631-0150_cd12e725-aa10-716d-e053-2995a90a649c	15631-0150	HUMAN OTC DRUG	COLCHICUM AUTUMNALE		COLCHICUM AUTUMNALE	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	COLCHICUM AUTUMNALE BULB	3	[hp_X]/1			N	20241231
15631-0152_caa12a2c-4b6a-21b5-e053-2a95a90acf86	15631-0152	HUMAN OTC DRUG	COLOCYNTHIS		COLOCYNTHIS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CITRULLUS COLOCYNTHIS FRUIT PULP	3	[hp_X]/1			N	20241231
15631-0154_ca7b4f22-746c-d16f-e053-2a95a90a95cc	15631-0154	HUMAN OTC DRUG	CONIUM MACULATUM		CONIUM MACULATUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CONIUM MACULATUM FLOWERING TOP	3	[hp_X]/1			N	20241231
15631-0159_cde80b18-2817-5135-e053-2995a90a6734	15631-0159	HUMAN OTC DRUG	CROTALUS HORRIDUS		CROTALUS HORRIDUS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CROTALUS HORRIDUS HORRIDUS VENOM	8	[hp_X]/1			N	20241231
15631-0163_ccd21752-185f-122b-e053-2a95a90a786d	15631-0163	HUMAN OTC DRUG	CUPRUM METALLICUM		CUPRUM METALLICUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	COPPER	3	[hp_X]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
15631-0167_cf04f31f-424a-6c45-e053-2a95a90aa38b	15631-0167	HUMAN OTC DRUG	DIGITALIS PURPUREA		DIGITALIS PURPUREA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	DIGITALIS	6	[hp_X]/1			N	20241231
15631-0171_cdd9e17c-669e-786e-e053-2995a90acc93	15631-0171	HUMAN OTC DRUG	DROSERA ROTUNDIFOLIA		DROSERA ROTUNDIFOLIA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	DROSERA ROTUNDIFOLIA	1	[hp_X]/1			N	20241231
15631-0172_cf0552df-d2ac-b862-e053-2995a90a9308	15631-0172	HUMAN OTC DRUG	DULCAMARA		DULCAMARA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SOLANUM DULCAMARA TOP	2	[hp_X]/1			N	20241231
15631-0182_cd743e02-ca96-8080-e053-2995a90ac210	15631-0182	HUMAN OTC DRUG	EUPATORIUM PERFOLIATUM		EUPATORIUM PERFOLIATUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	EUPATORIUM PERFOLIATUM FLOWERING TOP	1	[hp_X]/1			N	20241231
15631-0184_cdda036a-8e4c-1a19-e053-2995a90a834a	15631-0184	HUMAN OTC DRUG	EUPHRASIA OFFICINALIS		EUPHRASIA OFFICINALIS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	EUPHRASIA STRICTA	1	[hp_X]/1			N	20241231
15631-0190_cddc54c3-482e-17c1-e053-2995a90aeae8	15631-0190	HUMAN OTC DRUG	FERRUM METALLICUM		FERRUM METALLICUM	PELLET	ORAL	20151025		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	IRON	1	[hp_X]/1			N	20241231
15631-0192_cd7667cb-d9e1-20c7-e053-2995a90aa678	15631-0192	HUMAN OTC DRUG	FERRUM PHOSPHORICUM		FERRUM PHOSPHORICUM	PELLET	ORAL	20151025		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	FERROSOFERRIC PHOSPHATE	1	[hp_X]/1			N	20241231
15631-0207_ce14d277-6ec8-08c0-e053-2995a90a53d9	15631-0207	HUMAN OTC DRUG	GLONOINUM		GLONOINUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	NITROGLYCERIN	6	[hp_X]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
15631-0208_cde5c4a7-8ef4-8fb2-e053-2995a90ae612	15631-0208	HUMAN OTC DRUG	GNAPHALIUM POLYCEPHALUM		GNAPHALIUM POLYCEPHALUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	PSEUDOGNAPHALIUM OBTUSIFOLIUM	1	[hp_X]/1			N	20241231
15631-0210_ca98220e-298e-9932-e053-2a95a90a23ad	15631-0210	HUMAN OTC DRUG	GRAPHITES		GRAPHITES	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	GRAPHITE	1	[hp_X]/1			N	20241231
15631-0216_cd73a839-8978-7105-e053-2a95a90a1445	15631-0216	HUMAN OTC DRUG	HAMAMELIS VIRGINIANA		HAMAMELIS VIRGINIANA	PELLET	ORAL	20151031		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	1	[hp_X]/1			N	20241231
15631-0224_ca516bbc-c4cb-3006-e053-2a95a90a82ba	15631-0224	HUMAN OTC DRUG	HEPAR SULPHURIS CALCAREUM		HEPAR SULPHURIS CALCAREUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	CALCIUM SULFIDE	1	[hp_X]/1			N	20241231
15631-0226_cce596b5-69f8-f886-e053-2995a90af79a	15631-0226	HUMAN OTC DRUG	HYDRASTIS CANADENSIS		HYDRASTIS CANADENSIS	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	GOLDENSEAL	1	[hp_X]/1			N	20241231
15631-0228_ccd270d7-a945-4cf3-e053-2995a90a0f85	15631-0228	HUMAN OTC DRUG	HYOSCYAMUS NIGER		HYOSCYAMUS NIGER	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	HYOSCYAMUS NIGER	3	[hp_X]/1			N	20241231
15631-0229_ca3d01ed-3c2f-0a64-e053-2995a90a38d7	15631-0229	HUMAN OTC DRUG	HYPERICUM PERFORATUM		HYPERICUM PERFORATUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	HYPERICUM PERFORATUM	3	[hp_X]/1			N	20241231
15631-0232_ca788280-e0da-67f5-e053-2995a90ab6c0	15631-0232	HUMAN OTC DRUG	IGNATIA AMARA		IGNATIA AMARA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	STRYCHNOS IGNATII SEED	3	[hp_X]/1			N	20241231
15631-0235_cdb2cfb4-b400-68e8-e053-2995a90a8cf4	15631-0235	HUMAN OTC DRUG	INFLUENZINUM		INFLUENZINUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	INFLUENZA A VIRUS	8	[hp_X]/1			N	20241231
15631-0236_cf0479ce-fa13-5179-e053-2995a90a73ff	15631-0236	HUMAN OTC DRUG	IODIUM		IODIUM	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	IODINE	3	[hp_X]/1			N	20241231
15631-0237_cce5bc16-7c70-1ca4-e053-2995a90a1d07	15631-0237	HUMAN OTC DRUG	IPECACUANHA		IPECACUANHA	PELLET	ORAL	20150902		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	IPECAC	3	[hp_X]/1			N	20241231
15631-0240_ce16738e-4fbd-5a4b-e053-2995a90a4a84	15631-0240	HUMAN OTC DRUG	IRIS VERSICOLOR		IIRIS VERSICOLOR	PELLET	ORAL	20150902		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	IRIS VERSICOLOR ROOT	1	[hp_X]/1			N	20241231
15631-0247_ca9844e0-1f08-0d2b-e053-2995a90aeb43	15631-0247	HUMAN OTC DRUG	KALI BICHROMICUM		KALI BICHROMICUM	PELLET	ORAL	20150903		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	POTASSIUM DICHROMATE	3	[hp_X]/1			N	20241231
15631-0248_cd4f7ba3-554a-4e79-e053-2995a90adc42	15631-0248	HUMAN OTC DRUG	KALI BROMATUM		KALI BROMATUM	PELLET	ORAL	20150903		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	POTASSIUM BROMIDE	1	[hp_X]/1			N	20241231
15631-0249_ccf56902-450a-005a-e053-2995a90a8b5b	15631-0249	HUMAN OTC DRUG	KALI CARBONICUM		KALI CARBONICUM	PELLET	ORAL	20150905		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	POTASSIUM CARBONATE	2	[hp_X]/1			N	20241231
15631-0251_cd270a3e-df7d-b720-e053-2995a90a4c62	15631-0251	HUMAN OTC DRUG	KALI MURIATICUM		KALI MURIATICUM	PELLET	ORAL	20150905		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	POTASSIUM CHLORIDE	1	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
15631-0253_ccf4b8a3-7222-4237-e053-2a95a90a00b1	15631-0253	HUMAN OTC DRUG	KALI PHOSPHORICUM		KALI PHOSPHORICUM	PELLET	ORAL	20150905		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	POTASSIUM PHOSPHATE, DIBASIC	1	[hp_X]/1			N	20241231
15631-0255_ce16ed47-6b24-5ea8-e053-2995a90ad1b2	15631-0255	HUMAN OTC DRUG	KALMIA LATIFOLIA		KALMIA LATIFOLIA	PELLET	ORAL	20150905		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	KALMIA LATIFOLIA LEAF	3	[hp_X]/1			N	20241231
15631-0256_cd9e31c8-c233-6b83-e053-2a95a90a982c	15631-0256	HUMAN OTC DRUG	KREOSOTUM		KREOSOTUM	PELLET	ORAL	20150905		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	WOOD CREOSOTE	3	[hp_X]/1			N	20241231
15631-0261_ca9b3173-6db5-6de5-e053-2a95a90a9a82	15631-0261	HUMAN OTC DRUG	LACHESIS MUTUS		LACHESIS MUTUS	PELLET	ORAL	20150905		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	LACHESIS MUTA VENOM	8	[hp_X]/1			N	20241231
15631-0272_caa10608-92ac-34d9-e053-2a95a90af66a	15631-0272	HUMAN OTC DRUG	LEDUM PALUSTRE		LEDUM PALUSTRE	PELLET	ORAL	20150907		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	LEDUM PALUSTRE TWIG	1	[hp_X]/1			N	20241231
15631-0275_cf052224-e68b-9ccc-e053-2a95a90acf92	15631-0275	HUMAN OTC DRUG	LILIUM TIGRINUM		LILIUM TIGRINUM	PELLET	ORAL	20150907		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	LILIUM LANCIFOLIUM WHOLE FLOWERING	1	[hp_X]/1			N	20241231
15631-0278_ca3aa7a8-9d23-3d66-e053-2a95a90a05be	15631-0278	HUMAN OTC DRUG	LYCOPODIUM CLAVATUM		LYCOPODIUM CLAVATUM	PELLET	ORAL	20150907		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	LYCOPODIUM CLAVATUM SPORE	1	[hp_X]/1			N	20241231
15631-0282_cd4ee008-29fa-f655-e053-2a95a90ad245	15631-0282	HUMAN OTC DRUG	MAGNESIA PHOSPHORICA		MAGNESIA PHOSPHORICA	PELLET	ORAL	20150909		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	1	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
15631-0295_ca97e957-6552-230b-e053-2a95a90a4407	15631-0295	HUMAN OTC DRUG	MERCURIUS SOLUBILIS		MERCURIUS SOLUBILIS	PELLET	ORAL	20150910		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	MERCURIUS SOLUBILIS	6	[hp_X]/1			N	20241231
15631-0309_ca51bc44-0045-ff83-e053-2a95a90adb8c	15631-0309	HUMAN OTC DRUG	NATRUM MURIATICUM		NATRUM MURIATICUM	PELLET	ORAL	20150910		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SODIUM CHLORIDE	1	[hp_X]/1			N	20241231
15631-0312_cdb3000d-50e7-d6ac-e053-2995a90a7312	15631-0312	HUMAN OTC DRUG	NATRUM SULPHURICUM		NATRUM SULPHURICUM	PELLET	ORAL	20150911		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SODIUM SULFATE	1	[hp_X]/1			N	20241231
15631-0315_cd4f3603-bad8-2e88-e053-2a95a90a6004	15631-0315	HUMAN OTC DRUG	NITRICUM ACIDUM		NITRICUM ACIDUM	PELLET	ORAL	20150910		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	NITRIC ACID	6	[hp_X]/1			N	20241231
15631-0317_ca3b21cc-74c3-7a65-e053-2a95a90ae7c0	15631-0317	HUMAN OTC DRUG	NUX VOMICA		NUX VOMICA	PELLET	ORAL	20150910		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	STRYCHNOS NUX-VOMICA SEED	3	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
15631-0331_cf04ac6b-3b6e-fc24-e053-2995a90a56d1	15631-0331	HUMAN OTC DRUG	PASSIFLORA INCARNATA		PASSIFLORA INCARNATA	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	PASSIFLORA INCARNATA FLOWERING TOP	1	[hp_X]/1			N	20241231
15631-0332_cd74761a-a875-0d94-e053-2995a90a3a56	15631-0332	HUMAN OTC DRUG	PETROLEUM		PETROLEUM	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	KEROSENE	1	[hp_X]/1			N	20241231
15631-0335_ccf4a128-6889-454b-e053-2a95a90a1445	15631-0335	HUMAN OTC DRUG	PHOSPHORICUM ACIDUM		PHOSPHORICUM ACIDUM	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	PHOSPHORIC ACID	3	[hp_X]/1			N	20241231
15631-0336_ca7b6768-4d86-1c6d-e053-2995a90a2319	15631-0336	HUMAN OTC DRUG	PHOSPHORUS		PHOSPHORUS	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	PHOSPHORUS	4	[hp_X]/1			N	20241231
15631-0339_cd76d9ca-d583-0394-e053-2a95a90aa4fe	15631-0339	HUMAN OTC DRUG	PHYTOLACCA DECANDRA		PHYTOLACCA DECANDRA	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	PHYTOLACCA AMERICANA ROOT	2	[hp_X]/1			N	20241231
15631-0353_cd13512b-ebdb-a3ed-e053-2a95a90a9d27	15631-0353	HUMAN OTC DRUG	PLUMBUM METALLICUM		PLUMBUM METALLICUM	PELLET	ORAL	20150912		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	LEAD	6	[hp_X]/1			N	20241231
15631-0357_ca3d8643-bdbe-56d7-e053-2a95a90a6e8b	15631-0357	HUMAN OTC DRUG	PULSATILLA		PULSATILLA	PELLET	ORAL	20150914		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	PULSATILLA VULGARIS	1	[hp_X]/1			N	20241231
15631-0367_cce80de1-4134-b378-e053-2995a90ae3e0	15631-0367	HUMAN OTC DRUG	RAUWOLFIA SERPENTINA		RAUWOLFIA SERPENTINA	PELLET	ORAL	20151105		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	RAUWOLFIA SERPENTINA	6	[hp_X]/1			N	20241231
15631-0374_c9af460f-de1f-53db-e053-2995a90ab6eb	15631-0374	HUMAN OTC DRUG	RHUS TOXICODENDRON		RHUS TOXICODENDRON	PELLET	ORAL	20151030		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	TOXICODENDRON PUBESCENS LEAF	3	[hp_X]/1			N	20241231
15631-0379_ccd1fee9-f42e-ef76-e053-2a95a90a8ee5	15631-0379	HUMAN OTC DRUG	RUTA GRAVEOLENS		RUTA GRAVEOLENS	PELLET	ORAL	20151031		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	RUTA GRAVEOLENS FLOWERING TOP	1	[hp_X]/1			N	20241231
15631-0381_cd2679a5-ffc3-1611-e053-2a95a90acedd	15631-0381	HUMAN OTC DRUG	SABAL SERRULATA		SABAL SERRULATA	PELLET	ORAL	20151031		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SAW PALMETTO	1	[hp_X]/1			N	20241231
15631-0389_cce85602-10d1-1719-e053-2995a90adb31	15631-0389	HUMAN OTC DRUG	SANGUINARIA CANADENSIS		SANGUINARIA CANADENSIS	PELLET	ORAL	20151031		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SANGUINARIA CANADENSIS ROOT	1	[hp_X]/1			N	20241231
15631-0402_ca7b9dae-9855-5f31-e053-2995a90ab088	15631-0402	HUMAN OTC DRUG	SEPIA		SEPIA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SEPIA OFFICINALIS JUICE	1	[hp_X]/1			N	20241231
15631-0404_ca7bbcc8-2354-375c-e053-2995a90a72a0	15631-0404	HUMAN OTC DRUG	SILICEA		SILICEA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SILICON DIOXIDE	2	[hp_X]/1			N	20241231
15631-0410_cddc7c3c-74e8-1f19-e053-2a95a90a0306	15631-0410	HUMAN OTC DRUG	SPONGIA TOSTA		SPONGIA TOSTA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SPONGIA OFFICINALIS SKELETON, ROASTED	1	[hp_X]/1			N	20241231
15631-0413_ca9b0d4e-45f1-4317-e053-2995a90add70	15631-0413	HUMAN OTC DRUG	STAPHYSAGRIA		STAPHYSAGRIA	PELLET	ORAL	20151002		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	DELPHINIUM STAPHISAGRIA SEED	3	[hp_X]/1			N	20241231
15631-0417_ccd2ab56-24f8-2cc4-e053-2a95a90af528	15631-0417	HUMAN OTC DRUG	STRAMONIUM		STRAMONIUM	PELLET	ORAL	20151103		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	DATURA STRAMONIUM	6	[hp_X]/1			N	20241231
15631-0420_ca3d3f46-aec7-3b74-e053-2a95a90a2f07	15631-0420	HUMAN OTC DRUG	SULPHUR		SULPHUR	PELLET	ORAL	20151103		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	SULFUR	1	[hp_X]/1			N	20241231
15631-0425_cd12ba04-9ef8-5b56-e053-2995a90a9786	15631-0425	HUMAN OTC DRUG	SYZYGIUM JAMBOLANUM		SYZYGIUM JAMBOLANUM	PELLET	ORAL	20151103		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	JUNIPERUS SABINA LEAFY TWIG	3	[hp_X]/1			N	20241231
15631-0435_cd26b719-a620-4173-e053-2995a90a7fb3	15631-0435	HUMAN OTC DRUG	TEUCRIUM MARUM		TEUCRIUM MARUM	PELLET	ORAL	20151102		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	TEUCRIUM MARUM	1	[hp_X]/1			N	20241231
15631-0442_ca7afc38-2550-ec94-e053-2995a90ab5a4	15631-0442	HUMAN OTC DRUG	THUJA OCCIDENTALIS		THUJA OCCIDENTALIS	PELLET	ORAL	20151031		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	THUJA OCCIDENTALIS LEAFY TWIG	1	[hp_X]/1			N	20241231
15631-0450_cd4f1118-6964-30ee-e053-2a95a90a5c1e	15631-0450	HUMAN OTC DRUG	URTICA URENS		URTICA URENS	PELLET	ORAL	20151102		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	URTICA URENS	1	[hp_X]/1			N	20241231
15631-0469_cd740d55-5cc8-c335-e053-2a95a90a4735	15631-0469	HUMAN OTC DRUG	ZINCUM METALLICUM		ZINCUM METALLICUM	PELLET	ORAL	20151101		UNAPPROVED HOMEOPATHIC		Rxhomeo Private Limited d.b.a. Rxhomeo, Inc	ZINC	3	[hp_X]/1			N	20241231
15687-001_07110cac-0ea5-4e2f-e063-6394a90ae84d	15687-001	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20050905		NDA	NDA205766	Big Branch Breeders Service	NITROGEN	990	mL/L			N	20241231
15751-1321_0b632dea-ab89-f9bc-e063-6294a90a43cd	15751-1321	HUMAN OTC DRUG	Rosehip and Lemongrass Lip SPF 15		ZINC OXIDE	STICK	TOPICAL	20160427		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	ZINC OXIDE	35	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
15751-2222_0b5755ea-93b0-df2b-e063-6294a90a6f4a	15751-2222	HUMAN OTC DRUG	Tropical Vanilla Body Sunscreen Broad Spectrum SPF 32		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20120323		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	OCTINOXATE; ZINC OXIDE	60; 50	mg/mL; mg/mL			N	20241231
15751-2223_0b5761da-3d7c-d0a8-e063-6394a90abd2b	15751-2223	HUMAN OTC DRUG	Tropical Vanilla Sunscreen Broad Spectrum SPF 32		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20120307		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	OCTINOXATE; ZINC OXIDE	60; 50	mg/mL; mg/mL			N	20241231
15751-2235_0bde7fd6-c1c3-eae8-e063-6294a90a9d0f	15751-2235	HUMAN OTC DRUG	Caramel Latte Tinted Moisturizer Broad Spectrum SPF 25 Sunscreen Light To Medium		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20120317		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	OCTINOXATE; ZINC OXIDE	60; 60	mg/mL; mg/mL			N	20241231
15751-2259_0b5757da-9ffc-ec06-e063-6294a90adf64	15751-2259	HUMAN OTC DRUG	Vanilla Latte Tinted Moisturizer Broad Spectrum SPF 25 Sunscreen Light		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20120318		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	OCTINOXATE; ZINC OXIDE	60; 60	mg/mL; mg/mL			N	20241231
15751-2272_0b575bde-3f56-ec04-e063-6294a90aa692	15751-2272	HUMAN OTC DRUG	EMINENCE Bright Skin Moisturizer BROAD SPECTRUM SPF 30 SUNSCREEN		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20120726		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	OCTINOXATE; ZINC OXIDE	6; 4.5	g/100g; g/100g			N	20241231
15751-2286_0b5753e5-f78d-e69d-e063-6294a90a0662	15751-2286	HUMAN OTC DRUG	EMINENCE Red Currant Protective Moisturizer		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20130822		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	OCTINOXATE; ZINC OXIDE	60; 45	mg/mL; mg/mL			N	20241231
15751-2323_0b57738a-7694-ed2d-e063-6294a90a2613	15751-2323	HUMAN OTC DRUG	Lilikoi Light Defense Face Primer SPF 23		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20190301		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	45; 70	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
15751-3000_0b8238aa-5560-5d63-e063-6294a90a9a23	15751-3000	HUMAN OTC DRUG	Acne Advanced Treatment System		SALICYLIC ACID	KIT		20180901		OTC MONOGRAPH DRUG	M006	Eminence Organic Skin Care Ltd.						N	20241231
15751-3010_7aa59c18-e180-718e-e053-2a91aa0add9c	15751-3010	HUMAN OTC DRUG	Acne Advanced Cleansing		SALICYLIC ACID	LIQUID	TOPICAL	20180901		OTC MONOGRAPH FINAL	part333D	Eminence Organic Skin Care Ltd.	SALICYLIC ACID	10	mg/mL			N	20241231
15751-3020_0c5b3774-cdd0-a3f0-e063-6294a90ae079	15751-3020	HUMAN OTC DRUG	Acne Advanced Clarifying Masque		SALICYLIC ACID	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M006	Eminence Organic Skin Care Ltd.	SALICYLIC ACID	5	mg/mL			N	20241231
15751-3030_0c0aef9b-7255-0f3d-e063-6394a90aa271	15751-3030	HUMAN OTC DRUG	Acne Advanced Clarifying Hydrator		SALICYLIC ACID	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M006	Eminence Organic Skin Care Ltd.	SALICYLIC ACID	10	mg/mL			N	20241231
15751-3040_0b823450-fe49-fa67-e063-6394a90ace9b	15751-3040	HUMAN OTC DRUG	Lilikoi Mineral Defense Sport Sunscreen SPF 30		ZINC OXIDE	CREAM	TOPICAL	20190301		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care Ltd.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
15751-3050_0b57535a-0552-d8ae-e063-6294a90ada25	15751-3050	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200422		OTC MONOGRAPH DRUG	505G(a)(3)	Eminence Organic Skin Care Ltd.	ALCOHOL	.65	mL/mL			N	20241231
15751-3333_0b586450-2c23-70e7-e063-6394a90a5f33	15751-3333	HUMAN OTC DRUG	Lilikoi Mineral Defense Moisturizer SPF 33		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190301		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	78; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
15751-3500_0b822f79-c7d4-f7db-e063-6394a90a8130	15751-3500	HUMAN OTC DRUG	Eminence Tropical Vanilla Day Cream SPF 40 Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	ZINC OXIDE	200	mg/mL			N	20241231
15751-3501_0b8236b2-54a8-5e12-e063-6294a90a67ce	15751-3501	HUMAN OTC DRUG	Eminence Lilikoi Daily Defense Moisturizer SPF 40 Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	ZINC OXIDE	200	mg/mL			N	20241231
15751-3502_0b574360-38f4-df03-e063-6294a90a4d3b	15751-3502	HUMAN OTC DRUG	Eminence Red Currant Protective Moisturizer SPF 40 Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	ZINC OXIDE	200	mg/mL			N	20241231
15751-3503_0b823217-a1fd-f9d0-e063-6394a90a07ce	15751-3503	HUMAN OTC DRUG	Eminence Bright Skin Moisturizer SPF 40 Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care	ZINC OXIDE	200	mg/mL			N	20241231
15751-3504_0b576a93-1f44-f78c-e063-6294a90a8605	15751-3504	HUMAN OTC DRUG	Eminence Bright Skin Starter Set Kit		ZINC OXIDE	KIT		20210101		OTC MONOGRAPH DRUG	M020	Eminence Organic Skin Care						N	20241231
15751-3506_002a4766-0c7f-4ec7-e063-6294a90a78d8	15751-3506	HUMAN OTC DRUG	Eminence Radiant Protection SPF Fluid		ZINC OXIDE	LIQUID	TOPICAL	20230901		OTC MONOGRAPH NOT FINAL	part352	Eminence Organic Skin Care	ZINC OXIDE	150	mg/mL			N	20241231
15828-005_08bf6b23-2a97-3732-e063-6294a90a2305	15828-005	HUMAN OTC DRUG	Shine Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200522		OTC MONOGRAPH DRUG	505G(a)(3)	Zermat Internacional S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
15828-195_08bf865a-1d4d-4816-e063-6294a90a8e0f	15828-195	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200413		OTC MONOGRAPH DRUG	505G(a)(3)	Zermat Internacional S.A. de C.V.	ALCOHOL	.8	mL/mL			N	20241231
15828-196_08bfa6cc-1dc6-6d62-e063-6394a90a671e	15828-196	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200424		OTC MONOGRAPH DRUG	505G(a)(3)	Zermat Internacional S.A. de C.V.	ALCOHOL	.8	mL/mL			N	20241231
15828-197_08bf70ec-89ba-36e5-e063-6294a90a6772	15828-197	HUMAN OTC DRUG	SANIZER KIDS Multi-Purpose Sanitizer		ALCOHOL	SPRAY	TOPICAL	20201113		OTC MONOGRAPH DRUG	505G(a)(3)	Zermat Internacional S.A. de C.V.	ALCOHOL	.8	mL/mL			N	20241231
15828-198_08bfbb03-56a5-648c-e063-6394a90ad1ab	15828-198	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Zermat Internacional S.A. de C.V.	ALCOHOL	.8	mL/mL			N	20241231
15828-199_08bf865a-1d3c-4816-e063-6294a90a8e0f	15828-199	HUMAN OTC DRUG	SaniZER Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200710		OTC MONOGRAPH DRUG	505G(a)(3)	Zermat Internacional S.A. de C.V.	ALCOHOL	.8	mL/mL			N	20241231
15828-200_08bf969e-bfd5-2990-e063-6394a90ae08d	15828-200	HUMAN OTC DRUG	Zermat care hand sanitizer		ALCOHOL	GEL	TOPICAL	20200619		OTC MONOGRAPH DRUG	505G(a)(3)	Zermat Internacional S.A. de C.V.	ALCOHOL	.8	mL/mL			N	20241231
15828-206_0921110c-7e23-9b9b-e063-6394a90a65d0	15828-206	HUMAN OTC DRUG	Zermat Xtreme Roll-On Antiperspirant Deodorant		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20121018		OTC MONOGRAPH DRUG	M019	Zermat Internacional S.A. de C.V.	ALUMINUM CHLOROHYDRATE	8	g/100g			N	20241231
15828-207_09210d6f-6372-6145-e063-6394a90a0b70	15828-207	HUMAN OTC DRUG	Zermat Xtreme Roll-On Antiperspirant Deodorant		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20130320		OTC MONOGRAPH DRUG	M019	Zermat Internacional S.A. de C.V.	ALUMINUM CHLOROHYDRATE	10	g/100g			N	20241231
15828-735_08bfc21f-6a26-5e49-e063-6294a90a92a6	15828-735	HUMAN OTC DRUG	Zermat Skin Platinum Series Cellular Beauty Caviar and Collagen Day SPF 30		OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20160405		OTC MONOGRAPH DRUG	M020	Zermat Internacional S.A. de C.V.	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 30; 35	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
15828-737_08bfa6cc-1dd5-6d62-e063-6394a90a671e	15828-737	HUMAN OTC DRUG	Zermat Skin SPF 50 Broad Spectrum		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20160415		OTC MONOGRAPH DRUG	M020	Zermat Internacional S.A. de C.V.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	30; 100; 75; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
15828-870_091a068f-f9b3-b02b-e063-6294a90a95e6	15828-870	HUMAN OTC DRUG	zermat Antiperspirant Deodorant Roll-on for Men		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20131212		OTC MONOGRAPH DRUG	M019	Zermat Internacional S.A. de C.V.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
15828-871_09213a22-e185-9584-e063-6394a90a5981	15828-871	HUMAN OTC DRUG	zermat Antiperspirant Deodorant Roll-on for Women		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20131212		OTC MONOGRAPH DRUG	M019	Zermat Internacional S.A. de C.V.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
15828-880_09215eb2-3012-a3db-e063-6394a90ad247	15828-880	HUMAN OTC DRUG	zermat Kiwi ANTIPERSPIRANT DEODORANT ROLL-ON SENSITIVE SKIN		Aluminum chlorohydrate	LIQUID	TOPICAL	20131002		OTC MONOGRAPH DRUG	M019	Zermat Internacional	ALUMINUM CHLOROHYDRATE	10	g/100g			N	20241231
15828-881_092126df-e1fa-0afa-e063-6394a90a632e	15828-881	HUMAN OTC DRUG	Zermat Kiwi with Fragrance		Aluminum chlorohydrate	LIQUID	TOPICAL	20131002		OTC MONOGRAPH DRUG	M019	Zermat Internacional	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
15955-305_adf69aaa-e03b-419a-ac5b-e7b80cab3668	15955-305	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20121019		ANDA	ANDA203657	Alembic Labs LLC	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
15955-318_adf69aaa-e03b-419a-ac5b-e7b80cab3668	15955-318	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20121019		ANDA	ANDA203657	Alembic Labs LLC	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
15955-388_4bc960cb-872d-43da-81eb-0dbb058cfaad	15955-388	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20190626		ANDA	ANDA208681	Alembic Labs LLC	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
15955-389_4bc960cb-872d-43da-81eb-0dbb058cfaad	15955-389	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20190626		ANDA	ANDA208681	Alembic Labs LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
16030-101_039b83ec-e62a-e1f9-e063-6394a90ae83a	16030-101	HUMAN OTC DRUG	Hypromellose Eye Drops 0.7%		Hypromellose Eye Drops 0.7%	FOR SOLUTION	TOPICAL	20220901		OTC MONOGRAPH FINAL	part349	Aurolab	HYPROMELLOSE 2910 (4000 MPA.S)	7	mg/mL			N	20241231
16030-201_039b9ee7-e913-f323-e063-6294a90ab428	16030-201	HUMAN OTC DRUG	Polyvinyl Alcohol Eye Drops 1,4 % w/v		Polyvinyl Alcohol Eye Drops 1,4 % w/v	FOR SOLUTION	TOPICAL	20220920		OTC MONOGRAPH FINAL	part349	Aurolab	POLYVINYL ALCOHOL, UNSPECIFIED	5	mg/mL			N	20241231
16030-302_f27a4b27-491b-e5fd-e053-2995a90a0560	16030-302	HUMAN OTC DRUG	Aurovisc Lubricant HYPROMELLOSE 2208 (15000 MPA.S) Solution/Drops		Hypromellose Ophthalmic Solution 2% w/v	SOLUTION/ DROPS	OPHTHALMIC	20220926		OTC MONOGRAPH FINAL	part349	Aurolab	HYPROMELLOSE 2208 (15000 MPA.S)	20	mg/mL			N	20241231
16030-303_0349e633-32c5-62d3-e063-6294a90afdf3	16030-303	HUMAN OTC DRUG	Aurovisc Lubricant HYPROMELLOSE 2208 (15000 MPA.S) Gel/Drops		Hypromellose Ophthalmic Solution 2% w/v	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20220926		OTC MONOGRAPH FINAL	part349	Aurolab	HYPROMELLOSE 2208 (15000 MPA.S)	20	mg/mL			N	20241231
16030-401_039b9ee7-e912-f323-e063-6294a90ab428	16030-401	HUMAN OTC DRUG	AURO-CMC		Carboxymethylcellulose Eye Drops 0.5%	FOR SOLUTION	TOPICAL	20220920		OTC MONOGRAPH FINAL	part349	Aurolab	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	5	mg/mL			N	20241231
16030-501_039b9ee7-e910-f323-e063-6294a90ab428	16030-501	HUMAN OTC DRUG	Carboxymethylcellulose Sodium Eye Drops 0.5%		Carboxymethylcellulose Sodium Eye Drops 0.5%	FOR SOLUTION	TOPICAL	20220920		OTC MONOGRAPH FINAL	part349	Aurolab	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	5	mg/mL			N	20241231
16030-601_f3444446-1dae-79ff-e053-2a95a90af411	16030-601	HUMAN OTC DRUG	Aurodone Povidone Iodine 5 % Opthalmic Solution		Povidone Iodine 5 % Topical Solution	SOLUTION	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part333E	Aurolab	POVIDONE-IODINE	5	mg/mL			N	20241231
16103-348_597998c7-96d5-496b-8fcd-e9677dc15b34	16103-348	HUMAN OTC DRUG	Pharbedryl		Diphenhydramine HCl	CAPSULE	ORAL	20160201		OTC MONOGRAPH FINAL	part341	Pharbest Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
16103-353_f0009efc-d00c-4da1-a47b-0500372bb313	16103-353	HUMAN OTC DRUG	Pharbetol	Regular strength	Acetaminophen	TABLET	ORAL	20070109		OTC MONOGRAPH NOT FINAL	part343	Pharbest Pharmaceuticals, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
16103-356_5b9d6681-2ae6-47ef-9236-654dca7399fa	16103-356	HUMAN OTC DRUG	Adult Low Dose Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20070112		OTC MONOGRAPH FINAL	part343	Pharbest Pharmaceuticals, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
16103-366_1545bae4-9dda-4fdf-b2dd-13ac05edb47c	16103-366	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20070822		OTC MONOGRAPH FINAL	part343	Pharbest Pharmaceuticals, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
16103-387_887b312d-3c2c-4dcb-86eb-316dfb068bc9	16103-387	HUMAN OTC DRUG	MECLIZINE		Meclizine HCl 25mg	TABLET, CHEWABLE	ORAL	20180201		OTC MONOGRAPH FINAL	part336	Pharbest Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
16110-035_22b95283-4e1c-4c8a-bdf0-41dfae5cef27	16110-035	HUMAN PRESCRIPTION DRUG	Cordran		flurandrenolide	CREAM	TOPICAL	19651018		NDA	NDA012806	Almirall, LLC	FLURANDRENOLIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16110-042_01af69d3-0abc-47a3-b6ce-d577c5999544	16110-042	HUMAN PRESCRIPTION DRUG	Tazorac		tazarotene	GEL	CUTANEOUS	20200221		NDA	NDA020600	Almirall, LLC	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
16110-111_6655b612-f3b7-11eb-85b4-0800200c9a66	16110-111	HUMAN PRESCRIPTION DRUG	Verdeso		desonide	AEROSOL, FOAM	TOPICAL	20061006		NDA	NDA021978	Almirall, LLC	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16110-245_d2bf5f32-46e1-4c89-a271-45054f69ff7d	16110-245	HUMAN PRESCRIPTION DRUG	Seysara		sarecycline hydrochloride	TABLET, COATED	ORAL	20190104		NDA	NDA209521	Almirall, LLC	SARECYCLINE HYDROCHLORIDE	60	mg/1	P-Glycoprotein Inhibitors [MoA], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
16110-246_d2bf5f32-46e1-4c89-a271-45054f69ff7d	16110-246	HUMAN PRESCRIPTION DRUG	Seysara		sarecycline hydrochloride	TABLET, COATED	ORAL	20190104		NDA	NDA209521	Almirall, LLC	SARECYCLINE HYDROCHLORIDE	100	mg/1	P-Glycoprotein Inhibitors [MoA], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
16110-247_d2bf5f32-46e1-4c89-a271-45054f69ff7d	16110-247	HUMAN PRESCRIPTION DRUG	Seysara		sarecycline hydrochloride	TABLET, COATED	ORAL	20190104		NDA	NDA209521	Almirall, LLC	SARECYCLINE HYDROCHLORIDE	150	mg/1	P-Glycoprotein Inhibitors [MoA], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
16110-367_5f65bb67-03f1-4910-a17e-e85eb96025ba	16110-367	HUMAN PRESCRIPTION DRUG	Aczone		dapsone	GEL	TOPICAL	20210212		NDA	NDA021794	Almirall, LLC	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
16110-391_70dad989-cb85-41d4-8407-306d12bb49c2	16110-391	HUMAN PRESCRIPTION DRUG	Klisyri		tirbanibulin	OINTMENT	TOPICAL	20201214		NDA	NDA213189	Almirall, LLC	TIRBANIBULIN	10	mg/g	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
16110-518_428b4572-8671-4085-92b7-17d14d20f225	16110-518	HUMAN PRESCRIPTION DRUG	Altabax		retapamulin	OINTMENT	TOPICAL	20160501		NDA	NDA022055	Almirall, LLC	RETAPAMULIN	10	mg/g	Diterpenes [CS], Pleuromutilin Antibacterial [EPC]		N	20241231
16110-526_d5de2546-ff51-4370-bb6f-8995a47fe7b4	16110-526	HUMAN PRESCRIPTION DRUG	Aczone		dapsone	GEL	TOPICAL	20190910		NDA	NDA207154	Almirall, LLC	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
16110-587_51c2d862-4e37-41fb-956f-ef7e59f3a04b	16110-587	HUMAN PRESCRIPTION DRUG	CORDRAN		flurandrenolide	TAPE	TOPICAL	20180924		NDA	NDA016455	Almirall, LLC	FLURANDRENOLIDE	4	ug/cm2	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16110-601_2e463b1b-d30e-4ae6-95c3-853aba0221a4	16110-601	HUMAN PRESCRIPTION DRUG	Acticlate	CAP	doxycycline hyclate	CAPSULE	ORAL	20180531		NDA	NDA208253	Aqua Pharmaceuticals	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
16110-833_01af69d3-0abc-47a3-b6ce-d577c5999544	16110-833	HUMAN PRESCRIPTION DRUG	Tazorac		tazarotene	GEL	CUTANEOUS	20200221		NDA	NDA020600	Almirall, LLC	TAZAROTENE	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
16110-869_747ca787-4da2-43e0-b99e-ae7dc84fb0ae	16110-869	HUMAN PRESCRIPTION DRUG	AZELEX		azelaic acid	CREAM	CUTANEOUS	20180924		NDA	NDA020428	Almirall, LLC	AZELAIC ACID	.2	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20251231
16110-915_ec4c16f8-443f-43ce-b24a-5f121be65dc9	16110-915	HUMAN PRESCRIPTION DRUG	TAZORAC		tazarotene	CREAM	CUTANEOUS	20200203		NDA	NDA021184	Almirall, LLC	TAZAROTENE	.05	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
16110-916_ec4c16f8-443f-43ce-b24a-5f121be65dc9	16110-916	HUMAN PRESCRIPTION DRUG	TAZORAC		tazarotene	CREAM	CUTANEOUS	20200203		NDA	NDA021184	Almirall, LLC	TAZAROTENE	.1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
16129-001_e45c7416-bd3f-48d9-abba-6bba1fc3015d	16129-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F-18		Fludeoxyglucose F-18	INJECTION	INTRAVENOUS	20060329		ANDA	ANDA204264	Pharmalogic South Carolina, LLC	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
16175-0001_f3bb72b2-8b82-460d-a86e-a0717f49e33a	16175-0001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20080819		UNAPPROVED MEDICAL GAS		Calmar dba A&R Medical Supply	OXYGEN	99	L/100L			N	20241231
16252-514_ca204c4b-0e44-47d0-9fe0-6947a714315d	16252-514	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20061101		ANDA	ANDA076794	Actavis Pharma, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16252-515_ca204c4b-0e44-47d0-9fe0-6947a714315d	16252-515	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20061101		ANDA	ANDA076794	Actavis Pharma, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16252-516_ca204c4b-0e44-47d0-9fe0-6947a714315d	16252-516	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20061101		ANDA	ANDA076794	Actavis Pharma, Inc.	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16252-539_7d8fbb2a-23a9-44d8-9956-167d775a6aa6	16252-539	HUMAN PRESCRIPTION DRUG	Isradipine		Isradipine	CAPSULE	ORAL	20040105		ANDA	ANDA077317	Actavis Pharma, Inc.	ISRADIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
16252-540_7d8fbb2a-23a9-44d8-9956-167d775a6aa6	16252-540	HUMAN PRESCRIPTION DRUG	Isradipine		Isradipine	CAPSULE	ORAL	20060105		ANDA	ANDA077317	Actavis Pharma, Inc.	ISRADIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
16477-201_c74432dc-6d37-98c0-e053-2995a90a8b99	16477-201	HUMAN PRESCRIPTION DRUG	Hemmorex-HC		hydrocortisone acetate	SUPPOSITORY	RECTAL	20131112		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16477-202_c8d2785d-ec82-e6aa-e053-2995a90a9da7	16477-202	HUMAN PRESCRIPTION DRUG	Hemmorex-HC		hydrocortisone acetate	SUPPOSITORY	RECTAL	20131112		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16477-340_0772a519-0b5d-97dd-e063-6294a90a6cd9	16477-340	HUMAN PRESCRIPTION DRUG	Urea Cream 40%		Urea	CREAM	TOPICAL	20180504		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	UREA	400	mg/g			N	20241231
16477-341_0772c336-4031-9bc9-e063-6394a90aa1af	16477-341	HUMAN PRESCRIPTION DRUG	Urea Cream 41%		Urea	CREAM	TOPICAL	20180504		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	UREA	410	mg/g			N	20241231
16477-410_e60ddbd8-5351-19e0-e053-2995a90ac67a	16477-410	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide		Sodium Sulfacetamide	LIQUID	TOPICAL	20210317		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
16477-411_055a586a-a841-0205-e063-6394a90a44cb	16477-411	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide		Sodium Sulfacetamide	SHAMPOO	TOPICAL	20230913		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
16477-422_e8944cc2-dca5-1210-e053-2a95a90a406f	16477-422	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		Selenium Sulfide	SHAMPOO	TOPICAL	20220411		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	SELENIUM SULFIDE	22.5	mg/mL			N	20241231
16477-423_e8954224-5f4b-2f20-e053-2a95a90a8058	16477-423	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		Selenium Sulfide	SHAMPOO	TOPICAL	20200602		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	SELENIUM SULFIDE	23	mg/mL			N	20241231
16477-720_02573c73-ab83-62c9-e063-6394a90ac219	16477-720	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	ELIXIR	ORAL	20230804		UNAPPROVED DRUG OTHER		Laser Pharmaceuticals, LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
16496-544_fa50bc01-c31b-4062-a927-e3a412f8f76e	16496-544	HUMAN OTC DRUG	Antiseptic Hand		CHLOROXYLENOL	SOAP	TOPICAL	20050930		OTC MONOGRAPH NOT FINAL	part333E	Image Supply, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
16555-008_037058e3-f818-51d5-e063-6394a90a9361	16555-008	HUMAN OTC DRUG	INTRAL SENSITIVE SKIN ENVIRONMENTAL LIGHTWEIGHT SHIELD BROAD SPECTRUM SPF50		TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20170715		OTC MONOGRAPH FINAL	M020	DARPHIN DIST.	TITANIUM DIOXIDE; ZINC OXIDE	63; 40	mg/mL; mg/mL			N	20241231
16571-100_21b0f1b6-9603-4620-8d26-016b126bb88a	16571-100	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET	ORAL	20230601		ANDA	ANDA209012	Rising Pharma Holdings, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
16571-101_2a9f815d-e845-40d2-a82e-590b923b97cf	16571-101	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION/ DROPS	OPHTHALMIC	20080620		ANDA	ANDA078553	Rising Pharmaceuticals, Inc.	DICLOFENAC SODIUM	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-105_5df00dd1-32b6-4b08-8c7c-55a9c38cde5b	16571-105	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230610		ANDA	ANDA217411	Rising Pharma Holdings, Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-106_5df00dd1-32b6-4b08-8c7c-55a9c38cde5b	16571-106	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230610		ANDA	ANDA217411	Rising Pharma Holdings, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-107_5df00dd1-32b6-4b08-8c7c-55a9c38cde5b	16571-107	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230610		ANDA	ANDA217411	Rising Pharma Holdings, Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-108_5df00dd1-32b6-4b08-8c7c-55a9c38cde5b	16571-108	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230610		ANDA	ANDA217411	Rising Pharma Holdings, Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-109_5df00dd1-32b6-4b08-8c7c-55a9c38cde5b	16571-109	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230610		ANDA	ANDA217411	Rising Pharma Holdings, Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-110_5df00dd1-32b6-4b08-8c7c-55a9c38cde5b	16571-110	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230610		ANDA	ANDA217411	Rising Pharma Holdings, Inc.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-111_99de08ac-7b69-4d09-829b-14d8f620986e	16571-111	HUMAN OTC DRUG	CHLORHEXIDINE GLUCONATE		chlorhexidine gluconate	SOLUTION	TOPICAL	20230726		NDA	NDA019258	Rising Pharma Holdings, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
16571-112_50b17b16-b894-476d-b999-1598db5be2a6	16571-112	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20230529		ANDA	ANDA210959	Rising Pharma Holdings, Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
16571-113_9ca46d47-3a27-47d8-b2ca-a2f5719a8042	16571-113	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA217652	Rising Pharma Holdings, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
16571-114_9ca46d47-3a27-47d8-b2ca-a2f5719a8042	16571-114	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA217652	Rising Pharma Holdings, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
16571-115_9ca46d47-3a27-47d8-b2ca-a2f5719a8042	16571-115	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA217652	Rising Pharma Holdings, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
16571-116_0b09cb8d-b814-4c1d-9e2c-6673332bb807	16571-116	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20230719		ANDA	ANDA217995	Rising Pharma Holdings, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-117_0b09cb8d-b814-4c1d-9e2c-6673332bb807	16571-117	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20230719		ANDA	ANDA217995	Rising Pharma Holdings, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-120_95b96965-6924-4235-9c8b-5baed52ab54e	16571-120	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		CIPROFLOXACIN HYDROCHLORIDE	SOLUTION/ DROPS	TOPICAL	20080320		ANDA	ANDA077689	Rising Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	3.5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16571-126_fbe69d39-eaa1-49ff-8b17-27e5104b03fd	16571-126	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20200124		ANDA	ANDA204721	Rising Pharma Holdings, Inc.	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16571-127_fbe69d39-eaa1-49ff-8b17-27e5104b03fd	16571-127	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20200124		ANDA	ANDA204721	Rising Pharma Holdings, Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16571-128_748030c9-644e-499b-9925-0dd03894909d	16571-128	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate Oral Rinse		Chlorhexidine Gluconate Oral Rinse	SOLUTION	DENTAL	20230727		ANDA	ANDA075561	Rising Pharma Holdings, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
16571-136_3ce77d64-b08e-43b6-a3ab-3aca688f734a	16571-136	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20231020		ANDA	ANDA209912	Rising Pharma Holdings, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16571-137_3ce77d64-b08e-43b6-a3ab-3aca688f734a	16571-137	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20231020		ANDA	ANDA209912	Rising Pharma Holdings, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16571-138_3ce77d64-b08e-43b6-a3ab-3aca688f734a	16571-138	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20231020		ANDA	ANDA209912	Rising Pharma Holdings, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16571-139_3ce77d64-b08e-43b6-a3ab-3aca688f734a	16571-139	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20231020		ANDA	ANDA209912	Rising Pharma Holdings, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16571-150_124ac447-a986-492b-9a08-3c34330eddf2	16571-150	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	SOLUTION/ DROPS	TOPICAL	20101220		ANDA	ANDA077700	Rising Pharma Holdings, Inc.	LEVOFLOXACIN	5	mg/mL			N	20241231
16571-201_bc7e91ca-4264-4d1e-9c5d-28c87c33ebfd	16571-201	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	Rising Pharma Holdings, Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-202_bc7e91ca-4264-4d1e-9c5d-28c87c33ebfd	16571-202	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20101231		ANDA	ANDA090066	Rising Pharma Holdings, Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-203_bc7e91ca-4264-4d1e-9c5d-28c87c33ebfd	16571-203	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20101231		ANDA	ANDA090066	Rising Pharma Holdings, Inc.	DICLOFENAC SODIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-401_65ec42df-09a8-418a-b663-029a0733bdb7	16571-401	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20091001		ANDA	ANDA077829	Rising Pharma Holdings, Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
16571-402_76292d91-a281-4013-aac1-03f702038b10	16571-402	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20091001		ANDA	ANDA077829	Rising Pharma Holdings, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
16571-411_baebd19d-db54-4622-8b5e-c283ff8c359a	16571-411	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Rising Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16571-412_baebd19d-db54-4622-8b5e-c283ff8c359a	16571-412	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Rising Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16571-413_baebd19d-db54-4622-8b5e-c283ff8c359a	16571-413	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Rising Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16571-600_ca2c72ae-db00-4694-9fd0-d4b6b45f8108	16571-600	HUMAN PRESCRIPTION DRUG	CROMOLYN SODIUM		CROMOLYN SODIUM	SOLUTION, CONCENTRATE	ORAL	20111205		ANDA	ANDA202583	Rising Pharma Holdings, Inc.	CROMOLYN SODIUM	100	mg/5mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
16571-654_4ffc2ac9-b6e5-43b3-b7e5-747face7b214	16571-654	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET	ORAL	20220825		ANDA	ANDA204928	Rising Pharmaceuticals, Inc.	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
16571-655_4ffc2ac9-b6e5-43b3-b7e5-747face7b214	16571-655	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast Tablets	TABLET	ORAL	20220825		ANDA	ANDA204928	Rising Pharmaceuticals, Inc.	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
16571-657_f5d86ddf-a6fb-4311-9385-5b02a1842eeb	16571-657	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride		Cevimeline Hydrochloride	CAPSULE	ORAL	20140617		ANDA	ANDA203775	Rising Pharma Holdings, Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
16571-658_6c48c0f2-586b-48df-bb15-bff658a3b650	16571-658	HUMAN PRESCRIPTION DRUG	Norethindrone acetate		norethindrone acetate	TABLET	ORAL	20181105		ANDA	ANDA206490	Rising Pharmaceuticals, Inc.	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
16571-659_3ef3c033-c008-48f4-bcba-1793cdcec8cf	16571-659	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	CAPSULE	ORAL	20190402		ANDA	ANDA206803	Rising Pharma Holdings, Inc.	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
16571-660_baef1ff9-7d6f-44cc-80f4-09c2b7a8bb2d	16571-660	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Rising Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
16571-661_baef1ff9-7d6f-44cc-80f4-09c2b7a8bb2d	16571-661	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Rising Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
16571-662_baef1ff9-7d6f-44cc-80f4-09c2b7a8bb2d	16571-662	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Rising Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	50	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
16571-663_baef1ff9-7d6f-44cc-80f4-09c2b7a8bb2d	16571-663	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Rising Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
16571-664_b57176f1-5473-45dc-bf9a-8d95f4fd3ce7	16571-664	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	Rising Pharma Holdings, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
16571-665_b57176f1-5473-45dc-bf9a-8d95f4fd3ce7	16571-665	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	Rising Pharma Holdings, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
16571-667_9abc9dc4-1a62-480d-a0a9-fad16c154eae	16571-667	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
16571-668_9abc9dc4-1a62-480d-a0a9-fad16c154eae	16571-668	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
16571-669_e81ffc2f-9aa0-4b68-9d42-63d23dc30824	16571-669	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	100	mg/1		CIV	N	20241231
16571-670_e81ffc2f-9aa0-4b68-9d42-63d23dc30824	16571-670	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	15	mg/1		CIV	N	20241231
16571-671_9abc9dc4-1a62-480d-a0a9-fad16c154eae	16571-671	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
16571-672_e81ffc2f-9aa0-4b68-9d42-63d23dc30824	16571-672	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	30	mg/1		CIV	N	20241231
16571-673_9abc9dc4-1a62-480d-a0a9-fad16c154eae	16571-673	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
16571-674_e81ffc2f-9aa0-4b68-9d42-63d23dc30824	16571-674	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	60	mg/1		CIV	N	20241231
16571-675_a84eee2c-e36f-478c-8793-b153799ea38b	16571-675	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	LIQUID	ORAL	20200901		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
16571-676_de171b0a-3854-4aaa-889e-f2d999c0458c	16571-676	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20210201		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16571-680_9091dcc4-1398-4036-a3a9-cd2f82a3eb64	16571-680	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20200424		ANDA	ANDA211623	Rising Pharma Holdings, Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16571-681_9091dcc4-1398-4036-a3a9-cd2f82a3eb64	16571-681	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20200424		ANDA	ANDA211623	Rising Pharma Holdings, Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16571-682_9091dcc4-1398-4036-a3a9-cd2f82a3eb64	16571-682	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20200424		ANDA	ANDA211623	Rising Pharma Holdings, Inc.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16571-683_bf37fdc5-f579-48c9-baa3-8e516ac71a33	16571-683	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20201101		ANDA	ANDA212285	Rising Pharma Holdings, Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-684_bf37fdc5-f579-48c9-baa3-8e516ac71a33	16571-684	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20201101		ANDA	ANDA212285	Rising Pharma Holdings, Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-685_bf37fdc5-f579-48c9-baa3-8e516ac71a33	16571-685	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20201101		ANDA	ANDA212285	Rising Pharma Holdings, Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16571-687_cbad7d35-a9f3-4071-a4bd-3cc7e9be3956	16571-687	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20190905	20250228	ANDA	ANDA210959	Rising Pharma Holdings, Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	
16571-688_b3a58d34-7780-4056-b144-bad674c51494	16571-688	HUMAN PRESCRIPTION DRUG	FENOPROFEN CALCIUM		FENOPROFEN CALCIUM	CAPSULE	ORAL	20220801		ANDA	ANDA214475	Rising Pharma Holdings, Inc.	FENOPROFEN CALCIUM	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-689_bb341ca1-04d3-4a71-b79d-824653aa58a3	16571-689	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		CARBIDOPA, LEVODOPA AND ENTACAPONE	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA213212	Rising Pharma Holdings, Inc.	CARBIDOPA; ENTACAPONE; LEVODOPA	12.5; 200; 50	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
16571-690_bb341ca1-04d3-4a71-b79d-824653aa58a3	16571-690	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		CARBIDOPA, LEVODOPA AND ENTACAPONE	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA213212	Rising Pharma Holdings, Inc.	CARBIDOPA; ENTACAPONE; LEVODOPA	18.75; 200; 75	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
16571-691_bb341ca1-04d3-4a71-b79d-824653aa58a3	16571-691	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		CARBIDOPA, LEVODOPA AND ENTACAPONE	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA213212	Rising Pharma Holdings, Inc.	CARBIDOPA; ENTACAPONE; LEVODOPA	25; 200; 100	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
16571-692_bb341ca1-04d3-4a71-b79d-824653aa58a3	16571-692	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		CARBIDOPA, LEVODOPA AND ENTACAPONE	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA213212	Rising Pharma Holdings, Inc.	CARBIDOPA; ENTACAPONE; LEVODOPA	31.25; 200; 125	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
16571-693_bb341ca1-04d3-4a71-b79d-824653aa58a3	16571-693	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		CARBIDOPA, LEVODOPA AND ENTACAPONE	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA213212	Rising Pharma Holdings, Inc.	CARBIDOPA; ENTACAPONE; LEVODOPA	37.5; 200; 150	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
16571-694_bb341ca1-04d3-4a71-b79d-824653aa58a3	16571-694	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		CARBIDOPA, LEVODOPA AND ENTACAPONE	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA213212	Rising Pharma Holdings, Inc.	CARBIDOPA; ENTACAPONE; LEVODOPA	50; 200; 200	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
16571-695_e8114fdc-e28b-406b-bbcb-6a441de60b95	16571-695	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	Rising Pharma Holdings, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
16571-696_e8114fdc-e28b-406b-bbcb-6a441de60b95	16571-696	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207398	Rising Pharma Holdings, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
16571-697_b62ff2cb-32d6-4056-badb-343f922b3a21	16571-697	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111		ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16571-698_b62ff2cb-32d6-4056-badb-343f922b3a21	16571-698	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200111		ANDA	ANDA201921	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16571-705_a78e8baf-f2bf-49a5-97da-59cfb5a1fb9b	16571-705	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Rising Pharma Holdings, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-706_a78e8baf-f2bf-49a5-97da-59cfb5a1fb9b	16571-706	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Rising Pharma Holdings, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-707_a78e8baf-f2bf-49a5-97da-59cfb5a1fb9b	16571-707	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Rising Pharma Holdings, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-708_a78e8baf-f2bf-49a5-97da-59cfb5a1fb9b	16571-708	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Rising Pharma Holdings, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-716_0136092e-69c2-469e-937b-06193424b381	16571-716	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA203494	Rising Pharma Holdings, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
16571-717_cbd82913-f4c7-49c7-bd1a-c3f71e4da391	16571-717	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Rising Pharma Holdings, Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16571-718_cbd82913-f4c7-49c7-bd1a-c3f71e4da391	16571-718	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Rising Pharma Holdings, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16571-719_cbd82913-f4c7-49c7-bd1a-c3f71e4da391	16571-719	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Rising Pharma Holdings, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16571-720_cbd82913-f4c7-49c7-bd1a-c3f71e4da391	16571-720	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Rising Pharma Holdings, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16571-721_cbd82913-f4c7-49c7-bd1a-c3f71e4da391	16571-721	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Rising Pharma Holdings, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16571-722_cbd82913-f4c7-49c7-bd1a-c3f71e4da391	16571-722	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Rising Pharma Holdings, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16571-723_58d3a059-d175-4740-bf57-f156588c99b5	16571-723	HUMAN PRESCRIPTION DRUG	SULFAMYLON		mafenide acetate	CREAM	TOPICAL	20200518		NDA	NDA016763	Rising Pharma Holdings, Inc.	MAFENIDE ACETATE	85	mg/g	Methylated Sulfonamide Antibacterial [EPC], Methylated Sulfonamides [EXT]		N	20241231
16571-725_b4a7f61d-613e-4d8f-a3fc-37143c6e19c3	16571-725	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20220405		ANDA	ANDA213126	Rising Pharma Holdings, Inc.	CHLORZOXAZONE	375	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
16571-726_b4a7f61d-613e-4d8f-a3fc-37143c6e19c3	16571-726	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20220405		ANDA	ANDA213126	Rising Pharma Holdings, Inc.	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
16571-727_b4a7f61d-613e-4d8f-a3fc-37143c6e19c3	16571-727	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20220405		ANDA	ANDA213126	Rising Pharma Holdings, Inc.	CHLORZOXAZONE	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
16571-735_dba544da-0b98-4e4a-a71f-2e7fe64ad1b2	16571-735	HUMAN PRESCRIPTION DRUG	Methylergonovine Maleate		Methylergonovine Maleate	TABLET	ORAL	20210115		ANDA	ANDA211919	Rising Pharma Holdings, Inc.	METHYLERGONOVINE MALEATE	.2	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
16571-736_36cf4555-6fe9-42d8-8d3b-3ca9c134a5b8	16571-736	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216		ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
16571-737_36cf4555-6fe9-42d8-8d3b-3ca9c134a5b8	16571-737	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216		ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
16571-738_36cf4555-6fe9-42d8-8d3b-3ca9c134a5b8	16571-738	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201216		ANDA	ANDA205956	Rising Pharma Holdings, Inc.	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
16571-739_27857385-55ea-4630-a3ae-04df2812ed62	16571-739	HUMAN PRESCRIPTION DRUG	Sevelamer carbonate		Sevelamer carbonate	TABLET, FILM COATED	ORAL	20201216		ANDA	ANDA204451	Rising Pharmaceuticals, Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
16571-740_8c7eb014-e44d-4537-b1da-1492645edb27	16571-740	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20201223		NDA AUTHORIZED GENERIC	NDA009175	Rising Pharma Holdings, Inc.	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
16571-742_b8512fb0-87c2-45ae-b0db-189e467be449	16571-742	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210528		ANDA	ANDA203306	Rising Pharma Holdings, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16571-743_2b1b09a0-15ac-4899-9144-0ace036618db	16571-743	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20201006		NDA AUTHORIZED GENERIC	NDA012827	Rising Pharma Holdings, Inc.	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16571-744_2b1b09a0-15ac-4899-9144-0ace036618db	16571-744	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20201006		NDA AUTHORIZED GENERIC	NDA012827	Rising Pharma Holdings, Inc.	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16571-754_48173c90-79ed-459d-b259-947bc7952c13	16571-754	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Bacitracin Zinc		Neomycin and Polymyxin B Sulfates and Bacitracin Zinc	OINTMENT	OPHTHALMIC	20170407		NDA AUTHORIZED GENERIC	NDA050417	Rising Pharma Holdings, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 10000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
16571-755_77e6adf5-f122-42f1-a683-b8ace5df2a30	16571-755	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20230610		ANDA	ANDA078777	Rising Pharma Holdings, Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16571-756_77e6adf5-f122-42f1-a683-b8ace5df2a30	16571-756	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20230610		ANDA	ANDA078777	Rising Pharma Holdings, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16571-757_77e6adf5-f122-42f1-a683-b8ace5df2a30	16571-757	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20230610		ANDA	ANDA078777	Rising Pharma Holdings, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16571-758_8939542d-a9e1-4067-a129-389cb52ca650	16571-758	HUMAN PRESCRIPTION DRUG	NATEGLINIDE		NATEGLINIDE	TABLET	ORAL	20201216		ANDA	ANDA205544	Rising Pharmaceuticals, Inc.	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
16571-759_8939542d-a9e1-4067-a129-389cb52ca650	16571-759	HUMAN PRESCRIPTION DRUG	NATEGLINIDE		NATEGLINIDE	TABLET	ORAL	20201216		ANDA	ANDA205544	Rising Pharmaceuticals, Inc.	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
16571-762_9b83390c-da0f-4040-871e-6a7ef0882b46	16571-762	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine	TABLET	ORAL	20201201		ANDA	ANDA076858	Rising Pharma Holdings, Inc.	LEVOCARNITINE	330	mg/1	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
16571-767_e2aa9544-0136-463d-a73b-1a299534446a	16571-767	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160919		ANDA	ANDA206743	Rising Pharma Holdings, Inc.	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16571-768_e2aa9544-0136-463d-a73b-1a299534446a	16571-768	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160919		ANDA	ANDA206743	Rising Pharma Holdings, Inc.	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16571-769_4efdf507-ac8a-45c5-8eb7-2c1c5e5e909e	16571-769	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	SOLUTION	ORAL	20120403		ANDA	ANDA079062	Rising Pharma Holdings, Inc.	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16571-770_b472fd01-b492-4399-967d-ddfd4bb98faa	16571-770	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20110330		ANDA	ANDA091163	Rising Pharma Holdings, Inc.	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-771_b472fd01-b492-4399-967d-ddfd4bb98faa	16571-771	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20110330		ANDA	ANDA091163	Rising Pharma Holdings, Inc.	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-772_b472fd01-b492-4399-967d-ddfd4bb98faa	16571-772	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20110330		ANDA	ANDA091163	Rising Pharma Holdings, Inc.	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-773_c0e61ee2-86f3-4ac0-9aaa-deed4925e16b	16571-773	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Rising Pharma Holdings, Inc.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16571-774_c0e61ee2-86f3-4ac0-9aaa-deed4925e16b	16571-774	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Rising Pharma Holdings, Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16571-775_c0e61ee2-86f3-4ac0-9aaa-deed4925e16b	16571-775	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Rising Pharma Holdings, Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16571-776_addfc853-b1a7-43dd-b75e-3fc83811509c	16571-776	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20061002		ANDA	ANDA078008	Rising Pharma Holdings, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-777_addfc853-b1a7-43dd-b75e-3fc83811509c	16571-777	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20061002		ANDA	ANDA078008	Rising Pharma Holdings, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-778_b963d4b7-66f3-47d7-8671-7412d49e6cb3	16571-778	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA090056	Rising Pharma Holdings, Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
16571-779_b963d4b7-66f3-47d7-8671-7412d49e6cb3	16571-779	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA090056	Rising Pharma Holdings, Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
16571-780_cca322f3-3e46-4de8-9e37-8fe9039d40c7	16571-780	HUMAN PRESCRIPTION DRUG	carisoprodol		carisoprodol	TABLET	ORAL	20161108		ANDA	ANDA040792	Rising Pharma Holdings, Inc.	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
16571-781_cca322f3-3e46-4de8-9e37-8fe9039d40c7	16571-781	HUMAN PRESCRIPTION DRUG	carisoprodol		carisoprodol	TABLET	ORAL	20090806		ANDA	ANDA040792	Rising Pharma Holdings, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
16571-782_0280b504-4a42-44f3-8a1a-34a20eac054a	16571-782	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Rising Pharma Holdings, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
16571-783_0280b504-4a42-44f3-8a1a-34a20eac054a	16571-783	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Rising Pharma Holdings, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
16571-784_3a3a1ca1-4f00-4faa-8773-18b49cab24b7	16571-784	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	Rising Pharma Holdings, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
16571-785_c01be268-898c-43b8-9311-ac482f7b0060	16571-785	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20091104		ANDA	ANDA090401	Rising Pharma Holdings, Inc.	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16571-786_c01be268-898c-43b8-9311-ac482f7b0060	16571-786	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20091104		ANDA	ANDA090401	Rising Pharma Holdings, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16571-787_22fd6f15-5fa9-4572-9014-cc427d8dd691	16571-787	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Rising Pharma Holdings, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-788_22fd6f15-5fa9-4572-9014-cc427d8dd691	16571-788	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Rising Pharma Holdings, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-789_22fd6f15-5fa9-4572-9014-cc427d8dd691	16571-789	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Rising Pharma Holdings, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-790_22fd6f15-5fa9-4572-9014-cc427d8dd691	16571-790	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Rising Pharma Holdings, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-791_2f19b802-e931-471f-83f3-e116a84b1bb8	16571-791	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060314		ANDA	ANDA077606	Rising Pharma Holdings, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16571-792_2f19b802-e931-471f-83f3-e116a84b1bb8	16571-792	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060314		ANDA	ANDA077606	Rising Pharma Holdings, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16571-793_2f19b802-e931-471f-83f3-e116a84b1bb8	16571-793	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060314		ANDA	ANDA077606	Rising Pharma Holdings, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16571-794_c031b428-c7d0-440a-90ab-d88ceef3c57c	16571-794	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Rising Pharma Holdings, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-795_c031b428-c7d0-440a-90ab-d88ceef3c57c	16571-795	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Rising Pharma Holdings, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-796_c031b428-c7d0-440a-90ab-d88ceef3c57c	16571-796	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Rising Pharma Holdings, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-797_c031b428-c7d0-440a-90ab-d88ceef3c57c	16571-797	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Rising Pharma Holdings, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-798_c031b428-c7d0-440a-90ab-d88ceef3c57c	16571-798	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Rising Pharma Holdings, Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-799_c031b428-c7d0-440a-90ab-d88ceef3c57c	16571-799	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Rising Pharma Holdings, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16571-803_b2b64b02-ca34-492e-a789-959f89bfda55	16571-803	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160511		ANDA	ANDA207021	Rising Pharma Holdings, Inc.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
16571-804_b2b64b02-ca34-492e-a789-959f89bfda55	16571-804	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160511		ANDA	ANDA207021	Rising Pharma Holdings, Inc.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
16571-805_93f4f73b-1ff4-4a64-a8ec-4a574abc3dd6	16571-805	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20220209		ANDA	ANDA207555	Rising Pharma Holdings, Inc.	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
16571-809_cbd82913-f4c7-49c7-bd1a-c3f71e4da391	16571-809	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Rising Pharma Holdings, Inc.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16571-810_642b3258-7418-4209-bb88-2ca277a4fb2b	16571-810	HUMAN PRESCRIPTION DRUG	Trientine Hydrochloride		Trientine Hydrochloride	CAPSULE	ORAL	20210330		ANDA	ANDA212238	Rising Pharma Holdings, Inc.	TRIENTINE HYDROCHLORIDE	250	mg/1	Copper Chelating Activity [MoA], Copper Chelator [EPC], Metal Chelating Activity [MoA]		N	20241231
16571-812_642b3258-7418-4209-bb88-2ca277a4fb2b	16571-812	HUMAN PRESCRIPTION DRUG	Trientine Hydrochloride		Trientine Hydrochloride	CAPSULE	ORAL	20230922		ANDA	ANDA212238	Rising Pharma Holdings, Inc.	TRIENTINE HYDROCHLORIDE	500	mg/1	Copper Chelating Activity [MoA], Copper Chelator [EPC], Metal Chelating Activity [MoA]		N	20241231
16571-813_eb6d5dec-2e65-ad76-e053-2a95a90a6d32	16571-813	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20211101		ANDA	ANDA211038	Rising Pharma Holdings, Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
16571-814_82dc4f9f-0dc5-46f8-8deb-3966669470cd	16571-814	HUMAN PRESCRIPTION DRUG	Denta 5000 Plus		Sodium fluoride	CREAM	ORAL	20230703		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
16571-815_6ff13596-e232-4e07-bb60-b1d88a01b503	16571-815	HUMAN PRESCRIPTION DRUG	DentaGel		Sodium fluoride	GEL	ORAL	20230509		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
16571-816_f7c1aa83-a94a-4f97-bc30-66b8a89783b9	16571-816	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE		temozolomide	CAPSULE	ORAL	20221004		ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16571-817_f7c1aa83-a94a-4f97-bc30-66b8a89783b9	16571-817	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE		temozolomide	CAPSULE	ORAL	20221004		ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16571-818_f7c1aa83-a94a-4f97-bc30-66b8a89783b9	16571-818	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE		temozolomide	CAPSULE	ORAL	20221004		ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16571-819_f7c1aa83-a94a-4f97-bc30-66b8a89783b9	16571-819	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE		temozolomide	CAPSULE	ORAL	20221004		ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16571-820_f7c1aa83-a94a-4f97-bc30-66b8a89783b9	16571-820	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE		temozolomide	CAPSULE	ORAL	20221004		ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16571-821_f7c1aa83-a94a-4f97-bc30-66b8a89783b9	16571-821	HUMAN PRESCRIPTION DRUG	TEMOZOLOMIDE		temozolomide	CAPSULE	ORAL	20221004		ANDA	ANDA206309	Rising Pharma Holdings, Inc.	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16571-822_8b088034-c702-4b88-b4e3-421aa9739ec8	16571-822	HUMAN OTC DRUG	Loratadine		loratadine	TABLET	ORAL	20220310		ANDA	ANDA214684	Rising Pharmaceuticals, Inc	LORATADINE	10	mg/1			N	20241231
16571-824_448cc004-c7a5-42b0-9a2e-79790e66baa8	16571-824	HUMAN OTC DRUG	Meclizine HCl		MECLIZINE HYDROCHLORIDE CHEWABLE	TABLET, CHEWABLE	ORAL	20220818		OTC MONOGRAPH FINAL	part336	Rising Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
16571-825_cd0ad97f-9348-4b27-9fd0-a87bc1f93416	16571-825	HUMAN PRESCRIPTION DRUG	TOLMETIN SODIUM		tolmetin sodium	TABLET, FILM COATED	ORAL	20230411		ANDA	ANDA074473	Rising Pharma Holdings, Inc.	TOLMETIN SODIUM	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-826_b4e4a55d-506b-4c36-bc30-b4219d3d5e8f	16571-826	HUMAN PRESCRIPTION DRUG	Tolmetin Sodium		Tolmetin Sodium	CAPSULE	ORAL	20230630		ANDA	ANDA073393	Rising Pharma Holdings, Inc.	TOLMETIN SODIUM	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16571-827_0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e	16571-827	HUMAN PRESCRIPTION DRUG	CAPTOPRIL AND HYDROCHLOROTHIAZIDE		CAPTOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20230214		ANDA	ANDA074896	Rising Pharma Holdings, Inc.	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25; 15	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16571-828_0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e	16571-828	HUMAN PRESCRIPTION DRUG	CAPTOPRIL AND HYDROCHLOROTHIAZIDE		CAPTOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20230214		ANDA	ANDA074896	Rising Pharma Holdings, Inc.	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16571-829_0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e	16571-829	HUMAN PRESCRIPTION DRUG	CAPTOPRIL AND HYDROCHLOROTHIAZIDE		CAPTOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20230214		ANDA	ANDA074896	Rising Pharma Holdings, Inc.	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50; 15	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16571-830_0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e	16571-830	HUMAN PRESCRIPTION DRUG	CAPTOPRIL AND HYDROCHLOROTHIAZIDE		CAPTOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20230214		ANDA	ANDA074896	Rising Pharma Holdings, Inc.	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16571-831_dc245b70-6a0f-4f3d-8963-a8349068ef05	16571-831	HUMAN PRESCRIPTION DRUG	Probenecid		Probenecid	TABLET	ORAL	20231120		ANDA	ANDA217020	Rising Pharma Holdings, Inc.	PROBENECID	500	mg/1			N	20241231
16571-832_0723b4d1-495c-41b8-b2aa-3a385e1795ff	16571-832	HUMAN PRESCRIPTION DRUG	Probenecid and Colchicine		Probenecid and Colchicine	TABLET	ORAL	20231024		ANDA	ANDA217030	Rising Pharma Holdings, Inc.	COLCHICINE; PROBENECID	.5; 500	mg/1; mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
16571-833_b46177b2-68dc-4958-a4ec-d4bd6d887456	16571-833	HUMAN PRESCRIPTION DRUG	Pryidostigmine Bromide		Pyridostigmine Bromide	SOLUTION	ORAL	20220915		ANDA	ANDA208797	Rising Pharma Holdings, Inc.	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
16571-834_f635d795-9844-4e8d-9beb-8e4d31ad3d78	16571-834	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20220905		ANDA	ANDA210129	Rising Pharma Holdings, Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
16571-842_fe4e9cca-4035-4f2a-8802-ce569e2af05e	16571-842	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE EXTENDED RELEASE		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20231219		ANDA	ANDA217412	Rising Pharma Holdings, Inc.	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
16571-843_fe4e9cca-4035-4f2a-8802-ce569e2af05e	16571-843	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE EXTENDED RELEASE		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20231219		ANDA	ANDA217412	Rising Pharma Holdings, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
16571-862_4fb10afc-4904-4eea-a538-26e005e80173	16571-862	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801		ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16571-863_4fb10afc-4904-4eea-a538-26e005e80173	16571-863	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801		ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16571-867_6827ca69-0e15-4426-94ae-cb5f94bdbe65	16571-867	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220801		ANDA	ANDA207099	Rising Pharma Holdings, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-868_6827ca69-0e15-4426-94ae-cb5f94bdbe65	16571-868	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220801		ANDA	ANDA207099	Rising Pharma Holdings, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-869_6827ca69-0e15-4426-94ae-cb5f94bdbe65	16571-869	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220801		ANDA	ANDA207099	Rising Pharma Holdings, Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16571-875_7c1bd14b-7f8f-4ad6-9c3c-e6a0d9aad1cf	16571-875	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET	ORAL	20230622		ANDA	ANDA074461	Rising Pharma Holdings, Inc.	INDAPAMIDE	1.25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
16571-876_7c1bd14b-7f8f-4ad6-9c3c-e6a0d9aad1cf	16571-876	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET	ORAL	20230622		ANDA	ANDA074461	Rising Pharma Holdings, Inc.	INDAPAMIDE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
16571-880_cd6b21e6-4d3f-40b5-89ee-52a1c83d8700	16571-880	HUMAN OTC DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20221201		ANDA	ANDA216349	Rising Pharma Holdings, Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16571-881_341528b8-768e-4117-ab05-ee2914d7889c	16571-881	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20221025		ANDA	ANDA211064	Rising Pharma Holdings, Inc.	FOLIC ACID	1	mg/1			N	20241231
16571-883_5cd32f4f-2795-4776-ad00-f33f91bda391	16571-883	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20230921		NDA AUTHORIZED GENERIC	NDA016084	Rising Pharma Holdings, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16571-884_5cd32f4f-2795-4776-ad00-f33f91bda391	16571-884	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20230921		NDA AUTHORIZED GENERIC	NDA016084	Rising Pharma Holdings, Inc.	ALLOPURINOL	200	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16571-885_5cd32f4f-2795-4776-ad00-f33f91bda391	16571-885	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20230921		NDA AUTHORIZED GENERIC	NDA016084	Rising Pharma Holdings, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16571-888_8c7eb014-e44d-4537-b1da-1492645edb27	16571-888	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20230609		NDA AUTHORIZED GENERIC	NDA009175	Rising Pharma Holdings, Inc.	NITROFURANTOIN	50	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
16714-001_a8715ef8-25f7-4974-8753-d3befee78819	16714-001	HUMAN PRESCRIPTION DRUG	Doxorubicin hydrochloride		Doxorubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210322		ANDA	ANDA203622	Northstar RxLLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
16714-006_88f8635b-765e-4ad4-aeb6-f1f6873f2c02	16714-006	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	NorthStar Rx LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
16714-007_b3516c4d-025b-4238-9fd3-566af3ec5d7a	16714-007	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20200501		ANDA	ANDA213057	Northstar Rx LLC	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
16714-008_b3516c4d-025b-4238-9fd3-566af3ec5d7a	16714-008	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20200501		ANDA	ANDA213057	Northstar Rx LLC	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
16714-009_b3516c4d-025b-4238-9fd3-566af3ec5d7a	16714-009	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20200501		ANDA	ANDA213057	Northstar Rx LLC	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
16714-010_b3516c4d-025b-4238-9fd3-566af3ec5d7a	16714-010	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20200501		ANDA	ANDA213057	Northstar Rx LLC	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
16714-014_34026823-7bb3-4f3c-a125-32213d1eeb8c	16714-014	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA065063	Northstar RxLLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-015_a720341d-be60-448e-b39c-05cde487391f	16714-015	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200701		ANDA	ANDA091280	NorthStar RxLLC	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
16714-016_88f8635b-765e-4ad4-aeb6-f1f6873f2c02	16714-016	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	NorthStar Rx LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
16714-018_9bbd2475-b4f2-4776-b59e-add17f17984b	16714-018	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20201111		ANDA	ANDA205710	NorthStar RxLLC	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-019_9bbd2475-b4f2-4776-b59e-add17f17984b	16714-019	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20201111		ANDA	ANDA205710	NorthStar RxLLC	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-020_9bbd2475-b4f2-4776-b59e-add17f17984b	16714-020	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20201111		ANDA	ANDA205710	NorthStar RxLLC	BUDESONIDE	1	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-026_88f8635b-765e-4ad4-aeb6-f1f6873f2c02	16714-026	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	NorthStar Rx LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
16714-027_7d7ed052-95ae-6d58-f41f-ada9f8f97b81	16714-027	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloride		Irinotecan hydrochloride	INJECTION	INTRAVENOUS	20201115		ANDA	ANDA212993	Northstar Rx LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
16714-029_56c037ff-3dbb-1411-c344-f6cb4d0464f7	16714-029	HUMAN PRESCRIPTION DRUG	Etonogestrel and Ethinyl Estradiol Vaginal Ring		Etonogestrel and Ethinyl Estradiol Vaginal Ring	RING	VAGINAL	20231101		ANDA	ANDA211157	Northstar Rx LLC	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
16714-030_90f16b45-d931-47ef-88d6-eb775bcf976c	16714-030	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SHAMPOO	TOPICAL	20210328		ANDA	ANDA214867	NORTHSTAR RX LLC	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-034_dfc059d7-29ab-133b-e053-2a95a90a83d6	16714-034	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220329		ANDA	ANDA090515	NorthStar RxLLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-035_dfc059d7-29ab-133b-e053-2a95a90a83d6	16714-035	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20201015		ANDA	ANDA090515	NorthStar RxLLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-036_88f8635b-765e-4ad4-aeb6-f1f6873f2c02	16714-036	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	NorthStar Rx LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
16714-037_607e2c29-97d5-4658-9842-20b731706b18	16714-037	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20201202		ANDA	ANDA212932	NorthStar Rx LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
16714-038_a4510853-5f1c-45c2-8d31-1b26ece5010b	16714-038	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201021		ANDA	ANDA091272	NorthStar RxLLC	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
16714-039_b510d002-4c8e-4b5e-bc76-c49552e79d45	16714-039	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20201110		ANDA	ANDA211519	Northstar Rx LLC.	COLCHICEINE	.6	mg/1			N	20241231
16714-040_64e2f1e1-c514-9a53-a475-5fc612a789ea	16714-040	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20210908		ANDA	ANDA090495	NorthStar Rx LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
16714-041_049208c7-7904-4d26-92ac-d78d4179e3ca	16714-041	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091116		ANDA	ANDA078253	Northstar RxLLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16714-042_049208c7-7904-4d26-92ac-d78d4179e3ca	16714-042	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091116		ANDA	ANDA078253	Northstar RxLLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16714-043_2c0761fa-301e-47f5-855c-dbb6fedb3592	16714-043	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210610	20240630	ANDA	ANDA090174	Northstar Rx LLC.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-044_2c0761fa-301e-47f5-855c-dbb6fedb3592	16714-044	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210610	20240731	ANDA	ANDA090174	Northstar Rx LLC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-045_2c0761fa-301e-47f5-855c-dbb6fedb3592	16714-045	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210610	20240731	ANDA	ANDA090174	Northstar Rx LLC.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-046_88f8635b-765e-4ad4-aeb6-f1f6873f2c02	16714-046	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	NorthStar Rx LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
16714-047_eac8fe2a-e254-4c24-9660-6cf80b2d12bb	16714-047	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200511		ANDA	ANDA213368	Northstar Rx LLC	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-048_eac8fe2a-e254-4c24-9660-6cf80b2d12bb	16714-048	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200511		ANDA	ANDA213368	Northstar Rx LLC	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-049_eac8fe2a-e254-4c24-9660-6cf80b2d12bb	16714-049	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200511		ANDA	ANDA213368	Northstar Rx LLC	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-050_eac8fe2a-e254-4c24-9660-6cf80b2d12bb	16714-050	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200511		ANDA	ANDA213368	Northstar Rx LLC	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-051_eac8fe2a-e254-4c24-9660-6cf80b2d12bb	16714-051	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200511		ANDA	ANDA213368	Northstar Rx LLC	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-052_dd937dd9-8fad-42bc-bcd4-e3328c5d1ca5	16714-052	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20220809		ANDA	ANDA202928	NorthStar RxLLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
16714-055_d67221d7-7844-4a8a-8c32-8856d49b572a	16714-055	HUMAN PRESCRIPTION DRUG	Mupirocin		mupirocin calcium	CREAM	TOPICAL	20201125		ANDA	ANDA207116	NORTHSTAR RX LLC	MUPIROCIN CALCIUM	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
16714-056_88f8635b-765e-4ad4-aeb6-f1f6873f2c02	16714-056	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	NorthStar Rx LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
16714-059_0284b7a5-7a1f-4e37-9883-b7bdba68c42b	16714-059	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20210126		ANDA	ANDA205467	NorthStar RxLLC	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16714-060_0284b7a5-7a1f-4e37-9883-b7bdba68c42b	16714-060	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20210126		ANDA	ANDA205467	NorthStar RxLLC	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16714-063_3548fd9d-1bb7-40a9-86f5-28726b15e440	16714-063	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA205571	Northstar Rx LLC	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16714-064_3548fd9d-1bb7-40a9-86f5-28726b15e440	16714-064	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA205571	Northstar Rx LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16714-065_3548fd9d-1bb7-40a9-86f5-28726b15e440	16714-065	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA205571	Northstar Rx LLC	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16714-066_88f8635b-765e-4ad4-aeb6-f1f6873f2c02	16714-066	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	NorthStar Rx LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
16714-067_65000b5a-3d2e-4228-8757-cca85e663c80	16714-067	HUMAN PRESCRIPTION DRUG	Carbidopa		Carbidopa	TABLET	ORAL	20191021		ANDA	ANDA211055	NorthStar Rx LLC	CARBIDOPA	25	mg/1			N	20241231
16714-070_244e8f58-8aba-5ede-0b9d-a566f1021cfb	16714-070	HUMAN PRESCRIPTION DRUG	FULVESTRANT		fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20210823		ANDA	ANDA213553	Northstar Rx, LLC,	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
16714-071_860b4535-9619-47b7-97d5-910f8b22c7e9	16714-071	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20110101		ANDA	ANDA078504	Northstar RxLLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
16714-072_860b4535-9619-47b7-97d5-910f8b22c7e9	16714-072	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20110101		ANDA	ANDA078401	Northstar RxLLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
16714-074_2b1383b3-acce-43df-9aad-2d92c439b80f	16714-074	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	NorthStar RxLLC	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16714-075_2b1383b3-acce-43df-9aad-2d92c439b80f	16714-075	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	NorthStar RxLLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16714-076_2b1383b3-acce-43df-9aad-2d92c439b80f	16714-076	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	NorthStar RxLLC	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16714-077_2b1383b3-acce-43df-9aad-2d92c439b80f	16714-077	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	NorthStar RxLLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16714-081_8a5d7228-5e57-4aaa-8fcf-39fe159c7a48	16714-081	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	Northstar RxLLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
16714-082_8a5d7228-5e57-4aaa-8fcf-39fe159c7a48	16714-082	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	Northstar RxLLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
16714-083_8a5d7228-5e57-4aaa-8fcf-39fe159c7a48	16714-083	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	Northstar RxLLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
16714-084_6f9168d1-cac0-4fd1-8e68-52f2b4af7785	16714-084	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20200423		ANDA	ANDA089424	NorthStar Rx LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16714-085_6f9168d1-cac0-4fd1-8e68-52f2b4af7785	16714-085	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	20200423		ANDA	ANDA089424	NorthStar Rx LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16714-086_6f9168d1-cac0-4fd1-8e68-52f2b4af7785	16714-086	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	20200423		ANDA	ANDA089424	NorthStar Rx LLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16714-087_f649cb16-8cb4-5292-e053-2995a90a04fc	16714-087	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20200501		ANDA	ANDA209796	NorthStar RxLLC	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
16714-097_9a08dadf-b4e3-4ab8-91d3-12241605c43b	16714-097	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	OROPHARYNGEAL	20210401		ANDA	ANDA040708	NorthStar RxLLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
16714-098_a24bfd52-5fd3-4980-8e64-5ba6b0d93d67	16714-098	HUMAN PRESCRIPTION DRUG	tacrolimus		tacrolimus	CAPSULE	ORAL	20210331		ANDA	ANDA206662	NORTHSTAR RX LLC	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
16714-099_a24bfd52-5fd3-4980-8e64-5ba6b0d93d67	16714-099	HUMAN PRESCRIPTION DRUG	tacrolimus		tacrolimus	CAPSULE	ORAL	20210331		ANDA	ANDA206662	NORTHSTAR RX LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
16714-100_a24bfd52-5fd3-4980-8e64-5ba6b0d93d67	16714-100	HUMAN PRESCRIPTION DRUG	tacrolimus		tacrolimus	CAPSULE	ORAL	20210331		ANDA	ANDA206662	NORTHSTAR RX LLC	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
16714-101_ce9164d3-26bf-4ff7-b911-cbcdfdded793	16714-101	HUMAN PRESCRIPTION DRUG	Gemfibrozil		gemfibrozil	TABLET	ORAL	20101220		ANDA	ANDA079072	Northstar RxLLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
16714-110_8a8ff1ee-418a-41d3-b607-67d1dfb55a79	16714-110	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20191001		ANDA	ANDA040657	Northstar Rx LLC.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
16714-112_a3031cb7-423c-64e2-e1d4-2b07f2e7ba3a	16714-112	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20190918		ANDA	ANDA076006	NorthStar Rx LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-113_a3031cb7-423c-64e2-e1d4-2b07f2e7ba3a	16714-113	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20190918		ANDA	ANDA076006	NorthStar Rx LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-114_fcd7f665-7da9-1938-f957-1dc67b1a6a3c	16714-114	HUMAN PRESCRIPTION DRUG	Fluoxetine hydrochloride		Fluoxetine hydrochloride	TABLET, FILM COATED	ORAL; ORAL	20190918		ANDA	ANDA211721	NorthStar Rx LLC	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-115_d1c74c9f-51cd-4fdd-a49a-67cf6c8fe12d	16714-115	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191001		ANDA	ANDA206318	Northstar Rx LLC.	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
16714-116_d1c74c9f-51cd-4fdd-a49a-67cf6c8fe12d	16714-116	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191001		ANDA	ANDA206318	Northstar Rx LLC.	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
16714-117_d1c74c9f-51cd-4fdd-a49a-67cf6c8fe12d	16714-117	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191001		ANDA	ANDA206318	Northstar Rx LLC.	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
16714-119_f6d6a715-0341-9698-53c2-57466c491e60	16714-119	HUMAN PRESCRIPTION DRUG	Tobramycin Inhalation Solution		Tobramycin Inhalation Solution	INHALANT	RESPIRATORY (INHALATION)	20200521		ANDA	ANDA207080	NorthStar RxLLC	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
16714-120_8587454d-3782-2774-1a01-a85b7c192592	16714-120	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200116		ANDA	ANDA209965	NorthStar RxLLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
16714-121_6eb119e3-f030-44d3-98d7-42d9fe0edbcc	16714-121	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		pilocarpine hydrochloride	TABLET, FILM COATED	ORAL	20190813		ANDA	ANDA212377	NorthStar Rx LLC	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
16714-122_6eb119e3-f030-44d3-98d7-42d9fe0edbcc	16714-122	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		pilocarpine hydrochloride	TABLET, FILM COATED	ORAL	20190813		ANDA	ANDA212377	NorthStar Rx LLC	PILOCARPINE HYDROCHLORIDE	7.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
16714-123_3dba1b9f-de37-77e3-196d-0f4949648653	16714-123	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA078490	NorthStar Rx LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-128_1a83a458-0a7f-44f1-b805-6288b06a4359	16714-128	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20191121		ANDA	ANDA207813	Northstar Rx LLC.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
16714-129_1a83a458-0a7f-44f1-b805-6288b06a4359	16714-129	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20191121		ANDA	ANDA207813	Northstar Rx LLC.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
16714-130_d601dd41-2f8b-4450-8277-8f5ae3761ba8	16714-130	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20191119		ANDA	ANDA207550	NorthStar Rx LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-131_7d7ed052-95ae-6d58-f41f-ada9f8f97b81	16714-131	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloride		Irinotecan hydrochloride	INJECTION	INTRAVENOUS	20201115		ANDA	ANDA212993	Northstar Rx LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
16714-132_a422cc7f-3a62-46dc-91bd-7f8e392fb726	16714-132	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	NORTHSTAR RX LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-133_a422cc7f-3a62-46dc-91bd-7f8e392fb726	16714-133	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	NORTHSTAR RX LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-134_a422cc7f-3a62-46dc-91bd-7f8e392fb726	16714-134	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	NORTHSTAR RX LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-135_a422cc7f-3a62-46dc-91bd-7f8e392fb726	16714-135	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	NORTHSTAR RX LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-136_a422cc7f-3a62-46dc-91bd-7f8e392fb726	16714-136	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	NORTHSTAR RX LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-137_1f5ca3d3-f137-4efe-91d1-11fac6e8ebb1	16714-137	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20210125		ANDA	ANDA213434	Northstar Rx LLC	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
16714-140_d601dd41-2f8b-4450-8277-8f5ae3761ba8	16714-140	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20191119		ANDA	ANDA207550	NorthStar Rx LLC	TRIAMCINOLONE ACETONIDE	200	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-141_04230bfc-e6ad-1844-e063-6394a90a939e	16714-141	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201001		ANDA	ANDA205064	NorthStar RxLLC	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-142_04230bfc-e6ad-1844-e063-6394a90a939e	16714-142	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201001		ANDA	ANDA205064	NorthStar RxLLC	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-143_04230bfc-e6ad-1844-e063-6394a90a939e	16714-143	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201001		ANDA	ANDA205064	NorthStar RxLLC	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-144_04230bfc-e6ad-1844-e063-6394a90a939e	16714-144	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201001		ANDA	ANDA205064	NorthStar RxLLC	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-145_04230bfc-e6ad-1844-e063-6394a90a939e	16714-145	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201001		ANDA	ANDA205064	NorthStar RxLLC	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-146_04230bfc-e6ad-1844-e063-6394a90a939e	16714-146	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201001		ANDA	ANDA205064	NorthStar RxLLC	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-150_d601dd41-2f8b-4450-8277-8f5ae3761ba8	16714-150	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20191119		ANDA	ANDA207550	NorthStar Rx LLC	TRIAMCINOLONE ACETONIDE	400	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-151_03a5672d-d01c-495c-91d9-d1f4e8426093	16714-151	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211124		ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	2	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-152_03a5672d-d01c-495c-91d9-d1f4e8426093	16714-152	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211124		ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	4	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-153_03a5672d-d01c-495c-91d9-d1f4e8426093	16714-153	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211124		ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	12	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-154_03a5672d-d01c-495c-91d9-d1f4e8426093	16714-154	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211124		ANDA	ANDA214816	Northstar Rx LLC	TIAGABINE HYDROCHLORIDE	16	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-155_e4ca7445-38c6-87b9-ab5b-1c06f2153d23	16714-155	HUMAN PRESCRIPTION DRUG	norethindrone acetate and ethinyl estradiol, and ferrous fumarate		norethindrone acetate and ethinyl estradiol, and ferrous fumarate	KIT		20210407		ANDA	ANDA213317	Northstar Rx LLC						N	20241231
16714-156_c4d3b57f-6031-43e4-93db-143b789151c1	16714-156	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20210518		ANDA	ANDA212411	NorthStar RxLLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
16714-157_c32966cf-c512-5049-59d7-0a8970c23605	16714-157	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210412		ANDA	ANDA205229	Northstar Rx LLC	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
16714-158_c32966cf-c512-5049-59d7-0a8970c23605	16714-158	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210412		ANDA	ANDA205229	Northstar Rx LLC	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
16714-159_395f1d56-79aa-4ab2-8565-dade633d91cc	16714-159	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20210406		ANDA	ANDA078539	NorthStar Rx LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16714-160_395f1d56-79aa-4ab2-8565-dade633d91cc	16714-160	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20210406		ANDA	ANDA078539	NorthStar Rx LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16714-161_00b72cb7-8c7b-49f5-a735-405718e0f451	16714-161	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	GEL	TOPICAL	20210310		ANDA	ANDA214251	NORTHSTAR RX LLC	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
16714-164_6ecfa4c2-8dd8-46b3-88f6-c10d393bfe46	16714-164	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221101		ANDA	ANDA215241	Northstar Rx LLC.	MICAFUNGIN SODIUM	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
16714-165_c98d8fe3-6d83-4525-be4e-6309434efd0e	16714-165	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220718		ANDA	ANDA214655	Northstar Rx LLC.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
16714-166_459a6a45-6f10-4bdc-965c-0c83161cf06b	16714-166	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210505		ANDA	ANDA214803	Northstar Rx LLC	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
16714-167_459a6a45-6f10-4bdc-965c-0c83161cf06b	16714-167	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210505		ANDA	ANDA214803	Northstar Rx LLC	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
16714-168_459a6a45-6f10-4bdc-965c-0c83161cf06b	16714-168	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210505		ANDA	ANDA214803	Northstar Rx LLC	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
16714-170_c884344b-2520-4874-866c-bf9798b506d3	16714-170	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	CAPSULE	ORAL	20200701		ANDA	ANDA213046	NORTHSTAR RX LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
16714-171_a9995022-1f3f-f0dd-9672-60b074bfca01	16714-171	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210615		ANDA	ANDA076286	NorthStar Rx LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
16714-172_a9995022-1f3f-f0dd-9672-60b074bfca01	16714-172	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210615		ANDA	ANDA076286	NorthStar Rx LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
16714-173_96996532-2b61-b82d-c9db-d967eb3bd86e	16714-173	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	NORTHSTAR RX LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-174_96996532-2b61-b82d-c9db-d967eb3bd86e	16714-174	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	NORTHSTAR RX LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-175_96996532-2b61-b82d-c9db-d967eb3bd86e	16714-175	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	NORTHSTAR RX LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-176_96996532-2b61-b82d-c9db-d967eb3bd86e	16714-176	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	NORTHSTAR RX LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-178_7106b404-bb4d-43e4-9809-17bd2e95a63b	16714-178	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	CREAM	TOPICAL	20100305		ANDA	ANDA090368	NORTHSTAR RX LLC	FLUOROURACIL	50	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16714-181_8a74c69c-6834-4d59-9f51-9eeacdfb4d9e	16714-181	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	NorthStar Rx LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-182_8a74c69c-6834-4d59-9f51-9eeacdfb4d9e	16714-182	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	NorthStar Rx LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-183_8a74c69c-6834-4d59-9f51-9eeacdfb4d9e	16714-183	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	NorthStar Rx LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-184_8a74c69c-6834-4d59-9f51-9eeacdfb4d9e	16714-184	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	NorthStar Rx LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-185_1e12b24b-c259-7423-cf4a-494d2fbe098b	16714-185	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20211210		ANDA	ANDA210465	NorthStar Rx LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-186_1e12b24b-c259-7423-cf4a-494d2fbe098b	16714-186	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20211210		ANDA	ANDA210465	NorthStar Rx LLC	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-187_83cef7f7-673f-47fb-96ec-2d0dfa776c6c	16714-187	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20211018		ANDA	ANDA208691	NORTHSTAR RX LLC	SIROLIMUS	.5	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
16714-188_83cef7f7-673f-47fb-96ec-2d0dfa776c6c	16714-188	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20211018		ANDA	ANDA208691	NORTHSTAR RX LLC	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
16714-189_83cef7f7-673f-47fb-96ec-2d0dfa776c6c	16714-189	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20211018		ANDA	ANDA208691	NORTHSTAR RX LLC	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
16714-190_c814dfbf-6aa6-49db-834a-c95bb76be901	16714-190	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20210917		ANDA	ANDA205689	NORTHSTAR RXLLC	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
16714-191_c814dfbf-6aa6-49db-834a-c95bb76be901	16714-191	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20210917		ANDA	ANDA205689	NORTHSTAR RXLLC	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
16714-192_c814dfbf-6aa6-49db-834a-c95bb76be901	16714-192	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20210917		ANDA	ANDA205689	NORTHSTAR RXLLC	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
16714-193_c814dfbf-6aa6-49db-834a-c95bb76be901	16714-193	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20210917		ANDA	ANDA205689	NORTHSTAR RXLLC	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
16714-194_9386cb5f-ece0-47fd-82b5-8c80475a7094	16714-194	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211117		ANDA	ANDA077633	Northstar Rx LLC.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-195_9386cb5f-ece0-47fd-82b5-8c80475a7094	16714-195	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211117		ANDA	ANDA077633	Northstar Rx LLC.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-196_9386cb5f-ece0-47fd-82b5-8c80475a7094	16714-196	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211117		ANDA	ANDA077633	Northstar Rx LLC.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-197_9386cb5f-ece0-47fd-82b5-8c80475a7094	16714-197	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211117		ANDA	ANDA077633	Northstar Rx LLC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-198_98b2d3a5-0716-4dd0-8d55-b7fb85a5c8c8	16714-198	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20160122		ANDA	ANDA206837	NorthStar Rx LLC	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-199_98b2d3a5-0716-4dd0-8d55-b7fb85a5c8c8	16714-199	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20160122		ANDA	ANDA206837	NorthStar Rx LLC	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-200_1b0c626d-891f-429d-9471-76bbefba84dc	16714-200	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20210427		ANDA	ANDA090469	NorthStar Rx LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16714-201_1b0c626d-891f-429d-9471-76bbefba84dc	16714-201	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20210427		ANDA	ANDA090469	NorthStar Rx LLC	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16714-213_bbe6e724-0216-4014-8ee7-12afb4196826	16714-213	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20150828		ANDA	ANDA204310	NorthStar Rx LLC	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
16714-227_63065e30-4a50-42b0-9622-a393923c1e98	16714-227	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20210722		ANDA	ANDA090132	NorthStar RxLLC	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
16714-228_63065e30-4a50-42b0-9622-a393923c1e98	16714-228	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20210722		ANDA	ANDA090132	NorthStar RxLLC	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
16714-229_63065e30-4a50-42b0-9622-a393923c1e98	16714-229	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20210722		ANDA	ANDA090132	NorthStar RxLLC	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
16714-230_63065e30-4a50-42b0-9622-a393923c1e98	16714-230	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20210722		ANDA	ANDA090132	NorthStar RxLLC	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
16714-234_20659e2d-f79a-447a-87d9-0baeee7567fc	16714-234	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	NorthStar Rx LLC	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
16714-235_20659e2d-f79a-447a-87d9-0baeee7567fc	16714-235	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	NorthStar Rx LLC	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
16714-244_ffd93549-95d1-4e0e-9572-59f74325d60c	16714-244	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	POWDER, FOR SUSPENSION	ORAL	20210712		ANDA	ANDA091020	Northstar Rx LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
16714-245_4165aaf9-fbfa-4c69-ac38-f16a71a57e88	16714-245	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUPPOSITORY	RECTAL	20210825		ANDA	ANDA208953	Northstar Rx LLC.	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20251231
16714-246_e794576c-46e9-481b-8c68-5a6be27acd64	16714-246	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	LOTION	TOPICAL	20210628		ANDA	ANDA214526	NORTHSTAR RX LLC	CLINDAMYCIN PHOSPHATE	10	ug/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
16714-247_a42cb3cc-973a-46b7-8f67-35d2fe21a251	16714-247	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160331		ANDA	ANDA205780	NorthStar Rx LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
16714-248_014ef0ec-f371-ccc7-e063-6294a90a7349	16714-248	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant dimeglumine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230128		ANDA	ANDA214616	NorthStar RxLLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
16714-249_ea965a1b-4b94-413b-b91c-5c3cf1a6ac0d	16714-249	HUMAN PRESCRIPTION DRUG	Tretinoin		tretinoin	CREAM	TOPICAL	20190125		ANDA	ANDA211644	NORTHSTAR RX LLC	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
16714-250_b1e1b721-9c1a-4b2d-bd63-7c0153645a15	16714-250	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CREAM	TOPICAL	20190122		ANDA	ANDA211645	NORTHSTAR RX LLC	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
16714-257_6d101525-fff8-4f56-9023-b3f96aff7829	16714-257	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	Northstar Rx LLC.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-258_6d101525-fff8-4f56-9023-b3f96aff7829	16714-258	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	Northstar Rx LLC.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-259_6d101525-fff8-4f56-9023-b3f96aff7829	16714-259	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	Northstar Rx LLC.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-260_6d101525-fff8-4f56-9023-b3f96aff7829	16714-260	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	Northstar Rx LLC.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-261_6d101525-fff8-4f56-9023-b3f96aff7829	16714-261	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	Northstar Rx LLC.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-262_6d101525-fff8-4f56-9023-b3f96aff7829	16714-262	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	Northstar Rx LLC.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-267_3379f247-4a29-4373-9843-0b7f044c2276	16714-267	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20220421		ANDA	ANDA209828	NorthStar RxLLC	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-268_3379f247-4a29-4373-9843-0b7f044c2276	16714-268	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20220421		ANDA	ANDA209828	NorthStar RxLLC	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-292_17dd99e2-6b6b-48e6-937e-4ff888c41424	16714-292	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	NorthStar Rx LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-293_17dd99e2-6b6b-48e6-937e-4ff888c41424	16714-293	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	NorthStar Rx LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-294_ac92f07a-3146-413e-b717-ae0f72d0f68c	16714-294	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	NorthStar Rx LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-295_07a3d17a-ef85-4ef0-a054-24c8327ab726	16714-295	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091569	NorthStar Rx LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-296_07a3d17a-ef85-4ef0-a054-24c8327ab726	16714-296	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091569	NorthStar Rx LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-297_07a3d17a-ef85-4ef0-a054-24c8327ab726	16714-297	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	NorthStar Rx LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-298_131b8d82-6232-4dfb-9d81-189f482c14df	16714-298	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NorthStar Rx LLC	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
16714-299_131b8d82-6232-4dfb-9d81-189f482c14df	16714-299	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NorthStar Rx LLC	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
16714-301_6ecfa4c2-8dd8-46b3-88f6-c10d393bfe46	16714-301	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221101		ANDA	ANDA215241	Northstar Rx LLC.	MICAFUNGIN SODIUM	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
16714-302_c98d8fe3-6d83-4525-be4e-6309434efd0e	16714-302	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220718		ANDA	ANDA214655	Northstar Rx LLC.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
16714-309_a42cb3cc-973a-46b7-8f67-35d2fe21a251	16714-309	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160331		ANDA	ANDA205780	NorthStar Rx LLC	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
16714-310_dfc059d7-29ab-133b-e053-2a95a90a83d6	16714-310	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20211114		ANDA	ANDA090515	NorthStar RxLLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-330_54e35dd9-263c-43ad-83db-1bb785ce0d40	16714-330	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	NorthStar Rx LLC	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16714-332_54e35dd9-263c-43ad-83db-1bb785ce0d40	16714-332	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	NorthStar Rx LLC	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16714-340_8fa8e5c3-f70a-41e5-a118-2d86f7a71b69	16714-340	HUMAN PRESCRIPTION DRUG	Levonest		levonorgestrel and ethinyl estradiol	KIT		20101229		ANDA	ANDA090719	Northstar Rx LLC						N	20241231
16714-345_34a1dff5-eedc-4ab3-903f-0fa5d9fe5a7c	16714-345	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	POWDER, FOR SUSPENSION	ORAL	20210729		ANDA	ANDA214525	NorthStar RxLLC	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
16714-346_a7847482-79ef-4616-87b0-7c51e284f9be	16714-346	HUMAN PRESCRIPTION DRUG	Dasetta 7/7/7		norethindrone and ethinyl estradiol	KIT	ORAL	20111222		ANDA	ANDA090946	Northstar Rx LLC						N	20241231
16714-347_88394569-c2fb-417e-82c2-0f258a79c0d1	16714-347	HUMAN PRESCRIPTION DRUG	Philith		Norethindrone and Ethinyl Estradiol Tablets	KIT	ORAL	20111222		ANDA	ANDA090947	Northstar Rx LLC						N	20241231
16714-348_e5b82b4d-f1c2-4ab3-bd3f-90ef7fa760c1	16714-348	HUMAN PRESCRIPTION DRUG	Dasetta 1/35		Norethindrone and Ethinyl Estradiol	KIT	ORAL	20111222		ANDA	ANDA090948	Northstar Rx LLC						N	20241231
16714-354_3bf81553-6089-4841-86f0-a188d82fc6d7	16714-354	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	NorthStar Rx LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-355_3bf81553-6089-4841-86f0-a188d82fc6d7	16714-355	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	NorthStar Rx LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-356_3bf81553-6089-4841-86f0-a188d82fc6d7	16714-356	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	NorthStar Rx LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-357_3bf81553-6089-4841-86f0-a188d82fc6d7	16714-357	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	NorthStar Rx LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-358_29d37aea-2c61-4364-bbdf-a786d639dbab	16714-358	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20090115		ANDA	ANDA079063	NorthStar Rx LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-359_b65ade06-5fdd-465b-9123-54e898caa35d	16714-359	HUMAN PRESCRIPTION DRUG	Falmina		levonorgestrel and ethinyl estradiol	KIT		20130913		ANDA	ANDA090721	Northstar Rx LLC						N	20241231
16714-360_d41d4d72-3f5a-43e4-8453-35e477793f86	16714-360	HUMAN PRESCRIPTION DRUG	Mono-Linyah		norgestimate and ethinyl estradiol	KIT		20120523		ANDA	ANDA090523	Northstar Rx LLC						N	20241231
16714-363_ab06ed4b-8a95-4ab1-a3c8-51b185a70852	16714-363	HUMAN PRESCRIPTION DRUG	Tri-Linyah		Norgestimate and Ethinyl Estradiol	KIT		20120530		ANDA	ANDA090524	Northstar Rx LLC						N	20241231
16714-365_286aaa60-b89f-4a54-ba80-64efdfa96c38	16714-365	HUMAN PRESCRIPTION DRUG	Elinest		Norgestrel and Ethinyl Estradiol	KIT		20120107		ANDA	ANDA091105	Northstar Rx LLC						N	20241231
16714-366_4f831205-799a-4922-b53b-85dbd85e0a8a	16714-366	HUMAN PRESCRIPTION DRUG	SETLAKIN		Levonorgestrel and Ethinyl Estradiol	KIT		20150801		ANDA	ANDA090716	Northstar Rx LLC						N	20241231
16714-370_49975411-6285-49ce-b7c1-68cf59482261	16714-370	HUMAN PRESCRIPTION DRUG	Wera		norethindrone and ethinyl estradiol	KIT	ORAL	20120327		ANDA	ANDA091204	Northstar Rx LLC						N	20241231
16714-375_3f84ee66-809f-4084-82fe-31b83d39b65a	16714-375	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	NorthStar Rx LLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-376_3f84ee66-809f-4084-82fe-31b83d39b65a	16714-376	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	NorthStar Rx LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-377_3f84ee66-809f-4084-82fe-31b83d39b65a	16714-377	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	NorthStar Rx LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-378_3f84ee66-809f-4084-82fe-31b83d39b65a	16714-378	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	NorthStar Rx LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-379_3f84ee66-809f-4084-82fe-31b83d39b65a	16714-379	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	NorthStar Rx LLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-380_3f84ee66-809f-4084-82fe-31b83d39b65a	16714-380	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	NorthStar Rx LLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-388_1d291552-0e9b-4c67-b2bb-1028ac9e40b4	16714-388	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	NorthStar Rx LLC	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
16714-389_a5bd7efd-4460-446b-ad07-560287db39db	16714-389	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20130425		ANDA	ANDA065349	NorthStar Rx LLC	CEFADROXIL	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
16714-390_a5bd7efd-4460-446b-ad07-560287db39db	16714-390	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20130425		ANDA	ANDA065349	NorthStar Rx LLC	CEFADROXIL	500	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
16714-394_518e9779-a683-436e-a032-c6a0df0a0de2	16714-394	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	NorthStar Rx LLC	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
16714-395_518e9779-a683-436e-a032-c6a0df0a0de2	16714-395	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	NorthStar Rx LLC	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
16714-396_f8549985-02c2-4301-a433-fb846a06b078	16714-396	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130		ANDA	ANDA065381	NorthStar Rx LLC	CEFPROZIL	125	mg/5mL			N	20241231
16714-397_f8549985-02c2-4301-a433-fb846a06b078	16714-397	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130		ANDA	ANDA065381	NorthStar Rx LLC	CEFPROZIL	250	mg/5mL			N	20241231
16714-398_ad715bf5-d1a1-434b-8259-2c5d4292ce1f	16714-398	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA065340	NorthStar Rx LLC	CEFPROZIL	250	mg/1			N	20241231
16714-399_ad715bf5-d1a1-434b-8259-2c5d4292ce1f	16714-399	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA065340	NorthStar Rx LLC	CEFPROZIL	500	mg/1			N	20241231
16714-400_dbc05a33-4208-4d3f-8070-91dc5faa8ec7	16714-400	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	NorthStar Rx LLC	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
16714-401_dbc05a33-4208-4d3f-8070-91dc5faa8ec7	16714-401	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	NorthStar Rx LLC	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
16714-402_3c3d4973-bfda-476f-b094-52ac4648d7f8	16714-402	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	GRANULE, FOR SUSPENSION	ORAL	20070608		ANDA	ANDA065409	NorthStar Rx LLC	CEFPODOXIME PROXETIL	50	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
16714-403_3c3d4973-bfda-476f-b094-52ac4648d7f8	16714-403	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	GRANULE, FOR SUSPENSION	ORAL	20070608		ANDA	ANDA065409	NorthStar Rx LLC	CEFPODOXIME PROXETIL	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
16714-404_4a4d907b-e6c5-4563-8ec3-46f3c38812b5	16714-404	HUMAN PRESCRIPTION DRUG	PIMTREA		desogestrel/ethinyl estradiol and ethinyl estradiol	KIT		20130801		ANDA	ANDA091247	Northstar Rx LLC						N	20241231
16714-405_beef5d0b-1f9b-4002-b44b-fba0bafd32ce	16714-405	HUMAN PRESCRIPTION DRUG	Larin Fe 1.5/30		Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20130823		ANDA	ANDA091453	Northstar Rx LLC						N	20241231
16714-406_d9a9cc93-f201-41ad-b15f-da2b5d4cc9ee	16714-406	HUMAN PRESCRIPTION DRUG	Larin Fe 1/20		Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20130826		ANDA	ANDA091454	Northstar Rx LLC						N	20241231
16714-407_2f2b500e-c07b-4e89-9423-9263bf5499a7	16714-407	HUMAN PRESCRIPTION DRUG	Larin 1.5/30		Norethindrone Acetate/Ethinyl Estradiol	KIT		20140320		ANDA	ANDA202996	Northstar Rx LLC						N	20241231
16714-408_a80472fc-ae27-416b-b553-0ec58e678420	16714-408	HUMAN PRESCRIPTION DRUG	Larin 1/20		Norethindrone Acetate/Ethinyl Estradiol	KIT		20131204		ANDA	ANDA202995	Northstar Rx LLC						N	20241231
16714-416_a82999f8-24b3-4011-947b-e665b5cb27d8	16714-416	HUMAN PRESCRIPTION DRUG	Larin 24 Fe		Norethindrone acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20150218		ANDA	ANDA202994	Northstar Rx LLC						N	20241231
16714-439_9490e8e5-c16f-40e2-83b3-cc0f6660f3d7	16714-439	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20141101		ANDA	ANDA077066	Northstar RxLLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
16714-440_d9815244-f1c6-45bd-8f39-47ed32428fc9	16714-440	HUMAN PRESCRIPTION DRUG	DEBLITANE		Norethindrone	KIT		20130913		ANDA	ANDA202014	Northstar Rx LLC						N	20241231
16714-441_12cdd230-f9da-453c-8551-cd2726cdffd6	16714-441	HUMAN PRESCRIPTION DRUG	SHAROBEL		Norethindrone	KIT		20130913		ANDA	ANDA200961	Northstar Rx LLC						N	20241231
16714-442_ccd089bd-f62e-4aed-b714-083d487ba51c	16714-442	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20150806		ANDA	ANDA075496	Northstar RxLLC	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
16714-443_ccd089bd-f62e-4aed-b714-083d487ba51c	16714-443	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20150806		ANDA	ANDA075496	Northstar RxLLC	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
16714-444_ccd089bd-f62e-4aed-b714-083d487ba51c	16714-444	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20150806		ANDA	ANDA075459	Northstar RxLLC	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
16714-445_ccd089bd-f62e-4aed-b714-083d487ba51c	16714-445	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20150806		ANDA	ANDA075459	Northstar RxLLC	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
16714-446_11a82180-1ec5-4a05-8449-4cd30011b513	16714-446	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20141201	20240831	ANDA	ANDA085968	Northstar RxLLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	
16714-447_11a82180-1ec5-4a05-8449-4cd30011b513	16714-447	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20141201	20240831	ANDA	ANDA085968	Northstar RxLLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
16714-448_11a82180-1ec5-4a05-8449-4cd30011b513	16714-448	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20141201	20240831	ANDA	ANDA085968	Northstar RxLLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
16714-449_11a82180-1ec5-4a05-8449-4cd30011b513	16714-449	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20141201	20240831	ANDA	ANDA085968	Northstar RxLLC	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	
16714-450_11a82180-1ec5-4a05-8449-4cd30011b513	16714-450	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20141201	20240831	ANDA	ANDA085968	Northstar RxLLC	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	
16714-451_11a82180-1ec5-4a05-8449-4cd30011b513	16714-451	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20141201	20240831	ANDA	ANDA085968	Northstar RxLLC	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	
16714-452_eed3c37a-4c97-52aa-e053-2995a90a2588	16714-452	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Northstar RxLLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-453_eed3c37a-4c97-52aa-e053-2995a90a2588	16714-453	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Northstar RxLLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-454_eed3c37a-4c97-52aa-e053-2995a90a2588	16714-454	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Northstar RxLLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-455_eed3c37a-4c97-52aa-e053-2995a90a2588	16714-455	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Northstar RxLLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-456_eed3c37a-4c97-52aa-e053-2995a90a2588	16714-456	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Northstar RxLLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-457_eed3c37a-4c97-52aa-e053-2995a90a2588	16714-457	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Northstar RxLLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-464_e20e855c-c57f-4bcd-aad3-4b45e2846dca	16714-464	HUMAN PRESCRIPTION DRUG	Juleber		Desogestrel and Ethinyl Estradiol	KIT		20130712		ANDA	ANDA091234	Northstar Rx LLC						N	20241231
16714-467_d6937464-feb2-ada0-e053-2a95a90a3aef	16714-467	HUMAN PRESCRIPTION DRUG	CAPECITABINE		CAPECITABINE	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA202593	NORTHSTAR RXLLC	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16714-468_d6937464-feb2-ada0-e053-2a95a90a3aef	16714-468	HUMAN PRESCRIPTION DRUG	CAPECITABINE		CAPECITABINE	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA202593	NORTHSTAR RXLLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16714-476_34026823-7bb3-4f3c-a125-32213d1eeb8c	16714-476	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA065189	Northstar RxLLC	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-477_34026823-7bb3-4f3c-a125-32213d1eeb8c	16714-477	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA065064	Northstar RxLLC	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
16714-483_b8357ebf-fed5-489b-b564-2abd31b6e0a9	16714-483	HUMAN PRESCRIPTION DRUG	Clindamycin Palmitate Hydrochloride (Pediatric)		Clindamycin Palmitate Hydrochloride (Pediatric)	SOLUTION	ORAL	20130430		ANDA	ANDA202409	NorthStar Rx LLC	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
16714-484_f896c6af-773b-4b7a-9e50-73cc51da71ba	16714-484	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	NorthStar Rx LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16714-485_f896c6af-773b-4b7a-9e50-73cc51da71ba	16714-485	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	NorthStar Rx LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
16714-496_430a54e3-a9b4-4b22-abc7-6f162fb3f7ad	16714-496	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20010529		ANDA	ANDA075673	NORTHSTAR RX LLC	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.64; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-497_82762f26-dd4d-4600-a397-3e1a3571ff8f	16714-497	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	NORTHSTAR RX LLC	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16714-498_82762f26-dd4d-4600-a397-3e1a3571ff8f	16714-498	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	NORTHSTAR RX LLC	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16714-499_82762f26-dd4d-4600-a397-3e1a3571ff8f	16714-499	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	NORTHSTAR RX LLC	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16714-510_0302ece5-4e30-69e6-e063-6294a90a256b	16714-510	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20170501	20240229	ANDA	ANDA205085	NorthStar RxLLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	
16714-517_afe99d8a-b127-4a95-aed6-66e696630b28	16714-517	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160329		ANDA	ANDA205779	NorthStar Rx LLC	VANCOMYCIN HYDROCHLORIDE	5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
16714-523_7344409e-287a-343a-3b37-bc21e509c07f	16714-523	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20220222		ANDA	ANDA074943	NORTHSTAR RX LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-524_7344409e-287a-343a-3b37-bc21e509c07f	16714-524	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20220222		ANDA	ANDA074943	NORTHSTAR RX LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-525_7344409e-287a-343a-3b37-bc21e509c07f	16714-525	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20220222		ANDA	ANDA074943	NORTHSTAR RX LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-526_07e8e0c7-021f-012e-96a4-89728f81d435	16714-526	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY, METERED	NASAL	20220222		ANDA	ANDA076156	NORTHSTAR RX LLC	IPRATROPIUM BROMIDE	21	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16714-527_a9f4f469-7feb-dc25-8dbc-197642c49a6b	16714-527	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		ipratropium bromide	SPRAY, METERED	NASAL	20220222		ANDA	ANDA076155	NORTHSTAR RX LLC	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16714-528_e5b50fe9-165a-4649-afe1-c8b5fe5c960a	16714-528	HUMAN PRESCRIPTION DRUG	propofol		propofol	INJECTION, EMULSION	INTRAVENOUS	20220701		ANDA	ANDA206408	NorthStar Rx LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
16714-529_4bf3278c-116f-4db7-9af0-08faaf7691a4	16714-529	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20061227		ANDA	ANDA077910	NorthStar Rx LLC	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
16714-530_4bf3278c-116f-4db7-9af0-08faaf7691a4	16714-530	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20061227		ANDA	ANDA077910	NorthStar Rx LLC	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
16714-534_1fab5d61-9784-4a57-9895-cb797fae1400	16714-534	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20220309		ANDA	ANDA203442	NorthStar RxLLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
16714-535_f00461e3-12cb-3905-e053-2a95a90a4e12	16714-535	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20230402		ANDA	ANDA214321	NorthStar RxLLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
16714-536_aba12f19-227e-a6e0-2538-bf947445a8cd	16714-536	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220810		ANDA	ANDA210246	NORTHSTAR RX LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16714-537_dfc059d7-29ab-133b-e053-2a95a90a83d6	16714-537	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220329		ANDA	ANDA090515	NorthStar RxLLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-548_04819f39-0733-4781-825e-4c9f759ebd38	16714-548	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220801		ANDA	ANDA208308	NorthStar RxLLC	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
16714-549_04819f39-0733-4781-825e-4c9f759ebd38	16714-549	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220801		ANDA	ANDA208308	NorthStar RxLLC	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
16714-550_04819f39-0733-4781-825e-4c9f759ebd38	16714-550	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220801		ANDA	ANDA208308	NorthStar RxLLC	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
16714-552_04819f39-0733-4781-825e-4c9f759ebd38	16714-552	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220801		ANDA	ANDA208308	NorthStar RxLLC	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
16714-553_a11626b3-d7a9-43b0-85d4-38a582acd661	16714-553	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220623		ANDA	ANDA212317	Northstar Rx LLC	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
16714-554_a11626b3-d7a9-43b0-85d4-38a582acd661	16714-554	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220623		ANDA	ANDA212317	Northstar Rx LLC	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
16714-555_a11626b3-d7a9-43b0-85d4-38a582acd661	16714-555	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220623		ANDA	ANDA212317	Northstar Rx LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
16714-556_68f66df7-6aa0-481c-99b9-4314a3736ed1	16714-556	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20220801		ANDA	ANDA202313	NorthStar Rx LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
16714-557_d7cc0dfd-2d83-45ac-aef7-d8f5be09238d	16714-557	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	VAGINAL	20220624		ANDA	ANDA215794	Northstar Rx LLC	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
16714-558_fa078b35-ee9d-4b9f-bb8d-e77949c09f88	16714-558	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20220812		ANDA	ANDA077987	NorthStar RxLLC	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-559_fa078b35-ee9d-4b9f-bb8d-e77949c09f88	16714-559	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20220812		ANDA	ANDA077987	NorthStar RxLLC	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-560_fa078b35-ee9d-4b9f-bb8d-e77949c09f88	16714-560	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20220812		ANDA	ANDA077987	NorthStar RxLLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-562_2885e800-bd09-4031-b069-8bb153e15b98	16714-562	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-563_2885e800-bd09-4031-b069-8bb153e15b98	16714-563	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-564_2885e800-bd09-4031-b069-8bb153e15b98	16714-564	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-565_2885e800-bd09-4031-b069-8bb153e15b98	16714-565	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-566_2885e800-bd09-4031-b069-8bb153e15b98	16714-566	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-567_2885e800-bd09-4031-b069-8bb153e15b98	16714-567	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-568_2885e800-bd09-4031-b069-8bb153e15b98	16714-568	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-569_2885e800-bd09-4031-b069-8bb153e15b98	16714-569	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220121		ANDA	ANDA206734	Northstar Rx LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-570_fa078b35-ee9d-4b9f-bb8d-e77949c09f88	16714-570	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20220812		ANDA	ANDA077987	NorthStar RxLLC	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-572_585b897e-a1ed-418c-8c4e-96a385b9d72b	16714-572	HUMAN PRESCRIPTION DRUG	leuprolide acetate		leuprolide acetate	KIT		20220801		ANDA	ANDA078885	NorthStar RxLLC						N	20241231
16714-576_bcc699cf-925c-425c-ab3b-12724b1822af	16714-576	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220701		ANDA	ANDA204467	NorthStar RxLLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16714-577_bcc699cf-925c-425c-ab3b-12724b1822af	16714-577	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220701		ANDA	ANDA204467	NorthStar RxLLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16714-578_ee4ad9f3-8ded-53f0-e053-2995a90ae065	16714-578	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20221118		ANDA	ANDA207475	NorthStar RxLLC	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16714-590_b6988d7b-4a9b-4c1a-b9e1-197ef632abb3	16714-590	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20160912		ANDA	ANDA076363	Northstar Rx LLC	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
16714-591_b6988d7b-4a9b-4c1a-b9e1-197ef632abb3	16714-591	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20160912		ANDA	ANDA076363	Northstar Rx LLC	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
16714-601_1f8f910c-d003-4969-b3d7-a2cec1e3adca	16714-601	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	SOLUTION	ORAL	20081031		ANDA	ANDA078861	NorthStar Rx LLC	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-609_c98d8fe3-6d83-4525-be4e-6309434efd0e	16714-609	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220718		ANDA	ANDA214655	Northstar Rx LLC.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
16714-611_4e93b0ec-871b-41f6-a972-147bab3d5e9b	16714-611	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NorthStar Rx LLC	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-612_4e93b0ec-871b-41f6-a972-147bab3d5e9b	16714-612	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NorthStar Rx LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-613_4e93b0ec-871b-41f6-a972-147bab3d5e9b	16714-613	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NorthStar Rx LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-620_aba12f19-227e-a6e0-2538-bf947445a8cd	16714-620	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221118		ANDA	ANDA210246	NORTHSTAR RX LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16714-621_c4e9a658-250e-4e77-968d-d214bc665e61	16714-621	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	NorthStar Rx LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
16714-622_c4e9a658-250e-4e77-968d-d214bc665e61	16714-622	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	NorthStar Rx LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
16714-623_3fca77cd-0645-d615-fd67-34db69aa44fa	16714-623	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20170620		ANDA	ANDA202383	NorthStar Rx LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-624_3fca77cd-0645-d615-fd67-34db69aa44fa	16714-624	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20170620		ANDA	ANDA202383	NorthStar Rx LLC	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-625_3fca77cd-0645-d615-fd67-34db69aa44fa	16714-625	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20170620		ANDA	ANDA202383	NorthStar Rx LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-626_3fca77cd-0645-d615-fd67-34db69aa44fa	16714-626	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20170620		ANDA	ANDA202383	NorthStar Rx LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-627_3fca77cd-0645-d615-fd67-34db69aa44fa	16714-627	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20170620		ANDA	ANDA202383	NorthStar Rx LLC	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-628_09a6278b-2a52-7275-397f-f9bfaee771ba	16714-628	HUMAN PRESCRIPTION DRUG	Ciprofloxacin and Dexamethasone		Ciprofloxacin and Dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20220801		ANDA	ANDA205548	NorthStar RxLLC	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16714-631_35f6168c-3214-4c84-bda9-5a8195741a8a	16714-631	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	NorthStar Rx LLC	ALENDRONATE SODIUM	10	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
16714-632_35f6168c-3214-4c84-bda9-5a8195741a8a	16714-632	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	NorthStar Rx LLC	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
16714-633_35f6168c-3214-4c84-bda9-5a8195741a8a	16714-633	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	NorthStar Rx LLC	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
16714-634_3dba1b9f-de37-77e3-196d-0f4949648653	16714-634	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220603		ANDA	ANDA078490	NorthStar Rx LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-637_ee4b013a-434e-77ae-e053-2a95a90a1c6d	16714-637	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20221118		ANDA	ANDA203512	NorthStar RxLLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16714-638_ee4b013a-434e-77ae-e053-2a95a90a1c6d	16714-638	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20221118		ANDA	ANDA203512	NorthStar RxLLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16714-639_ee4b013a-434e-77ae-e053-2a95a90a1c6d	16714-639	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20221118		ANDA	ANDA203512	NorthStar RxLLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16714-643_c11c970c-ffa6-4661-b515-708bae4eddd6	16714-643	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN		MOXIFLOXACIN	SOLUTION/ DROPS	OPHTHALMIC	20171004		ANDA	ANDA206242	NorthStar Rx LLC	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
16714-644_87b32de1-012a-4078-9e90-b036e40da948	16714-644	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220801		ANDA	ANDA207757	Northstar Rx LLC.	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
16714-645_099c78c5-8f25-4dc6-a713-b934d0067438	16714-645	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20220818		ANDA	ANDA202467	NorthStar RxLLC	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
16714-646_099c78c5-8f25-4dc6-a713-b934d0067438	16714-646	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20220818		ANDA	ANDA202467	NorthStar RxLLC	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
16714-647_099c78c5-8f25-4dc6-a713-b934d0067438	16714-647	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20220818		ANDA	ANDA202467	NorthStar RxLLC	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
16714-651_0a6520c8-b496-42a1-9df8-7766e5182a99	16714-651	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	NorthStar Rx LLC	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
16714-652_0a6520c8-b496-42a1-9df8-7766e5182a99	16714-652	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	NorthStar Rx LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
16714-655_08f5d573-463e-8537-e063-6294a90a0059	16714-655	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20170126	20240930	ANDA	ANDA078627	Northstar Rx LLC	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-656_08f5d573-463e-8537-e063-6294a90a0059	16714-656	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20170126	20240930	ANDA	ANDA078627	Northstar Rx LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-657_08f5d573-463e-8537-e063-6294a90a0059	16714-657	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20170126	20240930	ANDA	ANDA078627	Northstar Rx LLC	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-658_08f5d573-463e-8537-e063-6294a90a0059	16714-658	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20170126	20240930	ANDA	ANDA078627	Northstar Rx LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-659_08f5d573-463e-8537-e063-6294a90a0059	16714-659	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20170126	20240930	ANDA	ANDA078627	Northstar Rx LLC	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
16714-661_8dbab4b4-2aa9-4881-b4bf-af4e67ef14d3	16714-661	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	NorthStar Rx LLC	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16714-662_8dbab4b4-2aa9-4881-b4bf-af4e67ef14d3	16714-662	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	NorthStar Rx LLC	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16714-663_8dbab4b4-2aa9-4881-b4bf-af4e67ef14d3	16714-663	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	NorthStar Rx LLC	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16714-671_71146976-eebd-4feb-b045-49c6f953039b	16714-671	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	SOLUTION	ORAL	20071128		ANDA	ANDA078776	NorthStar Rx LLC	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16714-672_d2f2ebbb-71df-41e2-b63e-44c49572a6c6	16714-672	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20211124		ANDA	ANDA214552	Northstar Rx LLC	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-673_d2f2ebbb-71df-41e2-b63e-44c49572a6c6	16714-673	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20211124		ANDA	ANDA214552	Northstar Rx LLC	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-674_d2f2ebbb-71df-41e2-b63e-44c49572a6c6	16714-674	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20211124		ANDA	ANDA214552	Northstar Rx LLC	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-675_d2f2ebbb-71df-41e2-b63e-44c49572a6c6	16714-675	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20211124		ANDA	ANDA214552	Northstar Rx LLC	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
16714-676_7579e3d0-2de6-4239-a7a8-118ed92075f5	16714-676	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20220218		ANDA	ANDA213914	NorthStar RxLLC	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
16714-677_7579e3d0-2de6-4239-a7a8-118ed92075f5	16714-677	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20220218		ANDA	ANDA213914	NorthStar RxLLC	SUNITINIB MALATE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
16714-678_7579e3d0-2de6-4239-a7a8-118ed92075f5	16714-678	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20220218		ANDA	ANDA213914	NorthStar RxLLC	SUNITINIB MALATE	37.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
16714-679_7579e3d0-2de6-4239-a7a8-118ed92075f5	16714-679	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20220218		ANDA	ANDA213914	NorthStar RxLLC	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
16714-681_d48a9386-a76e-4c11-b909-aaf0f8ee75b0	16714-681	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NorthStar Rx LLC	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-682_d48a9386-a76e-4c11-b909-aaf0f8ee75b0	16714-682	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NorthStar Rx LLC	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-683_d48a9386-a76e-4c11-b909-aaf0f8ee75b0	16714-683	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NorthStar Rx LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-684_d48a9386-a76e-4c11-b909-aaf0f8ee75b0	16714-684	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NorthStar Rx LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-685_d48a9386-a76e-4c11-b909-aaf0f8ee75b0	16714-685	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NorthStar Rx LLC	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-690_e5b50fe9-165a-4649-afe1-c8b5fe5c960a	16714-690	HUMAN PRESCRIPTION DRUG	propofol		propofol	INJECTION, EMULSION	INTRAVENOUS	20220701		ANDA	ANDA206408	NorthStar Rx LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
16714-691_d77cfdae-fb81-4dfe-a656-b71c86c63151	16714-691	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NorthStar Rx LLC	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-692_d77cfdae-fb81-4dfe-a656-b71c86c63151	16714-692	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NorthStar Rx LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-693_d77cfdae-fb81-4dfe-a656-b71c86c63151	16714-693	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NorthStar Rx LLC	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-694_d77cfdae-fb81-4dfe-a656-b71c86c63151	16714-694	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NorthStar Rx LLC	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-695_ed198b10-bd40-4071-87c4-854856534456	16714-695	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	POWDER, FOR SUSPENSION	ORAL	20090918		ANDA	ANDA079150	NorthStar Rx LLC	FLUCONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-696_ed198b10-bd40-4071-87c4-854856534456	16714-696	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	POWDER, FOR SUSPENSION	ORAL	20090918		ANDA	ANDA079150	NorthStar Rx LLC	FLUCONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16714-697_133ef786-a468-4f6c-8878-53e3b89f75a5	16714-697	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	NorthStar Rx LLC	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
16714-698_133ef786-a468-4f6c-8878-53e3b89f75a5	16714-698	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	NorthStar Rx LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
16714-699_afe99d8a-b127-4a95-aed6-66e696630b28	16714-699	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160329		ANDA	ANDA205779	NorthStar Rx LLC	VANCOMYCIN HYDROCHLORIDE	10	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
16714-700_1ee9f7a8-b1ca-42a7-b4d7-76bd8a5b99b7	16714-700	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	NorthStar Rx LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-701_1ee9f7a8-b1ca-42a7-b4d7-76bd8a5b99b7	16714-701	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	NorthStar Rx LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-702_1ee9f7a8-b1ca-42a7-b4d7-76bd8a5b99b7	16714-702	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	NorthStar Rx LLC	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-703_1ee9f7a8-b1ca-42a7-b4d7-76bd8a5b99b7	16714-703	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	NorthStar Rx LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-713_d4ffcb87-fd8f-430f-9d3a-26eb5b15ac95	16714-713	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170501		ANDA	ANDA090931	NorthStar RxLLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
16714-714_3003d0a8-047d-133a-00cf-a3db676666f7	16714-714	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA075576	NorthStar Rx LLC	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-715_3003d0a8-047d-133a-00cf-a3db676666f7	16714-715	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA075576	NorthStar Rx LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-717_566171a2-a0b1-4064-88bf-77c9a80bd0f1	16714-717	HUMAN PRESCRIPTION DRUG	ENTECAVIR		ENTECAVIR	TABLET, FILM COATED	ORAL	20170615		ANDA	ANDA206872	NorthStar RxLLC	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
16714-718_566171a2-a0b1-4064-88bf-77c9a80bd0f1	16714-718	HUMAN PRESCRIPTION DRUG	ENTECAVIR		ENTECAVIR	TABLET, FILM COATED	ORAL	20170615		ANDA	ANDA206872	NorthStar RxLLC	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
16714-720_45d19838-f1cd-4d7e-a4ba-02830a76a04d	16714-720	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	NorthStar Rx LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-721_45d19838-f1cd-4d7e-a4ba-02830a76a04d	16714-721	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	NorthStar Rx LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-722_45d19838-f1cd-4d7e-a4ba-02830a76a04d	16714-722	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	NorthStar Rx LLC	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
16714-729_2ba564bf-266b-44d7-9d5f-40e20336b318	16714-729	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	19920630		ANDA	ANDA073548	NORTHSTAR RX LLC	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-731_22f9facb-88df-400c-9f6e-c776f68789f3	16714-731	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20170926		ANDA	ANDA207446	NorthStar RxLLC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16714-732_22f9facb-88df-400c-9f6e-c776f68789f3	16714-732	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20170926		ANDA	ANDA207446	NorthStar RxLLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16714-733_22f9facb-88df-400c-9f6e-c776f68789f3	16714-733	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20170926		ANDA	ANDA207446	NorthStar RxLLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16714-734_22f9facb-88df-400c-9f6e-c776f68789f3	16714-734	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20170926		ANDA	ANDA207446	NorthStar RxLLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
16714-742_515391d8-92bc-84e3-2408-79a2d0b35ed2	16714-742	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20170829		ANDA	ANDA208657	NorthStar RxLLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
16714-743_62530d1a-98c7-4605-a95e-4bdf1b4f3d7c	16714-743	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE, COATED PELLETS	ORAL	20170901		ANDA	ANDA208591	NorthStar RxLLC	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
16714-755_fc2fb27b-9a53-4df1-874e-bb2ed5157aef	16714-755	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20180601		ANDA	ANDA079019	Northstar Rx LLC	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16714-756_fc2fb27b-9a53-4df1-874e-bb2ed5157aef	16714-756	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20180601		ANDA	ANDA079019	Northstar Rx LLC	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16714-757_fc2fb27b-9a53-4df1-874e-bb2ed5157aef	16714-757	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20180601		ANDA	ANDA079019	Northstar Rx LLC	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16714-758_fc2fb27b-9a53-4df1-874e-bb2ed5157aef	16714-758	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20180601		ANDA	ANDA079019	Northstar Rx LLC	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16714-759_fc2fb27b-9a53-4df1-874e-bb2ed5157aef	16714-759	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20180601		ANDA	ANDA079019	Northstar Rx LLC	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16714-760_fc2fb27b-9a53-4df1-874e-bb2ed5157aef	16714-760	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20180601		ANDA	ANDA079019	Northstar Rx LLC	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16714-761_fc2fb27b-9a53-4df1-874e-bb2ed5157aef	16714-761	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20180601		ANDA	ANDA079019	Northstar Rx LLC	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16714-763_edd0f498-92a1-4eb3-890f-ebbbe876fa5a	16714-763	HUMAN PRESCRIPTION DRUG	calcipotriene		calcipotriene	CREAM	TOPICAL	20150601		ANDA	ANDA205772	Northstar Rx LLC	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
16714-766_f15f86c9-5ebe-800a-e053-2995a90af842	16714-766	HUMAN PRESCRIPTION DRUG	Cefixime		cefixime	POWDER, FOR SUSPENSION	ORAL	20180511		ANDA	ANDA206938	NorthStar RxLLC	CEFIXIME	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
16714-767_f15f86c9-5ebe-800a-e053-2995a90af842	16714-767	HUMAN PRESCRIPTION DRUG	Cefixime		cefixime	POWDER, FOR SUSPENSION	ORAL	20180511		ANDA	ANDA206938	NorthStar RxLLC	CEFIXIME	200	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
16714-769_ffd56eaf-0612-f8ad-e053-6394a90a8a25	16714-769	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	POWDER	TOPICAL	20180521	20240930	ANDA	ANDA065203	NorthStar Rx LLC	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	
16714-770_dfffedf4-c1f0-4bbd-9978-80dcec656d72	16714-770	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20180417		ANDA	ANDA201889	NorthStar RxLLC	RASAGILINE MESYLATE	.5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
16714-771_dfffedf4-c1f0-4bbd-9978-80dcec656d72	16714-771	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20180417		ANDA	ANDA201889	NorthStar RxLLC	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
16714-775_c3010d7b-f928-464e-af7c-ca45a5320a20	16714-775	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	SUSPENSION	ORAL	20180410		ANDA	ANDA206314	NORTHSTAR RX LLC	FELBAMATE	600	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
16714-778_78dbdf38-ca70-44d7-9950-50a4af8cd673	16714-778	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190819		ANDA	ANDA208699	NORTHSTAR RX LLC	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-779_78dbdf38-ca70-44d7-9950-50a4af8cd673	16714-779	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190819		ANDA	ANDA208699	NORTHSTAR RX LLC	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-780_78dbdf38-ca70-44d7-9950-50a4af8cd673	16714-780	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190819		ANDA	ANDA208699	NORTHSTAR RX LLC	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-781_78dbdf38-ca70-44d7-9950-50a4af8cd673	16714-781	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190819		ANDA	ANDA208699	NORTHSTAR RX LLC	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16714-782_4259f758-540d-45e4-8424-48a0bcc714b5	16714-782	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	OINTMENT	TOPICAL	20180501		ANDA	ANDA208933	Northstar Rx LLC	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-795_9189c83d-3c2b-4802-9ad6-7fd0a143d689	16714-795	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	NorthStar Rx LLC	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
16714-796_65074e84-bd6d-423f-92ae-e4f2f7841dbb	16714-796	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20180618		ANDA	ANDA078327	NorthStar Rx LLC	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
16714-797_65074e84-bd6d-423f-92ae-e4f2f7841dbb	16714-797	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20180618		ANDA	ANDA078327	NorthStar Rx LLC	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
16714-798_65074e84-bd6d-423f-92ae-e4f2f7841dbb	16714-798	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20180618		ANDA	ANDA078327	NorthStar Rx LLC	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
16714-799_7bfd8f80-7f76-4de7-9c7e-b86cda46cb5b	16714-799	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	NorthStar Rx LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
16714-802_34e22ad9-4b91-42dd-a385-0f8cbc994aa5	16714-802	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Northstar Rx LLC	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-803_34e22ad9-4b91-42dd-a385-0f8cbc994aa5	16714-803	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Northstar Rx LLC	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-804_34e22ad9-4b91-42dd-a385-0f8cbc994aa5	16714-804	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Northstar Rx LLC	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-805_34e22ad9-4b91-42dd-a385-0f8cbc994aa5	16714-805	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Northstar Rx LLC	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-806_34e22ad9-4b91-42dd-a385-0f8cbc994aa5	16714-806	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Northstar Rx LLC	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-807_34e22ad9-4b91-42dd-a385-0f8cbc994aa5	16714-807	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Northstar Rx LLC	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-808_34e22ad9-4b91-42dd-a385-0f8cbc994aa5	16714-808	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Northstar Rx LLC	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-809_6b1a15cd-7fbb-4c5b-a3ee-973a1916ba38	16714-809	HUMAN OTC DRUG	New Day		levonorgestrel	TABLET	ORAL	20160311		ANDA	ANDA207976	Northstar Rx LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
16714-813_c0e3089d-7a9c-45ae-aff1-31df47f55552	16714-813	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20210201		ANDA	ANDA209838	NorthStar Rx LLC	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
16714-814_02091db1-8f35-40f1-9e7f-b9220d0cf625	16714-814	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20180606		ANDA	ANDA207179	NorthStar Rx LLC	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
16714-815_a5fc36d0-2569-52dd-e053-2a95a90a3dbf	16714-815	HUMAN PRESCRIPTION DRUG	Zoledronic acid		zoledronic acid	INJECTION	INTRAVENOUS	20180530		ANDA	ANDA205279	Northstar RxLLC	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
16714-816_96d5cdb2-e538-fecd-e053-2995a90aace4	16714-816	HUMAN PRESCRIPTION DRUG	Bicalutamide		Bicalutamide	TABLET, FILM COATED	ORAL	20180601		ANDA	ANDA078917	Northstar RxLLC	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
16714-820_eaeb1670-4e39-4541-8ff7-47057f3f5c36	16714-820	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20181112		ANDA	ANDA090636	NorthStar RxLLC	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
16714-821_500c390c-83f0-4008-9a85-0bcca9480678	16714-821	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Northstar Rx LLC	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-822_500c390c-83f0-4008-9a85-0bcca9480678	16714-822	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Northstar Rx LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-823_500c390c-83f0-4008-9a85-0bcca9480678	16714-823	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Northstar Rx LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-824_1df016a5-65cd-49d8-ae08-06c5ddfc94b5	16714-824	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20160120		ANDA	ANDA202868	Northstar Rx LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
16714-825_59aaf0aa-9074-4563-93ba-1c97e76352a2	16714-825	HUMAN PRESCRIPTION DRUG	propafenone hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170331		ANDA	ANDA205268	Northstar Rx LLC	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
16714-826_59aaf0aa-9074-4563-93ba-1c97e76352a2	16714-826	HUMAN PRESCRIPTION DRUG	propafenone hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170331		ANDA	ANDA205268	Northstar Rx LLC	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
16714-827_59aaf0aa-9074-4563-93ba-1c97e76352a2	16714-827	HUMAN PRESCRIPTION DRUG	propafenone hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170331		ANDA	ANDA205268	Northstar Rx LLC	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
16714-828_26846e2f-0ea1-42f0-850d-ad79154c5359	16714-828	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	OINTMENT	TOPICAL	20170915		ANDA	ANDA209996	Northstar Rx LLC	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
16714-829_b0f2c77a-5996-4613-9f02-cfe3aa36c2c9	16714-829	HUMAN PRESCRIPTION DRUG	budesonide		budesonide	CAPSULE, COATED PELLETS	ORAL	20180625		ANDA	ANDA206134	Northstar Rx LLC.	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-830_d76ad2c1-981a-4784-8a51-7e6bfdb1cec6	16714-830	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	TABLET, DELAYED RELEASE	ORAL	20180625		ANDA	ANDA091640	Northstar Rx LLC.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
16714-834_61ce36e0-ab4a-3536-b551-df710bac2449	16714-834	HUMAN PRESCRIPTION DRUG	Palonosetron		Palonosetron	INJECTION, SOLUTION	INTRAVENOUS	20180529		ANDA	ANDA201533	NorthStar Rx LLC	PALONOSETRON HYDROCHLORIDE	.05	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16714-835_64bde13b-b392-45ed-1d71-a9718b1c92de	16714-835	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20180726		ANDA	ANDA077565	NorthStar Rx LLC	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-836_64bde13b-b392-45ed-1d71-a9718b1c92de	16714-836	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20180726		ANDA	ANDA077565	NorthStar Rx LLC	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-837_64bde13b-b392-45ed-1d71-a9718b1c92de	16714-837	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20180726		ANDA	ANDA077565	NorthStar Rx LLC	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-838_64bde13b-b392-45ed-1d71-a9718b1c92de	16714-838	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20180726		ANDA	ANDA077565	NorthStar Rx LLC	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-840_ffd56eaf-0631-f8ad-e053-6394a90a8a25	16714-840	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180618	20240331	ANDA	ANDA207058	Northstar Rx LLC	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	
16714-841_ffd56eaf-0631-f8ad-e053-6394a90a8a25	16714-841	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180618	20240630	ANDA	ANDA207058	Northstar Rx LLC	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	
16714-842_ffd56eaf-0631-f8ad-e053-6394a90a8a25	16714-842	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180618	20240630	ANDA	ANDA207058	Northstar Rx LLC	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	
16714-849_57601a94-de02-4050-bbcf-fd7e6ac25825	16714-849	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180827		ANDA	ANDA208961	Northstar Rx LLC.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-850_57601a94-de02-4050-bbcf-fd7e6ac25825	16714-850	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180827		ANDA	ANDA208961	Northstar Rx LLC.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-851_57601a94-de02-4050-bbcf-fd7e6ac25825	16714-851	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180827		ANDA	ANDA208961	Northstar Rx LLC.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
16714-852_244a38b1-f628-490d-84fb-4264c0bec915	16714-852	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	Northstar Rx LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
16714-853_244a38b1-f628-490d-84fb-4264c0bec915	16714-853	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	Northstar Rx LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
16714-854_244a38b1-f628-490d-84fb-4264c0bec915	16714-854	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	Northstar Rx LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
16714-855_244a38b1-f628-490d-84fb-4264c0bec915	16714-855	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	Northstar Rx LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
16714-856_515391d8-92bc-84e3-2408-79a2d0b35ed2	16714-856	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20170829		ANDA	ANDA208657	NorthStar RxLLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
16714-857_ce662adb-9756-4528-e053-2995a90a74f4	16714-857	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20190108		ANDA	ANDA204555	NorthStar Rx LLC	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16714-858_ce662adb-9756-4528-e053-2995a90a74f4	16714-858	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20190108		ANDA	ANDA204555	NorthStar Rx LLC	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16714-859_ce662adb-9756-4528-e053-2995a90a74f4	16714-859	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20190108		ANDA	ANDA204555	NorthStar Rx LLC	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16714-860_9ce2694a-7b8d-484a-afe1-ae7d4b61291b	16714-860	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir	CAPSULE	ORAL	20190408		ANDA	ANDA204806	NorthStar Rx LLC	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
16714-861_9ce2694a-7b8d-484a-afe1-ae7d4b61291b	16714-861	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir	CAPSULE	ORAL	20190408		ANDA	ANDA204806	NorthStar Rx LLC	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
16714-862_9ce2694a-7b8d-484a-afe1-ae7d4b61291b	16714-862	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir	CAPSULE	ORAL	20190408		ANDA	ANDA204806	NorthStar Rx LLC	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
16714-866_d9b696fd-5d9c-4111-b872-286e59e89023	16714-866	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20181015		ANDA	ANDA205618	NorthStar RxLLC	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-867_d9b696fd-5d9c-4111-b872-286e59e89023	16714-867	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20181015		ANDA	ANDA205618	NorthStar RxLLC	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-868_d9b696fd-5d9c-4111-b872-286e59e89023	16714-868	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20181015		ANDA	ANDA205618	NorthStar RxLLC	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-869_d9b696fd-5d9c-4111-b872-286e59e89023	16714-869	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20181015		ANDA	ANDA205618	NorthStar RxLLC	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16714-870_7b9bda88-4331-4285-b897-1945948ea8b6	16714-870	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, DELAYED RELEASE	ORAL	20190814		ANDA	ANDA203925	NorthStar RxLLC	RISEDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
16714-878_20cfc009-f49f-4467-801b-9dadfb1672dc	16714-878	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20160701		ANDA	ANDA206498	Northstar Rx LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
16714-883_70b95626-59a2-4552-84e1-f0063ee9c452	16714-883	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20150528		ANDA	ANDA201831	Northstar Rx LLC	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
16714-884_70b95626-59a2-4552-84e1-f0063ee9c452	16714-884	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20150528		ANDA	ANDA201831	Northstar Rx LLC	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
16714-885_18577488-3451-473d-93de-5214f77fd4db	16714-885	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	OINTMENT	TOPICAL	20170731		ANDA	ANDA205510	Northstar Rx LLC	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
16714-886_f202dd8d-b51c-4544-a952-8a3acfd71c95	16714-886	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20181201		ANDA	ANDA205030	NorthStar Rx LLC	BLEOMYCIN SULFATE	15	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
16714-887_f60c3577-1411-eb3f-e053-2a95a90a4afd	16714-887	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181112		ANDA	ANDA209795	NorthStar RxLLC	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
16714-888_f60c3577-1411-eb3f-e053-2a95a90a4afd	16714-888	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181112		ANDA	ANDA209795	NorthStar RxLLC	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
16714-889_20109647-c47a-768a-5722-0c3cdfbff938	16714-889	HUMAN PRESCRIPTION DRUG	ERTAPENEM SODIUM		Ertapenem	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210713		ANDA	ANDA212040	NorthStar RxLLC	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
16714-891_beb7ffa0-6d89-4d03-a321-6e963faee5d4	16714-891	HUMAN PRESCRIPTION DRUG	Sumatriptan and Naproxen Sodium		Sumatriptan and Naproxen Sodium	TABLET, FILM COATED	ORAL	20181127		ANDA	ANDA202803	NorthStar RxLLC	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500; 85	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
16714-892_1c9a367e-6213-3309-3883-e18ba367d57e	16714-892	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220613		ANDA	ANDA208375	NorthStar RxLLC	DAPTOMYCIN	50	mg/mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
16714-893_3fca77cd-0645-d615-fd67-34db69aa44fa	16714-893	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20181120		ANDA	ANDA202383	NorthStar Rx LLC	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
16714-894_c65265e1-a7eb-43ea-890a-00a227570956	16714-894	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA203499	Northstar Rx LLC.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16714-895_c65265e1-a7eb-43ea-890a-00a227570956	16714-895	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA203499	Northstar Rx LLC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16714-896_c65265e1-a7eb-43ea-890a-00a227570956	16714-896	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA203499	Northstar Rx LLC.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16714-897_65a5d52e-8f46-41a1-9096-ae7143c97ba0	16714-897	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin	CREAM	TOPICAL	20190408		ANDA	ANDA076369	Northstar Rx LLC	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
16714-898_c892d447-9219-44ac-b9f0-ac3b05ba76eb	16714-898	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190220		ANDA	ANDA076301	Northstar RxLLC	LORATADINE	10	mg/1			N	20241231
16714-899_2d00700d-63a2-4a45-b607-028a883fe10a	16714-899	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20190218		ANDA	ANDA204097	NorthStar RxLLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
16714-900_10646963-100a-46c7-838f-f253d10a1e71	16714-900	HUMAN PRESCRIPTION DRUG	atovaquone		atovaquone	SUSPENSION	ORAL	20190301		ANDA	ANDA209685	Northstar Rx LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20251231
16714-903_a4510853-5f1c-45c2-8d31-1b26ece5010b	16714-903	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190410		ANDA	ANDA091272	NorthStar RxLLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
16714-904_a4510853-5f1c-45c2-8d31-1b26ece5010b	16714-904	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190410		ANDA	ANDA091272	NorthStar RxLLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
16714-905_a4510853-5f1c-45c2-8d31-1b26ece5010b	16714-905	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190410		ANDA	ANDA091272	NorthStar RxLLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
16714-906_3eaeb69f-49ab-4d30-936a-897970b311da	16714-906	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190515		ANDA	ANDA211705	NorthStar Rx LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16714-908_f202dd8d-b51c-4544-a952-8a3acfd71c95	16714-908	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20181201		ANDA	ANDA205030	NorthStar Rx LLC	BLEOMYCIN SULFATE	30	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
16714-909_5cb14433-28ce-45b1-a74d-b1ef88968b78	16714-909	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181101		ANDA	ANDA091365	NorthStar Rx LLC	GEMCITABINE HYDROCHLORIDE	200	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16714-916_92d35fa0-d08d-4c71-9be3-6fb35e9662cb	16714-916	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190306		ANDA	ANDA206156	NorthStar RxLLC	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16714-917_92d35fa0-d08d-4c71-9be3-6fb35e9662cb	16714-917	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190306		ANDA	ANDA206156	NorthStar RxLLC	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16714-918_92d35fa0-d08d-4c71-9be3-6fb35e9662cb	16714-918	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190306		ANDA	ANDA206156	NorthStar RxLLC	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16714-919_92d35fa0-d08d-4c71-9be3-6fb35e9662cb	16714-919	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190306		ANDA	ANDA206156	NorthStar RxLLC	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16714-920_92d35fa0-d08d-4c71-9be3-6fb35e9662cb	16714-920	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190306		ANDA	ANDA206156	NorthStar RxLLC	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16714-922_92d35fa0-d08d-4c71-9be3-6fb35e9662cb	16714-922	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190306		ANDA	ANDA206156	NorthStar RxLLC	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16714-927_2e93e459-72b1-43ba-5ca0-7901be66e462	16714-927	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190508		ANDA	ANDA201537	NorthStar RxLLC	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16714-929_639328e4-09a1-4c52-ff88-51e565be7c37	16714-929	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200320		ANDA	ANDA209965	NorthStar RxLLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
16714-930_5cb14433-28ce-45b1-a74d-b1ef88968b78	16714-930	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181101		ANDA	ANDA091365	NorthStar Rx LLC	GEMCITABINE HYDROCHLORIDE	1	g/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16714-936_49825a3d-cf77-4875-a89d-c9e903e68d51	16714-936	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20190326		ANDA	ANDA210028	Northstar Rx LLC.	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
16714-937_49825a3d-cf77-4875-a89d-c9e903e68d51	16714-937	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20190326		ANDA	ANDA210028	Northstar Rx LLC.	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
16714-948_4767fffc-d385-441d-9b0f-a41b975d1932	16714-948	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190320		ANDA	ANDA202424	NorthStar RxLLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-949_4767fffc-d385-441d-9b0f-a41b975d1932	16714-949	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190320		ANDA	ANDA202424	NorthStar RxLLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-950_4767fffc-d385-441d-9b0f-a41b975d1932	16714-950	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190320		ANDA	ANDA202424	NorthStar RxLLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-951_4767fffc-d385-441d-9b0f-a41b975d1932	16714-951	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190320		ANDA	ANDA202424	NorthStar RxLLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-952_4767fffc-d385-441d-9b0f-a41b975d1932	16714-952	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190320		ANDA	ANDA202424	NorthStar RxLLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-953_4767fffc-d385-441d-9b0f-a41b975d1932	16714-953	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190320		ANDA	ANDA202424	NorthStar RxLLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-954_4767fffc-d385-441d-9b0f-a41b975d1932	16714-954	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190320		ANDA	ANDA202424	NorthStar RxLLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
16714-955_fb8f0541-bd79-4f25-bc6c-7d75dbba0fe2	16714-955	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20021218		ANDA	ANDA075638	NORTHSTAR RX LLC	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
16714-956_891b790a-e808-4dc7-81d9-4005edab5fa4	16714-956	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20171016		ANDA	ANDA209506	NORTHSTAR RX LLC	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
16714-963_564a91be-2efd-3ec5-1996-1491749f271e	16714-963	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone Acetate	TABLET	ORAL	20200519		ANDA	ANDA208416	NorthStar Rx LLC	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
16714-964_7e2fb079-3302-fd35-dab4-1991e997daec	16714-964	HUMAN PRESCRIPTION DRUG	Aspirin and Dipyridamole		Aspirin and Dipyridamole	CAPSULE, EXTENDED RELEASE	ORAL	20190403		ANDA	ANDA209048	NorthStar Rx LLC	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
16714-967_27ee09a6-7bee-4e5f-9c52-b323bac2aa7b	16714-967	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20191106		ANDA	ANDA204268	Northstar Rx LLC	TESTOSTERONE	20.25	mg/1.25g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
16714-968_27ee09a6-7bee-4e5f-9c52-b323bac2aa7b	16714-968	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20191106		ANDA	ANDA205781	Northstar Rx LLC	TESTOSTERONE	20.25	mg/1.25g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
16714-969_27ee09a6-7bee-4e5f-9c52-b323bac2aa7b	16714-969	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20191106		ANDA	ANDA205781	Northstar Rx LLC	TESTOSTERONE	40.5	mg/2.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
16714-973_b60d67c8-affd-4ade-ad4e-01250bc0753a	16714-973	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20220322		ANDA	ANDA210189	Northstar Rx LLC.	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
16714-974_0d17ab59-88b0-40e3-b630-0671c8b0bfb3	16714-974	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20190917		ANDA	ANDA078541	NORTHSTAR RX LLC	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-975_fbdde863-0845-42a1-b4a5-a9e99a65b514	16714-975	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20231006		ANDA	ANDA210191	NORTHSTAR RX LLC	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
16714-977_e5b50fe9-165a-4649-afe1-c8b5fe5c960a	16714-977	HUMAN PRESCRIPTION DRUG	propofol		propofol	INJECTION, EMULSION	INTRAVENOUS	20220701		ANDA	ANDA206408	NorthStar Rx LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
16714-979_0db3d40a-29ae-8151-d2cb-2a75c0573a1b	16714-979	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190917		ANDA	ANDA078279	NorthStar Rx LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-980_0db3d40a-29ae-8151-d2cb-2a75c0573a1b	16714-980	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190917		ANDA	ANDA078279	NorthStar Rx LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16714-981_72bfa421-1b70-4cc4-a366-771028b02cff	16714-981	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20191125		ANDA	ANDA210760	NorthStar RxLLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
16714-984_1d40bf0b-022b-445f-95dd-aee2747523f6	16714-984	HUMAN PRESCRIPTION DRUG	clindamycin and benzoyl peroxide		clindamycin and benzoyl peroxide	GEL	TOPICAL	20190701		ANDA	ANDA209252	NorthStar RxLLC	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
16714-985_3978ee1f-a3e7-426b-9bec-3f8a285518ef	16714-985	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20220421		ANDA	ANDA209535	NorthStar RxLLC	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
16714-986_3978ee1f-a3e7-426b-9bec-3f8a285518ef	16714-986	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20220421		ANDA	ANDA209535	NorthStar RxLLC	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
16714-987_3978ee1f-a3e7-426b-9bec-3f8a285518ef	16714-987	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20220421		ANDA	ANDA209535	NorthStar RxLLC	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
16714-988_423b875c-02d0-4eb7-925e-4a1d0b0d9ccd	16714-988	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	NorthStar RxLLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-989_423b875c-02d0-4eb7-925e-4a1d0b0d9ccd	16714-989	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	NorthStar RxLLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-990_423b875c-02d0-4eb7-925e-4a1d0b0d9ccd	16714-990	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	NorthStar RxLLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-991_423b875c-02d0-4eb7-925e-4a1d0b0d9ccd	16714-991	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	NorthStar RxLLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16714-996_46aa8022-58f7-4699-b1e4-566dbfe1053b	16714-996	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	CREAM	TOPICAL	20191010		ANDA	ANDA208885	Northstar Rx LLC.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16714-997_68f66df7-6aa0-481c-99b9-4314a3736ed1	16714-997	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20220801		ANDA	ANDA202313	NorthStar Rx LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
16714-998_3eaeb69f-49ab-4d30-936a-897970b311da	16714-998	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190515		ANDA	ANDA211705	NorthStar Rx LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16714-999_b6a2702f-2528-4043-89c7-a0a8a5c7cf5c	16714-999	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20191125		ANDA	ANDA210761	NorthStar RxLLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
16729-001_0b341ea1-56c4-d2a5-e063-6294a90a3259	16729-001	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Accord Healthcare Inc	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16729-002_0b341ea1-56c4-d2a5-e063-6294a90a3259	16729-002	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Accord Healthcare Inc	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16729-003_0b341ea1-56c4-d2a5-e063-6294a90a3259	16729-003	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Accord Healthcare Inc	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16729-004_ff92b67e-c659-c9e0-e053-6394a90af562	16729-004	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Accord Healthcare, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-005_ff92b67e-c659-c9e0-e053-6394a90af562	16729-005	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Accord Healthcare, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-006_ff92b67e-c659-c9e0-e053-6394a90af562	16729-006	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Accord Healthcare, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-007_ff92b67e-c659-c9e0-e053-6394a90af562	16729-007	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Accord Healthcare, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-008_0e03244d-61de-bb5f-e063-6294a90a671c	16729-008	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	Accord Healthcare Inc.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16729-009_0e03244d-61de-bb5f-e063-6294a90a671c	16729-009	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	Accord Healthcare Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16729-010_0e03244d-61de-bb5f-e063-6294a90a671c	16729-010	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	Accord Healthcare Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16729-011_0e03244d-61de-bb5f-e063-6294a90a671c	16729-011	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	Accord Healthcare Inc.	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
16729-019_0e2f4e33-3ac1-3b42-e063-6394a90a3db8	16729-019	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	TABLET	ORAL	20090504		ANDA	ANDA065416	Accord Healthcare Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
16729-020_f2a02050-d11f-3983-e053-2a95a90a41d8	16729-020	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		PIOGLITAZONE	TABLET	ORAL	20130213	20250831	ANDA	ANDA200044	Accord Healthcare, Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	
16729-021_f2a02050-d11f-3983-e053-2a95a90a41d8	16729-021	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		PIOGLITAZONE	TABLET	ORAL	20130213	20250731	ANDA	ANDA200044	Accord Healthcare, Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	
16729-022_f2a02050-d11f-3983-e053-2a95a90a41d8	16729-022	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		PIOGLITAZONE	TABLET	ORAL	20130213	20250930	ANDA	ANDA200044	Accord Healthcare, Inc.	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	
16729-023_eb75ec08-47b6-2907-e053-2995a90a3309	16729-023	HUMAN PRESCRIPTION DRUG	Bicalutamide		Bicalutamide	TABLET	ORAL	20090706		ANDA	ANDA078917	Accord Healthcare Inc.	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
16729-034_0b860d2e-5d6d-3606-e063-6394a90a2435	16729-034	HUMAN PRESCRIPTION DRUG	Letrozole		letrozole	TABLET, FILM COATED	ORAL	20110602		ANDA	ANDA090934	Accord Healthcare, Inc.	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
16729-035_0aa6a01b-e78f-9e72-e063-6294a90a5bc0	16729-035	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	Accord Healthcare Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
16729-041_0e2f2968-dad8-4f59-e063-6394a90a0b8c	16729-041	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20110930		ANDA	ANDA091195	Accord Healthcare Inc.	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
16729-042_0e2f2968-dad8-4f59-e063-6394a90a0b8c	16729-042	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20110930		ANDA	ANDA091195	Accord Healthcare Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
16729-043_0e2f2968-dad8-4f59-e063-6394a90a0b8c	16729-043	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20110930		ANDA	ANDA091195	Accord Healthcare Inc.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
16729-044_fdeb3646-1603-1a19-e053-6394a90a1606	16729-044	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180802		ANDA	ANDA207687	Accord Healthcare Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-045_fdeb3646-1603-1a19-e053-6394a90a1606	16729-045	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	Accord Healthcare Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-046_fdeb3646-1603-1a19-e053-6394a90a1606	16729-046	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	Accord Healthcare Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-047_fdeb3646-1603-1a19-e053-6394a90a1606	16729-047	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	Accord Healthcare Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-048_0b85d412-d6c8-21cc-e063-6294a90a958c	16729-048	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170307		ANDA	ANDA201528	Accord Healthcare Inc.	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-049_0b85d412-d6c8-21cc-e063-6294a90a958c	16729-049	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170307		ANDA	ANDA201528	Accord Healthcare Inc.	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-050_0b85d412-d6c8-21cc-e063-6294a90a958c	16729-050	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170307		ANDA	ANDA201528	Accord Healthcare Inc.	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-051_0b85d412-d6c8-21cc-e063-6294a90a958c	16729-051	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170307		ANDA	ANDA201528	Accord Healthcare Inc.	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-064_0e03506d-c49a-0f79-e063-6394a90a0e9c	16729-064	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20130523		ANDA	ANDA090843	Accord Healthcare Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16729-065_0e03506d-c49a-0f79-e063-6394a90a0e9c	16729-065	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20130531		ANDA	ANDA090843	Accord Healthcare Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16729-066_0e03506d-c49a-0f79-e063-6394a90a0e9c	16729-066	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20130523		ANDA	ANDA090843	Accord Healthcare Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16729-067_0e03506d-c49a-0f79-e063-6394a90a0e9c	16729-067	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20130531		ANDA	ANDA090843	Accord Healthcare Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
16729-072_0e1e6b8e-1e8f-3b26-e063-6294a90ad5fb	16729-072	HUMAN PRESCRIPTION DRUG	CAPECITABINE		CAPECITABINE	TABLET, FILM COATED	ORAL	20150609		ANDA	ANDA202593	Accord Healthcare Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20251231
16729-073_0e1e6b8e-1e8f-3b26-e063-6294a90ad5fb	16729-073	HUMAN PRESCRIPTION DRUG	CAPECITABINE		CAPECITABINE	TABLET, FILM COATED	ORAL	20150520		ANDA	ANDA202593	Accord Healthcare Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20251231
16729-078_0acd065e-6914-bb1a-e063-6394a90a1979	16729-078	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20130613		ANDA	ANDA202323	Accord Healthcare, Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
16729-079_0acd065e-6914-bb1a-e063-6394a90a1979	16729-079	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20130613		ANDA	ANDA202323	Accord Healthcare, Inc.	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
16729-081_4809b267-b0d6-4588-e054-00144ff88e88	16729-081	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20120118		ANDA	ANDA091205	Accord Healthcare, Inc.	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
16729-089_f068663c-a9fb-e130-e053-2a95a90ab70e	16729-089	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20131108		ANDA	ANDA091643	Accord Healthcare, Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
16729-090_f9b5930f-a724-a6fb-e053-6294a90acda5	16729-090	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20100528		ANDA	ANDA090121	Accord Healthcare, Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
16729-092_ecb5724e-7163-e91b-e053-2995a90abe5a	16729-092	HUMAN PRESCRIPTION DRUG	GEMCITABINE HYDROCHLORIDE		GEMCITABINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110728		ANDA	ANDA091594	Accord Healthcare Inc.	GEMCITABINE HYDROCHLORIDE	200	mg/5mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-094_0e2f4e33-3ac1-3b42-e063-6394a90a3db8	16729-094	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	CAPSULE	ORAL	20090504		ANDA	ANDA090253	Accord Healthcare Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
16729-095_0c5002a0-4f98-1440-e063-6294a90adb92	16729-095	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20190101		ANDA	ANDA090681	Accord Healthcare Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-096_0c5002a0-4f98-1440-e063-6294a90adb92	16729-096	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20190101		ANDA	ANDA090681	Accord Healthcare Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-097_0c5002a0-4f98-1440-e063-6294a90adb92	16729-097	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20161101		ANDA	ANDA090681	Accord Healthcare Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-108_038047f2-a661-2d0b-e063-6394a90aca07	16729-108	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090610		ANDA	ANDA064144	Accord Healthcare Inc	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-109_0c5002a0-4f98-1440-e063-6294a90adb92	16729-109	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20190101		ANDA	ANDA090681	Accord Healthcare Inc.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-114_aedd6610-7160-2001-e053-2995a90a16cf	16729-114	HUMAN PRESCRIPTION DRUG	Etoposide		Etoposide	INJECTION	INTRAVENOUS	20150303		ANDA	ANDA074513	Accord Healthcare Inc.	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
16729-115_038047f2-a661-2d0b-e063-6394a90aca07	16729-115	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090618		ANDA	ANDA064144	Accord Healthcare Inc	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-116_038047f2-a661-2d0b-e063-6394a90aca07	16729-116	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110311		ANDA	ANDA064144	Accord Healthcare Inc	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-117_ecb5724e-7163-e91b-e053-2995a90abe5a	16729-117	HUMAN PRESCRIPTION DRUG	GEMCITABINE HYDROCHLORIDE		GEMCITABINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110801		ANDA	ANDA091594	Accord Healthcare Inc.	GEMCITABINE HYDROCHLORIDE	1	g/25mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-118_ecb5724e-7163-e91b-e053-2995a90abe5a	16729-118	HUMAN PRESCRIPTION DRUG	GEMCITABINE HYDROCHLORIDE		GEMCITABINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110831		ANDA	ANDA091594	Accord Healthcare Inc.	GEMCITABINE HYDROCHLORIDE	2	g/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-119_d481e75b-ffed-a218-e053-2995a90a19c5	16729-119	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20130411		ANDA	ANDA202717	Accord Healthcare Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
16729-129_0b85d412-d6c8-21cc-e063-6294a90a958c	16729-129	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170307		ANDA	ANDA201528	Accord Healthcare Inc.	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-130_0b85d412-d6c8-21cc-e063-6294a90a958c	16729-130	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170307		ANDA	ANDA201528	Accord Healthcare Inc.	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-131_ee323333-c885-25d1-e053-2995a90acddc	16729-131	HUMAN PRESCRIPTION DRUG	FLUDARABINE PHOSPHATE		FLUDARABINE	INJECTION	INTRAVENOUS	20221122		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Accord Healthcare, Inc.	FLUDARABINE PHOSPHATE	25	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-132_0c4fe827-5019-4fc1-e063-6394a90aba52	16729-132	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20171130		ANDA	ANDA206252	Accord Healthcare Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-134_0aa61d1a-5876-45b6-e063-6294a90ac936	16729-134	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20150429		ANDA	ANDA203154	Accord Healthcare Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16729-135_0aa61d1a-5876-45b6-e063-6294a90ac936	16729-135	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20150429		ANDA	ANDA203154	Accord Healthcare Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
16729-136_0e1e7f41-f78b-27cf-e063-6394a90a1ae0	16729-136	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Accord Healthcare Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
16729-137_0e1e7f41-f78b-27cf-e063-6394a90a1ae0	16729-137	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Accord Healthcare Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
16729-138_0e1e7f41-f78b-27cf-e063-6394a90a1ae0	16729-138	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Accord Healthcare Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
16729-139_0b33fbf1-c741-b24a-e063-6294a90aa510	16729-139	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20110718		ANDA	ANDA074550	Accord Healthcare Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16729-140_0b33fbf1-c741-b24a-e063-6294a90aa510	16729-140	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20110718		ANDA	ANDA074550	Accord Healthcare Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
16729-141_f824d537-0788-48c9-e053-6394a90ada3d	16729-141	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	20170410		ANDA	ANDA202873	Accord Healthcare Inc.	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-142_f824d537-0788-48c9-e053-6394a90ada3d	16729-142	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	20170410		ANDA	ANDA202873	Accord Healthcare Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-145_0c4fd2d3-3d06-f1f0-e063-6294a90abd19	16729-145	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Accord Healthcare Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-146_0c4fd2d3-3d06-f1f0-e063-6294a90abd19	16729-146	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Accord Healthcare Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-147_0c4fd2d3-3d06-f1f0-e063-6294a90abd19	16729-147	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Accord Healthcare Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-148_0c4fd2d3-3d06-f1f0-e063-6294a90abd19	16729-148	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Accord Healthcare Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-149_0c4fd2d3-3d06-f1f0-e063-6294a90abd19	16729-149	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Accord Healthcare Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-150_0c4fd2d3-3d06-f1f0-e063-6294a90abd19	16729-150	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Accord Healthcare Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-151_ecb5ba69-a8ed-3041-e053-2a95a90a7c73	16729-151	HUMAN PRESCRIPTION DRUG	topotecan hydrochloride		topotecan hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20130723		ANDA	ANDA202351	Accord Healthcare, Inc.	TOPOTECAN HYDROCHLORIDE	4	mg/4mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
16729-152_c2d4669a-76a4-4b64-e053-2a95a90a036d	16729-152	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20150212		ANDA	ANDA202392	Accord Healthcare Inc.	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-153_c2d4669a-76a4-4b64-e053-2a95a90a036d	16729-153	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20150212		ANDA	ANDA202392	Accord Healthcare Inc.	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-154_c2d4669a-76a4-4b64-e053-2a95a90a036d	16729-154	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20150212		ANDA	ANDA202392	Accord Healthcare Inc.	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-155_c2d4669a-76a4-4b64-e053-2a95a90a036d	16729-155	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20150212		ANDA	ANDA202392	Accord Healthcare Inc.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-156_ff92b67e-c659-c9e0-e053-6394a90af562	16729-156	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20140912		ANDA	ANDA078155	Accord Healthcare, Inc.	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-168_0e2f33f8-fbb4-aac4-e063-6294a90a0273	16729-168	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130305		ANDA	ANDA202389	Accord Healthcare Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
16729-169_0e2f33f8-fbb4-aac4-e063-6294a90a0273	16729-169	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130319		ANDA	ANDA202389	Accord Healthcare Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
16729-170_0e2f33f8-fbb4-aac4-e063-6294a90a0273	16729-170	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	Accord Healthcare Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
16729-171_0e0371d3-6a06-1572-e063-6394a90a505d	16729-171	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Accord Healthcare Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
16729-172_0e0371d3-6a06-1572-e063-6394a90a505d	16729-172	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205	20250331	ANDA	ANDA202446	Accord Healthcare Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
16729-173_0e0371d3-6a06-1572-e063-6394a90a505d	16729-173	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205	20240930	ANDA	ANDA202446	Accord Healthcare Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
16729-174_0e0371d3-6a06-1572-e063-6394a90a505d	16729-174	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141226	20250430	ANDA	ANDA202446	Accord Healthcare Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	
16729-175_0e0371d3-6a06-1572-e063-6394a90a505d	16729-175	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205	20250131	ANDA	ANDA202446	Accord Healthcare Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	
16729-176_0e0371d3-6a06-1572-e063-6394a90a505d	16729-176	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141226		ANDA	ANDA202446	Accord Healthcare Inc.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
16729-182_ae5013b5-8fe9-7755-e053-2a95a90aa821	16729-182	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130418		ANDA	ANDA202556	Accord Healthcare Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16729-183_ae5013b5-8fe9-7755-e053-2a95a90aa821	16729-183	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	Accord Healthcare Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16729-184_ae5013b5-8fe9-7755-e053-2a95a90aa821	16729-184	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	Accord Healthcare Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16729-189_f2b47e6d-5a9a-a7a6-e053-2995a90a19f1	16729-189	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20170911		ANDA	ANDA202555	Accord Healthcare Inc.	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
16729-200_0e35e677-c9ee-d9ad-e063-6394a90aff9d	16729-200	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Accord Healthcare Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20251231
16729-201_0e35e677-c9ee-d9ad-e063-6394a90aff9d	16729-201	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161114		ANDA	ANDA202557	Accord Healthcare Inc.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20251231
16729-202_0e35e677-c9ee-d9ad-e063-6394a90aff9d	16729-202	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Accord Healthcare Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20251231
16729-203_0e35e677-c9ee-d9ad-e063-6394a90aff9d	16729-203	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Accord Healthcare Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20251231
16729-211_f6f398c3-1894-37ac-e053-6294a90a5b73	16729-211	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150304		ANDA	ANDA202824	Accord Healthcare Inc.	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
16729-213_f6f398c3-1894-37ac-e053-6294a90a5b73	16729-213	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150422		ANDA	ANDA202824	Accord Healthcare Inc.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
16729-215_0e2ed027-e131-1b40-e063-6394a90a14b5	16729-215	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Accord Healthcare, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
16729-216_0e2ed027-e131-1b40-e063-6394a90a14b5	16729-216	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Accord Healthcare, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
16729-217_0e2ed027-e131-1b40-e063-6394a90a14b5	16729-217	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Accord Healthcare, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
16729-218_0acd5b3d-dafb-3566-e063-6294a90a819a	16729-218	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20131121		ANDA	ANDA202925	Accord Healthcare Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
16729-219_0acd5b3d-dafb-3566-e063-6294a90a819a	16729-219	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20150108		ANDA	ANDA202925	Accord Healthcare Inc.	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
16729-223_736ae550-f75e-98f6-e053-2991aa0a5f87	16729-223	HUMAN PRESCRIPTION DRUG	Temsirolimus		temsirolimus	KIT		20180813		ANDA	ANDA203153	Accord Healthcare Inc.						N	20241231
16729-224_df80c0a9-9560-8219-e053-2995a90ad683	16729-224	HUMAN PRESCRIPTION DRUG	Decitabine		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170308		ANDA	ANDA203475	Accord Healthcare Inc.	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-225_0c5fd19d-d14b-1648-e063-6394a90a50d8	16729-225	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Accord Healthcare, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16729-226_0c5fd19d-d14b-1648-e063-6394a90a50d8	16729-226	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Accord Healthcare, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16729-227_0c5fd19d-d14b-1648-e063-6394a90a50d8	16729-227	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Accord Healthcare, Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16729-229_f6f49a2d-2e3d-61f1-e053-6394a90abd73	16729-229	HUMAN PRESCRIPTION DRUG	PEMETREXED		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA203485	Accord Healthcare Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
16729-230_f6f49a2d-2e3d-61f1-e053-6394a90abd73	16729-230	HUMAN PRESCRIPTION DRUG	PEMETREXED		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA203485	Accord Healthcare Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
16729-232_f6f4f32a-f960-e131-e053-6394a90ab25d	16729-232	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Accord Healthcare Inc.	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16729-233_f6f4f32a-f960-e131-e053-6394a90ab25d	16729-233	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Accord Healthcare Inc.	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16729-234_f6f4f32a-f960-e131-e053-6394a90ab25d	16729-234	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Accord Healthcare Inc.	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16729-235_f6f4f32a-f960-e131-e053-6394a90ab25d	16729-235	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Accord Healthcare Inc.	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16729-236_f6f4f32a-f960-e131-e053-6394a90ab25d	16729-236	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Accord Healthcare Inc.	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16729-237_f6f4f32a-f960-e131-e053-6394a90ab25d	16729-237	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Accord Healthcare Inc.	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16729-238_f6f4f32a-f960-e131-e053-6394a90ab25d	16729-238	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Accord Healthcare Inc.	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
16729-239_f40db355-80f1-6c94-e053-2a95a90a3acd	16729-239	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		Dexmedetomidine	INJECTION, SOLUTION	INTRAVENOUS	20161221		ANDA	ANDA204023	Accord Healthcare Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
16729-240_f4c0b28f-27db-7e04-e053-2a95a90aa39c	16729-240	HUMAN PRESCRIPTION DRUG	Fosaprepitant		FOSAPREPITANT	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201022		ANDA	ANDA204025	Accord Healthcare Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
16729-242_8b2044ac-c38f-58f7-e053-2a95a90ab1ce	16729-242	HUMAN PRESCRIPTION DRUG	Zoledronic acid		zoledronic acid	INJECTION	INTRAVENOUS	20171016		ANDA	ANDA205279	Accord Healthcare Inc.	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
16729-243_0c601675-1499-39ec-e063-6394a90ac744	16729-243	HUMAN PRESCRIPTION DRUG	Topotecan		Topotecan	INJECTION	INTRAVENOUS	20200708		ANDA	ANDA204406	Accord Healthcare Inc.	TOPOTECAN	1	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
16729-244_f6f49a2d-2e3d-61f1-e053-6394a90abd73	16729-244	HUMAN PRESCRIPTION DRUG	PEMETREXED		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA203485	Accord Healthcare Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	1	g/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
16729-250_ef547fb0-34bb-6354-e053-2a95a90a90cb	16729-250	HUMAN PRESCRIPTION DRUG	bendamustine hydrochloride		bendamustine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221207		ANDA	ANDA205574	Accord Healthcare, Inc.	BENDAMUSTINE HYDROCHLORIDE	25	mg/5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-251_ef547fb0-34bb-6354-e053-2a95a90a90cb	16729-251	HUMAN PRESCRIPTION DRUG	bendamustine hydrochloride		bendamustine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221207		ANDA	ANDA205574	Accord Healthcare, Inc.	BENDAMUSTINE HYDROCHLORIDE	100	mg/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
16729-252_aedd1bd2-0e7f-3e54-e053-2a95a90aa65e	16729-252	HUMAN PRESCRIPTION DRUG	Esomeprazole sodium		Esomeprazole sodium	INJECTION	INTRAVENOUS	20161011		ANDA	ANDA205379	Accord Healthcare Inc.	ESOMEPRAZOLE SODIUM	40	mg/5mL	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
16729-259_cdd40b82-74eb-3b46-e053-2995a90aeabd	16729-259	HUMAN PRESCRIPTION DRUG	EPTIFIBATIDE		Eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20180405		ANDA	ANDA205557	Accord Healthcare Inc.	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
16729-260_cdd40b82-74eb-3b46-e053-2995a90aeabd	16729-260	HUMAN PRESCRIPTION DRUG	EPTIFIBATIDE		Eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20180409		ANDA	ANDA205557	Accord Healthcare Inc.	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
16729-261_f2b47e6d-5a9a-a7a6-e053-2995a90a19f1	16729-261	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20170911		ANDA	ANDA202555	Accord Healthcare Inc.	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
16729-267_05d9fc19-1a14-cea7-e063-6394a90a52d3	16729-267	HUMAN PRESCRIPTION DRUG	DOCETAXEL		docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20130530		NDA	NDA201195	Accord Healthcare Inc.	DOCETAXEL ANHYDROUS	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
16729-271_0b85efed-dee4-1aa7-e063-6394a90a5a3c	16729-271	HUMAN PRESCRIPTION DRUG	Itraconazole		ITRACONAZOLE	CAPSULE	ORAL	20170530		ANDA	ANDA205991	Accord Healthcare Inc.	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
16729-272_0e2f030a-d262-a36c-e063-6294a90a40ef	16729-272	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20190116		ANDA	ANDA205987	Accord Healthcare Inc.	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20251231
16729-273_0e2f030a-d262-a36c-e063-6294a90a40ef	16729-273	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20190116		ANDA	ANDA205987	Accord Healthcare Inc.	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20251231
16729-274_0e7e42cb-5f75-593f-e063-6294a90aed00	16729-274	HUMAN PRESCRIPTION DRUG	Ibandronate Sodium		ibandronate sodium	INJECTION, SOLUTION	INTRAVENOUS	20240101		ANDA	ANDA206058	Accord Healthcare Inc.	IBANDRONATE SODIUM	3	mg/3mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20251231
16729-275_0e1ed629-0701-49af-e063-6394a90a8e2e	16729-275	HUMAN PRESCRIPTION DRUG	Bivalirudin		bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181107		ANDA	ANDA206551	Accord Healthcare, Inc.	BIVALIRUDIN	250	mg/5mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20251231
16729-276_4930358c-89ed-1ac5-e054-00144ff88e88	16729-276	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20140314		ANDA	ANDA040798	Accord Healthcare, Inc.	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-276_aede51a3-92a6-d619-e053-2a95a90a16a0	16729-276	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20140314		ANDA	ANDA040743	Accord Healthcare, Inc.	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-277_c3ee702b-be0d-f3ca-e053-2995a90aec02	16729-277	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20140307		ANDA	ANDA040716	Accord Healthcare, Inc.	METHOTREXATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
16729-278_0aa6c9f6-e0f3-b582-e063-6394a90a3986	16729-278	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	Accord Healthcare, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-279_0aa6c9f6-e0f3-b582-e063-6394a90a3986	16729-279	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	Accord Healthcare, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-280_0aa6c9f6-e0f3-b582-e063-6394a90a3986	16729-280	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	Accord Healthcare, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-281_0aa6c9f6-e0f3-b582-e063-6394a90a3986	16729-281	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	Accord Healthcare, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-282_0aa6c9f6-e0f3-b582-e063-6394a90a3986	16729-282	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	Accord Healthcare, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-283_0aa6c9f6-e0f3-b582-e063-6394a90a3986	16729-283	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170214		ANDA	ANDA206251	Accord Healthcare, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-284_0c4ffbb2-a89f-4904-e063-6394a90a2503	16729-284	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Accord Healthcare Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-285_0c4ffbb2-a89f-4904-e063-6394a90a2503	16729-285	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Accord Healthcare Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-286_0c4ffbb2-a89f-4904-e063-6394a90a2503	16729-286	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Accord Healthcare Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-287_0c4ffbb2-a89f-4904-e063-6394a90a2503	16729-287	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Accord Healthcare Inc.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
16729-288_c43de769-d6d8-3bb9-e053-2995a90a5aa2	16729-288	HUMAN PRESCRIPTION DRUG	Cisplatin		Cisplatin	INJECTION	INTRAVENOUS	20161213		ANDA	ANDA206774	Accord Healthcare	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
16729-289_0e35e677-c9ee-d9ad-e063-6394a90aff9d	16729-289	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Accord Healthcare Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20251231
16729-292_0e1eac87-c9fb-4d7f-e063-6394a90a3070	16729-292	HUMAN PRESCRIPTION DRUG	Dalfampridine		Dalfampridine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180918		ANDA	ANDA206863	Accord Healthcare Inc.	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20251231
16729-293_0b2237e2-3ff3-8799-e063-6394a90a8ac3	16729-293	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, FILM COATED	ORAL	20181009		ANDA	ANDA206922	Accord Healthcare, Inc.	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16729-294_0b2237e2-3ff3-8799-e063-6394a90a8ac3	16729-294	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, FILM COATED	ORAL	20181009		ANDA	ANDA206922	Accord Healthcare, Inc.	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
16729-295_0acd2432-98d8-018e-e063-6294a90ad373	16729-295	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION	INTRACAVERNOUS	20170919		ANDA	ANDA206775	Accord Healthcare, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
16729-297_ce13a845-3a71-334f-e053-2995a90af35c	16729-297	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20161020		ANDA	ANDA206845	Accord Healthcare, Inc.	ONDANSETRON	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16729-298_d925044c-64a5-4a04-e053-2a95a90a8950	16729-298	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20161020		ANDA	ANDA206846	Accord Healthcare, Inc.	ONDANSETRON	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
16729-299_0c6030b4-2975-2153-e063-6394a90a947f	16729-299	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20181005		ANDA	ANDA206923	Accord Healthcare, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
16729-300_0c6030b4-2975-2153-e063-6394a90a947f	16729-300	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20181005		ANDA	ANDA206923	Accord Healthcare, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
16729-301_0c6030b4-2975-2153-e063-6394a90a947f	16729-301	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20181017		ANDA	ANDA206923	Accord Healthcare, Inc.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
16729-302_0c6030b4-2975-2153-e063-6394a90a947f	16729-302	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20181025		ANDA	ANDA206923	Accord Healthcare, Inc.	TRAZODONE HYDROCHLORIDE	300	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
16729-303_0acd9110-4ba4-227a-e063-6294a90ad942	16729-303	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200911		ANDA	ANDA206997	Accord Healthcare, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16729-304_0acd9110-4ba4-227a-e063-6294a90ad942	16729-304	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200911		ANDA	ANDA206997	Accord Healthcare, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16729-305_0acd9110-4ba4-227a-e063-6294a90ad942	16729-305	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200911		ANDA	ANDA206997	Accord Healthcare, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
16729-306_0e1e7f41-f749-27cf-e063-6394a90a1ae0	16729-306	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190109		ANDA	ANDA207475	Accord Healthcare Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20251231
16729-310_ecb63f11-0f08-729a-e053-2995a90afced	16729-310	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	20160324		NDA	NDA207174	Accord Healthcare, Inc.	PARICALCITOL	2	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
16729-311_ecb63f11-0f08-729a-e053-2995a90afced	16729-311	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	20160324		NDA	NDA207174	Accord Healthcare, Inc.	PARICALCITOL	5	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
16729-317_f6f3b74f-5af8-094b-e053-6394a90afa8a	16729-317	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161214		ANDA	ANDA207138	Accord Healthcare, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-318_f6f3b74f-5af8-094b-e053-6394a90afa8a	16729-318	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161220		ANDA	ANDA207138	Accord Healthcare, Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-319_f6f3b74f-5af8-094b-e053-6394a90afa8a	16729-319	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161214		ANDA	ANDA207138	Accord Healthcare, Inc.	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-320_f6f46e01-6204-a23a-e053-6294a90a75fa	16729-320	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180216		ANDA	ANDA207662	Accord Healthcare Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
16729-321_f6f46e01-6204-a23a-e053-6294a90a75fa	16729-321	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170427		ANDA	ANDA207662	Accord Healthcare Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
16729-322_f6f46e01-6204-a23a-e053-6294a90a75fa	16729-322	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170427		ANDA	ANDA207662	Accord Healthcare Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
16729-331_f5b66c1a-cf00-77ca-e053-2995a90aa2cf	16729-331	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20211119		ANDA	ANDA207659	Accord Healthcare Inc.	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
16729-332_0e2ec613-5375-858e-e063-6294a90ab95a	16729-332	HUMAN PRESCRIPTION DRUG	oxaliplatin		oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180517		ANDA	ANDA207474	Accord Healthcare Inc.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20251231
16729-342_0b33c4a0-e881-85fe-e063-6394a90ad5a2	16729-342	HUMAN PRESCRIPTION DRUG	FINGOLIMOD HYDROCHLORIDE		FINGOLIMOD HYDROCHLORIDE	CAPSULE	ORAL	20221018		ANDA	ANDA207991	Accord Healthcare Inc.	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
16729-346_0b8642f7-91fe-a981-e063-6294a90a2510	16729-346	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208049	Accord Healthcare, Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-347_0b8642f7-91fe-a981-e063-6294a90a2510	16729-347	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208049	Accord Healthcare, Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-348_0b8642f7-91fe-a981-e063-6294a90a2510	16729-348	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208049	Accord Healthcare, Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-349_0b8642f7-91fe-a981-e063-6294a90a2510	16729-349	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208049	Accord Healthcare, Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-350_0b8642f7-91fe-a981-e063-6294a90a2510	16729-350	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208049	Accord Healthcare, Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
16729-351_0e2ef789-efb4-8395-e063-6294a90a9145	16729-351	HUMAN PRESCRIPTION DRUG	Busulfan		busulfan	INJECTION	INTRAVENOUS	20190722		ANDA	ANDA210148	Accord Healthcare, Inc	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20251231
16729-352_0c605eec-fd7d-4cec-e063-6394a90ac4a1	16729-352	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET	ORAL	20220604		ANDA	ANDA208209	Accord Healthcare Inc.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
16729-353_0c605eec-fd7d-4cec-e063-6394a90ac4a1	16729-353	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET	ORAL	20220604		ANDA	ANDA208209	Accord Healthcare Inc.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
16729-354_0c605eec-fd7d-4cec-e063-6394a90ac4a1	16729-354	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET	ORAL	20220604		ANDA	ANDA208209	Accord Healthcare Inc.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
16729-364_cc192d08-55de-6825-e053-2a95a90a1ce2	16729-364	HUMAN PRESCRIPTION DRUG	TIGECYCLINE		TIGECYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190328		NDA	NDA208744	Accord Healthcare Inc.	TIGECYCLINE	50	mg/10mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
16729-366_0bd2657a-5e2b-9f22-e063-6294a90a213e	16729-366	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20200921		ANDA	ANDA209281	Accord Healthcare Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16729-367_0bd2657a-5e2b-9f22-e063-6294a90a213e	16729-367	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20200903		ANDA	ANDA209281	Accord Healthcare Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16729-368_0bd2657a-5e2b-9f22-e063-6294a90a213e	16729-368	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20200903		ANDA	ANDA209281	Accord Healthcare Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
16729-369_0c5fd8dc-2f34-1e3c-e063-6394a90a9506	16729-369	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	Accord Healthcare Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16729-370_0c5fd8dc-2f34-1e3c-e063-6394a90a9506	16729-370	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	Accord Healthcare Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16729-371_0c5fd8dc-2f34-1e3c-e063-6394a90a9506	16729-371	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200403		ANDA	ANDA209167	Accord Healthcare Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16729-372_0c5fd8dc-2f34-1e3c-e063-6394a90a9506	16729-372	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	Accord Healthcare Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
16729-375_ecb64f83-e355-31a4-e053-2a95a90a4071	16729-375	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20161222		ANDA	ANDA202554	Accord Healthcare Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-376_ecb64f83-e355-31a4-e053-2a95a90a4071	16729-376	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20160602		ANDA	ANDA202554	Accord Healthcare Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-377_ecb64f83-e355-31a4-e053-2a95a90a4071	16729-377	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20160425		ANDA	ANDA202554	Accord Healthcare Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-378_ecb64f83-e355-31a4-e053-2a95a90a4071	16729-378	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20160427		ANDA	ANDA202554	Accord Healthcare Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-379_ecb64f83-e355-31a4-e053-2a95a90a4071	16729-379	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20160520		ANDA	ANDA202554	Accord Healthcare Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-380_ecb64f83-e355-31a4-e053-2a95a90a4071	16729-380	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20160429		ANDA	ANDA202554	Accord Healthcare Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
16729-388_bae56d70-2cec-84eb-e053-2995a90a0ccd	16729-388	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20170825		ANDA	ANDA205824	Accord Healthcare Inc.	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
16729-389_bae56d70-2cec-84eb-e053-2995a90a0ccd	16729-389	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20170825		ANDA	ANDA205824	Accord Healthcare Inc.	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
16729-391_ecb6a530-5574-6877-e053-2a95a90aa57f	16729-391	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20180124		NDA	NDA209604	Accord Healthcare Inc.	GEMCITABINE HYDROCHLORIDE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-399_f6df1ae5-c226-ef81-e053-6294a90ac9fa	16729-399	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209690	Accord Healthcare Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
16729-400_f6df1ae5-c226-ef81-e053-6294a90ac9fa	16729-400	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209690	Accord Healthcare Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
16729-414_f6f398c3-1894-37ac-e053-6294a90a5b73	16729-414	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170614		ANDA	ANDA202824	Accord Healthcare Inc.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
16729-415_f6f398c3-1894-37ac-e053-6294a90a5b73	16729-415	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170710		ANDA	ANDA202824	Accord Healthcare Inc.	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
16729-416_0436f7b5-1dd6-37bf-e063-6394a90a963b	16729-416	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20210125		ANDA	ANDA210499	Accord Healthcare Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
16729-417_0436f7b5-1dd6-37bf-e063-6394a90a963b	16729-417	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20210113		ANDA	ANDA210499	Accord Healthcare Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
16729-418_0436f7b5-1dd6-37bf-e063-6394a90a963b	16729-418	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		Dimethyl fumarate	KIT		20220926		ANDA	ANDA210499	Accord Healthcare Inc.						N	20241231
16729-419_ecb6a530-5574-6877-e053-2a95a90aa57f	16729-419	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20180125		NDA	NDA209604	Accord Healthcare Inc.	GEMCITABINE HYDROCHLORIDE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-421_bdb965cd-8ffa-ae3b-e053-2a95a90afff9	16729-421	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	OINTMENT	TOPICAL	20190531		ANDA	ANDA211688	Accord Healthcare Inc.	TACROLIMUS	.3	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
16729-422_bdb965cd-8ffa-ae3b-e053-2a95a90afff9	16729-422	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	OINTMENT	TOPICAL	20190531		ANDA	ANDA211688	Accord Healthcare Inc.	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
16729-423_ecb6a530-5574-6877-e053-2a95a90aa57f	16729-423	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20180124		NDA	NDA209604	Accord Healthcare Inc.	GEMCITABINE HYDROCHLORIDE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-426_ecb6a530-5574-6877-e053-2a95a90aa57f	16729-426	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20180806		NDA	NDA209604	Accord Healthcare Inc.	GEMCITABINE HYDROCHLORIDE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-430_ece05032-2b63-15a2-e053-2a95a90a6033	16729-430	HUMAN PRESCRIPTION DRUG	ARGATROBAN		Argatroban	INJECTION	INTRAVENOUS	20211007		NDA	NDA212035	Accord Healthcare Inc.	ARGATROBAN	1	mg/mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
16729-432_ad2504de-4b7e-16ff-e053-2a95a90a60b1	16729-432	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE		DEXMEDETOMIDINE	INJECTION, SOLUTION	INTRAVENOUS	20180831		ANDA	ANDA204023	Accord Healthcare Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
16729-433_fae067e1-4b04-5e3d-e053-6394a90a6f15	16729-433	HUMAN PRESCRIPTION DRUG	EZETIMIBE		EZETIMIBE	TABLET	ORAL	20191007		ANDA	ANDA211550	Accord Healthcare Inc.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
16729-434_e57b47fd-3159-79f1-e053-2995a90ac996	16729-434	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190716		ANDA	ANDA212667	Accord Healthcare, Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
16729-435_ddc6ae65-7556-619b-e053-2995a90a3ebf	16729-435	HUMAN PRESCRIPTION DRUG	DAPTOMYCIN		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190624		ANDA	ANDA211961	Accord Healthcare Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
16729-436_c1a4ea92-4cfd-6e69-e053-2a95a90ac875	16729-436	HUMAN PRESCRIPTION DRUG	FULVESTRANT		Fulvestrant	INJECTION	INTRAMUSCULAR	20210112		ANDA	ANDA211689	Accord Healthcare Inc.	FULVESTRANT	250	mg/5mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
16729-440_0acd33c6-c29d-0b25-e063-6394a90a774f	16729-440	HUMAN PRESCRIPTION DRUG	CINACALCET		Cinacalcet	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA211892	Accord Healthcare, Inc.	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
16729-441_0acd33c6-c29d-0b25-e063-6394a90a774f	16729-441	HUMAN PRESCRIPTION DRUG	CINACALCET		Cinacalcet	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA211892	Accord Healthcare, Inc.	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
16729-442_0acd33c6-c29d-0b25-e063-6394a90a774f	16729-442	HUMAN PRESCRIPTION DRUG	CINACALCET		Cinacalcet	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA211892	Accord Healthcare, Inc.	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
16729-443_05c8f764-5481-64ba-e063-6294a90ac1f5	16729-443	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	Accord Healthcare Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16729-444_05c8f764-5481-64ba-e063-6294a90ac1f5	16729-444	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA210497	Accord Healthcare Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
16729-445_f9b52484-9104-faf2-e053-6294a90a93fb	16729-445	HUMAN PRESCRIPTION DRUG	CLOBAZAM		clobazam	TABLET	ORAL	20210528		ANDA	ANDA212398	Accord Healthcare Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
16729-446_f9b52484-9104-faf2-e053-6294a90a93fb	16729-446	HUMAN PRESCRIPTION DRUG	CLOBAZAM		clobazam	TABLET	ORAL	20210528		ANDA	ANDA212398	Accord Healthcare Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
16729-447_0b863437-3871-4790-e063-6394a90af5e8	16729-447	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-448_0b863437-3871-4790-e063-6394a90af5e8	16729-448	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-449_0b863437-3871-4790-e063-6394a90af5e8	16729-449	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-450_0b863437-3871-4790-e063-6394a90af5e8	16729-450	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-451_0b863437-3871-4790-e063-6394a90af5e8	16729-451	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-452_0b863437-3871-4790-e063-6394a90af5e8	16729-452	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-453_0b863437-3871-4790-e063-6394a90af5e8	16729-453	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-454_0b863437-3871-4790-e063-6394a90af5e8	16729-454	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-455_0b863437-3871-4790-e063-6394a90af5e8	16729-455	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-456_0b863437-3871-4790-e063-6394a90af5e8	16729-456	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-457_0b863437-3871-4790-e063-6394a90af5e8	16729-457	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-458_0b863437-3871-4790-e063-6394a90af5e8	16729-458	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	Accord Healthcare Inc.	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
16729-464_f9b4f7dc-ca9a-858c-e053-6394a90aff51	16729-464	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20220311		ANDA	ANDA213237	Accord Healthcare, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
16729-465_f9b4f7dc-ca9a-858c-e053-6394a90aff51	16729-465	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20220311		ANDA	ANDA213237	Accord Healthcare, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
16729-466_f9b4f7dc-ca9a-858c-e053-6394a90aff51	16729-466	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20220311		ANDA	ANDA213237	Accord Healthcare, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
16729-467_0bd310eb-431b-43b9-e063-6294a90aaccf	16729-467	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET, FILM COATED	ORAL	20220527		ANDA	ANDA212730	Accord Healthcare Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
16729-468_0bd310eb-431b-43b9-e063-6294a90aaccf	16729-468	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET, FILM COATED	ORAL	20220527		ANDA	ANDA212730	Accord Healthcare Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
16729-471_d393a343-b672-2587-e053-2995a90a3f5b	16729-471	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201217		ANDA	ANDA213238	Accord Healthcare, Inc.,	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16729-472_d393a343-b672-2587-e053-2995a90a3f5b	16729-472	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201210		ANDA	ANDA213238	Accord Healthcare, Inc.,	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16729-473_d393a343-b672-2587-e053-2995a90a3f5b	16729-473	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201210		ANDA	ANDA213238	Accord Healthcare, Inc.,	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16729-474_d393a343-b672-2587-e053-2995a90a3f5b	16729-474	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201210		ANDA	ANDA213238	Accord Healthcare, Inc.,	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
16729-477_f6cacd68-0f58-deb9-e053-6294a90aa266	16729-477	HUMAN PRESCRIPTION DRUG	REGADENOSON		REGADENOSON	INJECTION, SOLUTION	INTRAVENOUS	20230310		ANDA	ANDA213236	Accord Healthcare Inc.	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
16729-478_facb5264-f816-f955-e053-6394a90a9be6	16729-478	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20201223		ANDA	ANDA213936	Accord Healthcare, Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16729-479_facb5264-f816-f955-e053-6394a90a9be6	16729-479	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20201217		ANDA	ANDA213936	Accord Healthcare, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16729-480_facb5264-f816-f955-e053-6394a90a9be6	16729-480	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20201217		ANDA	ANDA213936	Accord Healthcare, Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
16729-483_0c604d5f-3209-7c5b-e063-6294a90a6072	16729-483	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION	INTRAVENOUS	20210730		ANDA	ANDA212868	Accord Healthcare, Inc.,	ATROPINE SULFATE	.05	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-484_0c604d5f-3209-7c5b-e063-6294a90a6072	16729-484	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION	INTRAVENOUS	20210730		ANDA	ANDA212868	Accord Healthcare, Inc.,	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-485_f6f73d4a-d833-f495-e053-6294a90a99f6	16729-485	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET	ORAL	20200512		ANDA	ANDA213342	Accord Healthcare, Inc.,	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
16729-486_0b8678e1-098f-bf7e-e063-6294a90ab1e8	16729-486	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20200824		ANDA	ANDA213343	Accord Healthcare Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
16729-490_0acd8394-304e-55b3-e063-6394a90a0f12	16729-490	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200820		ANDA	ANDA213338	Accord Healthcare, Inc.	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
16729-491_0acd8394-304e-55b3-e063-6394a90a0f12	16729-491	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200820		ANDA	ANDA213338	Accord Healthcare, Inc.	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
16729-492_0acd8394-304e-55b3-e063-6394a90a0f12	16729-492	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200820		ANDA	ANDA213338	Accord Healthcare, Inc.	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
16729-493_0c5fdda8-5045-46de-e063-6294a90a592b	16729-493	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210407		ANDA	ANDA213705	Accord Healthcare, Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
16729-500_cf8d5155-e374-c03d-e053-2995a90a0b23	16729-500	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210505		ANDA	ANDA070017	Accord Healthcare, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
16729-501_cf8d5155-e374-c03d-e053-2995a90a0b23	16729-501	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210421		ANDA	ANDA070017	Accord Healthcare, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
16729-502_cf8d5155-e374-c03d-e053-2995a90a0b23	16729-502	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210421		ANDA	ANDA070017	Accord Healthcare, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
16729-512_ecb6ac52-5413-bf6a-e053-2995a90a4ef2	16729-512	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210325		ANDA	ANDA213424	Accord Healthcare Inc.	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-522_08857028-70b4-8ae6-e063-6394a90aa6c0	16729-522	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, SOLUTION	INTRAVENOUS	20220908		NDA	NDA214408	Accord Healthcare Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
16729-525_f7056bbf-1020-054c-e053-6394a90a3ef3	16729-525	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20210111		NDA	NDA214652	Accord Healthcare Inc.	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-526_f7056bbf-1020-054c-e053-6394a90a3ef3	16729-526	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20210111		NDA	NDA214652	Accord Healthcare Inc.	ATROPINE SULFATE	1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
16729-533_0acd5b3d-dafc-3566-e063-6294a90a819a	16729-533	HUMAN PRESCRIPTION DRUG	DODEX INJECTABLE		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20220429		ANDA	ANDA083022	Accord Healthcare, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
16729-542_e9547945-10bc-6d51-e053-2a95a90a89c2	16729-542	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	CREAM	TOPICAL	20211111		ANDA	ANDA214845	Accord Healthcare Inc.	FLUOROURACIL	50	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
16729-545_e6d82717-984f-2b85-e053-2a95a90ac34f	16729-545	HUMAN PRESCRIPTION DRUG	CARMUSTINE		CARMUSTINE	KIT		20220818		NDA	NDA215000	Accord Healthcare Inc.						N	20241231
16729-548_e6d82717-984f-2b85-e053-2a95a90ac34f	16729-548	HUMAN PRESCRIPTION DRUG	CARMUSTINE		CARMUSTINE	KIT		20220818		NDA	NDA215000	Accord Healthcare Inc.						N	20241231
16729-549_799f8804-485e-46ca-b6c6-243f790f80e2	16729-549	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE		BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE	TABLET	SUBLINGUAL	20200901		ANDA	ANDA209069	Accord Healthcare, Inc	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
16729-550_799f8804-485e-46ca-b6c6-243f790f80e2	16729-550	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE		BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE	TABLET	SUBLINGUAL	20200901		ANDA	ANDA209069	Accord Healthcare, Inc	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
16729-561_f6f73d4a-d833-f495-e053-6294a90a99f6	16729-561	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET	ORAL	20210928		ANDA	ANDA213342	Accord Healthcare, Inc.,	HYDROXYCHLOROQUINE SULFATE	100	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
16729-562_f6f73d4a-d833-f495-e053-6294a90a99f6	16729-562	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET	ORAL	20210928		ANDA	ANDA213342	Accord Healthcare, Inc.,	HYDROXYCHLOROQUINE SULFATE	300	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
16729-563_f6f73d4a-d833-f495-e053-6294a90a99f6	16729-563	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET	ORAL	20210928		ANDA	ANDA213342	Accord Healthcare, Inc.,	HYDROXYCHLOROQUINE SULFATE	400	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
16781-384_d087a8ef-b68a-49f2-a4db-e708a49addc1	16781-384	HUMAN PRESCRIPTION DRUG	Locoid Lipocream		HYDROCORTISONE BUTYRATE	CREAM	TOPICAL	20130703		NDA	NDA020769	Bausch Health US, LLC	HYDROCORTISONE BUTYRATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16781-392_ed132a08-195d-4b70-9673-ff6af099e2e9	16781-392	HUMAN PRESCRIPTION DRUG	Locoid		HYDROCORTISONE BUTYRATE	LOTION	TOPICAL	20130703		NDA	NDA022076	Bausch Health US, LLC	HYDROCORTISONE BUTYRATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
16781-462_0fc73875-71bd-44de-8abc-0d7b79dcc015	16781-462	HUMAN PRESCRIPTION DRUG	Clindagel		CLINDAMYCIN	GEL	TOPICAL	20131125		NDA	NDA050782	Bausch Health US, LLC	CLINDAMYCIN PHOSPHATE	1	g/10mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
16837-246_067b3f67-0df0-eb95-e063-6294a90aa9a8	16837-246	HUMAN OTC DRUG	Pepcid Complete		Famotidine, Calcium Carbonate, and Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20090101		NDA	NDA020958	Johnson & Johnson Consumer Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
16837-298_f7dcec39-5b67-8d48-e053-6394a90ab712	16837-298	HUMAN OTC DRUG	Pepcid Complete		Famotidine, Calcium carbonate, and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20090301		NDA	NDA020958	Johnson & Johnson Consumer Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
16837-855_0be66c2c-b737-116a-e063-6394a90ab851	16837-855	HUMAN OTC DRUG	PEPCID AC	Maximum Strength	Famotidine	TABLET, FILM COATED	ORAL	20030901		NDA	NDA020325	Johnson & Johnson Consumer Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
16837-872_0bfbb97d-ab9c-8624-e063-6294a90ad8d5	16837-872	HUMAN OTC DRUG	Pepcid AC	Original Strength	Famotidine	TABLET, FILM COATED	ORAL	19951001		NDA	NDA020325	Johnson & Johnson Consumer Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
16837-891_f7dcf68c-1e0f-3714-e053-6294a90a08ab	16837-891	HUMAN OTC DRUG	Pepcid Complete		famotidine, calcium carbonate, and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20090301		NDA	NDA020958	Johnson & Johnson Consumer Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
16864-021_453e05e8-7571-4d4c-b4d9-676664e55b59	16864-021	HUMAN OTC DRUG	Triple Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	20210515		OTC MONOGRAPH FINAL	part347	Advantice Health, LLC	ZINC OXIDE	12.8	g/100g			N	20241231
16864-040_ca96dea6-0da9-4ff9-a08f-0267d56ae0b3	16864-040	HUMAN OTC DRUG	Triple Antifungal		Miconazole Nitrate	OINTMENT	TOPICAL	20210901		OTC MONOGRAPH FINAL	part333C	Advantice Health, LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
16864-100_d020249e-a8f4-4f76-aafe-871390055517	16864-100	HUMAN OTC DRUG	Kerasal for Athletes Foot Silky Clear		TOLNAFTATE	GEL	TOPICAL	20220228		OTC MONOGRAPH FINAL	part333C	Advantice Health, LLC	TOLNAFTATE	1	g/100g			N	20241231
16864-110_9eae4eb3-2ceb-4940-aa0e-e77222886d1b	16864-110	HUMAN OTC DRUG	Kerasal Athletes Foot powder		Tolnaftate	SPRAY	TOPICAL	20220228		OTC MONOGRAPH FINAL	part333C	Advantice Health, LLC	TOLNAFTATE	1	g/100g			N	20241231
16864-140_3a3a525b-49f0-49e8-804f-f64d71645618	16864-140	HUMAN OTC DRUG	Kerasal Athletes Foot Rapid Symptom Relief	Medicated Soak	Aluminum Sulfate Tetradecahydrate and Calcium Acetate Monohydrate	POWDER, FOR SOLUTION	TOPICAL	20120626		OTC MONOGRAPH NOT FINAL	part347	Advantice Health, LLC.	ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE	1347; 952	mg/1; mg/1			N	20241231
16864-240_79c5f8f8-a76b-4838-afe4-19f85c4d786a	16864-240	HUMAN OTC DRUG	Domeboro		Aluminum Sulfate Tetradecahydrate, Calcium Acetate Monohydrate	POWDER, FOR SOLUTION	TOPICAL	20120626		OTC MONOGRAPH NOT FINAL	part347	Advantice Health, LLC.	ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE	1347; 952	mg/1; mg/1			N	20241231
16864-440_9ab61e4a-5687-4c53-a47c-7838adc10067	16864-440	HUMAN OTC DRUG	New Skin Bandage		Benzethonium Chloride	LIQUID	TOPICAL	20110301		OTC MONOGRAPH NOT FINAL	part333A	Advantice Health, LLC	BENZETHONIUM CHLORIDE	1.8	mg/mL			N	20241231
16864-450_b1e39a0d-d58f-417d-ada7-69dce20b4c4b	16864-450	HUMAN OTC DRUG	New Skin Bandage		Benzethonium Chloride	SPRAY	TOPICAL	20110301		OTC MONOGRAPH NOT FINAL	part333A	Advantice Health, LLC.	BENZETHONIUM CHLORIDE	60	mg/g			N	20241231
16864-660_7000f70c-ddaf-4a2f-956e-b0c62ed5a5b8	16864-660	HUMAN OTC DRUG	Dermoplast Kids	First Aid	BENZETHONIUM CHLORIDE and BENZOCAINE	SPRAY	TOPICAL	20220301		OTC MONOGRAPH NOT FINAL	part333A	Advantice Health, LLC.	BENZETHONIUM CHLORIDE; BENZOCAINE	2; 150	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
16864-670_94644c24-6d8b-4450-a537-fa57711d504c	16864-670	HUMAN OTC DRUG	Dermoplast First Aid		BENZETHONIUM CHLORIDE and BENZOCAINE	SPRAY	TOPICAL	20100101		OTC MONOGRAPH NOT FINAL	part333A	Advantice Health, LLC	BENZETHONIUM CHLORIDE; BENZOCAINE	2; 200	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
16864-680_091fe5c1-550f-47dc-83d6-3d792fd22dcb	16864-680	HUMAN OTC DRUG	Dermoplast Pain Relieving		BENZOCAINE and LEVOMENTHOL	SPRAY	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part348	Advantice Health, LLC	BENZOCAINE; LEVOMENTHOL	200; 5	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
16864-681_b30118b0-b328-4782-8f68-8f99ab19fcd7	16864-681	HUMAN OTC DRUG	Dermoplast Sunburn and Burn Relief		benzocaine and levomenthol	SPRAY	TOPICAL	20210515		OTC MONOGRAPH NOT FINAL	part348	Advantice Health, LLC	BENZOCAINE; LEVOMENTHOL	200; 5	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
16864-682_62e741d9-46d7-4762-8b00-570e86c20385	16864-682	HUMAN OTC DRUG	Dermoplast Insect Itch and Sting Relief		BENZOCAINE and LEVOMENTHOL	SPRAY	TOPICAL	20210515		OTC MONOGRAPH NOT FINAL	part348	Advantice Health, LLC	BENZOCAINE; LEVOMENTHOL	200; 5	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
16864-690_0d12185e-8d41-7d76-e063-6294a90a2cf4	16864-690	HUMAN OTC DRUG	Dermoplast Pain relieving		BENZOCAINE, MENTHOL	SPRAY	TOPICAL	20220318		OTC MONOGRAPH DRUG	M017	Advantice Health	BENZOCAINE; MENTHOL	200; 5	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
16913-0001_0771b7d0-0a90-f08e-e063-6294a90ade8e	16913-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091028		UNAPPROVED MEDICAL GAS		Advanced Medical Equipment, LLC	OXYGEN	99	L/100L			N	20241231
17089-025_92ac92a1-762e-5c83-e053-2995a90a3350	17089-025	HUMAN OTC DRUG	GUNA-FLU		ACONITUM NAPELLUS - ASCLEPIAS CURASSAVICA - ATROPA BELLADONNA - CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE - COPPER - ECHINACEA ANGUSTIFOLIA - HAEMOPHILUS INFLUENZAE TYPE B -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ACONITUM NAPELLUS; ASCLEPIAS CURASSAVICA; ATROPA BELLADONNA; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; COPPER; ECHINACEA ANGUSTIFOLIA; HAEMOPHILUS INFLUENZAE TYPE B	5; 5; 5; 7; 3; 3; 9	[hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
17089-046_7e912b31-90b5-1494-e053-2a91aa0aa779	17089-046	HUMAN OTC DRUG	ANTI AGE SKIN		alpha-tocopherol - ascophyllum nodosum - botryoglossum platycarpum - fucus serratus - fucus vesiculosus - isoleucine - leucine - retinol - selenium - sus scrofa capillary tissue - sus scrofa collagen - sus scrofa placenta - sus scrofa skin - ubidecarenone - ulva lactuca extract - laminaria digitata	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ALPHA-TOCOPHEROL; ASCOPHYLLUM NODOSUM; BOTRYOGLOSSUM PLATYCARPUM; FUCUS SERRATUS; FUCUS VESICULOSUS; ISOLEUCINE; LAMINARIA DIGITATA; LEUCINE; RETINOL; SELENIUM; SUS SCROFA CAPILLARY TISSUE; SUS SCROFA COLLAGEN; SUS SCROFA PLACENTA; SUS SCROFA SKIN; UBIDECARENONE; ULVA LACTUCA EXTRACT	4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
17089-067_09280a09-14fa-dd5a-e063-6394a90a3eb0	17089-067	HUMAN OTC DRUG	ANTI AGE STRESS		acetylcysteine - ballota foetida - epinephrine - glutathione - interferon gamma-1b - lenograstim - lithium carbonate - melatonin - penicillium glabrum - potassium carbonate - pummelo - rhodotorula rubra - silver nitrate - strychnos nux-vomica seed - sus scrofa cerebral cortex - sus scrofa stomach - sus scrofa superior gastric plexus - sus scrofa thalamus -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ACETYLCYSTEINE; BALLOTA FOETIDA; EPINEPHRINE; GLUTATHIONE; INTERFERON GAMMA-1B; LENOGRASTIM; LITHIUM CARBONATE; MELATONIN; PENICILLIUM GLABRUM; POTASSIUM CARBONATE; PUMMELO; RHODOTORULA RUBRA; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRAL CORTEX; SUS SCROFA STOMACH; SUS SCROFA SUPERIOR GASTRIC PLEXUS; SUS SCROFA THALAMUS	4; 3; 9; 4; 5; 4; 8; 15; 8; 9; 3; 8; 9; 5; 4; 7; 7; 7	[hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Respiratory Secretion Viscosity [PE], Fungal Proteins [CS], Increased Glutathione Concentration [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Interferon gamma [EPC], Interferon-gamma [CS], Mood Stabilizer [EPC], Mucolytic [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Reduction Activity [MoA], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17089-068_09282248-723a-dc5b-e063-6394a90a4d88	17089-068	HUMAN OTC DRUG	ANTI AGE VEIN		ACONITUM NAPELLUS - APIS MELLIFERA - ARNICA MONTANA - ARSENIC TRIOXIDE - ATROPA BELLADONNA - CALCIUM FLUORIDE - CENTELLA ASIATICA - CINCHONA OFFICINALIS BARK - CRANBERRY - HORSE CHESTNUT - IRON - LACHESIS MUTA VENOM - MERCURY - PINEAPPLE - PULSATILLA VULGARIS - SUS SCROFA ARTERY - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA VEIN - VISCUM ALBUM FRUIT - WITCH HAZEL -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ACONITUM NAPELLUS; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CALCIUM FLUORIDE; CENTELLA ASIATICA; CINCHONA OFFICINALIS BARK; CRANBERRY; HORSE CHESTNUT; IRON; LACHESIS MUTA VENOM; MERCURY; PINEAPPLE; PULSATILLA VULGARIS; SUS SCROFA ARTERY; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; SUS SCROFA VEIN; VISCUM ALBUM FRUIT; WITCH HAZEL	10; 10; 10; 12; 10; 8; 3; 10; 3; 3; 10; 10; 10; 3; 10; 4; 7; 4; 3; 3	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17089-075_7e90559f-51b5-36ff-e053-2a91aa0a9b17	17089-075	HUMAN OTC DRUG	OMEOSPORT		.ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; ACONITIC ACID, (Z)-; ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; ASIAN GINSENG; BARIUM OXALOSUCCINATE; BEET; CEROUS OXALATE NONAHYDRATE; COENZYME A; CYSTEINE; FUMARIC ACID; LACTIC ACID; MAGNESIUM CARBONATE; MALIC ACID; MANGANESE PHOSPHATE, DIBASIC; PORK; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SUS SCROFA ADRENAL GLAND; SUS SCROFA EMBRYO; THIAMINE HYDROCHLORIDE	6; 6; 6; 8; 4; 3; 6; 2; 6; 6; 6; 6; 8; 2; 6; 6; 6; 6; 6; 6; 6; 6; 10; 6; 4	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Magnetic Resonance Contrast Activity [MoA], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Vegetable Proteins [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
17089-076_ed6d2061-074d-5dd0-e053-2995a90a2644	17089-076	HUMAN OTC DRUG	CITOMIX		ALDESLEUKIN - BINETRAKIN - CANAKINUMAB - CENTELLA ASIATICA - CRANBERRY - HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) - INTERFERON GAMMA-1B - LENOGRASTIM - PINEAPPLE - SUS SCROFA BONE MARROW - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA THYMUS -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ALDESLEUKIN; BINETRAKIN; CANAKINUMAB; CENTELLA ASIATICA; CRANBERRY; HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED); INTERFERON GAMMA-1B; LENOGRASTIM; PINEAPPLE; SUS SCROFA BONE MARROW; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; SUS SCROFA THYMUS	5; 4; 5; 3; 3; 7; 4; 4; 3; 4; 4; 4	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interferon gamma [EPC], Interferon-gamma [CS], Interleukin-2 [CS], Lymphocyte Growth Factor [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
17089-231_ed6d4807-3581-421a-e053-2995a90a1f54	17089-231	HUMAN OTC DRUG	GUNA-FEM		ADENOSINUM CICLOPHOSPHORICUM - LILIUM TIGRINUM - MELATONIN - SUS SCROFA ADRENAL GLAND - SUS SCROFA CORPUS LUTEUM - SUS SCROFA HYPOTHALAMUS - SUS SCROFA OVARY - SUS SCROFA PANCREAS - SUS SCROFA PINEAL GLAND - SUS SCROFA PITUITARY GLAND - SUS SCROFA THYMUS - THYROID -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ADENOSINE CYCLIC PHOSPHATE; LILIUM LANCIFOLIUM BULB; MELATONIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA CORPUS LUTEUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYMUS; THYROID	6; 6; 200; 30; 30; 30; 6; 30; 30; 30; 30; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
17089-233_7e7cd808-d7b9-f8c8-e053-2a91aa0a9804	17089-233	HUMAN OTC DRUG	GUNA-MALE		ADENOSINUM CICLOPHOSPHORICUM - MELATONIN - PHOSPHORUS - SUS SCROFA ADRENAL GLAND - SUS SCROFA HYPOTHALAMUS - SUS SCROFA PANCREAS - SUS SCROFA PINEAL GLAND - SUS SCROFA PITUITARY GLAND - SUS SCROFA TESTICLE - SUS SCROFA THYMUS - THYROID - TURNERA DIFFUSA TOP -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ADENOSINE CYCLIC PHOSPHATE; MELATONIN; PHOSPHORUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA TESTICLE; SUS SCROFA THYMUS; THYROID; TURNERA DIFFUSA LEAFY TWIG	6; 30; 6; 30; 30; 30; 30; 30; 30; 30; 30; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
17089-235_7e8f9d55-ff7c-cbe7-e053-2a91aa0a382e	17089-235	HUMAN OTC DRUG	GUNA-TONSILS		angelica sinensis root - binetrakin - interleukin-3 - lenograstim - melatonin - reishi - shiitake mushroom - sus scrofa blood - sus scrofa small intestine mucosa lymph follicle - sus scrofa spleen - interleukin-11 -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ANGELICA SINENSIS ROOT; BINETRAKIN; INTERLEUKIN-11; INTERLEUKIN-3; LENOGRASTIM; MELATONIN; REISHI; SHIITAKE MUSHROOM; SUS SCROFA BLOOD; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; SUS SCROFA SPLEEN	3; 4; 5; 5; 4; 4; 8; 8; 7; 4; 4	[hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g			N	20241231
17089-237_7e7d6ebc-5974-b9fc-e053-2991aa0a2ae5	17089-237	HUMAN OTC DRUG	GUNA-REACT		angelica sinensis root - arnica montana - asian ginseng - echinacea angustifolia - fomitopsis pinicola fruiting body - interferon gamma-1b - paeonia officinalis root - pork liver - reishi - silybum marianum seed - sus scrofa small intestine mucosa lymph follicle - turmeric -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ANGELICA SINENSIS ROOT; ARNICA MONTANA; ASIAN GINSENG; ECHINACEA ANGUSTIFOLIA; FOMITOPSIS PINICOLA FRUITING BODY; INTERFERON GAMMA-1B; PAEONIA OFFICINALIS ROOT; PORK LIVER; REISHI; SILYBUM MARIANUM SEED; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; TURMERIC	3; 4; 1; 3; 8; 4; 3; 4; 8; 3; 4; 3	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g	Interferon gamma [EPC], Interferon-gamma [CS]		N	20241231
17089-251_ed6d5169-d7e2-c4d7-e053-2a95a90a9ba7	17089-251	HUMAN OTC DRUG	GUNA-VIRUS		aldesleukin - everlasting extract - fomitopsis pinicola fruiting body - interferon gamma-1b - melatonin - metenkefalin - reishi - rice - serotonin - soybean - sus scrofa blood - sus scrofa small intestine mucosa lymph follicle - sus scrofa spleen -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ALDESLEUKIN; BROWN RICE; EVERLASTING EXTRACT; FOMITOPSIS PINICOLA FRUITING BODY; INTERFERON GAMMA-1B; MELATONIN; METENKEFALIN; REISHI; SEROTONIN; SOYBEAN; SUS SCROFA BLOOD; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; SUS SCROFA SPLEEN	5; 3; 3; 8; 3; 15; 4; 8; 6; 3; 4; 7; 4	[hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interferon gamma [EPC], Interferon-gamma [CS], Interleukin-2 [CS], Lymphocyte Growth Factor [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
17089-259_ed712a71-07a8-02bc-e053-2995a90a8c42	17089-259	HUMAN OTC DRUG	OSTEOBIOS		CALCITONIN HUMAN - CALCIUM CARBONATE - CALCIUM FLUORIDE - CALCIUM PHOSPHATE - ISOLEUCINE - LEUCINE - LYSINE - METHIONINE - PHENYLALANINE - SUS SCROFA BONE - SUS SCROFA PARATHYROID GLAND - THREONINE - TRYPTOPHAN - VALINE -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	CALCITONIN HUMAN; CALCIUM CARBONATE; CALCIUM FLUORIDE; CALCIUM PHOSPHATE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; PHENYLALANINE; SUS SCROFA BONE; SUS SCROFA PARATHYROID GLAND; THREONINE; TRYPTOPHAN; VALINE	6; 30; 30; 30; 3; 3; 3; 3; 3; 30; 30; 3; 3; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
17089-260_7e7c2115-72fe-9ca5-e053-2a91aa0ae101	17089-260	HUMAN PRESCRIPTION DRUG	GUNA-DIUR		amiloride - apis mellifera - berberis vulgaris fruit - hieracium pilosella flowering top - hydrochlorothiazide - solidago virgaurea flowering top - spironolactone - sus scrofa pituitary gland -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	AMILORIDE; APIS MELLIFERA; BERBERIS VULGARIS FRUIT; HIERACIUM PILOSELLA FLOWERING TOP; HYDROCHLOROTHIAZIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SPIRONOLACTONE; SUS SCROFA PITUITARY GLAND	4; 2; .3; .3; 4; .3; 4; 12	[hp_X]/30mL; [hp_X]/30mL; g/30mL; g/30mL; [hp_X]/30mL; g/30mL; [hp_X]/30mL; [hp_X]/30mL	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Potassium-sparing Diuretic [EPC], Standardized Insect Venom Allergenic Extract [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
17089-265_ed71627c-52fb-5ac2-e053-2a95a90ac90b	17089-265	HUMAN OTC DRUG	GUNA-MOOD		5-hydroxy tryptophan,dl - alfalfa - avena sativa flowering top - lachesis muta venom - phosphoric acid - salix alba bark - salmonella enterica subsp. enterica serovar typhi - sepia officinalis juice - serotonin - strychnos ignatii seed - sus scrofa pineal gland - sus scrofa thymus - tryptophan -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	5-HYDROXYTRYPTOPHAN, DL-; ALFALFA; AVENA SATIVA FLOWERING TOP; LACHESIS MUTA VENOM; PHOSPHORIC ACID; SALIX ALBA BARK; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SEPIA OFFICINALIS JUICE; SEROTONIN; STRYCHNOS IGNATII SEED; SUS SCROFA PINEAL GLAND; SUS SCROFA THYMUS; TRYPTOPHAN	3; 6; 6; 30; 200; 10; 30; 30; 30; 30; 200; 200; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
17089-290_7e9133b3-3360-2bd0-e053-2a91aa0a3bf3	17089-290	HUMAN OTC DRUG	GUNA-PMS		ARSENIC TRIOXIDE - ESTRADIOL - GOLDENSEAL - LACHESIS MUTA VENOM - MAGNESIUM PHOSPHATE - MATRICARIA RECUTITA - MELATONIN - PROGESTERONE - STRYCHNOS NUX-VOMICA SEED - SULFUR - SUS SCROFA OVARY - SUS SCROFA PITUITARY GLAND -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ARSENIC TRIOXIDE; ESTRADIOL; GOLDENSEAL; LACHESIS MUTA VENOM; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MATRICARIA RECUTITA; MELATONIN; PROGESTERONE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND	6; 6; 6; 4; 6; 6; 4; 6; 6; 6; 8; 8	[hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Progesterone [CS], Progesterone [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17089-291_ed71772d-4252-2e19-e053-2a95a90a5095	17089-291	HUMAN OTC DRUG	GUNA-LYMPHO		apis mellifera - calendula officinalis flower - centella asiatica - dodecahydroxycyclohexane dihydrate - equisetum hyemale - fumaric acid - goldenseal - graphite - juglans regia leaf - levothyroxine - magnesium phosphate - malic acid - myosotis arvensis - phytolacca americana root - sarsaparilla - sodium diethyl oxalacetate - sodium pyruvate - sus scrofa capillary tissue - sus scrofa small intestine mucosa lymph follicle - sus scrofa vein - taraxacum officinale -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	APIS MELLIFERA; CALENDULA OFFICINALIS FLOWER; CENTELLA ASIATICA; DODECAHYDROXYCYCLOHEXANE DIHYDRATE; EQUISETUM HYEMALE; FUMARIC ACID; GOLDENSEAL; GRAPHITE; JUGLANS REGIA LEAF; LEVOTHYROXINE; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MALIC ACID; MYOSOTIS ARVENSIS; PHYTOLACCA AMERICANA ROOT; SARSAPARILLA; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUS SCROFA CAPILLARY TISSUE; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; SUS SCROFA VEIN; TARAXACUM OFFICINALE	8; 1; 1; 6; 3; 6; 1; 30; 3; 12; 6; 6; 3; 3; 3; 6; 6; 6; 6; 6; 1	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
17089-293_ed711e94-8dba-9626-e053-2995a90a044c	17089-293	HUMAN OTC DRUG	GUNA-BOWEL		ALOE - ALUMINUM OXIDE - BRYONIA ALBA ROOT - CHELIDONIUM MAJUS - CHOLECALCIFEROL - COLLINSONIA - FRANGULA ALNUS BARK - NIACIN - PANTOTHENIC ACID - POTASSIUM CARBONATE - RHUBARB - SILYBUM MARIANUM SEED - SKATOLE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA COLON - SUS SCROFA RECTUM - TARAXACUM OFFICINALE - THIAMINE -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CHOLECALCIFEROL; COLLINSONIA; FRANGULA ALNUS BARK; NIACIN; PANTOTHENIC ACID; POTASSIUM CARBONATE; RHUBARB; SILYBUM MARIANUM SEED; SKATOLE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA COLON; SUS SCROFA RECTUM; TARAXACUM OFFICINALE; THIAMINE	2; 6; 6; 2; 2; 2; 2; 2; 2; 6; 2; 2; 10; 6; 6; 12; 12; 2; 4	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vitamin D [CS], Vitamin D [EPC]		N	20241231
17089-294_7dc2f897-b868-55aa-e053-2991aa0a0cb3	17089-294	HUMAN OTC DRUG	GUNA-SLEEP		avena sativa flowering top - canakinumab - chamomile - helleborus niger root - melatonin - melissa officinalis - pulsatilla vulgaris - serotonin - strychnos ignatii seed - sus scrofa pineal gland - valerian -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	AVENA SATIVA FLOWERING TOP; CANAKINUMAB; CHAMOMILE; HELLEBORUS NIGER ROOT; MELATONIN; MELISSA OFFICINALIS; PULSATILLA VULGARIS; SEROTONIN; STRYCHNOS IGNATII SEED; SUS SCROFA PINEAL GLAND; VALERIAN	6; 4; 6; 6; 4; 6; 6; 6; 6; 12; 6	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL			N	20241231
17089-295_7e8f7213-7f6e-14ab-e053-2991aa0a4669	17089-295	HUMAN OTC DRUG	GUNA-DERMO		ALDESLEUKIN - ARSENIC TRIOXIDE - ATROPA BELLADONNA - CANAKINUMAB - ECHINACEA ANGUSTIFOLIA - GRAPHITE - MELATONIN - PLANTAGO MAJOR - SOLANUM DULCAMARA FLOWER - SULFUR -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ALDESLEUKIN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CANAKINUMAB; ECHINACEA ANGUSTIFOLIA; GRAPHITE; MELATONIN; PLANTAGO MAJOR; SOLANUM DULCAMARA FLOWER; SULFUR	4; 6; 6; 7; 6; 6; 4; 4; 6; 6	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL	Increased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interleukin-2 [CS], Lymphocyte Growth Factor [EPC]		N	20241231
17089-296_7e8f9d55-ff6d-cbe7-e053-2a91aa0a382e	17089-296	HUMAN OTC DRUG	GUNA-HEMORRHOIDS		activated charcoal - arnica montana - atropa belladonna - canakinumab - hydrocotyle asiatica extract - aesculus hippocastanum flower - melissa officinalis - paeonia officinalis root - podophyllum peltatum root - pork liver - strychnos nux-vomica seed - sus scrofa small intestine mucosa lymph follicle - sus scrofa vein - hamamelis virginiana root bark/stem bark - anti-interleukin-1.alpha. immunoglobulin g rabbit -	SOLUTION/ DROPS	ORAL	20080416		UNAPPROVED HOMEOPATHIC		Guna spa	ACTIVATED CHARCOAL; AESCULUS HIPPOCASTANUM FLOWER; ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; ARNICA MONTANA; ATROPA BELLADONNA; CANAKINUMAB; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYDROCOTYLE ASIATICA EXTRACT; MELISSA OFFICINALIS; PAEONIA OFFICINALIS ROOT; PODOPHYLLUM PELTATUM ROOT; PORK LIVER; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; SUS SCROFA VEIN	10; 6; 4; 6; 6; 4; 6; 6; 6; 6; 4; 12; 6; 6; 4	[hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17089-298_ed719d6a-efa5-fdce-e053-2a95a90ab6ce	17089-298	HUMAN OTC DRUG	GUNA-KIDNEY		chondrodendron tomentosum root - clerodendranthus spicatus leaf - equisetum hyemale - escherichia coli - hieracium pilosella flowering top - methylene blue - nitric acid - ononis campestris - plantago major - pork kidney - potassium nitrate - proteus vulgaris - quinhydrone - sarsaparilla - solidago virgaurea flowering top - succinic acid - sus scrofa ureter - sus scrofa urinary bladder -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	CHONDRODENDRON TOMENTOSUM ROOT; CLERODENDRANTHUS SPICATUS LEAF; EQUISETUM HYEMALE; ESCHERICHIA COLI; HIERACIUM PILOSELLA FLOWERING TOP; METHYLENE BLUE; NITRIC ACID; ONONIS CAMPESTRIS; PLANTAGO MAJOR; PORK KIDNEY; POTASSIUM NITRATE; PROTEUS VULGARIS; QUINHYDRONE; SARSAPARILLA; SOLIDAGO VIRGAUREA FLOWERING TOP; SUCCINIC ACID; SUS SCROFA URETER; SUS SCROFA URINARY BLADDER	2; 2; 3; 12; 1; 8; 12; 2; 2; 8; 12; 12; 8; 2; 1; 6; 8; 8	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
17089-299_7e029048-a7aa-68a5-e053-2a91aa0af0be	17089-299	HUMAN OTC DRUG	GUNA-ALLERGY-PREV		AMBROSIA ARTEMISIIFOLIA - ANGUILLA ROSTRATA BLOOD SERUM - ARUNDO PLINIANA ROOT - BLACK CURRANT - CHELIDONIUM MAJUS - CITRIC ACID MONOHYDRATE - HISTAMINE DIHYDROCHLORIDE - HUMAN INTERLEUKIN 12 - INTERFERON GAMMA-1B - MANGANESE GLUCONATE - PARIETARIA OFFICINALIS - PHLEUM PRATENSE - SODIUM PYRUVATE - SODIUM SULFATE - SUCCINIC ACID - SULFUR - URTICA URENS - VIBURNUM OPULUS ROOT - WYETHIA HELENIOIDES ROOT -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	AMBROSIA ARTEMISIIFOLIA; ANGUILLA ROSTRATA BLOOD SERUM; ARUNDO PLINIANA ROOT; ASCLEPIAS CURASSAVICA; BLACK CURRANT; CITRIC ACID MONOHYDRATE; HISTAMINE DIHYDROCHLORIDE; HUMAN INTERLEUKIN 12; INTERFERON GAMMA-1B; MANGANESE GLUCONATE; PARIETARIA OFFICINALIS; PHLEUM PRATENSE; SODIUM PYRUVATE; SODIUM SULFATE; SUCCINIC ACID; SULFUR; URTICA URENS; VIBURNUM OPULUS ROOT; WYETHIA HELENIOIDES ROOT	18; 200; 18; 6; 1; 6; 30; 4; 4; 4; 18; 18; 6; 200; 6; 30; 18; 3; 18	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; g/30mL; [hp_X]/30mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Interferon gamma [EPC], Interferon-gamma [CS], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC]		N	20241231
17089-301_7d9b872d-b3be-64a9-e053-2991aa0a7808	17089-301	HUMAN OTC DRUG	GUNA-DIGEST		angelica archangelica root - anisum - artemisia abrotanum flowering top - ascorbic acid - citrullus colocynthis fruit pulp - gentiana lutea root - melatonin - niacin - pancrelipase amylase - pancrelipase lipase - pork liver - serotonin - strychnos nux-vomica seed - sus scrofa diencephalon - sus scrofa duodenum - sus scrofa gall bladder - sus scrofa pancreas - sus scrofa pylorus - thiamine hydrochloride - trypsin - tryptophan -	SOLUTION/ DROPS	ORAL	20181221		UNAPPROVED HOMEOPATHIC		Guna spa	ANGELICA ARCHANGELICA ROOT; ANISUM; ARTEMISIA ABROTANUM FLOWERING TOP; ASCORBIC ACID; CITRULLUS COLOCYNTHIS FRUIT PULP; GENTIANA LUTEA ROOT; MELATONIN; NIACIN; PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PORK LIVER; SEROTONIN; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA DIENCEPHALON; SUS SCROFA DUODENUM; SUS SCROFA GALLBLADDER; SUS SCROFA PANCREAS; SUS SCROFA PYLORUS; THIAMINE HYDROCHLORIDE; TRYPSIN; TRYPTOPHAN	1; 1; 1; 2; 3; 1; 4; 2; 2; 2; 8; 6; 3; 6; 8; 8; 8; 8; 4; 2; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vitamin C [EPC]		N	20241231
17089-302_ed80d394-0e03-88a4-e053-2995a90a6b2b	17089-302	HUMAN OTC DRUG	GUNA-STOMACH		ACTIVATED CHARCOAL - ANTIMONY TRISULFIDE - BISMUTH SUBNITRATE - DIOSCOREA VILLOSA ROOT - DOPAMINE - HUMAN EPIDERMAL GROWTH FACTOR - IPECAC - OREGANO - PICEA MARIANA RESIN - ROBINIA PSEUDOACACIA BARK - SEMECARPUS ANACARDIUM JUICE - SILVER NITRATE - SUS SCROFA STOMACH - SUS SCROFA SYMPATHETIC NERVE - MOMORDICA BALSAMINA IMMATURE FRUIT -	PELLET	ORAL	20180515		UNAPPROVED HOMEOPATHIC		Guna spa	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; BISMUTH SUBNITRATE; DIOSCOREA VILLOSA ROOT; DOPAMINE; HUMAN EPIDERMAL GROWTH FACTOR; IPECAC; MOMORDICA BALSAMINA IMMATURE FRUIT; OREGANO; PICEA MARIANA RESIN; ROBINIA PSEUDOACACIA BARK; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; SUS SCROFA STOMACH; SUS SCROFA SYMPATHETIC NERVE	6; 30; 6; 3; 6; 4; 30; 3; 10; 3; 2; 30; 30; 30; 6	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Bismuth [CS], Bismuth [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
17089-304_ed806a9b-af06-d713-e053-2a95a90a9730	17089-304	HUMAN OTC DRUG	GUNA-ARTHRO		.ALPHA.-KETOGLUTARIC ACID - ALPHA LIPOIC ACID - ASCORBIC ACID - BARIUM OXALOSUCCINATE - BLACK COHOSH - BRYONIA ALBA ROOT - CALCITONIN HUMAN - CHLORINE - COLCHICUM AUTUMNALE BULB - NADIDE -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BLACK COHOSH; BRYONIA ALBA ROOT; CALCITONIN HUMAN; CHLORINE; COLCHICUM AUTUMNALE BULB; NADIDE; NERVE GROWTH FACTOR; PRASTERONE; QUINHYDRONE; SODIUM DIETHYL OXALACETATE; SOLANUM DULCAMARA FLOWER; STRONTIUM CARBONATE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA ARTERY; SUS SCROFA CARTILAGE; SUS SCROFA CONJUNCTIVA; SUS SCROFA PARATHYROID GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA VEIN; TOXICODENDRON PUBESCENS LEAF; VELAFERMIN	3; 3; 3; 3; 6; 6; 6; 6; 6; 3; 4; 6; 3; 3; 6; 6; 3; 6; 6; 6; 6; 6; 6; 6; 6; 6; 4	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL	Ascorbic Acid [CS], Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Vitamin C [EPC]		N	20241231
17089-306_7e7be278-8d19-71c4-e053-2991aa0a377c	17089-306	HUMAN OTC DRUG	GUNA-DIZZY		.alpha.-ketoglutaric acid - ambergris - anamirta cocculus seed - conium maculatum flowering top - epinephrine - fumaric acid - malic acid - melatonin - mineral oil - pteridium aquilinum root - pyridoxine hydrochloride - quinhydrone - quinine - sus scrofa artery - sus scrofa cerebellum - sus scrofa placenta - thiamine hydrochloride - tobacco leaf -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	.ALPHA.-KETOGLUTARIC ACID; AMBERGRIS; ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; EPINEPHRINE; FUMARIC ACID; MALIC ACID; MELATONIN; MINERAL OIL; PTERIDIUM AQUILINUM ROOT; PYRIDOXINE HYDROCHLORIDE; QUINHYDRONE; QUININE SALICYLATE; SUS SCROFA ARTERY; SUS SCROFA CEREBELLUM; SUS SCROFA PLACENTA; THIAMINE HYDROCHLORIDE; TOBACCO LEAF	6; 6; 4; 3; 6; 6; 6; 4; 8; 8; 6; 6; 6; 6; 6; 6; 4; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Depigmenting Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17089-311_7df3b26c-3724-e74d-e053-2991aa0a8046	17089-311	HUMAN OTC DRUG	GUNA-LIVER		CEANOTHUS AMERICANUS LEAF - CHELIDONIUM MAJUS - CHIONANTHUS VIRGINICUS BARK - CHOLINE HYDROXIDE - COBALAMIN - CULVER ROOT - FUMARIC ACID - INOSITOL - LYCOPODIUM CLAVATUM SPORE - NIACIN - PORK LIVER - POTASSIUM SULFATE - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SILYBUM MARIANUM SEED - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SODIUM SULFATE - SUS SCROFA GALL BLADDER - SUS SCROFA JEJUNUM - SUS SCROFA PANCREAS - SUS SCROFA SPLEEN - TARAXACUM OFFICINALE - THIAMINE HYDROCHLORIDE -	PELLET	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CHOLINE HYDROXIDE; COBALAMIN; CULVER'S ROOT; FUMARIC ACID; INOSITOL; LYCOPODIUM CLAVATUM SPORE; NIACIN; PORK LIVER; POTASSIUM SULFATE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SILYBUM MARIANUM SEED; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SODIUM SULFATE; SUS SCROFA GALLBLADDER; SUS SCROFA JEJUNUM; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; TARAXACUM OFFICINALE; THIAMINE HYDROCHLORIDE	6; 2; 6; 4; 4; 6; 4; 4; 6; 6; 6; 12; 6; 6; 2; 4; 4; 8; 8; 8; 8; 8; 2; 6	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Analogs/Derivatives [Chemical/Ingredient], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
17089-337_7e8ef204-d58a-82d6-e053-2a91aa0a8234	17089-337	HUMAN OTC DRUG	GUNA-RERIO		DANIO RERIO EGG	SOLUTION/ DROPS	ORAL	20070418		UNAPPROVED HOMEOPATHIC		Guna spa	DANIO RERIO EGG	4	[hp_X]/30mL			N	20241231
17089-346_7d8cc52b-6267-2ea1-e053-2a91aa0a7018	17089-346	HUMAN OTC DRUG	GUNA-PROSTATE		aldesleukin - barium carbonate - chaste tree - chimaphila umbellata - clematis vitalba - conium maculatum flowering top - delphinium staphisagria seed - digitalis - ferric picrate - human interleukin-10 (nonglycosylated) - interferon gamma-1b - melatonin - saw palmetto - selenium - sus scrofa prostate - thuja occidentalis twig - transforming growth factor beta-1 - zinc -	SOLUTION/ DROPS	ORAL	20170101		UNAPPROVED HOMEOPATHIC		Guna spa	ALDESLEUKIN; BARIUM CARBONATE; CHASTE TREE; CHIMAPHILA UMBELLATA; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; FERRIC PICRATE; INTERFERON GAMMA-1B; INTERLEUKIN-10; MELATONIN; SAW PALMETTO; SELENIUM; SUS SCROFA PROSTATE; THUJA OCCIDENTALIS LEAFY TWIG; TRANSFORMING GROWTH FACTOR BETA-1; ZINC	4; 30; 6; 6; 3; 30; 30; 30; 30; 4; 4; 4; 3; 30; 200; 30; 4; 3	[hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL	Increased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interferon gamma [EPC], Interferon-gamma [CS], Interleukin-2 [CS], Iron [CS], Lymphocyte Growth Factor [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
17089-347_7e02b61a-2014-7b6d-e053-2991aa0abb80	17089-347	HUMAN OTC DRUG	GUNA-HYPERTENSION		arnica montana - fumaric acid - gold - lead - melatonin - melilotus - olea europaea flower - pork kidney - rauwolfia serpentina - sodium pyruvate - spigelia - sus scrofa adrenal gland - sus scrofa diencephalon - ubidecarenone - viscum album fruit -	SOLUTION/ DROPS	ORAL	20080416		UNAPPROVED HOMEOPATHIC		Guna spa	ARNICA MONTANA; FUMARIC ACID; GOLD; LEAD; MELATONIN; MELILOTUS; OLEA EUROPAEA FLOWER; PORK KIDNEY; RAUWOLFIA SERPENTINA; SODIUM PYRUVATE; SPIGELIA; SUS SCROFA ADRENAL GLAND; SUS SCROFA DIENCEPHALON; UBIDECARENONE; VISCUM ALBUM FRUIT	12; 3; 12; 12; 4; 6; 3; 6; 6; 3; 6; 200; 6; 3; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
17089-348_7e7d36fb-0ad4-58de-e053-2991aa0a300e	17089-348	HUMAN OTC DRUG	GUNA-SPASM		atropine sulfate - berberis vulgaris root bark - chelidonium majus - cobalt - cultivated mushroom - gelsemium sempervirens root - interleukin-10 - magnesium - melatonin - metenkefalin - sus scrofa sympathetic nerve - sus scrofa vagus nerve - watermelon - anti-interleukin-1.alpha. immunoglobulin g rabbit -	SOLUTION/ DROPS	ORAL	20080416		UNAPPROVED HOMEOPATHIC		Guna spa	ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; ATROPINE SULFATE; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; COBALT; CULTIVATED MUSHROOM; GELSEMIUM SEMPERVIRENS ROOT; INTERLEUKIN-10; MAGNESIUM; MELATONIN; METENKEFALIN; SUS SCROFA SYMPATHETIC NERVE; SUS SCROFA VAGUS NERVE; WATERMELON	4; 6; 3; 4; 4; 4; 6; 4; 4; 4; 4; 200; 6; 4	[hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Allergens [CS], Anticholinergic [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC]		N	20241231
17089-349_7d9af689-848b-3aea-e053-2a91aa0a70d2	17089-349	HUMAN OTC DRUG	GUNA-GERIATRICS		1,4-benzoquinone - arnica montana - oxytocin - barium carbonate - barium oxalosuccinate - corticotropin - lead - levothyroxine - lutrelin - malic acid - melatonin - neurotrophin-3 - neurotrophin-4 - phenylalanine - pork liver - pyruvic acid - rinfabate - sus scrofa adrenal gland - sus scrofa frontal lobe - sus scrofa hypothalamus - thyrotropin alfa - brain-derived neurotrophic factor human -	SOLUTION/ DROPS	ORAL	20080416		UNAPPROVED HOMEOPATHIC		Guna spa	ARNICA MONTANA; BARIUM CARBONATE; BARIUM OXALOSUCCINATE; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; CORTICOTROPIN; LEAD; LEVOTHYROXINE; LUTRELIN; MALIC ACID; MELATONIN; NEUROTROPHIN-3; NEUROTROPHIN-4; OXYTOCIN; PHENYLALANINE; PORK LIVER; PYRUVIC ACID; QUINONE; RINFABATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA FRONTAL LOBE; SUS SCROFA HYPOTHALAMUS; THYROTROPIN ALFA	6; 6; 3; 4; 6; 6; 6; 6; 3; 4; 4; 4; 6; 3; 6; 3; 3; 4; 6; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS], Thyroid Stimulating Hormone [EPC], Thyrotropin [CS], Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
17089-350_ed80e4f1-5ff1-5d2f-e053-2995a90afc23	17089-350	HUMAN OTC DRUG	GUNA-AWARENESS		BETAINE - BUFO BUFO CUTANEOUS GLAND - CALCIUM CARBONATE - CHROMIC SULFATE - CICUTA VIROSA ROOT - COPPER - FOLIC ACID - GOLD - COBALAMIN - IRON - LACHESIS MUTA VENOM - MELATONIN - MOLYBDENUM - NEUROTROPHIN-3 - NEUROTROPHIN-4 - OXYTOCIN - SILICON DIOXIDE - SUS SCROFA FRONTAL LOBE - SUS SCROFA TEMPORAL LOBE - THYROTROPIN ALFA - UBIDECARENONE - VANADIUM - ZINC - BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN -	SOLUTION/ DROPS	ORAL	20080416		UNAPPROVED HOMEOPATHIC		Guna spa	BETAINE; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; BUFO BUFO CUTANEOUS GLAND; CALCIUM CARBONATE; CHROMIC SULFATE; CICUTA VIROSA ROOT; COBALAMIN; COPPER; FOLIC ACID; GOLD; IRON; LACHESIS MUTA VENOM; MELATONIN; MOLYBDENUM; NEUROTROPHIN-3; NEUROTROPHIN-4; OXYTOCIN; SILICON DIOXIDE; SUS SCROFA FRONTAL LOBE; SUS SCROFA TEMPORAL LOBE; THYROTROPIN ALFA; UBIDECARENONE; VANADIUM; ZINC	3; 4; 12; 3; 3; 12; 3; 12; 3; 12; 3; 12; 4; 3; 4; 4; 6; 12; 6; 6; 3; 3; 6; 3	[hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Uterine Smooth Muscle Contraction or Tone [PE], Inhibit Ovum Fertilization [PE], Methylating Activity [MoA], Methylating Agent [EPC], Oxytocic [EPC], Oxytocin [CS], Standardized Chemical Allergen [EPC], Thyroid Stimulating Hormone [EPC], Thyrotropin [CS]		N	20241231
17089-370_ed80f8de-2fa8-9e58-e053-2a95a90a9b51	17089-370	HUMAN OTC DRUG	GUNA-BDNF		BRAIN-DERIVED NEUROTROPHIC FACTOR	SOLUTION/ DROPS	ORAL	20110331		UNAPPROVED HOMEOPATHIC		Guna spa	BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN	4	[hp_C]/30mL			N	20241231
17089-372_82de46fa-983c-fade-e053-2991aa0aea95	17089-372	HUMAN OTC DRUG	GUNA-EGF		EPIDERMAL GROWTH FACTOR	SOLUTION/ DROPS	ORAL	20110331		UNAPPROVED HOMEOPATHIC		Guna spa	HUMAN EPIDERMAL GROWTH FACTOR	4	[hp_C]/30mL			N	20241231
17089-373_ed812047-a685-5f21-e053-2a95a90a2019	17089-373	HUMAN OTC DRUG	GUNA-FGF		FIBROBLAST GROWTH FACTOR	SOLUTION/ DROPS	ORAL	20110331		UNAPPROVED HOMEOPATHIC		Guna spa	VELAFERMIN	4	[hp_C]/30mL			N	20241231
17089-375_82de60d9-3da1-ffac-e053-2991aa0a49d8	17089-375	HUMAN OTC DRUG	GUNA-GCSF		GRANULOCYTE COLONY STIMULATING FACTOR	SOLUTION/ DROPS	ORAL	20110331		UNAPPROVED HOMEOPATHIC		Guna spa	LENOGRASTIM	4	[hp_C]/30mL			N	20241231
17089-376_ed813de7-e0d4-74b9-e053-2995a90a6a73	17089-376	HUMAN OTC DRUG	GUNA-IGF		INSULIN-LIKE GROWTH FACTOR-1	SOLUTION/ DROPS	ORAL	20110331		UNAPPROVED HOMEOPATHIC		Guna spa	MECASERMIN	4	[hp_C]/30mL			N	20241231
17089-378_ed813de7-e0d5-74b9-e053-2995a90a6a73	17089-378	HUMAN OTC DRUG	GUNA-INF GAMMA		INTERFERON GAMMA-1B	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	INTERFERON GAMMA-1B	4	[hp_C]/30mL	Interferon gamma [EPC], Interferon-gamma [CS]		N	20241231
17089-380_ed8137f8-9931-234c-e053-2a95a90a5769	17089-380	HUMAN OTC DRUG	GUNA-IL 2		ALDESLEUKIN	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	ALDESLEUKIN	4	[hp_C]/30mL	Increased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interleukin-2 [CS], Lymphocyte Growth Factor [EPC]		N	20241231
17089-381_ed819152-2967-22be-e053-2a95a90a33f6	17089-381	HUMAN OTC DRUG	GUNA-IL 3		INTERLEUKIN-3	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	INTERLEUKIN-3	4	[hp_C]/30mL			N	20241231
17089-382_ed819152-2968-22be-e053-2a95a90a33f6	17089-382	HUMAN OTC DRUG	GUNA-IL 4		BINETRAKIN	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	BINETRAKIN	4	[hp_C]/30mL			N	20241231
17089-383_7e91aab5-b2ad-c62f-e053-2991aa0ad61e	17089-383	HUMAN OTC DRUG	GUNA-IL 5		INTERLEUKIN-5	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	INTERLEUKIN-5	4	[hp_C]/30mL			N	20241231
17089-388_ed8186ee-6e10-0c13-e053-2a95a90a8f0a	17089-388	HUMAN OTC DRUG	GUNA-IL 10		INTERLEUKIN-10	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	INTERLEUKIN-10	4	[hp_C]/30mL			N	20241231
17089-389_ed81a1dd-c087-49a5-e053-2995a90aad04	17089-389	HUMAN OTC DRUG	GUNA-IL 11		INTERLEUKIN-11	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	INTERLEUKIN-11	4	[hp_C]/30mL			N	20241231
17089-390_ed81a1dd-c092-49a5-e053-2995a90aad04	17089-390	HUMAN OTC DRUG	GUNA-IL 12		INTERLEUKIN-12 HUMAN RECOMBINANT	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	INTERLEUKIN-12 HUMAN RECOMBINANT	4	[hp_C]/30mL			N	20241231
17089-395_ed85374b-6458-049e-e053-2995a90a99df	17089-395	HUMAN OTC DRUG	GUNA-TGF BETA 1		TRANSFORMING GROWTH FACTOR BETA 1	SOLUTION/ DROPS	ORAL	20110331		UNAPPROVED HOMEOPATHIC		Guna spa	TRANSFORMING GROWTH FACTOR BETA-1	4	[hp_C]/30mL			N	20241231
17089-398_ed853c61-ca6e-4c3d-e053-2995a90aecb9	17089-398	HUMAN OTC DRUG	GUNA-ANTI IL 1		ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT- CANAKINUMAB	SOLUTION/ DROPS	ORAL	20080617		UNAPPROVED HOMEOPATHIC		Guna spa	ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; CANAKINUMAB	4; 4	[hp_C]/30mL; [hp_C]/30mL			N	20241231
17089-405_ed853c61-ca74-4c3d-e053-2995a90aecb9	17089-405	HUMAN OTC DRUG	GAMMA -12		INTERLEUKIN-12 HUMAN RECOMBINANT - INTERFERON GAMMA-1B -	SOLUTION/ DROPS	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Guna spa	INTERFERON GAMMA-1B; INTERLEUKIN-12 HUMAN RECOMBINANT	4; 4	[hp_C]/30mL; [hp_C]/30mL	Interferon gamma [EPC], Interferon-gamma [CS]		N	20241231
17089-406_7e8f7213-7f81-14ab-e053-2991aa0a4669	17089-406	HUMAN OTC DRUG	GUNA-REFLUX		ACTIVATED CHARCOAL - AETHUSA CYNAPIUM - APOMORPHINE HYDROCHLORIDE - BRYONIA ALBA ROOT - COLCHICUM AUTUMNALE BULB - IPECAC - LYCOPODIUM CLAVATUM SPORE - STRYCHNOS IGNATII SEED - STRYCHNOS NUX-VOMICA SEED - WATERMELON - SUS SCROFA STOMACH -	SOLUTION/ DROPS	ORAL	20100512		UNAPPROVED HOMEOPATHIC		Guna spa	ACTIVATED CHARCOAL; AETHUSA CYNAPIUM; APOMORPHINE HYDROCHLORIDE; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; IPECAC; LYCOPODIUM CLAVATUM SPORE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ESOPHAGUS; SUS SCROFA STOMACH; WATERMELON	12; 4; 6; 30; 6; 4; 5; 6; 4; 10; 10; 30	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dopamine Agonists [MoA], Dopaminergic Agonist [EPC], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17089-415_ed855a9b-4697-23e3-e053-2a95a90a41a0	17089-415	HUMAN OTC DRUG	EUBIOFLOR		ACTIVATED CHARCOAL - AETHUSA CYNAPIUM - ALTHAEA OFFICINALIS LEAF - BILBERRY - CANDIDA ALBICANS - UNCARIA TOMENTOSA - ESCHERICHIA COLI - INDOLE - MERCURIUS SOLUBILIS - OKOUBAKA AUBREVILLEI BARK - PORK LIVER - PROTEUS VULGARIS - SILYBUM MARIANUM SEED - SKATOLE - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA COLON - SUS SCROFA GALL BLADDER - SUS SCROFA PANCREAS - TABEBUIA IMPETIGINOSA BARK - TARAXACUM OFFICINALE - VERATRUM ALBUM ROOT -	SOLUTION/ DROPS	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	ACTIVATED CHARCOAL; AETHUSA CYNAPIUM; ALTHAEA OFFICINALIS LEAF; BILBERRY; CANDIDA ALBICANS; CAT'S CLAW; ESCHERICHIA COLI; INDOLE; MERCURIUS SOLUBILIS; OKOUBAKA AUBREVILLEI BARK; PORK LIVER; PROTEUS VULGARIS; SILYBUM MARIANUM SEED; SKATOLE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA COLON; SUS SCROFA GALLBLADDER; SUS SCROFA PANCREAS; TABEBUIA IMPETIGINOSA BARK; TARAXACUM OFFICINALE; VERATRUM ALBUM ROOT	6; 6; 4; 4; 30; 4; 30; 12; 200; 6; 12; 12; 4; 30; 6; 30; 6; 12; 4; 4; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17089-416_ed856151-91ca-5168-e053-2995a90a83e9	17089-416	HUMAN OTC DRUG	GUNA-MATRIX		ASCORBIC ACID - DODECAHYDROXYCYCLOHEXANE DIHYDRATE - FUCUS VESICULOSUS - HISTIDINE MONOHYDROCHLORIDE - HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) - HYALURONIDASE - LACTIC ACID, DL - MALIC ACID - NADIDE - PHENYLALANINE - PRASTERONE - PROLACTIN - RANCID BEEF - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SODIUM SULFATE - SUS SCROFA CONJUNCTIVA - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - THUJA OCCIDENTALIS TWIG - TYROSINE -	SOLUTION/ DROPS	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	ASCORBIC ACID; DODECAHYDROXYCYCLOHEXANE DIHYDRATE; FUCUS VESICULOSUS; HISTIDINE MONOHYDROCHLORIDE; HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED); HYALURONIDASE; LACTIC ACID, DL-; MALIC ACID; NADIDE; PHENYLALANINE; PRASTERONE; PROLACTIN; RANCID BEEF; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SODIUM SULFATE; SUS SCROFA CONJUNCTIVA; SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE; THUJA OCCIDENTALIS LEAFY TWIG; TYROSINE	4; 6; 4; 4; 4; 6; 4; 6; 6; 4; 6; 6; 12; 6; 6; 12; 6; 6; 12; 4	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Ascorbic Acid [CS], Endoglycosidase [EPC], Glycoside Hydrolases [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vitamin C [EPC]		N	20241231
17089-417_a8221c87-1093-812d-e053-2995a90abea7	17089-417	HUMAN OTC DRUG	GUNA-FLAM		ACONITUM NAPELLUS - APIS MELLIFERA - ATROPA BELLADONNA - BASIC CUPRIC CARBONATE - BRYONIA ALBA ROOT - CALCIUM SULFIDE - CITRIC ACID MONOHYDRATE - FERRIC PHOSPHATE - INTERLEUKIN-10 - MELATONIN - METENKEFALIN - PHYTOLACCA AMERICANA ROOT - RANCID BEEF - SODIUM PYRUVATE - SUS SCROFA CONJUNCTIVA - SUS SCROFA PINEAL GLAND - SUS SCROFA PITUITARY GLAND - TRANSFORMING GROWTH FACTOR BETA-1 - ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT -	SOLUTION/ DROPS	ORAL	20060523		UNAPPROVED HOMEOPATHIC		Guna spa	ACONITUM NAPELLUS; ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; APIS MELLIFERA; ATROPA BELLADONNA; BASIC CUPRIC CARBONATE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CITRIC ACID MONOHYDRATE; FERRIC PHOSPHATE; INTERLEUKIN-10; MELATONIN; METENKEFALIN; PHYTOLACCA AMERICANA ROOT; RANCID BEEF; SODIUM PYRUVATE; SUS SCROFA CONJUNCTIVA; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; TRANSFORMING GROWTH FACTOR BETA-1	6; 4; 6; 6; 4; 6; 6; 3; 6; 4; 4; 6; 6; 30; 3; 12; 6; 200; 4	[hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL	Acidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Bee Venoms [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17089-418_ed856317-182b-3f36-e053-2a95a90a20cc	17089-418	HUMAN OTC DRUG	GUNA-ALLERGY T		ammonium carbonate - apis mellifera - arsenic trioxide - blatta orientalis - cupric acetate - drimia maritima bulb - epinephrine - galphimia glauca flowering top - histamine dihydrochloride - luffa operculata - manganese gluconate - onion - schoenocaulon officinale seed - sodium chloride - sus scrofa adrenal gland - sus scrofa bronchus - sus scrofa nasal mucosa -	SOLUTION/ DROPS	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	AMMONIUM CARBONATE; APIS MELLIFERA; ARSENIC TRIOXIDE; BLATTA ORIENTALIS; CUPRIC ACETATE; DRIMIA MARITIMA BULB; EPINEPHRINE; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; MANGANESE GLUCONATE; ONION; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA BRONCHUS; SUS SCROFA NASAL MUCOSA	30; 200; 30; 12; 30; 30; 6; 12; 200; 12; 4; 30; 30; 30; 12; 200; 200	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17089-419_7e02aa23-f955-6990-e053-2a91aa0af032	17089-419	HUMAN OTC DRUG	GUNA-RHINO NOSE		apis mellifera - aralia racemosa root - ascorbic acid - black currant - copper - euphorbia resinifera resin - european elderberry - helianthemum canadense - histamine dihydrochloride - human interleukin 12 - human interleukin-10 (nonglycosylated) - interferon gamma-1b - manganese gluconate - melilotus - onion - plantago major - rosa canina fruit - silver nitrate -	SPRAY	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	APIS MELLIFERA; ARALIA RACEMOSA ROOT; ASCORBIC ACID; BLACK CURRANT; COPPER; EUPHORBIA RESINIFERA RESIN; EUROPEAN ELDERBERRY; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HUMAN INTERLEUKIN 12; INTERFERON GAMMA-1B; INTERLEUKIN-10; MANGANESE GLUCONATE; MELILOTUS; ONION; PLANTAGO MAJOR; ROSA CANINA FRUIT; SILVER NITRATE	12; 1; 2; 1; 4; 4; 2; 4; 200; 4; 4; 4; 4; 3; 8; 2; 1; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Interferon gamma [EPC], Interferon-gamma [CS], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], Vitamin C [EPC]		N	20241231
17089-420_ed85688e-3014-49b1-e053-2a95a90a8d03	17089-420	HUMAN OTC DRUG	MICOX		ASPERGILLUS NIGER VAR. NIGER - CANDIDA ALBICANS - CENTELLA ASIATICA - MALIC ACID - MERCURIC CHLORIDE - RHIZOPUS STOLONIFER - SODIUM DIETHYL OXALACETATE - SULFUR - TABEBUIA IMPETIGINOSA BARK -	SOLUTION/ DROPS	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CENTELLA ASIATICA; MALIC ACID; MERCURIC CHLORIDE; RHIZOPUS STOLONIFER; SODIUM DIETHYL OXALACETATE; SULFUR; TABEBUIA IMPETIGINOSA BARK	30; 30; 6; 12; 6; 30; 12; 6; 4	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
17089-450_7df27455-9844-979b-e053-2991aa0a616b	17089-450	HUMAN OTC DRUG	GUNA-CELL		acetylcarnitine, l-ampc-alpha-lipoic ac-a-tocopherol-ascorbic acid-calc carb-citric ac-cobalamin-colchicum-conium-cupric sulf-herring sperm dna-ferrous fumarate-folic acid-fumaric acid-kali aspartate-mang phos-mang gluconate-mang phos ii-pyruvaldehyde-nat oxalaceticum-sodium pyruvate-niacin-pantothenic acid-ph-podophyllum peltatum-pyridoxine hydrochloride-riboflavin-saccharomyces cerevisiae rna-selenomethionine-succinic acid-sulfur-thiamine hydrochloride-zinc	SOLUTION/ DROPS	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	.ALPHA.-LIPOIC ACID; .ALPHA.-TOCOPHEROL ACETATE, DL-; ACETYLCARNITINE; ADENOSINE CYCLIC PHOSPHATE; ASCORBIC ACID; CALCIUM CARBONATE; CITRIC ACID MONOHYDRATE; COBALAMIN; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; CUPRIC SULFATE; FERROUS FUMARATE; FOLIC ACID; FUMARIC ACID; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MANGANESE GLUCONATE; MANGANESE PHOSPHATE, DIBASIC; NIACIN; PANTOTHENIC ACID; PHOSPHORUS; PODOPHYLLUM PELTATUM ROOT; POTASSIUM ASPARTATE; PYRIDOXINE HYDROCHLORIDE; PYRUVALDEHYDE; RIBOFLAVIN; SACCHAROMYCES CEREVISIAE RNA; SELENOMETHIONINE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SULFUR; THIAMINE HYDROCHLORIDE; ZINC	3; 3; 3; 6; 3; 3; 3; 3; 6; 6; 3; 3; 3; 3; 6; 3; 3; 6; 3; 3; 4; 6; 3; 6; 10; 6; 6; 3; 3; 3; 3; 3; 4; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Acidifying Activity [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Carnitine Analog [EPC], Carnitine [CS], Cations, Divalent [CS], Decreased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
17089-451_7d9d997a-fda9-2a63-e053-2a91aa0a0000	17089-451	HUMAN OTC DRUG	GUNA-SINUS NOSE		ALTHAEA OFFICINALIS LEAF - ASCORBIC ACID - BLACK CURRANT - CALCIUM SULFIDE - COPPER - ECHINACEA ANGUSTIFOLIA - GOLDENSEAL - LACHESIS MUTA VENOM - LOBARIA PULMONARIA - MANGANESE - MERCURIC SULFIDE - ONION - PLANTAGO MAJOR - POTASSIUM CARBONATE - PULSATILLA VULGARIS - SILICON DIOXIDE - SILVER NITRATE - SINUSITISINUM - SUS SCROFA NASAL MUCOSA - SUS SCROFA THYMUS - SUS SCROFA URINARY BLADDER -	SPRAY	NASAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	ALTHAEA OFFICINALIS LEAF; ASCORBIC ACID; BLACK CURRANT; CALCIUM SULFIDE; COPPER; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; MANGANESE; MERCURIC SULFIDE; ONION; PLANTAGO MAJOR; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILICON DIOXIDE; SILVER NITRATE; SINUSITISINUM; SUS SCROFA NASAL MUCOSA; SUS SCROFA THYMUS; SUS SCROFA URINARY BLADDER	2; 2; 1; 8; 3; 3; 8; 30; 2; 3; 8; 8; 2; 8; 8; 8; 10; 30; 12; 12; 30	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], Vitamin C [EPC]		N	20241231
17089-452_7e8ff906-fbc2-e1bf-e053-2a91aa0a3326	17089-452	HUMAN OTC DRUG	GUNA-ORAL		ACHILLEA MILLEFOLIUM - ACONITUM NAPELLUS - ARNICA MONTANA - ATROPA BELLADONNA - CALCIUM SULFIDE - COMFREY ROOT - ECHINACEA ANGUSTIFOLIA - ECHINACEA PURPUREA - HYPERICUM PERFORATUM - SUS SCROFA TOOTH - WITCH HAZEL -	SPRAY	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; CALCIUM SULFIDE; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; HYPERICUM PERFORATUM; SUS SCROFA TOOTH; WITCH HAZEL	3; 3; 3; 4; 6; 6; 2; 2; 3; 12; 2	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
17089-453_b2576e8c-11d8-1d15-e053-2a95a90a72b1	17089-453	HUMAN OTC DRUG	GUNA-COUGH		ALTHAEA OFFICINALIS LEAF - ANTIMONY POTASSIUM TARTRATE - BRYONIA ALBA ROOT - CETRARIA ISLANDICA SUBSP. ISLANDICA - COCHINEAL - COPPER - DROSERA ROTUNDIFOLIA - ECHINACEA ANGUSTIFOLIA - GARDEN THYME - LOBARIA PULMONARIA - PLANTAGO MAJOR -	SOLUTION/ DROPS	ORAL	20100527		UNAPPROVED HOMEOPATHIC		Guna spa	ALTHAEA OFFICINALIS LEAF; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CETRARIA ISLANDICA SUBSP. ISLANDICA; COCHINEAL; COPPER; DROSERA ROTUNDIFOLIA; ECHINACEA ANGUSTIFOLIA; LOBARIA PULMONARIA; PLANTAGO MAJOR; THYME	1; 8; 6; 4; 6; 8; 1; 1; 4; 1; 1	[hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL; [hp_X]/150mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
17089-460_b2587436-faab-37c8-e053-2995a90a3fba	17089-460	HUMAN OTC DRUG	GUNA MATRIX DETOX		sodium sulfate - podophyllum peltatum root - solidago virgaurea flowering top - apis mellifera - equisetum hyemale - strychnos nux vomica seed - hamamelis virginiana root bark stem bark - lycopodium clavatum spore - galium aparine whole - thuja occidentalis leafy twig - berberis vulgaris root bark - myosotis arvensis - chelidonium majus whole - fucus vesiculosus -	SOLUTION/ DROPS	ORAL	20200714		UNAPPROVED HOMEOPATHIC		Guna spa	CONIUM MACULATUM FLOWERING TOP; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; GRAPHITE; MALIC ACID; MYOSOTIS ARVENSIS; RANCID BEEF; SILICON DIOXIDE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA VEIN; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS WHOLE	3; 6; 4; 12; 6; 4; 12; 8; 3; 3; 12; 2; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
17089-461_b2580118-8598-5057-e053-2a95a90aab4e	17089-461	HUMAN OTC DRUG	GUNA ALLERGY		Adrenalinum - allium cepa - ammonium carbonicum - apis mellifica - argentum nitricum - arsenicum album - cuprum aceticum - galphimia glauca - glandula suprarenalis suis - histaminum hydrochloricum - luffa operculata - matricaria chamomilla - mucosa nasalis suis - natrum muriaticum - sabadilla - scilla maritima -	SOLUTION/ DROPS	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Guna spa	AMMONIUM CARBONATE; APIS MELLIFERA; ARSENIC TRIOXIDE; CUPRIC ACETATE; DRIMIA MARITIMA BULB; EPINEPHRINE; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; MATRICARIA CHAMOMILLA WHOLE; ONION; SCHOENOCAULON OFFICINALE SEED; SILVER NITRATE; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA NASAL MUCOSA	12; 200; 12; 12; 12; 6; 6; 200; 6; 3; 12; 12; 30; 12; 6; 200	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17089-462_b2588f62-6cc5-327e-e053-2a95a90aaafb	17089-462	HUMAN OTC DRUG	GUNA LYMPHO DETOX		Aesculus hippocastanum - apis mellifera - calendula officinalis flower - hexaketocyclohexane - equisetum hyemale - fumaric acid - graphite - hydrastis canadensis - hydrocotyle asiatica - juglans regia - levothyroxine - magnesium phosphate - malic acid - myosotis arvensis - phytolacca americana root - sarsaparilla - sodium diethyl oxalacetate - sodium pyruvate - sus scrofa placenta - taraxacum officinale -	SOLUTION/ DROPS	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Guna spa	APIS MELLIFERA; CALENDULA OFFICINALIS FLOWER; CENTELLA ASIATICA WHOLE; DODECAHYDROXYCYCLOHEXANE DIHYDRATE; EQUISETUM HYEMALE; FUMARIC ACID; GOLDENSEAL; GRAPHITE; HORSE CHESTNUT; JUGLANS REGIA FRUIT RIND, IMMATURE; LEVOTHYROXINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MALIC ACID; MYOSOTIS ARVENSIS; PHYTOLACCA AMERICANA ROOT; SARSAPARILLA; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUS SCROFA PLACENTA; TARAXACUM OFFICINALE	8; 1; 2; 6; 3; 6; 5; 12; 2; 5; 12; 12; 6; 4; 4; 3; 6; 6; 6; 1	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
17089-463_b258aa33-c259-1343-e053-2a95a90af0c0	17089-463	HUMAN OTC DRUG	GUNA ARTHRO RELIEF		arteria suis - alpha ketoglutaricum acidum - alpha lipoicum acidum - ascorbicum acidum - barium oxalsuccinicum - bryonia alba - calcarea carbonica - cartilago suis - chlorinum - cimicifuga racemosa - colchicum autumnale - dulcamara - embryo suis - funiculus umbilicalis suis - glandula suprarenalis suis - nadidum - natrum oxalaceticum - natrum sulphuricum - placenta totalis suis - rhus toxicodendron - sulphur- vena suis -	SOLUTION/ DROPS	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Guna spa	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BLACK COHOSH; BRYONIA ALBA ROOT; CHLORINE; COLCHICUM AUTUMNALE BULB; NADIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM DIETHYL OXALACETATE; SODIUM SULFATE; SOLANUM DULCAMARA FLOWER; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA ARTERY; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA VEIN; TOXICODENDRON PUBESCENS LEAF	3; 8; 3; 6; 6; 6; 6; 6; 3; 4; 3; 8; 6; 4; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Ascorbic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vitamin C [EPC]		N	20241231
17089-464_af5aec5c-a562-6516-e053-2a95a90a3be9	17089-464	HUMAN OTC DRUG	GUNA FLAM RELIEF		ACONITUM NAPELLUS - APIS MELLIFERA - ARNICA MONTANA WHOLE - ATROPA BELLADONNA - BASIC CUPRIC CARBONATE - BRYONIA ALBA ROOT - MATRICARIA CHAMOMILLA WHOLE - CALCIUM SULFIDE - CITRIC ACID MONOHYDRATE - ECHINACEA ANGUSTIFOLIA - FERRIC PHOSPHATE - PHYTOLACCA AMERICANA ROOT - RANCID BEEF - SODIUM PYRUVATE - PORK LIVER - RANCID BEEF - SUS SCROFA PITUITARY GLAND -	SOLUTION/ DROPS	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Guna spa	ACONITUM NAPELLUS WHOLE; APIS MELLIFERA; ARNICA MONTANA; ATROPA BELLADONNA; BASIC CUPRIC CARBONATE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CITRIC ACID MONOHYDRATE; ECHINACEA ANGUSTIFOLIA WHOLE; FERRIC PHOSPHATE; MATRICARIA CHAMOMILLA WHOLE; PHYTOLACCA AMERICANA ROOT; PORK LIVER; RANCID BEEF; SODIUM PYRUVATE; SUS SCROFA PITUITARY GLAND	6; 6; 3; 6; 4; 6; 6; 3; 4; 12; 2; 6; 6; 30; 3; 200	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Acidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Bee Venoms [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17089-465_af5b9acf-ede8-0899-e053-2a95a90a1706	17089-465	HUMAN OTC DRUG	GUNA PAIN MANAGEMENT		achillea millefolium whole - bellis perennis whole - matricaria chamomilla whole - toxicodendron pubescens whole - ruta graveolens flowering top - comfrey root - apis mellifera - bryonia alba root - histamine hydrochloride - hypericum perforatum - kalmia latifolia leaf - arnica montana whole - pork liver -	SOLUTION/ DROPS	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Guna spa	ACHILLEA MILLEFOLIUM WHOLE; APIS MELLIFERA; ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BRYONIA ALBA ROOT; COMFREY ROOT; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; KALMIA LATIFOLIA LEAF; MATRICARIA CHAMOMILLA WHOLE; PORK LIVER; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	2; 30; 3; 2; 6; 6; 12; 3; 6; 2; 6; 4; 8	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17089-466_af5e38c0-3d5d-4733-e053-2a95a90afefe	17089-466	HUMAN OTC DRUG	GUNA DEEP CLEANSE		apis mellifera - berberis vulgaris root bark - chelidonium majus - chondrodendron tomentosum root - equisetum hyemale whole - fucus vesiculosus - galium aparine whole - hamamelis virginiana root bark - lycopodium clavatum spore - myosotis arvensis - podophyllum peltatum root - rancid beef - sodium sulfate - solidago virgaurea flowering top - strychnos nux vomica seed - thuja occidentalis leafy twig -	SOLUTION/ DROPS	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Guna spa	APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS ROOT; CHONDRODENDRON TOMENTOSUM ROOT; EQUISETUM HYEMALE WHOLE; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LYCOPODIUM CLAVATUM SPORE; MYOSOTIS ARVENSIS; PODOPHYLLUM PELTATUM ROOT; RANCID BEEF; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG	12; 3; 4; 6; 3; 6; 4; 2; 4; 4; 6; 12; 12; 4; 4; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17089-467_d32e09c7-895a-2b2d-e053-2a95a90a6eee	17089-467	HUMAN OTC DRUG	GUNA DEFENSE		calcium sulfide - centella asiatica - echinacea angustifolia whole - echinacea purpurea - thuja occidentalis leafy twig - vincetoxicum hirundinaria root - phytolacca americana root - sulfur -	PELLET	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Guna spa	CALCIUM SULFIDE; CENTELLA ASIATICA; ECHINACEA ANGUSTIFOLIA WHOLE; ECHINACEA PURPUREA; PHYTOLACCA AMERICANA ROOT; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; VINCETOXICUM HIRUNDINARIA ROOT	10; 4; 2; 2; 4; 10; 6; 6	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g			N	20241231
17089-469_b2e68392-b15d-1cf9-e053-2a95a90a5834	17089-469	HUMAN OTC DRUG	GUNA MOOD SUPPORT		arsenic trioxide - sepia officinalis juice - lycopodium clavatum spore - hypericum perforatum - gold -	SOLUTION/ DROPS	ORAL	20201115		UNAPPROVED HOMEOPATHIC		Guna spa	ARSENIC TRIOXIDE; GOLD; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; SEPIA OFFICINALIS JUICE	12; 30; 3; 30; 30	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
17089-470_b3aa6401-9af7-b0d5-e053-2995a90a10ef	17089-470	HUMAN OTC DRUG	GUNA BOWEL PLUS		ACTIVATED CHARCOAL - ALOE - ALUMINUM OXIDE - BRYONIA ALBA ROOT - CHELIDONIUM MAJUS - COLLINSONIA - FRANGULA ALNUS BARK - LYCOPODIUM CLAVATUM SPORE - POTASSIUM CARBONATE- RHUBARB - STRYCHNOS NUX VOMICA SEED - SILYBUM MARIANUM SEED - SKATOLE - SODIUM CARBONATE - SUS SCROFA PANCREAS - TARAXACUM OFFICINALE - THIAMINE -	SOLUTION/ DROPS	ORAL	20210117		UNAPPROVED HOMEOPATHIC		Guna spa	ACTIVATED CHARCOAL; ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLLINSONIA; FRANGULA ALNUS BARK; LYCOPODIUM CLAVATUM SPORE; POTASSIUM CARBONATE; RHUBARB; SILYBUM MARIANUM SEED; SKATOLE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; TARAXACUM OFFICINALE; THIAMINE	6; 4; 6; 6; 2; 2; 2; 2; 6; 2; 2; 6; 6; 6; 6; 2; 4	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17089-471_b3ffb7f9-fd2c-5f88-e053-2a95a90aa91c	17089-471	HUMAN OTC DRUG	GUNA SLEEP SUPPORT		avena sativa flowering top - caffeine - matricaria chamomilla whole - Passiflora incarnata flowering top -potassium bromide - zinc valerate dihydrate - silver nitrate - strychnos ingatii seed -	SOLUTION/ DROPS	ORAL	20210117		UNAPPROVED HOMEOPATHIC		Guna spa	AVENA SATIVA FLOWERING TOP; CAFFEINE; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM BROMIDE; SILVER NITRATE; STRYCHNOS IGNATII SEED; ZINC VALERATE DIHYDRATE	2; 6; 2; 2; 4; 30; 4; 4	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
17089-472_b48c5634-24d0-343e-e053-2995a90a3a9a	17089-472	HUMAN OTC DRUG	GUNA SINUS PLUS		ALTHAEA OFFICINALIS LEAF - CALCIUM SULFIDE - COPPER - DRIMIA MARITIMA BULB - ECHINACEA ANGUSTIFOLIA - HYDRASTIS CANADENSIS WHOLE - LOBARIA PULMONARIA - MANGANESE - MERCURIC SULFIDE - ONION - PLANTAGO MAJOR WHOLE - POTASSIUM DICHROMATE - PULSATILLA VULGARIS - SILICON DIOXIDE - SILVER NITRATE - SINUSITISINUM - SUS SCROFA NASAL MUCOSA -	SPRAY	NASAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	ALTHAEA OFFICINALIS LEAF; ASCORBIC ACID; CALCIUM SULFIDE; COPPER; DRIMIA MARITIMA BULB; ECHINACEA ANGUSTIFOLIA; HYDRASTIS CANADENSIS WHOLE; LOBARIA PULMONARIA; MANGANESE; MERCURIC SULFIDE; ONION; PLANTAGO MAJOR WHOLE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILICON DIOXIDE; SILVER NITRATE; SINUSITISINUM; SUS SCROFA NASAL MUCOSA	2; 3; 6; 8; 12; 3; 6; 2; 8; 8; 6; 2; 6; 6; 6; 10; 12; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], Vitamin C [EPC]		N	20241231
17089-473_ba446257-56b6-616f-e053-2a95a90a1f16	17089-473	HUMAN OTC DRUG	GUNA OSTEO		Arnica montana root - CALCIUM FLUORIDE - CALCIUM PHOSPHATE - equisetum hyemale - fumaric acid - SUS SCROFA UMBILICAL CORD - sus scrofa ovary - sus scrofa placenta - comfrey root - succinic acid - silicon dioxide -	SOLUTION/ DROPS	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	ARNICA MONTANA ROOT; CALCIUM FLUORIDE; CALCIUM PHOSPHATE; COMFREY ROOT; EQUISETUM HYEMALE; FUMARIC ACID; SILICON DIOXIDE; SUCCINIC ACID; SUS SCROFA OVARY; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD	3; 8; 8; 6; 3; 4; 8; 4; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
17089-474_ba7eb1a4-9059-c47c-e053-2a95a90a6cce	17089-474	HUMAN OTC DRUG	GUNA KIDNEY PLUS		calcium sulfide - chondrodendron tomentosum root - equisetum hyemale - sus scrofa pituitary gland - apis mellifera - urtica urens - sodium chloride - lobaria pulmonaria - horse chestnut - berberis vulgaris fruit - solidago viragaurea flowering top -	SOLUTION/ DROPS	ORAL	20210117		UNAPPROVED HOMEOPATHIC		Guna spa	APIS MELLIFERA; BERBERIS VULGARIS FRUIT; CALCIUM SULFIDE; CHONDRODENDRON TOMENTOSUM ROOT; EQUISETUM HYEMALE; HORSE CHESTNUT; LOBARIA PULMONARIA; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA PITUITARY GLAND; URTICA URENS	12; 3; 6; 4; 3; 2; 6; 10; 2; 200; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17089-475_b8db0bfe-4e97-25dc-e053-2a95a90aa847	17089-475	HUMAN OTC DRUG	GUNA DIGESTION PLUS		pork liver - lycopodium clavatum spore - strychnos nux vomica seed - sus scrofa pancreas - aethusa cynapium -	SOLUTION/ DROPS	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	AETHUSA CYNAPIUM; LYCOPODIUM CLAVATUM SPORE; PORK LIVER; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS	3; 4; 6; 4; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17089-476_d3322d60-dd44-8e96-e053-2995a90a54b0	17089-476	HUMAN OTC DRUG	GUNA HAY FEVER RELIEF		strychnos nux vomica seed - histamine dihydrochloride - manganese - schoenocaulon officinale seed - apis mellifera - arsenic trioxide - silver nitrate - onion - euphrasia stricta - galphimia glauca flowering top - sulfur -	PELLET	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	APIS MELLIFERA; ARSENIC TRIOXIDE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; MANGANESE; ONION; SCHOENOCAULON OFFICINALE SEED; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR	200; 30; 5; 4; 200; 8; 30; 6; 6; 4; 30	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
17089-477_c718c487-6d75-19aa-e053-2995a90aa549	17089-477	HUMAN OTC DRUG	GUNA STOMACH PLUS		Antimonium crudum - Argentum nitricum - Arsenicum album - Ipecacuanha - Nux vomica - Origanum majorana - Cuprum metallicum - Taraxacum officinale - Natrum phosphoricum -	PELLET	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; COPPER; IPECAC; ORIGANUM MAJORANA; SILVER NITRATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE ROOT	6; 6; 4; 8; 6; 6; 4; 4; 6	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17089-478_d32e3bbc-f536-6d6f-e053-2995a90aa9f4	17089-478	HUMAN OTC DRUG	GUNA LIVER PLUS		SODIUM PYRUVATE - SILYBUM MARIANUM SEED - CHELIDONIUM MAJUS - FUMARIC ACID - PORK LIVER - TARAXACUM OFFICINALE - LYCOPODIUM CLAVATUM SPORE - SODIUM SULFATE - PHOSPHORUS - BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; FUMARIC ACID; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PORK LIVER; SILYBUM MARIANUM SEED; SODIUM PYRUVATE; SODIUM SULFATE; TARAXACUM OFFICINALE	3; 4; 6; 6; 8; 6; 2; 3; 6; 3	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
17089-479_ba483fd7-f25d-cc95-e053-2995a90afd8a	17089-479	HUMAN OTC DRUG	GUNA THROAT AND GUMS		ACHILLEA MILLEFOLIUM - ACONITUM NAPELLUS - ARNICA MONTANA - ATROPA BELLADONNA - CALCIUM SULFIDE - COMFREY ROOT - ECHINACEA ANGUSTIFOLIA - ECHINACEA PURPUREA - HYPERICUM PERFORATUM - WITCH HAZEL -	SPRAY	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; CALCIUM SULFIDE; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; HYPERICUM PERFORATUM; WITCH HAZEL	3; 3; 3; 4; 6; 6; 2; 2; 3; 2	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
17089-500_ba48694e-5cb1-22ef-e053-2995a90a9965	17089-500	HUMAN OTC DRUG	GUNA HEALTHY BRAIN		Citrullus colocynthis fruit pulp - ubidecarenone - sus scrifa adrenal gland - sus scrofa placenta - selenium - thuja occidentalis leafy twig - conium maculatum flowering top - sus scrofa embryo - aconitum napellus - aloe - barium oxalosuccinate - sus scrofa cerebrum - arnica montana - sus scrofa hypothalamus -	SOLUTION/ DROPS	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	ACONITUM NAPELLUS; ALOE; ARNICA MONTANA; BARIUM OXALOSUCCINATE; CITRULLUS COLOCYNTHIS FRUIT PULP; CONIUM MACULATUM FLOWERING TOP; SELENIUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA CEREBRUM; SUS SCROFA EMBRYO; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PLACENTA; THUJA OCCIDENTALIS LEAFY TWIG; UBIDECARENONE	4; 4; 3; 6; 4; 4; 6; 6; 6; 6; 6; 6; 8; 5	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
17089-501_bb2217fc-c752-20b1-e053-2995a90a2562	17089-501	HUMAN OTC DRUG	GUNA FEMALE SUPPORT		lilium lancifolium whole flowering - sus scrofa ovary - sus scrofa pituitary gland - sepia officinalis juice - adenosine cyclic phosphate - pulsatilla vulgaris - sus scrofa hypothalamus - sus scrofa adrenal gland - sus scrofa pancreas - magnesium phosphate dibasic trihydrate	SOLUTION/ DROPS	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	ADENOSINE CYCLIC PHOSPHATE; LILIUM LANCIFOLIUM WHOLE FLOWERING; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND	6; 6; 10; 8; 10; 30; 30; 6; 30; 30	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17089-502_bb232817-c340-2af4-e053-2995a90afa56	17089-502	HUMAN OTC DRUG	GUNA MALE SUPPORT		TURNERA DIFFUSA LEAFY TWIG - adenosine cyclic phosphate - sus scrofa pituitary gland - sus scrofa hypothalamus - sus scrofa adrenal gland - sus scrofa pancreas - sus scrofa testicle - phosphorus -sus scrofa thyroid -	SOLUTION/ DROPS	ORAL	20210217		UNAPPROVED HOMEOPATHIC		Guna spa	ADENOSINE CYCLIC PHOSPHATE; PHOSPHORUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SUS SCROFA TESTICLE; SUS SCROFA THYROID; TURNERA DIFFUSA LEAFY TWIG	6; 6; 30; 30; 30; 30; 6; 30; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
17139-400_0a222fd7-f2ca-301c-e063-6294a90a6d81	17139-400	HUMAN PRESCRIPTION DRUG	Binosto		alendronate sodium	TABLET, EFFERVESCENT	ORAL	20120903		NDA	NDA202344	ASCEND Therapeutics	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
17139-562_0a2250c7-2e8a-5d24-e063-6294a90aa486	17139-562	HUMAN PRESCRIPTION DRUG	AndroGel		Testosterone	GEL	TRANSDERMAL	20230217		NDA	NDA022309	ASCEND Therapeutics U.S., LLC	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
17139-617_0a224f9b-1b96-17fa-e063-6394a90a16a8	17139-617	HUMAN PRESCRIPTION DRUG	EstroGel		estradiol	GEL, METERED	TOPICAL	20040209		NDA	NDA021166	ASCEND Therapeutics US, LLC	ESTRADIOL	.75	mg/1.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
17156-021_bc294a45-4008-4476-b7a4-9475b18d43a2	17156-021	HUMAN PRESCRIPTION DRUG	Indium in 111 Oxyquinoline		Indium In-111 Oxyquinoline	SOLUTION	INTRAVENOUS	19851201		NDA	NDA019044	Medi-Physics Inc. dba GE Healthcare.	INDIUM IN-111 OXYQUINOLINE	1	ug/mL			N	20251231
17156-022_87cca989-b750-4ca7-9b5a-6f00d0457c46	17156-022	HUMAN PRESCRIPTION DRUG	CERETEC		TECHNETIUM TC-99M EXAMETAZIME	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19881230		NDA	NDA019829	Medi-Physics Inc. dba GE Healthcare.	TECHNETIUM TC-99M EXAMETAZIME	.5	mg/5mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20251231
17156-023_ab9495db-a711-4f8b-8f62-0cd4d32f73c6	17156-023	HUMAN PRESCRIPTION DRUG	Ceretec		Exametazime	KIT		19881230		NDA	NDA019829	Medi-Physics Inc.						N	20251231
17156-024_cfb49f93-c931-4429-8a04-d3c6d1e913a0	17156-024	HUMAN PRESCRIPTION DRUG	Myoview		Tetrofosmin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19960209		NDA	NDA020372	Medi-Physics Inc. dba GE Healthcare	TETROFOSMIN	.23	mg/1			N	20251231
17156-026_3475dd6d-4e62-4907-9c45-00845816577f	17156-026	HUMAN PRESCRIPTION DRUG	Myoview		Tetrofosmin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090226		NDA	NDA020372	Medi-Physics Inc. dba GE Healthcare	TETROFOSMIN	1.38	mg/1			N	20251231
17156-067_98dce1b2-724b-43f5-8090-ee7c82c88910	17156-067	HUMAN PRESCRIPTION DRUG	Vizamyl		Flutemetamol F-18	SOLUTION	INTRAVENOUS	20140101		NDA	NDA203137	Medi-Physics, Inc. dba GE Healthcare	FLUTEMETAMOL F-18	4.05	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
17156-210_fd67b7dc-7c58-47ee-a7d1-51555c103555	17156-210	HUMAN PRESCRIPTION DRUG	DaTscan		Ioflupane I-123	INJECTION, SOLUTION	INTRAVENOUS	20110301		NDA	NDA022454	Medi-Physics Inc. dba GE Healthcare.	IOFLUPANE I-123	2	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20251231
17156-235_44cadee9-19ca-4756-ab85-0836b38db89f	17156-235	HUMAN PRESCRIPTION DRUG	AdreView		Iobenguane I-123	INJECTION	INTRAVENOUS	20080919		NDA	NDA022290	Medi-Physics Inc.	IOBENGUANE I-123	2	mCi/mL			N	20251231
17156-251_3dfabc30-f669-4287-9948-038c3a502d1f	17156-251	HUMAN PRESCRIPTION DRUG	Indium DTPA In 111		Indium In-111 Pentetate Disodium	SOLUTION	INTRATHECAL	19820218		NDA	NDA017707	Medi-Physics, Inc. dba GE Healthcare	INDIUM IN-111 PENTETATE DISODIUM	1	mCi/mL			N	20251231
17224-171_f709b80f-6425-790e-e053-6394a90a17fc	17224-171	HUMAN PRESCRIPTION DRUG	Fluoxetine		FLUOXETINE HYDROCHLORIDE	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Calvin Scott & Co., Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
17224-178_f790f48e-79bb-4d43-e053-6294a90a2b29	17224-178	HUMAN PRESCRIPTION DRUG	Furosemide		FUROSEMIDE	TABLET	ORAL	20060201		ANDA	ANDA077293	Calvin Scott & Co., Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
17224-311_da8083b6-aeff-e1ee-e053-2a95a90a0844	17224-311	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride Extended-Release 500mg		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20170608		ANDA	ANDA078321	Calvin Scott & Co., Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
17224-318_f99bf123-ea91-ced5-e053-6294a90a7715	17224-318	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	Calvin Scott & Co., Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
17224-322_f99d659b-77cf-36a7-e053-6394a90af7e2	17224-322	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	Calvin Scott & Co., Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
17224-672_f5ee265f-9765-de77-e053-2a95a90ac76f	17224-672	HUMAN PRESCRIPTION DRUG	benzphetamine hydrochloride		BENZPHETAMINE HYDROCHLORIDE	TABLET	ORAL	20100101		ANDA	ANDA090968	Calvin Scott & Co., Inc.	BENZPHETAMINE HYDROCHLORIDE	50	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
17224-730_f5d7711f-7d15-b15e-e053-2995a90ad173	17224-730	HUMAN PRESCRIPTION DRUG	DIETHYLPROPION HYDROCHLORIDE		DIETHYLPROPION HYDROCHLORIDE	TABLET	ORAL	20101227		ANDA	ANDA201212	Calvin Scott & Co., Inc.	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-760_f602756f-8f41-a199-e053-2995a90a6e10	17224-760	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride	ER	DIETHYLPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111024		ANDA	ANDA091680	Calvin Scott & Co., Inc.	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-800_f5c30a88-5815-5b42-e053-2995a90a437a	17224-800	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		PHENDIMETRAZINE TARTRATE	TABLET	ORAL	19780101		ANDA	ANDA091042	Calvin Scott & Co., Inc.	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
17224-840_f8c1610f-7eb5-07d4-e053-6294a90a07f5	17224-840	HUMAN PRESCRIPTION DRUG	LOMAIRA		PHENTERMINE HYDROCHLORIDE	TABLET	ORAL	20160912		ANDA	ANDA203495	Calvin Scott & Co., Inc.	PHENTERMINE HYDROCHLORIDE	8	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-851_f60149f4-c2a9-b4cf-e053-2995a90af524	17224-851	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		PHENTERMINE HYDROCHLORIDE	CAPSULE	ORAL	20190201		ANDA	ANDA205019	Calvin Scott & Co., Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-870_f8aba3a2-7dc5-fb9a-e053-6294a90ad49e	17224-870	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		PHENTERMINE HYDROCHLORIDE	CAPSULE	ORAL	20120807		ANDA	ANDA040886	Calvin Scott & Co., Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-872_f6041229-f36d-d3d4-e053-2995a90a98cc	17224-872	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		PHENTERMINE HYDROCHLORIDE	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Calvin Scott & Co., Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-877_f938a4c3-20ba-f826-e053-6294a90abfcf	17224-877	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		PHENTERMINE HYDROCHLORIDE	CAPSULE	ORAL	20120807		ANDA	ANDA040875	Calvin Scott & Co., Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-902_f54facdc-5442-7165-e053-2995a90ad093	17224-902	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		PHENTERMINE HYDROCHLORIDE	TABLET	ORAL	19780101		ANDA	ANDA040876	Calvin Scott & Co., Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17224-904_f6e232c2-4182-6274-e053-6294a90a5e38	17224-904	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		PHENTERMINE HYDROCHLORIDE	TABLET	ORAL	20170124		ANDA	ANDA205008	Calvin Scott & Co., Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
17238-424_0e867446-c65f-7ca9-e063-6394a90a21c2	17238-424	HUMAN PRESCRIPTION DRUG	Indocyanine Green		Indocyanine Green and Water	KIT		20080101		ANDA	ANDA040811	HUB Pharmaceuticals LLC						N	20251231
17238-900_0e86525e-501b-e995-e063-6294a90a4d9c	17238-900	HUMAN PRESCRIPTION DRUG	BioGlo		Fluorescein Sodium	STRIP	OPHTHALMIC	20120401		UNAPPROVED DRUG OTHER		HUB Pharmaceuticals, Inc.	FLUORESCEIN SODIUM	1	mg/mg	Diagnostic Dye [EPC], Dyes [MoA]		N	20251231
17238-920_0e8666d7-b6f3-f20b-e063-6294a90af644	17238-920	HUMAN PRESCRIPTION DRUG	GreenGlo		Lissamine Green	STRIP	OPHTHALMIC	20120401		UNAPPROVED DRUG OTHER		HUB Pharmaceuticals, Inc.	LIGHT GREEN SF YELLOWISH	1.5	mg/1.5mg			N	20251231
17270-553_dfc294ab-2065-4da8-b508-84f1a5d7785b	17270-553	HUMAN OTC DRUG	Primatene Mist		Epinephrine Inhalation	AEROSOL	RESPIRATORY (INHALATION)	20181214		NDA	NDA205920	Armstrong Pharmaceuticals, Inc.	EPINEPHRINE	125	ug/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17271-107_0af0d64c-9550-3a03-e063-6394a90ad227	17271-107	HUMAN OTC DRUG	BD E-Z Scrub 107		chlorhexidine gluconate	SOLUTION	TOPICAL	19891024		ANDA	ANDA072525	Becton Dickinson and Company	CHLORHEXIDINE GLUCONATE	40	g/1000mL	Decreased Cell Wall Integrity [PE]		N	20241231
17271-116_0b2e1ff5-3554-b155-e063-6294a90a7518	17271-116	HUMAN OTC DRUG	BD E-Z SCRUB		chloroxylenol	SOLUTION	TOPICAL	19890301		OTC MONOGRAPH DRUG	505G(a)(3)	Becton Dickinson and Company	CHLOROXYLENOL	30	mg/mL			N	20241231
17271-205_0b1abfac-d689-b41f-e063-6394a90ae07b	17271-205	HUMAN OTC DRUG	BD E-Z SCRUB		povidone-iodine	SOLUTION	TOPICAL	19950601		OTC MONOGRAPH DRUG	505G(a)(3)	Becton Dickinson and Company	POVIDONE-IODINE	100	mg/mL			N	20241231
17271-502_0b6a66a9-b8cc-ebfe-e063-6294a90a09f8	17271-502	HUMAN OTC DRUG	BD E-Z Scrub		chloroxylenol	SOLUTION	TOPICAL	20000401		OTC MONOGRAPH DRUG	505G(a)(3)	Becton Dickinson and Company	CHLOROXYLENOL	30	mg/mL			N	20241231
17271-503_0b69b61d-6057-5908-e063-6294a90afede	17271-503	HUMAN OTC DRUG	BD E-Z Scrub		Povidone-Iodine	SOLUTION	TOPICAL	20000401	20250131	OTC MONOGRAPH DRUG	505G(a)(3)	Becton Dickinson and Company	POVIDONE-IODINE	50	mg/mL			N	
17271-505_0b19417e-fd8c-8dfd-e063-6294a90aa64f	17271-505	HUMAN OTC DRUG	BD E-Z Scrub		chlorhexidine gluconate	SOLUTION	TOPICAL	20060101		NDA	NDA019127	Becton Dickinson and Company	CHLORHEXIDINE GLUCONATE	40	g/1000mL	Decreased Cell Wall Integrity [PE]		N	20241231
17271-506_0b1a043b-6ad7-482a-e063-6394a90a73aa	17271-506	HUMAN OTC DRUG	BD E-Z Scrub		chlorhexidine gluconate	SOLUTION	TOPICAL	20010401		NDA	NDA019422	Becton Dickinson and Company	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
17271-700_ee93e1a3-5343-4d6e-8bdb-9ed2546ed9ef	17271-700	HUMAN PRESCRIPTION DRUG	sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180723		ANDA	ANDA208122	Becton Dickinson and Company	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
17271-701_6719b664-e0d1-4e37-837f-d7f3c05e1ed9	17271-701	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Becton Dickinson and Company	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
17271-703_ab3d79da-7b4a-4224-b0e4-46bd00bf6444	17271-703	HUMAN PRESCRIPTION DRUG	3% Sodium Chloride		3% Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20200228		ANDA	ANDA209476	Becton Dickinson and Company	SODIUM CHLORIDE	3	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
17271-710_60e4de11-c42f-4ed2-afb1-3985b40e3e2b	17271-710	HUMAN PRESCRIPTION DRUG	LACTATED RINGERS		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190128		ANDA	ANDA209338	Becton Dickinson and Company	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
17271-720_37d2886f-95ad-4b8a-a981-b7b707ffd172	17271-720	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20161021		ANDA	ANDA207449	Becton Dickinson and Company	DEXTROSE MONOHYDRATE	50	mg/mL			N	20241231
17271-721_a62bffaf-bbbb-4608-a14f-24e39bc27897	17271-721	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20200205		ANDA	ANDA209448	Becton Dickinson and Company	DEXTROSE MONOHYDRATE	100	mg/mL			N	20241231
17271-750_6fdd6817-4ddf-43ab-94d9-e8072e8aa673	17271-750	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION, SOLUTION	INTRAVENOUS	20200228		ANDA	ANDA209689	Becton Dickinson and Company	WATER	1000	mL/1000mL			N	20241231
17312-001_0e760406-dd67-7bbf-e063-6294a90a74f9	17312-001	HUMAN OTC DRUG	Ring Relief		Arnica Montana, Calcium Sulfide, Hypericum Perforatum, Lycopodium Clavatum Spore, Thiosinaminum, Mercurius Solubilis, Salicylic Acid, Silicon Dioxide, Allylthiourea	LIQUID	AURICULAR (OTIC)	20060601		UNAPPROVED HOMEOPATHIC		TRP Company	ALLYLTHIOUREA; ARNICA MONTANA; CALCIUM SULFIDE; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SALICYLIC ACID; SILICON DIOXIDE	6; 6; 13; 6; 12; 13; 6; 13	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
17312-002_e64b400e-9deb-7fba-e053-2a95a90a8aac	17312-002	HUMAN OTC DRUG	Blur Relief		Jacobaea Maritima, Calcium Fluoride, Conium Maculatum Flowering Top, Euphrasia Stricta, Gelsemium Sempervirens Root, Sodium Chloride, Ruta Graveolens Flowering Top	LIQUID	INTRAOCULAR	20060601		UNAPPROVED HOMEOPATHIC		TRP Company	CALCIUM FLUORIDE; CONIUM MACULATUM FLOWERING TOP; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; JACOBAEA MARITIMA; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE	13; 6; 6; 6; 5; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
17312-013_f44d625f-3af5-9aa8-e053-2995a90af85b	17312-013	HUMAN OTC DRUG	Pink Eye Relief		ACONITUM NAPELLUS - APIS MELLIFERA - SILVER NITRATE - EUPHRASIA STRICTA - SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE -	LIQUID	OPHTHALMIC	20120901		UNAPPROVED HOMEOPATHIC		TRP Company	ACONITUM NAPELLUS; APIS MELLIFERA; EUPHRASIA STRICTA; SILVER NITRATE; SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	6; 6; 6; 12; 11	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-014_f6f4598b-d217-5a94-e053-6394a90ab6f6	17312-014	HUMAN OTC DRUG	Stye Relief		APIS MELLIFERA - CARBON DISULFIDE - PULSATILLA VULGARIS - SILICON DIOXIDE - DELPHINIUM STAPHISAGRIA SEED -	OINTMENT	TOPICAL	20111201		UNAPPROVED HOMEOPATHIC		TRP Company	APIS MELLIFERA; CARBON DISULFIDE; DELPHINIUM STAPHISAGRIA SEED; PULSATILLA VULGARIS; SILICON DIOXIDE	6; 6; 6; 6; 6	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-016_0e760c0e-2b0d-60bd-e063-6294a90acc4f	17312-016	HUMAN OTC DRUG	Temporary Fibromyalgia Pain and Discomfort Relief		ATROPA BELLADONNA - BRYONIA ALBA ROOT - CAUSTICUM - PHOSPHORUS - STRYCHNOS NUX-VOMICA SEED - PULSATILLA VULGARIS - TOXICODENDRON PUBESCENS LEAF -	TABLET, ORALLY DISINTEGRATING	ORAL	20111201		UNAPPROVED HOMEOPATHIC		TRP Company	ATROPA BELLADONNA; BRYONIA ALBA ROOT; CAUSTICUM; PHOSPHORUS; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
17312-017_0e75f6a1-d40e-6aac-e063-6294a90a775a	17312-017	HUMAN OTC DRUG	Asthma Therapy		ARSENIC TRIOXIDE - HISTAMINE DIHYDROCHLORIDE - DERMATOPHAGOIDES PTERONYSSINUS - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - STRYCHNOS NUX-VOMICA SEED - ASPIDOSPERMA QUEBRACHO-BLANCO BARK - SUPLHUR -	TABLET, ORALLY DISINTEGRATING	ORAL	20111201		UNAPPROVED HOMEOPATHIC		TRP Company	ARSENIC TRIOXIDE; ASPIDOSPERMA QUEBRACHO-BLANCO BARK; DERMATOPHAGOIDES PTERONYSSINUS; HISTAMINE DIHYDROCHLORIDE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR	6; 6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Insect Proteins [CS], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
17312-018_f1ed5bac-c956-0cb4-e053-2995a90af2a8	17312-018	HUMAN OTC DRUG	Bronchial Cough Therapy		ANTIMONY POTASSIUM TARTRATE - PROTORTONIA CACTI - DROSERA ROTUNDIFOLIA - ECHINACEA, UNSPECIFIED - CALCIUM SULFIDE - HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED - SPONGIA OFFICINALIS SKELETON, ROASTED -	TABLET, ORALLY DISINTEGRATING	ORAL	20111201		UNAPPROVED HOMEOPATHIC		TRP Company	ANTIMONY POTASSIUM TARTRATE; CALCIUM SULFIDE; DROSERA ROTUNDIFOLIA; ECHINACEA, UNSPECIFIED; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; PROTORTONIA CACTI; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 6; 6; 6; 18; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
17312-019_07f29685-f1ee-8222-e063-6294a90a2680	17312-019	HUMAN OTC DRUG	Irritable Bowel Syndrome Therapy		ASAFETIDA - BISMUTH SUBNITRATE - BRYONIA ALBA ROOT - ACTIVATED CHARCOAL - LYCOPODIUM CLAVATUM SPORE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - VERATRUM ALBUM ROOT -	TABLET, ORALLY DISINTEGRATING	ORAL	20111201		UNAPPROVED HOMEOPATHIC		TRP Company	ACTIVATED CHARCOAL; ASAFETIDA; BISMUTH SUBNITRATE; BRYONIA ALBA ROOT; LYCOPODIUM CLAVATUM SPORE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	6; 3; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17312-021_f1ed5637-311b-3407-e053-2a95a90a83a3	17312-021	HUMAN OTC DRUG	Sciatica Therapy		ARNICA MONTANA - CITRULLUS COLOCYNTHIS FRUIT PULP - PSEUDOGNAPHALIUM OBTUSIFOLIUM - HYPERICUM PERFORATUM - POTASSIUM IODIDE - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - TOXICODENDRON PUBESCENS LEAF -	TABLET, ORALLY DISINTEGRATING	ORAL	20111201		UNAPPROVED HOMEOPATHIC		TRP Company	ARNICA MONTANA; CITRULLUS COLOCYNTHIS FRUIT PULP; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17312-023_f1ed655a-b1f7-3eeb-e053-2995a90ac51c	17312-023	HUMAN OTC DRUG	Ring Relief		ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA -	TABLET, ORALLY DISINTEGRATING	ORAL	20111201		UNAPPROVED HOMEOPATHIC		TRP Company	ALLYLTHIOUREA; ARNICA MONTANA; CALCIUM SULFIDE; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SALICYLIC ACID; SILICON DIOXIDE	6; 6; 13; 6; 12; 13; 6; 13	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
17312-025_f1ed28d1-3456-2510-e053-2a95a90a71e1	17312-025	HUMAN OTC DRUG	EarAche Relief		APIS MELLIFERA, ARNICA MONTANA, ATROPA BELLADONNA, TRIBASIC CALCIUM PHOSPHATE, ECHINACEA, UNSPECIFIED, CALCIUM SULFIDE, MERCURIUS SOLUBILIS	TABLET, ORALLY DISINTEGRATING	ORAL	20130905		UNAPPROVED HOMEOPATHIC		TRP Company	APIS MELLIFERA; ARNICA MONTANA; ATROPA BELLADONNA; CALCIUM SULFIDE; ECHINACEA, UNSPECIFIED; MERCURIUS SOLUBILIS; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6; 6; 3; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-027_f4c5422c-356b-8fcf-e053-2995a90ae0d9	17312-027	HUMAN OTC DRUG	AgingEye Relief		TRIBASIC CALCIUM PHOSPHATE, CALENDULA OFFICINALIS FLOWERING TOP, CARBON DISULFIDE, JACOBAEA MARITIMA, CONIUM MACULATUM FLOWERING TOP, EUPHRASIA STRICTA, SELENIUM, ZINC	LIQUID	OPHTHALMIC	20140501		UNAPPROVED HOMEOPATHIC		TRP Company	CALENDULA OFFICINALIS FLOWERING TOP; CARBON DISULFIDE; CONIUM MACULATUM FLOWERING TOP; EUPHRASIA STRICTA; JACOBAEA MARITIMA; SELENIUM; TRIBASIC CALCIUM PHOSPHATE; ZINC	3; 6; 6; 6; 5; 12; 13; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
17312-029_f1ed5fe0-1f49-1fcf-e053-2995a90aa9b1	17312-029	HUMAN OTC DRUG	Diarrhea Relief		Aloe, Citrullus Colocynthis, Croton Tiglium, Lycopodium Clavatum, Magnesium Sulfate Heptahydrate, Phosphoric Acid, Thuja Occidentalis	TABLET, ORALLY DISINTEGRATING	ORAL	20150415		UNAPPROVED HOMEOPATHIC		TRP Company	ALOE; CITRULLUS COLOCYNTHIS FRUIT PULP; CROTON TIGLIUM SEED; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	5; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17312-031_f1ed6c97-9988-7080-e053-2995a90a20e2	17312-031	HUMAN OTC DRUG	Constipation Relief		Aloe, Potassium Alum, Oyster Shell Calcium Carbonate, Crude Activated Charcoal, Dioscorea Villosa Tuber, Veronicastrum Virginicum Root, Strychnos Nux Vomica Seed	TABLET, ORALLY DISINTEGRATING	ORAL	20150415		UNAPPROVED HOMEOPATHIC		TRP Company	ACTIVATED CHARCOAL; ALOE; DIOSCOREA VILLOSA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM ALUM; STRYCHNOS NUX-VOMICA SEED; VERONICASTRUM VIRGINICUM ROOT	6; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17312-032_f44e2c8b-e19d-3a03-e053-2995a90a8104	17312-032	HUMAN OTC DRUG	Allergy Eyes Relief		Allium cepa, Ambrosia, Apis, Euphrasia, Histamine hydrochloricum, Sabadilla, Sulphur	LIQUID	OPHTHALMIC	20170803		UNAPPROVED HOMEOPATHIC		TRP Company	ALLIUM CEPA WHOLE; AMBROSIA ARTEMISIIFOLIA; APIS MELLIFERA; EUPHRASIA STRICTA; HISTAMINE; SCHOENOCAULON OFFICINALE SEED; SULFUR	6; 6; 6; 6; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-034_f1ed5bac-c959-0cb4-e053-2995a90af2a8	17312-034	HUMAN OTC DRUG	Irritable Bowel Syndrome Therapy		ASAFETIDA - BISMUTH SUBNITRATE - BRYONIA ALBA ROOT - ACTIVATED CHARCOAL - LYCOPODIUM CLAVATUM SPORE - SODIUM CARBONATE - STRYCHNOS NUX-VOMICA SEED - VERATRUM ALBUM ROOT -	TABLET, ORALLY DISINTEGRATING	ORAL	20160401		UNAPPROVED HOMEOPATHIC		TRP Company	ACTIVATED CHARCOAL; ASAFETIDA; BISMUTH SUBNITRATE; BRYONIA ALBA ROOT; LYCOPODIUM CLAVATUM SPORE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	6; 3; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17312-039_cbab9d0c-dd7b-3613-e053-2a95a90a9045	17312-039	HUMAN OTC DRUG	Eye Floaters Relief		CHELIDONIUM MAJUS, PHYSOSTIGMA VENENOSUM SEED, EUPHRASIA STRICTA,POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, SILICON DIOXIDE, SEPIA OFFICINALIS JUICE	LIQUID	OPHTHALMIC	20180528		UNAPPROVED HOMEOPATHIC		TRP Company	CHELIDONIUM MAJUS; EUPHRASIA STRICTA; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; POTASSIUM SULFATE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE	6; 6; 12; 12; 10; 7; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
17312-040_cbabef2c-e105-0cd7-e053-2a95a90acb74	17312-040	HUMAN OTC DRUG	Eye Twitching Relief		AMANITA MUSCARIA FRUITING BODY, COPPER, EUPHRASIA STRICTA, PILOCARPUS JABORANDII WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, PHYSOSTIGMA VENENOSUM SEED, TIN	LIQUID	OPHTHALMIC	20180601		UNAPPROVED HOMEOPATHIC		TRP Company	AMANITA MUSCARIA FRUITING BODY; COPPER; EUPHRASIA STRICTA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYSOSTIGMA VENENOSUM SEED; PILOCARPUS JABORANDII WHOLE; TIN	7; 12; 6; 11; 6; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17312-041_f1ed655a-b1fb-3eeb-e053-2995a90ac51c	17312-041	HUMAN OTC DRUG	Migraine Headache Therapy		ATROPA BELLADONNA - BRYONIA ALBA ROOT - BLACK COHOSH - ARABICA COFFEE BEAN - NITROGLYCERIN - IRIS VERSICOLOR ROOT - SODIUM CHLORIDE -	TABLET, ORALLY DISINTEGRATING	ORAL	20160401		UNAPPROVED HOMEOPATHIC		TRP Company	ARABICA COFFEE BEAN; ATROPA BELLADONNA; BLACK COHOSH; BRYONIA ALBA ROOT; IRIS VERSICOLOR ROOT; NITROGLYCERIN; SODIUM CHLORIDE	3; 6; 6; 6; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
17312-042_158627e3-70f2-40eb-e054-00144ff88e88	17312-042	HUMAN OTC DRUG	Temporary Fibromyalgia Pain and Discomfort Relief		ATROPA BELLADONNA - BRYONIA ALBA ROOT - CAUSTICUM - PHOSPHORUS - STRYCHNOS NUX-VOMICA SEED - PULSATILLA VULGARIS - TOXICODENDRON PUBESCENS LEAF -	TABLET, ORALLY DISINTEGRATING	ORAL	20150507		UNAPPROVED HOMEOPATHIC		TRP Company	ATROPA BELLADONNA; BRYONIA ALBA ROOT; CAUSTICUM; PHOSPHORUS; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17312-056_f1ed5fe0-1f4a-1fcf-e053-2995a90aa9b1	17312-056	HUMAN OTC DRUG	Apetite Relief		Avena sativa, Berberis vulgaris, Calcarea carbonica, Capsicum annuum, Carbo vegetabilis, Fucus vesiculosus, Nux vomica, Thyroidinum	LOZENGE	ORAL	20160301		UNAPPROVED HOMEOPATHIC		TRP Company	ACTIVATED CHARCOAL; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; CAPSICUM; FUCUS VESICULOSUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED	6; 9; 12; 6; 6; 6; 18; 18	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
17312-058_f44e7633-0651-3ce1-e053-2a95a90a46b6	17312-058	HUMAN OTC DRUG	RedEye Relief		APIS MELLIFERA, EUPHRASIA STRICTA, CALCIUM SULFIDE, LOESELIA MEXICANA WHOLE, PULSATILLA VULGARIS	LIQUID	OPHTHALMIC	20180601		UNAPPROVED HOMEOPATHIC		TRP Company	APIS MELLIFERA; CALCIUM SULFIDE; EUPHRASIA STRICTA; LOESELIA MEXICANA WHOLE; PULSATILLA VULGARIS	6; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-077_f1ed6c97-998c-7080-e053-2995a90a20e2	17312-077	HUMAN PRESCRIPTION DRUG	ComPare2 Black Elderberry Cold and Flu Relief		Bryonia, Gelsemium sempervirens, Sambucus nigra, Sulphur, Zincum gluconicum	TABLET, ORALLY DISINTEGRATING	ORAL	20200520		UNAPPROVED HOMEOPATHIC		TRP COMPANY	BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SULFUR; ZINC GLUCONATE	6; 6; 3; 12; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
17312-094_f551671a-c7ce-21ea-e053-2a95a90a2056	17312-094	HUMAN OTC DRUG	Pink Eye Relief PF		ACONITUM NAPELLUS - APIS MELLIFERA - SILVER NITRATE - EUPHRASIA STRICTA - SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE -	LIQUID	OPHTHALMIC	20220808		UNAPPROVED HOMEOPATHIC		TRP Company	ACONITUM NAPELLUS; APIS MELLIFERA; EUPHRASIA STRICTA; SILVER NITRATE; SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	6; 6; 6; 12; 11	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-095_f55151c9-5eb2-44f7-e053-2a95a90a8472	17312-095	HUMAN OTC DRUG	Red Eye Relief PF		APIS MELLIFERA, EUPHRASIA STRICTA, CALCIUM SULFIDE, LOESELIA MEXICANA WHOLE, PULSATILLA VULGARIS	LIQUID	OPHTHALMIC	20220809		UNAPPROVED HOMEOPATHIC		TRP Company	APIS MELLIFERA; CALCIUM SULFIDE; EUPHRASIA STRICTA; LOESELIA MEXICANA WHOLE; PULSATILLA VULGARIS	6; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-096_f551534c-7a78-efea-e053-2995a90a8ee8	17312-096	HUMAN OTC DRUG	Dryness Relief PF		SILVER, SODIUM CHLORIDE, NUTMEG, RUTA GRAVEOLENS, SULFUR, ZINC	LIQUID	OPHTHALMIC	20220809		UNAPPROVED HOMEOPATHIC		TRP Company	NUTMEG; RUTA GRAVEOLENS FLOWERING TOP; SILVER; SODIUM CHLORIDE; SULFUR; ZINC	12; 8; 10; 6; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17312-097_f5516d22-738c-40df-e053-2995a90ad4c3	17312-097	HUMAN OTC DRUG	Allergy Eyes Relief PF		Allium cepa, Ambrosia, Apis, Euphrasia, Histamine hydrochloricum, Sabadilla, Sulphur	LIQUID	OPHTHALMIC	20220808		UNAPPROVED HOMEOPATHIC		TRP Company	ALLIUM CEPA WHOLE; AMBROSIA ARTEMISIIFOLIA; APIS MELLIFERA; EUPHRASIA STRICTA; HISTAMINE; SCHOENOCAULON OFFICINALE SEED; SULFUR	6; 6; 6; 6; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-098_e5d71b98-4eb9-98b2-e053-2995a90aed4f	17312-098	HUMAN OTC DRUG	Floaters Relief		CHELIDONIUM MAJUS, PHYSOSTIGMA VENENOSUM SEED, EUPHRASIA STRICTA,POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, SILICON DIOXIDE, SEPIA OFFICINALIS JUICE	LIQUID	OPHTHALMIC	20220809		UNAPPROVED HOMEOPATHIC		TRP Company	CHELIDONIUM MAJUS; EUPHRASIA STRICTA; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; POTASSIUM SULFATE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE	6; 6; 12; 12; 10; 7; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
17312-099_e5d84ba5-16d8-946e-e053-2a95a90a99b9	17312-099	HUMAN OTC DRUG	Twitching Relief		AMANITA MUSCARIA FRUITING BODY, COPPER, EUPHRASIA STRICTA, PILOCARPUS JABORANDII WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, PHYSOSTIGMA VENENOSUM SEED, TIN	LIQUID	OPHTHALMIC	20220809		UNAPPROVED HOMEOPATHIC		TRP Company	AMANITA MUSCARIA FRUITING BODY; COPPER; EUPHRASIA STRICTA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYSOSTIGMA VENENOSUM SEED; PILOCARPUS JABORANDII WHOLE; TIN	7; 12; 6; 11; 9; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17312-165_e5c3c19d-b8e5-2486-e053-2a95a90ae611	17312-165	HUMAN OTC DRUG	Eye Lid Relief		EPINEPHRINE, SILVER. CALCIUM SULFATE ANHYDROUS, CLEMATIS RECTA, EUPHRASIA STRICTA, GRAPHITE, GOLDENSEAL, PULSATILLA PULSATILLA VULGARIS	OINTMENT	TOPICAL	20180528		UNAPPROVED HOMEOPATHIC		TRP Company	CALCIUM SULFATE ANHYDROUS; CLEMATIS RECTA FLOWERING TOP; EPINEPHRINE; EUPHRASIA STRICTA; GOLDENSEAL; GRAPHITE; PULSATILLA VULGARIS; SILVER	9; 6; 7; 6; 6; 11; 6; 11	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17312-166_e5d76dcc-9df3-359a-e053-2995a90ab7f1	17312-166	HUMAN OTC DRUG	PinkEye Relief		ACONITUM NAPELLUS ROOT, APIS MELLIFERA, SILVER NITRATE, EUPHRASIA STRICTA, SODIUM ARSENATE DIBASIC HEPTAHYDRATE, VALERIAN	OINTMENT	TOPICAL	20180528		UNAPPROVED HOMEOPATHIC		TRP Company	ACONITUM NAPELLUS ROOT; APIS MELLIFERA; EUPHRASIA STRICTA; SILVER NITRATE; SODIUM ARSENATE, DIBASIC HEPTAHYDRATE; VALERIAN	6; 6; 6; 12; 11; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-167_f1ed7654-9572-1d03-e053-2a95a90a8432	17312-167	HUMAN OTC DRUG	RedEye Relief		APIS MELLIFERA, EUPHRASIA STRICTA, CALCIUM SULFIDE, LOESELIA MEXICANA WHOLE, PULSATILLA VULGARIS	OINTMENT	TOPICAL	20180528		UNAPPROVED HOMEOPATHIC		TRP Company	APIS MELLIFERA; CALCIUM SULFIDE; EUPHRASIA STRICTA; LOESELIA MEXICANA WHOLE; PULSATILLA VULGARIS	6; 12; 6; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-168_f1ed7811-cdc7-23f4-e053-2a95a90af36b	17312-168	HUMAN OTC DRUG	Allergy Eyes Relief Nighttime Formula		Allium cepa, Ambrosia, Apis, Euphrasia, Histamine hydochloricum, Sabadilla, Sulphur, Valeriana officinalis	OINTMENT	TOPICAL	20190415		UNAPPROVED HOMEOPATHIC		TRP Company	AMBROSIA ARTEMISIIFOLIA; APIS MELLIFERA; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; SCHOENOCAULON OFFICINALE SEED; SULFUR; VALERIAN	6; 6; 6; 12; 6; 6; 12; 6	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
17312-169_0229ca32-c4b5-15cd-e063-6294a90a9dac	17312-169	HUMAN OTC DRUG	Eye Lid Relief		EPINEPHRINE, SILVER, CALCIUM SULFATE ANHYDROUS, CLEMATIS RECTA, EUPHRASIA STRICTA, GRAPHITE, GOLDENSEAL	LIQUID	OPHTHALMIC	20210111		UNAPPROVED HOMEOPATHIC		TRP Company	CALCIUM SULFATE ANHYDROUS; CLEMATIS RECTA FLOWERING TOP; EPINEPHRINE; EUPHRASIA STRICTA; GOLDENSEAL; GRAPHITE; SILVER	9; 6; 7; 6; 6; 11; 11	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17312-170_751334b8-f21c-3f94-e053-2a91aa0a9bb9	17312-170	HUMAN OTC DRUG	Chronic Fatigue Therapy		EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS	TABLET, ORALLY DISINTEGRATING	ORAL	20180820		UNAPPROVED HOMEOPATHIC		TRP Company	CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; GOLD; HELLEBORUS NIGER ROOT; PHOSPHORIC ACID; SCUTELLARIA LATERIFLORA; THUJA OCCIDENTALIS LEAFY TWIG	6; 3; 7; 3; 8; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
17312-171_f1ed7811-cdca-23f4-e053-2a95a90af36b	17312-171	HUMAN OTC DRUG	Fibromyalgia Relief		BRYONIA ALBA ROOT - CAUSTICUM - LOESELIA MEXICANA WHOLE - MAGNESIUM PHOSPHATE - PULSATILLA VULGARIS - TOXICODENDRON PUBESCENS LEAF - VALERIAN	TABLET, ORALLY DISINTEGRATING	ORAL	20200528		UNAPPROVED HOMEOPATHIC		TRP Company	BRYONIA ALBA ROOT; CAUSTICUM; LOESELIA MEXICANA WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17312-172_e4c3feb9-ee5d-44e5-e053-2995a90a2cb4	17312-172	HUMAN OTC DRUG	Eye Strain Relief		ACONITUM NAPELLUS - APIS MELLIFERA - SILVER NITRATE - EUPHRASIA STRICTA - SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE -	LIQUID	OPHTHALMIC	20180827		UNAPPROVED HOMEOPATHIC		TRP Company	CONIUM MACULATUM FLOWERING TOP; EUPHRASIA STRICTA; PHYSOSTIGMA VENENOSUM SEED; POLYGALA SENEGA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE	6; 6; 13; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
17312-173_07f29bd8-c07a-d36b-e063-6294a90ab651	17312-173	HUMAN OTC DRUG	EarAche Relief PM		Apis mellifica, Arnica montana, Calcarea phosphorica, Chamomilla,Echinacea, Hepar sulphuris calcareum, Hoitzia, Passiflora, Valeriana officinalis	LIQUID	AURICULAR (OTIC)	20190919		UNAPPROVED HOMEOPATHIC		TRP Company	APIS MELLIFERA; ARNICA MONTANA; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; LOESELIA MEXICANA WHOLE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWER; TRIBASIC CALCIUM PHOSPHATE; VALERIAN	6; 6; 8; 3; 6; 12; 5; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
17312-174_f1ed7811-cdcf-23f4-e053-2a95a90af36b	17312-174	HUMAN OTC DRUG	Eye Strain Relief PM		Conium maculatum, Euphrasia, Natrium muriaticum, Physostigma venenosum, Ruta graveolens, Senega officinalis, Valeriana officinalis	OINTMENT	TOPICAL	20190415		UNAPPROVED HOMEOPATHIC		TRP Company	CONIUM MACULATUM FLOWERING TOP; EUPHRASIA STRICTA; PHYSOSTIGMA VENENOSUM SEED; POLYGALA SENEGA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE; VALERIAN	6; 6; 13; 6; 6; 8; 6	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g			N	20241231
17312-175_f1ed7f38-0957-40a1-e053-2a95a90ac440	17312-175	HUMAN OTC DRUG	Ring Relief PM Nighttime Formula		Arnica Montana, Calcium Sulfide, Hypericum Perforatum, Lycopodium Clavatum Spore, Thiosinaminum, Mercurius Solubilis, Salicylic Acid, Silicon Dioxide, Allylthiourea	LIQUID	AURICULAR (OTIC)	20190919		UNAPPROVED HOMEOPATHIC		TRP Company	ALLYLTHIOUREA; ARNICA MONTANA; CALCIUM SULFIDE; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWER; SALICYLIC ACID; SILICON DIOXIDE; VALERIAN	6; 6; 13; 6; 12; 12; 5; 6; 13; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
17312-176_f1ed7f38-0958-40a1-e053-2a95a90ac440	17312-176	HUMAN OTC DRUG	Swimmers Ear Complete Relief		CALCIUM SULFIDE, LOESELIA MEXICANA TOP, MERCURIUS SOLUBILIS, POTASSIUM CHLORIDE, SILICON DIOXIDE, TRIBASIC CALCIUM PHOSPHATE, VALERIAN	LIQUID	AURICULAR (OTIC)	20200411		UNAPPROVED HOMEOPATHIC		TRP Company	CALCIUM SULFIDE; LOESELIA MEXICANA TOP; MERCURIUS SOLUBILIS; POTASSIUM CHLORIDE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE; VALERIAN	13; 12; 12; 12; 13; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
17312-178_f44e0c07-056e-b0f5-e053-2a95a90a96ef	17312-178	HUMAN OTC DRUG	Dryness Relief		SILVER, SODIUM CHLORIDE, NUTMEG, RUTA GRAVEOLENS, SULFUR, ZINC	LIQUID	OPHTHALMIC	20210111		UNAPPROVED HOMEOPATHIC		TRP Company	NUTMEG; RUTA GRAVEOLENS FLOWERING TOP; SILVER; SODIUM CHLORIDE; SULFUR; ZINC	12; 8; 10; 6; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
17312-179_f1ed7066-b572-1158-e053-2a95a90a8b98	17312-179	HUMAN OTC DRUG	Com-Pare2 Flu Relief		Anas barbariae	TABLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		TRP Company	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
17312-182_cbab48dd-efaa-f04e-e053-2a95a90a9c35	17312-182	HUMAN OTC DRUG	Allergy Eyes Day and Night Relief Pack	Day and Night Relief Pack	Allium cepa, Ambrosia, Apis, Euphrasia, Histamine hydrochloricum, Sabadilla, Sulphur	KIT		20200411		UNAPPROVED HOMEOPATHIC		TRP Company						N	20241231
17312-401_f0305a11-4493-e237-e053-2995a90ad12e	17312-401	HUMAN OTC DRUG	Com-Pare2 Nighttime Eye		mineral oil, petrolatum	OINTMENT	OPHTHALMIC	20221219		OTC MONOGRAPH FINAL	part349	TRP Company	MINERAL OIL; PETROLATUM	425; 573	mg/g; mg/g			N	20241231
17312-403_f03cae27-7154-2e65-e053-2a95a90a38e3	17312-403	HUMAN OTC DRUG	Com-Pare2 Nighttime Eye		mineral oil and white petrolatum	OINTMENT	OPHTHALMIC	20221219		OTC MONOGRAPH FINAL	part349	TRP Company	MINERAL OIL; PETROLATUM	30; 940	mg/g; mg/g			N	20241231
17312-404_f03c6e87-a1d3-4b96-e053-2995a90aaedc	17312-404	HUMAN OTC DRUG	Com-Pare2 Nighttime Eye		Mineral Oil, White petrolatum	OINTMENT	OPHTHALMIC	20221220		OTC MONOGRAPH FINAL	part347	TRP Company	MINERAL OIL; PETROLATUM	200; 800	mg/g; mg/g			N	20241231
17312-405_f03cc9e7-bb36-7e5c-e053-2a95a90a73c6	17312-405	HUMAN OTC DRUG	Stye Eye		Mineral Oil, White Petrolatum Ointment	OINTMENT	OPHTHALMIC	20221219		OTC MONOGRAPH FINAL	part349	TRP Company	MINERAL OIL; PETROLATUM	319; 577	mg/g; mg/g			N	20241231
17312-417_00c66fb8-85f9-cbf4-e063-6394a90a0fc2	17312-417	HUMAN OTC DRUG	Eye Lid Relief PF		SILVER, CALCIUM SULFATE ANHYDROUS, CLEMATIS RECTA, EUPHRASIA STRICTA, SUS SCROFA ADRENAL GLAND, GRAPHITE, GOLDENSEAL	LIQUID	OPHTHALMIC	20230717		UNAPPROVED HOMEOPATHIC		TRP Company	CALCIUM SULFATE ANHYDROUS; CLEMATIS RECTA FLOWERING TOP; EUPHRASIA STRICTA; GOLDENSEAL; GRAPHITE; SILVER; SUS SCROFA ADRENAL GLAND	9; 6; 6; 6; 11; 11; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
17433-9876_05556741-fe8b-489b-e063-6394a90a5afe	17433-9876	HUMAN OTC DRUG	ENEMEEZ		DOCUSATE SODIUM	LIQUID	RECTAL	20120615		OTC MONOGRAPH NOT FINAL	part334	Enemeez LLC DBA Summit Pharmaceuticals	DOCUSATE SODIUM	283	mg/5mL			N	20241231
17433-9877_0555d5ed-ff59-3e3c-e063-6294a90a9949	17433-9877	HUMAN OTC DRUG	ENEMEEZ Plus		docusate sodium and benzocaine	LIQUID	RECTAL	20120615		OTC MONOGRAPH NOT FINAL	part334	Enemeez LLC DBA Summit Pharmaceuticals	BENZOCAINE; DOCUSATE SODIUM	20; 283	mg/5mL; mg/5mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
17433-9878_ecfb3572-aff3-375f-e053-2995a90ad328	17433-9878	HUMAN OTC DRUG	DocuSol		docusate sodium	LIQUID	RECTAL	20130708	20241031	OTC MONOGRAPH NOT FINAL	part334	Enemeez LLC DBA Summit Pharmaceuticals	DOCUSATE SODIUM	283	mg/5mL			N	
17433-9883_ecfb3572-aff2-375f-e053-2995a90ad328	17433-9883	HUMAN OTC DRUG	DocuSol Plus		docusate sodium w/benzocaine	LIQUID	RECTAL	20130712	20241031	OTC MONOGRAPH NOT FINAL	part334	Enemeez LLC DBA Summit Pharmaceuticals	BENZOCAINE; DOCUSATE SODIUM	20; 283	mg/5mL; mg/5mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
17433-9884_f2288397-b059-8deb-e053-2995a90a75fc	17433-9884	HUMAN OTC DRUG	DocuSol Kids		docusate sodium	LIQUID	RECTAL	20140114	20251130	OTC MONOGRAPH NOT FINAL	part334	Enemeez LLC DBA Summit Pharmaceuticals	DOCUSATE SODIUM	100	mg/5mL			N	
17433-9886_0555c9ae-a255-e54f-e063-6394a90a93ae	17433-9886	HUMAN OTC DRUG	Enemeez Kids		docusate sodium	LIQUID	RECTAL	20230103		OTC MONOGRAPH NOT FINAL	part334	Enemeez LLC DBA Summit Pharmaceuticals	DOCUSATE SODIUM	100	mg/5mL			N	20241231
17433-9991_ca0130ce-6240-60ff-e053-2995a90aa683	17433-9991	HUMAN OTC DRUG	CVS Adult Enema		docusate sodium w/benzocaine	LIQUID	RECTAL	20140901	20240630	OTC MONOGRAPH NOT FINAL	part334	Summit Pharmaceuticals	BENZOCAINE; DOCUSATE SODIUM	20; 283	mg/4.6g; mg/4.6g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
17478-067_aea7d858-c41e-4726-8678-9c2bf08e5d56	17478-067	HUMAN PRESCRIPTION DRUG	Alfentanil Hydrochloride		Alfentanil Hydrochloride	INJECTION	INTRAVENOUS	20100201		NDA	NDA019353	Akorn	ALFENTANIL HYDROCHLORIDE	500	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17478-097_d9736f0b-8fb3-44ff-aca7-b35c20538c50	17478-097	HUMAN PRESCRIPTION DRUG	Cyclopentolate Hydrochloride		Cyclopentolate Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19970113		ANDA	ANDA040165	Akorn	CYCLOPENTOLATE HYDROCHLORIDE	20	mg/mL			N	20241231
17478-100_d9736f0b-8fb3-44ff-aca7-b35c20538c50	17478-100	HUMAN PRESCRIPTION DRUG	Cyclopentolate Hydrochloride		Cyclopentolate Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19970113		ANDA	ANDA040164	Akorn	CYCLOPENTOLATE HYDROCHLORIDE	10	mg/mL			N	20241231
17478-181_f0012197-10b0-4fd6-8794-d2ea7ba23378	17478-181	HUMAN PRESCRIPTION DRUG	Pentobarbital Sodium		Pentobarbital Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190117		ANDA	ANDA083246	Akorn	PENTOBARBITAL SODIUM	50	mg/mL		CII	N	20241231
17478-201_760cc054-c113-4864-b311-613567e4862e	17478-201	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20150115	20241130	NDA	NDA207926	Akorn	PHENYLEPHRINE HYDROCHLORIDE	25	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
17478-206_760cc054-c113-4864-b311-613567e4862e	17478-206	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20150115	20240731	NDA	NDA207926	Akorn	PHENYLEPHRINE HYDROCHLORIDE	100	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
17478-422_266160e8-f5b5-4be3-a2b4-6f5ed8e99b0b	17478-422	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170228		ANDA	ANDA204043	Akorn	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
17478-447_44814e91-37c0-4652-8c2b-96a35e23c45b	17478-447	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	SYRUP	ORAL	20190312		NDA AUTHORIZED GENERIC	NDA015230	Akorn Operating Company LLC	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
17478-523_d6264ff8-cf8b-41eb-b1ac-d28dca13d13a	17478-523	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20050506		ANDA	ANDA075494	Akorn	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
17478-524_d6264ff8-cf8b-41eb-b1ac-d28dca13d13a	17478-524	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20050506		ANDA	ANDA075494	Akorn	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
17478-538_e574a61b-1d1c-4815-97ff-635c719572bb	17478-538	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061017		ANDA	ANDA040484	Akorn	ORPHENADRINE CITRATE	30	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
17478-542_f0e6a3b7-5974-47e8-96d3-cb2d2b0cd075	17478-542	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20110315		ANDA	ANDA078076	Akorn	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
17478-544_7d38776e-0cb1-491f-8033-506267830415	17478-544	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20141002		ANDA	ANDA090450	Akorn	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
17478-768_44814e91-37c0-4652-8c2b-96a35e23c45b	17478-768	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	TABLET	ORAL	20190312		NDA AUTHORIZED GENERIC	NDA015197	Akorn Operating Company LLC	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
17478-769_44814e91-37c0-4652-8c2b-96a35e23c45b	17478-769	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	TABLET	ORAL	20190312		NDA AUTHORIZED GENERIC	NDA015197	Akorn Operating Company LLC	AMINOCAPROIC ACID	1000	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
17478-957_d99b3c31-4826-4b1e-8c8d-3b3e5e1ae9f9	17478-957	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171026		ANDA	ANDA204043	Akorn	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
17518-011_71e4a719-6548-48f4-989e-44fd0e74ea90	17518-011	HUMAN OTC DRUG	3M DuraPrep Surgical		Iodine Povacrylex and Isopropyl Alcohol	SOLUTION	TOPICAL	20060929		NDA	NDA021586	3M Company	IODINE POVACRYLEX; ISOPROPYL ALCOHOL	6.02; 636.4	mg/mL; mg/mL			N	20241231
17518-011_a1189d63-9a49-43b2-b6c5-23845a7a7b24	17518-011	HUMAN OTC DRUG	3M DuraPrep Surgical		Iodine povacrylex and Isopropyl alcohol	SOLUTION	TOPICAL	20060929		NDA	NDA021586	3M Company	IODINE POVACRYLEX; ISOPROPYL ALCOHOL	6.02; 636.4	mg/mL; mg/mL			N	20241231
17518-030_161ef8e9-f9b7-45b1-81e5-2a480f49abef	17518-030	HUMAN OTC DRUG	3M Cavilon Durable Barrier		Dimethicone	CREAM	TOPICAL	20160601		OTC MONOGRAPH FINAL	part347	3M Company	DIMETHICONE	13000	mg/L	Skin Barrier Activity [PE]		N	20241231
17518-050_9c145ba4-47fb-4743-a355-5822996d387e	17518-050	HUMAN OTC DRUG	3M Avagard D		Alcohol	LOTION	TOPICAL	19991001		OTC MONOGRAPH NOT FINAL	part333E	3M Company	ALCOHOL	530.7	mg/mL			N	20241231
17518-051_0ee66f2f-c762-434c-bdb2-cc68e9b2c3ed	17518-051	HUMAN OTC DRUG	3M Avagard		Chlorhexidine Gluconate and Alcohol	LOTION	TOPICAL	20010614		NDA	NDA021074	3M Company	ALCOHOL; CHLORHEXIDINE GLUCONATE	506.3; 8.3	mg/mL; mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
17518-055_f0ca3f6d-ec1b-47e9-8d25-c5b831a4d794	17518-055	HUMAN OTC DRUG	3M Avagard Foaming Instant Hand Antiseptic		Alcohol	LIQUID	TOPICAL	20110527		OTC MONOGRAPH NOT FINAL	part333E	3M Company	ALCOHOL	548	mg/mL			N	20241231
17518-060_59e45b7b-882e-4e34-abe5-0a0930967335	17518-060	HUMAN OTC DRUG	3M Skin and Nasal Antiseptic		Povidone-Iodine	SOLUTION	TOPICAL	20090701		OTC MONOGRAPH NOT FINAL	part333E	3M Company	POVIDONE-IODINE	5	mg/mL			N	20241231
17518-082_5a8acb2a-9141-487d-a307-a9e119657b12	17518-082	HUMAN OTC DRUG	3M SoluPrep S		Chlorhexidine Gluconate and Isopropyl Alcohol	SOLUTION	TOPICAL	20230123		NDA	NDA208288	3M Company	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
17518-083_5a8acb2a-9141-487d-a307-a9e119657b12	17518-083	HUMAN OTC DRUG	3M SoluPrep S		Chlorhexidine Gluconate and Isopropyl Alcohol	SOLUTION	TOPICAL	20230123		NDA	NDA208288	3M Company	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
17575-001_070fbf6b-abb6-06e2-e063-6394a90a5e56	17575-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205767	AGL Inhalation Therapy Co.	OXYGEN	990	mL/L			N	20241231
17575-005_070fbe43-934d-0705-e063-6394a90a0816	17575-005	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205819	AGL Inhalation Therapy Co.	HELIUM	990	mL/L			N	20241231
17575-006_070fcc01-bfbb-9e67-e063-6294a90a3a70	17575-006	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205766	AGL Inhalation Therapy Co.	NITROGEN	990	mL/L			N	20241231
17575-011_070fd09d-1d6f-b7fe-e063-6294a90a4409	17575-011	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA206009	AGL Welding Supply Co., Inc.	NITROUS OXIDE	990	mL/L			N	20241231
17575-020_070fbf6b-abb5-06e2-e063-6394a90a5e56	17575-020	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Oxygen Mixture 5/95		Carbon Dioxide Oxygen Mixture 5/95	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205767	AGL Inhalation Therapy Co.	OXYGEN	950	mL/L			N	20241231
17575-038_070fd77f-416a-1b04-e063-6394a90a489c	17575-038	HUMAN PRESCRIPTION DRUG	Oxygen Helium Mixture 30/70		Oxygen Helium Mixture 30/70	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205767	AGL Inhalation Therapy Co.	OXYGEN	300	mL/L			N	20241231
17575-104_070fd2ef-d5c6-1bbd-e063-6394a90a8802	17575-104	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205764	AGL Inhalation Therapy Co.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
17575-192_070fcc01-bfbc-9e67-e063-6294a90a3a70	17575-192	HUMAN PRESCRIPTION DRUG	Oxygen Helium Mixture 20/80		Oxygen Helium Mixture 20/80	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205767	AGL Inhalation Therapy Co.	OXYGEN	200	mL/L			N	20241231
17575-300_070fbf6b-abb4-06e2-e063-6394a90a5e56	17575-300	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205767	AGL Welding Supply Co., Inc.	OXYGEN	210	mL/L			N	20241231
17714-009_999a5403-4945-d811-e053-2995a90a42dc	17714-009	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19880415		OTC MONOGRAPH FINAL	part343	Advance Pharmaceutical Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
17714-010_5cc8b5f1-4ae4-471b-e053-2991aa0a84c1	17714-010	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20020109		OTC MONOGRAPH FINAL	part343	Advance Pharmaceutical Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
17714-011_5cc9070d-57cd-a48a-e053-2a91aa0a449e	17714-011	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19900508		OTC MONOGRAPH FINAL	part343	Advance Pharmaceutical Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
17714-012_60f41580-e068-faad-e053-2a91aa0a9076	17714-012	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	19890205		OTC MONOGRAPH NOT FINAL	part343	Advance Pharmaceutical Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
17714-013_60f41580-e099-faad-e053-2a91aa0a9076	17714-013	HUMAN OTC DRUG	APAP		Acetaminophen	TABLET	ORAL	19890205		OTC MONOGRAPH NOT FINAL	part343	Advance Pharmaceutical Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
17714-014_60f41580-e0a5-faad-e053-2a91aa0a9076	17714-014	HUMAN OTC DRUG	APAP		Acetaminophen	TABLET	ORAL	19900114		OTC MONOGRAPH NOT FINAL	part343	Advance Pharmaceutical Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
17714-016_5cc9196c-68c7-c9c1-e053-2a91aa0acd8b	17714-016	HUMAN OTC DRUG	Anti Allergy		Chlorpheniramine Maleate	TABLET	ORAL	20020109		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
17714-019_7d3b0256-4a78-5490-e053-2a91aa0a68f0	17714-019	HUMAN OTC DRUG	Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	19991104		OTC MONOGRAPH FINAL	part332	Advance Pharmaceutical Inc.	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
17714-020_60f4322f-5ca5-096a-e053-2a91aa0a64eb	17714-020	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	19890912		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
17714-021_60f41580-e0b1-faad-e053-2a91aa0a9076	17714-021	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	19891005		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
17714-023_5cc9196c-68d7-c9c1-e053-2a91aa0acd8b	17714-023	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	TABLET	ORAL	20120901		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
17714-025_60f41580-e08d-faad-e053-2a91aa0a9076	17714-025	HUMAN OTC DRUG	ANTACID		Calcium Carbonate	TABLET	ORAL	19900406		OTC MONOGRAPH FINAL	part331	Advance Pharmaceutical Inc.	CALCIUM CARBONATE	648	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
17714-040_7d3cccab-252a-cd80-e053-2a91aa0acbcc	17714-040	HUMAN OTC DRUG	Simethicone		Simethicone	TABLET, CHEWABLE	ORAL	20121101		OTC MONOGRAPH FINAL	part332	Advance Pharmaceutical Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
17714-041_999a325a-9e12-4c31-e053-2a95a90a4f1e	17714-041	HUMAN OTC DRUG	ANTACID		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20071130		OTC MONOGRAPH FINAL	part331	Advance Pharmaceutical Inc.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
17714-043_f3d6ea88-840d-d5dd-e053-2995a90a0744	17714-043	HUMAN OTC DRUG	ANTACID		Calcium Carbonate	TABLET, CHEWABLE	ORAL	19960126		OTC MONOGRAPH FINAL	part331	Advance Pharmaceutical Inc.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
17714-045_60f4322f-5cb1-096a-e053-2a91aa0a64eb	17714-045	HUMAN OTC DRUG	Pepto Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20020109		OTC MONOGRAPH FINAL	part335	Advance Pharmaceutical Inc.	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
17714-076_d087743f-b830-2a5c-e053-2995a90abb20	17714-076	HUMAN OTC DRUG	Simethicone	Certified Plus	Simethicone	GEL	ORAL	20211111		OTC MONOGRAPH FINAL	part332	Advance Pharmaceutical Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
17714-115_5cc96295-eaf6-1c2a-e053-2a91aa0a18b3	17714-115	HUMAN OTC DRUG	Meclizine HCL		Meclizine HCl 25mg Chewable Tablets	TABLET, CHEWABLE	ORAL	20130701		OTC MONOGRAPH FINAL	part336	Advance Pharmaceutical Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
17714-117_5cc9755e-6d41-fa9f-e053-2991aa0afbef	17714-117	HUMAN OTC DRUG	Meclizine HCL 12.5 mg		Meclizine HCL 12.5 mg	TABLET	ORAL	20130701		OTC MONOGRAPH FINAL	part336	Advance Pharmaceutical Inc.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
17714-121_5cc8bd8c-1d8c-180b-e053-2a91aa0ac490	17714-121	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19990612		OTC MONOGRAPH FINAL	part343	Advance Pharmaceutical Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
17714-133_60f41580-e074-faad-e053-2a91aa0a9076	17714-133	HUMAN OTC DRUG	ACETAMINOPHEN PM		ACETAMINOPHEN PM	TABLET	ORAL	20020109		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
17714-135_60f4322f-5c99-096a-e053-2a91aa0a64eb	17714-135	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	TABLET	ORAL	20060926		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
17714-150_5cc973b8-e550-2f6c-e053-2a91aa0a9ab8	17714-150	HUMAN OTC DRUG	Mucus Relief Cough and Congestion DM		Guaifenesin and Dextromethorphan HBr	TABLET	ORAL	20170801		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
17714-152_5cc992c7-a1b3-46be-e053-2991aa0a1f8f	17714-152	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 400 mg	TABLET	ORAL	20161101		OTC MONOGRAPH FINAL	part341	Advance Pharmaceutical Inc.	GUAIFENESIN	400	mg/1			N	20241231
17772-101_0cf4e6db-c019-5157-e063-6294a90acf43	17772-101	HUMAN PRESCRIPTION DRUG	Trokendi XR		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20130816		NDA	NDA201635	Supernus Pharmaceuticals	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17772-102_0cf4e6db-c019-5157-e063-6294a90acf43	17772-102	HUMAN PRESCRIPTION DRUG	Trokendi XR		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20130816		NDA	NDA201635	Supernus Pharmaceuticals	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17772-103_0cf4e6db-c019-5157-e063-6294a90acf43	17772-103	HUMAN PRESCRIPTION DRUG	Trokendi XR		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20130816		NDA	NDA201635	Supernus Pharmaceuticals	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17772-104_0cf4e6db-c019-5157-e063-6294a90acf43	17772-104	HUMAN PRESCRIPTION DRUG	Trokendi XR		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20130816		NDA	NDA201635	Supernus Pharmaceuticals	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17772-121_0cf4cb65-adb7-e3ca-e063-6294a90a3e30	17772-121	HUMAN PRESCRIPTION DRUG	OXTELLAR XR		OXCARBAZEPINE	TABLET	ORAL	20130117		NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17772-122_0cf4cb65-adb7-e3ca-e063-6294a90a3e30	17772-122	HUMAN PRESCRIPTION DRUG	OXTELLAR XR		OXCARBAZEPINE	TABLET	ORAL	20130117		NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17772-123_0cf4cb65-adb7-e3ca-e063-6294a90a3e30	17772-123	HUMAN PRESCRIPTION DRUG	OXTELLAR XR		OXCARBAZEPINE	TABLET	ORAL	20130117		NDA	NDA202810	Supernus Pharmaceuticals, Inc.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17772-131_0cf4dfd5-09e2-4829-e063-6294a90afbfc	17772-131	HUMAN PRESCRIPTION DRUG	QELBREE		viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402		NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
17772-132_0cf4dfd5-09e2-4829-e063-6294a90afbfc	17772-132	HUMAN PRESCRIPTION DRUG	QELBREE		viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402		NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	150	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
17772-133_0cf4dfd5-09e2-4829-e063-6294a90afbfc	17772-133	HUMAN PRESCRIPTION DRUG	QELBREE		viloxazine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210402		NDA	NDA211964	Supernus Pharmaceuticals, Inc	VILOXAZINE HYDROCHLORIDE	200	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
17856-0023_180dd619-91a8-480e-92ec-87154f7f5c8e	17856-0023	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone hydrochloride	SOLUTION	ORAL	20180601		ANDA	ANDA209897	ALTANTIC BIOLOGICALS CORP	OXYCODONE HYDROCHLORIDE	20	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17856-0024_ddb0ee08-8906-4dba-b8ec-192357c06790	17856-0024	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20140414		ANDA	ANDA202333	ATLANTIC BIOLOGICALS CORP.	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
17856-0059_4924310d-4131-45e1-9774-c7c9cff21e8b	17856-0059	HUMAN PRESCRIPTION DRUG	promethazine hydrochloride		promethazine hydrochloride	SYRUP	ORAL	20120608		ANDA	ANDA091675	ATLANTIC BIOLOGICALS CORP	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
17856-0087_006b0771-3a21-4603-bf6b-dcd19abb29ca	17856-0087	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	extended-release	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150306		ANDA	ANDA091632	ATLANTIC BIOLOGICALS CORP.	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE	8; 10	mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
17856-0114_6d74d3ae-a390-4640-b4d4-c20141ae939e	17856-0114	HUMAN PRESCRIPTION DRUG	SSKI		Potassium Iodide	SOLUTION	ORAL	20171113		UNAPPROVED DRUG OTHER		ATLANTIC BIOLOGICALS CORP.	POTASSIUM IODIDE	1	g/mL			N	20241231
17856-0138_96ad6e18-7d64-40ba-a2b5-3dd00283b3e6	17856-0138	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		Lidocaine hydrochloride	SOLUTION	ORAL; TOPICAL	20230328		ANDA	ANDA216780	ATLANTIC BIOLOGICALS CORP.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
17856-0155_1902518a-023e-45aa-8a10-d64fdbf94827	17856-0155	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution		Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution	SOLUTION	ORAL	20201005		ANDA	ANDA040649	ATLANTIC BIOLOGICALS CORP.	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
17856-0166_bbed8399-0702-43e3-a991-6ff6024a1cdd	17856-0166	HUMAN OTC DRUG	ACETAMINOPHEN		Acetaminophen	ELIXIR	ORAL	20210518		OTC MONOGRAPH NOT FINAL	part343	ATLANTIC BIOLOGICALS CORP	ACETAMINOPHEN	160	mg/5mL			N	20241231
17856-0306_e7155d7d-45e1-4b47-82c9-5036eb8d2394	17856-0306	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20220315		ANDA	ANDA211884	ATLANTIC BIOLOGICALS CORP.	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
17856-0312_010d26a6-e4ad-4d97-b9d7-17cfd394b11d	17856-0312	HUMAN OTC DRUG	GAVILAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA091077	ATLANTIC BIOLOGICALS CORP.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
17856-0517_1b1dd08e-3de7-457b-9da8-1a3b49d0165e	17856-0517	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20080317		NDA	NDA022195	ATLANTIC BIOLOGICALS CORP.	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17856-0518_661f0649-d87e-46cc-9ad0-ffc478a95d58	17856-0518	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20080317		NDA	NDA022195	ATLANTIC BIOLOGICALS CORP.	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17856-0678_32d10b73-9b2c-4765-89be-e4b3f2f8a44b	17856-0678	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	LIQUID	ORAL	20200901		UNAPPROVED DRUG OTHER		ATLANTIC BIOLOGICALS CORP	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
17856-0698_edd37840-bbe3-4f99-9630-0ee793fb5c29	17856-0698	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	SOLUTION	ORAL	20180531		ANDA	ANDA202024	ATLANTIC BIOLOGICALS CORP.	GABAPENTIN	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
17856-0759_8cae7975-b84d-42b2-abe0-242804fc68d0	17856-0759	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20050425		ANDA	ANDA076913	ATLANTIC BIOLOGICALS CORP.	PREDNISOLONE SODIUM PHOSPHATE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
17856-0792_b291ea1d-42fe-4c43-a13a-97f6e53724d9	17856-0792	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	SOLUTION	ORAL	19950113		ANDA	ANDA074060	ATLANTIC BIOLOGICALS CORP.	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
17856-0799_eb3941c1-96e7-4bf4-9baf-d18398829439	17856-0799	HUMAN OTC DRUG	MYLICON		Simethicone	SUSPENSION	ORAL	20140501		OTC MONOGRAPH FINAL	part332	ATLANTIC BIOLOGICALS CORP.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
17856-0948_0a5d4bfd-2a7e-4635-b44b-82af91f1835b	17856-0948	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20230327		ANDA	ANDA210766	ATLANTIC BIOLOGICALS CORP.	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
17856-1008_e3c49b13-771b-4cfa-87f4-7d5bbe8ad8e7	17856-1008	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20120501		ANDA	ANDA064142	ATLANTIC BIOLOGICALS CORP.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
17856-1304_2baeb5d8-90b0-47eb-be2b-37a407d9460b	17856-1304	HUMAN OTC DRUG	Docusate Sodium Liquid		Docusate Sodium	LIQUID	ORAL	20201001		OTC MONOGRAPH NOT FINAL	part334	ATLANTIC BIOLOGICALS CORP.	DOCUSATE SODIUM	50	mg/5mL			N	20241231
17856-1458_00b41fd1-2c73-4b62-81ff-df8bc860d09a	17856-1458	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20180724		ANDA	ANDA210041	ATLANTIC BIOLOGICALS CORP.	POTASSIUM CHLORIDE	3	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
17856-1928_ccd747a3-68a9-4b4b-aa8c-a86ff00cb925	17856-1928	HUMAN PRESCRIPTION DRUG	Methadone Hydrocloride	dye-free, sugar-free, unflavored	methadone hydrochloride	CONCENTRATE	ORAL	20201102		ANDA	ANDA212093	ATLANTIC BIOLOGICALS CORP.	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17856-1929_910d1eee-540b-4024-a68c-ce7526bd4b65	17856-1929	HUMAN PRESCRIPTION DRUG	Methadone Hydrocloride	dye-free, sugar-free, unflavored	methadone hydrochloride	CONCENTRATE	ORAL	20201102		ANDA	ANDA212093	ATLANTIC BIOLOGICALS CORP.	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17856-3555_2b77fdd3-7cf7-45c7-a3bd-5eb0cbac6f42	17856-3555	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	19810522		ANDA	ANDA087393	ATLANTIC BIOLOGICALS CORP.	METHADONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17856-3556_2b77fdd3-7cf7-45c7-a3bd-5eb0cbac6f42	17856-3556	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	19820830		ANDA	ANDA087997	ATLANTIC BIOLOGICALS CORP.	METHADONE HYDROCHLORIDE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
17856-5309_36a1c0f4-b873-4928-a363-d373f13be4ba	17856-5309	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	19990207		ANDA	ANDA074937	ATLANTIC BIOLOGICALS CORP.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
18027-050_32838f19-46c8-4ed1-e054-00144ff8d46c	18027-050	HUMAN OTC DRUG	Pharmacys Prescription		Isopropyl Alcohol	LIQUID	TOPICAL	20160510		OTC MONOGRAPH FINAL	part344	American Consumer Products, LLC	ISOPROPYL ALCOHOL	1	mL/1			N	20241231
18087-0001_0d85b6fd-6741-8241-e063-6294a90a247b	18087-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20180901		UNAPPROVED MEDICAL GAS		Anaconda Oxygen & Respiratory Specialists Inc dba Anaconda Oxygen Service	OXYGEN	99	L/100L			N	20241231
18124-002_d95ab755-1c2e-4124-8ed7-075936257c25	18124-002	HUMAN PRESCRIPTION DRUG	Lactulose		Lactulose	SOLUTION	ORAL; RECTAL	20121210		ANDA	ANDA090502	Fresenius Kabi Austria GmbH	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
18124-011_0ef540ec-3e55-44d0-b8b9-e70407a54748	18124-011	HUMAN PRESCRIPTION DRUG	Cleviprex		clevidipine	EMULSION	INTRAVENOUS	20080915		NDA	NDA022156	Fresenius Kabi Austria GmbH	CLEVIDIPINE	.5	mg/mL	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
18482-002_07eecd86-52b6-514c-e063-6294a90ab79b	18482-002	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20050701		NDA	NDA206009	Inland Welding Supply dba A-L Compressed Gases	NITROUS OXIDE	995	mL/L			N	20241231
18482-004_07eecd86-52b5-514c-e063-6294a90ab79b	18482-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20050701		NDA	NDA206023	Inland Welding Supply dba A-L Compressed Gases	OXYGEN	210	mL/L			N	20241231
18482-018_07eecc9b-267d-c6c3-e063-6394a90a2e89	18482-018	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20050701		NDA	NDA206023	Inland Welding Supply dba A-L Compressed Gases	OXYGEN	995	mL/L			N	20241231
18482-020_07eecc9b-267c-c6c3-e063-6394a90a2e89	18482-020	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20050701		NDA	NDA206024	Inland Welding Supply dba A-L Compressed Gases	NITROGEN	991	mL/L			N	20241231
18657-117_a5769c00-04d8-495a-b132-bd43fca7a7b0	18657-117	HUMAN PRESCRIPTION DRUG	HYLENEX Recombinant		Hyaluronidase (Human Recombinant)	INJECTION, SOLUTION	SUBCUTANEOUS	20051202		BLA	BLA021859	Halozyme Therapeutics, Inc.	HYALURONIDASE (HUMAN RECOMBINANT)	150	[USP'U]/mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
18949-051_08c00977-1da5-6d24-e063-6294a90a9cfe	18949-051	HUMAN OTC DRUG	Renown Antibacterial Hand		CHLOROXYLENOL	LIQUID	TOPICAL	20230928		OTC MONOGRAPH DRUG	505G(a)(3)	HD Supply	CHLOROXYLENOL	3000	mg/L			N	20241231
18949-710_86d2b39f-b796-6630-e053-2991aa0a8f90	18949-710	HUMAN OTC DRUG	Maintenance Warehouse		Benzalkonium Chloride	SOAP	TOPICAL	20190415		OTC MONOGRAPH NOT FINAL	part333E	HD Supply Facilities Maintenance, Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
19188-123_0a976e5e-5405-3b27-e063-6294a90a3819	19188-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070917		UNAPPROVED MEDICAL GAS		All Saints Healthcare	OXYGEN	99	L/100L			N	20241231
19218-0001_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0001	HUMAN PRESCRIPTION DRUG	Oxygen Size B		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	196	L/196L			N	20241231
19218-0002_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0002	HUMAN PRESCRIPTION DRUG	Oxygen Size C		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	240	L/240L			N	20241231
19218-0003_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0003	HUMAN PRESCRIPTION DRUG	Oxygen Size D		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	396	L/396L			N	20241231
19218-0004_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0004	HUMAN PRESCRIPTION DRUG	Oxygen Size E		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	659	L/659L			N	20241231
19218-0005_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0005	HUMAN PRESCRIPTION DRUG	Oxygen Size M		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	3453	L/3453L			N	20241231
19218-0006_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0006	HUMAN PRESCRIPTION DRUG	Oxygen Size F		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	1567	L/1567L			N	20241231
19218-0007_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0007	HUMAN PRESCRIPTION DRUG	Oxygen Size H		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	6931	L/6931L			N	20241231
19218-0008_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0008	HUMAN PRESCRIPTION DRUG	Oxygen Size T		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	8688	L/8688L			N	20241231
19218-0009_0bb1eed8-269b-a81f-e063-6394a90a8a33	19218-0009	HUMAN PRESCRIPTION DRUG	Oxygen Size 400		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		UNAPPROVED MEDICAL GAS		Anesthesia Service, Inc.	OXYGEN	11321	L/11321L			N	20241231
19515-814_4a58458f-154a-459c-b757-df5be7caf1ff	19515-814	VACCINE	Flulaval Quadrivalent	2023/2024	influenza virus vaccine	SUSPENSION	INTRAMUSCULAR	20230630	20240630	BLA	BLA125163	ID Biomedical Corporation of Quebec	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
19979-000_eb680b5a-720a-4400-e053-2995a90a7842	19979-000	HUMAN PRESCRIPTION DRUG	Medical Oxygen Compressed		OXYGEN	GAS	RESPIRATORY (INHALATION)	20060201		NDA	NDA206023	Dickinson Home Medical Equipment	OXYGEN	1	L/L			N	20241231
20146-4000_9d8946cd-3361-4f00-b90f-d68e8ca57da1	20146-4000	HUMAN OTC DRUG	Breaze	Nasal Moisturizing	Oxymetazoline hydrochloride	SPRAY	NASAL	20150101		OTC MONOGRAPH FINAL	part341	Samson Pharmaceuticals, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
20146-4006_0df89447-0374-443c-b1ec-ab0193380a4b	20146-4006	HUMAN OTC DRUG	Breaze Nasal	Sinus Colds and Allergies	Oxymetazoline hydrochloride	SPRAY	NASAL	20150101		OTC MONOGRAPH FINAL	part341	Samson Pharmaceuticals, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
20175-072_0a97a59f-9999-4049-e063-6294a90abe2d	20175-072	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		O2 for U, Inc.	OXYGEN	99	L/100L			N	20241231
20276-044_feb8d51e-499c-c02d-e053-6294a90a595a	20276-044	HUMAN OTC DRUG	Lucky	Daily Moisturizing	dimethicone	LOTION	TOPICAL	20130131		OTC MONOGRAPH FINAL	M016	Delta Brands Inc	DIMETHICONE	1	g/100mL	Skin Barrier Activity [PE]		N	20241231
20276-047_feb923fe-6d33-e75a-e053-6294a90a24c7	20276-047	HUMAN OTC DRUG	Lucky	Dry Hair	pyrithione zinc	SHAMPOO	TOPICAL	20120630		OTC MONOGRAPH FINAL	M032	Delta Brands Inc	PYRITHIONE ZINC	.3	g/100mL			N	20241231
20276-049_b674745a-ef24-56ed-e053-2995a90ad0f2	20276-049	HUMAN OTC DRUG	Lucky	antibacterial deodorant	Benzalkonium Chloride	SOAP	TOPICAL	20161215		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
20276-100_eada2717-5cca-0c10-e053-2a95a90a0a2c	20276-100	HUMAN OTC DRUG	Chestrub		Camphor Menthol Eucalyptus Oil	OINTMENT	TOPICAL	20091115		OTC MONOGRAPH FINAL	part341	Delta Brands Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
20276-108_e08f6085-d271-518a-e053-2995a90a0495	20276-108	HUMAN OTC DRUG	LUCKY SUPER SOFT ANTIFUNGAL	For Athletes Foot	Tolnaftate	POWDER	TOPICAL	20180219		OTC MONOGRAPH FINAL	part333C	Delta Brands, Inc	TOLNAFTATE	1	g/100g			N	20241231
20276-109_f6021566-abc4-b2a4-e053-2a95a90a4099	20276-109	HUMAN OTC DRUG	Vaporizing Chestrub		Camphor Eucalyptus Oil Menthol	OINTMENT	TOPICAL	20221118		OTC MONOGRAPH FINAL	part341	Delta Brands Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
20276-120_eada3ada-9f43-702e-e053-2995a90ac056	20276-120	HUMAN OTC DRUG	LUCKY SUPER SOFT	Vitamin E	White Petrolatum	CREAM	TOPICAL	20150301		OTC MONOGRAPH FINAL	part347	Delta Brands Inc	PETROLATUM	30	g/100g			N	20241231
20276-121_eada5d23-b6c1-6a96-e053-2a95a90a959f	20276-121	HUMAN OTC DRUG	LUCKY SUPER SOFT	Cocoa Butter	White Petrolatum	CREAM	TOPICAL	20150301		OTC MONOGRAPH FINAL	part347	Delta Brands Inc	PETROLATUM	30	g/100g			N	20241231
20276-138_feba81e6-55bd-b43d-e053-6294a90abf41	20276-138	HUMAN OTC DRUG	LUCKY SUPER SOFT	FOAMING	Benzalkonium chloride	SOAP	TOPICAL	20210129		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
20276-144_feba4ab4-4555-de12-e053-6394a90a4bc6	20276-144	HUMAN OTC DRUG	LUCKY	antibacterial	Benzalkonium chloride	LIQUID	TOPICAL	20170301		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
20276-145_feba204b-205c-3120-e053-6394a90a82e7	20276-145	HUMAN OTC DRUG	LUCKY	antibacterial	Benzalkonium chloride	LIQUID	TOPICAL	20170301		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
20276-146_feba81e6-55c0-b43d-e053-6294a90abf41	20276-146	HUMAN OTC DRUG	LUCKY	antibacterial	Benzalkonium chloride	LIQUID	TOPICAL	20170301		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
20276-147_feba204b-205d-3120-e053-6394a90a82e7	20276-147	HUMAN OTC DRUG	LUCKY	antibacterial	Benzalkonium chloride	LIQUID	TOPICAL	20160510		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
20276-148_feba4ab4-4556-de12-e053-6394a90a4bc6	20276-148	HUMAN OTC DRUG	LUCKY SUPER SOFT	HAND SANITIZER	Benzalkonium chloride	LIQUID	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
20276-150_ff45bbfc-0591-04ff-e053-6394a90a35d6	20276-150	HUMAN OTC DRUG	Lucky Instant Hand Sanitizer with Vitamin E and Moisturizers		Ethyl Alcohol	LIQUID	TOPICAL	20100301		OTC MONOGRAPH NOT FINAL	part333E	Delta Brands Inc	ALCOHOL	62	mL/100mL			N	20241231
20276-151_febab581-1cb2-c694-e053-6394a90a7593	20276-151	HUMAN OTC DRUG	LUCKY	ANTIBACTERIAL HAND	Chloroxylenol	LIQUID	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands Inc	CHLOROXYLENOL	.3	g/100mL			N	20241231
20276-210_811484d4-628f-7220-e053-2a91aa0a488e	20276-210	HUMAN OTC DRUG	Lucky Blue Ice		Menthol Camphor	GEL	TOPICAL	20091115		OTC MONOGRAPH NOT FINAL	part348	Delta Brands Inc	CAMPHOR (SYNTHETIC); MENTHOL	.5; 1	g/100g; g/100g			N	20241231
20276-300_eff53d24-636a-6fa7-e053-2995a90a23eb	20276-300	HUMAN OTC DRUG	LUCKY SUPER SOFT Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part356	Delta Brands Inc	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
20276-330_b116ee5c-ac2b-704f-e053-2a95a90afed2	20276-330	HUMAN OTC DRUG	Lucky Epsom Salt		magnesium sulfate	GRANULE	ORAL	20160905		OTC MONOGRAPH NOT FINAL	part334	Delta Brands Inc	MAGNESIUM SULFATE, UNSPECIFIED FORM	100	g/100g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
20276-431_ffe5ce50-5675-5e85-e053-6394a90a9f0d	20276-431	HUMAN OTC DRUG	Wet Wipes		Benzalkonium chloride	SWAB	TOPICAL	20070123		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.1	g/1			N	20241231
20276-434_ffe5d0bd-4bba-4054-e053-6294a90a2809	20276-434	HUMAN OTC DRUG	Lucky SuperSoft	Wet Wipes	Benzalkonium chloride	CLOTH	TOPICAL	20150115		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.1	g/1			N	20241231
20276-435_01424913-54eb-2dbd-e063-6394a90ae0f7	20276-435	HUMAN OTC DRUG	Wet Wipes		Benzalkonium chloride	CLOTH	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/1			N	20241231
20276-436_eff54541-58b6-1a9c-e053-2995a90a9ac7	20276-436	HUMAN OTC DRUG	Personal CARE Wet Wipes	Citrus	Benzalkonium chloride	CLOTH	TOPICAL	20210107		OTC MONOGRAPH NOT FINAL	part333A	Delta Brands, Inc	BENZALKONIUM CHLORIDE	.13	g/1			N	20241231
20276-505_d78a5cbc-d9fd-1079-e053-2a95a90a1e6a	20276-505	HUMAN OTC DRUG	Petroleum Jelly		White Petrolatum	OINTMENT	TOPICAL	20110530		OTC MONOGRAPH FINAL	part347	Delta Brands Inc.	PETROLATUM	1	g/g			N	20241231
20276-551_b673291e-14bb-9b86-e053-2a95a90a8339	20276-551	HUMAN OTC DRUG	Lucky Super Soft	Anti Cavity with Free Toothbrush	Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20140227		OTC MONOGRAPH FINAL	part355	Delta Brands Inc	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
20276-552_b673291e-14bd-9b86-e053-2a95a90a8339	20276-552	HUMAN OTC DRUG	Lucky Super Soft	Whitening Anti Cavity with Free Toothbrush	Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20140227		OTC MONOGRAPH FINAL	part355	Delta Brands Inc	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
20276-700_86bbb477-bc71-38cf-e053-2991aa0af4ae	20276-700	HUMAN OTC DRUG	CLARISSE Antiperspirant Deodorant	Daily Protection	Aluminum chlorohydrate	STICK	TOPICAL	20161017		OTC MONOGRAPH FINAL	part350	Delta Brands Inc	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
20276-815_d78a5aeb-da63-6da8-e053-2995a90a9cd9	20276-815	HUMAN OTC DRUG	Petroleum Jelly	Scented	White Petrolatum	OINTMENT	TOPICAL	20130413		OTC MONOGRAPH FINAL	part347	Delta Brands Inc.	PETROLATUM	99.9	g/100g			N	20241231
20276-980_dfff9f17-9b4a-dd76-e053-2995a90a7b40	20276-980	HUMAN OTC DRUG	Lucky Supersoft Medicated Body	Triple Action	Menthol Zinc Oxide	POWDER	TOPICAL	20171211		OTC MONOGRAPH NOT FINAL	part348	Delta Brands Inc	MENTHOL; ZINC OXIDE	.15; 1	g/100g; g/100g			N	20241231
20394-752_08b5deae-205d-a0d8-e063-6394a90ab32e	20394-752	HUMAN OTC DRUG	Roll On Anti Perspirant	Alcohol Free	ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20081201		OTC MONOGRAPH DRUG	M019	Care Line Industries	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
20479-0682_0d1bc7b1-6bbf-cd20-e063-6294a90a8a9c	20479-0682	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100830		UNAPPROVED MEDICAL GAS		Hometown Medical LLC	OXYGEN	99	L/100L			N	20241231
20703-001_0a4a28e0-0ba4-cc11-e063-6394a90a1cfc	20703-001	HUMAN PRESCRIPTION DRUG	nitrogen		nitrogen	GAS	RESPIRATORY (INHALATION)	19840101		NDA	NDA205850	General Welding Supply Corp.	NITROGEN	999	mL/L			N	20241231
20703-002_0a4a3484-d5c8-d476-e063-6394a90a1736	20703-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19840101		NDA	NDA205849	General Welding Supply Corp.	OXYGEN	995	mL/L			N	20241231
20703-003_0a4a345a-e50b-d3de-e063-6394a90a2a98	20703-003	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19840101		NDA	NDA209989	General Welding Supply Corp.	NITROUS OXIDE	990	mL/L			N	20241231
20942-672_0787ff77-b715-1f49-e063-6394a90a6570	20942-672	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20080801		UNAPPROVED MEDICAL GAS		Peninsula Home Health Care	OXYGEN	99	L/100L			N	20241231
21130-006_067e9eec-ba56-dc37-e063-6294a90a2df2	21130-006	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230622		ANDA	ANDA091239	BETTER LIVING BRANDS, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-011_117900ff-eaa4-4a70-aa2a-132d8c1f6abf	21130-011	HUMAN OTC DRUG	signature care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20150901		ANDA	ANDA074937	Safeway	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-012_2deea3df-643c-4740-9e6b-79cb51319c8a	21130-012	HUMAN OTC DRUG	signature care 12 hour cough relief		dextromethorphan polistirex	SUSPENSION	ORAL	20150908		ANDA	ANDA091135	Safeway	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-014_b1094a74-b98b-4721-8550-75961d244090	21130-014	HUMAN OTC DRUG	EZ Nite Sleep		Diphenhydramine HCl	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-015_e0f13856-ca1e-4df4-8194-9163fa98c390	21130-015	HUMAN OTC DRUG	signature care infants gas relief		Simethicone	EMULSION	ORAL	20150904		OTC MONOGRAPH FINAL	part332	Safeway	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
21130-017_97a6c44b-59ba-4f08-a6e8-6eb3925709aa	21130-017	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20150728		OTC MONOGRAPH NOT FINAL	part333A	Better Living Brands LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
21130-018_76bba6b1-5b0c-4ca0-cbc2-fff549daba60	21130-018	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20181106		ANDA	ANDA207740	Albertsons Companies	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-020_c0a829fa-9bb6-4e10-9925-373652fb5711	21130-020	HUMAN OTC DRUG	Signature Care severe cold cough and flu	Nighttime	Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20151027		OTC MONOGRAPH FINAL	part341	Safeway	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-021_23c4bea8-88f9-41aa-95d6-ea7a616b0cdb	21130-021	HUMAN OTC DRUG	Fiber Caplets		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20201002		OTC MONOGRAPH DRUG	M007	SAFEWAY	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
21130-022_0ab14799-0b31-f11a-348f-74a0c8f08d22	21130-022	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20211101		ANDA	ANDA077367	Albertsons Companies	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-023_0ab14799-0b31-f11a-348f-74a0c8f08d22	21130-023	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20211101		ANDA	ANDA077367	Albertsons Companies	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-025_f449ab4c-fd09-40ab-b1c6-6d1aaf37b455	21130-025	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine Hydrochloride	LIQUID	ORAL	20090203		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-027_01af6236-f4ba-5999-e063-6394a90a3806	21130-027	HUMAN OTC DRUG	Maximum Strength Acid Controller		Famotidine	TABLET	ORAL	20230623		ANDA	ANDA217543	BETTER LIVING BRANDS LLC.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-028_0c35be70-7163-41d6-ba09-177195296636	21130-028	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20210503		ANDA	ANDA208077	Safeway, Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-030_34c32164-84a7-4aeb-ab27-f85280d5832c	21130-030	HUMAN OTC DRUG	Signature Care Ibuprofen PM		Diphenhydramine citrate, Ibuprofen	TABLET, FILM COATED	ORAL	20151113		ANDA	ANDA079113	Safeway	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-031_ce0503f2-c88b-4a93-a398-91f6aa5de4bc	21130-031	HUMAN OTC DRUG	Ultra Strength		Antacid Tablets	TABLET, CHEWABLE	ORAL	20201005		OTC MONOGRAPH DRUG	M001	SAFEWAY	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
21130-032_30a207f5-34a7-45ca-a1f8-5576b71c48d9	21130-032	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE	ORAL	20230920		ANDA	ANDA207753	Better Living Brands LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-033_3228feab-7394-44d2-ad23-b46ae1997107	21130-033	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230908		ANDA	ANDA206531	Better Living Brands, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-035_16ba2996-bec0-4caa-82c1-05d01e56fe6d	21130-035	HUMAN OTC DRUG	Signature Care Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20150901		ANDA	ANDA074937	Safeway	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-036_8c861a6d-593e-4a96-8f06-aae5e02271bb	21130-036	HUMAN OTC DRUG	Cold Flu and Sore Throat Relief	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20140630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-037_080f0bf2-a9f8-947a-e063-6394a90a8098	21130-037	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF		Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20230601		OTC MONOGRAPH DRUG	M013	BETTER LIVING BRANDS, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
21130-039_ffbb95fb-e93e-4e0a-86e3-6c452d040cef	21130-039	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230908		ANDA	ANDA206531	Better Living Brands LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-040_44d0726a-3148-445d-adf6-9dc6204fa0db	21130-040	HUMAN OTC DRUG	Signature Care Miconazole 1		Miconazole nitrate	KIT		20150928		ANDA	ANDA079114	Safeway						N	20241231
21130-041_862bbd6e-da03-4006-a2ee-2059db0c0935	21130-041	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210131		OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
21130-042_b0412b0b-32e8-49a6-b62a-717290693d7e	21130-042	HUMAN OTC DRUG	Loratadine		Loratadine Oral	SOLUTION	ORAL	20230925		ANDA	ANDA208931	Better Living Brands LLC	LORATADINE	5	mg/5mL			N	20241231
21130-043_0202853a-df3d-ff77-e063-6294a90acdd9	21130-043	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET	ORAL	20230808		OTC MONOGRAPH NOT FINAL	part343	BETTER LIVING BRANDS LLC.	ACETAMINOPHEN	325	mg/1			N	20241231
21130-044_e0160663-b2b8-4c43-87a1-bd3afe2ba2f6	21130-044	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20140630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-046_2a8939c1-79dc-df38-f185-03226deb8dd7	21130-046	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220412		ANDA	ANDA202194	Albertsons Companies	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-048_f43b966b-0d55-f5aa-e053-2995a90add66	21130-048	HUMAN OTC DRUG	Better Living Brands		Benzalkonium Chloride	SOAP	TOPICAL	20230208		OTC MONOGRAPH NOT FINAL	part333A	Better Living Brands LLC	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
21130-051_5c5768f8-927a-4669-bb99-1827a32dd94c	21130-051	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	20231108		OTC MONOGRAPH DRUG	M013	Better Living Brands LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-052_55b982d5-3d49-421a-9d28-eb2bd8a10b7e	21130-052	HUMAN OTC DRUG	Sleep Aid		Sleep Aid	CAPSULE, LIQUID FILLED	ORAL	20231108		OTC MONOGRAPH DRUG	M010	Better Living Brands LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-058_0d2fd6c3-9543-4bba-beb1-0892535c7715	21130-058	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20190630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.						N	20241231
21130-060_16010576-c3f9-43a9-a61c-2a71cd214880	21130-060	HUMAN OTC DRUG	signature care tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20150924		ANDA	ANDA075915	Safeway	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-061_0ccf862a-8d3e-0892-e063-6294a90a3e2f	21130-061	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20230930		ANDA	ANDA091353	Safeway, Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-062_0d1c6332-5e39-680c-e063-6394a90a70bd	21130-062	HUMAN OTC DRUG	Naproxen		Naproxen	TABLET	ORAL	20230830		ANDA	ANDA091353	Safeway, Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-064_b58f28e7-1e84-4bb8-ba3f-15b87647d3d1	21130-064	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20191001	20250228	ANDA	ANDA204097	Safeway, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
21130-069_fc323027-a3a4-481c-886e-6971024d4404	21130-069	HUMAN OTC DRUG	Pure petroleum		White Petrolatum	JELLY	TOPICAL	19890715		OTC MONOGRAPH FINAL	part347	Better Living Branes LLC	PETROLATUM	1	g/g			N	20241231
21130-071_776e7fc6-bd9e-4277-83ca-b2e0cb706198	21130-071	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20160229	20250228	OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
21130-072_084c1a59-50f7-42ec-b6f8-ec5d2a04c14c	21130-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19980325		OTC MONOGRAPH NOT FINAL	part356	Better Living Brands LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-073_51ce8612-389f-4e57-b0cf-b5a1fff1fa4d	21130-073	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200930		OTC MONOGRAPH FINAL	part332	Safeway, Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-074_068e2ba0-2db2-4c12-ad9e-47a7130c2a22	21130-074	HUMAN OTC DRUG	ACETAMINOPHEN ASPIRIN AND CAFFEINE		acetaminophen, aspirin and caffeine	TABLET, FILM COATED	ORAL	20230811		ANDA	ANDA211695	Better Living Brands, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
21130-078_26844e1b-f37b-4384-8cc3-b088b4c2c1b3	21130-078	HUMAN OTC DRUG	Signature Care		Castor	OIL	ORAL	20151116		OTC MONOGRAPH NOT FINAL	part334	Better Living Brands, LLC	CASTOR OIL	1	g/mL			N	20241231
21130-080_1b59ebd9-95a7-4e55-ab6a-c62fb2648f3e	21130-080	HUMAN OTC DRUG	Athletes Foot		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Safeway Inc.	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
21130-081_9459bcca-e3d3-a19c-e053-2995a90a931d	21130-081	HUMAN OTC DRUG	Enteric Coated Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20150805		OTC MONOGRAPH NOT FINAL	part343	Safeway	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-082_c763dbf8-aeca-487a-bbfe-cde642b304c0	21130-082	HUMAN OTC DRUG	Signature Care Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20160205		OTC MONOGRAPH FINAL	part341	Safeway	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-085_4cfff913-26bc-47b1-aa19-d659cb637fd0	21130-085	HUMAN OTC DRUG	Signature Care Lice Treatment		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20151111		OTC MONOGRAPH FINAL	part358G	Safeway	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
21130-087_de07ad01-841c-47fd-a4c7-65fe9f440b5c	21130-087	HUMAN OTC DRUG	Signature Care Acid Reducer Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160302		ANDA	ANDA077355	Safeway	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-088_8499049b-0bb3-4554-a38f-e70230f5d199	21130-088	HUMAN OTC DRUG	signature care esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Safeway	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-089_b5dc04e6-6930-4982-b1bc-094d92f7c238	21130-089	HUMAN OTC DRUG	Signature Care Allergy Relief		Fluticasone propionate	SPRAY, METERED	NASAL	20160531		ANDA	ANDA207957	Safeway	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-090_18eafcde-f5ed-480e-832d-080a73935508	21130-090	HUMAN OTC DRUG	signature care allergy relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20150917		ANDA	ANDA078336	Safeway	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-091_e6213f09-a6c6-42bc-9246-317440892bd2	21130-091	HUMAN OTC DRUG	Signature Care Non drowsy Daytime Severe Cold and Flu Relief		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20160129		OTC MONOGRAPH FINAL	part341	Safeway	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-093_0bb2dfd1-e920-ffc4-e063-6294a90aab54	21130-093	HUMAN OTC DRUG	Gas Relief Extra Strength		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20220701		OTC MONOGRAPH DRUG	M002	LIVING BETTER BRANDS LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-095_08f502dc-4667-278d-e063-6294a90a0dec	21130-095	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20151223	20251231	OTC MONOGRAPH DRUG	M013	Safeway	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
21130-097_fe254d59-11d2-e284-e053-6394a90a340e	21130-097	HUMAN OTC DRUG	Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20230613		ANDA	ANDA215486	BETTER LIVING BRANDS, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
21130-098_4471f8dd-d97b-4a3e-a238-cbf8cd606f11	21130-098	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20230519		ANDA	ANDA090760	Better Living Brands, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-099_b3b261a6-e56a-458a-a5a4-92bd95f4e2fc	21130-099	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	CAPSULE	ORAL	20231115		ANDA	ANDA209107	Better Living Brands, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-100_4505dba6-75e7-4ca5-9ca8-95384f093ddc	21130-100	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190724		ANDA	ANDA209339	Better Living Brands LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-101_443ef1a1-2676-4174-bc02-f8ae67fd6049	21130-101	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20190831	20250228	OTC MONOGRAPH FINAL	part341	Safeway, Inc.	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
21130-102_23910e7b-3d16-4eb8-965b-d1c30a08020d	21130-102	HUMAN OTC DRUG	Signature Care Miconazole 3		Miconazole nitrate	KIT		20151006		ANDA	ANDA075329	Safeway						N	20241231
21130-105_bd1ae7e5-de0c-8eee-2420-e677654b82a4	21130-105	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210625		ANDA	ANDA209752	Albertsons Companies	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
21130-108_08a4928b-7822-46ee-8e3c-cafce4acdae5	21130-108	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20220624		ANDA	ANDA207229	Better Living Brands, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
21130-110_b0183313-4810-4a9a-b1df-eefd21cea504	21130-110	HUMAN OTC DRUG	Extra Strength Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20201002		OTC MONOGRAPH DRUG	M002	SAFEWAY	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-111_e36b10d6-75a1-413e-bd04-fca97d3376b9	21130-111	HUMAN OTC DRUG	Signature Care Pain Relief		Acetaminophen	TABLET	ORAL	20150901		OTC MONOGRAPH NOT FINAL	part343	Safeway	ACETAMINOPHEN	500	mg/1			N	20241231
21130-112_67f61e92-0e8e-424e-a9e6-9e435fa67205	21130-112	HUMAN OTC DRUG	Nasal Decongestant	Maximum Strength	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
21130-120_b6d307ed-c6b6-45e5-a3a5-5d9a0ed8b1b0	21130-120	HUMAN OTC DRUG	Signature Care Triple Antibiotic		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20170509		OTC MONOGRAPH FINAL	part333B	Safeway	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
21130-121_ab7b1901-8aaf-4a6f-bb94-885fb22b941b	21130-121	HUMAN OTC DRUG	Signature Care Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20151103		ANDA	ANDA074760	Safeway	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-122_b84e8f4e-81ec-43ec-b8ea-39116c0a1363	21130-122	HUMAN OTC DRUG	signature care childrens allergy relief		Fluticasone Propionate	SPRAY, METERED	NASAL	20170620		ANDA	ANDA207957	Safeway	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-123_211bd285-6b6a-4833-bb31-1ba75ad1429e	21130-123	HUMAN OTC DRUG	Signature Care Allergy Relief		Loratadine	TABLET	ORAL	20160208		ANDA	ANDA076301	Safeway	LORATADINE	10	mg/1			N	20241231
21130-124_08f38579-7486-c6d6-e063-6394a90a3081	21130-124	HUMAN OTC DRUG	Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200101	20251031	ANDA	ANDA211544	SAFEWAY	ACETAMINOPHEN	650	mg/1			N	
21130-125_3f6a4089-3ba7-491a-bfe2-75eca72f3e6e	21130-125	HUMAN OTC DRUG	Digestive Relief		Bismuth Subsalicylate	TABLET, FILM COATED	ORAL	20201005		OTC MONOGRAPH DRUG	M008	SAFEWAY	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
21130-128_e1cf10fe-1057-4f51-b1b8-da147b5c84c2	21130-128	HUMAN OTC DRUG	Signature Care Omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180711		NDA	NDA209400	Safeway	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-129_e8e65b2e-5bf9-40b2-a318-a1bbd74ac7e6	21130-129	HUMAN OTC DRUG	Signature Care Nighttime Severe Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20160124		OTC MONOGRAPH FINAL	part341	Safeway	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-135_f3c5efc4-6e17-44e8-9bbc-2e2f46a4177a	21130-135	HUMAN OTC DRUG	Gas Relief		simethicone	TABLET, CHEWABLE	ORAL	20151111		OTC MONOGRAPH FINAL	part332	Safeway	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-137_267add53-4dd0-4272-b8e1-ddcfb2d0e0a7	21130-137	HUMAN OTC DRUG	Signature Care Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150918		NDA	NDA022032	Safeway	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-139_bae1702f-2f52-4851-bd72-591032e7d36d	21130-139	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20180501		ANDA	ANDA076805	Safeway Inc.	LORATADINE	5	mg/5mL			N	20241231
21130-142_aacbad0b-217e-46ce-9208-675b05d2100d	21130-142	HUMAN OTC DRUG	signature care vagicaine		Benzocaine, Resorcinol	CREAM	TOPICAL	20151014		OTC MONOGRAPH NOT FINAL	part348	Safeway	BENZOCAINE; RESORCINOL	20; 3	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
21130-145_28fcb03c-2a4b-40d2-bded-13bcaa56790c	21130-145	HUMAN OTC DRUG	Signature Care Hand Sanitizer Wipes with Aloe Vera		Alcohol	CLOTH	TOPICAL	20210414		OTC MONOGRAPH NOT FINAL	part333E	Better Living Brands LLC	ALCOHOL	70	g/100g			N	20241231
21130-146_d8e6c62a-f1e6-4d55-a126-4a15573d700b	21130-146	HUMAN OTC DRUG	Signature Care Hand Sanitizer Aloe Vera		Alcohol	SPRAY	TOPICAL	20200817		OTC MONOGRAPH NOT FINAL	part333E	Better Living Brands LLC	ALCOHOL	70	mL/100mL			N	20241231
21130-149_8ce1dada-2295-4ef1-b432-57a429968b48	21130-149	HUMAN OTC DRUG	Signature Care Hand Sanitizer Chamomile Scented		Alcohol	SPRAY	TOPICAL	20200817		OTC MONOGRAPH NOT FINAL	part333E	Better Living Brands LLC	ALCOHOL	70	mL/100mL			N	20241231
21130-150_6d32204d-654d-4b2a-a93d-92bf3be0fcb1	21130-150	HUMAN OTC DRUG	Signature Care Advanced Hand Sanitizer with Aloe		Alcohol	LIQUID	TOPICAL	20200817		OTC MONOGRAPH NOT FINAL	part333E	Better Living Brands LLC	ALCOHOL	70	mL/100mL			N	20241231
21130-151_a0d5e68d-4364-4782-bc91-5a6edbff7491	21130-151	HUMAN OTC DRUG	Signature Care Advanced Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200817		OTC MONOGRAPH NOT FINAL	part333E	Better Living Brands LLC	ALCOHOL	70	mL/100mL			N	20241231
21130-153_299f2e68-7d6e-4b4f-adbc-cb2c3fc8134c	21130-153	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	19981208		OTC MONOGRAPH DRUG	M032	Better Living Brands LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
21130-154_61232389-077d-46f0-b3fe-520c53dfbaa0	21130-154	HUMAN OTC DRUG	signature care itch relief		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part348	Safeway	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-155_0bd130d0-bcb3-d6ef-e063-6394a90ae2d1	21130-155	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20230714		OTC MONOGRAPH DRUG	M013	Better Living Brands LLC	ACETAMINOPHEN	500	mg/1			N	20241231
21130-163_ea3798b7-8782-4407-ba2e-90eaf56c00c6	21130-163	HUMAN OTC DRUG	signature care hair regrowth treatment for women		Minoxidil	AEROSOL, FOAM	TOPICAL	20170306		ANDA	ANDA091344	Safeway	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
21130-164_974dead2-c8fd-4d4a-9d17-f1bb4d08c9c8	21130-164	HUMAN OTC DRUG	Signature Care daytime nighttime severe cold and flu relief		acetaminophen, dextromethorphan HBr, doxylamine succinate, guaifenesin, phenylephrine HCl	KIT		20170601		OTC MONOGRAPH FINAL	part341	Safeway						N	20241231
21130-165_ee5f3360-a030-4640-99f7-da209dd5bcde	21130-165	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	BETTER LIVING BRANDS LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-166_9fe16fc5-77e3-47f5-a943-85bc6565c0d4	21130-166	HUMAN OTC DRUG	signature care Hydrocortisone		Hydrocortisone	LOTION	TOPICAL	20180810		OTC MONOGRAPH NOT FINAL	part348	Safeway	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-167_570737ad-faff-43e6-bf6a-8d474c2b89da	21130-167	HUMAN OTC DRUG	signature care aspirin		Aspirin	TABLET, FILM COATED	ORAL	20180326		OTC MONOGRAPH NOT FINAL	part343	Safeway	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-172_22010ed8-7fa6-402a-a314-523538183a55	21130-172	HUMAN OTC DRUG	signature care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20181029		ANDA	ANDA203690	Safeway	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-173_0bd83d75-3ffe-42d6-94ee-a66f5874edca	21130-173	HUMAN OTC DRUG	signature care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20180928		ANDA	ANDA206393	Safeway	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-176_b2b17cc7-398f-4cd7-a319-9e2deeb83432	21130-176	HUMAN OTC DRUG	Signature Care Allergy Relief D		Cetirizine HCl, Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20151015		ANDA	ANDA077170	Safeway	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
21130-178_236df05a-cf11-42f3-a347-b54f5113680c	21130-178	HUMAN OTC DRUG	signature care infants pain relief		Acetaminophen	SUSPENSION	ORAL	20180913		OTC MONOGRAPH NOT FINAL	part343	Safeway	ACETAMINOPHEN	160	mg/5mL			N	20241231
21130-179_449da1ee-474d-477e-843b-39b442501809	21130-179	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220415		ANDA	ANDA210453	Better Living Brands LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
21130-180_2b1d2ad6-0214-4af4-aa70-47c3b14e6faf	21130-180	HUMAN OTC DRUG	signature care naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20180403		ANDA	ANDA074661	Safeway	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-181_67c3369b-43a7-4a90-871d-d5ea4219f1d6	21130-181	HUMAN OTC DRUG	signature care acid reducer		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20150927		ANDA	ANDA202319	Safeway	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-183_84891034-cc81-4f2e-a9fd-fc53c0c44dd6	21130-183	HUMAN OTC DRUG	signature care anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181010		ANDA	ANDA209837	Safeway	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
21130-185_664c3faf-7cab-4bda-8987-07acb8e1142b	21130-185	HUMAN OTC DRUG	signature care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20181022		ANDA	ANDA203690	Safeway	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-186_4f20282f-0524-497c-9a83-a60bd6601b06	21130-186	HUMAN OTC DRUG	signature care nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20180827		ANDA	ANDA206394	Safeway	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-187_38392888-1e16-49ee-b149-2217936330b4	21130-187	HUMAN OTC DRUG	Signature Care Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210629		ANDA	ANDA074661	Safeway	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-189_4b34da58-a72e-4787-8fe3-fa13c6b91faf	21130-189	HUMAN OTC DRUG	Signature Care Childrens Allergy Relief		Cetirizine HCl	SOLUTION	ORAL	20160426		ANDA	ANDA204226	Safeway	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-191_0d1c33a5-8cd4-ec61-e063-6294a90a86e9	21130-191	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20230630		ANDA	ANDA215822	SAFEWAY	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-195_9467104a-5f8d-72d3-e053-2995a90a921f	21130-195	HUMAN OTC DRUG	Allergy Relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20191001		ANDA	ANDA206214	Safeway	LORATADINE	10	mg/1			N	20241231
21130-201_29c81639-447a-4fdc-908e-8b9987684cc7	21130-201	HUMAN OTC DRUG	Extra Strength		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200930		OTC MONOGRAPH DRUG	M001	BETTER LIVING BRANDS, LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
21130-203_2e677f43-ad81-49ea-85dc-53a1f76e3de2	21130-203	HUMAN OTC DRUG	Extra Strength		Antacid Tablets	TABLET, CHEWABLE	ORAL	20201005		OTC MONOGRAPH DRUG	M001	SAFEWAY	CALCIUM CARBONATE	750	mg/1			N	20241231
21130-204_22744b1f-71f8-4db8-b2d5-1da1ea2a452a	21130-204	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	Safeway Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
21130-205_40844181-70f3-4fb3-aa7b-e6686995ad66	21130-205	HUMAN OTC DRUG	Signature Care Athletes Foot		Tolnaftate	SPRAY	TOPICAL	20151011		OTC MONOGRAPH FINAL	part333C	Safeway	TOLNAFTATE	1	g/100g			N	20241231
21130-206_a81cba93-0880-496d-b365-870c9eb7ed26	21130-206	HUMAN OTC DRUG	Mucus Relief Max		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180528		ANDA	ANDA209215	Safeway	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
21130-207_97adc54d-7b8d-452c-bf93-5737ade39743	21130-207	HUMAN OTC DRUG	Extra Strength		Antacid Tablets	TABLET, CHEWABLE	ORAL	20201005		OTC MONOGRAPH DRUG	M001	SAFEWAY	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
21130-209_5a9b1125-e1ef-4970-9e07-70ee034d35f1	21130-209	HUMAN OTC DRUG	Extra Strength		Antacid Tablets	TABLET, CHEWABLE	ORAL	20201005		OTC MONOGRAPH DRUG	M001	SAFEWAY	CALCIUM CARBONATE	750	mg/1			N	20241231
21130-210_1976eb4c-93fb-4c61-a05e-1a9d0089e81c	21130-210	HUMAN OTC DRUG	Signature Care	Jock Itch	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Safeway Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-211_bdf1a198-bce7-4934-86e1-2e45ddd743c7	21130-211	HUMAN OTC DRUG	signature care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150928		ANDA	ANDA077007	Safeway	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-212_f2286026-810c-309e-e053-2995a90a71dc	21130-212	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate Antifungal Powder Spray	AEROSOL, SPRAY	TOPICAL	20210927		OTC MONOGRAPH FINAL	part333C	Better Living Brands	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-213_f2285eaa-39a2-86ae-e053-2a95a90ab7a0	21130-213	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20210927		OTC MONOGRAPH FINAL	part333C	Better Living Brands LLC	TOLNAFTATE	1.5	g/150g			N	20241231
21130-215_f2285eaa-39a1-86ae-e053-2a95a90ab7a0	21130-215	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20210927		OTC MONOGRAPH FINAL	part333C	Better Living Brands LLC	TOLNAFTATE	1.3	g/130g			N	20241231
21130-220_06492ef7-9a5b-dbec-e063-6294a90ab988	21130-220	HUMAN OTC DRUG	Pain Relief		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230926		ANDA	ANDA078682	Albertsons Companies	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-221_57487b79-812f-4626-a068-be397bb1f7fd	21130-221	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20230920		ANDA	ANDA208477	Better Living Brands, LLC	LORATADINE	10	mg/1			N	20241231
21130-222_8cc74573-9503-42e7-8ee8-c574c6acc900	21130-222	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20230721		ANDA	ANDA211059	Better Living Brands, LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
21130-223_0b359af6-54fc-cb9e-e063-6394a90a0bd0	21130-223	HUMAN OTC DRUG	CHILDRENS PAIN RELIEF		acetaminophen	TABLET, CHEWABLE	ORAL	20231115		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN	160	mg/1			N	20241231
21130-224_0b35e6d7-d8ed-de5d-e063-6394a90a1777	21130-224	HUMAN OTC DRUG	Acetaminophen and Diphenhydramine hydrochloride		Acetaminophen and Diphenhydramine hydrochloride	TABLET	ORAL	20231118		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-226_dbc0e74a-1e6b-48dc-8ab6-edf46ffd504e	21130-226	HUMAN OTC DRUG	Stay Awake	Maximum Strength	Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	Better Living Brands, LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
21130-228_61dd65a9-566e-4f32-868e-861fa7b32e0e	21130-228	HUMAN OTC DRUG	Ibuprofen and Diphenhydramine Citrate		Ibuprofen and Diphenhydramine Citrate	TABLET, COATED	ORAL	20231115		ANDA	ANDA216204	Better Living Brands, LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-229_1623f987-c2f8-42b3-8332-89b6c1756718	21130-229	HUMAN OTC DRUG	signature care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20181009		ANDA	ANDA076775	Safeway	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-241_f4a3b638-57c3-4812-ab4d-b8ffa4792619	21130-241	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20201001		OTC MONOGRAPH DRUG	M008	SAFEWAY	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
21130-243_0f09f326-b185-4a76-a761-b59c6391fc53	21130-243	HUMAN OTC DRUG	signature care childrens pain relief		Acetaminophen	SUSPENSION	ORAL	20150928		OTC MONOGRAPH NOT FINAL	part343	Safeway	ACETAMINOPHEN	160	mg/5mL			N	20241231
21130-247_28784bfb-8ab9-49a5-9762-148fe5127453	21130-247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20150715		OTC MONOGRAPH FINAL	part347	Better Living Brands LLC	PETROLATUM	410	mg/g			N	20241231
21130-249_f6b4a269-6d99-4274-b9a4-67533ac84205	21130-249	HUMAN OTC DRUG	signature care acid controller		Famotidine	TABLET, FILM COATED	ORAL	20150904		ANDA	ANDA075400	Safeway	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-252_ec93aea4-c8cd-6cf1-e053-2a95a90a9b9c	21130-252	HUMAN OTC DRUG	Safeway Instant Hand Sanitizing wipes		Alcohol	CLOTH	TOPICAL	20080101		OTC MONOGRAPH NOT FINAL	part333A	Safeway Inc.	ALCOHOL	.659	mL/mL			N	20241231
21130-261_06b97e58-9021-f781-e063-6394a90ab2ca	21130-261	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230612		ANDA	ANDA091239	BETTER LIVING BRANDS, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-265_06d27e26-9803-24e3-e063-6394a90a4260	21130-265	HUMAN OTC DRUG	Menthol Cough Drop		Menthol	LOZENGE	ORAL	20140522		OTC MONOGRAPH FINAL	part341	Safeway Inc.	MENTHOL	5.4	mg/1			N	20241231
21130-266_06d27f94-ed37-227d-e063-6394a90aa528	21130-266	HUMAN OTC DRUG	Cherry Cough Drop		Menthol	LOZENGE	ORAL	20140522		OTC MONOGRAPH FINAL	part341	Safeway Inc.	MENTHOL	5.8	mg/1			N	20241231
21130-269_539386e8-6dd2-4437-855a-c63e40bbd313	21130-269	HUMAN OTC DRUG	signature care nicotine		nicotine	GUM, CHEWING	ORAL	20181228		ANDA	ANDA206394	Safeway	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-270_94598f46-141d-d14e-e053-2a95a90a4283	21130-270	HUMAN OTC DRUG	Pain Relief Rapid Release Gelcaps	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20150805		OTC MONOGRAPH NOT FINAL	part343	Safeway	ACETAMINOPHEN	500	mg/1			N	20241231
21130-272_75d9f92f-9b85-4ced-ae29-1211a0076154	21130-272	HUMAN OTC DRUG	Signature Care Childrens Multi Symptom Cold		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20210708		OTC MONOGRAPH FINAL	part341	Safeway	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-273_35c7f1d0-36b5-44d8-8fd1-5542408aa88c	21130-273	HUMAN OTC DRUG	signature care hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20150904		ANDA	ANDA075598	Safeway	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
21130-278_a636a765-bb58-407e-a607-9d1393e1caab	21130-278	HUMAN OTC DRUG	Signature Care Anti Itch		Hydrocortisone	CREAM	TOPICAL	20151014		OTC MONOGRAPH NOT FINAL	part348	Safeway	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-281_b07d0d17-1dea-4af9-9589-969a13bca59c	21130-281	HUMAN OTC DRUG	Pain Reliever	Childrens	Acetaminophen	SUSPENSION	ORAL	20150630	20250630	OTC MONOGRAPH NOT FINAL	part343	Safeway, Inc.	ACETAMINOPHEN	160	mg/5mL			N	
21130-283_1dbef407-03fb-444d-b78e-781b60d1082a	21130-283	HUMAN OTC DRUG	Signature Care Ibuprofen PM		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20150901		ANDA	ANDA079113	Safeway	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-285_d3299f29-5de7-414b-b94a-1ed4fc12aa98	21130-285	HUMAN OTC DRUG	Dye Free Pain Reliever	Childrens	Acetaminophen	SUSPENSION	ORAL	20150630		OTC MONOGRAPH NOT FINAL	part343	Safeway, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
21130-287_153fb80b-4660-4ef0-8d2a-7497ad4a2f9e	21130-287	HUMAN OTC DRUG	Signature Care Athletes Foot		Clotrimazole	CREAM	TOPICAL	20151016		OTC MONOGRAPH FINAL	part333C	Safeway	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-288_08a4f03b-a10e-3408-e063-6394a90a5074	21130-288	HUMAN OTC DRUG	Pepperment Cough Drops		Menthol	LOZENGE	ORAL	20180718		OTC MONOGRAPH DRUG	M012	Safeway	MENTHOL	5.4	mg/1			N	20241231
21130-290_08a500c5-8649-8789-e063-6394a90ad327	21130-290	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20180725		OTC MONOGRAPH DRUG	M012	Safeway	MENTHOL	5.8	mg/1			N	20241231
21130-293_08a4e97a-0b48-34c8-e063-6394a90ae889	21130-293	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20180725		OTC MONOGRAPH DRUG	M012	Safeway	MENTHOL	7.5	mg/1			N	20241231
21130-296_07dc5152-177f-449c-84cd-2e4c007743c8	21130-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	19981208		OTC MONOGRAPH DRUG	M032	Better Living Brands LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
21130-298_4cafefea-bbe2-4373-983b-909e0cdc4f11	21130-298	HUMAN OTC DRUG	Vegetable Laxative		Sennosides	TABLET, FILM COATED	ORAL	19950127		OTC MONOGRAPH DRUG	505G(a)(3)	Better Living Brands, LLC	SENNOSIDES	8.6	mg/1			N	20241231
21130-299_1776600f-7fcf-4d5d-b252-f39cc730a7d8	21130-299	HUMAN OTC DRUG	Mint		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20090529		OTC MONOGRAPH NOT FINAL	part356	Better Living Brands	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
21130-301_93c52680-9876-418f-86e6-6825909b2631	21130-301	HUMAN OTC DRUG	signature care allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200626		ANDA	ANDA076011	Safeway	LORATADINE	10	mg/1			N	20241231
21130-302_23fb228d-c5d8-4a6a-b3e8-fe6687176363	21130-302	HUMAN OTC DRUG	Ultra Strength		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200930		OTC MONOGRAPH DRUG	M001	BETTER LIVING BRANDS LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
21130-308_06d27b10-f034-1471-e063-6394a90a4191	21130-308	HUMAN OTC DRUG	Signature Care Cherry Cough Drops		Menthol	LOZENGE	ORAL	20200603		OTC MONOGRAPH FINAL	part341	Safeway	MENTHOL	5.8	mg/1			N	20241231
21130-309_06d283b6-4c3b-1f7a-e063-6394a90a1c6b	21130-309	HUMAN OTC DRUG	Signature Care Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20200604		OTC MONOGRAPH FINAL	part341	Safeway	MENTHOL	7.5	mg/1			N	20241231
21130-310_f63d41de-ee5a-4aba-88e8-f62909998b65	21130-310	HUMAN OTC DRUG	Ultra Strength		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200930		OTC MONOGRAPH DRUG	M001	BETTER LIVING BRANDS LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
21130-313_4807892e-cb39-4a56-8d42-384ec7a827f6	21130-313	HUMAN OTC DRUG	signature care arthritis pain		diclofenac sodium	GEL	TOPICAL	20201029		ANDA	ANDA211253	Safeway	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-317_0bdc188d-b893-acbc-e063-6294a90acd68	21130-317	HUMAN OTC DRUG	Extra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20211222		OTC MONOGRAPH DRUG	M002	Better Living Brands LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-318_67b16e0e-358d-4590-bac9-5b8c3b8c56e8	21130-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19900715		OTC MONOGRAPH NOT FINAL	part356	Safeway Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-329_ce097425-582a-47b8-b21d-6b51e478b303	21130-329	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-334_fd8cd565-8cec-1e43-e053-6294a90a82b7	21130-334	HUMAN OTC DRUG	Wart Remover Liquid		Salicylic Acid	LIQUID	TOPICAL	20230607		OTC MONOGRAPH FINAL	part358B	Better Living Brands	SALICYLIC ACID	170	mg/mL			N	20241231
21130-335_fd7b3810-c848-4e37-e053-6294a90aa338	21130-335	HUMAN OTC DRUG	Anti-Fungal Liquid Maximum Strength		Tolnaftate	LIQUID	TOPICAL	20230606		OTC MONOGRAPH FINAL	part333C	Better Living Brands	TOLNAFTATE	10	mg/mL			N	20241231
21130-339_a136a900-3622-4e6f-bed6-71b62c01047e	21130-339	HUMAN OTC DRUG	Signature Care Cool Heat		Menthol, Methyl salicylate	CREAM	TOPICAL	20151202		OTC MONOGRAPH NOT FINAL	part348	Safeway	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 30	g/100g; g/100g			N	20241231
21130-341_2fbe67b0-c961-4599-b543-f966eeee1edc	21130-341	HUMAN OTC DRUG	signature care athletes foot		Miconazole Nitrate	SPRAY	TOPICAL	20151009		OTC MONOGRAPH FINAL	part333C	Safeway	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-343_f0953ae0-662d-464b-a4cf-8ce9c5757c27	21130-343	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20140630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-345_edafb3d0-9498-40ee-8361-2ebe828cad27	21130-345	HUMAN OTC DRUG	Night Time Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20150630	20240531	OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
21130-348_f0e863f7-4368-44b7-bdbb-4d8521f04624	21130-348	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20030102	20240804	OTC MONOGRAPH NOT FINAL	part334	Better Living Brands, LLC	SENNOSIDES	25	mg/1			N	
21130-350_f200c412-ae76-40a3-e053-2995a90a4e41	21130-350	HUMAN OTC DRUG	Signature Care Enamel Guard Sensitive	Gentle Whitening	Potassium nitrate, sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190302		OTC MONOGRAPH NOT FINAL	part356	Safeway	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
21130-351_f200d820-4549-3077-e053-2a95a90a9e19	21130-351	HUMAN OTC DRUG	Signature Care Sensitive	Maximum Strength	Potassium nitrate, Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190302		OTC MONOGRAPH NOT FINAL	part356	Safeway	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
21130-353_0ccd950a-3ed6-e0d0-e063-6294a90af6f2	21130-353	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20221212		OTC MONOGRAPH DRUG	M013	BETTER LIVING BRANDS LLC.	ACETAMINOPHEN	500	mg/1			N	20241231
21130-354_0ccdc7b3-14f8-7d15-e063-6394a90a503b	21130-354	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCl		Acetaminophen Diphenhydramine HCl	TABLET	ORAL	20221212		OTC MONOGRAPH DRUG	M013	BETTER LIVING BRANDS LLC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-356_0ccec4dd-8a29-c273-e063-6394a90a8048	21130-356	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20221208		OTC MONOGRAPH DRUG	M013	BETTER LIVING BRANDS LLC.	ACETAMINOPHEN	500	mg/1			N	20241231
21130-358_0ccf3743-d398-cc6c-e063-6294a90a1d7d	21130-358	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20190712		ANDA	ANDA202312	BETTER LIVING BRANDS LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-359_f6f317d8-a7c2-2ba3-e053-6394a90a5db0	21130-359	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20190712		ANDA	ANDA202312	BETTER LIVING BRANDS LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-363_53a31f8d-1d75-417b-8a35-93c2842b91f2	21130-363	HUMAN OTC DRUG	signature care infants ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20150928		ANDA	ANDA075217	Safeway	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-364_fb8a5884-32b5-430f-b71c-b2ae43fff788	21130-364	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20211015		ANDA	ANDA213105	Safeway, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-369_9d43b127-abf3-45a8-80e7-6baeed1d467c	21130-369	HUMAN OTC DRUG	Signature Care Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20151111		OTC MONOGRAPH NOT FINAL	part348	Safeway	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-371_5619412e-e425-4474-a1f1-b3bcae788f29	21130-371	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20150630	20240531	OTC MONOGRAPH FINAL	part335	Safeway, Inc.	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
21130-372_713176b0-6e39-444e-8745-572b50d02107	21130-372	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20150630	20250630	OTC MONOGRAPH FINAL	part335	Safeway, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
21130-375_ecdd06a5-ab3c-4781-8ae7-2dcf5c07932b	21130-375	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	Better Living Brands, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
21130-376_2192919f-3a5d-403d-b237-48c475321d53	21130-376	HUMAN OTC DRUG	Sore Throat		Phenol	SPRAY	ORAL	20141130		OTC MONOGRAPH NOT FINAL	part356	Safeway, Inc.	PHENOL	1.4	g/100mL			N	20241231
21130-378_ca36d61c-c70a-476a-8a9b-7cb9a48500ad	21130-378	HUMAN OTC DRUG	Triacting Daytime Cold Cough	Childrens	Dextromethorphan HBr, Phenylephrine HCl	SYRUP	ORAL	20150531		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	5; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-379_60d32ec1-7265-473d-a95d-d4cae914b345	21130-379	HUMAN OTC DRUG	Childrens Cold and Cough	Nighttime	Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20151231		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-383_155100dc-a514-4896-94f9-a3bbd8fb20ce	21130-383	HUMAN OTC DRUG	Adult Cough Relief DM		Dextromethorphan HBr	LIQUID	ORAL	20140630	20250630	OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
21130-385_31cba51e-3505-46d8-8cc6-db86a10c94bd	21130-385	HUMAN OTC DRUG	Adult Cough and Chest Congestion Relief DM	Non Drowsy	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20140630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-395_70058212-ce67-4d70-a921-c6146e4ef862	21130-395	HUMAN OTC DRUG	Signature Care Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20151024		OTC MONOGRAPH NOT FINAL	part348	Safeway	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-396_0ccf249b-2515-c2b8-e063-6294a90ae4c1	21130-396	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20190712		ANDA	ANDA079174	BETTER LIVING BRANDS LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-397_b81cd1ec-a0b4-4772-9396-abb36b7cb435	21130-397	HUMAN OTC DRUG	Aspirin	Low Dose Chewable	Aspirin	TABLET, CHEWABLE	ORAL	20010904		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-398_145e8ecc-1da3-6abe-6a2e-be7bd44e64f8	21130-398	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160201		ANDA	ANDA078878	Albertsons Companies	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-399_45e68222-fa35-4674-a1e0-99fbe63bab5c	21130-399	HUMAN OTC DRUG	MUCUS RELIEF MAX		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200717		ANDA	ANDA210453	Better Living Brands, LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
21130-401_dc7cc5b9-c0f2-4d57-89fc-2a0dd31ebd5f	21130-401	HUMAN OTC DRUG	signature care omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20200811		NDA	NDA022032	Safeway	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-404_7aa26b3d-e9e9-f2c7-2fe2-0ea58007b254	21130-404	HUMAN OTC DRUG	Acid Reducer 150		Ranitidine Hydrochloride Tablets 150mg	TABLET, COATED	ORAL	20120514		ANDA	ANDA078192	Safeway Inc	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-405_24e2c0f7-353c-4993-97b8-adc4332e3a60	21130-405	HUMAN OTC DRUG	IAllergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20200228		ANDA	ANDA204507	Safeway, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-409_705a1e7a-bc01-4274-8f42-a41c327c4d0b	21130-409	HUMAN OTC DRUG	Signature Care Triple Antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20151014		OTC MONOGRAPH FINAL	part333B	Safeway	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
21130-410_ff5391d0-d0dc-6f42-e053-6394a90aae9b	21130-410	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20230601		OTC MONOGRAPH NOT FINAL	part334	BETTER LIVING BRANDS LLC.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-417_f2150aa9-99bc-0c64-e053-2a95a90a1fde	21130-417	HUMAN OTC DRUG	Kids Strawberry FTP		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20191031		OTC MONOGRAPH FINAL	part355	Albertsons	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
21130-421_f0466221-2c5a-c9c5-e053-2a95a90a661e	21130-421	HUMAN OTC DRUG	Signature Care Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20150612		OTC MONOGRAPH FINAL	part343	Safeway, Inc	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-422_0ad190c5-45b4-4d66-8c98-8ed2759420d7	21130-422	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20200811		ANDA	ANDA208754	Safeway, Inc.	DOCOSANOL	100	mg/g			N	20241231
21130-428_020180ca-9e0d-5f6c-e063-6394a90ad8e0	21130-428	HUMAN OTC DRUG	Aspirin 81mg		Aspirin	TABLET, DELAYED RELEASE	ORAL	20230808		OTC MONOGRAPH NOT FINAL	part343	BETTER LIVING BRANDS LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-429_fcaf605f-82f0-4431-a17d-ba585df6492f	21130-429	HUMAN OTC DRUG	Signature Care Nasal Decongestant		Oxymetazoline Hydrochloride	SPRAY	NASAL	20150811		OTC MONOGRAPH FINAL	part341	Safeway	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
21130-431_ff44f1d9-7b3a-75c3-e053-6394a90abad8	21130-431	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET	ORAL	20230601		OTC MONOGRAPH NOT FINAL	part343	BETTER LIVING BRANDS LLC.	ACETAMINOPHEN	500	mg/1			N	20241231
21130-435_b3e6f087-85fe-4455-a91b-e1029ff913f1	21130-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150909		OTC MONOGRAPH FINAL	part355	LIVING BETTER BRANDS LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
21130-439_465b849c-604f-41f2-86cf-eb79802239cb	21130-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140910		OTC MONOGRAPH NOT FINAL	part333A	Safeway Inc.	ALCOHOL	700	mg/mL			N	20241231
21130-440_9d47bcef-ac34-445c-9e4d-3c091e5715a8	21130-440	HUMAN OTC DRUG	signature care anti diarrheal		loperamide HCl	SOLUTION	ORAL	20180712		ANDA	ANDA091292	Safeway	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
21130-441_4dba49d1-e872-4c85-b9c2-9c8b62b62219	21130-441	HUMAN OTC DRUG	Extra Strength Gas Relief		Simethicone Antigas	TABLET, CHEWABLE	ORAL	20201001		OTC MONOGRAPH DRUG	M002	SAFEWAY	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-443_71604633-c024-4ed5-a778-5d75e5e75b1b	21130-443	HUMAN OTC DRUG	Signature Care Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20161107		ANDA	ANDA078104	Safeway	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-446_4275dcbe-213c-401e-9621-bd7ab0d0f56b	21130-446	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20231231		OTC MONOGRAPH DRUG	M002	Safeway, Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-448_a0591d70-8bc8-43bc-a3a8-6999f8ee926c	21130-448	HUMAN OTC DRUG	Signature Care Triple Antibiotic		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20150927		OTC MONOGRAPH FINAL	part333B	Safeway	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
21130-452_62dd431d-c820-4611-803a-720b4dbf720d	21130-452	HUMAN OTC DRUG	signature care allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20220329		ANDA	ANDA076011	Safeway	LORATADINE	10	mg/1			N	20241231
21130-453_a7151914-2ed8-4e17-bccc-50419feea060	21130-453	HUMAN OTC DRUG	Nasal Decongestant PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-466_396475d1-d76a-4ade-8fb7-5df8c928dd3f	21130-466	HUMAN OTC DRUG	Pain Relief	Non Drowsy Daytime	Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-467_b449093f-5ae4-4fc6-9e13-fe9e2ef5eed2	21130-467	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Phenylephrine HCI DoxylamineSucinate	KIT		20180930		OTC MONOGRAPH FINAL	part341	Safeway, Inc.						N	20241231
21130-472_60f1fdff-c294-47b8-a67f-211f5cd8b3e3	21130-472	HUMAN OTC DRUG	Antacid Relief		Calcium carbonate	TABLET, CHEWABLE	ORAL	20151111		OTC MONOGRAPH FINAL	part331	Safeway	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
21130-475_c39fc394-87f4-4226-bf04-b6dfd2631b72	21130-475	HUMAN OTC DRUG	Signature Care Childrens Allergy Relief		Cetirizine HCl	SOLUTION	ORAL	20150928		ANDA	ANDA204226	Safeway	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-481_0254db16-146d-57a5-e063-6294a90a2ca6	21130-481	HUMAN OTC DRUG	Low dose aspirin 81mg		Aspirin	TABLET	ORAL	20230714		OTC MONOGRAPH NOT FINAL	part343	BETTER LIVING BRANDS LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-482_35ee6029-73f0-4239-9983-a1af2565c005	21130-482	HUMAN OTC DRUG	signature care allergy and congestion relief		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180402		ANDA	ANDA076050	Safeway	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
21130-492_f309b5df-ce3d-0d55-e053-2995a90a7878	21130-492	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20220610		OTC MONOGRAPH NOT FINAL	part343	SAFEWAY	ACETAMINOPHEN	500	mg/1			N	20241231
21130-499_78feda6f-bb4e-4bda-9535-e0d8c82fe8fa	21130-499	HUMAN OTC DRUG	Night Time Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20180131		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-501_32693503-8a84-4106-9001-a5404f946b8f	21130-501	HUMAN OTC DRUG	Regular Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20201005		OTC MONOGRAPH DRUG	M001	SAFEWAY	CALCIUM CARBONATE	500	mg/1			N	20241231
21130-502_de3874c6-e815-48ae-8ad2-88ff276acca4	21130-502	HUMAN OTC DRUG	Sinus Relief	MAXIMUM STRENGTH	Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20050623		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-505_2f4435a1-15c2-4819-966c-6a5f9e43b5d6	21130-505	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-508_ac703a32-8e0f-4dd4-b7b8-5fba72b7cd59	21130-508	HUMAN OTC DRUG	Antacid		Aluminum Hydroxide, Magnesium Hydroxide and Simethicone	SUSPENSION	ORAL	20151212		OTC MONOGRAPH FINAL	part332	Safeway	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-509_d7ed5c2d-cfff-4562-a5e9-76241e7d88cb	21130-509	HUMAN OTC DRUG	Signature Care Aspririn		aspirin	TABLET, FILM COATED	ORAL	20210610		OTC MONOGRAPH NOT FINAL	part343	Safeway	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-514_17bc964e-f813-490e-b3b4-b78a82840f81	21130-514	HUMAN OTC DRUG	signature care antacid plus gas relief		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	20150722		OTC MONOGRAPH FINAL	part331	Safeway	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-515_b913e9db-7cb5-40f9-b4c6-c448a898d2fa	21130-515	HUMAN OTC DRUG	Extra Strength Smooth		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20201005		OTC MONOGRAPH DRUG	M001	SAFEWAY	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
21130-516_95043c2f-52c7-425b-9382-cad076b7b245	21130-516	HUMAN OTC DRUG	Extra Strength Smooth		Antacid Tablets	TABLET, CHEWABLE	ORAL	20201001		OTC MONOGRAPH DRUG	M001	SAFEWAY	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
21130-518_fe956ee2-a6e3-41ec-b7cf-5ed174cbb33c	21130-518	HUMAN OTC DRUG	Daytime Mucus Relief Severe Cold and Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20180331	20250331	OTC MONOGRAPH FINAL	part341	Safeway, Inc.						N	
21130-520_5d7aec7b-44b4-4cdc-8361-fa19bdb74c65	21130-520	HUMAN OTC DRUG	Signature Care Cough Relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20210708		ANDA	ANDA091135	Safeway	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-522_90b91cbf-3900-4751-968b-b3a3f25cbd99	21130-522	HUMAN OTC DRUG	signature care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20181009		ANDA	ANDA076789	Safeway	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-526_5ef0c05a-40de-40cb-b52c-3f1ab96a5348	21130-526	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20090606		ANDA	ANDA076134	SAFEWAY INC.	LORATADINE	10	mg/1			N	20241231
21130-530_6cfe25a5-fe7d-46a4-a775-5a7a53ef1e94	21130-530	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20151231	20240531	OTC MONOGRAPH FINAL	part332	Safeway, Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
21130-539_09c397dd-c749-634f-e063-6394a90a52e7	21130-539	HUMAN OTC DRUG	Signature Care Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20150810		OTC MONOGRAPH DRUG	M003	Better Living Brands LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
21130-540_20e82955-cd31-4579-83fd-b349e6b0acc9	21130-540	HUMAN OTC DRUG	Pain Relief	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050225	20250201	OTC MONOGRAPH NOT FINAL	part343	Better Living Brands, LLC	ACETAMINOPHEN	160	mg/1			N	
21130-544_84c7e9e3-932a-4083-b0c0-55eff2a0dbc3	21130-544	HUMAN OTC DRUG	Signature Care Lidocaine Cream		Lidocaine	CREAM	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part348	Better Living Brands LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
21130-546_b75fd606-49ad-47c4-8f4c-b4dd4eb9ce9d	21130-546	HUMAN OTC DRUG	signature care acid reducer complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20211101		ANDA	ANDA077355	Safeway	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-554_0ccfe429-9698-376b-e063-6294a90a36ed	21130-554	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20230630		ANDA	ANDA213420	Safeway, Inc	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
21130-555_0204df46-cecc-bb76-e063-6294a90a59a9	21130-555	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET	ORAL	20230710		OTC MONOGRAPH NOT FINAL	part334	BETTER LIVING BRANDS LLC.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-556_7407cab3-5308-47ce-8adf-ba27f32d9fa3	21130-556	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine HCl	TABLET, COATED	ORAL	20071217	20240715	OTC MONOGRAPH NOT FINAL	part343	Better Living Brands, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
21130-559_7b064f76-5677-4003-8e52-b5967eff93d5	21130-559	HUMAN OTC DRUG	Signature Care First Aid Antibiotic		Neomycin, Polymyxin B, Pramoxine HCl	CREAM	TOPICAL	20151110		OTC MONOGRAPH FINAL	part333B	Safeway	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
21130-564_a2694f4b-cb2c-4efa-b138-9e5b25a78ea1	21130-564	HUMAN OTC DRUG	safeway acid reducer		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220418		ANDA	ANDA202319	Safeway	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-569_4fb5ec17-c80b-49db-972f-0eb0e4758f53	21130-569	HUMAN OTC DRUG	Signature Care Migraine Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20150901		ANDA	ANDA075794	Safeway	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
21130-575_d0f996a5-0119-40d4-b6da-a89a34b24a7b	21130-575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20151228		OTC MONOGRAPH NOT FINAL	part333A	Better Living Brands LLC	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
21130-577_330d4b46-a95a-4d4e-a42a-43ff47903b64	21130-577	HUMAN OTC DRUG	signature care hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20151120		OTC MONOGRAPH FINAL	part346	Safeway	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-578_4fa87eb7-e92a-49ff-a2f1-385ba7b9f570	21130-578	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20130708	20250228	OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM	100	mg/1			N	
21130-584_2a2d89dc-c9d1-469d-9ab7-b8ad5fcbb674	21130-584	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20160131	20240531	OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
21130-585_e7c23152-612b-4733-bb76-09a6929eddba	21130-585	HUMAN OTC DRUG	Signature Care Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150812		ANDA	ANDA072096	Safeway	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-586_6298a9da-9075-41f9-9d32-7881842223f1	21130-586	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20220418		OTC MONOGRAPH NOT FINAL	part343	Safeway, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
21130-589_cd9f4f22-13ed-44ac-9587-698c349a95a2	21130-589	HUMAN OTC DRUG	Signature Care Nasal Decongestant		oxymetazoline hydrochloride	SPRAY	NASAL	20150730		OTC MONOGRAPH FINAL	part341	Safeway	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
21130-591_02036bb1-e70b-9eec-e063-6294a90a8627	21130-591	HUMAN OTC DRUG	Laxative		Sennosides	TABLET	ORAL	20230622		OTC MONOGRAPH NOT FINAL	part334	BETTER LIVING BRANDS LLC.	SENNOSIDES	25	mg/1			N	20241231
21130-595_ef989cc7-4c77-467a-b5b0-63525a472e17	21130-595	HUMAN OTC DRUG	signature care nighttime severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20200710		OTC MONOGRAPH FINAL	part341	Safeway	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-596_080d8cdb-78bc-df6c-e063-6294a90afc00	21130-596	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET	ORAL	20230531		OTC MONOGRAPH DRUG	M012	BETTER LIVING BRANDS LLC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-598_708df4f0-806d-4de2-b7c9-8d24afd56859	21130-598	HUMAN OTC DRUG	Cold and Flu	DayTime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-600_b6d3301d-eca7-469f-9970-7d22f677e3ec	21130-600	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-601_0979de78-5329-41cb-928d-769726f58764	21130-601	HUMAN OTC DRUG	Eye Itch Relief		Ketotifen Fumarate	SOLUTION	OPHTHALMIC	20140820		NDA	NDA021996	Safeway	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
21130-602_290eee26-4984-41fb-be8c-90b63704cfcb	21130-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20021112		OTC MONOGRAPH NOT FINAL	part334	Safeway Inc	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-608_fd39cb89-6b3f-69e1-e053-6394a90aff3a	21130-608	HUMAN OTC DRUG	Pain Relief		Naproxen sodium	TABLET	ORAL	20230613		ANDA	ANDA090545	BETTER LIVING BRANDS, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-615_a711c0b6-ef44-4190-9b5a-47279f162976	21130-615	HUMAN OTC DRUG	Severe Sinus Congestion and Pain	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20130630		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-621_f21502e4-736a-05c7-e053-2a95a90a9336	21130-621	HUMAN OTC DRUG	4x Medicated Gum Cream		Benzocaine	CREAM	ORAL	20210507		OTC MONOGRAPH NOT FINAL	part356	Albertsons	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .25; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
21130-624_76a9255e-16d3-459d-b791-68e56c3b32f5	21130-624	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part335	Safeway, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
21130-627_6ab26285-b91d-48a3-93b0-9d3eece850cc	21130-627	HUMAN OTC DRUG	Sinus PE	Head Congestion and Mucus	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20221215		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-628_77c736b5-a467-4a71-8c3e-297269f26238	21130-628	HUMAN OTC DRUG	Signature Care Hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20151103		OTC MONOGRAPH FINAL	part346	Safeway	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-629_0995b70d-ffaf-8d7b-e063-6394a90acb4a	21130-629	HUMAN OTC DRUG	Antacid Plus		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20200801		OTC MONOGRAPH DRUG	M001	BETTER LIVING BRANDS, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-630_a5292bc2-4cf9-4791-a27d-fc41a2517a8b	21130-630	HUMAN OTC DRUG	Signature Care Allergy Relief		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210708		OTC MONOGRAPH FINAL	part341	Safeway	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-635_2cbd838e-2865-451a-86d5-b4fbaf659f03	21130-635	HUMAN OTC DRUG	Signature Care Daytime Cough		Dextromethorphan HBr	SOLUTION	ORAL	20150928		OTC MONOGRAPH FINAL	part341	Safeway	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/15mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-640_0ccf61f2-d1e0-e7ea-e063-6294a90a6339	21130-640	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20230630		ANDA	ANDA209274	SAFEWAY	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-642_565da3b2-4c8f-44ef-8883-5df9e6cb561a	21130-642	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20190331	20240531	OTC MONOGRAPH FINAL	part335	Safeway, Inc.	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
21130-644_f68fed64-a487-41c3-8de8-54b64b6d30cd	21130-644	HUMAN OTC DRUG	signature care allergy relief d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210216		ANDA	ANDA210719	Safeway	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
21130-645_f4351d32-4b78-48b6-b727-71b4d041d5da	21130-645	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20140725		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-646_23e8d6c0-b88d-47aa-b714-d12313af5157	21130-646	HUMAN OTC DRUG	DYE-FREE CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20200901		ANDA	ANDA210088	SAFEWAY	LORATADINE	5	mg/1			N	20241231
21130-649_0995a0e7-dceb-66d7-e063-6394a90ac7d0	21130-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	LIQUID	ORAL	20200801		OTC MONOGRAPH DRUG	M007	BETTER LIVING BRANDS, LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-650_83560aa2-b833-44bd-9ed7-763c10691beb	21130-650	HUMAN OTC DRUG	Cold and Flu	DayTime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20190630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-651_54006210-e6ae-44b5-90bf-c75052ea53f5	21130-651	HUMAN OTC DRUG	Signature Care Athletes foot		tolnaftate	SPRAY	TOPICAL	20151123		OTC MONOGRAPH FINAL	part333C	Safeway	TOLNAFTATE	1	g/100g			N	20241231
21130-656_81dfc089-bf9f-4c44-b483-ec893f692ede	21130-656	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20231128		ANDA	ANDA209207	Albertsons	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-661_0ccf70a9-7914-d5f1-e063-6394a90a9a89	21130-661	HUMAN OTC DRUG	Acetaminophen and Diphenhydramine HCL		Acetaminophen and Diphenhydramine HCL	TABLET	ORAL	20230630		OTC MONOGRAPH DRUG	M013	SAFEWAY	ACETAMINOPHEN; DIPHENHYDRAMINE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-662_9ffb11fb-e209-4110-a4df-295b144b3aae	21130-662	HUMAN OTC DRUG	Ultra Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part335	Safeway, Inc.	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
21130-664_0fe9e0ef-1dc4-4e70-8d7a-6e46397036dd	21130-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19980315		OTC MONOGRAPH NOT FINAL	part356	Better Living Brands LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-668_df533062-8a28-4f86-9cb3-92e7c0833ffd	21130-668	HUMAN OTC DRUG	Signature Care Isopropyl Alcohol Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20230412		OTC MONOGRAPH NOT FINAL	part333E	Better Living Brands LLC	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
21130-674_d2ba6d41-aee0-440c-9054-01d0d2d3a201	21130-674	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET, FILM COATED	ORAL	20231004		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-676_9df6f7d5-a828-47d7-b650-98b7171d2134	21130-676	HUMAN OTC DRUG	Womens Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	Better Living Brands, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-681_0ccfacb0-1b6d-2111-e063-6294a90a7296	21130-681	HUMAN OTC DRUG	Acetaminophen, Aspirin and Caffeine		Acetaminophen, Aspirin and Caffeine	TABLET	ORAL	20230804		ANDA	ANDA214039	Safeway, Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
21130-685_0ac13914-956b-5a36-e063-6294a90a36c9	21130-685	HUMAN OTC DRUG	Signature Care Alcohol Prep Pad		isopropyl alcohol	CLOTH	TOPICAL	20200831		OTC MONOGRAPH DRUG	M003	Better Living Brands LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
21130-689_00a3aae7-2925-4489-8b7b-1b82eb620864	21130-689	HUMAN OTC DRUG	Cough and Cold HBP		chlorpheniramine maleate, dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	Better Living Brands, LLC	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-690_fe75f23c-9c5e-03a4-e053-6294a90a696d	21130-690	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20230613		ANDA	ANDA090545	BETTER LIVING BRANDS LLC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-691_0995af63-7706-4f7a-e063-6294a90a5700	21130-691	HUMAN OTC DRUG	ANTACID PLUS		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20200801		OTC MONOGRAPH DRUG	M001	BETTER LIVING BRANDS LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-694_f45a1689-abd1-432c-a10b-f1b807a5081d	21130-694	HUMAN OTC DRUG	signature care anti nausea		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20150901		UNAPPROVED DRUG OTHER		Safeway	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
21130-695_01ed9809-46e1-ce83-e063-6294a90a73d9	21130-695	HUMAN OTC DRUG	Daytime Cold and Flu and Nigttime Cold and Flu		acetaminophen, dextromethorphan hbr, phenylephrine hcl and acetaminophen, dextromethorphan hbr, doxylamine succinate	KIT	ORAL	20230714		OTC MONOGRAPH FINAL	part341	BETTER LIVING BRANDS LLC.						N	20241231
21130-699_c1708099-423f-42ab-9938-f953f7e520d4	21130-699	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210528		ANDA	ANDA078682	Safeway, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-700_521da7c7-0dda-4f3a-9c0a-b4f2c17098ab	21130-700	HUMAN OTC DRUG	signature care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20151006		ANDA	ANDA077007	Safeway	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-701_8fccd6c6-38c5-477a-8c16-29d8bbffecef	21130-701	HUMAN OTC DRUG	signature care childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190610		ANDA	ANDA076359	Safeway	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-702_0cfa48cc-26af-c528-e063-6394a90a3aa9	21130-702	HUMAN OTC DRUG	Signature Care Eye Drops High Performance		Polyethylene glycol 400, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20181005		OTC MONOGRAPH DRUG	M018	Better Living Brands LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
21130-703_0cfa48cc-26b0-c528-e063-6394a90a3aa9	21130-703	HUMAN OTC DRUG	Signature Care Eye Drops Redness and Dry Eye Relief		Glycerin, Naphazoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20181005		OTC MONOGRAPH DRUG	M018	Better Living Brands LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
21130-704_0cfa02bf-0467-b685-e063-6394a90a728d	21130-704	HUMAN OTC DRUG	Signature Care Eye Drops Advanced Relief		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCl	SOLUTION/ DROPS	OPHTHALMIC	20181005		OTC MONOGRAPH DRUG	M018	Better Living Brands LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	100; 1000; 1000; 50	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
21130-705_0cfa5c76-fce7-9f22-e063-6394a90ade89	21130-705	HUMAN OTC DRUG	Signature Care Lubricant Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20190411		OTC MONOGRAPH DRUG	M018	Better Living Brands LLC	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
21130-708_7007afba-b5ec-4c6c-b5dc-98c2148bba19	21130-708	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20190830		ANDA	ANDA091314	Safeway, Inc.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
21130-709_8e2d583e-a977-468b-81e7-6894f9a8bc42	21130-709	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	BETTER LIVING BRANDS LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-712_06b96778-e304-ed07-e063-6294a90ad9e9	21130-712	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET	ORAL	20230531		ANDA	ANDA078933	BETTER LIVING BRANDS, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-713_46446132-005e-46a0-adf1-94817db3e8be	21130-713	HUMAN OTC DRUG	signature care tussin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180721		OTC MONOGRAPH FINAL	part341	Safeway	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-714_99049a60-d79e-4917-9254-97700a0ee112	21130-714	HUMAN OTC DRUG	signature care esomeprazole magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200702		ANDA	ANDA207193	Safeway	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-716_06ba0236-c86a-344c-e063-6294a90ae469	21130-716	HUMAN OTC DRUG	Dual Action		Acetaminophen, Ibuprofen	TABLET	ORAL	20230830		ANDA	ANDA216994	BETTER LIVING BRANDS, LLC	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-717_fb8fd266-c60a-4055-e053-6394a90a3e28	21130-717	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE	ORAL	20230520		OTC MONOGRAPH FINAL	part332	BETTER LIVING BRANDS, LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
21130-718_0a55d8b3-0539-2e0d-e063-6294a90a92a4	21130-718	HUMAN OTC DRUG	Esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20231020		ANDA	ANDA217264	BETTER LIVING BRANDS, LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-720_c68caf17-6ad0-5ce2-e053-2995a90a5655	21130-720	HUMAN OTC DRUG	SIGNATURE CARE BLEMISH AND BLACKHEAD CONTROL		SALICYLIC ACID	EMULSION	TOPICAL	20140813		OTC MONOGRAPH FINAL	part333D	SAFEWAY, INC.	SALICYLIC ACID	20	mg/g			N	20241231
21130-721_a600c219-5abe-b008-e053-2995a90a1ce2	21130-721	HUMAN OTC DRUG	SIGNATURE CARE SHEER FACE AND BODY SPF 70 SUNSCREEN		Avobenzone, Homosalate,Octisalate,Octocrylene,Oxybenzone	STICK	TOPICAL	20171113		OTC MONOGRAPH NOT FINAL	part352	SAFEWAY, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
21130-722_0a25883f-99a5-2915-e063-6294a90aedc3	21130-722	HUMAN OTC DRUG	SIGNATURE CARE ACNE TREATMENT		SALICYLIC ACID	LIQUID	TOPICAL	20120326		OTC MONOGRAPH DRUG	M020	SAFEWAY, INC.	SALICYLIC ACID	20	mg/mL			N	20241231
21130-723_d4f30568-37b5-2d92-e053-2a95a90a7ef8	21130-723	HUMAN OTC DRUG	OPEN NATURE SPF 50 MINERAL SUNSCREEN		ZINC OXIDE	LOTION	TOPICAL	20181205		OTC MONOGRAPH FINAL	part346	SAFEWAY, INC.	ZINC OXIDE	216	mg/mL			N	20241231
21130-724_92f68316-fe4c-4e9f-8f18-cbb66ac6deae	21130-724	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Safeway Inc.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
21130-725_dbed8ec9-c91a-4ba7-e053-2995a90afdc9	21130-725	HUMAN OTC DRUG	OPEN NATURE CHILDREN SPF 50 MINERAL SUNSCREEN		Zinc Oxide	LOTION	TOPICAL	20181205		OTC MONOGRAPH NOT FINAL	part352	SAFEWAY, INC.	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
21130-726_f12ff250-666d-6860-e053-2995a90a1a69	21130-726	HUMAN OTC DRUG	SIGNATURE CARE	SPORT SPF 50 SUNSCREEN	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20170816		OTC MONOGRAPH NOT FINAL	part352	SAFEWAY, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
21130-727_e3de504b-1684-5681-e053-2a95a90a5db4	21130-727	HUMAN OTC DRUG	SIGNATURE CARE	SPORT SPF 30 SUNSCREEN	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20170816		OTC MONOGRAPH NOT FINAL	part352	SAFEWAY, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
21130-728_ca6ebd4e-76a7-4eba-8198-fe0488a60c81	21130-728	HUMAN OTC DRUG	Better Living		Phenylephrine hydrochloride	SPRAY	NASAL	20190417		OTC MONOGRAPH DRUG	M012	BETTER LIVING BRANDS LLC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-729_e3de5415-5cbc-5d03-e053-2a95a90a9d93	21130-729	HUMAN OTC DRUG	SIGNATURE CARE	SPORT SPF 30 SUNSCREEN	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20170816		OTC MONOGRAPH NOT FINAL	part352	SAFEWAY, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
21130-730_a62b127a-c771-33a3-e053-2995a90af586	21130-730	HUMAN OTC DRUG	SIGNATURE CARE ACNE MEDICATION		BENZOYL PEROXIDE	GEL	TOPICAL	20141208		OTC MONOGRAPH FINAL	part333D	SAFEWAY, INC.	BENZOYL PEROXIDE	100	mg/g			N	20241231
21130-731_c6a0abad-c06c-6472-e053-2995a90adc8a	21130-731	HUMAN OTC DRUG	Safeway Signature Care Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20111214		OTC MONOGRAPH NOT FINAL	part352	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
21130-732_8106715b-00f4-4974-797d-b6a652d000ed	21130-732	HUMAN OTC DRUG	Allergy Relief		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180630		ANDA	ANDA210375	Albertsons Companies	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-733_d50695c6-c237-efb6-e053-2995a90aff04	21130-733	HUMAN OTC DRUG	Signature Care Aloe Vera Gel with Lidocaine		Lidocaine	GEL	TOPICAL	20111214		OTC MONOGRAPH NOT FINAL	part348	Safeway, Inc.	LIDOCAINE HYDROCHLORIDE	8	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
21130-734_baee6a77-3513-5e44-e053-2995a90afa7f	21130-734	HUMAN OTC DRUG	Signature Care Oil Free Acne Wash Pink Grapefruit Foaming Scrub		Salicylic Acid	LOTION	TOPICAL	20140813		OTC MONOGRAPH FINAL	part333D	Safeway, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
21130-736_baf1c2c9-4be8-7ea6-e053-2a95a90a72bf	21130-736	HUMAN OTC DRUG	Signature Care Sport SPF 15 Clear		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20111214		OTC MONOGRAPH NOT FINAL	part352	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-737_bac509a0-2806-418f-a36e-3023f30a7b79	21130-737	HUMAN OTC DRUG	Signature Care miconazole 1		Miconazole nitrate	KIT		20180711		ANDA	ANDA079114	Safeway						N	20241231
21130-738_37e600d3-ac83-49cd-bd69-aca133b98bdd	21130-738	HUMAN OTC DRUG	Maximum Strength Severe Congestion and Cough		Dextromethorphan HBr, Guaifenesin, and Phenylephrine HCl	LIQUID	ORAL	20200930		OTC MONOGRAPH DRUG	M012	SAFEWAY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-739_c5106c63-af52-c169-e053-2a95a90afef2	21130-739	HUMAN OTC DRUG	CVS Health	SPF 70 Ultra Sheer	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20111214		OTC MONOGRAPH NOT FINAL	part352	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-740_c6266a46-f28d-e583-e053-2995a90a7f6b	21130-740	HUMAN OTC DRUG	Safeway Signature Care Dry Touch Sunscreen SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20191011		OTC MONOGRAPH NOT FINAL	part352	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-741_a6a2cd63-5e78-45f1-aa6b-19616f9569ec	21130-741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20181205	20250228	ANDA	ANDA207235	Safeway, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
21130-743_a62a3a16-f716-2433-e053-2995a90a6804	21130-743	HUMAN OTC DRUG	SIGNATURE CARE	KIDS SPF 50 SUNSCREEN	HOMOSALATE, OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	LOTION	TOPICAL	20120104		OTC MONOGRAPH NOT FINAL	part352	SAFEWAY, INC.	HOMOSALATE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	150; 75; 50; 24	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-744_d5669bbf-0ab0-9869-e053-2a95a90ae415	21130-744	HUMAN OTC DRUG	Safeway Signature Sport Continuous Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20111214		OTC MONOGRAPH NOT FINAL	part352	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
21130-745_c5e53f68-745d-4592-8fb1-c6ad2c6a2ac9	21130-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228		ANDA	ANDA206568	Safeway, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-746_995c9a42-f8b9-478e-8adb-03ce45229072	21130-746	HUMAN OTC DRUG	better living brands childrens fever and pain reliver		Acetaminophen	SUSPENSION	ORAL	20190402		OTC MONOGRAPH DRUG	M013	BETTER LIVING BRANDS LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
21130-747_d61d5c6c-536b-cae4-e053-2a95a90ac1cf	21130-747	HUMAN OTC DRUG	Safeway Signature Care Kids Continuous Sunscreen Broad Spectrum SPF 50		Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	SPRAY	TOPICAL	20141202		OTC MONOGRAPH NOT FINAL	part352	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
21130-748_e1315d6f-a957-421c-b5b9-c7fee91e7315	21130-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	Safeway, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-750_51673d4a-81fc-48a3-af28-97d9dc685fde	21130-750	HUMAN OTC DRUG	Signature Care Hair Regrowth Treatment for men		Minoxidil	AEROSOL, FOAM	TOPICAL	20150904		ANDA	ANDA091344	Safeway	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
21130-751_dbeff89e-bc6d-9301-e053-2a95a90af7af	21130-751	HUMAN OTC DRUG	Open Nature Zinc Oxide Sunscreen Mineral Sunscreen SPF 30		Zinc Oxide	LOTION	TOPICAL	20181205		OTC MONOGRAPH NOT FINAL	part352	Safeway, Inc.	ZINC OXIDE	182.4	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
21130-752_f557a3f2-336c-1ee3-e053-2995a90a88d8	21130-752	HUMAN OTC DRUG	Safeway Signature Sport Sunscreen SPF 30		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20111214		OTC MONOGRAPH FINAL	M020	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
21130-753_f55912f6-d5fa-d9f4-e053-2a95a90adfb7	21130-753	HUMAN OTC DRUG	Safeway Signature Care No Breakout Sunscreen Face SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20191015		OTC MONOGRAPH FINAL	M020	Safeway, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 60; 40; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
21130-755_0cfa5f56-a6f2-c541-e063-6394a90a811a	21130-755	HUMAN OTC DRUG	Signature Care Eye Drops A.C.		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20230324		OTC MONOGRAPH DRUG	M018	Better Living Brands LLC	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
21130-756_0d38a141-af14-a727-e063-6294a90a716c	21130-756	HUMAN OTC DRUG	Signature Care Lubricant Eye Drops Long Lasting		Polyethylene glycol 400, propylene glycol	SOLUTION	OPHTHALMIC	20180402		OTC MONOGRAPH DRUG	M018	Better Living Brands, LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
21130-757_a7efa791-33f2-4059-9846-df08bc138cc1	21130-757	HUMAN OTC DRUG	signature care first aid antibiotic		Bacitracin	OINTMENT	TOPICAL	20150914		OTC MONOGRAPH FINAL	part333B	Safeway	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
21130-763_ecb11e10-e0b0-42e1-ae00-8bf360eeff4c	21130-763	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Better Living Brands, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-769_0ccfe788-9681-211b-e063-6394a90a6100	21130-769	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20231106		ANDA	ANDA211075	Safeway, Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-770_3048b39d-47ec-470e-9a8c-b2bad43d6088	21130-770	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Safeway, Inc.	DOCOSANOL	100	mg/g			N	20241231
21130-773_26725826-f6de-4c36-a72c-0471984181c4	21130-773	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, FILM COATED	ORAL	20221121		OTC MONOGRAPH DRUG	505G(a)(3)	Better Living Brands, LLC	SENNOSIDES	25	mg/1			N	20241231
21130-777_9dfc87b3-cb54-427e-a28f-850117e8103b	21130-777	HUMAN OTC DRUG	Signature Care Acid Controller	maximum strength	Famotidine	TABLET, FILM COATED	ORAL	20150904		ANDA	ANDA077351	Safeway	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
21130-778_3725d328-7909-46ae-b120-d71eb4c2c601	21130-778	HUMAN OTC DRUG	Motion Sickness Relief	Less Drowsy	Meclizine HCl	TABLET	ORAL	20020624		OTC MONOGRAPH DRUG	M009	Better Living Brands, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
21130-780_0d1c8cd2-44d5-8be6-e063-6394a90a9478	21130-780	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20230630		ANDA	ANDA210722	Safeway, Inc	LORATADINE	10	mg/1			N	20241231
21130-784_763513d2-273c-404d-8f8f-6df12b44fc6b	21130-784	HUMAN OTC DRUG	Allergy Relief		Fexofenadine hydrochloride	TABLET	ORAL	20130422		ANDA	ANDA076502	Safeway Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-789_effad365-d76f-71af-e053-2995a90aa020	21130-789	HUMAN OTC DRUG	Signature Care Hemorrhoidal		Mineral oil, Petrolatum, and Phenylephrine HCI	OINTMENT	TOPICAL	20160120		OTC MONOGRAPH FINAL	part346	Better Living Brands, LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-792_d700a3b8-35bd-48b1-9858-d4ab122fc9d0	21130-792	HUMAN OTC DRUG	Signature Care Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20191223		UNAPPROVED DRUG OTHER		Safeway	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
21130-793_9f7ea9f6-3e9c-4c14-bded-ec7b20db96fe	21130-793	HUMAN OTC DRUG	Ear Wax Removal Aid Drops		Carbamide peroxide	LIQUID	AURICULAR (OTIC)	20200113		OTC MONOGRAPH DRUG	M022	BETTER LIVING BRANDS, LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
21130-795_b4e8c8eb-ac2d-41f2-9317-d832a69fbd15	21130-795	HUMAN OTC DRUG	signature care antacid plus gas relief		Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20150901		OTC MONOGRAPH FINAL	part331	Safeway	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-800_adf26111-70bb-596c-e053-2995a90ac6f1	21130-800	HUMAN OTC DRUG	Signature Care Medicated Wipes Hemorrhoidal Wipes with Witch Hazel		Hemorrhoidal Wipes with Witch Hazel	CLOTH	TOPICAL	20200828		OTC MONOGRAPH FINAL	part346	Better Living Brands LLC	WITCH HAZEL	.5	mg/mL			N	20241231
21130-801_b4ab573c-d86b-42ea-90fd-14de8f8c7892	21130-801	HUMAN OTC DRUG	Signature Care Nasal Decongestant		Oxymetazoline HCl	SPRAY	NASAL	20150709		OTC MONOGRAPH FINAL	part341	Safeway	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
21130-802_a8718131-c1a5-4033-a65d-d9007e34f88c	21130-802	HUMAN OTC DRUG	signature care naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20180702		ANDA	ANDA074661	Safeway	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-803_6c8e5439-4ee4-4796-a1a6-4dec91dd1666	21130-803	HUMAN OTC DRUG	Vitamin A D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20121112		OTC MONOGRAPH FINAL	part347	Lucerne North America LLC	LANOLIN; PETROLATUM	133; 459	mg/g; mg/g			N	20241231
21130-804_83083259-97d6-44ef-a44a-e1c1f5203cf3	21130-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20090513		OTC MONOGRAPH NOT FINAL	part333A	Better Living Brands LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
21130-808_62ae1f99-df76-4b36-a99c-75e9305be11c	21130-808	HUMAN OTC DRUG	signature care naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20190620		ANDA	ANDA208499	Safeway	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-810_35690951-a1fb-4176-8913-aa76f6093723	21130-810	HUMAN OTC DRUG	70% Isopropyl Rubbing Alcohol		Isopropyl Rubbing Alcohol	SOLUTION	TOPICAL	20150701		OTC MONOGRAPH NOT FINAL	part333A	Better Living Brands LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
21130-811_cd9229df-350f-43a7-a0c7-cbc969e81316	21130-811	HUMAN OTC DRUG	signature care daytime severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20200704		OTC MONOGRAPH FINAL	part341	Safeway	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-813_7271f2d7-419a-4900-9d25-c14842195a89	21130-813	HUMAN OTC DRUG	signature care nasal decongestant		oxymetazoline hydrochloride	SPRAY	NASAL	20190531		OTC MONOGRAPH FINAL	part341	Safeway	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
21130-814_0d1ba355-dfbd-8307-e063-6294a90a1ac8	21130-814	HUMAN OTC DRUG	Naproxen Sodium Diphenhydramine Hydrochloride		Naproxen Sodium Diphenhydramine Hydrochloride	TABLET	ORAL	20230630		ANDA	ANDA213663	SAFEWAY	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-816_ec252533-4721-472d-8a53-e4eeb9a9c195	21130-816	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCL	CAPSULE	ORAL	20191129		OTC MONOGRAPH FINAL	part338	Safeway, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-818_bb90d586-be7a-4a3a-8c5c-a9916dce83d3	21130-818	HUMAN OTC DRUG	Signature Care Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150914		ANDA	ANDA072096	Safeway	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-819_702ecdce-9115-4017-b7cd-d975e43128d9	21130-819	HUMAN OTC DRUG	signature care hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20210529		ANDA	ANDA075598	Safeway	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
21130-820_44b45a9f-656f-4308-8d1e-83c68e606182	21130-820	HUMAN OTC DRUG	signature care nicotine		nicotine	GUM, CHEWING	ORAL	20190910		ANDA	ANDA206393	Safeway	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
21130-821_5b9a25ff-85f1-4d0b-b1bf-e7e78351e0a1	21130-821	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20210917		ANDA	ANDA211075	Safeway, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-822_a60b9cc2-5fa0-4e77-8aae-70bdf7f6197b	21130-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20150618		OTC MONOGRAPH FINAL	part346	Better Living Brands LLC	WITCH HAZEL	979	mg/mL			N	20241231
21130-823_9fabafb6-3474-489a-948e-4ceaf35afa0f	21130-823	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20210730		ANDA	ANDA208754	Safeway, Inc.	DOCOSANOL	100	mg/g			N	20241231
21130-825_8fb5cd26-54da-4d81-943b-1b029706e77a	21130-825	HUMAN OTC DRUG	signature care miconazole 7		miconazole nitrate	CREAM	VAGINAL	20181106		ANDA	ANDA074760	Safeway	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-827_e6f75805-c339-45dd-ad21-be56974436c4	21130-827	HUMAN OTC DRUG	Gentle Overnight Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20200203		OTC MONOGRAPH DRUG	505G(a)(3)	Better Living Brands, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-829_1cecd2eb-7b9c-449f-baa3-fd7b3dc9bc14	21130-829	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
21130-830_34d7e5ce-c6e5-4ae8-ba44-bc8fcfc53d93	21130-830	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20181231	20250228	OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
21130-832_c55bdfbb-1f34-4582-a18d-83a2a69b708f	21130-832	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190131	20250228	OTC MONOGRAPH FINAL	part332	Safeway, Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
21130-843_b6cf01a1-5363-4c23-8c14-ea343c1738f2	21130-843	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20181205		ANDA	ANDA206568	Safeway, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-845_0faf17b3-18f2-4252-9658-558209e76acc	21130-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20150626		OTC MONOGRAPH FINAL	part344	Better Living Brands	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
21130-847_b877c915-fe23-481a-bc42-67d9419127f8	21130-847	HUMAN OTC DRUG	signature care clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20150901		ANDA	ANDA090685	Safeway	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-849_a19eb5b4-4e54-4401-86a3-279a839b7702	21130-849	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190630		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-853_d9467d51-1c10-4e5d-9135-5370431f4a00	21130-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210129		OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
21130-855_931f8434-b6bb-4d7a-9133-74118a906215	21130-855	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20210129		OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
21130-856_a750b94d-6353-4063-bf4a-fc1fc83d184b	21130-856	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20231011		ANDA	ANDA204872	Better Living Brands, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-860_bff64735-5d2a-4dee-a787-7c28334ae0f1	21130-860	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20191129		OTC MONOGRAPH FINAL	part338	Safeway, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
21130-861_efe6e7e9-63dd-16b8-e053-2995a90a1885	21130-861	HUMAN OTC DRUG	Signature Care Cold and Hot		Menthol, and Methyl Salicylate	CREAM	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part348	Safeway Inc.	MENTHOL; METHYL SALICYLATE	10; 30	g/100g; g/100g			N	20241231
21130-866_76a7152f-4484-4475-8b47-7eb2cef359e7	21130-866	HUMAN OTC DRUG	Day Time Cold and Flu Relief	non drowsy	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150831		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-870_efe6f24d-e0d5-42dc-e053-2995a90a71d3	21130-870	HUMAN OTC DRUG	Signature Care Athletes Foot		Clotrimazole	CREAM	TOPICAL	20220210		OTC MONOGRAPH FINAL	part333C	Safeway	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
21130-871_e0afaf6f-e50f-4c2d-b176-4c61fcdc32ba	21130-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20150618		OTC MONOGRAPH NOT FINAL	part333A	Better Living Brands LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
21130-877_7a04c69f-83d3-46ce-a174-b45625103b3d	21130-877	HUMAN OTC DRUG	signature care ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150914		ANDA	ANDA077349	Safeway	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-878_9071ba84-ba91-4915-b92e-9382d312e4b6	21130-878	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20200930		OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
21130-880_87751e78-8c27-4178-bd26-b1dc728ea53d	21130-880	HUMAN OTC DRUG	Zinc Cold Therapy		ZINC GLUCONATE	TABLET, CHEWABLE	ORAL	20180228		UNAPPROVED HOMEOPATHIC		BETTER LIVING BRANDS LLC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
21130-881_d0019bee-b9d8-4846-8b7f-055001184e43	21130-881	HUMAN OTC DRUG	Zinc Cold Therapy		ZINC GLUCONATE	TABLET, CHEWABLE	ORAL	20180228		UNAPPROVED HOMEOPATHIC		BETTER LIVING BRANDS LLC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
21130-883_bf25d26e-b534-4358-944f-0227db0f6f3d	21130-883	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
21130-887_e2b1d3ec-3ee1-76f2-e053-2995a90accf9	21130-887	HUMAN OTC DRUG	Signature Care Antifungal Cream Tolnaftate 1%		Tolnaftate	CREAM	TOPICAL	20220104		OTC MONOGRAPH FINAL	part333C	BETTER LIVING BRANDS LLC	TOLNAFTATE	10	mg/g			N	20241231
21130-890_11838dd7-aea8-45f5-a25a-374b2e8858f6	21130-890	HUMAN OTC DRUG	signature care childrens 12 hour cough relief		Dextromethorphan polistirex	SUSPENSION	ORAL	20220527		ANDA	ANDA091135	Safeway	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-898_2e0c7551-18ee-4fdc-b440-97eeed78a711	21130-898	HUMAN OTC DRUG	Oatmeal		Dimethicone	LOTION	TOPICAL	20160309		OTC MONOGRAPH FINAL	part347	Better Living Brands, LLC	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
21130-899_e7422ddd-1963-45e8-a15b-397b6687764e	21130-899	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH FINAL	part341	Safeway, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-900_01b0f74a-a5a7-977e-e063-6394a90aa48e	21130-900	HUMAN OTC DRUG	Daytime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	BETTER LIVING BRANDS LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-901_0b93aded-9bcb-46c9-8df9-0031e1d864a0	21130-901	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20191227		OTC MONOGRAPH FINAL	part341	Safeway, Inc.						N	20241231
21130-904_a0fd5eb9-1f8b-4e6d-967a-24bd9ac3fa31	21130-904	HUMAN OTC DRUG	Pain Relief	Regular Strength, Aspirin Free	Acetaminophen	TABLET	ORAL	19900713		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN	325	mg/1			N	20251231
21130-906_8499982b-139a-42a9-8db3-28744ce068d9	21130-906	HUMAN OTC DRUG	Daytime Mucus Relief Severe Cold and Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20200131	20250228	OTC MONOGRAPH FINAL	part341	Safeway, Inc.						N	
21130-911_ea4c7e45-b602-4d8d-a98d-6a18a6e52f9a	21130-911	HUMAN OTC DRUG	signature care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20150904		ANDA	ANDA074937	Safeway	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-912_aaf5f461-574a-41f7-8b91-9e3c3bd20301	21130-912	HUMAN OTC DRUG	Vitamin A D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20171101		OTC MONOGRAPH DRUG	M016	Better Living Brands, LLC	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
21130-914_caec4d72-3aae-469d-9682-4b5fd07f01c9	21130-914	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20230331		ANDA	ANDA075209	Safeway, Inc.	LORATADINE	10	mg/1			N	20241231
21130-918_9f48e98f-5aa0-40a0-a11d-a6592b1878b8	21130-918	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	19900912		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-919_247310d1-7b6b-483f-89a2-d119786526ee	21130-919	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510	20240810	OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN	500	mg/1			N	
21130-920_ef6771dd-42a7-4ab6-8d0f-ba6040ff74c2	21130-920	HUMAN OTC DRUG	Daytime Mucus Relief Severe Cold and Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20190131	20250530	OTC MONOGRAPH FINAL	part341	Safeway, Inc.						N	
21130-921_95893e11-868f-4252-9ee2-20bc7a6d8347	21130-921	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Better Living Brands, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-926_8b9a5e10-02a5-4a3d-a4c2-83ca4e47c02d	21130-926	HUMAN OTC DRUG	Esomeprazole		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20221207		ANDA	ANDA212866	Safeway, Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
21130-927_d68c62e6-d57b-4974-a478-4bcd46520137	21130-927	HUMAN OTC DRUG	Sinus PE	Pressure, Pain and Mucus	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806	20250209	OTC MONOGRAPH FINAL	part341	Better Living Brands, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
21130-928_fae282cb-c367-3f20-e053-6294a90a61b8	21130-928	HUMAN OTC DRUG	Signature Care Medicated Cooling		Witch Hazel	CLOTH	TOPICAL	20161003		OTC MONOGRAPH FINAL	part346	Better Living Brands, LLC	WITCH HAZEL	500	mg/1			N	20241231
21130-937_09e2469a-d967-4852-95ad-d3d69fb95f14	21130-937	HUMAN OTC DRUG	signature care daytime severe cold		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20190517		OTC MONOGRAPH FINAL	part341	Safeway	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-940_01ebe37d-ae8d-2d2d-e063-6294a90ab090	21130-940	HUMAN OTC DRUG	Nighttime cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20230710		OTC MONOGRAPH FINAL	part341	BETTER LIVING BRANDS LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-941_c947df22-77f6-4fe4-b469-88e3964a880e	21130-941	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20150615		OTC MONOGRAPH FINAL	part347	Better Living Brands LLC	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; mg/mL			N	20241231
21130-942_4d334dfb-f5ba-4cb8-bb2c-69b404d45b81	21130-942	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20061011		OTC MONOGRAPH DRUG	M032	Living Better Brands LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
21130-944_9d3ed253-2e7f-4d5d-9161-276b81f3cecd	21130-944	HUMAN OTC DRUG	Awake	Maximum Strength	Caffeine	TABLET, FILM COATED	ORAL	19980414		OTC MONOGRAPH DRUG	M011	Better Living Brands, LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
21130-945_883c2a0a-c4c3-49b8-a649-8110df1e1eb8	21130-945	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	SOLUTION	ORAL	20210715		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN	1000	mg/30mL			N	20241231
21130-948_064b37c7-b1ce-4328-e063-6294a90a706c	21130-948	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20230926		NDA	NDA021920	Albertsons Companies	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-952_ac51da2b-4ccd-470a-ab56-91f06b15f055	21130-952	HUMAN OTC DRUG	Clear Anti Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20090428		OTC MONOGRAPH FINAL	part347	Better Living Brands LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
21130-956_08066632-3740-6360-e063-6294a90a2b5e	21130-956	HUMAN OTC DRUG	Signature Care Original		Oxymetazoline Hydrochloride	SPRAY	NASAL	20231018		OTC MONOGRAPH DRUG	M012	SAFEWAY, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
21130-957_e590b495-b8d4-4de6-baf3-eb7d7ad1311c	21130-957	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
21130-959_dcedccdc-552e-4b7e-b2f3-b524124ab858	21130-959	HUMAN OTC DRUG	Pain Relief	Added Strength	Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	19921117		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
21130-960_dc287aeb-1df4-119c-e053-2995a90af7c8	21130-960	HUMAN OTC DRUG	Albertsons Pain Relief Patch		LIDOCAINE	PATCH	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part348	Safeway	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
21130-961_dc645935-aa51-d07e-e053-2a95a90aa0d7	21130-961	HUMAN OTC DRUG	Albertson Lidocaine, Menthol Pain Relief Medicated Patch		lidocaine and menthol	PATCH	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part348	Safeway	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
21130-965_b5219cd2-cda9-402c-b0d6-953bd4ef6340	21130-965	HUMAN OTC DRUG	Butenafine Hydrochloride		Butenafine Hydrochloride	CREAM	TOPICAL	20230419		ANDA	ANDA205181	Albertsons	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
21130-969_a22e9a0c-12cf-419b-a141-b45b72e204c8	21130-969	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part333A	Safeway, Inc.	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
21130-970_e303090b-7755-4fe8-8545-727d0742f7be	21130-970	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part334	Safeway, Inc.	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
21130-975_ceb4a39e-d20c-4904-8792-282685439686	21130-975	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
21130-976_693ce6a4-763f-4783-bd36-543a16b3f81d	21130-976	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part333A	Safeway, Inc.	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
21130-977_2eb19211-096d-4b05-a6ff-5834468d957a	21130-977	HUMAN OTC DRUG	Isopropyl Alcohol Wintergreen		Isopropyl Alcohol	LIQUID	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part333A	Safeway, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
21130-978_f3f0f6a7-de67-4eb8-ba47-89d95be9a528	21130-978	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part333A	Safeway, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
21130-979_23f516cf-1847-4011-978b-f01d2a736fde	21130-979	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part356	Safeway, Inc.	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
21130-980_f640e547-cdcf-c487-e053-2995a90a792e	21130-980	HUMAN OTC DRUG	Signature Care Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part348	Safeway	MENTHOL, UNSPECIFIED FORM	50	mg/1			N	20241231
21130-981_b818fe52-e46a-0291-e053-2a95a90ad31b	21130-981	HUMAN OTC DRUG	Signature Care Hemorrhoidal Cream (with applicator)		Phenylephrine Hydrochloride, Pramoxine Hydrochloride, Glycerin, Petrolatum	CREAM	TOPICAL	20210104		OTC MONOGRAPH FINAL	part346	BETTER LIVING BRANDS, LLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	144; 150; 2.5; 10	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
21130-982_29376910-47c8-4b3b-9f7f-642c0d863c95	21130-982	HUMAN OTC DRUG	signature care miconazole 3		Miconazole nitrate	KIT		20151209		ANDA	ANDA076357	Safeway						N	20241231
21130-986_55826382-855d-433f-bf24-aaf1c8418340	21130-986	HUMAN OTC DRUG	Nighttime Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190715		ANDA	ANDA040564	Better Living Brands, LLC	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
21130-989_6969dca1-003e-4ca2-921b-2e7122c032ef	21130-989	HUMAN OTC DRUG	Mucus Relief DM MAXIMUM STRENGTH		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Better Living Brands LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-990_1d731ca7-4be1-4a31-aca4-cc8c9a78dda3	21130-990	HUMAN OTC DRUG	Menstrual Relief	Extra Strength	Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	Better Living Brands, LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
21130-992_01efeeef-bb93-3c38-e063-6294a90a86bb	21130-992	HUMAN OTC DRUG	Ibuprofen		Ibuprofen Tablets USP, 200mg	TABLET	ORAL	20230808		ANDA	ANDA091237	BETTER LIVING BRANDS, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21130-993_3381808a-38b2-41f9-9e30-853d7f6af372	21130-993	HUMAN OTC DRUG	Signature Care Hydrocortisone		hydrocortisone	CREAM	TOPICAL	20151110		OTC MONOGRAPH NOT FINAL	part348	Safeway	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21130-997_1d696cae-24d2-486f-937c-2b59784ac068	21130-997	HUMAN OTC DRUG	MUCUS RELIEF DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Better Living Brands LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
21130-998_01610e58-5ed1-ea20-e063-6394a90adf6c	21130-998	HUMAN OTC DRUG	Vegetable Laxative		Sennosides	TABLET	ORAL	20230612		OTC MONOGRAPH NOT FINAL	part334	BETTER LIVING BRANDS LLC.	SENNOSIDES A AND B	8.6	mg/1			N	20241231
21130-999_ba7cb110-d9f2-45f3-a21e-729345e8dd21	21130-999	HUMAN OTC DRUG	CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20190701		ANDA	ANDA210088	SAFEWAY	LORATADINE	5	mg/1			N	20241231
21220-119_080216bf-b975-8e8d-e063-6294a90ac8de	21220-119	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19720601		NDA	NDA205849	General Air Service & Supply Co	OXYGEN	995	mL/L			N	20241231
21220-120_080200ff-2d01-2dac-e063-6294a90a72dd	21220-120	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19740801		NDA	NDA205850	General Air Service & Supply Co	NITROGEN	999	mL/L			N	20241231
21220-122_080216bf-b974-8e8d-e063-6294a90ac8de	21220-122	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19761101		NDA	NDA205704	General Air Service & Supply Co	NITROUS OXIDE	995	mL/L			N	20241231
21220-123_080216bf-b96d-8e8d-e063-6294a90ac8de	21220-123	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19720601		NDA	NDA207166	General Air Service & Supply Co.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
21220-130_0801f94f-185a-573f-e063-6394a90ad85a	21220-130	HUMAN PRESCRIPTION DRUG	Oxygen Nitrogen Mixture		Oxygen Nitrogen Mixture	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205849	General Air Service & Supply Co.	OXYGEN	200	mL/L			N	20241231
21220-152_0802113f-b621-2ff9-e063-6294a90a5cb1	21220-152	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19740801		NDA	NDA205849	General Air Service & Supply Co	OXYGEN	210	mL/L			N	20241231
21220-155_08021bfc-d1e1-90a4-e063-6294a90a7759	21220-155	HUMAN PRESCRIPTION DRUG	Helium/Oxygen Mixture 80/20		Helium/Oxygen Mixture 80/20	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205849	General Air Service & Supply Co.	OXYGEN	200	mL/L			N	20241231
21220-156_080216bf-b973-8e8d-e063-6294a90ac8de	21220-156	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Oxygen Mixture		Carbon Dioxide Oxygen Mixture	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205849	General Air Service & Supply Co	OXYGEN	800	mL/L			N	20241231
21220-157_0802166a-c5b3-381e-e063-6394a90ad606	21220-157	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Air Mixture		Carbon Dioxide Air Mixture	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205852	General Air Service & Supply Co	CARBON DIOXIDE	50	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
21220-158_08021bfc-d1e3-90a4-e063-6294a90a7759	21220-158	HUMAN PRESCRIPTION DRUG	Helium/Oxygen Mixture 70/30		Helium/Oxygen Mixture 70/30	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205849	General Air Service & Supply Co	OXYGEN	300	mL/L			N	20241231
21220-200_0802166a-c5b4-381e-e063-6394a90ad606	21220-200	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	19580101		NDA	NDA216307	General Air Service & Supply Co	HELIUM	990	mL/L			N	20241231
21221-001_0a4a0de1-6fec-bf9a-e063-6394a90a32d9	21221-001	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20060303		NDA	NDA205850	General Cryogenic Technologies LLC	NITROGEN	990	mL/L			N	20241231
21221-002_0a4a28e0-0ba3-cc11-e063-6394a90a1cfc	21221-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20060303		NDA	NDA205849	General Cryogenic Technologies LLC	OXYGEN	995	mL/L			N	20241231
21586-011_4f8f6256-55f4-40ae-8112-6fbc5cc39b6d	21586-011	HUMAN PRESCRIPTION DRUG	Cefotaxime		cefotaxime injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190801		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		SteriMax Inc.	CEFOTAXIME SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
21586-012_4f8f6256-55f4-40ae-8112-6fbc5cc39b6d	21586-012	HUMAN PRESCRIPTION DRUG	Cefotaxime		cefotaxime injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190801		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		SteriMax Inc.	CEFOTAXIME SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
21624-001_0802489a-3813-cc8b-e063-6294a90a9b4e	21624-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19500101		NDA	NDA205889	Island Supply Welding Co Inc	OXYGEN	995	mL/L			N	20241231
21724-701_64cf0f22-82e3-4704-99a6-6a19c395bb89	21724-701	HUMAN PRESCRIPTION DRUG	PROCENTRA		dextroamphetamine sulfate	SOLUTION	ORAL	20140515		ANDA	ANDA040776	INDEPENDENCE PHARMACEUTICALS, LLC	DEXTROAMPHETAMINE SULFATE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
21749-022_ee69d167-3e98-4708-a1c1-ba5aeb198a9b	21749-022	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Biobased Content		ALCOHOL	LIQUID	TOPICAL	20170415		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-027_635d36a9-318e-4788-b238-4b4ac798365e	21749-027	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer be Peaceful		alcohol	GEL	TOPICAL	20161222		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-028_e041f4eb-d820-471f-84b4-291aacdd27ba	21749-028	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer be Vibrant		alcohol	GEL	TOPICAL	20161222		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-029_f5fc7233-5ba1-4da7-9a48-963dd0a58cd1	21749-029	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer be Blissful		alcohol	GEL	TOPICAL	20161222		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-050_7ee67b65-fd9a-4666-90f2-9cbb0cb8ade3	21749-050	HUMAN OTC DRUG	GOJO Antimicrobial Ltn Sp		Chloroxylenol	LIQUID	TOPICAL	20030713		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-060_e491e751-81f5-48f0-8d05-e872d343d3b8	21749-060	HUMAN OTC DRUG	GOJO RICH PINK Antibacterial Ltn Sp		Chloroxylenol	LIQUID	TOPICAL	20030731		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-080_8d549c49-e86f-4db5-9ef4-18872d9fc3f2	21749-080	HUMAN OTC DRUG	Luxury Foam Antibacterial		Chloroxylenol	LIQUID	TOPICAL	20120111		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-085_b756754c-0f2c-4740-8d82-e255057de0b8	21749-085	HUMAN OTC DRUG	Premium Foam Antibacterial		Chloroxylenol	LIQUID	TOPICAL	20120111		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-090_2f660ed5-b08e-47f2-8e3b-32415aa9a7bd	21749-090	HUMAN OTC DRUG	PROVON Foaming Antimicrobial Handwash with Moisturizers		Chloroxylenol	LIQUID	TOPICAL	20030713		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-095_53f64ed6-43d0-4d84-a11d-332f2d5fe989	21749-095	HUMAN OTC DRUG	MICRELL Antibacterial Foam Handwash		CHLOROXYLENOL	LIQUID	TOPICAL	20060623		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.005	mg/mL			N	20241231
21749-106_8b9f34c8-0963-0da2-e053-2a95a90a4e2d	21749-106	HUMAN OTC DRUG	Antimicrobial Skin Cleanser		Chlorhexidine Gluconate 2% Solution	LIQUID	TOPICAL	20080301		NDA	NDA019422	Gojo Industries, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
21749-111_1ab2bc75-1e8f-4e54-9fcb-6b7273e845de	21749-111	HUMAN OTC DRUG	PURELL Food Processing HEALTHY SOA P BAK E2 Antimicrobial Foam Soa p		Benzalkonium Chloride	LIQUID	TOPICAL	20190301		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
21749-112_816c8471-e491-4030-a1c8-13f6dbe2cc5b	21749-112	HUMAN OTC DRUG	GOJO E2 Foam Handwash with BAK		Benzalkonium Chloride	LIQUID	TOPICAL	20190301		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
21749-113_f582dd9c-bc99-40b3-b52f-9c5a9e3422bf	21749-113	HUMAN OTC DRUG	PURELL HEALTHY SP BAK E2 Antimicrobial Foam Sp		Benzalkonium Chloride	LIQUID	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
21749-114_6e2482d2-8090-4126-b743-0169fa71f89f	21749-114	HUMAN OTC DRUG	PURELL Antimicrobial Fragrance Free Foaming Hand SP		Benzalkonium Chloride	LIQUID	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
21749-127_62e0867d-6422-4a68-b133-dd4d5c791905	21749-127	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Calming Lavender		alcohol	GEL	TOPICAL	20211206		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	70	mL/100mL			N	20251231
21749-128_fd9dbfd5-ea56-4653-826b-6f202d190e61	21749-128	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Energizing Mint		alcohol	GEL	TOPICAL	20211206		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	70	mL/100mL			N	20241231
21749-211_3e902871-9f17-40e5-bbe3-d66305a83540	21749-211	HUMAN OTC DRUG	GOJO Ultra Mild Antimicrobial Ltn Sp with Chloroxylenol		Chloroxylenol	LIQUID	TOPICAL	20000824		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-225_8ba00543-347d-ac42-e053-2a95a90ae897	21749-225	HUMAN OTC DRUG	Purell Antimicrobial Foam		Chlorhexidine Gluconate 2% Solution	LIQUID	TOPICAL	20180201		NDA	NDA019422	GOJO Industries, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
21749-225_8e5afe1b-934c-4fb6-e053-2995a90a965e	21749-225	HUMAN OTC DRUG	Purell Antimicrobial Foam		Chlorhexidine Gluconate 2% Solution	LIQUID	TOPICAL	20180201		NDA	NDA019422	GOJO Industries, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
21749-291_8793f06b-e756-4f34-8d1d-56d6454e9651	21749-291	HUMAN OTC DRUG	SIGNATRY Ultra Antimicrobial Ltn Sp		Chloroxylenol	LIQUID	TOPICAL	20010919		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-359_c49161c0-86cb-40da-91d0-5fc4a944777a	21749-359	HUMAN OTC DRUG	PURELL Hand Sanitizing Wipes Clean Refreshing Scent		Benzalkonium Chloride Wipe	CLOTH	TOPICAL	20140801		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
21749-363_b2e067a5-1da6-465a-8e73-cb7edcc133e9	21749-363	HUMAN OTC DRUG	PURELL Hand Sanitizing Wipe		alcohol	CLOTH	TOPICAL	20070122		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	62	mL/100mL			N	20241231
21749-364_39396fce-547e-4914-b997-06c58033725e	21749-364	HUMAN OTC DRUG	PURELL Cottony Soft Hand Sanitizing Wipe		alcohol	CLOTH	TOPICAL	20120224		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	62	mL/100mL			N	20241231
21749-367_4f536f37-0341-441e-9b10-3b99e6f3708a	21749-367	HUMAN OTC DRUG	PURELL Hand Sanitizing Wipes Alcohol Formula		alcohol	CLOTH	TOPICAL	20120224		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	62	mL/100mL			N	20241231
21749-368_e2663024-6d4e-47e0-97bd-898b0cf9ec00	21749-368	HUMAN OTC DRUG	PURELL Hand Sanitizing Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20120314		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
21749-400_b8372789-8950-461a-8c00-fcca25dd6235	21749-400	HUMAN OTC DRUG	Excelon Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170614		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.5	mg/100mL			N	20241231
21749-405_2fbf30fc-75d0-4c4d-acef-7d555df406a9	21749-405	HUMAN OTC DRUG	GOJO Pink Antimicrobial Ltn Sp		Chloroxylenol	LIQUID	TOPICAL	20010626		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-416_743021cd-38c4-3825-e053-2a91aa0aa7f2	21749-416	HUMAN OTC DRUG	Antimicrobial Foam Handwash		Chlorhexidine Gluconate 2% Solution	LIQUID	TOPICAL	20180401		NDA	NDA019422	GOJO Industries, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
21749-442_18b774bd-1fde-407c-a5b7-8b48e730fbc7	21749-442	HUMAN OTC DRUG	PROVON Perineal Skin Prot	with 99 Petrolatum	Petrolatum	OINTMENT	TOPICAL	20100501		OTC MONOGRAPH FINAL	part347	GOJO Industries, Inc.	PETROLATUM	.99	g/g			N	20241231
21749-454_ea5f71b1-998e-4668-a873-f0bfe1092529	21749-454	HUMAN OTC DRUG	Primory Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170614		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.5	mg/100mL			N	20241231
21749-457_5e3242b0-85fd-41f6-84d1-c3f8ba41324e	21749-457	HUMAN OTC DRUG	GOJO PCMX E-2 Sanitizing Ltn Sp		Chloroxylenol	LIQUID	TOPICAL	20190225		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-461_74317b4d-3fc0-6fd5-e053-2a91aa0ab90f	21749-461	HUMAN OTC DRUG	Antiseptic Foam Handwash		Chlorhexidine Gluconate 2% Solution	LIQUID	TOPICAL	20111201		NDA	NDA019422	GOJO Industries, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
21749-501_c51e8e89-0974-49a0-96bb-f829aae8a988	21749-501	HUMAN OTC DRUG	GOJO Gold and Klean Antimicrobial Ltn Sp		Chloroxylenol	LIQUID	TOPICAL	20030713		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-521_d746a3b9-4ac9-43e6-935f-deff6267bdfa	21749-521	HUMAN OTC DRUG	GOJO Antimicrobial Foam Handwash with PCMX		CHLOROXYLENOL	LIQUID	TOPICAL	20140730		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.005	mg/mL			N	20241231
21749-522_31cf7122-71f5-4ab4-983c-8bf4298a10a6	21749-522	HUMAN OTC DRUG	PURELL Healthcare HEALTHY SP 0.5pct PCMX Antimicrobial Foam		Chloroxylenol	LIQUID	TOPICAL	20170714		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.005	mg/mL			N	20241231
21749-523_c5b3d13f-e93e-4b31-a0ea-e396e0de8f2d	21749-523	HUMAN OTC DRUG	GOJO E2 Foam Handwash with PCMX		GOJO E2 Foam Handwash with PCMX	LIQUID	TOPICAL	20140915		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.5	mg/100mL			N	20241231
21749-528_f339d960-8f11-4017-be6b-c130b9146679	21749-528	HUMAN OTC DRUG	PURELL Food Processing HEALTHY SP 0.5pct PCMX Antimicrobial E2 Foam Handwash		Chloroxylenol	LIQUID	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.005	mg/mL			N	20241231
21749-530_a87fcd5e-5081-4199-925b-b202558d1c93	21749-530	HUMAN OTC DRUG	PURELL Advanced Instant Hand Sanitizer Fragrance Free		ALCOHOL	LIQUID	TOPICAL	20140214		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-531_7f3226ae-256b-43f6-90f5-677d5e907d8a	21749-531	HUMAN OTC DRUG	PURELL HEALTHY SP PCMX E2 Antimicrobial Foam		Chloroxylenol	SOLUTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.005	mg/mL			N	20241231
21749-541_d853cc05-288e-42fd-aeca-e3c971be71d0	21749-541	HUMAN OTC DRUG	PROVON Foaming Antimicrobial Handwash with PCMX		CHLOROXYLENOL	LIQUID	TOPICAL	20130301		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.005	mg/mL			N	20241231
21749-543_ee1615fd-5286-4f80-a47a-3ade69e49131	21749-543	HUMAN OTC DRUG	GOJO E2 Foam Sanitizing So ap		TRICLOSAN	LIQUID	TOPICAL	20120101		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	TRICLOSAN	.003	mg/mL			N	20241231
21749-545_4c8e423c-8411-44ca-a737-aa59a4aa4142	21749-545	HUMAN OTC DRUG	Signatry Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170614		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.5	mg/100mL			N	20241231
21749-551_b19a8e33-91b6-4e66-b4b4-61c25e941752	21749-551	HUMAN OTC DRUG	ACQUAINT Antibacterial Foam Handwash		Chloroxylenol	LIQUID	TOPICAL	20040909		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-555_ccf4b924-55aa-4535-9b45-061e2cb5b21d	21749-555	HUMAN OTC DRUG	PRIMORY Antimicrobial Foam		Chloroxylenol	LIQUID	TOPICAL	20040909		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-580_4bcf951b-f83d-40f7-8bc2-980c3e6b9a2a	21749-580	HUMAN OTC DRUG	EXCELON Antimicrobial Foam		Chloroxylenol	LIQUID	TOPICAL	20040909		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-581_b8e131cb-0159-4983-bcf3-8cb02477c4d3	21749-581	HUMAN OTC DRUG	SIGNATRY Antimicrobial Foam		Chloroxylenol	LIQUID	TOPICAL	20040909		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-607_1c5fa8ba-4c22-4cf4-80d8-0a675c5cf432	21749-607	HUMAN OTC DRUG	PURELL SF607 Instant Hand Sanitizing		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20110103		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
21749-610_a917c745-f315-49ea-a7da-1eb724f71142	21749-610	HUMAN OTC DRUG	PURELL Antimicrobial Foaming Hand		Benzalkonium Chloride	LIQUID	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.5	mg/100mL			N	20241231
21749-622_5e32f111-2d51-4ac1-a381-15cdc8bbbf29	21749-622	HUMAN OTC DRUG	PURELL HEALTHY SP 0.5pct PCMX Antimicrobial Foam		Chloroxylenol	LIQUID	TOPICAL	20220923		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.5	mg/100mL			N	20241231
21749-625_205c83eb-7f3e-496c-a059-8e43da8a8ffb	21749-625	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Naturals Gel		Alcohol	GEL	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-684_c64a6810-e812-4bf7-9813-97ff165c9672	21749-684	HUMAN OTC DRUG	PURELL HEALTHY SP 0.5pct BAK Antimicrobial Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20211215		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
21749-685_f942f4be-1bb5-4801-af28-54515333d9f0	21749-685	HUMAN OTC DRUG	PURELL Professional HEALTHY SP 0.5pct BAK Antimicrobial Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
21749-686_6089e457-1db6-4a5a-b07e-ef0e44c2795d	21749-686	HUMAN OTC DRUG	PURELL Foodservice HEALTHY SP 0.5pct BAK Antimicrobial Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
21749-687_e8a7b8b3-7367-4f93-9bf2-7437e95b9ed4	21749-687	HUMAN OTC DRUG	PURELL Healthcare HEALTHY SP 0.5 BAK Antimicrobial Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20190615		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
21749-700_70c006b8-b9a2-411d-a49d-5959572b9d43	21749-700	HUMAN OTC DRUG	PURELL Advanced Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20110510		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-701_db6e24d1-f8d3-4811-b6dd-6a5ba5911b03	21749-701	HUMAN OTC DRUG	PURELL Advanced Skin Nourishing Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20120601		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-702_05deeeae-8c88-4ffb-b7cf-7ae98e920a8c	21749-702	HUMAN OTC DRUG	PURELL Advanced Green Certified Instant Hand Sanitizer		alcohol	GEL	TOPICAL	20111215		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-704_09c604b3-8da2-4df8-b9af-bcc13e720250	21749-704	HUMAN OTC DRUG	Purell Advanced Refreshing		alcohol	GEL	TOPICAL	20120315		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	70	mL/100mL			N	20251231
21749-706_d4e9bee3-3277-48f7-bea1-6e3af31a2cb0	21749-706	HUMAN OTC DRUG	PURELL Advanced E3 Rated Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20130331		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-713_535b90bd-11f8-4323-baaa-b40709ba4637	21749-713	HUMAN OTC DRUG	Purell Advanced Soothing		alcohol	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-715_12a0190e-d5d6-4d76-8b36-3587667dc1b6	21749-715	HUMAN OTC DRUG	PURELL Professional Advanced Hand Sanitizer Gel		alcohol	GEL	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-716_d6f8f797-bfbd-4ce2-bc50-1b10ca9fe660	21749-716	HUMAN OTC DRUG	PURELL Healthcare Advanced Hand Sanitizer Gel		alcohol	GEL	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-717_769f50f0-3048-4391-b47b-76d3a497512c	21749-717	HUMAN OTC DRUG	PURELL Professional Advanced Hand Sanitizer Fragrance Free Gel		alcohol	GEL	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-718_3aaf828e-f003-4eb6-98df-472b214a863a	21749-718	HUMAN OTC DRUG	PURELL Professional Advanced Hand Sanitizer Fragrance Free Gel		alcohol	GEL	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-740_b187fc6c-8394-4473-9d52-14cce36c2c78	21749-740	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Ocean Kiss		alcohol	GEL	TOPICAL	20111221		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-750_8b1c9ef6-a88e-4eea-8d4c-829d15e44f0d	21749-750	HUMAN OTC DRUG	PROVON Antimicrobial Ltn Sp with 0.3% PCMX		Chloroxylenol	LIQUID	TOPICAL	20130831		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-751_f871a458-49c3-4d28-a6e3-e7efb4c24afd	21749-751	HUMAN OTC DRUG	Purell Advanced Moisturizing 2in1		alcohol	GEL	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	70	mL/100mL			N	20241231
21749-801_2e6a7b20-67e3-4fe0-a343-59f7a42fbaa0	21749-801	HUMAN OTC DRUG	PURELL Advanced Skin Nourishing Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20110801		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-802_83e4bc78-2d8e-4aeb-a8ee-019985671508	21749-802	HUMAN OTC DRUG	PURELL Advanced E3 Rated Instant Hand Sanitizer Foam		alcohol	LIQUID	TOPICAL	20120601		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-806_d7349004-4311-42bc-9062-3d83d30ca290	21749-806	HUMAN OTC DRUG	PURELL Advanced Green Certified Instant Hand Sanitizer		alcohol	LIQUID	TOPICAL	20111215		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-807_4a10c193-f5dc-408d-b8f3-07b6fab58944	21749-807	HUMAN OTC DRUG	PURELL Advanced Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20110411		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-810_ff3ac817-29a7-45e6-b97b-6e871f78f7aa	21749-810	HUMAN OTC DRUG	PURELL Professional Advanced Hand Sanitizer Foam		ALCOHOL	LIQUID	TOPICAL	20170905		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-811_25d19432-2f78-4d2d-890f-cf52d540a13a	21749-811	HUMAN OTC DRUG	PURELL Healthcare Advanced Hand Sanitizer Foam		ALCOHOL	LIQUID	TOPICAL	20170905		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-812_f6578472-38d1-40f4-ba0e-6089836cc290	21749-812	HUMAN OTC DRUG	PURELL Foodservice Advanced Hand Sanitizer Foam		ALCOHOL	LIQUID	TOPICAL	20170905		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-821_baf2a056-8398-4bf0-9094-59e1cf84401d	21749-821	HUMAN OTC DRUG	PURELL Professional Advanced Hand Sanitizer Fragrance Free Foam		alcohol	LIQUID	TOPICAL	20170905		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-822_2d0263ed-5b81-4bf4-8a5d-62addcf6652d	21749-822	HUMAN OTC DRUG	PURELL Healthcare Advanced Hand Sanitizer Gentle and Free Foam		alcohol	LIQUID	TOPICAL	20170905	20240927	OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	
21749-823_1287ccd4-9780-4ad5-87c9-43a937cfa65b	21749-823	HUMAN OTC DRUG	PURELL Education Advanced Hand Sanitizer Gentle and Free Foam		alcohol	LIQUID	TOPICAL	20170905	20240927	OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	
21749-824_213ba555-cb5b-4b8c-ba2d-a0c910e45124	21749-824	HUMAN OTC DRUG	PURELL Food Processing Advanced Hand Sanitizer E3 Foam		alcohol	LIQUID	TOPICAL	20170905		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-826_a3cb4ead-d85b-4309-9711-d3bf57e4a40f	21749-826	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Gentle and Free Foam		alcohol	LIQUID	TOPICAL	20220201		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20251231
21749-827_964aac59-0541-4d7d-805d-bf12b2ef49b3	21749-827	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Fragrance Free Foam		alcohol	LIQUID	TOPICAL	20220615		OTC MONOGRAPH DRUG	505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-837_a60daa90-5a92-40fb-b9ab-6fc8c903a4a4	21749-837	HUMAN OTC DRUG	PURELL VF PLUS Hand Sanitizer Gel		alcohol	GEL	TOPICAL	20200101		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	85	mL/100mL			N	20251231
21749-850_6bf3b3cd-a681-21b6-e053-2991aa0a517a	21749-850	HUMAN OTC DRUG	Provon Antimicrobial Foam Handwash		Chlorhexidine Gluconate 2%	SOLUTION	TOPICAL	20160501		NDA	NDA019422	Gojo Industries, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
21749-850_8bb397f5-88ef-349d-e053-2995a90ab3fa	21749-850	HUMAN OTC DRUG	Provon Antimicrobial Foam Handwash		Chlorhexidine Gluconate 2%	SOLUTION	TOPICAL	20160701		NDA	NDA019422	Gojo Industries, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
21749-851_84451fad-26cb-44e1-96ce-42b1e8a7970c	21749-851	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Moisturizing 2in1 Foam		ALCOHOL	LIQUID	TOPICAL	20210415		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	70	mL/100mL			N	20241231
21749-852_80166bfb-5cc0-496d-95fa-e2db2b5ba1aa	21749-852	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Ultra Nourishing Foam		ALCOHOL	LIQUID	TOPICAL	20150201		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-853_025bc8b6-c16d-403b-be8b-8c1d0cb6a61e	21749-853	HUMAN OTC DRUG	GOJO Antibacterial Plum Foam Handwash with Biobased content		Benzalkonium Chloride	LIQUID	TOPICAL	20171201		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
21749-854_b0bf9aec-9c44-487a-8a7b-abc7e4076fc1	21749-854	HUMAN OTC DRUG	PURELL Healthcare Advanced Hand Sanitizer ULTRA NOURISHING Foam		ALCOHOL	LIQUID	TOPICAL	20171015		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21749-856_267f0243-8fdc-4b46-8887-7ff531c37848	21749-856	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer ULTRA NOURISHING Foam		ALCOHOL	LIQUID	TOPICAL	20231204		OTC MONOGRAPH DRUG	505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	70	mL/100mL			N	20241231
21749-875_ae72593d-8166-4d3d-8422-40335f7d29bd	21749-875	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer Naturals Foam		alcohol	LIQUID	TOPICAL	20210415		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	70	mL/100mL			N	20241231
21749-905_9eead74b-66b1-4ebe-9b69-592e6455b144	21749-905	HUMAN OTC DRUG	PURELL Advanced Hand Sanitizer PRIME DEFENSE		alcohol	GEL	TOPICAL	20201117		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	85	mL/100mL			N	20251231
21749-906_3fc01106-6172-405e-9a6d-2e6bd4fbeb30	21749-906	HUMAN OTC DRUG	PURELL Hand Sanitizer SP Unscented		alcohol	SPRAY	TOPICAL	20231211		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	85	mL/100mL			N	20251231
21749-907_783c0e2d-f489-4808-aba0-50969693ccdd	21749-907	HUMAN OTC DRUG	PURELL Hand Sanitizer SP Lavender and Verbena		alcohol	SPRAY	TOPICAL	20231211		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	85	mL/100mL			N	20251231
21749-908_50a680a0-8e55-448f-b987-4a20a212f489	21749-908	HUMAN OTC DRUG	PURELL Hand Sanitizer SP Tangerine and Pear		alcohol	SPRAY	TOPICAL	20231211		OTC MONOGRAPH DRUG	M505G(a)(3)	GOJO Industries, Inc.	ALCOHOL	85	mL/100mL			N	20251231
21749-968_8d0cc608-8cf6-48ed-95ac-ae014cbb68af	21749-968	HUMAN OTC DRUG	GOJO Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170614		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	BENZALKONIUM CHLORIDE	.5	mg/100mL			N	20241231
21749-975_bcc038f0-6ae7-484c-9793-5ebdcbacc908	21749-975	HUMAN OTC DRUG	MICRELL Antibacterial Ltn Sp		Chloroxylenol	LIQUID	TOPICAL	19980730		OTC MONOGRAPH DRUG	505G(a)(3)	GOJO INDUSTRIES, INC.	CHLOROXYLENOL	.003	mg/mL			N	20241231
21749-992_fbeebc0d-12ed-4beb-89d5-c6389398d088	21749-992	HUMAN OTC DRUG	PURELL Waterless Surgical Scrub		alcohol	LIQUID	TOPICAL	20111215		OTC MONOGRAPH NOT FINAL	part333E	GOJO Industries, Inc.	ALCOHOL	.7	mL/mL			N	20241231
21922-001_d3defaba-686c-1648-e053-2995a90a2643	21922-001	HUMAN PRESCRIPTION DRUG	Fluocinonide		fluocinonide topical solution usp, 0.05%	SOLUTION	TOPICAL	20190419		ANDA	ANDA209699	Encube Ethicals Private Limited	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21922-002_b54df664-45ec-3138-e053-2995a90a6dd7	21922-002	HUMAN PRESCRIPTION DRUG	Clindamycin Phoaphate Topical Solution USP, 1%		Clindamycin Phosphate Topical Solution USP, 1%	SOLUTION	TOPICAL	20190304		ANDA	ANDA209914	Encube Ethicals Private Limited	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
21922-003_b575b93d-a5a2-8ddd-e053-2995a90a4561	21922-003	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide Topical Solution USP, 0.01%		Fluocinolone Acetonide Topical Solution USP, 0.01%	SOLUTION	TOPICAL	20190320		ANDA	ANDA209913	Encube Ethicals Private Limited	FLUOCINOLONE ACETONIDE	.1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21922-004_b5754304-5933-da8e-e053-2a95a90a46ab	21922-004	HUMAN PRESCRIPTION DRUG	Desonide Ointment, 0.05%		Desonide Ointment, 0.05%	OINTMENT	TOPICAL	20190320		ANDA	ANDA210998	Encube Ethicals Private Limited	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21922-007_c7a745c8-8c1e-46f8-9f42-5e4f4e0088da	21922-007	HUMAN PRESCRIPTION DRUG	hydrocortisone valerate cream		hydrocortisone valerate cream	CREAM	TOPICAL	20221231		ANDA	ANDA211047	Encube Ethicals Private Limited	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21922-009_6ed03146-b87c-473e-846f-2643dd3593db	21922-009	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200130		ANDA	ANDA210986	Encube Ethicals Private Limited	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21922-011_34a5272c-c66f-4ae2-9b80-53f97ec6f613	21922-011	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus Ointment 0.1%	OINTMENT	TOPICAL	20231013		ANDA	ANDA212387	Encube Ethicals Private Limited	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
21922-016_f398aea3-d7dd-479d-bcdb-4b6a97e21839	21922-016	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate Cream USP, 0.05%	Clobetasol Propionate Cream USP, 0.05%	Clobetasol Propionate Cream USP, 0.05%	CREAM	TOPICAL	20201001		ANDA	ANDA212982	Encube Ethicals Private Limited	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21922-017_f6d8a55b-c0c6-4a1b-b51b-baf9446713e0	21922-017	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	Encube Ethicals Private Limited	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
21922-018_dd4646da-e9f6-402f-85f5-f85b0472087d	21922-018	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone Gel, 5%	GEL	TOPICAL	20231016		ANDA	ANDA212383	Encube Ethicals Private Limited	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
21922-019_62f86281-500c-446f-8988-b3ffee6ad8df	21922-019	HUMAN PRESCRIPTION DRUG	Testosterone Gel, 1%		Testosterone Gel, 1%	GEL	TRANSDERMAL	20211119		ANDA	ANDA212984	Encube Ethicals Private Limited	TESTOSTERONE	10	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
21922-020_10f2fff2-ca86-4797-98b9-5f5773d3859d	21922-020	HUMAN PRESCRIPTION DRUG	Tavaborole		TAVABOROLE topical solution, 5%	SOLUTION	TOPICAL	20201019		ANDA	ANDA211297	Encube Ethicals Private Limited	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
21922-021_222cfced-1367-4f49-a1f5-e8fd408d3cef	21922-021	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin Cream 5% w/w	CREAM	TOPICAL	20190408		ANDA	ANDA211303	Encube Ethicals Private Limited	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
21922-022_c232b13d-df3f-c875-e053-2a95a90a715c	21922-022	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	GEL	TOPICAL	20210520		ANDA	ANDA212433	Encube Ethicals Private Limited	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
21922-023_5b3137d3-c186-4c5d-89d2-ec5d1c3da8cd	21922-023	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20221010		ANDA	ANDA212385	Encube Ethicals Private Limited	DOCOSANOL	100	mg/g			N	20241231
21922-024_3cc6be50-0221-44d5-b2b3-83ad31e0cf42	21922-024	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide Ointment USP, 0.05%	OINTMENT	TOPICAL	20191202		ANDA	ANDA212384	Encube Ethicals Private Limited	TRIAMCINOLONE ACETONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
21922-025_c35038ef-b432-329e-e053-2a95a90a30f1	21922-025	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole Cream, 2%	CREAM	TOPICAL	20210527		ANDA	ANDA212443	Encube Ethicals Private Limited	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
21922-027_bf83e14a-84f9-d228-e053-2a95a90a5520	21922-027	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate Gel USP, 1%	GEL	TOPICAL	20200113		ANDA	ANDA212438	Encube Ethicals Private Limited	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
21922-029_b04496f9-f706-40d9-9f1a-9e71d336544c	21922-029	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	CREAM	TOPICAL	20210902		ANDA	ANDA213076	Encube Ethicals Private Limited	MUPIROCIN CALCIUM	2	g/100g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
21922-031_d5868c2d-5564-6eb1-e053-2a95a90a1a57	21922-031	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20190928		ANDA	ANDA207741	Encube Ethicals Private Limited	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
21922-036_d603c3a4-08a3-f0ff-e053-2995a90a676b	21922-036	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	LOTION	TOPICAL	20220119		ANDA	ANDA215607	Encube Ethicals Private Limited	CLINDAMYCIN PHOSPHATE	10	ug/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
21922-038_ab3f174c-a3c4-4ae9-b0bc-954efaadf8de	21922-038	HUMAN PRESCRIPTION DRUG	Azelaic Acid Gel		Azelaic Acid	GEL	TOPICAL	20231130		ANDA	ANDA208724	Encube Ethicals Private Limited	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
21922-039_63ed1e7e-d264-4e35-af83-ec37fa5b06d1	21922-039	HUMAN PRESCRIPTION DRUG	Metronidazole Vaginal Gel, 0.75%		Metronidazole	GEL	VAGINAL	20230617		ANDA	ANDA215610	Encube Ethicals Private Limited	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
21922-041_016537ca-bff8-4cc6-b956-e2d1cc1384cf	21922-041	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	SOLUTION	TOPICAL	20231106		ANDA	ANDA215612	Encube Ethicals Private Limited	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
21922-043_95dc7c2e-92ec-4c5c-924c-832642461c51	21922-043	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20230824		ANDA	ANDA215609	Encube Ethicals Private Limited	TRETINOIN	.8	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
21922-044_d54f37ec-63f2-d2a7-e053-2995a90a2ffa	21922-044	HUMAN OTC DRUG	DICLOFENAC SODIUM		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20220110		ANDA	ANDA210986	Encube Ethicals Private Limited	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
21922-045_be5a3ad1-4685-4098-bc9c-14a21b4afcbc	21922-045	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUSPENSION	RECTAL	20230601		ANDA	ANDA216941	Encube Ethicals Private Limited	MESALAMINE	4	g/60mL	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
21922-050_b192f338-4228-459a-8735-a7f9c6bec447	21922-050	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025%		Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025%	GEL	TOPICAL	20230904		ANDA	ANDA216943	Encube Ethicals Private Limited	CLINDAMYCIN PHOSPHATE; TRETINOIN	10; .25	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE], Retinoid [EPC], Retinoids [CS]		N	20241231
21922-051_fc6fcbb8-636b-c7ad-e053-6294a90aa414	21922-051	HUMAN PRESCRIPTION DRUG	Adapalene Gel USP, 0.3%		Adapalene Gel USP, 0.3%	GEL	TOPICAL	20230505		ANDA	ANDA200298	Encube Ethicals Private Limited	ADAPALENE	3	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
21922-052_66858a82-cfda-4ba9-aac7-cf65499f4b1a	21922-052	HUMAN PRESCRIPTION DRUG	Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%		Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%	GEL	TOPICAL	20230814		ANDA	ANDA206164	Encube Ethicals Private Limited	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
21922-053_79084b47-7481-4926-9837-e08f633b1ddf	21922-053	HUMAN PRESCRIPTION DRUG	CICLOPIROX		ciclopirox	SOLUTION	TOPICAL	20231109		ANDA	ANDA077687	Encube Ethicals Private Limited	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
21922-063_6a31a0c3-2b6e-40e3-b5ea-5c665afd3567	21922-063	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20230801		ANDA	ANDA205373	Encube Ethicals Private Limited	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
22431-014_ed860819-9879-ae24-e053-2a95a90afa5a	22431-014	HUMAN OTC DRUG	ARCTIC ICE pain relieving		MENTHOL	GEL	TOPICAL	20170223		OTC MONOGRAPH NOT FINAL	part348	Blue Cross Laboratories, Inc.	MENTHOL	2	g/100g			N	20241231
22431-020_605d28cb-3c08-355c-e053-2a91aa0af312	22431-020	HUMAN OTC DRUG	1.8oz Armstrong Hand Sanitizer with Aloe Vera and Vitamin E		ALCOHOL	GEL	TOPICAL	20171025		OTC MONOGRAPH NOT FINAL	part333A	BLUE CROSS LABORATORIES, INC.	ALCOHOL	65	mL/100mL			N	20241231
22431-021_af57356e-1a6e-bb7f-e053-2a95a90a3f30	22431-021	HUMAN OTC DRUG	HAND RX ANTIBACTERIAL HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	BLUE CROSS LABORATORIES, INC.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
22431-022_de5c637f-e96a-9ddc-e053-2995a90a0221	22431-022	HUMAN OTC DRUG	ARCTIC ICE		MENTHOL	GEL	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part348	BLUE CROSS LABORATORIES, INC.	MENTHOL	2	g/100g			N	20241231
22431-023_f27b1bb9-3cff-a391-e053-2995a90afc8b	22431-023	HUMAN OTC DRUG	Salon Designs Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20230124		OTC MONOGRAPH FINAL	M032	Blue Cross Laboratories LLC	PYRITHIONE ZINC	.3	g/100mL			N	20241231
22431-024_f27d7fbc-966a-7a03-e053-2a95a90ae752	22431-024	HUMAN OTC DRUG	Urban Wash Everday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20230124		OTC MONOGRAPH FINAL	M032	Blue Cross Laboratories, LLC	PYRITHIONE ZINC	.3	g/100mL			N	20241231
22431-123_38a0bf3e-b1d1-3d70-e054-00144ff88e88	22431-123	HUMAN OTC DRUG	MED AID CHEST RUB		Menthol and Camphor and Eucalyptus Oil	OINTMENT	TOPICAL	20150811		OTC MONOGRAPH NOT FINAL	part348	Blue Cross Laboratories, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
22431-126_bc5da2ca-a087-4199-87f8-4bcf88e4321a	22431-126	HUMAN OTC DRUG	Med Aid Chest Rub		Menthol,Camphor, Eucalyptus Oil	OINTMENT	TOPICAL	20120330		OTC MONOGRAPH FINAL	part341	Blue Cross Laboratories, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
22431-132_0fc4ce37-bc88-4011-b41d-7fcce9efec50	22431-132	HUMAN OTC DRUG	Hand Sanitizer Lemon Scent	Hand Rx	Ethyl Alcohol	GEL	TOPICAL	20140819		OTC MONOGRAPH NOT FINAL	part333E	Blue Cross Laboratories, Inc.	ALCOHOL	62	g/100mL			N	20241231
22431-145_f1ee44d8-b986-0d45-e053-2995a90a1186	22431-145	HUMAN OTC DRUG	Antimicrobial Liquid Citrus		Benzalkonium Chloride	SOAP	TOPICAL	20190621		OTC MONOGRAPH NOT FINAL	part333A	Blue Cross Laboratories, LLC	BENZALKONIUM CHLORIDE	.3	g/100mL			N	20241231
22431-221_f18c24f1-c6dc-4f1b-e053-2995a90a1f9c	22431-221	HUMAN OTC DRUG	Hand Rx Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200511		OTC MONOGRAPH NOT FINAL	part333A	Blue Cross Laboratories	ALCOHOL	62	mL/100mL			N	20241231
22431-222_a5b1f54a-a61f-d302-e053-2a95a90a2861	22431-222	HUMAN OTC DRUG	Blue Devil Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200513		OTC MONOGRAPH NOT FINAL	part333A	Blue Cross Laboratories	ALCOHOL	62	mL/100mL			N	20241231
22431-586_f18c4985-1a18-0cf2-e053-2995a90a36a6	22431-586	HUMAN OTC DRUG	Safety Gold Antibacterial Hand		Benzalkonium Chloride	SOAP	TOPICAL	20200826		OTC MONOGRAPH NOT FINAL	part333A	Blue Cross Laboratories	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
22431-705_838451bf-ebdd-56e7-e053-2a91aa0a6970	22431-705	HUMAN OTC DRUG	PETROLEUM		White Petroleum	JELLY	TOPICAL	20190225		OTC MONOGRAPH FINAL	part347	Blue Cross Laboratories, Inc.	PETROLATUM	1	g/g			N	20241231
22557-001_07eee3f4-8780-d062-e063-6294a90a2983	22557-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020101		NDA	NDA205840	AGP LLC	OXYGEN	99	L/100L			N	20241231
22557-002_07eef4a6-48c1-0c04-e063-6394a90abb0a	22557-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20020101		NDA	NDA205839	AGP LLC	NITROGEN	99	L/100L			N	20241231
22700-001_f37cd2f6-b7f0-40ed-e053-2a95a90a6875	22700-001	HUMAN OTC DRUG	Covergirl cgsmoothers BB Tinted Moisturizer	Broad Spectrum SPF 21 (all shades)	Octinoxate and Zinc Oxide	CREAM	TOPICAL	20160601		OTC MONOGRAPH NOT FINAL	part352	Noxell Corporation	OCTINOXATE; ZINC OXIDE	6; 3	g/100mL; g/100mL			N	20241231
22700-084_f30653cd-d027-12ae-e053-2a95a90ab5f2	22700-084	HUMAN OTC DRUG	Covergirl Aquasmooth	Broadspectrum SPF 20 All shades	Titanium Dioxide	CREAM	TOPICAL	20140315		OTC MONOGRAPH NOT FINAL	part352	Noxell Corporation	TITANIUM DIOXIDE	9	g/100g			N	20241231
22700-098_f3069e6f-eee8-2886-e053-2995a90afd8d	22700-098	HUMAN OTC DRUG	Covergirl Advanced Radiance	Age Defying Makeup plus Sunscreen SPF 10 (All shades)	Octinoxate and Titanium Dioxide	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Noxell	OCTINOXATE; TITANIUM DIOXIDE	20; 50	mg/mL; mg/mL			N	20241231
22700-127_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-127	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 805 Ivory	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-128_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-128	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 810 Classic Ivory	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-129_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-129	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 820 Creamy Natural	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-130_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-130	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 825 Buff Beige	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-131_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-131	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 832 Nude Beige	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-132_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-132	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 840 Natural Beige	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-133_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-133	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 842 Medium Beige	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-134_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-134	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 845 Warm Beige	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-135_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-135	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 850 Creamy Beige	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-136_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-136	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 855 Soft Honey	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-137_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-137	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 857 Golden Tan	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-138_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-138	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 860 Classic Tan	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-140_f3554082-9487-c0fb-e053-2995a90a1a8d	22700-140	HUMAN OTC DRUG	Covergirl Outlast Stay Fabulous 3in1 Foundation	Broad spectrum SPF 20 - 875 Soft Sable	Ensulizole	LIQUID	TOPICAL	20120625		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-152_f306d920-6c3b-358e-e053-2a95a90a3ef7	22700-152	HUMAN OTC DRUG	Covergirl Queen Collection All Day Flawless 3in1 Foundation	Broad Spectrum SPF 20 - Q855 Spicy Brown	Ensulizole	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Noxell	ENSULIZOLE	.03	mg/mL			N	20241231
22700-155_f3550377-34ef-2e8e-e053-2995a90a5bc9	22700-155	HUMAN OTC DRUG	Covergirl plus Olay Simply Ageless	Foundation plus Titanium Dioxide Sunscreen Broad Spectrum SPF 28 (All shades)	Titanium Dioxide	CREAM	TOPICAL	20150706		OTC MONOGRAPH NOT FINAL	part352	Noxell Corporation	TITANIUM DIOXIDE	4.9	mg/.1g			N	20241231
22700-156_f3063fc6-c025-376b-e053-2a95a90af3c9	22700-156	HUMAN OTC DRUG	Covergirl Outlast Active Foundation SPF 20		Octinoxate	LIQUID	TOPICAL	20190311		OTC MONOGRAPH NOT FINAL	part352	Noxell Corporation	OCTINOXATE	3	g/100mL			N	20241231
22700-157_f3063dd7-e7ee-495e-e053-2995a90a3e66	22700-157	HUMAN OTC DRUG	Covergirl TruBlend Base Business Everyday Defense Primer SPF 20		Ensulizole	LIQUID	TOPICAL	20190328		OTC MONOGRAPH NOT FINAL	part352	NOXELL CORPORATION	ENSULIZOLE	3	g/100mL			N	20241231
22700-200_f3555124-f1c3-0391-e053-2995a90af216	22700-200	HUMAN OTC DRUG	Covergirl Vitalist Healthy Foundation with Vitamins plus Ensulizole Sunscreen Broad Spectrum SPF 20 (All shades)		Ensulizole	LIQUID	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part352	Noxell Corporation	ENSULIZOLE	3	g/100mL			N	20241231
22700-201_f306c5d9-6461-2702-e053-2a95a90a5ef5	22700-201	HUMAN OTC DRUG	FULL SPECTRUM MATTE AMBITION SKIN PRIMER SPF 20		Ensulizole	LIQUID	TOPICAL	20190228		OTC MONOGRAPH NOT FINAL	part352	Noxell Corporation	ENSULIZOLE	3	g/100mL			N	20241231
22840-0033_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0033	HUMAN PRESCRIPTION DRUG	Standardized Mite Dermatophagoides farinae		Dermatophagoides farinae	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19870202		BLA	BLA101834	Greer Laboratories, Inc.	DERMATOPHAGOIDES FARINAE	5000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0034_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0034	HUMAN PRESCRIPTION DRUG	Standardized Mite Dermatophagoides farinae		Dermatophagoides farinae	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19870202		BLA	BLA101834	Greer Laboratories, Inc.	DERMATOPHAGOIDES FARINAE	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0035_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0035	HUMAN PRESCRIPTION DRUG	Standardized Mite Dermatophagoides pteronyssinus		Dermatophagoides pteronyssinus	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19890627		BLA	BLA101835	Greer Laboratories, Inc.	DERMATOPHAGOIDES PTERONYSSINUS	5000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0036_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0036	HUMAN PRESCRIPTION DRUG	Standardized Mite Dermatophagoides pteronyssinus		Dermatophagoides pteronyssinus	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19890627		BLA	BLA101835	Greer Laboratories, Inc.	DERMATOPHAGOIDES PTERONYSSINUS	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0037_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0037	HUMAN PRESCRIPTION DRUG	Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus		Dermatophagoides farinae and Dermatophagoides pteronyssinus	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	20100203		BLA	BLA101834	Greer Laboratories, Inc.	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	5000; 5000	[AU]/mL; [AU]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0038_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0038	HUMAN PRESCRIPTION DRUG	Standardized Mite Dermatophagoides farinae		Dermatophagoides farinae	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	20100203		BLA	BLA101834	Greer Laboratories, Inc.	DERMATOPHAGOIDES FARINAE	30000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0039_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0039	HUMAN PRESCRIPTION DRUG	Standardized Mite Dermatophagoides pteronyssinus		Dermatophagoides pteronyssinus	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	20100203		BLA	BLA101835	Greer Laboratories, Inc.	DERMATOPHAGOIDES PTERONYSSINUS	30000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0040_94191d1d-9858-602a-e053-2a95a90aa50f	22840-0040	HUMAN PRESCRIPTION DRUG	Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus		Dermatophagoides farinae and Dermatophagoides pteronyssinus	CONCENTRATE	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	20100203		BLA	BLA101834	Greer Laboratories, Inc.	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	15000; 15000	[AU]/mL; [AU]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-0100_efbdc240-30ca-1473-e053-2995a90a937b	22840-0100	STANDARDIZED ALLERGENIC	Standardized Cat Hair Allergenic Extract		Felis catus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19920924		BLA	BLA103397	Greer Laboratories, Inc.	FELIS CATUS DANDER; FELIS CATUS SKIN	5000; 5000	[BAU]/mL; [BAU]/mL	Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-0101_efbdc240-30ca-1473-e053-2995a90a937b	22840-0101	STANDARDIZED ALLERGENIC	Standardized Cat Hair Allergenic Extract		Felis catus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19920924		BLA	BLA103397	Greer Laboratories, Inc.	FELIS CATUS DANDER; FELIS CATUS SKIN	10000; 10000	[BAU]/mL; [BAU]/mL	Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-0200_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0200	STANDARDIZED ALLERGENIC	Standardized Bermuda Grass Pollen		Cynodon dactylon	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101836	Greer Laboratories, Inc.	CYNODON DACTYLON POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0201_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0201	STANDARDIZED ALLERGENIC	Standardized Kentucky (June) Bluegrass Pollen		Poa pratensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	POA PRATENSIS POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0202_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0202	STANDARDIZED ALLERGENIC	Standardized Kentucky (June) Bluegrass Pollen		Poa pratensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	POA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0203_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0203	STANDARDIZED ALLERGENIC	Standardized Meadow Fescue Pollen		Festuca elatior	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101838	Greer Laboratories, Inc.	FESTUCA PRATENSIS POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0204_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0204	STANDARDIZED ALLERGENIC	Standardized Meadow Fescue Pollen		Festuca elatior	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101838	Greer Laboratories, Inc.	FESTUCA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0205_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0205	STANDARDIZED ALLERGENIC	Standardized Orchard Grass Pollen		Dactylis glomerata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101839	Greer Laboratories, Inc.	DACTYLIS GLOMERATA POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0206_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0206	STANDARDIZED ALLERGENIC	Standardized Orchard Grass Pollen		Dactylis glomerata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101839	Greer Laboratories, Inc.	DACTYLIS GLOMERATA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0207_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0207	STANDARDIZED ALLERGENIC	Standardized Redtop Pollen		Agrostis alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101840	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0208_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0208	STANDARDIZED ALLERGENIC	Standardized Redtop Pollen		Agrostis alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101840	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0209_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0209	STANDARDIZED ALLERGENIC	Standardized Perennial Ryegrass Pollen		Lolium perenne	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101841	Greer Laboratories, Inc.	LOLIUM PERENNE POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0210_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0210	STANDARDIZED ALLERGENIC	Standardized Perennial Ryegrass Pollen		Lolium perenne	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101841	Greer Laboratories, Inc.	LOLIUM PERENNE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0211_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0211	STANDARDIZED ALLERGENIC	Standardized Sweet Vernal Grass Pollen		Anthoxanthum odoratum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101842	Greer Laboratories, Inc.	ANTHOXANTHUM ODORATUM POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0212_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0212	STANDARDIZED ALLERGENIC	Standardized Sweet Vernal Grass Pollen		Anthoxanthum odoratum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101842	Greer Laboratories, Inc.	ANTHOXANTHUM ODORATUM POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0213_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0213	STANDARDIZED ALLERGENIC	Standardized Timothy Pollen		Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101843	Greer Laboratories, Inc.	PHLEUM PRATENSE POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0214_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0214	STANDARDIZED ALLERGENIC	Standardized Timothy Pollen		Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101843	Greer Laboratories, Inc.	PHLEUM PRATENSE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0215_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0215	STANDARDIZED ALLERGENIC	Timothy-Orchard Standardized Grass Pollen Mix		Phleum pratense and Dactylis glomerata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101843	Greer Laboratories, Inc.	DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN	50000; 50000	[BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0216_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0216	STANDARDIZED ALLERGENIC	K-O-T Standardized Grass Pollen Mix		Poa pratensis, Dactylis glomerata and Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	3333.333; 3333.333; 3333.333	[BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0217_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0217	STANDARDIZED ALLERGENIC	K-O-T Standardized Grass Pollen Mix		Poa pratensis, Dactylis glomerata and Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	33333.333; 33333.333; 33333.333	[BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0218_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0218	STANDARDIZED ALLERGENIC	K-O-R-T Standardized Grass Pollen Mix		Poa pratensis, Dactylis glomerata, Agrostis alba and Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	2500; 2500; 2500; 2500	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0219_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0219	STANDARDIZED ALLERGENIC	K-O-R-T Standardized Grass Pollen Mix		Poa pratensis, Dactylis glomerata, Agrostis alba and Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	25000; 25000; 25000; 25000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0220_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0220	STANDARDIZED ALLERGENIC	K-O-R-T and Sweet Vernal Standardized Grass Pollen Mix		Poa pratensis, Dactylis glomerata, Agrostis alba, Phleum pratense, and Anthoxanthum odoratum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	2000; 2000; 2000; 2000; 2000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0221_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0221	STANDARDIZED ALLERGENIC	K-O-R-T and Sweet Vernal Standardized Grass Pollen Mix		Poa pratensis, Dactylis glomerata, Agrostis alba, Phleum pratense, and Anthoxanthum odoratum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	20000; 20000; 20000; 20000; 20000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0222_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0222	STANDARDIZED ALLERGENIC	7 Standardized Grass Pollen Mix		Poa pratensis, Festuca elatior, Dactylis glomerata, Lolium perenne, Agrositis alba, Anthoxanthum odoratum, and Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; FESTUCA PRATENSIS POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	1428.5714; 1428.5714; 1428.5714; 1428.5714; 1428.5714; 1428.5714; 1428.5714	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0223_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0223	STANDARDIZED ALLERGENIC	7 Standardized Grass Pollen Mix		Poa pratensis, Festuca elatior, Dactylis glomerata, Lolium perenne, Agrositis alba, Anthoxanthum odoratum, and Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; FESTUCA PRATENSIS POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	14285.714; 14285.714; 14285.714; 14285.714; 14285.714; 14285.714; 14285.714	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0224_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0224	STANDARDIZED ALLERGENIC	T-O-S Standardized Grass Pollen Mix		Phleum pratense, Dactylis glomerata and Anthoxanthum odoratum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101843	Greer Laboratories, Inc.	ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN	3333.333; 3333.333; 3333.333	[BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0225_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0225	STANDARDIZED ALLERGENIC	9 Southern Grass Pollen Mix		Poa pratensis, Festuca elatior, Dactylis glomerata, Lolium perenne, Agrositis alba, Anthoxanthum odoratum, and Phleum pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101837	Greer Laboratories, Inc.	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; FESTUCA PRATENSIS POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN	11111.11111; 11111.11111; 11111.11111; 11111.11111; 11111.11111; 11111.11111; 11111.11111; 11111.11111; 11111.11111	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0226_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0226	STANDARDIZED ALLERGENIC	Timothy-Orchard Standardized Grass Pollen Mix		Phleum pratense and Dactylis glomerata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101843	Greer Laboratories, Inc.	DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN	5000; 5000	[BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0227_0b663a70-4e95-9f7a-e063-6294a90a65ad	22840-0227	STANDARDIZED ALLERGENIC	T-O-S Standardized Grass Pollen Mix		Phleum pratense, Dactylis glomerata and Anthoxanthum odoratum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19680915		BLA	BLA101843	Greer Laboratories, Inc.	ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN	33333.333; 33333.333; 33333.333	[BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-0300_f0715b51-701c-25e2-e053-2995a90a0433	22840-0300	NON-STANDARDIZED ALLERGENIC	Short Ragweed Pollen		Ambrosia artemisiifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101844	Greer Laboratories, Inc.	AMBROSIA ARTEMISIIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-1000_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1000	NON-STANDARDIZED ALLERGENIC	Black Carpenter Ant		Camponotus pennsylvanicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAMPONOTUS PENNSYLVANICUS	.001	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-1001_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1001	NON-STANDARDIZED ALLERGENIC	Black Carpenter Ant		Camponotus pennsylvanicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAMPONOTUS PENNSYLVANICUS	.1	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-1003_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1003	NON-STANDARDIZED ALLERGENIC	Fire Ant		Solenopsis invicta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLENOPSIS INVICTA	.001	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-1005_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1005	NON-STANDARDIZED ALLERGENIC	Fire Ant		Solenopsis richteri	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLENOPSIS RICHTERI	.001	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-1009_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1009	NON-STANDARDIZED ALLERGENIC	American Cockroach		Periplaneta americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PERIPLANETA AMERICANA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1011_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1011	NON-STANDARDIZED ALLERGENIC	German Cockroach		Blattella germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLATTELLA GERMANICA	.001	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1013_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1013	NON-STANDARDIZED ALLERGENIC	Deer Fly		Chrysops vittatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHRYSOPS VITTATUS WHOLE	.025	g/mL			N	20241231
22840-1014_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1014	NON-STANDARDIZED ALLERGENIC	Deer Fly		Chrysops vittatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHRYSOPS VITTATUS WHOLE	.001	g/mL			N	20241231
22840-1016_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1016	NON-STANDARDIZED ALLERGENIC	Flea		Ctenocephalides felis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CTENOCEPHALIDES FELIS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1017_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1017	NON-STANDARDIZED ALLERGENIC	Flea		Ctenocephalides felis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CTENOCEPHALIDES FELIS	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1018_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1018	NON-STANDARDIZED ALLERGENIC	House Fly		Musca domestica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUSCA DOMESTICA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1022_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1022	NON-STANDARDIZED ALLERGENIC	Mosquito		Aedes taeniorhynchus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AEDES TAENIORHYNCHUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1023_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1023	NON-STANDARDIZED ALLERGENIC	Fire Ant		Solenopsis invicta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLENOPSIS INVICTA	.1	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-1024_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1024	NON-STANDARDIZED ALLERGENIC	American Cockroach		Periplaneta americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PERIPLANETA AMERICANA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1025_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1025	NON-STANDARDIZED ALLERGENIC	German Cockroach		Blattella germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLATTELLA GERMANICA	.1	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1026_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1026	NON-STANDARDIZED ALLERGENIC	House Fly		Musca domestica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUSCA DOMESTICA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1027_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1027	NON-STANDARDIZED ALLERGENIC	House Fly		Musca domestica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUSCA DOMESTICA	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1028_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1028	NON-STANDARDIZED ALLERGENIC	House Fly		Musca domestica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUSCA DOMESTICA	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1029_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1029	NON-STANDARDIZED ALLERGENIC	Mosquito		Aedes taeniorhynchus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AEDES TAENIORHYNCHUS	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1030_f89ac913-c072-e512-e053-6294a90a9d5d	22840-1030	NON-STANDARDIZED ALLERGENIC	Mosquito		Aedes taeniorhynchus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AEDES TAENIORHYNCHUS	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-1100_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1100	NON-STANDARDIZED ALLERGENIC	Cattle Epithelia		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOS TAURUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1101_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1101	NON-STANDARDIZED ALLERGENIC	Cattle Epithelia		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOS TAURUS SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1102_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1102	NON-STANDARDIZED ALLERGENIC	Cattle Epithelia		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOS TAURUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1103_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1103	NON-STANDARDIZED ALLERGENIC	Cattle Epithelia		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOS TAURUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1105_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1105	NON-STANDARDIZED ALLERGENIC	Dog Epithelia		Canis lupus familiaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANIS LUPUS FAMILIARIS SKIN	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1106_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1106	NON-STANDARDIZED ALLERGENIC	Dog Epithelia		Canis lupus familiaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANIS LUPUS FAMILIARIS SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1107_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1107	NON-STANDARDIZED ALLERGENIC	Dog Epithelia		Canis lupus familiaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANIS LUPUS FAMILIARIS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1108_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1108	NON-STANDARDIZED ALLERGENIC	Dog Epithelia		Canis lupus familiaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANIS LUPUS FAMILIARIS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1110_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1110	NON-STANDARDIZED ALLERGENIC	Dog Epithelia		Canis lupus familiaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANIS LUPUS FAMILIARIS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1111_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1111	NON-STANDARDIZED ALLERGENIC	Gerbil Epithelia		Meriones unguiculatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MERIONES UNGUICULATUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1112_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1112	NON-STANDARDIZED ALLERGENIC	Gerbil Epithelia		Meriones unguiculatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MERIONES UNGUICULATUS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1113_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1113	NON-STANDARDIZED ALLERGENIC	Gerbil Epithelia		Meriones unguiculatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MERIONES UNGUICULATUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1116_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1116	NON-STANDARDIZED ALLERGENIC	Goat Epithelia		Capra hircus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAPRA HIRCUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1117_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1117	NON-STANDARDIZED ALLERGENIC	Hamster Epithelia		Mesocricetus auratus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MESOCRICETUS AURATUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1118_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1118	NON-STANDARDIZED ALLERGENIC	Hamster Epithelia		Mesocricetus auratus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MESOCRICETUS AURATUS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1119_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1119	NON-STANDARDIZED ALLERGENIC	Hamster Epithelia		Mesocricetus auratus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MESOCRICETUS AURATUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1121_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1121	NON-STANDARDIZED ALLERGENIC	Hog Epithelia		Sus scrofa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SUS SCROFA SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1122_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1122	NON-STANDARDIZED ALLERGENIC	Hog Epithelia		Sus scrofa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SUS SCROFA SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1123_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1123	NON-STANDARDIZED ALLERGENIC	Hog Epithelia		Sus scrofa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SUS SCROFA SKIN	.002	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1125_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1125	NON-STANDARDIZED ALLERGENIC	Hog Epithelia		Sus scrofa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SUS SCROFA SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1126_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1126	NON-STANDARDIZED ALLERGENIC	Horse Epithelia		Equus caballus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EQUUS CABALLUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1127_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1127	NON-STANDARDIZED ALLERGENIC	Horse Epithelia		Equus caballus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EQUUS CABALLUS SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1128_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1128	NON-STANDARDIZED ALLERGENIC	Horse Epithelia		Equus caballus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EQUUS CABALLUS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1129_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1129	NON-STANDARDIZED ALLERGENIC	Horse Epithelia		Equus caballus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EQUUS CABALLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1130_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1130	NON-STANDARDIZED ALLERGENIC	Horse Epithelia		Equus caballus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EQUUS CABALLUS SKIN	.002	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1131_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1131	NON-STANDARDIZED ALLERGENIC	Horse Epithelia		Equus caballus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EQUUS CABALLUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1133_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1133	NON-STANDARDIZED ALLERGENIC	Mouse Epithelia		Mus musculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUS MUSCULUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1134_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1134	NON-STANDARDIZED ALLERGENIC	Mouse Epithelia		Mus musculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUS MUSCULUS SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1135_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1135	NON-STANDARDIZED ALLERGENIC	Mouse Epithelia		Mus musculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUS MUSCULUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1136_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1136	NON-STANDARDIZED ALLERGENIC	Mouse Epithelia		Mus musculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUS MUSCULUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1138_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1138	NON-STANDARDIZED ALLERGENIC	Rabbit Epithelia		Oryctolagus cuniculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ORYCTOLAGUS CUNICULUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1139_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1139	NON-STANDARDIZED ALLERGENIC	Rabbit Epithelia		Oryctolagus cuniculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ORYCTOLAGUS CUNICULUS SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1140_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1140	NON-STANDARDIZED ALLERGENIC	Rabbit Epithelia		Oryctolagus cuniculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ORYCTOLAGUS CUNICULUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1141_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1141	NON-STANDARDIZED ALLERGENIC	Rabbit Epithelia		Oryctolagus cuniculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ORYCTOLAGUS CUNICULUS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1142_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1142	NON-STANDARDIZED ALLERGENIC	Rabbit Epithelia		Oryctolagus cuniculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ORYCTOLAGUS CUNICULUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1144_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1144	NON-STANDARDIZED ALLERGENIC	Rat Epithelia		Rattus norvegicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RATTUS NORVEGICUS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1145_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1145	NON-STANDARDIZED ALLERGENIC	Rat Epithelia		Rattus norvegicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RATTUS NORVEGICUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1146_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1146	NON-STANDARDIZED ALLERGENIC	Rat Epithelia		Rattus norvegicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RATTUS NORVEGICUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1147_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1147	NON-STANDARDIZED ALLERGENIC	Rat Epithelia		Rattus norvegicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RATTUS NORVEGICUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1149_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1149	NON-STANDARDIZED ALLERGENIC	Canary Feathers		Serinus canaria	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SERINUS CANARIA FEATHER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1150_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1150	NON-STANDARDIZED ALLERGENIC	Canary Feathers		Serinus canaria	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SERINUS CANARIA FEATHER	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1151_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1151	NON-STANDARDIZED ALLERGENIC	Canary Feathers		Serinus canaria	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SERINUS CANARIA FEATHER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1153_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1153	NON-STANDARDIZED ALLERGENIC	Chicken Feathers		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GALLUS GALLUS FEATHER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1154_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1154	NON-STANDARDIZED ALLERGENIC	Chicken Feathers		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GALLUS GALLUS FEATHER	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1155_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1155	NON-STANDARDIZED ALLERGENIC	Chicken Feathers		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GALLUS GALLUS FEATHER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1157_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1157	NON-STANDARDIZED ALLERGENIC	Duck Feathers		Anas platyrhynchos	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1159_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1159	NON-STANDARDIZED ALLERGENIC	Goose Feathers		Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANSER ANSER FEATHER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1160_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1160	NON-STANDARDIZED ALLERGENIC	Goose Feathers		Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANSER ANSER FEATHER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1162_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1162	NON-STANDARDIZED ALLERGENIC	Parakeet Feathers		Melopsitticus undulatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELOPSITTACUS UNDULATUS FEATHER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1163_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1163	NON-STANDARDIZED ALLERGENIC	Parakeet Feathers		Melopsitticus undulatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELOPSITTACUS UNDULATUS FEATHER	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1164_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1164	NON-STANDARDIZED ALLERGENIC	Parakeet Feathers		Melopsitticus undulatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELOPSITTACUS UNDULATUS FEATHER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1167_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1167	NON-STANDARDIZED ALLERGENIC	Guinea Pig Epithelia		Cavia porcellus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAVIA PORCELLUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1168_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1168	NON-STANDARDIZED ALLERGENIC	Guinea Pig Epithelia		Cavia porcellus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAVIA PORCELLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1169_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1169	NON-STANDARDIZED ALLERGENIC	Guinea Pig Epithelia		Cavia porcellus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAVIA PORCELLUS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1170_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1170	NON-STANDARDIZED ALLERGENIC	Guinea Pig Epithelia		Cavia porcellus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAVIA PORCELLUS SKIN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1171_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1171	NON-STANDARDIZED ALLERGENIC	Guinea Pig Epithelia		Cavia porcellus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAVIA PORCELLUS SKIN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1173_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1173	NON-STANDARDIZED ALLERGENIC	Goat Epithelia		Capra hircus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAPRA HIRCUS SKIN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1174_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1174	NON-STANDARDIZED ALLERGENIC	Hog Epithelia		Sus scrofa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SUS SCROFA SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1175_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1175	NON-STANDARDIZED ALLERGENIC	Cattle Epithelia		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOS TAURUS SKIN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-1176_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1176	NON-STANDARDIZED ALLERGENIC	Duck Feathers		Anas platyrhynchos	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-1200_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1200	NON-STANDARDIZED ALLERGENIC	Bahia Grass		Paspalum notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASPALUM NOTATUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1201_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1201	NON-STANDARDIZED ALLERGENIC	Bahia Grass		Paspalum notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASPALUM NOTATUM POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1202_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1202	NON-STANDARDIZED ALLERGENIC	Bahia Grass		Paspalum notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASPALUM NOTATUM POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1203_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1203	NON-STANDARDIZED ALLERGENIC	Bahia Grass		Paspalum notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASPALUM NOTATUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1204_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1204	NON-STANDARDIZED ALLERGENIC	Bahia Grass		Paspalum notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASPALUM NOTATUM POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1205_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1205	NON-STANDARDIZED ALLERGENIC	Smooth Brome		Bromus inermis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROMUS INERMIS POLLEN	.1	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1206_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1206	NON-STANDARDIZED ALLERGENIC	Smooth Brome		Bromus inermis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROMUS INERMIS POLLEN	.001	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1207_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1207	NON-STANDARDIZED ALLERGENIC	Smooth Brome		Bromus inermis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROMUS INERMIS POLLEN	1000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1208_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1208	NON-STANDARDIZED ALLERGENIC	Reed Canarygrass		Phalaris arundinacea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PHALARIS ARUNDINACEA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1209_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1209	NON-STANDARDIZED ALLERGENIC	Reed Canarygrass		Phalaris arundinacea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PHALARIS ARUNDINACEA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1210_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1210	NON-STANDARDIZED ALLERGENIC	Reed Canarygrass		Phalaris arundinacea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PHALARIS ARUNDINACEA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1215_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1215	NON-STANDARDIZED ALLERGENIC	Johnson Grass		Sorghum halepense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SORGHUM HALEPENSE POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1216_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1216	NON-STANDARDIZED ALLERGENIC	Johnson Grass		Sorghum halepense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SORGHUM HALEPENSE POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1226_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1226	NON-STANDARDIZED ALLERGENIC	Giant Wild Ryegrass		Leymus condensatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEYMUS CONDENSATUS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1227_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1227	NON-STANDARDIZED ALLERGENIC	Giant Wild Ryegrass		Leymus condensatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEYMUS CONDENSATUS POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1228_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1228	NON-STANDARDIZED ALLERGENIC	Italian Ryegrass		Lolium multiflorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LOLIUM MULTIFLORUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1229_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1229	NON-STANDARDIZED ALLERGENIC	Italian Ryegrass		Lolium multiflorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LOLIUM MULTIFLORUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1230_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1230	NON-STANDARDIZED ALLERGENIC	Velvetgrass		Holcus lanatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HOLCUS LANATUS POLLEN	20000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1231_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1231	NON-STANDARDIZED ALLERGENIC	Velvetgrass		Holcus lanatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HOLCUS LANATUS POLLEN	.001	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1236_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1236	NON-STANDARDIZED ALLERGENIC	Western Wheatgrass		Pascopyrum smithii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASCOPYRUM SMITHII POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1237_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1237	NON-STANDARDIZED ALLERGENIC	Western Wheatgrass		Pascopyrum smithii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASCOPYRUM SMITHII POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1238_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1238	NON-STANDARDIZED ALLERGENIC	Western Wheatgrass		Pascopyrum smithii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASCOPYRUM SMITHII POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1239_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1239	NON-STANDARDIZED ALLERGENIC	Smooth Brome		Bromus inermis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROMUS INERMIS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1240_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1240	NON-STANDARDIZED ALLERGENIC	Smooth Brome		Bromus inermis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROMUS INERMIS POLLEN	40000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1241_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1241	NON-STANDARDIZED ALLERGENIC	Smooth Brome		Bromus inermis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROMUS INERMIS POLLEN	20000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1242_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1242	NON-STANDARDIZED ALLERGENIC	Reed Canarygrass		Phalaris arundinacea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PHALARIS ARUNDINACEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1243_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1243	NON-STANDARDIZED ALLERGENIC	Johnson Grass		Sorghum halepense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SORGHUM HALEPENSE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1244_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1244	NON-STANDARDIZED ALLERGENIC	Couch Quack Grass		Elymus repens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ELYMUS REPENS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1245_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1245	NON-STANDARDIZED ALLERGENIC	Giant Wild Ryegrass		Leymus condensatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEYMUS CONDENSATUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1246_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1246	NON-STANDARDIZED ALLERGENIC	Italian Ryegrass		Lolium multiflorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LOLIUM MULTIFLORUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1247_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1247	NON-STANDARDIZED ALLERGENIC	Italian Ryegrass		Lolium multiflorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LOLIUM MULTIFLORUM POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1248_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1248	NON-STANDARDIZED ALLERGENIC	Velvetgrass		Holcus lanatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HOLCUS LANATUS POLLEN	.1	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1249_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1249	NON-STANDARDIZED ALLERGENIC	Velvetgrass		Holcus lanatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HOLCUS LANATUS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1250_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-1250	NON-STANDARDIZED ALLERGENIC	Western Wheatgrass		Pascopyrum smithii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASCOPYRUM SMITHII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1300_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1300	NON-STANDARDIZED ALLERGENIC	Allscale		Atriplex polycarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX POLYCARPA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1301_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1301	NON-STANDARDIZED ALLERGENIC	Baccharis		Baccharis spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BACCHARIS HALIMIFOLIA POLLEN; BACCHARIS SAROTHROIDES WHOLE	.025; .025	g/mL; g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1302_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1302	NON-STANDARDIZED ALLERGENIC	Baccharis		Baccharis spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BACCHARIS HALIMIFOLIA POLLEN; BACCHARIS SAROTHROIDES WHOLE	.0005; .0005	g/mL; g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1304_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1304	NON-STANDARDIZED ALLERGENIC	Baccharis		Baccharis spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BACCHARIS HALIMIFOLIA POLLEN; BACCHARIS SAROTHROIDES WHOLE	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1305_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1305	NON-STANDARDIZED ALLERGENIC	Burrobrush		Hymenoclea salsola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA SALSOLA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1307_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1307	NON-STANDARDIZED ALLERGENIC	Burrobrush		Hymenoclea salsola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA SALSOLA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1308_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1308	NON-STANDARDIZED ALLERGENIC	Burrobrush		Hymenoclea salsola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA SALSOLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1309_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1309	NON-STANDARDIZED ALLERGENIC	Careless Weed, Amaranth Green		Amaranthus hybridus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS HYBRIDUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-1310_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1310	NON-STANDARDIZED ALLERGENIC	Careless Weed, Amaranth Green		Amaranthus hybridus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS HYBRIDUS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-1311_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1311	NON-STANDARDIZED ALLERGENIC	Careless Weed, Amaranth Green		Amaranthus hybridus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS HYBRIDUS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-1314_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1314	NON-STANDARDIZED ALLERGENIC	Cocklebur		Xanthium strumarium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	XANTHIUM STRUMARIUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1315_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1315	NON-STANDARDIZED ALLERGENIC	Yellow Curly Dock		Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX CRISPUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1316_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1316	NON-STANDARDIZED ALLERGENIC	Yellow Curly Dock		Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX CRISPUS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1317_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1317	NON-STANDARDIZED ALLERGENIC	Yellow Curly Dock		Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX CRISPUS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1318_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1318	NON-STANDARDIZED ALLERGENIC	Yellow Curly Dock		Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX CRISPUS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1320_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1320	NON-STANDARDIZED ALLERGENIC	Dog Fennel		Eupatorium capillifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUPATORIUM CAPILLIFOLIUM POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1321_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1321	NON-STANDARDIZED ALLERGENIC	Dog Fennel		Eupatorium capillifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUPATORIUM CAPILLIFOLIUM POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1322_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1322	NON-STANDARDIZED ALLERGENIC	Dog Fennel		Eupatorium capillifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUPATORIUM CAPILLIFOLIUM POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1323_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1323	NON-STANDARDIZED ALLERGENIC	Dog Fennel		Eupatorium capillifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUPATORIUM CAPILLIFOLIUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1325_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1325	NON-STANDARDIZED ALLERGENIC	Firebush Kochia		Kochia scoparia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1326_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1326	NON-STANDARDIZED ALLERGENIC	Firebush Kochia		Kochia scoparia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1327_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1327	NON-STANDARDIZED ALLERGENIC	Firebush Kochia		Kochia scoparia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1328_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1328	NON-STANDARDIZED ALLERGENIC	Firebush Kochia		Kochia scoparia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1330_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1330	NON-STANDARDIZED ALLERGENIC	Goldenrod		Solidago spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLIDAGO CANADENSIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1331_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1331	NON-STANDARDIZED ALLERGENIC	Goldenrod		Solidago spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLIDAGO CANADENSIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1332_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1332	NON-STANDARDIZED ALLERGENIC	Goldenrod		Solidago spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLIDAGO CANADENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1333_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1333	NON-STANDARDIZED ALLERGENIC	Goldenrod		Solidago spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLIDAGO CANADENSIS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1334_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1334	NON-STANDARDIZED ALLERGENIC	Goldenrod		Solidago spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLIDAGO CANADENSIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1339_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1339	NON-STANDARDIZED ALLERGENIC	Iodine Bush		Allenrolfea occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALLENROLFEA OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1340_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1340	NON-STANDARDIZED ALLERGENIC	Iodine Bush		Allenrolfea occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALLENROLFEA OCCIDENTALIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1341_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1341	NON-STANDARDIZED ALLERGENIC	Lambs Quarter		Chenopodium album	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHENOPODIUM ALBUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1343_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1343	NON-STANDARDIZED ALLERGENIC	Lenscale Quailbrush		Atriplex lentiformis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX LENTIFORMIS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1344_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1344	NON-STANDARDIZED ALLERGENIC	Lenscale Quailbrush		Atriplex lentiformis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX LENTIFORMIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1345_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1345	NON-STANDARDIZED ALLERGENIC	Burweed Giant Poverty Marsh Elder		Iva xanthifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CYCLACHAENA XANTHIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1348_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1348	NON-STANDARDIZED ALLERGENIC	Common Mugwort		Artemisia vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA VULGARIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1349_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1349	NON-STANDARDIZED ALLERGENIC	Prairie Mugwort Darkleaved Sagebrush		Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1350_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1350	NON-STANDARDIZED ALLERGENIC	Prairie Mugwort Darkleaved Sagebrush		Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1351_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1351	NON-STANDARDIZED ALLERGENIC	Prairie Mugwort Darkleaved Sagebrush		Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1352_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1352	NON-STANDARDIZED ALLERGENIC	Prairie Mugwort Darkleaved Sagebrush		Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1353_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1353	NON-STANDARDIZED ALLERGENIC	Prairie Mugwort Darkleaved Sagebrush		Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1354_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1354	NON-STANDARDIZED ALLERGENIC	True Rough Marsh Elder		Iva annua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	IVA ANNUA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1356_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1356	NON-STANDARDIZED ALLERGENIC	Nettle		Urtica dioica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	URTICA DIOICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1357_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1357	NON-STANDARDIZED ALLERGENIC	Nettle		Urtica dioica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	URTICA DIOICA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1358_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1358	NON-STANDARDIZED ALLERGENIC	Nettle		Urtica dioica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	URTICA DIOICA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1360_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1360	NON-STANDARDIZED ALLERGENIC	Palmers Amaranth		Amaranthus palmeri	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS PALMERI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1361_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1361	NON-STANDARDIZED ALLERGENIC	Palmers Amaranth		Amaranthus palmeri	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS PALMERI POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1362_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1362	NON-STANDARDIZED ALLERGENIC	Palmers Amaranth		Amaranthus palmeri	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS PALMERI POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1363_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1363	NON-STANDARDIZED ALLERGENIC	Rough Redroot Rough Redroot		Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1365_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1365	NON-STANDARDIZED ALLERGENIC	English Plantain		Plantago lanceolata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1366_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1366	NON-STANDARDIZED ALLERGENIC	English Plantain		Plantago lanceolata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1367_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1367	NON-STANDARDIZED ALLERGENIC	English Plantain		Plantago lanceolata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1368_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1368	NON-STANDARDIZED ALLERGENIC	English Plantain		Plantago lanceolata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1370_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1370	NON-STANDARDIZED ALLERGENIC	English Plantain		Plantago lanceolata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1371_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1371	NON-STANDARDIZED ALLERGENIC	Rabbit Bush		Ambrosia deltoidea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DELTOIDEA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1372_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1372	NON-STANDARDIZED ALLERGENIC	Rabbit Bush		Ambrosia deltoidea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DELTOIDEA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1373_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1373	NON-STANDARDIZED ALLERGENIC	Rabbit Bush		Ambrosia deltoidea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DELTOIDEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1374_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1374	NON-STANDARDIZED ALLERGENIC	Rabbit Bush		Ambrosia deltoidea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DELTOIDEA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1376_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1376	NON-STANDARDIZED ALLERGENIC	Desert Ragweed		Ambrosia dumosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DUMOSA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1377_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1377	NON-STANDARDIZED ALLERGENIC	Desert Ragweed		Ambrosia dumosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DUMOSA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1378_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1378	NON-STANDARDIZED ALLERGENIC	False Ragweed		Ambrosia acanthicarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1379_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1379	NON-STANDARDIZED ALLERGENIC	False Ragweed		Ambrosia acanthicarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1381_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1381	NON-STANDARDIZED ALLERGENIC	False Ragweed		Ambrosia acanthicarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1382_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1382	NON-STANDARDIZED ALLERGENIC	Giant Ragweed		Ambrosia trifida	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA TRIFIDA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1383_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1383	NON-STANDARDIZED ALLERGENIC	Giant Ragweed		Ambrosia trifida	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA TRIFIDA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1384_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1384	NON-STANDARDIZED ALLERGENIC	Giant Ragweed		Ambrosia trifida	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA TRIFIDA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1386_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1386	NON-STANDARDIZED ALLERGENIC	Giant Ragweed		Ambrosia trifida	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA TRIFIDA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1387_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1387	NON-STANDARDIZED ALLERGENIC	Giant Ragweed		Ambrosia trifida	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA TRIFIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1388_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1388	NON-STANDARDIZED ALLERGENIC	Slender Ragweed		Ambrosia confertiflora	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA CONFERTIFLORA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1389_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1389	NON-STANDARDIZED ALLERGENIC	Slender Ragweed		Ambrosia confertiflora	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA CONFERTIFLORA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1390_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1390	NON-STANDARDIZED ALLERGENIC	Southern Ragweed		Ambrosia bidentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA BIDENTATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1392_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1392	NON-STANDARDIZED ALLERGENIC	Southern Ragweed		Ambrosia bidentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA BIDENTATA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1393_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1393	NON-STANDARDIZED ALLERGENIC	Western Ragweed		Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA PSILOSTACHYA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1394_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1394	NON-STANDARDIZED ALLERGENIC	Western Ragweed		Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA PSILOSTACHYA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1395_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1395	NON-STANDARDIZED ALLERGENIC	Western Ragweed		Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA PSILOSTACHYA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1396_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1396	NON-STANDARDIZED ALLERGENIC	Western Ragweed		Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA PSILOSTACHYA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1398_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-1398	NON-STANDARDIZED ALLERGENIC	Western Ragweed		Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA PSILOSTACHYA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1400_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1400	NON-STANDARDIZED ALLERGENIC	Acacia Pollen		Acacia dealbata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1401_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1401	NON-STANDARDIZED ALLERGENIC	Acacia Pollen		Acacia dealbata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1402_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1402	NON-STANDARDIZED ALLERGENIC	Acacia Pollen		Acacia dealbata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1404_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1404	NON-STANDARDIZED ALLERGENIC	Red Alder Pollen		Alnus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RUBRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1405_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1405	NON-STANDARDIZED ALLERGENIC	Red Alder Pollen		Alnus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RUBRA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1406_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1406	NON-STANDARDIZED ALLERGENIC	Red Alder Pollen		Alnus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RUBRA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1408_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1408	NON-STANDARDIZED ALLERGENIC	Hazel Alder Pollen		Alnus serrulata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS SERRULATA POLLEN	.1	g/mL			N	20241231
22840-1409_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1409	NON-STANDARDIZED ALLERGENIC	Hazel Alder Pollen		Alnus serrulata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS SERRULATA POLLEN	40000	[PNU]/mL			N	20241231
22840-1411_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1411	NON-STANDARDIZED ALLERGENIC	Hazel Alder Pollen		Alnus serrulata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS SERRULATA POLLEN	.001	g/mL			N	20241231
22840-1412_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1412	NON-STANDARDIZED ALLERGENIC	White Alder Pollen		Alnus rhombifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RHOMBIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1413_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1413	NON-STANDARDIZED ALLERGENIC	Arizona Velvet Ash Pollen		Fraxinus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS VELUTINA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1414_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1414	NON-STANDARDIZED ALLERGENIC	Arizona Velvet Ash Pollen		Fraxinus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS VELUTINA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1416_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1416	NON-STANDARDIZED ALLERGENIC	Arizona Velvet Ash Pollen		Fraxinus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS VELUTINA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1417_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1417	NON-STANDARDIZED ALLERGENIC	Arizona Velvet Ash Pollen		Fraxinus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS VELUTINA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1418_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1418	NON-STANDARDIZED ALLERGENIC	Arizona Velvet Ash Pollen		Fraxinus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS VELUTINA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1419_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1419	NON-STANDARDIZED ALLERGENIC	Oregon Ash Pollen		Fraxinus latifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS LATIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1420_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1420	NON-STANDARDIZED ALLERGENIC	Oregon Ash Pollen		Fraxinus latifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS LATIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1421_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1421	NON-STANDARDIZED ALLERGENIC	Green Ash Pollen		Fraxinus pennsylvanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS PENNSYLVANICA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1422_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1422	NON-STANDARDIZED ALLERGENIC	Green Ash Pollen		Fraxinus pennsylvanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS PENNSYLVANICA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1424_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1424	NON-STANDARDIZED ALLERGENIC	Green Ash Pollen		Fraxinus pennsylvanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS PENNSYLVANICA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1425_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1425	NON-STANDARDIZED ALLERGENIC	White Ash Pollen		Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1426_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1426	NON-STANDARDIZED ALLERGENIC	White Ash Pollen		Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1427_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1427	NON-STANDARDIZED ALLERGENIC	White Ash Pollen		Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1428_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1428	NON-STANDARDIZED ALLERGENIC	White Ash Pollen		Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1430_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1430	NON-STANDARDIZED ALLERGENIC	Aspen Pollen		Populus tremuloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TREMULOIDES POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1431_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1431	NON-STANDARDIZED ALLERGENIC	Aspen Pollen		Populus tremuloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TREMULOIDES POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1433_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1433	NON-STANDARDIZED ALLERGENIC	Wax Myrtle Pollen		Morella cerifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORELLA CERIFERA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1434_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1434	NON-STANDARDIZED ALLERGENIC	Wax Myrtle Pollen		Morella cerifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORELLA CERIFERA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1435_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1435	NON-STANDARDIZED ALLERGENIC	Wax Myrtle Pollen		Morella cerifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORELLA CERIFERA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1437_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1437	NON-STANDARDIZED ALLERGENIC	American Beech Pollen		Fagus grandifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FAGUS GRANDIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1439_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1439	NON-STANDARDIZED ALLERGENIC	Australian Pine Beefwood Pollen		Casuarina equisetifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CASUARINA EQUISETIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1440_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1440	NON-STANDARDIZED ALLERGENIC	Australian Pine Beefwood Pollen		Casuarina equisetifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CASUARINA EQUISETIFOLIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1441_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1441	NON-STANDARDIZED ALLERGENIC	Australian Pine Beefwood Pollen		Casuarina equisetifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CASUARINA EQUISETIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1443_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1443	NON-STANDARDIZED ALLERGENIC	Australian Pine Beefwood Pollen		Casuarina equisetifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CASUARINA EQUISETIFOLIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1444_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1444	NON-STANDARDIZED ALLERGENIC	Black-Sweet Birch Pollen		Betula lenta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1445_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1445	NON-STANDARDIZED ALLERGENIC	Black-Sweet Birch Pollen		Betula lenta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1446_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1446	NON-STANDARDIZED ALLERGENIC	Black-Sweet Birch Pollen		Betula lenta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1448_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1448	NON-STANDARDIZED ALLERGENIC	Black-Sweet Birch Pollen		Betula lenta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1449_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1449	NON-STANDARDIZED ALLERGENIC	River Birch Pollen		Betula nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1450_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1450	NON-STANDARDIZED ALLERGENIC	River Birch Pollen		Betula nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1451_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1451	NON-STANDARDIZED ALLERGENIC	River Birch Pollen		Betula nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1452_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1452	NON-STANDARDIZED ALLERGENIC	River Birch Pollen		Betula nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1454_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1454	NON-STANDARDIZED ALLERGENIC	Spring Birch Pollen		Betula occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA OCCIDENTALIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1455_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1455	NON-STANDARDIZED ALLERGENIC	Spring Birch Pollen		Betula occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA OCCIDENTALIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1456_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1456	NON-STANDARDIZED ALLERGENIC	Spring Birch Pollen		Betula occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA OCCIDENTALIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1457_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1457	NON-STANDARDIZED ALLERGENIC	White Birch Pollen		Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA POPULIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1458_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1458	NON-STANDARDIZED ALLERGENIC	White Birch Pollen		Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA POPULIFOLIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1459_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1459	NON-STANDARDIZED ALLERGENIC	White Birch Pollen		Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA POPULIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1460_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1460	NON-STANDARDIZED ALLERGENIC	White Birch Pollen		Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA POPULIFOLIA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1461_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1461	NON-STANDARDIZED ALLERGENIC	White Birch Pollen		Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA POPULIFOLIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1462_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1462	NON-STANDARDIZED ALLERGENIC	White Birch Pollen		Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA POPULIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1464_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1464	NON-STANDARDIZED ALLERGENIC	Box Elder Pollen		Acer negundo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1466_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1466	NON-STANDARDIZED ALLERGENIC	Mountain Cedar Pollen		Juniperus ashei	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS ASHEI POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1467_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1467	NON-STANDARDIZED ALLERGENIC	Red Cedar Pollen		Juniperus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS VIRGINIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1468_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1468	NON-STANDARDIZED ALLERGENIC	Red Cedar Pollen		Juniperus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1469_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1469	NON-STANDARDIZED ALLERGENIC	Red Cedar Pollen		Juniperus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS VIRGINIANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1471_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1471	NON-STANDARDIZED ALLERGENIC	Salt Cedar Tamarisk Pollen		Tamarix gallica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TAMARIX GALLICA POLLEN	.1	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1472_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1472	NON-STANDARDIZED ALLERGENIC	Salt Cedar Tamarisk Pollen		Tamarix gallica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TAMARIX GALLICA POLLEN	.001	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1473_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1473	NON-STANDARDIZED ALLERGENIC	Salt Cedar Tamarisk Pollen		Tamarix gallica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TAMARIX GALLICA POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1474_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1474	NON-STANDARDIZED ALLERGENIC	Black Cottonwood Pollen		Populus trichocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TRICHOCARPA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1475_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1475	NON-STANDARDIZED ALLERGENIC	Black Cottonwood Pollen		Populus trichocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TRICHOCARPA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1477_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1477	NON-STANDARDIZED ALLERGENIC	Black Cottonwood Pollen		Populus trichocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TRICHOCARPA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1478_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1478	NON-STANDARDIZED ALLERGENIC	Eastern Cottonwood Pollen		Populus deltoides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS DELTOIDES POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1480_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1480	NON-STANDARDIZED ALLERGENIC	Arizona Fremont Cottonwood Pollen		Populus fremontii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS FREMONTII POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1481_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1481	NON-STANDARDIZED ALLERGENIC	Arizona Fremont Cottonwood Pollen		Populus fremontii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS FREMONTII POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1482_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1482	NON-STANDARDIZED ALLERGENIC	Arizona Fremont Cottonwood Pollen		Populus fremontii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS FREMONTII POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1483_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1483	NON-STANDARDIZED ALLERGENIC	Arizona Fremont Cottonwood Pollen		Populus fremontii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS FREMONTII POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1485_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1485	NON-STANDARDIZED ALLERGENIC	Western Cottonwood Pollen		Populus deltoides ssp. monilifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1486_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1486	NON-STANDARDIZED ALLERGENIC	Arizona Cypress Pollen		Callitropsis arizonica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CUPRESSUS ARIZONICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1487_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1487	NON-STANDARDIZED ALLERGENIC	Arizona Cypress Pollen		Callitropsis arizonica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CUPRESSUS ARIZONICA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1489_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1489	NON-STANDARDIZED ALLERGENIC	Bald Cypress Pollen		Taxodium distichum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TAXODIUM DISTICHUM POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1490_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1490	NON-STANDARDIZED ALLERGENIC	Bald Cypress Pollen		Taxodium distichum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TAXODIUM DISTICHUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1492_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1492	NON-STANDARDIZED ALLERGENIC	American Elm Pollen		Ulmus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS AMERICANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1494_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1494	NON-STANDARDIZED ALLERGENIC	Cedar Elm Pollen		Ulmus crassifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS CRASSIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1495_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1495	NON-STANDARDIZED ALLERGENIC	Cedar Elm Pollen		Ulmus crassifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS CRASSIFOLIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1496_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1496	NON-STANDARDIZED ALLERGENIC	Cedar Elm Pollen		Ulmus crassifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS CRASSIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1498_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1498	NON-STANDARDIZED ALLERGENIC	Siberian Elm Pollen		Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS PUMILA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1499_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-1499	NON-STANDARDIZED ALLERGENIC	Siberian Elm Pollen		Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS PUMILA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1500_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1500	NON-STANDARDIZED ALLERGENIC	Dandelion		Taraxacum officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TARAXACUM OFFICINALE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1501_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1501	NON-STANDARDIZED ALLERGENIC	Dandelion		Taraxacum officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TARAXACUM OFFICINALE POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1502_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1502	NON-STANDARDIZED ALLERGENIC	Dandelion		Taraxacum officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TARAXACUM OFFICINALE POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1503_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1503	NON-STANDARDIZED ALLERGENIC	Sunflower		Helianthus annuus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELIANTHUS ANNUUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1504_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1504	NON-STANDARDIZED ALLERGENIC	Sunflower		Helianthus annuus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELIANTHUS ANNUUS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1505_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1505	NON-STANDARDIZED ALLERGENIC	Sunflower		Helianthus annuus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELIANTHUS ANNUUS POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1506_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1506	NON-STANDARDIZED ALLERGENIC	Sunflower		Helianthus annuus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELIANTHUS ANNUUS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1507_0a986825-7b07-713b-e063-6394a90a377e	22840-1507	NON-STANDARDIZED ALLERGENIC	Alfalfa		Medicago sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MEDICAGO SATIVA POLLEN	.02	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1508_0a986825-7b07-713b-e063-6394a90a377e	22840-1508	NON-STANDARDIZED ALLERGENIC	Alfalfa		Medicago sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MEDICAGO SATIVA POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1509_0a986825-7b07-713b-e063-6394a90a377e	22840-1509	NON-STANDARDIZED ALLERGENIC	Alfalfa		Medicago sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MEDICAGO SATIVA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1511_0a986825-7b07-713b-e063-6394a90a377e	22840-1511	NON-STANDARDIZED ALLERGENIC	Mustard		Brassica spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BRASSICA RAPA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1512_0a986825-7b07-713b-e063-6394a90a377e	22840-1512	NON-STANDARDIZED ALLERGENIC	Mustard		Brassica spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BRASSICA RAPA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1513_0a986825-7b07-713b-e063-6394a90a377e	22840-1513	NON-STANDARDIZED ALLERGENIC	Mustard		Brassica spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BRASSICA RAPA POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1514_0a986825-7b07-713b-e063-6394a90a377e	22840-1514	NON-STANDARDIZED ALLERGENIC	Red Clover		Trifolium pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRIFOLIUM PRATENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1515_0a986825-7b07-713b-e063-6394a90a377e	22840-1515	NON-STANDARDIZED ALLERGENIC	Red Clover		Trifolium pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRIFOLIUM PRATENSE POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1516_0a986825-7b07-713b-e063-6394a90a377e	22840-1516	NON-STANDARDIZED ALLERGENIC	Sugar Beet Pollen		Beta vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETA VULGARIS POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1517_0a986825-7b07-713b-e063-6394a90a377e	22840-1517	NON-STANDARDIZED ALLERGENIC	Sugar Beet Pollen		Beta vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETA VULGARIS POLLEN	.02	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1518_0a986825-7b07-713b-e063-6394a90a377e	22840-1518	NON-STANDARDIZED ALLERGENIC	Sugar Beet Pollen		Beta vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETA VULGARIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1519_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1519	NON-STANDARDIZED ALLERGENIC	Cotton Linters		Gossypium hirsutum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COTTON FIBER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1520_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1520	NON-STANDARDIZED ALLERGENIC	Cotton Linters		Gossypium hirsutum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COTTON FIBER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1521_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1521	NON-STANDARDIZED ALLERGENIC	Flaxseed		Linum usitatissimum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FLAX SEED	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
22840-1523_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1523	NON-STANDARDIZED ALLERGENIC	Flaxseed		Linum usitatissimum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FLAX SEED	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
22840-1524_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1524	NON-STANDARDIZED ALLERGENIC	Gum Arabic		Acacia senegal	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1525_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1525	NON-STANDARDIZED ALLERGENIC	Karaya Gum		Sterculia urens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	KARAYA GUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-1526_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1526	NON-STANDARDIZED ALLERGENIC	Tragacanth Gum		Astragalus gummifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRAGACANTH	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1527_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1527	NON-STANDARDIZED ALLERGENIC	Kapok		Ceiba pentandra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CEIBA PENTANDRA FIBER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1529_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1529	NON-STANDARDIZED ALLERGENIC	Kapok		Ceiba pentandra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CEIBA PENTANDRA FIBER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1530_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1530	NON-STANDARDIZED ALLERGENIC	Orris Root		Iris germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	IRIS X GERMANICA NOTHOVAR. FLORENTINA ROOT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1531_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1531	NON-STANDARDIZED ALLERGENIC	Orris Root		Iris germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	IRIS X GERMANICA NOTHOVAR. FLORENTINA ROOT	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1533_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1533	NON-STANDARDIZED ALLERGENIC	Pyrethrum		Chrysanthemum cinerariifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PYRETHRUM EXTRACT	.1	g/mL			N	20241231
22840-1535_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1535	NON-STANDARDIZED ALLERGENIC	Pyrethrum		Chrysanthemum cinerariifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PYRETHRUM EXTRACT	.001	g/mL			N	20241231
22840-1537_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1537	NON-STANDARDIZED ALLERGENIC	Silk Worm		Bombyx mori	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOMBYX MORI FIBER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Silk [CS]		N	20241231
22840-1538_0a988aa3-165c-d51b-e063-6394a90aa198	22840-1538	NON-STANDARDIZED ALLERGENIC	Silk Worm		Bombyx mori	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOMBYX MORI FIBER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Silk [CS]		N	20241231
22840-1540_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1540	NON-STANDARDIZED ALLERGENIC	Tobacco, Leaf		Nicotiana tabacum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TOBACCO LEAF	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1542_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1542	NON-STANDARDIZED ALLERGENIC	Tobacco, Leaf		Nicotiana tabacum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TOBACCO LEAF	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1543_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1543	NON-STANDARDIZED ALLERGENIC	Tobacco, Leaf		Nicotiana tabacum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TOBACCO LEAF	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1553_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1553	NON-STANDARDIZED ALLERGENIC	Cotton Linters		Gossypium hirsutum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COTTON FIBER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1554_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1554	NON-STANDARDIZED ALLERGENIC	Cottonseed		Gossypium hirsutum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COTTON SEED	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
22840-1555_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1555	NON-STANDARDIZED ALLERGENIC	Cottonseed		Gossypium hirsutum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COTTON SEED	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
22840-1556_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1556	NON-STANDARDIZED ALLERGENIC	Gum Arabic		Acacia senegal	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1557_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1557	NON-STANDARDIZED ALLERGENIC	Karaya Gum		Sterculia urens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	KARAYA GUM	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-1558_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1558	NON-STANDARDIZED ALLERGENIC	Kapok		Ceiba pentandra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CEIBA PENTANDRA FIBER	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1559_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1559	NON-STANDARDIZED ALLERGENIC	Pyrethrum		Chrysanthemum cinerariifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PYRETHRUM EXTRACT	20000	[PNU]/mL			N	20241231
22840-1560_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-1560	NON-STANDARDIZED ALLERGENIC	Tobacco, Leaf		Nicotiana tabacum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TOBACCO LEAF	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-1561_0a986825-7b07-713b-e063-6394a90a377e	22840-1561	NON-STANDARDIZED ALLERGENIC	Alfalfa		Medicago sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MEDICAGO SATIVA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1562_0a986825-7b07-713b-e063-6394a90a377e	22840-1562	NON-STANDARDIZED ALLERGENIC	Cultivated Corn		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ZEA MAYS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1563_0a986825-7b07-713b-e063-6394a90a377e	22840-1563	NON-STANDARDIZED ALLERGENIC	Cultivated Corn		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ZEA MAYS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1564_0a986825-7b07-713b-e063-6394a90a377e	22840-1564	NON-STANDARDIZED ALLERGENIC	Mustard		Brassica spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BRASSICA RAPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1565_0a986825-7b07-713b-e063-6394a90a377e	22840-1565	NON-STANDARDIZED ALLERGENIC	Red Clover		Trifolium pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRIFOLIUM PRATENSE POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1566_0a986825-7b07-713b-e063-6394a90a377e	22840-1566	NON-STANDARDIZED ALLERGENIC	Cultivated Rye		Secale cereale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SECALE CEREALE POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1567_0a986825-7b07-713b-e063-6394a90a377e	22840-1567	NON-STANDARDIZED ALLERGENIC	Cultivated Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRITICUM AESTIVUM POLLEN	20000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1568_0a986825-7b07-713b-e063-6394a90a377e	22840-1568	NON-STANDARDIZED ALLERGENIC	Cultivated Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRITICUM AESTIVUM POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1569_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1569	NON-STANDARDIZED ALLERGENIC	Daisy		Leucanthemum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEUCANTHEMUM VULGARE POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1570_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1570	NON-STANDARDIZED ALLERGENIC	Daisy		Leucanthemum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEUCANTHEMUM VULGARE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1571_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1571	NON-STANDARDIZED ALLERGENIC	Dandelion		Taraxacum officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TARAXACUM OFFICINALE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1572_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1572	NON-STANDARDIZED ALLERGENIC	Dandelion		Taraxacum officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TARAXACUM OFFICINALE POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1573_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-1573	NON-STANDARDIZED ALLERGENIC	Dandelion		Taraxacum officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TARAXACUM OFFICINALE POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1574_0a986825-7b07-713b-e063-6394a90a377e	22840-1574	NON-STANDARDIZED ALLERGENIC	Cultivated Corn		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ZEA MAYS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1575_0a986825-7b07-713b-e063-6394a90a377e	22840-1575	NON-STANDARDIZED ALLERGENIC	Cultivated Corn		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ZEA MAYS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1576_0a986825-7b07-713b-e063-6394a90a377e	22840-1576	NON-STANDARDIZED ALLERGENIC	Cultivated Corn		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ZEA MAYS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1577_0a986825-7b07-713b-e063-6394a90a377e	22840-1577	NON-STANDARDIZED ALLERGENIC	Cultivated Corn		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ZEA MAYS POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1578_0a986825-7b07-713b-e063-6394a90a377e	22840-1578	NON-STANDARDIZED ALLERGENIC	Common Cultivated Oats		Avena sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AVENA SATIVA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1579_0a986825-7b07-713b-e063-6394a90a377e	22840-1579	NON-STANDARDIZED ALLERGENIC	Common Cultivated Oats		Avena sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AVENA SATIVA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1580_0a986825-7b07-713b-e063-6394a90a377e	22840-1580	NON-STANDARDIZED ALLERGENIC	Common Cultivated Oats		Avena sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AVENA SATIVA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1581_0a986825-7b07-713b-e063-6394a90a377e	22840-1581	NON-STANDARDIZED ALLERGENIC	Common Cultivated Oats		Avena sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AVENA SATIVA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1582_0a986825-7b07-713b-e063-6394a90a377e	22840-1582	NON-STANDARDIZED ALLERGENIC	Common Cultivated Oats		Avena sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AVENA SATIVA POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1583_0a986825-7b07-713b-e063-6394a90a377e	22840-1583	NON-STANDARDIZED ALLERGENIC	Cultivated Rye		Secale cereale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SECALE CEREALE POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1584_0a986825-7b07-713b-e063-6394a90a377e	22840-1584	NON-STANDARDIZED ALLERGENIC	Cultivated Rye		Secale cereale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SECALE CEREALE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1585_0a986825-7b07-713b-e063-6394a90a377e	22840-1585	NON-STANDARDIZED ALLERGENIC	Cultivated Rye		Secale cereale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SECALE CEREALE POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1586_0a986825-7b07-713b-e063-6394a90a377e	22840-1586	NON-STANDARDIZED ALLERGENIC	Cultivated Rye		Secale cereale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SECALE CEREALE POLLEN	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-1587_0a986825-7b07-713b-e063-6394a90a377e	22840-1587	NON-STANDARDIZED ALLERGENIC	Cultivated Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRITICUM AESTIVUM POLLEN	.1	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1588_0a986825-7b07-713b-e063-6394a90a377e	22840-1588	NON-STANDARDIZED ALLERGENIC	Cultivated Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRITICUM AESTIVUM POLLEN	40000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1589_0a986825-7b07-713b-e063-6394a90a377e	22840-1589	NON-STANDARDIZED ALLERGENIC	Cultivated Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRITICUM AESTIVUM POLLEN	.001	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1590_0a986825-7b07-713b-e063-6394a90a377e	22840-1590	NON-STANDARDIZED ALLERGENIC	Cultivated Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRITICUM AESTIVUM POLLEN	1000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-1600_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1600	NON-STANDARDIZED ALLERGENIC	Alternaria alternata		Alternaria alternata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1601_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1601	NON-STANDARDIZED ALLERGENIC	Alternaria alternata		Alternaria alternata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1602_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1602	NON-STANDARDIZED ALLERGENIC	Alternaria alternata		Alternaria alternata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1604_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1604	NON-STANDARDIZED ALLERGENIC	Alternaria alternata		Alternaria alternata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1605_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1605	NON-STANDARDIZED ALLERGENIC	Alternaria alternata		Alternaria alternata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1606_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1606	NON-STANDARDIZED ALLERGENIC	Acremonium strictum		Acremonium strictum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SAROCLADIUM STRICTUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1608_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1608	NON-STANDARDIZED ALLERGENIC	Aspergillus amstelodami		Aspergillus amstelodami	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUROTIUM AMSTELODAMI	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1609_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1609	NON-STANDARDIZED ALLERGENIC	Aspergillus amstelodami		Aspergillus amstelodami	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUROTIUM AMSTELODAMI	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1610_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1610	NON-STANDARDIZED ALLERGENIC	Aspergillus flavus		Aspergillus flavus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1612_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1612	NON-STANDARDIZED ALLERGENIC	Aspergillus flavus		Aspergillus flavus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1614_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1614	NON-STANDARDIZED ALLERGENIC	Aspergillus flavus		Aspergillus flavus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1615_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1615	NON-STANDARDIZED ALLERGENIC	Aspergillus fumigatus		Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FUMIGATUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1616_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1616	NON-STANDARDIZED ALLERGENIC	Aspergillus fumigatus		Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FUMIGATUS	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1617_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1617	NON-STANDARDIZED ALLERGENIC	Aspergillus fumigatus		Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FUMIGATUS	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1618_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1618	NON-STANDARDIZED ALLERGENIC	Aspergillus fumigatus		Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FUMIGATUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1619_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1619	NON-STANDARDIZED ALLERGENIC	Aspergillus fumigatus		Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FUMIGATUS	.002	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1621_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1621	NON-STANDARDIZED ALLERGENIC	Aspergillus fumigatus		Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FUMIGATUS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1622_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1622	NON-STANDARDIZED ALLERGENIC	Aspergillus nidulans		Aspergillus nidulans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIDULANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1623_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1623	NON-STANDARDIZED ALLERGENIC	Aspergillus nidulans		Aspergillus nidulans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIDULANS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1625_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1625	NON-STANDARDIZED ALLERGENIC	Aspergillus niger		Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIGER VAR. NIGER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1626_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1626	NON-STANDARDIZED ALLERGENIC	Aspergillus niger		Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIGER VAR. NIGER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1627_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1627	NON-STANDARDIZED ALLERGENIC	Aspergillus niger		Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIGER VAR. NIGER	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1628_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1628	NON-STANDARDIZED ALLERGENIC	Aspergillus niger		Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIGER VAR. NIGER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1630_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1630	NON-STANDARDIZED ALLERGENIC	Aureobasidium pullulans		Aureobasidium pullulans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1632_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1632	NON-STANDARDIZED ALLERGENIC	Bipolaris sorokiniana		Bipolaris sorokiniana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SATIVUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1633_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1633	NON-STANDARDIZED ALLERGENIC	Bipolaris sorokiniana		Bipolaris sorokiniana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SATIVUS	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1634_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1634	NON-STANDARDIZED ALLERGENIC	Bipolaris sorokiniana		Bipolaris sorokiniana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SATIVUS	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1635_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1635	NON-STANDARDIZED ALLERGENIC	Bipolaris sorokiniana		Bipolaris sorokiniana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SATIVUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1636_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1636	NON-STANDARDIZED ALLERGENIC	Bipolaris sorokiniana		Bipolaris sorokiniana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SATIVUS	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1639_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1639	NON-STANDARDIZED ALLERGENIC	Botrytis cinerea		Botrytis cinerea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOTRYTIS CINEREA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1640_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1640	NON-STANDARDIZED ALLERGENIC	Candida albicans		Candida albicans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1641_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1641	NON-STANDARDIZED ALLERGENIC	Candida albicans		Candida albicans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1642_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1642	NON-STANDARDIZED ALLERGENIC	Candida albicans		Candida albicans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1643_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1643	NON-STANDARDIZED ALLERGENIC	Candida albicans		Candida albicans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1644_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1644	NON-STANDARDIZED ALLERGENIC	Candida albicans		Candida albicans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1646_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1646	NON-STANDARDIZED ALLERGENIC	Candida albicans		Candida albicans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1647_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1647	NON-STANDARDIZED ALLERGENIC	Chaetomium globosum		Chaetomium globosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHAETOMIUM GLOBOSUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1648_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1648	NON-STANDARDIZED ALLERGENIC	Chaetomium globosum		Chaetomium globosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHAETOMIUM GLOBOSUM	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1650_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1650	NON-STANDARDIZED ALLERGENIC	Chaetomium globosum		Chaetomium globosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHAETOMIUM GLOBOSUM	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1651_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1651	NON-STANDARDIZED ALLERGENIC	Chaetomium globosum		Chaetomium globosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHAETOMIUM GLOBOSUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1653_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1653	NON-STANDARDIZED ALLERGENIC	Cladosporium herbarum		Cladosporium herbarum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM HERBARUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1654_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1654	NON-STANDARDIZED ALLERGENIC	Cladosporium herbarum		Cladosporium herbarum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM HERBARUM	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1656_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1656	NON-STANDARDIZED ALLERGENIC	Cladosporium herbarum		Cladosporium herbarum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM HERBARUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1657_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1657	NON-STANDARDIZED ALLERGENIC	Cladosporium herbarum		Cladosporium herbarum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM HERBARUM	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1659_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1659	NON-STANDARDIZED ALLERGENIC	Cladosporium sphaerospermum		Cladosporium sphaerospermum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM SPHAEROSPERMUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1660_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1660	NON-STANDARDIZED ALLERGENIC	Drechslera spicifera		Drechslera spicifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SPICIFER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1661_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1661	NON-STANDARDIZED ALLERGENIC	Drechslera spicifera		Drechslera spicifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SPICIFER	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1662_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1662	NON-STANDARDIZED ALLERGENIC	Drechslera spicifera		Drechslera spicifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SPICIFER	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1664_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1664	NON-STANDARDIZED ALLERGENIC	Drechslera spicifera		Drechslera spicifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SPICIFER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1666_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1666	NON-STANDARDIZED ALLERGENIC	Epicoccum nigrum		Epicoccum nigrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPICOCCUM NIGRUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1667_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1667	NON-STANDARDIZED ALLERGENIC	Epidermophyton floccosum		Epidermophyton floccosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPIDERMOPHYTON FLOCCOSUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1668_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1668	NON-STANDARDIZED ALLERGENIC	Epidermophyton floccosum		Epidermophyton floccosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPIDERMOPHYTON FLOCCOSUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1669_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1669	NON-STANDARDIZED ALLERGENIC	Epidermophyton floccosum		Epidermophyton floccosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPIDERMOPHYTON FLOCCOSUM	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1670_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1670	NON-STANDARDIZED ALLERGENIC	Fusarium moniliforme		Fusarium moniliforme	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1671_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1671	NON-STANDARDIZED ALLERGENIC	Fusarium moniliforme		Fusarium moniliforme	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1672_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1672	NON-STANDARDIZED ALLERGENIC	Fusarium moniliforme		Fusarium moniliforme	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1673_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1673	NON-STANDARDIZED ALLERGENIC	Fusarium moniliforme		Fusarium moniliforme	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1674_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1674	NON-STANDARDIZED ALLERGENIC	Fusarium moniliforme		Fusarium moniliforme	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1676_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1676	NON-STANDARDIZED ALLERGENIC	Fusarium solani		Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HAEMATONECTRIA HAEMATOCOCCA	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1677_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1677	NON-STANDARDIZED ALLERGENIC	Fusarium solani		Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HAEMATONECTRIA HAEMATOCOCCA	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1678_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1678	NON-STANDARDIZED ALLERGENIC	Fusarium solani		Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HAEMATONECTRIA HAEMATOCOCCA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1680_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1680	NON-STANDARDIZED ALLERGENIC	Geotrichum candidum		Geotrichum candidum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GEOTRICHUM CANDIDUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1681_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1681	NON-STANDARDIZED ALLERGENIC	Gliocladium viride		Gliocladium viride	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GLIOCLADIUM VIRIDE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1682_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1682	NON-STANDARDIZED ALLERGENIC	Gliocladium viride		Gliocladium viride	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GLIOCLADIUM VIRIDE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1683_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1683	NON-STANDARDIZED ALLERGENIC	Gliocladium viride		Gliocladium viride	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GLIOCLADIUM VIRIDE	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1684_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1684	NON-STANDARDIZED ALLERGENIC	Gliocladium viride		Gliocladium viride	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GLIOCLADIUM VIRIDE	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1685_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1685	NON-STANDARDIZED ALLERGENIC	Gliocladium viride		Gliocladium viride	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GLIOCLADIUM VIRIDE	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1686_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1686	NON-STANDARDIZED ALLERGENIC	Gliocladium viride		Gliocladium viride	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GLIOCLADIUM VIRIDE	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1687_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1687	NON-STANDARDIZED ALLERGENIC	Helminthosporium solani		Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELMINTHOSPORIUM SOLANI	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1689_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1689	NON-STANDARDIZED ALLERGENIC	Helminthosporium solani		Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELMINTHOSPORIUM SOLANI	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1690_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1690	NON-STANDARDIZED ALLERGENIC	Helminthosporium solani		Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELMINTHOSPORIUM SOLANI	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1691_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1691	NON-STANDARDIZED ALLERGENIC	Helminthosporium solani		Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELMINTHOSPORIUM SOLANI	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1692_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1692	NON-STANDARDIZED ALLERGENIC	Mucor circinelloides f. circinelloides		Mucor circinelloides f. circinelloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. CIRCINELLOIDES	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1694_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1694	NON-STANDARDIZED ALLERGENIC	Mucor plumbeus		Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR PLUMBEUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1695_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1695	NON-STANDARDIZED ALLERGENIC	Mucor plumbeus		Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR PLUMBEUS	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1696_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1696	NON-STANDARDIZED ALLERGENIC	Mucor plumbeus		Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR PLUMBEUS	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1698_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1698	NON-STANDARDIZED ALLERGENIC	Mucor plumbeus		Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR PLUMBEUS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-1699_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-1699	NON-STANDARDIZED ALLERGENIC	Neurospora intermedia		Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	NEUROSPORA INTERMEDIA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2301_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2301	NON-STANDARDIZED ALLERGENIC	Sheep Red Sorrel		Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2302_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2302	NON-STANDARDIZED ALLERGENIC	Sheep Red Sorrel		Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2303_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2303	NON-STANDARDIZED ALLERGENIC	Sheep Red Sorrel		Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2304_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2304	NON-STANDARDIZED ALLERGENIC	Sheep Red Sorrel		Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2306_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2306	NON-STANDARDIZED ALLERGENIC	Sheep Red Sorrel		Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2311_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2311	NON-STANDARDIZED ALLERGENIC	Common Sagebrush		Artemisia tridentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA TRIDENTATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2312_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2312	NON-STANDARDIZED ALLERGENIC	Common Sagebrush		Artemisia tridentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA TRIDENTATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2313_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2313	NON-STANDARDIZED ALLERGENIC	Common Sagebrush		Artemisia tridentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA TRIDENTATA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2315_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2315	NON-STANDARDIZED ALLERGENIC	Common Sagebrush		Artemisia tridentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA TRIDENTATA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2316_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2316	NON-STANDARDIZED ALLERGENIC	Common Sagebrush		Artemisia tridentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA TRIDENTATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2320_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2320	NON-STANDARDIZED ALLERGENIC	Annual Saltbush		Atriplex wrightii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX WRIGHTII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2321_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2321	NON-STANDARDIZED ALLERGENIC	Annual Saltbush		Atriplex wrightii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX WRIGHTII POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2322_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2322	NON-STANDARDIZED ALLERGENIC	Annual Saltbush		Atriplex wrightii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX WRIGHTII POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2324_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2324	NON-STANDARDIZED ALLERGENIC	Wingscale		Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2325_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2325	NON-STANDARDIZED ALLERGENIC	Wingscale		Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2326_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2326	NON-STANDARDIZED ALLERGENIC	Wingscale		Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2327_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2327	NON-STANDARDIZED ALLERGENIC	Wingscale		Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2329_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2329	NON-STANDARDIZED ALLERGENIC	Firebush Kochia		Kochia scoparia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2332_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2332	NON-STANDARDIZED ALLERGENIC	Wingscale		Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2333_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2333	NON-STANDARDIZED ALLERGENIC	Iodine Bush		Allenrolfea occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALLENROLFEA OCCIDENTALIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2334_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2334	NON-STANDARDIZED ALLERGENIC	Iodine Bush		Allenrolfea occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALLENROLFEA OCCIDENTALIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2335_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2335	NON-STANDARDIZED ALLERGENIC	Slender Ragweed		Ambrosia confertiflora	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA CONFERTIFLORA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2336_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2336	NON-STANDARDIZED ALLERGENIC	Slender Ragweed		Ambrosia confertiflora	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA CONFERTIFLORA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2339_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2339	NON-STANDARDIZED ALLERGENIC	Lenscale Quailbrush		Atriplex lentiformis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX LENTIFORMIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2342_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2342	NON-STANDARDIZED ALLERGENIC	Allscale		Atriplex polycarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX POLYCARPA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2343_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2343	NON-STANDARDIZED ALLERGENIC	Allscale		Atriplex polycarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX POLYCARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2344_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2344	NON-STANDARDIZED ALLERGENIC	Southern Ragweed		Ambrosia bidentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA BIDENTATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2345_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2345	NON-STANDARDIZED ALLERGENIC	Southern Ragweed		Ambrosia bidentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA BIDENTATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2347_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2347	NON-STANDARDIZED ALLERGENIC	False Ragweed		Ambrosia acanthicarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2348_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2348	NON-STANDARDIZED ALLERGENIC	False Ragweed		Ambrosia acanthicarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2351_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2351	NON-STANDARDIZED ALLERGENIC	Annual Saltbush		Atriplex wrightii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX WRIGHTII POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2352_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-2352	NON-STANDARDIZED ALLERGENIC	Desert Ragweed		Ambrosia dumosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DUMOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2400_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2400	NON-STANDARDIZED ALLERGENIC	Siberian Elm Pollen		Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS PUMILA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2401_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2401	NON-STANDARDIZED ALLERGENIC	Siberian Elm Pollen		Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS PUMILA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2403_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2403	NON-STANDARDIZED ALLERGENIC	Siberian Elm Pollen		Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS PUMILA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2404_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2404	NON-STANDARDIZED ALLERGENIC	Bluegum Eucalyptus Pollen		Eucalyptus globulus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUCALYPTUS GLOBULUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2405_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2405	NON-STANDARDIZED ALLERGENIC	Bluegum Eucalyptus Pollen		Eucalyptus globulus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUCALYPTUS GLOBULUS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2408_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2408	NON-STANDARDIZED ALLERGENIC	Hackberry Pollen		Celtis occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CELTIS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2409_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2409	NON-STANDARDIZED ALLERGENIC	Hackberry Pollen		Celtis occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CELTIS OCCIDENTALIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2410_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2410	NON-STANDARDIZED ALLERGENIC	Hackberry Pollen		Celtis occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CELTIS OCCIDENTALIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2411_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2411	NON-STANDARDIZED ALLERGENIC	Hackberry Pollen		Celtis occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CELTIS OCCIDENTALIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2413_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2413	NON-STANDARDIZED ALLERGENIC	American Hazelnut Pollen		Corylus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CORYLUS AMERICANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2414_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2414	NON-STANDARDIZED ALLERGENIC	American Hazelnut Pollen		Corylus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CORYLUS AMERICANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2415_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2415	NON-STANDARDIZED ALLERGENIC	American Hazelnut Pollen		Corylus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CORYLUS AMERICANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2417_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2417	NON-STANDARDIZED ALLERGENIC	Shagbark Hickory Pollen		Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA OVATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2418_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2418	NON-STANDARDIZED ALLERGENIC	Shagbark Hickory Pollen		Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA OVATA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2419_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2419	NON-STANDARDIZED ALLERGENIC	Shagbark Hickory Pollen		Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA OVATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2420_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2420	NON-STANDARDIZED ALLERGENIC	Shagbark Hickory Pollen		Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA OVATA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2423_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2423	NON-STANDARDIZED ALLERGENIC	Shellbark Hickory Pollen		Carya laciniosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA LACINIOSA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2424_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2424	NON-STANDARDIZED ALLERGENIC	White Hickory Pollen		Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2426_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2426	NON-STANDARDIZED ALLERGENIC	Oneseed Juniper Pollen		Juniperus monosperma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS MONOSPERMA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2427_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2427	NON-STANDARDIZED ALLERGENIC	Oneseed Juniper Pollen		Juniperus monosperma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS MONOSPERMA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2428_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2428	NON-STANDARDIZED ALLERGENIC	Oneseed Juniper Pollen		Juniperus monosperma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS MONOSPERMA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2429_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2429	NON-STANDARDIZED ALLERGENIC	Pinchot Juniper Pollen		Juniperus pinchotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS PINCHOTII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2431_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2431	NON-STANDARDIZED ALLERGENIC	Rocky Mountain Juniper Pollen		Juniperus scopulorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS SCOPULORUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2432_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2432	NON-STANDARDIZED ALLERGENIC	Rocky Mountain Juniper Pollen		Juniperus scopulorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS SCOPULORUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2433_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2433	NON-STANDARDIZED ALLERGENIC	Utah Juniper Pollen		Juniperus osteosperma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS OSTEOSPERMA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2434_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2434	NON-STANDARDIZED ALLERGENIC	Utah Juniper Pollen		Juniperus osteosperma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS OSTEOSPERMA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2436_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2436	NON-STANDARDIZED ALLERGENIC	Western Juniper Pollen		Juniperus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2437_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2437	NON-STANDARDIZED ALLERGENIC	Western Juniper Pollen		Juniperus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS OCCIDENTALIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2439_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2439	NON-STANDARDIZED ALLERGENIC	Black Locust Blossom		Robinia pseudoacacia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ROBINIA PSEUDOACACIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2440_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2440	NON-STANDARDIZED ALLERGENIC	Black Locust Blossom		Robinia pseudoacacia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ROBINIA PSEUDOACACIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2442_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2442	NON-STANDARDIZED ALLERGENIC	Black Locust Blossom		Robinia pseudoacacia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ROBINIA PSEUDOACACIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2443_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2443	NON-STANDARDIZED ALLERGENIC	Mango Blossom		Mangifera indica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MANGIFERA INDICA POLLEN	.05	g/mL			N	20241231
22840-2444_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2444	NON-STANDARDIZED ALLERGENIC	Mango Blossom		Mangifera indica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MANGIFERA INDICA POLLEN	.001	g/mL			N	20241231
22840-2445_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2445	NON-STANDARDIZED ALLERGENIC	Red Maple Pollen		Acer rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2446_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2446	NON-STANDARDIZED ALLERGENIC	Red Maple Pollen		Acer rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2447_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2447	NON-STANDARDIZED ALLERGENIC	Red Maple Pollen		Acer rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2448_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2448	NON-STANDARDIZED ALLERGENIC	Red Maple Pollen		Acer rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2449_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2449	NON-STANDARDIZED ALLERGENIC	Red Maple Pollen		Acer rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2450_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2450	NON-STANDARDIZED ALLERGENIC	Silver Soft Maple Pollen		Acer saccharinum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARINUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2451_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2451	NON-STANDARDIZED ALLERGENIC	Silver Soft Maple Pollen		Acer saccharinum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARINUM POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2452_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2452	NON-STANDARDIZED ALLERGENIC	Silver Soft Maple Pollen		Acer saccharinum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARINUM POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2453_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2453	NON-STANDARDIZED ALLERGENIC	Silver Soft Maple Pollen		Acer saccharinum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARINUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2454_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2454	NON-STANDARDIZED ALLERGENIC	Silver Soft Maple Pollen		Acer saccharinum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARINUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2455_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2455	NON-STANDARDIZED ALLERGENIC	Sugar Hard Maple Pollen		Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2457_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2457	NON-STANDARDIZED ALLERGENIC	Melaleuca Pollen		Melaleuca quinquenervia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELALEUCA QUINQUENERVIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2458_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2458	NON-STANDARDIZED ALLERGENIC	Melaleuca Pollen		Melaleuca quinquenervia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELALEUCA QUINQUENERVIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2459_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2459	NON-STANDARDIZED ALLERGENIC	Melaleuca Pollen		Melaleuca quinquenervia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELALEUCA QUINQUENERVIA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2460_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2460	NON-STANDARDIZED ALLERGENIC	Melaleuca Pollen		Melaleuca quinquenervia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELALEUCA QUINQUENERVIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2461_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2461	NON-STANDARDIZED ALLERGENIC	Melaleuca Pollen		Melaleuca quinquenervia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELALEUCA QUINQUENERVIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2463_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2463	NON-STANDARDIZED ALLERGENIC	Melaleuca Pollen		Melaleuca quinquenervia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELALEUCA QUINQUENERVIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2464_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2464	NON-STANDARDIZED ALLERGENIC	Velvet Mesquite Pollen		Prosopis velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PROSOPIS VELUTINA SEED	.001	g/mL			N	20241231
22840-2466_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2466	NON-STANDARDIZED ALLERGENIC	Paper Mulberry Pollen		Broussonetia papyrifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROUSSONETIA PAPYRIFERA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2467_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2467	NON-STANDARDIZED ALLERGENIC	Paper Mulberry Pollen		Broussonetia papyrifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROUSSONETIA PAPYRIFERA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2468_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2468	NON-STANDARDIZED ALLERGENIC	Paper Mulberry Pollen		Broussonetia papyrifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROUSSONETIA PAPYRIFERA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2475_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2475	NON-STANDARDIZED ALLERGENIC	White Mulberry Pollen		Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORUS ALBA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2476_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2476	NON-STANDARDIZED ALLERGENIC	White Mulberry Pollen		Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORUS ALBA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2478_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2478	NON-STANDARDIZED ALLERGENIC	White Mulberry Pollen		Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2479_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2479	NON-STANDARDIZED ALLERGENIC	Arizona Gambel Oak Pollen		Quercus gambelii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GAMBELII POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2480_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2480	NON-STANDARDIZED ALLERGENIC	Arizona Gambel Oak Pollen		Quercus gambelii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GAMBELII POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2481_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2481	NON-STANDARDIZED ALLERGENIC	Arizona Gambel Oak Pollen		Quercus gambelii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GAMBELII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2482_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2482	NON-STANDARDIZED ALLERGENIC	Black Oak Pollen		Quercus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VELUTINA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2483_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2483	NON-STANDARDIZED ALLERGENIC	Bur Oak Pollen		Quercus macrocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS MACROCARPA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2485_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2485	NON-STANDARDIZED ALLERGENIC	California Black Oak Pollen		Quercus kelloggii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS KELLOGGII POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2486_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2486	NON-STANDARDIZED ALLERGENIC	California Live Oak Pollen		Quercus agrifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2488_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2488	NON-STANDARDIZED ALLERGENIC	California White Oak Pollen		Quercus lobata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS LOBATA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2489_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2489	NON-STANDARDIZED ALLERGENIC	Post Oak Pollen		Quercus stellata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS STELLATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2490_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2490	NON-STANDARDIZED ALLERGENIC	Red Oak Pollen		Quercus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS RUBRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2491_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2491	NON-STANDARDIZED ALLERGENIC	Red Oak Pollen		Quercus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS RUBRA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2492_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2492	NON-STANDARDIZED ALLERGENIC	Red Oak Pollen		Quercus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS RUBRA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2493_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2493	NON-STANDARDIZED ALLERGENIC	Red Oak Pollen		Quercus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS RUBRA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2494_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2494	NON-STANDARDIZED ALLERGENIC	Red Oak Pollen		Quercus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2495_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2495	NON-STANDARDIZED ALLERGENIC	Red Oak Pollen		Quercus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS RUBRA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2497_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2497	NON-STANDARDIZED ALLERGENIC	Virginia Live Oak Pollen		Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VIRGINIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2498_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2498	NON-STANDARDIZED ALLERGENIC	Virginia Live Oak Pollen		Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VIRGINIANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2499_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-2499	NON-STANDARDIZED ALLERGENIC	Virginia Live Oak Pollen		Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-2600_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2600	NON-STANDARDIZED ALLERGENIC	Neurospora intermedia		Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	NEUROSPORA INTERMEDIA	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2601_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2601	NON-STANDARDIZED ALLERGENIC	Neurospora intermedia		Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	NEUROSPORA INTERMEDIA	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2602_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2602	NON-STANDARDIZED ALLERGENIC	Neurospora intermedia		Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	NEUROSPORA INTERMEDIA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2605_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2605	NON-STANDARDIZED ALLERGENIC	Paecilomyces variotii		Paecilomyces variotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PAECILOMYCES VARIOTII	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2606_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2606	NON-STANDARDIZED ALLERGENIC	Paecilomyces variotii		Paecilomyces variotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PAECILOMYCES VARIOTII	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2607_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2607	NON-STANDARDIZED ALLERGENIC	Paecilomyces variotii		Paecilomyces variotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PAECILOMYCES VARIOTII	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2608_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2608	NON-STANDARDIZED ALLERGENIC	Paecilomyces variotii		Paecilomyces variotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PAECILOMYCES VARIOTII	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2609_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2609	NON-STANDARDIZED ALLERGENIC	Paecilomyces variotii		Paecilomyces variotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PAECILOMYCES VARIOTII	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2610_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2610	NON-STANDARDIZED ALLERGENIC	Penicillium digitatum		Penicillium digitatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM DIGITATUM	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2612_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2612	NON-STANDARDIZED ALLERGENIC	Penicillium chrysogenum (notatum)		Penicillium chrysogenum (notatum)	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2614_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2614	NON-STANDARDIZED ALLERGENIC	Penicillium chrysogenum (notatum)		Penicillium chrysogenum (notatum)	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2615_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2615	NON-STANDARDIZED ALLERGENIC	Penicillium chrysogenum (notatum)		Penicillium chrysogenum (notatum)	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2616_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2616	NON-STANDARDIZED ALLERGENIC	Penicillium chrysogenum (notatum)		Penicillium chrysogenum (notatum)	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2618_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2618	NON-STANDARDIZED ALLERGENIC	Phoma betae		Phoma betae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLEOSPORA BETAE	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2619_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2619	NON-STANDARDIZED ALLERGENIC	Rhizopus oryzae		Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS	.1	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2620_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2620	NON-STANDARDIZED ALLERGENIC	Rhizopus oryzae		Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS	20000	[PNU]/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2621_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2621	NON-STANDARDIZED ALLERGENIC	Rhizopus oryzae		Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS	.001	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2623_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2623	NON-STANDARDIZED ALLERGENIC	Rhizopus stolonifer		Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS STOLONIFER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2624_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2624	NON-STANDARDIZED ALLERGENIC	Rhizopus stolonifer		Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS STOLONIFER	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2625_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2625	NON-STANDARDIZED ALLERGENIC	Rhizopus stolonifer		Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS STOLONIFER	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2627_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2627	NON-STANDARDIZED ALLERGENIC	Rhizopus stolonifer		Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS STOLONIFER	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2628_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2628	NON-STANDARDIZED ALLERGENIC	Rhodotorula mucilaginosa		Rhodotorula mucilaginosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHODOTORULA MUCILAGINOSA	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2630_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2630	NON-STANDARDIZED ALLERGENIC	Rhodotorula mucilaginosa		Rhodotorula mucilaginosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHODOTORULA MUCILAGINOSA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2631_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2631	NON-STANDARDIZED ALLERGENIC	Rhodotorula mucilaginosa		Rhodotorula mucilaginosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHODOTORULA MUCILAGINOSA	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2633_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2633	NON-STANDARDIZED ALLERGENIC	Saccharomyces cerevisiae		Saccharomyces cerevisiae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SACCHAROMYCES CEREVISIAE	.001	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2634_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2634	NON-STANDARDIZED ALLERGENIC	Saccharomyces cerevisiae		Saccharomyces cerevisiae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SACCHAROMYCES CEREVISIAE	.1	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2635_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2635	NON-STANDARDIZED ALLERGENIC	Stemphylium solani		Stemphylium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	STEMPHYLIUM SOLANI	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2636_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2636	NON-STANDARDIZED ALLERGENIC	Stemphylium solani		Stemphylium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	STEMPHYLIUM SOLANI	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2637_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2637	NON-STANDARDIZED ALLERGENIC	Stemphylium solani		Stemphylium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	STEMPHYLIUM SOLANI	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2638_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2638	NON-STANDARDIZED ALLERGENIC	Stemphylium solani		Stemphylium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	STEMPHYLIUM SOLANI	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2640_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2640	NON-STANDARDIZED ALLERGENIC	Trichoderma harzianum		Trichoderma harzianum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHODERMA HARZIANUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2641_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2641	NON-STANDARDIZED ALLERGENIC	Trichoderma harzianum		Trichoderma harzianum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHODERMA HARZIANUM	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2642_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2642	NON-STANDARDIZED ALLERGENIC	Trichoderma harzianum		Trichoderma harzianum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHODERMA HARZIANUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2644_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2644	NON-STANDARDIZED ALLERGENIC	Trichophyton mentagrophytes		Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON MENTAGROPHYTES	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2645_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2645	NON-STANDARDIZED ALLERGENIC	Trichophyton mentagrophytes		Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON MENTAGROPHYTES	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2646_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2646	NON-STANDARDIZED ALLERGENIC	Trichophyton mentagrophytes		Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON MENTAGROPHYTES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2648_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2648	NON-STANDARDIZED ALLERGENIC	Trichophyton mentagrophytes		Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON MENTAGROPHYTES	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2649_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2649	NON-STANDARDIZED ALLERGENIC	Trichophyton mentagrophytes		Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON MENTAGROPHYTES	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2650_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2650	NON-STANDARDIZED ALLERGENIC	Trichophyton rubrum		Trichophyton rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON RUBRUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2652_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2652	NON-STANDARDIZED ALLERGENIC	Trichothecium roseum		Trichothecium roseum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOTHECIUM ROSEUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2653_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2653	NON-STANDARDIZED ALLERGENIC	Trichothecium roseum		Trichothecium roseum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOTHECIUM ROSEUM	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2654_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2654	NON-STANDARDIZED ALLERGENIC	Trichothecium roseum		Trichothecium roseum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOTHECIUM ROSEUM	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2655_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2655	NON-STANDARDIZED ALLERGENIC	Trichothecium roseum		Trichothecium roseum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOTHECIUM ROSEUM	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2656_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2656	NON-STANDARDIZED ALLERGENIC	Trichothecium roseum		Trichothecium roseum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOTHECIUM ROSEUM	1000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2659_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2659	NON-STANDARDIZED ALLERGENIC	Mucor circinelloides f. lusitanicus		Mucor circinelloides f. lusitanicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2660_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2660	NON-STANDARDIZED ALLERGENIC	Aspergillus nidulans		Aspergillus nidulans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIDULANS	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2661_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2661	NON-STANDARDIZED ALLERGENIC	Bipolaris sorokiniana		Bipolaris sorokiniana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SATIVUS	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2662_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2662	NON-STANDARDIZED ALLERGENIC	Botrytis cinerea		Botrytis cinerea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOTRYTIS CINEREA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2663_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2663	NON-STANDARDIZED ALLERGENIC	Cladosporium sphaerospermum		Cladosporium sphaerospermum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM SPHAEROSPERMUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2664_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2664	NON-STANDARDIZED ALLERGENIC	Corn Smut		Ustilago maydis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO MAYDIS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2665_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2665	NON-STANDARDIZED ALLERGENIC	Epicoccum nigrum		Epicoccum nigrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPICOCCUM NIGRUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2666_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2666	NON-STANDARDIZED ALLERGENIC	Epidermophyton floccosum		Epidermophyton floccosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPIDERMOPHYTON FLOCCOSUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2667_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2667	NON-STANDARDIZED ALLERGENIC	Geotrichum candidum		Geotrichum candidum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GEOTRICHUM CANDIDUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2668_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2668	NON-STANDARDIZED ALLERGENIC	Helminthosporium solani		Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELMINTHOSPORIUM SOLANI	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2669_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2669	NON-STANDARDIZED ALLERGENIC	Mucor circinelloides f. circinelloides		Mucor circinelloides f. circinelloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. CIRCINELLOIDES	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2670_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2670	NON-STANDARDIZED ALLERGENIC	Mucor circinelloides f. circinelloides		Mucor circinelloides f. circinelloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. CIRCINELLOIDES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2671_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2671	NON-STANDARDIZED ALLERGENIC	Mucor circinelloides f. lusitanicus		Mucor circinelloides f. lusitanicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2672_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2672	NON-STANDARDIZED ALLERGENIC	Mucor plumbeus		Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR PLUMBEUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2673_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2673	NON-STANDARDIZED ALLERGENIC	Paecilomyces variotii		Paecilomyces variotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PAECILOMYCES VARIOTII	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2674_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2674	NON-STANDARDIZED ALLERGENIC	Phoma betae		Phoma betae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLEOSPORA BETAE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2675_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2675	NON-STANDARDIZED ALLERGENIC	Rhodotorula mucilaginosa		Rhodotorula mucilaginosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHODOTORULA MUCILAGINOSA	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2676_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2676	NON-STANDARDIZED ALLERGENIC	Saccharomyces cerevisiae		Saccharomyces cerevisiae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SACCHAROMYCES CEREVISIAE	20000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2677_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2677	NON-STANDARDIZED ALLERGENIC	Saccharomyces cerevisiae		Saccharomyces cerevisiae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SACCHAROMYCES CEREVISIAE	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2678_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2678	NON-STANDARDIZED ALLERGENIC	Saccharomyces cerevisiae		Saccharomyces cerevisiae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SACCHAROMYCES CEREVISIAE	40000	[PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2679_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2679	NON-STANDARDIZED ALLERGENIC	Acremonium strictum		Acremonium strictum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SAROCLADIUM STRICTUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2680_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2680	NON-STANDARDIZED ALLERGENIC	Trichoderma harzianum		Trichoderma harzianum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHODERMA HARZIANUM	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-2681_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-2681	NON-STANDARDIZED ALLERGENIC	Trichophyton rubrum		Trichophyton rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON RUBRUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-3400_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3400	NON-STANDARDIZED ALLERGENIC	Virginia Live Oak Pollen		Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VIRGINIANA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3401_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3401	NON-STANDARDIZED ALLERGENIC	Virginia Live Oak Pollen		Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VIRGINIANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3403_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3403	NON-STANDARDIZED ALLERGENIC	Water Oak Pollen		Quercus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3404_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3404	NON-STANDARDIZED ALLERGENIC	Water Oak Pollen		Quercus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS NIGRA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3405_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3405	NON-STANDARDIZED ALLERGENIC	Water Oak Pollen		Quercus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS NIGRA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3406_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3406	NON-STANDARDIZED ALLERGENIC	Western White Oak Pollen		Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GARRYANA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3408_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3408	NON-STANDARDIZED ALLERGENIC	White Oak Pollen		Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3409_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3409	NON-STANDARDIZED ALLERGENIC	White Oak Pollen		Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3410_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3410	NON-STANDARDIZED ALLERGENIC	White Oak Pollen		Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3411_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3411	NON-STANDARDIZED ALLERGENIC	White Oak Pollen		Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3412_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3412	NON-STANDARDIZED ALLERGENIC	White Oak Pollen		Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3414_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3414	NON-STANDARDIZED ALLERGENIC	Olive Pollen		Olea europaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3415_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3415	NON-STANDARDIZED ALLERGENIC	Olive Pollen		Olea europaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3416_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3416	NON-STANDARDIZED ALLERGENIC	Olive Pollen		Olea europaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3417_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3417	NON-STANDARDIZED ALLERGENIC	Olive Pollen		Olea europaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3419_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3419	NON-STANDARDIZED ALLERGENIC	Russian Olive Pollen		Elaeagnus angustifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ELAEAGNUS ANGUSTIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3420_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3420	NON-STANDARDIZED ALLERGENIC	Russian Olive Pollen		Elaeagnus angustifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ELAEAGNUS ANGUSTIFOLIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3421_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3421	NON-STANDARDIZED ALLERGENIC	Russian Olive Pollen		Elaeagnus angustifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ELAEAGNUS ANGUSTIFOLIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3423_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3423	NON-STANDARDIZED ALLERGENIC	Orange Pollen		Citrus X sinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CITRUS SINENSIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3424_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3424	NON-STANDARDIZED ALLERGENIC	Orange Pollen		Citrus X sinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CITRUS SINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3425_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3425	NON-STANDARDIZED ALLERGENIC	Orange Pollen		Citrus X sinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CITRUS SINENSIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3427_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3427	NON-STANDARDIZED ALLERGENIC	Queen Palm Pollen		Syagrus romanzoffiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3428_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3428	NON-STANDARDIZED ALLERGENIC	Queen Palm Pollen		Syagrus romanzoffiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3430_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3430	NON-STANDARDIZED ALLERGENIC	Queen Palm Pollen		Syagrus romanzoffiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3431_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3431	NON-STANDARDIZED ALLERGENIC	Pecan Pollen		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3432_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3432	NON-STANDARDIZED ALLERGENIC	Pecan Pollen		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3433_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3433	NON-STANDARDIZED ALLERGENIC	Pecan Pollen		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3434_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3434	NON-STANDARDIZED ALLERGENIC	Pecan Pollen		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3435_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3435	NON-STANDARDIZED ALLERGENIC	Pecan Pollen		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3436_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3436	NON-STANDARDIZED ALLERGENIC	Pecan Pollen		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3438_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-3438	NON-STANDARDIZED ALLERGENIC	Peppertree Pollen Mix		Schinus molle, Schinus terebinthifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SCHINUS MOLLE POLLEN; SCHINUS TEREBINTHIFOLIA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [Chemical/Ingredient]		N	20241231
22840-3439_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-3439	NON-STANDARDIZED ALLERGENIC	Peppertree Pollen Mix		Schinus molle, Schinus terebinthifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SCHINUS MOLLE POLLEN; SCHINUS TEREBINTHIFOLIA POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [Chemical/Ingredient]		N	20241231
22840-3440_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-3440	NON-STANDARDIZED ALLERGENIC	Peppertree Pollen Mix		Schinus molle, Schinus terebinthifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SCHINUS MOLLE POLLEN; SCHINUS TEREBINTHIFOLIA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [Chemical/Ingredient]		N	20241231
22840-3442_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-3442	NON-STANDARDIZED ALLERGENIC	Peppertree Pollen Mix		Schinus molle, Schinus terebinthifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SCHINUS MOLLE POLLEN; SCHINUS TEREBINTHIFOLIA POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [Chemical/Ingredient]		N	20241231
22840-3443_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3443	NON-STANDARDIZED ALLERGENIC	Loblolly Pine Pollen		Pinus taeda	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS TAEDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3444_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3444	NON-STANDARDIZED ALLERGENIC	Loblolly Pine Pollen		Pinus taeda	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS TAEDA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3445_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3445	NON-STANDARDIZED ALLERGENIC	Loblolly Pine Pollen		Pinus taeda	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS TAEDA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3446_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3446	NON-STANDARDIZED ALLERGENIC	Loblolly Pine Pollen		Pinus taeda	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS TAEDA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3448_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3448	NON-STANDARDIZED ALLERGENIC	Longleaf Pine Pollen		Pinus palustris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PALUSTRIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3449_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3449	NON-STANDARDIZED ALLERGENIC	Longleaf Pine Pollen		Pinus palustris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PALUSTRIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3450_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3450	NON-STANDARDIZED ALLERGENIC	Ponderosa Pine Pollen		Pinus ponderosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PONDEROSA POLLEN	.1	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-3451_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3451	NON-STANDARDIZED ALLERGENIC	Ponderosa Pine Pollen		Pinus ponderosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PONDEROSA POLLEN	.001	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-3453_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3453	NON-STANDARDIZED ALLERGENIC	Virginia Scrub Pine Pollen		Pinus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS VIRGINIANA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3454_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3454	NON-STANDARDIZED ALLERGENIC	Virginia Scrub Pine Pollen		Pinus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS VIRGINIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3455_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3455	NON-STANDARDIZED ALLERGENIC	Virginia Scrub Pine Pollen		Pinus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS VIRGINIANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3457_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3457	NON-STANDARDIZED ALLERGENIC	Eastern White Pine Pollen		Pinus strobus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS STROBUS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3458_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3458	NON-STANDARDIZED ALLERGENIC	Eastern White Pine Pollen		Pinus strobus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS STROBUS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3459_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3459	NON-STANDARDIZED ALLERGENIC	Eastern White Pine Pollen		Pinus strobus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS STROBUS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3461_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3461	NON-STANDARDIZED ALLERGENIC	Western White Pine Pollen		Pinus monticola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS MONTICOLA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3462_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3462	NON-STANDARDIZED ALLERGENIC	Western White Pine Pollen		Pinus monticola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS MONTICOLA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3463_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3463	NON-STANDARDIZED ALLERGENIC	Western White Pine Pollen		Pinus monticola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS MONTICOLA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3465_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3465	NON-STANDARDIZED ALLERGENIC	Yellow Pine Pollen		Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3466_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3466	NON-STANDARDIZED ALLERGENIC	Yellow Pine Pollen		Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3467_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3467	NON-STANDARDIZED ALLERGENIC	Yellow Pine Pollen		Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3469_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3469	NON-STANDARDIZED ALLERGENIC	Lombardys Poplar Pollen		Populus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS NIGRA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3470_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3470	NON-STANDARDIZED ALLERGENIC	Lombardys Poplar Pollen		Populus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS NIGRA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3472_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3472	NON-STANDARDIZED ALLERGENIC	Lombardys Poplar Pollen		Populus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS NIGRA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3473_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3473	NON-STANDARDIZED ALLERGENIC	White Poplar Pollen		Populus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS ALBA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3474_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3474	NON-STANDARDIZED ALLERGENIC	White Poplar Pollen		Populus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS ALBA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3475_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3475	NON-STANDARDIZED ALLERGENIC	White Poplar Pollen		Populus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS ALBA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3477_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3477	NON-STANDARDIZED ALLERGENIC	Privet Pollen		Ligustrum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIGUSTRUM VULGARE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3478_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3478	NON-STANDARDIZED ALLERGENIC	Privet Pollen		Ligustrum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIGUSTRUM VULGARE POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3479_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3479	NON-STANDARDIZED ALLERGENIC	Privet Pollen		Ligustrum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIGUSTRUM VULGARE POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3481_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3481	NON-STANDARDIZED ALLERGENIC	Sweetgum Pollen		Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3482_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3482	NON-STANDARDIZED ALLERGENIC	Sweetgum Pollen		Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3483_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3483	NON-STANDARDIZED ALLERGENIC	Sweetgum Pollen		Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3485_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3485	NON-STANDARDIZED ALLERGENIC	Sweetgum Pollen		Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3486_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3486	NON-STANDARDIZED ALLERGENIC	Sweetgum Pollen		Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3487_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3487	NON-STANDARDIZED ALLERGENIC	American Sycamore Pollen		Platanus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS OCCIDENTALIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3488_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3488	NON-STANDARDIZED ALLERGENIC	American Sycamore Pollen		Platanus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS OCCIDENTALIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3489_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3489	NON-STANDARDIZED ALLERGENIC	American Sycamore Pollen		Platanus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS OCCIDENTALIS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3490_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3490	NON-STANDARDIZED ALLERGENIC	American Sycamore Pollen		Platanus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3491_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3491	NON-STANDARDIZED ALLERGENIC	American Sycamore Pollen		Platanus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS OCCIDENTALIS POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3493_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3493	NON-STANDARDIZED ALLERGENIC	California Western Sycamore Pollen		Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS RACEMOSA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3494_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3494	NON-STANDARDIZED ALLERGENIC	California Western Sycamore Pollen		Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS RACEMOSA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3495_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3495	NON-STANDARDIZED ALLERGENIC	California Western Sycamore Pollen		Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS RACEMOSA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3497_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3497	NON-STANDARDIZED ALLERGENIC	California Western Sycamore Pollen		Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS RACEMOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3498_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3498	NON-STANDARDIZED ALLERGENIC	Black Walnut Pollen		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-3499_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-3499	NON-STANDARDIZED ALLERGENIC	Black Walnut Pollen		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS NIGRA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4400_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4400	NON-STANDARDIZED ALLERGENIC	Black Walnut Pollen		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS NIGRA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4401_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4401	NON-STANDARDIZED ALLERGENIC	Black Walnut Pollen		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4402_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4402	NON-STANDARDIZED ALLERGENIC	Black Walnut Pollen		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS NIGRA POLLEN	.02	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4403_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4403	NON-STANDARDIZED ALLERGENIC	Black Walnut Pollen		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS NIGRA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4405_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4405	NON-STANDARDIZED ALLERGENIC	California Black Walnut Pollen		Juglans californica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4407_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4407	NON-STANDARDIZED ALLERGENIC	California Black Walnut Pollen		Juglans californica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4409_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4409	NON-STANDARDIZED ALLERGENIC	English Walnut Pollen		Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS REGIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4410_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4410	NON-STANDARDIZED ALLERGENIC	English Walnut Pollen		Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS REGIA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4411_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4411	NON-STANDARDIZED ALLERGENIC	English Walnut Pollen		Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS REGIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4412_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4412	NON-STANDARDIZED ALLERGENIC	English Walnut Pollen		Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS REGIA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4414_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4414	NON-STANDARDIZED ALLERGENIC	Arroyo Willow Pollen		Salix lasiolepis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SALIX LASIOLEPIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4416_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4416	NON-STANDARDIZED ALLERGENIC	Black Willow Pollen		Salix nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SALIX NIGRA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4418_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4418	NON-STANDARDIZED ALLERGENIC	Water Oak Pollen		Quercus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS NIGRA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4419_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4419	NON-STANDARDIZED ALLERGENIC	Lombardys Poplar Pollen		Populus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4421_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4421	NON-STANDARDIZED ALLERGENIC	Western White Oak Pollen		Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GARRYANA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4422_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4422	NON-STANDARDIZED ALLERGENIC	Acacia Pollen		Acacia dealbata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4423_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4423	NON-STANDARDIZED ALLERGENIC	Hazel Alder Pollen		Alnus serrulata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS SERRULATA POLLEN	20000	[PNU]/mL			N	20241231
22840-4424_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4424	NON-STANDARDIZED ALLERGENIC	Hazel Alder Pollen		Alnus serrulata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS SERRULATA POLLEN	.05	g/mL			N	20241231
22840-4425_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4425	NON-STANDARDIZED ALLERGENIC	Red Alder Pollen		Alnus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RUBRA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4426_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4426	NON-STANDARDIZED ALLERGENIC	White Alder Pollen		Alnus rhombifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RHOMBIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4427_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4427	NON-STANDARDIZED ALLERGENIC	White Alder Pollen		Alnus rhombifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RHOMBIFOLIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4428_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4428	NON-STANDARDIZED ALLERGENIC	Oregon Ash Pollen		Fraxinus latifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS LATIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4430_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4430	NON-STANDARDIZED ALLERGENIC	White Ash Pollen		Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4431_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4431	NON-STANDARDIZED ALLERGENIC	Aspen Pollen		Populus tremuloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TREMULOIDES POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4432_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4432	NON-STANDARDIZED ALLERGENIC	Aspen Pollen		Populus tremuloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TREMULOIDES POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4433_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4433	NON-STANDARDIZED ALLERGENIC	Wax Myrtle Pollen		Morella cerifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORELLA CERIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4434_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4434	NON-STANDARDIZED ALLERGENIC	American Beech Pollen		Fagus grandifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FAGUS GRANDIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4435_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4435	NON-STANDARDIZED ALLERGENIC	Black-Sweet Birch Pollen		Betula lenta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4436_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4436	NON-STANDARDIZED ALLERGENIC	Spring Birch Pollen		Betula occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4437_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4437	NON-STANDARDIZED ALLERGENIC	Box Elder Pollen		Acer negundo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4438_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4438	NON-STANDARDIZED ALLERGENIC	Mountain Cedar Pollen		Juniperus ashei	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS ASHEI POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4439_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4439	NON-STANDARDIZED ALLERGENIC	Arizona Fremont Cottonwood Pollen		Populus fremontii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS FREMONTII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4440_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4440	NON-STANDARDIZED ALLERGENIC	Black Cottonwood Pollen		Populus trichocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TRICHOCARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4441_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4441	NON-STANDARDIZED ALLERGENIC	Eastern Cottonwood Pollen		Populus deltoides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS DELTOIDES POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4442_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4442	NON-STANDARDIZED ALLERGENIC	Western Cottonwood Pollen		Populus deltoides ssp. monilifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4443_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4443	NON-STANDARDIZED ALLERGENIC	American Elm Pollen		Ulmus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS AMERICANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4444_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4444	NON-STANDARDIZED ALLERGENIC	Bluegum Eucalyptus Pollen		Eucalyptus globulus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUCALYPTUS GLOBULUS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4445_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4445	NON-STANDARDIZED ALLERGENIC	Hackberry Pollen		Celtis occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CELTIS OCCIDENTALIS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4446_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4446	NON-STANDARDIZED ALLERGENIC	American Hazelnut Pollen		Corylus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CORYLUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4447_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4447	NON-STANDARDIZED ALLERGENIC	Shagbark Hickory Pollen		Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA OVATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4448_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4448	NON-STANDARDIZED ALLERGENIC	Shagbark Hickory Pollen		Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA OVATA POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4449_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4449	NON-STANDARDIZED ALLERGENIC	Shellbark Hickory Pollen		Carya laciniosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA LACINIOSA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4450_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4450	NON-STANDARDIZED ALLERGENIC	Shellbark Hickory Pollen		Carya laciniosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA LACINIOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4451_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4451	NON-STANDARDIZED ALLERGENIC	Shellbark Hickory Pollen		Carya laciniosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA LACINIOSA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4452_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4452	NON-STANDARDIZED ALLERGENIC	White Hickory Pollen		Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4453_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4453	NON-STANDARDIZED ALLERGENIC	Pinchot Juniper Pollen		Juniperus pinchotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS PINCHOTII POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4454_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4454	NON-STANDARDIZED ALLERGENIC	Rocky Mountain Juniper Pollen		Juniperus scopulorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS SCOPULORUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4455_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4455	NON-STANDARDIZED ALLERGENIC	Black Locust Blossom		Robinia pseudoacacia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ROBINIA PSEUDOACACIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4456_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4456	NON-STANDARDIZED ALLERGENIC	Sugar Hard Maple Pollen		Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4457_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4457	NON-STANDARDIZED ALLERGENIC	Velvet Mesquite Pollen		Prosopis velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PROSOPIS VELUTINA SEED	.1	g/mL			N	20241231
22840-4458_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4458	NON-STANDARDIZED ALLERGENIC	White Mulberry Pollen		Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORUS ALBA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4459_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4459	NON-STANDARDIZED ALLERGENIC	White Mulberry Pollen		Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORUS ALBA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4460_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4460	NON-STANDARDIZED ALLERGENIC	Arizona Gambel Oak Pollen		Quercus gambelii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GAMBELII POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4461_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4461	NON-STANDARDIZED ALLERGENIC	Black Oak Pollen		Quercus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VELUTINA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4462_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4462	NON-STANDARDIZED ALLERGENIC	Bur Oak Pollen		Quercus macrocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS MACROCARPA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4463_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4463	NON-STANDARDIZED ALLERGENIC	Bur Oak Pollen		Quercus macrocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS MACROCARPA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4464_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4464	NON-STANDARDIZED ALLERGENIC	California Black Oak Pollen		Quercus kelloggii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS KELLOGGII POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4465_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4465	NON-STANDARDIZED ALLERGENIC	California Live Oak Pollen		Quercus agrifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4466_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4466	NON-STANDARDIZED ALLERGENIC	California Live Oak Pollen		Quercus agrifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4467_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4467	NON-STANDARDIZED ALLERGENIC	California White Oak Pollen		Quercus lobata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS LOBATA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4468_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4468	NON-STANDARDIZED ALLERGENIC	California White Oak Pollen		Quercus lobata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS LOBATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4469_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4469	NON-STANDARDIZED ALLERGENIC	Post Oak Pollen		Quercus stellata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS STELLATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4470_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4470	NON-STANDARDIZED ALLERGENIC	Western White Oak Pollen		Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GARRYANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4471_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4471	NON-STANDARDIZED ALLERGENIC	Western White Oak Pollen		Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GARRYANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4472_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4472	NON-STANDARDIZED ALLERGENIC	Olive Pollen		Olea europaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4473_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4473	NON-STANDARDIZED ALLERGENIC	Russian Olive Pollen		Elaeagnus angustifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ELAEAGNUS ANGUSTIFOLIA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4474_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4474	NON-STANDARDIZED ALLERGENIC	Orange Pollen		Citrus X sinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CITRUS SINENSIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4475_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4475	NON-STANDARDIZED ALLERGENIC	Queen Palm Pollen		Syagrus romanzoffiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4476_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4476	NON-STANDARDIZED ALLERGENIC	Queen Palm Pollen		Syagrus romanzoffiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4477_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4477	NON-STANDARDIZED ALLERGENIC	Australian Pine Beefwood Pollen		Casuarina equisetifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CASUARINA EQUISETIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4478_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4478	NON-STANDARDIZED ALLERGENIC	Longleaf Pine Pollen		Pinus palustris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PALUSTRIS POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4479_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4479	NON-STANDARDIZED ALLERGENIC	Ponderosa Pine Pollen		Pinus ponderosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PONDEROSA POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-4480_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4480	NON-STANDARDIZED ALLERGENIC	Eastern White Pine Pollen		Pinus strobus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS STROBUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4481_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4481	NON-STANDARDIZED ALLERGENIC	Eastern White Pine Pollen		Pinus strobus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS STROBUS POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4482_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4482	NON-STANDARDIZED ALLERGENIC	Western White Pine Pollen		Pinus monticola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS MONTICOLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4483_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4483	NON-STANDARDIZED ALLERGENIC	White Poplar Pollen		Populus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4484_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4484	NON-STANDARDIZED ALLERGENIC	White Poplar Pollen		Populus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS ALBA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4485_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4485	NON-STANDARDIZED ALLERGENIC	Privet Pollen		Ligustrum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIGUSTRUM VULGARE POLLEN	10000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4486_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4486	NON-STANDARDIZED ALLERGENIC	California Western Sycamore Pollen		Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS RACEMOSA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4487_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4487	NON-STANDARDIZED ALLERGENIC	California Black Walnut Pollen		Juglans californica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4488_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4488	NON-STANDARDIZED ALLERGENIC	California Black Walnut Pollen		Juglans californica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4489_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4489	NON-STANDARDIZED ALLERGENIC	English Walnut Pollen		Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS REGIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4490_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4490	NON-STANDARDIZED ALLERGENIC	Arroyo Willow Pollen		Salix lasiolepis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SALIX LASIOLEPIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4491_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4491	NON-STANDARDIZED ALLERGENIC	Black Willow Pollen		Salix nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SALIX NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4492_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4492	NON-STANDARDIZED ALLERGENIC	White Alder Pollen		Alnus rhombifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RHOMBIFOLIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-4493_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-4493	NON-STANDARDIZED ALLERGENIC	River Birch Pollen		Betula nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5000_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5000	NON-STANDARDIZED ALLERGENIC	Black Carpenter Ant		Camponotus pennsylvanicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAMPONOTUS PENNSYLVANICUS	.05	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-5001_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5001	NON-STANDARDIZED ALLERGENIC	Fire Ant		Solenopsis invicta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLENOPSIS INVICTA	.05	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-5002_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5002	NON-STANDARDIZED ALLERGENIC	Fire Ant		Solenopsis richteri	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLENOPSIS RICHTERI	.05	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
22840-5004_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5004	NON-STANDARDIZED ALLERGENIC	American Cockroach		Periplaneta americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PERIPLANETA AMERICANA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-5005_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5005	NON-STANDARDIZED ALLERGENIC	German Cockroach		Blattella germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLATTELLA GERMANICA	.05	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-5006_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5006	NON-STANDARDIZED ALLERGENIC	Deer Fly		Chrysops vittatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHRYSOPS VITTATUS WHOLE	.025	g/mL			N	20241231
22840-5007_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5007	NON-STANDARDIZED ALLERGENIC	House Fly		Musca domestica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUSCA DOMESTICA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-5009_f89ac913-c072-e512-e053-6294a90a9d5d	22840-5009	NON-STANDARDIZED ALLERGENIC	Mosquito		Aedes taeniorhynchus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AEDES TAENIORHYNCHUS	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-5100_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5100	NON-STANDARDIZED ALLERGENIC	Cattle Epithelia		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOS TAURUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5101_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5101	NON-STANDARDIZED ALLERGENIC	Dog Epithelia		Canis lupus familiaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANIS LUPUS FAMILIARIS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5102_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5102	NON-STANDARDIZED ALLERGENIC	Gerbil Epithelia		Meriones unguiculatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MERIONES UNGUICULATUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5103_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5103	NON-STANDARDIZED ALLERGENIC	Goat Epithelia		Capra hircus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAPRA HIRCUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5104_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5104	NON-STANDARDIZED ALLERGENIC	Hamster Epithelia		Mesocricetus auratus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MESOCRICETUS AURATUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5105_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5105	NON-STANDARDIZED ALLERGENIC	Hog Epithelia		Sus scrofa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SUS SCROFA SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5106_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5106	NON-STANDARDIZED ALLERGENIC	Horse Epithelia		Equus caballus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EQUUS CABALLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5107_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5107	NON-STANDARDIZED ALLERGENIC	Mouse Epithelia		Mus musculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUS MUSCULUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5108_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5108	NON-STANDARDIZED ALLERGENIC	Rabbit Epithelia		Oryctolagus cuniculus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ORYCTOLAGUS CUNICULUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5109_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5109	NON-STANDARDIZED ALLERGENIC	Rat Epithelia		Rattus norvegicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RATTUS NORVEGICUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5110_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5110	NON-STANDARDIZED ALLERGENIC	Canary Feathers		Serinus canaria	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SERINUS CANARIA FEATHER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-5111_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5111	NON-STANDARDIZED ALLERGENIC	Chicken Feathers		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GALLUS GALLUS FEATHER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-5112_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5112	NON-STANDARDIZED ALLERGENIC	Duck Feathers		Anas platyrhynchos	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-5113_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5113	NON-STANDARDIZED ALLERGENIC	Goose Feathers		Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANSER ANSER FEATHER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-5114_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5114	NON-STANDARDIZED ALLERGENIC	Parakeet Feathers		Melopsitticus undulatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELOPSITTACUS UNDULATUS FEATHER	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Feathers [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-5115_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5115	NON-STANDARDIZED ALLERGENIC	Guinea Pig Epithelia		Cavia porcellus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAVIA PORCELLUS SKIN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
22840-5200_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5200	NON-STANDARDIZED ALLERGENIC	Bahia Grass		Paspalum notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASPALUM NOTATUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5201_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5201	NON-STANDARDIZED ALLERGENIC	Smooth Brome		Bromus inermis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROMUS INERMIS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-5202_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5202	NON-STANDARDIZED ALLERGENIC	Reed Canarygrass		Phalaris arundinacea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PHALARIS ARUNDINACEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5204_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5204	NON-STANDARDIZED ALLERGENIC	Couch Quack Grass		Elymus repens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ELYMUS REPENS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5205_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5205	NON-STANDARDIZED ALLERGENIC	Johnson Grass		Sorghum halepense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SORGHUM HALEPENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5208_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5208	NON-STANDARDIZED ALLERGENIC	Italian Ryegrass		Lolium multiflorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LOLIUM MULTIFLORUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5209_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5209	NON-STANDARDIZED ALLERGENIC	Velvetgrass		Holcus lanatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HOLCUS LANATUS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-5211_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5211	NON-STANDARDIZED ALLERGENIC	Western Wheatgrass		Pascopyrum smithii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PASCOPYRUM SMITHII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5212_0a99d16b-38ec-9e50-e063-6394a90a2af4	22840-5212	NON-STANDARDIZED ALLERGENIC	Giant Wild Ryegrass		Leymus condensatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEYMUS CONDENSATUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5300_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5300	NON-STANDARDIZED ALLERGENIC	Allscale		Atriplex polycarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX POLYCARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5301_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5301	NON-STANDARDIZED ALLERGENIC	Baccharis		Baccharis spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BACCHARIS HALIMIFOLIA POLLEN; BACCHARIS SAROTHROIDES WHOLE	.0125; .0125	g/mL; g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5302_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5302	NON-STANDARDIZED ALLERGENIC	Burrobrush		Hymenoclea salsola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA SALSOLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5303_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5303	NON-STANDARDIZED ALLERGENIC	Careless Weed, Amaranth Green		Amaranthus hybridus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS HYBRIDUS POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-5304_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5304	NON-STANDARDIZED ALLERGENIC	Cocklebur		Xanthium strumarium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	XANTHIUM STRUMARIUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5305_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5305	NON-STANDARDIZED ALLERGENIC	Yellow Curly Dock		Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX CRISPUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5306_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5306	NON-STANDARDIZED ALLERGENIC	Dog Fennel		Eupatorium capillifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUPATORIUM CAPILLIFOLIUM POLLEN	.0125	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5307_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5307	NON-STANDARDIZED ALLERGENIC	Firebush Kochia		Kochia scoparia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5308_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5308	NON-STANDARDIZED ALLERGENIC	Goldenrod		Solidago spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOLIDAGO CANADENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5309_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5309	NON-STANDARDIZED ALLERGENIC	Water Hemp		Amaranthus rudis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS TUBERCULATUS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-5310_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5310	NON-STANDARDIZED ALLERGENIC	Iodine Bush		Allenrolfea occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALLENROLFEA OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5311_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5311	NON-STANDARDIZED ALLERGENIC	Lambs Quarter		Chenopodium album	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHENOPODIUM ALBUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5312_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5312	NON-STANDARDIZED ALLERGENIC	Lenscale Quailbrush		Atriplex lentiformis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX LENTIFORMIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5313_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5313	NON-STANDARDIZED ALLERGENIC	Burweed Giant Poverty Marsh Elder		Iva xanthifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CYCLACHAENA XANTHIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5314_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5314	NON-STANDARDIZED ALLERGENIC	Common Mugwort		Artemisia vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA VULGARIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5315_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5315	NON-STANDARDIZED ALLERGENIC	Prairie Mugwort Darkleaved Sagebrush		Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5316_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5316	NON-STANDARDIZED ALLERGENIC	True Rough Marsh Elder		Iva annua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	IVA ANNUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5317_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5317	NON-STANDARDIZED ALLERGENIC	Nettle		Urtica dioica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	URTICA DIOICA POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5318_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5318	NON-STANDARDIZED ALLERGENIC	Palmers Amaranth		Amaranthus palmeri	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS PALMERI POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5319_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5319	NON-STANDARDIZED ALLERGENIC	Rough Redroot Rough Redroot		Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5320_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5320	NON-STANDARDIZED ALLERGENIC	Spiny Pigweed		Amaranthus spinosus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS SPINOSUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5321_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5321	NON-STANDARDIZED ALLERGENIC	English Plantain		Plantago lanceolata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5322_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5322	NON-STANDARDIZED ALLERGENIC	Rabbit Bush		Ambrosia deltoidea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DELTOIDEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5323_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5323	NON-STANDARDIZED ALLERGENIC	Desert Ragweed		Ambrosia dumosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA DUMOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5324_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5324	NON-STANDARDIZED ALLERGENIC	False Ragweed		Ambrosia acanthicarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5325_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5325	NON-STANDARDIZED ALLERGENIC	Giant Ragweed		Ambrosia trifida	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA TRIFIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5326_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5326	NON-STANDARDIZED ALLERGENIC	Slender Ragweed		Ambrosia confertiflora	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA CONFERTIFLORA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5327_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5327	NON-STANDARDIZED ALLERGENIC	Southern Ragweed		Ambrosia bidentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA BIDENTATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5328_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5328	NON-STANDARDIZED ALLERGENIC	Western Ragweed		Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA PSILOSTACHYA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5329_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5329	NON-STANDARDIZED ALLERGENIC	Russian Thistle		Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SALSOLA KALI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5330_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5330	NON-STANDARDIZED ALLERGENIC	Sheep Red Sorrel		Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5332_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5332	NON-STANDARDIZED ALLERGENIC	Common Sagebrush		Artemisia tridentata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA TRIDENTATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5334_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5334	NON-STANDARDIZED ALLERGENIC	Annual Saltbush		Atriplex wrightii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX WRIGHTII POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5335_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-5335	NON-STANDARDIZED ALLERGENIC	Wingscale		Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5400_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5400	NON-STANDARDIZED ALLERGENIC	Acacia Pollen		Acacia dealbata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5401_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5401	NON-STANDARDIZED ALLERGENIC	Red Alder Pollen		Alnus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5402_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5402	NON-STANDARDIZED ALLERGENIC	Hazel Alder Pollen		Alnus serrulata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS SERRULATA POLLEN	.05	g/mL			N	20241231
22840-5403_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5403	NON-STANDARDIZED ALLERGENIC	White Alder Pollen		Alnus rhombifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALNUS RHOMBIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5404_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5404	NON-STANDARDIZED ALLERGENIC	Arizona Velvet Ash Pollen		Fraxinus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS VELUTINA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5405_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5405	NON-STANDARDIZED ALLERGENIC	Oregon Ash Pollen		Fraxinus latifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS LATIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5406_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5406	NON-STANDARDIZED ALLERGENIC	Green Ash Pollen		Fraxinus pennsylvanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS PENNSYLVANICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5407_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5407	NON-STANDARDIZED ALLERGENIC	White Ash Pollen		Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5408_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5408	NON-STANDARDIZED ALLERGENIC	Aspen Pollen		Populus tremuloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TREMULOIDES POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5409_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5409	NON-STANDARDIZED ALLERGENIC	Wax Myrtle Pollen		Morella cerifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORELLA CERIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5410_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5410	NON-STANDARDIZED ALLERGENIC	American Beech Pollen		Fagus grandifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FAGUS GRANDIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5411_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5411	NON-STANDARDIZED ALLERGENIC	Australian Pine Beefwood Pollen		Casuarina equisetifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CASUARINA EQUISETIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5412_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5412	NON-STANDARDIZED ALLERGENIC	Black-Sweet Birch Pollen		Betula lenta	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5413_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5413	NON-STANDARDIZED ALLERGENIC	River Birch Pollen		Betula nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5414_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5414	NON-STANDARDIZED ALLERGENIC	Spring Birch Pollen		Betula occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5415_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5415	NON-STANDARDIZED ALLERGENIC	White Birch Pollen		Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA POPULIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5416_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5416	NON-STANDARDIZED ALLERGENIC	Box Elder Pollen		Acer negundo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5417_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5417	NON-STANDARDIZED ALLERGENIC	Mountain Cedar Pollen		Juniperus ashei	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS ASHEI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5418_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5418	NON-STANDARDIZED ALLERGENIC	Red Cedar Pollen		Juniperus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5419_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5419	NON-STANDARDIZED ALLERGENIC	Salt Cedar Tamarisk Pollen		Tamarix gallica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TAMARIX GALLICA POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-5420_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5420	NON-STANDARDIZED ALLERGENIC	Black Cottonwood Pollen		Populus trichocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS TRICHOCARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5421_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5421	NON-STANDARDIZED ALLERGENIC	Eastern Cottonwood Pollen		Populus deltoides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS DELTOIDES POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5422_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5422	NON-STANDARDIZED ALLERGENIC	Arizona Fremont Cottonwood Pollen		Populus fremontii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS FREMONTII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5423_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5423	NON-STANDARDIZED ALLERGENIC	Western Cottonwood Pollen		Populus deltoides ssp. monilifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5424_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5424	NON-STANDARDIZED ALLERGENIC	Arizona Cypress Pollen		Callitropsis arizonica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CUPRESSUS ARIZONICA POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5425_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5425	NON-STANDARDIZED ALLERGENIC	Bald Cypress Pollen		Taxodium distichum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TAXODIUM DISTICHUM POLLEN	.0125	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5426_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5426	NON-STANDARDIZED ALLERGENIC	American Elm Pollen		Ulmus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5427_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5427	NON-STANDARDIZED ALLERGENIC	Cedar Elm Pollen		Ulmus crassifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS CRASSIFOLIA POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5428_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5428	NON-STANDARDIZED ALLERGENIC	Bluegum Eucalyptus Pollen		Eucalyptus globulus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUCALYPTUS GLOBULUS POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5429_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5429	NON-STANDARDIZED ALLERGENIC	Hackberry Pollen		Celtis occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CELTIS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5430_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5430	NON-STANDARDIZED ALLERGENIC	American Hazelnut Pollen		Corylus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CORYLUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5431_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5431	NON-STANDARDIZED ALLERGENIC	Shagbark Hickory Pollen		Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA OVATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5432_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5432	NON-STANDARDIZED ALLERGENIC	Shellbark Hickory Pollen		Carya laciniosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA LACINIOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5433_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5433	NON-STANDARDIZED ALLERGENIC	White Hickory Pollen		Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5434_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5434	NON-STANDARDIZED ALLERGENIC	Oneseed Juniper Pollen		Juniperus monosperma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS MONOSPERMA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5435_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5435	NON-STANDARDIZED ALLERGENIC	Pinchot Juniper Pollen		Juniperus pinchotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS PINCHOTII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5436_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5436	NON-STANDARDIZED ALLERGENIC	Western Juniper Pollen		Juniperus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS OCCIDENTALIS POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5437_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5437	NON-STANDARDIZED ALLERGENIC	Black Locust Blossom		Robinia pseudoacacia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ROBINIA PSEUDOACACIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5438_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5438	NON-STANDARDIZED ALLERGENIC	Mango Blossom		Mangifera indica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MANGIFERA INDICA POLLEN	.025	g/mL			N	20241231
22840-5439_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5439	NON-STANDARDIZED ALLERGENIC	Red Maple Pollen		Acer rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5440_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5440	NON-STANDARDIZED ALLERGENIC	Silver Soft Maple Pollen		Acer saccharinum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARINUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5441_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5441	NON-STANDARDIZED ALLERGENIC	Sugar Hard Maple Pollen		Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5442_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5442	NON-STANDARDIZED ALLERGENIC	Melaleuca Pollen		Melaleuca quinquenervia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MELALEUCA QUINQUENERVIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5443_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5443	NON-STANDARDIZED ALLERGENIC	Velvet Mesquite Pollen		Prosopis velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PROSOPIS VELUTINA SEED	.05	g/mL			N	20241231
22840-5444_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5444	NON-STANDARDIZED ALLERGENIC	Paper Mulberry Pollen		Broussonetia papyrifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROUSSONETIA PAPYRIFERA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5445_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5445	NON-STANDARDIZED ALLERGENIC	Red Mulberry Pollen		Morus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5446_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5446	NON-STANDARDIZED ALLERGENIC	White Mulberry Pollen		Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MORUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5447_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5447	NON-STANDARDIZED ALLERGENIC	Arizona Gambel Oak Pollen		Quercus gambelii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GAMBELII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5448_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5448	NON-STANDARDIZED ALLERGENIC	Black Oak Pollen		Quercus velutina	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VELUTINA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5449_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5449	NON-STANDARDIZED ALLERGENIC	California Black Oak Pollen		Quercus kelloggii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS KELLOGGII POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5450_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5450	NON-STANDARDIZED ALLERGENIC	California Live Oak Pollen		Quercus agrifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5451_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5451	NON-STANDARDIZED ALLERGENIC	California White Oak Pollen		Quercus lobata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS LOBATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5452_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5452	NON-STANDARDIZED ALLERGENIC	Post Oak Pollen		Quercus stellata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS STELLATA POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5453_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5453	NON-STANDARDIZED ALLERGENIC	Red Oak Pollen		Quercus rubra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5454_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5454	NON-STANDARDIZED ALLERGENIC	Virginia Live Oak Pollen		Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5455_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5455	NON-STANDARDIZED ALLERGENIC	Water Oak Pollen		Quercus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5456_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5456	NON-STANDARDIZED ALLERGENIC	Western White Oak Pollen		Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS GARRYANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5457_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5457	NON-STANDARDIZED ALLERGENIC	Russian Olive Pollen		Elaeagnus angustifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ELAEAGNUS ANGUSTIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5458_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5458	NON-STANDARDIZED ALLERGENIC	Queen Palm Pollen		Syagrus romanzoffiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SYAGRUS ROMANZOFFIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5459_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5459	NON-STANDARDIZED ALLERGENIC	Pecan Pollen		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5460_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-5460	NON-STANDARDIZED ALLERGENIC	Peppertree Pollen Mix		Schinus molle, Schinus terebinthifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SCHINUS MOLLE POLLEN; SCHINUS TEREBINTHIFOLIA POLLEN	.0125; .0125	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [Chemical/Ingredient]		N	20241231
22840-5461_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5461	NON-STANDARDIZED ALLERGENIC	Loblolly Pine Pollen		Pinus taeda	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS TAEDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5462_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5462	NON-STANDARDIZED ALLERGENIC	Longleaf Pine Pollen		Pinus palustris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PALUSTRIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5463_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5463	NON-STANDARDIZED ALLERGENIC	Ponderosa Pine Pollen		Pinus ponderosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS PONDEROSA POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-5464_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5464	NON-STANDARDIZED ALLERGENIC	Virginia Scrub Pine Pollen		Pinus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5465_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5465	NON-STANDARDIZED ALLERGENIC	Eastern White Pine Pollen		Pinus strobus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS STROBUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5466_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5466	NON-STANDARDIZED ALLERGENIC	Western White Pine Pollen		Pinus monticola	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS MONTICOLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5467_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5467	NON-STANDARDIZED ALLERGENIC	Yellow Pine Pollen		Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5468_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5468	NON-STANDARDIZED ALLERGENIC	Lombardys Poplar Pollen		Populus nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS NIGRA POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5469_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5469	NON-STANDARDIZED ALLERGENIC	White Poplar Pollen		Populus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POPULUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5470_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5470	NON-STANDARDIZED ALLERGENIC	Privet Pollen		Ligustrum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIGUSTRUM VULGARE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5471_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5471	NON-STANDARDIZED ALLERGENIC	Sweetgum Pollen		Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIQUIDAMBAR STYRACIFLUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5472_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5472	NON-STANDARDIZED ALLERGENIC	American Sycamore Pollen		Platanus occidentalis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5473_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5473	NON-STANDARDIZED ALLERGENIC	California Western Sycamore Pollen		Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLATANUS RACEMOSA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5474_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5474	NON-STANDARDIZED ALLERGENIC	Black Walnut Pollen		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5475_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5475	NON-STANDARDIZED ALLERGENIC	California Black Walnut Pollen		Juglans californica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5476_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5476	NON-STANDARDIZED ALLERGENIC	English Walnut Pollen		Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS REGIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5477_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5477	NON-STANDARDIZED ALLERGENIC	Arroyo Willow Pollen		Salix lasiolepis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SALIX LASIOLEPIS POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5478_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5478	NON-STANDARDIZED ALLERGENIC	Black Willow Pollen		Salix nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SALIX NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5479_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5479	NON-STANDARDIZED ALLERGENIC	Siberian Elm Pollen		Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS PUMILA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5480_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5480	NON-STANDARDIZED ALLERGENIC	Rocky Mountain Juniper Pollen		Juniperus scopulorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS SCOPULORUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5481_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5481	NON-STANDARDIZED ALLERGENIC	Utah Juniper Pollen		Juniperus osteosperma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS OSTEOSPERMA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5482_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5482	NON-STANDARDIZED ALLERGENIC	White Oak Pollen		Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5483_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5483	NON-STANDARDIZED ALLERGENIC	Olive Pollen		Olea europaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5484_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5484	NON-STANDARDIZED ALLERGENIC	Orange Pollen		Citrus X sinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CITRUS SINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5485_0a987c57-50fc-c8df-e063-6394a90a56bf	22840-5485	NON-STANDARDIZED ALLERGENIC	Bur Oak Pollen		Quercus macrocarpa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS MACROCARPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5500_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-5500	NON-STANDARDIZED ALLERGENIC	Daisy		Leucanthemum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEUCANTHEMUM VULGARE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5501_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-5501	NON-STANDARDIZED ALLERGENIC	Dandelion		Taraxacum officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TARAXACUM OFFICINALE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5502_0a98cde1-27d0-d6bb-e063-6394a90a7d25	22840-5502	NON-STANDARDIZED ALLERGENIC	Sunflower		Helianthus annuus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELIANTHUS ANNUUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5503_0a986825-7b07-713b-e063-6394a90a377e	22840-5503	NON-STANDARDIZED ALLERGENIC	Alfalfa		Medicago sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MEDICAGO SATIVA POLLEN	.02	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5505_0a986825-7b07-713b-e063-6394a90a377e	22840-5505	NON-STANDARDIZED ALLERGENIC	Mustard		Brassica spp.	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BRASSICA RAPA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5506_0a986825-7b07-713b-e063-6394a90a377e	22840-5506	NON-STANDARDIZED ALLERGENIC	Red Clover		Trifolium pratense	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRIFOLIUM PRATENSE POLLEN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5507_0a986825-7b07-713b-e063-6394a90a377e	22840-5507	NON-STANDARDIZED ALLERGENIC	Sugar Beet Pollen		Beta vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETA VULGARIS POLLEN	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5508_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5508	NON-STANDARDIZED ALLERGENIC	Cotton Linters		Gossypium hirsutum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COTTON FIBER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5509_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5509	NON-STANDARDIZED ALLERGENIC	Cottonseed		Gossypium hirsutum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COTTON SEED	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
22840-5510_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5510	NON-STANDARDIZED ALLERGENIC	Flaxseed		Linum usitatissimum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FLAX SEED	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
22840-5511_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5511	NON-STANDARDIZED ALLERGENIC	Gum Arabic		Acacia senegal	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA	.005	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5512_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5512	NON-STANDARDIZED ALLERGENIC	Karaya Gum		Sterculia urens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	KARAYA GUM	.005	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5513_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5513	NON-STANDARDIZED ALLERGENIC	Tragacanth Gum		Astragalus gummifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRAGACANTH	.005	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5514_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5514	NON-STANDARDIZED ALLERGENIC	Kapok		Ceiba pentandra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CEIBA PENTANDRA FIBER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5515_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5515	NON-STANDARDIZED ALLERGENIC	Orris Root		Iris germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	IRIS X GERMANICA NOTHOVAR. FLORENTINA ROOT	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5516_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5516	NON-STANDARDIZED ALLERGENIC	Pyrethrum		Chrysanthemum cinerariifolium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PYRETHRUM EXTRACT	.05	g/mL			N	20241231
22840-5517_0a988aa3-165c-d51b-e063-6394a90aa198	22840-5517	NON-STANDARDIZED ALLERGENIC	Silk Worm		Bombyx mori	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOMBYX MORI FIBER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Silk [CS]		N	20241231
22840-5518_f89b29af-b6aa-91d6-e053-6294a90a7a9d	22840-5518	NON-STANDARDIZED ALLERGENIC	Tobacco, Leaf		Nicotiana tabacum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TOBACCO LEAF	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5520_0a986825-7b07-713b-e063-6394a90a377e	22840-5520	NON-STANDARDIZED ALLERGENIC	Cultivated Corn		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ZEA MAYS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5521_0a986825-7b07-713b-e063-6394a90a377e	22840-5521	NON-STANDARDIZED ALLERGENIC	Common Cultivated Oats		Avena sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AVENA SATIVA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5522_0a986825-7b07-713b-e063-6394a90a377e	22840-5522	NON-STANDARDIZED ALLERGENIC	Cultivated Rye		Secale cereale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SECALE CEREALE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
22840-5523_0a986825-7b07-713b-e063-6394a90a377e	22840-5523	NON-STANDARDIZED ALLERGENIC	Cultivated Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRITICUM AESTIVUM POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-5600_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5600	NON-STANDARDIZED ALLERGENIC	Alternaria alternata		Alternaria alternata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5601_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5601	NON-STANDARDIZED ALLERGENIC	Acremonium strictum		Acremonium strictum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SAROCLADIUM STRICTUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5602_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5602	NON-STANDARDIZED ALLERGENIC	Aspergillus amstelodami		Aspergillus amstelodami	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EUROTIUM AMSTELODAMI	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5603_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5603	NON-STANDARDIZED ALLERGENIC	Aspergillus flavus		Aspergillus flavus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS	.025	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5604_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5604	NON-STANDARDIZED ALLERGENIC	Aspergillus fumigatus		Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FUMIGATUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5605_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5605	NON-STANDARDIZED ALLERGENIC	Aspergillus nidulans		Aspergillus nidulans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIDULANS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5606_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5606	NON-STANDARDIZED ALLERGENIC	Aspergillus niger		Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS NIGER VAR. NIGER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5607_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5607	NON-STANDARDIZED ALLERGENIC	Aureobasidium pullulans		Aureobasidium pullulans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5608_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5608	NON-STANDARDIZED ALLERGENIC	Bipolaris sorokiniana		Bipolaris sorokiniana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SATIVUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5609_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5609	NON-STANDARDIZED ALLERGENIC	Botrytis cinerea		Botrytis cinerea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BOTRYTIS CINEREA	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5610_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5610	NON-STANDARDIZED ALLERGENIC	Candida albicans		Candida albicans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5612_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5612	NON-STANDARDIZED ALLERGENIC	Chaetomium globosum		Chaetomium globosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHAETOMIUM GLOBOSUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5613_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5613	NON-STANDARDIZED ALLERGENIC	Cladosporium herbarum		Cladosporium herbarum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM HERBARUM	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5614_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5614	NON-STANDARDIZED ALLERGENIC	Cladosporium sphaerospermum		Cladosporium sphaerospermum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CLADOSPORIUM SPHAEROSPERMUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5615_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5615	NON-STANDARDIZED ALLERGENIC	Drechslera spicifera		Drechslera spicifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCHLIOBOLUS SPICIFER	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5616_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5616	NON-STANDARDIZED ALLERGENIC	Epicoccum nigrum		Epicoccum nigrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPICOCCUM NIGRUM	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5617_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5617	NON-STANDARDIZED ALLERGENIC	Epidermophyton floccosum		Epidermophyton floccosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EPIDERMOPHYTON FLOCCOSUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5618_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5618	NON-STANDARDIZED ALLERGENIC	Fusarium moniliforme		Fusarium moniliforme	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5619_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5619	NON-STANDARDIZED ALLERGENIC	Fusarium solani		Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HAEMATONECTRIA HAEMATOCOCCA	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5620_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5620	NON-STANDARDIZED ALLERGENIC	Geotrichum candidum		Geotrichum candidum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GEOTRICHUM CANDIDUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5621_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5621	NON-STANDARDIZED ALLERGENIC	Gliocladium viride		Gliocladium viride	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GLIOCLADIUM VIRIDE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5622_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5622	NON-STANDARDIZED ALLERGENIC	Helminthosporium solani		Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HELMINTHOSPORIUM SOLANI	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5623_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5623	NON-STANDARDIZED ALLERGENIC	Microsporum canis		Microsporum canis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MICROSPORUM CANIS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5624_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5624	NON-STANDARDIZED ALLERGENIC	Mucor circinelloides f. circinelloides		Mucor circinelloides f. circinelloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. CIRCINELLOIDES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5625_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5625	NON-STANDARDIZED ALLERGENIC	Mucor circinelloides f. lusitanicus		Mucor circinelloides f. lusitanicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5626_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5626	NON-STANDARDIZED ALLERGENIC	Mucor plumbeus		Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR PLUMBEUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5627_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5627	NON-STANDARDIZED ALLERGENIC	Neurospora intermedia		Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	NEUROSPORA INTERMEDIA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5629_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5629	NON-STANDARDIZED ALLERGENIC	Paecilomyces variotii		Paecilomyces variotii	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PAECILOMYCES VARIOTII	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5630_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5630	NON-STANDARDIZED ALLERGENIC	Penicillium digitatum		Penicillium digitatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM DIGITATUM	.0125	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5631_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5631	NON-STANDARDIZED ALLERGENIC	Penicillium chrysogenum (notatum)		Penicillium chrysogenum (notatum)	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5632_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5632	NON-STANDARDIZED ALLERGENIC	Phoma betae		Phoma betae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLEOSPORA BETAE	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5633_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5633	NON-STANDARDIZED ALLERGENIC	Rhizopus oryzae		Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS	.05	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5634_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5634	NON-STANDARDIZED ALLERGENIC	Rhizopus stolonifer		Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS STOLONIFER	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5635_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5635	NON-STANDARDIZED ALLERGENIC	Rhodotorula mucilaginosa		Rhodotorula mucilaginosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHODOTORULA MUCILAGINOSA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5636_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5636	NON-STANDARDIZED ALLERGENIC	Saccharomyces cerevisiae		Saccharomyces cerevisiae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SACCHAROMYCES CEREVISIAE	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5637_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5637	NON-STANDARDIZED ALLERGENIC	Stemphylium solani		Stemphylium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	STEMPHYLIUM SOLANI	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5638_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5638	NON-STANDARDIZED ALLERGENIC	Trichoderma harzianum		Trichoderma harzianum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHODERMA HARZIANUM	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5639_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5639	NON-STANDARDIZED ALLERGENIC	Trichophyton mentagrophytes		Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON MENTAGROPHYTES	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5640_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5640	NON-STANDARDIZED ALLERGENIC	Trichophyton rubrum		Trichophyton rubrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOPHYTON RUBRUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5641_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5641	NON-STANDARDIZED ALLERGENIC	Trichothecium roseum		Trichothecium roseum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TRICHOTHECIUM ROSEUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5642_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5642	NON-STANDARDIZED ALLERGENIC	Mycogone perniciosa		Mycogone perniciosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HYPOMYCES PERNICIOSUS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5648_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5648	NON-STANDARDIZED ALLERGENIC	Bermuda Grass Smut		Ustilago cynodontis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO CYNODONTIS	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5649_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5649	NON-STANDARDIZED ALLERGENIC	Corn Smut		Ustilago maydis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO MAYDIS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5650_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5650	NON-STANDARDIZED ALLERGENIC	Loose Kernel Smut		Sporisorium cruentum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SPORISORIUM CRUENTUM	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5651_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5651	NON-STANDARDIZED ALLERGENIC	Oat Smut		Ustilago avenae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO AVENAE	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5652_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5652	NON-STANDARDIZED ALLERGENIC	Barley Loose Smut		Ustilago nuda	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO NUDA	.025	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5653_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-5653	NON-STANDARDIZED ALLERGENIC	Loose Smut, Wheat		Ustilago tritici	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO TRITICI	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-5700_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5700	NON-STANDARDIZED ALLERGENIC	Apple		Malus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	APPLE	.025	g/mL	Allergens [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5701_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5701	NON-STANDARDIZED ALLERGENIC	Apricot		Prunus armeniaca	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	APRICOT	.025	g/mL	Allergens [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5702_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5702	NON-STANDARDIZED ALLERGENIC	Banana		Musa acuminata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUSA ACUMINATA FRUIT	.025	g/mL			N	20241231
22840-5703_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5703	NON-STANDARDIZED ALLERGENIC	Whole Grain Barley		Hordeum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BARLEY	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5704_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5704	NON-STANDARDIZED ALLERGENIC	Lima Bean		Phaseolus lunatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LIMA BEAN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5705_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5705	NON-STANDARDIZED ALLERGENIC	Navy Bean		Phaseolus vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	KIDNEY BEAN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
22840-5706_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5706	NON-STANDARDIZED ALLERGENIC	String Green Bean		Phaseolus vulgaris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	STRING BEAN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5707_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5707	NON-STANDARDIZED ALLERGENIC	Blueberry		Vaccinium myrtilloides	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	VELVETLEAF HUCKLEBERRY	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5708_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5708	NON-STANDARDIZED ALLERGENIC	Broccoli		Brassica oleracea var. botrytis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROCCOLI	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5709_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5709	NON-STANDARDIZED ALLERGENIC	Buckwheat		Fagopyrum esculentum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BUCKWHEAT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5710_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5710	NON-STANDARDIZED ALLERGENIC	Cabbage		Brassica oleracea var. capitata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CABBAGE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5711_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5711	NON-STANDARDIZED ALLERGENIC	Cantaloupe Muskmelon		Cucumis melo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUSKMELON	.05	g/mL			N	20241231
22840-5712_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5712	NON-STANDARDIZED ALLERGENIC	Carrot		Daucus carota	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARROT	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5713_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5713	NON-STANDARDIZED ALLERGENIC	Cauliflower		Brassica oleracea var. botrytis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CAULIFLOWER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
22840-5714_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5714	NON-STANDARDIZED ALLERGENIC	Celery		Apium graveolens var. dulce	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CELERY	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5715_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5715	NON-STANDARDIZED ALLERGENIC	Cherry		Prunus avium	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SWEET CHERRY	.05	g/mL			N	20241231
22840-5716_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5716	NON-STANDARDIZED ALLERGENIC	Chocolate Cacao Bean		Theobroma cacao	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	THEOBROMA CACAO WHOLE	.05	g/mL			N	20241231
22840-5717_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5717	NON-STANDARDIZED ALLERGENIC	Cinnamon		Cinnamomum verum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CINNAMON	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5718_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5718	NON-STANDARDIZED ALLERGENIC	Coffee		Coffea arabica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COFFEA ARABICA SEED, ROASTED	.05	g/mL			N	20241231
22840-5719_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5719	NON-STANDARDIZED ALLERGENIC	Corn Food		Zea mays	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CORN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5720_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5720	NON-STANDARDIZED ALLERGENIC	Cranberry		Vaccinium macrocarpon	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CRANBERRY	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5721_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5721	NON-STANDARDIZED ALLERGENIC	Cucumber		Cucumis sativus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CUCUMBER	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5722_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5722	NON-STANDARDIZED ALLERGENIC	Garlic		Allium sativum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GARLIC	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5723_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5723	NON-STANDARDIZED ALLERGENIC	Ginger		Zingiber officinale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GINGER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5724_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5724	NON-STANDARDIZED ALLERGENIC	White Seedless Grape		Vitis vinifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	WINE GRAPE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5725_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5725	NON-STANDARDIZED ALLERGENIC	Grapefruit		Citrus X paradisi	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GRAPEFRUIT	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5726_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5726	NON-STANDARDIZED ALLERGENIC	Hops Food		Humulus lupulus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	HOPS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5727_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5727	NON-STANDARDIZED ALLERGENIC	Lemon		Citrus X limon	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LEMON	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5728_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5728	NON-STANDARDIZED ALLERGENIC	Lettuce		Lactuca sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LACTUCA SATIVA WHOLE	.025	g/mL			N	20241231
22840-5729_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5729	NON-STANDARDIZED ALLERGENIC	Malt		Hordeum vulgare	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BARLEY	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5730_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5730	NON-STANDARDIZED ALLERGENIC	Mushroom		Agaricus campestris	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FIELD MUSHROOM	.025	g/mL			N	20241231
22840-5731_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5731	NON-STANDARDIZED ALLERGENIC	Mustard Food		Sinapis alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	WHITE MUSTARD SEED	.025	g/mL			N	20241231
22840-5732_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5732	NON-STANDARDIZED ALLERGENIC	Nutmeg		Myristica fragrans	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MYRISTICA FRAGRANS FRUIT	.05	g/mL			N	20241231
22840-5733_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5733	NON-STANDARDIZED ALLERGENIC	Oat Food		Avena sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OAT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5734_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5734	NON-STANDARDIZED ALLERGENIC	Green Olive		Olea europaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GREEN OLIVE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
22840-5735_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5735	NON-STANDARDIZED ALLERGENIC	Onion		Allium cepa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ONION	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5736_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5736	NON-STANDARDIZED ALLERGENIC	Orange		Citrus X sinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ORANGE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5737_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5737	NON-STANDARDIZED ALLERGENIC	Green English Pea		Pisum sativum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PISUM SATIVUM WHOLE	.05	g/mL			N	20241231
22840-5738_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5738	NON-STANDARDIZED ALLERGENIC	Peach		Prunus persica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PEACH	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5739_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5739	NON-STANDARDIZED ALLERGENIC	Pear		Pyrus communis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PEAR	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5740_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5740	NON-STANDARDIZED ALLERGENIC	Black Pepper		Piper nigrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLACK PEPPER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5741_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5741	NON-STANDARDIZED ALLERGENIC	Green Pepper		Piper nigrum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GREEN BELL PEPPER	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5742_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5742	NON-STANDARDIZED ALLERGENIC	Pineapple		Ananas comosus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINEAPPLE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5743_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5743	NON-STANDARDIZED ALLERGENIC	Sweet Potato		Ipomoea batatas	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SWEET POTATO	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5744_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5744	NON-STANDARDIZED ALLERGENIC	White Potato		Solanum tuberosum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	POTATO	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5745_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5745	NON-STANDARDIZED ALLERGENIC	Red Raspberry		Rubus idaeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RASPBERRY	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5746_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5746	NON-STANDARDIZED ALLERGENIC	Rice Food		Oryza sativa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BROWN RICE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5747_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5747	NON-STANDARDIZED ALLERGENIC	Rye Food		Secale cereale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RYE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5748_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5748	NON-STANDARDIZED ALLERGENIC	Sesame Seed		Sesamum indicum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SESAME SEED	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
22840-5749_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5749	NON-STANDARDIZED ALLERGENIC	Soybean Food		Glycine max	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOYBEAN	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5750_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5750	NON-STANDARDIZED ALLERGENIC	Spinach		Spinacia oleracea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SPINACH	.01	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5751_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5751	NON-STANDARDIZED ALLERGENIC	Yellow Summer Squash		Cucurbita pepo var. ovifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CUCURBITA PEPO SUBSP. OVIFERA WHOLE	.025	g/mL			N	20241231
22840-5752_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5752	NON-STANDARDIZED ALLERGENIC	Strawberry		Fragaria X ananassa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	STRAWBERRY	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5753_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5753	NON-STANDARDIZED ALLERGENIC	Tomato		Solanum lycopersicum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TOMATO	.025	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
22840-5754_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5754	NON-STANDARDIZED ALLERGENIC	Vanilla		Vanilla planifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	VANILLA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5755_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5755	NON-STANDARDIZED ALLERGENIC	Watermelon		Citrullus lanatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	WATERMELON	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5756_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5756	NON-STANDARDIZED ALLERGENIC	Whole Wheat		Triticum aestivum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	WHEAT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5757_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5757	NON-STANDARDIZED ALLERGENIC	Beef		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BEEF	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5758_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5758	NON-STANDARDIZED ALLERGENIC	Lamb		Ovis aries	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	LAMB	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5759_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5759	NON-STANDARDIZED ALLERGENIC	Pork		Sus scrofa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PORK	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5760_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5760	NON-STANDARDIZED ALLERGENIC	Chicken Meat		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHICKEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
22840-5761_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5761	NON-STANDARDIZED ALLERGENIC	Chicken Egg White		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EGG WHITE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5762_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5762	NON-STANDARDIZED ALLERGENIC	Chicken Egg Whole		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EGG	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5763_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5763	NON-STANDARDIZED ALLERGENIC	Chicken Egg Yolk		Gallus gallus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EGG YOLK	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5764_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5764	NON-STANDARDIZED ALLERGENIC	Turkey Meat		Meleagris gallopavo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	TURKEY	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
22840-5765_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5765	NON-STANDARDIZED ALLERGENIC	Cow Milk		Bos taurus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SKIM MILK	.05	g/mL			N	20241231
22840-5766_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5766	NON-STANDARDIZED ALLERGENIC	Black Bass		Centropristis striata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLACK SEA BASS	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5767_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5767	NON-STANDARDIZED ALLERGENIC	Catfish		Ictalurus punctatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CHANNEL CATFISH	.05	g/mL			N	20241231
22840-5768_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5768	NON-STANDARDIZED ALLERGENIC	Clam		Mercenaria mercenaria	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	NORTHERN QUAHOG	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
22840-5769_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5769	NON-STANDARDIZED ALLERGENIC	Atlantic Cod		Gadus morhua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATLANTIC COD	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5770_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5770	NON-STANDARDIZED ALLERGENIC	Crab		Callinectes sapidus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLUE CRAB	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
22840-5771_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5771	NON-STANDARDIZED ALLERGENIC	Flounder		Paralichthys lethostigma	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SOUTHERN FLOUNDER	.05	g/mL			N	20241231
22840-5772_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5772	NON-STANDARDIZED ALLERGENIC	Maine Lobster		Homarus americanus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMERICAN LOBSTER	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
22840-5773_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5773	NON-STANDARDIZED ALLERGENIC	Mackerel		Scomber scombrus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATLANTIC MACKEREL	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5774_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5774	NON-STANDARDIZED ALLERGENIC	Oyster		Crassostrea virginica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	EASTERN OYSTER	.05	g/mL			N	20241231
22840-5775_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5775	NON-STANDARDIZED ALLERGENIC	Ocean Perch		Sebastes alutus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PACIFIC OCEAN PERCH	.05	g/mL			N	20241231
22840-5776_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5776	NON-STANDARDIZED ALLERGENIC	Salmon		Salmo salar	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATLANTIC SALMON	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5777_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5777	NON-STANDARDIZED ALLERGENIC	Scallops		Placopecten magellanicus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SEA SCALLOP	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
22840-5778_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5778	NON-STANDARDIZED ALLERGENIC	Shrimp		Farfantepenaeus aztecus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	NORTHERN BROWN SHRIMP	.05	g/mL			N	20241231
22840-5779_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5779	NON-STANDARDIZED ALLERGENIC	Lake Trout		Oncorhynchus mykiss	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RAINBOW TROUT	.05	g/mL			N	20241231
22840-5780_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5780	NON-STANDARDIZED ALLERGENIC	Tuna		Thunnus albacares	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	YELLOWFIN TUNA	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5781_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5781	NON-STANDARDIZED ALLERGENIC	Almond Food		Prunus dulcis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALMOND	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
22840-5782_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5782	NON-STANDARDIZED ALLERGENIC	Brazil Nut		Bertholletia excelsa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BERTHOLLETIA EXCELSA WHOLE	.05	g/mL			N	20241231
22840-5783_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5783	NON-STANDARDIZED ALLERGENIC	Cashew Nut		Anacardium occidentale	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	.05	g/mL			N	20241231
22840-5784_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5784	NON-STANDARDIZED ALLERGENIC	Coconut		Cocos nucifera	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	COCONUT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-5785_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5785	NON-STANDARDIZED ALLERGENIC	Filbert Hazelnut Food		Corylus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMERICAN HAZELNUT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Plant Proteins [CS]		N	20241231
22840-5786_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5786	NON-STANDARDIZED ALLERGENIC	Peanut		Arachis hypogaea	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PEANUT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
22840-5787_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5787	NON-STANDARDIZED ALLERGENIC	Pecan Food		Carya illinoinensis	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PECAN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
22840-5788_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5788	NON-STANDARDIZED ALLERGENIC	Black Walnut Food		Juglans nigra	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLACK WALNUT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
22840-5789_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-5789	NON-STANDARDIZED ALLERGENIC	English Walnut		Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ENGLISH WALNUT	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
22840-9000_f89ac913-c072-e512-e053-6294a90a9d5d	22840-9000	NON-STANDARDIZED ALLERGENIC	2 Cockroach Mix		Periplaneta americana and Blattella germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-9002_f89ac913-c072-e512-e053-6294a90a9d5d	22840-9002	NON-STANDARDIZED ALLERGENIC	2 Cockroach Mix		Periplaneta americana and Blattella germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-9003_f89ac913-c072-e512-e053-6294a90a9d5d	22840-9003	NON-STANDARDIZED ALLERGENIC	2 Cockroach Mix		Periplaneta americana and Blattella germanica	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
22840-9100_0a988aa3-165c-d51b-e063-6394a90aa198	22840-9100	NON-STANDARDIZED ALLERGENIC	Mixed Feathers		Gallus gallus, Anas platyrhynchos and Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.033; .033; .033	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-9101_0a988aa3-165c-d51b-e063-6394a90aa198	22840-9101	NON-STANDARDIZED ALLERGENIC	Mixed Feathers		Gallus gallus, Anas platyrhynchos and Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	6666.6666; 6666.6666; 6666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-9102_0a988aa3-165c-d51b-e063-6394a90aa198	22840-9102	NON-STANDARDIZED ALLERGENIC	Mixed Feathers		Gallus gallus, Anas platyrhynchos and Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	3333.3333; 3333.3333; 3333.3333	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-9103_0a988aa3-165c-d51b-e063-6394a90aa198	22840-9103	NON-STANDARDIZED ALLERGENIC	Mixed Feathers		Gallus gallus, Anas platyrhynchos and Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.0166; .0166; .0166	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-9104_0a988aa3-165c-d51b-e063-6394a90aa198	22840-9104	NON-STANDARDIZED ALLERGENIC	Mixed Feathers		Gallus gallus, Anas platyrhynchos and Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.0006666; .0006666; .0006666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-9105_0a988aa3-165c-d51b-e063-6394a90aa198	22840-9105	NON-STANDARDIZED ALLERGENIC	Mixed Feathers		Gallus gallus, Anas platyrhynchos and Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-9107_0a988aa3-165c-d51b-e063-6394a90aa198	22840-9107	NON-STANDARDIZED ALLERGENIC	Mixed Feathers		Gallus gallus, Anas platyrhynchos and Anser anser	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.0166; .0166; .0166	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
22840-9300_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9300	NON-STANDARDIZED ALLERGENIC	3 Weed Mix		Xanthium strumarium, Chenopodium album, Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; XANTHIUM STRUMARIUM POLLEN	6666.666; 6666.666; 6666.666	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9301_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9301	NON-STANDARDIZED ALLERGENIC	3 Weed Mix		Xanthium strumarium, Chenopodium album, Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; XANTHIUM STRUMARIUM POLLEN	13333.333; 13333.333; 13333.333	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9302_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9302	NON-STANDARDIZED ALLERGENIC	3 Weed Mix		Xanthium strumarium, Chenopodium album, Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; XANTHIUM STRUMARIUM POLLEN	.03333; .03333; .03333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9304_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9304	NON-STANDARDIZED ALLERGENIC	3 Weed Mix		Xanthium strumarium, Chenopodium album, Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; XANTHIUM STRUMARIUM POLLEN	.0003; .0003; .0003	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9305_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9305	NON-STANDARDIZED ALLERGENIC	3 Weed Mix		Xanthium strumarium, Chenopodium album, Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; XANTHIUM STRUMARIUM POLLEN	.01666; .01666; .01666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9306_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9306	NON-STANDARDIZED ALLERGENIC	3 Weed Mix		Xanthium strumarium, Chenopodium album, Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; XANTHIUM STRUMARIUM POLLEN	.01666; .01666; .01666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9307_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9307	NON-STANDARDIZED ALLERGENIC	Central Western Weed Mix		Kochia scoparia, Chenopodium album and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN; CHENOPODIUM ALBUM POLLEN; SALSOLA KALI POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9308_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9308	NON-STANDARDIZED ALLERGENIC	Central Western Weed Mix		Kochia scoparia, Chenopodium album and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN; CHENOPODIUM ALBUM POLLEN; SALSOLA KALI POLLEN	.016666; .016666; .016666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9309_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9309	NON-STANDARDIZED ALLERGENIC	Common Weed Mix		Xanthium strumarium, Plantago lanceolata, Chenopodium album, Amaranthus retroflexus and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; SALSOLA KALI POLLEN; XANTHIUM STRUMARIUM POLLEN	.02; .02; .02; .02; .02	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9310_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9310	NON-STANDARDIZED ALLERGENIC	Common Weed Mix		Xanthium strumarium, Plantago lanceolata, Chenopodium album, Amaranthus retroflexus and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; SALSOLA KALI POLLEN; XANTHIUM STRUMARIUM POLLEN	.0002; .0002; .0002; .0002; .0002	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9312_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9312	NON-STANDARDIZED ALLERGENIC	Common Weed Mix		Xanthium strumarium, Plantago lanceolata, Chenopodium album, Amaranthus retroflexus and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; SALSOLA KALI POLLEN; XANTHIUM STRUMARIUM POLLEN	4000; 4000; 4000; 4000; 4000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9313_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9313	NON-STANDARDIZED ALLERGENIC	Common Weed Mix		Xanthium strumarium, Plantago lanceolata, Chenopodium album, Amaranthus retroflexus and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; SALSOLA KALI POLLEN; XANTHIUM STRUMARIUM POLLEN	8000; 8000; 8000; 8000; 8000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9314_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9314	NON-STANDARDIZED ALLERGENIC	Common Weed Mix		Xanthium strumarium, Plantago lanceolata, Chenopodium album, Amaranthus retroflexus and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; PLANTAGO LANCEOLATA POLLEN; SALSOLA KALI POLLEN; XANTHIUM STRUMARIUM POLLEN	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9315_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9315	NON-STANDARDIZED ALLERGENIC	Dock-Sorrel Mix		Rumex acetosella and Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9316_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9316	NON-STANDARDIZED ALLERGENIC	Dock-Sorrel Mix		Rumex acetosella and Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9317_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9317	NON-STANDARDIZED ALLERGENIC	Dock-Sorrel Mix		Rumex acetosella and Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9319_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9319	NON-STANDARDIZED ALLERGENIC	Dock-Sorrel Mix		Rumex acetosella and Rumex crispus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9320_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9320	NON-STANDARDIZED ALLERGENIC	National Weed Mix		Xanthium strumarium, Ambrosia trifida, Chenopodium album, Amaranthus retroflexus and Ambrosia artemisiifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN; CHENOPODIUM ALBUM POLLEN; XANTHIUM STRUMARIUM POLLEN	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
22840-9321_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9321	NON-STANDARDIZED ALLERGENIC	Pigweed Mix		Amaranthus hybridus, Amaranthus palmeri and Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS HYBRIDUS POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN	.01666; .01666; .01666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9322_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9322	NON-STANDARDIZED ALLERGENIC	Pigweed Mix		Amaranthus hybridus, Amaranthus palmeri and Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS HYBRIDUS POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN	.00033; .00033; .00033	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9324_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9324	NON-STANDARDIZED ALLERGENIC	Pigweed Mix		Amaranthus hybridus, Amaranthus palmeri and Amaranthus retroflexus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMARANTHUS HYBRIDUS POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN	.0083; .0083; .0083	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9325_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9325	NON-STANDARDIZED ALLERGENIC	Plantain Sorrel Mix		Plantago lanceolata and Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN; RUMEX ACETOSELLA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9326_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9326	NON-STANDARDIZED ALLERGENIC	Plantain Sorrel Mix		Plantago lanceolata and Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN; RUMEX ACETOSELLA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9327_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9327	NON-STANDARDIZED ALLERGENIC	Plantain Sorrel Mix		Plantago lanceolata and Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN; RUMEX ACETOSELLA POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9328_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9328	NON-STANDARDIZED ALLERGENIC	Plantain Sorrel Mix		Plantago lanceolata and Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN; RUMEX ACETOSELLA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9330_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9330	NON-STANDARDIZED ALLERGENIC	Sage Mix		Artemisia tridentata and Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9331_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9331	NON-STANDARDIZED ALLERGENIC	Sage Mix		Artemisia tridentata and Artemisia ludoviciana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9332_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9332	NON-STANDARDIZED ALLERGENIC	Scale Atriplex Mix		Atriplex polycarpa, Atriplex lentiformis and Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN	.03333; .03333; .03333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9333_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9333	NON-STANDARDIZED ALLERGENIC	Scale Atriplex Mix		Atriplex polycarpa, Atriplex lentiformis and Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN	13333.333; 13333.333; 13333.333	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9334_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9334	NON-STANDARDIZED ALLERGENIC	Scale Atriplex Mix		Atriplex polycarpa, Atriplex lentiformis and Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9336_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9336	NON-STANDARDIZED ALLERGENIC	Scale Atriplex Mix		Atriplex polycarpa, Atriplex lentiformis and Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9337_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9337	NON-STANDARDIZED ALLERGENIC	Scale Atriplex Mix		Atriplex polycarpa, Atriplex lentiformis and Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9339_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9339	NON-STANDARDIZED ALLERGENIC	Western Ragweed Mix		Ambrosia acanthicarpa, Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9340_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9340	NON-STANDARDIZED ALLERGENIC	Western Ragweed Mix		Ambrosia acanthicarpa, Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9341_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9341	NON-STANDARDIZED ALLERGENIC	Western Ragweed Mix		Ambrosia acanthicarpa, Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9342_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9342	NON-STANDARDIZED ALLERGENIC	Western Ragweed Mix		Ambrosia acanthicarpa, Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9344_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9344	NON-STANDARDIZED ALLERGENIC	Western Ragweed Mix		Ambrosia acanthicarpa, Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN	.0166666; .0166666	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9349_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9349	NON-STANDARDIZED ALLERGENIC	Central Western Weed Mix		Kochia scoparia, Chenopodium album and Salsola kali	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BASSIA SCOPARIA POLLEN; CHENOPODIUM ALBUM POLLEN; SALSOLA KALI POLLEN	6666.6666; 6666.6666; 6666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9352_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9352	NON-STANDARDIZED ALLERGENIC	Plantain Sorrel Mix		Plantago lanceolata and Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN; RUMEX ACETOSELLA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9353_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9353	NON-STANDARDIZED ALLERGENIC	Plantain Sorrel Mix		Plantago lanceolata and Rumex acetosella	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PLANTAGO LANCEOLATA POLLEN; RUMEX ACETOSELLA POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9354_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9354	NON-STANDARDIZED ALLERGENIC	Scale Atriplex Mix		Atriplex polycarpa, Atriplex lentiformis and Atriplex canescens	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN	6666.6666; 6666.6666; 6666.6666	g/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9355_f89eba01-cc76-7aed-e053-6294a90a3a97	22840-9355	NON-STANDARDIZED ALLERGENIC	Western Ragweed Mix		Ambrosia acanthicarpa, Ambrosia psilostachya	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9401_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9401	NON-STANDARDIZED ALLERGENIC	Ash Pollen Mix		Fraxinus pennsylvanica, Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9402_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9402	NON-STANDARDIZED ALLERGENIC	Ash Pollen Mix		Fraxinus pennsylvanica, Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9403_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9403	NON-STANDARDIZED ALLERGENIC	Birch Pollen Mix		Betula lenta, Betula nigra and Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	.0083333; .0083333; .0083333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9404_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9404	NON-STANDARDIZED ALLERGENIC	Birch Pollen Mix		Betula lenta, Betula nigra and Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	6666.6666; 6666.6666; 6666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9405_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9405	NON-STANDARDIZED ALLERGENIC	Birch Pollen Mix		Betula lenta, Betula nigra and Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	13333.333; 13333.333; 13333.333	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9407_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9407	NON-STANDARDIZED ALLERGENIC	Birch Pollen Mix		Betula lenta, Betula nigra and Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9408_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9408	NON-STANDARDIZED ALLERGENIC	Birch Pollen Mix		Betula lenta, Betula nigra and Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9409_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9409	NON-STANDARDIZED ALLERGENIC	Elm Pollen Mix		Ulmus americana and Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9411_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9411	NON-STANDARDIZED ALLERGENIC	Elm Pollen Mix		Ulmus americana and Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9412_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9412	NON-STANDARDIZED ALLERGENIC	Hickory Pollen Mix		Carya glabra, Carya ovata, Carya laciniosa and Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN	5000; 5000; 5000; 5000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9413_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9413	NON-STANDARDIZED ALLERGENIC	Hickory Pollen Mix		Carya glabra, Carya ovata, Carya laciniosa and Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN	.025; .025; .025; .025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9414_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9414	NON-STANDARDIZED ALLERGENIC	Hickory Pollen Mix		Carya glabra, Carya ovata, Carya laciniosa and Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN	10000; 10000; 10000; 10000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9416_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9416	NON-STANDARDIZED ALLERGENIC	Hickory Pollen Mix		Carya glabra, Carya ovata, Carya laciniosa and Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN	.00025; .00025; .00025; .00025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9417_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9417	NON-STANDARDIZED ALLERGENIC	Hickory Pollen Mix		Carya glabra, Carya ovata, Carya laciniosa and Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9418_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9418	NON-STANDARDIZED ALLERGENIC	Hickory-Pecan Pollen Mix		Carya illinoinensis and Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9419_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9419	NON-STANDARDIZED ALLERGENIC	Hickory-Pecan Pollen Mix		Carya illinoinensis and Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9420_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9420	NON-STANDARDIZED ALLERGENIC	Hickory-Pecan Pollen Mix		Carya illinoinensis and Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9422_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9422	NON-STANDARDIZED ALLERGENIC	Hickory-Pecan Pollen Mix		Carya illinoinensis and Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9423_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9423	NON-STANDARDIZED ALLERGENIC	Juniper Pollen Mix		Juniperus monosperma and Juniperus scopulorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS MONOSPERMA POLLEN; JUNIPERUS SCOPULORUM POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9424_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9424	NON-STANDARDIZED ALLERGENIC	Juniper Pollen Mix		Juniperus monosperma and Juniperus scopulorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS MONOSPERMA POLLEN; JUNIPERUS SCOPULORUM POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9425_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9425	NON-STANDARDIZED ALLERGENIC	Juniper Pollen Mix		Juniperus monosperma and Juniperus scopulorum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUNIPERUS MONOSPERMA POLLEN; JUNIPERUS SCOPULORUM POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9426_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9426	NON-STANDARDIZED ALLERGENIC	2 Maple Pollen Mix		Acer rubrum and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9427_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9427	NON-STANDARDIZED ALLERGENIC	2 Maple Pollen Mix		Acer rubrum and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9428_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9428	NON-STANDARDIZED ALLERGENIC	3 Maple Pollen Mix		Acer rubrum, Acer saccharinum and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; ACER SACCHARUM POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9429_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9429	NON-STANDARDIZED ALLERGENIC	3 Maple Pollen Mix		Acer rubrum, Acer saccharinum and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; ACER SACCHARUM POLLEN	.0333333; .0333333; .0333333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9430_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9430	NON-STANDARDIZED ALLERGENIC	3 Maple Pollen Mix		Acer rubrum, Acer saccharinum and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; ACER SACCHARUM POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9431_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9431	NON-STANDARDIZED ALLERGENIC	Maple-Box Elder Pollen Mix		Acer saccharum and Acer negundo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9433_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9433	NON-STANDARDIZED ALLERGENIC	Maple Box Elder Pollen Mix		Acer saccharum and Acer negundo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9434_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9434	NON-STANDARDIZED ALLERGENIC	Pine Pollen Mix		Pinus taeda, Pinus strobus and Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN	.0333333; .0333333; .0333333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9435_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9435	NON-STANDARDIZED ALLERGENIC	Pine Pollen Mix		Pinus taeda, Pinus strobus and Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN	6666.6666; 6666.6666; 6666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9436_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9436	NON-STANDARDIZED ALLERGENIC	Pine Pollen Mix		Pinus taeda, Pinus strobus and Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9437_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9437	NON-STANDARDIZED ALLERGENIC	Pine Pollen Mix		Pinus taeda, Pinus strobus and Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN	3333.3333; 3333.3333; 3333.3333	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9439_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9439	NON-STANDARDIZED ALLERGENIC	Pine Pollen Mix		Pinus taeda, Pinus strobus and Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9440_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9440	NON-STANDARDIZED ALLERGENIC	Pine Pollen Mix		Pinus taeda, Pinus strobus and Pinus echinata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9441_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9441	NON-STANDARDIZED ALLERGENIC	Eastern Oak Pollen Mix		Quercus velutina, Quercus rubra and Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VELUTINA POLLEN	.0333333; .0333333; .0333333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9442_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9442	NON-STANDARDIZED ALLERGENIC	Eastern Oak Pollen Mix		Quercus velutina, Quercus rubra and Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VELUTINA POLLEN	13333.333; 13333.333; 13333.333	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9443_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9443	NON-STANDARDIZED ALLERGENIC	Eastern Oak Pollen Mix		Quercus velutina, Quercus rubra and Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VELUTINA POLLEN	6666.6666; 6666.6666; 6666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9444_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9444	NON-STANDARDIZED ALLERGENIC	Eastern Oak Pollen Mix		Quercus velutina, Quercus rubra and Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VELUTINA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9445_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9445	NON-STANDARDIZED ALLERGENIC	Eastern Oak Pollen Mix		Quercus velutina, Quercus rubra and Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VELUTINA POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9447_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9447	NON-STANDARDIZED ALLERGENIC	Eastern Oak Pollen Mix		Quercus velutina, Quercus rubra and Quercus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VELUTINA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9448_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9448	NON-STANDARDIZED ALLERGENIC	Eastern 6 Tree Pollen Mix		Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN	.0166666; .0166666; .0166666; .0166666; .0166666; .0166666	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9449_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9449	NON-STANDARDIZED ALLERGENIC	Eastern 6 Tree Pollen Mix		Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN	3333.3333; 3333.3333; 3333.3333; 3333.3333; 3333.3333; 3333.3333	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9450_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9450	NON-STANDARDIZED ALLERGENIC	Eastern 6 Tree Pollen Mix		Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN	.0001666; .0001666; .0001666; .0001666; .0001666; .0001666	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9452_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9452	NON-STANDARDIZED ALLERGENIC	Eastern 6 Tree Pollen Mix		Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN	6666.6666; 6666.6666; 6666.6666; 6666.6666; 6666.6666; 6666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9453_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9453	NON-STANDARDIZED ALLERGENIC	Eastern 6 Tree Pollen Mix		Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN	.0083333; .0083333; .0083333; .0083333; .0083333; .0083333	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9454_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9454	NON-STANDARDIZED ALLERGENIC	Eastern 7 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.0071428; .0071428; .0071428; .0071428; .0071428; .0071428; .0071428	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9455_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9455	NON-STANDARDIZED ALLERGENIC	Eastern 7 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.0142857; .0142857; .0142857; .0142857; .0142857; .0142857; .0142857	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9456_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9456	NON-STANDARDIZED ALLERGENIC	Eastern 7 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.0001428; .0001428; .0001428; .0001428; .0001428; .0001428; .0001428	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9458_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9458	NON-STANDARDIZED ALLERGENIC	Eastern 7 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	5714.2857; 5714.2857; 5714.2857; 5714.2857; 5714.2857; 5714.2857; 5714.2857	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9459_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9459	NON-STANDARDIZED ALLERGENIC	Eastern 7 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.0071428; .0071428; .0071428; .0071428; .0071428; .0071428; .0071428	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9460_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9460	NON-STANDARDIZED ALLERGENIC	Eastern 8 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Fraxinus americana and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.000125; .000125; .000125; .000125; .000125; .000125; .000125; .000125	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9462_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9462	NON-STANDARDIZED ALLERGENIC	Eastern 8 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Fraxinus americana and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9464_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9464	NON-STANDARDIZED ALLERGENIC	Eastern 10 Tree Pollen Mix		Platanus occidentalis, Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Fraxinus americana, Acer saccharum and Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.0001; .0001; .0001; .0001; .0001; .0001; .0001; .0001; .0001; .0001	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9465_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9465	NON-STANDARDIZED ALLERGENIC	Eastern 10 Tree Pollen Mix		Platanus occidentalis, Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Fraxinus americana, Acer saccharum and Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.005; .005; .005; .005; .005; .005; .005; .005; .005; .005	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9466_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9466	NON-STANDARDIZED ALLERGENIC	Central Eastern 4 Tree Pollen Mix		Ulmus americana, Acer negundo, Carya illinoinensis and Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN; CARYA ILLINOINENSIS POLLEN; QUERCUS VIRGINIANA POLLEN; ULMUS AMERICANA POLLEN	.00025; .00025; .00025; .00025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9468_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9468	NON-STANDARDIZED ALLERGENIC	Central Eastern 4 Tree Pollen Mix		Ulmus americana, Acer negundo, Carya illinoinensis and Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN; CARYA ILLINOINENSIS POLLEN; QUERCUS VIRGINIANA POLLEN; ULMUS AMERICANA POLLEN	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9469_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9469	NON-STANDARDIZED ALLERGENIC	Western Oak Pollen Mix		Quercus kelloggii, Quercus agrifolia and Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN; QUERCUS GARRYANA POLLEN; QUERCUS KELLOGGII POLLEN	.0333333; .0333333; .0333333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9470_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9470	NON-STANDARDIZED ALLERGENIC	Western Oak Pollen Mix		Quercus kelloggii, Quercus agrifolia and Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN; QUERCUS GARRYANA POLLEN; QUERCUS KELLOGGII POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9472_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9472	NON-STANDARDIZED ALLERGENIC	Western Oak Pollen Mix		Quercus kelloggii, Quercus agrifolia and Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN; QUERCUS GARRYANA POLLEN; QUERCUS KELLOGGII POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9473_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9473	NON-STANDARDIZED ALLERGENIC	Western 3 Tree Pollen Mix		Olea europaea, Ulmus pumila and Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN; PLATANUS RACEMOSA POLLEN; ULMUS PUMILA POLLEN	.0003333; .0003333; .0003333	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9474_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9474	NON-STANDARDIZED ALLERGENIC	Western 3 Tree Pollen Mix		Olea europaea, Ulmus pumila and Platanus racemosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	OLEA EUROPAEA POLLEN; PLATANUS RACEMOSA POLLEN; ULMUS PUMILA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9475_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9475	NON-STANDARDIZED ALLERGENIC	Western 10 Tree Pollen Mix		Acacia dealbata, Acer negundo, Populus fremontii, Olea europaea, Ulmus pumila, Betula occidentalis, Juniperus occidentalis, Platanus racemosa, Quercus garryana and Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN; ACER NEGUNDO POLLEN; BETULA OCCIDENTALIS POLLEN; JUNIPERUS OCCIDENTALIS POLLEN; MORUS ALBA POLLEN; OLEA EUROPAEA POLLEN; PLATANUS RACEMOSA POLLEN; POPULUS FREMONTII POLLEN; QUERCUS GARRYANA POLLEN; ULMUS PUMILA POLLEN	.01; .01; .01; .01; .01; .01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9476_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9476	NON-STANDARDIZED ALLERGENIC	Western 10 Tree Pollen Mix		Acacia dealbata, Acer negundo, Populus fremontii, Olea europaea, Ulmus pumila, Betula occidentalis, Juniperus occidentalis, Platanus racemosa, Quercus garryana and Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN; ACER NEGUNDO POLLEN; BETULA OCCIDENTALIS POLLEN; JUNIPERUS OCCIDENTALIS POLLEN; MORUS ALBA POLLEN; OLEA EUROPAEA POLLEN; PLATANUS RACEMOSA POLLEN; POPULUS FREMONTII POLLEN; QUERCUS GARRYANA POLLEN; ULMUS PUMILA POLLEN	2000; 2000; 2000; 2000; 2000; 2000; 2000; 2000; 2000; 2000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9477_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9477	NON-STANDARDIZED ALLERGENIC	Western 10 Tree Pollen Mix		Acacia dealbata, Acer negundo, Populus fremontii, Olea europaea, Ulmus pumila, Betula occidentalis, Juniperus occidentalis, Platanus racemosa, Quercus garryana and Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN; ACER NEGUNDO POLLEN; BETULA OCCIDENTALIS POLLEN; JUNIPERUS OCCIDENTALIS POLLEN; MORUS ALBA POLLEN; OLEA EUROPAEA POLLEN; PLATANUS RACEMOSA POLLEN; POPULUS FREMONTII POLLEN; QUERCUS GARRYANA POLLEN; ULMUS PUMILA POLLEN	.0001; .0001; .0001; .0001; .0001; .0001; .0001; .0001; .0001; .0001	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9478_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9478	NON-STANDARDIZED ALLERGENIC	Western 10 Tree Pollen Mix		Acacia dealbata, Acer negundo, Populus fremontii, Olea europaea, Ulmus pumila, Betula occidentalis, Juniperus occidentalis, Platanus racemosa, Quercus garryana and Morus alba	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACACIA DEALBATA POLLEN; ACER NEGUNDO POLLEN; BETULA OCCIDENTALIS POLLEN; JUNIPERUS OCCIDENTALIS POLLEN; MORUS ALBA POLLEN; OLEA EUROPAEA POLLEN; PLATANUS RACEMOSA POLLEN; POPULUS FREMONTII POLLEN; QUERCUS GARRYANA POLLEN; ULMUS PUMILA POLLEN	.005; .005; .005; .005; .005; .005; .005; .005; .005; .005	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9479_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9479	NON-STANDARDIZED ALLERGENIC	11 Tree Pollen Mix		Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.0090909; .0090909; .0090909; .0090909; .0090909; .0090909; .0090909; .0090909; .0090909; .0090909; .0090909	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9481_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9481	NON-STANDARDIZED ALLERGENIC	11 Tree Pollen Mix		Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.0000909; .0000909; .0000909; .0000909; .0000909; .0000909; .0000909; .0000909; .0000909; .0000909; .0000909	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9482_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9482	NON-STANDARDIZED ALLERGENIC	11 Tree Pollen Mix		Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	1818.1818; 1818.1818; 1818.1818; 1818.1818; 1818.1818; 1818.1818; 1818.1818; 1818.1818; 1818.1818; 1818.1818; 1818.1818	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9483_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9483	NON-STANDARDIZED ALLERGENIC	11 Tree Pollen Mix		Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	3636.3636; 3636.3636; 3636.3636; 3636.3636; 3636.3636; 3636.3636; 3636.3636; 3636.3636; 3636.3636; 3636.3636; 3636.3636	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9484_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9484	NON-STANDARDIZED ALLERGENIC	11 Tree Pollen Mix		Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9485_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9485	NON-STANDARDIZED ALLERGENIC	11 Tree Pollen Mix		Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454; .0045454	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9487_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9487	NON-STANDARDIZED ALLERGENIC	Western Walnut Pollen Mix		Juglans californica and Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN; JUGLANS REGIA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9488_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9488	NON-STANDARDIZED ALLERGENIC	Western Walnut Pollen Mix		Juglans californica and Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN; JUGLANS REGIA POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9490_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9490	NON-STANDARDIZED ALLERGENIC	Western Walnut Pollen Mix		Juglans californica and Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN; JUGLANS REGIA POLLEN	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9491_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9491	NON-STANDARDIZED ALLERGENIC	Western Walnut Pollen Mix		Juglans californica and Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN; JUGLANS REGIA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9492_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9492	NON-STANDARDIZED ALLERGENIC	Ash Pollen Mix		Fraxinus pennsylvanica, Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9493_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9493	NON-STANDARDIZED ALLERGENIC	Birch Pollen Mix		Betula lenta, Betula nigra and Betula populifolia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9494_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9494	NON-STANDARDIZED ALLERGENIC	Central Eastern 4 Tree Pollen Mix		Ulmus americana, Acer negundo, Carya illinoinensis and Quercus virginiana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN; CARYA ILLINOINENSIS POLLEN; QUERCUS VIRGINIANA POLLEN; ULMUS AMERICANA POLLEN	.025; .025; .025; .025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9495_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9495	NON-STANDARDIZED ALLERGENIC	Eastern 10 Tree Pollen Mix		Platanus occidentalis, Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Fraxinus americana, Acer saccharum and Liquidambar styraciflua	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.01; .01; .01; .01; .01; .01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9496_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9496	NON-STANDARDIZED ALLERGENIC	Eastern 6 Tree Pollen Mix		Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN	1666.6666; 1666.6666; 1666.6666; 1666.6666; 1666.6666; 1666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9497_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9497	NON-STANDARDIZED ALLERGENIC	Eastern 7 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata and Fraxinus americana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	2857.1428; 2857.1428; 2857.1428; 2857.1428; 2857.1428; 2857.1428; 2857.1428	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9498_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9498	NON-STANDARDIZED ALLERGENIC	Eastern 8 Tree Pollen Mix		Ulmus americana, Fagus grandifolia, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Fraxinus americana and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; ULMUS AMERICANA POLLEN	.0125; .0125; .0125; .0125; .0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9499_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9499	NON-STANDARDIZED ALLERGENIC	Elm Pollen Mix		Ulmus americana and Ulmus pumila	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9600_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9600	NON-STANDARDIZED ALLERGENIC	Mold Mix 1		Alternaria alternata, Aspergillus niger, Bipolaris sorokiniana, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.02; .02; .02; .02; .02	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9601_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9601	NON-STANDARDIZED ALLERGENIC	Mold Mix 1		Alternaria alternata, Aspergillus niger, Bipolaris sorokiniana, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	4000; 4000; 4000; 4000; 4000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9602_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9602	NON-STANDARDIZED ALLERGENIC	Mold Mix 1		Alternaria alternata, Aspergillus niger, Bipolaris sorokiniana, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	8000; 8000; 8000; 8000; 8000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9603_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9603	NON-STANDARDIZED ALLERGENIC	Mold Mix 1		Alternaria alternata, Aspergillus niger, Bipolaris sorokiniana, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9604_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9604	NON-STANDARDIZED ALLERGENIC	Mold Mix 1		Alternaria alternata, Aspergillus niger, Bipolaris sorokiniana, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.0002; .0002; .0002; .0002; .0002	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9606_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9606	NON-STANDARDIZED ALLERGENIC	Mold Mix 1		Alternaria alternata, Aspergillus niger, Bipolaris sorokiniana, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9607_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9607	NON-STANDARDIZED ALLERGENIC	Mold Mix 2		Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; RHIZOPUS STOLONIFER	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9608_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9608	NON-STANDARDIZED ALLERGENIC	Mold Mix 2		Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; RHIZOPUS STOLONIFER	4000; 4000; 4000; 4000; 4000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9609_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9609	NON-STANDARDIZED ALLERGENIC	Mold Mix 2		Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; RHIZOPUS STOLONIFER	2000; 2000; 2000; 2000; 2000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9610_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9610	NON-STANDARDIZED ALLERGENIC	Mold Mix 2		Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; RHIZOPUS STOLONIFER	8000; 8000; 8000; 8000; 8000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9612_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9612	NON-STANDARDIZED ALLERGENIC	Mold Mix 2		Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; RHIZOPUS STOLONIFER	.0002; .0002; .0002; .0002; .0002	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9613_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9613	NON-STANDARDIZED ALLERGENIC	Mold Mix 2		Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	AUREOBASIDIUM PULLULANS VAR. PULLUTANS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; RHIZOPUS STOLONIFER	.005; .005; .005; .005; .005	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9614_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9614	NON-STANDARDIZED ALLERGENIC	Mold Mix 3		Alternaria alternata, Aspergillus niger, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.00025; .00025; .00025; .00025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9616_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9616	NON-STANDARDIZED ALLERGENIC	Mold Mix 3		Alternaria alternata, Aspergillus niger, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	5000; 5000; 5000; 5000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9617_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9617	NON-STANDARDIZED ALLERGENIC	Mold Mix 3		Alternaria alternata, Aspergillus niger, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.025; .025; .025; .025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9618_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9618	NON-STANDARDIZED ALLERGENIC	Mold Mix 3		Alternaria alternata, Aspergillus niger, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	10000; 10000; 10000; 10000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9619_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9619	NON-STANDARDIZED ALLERGENIC	Mold Mix 3		Alternaria alternata, Aspergillus niger, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9620_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9620	NON-STANDARDIZED ALLERGENIC	Mold Mix 3		Alternaria alternata, Aspergillus niger, Cladosporium sphaerospermum and Penicillium notatum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CLADOSPORIUM SPHAEROSPERMUM; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9621_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9621	NON-STANDARDIZED ALLERGENIC	AHH Mold Mix		Alternaria alternata, Bipolaris sorokiniana and Cladosporium sphaerospermum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS	.0166; .0166; .0166	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9622_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9622	NON-STANDARDIZED ALLERGENIC	AHH Mold Mix		Alternaria alternata, Bipolaris sorokiniana and Cladosporium sphaerospermum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS	.00033; .00033; .00033	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9623_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9623	NON-STANDARDIZED ALLERGENIC	AHH Mold Mix		Alternaria alternata, Bipolaris sorokiniana and Cladosporium sphaerospermum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS	.0166; .0166; .0166	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9624_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9624	NON-STANDARDIZED ALLERGENIC	Alternaria/Hormodendrum Mix		Alternaria alternata and Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9625_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9625	NON-STANDARDIZED ALLERGENIC	Alternaria/Hormodendrum Mix		Alternaria alternata and Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9626_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9626	NON-STANDARDIZED ALLERGENIC	Alternaria Hormodendrum Mix		Alternaria alternata and Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9627_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9627	NON-STANDARDIZED ALLERGENIC	Aspergillus Mix		Aspergillus amstelodami, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans and Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; EUROTIUM AMSTELODAMI	.02; .02; .02; .02; .02	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9628_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9628	NON-STANDARDIZED ALLERGENIC	Aspergillus Mix		Aspergillus amstelodami, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans and Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; EUROTIUM AMSTELODAMI	8000; 8000; 8000; 8000; 8000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9629_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9629	NON-STANDARDIZED ALLERGENIC	Aspergillus Mix		Aspergillus amstelodami, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans and Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; EUROTIUM AMSTELODAMI	4000; 4000; 4000; 4000; 4000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9630_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9630	NON-STANDARDIZED ALLERGENIC	Aspergillus Mix		Aspergillus amstelodami, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans and Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; EUROTIUM AMSTELODAMI	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9631_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9631	NON-STANDARDIZED ALLERGENIC	Aspergillus Mix		Aspergillus amstelodami, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans and Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; EUROTIUM AMSTELODAMI	.0002; .0002; .0002; .0002; .0002	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9633_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9633	NON-STANDARDIZED ALLERGENIC	Aspergillus Mix		Aspergillus amstelodami, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans and Aspergillus niger	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; EUROTIUM AMSTELODAMI	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9634_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9634	NON-STANDARDIZED ALLERGENIC	Dematiaceae Mix		Alternaria alternata, Aureobasidium pullulans, Bipolaris sorokiniana, Cladosporium herbarum, Curvularia spicifera and Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CLADOSPORIUM HERBARUM; COCHLIOBOLUS SATIVUS; COCHLIOBOLUS SPICIFER; HELMINTHOSPORIUM SOLANI	.0083; .0083; .0083; .0083; .0083; .0083	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9635_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9635	NON-STANDARDIZED ALLERGENIC	Dematiaceae Mix		Alternaria alternata, Aureobasidium pullulans, Bipolaris sorokiniana, Cladosporium herbarum, Curvularia spicifera and Helminthosporium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CLADOSPORIUM HERBARUM; COCHLIOBOLUS SATIVUS; COCHLIOBOLUS SPICIFER; HELMINTHOSPORIUM SOLANI	.0042; .0042; .0042; .0042; .0042; .0042	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9636_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9636	NON-STANDARDIZED ALLERGENIC	Fusarium Mix		Gibberella fujikuroi and Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI; HAEMATONECTRIA HAEMATOCOCCA	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9637_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9637	NON-STANDARDIZED ALLERGENIC	Fusarium Mix		Gibberella fujikuroi and Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI; HAEMATONECTRIA HAEMATOCOCCA	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9638_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9638	NON-STANDARDIZED ALLERGENIC	Fusarium Mix		Gibberella fujikuroi and Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI; HAEMATONECTRIA HAEMATOCOCCA	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9639_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9639	NON-STANDARDIZED ALLERGENIC	Fusarium Mix		Gibberella fujikuroi and Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI; HAEMATONECTRIA HAEMATOCOCCA	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9641_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9641	NON-STANDARDIZED ALLERGENIC	Fusarium Mix		Gibberella fujikuroi and Fusarium solani	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	GIBBERELLA FUJIKUROI; HAEMATONECTRIA HAEMATOCOCCA	.0125; .0125	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9642_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9642	NON-STANDARDIZED ALLERGENIC	Monilia Mix		Candida albicans and Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS; NEUROSPORA INTERMEDIA	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9643_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9643	NON-STANDARDIZED ALLERGENIC	Monilia Mix		Candida albicans and Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS; NEUROSPORA INTERMEDIA	500; 500	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9644_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9644	NON-STANDARDIZED ALLERGENIC	Monilia Mix		Candida albicans and Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS; NEUROSPORA INTERMEDIA	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9645_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9645	NON-STANDARDIZED ALLERGENIC	Monilia Mix		Candida albicans and Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS; NEUROSPORA INTERMEDIA	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9646_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9646	NON-STANDARDIZED ALLERGENIC	Mucor Mix		Mucor circinelloides f. lusitanicus and Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS; MUCOR PLUMBEUS	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9648_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9648	NON-STANDARDIZED ALLERGENIC	Mucor Mix		Mucor circinelloides f. lusitanicus and Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS; MUCOR PLUMBEUS	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9649_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9649	NON-STANDARDIZED ALLERGENIC	New Stock Fungi Mix		Acremonium strictum, Alternaria alternata, Aspergillus niger, Aureobasidium pullulans, Bipolaris sorokiniana, Botrytis cinerea, Candida albicans, Chaetomium globosum, Cladosporium sphaerospermum, Epicoccum nigrum, Gibberella fujikuroi, Mucor plumbeus, Penicillium notatum, Phoma betae, Rhizopus stolonifer and Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACREMONIUM STRICTUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOTRYTIS CINEREA; CANDIDA ALBICANS; CHAETOMIUM GLOBOSUM; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; EPICOCCUM NIGRUM; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PLEOSPORA BETAE; RHIZOPUS STOLONIFER; TRICHOPHYTON MENTAGROPHYTES	.00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625; .00625	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9650_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9650	NON-STANDARDIZED ALLERGENIC	New Stock Fungi Mix		Acremonium strictum, Alternaria alternata, Aspergillus niger, Aureobasidium pullulans, Bipolaris sorokiniana, Botrytis cinerea, Candida albicans, Chaetomium globosum, Cladosporium sphaerospermum, Epicoccum nigrum, Gibberella fujikuroi, Mucor plumbeus, Penicillium notatum, Phoma betae, Rhizopus stolonifer and Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACREMONIUM STRICTUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOTRYTIS CINEREA; CANDIDA ALBICANS; CHAETOMIUM GLOBOSUM; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; EPICOCCUM NIGRUM; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PLEOSPORA BETAE; RHIZOPUS STOLONIFER; TRICHOPHYTON MENTAGROPHYTES	.0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625; .0000625	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9651_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9651	NON-STANDARDIZED ALLERGENIC	New Stock Fungi Mix		Acremonium strictum, Alternaria alternata, Aspergillus niger, Aureobasidium pullulans, Bipolaris sorokiniana, Botrytis cinerea, Candida albicans, Chaetomium globosum, Cladosporium sphaerospermum, Epicoccum nigrum, Gibberella fujikuroi, Mucor plumbeus, Penicillium notatum, Phoma betae, Rhizopus stolonifer and Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACREMONIUM STRICTUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOTRYTIS CINEREA; CANDIDA ALBICANS; CHAETOMIUM GLOBOSUM; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; EPICOCCUM NIGRUM; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PLEOSPORA BETAE; RHIZOPUS STOLONIFER; TRICHOPHYTON MENTAGROPHYTES	1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250; 1250	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9652_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9652	NON-STANDARDIZED ALLERGENIC	New Stock Fungi Mix		Acremonium strictum, Alternaria alternata, Aspergillus niger, Aureobasidium pullulans, Bipolaris sorokiniana, Botrytis cinerea, Candida albicans, Chaetomium globosum, Cladosporium sphaerospermum, Epicoccum nigrum, Gibberella fujikuroi, Mucor plumbeus, Penicillium notatum, Phoma betae, Rhizopus stolonifer and Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACREMONIUM STRICTUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOTRYTIS CINEREA; CANDIDA ALBICANS; CHAETOMIUM GLOBOSUM; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; EPICOCCUM NIGRUM; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PLEOSPORA BETAE; RHIZOPUS STOLONIFER; TRICHOPHYTON MENTAGROPHYTES	.003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9653_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9653	NON-STANDARDIZED ALLERGENIC	New Stock Fungi Mix		Acremonium strictum, Alternaria alternata, Aspergillus niger, Aureobasidium pullulans, Bipolaris sorokiniana, Botrytis cinerea, Candida albicans, Chaetomium globosum, Cladosporium sphaerospermum, Epicoccum nigrum, Gibberella fujikuroi, Mucor plumbeus, Penicillium notatum, Phoma betae, Rhizopus stolonifer and Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACREMONIUM STRICTUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOTRYTIS CINEREA; CANDIDA ALBICANS; CHAETOMIUM GLOBOSUM; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; EPICOCCUM NIGRUM; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PLEOSPORA BETAE; RHIZOPUS STOLONIFER; TRICHOPHYTON MENTAGROPHYTES	.003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125; .003125	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9654_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9654	NON-STANDARDIZED ALLERGENIC	Penicillium Mix		Penicillium camemberti, Penicillium chrysogenum, Penicillium digitatum, Penicillium notatum and Penicillium roqueforti	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	.025; .025; .025; .025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9655_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9655	NON-STANDARDIZED ALLERGENIC	Penicillium Mix		Penicillium camemberti, Penicillium chrysogenum, Penicillium digitatum, Penicillium notatum and Penicillium roqueforti	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	10000; 10000; 10000; 10000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9656_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9656	NON-STANDARDIZED ALLERGENIC	Penicillium Mix		Penicillium camemberti, Penicillium chrysogenum, Penicillium digitatum, Penicillium notatum and Penicillium roqueforti	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	5000; 5000; 5000; 5000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9657_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9657	NON-STANDARDIZED ALLERGENIC	Penicillium Mix		Penicillium camemberti, Penicillium chrysogenum, Penicillium digitatum, Penicillium notatum and Penicillium roqueforti	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9659_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9659	NON-STANDARDIZED ALLERGENIC	Penicillium Mix		Penicillium camemberti, Penicillium chrysogenum, Penicillium digitatum, Penicillium notatum and Penicillium roqueforti	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	.00025; .00025; .00025; .00025	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9660_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9660	NON-STANDARDIZED ALLERGENIC	Penicillium Mix		Penicillium camemberti, Penicillium chrysogenum, Penicillium digitatum, Penicillium notatum and Penicillium roqueforti	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9661_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9661	NON-STANDARDIZED ALLERGENIC	Phycomycetes Mix		Mucor circinelloides f. lusitanicus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS; RHIZOPUS STOLONIFER	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9662_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9662	NON-STANDARDIZED ALLERGENIC	Phycomycetes Mix		Mucor circinelloides f. lusitanicus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS; RHIZOPUS STOLONIFER	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9664_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9664	NON-STANDARDIZED ALLERGENIC	Phycomycetes Mix		Mucor circinelloides f. lusitanicus and Rhizopus stolonifer	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS; RHIZOPUS STOLONIFER	.0125; .0125	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9665_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9665	NON-STANDARDIZED ALLERGENIC	Rhizopus Mix		Rhizopus stolonifer and Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS; RHIZOPUS STOLONIFER	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9666_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9666	NON-STANDARDIZED ALLERGENIC	Rhizopus Mix		Rhizopus stolonifer and Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS; RHIZOPUS STOLONIFER	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9668_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9668	NON-STANDARDIZED ALLERGENIC	Rhizopus Mix		Rhizopus stolonifer and Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS; RHIZOPUS STOLONIFER	.0005; .0005	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9669_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9669	NON-STANDARDIZED ALLERGENIC	Rhizopus Mix		Rhizopus stolonifer and Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS; RHIZOPUS STOLONIFER	.0125; .0125	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9670_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9670	NON-STANDARDIZED ALLERGENIC	Grain Smut Mix		Ustilago maydis, Ustilago tritici, Ustilago nuda and Ustilago avenae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO AVENAE; USTILAGO MAYDIS; USTILAGO NUDA; USTILAGO TRITICI	.00625; .00625; .00625; .00625	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9671_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9671	NON-STANDARDIZED ALLERGENIC	Grass Smut Mix		Ustilago cynodontis and Sporisorium cruentum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SPORISORIUM CRUENTUM; USTILAGO CYNODONTIS	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9672_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9672	NON-STANDARDIZED ALLERGENIC	Mucor Mix		Mucor circinelloides f. lusitanicus and Mucor plumbeus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	MUCOR CIRCINELLOIDES F. LUSITANICUS; MUCOR PLUMBEUS	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9673_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9673	NON-STANDARDIZED ALLERGENIC	AHH Mold Mix		Alternaria alternata, Bipolaris sorokiniana and Cladosporium sphaerospermum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS	13333.333; 13333.333; 13333.333	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9674_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9674	NON-STANDARDIZED ALLERGENIC	Alternaria/Hormodendrum Mix		Alternaria alternata and Aspergillus fumigatus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9675_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9675	NON-STANDARDIZED ALLERGENIC	Grain Smut Mix		Ustilago maydis, Ustilago tritici, Ustilago nuda and Ustilago avenae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	USTILAGO AVENAE; USTILAGO MAYDIS; USTILAGO NUDA; USTILAGO TRITICI	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9676_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9676	NON-STANDARDIZED ALLERGENIC	Grass Smut Mix		Ustilago cynodontis and Sporisorium cruentum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	SPORISORIUM CRUENTUM; USTILAGO CYNODONTIS	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9677_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9677	NON-STANDARDIZED ALLERGENIC	Monilia Mix		Candida albicans and Neurospora intermedia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CANDIDA ALBICANS; NEUROSPORA INTERMEDIA	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9678_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9678	NON-STANDARDIZED ALLERGENIC	New Stock Fungi Mix		Acremonium strictum, Alternaria alternata, Aspergillus niger, Aureobasidium pullulans, Bipolaris sorokiniana, Botrytis cinerea, Candida albicans, Chaetomium globosum, Cladosporium sphaerospermum, Epicoccum nigrum, Gibberella fujikuroi, Mucor plumbeus, Penicillium notatum, Phoma betae, Rhizopus stolonifer and Trichophyton mentagrophytes	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACREMONIUM STRICTUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOTRYTIS CINEREA; CANDIDA ALBICANS; CHAETOMIUM GLOBOSUM; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; EPICOCCUM NIGRUM; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PLEOSPORA BETAE; RHIZOPUS STOLONIFER; TRICHOPHYTON MENTAGROPHYTES	2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500; 2500	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9679_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9679	NON-STANDARDIZED ALLERGENIC	Penicillium Mix		Penicillium camemberti, Penicillium chrysogenum, Penicillium digitatum, Penicillium notatum and Penicillium roqueforti	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	2500; 2500; 2500; 2500	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9680_f89a60ab-6ef1-b8ce-e053-6394a90afacf	22840-9680	NON-STANDARDIZED ALLERGENIC	Rhizopus Mix		Rhizopus stolonifer and Rhizopus oryzae	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	RHIZOPUS ARRHIZUS; RHIZOPUS STOLONIFER	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
22840-9700_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-9700	NON-STANDARDIZED ALLERGENIC	Fish Mix		Gadus morhua, Paralichthys lethostigma, Hippoglossus hippoglossus, Scomber scombrus and Thunnus albacares	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ATLANTIC COD; ATLANTIC HALIBUT; ATLANTIC MACKEREL; SOUTHERN FLOUNDER; YELLOWFIN TUNA	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
22840-9701_0a9990cb-6070-ca3e-e063-6294a90a8aac	22840-9701	NON-STANDARDIZED ALLERGENIC	Shellfish Mix		Mercenaria mercenaria, Callinectes sapidus, Crassostrea virginica, Placopecten magellanicus and Farfantepenaeus aztecus	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	BLUE CRAB; EASTERN OYSTER; NORTHERN BROWN SHRIMP; NORTHERN QUAHOG; SEA SCALLOP	.01; .01; .01; .01; .01	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT], Shellfish Proteins [EXT], Shellfish Proteins [EXT]		N	20241231
22840-9800_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9800	NON-STANDARDIZED ALLERGENIC	Hickory Pollen Mix		Carya glabra, Carya ovata, Carya laciniosa and Carya tomentosa	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN	.0125; .0125; .0125; .0125	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9801_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9801	NON-STANDARDIZED ALLERGENIC	Hickory-Pecan Pollen Mix		Carya illinoinensis and Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9802_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9802	NON-STANDARDIZED ALLERGENIC	Hickory-Pecan Pollen Mix		Carya illinoinensis and Carya ovata	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9803_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9803	NON-STANDARDIZED ALLERGENIC	2 Maple Pollen Mix		Acer rubrum and Acer saccharum	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN	10000; 10000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9804_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9804	NON-STANDARDIZED ALLERGENIC	Maple-Box Elder Pollen Mix		Acer saccharum and Acer negundo	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9805_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9805	NON-STANDARDIZED ALLERGENIC	Western Oak Pollen Mix		Quercus kelloggii, Quercus agrifolia and Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN; QUERCUS GARRYANA POLLEN; QUERCUS KELLOGGII POLLEN	.0166666; .0166666; .0166666	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9806_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9806	NON-STANDARDIZED ALLERGENIC	Western Oak Pollen Mix		Quercus kelloggii, Quercus agrifolia and Quercus garryana	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	QUERCUS AGRIFOLIA POLLEN; QUERCUS GARRYANA POLLEN; QUERCUS KELLOGGII POLLEN	6666.6666; 6666.6666; 6666.6666	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
22840-9807_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9807	NON-STANDARDIZED ALLERGENIC	Western Walnut Pollen Mix		Juglans californica and Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN; JUGLANS REGIA POLLEN	.025; .025	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
22840-9808_f89bc3db-cf2a-49d2-e053-6394a90acd8f	22840-9808	NON-STANDARDIZED ALLERGENIC	Western Walnut Pollen Mix		Juglans californica and Juglans regia	SOLUTION	INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS	19810915		BLA	BLA101833	Greer Laboratories, Inc.	JUGLANS CALIFORNICA POLLEN; JUGLANS REGIA POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
23155-001_55cf4bfc-8b55-499f-9aa1-c0cd8ec454d8	23155-001	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-002_55cf4bfc-8b55-499f-9aa1-c0cd8ec454d8	23155-002	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-003_55cf4bfc-8b55-499f-9aa1-c0cd8ec454d8	23155-003	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-004_55cf4bfc-8b55-499f-9aa1-c0cd8ec454d8	23155-004	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-008_5bb598d0-39a7-4bb1-aa1e-e53e7b9a4aec	23155-008	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
23155-009_5bb598d0-39a7-4bb1-aa1e-e53e7b9a4aec	23155-009	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
23155-019_855bcbd0-211b-4fdd-b8bb-8a1ad2238171	23155-019	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	19731112	20240630	ANDA	ANDA080197	HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	
23155-023_774a9072-c089-4cbf-865f-0c88271b5e7c	23155-023	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
23155-024_774a9072-c089-4cbf-865f-0c88271b5e7c	23155-024	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
23155-025_774a9072-c089-4cbf-865f-0c88271b5e7c	23155-025	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
23155-026_751ba5e8-14b3-4fdb-8e8e-ca59867fd257	23155-026	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20110107		ANDA	ANDA071881	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	80	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
23155-028_866f210b-dc8d-4178-b7ba-bc16454ae460	23155-028	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20210808		ANDA	ANDA201336	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
23155-029_866f210b-dc8d-4178-b7ba-bc16454ae460	23155-029	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20210808		ANDA	ANDA201336	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
23155-030_866f210b-dc8d-4178-b7ba-bc16454ae460	23155-030	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20210808		ANDA	ANDA201336	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
23155-038_f5c47e63-480c-4a89-a873-4fee351dc9ac	23155-038	HUMAN PRESCRIPTION DRUG	Paromomycin Sulfate		Paromomycin Sulfate	CAPSULE	ORAL	20091022	20240331	ANDA	ANDA065173	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PAROMOMYCIN SULFATE	250	mg/1	Antiprotozoal [EPC]		N	
23155-043_cfa52b95-f6ee-4a2c-a320-e190f716d33b	23155-043	HUMAN PRESCRIPTION DRUG	leflunomide		leflunomide	TABLET	ORAL	20091029		ANDA	ANDA077086	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
23155-044_cfa52b95-f6ee-4a2c-a320-e190f716d33b	23155-044	HUMAN PRESCRIPTION DRUG	leflunomide		leflunomide	TABLET	ORAL	20091029		ANDA	ANDA077086	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
23155-048_1fdb9a9f-baeb-46c0-91b8-6552c3784c39	23155-048	HUMAN PRESCRIPTION DRUG	FELODIPINE		FELODIPINE	TABLET, EXTENDED RELEASE	ORAL	20131108		ANDA	ANDA201964	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-049_1fdb9a9f-baeb-46c0-91b8-6552c3784c39	23155-049	HUMAN PRESCRIPTION DRUG	FELODIPINE		FELODIPINE	TABLET, EXTENDED RELEASE	ORAL	20131108		ANDA	ANDA201964	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-050_1fdb9a9f-baeb-46c0-91b8-6552c3784c39	23155-050	HUMAN PRESCRIPTION DRUG	FELODIPINE		FELODIPINE	TABLET, EXTENDED RELEASE	ORAL	20131108		ANDA	ANDA201964	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-051_1ffc4cd5-8e07-4bd3-b471-c57283c49cbf	23155-051	HUMAN PRESCRIPTION DRUG	nystatin		nystatin	TABLET, COATED	ORAL	20111031		ANDA	ANDA062474	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NYSTATIN	500000	[USP'U]/1	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
23155-054_180ad605-bfed-4db4-ad04-aa7b9fd36f62	23155-054	HUMAN PRESCRIPTION DRUG	naratriptan		naratriptan	TABLET	ORAL	20110315		ANDA	ANDA200502	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NARATRIPTAN HYDROCHLORIDE	1	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
23155-055_180ad605-bfed-4db4-ad04-aa7b9fd36f62	23155-055	HUMAN PRESCRIPTION DRUG	naratriptan		naratriptan	TABLET	ORAL	20110315		ANDA	ANDA200502	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NARATRIPTAN HYDROCHLORIDE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
23155-056_dde70749-e2c1-4ba6-bdba-f08a456e803c	23155-056	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
23155-057_dde70749-e2c1-4ba6-bdba-f08a456e803c	23155-057	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
23155-058_dde70749-e2c1-4ba6-bdba-f08a456e803c	23155-058	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
23155-059_751ba5e8-14b3-4fdb-8e8e-ca59867fd257	23155-059	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20151015		ANDA	ANDA071881	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	40	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
23155-070_649d3946-dc8c-4319-814f-a991d417d380	23155-070	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20120115		ANDA	ANDA040734	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
23155-071_649d3946-dc8c-4319-814f-a991d417d380	23155-071	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20120115		ANDA	ANDA040734	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
23155-092_c2bacf15-e521-4d06-b4c6-45b40036b73c	23155-092	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20180213		ANDA	ANDA205210	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-093_c2bacf15-e521-4d06-b4c6-45b40036b73c	23155-093	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20180213		ANDA	ANDA205210	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-094_c2bacf15-e521-4d06-b4c6-45b40036b73c	23155-094	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20180213		ANDA	ANDA205210	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-095_c2bacf15-e521-4d06-b4c6-45b40036b73c	23155-095	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20180213		ANDA	ANDA205210	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-097_774a9072-c089-4cbf-865f-0c88271b5e7c	23155-097	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
23155-115_ee5fdf68-df2d-4965-8224-2c2df30f2f22	23155-115	HUMAN PRESCRIPTION DRUG	glipizide and metformin hcl		glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20100629		ANDA	ANDA078728	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
23155-116_ee5fdf68-df2d-4965-8224-2c2df30f2f22	23155-116	HUMAN PRESCRIPTION DRUG	glipizide and metformin hcl		glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20100629		ANDA	ANDA078728	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
23155-117_ee5fdf68-df2d-4965-8224-2c2df30f2f22	23155-117	HUMAN PRESCRIPTION DRUG	glipizide and metformin hcl		glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20100629		ANDA	ANDA078728	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
23155-133_90713c1e-c1a9-4607-aea2-687b4019a2ed	23155-133	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20120501		ANDA	ANDA091605	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-134_90713c1e-c1a9-4607-aea2-687b4019a2ed	23155-134	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20120501		ANDA	ANDA091605	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-135_90713c1e-c1a9-4607-aea2-687b4019a2ed	23155-135	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20120501		ANDA	ANDA091605	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-136_90713c1e-c1a9-4607-aea2-687b4019a2ed	23155-136	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20120501		ANDA	ANDA091605	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-141_599f2c2d-dcd8-4e17-a2a8-2266ac4a8a56	23155-141	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE	DELAYED RELEASE	doxycycline hyclate	TABLET, DELAYED RELEASE	ORAL	20130430		ANDA	ANDA200856	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-142_599f2c2d-dcd8-4e17-a2a8-2266ac4a8a56	23155-142	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE	DELAYED RELEASE	doxycycline hyclate	TABLET, DELAYED RELEASE	ORAL	20130430		ANDA	ANDA200856	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-143_599f2c2d-dcd8-4e17-a2a8-2266ac4a8a56	23155-143	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE	DELAYED RELEASE	doxycycline hyclate	TABLET, DELAYED RELEASE	ORAL	20130430		ANDA	ANDA200856	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-147_84ff1519-f0a6-4d8f-afd3-bce6f78813aa	23155-147	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20210416		ANDA	ANDA202271	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
23155-148_84ff1519-f0a6-4d8f-afd3-bce6f78813aa	23155-148	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20210416		ANDA	ANDA202271	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
23155-149_84ff1519-f0a6-4d8f-afd3-bce6f78813aa	23155-149	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20210416		ANDA	ANDA202271	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACARBOSE	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
23155-166_2514df40-d3e3-4280-aeb1-ce44ebb2302a	23155-166	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20140813		ANDA	ANDA203521	Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	TRANEXAMIC ACID	1	g/10mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
23155-170_f4991976-8a87-4a00-839f-3f62c561c230	23155-170	HUMAN PRESCRIPTION DRUG	Zoledronic acid		Zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230831		ANDA	ANDA201783	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
23155-178_649023db-b51a-4696-ae92-28c926efc2d6	23155-178	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20100607		ANDA	ANDA075522	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
23155-180_0b8a6f4d-f844-41f5-9659-ec3989cfc390	23155-180	HUMAN PRESCRIPTION DRUG	Trimethobenzamide Hydrochloride		Trimethobenzamide Hydrochloride	CAPSULE	ORAL	20231121		ANDA	ANDA205950	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TRIMETHOBENZAMIDE HYDROCHLORIDE	300	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
23155-191_80f78a5d-f6b0-444d-9805-22984cb17d3f	23155-191	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20160819		ANDA	ANDA206975	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
23155-192_80f78a5d-f6b0-444d-9805-22984cb17d3f	23155-192	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20160819		ANDA	ANDA206975	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
23155-193_5b0a4c83-e74a-4597-8289-42bbd7549195	23155-193	HUMAN PRESCRIPTION DRUG	COLISTIMETHATE SODIUM		COLISTIMETHATE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210909		ANDA	ANDA202359	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	COLISTIMETHATE SODIUM	150	mg/4mL	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
23155-194_b9bbf7c7-2447-4cb1-a0c2-662a9d01d6d9	23155-194	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE	ORAL	20101207		ANDA	ANDA202644	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NIFEDIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-195_b9bbf7c7-2447-4cb1-a0c2-662a9d01d6d9	23155-195	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE	ORAL	20101207		ANDA	ANDA202644	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NIFEDIPINE	20	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-202_e8b62009-b9ec-4303-86b4-e4abdc210a2c	23155-202	HUMAN OTC DRUG	Acetamiophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20180601		ANDA	ANDA207035	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
23155-216_963405a6-8cd9-4d70-9de9-2afc6eab1488	23155-216	HUMAN PRESCRIPTION DRUG	CIDOFOVIR DIHYDRATE		CIDOFOVIR DIHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20120806		ANDA	ANDA202501	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CIDOFOVIR	375	mg/5mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog [EXT]		N	20241231
23155-227_6e0a075f-822f-457d-8ccc-e63a16746d76	23155-227	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20130808		ANDA	ANDA074891	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
23155-228_6e0a075f-822f-457d-8ccc-e63a16746d76	23155-228	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20130808		ANDA	ANDA074891	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
23155-229_80c071c3-e2a5-4803-96a2-b985f27610f4	23155-229	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		acyclovir	CAPSULE	ORAL	20140602		ANDA	ANDA074889	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
23155-240_a9c0f2bb-0052-4edc-a04d-1c4f599118bb	23155-240	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20140103		ANDA	ANDA204756	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
23155-246_a94fad9c-da90-46ad-8644-f956976a6556	23155-246	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20210719		ANDA	ANDA078554	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
23155-247_a94fad9c-da90-46ad-8644-f956976a6556	23155-247	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20210719		ANDA	ANDA078554	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
23155-248_a94fad9c-da90-46ad-8644-f956976a6556	23155-248	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20210719		ANDA	ANDA078554	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
23155-249_a94fad9c-da90-46ad-8644-f956976a6556	23155-249	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20210719		ANDA	ANDA078554	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
23155-250_a94fad9c-da90-46ad-8644-f956976a6556	23155-250	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20210719		ANDA	ANDA078554	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
23155-258_08c358a9-441f-41ec-bbb1-8a775d47e641	23155-258	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA202313	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
23155-287_9538a2b5-9fb4-4b51-96e6-e21106d583d7	23155-287	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	TABLET	ORAL	20161027		ANDA	ANDA205530	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
23155-288_9538a2b5-9fb4-4b51-96e6-e21106d583d7	23155-288	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	TABLET	ORAL	20161027		ANDA	ANDA205530	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
23155-290_0b02f63a-2a78-4b27-b182-2a0de625fb19	23155-290	HUMAN PRESCRIPTION DRUG	Amikacin Sulfate		Amikacin Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131224		ANDA	ANDA204040	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMIKACIN SULFATE	250	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
23155-294_12b02120-1734-4014-b712-1dc14dbe4686	23155-294	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20120326		ANDA	ANDA204147	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-313_997907e5-6f68-4cf2-beee-c0e84213d55d	23155-313	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211006		ANDA	ANDA202693	Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	ACETAZOLAMIDE SODIUM	500	mg/5mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
23155-345_7d4da3aa-506c-4903-a495-e8e0d95585ac	23155-345	HUMAN PRESCRIPTION DRUG	propofol		propofol	INJECTION, EMULSION	INTRAVENOUS	20211012		ANDA	ANDA206408	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
23155-362_fde42fdf-13e9-4328-93da-bb44f1860861	23155-362	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20170612		ANDA	ANDA209171	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
23155-473_032980d6-508a-4311-b476-589c1f3403a3	23155-473	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140902		ANDA	ANDA203428	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
23155-486_751ba5e8-14b3-4fdb-8e8e-ca59867fd257	23155-486	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20180720		ANDA	ANDA071881	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
23155-489_3ed8c1cf-5b26-49fc-adb2-264572e68cbe	23155-489	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20170526		ANDA	ANDA207880	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
23155-490_3ed8c1cf-5b26-49fc-adb2-264572e68cbe	23155-490	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20170526		ANDA	ANDA207880	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
23155-497_88c2ca6f-c17c-46d6-a15e-259957889c22	23155-497	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE EDISYLATE		PROCHLORPERAZINE EDISYLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150114		ANDA	ANDA204147	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-500_aeef86c5-2527-49ec-8a53-811e84d6e78f	23155-500	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
23155-501_aeef86c5-2527-49ec-8a53-811e84d6e78f	23155-501	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
23155-502_aeef86c5-2527-49ec-8a53-811e84d6e78f	23155-502	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
23155-512_e6eeed80-ac78-485d-84f5-b9b5a61e4563	23155-512	HUMAN PRESCRIPTION DRUG	nimodipine		nimodipine	CAPSULE, LIQUID FILLED	ORAL	20171107		ANDA	ANDA077811	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NIMODIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-517_e9bb7268-bb58-4aa5-aacf-9f1202436e77	23155-517	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20221125		ANDA	ANDA208230	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
23155-518_e9bb7268-bb58-4aa5-aacf-9f1202436e77	23155-518	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20221125		ANDA	ANDA208230	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
23155-519_649023db-b51a-4696-ae92-28c926efc2d6	23155-519	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA075522	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
23155-523_4a8ee5b4-7c34-4148-8172-56b4f07798c8	23155-523	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150626		ANDA	ANDA204147	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-524_d209501e-305d-4d22-9673-e8bdd54728dc	23155-524	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20140813		ANDA	ANDA203521	Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	TRANEXAMIC ACID	1	g/10mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
23155-530_bfcf5966-5504-49de-976a-58d2df90d6e4	23155-530	HUMAN PRESCRIPTION DRUG	Trospium Chloride		Trospium Chloride	TABLET, FILM COATED	ORAL	20160830		ANDA	ANDA204945	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
23155-531_409481da-2f0f-42fb-a0c8-7de295ad36c6	23155-531	HUMAN PRESCRIPTION DRUG	calcium acetate		calcium acetate	CAPSULE	ORAL	20150707		ANDA	ANDA202315	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
23155-532_b7244494-bae5-4434-9b8f-d5ed6d33619a	23155-532	HUMAN PRESCRIPTION DRUG	ETHOSUXIMIDE		ETHOSUXIMIDE	CAPSULE	ORAL	20150909		ANDA	ANDA200892	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
23155-538_a125bca3-2c05-4db0-a271-a6fd7f97a290	23155-538	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	CAPSULE	ORAL	20201031		ANDA	ANDA205360	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXERCALCIFEROL	.5	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
23155-539_a125bca3-2c05-4db0-a271-a6fd7f97a290	23155-539	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	CAPSULE	ORAL	20201031		ANDA	ANDA205360	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXERCALCIFEROL	1	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
23155-540_a125bca3-2c05-4db0-a271-a6fd7f97a290	23155-540	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	CAPSULE	ORAL	20201031		ANDA	ANDA205360	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXERCALCIFEROL	2.5	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
23155-547_18f0b335-a004-46a7-aa36-987a4ead789b	23155-547	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20120615		ANDA	ANDA079224	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
23155-548_452aa010-760f-46ff-99df-dad8b0946a55	23155-548	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20151109		ANDA	ANDA079224	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
23155-549_18f0b335-a004-46a7-aa36-987a4ead789b	23155-549	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20120615		ANDA	ANDA090648	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
23155-550_452aa010-760f-46ff-99df-dad8b0946a55	23155-550	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20151109		ANDA	ANDA090648	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
23155-578_dcde872d-581d-4304-b3ef-63c569d5c03b	23155-578	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-579_dcde872d-581d-4304-b3ef-63c569d5c03b	23155-579	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-580_dcde872d-581d-4304-b3ef-63c569d5c03b	23155-580	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-581_dcde872d-581d-4304-b3ef-63c569d5c03b	23155-581	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-582_dcde872d-581d-4304-b3ef-63c569d5c03b	23155-582	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-583_dcde872d-581d-4304-b3ef-63c569d5c03b	23155-583	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-600_a9663429-58ab-47fe-a0f6-6f79bc524581	23155-600	HUMAN PRESCRIPTION DRUG	Midazolam hydrochloride		Midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20161108		ANDA	ANDA090696	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
23155-601_e20feff9-3aca-4bc1-a5c3-44fff8a9459c	23155-601	HUMAN PRESCRIPTION DRUG	Midazolam hydrochloride		Midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20161107		ANDA	ANDA090850	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
23155-603_6b2e0bbb-397e-49b2-aaea-3ec3896b8beb	23155-603	HUMAN PRESCRIPTION DRUG	clindamycin palmitate hydrochloride		clindamycin palmitate hydrochloride	GRANULE, FOR SOLUTION	ORAL	20180511		ANDA	ANDA207047	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
23155-604_097943ec-6444-4939-b4d8-20172f2b50bb	23155-604	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20210218		ANDA	ANDA207196	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
23155-605_097943ec-6444-4939-b4d8-20172f2b50bb	23155-605	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20210218		ANDA	ANDA207196	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
23155-606_d512ee19-1141-4887-b0ab-123d408b5515	23155-606	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20170227		ANDA	ANDA207201	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
23155-607_d512ee19-1141-4887-b0ab-123d408b5515	23155-607	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20170227		ANDA	ANDA207201	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
23155-611_599f2c2d-dcd8-4e17-a2a8-2266ac4a8a56	23155-611	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE	DELAYED RELEASE	doxycycline hyclate	TABLET, DELAYED RELEASE	ORAL	20180316		ANDA	ANDA200856	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	200	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
23155-620_8896d9c7-acf3-4f1f-9632-e1db41a9d5d7	23155-620	HUMAN PRESCRIPTION DRUG	phenylephrine hydrochloride		phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20230228		ANDA	ANDA209968	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
23155-621_43972e52-b7af-4a00-b77c-1f37ad9cd811	23155-621	HUMAN PRESCRIPTION DRUG	CALCIUM ACETATE		CALCIUM ACETATE	TABLET	ORAL	20150122		ANDA	ANDA202885	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
23155-628_649023db-b51a-4696-ae92-28c926efc2d6	23155-628	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181115		ANDA	ANDA210822	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
23155-649_2f4a4d58-0812-4e71-997d-256b96861e4d	23155-649	HUMAN PRESCRIPTION DRUG	CARMUSTINE		CARMUSTINE	KIT		20191001		NDA AUTHORIZED GENERIC	NDA017422	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.						N	20241231
23155-651_134f98f1-cf53-4f44-9854-5dfe8ed00a66	23155-651	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20171129		ANDA	ANDA205245	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
23155-652_134f98f1-cf53-4f44-9854-5dfe8ed00a66	23155-652	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20171129		ANDA	ANDA205245	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
23155-660_f0a9dea8-4f6b-4403-a163-cd5d9e3c4bee	23155-660	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20211119		ANDA	ANDA212189	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20251231
23155-661_f0a9dea8-4f6b-4403-a163-cd5d9e3c4bee	23155-661	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20211119		ANDA	ANDA212189	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20251231
23155-662_4242476d-8618-4233-a647-5e705fcf29cb	23155-662	HUMAN PRESCRIPTION DRUG	CALCITRIOL		CALCITRIOL	CAPSULE	ORAL	20180529		ANDA	ANDA091356	Avet Pharmaceuticals Inc.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
23155-663_4242476d-8618-4233-a647-5e705fcf29cb	23155-663	HUMAN PRESCRIPTION DRUG	CALCITRIOL		CALCITRIOL	CAPSULE	ORAL	20180529		ANDA	ANDA091356	Avet Pharmaceuticals Inc.	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
23155-685_cd8892cd-846b-462f-ab72-d1dfd1a0e0b9	23155-685	HUMAN PRESCRIPTION DRUG	OCTREOTIDE ACETATE		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220525		ANDA	ANDA203765	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	OCTREOTIDE ACETATE	200	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
23155-686_cd8892cd-846b-462f-ab72-d1dfd1a0e0b9	23155-686	HUMAN PRESCRIPTION DRUG	OCTREOTIDE ACETATE		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220525		ANDA	ANDA203765	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	OCTREOTIDE ACETATE	1000	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
23155-687_cd8892cd-846b-462f-ab72-d1dfd1a0e0b9	23155-687	HUMAN PRESCRIPTION DRUG	OCTREOTIDE ACETATE		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220525		ANDA	ANDA204669	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	OCTREOTIDE ACETATE	50	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
23155-688_cd8892cd-846b-462f-ab72-d1dfd1a0e0b9	23155-688	HUMAN PRESCRIPTION DRUG	OCTREOTIDE ACETATE		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220525		ANDA	ANDA204669	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
23155-689_cd8892cd-846b-462f-ab72-d1dfd1a0e0b9	23155-689	HUMAN PRESCRIPTION DRUG	OCTREOTIDE ACETATE		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220525		ANDA	ANDA204669	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
23155-693_2ced6d4d-8056-4444-9405-1a2e234f2e51	23155-693	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20200922		ANDA	ANDA204467	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
23155-694_2ced6d4d-8056-4444-9405-1a2e234f2e51	23155-694	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20200922		ANDA	ANDA204467	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
23155-704_a762e947-8a04-405f-9441-03c762a13350	23155-704	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20200428		ANDA	ANDA075479	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-705_a762e947-8a04-405f-9441-03c762a13350	23155-705	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20200428		ANDA	ANDA075479	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-723_5efc7586-8609-4c16-849a-bbd60a8d5326	23155-723	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20200222		ANDA	ANDA074787	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
23155-724_5efc7586-8609-4c16-849a-bbd60a8d5326	23155-724	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20200222		ANDA	ANDA074787	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
23155-725_5efc7586-8609-4c16-849a-bbd60a8d5326	23155-725	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20200222		ANDA	ANDA074787	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
23155-735_daad3537-a1d2-451d-ab24-3d8649ff9487	23155-735	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-736_daad3537-a1d2-451d-ab24-3d8649ff9487	23155-736	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-737_daad3537-a1d2-451d-ab24-3d8649ff9487	23155-737	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-738_daad3537-a1d2-451d-ab24-3d8649ff9487	23155-738	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
23155-741_ef9832f8-1079-41dc-be43-a6092c89c640	23155-741	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20220627		ANDA	ANDA089763	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
23155-742_ef9832f8-1079-41dc-be43-a6092c89c640	23155-742	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20220512		ANDA	ANDA081236	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	THEOPHYLLINE ANHYDROUS	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
23155-746_a552aa32-430a-482f-b24a-048f98eaa102	23155-746	HUMAN PRESCRIPTION DRUG	Rasagiline mesylate		Rasagiline mesylate	TABLET	ORAL	20230531		ANDA	ANDA206153	Avet Pharmaceuticals Inc.	RASAGILINE MESYLATE	.5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
23155-747_a552aa32-430a-482f-b24a-048f98eaa102	23155-747	HUMAN PRESCRIPTION DRUG	Rasagiline mesylate		Rasagiline mesylate	TABLET	ORAL	20230531		ANDA	ANDA206153	Avet Pharmaceuticals Inc.	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
23155-748_d0251a47-daa6-431d-9f61-5eafa55d2f85	23155-748	HUMAN PRESCRIPTION DRUG	pentamidine isethionate		pentamidine isethionate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210108		ANDA	ANDA213806	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PENTAMIDINE ISETHIONATE	300	mg/300mg	Antiprotozoal [EPC]		N	20241231
23155-749_a25a7d73-e5a7-44a1-8cd6-2d4d8e76de3f	23155-749	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-750_a25a7d73-e5a7-44a1-8cd6-2d4d8e76de3f	23155-750	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-751_a25a7d73-e5a7-44a1-8cd6-2d4d8e76de3f	23155-751	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-752_a25a7d73-e5a7-44a1-8cd6-2d4d8e76de3f	23155-752	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-757_84e1b274-b25f-4cee-b50d-fac0503f4330	23155-757	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20230223		ANDA	ANDA076465	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
23155-758_84e1b274-b25f-4cee-b50d-fac0503f4330	23155-758	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20230223		ANDA	ANDA076465	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
23155-759_84e1b274-b25f-4cee-b50d-fac0503f4330	23155-759	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20230223		ANDA	ANDA076465	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
23155-763_9050ff15-5fa6-4c8b-b312-aedf4fd6175b	23155-763	HUMAN PRESCRIPTION DRUG	Lithium carbonate		Lithium carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201020		ANDA	ANDA205532	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
23155-764_5bb598d0-39a7-4bb1-aa1e-e53e7b9a4aec	23155-764	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20230502		ANDA	ANDA085182	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
23155-766_668956fd-53e9-478d-bdff-e93d305c671d	23155-766	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20200401		ANDA	ANDA062752	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TETRACYCLINE HYDROCHLORIDE	250	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
23155-767_668956fd-53e9-478d-bdff-e93d305c671d	23155-767	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20200401		ANDA	ANDA062752	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
23155-771_049dbba3-cc3f-41a9-8a5f-db7444a506b2	23155-771	HUMAN PRESCRIPTION DRUG	foscarnet sodium		foscarnet sodium	INJECTION, SOLUTION	INTRAVENOUS	20230605		ANDA	ANDA213807	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FOSCARNET SODIUM	24	mg/mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
23155-772_a762e947-8a04-405f-9441-03c762a13350	23155-772	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-773_a762e947-8a04-405f-9441-03c762a13350	23155-773	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
23155-785_3ebb06f5-d114-4678-98a7-2b5b22e92bc2	23155-785	HUMAN PRESCRIPTION DRUG	Amikacin Sulfate		Amikacin Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201215		ANDA	ANDA204040	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMIKACIN SULFATE	500	mg/2mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
23155-786_3ebb06f5-d114-4678-98a7-2b5b22e92bc2	23155-786	HUMAN PRESCRIPTION DRUG	Amikacin Sulfate		Amikacin Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201215		ANDA	ANDA204040	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMIKACIN SULFATE	1	g/4mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
23155-787_014ebddc-7e6b-4291-8899-65df122cc0bf	23155-787	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA040904	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
23155-790_7e4f4719-405d-4e6d-9267-9e75f795ce51	23155-790	HUMAN PRESCRIPTION DRUG	CARMUSTINE		CARMUSTINE	KIT		20210301		NDA AUTHORIZED GENERIC	NDA017422	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.						N	20241231
23155-794_89ed6385-cf6a-458e-81ea-c7f3fead41c5	23155-794	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211230		ANDA	ANDA214908	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-795_89ed6385-cf6a-458e-81ea-c7f3fead41c5	23155-795	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211230		ANDA	ANDA214908	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-796_89ed6385-cf6a-458e-81ea-c7f3fead41c5	23155-796	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211230		ANDA	ANDA214908	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-797_89ed6385-cf6a-458e-81ea-c7f3fead41c5	23155-797	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211230		ANDA	ANDA214908	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-798_89ed6385-cf6a-458e-81ea-c7f3fead41c5	23155-798	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepn Hydrochloride	CAPSULE	ORAL	20211230		ANDA	ANDA214908	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
23155-799_02585a44-bdb8-4d3f-bf1d-0d300dfb205f	23155-799	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET	ORAL	20220710		ANDA	ANDA210163	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-800_02585a44-bdb8-4d3f-bf1d-0d300dfb205f	23155-800	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET	ORAL	20220710		ANDA	ANDA210163	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-801_02585a44-bdb8-4d3f-bf1d-0d300dfb205f	23155-801	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET	ORAL	20220710		ANDA	ANDA210163	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-802_02585a44-bdb8-4d3f-bf1d-0d300dfb205f	23155-802	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET	ORAL	20220710		ANDA	ANDA210163	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-803_20d5cc4d-5a36-4a6e-9895-437936cd0e98	23155-803	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20230625		ANDA	ANDA213590	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-804_20d5cc4d-5a36-4a6e-9895-437936cd0e98	23155-804	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20230625		ANDA	ANDA213590	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-805_20d5cc4d-5a36-4a6e-9895-437936cd0e98	23155-805	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20230625		ANDA	ANDA213590	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-806_20d5cc4d-5a36-4a6e-9895-437936cd0e98	23155-806	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20230625		ANDA	ANDA213590	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-807_20d5cc4d-5a36-4a6e-9895-437936cd0e98	23155-807	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20230625		ANDA	ANDA213590	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
23155-809_9c09c2d2-ef29-4654-be7d-ed3b2b508f43	23155-809	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20211223		ANDA	ANDA090455	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
23155-810_8be54c67-6800-4c7f-9cbb-0a38b5511250	23155-810	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20220131		ANDA	ANDA208165	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
23155-823_3bbcf6ce-236e-4298-81b3-f02cde1f98af	23155-823	HUMAN PRESCRIPTION DRUG	Cabergoline		Cabergoline	TABLET	ORAL	20220615		ANDA	ANDA076310	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CABERGOLINE	.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
23155-830_2dab9b9d-d85e-46f3-9518-c9f6e4fbf70e	23155-830	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	CAPSULE	ORAL	20220630		ANDA	ANDA090055	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
23155-831_184ef03f-e348-4286-b501-70750b74ec2a	23155-831	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221115		ANDA	ANDA202693	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ACETAZOLAMIDE SODIUM	500	mg/5mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
23155-832_b91df4b7-af1d-4b15-9d8d-41d973bbb284	23155-832	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20230802		ANDA	ANDA040858	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-833_b91df4b7-af1d-4b15-9d8d-41d973bbb284	23155-833	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20230802		ANDA	ANDA040858	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-834_b91df4b7-af1d-4b15-9d8d-41d973bbb284	23155-834	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20230802		ANDA	ANDA040858	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-835_b91df4b7-af1d-4b15-9d8d-41d973bbb284	23155-835	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20230802		ANDA	ANDA040858	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
23155-836_2dab9b9d-d85e-46f3-9518-c9f6e4fbf70e	23155-836	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	TABLET, FILM COATED	ORAL	20221015		ANDA	ANDA090456	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
23155-837_f7f1630a-c75c-442c-982c-03f6b0132e0b	23155-837	HUMAN PRESCRIPTION DRUG	CYCLOSPORINE		CYCLOSPORINE	CAPSULE, LIQUID FILLED	ORAL	20221130		ANDA	ANDA216046	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
23155-838_f7f1630a-c75c-442c-982c-03f6b0132e0b	23155-838	HUMAN PRESCRIPTION DRUG	CYCLOSPORINE		CYCLOSPORINE	CAPSULE, LIQUID FILLED	ORAL	20221130		ANDA	ANDA216046	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CYCLOSPORINE	50	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
23155-839_f7f1630a-c75c-442c-982c-03f6b0132e0b	23155-839	HUMAN PRESCRIPTION DRUG	CYCLOSPORINE		CYCLOSPORINE	CAPSULE, LIQUID FILLED	ORAL	20221130		ANDA	ANDA216046	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
23155-840_38c4bcfa-d24c-4b8a-a2bc-d39a28896c76	23155-840	HUMAN PRESCRIPTION DRUG	diclofenac potassium		diclofenac potassium	CAPSULE, LIQUID FILLED	ORAL	20221121		ANDA	ANDA210078	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
23155-841_f999653d-b79a-b048-e053-6394a90af869	23155-841	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
23155-842_f999653d-b79a-b048-e053-6394a90af869	23155-842	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
23155-843_f999653d-b79a-b048-e053-6394a90af869	23155-843	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
23155-844_de9b62a1-203f-44b5-bf94-e439fb8a42e2	23155-844	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20230315		ANDA	ANDA090011	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMLODIPINE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-845_de9b62a1-203f-44b5-bf94-e439fb8a42e2	23155-845	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20230315		ANDA	ANDA090011	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMLODIPINE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-846_de9b62a1-203f-44b5-bf94-e439fb8a42e2	23155-846	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20230315		ANDA	ANDA090011	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMLODIPINE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-847_de9b62a1-203f-44b5-bf94-e439fb8a42e2	23155-847	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20230315		ANDA	ANDA090011	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	AMLODIPINE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
23155-848_1ac5387a-8da0-4d04-b49a-d26eed19b975	23155-848	HUMAN PRESCRIPTION DRUG	MYCOPHENOLATE MOFETIL		MYCOPHENOLATE MOFETIL	POWDER, FOR SUSPENSION	ORAL	20230905		ANDA	ANDA212634	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
23155-850_fc88aa14-2ac3-c407-e053-6294a90a01e5	23155-850	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		Chloroquine Phosphate	TABLET, COATED	ORAL	20230320		ANDA	ANDA214756	Avet Pharmaceuticals Inc.	CHLOROQUINE PHOSPHATE	500	mg/1	Antimalarial [EPC]		N	20241231
23155-855_e8baf423-8e08-40f4-bb54-06ddab0b086f	23155-855	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20230326		ANDA	ANDA209173	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
23155-856_514f6c0a-b13a-4b0a-ab98-15f7d9b25171	23155-856	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20230326		ANDA	ANDA211667	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	POTASSIUM CHLORIDE	1.5	g/1.58g			N	20241231
23155-857_f86d2158-b079-3f74-e053-6394a90aa4b6	23155-857	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole Tablets	TABLET	ORAL	20190228		ANDA	ANDA206037	Avet Pharmaceuticals Inc	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
23155-858_ef280d64-06f3-4918-98ba-972317bc2b70	23155-858	HUMAN PRESCRIPTION DRUG	vancomycin hydrochloride		vancomycin hydrochloride	CAPSULE	ORAL	20230625		ANDA	ANDA065490	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
23155-859_ef280d64-06f3-4918-98ba-972317bc2b70	23155-859	HUMAN PRESCRIPTION DRUG	vancomycin hydrochloride		vancomycin hydrochloride	CAPSULE	ORAL	20230625		ANDA	ANDA065490	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	VANCOMYCIN HYDROCHLORIDE	250	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
23155-860_501b9f97-074d-4a0b-87f5-54fd1ae5cb46	23155-860	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20230625		ANDA	ANDA212632	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
23155-861_501b9f97-074d-4a0b-87f5-54fd1ae5cb46	23155-861	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20230625		ANDA	ANDA212632	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
23155-863_3c2fad0f-6e71-4413-ba13-bc2d56b4ba22	23155-863	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Griseofulvin	TABLET	ORAL	20230630		ANDA	ANDA061996	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	GRISEOFULVIN	125	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
23155-864_3c2fad0f-6e71-4413-ba13-bc2d56b4ba22	23155-864	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Griseofulvin	TABLET	ORAL	20230630		ANDA	ANDA061996	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	GRISEOFULVIN	250	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
23155-865_cfc9be03-9600-4068-bd25-241a04c0c9f0	23155-865	HUMAN PRESCRIPTION DRUG	GRISEOFULVIN MICROSIZE		griseofulvin	TABLET	ORAL	20230630		ANDA	ANDA060569	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	GRISEOFULVIN	500	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
23155-866_cee5cf55-c343-4ba5-ab20-b020f8a21237	23155-866	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20230602		ANDA	ANDA211314	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
23155-867_cee5cf55-c343-4ba5-ab20-b020f8a21237	23155-867	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20230625		ANDA	ANDA211314	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
23155-868_cee5cf55-c343-4ba5-ab20-b020f8a21237	23155-868	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20230625		ANDA	ANDA211314	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
23155-869_d99cb729-d9df-4b1f-b6f8-1aba7008b2de	23155-869	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION	INTRAVENOUS	20211007		ANDA	ANDA215059	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
23155-870_d99cb729-d9df-4b1f-b6f8-1aba7008b2de	23155-870	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION	INTRAVENOUS	20220422		ANDA	ANDA215059	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
23155-871_98d688f8-ec71-4b98-86b8-d405bdffc4c3	23155-871	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20230724		ANDA	ANDA076894	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TORSEMIDE	5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
23155-872_98d688f8-ec71-4b98-86b8-d405bdffc4c3	23155-872	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20230724		ANDA	ANDA076894	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
23155-873_98d688f8-ec71-4b98-86b8-d405bdffc4c3	23155-873	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20230724		ANDA	ANDA076894	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
23155-874_98d688f8-ec71-4b98-86b8-d405bdffc4c3	23155-874	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20230724		ANDA	ANDA076894	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
23155-875_fe493fe0-7848-ce6e-e053-6394a90a9d25	23155-875	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole Tablets	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA205869	Avet Pharmaceuticals Inc.	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
23155-876_cb748971-2531-4478-8dff-e01cd87dec09	23155-876	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20230906		ANDA	ANDA076102	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901)	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
23155-877_cb748971-2531-4478-8dff-e01cd87dec09	23155-877	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20230906		ANDA	ANDA076102	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901)	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
23155-878_cb748971-2531-4478-8dff-e01cd87dec09	23155-878	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20230906		ANDA	ANDA076102	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901)	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
23155-879_cb748971-2531-4478-8dff-e01cd87dec09	23155-879	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20230906		ANDA	ANDA076102	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901)	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
23155-880_cb748971-2531-4478-8dff-e01cd87dec09	23155-880	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20230906		ANDA	ANDA076102	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901)	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
23155-881_cb748971-2531-4478-8dff-e01cd87dec09	23155-881	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20230906		ANDA	ANDA076102	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901)	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
23155-882_52992f53-da88-4d31-a480-11f290908f0c	23155-882	HUMAN PRESCRIPTION DRUG	PACLITAXEL	PACLITAXEL	paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20230831		ANDA	ANDA207326	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
23155-883_52992f53-da88-4d31-a480-11f290908f0c	23155-883	HUMAN PRESCRIPTION DRUG	PACLITAXEL	PACLITAXEL	paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20230831		ANDA	ANDA207326	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
23155-884_52992f53-da88-4d31-a480-11f290908f0c	23155-884	HUMAN PRESCRIPTION DRUG	PACLITAXEL	PACLITAXEL	paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20230831		ANDA	ANDA207326	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
23155-886_64620e9e-ef95-43e7-b03f-28d4c607b7d8	23155-886	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20231006		ANDA	ANDA207905	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
23319-0007_fc0d0c0e-a419-bdcd-e053-6294a90ab06b	23319-0007	HUMAN OTC DRUG	YANBAL BASE LIQUIDA MATIFICANTE MATTIFYING FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15 TONO 1		octinoxate	LIQUID	TOPICAL	20181115	20240930	OTC MONOGRAPH NOT FINAL	part352	Yanbal USA, Inc.	OCTINOXATE	40	mg/mL			N	
23319-0008_fc0d0c0e-a419-bdcd-e053-6294a90ab06b	23319-0008	HUMAN OTC DRUG	YANBAL BASE LIQUIDA MATIFICANTE MATTIFYING FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15 TONO 2		octinoxate	LIQUID	TOPICAL	20181115	20241031	OTC MONOGRAPH NOT FINAL	part352	Yanbal USA, Inc.	OCTINOXATE	40	mg/mL			N	
23319-0009_fc0d0c0e-a419-bdcd-e053-6294a90ab06b	23319-0009	HUMAN OTC DRUG	YANBAL BASE LIQUIDA MATIFICANTE MATTIFYING FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15 TONO 3		octinoxate	LIQUID	TOPICAL	20181115	20240930	OTC MONOGRAPH NOT FINAL	part352	Yanbal USA, Inc.	OCTINOXATE	40	mg/mL			N	
23390-1020_0bdd74f8-1619-0524-e063-6394a90a92e5	23390-1020	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20060505		UNAPPROVED MEDICAL GAS		Denman Services, Inc.	OXYGEN	99	L/100L			N	20241231
23590-300_0d19fbbd-6fd3-2e63-e063-6294a90a1e4a	23590-300	HUMAN OTC DRUG	Summit E2		Benzalkonium Chloride	SOAP	TOPICAL	20210301	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	R. L. Williams Company	BENZALKONIUM CHLORIDE	1	mg/mL			N	
23594-101_f18bc6c7-96c7-4816-e053-2995a90a3415	23594-101	HUMAN PRESCRIPTION DRUG	Karbinal	ER	Carbinoxamine Maleate	SUSPENSION, EXTENDED RELEASE	ORAL	20140103		NDA	NDA022556	Aytu Therapeutics, LLC	CARBINOXAMINE MALEATE	4	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
23635-581_4320ac2a-ae58-4d6e-8e70-d3f2885515fc	23635-581	HUMAN PRESCRIPTION DRUG	Roxicodone		oxycodone hydrochloride	TABLET	ORAL	20000831		NDA	NDA021011	SpecGx LLC	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
23635-582_4320ac2a-ae58-4d6e-8e70-d3f2885515fc	23635-582	HUMAN PRESCRIPTION DRUG	Roxicodone		oxycodone hydrochloride	TABLET	ORAL	20000831		NDA	NDA021011	SpecGx LLC	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
23647-001_0803231b-7fcd-6f86-e063-6394a90a9808	23647-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20111030		NDA	NDA205712	SYOXSA, Inc.	OXYGEN	995	mL/L			N	20241231
23647-002_08031467-57ef-f232-e063-6394a90a4092	23647-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20111030		NDA	NDA205829	SYOXSA, Inc.	NITROGEN	990	mL/L			N	20241231
23647-003_080332db-7a15-0103-e063-6294a90a9c3a	23647-003	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20181130		NDA	NDA205889	SYOXSA, Inc.	OXYGEN	210	mL/L			N	20241231
23650-001_0761b91e-565d-f275-e063-6294a90abcf0	23650-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20060101		NDA	NDA205767	New Bedford Welding Supply, Inc.	OXYGEN	990	mL/L			N	20241231
23667-050_0b5888f1-148b-8a06-e063-6394a90aa496	23667-050	HUMAN OTC DRUG	Banana Boat kids mineral Vanishing Green Foam SPF 50 Amazing Apple		TITANIUM DIOXIDE, ZINC OXIDE	AEROSOL, FOAM	TOPICAL	20210401		OTC MONOGRAPH DRUG	M020	Formulated Solutions, LLC	TITANIUM DIOXIDE; ZINC OXIDE	49; 71	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
23667-060_0b588ccf-e4c6-9784-e063-6394a90ababd	23667-060	HUMAN OTC DRUG	Banana Boat kids mineral Vanishing Blue Foam SPF 50 Berry Blast		TITANIUM DIOXIDE, ZINC OXIDE	AEROSOL, FOAM	TOPICAL	20210401		OTC MONOGRAPH DRUG	M020	Formulated Solutions, LLC	TITANIUM DIOXIDE; ZINC OXIDE	49; 71	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
23667-102_0b588269-4cbf-8202-e063-6394a90a3e61	23667-102	HUMAN OTC DRUG	Doctors Kline and Green Board Certified Dermatologist Hand Sanitizer Alcohol Antiseptic		ALCOHOL	LIQUID	TOPICAL	20210209		OTC MONOGRAPH DRUG	505G(a)(3)	Formulated Solutions, LLC	ALCOHOL	77	mL/100mL			N	20241231
23667-103_0b588590-f47f-851e-e063-6394a90ac9a3	23667-103	HUMAN OTC DRUG	Doctors Kline and Green Board Certified Dermatologist Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210209		OTC MONOGRAPH DRUG	505G(a)(3)	Formulated Solutions, LLC	ALCOHOL	77	mL/100mL			N	20241231
23667-104_0b589014-59b1-916d-e063-6394a90ae72d	23667-104	HUMAN OTC DRUG	Doctors Kline and Green Board Certified Dermatologist Hand Sanitizer Antiseptic		ALCOHOL	AEROSOL, FOAM	TOPICAL	20210209		OTC MONOGRAPH DRUG	505G(a)(3)	Formulated Solutions, LLC	ALCOHOL	62	mL/100mL			N	20241231
23667-800_0b8248bd-67e8-fa6f-e063-6394a90a683e	23667-800	HUMAN OTC DRUG	Coppertone Clearly Sheer Whipped Sunscreen Broad Spectrum SPF 50	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20170209		OTC MONOGRAPH DRUG	M020	Formulated Solutions, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 45; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
23667-801_0b8242d9-98af-fb72-e063-6394a90a39f0	23667-801	HUMAN OTC DRUG	Coppertone Clearly Sheer Whipped Sunscreen Broad Spectrum SPF 30	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170209		OTC MONOGRAPH DRUG	M020	Formulated Solutions, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
23667-802_0b82732b-5864-0e3d-e063-6394a90aea83	23667-802	HUMAN OTC DRUG	Copperstone Water Babies Pure and Simple Whipped Sunscreen Broad Spectrum SPF 50	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20170209		OTC MONOGRAPH DRUG	M020	Formulated Solutions, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 45; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
23667-803_0b824cea-2a4f-6e18-e063-6294a90a8093	23667-803	HUMAN OTC DRUG	GoodSense Athletes Foot Antifungal		TOLNAFTATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-804_0b82700a-5ae4-0af6-e063-6394a90a2404	23667-804	HUMAN OTC DRUG	Good Neighbor Pharmacy Athletes foot Relief Antifungal		MICONAZOLE NITRATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
23667-805_0b827b40-b501-a226-e063-6294a90ad17b	23667-805	HUMAN OTC DRUG	CVS Health Antifungal Anthletes Foot		TOLNAFTATE	SPRAY	TOPICAL	20170209		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-806_0b824859-467a-ffcd-e063-6394a90a1e0a	23667-806	HUMAN OTC DRUG	GoodSense Powder Jock Itch Antifungal		TOLNAFTATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-807_0b826cf7-a501-806c-e063-6294a90a2f5f	23667-807	HUMAN OTC DRUG	Walgreens Maximum Strength Jock Itch Antifungal		TOLNAFTATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-808_0b587906-d569-e5b7-e063-6294a90a2fc0	23667-808	HUMAN OTC DRUG	Meijer Jock Itch Relief Antifungal		MICONAZOLE NITRATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
23667-809_0b82602d-37c1-0320-e063-6394a90a724c	23667-809	HUMAN OTC DRUG	Meijer Maximum Strength Jock Itch Relief Antifungal		TOLNAFTATE	SPRAY	TOPICAL	20170121		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-810_0b825a85-881a-0270-e063-6394a90a898a	23667-810	HUMAN OTC DRUG	Meijer Maximum Strength Anthletes foot Antifungal		TOLNAFTATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-811_0b82539a-b8e8-7e16-e063-6294a90a22ac	23667-811	HUMAN OTC DRUG	Meijer Maximum Strength Athletes Foot Antifungal		TOLNAFTATE	LIQUID	TOPICAL	20170121		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-812_0b587f61-d488-f827-e063-6294a90aff19	23667-812	HUMAN OTC DRUG	Signature Care Athletes Foot		MICONAZOLE NITRATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
23667-813_0b8265fb-804f-0711-e063-6394a90a4576	23667-813	HUMAN OTC DRUG	Signature Care Athletes Foot Antifungal		TOLNAFTATE	LIQUID	TOPICAL	20170121		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-814_0b82635d-60b7-820c-e063-6294a90ac036	23667-814	HUMAN OTC DRUG	Signature Athletes Foot Antifungal		TOLNAFTATE	POWDER	TOPICAL	20170121		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-815_0b826858-c2ce-ffe7-e063-6394a90aa4cc	23667-815	HUMAN OTC DRUG	SmartSense Maximum Strength Athletes Foot Relief antifungal		TOLNAFTATE	SPRAY	TOPICAL	20170123		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-816_0b826ae5-eea8-8b35-e063-6294a90adc3f	23667-816	HUMAN OTC DRUG	Up and Up Soothing Antifungal		TOLNAFTATE	LIQUID	TOPICAL	20170123		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-817_0b827897-fb61-0f73-e063-6394a90ac59f	23667-817	HUMAN OTC DRUG	Walgreens Medicated Antifungal Athletes Foot		MICONAZOLE NITRATE	SPRAY	TOPICAL	20170123		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
23667-818_0b82765d-064b-9e90-e063-6294a90a7246	23667-818	HUMAN OTC DRUG	Walgreens Medicated Antifungal Athletes Foot		TOLNAFTATE	SPRAY	TOPICAL	20170123		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23667-819_0c02e9b6-ff74-c0c7-e063-6294a90adbe3	23667-819	HUMAN OTC DRUG	Good Neighbor Pharmacy Jock Itch Relief Antifungal		MICONAZOLE NITRATE	SPRAY	TOPICAL	20170209		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
23667-820_0b824501-d804-fb69-e063-6394a90a2b7c	23667-820	HUMAN OTC DRUG	Good Neighbor Pharmacy Maximum Strength Athletes Foot Relief Antifungal		TOLNAFTATE	SPRAY	TOPICAL	20170120		OTC MONOGRAPH DRUG	M005	Formulated Solutions, LLC	TOLNAFTATE	10	mg/g			N	20241231
23710-100_d488dcc9-a064-2814-e053-2995a90ac26a	23710-100	HUMAN PRESCRIPTION DRUG	ECOZA		econazole nitrate	AEROSOL, FOAM	TOPICAL	20201002		NDA	NDA205175	Exeltis USA Dermatology, LLC	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
23731-6030_49d76384-a8fa-44ed-99b4-1f75ee4a435d	23731-6030	HUMAN PRESCRIPTION DRUG	triCitrasol		Trisodium Citrate dihydrate	SOLUTION	EXTRACORPOREAL	20030710		NDA	BN010409	Citra Labs LLC	TRISODIUM CITRATE DIHYDRATE	14	g/30mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
23731-6051_9a133b17-0377-431f-b839-3e090fdabd78	23731-6051	HUMAN PRESCRIPTION DRUG	Anticoagulant Citrate Dextrose A		Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate	SOLUTION	EXTRACORPOREAL	20030826		NDA	BN020037	Citra Labs LLC	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.073; .245; .22	g/10mL; g/10mL; g/10mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2	23731-7000	HUMAN PRESCRIPTION DRUG	Rejuvesol		Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate	SOLUTION	EXTRACORPOREAL	19970226		NDA	BN950522	Citra Labs, LLC	ADENINE; INOSINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PYRUVATE	.034; 1.34; .73; .311; .55	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
24027-0699_06d6de24-fbe1-ec5d-e063-6394a90a4fff	24027-0699	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20001023		UNAPPROVED MEDICAL GAS		Broadway Medical Service & Supply, Inc.	OXYGEN	99	L/100L			N	20241231
24075-0411_73a7640c-b052-4124-be20-04ed75c6a665	24075-0411	HUMAN PRESCRIPTION DRUG	Conjupri		levamlodipine	TABLET	ORAL	20211008		NDA	NDA212895	CSPC Ouyi Pharmaceutical Co. Ltd	LEVAMLODIPINE MALEATE	2.5	mg/2.5mg			N	20241231
24075-0413_73a7640c-b052-4124-be20-04ed75c6a665	24075-0413	HUMAN PRESCRIPTION DRUG	Conjupri		levamlodipine	TABLET	ORAL	20211008		NDA	NDA212895	CSPC Ouyi Pharmaceutical Co. Ltd	LEVAMLODIPINE MALEATE	5	mg/5mg			N	20241231
24201-002_6405fdb8-edd0-4057-a50f-5562cf3c216f	24201-002	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20221115		NDA	NDA214253	Hikma Pharmaceuticals USA Inc.	LEVOTHYROXINE SODIUM	100	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
24201-010_f1ed09ca-2200-2603-e053-2995a90af46d	24201-010	HUMAN PRESCRIPTION DRUG	Pentobarbital Sodium		Pentobarbital Sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180226		ANDA	ANDA203619	Hikma Pharmaceuticals USA Inc. (dba Leucadia Pharmaceuticals)	PENTOBARBITAL SODIUM	50	mg/mL		CII	N	20241231
24201-100_467f3493-4c82-4f93-8b18-0b52af9612a4	24201-100	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20201207		ANDA	ANDA202605	Hikma Pharmaceuticals USA Inc.	ACETAMINOPHEN	10	mg/mL			N	20241231
24201-101_f2385edd-45ba-4ce8-97a0-ac301d067536	24201-101	HUMAN PRESCRIPTION DRUG	Valrubicin Intravesical Solution		Valrubicin Intravesical Solution	SOLUTION, CONCENTRATE	INTRAVESICAL	20190423		ANDA	ANDA206430	Hikma Pharmaceuticals USA Inc.	VALRUBICIN	40	mg/mL			N	20241231
24201-110_98995ca7-dbd4-4004-a756-de58eaddac54	24201-110	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20230301		ANDA	ANDA202605	Hikma Pharmaceuticals USA Inc.	ACETAMINOPHEN	10	mg/mL			N	20241231
24201-150_4e917729-3eac-400c-bbaf-8b30a04a380c	24201-150	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate Injectable Suspension		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20230501		ANDA	ANDA214309	Hikma Pharmaceuticals USA inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
24201-201_f1ecb12e-730f-74b1-e053-2995a90ace9d	24201-201	HUMAN PRESCRIPTION DRUG	Sodium Tetradecyl Sulfate		Sodium Tetradecyl Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20191209		ANDA	ANDA209937	Hikma Pharmaceuticals USA Inc. (dba Leucadia Pharmaceuticals)	SODIUM TETRADECYL SULFATE	30	mg/mL			N	20241231
24201-207_09ce1cbd-7fed-79d2-e063-6294a90a1db3	24201-207	HUMAN PRESCRIPTION DRUG	Icatibant		icatibant	INJECTION, SOLUTION	SUBCUTANEOUS	20200309		ANDA	ANDA211021	Hikma Pharmaceuticals USA Inc.	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
24201-400_f1ec9f3b-0646-7ca0-e053-2995a90a4f33	24201-400	HUMAN PRESCRIPTION DRUG	Calcitonin Salmon		calcitonin salmon	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20210514		ANDA	ANDA212416	Hikma Pharmaceuticals USA Inc.(dba Leucadia Pharmaceuticals)	CALCITONIN SALMON	200	[USP'U]/mL	Calcitonin [CS], Calcitonin [EPC]		N	20241231
24201-463_01aa3f3f-2547-4fb2-aa4e-f7b2e49326f0	24201-463	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	SPRAY	NASAL	20200414		ANDA	ANDA211393	Hikma Pharmaceuticals USA Inc.	DIHYDROERGOTAMINE MESYLATE	4	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
24205-080_83e8d0f3-5d3a-45a8-b68a-238a72e9bffd	24205-080	HUMAN OTC DRUG	COMPANIONS Luxury Foam Hand So ap, Antimicrobial		Chloroxylenol	LIQUID	TOPICAL	20051115		OTC MONOGRAPH NOT FINAL	part333E	UniPro Foodservice, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
24208-001_a21e35cf-e18f-44d7-aa83-ab252094b261	24208-001	HUMAN OTC DRUG	PURPOSE		Octinoxate, Octisalate and Oxybenzone	LOTION	TOPICAL	20131007		OTC MONOGRAPH NOT FINAL	part352	Bausch & Lomb Incorporated	OCTINOXATE; OCTISALATE; OXYBENZONE	7.5; 5; 3	g/100g; g/100g; g/100g			N	20241231
24208-002_22bb835d-0433-4e75-bada-5cb60113d298	24208-002	HUMAN PRESCRIPTION DRUG	VITRASE		hyaluronidase, ovine	INJECTION, SOLUTION	SUBCUTANEOUS	20050201		BLA	BLA021640	Bausch & Lomb Incorporated	HYALURONIDASE, OVINE	200	[USP'U]/mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
24208-004_3829130f-c974-4bd8-a839-8f8efee0580d	24208-004	HUMAN PRESCRIPTION DRUG	Istalol		Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20040802		NDA	NDA021516	Bausch & Lomb Incorporated	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
24208-005_1bd4d58b-000c-42f1-9972-e09d303cd3a4	24208-005	HUMAN OTC DRUG	Advanced Eye Relief Eye Wash		water solution	SOLUTION/ DROPS	OPHTHALMIC	20170202		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorprated	WATER	99.05	mL/100mL			N	20241231
24208-006_3800fa3b-4cff-41af-9a07-f45562064ab6	24208-006	HUMAN OTC DRUG	Biotrue Hydration Boost		Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20210430		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	GLYCERIN	5	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
24208-022_65e6efe6-26f9-4d78-81f1-296cb4381353	24208-022	HUMAN PRESCRIPTION DRUG	Methazolamide		methazolamide	TABLET	ORAL	20201002		ANDA	ANDA207438	Bausch & Lomb Incorporated	METHAZOLAMIDE	25	mg/1			N	20241231
24208-023_65e6efe6-26f9-4d78-81f1-296cb4381353	24208-023	HUMAN PRESCRIPTION DRUG	Methazolamide		methazolamide	TABLET	ORAL	20201002		ANDA	ANDA207438	Bausch & Lomb Incorporated	METHAZOLAMIDE	50	mg/1			N	20241231
24208-040_6a81389a-79a4-4a3c-81d4-621c3b4add6f	24208-040	HUMAN PRESCRIPTION DRUG	Xipere		triamcinolone acetonide	INJECTION, SUSPENSION	OPHTHALMIC	20211217		NDA	NDA211950	Bausch & Lomb Incorporated	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-061_ea853bf8-40a6-42b1-9667-1e24152762fe	24208-061	HUMAN OTC DRUG	Alcohol Antiseptic		alcohol	GEL	TOPICAL	20200413		OTC MONOGRAPH NOT FINAL	part333A	Bausch & Lomb Incorporated	ALCOHOL	.8	mL/g			N	20241231
24208-092_b03a40af-5fbc-490f-97a1-505dbddaa04f	24208-092	HUMAN PRESCRIPTION DRUG	Tetracaine Hydrochloride		Tetracaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20220923		NDA	NDA210821	Bausch & Lomb Incorporated	TETRACAINE HYDROCHLORIDE	5	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
24208-276_09c065db-6187-4dfb-88ec-9b5ff11d39ae	24208-276	HUMAN OTC DRUG	Muro 128		sodium chloride	SOLUTION	OPHTHALMIC	20110101		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	SODIUM CHLORIDE	20	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
24208-277_c9211ab1-d0af-4298-bfc1-9840cc131903	24208-277	HUMAN OTC DRUG	Muro 128		sodium chloride	SOLUTION	OPHTHALMIC	20110101		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	SODIUM CHLORIDE	50	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
24208-290_e4711e46-d1d7-49b1-ac17-1062b22960a5	24208-290	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19931129		ANDA	ANDA064052	Bausch & Lomb Incorporated	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
24208-295_8ef3520d-ac67-4e2d-b0a6-f876e4d1d89f	24208-295	HUMAN PRESCRIPTION DRUG	Tobramycin and Dexamethasone		Tobramycin and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19991027		ANDA	ANDA064134	Bausch & Lomb Incorporated	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-299_ef44228f-e365-4d7f-b143-529257efffbe	24208-299	HUMAN PRESCRIPTION DRUG	LOTEMAX		loteprednol etabonate	SUSPENSION/ DROPS	OPHTHALMIC	19980309		NDA	NDA020583	Bausch & Lomb Incorporated	LOTEPREDNOL ETABONATE	5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-313_1024942d-cc5a-499e-abb6-72dd5a53328c	24208-313	HUMAN OTC DRUG	Soothe Night Time		white petrolatum mineral oil	OINTMENT	OPHTHALMIC	20111115		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	MINERAL OIL; PETROLATUM	200; 800	mg/g; mg/g			N	20241231
24208-314_7447bbfb-f922-4866-a9d0-09d469433780	24208-314	HUMAN PRESCRIPTION DRUG	Flurbiprofen Sodium		Flurbiprofen Sodium	SOLUTION/ DROPS	OPHTHALMIC	19950104		ANDA	ANDA074447	Bausch & Lomb Incorporated	FLURBIPROFEN SODIUM	.3	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24208-315_b8fd40b3-3fc0-4f9f-b14c-60a40f911511	24208-315	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19970214		ANDA	ANDA064120	Bausch & Lomb Incorporated	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-317_06ea3d35-67bf-d0b8-e063-6294a90a5b0c	24208-317	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium and Prednisolone Sodium Phosphate		Sulfacetamide Sodium and Prednisolone Sodium Phosphate	SOLUTION/ DROPS	OPHTHALMIC	19951229		ANDA	ANDA074449	Bausch & Lomb Incoporated	PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM	2.3; 100	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
24208-342_cf238898-6f21-446b-a0b1-a82bd065580e	24208-342	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SOLUTION	NASAL	19990125		ANDA	ANDA074830	Bauch & Lomb Incorporated	DESMOPRESSIN ACETATE	.1	mg/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
24208-344_0e9c8bb5-9e72-2fd1-e063-6294a90a668a	24208-344	HUMAN PRESCRIPTION DRUG	Flunisolide		Flunisolide	SOLUTION	NASAL	20020220		ANDA	ANDA074805	Bausch & Lomb Incorporated	FLUNISOLIDE	.25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
24208-353_138577af-1a4e-48fb-b088-47f54c896442	24208-353	HUMAN PRESCRIPTION DRUG	Alrex		loteprednol etabonate	SUSPENSION/ DROPS	OPHTHALMIC	19980309		NDA	NDA020803	Bausch & Lomb Incorporated	LOTEPREDNOL ETABONATE	2	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-358_4e532599-a607-4047-a600-d3e32fd515a4	24208-358	HUMAN PRESCRIPTION DRUG	Zylet		loteprednol etabonate and tobramycin	SUSPENSION/ DROPS	OPHTHALMIC	20041214		NDA	NDA050804	Bausch & Lomb Incorporated	LOTEPREDNOL ETABONATE; TOBRAMYCIN	5; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-377_6f7d2be7-55e0-468f-a35d-c7c02849752b	24208-377	HUMAN PRESCRIPTION DRUG	MIEBO		Perfluorohexyloctane	SOLUTION	OPHTHALMIC	20230518		NDA	NDA216675	Bausch & Lomb Incorporated	PERFLUOROHEXYLOCTANE	1	mg/mg			N	20241231
24208-385_679c25d1-0010-47a9-9ffb-38c00b037480	24208-385	HUMAN OTC DRUG	Muro 128		sodium chloride	OINTMENT	OPHTHALMIC	20110101		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	SODIUM CHLORIDE	50	mg/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
24208-398_a2b4ae27-595c-4938-a93a-715339b7eab7	24208-398	HUMAN PRESCRIPTION DRUG	Ipratropium bromide		Ipratropium bromide	SPRAY, METERED	NASAL	20030331		ANDA	ANDA076025	Bausch & Lomb Incorporated	IPRATROPIUM BROMIDE	21	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
24208-399_24982952-0064-4ed9-8276-210e482c8358	24208-399	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY, METERED	NASAL	20030331		ANDA	ANDA076103	Bausch & Lomb Incorporated	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
24208-410_3f88eb9b-9978-4379-b034-92c45b6c259c	24208-410	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20080317		ANDA	ANDA076128	Bausch & Lomb Incorporated	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
24208-411_50ab3851-8101-408a-885b-13f78cd0e031	24208-411	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION/ DROPS	OPHTHALMIC	20030528		ANDA	ANDA076260	Bausch & Lomb Incorporated	BRIMONIDINE TARTRATE	2	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
24208-416_6957f5e4-982a-470f-99c9-ff96270cde3c	24208-416	HUMAN PRESCRIPTION DRUG	Retisert		Fluocinolone Acetonide	IMPLANT	INTRAVITREAL	20050408		NDA	NDA021737	Bausch & Lomb Incorporated	FLUOCINOLONE ACETONIDE	.59	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-430_224a5792-637b-4b92-ba2b-b334e6a06f0f	24208-430	HUMAN OTC DRUG	Opcon-A		Naphazoline hydrochloride and Pheniramine maleate	SOLUTION/ DROPS	OPHTHALMIC	19940608		NDA	NDA020065	Bausch & Lomb Incorporated	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.2675; 3.15	mg/mL; mg/mL			N	20241231
24208-434_5c506f49-e321-4503-bca6-c87d5a184e14	24208-434	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20040514		ANDA	ANDA076622	Bausch & Lomb Incorporated	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
24208-443_b1d6fda8-73c9-478f-addd-14949e0454e4	24208-443	HUMAN PRESCRIPTION DRUG	Lotemax		loteprednol etabonate	OINTMENT	OPHTHALMIC	20110415		NDA	NDA200738	Bausch & Lomb Incorporated	LOTEPREDNOL ETABONATE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-446_2b3a99b3-0edb-428b-ae41-67d297956a65	24208-446	HUMAN PRESCRIPTION DRUG	Besivance		Besifloxacin	SUSPENSION	OPHTHALMIC	20090528		NDA	NDA022308	Bausch & Lomb Incorporated	BESIFLOXACIN	6	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
24208-450_4591fc36-d88f-42d0-bba0-c5e47a4d4278	24208-450	HUMAN OTC DRUG	Advanced Eye Relief/ Redness Maximum Relief		Naphazoline Hydrochloride and Hypromellose	SOLUTION/ DROPS	OPHTHALMIC	20100902		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	HYPROMELLOSE, UNSPECIFIED; NAPHAZOLINE HYDROCHLORIDE	5; .3	mg/mL; mg/mL			N	20241231
24208-454_e01fd36f-4399-43af-bb3f-e6164690350a	24208-454	HUMAN OTC DRUG	Advanced Eye Relief Dry Eye Rejuvenation		glycerin propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20100901		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	GLYCERIN; PROPYLENE GLYCOL	3; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
24208-457_d6bfd7c9-4a36-4426-a82e-ace8d2932af2	24208-457	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION/ DROPS	OPHTHALMIC	20071228		ANDA	ANDA078792	Bausch & Lomb Incorporated	DICLOFENAC SODIUM	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24208-463_e15c159e-46a6-48e9-a200-65dfb40d31d0	24208-463	HUMAN PRESCRIPTION DRUG	Latanoprost		latanoprost	SOLUTION/ DROPS	OPHTHALMIC	20110322		ANDA	ANDA201006	Bausch & Lomb Incorporated	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
24208-464_9702bb56-cb22-450f-bb4c-a5a7714774a3	24208-464	HUMAN PRESCRIPTION DRUG	BRINZOLAMIDE		brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	20220331		ANDA	ANDA204884	Bausch & Lomb Incorporated	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
24208-485_f36cf152-efdb-424c-8669-34f0f76625eb	24208-485	HUMAN PRESCRIPTION DRUG	Dorzolamide HCl		Dorzolamide HCl	SOLUTION/ DROPS	OPHTHALMIC	20090625		ANDA	ANDA090143	Bausch & Lomb Incorporated	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
24208-486_07b50c6a-8d83-47f6-9f52-d40b199a2059	24208-486	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20090714		ANDA	ANDA090037	Bausch & Lomb Incorporated	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-490_4923b99e-7c6a-4b9d-a15d-b96be25af237	24208-490	HUMAN OTC DRUG	Soothe XP		light mineral oil and mineral oil	SOLUTION/ DROPS	OPHTHALMIC	20100826		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	LIGHT MINERAL OIL; MINERAL OIL	10; 45	mg/mL; mg/mL			N	20241231
24208-495_3ede1d37-bc07-48b6-9a27-200ecd39c81d	24208-495	HUMAN OTC DRUG	Soothe		glycerin and propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20100826		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	GLYCERIN; PROPYLENE GLYCOL	6; 6	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
24208-496_0c488889-6c37-44a2-94e2-97f98d48d6fb	24208-496	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20210316		NDA AUTHORIZED GENERIC	NDA019463	BAUSCH & LOMB INCORPORATED	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-498_fb4b627c-422c-471a-bcec-fff7187d79d7	24208-498	HUMAN PRESCRIPTION DRUG	Timoptic in Ocudose		Timolol Maleate	SOLUTION	OPHTHALMIC	20220217		NDA	NDA019463	Bausch & Lomb Incorporated	TIMOLOL MALEATE	3.4	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-499_fb4b627c-422c-471a-bcec-fff7187d79d7	24208-499	HUMAN PRESCRIPTION DRUG	Timoptic in Ocudose		Timolol Maleate	SOLUTION	OPHTHALMIC	20220217		NDA	NDA019463	Bausch & Lomb Incorporated	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-503_64859b19-098f-4717-89d0-5d4c87ccad77	24208-503	HUMAN PRESCRIPTION DRUG	LOTEMAX		loteprednol etabonate	GEL	OPHTHALMIC	20121012		NDA	NDA202872	Bausch & Lomb Incorporated	LOTEPREDNOL ETABONATE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-504_06204573-97d3-4253-8685-87273ea08d58	24208-504	HUMAN PRESCRIPTION DRUG	Vyzulta		latanoprostene bunod	SOLUTION/ DROPS	OPHTHALMIC	20171102		NDA	NDA207795	Bausch & Lomb Incorporated	LATANOPROSTENE BUNOD	.24	mg/mL			N	20241231
24208-505_824dc29c-3ab9-4e52-9a4d-82ca578ee3b0	24208-505	HUMAN PRESCRIPTION DRUG	Levobunolol Hydrochloride		Levobunolol Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19940304		ANDA	ANDA074326	Bausch & Lomb Incorporated	LEVOBUNOLOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-507_91998c80-00ef-40b9-8316-c95b6e4aa713	24208-507	HUMAN PRESCRIPTION DRUG	Lotemax SM		loteprednol etabonate	GEL	OPHTHALMIC	20190225		NDA	NDA208219	Bausch & Lomb Incorporated	LOTEPREDNOL ETABONATE	3.8	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-508_0cdbef52-3996-4d79-85ae-c5dd70ac93ed	24208-508	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		loteprednol etabonate	GEL	OPHTHALMIC	20210217		NDA AUTHORIZED GENERIC	NDA202872	Bausch & Lomb Incorporated	LOTEPREDNOL ETABONATE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-535_b8c21385-1cb8-4aff-9dee-8a7e4899a3b9	24208-535	HUMAN PRESCRIPTION DRUG	ZIRGAN		ganciclovir	GEL	OPHTHALMIC	20100430		NDA	NDA022211	Bausch & Lomb Incorporated	GANCICLOVIR	1.5	mg/g	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
24208-537_31470602-4f2f-4341-a0b3-ddf14278df7e	24208-537	HUMAN OTC DRUG	LUMIFY Redness Reliever Eye Drops		BRIMONIDINE TARTRATE	SOLUTION/ DROPS	OPHTHALMIC	20171222		NDA	NDA208144	Bausch & Lomb Incorporated	BRIMONIDINE TARTRATE	.25	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
24208-539_19c42ee4-9f98-48da-85ea-52090070c2e2	24208-539	HUMAN PRESCRIPTION DRUG	Miochol E		acetylcholine chloride	KIT		19930922		NDA	NDA020213	Bausch & Lomb Incorporated						N	20241231
24208-555_498152a1-902c-49d3-b833-5eeebbab4a74	24208-555	HUMAN PRESCRIPTION DRUG	Bacitracin Zinc and Polymyxin B Sulfate		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	OPHTHALMIC	20080425		ANDA	ANDA064046	Bausch & Lomb Incorporated	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-560_f48ec619-2eda-4360-9c67-bb79bdd00353	24208-560	HUMAN PRESCRIPTION DRUG	Visudyne		verteporfin for injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20000412		NDA	NDA021119	Bausch & Lomb Incorporated	VERTEPORFIN	15	mg/1	Photoabsorption [MoA], Photoenhancer [EPC], Photosensitizing Activity [PE]		N	20241231
24208-580_2bcd8a77-35c9-4c81-8450-361b7512ccc8	24208-580	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19940511		ANDA	ANDA064048	Bausch & Lomb Incorporated	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
24208-585_f7ca9591-4d7b-4c5e-b54e-e08fd8cf6755	24208-585	HUMAN PRESCRIPTION DRUG	Tropicamide		Tropicamide	SOLUTION/ DROPS	OPHTHALMIC	19940727		ANDA	ANDA040064	Bausch & Lomb Incorporated	TROPICAMIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
24208-590_f7ca9591-4d7b-4c5e-b54e-e08fd8cf6755	24208-590	HUMAN PRESCRIPTION DRUG	Tropicamide		Tropicamide	SOLUTION/ DROPS	OPHTHALMIC	19940727		ANDA	ANDA040067	Bausch & Lomb Incorporated	TROPICAMIDE	5	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
24208-600_b3390c57-33f9-492b-bc81-333d41736f88	24208-600	HUMAN OTC DRUG	Alaway Preservative Free		ketotifen fumarate	SOLUTION/ DROPS	OPHTHALMIC	20200924		ANDA	ANDA208158	Bausch & Lomb Incorporated	KETOTIFEN FUMARATE	.35	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
24208-601_4f27a942-b5f3-4a01-8022-49deced585f8	24208-601	HUMAN OTC DRUG	Alaway		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20061201		NDA	NDA021996	Bausch & Lomb Incorporated	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
24208-602_cb93cfd7-e943-4d05-81ca-03ca5cd7680b	24208-602	HUMAN PRESCRIPTION DRUG	Prolensa		Bromfenac Sodium	SOLUTION/ DROPS	OPHTHALMIC	20130405		NDA	NDA203168	Bausch & Lomb Incorporated	BROMFENAC SODIUM	.7	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24208-629_a4c88d72-eb17-446a-9da5-6bcf1263377f	24208-629	HUMAN PRESCRIPTION DRUG	Bepreve		bepotastine besilate	SOLUTION/ DROPS	OPHTHALMIC	20090908		NDA	NDA022288	Bausch & Lomb Incorporated	BEPOTASTINE BESYLATE	15	mg/mL	Histamine-1 Receptor Antagonist [EPC]		N	20241231
24208-630_995f4fe0-d861-4137-8090-a8ffc71c46f4	24208-630	HUMAN PRESCRIPTION DRUG	Bepotastine Besilate		bepotastine besilate	SOLUTION/ DROPS	OPHTHALMIC	20210528		NDA AUTHORIZED GENERIC	NDA022288	Bausch & Lomb Incorporated	BEPOTASTINE BESILATE	15	mg/mL	Histamine-1 Receptor Antagonist [EPC]		N	20241231
24208-631_c4177a4a-3251-451f-92fb-5d2e2ad1a670	24208-631	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone	SOLUTION/ DROPS	AURICULAR (OTIC)	19951229		ANDA	ANDA064053	Bausch & Lomb Incoporated	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-635_90e7f708-eefd-4a4e-afc9-51eadc98d287	24208-635	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19960828		ANDA	ANDA064065	Bausch & Lomb Incorporated	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-670_39869c1b-2b30-482e-b88e-9177cd85ea16	24208-670	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		sulfacetamide sodium	SOLUTION/ DROPS	OPHTHALMIC	19941228		ANDA	ANDA040066	Bausch & Lomb Incorporated	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
24208-715_87bea906-f7cf-4987-abb2-02981b5ea0e2	24208-715	HUMAN PRESCRIPTION DRUG	PREDNISOLONE SODIUM PHOSPHATE		PREDNISOLONE SODIUM PHOSPHATE	SOLUTION/ DROPS	OPHTHALMIC	19940729		ANDA	ANDA040070	Bausch & Lomb Incorporated	PREDNISOLONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-720_466190ae-63f8-4b89-a71e-f1b91f90c764	24208-720	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	SOLUTION/ DROPS	OPHTHALMIC	19960726		ANDA	ANDA040069	Bausch & Lomb Incorporated	DEXAMETHASONE SODIUM PHOSPHATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24208-730_46f24726-30f8-471b-b0be-b7da62d88bfc	24208-730	HUMAN PRESCRIPTION DRUG	Proparacaine Hydrochloride		Proparacaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19950929		ANDA	ANDA040074	Bausch & Lomb Incorporated	PROPARACAINE HYDROCHLORIDE	5	mg/mL	Local Anesthesia [PE], Local Anesthetic [EPC]		N	20241231
24208-734_bc60e95e-6fb2-4e5f-a5df-40490b2ee204	24208-734	HUMAN PRESCRIPTION DRUG	Fluorescein Sodium and Benoxinate Hydrochloride		Fluorescein Sodium and Benoxinate Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20200320		NDA	NDA211039	Bausch & Lomb Incorporated	BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM	4.4; 2.6	mg/mL; mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
24208-735_34fff06e-fa45-478a-b136-e019483fa07d	24208-735	HUMAN PRESCRIPTION DRUG	Cyclopentolate Hydrochloride		Cyclopentolate Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19940429		ANDA	ANDA040075	Bausch & Lomb Incorporated	CYCLOPENTOLATE HYDROCHLORIDE	10	mg/mL			N	20241231
24208-742_bc77777a-9889-478f-ace3-18497e297337	24208-742	HUMAN OTC DRUG	Soothe XP Preservative Free		light mineral oil and mineral oil	SOLUTION/ DROPS	OPHTHALMIC	20180418		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	LIGHT MINERAL OIL; MINERAL OIL	10; 45	mg/mL; mg/mL			N	20241231
24208-780_9c2e68b9-9451-4900-8ca4-23953768cbbe	24208-780	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Bacitracin Zinc		Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc	OINTMENT	OPHTHALMIC	19951030		ANDA	ANDA064064	Bausch & Lomb Incorporated	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 10000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-785_c4ec5675-9cff-4230-ba98-37ba9e66d1b0	24208-785	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone		Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone	OINTMENT	OPHTHALMIC	19951030		ANDA	ANDA064068	Bausch & Lomb Incorporated	BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 10; 3.5; 10000	[USP'U]/g; mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-790_2d33d075-f50b-497d-977b-bcd41bc72637	24208-790	HUMAN PRESCRIPTION DRUG	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN		neomycin sulfate, polymyxin b sulfate and gramicidin	SOLUTION/ DROPS	OPHTHALMIC	19960131		ANDA	ANDA064047	Bausch & Lomb Incorporated	GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	.025; 1.75; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-795_ec763c42-6065-4d6b-8eb8-7b12c844dac1	24208-795	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin Sulfate, Polymyxin B Sulfate, and Dexamethasone	OINTMENT	OPHTHALMIC	19940725		ANDA	ANDA064063	Bausch & Lomb Incorporated	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-800_881642a5-c908-4e00-89b2-5716c4c41037	24208-800	HUMAN PRESCRIPTION DRUG	Lacrisert		hydroxypropyl cellulose	INSERT	OPHTHALMIC	19810601		NDA	NDA018771	Bausch & Lomb Incorporated	HYDROXYPROPYL CELLULOSE (1600000 WAMW)	5	mg/1	Demulcent Activity [MoA], Demulcent [EPC]		N	20251231
24208-812_cade935b-98f5-4940-8f62-73ad8af1dd0a	24208-812	HUMAN PRESCRIPTION DRUG	Timoptic		Timolol Maleate	SOLUTION	OPHTHALMIC	20161230		NDA	NDA018086	Bausch & Lomb Incorporated	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-813_cade935b-98f5-4940-8f62-73ad8af1dd0a	24208-813	HUMAN PRESCRIPTION DRUG	Timoptic		Timolol Maleate	SOLUTION	OPHTHALMIC	20161230		NDA	NDA018086	Bausch & Lomb Incorporated	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-814_cb6890c5-7788-453b-910d-10c2bee17d04	24208-814	HUMAN PRESCRIPTION DRUG	Timoptic-XE		Timolol Maleate	SOLUTION	OPHTHALMIC	20160531		NDA	NDA020330	Bausch & Lomb Incorporated	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-816_cb6890c5-7788-453b-910d-10c2bee17d04	24208-816	HUMAN PRESCRIPTION DRUG	Timoptic-XE		Timolol Maleate	SOLUTION	OPHTHALMIC	20160531		NDA	NDA020330	Bausch & Lomb Incorporated	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-818_b2a3e6e1-d01c-4d14-85ac-41905306d769	24208-818	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20180214		NDA AUTHORIZED GENERIC	NDA020330	Bausch & Lomb Incorporated	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-819_b2a3e6e1-d01c-4d14-85ac-41905306d769	24208-819	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20180214		NDA AUTHORIZED GENERIC	NDA020330	Bausch & Lomb Incorporated	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24208-825_72b36d2b-77a4-4b9e-b99d-99bf20e45cc5	24208-825	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	OINTMENT	OPHTHALMIC	19900930		UNAPPROVED DRUG OTHER		Bausch & Lomb Incorporated	ATROPINE SULFATE	10	mg/g	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
24208-830_3883596b-eeb8-450a-bfed-fea0dcb3629d	24208-830	HUMAN PRESCRIPTION DRUG	Neomycin Polymyxin B Sulfates and Dexamethasone		Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19950913		ANDA	ANDA064135	Bausch & Lomb Incorporated	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24208-910_3236d51d-3f18-4713-8443-bd2d85cde58b	24208-910	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19940729		ANDA	ANDA064067	Bausch & Lomb Incorporated	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24208-911_0df822d2-3f12-e65c-e063-6394a90a3a39	24208-911	HUMAN PRESCRIPTION DRUG	Xiidra		Lifitegrast	SOLUTION/ DROPS	OPHTHALMIC	20240102		NDA	NDA208073	Bausch & Lomb Incorporated	LIFITEGRAST	50	mg/mL	Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]		N	20251231
24208-965_4c049745-e1cc-49b8-a696-6ceda01b7c03	24208-965	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	SOLUTION	OPHTHALMIC	20220713		NDA	NDA213581	Bausch & Lomb Incorporated	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
24275-0185_09abfc29-c5d8-74fe-e063-6394a90a5adb	24275-0185	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F18		Fludeoxyglucose F18	INJECTION	INTRAVENOUS	20111204		ANDA	ANDA203902	UCSF Radiopharmaceutical Facility	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24275-0385_09abfc29-c601-74fe-e063-6394a90a5adb	24275-0385	HUMAN PRESCRIPTION DRUG	Ammonia N 13		NH3N13	INJECTION	INTRAVENOUS	20081106		ANDA	ANDA204496	UCSF Radiopharmaceutical Facility	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24275-0525_09ac17d8-d7de-6ecf-e063-6394a90aff66	24275-0525	HUMAN PRESCRIPTION DRUG	Gallium Ga-68 PSMA-11		GALLIUM GA-68 GOZETOTIDE	INJECTION, SOLUTION	INTRAVENOUS	20201214		NDA	NDA212643	UCSF Radiopharmaceutical Facility	GALLIUM GA-68 GOZETOTIDE	5	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
24286-0253_b4500d48-ecad-46f2-e053-2a95a90a7352	24286-0253	HUMAN OTC DRUG	ZAP Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20190221		OTC MONOGRAPH FINAL	part358G	DLC laboratories Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
24286-1253_b450bc00-904a-7ea5-e053-2a95a90ab6b6	24286-1253	HUMAN OTC DRUG	Quita Piojos Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20190221		OTC MONOGRAPH FINAL	part358G	DLC Laboratories	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
24286-1292_f22dd8e5-05b8-61b2-e053-2995a90a457b	24286-1292	HUMAN OTC DRUG	Ocusan Dry Eyes		Polyethylene Glycol 400, Propylene Glycol	LIQUID	OPHTHALMIC	20191216		OTC MONOGRAPH FINAL	part349	DLC Laboratories, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
24286-1521_cdd0f519-3002-4130-90e0-9d9c430090bd	24286-1521	HUMAN OTC DRUG	De La Cruz Camphor		CAMPHOR	OINTMENT	TOPICAL	20120726		OTC MONOGRAPH NOT FINAL	part348	DLC Laboratories, Inc.	CAMPHOR (SYNTHETIC)	11	g/100g			N	20241231
24286-1523_d6811023-95bf-974c-e053-2a95a90aa889	24286-1523	HUMAN OTC DRUG	De La Cruz Desempacho		SODIUM BICARBONATE	LIQUID	ORAL	20160315		OTC MONOGRAPH FINAL	part331	DLC LABORATORIES, INC.	SODIUM BICARBONATE	525	mg/15mL	Alkalinizing Activity [MoA]		N	20241231
24286-1525_d282404b-2979-316d-e053-2995a90aea2c	24286-1525	HUMAN OTC DRUG	De La Cruz Sulfur Acne Medication		SULFUR	OINTMENT	TOPICAL	20140811		OTC MONOGRAPH FINAL	part333D	DLC Laboratories, Inc.	SULFUR	10	g/100g			N	20241231
24286-1526_ffc31389-021b-6bca-e053-6294a90ae9e3	24286-1526	HUMAN OTC DRUG	De La Cruz Castor Oil		CASTOR Oil	OIL	ORAL	20120727		OTC MONOGRAPH NOT FINAL	part334	DLC Laboratories, Inc.	CASTOR OIL	1	g/mL			N	20241231
24286-1528_0c940d4f-cca2-7175-e063-6394a90af568	24286-1528	HUMAN OTC DRUG	De La Cruz Tincture of Iodine		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	19790101		OTC MONOGRAPH DRUG	M003	DLC Laboratories, Inc.	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
24286-1529_0c940b54-dfdc-9d84-e063-6294a90a7a0c	24286-1529	HUMAN OTC DRUG	De La Cruz Decolorized Iodine		Ethyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	DLC Laboratories, Inc.	ALCOHOL	.45	mL/mL			N	20241231
24286-1531_fbd11484-90b4-4562-e053-6294a90a10c6	24286-1531	HUMAN OTC DRUG	DE LA CRUZ GENTIAN VIOLET		GENTIAN VIOLET	TINCTURE	TOPICAL	20121101		OTC MONOGRAPH NOT FINAL	part333E	DLC Laboratories, Inc.	GENTIAN VIOLET	1	g/100mL			N	20241231
24286-1532_0ccb3e8a-3cff-1364-e063-6294a90a70e8	24286-1532	HUMAN OTC DRUG	Tincture Merthiolate		BENZALKONIUM CHLORIDE	TINCTURE	TOPICAL	20130322		OTC MONOGRAPH DRUG	M003	DLC Laboratories, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
24286-1533_9d72de57-4d2e-4489-a9c5-a0f36c24bca1	24286-1533	HUMAN OTC DRUG	QUITA COLICOS Gas RELIEF Drops		Simethicone	LIQUID	ORAL	20140318		OTC MONOGRAPH FINAL	part332	DLC Laboratories, Inc.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
24286-1537_f2642ece-8211-50cd-e053-2995a90a235a	24286-1537	HUMAN OTC DRUG	DE LA CRUZ SODIUM BICARBONATE ANTACID		SODIUM BICARBONATE	POWDER	ORAL	20130925		OTC MONOGRAPH FINAL	part331	DLC Laboratories, Inc.	SODIUM BICARBONATE	2.6	g/2.6g	Alkalinizing Activity [MoA]		N	20241231
24286-1546_ec71398c-f23e-164e-e053-2995a90a8268	24286-1546	HUMAN OTC DRUG	BACTIMICINA COUGH AND COLD		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20131106		OTC MONOGRAPH FINAL	part341	DLC Laboratories, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
24286-1550_ef1d29b1-242a-cffc-e053-2995a90a135c	24286-1550	HUMAN OTC DRUG	Bactimicina Childrens Pain and Fever		ACETAMINOPHEN	LIQUID	ORAL	20141117		OTC MONOGRAPH NOT FINAL	part343	DLC Laboratories, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
24286-1551_ec825493-c60d-d04a-e053-2a95a90a8b96	24286-1551	HUMAN OTC DRUG	Bactimicina Childrens Cough and Cold		CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE	LIQUID	ORAL	20091023		OTC MONOGRAPH FINAL	part341	DLC Laboratories, Inc.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	1; 7.5	mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24286-1554_d57f0370-7b7c-e8d1-e053-2995a90aaf83	24286-1554	HUMAN OTC DRUG	Earths Care Pain Relieving		CAMPHOR, MENTHOL, METHYL SALICYLATE	OINTMENT	TOPICAL	20111129		OTC MONOGRAPH NOT FINAL	part348	DLC Laboratories, Inc.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	4; 10; 15	g/100g; g/100g; g/100g			N	20241231
24286-1556_d57f125d-9b08-6ac7-e053-2995a90a020f	24286-1556	HUMAN OTC DRUG	Earths Care Acne Treatment Mask		SULFUR	CREAM	TOPICAL	20130118		OTC MONOGRAPH FINAL	part333D	DLC Laboratories, Inc.	SULFUR	5	g/100g			N	20241231
24286-1557_d554be20-c277-1b60-e053-2a95a90a950e	24286-1557	HUMAN OTC DRUG	Earths Care Acne Spot Treatment		SULFUR	CREAM	TOPICAL	20130118		OTC MONOGRAPH FINAL	part333D	DLC Laboratories, Inc.	SULFUR	10	g/100g			N	20241231
24286-1558_fed0330c-587e-f296-e053-6394a90affd8	24286-1558	HUMAN OTC DRUG	EARTHS CARE ANTI-ITCH		CAMPHOR (NATURAL), MENTHOL	CREAM	TOPICAL	20131030		OTC MONOGRAPH NOT FINAL	part348	DLC Laboratories, Inc.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	.5; 1	g/100g; g/100g			N	20241231
24286-1559_e125c6aa-c4f6-4ff7-985a-a3c7b7574575	24286-1559	HUMAN OTC DRUG	EARTHS CARE ARTHRITIS		CAPSAICIN	CREAM	TOPICAL	20130925		OTC MONOGRAPH NOT FINAL	part348	DLC Laboratories, Inc.	CAPSAICIN	.1	g/100g			N	20241231
24286-1560_d57f1d80-afe8-946f-e053-2995a90a0e15	24286-1560	HUMAN OTC DRUG	Maximum Strength Hydrocortisone		HYDROCORTISONE	OINTMENT	TOPICAL	20130322		OTC MONOGRAPH NOT FINAL	part348	DLC Laboratories, Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24286-1563_6fedbdf1-8f2f-42be-8d66-95cf2534384e	24286-1563	HUMAN OTC DRUG	EARTHS CARE MUSCLE AND JOINT RUB		camphor	OINTMENT	TOPICAL	20130917		OTC MONOGRAPH NOT FINAL	part348	DLC Laboratories, Inc.	CAMPHOR (NATURAL)	3	g/100g			N	20241231
24286-1564_d633f94b-838f-46e0-a89e-8ab65301fe2b	24286-1564	HUMAN OTC DRUG	VAPOREX		CAMPHOR (SYNTHETIC), EUCALYPTUS Oil, and MENTHOL	OINTMENT	TOPICAL	20130312		OTC MONOGRAPH FINAL	part341	DLC Laboratories, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
24286-1565_ffc25b31-7556-be0d-e053-6294a90ad55c	24286-1565	HUMAN OTC DRUG	BACTIMICINA CHILDRENS ALLERGY		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20150617		OTC MONOGRAPH FINAL	part341	DLC Laboratories, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
24286-1566_fed071e9-48d3-1462-e053-6394a90a005f	24286-1566	HUMAN OTC DRUG	DE LA CRUZ DIAPER RASH		ALLANTOIN, PETROLATUM, and ZINC OXIDE	OINTMENT	TOPICAL	20150710		OTC MONOGRAPH FINAL	part347	DLC Laboratories, Inc.	ALLANTOIN; PETROLATUM; ZINC OXIDE	1; 45; 40	g/100g; g/100g; g/100g			N	20241231
24286-1570_ec852362-45ca-9e49-e053-2995a90a1ede	24286-1570	HUMAN OTC DRUG	Earths Care Hemorrhoid Relief		Witch Hazel and Menthol, Unspecified Form	CREAM	TOPICAL	20170601		OTC MONOGRAPH FINAL	part347	DLC Laboratories, Inc.	MENTHOL, UNSPECIFIED FORM; WITCH HAZEL	.8; 10	g/100g; g/100g			N	20241231
24286-1571_ec95c1b5-870f-2a0b-e053-2a95a90a7f5f	24286-1571	HUMAN OTC DRUG	Earths Care Eczema		Oatmeal	LOTION	TOPICAL	20181119		OTC MONOGRAPH FINAL	part347	DLC Laboratories, Inc.	OATMEAL	1.8	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
24286-1573_fea85a67-4e87-030e-e053-6294a90a89a3	24286-1573	HUMAN OTC DRUG	Acne Treatment with Sulfur		SULFUR	OINTMENT	TOPICAL	20190816		OTC MONOGRAPH FINAL	part333D	DLC Laboratories, Inc.	SULFUR	5	g/100g			N	20241231
24286-1574_d23047be-a525-881a-e053-2995a90a4808	24286-1574	HUMAN OTC DRUG	Acne Treatment with Sulfur		SULFUR	OINTMENT	TOPICAL	20190826		OTC MONOGRAPH FINAL	part333D	DLC Laboratories, Inc.	SULFUR	10	g/100g			N	20241231
24286-1575_f22e282e-85b7-2286-e053-2995a90a08e6	24286-1575	HUMAN OTC DRUG	Colirio Ocusan		TETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, POVIDONE, UNSPECIFIED, and DEXTRAN 70	LIQUID	OPHTHALMIC	20191216		OTC MONOGRAPH FINAL	part349	DLC Laboratories, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
24286-1576_ecf9957d-55d5-6f94-e053-2995a90a6cba	24286-1576	HUMAN OTC DRUG	Earths Care Anti-Itch		CAMPHOR (NATURAL) and MENTHOL, UNSPECIFIED FORM	LOTION	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part348	DLC Laboratories, Inc.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	.5; 1	g/100mL; g/100mL			N	20241231
24286-1577_d3abce13-cc88-e661-e053-2a95a90a1b7c	24286-1577	HUMAN OTC DRUG	Bactimicina for Sore Throat		Benzocaine	LOZENGE	ORAL	20211221		OTC MONOGRAPH NOT FINAL	part356	DLC Laboratories, Inc.	BENZOCAINE	15	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
24312-001_07105a22-70e6-b2d0-e063-6394a90aea4d	24312-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20040101		NDA	NDA205712	Airtec Gases, LLC	OXYGEN	99	L/100L			N	20241231
24312-002_071038d9-8178-6953-e063-6394a90a8a84	24312-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20040101		NDA	NDA205713	Airtec Gases, LLC	NITROGEN	99	L/100L			N	20241231
24312-003_07101a26-8f4a-6909-e063-6394a90a3b5f	24312-003	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	20040101		NDA	NDA205704	Airtec Gases, LLC	NITROUS OXIDE	99	L/100L			N	20241231
24330-110_778699fa-4226-4ebb-8c47-cde4725e4ddb	24330-110	HUMAN OTC DRUG	First Degree		Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria	TINCTURE	TOPICAL	20070101		UNAPPROVED HOMEOPATHIC		Welmedix LLC	CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; LYTTA VESICATORIA	1; 1; 3	[hp_Q]/.1g; [hp_Q]/.1g; [hp_X]/.1g			N	20241231
24330-130_cbfe71fd-2d5c-4c98-8caf-68fe49e54b6f	24330-130	HUMAN OTC DRUG	First Degree Maximum Strength Burn		Pramoxine Hydrochloride	CREAM	TOPICAL	20170309		OTC MONOGRAPH NOT FINAL	part348	Welmedix LLC	PRAMOXINE HYDROCHLORIDE	10	mg/g			N	20241231
24330-210_3d715022-70be-44aa-bfa3-f37823e35421	24330-210	HUMAN OTC DRUG	SunBurnt Advanced After-Sun		Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria	GEL	TOPICAL	20070101		UNAPPROVED HOMEOPATHIC		Welmedix LLC	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; LYTTA VESICATORIA	1; 1; 3	[hp_Q]/.1g; [hp_Q]/.1g; [hp_X]/.1g			N	20241231
24330-240_cd41cc55-ae90-4c02-a405-cc81cd06ce2e	24330-240	HUMAN OTC DRUG	SunBurnt PLUS Pain Relief		Lidocaine Hydrochloride	GEL	TOPICAL	20180315		OTC MONOGRAPH NOT FINAL	part348	Welmedix LLC dba Welmedix Consumer Healthcare	LIDOCAINE HYDROCHLORIDE	1	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
24330-410_fa1b9e71-737e-4af5-9a44-2cd160a298a2	24330-410	HUMAN OTC DRUG	Welmedix HomeCare PRO Extra Strength Rapid Rash Relief		Petrolatum, Zinc Oxide	CREAM	TOPICAL	20130401		OTC MONOGRAPH DRUG	M012	Welmedix LLC	PETROLATUM; ZINC OXIDE	49; 15	g/100g; g/100g			N	20241231
24330-412_a70a8a79-31cd-4833-b040-5372e02515e9	24330-412	HUMAN OTC DRUG	Welmedix HomeCare PRO Fragile Skin Protectant		Petrolatum	OINTMENT	TOPICAL	20130401		OTC MONOGRAPH DRUG	M012	Welmedix LLC	PETROLATUM	42	g/100g			N	20241231
24338-005_4456cfa6-da14-45fb-8794-899fcea1c43f	24338-005	HUMAN PRESCRIPTION DRUG	Adthyza Thyroid		Levothyroxine and Liothyronine	TABLET	ORAL	20231218		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	9.5; 2.25	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-006_4456cfa6-da14-45fb-8794-899fcea1c43f	24338-006	HUMAN PRESCRIPTION DRUG	Adthyza Thyroid		Levothyroxine and Liothyronine	TABLET	ORAL	20231218		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	19; 4.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-007_4456cfa6-da14-45fb-8794-899fcea1c43f	24338-007	HUMAN PRESCRIPTION DRUG	Adthyza Thyroid		Levothyroxine and Liothyronine	TABLET	ORAL	20231218		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	38; 9	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-008_4456cfa6-da14-45fb-8794-899fcea1c43f	24338-008	HUMAN PRESCRIPTION DRUG	Adthyza Thyroid		Levothyroxine and Liothyronine	TABLET	ORAL	20231218		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	57; 13.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-009_4456cfa6-da14-45fb-8794-899fcea1c43f	24338-009	HUMAN PRESCRIPTION DRUG	Adthyza Thyroid		Levothyroxine and Liothyronine	TABLET	ORAL	20231218		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	76; 18	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-010_b89cb02f-2613-4464-8fd5-94e5d03d3257	24338-010	HUMAN PRESCRIPTION DRUG	BiDil		Hydralazine hydrochloride and Isosorbide dinitrate	TABLET, FILM COATED	ORAL	20121205		NDA	NDA020727	Azurity	HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE	37.5; 20	mg/1; mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC], Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
24338-016_91f59ed1-3217-40ca-98bf-25e84ca3902f	24338-016	HUMAN PRESCRIPTION DRUG	Adthyza	thyroid	Levothyroxine and Liothyronine	TABLET	ORAL	20230220		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	9.5; 2.25	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-022_7beeb1e9-69e0-4acc-9f3b-7d068e68b011	24338-022	HUMAN PRESCRIPTION DRUG	Evekeo		Amphetamine Sulfate	TABLET	ORAL	20151101		ANDA	ANDA200166	AZURITY PHARMACEUTICALS, INC.	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-026_7beeb1e9-69e0-4acc-9f3b-7d068e68b011	24338-026	HUMAN PRESCRIPTION DRUG	Evekeo		Amphetamine Sulfate	TABLET	ORAL	20151101		ANDA	ANDA200166	AZURITY PHARMACEUTICALS, INC.	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-031_571d06d1-52f6-46ed-a3ba-9f2c71b60781	24338-031	HUMAN PRESCRIPTION DRUG	Evekeo ODT		AMPHETAMINE SULFATE	TABLET, ORALLY DISINTEGRATING	ORAL	20190628		NDA	NDA209905	Azurity Pharmaceuticals, Inc.	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-032_91f59ed1-3217-40ca-98bf-25e84ca3902f	24338-032	HUMAN PRESCRIPTION DRUG	Adthyza	thyroid	Levothyroxine and Liothyronine	TABLET	ORAL	20230220		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	19; 4.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-033_571d06d1-52f6-46ed-a3ba-9f2c71b60781	24338-033	HUMAN PRESCRIPTION DRUG	Evekeo ODT		AMPHETAMINE SULFATE	TABLET, ORALLY DISINTEGRATING	ORAL	20190628		NDA	NDA209905	Azurity Pharmaceuticals, Inc.	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-035_571d06d1-52f6-46ed-a3ba-9f2c71b60781	24338-035	HUMAN PRESCRIPTION DRUG	Evekeo ODT		AMPHETAMINE SULFATE	TABLET, ORALLY DISINTEGRATING	ORAL	20190628		NDA	NDA209905	Azurity Pharmaceuticals, Inc.	AMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-037_571d06d1-52f6-46ed-a3ba-9f2c71b60781	24338-037	HUMAN PRESCRIPTION DRUG	Evekeo ODT		AMPHETAMINE SULFATE	TABLET, ORALLY DISINTEGRATING	ORAL	20190628		NDA	NDA209905	Azurity Pharmaceuticals, Inc.	AMPHETAMINE SULFATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-050_38ee529a-9515-4e98-8722-5b6c848f7d74	24338-050	HUMAN PRESCRIPTION DRUG	Gliadel		carmustine	WAFER	INTRACAVITARY	20121213		NDA	NDA020637	Arbor Pharmaceuticals	CARMUSTINE	7.7	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
24338-065_91f59ed1-3217-40ca-98bf-25e84ca3902f	24338-065	HUMAN PRESCRIPTION DRUG	Adthyza	thyroid	Levothyroxine and Liothyronine	TABLET	ORAL	20230220		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	38; 9	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-097_91f59ed1-3217-40ca-98bf-25e84ca3902f	24338-097	HUMAN PRESCRIPTION DRUG	Adthyza	thyroid	Levothyroxine and Liothyronine	TABLET	ORAL	20230220		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	57; 13.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-100_0ca69356-c906-e9a9-e063-6394a90a9395	24338-100	HUMAN PRESCRIPTION DRUG	E.E.S	400	Erythromycin Ethylsuccinate	TABLET	ORAL	20110503		ANDA	ANDA061905	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-102_1afb465a-744a-48a9-a74b-9dad81fee83c	24338-102	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20110906		ANDA	ANDA061621	Arbor Pharmaceuticals, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-104_1afb465a-744a-48a9-a74b-9dad81fee83c	24338-104	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20110906		ANDA	ANDA061621	Arbor Pharmaceuticals, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-106_4a87d462-4bab-43ac-8003-4749f4219980	24338-106	HUMAN PRESCRIPTION DRUG	Erythrocin Stearate		ERYTHROMYCIN STEARATE	TABLET, FILM COATED	ORAL	20110801		ANDA	ANDA060359	Arbor Pharmaceuticals, Inc.	ERYTHROMYCIN STEARATE	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-110_0ca6d238-d01f-04ea-e063-6394a90a7b84	24338-110	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN ETHYLSUCCINATE		Erythromycin Ethylsuccinate	TABLET	ORAL	20111003		ANDA	ANDA061904	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-113_91f59ed1-3217-40ca-98bf-25e84ca3902f	24338-113	HUMAN PRESCRIPTION DRUG	Adthyza	thyroid	Levothyroxine and Liothyronine	TABLET	ORAL	20230220		UNAPPROVED DRUG OTHER		Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	76; 18	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
24338-120_6f949818-8773-4dfd-96bd-a0d67ffc92c0	24338-120	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN		Erythromycin	CAPSULE, DELAYED RELEASE	ORAL	20120110		ANDA	ANDA062746	Arbor Pharmaceuticals, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-122_f7f33758-f601-4397-baa4-30286a9a3a39	24338-122	HUMAN PRESCRIPTION DRUG	ERY-TAB		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20110418		ANDA	ANDA062298	Arbor Pharmaceuticals, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-124_f7f33758-f601-4397-baa4-30286a9a3a39	24338-124	HUMAN PRESCRIPTION DRUG	ERY-TAB		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20110418		ANDA	ANDA062298	Arbor Pharmaceuticals, Inc.	ERYTHROMYCIN	333	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-126_f7f33758-f601-4397-baa4-30286a9a3a39	24338-126	HUMAN PRESCRIPTION DRUG	ERY-TAB		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20110418		ANDA	ANDA062298	Arbor Pharmaceuticals, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-130_0ca6c02b-5b9f-39c3-e063-6294a90a4c18	24338-130	HUMAN PRESCRIPTION DRUG	Ery-Ped		Erythromycin Ethylsuccinate	SUSPENSION	ORAL	20120614		NDA	NDA050207	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-132_0ca6c02b-5b9f-39c3-e063-6294a90a4c18	24338-132	HUMAN PRESCRIPTION DRUG	Ery-Ped		Erythromycin Ethylsuccinate	SUSPENSION	ORAL	20110705		NDA	NDA050207	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-134_0ca69356-c906-e9a9-e063-6394a90a9395	24338-134	HUMAN PRESCRIPTION DRUG	E.E.S		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20110418		NDA	NDA050207	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-136_0ca69356-c906-e9a9-e063-6394a90a9395	24338-136	HUMAN PRESCRIPTION DRUG	E.E.S		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20110418		NDA	NDA050207	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
24338-150_c5bd9357-646f-477a-882e-6a6c778e1c43	24338-150	HUMAN PRESCRIPTION DRUG	TRIPTODUR		triptorelin	KIT		20170908		NDA	NDA208956	Azurity Pharmaceuticals, Inc.						N	20241231
24338-185_109a8515-714e-4fa5-9995-fc8f6c34b64e	24338-185	HUMAN OTC DRUG	Sklice		ivermectin	LOTION	TOPICAL	20220831		NDA	NDA202736	Azurity Pharmaceuticals	IVERMECTIN	5	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
24338-230_8c3aba10-0b86-4b03-8952-adc2a2b950b4	24338-230	HUMAN PRESCRIPTION DRUG	Nymalize		nimodipine	SOLUTION	ORAL	20200504		NDA	NDA203340	Azurity Pharmaceuticals, Inc.	NIMODIPINE	30	mg/5mL	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24338-260_8c3aba10-0b86-4b03-8952-adc2a2b950b4	24338-260	HUMAN PRESCRIPTION DRUG	Nymalize		nimodipine	SOLUTION	ORAL	20200504		NDA	NDA203340	Azurity Pharmaceuticals, Inc.	NIMODIPINE	60	mg/10mL	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24338-530_a9f50c2c-41f4-44af-84c5-15def9b0f709	24338-530	HUMAN PRESCRIPTION DRUG	SOTYLIZE		SOTALOL HYDROCHLORIDE	SOLUTION	ORAL	20150301		NDA	NDA205108	Arbor Pharmaceuticals, Inc.	SOTALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
24338-850_ca930673-eecb-4c89-821f-c0dbd4b208b2	24338-850	HUMAN PRESCRIPTION DRUG	Zenzedi		Dextroamphetamine Sulfate	TABLET	ORAL	20130531		ANDA	ANDA090533	AZURITY PHARMACEUTICALS, INC.	DEXTROAMPHETAMINE SULFATE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-851_ca930673-eecb-4c89-821f-c0dbd4b208b2	24338-851	HUMAN PRESCRIPTION DRUG	Zenzedi		Dextroamphetamine Sulfate	TABLET	ORAL	20130531		ANDA	ANDA090533	AZURITY PHARMACEUTICALS, INC.	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-852_ca930673-eecb-4c89-821f-c0dbd4b208b2	24338-852	HUMAN PRESCRIPTION DRUG	Zenzedi		Dextroamphetamine Sulfate	TABLET	ORAL	20130531		ANDA	ANDA090533	AZURITY PHARMACEUTICALS, INC.	DEXTROAMPHETAMINE SULFATE	7.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-853_ca930673-eecb-4c89-821f-c0dbd4b208b2	24338-853	HUMAN PRESCRIPTION DRUG	Zenzedi		Dextroamphetamine Sulfate	TABLET	ORAL	20130531		ANDA	ANDA090533	AZURITY PHARMACEUTICALS, INC.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-854_ca930673-eecb-4c89-821f-c0dbd4b208b2	24338-854	HUMAN PRESCRIPTION DRUG	Zenzedi		Dextroamphetamine Sulfate	TABLET	ORAL	20140501		ANDA	ANDA090533	AZURITY PHARMACEUTICALS, INC.	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-855_ca930673-eecb-4c89-821f-c0dbd4b208b2	24338-855	HUMAN PRESCRIPTION DRUG	Zenzedi		Dextroamphetamine Sulfate	TABLET	ORAL	20140501		ANDA	ANDA090533	AZURITY PHARMACEUTICALS, INC.	DEXTROAMPHETAMINE SULFATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24338-856_ca930673-eecb-4c89-821f-c0dbd4b208b2	24338-856	HUMAN PRESCRIPTION DRUG	Zenzedi		Dextroamphetamine Sulfate	TABLET	ORAL	20140501		ANDA	ANDA090533	AZURITY PHARMACEUTICALS, INC.	DEXTROAMPHETAMINE SULFATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24357-012_f905c489-05c0-0627-e053-6294a90aca28	24357-012	HUMAN PRESCRIPTION DRUG	Epinephrine Professional EMS		Epinephrine Convenience Kit	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20190701		NDA	NDA204200	Focus Health Group						N	20241231
24357-701_0c002c9f-ad88-6cba-e063-6294a90a5295	24357-701	HUMAN OTC DRUG	Anecream		Lidocaine 4%	CREAM	TOPICAL	20070601		OTC MONOGRAPH DRUG	M017	Focus Health Group	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
24357-702_0e0cb3af-dbae-57ff-e063-6394a90aa485	24357-702	HUMAN OTC DRUG	Anecream 5		Lidocaine 5%	CREAM	TOPICAL	20111220		OTC MONOGRAPH DRUG	M015	Focus Health Group	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
24385-003_0c826ee9-0b07-b7f0-e063-6394a90ac0da	24385-003	HUMAN OTC DRUG	GNP Gentian Violet 1%		Gentian Violet 1%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Amerrisource Bergen	GENTIAN VIOLET	10	mg/mL			N	20241231
24385-005_cadf822d-ef46-45bd-b6eb-4164996fc6f4	24385-005	HUMAN OTC DRUG	Good Neighbor Pharmacy Day Time		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20060720		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
24385-006_0cfa48cc-26b5-c528-e063-6394a90a3aa9	24385-006	HUMAN OTC DRUG	GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS		polyvinyl alcohol, povidone	SOLUTION/ DROPS	OPHTHALMIC	20010129		OTC MONOGRAPH DRUG	M018	AmerisourceBergen	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
24385-009_871bd1a6-0e99-40e2-af2f-39e804fa7c74	24385-009	HUMAN OTC DRUG	Good Neighbor Pharmacy ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19940809		ANDA	ANDA074937	Amerisource Bergen	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-011_32007f23-8b58-408f-b8a8-0f3a0cc5ba2d	24385-011	HUMAN OTC DRUG	Good Neighbor pharmacy muscle rub		Menthol, Methyl salicylate	CREAM	TOPICAL	20060117		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
24385-017_0d374fd6-23ac-43ce-82a2-2ad56ab8f392	24385-017	HUMAN OTC DRUG	GNP Pink Bismuth		Bismuth Subsalicylate	TABLET	ORAL	20110808		OTC MONOGRAPH FINAL	part335	Amerisource Bergen	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
24385-021_1da6a44a-e47b-4775-92a7-56ffe50b970e	24385-021	HUMAN OTC DRUG	Good Neighbor Pharmacy	Hydrocortisone Plus 12 Moisturizers	Hydrocortisone	CREAM	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	AmerisourceBergen	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24385-024_05923478-4d08-48da-9bcb-aae7f2fb5d58	24385-024	HUMAN OTC DRUG	GNP Pink Bismuth		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20110707		OTC MONOGRAPH FINAL	part335	Amerisource Bergen	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
24385-026_ca59e74a-ba95-4f3d-a3c7-9abd7435c2e0	24385-026	HUMAN OTC DRUG	Good Neighbor Pharmacy Mucus Relief DM		Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	AmerisourceBergen Drug Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24385-028_f795ad86-2dc2-4b5a-a0a3-61e890e3d6b7	24385-028	HUMAN OTC DRUG	Good Neighbor Pharmacy Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19930319		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
24385-032_a1734cdc-1ac1-4c78-be6f-b7e15287f593	24385-032	HUMAN OTC DRUG	Tolnaftate	Antifungal	Tolnaftate	CREAM	TOPICAL	20060217		OTC MONOGRAPH FINAL	part333C	Amerisource Bergen	TOLNAFTATE	10	mg/g			N	20241231
24385-034_23d9fc64-fc1a-4d1f-af2d-8b4ca72dda5b	24385-034	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20141028		OTC MONOGRAPH NOT FINAL	part333A	AmerisourceBergen	ALCOHOL	700	mg/mL			N	20241231
24385-036_2e798e16-3c68-45fe-b9a6-ae8e636715cf	24385-036	HUMAN OTC DRUG	good neighbor pharmacy day time	cold and flu	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20120802		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
24385-053_0c82455f-5207-fa88-e063-6294a90a2518	24385-053	HUMAN OTC DRUG	Povidone Iodine		povidone-iodine	SOLUTION	TOPICAL	20050201		OTC MONOGRAPH DRUG	M003	Amerisource Bergen	POVIDONE-IODINE	.1	g/mL			N	20241231
24385-054_bbe13cfe-f25e-4f48-8815-30146ab1f1a2	24385-054	HUMAN OTC DRUG	good neighbor pharmacy nasal decongestant		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19990812		ANDA	ANDA075153	Amerisource Bergen	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
24385-058_60e96ca6-82af-4314-bcab-bb59c262417c	24385-058	HUMAN OTC DRUG	Good Neighbor Pharmacy ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060614		ANDA	ANDA077349	Amerisource Bergen	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-059_c0773f33-7e8a-4f37-bf6b-96e3d06e1195	24385-059	HUMAN OTC DRUG	Good Neighbor Pharmacy ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060328		ANDA	ANDA077349	Amerisource Bergen	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-060_6f2348de-0064-44ab-99fc-590b498f5213	24385-060	HUMAN OTC DRUG	Good Neighbor Pharmacy	Bacitracin Zinc	Bacitracin Zinc	OINTMENT	TOPICAL	20060511		OTC MONOGRAPH FINAL	part333B	AmerisourceBergen	BACITRACIN ZINC	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
24385-067_a901b82c-c678-4f5e-9650-932929c7f5d3	24385-067	HUMAN OTC DRUG	good neighbor pharmacy nasal	extra moisturizing	Oxymetazoline HCl	SPRAY	NASAL	19950504		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
24385-072_0c81fa69-5856-a37e-e063-6394a90a19c6	24385-072	HUMAN OTC DRUG	GNP Caldyphen		Calamine and Pramoxine Hydrochloride	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	Amerisource Bergen	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
24385-075_0cfa2cc7-bb82-af55-e063-6394a90a28f0	24385-075	HUMAN OTC DRUG	Good Neighbor Pharmacy Eye Drops Original Formula		Tetrahydrozoline HCl 0.05%	SOLUTION/ DROPS	OPHTHALMIC	20010129		OTC MONOGRAPH DRUG	M018	AmerisourceBergen Drug Corporation	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
24385-077_0cfa2cc7-bb83-af55-e063-6394a90a28f0	24385-077	HUMAN OTC DRUG	Good Neighbor Pharmacy Eye Drops	Advanced Relief	DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20010129		OTC MONOGRAPH DRUG	M018	AmerisourceBergen Drug Corporation	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
24385-092_9f840c4e-56cc-4376-89d7-711ba274cc1d	24385-092	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	19920615	20250430	OTC MONOGRAPH FINAL	part347	AMERISOURCE BEGEN	PETROLATUM	1	g/g			N	
24385-106_340522ba-c696-4b7a-b471-23297452ec84	24385-106	HUMAN OTC DRUG	Good Neighbor Pharmacy Antacid	Extra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20100712		OTC MONOGRAPH FINAL	part331	AmerisourceBergen Drug Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
24385-110_08fe560f-f7ac-484c-960e-ee0057bc202d	24385-110	HUMAN OTC DRUG	Good Neighbor Pharmacy	Clotrimazole 3	Clotrimazole	CREAM	VAGINAL	20000412		NDA	NDA021143	AmerisourceBergen	CLOTRIMAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24385-111_bd6c54f4-4df7-4413-8c45-957602096172	24385-111	HUMAN OTC DRUG	Good Neighbor Pharmacy Heartburn Relief		Cimetidine	TABLET, FILM COATED	ORAL	20000105		ANDA	ANDA075285	Amerisource Bergen	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
24385-116_89ebd74f-9e6a-4588-8b84-c885dd52b37b	24385-116	HUMAN OTC DRUG	good neighbor pharmacy Lice		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070731		OTC MONOGRAPH FINAL	part358G	Amerisource Bergen	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
24385-118_da6715b7-a1ea-4dca-87a4-1da7dda68890	24385-118	HUMAN OTC DRUG	GNP Regular Strength Gas Relief		DIMETHICONE	TABLET, CHEWABLE	ORAL	20110808		OTC MONOGRAPH FINAL	part332	Amerisource Bergen	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
24385-121_effef46a-eecd-4e0b-e053-2a95a90a55cb	24385-121	HUMAN OTC DRUG	Soft Tip Squeeze bottle Sinus Wash	Good Neighbor Pharmacy	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		AMERISOURCE BEGEN						N	20241231
24385-125_87f06e2f-d183-4261-86fd-321abfd8102c	24385-125	HUMAN OTC DRUG	Good Neighbor Pharmacy Fiber-Caps Fiber Laxative	Stimulant Free	Calcium Polycarbophil	CAPSULE	ORAL	20100713		OTC MONOGRAPH NOT FINAL	part334	Amerisourcebergen Drug Corporation	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
24385-143_cdf59e4a-407c-4201-aff3-2563517c6787	24385-143	HUMAN OTC DRUG	Good Neighbor Pharmacy	Triple Antibiotic Plus Pain Relief	Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, and Pramoxine hydrochloride	OINTMENT	TOPICAL	20120331		OTC MONOGRAPH FINAL	part333B	Amerisource Bergen	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
24385-145_cf3ff0fc-996e-482c-bc2d-4ecb1e2d887b	24385-145	HUMAN OTC DRUG	good neighbor pharmacy pain relief	extra strength	Acetaminophen	TABLET, FILM COATED	ORAL	20060105		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	500	mg/1			N	20241231
24385-165_d4d2bfd8-a151-4f9b-8e81-8485e825df9a	24385-165	HUMAN OTC DRUG	good neighbor pharmacy arthritis pain		Trolamine Salicylate	CREAM	TOPICAL	19900215		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	TROLAMINE SALICYLATE	10	g/100g			N	20241231
24385-175_a263c717-68d2-48f2-8478-8b8e7ca456c4	24385-175	HUMAN OTC DRUG	Good Neighbor Pharmacy All Day Allergy D		Cetirizine HCl, Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20080506		ANDA	ANDA077170	Amerisource Bergen	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
24385-190_f500fedd-db75-44e4-a707-4c2d11221147	24385-190	HUMAN OTC DRUG	Good Neighbor Pharmacy	Hydrocortisone With Aloe for Sensitive Skin	Hydrocortisone	CREAM	TOPICAL	20010913		OTC MONOGRAPH NOT FINAL	part348	AmerisourceBergen	HYDROCORTISONE	.5	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24385-205_f13f5594-73a7-4993-aa62-dddd157e9322	24385-205	HUMAN OTC DRUG	Good Neighbor Pharmacy	Clotrimazole	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	AmerisourceBergen	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24385-207_0c82646c-e2f2-c014-e063-6394a90a5be6	24385-207	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Amerisource Bergen	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
24385-210_78575eb6-cbf4-4967-a519-2a9983495da1	24385-210	HUMAN OTC DRUG	Anti-Itch		Diphenhydramine hydrochloride and Zinc acetate	CREAM	TOPICAL	20050920		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
24385-213_0c82455f-520a-fa88-e063-6294a90a2518	24385-213	HUMAN OTC DRUG	GNP Idoinde Tincture 2% Mild		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Amerisource Bergen	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
24385-251_d52b1f0b-8f95-d347-e053-2a95a90a7d3b	24385-251	HUMAN OTC DRUG	Sinus Wash Saline Packets	Good Neighbor Pharmacy	SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20220108		UNAPPROVED DRUG OTHER		AMERISOURCE BEGEN	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
24385-252_d52b8515-0156-8e6b-e053-2a95a90a89de	24385-252	HUMAN OTC DRUG	Soft Tip Neti Pot Soothing Sinus Relief	Good Neighbor	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		AMERISOURCE BEGEN						N	20241231
24385-267_d852ae18-4e91-4763-e053-2995a90aa0f3	24385-267	HUMAN OTC DRUG	Sinus Wash Saline Packets	Good Neighbor Pharmacy	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220108		UNAPPROVED DRUG OTHER		AMERISOURCE BEGEN						N	20241231
24385-274_dc33c207-96bf-4aa9-aeac-4da2280d3d43	24385-274	HUMAN OTC DRUG	Good Neighbor Pharmacy	Hydrocortisone with Aloe	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	AmerisourceBergen	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24385-276_32d590c2-02bd-41e7-b28e-bffdf80e44e7	24385-276	HUMAN OTC DRUG	Good Neighbor Pharmacy	Hydrocortisone	Hydrocortisone	OINTMENT	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	AmerisourceBergen	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24385-278_26614498-c160-42ef-b068-78714eff786f	24385-278	HUMAN OTC DRUG	good neighbor pharmacy aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19970626		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
24385-352_c5a93af7-b564-4e63-8a42-acfba7ebbbda	24385-352	HUMAN OTC DRUG	Good Neighbor Pharmacy Nasal		Oxymetazoline HCl	SPRAY	NASAL	20020306		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
24385-359_f6e36a6f-0d45-4952-a110-28021c44cb3b	24385-359	HUMAN OTC DRUG	Good Neighbor Pharmacy Tussin dm		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19910827		OTC MONOGRAPH DRUG	M004	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24385-361_c96018d1-2ef9-47d8-9a82-6b2aef290d24	24385-361	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020513		ANDA	ANDA074937	Amerisource Bergen	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-365_c4fe9d07-8c87-4594-bd74-2a134d20752d	24385-365	HUMAN OTC DRUG	good neighbor pharmacy migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020513		ANDA	ANDA075794	Amerisource Bergen	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
24385-370_6a1a32f4-62b8-4ddd-a02b-16c09dc6eb1a	24385-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20141027		OTC MONOGRAPH NOT FINAL	part333A	Amerisource Begen	ALCOHOL	70	mL/100mL			N	20241231
24385-372_e5317033-bddf-47ec-959c-8ba28d5aa461	24385-372	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020402		ANDA	ANDA074937	Amerisource Bergen	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-379_63b842a7-f9d0-4d28-a8b0-c75d98a63b1b	24385-379	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Allergy		Diphenhydramine Hydrochloride	SOLUTION	ORAL	19890815		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
24385-385_f5b1cf68-bb1a-427a-a61c-5d72c3b14079	24385-385	HUMAN OTC DRUG	Good Neighbor Pharmacy Acid Reducer	Maximum Strength	Famotidine	TABLET, FILM COATED	ORAL	20061024		ANDA	ANDA077351	Amerisource Bergen	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
24385-390_9e1a7203-1a61-4638-9872-af89688698ef	24385-390	HUMAN OTC DRUG	good neighbor pharmacy nose		Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	19940401		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
24385-407_0c822f72-cc76-b188-e063-6394a90a272b	24385-407	HUMAN OTC DRUG	Calamine Phenolated Topical Suspension		Calamine and Zinc Oxide and Phenol	LOTION	TOPICAL	20080101	20260430	OTC MONOGRAPH DRUG	M016	Amerisource Bergen	PHENOL; ZINC OXIDE	10; 160	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
24385-413_0c827e0d-14a2-ad56-e063-6394a90a0de5	24385-413	HUMAN OTC DRUG	GNP Calamine Topical Suspension		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	Amerisource Bergen	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
24385-431_42f797b6-6442-4f87-bd3c-bb49aad8f11a	24385-431	HUMAN OTC DRUG	Good Neighbor Pharmacy Sleep Aid		Diphenhydramine Hydrochloride	TABLET	ORAL	20010414		OTC MONOGRAPH FINAL	part338	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
24385-432_59daa800-3923-4a17-aca5-e5755a1d7b50	24385-432	HUMAN OTC DRUG	Good Neighbor Pharmacy Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19890815		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
24385-441_32f7922d-5012-41f3-aab6-4f711d1a0453	24385-441	HUMAN OTC DRUG	Good Neighbor Pharmacy Sleep Aid		Doxylamine succinate	TABLET	ORAL	19970626		ANDA	ANDA040167	Amerisource Bergen	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
24385-451_d8517c3c-da2e-8d5e-e053-2a95a90a2b66	24385-451	HUMAN OTC DRUG	Soft Tip Neti Pot	Good Neighbor Pharmacy	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		AMERISOURCE BEGEN						N	20241231
24385-461_edbf352e-72ec-45ee-ab11-f7cd5134ec8f	24385-461	HUMAN OTC DRUG	Good Neighbor Pharmacy night time	cough	Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20030630		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24385-466_61c0e797-cc6e-414d-9205-1eb941118b4d	24385-466	HUMAN OTC DRUG	GNP Fiber Therapy		Methylcellulose	TABLET	ORAL	20110909		OTC MONOGRAPH NOT FINAL	part334	Amerisource Bergen	METHYLCELLULOSE (4000 CPS)	500	mg/1			N	20241231
24385-471_0bd2d45c-8dac-4bf0-b10c-0b63c105f355	24385-471	HUMAN OTC DRUG	good neighbor pharmacy loratadine		Loratadine	TABLET	ORAL	20081110		ANDA	ANDA076301	Amerisource Bergen	LORATADINE	10	mg/1			N	20241231
24385-479_059b3884-0ac3-44fb-98df-545e768b58ba	24385-479	HUMAN OTC DRUG	Good Neighbor Pharmacy allergy		Diphenhydramine Hydrochloride	TABLET	ORAL	19910830		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
24385-484_0ac83cdf-f008-4cb2-b8af-6bc2ed95703c	24385-484	HUMAN OTC DRUG	Good Neighbor Pharmacy Pain Relief		Acetaminophen	TABLET	ORAL	19891215		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	500	mg/1			N	20241231
24385-485_c9b3c835-9d29-40f8-a056-85d921b743e9	24385-485	HUMAN OTC DRUG	Good Neighbor Pharmacy Antacid	Regular Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20100713		OTC MONOGRAPH FINAL	part331	AmerisourceBergen Drug Corporation	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
24385-493_2c1c1f59-92c6-4f38-877c-33fd148e724c	24385-493	HUMAN OTC DRUG	Good Neighbor Pharmacy Tussin		Dextromethorphan Hydrobromide	LIQUID	ORAL	19920210		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24385-515_0c82455f-520c-fa88-e063-6294a90a2518	24385-515	HUMAN OTC DRUG	GNP Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Amerisource Bergen	CASTOR OIL	1	mg/mL			N	20241231
24385-519_16b0ec52-8217-40d5-a30c-b6cc85e80e57	24385-519	HUMAN OTC DRUG	good neighbor pharmacy cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060911		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
24385-524_ff2032fb-2379-49db-918e-b98609fe88af	24385-524	HUMAN OTC DRUG	Good Neighbor Pharmacy		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	AmerisourceBergen	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
24385-531_43fab141-e3fa-4f41-83bd-fb3724a08f6e	24385-531	HUMAN OTC DRUG	Good Neighbor Pharmacy	Childrens Loratadine	Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	AmerisourceBergen	LORATADINE	5	mg/5mL			N	20241231
24385-543_bd16275a-90f0-492e-b33b-7600b728ab0b	24385-543	HUMAN OTC DRUG	Good Neighbor Pharmacy	Childrens Loratadine	Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	AmerisourceBergen	LORATADINE	5	mg/5mL			N	20241231
24385-550_590f8dc7-19ab-4645-bb3c-fb26242c52b0	24385-550	HUMAN OTC DRUG	good neighbor pharmacy ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20041012		ANDA	ANDA075217	Amerisource Bergen	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-554_9764d636-0933-4926-8950-2e60ba594eef	24385-554	HUMAN OTC DRUG	good neighbor pharmacy anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030512		ANDA	ANDA075232	Amerisource Bergen	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
24385-578_3337935f-f7d1-427d-ae1d-8ae3c72bce7c	24385-578	HUMAN OTC DRUG	good neighbor pharmacy tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19940919		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24385-590_3cecbdc8-ab68-4f0a-a0d0-30a3609be3ad	24385-590	HUMAN OTC DRUG	Good Neighbor Pharmacy Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	19991011		ANDA	ANDA074760	Amerisource Bergen	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24385-598_05c0ff6b-c219-4968-8b8f-8354fe9fcc57	24385-598	HUMAN OTC DRUG	Good Neighbor Pharmacy Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050831		ANDA	ANDA078326	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
24385-602_0778a62e-8142-4104-92a9-072f9d3fc1d0	24385-602	HUMAN OTC DRUG	Good Neighbor Pharmacy Mucus Relief		Guaifenesin	TABLET	ORAL	20111001		OTC MONOGRAPH FINAL	part341	AmerisourceBergen Drug Corp	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
24385-603_492aa5a2-7ac0-4d46-a95b-07efb5273f78	24385-603	HUMAN OTC DRUG	good neighbor pharmacy nasal decongestant pe	non drowsy	Phenylephrine Hydrochloride	TABLET	ORAL	20050628		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
24385-604_ba365ed2-3f47-4013-a17b-0b43f4edf4be	24385-604	HUMAN OTC DRUG	good neighbor pharmacy ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19900115		ANDA	ANDA072096	Amerisource Bergen	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-606_7c90993d-337f-488d-b393-42fe7841400e	24385-606	HUMAN OTC DRUG	Good Neighbor Pharmacy Miconazole Nitrate		Miconazole nitrate	KIT		20000502		ANDA	ANDA075329	Amerisource Bergen						N	20241231
24385-619_78d90f69-0302-49b5-9271-cd2868e3b13c	24385-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20100712		OTC MONOGRAPH FINAL	part347	Amerisource Bergen	DIMETHICONE	13.13	mg/mL	Skin Barrier Activity [PE]		N	20241231
24385-647_688214f0-da01-459e-9381-79d104846e72	24385-647	HUMAN OTC DRUG	good neighbor pharmacy ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19890915		ANDA	ANDA072096	Amerisource Bergen	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-675_98157fe2-4b2b-4518-a354-56e637819a75	24385-675	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20150531	20241227	OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen Drug Corporation (Good Neighbor Pharmacy) 24385	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
24385-903_f5edba62-afea-49d4-8e2c-12369eb9ea0a	24385-903	HUMAN OTC DRUG	Laxative	Enteric Coated	Bisacodyl	TABLET, COATED	ORAL	20111024	20241227	OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen Drug Corporation (Good Neighbor Pharmacy) 24385	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
24385-904_93e66581-99e0-41e7-9197-383868b6fb45	24385-904	HUMAN OTC DRUG	Good Neighbor Pharmacy Tussin CF		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20060327		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
24385-905_a6babfc3-884b-461c-9f4b-341076b46d2e	24385-905	HUMAN OTC DRUG	good neighbor pharmacy ibuprofen		Ibuprofen	SUSPENSION	ORAL	19990128		ANDA	ANDA074937	Amerisource Bergen	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24385-985_f5377165-abd0-4392-9f56-4a3b2ab89dbe	24385-985	HUMAN OTC DRUG	Childrens Mucus Relief	cough	Dextromethorphan HBr, Guaifensin	LIQUID	ORAL	20120229		OTC MONOGRAPH FINAL	part341	AmerisourceBergen Drug Corporation (Good Neighbor Pharmacy) 24385	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24385-998_98321a10-208e-44c8-a562-c0d9098f5e9b	24385-998	HUMAN OTC DRUG	good neighbor pharmacy all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080115		ANDA	ANDA078336	Amerisource Bergen	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
24417-001_ea94086a-dfc3-31b1-e053-2a95a90abb8a	24417-001	HUMAN PRESCRIPTION DRUG	FLUDEOXYGLUCOSE F 18		FLUDEOXYGLUCOSE F-18	INJECTION	INTRAVENOUS	20111212		ANDA	ANDA203990	UIHC-P E T IMAGING CENTER	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24417-681_d8871970-cf1c-4cd2-86ed-0565c0dfb5cc	24417-681	HUMAN PRESCRIPTION DRUG	Ga-68-DOTATOC		EDOTREOTIDE GALLIUM GA-68	INJECTION, SOLUTION	INTRAVENOUS	20190901		NDA	NDA210828	UIHC  P E T Imaging Center	EDOTREOTIDE GALLIUM GA-68	4	mCi/mL			N	20241231
24450-113_19040c38-c4fb-4162-9f11-b296c1e43736	24450-113	HUMAN PRESCRIPTION DRUG	AMMONIA N-13		AMMONIA N-13	INJECTION	INTRAVENOUS	20141101		ANDA	ANDA203783	Brigham and Women's Hospital, Inc., The	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24450-647_21bdce90-ba9a-4304-876b-79a11840d532	24450-647	HUMAN PRESCRIPTION DRUG	FLUDEOXYGLUCOSE F-18		FLUDEOXYGLUCOSE F-18	INJECTION	INTRAVENOUS	20141030		ANDA	ANDA203816	BRIGHAM AND WOMEN`S HOSPITAL, INC., THE	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24470-900_efa5b935-0bba-0842-e053-2a95a90af0d1	24470-900	HUMAN OTC DRUG	BP Wash		BENZOYL PEROXIDE	EMULSION	TOPICAL	20111215		OTC MONOGRAPH FINAL	part333D	CINTEX SERVICES, LLC	BENZOYL PEROXIDE	50	mg/g			N	20241231
24470-901_efa5bd98-6348-6784-e053-2995a90a4cc0	24470-901	HUMAN OTC DRUG	BP Wash		BENZOYL PEROXIDE	EMULSION	TOPICAL	20120115		OTC MONOGRAPH FINAL	part333D	CINTEX SERVICES, LLC	BENZOYL PEROXIDE	100	mg/g			N	20241231
24470-911_b710d135-fcd9-5ce0-e053-2995a90a8a06	24470-911	HUMAN OTC DRUG	BP Wash		BENZOYL PEROXIDE	EMULSION	TOPICAL	20110815		OTC MONOGRAPH FINAL	part333D	CINTEX SERVICES, LLC	BENZOYL PEROXIDE	25	mg/g			N	20241231
24470-917_d3ad0b81-41dc-31f0-e053-2a95a90a896d	24470-917	HUMAN PRESCRIPTION DRUG	ergotamine tartrate and caffeine		ergotamine tartrate and caffeine	TABLET, FILM COATED	ORAL	20161123		ANDA	ANDA040590	Cintex Services, LLC	CAFFEINE; ERGOTAMINE TARTRATE	100; 1	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Ergotamine Derivative [EPC], Ergotamines [CS], Methylxanthine [EPC], Xanthines [CS]		N	20241231
24470-920_abbf5cd6-1be7-100a-e053-2a95a90a8b7a	24470-920	HUMAN PRESCRIPTION DRUG	DESONIDE		Desonide	GEL	TOPICAL	20200709		ANDA	ANDA202470	Cintex Services, LLC	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24470-922_b490c63a-9732-eb3a-e053-2a95a90a23f7	24470-922	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	OINTMENT	TOPICAL	20201110		ANDA	ANDA213619	Cintex Services, LLC	TRIAMCINOLONE ACETONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24470-923_fc5f1728-0a66-bbb7-e053-6394a90a73e8	24470-923	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20210923		ANDA	ANDA215158	Cintex Services, LLC	CHLORZOXAZONE	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
24470-924_0cdebf8e-9142-b74c-e063-6394a90a3229	24470-924	HUMAN PRESCRIPTION DRUG	DICLOFENAC POTASSIUM		diclofenac potassium, film coated	TABLET	ORAL	20231219		ANDA	ANDA215787	Cintex Services, LLC	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24478-074_385f574f-403c-4603-9e3c-efe1cb2b8572	24478-074	HUMAN PRESCRIPTION DRUG	QuilliChew ER		methylphenidate hydrochloride	TABLET, CHEWABLE, EXTENDED RELEASE	ORAL	20160418		NDA	NDA207960	NextWave Pharmaceuticals, Inc	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-075_385f574f-403c-4603-9e3c-efe1cb2b8572	24478-075	HUMAN PRESCRIPTION DRUG	QuilliChew ER		methylphenidate hydrochloride	TABLET, CHEWABLE, EXTENDED RELEASE	ORAL	20160418		NDA	NDA207960	NextWave Pharmaceuticals, Inc	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-076_385f574f-403c-4603-9e3c-efe1cb2b8572	24478-076	HUMAN PRESCRIPTION DRUG	QuilliChew ER		methylphenidate hydrochloride	TABLET, CHEWABLE, EXTENDED RELEASE	ORAL	20160418		NDA	NDA207960	NextWave Pharmaceuticals, Inc	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-102_4502ddc0-0a4f-4af3-bd41-8bbe0de0e774	24478-102	HUMAN PRESCRIPTION DRUG	Dyanavel XR		amphetamine	SUSPENSION, EXTENDED RELEASE	ORAL	20151001		NDA	NDA208147	NextWave Pharmaceuticals, Inc	AMPHETAMINE	2.5	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-106_4502ddc0-0a4f-4af3-bd41-8bbe0de0e774	24478-106	HUMAN PRESCRIPTION DRUG	DYANAVEL XR		amphetamine	TABLET, EXTENDED RELEASE	ORAL	20211104		NDA	NDA210526	NextWave Pharmaceuticals, Inc	AMPHETAMINE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-108_4502ddc0-0a4f-4af3-bd41-8bbe0de0e774	24478-108	HUMAN PRESCRIPTION DRUG	DYANAVEL XR		amphetamine	TABLET, EXTENDED RELEASE	ORAL	20211104		NDA	NDA210526	NextWave Pharmaceuticals, Inc	AMPHETAMINE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-109_4502ddc0-0a4f-4af3-bd41-8bbe0de0e774	24478-109	HUMAN PRESCRIPTION DRUG	DYANAVEL XR		amphetamine	TABLET, EXTENDED RELEASE	ORAL	20211104		NDA	NDA210526	NextWave Pharmaceuticals, Inc	AMPHETAMINE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-110_4502ddc0-0a4f-4af3-bd41-8bbe0de0e774	24478-110	HUMAN PRESCRIPTION DRUG	DYANAVEL XR		amphetamine	TABLET, EXTENDED RELEASE	ORAL	20211104		NDA	NDA210526	NextWave Pharmaceuticals, Inc	AMPHETAMINE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-321_90868433-fce7-422b-9e00-2e9aabec1f2c	24478-321	HUMAN PRESCRIPTION DRUG	Quillivant	XR	methylphenidate hydrochloride	SUSPENSION, EXTENDED RELEASE	ORAL	20121001		NDA	NDA202100	NextWave Pharmaceuticals, Inc	METHYLPHENIDATE HYDROCHLORIDE	300	mg/60mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-322_90868433-fce7-422b-9e00-2e9aabec1f2c	24478-322	HUMAN PRESCRIPTION DRUG	Quillivant	XR	methylphenidate hydrochloride	SUSPENSION, EXTENDED RELEASE	ORAL	20121001		NDA	NDA202100	NextWave Pharmaceuticals, Inc	METHYLPHENIDATE HYDROCHLORIDE	600	mg/120mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-323_90868433-fce7-422b-9e00-2e9aabec1f2c	24478-323	HUMAN PRESCRIPTION DRUG	Quillivant	XR	methylphenidate hydrochloride	SUSPENSION, EXTENDED RELEASE	ORAL	20121001		NDA	NDA202100	NextWave Pharmaceuticals, Inc	METHYLPHENIDATE HYDROCHLORIDE	750	mg/150mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24478-324_90868433-fce7-422b-9e00-2e9aabec1f2c	24478-324	HUMAN PRESCRIPTION DRUG	Quillivant	XR	methylphenidate hydrochloride	SUSPENSION, EXTENDED RELEASE	ORAL	20130104		NDA	NDA202100	NextWave Pharmaceuticals, Inc	METHYLPHENIDATE HYDROCHLORIDE	900	mg/180mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
24492-850_a97f6d2a-c3ba-4a4f-850a-457f3251a201	24492-850	HUMAN PRESCRIPTION DRUG	Kitabis Pak		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20150219		NDA	NDA205433	Pari Respiratory Equipment, Inc.	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
24509-0001_71425e13-a20e-4ddc-b61b-5436a5ab017e	24509-0001	HUMAN OTC DRUG	Noevir Raysela UV Shield Primer		ZINC OXIDE, OCTINOXATE	CREAM	CUTANEOUS	20180410		OTC MONOGRAPH FINAL	part352	Nippon Shikizai, Inc.	OCTINOXATE; ZINC OXIDE	69.9; 176.7	mg/g; mg/g			N	20241231
24510-050_77566648-5900-47a6-b019-e5c62f11b09a	24510-050	HUMAN PRESCRIPTION DRUG	Nucynta		tapentadol hydrochloride	TABLET, FILM COATED	ORAL	20190401		NDA	NDA022304	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	50	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24510-058_550b9ed6-ebbd-4982-9b45-6bccc9b43bb4	24510-058	HUMAN PRESCRIPTION DRUG	Nucynta	ER	tapentadol hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190419		NDA	NDA200533	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	50	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24510-075_77566648-5900-47a6-b019-e5c62f11b09a	24510-075	HUMAN PRESCRIPTION DRUG	Nucynta		tapentadol hydrochloride	TABLET, FILM COATED	ORAL	20190401		NDA	NDA022304	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	75	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24510-100_77566648-5900-47a6-b019-e5c62f11b09a	24510-100	HUMAN PRESCRIPTION DRUG	Nucynta		tapentadol hydrochloride	TABLET, FILM COATED	ORAL	20190401		NDA	NDA022304	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	100	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24510-110_748773b1-947f-437e-a875-a05076d8d56b	24510-110	HUMAN PRESCRIPTION DRUG	XTAMPZA	ER	OXYCODONE	CAPSULE, EXTENDED RELEASE	ORAL	20160510		NDA	NDA208090	Collegium Pharmaceutical, Inc.	OXYCODONE	9	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
24510-115_748773b1-947f-437e-a875-a05076d8d56b	24510-115	HUMAN PRESCRIPTION DRUG	XTAMPZA	ER	OXYCODONE	CAPSULE, EXTENDED RELEASE	ORAL	20160510		NDA	NDA208090	Collegium Pharmaceutical, Inc.	OXYCODONE	13.5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
24510-116_550b9ed6-ebbd-4982-9b45-6bccc9b43bb4	24510-116	HUMAN PRESCRIPTION DRUG	Nucynta	ER	tapentadol hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190419		NDA	NDA200533	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	100	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24510-120_748773b1-947f-437e-a875-a05076d8d56b	24510-120	HUMAN PRESCRIPTION DRUG	XTAMPZA	ER	OXYCODONE	CAPSULE, EXTENDED RELEASE	ORAL	20160510		NDA	NDA208090	Collegium Pharmaceutical, Inc.	OXYCODONE	18	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
24510-130_748773b1-947f-437e-a875-a05076d8d56b	24510-130	HUMAN PRESCRIPTION DRUG	XTAMPZA	ER	OXYCODONE	CAPSULE, EXTENDED RELEASE	ORAL	20160510		NDA	NDA208090	Collegium Pharmaceutical, Inc.	OXYCODONE	27	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
24510-140_748773b1-947f-437e-a875-a05076d8d56b	24510-140	HUMAN PRESCRIPTION DRUG	XTAMPZA	ER	OXYCODONE	CAPSULE, EXTENDED RELEASE	ORAL	20160510		NDA	NDA208090	Collegium Pharmaceutical, Inc.	OXYCODONE	36	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
24510-174_550b9ed6-ebbd-4982-9b45-6bccc9b43bb4	24510-174	HUMAN PRESCRIPTION DRUG	Nucynta	ER	tapentadol hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190419		NDA	NDA200533	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	150	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24510-232_550b9ed6-ebbd-4982-9b45-6bccc9b43bb4	24510-232	HUMAN PRESCRIPTION DRUG	Nucynta	ER	tapentadol hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190419		NDA	NDA200533	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	200	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24510-291_550b9ed6-ebbd-4982-9b45-6bccc9b43bb4	24510-291	HUMAN PRESCRIPTION DRUG	Nucynta	ER	tapentadol hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190419		NDA	NDA200533	Collegium Pharmaceutical, Inc.	TAPENTADOL HYDROCHLORIDE	250	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
24555-0002_0c511f89-82ba-9e7b-e063-6394a90a0fac	24555-0002	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20240101		ANDA	ANDA207276	Correct Rx Pharmacy Services, Inc.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
24555-0008_0c511f89-82ba-9e7b-e063-6394a90a0fac	24555-0008	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20240101		ANDA	ANDA207276	Correct Rx Pharmacy Services, Inc.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
24555-0015_0c7d1406-7c8c-ef90-e063-6394a90ad8e5	24555-0015	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA065256	Correct Rx Pharmacy Services, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
24555-0199_0ccf5ed7-034e-e3d5-e063-6294a90ad9db	24555-0199	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20240101		ANDA	ANDA078925	Correct Rx Pharmacy Services, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
24555-0319_0c52aa5e-cb31-f0af-e063-6294a90a557b	24555-0319	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA091625	Correct Rx Pharmacy Services, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24555-0320_0c52aa5e-cb31-f0af-e063-6294a90a557b	24555-0320	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA091625	Correct Rx Pharmacy Services, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24555-0321_0c52aa5e-cb31-f0af-e063-6294a90a557b	24555-0321	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA091625	Correct Rx Pharmacy Services, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24555-0332_0ccc58ec-9f0c-f6ee-e063-6394a90ac043	24555-0332	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20240101		ANDA	ANDA077321	Correct Rx Pharmacy Services, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
24555-0333_0ccc58ec-9f0c-f6ee-e063-6394a90ac043	24555-0333	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20240101		ANDA	ANDA077321	Correct Rx Pharmacy Services, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
24555-0334_0ccc58ec-9f0c-f6ee-e063-6394a90ac043	24555-0334	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20240101		ANDA	ANDA077321	Correct Rx Pharmacy Services, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
24555-0335_0ccc58ec-9f0c-f6ee-e063-6394a90ac043	24555-0335	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20240101		ANDA	ANDA077321	Correct Rx Pharmacy Services, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
24555-0486_0ccc58ec-9f0c-f6ee-e063-6394a90ac043	24555-0486	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20240101		ANDA	ANDA077321	Correct Rx Pharmacy Services, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
24555-0674_0c7ce3d7-64f9-70fc-e063-6294a90a3ffd	24555-0674	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20240101		ANDA	ANDA087479	Correct Rx Pharmacy Services, Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
24555-0676_0c7ce3d7-64f9-70fc-e063-6294a90a3ffd	24555-0676	HUMAN PRESCRIPTION DRUG	Hydroxyzine pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20240101		ANDA	ANDA086183	Correct Rx Pharmacy Services, Inc.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
24555-0720_0ccef180-0e7d-cf2b-e063-6394a90adf0c	24555-0720	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20240101		ANDA	ANDA078043	Correct Rx Pharmacy Services, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
24555-0721_0ccef180-0e7d-cf2b-e063-6394a90adf0c	24555-0721	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20240101		ANDA	ANDA078043	Correct Rx Pharmacy Services, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
24555-2020_0c7d1ebd-8f61-8fa8-e063-6294a90a3bf9	24555-2020	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20240101		ANDA	ANDA064076	Correct Rx Pharmacy Services, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
24555-2613_0c7d1ebd-8f61-8fa8-e063-6294a90a3bf9	24555-2613	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20240101		ANDA	ANDA064076	Correct Rx Pharmacy Services, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
24559-001_0c5b3fe9-184f-0f34-e063-6294a90ad802	24559-001	HUMAN OTC DRUG	INTELLIGENT BEAUTY LABS Age Defying Day Broad Spectrum SPF 20		AVOBENZONE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20130125		OTC MONOGRAPH DRUG	M020	DermStore, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	20; 75; 46	mg/mL; mg/mL; mg/mL			N	20241231
24562-001_fb6abb63-1d1f-4f67-9302-de6340bca1b3	24562-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose	F 18	Fludeoxyglucose F-18	INJECTION, SOLUTION	INTRAVENOUS	20150514		ANDA	ANDA203710	Biomedical Research Foundation of Northwest Louisiana	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24562-002_0e9be92f-b0e1-4c34-a786-6a84fdfb9833	24562-002	HUMAN PRESCRIPTION DRUG	Sodium Fluoride F 18		SODIUM FLUORIDE F-18	INJECTION, SOLUTION	INTRAVENOUS	20150122		ANDA	ANDA204351	Biomedical Research Foundation of Northwest Louisiana	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24562-003_b0279f0d-06f8-4958-b492-22ba4e9361d5	24562-003	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F18		Fludeoxyglucose F-18	INJECTION, SOLUTION	INTRAVENOUS	20150514		ANDA	ANDA203837	Biomedical Research Foundation of Northwest Louisiana	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24562-004_f15cd29f-ae65-4b11-bafc-1876673181f5	24562-004	HUMAN PRESCRIPTION DRUG	Ammonia N 13		Ammonia N-13	INJECTION, SOLUTION	INTRAVENOUS	20150514		ANDA	ANDA204352	Biomedical Research Foundation of Northwest Louisiana	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
24571-102_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-102	HUMAN PRESCRIPTION DRUG	PRISMASOL	BGK2/0	magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride	INJECTION	INTRAVENOUS	20061025		NDA	NDA021703	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	22; 5.4; 2.03; .157; 3.09; 6.46	g/L; g/L; g/L; g/L; g/L; g/L	Acidifying Activity [MoA], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-103_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-103	HUMAN PRESCRIPTION DRUG	PRISMASOL	BGK2/3.5	calcium chloride, magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride	INJECTION	INTRAVENOUS	20061025		NDA	NDA021703	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	5.15; 22; 5.4; 2.03; .157; 3.09; 6.46	g/L; g/L; g/L; g/L; g/L; g/L; g/L	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-105_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-105	HUMAN PRESCRIPTION DRUG	PRISMASOL	BGK4/2.5	calcium chloride, magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride	INJECTION	INTRAVENOUS	20061025		NDA	NDA021703	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	3.68; 22; 5.4; 3.05; .314; 3.09; 6.46	g/L; g/L; g/L; g/L; g/L; g/L; g/L	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-108_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-108	HUMAN PRESCRIPTION DRUG	PRISMASOL	BGK0/2.5	calcium chloride, magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride and sodium bicarbonate	INJECTION	INTRAVENOUS	20061025		NDA	NDA021703	Baxter Healthcare Corporation	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	3.68; 22; 5.4; 3.05; 3.09; 6.46	g/L; g/L; g/L; g/L; g/L; g/L	Acidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-111_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-111	HUMAN PRESCRIPTION DRUG	PRISMASOL	B22GK4/0	magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride	INJECTION	INTRAVENOUS	20061025		NDA	NDA021703	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	22; 5.4; 3.05; .314; 2.21; 7.07	g/L; g/L; g/L; g/L; g/L; g/L	Acidifying Activity [MoA], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-113_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-113	HUMAN PRESCRIPTION DRUG	PRISMASOL	BK0/0/1.2	magnesium chloride, lactic acid, sodium chloride and sodium bicarbonate	INJECTION	INTRAVENOUS	20061025		NDA	NDA021703	Baxter Healthcare Corporation	LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	5.4; 2.44; 3.09; 6.46	g/L; g/L; g/L; g/L	Acidifying Activity [MoA], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-114_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-114	HUMAN PRESCRIPTION DRUG	PRISMASOL	BGK4/0/1.2	magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride	INJECTION	INTRAVENOUS	20061025		NDA	NDA021703	Baxter Healthcare Corporation	DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	22; 5.4; 2.44; .314; 3.09; 6.46	g/L; g/L; g/L; g/L; g/L; g/L	Acidifying Activity [MoA], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-116_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-116	HUMAN PRESCRIPTION DRUG	PHOXILLUM	BK4/2.5	calcium chloride, magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride and sodium phosphate dibasic dihydrate	INJECTION	INTRAVENOUS	20150113		NDA	NDA207026	Baxter Healthcare Corporation	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, DIHYDRATE	3.68; 3.05; .314; 3.09; 6.34; .187	g/L; g/L; g/L; g/L; g/L; g/L	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-117_51955077-01ba-49f1-97b6-b2189b15e8aa	24571-117	HUMAN PRESCRIPTION DRUG	PHOXILLUM	B22K4/0	magnesium chloride, sodium chloride, sodium bicarbonate, potassium chloride and sodium phosphate dibasic dihydrate	INJECTION	INTRAVENOUS	20150113		NDA	NDA207026	Baxter Healthcare Corporation	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, DIHYDRATE	3.05; .314; 2.21; 6.95; .187	g/L; g/L; g/L; g/L; g/L	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24571-123_267ae8b8-32c6-40f8-b977-0d4bd67122b9	24571-123	HUMAN PRESCRIPTION DRUG	REGIOCIT		Sodium Chloride, Sodium Citrate	INJECTION, SOLUTION	EXTRACORPOREAL	20200918		UNAPPROVED DRUG OTHER		Baxter Healthcare Corporation	SODIUM CHLORIDE; SODIUM CITRATE, UNSPECIFIED FORM	5.03; 5.29	g/1000mL; g/1000mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
24584-1111_6c052e39-545c-4686-aa3e-d17ab471a50e	24584-1111	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20190402		ANDA	ANDA212432	Piramal Healthcare UK Limited	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
24584-1112_6c052e39-545c-4686-aa3e-d17ab471a50e	24584-1112	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20190402		ANDA	ANDA212432	Piramal Healthcare UK Limited	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
24658-260_0e1f9b8f-3cc0-4ece-9d2c-dd767a3be47c	24658-260	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20110401		ANDA	ANDA078012	PuraCap Laboratories LLC dba Blu Pharmaceuticals	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
24658-261_9333c674-5714-41ed-8a16-dc7c3e50b9a4	24658-261	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET	ORAL	20230823		ANDA	ANDA207752	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-262_9333c674-5714-41ed-8a16-dc7c3e50b9a4	24658-262	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET	ORAL	20230823		ANDA	ANDA207752	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-263_9333c674-5714-41ed-8a16-dc7c3e50b9a4	24658-263	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET	ORAL	20230823		ANDA	ANDA207752	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-264_9333c674-5714-41ed-8a16-dc7c3e50b9a4	24658-264	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET	ORAL	20230823		ANDA	ANDA207752	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-266_d82647da-465b-4e2e-8cf8-72d50f047b3e	24658-266	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20230314		ANDA	ANDA074557	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
24658-270_31655681-125c-4eaa-959b-8f434bb43590	24658-270	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE LIGHT		cholestyramine light	POWDER, FOR SUSPENSION	ORAL	20230314		ANDA	ANDA074558	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	CHOLESTYRAMINE	4	g/5.7g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
24658-271_31655681-125c-4eaa-959b-8f434bb43590	24658-271	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE LIGHT		cholestyramine light	POWDER, FOR SUSPENSION	ORAL	20230314		ANDA	ANDA074558	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	CHOLESTYRAMINE	4	g/5.7g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
24658-311_99ca92d7-b096-4c60-be78-ced4e19046cb	24658-311	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20211119		ANDA	ANDA062269	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
24658-312_99ca92d7-b096-4c60-be78-ced4e19046cb	24658-312	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20131125		ANDA	ANDA062269	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
24658-350_52d4fc86-227a-4a74-9f42-50fd184714d8	24658-350	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		OMEGA-3-ACID ETHYL ESTERS	CAPSULE, LIQUID FILLED	ORAL	20200702		ANDA	ANDA210093	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
24658-500_308c04fb-d7de-2e5d-33e0-0b933531ae6c	24658-500	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	PuraCap Laboratories, LLC	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-501_308c04fb-d7de-2e5d-33e0-0b933531ae6c	24658-501	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	PuraCap Laboratories, LLC	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-502_308c04fb-d7de-2e5d-33e0-0b933531ae6c	24658-502	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	PuraCap Laboratories, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-503_308c04fb-d7de-2e5d-33e0-0b933531ae6c	24658-503	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	PuraCap Laboratories, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-504_308c04fb-d7de-2e5d-33e0-0b933531ae6c	24658-504	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	PuraCap Laboratories, LLC	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
24658-700_7ee988e7-153d-4d55-b4ec-1a8da8f78f1d	24658-700	HUMAN PRESCRIPTION DRUG	Betaxolol		Betaxolol	TABLET, FILM COATED	ORAL	20160822		ANDA	ANDA075541	PuraCap Laboratories LLC	BETAXOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24658-701_7ee988e7-153d-4d55-b4ec-1a8da8f78f1d	24658-701	HUMAN PRESCRIPTION DRUG	Betaxolol		Betaxolol	TABLET, FILM COATED	ORAL	20160822		ANDA	ANDA075541	PuraCap Laboratories LLC	BETAXOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24658-702_97ace322-341a-4d52-8c63-17265ed9aa8d	24658-702	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20210910		ANDA	ANDA040275	PURACAP LABORATORIES, LLC	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
24658-703_97ace322-341a-4d52-8c63-17265ed9aa8d	24658-703	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20210910		ANDA	ANDA040275	PURACAP LABORATORIES, LLC	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
24658-704_97ace322-341a-4d52-8c63-17265ed9aa8d	24658-704	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20210910		ANDA	ANDA040275	PURACAP LABORATORIES, LLC	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
24658-706_63e01689-305e-47f2-b74b-0edeb0069b09	24658-706	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	20200430		ANDA	ANDA207531	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
24658-708_63e01689-305e-47f2-b74b-0edeb0069b09	24658-708	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	20200430		ANDA	ANDA207531	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
24658-710_7e91e43f-0422-f04b-e053-2a91aa0a2a09	24658-710	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline Hydrochloride	TABLET, FILM COATED	ORAL	20171007		ANDA	ANDA065447	PuraCap Laboratories LLC	DEMECLOCYCLINE HYDROCHLORIDE	150	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
24658-711_7e91e43f-0422-f04b-e053-2a91aa0a2a09	24658-711	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline Hydrochloride	TABLET, FILM COATED	ORAL	20171007		ANDA	ANDA065447	PuraCap Laboratories LLC	DEMECLOCYCLINE HYDROCHLORIDE	300	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
24658-720_a0b7130d-d064-4916-80c6-c1168a21ed0c	24658-720	HUMAN PRESCRIPTION DRUG	Flavoxate Hydrochloride		Flavoxate Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA076835	PuraCap Laboratories LLC dba Blu Pharmaceuticals	FLAVOXATE HYDROCHLORIDE	100	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
24658-730_7ea99ece-0ef4-6bd1-e053-2a91aa0a7e8c	24658-730	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20161114		ANDA	ANDA074673	PuraCap Laboratories LLC dba Blu Pharmaceuticals	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24658-731_7ea99ece-0ef4-6bd1-e053-2a91aa0a7e8c	24658-731	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20161114		ANDA	ANDA074673	PuraCap Laboratories LLC dba Blu Pharmaceuticals	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24658-750_69c60be8-143d-4a50-8a66-46c01c416372	24658-750	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20161215		ANDA	ANDA074928	PuraCap Laboratories LLC dba Blu Pharmaceuticals	NICARDIPINE HYDROCHLORIDE	20	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24658-751_69c60be8-143d-4a50-8a66-46c01c416372	24658-751	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20161215		ANDA	ANDA074928	PuraCap Laboratories LLC dba Blu Pharmaceuticals	NICARDIPINE HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24658-760_ae811fb8-9a78-496f-b710-663bc678f8e7	24658-760	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20161215		ANDA	ANDA202333	PuraCap Laboratories, LLC	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
24658-770_58719d2a-5a17-4651-bb1d-0cc5df85be11	24658-770	HUMAN PRESCRIPTION DRUG	SULINDAC		SULINDAC	TABLET	ORAL	20161114		ANDA	ANDA072710	PuraCap Laboratories LLC dba Blu Pharmaceuticals	SULINDAC	150	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24658-771_58719d2a-5a17-4651-bb1d-0cc5df85be11	24658-771	HUMAN PRESCRIPTION DRUG	SULINDAC		SULINDAC	TABLET	ORAL	20161114		ANDA	ANDA072711	PuraCap Laboratories LLC dba Blu Pharmaceuticals	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
24658-780_b72f499b-e040-4c74-84cf-14d3e7da7245	24658-780	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20161215		ANDA	ANDA075517	PuraCap Laboratories, LLC	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
24658-790_7ea9ad08-6f32-ebc1-e053-2a91aa0a7ade	24658-790	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160401		ANDA	ANDA075965	PuraCap Laboratories LLC dba Blu Pharmaceuticals	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
24658-791_7ea9ad08-6f32-ebc1-e053-2a91aa0a7ade	24658-791	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160401		ANDA	ANDA075965	PuraCap Laboratories LLC dba Blu Pharmaceuticals	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
24658-792_7ea9ad08-6f32-ebc1-e053-2a91aa0a7ade	24658-792	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160401		ANDA	ANDA075965	PuraCap Laboratories LLC dba Blu Pharmaceuticals	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
24658-793_14002bad-2577-436d-91ca-ec1b80ab0c97	24658-793	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20230314		ANDA	ANDA210675	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
24658-794_14002bad-2577-436d-91ca-ec1b80ab0c97	24658-794	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20230314		ANDA	ANDA210675	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
24658-795_14002bad-2577-436d-91ca-ec1b80ab0c97	24658-795	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20230314		ANDA	ANDA210675	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
24658-796_14002bad-2577-436d-91ca-ec1b80ab0c97	24658-796	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20230314		ANDA	ANDA210675	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
24658-797_14002bad-2577-436d-91ca-ec1b80ab0c97	24658-797	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20230314		ANDA	ANDA210675	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
24658-798_fc98e7a7-06f6-4036-b973-43fae1b77ccc	24658-798	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	TABLET	ORAL	20230124		ANDA	ANDA213928	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
24658-799_fc98e7a7-06f6-4036-b973-43fae1b77ccc	24658-799	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	TABLET	ORAL	20230124		ANDA	ANDA213928	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	AMINOCAPROIC ACID	1000	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
24658-801_28109dee-3e5e-492b-b7d9-9ba46c0b5324	24658-801	HUMAN PRESCRIPTION DRUG	RIFAMPIN		rifampin	CAPSULE	ORAL	20230314		ANDA	ANDA064150	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	RIFAMPIN	150	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
24658-802_28109dee-3e5e-492b-b7d9-9ba46c0b5324	24658-802	HUMAN PRESCRIPTION DRUG	RIFAMPIN		rifampin	CAPSULE	ORAL	20230314		ANDA	ANDA064150	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
24658-999_8f808940-188e-4624-aee2-a84e3d7b58d7	24658-999	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20210930		ANDA	ANDA075517	PuraCap Laboratories, LLC	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
24689-101_ced62618-e87e-12b9-e053-2a95a90a3013	24689-101	HUMAN PRESCRIPTION DRUG	Hydroquinone cream		Hydroquinone	CREAM	TOPICAL	20211101		UNAPPROVED DRUG OTHER		APNAR PHARMA LP	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
24689-102_da4ff888-1b0c-8c8b-e053-2995a90a13fa	24689-102	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20211001		UNAPPROVED DRUG OTHER		APNAR PHARMA LP	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24689-103_da4ff888-1b0c-8c8b-e053-2995a90a13fa	24689-103	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20211001		UNAPPROVED DRUG OTHER		APNAR PHARMA LP	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
24689-104_d42f2d2e-b9f9-7c22-e053-2995a90a9661	24689-104	HUMAN PRESCRIPTION DRUG	PRYIDOSTIGMINE BROMIDE		pyridostigmine bromide	SOLUTION	ORAL	20220120		ANDA	ANDA208797	Apnar Pharma LP	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
24689-105_d4595cc8-7960-6c44-e053-2995a90adb3e	24689-105	HUMAN PRESCRIPTION DRUG	AMANTADINE HYDROCHLORIDE		amantadine hydrochloride	CAPSULE	ORAL	20220120		ANDA	ANDA210129	APNAR PHARMA LP	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
24689-106_d46add79-d825-19ec-e053-2995a90aeced	24689-106	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		levetiracetam	SOLUTION	ORAL	20220120		ANDA	ANDA078582	APNAR PHARMA LP	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
24689-112_d446abf8-c0db-f07f-e053-2995a90a353c	24689-112	HUMAN PRESCRIPTION DRUG	AMANTADINE HYDROCHLORIDE		amantadine hydrochloride	TABLET	ORAL	20220120		ANDA	ANDA210215	Apnar Pharma LP	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
24689-119_ed02a41a-81ec-5021-e053-2995a90a2412	24689-119	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20211220		ANDA	ANDA075584	Apnar Pharma LP	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
24689-120_ed02a41a-81ec-5021-e053-2995a90a2412	24689-120	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20211220		ANDA	ANDA075584	Apnar Pharma LP	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
24689-121_f17e72c0-45e7-1e82-e053-2a95a90a115f	24689-121	HUMAN OTC DRUG	Acetaminophen,Caffeine and Pyrilamine Maleate		Acetaminophen,Caffeine and Pyrilamine Maleate	TABLET	ORAL	20220705		OTC MONOGRAPH NOT FINAL	part343	APNAR PHARMA LP	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
24689-122_f17dd3fb-510e-011b-e053-2a95a90a57e4	24689-122	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20221230		OTC MONOGRAPH FINAL	part341	APNAR PHARMA LP	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
24689-123_f17dcc88-303d-4e1f-e053-2a95a90ae08d	24689-123	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan Hydrobromide		Guaifenesin and Dextromethorphan Hydrobromide	TABLET	ORAL	20221230		OTC MONOGRAPH FINAL	part341	APNAR PHARMA LP	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
24689-124_0836052f-6382-9f0f-e063-6294a90a1e98	24689-124	HUMAN OTC DRUG	Lidocaine 5%		Lidocaine	CREAM	RECTAL; TOPICAL	20211101		OTC MONOGRAPH DRUG	M015	Apnar Pharma LP	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
24689-129_ec9edf75-b9cd-0b99-e053-2995a90a391f	24689-129	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20221121		OTC MONOGRAPH NOT FINAL	part334	Apnar Pharma LP	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24689-130_05b0732b-0130-78ee-e063-6294a90a839a	24689-130	HUMAN OTC DRUG	Docusate sodium		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20230925		OTC MONOGRAPH FINAL	M007	APNAR PHARMA LP	DOCUSATE SODIUM	100	mg/1			N	20241231
24689-132_08353d99-4377-eb64-e063-6294a90aa949	24689-132	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20220805		OTC MONOGRAPH DRUG	M001	APNAR PHARMA LP	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
24689-137_08352100-b59d-c799-e063-6294a90a5e3b	24689-137	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	TABLET	ORAL	20220624		OTC MONOGRAPH DRUG	M001	APNAR PHARMA LP	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
24689-138_e4d785a7-a689-3acb-e053-2a95a90a6d2e	24689-138	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220729		OTC MONOGRAPH FINAL	M009	APNAR PHARMA LP	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
24689-139_e4d785a7-a689-3acb-e053-2a95a90a6d2e	24689-139	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220729		OTC MONOGRAPH FINAL	M009	APNAR PHARMA LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
24689-144_0835c630-aaf2-b231-e063-6394a90a46c7	24689-144	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20220805		OTC MONOGRAPH DRUG	M012	APNAR PHARMA LP	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
24689-146_ed43bf21-f3db-245c-e053-2995a90a504c	24689-146	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20221121		OTC MONOGRAPH FINAL	M009	APNAR PHARMA LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
24689-152_08358a96-cb92-14cd-e063-6394a90ac029	24689-152	HUMAN OTC DRUG	DAYTIME NIGHTTIME COLD FLU RELIEF		Acetaminophen, Dextromethorphan hbr, Doxylamine succinate, Phenylephrine hcl	KIT		20230511		OTC MONOGRAPH DRUG	M012	APNAR PHARMA LP						N	20241231
24689-154_faaf5d51-d81e-3acc-e053-6294a90ae08f	24689-154	HUMAN OTC DRUG	SleepAid (Diphenhydramine HCL)		Diphenhydramine HCL	CAPSULE, LIQUID FILLED	ORAL	20230504		OTC MONOGRAPH FINAL	M010	APNAR PHARMA LP	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
24689-792_fe9e2ceb-8b5f-3773-e053-6294a90ad5f5	24689-792	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Apnar Pharma LP	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
24689-855_fe9e2ceb-8b5f-3773-e053-6294a90ad5f5	24689-855	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Apnar Pharma LP	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
24689-882_fe9e2ceb-8b5f-3773-e053-6294a90ad5f5	24689-882	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Apnar Pharma LP	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
24689-961_fe9e2ceb-8b5f-3773-e053-6294a90ad5f5	24689-961	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Apnar Pharma LP	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
24694-001_8cd8eb0c-f493-4045-a941-3eaf075c16c6	24694-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19980101		NDA	NDA205849	Greenville Truck and Welding Supplies LLC	OXYGEN	99	L/100L			N	20241231
24724-014_7ba4b972-10a4-43d3-9b5f-ec4915db9d88	24724-014	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, FILM COATED	ORAL	20090603		ANDA	ANDA079148	INDICUS PHARMA LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
24724-015_7ba4b972-10a4-43d3-9b5f-ec4915db9d88	24724-015	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, FILM COATED	ORAL	20090603		ANDA	ANDA079148	INDICUS PHARMA LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
24724-016_7ba4b972-10a4-43d3-9b5f-ec4915db9d88	24724-016	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, FILM COATED	ORAL	20090603		ANDA	ANDA079148	INDICUS PHARMA LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
24765-001_0d0b0996-2086-e38b-e063-6294a90ae522	24765-001	HUMAN OTC DRUG	MIRACLE STEMCELL ALL-IN-ONE		Dexpanthenol, Niacinamide	SHAMPOO	TOPICAL	20231208		UNAPPROVED DRUG OTHER		PHARMACAL-INTERNATIONAL. CO., LTD	DEXPANTHENOL; NIACINAMIDE	.2; .1	g/100g; g/100g			N	20241231
24765-105_03245ecc-f05c-f36b-e063-6294a90aa9fc	24765-105	HUMAN OTC DRUG	myCellCare		GLYCERIN	CREAM	TOPICAL	20161007		UNAPPROVED DRUG OTHER		Pharmacal-International. Co., Ltd.	GLYCERIN	.175	mg/5mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
24765-109_03245ecc-f065-f36b-e063-6294a90aa9fc	24765-109	HUMAN OTC DRUG	Cellzyme Secret Therapy		GLYCERIN,HYDROXYETHYL ETHYLCELLULOSE ,ALLANTOIN	LIQUID	TOPICAL	20170816		UNAPPROVED DRUG OTHER		PHARMACAL-INTERNATIONAL. CO., LTD	ALLANTOIN; GLYCERIN; HYDROXYETHYL ETHYLCELLULOSE	.145; 5.2; 1.925	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
24765-127_03245e1b-54fb-949b-e063-6294a90a4e54	24765-127	HUMAN OTC DRUG	Dental Clear Premium		SODIUM FLUORIDE	RINSE	ORAL	20200314		UNAPPROVED DRUG OTHER		Pharmacal-International. Co., Ltd.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
24765-132_032473cc-b87a-61c9-e063-6294a90a8a2e	24765-132	HUMAN OTC DRUG	Killfire Mouthwash		SODIUM FLUORIDE	RINSE	ORAL	20210525		UNAPPROVED DRUG OTHER		Pharmacal-International. Co., Ltd.	SODIUM FLUORIDE	.02	g/100mL			N	20241231
24765-133_03243f48-b5e4-c0bb-e063-6394a90a3157	24765-133	HUMAN OTC DRUG	Kill fireToothpaste		SODIUM FLUORIDE	PASTE	ORAL	20210615		UNAPPROVED DRUG OTHER		Pharmacal-International. Co., Ltd.	SODIUM FLUORIDE	.02	g/100g			N	20241231
24765-134_03243f48-b5ef-c0bb-e063-6394a90a3157	24765-134	HUMAN OTC DRUG	Killfire mouth freshener		Cetylpyridinium Chloride	SPRAY	ORAL	20211029		UNAPPROVED DRUG OTHER		Pharmacal-International. Co., Ltd.	CETYLPYRIDINIUM CHLORIDE	.05	g/100mL			N	20241231
24794-100_d60ad691-00fd-da4f-e053-2a95a90a646b	24794-100	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-101_d60ad646-f3cd-676b-e053-2a95a90a9b30	24794-101	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-102_d60ad646-f3d7-676b-e053-2a95a90a9b30	24794-102	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-103_d61895e1-6f77-4d3d-e053-2995a90a1729	24794-103	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-104_d618924d-d63d-3f93-e053-2a95a90a9439	24794-104	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-105_d6189e9f-f384-2bef-e053-2a95a90af5eb	24794-105	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-106_d618a91c-6ade-e039-e053-2a95a90ac04d	24794-106	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-107_d618aed2-f47f-3d82-e053-2a95a90a4c25	24794-107	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-108_d5f4f5b4-2d80-6c1b-e053-2995a90ab23b	24794-108	HUMAN PRESCRIPTION DRUG	Zap Neutral		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	4.086	g/454g			N	20241231
24794-109_d618b2f9-a1fe-7dc0-e053-2a95a90adef1	24794-109	HUMAN PRESCRIPTION DRUG	Zap APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Crosstex International Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
24794-220_d618d600-e573-0793-e053-2a95a90a4c94	24794-220	HUMAN OTC DRUG	Gumnumb Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Crosstex International Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
24794-221_d618d90d-cd4f-4e4d-e053-2a95a90ad09b	24794-221	HUMAN OTC DRUG	Gumnumb Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Crosstex International Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
24794-222_d618dc41-812c-381f-e053-2a95a90ae31d	24794-222	HUMAN OTC DRUG	Gumnumb Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Crosstex International Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
24794-223_d618fcdf-8de3-ca4d-e053-2a95a90a6d84	24794-223	HUMAN OTC DRUG	Gumnumb Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Crosstex International Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
24794-224_d618ffce-a6f6-251b-e053-2a95a90a141b	24794-224	HUMAN OTC DRUG	Gumnumb Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Crosstex International Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
24794-225_d61905c0-3d7b-92c0-e053-2995a90ad1f3	24794-225	HUMAN OTC DRUG	Gumnumb Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Crosstex International Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
24882-001_f3b98129-baa6-42b9-e053-2a95a90a56d7	24882-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Foundation Health, LLC	OXYGEN	99	L/100L			N	20241231
24887-001_f3c2da09-c766-4b37-9cff-f6f0a844855d	24887-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19920101		NDA	NDA206023	Superior Oxygen & Medical Equipment	OXYGEN	99	L/100L			N	20241231
24909-010_f650a45a-4958-31a9-e053-2995a90a619a	24909-010	HUMAN OTC DRUG	MYCO Clinic Pain Relief		Menthol	CREAM	TOPICAL	20230224		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	MENTHOL	4	g/100g			N	20241231
24909-011_f650a8c8-a37f-6f62-e053-2a95a90a2de4	24909-011	HUMAN OTC DRUG	MYCO Clinic Pain Relief		Camphor, Menthol	OIL	TOPICAL	20230224		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	CAMPHOR (NATURAL); MENTHOL	3.1; 7	g/100mL; g/100mL			N	20241231
24909-012_f650ae78-f76e-d557-e053-2995a90ad546	24909-012	HUMAN OTC DRUG	MYCO Clinic Pain Relief		Camphor, Menthol	STICK	TOPICAL	20230224		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	CAMPHOR (NATURAL); MENTHOL	11; 16	g/100g; g/100g			N	20241231
24909-013_f650a8c8-a389-6f62-e053-2a95a90a2de4	24909-013	HUMAN OTC DRUG	MYCO Clinic Pain Relief		Camphor, Menthol	OINTMENT	TOPICAL	20230224		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	CAMPHOR (NATURAL); MENTHOL	11; 16	g/100g; g/100g			N	20241231
24909-025_fc896f3b-fa22-cc1a-e053-6294a90a7d25	24909-025	HUMAN OTC DRUG	TerrasilMed Infection Control and Protection		Allantoin,Benzethonium Chloride	OINTMENT	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part333A	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN; BENZETHONIUM CHLORIDE	.5; .1	g/100g; g/100g			N	20241231
24909-026_fc89863d-d366-3370-e053-6294a90a8837	24909-026	HUMAN OTC DRUG	TerrasilMed ANTIFUNGAL		Clotrimazole	OINTMENT	TOPICAL	20230508		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-027_fc89863d-d371-3370-e053-6294a90a8837	24909-027	HUMAN OTC DRUG	TerrasilMed BURN CARE		Allantoin,Menthol	OINTMENT	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN; MENTHOL	.5; .15	g/100g; g/100g			N	20241231
24909-028_fc89b67e-c195-4c34-e053-6394a90a45e4	24909-028	HUMAN OTC DRUG	TerrasilMed Wound Cleanser		Allantoin,Benzethonium Chloride	OINTMENT	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part333A	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN; BENZETHONIUM CHLORIDE	.5; .2	g/100mL; g/100mL			N	20241231
24909-029_0b76e13e-b6dd-3582-e063-6294a90a7258	24909-029	HUMAN OTC DRUG	TerrasilMed ONC		ALLANTOIN	OINTMENT	TOPICAL	20230916		OTC MONOGRAPH DRUG	M016	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN	.5	g/100g			N	20241231
24909-030_0940efa3-402c-991d-e063-6294a90a7aef	24909-030	HUMAN OTC DRUG	terrasil Infection Protection Wound Care		ALLANTOIN	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	ALLANTOIN	.5	g/100g			N	20241231
24909-031_094103e7-ca03-04c2-e063-6294a90a68cf	24909-031	HUMAN OTC DRUG	terrasil Infection Protection Wound Care Maximum Strength		ALLANTOIN	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	ALLANTOIN	.6	g/100g			N	20241231
24909-032_0b5ff49f-f831-fefb-e063-6294a90a983a	24909-032	HUMAN OTC DRUG	terrasil Skin Repair		ALLANTOIN	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	ALLANTOIN	.5	g/100g			N	20241231
24909-033_0940d87c-e207-9211-e063-6394a90a3b4f	24909-033	HUMAN OTC DRUG	terrasil Skin Repair Maximum Strength		ALLANTOIN	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	ALLANTOIN	.6	g/100g			N	20241231
24909-034_0b5ff6b2-eb7f-6d6f-e063-6394a90a6ee8	24909-034	HUMAN OTC DRUG	terrasil Diabetics Ulcer and Sore Relief		ALLANTOIN	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	ALLANTOIN	.6	g/100g			N	20241231
24909-035_0b5feb0a-28c3-ef9e-e063-6294a90ae58a	24909-035	HUMAN OTC DRUG	terrasil Bed Sore and Pressure Sore Relief		ALLANTOIN	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	ALLANTOIN	.6	g/100g			N	20241231
24909-036_05e3732c-7c6a-119e-e063-6294a90a970a	24909-036	HUMAN OTC DRUG	Terrasil Tinea Antifungal Cleansing Bar		THUJA OCCIDENTALIS WHOLE	SOAP	TOPICAL	20230901		UNAPPROVED HOMEOPATHIC		Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	THUJA OCCIDENTALIS WHOLE	6	[hp_X]/g			N	20241231
24909-037_0890cd78-11da-b007-e063-6394a90a3e2c	24909-037	HUMAN OTC DRUG	terrasil Antifungal Cleansing Bar		CLOTRIMAZOLE	SOAP	TOPICAL	20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-038_09aa1e48-454d-491b-e063-6394a90ab19a	24909-038	HUMAN OTC DRUG	terrasil The Fungal Solution Kit		CLOTRIMAZOLE	KIT		20231002		OTC MONOGRAPH DRUG	M005	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions						N	20241231
24909-040_09aa75c0-6911-8048-e063-6394a90afde6	24909-040	HUMAN OTC DRUG	terrasil First Aid Antiseptic Wound and Burn Care Kit		HEXYLRESORCINOL	KIT		20231002		OTC MONOGRAPH DRUG	M003	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions						N	20241231
24909-041_092d466b-e3dc-41b9-e063-6394a90aded0	24909-041	HUMAN OTC DRUG	terrasil First Aid Antiseptic Wound and Burn Care		HEXYLRESORCINOL	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M003	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	HEXYLRESORCINOL	.1	g/100g			N	20241231
24909-060_0b5fe845-13c8-f7d3-e063-6294a90a8141	24909-060	HUMAN OTC DRUG	terrasil Eczema and Psoriasis Severe Outbreak		GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG	OINTMENT	TOPICAL	20231110		UNAPPROVED HOMEOPATHIC		Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	GRAPHITE; SODIUM CHLORIDE; SYMPHYTUM OFFICINALE WHOLE; THUJA OCCIDENTALIS LEAFY TWIG	10; 3; 1; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
24909-061_0941137d-be3d-fc15-e063-6294a90a080e	24909-061	HUMAN OTC DRUG	HerpaOne		GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG	OINTMENT	TOPICAL	20230926		UNAPPROVED HOMEOPATHIC		Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	GRAPHITE; SODIUM CHLORIDE; SYMPHYTUM OFFICINALE WHOLE; THUJA OCCIDENTALIS LEAFY TWIG	10; 3; 1; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
24909-062_0b600ba1-6ed3-19f0-e063-6294a90acf7a	24909-062	HUMAN OTC DRUG	terragen HG Formula Maximum Strength		GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG	OINTMENT	TOPICAL	20231110		UNAPPROVED HOMEOPATHIC		Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	GRAPHITE; SODIUM CHLORIDE; SYMPHYTUM OFFICINALE WHOLE; THUJA OCCIDENTALIS LEAFY TWIG	10; 3; 1; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
24909-063_0b600ba1-6ec8-19f0-e063-6294a90acf7a	24909-063	HUMAN OTC DRUG	terrasil IPL Relief		GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG	OINTMENT	TOPICAL	20231110		UNAPPROVED HOMEOPATHIC		Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	GRAPHITE; SODIUM CHLORIDE; SYMPHYTUM OFFICINALE WHOLE; THUJA OCCIDENTALIS LEAFY TWIG	10; 3; 1; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
24909-100_fb2fdeff-7ff6-3d0d-e053-6294a90ab797	24909-100	HUMAN OTC DRUG	Terrasil Jock-Itch Treatment	MAX	Clotrimazole	OINTMENT	TOPICAL	20140512		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-102_0890d966-e47c-03b8-e063-6294a90afde8	24909-102	HUMAN OTC DRUG	Terrasil Ringworm Treatment	MAX	Clotrimazole	OINTMENT	TOPICAL	20140512		OTC MONOGRAPH DRUG	M005	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-104_0b76ea15-247a-3afa-e063-6294a90a9d3f	24909-104	HUMAN OTC DRUG	Terrasil Tinea Treatment	MAX	Clotrimazole	OINTMENT	TOPICAL	20140512		OTC MONOGRAPH DRUG	M005	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-106_092f9970-a5df-3896-e063-6294a90a8aec	24909-106	HUMAN OTC DRUG	Terrasil Anti-Fungal Treatment	MAX	Clotrimazole	OINTMENT	TOPICAL	20120907		OTC MONOGRAPH DRUG	M005	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-119_4508d09e-d050-46e1-9ab8-76245dc28c6f	24909-119	HUMAN OTC DRUG	Terrasil Balanitis Relief		Sulfur, Symphytum Officinale (Comfrey)	OINTMENT	TOPICAL	20140610		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	SULFUR; SYMPHYTUM OFFICINALE WHOLE	1; 1	[hp_X]/g; [hp_X]/g			N	20241231
24909-142_40f9c087-aaee-419d-9fba-295fa0cd98b8	24909-142	HUMAN OTC DRUG	Terragen HG Treatment		Graphites, Natrum Muriaticum, Ranunculus Bulbosus, Thuja Occidentalis	OINTMENT	TOPICAL	20121011		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	GRAPHITE; RANUNCULUS BULBOSUS; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG	10; 10; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
24909-143_fb5a415b-d0a4-85da-e053-6394a90a9bbc	24909-143	HUMAN OTC DRUG	Terragen HG Treatment	Maximum Strength	Graphites, Natrum Muriaticum, Ranunculus Bulbosus, Thuja Occidentalis	OINTMENT	TOPICAL	20121011		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	GRAPHITE; RANUNCULUS BULBOSUS; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG	10; 10; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
24909-146_0c7b2dc8-0ce9-46e2-87d2-43512ccfc4e6	24909-146	HUMAN OTC DRUG	Terrasil IPL Relief		Thuja Occidentalis	OINTMENT	TOPICAL	20140314		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/g			N	20241231
24909-147_cc3ee617-fae1-40dc-bea3-e0559f504618	24909-147	HUMAN OTC DRUG	Terrasil IPL Relief	Maximum Strength	Thuja Occidentalis	OINTMENT	TOPICAL	20140314		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS LEAFY TWIG	3	[hp_X]/g			N	20241231
24909-150_f40d3c0a-f7d1-18a2-e053-2995a90a35cb	24909-150	HUMAN OTC DRUG	Terragen HG Treatment	Maximum Strength	Graphites, Natrum Muriaticum, Ranunculus Bulbosus, Thuja Occidentalis	OINTMENT	TOPICAL	20121011		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	GRAPHITE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG	10; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
24909-155_8da19e69-2657-4659-a231-7616a4e8c1e6	24909-155	HUMAN OTC DRUG	Terrasil SERIOUS FUNGAL TREATMENT		Clotrimazole, Thuja Occidentalis	KIT		20170101		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC						N	20241231
24909-158_2191cb52-5b9f-4ef2-a988-9f1093a29e44	24909-158	HUMAN OTC DRUG	Terrasil Serious First Aid		Calendula	OINTMENT	TOPICAL	20180101		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS WHOLE	1	[hp_X]/g			N	20241231
24909-159_89966582-906b-46d0-9c18-3998760de58d	24909-159	HUMAN OTC DRUG	Terrasil Itch, Rash and Pain Relief		Allantoin, Menthol	OINTMENT	TOPICAL	20170101		OTC MONOGRAPH FINAL	part347	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN; MENTHOL	.5; .1	g/100g; g/100g			N	20241231
24909-160_ad771c96-5c3b-413c-a89f-eba2d9e44821	24909-160	HUMAN OTC DRUG	Terrasil Itch, Rash and Pain Relief Maximum Strength		Allantoin, Menthol	OINTMENT	TOPICAL	20170101		OTC MONOGRAPH FINAL	part347	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN; MENTHOL	.5; .15	1/100g; g/100g			N	20241231
24909-161_ee141b70-944d-741c-e053-2995a90a4109	24909-161	HUMAN OTC DRUG	Terrasil Fast and Natural Wart Removal		Thuja Occidentalis	OINTMENT	TOPICAL	20140310		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/g			N	20241231
24909-167_017b4454-5d00-4c32-81b8-eacc39ac3835	24909-167	HUMAN OTC DRUG	Terrasil Eczema and Psoriasis		Thuja Occidentalis, Symphytum Officinale	KIT		20160420		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC						N	20241231
24909-168_3024ec87-b489-46d9-a523-f6d74895e5a8	24909-168	HUMAN OTC DRUG	terrasil INFECTION PROTECTION WOUND CARE		Calendula, Thuja Occidentalis	OINTMENT	TOPICAL	20160701		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	CALENDULA OFFICINALIS FLOWER; THUJA OCCIDENTALIS WHOLE	1; 6	[hp_X]/50g; [hp_X]/50g			N	20241231
24909-169_1db22d7c-2f00-43c4-8bad-220255b99ee0	24909-169	HUMAN OTC DRUG	terrasil INFECTION PROTECTION WOUND CARE MAXIMUM STRENGTH		Calendula, Thuja Occidentalis , Symphytum Officinale (Comfrey)	OINTMENT	TOPICAL	20160701		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	CALENDULA OFFICINALIS FLOWER; COMFREY; THUJA OCCIDENTALIS WHOLE	1; 1; 6	[hp_X]/50g; [hp_X]/50g; [hp_X]/50g			N	20241231
24909-170_b9510f41-fbaf-4cdd-bf5b-ca30f619b9c1	24909-170	HUMAN OTC DRUG	Terrasil SERIOUS TINEA TREATMENT		Clotrimazole, Thuja Occidentalis	KIT		20170101		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC						N	20241231
24909-180_557569db-26cc-4d1d-8fa3-c047ac2a0310	24909-180	HUMAN OTC DRUG	Terrasil SKIN REPAIR		Calendula, Thuja Occidentalis	OINTMENT	TOPICAL	20170101		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	CALENDULA OFFICINALIS FLOWER; THUJA OCCIDENTALIS WHOLE	1; 6	[hp_X]/g; [hp_X]/g			N	20241231
24909-181_3e4ebdf6-50ce-41b7-b949-bf8691951a72	24909-181	HUMAN OTC DRUG	Terrasil SKIN REPAIR	MAXIMUM STRENGTH	Calendula, Symphytum Officinale, Thuja Occidentalis	OINTMENT	TOPICAL	20170101		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	CALENDULA OFFICINALIS FLOWER; COMFREY ROOT; THUJA OCCIDENTALIS WHOLE	1; 1; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
24909-186_6c3d9a92-620e-4953-aa0b-f7e34bbbf32f	24909-186	HUMAN OTC DRUG	Terrasil FAST AND NATURAL WART REMOVAL	MAXIMUM STRENGTH	Thuja Occidentalis	OINTMENT	TOPICAL	20180101		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS WHOLE	3	[hp_X]/g			N	20241231
24909-190_e960d241-1228-444d-8adf-f483b4e27618	24909-190	HUMAN OTC DRUG	Terrasil Rapid-Relief Vaginal		Miconazole Nitrate, Thuja occidentalis	KIT		20170101		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC						N	20241231
24909-191_f052e078-5ddd-44df-baa9-d07599eca056	24909-191	HUMAN OTC DRUG	Terrasil FLEX Pain Relief and Muscle Rub		Menthol	CREAM	TOPICAL	20190806		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	MENTHOL	4	g/100g			N	20241231
24909-192_20dde967-de8f-4119-a17b-ecf9877fc8ef	24909-192	HUMAN OTC DRUG	Terrasil FLEX -Pain Relief and Muscle Rub MAX		Menthol	OINTMENT	TOPICAL	20190806		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	MENTHOL	8	g/100g			N	20241231
24909-193_5a1bc6ef-6e27-43ad-bf83-ee24a4b3025c	24909-193	HUMAN OTC DRUG	Terrasil Burn Care and Relief maximum strength		ALLANTOIN, MENTHOL	OINTMENT	TOPICAL	20200115		OTC MONOGRAPH FINAL	part347	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN; MENTHOL	.5; .15	g/100g; g/100g			N	20241231
24909-194_6fc945c1-3938-4981-8023-ff559764fe9e	24909-194	HUMAN OTC DRUG	Terrasil Burn Care and Relief		ALLANTOIN, MENTHOL	OINTMENT	TOPICAL	20200115		OTC MONOGRAPH FINAL	part347	Aidance Skincare & Topical Solutions, LLC	ALLANTOIN; MENTHOL	.5; .1	g/100g; g/100g			N	20241231
24909-195_a5f8b88d-68a2-43b4-a9e1-1cd6ea9c1d2b	24909-195	HUMAN OTC DRUG	Terrasil Diabetics Ulcer and Sore Relief		CALENDULA OFFICINALIS FLOWER, THUJA OCCIDENTALIS WHOLE	OINTMENT	TOPICAL	20201201		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	CALENDULA OFFICINALIS FLOWER; THUJA OCCIDENTALIS WHOLE	1; 6	[hp_X]/44g; [hp_X]/44g			N	20241231
24909-196_8ddeb465-29d5-4677-b097-d422b5fe0033	24909-196	HUMAN OTC DRUG	Terrasil Bed Sore and Pressure Sore Relief		CALENDULA OFFICINALIS FLOWER, THUJA OCCIDENTALIS WHOLE	OINTMENT	TOPICAL	20201201		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	CALENDULA OFFICINALIS FLOWER; THUJA OCCIDENTALIS WHOLE	1; 6	[hp_X]/44g; [hp_X]/44g			N	20241231
24909-197_c93a71a9-45ee-d231-e053-2995a90af265	24909-197	HUMAN OTC DRUG	Terrasil Arthritis Cream		Menthol	CREAM	TOPICAL	20210728		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	MENTHOL, UNSPECIFIED FORM	4	g/100g			N	20241231
24909-198_c93ac12a-ec56-663a-e053-2995a90ad082	24909-198	HUMAN OTC DRUG	Terrasil Joint Pain Cream		Menthol	CREAM	TOPICAL	20210728		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	MENTHOL, UNSPECIFIED FORM	4	g/100g			N	20241231
24909-199_c93a9537-1231-c97c-e053-2a95a90a9fe6	24909-199	HUMAN OTC DRUG	Terrasil Back Pain Cream		Menthol	CREAM	TOPICAL	20210728		OTC MONOGRAPH NOT FINAL	part348	Aidance Skincare & Topical Solutions, LLC	MENTHOL, UNSPECIFIED FORM	4	g/100g			N	20241231
24909-202_f0e4459a-7455-41e8-a426-5d1f0ebb4465	24909-202	HUMAN OTC DRUG	Femmesil	Maximum Strength	Miconazole Nitrate	OINTMENT	TOPICAL	20120907		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-203_81ce9d2e-4fab-411b-8f70-ea84b113c6ed	24909-203	HUMAN OTC DRUG	Femmesil		Clotrimazole	CREAM	TOPICAL	20141130		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-204_cc343a2e-862c-e07c-e053-2995a90a89a1	24909-204	HUMAN OTC DRUG	Terrasil Ringworm Anti-Fungal Cleansing Bar 75g		Thuja Occidentalis 6X HPUS	SOAP	TOPICAL	20210825		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS WHOLE	6	[hp_X]/g			N	20241231
24909-205_cc349606-efd7-a582-e053-2995a90a98e1	24909-205	HUMAN OTC DRUG	Terrasil Wart Remover for Kids 14g		Thuja Occidentalis 6X HPUS	SOAP	TOPICAL	20210825		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS WHOLE	6	[hp_X]/g			N	20241231
24909-206_cea7f25c-412d-39a3-e053-2995a90aef96	24909-206	HUMAN OTC DRUG	Terrasil Antibacterial Skin Repair 200g		Calendula 1X HPUS, Thuja Occidentalis 6X HPUS	OINTMENT	TOPICAL	20211004		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	CALENDULA OFFICINALIS FLOWER; THUJA OCCIDENTALIS WHOLE	1; 6	[hp_X]/g; [hp_X]/g			N	20241231
24909-207_09a92161-51b2-cbf3-e063-6294a90a79b4	24909-207	HUMAN OTC DRUG	Terrasil Athletes Foot AntiFungal Treatment Max		Clotrimazole	OINTMENT	TOPICAL	20220105		OTC MONOGRAPH DRUG	M005	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-208_d84acf50-9701-a4ad-e053-2a95a90afd75	24909-208	HUMAN OTC DRUG	Terrasil Antifungal Cream Maximum Strength		Clotrimazole	CREAM	TOPICAL	20220101		OTC MONOGRAPH FINAL	part333C	Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-210_dfdaddd6-2d1d-30af-e053-2995a90a65f9	24909-210	HUMAN OTC DRUG	TTerrasil Athletes Foot Cleansing Bar		Thuja Occidentalis	SOAP	TOPICAL	20220430		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS LEAF	6	[hp_X]/g			N	20241231
24909-211_dfdae45a-2583-5a6b-e053-2995a90a4c7f	24909-211	HUMAN OTC DRUG	Femmesil Cleansing Bar		Thuja Occidentalis	SOAP	TOPICAL	20220630		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS LEAF	6	[hp_X]/g			N	20241231
24909-212_08910915-f503-afdf-e063-6294a90a5dfc	24909-212	HUMAN OTC DRUG	Terrasil JockItch Treatment Maximum Strength		Clotrimazole	OINTMENT	TOPICAL	20211101		OTC MONOGRAPH DRUG	M005	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-214_09a92161-51bd-cbf3-e063-6294a90a79b4	24909-214	HUMAN OTC DRUG	Terrasil Jock Itch Treatment Maximum Strength		Clotrimazole	OINTMENT	TOPICAL	20220630		OTC MONOGRAPH DRUG	M005	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-215_df62a3f7-1a81-7dff-e053-2995a90af540	24909-215	HUMAN OTC DRUG	Terrasil Tinea Treatment Maximum Strength		Clotrimazole	OINTMENT	TOPICAL	20210101		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-216_dffc9e20-bec9-25bd-e053-2a95a90a3804	24909-216	HUMAN OTC DRUG	Terrasil Balanitis Relief		Sulfur, Symphytum Officinale	OINTMENT	TOPICAL	20160603		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	SULFUR; SYMPHYTUM OFFICINALE WHOLE	1; 1	[hp_X]/g; [hp_X]/g			N	20241231
24909-217_dffca507-5d52-0cc3-e053-2a95a90abb09	24909-217	HUMAN OTC DRUG	Terrasil Antifungal Cleansing Bar		Thuja Occidentalis	SOAP	TOPICAL	20220525		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	THUJA OCCIDENTALIS WHOLE	6	[hp_X]/g			N	20241231
24909-218_dffca507-5d5d-0cc3-e053-2a95a90abb09	24909-218	HUMAN OTC DRUG	Terrasil Anti-Fungal Treatment		Clotrimazole	OINTMENT	TOPICAL	20120907		OTC MONOGRAPH FINAL	part333C	Aidance Skincare & Topical Solutions, LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
24909-220_f212319b-344b-0e5b-e053-2a95a90a4b6a	24909-220	HUMAN OTC DRUG	Herpa one		Natrum Muriaticum,Graphites,Thuja	OINTMENT	TOPICAL	20120907		UNAPPROVED HOMEOPATHIC		Aidance Skincare & Topical Solutions, LLC	GRAPHITE; SODIUM CHLORIDE; THUJA OCCIDENTALIS WHOLE	10; 6; 6	[hp_X]/44g; [hp_X]/44g; [hp_X]/44g			N	20241231
24979-001_0fcb578b-4494-4bf3-bc87-81ace66d8542	24979-001	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221201		ANDA	ANDA202666	TWI PHARMACEUTICALS, INC.	DEXLANSOPRAZOLE	30	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
24979-002_0fcb578b-4494-4bf3-bc87-81ace66d8542	24979-002	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221201		ANDA	ANDA202666	TWI PHARMACEUTICALS, INC.	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
24979-004_6b25f2b2-c3e5-4188-ae2f-45369b020ba5	24979-004	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20150301		ANDA	ANDA203104	TWi Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
24979-009_42d7498d-314e-4e20-9c5e-de2e6f0dffd2	24979-009	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	TWI Pharmaceuticals, Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24979-009_7699449e-678a-40ac-9c07-75936eb4ae99	24979-009	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	TWi Pharmaceuticals, Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24979-010_42d7498d-314e-4e20-9c5e-de2e6f0dffd2	24979-010	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	TWI Pharmaceuticals, Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24979-010_7699449e-678a-40ac-9c07-75936eb4ae99	24979-010	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	TWi Pharmaceuticals, Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24979-011_42d7498d-314e-4e20-9c5e-de2e6f0dffd2	24979-011	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	TWI Pharmaceuticals, Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24979-011_7699449e-678a-40ac-9c07-75936eb4ae99	24979-011	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	TWi Pharmaceuticals, Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
24979-026_37a3f664-1e09-4f98-b6ce-4f516920d9fb	24979-026	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-027_37a3f664-1e09-4f98-b6ce-4f516920d9fb	24979-027	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-028_37a3f664-1e09-4f98-b6ce-4f516920d9fb	24979-028	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-029_37a3f664-1e09-4f98-b6ce-4f516920d9fb	24979-029	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-030_37a3f664-1e09-4f98-b6ce-4f516920d9fb	24979-030	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-035_319760f2-ba12-42ae-8a3b-0c577d3efa1c	24979-035	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		ANDA	ANDA091281	TWi Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
24979-036_319760f2-ba12-42ae-8a3b-0c577d3efa1c	24979-036	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		ANDA	ANDA091281	TWi Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	30	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
24979-037_19721ece-1989-43be-b7d3-c5415b5fd8d2	24979-037	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20191001		ANDA	ANDA207206	TWi Pharmaceuticals, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24979-038_19721ece-1989-43be-b7d3-c5415b5fd8d2	24979-038	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20191001		ANDA	ANDA207206	TWi Pharmaceuticals, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24979-039_19721ece-1989-43be-b7d3-c5415b5fd8d2	24979-039	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20191001		ANDA	ANDA207206	TWi Pharmaceuticals, Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24979-040_19721ece-1989-43be-b7d3-c5415b5fd8d2	24979-040	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20191001		ANDA	ANDA207206	TWi Pharmaceuticals, Inc.	METOPROLOL TARTRATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
24979-041_94c36a8c-a73f-42af-96d4-09a477627f84	24979-041	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20150301		ANDA	ANDA203139	TWi Pharmaceuticals, Inc.	MEGESTROL ACETATE	125	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
24979-078_241ef515-f7bb-4ea6-b1a2-c309b847a907	24979-078	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20191231		ANDA	ANDA209390	TWi Pharmaceuticals, Inc.	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
24979-085_12a82177-845c-4160-8c8e-947228effa19	24979-085	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	TWi Pharmaceuticals, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
24979-086_12a82177-845c-4160-8c8e-947228effa19	24979-086	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	TWi Pharmaceuticals, Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
24979-087_12a82177-845c-4160-8c8e-947228effa19	24979-087	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	TWi Pharmaceuticals, Inc.	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
24979-101_b183cba1-7e63-44d2-9165-a2e4f3aaa1f0	24979-101	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	TWi Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
24979-102_b183cba1-7e63-44d2-9165-a2e4f3aaa1f0	24979-102	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	TWi Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
24979-109_afa99e3a-acb2-4f31-a53a-26b8d512fa9c	24979-109	HUMAN PRESCRIPTION DRUG	Fenofibric Acid	Delayed-Release	Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20200601		ANDA	ANDA210469	TWi Pharmaceuticals, Inc.	CHOLINE FENOFIBRATE	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
24979-112_afa99e3a-acb2-4f31-a53a-26b8d512fa9c	24979-112	HUMAN PRESCRIPTION DRUG	Fenofibric Acid	Delayed-Release	Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20200601		ANDA	ANDA210469	TWi Pharmaceuticals, Inc.	CHOLINE FENOFIBRATE	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
24979-127_dbaae345-1efa-42cd-99d7-691739331b91	24979-127	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20201201		ANDA	ANDA210382	TWi Pharmaceuticals, Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
24979-128_dbaae345-1efa-42cd-99d7-691739331b91	24979-128	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20201201		ANDA	ANDA210382	TWi Pharmaceuticals, Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
24979-130_4c1484db-acd5-45a4-8b41-78e382b5ad45	24979-130	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	SOLUTION	TOPICAL	20211231		ANDA	ANDA209836	TWi Pharmaceuticals, Inc.	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
24979-132_e68d5e07-275d-457c-a42f-dc99b5fc38b9	24979-132	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20200713		ANDA	ANDA211832	TWi Pharmaceuticals, Inc.	TERBUTALINE SULFATE	2.5	mg/1			N	20241231
24979-133_e68d5e07-275d-457c-a42f-dc99b5fc38b9	24979-133	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20200713		ANDA	ANDA211832	TWi Pharmaceuticals, Inc.	TERBUTALINE SULFATE	5	mg/1			N	20241231
24979-136_a92a6341-b7f6-4abf-8203-4c1aefb910fe	24979-136	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	TWi Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
24979-137_a92a6341-b7f6-4abf-8203-4c1aefb910fe	24979-137	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	TWi Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
24979-138_a92a6341-b7f6-4abf-8203-4c1aefb910fe	24979-138	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	TWi Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
24979-139_a92a6341-b7f6-4abf-8203-4c1aefb910fe	24979-139	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	TWi Pharmaceuticals, Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
24979-160_21aa5daf-ea74-4566-9874-31c2d1a6768d	24979-160	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20211108		ANDA	ANDA214289	TWi Pharmaceuticals, Inc.	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
24979-161_21aa5daf-ea74-4566-9874-31c2d1a6768d	24979-161	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20211108		ANDA	ANDA214289	TWi Pharmaceuticals, Inc.	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
24979-181_ad469e4a-663e-4c2e-bdbd-12cdf329ef28	24979-181	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA217377	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-182_ad469e4a-663e-4c2e-bdbd-12cdf329ef28	24979-182	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA217377	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-183_ad469e4a-663e-4c2e-bdbd-12cdf329ef28	24979-183	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA217377	TWi Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
24979-186_6be8102e-96b9-4cfb-9ce8-d417d9f1cc70	24979-186	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20190930		ANDA	ANDA200959	TWi Pharmaceuticals, Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
24979-198_ef3592ef-2184-43de-9f37-062bd24079d6	24979-198	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20220901		ANDA	ANDA216399	TWi Pharmaceuticals, Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24979-199_ef3592ef-2184-43de-9f37-062bd24079d6	24979-199	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20220901		ANDA	ANDA216399	TWi Pharmaceuticals, Inc.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24979-200_ad8fc48f-58f5-48bf-a2b7-995945660f29	24979-200	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20230701		ANDA	ANDA216782	TWi Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
24979-201_d8096fba-9935-458c-b0a9-7fcb53d113a4	24979-201	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230201		ANDA	ANDA217054	TWi Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
24979-210_1c54c8f1-81f6-4654-93ec-d6f3db1255de	24979-210	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE	ORAL	20231205		ANDA	ANDA217694	TWi Pharmaceuticals, Inc.	TOPIRAMATE	15	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
24979-211_1c54c8f1-81f6-4654-93ec-d6f3db1255de	24979-211	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE	ORAL	20231205		ANDA	ANDA217694	TWi Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
24979-231_d88fbca8-091c-4be4-bba9-8b00d92fcced	24979-231	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA209688	TWi Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
24979-232_d88fbca8-091c-4be4-bba9-8b00d92fcced	24979-232	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA209688	TWi Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
24979-247_87ba21ae-96ae-4ebd-b7d1-dd349e370b21	24979-247	HUMAN PRESCRIPTION DRUG	Forfivo	XL	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231215		NDA	NDA022497	TWi Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	450	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
24979-248_cd118a70-9f7a-45bd-9495-7d621f45ce45	24979-248	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride		bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231215		NDA AUTHORIZED GENERIC	NDA022497	TWi Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	450	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
24979-533_7e49ee6b-0131-49cd-bc67-6889ce4c90f0	24979-533	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	TWi Pharmaceuticals, Inc.	GUANFACINE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24979-534_7e49ee6b-0131-49cd-bc67-6889ce4c90f0	24979-534	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	TWi Pharmaceuticals, Inc.	GUANFACINE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24979-536_7e49ee6b-0131-49cd-bc67-6889ce4c90f0	24979-536	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	TWi Pharmaceuticals, Inc.	GUANFACINE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24979-538_7e49ee6b-0131-49cd-bc67-6889ce4c90f0	24979-538	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	TWi Pharmaceuticals, Inc.	GUANFACINE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
24979-703_cceebcc4-476b-4e95-a711-9a58936a16bf	24979-703	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220101		NDA AUTHORIZED GENERIC	NDA022287	TWI PHARMACEUTICALS, INC.	DEXLANSOPRAZOLE	30	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
24979-704_cceebcc4-476b-4e95-a711-9a58936a16bf	24979-704	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220101		NDA AUTHORIZED GENERIC	NDA022287	TWI PHARMACEUTICALS, INC.	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
24979-710_1f41135d-3da4-45b2-9462-6482256fa728	24979-710	HUMAN PRESCRIPTION DRUG	Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)		Paclitaxel	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20220401		NDA AUTHORIZED GENERIC	NDA021660	TWi Pharmaceuticals, Inc.	PACLITAXEL	100	mg/20mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
24979-715_085c6ab6-fe4f-1b08-e063-6294a90ac9bc	24979-715	HUMAN PRESCRIPTION DRUG	sorafenib		sorafenib	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA209050	TWi Pharmaceuticals USA, Inc.	SORAFENIB	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
25000-011_b0149996-6130-40ea-9ccb-0ba3c4be3972	25000-011	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20170427		ANDA	ANDA204376	MARKSANS PHARMA LIMITED	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
25000-012_d2da21f1-d7f6-43c0-b66f-5b7d14774688	25000-012	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20161231		ANDA	ANDA204948	MARKSANS PHARMA LIMITED	PARICALCITOL	1	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
25000-014_d2da21f1-d7f6-43c0-b66f-5b7d14774688	25000-014	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20161231		ANDA	ANDA204948	MARKSANS PHARMA LIMITED	PARICALCITOL	2	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
25000-017_d2da21f1-d7f6-43c0-b66f-5b7d14774688	25000-017	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20161231		ANDA	ANDA204948	MARKSANS PHARMA LIMITED	PARICALCITOL	4	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
25000-021_adf6c78c-edb1-4ffb-a934-d8cb772e621f	25000-021	HUMAN OTC DRUG	Loratadine		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20161001		ANDA	ANDA206214	MARKSANS PHARMA LIMITED	LORATADINE	10	mg/1			N	20241231
25000-041_c7abd113-e773-4217-aa2c-86a31916aa0a	25000-041	HUMAN OTC DRUG	Guaifenesin 1200 mg		Guaifenesin 1200 mg	TABLET	ORAL	20230823		ANDA	ANDA217780	MARKSANS PHARMA LIMITED	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
25000-042_c7abd113-e773-4217-aa2c-86a31916aa0a	25000-042	HUMAN OTC DRUG	Guaifenesin 600 mg		Guaifenesin 600 mg	TABLET	ORAL	20230823		ANDA	ANDA217780	MARKSANS PHARMA LIMITED	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
25000-062_009afd24-3f12-4208-876d-f22ce92a40ce	25000-062	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200818		ANDA	ANDA079205	MARKSANS PHARMA LIMITED	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-071_9e2c09cd-1bd4-4a86-8911-ba904d8a76cb	25000-071	HUMAN OTC DRUG	Acetaminophen Extended-Release Tablets, 650 mg		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20210902		ANDA	ANDA215486	MARKSANS PHARMA LIMITED	ACETAMINOPHEN	650	mg/1			N	20241231
25000-075_87d67acf-1c55-41a7-b323-3cc23c236c59	25000-075	HUMAN OTC DRUG	Esomeprazole Magnesium Delayed-Release Capsules, 20 mg		Esomeprazole Magnesium Delayed-Release Capsules, 20 mg	CAPSULE, DELAYED RELEASE	ORAL	20230930		ANDA	ANDA217264	MARKSANS PHARMA LIMITED	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
25000-080_6f2c972e-3a8a-4d50-bc65-dce5b74ccf8d	25000-080	HUMAN OTC DRUG	Acetaminophen 250 mg and Ibuprofen 125 mg		Acetaminophen 250 mg and Ibuprofen 125 mg Tablets	TABLET, FILM COATED	ORAL	20230711		ANDA	ANDA216994	MARKSANS PHARMA LIMITED	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-086_511aedb2-9dfd-4838-8be8-e5c32124f187	25000-086	HUMAN OTC DRUG	Famotidine 10 mg		Famotidine 10 mg	TABLET, COATED	ORAL	20230310		ANDA	ANDA217543	MARKSANS PHARMA LIMITED	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
25000-087_511aedb2-9dfd-4838-8be8-e5c32124f187	25000-087	HUMAN OTC DRUG	Famotidine 20 mg		Famotidine 20 mg	TABLET, COATED	ORAL	20230310		ANDA	ANDA217543	MARKSANS PHARMA LIMITED	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
25000-101_d303d298-6012-49a4-aff0-ff0f0aeadb1b	25000-101	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	MARKSANS PHARMA LIMITED	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
25000-102_d303d298-6012-49a4-aff0-ff0f0aeadb1b	25000-102	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	MARKSANS PHARMA LIMITED	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
25000-103_f69135ae-f0dd-487b-a4a9-b2cf36ebe388	25000-103	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20110228		ANDA	ANDA090007	MARKSANS PHARMA LIMITED	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
25000-104_f69135ae-f0dd-487b-a4a9-b2cf36ebe388	25000-104	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20110228		ANDA	ANDA090007	MARKSANS PHARMA LIMITED	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
25000-105_f69135ae-f0dd-487b-a4a9-b2cf36ebe388	25000-105	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20110228		ANDA	ANDA090007	MARKSANS PHARMA LIMITED	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
25000-108_9e2c09cd-1bd4-4a86-8911-ba904d8a76cb	25000-108	HUMAN OTC DRUG	Acetaminophen Extended-Release Tablets, 650 mg		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20221014		ANDA	ANDA215486	MARKSANS PHARMA LIMITED	ACETAMINOPHEN	650	mg/1			N	20241231
25000-114_1bdc2c02-575f-4b55-ad66-47108f628d18	25000-114	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20110725		ANDA	ANDA091239	MARKSANS PHARMA LIMITED	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-117_1bdc2c02-575f-4b55-ad66-47108f628d18	25000-117	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20110725		ANDA	ANDA091239	MARKSANS PHARMA LIMITED	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-121_b9644160-0fe4-4bd8-a1e8-dd6c418d8fb2	25000-121	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20110228		ANDA	ANDA090796	MARKSANS PHARMA LIMITED	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-122_b9644160-0fe4-4bd8-a1e8-dd6c418d8fb2	25000-122	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20110228		ANDA	ANDA090796	MARKSANS PHARMA LIMITED	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-123_b9644160-0fe4-4bd8-a1e8-dd6c418d8fb2	25000-123	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20110228		ANDA	ANDA090796	MARKSANS PHARMA LIMITED	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-131_b682b3b4-7055-4ae2-9624-e67fb2057fbd	25000-131	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20120601		ANDA	ANDA090888	MARKSANS PHARMA LIMITED	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
25000-132_b682b3b4-7055-4ae2-9624-e67fb2057fbd	25000-132	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20120601		ANDA	ANDA090888	MARKSANS PHARMA LIMITED	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
25000-133_009afd24-3f12-4208-876d-f22ce92a40ce	25000-133	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170901		ANDA	ANDA079205	MARKSANS PHARMA LIMITED	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-134_b682b3b4-7055-4ae2-9624-e67fb2057fbd	25000-134	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20120601		ANDA	ANDA090888	MARKSANS PHARMA LIMITED	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
25000-135_e0bdfb43-8e4d-4ff4-9642-f3bd460b8465	25000-135	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20151106		ANDA	ANDA091237	MARKSANS PHARMA LIMITED	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-136_e0bdfb43-8e4d-4ff4-9642-f3bd460b8465	25000-136	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20151106		ANDA	ANDA091237	MARKSANS PHARMA LIMITED	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-138_09a45eee-ddf8-428a-bbe9-39e691792356	25000-138	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20110228		ANDA	ANDA091416	MARKSANS PHARMA LIMITED	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-139_09a45eee-ddf8-428a-bbe9-39e691792356	25000-139	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20110228		ANDA	ANDA091416	MARKSANS PHARMA LIMITED	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-140_09a45eee-ddf8-428a-bbe9-39e691792356	25000-140	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20110228		ANDA	ANDA091416	MARKSANS PHARMA LIMITED	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-141_1e0b6883-f02c-4259-b905-9716dd72bcbf	25000-141	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium, Coated Tablets	TABLET	ORAL	20110528		ANDA	ANDA090545	MARKSANS PHARMA LIMITED	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-144_1e0b6883-f02c-4259-b905-9716dd72bcbf	25000-144	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium Tablet, coated	TABLET	ORAL	20110504		ANDA	ANDA090545	MARKSANS PHARMA LIMITED	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25000-147_46219345-2dd8-4502-a0fc-1631e354dc98	25000-147	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220129		ANDA	ANDA075465	MARKSANS PHARMA LIMITED	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
25000-148_46219345-2dd8-4502-a0fc-1631e354dc98	25000-148	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220129		ANDA	ANDA075465	MARKSANS PHARMA LIMITED	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
25000-149_46219345-2dd8-4502-a0fc-1631e354dc98	25000-149	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220129		ANDA	ANDA075465	MARKSANS PHARMA LIMITED	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
25000-179_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-179	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	25	mg/1		CV	N	20241231
25000-180_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-180	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	50	mg/1		CV	N	20241231
25000-181_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-181	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	75	mg/1		CV	N	20241231
25000-182_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-182	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	100	mg/1		CV	N	20241231
25000-183_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-183	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	150	mg/1		CV	N	20241231
25000-184_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-184	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	200	mg/1		CV	N	20241231
25000-185_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-185	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	225	mg/1		CV	N	20241231
25000-186_9ea942a4-bdfe-4505-bd9e-2fd78ca6345b	25000-186	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220801		ANDA	ANDA216197	MARKSANS PHARMA LIMITED	PREGABALIN	300	mg/1		CV	N	20241231
25000-219_27416199-4b9b-48c1-99e9-0766015cf840	25000-219	HUMAN OTC DRUG	Cetirizine Hydrochloride Tablets, 5 mg		Cetirizine Hydrochloride	TABLET	ORAL	20220113		ANDA	ANDA078933	MARKSANS PHARMA LIMITED	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
25000-220_27416199-4b9b-48c1-99e9-0766015cf840	25000-220	HUMAN OTC DRUG	Cetirizine Hydrochloride Tablets, 10 mg		Cetirizine Hydrochloride	TABLET	ORAL	20220113		ANDA	ANDA078933	MARKSANS PHARMA LIMITED	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
25000-608_c8aa863f-eb1f-4b66-9ec6-2af2c7958248	25000-608	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20220527		ANDA	ANDA090723	MARKSANS PHARMA LIMITED	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
25000-609_c8aa863f-eb1f-4b66-9ec6-2af2c7958248	25000-609	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20220527		ANDA	ANDA090723	MARKSANS PHARMA LIMITED	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
25000-610_c8aa863f-eb1f-4b66-9ec6-2af2c7958248	25000-610	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20220527		ANDA	ANDA090723	MARKSANS PHARMA LIMITED	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
25010-210_fc9fc557-cd95-4c2a-869e-68c0619fd35e	25010-210	HUMAN PRESCRIPTION DRUG	SODIUM EDECRIN		ethacrynate sodium	POWDER, FOR SOLUTION	INTRAVENOUS	19670110		NDA	NDA016093	Bausch Health US, LLC	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
25010-215_fc9fc557-cd95-4c2a-869e-68c0619fd35e	25010-215	HUMAN PRESCRIPTION DRUG	EDECRIN		ethacrynic acid	TABLET	ORAL	19670110		NDA	NDA016092	Bausch Health US, LLC	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
25010-305_7997d826-eb49-4688-9833-e668985c1e74	25010-305	HUMAN PRESCRIPTION DRUG	Demser		metyrosine	CAPSULE	ORAL	19791003		NDA	NDA017871	Bausch Health US, LLC	METYROSINE	250	mg/1	Catecholamine Synthesis Inhibitor [EPC], Catecholamine Synthesis Inhibitors [MoA]		N	20241231
25010-705_4089c80f-75b8-4fa8-a464-f4561f29ec1d	25010-705	HUMAN PRESCRIPTION DRUG	Cuprimine		penicillamine	CAPSULE	ORAL	19701204		NDA	NDA019853	Bausch Health US, LLC	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
25010-711_7f4ee67e-645e-4fdd-811a-2dc169653684	25010-711	HUMAN PRESCRIPTION DRUG	Lodosyn		carbidopa	TABLET	ORAL	20100413		NDA	NDA017830	Bausch Health US, LLC	CARBIDOPA	25	mg/1			N	20241231
25021-100_6dfa594e-90e8-4085-af30-6d3660a6bebf	25021-100	HUMAN PRESCRIPTION DRUG	cefazolin		cefazolin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20090201		ANDA	ANDA065303	Sagent Pharmaceuticals	CEFAZOLIN SODIUM	500	mg/2.2mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-101_076660ff-6659-4b5b-bf10-d9aff95d7e91	25021-101	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150701	20240131	ANDA	ANDA065303	Sagent Pharmaceuticals	CEFAZOLIN SODIUM	1	g/3mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
25021-101_6dfa594e-90e8-4085-af30-6d3660a6bebf	25021-101	HUMAN PRESCRIPTION DRUG	cefazolin		cefazolin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20090201		ANDA	ANDA065303	Sagent Pharmaceuticals	CEFAZOLIN SODIUM	1	g/3mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-102_76e20ece-6f09-4938-9732-3f4776848651	25021-102	HUMAN PRESCRIPTION DRUG	Cefazolin		cefazolin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20150701	20240331	ANDA	ANDA065306	Sagent Pharmaceuticals	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
25021-102_b04fdcb7-24fb-4290-9cac-70d7a04ebcd1	25021-102	HUMAN PRESCRIPTION DRUG	Cefazolin		cefazolin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20090401		ANDA	ANDA065306	Sagent Pharmaceuticals	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-106_71bf5ebd-afe1-4906-86ef-76d7e205ec68	25021-106	HUMAN PRESCRIPTION DRUG	ceftriaxone		ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065329	Sagent Pharmaceuticals	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-106_af924df1-f647-41dd-b26d-3fef3684362d	25021-106	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150701	20240430	ANDA	ANDA065329	Sagent Pharmaceuticals	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
25021-107_71bf5ebd-afe1-4906-86ef-76d7e205ec68	25021-107	HUMAN PRESCRIPTION DRUG	ceftriaxone		ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065329	Sagent Pharmaceuticals	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-109_b43cf6e8-a0e4-4f66-9559-6fcc65c40532	25021-109	HUMAN PRESCRIPTION DRUG	Cefoxitin		cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091105		ANDA	ANDA065414	Sagent Pharmaceuticals	CEFOXITIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
25021-110_b43cf6e8-a0e4-4f66-9559-6fcc65c40532	25021-110	HUMAN PRESCRIPTION DRUG	Cefoxitin		cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091105		ANDA	ANDA065414	Sagent Pharmaceuticals	CEFOXITIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
25021-111_79813968-4f6f-49a9-9a94-18607a1bcfbf	25021-111	HUMAN PRESCRIPTION DRUG	Cefoxitin		cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20100812		ANDA	ANDA065415	Sagent Pharmaceuticals	CEFOXITIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-114_c30953aa-a1e5-45b5-97a5-6bb9d0b0bd6f	25021-114	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		ciprofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20080324		ANDA	ANDA078252	Sagent Pharmaceuticals	CIPROFLOXACIN	2	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
25021-115_1364c509-7e59-41d5-8a93-c138898dedfc	25021-115	HUMAN PRESCRIPTION DRUG	Clindamycin		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20120515		ANDA	ANDA090109	Sagent Pharmaceuticals	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
25021-115_d8c15b1b-89ef-4a7d-8352-66fafad2ad3f	25021-115	HUMAN PRESCRIPTION DRUG	Clindamycin		Clindamycin Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120515		ANDA	ANDA090108	Sagent Pharmaceuticals	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
25021-118_7637e212-e462-4420-a15d-3555a0993486	25021-118	HUMAN PRESCRIPTION DRUG	Cefuroxime sodium		Cefuroxime sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160901		ANDA	ANDA064125	Sagent Pharmaceuticals	CEFUROXIME SODIUM	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-119_7637e212-e462-4420-a15d-3555a0993486	25021-119	HUMAN PRESCRIPTION DRUG	Cefuroxime sodium		Cefuroxime sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160901		ANDA	ANDA064125	Sagent Pharmaceuticals	CEFUROXIME SODIUM	1.5	g/16mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-121_9ebd16c5-4b93-40dc-a672-4f28ff3b523a	25021-121	HUMAN PRESCRIPTION DRUG	cefepime		cefepime hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150701	20240630	ANDA	ANDA065441	Sagent Pharmaceuticals	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
25021-121_a980a9e1-16f8-41c8-a8e4-31101948966c	25021-121	HUMAN PRESCRIPTION DRUG	cefepime		cefepime hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080501		ANDA	ANDA065441	Sagent Pharmaceuticals	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-122_9ebd16c5-4b93-40dc-a672-4f28ff3b523a	25021-122	HUMAN PRESCRIPTION DRUG	cefepime		cefepime hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20150701	20240731	ANDA	ANDA065441	Sagent Pharmaceuticals	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
25021-122_a980a9e1-16f8-41c8-a8e4-31101948966c	25021-122	HUMAN PRESCRIPTION DRUG	cefepime		cefepime hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20080501		ANDA	ANDA065441	Sagent Pharmaceuticals	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-127_6b34b5ad-001f-4c39-8415-a223eb692b46	25021-127	HUMAN PRESCRIPTION DRUG	Ceftazidime		ceftazidime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080515		ANDA	ANDA062640	Sagent Pharmaceuticals	CEFTAZIDIME	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-128_6b34b5ad-001f-4c39-8415-a223eb692b46	25021-128	HUMAN PRESCRIPTION DRUG	Ceftazidime		ceftazidime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20080515		ANDA	ANDA062640	Sagent Pharmaceuticals	CEFTAZIDIME	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-129_c6b97c07-4742-4c33-8266-a154bd634da5	25021-129	HUMAN PRESCRIPTION DRUG	Ceftazidime		ceftazidime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20080515		ANDA	ANDA062640	Sagent Pharmaceuticals	CEFTAZIDIME	6	g/30mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
25021-131_a558e550-a296-4a2b-a759-d2511513e78d	25021-131	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	INJECTION, SOLUTION	INTRAVENOUS	20091115		ANDA	ANDA206191	Sagent Pharmaceuticals	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
25021-132_a1a28f60-b357-4672-b9ca-90568cdd7b69	25021-132	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20110620		ANDA	ANDA090343	Sagent Pharmaceuticals	LEVOFLOXACIN	5	mg/mL			N	20241231
25021-136_48afac8f-ce2e-4f1e-a676-b9ffa0082a98	25021-136	HUMAN PRESCRIPTION DRUG	ampicillin		ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140701		ANDA	ANDA090354	Sagent Pharmaceuticals	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-137_48afac8f-ce2e-4f1e-a676-b9ffa0082a98	25021-137	HUMAN PRESCRIPTION DRUG	ampicillin		ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140701		ANDA	ANDA090354	Sagent Pharmaceuticals	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-139_947fd62b-aced-4108-a239-3258d89c2da0	25021-139	HUMAN PRESCRIPTION DRUG	Nafcillin		nafcillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20121025		ANDA	ANDA090582	Sagent Pharmaceuticals	NAFCILLIN SODIUM	1	g/4mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-140_947fd62b-aced-4108-a239-3258d89c2da0	25021-140	HUMAN PRESCRIPTION DRUG	Nafcillin		nafcillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20121025		ANDA	ANDA090582	Sagent Pharmaceuticals	NAFCILLIN SODIUM	2	g/8mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-141_9acd3c53-9e83-4462-b8cc-6299085640d1	25021-141	HUMAN PRESCRIPTION DRUG	Nafcillin		nafcillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20121025		ANDA	ANDA090580	Sagent Pharmaceuticals	NAFCILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-142_2dcaa8be-c8ec-4327-863e-c98504197b87	25021-142	HUMAN PRESCRIPTION DRUG	ampicillin and sulbactam		ampicillin and sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100630		ANDA	ANDA065406	Sagent Pharmaceuticals	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
25021-143_2dcaa8be-c8ec-4327-863e-c98504197b87	25021-143	HUMAN PRESCRIPTION DRUG	ampicillin and sulbactam		ampicillin and sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100630		ANDA	ANDA065406	Sagent Pharmaceuticals	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
25021-144_cd4b83d3-0e68-483a-8b7b-97879fda9762	25021-144	HUMAN PRESCRIPTION DRUG	ampicillin and sulbactam		ampicillin and sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20100812		ANDA	ANDA065403	Sagent Pharmaceuticals	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
25021-146_d20bc39b-1c49-4dd7-8cde-2edcfe061c76	25021-146	HUMAN PRESCRIPTION DRUG	Oxacillin		oxacillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120601		ANDA	ANDA091246	Sagent Pharmaceuticals	OXACILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-150_9421f884-7b57-4a9a-8389-a45a70dd4598	25021-150	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230715		ANDA	ANDA205694	Sagent Pharmaceuticals	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
25021-151_9421f884-7b57-4a9a-8389-a45a70dd4598	25021-151	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230715		ANDA	ANDA205694	Sagent Pharmaceuticals	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
25021-157_05c289e7-a816-4854-b0bb-0e79860b7cd7	25021-157	HUMAN PRESCRIPTION DRUG	Vancomycin		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120920		ANDA	ANDA200837	Sagent Pharmaceuticals	VANCOMYCIN HYDROCHLORIDE	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
25021-158_05c289e7-a816-4854-b0bb-0e79860b7cd7	25021-158	HUMAN PRESCRIPTION DRUG	Vancomycin		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120920		ANDA	ANDA200837	Sagent Pharmaceuticals	VANCOMYCIN HYDROCHLORIDE	10	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
25021-162_d20bc39b-1c49-4dd7-8cde-2edcfe061c76	25021-162	HUMAN PRESCRIPTION DRUG	Oxacillin		oxacillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120601		ANDA	ANDA091246	Sagent Pharmaceuticals	OXACILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-162_f642e8d3-13d4-4831-b9c5-60298c952792	25021-162	HUMAN PRESCRIPTION DRUG	Oxacillin		oxacillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181015		ANDA	ANDA091246	Sagent Pharmaceuticals	OXACILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-163_5a78dae8-2723-43b4-9d75-beb1532c8cc4	25021-163	HUMAN PRESCRIPTION DRUG	Oxacillin		oxacillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20181015		ANDA	ANDA091245	Sagent Pharmaceuticals	OXACILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-163_d984ca46-02be-4252-8aec-818ec166eea0	25021-163	HUMAN PRESCRIPTION DRUG	Oxacillin		oxacillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120601		ANDA	ANDA091245	Sagent Pharmaceuticals	OXACILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
25021-173_628539d5-fc0d-44a8-a854-b1e78382e78d	25021-173	HUMAN PRESCRIPTION DRUG	amikacin sulfate		amikacin sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160615		ANDA	ANDA203323	Sagent Pharmaceuticals	AMIKACIN SULFATE	250	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
25021-174_a3f62ffc-f089-4f4c-bad1-99f60f1d88b0	25021-174	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191115		ANDA	ANDA207104	Sagent Pharmaceuticals	DAPTOMYCIN	50	mg/mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
25021-175_da5fb916-ca41-4931-b785-80db9876dffd	25021-175	HUMAN PRESCRIPTION DRUG	Piperacillin, Tazobactam		Piperacillin Sodium, Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211215		ANDA	ANDA208674	Sagent Pharmaceuticals	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
25021-176_da5fb916-ca41-4931-b785-80db9876dffd	25021-176	HUMAN PRESCRIPTION DRUG	Piperacillin, Tazobactam		Piperacillin Sodium, Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210915		ANDA	ANDA208674	Sagent Pharmaceuticals	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
25021-177_da5fb916-ca41-4931-b785-80db9876dffd	25021-177	HUMAN PRESCRIPTION DRUG	Piperacillin, Tazobactam		Piperacillin Sodium, Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211015		ANDA	ANDA208674	Sagent Pharmaceuticals	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
25021-179_8975a758-a60c-43ab-94d2-b324eef78476	25021-179	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180115		NDA	NDA208385	Sagent Pharmaceuticals	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
25021-179_bd554c4f-8286-4db5-bb82-681d17bd4884	25021-179	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200201		NDA	NDA208385	Sagent Pharmaceuticals	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
25021-181_89a82001-c80b-4df0-9b2f-fd96fb94e721	25021-181	HUMAN PRESCRIPTION DRUG	Piperacillin, Tazobactam		Piperacillin Sodium, Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210228		ANDA	ANDA208675	Sagent Pharmaceuticals	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/152mL; g/152mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
25021-182_3013653c-01f3-4ec7-a7fa-3e7b49adc4f0	25021-182	HUMAN PRESCRIPTION DRUG	Cefuroxime sodium		Cefuroxime sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160901		ANDA	ANDA064125	Sagent Pharmaceuticals	CEFUROXIME SODIUM	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-183_3013653c-01f3-4ec7-a7fa-3e7b49adc4f0	25021-183	HUMAN PRESCRIPTION DRUG	Cefuroxime sodium		Cefuroxime sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160901		ANDA	ANDA064125	Sagent Pharmaceuticals	CEFUROXIME SODIUM	1.5	g/16mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
25021-184_a12b6468-d4fb-4486-8527-786139787ba1	25021-184	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION, SOLUTION	INTRAVENOUS	20191015		ANDA	ANDA079104	Sagent Pharmaceuticals	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
25021-184_a157a5cd-cdb2-444f-ae87-fc37d7c621f8	25021-184	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	INJECTION, SOLUTION	INTRAVENOUS	20180115		ANDA	ANDA079104	Sagent Pharmaceuticals	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
25021-185_696f706f-39d7-4647-a506-2ebf7b956cc1	25021-185	HUMAN PRESCRIPTION DRUG	ganciclovir		ganciclovir sodium	INJECTION, SOLUTION	INTRAVENOUS	20180215		ANDA	ANDA207645	Sagent Pharmaceuticals	GANCICLOVIR SODIUM	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
25021-189_f5829ec8-15e6-43a4-a5f0-68ea0cddb8c8	25021-189	HUMAN PRESCRIPTION DRUG	Foscarnet Sodium		Foscarnet Sodium	INJECTION, SOLUTION	INTRAVENOUS	20210515		ANDA	ANDA213001	Sagent Pharmaceuticals	FOSCARNET SODIUM	24	mg/mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
25021-190_528104cc-53a8-44f2-9e2f-3a2f77324b48	25021-190	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210615		ANDA	ANDA213363	Sagent Pharmaceuticals	MICAFUNGIN SODIUM	50	mg/5mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
25021-191_528104cc-53a8-44f2-9e2f-3a2f77324b48	25021-191	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210615		ANDA	ANDA213363	Sagent Pharmaceuticals	MICAFUNGIN SODIUM	100	mg/5mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
25021-192_f5d512c1-4d28-408e-b0bc-d9c3cab8972c	25021-192	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		ciprofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20221215		ANDA	ANDA078252	Sagent Pharmaceuticals	CIPROFLOXACIN	2	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
25021-193_36277638-639e-4141-9ad0-a5afaa12043b	25021-193	HUMAN PRESCRIPTION DRUG	Lincomycin		Lincomycin Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20230415		ANDA	ANDA215657	Sagent Pharmaceuticals	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
25021-194_3a261cef-2cc8-457f-977b-56c21d865caf	25021-194	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230715		ANDA	ANDA207092	Sagent Pharmaceuticals	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
25021-195_3a261cef-2cc8-457f-977b-56c21d865caf	25021-195	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230715		ANDA	ANDA207092	Sagent Pharmaceuticals	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
25021-201_a8bb73a3-673c-43dc-a9e3-031adb8136fe	25021-201	HUMAN PRESCRIPTION DRUG	Mesna		mesna	INJECTION, SOLUTION	INTRAVENOUS	20101201		ANDA	ANDA090913	Sagent Pharmaceuticals	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
25021-204_98db642d-e752-453f-9175-10238e4b3191	25021-204	HUMAN PRESCRIPTION DRUG	Vinorelbine		Vinorelbine	INJECTION, SOLUTION	INTRAVENOUS	20140915		ANDA	ANDA091106	Sagent Pharmaceuticals	VINORELBINE TARTRATE	10	mg/mL	Vinca Alkaloid [EPC], Vinca Alkaloids [CS]		N	20241231
25021-207_ecebeba3-8ead-4c7f-b22c-fdcf977adfe6	25021-207	HUMAN PRESCRIPTION DRUG	doxorubicin hydrochloride		doxorubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20131031		ANDA	ANDA209825	Sagent Pharmaceuticals	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
25021-215_2fcef624-1d6a-43ad-873b-495048cfc763	25021-215	HUMAN PRESCRIPTION DRUG	fluorouracil		fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20160915		ANDA	ANDA203609	Sagent Pharmaceuticals	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-219_350e175f-f66a-4707-a35a-c7460c3bd3d9	25021-219	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231101		ANDA	ANDA212826	Sagent Pharmaceuticals	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-223_90be6aab-dfa3-4d2f-9dcb-cc1858f7c67e	25021-223	HUMAN PRESCRIPTION DRUG	cytarabine		cytarabine	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20230601		ANDA	ANDA211938	Sagent Pharmaceuticals	CYTARABINE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-226_4c30347e-fd7f-418b-b85b-637b607c09fb	25021-226	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION	INTRAVENOUS	20230215		ANDA	ANDA215059	Sagent Pharmaceuticals	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
25021-227_4c30347e-fd7f-418b-b85b-637b607c09fb	25021-227	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION	INTRAVENOUS	20230215		ANDA	ANDA215059	Sagent Pharmaceuticals	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
25021-229_e9aed280-7c58-4817-b54d-ccbbdd4af575	25021-229	HUMAN PRESCRIPTION DRUG	cytarabine		cytarabine	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20230601		ANDA	ANDA211937	Sagent Pharmaceuticals	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-230_34acdbd5-5ca7-485d-8cfe-06c58e5f54d7	25021-230	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		irinotecan hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20140815		ANDA	ANDA090675	Sagent Pharmaceuticals	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
25021-231_5abf7332-094e-4d52-bee9-8d3e31287392	25021-231	HUMAN PRESCRIPTION DRUG	decitabine		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180815		ANDA	ANDA205539	Sagent Pharmaceuticals	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-233_ea36fe0f-fd6b-470b-a4b6-e1cc7a996157	25021-233	HUMAN PRESCRIPTION DRUG	oxaliplatin		oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20140915		ANDA	ANDA203869	Sagent Pharmaceuticals	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
25021-234_8c16221f-8a11-4ad2-b1ab-dc06f080d90f	25021-234	HUMAN PRESCRIPTION DRUG	gemcitabine		gemcitabine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20141229		ANDA	ANDA202485	Sagent Pharmaceuticals	GEMCITABINE HYDROCHLORIDE	200	mg/5mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-235_8c16221f-8a11-4ad2-b1ab-dc06f080d90f	25021-235	HUMAN PRESCRIPTION DRUG	gemcitabine		gemcitabine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20141229		ANDA	ANDA202485	Sagent Pharmaceuticals	GEMCITABINE HYDROCHLORIDE	1	g/25mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-241_673100ef-2b51-4ba2-af5c-fe7c52220636	25021-241	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170515		ANDA	ANDA207050	Sagent Pharmaceuticals	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
25021-242_ec7f6839-a01c-4b1b-b4b3-5573037706dd	25021-242	HUMAN PRESCRIPTION DRUG	Fludarabine Phosphate		Fludarabine Phosphate	INJECTION, SOLUTION	INTRAVENOUS	20161015		ANDA	ANDA076661	Sagent Pharmaceuticals	FLUDARABINE PHOSPHATE	25	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
25021-244_f083350e-ec7e-415d-85a3-1e48e414dbf2	25021-244	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		BORTEZOMIB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220501		ANDA	ANDA208392	Sagent Pharmaceuticals	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
25021-245_9ebbe3c6-4c2b-4391-8352-fa96b2bc2f4c	25021-245	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel Anhydrous	INJECTION, SOLUTION	INTRAVENOUS	20170915		ANDA	ANDA207252	Sagent Pharmaceuticals	DOCETAXEL ANHYDROUS	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
25021-246_0f528533-434c-4ce1-8596-a69319aee583	25021-246	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20180615		ANDA	ANDA209150	Sagent Pharmaceuticals	THIOTEPA	15	mg/1.5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
25021-250_865914d0-b74e-4beb-a7d1-e31a82b75c05	25021-250	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230615		ANDA	ANDA215687	Sagent Pharmaceuticals	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
25021-251_865914d0-b74e-4beb-a7d1-e31a82b75c05	25021-251	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230615		ANDA	ANDA215687	Sagent Pharmaceuticals	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
25021-252_9b41ea95-d383-46e8-9823-5d0447dec0ab	25021-252	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230615		ANDA	ANDA216648	Sagent Pharmaceuticals	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
25021-253_64bcce1a-6e31-4e73-8da5-11aa9e890da2	25021-253	HUMAN PRESCRIPTION DRUG	Cisplatin		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20230701		ANDA	ANDA207323	Sagent Pharmaceuticals	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
25021-254_841e3024-e160-4c4b-93d3-1e79d628d95b	25021-254	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel Anhydrous	INJECTION	INTRAVENOUS	20230801		ANDA	ANDA213510	Sagent Pharmaceuticals	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
25021-301_96af4fa9-0963-4db1-aab7-d371d3aee5ce	25021-301	HUMAN PRESCRIPTION DRUG	adenosine		adenosine	INJECTION	INTRAVENOUS	20140416		ANDA	ANDA077283	Sagent Pharmaceuticals	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
25021-303_b0c162ae-0af5-4443-9136-edf762c90e11	25021-303	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20100510		ANDA	ANDA204205	Sagent Pharmaceuticals	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
25021-305_09b4e4be-edc0-4a5e-abb2-1572287f2abe	25021-305	HUMAN PRESCRIPTION DRUG	chlorothiazide sodium		chlorothiazide sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191215		ANDA	ANDA202462	Sagent Pharmaceuticals	CHLOROTHIAZIDE SODIUM	500	mg/18mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
25021-305_392236fc-f848-420c-b239-bf08617e762a	25021-305	HUMAN PRESCRIPTION DRUG	chlorothiazide sodium		chlorothiazide sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151012		ANDA	ANDA202462	Sagent Pharmaceuticals	CHLOROTHIAZIDE SODIUM	500	mg/18mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
25021-308_92156cbb-9978-455a-b89c-4addbaa8d950	25021-308	HUMAN PRESCRIPTION DRUG	esmolol hydrochloride		esmolol hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20190715		ANDA	ANDA207107	Sagent Pharmaceuticals	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
25021-309_92156cbb-9978-455a-b89c-4addbaa8d950	25021-309	HUMAN PRESCRIPTION DRUG	esmolol hydrochloride		esmolol hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20190715		ANDA	ANDA207107	Sagent Pharmaceuticals	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
25021-311_222ce48f-2856-4be2-b16f-6fca38c0dceb	25021-311	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210315		ANDA	ANDA213902	Sagent Pharmaceuticals	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
25021-312_b4eb5dd2-5e25-4ecc-ac57-8897f2b6984a	25021-312	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210315		ANDA	ANDA214361	Sagent Pharmaceuticals	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
25021-313_753b9d9d-f4a7-4604-8bfe-20d0a811883a	25021-313	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20210115		ANDA	ANDA213585	Sagent Pharmaceuticals	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
25021-315_045c8994-a54f-4b5c-8b70-7cf7c962a59f	25021-315	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201015		ANDA	ANDA209967	Sagent Pharmaceuticals	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
25021-316_e6292d0c-6c54-4c32-81b9-a14261ad3086	25021-316	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		Norepinephrine Bitartrate	INJECTION, SOLUTION	INTRAVENOUS	20210701		ANDA	ANDA214323	Sagent Pharmaceuticals	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
25021-317_02cc0ab9-5ab4-4016-9ec2-b96c4cb2be41	25021-317	HUMAN PRESCRIPTION DRUG	labetalol hydrochloride		labetalol hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220901		ANDA	ANDA214533	Sagent Pharmaceuticals	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
25021-318_8a87ae13-88ca-49ae-bfd3-1ffb71cf9cbe	25021-318	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION	INTRAVENOUS	20230315		ANDA	ANDA206778	Sagent Pharmaceuticals	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
25021-400_bff4492d-1f5a-4953-adec-28824662b4e6	25021-400	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20100706		ANDA	ANDA090808	Sagent Pharmaceuticals	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
25021-401_abc3d7f0-6a62-4542-bc8e-257f87322b93	25021-401	HUMAN PRESCRIPTION DRUG	Heparin Sodium		heparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20100706		ANDA	ANDA090810	Sagent Pharmaceuticals	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
25021-402_bff4492d-1f5a-4953-adec-28824662b4e6	25021-402	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20100706		ANDA	ANDA090808	Sagent Pharmaceuticals	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
25021-403_bff4492d-1f5a-4953-adec-28824662b4e6	25021-403	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20100706		ANDA	ANDA090808	Sagent Pharmaceuticals	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
25021-404_bb6d321d-a569-4736-88a0-c979074d71ef	25021-404	HUMAN PRESCRIPTION DRUG	Heparin Sodium		heparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20100706		ANDA	ANDA090809	Sagent Pharmaceuticals	HEPARIN SODIUM	20000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
25021-408_9a1ccb0d-f56a-467a-9c2f-ad4e4dadf0f1	25021-408	HUMAN PRESCRIPTION DRUG	eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20180715		ANDA	ANDA204693	Sagent Pharmaceuticals	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
25021-409_9a1ccb0d-f56a-467a-9c2f-ad4e4dadf0f1	25021-409	HUMAN PRESCRIPTION DRUG	eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20180715		ANDA	ANDA204693	Sagent Pharmaceuticals	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
25021-410_0f60383f-d466-4b5b-a501-62dda52eb3b7	25021-410	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20231001		ANDA	ANDA078990	Sagent Pharmaceuticals	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
25021-411_0f60383f-d466-4b5b-a501-62dda52eb3b7	25021-411	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20231001		ANDA	ANDA078990	Sagent Pharmaceuticals	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
25021-414_e24e6287-dacb-43c2-ba01-de284ac90ee1	25021-414	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION, SOLUTION	INTRAVENOUS	20210415		ANDA	ANDA214235	Sagent Pharmaceuticals	ARGATROBAN	1	mg/mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
25021-415_3fd920b8-1b08-4882-9ed4-dd1b5b52af94	25021-415	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20230715		ANDA	ANDA207239	Sagent Pharmaceuticals	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
25021-460_38826b8c-4425-459d-8e74-100081444f38	25021-460	HUMAN PRESCRIPTION DRUG	desmopressin acetate		desmopressin acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180315		ANDA	ANDA204695	Sagent Pharmaceuticals	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
25021-461_4ab3a33b-43cc-4597-9f03-543f9a0f7ec1	25021-461	HUMAN PRESCRIPTION DRUG	desmopressin acetate		desmopressin acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180315		ANDA	ANDA204751	Sagent Pharmaceuticals	DESMOPRESSIN ACETATE	40	ug/10mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
25021-463_bc5937db-3bb4-4d44-bd2a-b1223863ec90	25021-463	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230415		ANDA	ANDA090834	Sagent Pharmaceuticals	OCTREOTIDE ACETATE	50	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
25021-464_bc5937db-3bb4-4d44-bd2a-b1223863ec90	25021-464	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230415		ANDA	ANDA090834	Sagent Pharmaceuticals	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
25021-465_bc5937db-3bb4-4d44-bd2a-b1223863ec90	25021-465	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230415		ANDA	ANDA090834	Sagent Pharmaceuticals	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
25021-466_bc5937db-3bb4-4d44-bd2a-b1223863ec90	25021-466	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230415		ANDA	ANDA091041	Sagent Pharmaceuticals	OCTREOTIDE ACETATE	200	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
25021-467_bc5937db-3bb4-4d44-bd2a-b1223863ec90	25021-467	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230415		ANDA	ANDA091041	Sagent Pharmaceuticals	OCTREOTIDE ACETATE	1000	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
25021-468_2662e418-ef9b-40be-abbd-db71401e3c20	25021-468	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium Anhydrous	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20240101		ANDA	ANDA208749	Sagent Pharmaceuticals	LEVOTHYROXINE SODIUM ANHYDROUS	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
25021-469_2662e418-ef9b-40be-abbd-db71401e3c20	25021-469	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium Anhydrous	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20240101		ANDA	ANDA208749	Sagent Pharmaceuticals	LEVOTHYROXINE SODIUM ANHYDROUS	200	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
25021-470_2662e418-ef9b-40be-abbd-db71401e3c20	25021-470	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium Anhydrous	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20240101		ANDA	ANDA208749	Sagent Pharmaceuticals	LEVOTHYROXINE SODIUM ANHYDROUS	500	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
25021-500_8a23c1cc-96bc-4c06-be1e-c250244b4980	25021-500	HUMAN PRESCRIPTION DRUG	thiamine hydrochloride		thiamine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210120		ANDA	ANDA206106	Sagent Pharmaceuticals	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
25021-502_b1dd7657-05bd-4062-89f1-9e11f0042f3e	25021-502	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20230315		ANDA	ANDA215107	Sagent Pharmaceuticals	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
25021-601_c49b7246-9be8-4808-b631-c2949ba5892b	25021-601	HUMAN PRESCRIPTION DRUG	caffeine citrate		caffeine citrate	SOLUTION	INTRAVENOUS	20120915		ANDA	ANDA090827	Sagent Pharmaceuticals	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
25021-602_c49b7246-9be8-4808-b631-c2949ba5892b	25021-602	HUMAN PRESCRIPTION DRUG	caffeine citrate		caffeine citrate	SOLUTION	ORAL	20120915		ANDA	ANDA091102	Sagent Pharmaceuticals	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
25021-608_3d93575e-43b4-4e06-979b-125baa1d5db9	25021-608	HUMAN PRESCRIPTION DRUG	propofol		propofol	INJECTION, EMULSION	INTRAVENOUS	20140701		ANDA	ANDA075102	Sagent Pharmaceuticals	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
25021-609_313efcad-0c65-49cb-940b-b4e6de4c6dff	25021-609	HUMAN PRESCRIPTION DRUG	dihydroergotamine mesylate		dihydroergotamine mesylate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220915		ANDA	ANDA207264	Sagent Pharmaceuticals	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
25021-610_bbd97c00-c7ad-4a28-86fd-4957d534e5ef	25021-610	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20220115		ANDA	ANDA210652	Sagent Pharmaceuticals	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
25021-611_bbd97c00-c7ad-4a28-86fd-4957d534e5ef	25021-611	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20220115		ANDA	ANDA210652	Sagent Pharmaceuticals	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
25021-612_f91b940b-e459-46c8-886a-c1da0265da54	25021-612	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20210215		ANDA	ANDA213917	Sagent Pharmaceuticals	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
25021-651_393d82d5-94f5-43fd-b5c8-d0554795233f	25021-651	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		orphenadrine citrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20111001		ANDA	ANDA090585	Sagent Pharmaceuticals	ORPHENADRINE CITRATE	30	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
25021-652_086afe58-e11d-4ac3-b71d-04ce227e0c60	25021-652	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride		ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20190715		ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
25021-655_943346c0-d98e-4ac2-a1a2-75427decf2fc	25021-655	HUMAN PRESCRIPTION DRUG	midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120319		ANDA	ANDA090696	Sagent Pharmaceuticals	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
25021-661_002ea282-09ba-4d79-8bd1-94c9859f442b	25021-661	HUMAN PRESCRIPTION DRUG	midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120319		ANDA	ANDA090850	Sagent Pharmaceuticals	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
25021-662_65d26701-dd17-4167-a4f1-7613508f8ecf	25021-662	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20111220		ANDA	ANDA091458	Sagent Pharmaceuticals	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
25021-668_469efca1-43dc-4508-a260-fc969f20d620	25021-668	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		cisatracurium besylate	INJECTION, SOLUTION	INTRAVENOUS	20211101		ANDA	ANDA201836	Sagent Pharmaceuticals	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
25021-669_469efca1-43dc-4508-a260-fc969f20d620	25021-669	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		cisatracurium besylate	INJECTION, SOLUTION	INTRAVENOUS	20211101		ANDA	ANDA201836	Sagent Pharmaceuticals	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
25021-670_469efca1-43dc-4508-a260-fc969f20d620	25021-670	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		cisatracurium besylate	INJECTION, SOLUTION	INTRAVENOUS	20211101		ANDA	ANDA201851	Sagent Pharmaceuticals	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
25021-671_086afe58-e11d-4ac3-b71d-04ce227e0c60	25021-671	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride		ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20181215		ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
25021-671_ae84a6fa-62a4-4e50-9d5d-01197c4f8f34	25021-671	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride		ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20200101		ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
25021-673_dc404ae0-b79d-4616-86eb-625b82d3d666	25021-673	HUMAN PRESCRIPTION DRUG	glydo		lidocaine hydrochloride	JELLY	TOPICAL	20140915		ANDA	ANDA201094	Sagent Pharmaceuticals	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
25021-674_b6654b66-f0c8-49be-b43b-e3295cfd2a55	25021-674	HUMAN PRESCRIPTION DRUG	etomidate		etomidate	INJECTION, SOLUTION	INTRAVENOUS	20120810	20240831	ANDA	ANDA215028	Sagent Pharmaceuticals	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	
25021-675_5b7bad7e-ec8a-4e45-8379-b1229a679030	25021-675	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180215		ANDA	ANDA205404	Sagent Pharmaceuticals	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
25021-676_5eb44748-b3d4-4d86-a172-9f03eb804671	25021-676	HUMAN PRESCRIPTION DRUG	pentobarbital sodium		pentobarbital sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170419		ANDA	ANDA206404	Sagent Pharmaceuticals	PENTOBARBITAL SODIUM	50	mg/mL		CII	N	20241231
25021-677_61ccdb14-ac65-4fa3-8852-33b4917928aa	25021-677	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20211015		ANDA	ANDA215022	Sagent Pharmaceuticals	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
25021-678_9ae563da-240a-468d-bc42-ed4667df2392	25021-678	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION, SOLUTION	INTRATHECAL	20210715		ANDA	ANDA210048	Sagent Pharmaceuticals	BACLOFEN	500	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
25021-679_9ae563da-240a-468d-bc42-ed4667df2392	25021-679	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION, SOLUTION	INTRATHECAL	20210715		ANDA	ANDA210048	Sagent Pharmaceuticals	BACLOFEN	2000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
25021-680_a8bc8f3d-05f0-43f7-aa9b-024158d9aae6	25021-680	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION, SOLUTION	INTRATHECAL	20210715		ANDA	ANDA210315	Sagent Pharmaceuticals	BACLOFEN	1000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
25021-681_570e9773-fda9-492f-bdef-7dd6814fd3b2	25021-681	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION, SOLUTION	INTRATHECAL	20210715		ANDA	ANDA210777	Sagent Pharmaceuticals	BACLOFEN	50	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
25021-682_51a16c65-47e0-405c-8c84-82a6a28b3efd	25021-682	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230715		ANDA	ANDA216809	Sagent Pharmaceuticals	KETAMINE HYDROCHLORIDE	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
25021-683_51a16c65-47e0-405c-8c84-82a6a28b3efd	25021-683	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230715		ANDA	ANDA216809	Sagent Pharmaceuticals	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
25021-684_51a16c65-47e0-405c-8c84-82a6a28b3efd	25021-684	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230715		ANDA	ANDA216809	Sagent Pharmaceuticals	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
25021-687_1d066c67-eac2-494a-ad10-ba7e9c60b0e9	25021-687	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20231015		ANDA	ANDA205656	Sagent Pharmaceuticals	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
25021-700_ff55e1ab-2a8d-4a56-8b72-5e0a8e00d866	25021-700	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140905		ANDA	ANDA204216	Sagent Pharmaceuticals	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25021-701_ff55e1ab-2a8d-4a56-8b72-5e0a8e00d866	25021-701	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140905		ANDA	ANDA204216	Sagent Pharmaceuticals	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
25021-751_3be5a5fc-a829-4816-bfee-d597fe7b7839	25021-751	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220715		ANDA	ANDA204400	Sagent Pharmaceuticals	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
25021-777_c45489bd-19e3-4a26-a116-96c1f30b8e85	25021-777	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120830		ANDA	ANDA079224	Sagent Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
25021-780_1509ffd3-7057-4115-9a11-07f6c56780ee	25021-780	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20131101		ANDA	ANDA091627	Sagent Pharmaceuticals	LEVETIRACETAM	500	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
25021-783_5679dbc2-6417-4a54-a627-7f72293879ad	25021-783	HUMAN PRESCRIPTION DRUG	palonosetron hydrochloride		palonosetron hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180615		ANDA	ANDA204289	Sagent Pharmaceuticals	PALONOSETRON HYDROCHLORIDE	.05	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
25021-790_18174b35-89ba-487a-bbc5-95716b8c1274	25021-790	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE EDISYLATE		PROCHLORPERAZINE EDISYLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211115		ANDA	ANDA214107	Sagent Pharmaceuticals	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
25021-791_67346497-1e9a-41be-9ff6-d5339ce16ab9	25021-791	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	INJECTION, SOLUTION	INTRAVENOUS	20220317		ANDA	ANDA214301	Sagent Pharmaceuticals	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
25021-801_5c4dd673-9630-4dff-8725-12a5eb2c11f7	25021-801	HUMAN PRESCRIPTION DRUG	zoledronic acid		zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20141229		ANDA	ANDA091493	Sagent Pharmaceuticals	ZOLEDRONIC ACID	.8	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
25021-806_0ee8e325-6089-44b2-8882-055e1c1e3474	25021-806	HUMAN PRESCRIPTION DRUG	haloperidol		haloperidol lactate	INJECTION, SOLUTION	INTRAMUSCULAR	20111024		ANDA	ANDA091637	Sagent Pharmaceuticals	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
25021-812_19a4f870-c3c9-4b28-bab4-3bb12156e602	25021-812	HUMAN PRESCRIPTION DRUG	Acetylcysteine		acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20220215		ANDA	ANDA091684	Sagent Pharmaceuticals	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
25021-812_d2afdd40-ad6f-4a30-9700-084b13c11ba6	25021-812	HUMAN PRESCRIPTION DRUG	Acetylcysteine		acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20180415		ANDA	ANDA091684	Sagent Pharmaceuticals	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
25021-813_ff2ba160-e2f9-4ab9-9e67-2409f02c923e	25021-813	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120915		ANDA	ANDA200753	Sagent Pharmaceuticals	LEUCOVORIN CALCIUM	50	mg/5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
25021-814_ff2ba160-e2f9-4ab9-9e67-2409f02c923e	25021-814	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120915		ANDA	ANDA200753	Sagent Pharmaceuticals	LEUCOVORIN CALCIUM	100	mg/10mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
25021-815_ff2ba160-e2f9-4ab9-9e67-2409f02c923e	25021-815	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120915		ANDA	ANDA200753	Sagent Pharmaceuticals	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
25021-816_ff2ba160-e2f9-4ab9-9e67-2409f02c923e	25021-816	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120915		ANDA	ANDA200855	Sagent Pharmaceuticals	LEUCOVORIN CALCIUM	350	mg/17.5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
25021-820_13e1ca54-4fc4-4e93-a52d-c9320865e3cb	25021-820	HUMAN PRESCRIPTION DRUG	methylprednisolone acetate		methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20211115		ANDA	ANDA201835	Sagent Pharmaceuticals	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
25021-821_13e1ca54-4fc4-4e93-a52d-c9320865e3cb	25021-821	HUMAN PRESCRIPTION DRUG	methylprednisolone acetate		methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20211115		ANDA	ANDA201835	Sagent Pharmaceuticals	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
25021-826_64729491-8543-4a2d-a3fc-31f3db07e482	25021-826	HUMAN PRESCRIPTION DRUG	zoledronic acid		zoledronic acid	INJECTION, SOLUTION	INTRAVENOUS	20130302		NDA	NDA203231	Sagent Pharmaceuticals	ZOLEDRONIC ACID	.04	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
25021-826_f07e5c60-6ea3-4323-a9fe-b35264e667b6	25021-826	HUMAN PRESCRIPTION DRUG	zoledronic acid		zoledronic acid	INJECTION, SOLUTION	INTRAVENOUS	20150901		NDA	NDA203231	Sagent Pharmaceuticals	ZOLEDRONIC ACID	.04	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
25021-828_4619074b-a86b-41a6-bd98-76d15166764c	25021-828	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180415		ANDA	ANDA209110	Sagent Pharmaceuticals	LEUCOVORIN CALCIUM	500	mg/50mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
25021-829_2a2d60c6-d777-411f-9ccb-d742fe777dda	25021-829	HUMAN PRESCRIPTION DRUG	Fomepizole		Fomepizole	INJECTION	INTRAVENOUS	20231115		ANDA	ANDA216791	Sagent Pharmaceuticals	FOMEPIZOLE	1.5	g/1.5mL	Antidote [EPC]		N	20241231
25021-830_159d3310-b6eb-4f9f-a83f-c7768d4360ed	25021-830	HUMAN PRESCRIPTION DRUG	zoledronic acid		zoledronic acid	INJECTION, SOLUTION	INTRAVENOUS	20130302		ANDA	ANDA202828	Sagent Pharmaceuticals	ZOLEDRONIC ACID	.05	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
25021-831_cab94495-c45d-4b65-9654-cf2cda8b9dcb	25021-831	HUMAN PRESCRIPTION DRUG	haloperidol decanoate		haloperidol decanoate	INJECTION, SOLUTION	INTRAMUSCULAR	20171115		ANDA	ANDA205241	Sagent Pharmaceuticals	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
25021-833_cab94495-c45d-4b65-9654-cf2cda8b9dcb	25021-833	HUMAN PRESCRIPTION DRUG	haloperidol decanoate		haloperidol decanoate	INJECTION, SOLUTION	INTRAMUSCULAR	20171115		ANDA	ANDA205241	Sagent Pharmaceuticals	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
25021-834_cab94495-c45d-4b65-9654-cf2cda8b9dcb	25021-834	HUMAN PRESCRIPTION DRUG	haloperidol decanoate		haloperidol decanoate	INJECTION, SOLUTION	INTRAMUSCULAR	20171115		ANDA	ANDA205241	Sagent Pharmaceuticals	HALOPERIDOL DECANOATE	500	mg/5mL	Typical Antipsychotic [EPC]		N	20241231
25021-836_0cced8a7-58b3-43e5-afca-2d6d3ed4c017	25021-836	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20230415		ANDA	ANDA214528	Sagent Pharmaceuticals	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
25021-838_bd85ef0f-3c47-4d48-9ba0-9d4e012698cf	25021-838	HUMAN PRESCRIPTION DRUG	Fluphenazine Decanoate		Fluphenazine Decanoate	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20230801		ANDA	ANDA215509	Sagent Pharmaceuticals	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
25047-751_0d8c3056-ede4-46b9-a1d1-fb68cfe7b7b6	25047-751	HUMAN OTC DRUG	KOLORZ TOPICAL ANESTHETIC	TRIPLE MINT	Benzocaine	GEL	DENTAL	20190906		OTC MONOGRAPH NOT FINAL	part356	DMG AMERICA, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
25047-752_0d8c3056-ede4-46b9-a1d1-fb68cfe7b7b6	25047-752	HUMAN OTC DRUG	KOLORZ TOPICAL ANESTHETIC	CHERRY BURST	BENZOCAINE	GEL	DENTAL	20190906		OTC MONOGRAPH NOT FINAL	part356	DMG AMERICA, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
25047-753_0d8c3056-ede4-46b9-a1d1-fb68cfe7b7b6	25047-753	HUMAN OTC DRUG	KOLORZ TOPICAL ANESTHETIC	COTTON CANDY	BENZOCAINE	GEL	DENTAL	20190906		OTC MONOGRAPH NOT FINAL	part356	DMG AMERICA, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
25047-754_0d8c3056-ede4-46b9-a1d1-fb68cfe7b7b6	25047-754	HUMAN OTC DRUG	KOLORZ TOPICAL ANESTHETIC	BLUE RASBERRY	BENZOCAINE	GEL	DENTAL	20190906		OTC MONOGRAPH NOT FINAL	part356	DMG AMERICA, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
25047-755_0d8c3056-ede4-46b9-a1d1-fb68cfe7b7b6	25047-755	HUMAN OTC DRUG	KOLORZ TOPICAL ANESTHETIC	PINA COLADA	BENZOCAINE	GEL	DENTAL	20190906		OTC MONOGRAPH NOT FINAL	part356	DMG AMERICA, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
25047-761_abc23b24-2fa2-410c-b452-e57a3bca7af2	25047-761	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE FOAM	TRIPLE MINT	SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	1.23	g/g			N	20241231
25047-762_abc23b24-2fa2-410c-b452-e57a3bca7af2	25047-762	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE FOAM	CHERRY CHEESECAKE	SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	1.23	g/g			N	20241231
25047-763_abc23b24-2fa2-410c-b452-e57a3bca7af2	25047-763	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE FOAM	COTTON CANDY	SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	1.23	g/g			N	20241231
25047-764_abc23b24-2fa2-410c-b452-e57a3bca7af2	25047-764	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE FOAM	BLUE RASPBERRY	SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	1.23	mg/g			N	20241231
25047-765_79be0b6b-34c3-4e14-9702-54e7d4f1104e	25047-765	HUMAN PRESCRIPTION DRUG	KOLORZ NEUTRAL FLUORIDE FOAM	TRIPLE MINT	SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	.9	mg/g			N	20241231
25047-771_5923eecb-9971-46fb-90f7-68ef2262d0f3	25047-771	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE	TRIPLE MINT	SODIUM FLUORIDE	GEL	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	12.3	mg/mL			N	20241231
25047-772_5923eecb-9971-46fb-90f7-68ef2262d0f3	25047-772	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE	CHERRY CHEESECAKE	SODIUM FLUORIDE	GEL	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	12.3	mg/mL			N	20241231
25047-773_5923eecb-9971-46fb-90f7-68ef2262d0f3	25047-773	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE	COTTON CANDY	SODIUM FLUORIDE	GEL	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	12.3	mg/mL			N	20241231
25047-774_5923eecb-9971-46fb-90f7-68ef2262d0f3	25047-774	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE	BLUE RASPBERRY	SODIUM FLUORIDE	GEL	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	12.3	mg/mL			N	20241231
25047-775_5923eecb-9971-46fb-90f7-68ef2262d0f3	25047-775	HUMAN PRESCRIPTION DRUG	KOLORZ SIXTY SECOND FLUORIDE	PINA COLADA	SODIUM FLUORIDE	GEL	DENTAL	20061122		UNAPPROVED DRUG OTHER		DMG AMERICA, LLC	SODIUM FLUORIDE	12.3	mg/mL			N	20241231
25208-001_09e14425-6dfb-40ba-8bf2-ba9cd28774d8	25208-001	HUMAN PRESCRIPTION DRUG	AGGRASTAT		TIROFIBAN	INJECTION, SOLUTION	INTRAVENOUS	20161015		NDA	NDA020912	Medicure International Inc	TIROFIBAN HYDROCHLORIDE	3.75	mg/15mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
25208-002_09e14425-6dfb-40ba-8bf2-ba9cd28774d8	25208-002	HUMAN PRESCRIPTION DRUG	AGGRASTAT		TIROFIBAN	INJECTION, SOLUTION	INTRAVENOUS	19980514		NDA	NDA020913	Medicure International Inc	TIROFIBAN HYDROCHLORIDE	5	mg/100mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
25208-201_275ce6f0-da4d-4b80-817e-a9d648529fcf	25208-201	HUMAN PRESCRIPTION DRUG	ZYPITAMAG		Pitavastatin Magnesium	TABLET, FILM COATED	ORAL	20180309		NDA	NDA208379	Medicure International Inc	PITAVASTATIN	2	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
25208-202_275ce6f0-da4d-4b80-817e-a9d648529fcf	25208-202	HUMAN PRESCRIPTION DRUG	ZYPITAMAG		Pitavastatin Magnesium	TABLET, FILM COATED	ORAL	20180309		NDA	NDA208379	Medicure International Inc	PITAVASTATIN	4	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
25208-901_f061f506-22a3-4d03-8db1-f3d739e51b84	25208-901	HUMAN PRESCRIPTION DRUG	AGGRASTAT		TIROFIBAN	INJECTION, SOLUTION	INTRAVENOUS	20161015		NDA	NDA020912	Medicure International Inc	TIROFIBAN HYDROCHLORIDE	3.75	mg/15mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
25208-902_f061f506-22a3-4d03-8db1-f3d739e51b84	25208-902	HUMAN PRESCRIPTION DRUG	AGGRASTAT		TIROFIBAN	INJECTION, SOLUTION	INTRAVENOUS	19980514		NDA	NDA020913	Medicure International Inc	TIROFIBAN HYDROCHLORIDE	5	mg/100mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
25280-006_9848a2a3-4521-6e62-e053-2995a90a1a0a	25280-006	HUMAN OTC DRUG	Loesch Hair Regrowth Formula	Unscented Topical Solution Extra-Strength for Men	minoxidil	SOLUTION	TOPICAL	20140730		ANDA	ANDA075598	Loesch Laboratory Consultant, INC.	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
25280-007_97f30e90-b82b-9e29-e053-2a95a90a7f62	25280-007	HUMAN OTC DRUG	Loesch Hair Regrowth Formula	Unscented Topical Solution Regular-Strength for Men and Women	minoxidil	SOLUTION	TOPICAL	20140811		ANDA	ANDA075357	Loesch Laboratory Consultant, INC.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
25357-025_d64a5f12-9453-4172-a6a7-c9509ab15f52	25357-025	HUMAN PRESCRIPTION DRUG	Photrexa Cross-linking Kit		riboflavin 5-phosphate ophthalmic	KIT	OPHTHALMIC	20170925		NDA	NDA203324	Glaukos Corporation						N	20241231
25357-100_4d6a4ed8-f400-4bd7-83e0-c7504c7e0a44	25357-100	HUMAN PRESCRIPTION DRUG	iDose TR		Travoprost Intracameral	IMPLANT	INTRACAMERAL	20231213		NDA	NDA218010	Glaukos Corporation	TRAVOPROST	75	ug/1	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
25543-200_d824fb93-a2b8-7712-e053-2995a90a2a9f	25543-200	HUMAN PRESCRIPTION DRUG	Compressed Oxygen		Compressed Oxygen	GAS	RESPIRATORY (INHALATION)	20100422		NDA	NDA205840	Airgas, Inc.	OXYGEN	1	L/L			N	20241231
25682-001_68907414-19b7-43c7-be48-9768bb97d696	25682-001	HUMAN PRESCRIPTION DRUG	SOLIRIS		ECULIZUMAB	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20070402		BLA	BLA125166	Alexion Pharmaceuticals Inc.	ECULIZUMAB	300	mg/30mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
25682-007_5b55da2a-7a4d-435b-bf23-34a23e960a6d	25682-007	HUMAN PRESCRIPTION DRUG	KANUMA		Sebelipase alfa	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20151208		BLA	BLA125561	Alexion Pharmaceuticals, Inc.	SEBELIPASE ALFA	2	mg/mL	Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC], Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC], Sterol Esterase [CS]		N	20241231
25682-010_218a7adc-f119-4c28-aa84-41d8bc666f4b	25682-010	HUMAN PRESCRIPTION DRUG	STRENSIQ		ASFOTASE ALFA	SOLUTION	SUBCUTANEOUS	20151023		BLA	BLA125513	Alexion Pharmaceuticals, Inc.	ASFOTASE ALFA	18	mg/.45mL	Alkaline Phosphatase [CS], Tissue-nonspecific Alkaline Phosphatase [EPC]		N	20241231
25682-013_218a7adc-f119-4c28-aa84-41d8bc666f4b	25682-013	HUMAN PRESCRIPTION DRUG	STRENSIQ		ASFOTASE ALFA	SOLUTION	SUBCUTANEOUS	20151023		BLA	BLA125513	Alexion Pharmaceuticals, Inc.	ASFOTASE ALFA	28	mg/.7mL	Alkaline Phosphatase [CS], Tissue-nonspecific Alkaline Phosphatase [EPC]		N	20241231
25682-016_218a7adc-f119-4c28-aa84-41d8bc666f4b	25682-016	HUMAN PRESCRIPTION DRUG	STRENSIQ		ASFOTASE ALFA	SOLUTION	SUBCUTANEOUS	20151023		BLA	BLA125513	Alexion Pharmaceuticals, Inc.	ASFOTASE ALFA	40	mg/mL	Alkaline Phosphatase [CS], Tissue-nonspecific Alkaline Phosphatase [EPC]		N	20241231
25682-019_218a7adc-f119-4c28-aa84-41d8bc666f4b	25682-019	HUMAN PRESCRIPTION DRUG	STRENSIQ		ASFOTASE ALFA	SOLUTION	SUBCUTANEOUS	20151023		BLA	BLA125513	Alexion Pharmaceuticals, Inc.	ASFOTASE ALFA	80	mg/.8mL	Alkaline Phosphatase [CS], Tissue-nonspecific Alkaline Phosphatase [EPC]		N	20241231
25682-022_c8439051-24bd-414a-8bd7-26d307991212	25682-022	HUMAN PRESCRIPTION DRUG	Ultomiris		ravulizumab	SOLUTION, CONCENTRATE	INTRAVENOUS	20181221		BLA	BLA761108	Alexion Pharmaceuticals Inc.	RAVULIZUMAB	300	mg/30mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
25682-025_c8439051-24bd-414a-8bd7-26d307991212	25682-025	HUMAN PRESCRIPTION DRUG	Ultomiris		ravulizumab	SOLUTION, CONCENTRATE	INTRAVENOUS	20201009		BLA	BLA761108	Alexion Pharmaceuticals Inc.	RAVULIZUMAB	300	mg/3mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
25682-028_c8439051-24bd-414a-8bd7-26d307991212	25682-028	HUMAN PRESCRIPTION DRUG	Ultomiris		ravulizumab	SOLUTION, CONCENTRATE	INTRAVENOUS	20201009		BLA	BLA761108	Alexion Pharmaceuticals Inc.	RAVULIZUMAB	1100	mg/11mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
25682-031_c8439051-24bd-414a-8bd7-26d307991212	25682-031	HUMAN PRESCRIPTION DRUG	ULTOMIRIS		RAVULIZUMAB	KIT		20230401		BLA	BLA761108	Alexion Pharmaceuticals Inc.						N	20241231
26052-022_7c21fef5-fe2e-c36b-e053-2a91aa0ac534	26052-022	HUMAN OTC DRUG	NAS MAX STRENGTH SPOT TREATMENT		SALICYLIC ACID	CREAM	TOPICAL	20111101		OTC MONOGRAPH FINAL	part333D	BURT'S BEES, INC.	SALICYLIC ACID	2	g/100g			N	20241231
26052-027_307502c3-3de0-3a99-e054-00144ff88e88	26052-027	HUMAN OTC DRUG	Renewal Firming Day	Broad Spectrum SPF 30	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20150101		OTC MONOGRAPH FINAL	part352	BURT'S BEES, INC.	TITANIUM DIOXIDE; ZINC OXIDE	2.53; 11.9	g/100g; g/100g			N	20241231
26052-028_7d8cda7b-488c-6d66-e053-2991aa0ab3ee	26052-028	HUMAN OTC DRUG	BURTS BEES BABY BEE DIAPER RASH		ZINC OXIDE	OINTMENT	TOPICAL	20150529		OTC MONOGRAPH FINAL	part347	BURT'S BEES, INC.	ZINC OXIDE	40	g/100g			N	20241231
26052-029_7d8cda7b-4881-6d66-e053-2991aa0ab3ee	26052-029	HUMAN OTC DRUG	MEDICATED LIP BALM		MENTHOL AND EUCALYPTUS	STICK	TOPICAL	20160104		OTC MONOGRAPH NOT FINAL	part348	Burt's Bees, Inc.	MENTHOL	.9	g/100g			N	20241231
26052-030_06f88974-4265-a7f5-e063-6394a90a7d28	26052-030	HUMAN OTC DRUG	BB Broad Spectrum SPF 15 Light		Zinc Oxide Titanium Dioxide	CREAM	TOPICAL	20151101		OTC MONOGRAPH DRUG	M020	Burt's Bees	TITANIUM DIOXIDE; ZINC OXIDE	5.3; 7	g/100g; g/100g			N	20241231
26052-031_06d27b10-f038-1471-e063-6394a90a4191	26052-031	HUMAN OTC DRUG	BB Broad Spectrum SPF 15 Light to Medium		Zinc Oxide Titanium Dioxide	CREAM	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part352	Burt's Bees	TITANIUM DIOXIDE; ZINC OXIDE	4.7; 7	g/100g; g/100g			N	20241231
26052-032_06f89ff9-a220-a95f-e063-6394a90a2187	26052-032	HUMAN OTC DRUG	BB Broad Spectrum SPF 15 Medium		Zinc Oxide Titanium Dioxide	CREAM	TOPICAL	20151101		OTC MONOGRAPH DRUG	M020	Burt's Bees	TITANIUM DIOXIDE; ZINC OXIDE	4.7; 7	g/100g; g/100g			N	20241231
26052-036_7d3cece5-17b5-404a-e053-2a91aa0a549a	26052-036	HUMAN OTC DRUG	ALL WEATHER SPF 15 LIP BALM		Zinc Oxide	STICK	TOPICAL	20171201		OTC MONOGRAPH FINAL	part352	Burt's Bees	ZINC OXIDE	11	g/100g			N	20241231
26052-039_06ea3b0d-2e5e-d536-e063-6294a90a460c	26052-039	HUMAN OTC DRUG	NAS PURIFYING CLEANSER		SALICYLIC ACID	GEL	TOPICAL	20210301		OTC MONOGRAPH FINAL	part333D	Burt's Bees, Inc.	SALICYLIC ACID	1	g/100mL			N	20241231
26052-040_06f85507-a22c-1c34-e063-6294a90afe02	26052-040	HUMAN OTC DRUG	NAS PORE REFINING SCRUB		SALICYLIC ACID	EMULSION	TOPICAL	20210301		OTC MONOGRAPH DRUG	M006	BURT'S BEES, INC.	SALICYLIC ACID	1	g/100g			N	20241231
26052-041_06f88363-e443-8506-e063-6394a90a57a9	26052-041	HUMAN OTC DRUG	NAS Targeted Spot Treatment		SALICYLIC ACID	LIQUID	TOPICAL	20210301		OTC MONOGRAPH DRUG	M006	Burt's Bees	SALICYLIC ACID	.75	g/100g			N	20241231
26052-042_06ea4a82-ecaa-6320-e063-6394a90ab9a0	26052-042	HUMAN OTC DRUG	NAS Toner		SALICYLIC ACID	LIQUID	TOPICAL	20210301		OTC MONOGRAPH FINAL	part333D	BURT'S BEES, INC.	SALICYLIC ACID	1	g/1001			N	20241231
26052-100_f213e192-d216-2cd0-e053-2a95a90a32f5	26052-100	HUMAN OTC DRUG	Tinted Lip Balm SPF30 Sienna Rose		SPF30 Lip Balm	STICK	TOPICAL	20220301		OTC MONOGRAPH FINAL	part352	Burt's Bees Inc.	ZINC OXIDE	19	g/100g			N	20241231
26052-101_f2137664-c6bf-634d-e053-2995a90ab984	26052-101	HUMAN OTC DRUG	Tinted Lip Balm SPF30 Wild Peony		SPF30 Lip Balm	STICK	TOPICAL	20220301		OTC MONOGRAPH FINAL	part352	Burt's Bees Inc.	ZINC OXIDE	19	g/100g			N	20241231
26052-492_ec1f509c-8fbb-a271-e053-2995a90af811	26052-492	HUMAN OTC DRUG	Burts Bees Calming Day	SPF30	Zinc OXide	LOTION	TOPICAL	20211001		OTC MONOGRAPH FINAL	M020	Burts Bees	ZINC OXIDE	16.9	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
26052-493_ec1f5d0c-3f5c-0063-e053-2a95a90abeb8	26052-493	HUMAN OTC DRUG	Burts Bees Firming Day	SPF30	Zinc OXide	LOTION	TOPICAL	20211001		OTC MONOGRAPH FINAL	M020	Burts Bees	ZINC OXIDE	16.9	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
26124-002_fc4d088b-385f-1235-e053-6394a90a5a00	26124-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19720110		NDA	NDA205889	HELGET, INC.	OXYGEN	999	mL/L			N	20241231
26550-001_088887f7-e03b-d47a-e063-6294a90a00df	26550-001	HUMAN OTC DRUG	X3 Clean		BENZALKONIUM CHLORIDE	AEROSOL, FOAM	TOPICAL	20090901		OTC MONOGRAPH DRUG	M003	X3 Labs Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
26550-002_0888c3af-5d75-80be-e063-6394a90aca09	26550-002	HUMAN OTC DRUG	X3 Clean		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20090901		OTC MONOGRAPH DRUG	M003	X3 Labs Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
26866-001_06d645e3-1abf-1031-e063-6394a90a0514	26866-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091030		UNAPPROVED MEDICAL GAS		Bandy's Pharmacy	OXYGEN	99	L/100L			N	20241231
27017-020_f1ec6441-50ae-7764-e053-2995a90a851c	27017-020	HUMAN OTC DRUG	Xlear Cough Drops (Black Cherry)		Menthol	LOZENGE	ORAL	20191212		OTC MONOGRAPH FINAL	part341	Xlear Inc.	MENTHOL	4	mg/1			N	20241231
27017-021_f1ec5d88-5cad-5f59-e053-2995a90ae2c8	27017-021	HUMAN OTC DRUG	Xlear Cough Drops (Green Apple)		Menthol	LOZENGE	ORAL	20191212		OTC MONOGRAPH FINAL	part341	Xlear Inc.	MENTHOL	4	mg/1			N	20241231
27017-022_f1ec5d88-5cae-5f59-e053-2995a90ae2c8	27017-022	HUMAN OTC DRUG	Xlear Cough Drops (Honey Lemon)		Menthol	LOZENGE	ORAL	20191212		OTC MONOGRAPH FINAL	part341	Xlear Inc.	MENTHOL	4	mg/1			N	20241231
27241-001_d8e6ba7a-d86b-4d93-bbe4-557e6c84add5	27241-001	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Ajanta Pharma USA Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-002_d8e6ba7a-d86b-4d93-bbe4-557e6c84add5	27241-002	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Ajanta Pharma USA Inc.	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-003_d8e6ba7a-d86b-4d93-bbe4-557e6c84add5	27241-003	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Ajanta Pharma USA Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-004_d8e6ba7a-d86b-4d93-bbe4-557e6c84add5	27241-004	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Ajanta Pharma USA Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-005_d8e6ba7a-d86b-4d93-bbe4-557e6c84add5	27241-005	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Ajanta Pharma USA Inc.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-006_d8e6ba7a-d86b-4d93-bbe4-557e6c84add5	27241-006	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Ajanta Pharma USA Inc.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-015_3e514c81-3941-446b-9b2d-024140da6f2e	27241-015	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	GRANULE	ORAL	20150813		ANDA	ANDA203438	Ajanta Pharma USA Inc.	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
27241-016_3e514c81-3941-446b-9b2d-024140da6f2e	27241-016	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, CHEWABLE	ORAL	20150813		ANDA	ANDA203328	Ajanta Pharma USA Inc.	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
27241-017_3e514c81-3941-446b-9b2d-024140da6f2e	27241-017	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST	TABLET, CHEWABLE	ORAL	20150813		ANDA	ANDA203328	Ajanta Pharma USA Inc.	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
27241-018_3e514c81-3941-446b-9b2d-024140da6f2e	27241-018	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, COATED	ORAL	20150813		ANDA	ANDA203432	Ajanta Pharma USA Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
27241-019_7fa5fadd-5274-4a60-84d2-f955e6b3d719	27241-019	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20161018		ANDA	ANDA203957	Ajanta Pharma USA Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-020_7fa5fadd-5274-4a60-84d2-f955e6b3d719	27241-020	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20161018		ANDA	ANDA203957	Ajanta Pharma USA Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-021_0d91af56-c098-4fe3-bfec-d5efc57c6b07	27241-021	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET	ORAL	20160531		ANDA	ANDA204041	Ajanta Pharma USA Inc.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
27241-022_0d91af56-c098-4fe3-bfec-d5efc57c6b07	27241-022	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET	ORAL	20160531		ANDA	ANDA204041	Ajanta Pharma USA Inc.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
27241-029_17758078-fc1e-42e3-9244-1f13a74936bb	27241-029	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	FOR SUSPENSION	ORAL	20160727		ANDA	ANDA205545	Ajanta Pharma USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	20; 1680	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-030_17758078-fc1e-42e3-9244-1f13a74936bb	27241-030	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	FOR SUSPENSION	ORAL	20160727		ANDA	ANDA205545	Ajanta Pharma USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	40; 1680	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-031_9fe18b5c-31b9-490c-ab38-ba72388746a0	27241-031	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE	ORAL	20160715		ANDA	ANDA204228	Ajanta Pharma USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-032_9fe18b5c-31b9-490c-ab38-ba72388746a0	27241-032	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE	ORAL	20160715		ANDA	ANDA204228	Ajanta Pharma USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-037_d8e03cda-d4c4-4ec0-bdd3-bfe1aec624e7	27241-037	HUMAN PRESCRIPTION DRUG	solifenacin succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA205483	Ajanta Pharma USA Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
27241-038_d8e03cda-d4c4-4ec0-bdd3-bfe1aec624e7	27241-038	HUMAN PRESCRIPTION DRUG	solifenacin succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA205483	Ajanta Pharma USA Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
27241-039_43c6da47-7266-4987-96a4-3d6970a390c2	27241-039	HUMAN PRESCRIPTION DRUG	eletriptan hydrobromide		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170829		ANDA	ANDA205186	Ajanta Pharma USA Inc.	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
27241-040_43c6da47-7266-4987-96a4-3d6970a390c2	27241-040	HUMAN PRESCRIPTION DRUG	eletriptan hydrobromide		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170829		ANDA	ANDA205186	Ajanta Pharma USA Inc.	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
27241-041_084c03c7-d531-4b1e-a12b-cee2d6eb05d2	27241-041	HUMAN PRESCRIPTION DRUG	almotriptan		almotriptan	TABLET, FILM COATED	ORAL	20151007		ANDA	ANDA205523	Ajanta Pharma USA Inc.	ALMOTRIPTAN MALATE	6.25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
27241-042_084c03c7-d531-4b1e-a12b-cee2d6eb05d2	27241-042	HUMAN PRESCRIPTION DRUG	almotriptan		almotriptan	TABLET, FILM COATED	ORAL	20151007		ANDA	ANDA205523	Ajanta Pharma USA Inc.	ALMOTRIPTAN MALATE	12.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
27241-049_f29b52f3-3f73-43d4-8919-0cbe13fbfb44	27241-049	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET	ORAL	20170831		ANDA	ANDA205792	Ajanta Pharma USA Inc.	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
27241-051_83833e1c-a387-4ab6-a677-5d9e70d16c62	27241-051	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Ajanta Pharma USA Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-052_83833e1c-a387-4ab6-a677-5d9e70d16c62	27241-052	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Ajanta Pharma USA Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-053_83833e1c-a387-4ab6-a677-5d9e70d16c62	27241-053	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Ajanta Pharma USA Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-054_83833e1c-a387-4ab6-a677-5d9e70d16c62	27241-054	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Ajanta Pharma USA Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-055_83833e1c-a387-4ab6-a677-5d9e70d16c62	27241-055	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Ajanta Pharma USA Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-056_83833e1c-a387-4ab6-a677-5d9e70d16c62	27241-056	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Ajanta Pharma USA Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-062_96d25448-0652-4def-a176-d114fa911bc6	27241-062	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET	ORAL	20160531		ANDA	ANDA206181	Ajanta Pharma USA Inc.	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
27241-063_96d25448-0652-4def-a176-d114fa911bc6	27241-063	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET	ORAL	20160531		ANDA	ANDA206181	Ajanta Pharma USA Inc.	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
27241-064_e6fc5858-56af-49e1-871d-f1e733dc9a23	27241-064	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20190425		ANDA	ANDA206714	Ajanta Pharma USA Inc.	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
27241-065_e6fc5858-56af-49e1-871d-f1e733dc9a23	27241-065	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20190425		ANDA	ANDA206714	Ajanta Pharma USA Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
27241-067_da3ca7ae-4180-4ea5-be36-0b69b69661bd	27241-067	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Ajanta Pharma USA Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-068_da3ca7ae-4180-4ea5-be36-0b69b69661bd	27241-068	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Ajanta Pharma USA Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-069_da3ca7ae-4180-4ea5-be36-0b69b69661bd	27241-069	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Ajanta Pharma USA Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-070_53a3fde2-fa5d-48cd-9c68-4708af353f25	27241-070	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20150827		ANDA	ANDA206528	Ajanta Pharma USA Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
27241-071_53a3fde2-fa5d-48cd-9c68-4708af353f25	27241-071	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20150827		ANDA	ANDA206528	Ajanta Pharma USA Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
27241-083_42c458f5-ccfc-425b-b645-9c9497f759de	27241-083	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartan medoxomil		Amlodipine besylate and Olmesartan medoxomil	TABLET	ORAL	20170206		ANDA	ANDA207216	Ajanta Pharma USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
27241-084_42c458f5-ccfc-425b-b645-9c9497f759de	27241-084	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartan medoxomil		Amlodipine besylate and Olmesartan medoxomil	TABLET	ORAL	20170206		ANDA	ANDA207216	Ajanta Pharma USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
27241-085_42c458f5-ccfc-425b-b645-9c9497f759de	27241-085	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartan medoxomil		Amlodipine besylate and Olmesartan medoxomil	TABLET	ORAL	20170206		ANDA	ANDA207216	Ajanta Pharma USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
27241-086_42c458f5-ccfc-425b-b645-9c9497f759de	27241-086	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartan medoxomil		Amlodipine besylate and Olmesartan medoxomil	TABLET	ORAL	20170206		ANDA	ANDA207216	Ajanta Pharma USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
27241-097_4a2a4031-841a-4bf7-aeb2-b4ab38eaa224	27241-097	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Ajanta Pharma USA Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-098_4a2a4031-841a-4bf7-aeb2-b4ab38eaa224	27241-098	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Ajanta Pharma USA Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-099_4a2a4031-841a-4bf7-aeb2-b4ab38eaa224	27241-099	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Ajanta Pharma USA Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-108_a067f4ee-c5bb-4482-9b03-9bf761fe41a9	27241-108	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171121		ANDA	ANDA209686	Ajanta Pharma USA Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
27241-109_d7fd99da-f17a-4124-9014-70bbe43d78f6	27241-109	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	CAPSULE	ORAL	20180927		ANDA	ANDA209859	Ajanta Pharma USA Inc.	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
27241-110_d7fd99da-f17a-4124-9014-70bbe43d78f6	27241-110	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	CAPSULE	ORAL	20180927		ANDA	ANDA209859	Ajanta Pharma USA Inc.	RANITIDINE HYDROCHLORIDE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
27241-111_10edaf02-343f-49b3-8604-ea231ba6bbc9	27241-111	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Ajanta Pharma USA Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-112_10edaf02-343f-49b3-8604-ea231ba6bbc9	27241-112	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Ajanta Pharma USA Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-113_10edaf02-343f-49b3-8604-ea231ba6bbc9	27241-113	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Ajanta Pharma USA Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-114_10edaf02-343f-49b3-8604-ea231ba6bbc9	27241-114	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Ajanta Pharma USA Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-115_73b581e8-606f-4264-8358-d3dd657d2325	27241-115	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	CAPSULE, COATED PELLETS	ORAL	20200515		ANDA	ANDA213181	Ajanta Pharma USA Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-116_7c9c78df-a05a-4d72-b9af-336ec0df643f	27241-116	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20180720		ANDA	ANDA210138	Ajanta Pharma USA Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27241-117_7c9c78df-a05a-4d72-b9af-336ec0df643f	27241-117	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20180720		ANDA	ANDA210138	Ajanta Pharma USA Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27241-118_a6fc271f-86e9-4ed1-9cb9-d836553e54cf	27241-118	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180910		ANDA	ANDA210705	Ajanta Pharma USA Inc.	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27241-119_a6fc271f-86e9-4ed1-9cb9-d836553e54cf	27241-119	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180910		ANDA	ANDA210705	Ajanta Pharma USA Inc.	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27241-120_a6fc271f-86e9-4ed1-9cb9-d836553e54cf	27241-120	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180910		ANDA	ANDA210705	Ajanta Pharma USA Inc.	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27241-123_762189bd-b5af-4931-accf-4bce4e101b52	27241-123	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20220704		ANDA	ANDA210392	Ajanta Pharma USA Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-124_fa062401-c120-43fc-9a3d-236fed4ef368	27241-124	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20180504		ANDA	ANDA210394	Ajanta Pharma USA Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27241-125_ca27bc3a-9222-41bb-9f61-e83485826eef	27241-125	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190823		ANDA	ANDA210054	Ajanta Pharma USA Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
27241-126_ca27bc3a-9222-41bb-9f61-e83485826eef	27241-126	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190823		ANDA	ANDA210054	Ajanta Pharma USA Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
27241-132_235dc9dc-2527-42ee-aa93-e408a98fd195	27241-132	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20230911		ANDA	ANDA211151	Ajanta Pharma USA Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
27241-133_235dc9dc-2527-42ee-aa93-e408a98fd195	27241-133	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20230911		ANDA	ANDA211151	Ajanta Pharma USA Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
27241-134_d0a38bfc-2e3b-4061-bd01-ae201c3a9972	27241-134	HUMAN PRESCRIPTION DRUG	Cholestyramine		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20200406		ANDA	ANDA211119	Ajanta Pharma USA Inc.	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
27241-139_fe9a2cf2-74d6-481a-a154-7f8198da0fda	27241-139	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	FOR SUSPENSION	ORAL	20200528		ANDA	ANDA212784	Ajanta Pharma USA Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
27241-140_12da75f8-43b2-45bd-b14c-10f16192034a	27241-140	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20180924		ANDA	ANDA211012	Ajanta Pharma USA Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
27241-141_12da75f8-43b2-45bd-b14c-10f16192034a	27241-141	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20180924		ANDA	ANDA211012	Ajanta Pharma USA Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
27241-144_dc737b0e-d66a-4538-b934-a6e9fc0c2d24	27241-144	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA211060	Ajanta Pharma USA Inc.	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
27241-145_dc737b0e-d66a-4538-b934-a6e9fc0c2d24	27241-145	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA211060	Ajanta Pharma USA Inc.	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
27241-153_f0f73b81-1193-488a-bc9f-5bf3e1487e96	27241-153	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	TABLET	ORAL	20200601		ANDA	ANDA211584	Ajanta Pharma USA Inc.	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
27241-154_f0f73b81-1193-488a-bc9f-5bf3e1487e96	27241-154	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	TABLET	ORAL	20200601		ANDA	ANDA211584	Ajanta Pharma USA Inc.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
27241-155_dd81a4d5-e308-4db2-99cc-de3753cb1a4b	27241-155	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20190228		ANDA	ANDA211655	Ajanta Pharma USA Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
27241-156_dd81a4d5-e308-4db2-99cc-de3753cb1a4b	27241-156	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20190228		ANDA	ANDA211655	Ajanta Pharma USA Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
27241-157_dd81a4d5-e308-4db2-99cc-de3753cb1a4b	27241-157	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20190228		ANDA	ANDA211655	Ajanta Pharma USA Inc.	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
27241-158_7a7e79d7-afc4-4675-9067-dc823b8a653e	27241-158	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET	ORAL	20191226		ANDA	ANDA212234	Ajanta Pharma USA Inc.	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
27241-159_9b16302a-f8e7-4fa0-8d04-a5d5c2071cc6	27241-159	HUMAN PRESCRIPTION DRUG	Valganciclovir hydrochloride		Valganciclovir hydrochloride	POWDER, FOR SOLUTION	ORAL	20200113		ANDA	ANDA212890	Ajanta Pharma USA Inc.	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
27241-160_bd64ff5c-f4bd-46a9-b02c-ee18d473f26e	27241-160	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20191213		ANDA	ANDA212809	Ajanta Pharma USA Inc.	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
27241-161_bd64ff5c-f4bd-46a9-b02c-ee18d473f26e	27241-161	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20191213		ANDA	ANDA212809	Ajanta Pharma USA Inc.	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
27241-162_bd64ff5c-f4bd-46a9-b02c-ee18d473f26e	27241-162	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20191213		ANDA	ANDA212809	Ajanta Pharma USA Inc.	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
27241-163_bd64ff5c-f4bd-46a9-b02c-ee18d473f26e	27241-163	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20191213		ANDA	ANDA212809	Ajanta Pharma USA Inc.	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
27241-164_4a2a4031-841a-4bf7-aeb2-b4ab38eaa224	27241-164	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190325		ANDA	ANDA208706	Ajanta Pharma USA Inc.	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-167_4f6891be-49a9-4884-a1ce-35e148c7c156	27241-167	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Ajanta Pharma USA Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-168_4f6891be-49a9-4884-a1ce-35e148c7c156	27241-168	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Ajanta Pharma USA Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-169_4f6891be-49a9-4884-a1ce-35e148c7c156	27241-169	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Ajanta Pharma USA Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-170_4f6891be-49a9-4884-a1ce-35e148c7c156	27241-170	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Ajanta Pharma USA Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-171_4f6891be-49a9-4884-a1ce-35e148c7c156	27241-171	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Ajanta Pharma USA Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-175_48242562-2dd5-4614-bfe7-45bff63561ef	27241-175	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	POWDER, FOR SUSPENSION	ORAL	20191127		ANDA	ANDA212883	Ajanta Pharma USA Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
27241-176_6a48a21b-0533-4939-b7c8-8b7723149e85	27241-176	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET	ORAL	20201227		ANDA	ANDA213621	Ajanta Pharma USA Inc.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
27241-177_6a48a21b-0533-4939-b7c8-8b7723149e85	27241-177	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET	ORAL	20201227		ANDA	ANDA213621	Ajanta Pharma USA Inc.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
27241-179_aec77e0a-fae4-4677-af33-512cb1b3c563	27241-179	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20220331		ANDA	ANDA213349	Ajanta Pharma USA Inc.	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
27241-180_aec77e0a-fae4-4677-af33-512cb1b3c563	27241-180	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20220331		ANDA	ANDA213349	Ajanta Pharma USA Inc.	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
27241-181_aec77e0a-fae4-4677-af33-512cb1b3c563	27241-181	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20220331		ANDA	ANDA213349	Ajanta Pharma USA Inc.	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
27241-182_aec77e0a-fae4-4677-af33-512cb1b3c563	27241-182	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20220331		ANDA	ANDA213349	Ajanta Pharma USA Inc.	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
27241-183_081076c1-7006-4b31-91ff-62bc870a57f4	27241-183	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20210119		ANDA	ANDA213271	Ajanta Pharma USA Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-184_081076c1-7006-4b31-91ff-62bc870a57f4	27241-184	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20210119		ANDA	ANDA213271	Ajanta Pharma USA Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-185_081076c1-7006-4b31-91ff-62bc870a57f4	27241-185	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20210119		ANDA	ANDA213271	Ajanta Pharma USA Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-186_081076c1-7006-4b31-91ff-62bc870a57f4	27241-186	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20210119		ANDA	ANDA213271	Ajanta Pharma USA Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-188_eebec6df-17ee-43b8-9d51-bd6d12c24b69	27241-188	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200409		ANDA	ANDA213651	Ajanta Pharma USA Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
27241-189_eebec6df-17ee-43b8-9d51-bd6d12c24b69	27241-189	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200409		ANDA	ANDA213651	Ajanta Pharma USA Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
27241-191_00df7e37-3e36-45bd-a1c9-72bacaf14c5d	27241-191	HUMAN PRESCRIPTION DRUG	Tolterodine tartrate		Tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200625		ANDA	ANDA213397	Ajanta Pharma USA Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
27241-192_00df7e37-3e36-45bd-a1c9-72bacaf14c5d	27241-192	HUMAN PRESCRIPTION DRUG	Tolterodine tartrate		Tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200625		ANDA	ANDA213397	Ajanta Pharma USA Inc.	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
27241-199_b1f03a9d-03b5-4402-bfb6-fb7055e896a6	27241-199	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214391	Ajanta Pharma USA Inc.	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
27241-200_b1f03a9d-03b5-4402-bfb6-fb7055e896a6	27241-200	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214391	Ajanta Pharma USA Inc.	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
27241-201_b1f03a9d-03b5-4402-bfb6-fb7055e896a6	27241-201	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214391	Ajanta Pharma USA Inc.	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
27241-202_d80debfa-5a0b-4f3d-bc4b-eeeb116c238e	27241-202	HUMAN PRESCRIPTION DRUG	Naproxen and esomeprazole magnesium		Naproxen and esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20221006		ANDA	ANDA213699	Ajanta Pharma USA Inc.	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 375	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-203_d80debfa-5a0b-4f3d-bc4b-eeeb116c238e	27241-203	HUMAN PRESCRIPTION DRUG	Naproxen and esomeprazole magnesium		Naproxen and esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20221006		ANDA	ANDA213699	Ajanta Pharma USA Inc.	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 500	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27241-204_430dc8c4-7349-42d5-9036-b0bdcc02a839	27241-204	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET	ORAL	20230203		ANDA	ANDA213718	Ajanta Pharma USA Inc.	BREXPIPRAZOLE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-205_430dc8c4-7349-42d5-9036-b0bdcc02a839	27241-205	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET	ORAL	20230203		ANDA	ANDA213718	Ajanta Pharma USA Inc.	BREXPIPRAZOLE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-206_430dc8c4-7349-42d5-9036-b0bdcc02a839	27241-206	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET	ORAL	20230203		ANDA	ANDA213718	Ajanta Pharma USA Inc.	BREXPIPRAZOLE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-207_430dc8c4-7349-42d5-9036-b0bdcc02a839	27241-207	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET	ORAL	20230203		ANDA	ANDA213718	Ajanta Pharma USA Inc.	BREXPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-208_430dc8c4-7349-42d5-9036-b0bdcc02a839	27241-208	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET	ORAL	20230203		ANDA	ANDA213718	Ajanta Pharma USA Inc.	BREXPIPRAZOLE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-209_430dc8c4-7349-42d5-9036-b0bdcc02a839	27241-209	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET	ORAL	20230203		ANDA	ANDA213718	Ajanta Pharma USA Inc.	BREXPIPRAZOLE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27241-210_a0384dc3-9ab1-4632-bbb8-4e84e0a6a2e8	27241-210	HUMAN PRESCRIPTION DRUG	Clomipramine hydrochloride		Clomipramine hydrochloride	CAPSULE	ORAL	20201223		ANDA	ANDA213897	Ajanta Pharma USA Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-211_a0384dc3-9ab1-4632-bbb8-4e84e0a6a2e8	27241-211	HUMAN PRESCRIPTION DRUG	Clomipramine hydrochloride		Clomipramine hydrochloride	CAPSULE	ORAL	20201223		ANDA	ANDA213897	Ajanta Pharma USA Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-212_a0384dc3-9ab1-4632-bbb8-4e84e0a6a2e8	27241-212	HUMAN PRESCRIPTION DRUG	Clomipramine hydrochloride		Clomipramine hydrochloride	CAPSULE	ORAL	20201223		ANDA	ANDA213897	Ajanta Pharma USA Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
27241-216_364cb6d2-3c70-47a4-b18a-cc7626ac55a8	27241-216	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20210520		ANDA	ANDA214129	Ajanta Pharma USA Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
27241-217_364cb6d2-3c70-47a4-b18a-cc7626ac55a8	27241-217	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20210520		ANDA	ANDA214129	Ajanta Pharma USA Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
27241-221_f53bdeb9-03b6-41f0-aefb-eaeaf38e72c6	27241-221	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20230412		ANDA	ANDA214691	Ajanta Pharma USA Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-222_f53bdeb9-03b6-41f0-aefb-eaeaf38e72c6	27241-222	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20230412		ANDA	ANDA214691	Ajanta Pharma USA Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-223_f53bdeb9-03b6-41f0-aefb-eaeaf38e72c6	27241-223	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20230412		ANDA	ANDA214691	Ajanta Pharma USA Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-224_f53bdeb9-03b6-41f0-aefb-eaeaf38e72c6	27241-224	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20230412		ANDA	ANDA214691	Ajanta Pharma USA Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
27241-227_d2603933-ccb9-4562-acc1-1d78ec6bc1e9	27241-227	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311		ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27241-228_d2603933-ccb9-4562-acc1-1d78ec6bc1e9	27241-228	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311		ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27241-229_d2603933-ccb9-4562-acc1-1d78ec6bc1e9	27241-229	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311		ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27241-230_d2603933-ccb9-4562-acc1-1d78ec6bc1e9	27241-230	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20220311		ANDA	ANDA215663	Ajanta Pharma USA Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27241-231_2e3c4854-89a1-4e3f-88d4-e164829585fb	27241-231	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230324		ANDA	ANDA216193	Ajanta Pharma USA Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-232_2e3c4854-89a1-4e3f-88d4-e164829585fb	27241-232	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230324		ANDA	ANDA216193	Ajanta Pharma USA Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-233_2e3c4854-89a1-4e3f-88d4-e164829585fb	27241-233	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230324		ANDA	ANDA216193	Ajanta Pharma USA Inc.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
27241-240_4d243bc2-025a-451e-ac43-b3e567b0f5b7	27241-240	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210309		ANDA	ANDA213962	Ajanta Pharma USA Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
27241-241_4d243bc2-025a-451e-ac43-b3e567b0f5b7	27241-241	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210309		ANDA	ANDA213962	Ajanta Pharma USA Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
27241-242_889f869a-e071-4c1a-afea-775b60bafde7	27241-242	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20230427		ANDA	ANDA217293	Ajanta Pharma USA Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
27241-243_889f869a-e071-4c1a-afea-775b60bafde7	27241-243	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20230427		ANDA	ANDA217293	Ajanta Pharma USA Inc.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
27241-249_a88e7069-230c-4105-ade0-a98968e18671	27241-249	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	FOR SUSPENSION	ORAL	20220425		ANDA	ANDA217529	Ajanta Pharma USA Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
27241-252_5bfb3960-acc0-4dbf-aaa3-cdb10d4d6522	27241-252	HUMAN PRESCRIPTION DRUG	Fluphenazine hydrochloride		Fluphenazine hydrochloride	TABLET	ORAL	20230105		ANDA	ANDA217410	Ajanta Pharma USA Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
27241-253_5bfb3960-acc0-4dbf-aaa3-cdb10d4d6522	27241-253	HUMAN PRESCRIPTION DRUG	Fluphenazine hydrochloride		Fluphenazine hydrochloride	TABLET	ORAL	20230105		ANDA	ANDA217410	Ajanta Pharma USA Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
27241-254_5bfb3960-acc0-4dbf-aaa3-cdb10d4d6522	27241-254	HUMAN PRESCRIPTION DRUG	Fluphenazine hydrochloride		Fluphenazine hydrochloride	TABLET	ORAL	20230105		ANDA	ANDA217410	Ajanta Pharma USA Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
27241-255_5bfb3960-acc0-4dbf-aaa3-cdb10d4d6522	27241-255	HUMAN PRESCRIPTION DRUG	Fluphenazine hydrochloride		Fluphenazine hydrochloride	TABLET	ORAL	20230105		ANDA	ANDA217410	Ajanta Pharma USA Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
27241-256_82ea85ef-22c8-49df-9bfb-92ea060bc464	27241-256	HUMAN PRESCRIPTION DRUG	Pantoprazole sodium		Pantoprazole sodium	FOR SUSPENSION	ORAL	20230209		ANDA	ANDA217416	Ajanta Pharma USA Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
27281-029_d44c110b-8910-67a2-e053-2a95a90a6a03	27281-029	HUMAN OTC DRUG	Livergen		Arnica montana, Bryonia, Carduus marianus, Chelidonium majus, DNA, Hepar suis, Oleum animale, Pancreas suis, Taraxacum officinale.	LIQUID	ORAL	20131113		UNAPPROVED HOMEOPATHIC		Sunway Biotech LLC	ARNICA MONTANA; BRYONIA ALBA ROOT; CERVUS ELAPHUS HORN OIL; CHELIDONIUM MAJUS; HERRING SPERM DNA; MILK THISTLE; PORK LIVER; SUS SCROFA PANCREAS; TARAXACUM OFFICINALE	3; 200; 8; 200; 6; 1; 6; 8; 2	[hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
27281-039_d44c243b-ca3d-fee5-e053-2a95a90ace90	27281-039	HUMAN OTC DRUG	VIVACITY		Alfalfa, Arnica Montana, Avena Sativa, Galium Aparine, Hepar Suis, Hypericum Perforatum, Korean Ginseng, Oleum Animale, Pituitary Suis, Rhus Toxicodendron, RNA, Thuja occidentalis	LIQUID	ORAL	20180205		UNAPPROVED HOMEOPATHIC		Sunway Biotech LLC	ALFALFA; ARNICA MONTANA; ASIAN GINSENG; AVENA SATIVA FLOWERING TOP; CERVUS ELAPHUS HORN OIL; GALIUM APARINE; HYPERICUM PERFORATUM; PORK LIVER; SACCHAROMYCES CEREVISIAE RNA; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	2; 3; 2; 2; 6; 3; 200; 6; 6; 8; 30; 200	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL			N	20241231
27281-049_d44c13ea-157e-a23c-e053-2995a90a4f07	27281-049	HUMAN OTC DRUG	Immune Booster		Apis mellifica, Baptisia tinctoria, Carduus marianus, Echinacea angustifolia, Gallum aparine, Mercurius corrosivus, Mercurius sulphuratus ruber, Nitricum acidum, Sulphur iodatum, Thuja occidentalis.	LIQUID	ORAL	20131113		UNAPPROVED HOMEOPATHIC		Sunway Biotech LLC	APIS MELLIFERA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; MERCURIC CHLORIDE; MERCURIC SULFIDE; MILK THISTLE; NITRIC ACID; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG	200; 6; 6; 3; 200; 30; 3; 30; 200; 200	[hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
27437-050_9caa35b5-7bc7-b39c-e053-2995a90af423	27437-050	HUMAN PRESCRIPTION DRUG	Methergine		Methylergonovine maleate	TABLET	ORAL	20160404		ANDA	ANDA091577	Lupin Pharmaceuticals, Inc.	METHYLERGONOVINE MALEATE	.2	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
27437-051_fe8dadfb-2b46-433c-b3fa-9d9c3d0548b5	27437-051	HUMAN PRESCRIPTION DRUG	SOLOSEC		secnidazole	GRANULE	ORAL	20171030		NDA	NDA209363	Lupin Pharmaceuticals, Inc.	SECNIDAZOLE	2	g/4.8g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
27437-055_1bd67349-2170-4e87-b779-673a17f6c7a1	27437-055	HUMAN PRESCRIPTION DRUG	BROVANA		Arformoterol Tartrate	SOLUTION	RESPIRATORY (INHALATION)	20231001		NDA	NDA021912	Lupin Pharmaceuticals, Inc.	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
27437-056_76121625-67a5-4464-8f35-4740e9c71196	27437-056	HUMAN PRESCRIPTION DRUG	Xopenex HFA		levalbuterol tartrate	AEROSOL, METERED	ORAL	20231101		NDA	NDA021730	Lupin Pharmaceuticals, Inc.	LEVALBUTEROL TARTRATE	45	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
27437-107_78e361aa-c956-473f-9a32-a24e5a54eec9	27437-107	HUMAN PRESCRIPTION DRUG	Antara		fenofibrate	CAPSULE	ORAL	20131101		NDA	NDA021695	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27437-108_78e361aa-c956-473f-9a32-a24e5a54eec9	27437-108	HUMAN PRESCRIPTION DRUG	Antara		fenofibrate	CAPSULE	ORAL	20131101		NDA	NDA021695	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	90	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27437-109_68014370-9cb1-49bf-a04e-dc35ba5cf408	27437-109	HUMAN PRESCRIPTION DRUG	ANTARA		FENOFIBRATE	CAPSULE	ORAL	20090925		NDA	NDA021695	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	43	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27437-110_68014370-9cb1-49bf-a04e-dc35ba5cf408	27437-110	HUMAN PRESCRIPTION DRUG	ANTARA		FENOFIBRATE	CAPSULE	ORAL	20090925		NDA	NDA021695	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	130	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
27437-201_ddcc8926-f489-4ea1-93eb-e959ea8f2e1f	27437-201	HUMAN PRESCRIPTION DRUG	SUPRAX		cefixime	TABLET	ORAL	20080401		ANDA	ANDA065130	Lupin Pharmaceuticals, Inc.	CEFIXIME	400	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
27437-203_ddcc8926-f489-4ea1-93eb-e959ea8f2e1f	27437-203	HUMAN PRESCRIPTION DRUG	SUPRAX		cefixime	TABLET, CHEWABLE	ORAL	20121205		ANDA	ANDA065380	Lupin Pharmaceuticals, Inc.	CEFIXIME	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
27437-205_ddcc8926-f489-4ea1-93eb-e959ea8f2e1f	27437-205	HUMAN PRESCRIPTION DRUG	SUPRAX		cefixime	TABLET, CHEWABLE	ORAL	20121205		ANDA	ANDA065380	Lupin Pharmaceuticals, Inc.	CEFIXIME	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
27437-206_ddcc8926-f489-4ea1-93eb-e959ea8f2e1f	27437-206	HUMAN PRESCRIPTION DRUG	SUPRAX		cefixime	POWDER, FOR SUSPENSION	ORAL	20070601		ANDA	ANDA065355	Lupin Pharmaceuticals, Inc.	CEFIXIME	200	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
27495-008_099849f6-7f19-afc2-e063-6294a90a8d5c	27495-008	HUMAN OTC DRUG	Overtime		Methyl Salicylate, Menthol and Capsaicin	LOTION	TOPICAL	20070101		UNAPPROVED DRUG OTHER		Physicians Science & Nature Inc.	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.0225; 6; 18	g/60mL; g/60mL; g/60mL			N	20241231
27505-004_0cf4a4b6-9e6b-dc85-e063-6394a90a2762	27505-004	HUMAN PRESCRIPTION DRUG	APOKYN		APOMORPHINE HYDROCHLORIDE	INJECTION	SUBCUTANEOUS	20040702		NDA	NDA021264	MDD US Operations, LLC	APOMORPHINE HYDROCHLORIDE	30	mg/3mL	Dopamine Agonists [MoA], Dopaminergic Agonist [EPC]		N	20241231
27505-110_0cf4e97f-18de-5426-e063-6294a90ac4b0	27505-110	HUMAN PRESCRIPTION DRUG	Xadago		safinamide mesylate	TABLET, FILM COATED	ORAL	20170508		NDA	NDA207145	MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.	SAFINAMIDE MESYLATE	50	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
27505-111_0cf4e97f-18de-5426-e063-6294a90ac4b0	27505-111	HUMAN PRESCRIPTION DRUG	Xadago		safinamide mesylate	TABLET, FILM COATED	ORAL	20170508		NDA	NDA207145	MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.	SAFINAMIDE MESYLATE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
27561-001_0df86c68-1161-515e-e063-6294a90a416a	27561-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170112		UNAPPROVED MEDICAL GAS		Elixair Medical Inc	OXYGEN	99	L/100L			N	20251231
27789-911_09c29a75-1487-1335-e063-6394a90a7f27	27789-911	HUMAN OTC DRUG	Zcaine Fast Acting Anesthetic		LIDOCAINE	GEL	TOPICAL	20120404		OTC MONOGRAPH DRUG	M017	PHI, Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
27808-002_ea4c72ec-0f8a-40f8-9897-325abc55def1	27808-002	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	SOLUTION	ORAL	20150313		ANDA	ANDA079059	Tris Pharma Inc	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
27808-033_2668752f-f4c2-4787-8c19-3d5e1f10e622	27808-033	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	SOLUTION	ORAL	20120802		ANDA	ANDA091586	Tris Pharma Inc	THEOPHYLLINE ANHYDROUS	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
27808-035_1de1665a-c08a-4284-9426-adf3ed6389ff	27808-035	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-036_1de1665a-c08a-4284-9426-adf3ed6389ff	27808-036	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-037_1de1665a-c08a-4284-9426-adf3ed6389ff	27808-037	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-049_61b0a54b-1b7d-42fc-8c48-79400d7759b2	27808-049	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	SOLUTION	ORAL	20211230		ANDA	ANDA201295	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-051_df54c585-7891-4bbc-9194-51284e944585	27808-051	HUMAN PRESCRIPTION DRUG	promethazine hydrochloride		promethazine hydrochloride	SYRUP	ORAL	20120608		ANDA	ANDA091675	Tris Pharma Inc	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
27808-057_4c07a6e7-ee16-4182-a23d-81842ddec48c	27808-057	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide		Promethazine Hydrochloride and Dextromethorphan Hydrobromide	SOLUTION	ORAL	20140131		ANDA	ANDA091687	Tris Pharma Inc	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
27808-058_41620c2b-2680-41b0-9d8b-1c52396bd024	27808-058	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20150304		ANDA	ANDA091601	Tris Pharma Inc	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-059_41620c2b-2680-41b0-9d8b-1c52396bd024	27808-059	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20150304		ANDA	ANDA091601	Tris Pharma Inc	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-065_3939b644-17f0-49ea-ae75-ae6a98d4a3ef	27808-065	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Codeine Phosphate		Promethazine Hydrochloride and Codeine Phosphate	SOLUTION	ORAL	20180312		ANDA	ANDA200386	Tris Pharma Inc	CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE	10; 6.25	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]	CV	N	20241231
27808-082_9da93130-9f01-408f-a682-42d32476e86e	27808-082	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20150921		ANDA	ANDA203518	Tris Pharma Inc	MORPHINE SULFATE	20	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
27808-085_e8a2eb89-7ce9-44cc-ba29-f140b64a4a0b	27808-085	HUMAN PRESCRIPTION DRUG	Dextroamphetamine		Dextroamphetamine	SOLUTION	ORAL	20130531		ANDA	ANDA203644	Tris Pharma Inc	DEXTROAMPHETAMINE SULFATE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-086_a08ac442-abf5-41ec-9510-bf5deb631d54	27808-086	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	extended-release	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150306		ANDA	ANDA091632	Tris Pharma Inc	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE	8; 10	mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-089_e79171ac-e56d-4b8c-b299-eca7215d28e6	27808-089	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20220820		ANDA	ANDA206095	Tris Pharma Inc	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-090_e79171ac-e56d-4b8c-b299-eca7215d28e6	27808-090	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20220820		ANDA	ANDA206095	Tris Pharma Inc	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-091_54e7238c-57b8-42e6-a65b-facfc24c3e98	27808-091	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		ANDA	ANDA207901	Tris Pharma Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-092_54e7238c-57b8-42e6-a65b-facfc24c3e98	27808-092	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		ANDA	ANDA207901	Tris Pharma Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-093_54e7238c-57b8-42e6-a65b-facfc24c3e98	27808-093	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		ANDA	ANDA207901	Tris Pharma Inc	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
27808-099_33793609-a343-4194-8417-247b70b514de	27808-099	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	SYRUP	ORAL	20211221		ANDA	ANDA205431	Tris Pharma Inc	CYPROHEPTADINE HYDROCHLORIDE	2	mg/5mL			N	20241231
27808-114_46260d71-221c-498b-bc9c-1fb26f8ed1bb	27808-114	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160407		ANDA	ANDA202214	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-115_46260d71-221c-498b-bc9c-1fb26f8ed1bb	27808-115	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160407		ANDA	ANDA202214	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-116_46260d71-221c-498b-bc9c-1fb26f8ed1bb	27808-116	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160407		ANDA	ANDA202214	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-130_a36d5ed6-8889-434a-bb69-7ed4036f4f1e	27808-130	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	SOLUTION	ORAL	20211230		ANDA	ANDA201295	Tris Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
27808-155_0454ba8a-0b1d-4711-9153-6496fc49236d	27808-155	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Tris Pharma Inc	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
27808-156_0454ba8a-0b1d-4711-9153-6496fc49236d	27808-156	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Tris Pharma Inc	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
27808-157_0454ba8a-0b1d-4711-9153-6496fc49236d	27808-157	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Tris Pharma Inc	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
27808-158_0454ba8a-0b1d-4711-9153-6496fc49236d	27808-158	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Tris Pharma Inc	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
27808-163_d737452f-646c-7bfe-e053-2a95a90a61c1	27808-163	HUMAN PRESCRIPTION DRUG	Sildenafil		sildenafil citrate	POWDER, FOR SUSPENSION	ORAL	20211117		ANDA	ANDA212312	Tris Pharma Inc	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
27808-168_f15016a3-b389-4ca4-9127-f6f438254434	27808-168	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20220126		ANDA	ANDA214076	Tris Pharma Inc	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
27808-169_f15016a3-b389-4ca4-9127-f6f438254434	27808-169	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20220126		ANDA	ANDA214076	Tris Pharma Inc	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
27808-190_f8069c7b-5cf8-49af-a3e3-ee5b0f1c88b5	27808-190	HUMAN PRESCRIPTION DRUG	Colesevelam hydrochloride		Colesevelam hydrochloride	TABLET	ORAL	20201019		ANDA	ANDA209946	Tris Pharma Inc	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
27808-206_7a3e937f-5938-4fa5-87da-3cbf111e582e	27808-206	HUMAN PRESCRIPTION DRUG	Febuxostat		febuxostat	TABLET	ORAL	20200928		ANDA	ANDA210292	Tris Pharma Inc	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
27808-207_7a3e937f-5938-4fa5-87da-3cbf111e582e	27808-207	HUMAN PRESCRIPTION DRUG	Febuxostat		febuxostat	TABLET	ORAL	20200928		ANDA	ANDA210292	Tris Pharma Inc	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
27808-222_d399533a-4204-4f43-b36e-545a79661c26	27808-222	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20201029		ANDA	ANDA212807	Tris Pharma Inc	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27808-223_d399533a-4204-4f43-b36e-545a79661c26	27808-223	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20201029		ANDA	ANDA212807	Tris Pharma Inc	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27808-224_d399533a-4204-4f43-b36e-545a79661c26	27808-224	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20201029		ANDA	ANDA212807	Tris Pharma Inc	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27808-225_d399533a-4204-4f43-b36e-545a79661c26	27808-225	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20201029		ANDA	ANDA212807	Tris Pharma Inc	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
27808-233_b0d13cbb-914c-42d9-8945-7e67312ba143	27808-233	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	Tris Pharma Inc	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
27808-234_6cc4dc1c-d6c1-4aa6-a0a6-ef04a312439b	27808-234	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20191009		ANDA	ANDA211343	Tris Pharma Inc	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
27808-235_41e94baa-cd82-4e58-a498-015ae3fd2fc0	27808-235	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210715		ANDA	ANDA214322	Tris Pharma Inc	PREGABALIN	50	mg/1		CV	N	20241231
27808-236_41e94baa-cd82-4e58-a498-015ae3fd2fc0	27808-236	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210715		ANDA	ANDA214322	Tris Pharma Inc	PREGABALIN	75	mg/1		CV	N	20241231
27808-237_41e94baa-cd82-4e58-a498-015ae3fd2fc0	27808-237	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210715		ANDA	ANDA214322	Tris Pharma Inc	PREGABALIN	100	mg/1		CV	N	20241231
27808-238_41e94baa-cd82-4e58-a498-015ae3fd2fc0	27808-238	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210715		ANDA	ANDA214322	Tris Pharma Inc	PREGABALIN	150	mg/1		CV	N	20241231
27808-239_41e94baa-cd82-4e58-a498-015ae3fd2fc0	27808-239	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210715		ANDA	ANDA214322	Tris Pharma Inc	PREGABALIN	200	mg/1		CV	N	20241231
27808-240_41e94baa-cd82-4e58-a498-015ae3fd2fc0	27808-240	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210715		ANDA	ANDA214322	Tris Pharma Inc	PREGABALIN	225	mg/1		CV	N	20241231
27808-241_41e94baa-cd82-4e58-a498-015ae3fd2fc0	27808-241	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210715		ANDA	ANDA214322	Tris Pharma Inc	PREGABALIN	300	mg/1		CV	N	20241231
27808-243_299cd2a3-f5a6-4e6e-8f26-84da23cff30c	27808-243	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220319		ANDA	ANDA208308	Tris Pharma Inc	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
27808-244_299cd2a3-f5a6-4e6e-8f26-84da23cff30c	27808-244	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220319		ANDA	ANDA208308	Tris Pharma Inc	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
27808-245_299cd2a3-f5a6-4e6e-8f26-84da23cff30c	27808-245	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220319		ANDA	ANDA208308	Tris Pharma Inc	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
27808-246_299cd2a3-f5a6-4e6e-8f26-84da23cff30c	27808-246	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220319		ANDA	ANDA208308	Tris Pharma Inc	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
27808-263_2343b818-e02d-4ced-b54e-ec719a8d53f3	27808-263	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA091491	Tris Pharma Inc	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27808-264_2343b818-e02d-4ced-b54e-ec719a8d53f3	27808-264	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA091491	Tris Pharma Inc	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27808-265_2343b818-e02d-4ced-b54e-ec719a8d53f3	27808-265	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA091491	Tris Pharma Inc	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27808-266_2343b818-e02d-4ced-b54e-ec719a8d53f3	27808-266	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA091491	Tris Pharma Inc	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
27808-275_fe34e06f-c075-5940-e053-6394a90acd41	27808-275	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20230520		ANDA	ANDA210552	Tris Pharma, Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
27808-276_fe34e06f-c075-5940-e053-6394a90acd41	27808-276	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20230520		ANDA	ANDA210552	Tris Pharma, Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
27808-277_fe34e06f-c075-5940-e053-6394a90acd41	27808-277	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20230520		ANDA	ANDA210552	Tris Pharma, Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
27854-115_cb37d74c-450d-462e-bf2c-8bec9864a35f	27854-115	HUMAN OTC DRUG	Melox		Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20180601		OTC MONOGRAPH FINAL	part331	Belmora LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
27854-117_30664d3b-521c-4914-9c59-88688f8f63d4	27854-117	HUMAN OTC DRUG	Melox		Aluminum hydroxide, Magnesium hydroxide, Simethicone	LIQUID	ORAL	20230501		OTC MONOGRAPH FINAL	part331	Belmora LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
27854-119_fa049b30-8416-43f0-925f-26ec17a1d68a	27854-119	HUMAN OTC DRUG	ACTIFED		Phenylephrine hydrochloride	TABLET	ORAL	20230801		OTC MONOGRAPH FINAL	part341	Belmora LLC	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
27854-120_da828327-8d78-8375-e053-2995a90abdf1	27854-120	HUMAN OTC DRUG	Belmora Melox Agrura		calcium carbonate	TABLET, CHEWABLE	ORAL	20190603		OTC MONOGRAPH FINAL	part331	Belmora, LLC	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
27854-160_d1f0d4f4-ac07-4019-ab03-f211b8aa68a4	27854-160	HUMAN OTC DRUG	Flanax		Naproxen Sodium	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA204872	Belmora LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27854-165_0eaa7004-6ad9-497d-8e69-8c1ff2459f54	27854-165	HUMAN OTC DRUG	Flanax Menstrual Pain Reliever		Naproxen Sodium	TABLET, FILM COATED	ORAL	20170123		ANDA	ANDA204872	Belmora LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27854-170_e8ea9ae2-375a-4bb9-b807-4c101ce9f3d7	27854-170	HUMAN OTC DRUG	AnaDent		Naproxen Sodium	TABLET, FILM COATED	ORAL	20170123		ANDA	ANDA204872	Belmora LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27854-177_808e52ba-b263-4218-96ac-6712279a630c	27854-177	HUMAN OTC DRUG	Anadent Kanka Gel		Benzocaine	GEL	DENTAL	20220415		OTC MONOGRAPH NOT FINAL	part356	BELMORA LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
27854-178_d2dfd707-8d68-45dd-9e32-d7cc34a500be	27854-178	HUMAN OTC DRUG	AnaDent Childrens Kanka Gel		Eugenol	GEL	DENTAL	20221108		OTC MONOGRAPH NOT FINAL	part356	Belmora LLC	EUGENOL	12	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
27854-222_3a7d51b5-7cc9-4a46-9bb9-ff212104ec29	27854-222	HUMAN OTC DRUG	Actrogel		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20220706		ANDA	ANDA078682	Belmora LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27854-299_76fd7f91-dc2c-49ac-9516-b696023d2bca	27854-299	HUMAN OTC DRUG	Complete Cold Relief		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20220223		OTC MONOGRAPH DRUG	M012	Belmora LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
27854-301_de59f666-f6ed-4ba2-aca2-45df8b877d09	27854-301	HUMAN OTC DRUG	SEDALMEX		Acetaminophen, Caffeine	TABLET, COATED	ORAL	20190808		OTC MONOGRAPH DRUG	M013	Belmora LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
27854-311_08984a42-e04e-467f-b19e-dfc61cb4d730	27854-311	HUMAN OTC DRUG	FLANAX BACK PAIN RELIEF		Lidocaine	PATCH	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part348	Belmora Llc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
27854-333_bb1ea19e-ae02-4164-ae9c-7323d5132ff0	27854-333	HUMAN OTC DRUG	Flanax Back Pain Relief		Lidocaine	PATCH	TOPICAL	20211215		OTC MONOGRAPH NOT FINAL	part348	Belmora LLC	LIDOCAINE	4	g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
27854-350_738901ba-0308-4319-b7d8-332a762dfd60	27854-350	HUMAN OTC DRUG	Sedalmex XL Flu		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220324		OTC MONOGRAPH DRUG	M012	Belmora LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
27854-375_e555bc16-f288-4df4-aefa-822da40fc9cc	27854-375	HUMAN OTC DRUG	Nocto Sleep Aid		Doxylamine succinate	TABLET	ORAL	20191031		ANDA	ANDA040564	Belmora LLC	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
27854-388_2c620215-350e-430e-9946-25db1b45ddf0	27854-388	HUMAN OTC DRUG	Regular Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20220105		OTC MONOGRAPH NOT FINAL	part343	Belmora LLC	ACETAMINOPHEN	325	mg/1			N	20241231
27854-400_954a3d27-8e72-47ac-9f07-055a493635af	27854-400	HUMAN OTC DRUG	Flanax Liniment		Methyl Salicylate, Menthol, Capsaicin	LINIMENT	TOPICAL	20200911		OTC MONOGRAPH NOT FINAL	part348	Belmora Llc	CAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.025; 10; 28	g/100g; g/100g; g/100g			N	20241231
27854-404_eb98339b-6b89-4082-9609-38f08e214cd9	27854-404	HUMAN OTC DRUG	Flanax Liniment Unit Dose Display		Methyl Salicylate, Menthol, Capsaicin	LINIMENT	TOPICAL	20220215		OTC MONOGRAPH NOT FINAL	part348	Belmora LLC	CAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.025; 10; 28	g/100g; g/100g; g/100g			N	20241231
27854-505_937b99a5-63ed-4f0d-8866-69c60d9743d8	27854-505	HUMAN OTC DRUG	Flanax Pain Reliever/Fever reducer		Naproxen Sodium	TABLET, COATED	ORAL	20200515		ANDA	ANDA090545	Belmora LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27854-555_ad9f55f6-f7c5-4727-8e75-dcfd0a13c70b	27854-555	HUMAN OTC DRUG	Belmora Flanax		Naproxen Sodium	TABLET	ORAL	20200720		ANDA	ANDA090545	Belmora LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27854-700_4215c852-11ed-4b06-b132-3674265078e3	27854-700	HUMAN OTC DRUG	Flanax Pain Reliever/Fever Reducer		Naproxen sodium	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA205497	Belmora LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27854-701_5ac02446-13da-43d5-9647-fe469294acec	27854-701	HUMAN OTC DRUG	Ana-Dent PAIN RELIEF		Naproxen Sodium	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA205497	Belmora LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
27860-014_06bf4c31-6395-c7c3-e063-6294a90a4471	27860-014	HUMAN OTC DRUG	Model AA-2012		Model AA-2012	KIT		20220601		UNAPPROVED DRUG OTHER		AEROSPACE ACCESSORY SERVICE						N	20241231
28105-421_db3a1489-fcb1-4442-b309-4eb8ad9b9f46	28105-421	HUMAN PRESCRIPTION DRUG	TOLAK		FLUOROURACIL	CREAM	TOPICAL	20150918		NDA	NDA022259	HILL DERMACEUTICALS, INC.	FLUOROURACIL	.04	g/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
28595-120_f3969c77-94b7-c020-e053-2a95a90a6705	28595-120	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN LINGUAL		Nitroglycerin	SPRAY	ORAL	20190701		NDA AUTHORIZED GENERIC	NDA018705	Allegis Pharmaceuticals, LLC	NITROGLYCERIN	400	ug/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
28595-224_ffd1abb5-8b32-424e-e053-6394a90aed4c	28595-224	HUMAN PRESCRIPTION DRUG	URIMAR-T CAPS		methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate	CAPSULE	ORAL	20230628		UNAPPROVED DRUG OTHER		Allegis Pharmaceuticals, LLC	HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.12; 120; 10.8; 36.2; 40.8	mg/1; mg/1; mg/1; mg/1; mg/1	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
28595-240_f76f65a2-331f-aba6-e053-6394a90a3638	28595-240	HUMAN PRESCRIPTION DRUG	Augmentin		Amoxicillin and Clavulanate Potassium	FOR SUSPENSION	ORAL	20230223		NDA	NDA050575	Allegis Pharmaceuticals, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	125; 31.25	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
28595-550_0e77f59d-7759-18be-e063-6394a90afa66	28595-550	HUMAN PRESCRIPTION DRUG	NITROLINGUAL		Nitroglycerin	SPRAY	ORAL	20190701		NDA	NDA018705	Allegis Pharmaceuticals, LLC	NITROGLYCERIN	400	ug/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
28595-570_fd005151-3669-d822-e053-6394a90a933d	28595-570	HUMAN PRESCRIPTION DRUG	Spinosad		spinosad	SUSPENSION	TOPICAL	20140625		NDA AUTHORIZED GENERIC	NDA022408	Allegis Pharmaceuticals, LLC	SPINOSAD	9	mg/mL	Pediculicide [EPC]		N	20241231
28595-801_0e7690d0-b1d3-bc5e-e063-6294a90afc18	28595-801	HUMAN OTC DRUG	HISTEX PD Drops		TRIPROLIDINE HYDROCHLORIDE	SYRUP	ORAL	20140306		OTC MONOGRAPH DRUG	M012	Allegis Pharmaceuticals, LLC	TRIPROLIDINE HYDROCHLORIDE	.938	mg/mL			N	20251231
28595-802_0e764061-e7a9-6701-e063-6394a90a489f	28595-802	HUMAN OTC DRUG	HISTEX		TRIPROLIDINE HYDROCHLORIDE	SYRUP	ORAL	20140304		OTC MONOGRAPH DRUG	M012	Allegis Pharmaceuticals, LLC	TRIPROLIDINE HYDROCHLORIDE	2.5	mg/5mL			N	20251231
28595-804_0e764fe3-cd4a-71c8-e063-6394a90afa31	28595-804	HUMAN OTC DRUG	HISTEX-DM		DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE	SYRUP	ORAL	20140319		OTC MONOGRAPH DRUG	M012	Allegis Pharmaceuticals, LLC	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	20; 10; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
28595-808_0e76491a-432d-7333-e063-6394a90af2e5	28595-808	HUMAN OTC DRUG	HISTEX PDX Drops		TRIPROLIDINE HYDROCHLORIDE	SYRUP	ORAL	20230116		OTC MONOGRAPH DRUG	M012	Allegis Pharmaceuticals, LLC	TRIPROLIDINE HYDROCHLORIDE	1.25	mg/mL			N	20251231
28595-809_0d08439b-3e83-1798-e063-6394a90a1f52	28595-809	HUMAN OTC DRUG	HISTEX PD Drops New Formulation		TRIPROLIDINE HYDROCHLORIDE	SYRUP	ORAL	20231213		OTC MONOGRAPH DRUG	M012	Allegis Pharmaceuticals, LLC	TRIPROLIDINE HYDROCHLORIDE	1.25	mg/mL			N	20241231
28595-840_026b8533-eb51-9586-e063-6394a90af516	28595-840	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone Lotion Kit	KIT	TOPICAL	20230808		UNAPPROVED DRUG OTHER		Allegis Pharmaceuicals LLC						N	20241231
28595-900_0e768a0e-1c4e-7a5b-e063-6394a90a8097	28595-900	HUMAN OTC DRUG	Ru-Hist D		Brompheniramine Maleate and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20131101		OTC MONOGRAPH DRUG	M012	Allegis Pharmaceuticals, LLC	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
28691-0010_ea625e81-1cbd-4987-8923-8cb7d5077401	28691-0010	HUMAN OTC DRUG	Antiseptic Bandages		Benzalkonium chloride	DRESSING	TOPICAL	20161007		OTC MONOGRAPH NOT FINAL	part333A	Pharmaplast SAE	BENZALKONIUM CHLORIDE	.1	mg/100mg			N	20241231
28691-0400_4172a3f9-e00b-4253-b673-9034ef4bd1e2	28691-0400	HUMAN OTC DRUG	Wart Remover		Salicylic Acid	PLASTER	TOPICAL	20161007		OTC MONOGRAPH FINAL	part358B	Pharmaplast SAE	SALICYLIC ACID	.4	g/1			N	20241231
28691-1300_0396a10e-46e6-4db8-847d-01cd35e08e93	28691-1300	HUMAN OTC DRUG	BZK Antiseptic Towelette		Benzalkonium Chloride	CLOTH	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333A	Pharmaplast SAE	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
28691-4000_7508e829-086d-4f54-8f13-fcd0cd926354	28691-4000	HUMAN OTC DRUG	Cure-Aid Corn Plasters		Salicylic acid	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358F	Pharmaplast SAE	SALICYLIC ACID	40	mg/1			N	20241231
28691-7000_8635c69a-62f3-4e40-bcd0-94e8458068c0	28691-7000	HUMAN OTC DRUG	Alcohol swab		Isopropyl Alcohol	SWAB	TOPICAL	20161007		OTC MONOGRAPH NOT FINAL	part333A	Pharmaplast SAE	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
29033-001_cc6d208a-826c-4aae-a78e-da1a91c60699	29033-001	HUMAN PRESCRIPTION DRUG	Theophylline	(Anhydrous)	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20200123		ANDA	ANDA040560	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	400	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
29033-002_cc6d208a-826c-4aae-a78e-da1a91c60699	29033-002	HUMAN PRESCRIPTION DRUG	Theophylline	(Anhydrous)	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20200123		ANDA	ANDA040560	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	600	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
29033-003_60a4a349-5bb9-4685-86f8-b74068f1c614	29033-003	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	Nostrum Laboratories, Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
29033-004_a2219a27-afeb-4fa2-b1b2-37b7bbd65b92	29033-004	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20200217		ANDA	ANDA076697	Nostrum Laboratories, Inc.	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
29033-012_7a032585-1f84-4c4b-a1a7-0088f1d53e8d	29033-012	HUMAN PRESCRIPTION DRUG	Piroxicam		piroxicam	CAPSULE	ORAL	20200220		ANDA	ANDA074116	Nostrum Laboratories, Inc.	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29033-013_7a032585-1f84-4c4b-a1a7-0088f1d53e8d	29033-013	HUMAN PRESCRIPTION DRUG	Piroxicam		piroxicam	CAPSULE	ORAL	20200220		ANDA	ANDA074118	Nostrum Laboratories, Inc.	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29033-019_a2219a27-afeb-4fa2-b1b2-37b7bbd65b92	29033-019	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20200217		ANDA	ANDA076697	Nostrum Laboratories, Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
29033-020_a2219a27-afeb-4fa2-b1b2-37b7bbd65b92	29033-020	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20200217		ANDA	ANDA076697	Nostrum Laboratories, Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
29033-026_6ff0e3ce-3974-4fd7-b4cc-bbe90a86f45a	29033-026	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20151026		ANDA	ANDA203179	Nostrum Laboratories, Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
29033-028_b00152ed-f667-4169-9082-e15730302669	29033-028	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20160201		ANDA	ANDA205415	Nostrum Laboratories, Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29033-029_b00152ed-f667-4169-9082-e15730302669	29033-029	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20160201		ANDA	ANDA205415	Nostrum Laboratories, Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29033-030_c0fe369e-a5c2-46ef-aa0c-7d21d43101b6	29033-030	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20160330		ANDA	ANDA204691	Nostrum Laboratories, Inc.	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
29033-031_b80bc941-0d74-4af6-a4b9-b5a2282c1816	29033-031	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180102		ANDA	ANDA203832	Nostrum Laboratories, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
29033-032_b80bc941-0d74-4af6-a4b9-b5a2282c1816	29033-032	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180102		ANDA	ANDA203832	Nostrum Laboratories, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
29033-036_0052abbe-14fe-425d-b643-066cc17c0eab	29033-036	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20160509		ANDA	ANDA203887	Nostrum Laboratories, Inc.	DAPSONE	25	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
29033-037_0052abbe-14fe-425d-b643-066cc17c0eab	29033-037	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20160509		ANDA	ANDA203887	Nostrum Laboratories, Inc.	DAPSONE	100	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
29033-045_11ed7ee6-1687-4eab-88fd-22fee419a846	29033-045	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170327		ANDA	ANDA205468	Nostrum Laboratories, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
29033-046_11ed7ee6-1687-4eab-88fd-22fee419a846	29033-046	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170327		ANDA	ANDA205468	Nostrum Laboratories, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
29033-055_9581a519-20ce-4b4c-a1d6-31a97314c634	29033-055	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200806		ANDA	ANDA076756	Nostrum Laboratories Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
29033-056_9581a519-20ce-4b4c-a1d6-31a97314c634	29033-056	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200806		ANDA	ANDA076756	Nostrum Laboratories Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
29033-057_90d06aba-2957-49b2-ac92-8af86d2681cd	29033-057	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230816		ANDA	ANDA087400	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	100	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
29033-058_90d06aba-2957-49b2-ac92-8af86d2681cd	29033-058	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230816		ANDA	ANDA087400	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	200	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
29033-059_90d06aba-2957-49b2-ac92-8af86d2681cd	29033-059	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230816		ANDA	ANDA087400	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
29033-060_90d06aba-2957-49b2-ac92-8af86d2681cd	29033-060	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230816		ANDA	ANDA087400	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
29033-207_b5b3d428-c37e-4507-aa3a-2ff22fa4e937	29033-207	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20170512		ANDA	ANDA207237	Nostrum Laboratories, Inc.	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
29033-214_b5b3d428-c37e-4507-aa3a-2ff22fa4e937	29033-214	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20211001		ANDA	ANDA207237	Nostrum Laboratories, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
29033-215_bfdc909c-9178-4c17-8ecc-83f1bfbb2702	29033-215	HUMAN PRESCRIPTION DRUG	Butalbital, Aspirin, and Caffeine		Butalbital, Aspirin, and Caffeine	CAPSULE	ORAL	20220502		ANDA	ANDA078149	Nostrum Laboratories, Inc.	ASPIRIN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	20241231
29033-405_778f64a4-c8fa-4720-ac5e-787fbcd4768c	29033-405	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride and Acetaminophen		Oxycodone Hydrochloride and Acetaminophen	SOLUTION	ORAL	20211201		ANDA	ANDA201448	Nostrum Laboratories, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
29033-503_d227867b-99e7-4f02-ba50-8fc3297377d0	29033-503	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	SOLUTION	ORAL	20230321		ANDA	ANDA075292	Nostrum Laboratories Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
29149-001_076177e4-8cce-3644-e063-6294a90a02a4	29149-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20080801		NDA	NDA206023	Landmark Healthcare, Inc.	OXYGEN	990	mL/L			N	20241231
29181-001_0d1c2353-1019-6235-e063-6394a90a82a4	29181-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Star Valley Medical Supply	OXYGEN	99	L/100L			N	20241231
29273-401_f44563c4-4006-f88b-e053-2a95a90a2beb	29273-401	HUMAN PRESCRIPTION DRUG	FloLipid		Simvastatin	SUSPENSION	ORAL	20171101		NDA	NDA206679	Salerno Pharmaceuticals Co.	SIMVASTATIN	20	mg/5mL	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
29273-402_f44563c4-4006-f88b-e053-2a95a90a2beb	29273-402	HUMAN PRESCRIPTION DRUG	FloLipid		Simvastatin	SUSPENSION	ORAL	20171101		NDA	NDA206679	Salerno Pharmaceuticals Co.	SIMVASTATIN	40	mg/5mL	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
29300-111_2d955155-686d-40cd-898e-df7d760247a5	29300-111	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Unichem Pharmaceuticals (USA), Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-112_2d955155-686d-40cd-898e-df7d760247a5	29300-112	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Unichem Pharmaceuticals (USA), Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-113_2d955155-686d-40cd-898e-df7d760247a5	29300-113	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Unichem Pharmaceuticals (USA), Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-114_2d955155-686d-40cd-898e-df7d760247a5	29300-114	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Unichem Pharmaceuticals (USA), Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-115_9df497de-be9f-4244-a769-a72a0e64dc42	29300-115	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Unichem Pharmaceuticals (USA), Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
29300-116_9df497de-be9f-4244-a769-a72a0e64dc42	29300-116	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Unichem Pharmaceuticals (USA), Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
29300-117_9df497de-be9f-4244-a769-a72a0e64dc42	29300-117	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Unichem Pharmaceuticals (USA), Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
29300-118_9df497de-be9f-4244-a769-a72a0e64dc42	29300-118	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Unichem Pharmaceuticals (USA), Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
29300-124_4eb8c711-8149-410d-8fc3-7da7119aad2a	29300-124	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Unichem Pharmaceuticals (USA), Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-125_4eb8c711-8149-410d-8fc3-7da7119aad2a	29300-125	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Unichem Pharmaceuticals (USA), Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-126_958d523d-b040-4475-ad89-6278e5cf0f60	29300-126	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol fumarate	TABLET	ORAL	20090921		ANDA	ANDA078635	Unichem Pharmaceuticals (USA), Inc.	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-127_958d523d-b040-4475-ad89-6278e5cf0f60	29300-127	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol fumarate	TABLET	ORAL	20090921		ANDA	ANDA078635	Unichem Pharmaceuticals (USA), Inc.	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-128_04e2c83b-4c31-41f8-bc75-f82ef1b30d07	29300-128	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-129_04e2c83b-4c31-41f8-bc75-f82ef1b30d07	29300-129	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-130_499f2d9f-9fa0-4b30-8115-ff9e932abc04	29300-130	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20100315		ANDA	ANDA090510	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-131_24b4fbb6-3d16-48f7-864c-71e85813a9a2	29300-131	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20090505		ANDA	ANDA078989	Unichem Pharmaceuticals (USA), Inc.	ZALEPLON	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
29300-132_24b4fbb6-3d16-48f7-864c-71e85813a9a2	29300-132	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20090505		ANDA	ANDA078989	Unichem Pharmaceuticals (USA), Inc.	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
29300-135_5929c96f-9fa9-4399-84aa-28584da9966a	29300-135	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	Unichem Pharmaceuticals (USA), Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-136_5929c96f-9fa9-4399-84aa-28584da9966a	29300-136	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	Unichem Pharmaceuticals (USA), Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-137_5929c96f-9fa9-4399-84aa-28584da9966a	29300-137	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	Unichem Pharmaceuticals (USA), Inc.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-138_d405e38e-5f4d-4977-b36b-fca8c23cf294	29300-138	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	Unichem Pharmaceuticals (USA), Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-139_d405e38e-5f4d-4977-b36b-fca8c23cf294	29300-139	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	Unichem Pharmaceuticals (USA), Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-140_d405e38e-5f4d-4977-b36b-fca8c23cf294	29300-140	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	Unichem Pharmaceuticals (USA), Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-144_dd80e5c3-1bec-4d7e-94cf-6ac6e3b528a3	29300-144	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20151014		ANDA	ANDA203030	Unichem Pharmaceuticals (USA), Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-145_dd80e5c3-1bec-4d7e-94cf-6ac6e3b528a3	29300-145	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20151014		ANDA	ANDA203030	Unichem Pharmaceuticals (USA), Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-146_dd80e5c3-1bec-4d7e-94cf-6ac6e3b528a3	29300-146	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20151014		ANDA	ANDA203030	Unichem Pharmaceuticals (USA), Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-147_ae8b994b-83cc-49ab-9b59-047add2d7e19	29300-147	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-148_ae8b994b-83cc-49ab-9b59-047add2d7e19	29300-148	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-149_ae8b994b-83cc-49ab-9b59-047add2d7e19	29300-149	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-150_ae8b994b-83cc-49ab-9b59-047add2d7e19	29300-150	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-151_ae8b994b-83cc-49ab-9b59-047add2d7e19	29300-151	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-152_ae8b994b-83cc-49ab-9b59-047add2d7e19	29300-152	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-155_8190595a-be8e-4fd0-bcdf-30b6ba64ef5a	29300-155	HUMAN PRESCRIPTION DRUG	Alfuzosin hydrochloride		Alfuzosin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160315		ANDA	ANDA203192	Unichem Pharmaceuticals (USA), Inc.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
29300-157_8a96534f-4c2d-450a-947e-9956a558e5af	29300-157	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210112		ANDA	ANDA213301	Unichem Pharmaceuticals (USA), Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-158_8a96534f-4c2d-450a-947e-9956a558e5af	29300-158	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210112		ANDA	ANDA213301	Unichem Pharmaceuticals (USA), Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-168_1ff0cf9a-9b0b-4733-9ed7-315a09c60555	29300-168	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	Unichem Pharmaceuticals (USA), Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-169_1ff0cf9a-9b0b-4733-9ed7-315a09c60555	29300-169	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	Unichem Pharmaceuticals (USA), Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-171_16cd3370-8ddc-4dbb-82b3-98e128fb3482	29300-171	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA200022	Unichem Pharmaceuticals (USA), Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
29300-172_16cd3370-8ddc-4dbb-82b3-98e128fb3482	29300-172	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA200022	Unichem Pharmaceuticals (USA), Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
29300-175_1ad96b06-d732-45f8-a778-ae89bad30974	29300-175	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20220221		ANDA	ANDA203025	Unichem Pharmaceuticals (USA), Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-176_1ad96b06-d732-45f8-a778-ae89bad30974	29300-176	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20220221		ANDA	ANDA203025	Unichem Pharmaceuticals (USA), Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-177_1ad96b06-d732-45f8-a778-ae89bad30974	29300-177	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20220221		ANDA	ANDA203025	Unichem Pharmaceuticals (USA), Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-178_1ad96b06-d732-45f8-a778-ae89bad30974	29300-178	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20220221		ANDA	ANDA203025	Unichem Pharmaceuticals (USA), Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-179_1ad96b06-d732-45f8-a778-ae89bad30974	29300-179	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20220221		ANDA	ANDA203025	Unichem Pharmaceuticals (USA), Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-180_1ad96b06-d732-45f8-a778-ae89bad30974	29300-180	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20220221		ANDA	ANDA203025	Unichem Pharmaceuticals (USA), Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-187_f7cb68c7-a567-48a7-b4a7-5bb9f06df844	29300-187	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET	ORAL	20101012		ANDA	ANDA079106	Unichem Pharmaceuticals (USA), Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
29300-188_f7cb68c7-a567-48a7-b4a7-5bb9f06df844	29300-188	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET	ORAL	20101012		ANDA	ANDA079106	Unichem Pharmaceuticals (USA), Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
29300-189_f7cb68c7-a567-48a7-b4a7-5bb9f06df844	29300-189	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET	ORAL	20101012		ANDA	ANDA079106	Unichem Pharmaceuticals (USA), Inc.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
29300-190_e82b93f5-8b37-4327-81f9-0cbfcf3d29ac	29300-190	HUMAN PRESCRIPTION DRUG	losartan potassium and hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170721		ANDA	ANDA204832	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-191_e82b93f5-8b37-4327-81f9-0cbfcf3d29ac	29300-191	HUMAN PRESCRIPTION DRUG	losartan potassium and hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170721		ANDA	ANDA204832	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-192_e82b93f5-8b37-4327-81f9-0cbfcf3d29ac	29300-192	HUMAN PRESCRIPTION DRUG	losartan potassium and hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170721		ANDA	ANDA204832	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-207_45e8c5e4-4fe1-4a0c-8b0d-a1f5fb9fbdbe	29300-207	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20190301		ANDA	ANDA207011	Unichem Pharmaceuticals (USA), Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
29300-208_45e8c5e4-4fe1-4a0c-8b0d-a1f5fb9fbdbe	29300-208	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20190301		ANDA	ANDA207011	Unichem Pharmaceuticals (USA), Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
29300-209_45e8c5e4-4fe1-4a0c-8b0d-a1f5fb9fbdbe	29300-209	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20190301		ANDA	ANDA207011	Unichem Pharmaceuticals (USA), Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
29300-210_45e8c5e4-4fe1-4a0c-8b0d-a1f5fb9fbdbe	29300-210	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20190301		ANDA	ANDA207011	Unichem Pharmaceuticals (USA), Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
29300-211_45e8c5e4-4fe1-4a0c-8b0d-a1f5fb9fbdbe	29300-211	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20190301		ANDA	ANDA207011	Unichem Pharmaceuticals (USA), Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
29300-212_cef46418-15cb-4277-ac96-158bad675cdd	29300-212	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20151207		ANDA	ANDA203020	Unichem Pharmaceuticals (USA), Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-213_cef46418-15cb-4277-ac96-158bad675cdd	29300-213	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20151207		ANDA	ANDA203020	Unichem Pharmaceuticals (USA), Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-214_cef46418-15cb-4277-ac96-158bad675cdd	29300-214	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20151207		ANDA	ANDA203020	Unichem Pharmaceuticals (USA), Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-215_1dd7c47b-cddf-46d9-ace0-ff4b2a59823a	29300-215	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170919		ANDA	ANDA207018	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-216_1dd7c47b-cddf-46d9-ace0-ff4b2a59823a	29300-216	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170919		ANDA	ANDA207018	Unichem Pharmaceuticals (USA), Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
29300-220_57f07f65-1a14-4423-9da8-975664ca0684	29300-220	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, FILM COATED	ORAL	20160101		ANDA	ANDA204290	Unichem Pharmaceuticals (USA), Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
29300-221_57f07f65-1a14-4423-9da8-975664ca0684	29300-221	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20180820		ANDA	ANDA208621	Unichem Pharmaceuticals (USA), Inc.	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
29300-222_57f07f65-1a14-4423-9da8-975664ca0684	29300-222	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20180820		ANDA	ANDA208621	Unichem Pharmaceuticals (USA), Inc.	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
29300-226_786e500c-c3d9-49d4-a227-9d41c04f209c	29300-226	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	Unichem Pharmaceuticals (USA), Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
29300-227_786e500c-c3d9-49d4-a227-9d41c04f209c	29300-227	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	Unichem Pharmaceuticals (USA), Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
29300-232_4d1e743f-8954-4634-b95b-adb7ae41a549	29300-232	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180504		ANDA	ANDA209261	Unichem Pharmaceuticals (USA), Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-233_4d1e743f-8954-4634-b95b-adb7ae41a549	29300-233	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180504		ANDA	ANDA209261	Unichem Pharmaceuticals (USA), Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-234_4d1e743f-8954-4634-b95b-adb7ae41a549	29300-234	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180504		ANDA	ANDA209261	Unichem Pharmaceuticals (USA), Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-235_4d1e743f-8954-4634-b95b-adb7ae41a549	29300-235	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180504		ANDA	ANDA209261	Unichem Pharmaceuticals (USA), Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
29300-239_9faf1be0-1f13-47c0-b2aa-3ad62e5037e9	29300-239	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET	ORAL	20200805		ANDA	ANDA205399	Unichem Pharmaceuticals (USA), Inc.	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
29300-240_9faf1be0-1f13-47c0-b2aa-3ad62e5037e9	29300-240	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET	ORAL	20200805		ANDA	ANDA205399	Unichem Pharmaceuticals (USA), Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
29300-244_ef78a61a-865b-447a-9324-3044e41db506	29300-244	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Unichem Pharmaceuticals (USA), Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
29300-245_ef78a61a-865b-447a-9324-3044e41db506	29300-245	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Unichem Pharmaceuticals (USA), Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
29300-246_ef78a61a-865b-447a-9324-3044e41db506	29300-246	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Unichem Pharmaceuticals (USA), Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
29300-247_ef78a61a-865b-447a-9324-3044e41db506	29300-247	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Unichem Pharmaceuticals (USA), Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
29300-248_c40f39a9-434c-41f3-9258-deb4a34457d3	29300-248	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20160623		ANDA	ANDA203656	Unichem Pharmaceuticals (USA), Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
29300-249_c40f39a9-434c-41f3-9258-deb4a34457d3	29300-249	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20160623		ANDA	ANDA203656	Unichem Pharmaceuticals (USA), Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
29300-250_c40f39a9-434c-41f3-9258-deb4a34457d3	29300-250	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20161110		ANDA	ANDA204831	Unichem Pharmaceuticals (USA), Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
29300-251_c40f39a9-434c-41f3-9258-deb4a34457d3	29300-251	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20161110		ANDA	ANDA204831	Unichem Pharmaceuticals (USA), Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
29300-252_ae4c7f3b-b4bf-485c-b8cd-556868269cc5	29300-252	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20221001		ANDA	ANDA212719	Unichem Pharmaceuticals (USA), Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-253_ae4c7f3b-b4bf-485c-b8cd-556868269cc5	29300-253	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20221001		ANDA	ANDA212719	Unichem Pharmaceuticals (USA), Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-254_ae4c7f3b-b4bf-485c-b8cd-556868269cc5	29300-254	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20221001		ANDA	ANDA212719	Unichem Pharmaceuticals (USA), Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-255_77ea4fa8-c2a8-4a7f-be81-c56836939005	29300-255	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20170801		ANDA	ANDA208340	Unichem Pharmaceuticals (USA), Inc.	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-256_77ea4fa8-c2a8-4a7f-be81-c56836939005	29300-256	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20170801		ANDA	ANDA208340	Unichem Pharmaceuticals (USA), Inc.	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-268_69ca309f-1132-40c9-b250-665c360968e3	29300-268	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20170307		ANDA	ANDA207835	Unichem Pharmaceuticals (USA), Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
29300-269_69ca309f-1132-40c9-b250-665c360968e3	29300-269	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20170307		ANDA	ANDA207835	Unichem Pharmaceuticals (USA), Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
29300-270_45e8c5e4-4fe1-4a0c-8b0d-a1f5fb9fbdbe	29300-270	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20190301		ANDA	ANDA207011	Unichem Pharmaceuticals (USA), Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
29300-286_5071d25d-e93c-4ccd-bc40-0ab7af751ebb	29300-286	HUMAN PRESCRIPTION DRUG	tadalafil		tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209250	Unichem Pharmaceuticals (USA), Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
29300-287_5071d25d-e93c-4ccd-bc40-0ab7af751ebb	29300-287	HUMAN PRESCRIPTION DRUG	tadalafil		tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209250	Unichem Pharmaceuticals (USA), Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
29300-288_5071d25d-e93c-4ccd-bc40-0ab7af751ebb	29300-288	HUMAN PRESCRIPTION DRUG	tadalafil		tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209250	Unichem Pharmaceuticals (USA), Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
29300-289_5071d25d-e93c-4ccd-bc40-0ab7af751ebb	29300-289	HUMAN PRESCRIPTION DRUG	tadalafil		tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209250	Unichem Pharmaceuticals (USA), Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
29300-296_429d55c7-1e90-4345-a6d4-59f689557f40	29300-296	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230316		ANDA	ANDA213083	Unichem Pharmaceuticals (USA), Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
29300-297_429d55c7-1e90-4345-a6d4-59f689557f40	29300-297	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230316		ANDA	ANDA213083	Unichem Pharmaceuticals (USA), Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
29300-301_b60d626b-a3ab-45a0-9abc-cce73f2039da	29300-301	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20231016		ANDA	ANDA213315	Unichem Pharmaceuticals (USA), Inc.	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
29300-302_b60d626b-a3ab-45a0-9abc-cce73f2039da	29300-302	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20231016		ANDA	ANDA213315	Unichem Pharmaceuticals (USA), Inc.	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
29300-308_e30ce128-38bb-4569-88c8-57b709b3e3b2	29300-308	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220815		ANDA	ANDA215478	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-309_e30ce128-38bb-4569-88c8-57b709b3e3b2	29300-309	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220815		ANDA	ANDA215478	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-310_e30ce128-38bb-4569-88c8-57b709b3e3b2	29300-310	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220815		ANDA	ANDA215478	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-311_e30ce128-38bb-4569-88c8-57b709b3e3b2	29300-311	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220815		ANDA	ANDA215478	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-312_e30ce128-38bb-4569-88c8-57b709b3e3b2	29300-312	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220815		ANDA	ANDA215478	Unichem Pharmaceuticals (USA), Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
29300-316_b86514bb-961e-4cf9-9f52-d5f441b7c97f	29300-316	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20170307		ANDA	ANDA207836	Unichem Pharmaceuticals (USA), Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
29300-317_b86514bb-961e-4cf9-9f52-d5f441b7c97f	29300-317	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20170307		ANDA	ANDA207836	Unichem Pharmaceuticals (USA), Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
29300-328_82c150d9-febf-4425-bf85-0e4586ae1741	29300-328	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20200323		ANDA	ANDA211701	Unichem Pharmaceuticals (USA), Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
29300-329_82c150d9-febf-4425-bf85-0e4586ae1741	29300-329	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20200323		ANDA	ANDA211701	Unichem Pharmaceuticals (USA), Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
29300-333_a126115d-3e90-411b-91de-ccde9090e90f	29300-333	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190806		ANDA	ANDA211627	Unichem Pharmaceuticals (USA), Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
29300-334_a126115d-3e90-411b-91de-ccde9090e90f	29300-334	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190806		ANDA	ANDA211627	Unichem Pharmaceuticals (USA), Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
29300-343_513de439-4155-4a5d-a25c-bced499e293a	29300-343	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20200709		ANDA	ANDA212067	Unichem Pharmaceuticals (USA), Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
29300-344_513de439-4155-4a5d-a25c-bced499e293a	29300-344	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20200709		ANDA	ANDA212067	Unichem Pharmaceuticals (USA), Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
29300-349_799fe921-a30c-49a4-87c4-0773cf7743ee	29300-349	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	Unichem Pharmaceuticals (USA), Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
29300-350_799fe921-a30c-49a4-87c4-0773cf7743ee	29300-350	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	Unichem Pharmaceuticals (USA), Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
29300-355_64a9ffec-db61-418f-aac4-666b1e176263	29300-355	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA211825	Unichem Pharmaceuticals (USA), Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
29300-359_ca43a6d6-5537-4881-bf75-b43ade430dd1	29300-359	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20200901		ANDA	ANDA213446	Unichem Pharmaceuticals (USA), Inc.	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
29300-373_8a96534f-4c2d-450a-947e-9956a558e5af	29300-373	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210112		ANDA	ANDA213301	Unichem Pharmaceuticals (USA), Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-374_8a96534f-4c2d-450a-947e-9956a558e5af	29300-374	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210112		ANDA	ANDA213301	Unichem Pharmaceuticals (USA), Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29300-375_1a80b28a-62f6-443e-8e8d-fc89b74be5ea	29300-375	HUMAN PRESCRIPTION DRUG	Nebivolol Hydrochloride		Nebivolol Hydrochloride	TABLET	ORAL	20220404		ANDA	ANDA213830	Unichem Pharmaceuticals (USA), Inc.	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-376_1a80b28a-62f6-443e-8e8d-fc89b74be5ea	29300-376	HUMAN PRESCRIPTION DRUG	Nebivolol Hydrochloride		Nebivolol Hydrochloride	TABLET	ORAL	20220404		ANDA	ANDA213830	Unichem Pharmaceuticals (USA), Inc.	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-377_1a80b28a-62f6-443e-8e8d-fc89b74be5ea	29300-377	HUMAN PRESCRIPTION DRUG	Nebivolol Hydrochloride		Nebivolol Hydrochloride	TABLET	ORAL	20220404		ANDA	ANDA213830	Unichem Pharmaceuticals (USA), Inc.	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-378_1a80b28a-62f6-443e-8e8d-fc89b74be5ea	29300-378	HUMAN PRESCRIPTION DRUG	Nebivolol Hydrochloride		Nebivolol Hydrochloride	TABLET	ORAL	20220404		ANDA	ANDA213830	Unichem Pharmaceuticals (USA), Inc.	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-379_a6527387-ec89-41a1-b85a-c0fb7b4a7db7	29300-379	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20221112		ANDA	ANDA213834	Unichem Pharmaceuticals (USA), Inc.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
29300-380_9390848b-5ce6-4746-8d27-75367862291e	29300-380	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220225		ANDA	ANDA214643	Unichem Pharmaceuticals (USA), Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-381_9390848b-5ce6-4746-8d27-75367862291e	29300-381	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220225		ANDA	ANDA214643	Unichem Pharmaceuticals (USA), Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-382_d4ccdef2-d0be-4c67-9123-885b064ea3b8	29300-382	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20221101		ANDA	ANDA213284	Unichem Pharmaceuticals (USA), Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
29300-389_b816ed37-e579-43a1-9b34-2bb3675eb1c2	29300-389	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210811		ANDA	ANDA213359	Unichem Pharmaceuticals (USA), Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
29300-396_0f1b84e6-292c-4f46-b475-26c4dec1fbc2	29300-396	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	Unichem Pharmaceuticals (USA), Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
29300-397_0f1b84e6-292c-4f46-b475-26c4dec1fbc2	29300-397	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	Unichem Pharmaceuticals (USA), Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
29300-398_0f1b84e6-292c-4f46-b475-26c4dec1fbc2	29300-398	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	Unichem Pharmaceuticals (USA), Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
29300-399_b816ed37-e579-43a1-9b34-2bb3675eb1c2	29300-399	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210811		ANDA	ANDA213359	Unichem Pharmaceuticals (USA), Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
29300-400_04be779a-adb5-4308-bedb-d3126f26d873	29300-400	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20201125		ANDA	ANDA213302	Unichem Pharmaceuticals (USA), Inc.	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
29300-401_04be779a-adb5-4308-bedb-d3126f26d873	29300-401	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20201125		ANDA	ANDA213302	Unichem Pharmaceuticals (USA), Inc.	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
29300-410_b7b6651a-694f-4bf0-a72b-0b4a0234580d	29300-410	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191121		ANDA	ANDA213136	Unichem Pharmaceuticals (USA), Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-411_b7b6651a-694f-4bf0-a72b-0b4a0234580d	29300-411	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191121		ANDA	ANDA213136	Unichem Pharmaceuticals (USA), Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-412_b7b6651a-694f-4bf0-a72b-0b4a0234580d	29300-412	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191121		ANDA	ANDA213136	Unichem Pharmaceuticals (USA), Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
29300-413_cc113cd6-8904-4485-b1b2-15dd5ff7468b	29300-413	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Unichem Pharmaceuticals (USA), Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
29300-414_cc113cd6-8904-4485-b1b2-15dd5ff7468b	29300-414	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Unichem Pharmaceuticals (USA), Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
29300-415_cc113cd6-8904-4485-b1b2-15dd5ff7468b	29300-415	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Unichem Pharmaceuticals (USA), Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
29300-419_65fa5f9f-4d90-4d30-9a41-b62f6cf13ada	29300-419	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Unichem Pharmaceuticals (USA), Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
29300-420_65fa5f9f-4d90-4d30-9a41-b62f6cf13ada	29300-420	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Unichem Pharmaceuticals (USA), Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
29300-421_65fa5f9f-4d90-4d30-9a41-b62f6cf13ada	29300-421	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Unichem Pharmaceuticals (USA), Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
29300-422_65fa5f9f-4d90-4d30-9a41-b62f6cf13ada	29300-422	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Unichem Pharmaceuticals (USA), Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
29300-423_65fa5f9f-4d90-4d30-9a41-b62f6cf13ada	29300-423	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Unichem Pharmaceuticals (USA), Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
29300-424_65fa5f9f-4d90-4d30-9a41-b62f6cf13ada	29300-424	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Unichem Pharmaceuticals (USA), Inc.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
29300-428_337bce43-76dd-4e1c-bd1d-fcfc078baf0b	29300-428	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210709		ANDA	ANDA214492	Unichem Pharmaceuticals (USA), Inc.	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
29300-429_337bce43-76dd-4e1c-bd1d-fcfc078baf0b	29300-429	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210709		ANDA	ANDA214492	Unichem Pharmaceuticals (USA), Inc.	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
29300-430_337bce43-76dd-4e1c-bd1d-fcfc078baf0b	29300-430	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210709		ANDA	ANDA214492	Unichem Pharmaceuticals (USA), Inc.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
29300-458_9df9e7f8-a9b3-4919-94f9-07c81ff7c8b3	29300-458	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine Hydrochloride	TABLET	ORAL	20210303		ANDA	ANDA214689	Unichem Pharmaceuticals (USA), Inc.	GUANFACINE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-459_9df9e7f8-a9b3-4919-94f9-07c81ff7c8b3	29300-459	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine Hydrochloride	TABLET	ORAL	20210303		ANDA	ANDA214689	Unichem Pharmaceuticals (USA), Inc.	GUANFACINE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-468_5929c96f-9fa9-4399-84aa-28584da9966a	29300-468	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20201224		ANDA	ANDA078895	Unichem Pharmaceuticals (USA), Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
29300-474_513de439-4155-4a5d-a25c-bced499e293a	29300-474	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20230615		ANDA	ANDA212067	Unichem Pharmaceuticals (USA), Inc.	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
29300-477_ef78a61a-865b-447a-9324-3044e41db506	29300-477	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20231017		ANDA	ANDA210907	Unichem Pharmaceuticals (USA), Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
29300-478_ef78a61a-865b-447a-9324-3044e41db506	29300-478	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20231017		ANDA	ANDA210907	Unichem Pharmaceuticals (USA), Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
29485-1005_0bc929a5-ed16-f40d-e063-6294a90a8294	29485-1005	HUMAN OTC DRUG	ADVIL		IBUPROFEN Tablet coated	TABLET, COATED	ORAL	20020430	20251118	NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-1007_0bc95bde-fc88-2abc-e063-6294a90a3658	29485-1007	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20080901	20260123	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
29485-1013_0bc9785e-681f-58be-e063-6394a90ab576	29485-1013	HUMAN OTC DRUG	Aleve		Naproxen sodium tablet	TABLET	ORAL	20020430	20250930	NDA	NDA020204	Lil' Drug Store Products, Inc.	NAPROXEN SODIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-1017_0bc9785e-6827-58be-e063-6394a90ab576	29485-1017	HUMAN OTC DRUG	Bayer Genuine Aspirin		Bayer Genuine Aspirin	TABLET, COATED	ORAL	20020430	20250930	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
29485-1216_0bc9b688-9534-6bbc-e063-6294a90ac6a7	29485-1216	HUMAN OTC DRUG	Dramamine		DIMENHYDRINATE	TABLET, CHEWABLE	ORAL	19940101	20241231	OTC MONOGRAPH DRUG	M009	Lil' Drug Store Products, Inc.	DIMENHYDRINATE	50	mg/1			N	
29485-1465_0bca1920-4b72-76de-e063-6394a90a7ffb	29485-1465	HUMAN OTC DRUG	Motrin IB		Ibuprofen	TABLET, FILM COATED	ORAL	20000801	20251025	NDA	NDA019012	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-1531_00d86cb8-f8f0-e7e2-e063-6294a90add1d	29485-1531	HUMAN OTC DRUG	Pepto Bismol		BISMUTH SUBSALICYLATE	TABLET, CHEWABLE	ORAL	20020430	20251103	OTC MONOGRAPH FINAL	M001	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	
29485-1887_00c881a1-2ca9-a9c0-e063-6294a90a3e0a	29485-1887	HUMAN OTC DRUG	TYLENOL Acetaminophen Extra Strength		Acetaminophen	TABLET, COATED	ORAL	19840819	20250506	OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
29485-2802_00ecf118-0cb1-61a0-e063-6294a90a9967	29485-2802	HUMAN OTC DRUG	Midol Complete		acetaminophen, caffeine, and pyrilamine maleate tablet	TABLET	ORAL	20050629	20241231	OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
29485-2893_00c7ebb1-8634-4973-e063-6294a90a3d22	29485-2893	HUMAN OTC DRUG	Advil Liqui-Gels		IBUPROFEN Capsule, Liquid-filled	CAPSULE, LIQUID FILLED	ORAL	20030228	20251013	NDA	NDA020402	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-5043_00d9abda-9a9a-52fc-e063-6294a90a6c50	29485-5043	HUMAN OTC DRUG	24/7 Life Cold and Flu DayTime Severe		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl tablet, film coated	TABLET, FILM COATED	ORAL	20211027		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
29485-5053_00d987f6-9cb6-fc9a-e063-6394a90af1c5	29485-5053	HUMAN OTC DRUG	Cold and Flu Nighttime Severe		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20211027		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
29485-5270_00ed6289-2aa5-40b9-e063-6294a90a1c31	29485-5270	HUMAN OTC DRUG	Nicorette Fruit Chill nicotine polacrilex		Nicotine	GUM, CHEWING	ORAL	20090914		NDA	NDA020066	Lil' Drug Store Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
29485-5271_00ed6289-2aa7-40b9-e063-6294a90a1c31	29485-5271	HUMAN OTC DRUG	Nicorette White Mint nicotine polacrilex		Nicotine	GUM, CHEWING	ORAL	20090629		NDA	NDA020066	Lil' Drug Store Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
29485-5515_00d987f6-9cb4-fc9a-e063-6394a90af1c5	29485-5515	HUMAN OTC DRUG	24 / 7 Life Non-Drowsy Allergy Relief		loratadine tablet	TABLET	ORAL	20221024		ANDA	ANDA210722	Lil' Drug Store Products, Inc.	LORATADINE	10	mg/1			N	20241231
29485-6486_00ec0d40-786a-1d3f-e063-6394a90a5f0d	29485-6486	HUMAN OTC DRUG	Extra Strength Headache Relief		acetaminophen, aspirin, and caffeine	TABLET	ORAL	20210825		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
29485-6500_0bc929a5-ed16-f40d-e063-6294a90a8294	29485-6500	HUMAN OTC DRUG	ADVIL		IBUPROFEN Tablet coated	TABLET, COATED	ORAL	20170817	20251231	NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-6502_0bc9785e-681f-58be-e063-6394a90ab576	29485-6502	HUMAN OTC DRUG	Aleve		Naproxen sodium tablet	TABLET	ORAL	20170825	20251231	NDA	NDA020204	Lil' Drug Store Products, Inc.	NAPROXEN SODIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-6503_0bd96cdb-fc6e-b965-e063-6394a90a9373	29485-6503	HUMAN OTC DRUG	ALKA-SELTZER ORIGINAL		anhydrous citric acid, aspirin, and sodium bicarbonate tablet, effervescent	TABLET, EFFERVESCENT	ORAL	20190516	20251231	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
29485-6506_0bc95bde-fc88-2abc-e063-6294a90a3658	29485-6506	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20170825	20251231	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
29485-6510_0bde721a-03e7-52b5-e063-6394a90aefff	29485-6510	HUMAN OTC DRUG	EXCEDRIN EXTRA STRENGTH PAIN RELIEVER		ACETAMINOPHEN, ASPIRIN, and CAFFEINE	TABLET, FILM COATED	ORAL	20170825	20251231	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
29485-6512_0bca1920-4b72-76de-e063-6394a90a7ffb	29485-6512	HUMAN OTC DRUG	Motrin IB		Ibuprofen	TABLET, FILM COATED	ORAL	20170825	20251231	NDA	NDA019012	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-6522_00c52f51-fc7e-3eea-e063-6394a90ab379	29485-6522	HUMAN OTC DRUG	DUAL ACTION Pepcid Complete		famotidine, calcium carbonate, and magnesium hydroxide tablet, chewable	TABLET, CHEWABLE	ORAL	20200729		NDA	NDA020958	Lil' Drug Store Products, Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
29485-6526_0bc9785e-6827-58be-e063-6394a90ab576	29485-6526	HUMAN OTC DRUG	Bayer Genuine Aspirin		Bayer Genuine Aspirin	TABLET, COATED	ORAL	20170825	20251231	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
29485-6533_00c5d30a-4422-2c2f-e063-6294a90add9e	29485-6533	HUMAN OTC DRUG	ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated		Advil PM	TABLET, COATED	ORAL	20170825		NDA	NDA021394	Lil Drug Store Products, Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29485-6536_00d97309-1e55-e72d-e063-6294a90a006f	29485-6536	HUMAN OTC DRUG	24/7 Life Medicated Chest Rub		camphor, eucalyptus oil, menthol ointment	OINTMENT	TOPICAL	20221111		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
29485-6538_00ebf8c0-d7ed-7d43-e063-6294a90adf5c	29485-6538	HUMAN OTC DRUG	EXTRA STRENGHT HEADACHE RELIEF		acetaminophen, aspirin, caffeine	TABLET	ORAL	20210825		OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
29485-6547_00c881a1-2ca9-a9c0-e063-6294a90a3e0a	29485-6547	HUMAN OTC DRUG	TYLENOL Acetaminophen Extra Strength		Acetaminophen	TABLET, COATED	ORAL	20170825		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
29485-6552_00c7ebb1-8634-4973-e063-6294a90a3d22	29485-6552	HUMAN OTC DRUG	Advil Liqui-Gels		IBUPROFEN Capsule, Liquid-filled	CAPSULE, LIQUID FILLED	ORAL	20170825		NDA	NDA020402	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29485-6556_00c7d82f-6568-f10e-e063-6394a90a4773	29485-6556	HUMAN OTC DRUG	TYLENOL COLD PLUS FLU SEVERE		Acetaminophen, Dextromethorphan HBr,Phenylephrine HCl, Guaifenesin	TABLET	ORAL	20170825		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
29485-6557_00c79d2d-03f6-7bc6-e063-6294a90a9aaa	29485-6557	HUMAN OTC DRUG	TYLENOL SINUS SEVERE		ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20170825		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
29485-6580_00c49b5f-1ff4-e762-e063-6394a90a28a6	29485-6580	HUMAN OTC DRUG	DAYQUIL SEVERE PLUS VAPOCOOL COLD AND FLU		acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine	TABLET, COATED	ORAL	20170825	20251123	OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
29485-6644_00c5d30a-4422-2c2f-e063-6294a90add9e	29485-6644	HUMAN OTC DRUG	ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated		Advil PM	TABLET, COATED	ORAL	20100311	20251116	NDA	NDA021394	Lil Drug Store Products, Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-6749_0bc929a5-ed16-f40d-e063-6294a90a8294	29485-6749	HUMAN OTC DRUG	ADVIL		IBUPROFEN Tablet coated	TABLET, COATED	ORAL	20170206	20251107	NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-6751_0bc9785e-681f-58be-e063-6394a90ab576	29485-6751	HUMAN OTC DRUG	Aleve		Naproxen sodium tablet	TABLET	ORAL	20020206	20250930	NDA	NDA020204	Lil' Drug Store Products, Inc.	NAPROXEN SODIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-6754_00d86cb8-f8f0-e7e2-e063-6294a90add1d	29485-6754	HUMAN OTC DRUG	Pepto Bismol		BISMUTH SUBSALICYLATE	TABLET, CHEWABLE	ORAL	20170206	20251013	OTC MONOGRAPH FINAL	M001	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	
29485-6924_0bc9785e-6827-58be-e063-6394a90ab576	29485-6924	HUMAN OTC DRUG	Bayer Genuine Aspirin		Bayer Genuine Aspirin	TABLET, COATED	ORAL	20160107	20251116	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
29485-6925_0bc9b688-9534-6bbc-e063-6294a90ac6a7	29485-6925	HUMAN OTC DRUG	Dramamine		DIMENHYDRINATE	TABLET, CHEWABLE	ORAL	20170206	20241231	OTC MONOGRAPH DRUG	M009	Lil' Drug Store Products, Inc.	DIMENHYDRINATE	50	mg/1			N	
29485-6926_00c881a1-2ca9-a9c0-e063-6294a90a3e0a	29485-6926	HUMAN OTC DRUG	TYLENOL Acetaminophen Extra Strength		ACETAMINOPHEN	TABLET, COATED	ORAL	19840819	20251107	OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
29485-6931_0bc95bde-fc88-2abc-e063-6294a90a3658	29485-6931	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20170206	20251107	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
29485-6939_00c7ebb1-8634-4973-e063-6294a90a3d22	29485-6939	HUMAN OTC DRUG	Advil Liqui-Gels		IBUPROFEN Capsule, Liquid-filled	CAPSULE, LIQUID FILLED	ORAL	20030228	20251110	NDA	NDA020402	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-7003_00c881a1-2ca9-a9c0-e063-6294a90a3e0a	29485-7003	HUMAN OTC DRUG	TYLENOL Acetaminophen Extra Strength		ACETAMINOPHEN	TABLET, COATED	ORAL	19840819		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
29485-7006_0bca1920-4b72-76de-e063-6394a90a7ffb	29485-7006	HUMAN OTC DRUG	Motrin IB		Ibuprofen	TABLET, FILM COATED	ORAL	20170509	20251231	NDA	NDA019012	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-7008_00c5d30a-4422-2c2f-e063-6294a90add9e	29485-7008	HUMAN OTC DRUG	ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated		Advil PM	TABLET, COATED	ORAL	20170424		NDA	NDA021394	Lil Drug Store Products, Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29485-7012_0bc929a5-ed16-f40d-e063-6294a90a8294	29485-7012	HUMAN OTC DRUG	ADVIL		IBUPROFEN Tablet coated	TABLET, COATED	ORAL	20161101	20251231	NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-7025_00c881a1-2ca9-a9c0-e063-6294a90a3e0a	29485-7025	HUMAN OTC DRUG	TYLENOL Acetaminophen Extra Strength		ACETAMINOPHEN	TABLET, COATED	ORAL	19840819		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
29485-7088_00c5d30a-4422-2c2f-e063-6294a90add9e	29485-7088	HUMAN OTC DRUG	ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated		Advil PM	TABLET, COATED	ORAL	20110831	20260123	NDA	NDA021394	Lil Drug Store Products, Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-7318_0bde6cb8-4ea4-da1f-e063-6294a90a0fd4	29485-7318	HUMAN OTC DRUG	ALKA-SELTZER PLUS COLD AND FLU		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide tablet tablet, effervescent	TABLET, EFFERVESCENT	ORAL	20211223	20251231	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
29485-7358_00ecf118-0cb1-61a0-e063-6294a90a9967	29485-7358	HUMAN OTC DRUG	Midol Complete		acetaminophen, caffeine, and pyrilamine maleate tablet	TABLET	ORAL	20130507	20241231	OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
29485-7533_0bc9785e-6827-58be-e063-6394a90ab576	29485-7533	HUMAN OTC DRUG	Bayer Genuine Aspirin		Bayer Genuine Aspirin	TABLET, COATED	ORAL	20161101		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
29485-7534_0bc9785e-681f-58be-e063-6394a90ab576	29485-7534	HUMAN OTC DRUG	Aleve		Naproxen sodium tablet	TABLET	ORAL	20161101	20251231	NDA	NDA020204	Lil' Drug Store Products, Inc.	NAPROXEN SODIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-7535_0bd96cdb-fc6e-b965-e063-6394a90a9373	29485-7535	HUMAN OTC DRUG	ALKA-SELTZER ORIGINAL		anhydrous citric acid, aspirin, and sodium bicarbonate tablet, effervescent	TABLET, EFFERVESCENT	ORAL	20161117	20251231	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
29485-7937_00c5d30a-4422-2c2f-e063-6294a90add9e	29485-7937	HUMAN OTC DRUG	ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated		Advil PM	TABLET, COATED	ORAL	20170206	20251107	NDA	NDA021394	Lil Drug Store Products, Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-7938_0bca1920-4b72-76de-e063-6394a90a7ffb	29485-7938	HUMAN OTC DRUG	Motrin IB		Ibuprofen	TABLET, FILM COATED	ORAL	20170206	20260123	NDA	NDA019012	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
29485-7963_0bc95bde-fc88-2abc-e063-6294a90a3658	29485-7963	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20151019	20251231	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
29485-7964_00ecf118-0cb1-61a0-e063-6294a90a9967	29485-7964	HUMAN OTC DRUG	Midol Complete		acetaminophen, caffeine, and pyrilamine maleate tablet	TABLET	ORAL	20151019		OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
29485-8026_00ec894a-7901-2b06-e063-6394a90ae863	29485-8026	HUMAN OTC DRUG	EXCEDRIN EXTRA STRENGTH PAIN RELIEVER		ACETAMINOPHEN, ASPIRIN, and CAFFEINE	TABLET, FILM COATED	ORAL	20060927	20241231	OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
29485-8027_0bde721a-03e7-52b5-e063-6394a90aefff	29485-8027	HUMAN OTC DRUG	EXCEDRIN EXTRA STRENGTH PAIN RELIEVER		ACETAMINOPHEN, ASPIRIN, and CAFFEINE	TABLET, FILM COATED	ORAL	20060927	20260224	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
29485-8028_00eccaeb-7718-7d22-e063-6294a90a8dd3	29485-8028	HUMAN OTC DRUG	EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine		Acetaminophen, Aspirin, and Caffeine	TABLET, FILM COATED	ORAL	20100215	20260224	NDA	NDA020802	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
29485-8048_0bc9b688-9534-6bbc-e063-6294a90ac6a7	29485-8048	HUMAN OTC DRUG	Dramamine		DIMENHYDRINATE	TABLET, CHEWABLE	ORAL	19940101	20251231	OTC MONOGRAPH DRUG	M009	Lil' Drug Store Products, Inc.	DIMENHYDRINATE	50	mg/1			N	
29485-8055_00c79d2d-03f6-7bc6-e063-6294a90a9aaa	29485-8055	HUMAN OTC DRUG	TYLENOL SINUS SEVERE		ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20170418	20250506	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
29485-8057_00c79d2d-03f6-7bc6-e063-6294a90a9aaa	29485-8057	HUMAN OTC DRUG	TYLENOL SINUS SEVERE		ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20170822		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
29485-8060_00c7d82f-6568-f10e-e063-6394a90a4773	29485-8060	HUMAN OTC DRUG	TYLENOL COLD PLUS FLU SEVERE		Acetaminophen, Dextromethorphan HBr,Phenylephrine HCl, Guaifenesin	TABLET	ORAL	20170418		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
29485-8062_00c7d82f-6568-f10e-e063-6394a90a4773	29485-8062	HUMAN OTC DRUG	TYLENOL COLD PLUS FLU SEVERE		Acetaminophen, Dextromethorphan HBr,Phenylephrine HCl, Guaifenesin	TABLET	ORAL	20170822		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
29485-8120_00c41c2b-fe29-0631-e063-6294a90a2019	29485-8120	HUMAN OTC DRUG	TUMS CHEWY BITES		calcium carbonate tablet, chewable	TABLET, CHEWABLE	ORAL	20190207		OTC MONOGRAPH FINAL	M001	Lil' Drug Store Products, Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
29485-8127_00d85a52-ea6f-3ae1-e063-6394a90a1902	29485-8127	HUMAN OTC DRUG	MYLANTA MAXIMUM STRENGTH CLASSIC FLAVOR antacid and anti gas		ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, and DIMETHICONE	LIQUID	ORAL	20161110	20260331	OTC MONOGRAPH FINAL	M001	Lil' Drug Store Products, Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Skin Barrier Activity [PE]		N	
29485-8152_00d987f6-9cb5-fc9a-e063-6394a90af1c5	29485-8152	HUMAN OTC DRUG	24/7 Life IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20201216		ANDA	ANDA075010	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29485-8153_00d8b69c-5fd7-1e32-e063-6394a90a01a9	29485-8153	HUMAN OTC DRUG	24 / 7 Life Stomach Relief		bismuth subsalicylate tablet	TABLET, CHEWABLE	ORAL	20201217		OTC MONOGRAPH FINAL	M008	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
29485-8155_00d9d501-8fbb-a414-e063-6294a90afd53	29485-8155	HUMAN OTC DRUG	24 / 7 Life Extra Strength Pain Reliever		Acetaminophen tablet	TABLET	ORAL	20210105		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
29485-8156_00d987f6-9cb4-fc9a-e063-6394a90af1c5	29485-8156	HUMAN OTC DRUG	24 / 7 Life Non-Drowsy Allergy Relief		loratadine tablet	TABLET	ORAL	20201217		ANDA	ANDA210722	Lil' Drug Store Products, Inc.	LORATADINE	10	mg/1			N	20241231
29485-8157_00da7a23-4bd8-0050-e063-6394a90a3779	29485-8157	HUMAN OTC DRUG	24/7 Life Allergy Relief		Diphenhydramine Antihistamine	TABLET, FILM COATED	ORAL	20201212		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
29485-8158_00d97309-1e5b-e72d-e063-6294a90a006f	29485-8158	HUMAN OTC DRUG	24 / 7 Life Extra Strength Pain Reliever PM		acetaminophen, diphenhydramine hcl tablet, film coated	TABLET, FILM COATED	ORAL	20201217		OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
29485-9281_00da365d-2983-9c9e-e063-6294a90a8931	29485-9281	HUMAN OTC DRUG	Extra Strength Pain Reliever		Acetaminophen 500 mg	TABLET	ORAL	20170117		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
29485-9285_00da41c1-219b-cbb5-e063-6294a90a5390	29485-9285	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl 25 mg	TABLET, FILM COATED	ORAL	20160711		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
29485-9286_00d9fee4-6cfb-1a8a-e063-6294a90a568f	29485-9286	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCI	TABLET	ORAL	20160727		ANDA	ANDA074091	Lil' Drug Store Products, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
29485-9291_00ec4850-6786-538c-e063-6294a90a9776	29485-9291	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN 200MG	TABLET, FILM COATED	ORAL	20170502		ANDA	ANDA075010	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
29500-7820_ef578879-4c82-bc46-e053-2995a90a8e21	29500-7820	HUMAN OTC DRUG	Vagicaine		BENZOCAINE, RESORCINOL	CREAM	TOPICAL	20140228		OTC MONOGRAPH NOT FINAL	part348	Personal Care Products, Inc.	BENZOCAINE; RESORCINOL	5.67; .85	g/28g; g/28g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
29784-142_089fcdb1-9835-b024-e063-6394a90a26d5	29784-142	HUMAN OTC DRUG	ProCure Hydrocortisone Cream Plus		HYDROCORTISONE	CREAM	TOPICAL	20220201		OTC MONOGRAPH DRUG	M017	PROFOOT Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
29784-181_0ac47078-d549-277f-e063-6294a90ae934	29784-181	HUMAN OTC DRUG	ProClearz	Maximum Strength Fungal Shield Brush-on Antifungal	Tolnaftate	SOLUTION	TOPICAL	20121022		OTC MONOGRAPH DRUG	M005	Profoot, Inc.	TOLNAFTATE	10	mg/mL			N	20241231
29784-600_089ff901-8a4a-2da2-e063-6394a90a97cc	29784-600	HUMAN OTC DRUG	Profoot Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	KIT		20180926		OTC MONOGRAPH DRUG	M017	Profoot, Inc.						N	20241231
29784-601_0777293c-73f6-8802-e063-6294a90a4b87	29784-601	HUMAN OTC DRUG	Profoot Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	KIT		20231012		OTC MONOGRAPH DRUG	M017	Profoot, Inc.						N	20241231
29784-602_08195e48-e02b-8011-e063-6394a90aae6b	29784-602	HUMAN OTC DRUG	Profoot Plantar Relief Strips		CAMPHOR (NATURAL), MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20231018		OTC MONOGRAPH DRUG	M017	Profoot Inc.	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	12; 57; 63	mg/g; mg/g; mg/g			N	20241231
29943-002_90eca37f-ade3-499e-b28a-3647d57a446b	29943-002	HUMAN OTC DRUG	blink tears		polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20080201		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	POLYETHYLENE GLYCOL 400	2.5	mg/mL			N	20241231
29943-004_bfb360ac-b2e2-43e3-80a5-9c768718cb2e	29943-004	HUMAN OTC DRUG	blink gel tears		polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20080501		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	POLYETHYLENE GLYCOL 400	2.5	mg/mL			N	20241231
29943-006_0067a0fe-9b06-4837-9e60-af15cd6bf3c4	29943-006	HUMAN OTC DRUG	BLINK TRIPLE CARE		Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20220501		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	POLYETHYLENE GLYCOL 400	2.5	mg/mL			N	20241231
29978-127_f1f45dab-0e10-8327-e053-2a95a90a8053	29978-127	HUMAN OTC DRUG	Capron DM		Dextromethorphan HBr and Pyrilamine Maleate	LIQUID	ORAL	20130620		OTC MONOGRAPH FINAL	part341	Capital Pharmaceutical, LLC	DEXTROMETHORPHAN HYDROBROMIDE; PYRILAMINE MALEATE	7.5; 7.5	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
29978-420_0df9d932-80b6-9cf7-e063-6394a90a425a	29978-420	HUMAN OTC DRUG	CapCof		Codeine Phosphate, Phenylephrine Hydrochloride, Chlorpheniramine Maleate	LIQUID	ORAL	20101008		OTC MONOGRAPH DRUG	M012	Capital Pharmaceutical, LLC	CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], alpha-1 Adrenergic Agonist [EPC]	CV	N	20251231
29978-601_0df9e119-d22f-a052-e063-6394a90a572e	29978-601	HUMAN OTC DRUG	Capmist DM		Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride	TABLET	ORAL	20130620		OTC MONOGRAPH DRUG	M012	Capital Pharmaceutical, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	15; 400; 60	mg/1; mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
29978-918_0df96321-505c-7f42-e063-6394a90a404a	29978-918	HUMAN OTC DRUG	Alevazol		Clotrimazole	OINTMENT	TOPICAL	20140901		UNAPPROVED DRUG OTHER		Capital Pharmaceutical, LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20251231
29998-001_8d1b364e-50f4-4cc1-8153-9b05ae02220d	29998-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F-18	INJECTION	INTRAVENOUS	20111208		ANDA	ANDA204759	Kettering Medical Center	FLUDEOXYGLUCOSE F-18	40	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
30056-004_fb0bcdb1-a99e-6a21-e053-6394a90aa611	30056-004	HUMAN OTC DRUG	Elgin Pain Relief		Menthol	GEL	TOPICAL	20160711		OTC MONOGRAPH NOT FINAL	part348	Eco-Logics, Inc.	MENTHOL	35	mg/g			N	20241231
30056-004_fb48a6a3-8cd4-d3a5-e053-6294a90adac5	30056-004	HUMAN OTC DRUG	Elgin Pain Relief		Menthol	GEL	TOPICAL	20160711		OTC MONOGRAPH NOT FINAL	part348	Eco-Logics, Inc.	MENTHOL	35	mg/g			N	20241231
30056-004_fb493a10-73b9-5073-e053-6294a90a7f7f	30056-004	HUMAN OTC DRUG	Elgin Pain Relief		Menthol	GEL	TOPICAL	20160711		OTC MONOGRAPH NOT FINAL	part348	Eco-Logics, Inc.	MENTHOL	35	mg/g			N	20241231
30056-006_fbed0758-de4e-722d-e053-6294a90a80c0	30056-006	HUMAN OTC DRUG	Advanced Healing Diabetic Skin Care		Dimethicone	LOTION	TOPICAL	20101201		OTC MONOGRAPH FINAL	M016	Eco-Logics, Inc.	DIMETHICONE	10	mg/g	Skin Barrier Activity [PE]		N	20241231
30142-000_b7746808-7520-47e0-a335-48460463f29b	30142-000	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	62	mL/100mL			N	20241231
30142-001_c02107c2-0f81-4910-a737-dd5a8fa66793	30142-001	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20110112		OTC MONOGRAPH FINAL	part333D	Kroger Co.	SALICYLIC ACID	19.8	mg/g			N	20241231
30142-004_d340d085-0d63-4a97-bcfe-05e7edf2bd2b	30142-004	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20130118		OTC MONOGRAPH FINAL	part355	Kroger Co	SODIUM FLUORIDE	.2	mg/mL			N	20241231
30142-005_b7aec228-5205-45a3-a794-d761edcc8ba5	30142-005	HUMAN OTC DRUG	Saline Laxative		sodium phosphate	ENEMA	RECTAL	20120831		OTC MONOGRAPH NOT FINAL	part334	Kroger Company	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
30142-010_a1b091b2-ba84-4a68-a241-838c97cdd76c	30142-010	HUMAN OTC DRUG	Eye Wash		water solution	SOLUTION/ DROPS	OPHTHALMIC	20170101		OTC MONOGRAPH FINAL	part349	Kroger Company	WATER	99.05	mL/100mL			N	20241231
30142-012_477806d7-2008-d442-631f-e54a479c3862	30142-012	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium 20.6mg Capsules	CAPSULE, DELAYED RELEASE	ORAL	20160101		ANDA	ANDA078878	The Kroger Co.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-017_092f2545-927f-4cb6-8ca0-39f6b21e4305	30142-017	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Kroger Company	LORATADINE	5	mg/5mL			N	20241231
30142-020_018b41fa-60eb-4e9a-9a26-ad6317785263	30142-020	HUMAN OTC DRUG	Diaper Rash		ZINC OXIDE	PASTE	TOPICAL	20090515		OTC MONOGRAPH FINAL	part347	Kroger Co	ZINC OXIDE	400	mg/g			N	20241231
30142-021_7c66952b-2edf-4e92-9628-2bdf32f67dd5	30142-021	HUMAN OTC DRUG	nighttime cold and cough	childrens	Diphenhydramine HCl, Phenylephrine HCl	SOLUTION	ORAL	20070829		OTC MONOGRAPH FINAL	part341	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-022_a2ba35c2-54d0-407e-adf2-3462f1f75e4e	30142-022	HUMAN OTC DRUG	Vitamin A D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20130701		OTC MONOGRAPH DRUG	M016	Krogers	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
30142-023_adfdd49c-de8f-453e-93aa-6d61fde82e2d	30142-023	HUMAN OTC DRUG	Childrens Multi Symptom Fever and Cold		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SUSPENSION	ORAL	20150623		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-025_0a1b7b70-38e0-9a3e-a59e-85c3d52534ea	30142-025	HUMAN OTC DRUG	Diclofenac Sodium Topical Gel 1%		Diclofenac sodium topical gel, 1%	GEL	TOPICAL	20210131		ANDA	ANDA210986	Kroger Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-026_21decaa0-a508-424c-a50d-a2933c27f9d9	30142-026	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Kroger Company	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
30142-027_ee3d597c-5746-4b40-96c4-ed910a3e745a	30142-027	HUMAN OTC DRUG	Aspirin	Low Dose Safety Coated	Aspirin	TABLET	ORAL	20130308	20240329	OTC MONOGRAPH NOT FINAL	part343	The Kroger Co.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
30142-028_08a1ea95-479e-f314-e063-6294a90a0f37	30142-028	HUMAN OTC DRUG	Honey Lemon cough drop		Menthol	LOZENGE	ORAL	20140528		OTC MONOGRAPH DRUG	M012	The Kroger Co.	MENTHOL	7.5	mg/1			N	20241231
30142-028_08a201f2-64a3-552e-e063-6394a90a0686	30142-028	HUMAN OTC DRUG	Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20140528		OTC MONOGRAPH DRUG	M012	The Kroger Co.	MENTHOL	7.5	mg/1			N	20241231
30142-028_08a20a73-141b-551a-e063-6394a90a758f	30142-028	HUMAN OTC DRUG	Honey Lemon cough drop		Menthol	LOZENGE	ORAL	20140528		OTC MONOGRAPH DRUG	M012	The Kroger Co.	MENTHOL	7.5	mg/1			N	20241231
30142-029_e61b1264-b03f-482f-8fb9-d4758f04bada	30142-029	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20051215		ANDA	ANDA076775	Kroger Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-031_08a1a1e3-05eb-5508-e063-6294a90a8fa0	30142-031	HUMAN OTC DRUG	Menthol cough drop		menthol	LOZENGE	ORAL	20140528		OTC MONOGRAPH DRUG	M012	The Kroger Co.	MENTHOL	5.4	mg/1			N	20241231
30142-032_06d25fb7-bd75-0046-e063-6394a90a83b3	30142-032	HUMAN OTC DRUG	Cherry cough drop		Menthol	LOZENGE	ORAL	20140528		OTC MONOGRAPH FINAL	part341	The Kroget Co.	MENTHOL	5.8	mg/1			N	20241231
30142-033_0bd2580e-566d-6366-e063-6394a90aebd2	30142-033	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20220202		OTC MONOGRAPH DRUG	M013	KROGER COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
30142-034_06d26cff-523a-f5c0-e063-6294a90a57f5	30142-034	HUMAN OTC DRUG	SF Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20140528		OTC MONOGRAPH FINAL	part341	The Kroger Co.	MENTHOL	7.6	mg/1			N	20241231
30142-036_08a20e5b-dde2-5cd1-e063-6294a90a7204	30142-036	HUMAN OTC DRUG	Assorted Fruit Panned Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20151118		OTC MONOGRAPH DRUG	M001	The Kroger Company	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
30142-037_b5456f61-f117-4f80-a905-523a5b996e9f	30142-037	HUMAN OTC DRUG	Triple Antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20170503		OTC MONOGRAPH FINAL	part333B	Kroger Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
30142-038_08a1ff0f-27e3-3b7b-e063-6394a90a9bb1	30142-038	HUMAN OTC DRUG	Berry Flavored Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181009		OTC MONOGRAPH DRUG	M001	Kroger	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
30142-039_08a201f2-64ad-552e-e063-6394a90a0686	30142-039	HUMAN OTC DRUG	Antacid - Anti-Gas Relief		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190128		OTC MONOGRAPH DRUG	M001	Kroger	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
30142-040_7b8d356a-57e5-4220-9098-87eeaae8e9ce	30142-040	HUMAN OTC DRUG	Dual Action Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160201		ANDA	ANDA077355	Kroger Company	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-042_08a22de8-5428-ca1a-e063-6394a90a9166	30142-042	HUMAN OTC DRUG	Kroger Menthol Cough Drops		Menthol	LOZENGE	ORAL	20200409		OTC MONOGRAPH DRUG	M012	Kroger	MENTHOL	5.4	mg/1			N	20241231
30142-043_2820c349-78a3-469f-9f02-cb3bf9795116	30142-043	HUMAN OTC DRUG	Gel Cooling Pain Relief		Menthol	GEL	TOPICAL	20200215		OTC MONOGRAPH NOT FINAL	part348	Kroger	MENTHOL	160	mg/mL			N	20241231
30142-045_06d25564-4c80-0b3a-e063-6294a90a38bf	30142-045	HUMAN OTC DRUG	Kroger Cherry Cough Drops		Menthol	LOZENGE	ORAL	20200409		OTC MONOGRAPH FINAL	part341	Kroger	MENTHOL	5.8	mg/1			N	20241231
30142-048_3401da3b-45a8-4322-892d-9de153e3ea2d	30142-048	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20150131	20240223	ANDA	ANDA078682	The Kroger Co.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
30142-050_9725bc79-f31a-4b45-ad9c-1c07136916be	30142-050	HUMAN OTC DRUG	ibuprofen pm		diphenhydramine citrate and ibuprofen	TABLET, FILM COATED	ORAL	20090406		ANDA	ANDA079113	Kroger Company	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-051_c8cbd869-e5a1-4c67-aa35-f6da0cff31e7	30142-051	HUMAN OTC DRUG	DayTime NiteTime Severe		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20170524		OTC MONOGRAPH FINAL	part341	Kroger Company						N	20241231
30142-052_0bd2025f-c8af-690a-e063-6294a90a439c	30142-052	HUMAN OTC DRUG	Acetaminophen Regular Strength		Acetaminophen	TABLET	ORAL	20220202		OTC MONOGRAPH DRUG	M013	KROGER COMPANY	ACETAMINOPHEN	325	mg/1			N	20241231
30142-053_f0d5fbf0-cf4f-218d-e053-2a95a90ada47	30142-053	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190503		ANDA	ANDA078682	KROGER COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-058_013f034c-15f9-4da2-b74c-ac999b276053	30142-058	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20210308		ANDA	ANDA213557	KROGER COMPANY	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-059_ace3970d-b14d-43df-99da-88343d9dc152	30142-059	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210315		ANDA	ANDA209116	KROGER COMPANY	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-060_2522dee7-54f3-4854-9e6d-a7bc1fa83286	30142-060	HUMAN OTC DRUG	Nicotine Mini		Nicotine Polacrilex	LOZENGE	ORAL	20160212		ANDA	ANDA203690	Kroger Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-062_00345362-5d45-4ddc-8661-244992db84b0	30142-062	HUMAN OTC DRUG	Loratadine		Loratadine Oral	SOLUTION	ORAL	20210315		ANDA	ANDA208931	KROGER COMPANY	LORATADINE	5	mg/5mL			N	20241231
30142-063_17760de0-6e36-48e5-aa8b-dd51a1aed902	30142-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20090504		OTC MONOGRAPH FINAL	part347	Kroger CO	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; g/mL			N	20241231
30142-064_54a3db8b-8ddb-468b-aa0f-8cad61ee643c	30142-064	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	Kroger Company	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
30142-066_e4cdd8db-2b44-41b0-8f38-55c6dff1a9ab	30142-066	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210315		ANDA	ANDA208314	KROGER COMPANY	LORATADINE	10	mg/1			N	20241231
30142-068_0bd12b06-232b-934c-e063-6294a90a2615	30142-068	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20210204		OTC MONOGRAPH DRUG	M013	KROGER COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
30142-069_a849c253-796c-4f1e-81f6-bfafd4f90cc9	30142-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	19890715		OTC MONOGRAPH FINAL	part347	Kroger Co	PETROLATUM	1	g/g			N	20241231
30142-072_e3812b44-914c-4263-a71c-dbac4ccb32e4	30142-072	HUMAN OTC DRUG	Mouth Rinse		EUCALYPTOL, MENTHOL, METHYLSALICYLATE, THYMOL	MOUTHWASH	ORAL	19891111		OTC MONOGRAPH DRUG	505G(a)(3)	Kroger	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-073_66f38f0b-29d8-46e4-9d94-b1fe3bbb0a79	30142-073	HUMAN OTC DRUG	Glazed Pear		Ethyl Alcohol	GEL	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Kroger, CO.,	ALCOHOL	62	mg/mL			N	20241231
30142-075_a0072c60-e495-4aef-9c44-1f93ef9be9a0	30142-075	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210118		OTC MONOGRAPH FINAL	part352	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
30142-077_8a10eaa8-249a-48ad-a5bb-42ced191d0f3	30142-077	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20230313		ANDA	ANDA206877	KROGER COMPANY	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-078_f4dc4d11-c9ec-4771-82fe-b353b91be9d7	30142-078	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	20010419		OTC MONOGRAPH NOT FINAL	part334	Kroger Co	CASTOR OIL	1	g/mL			N	20241231
30142-080_42c428de-a4af-4e91-9314-ca79a575623e	30142-080	HUMAN OTC DRUG	Kroger	Antifungal	Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Kroger Company	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
30142-081_3401aece-12e2-4029-ab26-bcab5c8ac032	30142-081	HUMAN OTC DRUG	miconazole 3		Miconazole nitrate	KIT		20000223		ANDA	ANDA075329	Kroger Company						N	20241231
30142-084_f3419b2c-4d89-4326-8442-85e7b10a7a2d	30142-084	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20160229	20250829	OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
30142-086_02b01b11-c905-4e64-88bb-a2d52f854fb6	30142-086	HUMAN OTC DRUG	Kroger Nighttime Cold and Flu Softgel		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20220831		OTC MONOGRAPH FINAL	part341	The Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-087_324a5035-4c12-43cc-8b00-40b0b7655025	30142-087	HUMAN OTC DRUG	Kroger Daytime Cold and Flu Softgel		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220831		OTC MONOGRAPH FINAL	part341	The Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-088_3407e173-864a-44ed-b25a-e26fdb0dc007	30142-088	HUMAN OTC DRUG	Iodine Tincture		Iodine tincture	SOLUTION/ DROPS	TOPICAL	20010621		OTC MONOGRAPH NOT FINAL	part333A	Kroger Co	IODINE	20	mg/mL			N	20241231
30142-089_f2f53cf9-3716-07ff-e053-2a95a90a03fb	30142-089	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20180401		OTC MONOGRAPH FINAL	part333C	Kroger Co.	MICONAZOLE NITRATE	1.3	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
30142-091_3e63bd91-4768-de26-6a57-e2ade9e6aaca	30142-091	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride 60 mg	TABLET	ORAL	20220103		ANDA	ANDA076502	Kroger Company	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-096_adf29187-2c34-46e2-820f-fee86a24345d	30142-096	HUMAN OTC DRUG	flu and severe cold and cough	daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20120117		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-097_54cf0685-e37e-a864-5cec-26a871043192	30142-097	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA215434	Kroger Company	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-099_740167b1-a919-4f8a-a77d-3bdc12db0412	30142-099	HUMAN OTC DRUG	Deep Cleaning Astringent		Salicylic acid	LIQUID	TOPICAL	20150804		OTC MONOGRAPH FINAL	part333D	Krogers	SALICYLIC ACID	18	mg/mL			N	20241231
30142-107_a1387420-951b-41fc-87ca-97e4f988ae2f	30142-107	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20100706	20240531	OTC MONOGRAPH FINAL	part341	The Kroger Co.	GUAIFENESIN	400	mg/1			N	
30142-108_f18845a1-4a67-4727-bb48-eaaff9d6292f	30142-108	HUMAN OTC DRUG	Ultra Strength	Natural Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191119		OTC MONOGRAPH FINAL	part331	KROGER COMPANY	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
30142-109_aaf8eb37-aba5-41b1-b472-bd8598b9110e	30142-109	HUMAN OTC DRUG	Mucus Relief DM		Dextromethorphan Hydrobromide and Guaifenesin	TABLET, COATED	ORAL	20100102	20240223	OTC MONOGRAPH FINAL	part341	The Kroger Co.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
30142-115_8e318b8b-efa9-40fd-95da-5b615b98ad7c	30142-115	HUMAN OTC DRUG	Kroger Extra Strength Smooth Antacid	Assorted Berry	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	KROGER COMPANY	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
30142-124_61ca21e0-5c85-4d10-8540-836318937297	30142-124	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	19980623		ANDA	ANDA090711	Kroger Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-125_f31a7145-54c6-7627-e053-2a95a90a35ec	30142-125	HUMAN OTC DRUG	Tolnafate		Foot and Sneaker Spray	AEROSOL, SPRAY	TOPICAL	20120102		OTC MONOGRAPH FINAL	part333C	Kroger Co.	TOLNAFTATE	1.3	g/113g			N	20241231
30142-126_f31aa1c4-eda6-35ea-e053-2995a90a588c	30142-126	HUMAN OTC DRUG	Salicylic Acid		Medicated Plantar Wart Remover	PATCH	TOPICAL	20120130		OTC MONOGRAPH FINAL	part358B	Kroger Co.	SALICYLIC ACID	40	mg/241			N	20241231
30142-127_f31a97e1-592b-1282-e053-2995a90ac1c9	30142-127	HUMAN OTC DRUG	Salicylic Acid		Wart Removers	PATCH	TOPICAL	20120112		OTC MONOGRAPH FINAL	part358B	Kroger Co.	SALICYLIC ACID	40	mg/181			N	20241231
30142-128_f31aa99a-f444-c339-e053-2a95a90a4c1a	30142-128	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20120112		OTC MONOGRAPH FINAL	part358F	Kroger Co.	SALICYLIC ACID	40	mg/91			N	20241231
30142-129_f31a7145-54c5-7627-e053-2a95a90a35ec	30142-129	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20120229		OTC MONOGRAPH FINAL	part358F	Kroger Co.	SALICYLIC ACID	40	mg/41			N	20241231
30142-131_601f58c2-9b1b-961b-1f23-2c0d7a885604	30142-131	HUMAN OTC DRUG	Ranitidine 75		Ranitidine Tablets USP, 75mg	TABLET	ORAL	20110331		ANDA	ANDA075294	The Kroger Co.	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
30142-132_27e93e22-1709-4ec6-bf6e-7c8d9fd36241	30142-132	HUMAN OTC DRUG	Fiber Caplets		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20191126		OTC MONOGRAPH NOT FINAL	part334	THE KROGER CO.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
30142-134_f3953452-2bb0-9c96-e053-2a95a90aed50	30142-134	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief	SPRAY	TOPICAL	20120229		OTC MONOGRAPH NOT FINAL	part348	Kroger Co.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-137_bd1d5672-dce6-47dc-96be-26bce0db708d	30142-137	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20210416		ANDA	ANDA213203	KROGER COMPANY	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-138_05ef8c53-e6f4-4064-a951-ac6e1b68b0a9	30142-138	HUMAN OTC DRUG	Ultra Strength digestive relief		Bismuth subsalicylate	TABLET	ORAL	20191118		OTC MONOGRAPH FINAL	part335	THE KROGER CO.	BISMUTH SUBSALICYLATE	525	mg/1			N	20241231
30142-141_182928ed-1fa1-4789-901f-c473cf0ea9c0	30142-141	HUMAN OTC DRUG	heartburn prevention	original strength	Famotidine	TABLET	ORAL	20091009		ANDA	ANDA075400	Kroger Company	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
30142-142_f2f5507b-6295-c124-e053-2995a90a5b16	30142-142	HUMAN OTC DRUG	Miconazole Nitrate		Antifungal Liquid Continuous Spray	AEROSOL, SPRAY	TOPICAL	20171211		OTC MONOGRAPH FINAL	part333C	Kroger Co.	MICONAZOLE NITRATE	2	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
30142-146_f200dc4a-87d9-10b5-e053-2a95a90ad5b5	30142-146	HUMAN OTC DRUG	Simple Truth	Kids Flouride	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20190225		OTC MONOGRAPH FINAL	part355	Kroger Company	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
30142-149_01503a88-2b63-d740-e063-6294a90a0381	30142-149	HUMAN OTC DRUG	Kroger	Extra Whitening	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	Kroger	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
30142-150_f31a8720-bc26-7854-e053-2a95a90aac03	30142-150	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171206		OTC MONOGRAPH NOT FINAL	part333A	Kroger Co.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
30142-151_f2f5507b-6296-c124-e053-2995a90a5b16	30142-151	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover Kit	LIQUID	TOPICAL	20171206		OTC MONOGRAPH FINAL	part358F	Kroger Co.	SALICYLIC ACID	.17	mg/9mL			N	20241231
30142-152_f31a8720-bc27-7854-e053-2a95a90aac03	30142-152	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20171206		OTC MONOGRAPH FINAL	part358B	Kroger Co.	SALICYLIC ACID	.17	mg/9mL			N	20241231
30142-153_4dc51735-9bdb-4ce2-826f-b0a5358cee93	30142-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH FINAL	part358H	Kroger Co	PYRITHIONE ZINC	1	kg/100L			N	20241231
30142-156_f2f53cf9-3715-07ff-e053-2a95a90a03fb	30142-156	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus Spray	AEROSOL, SPRAY	TOPICAL	20171206		OTC MONOGRAPH NOT FINAL	part348	Kroger Co.	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g			N	20241231
30142-157_4d5011ee-44d8-4369-8361-fe592d21820d	30142-157	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20210525		ANDA	ANDA207229	KROGER COMPANY	ACETAMINOPHEN	650	mg/1			N	20241231
30142-158_fad9918f-b459-49a3-bd43-c2a4328ad074	30142-158	HUMAN OTC DRUG	nighttime sleep aid		Doxylamine succinate	TABLET	ORAL	20140715	20240131	ANDA	ANDA040167	Kroger Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
30142-159_f0ff0f07-b0b0-e559-e053-2995a90a2418	30142-159	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190301		NDA	NDA021855	KROGER COMPANY	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
30142-162_2e70d29f-a0ba-448b-b1ad-0b0709ad5b87	30142-162	HUMAN OTC DRUG	Kids Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191030		OTC MONOGRAPH FINAL	part331	THE KROGER CO.	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
30142-163_740121da-61a6-4df9-8d56-66555734d3f2	30142-163	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20050912		OTC MONOGRAPH DRUG	M021	Kroger	SODIUM FLUORIDE	.2	mg/mL			N	20241231
30142-164_6b89c5dc-fc76-43a4-98fa-84a1fb540ecf	30142-164	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Krogers	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-165_0bd2025f-c8c1-690a-e063-6294a90a439c	30142-165	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20210306		OTC MONOGRAPH DRUG	M013	KROGER COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
30142-166_aa9320f1-068f-4253-88ef-4113a6719194	30142-166	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION	ORAL	20021120		ANDA	ANDA074937	Kroger Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-169_185308e9-76a6-4245-bdab-06b22a79a400	30142-169	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	CAPSULE	ORAL	20210324		ANDA	ANDA209107	KROGER COMPANY	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-170_ff0b21da-497b-488e-affa-3caf2bd1047e	30142-170	HUMAN OTC DRUG	nicotine polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20051215		ANDA	ANDA076789	Kroger Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-171_c2746ea9-5585-4c9d-a81f-9155a8c604a1	30142-171	HUMAN OTC DRUG	Infants Gas Relief	Dye Free	Simethicone Antigas	EMULSION	ORAL	20190716		OTC MONOGRAPH FINAL	part332	THE KROGER CO.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
30142-172_38264bca-705b-4ca5-8387-ad60736a2eb8	30142-172	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20210315		ANDA	ANDA090760	KROGER COMPANY	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-174_2afb2ab6-21d5-40a3-876b-715568813d26	30142-174	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20141031	20240223	NDA	NDA021920	The Kroger Co.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
30142-180_5ac40c37-846a-471f-a71c-671cf0906a0b	30142-180	HUMAN OTC DRUG	Healing		petrolatum	OINTMENT	TOPICAL	19880215		OTC MONOGRAPH FINAL	part347	The Kroger CO.	PETROLATUM	340	mg/g			N	20241231
30142-181_45ed917a-f08f-41c9-8034-625e32efa2b6	30142-181	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET	ORAL	20140328	20240223	OTC MONOGRAPH NOT FINAL	part343	The Kroger Co.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
30142-184_0bd1a511-9f43-1a0a-e063-6394a90a10b7	30142-184	HUMAN OTC DRUG	Aurophen Regular Strength		Acetaminophen	TABLET	ORAL	20210622		OTC MONOGRAPH DRUG	M013	KROGER COMPANY	ACETAMINOPHEN	325	mg/1			N	20241231
30142-185_ce41f4ac-08c2-444e-9c56-aacbc73517a5	30142-185	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20180224		OTC MONOGRAPH NOT FINAL	part333A	Kroger	ALCOHOL	62	mg/mL			N	20241231
30142-188_58e74823-36bf-4a35-8467-1c4c3f4e1515	30142-188	HUMAN OTC DRUG	Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20131213		OTC MONOGRAPH FINAL	part346	Kroger Company	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-189_53f8b3ca-654c-4a53-86fe-70ed0f469550	30142-189	HUMAN OTC DRUG	childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20160310		ANDA	ANDA204226	Kroger Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-190_3db00bfd-edb5-40ad-8af3-f955204cd368	30142-190	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20100914		ANDA	ANDA090711	Kroger Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-191_c4dd2e48-ab73-4dd7-89b3-d5248b55be7c	30142-191	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, COATED	ORAL	20131230		OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-192_e89d7311-ab3c-451e-ac55-3aae385c7524	30142-192	HUMAN OTC DRUG	lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20190405		NDA	NDA208025	Kroger Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-193_0bd0ff2d-0803-d2e0-e063-6394a90ac336	30142-193	HUMAN OTC DRUG	Acetaminophen and Diphenhydramine hydrochloride		Acetaminophen and Diphenhydramine hydrochloride	TABLET	ORAL	20210306		OTC MONOGRAPH DRUG	M013	KROGER COMPANY	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-194_b8aee544-f55b-4b97-a045-490ee35588d0	30142-194	HUMAN OTC DRUG	heartburn prevention		Famotidine	TABLET, FILM COATED	ORAL	20150205		ANDA	ANDA077351	Kroger Company	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
30142-195_f2f5516b-720c-0870-e053-2a95a90a87ee	30142-195	HUMAN OTC DRUG	Allantoin		Advanced Derma Spray	AEROSOL, SPRAY	TOPICAL	20180212		OTC MONOGRAPH FINAL	part347	Kroger Co.	ALLANTOIN	.425	g/85g			N	20241231
30142-197_f0f33a91-c911-934f-e053-2a95a90a1c5f	30142-197	HUMAN OTC DRUG	Kroger Sport Sunscreen Broad Spectrum SPF 15		Avobenzone, Homosalate, Octisalate	AEROSOL, SPRAY	TOPICAL	20191125		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE	20; 100; 50	mg/g; mg/g; mg/g			N	20241231
30142-199_cc530c8a-7c1e-4777-82df-10e3dbea545c	30142-199	HUMAN OTC DRUG	miconazole 1		Miconazole nitrate	KIT		20100608		ANDA	ANDA079114	Kroger Company						N	20241231
30142-200_52c77406-9d9b-4714-b18f-7840cae13176	30142-200	HUMAN OTC DRUG	Kroger Extra Strength	Assorted Berry	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	KROGER COMPANY	CALCIUM CARBONATE	750	mg/1			N	20241231
30142-204_5c47be82-2666-4fbc-8867-a4d72c2aba3e	30142-204	HUMAN OTC DRUG	Kroger Extra Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190521		OTC MONOGRAPH FINAL	part331	KROGER COMPANY	CALCIUM CARBONATE	750	mg/1			N	20241231
30142-205_155845af-b486-480e-b7cd-9c2954d169e6	30142-205	HUMAN OTC DRUG	Therapeutic T Plus		Coal Tar	SHAMPOO	TOPICAL	20110331		OTC MONOGRAPH FINAL	part358H	The Kroger Co	COAL TAR	5	mg/mL			N	20241231
30142-207_9924975e-cb73-48f8-9d19-953080c5f0c5	30142-207	HUMAN OTC DRUG	Kroger Extra Strength	Sugar Free	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	KROGER COMPANY	CALCIUM CARBONATE	750	mg/1			N	20241231
30142-208_a1ff9035-d7ef-41dd-99b3-b1543ef8f986	30142-208	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20170425		ANDA	ANDA206394	Kroger Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-209_598eca41-6645-48d1-a355-4bfd0a71b277	30142-209	HUMAN OTC DRUG	Nicotine Mini		Nicotine Polacrilex	LOZENGE	ORAL	20160419		ANDA	ANDA203690	Kroger Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-210_f48462c5-4628-4207-bcdc-f7ccd33d9077	30142-210	HUMAN OTC DRUG	Butenafine Hydrochloride	Athletes Foot	Butenafine Hydrochloride	CREAM	TOPICAL	20171116		ANDA	ANDA205181	Kroger Company	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
30142-211_9c833d2f-06f0-4f62-9d4d-04df28329dae	30142-211	HUMAN OTC DRUG	All Day Allergy		Cetirizine HCl	CAPSULE	ORAL	20131230	20250228	NDA	NDA022429	The Kroger Co.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
30142-212_f2151442-dc75-e8a7-e053-2995a90a5ea5	30142-212	HUMAN OTC DRUG	4x Medicated Toothache and Gum Cream		Benzocaine	CREAM	ORAL	20200623		OTC MONOGRAPH NOT FINAL	part356	Kroger	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .25; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
30142-219_6f626328-129c-49a8-a651-b7c3fee34600	30142-219	HUMAN OTC DRUG	Blackhead Clearing Scrub		Salicylic acid	GEL	TOPICAL	20140118		OTC MONOGRAPH FINAL	part333D	The Kroger Co.	SALICYLIC ACID	19.4	mg/g			N	20241231
30142-220_f71e9c0b-116e-1b10-e053-6394a90abd2f	30142-220	HUMAN OTC DRUG	KROGER BABY SUNSCREEN SPF 50		OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20191125		OTC MONOGRAPH FINAL	M020	THE KROGER COMPANY	OCTISALATE; ZINC OXIDE	50; 145	mg/mL; mg/mL			N	20241231
30142-221_63d8bc15-0bdd-4da7-b06e-2537fd88b143	30142-221	HUMAN OTC DRUG	Kroger Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190920		UNAPPROVED DRUG OTHER		THE KROGER CO	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
30142-223_f21502e4-736b-05c7-e053-2a95a90a9336	30142-223	HUMAN OTC DRUG	Natural Adult Fluoride		Sodium monofluorophosphate	PASTE	DENTAL	20200602		OTC MONOGRAPH FINAL	part355	Kroger	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
30142-226_7c639af6-8978-4c02-a420-3d62c0c43b7c	30142-226	HUMAN OTC DRUG	Creamy Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	19940619		OTC MONOGRAPH FINAL	part347	Kroger Co.	ZINC OXIDE	13	kg/100kg			N	20241231
30142-229_0c05e1f7-a3d0-8e69-e063-6394a90aecc3	30142-229	HUMAN OTC DRUG	EZ NITE SLEEP		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20190425		OTC MONOGRAPH DRUG	M010	THE KROGER CO.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-232_f0d69552-16af-4e34-e053-2a95a90a4104	30142-232	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20210824		ANDA	ANDA090397	KROGER COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-233_aae76ebe-e6e9-4ba8-89bf-bc878bf6e3ed	30142-233	HUMAN OTC DRUG	Kroger Daytime and Nighttime Cold and Flu Softgel		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, Doxylamine Succinate	KIT		20220831		OTC MONOGRAPH FINAL	part341	The Kroger Company						N	20241231
30142-237_f720002b-cc0b-6dcb-e053-6394a90a3a73	30142-237	HUMAN OTC DRUG	Kroger Baby Sunscreen SPF 50		Avobenzone, Homosalate ,Octisalate, Octocrylene	SPRAY	TOPICAL	20191125		OTC MONOGRAPH FINAL	M020	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 130; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
30142-239_f71ee5a4-6ee7-2283-e053-6294a90a33b0	30142-239	HUMAN OTC DRUG	Kroger Invisible Sunscreen SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20190927		OTC MONOGRAPH FINAL	M020	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 110; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-240_f76e2831-5c71-7a62-e053-6294a90a937b	30142-240	HUMAN OTC DRUG	Kroger Sunscreen Oil SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190927		OTC MONOGRAPH FINAL	M020	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-241_f76fa137-4bac-076a-e053-6394a90a6e12	30142-241	HUMAN OTC DRUG	Kroger Shimmer Sunscreen Hydrating SPF 40		AVOBENZONE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20220824		OTC MONOGRAPH FINAL	M020	THE KROGER COMPANY	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
30142-248_1fbd5435-0409-4fe5-a596-7d672e438696	30142-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20090105		OTC MONOGRAPH FINAL	part341	Kroger Co	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
30142-251_cebbf4bd-5103-4eec-9afc-2f6a1a84e40d	30142-251	HUMAN OTC DRUG	arthricream		Trolamine Salicylate	CREAM	TOPICAL	19920204	20241031	OTC MONOGRAPH NOT FINAL	part348	Kroger Company	TROLAMINE SALICYLATE	10	g/100g			N	
30142-252_0c03089e-e915-d0b2-e063-6294a90ab34f	30142-252	HUMAN OTC DRUG	Kroger Complete Lice Treatment Kit		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20231001		OTC MONOGRAPH DRUG	M031	The Kroger Co						N	20241231
30142-253_0bf16c90-0bd7-c464-e063-6294a90ad9cc	30142-253	HUMAN OTC DRUG	Kroger Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	The Kroger Co	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
30142-255_ee65d22f-4b28-4a0a-b6e7-11e2aec75f2a	30142-255	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20100515		ANDA	ANDA075217	Kroger Company	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-258_603b1380-1d07-6016-b14a-e5560204a6ee	30142-258	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20210212		ANDA	ANDA208150	Kroger Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
30142-261_18de21e4-44e4-d851-435c-50406db04973	30142-261	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190315		ANDA	ANDA207673	The Kroger Co.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-264_9d2c8eaa-a01e-4fde-aef2-7abc4e04a523	30142-264	HUMAN OTC DRUG	Daily Acne Control Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20140818		OTC MONOGRAPH FINAL	part333D	Kroger Inc	BENZOYL PEROXIDE	100	mg/g			N	20241231
30142-273_d22fc7ef-2156-468b-80bf-c027cb578635	30142-273	HUMAN OTC DRUG	esomeprazole magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220513		ANDA	ANDA207193	Kroger Company	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-279_120e1f55-59fb-4c4f-a96e-04fdd1f839a2	30142-279	HUMAN OTC DRUG	hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140823		OTC MONOGRAPH FINAL	part346	Kroger Company	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-285_f0fa8adc-3f3b-69aa-e053-2995a90a80d8	30142-285	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190201		NDA	NDA021920	KROGER COMPANY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-288_ec7d992b-1d45-b01b-5a59-e6b67d25cad7	30142-288	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220110		ANDA	ANDA202194	Kroger Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-292_166db21c-7c77-489c-b614-fa37c1c87f07	30142-292	HUMAN OTC DRUG	Kroger Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20210129		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-294_57e594c2-69f4-4272-a3bf-400a70606dbb	30142-294	HUMAN OTC DRUG	hair regrowth treatment for men		Minoxidil	AEROSOL, FOAM	TOPICAL	20120410		ANDA	ANDA091344	Kroger Company	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
30142-296_d3570e5d-d11f-43a1-bf1c-7688244c0f51	30142-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20110401		OTC MONOGRAPH FINAL	part358H	The Kroger Co	PYRITHIONE ZINC	10	mg/mL			N	20241231
30142-299_e51a3c49-f035-45e5-883f-e0911f648551	30142-299	HUMAN OTC DRUG	Alcohol Free Antiseptic		cetylpyridinium chloride	MOUTHWASH	ORAL	20090515		OTC MONOGRAPH NOT FINAL	part356	Kroger Co	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
30142-300_78ba685b-bc66-4924-b015-a00646183059	30142-300	HUMAN OTC DRUG	Kroger Ultra Strength	Assorted Berry	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH FINAL	part331	KROGER COMPANY	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
30142-303_c00797cf-292b-437d-8119-1645abb0f989	30142-303	HUMAN OTC DRUG	nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20160621		OTC MONOGRAPH FINAL	part341	Kroger Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
30142-304_af2b34b9-b4f6-4f8e-aaea-bb7e29789e2b	30142-304	HUMAN OTC DRUG	Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	19901115		OTC MONOGRAPH FINAL	part341	Kroger Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
30142-305_1bbb740a-74f4-4b17-9a51-a136d53ee75d	30142-305	HUMAN OTC DRUG	Kroger	ATHLETES FOOT	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Kroger Company	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
30142-306_ccbe0ce6-dedc-48b8-9cd8-2936905023a1	30142-306	HUMAN OTC DRUG	gentle lax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	Kroger Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-307_de0772e9-f64b-4a9c-83cd-238773e39890	30142-307	HUMAN OTC DRUG	Kroger Ultra Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190521		OTC MONOGRAPH FINAL	part331	KROGER COMPANY	CALCIUM CARBONATE	1000	mg/1			N	20241231
30142-309_9d221fab-805d-49a3-8aaa-c0ea6486eb5b	30142-309	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170425		ANDA	ANDA206393	Kroger Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-311_5a015634-29ed-4f44-8b5e-db61d6805ad9	30142-311	HUMAN OTC DRUG	Everyday Clean		Pyrithione Zinc	SHAMPOO	TOPICAL	20110401		OTC MONOGRAPH FINAL	part358H	Kroger Co	PYRITHIONE ZINC	10	mg/mL			N	20241231
30142-318_df498cec-99eb-479f-bd07-3f5c64379c02	30142-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19910615		OTC MONOGRAPH NOT FINAL	part356	Kroger Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-322_89a77349-9ee1-4de9-83ab-5f61ac4223ca	30142-322	HUMAN OTC DRUG	Cold Sore Fever Blister		Docosanol	CREAM	TOPICAL	20200701		ANDA	ANDA208754	The Kroger Co.	DOCOSANOL	100	mg/g			N	20241231
30142-324_75398a28-ad98-4495-a57c-bd317bab7d52	30142-324	HUMAN OTC DRUG	Kroger Stomach Relief		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20200331		OTC MONOGRAPH FINAL	part335	KROGER COMPANY	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
30142-326_f38fa9b5-d9ee-4233-92cd-74bf9382f898	30142-326	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130801		OTC MONOGRAPH NOT FINAL	part356	Kroger Co.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-330_63d21ecc-ea5d-45bd-bdf3-930b405243b9	30142-330	HUMAN OTC DRUG	Kroger Extra Strength		Simethicone Antigas	CAPSULE, LIQUID FILLED	ORAL	20200331		OTC MONOGRAPH FINAL	part332	KROGER COMPANY	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
30142-333_0cfa1586-42f7-ba69-e063-6394a90ab310	30142-333	HUMAN OTC DRUG	Kroger High Performance Lubricant Eye Drops		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20220305		OTC MONOGRAPH DRUG	M018	Kroger	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
30142-335_e7af2f0f-e0c9-4508-a4aa-4ee9a2d0c4e5	30142-335	HUMAN OTC DRUG	Nighttime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110827		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-344_92905bdf-11d3-4a98-84db-965033386cd0	30142-344	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20070427		ANDA	ANDA077007	Kroger Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-349_0cfa1586-42f8-ba69-e063-6394a90ab310	30142-349	HUMAN OTC DRUG	Kroger Eye Drops Seasonal Relief		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20230323		OTC MONOGRAPH DRUG	M018	Kroger	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
30142-359_927a3194-abdb-42a7-a5d0-2c1f4c0d97be	30142-359	HUMAN OTC DRUG	Tussin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19911104		OTC MONOGRAPH FINAL	part341	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-362_f200b471-d49c-4717-e053-2995a90a7814	30142-362	HUMAN OTC DRUG	Kroger Enamel Protection Sensitive	Gentle Whitening	Potassium nitrate, sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190225		OTC MONOGRAPH NOT FINAL	part356	Kroger Company	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
30142-367_bf844708-79b4-4c2b-bf27-199d0c91f780	30142-367	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210503		OTC MONOGRAPH DRUG	M010	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-369_9c52bca4-c3aa-491b-b405-465805576a13	30142-369	HUMAN OTC DRUG	hydrocortisone 1		Hydrocortisone	CREAM	TOPICAL	20190603		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
30142-370_b107fff1-e897-48bb-80b5-6f065426c4e8	30142-370	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, COATED	ORAL	20110110	20240223	OTC MONOGRAPH NOT FINAL	part343	The Kroger Co.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
30142-371_ca95dc3f-135d-420b-a68b-b834ba3b691e	30142-371	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20160331	20240223	OTC MONOGRAPH FINAL	part335	The Kroger Co.	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
30142-372_df394abb-a21f-4249-9813-0db2e408d068	30142-372	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20151031	20250530	OTC MONOGRAPH FINAL	part335	The Kroger Co.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
30142-373_0cfa7760-7b53-d0b6-e063-6294a90a1fef	30142-373	HUMAN OTC DRUG	Kroger Lubricant Eye		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20150601		OTC MONOGRAPH DRUG	M018	The Kroger Co.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
30142-375_67bffa9f-55b4-4eb5-9f6a-4168ebf79314	30142-375	HUMAN OTC DRUG	EZ Nite Sleep		Diphenhydramine HCl	LIQUID	ORAL	20150331	20240329	OTC MONOGRAPH FINAL	part341	The Kroger Co.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
30142-383_d2a07e41-c88b-49d2-8c29-c848817afae0	30142-383	HUMAN OTC DRUG	naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20190620		ANDA	ANDA208499	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-384_94c99b43-07a7-4f3b-b3be-24cd37e9a5c7	30142-384	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120828		ANDA	ANDA091135	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-386_038e8ab0-6244-4533-8d57-828d6babe82f	30142-386	HUMAN OTC DRUG	Sleep Aid		Doxylamine succinate	TABLET	ORAL	20210316		ANDA	ANDA040564	Kroger Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
30142-388_40dc1d36-58f0-4ff1-8365-f162666a5862	30142-388	HUMAN OTC DRUG	nasal		Oxymetazoline HCl	SPRAY	NASAL	20021120		OTC MONOGRAPH FINAL	part341	Kroger Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
30142-390_01f90bf4-b5f8-4edd-856d-1653f65ebc42	30142-390	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20190603		OTC MONOGRAPH DRUG	M013	Kroger Company	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
30142-391_10193524-01d6-4c49-9ee1-ef4f1ec20a15	30142-391	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20210526		OTC MONOGRAPH DRUG	M013	Kroger Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20251231
30142-394_f8534a01-e3d1-4c2d-8285-dac336362f55	30142-394	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180410		NDA	NDA209400	Kroger Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-398_c9bce135-e1e4-4faa-b74c-22f69a060a3e	30142-398	HUMAN OTC DRUG	Eye Itch Relief		ketotifen fumarate	SOLUTION/ DROPS	OPHTHALMIC	20220601		NDA	NDA021996	Kroger Company	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
30142-402_8a6becba-8a85-4e31-9e92-e24627847494	30142-402	HUMAN OTC DRUG	childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20191009		ANDA	ANDA076359	Kroger Company	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-407_08649f4b-9276-f53f-e063-6394a90a023a	30142-407	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20200301		OTC MONOGRAPH DRUG	M007	KROGER COMPANY	DOCUSATE SODIUM	100	mg/1			N	20241231
30142-411_e567291e-ba64-4a4a-b259-f58aa70abacf	30142-411	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20170413		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
30142-415_e11fc990-e29c-4cd5-893f-5dbb52772ab0	30142-415	HUMAN OTC DRUG	sinus relief		acetaminophen, guaifenesin, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20191125		OTC MONOGRAPH FINAL	part341	Kroger Company						N	20241231
30142-421_efa2dd67-29f8-9c8f-e053-2a95a90a4f81	30142-421	HUMAN OTC DRUG	Kroger Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20150113		OTC MONOGRAPH FINAL	part343	Kroger Company	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
30142-423_42670fee-2881-47ec-8e69-becbd3ade181	30142-423	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, SUGAR COATED	ORAL	20011013		ANDA	ANDA074567	The Kroger Company	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-434_a1a1d47e-c41d-4532-bc7a-74fefa91b909	30142-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130801		OTC MONOGRAPH NOT FINAL	part356	Kroger Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-439_b969c7aa-1f34-4821-b3b1-e6fd5c121293	30142-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130115		OTC MONOGRAPH NOT FINAL	part333A	The Kroger CO.	ALCOHOL	700	mg/mL			N	20241231
30142-446_7259416e-3b4f-40aa-8fec-7072b7077d2d	30142-446	HUMAN OTC DRUG	allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20210604		ANDA	ANDA076011	Kroger Company	LORATADINE	10	mg/1			N	20241231
30142-447_87210e6e-8312-9d26-4381-b6836b9ab254	30142-447	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20150422		ANDA	ANDA076667	The Kroger Co.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-449_25816217-b652-413e-b87b-496f27f35d1b	30142-449	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	TABLET, CHEWABLE	ORAL	20210318		OTC MONOGRAPH DRUG	M013	Kroger Company	ACETAMINOPHEN	160	mg/1			N	20241231
30142-450_cd718ae3-9529-4629-9e86-9db8b3a9f082	30142-450	HUMAN OTC DRUG	all day allergy d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200402		ANDA	ANDA210719	Kroger Company	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-451_a432a879-9ed8-4996-8fc4-5a47f0299a8a	30142-451	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM	100	mg/1			N	20241231
30142-453_2db01a14-59f7-4a7f-a5c0-d46710588aa3	30142-453	HUMAN OTC DRUG	lice complete kit		piperonyl butoxide, pyrethrum extract	KIT		20180915		OTC MONOGRAPH FINAL	part358G	Kroger Company						N	20241231
30142-454_09fb4f9c-f0c1-4f54-9636-7b73ef00ac29	30142-454	HUMAN OTC DRUG	fast mucus relief		dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20190524		OTC MONOGRAPH FINAL	part341	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-455_f2165843-4ca4-442b-9086-d8073c011ec5	30142-455	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20131214		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
30142-459_9bc33c02-1a31-4a97-8afa-ef55cc5fe627	30142-459	HUMAN OTC DRUG	NightTime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110826		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-466_581c354e-0bf7-4418-ab98-fd40a7da7840	30142-466	HUMAN OTC DRUG	Sinus Plus Headache		Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210511		OTC MONOGRAPH DRUG	M012	Kroger Company	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-467_aa8fd578-4875-426a-a94e-9d874d803d91	30142-467	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19921006		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
30142-470_d1d536bf-06aa-4746-8dcc-be09bea58cde	30142-470	HUMAN OTC DRUG	Cold Multi-Symptom		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210512		OTC MONOGRAPH DRUG	M012	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-471_085eef86-2058-4a43-b023-efbadb5dacf4	30142-471	HUMAN OTC DRUG	Kroger Mucus Relief		Guaifenesin	TABLET	ORAL	20210127		OTC MONOGRAPH FINAL	part341	THE KROGER CO	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
30142-472_dda33150-4777-4b98-95bf-53d95a1751d2	30142-472	HUMAN OTC DRUG	Kroger Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20210310		OTC MONOGRAPH FINAL	part341	THE KROGER CO	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-475_6f4e8a17-9fca-4381-b487-f92dedfc7467	30142-475	HUMAN OTC DRUG	Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20151023		ANDA	ANDA204226	Kroger Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-481_c6a3c748-144b-4321-8b16-21f48461bc20	30142-481	HUMAN OTC DRUG	Kroger Extra Strength	Gas Relief	Simethicone Antigas	TABLET, CHEWABLE	ORAL	20200330		OTC MONOGRAPH FINAL	part332	KROGER COMPANY	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
30142-482_151183d7-d5e5-4450-8ec5-809a305ae4f8	30142-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20140507		OTC MONOGRAPH FINAL	part355	The Kroger Co	SODIUM FLUORIDE	.1	mg/mL			N	20241231
30142-485_f8249ab1-f449-400f-b5ee-22e63876619a	30142-485	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20160229	20240531	OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
30142-487_8dbccf92-1e3f-4e0e-8d7f-47db76c3294f	30142-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160630	20250630	OTC MONOGRAPH FINAL	part347	The Kroger Co.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
30142-494_edcbf3b1-819e-4873-b954-c6af366a5a06	30142-494	HUMAN OTC DRUG	cough dm		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20180628		ANDA	ANDA091135	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-496_05c61767-4653-48db-81a4-d54f05b68824	30142-496	HUMAN OTC DRUG	Daily Baby		Dimethicone	LOTION	TOPICAL	20220728		OTC MONOGRAPH FINAL	part347	Kroger Co	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
30142-505_f1938422-adf9-dc0c-aef4-b87982beff18	30142-505	HUMAN OTC DRUG	Heratburn Relief		Ranitidine	TABLET, COATED	ORAL	20110424		ANDA	ANDA078192	The Kroger Co.	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
30142-506_524fc57e-1c93-4944-8b51-9281e519c1a3	30142-506	HUMAN OTC DRUG	fast cold and flu relief		Acetaminophen, dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20170622		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-507_000e657c-d71f-4d22-960d-02d27ff9d9c4	30142-507	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20150818		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	500	mg/1			N	20241231
30142-508_a6057fe6-4774-4e27-9d16-590033b20f3a	30142-508	HUMAN OTC DRUG	Mucus Relief DM		Dextromethorphan Hydrobromide Guaifenesin	LIQUID	ORAL	20200901		OTC MONOGRAPH FINAL	part341	The Kroger Co.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-513_041c2a12-1fd4-49b3-8e4b-c4dfc46c3846	30142-513	HUMAN OTC DRUG	childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20191009		ANDA	ANDA076359	Kroger Company	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-514_f4614ab4-2726-46c8-ade9-38ff514fb724	30142-514	HUMAN OTC DRUG	anti diarrheal		loperamide HCl	SOLUTION	ORAL	20180611		ANDA	ANDA091292	Kroger Company	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
30142-516_a311f904-a0d6-4988-a69b-4d19f868ab46	30142-516	HUMAN OTC DRUG	tussin cf	non drowsy	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	19890915		OTC MONOGRAPH FINAL	part341	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-517_d9e7a8c1-51c8-40d2-868f-c9130fb40f45	30142-517	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060427		ANDA	ANDA077349	Kroger Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-520_87fbf8a5-0ebe-4ab6-af1d-6484cbf3d9fd	30142-520	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20161231	20250530	NDA	NDA021855	The Kroger Co.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	
30142-522_c57c96e6-d721-4178-80d8-f076439acc08	30142-522	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalat, Octocrylene	LOTION	TOPICAL	20211130		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-523_9bec2aac-7372-4cc9-bebb-49f095e1cdba	30142-523	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20100819		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	65	mL/100mL			N	20241231
30142-524_b5ada115-bbc7-4043-a7cc-0a6bf5c9af68	30142-524	HUMAN OTC DRUG	Kroger Digestive Relief		Bismuth Subsalicylate	TABLET, FILM COATED	ORAL	20200331		OTC MONOGRAPH FINAL	part335	KROGER COMPANY	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
30142-526_7d132c9a-70a2-418d-9b4d-0c075c1e93c3	30142-526	HUMAN OTC DRUG	Kroger		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20221003		NDA	NDA022015	KROGER COMPANY	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-529_142401b0-c852-4256-9754-7c5f371f9570	30142-529	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20181231	20250829	OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
30142-536_998e7a9e-feec-4a3e-87e4-7c91c1c33f42	30142-536	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20170419		OTC MONOGRAPH FINAL	part333B	Kroger Company	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
30142-539_755fbc57-718d-42d4-9894-45a289c542c5	30142-539	HUMAN OTC DRUG	nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20140218		OTC MONOGRAPH FINAL	part341	Kroger Company	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-541_78c34b69-83c4-4aa6-ac0c-360785e64fc9	30142-541	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20170405		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
30142-547_0994a032-bd01-d389-e063-6294a90afbe0	30142-547	HUMAN OTC DRUG	Milk of Magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20200301		OTC MONOGRAPH DRUG	M007	KROGER COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-549_2d42fca6-50df-4bc3-bc3b-3c724c30f3df	30142-549	HUMAN OTC DRUG	ez nite sleep		diphenhydramine hydrochloride	SOLUTION	ORAL	20190509		OTC MONOGRAPH FINAL	part338	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-553_2564c634-d6c0-4317-845a-4e46370b52e3	30142-553	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210528		OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM	100	mg/1			N	20241231
30142-554_45741d54-4211-49c6-b963-fd44b8b0e8f6	30142-554	HUMAN OTC DRUG	Kroger Allergy Relief		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210317		OTC MONOGRAPH FINAL	part341	THE KROGER CO	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-557_4e390c9f-df66-4288-a43a-078cb675782a	30142-557	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080225		NDA	NDA022032	Kroger Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-558_0a4bb769-5c75-4c54-aea4-39be1e91e5fb	30142-558	HUMAN OTC DRUG	Kroger Nighttime Sleep-Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210415		OTC MONOGRAPH FINAL	part338	THE KROGER CO	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-561_167af0f8-7d0e-44ba-ae99-27c690b98a63	30142-561	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	19870715		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	500	mg/1			N	20241231
30142-564_3d5f562a-31d8-42ec-9e24-bd474542c416	30142-564	HUMAN OTC DRUG	Kroger Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190920		UNAPPROVED DRUG OTHER		THE KROGER CO	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
30142-570_f21501ac-d3df-1800-e053-2a95a90ade03	30142-570	HUMAN OTC DRUG	Gum Purify		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220314		OTC MONOGRAPH NOT FINAL	part356	Kroger	STANNOUS FLUORIDE	.454	g/100g			N	20241231
30142-572_4a751ec2-49ae-465d-845e-7813b5e1551a	30142-572	HUMAN OTC DRUG	fast mucus relief		acetaminophen, dextromethporphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20190509		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-576_32e82163-ce81-461f-b2c0-ef4245f59340	30142-576	HUMAN OTC DRUG	Oral Antivavity		Sodium fluoride	MOUTHWASH	ORAL	20150206		OTC MONOGRAPH FINAL	part355	Kroger Co	SODIUM FLUORIDE	10.41	mg/mL			N	20241231
30142-581_9a0fb0d2-fcf8-432c-909f-bde0d8b30f56	30142-581	HUMAN OTC DRUG	Anti Diarrheal Anti Gas		Loperamide Hydrochloride, Simethicone	TABLET	ORAL	20190424		ANDA	ANDA209837	Kroger Company	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
30142-582_41080e60-0351-4d6a-9fed-e1c625a09134	30142-582	HUMAN OTC DRUG	anti itch		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20170330		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-583_f8716a41-3a1b-0a74-e053-6294a90af590	30142-583	HUMAN OTC DRUG	Kroger Pain Relief Lidocaine Patch		Lidocaine	PATCH	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
30142-584_87c98b55-6520-4a11-af45-318293e3ba0c	30142-584	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20171031	20240223	OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM	100	mg/1			N	
30142-586_6d2e479e-4d45-4ee2-bda2-800b4f1c9a2a	30142-586	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20190331		OTC MONOGRAPH NOT FINAL	part343	The Kroger Co.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
30142-589_9b6db68b-666f-4714-a05d-ce7529a51109	30142-589	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part333A	Krogers	ALCOHOL	545	mg/mL			N	20241231
30142-590_0c375de5-47dd-4398-9d0d-48f55694485e	30142-590	HUMAN OTC DRUG	pain and fever		acetaminophen	SUSPENSION	ORAL	19930331		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
30142-593_ae92443d-4c6e-45a7-b957-fa0d80dbaadf	30142-593	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20170209		NDA	NDA022032	Kroger Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-596_7b3d6260-0943-4f91-b9b4-6bccadfd5124	30142-596	HUMAN OTC DRUG	Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20120917		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	70	mL/100mL			N	20241231
30142-597_5859d838-0ea4-43c4-a36c-397bef0290ca	30142-597	HUMAN OTC DRUG	NightTime DayTime Severe Cold and Flu		acetaminophen, dextromethorphan HBr, doxylamine succinate, guaifenesin, phenylephrine HCl	KIT		20140924		OTC MONOGRAPH FINAL	part341	Kroger Company						N	20241231
30142-602_f0e75bb5-74ea-46a1-8377-3a513b2d6c29	30142-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	19931021		OTC MONOGRAPH NOT FINAL	part334	Kroger Co.	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-603_44f848a9-c69b-443d-8989-a076d3af9a99	30142-603	HUMAN OTC DRUG	daytime severe cold and flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20141010		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-604_7356cf54-ce69-43c5-ac2d-53d827d9c934	30142-604	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880115		ANDA	ANDA072096	Kroger Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-608_cdf68dbd-7dd3-4bfe-815e-6a8ef0d1f308	30142-608	HUMAN OTC DRUG	Kroger Regular Strength	Pink Bismuth	Bismuth Subsalicylate	SUSPENSION	ORAL	20200330		OTC MONOGRAPH FINAL	part335	KROGER COMPANY	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
30142-610_08135b12-cb18-4486-a36c-3a9c94c0c3b2	30142-610	HUMAN OTC DRUG	Kroger Extra Strength		aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	THE KROGER CO.,	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
30142-611_29c914f7-dfd8-2f34-2cab-9a239e6c58a9	30142-611	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20190115		ANDA	ANDA076667	The Kroger Co.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-612_53837a90-8a7c-42b0-af6c-10044ff8de34	30142-612	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20050822		ANDA	ANDA076301	Kroger Company	LORATADINE	10	mg/1			N	20241231
30142-613_36532e73-f960-44a9-899f-db7007ab90c5	30142-613	HUMAN OTC DRUG	sinus		Pseudoephedrine hydrochloride	TABLET, FILM COATED	ORAL	20200918		OTC MONOGRAPH FINAL	part341	Kroger Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-616_d5a461e4-b33a-400a-9a72-7df9905c2031	30142-616	HUMAN OTC DRUG	Sinus Relief	Daytime Nighttime	Acetaminophen, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20210601		OTC MONOGRAPH DRUG	M012	Kroger Company						N	20241231
30142-619_10fb04fa-4b9b-4a68-9f67-7e346c7a2deb	30142-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	19870715		OTC MONOGRAPH FINAL	part347	Kroger	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
30142-621_f200d820-4558-3077-e053-2a95a90a9e19	30142-621	HUMAN OTC DRUG	Kroger Company	Radiant White	Fluoride	PASTE, DENTIFRICE	DENTAL	20140224		OTC MONOGRAPH FINAL	part355	Kroger Company	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
30142-622_1eb35870-8718-47ae-bb36-093f4cbae68a	30142-622	HUMAN OTC DRUG	Cranberry Garland		Ethyl Alcohol	GEL	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Kroger, CO.,	ALCOHOL	62	mg/mL			N	20241231
30142-624_1fc45718-8a53-42e8-bc71-94e525d2dfa4	30142-624	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part335	The Kroger Co.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
30142-625_b6c58df0-0002-43d8-8621-e47b8ad19eda	30142-625	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20180430		OTC MONOGRAPH NOT FINAL	part343	The Kroger Co.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
30142-626_bd2e4c53-1581-4c5b-ae49-a3656da6cfea	30142-626	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201028		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
30142-628_caa07a5c-da10-463d-8f62-1237549f6cf9	30142-628	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20140826		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co.,	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
30142-630_56278c51-9c44-4329-9558-f11f08a1dbe8	30142-630	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20171213		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 150; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
30142-632_e128ee0c-e42e-4cf5-a337-2617435d9dad	30142-632	HUMAN OTC DRUG	hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20210513		ANDA	ANDA075598	Kroger Company	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
30142-634_f0c14c52-414c-492e-b28a-50e4d805bcdf	30142-634	HUMAN OTC DRUG	Night Time Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20200930		OTC MONOGRAPH DRUG	M012	The Kroger Co.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-635_f3fecbfc-bcd2-47df-9b9d-92b2483a7488	30142-635	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20181231	20240531	OTC MONOGRAPH FINAL	part338	The Kroger Co.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
30142-637_0994d113-ef58-2daa-e063-6394a90a030f	30142-637	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20210301		OTC MONOGRAPH DRUG	M001	KROGER COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-638_0994b9a4-bc60-566e-e063-6294a90afc18	30142-638	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20200301		OTC MONOGRAPH DRUG	M001	KROGER COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-639_0994d113-ef59-2daa-e063-6394a90a030f	30142-639	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID MINT		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20210301		OTC MONOGRAPH DRUG	M001	KROGER COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-641_82d49420-d332-468d-b382-1ac43a25dbaf	30142-641	HUMAN OTC DRUG	Sinus Decongestion		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20210413		OTC MONOGRAPH DRUG	M012	Kroger Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-647_f8cb0ac4-b0f0-415b-bcf4-fcef3a3cab7b	30142-647	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19901015		ANDA	ANDA072096	Kroger Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-649_0994a4fb-0736-0f98-e063-6394a90a8a58	30142-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20200301		OTC MONOGRAPH DRUG	M007	KROGER COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-651_94f92e26-fdfd-4458-a1a3-385b0aad1edc	30142-651	HUMAN OTC DRUG	childrens allergy		diphenhydramine hydrochloride	SOLUTION	ORAL	20200617		OTC MONOGRAPH FINAL	part341	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-656_5deba051-8078-464f-94f7-b3b85dfbf4a5	30142-656	HUMAN OTC DRUG	Day Time		acetaminophen, dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060611		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-657_64ee7a72-ceea-4b5e-905a-cc2a5272d8b9	30142-657	HUMAN OTC DRUG	gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20030124		OTC MONOGRAPH FINAL	part332	Kroger Company	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
30142-660_e5b4a041-8478-49d2-ad84-30ed520b445d	30142-660	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20021120		ANDA	ANDA074937	Kroger Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-663_f2bedd9e-a9ca-4bed-897e-620d34e28659	30142-663	HUMAN OTC DRUG	Crisp Apple Hand Sani		Ethyl Alcohol	LIQUID	TOPICAL	20140123		OTC MONOGRAPH NOT FINAL	part333A	Kroger	ALCOHOL	65	mL/100mL			N	20241231
30142-664_e86d0742-66b1-4ee1-b7be-b52c025787da	30142-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19940805		OTC MONOGRAPH NOT FINAL	part356	Kroger CO.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-666_1602d6ae-d82f-4fca-83c4-fc3490c0a153	30142-666	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20200930		OTC MONOGRAPH FINAL	part341	The Kroger Co.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-667_725490d8-e8b2-4aa7-a422-072ded904958	30142-667	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Phenylephrine HCI DoxylamineSucinate	KIT		20201030		OTC MONOGRAPH FINAL	part341	The Kroger Co.						N	20241231
30142-668_1497ba1f-5a74-4371-acb7-ffbf38ecb3a5	30142-668	HUMAN OTC DRUG	NightTime Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20021120		OTC MONOGRAPH FINAL	part341	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-671_21a3ab34-bd57-4771-851c-a29a8cfe5e11	30142-671	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20220603		ANDA	ANDA074707	The Kroger Co.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-679_3abf14ec-71e3-4f41-9c86-dee78e785b3a	30142-679	HUMAN OTC DRUG	Triple Antibiotic plus pain relief		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20170427		OTC MONOGRAPH FINAL	part333B	Kroger Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
30142-680_5c50a5c9-ca2b-4694-a4a0-c17c56db5cf8	30142-680	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20220225		OTC MONOGRAPH FINAL	part335	The Kroger Co.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
30142-687_a60b693d-2248-4b2b-b77e-a53545e5a325	30142-687	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	30; 150; 50; 60	mg/g; mg/g; mg/g; mg/g			N	20241231
30142-688_de6bdbfc-3af0-4350-b1cb-4a7190f39248	30142-688	HUMAN OTC DRUG	Sinus Relief		Acetaminophen, guaifenesin, diphenhydramine HCl, phenylephrine HCl	KIT		20150410		OTC MONOGRAPH FINAL	part341	Kroger Company						N	20241231
30142-690_5023f272-34b2-4cfe-a049-128285349612	30142-690	HUMAN OTC DRUG	Kroger Sheer dry-touch SFP 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part352	Krogers	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 8; 5; 4; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
30142-696_8df01884-92c8-4e5e-9740-d7b0a35c1d95	30142-696	HUMAN OTC DRUG	nicotine		nicotine polacrilex	LOZENGE	ORAL	20190417		ANDA	ANDA203690	Kroger Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-697_6c61fde6-fddc-4c29-a30c-1b9a4fd52460	30142-697	HUMAN OTC DRUG	lidocaine		lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20190517		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	LIDOCAINE	4	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
30142-698_b8ddb555-cd95-4a43-9b14-06d5594c1ef9	30142-698	HUMAN OTC DRUG	Cold and Flu HBP		Acetaminophen, Chlorpheniramine maleate	TABLET, FILM COATED	ORAL	20220414		OTC MONOGRAPH DRUG	M012	Kroger Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	325; 2	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-704_8c085001-2fd7-465d-99cc-4dec9c3fae84	30142-704	HUMAN OTC DRUG	daytime cold and flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20140930		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-708_a3fc2487-e443-4d44-8d75-289e1ca82a6d	30142-708	HUMAN OTC DRUG	Kroger Anti Nausea	Cherry Flavor	Dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20200331		UNAPPROVED DRUG OTHER		KROGER COMPANY	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
30142-710_9a92e6c7-6f79-4e52-85da-c0f1baf618a7	30142-710	HUMAN OTC DRUG	Kroger Senna Laxative	Regular Strength	Sennosides	TABLET	ORAL	20200428		OTC MONOGRAPH NOT FINAL	part334	KROGER COMPANY	SENNOSIDES	8.6	mg/1			N	20241231
30142-711_2e34a175-38c1-4df5-8f4b-b57b565e9a19	30142-711	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.9; 133.9; 51.5; 72.1; 41.2	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-714_841c1c3c-9191-4629-96f3-4c14d3dc7314	30142-714	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20161128		OTC MONOGRAPH DRUG	M007	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-715_4be5f705-6acb-465c-bc0e-b4c487fc5a84	30142-715	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCL	CAPSULE	ORAL	20210326		OTC MONOGRAPH FINAL	part338	The Kroger Co.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-716_51d40a20-6d7d-4f43-b5a0-5447b0384273	30142-716	HUMAN OTC DRUG	Severe Cold and Flu Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, GUAIFENESIN PHENYLEPHRINE HCL	LIQUID	ORAL	20180331	20250331	OTC MONOGRAPH FINAL	part341	The Kroger Co.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
30142-717_4357a298-7d61-3959-4b1b-978161cc5096	30142-717	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180930		ANDA	ANDA210375	KROGER COMPANY	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-718_daec9a7f-dcec-4daa-a0d4-e14237f31338	30142-718	HUMAN OTC DRUG	Kroger	No Drip	Allergy Sinus	SPRAY	NASAL	20200904		OTC MONOGRAPH FINAL	part341	KROGER COMPANY	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
30142-719_7214bcc4-79e5-4343-aa18-6075d5c45bab	30142-719	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20180522		ANDA	ANDA091344	Kroger Company	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
30142-720_1f8c321e-1b76-4180-b797-714b76fa3487	30142-720	HUMAN OTC DRUG	acetaminophen and ibuprofen		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230516		ANDA	ANDA214836	Kroger Company	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-722_1980fa67-3476-4f79-8d0e-92e2cc442799	30142-722	HUMAN OTC DRUG	Daytime Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, GUAIFENESIN PHENYLEPHRINE HCL	LIQUID	ORAL	20200128		OTC MONOGRAPH FINAL	part341	The Kroger Co.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-723_84ae0ea9-82ae-4f98-a919-56c004444596	30142-723	HUMAN OTC DRUG	childrens allergy relief		loratadine	SOLUTION	ORAL	20200730		ANDA	ANDA075728	Kroger Company	LORATADINE	5	mg/5mL			N	20241231
30142-724_30f55072-7961-4219-ab30-6675c87cc603	30142-724	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	The Kroger Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-725_bb3d2b9a-ef7d-4a7b-9604-582780396ea0	30142-725	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20231025		ANDA	ANDA090962	The Kroger Co.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
30142-726_7f28f629-6deb-4b92-9db5-255dee72d80c	30142-726	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	20190603		OTC MONOGRAPH DRUG	M011	Kroger Company	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
30142-727_5d6f3b1e-c17f-4fd6-a1b8-3c0654e46a3c	30142-727	HUMAN OTC DRUG	Sinus Congestion and Pain		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20190531		OTC MONOGRAPH DRUG	M012	Kroger Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-728_a6e9518a-3ac3-49f3-a0ae-d85376f3b4bf	30142-728	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20231031		ANDA	ANDA202300	The Kroger Co.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-730_d7d50194-860b-4c83-9a36-7a9f7186b1fd	30142-730	HUMAN OTC DRUG	Kroger Odor Free Arthricream Rub Pain Relieving		Trolamine Salicylate 10%	CREAM	TOPICAL	20220530		OTC MONOGRAPH NOT FINAL	part348	THE KROGER CO	TROLAMINE SALICYLATE	100	mg/g			N	20241231
30142-731_aa3d6418-1b9c-4c3b-885d-5689b2dc5676	30142-731	HUMAN OTC DRUG	Maximum Strength Cold Flu and Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20200903		OTC MONOGRAPH FINAL	part341	KROGER COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-733_c1ffbffa-3a64-4879-996f-8a95b114eb35	30142-733	HUMAN OTC DRUG	Night Time Day Time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20130914		OTC MONOGRAPH FINAL	part341	Kroger Company						N	20241231
30142-736_3c27d20d-479c-4782-87ce-53ec72e254d9	30142-736	HUMAN OTC DRUG	Maximum Strength Nighttime Cold and Flu		Acetaminophen , Diphenhydramine HCl,Phenylephrine HCl	LIQUID	ORAL	20200904		OTC MONOGRAPH FINAL	part341	THE KROGER CO	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-738_2445536f-0bff-401f-901b-f691e6a94e0d	30142-738	HUMAN OTC DRUG	Kroger Maximum Strength Severe Congestion and Cough		Dextromethorphan HBr, Guaifenesin, and Phenylephrine HCl	LIQUID	ORAL	20200903		OTC MONOGRAPH FINAL	part341	KROGER COMPANY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-740_ad552750-269e-4e07-bf9f-5ed28fcd68ec	30142-740	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20211231		ANDA	ANDA212385	The Kroger Co.	DOCOSANOL	100	mg/g			N	20241231
30142-741_cf681f82-6b6f-4dc8-9c5a-7f8aa74e3ff8	30142-741	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180228	20250228	ANDA	ANDA207235	The Kroger Co.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
30142-743_b51cbecf-db0b-427c-8299-12aa054ceeee	30142-743	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190930		ANDA	ANDA206568	The Kroger Co.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-745_71ec990d-00d1-4fdb-94da-4e2f421aaffa	30142-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	The Kroger Co.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-747_c1390f48-d7a5-4258-9048-7ee35f8b0a76	30142-747	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl, Menthol	GEL	TOPICAL	20211124		OTC MONOGRAPH NOT FINAL	part348	The Kroger Co	LIDOCAINE HYDROCHLORIDE; MENTHOL	7; 2	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
30142-748_e02ba5d6-1d30-4bea-abd8-1327807e280c	30142-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401	20240531	ANDA	ANDA208363	The Kroger Co.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
30142-749_420dcf9f-3a4a-4afe-a327-cd454690ad4b	30142-749	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190312		ANDA	ANDA206394	Kroger Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-750_01cc030f-6b09-4fcf-8c39-0d1aa55b6c35	30142-750	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180831	20240531	ANDA	ANDA206999	The Kroger Co.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
30142-752_0055b3d0-bdc7-433d-ab4d-1047dae6d241	30142-752	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20230131		OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	SENNOSIDES	8.6	mg/1			N	20241231
30142-753_00b2e777-2778-4865-8cfa-a340b8e1f0ae	30142-753	HUMAN OTC DRUG	naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET	ORAL	20190620		ANDA	ANDA208499	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-757_541a46f7-147c-49d1-be1c-0c64f650728a	30142-757	HUMAN OTC DRUG	Urinary Pain Relief		Phenazopyridine Hydrochloride	TABLET	ORAL	20210501		UNAPPROVED DRUG OTHER		KROGER COMPANY	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
30142-763_54ed605c-c736-41e4-a6a8-f9b8cc501db9	30142-763	HUMAN OTC DRUG	NightTime Severe Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20140813		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-764_88249e08-72ed-4c7b-9937-38da2809ad8a	30142-764	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.6; 119; 45.9; 45.9; 55.08	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-766_7a8098f9-3ba0-477d-bc6a-cc8bb1e2701e	30142-766	HUMAN OTC DRUG	infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20120315		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
30142-775_78e445fa-60c0-48d4-96a3-bfd711300a8f	30142-775	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20200506		ANDA	ANDA076497	Kroger Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
30142-776_ca9e78a2-4703-481e-bc1d-3b84b84d0a16	30142-776	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20180224		OTC MONOGRAPH NOT FINAL	part333A	Kroger	ALCOHOL	62	mg/mL			N	20241231
30142-777_a2e06e41-17b4-42dc-b89a-f3a15fbdd3bc	30142-777	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20180224		OTC MONOGRAPH NOT FINAL	part333A	Kroger	ALCOHOL	62	mg/mL			N	20241231
30142-778_c1088f0a-ab15-472c-92b9-248c274986ec	30142-778	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20171031		OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM	100	mg/1			N	20241231
30142-786_45d5ccfe-4d6e-4923-8d1b-25e070153d80	30142-786	HUMAN OTC DRUG	allergy and congestion relief		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180518		ANDA	ANDA076050	Kroger Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-788_09255423-f973-44da-9068-40570c646f47	30142-788	HUMAN OTC DRUG	Clean Apple		Pyrithione zinc	SHAMPOO	TOPICAL	20131206		OTC MONOGRAPH FINAL	part358H	Kroger	PYRITHIONE ZINC	1	g/mL			N	20241231
30142-790_e337150a-0c3c-41c8-bc20-026f1b6f3f89	30142-790	HUMAN OTC DRUG	antibiotic plus pain relief		Neomycin, Polymyxin B, Pramoxine Hydrochloride	CREAM	TOPICAL	20190214		OTC MONOGRAPH FINAL	part333B	Kroger Company	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
30142-791_f4eb632b-0096-8e20-e053-2995a90a6e58	30142-791	HUMAN OTC DRUG	KROGER MEDICATED WIPES	HEMORRHOIDAL WIPE WITH WITCH HAZEL AND ALOE	witch hazel cloth	SWAB	TOPICAL	20230101		OTC MONOGRAPH FINAL	part346	The Kroger Co.	WITCH HAZEL	.5	g/g			N	20241231
30142-797_c10c8e76-ac49-4f73-9fbb-75bc17f969a8	30142-797	HUMAN OTC DRUG	nicotine		nicotine polacrilex	LOZENGE	ORAL	20190417		ANDA	ANDA203690	Kroger Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-803_97bdc298-58ad-4e20-af73-486cdbdc91b6	30142-803	HUMAN OTC DRUG	Winter Apple		Hand Sanitizer	GEL	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Kroger, CO.,	ALCOHOL	62	mg/mL			N	20241231
30142-804_776c6e35-ff80-427d-9cd5-7ce36c030e1f	30142-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
30142-805_a52465a7-7c9d-64d6-e053-2a95a90afd01	30142-805	HUMAN OTC DRUG	KROGER BABY SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20171023		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
30142-806_30a8b10e-ea11-4c61-89b1-4c223c5c7bcd	30142-806	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20191228		OTC MONOGRAPH NOT FINAL	part334	Krogers	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-808_a5256f15-9109-2d91-e053-2a95a90a5503	30142-808	HUMAN OTC DRUG	KROGER SPORT SPF 15 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20171102		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
30142-809_0d726a35-5812-c382-e063-6294a90a6a39	30142-809	HUMAN OTC DRUG	Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20100331		OTC MONOGRAPH DRUG	M003	The Kroger Company	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
30142-810_724f3fce-8076-4772-b027-0e3ddb3af8d9	30142-810	HUMAN OTC DRUG	70% Isopropyl Rubbing Alcohol		Isopropyl Rubbing Alcohol	SOLUTION	TOPICAL	20150828		OTC MONOGRAPH NOT FINAL	part333A	Kroger CO	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
30142-812_baf180e2-e004-59fe-e053-2995a90a1f94	30142-812	HUMAN OTC DRUG	SIMPLE TRUTH MINERAL BASED SPF 30 SUNSCREEN		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20180926		OTC MONOGRAPH FINAL	part347	THE KROGER COMPANY	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/mL; mg/mL			N	20241231
30142-813_c50d790b-a7cb-4cde-adeb-8628afb47d61	30142-813	HUMAN OTC DRUG	nasal allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20200317		ANDA	ANDA078104	Kroger Company	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
30142-814_a52757bb-2a2a-41cb-e053-2a95a90ad5cb	30142-814	HUMAN OTC DRUG	KROGER DRY TOUCH ULTRA SHEER SPF 70 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20161128		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-815_c704e066-ae6e-e927-e053-2995a90ae799	30142-815	HUMAN OTC DRUG	KROGER TANNING SPF 15 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20171103		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
30142-816_1ce83456-2860-4b58-9d06-384fed6923da	30142-816	HUMAN OTC DRUG	Dandruff		Selenium sulfide	SHAMPOO	TOPICAL	20130601		OTC MONOGRAPH FINAL	part358H	Kroger	SELENIUM SULFIDE	10	mg/mL			N	20241231
30142-817_a59c19eb-68b8-44c7-af2d-0ea1002d28c6	30142-817	HUMAN OTC DRUG	Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20010924		OTC MONOGRAPH FINAL	part341	Kroger Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
30142-818_ff0c86ed-9901-4479-871f-60832a06b808	30142-818	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20140212		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
30142-819_08a348a0-009f-4f33-e063-6394a90ad6ed	30142-819	HUMAN OTC DRUG	SIMPLE TRUTH MINERAL BASED SPF 50 SUNSCREEN		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20180920		OTC MONOGRAPH DRUG	M020	THE KROGER COMPANY	TITANIUM DIOXIDE; ZINC OXIDE	30; 150	mg/mL; mg/mL			N	20241231
30142-820_a55f0079-0bb4-7400-e053-2a95a90aa5b6	30142-820	HUMAN OTC DRUG	KROGER KIDS SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20161130		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-821_a55f9eb9-9c27-71d4-e053-2995a90a80a1	30142-821	HUMAN OTC DRUG	KROGER BABY SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20161130		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-822_d48ce51e-7aa7-4e60-8be0-e075915e3403	30142-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	19890715		OTC MONOGRAPH FINAL	part346	Kroger Co	WITCH HAZEL	979	mg/mL			N	20241231
30142-825_4f5abe8d-92ee-4fdc-bd96-95049a2f1076	30142-825	HUMAN OTC DRUG	Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20020715		ANDA	ANDA074760	Kroger Company	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
30142-826_e789d804-e155-4c04-8fa3-64024064f4e2	30142-826	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20140909		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co.,	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
30142-827_af151874-74bc-47cd-a005-bf8dc847d8d8	30142-827	HUMAN OTC DRUG	Laxative	Gentle	Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Kroger Company	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-828_b74f0892-9b7b-4b58-bddd-feaf50f2d931	30142-828	HUMAN OTC DRUG	Sinus Relief Pressure and Pain		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20190603		OTC MONOGRAPH DRUG	M012	Kroger Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-830_f782d1cb-5901-4e18-940d-9a4ac1e191d0	30142-830	HUMAN OTC DRUG	Senna S		Docusate Sodium, Sennosides	TABLET	ORAL	20190131	20250530	OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
30142-831_87ca4adb-48a9-452d-9d4d-434dc729844f	30142-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part334	Kroger Co	MINERAL OIL	999	mg/mL			N	20241231
30142-833_11a4e5ca-9e3d-478b-8ed3-66dce627a5ad	30142-833	HUMAN OTC DRUG	tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220607		OTC MONOGRAPH FINAL	part341	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-834_02a408ff-6235-4842-97b0-c2f1139fddd7	30142-834	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	62	mL/100mL			N	20241231
30142-835_c237eeb1-b6d7-49b6-acdf-34dea65b6484	30142-835	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20180430	20241227	OTC MONOGRAPH FINAL	part338	The Kroger Co.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
30142-836_0cfa7760-7b54-d0b6-e063-6294a90a1fef	30142-836	HUMAN OTC DRUG	Kroger Eye Drops Advanced Relief		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	Kroger Company	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
30142-840_f2f53cf9-3714-07ff-e053-2a95a90a03fb	30142-840	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20220411		OTC MONOGRAPH FINAL	part333C	Kroger Co.	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
30142-841_f5c8dd16-e954-ff6e-e053-2a95a90a8c40	30142-841	HUMAN OTC DRUG	Tolnaftate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20220311		OTC MONOGRAPH FINAL	part333C	Kroger Co.	TOLNAFTATE	1.3	g/130g			N	20241231
30142-842_830492d8-db41-410c-bec6-eaae4d809ccc	30142-842	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	62	mL/100mL			N	20241231
30142-843_de6c1f78-dcd6-4af0-b505-e8af923886a9	30142-843	HUMAN OTC DRUG	tussin dm max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180628		OTC MONOGRAPH FINAL	part341	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-845_611560fa-e48b-4670-a8cb-9abb1acd3b20	30142-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19890715		OTC MONOGRAPH FINAL	part344	Kroger Co	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
30142-847_e1070003-915f-423b-8649-1572bfa6407f	30142-847	HUMAN OTC DRUG	Allergy		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20190716		OTC MONOGRAPH FINAL	part341	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-848_dd9e25ed-653b-4781-9905-a5e15f723c02	30142-848	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190605		ANDA	ANDA206393	Kroger Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-849_48e07287-535d-4895-ba2a-48ec9b504f5f	30142-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201214		OTC MONOGRAPH NOT FINAL	part333A	Kroger	ALCOHOL	62	mL/100mL			N	20241231
30142-853_39947ed3-979c-4c9e-b6a0-6e15270a9f5f	30142-853	HUMAN OTC DRUG	Sinus Congestion		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210319		OTC MONOGRAPH DRUG	M012	Kroger Company	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-855_c255a15b-48af-49d5-b1c0-65211517827b	30142-855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20221014		OTC MONOGRAPH NOT FINAL	part356	The Kroger Co.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-859_52bc8185-39a9-46b2-bda6-c266ca9a2f0f	30142-859	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20220603		ANDA	ANDA074507	The Kroger Co.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-865_32bf7817-5731-476a-82b4-4b81f3e77f91	30142-865	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200430		OTC MONOGRAPH NOT FINAL	part343	The Kroger Co.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
30142-866_3ce18db5-0dce-420b-bdab-f7c0799fdf3d	30142-866	HUMAN OTC DRUG	lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070713		OTC MONOGRAPH FINAL	part358G	Kroger Company	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
30142-869_480fb43e-9f65-4229-ae8f-42ad078324b6	30142-869	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230714		ANDA	ANDA212385	The Kroger Co.	DOCOSANOL	100	mg/g			N	20241231
30142-870_ea2d3214-396b-df50-e053-2995a90aaa1e	30142-870	HUMAN OTC DRUG	Kroger Dual Effects Moisturizer		Salicylic Acid	LOTION	TOPICAL	20180426		OTC MONOGRAPH FINAL	part358F	THE KROGER CO	SALICYLIC ACID	5	mg/mL			N	20241231
30142-871_439d9cc0-2d60-4e79-ae39-581ebc8dfcf1	30142-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20170709		OTC MONOGRAPH NOT FINAL	part333A	Kroger Co.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
30142-873_1c7b77a7-bf22-442b-b6fc-e52098604e63	30142-873	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	LOZENGE	ORAL	20070427		ANDA	ANDA077007	Kroger Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
30142-875_b4e00116-ec99-192c-e053-2a95a90aa117	30142-875	HUMAN OTC DRUG	Kroger Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20140421		OTC MONOGRAPH FINAL	part341	Kroger Company	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-876_6db79f71-210c-4f5c-9c80-c9fe9149cb3a	30142-876	HUMAN OTC DRUG	Senna S Dual Action		Docusate Sodium Sennosides	TABLET	ORAL	20191129	20250530	OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
30142-877_020fad02-6e96-47ab-8e51-0b8dec48625b	30142-877	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20150106		OTC MONOGRAPH FINAL	part333D	Kroger	BENZOYL PEROXIDE	1	mg/g			N	20241231
30142-878_278200e2-32d4-bc93-8e87-7baa720fde9a	30142-878	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20180930		ANDA	ANDA076502	KROGER COMPANY	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-879_a4d7a858-0f35-82bd-e053-2a95a90a07c9	30142-879	HUMAN OTC DRUG	DAILY SPF 15		AVOBENZONE, OCTINOXATE, OCTISALATE	LOTION	TOPICAL	20180607		OTC MONOGRAPH NOT FINAL	part352	THE KROGER CO	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
30142-881_bfe1e380-a4a5-4515-e053-2995a90a827f	30142-881	HUMAN OTC DRUG	MINERAL BASED SPF 50 SUNSCREEN		ZINC OXIDE, TITANIUM DIOXIDE	STICK	TOPICAL	20181206		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	TITANIUM DIOXIDE; ZINC OXIDE	70; 47	mg/g; mg/g			N	20241231
30142-883_849dc3c6-12df-4b9c-a64d-ef27c6e65227	30142-883	HUMAN OTC DRUG	Senna S Dual Action		Docusate Sodium, Sennosides	TABLET	ORAL	20191129	20250530	OTC MONOGRAPH NOT FINAL	part334	The Kroger Co.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
30142-885_c742b05c-0132-c04f-e053-2995a90a45e2	30142-885	HUMAN OTC DRUG	SPORT SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20170815		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
30142-887_a4fb1996-9dfb-5983-e053-2a95a90a9945	30142-887	HUMAN OTC DRUG	KROGER SPORT SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20171024		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
30142-889_a4fd9c0a-b6f4-e2da-e053-2a95a90aacbf	30142-889	HUMAN OTC DRUG	KROGER KIDS SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20171102		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
30142-892_f2049e1b-a822-e269-e053-2995a90a32c9	30142-892	HUMAN OTC DRUG	Medicated Pain Relief Patch		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20171012		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
30142-893_a522bbff-0d2d-b603-e053-2a95a90a97e7	30142-893	HUMAN OTC DRUG	KROGER SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20171103		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
30142-894_a91ae575-e48b-43bf-af7f-cc61b05ac91c	30142-894	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	20190603		OTC MONOGRAPH DRUG	M012	Kroger Company	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-895_c8d2e1ce-fa2a-5c8b-e053-2995a90a6996	30142-895	HUMAN OTC DRUG	KROGER DRY TOUCH ULTRA SHEER SPF 100 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20160912		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-896_a7f777e3-823d-4246-bf5b-f80682ba2ed6	30142-896	HUMAN OTC DRUG	migraine relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA075794	Kroger Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
30142-897_1b6a5d2f-b6b5-4220-a26b-659595180bdf	30142-897	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19990119		ANDA	ANDA074937	Kroger Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-899_93de5467-1916-4e4b-8349-920320701da1	30142-899	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Krogers	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30142-934_c70972fa-00cd-26a0-e053-2a95a90aee55	30142-934	HUMAN OTC DRUG	Kroger Dry Oil Tanning Sunscreen Broad Spectrum SPF 15 Reef Friendly		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20181120		OTC MONOGRAPH NOT FINAL	part352	THE KROGER COMPANY	AVOBENZONE; HOMOSALATE; OCTISALATE	20; 100; 50	mg/g; mg/g; mg/g			N	20241231
30142-940_cd0dc81f-983e-4a56-9e5a-46aca6a585d9	30142-940	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190708		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
30142-941_895f9ead-25af-4f77-8248-32b65cec3764	30142-941	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	567	mg/mL			N	20241231
30142-942_44732efd-a096-4edb-a508-22544cc1c77b	30142-942	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	567	mg/mL			N	20241231
30142-943_bcc6d90f-2763-4f85-9090-9e9a1007fd78	30142-943	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20190603		OTC MONOGRAPH DRUG	M009	Kroger Company	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
30142-944_cf8bc8f9-5d67-40ae-b8cf-1be44aad33a9	30142-944	HUMAN OTC DRUG	hemorrhoidal	maximum strength pain relief	glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20091007		OTC MONOGRAPH FINAL	part346	Kroger Company	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-945_c8eaae9c-5110-6893-e053-2995a90ad951	30142-945	HUMAN OTC DRUG	KROGER CLARIFY CARE ACNE WASH		SALICYLIC ACID	LIQUID	TOPICAL	20170724		OTC MONOGRAPH FINAL	part358H	THE KROGER COMPANY	SALICYLIC ACID	20	mg/mL			N	20241231
30142-948_38242995-b5ff-423c-9517-8a6c8255a197	30142-948	HUMAN OTC DRUG	GUAIFENESIN AND DEXTROMETHORPHAN HBR		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20220523		ANDA	ANDA214781	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-949_44efc825-c892-4a79-9f32-a2beaf5d2316	30142-949	HUMAN OTC DRUG	night time cold and flu		acetaminophen, diphenhydramine hydrochloride, phenylephrine hydrochloride	SOLUTION	ORAL	20190522		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-954_18e308e0-34d0-8b4a-a597-4b6fa6fe898e	30142-954	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, COATED	ORAL	20210804		ANDA	ANDA075168	Kroger Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-955_ce01a47b-62d0-49c9-8a17-e81ac21f63eb	30142-955	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210118		OTC MONOGRAPH FINAL	part352	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
30142-956_4cf97dfc-f6d5-4e64-9b42-ea994b6a3a04	30142-956	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	62	mL/100mL			N	20241231
30142-961_5b667b46-235a-4d9c-aea1-0ec8286e3bbc	30142-961	HUMAN OTC DRUG	GUAIFENESIN		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220428		ANDA	ANDA209254	Kroger Company	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
30142-962_7b7122bb-375b-4a86-a494-1dd8995083a9	30142-962	HUMAN OTC DRUG	Guaifenesin	Extended Release	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220420		ANDA	ANDA209254	Kroger Company	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
30142-963_68444eae-5f25-4a1c-bcde-a6bab50377af	30142-963	HUMAN OTC DRUG	GUAIFENESIN AND DEXTROMETHORPHAN HBR		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20220523		ANDA	ANDA214781	Kroger Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
30142-964_befa80f3-83a7-448c-80d8-9d02808bbcf2	30142-964	HUMAN OTC DRUG	flu and severe cold and cough	nighttime	Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20100902		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-965_6d6fb236-5183-46c9-80b5-27ee13729765	30142-965	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170627		ANDA	ANDA209207	Kroger Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
30142-967_77ce98b8-4c34-41de-8d2b-45137f48a692	30142-967	HUMAN OTC DRUG	Pseudoephedrine hydrochloride		PSEUDOEPHEDRINE HYDROCHLORIDE	TABLET	ORAL	20210219		ANDA	ANDA077442	The Kroger Company	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
30142-968_02638c5b-50c5-4b54-bbf8-6427f298b88a	30142-968	HUMAN OTC DRUG	Acetaminophen		ACETAMINOPHEN	TABLET, EXTENDED RELEASE	ORAL	20210219		ANDA	ANDA076200	The Kroger Company	ACETAMINOPHEN	650	mg/1			N	20241231
30142-969_14a52591-4042-47ee-98f0-dacbec24fa82	30142-969	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part343	The Kroger Co.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
30142-970_be2cae5f-8d4d-4be7-9d6b-588444e2f804	30142-970	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210219		ANDA	ANDA076200	The Kroger Company	ACETAMINOPHEN	650	mg/1			N	20241231
30142-973_4ae4e923-ecc8-4330-b5f3-00fa05060b14	30142-973	HUMAN OTC DRUG	hydrocortisone		hydrocortisone	CREAM	TOPICAL	20170515		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
30142-975_8c576323-e94c-49e8-85a5-d4f530bafc7d	30142-975	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20140405		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	500	mg/1			N	20241231
30142-976_4bf24135-ac08-48be-8c4d-68e22734c859	30142-976	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160308		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	567	mg/mL			N	20241231
30142-979_f204ae47-c5c7-54cf-e053-2a95a90a49ca	30142-979	HUMAN OTC DRUG	Kroger Hot and Cold Medicated Patch		MENTHOL	PATCH	TOPICAL	20180427		OTC MONOGRAPH NOT FINAL	part348	Kroger Company	MENTHOL	5	g/100g			N	20241231
30142-981_34741e80-d661-4c46-9d71-294c3090c813	30142-981	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20210630		ANDA	ANDA208754	The Kroger Co.	DOCOSANOL	100	mg/g			N	20241231
30142-983_8feee2e5-b45a-8e32-1fcb-18d167fb6d3e	30142-983	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221001		ANDA	ANDA202194	Kroger Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-984_5e38fb1a-88f5-408d-b3c1-4a1e93d41283	30142-984	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20210402		ANDA	ANDA210088	KROGER COMPANY	LORATADINE	5	mg/1			N	20241231
30142-985_14ebcdeb-214c-48f2-92fa-a67fad8cbf4d	30142-985	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20200729		OTC MONOGRAPH FINAL	part352	Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
30142-987_ffe9a8a0-f220-41be-b974-032b3c303f4d	30142-987	HUMAN OTC DRUG	Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20070821		OTC MONOGRAPH FINAL	part341	Kroger Company	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-988_aa18b23e-1ef4-4039-8a8b-048a5756efd6	30142-988	HUMAN OTC DRUG	Childrens Multi Symptom Fever and Cold		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SUSPENSION	ORAL	20200903		OTC MONOGRAPH FINAL	part341	THE KROGER CO.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
30142-989_d1f98f06-8779-4753-af5f-b45fffea3d92	30142-989	HUMAN OTC DRUG	esomeprazole		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200807		ANDA	ANDA212866	THE KROGER COMPANY	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-992_759b705a-526e-47e2-97f9-a78ab21a2c5d	30142-992	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20200715		ANDA	ANDA207891	THE KROGER COMPANY	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
30142-993_bdbf911e-a0e3-405b-bd74-f80a6750acf6	30142-993	HUMAN OTC DRUG	Ultra Strength Antacid		Antacid Tablets	TABLET, CHEWABLE	ORAL	20180105		OTC MONOGRAPH FINAL	part331	THE KROGER CO.,	CALCIUM CARBONATE	1000	mg/1			N	20241231
30142-995_df62c3c8-ab94-2b7f-e053-2a95a90a1caa	30142-995	HUMAN OTC DRUG	Cetirizine HCl		Cetirizine HCl	CAPSULE	ORAL	20190603		NDA	NDA022429	KROGER COMPANY	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
30142-996_6f7f7005-22db-4b88-9771-e31c21e9b2b1	30142-996	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20190522		ANDA	ANDA210088	KROGER COMPANY	LORATADINE	5	mg/1			N	20241231
30142-999_d9f3c936-aa24-457f-b8e7-641b7987e8c1	30142-999	HUMAN OTC DRUG	Zinc Cold therapy		ZINC GLUCONATE	TABLET	ORAL	20180112		UNAPPROVED HOMEOPATHIC		THE KROGER CO.,	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
30237-8900_0800e936-4297-61d4-e063-6394a90a74b1	30237-8900	CELLULAR THERAPY	PROVENGE		sipuleucel-T	INJECTION	INTRAVENOUS	20100429		BLA	BLA125197	Dendreon Pharmaceuticals LLC	SIPULEUCEL-T	50000000	1/1	Autologous Cellular Immunotherapy [EPC], Cell-mediated Immunity [PE], Cells, Cultured, Autologous [EXT], Leukocytes, Mononuclear [CS]		N	20241231
30400-100_cd8643ef-dc84-8bc1-e053-2995a90a007b	30400-100	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20120629		OTC MONOGRAPH NOT FINAL	part333A	Jell Pharmaceuticals Pvt. Ltd.	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
30400-101_f15a177d-a20c-7751-e053-2995a90ad983	30400-101	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 50% WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	Jell Pharmaceuticals Pvt. Ltd.	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
30400-210_8d4443ec-fc8c-0119-e053-2a95a90a68f0	30400-210	HUMAN OTC DRUG	Epsom Salts		Magnesium Sulfate	GRANULE	ORAL	20190709		OTC MONOGRAPH NOT FINAL	part334	Jell Pharmaceuticals Pvt. Ltd.	MAGNESIUM SULFATE HEPTAHYDRATE	100	g/100g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
30400-214_ab806753-7242-8bb8-e053-2995a90a6528	30400-214	HUMAN OTC DRUG	Jell Pharmaceuticals Vitamin A D		Petrolatum	OINTMENT	TOPICAL	20140424		OTC MONOGRAPH FINAL	part347	Jell Pharmaceuticals Pvt. Ltd.	PETROLATUM	.76	g/g			N	20241231
30400-215_d976e5f0-1be6-d9c4-e053-2a95a90a44a4	30400-215	HUMAN OTC DRUG	Jell	with Vitamin A D	Lanolin, Petrolatum	OINTMENT	TOPICAL	20220112		OTC MONOGRAPH FINAL	part347	Jell Pharmaceuticals Pvt Ltd.	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
30400-250_de47ea21-ca81-d571-e053-2995a90ad2d8	30400-250	HUMAN OTC DRUG	3 Hydrogen Peroxide		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20210110		OTC MONOGRAPH NOT FINAL	part333A	Jell Pharmaceuticals Pvt Ltd.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
30400-501_cd84821c-0764-5c4f-e053-2a95a90abd1e	30400-501	HUMAN OTC DRUG	Shea Butter Petroleum Jelly		Petrolatum Jelly	JELLY	TOPICAL	20210510		OTC MONOGRAPH FINAL	part347	Jell Pharmaceuticals Pvt. Ltd.	PETROLATUM	99.6	g/100g			N	20241231
30400-503_cdac43ca-455f-2dcc-e053-2a95a90aabdb	30400-503	HUMAN OTC DRUG	Cocoa Butter Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20201224		OTC MONOGRAPH FINAL	part347	Jell Pharmaceuticals Pvt. Ltd.	PETROLATUM	99	g/100g			N	20241231
30400-504_cd98841e-8a82-2667-e053-2a95a90a15ef	30400-504	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70%		Isopropyl Alcohol	LIQUID	TOPICAL	20120315		OTC MONOGRAPH NOT FINAL	part333A	Jell Pharmaceuticals Pvt. Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
30400-505_cd98812b-017b-2cd2-e053-2a95a90a38ce	30400-505	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20140530		OTC MONOGRAPH NOT FINAL	part333A	Jell Pharmaceuticals Pvt. Ltd.	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
30400-506_cdaaf8cd-1bcd-bf8c-e053-2a95a90af887	30400-506	HUMAN OTC DRUG	Medicated Body	Powder	MENTHOL	POWDER	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part348	Jell Pharmaceuticals Pvt Ltd	MENTHOL	.42	g/283g			N	20241231
30400-507_cdaaf8cd-1bda-bf8c-e053-2a95a90af887	30400-507	HUMAN OTC DRUG	Maximum Strength Medicated Foot Powder		Medicated Foot Powder	POWDER	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part348	Jell Pharmaceuticals Pvt. Ltd.	MENTHOL	.1	g/g			N	20241231
30400-509_cdc297d6-bf37-7ecb-e053-2995a90ae719	30400-509	HUMAN OTC DRUG	Pure Petrolatum Jelly		Petrolatum	JELLY	TOPICAL	20161015		OTC MONOGRAPH FINAL	part347	Jell Pharmaceuticals Pvt. Ltd.	PETROLATUM	100	g/100g			N	20241231
30400-601_d0e6273a-ff30-2c37-e053-2995a90accf5	30400-601	HUMAN OTC DRUG	91% Isopropyl Rubbing Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20210114		OTC MONOGRAPH NOT FINAL	part333A	Jell Pharmaceuticals Pvt Ltd.	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
30400-701_d80b9cc1-55f6-76d5-e053-2995a90aa967	30400-701	HUMAN OTC DRUG	Medicated Chest Rub		Camphor, Menthol, Eucalyptus Oil	CREAM	TOPICAL	20220214		OTC MONOGRAPH FINAL	part341	Jell Pharmaceuticals Pvt Ltd.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
30400-702_d80cada1-5c90-8e38-e053-2995a90a89ac	30400-702	HUMAN OTC DRUG	Health Smart Vaporizing Chest Rub		Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20220215		OTC MONOGRAPH NOT FINAL	part348	Jell Pharmaceuticals Pvt Ltd.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
30400-703_d80d15cb-3aee-1285-e053-2a95a90a6d52	30400-703	HUMAN OTC DRUG	BABY FRESH SCENT PETROLEUM		White Petroleum	JELLY	TOPICAL	20220215		OTC MONOGRAPH FINAL	part347	Jell Pharmaceuticals Pvt Ltd.	PETROLATUM	99.9	g/100g			N	20241231
30698-007_99434ba3-9608-4f9e-9dc9-5a68f9b94bfa	30698-007	HUMAN PRESCRIPTION DRUG	Norpramin		desipramine hydrochloride	TABLET, SUGAR COATED	ORAL	19641120		NDA	NDA014399	Validus Pharmaceuticals LLC	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
30698-011_99434ba3-9608-4f9e-9dc9-5a68f9b94bfa	30698-011	HUMAN PRESCRIPTION DRUG	Norpramin		desipramine hydrochloride	TABLET, SUGAR COATED	ORAL	19641120		NDA	NDA014399	Validus Pharmaceuticals LLC	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
30698-015_99434ba3-9608-4f9e-9dc9-5a68f9b94bfa	30698-015	HUMAN PRESCRIPTION DRUG	Norpramin		desipramine hydrochloride	TABLET, SUGAR COATED	ORAL	19641120		NDA	NDA014399	Validus Pharmaceuticals LLC	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
30698-019_99434ba3-9608-4f9e-9dc9-5a68f9b94bfa	30698-019	HUMAN PRESCRIPTION DRUG	Norpramin		desipramine hydrochloride	TABLET, SUGAR COATED	ORAL	19641120		NDA	NDA014399	Validus Pharmaceuticals LLC	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
30698-020_99434ba3-9608-4f9e-9dc9-5a68f9b94bfa	30698-020	HUMAN PRESCRIPTION DRUG	Norpramin		desipramine hydrochloride	TABLET, SUGAR COATED	ORAL	19641120		NDA	NDA014399	Validus Pharmaceuticals LLC	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
30698-021_99434ba3-9608-4f9e-9dc9-5a68f9b94bfa	30698-021	HUMAN PRESCRIPTION DRUG	Norpramin		desipramine hydrochloride	TABLET, SUGAR COATED	ORAL	19641120		NDA	NDA014399	Validus Pharmaceuticals LLC	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
30698-032_ea94253e-2d65-4ddb-a865-633e60c76314	30698-032	HUMAN PRESCRIPTION DRUG	Marplan		isocarboxazid	TABLET	ORAL	19590701		NDA	NDA011961	Validus Pharmaceuticals LLC	ISOCARBOXAZID	10	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
30698-060_b0a7b3a5-1f19-409d-bdd7-3bf3254be55b	30698-060	HUMAN PRESCRIPTION DRUG	Lasix		FUROSEMIDE	TABLET	ORAL	19780424		NDA	NDA016273	Validus Pharmaceuticals LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
30698-066_b0a7b3a5-1f19-409d-bdd7-3bf3254be55b	30698-066	HUMAN PRESCRIPTION DRUG	Lasix		FUROSEMIDE	TABLET	ORAL	19780424		NDA	NDA016273	Validus Pharmaceuticals LLC	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
30698-067_b0a7b3a5-1f19-409d-bdd7-3bf3254be55b	30698-067	HUMAN PRESCRIPTION DRUG	Lasix		FUROSEMIDE	TABLET	ORAL	19780424		NDA	NDA016273	Validus Pharmaceuticals LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
30698-143_b559b0bb-025f-4c4a-b854-03ef91a4bcff	30698-143	HUMAN PRESCRIPTION DRUG	Rocaltrol		calcitriol	CAPSULE, GELATIN COATED	ORAL	20090820		NDA	NDA018044	Validus Pharmaceuticals LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
30698-144_b559b0bb-025f-4c4a-b854-03ef91a4bcff	30698-144	HUMAN PRESCRIPTION DRUG	Rocaltrol		calcitriol	CAPSULE, GELATIN COATED	ORAL	20090820		NDA	NDA018044	Validus Pharmaceuticals LLC	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
30698-201_6dfbba03-14f3-496d-abe3-ffd7b4c4984d	30698-201	HUMAN PRESCRIPTION DRUG	Parlodel		bromocriptine mesylate	CAPSULE, GELATIN COATED	ORAL	20140428		NDA	NDA017962	Validus Pharmaceuticals LLC	BROMOCRIPTINE MESYLATE	5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
30698-202_6dfbba03-14f3-496d-abe3-ffd7b4c4984d	30698-202	HUMAN PRESCRIPTION DRUG	Parlodel		bromocriptine mesylate	TABLET	ORAL	20140428		NDA	NDA017962	Validus Pharmaceuticals LLC	BROMOCRIPTINE MESYLATE	2.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
30698-220_0df5b325-3209-4bbc-ab6b-a51aa6e52513	30698-220	HUMAN PRESCRIPTION DRUG	ANZEMET		dolasetron mesylate	TABLET, FILM COATED	ORAL	19970911		NDA	NDA020623	Validus Pharmaceuticals LLC	DOLASETRON MESYLATE	50	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
30698-335_8b9a37da-3e81-4656-8846-c330e7d634ff	30698-335	HUMAN PRESCRIPTION DRUG	Demerol		Meperidine Hydrochloride	TABLET	ORAL	19421110		NDA	NDA005010	Validus Pharmaceuticals LLC	MEPERIDINE HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
30698-337_8b9a37da-3e81-4656-8846-c330e7d634ff	30698-337	HUMAN PRESCRIPTION DRUG	Demerol		Meperidine Hydrochloride	TABLET	ORAL	19421110		NDA	NDA005010	Validus Pharmaceuticals LLC	MEPERIDINE HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
30698-419_6668b078-d0cd-4a79-b304-e1b70c9f8753	30698-419	HUMAN PRESCRIPTION DRUG	EQUETRO		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20041210		NDA	NDA021710	Validus Pharmaceuticals LLC	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
30698-421_6668b078-d0cd-4a79-b304-e1b70c9f8753	30698-421	HUMAN PRESCRIPTION DRUG	EQUETRO		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20041210		NDA	NDA021710	Validus Pharmaceuticals LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
30698-423_6668b078-d0cd-4a79-b304-e1b70c9f8753	30698-423	HUMAN PRESCRIPTION DRUG	EQUETRO		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20041210		NDA	NDA021710	Validus Pharmaceuticals LLC	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
30698-448_c559c519-563d-4479-989b-394f63349009	30698-448	HUMAN PRESCRIPTION DRUG	Lotensin		benazepril hydrochloride	TABLET	ORAL	19910621		NDA	NDA019851	Validus Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
30698-449_c559c519-563d-4479-989b-394f63349009	30698-449	HUMAN PRESCRIPTION DRUG	Lotensin		benazepril hydrochloride	TABLET	ORAL	19910621		NDA	NDA019851	Validus Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
30698-450_c559c519-563d-4479-989b-394f63349009	30698-450	HUMAN PRESCRIPTION DRUG	Lotensin		benazepril hydrochloride	TABLET	ORAL	19910621		NDA	NDA019851	Validus Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
30698-452_93bc7b7d-8de7-47dd-89db-a3c747e199eb	30698-452	HUMAN PRESCRIPTION DRUG	Lotensin HCT		benazepril hydrochloride and hydrochlorothiazide	TABLET	ORAL	19920530		NDA	NDA020033	Validus Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
30698-453_93bc7b7d-8de7-47dd-89db-a3c747e199eb	30698-453	HUMAN PRESCRIPTION DRUG	Lotensin HCT		benazepril hydrochloride and hydrochlorothiazide	TABLET	ORAL	19920530		NDA	NDA020033	Validus Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
30698-454_93bc7b7d-8de7-47dd-89db-a3c747e199eb	30698-454	HUMAN PRESCRIPTION DRUG	Lotensin HCT		benazepril hydrochloride and hydrochlorothiazide	TABLET	ORAL	19920530		NDA	NDA020033	Validus Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
30698-458_91ce759d-465e-452a-abb3-3d77fb0a27eb	30698-458	HUMAN PRESCRIPTION DRUG	Lopressor		metoprolol tartrate	TABLET	ORAL	20140505		NDA	NDA017963	Validus Pharmaceuticals LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
30698-459_91ce759d-465e-452a-abb3-3d77fb0a27eb	30698-459	HUMAN PRESCRIPTION DRUG	Lopressor		metoprolol tartrate	TABLET	ORAL	20140505		NDA	NDA017963	Validus Pharmaceuticals LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
30698-477_1b35ea4d-8733-4f56-9143-168fc49e2247	30698-477	HUMAN PRESCRIPTION DRUG	HIPREX		Methenamine Hippurate	TABLET	ORAL	19760909		NDA	NDA017681	Validus Pharmaceuticals LLC	METHENAMINE HIPPURATE	1	g/1			N	20241231
30698-493_6a525360-90cf-4031-beb2-6ddeb2b3af8c	30698-493	HUMAN PRESCRIPTION DRUG	DRISDOL		ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20180401		NDA	NDA003444	Validus Pharmaceuticals LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
30698-630_ef39d792-2e46-40a9-b0ac-c2fc34a93ba0	30698-630	HUMAN PRESCRIPTION DRUG	Bumex		Bumetanide	TABLET	ORAL	19830228		NDA	NDA018225	Validus Pharmaceuticals LLC	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
30698-631_ef39d792-2e46-40a9-b0ac-c2fc34a93ba0	30698-631	HUMAN PRESCRIPTION DRUG	Bumex		Bumetanide	TABLET	ORAL	19830228		NDA	NDA018225	Validus Pharmaceuticals LLC	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
30698-632_ef39d792-2e46-40a9-b0ac-c2fc34a93ba0	30698-632	HUMAN PRESCRIPTION DRUG	Bumex		Bumetanide	TABLET	ORAL	19830228		NDA	NDA018225	Validus Pharmaceuticals LLC	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
30698-911_b559b0bb-025f-4c4a-b854-03ef91a4bcff	30698-911	HUMAN PRESCRIPTION DRUG	Rocaltrol		calcitriol	SOLUTION	ORAL	20090723		NDA	NDA021068	Validus Pharmaceuticals LLC	CALCITRIOL	1	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
30805-001_b43cfcf9-dd19-7b9f-e053-2a95a90a1800	30805-001	HUMAN OTC DRUG	Symmetry Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20071116		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	ALCOHOL	62	mL/100mL			N	20241231
30805-003_bb8fde35-8103-3ef0-e053-2995a90a3782	30805-003	HUMAN OTC DRUG	Symmetry Foaming Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20071116		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	ALCOHOL	62	mL/100mL			N	20241231
30805-006_38b8a54b-281a-44fd-9e5e-2e7ad818b169	30805-006	HUMAN OTC DRUG	Symmetry Antimicrobial Foaming Hand Wash		Chloroxylenol	SOLUTION	TOPICAL	20071116		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	CHLOROXYLENOL	.3	g/100mL			N	20241231
30805-009_bb8feade-61b1-adcc-e053-2995a90aa418	30805-009	HUMAN OTC DRUG	Symmetry Foaming Hand Sanitizer-Fragrance Free with Aloe and Vitamin E		Alcohol	LIQUID	TOPICAL	20111004		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	ALCOHOL	62	mL/100mL			N	20241231
30805-010_39935c6b-8456-4166-ba1e-b18b4a79383c	30805-010	HUMAN OTC DRUG	Symmetry Non-Alcohol Foaming Hand Sanitizer with Allantoin and Aloe		Benzalkonium Chloride	SOLUTION	TOPICAL	20111101		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
30805-012_a28ff21e-a508-8257-e053-2a95a90afd4e	30805-012	HUMAN OTC DRUG	Altra Foaming Hand Sanitizer with Aloe and Vitamin E		ALCOHOL	SOLUTION	TOPICAL	20200405		OTC MONOGRAPH NOT FINAL	part333E	Buckeye International, Inc.	ALCOHOL	62	mL/100mL			N	20241231
30805-013_a2963c01-55f8-a3cc-e053-2a95a90a72c6	30805-013	HUMAN OTC DRUG	Altra Foaming Hand Sanitizer Fragrance Free with Aloe and Vitamin E		ALCOHOL	SOLUTION	TOPICAL	20200405		OTC MONOGRAPH NOT FINAL	part333E	Buckeye International, Inc.	ALCOHOL	62	mL/100mL			N	20241231
30805-014_a2974445-eaa4-d9f0-e053-2995a90a78fc	30805-014	HUMAN OTC DRUG	Altra Hand Sanitizer with Aloe and Vitamin E		ALCOHOL	SOLUTION	TOPICAL	20200405		OTC MONOGRAPH NOT FINAL	part333E	Buckeye International, Inc.	ALCOHOL	62	mL/100mL			N	20241231
30805-015_a35ad6ce-700d-5b42-e053-2995a90a7da6	30805-015	HUMAN OTC DRUG	Altra Non-Alcohol Foaming Hand Sanitizer with Allantoin and Aloe		Benzalkonium Chloride	SOLUTION	TOPICAL	20200415		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
30805-016_a3ce509c-d91a-0752-e053-2995a90a8ac4	30805-016	HUMAN OTC DRUG	Altra Antimicrobial Foaming Hand Wash with 0.3% PCMX		CHLOROXYLENOL	SOLUTION	TOPICAL	20200415		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	CHLOROXYLENOL	.3	g/100mL			N	20241231
30805-017_04df34dd-9596-9cf8-e063-6294a90aaf46	30805-017	HUMAN OTC DRUG	SYMMETRY ANTIMICROBIAL FOAMING HAND WASH w/Benzalkonium Chloride		Benzalkonium Chloride	SOLUTION	TOPICAL	20220628		OTC MONOGRAPH NOT FINAL	part333A	Buckeye International, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
30807-0003_0ce13d6d-7303-96cd-e063-6394a90a3c8d	30807-0003	HUMAN OTC DRUG	NAKED SUNDAYS BROAD SPECTRUM SUNSCREEN	SPF 50	Zinc Oxide	CREAM	TOPICAL	20231006		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	ZINC OXIDE	22.75	g/100g			N	20241231
30807-0004_0d473351-cf14-e8f3-e063-6294a90ad5d1	30807-0004	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220701		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
30807-1120_0d447d80-c9f5-ad0a-e063-6294a90ac9cb	30807-1120	HUMAN OTC DRUG	CLEAR GLOW RADIANT SUN SERUM	SPF50	Avobenzone 15mg/g, Homosalate 5mg/g, Octocrylene 25mg/g, (SUNSCREEN)	LOTION	TOPICAL	20220131		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	g/100mL; g/100mL; g/100mL			N	20241231
30807-5005_0d465727-a7a1-ebb4-e063-6394a90ad607	30807-5005	HUMAN OTC DRUG	GLOW BODY MIST	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	4.5; 15; 7.5; 10.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
30807-6000_0d57ef82-cd42-14a9-e063-6394a90a7774	30807-6000	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220807		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
30807-6006_0d463a36-244d-7f70-e063-6294a90a8391	30807-6006	HUMAN OTC DRUG	HYDRATING GLOW MIST	SPF 50	AVOBENZONE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20201201		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
30807-7000_0d489a35-0430-7a85-e063-6394a90a56de	30807-7000	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220807		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
30807-8000_0d48a6ad-9751-caec-e063-6294a90a6910	30807-8000	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220807		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
30807-9000_0d43e25b-0075-dd25-e063-6294a90a4a7f	30807-9000	HUMAN OTC DRUG	ANTIOXIDANT BODY SUNSCREEN CREME SPF50 BROAD SPECTRUM		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Wild Child Laboratories Pty Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
30807-9810_0cf60e5b-edf8-4dc9-e063-6394a90a5848	30807-9810	HUMAN OTC DRUG	NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS Sheer Tint 40mL	SPF 50	Titanium Oxide, Zinc Oxide	LIQUID	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	WILD CHILD LABORATORIES PTY LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 14.9	g/100mL; g/100mL			N	20241231
30807-9820_0cf4318f-67fe-ce24-e063-6294a90a6080	30807-9820	HUMAN OTC DRUG	NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS Blush 40mL	SPF 50	Titanium Oxide, Zinc Oxide	LIQUID	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	Wild Child Laboratories PTY LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 14.9	g/100mL; g/100mL			N	20241231
30815-0040_c8c85250-96ad-4bd8-9f74-a55737881fd3	30815-0040	HUMAN PRESCRIPTION DRUG	Hydro-Q		Hydroquinone	GEL	TOPICAL	20081208		UNAPPROVED DRUG OTHER		Dermavance Pharmaceuticals	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
31462-001_088b81e4-76c5-6680-e063-6294a90acb73	31462-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100719		UNAPPROVED MEDICAL GAS		Hometown Medical & Equipment, LLC	OXYGEN	99	L/100L			N	20241231
31507-544_09041e53-4ca9-9992-e063-6394a90a3062	31507-544	HUMAN OTC DRUG	SENTRY ANTISEPTIC HANDSOAP		CHLOROXYLENOL	SOAP	TOPICAL	20231030		OTC MONOGRAPH DRUG	505G(a)(3)	Wechem, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
31507-585_6f721766-664e-4bb9-bd9d-a496f85c05fc	31507-585	HUMAN OTC DRUG	Hand Guard Foaming Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20190711		OTC MONOGRAPH NOT FINAL	part333E	Wechem, Inc.	ALCOHOL	.62	mL/mL			N	20241231
31507-876_c81acd72-7a7b-4d0b-adb3-24ce3513de01	31507-876	HUMAN OTC DRUG	Hand Guard High Foaming Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part333E	Wechem, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
31720-202_0d9cbebe-65a2-64df-e063-6394a90a626d	31720-202	HUMAN OTC DRUG	Sephora 8hr Mattifying Moisturizer Sunscreen Broad Spectrum SPF 20		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	CREAM	TOPICAL	20121119		OTC MONOGRAPH DRUG	M020	S+	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	30; 75; 23.7	mg/mL; mg/mL; mg/mL			N	20241231
31720-231_0a2e9eed-bf48-ade4-e063-6294a90a70f5	31720-231	HUMAN OTC DRUG	DAILY SUNSCREEN BROAD SPECTRUM SPF 30		ZINC OXIDE	CREAM	TOPICAL	20231115		OTC MONOGRAPH DRUG	M020	S+	ZINC OXIDE	155	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
31720-301_0d9c7c4a-6a07-6229-e063-6394a90a9008	31720-301	HUMAN OTC DRUG	Acne Treatment Gel		SALICYLIC ACID	GEL	TOPICAL	20221205		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-701_0d9c9f0d-dde4-62ed-e063-6394a90a0f04	31720-701	HUMAN OTC DRUG	Bright future skin tint SPF 25 7 ivoire clair light		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-702_0d9cfb04-5c52-9b9c-e063-6394a90a1d28	31720-702	HUMAN OTC DRUG	Bright future skin tint SPF 25 11 ivoire pur pure		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-703_0d9d19aa-c763-9ad4-e063-6394a90a79e9	31720-703	HUMAN OTC DRUG	Bright future skin tint SPF 25 12 ecru Ecru		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-704_0d9d422a-4e15-ac05-e063-6394a90adad2	31720-704	HUMAN OTC DRUG	Bright future skin tint SPF 25 31 amande Almond		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-705_0d9d4afc-1f22-95de-e063-6394a90a9c44	31720-705	HUMAN OTC DRUG	Bright future skin tint SPF 25 46 noix de pecan Pecan		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-706_0d9f3dea-9464-705c-e063-6294a90a3bf2	31720-706	HUMAN OTC DRUG	Bright future skin tint SPF 25 20 creme		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-707_0d9f5b7c-9641-892c-e063-6394a90a274e	31720-707	HUMAN OTC DRUG	Bright future skin tint SPF 25 25 beige Beige		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-708_0d9f5b97-ce2f-8382-e063-6394a90a5b84	31720-708	HUMAN OTC DRUG	Bright future skin tint SPF 25 33 noix Walnut		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-709_0d9f5b97-ce30-8382-e063-6394a90a5b84	31720-709	HUMAN OTC DRUG	Bright future skin tint SPF 25 35 bronze		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-710_0d9f5b97-ce33-8382-e063-6394a90a5b84	31720-710	HUMAN OTC DRUG	Bright future skin tint SPF 25 44 Praline		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	S+	OCTINOXATE; TITANIUM DIOXIDE	74.9; 22.8	mg/mL; mg/mL			N	20241231
31720-951_0d9f5b7c-9645-892c-e063-6394a90a274e	31720-951	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	01 ivory	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-952_0d9f5384-e2e5-7d31-e063-6394a90ad839	31720-952	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	2 linen	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-953_0d9f80c6-39f4-c894-e063-6294a90a00c8	31720-953	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	3 shell	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-954_0d9f4d98-a4a1-89e2-e063-6394a90acde0	31720-954	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	4 sand	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-955_0d9f5b97-ce34-8382-e063-6394a90a5b84	31720-955	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	5 beige	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-956_0d9f4d98-a4a0-89e2-e063-6394a90acde0	31720-956	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	6 Honey	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-957_0d9f5b7c-9644-892c-e063-6394a90a274e	31720-957	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	7 olive	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-958_0d9f5b7c-9643-892c-e063-6394a90a274e	31720-958	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	8 amber	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-959_0d9f5b7c-9642-892c-e063-6394a90a274e	31720-959	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	9 almond	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-960_0d9f61ee-c973-aecf-e063-6294a90ac1d7	31720-960	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	10 walnut	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-961_0d9f5b97-ce2e-8382-e063-6394a90a5b84	31720-961	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	2.5 bisque	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-962_0d9f3f3a-a328-559a-e063-6394a90a4228	31720-962	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	9.5 chai	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-963_0d9f5384-e2e4-7d31-e063-6394a90ad839	31720-963	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	11 coffee	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-964_0d9f4d98-a49f-89e2-e063-6394a90acde0	31720-964	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	12 cocoa	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31720-965_0d9f3f3a-a324-559a-e063-6394a90a4228	31720-965	HUMAN OTC DRUG	CLEAR AND COVER ACNE TREATMENT CONCEALER CLEAR AND COVER ACNE TREATMENT CONCEALER	13 fudge	SALICYLIC ACID	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M006	S+	SALICYLIC ACID	20	mg/mL			N	20241231
31722-001_ac179816-95cd-4657-abd1-198f7b0f0398	31722-001	HUMAN PRESCRIPTION DRUG	lamivudine		lamivudine	TABLET, FILM COATED	ORAL	20190321		ANDA	ANDA211306	Camber Pharmaceuticals, Inc.	LAMIVUDINE	100	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-002_cfe02725-778f-e2e9-e053-2995a90ab1ce	31722-002	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Camber Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-003_cfe02725-778f-e2e9-e053-2995a90ab1ce	31722-003	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Camber Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-004_cfe02725-778f-e2e9-e053-2995a90ab1ce	31722-004	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Camber Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-005_ef4dbb3d-1d1f-0b62-e053-2995a90a921c	31722-005	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUPPOSITORY	RECTAL	20200319		ANDA	ANDA213377	Camber Pharmaceuticals, Inc.	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
31722-006_f5bf5b1e-ba55-339d-e053-2995a90ae959	31722-006	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	SOLUTION	ORAL	20200901		ANDA	ANDA212239	Camber Pharmaceuticals, Inc.	ITRACONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
31722-007_5d30ffab-38a1-411d-94ad-0a15c227d882	31722-007	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET, FILM COATED	ORAL	20200910		ANDA	ANDA212475	Camber Pharmaceuticals, Inc.	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
31722-008_5d30ffab-38a1-411d-94ad-0a15c227d882	31722-008	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET, FILM COATED	ORAL	20200910		ANDA	ANDA212475	Camber Pharmaceuticals, Inc.	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
31722-009_ba9714ab-cd20-3fd0-e053-2a95a90ab482	31722-009	HUMAN PRESCRIPTION DRUG	vigabatrin for oral solution		vigabatrin	POWDER, FOR SOLUTION	ORAL	20210126		ANDA	ANDA213519	Camber Pharmaceuticals, Inc.	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
31722-010_c9c062e6-c790-3f45-e053-2995a90aaa67	31722-010	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA211726	Camber Pharmaceuticals, Inc.	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
31722-011_c3da2629-9582-c090-e053-2995a90ab907	31722-011	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20210514		ANDA	ANDA214341	Camber Pharmaceuticals, Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
31722-012_c3da2629-9582-c090-e053-2995a90ab907	31722-012	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20210514		ANDA	ANDA214341	Camber Pharmaceuticals, Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
31722-013_c3da2629-9582-c090-e053-2995a90ab907	31722-013	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20210514		ANDA	ANDA214341	Camber Pharmaceuticals, Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
31722-014_c9c062e6-c790-3f45-e053-2995a90aaa67	31722-014	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210809		ANDA	ANDA211726	Camber Pharmaceuticals, Inc.	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
31722-015_c9c062e6-c790-3f45-e053-2995a90aaa67	31722-015	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210809		ANDA	ANDA211726	Camber Pharmaceuticals, Inc.	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
31722-016_e3b10753-2b28-5dd9-e053-2995a90a8687	31722-016	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	SOLUTION	ORAL	20220705		ANDA	ANDA213698	Camber Pharmaceuticals, Inc.	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
31722-017_d1215804-20c7-e3f3-e053-2a95a90aa13b	31722-017	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215767	Camber Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
31722-018_d1215804-20c7-e3f3-e053-2a95a90aa13b	31722-018	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215767	Camber Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
31722-019_0cd6854c-dae9-9cd7-e063-6394a90a8dfe	31722-019	HUMAN PRESCRIPTION DRUG	Diatrizoate Meglumine and Diatrizoate Sodium		Diatrizoate Meglumine and Diatrizoate Sodium	SOLUTION	ORAL; RECTAL	20231117		ANDA	ANDA215049	Camber Pharmaceuticals, Inc.	DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM	660; 100	mg/mL; mg/mL	Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA]		N	20241231
31722-020_d7a8fe4e-7b8e-05b0-e053-2995a90a6291	31722-020	HUMAN PRESCRIPTION DRUG	Enalapril maleate oral solution		Enalapril maleate	SOLUTION	ORAL	20220214		ANDA	ANDA214467	Camber Pharmaceuticals, Inc.	ENALAPRIL MALEATE	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
31722-021_07e9401d-041e-2f7d-e063-6394a90a1040	31722-021	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230923		ANDA	ANDA215527	Camber Pharmaceuticals, Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
31722-022_07e9401d-041e-2f7d-e063-6394a90a1040	31722-022	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230926		ANDA	ANDA215527	Camber Pharmaceuticals, Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
31722-023_d6678e84-1f39-9a5d-e053-2995a90a75ce	31722-023	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20220111		ANDA	ANDA215939	Camber Pharmaceuticals, Inc.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-024_d6678e84-1f39-9a5d-e053-2995a90a75ce	31722-024	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20220111		ANDA	ANDA215939	Camber Pharmaceuticals, Inc.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-025_d6678e84-1f39-9a5d-e053-2995a90a75ce	31722-025	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20220111		ANDA	ANDA215939	Camber Pharmaceuticals, Inc.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-027_e52cdf06-9178-ab2f-e053-2a95a90af2b3	31722-027	HUMAN PRESCRIPTION DRUG	solifenacin succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20220615		ANDA	ANDA215761	Camber Pharmaceuticals, Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
31722-028_e52cdf06-9178-ab2f-e053-2a95a90af2b3	31722-028	HUMAN PRESCRIPTION DRUG	solifenacin succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20220615		ANDA	ANDA215761	Camber Pharmaceuticals, Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
31722-029_02689fca-db02-41df-e063-6294a90a91dc	31722-029	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	GRANULE	ORAL	20230316		ANDA	ANDA216229	Camber Pharmaceuticals, Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
31722-030_02689fca-db02-41df-e063-6294a90a91dc	31722-030	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	GRANULE	ORAL	20220922		ANDA	ANDA216229	Camber Pharmaceuticals, Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
31722-031_02689fca-db02-41df-e063-6294a90a91dc	31722-031	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	GRANULE	ORAL	20220922		ANDA	ANDA216229	Camber Pharmaceuticals, Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
31722-032_092a2d03-1a01-a7ac-e063-6394a90a01b4	31722-032	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	GRANULE, DELAYED RELEASE	ORAL	20231027		ANDA	ANDA216139	Camber Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-035_ed1784ab-0920-349b-e053-2995a90a3172	31722-035	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		aminocaproic acid	SOLUTION	ORAL	20221104		ANDA	ANDA216464	Camber Pharmaceuticals, Inc.	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
31722-036_ed93311a-2bfc-3875-e053-2a95a90ac6f0	31722-036	HUMAN PRESCRIPTION DRUG	Mexiletine hydrochloride		Mexiletine hydrochloride	CAPSULE	ORAL	20221109		ANDA	ANDA216463	Camber Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
31722-037_ed93311a-2bfc-3875-e053-2a95a90ac6f0	31722-037	HUMAN PRESCRIPTION DRUG	Mexiletine hydrochloride		Mexiletine hydrochloride	CAPSULE	ORAL	20221109		ANDA	ANDA216463	Camber Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
31722-038_ed93311a-2bfc-3875-e053-2a95a90ac6f0	31722-038	HUMAN PRESCRIPTION DRUG	Mexiletine hydrochloride		Mexiletine hydrochloride	CAPSULE	ORAL	20221109		ANDA	ANDA216463	Camber Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
31722-040_ecb3a4da-a4fc-7803-e053-2a95a90a0f3f	31722-040	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20221102		ANDA	ANDA216446	Camber Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
31722-041_ecb3a4da-a4fc-7803-e053-2a95a90a0f3f	31722-041	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20221102		ANDA	ANDA216446	Camber Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
31722-044_eaf892a4-41c4-70e0-e053-2995a90a2079	31722-044	HUMAN PRESCRIPTION DRUG	Zileuton		Zileuton	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221011		ANDA	ANDA215742	Camber Pharmaceuticals, Inc.	ZILEUTON	600	mg/1	5-Lipoxygenase Inhibitor [EPC], 5-Lipoxygenase Inhibitors [MoA], Decreased Leukotriene Production [PE]		N	20241231
31722-045_eaab4da5-4df3-66fb-e053-2995a90ae47f	31722-045	HUMAN PRESCRIPTION DRUG	sapropterin dihydrochloride		sapropterin dihydrochloride	TABLET	ORAL	20220823		ANDA	ANDA215534	Camber Pharmaceuticals, Inc.	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
31722-046_e17951ce-a188-3f65-e053-2995a90afc3c	31722-046	HUMAN PRESCRIPTION DRUG	Diclofenac potassium		Diclofenac potassium	POWDER, FOR SOLUTION	ORAL	20220304		ANDA	ANDA215375	Camber Pharmaceuticals, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-047_eaab2cef-90ba-2002-e053-2a95a90a09fc	31722-047	HUMAN PRESCRIPTION DRUG	Sapropterin dihydrochloride		Sapropterin dihydrochloride	POWDER, FOR SOLUTION	ORAL	20220818		ANDA	ANDA215420	Camber Pharmaceuticals, Inc.	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
31722-048_eaab2cef-90ba-2002-e053-2a95a90a09fc	31722-048	HUMAN PRESCRIPTION DRUG	Sapropterin dihydrochloride		Sapropterin dihydrochloride	POWDER, FOR SOLUTION	ORAL	20220818		ANDA	ANDA215420	Camber Pharmaceuticals, Inc.	SAPROPTERIN DIHYDROCHLORIDE	500	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
31722-049_fe285cf1-1e78-943b-e053-6394a90a760d	31722-049	HUMAN PRESCRIPTION DRUG	EPLERENONE		EPLERENONE	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA213812	Camber Pharmaceuticals, Inc.	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
31722-050_fe285cf1-1e78-943b-e053-6394a90a760d	31722-050	HUMAN PRESCRIPTION DRUG	EPLERENONE		EPLERENONE	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA213812	Camber Pharmaceuticals, Inc.	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
31722-063_03961211-aab3-1a19-e063-6394a90a2268	31722-063	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	POWDER, FOR SUSPENSION	ORAL	20230817		ANDA	ANDA217330	Camber Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
31722-066_fe27b9b7-06f2-3f3b-e053-6394a90a0be5	31722-066	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230531		ANDA	ANDA216800	Camber Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-067_fe27b9b7-06f2-3f3b-e053-6394a90a0be5	31722-067	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230531		ANDA	ANDA216800	Camber Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-068_fe27b9b7-06f2-3f3b-e053-6394a90a0be5	31722-068	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230531		ANDA	ANDA216800	Camber Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-077_05c7eb1d-0b79-ee46-e063-6294a90abfe4	31722-077	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230908		ANDA	ANDA217422	Camber Pharmaceuticals, Inc.	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
31722-078_05c7eb1d-0b79-ee46-e063-6294a90abfe4	31722-078	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230908		ANDA	ANDA217422	Camber Pharmaceuticals, Inc.	THEOPHYLLINE ANHYDROUS	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
31722-102_774368a9-067c-4071-a397-2153d1a90242	31722-102	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210104		ANDA	ANDA212513	Camber Pharmaceuticals Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
31722-103_5480ebd3-5b39-4f8b-bb03-05617f6f519f	31722-103	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20201007		ANDA	ANDA209403	Camber Pharmaceuticals, Inc.	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
31722-104_5480ebd3-5b39-4f8b-bb03-05617f6f519f	31722-104	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20201007		ANDA	ANDA209403	Camber Pharmaceuticals, Inc.	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
31722-105_5480ebd3-5b39-4f8b-bb03-05617f6f519f	31722-105	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20201007		ANDA	ANDA209403	Camber Pharmaceuticals, Inc.	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
31722-108_e073e3ca-04f9-a4ba-e053-2a95a90af358	31722-108	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		oseltamivir phosphate	POWDER, FOR SUSPENSION	ORAL	20220328		ANDA	ANDA209590	Camber Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
31722-116_d28ce94e-0099-75b4-e053-2a95a90a037f	31722-116	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		Lidocaine hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20211108		ANDA	ANDA214336	Camber Pharmaceuticals, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
31722-117_ee31d871-dc3a-bc36-e053-2a95a90a68e3	31722-117	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20211108		ANDA	ANDA214339	Camber Pharmaceuticals, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
31722-118_ee31d871-dc3a-bc36-e053-2a95a90a68e3	31722-118	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20211108		ANDA	ANDA214339	Camber Pharmaceuticals, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
31722-119_2d6e7e03-f816-49c3-bb51-2464c31301a6	31722-119	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Camber Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-120_2d6e7e03-f816-49c3-bb51-2464c31301a6	31722-120	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Camber Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	12	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-121_2d6e7e03-f816-49c3-bb51-2464c31301a6	31722-121	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Camber Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	16	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-122_2d6e7e03-f816-49c3-bb51-2464c31301a6	31722-122	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Camber Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	32	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-123_495259b8-9f81-4b6e-aa51-d199aa0edfb8	31722-123	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Camber Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-124_495259b8-9f81-4b6e-aa51-d199aa0edfb8	31722-124	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Camber Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-125_495259b8-9f81-4b6e-aa51-d199aa0edfb8	31722-125	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Camber Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-126_495259b8-9f81-4b6e-aa51-d199aa0edfb8	31722-126	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Camber Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-128_0b03cc05-5962-498a-aa5d-5f18c844cc09	31722-128	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210120		ANDA	ANDA214603	Camber Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
31722-129_cb7e4f56-0ffe-4809-991c-1751b62e63c7	31722-129	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Camber Pharmaceuticals, Inc	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
31722-130_cb7e4f56-0ffe-4809-991c-1751b62e63c7	31722-130	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Camber Pharmaceuticals, Inc	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
31722-131_ea6f1af7-b293-4e0e-9559-fa6085a64c3e	31722-131	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161024		ANDA	ANDA206574	Camber Pharmaceuticals, Inc.	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
31722-132_cb7e4f56-0ffe-4809-991c-1751b62e63c7	31722-132	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Camber Pharmaceuticals, Inc	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
31722-133_dd7e7134-d695-4776-92ce-8c940715a702	31722-133	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20210120		ANDA	ANDA214422	Camber Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
31722-134_dd7e7134-d695-4776-92ce-8c940715a702	31722-134	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210120		ANDA	ANDA214422	Camber Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
31722-135_dd7e7134-d695-4776-92ce-8c940715a702	31722-135	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210120		ANDA	ANDA214422	Camber Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
31722-136_fc6c74eb-f298-b91f-e053-6394a90afe14	31722-136	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil Powder,	FOR SUSPENSION	ORAL	20210511		ANDA	ANDA213014	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-138_b9999125-6db4-4000-b022-36cc3509e21d	31722-138	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Camber Pharmaceuticals, Inc.	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
31722-141_99fac9d2-a1a4-40c3-8530-098acc7e16c6	31722-141	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20051207		ANDA	ANDA074737	Camber Pharmaceuticals, Inc.	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-142_99fac9d2-a1a4-40c3-8530-098acc7e16c6	31722-142	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20051207		ANDA	ANDA074737	Camber Pharmaceuticals, Inc.	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-143_99fac9d2-a1a4-40c3-8530-098acc7e16c6	31722-143	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20051207		ANDA	ANDA074737	Camber Pharmaceuticals, Inc.	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-144_99fac9d2-a1a4-40c3-8530-098acc7e16c6	31722-144	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20051207		ANDA	ANDA074737	Camber Pharmaceuticals, Inc.	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-145_7e92b878-15e8-41a4-b672-e9c974dd9f4e	31722-145	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	Camber Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
31722-146_7e92b878-15e8-41a4-b672-e9c974dd9f4e	31722-146	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	Camber Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
31722-147_7e92b878-15e8-41a4-b672-e9c974dd9f4e	31722-147	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	Camber Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
31722-148_7b79cee4-1db1-4896-8d6d-0fdb446b9776	31722-148	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Camber Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-149_7b79cee4-1db1-4896-8d6d-0fdb446b9776	31722-149	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Camber Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-150_7b79cee4-1db1-4896-8d6d-0fdb446b9776	31722-150	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Camber Pharmaceuticals, Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-151_c81a83dd-01a0-4f7e-e053-2995a90a5fae	31722-151	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-152_c81a83dd-01a0-4f7e-e053-2995a90a5fae	31722-152	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-153_c81a83dd-01a0-4f7e-e053-2995a90a5fae	31722-153	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-154_c81a83dd-01a0-4f7e-e053-2995a90a5fae	31722-154	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-155_eac552ea-6080-4935-a154-39ab177ef350	31722-155	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210510		ANDA	ANDA213709	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-156_eac552ea-6080-4935-a154-39ab177ef350	31722-156	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210510		ANDA	ANDA213709	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-157_eac552ea-6080-4935-a154-39ab177ef350	31722-157	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210510		ANDA	ANDA213709	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-158_eac552ea-6080-4935-a154-39ab177ef350	31722-158	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210510		ANDA	ANDA213709	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-159_eac552ea-6080-4935-a154-39ab177ef350	31722-159	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210510		ANDA	ANDA213709	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-160_0f3408b4-44be-4a92-a59f-9b5a9716bc9a	31722-160	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20161006		ANDA	ANDA204774	Camber Pharmaceuticals, Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-161_0f3408b4-44be-4a92-a59f-9b5a9716bc9a	31722-161	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20161006		ANDA	ANDA204774	Camber Pharmaceuticals, Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-162_0f3408b4-44be-4a92-a59f-9b5a9716bc9a	31722-162	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20161006		ANDA	ANDA204774	Camber Pharmaceuticals, Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-163_eac552ea-6080-4935-a154-39ab177ef350	31722-163	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210510		ANDA	ANDA213709	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-164_eac552ea-6080-4935-a154-39ab177ef350	31722-164	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210510		ANDA	ANDA213709	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-165_014f00f9-34a5-4aca-e063-6294a90a1019	31722-165	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant dimeglumine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210729		ANDA	ANDA214616	Camber Pharmaceuticals, Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
31722-166_7218d5fc-4928-4009-975d-65337f13b434	31722-166	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Camber Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-167_7218d5fc-4928-4009-975d-65337f13b434	31722-167	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Camber Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-168_df6e8fb3-3f0e-89de-e053-2995a90a7051	31722-168	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20201230		ANDA	ANDA204343	Camber Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-169_df6e8fb3-3f0e-89de-e053-2995a90a7051	31722-169	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20201230		ANDA	ANDA204343	Camber Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-170_df6e8fb3-3f0e-89de-e053-2995a90a7051	31722-170	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20201230		ANDA	ANDA204343	Camber Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-172_cfe12692-404c-ae05-e053-2995a90aa182	31722-172	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Camber Pharmaceuticals, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-173_509d29a8-a7a6-497c-9371-8d9282870046	31722-173	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Camber Pharmaceutical Inc	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-174_509d29a8-a7a6-497c-9371-8d9282870046	31722-174	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Camber Pharmaceutical Inc	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-175_509d29a8-a7a6-497c-9371-8d9282870046	31722-175	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Camber Pharmaceutical Inc	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-176_cfe12692-404c-ae05-e053-2995a90aa182	31722-176	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Camber Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-177_cfe12692-404c-ae05-e053-2995a90aa182	31722-177	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Camber Pharmaceuticals, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-178_cfe12692-404c-ae05-e053-2995a90aa182	31722-178	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Camber Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-179_cfe12692-404c-ae05-e053-2995a90aa182	31722-179	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Camber Pharmaceuticals, Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-180_cfe12692-404c-ae05-e053-2995a90aa182	31722-180	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Camber Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
31722-181_7575ca4b-9c64-4557-9c2d-01085682c3ff	31722-181	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210922		ANDA	ANDA215414	Camber Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-182_7575ca4b-9c64-4557-9c2d-01085682c3ff	31722-182	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210922		ANDA	ANDA215414	Camber Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-183_7575ca4b-9c64-4557-9c2d-01085682c3ff	31722-183	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210922		ANDA	ANDA215414	Camber Pharmaceuticals, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-184_7575ca4b-9c64-4557-9c2d-01085682c3ff	31722-184	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210922		ANDA	ANDA215414	Camber Pharmaceuticals, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-185_bcd965a0-adae-4726-8b11-a4e84cf59d84	31722-185	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-186_bcd965a0-adae-4726-8b11-a4e84cf59d84	31722-186	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-187_bcd965a0-adae-4726-8b11-a4e84cf59d84	31722-187	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-188_bcd965a0-adae-4726-8b11-a4e84cf59d84	31722-188	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-189_bcd965a0-adae-4726-8b11-a4e84cf59d84	31722-189	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-191_560e8cac-91f2-47dc-ac17-4d511598c49a	31722-191	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-192_560e8cac-91f2-47dc-ac17-4d511598c49a	31722-192	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-193_560e8cac-91f2-47dc-ac17-4d511598c49a	31722-193	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-194_560e8cac-91f2-47dc-ac17-4d511598c49a	31722-194	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-195_bcd965a0-adae-4726-8b11-a4e84cf59d84	31722-195	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Camber Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-203_6708697e-b1a3-4de8-b964-21969afb7834	31722-203	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	INJECTION	INTRAVENOUS	20220914		ANDA	ANDA216335	Camber Pharmaceuticals, Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
31722-204_0148eeab-875a-8927-e063-6394a90a6436	31722-204	HUMAN PRESCRIPTION DRUG	pantoprazole sodium		pantoprazole sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220518		ANDA	ANDA213778	Camber Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-205_e8c546a7-cc7c-a8de-e053-2995a90aad43	31722-205	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20220727		ANDA	ANDA216617	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN	10	mg/mL			N	20241231
31722-210_e449bca2-14c8-ae21-e053-2a95a90a942b	31722-210	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220706		ANDA	ANDA216591	Camber Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
31722-211_e449bca2-14c8-ae21-e053-2a95a90a942b	31722-211	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220706		ANDA	ANDA216591	Camber Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
31722-215_f16ae2ef-72ac-19ba-e053-2995a90a629b	31722-215	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221223		ANDA	ANDA216445	Camber Pharmaceuticals, Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
31722-216_ec153388-c19e-e94d-e053-2a95a90a6387	31722-216	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220923		ANDA	ANDA216413	Camber Pharmaceuticals, Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
31722-226_58aee470-56a6-4768-9049-d5df475abb6f	31722-226	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20230608		ANDA	ANDA217579	Camber Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-227_58aee470-56a6-4768-9049-d5df475abb6f	31722-227	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20230608		ANDA	ANDA217579	Camber Pharmaceuticals, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-229_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-229	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-230_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-230	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-231_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-231	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-232_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-232	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-233_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-233	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-234_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-234	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-235_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-235	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-236_81c8ba81-82ac-4c18-b28b-da9c71520f35	31722-236	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Camber Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-240_0e8f53a4-f374-84ba-e063-6394a90a3402	31722-240	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine extended-release	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA213949	Camber Pharmaceuticals Inc	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
31722-241_0e8f53a4-f374-84ba-e063-6394a90a3402	31722-241	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine extended-release	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA213949	Camber Pharmaceuticals Inc	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
31722-242_0e8f53a4-f374-84ba-e063-6394a90a3402	31722-242	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine extended-release	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA213949	Camber Pharmaceuticals Inc	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
31722-243_0e8f53a4-f374-84ba-e063-6394a90a3402	31722-243	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine extended-release	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA213949	Camber Pharmaceuticals Inc	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
31722-244_0e8f53a4-f374-84ba-e063-6394a90a3402	31722-244	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine extended-release	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA213949	Camber Pharmaceuticals Inc	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
31722-245_0e8f53a4-f374-84ba-e063-6394a90a3402	31722-245	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine extended-release	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA213949	Camber Pharmaceuticals Inc	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
31722-246_f6fdd0c0-59de-107a-e053-6394a90a097d	31722-246	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209598	Camber Pharmaceuticals, Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
31722-247_f6fdd0c0-59de-107a-e053-6394a90a097d	31722-247	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209598	Camber Pharmaceuticals, Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
31722-252_07467eb5-ee01-489e-e063-6294a90acb5b	31722-252	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230803		ANDA	ANDA217748	Camber Pharmaceuticals, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
31722-253_07467eb5-ee01-489e-e063-6294a90acb5b	31722-253	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230803		ANDA	ANDA217748	Camber Pharmaceuticals, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
31722-254_feb638aa-4380-7d6b-e053-6394a90a3537	31722-254	HUMAN PRESCRIPTION DRUG	Sugammadex		Sugammadex	INJECTION	INTRAVENOUS	20230609		ANDA	ANDA214337	Camber Pharmaceuticals, Inc.	SUGAMMADEX SODIUM	100	mg/mL	gamma-Cyclodextrins [CS]		N	20241231
31722-255_feb638aa-4380-7d6b-e053-6394a90a3537	31722-255	HUMAN PRESCRIPTION DRUG	Sugammadex		Sugammadex	INJECTION, SOLUTION	INTRAVENOUS	20230609		ANDA	ANDA214337	Camber Pharmaceuticals, Inc.	SUGAMMADEX SODIUM	100	mg/mL	gamma-Cyclodextrins [CS]		N	20241231
31722-257_0058f220-5404-504f-e063-6394a90aebdf	31722-257	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230511		ANDA	ANDA212414	Camber Pharmaceuticals, Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
31722-258_0058f220-5404-504f-e063-6394a90aebdf	31722-258	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230511		ANDA	ANDA212414	Camber Pharmaceuticals, Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
31722-259_0058f220-5404-504f-e063-6394a90aebdf	31722-259	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230511		ANDA	ANDA212414	Camber Pharmaceuticals, Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
31722-260_0058f220-5404-504f-e063-6394a90aebdf	31722-260	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230511		ANDA	ANDA212414	Camber Pharmaceuticals, Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
31722-261_0058f220-5404-504f-e063-6394a90aebdf	31722-261	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230511		ANDA	ANDA212414	Camber Pharmaceuticals, Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
31722-262_0058f220-5404-504f-e063-6394a90aebdf	31722-262	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230511		ANDA	ANDA212414	Camber Pharmaceuticals, Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
31722-284_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-284	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-285_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-285	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-286_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-286	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-287_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-287	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-288_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-288	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-289_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-289	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-290_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-290	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-291_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-291	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-292_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-292	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-293_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-293	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-294_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-294	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.2	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-295_7c79df0b-836b-479b-a7a6-8e09b802a84e	31722-295	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Camber Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.3	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
31722-305_ffa9181e-285d-5838-e053-6394a90a3aae	31722-305	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230620		ANDA	ANDA217166	Camber Pharmaceuticals, Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-306_ffa9181e-285d-5838-e053-6394a90a3aae	31722-306	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230620		ANDA	ANDA217166	Camber Pharmaceuticals, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-308_f869b52f-c488-746b-e053-6394a90a48d8	31722-308	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR	20230322		ANDA	ANDA217466	Camber Pharmaceuticals, Inc.	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]		N	20241231
31722-315_fc593488-95d5-4f44-b59f-86474c6c6c4d	31722-315	HUMAN PRESCRIPTION DRUG	IBUPROFEN AND FAMOTIDINE		Ibuprofen and famotidine	TABLET	ORAL	20230315		ANDA	ANDA216814	Camber Pharmaceuticals, Inc.	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-424_067aa82f-d0f9-2a39-e063-6294a90a1172	31722-424	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210815		ANDA	ANDA214344	Camber Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-425_067aa82f-d0f9-2a39-e063-6294a90a1172	31722-425	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210815		ANDA	ANDA214344	Camber Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-426_067aa82f-d0f9-2a39-e063-6294a90a1172	31722-426	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210815		ANDA	ANDA214344	Camber Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-427_067aa82f-d0f9-2a39-e063-6294a90a1172	31722-427	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210815		ANDA	ANDA214344	Camber Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-428_04c5089e-5884-263e-e063-6394a90aed54	31722-428	HUMAN PRESCRIPTION DRUG	Eslicarbazepine acetate		Eslicarbazepine acetate	TABLET	ORAL	20230803		ANDA	ANDA211186	Camber Pharmaceuticals, Inc.	ESLICARBAZEPINE ACETATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-429_04c5089e-5884-263e-e063-6394a90aed54	31722-429	HUMAN PRESCRIPTION DRUG	Eslicarbazepine acetate		Eslicarbazepine acetate	TABLET	ORAL	20230803		ANDA	ANDA211186	Camber Pharmaceuticals, Inc.	ESLICARBAZEPINE ACETATE	400	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-430_04c5089e-5884-263e-e063-6394a90aed54	31722-430	HUMAN PRESCRIPTION DRUG	Eslicarbazepine acetate		Eslicarbazepine acetate	TABLET	ORAL	20230803		ANDA	ANDA211186	Camber Pharmaceuticals, Inc.	ESLICARBAZEPINE ACETATE	600	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-431_04c5089e-5884-263e-e063-6394a90aed54	31722-431	HUMAN PRESCRIPTION DRUG	Eslicarbazepine acetate		Eslicarbazepine acetate	TABLET	ORAL	20230803		ANDA	ANDA211186	Camber Pharmaceuticals, Inc.	ESLICARBAZEPINE ACETATE	800	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-434_0e6cf824-98ae-5d94-e063-6394a90a84ef	31722-434	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET, FILM COATED	ORAL	20231120		ANDA	ANDA213669	Camber Pharmaceuticals, Inc.	BREXPIPRAZOLE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20251231
31722-435_0e6cf824-98ae-5d94-e063-6394a90a84ef	31722-435	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET, FILM COATED	ORAL	20231120		ANDA	ANDA213669	Camber Pharmaceuticals, Inc.	BREXPIPRAZOLE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
31722-436_0e6cf824-98ae-5d94-e063-6394a90a84ef	31722-436	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET, FILM COATED	ORAL	20231120		ANDA	ANDA213669	Camber Pharmaceuticals, Inc.	BREXPIPRAZOLE	1	mg/1	Atypical Antipsychotic [EPC]		N	20251231
31722-437_0e6cf824-98ae-5d94-e063-6394a90a84ef	31722-437	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET, FILM COATED	ORAL	20231120		ANDA	ANDA213669	Camber Pharmaceuticals, Inc.	BREXPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20251231
31722-438_0e6cf824-98ae-5d94-e063-6394a90a84ef	31722-438	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET, FILM COATED	ORAL	20231120		ANDA	ANDA213669	Camber Pharmaceuticals, Inc.	BREXPIPRAZOLE	3	mg/1	Atypical Antipsychotic [EPC]		N	20251231
31722-439_0e6cf824-98ae-5d94-e063-6394a90a84ef	31722-439	HUMAN PRESCRIPTION DRUG	Brexpiprazole		Brexpiprazole	TABLET, FILM COATED	ORAL	20231120		ANDA	ANDA213669	Camber Pharmaceuticals, Inc.	BREXPIPRAZOLE	4	mg/1	Atypical Antipsychotic [EPC]		N	20251231
31722-500_ee32d5bd-38fb-4a93-e053-2a95a90a0464	31722-500	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20080529		ANDA	ANDA040805	Camber Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
31722-501_ee32d5bd-38fb-4a93-e053-2a95a90a0464	31722-501	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20080529		ANDA	ANDA040805	Camber Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
31722-502_ee32d5bd-38fb-4a93-e053-2a95a90a0464	31722-502	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20080529		ANDA	ANDA040805	Camber Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
31722-504_fbbb1836-2fa8-f7a6-e053-6394a90a8718	31722-504	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	TABLET, FILM COATED	ORAL	20180427		ANDA	ANDA078886	Camber Pharmaceuticals, Inc.	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c	31722-505	HUMAN PRESCRIPTION DRUG	Nevirapine		Nevirapine	TABLET	ORAL	20120523		ANDA	ANDA078584	Camber Pharmaceuticals, Inc.	NEVIRAPINE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-506_e8ca069d-b3f8-35bf-e053-2a95a90a0699	31722-506	HUMAN PRESCRIPTION DRUG	LAMIVUDINE and ZIDOVUDINE		LAMIVUDINE and ZIDOVUDINE	TABLET, FILM COATED	ORAL	20150918		ANDA	ANDA079124	Camber Pharmaceuticals, Inc.	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-509_fbbb4305-5ef7-b4b5-e053-6294a90a278c	31722-509	HUMAN PRESCRIPTION DRUG	Zidovudine		Zidovudine	TABLET	ORAL	20080425		ANDA	ANDA090092	Camber Pharmaceuticals, Inc.	ZIDOVUDINE	300	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-510_00582961-060a-58b6-e063-6394a90aa25a	31722-510	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA200895	Camber Pharmaceuticals, Inc.	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-511_00582961-060a-58b6-e063-6394a90aa25a	31722-511	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA200895	Camber Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-512_00582961-060a-58b6-e063-6394a90aa25a	31722-512	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA200895	Camber Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-513_00582961-060a-58b6-e063-6394a90aa25a	31722-513	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20141203		ANDA	ANDA200895	Camber Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-514_00582961-060a-58b6-e063-6394a90aa25a	31722-514	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA200895	Camber Pharmaceuticals, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-519_b53c7dd5-5e4b-4179-b171-da7eada45a24	31722-519	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Camber Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
31722-520_b53c7dd5-5e4b-4179-b171-da7eada45a24	31722-520	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Camber Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
31722-521_b53c7dd5-5e4b-4179-b171-da7eada45a24	31722-521	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Camber Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
31722-522_b53c7dd5-5e4b-4179-b171-da7eada45a24	31722-522	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Camber Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
31722-525_509abf9e-c201-4189-9499-01562e8afdd3	31722-525	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150613		ANDA	ANDA090061	Camber Pharmaceuticals, Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
31722-526_0ebbabf3-0681-484d-ab8d-58e670d80a0d	31722-526	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090060	Camber Pharmaceuticals, Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
31722-527_0c6e00a2-31e8-4e84-928d-80e69a5fc634	31722-527	HUMAN PRESCRIPTION DRUG	omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190926		ANDA	ANDA204012	Camber Pharmaceuticals, Inc.	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-528_0c6e00a2-31e8-4e84-928d-80e69a5fc634	31722-528	HUMAN PRESCRIPTION DRUG	omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190926		ANDA	ANDA204012	Camber Pharmaceuticals, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-529_4ee76b17-e459-457b-b67a-bb062a408150	31722-529	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	Camber Pharmaceuticals, Inc.	TORSEMIDE	5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
31722-530_4ee76b17-e459-457b-b67a-bb062a408150	31722-530	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	Camber Pharmaceuticals, Inc.	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
31722-531_4ee76b17-e459-457b-b67a-bb062a408150	31722-531	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	Camber Pharmaceuticals, Inc.	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
31722-532_4ee76b17-e459-457b-b67a-bb062a408150	31722-532	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	Camber Pharmaceuticals, Inc.	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
31722-533_bf48c1c6-3723-1fde-e053-2995a90af824	31722-533	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Camber Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
31722-534_bf48c1c6-3723-1fde-e053-2995a90af824	31722-534	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Camber Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
31722-535_f3388e9a-2c01-de8d-e053-2a95a90aa213	31722-535	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA090636	Camber Pharmaceuticals, Inc.	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
31722-536_49199764-7b0e-401e-b6a1-252204a35a14	31722-536	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Camber Pharmaceuticals, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-537_49199764-7b0e-401e-b6a1-252204a35a14	31722-537	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Camber Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-538_49199764-7b0e-401e-b6a1-252204a35a14	31722-538	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Camber Pharmaceuticals, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-539_49199764-7b0e-401e-b6a1-252204a35a14	31722-539	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Camber Pharmaceuticals, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-542_ee36e7dd-8f63-76d3-e053-2995a90aab8c	31722-542	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Camber Pharmaceuticals, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-543_ee36e7dd-8f63-76d3-e053-2995a90aab8c	31722-543	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Camber Pharmaceuticals, Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-544_f0c7a72e-0f38-6613-e053-2a95a90a612c	31722-544	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20091215		ANDA	ANDA090702	Camber Pharmaceuticals, Inc.	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
31722-545_f0c7a72e-0f38-6613-e053-2a95a90a612c	31722-545	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20091215		ANDA	ANDA090702	Camber Pharmaceuticals, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
31722-546_f0c7a72e-0f38-6613-e053-2a95a90a612c	31722-546	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20091215		ANDA	ANDA090702	Camber Pharmaceuticals, Inc.	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
31722-551_3bcef19b-a3e5-4ff6-be82-e0a1d2fa0037	31722-551	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20120629		ANDA	ANDA091264	Camber Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
31722-556_c3de2763-2221-d566-e053-2995a90ab15f	31722-556	HUMAN PRESCRIPTION DRUG	Lopinavir and ritonavir		Lopinavir and ritonavir	TABLET, FILM COATED	ORAL	20210607		ANDA	ANDA091677	Camber Pharmaceuticals, Inc.	LOPINAVIR; RITONAVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
31722-557_cadff788-2bc6-48e3-af25-392802a99c2c	31722-557	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET	ORAL	20130918		ANDA	ANDA091560	Camber Pharmaceuticals, Inc.	ABACAVIR SULFATE	300	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-560_d7fc2529-1ef3-7206-e053-2a95a90a4c9a	31722-560	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20211007		ANDA	ANDA201806	Camber Pharmaceuticals, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
31722-562_34da1f28-8687-4286-a674-ac3cb61440f5	31722-562	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	SOLUTION	ORAL	20160926		ANDA	ANDA201107	Camber Pharmaceuticals, Inc.	ABACAVIR SULFATE	20	mg/mL	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-564_129dea0d-157f-4ad1-8de6-ea4ecc0feffe	31722-564	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	SOLUTION	ORAL	20151221		ANDA	ANDA201450	Camber Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
31722-565_be88b60c-b961-435d-b2c6-689102a61b8b	31722-565	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20150724		ANDA	ANDA201807	Camber Pharmaceuticals, Inc.	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-567_06f285d0-a267-615d-e063-6394a90a68ff	31722-567	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20230914		ANDA	ANDA202083	Camber Pharmaceuticals, Inc.	DARUNAVIR	400	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
31722-568_06f285d0-a267-615d-e063-6394a90a68ff	31722-568	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20230914		ANDA	ANDA202083	Camber Pharmaceuticals, Inc.	DARUNAVIR	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
31722-569_f51e5509-d719-9ffa-e053-2a95a90a9d56	31722-569	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	SOLUTION	ORAL	20120612		ANDA	ANDA202221	Camber Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
31722-570_03b7dceb-2128-4324-b068-7f76a2d9887e	31722-570	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200518		ANDA	ANDA203083	Camber Pharmaceuticals, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-571_03b7dceb-2128-4324-b068-7f76a2d9887e	31722-571	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200518		ANDA	ANDA203083	Camber Pharmaceuticals, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-574_edd2b32c-2a35-48fe-bd50-4defa42c3fb1	31722-574	HUMAN PRESCRIPTION DRUG	Levetiracetam	Levetiracetam	Levetiracetam	SOLUTION	ORAL	20150611		ANDA	ANDA203052	Camber Pharmaceuticals, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-579_d6904ba1-cfd4-b9e4-e053-2a95a90a1106	31722-579	HUMAN PRESCRIPTION DRUG	Maraviroc		Maraviroc	TABLET, FILM COATED	ORAL	20220206		ANDA	ANDA203347	Camber Pharmaceuticals, Inc.	MARAVIROC	150	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
31722-580_d6904ba1-cfd4-b9e4-e053-2a95a90a1106	31722-580	HUMAN PRESCRIPTION DRUG	Maraviroc		Maraviroc	TABLET, FILM COATED	ORAL	20220206		ANDA	ANDA203347	Camber Pharmaceuticals, Inc.	MARAVIROC	300	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
31722-581_74de48c9-1785-40b1-b55f-e3bc1641f8d9	31722-581	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160811		ANDA	ANDA204343	Camber Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-582_74de48c9-1785-40b1-b55f-e3bc1641f8d9	31722-582	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160811		ANDA	ANDA204343	Camber Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-583_74de48c9-1785-40b1-b55f-e3bc1641f8d9	31722-583	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160811		ANDA	ANDA204343	Camber Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
31722-585_c9f7f6d8-2d97-fc90-e053-2a95a90af0f8	31722-585	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203825	Camber Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-586_c9f7f6d8-2d97-fc90-e053-2a95a90af0f8	31722-586	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203825	Camber Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-587_c9f7f6d8-2d97-fc90-e053-2a95a90af0f8	31722-587	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203825	Camber Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-588_c9f7f6d8-2d97-fc90-e053-2a95a90af0f8	31722-588	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203825	Camber Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-589_f57120d2-136e-b289-e053-2995a90ad0b8	31722-589	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201106		ANDA	ANDA205541	Camber Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-590_f57120d2-136e-b289-e053-2995a90ad0b8	31722-590	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201106		ANDA	ANDA205541	Camber Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-591_f57120d2-136e-b289-e053-2995a90ad0b8	31722-591	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201106		ANDA	ANDA205541	Camber Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-592_f57120d2-136e-b289-e053-2995a90ad0b8	31722-592	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201106		ANDA	ANDA205541	Camber Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
31722-595_da9f8c91-31dc-43a9-b3e5-986b46b777ac	31722-595	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20160714		ANDA	ANDA204598	Camber Pharmaceuticals, Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
31722-596_da9f8c91-31dc-43a9-b3e5-986b46b777ac	31722-596	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20160714		ANDA	ANDA204598	Camber Pharmaceuticals, Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
31722-597_f5490379-7440-5901-e053-2a95a90ac1f4	31722-597	HUMAN PRESCRIPTION DRUG	Ritonavir		Ritonavir	TABLET	ORAL	20180917		ANDA	ANDA204587	Camber Pharmaceuticals, Inc.	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
31722-598_c3c611a2-394b-4427-e053-2a95a90a433f	31722-598	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA204993	Camber Pharmaceuticals, Inc.	RUFINAMIDE	200	mg/1			N	20241231
31722-599_c3c611a2-394b-4427-e053-2a95a90a433f	31722-599	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA204993	Camber Pharmaceuticals, Inc.	RUFINAMIDE	400	mg/1			N	20241231
31722-603_c3de2763-2221-d566-e053-2995a90ab15f	31722-603	HUMAN PRESCRIPTION DRUG	Lopinavir and ritonavir		Lopinavir and ritonavir	TABLET, FILM COATED	ORAL	20210607		ANDA	ANDA091677	Camber Pharmaceuticals, Inc.	LOPINAVIR; RITONAVIR	100; 25	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
31722-607_e16012ae-5972-470b-8a22-b0626a029e95	31722-607	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20170602		ANDA	ANDA206419	Camber Pharmaceuticals, Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
31722-608_e16012ae-5972-470b-8a22-b0626a029e95	31722-608	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20170602		ANDA	ANDA206419	Camber Pharmaceuticals, Inc.	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
31722-610_241c4b7e-f719-4828-8639-ea613b8a6583	31722-610	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
31722-611_241c4b7e-f719-4828-8639-ea613b8a6583	31722-611	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
31722-612_241c4b7e-f719-4828-8639-ea613b8a6583	31722-612	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
31722-613_241c4b7e-f719-4828-8639-ea613b8a6583	31722-613	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
31722-614_241c4b7e-f719-4828-8639-ea613b8a6583	31722-614	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
31722-615_241c4b7e-f719-4828-8639-ea613b8a6583	31722-615	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
31722-616_241c4b7e-f719-4828-8639-ea613b8a6583	31722-616	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	225	mg/1		CV	N	20241231
31722-617_241c4b7e-f719-4828-8639-ea613b8a6583	31722-617	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Camber Pharmaceuticals, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
31722-621_fff4463f-e37e-d8d5-e053-6294a90ac49e	31722-621	HUMAN PRESCRIPTION DRUG	Dabigatran Etexilate		Dabigatran Etexilate	CAPSULE	ORAL	20200506		ANDA	ANDA207961	Camber Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	75	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
31722-622_fff4463f-e37e-d8d5-e053-6294a90ac49e	31722-622	HUMAN PRESCRIPTION DRUG	Dabigatran Etexilate		Dabigatran Etexilate	CAPSULE	ORAL	20200506		ANDA	ANDA207961	Camber Pharmaceuticals, Inc.	DABIGATRAN ETEXILATE MESYLATE	150	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
31722-623_fa61de4b-e3e1-e16c-e053-6394a90a6118	31722-623	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20221015		ANDA	ANDA208213	Camber Pharmaceuticals, Inc.	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
31722-627_eeabafb5-f74e-755e-e053-2995a90a52e5	31722-627	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20220531		ANDA	ANDA209301	Camber Pharmaceuticals, Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
31722-628_d77f72ed-633d-dd26-e053-2995a90a98d8	31722-628	HUMAN PRESCRIPTION DRUG	EZETIMIBE		EZETIMIBE	TABLET	ORAL	20220213		ANDA	ANDA210859	Camber Pharmaceuticals, Inc.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
31722-629_525cd202-a971-44fb-829b-7cabcb0e40e3	31722-629	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20181011		ANDA	ANDA210692	Camber Pharmaceuticals, Inc.	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
31722-630_2a673aa2-e8f0-4aa4-8782-6fb3067ff108	31722-630	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Camber Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1			N	20241231
31722-631_2a673aa2-e8f0-4aa4-8782-6fb3067ff108	31722-631	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Camber Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1			N	20241231
31722-632_2a673aa2-e8f0-4aa4-8782-6fb3067ff108	31722-632	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Camber Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1			N	20241231
31722-635_b9880aad-5fbe-470b-a7a0-d963ba4bc98b	31722-635	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20200214		ANDA	ANDA204793	Camber Pharmaceuticals, Inc.	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
31722-636_b9880aad-5fbe-470b-a7a0-d963ba4bc98b	31722-636	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20200214		ANDA	ANDA204793	Camber Pharmaceuticals, Inc.	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
31722-639_f4de34fd-275d-24e1-e053-2995a90afb43	31722-639	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181022		ANDA	ANDA209795	Camber Pharmaceuticals, Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
31722-640_f4de34fd-275d-24e1-e053-2995a90afb43	31722-640	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20181022		ANDA	ANDA209795	Camber Pharmaceuticals, Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
31722-641_f4e0965c-10a9-5b3c-e053-2995a90a4a5f	31722-641	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20200224		ANDA	ANDA209796	Camber Pharmaceuticals, Inc.	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
31722-643_a3892605-4eb1-4d6e-a675-f7f7d4302f38	31722-643	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209908	Camber Pharmaceuticals, Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-644_a3892605-4eb1-4d6e-a675-f7f7d4302f38	31722-644	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209908	Camber Pharmaceuticals, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-645_a3892605-4eb1-4d6e-a675-f7f7d4302f38	31722-645	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209908	Camber Pharmaceuticals, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-646_a3892605-4eb1-4d6e-a675-f7f7d4302f38	31722-646	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209908	Camber Pharmaceuticals, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-647_0b3039c8-da1b-416b-e063-6294a90ae7c2	31722-647	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190205		ANDA	ANDA209907	Camber Pharmaceuticals, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-653_d7089d2c-e059-49d3-e053-2a95a90a3dd5	31722-653	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20220207		ANDA	ANDA212278	Camber Pharmaceuticals, Inc.	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
31722-654_d7089d2c-e059-49d3-e053-2a95a90a3dd5	31722-654	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20220207		ANDA	ANDA212278	Camber Pharmaceuticals, Inc.	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
31722-655_d7089d2c-e059-49d3-e053-2a95a90a3dd5	31722-655	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20220207		ANDA	ANDA212278	Camber Pharmaceuticals, Inc.	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
31722-657_f8b7f421-0595-0fae-e053-6394a90a43c7	31722-657	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		DIMETHYL FUMARATE	CAPSULE, DELAYED RELEASE	ORAL	20200924		ANDA	ANDA210500	Camber Pharmaceuticals, Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
31722-658_f8b7f421-0595-0fae-e053-6394a90a43c7	31722-658	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		DIMETHYL FUMARATE	CAPSULE, DELAYED RELEASE	ORAL	20200924		ANDA	ANDA210500	Camber Pharmaceuticals, Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
31722-659_f7acb0a4-3398-4d1b-8828-8435017d2497	31722-659	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	SOLUTION	ORAL	20190401		ANDA	ANDA210914	Camber Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	2.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
31722-664_f296f8da-f1b9-7e88-e053-2995a90aef24	31722-664	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA211977	Camber Pharmaceuticals, Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-665_f296f8da-f1b9-7e88-e053-2995a90aef24	31722-665	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA211977	Camber Pharmaceuticals, Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-668_dedfd14d-159a-50cc-e053-2995a90a016b	31722-668	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220505		ANDA	ANDA212788	Camber Pharmaceuticals, Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
31722-669_dedfd14d-159a-50cc-e053-2995a90a016b	31722-669	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220505		ANDA	ANDA212788	Camber Pharmaceuticals, Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
31722-676_fa61de4b-e3e1-e16c-e053-6394a90a6118	31722-676	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20230418		ANDA	ANDA208213	Camber Pharmaceuticals, Inc.	ROFLUMILAST	250	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
31722-677_f00382d7-d652-18a4-e053-2995a90a58d1	31722-677	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20221208		ANDA	ANDA214321	Camber Pharmaceuticals, Inc.	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
31722-678_09a2708f-ed1b-b986-e063-6394a90a8fb5	31722-678	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline tartrate	TABLET, FILM COATED	ORAL	20231023		ANDA	ANDA214571	Camber Pharmaceuticals, Inc.	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
31722-679_09a2708f-ed1b-b986-e063-6394a90a8fb5	31722-679	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline tartrate	TABLET, FILM COATED	ORAL	20231023		ANDA	ANDA214571	Camber Pharmaceuticals, Inc.	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
31722-680_f8b7f421-0595-0fae-e053-6394a90a43c7	31722-680	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		dimethyl fumarate	KIT		20200924		ANDA	ANDA210500	Camber Pharmaceuticals, Inc.						N	20241231
31722-681_e87a8107-f6d9-5bf2-e053-2a95a90afc80	31722-681	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	SUSPENSION	ORAL	20220701		ANDA	ANDA215669	Camber Pharmaceuticals, Inc.	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-682_f5325374-95a9-888c-e053-2a95a90ac59d	31722-682	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	SUSPENSION	ORAL	20220607		ANDA	ANDA215776	Camber Pharmaceuticals, Inc.	NAPROXEN	25	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-683_e53ee9ec-7121-2b81-e053-2a95a90afe9f	31722-683	HUMAN PRESCRIPTION DRUG	TRIENTINE HYDROCHLORIDE		TRIENTINE HYDROCHLORIDE	CAPSULE	ORAL	20220623		ANDA	ANDA216356	Camber Pharmaceuticals, Inc.	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
31722-686_eb4bc57d-9d4e-14b8-e053-2a95a90a8729	31722-686	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20220825		ANDA	ANDA216651	Camber Pharmaceuticals, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
31722-687_092949c0-66ac-6323-e063-6394a90a3ae1	31722-687	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	SUSPENSION	ORAL	20231020		ANDA	ANDA216749	Camber Pharmaceuticals, Inc.	OXCARBAZEPINE	60	mg/mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
31722-688_0d914e03-3610-c662-e063-6294a90a5430	31722-688	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	SUSPENSION	ORAL	20231205		ANDA	ANDA216841	Camber Pharmaceuticals, Inc.	RUFINAMIDE	40	mg/mL			N	20241231
31722-690_09a2708f-ed1b-b986-e063-6394a90a8fb5	31722-690	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline tartrate	KIT		20231023		ANDA	ANDA214571	Camber Pharmaceuticals, Inc.						N	20241231
31722-700_ef63ba56-c284-4da0-a2e9-e0ba16442a66	31722-700	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Camber Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-701_ef63ba56-c284-4da0-a2e9-e0ba16442a66	31722-701	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Camber Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-702_ef63ba56-c284-4da0-a2e9-e0ba16442a66	31722-702	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Camber Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-704_be6fd5b1-3f97-09f6-e053-2995a90a2272	31722-704	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	Camber Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-705_be6fd5b1-3f97-09f6-e053-2995a90a2272	31722-705	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	Camber Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-706_bbad4d2d-87e5-0adb-e053-2995a90acf1b	31722-706	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202438	Camber Pharmaceuticals, Inc.	FAMCICLOVIR	125	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-707_bbad4d2d-87e5-0adb-e053-2995a90acf1b	31722-707	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202438	Camber Pharmaceuticals, Inc.	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-708_bbad4d2d-87e5-0adb-e053-2995a90acf1b	31722-708	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202438	Camber Pharmaceuticals, Inc.	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-709_dc1c1ddb-f16b-4d7a-aabe-cf8bdf8b7998	31722-709	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-710_dc1c1ddb-f16b-4d7a-aabe-cf8bdf8b7998	31722-710	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-711_dc1c1ddb-f16b-4d7a-aabe-cf8bdf8b7998	31722-711	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-712_e44a0136-fc34-0abe-e053-2a95a90a6767	31722-712	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Camber Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-713_e44a0136-fc34-0abe-e053-2a95a90a6767	31722-713	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Camber Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
31722-714_bdf74b27-8e7e-e4d6-e053-2a95a90a7b1a	31722-714	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	Camber Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-715_bdf74b27-8e7e-e4d6-e053-2a95a90a7b1a	31722-715	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	Camber Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-716_bdf74b27-8e7e-e4d6-e053-2a95a90a7b1a	31722-716	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	Camber Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-717_bdf74b27-8e7e-e4d6-e053-2a95a90a7b1a	31722-717	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	Camber Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-718_bdf74b27-8e7e-e4d6-e053-2a95a90a7b1a	31722-718	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	Camber Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-719_bdf74b27-8e7e-e4d6-e053-2a95a90a7b1a	31722-719	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	Camber Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-720_bdf74b27-8e7e-e4d6-e053-2a95a90a7b1a	31722-720	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	Camber Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
31722-721_548b829b-08e0-45a6-8319-34eefadb79b8	31722-721	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Camber Pharmaceuticals, Inc.	LEVOFLOXACIN	250	mg/1			N	20241231
31722-722_548b829b-08e0-45a6-8319-34eefadb79b8	31722-722	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Camber Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
31722-723_548b829b-08e0-45a6-8319-34eefadb79b8	31722-723	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Camber Pharmaceuticals, Inc.	LEVOFLOXACIN	750	mg/1			N	20241231
31722-726_c545bd81-2e5a-22f3-e053-2a95a90a3654	31722-726	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	Camber Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
31722-727_c503ea71-c663-3cfc-e053-2a95a90a9aaa	31722-727	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20150527		ANDA	ANDA204093	Camber Pharmaceuticals, Inc.	MONTELUKAST	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
31722-728_c503ea71-c663-3cfc-e053-2a95a90a9aaa	31722-728	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20150527		ANDA	ANDA204093	Camber Pharmaceuticals, Inc.	MONTELUKAST	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
31722-729_088a5ed0-89a1-c72a-e063-6394a90a74af	31722-729	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	Camber Pharmaceuticals, Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-730_088a5ed0-89a1-c72a-e063-6394a90a74af	31722-730	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	Camber Pharmaceuticals, Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-731_088a5ed0-89a1-c72a-e063-6394a90a74af	31722-731	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	Camber Pharmaceuticals, Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-736_e4da0a36-7416-0c27-e053-2995a90a99f9	31722-736	HUMAN PRESCRIPTION DRUG	Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate		Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20220124		ANDA	ANDA203053	Camber Pharmaceuticals, Inc.	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
31722-737_f994d1c2-8255-d363-e053-6394a90ab68c	31722-737	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20150202		ANDA	ANDA203034	Camber Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
31722-738_f994d1c2-8255-d363-e053-6394a90ab68c	31722-738	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20150202		ANDA	ANDA203034	Camber Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
31722-739_bbacfc3f-f4b1-52b0-e053-2a95a90aec76	31722-739	HUMAN PRESCRIPTION DRUG	Lamivudine and Zidovudine		Lamivudine and Zidovudine	TABLET, FILM COATED	ORAL	20140206		ANDA	ANDA203259	Camber Pharmaceuticals, Inc.	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-745_222acee8-e4e7-4ed3-8965-47a1cde2298c	31722-745	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-746_222acee8-e4e7-4ed3-8965-47a1cde2298c	31722-746	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-747_222acee8-e4e7-4ed3-8965-47a1cde2298c	31722-747	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-748_222acee8-e4e7-4ed3-8965-47a1cde2298c	31722-748	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA203311	Camber Pharmaceuticals, Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
31722-749_03b4c341-17b8-46ca-9096-acc19ba3c740	31722-749	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA204239	Camber Pharmaceuticals, Inc.	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
31722-752_d9e41de4-7a94-4081-b233-833b33e67ad6	31722-752	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20140102		ANDA	ANDA203260	Camber Pharmaceuticals, Inc.	LAMIVUDINE	100	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-753_f61245ec-3e83-4bf6-bb95-8e4ff81bb6b7	31722-753	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20140106		ANDA	ANDA203277	Camber Pharmaceuticals, Inc.	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-754_f61245ec-3e83-4bf6-bb95-8e4ff81bb6b7	31722-754	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20140106		ANDA	ANDA203277	Camber Pharmaceuticals, Inc.	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-758_04d99965-cea0-8e7d-e063-6394a90ab281	31722-758	HUMAN PRESCRIPTION DRUG	CLOPIDOGREL		CLOPIDOGREL	TABLET	ORAL	20230804		ANDA	ANDA205345	Camber Pharmaceuticals, Inc.	CLOPIDOGREL	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
31722-759_04d99965-cea0-8e7d-e063-6394a90ab281	31722-759	HUMAN PRESCRIPTION DRUG	CLOPIDOGREL		CLOPIDOGREL	TABLET	ORAL	20230804		ANDA	ANDA205345	Camber Pharmaceuticals, Inc.	CLOPIDOGREL	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
31722-764_e6811a27-0a08-78b3-e053-2995a90a90b3	31722-764	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA204316	Camber Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-765_e6811a27-0a08-78b3-e053-2995a90a90b3	31722-765	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA204316	Camber Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-766_e6811a27-0a08-78b3-e053-2995a90a90b3	31722-766	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA204316	Camber Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-767_e6811a27-0a08-78b3-e053-2995a90a90b3	31722-767	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA204316	Camber Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-768_e6811a27-0a08-78b3-e053-2995a90a90b3	31722-768	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA204316	Camber Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-769_e6811a27-0a08-78b3-e053-2995a90a90b3	31722-769	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA204316	Camber Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-776_f79e9bff-ee37-27a2-e053-6294a90a54f8	31722-776	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-777_bf4dff3e-da07-2dcf-e053-2995a90ad606	31722-777	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	Camber Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-778_bf4dff3e-da07-2dcf-e053-2995a90ad606	31722-778	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	Camber Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
31722-805_c9a8a649-3330-59a0-e053-2995a90ad3c3	31722-805	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20210802		ANDA	ANDA204397	Camber Pharmaceuticals, Inc.	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
31722-806_c9a8a649-3330-59a0-e053-2995a90ad3c3	31722-806	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20210802		ANDA	ANDA204397	Camber Pharmaceuticals, Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
31722-807_eabf0e61-425e-9c9f-e053-2a95a90ade8e	31722-807	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA204389	Camber Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
31722-808_eabf0e61-425e-9c9f-e053-2a95a90ade8e	31722-808	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA204389	Camber Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
31722-812_ef3bd810-b27b-6ac2-e053-2995a90ac997	31722-812	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204787	Camber Pharmaceuticals, Inc.	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
31722-813_ef3bd810-b27b-6ac2-e053-2995a90ac997	31722-813	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204787	Camber Pharmaceuticals, Inc.	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
31722-814_ef3bd810-b27b-6ac2-e053-2995a90ac997	31722-814	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204787	Camber Pharmaceuticals, Inc.	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
31722-815_ef3bd810-b27b-6ac2-e053-2995a90ac997	31722-815	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204787	Camber Pharmaceuticals, Inc.	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
31722-819_fbe045fd-8e53-3f95-e053-6394a90a3001	31722-819	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-820_fbe045fd-8e53-3f95-e053-6394a90a3001	31722-820	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-821_3a2ffa8c-f4c5-47e2-8775-5d0edfa55658	31722-821	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET, COATED	ORAL	20150817		ANDA	ANDA204574	Camber Pharmaceuticals, Inc.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
31722-822_3a2ffa8c-f4c5-47e2-8775-5d0edfa55658	31722-822	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET, COATED	ORAL	20150817		ANDA	ANDA204574	Camber Pharmaceuticals, Inc.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
31722-827_fbe045fd-8e53-3f95-e053-6394a90a3001	31722-827	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-828_fbe045fd-8e53-3f95-e053-6394a90a3001	31722-828	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-829_fbe045fd-8e53-3f95-e053-6394a90a3001	31722-829	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-830_fbe045fd-8e53-3f95-e053-6394a90a3001	31722-830	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-832_323351f4-9d68-40a8-b77e-aaf46cc0f1f2	31722-832	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET, FILM COATED	ORAL	20160318		ANDA	ANDA205166	Camber Pharmaceuticals, Inc.	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
31722-833_b0469a25-eb70-451f-a836-514908b1e784	31722-833	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20150821		ANDA	ANDA205740	Camber Pharmaceuticals, Inc.	ENTECAVIR ANHYDROUS	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-834_b0469a25-eb70-451f-a836-514908b1e784	31722-834	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20150821		ANDA	ANDA205740	Camber Pharmaceuticals, Inc.	ENTECAVIR ANHYDROUS	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
31722-837_eaad537e-d8e5-24a2-e053-2a95a90ad075	31722-837	HUMAN PRESCRIPTION DRUG	VALGANCICLOVIR		VALGANCICLOVIR HYDROCHLORIDE	POWDER, FOR SOLUTION	ORAL	20221004		ANDA	ANDA211475	Camber Pharmaceuticals, Inc.	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
31722-845_f6e9a43c-e301-ff1f-e053-6394a90a1458	31722-845	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20230302		ANDA	ANDA204836	Camber Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
31722-865_05657697-e108-9eaf-e063-6294a90a5d97	31722-865	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	GRANULE, FOR SUSPENSION	ORAL	20221031		ANDA	ANDA211813	Camber Pharmaceuticals, Inc.	LINEZOLID	100	mg/5mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
31722-868_e7e86fa1-8352-5245-e053-2995a90a70f6	31722-868	HUMAN PRESCRIPTION DRUG	Tolvaptan		Tolvaptan	TABLET	ORAL	20220906		ANDA	ANDA205646	Camber Pharmaceuticals, Inc.	TOLVAPTAN	15	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
31722-869_e7e86fa1-8352-5245-e053-2995a90a70f6	31722-869	HUMAN PRESCRIPTION DRUG	Tolvaptan		Tolvaptan	TABLET	ORAL	20210716		ANDA	ANDA205646	Camber Pharmaceuticals, Inc.	TOLVAPTAN	30	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
31722-872_fb680aba-6d5a-2676-e053-6294a90a467f	31722-872	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220921		ANDA	ANDA212674	Camber Pharmaceuticals, Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
31722-873_fb680aba-6d5a-2676-e053-6294a90a467f	31722-873	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220921		ANDA	ANDA212674	Camber Pharmaceuticals, Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
31722-874_e5f24116-74a6-1eb8-e053-2a95a90a28cc	31722-874	HUMAN PRESCRIPTION DRUG	SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID		SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID	POWDER, METERED	ORAL	20220718		ANDA	ANDA212789	Camber Pharmaceuticals, Inc.	ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE	12; 3.5; 10	g/16.1g; g/16.1g; mg/16.1g	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
31722-882_1218971e-525e-47cd-bde6-79dbc1140219	31722-882	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	Camber Pharmaceuticals, Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-883_1218971e-525e-47cd-bde6-79dbc1140219	31722-883	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	Camber Pharmaceuticals, Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-884_1218971e-525e-47cd-bde6-79dbc1140219	31722-884	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	Camber Pharmaceuticals, Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-885_1218971e-525e-47cd-bde6-79dbc1140219	31722-885	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	Camber Pharmaceuticals, Inc.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
31722-889_0d7e2183-0376-b98d-e063-6294a90ab465	31722-889	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod	CAPSULE	ORAL	20190927		ANDA	ANDA207933	Camber Pharmaceuticals, Inc.	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
31722-899_c9c0c7c1-6f07-596e-e053-2995a90aae1e	31722-899	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20210813		ANDA	ANDA208993	Camber Pharmaceuticals, Inc.	COLCHICINE	.6	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
31722-906_540a17f8-b64d-41e1-a96b-d55bc8c48f3d	31722-906	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE		PRAMIPEXOLE	TABLET	ORAL	20150801		ANDA	ANDA203855	Camber Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
31722-907_540a17f8-b64d-41e1-a96b-d55bc8c48f3d	31722-907	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE		PRAMIPEXOLE	TABLET	ORAL	20150801		ANDA	ANDA203855	Camber Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
31722-908_540a17f8-b64d-41e1-a96b-d55bc8c48f3d	31722-908	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE		PRAMIPEXOLE	TABLET	ORAL	20150801		ANDA	ANDA203855	Camber Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
31722-909_540a17f8-b64d-41e1-a96b-d55bc8c48f3d	31722-909	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE		PRAMIPEXOLE	TABLET	ORAL	20150801		ANDA	ANDA203855	Camber Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
31722-910_540a17f8-b64d-41e1-a96b-d55bc8c48f3d	31722-910	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE		PRAMIPEXOLE	TABLET	ORAL	20150801		ANDA	ANDA203855	Camber Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
31722-911_540a17f8-b64d-41e1-a96b-d55bc8c48f3d	31722-911	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE		PRAMIPEXOLE	TABLET	ORAL	20150801		ANDA	ANDA203855	Camber Pharmaceuticals, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
31722-917_89fb5e4f-0b68-42f8-a91f-8f07cbaec4b6	31722-917	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Camber Pharmaceuticals Inc	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-918_89fb5e4f-0b68-42f8-a91f-8f07cbaec4b6	31722-918	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Camber Pharmaceuticals Inc	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-919_c99f3445-aceb-47c7-9f35-4f906aad08aa	31722-919	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20170808		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-920_c99f3445-aceb-47c7-9f35-4f906aad08aa	31722-920	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20170801		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-921_c99f3445-aceb-47c7-9f35-4f906aad08aa	31722-921	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20170801		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-922_c99f3445-aceb-47c7-9f35-4f906aad08aa	31722-922	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20170801		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-923_c99f3445-aceb-47c7-9f35-4f906aad08aa	31722-923	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20170801		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-924_c99f3445-aceb-47c7-9f35-4f906aad08aa	31722-924	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20170801		ANDA	ANDA205064	Camber Pharmaceuticals, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
31722-926_3547512f-45f7-4c6a-8fb0-2144eff24b11	31722-926	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	Camber Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-927_3547512f-45f7-4c6a-8fb0-2144eff24b11	31722-927	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	Camber Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-928_3547512f-45f7-4c6a-8fb0-2144eff24b11	31722-928	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	Camber Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-929_88ba8429-4b8b-44b8-a62c-f3479f266313	31722-929	HUMAN PRESCRIPTION DRUG	OXYMORPHONE HYDROCHLORIDE		OXYMORPHONE HYDROCHLORIDE	TABLET	ORAL	20180301		ANDA	ANDA210175	Camber Pharmaceuticals, Inc	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-930_88ba8429-4b8b-44b8-a62c-f3479f266313	31722-930	HUMAN PRESCRIPTION DRUG	OXYMORPHONE HYDROCHLORIDE		OXYMORPHONE HYDROCHLORIDE	TABLET	ORAL	20180301		ANDA	ANDA210175	Camber Pharmaceuticals, Inc	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-934_0b315373-6447-52e5-e063-6294a90a448c	31722-934	HUMAN PRESCRIPTION DRUG	Drospirenone and ethinyl estradiol		Drospirenone and ethinyl estradiol	KIT		20190322		ANDA	ANDA211944	Camber Pharmaceuticals, Inc.						N	20241231
31722-935_e8325090-6671-4058-8b1a-39c16ea4dc47	31722-935	HUMAN PRESCRIPTION DRUG	Albendazole	200 mg	Albendazole	TABLET, FILM COATED	ORAL	20181215		ANDA	ANDA210011	Camber Pharmaceuticals	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
31722-936_1e7e8dd7-2708-44a7-9f30-579410e21680	31722-936	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20190225		ANDA	ANDA207420	Camber Pharmaceuticals, Inc.	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
31722-940_1fb1cd4e-2efd-4893-885a-c05994325955	31722-940	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 2.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
31722-941_1fb1cd4e-2efd-4893-885a-c05994325955	31722-941	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
31722-942_1fb1cd4e-2efd-4893-885a-c05994325955	31722-942	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
31722-943_1fb1cd4e-2efd-4893-885a-c05994325955	31722-943	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
31722-944_f83fc012-e4b3-0554-e053-6294a90a4070	31722-944	HUMAN PRESCRIPTION DRUG	Levonorgetsrel and Ethinyl Estradiol		Levonorgetsrel and Ethinyl Estradiol	KIT		20230213		ANDA	ANDA212298	Camber Pharmaceuticals, Inc.						N	20241231
31722-945_05b50c53-ab5a-4a83-e063-6394a90a6214	31722-945	HUMAN PRESCRIPTION DRUG	Drospirenone and Ethinyl Estradiol		Drospirenone and Ethinyl Estradiol	KIT		20200124		ANDA	ANDA213034	Camber Pharmaceuticals, Inc.						N	20241231
31722-946_a3b8f3fe-fe65-4f0a-9477-84066f559eed	31722-946	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20190103		ANDA	ANDA211228	Camber Pharmaceuticals, Inc	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-947_a3b8f3fe-fe65-4f0a-9477-84066f559eed	31722-947	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20190103		ANDA	ANDA211228	Camber Pharmaceuticals, Inc	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-948_8b6c9898-1c57-4db7-bbb7-ae5fdc74ab4b	31722-948	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-949_8b6c9898-1c57-4db7-bbb7-ae5fdc74ab4b	31722-949	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-950_8b6c9898-1c57-4db7-bbb7-ae5fdc74ab4b	31722-950	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-951_8b6c9898-1c57-4db7-bbb7-ae5fdc74ab4b	31722-951	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
31722-952_1d1d77b9-0f73-4daf-8ca6-0837caa03bac	31722-952	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Camber Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-953_1d1d77b9-0f73-4daf-8ca6-0837caa03bac	31722-953	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Camber Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-954_1d1d77b9-0f73-4daf-8ca6-0837caa03bac	31722-954	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Camber Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-955_1d1d77b9-0f73-4daf-8ca6-0837caa03bac	31722-955	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Camber Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
31722-956_30c74d00-0712-4c09-a7dc-6d1866860f03	31722-956	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Camber Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
31722-957_30c74d00-0712-4c09-a7dc-6d1866860f03	31722-957	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Camber Pharmaceuticals, Inc.	BENZONATATE	150	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
31722-958_30c74d00-0712-4c09-a7dc-6d1866860f03	31722-958	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Camber Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
31722-960_5cb7ed1a-3536-4627-a8d3-c7a835d974db	31722-960	HUMAN PRESCRIPTION DRUG	DRONABINOL		dronabinol	CAPSULE	ORAL	20200210		ANDA	ANDA207421	Camber Pharmaceuticals Inc	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
31722-961_5cb7ed1a-3536-4627-a8d3-c7a835d974db	31722-961	HUMAN PRESCRIPTION DRUG	DRONABINOL		dronabinol	CAPSULE	ORAL	20200210		ANDA	ANDA207421	Camber Pharmaceuticals Inc	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
31722-962_5cb7ed1a-3536-4627-a8d3-c7a835d974db	31722-962	HUMAN PRESCRIPTION DRUG	DRONABINOL		dronabinol	CAPSULE	ORAL	20200210		ANDA	ANDA207421	Camber Pharmaceuticals Inc	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
31722-965_96ab1605-e171-4e86-b357-2d9378f7a05a	31722-965	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA202659	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-966_96ab1605-e171-4e86-b357-2d9378f7a05a	31722-966	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA202659	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-967_96ab1605-e171-4e86-b357-2d9378f7a05a	31722-967	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA202659	Camber Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
31722-981_f53099bb-c2d6-4dd2-e053-2a95a90a6db5	31722-981	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200504		ANDA	ANDA213810	Camber Pharmaceuticals, Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
31722-994_8265ddeb-9723-49af-85fa-0699c4c3c6d7	31722-994	HUMAN PRESCRIPTION DRUG	neostigmine methylsulfate		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210104		ANDA	ANDA212512	Camber Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
31722-995_8265ddeb-9723-49af-85fa-0699c4c3c6d7	31722-995	HUMAN PRESCRIPTION DRUG	neostigmine methylsulfate		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210104		ANDA	ANDA212512	Camber Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
31722-996_1594cf72-dff0-4591-95eb-31922058799c	31722-996	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
31722-997_1594cf72-dff0-4591-95eb-31922058799c	31722-997	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Camber Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
31722-998_b9999125-6db4-4000-b022-36cc3509e21d	31722-998	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Camber Pharmaceuticals, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
31722-999_b9999125-6db4-4000-b022-36cc3509e21d	31722-999	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201014		ANDA	ANDA212378	Camber Pharmaceuticals, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
32267-940_d114a69a-cc10-5368-e053-2995a90aa9ac	32267-940	HUMAN OTC DRUG	Gy-Na-Tren		Boric Acid, Marigold, Coneflower, Arborvitae, Borate of Sodium, Beechwood Kreosote, Wind Flower, Lactobacillus Acidophilus, Vitamin C	KIT		20160502		UNAPPROVED HOMEOPATHIC		Natren Inc.						N	20241231
32472-102_417d8bb2-b630-4b70-a621-431c9e711a2a	32472-102	HUMAN OTC DRUG	Premieres Pain		menthol	SPRAY	TOPICAL	20110307		OTC MONOGRAPH NOT FINAL	part348	Premiere Enterprises	MENTHOL	7	g/100mL			N	20241231
32472-102_8452dfb4-72d3-4f3c-85db-21e24acf45b0	32472-102	HUMAN OTC DRUG	PREMIERES PAIN		menthol	SPRAY	TOPICAL	20110112		OTC MONOGRAPH NOT FINAL	part348	Premiere Enterprises	MENTHOL	7	g/100mL			N	20241231
32472-102_bbc86983-10f7-496c-bf71-304e51eac2df	32472-102	HUMAN OTC DRUG	PREMIERES PAIN		menthol	SPRAY	TOPICAL	20101228		OTC MONOGRAPH NOT FINAL	part348	Premiere Enterprises	MENTHOL	.07	g/mL			N	20241231
32909-105_b772792e-1934-4684-9c79-af01538ef140	32909-105	HUMAN PRESCRIPTION DRUG	Varibar Thin Liquid		barium sulfate	POWDER, FOR SUSPENSION	ORAL	20190430		NDA	NDA208036	E-Z-EM Canada Inc	BARIUM SULFATE	.81	g/g	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-116_812e1e37-1e0f-831b-6a7e-60fdc7c43e82	32909-116	HUMAN PRESCRIPTION DRUG	Varibar Nectar		barium sulfate	SUSPENSION	ORAL	20201101		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	400	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-125_f902a00b-e60a-4990-a2e4-1278512bd2bf	32909-125	HUMAN PRESCRIPTION DRUG	Varibar Pudding		Barium Sulfate	PASTE	ORAL	20161014		NDA	NDA208844	E-Z-EM Canada Inc	BARIUM SULFATE	400	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-146_3953f49a-66e3-4d33-8840-f23df945cf55	32909-146	HUMAN PRESCRIPTION DRUG	ENTERO Vu 24%		barium sulfate	SUSPENSION	ORAL	20201001		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	240	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-167_cc808f88-e17d-09d6-b414-aae53d998ec7	32909-167	HUMAN PRESCRIPTION DRUG	Liquid Polibar Plus		Barium Sulfate	SUSPENSION	ORAL; RECTAL	20210201		UNAPPROVED DRUG OTHER		E-Z-EM Canada Inc	BARIUM SULFATE	1.05	g/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-187_2865005d-5345-6eab-6d31-24e97d1c4fdd	32909-187	HUMAN PRESCRIPTION DRUG	E-Z-Paque		barium sulfate	SUSPENSION	ORAL	20201101		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	.6	g/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-741_db6ed7ab-308b-3b8e-8d97-c1dac14773a5	32909-741	HUMAN PRESCRIPTION DRUG	Readi-Cat 2 Berry Smoothie		Barium Sulfate	SUSPENSION	ORAL	20201101		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	20	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-742_db6ed7ab-308b-3b8e-8d97-c1dac14773a5	32909-742	HUMAN PRESCRIPTION DRUG	Readi-Cat 2 Banana Smoothie		Barium Sulfate	SUSPENSION	ORAL	20201101		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	20	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-744_db6ed7ab-308b-3b8e-8d97-c1dac14773a5	32909-744	HUMAN PRESCRIPTION DRUG	Readi-Cat 2		Barium Sulfate	SUSPENSION	ORAL	20201101		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	20	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-746_db6ed7ab-308b-3b8e-8d97-c1dac14773a5	32909-746	HUMAN PRESCRIPTION DRUG	Readi-Cat 2 Creamy Vanilla Smoothie		Barium Sulfate	SUSPENSION	ORAL	20201101		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	20	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-747_db6ed7ab-308b-3b8e-8d97-c1dac14773a5	32909-747	HUMAN PRESCRIPTION DRUG	Readi-Cat 2 Mochaccino Smoothie		Barium Sulfate	SUSPENSION	ORAL	20201101		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	20	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-750_4029c3b1-0278-419e-bbf6-1fb67b3f8bbf	32909-750	HUMAN PRESCRIPTION DRUG	E-Z-Paque		barium sulfate	POWDER, FOR SUSPENSION	ORAL	20170601		NDA	NDA208036	E-Z-EM Canada Inc	BARIUM SULFATE	960	mg/g	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-764_b4b5d5fa-137f-4e33-b145-9f85f2acc420	32909-764	HUMAN PRESCRIPTION DRUG	E-Z-HD		barium sulfate	POWDER, FOR SUSPENSION	ORAL	20160111		NDA	NDA208036	E-Z-EM Canada Inc	BARIUM SULFATE	980	mg/g	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-770_0a074f8c-8ff8-b04e-824a-4ea5512faed4	32909-770	HUMAN PRESCRIPTION DRUG	E-Z-Paste		Barium Sulfate	CREAM	ORAL	19740601		UNAPPROVED DRUG OTHER		E-Z-EM Canada Inc	BARIUM SULFATE	.6	g/g	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-814_14ae1571-3fcc-425e-aee1-469b5da4d113	32909-814	HUMAN PRESCRIPTION DRUG	Tagitol V		Barium Sulfate	SUSPENSION	ORAL	20170804		NDA	NDA208143	E-Z-EM Canada Inc	BARIUM SULFATE	400	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
32909-927_aeb1f0d2-3061-4c4f-b60a-10384810ca61	32909-927	HUMAN PRESCRIPTION DRUG	NeuLumEX		Barium Sulfate	SUSPENSION	ORAL	20210601		UNAPPROVED DRUG OTHER		E-Z-EM Canada Inc	BARIUM SULFATE	1	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
33217-001_c7fd8ba2-73f4-4cb1-a82d-9119a0149eb1	33217-001	HUMAN OTC DRUG	CHING WAN HUNG SOOTHING HERBAL BALM		MENTHOL	OINTMENT	TOPICAL	20120812		OTC MONOGRAPH NOT FINAL	part348	TIANJIN DARENTANG JINGWANHONG PHARMACEUTICAL CO., LTD.	MENTHOL	1	g/100g			N	20241231
33332-323_0375b637-66ce-48ca-b6df-526c141af364	33332-323	VACCINE	Afluria Quadrivalent		INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230701	20240731	BLA	BLA125254	Seqirus PTY LTD.	INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
33332-423_0375b637-66ce-48ca-b6df-526c141af364	33332-423	VACCINE	Afluria Quadrivalent		INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230701	20240731	BLA	BLA125254	Seqirus PTY LTD.	INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
33335-001_07620b8d-75d3-8585-e063-6294a90a1d48	33335-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19410101		NDA	NDA205767	WELSCO, INC.	OXYGEN	995	mL/L			N	20241231
33335-002_076219c3-500a-def9-e063-6294a90a0468	33335-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20010101		NDA	NDA205766	WELSCO, INC.	NITROGEN	990	mL/L			N	20241231
33335-003_07620b8d-75d2-8585-e063-6294a90a1d48	33335-003	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20120102		NDA	NDA206009	WELSCO, INC.	NITROUS OXIDE	990	mL/L			N	20241231
33342-001_9e19f010-5f8a-4582-8d49-c385698d9996	33342-001	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20190502		ANDA	ANDA090198	Macleods Pharmaceuticals Limited	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
33342-002_9e19f010-5f8a-4582-8d49-c385698d9996	33342-002	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20190502		ANDA	ANDA090198	Macleods Pharmaceuticals Limited	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
33342-003_c28a7cc4-0638-4fc2-a549-a87887e8d50e	33342-003	HUMAN PRESCRIPTION DRUG	Lamivudine and Zidovudine		Lamivudine and Zidovudine	TABLET	ORAL	20180830		ANDA	ANDA090679	Macleods Pharmaceuticals Limited	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
33342-004_99d52ed2-f3e5-476a-8ba6-ed2cee3aae8a	33342-004	HUMAN PRESCRIPTION DRUG	Nevirapine		Nevirapine	TABLET	ORAL	20190128		ANDA	ANDA090688	Macleods Pharmaceuticals Limited	NEVIRAPINE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
33342-021_a93c9307-dbab-4fd3-95f9-861a0ec83771	33342-021	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20250731	ANDA	ANDA200839	Macleods Pharmaceuticals Limited	LEVOFLOXACIN	250	mg/1			N	
33342-022_a93c9307-dbab-4fd3-95f9-861a0ec83771	33342-022	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20250731	ANDA	ANDA200839	Macleods Pharmaceuticals Limited	LEVOFLOXACIN	500	mg/1			N	
33342-023_a93c9307-dbab-4fd3-95f9-861a0ec83771	33342-023	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20251130	ANDA	ANDA200839	Macleods Pharmaceuticals Limited	LEVOFLOXACIN	750	mg/1			N	
33342-024_4557cd57-f027-4925-8372-628ed411f9f5	33342-024	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20120113		ANDA	ANDA201022	Macleods Pharmaceuticals Limited	FAMCICLOVIR	125	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
33342-025_4557cd57-f027-4925-8372-628ed411f9f5	33342-025	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20120113		ANDA	ANDA201022	Macleods Pharmaceuticals Limited	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
33342-026_4557cd57-f027-4925-8372-628ed411f9f5	33342-026	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20120113		ANDA	ANDA201022	Macleods Pharmaceuticals Limited	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
33342-027_4bf742a3-3c8f-4bd3-b973-54370cbef345	33342-027	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	Macleods Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-028_4bf742a3-3c8f-4bd3-b973-54370cbef345	33342-028	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	Macleods Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-029_4bf742a3-3c8f-4bd3-b973-54370cbef345	33342-029	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20121214		ANDA	ANDA201787	Macleods Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-030_4bf742a3-3c8f-4bd3-b973-54370cbef345	33342-030	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20121214		ANDA	ANDA201787	Macleods Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-041_c2b25818-99a3-474b-a04c-929df1110834	33342-041	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190302		ANDA	ANDA202255	Macleods Pharmaceuticals Limited	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-042_c2b25818-99a3-474b-a04c-929df1110834	33342-042	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190302		ANDA	ANDA202255	Macleods Pharmaceuticals Limited	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-043_c2b25818-99a3-474b-a04c-929df1110834	33342-043	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190302		ANDA	ANDA202255	Macleods Pharmaceuticals Limited	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-044_d7794ff2-be15-49f3-8c05-d7813b9bc1b8	33342-044	HUMAN PRESCRIPTION DRUG	Losartan potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20120510		ANDA	ANDA202230	Macleods Pharmaceuticals Limited	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-045_d7794ff2-be15-49f3-8c05-d7813b9bc1b8	33342-045	HUMAN PRESCRIPTION DRUG	Losartan potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20120601		ANDA	ANDA202230	Macleods Pharmaceuticals Limited	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-046_d7794ff2-be15-49f3-8c05-d7813b9bc1b8	33342-046	HUMAN PRESCRIPTION DRUG	Losartan potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20120601		ANDA	ANDA202230	Macleods Pharmaceuticals Limited	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-047_f16a837e-a180-4080-bbb8-f994841d9fa1	33342-047	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202254	Macleods Pharmaceuticals Limited	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-048_f16a837e-a180-4080-bbb8-f994841d9fa1	33342-048	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202254	Macleods Pharmaceuticals Limited	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-049_f16a837e-a180-4080-bbb8-f994841d9fa1	33342-049	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202254	Macleods Pharmaceuticals Limited	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-050_6e1eca59-3423-4834-89c7-e776c53e53da	33342-050	HUMAN PRESCRIPTION DRUG	Losartan potassium and Hydrochlorothiazide		Losartan potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120910		ANDA	ANDA202289	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-051_6e1eca59-3423-4834-89c7-e776c53e53da	33342-051	HUMAN PRESCRIPTION DRUG	Losartan potassium and Hydrochlorothiazide		Losartan potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120503		ANDA	ANDA202289	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-052_6e1eca59-3423-4834-89c7-e776c53e53da	33342-052	HUMAN PRESCRIPTION DRUG	Losartan potassium and Hydrochlorothiazide		Losartan potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120503		ANDA	ANDA202289	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-053_3efc335d-89f7-434c-a6de-dc0ca5dc8b29	33342-053	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	SOLUTION	ORAL	20160331		ANDA	ANDA202754	Macleods Pharmaceuticals Limited	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
33342-054_7d118937-d5b2-402f-8e24-f70a48c1d432	33342-054	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130214		ANDA	ANDA202467	Macleods Pharmaceuticals Limited	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
33342-055_7d118937-d5b2-402f-8e24-f70a48c1d432	33342-055	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130214		ANDA	ANDA202467	Macleods Pharmaceuticals Limited	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
33342-056_7d118937-d5b2-402f-8e24-f70a48c1d432	33342-056	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130214		ANDA	ANDA202467	Macleods Pharmaceuticals Limited	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
33342-057_9c5aa8e7-9ba5-4103-90a1-e83734479ad6	33342-057	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120927		ANDA	ANDA202414	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-058_9c5aa8e7-9ba5-4103-90a1-e83734479ad6	33342-058	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120927		ANDA	ANDA202414	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-060_acd0f7c0-634d-461e-8d01-58437dd6ae22	33342-060	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20121016		ANDA	ANDA202928	Macleods Pharmaceuticals Limited	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
33342-061_4bf742a3-3c8f-4bd3-b973-54370cbef345	33342-061	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20140123		ANDA	ANDA202631	Macleods Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-062_1fff1472-c659-469c-8786-f3c9b6689524	33342-062	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20160919		ANDA	ANDA202696	Macleods Pharmaceuticals Limited	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-063_1fff1472-c659-469c-8786-f3c9b6689524	33342-063	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20160919		ANDA	ANDA202696	Macleods Pharmaceuticals Limited	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-064_1fff1472-c659-469c-8786-f3c9b6689524	33342-064	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20160919		ANDA	ANDA202696	Macleods Pharmaceuticals Limited	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-065_1fff1472-c659-469c-8786-f3c9b6689524	33342-065	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20160919		ANDA	ANDA202696	Macleods Pharmaceuticals Limited	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-066_eb37161b-3f17-0403-e053-2995a90aea2c	33342-066	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	SOLUTION	ORAL	20151013		ANDA	ANDA202790	Macleods Pharmaceuticals Limited	MEMANTINE HYDROCHLORIDE	2	mg/mL	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
33342-067_6e2eb8c7-99ea-40b7-a6b5-f166ef14b91c	33342-067	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Macleods Pharmaceuticals Limited	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-068_6e2eb8c7-99ea-40b7-a6b5-f166ef14b91c	33342-068	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Macleods Pharmaceuticals Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-069_6e2eb8c7-99ea-40b7-a6b5-f166ef14b91c	33342-069	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Macleods Pharmaceuticals Limited	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-070_6e2eb8c7-99ea-40b7-a6b5-f166ef14b91c	33342-070	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Macleods Pharmaceuticals Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-071_6e2eb8c7-99ea-40b7-a6b5-f166ef14b91c	33342-071	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Macleods Pharmaceuticals Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-072_6e2eb8c7-99ea-40b7-a6b5-f166ef14b91c	33342-072	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Macleods Pharmaceuticals Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-074_a1b947a6-e356-4442-9df7-9e82b299a852	33342-074	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-075_a1b947a6-e356-4442-9df7-9e82b299a852	33342-075	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-076_a1b947a6-e356-4442-9df7-9e82b299a852	33342-076	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET	ORAL	20130419		ANDA	ANDA203145	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-077_a1b947a6-e356-4442-9df7-9e82b299a852	33342-077	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-078_a1b947a6-e356-4442-9df7-9e82b299a852	33342-078	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-083_b05255c0-7882-4096-aac1-9330eb7d08a0	33342-083	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20150227		ANDA	ANDA203044	Macleods Pharmaceuticals Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-084_b05255c0-7882-4096-aac1-9330eb7d08a0	33342-084	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20150227		ANDA	ANDA203044	Macleods Pharmaceuticals Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-085_b05255c0-7882-4096-aac1-9330eb7d08a0	33342-085	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20150227		ANDA	ANDA203044	Macleods Pharmaceuticals Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-086_b05255c0-7882-4096-aac1-9330eb7d08a0	33342-086	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20150227		ANDA	ANDA203044	Macleods Pharmaceuticals Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-087_fe80232a-c329-47ed-8edd-7786e06f3c08	33342-087	HUMAN PRESCRIPTION DRUG	Rizatriptan		Rizatriptan	TABLET, FILM COATED	ORAL	20140311		ANDA	ANDA203147	Macleods Pharmaceuticals Limited	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
33342-088_fe80232a-c329-47ed-8edd-7786e06f3c08	33342-088	HUMAN PRESCRIPTION DRUG	Rizatriptan		Rizatriptan	TABLET, FILM COATED	ORAL	20140311		ANDA	ANDA203147	Macleods Pharmaceuticals Limited	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
33342-089_3ac90f1e-d2a5-4645-972b-0d627e4cc860	33342-089	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20140902		ANDA	ANDA203148	Macleods Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-090_3ac90f1e-d2a5-4645-972b-0d627e4cc860	33342-090	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20140902		ANDA	ANDA203148	Macleods Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-091_3ac90f1e-d2a5-4645-972b-0d627e4cc860	33342-091	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20140902		ANDA	ANDA203148	Macleods Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-092_3ac90f1e-d2a5-4645-972b-0d627e4cc860	33342-092	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20140902		ANDA	ANDA203148	Macleods Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
33342-093_137f6265-8c70-4748-a0d5-3976274e4ea0	33342-093	HUMAN PRESCRIPTION DRUG	rizatriptan benzoate		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20140923		ANDA	ANDA203146	Macleods Pharmaceuticals Limited	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
33342-094_137f6265-8c70-4748-a0d5-3976274e4ea0	33342-094	HUMAN PRESCRIPTION DRUG	rizatriptan benzoate		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20140923		ANDA	ANDA203146	Macleods Pharmaceuticals Limited	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
33342-096_69323723-c3fd-4da8-8498-67ca19ce6dc1	33342-096	HUMAN PRESCRIPTION DRUG	tenofovir disproxil fumarate		tenofovir disproxil fumarate	TABLET	ORAL	20180126		ANDA	ANDA203232	Macleods Pharmaceuticals Limited	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
33342-097_fa641ff6-005b-47c5-bade-8709129d7ac9	33342-097	HUMAN PRESCRIPTION DRUG	Tolterodine tartrate		Tolterodine tartrate	TABLET, FILM COATED	ORAL	20201008		ANDA	ANDA203409	Macleods Pharmaceuticals Limited	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
33342-098_fa641ff6-005b-47c5-bade-8709129d7ac9	33342-098	HUMAN PRESCRIPTION DRUG	Tolterodine tartrate		Tolterodine tartrate	TABLET, FILM COATED	ORAL	20201008		ANDA	ANDA203409	Macleods Pharmaceuticals Limited	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
33342-099_e8676630-c511-427b-af62-969f338d96cf	33342-099	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20160614		ANDA	ANDA203359	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-100_e8676630-c511-427b-af62-969f338d96cf	33342-100	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20160614		ANDA	ANDA203359	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-101_e8676630-c511-427b-af62-969f338d96cf	33342-101	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20160614		ANDA	ANDA203359	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-102_c0c72c6c-cc59-47ba-9dfb-0af985ae7ea6	33342-102	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET	ORAL	20140911		ANDA	ANDA203366	Macleods Pharmaceuticals Limited	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
33342-103_e8676630-c511-427b-af62-969f338d96cf	33342-103	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20160614		ANDA	ANDA203359	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-104_e8676630-c511-427b-af62-969f338d96cf	33342-104	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20160614		ANDA	ANDA203359	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-105_e8676630-c511-427b-af62-969f338d96cf	33342-105	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20160614		ANDA	ANDA203359	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-106_c03e8723-bcb6-475f-be78-c0a3b3ca3619	33342-106	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA203442	Macleods Pharmaceuticals Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
33342-107_b9aa3974-ab54-40f4-b859-ecd3d33ef900	33342-107	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151209		ANDA	ANDA203533	Macleods Pharmaceuticals Limited	RISEDRONATE SODIUM	5	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
33342-108_b9aa3974-ab54-40f4-b859-ecd3d33ef900	33342-108	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151209		ANDA	ANDA203533	Macleods Pharmaceuticals Limited	RISEDRONATE SODIUM	30	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
33342-109_b9aa3974-ab54-40f4-b859-ecd3d33ef900	33342-109	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151209		ANDA	ANDA203533	Macleods Pharmaceuticals Limited	RISEDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
33342-110_a12af8c6-41af-4850-b725-4f8226b35b67	33342-110	HUMAN PRESCRIPTION DRUG	Montelukast sodium		Montelukast sodium	TABLET, CHEWABLE	ORAL	20150313		ANDA	ANDA203582	Macleods Pharmaceuticals Limited	MONTELUKAST	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
33342-111_a12af8c6-41af-4850-b725-4f8226b35b67	33342-111	HUMAN PRESCRIPTION DRUG	Montelukast sodium		Montelukast sodium	TABLET, CHEWABLE	ORAL	20150313		ANDA	ANDA203582	Macleods Pharmaceuticals Limited	MONTELUKAST	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
33342-114_4079c843-42ee-4f7a-a4a0-9498ba6cf12d	33342-114	HUMAN PRESCRIPTION DRUG	Candesartan		Candesartan	TABLET	ORAL	20161206		ANDA	ANDA203813	Macleods Pharmaceuticals Limited	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-115_4079c843-42ee-4f7a-a4a0-9498ba6cf12d	33342-115	HUMAN PRESCRIPTION DRUG	Candesartan		Candesartan	TABLET	ORAL	20161206		ANDA	ANDA203813	Macleods Pharmaceuticals Limited	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-116_4079c843-42ee-4f7a-a4a0-9498ba6cf12d	33342-116	HUMAN PRESCRIPTION DRUG	Candesartan		Candesartan	TABLET	ORAL	20161206		ANDA	ANDA203813	Macleods Pharmaceuticals Limited	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-117_4079c843-42ee-4f7a-a4a0-9498ba6cf12d	33342-117	HUMAN PRESCRIPTION DRUG	Candesartan		Candesartan	TABLET	ORAL	20161206		ANDA	ANDA203813	Macleods Pharmaceuticals Limited	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-121_03d991fd-4f2c-4086-acaf-267967cff68f	33342-121	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103	20271031	ANDA	ANDA203814	Macleods Pharmaceuticals Limited	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
33342-122_4e6a8669-140d-472d-915c-d10830e3b4cd	33342-122	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20161008		ANDA	ANDA204111	Macleods Pharmaceuticals Limited	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-123_4e6a8669-140d-472d-915c-d10830e3b4cd	33342-123	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20161008		ANDA	ANDA204111	Macleods Pharmaceuticals Limited	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-124_4e6a8669-140d-472d-915c-d10830e3b4cd	33342-124	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20161008		ANDA	ANDA204111	Macleods Pharmaceuticals Limited	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-125_4e6a8669-140d-472d-915c-d10830e3b4cd	33342-125	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20161008		ANDA	ANDA204111	Macleods Pharmaceuticals Limited	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-126_4e6a8669-140d-472d-915c-d10830e3b4cd	33342-126	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20161008		ANDA	ANDA204111	Macleods Pharmaceuticals Limited	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-127_4e6a8669-140d-472d-915c-d10830e3b4cd	33342-127	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20161008		ANDA	ANDA204111	Macleods Pharmaceuticals Limited	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-131_66ca941e-6590-41a6-8d8f-caa2013089d0	33342-131	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20150307		ANDA	ANDA204100	Macleods Pharmaceuticals Limited	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-132_66ca941e-6590-41a6-8d8f-caa2013089d0	33342-132	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20150307		ANDA	ANDA204100	Macleods Pharmaceuticals Limited	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-133_66ca941e-6590-41a6-8d8f-caa2013089d0	33342-133	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20150307		ANDA	ANDA204100	Macleods Pharmaceuticals Limited	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 25	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-134_fb91b782-1195-4212-b130-9e078dc47dcd	33342-134	HUMAN PRESCRIPTION DRUG	QUETIAPINE		QUETIAPINE	TABLET, EXTENDED RELEASE	ORAL	20171101		ANDA	ANDA204253	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-135_fb91b782-1195-4212-b130-9e078dc47dcd	33342-135	HUMAN PRESCRIPTION DRUG	QUETIAPINE		QUETIAPINE	TABLET, EXTENDED RELEASE	ORAL	20171101		ANDA	ANDA204253	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-136_fb91b782-1195-4212-b130-9e078dc47dcd	33342-136	HUMAN PRESCRIPTION DRUG	QUETIAPINE		QUETIAPINE	TABLET, EXTENDED RELEASE	ORAL	20171101		ANDA	ANDA204253	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-137_fb91b782-1195-4212-b130-9e078dc47dcd	33342-137	HUMAN PRESCRIPTION DRUG	QUETIAPINE		QUETIAPINE	TABLET, EXTENDED RELEASE	ORAL	20171101		ANDA	ANDA204253	Macleods Pharmaceuticals Limited	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-138_3b244bb3-2e8b-4fde-b69d-330aca56fb8e	33342-138	HUMAN PRESCRIPTION DRUG	Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate		Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210913		ANDA	ANDA204287	Macleods Pharmaceuticals Limited	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
33342-141_3ce6010c-10dd-4e6f-9517-d71c0489a7c5	33342-141	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, FILM COATED	ORAL	20171101		ANDA	ANDA205330	Macleods Pharmaceuticals Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
33342-142_3ce6010c-10dd-4e6f-9517-d71c0489a7c5	33342-142	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, FILM COATED	ORAL	20171101		ANDA	ANDA205330	Macleods Pharmaceuticals Limited	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
33342-143_3ce6010c-10dd-4e6f-9517-d71c0489a7c5	33342-143	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, FILM COATED	ORAL	20171101		ANDA	ANDA205330	Macleods Pharmaceuticals Limited	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
33342-144_a28d3d06-0479-4c6a-9e92-34b4ef776ac2	33342-144	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	Macleods Pharmaceuticals Limited	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-145_a28d3d06-0479-4c6a-9e92-34b4ef776ac2	33342-145	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	Macleods Pharmaceuticals Limited	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-146_a28d3d06-0479-4c6a-9e92-34b4ef776ac2	33342-146	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	Macleods Pharmaceuticals Limited	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-147_a28d3d06-0479-4c6a-9e92-34b4ef776ac2	33342-147	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	Macleods Pharmaceuticals Limited	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-150_5241a8d8-433b-45ba-b732-e0c496944b55	33342-150	HUMAN PRESCRIPTION DRUG	IBANDRONATE SODIUM		IBANDRONATE SODIUM	TABLET, FILM COATED	ORAL	20171101		ANDA	ANDA206887	Macleods Pharmaceuticals Limited	IBANDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
33342-151_b02d220c-5dd4-4557-880a-7d4c0d8927b9	33342-151	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20191024		ANDA	ANDA204632	Macleods Pharmaceuticals Limited	VARDENAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-152_b02d220c-5dd4-4557-880a-7d4c0d8927b9	33342-152	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20191024		ANDA	ANDA204632	Macleods Pharmaceuticals Limited	VARDENAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-153_b02d220c-5dd4-4557-880a-7d4c0d8927b9	33342-153	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20191024		ANDA	ANDA204632	Macleods Pharmaceuticals Limited	VARDENAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-154_b02d220c-5dd4-4557-880a-7d4c0d8927b9	33342-154	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20191024		ANDA	ANDA204632	Macleods Pharmaceuticals Limited	VARDENAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-155_ee4b91b0-3525-4a94-b0ed-fd694ed1154c	33342-155	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Macleods Pharmaceuticals Limited	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
33342-156_ee4b91b0-3525-4a94-b0ed-fd694ed1154c	33342-156	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Macleods Pharmaceuticals Limited	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
33342-157_ee4b91b0-3525-4a94-b0ed-fd694ed1154c	33342-157	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Macleods Pharmaceuticals Limited	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
33342-158_ee4b91b0-3525-4a94-b0ed-fd694ed1154c	33342-158	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Macleods Pharmaceuticals Limited	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
33342-159_95b0ff14-97b3-4b8c-8545-f066a45c2f82	33342-159	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170125		ANDA	ANDA204645	Macleods Pharmaceuticals Limited	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
33342-160_a8dec0c9-e33c-4fca-99d6-7c94dc7c3312	33342-160	HUMAN PRESCRIPTION DRUG	Duloxetine Hydrochloride		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20170324		ANDA	ANDA204815	Macleods Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
33342-161_a8dec0c9-e33c-4fca-99d6-7c94dc7c3312	33342-161	HUMAN PRESCRIPTION DRUG	Duloxetine Hydrochloride		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20170324		ANDA	ANDA204815	Macleods Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
33342-162_a8dec0c9-e33c-4fca-99d6-7c94dc7c3312	33342-162	HUMAN PRESCRIPTION DRUG	Duloxetine Hydrochloride		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20170324		ANDA	ANDA204815	Macleods Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
33342-173_03ff0f7e-6aa1-4c38-8c9a-5f1c6a56c747	33342-173	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA204801	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-174_03ff0f7e-6aa1-4c38-8c9a-5f1c6a56c747	33342-174	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA204801	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-175_03ff0f7e-6aa1-4c38-8c9a-5f1c6a56c747	33342-175	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA204801	Macleods Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
33342-176_53b0c347-c235-4c41-8a9d-5ea1030d16c8	33342-176	HUMAN PRESCRIPTION DRUG	Pioglitazole and metformin hydrochloride		Pioglitazole and metformin hydrochloride	TABLET	ORAL	20151106		ANDA	ANDA204802	Macleods Pharmaceuticals Limited	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	500; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
33342-177_53b0c347-c235-4c41-8a9d-5ea1030d16c8	33342-177	HUMAN PRESCRIPTION DRUG	Pioglitazole and metformin hydrochloride		Pioglitazole and metformin hydrochloride	TABLET	ORAL	20151106		ANDA	ANDA204802	Macleods Pharmaceuticals Limited	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	850; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
33342-178_c9d7d145-3702-4b5c-9808-c9a52636858d	33342-178	HUMAN PRESCRIPTION DRUG	Olmesartan medoxomil		Olmesartan medoxomil	TABLET	ORAL	20170425		ANDA	ANDA204814	Macleods Pharmaceuticals Limited	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-179_c9d7d145-3702-4b5c-9808-c9a52636858d	33342-179	HUMAN PRESCRIPTION DRUG	Olmesartan medoxomil		Olmesartan medoxomil	TABLET	ORAL	20170425		ANDA	ANDA204814	Macleods Pharmaceuticals Limited	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-180_c9d7d145-3702-4b5c-9808-c9a52636858d	33342-180	HUMAN PRESCRIPTION DRUG	Olmesartan medoxomil		Olmesartan medoxomil	TABLET	ORAL	20170425		ANDA	ANDA204814	Macleods Pharmaceuticals Limited	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
33342-187_1e775abd-a99d-4dad-b5fc-146e770d220e	33342-187	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET	ORAL	20220303		ANDA	ANDA204934	Macleods Pharmaceuticals Limited	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
33342-189_1e775abd-a99d-4dad-b5fc-146e770d220e	33342-189	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET	ORAL	20220303		ANDA	ANDA204934	Macleods Pharmaceuticals Limited	NIACIN	1000	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
33342-190_ec147040-b267-4905-b311-09ebce2080b4	33342-190	HUMAN PRESCRIPTION DRUG	AMLODIPINE and OLMESARTAN medoxomil		AMLODIPINE and OLMESARTAN medoxomil	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA206884	Macleods Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
33342-191_ec147040-b267-4905-b311-09ebce2080b4	33342-191	HUMAN PRESCRIPTION DRUG	AMLODIPINE and OLMESARTAN medoxomil		AMLODIPINE and OLMESARTAN medoxomil	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA206884	Macleods Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
33342-192_ec147040-b267-4905-b311-09ebce2080b4	33342-192	HUMAN PRESCRIPTION DRUG	AMLODIPINE and OLMESARTAN medoxomil		AMLODIPINE and OLMESARTAN medoxomil	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA206884	Macleods Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
33342-193_ec147040-b267-4905-b311-09ebce2080b4	33342-193	HUMAN PRESCRIPTION DRUG	AMLODIPINE and OLMESARTAN medoxomil		AMLODIPINE and OLMESARTAN medoxomil	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA206884	Macleods Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
33342-194_ea9c3795-420f-49fb-918c-7033a1f06963	33342-194	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171006		ANDA	ANDA204889	Macleods Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
33342-195_ea9c3795-420f-49fb-918c-7033a1f06963	33342-195	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171006		ANDA	ANDA204889	Macleods Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
33342-196_ea9c3795-420f-49fb-918c-7033a1f06963	33342-196	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171006		ANDA	ANDA204889	Macleods Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
33342-200_005482e6-b2a2-4b96-93a9-aab2e13f4eb2	33342-200	HUMAN PRESCRIPTION DRUG	LEVOCETIRIZINE DIHYDROCHLORIDE		LEVOCETIRIZINE DIHYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160111		ANDA	ANDA205564	Macleods Pharmaceuticals Limited	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
33342-201_dce3d135-160c-429c-9067-3e557dded907	33342-201	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20151007		ANDA	ANDA205702	Macleods Pharmaceuticals Limited	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
33342-203_0191f1d5-d34e-4185-93dd-3f411aa0e296	33342-203	HUMAN PRESCRIPTION DRUG	Vardenafil		Vardenafil	TABLET	ORAL	20181026		ANDA	ANDA205988	Macleods Pharmaceuticals Limited	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	11.85	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-208_36135e40-8934-4e1c-bb35-eafaf3715f48	33342-208	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA206156	Macleods Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
33342-209_36135e40-8934-4e1c-bb35-eafaf3715f48	33342-209	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA206156	Macleods Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
33342-210_36135e40-8934-4e1c-bb35-eafaf3715f48	33342-210	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA206156	Macleods Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
33342-211_36135e40-8934-4e1c-bb35-eafaf3715f48	33342-211	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA206156	Macleods Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
33342-212_36135e40-8934-4e1c-bb35-eafaf3715f48	33342-212	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA206156	Macleods Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
33342-213_36135e40-8934-4e1c-bb35-eafaf3715f48	33342-213	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA206156	Macleods Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	3.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
33342-214_36135e40-8934-4e1c-bb35-eafaf3715f48	33342-214	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA206156	Macleods Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
33342-215_71ac3281-7894-441c-82bb-d12a34e2c347	33342-215	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20230419		ANDA	ANDA206100	Macleods Pharmaceuticals Limited	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
33342-238_b601aa05-6da0-4643-9e67-79d96985197e	33342-238	HUMAN PRESCRIPTION DRUG	NEVIRAPINE		NEVIRAPINE	TABLET, EXTENDED RELEASE	ORAL	20171007		ANDA	ANDA206879	Macleods Pharmaceuticals Limited	NEVIRAPINE	400	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
33342-239_3ce6010c-10dd-4e6f-9517-d71c0489a7c5	33342-239	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20161208		ANDA	ANDA206955	Macleods Pharmaceuticals Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
33342-240_3ce6010c-10dd-4e6f-9517-d71c0489a7c5	33342-240	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20161208		ANDA	ANDA206955	Macleods Pharmaceuticals Limited	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
33342-241_6926ebbe-2d74-4d5f-b642-c1bfe3a4e305	33342-241	HUMAN PRESCRIPTION DRUG	Sevelamer Hydrochloride		Sevelamer Hydrochloride	TABLET, FILM COATED	ORAL	20230526		ANDA	ANDA206883	Macleods Pharmaceuticals Limited	SEVELAMER HYDROCHLORIDE	400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
33342-242_6926ebbe-2d74-4d5f-b642-c1bfe3a4e305	33342-242	HUMAN PRESCRIPTION DRUG	Sevelamer Hydrochloride		Sevelamer Hydrochloride	TABLET, FILM COATED	ORAL	20230526		ANDA	ANDA206883	Macleods Pharmaceuticals Limited	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
33342-248_7a93246c-9323-40c4-b590-a40dcb133c8c	33342-248	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20230322		ANDA	ANDA207209	Macleods Pharmaceuticals Limited	REPAGLINIDE	.5	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
33342-249_7a93246c-9323-40c4-b590-a40dcb133c8c	33342-249	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20230322		ANDA	ANDA207209	Macleods Pharmaceuticals Limited	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
33342-250_7a93246c-9323-40c4-b590-a40dcb133c8c	33342-250	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20230322		ANDA	ANDA207209	Macleods Pharmaceuticals Limited	REPAGLINIDE	2	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
33342-256_8a7e0bc7-08b6-41f2-b0c8-4e4bf3b92181	33342-256	HUMAN PRESCRIPTION DRUG	oseltamavir phosphate		oseltamavir phosphate	CAPSULE	ORAL	20170921		ANDA	ANDA207211	Macleods Pharmaceuticals Limited	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
33342-257_8a7e0bc7-08b6-41f2-b0c8-4e4bf3b92181	33342-257	HUMAN PRESCRIPTION DRUG	oseltamavir phosphate		oseltamavir phosphate	CAPSULE	ORAL	20170921		ANDA	ANDA207211	Macleods Pharmaceuticals Limited	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
33342-258_8a7e0bc7-08b6-41f2-b0c8-4e4bf3b92181	33342-258	HUMAN PRESCRIPTION DRUG	oseltamavir phosphate		oseltamavir phosphate	CAPSULE	ORAL	20170921		ANDA	ANDA207211	Macleods Pharmaceuticals Limited	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
33342-260_dbfe123b-ac93-4c21-9538-c0c1e61e7bd9	33342-260	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET	ORAL	20170606		ANDA	ANDA207210	Macleods Pharmaceuticals Limited	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
33342-265_834710f1-50c8-48f0-909f-13e399f2e263	33342-265	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20191008		ANDA	ANDA207244	Macleods Pharmaceuticals Limited	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-266_834710f1-50c8-48f0-909f-13e399f2e263	33342-266	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20191008		ANDA	ANDA207244	Macleods Pharmaceuticals Limited	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-267_834710f1-50c8-48f0-909f-13e399f2e263	33342-267	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20191008		ANDA	ANDA207244	Macleods Pharmaceuticals Limited	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-268_834710f1-50c8-48f0-909f-13e399f2e263	33342-268	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20191008		ANDA	ANDA207244	Macleods Pharmaceuticals Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-274_eb38172a-f884-4a94-be6d-73ad338fb29c	33342-274	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat tablets 40 mg	FILM	ORAL	20190404		ANDA	ANDA207293	Macleods Pharmaceuticals Limited	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
33342-275_eb38172a-f884-4a94-be6d-73ad338fb29c	33342-275	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat tablets 80 mg	FILM	ORAL	20190404		ANDA	ANDA207293	Macleods Pharmaceuticals Limited	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
33342-276_2abbe156-e5ab-484c-aed7-fa4b5f06698d	33342-276	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729		ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
33342-277_2abbe156-e5ab-484c-aed7-fa4b5f06698d	33342-277	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729		ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
33342-278_8b7e0bf0-c13c-4d67-ba78-68fc6ef8b9b2	33342-278	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20191017		ANDA	ANDA207290	Macleods Pharmaceuticals Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-297_672222e3-12b9-488f-a5ee-c47736d65cce	33342-297	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20151013		ANDA	ANDA202840	Macleods Pharmaceuticals Limited	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
33342-298_672222e3-12b9-488f-a5ee-c47736d65cce	33342-298	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20151013		ANDA	ANDA202840	Macleods Pharmaceuticals Limited	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
33342-299_66cfec66-191e-4af9-a623-8464417fab6d	33342-299	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Macleods Pharmaceuticals Limited	ESZOPICLONE	1	mg/1		CIV	N	20241231
33342-300_66cfec66-191e-4af9-a623-8464417fab6d	33342-300	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Macleods Pharmaceuticals Limited	ESZOPICLONE	2	mg/1		CIV	N	20241231
33342-301_66cfec66-191e-4af9-a623-8464417fab6d	33342-301	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	Macleods Pharmaceuticals Limited	ESZOPICLONE	3	mg/1		CIV	N	20241231
33342-314_a251e4cb-01f1-4fd8-bd30-362126b85073	33342-314	HUMAN PRESCRIPTION DRUG	Propylthiouracil		Propylthiouracil	TABLET	ORAL	20230510		ANDA	ANDA208867	Macleods Pharmaceuticals Limited	PROPYLTHIOURACIL	50	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
33342-320_a439ac59-42f3-412b-b987-14fc152a974f	33342-320	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	20180424		ANDA	ANDA209283	Macleods Pharmaceuticals Limited	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-321_7b4cca50-7139-4d48-8f4a-f8204fc46b2e	33342-321	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SOLUTION	TOPICAL	20171104		ANDA	ANDA209361	Macleods Pharmaceuticals Limited	CLOBETASOL PROPIONATE	.4625	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-327_3d287790-0065-44fb-a7e6-388ecd89e47b	33342-327	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	Macleods Pharmaceuticals Limited	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-328_3d287790-0065-44fb-a7e6-388ecd89e47b	33342-328	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	Macleods Pharmaceuticals Limited	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-329_3d287790-0065-44fb-a7e6-388ecd89e47b	33342-329	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	Macleods Pharmaceuticals Limited	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-331_4bf4845e-e160-4d69-a021-7d95c9d99e83	33342-331	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20181123		ANDA	ANDA209828	Macleods Pharmaceuticals Limited	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-332_4bf4845e-e160-4d69-a021-7d95c9d99e83	33342-332	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20181123		ANDA	ANDA209828	Macleods Pharmaceuticals Limited	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-333_4bf4845e-e160-4d69-a021-7d95c9d99e83	33342-333	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20181123		ANDA	ANDA209828	Macleods Pharmaceuticals Limited	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
33342-335_ffced53c-9400-4e35-9a24-94c468dde010	33342-335	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20230524		ANDA	ANDA209827	Macleods Pharmaceuticals Limited	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
33342-336_ffced53c-9400-4e35-9a24-94c468dde010	33342-336	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20230524		ANDA	ANDA209827	Macleods Pharmaceuticals Limited	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
33342-384_4a96f732-bbce-426f-9780-89115cac638b	33342-384	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA211166	Macleods Pharmaceuticals Limited	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
33342-385_4a96f732-bbce-426f-9780-89115cac638b	33342-385	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA211166	Macleods Pharmaceuticals Limited	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
33342-393_91372235-ea2b-401e-83cd-f7e328f88365	33342-393	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-394_91372235-ea2b-401e-83cd-f7e328f88365	33342-394	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-395_91372235-ea2b-401e-83cd-f7e328f88365	33342-395	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-396_91372235-ea2b-401e-83cd-f7e328f88365	33342-396	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-397_91372235-ea2b-401e-83cd-f7e328f88365	33342-397	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-398_91372235-ea2b-401e-83cd-f7e328f88365	33342-398	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-399_91372235-ea2b-401e-83cd-f7e328f88365	33342-399	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-400_91372235-ea2b-401e-83cd-f7e328f88365	33342-400	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-401_91372235-ea2b-401e-83cd-f7e328f88365	33342-401	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-402_91372235-ea2b-401e-83cd-f7e328f88365	33342-402	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-403_91372235-ea2b-401e-83cd-f7e328f88365	33342-403	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-404_91372235-ea2b-401e-83cd-f7e328f88365	33342-404	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20221221		ANDA	ANDA211417	Macleods Pharmaceuticals Limited	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
33342-405_0232ecb1-30e0-4eba-8552-354dcc332849	33342-405	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20210301		ANDA	ANDA211697	Macleods Pharmaceuticals Limited	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
33342-419_2b07a830-93ba-427a-95fc-5138a6309f1e	33342-419	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230609		ANDA	ANDA212124	Macleods Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-420_2b07a830-93ba-427a-95fc-5138a6309f1e	33342-420	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230609		ANDA	ANDA212124	Macleods Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-421_2b07a830-93ba-427a-95fc-5138a6309f1e	33342-421	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230609		ANDA	ANDA212124	Macleods Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-422_2b07a830-93ba-427a-95fc-5138a6309f1e	33342-422	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230609		ANDA	ANDA212124	Macleods Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-423_2b07a830-93ba-427a-95fc-5138a6309f1e	33342-423	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230609		ANDA	ANDA212124	Macleods Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
33342-439_49a1e24d-5821-45a5-bf2f-0497f4fd3a1b	33342-439	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	TOPICAL	20180813		ANDA	ANDA212444	Macleods Pharmaceuticals Limited	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
33342-447_3695f057-de86-4c9a-9d43-ff0a6acdffe7	33342-447	HUMAN PRESCRIPTION DRUG	Pyrazinamide		Pyrazinamide	TABLET	ORAL	20200727		ANDA	ANDA212541	Macleods Pharmaceuticals Limited	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
33342-469_d8ebb61a-a326-4f0d-a346-c3db045c3fb0	33342-469	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20210825		ANDA	ANDA213566	Macleods Pharmaceuticals Limited	NYSTATIN	100000	1/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
33342-481_fe3db8b2-9de4-4f9e-b763-8536a1e4cea8	33342-481	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20210129		ANDA	ANDA213826	Macleods Pharmaceuticals Limited	NYSTATIN	100000	1/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
33342-482_f23f4207-1d1b-4eb2-9b7f-a70ced65192a	33342-482	HUMAN PRESCRIPTION DRUG	Nystatin and triamcinolone acetonide		Nystatin and triamcinolone acetonide	CREAM	TOPICAL	20220831		ANDA	ANDA214181	Macleods Pharmaceuticals Limited	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
33342-483_15bf2ff1-510e-4f0e-9817-8af28790e01b	33342-483	HUMAN PRESCRIPTION DRUG	Nystatin and triamcinolone acetonide		Nystatin and triamcinolone acetonide	OINTMENT	TOPICAL	20210901		ANDA	ANDA214751	Macleods Pharmaceuticals Limited	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
33342-531_fc165a6d-24b0-4753-a7ac-94a134dca0d3	33342-531	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Macleods Pharmaceuticals Limited	LEVOFLOXACIN	250	mg/1			N	20241231
33342-532_fc165a6d-24b0-4753-a7ac-94a134dca0d3	33342-532	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Macleods Pharmaceuticals Limited	LEVOFLOXACIN	500	mg/1			N	20241231
33342-533_fc165a6d-24b0-4753-a7ac-94a134dca0d3	33342-533	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Macleods Pharmaceuticals Limited	LEVOFLOXACIN	750	mg/1			N	20241231
33342-536_61a0ebd9-8dc9-4bcc-b07b-f3d6398ea96e	33342-536	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103		ANDA	ANDA203814	Macleods Pharmaceuticals Limited	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
33342-537_b2886083-0cf3-4a76-8161-9183595ad7e8	33342-537	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20230405		ANDA	ANDA205702	Macleods Pharmaceuticals Limited	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
33758-001_08029ab0-4ac1-5dcb-e063-6394a90a48d2	33758-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19720601		NDA	NDA205889	Modern Supply Company, Inc.	OXYGEN	990	mL/L			N	20241231
33992-0072_96813a85-88f7-445b-9f00-5b68a0fb55e5	33992-0072	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20090512		OTC MONOGRAPH NOT FINAL	part356	Dollar Tree Stores	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
33992-0169_4f1b212f-7eaa-463b-b9a3-53c327b616fd	33992-0169	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET	ORAL	20200313		ANDA	ANDA079096	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
33992-0211_82887a56-ce47-4c5b-a01c-482a3ad46359	33992-0211	HUMAN OTC DRUG	Isopropyl Alcohol		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20040811		OTC MONOGRAPH NOT FINAL	part333A	Greenbrier International, Inc.	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
33992-0282_454d2f0d-a13a-40f9-8dde-be6dfe78419d	33992-0282	HUMAN OTC DRUG	Pain Relief	Childrens	Acetaminophen	SUSPENSION	ORAL	20160630	20250131	OTC MONOGRAPH NOT FINAL	part343	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	ACETAMINOPHEN	160	mg/5mL			N	
33992-0292_d14546e0-45a3-47bc-a723-5c8dc5067834	33992-0292	HUMAN OTC DRUG	Allergy Relief	Childrens	Diphenhydramine Hydrochloride	LIQUID	ORAL	20160630	20250131	OTC MONOGRAPH FINAL	part341	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
33992-0299_7b727a50-dd12-4e6b-8488-60a2d4d6a77f	33992-0299	HUMAN OTC DRUG	Multi-Action Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part356	Greenbrier International, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
33992-0318_39c7a0c1-5d89-47c0-8238-93dd7d5c607e	33992-0318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part356	GREENBRIER INTERNATIONAL, INC.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
33992-0344_4c8d8a8a-23b0-48ed-8997-5723eb4bef5e	33992-0344	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171031	20241031	OTC MONOGRAPH FINAL	part341	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
33992-0372_0e151be5-a0b8-4ae7-b0a3-0bf22f5a7dab	33992-0372	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20160430	20250131	OTC MONOGRAPH FINAL	part335	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
33992-0379_1daf7a40-0e16-408a-917d-014ee3946409	33992-0379	HUMAN OTC DRUG	NightTime Cold and Cough	Children	Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20170831	20240831	OTC MONOGRAPH FINAL	part341	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
33992-0385_5732a803-ae51-472f-af3f-17347630d5af	33992-0385	HUMAN OTC DRUG	Tussin DM Cough and Chest Congestion		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160430	20240430	OTC MONOGRAPH FINAL	part341	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
33992-0389_f9e1e31f-01c7-4d6e-9290-fa5739cc81de	33992-0389	HUMAN OTC DRUG	Tussin Mucus and Chest Congestion		Guaifenesin	LIQUID	ORAL	20160430	20240430	OTC MONOGRAPH FINAL	part341	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
33992-0498_04e21867-c530-4c9c-8862-61eb7e51be7d	33992-0498	HUMAN OTC DRUG	Petrolatum		Petrolatum	CREAM	TOPICAL	20190517		OTC MONOGRAPH FINAL	part347	Greenbrier International, Inc.	PETROLATUM	30	g/100g			N	20241231
33992-0499_41de449c-fada-455f-a565-c8a54589a93c	33992-0499	HUMAN OTC DRUG	Petrolatum		Petrolatum	CREAM	TOPICAL	20190204		OTC MONOGRAPH FINAL	part347	Greenbrier International, Inc.	PETROLATUM	30	g/100g			N	20241231
33992-0503_d037eb6c-2388-40f9-88ca-2d75191df9e1	33992-0503	HUMAN OTC DRUG	Cold Multi-Symptom	Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804		OTC MONOGRAPH DRUG	M012	GREENBRIER INTERNATIONAL, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
33992-0527_3c0d95e8-77fb-4e36-826a-962e010105c2	33992-0527	HUMAN OTC DRUG	Severe Sinus Congestion and Pain Daytime		Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	GREENBRIER INTERNATIONAL, INC.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
33992-0574_605cd01f-9ac9-0e53-e053-2991aa0a75b9	33992-0574	HUMAN OTC DRUG	ASSURED VAPORIZING CHEST RUB		menthol, camphor, eucalyptus oil ointment	GEL	TOPICAL	20120106		OTC MONOGRAPH NOT FINAL	part348	GREENBRIER INTERNATIONAL, INC.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
33992-0575_73db0b1b-e979-bf01-e053-2a91aa0aa45f	33992-0575	HUMAN OTC DRUG	ASSURED VAPORIZING CHEST RUB		menthol, camphor, eucalyptus oil ointment	GEL	TOPICAL	20120106		OTC MONOGRAPH NOT FINAL	part348	GREENBRIER INTERNATIONAL, INC.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
33992-0612_992bb918-7044-432f-9b51-4fb673954b23	33992-0612	HUMAN OTC DRUG	Assured Allergy Relief		Loratadine	TABLET	ORAL	20170731	20240131	ANDA	ANDA076301	Greenbrier International Inc.	LORATADINE	10	mg/1			N	
33992-0664_af685a36-3b50-4cdb-b6bd-02718892334e	33992-0664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20161221		OTC MONOGRAPH NOT FINAL	part356	Greenbrier International, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
33992-0741_3d783bc0-0de3-4dda-ba00-f2e061200f6c	33992-0741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180131		ANDA	ANDA207235	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
33992-0741_591a337c-a96b-4130-bb8d-577452e5dac6	33992-0741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180331		ANDA	ANDA207235	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
33992-0745_7c788de1-814a-4583-a8c3-fb47c9c0b8e6	33992-0745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
33992-0811_f97680f0-78b0-425e-8219-bbd70b79b596	33992-0811	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180930		ANDA	ANDA205291	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
33992-0822_a780dfaa-69d8-4c74-9ff6-05f34bed8f8e	33992-0822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20160623		OTC MONOGRAPH FINAL	part347	Greenbrier International, Inc	WITCH HAZEL	841	mg/mL			N	20241231
33992-0843_e9d156aa-685d-48d5-8fbb-41af954b3cff	33992-0843	HUMAN OTC DRUG	Ibuprofen Minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180430		ANDA	ANDA206568	ASSURED / DOLLAR TREE (Greenbrier International, Inc.)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
33992-0864_99019186-1eae-4a1b-98dd-713e29105bce	33992-0864	HUMAN OTC DRUG	50% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	20141008		OTC MONOGRAPH NOT FINAL	part333A	Greenbrier International, Inc.	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
33992-0871_611885db-1a56-469f-9cef-feef4bcf3239	33992-0871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20090512		OTC MONOGRAPH NOT FINAL	part333A	Greenbrier International, Inc	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
33992-1136_d85735b7-7a77-42df-8fb1-9fefb8aaa791	33992-1136	HUMAN OTC DRUG	Assured	Muscle Rub	Menthol	GEL	TOPICAL	20120515		OTC MONOGRAPH NOT FINAL	part348	Greenbrier International, Inc.	MENTHOL, UNSPECIFIED FORM	2.5	g/100g			N	20241231
33992-4130_0ccb40f9-0734-b059-e063-6394a90aa03c	33992-4130	HUMAN OTC DRUG	Assured Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	20200127		OTC MONOGRAPH DRUG	M016	Greenbriar International	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
33992-7991_7fcfde78-2299-63a0-e053-2991aa0a0cf3	33992-7991	HUMAN OTC DRUG	Assured Vaporizing Chest Rub		Camphor and Eucalyptus Oil and Menthol	OINTMENT	TOPICAL	20180626		OTC MONOGRAPH FINAL	part341	Greenbrier International, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
33992-7992_7fcfde78-22a9-63a0-e053-2991aa0a0cf3	33992-7992	HUMAN OTC DRUG	Assured Vaporizing Chest Rub		Camphor and Eucalyptus Oil and Menthol	OINTMENT	TOPICAL	20190118		OTC MONOGRAPH FINAL	part341	Greenbrier International, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
33992-7996_580f2345-12c0-5155-e053-2a91aa0ab013	33992-7996	HUMAN OTC DRUG	Assured Vaporizing Chest Rub		Camphor and Eucalyptus Oil and Menthol	OINTMENT	TOPICAL	20151120		OTC MONOGRAPH NOT FINAL	part348	Greenbrier International, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
33992-8684_db88efcb-e172-5f71-e053-2a95a90a0be1	33992-8684	HUMAN OTC DRUG	ASSURED NASAL RELIEF ORIGINAL		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20110308		OTC MONOGRAPH FINAL	part341	GREENBRIER INTERNATIONAL, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
34057-001_0802ac5f-caae-0225-e063-6294a90ab398	34057-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205849	Oxarc, LLC	OXYGEN	990	mL/L			N	20241231
34057-006_0802d996-8a4b-ce42-e063-6394a90a91ea	34057-006	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205847	Oxarc, LLC	AIR	1000	mL/L			N	20241231
34057-010_0802a852-5adf-f1cc-e063-6294a90a199f	34057-010	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA206009	Oxarc, LLC	NITROUS OXIDE	990	mL/L			N	20241231
34057-014_0802da16-fec7-cf04-e063-6394a90ab0ff	34057-014	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205850	Oxarc, LLC	NITROGEN	990	mL/L			N	20241231
34057-501_0802bcb4-fca6-2397-e063-6294a90a2862	34057-501	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20150709		NDA	NDA205852	Oxarc, LLC	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
34645-0001_085cf04e-cf75-92d5-e063-6394a90a2d9a	34645-0001	HUMAN OTC DRUG	Alcohol Prep Pad Non-Sterile		ISOPROPYL ALCOHOL	PATCH	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
34645-0003_085cd253-6c33-3a99-e063-6394a90ab93d	34645-0003	HUMAN OTC DRUG	Jianerkang Sanitizing Wipe		ALCOHOL	CLOTH	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ALCOHOL	.7	mL/mL			N	20241231
34645-0004_085ce1b9-2652-8067-e063-6294a90afc04	34645-0004	HUMAN OTC DRUG	Jianerkang Wipes		ALCOHOL	CLOTH	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ALCOHOL	.75	mL/mL			N	20241231
34645-0005_085d20a0-8c95-0d49-e063-6394a90a97f5	34645-0005	HUMAN OTC DRUG	Alcohol Prep Pad Sterile		ISOPROPYL ALCOHOL	PATCH	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
34645-0006_085ce5e1-bb0b-a353-e063-6394a90a5721	34645-0006	HUMAN OTC DRUG	Alcohol Preps Sterile		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/g			N	20241231
34645-0007_085d2400-ffdb-39e9-e063-6294a90a7527	34645-0007	HUMAN OTC DRUG	Instant Hand Sanitizer STERILE 70 Ethyl Alcohol		ALCOHOL	CLOTH	TOPICAL	20200901		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ALCOHOL	.7	mL/mL			N	20241231
34645-0008_085cf04e-cf5b-92d5-e063-6394a90a2d9a	34645-0008	HUMAN OTC DRUG	Alcohol Prep Pad 70 Isopropyl Alcohol		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20200901		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
34645-0009_085d0195-7022-e123-e063-6294a90ab344	34645-0009	HUMAN OTC DRUG	WIPE OUT Antibacterial Wipes, Lemon Scent		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200916		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
34645-0010_085d20a0-8ca3-0d49-e063-6394a90a97f5	34645-0010	HUMAN OTC DRUG	WIPE OUT Antibacterial Wipes, Fresh Scent		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200912		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
34645-0013_085d0195-7031-e123-e063-6294a90ab344	34645-0013	HUMAN OTC DRUG	Povidone Iodine Prep Solution Sterile		POVIDONE-IODINE	SOLUTION	TOPICAL	20210101		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
34645-0015_085ce1b9-2645-8067-e063-6294a90afc04	34645-0015	HUMAN OTC DRUG	Obstetrical Towelette		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210801		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
34645-0016_085ec0ff-b5c2-2628-e063-6294a90ade13	34645-0016	HUMAN OTC DRUG	Alcohol Swabstick		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20210801		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	70	mL/g			N	20241231
34645-0017_085eab46-3c1a-cf27-e063-6294a90a30fd	34645-0017	HUMAN OTC DRUG	BZK Antiseptic Towelette Non-Sterile		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210801		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
34645-0018_085e7fe4-e6ae-9dd9-e063-6294a90a9d87	34645-0018	HUMAN OTC DRUG	BZK Antiseptic Towelette Sterile		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210801		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
34645-0019_085eab46-3c27-cf27-e063-6294a90a30fd	34645-0019	HUMAN OTC DRUG	Cleansing Towelette		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210801		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
34645-0020_085ed7b2-3c40-ca15-e063-6394a90a246a	34645-0020	HUMAN OTC DRUG	Alcohol Swabsticks 3s Sterile		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
34645-0021_085ec0ff-b5d2-2628-e063-6294a90ade13	34645-0021	HUMAN OTC DRUG	Alcohol Swabsticks 1s Sterile		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
34645-0022_085ce5e1-bafc-a353-e063-6394a90a5721	34645-0022	HUMAN OTC DRUG	POVIDONE IODINE PREP PAD Sterile		POVIDONE-IODINE	CLOTH	TOPICAL	20221119		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
34645-0023_085cd253-6c24-3a99-e063-6394a90ab93d	34645-0023	HUMAN OTC DRUG	POVIDONE IODINE SCRUB SWABSTICK 3s		POVIDONE-IODINE	SWAB	TOPICAL	20221119		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
34645-1028_085cf04e-cf69-92d5-e063-6394a90a2d9a	34645-1028	HUMAN OTC DRUG	Povidone Iodine Impregnated		Povidone Iodine	SPONGE	TOPICAL	20150910		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	mg/mL			N	20241231
34645-1029_085d20a0-8cb5-0d49-e063-6394a90a97f5	34645-1029	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine	SWAB	TOPICAL	20150910		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	.1	mg/mL			N	20241231
34645-1030_085d4652-ab23-36c0-e063-6294a90a01a9	34645-1030	HUMAN OTC DRUG	Povidone Iodine Impregnated		Povidone Iodine	SPONGE	TOPICAL	20150303		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	.1	mg/mL			N	20241231
34645-1031_085eab46-3c0c-cf27-e063-6294a90a30fd	34645-1031	HUMAN OTC DRUG	Povidone Iodine Impregnated		Povidone Iodine	SPONGE	TOPICAL	20150303		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	mg/mL			N	20241231
34645-1032_085eb07c-f4dd-b961-e063-6394a90a54ad	34645-1032	HUMAN OTC DRUG	Povidone Iodine Impregnated		Povidone Iodine	SPONGE	TOPICAL	20150303		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	mg/mL			N	20241231
34645-1040_085afb0e-73f4-114f-e063-6394a90a7fb9	34645-1040	HUMAN OTC DRUG	Povidone Iodine Topical Solution Paint		Povidone Iodine 10%	LIQUID	TOPICAL	20150331		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
34645-1041_085b28a4-8daa-0685-e063-6294a90a0d08	34645-1041	HUMAN OTC DRUG	Povidone Iodine Topical Solution Paint		Povidone Iodine 10%	LIQUID	TOPICAL	20150331		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
34645-1042_085b2e45-62ce-c1b9-e063-6394a90a4ce4	34645-1042	HUMAN OTC DRUG	Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20150611		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
34645-1043_085e7fe4-e6a2-9dd9-e063-6294a90a9d87	34645-1043	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine	SWAB	TOPICAL	20150611		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	.1	mg/mL			N	20241231
34645-1044_085eb630-8dae-1fca-e063-6294a90af6cc	34645-1044	HUMAN OTC DRUG	Povidone Iodine Scrub		Povidone Iodine	SWAB	TOPICAL	20150611		OTC MONOGRAPH DRUG	505G(a)(3)	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	.75	mg/mL			N	20241231
34645-2105_085b3032-f1a1-4f71-e063-6294a90a1c05	34645-2105	HUMAN OTC DRUG	Lemon Glycerin		Glycerin	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M016	Jianerkang Medical Co., Ltd	GLYCERIN	500	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
34645-3008_085cd253-6c17-3a99-e063-6394a90ab93d	34645-3008	HUMAN OTC DRUG	Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
34645-3018_085cc9b2-0c53-e10b-e063-6394a90a4d99	34645-3018	HUMAN OTC DRUG	Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
34645-3025_085b55e5-b446-5e3a-e063-6394a90a055d	34645-3025	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
34645-3110_085ccd9f-a7d4-3620-e063-6394a90a0175	34645-3110	HUMAN OTC DRUG	Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
34645-3111_085cd253-6c0a-3a99-e063-6394a90ab93d	34645-3111	HUMAN OTC DRUG	Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
34645-4008_085b28a4-8db7-0685-e063-6294a90a0d08	34645-4008	HUMAN OTC DRUG	Povidone Iodine Prep Pad		Povidone-Iodine	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	mg/100mL			N	20241231
34645-4009_085b3032-f1ad-4f71-e063-6294a90a1c05	34645-4009	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine	SOLUTION	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	mg/mL			N	20241231
34645-4010_085ba045-3c6d-fb30-e063-6394a90a3491	34645-4010	HUMAN OTC DRUG	Povidone Iodine Impregnated		Povidone Iodine	SPONGE	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	mg/mL			N	20241231
34645-4011_f3b22fdc-6152-d436-e053-2995a90a185a	34645-4011	HUMAN OTC DRUG	Povidone Iodine Wipe		Povidone-Iodine	SWAB	TOPICAL	20230202		OTC MONOGRAPH FINAL	part333C	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	mg/100mL			N	20241231
34645-4020_085ba045-3c79-fb30-e063-6394a90a3491	34645-4020	HUMAN OTC DRUG	Povidone Iodine Impregnated		Povidone Iodine	SPONGE	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	mg/mL			N	20241231
34645-4025_085bb064-09fb-cb0d-e063-6294a90a16a1	34645-4025	HUMAN OTC DRUG	Povidone Iodine Scrub		Povidone-Iodine	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	mg/mL			N	20241231
34645-4050_085bb064-0a09-cb0d-e063-6294a90a16a1	34645-4050	HUMAN OTC DRUG	Povidone Iodine Scrub		Povidone-Iodine	SWAB	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	mg/mL			N	20241231
34645-4059_085bbc1a-02e7-ea11-e063-6394a90a3391	34645-4059	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine	SOLUTION	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	mg/mL			N	20241231
34645-4188_085bc532-b22e-8f18-e063-6394a90a03ae	34645-4188	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine	SOLUTION	TOPICAL	20100101		OTC MONOGRAPH DRUG	M005	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	mg/mL			N	20241231
34645-4190_085bcc1d-8ee9-1348-e063-6394a90af6cf	34645-4190	HUMAN OTC DRUG	Sting Relief		BENZOCAINE, ISOPROPYL ALCOHOL	SWAB	TOPICAL	20161003		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	BENZOCAINE; ISOPROPYL ALCOHOL	6; 60	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
34645-5008_085c7bca-1ee1-9d63-e063-6294a90a6e18	34645-5008	HUMAN OTC DRUG	BZK		Benzalkonium Chloride	SWAB	TOPICAL	20060101		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
34645-5500_085bd3da-9cdd-fe96-e063-6294a90ab572	34645-5500	HUMAN OTC DRUG	Povidone Iodine Prep Pad		POVIDONE-IODINE	SOLUTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	g/100g			N	20241231
34645-5501_085c75f1-c9c9-cbb2-e063-6294a90a07c2	34645-5501	HUMAN OTC DRUG	Povidone Iodine Prep		POVIDONE-IODINE	SOLUTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	g/100g			N	20241231
34645-5502_085cba19-9c39-0b9c-e063-6394a90acbc9	34645-5502	HUMAN OTC DRUG	Povidone Iodine Scrub		POVIDONE-IODINE	SOLUTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	7.5	g/100g			N	20241231
34645-5503_085c95d0-d8b1-1513-e063-6294a90a8312	34645-5503	HUMAN OTC DRUG	Povidone Iodine Prep		POVIDONE-IODINE	SOLUTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	g/100g			N	20241231
34645-5504_085caf56-2a08-923c-e063-6294a90af7f7	34645-5504	HUMAN OTC DRUG	Povidone Iodine Prep		POVIDONE-IODINE	SOLUTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	POVIDONE-IODINE	10	g/100g			N	20241231
34645-5505_085cf04e-cf4d-92d5-e063-6394a90a2d9a	34645-5505	HUMAN OTC DRUG	Alcohol Prep Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20230501		OTC MONOGRAPH DRUG	M003	Jianerkang Medical Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
34666-001_9aa46929-cd09-1a76-e053-2995a90a3f50	34666-001	HUMAN OTC DRUG	Arnica Montana Nartex		Arnica montana, Hamamelis Virginiana	CREAM	TOPICAL	20070601		UNAPPROVED HOMEOPATHIC		NARTEX LABORATORIOS HOMEOPATICOS SA DE CV	ARNICA MONTANA; HAMAMELIS VIRGINIANA LEAF	1.73; .0178	g/29.7g; g/29.7g			N	20241231
34666-001_d4555a15-6cee-3fa0-e053-2995a90a379b	34666-001	HUMAN OTC DRUG	Arnica Montana Nartex		Arnica montana, Hamamelis Virginiana	CREAM	TOPICAL	20210928		UNAPPROVED HOMEOPATHIC		NARTEX LABORATORIOS HOMEOPATICOS SA DE CV	ARNICA MONTANA; HAMAMELIS VIRGINIANA LEAF	1.73; .0178	g/29.7g; g/29.7g			N	20241231
34666-001_d63b3652-6e20-0d8b-e053-2a95a90ab9ed	34666-001	HUMAN OTC DRUG	Arnica Montana Nartex		Arnica montana, Hamamelis Virginiana	CREAM	TOPICAL	20220121		UNAPPROVED HOMEOPATHIC		NARTEX LABORATORIOS HOMEOPATICOS SA DE CV	ARNICA MONTANA; HAMAMELIS VIRGINIANA LEAF	1.73; .0178	g/29.7g; g/29.7g			N	20241231
34666-007_7e0888e7-ea6b-2831-e053-2991aa0a438a	34666-007	HUMAN OTC DRUG	Arnica Montana Nartex		Arnica Montana, Hamamelis virginica	OINTMENT	TOPICAL	20101223		UNAPPROVED HOMEOPATHIC		NARTEX LABORATORIOS HOMEOPATICOS SA DE CV	ARNICA MONTANA; HAMAMELIS VIRGINIANA LEAF	1.66; 1.66	g/28g; g/28g			N	20241231
34666-008_7e0888e7-ea78-2831-e053-2991aa0a438a	34666-008	HUMAN OTC DRUG	Simplex		Passiflora incarnata, Ignatia Amara, Valeriana Officinalis	TABLET	ORAL	20101223		UNAPPROVED HOMEOPATHIC		Nartex Laboratories	PASSIFLORA INCARNATA FLOWER; STRYCHNOS IGNATII SEED; VALERIAN	3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
34666-010_6637cdc3-5654-4469-e053-2991aa0abb48	34666-010	HUMAN OTC DRUG	Arnica Recovery		Arnica Montana	TABLET	ORAL	20110701		UNAPPROVED HOMEOPATHIC		NARTEX LABORATORIOS HOMEOPATICOS SA DE CV	ARNICA MONTANA	6	[hp_C]/1			N	20241231
34666-020_86431a9a-5b54-c28a-e053-2991aa0a9901	34666-020	HUMAN OTC DRUG	Arnica Treatment Pack		Arnica Treatment Pack	KIT	ORAL; TOPICAL	20190411		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos SA DE CV						N	20241231
34666-191_6639326d-58c8-5ffb-e053-2991aa0ab583	34666-191	HUMAN OTC DRUG	Hemorrhoidex		Aesculus hipp, Collinsonia, Hamamelis	TABLET	ORAL	20150301		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos SA DE CV	COLLINSONIA CANADENSIS ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
34666-201_d919c075-1e24-9f58-e053-2995a90ad015	34666-201	HUMAN OTC DRUG	Hemorrhoidex		Ratanhia, Hamamelis	OINTMENT	TOPICAL	20150417		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos SA DE CV	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; KRAMERIA LAPPACEA ROOT	1; 3	[hp_X]/28.35g; [hp_X]/28.35g			N	20241231
34666-281_86567f91-7793-1094-e053-2991aa0a4a0b	34666-281	HUMAN OTC DRUG	Arnica Montana Nartex		Arnica Montana Nartex	GEL	TOPICAL	20190125		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos SA DE CV	ARNICA MONTANA; BELLIS PERENNIS; CALENDULA OFFICINALIS WHOLE; HAMAMELIS VIRGINIANA WHOLE; MATRICARIA CHAMOMILLA	1; 3; 1; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
34666-291_8656fff4-937d-09b7-e053-2a91aa0af4db	34666-291	HUMAN OTC DRUG	Hemorrhoid-X Treatment Pack		Hemorrhoid-X Treatment Pack	KIT	ORAL; TOPICAL	20190411		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos SA DE CV						N	20241231
34666-301_b6aee769-cf30-3809-e053-2a95a90a3571	34666-301	HUMAN OTC DRUG	Intime Cesens		Intime Cesens	GEL	TRANSDERMAL	20200611		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos SA DE CV	CALENDULA OFFICINALIS WHOLE; HAMAMELIS VIRGINIANA WHOLE; HYDRASTIS CANADENSIS WHOLE; MATRICARIA CHAMOMILLA	1; 3; 5; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
34666-311_b109be2f-096e-20fd-e053-2a95a90a7f13	34666-311	HUMAN OTC DRUG	Elberry Up		Sambucus Nigra, Sulphur, Bryonia	TABLET	ORAL	20200903		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos SA DE CV	BRYONIA ALBA ROOT; SAMBUCUS NIGRA FLOWERING TOP; SULFUR	6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
34666-400_c16fe5ed-cc2b-77a9-e053-2a95a90ae114	34666-400	HUMAN OTC DRUG	Arnica Montana Nartex		Arnica montana, Hamamelis virginiana	GEL	TOPICAL	20210430		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. de C.V.	ARNICA MONTANA; HAMAMELIS VIRGINIANA WHOLE	1; 1	[hp_X]/g; [hp_X]/g			N	20241231
34666-401_c1708f58-3f1e-449f-e053-2a95a90aa4d4	34666-401	HUMAN OTC DRUG	Arnica WH MONTANA NARTEX		Arnica montana, Hamamelis virginiana	GEL	TOPICAL	20210519		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. de C.V.	ARNICA MONTANA; HAMAMELIS VIRGINIANA WHOLE	1; 1	[hp_X]/g; [hp_X]/g			N	20241231
34666-402_d2439b65-3876-c1a6-e053-2a95a90a40aa	34666-402	HUMAN OTC DRUG	Simply Dreams		Passiflora incarnata, Valeriana officinalis	TABLET	ORAL	20211203		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. De C.V.	PASSIFLORA INCARNATA FLOWERING TOP; VALERIAN	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
34666-403_d244bc14-51d3-2c4c-e053-2995a90a63a9	34666-403	HUMAN OTC DRUG	Simply Harmony		Ignatia amara, Passiflora incarnata, Valeriana officinalis, Kali phosphoricum	TABLET	ORAL	20211203		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. De C.V.	DIBASIC POTASSIUM PHOSPHATE; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; VALERIAN	6; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
34666-404_d24517c9-11d8-28f5-e053-2995a90a0196	34666-404	HUMAN OTC DRUG	Simply Shift		Passiflora incarnata, Valeriana officinalis, Arnica montana	TABLET	ORAL	20211203		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. De C.V.	ARNICA MONTANA; PASSIFLORA INCARNATA FLOWERING TOP; VALERIAN	12; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
34666-405_d469349c-1164-1b5d-e053-2a95a90ae83a	34666-405	HUMAN OTC DRUG	Hemorrhoidex		Hamamelis virginiana, Ratanhia	GEL	TOPICAL	20211230		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. de C.V.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; KRAMERIA LAPPACEA ROOT	1; 3	[hp_X]/64.9g; [hp_X]/64.9g			N	20241231
34666-406_d46a3ac3-a37b-743d-e053-2a95a90ab0b1	34666-406	HUMAN OTC DRUG	Schusslers Immune		Echinacea, Ferrum phosphoricum, Kali muriaticum, Zincum gluconicum	TABLET	ORAL	20220113		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. de C.V.	ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; POTASSIUM CHLORIDE; ZINC GLUCONATE	3; 6; 6; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
34666-407_d469fd01-4a38-3e63-e053-2a95a90a0a66	34666-407	HUMAN OTC DRUG	Arnica Active Montana Nartex		Arnica montana, Hamamelis virginiana	GEL	TOPICAL	20211230		UNAPPROVED HOMEOPATHIC		Nartex Laboratorios Homeopaticos, S.A. de C.V.	ARNICA MONTANA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	1; 1	[hp_X]/74g; [hp_X]/74g			N	20241231
34908-636_e131c669-f8b2-4d96-a51f-9d33c31ac3a0	34908-636	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Novast Laboratories, Ltd.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
34908-637_e131c669-f8b2-4d96-a51f-9d33c31ac3a0	34908-637	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Novast Laboratories, Ltd.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
34908-638_e131c669-f8b2-4d96-a51f-9d33c31ac3a0	34908-638	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Novast Laboratories, Ltd.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
34908-639_e131c669-f8b2-4d96-a51f-9d33c31ac3a0	34908-639	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Novast Laboratories, Ltd.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
34940-003_0804658c-3a11-4213-e063-6394a90ab25c	34940-003	HUMAN PRESCRIPTION DRUG	nitrogen		nitrogen	GAS	RESPIRATORY (INHALATION)	20101108		NDA	NDA205866	WAYNE OXYGEN AND WELDING SUPPLY COMPANY	NITROGEN	990	mL/L			N	20241231
34940-004_080471ff-075d-bac1-e063-6294a90a33e2	34940-004	HUMAN PRESCRIPTION DRUG	oxygen		oxygen	GAS	RESPIRATORY (INHALATION)	20101108		NDA	NDA205865	WAYNE OXYGEN AND WELDING SUPPLY COMPANY	OXYGEN	990	mL/L			N	20241231
35000-013_620d2d4c-4120-4281-b558-c72f29bf0388	35000-013	HUMAN OTC DRUG	Colgate MaxFresh with Mini Breath Clean Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20131011		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-014_075bb0fd-7d21-45e0-a5b7-af5f4e7de1f8	35000-014	HUMAN OTC DRUG	Colgate MaxFresh with Mini Breath Cool Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20130923		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20251231
35000-023_a100056b-717b-4007-8059-92f51f8a455b	35000-023	HUMAN OTC DRUG	Colgate Sensitive plus Whitening		POTASSIUM NITRATE and SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20190225		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
35000-024_79cd0836-5dec-4402-8b83-8576ab43606d	35000-024	HUMAN OTC DRUG	Colgate Sensitive Complete Protection		POTASSIUM NITRATE and SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20181113		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
35000-028_2463014a-b121-496c-8889-449a4b32fb5f	35000-028	HUMAN OTC DRUG	Colgate MaxClean with Whitening Smartfoam		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20191024		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20251231
35000-068_760b36bf-6395-4a42-8b3e-2b74d193d79a	35000-068	HUMAN OTC DRUG	Irish Spring Antibacterial Bar		Chloroxylenol	SOAP	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	CHLOROXYLENOL	3	mg/g			N	20241231
35000-069_1277045c-c3b6-4e78-b423-2b7383dea0f2	35000-069	HUMAN OTC DRUG	Protex Complete Antibacterial Bar		Chloroxylenol	SOAP	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	CHLOROXYLENOL	3	mg/g			N	20241231
35000-081_c3251c15-0868-412d-960d-1bb310a11212	35000-081	HUMAN OTC DRUG	SoftSoap Antibacterial with moisturizers White Tea and Berry Fusion		Benzalkonium chloride	LIQUID	TOPICAL	20150520		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-086_6aa7256f-0fd8-4ce1-8085-9c8b5cf748c1	35000-086	HUMAN OTC DRUG	SoftSoap Antibacterial with moisturizers Crisp Clean		Benzalkonium chloride	LIQUID	TOPICAL	20130119		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-087_96b0abd0-94f2-4739-a729-d22dde188a68	35000-087	HUMAN OTC DRUG	SoftSoap Antibacterial with moisturizers Fresh Citrus		Benzalkonium chloride	LIQUID	TOPICAL	20130119		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-088_1f34bf59-8533-4dbc-9f26-a6b901ec8c97	35000-088	HUMAN OTC DRUG	SoftSoap Antibacterial Kitchen Fresh Hands		Benzalkonium chloride	LIQUID	TOPICAL	20160819		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-096_1019a52a-836e-4ac7-bca8-a5cfe486b62e	35000-096	HUMAN OTC DRUG	Softsoap Antibacterial Clean and Protect Cool Splash		Benzalkonium Chloride	LIQUID	TOPICAL	20201123		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-098_dd76f046-c6e8-4437-9315-501fafab8393	35000-098	HUMAN OTC DRUG	Softsoap Antibacterial Kitchen Fresh Hands		Benzalkonium Chloride Liquid	LIQUID	TOPICAL	20200214		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-099_75d4f048-eecd-4311-ab85-a0c473693260	35000-099	HUMAN OTC DRUG	Softsoap Antibacterial with Moisturizers Fresh Citrus LHS		Benzalkonium Chloride Liquid	LIQUID	TOPICAL	20200214		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-100_397eb385-60b8-415e-8366-dcccc0a401c7	35000-100	HUMAN OTC DRUG	Softsoap Antibacterial with Moisturizers Crisp Clean LHS		Benzalkonium Chloride Liquid	LIQUID	TOPICAL	20200214		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-101_c148b42e-d426-47f2-9cfe-c0f83959f3bd	35000-101	HUMAN OTC DRUG	Softsoap Antibacterial with Moisturizers White Tea and Berry LHS		Benzalkonium Chloride Liquid	LIQUID	TOPICAL	20200212		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-102_8bd64d65-07b8-4a02-9b70-a7f3e8d14899	35000-102	HUMAN OTC DRUG	Softsoap Antibacterial Sparkling Pear		Benzalkonium Chloride	LIQUID	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-127_5afcebc5-644a-49c9-b27f-676e82042a51	35000-127	HUMAN OTC DRUG	Colgate MaxFresh Knockout		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20191024		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-128_b1615f7f-0774-4187-8292-d555071d5077	35000-128	HUMAN OTC DRUG	Colgate Sensitive Prevent and Repair		POTASSIUM NITRATE and SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20191025		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
35000-135_074d21b5-5a6d-418b-a34b-ee98a93f78a8	35000-135	HUMAN OTC DRUG	CO Oh So Dazzling Sweet Mint		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20201101	20240630	OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.5	mg/g			N	
35000-136_0ba3a455-58ab-42c3-a710-2cfafe171312	35000-136	HUMAN OTC DRUG	Colgate Co Oh So Glowing		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20220110	20240131	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	
35000-169_3ab1be71-3cd8-46d8-89fe-bf8ed65e5015	35000-169	HUMAN OTC DRUG	Colgate Total SF Advanced Deep Clean		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20181101		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-172_a78f2728-b7d3-4f26-a7e4-2d8a99d0d979	35000-172	HUMAN OTC DRUG	Colgate Total SF Clean Mint		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20181101		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-174_62d4c822-a9ab-43d6-8800-a4b868a75ada	35000-174	HUMAN OTC DRUG	Colgate Total SF Mint Stripe Gel		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20181101		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-175_65b67393-e20b-4f08-bc93-1a8d37dc9f1b	35000-175	HUMAN OTC DRUG	Colgate Total SF Whitening Gel		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20181101		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-176_4e6fed4e-92d6-471f-93b4-df84175bf6be	35000-176	HUMAN OTC DRUG	Colgate Total SF Whitening		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20181101		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-178_dac11dd2-29dc-447e-bd27-83e1b9700e9d	35000-178	HUMAN OTC DRUG	Colgate Total SF Advanced Whitening		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20190514		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-179_d14191dc-ea56-4963-895e-3d29679e36ee	35000-179	HUMAN OTC DRUG	Colgate Total Whitening Fresh Boost		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20211126		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-180_8a0de0c8-559a-4104-8539-867291330294	35000-180	HUMAN OTC DRUG	Colgate Total Plaque Pro Release Fresh Mint		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20221109		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-181_75a295fc-80ab-4d78-a693-575426878cc6	35000-181	HUMAN OTC DRUG	Colgate Total Plaque Pro Release Whitening		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20221109		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-190_441bfd3e-8065-453d-afce-537b755f8814	35000-190	HUMAN OTC DRUG	Colgate Kids Maximum Cavity Protection		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210222		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-191_94c22077-bc62-491d-b7d1-45ec1817a34e	35000-191	HUMAN OTC DRUG	Colgate Kids Maximum Cavity Protection Batman		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210222		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-192_661eb659-d04d-41e6-b923-134a4638c783	35000-192	HUMAN OTC DRUG	Colgate Kids Sloth	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210301	20240630	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	
35000-193_a927e91b-cee5-4706-85e3-b779834b7f28	35000-193	HUMAN OTC DRUG	Colgate Kids Minions		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210301	20240630	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	
35000-194_844eb9e3-8720-4268-af66-75d162c1632a	35000-194	HUMAN OTC DRUG	Colgate Kids Ryans World		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210301	20240630	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	
35000-195_7b02a575-02ee-46c6-914d-bf9d0b3be81c	35000-195	HUMAN OTC DRUG	Colgate Kids Trolls		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210301	20240630	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	
35000-196_ab43d230-d38f-436f-b62e-7a2439770a1b	35000-196	HUMAN OTC DRUG	Colgate Maximum Cavity Protection	Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20200505		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-197_bcec8c0b-09b9-4837-83dd-1049c5843802	35000-197	HUMAN OTC DRUG	Colgate Maximum Cavity Protection Wonder Woman		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210323	20240630	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	
35000-198_41961b0d-23d5-4b78-8e8a-5397ccd35dfb	35000-198	HUMAN OTC DRUG	Colgate Kids Hum	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20211101	20240630	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	
35000-199_dbdbac3f-9771-48fa-b155-5fff59cda382	35000-199	HUMAN OTC DRUG	Colgate Kids Space Jam	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20211206		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-219_02a3c43d-f648-4952-a078-b93fbae45f86	35000-219	HUMAN OTC DRUG	Colgate Gum Renewal Deep Clean		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20220304	20241231	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	
35000-220_28ffe079-13ad-4ab6-87fa-3a38220e84b5	35000-220	HUMAN OTC DRUG	Colgate Renewal Whitening Restoration		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20201103	20241231	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	
35000-222_b1897226-fbc0-4244-a7d3-922a5de38d04	35000-222	HUMAN OTC DRUG	Colgate Renewal Whitening Restoration		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20201109	20241230	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	
35000-223_ac4855d1-3195-4eff-80ca-e2be915a01d1	35000-223	HUMAN OTC DRUG	Colgate Renewal Enamel Fortify		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20201103	20240309	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	
35000-224_aafc2473-3eae-47e7-8ec7-317854d5efce	35000-224	HUMAN OTC DRUG	Colgate Renewal Sensitivity Repair		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20201103	20241231	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	
35000-225_dca101d5-92d0-41d5-877b-30efb3695af1	35000-225	HUMAN OTC DRUG	Colgate Enamel Renewal Sensitivity		POTASSIUM NITRATE and SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20211115	20241231	OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	
35000-226_719c3000-1ee2-4fc9-a797-3a9ffde42d37	35000-226	HUMAN OTC DRUG	Colgate Enamel Renewal Whitening		POTASSIUM NITRATE and SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20211115	20241231	OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	
35000-227_e1e62190-03cd-4acc-99e9-59e374876411	35000-227	HUMAN OTC DRUG	Colgate Enamel Renewal Deep Clean		POTASSIUM NITRATE and SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20211115	20241231	OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	
35000-249_f2a877b5-60a7-4514-8054-6a9c210f5297	35000-249	HUMAN OTC DRUG	Softsoap Antibacterial with Moisturizers White Tea and Berry LHS		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-250_3699577a-1da9-4523-9197-df771954f138	35000-250	HUMAN OTC DRUG	Softsoap Antibacterial with Moisturizers Fresh Citrus LHS		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-251_991d4c5b-5c9c-42e2-a1ec-52d63218c0b7	35000-251	HUMAN OTC DRUG	Softsoap Antibacterial with Moisturizers Crisp Clean LHS		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-252_c57b83c4-e7ac-4a3c-9ccd-7433c3d05f74	35000-252	HUMAN OTC DRUG	Softsoap Antibacterial Sparkling Pear		Benzalkonium Chloride	LIQUID	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-253_850fa550-9557-4ecd-a935-0a1b72b90e4f	35000-253	HUMAN OTC DRUG	SoftSoap Antibacterial Kitchen Fresh Hands		Benzalkonium chloride	LIQUID	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-254_9164e943-b3c3-4bb3-9f7f-943bc33f7f2d	35000-254	HUMAN OTC DRUG	Softsoap Antibacterial Clean and Protect Cool Splash		Benzalkonium Chloride	LIQUID	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-255_be239f80-c6df-4a9a-883d-2fc0c8a97268	35000-255	HUMAN OTC DRUG	Protex Balance antibacterial hand		Benzalkonium chloride	LIQUID	TOPICAL	20221017		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-256_e0af5c06-c880-49f7-bf19-642129195971	35000-256	HUMAN OTC DRUG	Softsoap AB Sensitive Rose Water and Aloe LHS		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20221202		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-257_d79d3c8e-66ba-4a41-a345-dabcb380a1a1	35000-257	HUMAN OTC DRUG	COLGATE Great Regular Flavor		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20220618		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-261_675b5ec7-6e88-4607-8b39-86c498dc34a4	35000-261	HUMAN OTC DRUG	Colgate Optic White Stain Fighter Clean Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220601		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1	mg/g			N	20241231
35000-262_69b11415-dd70-42ca-b094-148d0973995e	35000-262	HUMAN OTC DRUG	COLGATE OPTIC WHITE CHARCOAL		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220601		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1	mg/g			N	20241231
35000-263_6809bba8-1197-4218-8c2b-267374b8a40d	35000-263	HUMAN OTC DRUG	Colgate Optic White Stain Fighter Fresh Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220601		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1	mg/g			N	20241231
35000-264_e57439cb-12d9-443f-8653-0095c42378ab	35000-264	HUMAN OTC DRUG	Colgate Optic White Stain Fighter	With Baking Soda	SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220602		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-334_dcaaa0d6-62a7-4d9c-8812-a8407a856108	35000-334	HUMAN OTC DRUG	Colgate Kids Unicorn Alcohol Free		SODIUM FLUORIDE	RINSE	DENTAL	20220105		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	.1	mg/mL			N	20251231
35000-365_e60c6a1e-7a9b-4524-ae2c-e02609fb06e4	35000-365	HUMAN OTC DRUG	Colgate Kids Llama	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20201221		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-383_c0df753b-f0f6-4f7e-865e-4ec486226999	35000-383	HUMAN OTC DRUG	Colgate Kids Trolls Alcohol Free Anti-Cavity Sparkle Time Bubble Fruit		SODIUM FLUORIDE	RINSE	DENTAL	20160805	20241230	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	.1	mg/mL			N	
35000-386_076337f8-49f4-4359-a5e6-5d2aad6e2d1f	35000-386	HUMAN OTC DRUG	Mens Speed Stick Overtime Odor Control with Charcoal - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20161116		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-387_264ff4ed-647b-43b2-906c-df3f245e26c6	35000-387	HUMAN OTC DRUG	Mens Speed Stick Irish Spring Celtic Ice - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20161117		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-388_e3d18d40-47ff-4ea3-bc7a-44c7fcebda00	35000-388	HUMAN OTC DRUG	Mens Speed Stick Irish Spring Original - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20161117		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-396_102b3876-17be-4a8b-9d38-4534878c214e	35000-396	HUMAN OTC DRUG	Lady Speed Stick Double Defense Active Fresh - antiperspirant/deodorant		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20170309		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-397_49d155a3-a61f-4fa4-b3f5-8fecf4c7748a	35000-397	HUMAN OTC DRUG	Lady Speed Stick Double Defense Floral Fresh - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20170309		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-407_968c8250-819f-4fe4-a11a-be30808d6e14	35000-407	HUMAN OTC DRUG	Lady Speed Stick Invisible Dry Shower Fresh Antiperspirant Deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20170325		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	158	mg/g			N	20241231
35000-415_dd59383d-52fc-45e5-b6d2-9565cc3989fa	35000-415	HUMAN OTC DRUG	Softsoap Antibacterial Wicked Citrus		Benzalkonium chloride	LIQUID	TOPICAL	20170801		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-416_7ee61725-cf3c-41d1-aee7-e58497da15ae	35000-416	HUMAN OTC DRUG	Lady Speed Stick Invisible Dry Power Spring Blossom - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20170724		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	159	mg/g			N	20241231
35000-417_cf3016d4-c51c-48b1-8f42-e566bd1412b1	35000-417	HUMAN OTC DRUG	Lady Speed Stick Power Wild Freesia		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20160501		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	159	mg/g			N	20241231
35000-418_b35fff64-6054-40fb-9406-54698163f979	35000-418	HUMAN OTC DRUG	Colgate Ultra White Charcoal		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20200731		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-419_4b4eb388-1772-498d-9d5c-9b5ae772cbe2	35000-419	HUMAN OTC DRUG	TP COL OW Purple		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20231001		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-571_bf8a4bf1-d341-4488-a34a-c878790549c1	35000-571	HUMAN OTC DRUG	Colgate Total Whitening Charcoal		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20201210		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-572_78a62b57-9e3b-4a60-af06-47347fff92fc	35000-572	HUMAN OTC DRUG	Colgate Total Gum Protection		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20201211	20241230	OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	
35000-581_462660ea-b744-4b3d-a688-3d38b9abf393	35000-581	HUMAN OTC DRUG	Lady Speed Stick Invisible Dry Power Powder Fresh		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20130203		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-582_268b769d-86ae-4c2c-ba96-4af859057379	35000-582	HUMAN OTC DRUG	Lady Speed Stick	Invisible Dry Power Wild Freesia	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20130203		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-605_157702fc-793f-43b8-a9cb-a975f8eb30a3	35000-605	HUMAN OTC DRUG	Speed Stick Fresh Antiperspirant Deodorant		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20150903		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	159	mg/g			N	20241231
35000-606_1aeb45c9-73c4-4d2c-b0ad-28da10c884cc	35000-606	HUMAN OTC DRUG	Speed Stick Clean Antiperspirant Deodorant		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20150903		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	158	mg/g			N	20241231
35000-607_197cbae0-0077-42fb-8b50-198fdaa55b77	35000-607	HUMAN OTC DRUG	Speed Stick Cool Clean		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20200204		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	158	mg/g			N	20241231
35000-622_a4577bae-d21c-45d4-8c3a-e555acb07a7c	35000-622	HUMAN OTC DRUG	Lady Speed Stick	Invisible Dry	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20101213		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-662_3e53a239-d050-4bf1-b640-f86b5caa885e	35000-662	HUMAN OTC DRUG	Speed Stick	24/7 Fresh Rush	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20101210		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-665_b1604456-1995-4b78-991f-d109a15eedf1	35000-665	HUMAN OTC DRUG	Mens Speed Stick Fresh Rush - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20181126		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	158	mg/g			N	20241231
35000-666_96a4e32a-4c66-4b67-8337-aad0d9bba219	35000-666	HUMAN OTC DRUG	Mens Speed Stick Stainguard Clean - antiperspirant/deodorant		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20181203		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	100	mg/g			N	20241231
35000-667_9333db27-4521-4a7e-a3e1-03875323bdfe	35000-667	HUMAN OTC DRUG	Mens Speed Irish Spring Pure Fresh - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20181203		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	156	mg/g			N	20241231
35000-668_123f14e9-22d8-4de5-8149-76a83d791f9c	35000-668	HUMAN OTC DRUG	Mens Speed Irish Spring Charcoal - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20200312		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	156	mg/g			N	20241231
35000-670_16fb2287-538c-4ec2-880e-ae0e03a8c578	35000-670	HUMAN OTC DRUG	Speed Stick	Unscented Antiperspirant Deodorant	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20110801		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-675_16fb355d-7e65-466f-956a-ba9ec98c120d	35000-675	HUMAN OTC DRUG	Protex Balance antibacterial hand		Benzalkonium chloride	LIQUID	TOPICAL	20130822		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-677_caa86f58-a798-4e08-a302-58a380ad3dac	35000-677	HUMAN OTC DRUG	SoftSoap Antibacterial Kitchen Fresh Hands		Benzalkonium chloride	LIQUID	TOPICAL	20160819		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-678_4e49775d-244b-4b41-81b2-0b4e1c05a478	35000-678	HUMAN OTC DRUG	Hello Activated Charcoal		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
35000-679_aac0dcd4-6215-4459-8707-a70a2bfc969f	35000-679	HUMAN OTC DRUG	Hello Dragon Dazzle	Dragon Dazzle Fluoride	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
35000-680_247c4218-27bb-4f58-a021-fe7d10ab24d5	35000-680	HUMAN OTC DRUG	Hello Magical Mermaid		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-681_35fc33cd-4ce2-426d-ba4b-97345cd25a71	35000-681	HUMAN OTC DRUG	Hello Mighty Multi tasker		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
35000-682_c7953ee4-f4f1-4637-a093-127d8850423f	35000-682	HUMAN OTC DRUG	Hello Naturally Whitening		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
35000-683_fcefe14c-c1e0-4f48-8f37-d3eff53d04f3	35000-683	HUMAN OTC DRUG	Hello Peace Out Plaque	peace out, plaque antigingivitis	CETYLPYRIDINIUM CHLORIDE	MOUTHWASH	DENTAL	20230701		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	CETYLPYRIDINIUM CHLORIDE	15	mg/20mL			N	20241231
35000-684_25c4cc6c-154b-4fc8-aa03-2a2657f0e12a	35000-684	HUMAN OTC DRUG	Hello See Ya Sensitivity		Potassium nitrate and Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.5	mg/g; mg/g			N	20241231
35000-685_19dd60ab-7eed-494a-b228-c5124c554e4b	35000-685	HUMAN OTC DRUG	Hello Wild Strawberry		Sodium fluoride	MOUTHWASH	DENTAL	20230701		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	.02	g/100mL			N	20241231
35000-686_547c89b9-7910-4167-acaf-5596e3a95ccb	35000-686	HUMAN OTC DRUG	Hello Unicorn Sparkle		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-687_dec4fe78-6cad-4b55-b597-a5383f1c68be	35000-687	HUMAN OTC DRUG	Hello Unicorn Splash	unicorn splash anticavity fluoride rinse	sodium fluoride	MOUTHWASH	DENTAL	20230701		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	.02	g/100mL			N	20241231
35000-688_8d6532c5-963a-494b-958e-fc841a62666c	35000-688	HUMAN OTC DRUG	Hello Kids Wild Strawberry	Wild Strawberry	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20230701		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
35000-689_6f722bc8-60c2-4954-9f12-1457a2a318bc	35000-689	HUMAN OTC DRUG	Hello Vitamin C Whitening		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20240101		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
35000-694_52bd3dba-3f0c-4fc8-b59f-1a0ddc1dc4fb	35000-694	HUMAN OTC DRUG	Mens Speed Overtime Odor Control with Charcoal - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20181116		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	156	mg/g			N	20241231
35000-695_e9751483-0936-4235-b225-b8f5519b8ef3	35000-695	HUMAN OTC DRUG	Mens Speed Stick Overtime - antiperspirant/deodorant		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20181116		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	156	mg/g			N	20241231
35000-696_a70afbc3-3828-4d28-b23e-aa1e7a83879b	35000-696	HUMAN OTC DRUG	Mens Speed Stick Irish Spring Celtic Ice - antiperspirant/deodorant		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20181116		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-697_c248a9ce-fea0-4a1f-a7b9-06432511db04	35000-697	HUMAN OTC DRUG	Mens Speed Stick Irish Spring Original - antiperspirant/deodorant		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20181116		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-711_405710d5-680a-4eca-8a2e-6bb3d519c815	35000-711	HUMAN OTC DRUG	Lady Speed Stick	Teen Spirit Pink Crush	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20101210		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	159	mg/g			N	20241231
35000-711_c0263fd6-22fa-459e-ac4a-a7cfcb184312	35000-711	HUMAN OTC DRUG	Lady Speed Stick	Teen Spirit Pink Crush	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20101210		OTC MONOGRAPH DRUG	M019	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	159	mg/g			N	20241231
35000-716_46ae4c03-f9d3-4c70-9b3f-2ee155332b39	35000-716	HUMAN OTC DRUG	Lady Speed Stick	24x7 Powder Burst	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20110609		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	154	mg/g			N	20241231
35000-720_3bf4fc5e-3084-4836-9d8b-be8982911946	35000-720	HUMAN OTC DRUG	Colgate Total Advanced Pro-Shield Peppermint Blast		CETYLPYRIDINIUM CHLORIDE	RINSE	DENTAL	20130506		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	CETYLPYRIDINIUM CHLORIDE	15	mg/20mL			N	20241231
35000-723_4da2d7a2-0dbc-43b6-b086-46bf119fe64b	35000-723	HUMAN OTC DRUG	Colgate Total Advanced Gum Health Mouthwash		CETYLPYRIDINIUM CHLORIDE	RINSE	DENTAL	20150301		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	CETYLPYRIDINIUM CHLORIDE	.75	mg/mL			N	20241231
35000-727_caeceb78-d7a4-438b-aab8-bd759af599be	35000-727	HUMAN OTC DRUG	Colgate Kids Minions Mouthwash		SODIUM FLUORIDE	RINSE	DENTAL	20150801		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	.1	mg/mL			N	20251231
35000-728_63ca8818-e464-4966-86a8-04f4379bda3c	35000-728	HUMAN OTC DRUG	Colgate Enamel Health Mouthwash		SODIUM FLUORIDE	RINSE	DENTAL	20150801	20260331	OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	.1	mg/mL			N	
35000-729_6f1e6625-a395-4443-801b-e14337b705ea	35000-729	HUMAN OTC DRUG	Speed Stick Gear Overtime Relentless Antiperspirant Deodorant		Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20151022		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	153	mg/g			N	20241231
35000-731_aad5ad8d-875d-4cd3-b0be-38d9f62e071f	35000-731	HUMAN OTC DRUG	Colgate Total 12 Hr Pro-Shield Spearmint Surge		CETYLPYRIDINIUM CHLORIDE	RINSE	DENTAL	20150901		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	CETYLPYRIDINIUM CHLORIDE	15	mg/20mL			N	20241231
35000-733_9e60bdeb-c569-4496-b9e0-586c51e0bfe2	35000-733	HUMAN OTC DRUG	SoftSoap Antibacterial Hand Citrus Cheer		Benzalkonium chloride	LIQUID	TOPICAL	20170915		OTC MONOGRAPH NOT FINAL	part333E	Colgate-Palmolive Company	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
35000-734_fe5818ff-c97c-4597-a7c9-c91aa7bd056f	35000-734	HUMAN OTC DRUG	Colgate Enamel Strength Mouthwash		SODIUM FLUORIDE	RINSE	DENTAL	20191003		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive - do not use	SODIUM FLUORIDE	.1	mg/mL			N	20251231
35000-735_ca93ec91-7126-4269-b909-1f91830073a4	35000-735	HUMAN OTC DRUG	Colgate Total Ultra Fresh		CETYLPYRIDINIUM CHLORIDE	RINSE	DENTAL	20220101		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	CETYLPYRIDINIUM CHLORIDE	15	mg/20L			N	20241231
35000-740_2072229b-a95d-4a80-9f7a-45636d49bccf	35000-740	HUMAN OTC DRUG	Colgate RE revive		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210807		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-741_ce63358d-740e-454f-bf4f-e99c1bfabfab	35000-741	HUMAN OTC DRUG	Colgate RE refresh		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210807		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-742_06d86858-2691-47d7-a35d-d2c7e508a473	35000-742	HUMAN OTC DRUG	Colgate RE repair		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210807		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-743_213559a6-9ecf-4dec-b36a-40baf45a3937	35000-743	HUMAN OTC DRUG	Colgate RE reenergize		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210807		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-744_cd6cd26f-d3ee-4ecf-bb4e-a456d22d564e	35000-744	HUMAN OTC DRUG	Colgate RE renew		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20210807		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-745_3573d751-c4f0-42c0-bc63-e1fa95077d42	35000-745	HUMAN OTC DRUG	Colgate Re Variety Pack		SODIUM FLUORIDE	KIT		20211001		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company						N	20241231
35000-746_bc7b1cd5-01e1-4386-836c-77f4a8ffefd2	35000-746	HUMAN OTC DRUG	Colgate Double Fresh		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20211124		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	2.4	mg/g			N	20241231
35000-747_0fba6852-08bf-434e-8e4f-a2ae15c4c6d8	35000-747	HUMAN OTC DRUG	Colgate Optic White Pro Series Stain Prevention		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20211123		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
35000-748_bdf4041c-e2b6-4c6a-b08c-a02353fd6b66	35000-748	HUMAN OTC DRUG	Colgate Optic White ProSeries Enamel Strenght		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20211123		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.5	mg/g			N	20241231
35000-749_c1dcd8b1-bf6c-454a-8667-e7db735fd0ae	35000-749	HUMAN OTC DRUG	Colgate Optic White ProSeries Vividly Fresh		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20211123		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
35000-758_fc820364-0ef9-492d-8474-7d649a533abd	35000-758	HUMAN OTC DRUG	Colgate Optic White Sparkling		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20220727		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-809_8c2ef2f8-0bd5-4b75-a09f-f4e7dd14e73a	35000-809	HUMAN OTC DRUG	Colgate Optic White Stain Fighter	With Baking Soda	SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20211115		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-845_37f8c6bd-cfff-44f5-9d50-5f68648a0614	35000-845	HUMAN OTC DRUG	Lady Speed Stick	Stainguard Powder Fresh	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20110601		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	100	mg/g			N	20241231
35000-846_2396aeca-8759-4145-a990-bd40556c4452	35000-846	HUMAN OTC DRUG	Lady Speed Stick	Stainguard Daringly Fresh	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20110601		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	100	mg/g			N	20241231
35000-848_5b5a7137-e90e-42ee-8dc4-720d84c4d550	35000-848	HUMAN OTC DRUG	Speed Stick	Stainguard Fresh	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20111012		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	100	mg/g			N	20241231
35000-854_66fc091d-d5ef-46f6-a692-79b128a1b678	35000-854	HUMAN OTC DRUG	Speed Stick	Power Ultimate Sport	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20110801		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	180	mg/g			N	20241231
35000-855_1be75234-8c4a-44e6-b5d7-b01d3c8ccfb2	35000-855	HUMAN OTC DRUG	Lady Speed Stick	24/7 FRESH FUSION	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20111204		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	180	mg/g			N	20241231
35000-856_623e94ee-2ffd-4ce3-8a29-ff0b25e2d90d	35000-856	HUMAN OTC DRUG	Lady Speed Stick	Invisible Dry Shower Fresh	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20111204		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	180	mg/g			N	20241231
35000-860_107848ef-b803-40e5-8e9d-eed5b481c283	35000-860	HUMAN OTC DRUG	Speed Stick	24/7 Fresh Rush	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20111204		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	180	mg/g			N	20241231
35000-863_035b8acc-18e7-4c10-a11b-c51c674a0e33	35000-863	HUMAN OTC DRUG	Speed Stick Overtime Clear Gel		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20170221		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	180	mg/g			N	20241231
35000-864_84b96636-c682-4704-9b16-b88795a98931	35000-864	HUMAN OTC DRUG	Speed Stick Power Fresh	Power Fresh	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20200323		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	159	mg/g			N	20241231
35000-867_741d4a42-da3f-4e2c-93d5-bfffedf0c3f5	35000-867	HUMAN OTC DRUG	Speed Stick	Irish Spring Original	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20111204		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-871_836e87e4-f164-4ea1-9937-0837df64f64d	35000-871	HUMAN OTC DRUG	Speed Stick	Power Fresh	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20110801		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-872_48e337f2-337e-4a06-95d1-e28959e74fac	35000-872	HUMAN OTC DRUG	Speed Stick	Power Ultimate Sport	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20120626		OTC MONOGRAPH FINAL	part350	Colgate-Palmolive Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	160	mg/g			N	20241231
35000-893_21e8a07a-2df7-4f11-bff8-247335e298dd	35000-893	HUMAN OTC DRUG	Colgate Optic White Stain Prevention		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20220107		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-899_44da1b5a-c56a-46a4-bcb0-fde7784c8409	35000-899	HUMAN OTC DRUG	Colgate Max Fresh	Advanced Whitening	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20211016		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	2.4	mg/g			N	20241231
35000-900_c7d9f799-bad2-417f-974d-30499cd2031a	35000-900	HUMAN OTC DRUG	COLGATE SPARKLING WHITE CINNAMINT		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20121001		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-902_0894c87e-2e18-48dc-bfdd-175645c7e4b9	35000-902	HUMAN OTC DRUG	Colgate Max Fresh Clean Mint		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110801		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	2.4	mg/g			N	20241231
35000-903_713de90b-5955-41aa-bee3-efb1a6c02dd5	35000-903	HUMAN OTC DRUG	Colgate	Max Fresh Cool Mint	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110801		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-905_ef6b81cf-b48c-452e-98fb-423c683cbf12	35000-905	HUMAN OTC DRUG	COLGATE KIDS WATERMELON FLAVOR		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110726		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-907_8aed9b0a-e131-400e-b3c4-764c27251ca8	35000-907	HUMAN OTC DRUG	COLGATE	2IN1 WHITENING STAIN LIFTERS	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110726		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-908_330b28ce-dd8b-4370-a245-6c3a515226b2	35000-908	HUMAN OTC DRUG	COLGATE	MAX WHITE WITH MINI BRIGHT STRIPS Crystal MINT	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110726		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-913_950de719-b371-4ca5-8859-b4b0da9b4eb5	35000-913	HUMAN OTC DRUG	COLGATE Great Regular Flavor		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20051105		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-914_4dd27637-354c-4f8f-b622-b4f0bf0d0f62	35000-914	HUMAN OTC DRUG	Colgate Cavity Protection Fresh Mint		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20190805		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-916_9f26a24f-61f8-44ad-9400-1a0e642e4497	35000-916	HUMAN OTC DRUG	Colgate	ULTRA BRITE Baking Soda and Peroxide Whitening	SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20111201		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
35000-917_2e101943-226d-42f0-80b3-dca4905ace91	35000-917	HUMAN OTC DRUG	COLGATE ULTRA BRITE ADVANCED WHITENING ALL IN ONE CLEAN MINT		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20051116		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-918_7bca8481-5100-459b-af98-93a5688b073e	35000-918	HUMAN OTC DRUG	Colgate Kids	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20161111		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-919_2a585156-3654-4416-bdf1-f4c31dcbf951	35000-919	HUMAN OTC DRUG	Colgate	Sparkling White Mint Zing	SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20130301		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-922_53ea6b73-2d40-4419-8ec6-fbe37a3ea3e4	35000-922	HUMAN OTC DRUG	COLGATE SENSITIVE WHITENING FRESH MINT		POTASSIUM NITRATE and SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20151016		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
35000-924_937a0524-950f-4ee0-840f-7a555fd24126	35000-924	HUMAN OTC DRUG	Colgate	Tartar Control Whitening Crisp Mint	SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20110108		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-926_27fcef32-bf70-4a26-843e-8c5c6ef74a38	35000-926	HUMAN OTC DRUG	Colgate Junior Bubble Fruit		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20161111		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-927_10b39656-1a49-42e2-a559-93c035c1b2f4	35000-927	HUMAN OTC DRUG	COLGATE 2IN1	ICY BLAST	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110726		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-930_61313e18-75b2-4bbb-8f74-19e93b60247d	35000-930	HUMAN OTC DRUG	Colgate	Max Clean Effervescent Mint	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110318		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-931_959eda0e-43e3-4b9d-8c44-bcf6d1b3d666	35000-931	HUMAN OTC DRUG	Colgate Max Clean	Spearmint Blast	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110801		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	24	mg/g			N	20241231
35000-936_d32d7cc8-1daf-4a26-ba55-24b6cd4df48c	35000-936	HUMAN OTC DRUG	Colgate Optic White Stain Fighter Fresh Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20171130		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1	mg/g			N	20241231
35000-937_27b14d80-678f-45cd-b760-a88636f099e6	35000-937	HUMAN OTC DRUG	Colgate Optic White Stain Fighter Clean Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20171130		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1	mg/g			N	20241231
35000-941_be016e92-4970-459f-8720-e3ecb0084408	35000-941	HUMAN OTC DRUG	Colgate Triple Action		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20101201		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-947_1cad1308-57a9-49ed-8605-7e49a6a63dab	35000-947	HUMAN OTC DRUG	Colgate Max Fresh Cool Mint		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20080406		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-950_78ec320b-064f-41d6-b5f1-bdf11ccfe75b	35000-950	HUMAN OTC DRUG	Colgate Junior Kids Batman Mild Bubble Fruit Fluoride		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20180709		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-953_d3962909-f60b-441c-898b-08beb5fc71af	35000-953	HUMAN OTC DRUG	Colgate Cavity Protection		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20140406		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-954_a7a3691c-956a-489d-b3b0-6f4cf34c44dd	35000-954	HUMAN OTC DRUG	Colgate Fluoride - Trolls - Mild Bubble Fruit		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20160630		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-956_f5f0193b-d25f-4e77-a6aa-80a9e6526e2b	35000-956	HUMAN OTC DRUG	COLGATE KIDS - BUBBLEFRUIT		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20190412		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-958_df1ede30-4d3e-4e06-961e-bdcde52d1d0f	35000-958	HUMAN OTC DRUG	Colgate Junior Mixed Kids Bubble Fruit Fluoride		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20170626		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-959_6eef8ab3-bbac-49c5-a23d-a83c8f52c056	35000-959	HUMAN OTC DRUG	COLGATE	Baking Soda and Peroxide Whitening Brisk Mint	SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20110820		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-965_5de6601e-26e3-4b83-a211-762ebf2b8374	35000-965	HUMAN OTC DRUG	Colgate Sensitive Complete Protection		SODIUM FLUORIDE and POTASSIUM NITRATE	PASTE, DENTIFRICE	DENTAL	20131218		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.4	mg/g; mg/g			N	20241231
35000-969_6a7656f3-768e-44b5-b39e-543011b568e9	35000-969	HUMAN OTC DRUG	Colgate Deep Clean Fluoride		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20150129		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-972_64c393a2-7de4-4011-b2b4-dee603e53e6a	35000-972	HUMAN OTC DRUG	Colgate MaxFresh with Whitening KnockOut Fluoride		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20160105		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-973_e5975a5c-d478-4796-8f90-6c216dc31f2c	35000-973	HUMAN OTC DRUG	Colgate Optic White Platinum Stain-Less		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20171114		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-974_6d97615f-1157-47de-bb51-43603cffbb8e	35000-974	HUMAN OTC DRUG	Colgate Essentials		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20180409		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-977_3d9302b0-72ef-4d21-aee6-d922c418b7ff	35000-977	HUMAN OTC DRUG	Colgate Optic White Advanced Icy Fresh		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191014		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-978_1914b25d-d6ab-45a1-ae87-b7623548f0ab	35000-978	HUMAN OTC DRUG	Colgate Optic White Advanced Sparkling White		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191014		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-979_4d04c04b-898f-4f97-9533-a8cf8c9089cf	35000-979	HUMAN OTC DRUG	Colgate Optic White Advanced Vibrant Clean		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191014		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.5	mg/g			N	20241231
35000-980_bcf9d01b-564b-4e79-92b0-88bd07224281	35000-980	HUMAN OTC DRUG	Colgate Optic White Renewal Enamel Strength		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191104		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1.5	mg/g			N	20241231
35000-981_3627e3e6-33e8-4372-b429-42b5f663a86b	35000-981	HUMAN OTC DRUG	Colgate Optic White Renewal Lasting Fresh		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191104		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-982_47a2f433-4975-4c23-b467-079d84021888	35000-982	HUMAN OTC DRUG	Colgate Optic White Renewal High Impact White		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191104		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
35000-986_8bca9771-60c3-4968-87dd-54f68e673cd4	35000-986	HUMAN OTC DRUG	Colgate Kids Llama	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20200505		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-987_c5cf8179-5cb9-4189-bb02-532ff9c8af8d	35000-987	HUMAN OTC DRUG	Colgate Kids Sloth	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20200505		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-988_6aa675eb-cd4f-4011-8d9b-936e46d14709	35000-988	HUMAN OTC DRUG	Colgate Optic White Charcoal		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20200505		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-990_d00e3737-34cb-44b6-861f-ec618799664c	35000-990	HUMAN OTC DRUG	Colgate MaxFresh Charcoal		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20201001		OTC MONOGRAPH DRUG	M021	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20251231
35000-991_0122c6a6-066a-4459-8451-c224e4329261	35000-991	HUMAN OTC DRUG	Colgate Ultra Fresh		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20201016		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-992_7b32fd85-c012-4697-8f7f-c5ec56d602a6	35000-992	HUMAN OTC DRUG	Colgate Ultra Relief		SODIUM FLUORIDE and POTASSIUM NITRATE	PASTE, DENTIFRICE	DENTAL	20201016		OTC MONOGRAPH NOT FINAL	part356	Colgate-Palmolive Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.4	mg/g; mg/g			N	20241231
35000-993_f61df214-3a6e-4fcd-9caa-a8d85115d086	35000-993	HUMAN OTC DRUG	Colgate Ultra Protect		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20201016		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35000-996_69fd4e30-23f8-4a1e-b806-07be972c9375	35000-996	HUMAN OTC DRUG	Colgate Kids Space Jam	Mild Bubble Fruit Flavor	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20210528		OTC MONOGRAPH FINAL	part355	Colgate-Palmolive Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
35192-007_078990cb-75b4-9a42-e063-6394a90a1074	35192-007	HUMAN OTC DRUG	UMBRELLA		OCTINOXATE TITANIUM DIOXIDE	LOTION	TOPICAL	20130801		OTC MONOGRAPH DRUG	M020	CA-BOTANA INTERNATIONAL	OCTINOXATE; TITANIUM DIOXIDE	2.268; 2.268	g/56.7g; g/56.7g			N	20241231
35192-010_07da204d-03e5-5010-e063-6394a90ad41b	35192-010	HUMAN OTC DRUG	Umbrella Sunscreen		Octinoxate Titanium Dioxide	LOTION	TOPICAL	20120601		OTC MONOGRAPH DRUG	M020	CA-BOTANA INTERNATIONAL	OCTINOXATE; TITANIUM DIOXIDE	8.5; 6.8	g/113.4g; g/113.4g			N	20241231
35192-011_07fd4ec5-2e20-f584-e063-6394a90a32d1	35192-011	HUMAN OTC DRUG	ULTRA UMBRELLA		OCTINOXATE TITANIUM DIOXIDE	LOTION	TOPICAL	20130801		OTC MONOGRAPH DRUG	M020	CA-BOTANA INTERNATIONAL	OCTINOXATE; TITANIUM DIOXIDE	4.536; 4.536	g/113.4g; g/113.4g			N	20241231
35192-012_0789347c-8b3b-e3dc-e063-6394a90a612b	35192-012	HUMAN OTC DRUG	Shimmery Sun		Octinoxate Titanium Dioxide	LOTION	TOPICAL	20120601		OTC MONOGRAPH DRUG	M020	CA-BOTANA INTERNATIONAL	OCTINOXATE; TITANIUM DIOXIDE	4.536; 5.67	g/113.4g; g/113.4g			N	20241231
35192-016_07a1a0d2-0bb7-40e5-e063-6294a90a7e30	35192-016	HUMAN OTC DRUG	Controlling balm with tea tree oil		SALICYLIC ACID	EMULSION	TOPICAL	20141109		OTC MONOGRAPH DRUG	M006	CA-BOTANA INTERNATIONAL	SALICYLIC ACID	.24	mg/29.6mg			N	20241231
35192-017_07a1ca7d-3400-04ce-e063-6394a90afbcd	35192-017	HUMAN OTC DRUG	Controlling Cream		BENZOYL PEROXIDE	CREAM	TOPICAL	20141109		OTC MONOGRAPH DRUG	M006	CA-BOTANA INTERNATIONAL	BENZOYL PEROXIDE	.8	mg/29.6mg			N	20241231
35192-018_07edd14e-53dc-7161-e063-6294a90ad319	35192-018	HUMAN OTC DRUG	Controlling balm with tea tree oil		SALICYLIC ACID	EMULSION	TOPICAL	20141109		OTC MONOGRAPH DRUG	M006	CA-BOTANA INTERNATIONAL	SALICYLIC ACID	1.89	mg/237mg			N	20241231
35192-020_079ac9a2-8a00-2910-e063-6394a90ad858	35192-020	HUMAN OTC DRUG	Weh-Weh Pain reliever gel		Menthol	GEL	TOPICAL	20160131		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	MENTHOL	6	g/120g			N	20241231
35192-023_0789835a-5124-e10b-e063-6294a90a14a7	35192-023	HUMAN OTC DRUG	Weh-Weh Natural Pain relief oil		Capsaicin	OIL	TOPICAL	20160131		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	CAPSAICIN	.075	g/50g			N	20241231
35192-026_079ae211-51eb-6892-e063-6394a90a2aca	35192-026	HUMAN OTC DRUG	Kope Pain relief gel		Lidocaine	GEL	TOPICAL	20170630		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	LIDOCAINE	4	g/50g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
35192-027_06eb328c-2f60-74c0-e063-6394a90a8b87	35192-027	HUMAN OTC DRUG	Kope Pain relief gel		Lidocaine	GEL	TOPICAL	20170715		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	LIDOCAINE	4	g/50g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
35192-029_07da58c3-43a6-9d3a-e063-6394a90a3068	35192-029	HUMAN OTC DRUG	Skin protectant		Astrigent	CREAM	TOPICAL	20200410		OTC MONOGRAPH DRUG	M016	CA-Botana International	ALUMINUM ACETATE	.2	g/30g			N	20241231
35192-039_07da88ff-47e6-a511-e063-6294a90aac5e	35192-039	HUMAN OTC DRUG	Kanjo PAIN RELIEF Gel		Menthol	GEL	TOPICAL	20200831		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	MENTHOL	6	g/120g			N	20241231
35192-040_07de121d-26b0-8232-e063-6294a90a99ac	35192-040	HUMAN OTC DRUG	Kanjo Natural Pain relief oil		Capsaicin	OIL	TOPICAL	20200914		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	CAPSAICIN	.075	g/50g			N	20241231
35192-041_080f7d09-f0c3-20e0-e063-6294a90ad273	35192-041	HUMAN OTC DRUG	Skin protectant		Astrigent	CREAM	TOPICAL	20201027		OTC MONOGRAPH DRUG	M016	CA-Botana International	ALUMINUM ACETATE	.2	g/30g			N	20241231
35192-042_06e66fa7-b3bd-1734-e063-6294a90a7864	35192-042	HUMAN OTC DRUG	Mineral Sunscreen		Zinc Oxide	EMULSION	TOPICAL	20210430		OTC MONOGRAPH DRUG	M020	CA-Botana International	ZINC OXIDE	23.814	g/113.4g			N	20241231
35192-043_06e7248d-e6b7-eaac-e063-6394a90aceb3	35192-043	HUMAN OTC DRUG	Sunscreen Flawless Skin fluid tinted		Zinc Oxide	EMULSION	TOPICAL	20210430		OTC MONOGRAPH DRUG	M020	CA-Botana International	ZINC OXIDE	9.919	g/61g			N	20241231
35192-044_06e5f9d1-98bb-987e-e063-6394a90a88f3	35192-044	HUMAN OTC DRUG	Mineral Sunscreen		Zinc Oxide	EMULSION	TOPICAL	20210815		OTC MONOGRAPH DRUG	M020	CA-Botana International	ZINC OXIDE	12.81	g/12.81g			N	20241231
35192-045_07fdfecb-c2f7-c7f8-e063-6394a90a7696	35192-045	HUMAN OTC DRUG	Sunscreen Karina Skin Care SPF 15		Octinoxate,	EMULSION	TOPICAL	20220124		OTC MONOGRAPH DRUG	M020	CA-Botana International	OCTINOXATE	7.5	g/141.7g			N	20241231
35192-046_07fe6c1e-41b7-8171-e063-6394a90a5956	35192-046	HUMAN OTC DRUG	Visage		Zinc Oxide	EMULSION	TOPICAL	20220404		OTC MONOGRAPH DRUG	M020	CA-Botana International	ZINC OXIDE	12.81	g/12.81g			N	20241231
35192-047_0800df29-d8f7-a8c4-e063-6394a90acb74	35192-047	HUMAN OTC DRUG	Visage Pro Peach Fuzz		Sunscreen Visage Pro Peach Fuzz 5	EMULSION	TOPICAL	20220722		OTC MONOGRAPH DRUG	M020	CA-Botana International	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7; 2.5; 5; 7	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
35192-048_09ac4473-f66b-8290-e063-6294a90ae1e8	35192-048	HUMAN OTC DRUG	Sunscreen		Zinc Oxide	EMULSION	TOPICAL	20220726		OTC MONOGRAPH DRUG	M020	CA-Botana International	ZINC OXIDE	12.81	g/12.81g			N	20241231
35192-050_09ac1740-534d-83b5-e063-6394a90a6030	35192-050	HUMAN OTC DRUG	Sunscreen		Zinc Oxide	EMULSION	TOPICAL	20220731		OTC MONOGRAPH DRUG	M020	CA-Botana International	ZINC OXIDE	12.81	g/12.81g			N	20241231
35192-051_08028904-49cc-1659-e063-6394a90a9573	35192-051	HUMAN OTC DRUG	Sunscreen		Zinc Oxide	EMULSION	TOPICAL	20220912		OTC MONOGRAPH DRUG	M020	CA-Botana International	ZINC OXIDE	21	g/100g			N	20241231
35192-052_08034a42-141c-bdef-e063-6394a90ac603	35192-052	HUMAN OTC DRUG	Dr Bump gel 4		Menthol	GEL	TOPICAL	20200930		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	MENTHOL	6	g/120g			N	20241231
35192-053_0804536d-bb3e-ef23-e063-6394a90af31b	35192-053	HUMAN OTC DRUG	Dr Bump gel 16		Menthol	GEL	TOPICAL	20200920		OTC MONOGRAPH DRUG	M017	CA-BOTANA INTERNATIONAL	MENTHOL	24	g/120g			N	20241231
35208-031_b0da0932-ad12-458d-b4de-5d1174cff448	35208-031	HUMAN PRESCRIPTION DRUG	Levetiracetam	Extended-release	Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20161003		ANDA	ANDA204511	IntelliPharmaCeutics Corp.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
35208-032_b0da0932-ad12-458d-b4de-5d1174cff448	35208-032	HUMAN PRESCRIPTION DRUG	Levetiracetam	Extended-release	Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20161003		ANDA	ANDA204511	IntelliPharmaCeutics Corp.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
35324-001_0aefc951-f5b7-9535-e063-6394a90a54e8	35324-001	HUMAN OTC DRUG	DermaZinc		pyrithione zinc	CREAM	TOPICAL	20220829		OTC MONOGRAPH DRUG	M032	WynnPharm Inc	PYRITHIONE ZINC	.25	g/100g			N	20241231
35324-002_0aefcfef-95e0-3da6-e063-6294a90a948c	35324-002	HUMAN OTC DRUG	DermaZinc		pyrithione zinc	SPRAY	TOPICAL	20220829		OTC MONOGRAPH DRUG	M032	WynnPharm Inc	PYRITHIONE ZINC	.25	g/100mL			N	20241231
35324-003_0aefc6a8-7430-ac40-e063-6394a90a41a3	35324-003	HUMAN OTC DRUG	DermaZinc		pyrithione zinc	SHAMPOO	TOPICAL	20220829		OTC MONOGRAPH DRUG	M032	WynnPharm Inc	PYRITHIONE ZINC	2	g/100mL			N	20241231
35324-274_09d7163b-7e66-1473-e063-6294a90a81a1	35324-274	HUMAN OTC DRUG	ARNIMAX Penetrating Pain Relief Gel		MENTHOL	GEL	TOPICAL	20220215		OTC MONOGRAPH DRUG	M017	WYNNPHARM INC.	MENTHOL	30	mg/g			N	20241231
35324-276_09d70e71-d1be-2749-e063-6294a90abd05	35324-276	HUMAN OTC DRUG	INVIGO FLEX Pain Relief Gel		MENTHOL	GEL	TOPICAL	20220215		OTC MONOGRAPH DRUG	M017	WYNNPHARM INC.	MENTHOL	30	mg/g			N	20241231
35356-125_9bef500a-9612-442a-9ab9-1dc9da83b35b	35356-125	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		pravastatin sodium	TABLET	ORAL	20110718		ANDA	ANDA076341	Lake Erie Medical DBA Quality Care Products LLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
35356-197_4ded9d03-c287-4239-bcbe-6992cfae7708	35356-197	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20101110		ANDA	ANDA077557	Quality Care Products LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
35356-439_fdf5e827-a5c9-49f6-b673-79ae2d15c54c	35356-439	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Quality Care Products, LLC	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
35356-642_111f6223-5d69-424f-9456-5c2823014e48	35356-642	HUMAN OTC DRUG	Dendracin Neurodendraxcin		Methyl Salicylate, Menthol and Capsaicin	LOTION	TOPICAL	20111114	20260131	OTC MONOGRAPH DRUG	M017	Quality Care Products, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.015; 6; 18	g/60mL; g/60mL; g/60mL			N	
35356-662_ea7f26f6-f19d-4a00-8f01-9f69e6b382a3	35356-662	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20070206		ANDA	ANDA076286	Quality Care Products, LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
35356-663_b120edb5-bd7c-481b-8535-0110960e742b	35356-663	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Quality Care Products LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
35356-664_b120edb5-bd7c-481b-8535-0110960e742b	35356-664	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Quality Care Products LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
35356-696_8baebecd-e02b-4c4c-96c7-7df78740355e	35356-696	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20100420		ANDA	ANDA074754	Lake Erie Medical DBA Quality Care Products LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35356-697_286c4f19-4b7a-4232-ba80-eb45a6bbbd71	35356-697	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	Lake Erie Medical DBA Quality Care Products LLC	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35356-699_9f8ffb4b-d185-4908-8793-4f6e617405f1	35356-699	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Lake Erie Medical DBA Quality Care Products LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35356-713_09e3ec78-4a4b-4c3a-996a-ea7209d56342	35356-713	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	TABLET, FILM COATED	ORAL	19980811		ANDA	ANDA075219	Lake Erie Medical DBA Quality Care Products LLC	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35356-714_28942ad1-fdd9-49cd-a5ee-81942dc2b298	35356-714	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	Quality Care Products LLC	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35356-725_28942ad1-fdd9-49cd-a5ee-81942dc2b298	35356-725	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20101231		ANDA	ANDA090066	Quality Care Products LLC	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35356-728_11ef7f63-df75-4b12-b246-dff87be2d877	35356-728	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Lake Erie Medical DBA Quality Care Products LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
35356-733_f669a7c7-742e-4ef5-9ef4-d2c91bd239d7	35356-733	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA075593	Quality Care Products, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
35356-777_4803bf3d-fb5c-4eac-ab42-e188711fa441	35356-777	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20060927		ANDA	ANDA077912	Lake Erie Medical DBA Quality Care Products LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
35356-778_4803bf3d-fb5c-4eac-ab42-e188711fa441	35356-778	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20060927		ANDA	ANDA077912	Lake Erie Medical DBA Quality Care Products LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
35356-790_0a9759ab-0b91-4337-a85d-418c266a84c1	35356-790	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Lake Erie Medical DBA Quality Care Products LLC	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
35356-801_29be54ae-baf5-46a4-a1f2-89a5481d79d7	35356-801	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20120802		ANDA	ANDA202677	Quality Care Products, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
35356-807_b9b393f1-2684-41b5-ad51-f48e4519425d	35356-807	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20100315		ANDA	ANDA090510	Quality Care Products LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
35356-808_ac7075b8-c99a-46d1-98ea-28163e60984b	35356-808	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Quality Care Products LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35356-812_b8f7196d-8813-4320-80d9-21ee7530f954	35356-812	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20101231		ANDA	ANDA071322	Quality Care Products LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
35356-821_b120edb5-bd7c-481b-8535-0110960e742b	35356-821	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20120628		ANDA	ANDA071457	Quality Care Products LLC	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
35356-839_41d57ea0-f999-45f8-8ed9-53ba3fa9467e	35356-839	HUMAN PRESCRIPTION DRUG	Oxycodone Hydchloride		Oxycodone Hydchloride	TABLET	ORAL	20111220		ANDA	ANDA091393	Quality Care Products LLC	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
35356-887_430726de-472b-4895-9ee4-edc5430600bd	35356-887	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Quality Care Products LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
35356-903_29c8a6ff-f55c-497f-8421-43cb60d01e86	35356-903	HUMAN PRESCRIPTION DRUG	Acyclovir		acyclovir	TABLET	ORAL	20120921		ANDA	ANDA077309	Lake Erie Medical DBA Quality Care Products LLC	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
35356-914_c9eebb2e-948e-44b1-ac62-4dd7cbbc8588	35356-914	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Quality Care Products LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
35356-919_9bef500a-9612-442a-9ab9-1dc9da83b35b	35356-919	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		pravastatin sodium	TABLET	ORAL	20110718		ANDA	ANDA076341	Lake Erie Medical DBA Quality Care Products LLC	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
35356-921_9bef500a-9612-442a-9ab9-1dc9da83b35b	35356-921	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		pravastatin sodium	TABLET	ORAL	20110718		ANDA	ANDA076341	Lake Erie Medical DBA Quality Care Products LLC	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
35356-963_0dfbe905-16ce-4581-9ad2-5f636c11156f	35356-963	HUMAN OTC DRUG	New Terocin		Methyl Salicylate, Capsaicin, and Menthol	LOTION	TOPICAL	20130313	20250930	OTC MONOGRAPH DRUG	M017	Quality Care Products, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.025; 10; 25	g/100mL; g/100mL; g/100mL			N	
35356-968_836d18de-2660-45e9-a655-df7c4f81926f	35356-968	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		Oxymorphone Hydrochloride	TABLET	ORAL	20130211	20240430	ANDA	ANDA203601	Lake Erie Medical DBA Quality Care Products LLC	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
35369-0501_4867014d-e8d1-45f0-8a4e-e0e7f5f09b68	35369-0501	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20180810		ANDA	ANDA204959	Shandong Anxin Pharmaceutical Co., Ltd.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
35369-0502_4867014d-e8d1-45f0-8a4e-e0e7f5f09b68	35369-0502	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20180810		ANDA	ANDA204959	Shandong Anxin Pharmaceutical Co., Ltd.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
35369-0503_4867014d-e8d1-45f0-8a4e-e0e7f5f09b68	35369-0503	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20180810		ANDA	ANDA204959	Shandong Anxin Pharmaceutical Co., Ltd.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
35369-0504_13a59f4a-8655-4f0e-ac90-3100c89e7fe7	35369-0504	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230414		ANDA	ANDA217243	Shandong Anxin Pharmaceutical Co., Ltd.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
35418-010_06e68891-351b-1caa-e063-6294a90aa572	35418-010	HUMAN OTC DRUG	cherry throat relief lozenges		benzocaine	LOZENGE	ORAL	20160414		OTC MONOGRAPH NOT FINAL	part356	Zee Medical	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
35418-123_0ea718d4-6b2b-b9ee-e063-6294a90a8111	35418-123	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	20140116		ANDA	ANDA074091	Zee Medical Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
35418-242_f19c54d1-943b-1395-e053-2a95a90a9342	35418-242	HUMAN OTC DRUG	Zee Pain Aid		Acetaminophen Salicylamide Aspirin	TABLET	ORAL	20120612	20240901	OTC MONOGRAPH NOT FINAL	part343	Zee Medical Inc	ACETAMINOPHEN; ASPIRIN; SALICYLAMIDE	110; 162; 152	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
35418-402_6016d1da-5c76-7acc-e053-2a91aa0a3e57	35418-402	HUMAN OTC DRUG	Isopropyl Alcohol		Alcohol	SPRAY	TOPICAL	20100708		OTC MONOGRAPH NOT FINAL	part333E	Zee Medical	ALCOHOL	70	mL/100mL			N	20241231
35420-123_f4e8b4b2-dc0d-b214-e053-2995a90ad2d8	35420-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20120220		UNAPPROVED MEDICAL GAS		Smith's Home Medical Equipment, Inc.	OXYGEN	99	L/100L			N	20241231
35484-204_0d1b30d3-e060-e0de-e063-6394a90a633f	35484-204	HUMAN OTC DRUG	Sore Throat 911		Potassium Chloride	LOTION	TOPICAL	20200309		UNAPPROVED HOMEOPATHIC		DelCorean, LLC	POTASSIUM CATION	.05	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
35484-924_0d1b2e11-0089-0fb9-e063-6294a90a8525	35484-924	HUMAN OTC DRUG	Cramp911		Magnesium sulfate, Copper sulfate	LOTION	TOPICAL	20080901		UNAPPROVED HOMEOPATHIC		DelCorean, LLC	BASIC COPPER SULFATE; MAGNESIUM SULFATE, UNSPECIFIED FORM	.05; .05	[hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
35484-924_0d1b2f8d-a750-ea40-e063-6394a90a334f	35484-924	HUMAN OTC DRUG	Cramp911		Magnesium Sulfate, Copper Sulfate	LOTION	TOPICAL	20080901		UNAPPROVED HOMEOPATHIC		DelCorean, LLC	BASIC COPPER SULFATE; MAGNESIUM SULFATE, UNSPECIFIED	.05; .05	[hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
35561-285_0e05294c-89f0-6ceb-e063-6294a90a732c	35561-285	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succiate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA210281	AustarPharma LLC	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
35561-286_0e05294c-89f0-6ceb-e063-6294a90a732c	35561-286	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA210281	AustarPharma LLC	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
35561-345_32635c18-4e13-4d3f-92e8-790fa82c5c0c	35561-345	HUMAN PRESCRIPTION DRUG	Fenofibrate		FENOFIBRATE	CAPSULE	ORAL	20171117		ANDA	ANDA207805	Austarpharma, LLC	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
35561-346_32635c18-4e13-4d3f-92e8-790fa82c5c0c	35561-346	HUMAN PRESCRIPTION DRUG	Fenofibrate		FENOFIBRATE	CAPSULE	ORAL	20171117		ANDA	ANDA207805	Austarpharma, LLC	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
35561-347_32635c18-4e13-4d3f-92e8-790fa82c5c0c	35561-347	HUMAN PRESCRIPTION DRUG	Fenofibrate		FENOFIBRATE	CAPSULE	ORAL	20171117		ANDA	ANDA207805	Austarpharma, LLC	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
35561-355_0e052da8-dac8-3d62-e063-6294a90ad7a8	35561-355	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE ER		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA215591	AustarPharma LLC	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
35561-356_0e052da8-dac8-3d62-e063-6294a90ad7a8	35561-356	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE ER		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA215591	AustarPharma LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
35561-357_0e052da8-dac8-3d62-e063-6294a90ad7a8	35561-357	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE ER		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA215591	AustarPharma LLC	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
35573-400_6f4441c9-de08-4cff-bf39-ac483002a8df	35573-400	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20180713		ANDA	ANDA203687	Burel Pharmaceuticals, LLC	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
35573-404_ee9c58f6-c363-2cf3-e053-2a95a90a3f5e	35573-404	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	PASTE	DENTAL	20190509		ANDA	ANDA205592	Burel Pharmaceuticals, LLC	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
35573-409_24ba32c4-92ea-40f4-830c-0803ee262b08	35573-409	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Burel Pharmaceuticals, LLC	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-410_24ba32c4-92ea-40f4-830c-0803ee262b08	35573-410	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Burel Pharmaceuticals, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-411_24ba32c4-92ea-40f4-830c-0803ee262b08	35573-411	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Burel Pharmaceuticals, LLC	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-412_24ba32c4-92ea-40f4-830c-0803ee262b08	35573-412	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Burel Pharmaceuticals, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-413_f4033ddd-4af5-812e-e053-2a95a90a2d17	35573-413	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20190930		ANDA	ANDA209312	Burel Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
35573-414_f4033ddd-4af5-812e-e053-2a95a90a2d17	35573-414	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20190930		ANDA	ANDA209312	Burel Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
35573-415_b721a775-ea64-4567-a360-1eb9c2126af6	35573-415	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530	20250131	ANDA	ANDA079016	Burel Pharmaceuticals, LLC	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	
35573-416_b721a775-ea64-4567-a360-1eb9c2126af6	35573-416	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530	20250131	ANDA	ANDA079016	Burel Pharmaceuticals, LLC	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	
35573-417_b721a775-ea64-4567-a360-1eb9c2126af6	35573-417	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530	20250131	ANDA	ANDA079016	Burel Pharmaceuticals, LLC	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	
35573-418_b721a775-ea64-4567-a360-1eb9c2126af6	35573-418	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530	20250131	ANDA	ANDA079016	Burel Pharmaceuticals, LLC	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	
35573-419_b721a775-ea64-4567-a360-1eb9c2126af6	35573-419	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530	20250131	ANDA	ANDA079016	Burel Pharmaceuticals, LLC	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	
35573-420_b721a775-ea64-4567-a360-1eb9c2126af6	35573-420	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530	20250131	ANDA	ANDA079016	Burel Pharmaceuticals, LLC	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	
35573-421_b721a775-ea64-4567-a360-1eb9c2126af6	35573-421	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530	20250131	ANDA	ANDA079016	Burel Pharmaceuticals, LLC	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	
35573-422_eda6b4a9-342f-4efa-b002-79ce056d4219	35573-422	HUMAN PRESCRIPTION DRUG	OLANZAPINE		olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Burel Pharmaceuticals, LLC	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
35573-423_eda6b4a9-342f-4efa-b002-79ce056d4219	35573-423	HUMAN PRESCRIPTION DRUG	OLANZAPINE		olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Burel Pharmaceuticals, LLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
35573-424_eda6b4a9-342f-4efa-b002-79ce056d4219	35573-424	HUMAN PRESCRIPTION DRUG	OLANZAPINE		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Burel Pharmaceuticals, LLC	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
35573-425_eda6b4a9-342f-4efa-b002-79ce056d4219	35573-425	HUMAN PRESCRIPTION DRUG	OLANZAPINE		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Burel Pharmaceuticals, LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
35573-426_eda6b4a9-342f-4efa-b002-79ce056d4219	35573-426	HUMAN PRESCRIPTION DRUG	OLANZAPINE		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Burel Pharmaceuticals, LLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
35573-427_eda6b4a9-342f-4efa-b002-79ce056d4219	35573-427	HUMAN PRESCRIPTION DRUG	OLANZAPINE		olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Burel Pharmaceuticals, LLC	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
35573-428_d004eeef-231d-461b-8149-0f9ca1801420	35573-428	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20200420		ANDA	ANDA202038	Burel Pharmaceuticals, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
35573-433_748e48d8-09d3-413c-b724-883b6b47f01e	35573-433	HUMAN PRESCRIPTION DRUG	KETOCONAZOLE		ketoconazole	TABLET	ORAL	20200410		ANDA	ANDA075912	Burel Pharmaceuticals, LLC	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
35573-434_70124866-ecd6-494c-90da-d1e2ad0c8100	35573-434	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 ppm		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200228		UNAPPROVED DRUG OTHER		Burel Pharmaceuticals LLC	SODIUM FLUORIDE	5	mg/g			N	20241231
35573-435_0de90332-2887-482b-8787-1fbbc6500c00	35573-435	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 1.1%		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20200228		UNAPPROVED DRUG OTHER		Burel Pharmaceuticals LLC	SODIUM FLUORIDE	5	mg/g			N	20241231
35573-436_8beb166a-d8f6-4b77-b191-3d7f5699a6f3	35573-436	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20210501		ANDA	ANDA076868	Burel Pharmaceuticals, LLC	LOXAPINE SUCCINATE	5	mg/1			N	20241231
35573-437_8beb166a-d8f6-4b77-b191-3d7f5699a6f3	35573-437	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20210501		ANDA	ANDA076868	Burel Pharmaceuticals, LLC	LOXAPINE SUCCINATE	10	mg/1			N	20241231
35573-438_8beb166a-d8f6-4b77-b191-3d7f5699a6f3	35573-438	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20210501		ANDA	ANDA076868	Burel Pharmaceuticals, LLC	LOXAPINE SUCCINATE	25	mg/1			N	20241231
35573-439_8beb166a-d8f6-4b77-b191-3d7f5699a6f3	35573-439	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20210501		ANDA	ANDA076868	Burel Pharmaceuticals, LLC	LOXAPINE SUCCINATE	50	mg/1			N	20241231
35573-440_553e9517-6ce2-4105-99fc-02de9c95ad6f	35573-440	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20210531		ANDA	ANDA071130	Burel Pharmaceuticals, LLC	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
35573-441_fdc7985f-5873-458b-9103-6ec550164e40	35573-441	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20210531		ANDA	ANDA071131	Burel Pharmaceuticals, LLC	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
35573-442_dcd9c7a9-13ee-4740-890a-1d01473b30f2	35573-442	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20210531		ANDA	ANDA071132	Burel Pharmaceuticals, LLC	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
35573-443_0639bb69-d41d-4786-af70-797c452fbbfb	35573-443	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20210401		ANDA	ANDA203653	Burel Pharmaceuticals, LLC	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
35573-444_0639bb69-d41d-4786-af70-797c452fbbfb	35573-444	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20210401		ANDA	ANDA203653	Burel Pharmaceuticals, LLC	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
35573-445_0639bb69-d41d-4786-af70-797c452fbbfb	35573-445	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20210401		ANDA	ANDA203653	Burel Pharmaceuticals, LLC	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
35573-446_f389cc21-71b1-c110-e053-2a95a90a933b	35573-446	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE ER		TROSPIUM CHLORIDE ER	CAPSULE	ORAL	20210805		ANDA	ANDA213185	35573	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
35573-447_3ccf844c-7ef0-4dbe-9e27-bc3645903189	35573-447	HUMAN PRESCRIPTION DRUG	Leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20220103		ANDA	ANDA213497	Burel Pharmaceuticals, LLC	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
35573-448_3ccf844c-7ef0-4dbe-9e27-bc3645903189	35573-448	HUMAN PRESCRIPTION DRUG	Leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20220103		ANDA	ANDA213497	Burel Pharmaceuticals, LLC	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
35573-450_a7781f3a-442a-4c9f-9f8a-90dfe9413f2a	35573-450	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20220415		ANDA	ANDA210616	Burel Pharmaceuticals, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
35573-453_5d41ef57-c955-4158-bb9f-6f25111d7b4b	35573-453	HUMAN OTC DRUG	Benzoyl Peroxide		Benzoyl Peroxide	LIQUID	TOPICAL	20220415		OTC MONOGRAPH DRUG	M006	Burel Pharmaceuticals, LLC	BENZOYL PEROXIDE	50	mg/mL			N	20241231
35573-454_5d41ef57-c955-4158-bb9f-6f25111d7b4b	35573-454	HUMAN OTC DRUG	Benzoyl Peroxide		Benzoyl Peroxide	LIQUID	TOPICAL	20220415		OTC MONOGRAPH DRUG	M006	Burel Pharmaceuticals, LLC	BENZOYL PEROXIDE	100	mg/mL			N	20241231
35573-455_877b0e9f-f7c3-40a9-905d-eb1c9eaec4e6	35573-455	HUMAN PRESCRIPTION DRUG	BUTALBITAL AND ACETAMINOPHEN		butalbital and acetaminophen	TABLET	ORAL	20221201		ANDA	ANDA214088	Burel Pharmaceuticals, LLC	ACETAMINOPHEN; BUTALBITAL	300; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
35573-456_877b0e9f-f7c3-40a9-905d-eb1c9eaec4e6	35573-456	HUMAN PRESCRIPTION DRUG	BUTALBITAL AND ACETAMINOPHEN		butalbital and acetaminophen	TABLET	ORAL	20221201		ANDA	ANDA214088	Burel Pharmaceuticals, LLC	ACETAMINOPHEN; BUTALBITAL	325; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
35573-457_f47b85b1-a7d3-437b-a3db-a81e1f1716c4	35573-457	HUMAN PRESCRIPTION DRUG	NICARDIPINE HYDROCHLORIDE		nicardipine hydrochloride	CAPSULE	ORAL	20230108		ANDA	ANDA215377	Burel Pharmaceuticals, LLC	NICARDIPINE HYDROCHLORIDE	20	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
35573-458_f47b85b1-a7d3-437b-a3db-a81e1f1716c4	35573-458	HUMAN PRESCRIPTION DRUG	NICARDIPINE HYDROCHLORIDE		nicardipine hydrochloride	CAPSULE	ORAL	20230108		ANDA	ANDA215377	Burel Pharmaceuticals, LLC	NICARDIPINE HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
35573-459_5d8ac14d-dd85-4d80-9e3d-07a52e1f72ab	35573-459	HUMAN PRESCRIPTION DRUG	Carglumic acid		Carglumic acid	TABLET, FOR SUSPENSION	ORAL	20221219		ANDA	ANDA213395	Burel Pharmaceuticals, LLC	CARGLUMIC ACID	200	mg/1	Carbamoyl Phosphate Synthetase 1 Activator [EPC], Carbamoyl Phosphate Synthetase 1 Activators [MoA]		N	20241231
35573-460_f7b73269-98cf-2ee2-e053-6394a90afce1	35573-460	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20230401		ANDA	ANDA215556	Burel Pharmaceuticals, LLC	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-461_f7b73269-98cf-2ee2-e053-6394a90afce1	35573-461	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20230401		ANDA	ANDA215556	Burel Pharmaceuticals, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-462_f7b73269-98cf-2ee2-e053-6394a90afce1	35573-462	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20230401		ANDA	ANDA215556	Burel Pharmaceuticals, LLC	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-463_f7b73269-98cf-2ee2-e053-6394a90afce1	35573-463	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20230401		ANDA	ANDA215556	Burel Pharmaceuticals, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
35573-464_7549ee4c-4fa3-4e7d-9864-580835d80d39	35573-464	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Burel Pharmaceuticals, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
35573-465_7549ee4c-4fa3-4e7d-9864-580835d80d39	35573-465	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Burel Pharmaceuticals, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
35573-466_7549ee4c-4fa3-4e7d-9864-580835d80d39	35573-466	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Burel Pharmaceuticals, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
35573-467_7549ee4c-4fa3-4e7d-9864-580835d80d39	35573-467	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Burel Pharmaceuticals, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
35573-468_7549ee4c-4fa3-4e7d-9864-580835d80d39	35573-468	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Burel Pharmaceuticals, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
35573-469_7549ee4c-4fa3-4e7d-9864-580835d80d39	35573-469	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Burel Pharmaceuticals, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
35781-0600_0e9b6697-28a6-f69f-e063-6394a90a9d11	35781-0600	HUMAN PRESCRIPTION DRUG	RIZAFILM		rizatriptan benzoate	FILM	ORAL	20240110		NDA	NDA205394	Gensco Laboratories LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
35916-0423_f1f68723-3021-8405-e053-2995a90a5be8	35916-0423	HUMAN OTC DRUG	Sennosides		Sennosides	CAPSULE, LIQUID FILLED	ORAL	20190529		OTC MONOGRAPH NOT FINAL	part334	SOFTGEL HEALTHCARE PRIVATE LIMITED	SENNOSIDES	17.2	mg/1			N	20241231
36000-008_239b0975-6153-4248-9741-bee4924338f4	36000-008	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20080804		ANDA	ANDA078024	Baxter Healthcare Corporation	CIPROFLOXACIN	2	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
36000-009_239b0975-6153-4248-9741-bee4924338f4	36000-009	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20080804		ANDA	ANDA078024	Baxter Healthcare Corporation	CIPROFLOXACIN	2	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
36000-012_191693ef-4c1a-4de9-aadc-610f1428ef33	36000-012	HUMAN PRESCRIPTION DRUG	ONDANSETRON HYDROCHLORIDE		ONDANSETRON HYDROCHLORIDE	SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130313		ANDA	ANDA078287	Baxter Healthcare Corporation	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
36000-033_082374ab-1444-49ff-9b77-62be14e38951	36000-033	HUMAN PRESCRIPTION DRUG	Metoprolol		metoprolol tartrate	INJECTION	INTRAVENOUS	20120925		ANDA	ANDA078950	Baxter Healthcare Corporation	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
36000-045_04a08867-e3de-45eb-bf7a-18c58ff87029	36000-045	HUMAN PRESCRIPTION DRUG	Levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20130701		ANDA	ANDA091436	Baxter Healthcare Corporation	LEVOFLOXACIN	25	mg/mL			N	20241231
36000-046_04a08867-e3de-45eb-bf7a-18c58ff87029	36000-046	HUMAN PRESCRIPTION DRUG	Levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20130701		ANDA	ANDA091397	Baxter Healthcare Corporation	LEVOFLOXACIN	5	mg/mL			N	20241231
36000-047_04a08867-e3de-45eb-bf7a-18c58ff87029	36000-047	HUMAN PRESCRIPTION DRUG	Levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20130701		ANDA	ANDA091397	Baxter Healthcare Corporation	LEVOFLOXACIN	5	mg/mL			N	20241231
36000-048_04a08867-e3de-45eb-bf7a-18c58ff87029	36000-048	HUMAN PRESCRIPTION DRUG	Levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20130701		ANDA	ANDA091397	Baxter Healthcare Corporation	LEVOFLOXACIN	5	mg/mL			N	20241231
36000-063_c11792af-0cf2-4f9c-b8e7-d915b3c4d4c4	36000-063	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Baxter Healthcare Corporation	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
36000-064_c11792af-0cf2-4f9c-b8e7-d915b3c4d4c4	36000-064	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Baxter Healthcare Corporation	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
36000-065_c11792af-0cf2-4f9c-b8e7-d915b3c4d4c4	36000-065	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Baxter Healthcare Corporation	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
36000-092_897fa716-4387-45d2-b7ce-740123cbb339	36000-092	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRASPINAL	20160808		ANDA	ANDA207266	Baxter Healthcare Corporation	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
36000-148_1937cd32-e80c-48f2-ae26-674522761def	36000-148	HUMAN PRESCRIPTION DRUG	Flumazenil		Flumazenil	INJECTION	INTRAVENOUS	20171001		ANDA	ANDA076755	Baxter Healthcare Corporation	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
36000-149_1937cd32-e80c-48f2-ae26-674522761def	36000-149	HUMAN PRESCRIPTION DRUG	Flumazenil		Flumazenil	INJECTION	INTRAVENOUS	20171001		ANDA	ANDA076755	Baxter Healthcare Corporation	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
36000-162_19e8e604-c9ee-4cd4-b2ac-42a1e1b9f597	36000-162	HUMAN PRESCRIPTION DRUG	Norepinephrine bitartrate		Norepinephrine bitartrate	INJECTION	INTRAVENOUS	20120401		ANDA	ANDA040859	Baxter Healthcare Corporation	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
36000-242_48455a2b-67f2-431b-8931-0f9f3ec46286	36000-242	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160715		ANDA	ANDA206965	Baxter Healthcare Corporation	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
36000-244_48455a2b-67f2-431b-8931-0f9f3ec46286	36000-244	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160715		ANDA	ANDA206965	Baxter Healthcare Corporation	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
36000-282_c11792af-0cf2-4f9c-b8e7-d915b3c4d4c4	36000-282	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Baxter Healthcare Corporation	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
36000-283_c11792af-0cf2-4f9c-b8e7-d915b3c4d4c4	36000-283	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Baxter Healthcare Corporation	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
36000-284_c11792af-0cf2-4f9c-b8e7-d915b3c4d4c4	36000-284	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Baxter Healthcare Corporation	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
36000-289_79de283b-cad1-4a37-8dff-f0681f5daa08	36000-289	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	INJECTION	SUBCUTANEOUS	20230119		ANDA	ANDA207101	Baxter Healthcare Corporation	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
36000-294_4ef200a6-1a6e-4f71-bf22-5810ebeecbbf	36000-294	HUMAN PRESCRIPTION DRUG	Levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20130701		ANDA	ANDA091397	Baxter Healthcare Corporation	LEVOFLOXACIN	5	mg/mL			N	20241231
36000-295_4ef200a6-1a6e-4f71-bf22-5810ebeecbbf	36000-295	HUMAN PRESCRIPTION DRUG	Levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20130701		ANDA	ANDA091397	Baxter Healthcare Corporation	LEVOFLOXACIN	5	mg/mL			N	20241231
36000-296_4ef200a6-1a6e-4f71-bf22-5810ebeecbbf	36000-296	HUMAN PRESCRIPTION DRUG	Levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20130701		ANDA	ANDA091397	Baxter Healthcare Corporation	LEVOFLOXACIN	5	mg/mL			N	20241231
36000-297_65c9048d-3b05-4df9-9b61-5ea327e4c7aa	36000-297	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	INJECTION, SOLUTION	INTRAVENOUS	20080804		ANDA	ANDA078024	Baxter Healthcare Corporation	CIPROFLOXACIN	2	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
36000-298_65c9048d-3b05-4df9-9b61-5ea327e4c7aa	36000-298	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	INJECTION, SOLUTION	INTRAVENOUS	20080804		ANDA	ANDA078024	Baxter Healthcare Corporation	CIPROFLOXACIN	2	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
36000-302_cef381b6-94f1-44f1-a014-49cba9dd0e2b	36000-302	HUMAN PRESCRIPTION DRUG	methocarbamol		methocarbamol	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220714		ANDA	ANDA215065	Baxter Healthcare Corporation	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
36000-306_f98df916-2286-4142-abfa-14bee5b102c7	36000-306	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20210917		ANDA	ANDA214331	Baxter Healthcare Corporation	ACETAMINOPHEN	10	mg/mL			N	20241231
36000-308_b605ed44-1c6e-4ce8-971f-61b6640aff36	36000-308	HUMAN PRESCRIPTION DRUG	naloxone hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210129		ANDA	ANDA214785	Baxter Healthcare Corporation	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
36000-310_4adfd325-5c8a-477d-a3ef-5d886d44ffa3	36000-310	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20221107		ANDA	ANDA214792	Baxter Healthcare Corporation	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
36000-320_26ae2de7-7634-4eb9-8584-8f0613357778	36000-320	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210126		ANDA	ANDA076051	Baxter Healthcare Corporation	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
36000-322_26ae2de7-7634-4eb9-8584-8f0613357778	36000-322	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210126		ANDA	ANDA076051	Baxter Healthcare Corporation	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
36000-324_26ae2de7-7634-4eb9-8584-8f0613357778	36000-324	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210126		ANDA	ANDA076051	Baxter Healthcare Corporation	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
36000-326_0250c21a-fa1f-4f35-98a4-9620ada5231a	36000-326	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		palonosetron hydrochloride	INJECTION	INTRAVENOUS	20211112		ANDA	ANDA206916	Baxter Healthcare Corporation	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
36000-352_3d88adda-9580-44bf-b75c-d615c973c1e1	36000-352	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	INJECTION	INTRAVENOUS	20231002		ANDA	ANDA217059	Baxter Healthcare Corporation	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
36000-354_3d88adda-9580-44bf-b75c-d615c973c1e1	36000-354	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	INJECTION	IONTOPHORESIS	20231002		ANDA	ANDA217059	Baxter Healthcare Corporation	LEVETIRACETAM	15	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
36000-356_3d88adda-9580-44bf-b75c-d615c973c1e1	36000-356	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	INJECTION	INTRAVENOUS	20231002		ANDA	ANDA217059	Baxter Healthcare Corporation	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
36000-364_a81d66a7-b714-439e-ad7b-c7caf9d6f3b8	36000-364	HUMAN PRESCRIPTION DRUG	regadenoson		regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20230523		ANDA	ANDA217455	Baxter Healthcare Corporation	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
36590-6461_09bd5322-f4bd-ae4f-e063-6294a90a8509	36590-6461	HUMAN OTC DRUG	Vonaflex		Lidocaine Lotion	LOTION	CUTANEOUS; RECTAL; TOPICAL; VAGINAL	20220825		UNAPPROVED DRUG OTHER		Cymbiotics, Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
36800-001_7f74e3f1-8a42-433e-ab39-8a5dad9c833b	36800-001	HUMAN OTC DRUG	Mouth Rinse		sodium fluoride	MOUTHWASH	ORAL	20101230		OTC MONOGRAPH DRUG	M021	Topco associates LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
36800-002_b7dd72f7-51ad-466a-90f4-deabf2c0a22c	36800-002	HUMAN OTC DRUG	topcare enema		Dibasic sodium phosphate, Monobasic sodium phosphate	ENEMA	RECTAL	20091105		OTC MONOGRAPH NOT FINAL	part334	Topco Associates LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
36800-004_eee9eba2-473d-45e0-a96f-24c968085839	36800-004	HUMAN OTC DRUG	Anticavity Fluoride Rinse		SODIUM FLUORIDE	RINSE	ORAL	20040408		OTC MONOGRAPH FINAL	part355	Topco Associates LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
36800-005_f3959288-e6ac-c8f3-e053-2a95a90a888d	36800-005	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20120103		OTC MONOGRAPH FINAL	part358B	Topco Associates LLC	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
36800-006_f31f0567-11a5-07df-e053-2a95a90ae932	36800-006	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20120103		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	TOLNAFTATE	1.5	g/150g			N	20241231
36800-009_0b30fdd8-f6a1-4bc0-912f-e672b9047e2f	36800-009	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20091014		OTC MONOGRAPH FINAL	part333D	Topco Associates LLC	SALICYLIC ACID	19.8	mg/g			N	20241231
36800-011_e58c798d-f969-48e7-861d-6908fbeecb9e	36800-011	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20040729		OTC MONOGRAPH NOT FINAL	part333E	Topco Associates LLC	POVIDONE-IODINE	10	mg/mL			N	20241231
36800-017_ee958dbc-c5dc-4934-b3d5-1f73ccd0a5e3	36800-017	HUMAN OTC DRUG	Vitamin A D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20140127		OTC MONOGRAPH DRUG	M016	Topco Associates LLC	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
36800-018_833484f8-7155-45d6-8744-0d91927a0d89	36800-018	HUMAN OTC DRUG	TopCare	Hydrocortisone	Hydrocortisone	OINTMENT	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-019_f31f4095-2c2f-59b2-e053-2995a90ad155	36800-019	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20120103		OTC MONOGRAPH FINAL	part358F	Topco Associates LLC	SALICYLIC ACID	40	mg/41			N	20241231
36800-020_14fc3c3c-265c-42ee-899e-1e16ff1cb23c	36800-020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	PASTE	TOPICAL	20120510		OTC MONOGRAPH FINAL	part347	TopCo	ZINC OXIDE	400	mg/g			N	20241231
36800-021_f31f3839-d4bc-ab65-e053-2a95a90a4d3d	36800-021	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20120103		OTC MONOGRAPH FINAL	part358F	Topco Associates LLC	SALICYLIC ACID	40	mg/91			N	20241231
36800-023_f31f3839-d4ba-ab65-e053-2a95a90a4d3d	36800-023	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Spray	AEROSOL, SPRAY	TOPICAL	20120105		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	TOLNAFTATE	1.13	g/113g			N	20241231
36800-029_7e56b74d-bc8a-456d-bd6d-ae9c634d3f1f	36800-029	HUMAN OTC DRUG	TopCare Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050420		ANDA	ANDA076775	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-031_f31f17c7-b923-48a5-e053-2a95a90a5058	36800-031	HUMAN OTC DRUG	Lidocaine		Burn Relief	AEROSOL, SPRAY	TOPICAL	20120103		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
36800-034_0ac79685-0288-b9ba-efe6-10427cd44b45	36800-034	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160825		ANDA	ANDA074612	Topco Associates LLC	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-035_c89137a7-f348-4860-8106-c21adbf3d7bf	36800-035	HUMAN OTC DRUG	MUCUS RELIEF	Cold and Sinus Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20151130	20241231	OTC MONOGRAPH DRUG	M012	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
36800-036_52b6cd43-6570-4707-bc2a-67d2a7131a98	36800-036	HUMAN OTC DRUG	Mucus Relief	Cold Flu and Sore Throat Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150731		OTC MONOGRAPH DRUG	M012	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-037_4dfa3ab5-b81e-4629-83e1-bc06cd5fae9a	36800-037	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150228		OTC MONOGRAPH DRUG	M012	TOP CARE (Topco Associates LLC)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-039_240eec5e-d2df-4893-85fb-51aed17e5ea0	36800-039	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20141031		OTC MONOGRAPH FINAL	part347	TOP CARE (Topco Associates LLC)	WITCH HAZEL	842	mg/mL			N	20241231
36800-040_8a95aa4f-4ec9-4dc6-8be2-b0bfe4bddc11	36800-040	HUMAN OTC DRUG	TopCare Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		TOPCO ASSOCIATES LLC	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
36800-043_f31f30cc-b37b-b152-e053-2a95a90a1c7f	36800-043	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel	GEL	TOPICAL	20141007		OTC MONOGRAPH FINAL	part358B	Topco Associates LLC	SALICYLIC ACID	.17	g/7g			N	20241231
36800-045_7b77710f-2278-4357-b5ff-6adf3bc1d8a9	36800-045	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20150228	20241231	OTC MONOGRAPH DRUG	M008	TOP CARE (Topco Associates LLC)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
36800-049_a0c731ca-4dec-4150-9732-a3320468ac12	36800-049	HUMAN OTC DRUG	Athletes Foot		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	TOPCO ASSOCIATES LLC	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
36800-050_175bd013-714a-4d59-897d-1503cbad48ae	36800-050	HUMAN OTC DRUG	Topcare Ibuprofen PM		diphenhydramine citrate and ibuprofen	TABLET, FILM COATED	ORAL	20090218		ANDA	ANDA079113	Topco Associates LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-051_56bca197-e45e-40a5-9924-01580ba2ccda	36800-051	HUMAN OTC DRUG	TopCare	Hydrocortisone Plus 12 Moisturizers	Hydrocortisone	CREAM	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-052_cbbdbcd1-b4ad-4e7c-a90e-f71d56cade04	36800-052	HUMAN OTC DRUG	TopCare	Tolnaftate Antifungal	Tolnaftate	CREAM	TOPICAL	20060217		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	TOLNAFTATE	10	mg/g			N	20241231
36800-054_1dc8f02b-e7c0-4a83-b9f4-49d7384a7ba6	36800-054	HUMAN OTC DRUG	topcare 12 hour decongestant		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000425		ANDA	ANDA075153	Topco Associates LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
36800-056_046e7bf1-e381-42fe-b5f0-47eea7d9edd9	36800-056	HUMAN OTC DRUG	TopCare	Triple Antibiotic Plus Pain Relief	Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, and Pramoxine hydrochloride	OINTMENT	TOPICAL	20120331		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
36800-057_f87a7ca3-ce73-42b9-a1a7-4fe495e1fbb7	36800-057	HUMAN OTC DRUG	Topcare Infants Ibuprofen		ibuprofen	SUSPENSION	ORAL	20020122		ANDA	ANDA075217	Topco Associates LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-059_09c7ad10-600d-4f02-874a-d610a9d25009	36800-059	HUMAN OTC DRUG	TopCare	Hydrocortisone 1% with Aloe	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-063_aabb3049-e037-4888-9224-19e4d979d4d1	36800-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	19910915		OTC MONOGRAPH FINAL	part347	Topco Associates LLC	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL			N	20241231
36800-064_0ccb3e8a-3d00-1364-e063-6294a90a70e8	36800-064	HUMAN OTC DRUG	TopCare Swimmers Ear Drops		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20190103		OTC MONOGRAPH DRUG	M014	TOPCO ASSOCIATES	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
36800-069_2607af2b-2f25-4aa6-9ce9-8f85e95a00d1	36800-069	HUMAN OTC DRUG	Pure petroleum		White Petrolatum	JELLY	TOPICAL	19910815		OTC MONOGRAPH FINAL	part347	Topco Associates LLC	PETROLATUM	1	g/g			N	20241231
36800-070_b523b32b-f4d0-446a-8344-bdf52e578d71	36800-070	HUMAN OTC DRUG	TopCare	Miconazole 3 Yeast Infection Relief	Miconazole Nitrate	CREAM	VAGINAL	20050302		ANDA	ANDA076773	Topco Associates LLC	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-071_6d486f98-f5c2-46d8-b270-22917f009901	36800-071	HUMAN OTC DRUG	Isopropyl Alcohol	50 Percent	Isopropyl alcohol	LIQUID	TOPICAL	20141031		OTC MONOGRAPH NOT FINAL	part333A	TOP CARE (Topco Associates LLC)	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
36800-072_b3df9c61-f19b-401c-b110-9c552dce585e	36800-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyol salicylate, Thymol	MOUTHWASH	ORAL	19950707		OTC MONOGRAPH NOT FINAL	part348	TOPCO ASSOCIATES, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-074_c2b22cd7-e373-4773-97ad-3108ef71be01	36800-074	HUMAN OTC DRUG	Topcare Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060410		ANDA	ANDA077349	Topco Associates LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-075_f31f4b39-f9d4-3bc7-e053-2a95a90a4bc9	36800-075	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Maximum Strength	LIQUID	TOPICAL	20210311		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	TOLNAFTATE	.3	g/30mL			N	20241231
36800-077_d97254ff-d922-4249-974e-7ffa36e30665	36800-077	HUMAN OTC DRUG	Isopropyl Alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20141031		OTC MONOGRAPH NOT FINAL	part333A	TOP CARE (Topco Associates LLC)	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
36800-080_a7a50c80-4e9a-41b0-ab6d-44c03ed2449d	36800-080	HUMAN OTC DRUG	Athletes Foot		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Topco Associates LLC	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
36800-081_8de310e1-b64c-46c5-8f06-bda80238083f	36800-081	HUMAN OTC DRUG	topcare miconazole 3	combination pack	Miconazole nitrate	KIT		20000510		ANDA	ANDA075329	Topco Associates LLC						N	20241231
36800-082_c8830a0b-046e-410b-a4a3-4b3a9f37f5b4	36800-082	HUMAN OTC DRUG	topcare dual action complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20160229		ANDA	ANDA077355	Topco Associates LLC	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-084_8ca820a9-429c-4059-8855-9ccd2b9cc8f7	36800-084	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20160131		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
36800-085_2e0d66ec-c1d7-4d31-be37-bf12c29d3b44	36800-085	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20151231		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
36800-087_c7703146-e963-480e-8b23-6b05726b68dd	36800-087	HUMAN OTC DRUG	Everyday Clean		Pyrithione Zinc	SHAMPOO	TOPICAL	20061030		OTC MONOGRAPH FINAL	part358H	Topco Associates LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
36800-088_eaf6cd8c-63b5-42e9-aeaa-e911c19b9e4c	36800-088	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20200730		ANDA	ANDA091314	TOP CARE (Topco Associates LLC)	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
36800-089_7f02b2cd-03fa-4167-aad5-e2c8859e70fe	36800-089	HUMAN OTC DRUG	TopCare	Bacitracin Zinc	Bacitracin Zinc	OINTMENT	TOPICAL	20060511		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	BACITRACIN ZINC	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
36800-093_c5100983-419c-93f7-e053-2995a90a8df5	36800-093	HUMAN OTC DRUG	TopCare Everyday Ultimate Sheer Sun Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-094_2886e45d-ddcc-4f3b-ae88-26d7e5c528f8	36800-094	HUMAN OTC DRUG	TopCare Nasal Decongestant PE		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20050912		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-095_d0d6d84f-e932-4080-e053-2995a90a6a3c	36800-095	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20121130		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-096_cdbca6a3-90ae-4432-aabf-afee73326388	36800-096	HUMAN OTC DRUG	topcare flu and severe cold and cough	daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20120117		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-097_6ca0ed6a-4b37-44b1-97d1-7855ab238077	36800-097	HUMAN OTC DRUG	Eye Itch Relief		ketotifen fumarate	SOLUTION/ DROPS	OPHTHALMIC	20220315		NDA	NDA021996	TOPCO ASSOCIATES LLC	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
36800-099_a97db864-b5fa-4dad-b040-528bb0f2e68b	36800-099	HUMAN OTC DRUG	TopCare	Hydrocortisone Intensive Healing Formula	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-104_4c1cf5e1-495e-4a59-a626-4c39e7dee0f7	36800-104	HUMAN OTC DRUG	Topco Stomach Relief		Bismuth subsalicylate	TABLET	ORAL	20201001		OTC MONOGRAPH FINAL	part335	Topco Associates, LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
36800-116_f42c4f8c-70bd-4c98-ba40-7b2379e66165	36800-116	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20200131		OTC MONOGRAPH FINAL	part338	TOP CARE (Topco Associates LLC)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-117_92a16930-8102-456e-99d4-a0aa10151c34	36800-117	HUMAN OTC DRUG	Topcare Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120910		ANDA	ANDA202319	Topco Associates LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-119_fd6a2537-8db2-492d-b045-6404df2fb9c3	36800-119	HUMAN OTC DRUG	Infants Gas relief		Simethicone	SOLUTION/ DROPS	ORAL	20130301		OTC MONOGRAPH FINAL	part332	Topco Associates, LLC	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
36800-121_8ca43c38-6c67-4af8-b7ba-ab2adbb65233	36800-121	HUMAN OTC DRUG	TopCare Omeprazole delayed release		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20160202		NDA	NDA022032	Topco Associates LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-122_c90d68a0-22e1-4a37-8487-16ecdc431ede	36800-122	HUMAN OTC DRUG	Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20180928		OTC MONOGRAPH FINAL	part332	Topco Associates, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-125_17e3b2d6-9cf8-469b-981d-ff772d43d3c3	36800-125	HUMAN OTC DRUG	Gas Relief	ultra strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20101004		OTC MONOGRAPH FINAL	part332	TOP CARE (Topco Associates LLC)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-126_f31f17c7-b920-48a5-e053-2a95a90a5058	36800-126	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief Continuous Spray	AEROSOL, SPRAY	TOPICAL	20190305		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.5; .075	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-127_1d793683-bb45-4dd5-8539-65e7dc6bb4f2	36800-127	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20210413		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-128_269b8784-1ee1-4c33-8193-b5d31454b72b	36800-128	HUMAN OTC DRUG	TopCare Childrens Allergy Relief Nasal 24 Hour		Fluticasone Propionate	SPRAY, METERED	NASAL	20160728		ANDA	ANDA207957	Topco Associates LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-132_c5601d2d-564f-367e-e053-2a95a90a6280	36800-132	HUMAN OTC DRUG	TOPCARE EVERYDAY ULTRA PROTECTION SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20140211		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-134_0c070058-9e26-cc8c-e063-6394a90ad801	36800-134	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20190628		OTC MONOGRAPH DRUG	M008	TOP CARE (Topco Associates LLC)	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
36800-135_0c0707e2-d340-fb56-e063-6394a90a0500	36800-135	HUMAN OTC DRUG	SENNA		SENNOSIDES	CAPSULE	ORAL	20210113		OTC MONOGRAPH DRUG	M007	TOP CARE (Topco Associates LLC)	SENNOSIDES	8.6	mg/1			N	20241231
36800-137_16dbbd46-e77e-4d95-aef3-550f76bb237e	36800-137	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20190331		ANDA	ANDA207342	TOP CARE (Topco Associates LLC)	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
36800-140_8c286271-74a5-45fc-bb9e-57ee386bc883	36800-140	HUMAN OTC DRUG	Topcare All Day Pain Relief		Naproxen sodium	TABLET, FILM COATED	ORAL	20071203		ANDA	ANDA074661	Topco Associates LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-141_1725c719-1f4a-48db-bb08-8130cd88a210	36800-141	HUMAN OTC DRUG	TopCare Acid Reducer		Famotidine	TABLET, FILM COATED	ORAL	20090911		ANDA	ANDA075400	Topco Associates LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
36800-143_bc2997cc-c47f-4a91-a12f-2dacd7fefd77	36800-143	HUMAN OTC DRUG	topcare nite time cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20140202		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-153_aa27d177-3eea-4aab-a1d8-21aacbd4e018	36800-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19971215		OTC MONOGRAPH FINAL	part358H	Topco Associates LLC	PYRITHIONE ZINC	1	kg/100L			N	20241231
36800-156_f204ae47-c5c8-54cf-e053-2a95a90a49ca	36800-156	HUMAN OTC DRUG	TOPCARE PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part348	TOPCO ASSOCIATES, LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
36800-157_940736d8-cfc2-4791-a74d-0b118082fa47	36800-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-159_15eae8e3-d045-4915-a9bf-627fc04a2cf2	36800-159	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20211101		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM	250	mg/1			N	20241231
36800-161_9c237d5a-a28e-4e4b-9f67-f6a84e47cba8	36800-161	HUMAN OTC DRUG	Topcare pain and fever		Acetaminophen	SUSPENSION	ORAL	20110826		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-164_e8679619-36d9-4f96-beb6-42f88db836e0	36800-164	HUMAN OTC DRUG	citroma		Magesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	TOPCO ASSOC, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-166_1ab9c7dc-ca1d-48a3-811f-53b02dd36aa9	36800-166	HUMAN OTC DRUG	topcare childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020730		ANDA	ANDA074937	Topco Associates LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-167_c626b70f-f8a8-461e-e053-2995a90a9ff9	36800-167	HUMAN OTC DRUG	Topcare Everyday Ultimate Sheer Sun Broad Spectrum SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190724		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-170_0ef9405d-d300-45f0-a1bb-f358dfd9245d	36800-170	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050419		ANDA	ANDA076789	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-180_6fe07c0a-a5f6-45dd-b67e-ea214d3870e3	36800-180	HUMAN OTC DRUG	top care all day allergy		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20200606		ANDA	ANDA207235	Topco Associates LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-186_c8aefe71-d6e1-2767-e053-2995a90a9bab	36800-186	HUMAN OTC DRUG	TOPCARE EVERYDAY SPORT CONTINUOUS BROAD SPECTRUM SPF 30		Avobenzone, Homosalate, Octocrylene,	AEROSOL, SPRAY	TOPICAL	20181220		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/g; mg/g; mg/g			N	20241231
36800-187_98cf5eba-82eb-47ce-8e8e-bab4868e49a4	36800-187	HUMAN OTC DRUG	Menstrual Relief		Acetaminophen, Caffeine and Pyrilamine maleate	TABLET	ORAL	20140331		OTC MONOGRAPH NOT FINAL	part343	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
36800-189_15730e7e-0610-4e21-af6c-098f6615dd21	36800-189	HUMAN OTC DRUG	Topcare Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20131223		ANDA	ANDA204226	Topco Associates LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-190_dcc743f3-cc8d-4bab-a681-94a3ecd889f9	36800-190	HUMAN OTC DRUG	Bisacody	Enteric Coated	Bisacodyl	TABLET, COATED	ORAL	20130110		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-191_ce881895-0b21-462a-a27b-3bcec81c9147	36800-191	HUMAN OTC DRUG	Fiber Laxative		Methylcellulose	TABLET	ORAL	20171201		OTC MONOGRAPH NOT FINAL	part334	Topco Associates, LLC	METHYLCELLULOSE (4000 CPS)	500	mg/1			N	20241231
36800-192_c16d0483-552c-41da-8468-94f9ca59029b	36800-192	HUMAN OTC DRUG	All Day Moisture		Octinoxate, Zinc Oxide	LOTION	TOPICAL	20200205		OTC MONOGRAPH FINAL	part352	Topco	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-193_f0e7ea64-b872-0fc4-e053-2a95a90ae18d	36800-193	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210702		ANDA	ANDA078682	TOP CARE (Topco Associates LLC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-194_dc92915b-2bb6-4982-acf6-6f1b093d314c	36800-194	HUMAN OTC DRUG	TopCare Acid Reducer		Famotidine	TABLET, FILM COATED	ORAL	20060928		ANDA	ANDA077351	Topco Associates LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
36800-197_e1c55edf-fd0b-4faf-a5bf-0c74f1113e15	36800-197	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH FINAL	part347	TOP CARE (Topco Associates LLC)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-199_7825695c-f9cb-430d-b77a-995c4eb54bb6	36800-199	HUMAN OTC DRUG	topcare miconazole 1		Miconazole nitrate	KIT		20100617		ANDA	ANDA079114	Topco Associates LLC						N	20241231
36800-200_8b32b6bb-19f8-4a4a-ad4b-009b56fec59a	36800-200	HUMAN OTC DRUG	Topcare ZZZ Sleep		Diphenhydramine HCl	SOLUTION	ORAL	20130820		OTC MONOGRAPH FINAL	part338	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-201_f2151442-dc76-e8a7-e053-2995a90a5ea5	36800-201	HUMAN OTC DRUG	Sensitive Whitening Anticavity		Stannous flouride	PASTE, DENTIFRICE	DENTAL	20191031		OTC MONOGRAPH NOT FINAL	part356	Topco	STANNOUS FLUORIDE	.454	g/100g			N	20241231
36800-202_baf3d0df-b93a-41b2-bcfe-ec9ce87d3655	36800-202	HUMAN OTC DRUG	topcare childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19900115		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-203_39100843-9a4b-4d15-b4ee-31c76e5c160c	36800-203	HUMAN OTC DRUG	Topcare Antacid Calcium		Calcium carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
36800-204_f0fce18a-cc1c-347f-e053-2a95a90ac3b9	36800-204	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20210702		NDA	NDA021920	TOP CARE (Topco Associates LLC)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-205_e709fcf4-b5b5-49d0-b0c0-c417cf032e81	36800-205	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20051227		OTC MONOGRAPH FINAL	part358H	Topco Associates LLC	COAL TAR	25	mg/mL			N	20241231
36800-206_77e8701e-f9a3-42bf-ac4d-424b9e96d7fc	36800-206	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050422		ANDA	ANDA078325	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-207_0ccb3ccc-352f-2d08-e063-6394a90ac91a	36800-207	HUMAN OTC DRUG	Top Care Decolorized Iodine		Ethyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	TOPCO ASSOCIATES LLC	ALCOHOL	.45	mL/mL			N	20241231
36800-208_f10fa51b-9cb9-502a-e053-2995a90a11d1	36800-208	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210702		NDA	NDA021855	TOP CARE (Topco Associates LLC)	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
36800-213_e82298e5-9144-4d3d-bf4d-c943c14f265a	36800-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20031020		OTC MONOGRAPH FINAL	part355	Topco Associates, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
36800-214_78fcb1b9-8313-49a8-adff-7f9e42a7da24	36800-214	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20090515		OTC MONOGRAPH DRUG	M022	TOP CARE (Topco Associates LLC)	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
36800-218_131543cb-8203-4ba5-97c5-66e083ca15cd	36800-218	HUMAN OTC DRUG	Clear Anti Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20090603		OTC MONOGRAPH FINAL	part347	TOPCO ASSOCIATES	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-219_b887e1ef-e71d-45ec-b6f3-c6e8a8710ddf	36800-219	HUMAN OTC DRUG	Topcare Mucus DM		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190710		ANDA	ANDA207602	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-221_07143a46-70eb-e36f-e063-6394a90ae628	36800-221	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210818		ANDA	ANDA078682	TOP CARE (Topco Associates LLC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-222_343d4087-6c6d-430a-a927-d1c0cedf420e	36800-222	HUMAN OTC DRUG	topcare fluticasone propionate nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160624		ANDA	ANDA207957	Topco Associates LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-224_f208e8d5-90a0-4c10-a15c-d9a8c3d76d26	36800-224	HUMAN OTC DRUG	topcare anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030226		ANDA	ANDA075232	Topco Associates LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
36800-226_f73f0d09-23bb-4d5c-8649-c9434b0c2c86	36800-226	HUMAN OTC DRUG	Topco Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210601		ANDA	ANDA209215	Topco Associates, LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
36800-237_f0e8a4d9-1a2e-4be2-e053-2995a90a5604	36800-237	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20211015		ANDA	ANDA090397	TOP CARE (Topco Associates LLC)	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-239_c8c16050-760f-4038-e053-2995a90aa870	36800-239	HUMAN OTC DRUG	TOPCARE EVERYDAY CONTINUOUS BROAD SPECTRUM SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
36800-241_e685d7d8-ba5f-424a-9a98-54bde72bfacf	36800-241	HUMAN OTC DRUG	Topcare All Day Allergy		levocetirizine dihydrochloride	TABLET, FILM COATED	ORAL	20200205		ANDA	ANDA211983	Topco Associates LLC	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-243_0e431b1d-a6ee-49e4-804c-6a927114d5b5	36800-243	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part343	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
36800-246_ad12cf2b-5de4-4cad-ad26-a4f400c86c8f	36800-246	HUMAN OTC DRUG	topcare headache relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220201		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
36800-247_ce55559d-f6cb-490e-bba1-21b32f4da7e9	36800-247	HUMAN OTC DRUG	Healing		Petrolatum	OINTMENT	TOPICAL	20131101		OTC MONOGRAPH FINAL	part347	Topco Associates LLC	PETROLATUM	410	mg/g			N	20241231
36800-250_ef578879-4c84-bc46-e053-2995a90a8e21	36800-250	HUMAN OTC DRUG	Cold Relief Multi-Symptom		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	KIT		20111001		OTC MONOGRAPH FINAL	part341	TopCare						N	20241231
36800-251_d5034e20-3ce2-a4c4-e053-2995a90a9527	36800-251	HUMAN OTC DRUG	TOPCO TOPCARE EVERYDAY MINERAL SUNSCREEN ZINC OXIDE SPF 50		ZINC OXIDE	LOTION	TOPICAL	20201202		OTC MONOGRAPH FINAL	part346	TOPCO ASSOCIATES LLC	ZINC OXIDE	216	mg/mL			N	20241231
36800-252_f3971b85-a140-4195-e053-2995a90a73cb	36800-252	HUMAN OTC DRUG	Menthol		Maximum Strength Medicated Foot Powder Talc Free	POWDER	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	MENTHOL	2.8	g/283g			N	20241231
36800-255_c10ff53b-f979-4be5-a5fd-2f66b893eabf	36800-255	HUMAN OTC DRUG	Topcare Ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20040910		ANDA	ANDA075217	Topco Associates LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-257_dbee4319-92d3-5773-e053-2a95a90aa7fe	36800-257	HUMAN OTC DRUG	TopCare Everyday Kids Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20201202		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-260_dbf03701-d160-130c-e053-2a95a90a19b8	36800-260	HUMAN OTC DRUG	TopCare Everyday Mineral Sunscreen Zinc Oxide SPF 30		Zinc Oxide	LOTION	TOPICAL	20201202		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	ZINC OXIDE	182.4	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-261_f0de2999-f12c-89b1-e053-2a95a90ac610	36800-261	HUMAN OTC DRUG	TopCare Everyday Sport Sun SPF 50		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20201028		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
36800-264_b7b5ecd3-cf26-4f67-b710-d95cd25c8bbb	36800-264	HUMAN OTC DRUG	topcare all night pain relief pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20190808		ANDA	ANDA208499	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-267_0ccb3e8a-3d01-1364-e063-6294a90a70e8	36800-267	HUMAN OTC DRUG	TopCare Calaclear		pramoxine hydrochloride and zinc acetate lotion	LOTION	TOPICAL	20190716		OTC MONOGRAPH DRUG	M016	TOPCO ASSOCIATES LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-268_0ccb3962-d499-0a6c-e063-6294a90a0d41	36800-268	HUMAN OTC DRUG	TopCare Calagesic		calamine and pramoxine hydrochloride lotion	LOTION	TOPICAL	20190716		OTC MONOGRAPH DRUG	M016	TOPCO ASSOCIATES LLC	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-269_6ae67e4a-1fe4-4875-8cc1-6567b9e6e3f7	36800-269	HUMAN OTC DRUG	topcare nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20191206		ANDA	ANDA206394	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-270_0ccb3962-d49c-0a6c-e063-6294a90a0d41	36800-270	HUMAN OTC DRUG	Top Care Castor Oil		Castor Oil	OIL	ORAL	20190716		OTC MONOGRAPH DRUG	M007	TOPCO ASSOCIATES LLC	CASTOR OIL	1	mg/mL			N	20241231
36800-274_8100f80d-50cb-4f9f-89fd-e0e7fc7f8c0f	36800-274	HUMAN OTC DRUG	Topcare Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20050329		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-275_1010d627-8cbb-4488-8ea8-ce6e570143db	36800-275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20141031		OTC MONOGRAPH NOT FINAL	part333A	TOP CARE (Topco Associates LLC)	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
36800-276_8eba5045-0926-4739-952c-3f476903b1c6	36800-276	HUMAN OTC DRUG	Isopropyl Alcohol	70 Percent	Isopropyl Alcohol	LIQUID	TOPICAL	20141031		OTC MONOGRAPH NOT FINAL	part333A	TOP CARE (Topco Associates LLC)	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
36800-278_f0e8cdee-69ea-65c6-e053-2995a90a7ada	36800-278	HUMAN OTC DRUG	TopCare Everyday SPORT Sun Broad Spectrum SPF 30		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20181102		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
36800-279_4bc5f385-3c5d-4599-b1a0-b2cf53831f94	36800-279	HUMAN OTC DRUG	topcare hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20141103		OTC MONOGRAPH FINAL	part346	Topco Associates LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-280_f12c09d6-95cd-2ab3-e053-2995a90aa1b9	36800-280	HUMAN OTC DRUG	TopCare Everyday Sport Sun Broad Spectrum SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20190724		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-281_733bdd8e-27f9-4106-b9a7-b13947c3003b	36800-281	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20020528		OTC MONOGRAPH FINAL	part358H	Topco Associates LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
36800-284_f150f2b2-2f07-9426-e053-2995a90a797f	36800-284	HUMAN OTC DRUG	TopCare Everyday Mineral Sunscreen Continuous Broad Spectrum SPF 50 Reef-Conscious Formula		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20220117		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
36800-286_ee297186-699a-dc48-e053-2995a90a266b	36800-286	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20211101		ANDA	ANDA202312	TOPCO ASSOCIATES LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-291_24f413f7-773e-480f-8f94-1a1597d0788b	36800-291	HUMAN OTC DRUG	topcare nite time cold and flu		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20150804		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-292_ca4c415c-bb61-4b86-ab67-0249151ba49c	36800-292	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Topco Associates, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-293_2ba7f1cb-4b66-4d62-891a-6e17becb5841	36800-293	HUMAN OTC DRUG	Topcare Nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20150204		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
36800-294_5418bc37-f938-4835-8493-9e0492abe0cc	36800-294	HUMAN OTC DRUG	Vapor Inhaler	levmetamfetamine nasal decongestant, TopCare health	Levmetamfetamine	INHALANT	NASAL	20210219		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	LEVMETAMFETAMINE	50	mg/1			N	20241231
36800-295_09643d27-20fe-4228-abb4-edc0c8ed739c	36800-295	HUMAN OTC DRUG	topcare Lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20200618		NDA	NDA208025	Topco Associates LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-297_8875a1f7-fffc-4041-81c6-a9717eb7325a	36800-297	HUMAN OTC DRUG	Cough and Runny Nose	Childrens Plus	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide	SUSPENSION	ORAL	20151231		OTC MONOGRAPH FINAL	part341	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-298_ef580a76-451b-16b7-e053-2995a90aa144	36800-298	HUMAN OTC DRUG	Mucus Relief Cold and Flu All In One		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200701		OTC MONOGRAPH FINAL	part341	TOPCARE	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-299_e6ad046c-c421-4eaf-a511-26b165ff0660	36800-299	HUMAN OTC DRUG	Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	19930803		OTC MONOGRAPH NOT FINAL	part356	Topco Associates LLC	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
36800-300_c5589361-9f74-4b6e-8521-22255a5cfd94	36800-300	HUMAN OTC DRUG	Topcare Tussin	Cough Long Acting	Dextromethorphan Hydrobromide	SOLUTION	ORAL	19921021		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-301_98540b76-76d6-4e18-a290-290ff25cbc89	36800-301	HUMAN OTC DRUG	TopCare Day Time Nite Time Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20180908		OTC MONOGRAPH FINAL	part341	Topco Associates LLC						N	20241231
36800-304_a1aa2ebe-e0f4-4665-9dd0-d236c0130380	36800-304	HUMAN OTC DRUG	Topcare Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	19891215		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
36800-305_ce11001d-fbd3-4cd9-aabf-00bae620b2c5	36800-305	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20210319	20241027	OTC MONOGRAPH DRUG	505G(a)(3)	Topco Associates, LLC	SENNOSIDES	25	mg/1			N	
36800-306_a0200973-ece3-40b5-9ef5-898ce84ef347	36800-306	HUMAN OTC DRUG	Topcare ClearLax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	Topco Associates LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-307_988ec368-3820-4af6-8bb4-92cd90319e0e	36800-307	HUMAN OTC DRUG	topcare nite time cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20190910		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-312_f31e9cec-b680-1c72-e053-2995a90aaa90	36800-312	HUMAN OTC DRUG	TopCare Everyday Sport Continuous Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
36800-314_2fd6d11f-1958-4fe2-b52f-90e071f8f0e0	36800-314	HUMAN OTC DRUG	TopCare Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		Topco Associates LLC	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
36800-316_a27f25fd-eb27-4a01-bf6a-bc5eb0a288e5	36800-316	HUMAN OTC DRUG	Severe Cold and Cough	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20151130		OTC MONOGRAPH DRUG	M012	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-317_50a1e4d6-f99d-4f7f-877e-f26803460704	36800-317	HUMAN OTC DRUG	Flu Relief Therapy	Nighttime	Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20150831		OTC MONOGRAPH DRUG	M012	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-318_b9d0c3f7-0562-4380-b38a-f2a3210edadb	36800-318	HUMAN OTC DRUG	Original Antiseptic		EUCALYPTOL, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	19900715		OTC MONOGRAPH NOT FINAL	part356	Topco Associates, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-320_d0d5c17f-6d3f-780c-e053-2995a90a835c	36800-320	HUMAN OTC DRUG	Sinus Pressure plus Pain PE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210618		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-322_d0d6c191-802d-298d-e053-2a95a90af19a	36800-322	HUMAN OTC DRUG	Sinus plus Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200701		OTC MONOGRAPH FINAL	part341	TOPCARE	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-324_be50fef5-cca9-4c4f-92b7-63f3680b0876	36800-324	HUMAN OTC DRUG	Gas Relief Ultra Strength		DIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20210501		OTC MONOGRAPH FINAL	part332	TOPCO ASSOCIATES LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-327_c6888e5b-7958-4c99-90ca-c5221d9dbbfc	36800-327	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20190515		OTC MONOGRAPH DRUG	505G(a)(3)	Topco Associates, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-329_ed40bdf0-fc03-4888-bc09-1e074580bc38	36800-329	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20150731	20250731	OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
36800-334_ce746ebb-871f-4425-ab1f-732c606ec06a	36800-334	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	OIL	ORAL; TOPICAL	20161130		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	MINERAL OIL	100	mg/100mL			N	20241231
36800-335_9d5c21db-e59f-471f-823b-95c1df82960e	36800-335	HUMAN OTC DRUG	topcare nite time cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110818		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-336_4f9fa34d-9a25-42be-a68a-bb1055b773b0	36800-336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxind HCl	LOTION	TOPICAL	20090521		OTC MONOGRAPH FINAL	part347	Topco associates LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
36800-338_646c11ce-99bb-4dc7-b09c-70f994bca7f1	36800-338	HUMAN OTC DRUG	TopCare Stomach Relief	Regular Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20190307		OTC MONOGRAPH DRUG	M008	TOPCO ASSOCIATES LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
36800-341_6c47a159-a1ee-4c91-9270-331e1e82bfa4	36800-341	HUMAN OTC DRUG	TopCare Stomach Relief	Ultra Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20190314		OTC MONOGRAPH DRUG	M008	TOPCO ASSOCIATES LLC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
36800-342_50ceff1e-b6df-40f8-89f3-667cc8f9e750	36800-342	HUMAN OTC DRUG	Maximum Strength Antacid Mint		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20200901		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-344_06f0a3bf-5612-4792-8c99-1baeafaac653	36800-344	HUMAN OTC DRUG	Topcare Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20090903		ANDA	ANDA077007	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-346_f41d5ae5-a425-e899-e053-2a95a90a30df	36800-346	HUMAN OTC DRUG	TopCare Everyday Ultra Protection Sun SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181102		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-347_f71c906a-9c1f-e358-e053-6294a90a691f	36800-347	HUMAN OTC DRUG	TOPCO TOPCARE EVERYDAY BABY PROTECTION SUN SPF 50		OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20181102		OTC MONOGRAPH FINAL	M020	TOPCO ASSOCIATES LLC	OCTISALATE; ZINC OXIDE	50; 145	mg/mL; mg/mL			N	20241231
36800-348_c46f0761-169a-4f2e-9db2-4426c003c935	36800-348	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190731		ANDA	ANDA206568	TOP CARE (Topco Associates LLC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-351_f71e019b-392b-f8eb-e053-6394a90a871e	36800-351	HUMAN OTC DRUG	Topco Topcare Everyday Mineral Sunscreen Continuous SPF 30		ZINC OXIDE	SPRAY	TOPICAL	20201217		OTC MONOGRAPH FINAL	M020	TOPCO ASSOCIATES LLC	ZINC OXIDE	150	mg/g			N	20241231
36800-354_24b03151-fabc-4dbc-81e4-cb9fc268d738	36800-354	HUMAN OTC DRUG	Body Wash		Salicylic Acid	GEL	TOPICAL	20150115		OTC MONOGRAPH FINAL	part333D	TopCo Associates LLC	SALICYLIC ACID	25	mg/mL			N	20241231
36800-359_c91450dd-5fd1-4919-bbc8-0dca11726508	36800-359	HUMAN OTC DRUG	Topcare Tussin DM		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19910814		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-363_d6a8c36e-4c50-4c16-96a0-2b056a050e17	36800-363	HUMAN OTC DRUG	topcare childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20190920		ANDA	ANDA210033	Topco Associates LLC	LORATADINE	5	mg/1			N	20241231
36800-367_802f5d8d-6d0b-498e-ae24-f1448b290900	36800-367	HUMAN OTC DRUG	TopCare Allergy Relief		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210713		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-368_ec7ca338-99f6-4eed-a0fb-432d7c37b7f1	36800-368	HUMAN OTC DRUG	TopCare All Day Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	19970114		ANDA	ANDA074661	Topco Associates LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-369_78e4d3ce-8928-40c9-af82-1530f32e0a7c	36800-369	HUMAN OTC DRUG	Topcare 8 Hour Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170405		ANDA	ANDA075077	Topco Associates LLC	ACETAMINOPHEN	650	mg/1			N	20241231
36800-370_5c960654-45ac-4373-9541-40a761844f6f	36800-370	HUMAN OTC DRUG	Advanced		Ethyl Alcohol	GEL	TOPICAL	20120927		OTC MONOGRAPH NOT FINAL	part333A	TOPCO Assoc. LLC	ALCOHOL	70	mL/100mL			N	20241231
36800-372_f31f0567-11a6-07df-e053-2a95a90ae932	36800-372	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Solution	LIQUID	TOPICAL	20131120		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	UNDECYLENIC ACID	7.5	g/30g			N	20241231
36800-373_f39c1f3c-39f3-6fe4-e053-2995a90a75f5	36800-373	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20171206		OTC MONOGRAPH FINAL	part358F	Topco Associates LLC	SALICYLIC ACID	40	mg/41			N	20241231
36800-375_9e612581-f787-4fd1-8642-1b5b55f6e178	36800-375	HUMAN OTC DRUG	topcare nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	19980622		ANDA	ANDA090711	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-376_f3974ff9-3779-51f6-e053-2a95a90a0e90	36800-376	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20171206		OTC MONOGRAPH FINAL	part358B	Topco Associates LLC	SALICYLIC ACID	.17	mg/9mL			N	20241231
36800-377_f31f1166-23da-1d0b-e053-2a95a90a26ed	36800-377	HUMAN OTC DRUG	Salicylic acid		Wart Remover	PLASTER	TOPICAL	20171206		OTC MONOGRAPH FINAL	part358B	Topco Associates LLC	SALICYLIC ACID	.4	g/181			N	20241231
36800-378_f39710fd-b37a-e145-e053-2a95a90a7fad	36800-378	HUMAN OTC DRUG	Salicylic Acid		Medicated Plantar Wart Remover	PATCH	TOPICAL	20171206		OTC MONOGRAPH FINAL	part358B	Topco Associates LLC	SALICYLIC ACID	40	mg/241			N	20241231
36800-379_b0992995-42fa-4e5d-8753-0f9bbe179d09	36800-379	HUMAN OTC DRUG	Topcare childrens allergy		Diphenhydramine Hydrochloride	SOLUTION	ORAL	19871215		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-381_1fad778c-f98c-4ce4-8450-3e02f54fb3a6	36800-381	HUMAN OTC DRUG	TopCare	Antibiotic Plus Pain Relief	Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	CREAM	TOPICAL	20120321		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
36800-382_f31f0567-11a4-07df-e053-2a95a90ae932	36800-382	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20140710		OTC MONOGRAPH NOT FINAL	part333A	Topco Associates LLC	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
36800-384_f31f30cc-b377-b152-e053-2a95a90a1c7f	36800-384	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Powder Spray Talc Free	AEROSOL, POWDER	TOPICAL	20171207		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-385_f3974966-74a3-acaf-e053-2995a90a2404	36800-385	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20171207		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-388_d9a9a135-6000-4661-a745-c01e75f520da	36800-388	HUMAN OTC DRUG	Topcare Nasal		Oxymetazoline HCl	SPRAY	NASAL	20021126		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
36800-391_5fbf31ab-9c08-4535-8003-54d31639c02d	36800-391	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20190101		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
36800-392_1c4169e0-0ba3-49ce-bb4a-649fd12b368e	36800-392	HUMAN OTC DRUG	topcare lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210729		ANDA	ANDA202319	Topco Associates LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-395_7ec9e304-61fc-4236-9ab1-2ed6035240d2	36800-395	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20140430		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-397_c30ce0b0-ddce-4143-84f9-7fd1b61abe46	36800-397	HUMAN OTC DRUG	Topcare pain and fever	childrens	acetaminophen	SUSPENSION	ORAL	20120228		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-398_f31f30cc-b37c-b152-e053-2a95a90a1c7f	36800-398	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus Spray	AEROSOL, SPRAY	TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-401_8a6c911b-56f9-0884-e053-2a95a90a5d3c	36800-401	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20131101		NDA	NDA019125	Topco Associates LLC	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
36800-410_0fdbf571-5248-4015-8c15-1821f7c716c2	36800-410	HUMAN OTC DRUG	Day Time Cold and Flu Severe		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI	CAPSULE, LIQUID FILLED	ORAL	20160613		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; 1/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-411_68ed6816-939a-4778-80e9-fff788e45a23	36800-411	HUMAN OTC DRUG	Night Time Cold and Flu Severe		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160602		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-412_1cd4cc73-9659-49c5-97db-49b43949e746	36800-412	HUMAN OTC DRUG	DayTime Cold and Flu Severe and NightTime Cold and Flu Severe		acetaminophen, dextromethorphan hydrobromide, guaifenesin, doxylamine succinate, phenylephrine hydrochloride	KIT		20160628		OTC MONOGRAPH FINAL	part341	Topco Associates LLC						N	20241231
36800-413_e8b68c89-b31e-4be8-a024-f1e7549df522	36800-413	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160719		OTC MONOGRAPH FINAL	part338	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-414_a5243d80-a40e-44cd-976c-ee9608db8f38	36800-414	HUMAN OTC DRUG	Extra Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160711		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	500	mg/1			N	20241231
36800-415_12c6e440-72d2-4bfc-b45d-60d28efa68a3	36800-415	HUMAN OTC DRUG	Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20160706		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-416_6a961ec1-d3e2-4d75-9473-7303f17f58cc	36800-416	HUMAN OTC DRUG	topcare triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20200226		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
36800-417_c0842c7e-dda1-47d3-9af9-da14f8f78e0a	36800-417	HUMAN OTC DRUG	Topcare Sinus and Cold D		Naproxen sodium, Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130814		ANDA	ANDA076518	Topco Associates LLC	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
36800-418_fac8e2d9-99c6-47c0-b293-8f2e1f82c8d9	36800-418	HUMAN OTC DRUG	Topcare Cold Sore Treatment		camphor, menthol, phenol, white petrolatum	GEL	TOPICAL	20200309		OTC MONOGRAPH NOT FINAL	part333E	Topco Associates LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
36800-419_d4f7e3a8-e54a-49c5-a5bc-933216057cda	36800-419	HUMAN OTC DRUG	Topcare Mucus Relief		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20071127		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-421_f0466409-197d-9d2e-e053-2995a90adf51	36800-421	HUMAN OTC DRUG	TopCare Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20140811		OTC MONOGRAPH FINAL	part343	Topco Associates LLC	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-426_c8f0b202-6e0b-4ead-980d-2198d2af3705	36800-426	HUMAN OTC DRUG	Topcare Tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20080303		ANDA	ANDA075915	Topco Associates LLC	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-431_794ac57b-5dfb-4414-a01b-084f3676c90c	36800-431	HUMAN OTC DRUG	topcare sleep aid	nighttime	Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20010911		OTC MONOGRAPH FINAL	part338	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-432_4b199c18-a168-4aab-b4b6-b2bd16fa6488	36800-432	HUMAN OTC DRUG	Topcare Nasal Decongestant	Maximum Strength Non Drowsy	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19880115		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
36800-434_496abdef-140f-4a23-92ba-583f7d36dc25	36800-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130801		OTC MONOGRAPH NOT FINAL	part356	TopCo Associates, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-435_86833755-0032-4490-9363-e4658568b980	36800-435	HUMAN OTC DRUG	Regular Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20170105		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	325	mg/1			N	20241231
36800-435_e5a69956-f0a9-4e00-8264-a9e745416a4f	36800-435	HUMAN OTC DRUG	Regular Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160711		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	325	mg/1			N	20241231
36800-436_a4ddb87a-ee57-482d-84f5-a1018c19d0aa	36800-436	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180529		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-437_8010869f-f7fa-4987-ae5a-0e0f13a245ea	36800-437	HUMAN OTC DRUG	Topcare pain relief PM	extra strength non habit forming	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19920721		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-440_a15041f7-99a8-4b99-8bbc-727bb7554d3d	36800-440	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180530		ANDA	ANDA206568	Topco Associates LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-441_b31d584d-5d1c-42e4-8326-e02f4ddebbc5	36800-441	HUMAN OTC DRUG	TopCare Sleep Aid		Doxylamine succinate	TABLET	ORAL	19970129		ANDA	ANDA040167	Topco Associates LLC	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
36800-443_f3bc8c89-738f-7579-e053-2a95a90a2360	36800-443	HUMAN OTC DRUG	Topcare	Maximum Strength	Benzocaine	LIQUID	ORAL	20141001		OTC MONOGRAPH NOT FINAL	part356	Topco Associates LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
36800-448_eb748140-aec8-4fcf-9597-20610d87635a	36800-448	HUMAN OTC DRUG	topcare all day allergy		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220228		ANDA	ANDA213105	Topco Associates LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-449_667fc9e6-2b27-4bb9-a527-4f229bba7a25	36800-449	HUMAN OTC DRUG	childrens Pain and Fever		Acetaminophen	TABLET, CHEWABLE	ORAL	20190215		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ACETAMINOPHEN	160	mg/1			N	20241231
36800-450_a28e223d-f4de-4d1b-adef-bfc6100682e6	36800-450	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	TABLET, CHEWABLE	ORAL	20190215		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ACETAMINOPHEN	160	mg/1			N	20241231
36800-451_f202ed09-ce0e-6f27-e053-2a95a90ad894	36800-451	HUMAN OTC DRUG	TopCare Sensitive	Extra Whitening	Potassium nitrate, Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	TOPCO Assoc. LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
36800-455_b5b1ce8c-13d7-442f-8582-9bd75cdb884c	36800-455	HUMAN OTC DRUG	topcare 8 hr arthritis pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180710		ANDA	ANDA075077	Topco Associates LLC	ACETAMINOPHEN	650	mg/1			N	20241231
36800-456_c8071997-8c37-46f7-bba4-8495b8d53d32	36800-456	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20061218		ANDA	ANDA076777	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-458_c6979bbb-d34f-4967-9109-cfcaf89329ab	36800-458	HUMAN OTC DRUG	TopCare All Day Allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080110		ANDA	ANDA078336	Topco Associates LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-459_ac9b1579-65bc-49a7-8f62-f667b22d3859	36800-459	HUMAN OTC DRUG	topcare nite time cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110819		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-460_b120dcfb-2472-44ea-943e-c19c848634f5	36800-460	HUMAN OTC DRUG	Topcare Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230728		ANDA	ANDA206394	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-465_6d8a1ba3-aece-43e5-98f5-b611a96e25e4	36800-465	HUMAN OTC DRUG	Fiber Laxative		Calcium polycarbophil	TABLET	ORAL	20200801		OTC MONOGRAPH NOT FINAL	part334	Topco Associates, LLC	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
36800-466_e7f074f7-05e2-4df3-9d1c-ab4ad2b08c2b	36800-466	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20211105		OTC MONOGRAPH NOT FINAL	part343	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-467_a386d771-7d33-4cac-9d30-89ad6211b8a4	36800-467	HUMAN OTC DRUG	Topcare Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19920824		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-468_1bb29bfc-a7e6-45ea-b932-a5c9a56c7c78	36800-468	HUMAN OTC DRUG	TopCare Antacid Calcium		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
36800-470_3ced0ad1-110f-4510-a758-2f538796586f	36800-470	HUMAN OTC DRUG	TopCare Pain Relieving	Analgesic	LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20200325		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
36800-471_ee1ecf2b-0153-40dd-ac05-7f3507eb2d85	36800-471	HUMAN OTC DRUG	Topcare Hydrocortisone		hydrocortisone	OINTMENT	TOPICAL	20200403		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-474_ef580a76-4531-16b7-e053-2995a90aa144	36800-474	HUMAN OTC DRUG	Head Congestion plus Flu Severe PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210430		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-475_97317935-9b54-4d2b-a5dc-601ab859edbb	36800-475	HUMAN OTC DRUG	TopCare Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20160202		ANDA	ANDA204226	Topco Associates LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-478_f6db8bf0-4a58-4b10-b18c-08ac7d4e3314	36800-478	HUMAN OTC DRUG	Topcare Antacid Calcium		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC.	CALCIUM CARBONATE	500	mg/1			N	20241231
36800-482_e7774d7c-4eff-4c79-8a22-cea6f617146e	36800-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20130919		OTC MONOGRAPH FINAL	part355	TOPCO Associates LLC	SODIUM FLUORIDE	.219	mg/mL			N	20241231
36800-484_250842b4-8344-4623-94ba-18c62ca4501c	36800-484	HUMAN OTC DRUG	Topcare Pain Relief		Acetaminophen	TABLET	ORAL	19870715		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	500	mg/1			N	20241231
36800-485_ecde8453-37a3-4a57-bc7b-bfa4c4ac6ab5	36800-485	HUMAN OTC DRUG	Topcare Antacid Calcium	Regular Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	500	mg/1			N	20241231
36800-487_1fdcc86f-aa12-4cf0-9e8e-5b67175f306f	36800-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160831		OTC MONOGRAPH FINAL	part347	TOP CARE (Topco Associates LLC)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-488_c2d4a677-a880-4b69-8f58-191e28600cbf	36800-488	HUMAN OTC DRUG	TopCare Extra Strength Gas Relief	Cherry Creme	Simethicone	TABLET, CHEWABLE	ORAL	20190307		OTC MONOGRAPH DRUG	M002	TOPCO ASSOCIATES LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-489_2acf8f8a-dea5-46a3-bff7-d920e0276721	36800-489	HUMAN OTC DRUG	Topcare Antacid Calcium	Extra Strength	Calcium carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
36800-489_f585a1d4-fcb0-40a3-bb55-39d919e84fb9	36800-489	HUMAN OTC DRUG	Topcare Antacid Calcium	Extra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC.	CALCIUM CARBONATE	750	mg/1			N	20241231
36800-490_3246f80c-4cc3-45ef-afe4-70f55419219e	36800-490	HUMAN OTC DRUG	Topcare All Day Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	19970114		ANDA	ANDA074661	Topco Associates LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-492_63df38f5-de50-4541-9da4-e066da4a6783	36800-492	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20160630		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	SENNOSIDES	25	mg/1			N	20241231
36800-494_d8b67767-4748-4233-b41e-7d676d4730e5	36800-494	HUMAN OTC DRUG	TopCare Cough DM		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150730		ANDA	ANDA091135	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-495_2feb1ba9-9227-4aad-a2e2-2d4243d0ac0f	36800-495	HUMAN OTC DRUG	TopCare	Antifungal	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-497_ddeaf669-7142-4981-b918-02cc3af53356	36800-497	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20200617		OTC MONOGRAPH FINAL	part358H	TopCo	PYRITHIONE ZINC	10	mg/mL			N	20241231
36800-499_4a79203a-e616-4e6b-9072-8308a4b30406	36800-499	HUMAN OTC DRUG	topcare hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20140328		OTC MONOGRAPH FINAL	part346	Topco Associates LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-502_d0d6b2c5-5332-e798-e053-2a95a90a381a	36800-502	HUMAN OTC DRUG	COLD AND FLU SEVERE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20130701		OTC MONOGRAPH FINAL	part341	TOPCARE	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-505_d0d6d84f-e91d-4080-e053-2995a90a6a3c	36800-505	HUMAN OTC DRUG	Sinus Congestion and Pain Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20130701		OTC MONOGRAPH FINAL	part341	TopCare	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-506_5dabe2dc-3001-4e1d-ba35-3254157ab513	36800-506	HUMAN OTC DRUG	TopCare	Anti-Itch	Diphenhydramine Hydrochloride and Zinc Acetate	CREAM	TOPICAL	20050920		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-507_9faf3e3c-a262-4c34-b613-998bddded756	36800-507	HUMAN OTC DRUG	Topcare ZZZ Sleep		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20140128		OTC MONOGRAPH FINAL	part338	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-508_2a37224c-7d6f-4acc-986d-4961090e191b	36800-508	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20210930		OTC MONOGRAPH FINAL	part333C	TOP CARE (Topco Associates LLC)	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-509_03489b61-4a19-4309-a6f4-0eb4e7af62ea	36800-509	HUMAN OTC DRUG	Cough Relief	Adult	Dextromethorphan HBr	LIQUID	ORAL	20160331		OTC MONOGRAPH FINAL	part341	TOP CARE (Topco Associates LLC)	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-510_f7d78940-3cb3-4de4-aa79-0f5973a7af18	36800-510	HUMAN OTC DRUG	TopCare Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20100104		UNAPPROVED DRUG OTHER		TOPCO ASSOCIATES LLC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
36800-512_f2151bf2-f794-5213-e053-2a95a90aaf2a	36800-512	HUMAN OTC DRUG	TopCare Oral Pain Relief	Maximum Strength	Benzocaine	GEL	TOPICAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Topco Associates LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
36800-513_35fab784-ff92-4321-bde6-509f4667e384	36800-513	HUMAN OTC DRUG	Beauty Hydrating		Homosalate, Zinc Oxide	LOTION	TOPICAL	20200602		OTC MONOGRAPH NOT FINAL	part352	Topco	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-514_ef5805b4-d0ac-ed5c-e053-2a95a90a1839	36800-514	HUMAN OTC DRUG	Cold plus Head Congestion		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221208		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-515_e2e77354-5537-469c-bc3e-3bcf04eb144e	36800-515	HUMAN OTC DRUG	topcare tussin	mucus plus chest congestion	Guaifenesin	SOLUTION	ORAL	19900115		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	GUAIFENESIN	200	mg/10mL			N	20241231
36800-516_4072cabb-88fb-472d-b568-d4427286365e	36800-516	HUMAN OTC DRUG	topcare tussin CF		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	19920715		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-517_cb64069b-742b-48ee-b2c3-ee4c1c1654d9	36800-517	HUMAN OTC DRUG	Topcare ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060428		ANDA	ANDA077349	Topco Associates LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-519_12471777-fc9a-4a07-8e71-2575c1c28c92	36800-519	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	19901115		OTC MONOGRAPH FINAL	part347	Topco Associates, LLC	PETROLATUM	1	g/g			N	20241231
36800-521_ef5805b4-d0c2-ed5c-e053-2a95a90a1839	36800-521	HUMAN OTC DRUG	Cold Max		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221208		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-522_2f39a104-1cba-4b9f-9910-872503cf40f0	36800-522	HUMAN OTC DRUG	topcare day time cold and flu relief	multi symptom relief	acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20060717		OTC MONOGRAPH DRUG	M012	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-524_684bfb31-742e-4120-962f-569e5e5b44cc	36800-524	HUMAN OTC DRUG	topcare hydrocortisone		hydrocortisone	CREAM	TOPICAL	20200214		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-525_a40e239e-8b06-4e21-b1f2-f32fe118a188	36800-525	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160715		OTC MONOGRAPH NOT FINAL	part343	TOP CARE (Topco Associates LLC)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
36800-526_45a615f0-2d70-4423-a9e6-582d09f2f893	36800-526	HUMAN OTC DRUG	topcare athritis pain reliever		diclofenac sodium	GEL	TOPICAL	20200901		ANDA	ANDA211253	Topco Associates LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-529_d8901910-8635-4a49-8c23-9642019d1150	36800-529	HUMAN OTC DRUG	TopCare Pain Relief	Maximum Strength	Lidocaine Hydrochloride	LIQUID	TOPICAL	20190412		OTC MONOGRAPH DRUG	M015	TOPCO ASSOCIATES	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
36800-532_397688ec-dfe2-4e28-808c-6e57b46ca2eb	36800-532	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20061030		ANDA	ANDA076779	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-533_1af50aea-ee43-46d6-a620-7ff51d2fb353	36800-533	HUMAN OTC DRUG	Topcare Migraine Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20180720		ANDA	ANDA075794	Topco Associates LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
36800-536_db5a21bd-60c1-4484-86f7-51f5e4df1ca7	36800-536	HUMAN OTC DRUG	Antibiotic		bacitracin	OINTMENT	TOPICAL	20200403		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
36800-539_f06bbce5-3e07-4dee-abbd-8e0a8306177d	36800-539	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130212		ANDA	ANDA090711	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-545_3f7f5dd7-96c8-4f4a-b4d9-60f6962ecef5	36800-545	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20210319		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-552_82799f73-b5b9-4464-b347-8ee07610c3fb	36800-552	HUMAN OTC DRUG	Topcare Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120830		ANDA	ANDA091135	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-555_63eb3b05-e05a-46bc-8097-77c93db1b8c3	36800-555	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200730		OTC MONOGRAPH DRUG	M007	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
36800-556_3f3f3bf5-cdbc-4bb3-bac3-8f5d8db06029	36800-556	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20200103		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-557_d4a86bff-f60c-480d-a8c0-ed261c16c9c9	36800-557	HUMAN OTC DRUG	Topcare Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	19931214		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-558_a9fd3634-80ac-44c5-aec1-3ab17f218d68	36800-558	HUMAN OTC DRUG	Topco Fiber Therapy	Sugar Free	Psyllium Husk	POWDER	ORAL	20190418		OTC MONOGRAPH DRUG	M007	TOPCO ASSOCIATES LLC	PSYLLIUM HUSK	3.4	g/5.79g			N	20241231
36800-564_760114cb-d1ec-4cff-bac7-d42b82098545	36800-564	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
36800-566_58bf2e7c-59a5-44cd-9dab-d54b45f6f0d2	36800-566	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCL	TABLET	ORAL	20191129	20240223	OTC MONOGRAPH FINAL	part341	TOP CARE (Topco Associates LLC)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
36800-567_936d810f-985c-44b8-b200-c746885467c0	36800-567	HUMAN OTC DRUG	topcare day time nite time cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20120807		OTC MONOGRAPH FINAL	part341	Topco Associates LLC						N	20241231
36800-568_411aab31-5836-4515-9732-68fb8278a3a0	36800-568	HUMAN OTC DRUG	Stool Softener Laxative	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM	250	mg/1			N	20241231
36800-570_0751a5f5-c432-6934-e063-6294a90ab156	36800-570	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20231010		ANDA	ANDA078682	TOP CARE (Topco Associates LLC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-572_6f318e35-9218-aa09-781e-479bd3de7c5d	36800-572	HUMAN OTC DRUG	Allergy Relief		Fluticasone Propionate	SPRAY, METERED	NASAL	20180418		ANDA	ANDA208150	Topco Associates LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-575_d0d5bb27-cd53-7ad5-e053-2995a90ad1f0	36800-575	HUMAN OTC DRUG	Cold and Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170630		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-578_48ffeb53-c30e-4d1a-80b7-62329257dbc2	36800-578	HUMAN OTC DRUG	Topcare tussin dm	sugar free cough and chest congestion	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19950404		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-580_27ec6ced-80f3-4454-a68d-7fe680705df2	36800-580	HUMAN OTC DRUG	Topcare Nite Time Day Time	Cold and Flu	Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20140429		OTC MONOGRAPH FINAL	part341	Topco Associates LLC						N	20241231
36800-581_44bebc57-1398-488a-957b-16d4ccdeaad5	36800-581	HUMAN OTC DRUG	topcare day time cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20190910		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-582_59c16c09-c23d-4a37-8460-d6c00a268ed5	36800-582	HUMAN OTC DRUG	Regular Strength Antacid Mint		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20201001		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-583_6800c4b3-c705-4b77-82bd-64da73b92600	36800-583	HUMAN OTC DRUG	topcare loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20180912		ANDA	ANDA091292	Topco Associates LLC	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
36800-584_56fdadcb-b2b8-4219-b55d-edb210cfe3c8	36800-584	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20180731	20241231	OTC MONOGRAPH DRUG	M007	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM	100	mg/1			N	
36800-585_e6676031-18a6-4eb0-8241-737ed68d1591	36800-585	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20090320		OTC MONOGRAPH DRUG	M012	Topco Associates, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-587_31d2e77d-5eda-4f47-917c-3390d6c782af	36800-587	HUMAN OTC DRUG	Maximum Strength Antacid Cherry liquid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20201001		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-589_939dc347-0610-4db1-a90d-1c1e10722988	36800-589	HUMAN OTC DRUG	70% Isopropyl Rubbing Alcohol		Isopropyl Rubbing Alcohol	SOLUTION	TOPICAL	20150828		OTC MONOGRAPH NOT FINAL	part333A	TOPCO ASSOCIATES LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
36800-590_d7e279db-5499-4414-916f-763d4633fb8b	36800-590	HUMAN OTC DRUG	topcare infants pain and fever		acetaminophen	SUSPENSION	ORAL	19930721		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-591_73d946c8-edf1-4be9-9cf2-50ca5a309856	36800-591	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20191223		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
36800-592_5a15fc6d-ba27-4a54-9af3-fe98ec1a4a37	36800-592	HUMAN OTC DRUG	Topcare Mucus DM		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180906		ANDA	ANDA207602	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-593_e5181f72-eaa1-48f9-8ff2-bc0e9c427b94	36800-593	HUMAN OTC DRUG	Topcare Day Time Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20170725		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-594_0827eb15-2d01-43cc-a390-ff625eb71f33	36800-594	HUMAN OTC DRUG	topcare nite time cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20190801		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-595_75c085ef-dc1a-4793-811b-e586cc0d69c5	36800-595	HUMAN OTC DRUG	topcare Antacid Calcium	Ultra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
36800-596_f6580029-ea7e-4b41-b3eb-9c9c03d1baef	36800-596	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20160629		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES, LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
36800-597_0b957b6a-91e9-48a2-b38e-8e39a580115a	36800-597	HUMAN OTC DRUG	Topcare Day Time Nite Time Cold and Flu		acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20140628		OTC MONOGRAPH FINAL	part341	Topco Associates LLC						N	20241231
36800-600_01ce4936-7cab-4ae5-bf00-f279c0bd17df	36800-600	HUMAN OTC DRUG	TopCare	Cherry Flavor	Phenol	SPRAY	ORAL	20190305		OTC MONOGRAPH DRUG	M022	TOPCO ASSOCIATES, LLC	PHENOL	1.4	g/100mL			N	20241231
36800-601_5b5a2c7c-c070-48f5-9bf5-902b42e15b9b	36800-601	HUMAN OTC DRUG	topcare omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180402		NDA	NDA209400	Topco Associates LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-602_cf0717a9-c00d-46ca-b3f1-3f376e046793	36800-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	19990715		OTC MONOGRAPH NOT FINAL	part334	TOPCO Associates, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-603_0a2e93b2-7253-40ac-8ea4-ddd9eb03d739	36800-603	HUMAN OTC DRUG	Topcare Day Time Cold and Flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20140613		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-604_a3c28b9b-e9c2-4553-89e6-43e87b368564	36800-604	HUMAN OTC DRUG	TopCare Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880215		ANDA	ANDA072096	Topco Associates LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-605_b0015f7d-7eb0-4a76-a83d-85576051d9c7	36800-605	HUMAN OTC DRUG	Mucus Relief DM Max	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160430		OTC MONOGRAPH DRUG	M012	TOP CARE (Topco Associates LLC)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-606_190a674c-62dc-4b48-ae71-7dba25c0e54e	36800-606	HUMAN OTC DRUG	Topcare Sore Throat	Menthol Flavor	Phenol	SPRAY	ORAL	20190306		OTC MONOGRAPH DRUG	M022	TOPCO ASSOCIATES LLC	PHENOL	1.4	g/100mL			N	20241231
36800-608_3e49bf56-baef-4c33-a38b-a25794c15622	36800-608	HUMAN OTC DRUG	topcare childrens allergy		loratadine	SOLUTION	ORAL	20200708		ANDA	ANDA075728	Topco Associates LLC	LORATADINE	5	mg/5mL			N	20241231
36800-611_47f02151-689c-4592-ab13-6c4e259d7a6c	36800-611	HUMAN OTC DRUG	topcare allergy and congestion relief		loratadine, pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180518		ANDA	ANDA076050	Topco Associates LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
36800-612_0d420212-edb1-43f2-aad3-c82b82227310	36800-612	HUMAN OTC DRUG	TopCare Allergy Relief	24 hour	Loratadine	TABLET	ORAL	20050125		ANDA	ANDA076301	Topco Associates LLC	LORATADINE	10	mg/1			N	20241231
36800-614_559f6cb3-278b-4fc5-9f85-2e129812c385	36800-614	HUMAN OTC DRUG	Topcare Nite Time Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20170801		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-615_d95cf1f8-a122-4527-b1f2-95e3b8569b55	36800-615	HUMAN OTC DRUG	Topcare Antacid Extra Strength	Assorted Berry	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190313		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
36800-616_967e727c-731d-49b9-a6a0-5303597a6068	36800-616	HUMAN OTC DRUG	topcare dual action complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160229		ANDA	ANDA077355	Topco Associates LLC	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-619_1e956cac-469b-4a06-8b06-530d3ef3298b	36800-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20100903		OTC MONOGRAPH FINAL	part347	TopCo Associates LLC	DIMETHICONE	13.13	mg/mL	Skin Barrier Activity [PE]		N	20241231
36800-621_f9221990-cb52-4305-8833-d805fac324d4	36800-621	HUMAN OTC DRUG	Topcare Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170125		ANDA	ANDA078104	Topco Associates LLC	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-622_1c8c862b-2550-418c-940f-6682b997f674	36800-622	HUMAN OTC DRUG	topcare anti itch		diphenhydramine hydrochloride, zinc acetate	CREAM	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-624_f215108e-7691-cf8f-e053-2995a90a1e29	36800-624	HUMAN OTC DRUG	Topco 4x Medicated Toothache and Gum Gel		Benzocaine	GEL	ORAL	20201118		OTC MONOGRAPH NOT FINAL	part356	TopCare	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .5; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
36800-625_9815dea6-4893-4d56-8209-c309cc535df5	36800-625	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20190331	20241231	OTC MONOGRAPH DRUG	M008	TOP CARE (Topco Associates LLC)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
36800-626_dfe837af-7006-48c4-8fda-889a19e54421	36800-626	HUMAN OTC DRUG	Magnesium Citrate	Saline Laxative	Magnesium citrate	LIQUID	ORAL	20150731	20250731	OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
36800-627_6412cd47-7a90-4766-8721-4319b2621b7a	36800-627	HUMAN OTC DRUG	topcare esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200312		ANDA	ANDA207193	Topco Associates LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-628_d0d5c17f-6d2a-780c-e053-2995a90a835c	36800-628	HUMAN OTC DRUG	Allergy Multi Symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210723		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-629_ed4f8790-6cfe-4de9-9193-401908cbdd4d	36800-629	HUMAN OTC DRUG	Topcare lice killing creme rinse		Permethrin	LOTION	TOPICAL	20200131		ANDA	ANDA076090	Topco Associates LLC	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
36800-631_d0d6b66c-fe71-3534-e053-2a95a90ac923	36800-631	HUMAN OTC DRUG	Sinus Congestion PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210426		OTC MONOGRAPH FINAL	part341	TOPCARE	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-632_ea392a2b-465a-6a66-e053-2a95a90a62c8	36800-632	HUMAN OTC DRUG	Arthritis Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20221004		ANDA	ANDA211544	TOPCO ASSOCIATES LLC	ACETAMINOPHEN	650	mg/1			N	20241231
36800-633_0bd10a98-0d1c-4ae7-b758-25916d54fae1	36800-633	HUMAN OTC DRUG	topcare anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181009		ANDA	ANDA209837	Topco Associates LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
36800-636_429dfe02-50b7-414a-98af-cc3c9b0afddb	36800-636	HUMAN OTC DRUG	Topcare Esomeprazole Magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Topco Associates LLC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-638_e5efd907-b111-478b-811d-5e7cfd3a645c	36800-638	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210205		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM	100	mg/1			N	20241231
36800-641_50a66a1b-d6a4-47f9-9c18-8fedb22a9779	36800-641	HUMAN OTC DRUG	TOPCARE EYE DROPS		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20190531		OTC MONOGRAPH FINAL	part349	Topco Associates LLC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
36800-642_626d0086-904e-439e-8055-c7d239a82add	36800-642	HUMAN OTC DRUG	Sinus and Allergy Relief PE		Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20210702		OTC MONOGRAPH DRUG	M012	Topco Associates, LLC	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-647_75c5f0ba-2938-4a08-a397-d47b436909ef	36800-647	HUMAN OTC DRUG	Topcare Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19881115		ANDA	ANDA072096	Topco Associates LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-648_ba8a6033-23b7-47f4-ada3-6a9ccf3c036c	36800-648	HUMAN OTC DRUG	Topcare Nasal Four		Phenylephrine hydrochloride	SPRAY	NASAL	20021210		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-649_0995e01a-3926-844c-e063-6394a90a35bd	36800-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	LIQUID	ORAL	20201201		OTC MONOGRAPH DRUG	M007	TOP CARE (TOPCO ASSOCIATES LLC)	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-650_c5f7a858-8f41-4ea5-8354-aa9098741447	36800-650	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170213		ANDA	ANDA206393	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-653_08f3ce32-81a9-f9d2-e063-6394a90ab17d	36800-653	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210831		ANDA	ANDA211075	TOPCO ASSOCIATES LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-654_0c07030d-16ec-8b42-e063-6294a90ab327	36800-654	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20191010		OTC MONOGRAPH DRUG	M010	TopCo Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-655_0c0707e2-d341-fb56-e063-6394a90a0500	36800-655	HUMAN OTC DRUG	Daytime Severe Cold and Flu Relief Softgels		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, Guaifenesin, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20191031		OTC MONOGRAPH DRUG	M012	TopCo Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-659_0c070987-c608-7b3b-e063-6294a90ad9de	36800-659	HUMAN OTC DRUG	SEVERE NIGHTTIME COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20191031		OTC MONOGRAPH DRUG	M012	TopCo Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-660_572738a7-c864-4437-a5bb-da0ca6f03a10	36800-660	HUMAN OTC DRUG	Topcare Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020702		ANDA	ANDA074937	Topco Associates LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-661_57cc6a4b-adbb-4606-8afd-e18fc8abb20e	36800-661	HUMAN OTC DRUG	TopCare	Regular Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20190507		OTC MONOGRAPH DRUG	M008	TOPCO ASSOCIATES LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
36800-664_92db15b5-67d5-4365-9fcf-fec00c98d7b0	36800-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19921026		OTC MONOGRAPH NOT FINAL	part356	Topco Associates LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-668_ea8231ee-7167-4be8-bb37-f3a11f8fc355	36800-668	HUMAN OTC DRUG	topcare nite time	cough	Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20021210		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-669_0c070058-9e22-cc8c-e063-6394a90ad801	36800-669	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210810		OTC MONOGRAPH DRUG	M012	TOPCO ASSOCIATES LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-670_e31769bf-c362-6867-e053-2a95a90aebf1	36800-670	HUMAN OTC DRUG	TopCare Health Pain Relief		Menthol, Camphor, and Methyl Salicylate	PATCH	TOPICAL	20220308		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	.012; .057; .063	mg/g; mg/g; mg/g			N	20241231
36800-672_9568634c-dc7b-43e9-ad8f-013b3fdbfcf8	36800-672	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20150724		OTC MONOGRAPH DRUG	M010	Topco Associates, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-673_1383178d-120e-487b-a34f-6184ae2f7d33	36800-673	HUMAN OTC DRUG	topcare complete lice treatment kit		piperonyl butoxide, pyrethrum extract	KIT		20190109		OTC MONOGRAPH FINAL	part358G	Topco Associates LLC						N	20241231
36800-674_0995b5bc-832d-7123-e063-6294a90ac30a	36800-674	HUMAN OTC DRUG	Milk of Magnesia mint		Magnesium hydroxide	SUSPENSION	ORAL	20201201		OTC MONOGRAPH DRUG	M007	TOP CARE (TOPCO ASSOCIATES LLC)	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-675_0c0702c2-b281-597b-e063-6294a90a8663	36800-675	HUMAN OTC DRUG	EXTRA STRENGHT HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20201028		OTC MONOGRAPH DRUG	M013	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
36800-676_ed14e802-1cb6-4e80-97da-874d00ce8857	36800-676	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20190501		OTC MONOGRAPH DRUG	505G(a)(3)	Topco Associates, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-681_f2151bf2-f795-5213-e053-2a95a90aaf2a	36800-681	HUMAN OTC DRUG	Top Care	Enamel Guard	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	TOPCO Assoc. LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	5; 1.5	g/100g; g/100g			N	20241231
36800-684_0995e648-9f2c-9d3f-e063-6394a90ab072	36800-684	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20201201		OTC MONOGRAPH DRUG	M007	TOP CARE (TOPCO ASSOCIATES LLC)	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-685_b780ff97-a999-4527-9e0d-0337f4f8c1e1	36800-685	HUMAN OTC DRUG	Topcare ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19950203		ANDA	ANDA074937	Topco Associates LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-689_577e0293-b227-465c-8731-df8cf103fd49	36800-689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	Topco Associates, LLC	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-691_51cf462b-21b6-44e2-b97a-da14622f3947	36800-691	HUMAN OTC DRUG	topcare allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20210823		ANDA	ANDA212971	Topco Associates LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-692_9d18045f-760b-4a32-b0ec-1ac890791788	36800-692	HUMAN OTC DRUG	Topcare Extra Strength Antacid	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190313		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
36800-694_b6e48811-dc4f-4348-aa79-658ed2986b2f	36800-694	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	Topco Associates, LLC	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-696_b01419cc-7b1f-495e-96bb-a65a810f90a3	36800-696	HUMAN OTC DRUG	topcare back and muscle pain		naproxen sodium	TABLET, FILM COATED	ORAL	20190625		ANDA	ANDA074661	Topco Associates LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-697_d0d5b480-1aa3-425e-e053-2995a90a4ed2	36800-697	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210201		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-699_f096ff5b-7ee4-4ff3-af98-5f671572e83e	36800-699	HUMAN OTC DRUG	Topcare childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19970826		OTC MONOGRAPH DRUG	M013	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-700_dd6a6ec8-7efc-4289-9e96-0327e30fafb7	36800-700	HUMAN OTC DRUG	topcare day time		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20060928		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-702_0ccb3ccc-3531-2d08-e063-6394a90ac91a	36800-702	HUMAN OTC DRUG	TopCare Calamine		calamine 8% and zinc oxide 8% lotion	LOTION	TOPICAL	20190716		OTC MONOGRAPH DRUG	M016	TOPCO ASSOCIATES LLC	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-704_0d55f658-bd20-458f-b22a-973eb40ab704	36800-704	HUMAN OTC DRUG	PE Sinus Congestion		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220315		OTC MONOGRAPH DRUG	M012	Topco Associates, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
36800-705_4863e91d-f16d-4a61-8f24-5889fa59a2a3	36800-705	HUMAN OTC DRUG	topcare ibuprofen		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210924		ANDA	ANDA203599	Topco Associates LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-706_790d8277-d9af-46bb-ae3a-dfbf49b3d1be	36800-706	HUMAN OTC DRUG	topcare allergy and congestion relief		loratadine, pseudoephedrine sulfate	TABLET, EXTENDED RELEASE	ORAL	20230816		ANDA	ANDA075989	Topco Associates LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
36800-707_8dc443af-5f4e-4ff2-afd5-d051ebb13da1	36800-707	HUMAN OTC DRUG	Topco tussin cf max		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20170911		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-708_f3922fa3-1564-4e73-b1da-6366cca73403	36800-708	HUMAN OTC DRUG	Anti Nausea Liquid		phosphorated carbohydrate	SOLUTION	ORAL	20180514		UNAPPROVED DRUG OTHER		TOPCO ASSOCIATES LLC	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
36800-709_fe9eadf6-e0b4-4931-8113-f267e0a71068	36800-709	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Toppco	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
36800-710_0c071da6-bf8b-9261-e063-6294a90ab0c5	36800-710	HUMAN OTC DRUG	Bismuth Subsalicylate		Bismuth Subsalicylate	CAPSULE, GELATIN COATED	ORAL	20210219		OTC MONOGRAPH DRUG	M008	TOPCO ASSOCIATES LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
36800-711_920aa75e-60d5-4765-96c7-37708a540629	36800-711	HUMAN OTC DRUG	topcare sinus nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20180717		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
36800-717_79da599e-4ded-482d-bc37-3b5b7601db99	36800-717	HUMAN OTC DRUG	TopCare Multi Symptom Severe Cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20160824		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-734_cbb1fe15-176e-4c75-8cfd-8cd3e49927c5	36800-734	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130215		ANDA	ANDA203690	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-741_05f82d58-b3f4-443e-92a1-c982951e4ca7	36800-741	HUMAN OTC DRUG	All Day Allergy		Cetirizine HCl	CAPSULE	ORAL	20180228		ANDA	ANDA207235	TOP CARE (Topco Associates LLC)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-744_31cdaa1a-0e89-4c41-a0d1-1ac57ed040dc	36800-744	HUMAN OTC DRUG	topcare all day allergy d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200327		ANDA	ANDA210719	Topco Associates LLC	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
36800-745_d9fb5e6d-2125-49f2-a8a6-51dbcd90d6a6	36800-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180331		ANDA	ANDA206568	TOP CARE (Topco Associates LLC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-748_5d2ee41d-5c65-4291-a545-019ed68950c5	36800-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	TOP CARE (Topco Associates LLC)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-749_c1b597e6-2b92-42dd-ad3f-57ef1dee4d34	36800-749	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180331		ANDA	ANDA206568	TOP CARE (Topco Associates LLC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-754_187f38b5-f51b-4fe8-80ae-610f2a01c772	36800-754	HUMAN OTC DRUG	TopCare Antifungal	Maximum Strength	Undecylenic Acid	LIQUID	TOPICAL	20190422		OTC MONOGRAPH DRUG	M005	TOPCO ASSOCIATES LLC	UNDECYLENIC ACID	25	mg/30mL			N	20241231
36800-755_d73a2295-d441-429a-a44e-b8e10da350ba	36800-755	HUMAN OTC DRUG	topcare allergy relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20200802		ANDA	ANDA202538	Topco Associates LLC	LORATADINE	10	mg/1			N	20241231
36800-756_c0457da6-52b2-4775-9282-ab6d09a9fb37	36800-756	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20180731		ANDA	ANDA200888	TOP CARE (Topco Associates LLC)	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-757_85231001-706f-4c2d-b0ca-7b9f85291a7e	36800-757	HUMAN OTC DRUG	topcare day time nite time cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20190923		OTC MONOGRAPH FINAL	part341	Topco Associates LLC						N	20241231
36800-761_ee29473d-92cb-d23a-e053-2a95a90a1343	36800-761	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210930		ANDA	ANDA211075	TOPCO ASSOCIATES LLC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-763_825043c1-d5eb-47f1-8327-5997226e3129	36800-763	HUMAN OTC DRUG	Topcare Nite Time Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20140609		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-766_631553ac-f249-4df5-9789-7fa76ab0b5b6	36800-766	HUMAN OTC DRUG	topcare infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20111103		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-768_d04a5435-c302-5722-e053-2995a90a8b12	36800-768	HUMAN OTC DRUG	Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20100701		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-769_42300688-f027-4a64-9317-d2bf8645133a	36800-769	HUMAN OTC DRUG	Topcare Stomach Relief cherry		Bismuth subsalicylate	LIQUID	ORAL	20211217		OTC MONOGRAPH FINAL	part335	Topco Associates, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
36800-770_ee297186-69af-dc48-e053-2995a90a266b	36800-770	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20140331		OTC MONOGRAPH NOT FINAL	part343	TopCo Associates LLC	ACETAMINOPHEN	500	mg/1			N	20241231
36800-775_df744ff0-07bb-0f2e-e053-2995a90aa4c0	36800-775	HUMAN OTC DRUG	Pressure Plus Pain PE Plus Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170630	20240630	OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
36800-778_84f0279b-59b2-4ac7-9247-0d13d2b5f934	36800-778	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180331	20241231	OTC MONOGRAPH DRUG	M007	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM	100	mg/1			N	
36800-778_8d3a8959-9330-4150-9e78-5abea00bdbd8	36800-778	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180731	20241231	OTC MONOGRAPH DRUG	M007	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM	100	mg/1			N	
36800-779_2e7e553e-919a-4189-81bc-433bf33d4838	36800-779	HUMAN OTC DRUG	topcare 8 hr arthritis pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180412		ANDA	ANDA075077	Topco Associates LLC	ACETAMINOPHEN	650	mg/1			N	20241231
36800-780_6173dcac-e635-4ae3-a911-bff0605d636e	36800-780	HUMAN OTC DRUG	topcare triple antibiotic		bacitracin zinc, neomycin, polymyxin B, pramoxine hydrochloride	OINTMENT	TOPICAL	20200315		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
36800-782_6381c9e2-ff95-42f8-8b4f-0031692f5931	36800-782	HUMAN OTC DRUG	Topco Miconazole 3		miconazole nitrate	CREAM	VAGINAL	20200427		ANDA	ANDA091366	Topco Associates LLC	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-783_4e0d873c-4613-4351-afe7-21712b06cda2	36800-783	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20190731		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
36800-784_0c9025e4-f450-4af7-b624-dad01f7fcd8a	36800-784	HUMAN OTC DRUG	Sleep Aid Nighttime		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210501		OTC MONOGRAPH FINAL	part338	TOPCO ASSOCIATES LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-785_609f7ee9-9953-4f01-97ba-a724f7ce9a71	36800-785	HUMAN OTC DRUG	Gas Relief Extra Strength		DIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20210501		OTC MONOGRAPH FINAL	part332	TOPCO ASSOCIATES LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-786_e6033ccb-f4b7-4299-82e8-e8023dbd90d7	36800-786	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20160131		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	SENNOSIDES	8.6	mg/1			N	20241231
36800-787_5942d33b-baef-4edd-9a28-72698f8e69c2	36800-787	HUMAN OTC DRUG	Topcare Day Time Nite Time Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride,Guaifenesin	KIT		20190917		OTC MONOGRAPH FINAL	part341	Topco Associates LLC						N	20241231
36800-788_a6916be3-2cde-4de8-b03d-e8b2c80d4fe5	36800-788	HUMAN OTC DRUG	topcare tussin dm max		Dextromethorphan hydrobromide, Doxylamine succinate	SOLUTION	ORAL	20190502		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-790_c636eb6f-ce54-42ff-a585-c7da1af52b92	36800-790	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET	ORAL	20180228		OTC MONOGRAPH FINAL	part341	TOP CARE (Topco Associates LLC)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-793_efd0e9b0-5108-fa6d-e053-2995a90a092f	36800-793	HUMAN OTC DRUG	Head Congestion plus Mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210426		OTC MONOGRAPH FINAL	part341	TOPCARE	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-794_176e9443-0b0b-48c2-ab57-880d5404fbf1	36800-794	HUMAN OTC DRUG	TopCare Chest Congestion Relief		Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
36800-803_70f4a9d3-afa4-43fd-a54d-af63dace630c	36800-803	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150915		OTC MONOGRAPH FINAL	part355	TOPCO ASSOCIATES LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
36800-804_7a07681f-a683-475b-849d-39398c6f4e1b	36800-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19910315		OTC MONOGRAPH NOT FINAL	part333A	TopCo Assoc LLC	ISOPROPYL ALCOHOL	.91	mg/mL			N	20241231
36800-805_b15878c2-8299-4ed3-8ce6-6cc0d7cd193d	36800-805	HUMAN OTC DRUG	TopCare Health Cold Remedy	Cherry Flavor	Zincum Gluconicum	TABLET	ORAL	20190417		UNAPPROVED HOMEOPATHIC		TOPCO ASSOCIATES LLC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-806_67a8a86b-1416-498e-8445-5eed764ef12f	36800-806	HUMAN OTC DRUG	TopCare Zinc Cold Remedy	Citrus Flavor	ZINC GLUCONATE	TABLET	ORAL	20190418		UNAPPROVED HOMEOPATHIC		TOPCO ASSOCIATES LLC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-811_939724ea-dd93-4790-9c31-d7570b35ec2d	36800-811	HUMAN OTC DRUG	topcare childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190904		ANDA	ANDA076359	Topco Associates LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-814_06d32f69-7075-181e-e063-6294a90abb61	36800-814	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20130322		OTC MONOGRAPH FINAL	part341	Topco Associates	MENTHOL	5.4	mg/1			N	20241231
36800-815_08f43076-fc12-0d3b-e063-6394a90a94ef	36800-815	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20130320		OTC MONOGRAPH DRUG	M012	TopCo Associates	MENTHOL	5.8	mg/1			N	20241231
36800-815_08f4599b-de5f-2bc7-e063-6394a90a69ab	36800-815	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20130320		OTC MONOGRAPH DRUG	M012	TopCo Associates	MENTHOL	5.8	mg/1			N	20241231
36800-816_06d32f69-7077-181e-e063-6294a90abb61	36800-816	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20130320		OTC MONOGRAPH FINAL	part341	Topco Associates	MENTHOL	7.5	mg/1			N	20241231
36800-816_08f4599b-de64-2bc7-e063-6394a90a69ab	36800-816	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20130322		OTC MONOGRAPH DRUG	M012	Topco Associates	MENTHOL	7.5	mg/1			N	20241231
36800-816_08f48ebd-dd78-3c38-e063-6394a90a563a	36800-816	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20130320		OTC MONOGRAPH DRUG	M012	Topco Associates	MENTHOL	7.5	mg/1			N	20241231
36800-817_59f39b38-4356-414e-9df0-78434402e91a	36800-817	HUMAN OTC DRUG	Topcare Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	19960806		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
36800-818_08f4b983-903b-4e9c-e063-6394a90a7cf7	36800-818	HUMAN OTC DRUG	strawberry cough drops		menthol	LOZENGE	ORAL	20130322		OTC MONOGRAPH DRUG	M012	Topco Associates	MENTHOL	2.7	mg/1			N	20241231
36800-819_06d33b7f-69fd-472f-e063-6294a90a7624	36800-819	HUMAN OTC DRUG	sugar free menthol cough drops		menthol	LOZENGE	ORAL	20130322		OTC MONOGRAPH FINAL	part341	Topco Associates	MENTHOL	5.8	mg/1			N	20241231
36800-820_08f4f75a-5cba-135e-e063-6294a90a2f73	36800-820	HUMAN OTC DRUG	sugar free cherry cough drops		menthol	LOZENGE	ORAL	20130322		OTC MONOGRAPH DRUG	M012	Topco Associates	MENTHOL	5.8	mg/1			N	20241231
36800-822_06d32288-b7c0-d549-e063-6394a90a1a4e	36800-822	HUMAN OTC DRUG	sugar free honey lemon cough drops		menthol	LOZENGE	ORAL	20130322		OTC MONOGRAPH FINAL	part341	Topco Associates	MENTHOL	7.6	mg/1			N	20241231
36800-823_08f505b5-f1c3-69d1-e063-6394a90a02fb	36800-823	HUMAN OTC DRUG	berry breezer throat drop		pectin	LOZENGE	ORAL	20130322		OTC MONOGRAPH DRUG	M012	Topco Associates	PECTIN	7	mg/1			N	20241231
36800-825_887383d2-df39-4e9f-9b11-4fa83dc578ce	36800-825	HUMAN OTC DRUG	Topcare Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20000229		ANDA	ANDA074760	Topco Associates LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-828_08f50eab-86d3-3412-e063-6294a90a1411	36800-828	HUMAN OTC DRUG	assorted fruit antacid flavor chews		calcium carbonate	TABLET, CHEWABLE	ORAL	20150601		OTC MONOGRAPH DRUG	M001	Topco Associates	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
36800-830_08f57305-0c4a-96b1-e063-6394a90a77df	36800-830	HUMAN OTC DRUG	cherry antacid soft chew		calcium carbonate	TABLET, CHEWABLE	ORAL	20130626		OTC MONOGRAPH DRUG	M001	Topco Associates	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
36800-832_06d30f3b-a71f-15a7-e063-6294a90aa6e9	36800-832	HUMAN OTC DRUG	Cherry Sore Throat Lozenge		Benzocaine	LOZENGE	ORAL	20171219		OTC MONOGRAPH NOT FINAL	part356	TopCo	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
36800-835_0c7fdbaa-6425-7749-e063-6294a90a7a36	36800-835	HUMAN OTC DRUG	TopCare Earwax Removal Kit		CARBAMIDE PEROXIDE	LIQUID	AURICULAR (OTIC)	20141128		OTC MONOGRAPH DRUG	M014	TOPCO ASSOCIATES LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
36800-836_06d3412f-a3a4-5513-e063-6294a90a8051	36800-836	HUMAN OTC DRUG	Mixed Berry Sore Throat Lozenges		Benzocaine	LOZENGE	ORAL	20180803		OTC MONOGRAPH NOT FINAL	part356	Topco Associates	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-839_a03af92b-b719-4cc7-bb02-25ac7c145db2	36800-839	HUMAN OTC DRUG	topcare childrens mucus relief multi symptom cold		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20140808		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-844_e5ad96f2-e6fe-430b-9537-0abce98e0392	36800-844	HUMAN OTC DRUG	Awake	Maximum Strength	Caffeine	TABLET, FILM COATED	ORAL	19980414		OTC MONOGRAPH DRUG	M011	Topco Associates, LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
36800-845_0cfa8361-29ff-1808-e063-6294a90a0bff	36800-845	HUMAN OTC DRUG	TopCare Health Dry Eye Relief Eye Drops		glycerin, hypromellose, polyethylene glycol 400	SOLUTION	OPHTHALMIC	20200206		OTC MONOGRAPH DRUG	M018	Topco Associates LLC	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
36800-846_bb735629-b3d0-ff1f-e053-2995a90aae76	36800-846	HUMAN OTC DRUG	Top Care Ear Relief Ear Drops		CHAMOMILE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20070701		UNAPPROVED HOMEOPATHIC		Topco Associates LLC	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
36800-847_d5d04244-e6b3-4ecb-b62f-e5658d7fb552	36800-847	HUMAN OTC DRUG	topcare tussin dm max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180926		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-848_c2cccf0d-9e00-4cdf-a82c-fa3ad895efe8	36800-848	HUMAN OTC DRUG	Cold and Flu Severe Nighttime		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210501		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.5; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-849_4cfd20cd-d63b-462d-a4a4-b6d2ed05d126	36800-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201220		OTC MONOGRAPH NOT FINAL	part333A	Topco	ALCOHOL	62	mL/100mL			N	20241231
36800-853_4bd57bff-c68b-497f-801d-e60d9c7b8390	36800-853	HUMAN OTC DRUG	Topcare Allergy Relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200625		ANDA	ANDA076011	Topco Associates LLC	LORATADINE	10	mg/1			N	20241231
36800-855_0cfa87ca-f1d4-c578-e063-6394a90a7626	36800-855	HUMAN OTC DRUG	Topcare Health Ultra Itch Relief Astringent Eye Drops		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20200201		OTC MONOGRAPH DRUG	M018	Topco Associates LLC	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
36800-856_0cfa88e0-a3dd-180c-e063-6294a90ae2ac	36800-856	HUMAN OTC DRUG	TopCare Health Advanced Moisturizing Plus Redness Relief		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200204		OTC MONOGRAPH DRUG	M018	Topco Associates LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
36800-857_939c11c2-5f62-4156-a13b-e5f94c2506b4	36800-857	HUMAN OTC DRUG	Topcare Athletes Foot		clotrimazole	CREAM	TOPICAL	20200403		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
36800-858_0cfa5c76-fce8-9f22-e063-6394a90ade89	36800-858	HUMAN OTC DRUG	TopCare Health Original Eye Drops		tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200206		OTC MONOGRAPH DRUG	M018	Topco Associates LLC	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
36800-859_b35ae8cc-a5f5-4b2a-9102-816357051d56	36800-859	HUMAN OTC DRUG	topcare childrens night time cold and cough		Diphenhydramine hydrochloride, Phenylephrine hydrochloride	SOLUTION	ORAL	20190416		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-860_efe77dbd-f918-6230-e053-2a95a90a7222	36800-860	HUMAN OTC DRUG	Topcare Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20190423		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	MENTHOL	50	mg/1			N	20241231
36800-861_d7adc4f4-6bb6-4078-ab48-07dd8649c4d0	36800-861	HUMAN OTC DRUG	Laxative Docusate Sodium with Senna		Docusate Sodium and Sennosides	TABLET, COATED	ORAL	20210501		OTC MONOGRAPH NOT FINAL	part334	TOPCO ASSOCIATES LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
36800-862_26209bed-7e84-44d6-b6e5-d41d2c35228e	36800-862	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20200228		OTC MONOGRAPH NOT FINAL	part334	TOP CARE (Topco Associates LLC)	DOCUSATE SODIUM	100	mg/1			N	20241231
36800-863_8943b9d7-4616-4cc1-8c25-7e8e194e9399	36800-863	HUMAN OTC DRUG	Topcare Nicotine Gum		Nicotine polacrilex	GUM, CHEWING	ORAL	20170213		ANDA	ANDA206394	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-864_050b4ae2-520c-4549-9fc4-0eabe8f446a8	36800-864	HUMAN OTC DRUG	50% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	20170403		OTC MONOGRAPH NOT FINAL	part333A	TopCo Associates	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
36800-866_772ef23b-b1f2-47f8-a829-5cc83ceacd46	36800-866	HUMAN OTC DRUG	Topcare Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070905		OTC MONOGRAPH FINAL	part358G	Topco Associates LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
36800-871_9f7b0431-4df0-4bac-a1f2-84ac96525609	36800-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20150731		OTC MONOGRAPH NOT FINAL	part333A	TOPCO ASSOCIATES	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
36800-873_bf7ccb4b-88a1-474a-9c62-c91701fb15cf	36800-873	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20061227		ANDA	ANDA077007	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-875_6d8e1117-9680-416d-8bc8-8e836e8da6a0	36800-875	HUMAN OTC DRUG	Salicylic Acid		Astringent	LIQUID	TOPICAL	20090601		OTC MONOGRAPH FINAL	part333D	TOPCO ASSOCIATES LLC	SALICYLIC ACID	5	mg/mL			N	20241231
36800-876_f31f30cc-b379-b152-e053-2a95a90a1c7f	36800-876	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20170522		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	TOLNAFTATE	1.3	g/130g			N	20241231
36800-877_f31f2be7-58f7-0a5d-e053-2a95a90af96c	36800-877	HUMAN OTC DRUG	Tolnaftate		Tolnaftate Jock Itch Powder Spray Talc Free	AEROSOL, SPRAY	TOPICAL	20171031		OTC MONOGRAPH FINAL	part333C	Topco Associates LLC	TOLNAFTATE	1.3	g/130g			N	20241231
36800-880_d0d6d527-c25b-0646-e053-2995a90abf86	36800-880	HUMAN OTC DRUG	Aspirin 81mg	Adult Low Dose	ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20161003		OTC MONOGRAPH NOT FINAL	part343	TopCare	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-881_854fdaa8-d296-43f0-8ebb-739702fbb5d1	36800-881	HUMAN OTC DRUG	Topcare Antacid Calcium		calcium carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
36800-894_8c6d8d77-7bc4-45a2-a13e-019adc036ceb	36800-894	HUMAN OTC DRUG	TopCare Maximum Strength Pain Relieving	Analgesic	MENTHOL, UNSPECIFIED FORM	LIQUID	TOPICAL	20200325		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	MENTHOL, UNSPECIFIED FORM	160	mg/mL			N	20241231
36800-897_425d20bf-3122-45aa-b83d-2a68ce57ef9e	36800-897	HUMAN OTC DRUG	topcare ibuprofen		Ibuprofen	SUSPENSION	ORAL	19981231		ANDA	ANDA074937	Topco Associates LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-898_f32d3b02-ea5e-4e47-9b22-6592b3193c21	36800-898	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20131018		OTC MONOGRAPH NOT FINAL	part333A	Topco	ALCOHOL	70	mL/100mL			N	20241231
36800-899_dde54df7-f8ab-437d-bb92-9e274723893f	36800-899	HUMAN OTC DRUG	TopCare Cough DM		Dextromethorphan polistirex	SUSPENSION	ORAL	20150730		ANDA	ANDA091135	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-900_d0d6d527-c285-0646-e053-2995a90abf86	36800-900	HUMAN OTC DRUG	Pain Relief	Regular Strength	Acetaminophen	TABLET	ORAL	20110830		OTC MONOGRAPH NOT FINAL	part343	TopCo Associates LLC	ACETAMINOPHEN	325	mg/1			N	20241231
36800-903_b8bde0b4-2987-4d9e-986e-7988933439dc	36800-903	HUMAN OTC DRUG	Topcare Cold		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SUSPENSION	ORAL	20090724		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-905_d0d6d527-c26f-0646-e053-2995a90abf86	36800-905	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET	ORAL	20110830		OTC MONOGRAPH NOT FINAL	part343	TopCo Associates LLC	ACETAMINOPHEN	500	mg/1			N	20241231
36800-907_9741bae5-851c-4a51-a1f6-cbcfca41da4d	36800-907	HUMAN OTC DRUG	Topcare Nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20160714		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
36800-909_ee9eea01-71f3-874a-e053-2995a90a575a	36800-909	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110830		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-910_d0d6d527-c239-0646-e053-2995a90abf86	36800-910	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20110830		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-914_d0d6b66c-fe5b-3534-e053-2a95a90ac923	36800-914	HUMAN OTC DRUG	Cold Max Nighttime		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110830		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-915_0d4bfaa9-04bd-49a3-a0e3-ef012dd4f995	36800-915	HUMAN OTC DRUG	TopCare Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080229		NDA	NDA022032	Topco Associates LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
36800-921_d0d6a271-c06d-dc73-e053-2995a90a50f5	36800-921	HUMAN OTC DRUG	Cold Max Daytime		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110830		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-922_8d5bd1d6-2d93-410a-9b21-c458581eae04	36800-922	HUMAN OTC DRUG	Topcare Mucus Relief	Severe Congestion and Cold	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20130628		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-924_d0d6b6fd-5bce-34fe-e053-2a95a90a336a	36800-924	HUMAN OTC DRUG	Cold Plus Head Congestion Daytime		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110830		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-925_d0d6b66c-fe44-3534-e053-2a95a90ac923	36800-925	HUMAN OTC DRUG	Cold Plus Head Congestion Nighttime		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110830		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-927_ef580a76-4547-16b7-e053-2995a90aa144	36800-927	HUMAN OTC DRUG	Cold Plus Head Congestion Day and Night		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	KIT		20110830		OTC MONOGRAPH FINAL	part341	TopCo Associates LLC						N	20241231
36800-930_a3f849e3-85e3-4ad8-a385-65254dda5f12	36800-930	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	Topco Associates, LLC	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
36800-931_ff71d99f-a404-44b7-8819-7677d9b580e1	36800-931	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20041222		OTC MONOGRAPH NOT FINAL	part334	TopCo Associates	MINERAL OIL	999	mg/mL			N	20241231
36800-932_71145cd8-ef8b-4104-b3d1-ab529c4f0c3e	36800-932	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20190331		ANDA	ANDA207342	TOP CARE (Topco Associates LLC)	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
36800-933_0c070793-1501-78f9-e063-6294a90a335d	36800-933	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20200206		OTC MONOGRAPH DRUG	M012	TOPCO ASSOCIATES LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-934_a7560b7b-c1dd-4cc0-a552-2b1b990f2544	36800-934	HUMAN OTC DRUG	topcare migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20220616		ANDA	ANDA075794	Topco Associates LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
36800-937_57a1df02-6bcc-4035-9547-b6b9e6625ee5	36800-937	HUMAN OTC DRUG	Allergy Relief Caplet		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20210501		OTC MONOGRAPH DRUG	M012	TOPCO ASSOCIATES LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
36800-938_db9bc5b7-3396-495b-b15d-ceca1101d7c5	36800-938	HUMAN OTC DRUG	Vegetable Laxative and Stool Softner		docusate sodium and sennosides	TABLET, COATED	ORAL	20210501		OTC MONOGRAPH NOT FINAL	part334	TOPCO ASSOCIATES LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
36800-939_f28df9dd-a3d4-437a-a54a-a67a492dd2ff	36800-939	HUMAN OTC DRUG	topcare hydrocortisone		hydrocortisone	CREAM	TOPICAL	20200315		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-940_c5eccff3-afb8-25ce-e053-2995a90aa0fe	36800-940	HUMAN OTC DRUG	TOPCARE EVERYDAY SPORT SPF 70 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20190103		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-941_8bcd598c-08de-4f19-b55a-e9012ed6ce7a	36800-941	HUMAN OTC DRUG	Tartar Control Plus		eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130801		OTC MONOGRAPH NOT FINAL	part356	Topco Associates LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
36800-943_6a7e3c09-e8c2-4c3e-9bde-628e1e468732	36800-943	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20190530		OTC MONOGRAPH DRUG	M009	Topco Associates, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
36800-944_3aaad9ad-9fce-4f68-9cee-41c999faba57	36800-944	HUMAN OTC DRUG	topcare hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20111103		OTC MONOGRAPH FINAL	part346	Topco Associates LLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-945_c8989cce-5519-1de4-e053-2995a90a9976	36800-945	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333A	TOPCO	ALCOHOL	70	mg/100g			N	20241231
36800-946_b595d2c1-22a2-480a-aa25-c66359940f85	36800-946	HUMAN OTC DRUG	topcare infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20110824		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
36800-947_b5f37356-41cc-4eb6-9b87-70a3a0888f1d	36800-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic acid 2%	LOTION	TOPICAL	20090521		OTC MONOGRAPH FINAL	part333D	Topco Associates, LLC	SALICYLIC ACID	20.6	mg/mL			N	20241231
36800-948_416e7c4b-bc6d-4890-91d8-f00ae026b4ed	36800-948	HUMAN OTC DRUG	topcare day time cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20190801		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-952_0060da24-524b-4994-83a4-8edf9b05b19d	36800-952	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	19910915		OTC MONOGRAPH NOT FINAL	part334	TOPCO Associates LLC	CASTOR OIL	1	g/mL			N	20241231
36800-953_baff690e-937e-cf8c-e053-2995a90af7cd	36800-953	HUMAN OTC DRUG	TopCare Everyday After Sun Cooling		Lidocaine Hydrochloride	GEL	TOPICAL	20181205		OTC MONOGRAPH NOT FINAL	part348	TOPCO ASSOCIATES LLC	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
36800-956_bfe076fa-f220-2c46-e053-2a95a90acee4	36800-956	HUMAN OTC DRUG	MINERAL SUNSCREEN SPF 50		ZINC OXIDE, TITANIUM DIOXIDE	STICK	TOPICAL	20201019		OTC MONOGRAPH NOT FINAL	part352	TOPCO ASSOCIATES LLC	TITANIUM DIOXIDE; ZINC OXIDE	70; 47	mg/g; mg/g			N	20241231
36800-957_bd043d8b-19d9-409b-9def-03befd19604d	36800-957	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130214		ANDA	ANDA203690	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-960_e4091328-b2bf-41d5-a19f-9f8c9c6959d8	36800-960	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333A	Topco	ALCOHOL	62	mL/100mL			N	20241231
36800-962_629835d9-9992-40eb-b80e-2d4971720b8b	36800-962	HUMAN OTC DRUG	Topcare antacid calcium		Calcium carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	Topco Associates LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
36800-963_5ef2033d-949f-43d2-993b-2f16729cbaf1	36800-963	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200730		OTC MONOGRAPH FINAL	part332	TOP CARE (Topco Associates LLC)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
36800-964_502a8657-8fe5-40f6-827e-d7fd8471a222	36800-964	HUMAN OTC DRUG	topcare flu and severe cold and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20120910		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-967_15a281f4-f652-4729-9214-9d8a9eac4361	36800-967	HUMAN OTC DRUG	topcare nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20191206		ANDA	ANDA206393	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
36800-968_a84f40e2-1f7e-4c09-ac2c-24eefb36bce0	36800-968	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, COATED	ORAL	20200401		OTC MONOGRAPH NOT FINAL	part343	TOP CARE (Topco Associates LLC)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
36800-971_a563905c-9caa-45f2-97dd-eb4f22c6ac82	36800-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20130919		OTC MONOGRAPH FINAL	part355	TOPCO Associates LLC	SODIUM FLUORIDE	.02	mg/mL			N	20241231
36800-972_0cfa87ca-f1d5-c578-e063-6394a90a7626	36800-972	HUMAN OTC DRUG	Topcare Health Artificial Tears		polyvinyl alcohol, povidone	SOLUTION	OPHTHALMIC	20200131		OTC MONOGRAPH DRUG	M018	Topco Associates LLC	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
36800-973_0dd60f14-a715-4297-9491-3ec1599ce755	36800-973	HUMAN OTC DRUG	topcare pain relief		acetaminophen	TABLET, FILM COATED	ORAL	20201111		OTC MONOGRAPH NOT FINAL	part343	Topco Associates LLC	ACETAMINOPHEN	500	mg/1			N	20241231
36800-975_0cfa9846-2cd8-d0fc-e063-6394a90af06b	36800-975	HUMAN OTC DRUG	Topcare Maximum Redness Relief Eye Drops		glycerin, naphazoline hydrochloride	SOLUTION	OPHTHALMIC	20200204		OTC MONOGRAPH DRUG	M018	Topco Assoc LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
36800-976_1da253a6-ba2e-4cc8-8e32-d33944870f99	36800-976	HUMAN OTC DRUG	Topcare Antibiotic		neomycin, polymyxin B, pramoxine hydrochloride	CREAM	TOPICAL	20200403		OTC MONOGRAPH FINAL	part333B	Topco Associates LLC	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
36800-978_0cfa87ca-f1d7-c578-e063-6394a90a7626	36800-978	HUMAN OTC DRUG	Topcare Health Lubricant Eye Drops		polyethylene glycol 400, propylene glycol	SOLUTION	OPHTHALMIC	20200207		OTC MONOGRAPH DRUG	M018	Topco Assoc LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
36800-979_c06d5563-e50a-4783-93bf-70d9641649c5	36800-979	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength	Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
36800-981_1c7cf205-a1db-4e47-be71-0ebe2c4e9e83	36800-981	HUMAN OTC DRUG	Topcare Hydrocortisone		hydrocortisone	CREAM	TOPICAL	20200320		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
36800-984_c203c086-40cf-478e-8f4e-5b672749311d	36800-984	HUMAN OTC DRUG	Laxative Senna		Sennosides	TABLET, COATED	ORAL	20210501		OTC MONOGRAPH NOT FINAL	part334	TOPCO ASSOCIATES LLC	SENNOSIDES	8.6	mg/1			N	20241231
36800-986_de6ac8d5-4962-47bc-a893-b65781360bd3	36800-986	HUMAN OTC DRUG	Cold and Flu Severe Daytime		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210501		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-987_ca8508df-fcbd-4b8c-82f8-bbfb5c9f5c05	36800-987	HUMAN OTC DRUG	Topcare childrens cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060929		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-988_5d1c9629-ff3c-4bd6-9292-93487de52a96	36800-988	HUMAN OTC DRUG	TopCare Chest Congestion and Cough Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20091207		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
36800-989_c2c7762a-0424-409e-853f-492478ac6e4b	36800-989	HUMAN OTC DRUG	Topcare Chest Congestion and Sinus Congestion Relief PE		Guaifenesin/phenylephrine	TABLET	ORAL	20060605		OTC MONOGRAPH FINAL	part341	TOPCO ASSOCIATES LLC	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
36800-991_dd3919f1-7a78-460f-b504-bd9d1b4593aa	36800-991	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20190130		OTC MONOGRAPH DRUG	M013	Topco Associates, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
36800-993_1909045f-8a59-47d3-844c-a49fa61ca541	36800-993	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Topco Associates, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
36800-994_d4716e40-b7fc-445f-8cb5-70e9a98f876a	36800-994	HUMAN OTC DRUG	Chocolated Laxative	Regular Strength Sennosides Stimulant Laxative TopCare health	Sennosides	TABLET, CHEWABLE	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	Topco Associates	SENNOSIDES	15	mg/1			N	20241231
37000-005_07ec6c20-73c8-e5e4-e063-6294a90a7e55	37000-005	HUMAN OTC DRUG	Crest Cavity Protection Regular		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	19840802		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-008_07ec5d59-1e2f-896e-e063-6294a90afd04	37000-008	HUMAN OTC DRUG	Crest Tartar Protection		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	19921106		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-009_0026fe25-49cf-7c37-e063-6394a90a7c57	37000-009	HUMAN OTC DRUG	Crest Tartar Protection	Fresh Mint Gel	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	19950616		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-015_07e9c83a-c74f-8223-e063-6294a90ac4d4	37000-015	HUMAN OTC DRUG	Vicks NyQuil HBP	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate	LIQUID	ORAL	20170201	20240711	OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
37000-023_0bb37e24-22e1-1c4d-e063-6394a90a6429	37000-023	HUMAN OTC DRUG	Metamucil	Therapy for Regularity	Psyllium Husk	POWDER	ORAL	19890331		OTC MONOGRAPH DRUG	M007	The Procter & Gamble Manufacturing Company	PSYLLIUM HUSK	3.4	g/12g			N	20241231
37000-024_0bb3ebdc-93e8-0249-e063-6294a90a65da	37000-024	HUMAN OTC DRUG	Metamucil	Therapy for regularity	Psyllium Husk	POWDER	ORAL	19941215		OTC MONOGRAPH DRUG	M007	The Procter & Gamble Manufacturing Company	PSYLLIUM HUSK	3.4	g/5.8g			N	20241231
37000-025_07fe1914-0c4f-9021-e063-6394a90a1d8d	37000-025	HUMAN OTC DRUG	Crest Cavity Protection	Cool Mint Gel	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	19950616		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-027_07e9bd23-6ce1-9b3d-e063-6394a90a144f	37000-027	HUMAN OTC DRUG	Vicks DayQuil	HBP	Acetaminophen, Dextromethorphan Hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20170201	20240126	OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	325; 10	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
37000-033_07de2b7e-96fa-162d-e063-6394a90a4488	37000-033	HUMAN OTC DRUG	Vicks DayQuil and Vicks NyQuil	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Doxylamine Succinate	KIT	ORAL	20130801		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
37000-044_0788d9bf-2b11-e81a-e063-6294a90ae43c	37000-044	HUMAN OTC DRUG	Crest Baking Soda and Peroxide	Whitening with Tartar Protection	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20130701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
37000-045_07fe1914-0c4e-9021-e063-6394a90a1d8d	37000-045	HUMAN OTC DRUG	Vicks DayQuil and Vicks NyQuil	Severe Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and doxylamine succinate	KIT		20140731		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
37000-049_07fe1eae-eb86-de4b-e063-6394a90a267c	37000-049	HUMAN OTC DRUG	Kids Crest Cavity Protection	Sparkle Fun	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20020905		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-070_f56633ba-4e02-3d0d-e053-2a95a90af687	37000-070	HUMAN OTC DRUG	Head and Shoulders 2in1	Classic Clean	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-071_f8366728-4c71-a518-e053-6394a90a0630	37000-071	HUMAN OTC DRUG	Head and Shoulders	Classic Clean	Pyrithione Zinc	SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-077_f5b67530-ab7d-96a9-e053-2995a90ac86a	37000-077	HUMAN OTC DRUG	Head and Shoulders	Green Apple	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-078_f5c5f3b6-e8f1-1120-e053-2995a90ae8fa	37000-078	HUMAN OTC DRUG	Head and Shoulders	Green Apple 2in1	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-079_f30a97d9-849f-3ddf-e053-2a95a90afecb	37000-079	HUMAN OTC DRUG	Head and Shoulders	Itchy Scalp	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-081_f30a9db3-569a-2137-e053-2a95a90a78c2	37000-081	HUMAN OTC DRUG	Head and Shoulders	Itchy Scalp 2in1	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-092_f5c6a34f-d9fa-b672-e053-2a95a90add31	37000-092	HUMAN OTC DRUG	Head and Shoulders	Dry Scalp Care	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-093_f5ca90b5-3e59-15e2-e053-2995a90a63d9	37000-093	HUMAN OTC DRUG	Head and Shoulders	Dry Scalp Care 2in1	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-094_f57807c7-e309-7522-e053-2a95a90a879a	37000-094	HUMAN OTC DRUG	Head and Shoulders	Smooth and Silky	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-095_f82343b5-9e99-e40b-e053-6294a90a011e	37000-095	HUMAN OTC DRUG	Head and Shoulders	Smooth and Silky 2in1	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
37000-131_0ce0c30e-86a7-7906-e063-6394a90a284d	37000-131	HUMAN OTC DRUG	Secret Antiperspirant/Deodorant	Shower Fresh	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20110201		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	.15	g/g			N	20241231
37000-134_0ce0ff7e-6074-4a39-e063-6294a90accfb	37000-134	HUMAN OTC DRUG	Secret Antiperspirant	Powder Fresh	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20070401		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	.24	g/g			N	20241231
37000-135_0ce10f4c-10cf-9a23-e063-6394a90a2438	37000-135	HUMAN OTC DRUG	Secret Roll-On	Powder Fresh	ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20010121		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	14	g/100mL			N	20241231
37000-154_0ce1b132-1f2a-d344-e063-6394a90a57d7	37000-154	HUMAN OTC DRUG	Old Spice High Endurance	Pure Sport	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20120501		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	17	g/100g			N	20241231
37000-166_0788b944-ef59-dd6f-e063-6394a90a04dc	37000-166	HUMAN OTC DRUG	Crest Pro Health	Advanced Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20181105		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-167_0788f51e-79b0-1420-e063-6294a90a902f	37000-167	HUMAN OTC DRUG	Kids Crest	Bubblegum Rush	Sodium Fluoride	RINSE	ORAL	20181203		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37000-171_0788e40d-c3af-85e0-e063-6394a90a5678	37000-171	HUMAN OTC DRUG	Crest	Strawberry	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20181218		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-174_0788f52f-8206-1518-e063-6294a90a4f31	37000-174	HUMAN OTC DRUG	Crest	Bubblegum	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20181218		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-208_0788f671-79fd-9f8e-e063-6394a90a4b8a	37000-208	HUMAN OTC DRUG	Crest Scope	Advanced	Sodium Fluoride	RINSE	ORAL	20190101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37000-215_0788fd02-6708-acd8-e063-6294a90aa51f	37000-215	HUMAN OTC DRUG	Crest 3D White Whitening Therapy	Deep Clean Charcoal	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190101		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-275_efb89310-4c22-c47b-e053-2995a90a9ba6	37000-275	HUMAN OTC DRUG	Olay Complete All Day	Moisture Sensitive with Broad Spectrum SPF 15	Octinoxate and Zinc Oxide	CREAM	TOPICAL	20120401	20240630	OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	OCTINOXATE; ZINC OXIDE	6; 3	g/100g; g/100g			N	
37000-363_ff0be6df-611d-8f66-e053-6294a90a52e1	37000-363	HUMAN OTC DRUG	Secret Clinical	Clear Completely Clean	Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20131101	20250301	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	.2	g/g			N	
37000-376_0788e40d-c3b0-85e0-e063-6394a90a5678	37000-376	HUMAN OTC DRUG	Crest Pro-Health	Gum and Sensitivity All Day Protection	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20190109		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-377_08034a76-4f18-e56c-e063-6394a90a12d8	37000-377	HUMAN OTC DRUG	Crest Pro-Health	Gum and Sensitivity Gentle Whitening	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20190109		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-400_fc11b02d-15fc-f1a5-e053-6394a90a4803	37000-400	HUMAN OTC DRUG	Crest 3D White	Luxe Diamond Strong	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20130901		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
37000-401_0788f51e-79b1-1420-e063-6294a90a902f	37000-401	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Whitening plus Baking Soda and Peroxide with Tartar Protection	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20180123		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
37000-438_070d025c-05cf-8f7e-e063-6394a90ad541	37000-438	HUMAN OTC DRUG	Pepto-Bismol		Bismuth subsalicylate	SUSPENSION	ORAL	20180301		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
37000-439_06f991ae-6a05-d38b-e063-6394a90a0aa0	37000-439	HUMAN OTC DRUG	Pepto-Bismol	Cherry	Bismuth subsalicylate	SUSPENSION	ORAL	20180301		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
37000-440_070d0892-79d8-7e41-e063-6394a90a9cc0	37000-440	HUMAN OTC DRUG	Pepto-Bismol	Ultra	Bismuth subsalicylate	SUSPENSION	ORAL	20180301		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	525	mg/15mL			N	20241231
37000-441_070cfe37-1cb9-61ab-e063-6294a90a272d	37000-441	HUMAN OTC DRUG	Pepto-Bismol	Ultra Cherry	Bismuth subsalicylate	SUSPENSION	ORAL	20180301		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	525	mg/15mL			N	20241231
37000-445_0788d9bf-2b13-e81a-e063-6294a90ae43c	37000-445	HUMAN OTC DRUG	Crest Complete plus	Whitening plus Scope Outlast	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190909		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-451_080347ae-82de-bf77-e063-6394a90aea6d	37000-451	HUMAN OTC DRUG	Crest Pro-Health Multi-Protection	Refreshing Clean Mint	Cetylpyridinium chloride	RINSE	ORAL	20110203		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.014	g/20mL			N	20241231
37000-452_08034a42-141e-bdef-e063-6394a90ac603	37000-452	HUMAN OTC DRUG	Crest Pro-Health		Cetylpyridinium chloride	RINSE	ORAL	20110314		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.014	g/mL			N	20241231
37000-455_04132190-1b24-24e0-e063-6394a90ad26e	37000-455	HUMAN OTC DRUG	Prilosec OTC		omeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20030714		NDA	NDA021229	The Procter & Gamble Manufacturing Company	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37000-456_fc11daa1-8a74-3532-e053-6294a90a98b5	37000-456	HUMAN OTC DRUG	Crest 3DWhite Whitening Therapy	Sensitivity Care	Potassium Nitrate, Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20170712		OTC MONOGRAPH NOT FINAL	part356	The Procter & Gamble Manufacturing Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.4	mg/g; mg/g			N	20241231
37000-457_fd021bae-6117-dc6a-e053-6394a90a652c	37000-457	HUMAN OTC DRUG	Crest 3D White Whitening Therapy	Enamel Care	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20170712		OTC MONOGRAPH FINAL	part355	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-459_04131ee0-9a20-06ce-e063-6394a90ad46d	37000-459	HUMAN OTC DRUG	Prilosec OTC		OMEPRAZOLE MAGNESIUM	TABLET, DELAYED RELEASE	ORAL	20120815		NDA	NDA021229	The Procter & Gamble Manufacturing Company	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37000-469_07fe1914-0c50-9021-e063-6394a90a1d8d	37000-469	HUMAN OTC DRUG	Crest	Tartar Protection Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20031006		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-479_07fe09fd-39ad-5ffc-e063-6294a90afd0d	37000-479	HUMAN OTC DRUG	Crest Pro-Health	Intense Clean Mint	Cetylpyridinium chloride	RINSE	ORAL	20180101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.05	g/mL			N	20241231
37000-480_07fe173b-5ce1-7af6-e063-6294a90a4dd9	37000-480	HUMAN OTC DRUG	Crest Pro-Health	Intense Fresh Mint	Cetylpyridinium chloride	RINSE	ORAL	20180101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.05	g/mL			N	20241231
37000-481_f988c6c3-f42a-cde5-e053-6394a90af5cf	37000-481	HUMAN OTC DRUG	Crest	Gum Detoxify	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20170801		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-489_07fe247b-9a05-88f4-e063-6294a90ae555	37000-489	HUMAN OTC DRUG	Crest Gum Detoxify	plus Whitening	Stannous Fluoride	KIT		20180101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company						N	20241231
37000-492_07fe1cee-eae6-3d4a-e063-6294a90a03be	37000-492	HUMAN OTC DRUG	Crest Gum Detoxify	Gentle Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20180129		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-494_fc11cd9f-2fb2-c119-e053-6394a90a84d6	37000-494	HUMAN OTC DRUG	Crest Complete Multi Benefit	Whitening plus Scope Minty Fresh Gel	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20170801		OTC MONOGRAPH FINAL	part355	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-495_fc11cd9f-2fb3-c119-e053-6394a90a84d6	37000-495	HUMAN OTC DRUG	Crest	Blue Bubble Gum	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20080801		OTC MONOGRAPH FINAL	part355	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-500_078b5083-a809-df14-e063-6394a90abd3e	37000-500	HUMAN OTC DRUG	ZzzQuil	Nighttime Sleep-Aid	DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20111208		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37000-501_075e6c43-5fec-3888-e063-6294a90a1f76	37000-501	HUMAN OTC DRUG	ZzzQuil	Nighttime Sleep-Aid	Diphenhydramine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20111208		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37000-504_07fe09fd-39ae-5ffc-e063-6294a90afd0d	37000-504	HUMAN OTC DRUG	Crest Complete Multi Benefit	Whitening plus Scope Outlast	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20090908		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-505_07fe1914-0ca1-9021-e063-6394a90a1d8d	37000-505	HUMAN OTC DRUG	Crest Gum and Enamel Repair	Intensive Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20180401		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-506_07fe1914-0ca3-9021-e063-6394a90a1d8d	37000-506	HUMAN OTC DRUG	Crest Gum and Enamel Repair	Advanced Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20180401		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-511_07fe1eae-eb8d-de4b-e063-6394a90a267c	37000-511	HUMAN OTC DRUG	Kids Crest	Strawberry Rush	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20180701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-517_07d87387-7de6-fedf-e063-6394a90a8b19	37000-517	HUMAN OTC DRUG	Vicks DayQuil Severe	Cold and Flu	Acetaminophen, Phenylephine HCl, Dextromethorphan Hydrobromide, and Guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20180710		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-518_0aaeaa08-d65f-cb12-e063-6394a90a9163	37000-518	HUMAN OTC DRUG	Vicks NyQuil Severe	Cold and Flu	Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, and Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20180710		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-523_08b52c38-cf02-9ae6-e063-6294a90a02c1	37000-523	HUMAN OTC DRUG	NyQuil Severe plus Vicks VapoCool	Cold and Flu	Acetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide	TABLET, COATED	ORAL	20180801		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-524_08b52ade-593b-c69d-e063-6294a90adc5c	37000-524	HUMAN OTC DRUG	DayQuil Severe plus Vicks VapoCool	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20180801		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-535_070d0fc2-c07b-5f13-e063-6294a90a877d	37000-535	HUMAN OTC DRUG	Pepto Bismol	Liquicaps	Bismuth subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20180301		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
37000-537_0b3cb53e-1d79-f343-e063-6394a90a17ca	37000-537	HUMAN OTC DRUG	Pepto Bismol	Diarrhea Liquicaps	Bismuth subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20180301	20260630	OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	262	mg/1			N	
37000-538_0b38c13a-bc61-c3ab-e063-6394a90a0b5d	37000-538	HUMAN OTC DRUG	Pepto	Diarrhea	Bismuth subsalicylate	SUSPENSION	ORAL	20180301	20260630	OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	525	mg/30mL			N	
37000-576_0802f2ef-d5ae-d9ac-e063-6294a90ab0a1	37000-576	HUMAN OTC DRUG	Crest	Gum Care	Cetylpyridinium chloride	RINSE	ORAL	20180807		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.014	g/mL			N	20241231
37000-597_070e804e-bf92-5804-e063-6394a90ab38c	37000-597	HUMAN OTC DRUG	Vicks VapoCOOL	Severe WINTERFROST	Menthol	LOZENGE	ORAL	20171229		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	MENTHOL	20	mg/1			N	20241231
37000-598_06f991ae-6a09-d38b-e063-6394a90a0aa0	37000-598	HUMAN OTC DRUG	Vicks ZzzQuil	NIGHT PAIN NIGHTTIME SLEEP-AID PAIN RELIEVER	Diphenhydramine HCl, Acetaminophen	LIQUID	ORAL	20200601		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37000-601_f392248e-bb21-35f5-e053-2995a90a7bde	37000-601	HUMAN OTC DRUG	Safeguard	Antibacterial Foaming	Benzalkonium Chloride	SOAP	TOPICAL	20100701		OTC MONOGRAPH FINAL	M005	The Procter & Gamble Manufacturing Company	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
37000-602_f3922a5a-f2e2-57e3-e053-2995a90a3a70	37000-602	HUMAN OTC DRUG	Safeguard	Antibacterial E2 Foaming	Benzalkonium Chloride	SOAP	TOPICAL	20100701		OTC MONOGRAPH FINAL	M005	The Procter & Gamble Manufacturing Company	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
37000-603_0310a02b-4c4f-cb55-e063-6394a90ab94c	37000-603	HUMAN OTC DRUG	Safeguard	Hand Sanitizer	Alcohol	GEL	TOPICAL	20100701		OTC MONOGRAPH NOT FINAL	part333E	The Procter & Gamble Manufacturing Company	ALCOHOL	64	g/100mL			N	20241231
37000-604_fd026a43-7c2e-6db7-e053-6394a90a33dd	37000-604	HUMAN OTC DRUG	Crest Pro-Health	With a Touch of Scope	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20170617		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-616_0e76cd12-9f3b-c98f-e063-6394a90ad9fb	37000-616	HUMAN OTC DRUG	Dawn Ultra Antibacterial Hand	Apple Blossom Scent	Chloroxylenol	SOAP	TOPICAL	20140707		OTC MONOGRAPH DRUG	M003	The Procter & Gamble Manufacturing Company	CHLOROXYLENOL	.3	g/100mL			N	20251231
37000-617_0e8a911a-4cc6-c38d-e063-6394a90afb17	37000-617	HUMAN OTC DRUG	Dawn Ultra Antibacterial Hand	Orange Scent	Chloroxylenol	SOAP	TOPICAL	20140707		OTC MONOGRAPH DRUG	M003	The Procter & Gamble Manufacturing Company	CHLOROXYLENOL	.3	g/100mL			N	20251231
37000-680_07e9cf29-1386-c4a1-e063-6394a90a347c	37000-680	HUMAN OTC DRUG	Vicks VapoDrops	Cough Relief	Menthol	LOZENGE	ORAL	20090430	20240229	OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	MENTHOL	3.3	mg/1			N	
37000-712_079b3675-615f-1aac-e063-6394a90abb95	37000-712	HUMAN OTC DRUG	Vicks childrens	Cough Congestion Night	Phenylephrine Hydrochloride and Diphenhydramine Hydrochloride	LIQUID	ORAL	20190422		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	12.5; 5	mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-759_079b569d-fc3e-e36b-e063-6294a90a6378	37000-759	HUMAN OTC DRUG	Vicks Childrens	Cold Multi Symptom	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20190423	20250203	OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
37000-810_07de9f34-aa3c-8453-e063-6394a90aeb49	37000-810	HUMAN OTC DRUG	Vicks DayQuil	Severe Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20130722		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-812_07dea580-b714-3258-e063-6294a90afbb4	37000-812	HUMAN OTC DRUG	Vicks NyQuil	Severe Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20130722		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-814_07da7322-12fa-2c68-e063-6394a90a57f0	37000-814	HUMAN OTC DRUG	Vicks DayQuil and Vicks NyQuil	Severe Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and doxylamine succinate	KIT		20130722		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
37000-815_07d66fb2-f4d1-479c-e063-6394a90a5e91	37000-815	HUMAN OTC DRUG	Vicks NyQuil	Severe Cold and Flu	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and phenylephrine hydrochloride	SOLUTION	ORAL	20140721		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-822_079e1875-472d-5711-e063-6294a90a5846	37000-822	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Plus Scope	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20110701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
37000-823_079e21a0-89cf-1f42-e063-6394a90aa9d6	37000-823	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Tartar Control Whitening Plus Scope	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20110701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
37000-826_079e0819-6b5a-f6fd-e063-6294a90ae92e	37000-826	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Whitening Plus Cinnamon Expressions	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20110701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
37000-828_079dfc9c-eb11-1e24-e063-6294a90a92ba	37000-828	HUMAN OTC DRUG	Crest Complete Multi-benefit	Tartar Control Whitening Plus Scope	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20110701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.1	mg/g			N	20241231
37000-839_079e1875-4732-5711-e063-6294a90a5846	37000-839	HUMAN OTC DRUG	Kids Crest	Bubblegum Flavor	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20110401		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-843_079e21a0-89d2-1f42-e063-6394a90aa9d6	37000-843	HUMAN OTC DRUG	Crest Pro-Health	Clinical	Cetylpyridinium chloride	RINSE	ORAL	20110220		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.02	g/20mL			N	20241231
37000-853_079e0819-6b5c-f6fd-e063-6294a90ae92e	37000-853	HUMAN OTC DRUG	Crest 3D White		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20140204		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-856_06fa0b74-c933-8746-e063-6394a90a8099	37000-856	HUMAN OTC DRUG	Crest Pro-Health HD		Stannous Fluoride	KIT		20140315		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company						N	20241231
37000-862_079e21a0-89da-1f42-e063-6394a90aa9d6	37000-862	HUMAN OTC DRUG	Crest 3D White Luxe	Diamond Strong	Sodium Fluoride	RINSE	ORAL	20150219		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37000-863_079e140a-b3a0-1c2e-e063-6394a90a8491	37000-863	HUMAN OTC DRUG	Crest 3D White Brilliance	Daily Cleansing and Whitening System	Stannous Fluoride	KIT		20150205		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company						N	20241231
37000-865_fc11d569-aa9a-e383-e053-6394a90a3424	37000-865	HUMAN OTC DRUG	Crest Pro-Health	Advanced w/Extra Deep Clean	Sodium Fluoride	RINSE	ORAL	20150720		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37000-866_07d4e51d-5334-4028-e063-6294a90ad443	37000-866	HUMAN OTC DRUG	Crest Pro-Health	Advanced w/Extra Deep Clean	Sodium Fluoride	RINSE	ORAL	20160729		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37000-867_07d4c69c-2c5a-4126-e063-6394a90a850c	37000-867	HUMAN OTC DRUG	Crest Pro-Health	Advanced w/Extra Whitening	Sodium Fluoride	RINSE	ORAL	20150720		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37000-868_07d531c5-c3cf-35c1-e063-6294a90a0374	37000-868	HUMAN OTC DRUG	Crest	Fresh and White	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20150309		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-873_07d56611-c14a-897c-e063-6394a90a8b4f	37000-873	HUMAN OTC DRUG	Crest 3D White	Brilliance	sodium fluoride	PASTE, DENTIFRICE	DENTAL	20150706		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
37000-875_07ea0dc0-3c26-494e-e063-6294a90a2e44	37000-875	HUMAN OTC DRUG	Crest 3D White	Arctic Fresh	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20160118		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-876_07ea098f-0250-21d5-e063-6294a90a3be5	37000-876	HUMAN OTC DRUG	Crest 3D White	Radiant Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20160118		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-880_07ea14a6-e9ca-0ced-e063-6394a90ad25e	37000-880	HUMAN OTC DRUG	Crest Pro-Health Advanced		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20161229		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
37000-882_07ea0f33-ca61-4b08-e063-6294a90a02dc	37000-882	HUMAN OTC DRUG	Crest Pro-Health		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20161219		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-885_090587e1-9632-59b2-e063-6294a90a6f32	37000-885	HUMAN OTC DRUG	Crest Pro-Health	Extra Whitening Power	Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20160101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
37000-888_07ea187d-b3d6-16a6-e063-6394a90a13e4	37000-888	HUMAN OTC DRUG	Crest Pro-Health		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20161219		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-891_07ea4568-cee9-c585-e063-6294a90ac984	37000-891	HUMAN OTC DRUG	Crest Pro-Health Advanced		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20161229		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
37000-892_07ea4568-ceea-c585-e063-6294a90ac984	37000-892	HUMAN OTC DRUG	Crest Pro-Health Advanced		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20161229		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
37000-896_fc11cd9f-2fc1-c119-e053-6394a90a84d6	37000-896	HUMAN OTC DRUG	Kids Crest	Strawberry Rush	Sodium Fluoride	RINSE	ORAL	20171215		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37000-897_f8225acc-3cc8-8fa7-e053-6294a90a7027	37000-897	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Extra Whitening plus Scope Advanced Freshness	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20171226		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-898_f832b291-30b1-1273-e053-6294a90af75b	37000-898	HUMAN OTC DRUG	Crest Sensitivity	Whitening plus Scope	Sodium Fluoride and Potassium Nitrate	PASTE, DENTIFRICE	DENTAL	20180101		OTC MONOGRAPH NOT FINAL	part356	The Procter & Gamble Manufacturing Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.4	mg/g; mg/g			N	20241231
37000-899_fd0300a2-0a61-326c-e053-6394a90a4531	37000-899	HUMAN OTC DRUG	Crest Sensitvity	Complete Protection	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20180116		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
37000-916_07ea6a8d-4030-0c5e-e063-6294a90a4a6e	37000-916	HUMAN OTC DRUG	Crest 3D White	Brilliance Blast	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20180701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
37000-925_08034a42-141d-bdef-e063-6394a90ac603	37000-925	HUMAN OTC DRUG	Burts Bees	Extra White Zen Peppermint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190109		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
37000-928_079b699b-fbaa-0136-e063-6294a90a1447	37000-928	HUMAN OTC DRUG	Vicks VapoCool	Sore Throat	Benzocaine and Menthol	LIQUID	ORAL	20191009		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	BENZOCAINE; MENTHOL	5; 1	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37000-931_fd033a3c-74cb-f8ec-e053-6294a90aa7a8	37000-931	HUMAN OTC DRUG	Crest Pro-Health	Gum and Sensitivity Gentle Cleaning	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20190701		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-932_07753de0-d2d2-05bc-e063-6394a90a5568	37000-932	HUMAN OTC DRUG	Crest 3D White	Stain Eraser Icy Clean Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-934_07ea14a6-e9c9-0ced-e063-6394a90ad25e	37000-934	HUMAN OTC DRUG	Vicks DayQuil Severe and Vicks NyQuil Severe	Cold and Flu	Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, Guaifenesin and Doxylamine Succinate	KIT		20190704		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
37000-935_079bb7e2-552d-cf0e-e063-6394a90a74c8	37000-935	HUMAN OTC DRUG	Vicks VapoCool	Sore Throat	Benzocaine and Menthol	LOZENGE	ORAL	20191009		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	BENZOCAINE; MENTHOL	15; 20	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37000-938_0811cfb8-2863-8528-e063-6294a90ad836	37000-938	HUMAN OTC DRUG	Crest 3D White	Stain Shield	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
37000-943_0784bc2b-c06d-7d2b-e063-6394a90a4534	37000-943	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Whitening plus Cinnamon Expressions	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-944_080348e9-9454-b6fc-e063-6294a90a401e	37000-944	HUMAN OTC DRUG	Crest 3D White	Deep Clean	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-945_07851937-ed1a-f0ab-e063-6294a90a14e8	37000-945	HUMAN OTC DRUG	Crest 3D White	Charcoal	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190701		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-946_07852658-ea17-0b48-e063-6394a90afa88	37000-946	HUMAN OTC DRUG	Crest complete plus	Whitening Deep Clean	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190801		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
37000-947_07851937-ed1b-f0ab-e063-6294a90a14e8	37000-947	HUMAN OTC DRUG	Crest Complete plus	Whitening Intense Freshness	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190801		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
37000-948_08034a76-4f17-e56c-e063-6394a90a12d8	37000-948	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Whitening Scope Outlast	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190801		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
37000-949_0785234b-7460-f0cb-e063-6294a90ace75	37000-949	HUMAN OTC DRUG	Crest Pro-Health	Gum and Breath Purify	Cetylpyridinium chloride	RINSE	ORAL	20200131		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.014	g/20mL			N	20241231
37000-950_07d86edf-0363-dd5d-e063-6294a90a1349	37000-950	HUMAN OTC DRUG	Vicks Sinex Severe	All in One Sinus	Acetaminophen, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20180710		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-951_07d86448-2326-e5ae-e063-6294a90a3d61	37000-951	HUMAN OTC DRUG	Vicks Sinex Severe	All in One Sinus Mucus	Acetaminophen, Phenylephrine HCl, Guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20180710		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37000-952_07851937-ed1e-f0ab-e063-6294a90a14e8	37000-952	HUMAN OTC DRUG	Burts Bees	Charcoal Peppermint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200101		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
37000-954_07ea4568-cef0-c585-e063-6294a90ac984	37000-954	HUMAN OTC DRUG	Crest 3D White	Ultra	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-955_078510e1-1ce5-58f4-e063-6294a90a06fb	37000-955	HUMAN OTC DRUG	Crest Complete plus	Extra Whitening with Tartar Protection	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-956_07853ef8-152e-63dd-e063-6394a90a26c6	37000-956	HUMAN OTC DRUG	Crest Complete plus	Whitening Cinnamon Expressions	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-958_06fd57fc-7f75-28bd-e063-6394a90a17c5	37000-958	HUMAN OTC DRUG	Crest Pro-Health	Pro Active Defense Whole Mouth Protection	Sodium Fluoride	RINSE	ORAL	20200131		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	2.2	mg/10mL			N	20241231
37000-959_079b5b51-63f1-ebfc-e063-6394a90a731f	37000-959	HUMAN OTC DRUG	Vicks Jarabe	Cough Congestion	Dextromethorphan HBr and Guaifenesin	LIQUID	ORAL	20200323		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/7.5mL; mg/7.5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37000-962_07ec67e8-a3ed-a416-e063-6294a90a881e	37000-962	HUMAN OTC DRUG	Oral B Mouth Sore	Special Care Rinse	Sodium Fluoride	RINSE	ORAL	20200102		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	HYDROGEN PEROXIDE	.03	mL/20mL			N	20241231
37000-963_07ec695c-c881-0fa4-e063-6394a90a1bd9	37000-963	HUMAN OTC DRUG	Crest Pro Health Gum and Breath Purify	Deep Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20200107		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-964_07856f2f-be25-034d-e063-6294a90a113c	37000-964	HUMAN OTC DRUG	Crest Pro Health Gum and Breath Purify	Healthy White	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20200107		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-965_078559ad-26e6-f477-e063-6394a90a959a	37000-965	HUMAN OTC DRUG	Burts Bees	Charcoal Peppermint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200228		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
37000-966_07856f2f-be27-034d-e063-6294a90a113c	37000-966	HUMAN OTC DRUG	Crest 3D White Whitening Therapy	Charcoal with Tea Tree Oil	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20200102		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-967_078559ad-26e7-f477-e063-6394a90a959a	37000-967	HUMAN OTC DRUG	Crest 3D White Whitening Therapy	Charcoal with Ginger Oil	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20200102		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-972_078556ab-b32d-7ced-e063-6394a90a9bef	37000-972	HUMAN OTC DRUG	Native	Charcoal	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200101		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
37000-973_07857381-74d8-21ae-e063-6294a90a4172	37000-973	HUMAN OTC DRUG	Native	Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200101		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
37000-974_078b733e-0901-d25b-e063-6294a90a2e4b	37000-974	HUMAN OTC DRUG	Vicks ZzzQuil	Night Pain	Diphenhydramine Hydrochloride and Acetaminophen	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37000-976_07853ef8-1531-63dd-e063-6394a90a26c6	37000-976	HUMAN OTC DRUG	Crest Pro-Health	Pro Active Defense Whole Mouth Clean	Cetylpyridinium chloride	RINSE	ORAL	20200131		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.014	g/20mL			N	20241231
37000-977_07857a1b-4aa2-643b-e063-6394a90aa799	37000-977	HUMAN OTC DRUG	Crest 3D White Whitening Therapy	Gentle Clean Charcoal with Hemp Seed Oil	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20200701		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-978_078556ab-b32e-7ced-e063-6394a90a9bef	37000-978	HUMAN OTC DRUG	Crest Mystic	Enchanted Strawberry	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-979_078616b3-9cc0-f4c5-e063-6294a90a1778	37000-979	HUMAN OTC DRUG	Crest Mystic	Magical Bubblegum	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-980_07861a26-d918-f869-e063-6294a90a5559	37000-980	HUMAN OTC DRUG	Burts Bees	Kids Strawberry Splash	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201218		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
37000-981_080357d4-69ec-e795-e063-6394a90af25a	37000-981	HUMAN OTC DRUG	Kids Crest	Pure Strawberry	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-982_07748d10-b324-1b5c-e063-6394a90ab245	37000-982	HUMAN OTC DRUG	Crest	Splash	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-983_07864893-6505-70ce-e063-6294a90a0d68	37000-983	HUMAN OTC DRUG	Crest Complete Plus	Scope Outlast	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-984_07ec735e-0dd6-1054-e063-6394a90af068	37000-984	HUMAN OTC DRUG	Crest Complete Plus	3 in 1	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-987_07861a26-d919-f869-e063-6294a90a5559	37000-987	HUMAN OTC DRUG	Crest Pro-Health Advanced	Enamel Restore	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
37000-988_07861a26-d91a-f869-e063-6294a90a5559	37000-988	HUMAN OTC DRUG	Crest Pro-Health Advanced	with a touch of Scope	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
37000-989_07861a26-d91b-f869-e063-6294a90a5559	37000-989	HUMAN OTC DRUG	Crest 3D White	Brilliance Charcoal	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-990_07864893-6506-70ce-e063-6294a90a0d68	37000-990	HUMAN OTC DRUG	Crest Premium Plus	Scope Dual Blast Active Foam	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-991_07864f87-188e-954c-e063-6394a90a5405	37000-991	HUMAN OTC DRUG	Crest Premium Plus	Scope Outlast Active Foam	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-992_08033e75-e85e-bf9f-e063-6394a90a2a54	37000-992	HUMAN OTC DRUG	Crest Premium Plus	Anti-Bacterial	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
37000-993_07864893-6507-70ce-e063-6294a90a0d68	37000-993	HUMAN OTC DRUG	Crest Premium Plus	Advanced Whitening Active Foam	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-994_0788b944-ef58-dd6f-e063-6394a90a04dc	37000-994	HUMAN OTC DRUG	Crest Premium Plus	Deep Clean Active Foam	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210107		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
37000-995_080308f4-a974-06a7-e063-6294a90ab956	37000-995	HUMAN OTC DRUG	Crest Premium Plus	Sensitivity Active Foam	Sodium Fluoride and Potassium Nitrate	PASTE, DENTIFRICE	DENTAL	20210107		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.4	mg/g; mg/g			N	20241231
37000-996_070fd2ef-d5cc-1bbd-e063-6394a90a8802	37000-996	HUMAN OTC DRUG	Pepto Bismol	Chews	Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20200901		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
37000-997_078ab558-5f60-e466-e063-6394a90ad5a4	37000-997	HUMAN OTC DRUG	Vicks Formula 44	Cough Drops	Menthol	LOZENGE	ORAL	20201130		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	MENTHOL	5.8	mg/1			N	20241231
37012-004_80820bf9-3c72-48c0-9128-65ad2041c9be	37012-004	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20110615		OTC MONOGRAPH FINAL	part355	Shopko Stores Operating Co.LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
37012-069_5b823c1a-329d-4def-884b-78f38e3ebea2	37012-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	19901215		OTC MONOGRAPH FINAL	part347	Shopko	PETROLATUM	1	g/g			N	20241231
37012-072_189c49a6-a650-4a31-a3fd-8106b79e6a04	37012-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL	MOUTHWASH	ORAL	20080108		OTC MONOGRAPH NOT FINAL	part348	Shopko	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37012-098_b213a305-3bf2-46da-bf38-d565a9169074	37012-098	HUMAN OTC DRUG	Skopko Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Skopko	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
37012-213_8a4d137e-efbb-42c3-97c6-d173f2cf0aa5	37012-213	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20110602		OTC MONOGRAPH FINAL	part355	Shopko Stores Operating Co., LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
37012-239_f3372e1d-a50e-430c-8da8-1ac7fc362e45	37012-239	HUMAN OTC DRUG	Allergy Relief-D	24 Hour	Loratadine and Pseudoephedrine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20160301	20240531	ANDA	ANDA075706	Shopko Stores Operating Co., LLC.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
37012-299_7224ad8e-df55-4641-b2ee-07443b209c6d	37012-299	HUMAN OTC DRUG	Antiseptic		Cetylpyridinium chloride	MOUTHWASH	ORAL	20090813		OTC MONOGRAPH NOT FINAL	part356	Shopko Stores Operating	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
37012-318_96c6230c-1e40-4ece-a057-a2a351450628	37012-318	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	19910109		OTC MONOGRAPH NOT FINAL	part356	Shopko Operating Co., LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37012-370_18fe898e-ee90-4332-b08d-df9b35a18ce6	37012-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20130315		OTC MONOGRAPH NOT FINAL	part333A	ShopKo Stores Operating Co., LLC	ALCOHOL	70	mL/100mL			N	20241231
37012-435_a30f768c-dd7a-44f9-ad95-0dce7888d94f	37012-435	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	LIQUID	ORAL	20150401		OTC MONOGRAPH FINAL	part355	ShopKo	SODIUM FLUORIDE	.2	mg/mL			N	20241231
37012-439_523608f5-a6f6-4beb-85c0-3f10224daef1	37012-439	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohl	LIQUID	TOPICAL	20130102		OTC MONOGRAPH NOT FINAL	part333A	Shopko Stores Operating Co., LLC	ALCOHOL	616	mg/mL			N	20241231
37012-482_b8188286-e10b-4abb-a245-35a096c1287e	37012-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	19820715		OTC MONOGRAPH FINAL	part355	ShopKo Stores Operating., LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37012-602_fcee01e3-a335-410c-a8c5-0e862036bc92	37012-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20090605		OTC MONOGRAPH NOT FINAL	part334	ShopKo Stores Operating Co., LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37012-664_e2798895-1162-4693-ae5b-a8e1866fbba1	37012-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20080102		OTC MONOGRAPH NOT FINAL	part356	Shopko Store Operating Co, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37012-727_530d5715-9186-47c3-bbe2-f223778d4910	37012-727	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20181231	20240229	ANDA	ANDA207342	Shopko Stores Operating Co., LLC.	GUAIFENESIN	1200	mg/1			N	
37012-728_4bc5f122-3e71-4222-9aea-d47f8e6ff456	37012-728	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20181231	20240531	ANDA	ANDA207342	Shopko Stores Operating Co., LLC.	GUAIFENESIN	600	mg/1			N	
37012-810_f348ef29-0a40-490a-b003-b002a1b5b46d	37012-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20080102		OTC MONOGRAPH NOT FINAL	part333A	Shopko Stores Operating Co	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
37012-822_9dea3797-c29f-4feb-ac36-8d2509eea6da	37012-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20080108		OTC MONOGRAPH FINAL	part346	Shopko Stores Operating Co., LLC	WITCH HAZEL	979	mg/mL			N	20241231
37012-831_e8dc0c1c-b41b-4ea1-8249-94355741e59d	37012-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20080102		OTC MONOGRAPH NOT FINAL	part334	Shopko Stores Operating Co., LLC	MINERAL OIL	999	mg/mL			N	20241231
37012-871_a8480a5a-7010-4d78-96cb-565751932ad4	37012-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20090122		OTC MONOGRAPH NOT FINAL	part333A	Shopko Stores Operating Co, LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
37205-024_e42a41ce-14a2-6abb-e053-2a95a90a9216	37205-024	HUMAN OTC DRUG	LEADER Castor		Castor Oil	OIL	ORAL	20120315	20240229	OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	CASTOR OIL	1	mg/mL			N	
37205-378_50612f6b-c83f-451b-a2c0-09d9a542718f	37205-378	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	Cardinal Health	LORATADINE	5	mg/5mL			N	20241231
37205-583_9949ea76-b979-4969-80dd-5f17d586638b	37205-583	HUMAN OTC DRUG	Miconazole 3 Combination Pack		miconazole nitrate	KIT	VAGINAL	20021202		ANDA	ANDA074926	Cardinal Health (Leader) 37205						N	20241231
37205-589_e4de4653-3527-47f5-b049-b49271d5cee9	37205-589	HUMAN OTC DRUG	Miconazole 3 Combination Pack		miconazole nitrate	KIT	VAGINAL	20010202		ANDA	ANDA074926	Cardinal Health (Leader) 37205						N	20241231
37205-721_ea2d3214-396d-df50-e053-2995a90aaa1e	37205-721	HUMAN OTC DRUG	Leader	Baby Sunscreen SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-723_d60c092f-9a12-d5bf-e053-2995a90a23c8	37205-723	HUMAN OTC DRUG	Leader Kids	SPF 50 Sunscreen	Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	AEROSOL, SPRAY	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-725_ea2d89d3-9720-5e27-e053-2a95a90a5d8b	37205-725	HUMAN OTC DRUG	Leader	Sport Sunscreen SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-726_d56a7dfc-78d5-4022-e053-2995a90acb50	37205-726	HUMAN OTC DRUG	Leader	Sport SPF 30	Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	AEROSOL, SPRAY	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-728_ea2d9a8d-9d98-70bf-e053-2a95a90a3dec	37205-728	HUMAN OTC DRUG	Leader	General Protection Sunscreen SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 105; 50; 20; 20	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-729_ea2db986-722d-7f1a-e053-2a95a90a7286	37205-729	HUMAN OTC DRUG	Leader	General Protection Sunscreen SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-731_ea2db986-723c-7f1a-e053-2a95a90a7286	37205-731	HUMAN OTC DRUG	Leader	General Protection SPF 30	Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	AEROSOL, SPRAY	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-732_ea2dd7a0-7ce7-0901-e053-2a95a90ae7be	37205-732	HUMAN OTC DRUG	Leader	General Protection SPF 70	Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	AEROSOL, SPRAY	TOPICAL	20120115		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37205-736_8dca78c2-dc75-4a97-8a89-8bc0d1fa8e1a	37205-736	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20121211	20240126	ANDA	ANDA078682	Cardinal Health (Leader) 37205	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
37205-824_93f93142-2b32-4589-904d-48290c2622e0	37205-824	HUMAN OTC DRUG	Pain Relieving		MENTHOL	GEL	TOPICAL	20120118	20241231	OTC MONOGRAPH NOT FINAL	part348	Cardinal Health	MENTHOL, UNSPECIFIED FORM	35	mg/mL			N	
37662-0001_ded91dc7-7d8f-0a52-e053-2995a90a4a67	37662-0001	HUMAN OTC DRUG	Beryllium Nitricum		Beryllium Nitricum	PELLET	ORAL	20220512		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM NITRATE	6	[hp_C]/1			N	20241231
37662-0002_ded91dc7-7d8f-0a52-e053-2995a90a4a67	37662-0002	HUMAN OTC DRUG	Beryllium Nitricum		Beryllium Nitricum	PELLET	ORAL	20220512		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM NITRATE	12	[hp_C]/1			N	20241231
37662-0003_ded91dc7-7d8f-0a52-e053-2995a90a4a67	37662-0003	HUMAN OTC DRUG	Beryllium Nitricum		Beryllium Nitricum	PELLET	ORAL	20220512		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM NITRATE	30	[hp_C]/1			N	20241231
37662-0004_ded91dc7-7d8f-0a52-e053-2995a90a4a67	37662-0004	HUMAN OTC DRUG	Beryllium Nitricum		Beryllium Nitricum	PELLET	ORAL	20220512		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM NITRATE	100	[hp_C]/1			N	20241231
37662-0005_ded91dc7-7d8f-0a52-e053-2995a90a4a67	37662-0005	HUMAN OTC DRUG	Beryllium Nitricum		Beryllium Nitricum	PELLET	ORAL	20220512		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM NITRATE	200	[hp_C]/1			N	20241231
37662-0006_ded91dc7-7d8f-0a52-e053-2995a90a4a67	37662-0006	HUMAN OTC DRUG	Beryllium Nitricum		Beryllium Nitricum	PELLET	ORAL	20220512		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM NITRATE	500	[hp_C]/1			N	20241231
37662-0007_ded91dc7-7d8f-0a52-e053-2995a90a4a67	37662-0007	HUMAN OTC DRUG	Beryllium Nitricum		Beryllium Nitricum	PELLET	ORAL	20220512		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM NITRATE	1	[hp_M]/1			N	20241231
37662-0008_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0008	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	6	[hp_C]/1			N	20241231
37662-0009_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0009	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	12	[hp_C]/1			N	20241231
37662-0010_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0010	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	30	[hp_C]/1			N	20241231
37662-0011_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0011	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	100	[hp_C]/1			N	20241231
37662-0012_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0012	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	200	[hp_C]/1			N	20241231
37662-0013_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0013	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	500	[hp_C]/1			N	20241231
37662-0014_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0014	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	1	[hp_M]/1			N	20241231
37662-0015_df2509a8-ba0d-e1b9-e053-2a95a90af056	37662-0015	HUMAN OTC DRUG	Beryllium Sulphuricum		Beryllium Sulphuricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM SULFATE TETRAHYDRATE	1	[hp_Q]/1			N	20241231
37662-0016_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0016	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	6	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0017_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0017	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	12	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0018_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0018	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	30	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0019_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0019	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	100	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0020_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0020	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	200	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0021_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0021	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	500	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0022_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0022	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	1	[hp_M]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0023_df26771d-0d69-dcbd-e053-2a95a90a8520	37662-0023	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	1	[hp_Q]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-0032_df295467-626e-6b08-e053-2a95a90adee1	37662-0032	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	6	[hp_C]/1			N	20241231
37662-0033_df295467-626e-6b08-e053-2a95a90adee1	37662-0033	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	12	[hp_C]/1			N	20241231
37662-0034_df295467-626e-6b08-e053-2a95a90adee1	37662-0034	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	30	[hp_C]/1			N	20241231
37662-0035_df295467-626e-6b08-e053-2a95a90adee1	37662-0035	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	100	[hp_C]/1			N	20241231
37662-0036_df295467-626e-6b08-e053-2a95a90adee1	37662-0036	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	200	[hp_C]/1			N	20241231
37662-0037_df295467-626e-6b08-e053-2a95a90adee1	37662-0037	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	500	[hp_C]/1			N	20241231
37662-0038_df295467-626e-6b08-e053-2a95a90adee1	37662-0038	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	1	[hp_M]/1			N	20241231
37662-0039_df295467-626e-6b08-e053-2a95a90adee1	37662-0039	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	10	[hp_M]/1			N	20241231
37662-0040_df295467-626e-6b08-e053-2a95a90adee1	37662-0040	HUMAN OTC DRUG	Calcarea Arsenicica		Calcarea Arsenicica	PELLET	ORAL	20220516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ARSENATE	1	[hp_Q]/1			N	20241231
37662-0041_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0041	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	6	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0042_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0042	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	12	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0043_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0043	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0044_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0044	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	100	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0045_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0045	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	200	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0046_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0046	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	500	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0047_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0047	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	1	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0048_df3828ff-cd22-97ca-e053-2a95a90a9c8a	37662-0048	HUMAN OTC DRUG	Calcarea Acetica		Calcarea Acetica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM ACETATE	1	[hp_Q]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0049_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0049	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	6	[hp_C]/1			N	20241231
37662-0050_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0050	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	12	[hp_C]/1			N	20241231
37662-0051_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0051	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	30	[hp_C]/1			N	20241231
37662-0052_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0052	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	100	[hp_C]/1			N	20241231
37662-0053_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0053	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	200	[hp_C]/1			N	20241231
37662-0054_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0054	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	500	[hp_C]/1			N	20241231
37662-0055_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0055	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	1	[hp_M]/1			N	20241231
37662-0056_df38e786-bb21-75d6-e053-2a95a90a86c0	37662-0056	HUMAN OTC DRUG	Calcarea Bromata		Calcarea Bromata	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM BROMATE	1	[hp_Q]/1			N	20241231
37662-0057_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0057	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	6	[hp_C]/1			N	20241231
37662-0058_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0058	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	12	[hp_C]/1			N	20241231
37662-0059_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0059	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_C]/1			N	20241231
37662-0060_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0060	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	100	[hp_C]/1			N	20241231
37662-0061_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0061	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	200	[hp_C]/1			N	20241231
37662-0062_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0062	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	500	[hp_C]/1			N	20241231
37662-0063_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0063	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	1	[hp_M]/1			N	20241231
37662-0064_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0064	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	10	[hp_M]/1			N	20241231
37662-0065_df3a8618-e6bc-17f8-e053-2995a90a17db	37662-0065	HUMAN OTC DRUG	Calcarea Carbonica		Calcarea Carbonica	PELLET	ORAL	20220517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC,	OYSTER SHELL CALCIUM CARBONATE, CRUDE	1	[hp_Q]/1			N	20241231
37662-0066_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0066	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	6	[hp_C]/1			N	20241231
37662-0067_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0067	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	12	[hp_C]/1			N	20241231
37662-0068_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0068	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	30	[hp_C]/1			N	20241231
37662-0069_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0069	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	100	[hp_C]/1			N	20241231
37662-0070_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0070	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	200	[hp_C]/1			N	20241231
37662-0071_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0071	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	500	[hp_C]/1			N	20241231
37662-0072_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0072	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	1	[hp_M]/1			N	20241231
37662-0073_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0073	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	10	[hp_M]/1			N	20241231
37662-0074_df4c44e5-e8ca-588c-e053-2a95a90a9d0b	37662-0074	HUMAN OTC DRUG	Calcarea Caustica		Calcarea Caustica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM HYDROXIDE	1	[hp_Q]/1			N	20241231
37662-0075_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0075	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-0076_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0076	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-0077_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0077	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-0078_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0078	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-0079_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0079	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-0080_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0080	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-0081_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0081	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-0082_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0082	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	10	[hp_M]/1			N	20241231
37662-0083_df4d09a9-a719-510c-e053-2995a90a3d6b	37662-0083	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM FLUORIDE	1	[hp_Q]/1			N	20241231
37662-0084_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0084	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	6	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0085_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0085	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	12	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0086_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0086	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0087_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0087	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	100	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0088_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0088	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	200	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0089_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0089	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	500	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0090_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0090	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	1	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0091_df505f8d-6e8d-9621-e053-2a95a90a277f	37662-0091	HUMAN OTC DRUG	Calcarea Iodata		Calcarea Iodata	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM IODIDE	10	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0092_df517477-164c-33cc-e053-2a95a90a2083	37662-0092	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	6	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0093_df517477-164c-33cc-e053-2a95a90a2083	37662-0093	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	12	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0094_df517477-164c-33cc-e053-2a95a90a2083	37662-0094	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0095_df517477-164c-33cc-e053-2a95a90a2083	37662-0095	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	100	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0096_df517477-164c-33cc-e053-2a95a90a2083	37662-0096	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	200	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0097_df517477-164c-33cc-e053-2a95a90a2083	37662-0097	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	500	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0098_df517477-164c-33cc-e053-2a95a90a2083	37662-0098	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	1	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0099_df517477-164c-33cc-e053-2a95a90a2083	37662-0099	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	10	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0100_df517477-164c-33cc-e053-2a95a90a2083	37662-0100	HUMAN OTC DRUG	Calcarea Muriatica		Calcarea Muriatica	PELLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM CHLORIDE	1	[hp_Q]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0101_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0101	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	6	[hp_C]/1			N	20241231
37662-0102_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0102	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	12	[hp_C]/1			N	20241231
37662-0103_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0103	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	30	[hp_C]/1			N	20241231
37662-0104_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0104	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	100	[hp_C]/1			N	20241231
37662-0105_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0105	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	200	[hp_C]/1			N	20241231
37662-0106_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0106	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	500	[hp_C]/1			N	20241231
37662-0107_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0107	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	1	[hp_M]/1			N	20241231
37662-0108_df5f64b0-f0bd-592b-e053-2995a90afec7	37662-0108	HUMAN OTC DRUG	Calcarea Nitrica		Calcarea Nitrica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM NITRITE	1	[hp_Q]/1			N	20241231
37662-0109_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0109	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	6	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0110_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0110	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	12	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0111_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0111	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0112_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0112	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	100	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0113_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0113	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	200	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0114_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0114	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	500	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0115_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0115	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	1	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0116_df616b0e-7d4d-5f67-e053-2995a90a2a99	37662-0116	HUMAN OTC DRUG	Calcarea Oxalica		Calcarea Oxalica	PELLET	ORAL	20220519		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM OXALATE MONOHYDRATE	1	[hp_Q]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0117_dfc4d969-8412-7881-e053-2995a90a3707	37662-0117	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	6	[hp_C]/1			N	20241231
37662-0118_dfc4d969-8412-7881-e053-2995a90a3707	37662-0118	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	12	[hp_C]/1			N	20241231
37662-0119_dfc4d969-8412-7881-e053-2995a90a3707	37662-0119	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	30	[hp_C]/1			N	20241231
37662-0120_dfc4d969-8412-7881-e053-2995a90a3707	37662-0120	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	100	[hp_C]/1			N	20241231
37662-0121_dfc4d969-8412-7881-e053-2995a90a3707	37662-0121	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	200	[hp_C]/1			N	20241231
37662-0122_dfc4d969-8412-7881-e053-2995a90a3707	37662-0122	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	500	[hp_C]/1			N	20241231
37662-0123_dfc4d969-8412-7881-e053-2995a90a3707	37662-0123	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	1	[hp_M]/1			N	20241231
37662-0124_dfc4d969-8412-7881-e053-2995a90a3707	37662-0124	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	10	[hp_M]/1			N	20241231
37662-0125_dfc4d969-8412-7881-e053-2995a90a3707	37662-0125	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRIBASIC CALCIUM PHOSPHATE	1	[hp_Q]/1			N	20241231
37662-0126_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0126	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	6	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0127_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0127	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	12	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0128_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0128	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0129_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0129	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	100	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0130_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0130	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	200	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0131_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0131	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	500	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0132_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0132	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	1	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0133_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0133	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	10	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0134_dfc69349-a757-6cd9-e053-2995a90a5e51	37662-0134	HUMAN OTC DRUG	Calcarea Silicata		Calcarea Silicata	PELLET	ORAL	20220524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SILICATE	1	[hp_Q]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0135_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0135	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	6	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0136_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0136	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	12	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0137_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0137	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0138_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0138	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	100	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0139_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0139	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	200	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0140_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0140	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	500	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0141_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0141	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	1	[hp_M]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0142_dfd9687a-8f96-0dd3-e053-2995a90af07f	37662-0142	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALCIUM SULFATE ANHYDROUS	1	[hp_Q]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37662-0143_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0143	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-0144_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0144	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-0145_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0145	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-0146_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0146	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-0147_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0147	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-0148_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0148	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-0149_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0149	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-0150_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0150	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	10	[hp_M]/1			N	20241231
37662-0151_dfda3740-aa95-a083-e053-2a95a90a83a2	37662-0151	HUMAN OTC DRUG	Calendula Officinalis		Calendula Officinalis	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_Q]/1			N	20241231
37662-0152_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0152	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0153_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0153	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0154_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0154	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0155_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0155	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0156_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0156	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0157_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0157	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0158_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0158	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0159_dfdb3bf9-0db5-37a1-e053-2a95a90abba8	37662-0159	HUMAN OTC DRUG	Capsicum Annuum		Capsicum Annuum	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSICUM	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
37662-0160_e3e1a345-0184-9cbe-e053-2a95a90adff0	37662-0160	HUMAN OTC DRUG	Acidum Carbolicum		Acidum Carbolicum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHENOL	6	[hp_C]/1			N	20241231
37662-0161_e3e1a345-0184-9cbe-e053-2a95a90adff0	37662-0161	HUMAN OTC DRUG	Acidum Carbolicum		Acidum Carbolicum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHENOL	12	[hp_C]/1			N	20241231
37662-0162_e3e1a345-0184-9cbe-e053-2a95a90adff0	37662-0162	HUMAN OTC DRUG	Acidum Carbolicum		Acidum Carbolicum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHENOL	30	[hp_C]/1			N	20241231
37662-0163_e3e1a345-0184-9cbe-e053-2a95a90adff0	37662-0163	HUMAN OTC DRUG	Acidum Carbolicum		Acidum Carbolicum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHENOL	100	[hp_C]/1			N	20241231
37662-0164_e3e1a345-0184-9cbe-e053-2a95a90adff0	37662-0164	HUMAN OTC DRUG	Acidum Carbolicum		Acidum Carbolicum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHENOL	200	[hp_C]/1			N	20241231
37662-0165_e3e1a345-0184-9cbe-e053-2a95a90adff0	37662-0165	HUMAN OTC DRUG	Acidum Carbolicum		Acidum Carbolicum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHENOL	500	[hp_C]/1			N	20241231
37662-0166_e3e1a345-0184-9cbe-e053-2a95a90adff0	37662-0166	HUMAN OTC DRUG	Acidum Carbolicum		Acidum Carbolicum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHENOL	1	[hp_M]/1			N	20241231
37662-0167_e41c0322-5723-3107-e053-2995a90aff8e	37662-0167	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	6	[hp_C]/1			N	20241231
37662-0168_e41c0322-5723-3107-e053-2995a90aff8e	37662-0168	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	12	[hp_C]/1			N	20241231
37662-0169_e41c0322-5723-3107-e053-2995a90aff8e	37662-0169	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	30	[hp_C]/1			N	20241231
37662-0170_e41c0322-5723-3107-e053-2995a90aff8e	37662-0170	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	100	[hp_C]/1			N	20241231
37662-0171_e41c0322-5723-3107-e053-2995a90aff8e	37662-0171	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	200	[hp_C]/1			N	20241231
37662-0172_e41c0322-5723-3107-e053-2995a90aff8e	37662-0172	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	500	[hp_C]/1			N	20241231
37662-0173_e41c0322-5723-3107-e053-2995a90aff8e	37662-0173	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	1	[hp_M]/1			N	20241231
37662-0174_e41c0322-5723-3107-e053-2995a90aff8e	37662-0174	HUMAN OTC DRUG	Carboneum Bromatum		Carboneum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TETRABROMOMETHANE	1	[hp_Q]/1			N	20241231
37662-0175_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0175	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	6	[hp_C]/1			N	20241231
37662-0176_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0176	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	12	[hp_C]/1			N	20241231
37662-0177_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0177	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	30	[hp_C]/1			N	20241231
37662-0178_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0178	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	100	[hp_C]/1			N	20241231
37662-0179_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0179	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	200	[hp_C]/1			N	20241231
37662-0180_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0180	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	500	[hp_C]/1			N	20241231
37662-0181_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0181	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	1	[hp_M]/1			N	20241231
37662-0182_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0182	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	10	[hp_M]/1			N	20241231
37662-0183_dfdce86b-5e38-caa9-e053-2a95a90a818c	37662-0183	HUMAN OTC DRUG	Carboneum Sulphuratum		Carboneum Sulphuratum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARBON DISULFIDE	1	[hp_Q]/1			N	20241231
37662-0184_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0184	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	6	[hp_C]/1			N	20241231
37662-0185_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0185	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	12	[hp_C]/1			N	20241231
37662-0186_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0186	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	30	[hp_C]/1			N	20241231
37662-0187_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0187	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	100	[hp_C]/1			N	20241231
37662-0188_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0188	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	200	[hp_C]/1			N	20241231
37662-0189_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0189	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	500	[hp_C]/1			N	20241231
37662-0190_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0190	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	1	[hp_M]/1			N	20241231
37662-0191_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0191	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	10	[hp_M]/1			N	20241231
37662-0192_dfedc54a-c97a-8db3-e053-2a95a90a1a63	37662-0192	HUMAN OTC DRUG	Carduus Marianus		Carduus Marianus	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MILK THISTLE	1	[hp_Q]/1			N	20241231
37662-0201_dfefc58e-9d36-7a15-e053-2995a90a360b	37662-0201	HUMAN OTC DRUG	Castoreum		Castoreum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CASTOR FIBER SCENT GLAND SECRETION	6	[hp_C]/1			N	20241231
37662-0202_dfefc58e-9d36-7a15-e053-2995a90a360b	37662-0202	HUMAN OTC DRUG	Castoreum		Castoreum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CASTOR FIBER SCENT GLAND SECRETION	12	[hp_C]/1			N	20241231
37662-0203_dfefc58e-9d36-7a15-e053-2995a90a360b	37662-0203	HUMAN OTC DRUG	Castoreum		Castoreum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CASTOR FIBER SCENT GLAND SECRETION	30	[hp_C]/1			N	20241231
37662-0204_dfefc58e-9d36-7a15-e053-2995a90a360b	37662-0204	HUMAN OTC DRUG	Castoreum		Castoreum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CASTOR FIBER SCENT GLAND SECRETION	100	[hp_C]/1			N	20241231
37662-0205_dfefc58e-9d36-7a15-e053-2995a90a360b	37662-0205	HUMAN OTC DRUG	Castoreum		Castoreum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CASTOR FIBER SCENT GLAND SECRETION	200	[hp_C]/1			N	20241231
37662-0206_dfefc58e-9d36-7a15-e053-2995a90a360b	37662-0206	HUMAN OTC DRUG	Castoreum		Castoreum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CASTOR FIBER SCENT GLAND SECRETION	500	[hp_C]/1			N	20241231
37662-0207_dfefc58e-9d36-7a15-e053-2995a90a360b	37662-0207	HUMAN OTC DRUG	Castoreum		Castoreum	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CASTOR FIBER SCENT GLAND SECRETION	1	[hp_M]/1			N	20241231
37662-0208_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0208	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	6	[hp_C]/1			N	20241231
37662-0209_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0209	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	12	[hp_C]/1			N	20241231
37662-0210_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0210	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	30	[hp_C]/1			N	20241231
37662-0211_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0211	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	100	[hp_C]/1			N	20241231
37662-0212_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0212	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	200	[hp_C]/1			N	20241231
37662-0213_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0213	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	500	[hp_C]/1			N	20241231
37662-0214_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0214	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	1	[hp_M]/1			N	20241231
37662-0215_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0215	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	10	[hp_M]/1			N	20241231
37662-0216_dff1eec8-4577-ddc4-e053-2a95a90af762	37662-0216	HUMAN OTC DRUG	Caulophyllum Thalictroides		Caulophyllum Thalictroides	PELLET	ORAL	20220526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAULOPHYLLUM THALICTROIDES ROOT	1	[hp_Q]/1			N	20241231
37662-0217_e0049d35-b615-56af-e053-2995a90ae769	37662-0217	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	6	[hp_C]/1			N	20241231
37662-0218_e0049d35-b615-56af-e053-2995a90ae769	37662-0218	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	12	[hp_C]/1			N	20241231
37662-0219_e0049d35-b615-56af-e053-2995a90ae769	37662-0219	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	30	[hp_C]/1			N	20241231
37662-0220_e0049d35-b615-56af-e053-2995a90ae769	37662-0220	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	100	[hp_C]/1			N	20241231
37662-0221_e0049d35-b615-56af-e053-2995a90ae769	37662-0221	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	200	[hp_C]/1			N	20241231
37662-0222_e0049d35-b615-56af-e053-2995a90ae769	37662-0222	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	500	[hp_C]/1			N	20241231
37662-0223_e0049d35-b615-56af-e053-2995a90ae769	37662-0223	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	1	[hp_M]/1			N	20241231
37662-0224_e0049d35-b615-56af-e053-2995a90ae769	37662-0224	HUMAN OTC DRUG	Ceanothus Americanus		Ceanothus Americanus	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CEANOTHUS AMERICANUS LEAF	1	[hp_Q]/1			N	20241231
37662-0225_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0225	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	6	[hp_C]/1			N	20241231
37662-0226_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0226	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	12	[hp_C]/1			N	20241231
37662-0227_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0227	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	30	[hp_C]/1			N	20241231
37662-0228_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0228	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	100	[hp_C]/1			N	20241231
37662-0229_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0229	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	200	[hp_C]/1			N	20241231
37662-0230_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0230	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	500	[hp_C]/1			N	20241231
37662-0231_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0231	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	1	[hp_M]/1			N	20241231
37662-0232_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0232	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	10	[hp_M]/1			N	20241231
37662-0233_e006125d-f766-9e04-e053-2a95a90a4d81	37662-0233	HUMAN OTC DRUG	Chamomilla		Chamomilla	PELLET	ORAL	20220527		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MATRICARIA CHAMOMILLA WHOLE	1	[hp_Q]/1			N	20241231
37662-0234_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0234	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	6	[hp_C]/1			N	20241231
37662-0235_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0235	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	12	[hp_C]/1			N	20241231
37662-0236_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0236	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	30	[hp_C]/1			N	20241231
37662-0237_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0237	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	100	[hp_C]/1			N	20241231
37662-0238_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0238	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	200	[hp_C]/1			N	20241231
37662-0239_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0239	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	500	[hp_C]/1			N	20241231
37662-0240_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0240	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	1	[hp_M]/1			N	20241231
37662-0241_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0241	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	10	[hp_M]/1			N	20241231
37662-0242_e054c02c-fada-4b68-e053-2995a90a6ced	37662-0242	HUMAN OTC DRUG	Chelidonium Majus		Chelidonium Majus	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHELIDONIUM MAJUS	1	[hp_Q]/1			N	20241231
37662-0243_e056f110-ad6e-8d3e-e053-2995a90ad3c4	37662-0243	HUMAN OTC DRUG	Chlorinum		Chlorinum	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLORINE	6	[hp_C]/1			N	20241231
37662-0244_e056f110-ad6e-8d3e-e053-2995a90ad3c4	37662-0244	HUMAN OTC DRUG	Chlorinum		Chlorinum	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLORINE	12	[hp_C]/1			N	20241231
37662-0245_e056f110-ad6e-8d3e-e053-2995a90ad3c4	37662-0245	HUMAN OTC DRUG	Chlorinum		Chlorinum	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLORINE	30	[hp_C]/1			N	20241231
37662-0246_e056f110-ad6e-8d3e-e053-2995a90ad3c4	37662-0246	HUMAN OTC DRUG	Chlorinum		Chlorinum	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLORINE	100	[hp_C]/1			N	20241231
37662-0247_e056f110-ad6e-8d3e-e053-2995a90ad3c4	37662-0247	HUMAN OTC DRUG	Chlorinum		Chlorinum	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLORINE	200	[hp_C]/1			N	20241231
37662-0248_e056f110-ad6e-8d3e-e053-2995a90ad3c4	37662-0248	HUMAN OTC DRUG	Chlorinum		Chlorinum	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLORINE	500	[hp_C]/1			N	20241231
37662-0249_e056f110-ad6e-8d3e-e053-2995a90ad3c4	37662-0249	HUMAN OTC DRUG	Chlorinum		Chlorinum	PELLET	ORAL	20220531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLORINE	1	[hp_M]/1			N	20241231
37662-0250_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0250	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	6	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0251_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0251	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	12	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0252_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0252	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	30	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0253_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0253	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	100	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0254_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0254	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	200	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0255_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0255	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	500	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0256_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0256	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	1	[hp_M]/1	Antimalarial [EPC]		N	20241231
37662-0257_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0257	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	10	[hp_M]/1	Antimalarial [EPC]		N	20241231
37662-0258_e066fe81-39e1-3e40-e053-2a95a90ac0cf	37662-0258	HUMAN OTC DRUG	Chininum Sulphuricum		Chininum Sulphuricum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUININE SULFATE	1	[hp_Q]/1	Antimalarial [EPC]		N	20241231
37662-0259_e068111e-2d56-40f2-e053-2995a90a3518	37662-0259	HUMAN OTC DRUG	Chloroformum		Chloroformum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROFORM	6	[hp_C]/1			N	20241231
37662-0260_e068111e-2d56-40f2-e053-2995a90a3518	37662-0260	HUMAN OTC DRUG	Chloroformum		Chloroformum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROFORM	12	[hp_C]/1			N	20241231
37662-0261_e068111e-2d56-40f2-e053-2995a90a3518	37662-0261	HUMAN OTC DRUG	Chloroformum		Chloroformum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROFORM	30	[hp_C]/1			N	20241231
37662-0262_e068111e-2d56-40f2-e053-2995a90a3518	37662-0262	HUMAN OTC DRUG	Chloroformum		Chloroformum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROFORM	100	[hp_C]/1			N	20241231
37662-0263_e068111e-2d56-40f2-e053-2995a90a3518	37662-0263	HUMAN OTC DRUG	Chloroformum		Chloroformum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROFORM	200	[hp_C]/1			N	20241231
37662-0264_e068111e-2d56-40f2-e053-2995a90a3518	37662-0264	HUMAN OTC DRUG	Chloroformum		Chloroformum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROFORM	500	[hp_C]/1			N	20241231
37662-0265_e068111e-2d56-40f2-e053-2995a90a3518	37662-0265	HUMAN OTC DRUG	Chloroformum		Chloroformum	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROFORM	1	[hp_M]/1			N	20241231
37662-0266_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0266	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	6	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0267_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0267	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	12	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0268_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0268	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	30	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0269_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0269	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	100	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0270_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0270	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	200	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0271_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0271	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	500	[hp_C]/1	Antimalarial [EPC]		N	20241231
37662-0272_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0272	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	1	[hp_M]/1	Antimalarial [EPC]		N	20241231
37662-0273_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0273	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	10	[hp_M]/1	Antimalarial [EPC]		N	20241231
37662-0274_e06a5ca9-e6f0-8803-e053-2a95a90a7277	37662-0274	HUMAN OTC DRUG	Chloroquinum Phos.		Chloroquinum Phos.	PELLET	ORAL	20220601		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHLOROQUINE PHOSPHATE	1	[hp_Q]/1	Antimalarial [EPC]		N	20241231
37662-0275_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0275	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	6	[hp_C]/1			N	20241231
37662-0276_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0276	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	12	[hp_C]/1			N	20241231
37662-0277_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0277	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	30	[hp_C]/1			N	20241231
37662-0278_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0278	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	100	[hp_C]/1			N	20241231
37662-0279_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0279	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	200	[hp_C]/1			N	20241231
37662-0280_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0280	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	500	[hp_C]/1			N	20241231
37662-0281_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0281	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	1	[hp_M]/1			N	20241231
37662-0282_e07b621d-4269-d3c0-e053-2a95a90ae6de	37662-0282	HUMAN OTC DRUG	Chromium Oxydatum		Chromium Oxydatum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC OXIDE	1	[hp_Q]/1			N	20241231
37662-0283_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0283	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	6	[hp_C]/1			N	20241231
37662-0284_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0284	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	12	[hp_C]/1			N	20241231
37662-0285_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0285	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	30	[hp_C]/1			N	20241231
37662-0286_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0286	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	100	[hp_C]/1			N	20241231
37662-0287_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0287	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	200	[hp_C]/1			N	20241231
37662-0288_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0288	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	500	[hp_C]/1			N	20241231
37662-0289_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0289	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	1	[hp_M]/1			N	20241231
37662-0290_e07d8748-7d6c-0d84-e053-2a95a90ad536	37662-0290	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE	1	[hp_Q]/1			N	20241231
37662-0291_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0291	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	6	[hp_C]/1			N	20241231
37662-0292_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0292	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	12	[hp_C]/1			N	20241231
37662-0293_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0293	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	30	[hp_C]/1			N	20241231
37662-0294_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0294	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	100	[hp_C]/1			N	20241231
37662-0295_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0295	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	200	[hp_C]/1			N	20241231
37662-0296_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0296	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	500	[hp_C]/1			N	20241231
37662-0297_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0297	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	1	[hp_M]/1			N	20241231
37662-0298_e07ee903-2c95-6b5e-e053-2995a90a413e	37662-0298	HUMAN OTC DRUG	Cicuta Virosa		Cicuta Virosa	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CICUTA VIROSA ROOT	10	[hp_M]/1			N	20241231
37662-0299_e08036b3-641e-6d07-e053-2a95a90aa207	37662-0299	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COFFEA ARABICA SEED, ROASTED	6	[hp_C]/1			N	20241231
37662-0300_e08036b3-641e-6d07-e053-2a95a90aa207	37662-0300	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COFFEA ARABICA SEED, ROASTED	12	[hp_C]/1			N	20241231
37662-0301_e08036b3-641e-6d07-e053-2a95a90aa207	37662-0301	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COFFEA ARABICA SEED, ROASTED	30	[hp_C]/1			N	20241231
37662-0302_e08036b3-641e-6d07-e053-2a95a90aa207	37662-0302	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COFFEA ARABICA SEED, ROASTED	100	[hp_C]/1			N	20241231
37662-0303_e08036b3-641e-6d07-e053-2a95a90aa207	37662-0303	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COFFEA ARABICA SEED, ROASTED	200	[hp_C]/1			N	20241231
37662-0304_e08036b3-641e-6d07-e053-2a95a90aa207	37662-0304	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COFFEA ARABICA SEED, ROASTED	500	[hp_C]/1			N	20241231
37662-0305_e08036b3-641e-6d07-e053-2a95a90aa207	37662-0305	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	PELLET	ORAL	20220602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COFFEA ARABICA SEED, ROASTED	1	[hp_M]/1			N	20241231
37662-0306_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0306	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	6	[hp_C]/1			N	20241231
37662-0307_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0307	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	12	[hp_C]/1			N	20241231
37662-0308_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0308	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	30	[hp_C]/1			N	20241231
37662-0309_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0309	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	100	[hp_C]/1			N	20241231
37662-0310_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0310	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	200	[hp_C]/1			N	20241231
37662-0311_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0311	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	500	[hp_C]/1			N	20241231
37662-0312_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0312	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	1	[hp_M]/1			N	20241231
37662-0313_e08eb7fa-7315-63ed-e053-2a95a90a97c6	37662-0313	HUMAN OTC DRUG	Cimicifuga Racemosa		Cimicifuga Racemosa	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK COHOSH	1	[hp_Q]/1			N	20241231
37662-0314_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0314	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-0315_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0315	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-0316_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0316	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-0317_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0317	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-0318_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0318	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-0319_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0319	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-0320_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0320	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-0321_e0912aa1-7f92-4877-e053-2995a90a5ff8	37662-0321	HUMAN OTC DRUG	Cina		Cina	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA CINA PRE-FLOWERING TOP	10	[hp_M]/1			N	20241231
37662-0322_e093713d-a0f6-cc29-e053-2995a90aa2e3	37662-0322	HUMAN OTC DRUG	Cinnabaris		Cinnabaris	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFIDE	6	[hp_C]/1			N	20241231
37662-0323_e093713d-a0f6-cc29-e053-2995a90aa2e3	37662-0323	HUMAN OTC DRUG	Cinnabaris		Cinnabaris	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFIDE	12	[hp_C]/1			N	20241231
37662-0324_e093713d-a0f6-cc29-e053-2995a90aa2e3	37662-0324	HUMAN OTC DRUG	Cinnabaris		Cinnabaris	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFIDE	30	[hp_C]/1			N	20241231
37662-0325_e093713d-a0f6-cc29-e053-2995a90aa2e3	37662-0325	HUMAN OTC DRUG	Cinnabaris		Cinnabaris	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFIDE	100	[hp_C]/1			N	20241231
37662-0326_e093713d-a0f6-cc29-e053-2995a90aa2e3	37662-0326	HUMAN OTC DRUG	Cinnabaris		Cinnabaris	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFIDE	200	[hp_C]/1			N	20241231
37662-0327_e093713d-a0f6-cc29-e053-2995a90aa2e3	37662-0327	HUMAN OTC DRUG	Cinnabaris		Cinnabaris	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFIDE	500	[hp_C]/1			N	20241231
37662-0328_e093713d-a0f6-cc29-e053-2995a90aa2e3	37662-0328	HUMAN OTC DRUG	Cinnabaris		Cinnabaris	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFIDE	1	[hp_M]/1			N	20241231
37662-0329_e0949e54-9a26-ba0c-e053-2995a90a1cb7	37662-0329	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-0330_e0949e54-9a26-ba0c-e053-2995a90a1cb7	37662-0330	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-0331_e0949e54-9a26-ba0c-e053-2995a90a1cb7	37662-0331	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-0332_e0949e54-9a26-ba0c-e053-2995a90a1cb7	37662-0332	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-0333_e0949e54-9a26-ba0c-e053-2995a90a1cb7	37662-0333	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-0334_e0949e54-9a26-ba0c-e053-2995a90a1cb7	37662-0334	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-0335_e0949e54-9a26-ba0c-e053-2995a90a1cb7	37662-0335	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20220603		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-0336_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0336	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	6	[hp_C]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0337_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0337	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	12	[hp_C]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0338_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0338	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	30	[hp_C]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0339_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0339	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	100	[hp_C]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0340_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0340	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	200	[hp_C]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0341_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0341	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	500	[hp_C]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0342_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0342	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	1	[hp_M]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0343_e0cc472a-dbac-71c3-e053-2995a90adf50	37662-0343	HUMAN OTC DRUG	Citalopram		Citalopram	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITALOPRAM	1	[hp_Q]/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
37662-0344_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0344	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	6	[hp_C]/1			N	20241231
37662-0345_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0345	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	12	[hp_C]/1			N	20241231
37662-0346_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0346	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	30	[hp_C]/1			N	20241231
37662-0347_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0347	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	100	[hp_C]/1			N	20241231
37662-0348_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0348	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	200	[hp_C]/1			N	20241231
37662-0349_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0349	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	500	[hp_C]/1			N	20241231
37662-0350_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0350	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	1	[hp_M]/1			N	20241231
37662-0351_e0ce54b3-79e5-1148-e053-2995a90a7d86	37662-0351	HUMAN OTC DRUG	Citrus Limonum		Citrus Limonum	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMON JUICE	1	[hp_Q]/1			N	20241231
37662-0352_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0352	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-0353_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0353	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-0354_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0354	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-0355_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0355	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-0356_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0356	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-0357_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0357	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-0358_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0358	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-0359_e0d00cd4-575d-f0f6-e053-2a95a90a75cb	37662-0359	HUMAN OTC DRUG	Clematis Erecta		Clematis Erecta	PELLET	ORAL	20220606		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLEMATIS RECTA FLOWERING TOP	1	[hp_Q]/1			N	20241231
37662-0360_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0360	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	6	[hp_C]/1			N	20241231
37662-0361_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0361	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	12	[hp_C]/1			N	20241231
37662-0362_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0362	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	30	[hp_C]/1			N	20241231
37662-0363_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0363	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	100	[hp_C]/1			N	20241231
37662-0364_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0364	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	200	[hp_C]/1			N	20241231
37662-0365_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0365	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	500	[hp_C]/1			N	20241231
37662-0366_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0366	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	1	[hp_M]/1			N	20241231
37662-0367_e0e014f1-1369-cf72-e053-2a95a90ad0f0	37662-0367	HUMAN OTC DRUG	Cerium Oxydatum		Cerium Oxydatum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CERIC OXIDE	1	[hp_Q]/1			N	20241231
37662-0368_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0368	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-0369_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0369	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-0370_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0370	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-0371_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0371	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-0372_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0372	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-0373_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0373	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-0374_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0374	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-0375_e0e2265c-09a2-16d1-e053-2995a90a9c97	37662-0375	HUMAN OTC DRUG	Cesium Muriaticum		Cesium Muriaticum	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CESIUM CHLORIDE	1	[hp_Q]/1			N	20241231
37662-0376_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0376	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	6	[hp_C]/1			N	20241231
37662-0377_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0377	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	12	[hp_C]/1			N	20241231
37662-0378_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0378	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	30	[hp_C]/1			N	20241231
37662-0379_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0379	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	100	[hp_C]/1			N	20241231
37662-0380_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0380	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	200	[hp_C]/1			N	20241231
37662-0381_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0381	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	500	[hp_C]/1			N	20241231
37662-0382_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0382	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	1	[hp_M]/1			N	20241231
37662-0383_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0383	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	10	[hp_M]/1			N	20241231
37662-0384_e0e3c4ba-2796-5de5-e053-2a95a90aabe2	37662-0384	HUMAN OTC DRUG	China Officinalis		China Officinalis	PELLET	ORAL	20220607		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINCHONA OFFICINALIS BARK	1	[hp_Q]/1			N	20241231
37662-0385_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0385	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	6	[hp_C]/1			N	20241231
37662-0386_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0386	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	12	[hp_C]/1			N	20241231
37662-0387_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0387	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	30	[hp_C]/1			N	20241231
37662-0388_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0388	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	100	[hp_C]/1			N	20241231
37662-0389_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0389	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	200	[hp_C]/1			N	20241231
37662-0390_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0390	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	500	[hp_C]/1			N	20241231
37662-0391_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0391	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	1	[hp_M]/1			N	20241231
37662-0392_e0f2e8cb-80a2-4f05-e053-2a95a90a0d02	37662-0392	HUMAN OTC DRUG	Chromium Bromatum		Chromium Bromatum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC BROMIDE	1	[hp_Q]/1			N	20241231
37662-0393_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0393	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	6	[hp_C]/1			N	20241231
37662-0394_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0394	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	12	[hp_C]/1			N	20241231
37662-0395_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0395	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	30	[hp_C]/1			N	20241231
37662-0396_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0396	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	100	[hp_C]/1			N	20241231
37662-0397_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0397	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	200	[hp_C]/1			N	20241231
37662-0398_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0398	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	500	[hp_C]/1			N	20241231
37662-0399_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0399	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	1	[hp_M]/1			N	20241231
37662-0400_e0f48ead-f326-6e17-e053-2995a90a4e7a	37662-0400	HUMAN OTC DRUG	Chromium Fluoratum		Chromium Fluoratum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC FLUORIDE	1	[hp_Q]/1			N	20241231
37662-0401_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0401	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0402_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0402	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0403_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0403	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0404_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0404	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0405_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0405	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0406_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0406	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0407_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0407	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0408_e0f57783-2053-a3bc-e053-2995a90a8bd2	37662-0408	HUMAN OTC DRUG	Chromium Metallicum		Chromium Metallicum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIUM	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0409_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0409	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	6	[hp_C]/1			N	20241231
37662-0410_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0410	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	12	[hp_C]/1			N	20241231
37662-0411_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0411	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	30	[hp_C]/1			N	20241231
37662-0412_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0412	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	100	[hp_C]/1			N	20241231
37662-0413_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0413	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	200	[hp_C]/1			N	20241231
37662-0414_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0414	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	500	[hp_C]/1			N	20241231
37662-0415_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0415	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	1	[hp_M]/1			N	20241231
37662-0416_e0f6769c-f8e4-09d3-e053-2995a90a97c7	37662-0416	HUMAN OTC DRUG	Chromium Muriaticum		Chromium Muriaticum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC CHLORIDE	1	[hp_Q]/1			N	20241231
37662-0417_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0417	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	6	[hp_C]/1			N	20241231
37662-0418_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0418	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	12	[hp_C]/1			N	20241231
37662-0419_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0419	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	30	[hp_C]/1			N	20241231
37662-0420_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0420	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	100	[hp_C]/1			N	20241231
37662-0421_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0421	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	200	[hp_C]/1			N	20241231
37662-0422_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0422	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	500	[hp_C]/1			N	20241231
37662-0423_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0423	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	1	[hp_M]/1			N	20241231
37662-0424_e0f83174-871a-0057-e053-2a95a90ab83d	37662-0424	HUMAN OTC DRUG	Chromium Nitricum		Chromium Nitricum	PELLET	ORAL	20220608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC NITRATE NONAHYDRATE	1	[hp_Q]/1			N	20241231
37662-0425_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0425	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	6	[hp_C]/1			N	20241231
37662-0426_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0426	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	12	[hp_C]/1			N	20241231
37662-0427_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0427	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	30	[hp_C]/1			N	20241231
37662-0428_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0428	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	100	[hp_C]/1			N	20241231
37662-0429_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0429	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	200	[hp_C]/1			N	20241231
37662-0430_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0430	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	500	[hp_C]/1			N	20241231
37662-0431_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0431	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	1	[hp_M]/1			N	20241231
37662-0432_e106918d-3ec7-4c5e-e053-2995a90ab69c	37662-0432	HUMAN OTC DRUG	Chromium Phosphoricum		Chromium Phosphoricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC PHOSPHATE	1	[hp_Q]/1			N	20241231
37662-0433_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0433	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	6	[hp_C]/1			N	20241231
37662-0434_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0434	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	12	[hp_C]/1			N	20241231
37662-0435_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0435	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	30	[hp_C]/1			N	20241231
37662-0436_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0436	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	100	[hp_C]/1			N	20241231
37662-0437_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0437	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	200	[hp_C]/1			N	20241231
37662-0438_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0438	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	500	[hp_C]/1			N	20241231
37662-0439_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0439	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	1	[hp_M]/1			N	20241231
37662-0440_e109173f-0815-0d91-e053-2a95a90a8f6c	37662-0440	HUMAN OTC DRUG	Chromium Sulphuricum		Chromium Sulphuricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHROMIC SULFATE DECAHYDRATE	1	[hp_Q]/1			N	20241231
37662-0441_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0441	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0442_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0442	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0443_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0443	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0444_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0444	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0445_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0445	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0446_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0446	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0447_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0447	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0448_e10a546c-9b10-1f78-e053-2a95a90a40d3	37662-0448	HUMAN OTC DRUG	Cobaltum Metallicum		Cobaltum Metallicum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-0449_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0449	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	6	[hp_C]/1			N	20241231
37662-0450_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0450	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	12	[hp_C]/1			N	20241231
37662-0451_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0451	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	30	[hp_C]/1			N	20241231
37662-0452_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0452	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	100	[hp_C]/1			N	20241231
37662-0453_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0453	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	200	[hp_C]/1			N	20241231
37662-0454_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0454	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	500	[hp_C]/1			N	20241231
37662-0455_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0455	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	1	[hp_M]/1			N	20241231
37662-0456_e10c57d2-e00d-536b-e053-2995a90ab77c	37662-0456	HUMAN OTC DRUG	Cobaltum Muriaticum		Cobaltum Muriaticum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CHLORIDE	1	[hp_Q]/1			N	20241231
37662-0457_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0457	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	6	[hp_C]/1			N	20241231
37662-0458_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0458	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	12	[hp_C]/1			N	20241231
37662-0459_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0459	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	30	[hp_C]/1			N	20241231
37662-0460_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0460	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	100	[hp_C]/1			N	20241231
37662-0461_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0461	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	200	[hp_C]/1			N	20241231
37662-0462_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0462	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	500	[hp_C]/1			N	20241231
37662-0463_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0463	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	1	[hp_M]/1			N	20241231
37662-0464_e10d3731-69ab-4255-e053-2995a90a29d2	37662-0464	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20220609		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	1	[hp_Q]/1			N	20241231
37662-0465_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0465	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	6	[hp_C]/1			N	20241231
37662-0466_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0466	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	12	[hp_C]/1			N	20241231
37662-0467_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0467	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	30	[hp_C]/1			N	20241231
37662-0468_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0468	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	100	[hp_C]/1			N	20241231
37662-0469_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0469	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	200	[hp_C]/1			N	20241231
37662-0470_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0470	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	500	[hp_C]/1			N	20241231
37662-0471_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0471	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	1	[hp_M]/1			N	20241231
37662-0472_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0472	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	10	[hp_M]/1			N	20241231
37662-0473_e11d2015-acb5-5f6d-e053-2a95a90a891a	37662-0473	HUMAN OTC DRUG	Cocculus Indicus		Cocculus Indicus	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAMIRTA COCCULUS SEED	1	[hp_Q]/1			N	20241231
37662-0474_e11f9e2b-f428-225f-e053-2a95a90ad825	37662-0474	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLCHICUM AUTUMNALE BULB	6	[hp_C]/1			N	20241231
37662-0475_e11f9e2b-f428-225f-e053-2a95a90ad825	37662-0475	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLCHICUM AUTUMNALE BULB	12	[hp_C]/1			N	20241231
37662-0476_e11f9e2b-f428-225f-e053-2a95a90ad825	37662-0476	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLCHICUM AUTUMNALE BULB	30	[hp_C]/1			N	20241231
37662-0477_e11f9e2b-f428-225f-e053-2a95a90ad825	37662-0477	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLCHICUM AUTUMNALE BULB	100	[hp_C]/1			N	20241231
37662-0478_e11f9e2b-f428-225f-e053-2a95a90ad825	37662-0478	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLCHICUM AUTUMNALE BULB	200	[hp_C]/1			N	20241231
37662-0479_e11f9e2b-f428-225f-e053-2a95a90ad825	37662-0479	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLCHICUM AUTUMNALE BULB	500	[hp_C]/1			N	20241231
37662-0480_e11f9e2b-f428-225f-e053-2a95a90ad825	37662-0480	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLCHICUM AUTUMNALE BULB	1	[hp_M]/1			N	20241231
37662-0481_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0481	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	6	[hp_C]/1			N	20241231
37662-0482_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0482	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	12	[hp_C]/1			N	20241231
37662-0483_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0483	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	30	[hp_C]/1			N	20241231
37662-0484_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0484	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	100	[hp_C]/1			N	20241231
37662-0485_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0485	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	200	[hp_C]/1			N	20241231
37662-0486_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0486	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	500	[hp_C]/1			N	20241231
37662-0487_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0487	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	1	[hp_M]/1			N	20241231
37662-0488_e120ae15-273e-f3cd-e053-2a95a90a9d0e	37662-0488	HUMAN OTC DRUG	Collinsonia Canadensis		Collinsonia Canadensis	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COLLINSONIA CANADENSIS ROOT	1	[hp_Q]/1			N	20241231
37662-0489_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0489	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	6	[hp_C]/1			N	20241231
37662-0490_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0490	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	12	[hp_C]/1			N	20241231
37662-0491_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0491	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	30	[hp_C]/1			N	20241231
37662-0492_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0492	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	100	[hp_C]/1			N	20241231
37662-0493_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0493	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	200	[hp_C]/1			N	20241231
37662-0494_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0494	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	500	[hp_C]/1			N	20241231
37662-0495_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0495	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	1	[hp_M]/1			N	20241231
37662-0496_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0496	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	10	[hp_M]/1			N	20241231
37662-0497_e12191cb-db2b-2f9d-e053-2a95a90a7110	37662-0497	HUMAN OTC DRUG	Coccus Cacti		Coccus Cacti	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PROTORTONIA CACTI	1	[hp_Q]/1			N	20241231
37662-0498_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0498	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0499_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0499	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0500_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0500	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0501_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0501	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0502_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0502	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0503_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0503	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0504_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0504	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0505_e1591c16-08b1-05fb-e053-2a95a90a9995	37662-0505	HUMAN OTC DRUG	Coffea Cruda		Coffea Cruda	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARABICA COFFEE BEAN	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-0506_e15b7eb3-dbd1-b03c-e053-2a95a90a3e34	37662-0506	HUMAN OTC DRUG	Cresolum		Cresolum	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRESOL	6	[hp_C]/1			N	20241231
37662-0507_e15b7eb3-dbd1-b03c-e053-2a95a90a3e34	37662-0507	HUMAN OTC DRUG	Cresolum		Cresolum	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRESOL	12	[hp_C]/1			N	20241231
37662-0508_e15b7eb3-dbd1-b03c-e053-2a95a90a3e34	37662-0508	HUMAN OTC DRUG	Cresolum		Cresolum	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRESOL	30	[hp_C]/1			N	20241231
37662-0509_e15b7eb3-dbd1-b03c-e053-2a95a90a3e34	37662-0509	HUMAN OTC DRUG	Cresolum		Cresolum	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRESOL	100	[hp_C]/1			N	20241231
37662-0510_e15b7eb3-dbd1-b03c-e053-2a95a90a3e34	37662-0510	HUMAN OTC DRUG	Cresolum		Cresolum	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRESOL	200	[hp_C]/1			N	20241231
37662-0511_e15b7eb3-dbd1-b03c-e053-2a95a90a3e34	37662-0511	HUMAN OTC DRUG	Cresolum		Cresolum	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRESOL	500	[hp_C]/1			N	20241231
37662-0512_e15b7eb3-dbd1-b03c-e053-2a95a90a3e34	37662-0512	HUMAN OTC DRUG	Cresolum		Cresolum	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRESOL	1	[hp_M]/1			N	20241231
37662-0513_e15c8fc4-f44c-5922-e053-2995a90a6e41	37662-0513	HUMAN OTC DRUG	Croton Tiglium		Croton Tiglium	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CROTON TIGLIUM SEED	6	[hp_C]/1			N	20241231
37662-0514_e15c8fc4-f44c-5922-e053-2995a90a6e41	37662-0514	HUMAN OTC DRUG	Croton Tiglium		Croton Tiglium	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CROTON TIGLIUM SEED	12	[hp_C]/1			N	20241231
37662-0515_e15c8fc4-f44c-5922-e053-2995a90a6e41	37662-0515	HUMAN OTC DRUG	Croton Tiglium		Croton Tiglium	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CROTON TIGLIUM SEED	30	[hp_C]/1			N	20241231
37662-0516_e15c8fc4-f44c-5922-e053-2995a90a6e41	37662-0516	HUMAN OTC DRUG	Croton Tiglium		Croton Tiglium	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CROTON TIGLIUM SEED	100	[hp_C]/1			N	20241231
37662-0517_e15c8fc4-f44c-5922-e053-2995a90a6e41	37662-0517	HUMAN OTC DRUG	Croton Tiglium		Croton Tiglium	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CROTON TIGLIUM SEED	200	[hp_C]/1			N	20241231
37662-0518_e15c8fc4-f44c-5922-e053-2995a90a6e41	37662-0518	HUMAN OTC DRUG	Croton Tiglium		Croton Tiglium	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CROTON TIGLIUM SEED	500	[hp_C]/1			N	20241231
37662-0519_e15c8fc4-f44c-5922-e053-2995a90a6e41	37662-0519	HUMAN OTC DRUG	Croton Tiglium		Croton Tiglium	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CROTON TIGLIUM SEED	1	[hp_M]/1			N	20241231
37662-0520_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0520	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	6	[hp_C]/1			N	20241231
37662-0521_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0521	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	12	[hp_C]/1			N	20241231
37662-0522_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0522	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	30	[hp_C]/1			N	20241231
37662-0523_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0523	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	100	[hp_C]/1			N	20241231
37662-0524_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0524	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	200	[hp_C]/1			N	20241231
37662-0525_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0525	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	500	[hp_C]/1			N	20241231
37662-0526_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0526	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	1	[hp_M]/1			N	20241231
37662-0527_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0527	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	10	[hp_M]/1			N	20241231
37662-0528_e15d0218-6a3b-69a6-e053-2995a90a4dcc	37662-0528	HUMAN OTC DRUG	Colocynthis		Colocynthis	PELLET	ORAL	20220613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	1	[hp_Q]/1			N	20241231
37662-0529_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0529	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	6	[hp_C]/1			N	20241231
37662-0530_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0530	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	12	[hp_C]/1			N	20241231
37662-0531_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0531	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	30	[hp_C]/1			N	20241231
37662-0532_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0532	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	100	[hp_C]/1			N	20241231
37662-0533_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0533	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	200	[hp_C]/1			N	20241231
37662-0534_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0534	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	500	[hp_C]/1			N	20241231
37662-0535_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0535	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	1	[hp_M]/1			N	20241231
37662-0536_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0536	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	10	[hp_M]/1			N	20241231
37662-0537_e16c9eb1-25fe-2162-e053-2995a90ae3a0	37662-0537	HUMAN OTC DRUG	Comocladia Dentata		Comocladia Dentata	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMOCLADIA DENTATA BARK/LEAF	1	[hp_Q]/1			N	20241231
37662-0538_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0538	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	6	[hp_C]/1			N	20241231
37662-0539_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0539	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	12	[hp_C]/1			N	20241231
37662-0540_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0540	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	30	[hp_C]/1			N	20241231
37662-0541_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0541	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	100	[hp_C]/1			N	20241231
37662-0542_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0542	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	200	[hp_C]/1			N	20241231
37662-0543_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0543	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	500	[hp_C]/1			N	20241231
37662-0544_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0544	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	1	[hp_M]/1			N	20241231
37662-0545_e16d50ec-1192-5ffd-e053-2995a90a7aed	37662-0545	HUMAN OTC DRUG	Condurango		Condurango	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MARSDENIA CONDURANGO BARK	1	[hp_Q]/1			N	20241231
37662-0546_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0546	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-0547_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0547	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-0548_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0548	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-0549_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0549	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-0550_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0550	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-0551_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0551	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-0552_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0552	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-0553_e16f6275-98f0-9213-e053-2a95a90ababf	37662-0553	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CONIUM MACULATUM FLOWERING TOP	1	[hp_Q]/1			N	20241231
37662-0554_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0554	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	6	[hp_C]/1			N	20241231
37662-0555_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0555	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	12	[hp_C]/1			N	20241231
37662-0556_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0556	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	30	[hp_C]/1			N	20241231
37662-0557_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0557	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	100	[hp_C]/1			N	20241231
37662-0558_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0558	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	200	[hp_C]/1			N	20241231
37662-0559_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0559	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	500	[hp_C]/1			N	20241231
37662-0560_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0560	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	1	[hp_M]/1			N	20241231
37662-0561_e1711846-27b5-7647-e053-2a95a90a61c2	37662-0561	HUMAN OTC DRUG	Copaiva Officinalis		Copaiva Officinalis	PELLET	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPAIFERA OFFICINALIS RESIN	1	[hp_Q]/1			N	20241231
37662-0562_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0562	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	6	[hp_C]/1			N	20241231
37662-0563_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0563	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	12	[hp_C]/1			N	20241231
37662-0564_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0564	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	30	[hp_C]/1			N	20241231
37662-0565_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0565	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	100	[hp_C]/1			N	20241231
37662-0566_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0566	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	200	[hp_C]/1			N	20241231
37662-0567_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0567	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	500	[hp_C]/1			N	20241231
37662-0568_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0568	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	1	[hp_M]/1			N	20241231
37662-0569_e1819aaa-fce1-f277-e053-2a95a90ae8d3	37662-0569	HUMAN OTC DRUG	Coriandrum Sativum (Coriander)		Coriandrum Sativum (Coriander)	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CORIANDER	1	[hp_Q]/1			N	20241231
37662-0570_e4565be2-d734-4345-e053-2995a90a9c12	37662-0570	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	6	[hp_C]/1			N	20241231
37662-0571_e4565be2-d734-4345-e053-2995a90a9c12	37662-0571	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	12	[hp_C]/1			N	20241231
37662-0572_e4565be2-d734-4345-e053-2995a90a9c12	37662-0572	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	30	[hp_C]/1			N	20241231
37662-0573_e4565be2-d734-4345-e053-2995a90a9c12	37662-0573	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	100	[hp_C]/1			N	20241231
37662-0574_e4565be2-d734-4345-e053-2995a90a9c12	37662-0574	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	200	[hp_C]/1			N	20241231
37662-0575_e4565be2-d734-4345-e053-2995a90a9c12	37662-0575	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	500	[hp_C]/1			N	20241231
37662-0576_e4565be2-d734-4345-e053-2995a90a9c12	37662-0576	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	1	[hp_M]/1			N	20241231
37662-0577_e4565be2-d734-4345-e053-2995a90a9c12	37662-0577	HUMAN OTC DRUG	Cryptomeria Japonica		Cryptomeria Japonica	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CRYPTOMERIA JAPONICA WHOLE	1	[hp_Q]/1			N	20241231
37662-0578_e183141e-c81e-346a-e053-2a95a90a5393	37662-0578	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	6	[hp_C]/1			N	20241231
37662-0579_e183141e-c81e-346a-e053-2a95a90a5393	37662-0579	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	12	[hp_C]/1			N	20241231
37662-0580_e183141e-c81e-346a-e053-2a95a90a5393	37662-0580	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	30	[hp_C]/1			N	20241231
37662-0581_e183141e-c81e-346a-e053-2a95a90a5393	37662-0581	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	100	[hp_C]/1			N	20241231
37662-0582_e183141e-c81e-346a-e053-2a95a90a5393	37662-0582	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	200	[hp_C]/1			N	20241231
37662-0583_e183141e-c81e-346a-e053-2a95a90a5393	37662-0583	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	500	[hp_C]/1			N	20241231
37662-0584_e183141e-c81e-346a-e053-2a95a90a5393	37662-0584	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	1	[hp_M]/1			N	20241231
37662-0585_e183141e-c81e-346a-e053-2a95a90a5393	37662-0585	HUMAN OTC DRUG	Cubeba Officinalis		Cubeba Officinalis	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER CUBEBA FRUIT	1	[hp_Q]/1			N	20241231
37662-0586_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0586	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	6	[hp_C]/1			N	20241231
37662-0587_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0587	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	12	[hp_C]/1			N	20241231
37662-0588_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0588	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	30	[hp_C]/1			N	20241231
37662-0589_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0589	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	100	[hp_C]/1			N	20241231
37662-0590_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0590	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	200	[hp_C]/1			N	20241231
37662-0591_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0591	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	500	[hp_C]/1			N	20241231
37662-0592_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0592	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	1	[hp_M]/1			N	20241231
37662-0593_e184a0f6-059d-13c6-e053-2a95a90a928a	37662-0593	HUMAN OTC DRUG	Cuprum Aceticum		Cuprum Aceticum	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC ACETATE	1	[hp_Q]/1			N	20241231
37662-0594_e1958178-cf2d-290a-e053-2995a90a926c	37662-0594	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	6	[hp_C]/1			N	20241231
37662-0595_e1958178-cf2d-290a-e053-2995a90a926c	37662-0595	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	12	[hp_C]/1			N	20241231
37662-0596_e1958178-cf2d-290a-e053-2995a90a926c	37662-0596	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	30	[hp_C]/1			N	20241231
37662-0597_e1958178-cf2d-290a-e053-2995a90a926c	37662-0597	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	100	[hp_C]/1			N	20241231
37662-0598_e1958178-cf2d-290a-e053-2995a90a926c	37662-0598	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	200	[hp_C]/1			N	20241231
37662-0599_e1958178-cf2d-290a-e053-2995a90a926c	37662-0599	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	500	[hp_C]/1			N	20241231
37662-0600_e1958178-cf2d-290a-e053-2995a90a926c	37662-0600	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	1	[hp_M]/1			N	20241231
37662-0601_e1958178-cf2d-290a-e053-2995a90a926c	37662-0601	HUMAN OTC DRUG	Cuprum Carbonicum		Cuprum Carbonicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BASIC CUPRIC CARBONATE	1	[hp_Q]/1			N	20241231
37662-0602_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0602	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	6	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0603_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0603	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	12	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0604_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0604	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	30	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0605_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0605	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	100	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0606_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0606	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	200	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0607_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0607	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	500	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0608_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0608	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	1	[hp_M]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0609_e1965bd5-78f1-0b40-e053-2a95a90a4a13	37662-0609	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	PELLET	ORAL	20220616		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COPPER	1	[hp_Q]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
37662-0610_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0610	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	6	[hp_C]/1			N	20241231
37662-0611_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0611	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	12	[hp_C]/1			N	20241231
37662-0612_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0612	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	30	[hp_C]/1			N	20241231
37662-0613_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0613	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	100	[hp_C]/1			N	20241231
37662-0614_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0614	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	200	[hp_C]/1			N	20241231
37662-0615_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0615	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	500	[hp_C]/1			N	20241231
37662-0616_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0616	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	1	[hp_M]/1			N	20241231
37662-0617_e1a79248-ab58-07e0-e053-2a95a90a1623	37662-0617	HUMAN OTC DRUG	Cuprum Muriaticum		Cuprum Muriaticum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC CHLORIDE ANHYDROUS	1	[hp_Q]/1			N	20241231
37662-0618_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0618	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	6	[hp_C]/1			N	20241231
37662-0619_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0619	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	12	[hp_C]/1			N	20241231
37662-0620_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0620	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	30	[hp_C]/1			N	20241231
37662-0621_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0621	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	100	[hp_C]/1			N	20241231
37662-0622_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0622	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	200	[hp_C]/1			N	20241231
37662-0623_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0623	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	500	[hp_C]/1			N	20241231
37662-0624_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0624	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	1	[hp_M]/1			N	20241231
37662-0625_e1a9b132-82e3-9ef0-e053-2a95a90a652c	37662-0625	HUMAN OTC DRUG	Cuprum Nitricum		Cuprum Nitricum	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC NITRATE HEXAHYDRATE	1	[hp_Q]/1			N	20241231
37662-0626_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0626	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	6	[hp_C]/1			N	20241231
37662-0627_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0627	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	12	[hp_C]/1			N	20241231
37662-0628_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0628	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	30	[hp_C]/1			N	20241231
37662-0629_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0629	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	100	[hp_C]/1			N	20241231
37662-0630_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0630	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	200	[hp_C]/1			N	20241231
37662-0631_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0631	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	500	[hp_C]/1			N	20241231
37662-0632_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0632	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	1	[hp_M]/1			N	20241231
37662-0633_e1ac85ba-a66c-ab9e-e053-2a95a90ade80	37662-0633	HUMAN OTC DRUG	Dioscorea Villosa		Dioscorea Villosa	PELLET	ORAL	20220617		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIOSCOREA VILLOSA TUBER	1	[hp_Q]/1			N	20241231
37662-0634_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0634	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	6	[hp_C]/1			N	20241231
37662-0635_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0635	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	12	[hp_C]/1			N	20241231
37662-0636_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0636	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	30	[hp_C]/1			N	20241231
37662-0637_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0637	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	100	[hp_C]/1			N	20241231
37662-0638_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0638	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	200	[hp_C]/1			N	20241231
37662-0639_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0639	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	500	[hp_C]/1			N	20241231
37662-0640_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0640	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	1	[hp_M]/1			N	20241231
37662-0641_e1e4e755-4900-3560-e053-2a95a90ac605	37662-0641	HUMAN OTC DRUG	Dolichos Pruriens		Dolichos Pruriens	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MUCUNA PRURIENS FRUIT TRICHOME	1	[hp_Q]/1			N	20241231
37662-0642_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0642	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	6	[hp_C]/1			N	20241231
37662-0643_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0643	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	12	[hp_C]/1			N	20241231
37662-0644_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0644	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	30	[hp_C]/1			N	20241231
37662-0645_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0645	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	100	[hp_C]/1			N	20241231
37662-0646_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0646	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	200	[hp_C]/1			N	20241231
37662-0647_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0647	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	500	[hp_C]/1			N	20241231
37662-0648_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0648	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	1	[hp_M]/1			N	20241231
37662-0649_e1e64a61-d0eb-0f8e-e053-2a95a90af186	37662-0649	HUMAN OTC DRUG	Drosera Rotundifolia		Drosera Rotundifolia	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DROSERA ROTUNDIFOLIA WHOLE	1	[hp_Q]/1			N	20241231
37662-0650_e1e8fe74-6f66-4685-e053-2a95a90a3bed	37662-0650	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	6	[hp_C]/1			N	20241231
37662-0651_e1e8fe74-6f66-4685-e053-2a95a90a3bed	37662-0651	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	12	[hp_C]/1			N	20241231
37662-0652_e1e8fe74-6f66-4685-e053-2a95a90a3bed	37662-0652	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	30	[hp_C]/1			N	20241231
37662-0653_e1e8fe74-6f66-4685-e053-2a95a90a3bed	37662-0653	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	100	[hp_C]/1			N	20241231
37662-0654_e1e8fe74-6f66-4685-e053-2a95a90a3bed	37662-0654	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	200	[hp_C]/1			N	20241231
37662-0655_e1e8fe74-6f66-4685-e053-2a95a90a3bed	37662-0655	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	500	[hp_C]/1			N	20241231
37662-0656_e1e8fe74-6f66-4685-e053-2a95a90a3bed	37662-0656	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	1	[hp_M]/1			N	20241231
37662-0657_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0657	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	6	[hp_C]/1			N	20241231
37662-0658_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0658	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	12	[hp_C]/1			N	20241231
37662-0659_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0659	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	30	[hp_C]/1			N	20241231
37662-0660_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0660	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	100	[hp_C]/1			N	20241231
37662-0661_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0661	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	200	[hp_C]/1			N	20241231
37662-0662_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0662	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	500	[hp_C]/1			N	20241231
37662-0663_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0663	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	1	[hp_M]/1			N	20241231
37662-0664_e1f8903e-f595-7cb3-e053-2a95a90ab08d	37662-0664	HUMAN OTC DRUG	Cuprum Oxydatum Nigrum		Cuprum Oxydatum Nigrum	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC OXIDE	1	[hp_Q]/1			N	20241231
37662-0665_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0665	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	6	[hp_C]/1			N	20241231
37662-0666_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0666	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	12	[hp_C]/1			N	20241231
37662-0667_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0667	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	30	[hp_C]/1			N	20241231
37662-0668_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0668	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	100	[hp_C]/1			N	20241231
37662-0669_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0669	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	200	[hp_C]/1			N	20241231
37662-0670_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0670	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	500	[hp_C]/1			N	20241231
37662-0671_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0671	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	1	[hp_M]/1			N	20241231
37662-0672_e1fa828f-be29-0fa0-e053-2a95a90a2f91	37662-0672	HUMAN OTC DRUG	Echinacea Angustifolia		Echinacea Angustifolia	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ECHINACEA ANGUSTIFOLIA WHOLE	1	[hp_Q]/1			N	20241231
37662-0673_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0673	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	6	[hp_C]/1			N	20241231
37662-0674_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0674	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	12	[hp_C]/1			N	20241231
37662-0675_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0675	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	30	[hp_C]/1			N	20241231
37662-0676_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0676	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	100	[hp_C]/1			N	20241231
37662-0677_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0677	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	200	[hp_C]/1			N	20241231
37662-0678_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0678	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	500	[hp_C]/1			N	20241231
37662-0679_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0679	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	1	[hp_M]/1			N	20241231
37662-0680_e1fbe5b7-0efe-aed3-e053-2995a90a29e0	37662-0680	HUMAN OTC DRUG	Equisetum Hyemale		Equisetum Hyemale	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EQUISETUM HYEMALE	1	[hp_Q]/1			N	20241231
37662-0681_e1fe022c-d1db-183a-e053-2995a90ae17f	37662-0681	HUMAN OTC DRUG	Eucalyptus Globulus		Eucalyptus Globulus	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUCALYPTUS GLOBULUS LEAF	6	[hp_C]/1			N	20241231
37662-0682_e1fe022c-d1db-183a-e053-2995a90ae17f	37662-0682	HUMAN OTC DRUG	Eucalyptus Globulus		Eucalyptus Globulus	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUCALYPTUS GLOBULUS LEAF	12	[hp_C]/1			N	20241231
37662-0683_e1fe022c-d1db-183a-e053-2995a90ae17f	37662-0683	HUMAN OTC DRUG	Eucalyptus Globulus		Eucalyptus Globulus	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUCALYPTUS GLOBULUS LEAF	30	[hp_C]/1			N	20241231
37662-0684_e1fe022c-d1db-183a-e053-2995a90ae17f	37662-0684	HUMAN OTC DRUG	Eucalyptus Globulus		Eucalyptus Globulus	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUCALYPTUS GLOBULUS LEAF	100	[hp_C]/1			N	20241231
37662-0685_e1fe022c-d1db-183a-e053-2995a90ae17f	37662-0685	HUMAN OTC DRUG	Eucalyptus Globulus		Eucalyptus Globulus	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUCALYPTUS GLOBULUS LEAF	200	[hp_C]/1			N	20241231
37662-0686_e1fe022c-d1db-183a-e053-2995a90ae17f	37662-0686	HUMAN OTC DRUG	Eucalyptus Globulus		Eucalyptus Globulus	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUCALYPTUS GLOBULUS LEAF	500	[hp_C]/1			N	20241231
37662-0687_e1fe022c-d1db-183a-e053-2995a90ae17f	37662-0687	HUMAN OTC DRUG	Eucalyptus Globulus		Eucalyptus Globulus	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUCALYPTUS GLOBULUS LEAF	1	[hp_M]/1			N	20241231
37662-0688_e1fef03a-ed77-4294-e053-2995a90aee67	37662-0688	HUMAN OTC DRUG	Ethylicum (ETOH, aka Alcoholus)		Ethylicum (ETOH, aka Alcoholus)	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALCOHOL	6	[hp_C]/1			N	20241231
37662-0689_e1fef03a-ed77-4294-e053-2995a90aee67	37662-0689	HUMAN OTC DRUG	Ethylicum (ETOH, aka Alcoholus)		Ethylicum (ETOH, aka Alcoholus)	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALCOHOL	12	[hp_C]/1			N	20241231
37662-0690_e1fef03a-ed77-4294-e053-2995a90aee67	37662-0690	HUMAN OTC DRUG	Ethylicum (ETOH, aka Alcoholus)		Ethylicum (ETOH, aka Alcoholus)	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALCOHOL	30	[hp_C]/1			N	20241231
37662-0691_e1fef03a-ed77-4294-e053-2995a90aee67	37662-0691	HUMAN OTC DRUG	Ethylicum (ETOH, aka Alcoholus)		Ethylicum (ETOH, aka Alcoholus)	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALCOHOL	100	[hp_C]/1			N	20241231
37662-0692_e1fef03a-ed77-4294-e053-2995a90aee67	37662-0692	HUMAN OTC DRUG	Ethylicum (ETOH, aka Alcoholus)		Ethylicum (ETOH, aka Alcoholus)	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALCOHOL	200	[hp_C]/1			N	20241231
37662-0693_e1fef03a-ed77-4294-e053-2995a90aee67	37662-0693	HUMAN OTC DRUG	Ethylicum (ETOH, aka Alcoholus)		Ethylicum (ETOH, aka Alcoholus)	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALCOHOL	500	[hp_C]/1			N	20241231
37662-0694_e1fef03a-ed77-4294-e053-2995a90aee67	37662-0694	HUMAN OTC DRUG	Ethylicum (ETOH, aka Alcoholus)		Ethylicum (ETOH, aka Alcoholus)	PELLET	ORAL	20220621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALCOHOL	1	[hp_M]/1			N	20241231
37662-0695_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0695	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	6	[hp_C]/1			N	20241231
37662-0696_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0696	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	12	[hp_C]/1			N	20241231
37662-0697_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0697	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	30	[hp_C]/1			N	20241231
37662-0698_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0698	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	100	[hp_C]/1			N	20241231
37662-0699_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0699	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	200	[hp_C]/1			N	20241231
37662-0700_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0700	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	500	[hp_C]/1			N	20241231
37662-0701_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0701	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	1	[hp_M]/1			N	20241231
37662-0702_e2fe1826-4b3f-1916-e053-2a95a90a0a42	37662-0702	HUMAN OTC DRUG	Erbium Metallicum		Erbium Metallicum	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM	1	[hp_Q]/1			N	20241231
37662-0703_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0703	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	6	[hp_C]/1			N	20241231
37662-0704_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0704	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	12	[hp_C]/1			N	20241231
37662-0705_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0705	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	30	[hp_C]/1			N	20241231
37662-0706_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0706	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	100	[hp_C]/1			N	20241231
37662-0707_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0707	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	200	[hp_C]/1			N	20241231
37662-0708_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0708	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	500	[hp_C]/1			N	20241231
37662-0709_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0709	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	1	[hp_M]/1			N	20241231
37662-0710_e301c983-7b0c-234e-e053-2995a90a3a0f	37662-0710	HUMAN OTC DRUG	Erigeron Canadensis		Erigeron Canadensis	PELLET	ORAL	20220704		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERIGERON CANADENSIS	1	[hp_Q]/1			N	20241231
37662-0711_e3168646-9631-3238-e053-2995a90a4a4b	37662-0711	HUMAN OTC DRUG	Fagus Sylvatica		Fagus Sylvatica	PELLET	ORAL	20220705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FAGUS SYLVATICA NUT	6	[hp_C]/1			N	20241231
37662-0712_e3168646-9631-3238-e053-2995a90a4a4b	37662-0712	HUMAN OTC DRUG	Fagus Sylvatica		Fagus Sylvatica	PELLET	ORAL	20220705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FAGUS SYLVATICA NUT	12	[hp_C]/1			N	20241231
37662-0713_e3168646-9631-3238-e053-2995a90a4a4b	37662-0713	HUMAN OTC DRUG	Fagus Sylvatica		Fagus Sylvatica	PELLET	ORAL	20220705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FAGUS SYLVATICA NUT	30	[hp_C]/1			N	20241231
37662-0714_e3168646-9631-3238-e053-2995a90a4a4b	37662-0714	HUMAN OTC DRUG	Fagus Sylvatica		Fagus Sylvatica	PELLET	ORAL	20220705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FAGUS SYLVATICA NUT	100	[hp_C]/1			N	20241231
37662-0715_e3168646-9631-3238-e053-2995a90a4a4b	37662-0715	HUMAN OTC DRUG	Fagus Sylvatica		Fagus Sylvatica	PELLET	ORAL	20220705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FAGUS SYLVATICA NUT	200	[hp_C]/1			N	20241231
37662-0716_e3168646-9631-3238-e053-2995a90a4a4b	37662-0716	HUMAN OTC DRUG	Fagus Sylvatica		Fagus Sylvatica	PELLET	ORAL	20220705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FAGUS SYLVATICA NUT	500	[hp_C]/1			N	20241231
37662-0717_e3168646-9631-3238-e053-2995a90a4a4b	37662-0717	HUMAN OTC DRUG	Fagus Sylvatica		Fagus Sylvatica	PELLET	ORAL	20220705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FAGUS SYLVATICA NUT	1	[hp_M]/1			N	20241231
37662-0718_e31839d9-7a8e-5c83-e053-2a95a90a550b	37662-0718	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC CHLORIDE	6	[hp_C]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37662-0719_e31839d9-7a8e-5c83-e053-2a95a90a550b	37662-0719	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC CHLORIDE	12	[hp_C]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37662-0720_e31839d9-7a8e-5c83-e053-2a95a90a550b	37662-0720	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC CHLORIDE	30	[hp_C]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37662-0721_e31839d9-7a8e-5c83-e053-2a95a90a550b	37662-0721	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC CHLORIDE	100	[hp_C]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37662-0722_e31839d9-7a8e-5c83-e053-2a95a90a550b	37662-0722	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC CHLORIDE	200	[hp_C]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37662-0723_e31839d9-7a8e-5c83-e053-2a95a90a550b	37662-0723	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC CHLORIDE	500	[hp_C]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37662-0724_e31839d9-7a8e-5c83-e053-2a95a90a550b	37662-0724	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC CHLORIDE	1	[hp_M]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37662-0725_e3281609-460b-4982-e053-2995a90a01c5	37662-0725	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	6	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0726_e3281609-460b-4982-e053-2995a90a01c5	37662-0726	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	12	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0727_e3281609-460b-4982-e053-2995a90a01c5	37662-0727	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	30	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0728_e3281609-460b-4982-e053-2995a90a01c5	37662-0728	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	100	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0729_e3281609-460b-4982-e053-2995a90a01c5	37662-0729	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	200	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0730_e3281609-460b-4982-e053-2995a90a01c5	37662-0730	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	500	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0731_e3281609-460b-4982-e053-2995a90a01c5	37662-0731	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	1	[hp_M]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0732_e3281609-460b-4982-e053-2995a90a01c5	37662-0732	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	1	[hp_Q]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-0733_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0733	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	6	[hp_C]/1			N	20241231
37662-0734_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0734	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	12	[hp_C]/1			N	20241231
37662-0735_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0735	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	30	[hp_C]/1			N	20241231
37662-0736_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0736	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	100	[hp_C]/1			N	20241231
37662-0737_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0737	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	200	[hp_C]/1			N	20241231
37662-0738_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0738	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	500	[hp_C]/1			N	20241231
37662-0739_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0739	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	1	[hp_M]/1			N	20241231
37662-0740_e32972ed-96e0-73f4-e053-2a95a90a61da	37662-0740	HUMAN OTC DRUG	Formica Rufa		Formica Rufa	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMICA RUFA	1	[hp_Q]/1			N	20241231
37662-0741_e32c56fe-69d6-23c7-e053-2a95a90a51bd	37662-0741	HUMAN OTC DRUG	Foeniculum Vulgare		Foeniculum Vulgare	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRATIOLA OFFICINALIS	6	[hp_C]/1			N	20241231
37662-0742_e32c56fe-69d6-23c7-e053-2a95a90a51bd	37662-0742	HUMAN OTC DRUG	Foeniculum Vulgare		Foeniculum Vulgare	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRATIOLA OFFICINALIS	12	[hp_C]/1			N	20241231
37662-0743_e32c56fe-69d6-23c7-e053-2a95a90a51bd	37662-0743	HUMAN OTC DRUG	Foeniculum Vulgare		Foeniculum Vulgare	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRATIOLA OFFICINALIS	30	[hp_C]/1			N	20241231
37662-0744_e32c56fe-69d6-23c7-e053-2a95a90a51bd	37662-0744	HUMAN OTC DRUG	Foeniculum Vulgare		Foeniculum Vulgare	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRATIOLA OFFICINALIS	100	[hp_C]/1			N	20241231
37662-0745_e32c56fe-69d6-23c7-e053-2a95a90a51bd	37662-0745	HUMAN OTC DRUG	Foeniculum Vulgare		Foeniculum Vulgare	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRATIOLA OFFICINALIS	200	[hp_C]/1			N	20241231
37662-0746_e32c56fe-69d6-23c7-e053-2a95a90a51bd	37662-0746	HUMAN OTC DRUG	Foeniculum Vulgare		Foeniculum Vulgare	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRATIOLA OFFICINALIS	500	[hp_C]/1			N	20241231
37662-0747_e32c56fe-69d6-23c7-e053-2a95a90a51bd	37662-0747	HUMAN OTC DRUG	Foeniculum Vulgare		Foeniculum Vulgare	PELLET	ORAL	20220706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRATIOLA OFFICINALIS	1	[hp_M]/1			N	20241231
37662-0748_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0748	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	6	[hp_C]/1			N	20241231
37662-0749_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0749	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	12	[hp_C]/1			N	20241231
37662-0750_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0750	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	30	[hp_C]/1			N	20241231
37662-0751_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0751	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	100	[hp_C]/1			N	20241231
37662-0752_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0752	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	200	[hp_C]/1			N	20241231
37662-0753_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0753	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	500	[hp_C]/1			N	20241231
37662-0754_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0754	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	1	[hp_M]/1			N	20241231
37662-0755_e33b7f47-e30f-1ef4-e053-2a95a90a3e9a	37662-0755	HUMAN OTC DRUG	Acidum Formicum		Acidum Formicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMIC ACID	1	[hp_Q]/1			N	20241231
37662-0756_e33deff6-5900-c979-e053-2995a90a58de	37662-0756	HUMAN OTC DRUG	Acidum Gallicum		Acidum Gallicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIC ACID MONOHYDRATE	6	[hp_C]/1			N	20241231
37662-0757_e33deff6-5900-c979-e053-2995a90a58de	37662-0757	HUMAN OTC DRUG	Acidum Gallicum		Acidum Gallicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIC ACID MONOHYDRATE	12	[hp_C]/1			N	20241231
37662-0758_e33deff6-5900-c979-e053-2995a90a58de	37662-0758	HUMAN OTC DRUG	Acidum Gallicum		Acidum Gallicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIC ACID MONOHYDRATE	30	[hp_C]/1			N	20241231
37662-0759_e33deff6-5900-c979-e053-2995a90a58de	37662-0759	HUMAN OTC DRUG	Acidum Gallicum		Acidum Gallicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIC ACID MONOHYDRATE	100	[hp_C]/1			N	20241231
37662-0760_e33deff6-5900-c979-e053-2995a90a58de	37662-0760	HUMAN OTC DRUG	Acidum Gallicum		Acidum Gallicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIC ACID MONOHYDRATE	200	[hp_C]/1			N	20241231
37662-0761_e33deff6-5900-c979-e053-2995a90a58de	37662-0761	HUMAN OTC DRUG	Acidum Gallicum		Acidum Gallicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIC ACID MONOHYDRATE	500	[hp_C]/1			N	20241231
37662-0762_e33deff6-5900-c979-e053-2995a90a58de	37662-0762	HUMAN OTC DRUG	Acidum Gallicum		Acidum Gallicum	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIC ACID MONOHYDRATE	1	[hp_M]/1			N	20241231
37662-0763_e34062cf-5f3e-fcc5-e053-2995a90afc14	37662-0763	HUMAN OTC DRUG	Glycyrrhiza Glabra		Glycyrrhiza Glabra	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCYRRHIZA GLABRA	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-0764_e34062cf-5f3e-fcc5-e053-2995a90afc14	37662-0764	HUMAN OTC DRUG	Glycyrrhiza Glabra		Glycyrrhiza Glabra	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCYRRHIZA GLABRA	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-0765_e34062cf-5f3e-fcc5-e053-2995a90afc14	37662-0765	HUMAN OTC DRUG	Glycyrrhiza Glabra		Glycyrrhiza Glabra	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCYRRHIZA GLABRA	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-0766_e34062cf-5f3e-fcc5-e053-2995a90afc14	37662-0766	HUMAN OTC DRUG	Glycyrrhiza Glabra		Glycyrrhiza Glabra	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCYRRHIZA GLABRA	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-0767_e34062cf-5f3e-fcc5-e053-2995a90afc14	37662-0767	HUMAN OTC DRUG	Glycyrrhiza Glabra		Glycyrrhiza Glabra	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCYRRHIZA GLABRA	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-0768_e34062cf-5f3e-fcc5-e053-2995a90afc14	37662-0768	HUMAN OTC DRUG	Glycyrrhiza Glabra		Glycyrrhiza Glabra	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCYRRHIZA GLABRA	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-0769_e34062cf-5f3e-fcc5-e053-2995a90afc14	37662-0769	HUMAN OTC DRUG	Glycyrrhiza Glabra		Glycyrrhiza Glabra	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCYRRHIZA GLABRA	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-0770_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0770	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	6	[hp_C]/1			N	20241231
37662-0771_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0771	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	12	[hp_C]/1			N	20241231
37662-0772_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0772	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	30	[hp_C]/1			N	20241231
37662-0773_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0773	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	100	[hp_C]/1			N	20241231
37662-0774_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0774	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	200	[hp_C]/1			N	20241231
37662-0775_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0775	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	500	[hp_C]/1			N	20241231
37662-0776_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0776	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	1	[hp_M]/1			N	20241231
37662-0777_e3418e1a-0928-4f5a-e053-2995a90a5c42	37662-0777	HUMAN OTC DRUG	Gambogia		Gambogia	PELLET	ORAL	20220707		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GAMBOGE	10	[hp_M]/1			N	20241231
37662-0778_e34f8796-85b6-2946-e053-2995a90a251e	37662-0778	HUMAN OTC DRUG	Glycerinum		Glycerinum	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCERIN	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37662-0779_e34f8796-85b6-2946-e053-2995a90a251e	37662-0779	HUMAN OTC DRUG	Glycerinum		Glycerinum	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCERIN	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37662-0780_e34f8796-85b6-2946-e053-2995a90a251e	37662-0780	HUMAN OTC DRUG	Glycerinum		Glycerinum	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCERIN	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37662-0781_e34f8796-85b6-2946-e053-2995a90a251e	37662-0781	HUMAN OTC DRUG	Glycerinum		Glycerinum	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCERIN	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37662-0782_e34f8796-85b6-2946-e053-2995a90a251e	37662-0782	HUMAN OTC DRUG	Glycerinum		Glycerinum	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCERIN	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37662-0783_e34f8796-85b6-2946-e053-2995a90a251e	37662-0783	HUMAN OTC DRUG	Glycerinum		Glycerinum	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCERIN	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37662-0784_e34f8796-85b6-2946-e053-2995a90a251e	37662-0784	HUMAN OTC DRUG	Glycerinum		Glycerinum	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GLYCERIN	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37662-0785_e3517252-4687-119c-e053-2995a90ad15a	37662-0785	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	6	[hp_C]/1			N	20241231
37662-0786_e3517252-4687-119c-e053-2995a90ad15a	37662-0786	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	12	[hp_C]/1			N	20241231
37662-0787_e3517252-4687-119c-e053-2995a90ad15a	37662-0787	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	30	[hp_C]/1			N	20241231
37662-0788_e3517252-4687-119c-e053-2995a90ad15a	37662-0788	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	100	[hp_C]/1			N	20241231
37662-0789_e3517252-4687-119c-e053-2995a90ad15a	37662-0789	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	200	[hp_C]/1			N	20241231
37662-0790_e3517252-4687-119c-e053-2995a90ad15a	37662-0790	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	500	[hp_C]/1			N	20241231
37662-0791_e3517252-4687-119c-e053-2995a90ad15a	37662-0791	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	1	[hp_M]/1			N	20241231
37662-0792_e3517252-4687-119c-e053-2995a90ad15a	37662-0792	HUMAN OTC DRUG	Graphites		Graphites	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRAPHITE	1	[hp_Q]/1			N	20241231
37662-0793_e35436a4-beb3-4dc8-e053-2995a90aa8fc	37662-0793	HUMAN OTC DRUG	Juglans Cinerea		Juglans Cinerea	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUGLANS CINEREA BRANCH BARK/ROOT BARK	6	[hp_C]/1			N	20241231
37662-0794_e35436a4-beb3-4dc8-e053-2995a90aa8fc	37662-0794	HUMAN OTC DRUG	Juglans Cinerea		Juglans Cinerea	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUGLANS CINEREA BRANCH BARK/ROOT BARK	12	[hp_C]/1			N	20241231
37662-0795_e35436a4-beb3-4dc8-e053-2995a90aa8fc	37662-0795	HUMAN OTC DRUG	Juglans Cinerea		Juglans Cinerea	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUGLANS CINEREA BRANCH BARK/ROOT BARK	30	[hp_C]/1			N	20241231
37662-0796_e35436a4-beb3-4dc8-e053-2995a90aa8fc	37662-0796	HUMAN OTC DRUG	Juglans Cinerea		Juglans Cinerea	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUGLANS CINEREA BRANCH BARK/ROOT BARK	100	[hp_C]/1			N	20241231
37662-0797_e35436a4-beb3-4dc8-e053-2995a90aa8fc	37662-0797	HUMAN OTC DRUG	Juglans Cinerea		Juglans Cinerea	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUGLANS CINEREA BRANCH BARK/ROOT BARK	200	[hp_C]/1			N	20241231
37662-0798_e35436a4-beb3-4dc8-e053-2995a90aa8fc	37662-0798	HUMAN OTC DRUG	Juglans Cinerea		Juglans Cinerea	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUGLANS CINEREA BRANCH BARK/ROOT BARK	500	[hp_C]/1			N	20241231
37662-0799_e35436a4-beb3-4dc8-e053-2995a90aa8fc	37662-0799	HUMAN OTC DRUG	Juglans Cinerea		Juglans Cinerea	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUGLANS CINEREA BRANCH BARK/ROOT BARK	1	[hp_M]/1			N	20241231
37662-0800_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0800	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-0801_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0801	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-0802_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0802	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-0803_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0803	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-0804_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0804	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-0805_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0805	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-0806_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0806	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-0807_e355e70e-539d-1e65-e053-2995a90a2c6a	37662-0807	HUMAN OTC DRUG	Helianthus Annuus		Helianthus Annuus	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELIANTHUS ANNUUS FLOWERING TOP	1	[hp_Q]/1			N	20241231
37662-0808_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0808	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	6	[hp_C]/1			N	20241231
37662-0809_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0809	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	12	[hp_C]/1			N	20241231
37662-0810_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0810	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	30	[hp_C]/1			N	20241231
37662-0811_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0811	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	100	[hp_C]/1			N	20241231
37662-0812_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0812	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	200	[hp_C]/1			N	20241231
37662-0813_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0813	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	500	[hp_C]/1			N	20241231
37662-0814_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0814	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	1	[hp_M]/1			N	20241231
37662-0815_e38e22eb-2382-8fce-e053-2995a90abfad	37662-0815	HUMAN OTC DRUG	Indium Metallicum		Indium Metallicum	PELLET	ORAL	20220711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIUM	1	[hp_Q]/1			N	20241231
37662-0816_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0816	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	6	[hp_C]/1			N	20241231
37662-0817_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0817	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	12	[hp_C]/1			N	20241231
37662-0818_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0818	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	30	[hp_C]/1			N	20241231
37662-0819_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0819	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	100	[hp_C]/1			N	20241231
37662-0820_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0820	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	200	[hp_C]/1			N	20241231
37662-0821_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0821	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	500	[hp_C]/1			N	20241231
37662-0822_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0822	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	1	[hp_M]/1			N	20241231
37662-0823_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0823	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	10	[hp_M]/1			N	20241231
37662-0824_e3a004d3-f771-e4e9-e053-2995a90ab43c	37662-0824	HUMAN OTC DRUG	Digitalis Purpurea		Digitalis Purpurea	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIGITALIS	1	[hp_Q]/1			N	20241231
37662-0825_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0825	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	6	[hp_C]/1			N	20241231
37662-0826_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0826	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	12	[hp_C]/1			N	20241231
37662-0827_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0827	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	30	[hp_C]/1			N	20241231
37662-0828_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0828	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	100	[hp_C]/1			N	20241231
37662-0829_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0829	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	200	[hp_C]/1			N	20241231
37662-0830_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0830	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	500	[hp_C]/1			N	20241231
37662-0831_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0831	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	1	[hp_M]/1			N	20241231
37662-0832_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0832	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	10	[hp_M]/1			N	20241231
37662-0833_e3a2a1ed-daa2-1323-e053-2a95a90afdc0	37662-0833	HUMAN OTC DRUG	Euphrasia Officinalis		Euphrasia Officinalis	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUPHRASIA STRICTA	1	[hp_Q]/1			N	20241231
37662-0834_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0834	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	6	[hp_C]/1			N	20241231
37662-0835_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0835	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	12	[hp_C]/1			N	20241231
37662-0836_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0836	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	30	[hp_C]/1			N	20241231
37662-0837_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0837	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	100	[hp_C]/1			N	20241231
37662-0838_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0838	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	200	[hp_C]/1			N	20241231
37662-0839_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0839	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	500	[hp_C]/1			N	20241231
37662-0840_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0840	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	1	[hp_M]/1			N	20241231
37662-0841_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0841	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	10	[hp_M]/1			N	20241231
37662-0842_e3a44238-9629-9697-e053-2a95a90aaf29	37662-0842	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRON	1	[hp_Q]/1			N	20241231
37662-0843_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0843	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	6	[hp_C]/1			N	20241231
37662-0844_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0844	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	12	[hp_C]/1			N	20241231
37662-0845_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0845	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	30	[hp_C]/1			N	20241231
37662-0846_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0846	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	100	[hp_C]/1			N	20241231
37662-0847_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0847	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	200	[hp_C]/1			N	20241231
37662-0848_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0848	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	500	[hp_C]/1			N	20241231
37662-0849_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0849	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	1	[hp_M]/1			N	20241231
37662-0850_e3a5f645-9d35-1a6d-e053-2995a90a030e	37662-0850	HUMAN OTC DRUG	Ferrum Sulphuricum		Ferrum Sulphuricum	PELLET	ORAL	20220712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERROUS SULFATE	1	[hp_Q]/1			N	20241231
37662-0851_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0851	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	6	[hp_C]/1			N	20241231
37662-0852_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0852	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	12	[hp_C]/1			N	20241231
37662-0853_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0853	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	30	[hp_C]/1			N	20241231
37662-0854_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0854	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	100	[hp_C]/1			N	20241231
37662-0855_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0855	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	200	[hp_C]/1			N	20241231
37662-0856_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0856	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	500	[hp_C]/1			N	20241231
37662-0857_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0857	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	1	[hp_M]/1			N	20241231
37662-0858_e3b4ac93-e12d-7aac-e053-2a95a90a5e2e	37662-0858	HUMAN OTC DRUG	Iridium Metallicum		Iridium Metallicum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIDIUM	1	[hp_Q]/1			N	20241231
37662-0859_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0859	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0860_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0860	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0861_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0861	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0862_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0862	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0863_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0863	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0864_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0864	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0865_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0865	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0866_e3b7552d-2aab-9d5b-e053-2a95a90ab6f6	37662-0866	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0867_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0867	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	6	[hp_C]/1			N	20241231
37662-0868_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0868	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	12	[hp_C]/1			N	20241231
37662-0869_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0869	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	30	[hp_C]/1			N	20241231
37662-0870_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0870	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	100	[hp_C]/1			N	20241231
37662-0871_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0871	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	200	[hp_C]/1			N	20241231
37662-0872_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0872	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	500	[hp_C]/1			N	20241231
37662-0873_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0873	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	1	[hp_M]/1			N	20241231
37662-0874_e3b95958-183d-5401-e053-2a95a90ae33c	37662-0874	HUMAN OTC DRUG	Kali Bromatum		Kali Bromatum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM BROMIDE	1	[hp_Q]/1			N	20241231
37662-0875_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0875	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0876_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0876	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0877_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0877	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0878_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0878	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0879_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0879	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0880_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0880	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0881_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0881	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0882_e3baf111-d3e8-7f7f-e053-2995a90a84e6	37662-0882	HUMAN OTC DRUG	Kali Chloricum		Kali Chloricum	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORATE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0883_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0883	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0884_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0884	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0885_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0885	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0886_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0886	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0887_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0887	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0888_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0888	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0889_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0889	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0890_e3c8e13d-a67e-162c-e053-2a95a90abd11	37662-0890	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CHLORIDE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-0891_e3cada58-aa1b-8792-e053-2a95a90a388f	37662-0891	HUMAN OTC DRUG	Kali Nitricum		Kali Nitricum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM NITRATE	6	[hp_C]/1			N	20241231
37662-0892_e3cada58-aa1b-8792-e053-2a95a90a388f	37662-0892	HUMAN OTC DRUG	Kali Nitricum		Kali Nitricum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM NITRATE	12	[hp_C]/1			N	20241231
37662-0893_e3cada58-aa1b-8792-e053-2a95a90a388f	37662-0893	HUMAN OTC DRUG	Kali Nitricum		Kali Nitricum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM NITRATE	30	[hp_C]/1			N	20241231
37662-0894_e3cada58-aa1b-8792-e053-2a95a90a388f	37662-0894	HUMAN OTC DRUG	Kali Nitricum		Kali Nitricum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM NITRATE	100	[hp_C]/1			N	20241231
37662-0895_e3cada58-aa1b-8792-e053-2a95a90a388f	37662-0895	HUMAN OTC DRUG	Kali Nitricum		Kali Nitricum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM NITRATE	200	[hp_C]/1			N	20241231
37662-0896_e3cada58-aa1b-8792-e053-2a95a90a388f	37662-0896	HUMAN OTC DRUG	Kali Nitricum		Kali Nitricum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM NITRATE	500	[hp_C]/1			N	20241231
37662-0897_e3cada58-aa1b-8792-e053-2a95a90a388f	37662-0897	HUMAN OTC DRUG	Kali Nitricum		Kali Nitricum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM NITRATE	1	[hp_M]/1			N	20241231
37662-0898_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0898	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	6	[hp_C]/1			N	20241231
37662-0899_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0899	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	12	[hp_C]/1			N	20241231
37662-0900_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0900	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	30	[hp_C]/1			N	20241231
37662-0901_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0901	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	100	[hp_C]/1			N	20241231
37662-0902_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0902	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	200	[hp_C]/1			N	20241231
37662-0903_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0903	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	500	[hp_C]/1			N	20241231
37662-0904_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0904	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	1	[hp_M]/1			N	20241231
37662-0905_e3cbb973-4e7a-ce48-e053-2995a90abe02	37662-0905	HUMAN OTC DRUG	Kalmia Latifolia		Kalmia Latifolia	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KALMIA LATIFOLIA LEAF	1	[hp_Q]/1			N	20241231
37662-0906_e3cd86fd-ba75-8bc4-e053-2a95a90abb54	37662-0906	HUMAN OTC DRUG	Lac Defloratum		Lac Defloratum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SKIM MILK	6	[hp_C]/1			N	20241231
37662-0907_e3cd86fd-ba75-8bc4-e053-2a95a90abb54	37662-0907	HUMAN OTC DRUG	Lac Defloratum		Lac Defloratum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SKIM MILK	12	[hp_C]/1			N	20241231
37662-0908_e3cd86fd-ba75-8bc4-e053-2a95a90abb54	37662-0908	HUMAN OTC DRUG	Lac Defloratum		Lac Defloratum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SKIM MILK	30	[hp_C]/1			N	20241231
37662-0909_e3cd86fd-ba75-8bc4-e053-2a95a90abb54	37662-0909	HUMAN OTC DRUG	Lac Defloratum		Lac Defloratum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SKIM MILK	100	[hp_C]/1			N	20241231
37662-0910_e3cd86fd-ba75-8bc4-e053-2a95a90abb54	37662-0910	HUMAN OTC DRUG	Lac Defloratum		Lac Defloratum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SKIM MILK	200	[hp_C]/1			N	20241231
37662-0911_e3cd86fd-ba75-8bc4-e053-2a95a90abb54	37662-0911	HUMAN OTC DRUG	Lac Defloratum		Lac Defloratum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SKIM MILK	500	[hp_C]/1			N	20241231
37662-0912_e3cd86fd-ba75-8bc4-e053-2a95a90abb54	37662-0912	HUMAN OTC DRUG	Lac Defloratum		Lac Defloratum	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SKIM MILK	1	[hp_M]/1			N	20241231
37662-0913_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0913	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	6	[hp_C]/1			N	20241231
37662-0914_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0914	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	12	[hp_C]/1			N	20241231
37662-0915_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0915	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	30	[hp_C]/1			N	20241231
37662-0916_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0916	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	100	[hp_C]/1			N	20241231
37662-0917_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0917	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	200	[hp_C]/1			N	20241231
37662-0918_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0918	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	500	[hp_C]/1			N	20241231
37662-0919_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0919	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	1	[hp_M]/1			N	20241231
37662-0920_e3cec038-db11-d5bd-e053-2995a90a23f5	37662-0920	HUMAN OTC DRUG	Lactuca Virosa		Lactuca Virosa	PELLET	ORAL	20220714		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTUCA VIROSA	1	[hp_Q]/1			N	20241231
37662-0921_e3dc20b9-1e39-47df-e053-2995a90abc04	37662-0921	HUMAN OTC DRUG	Gelsemium Sempervirens		Gelsemium Sempervirens	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GELSEMIUM SEMPERVIRENS ROOT	6	[hp_C]/1			N	20241231
37662-0922_e3dc20b9-1e39-47df-e053-2995a90abc04	37662-0922	HUMAN OTC DRUG	Gelsemium Sempervirens		Gelsemium Sempervirens	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GELSEMIUM SEMPERVIRENS ROOT	12	[hp_C]/1			N	20241231
37662-0923_e3dc20b9-1e39-47df-e053-2995a90abc04	37662-0923	HUMAN OTC DRUG	Gelsemium Sempervirens		Gelsemium Sempervirens	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_C]/1			N	20241231
37662-0924_e3dc20b9-1e39-47df-e053-2995a90abc04	37662-0924	HUMAN OTC DRUG	Gelsemium Sempervirens		Gelsemium Sempervirens	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GELSEMIUM SEMPERVIRENS ROOT	100	[hp_C]/1			N	20241231
37662-0925_e3dc20b9-1e39-47df-e053-2995a90abc04	37662-0925	HUMAN OTC DRUG	Gelsemium Sempervirens		Gelsemium Sempervirens	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GELSEMIUM SEMPERVIRENS ROOT	200	[hp_C]/1			N	20241231
37662-0926_e3dc20b9-1e39-47df-e053-2995a90abc04	37662-0926	HUMAN OTC DRUG	Gelsemium Sempervirens		Gelsemium Sempervirens	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GELSEMIUM SEMPERVIRENS ROOT	500	[hp_C]/1			N	20241231
37662-0927_e3dc20b9-1e39-47df-e053-2995a90abc04	37662-0927	HUMAN OTC DRUG	Gelsemium Sempervirens		Gelsemium Sempervirens	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GELSEMIUM SEMPERVIRENS ROOT	1	[hp_M]/1			N	20241231
37662-0928_e3dd4ac1-429f-723b-e053-2a95a90a892d	37662-0928	HUMAN OTC DRUG	Gnaphalium Polycephalum		Gnaphalium Polycephalum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PSEUDOGNAPHALIUM OBTUSIFOLIUM	6	[hp_C]/1			N	20241231
37662-0929_e3dd4ac1-429f-723b-e053-2a95a90a892d	37662-0929	HUMAN OTC DRUG	Gnaphalium Polycephalum		Gnaphalium Polycephalum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PSEUDOGNAPHALIUM OBTUSIFOLIUM	12	[hp_C]/1			N	20241231
37662-0930_e3dd4ac1-429f-723b-e053-2a95a90a892d	37662-0930	HUMAN OTC DRUG	Gnaphalium Polycephalum		Gnaphalium Polycephalum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PSEUDOGNAPHALIUM OBTUSIFOLIUM	30	[hp_C]/1			N	20241231
37662-0931_e3dd4ac1-429f-723b-e053-2a95a90a892d	37662-0931	HUMAN OTC DRUG	Gnaphalium Polycephalum		Gnaphalium Polycephalum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PSEUDOGNAPHALIUM OBTUSIFOLIUM	100	[hp_C]/1			N	20241231
37662-0932_e3dd4ac1-429f-723b-e053-2a95a90a892d	37662-0932	HUMAN OTC DRUG	Gnaphalium Polycephalum		Gnaphalium Polycephalum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PSEUDOGNAPHALIUM OBTUSIFOLIUM	200	[hp_C]/1			N	20241231
37662-0933_e3dd4ac1-429f-723b-e053-2a95a90a892d	37662-0933	HUMAN OTC DRUG	Gnaphalium Polycephalum		Gnaphalium Polycephalum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PSEUDOGNAPHALIUM OBTUSIFOLIUM	500	[hp_C]/1			N	20241231
37662-0934_e3dd4ac1-429f-723b-e053-2a95a90a892d	37662-0934	HUMAN OTC DRUG	Gnaphalium Polycephalum		Gnaphalium Polycephalum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PSEUDOGNAPHALIUM OBTUSIFOLIUM	1	[hp_M]/1			N	20241231
37662-0935_e3de9925-99d5-a9e8-e053-2a95a90ab34f	37662-0935	HUMAN OTC DRUG	Lithium Carbonicum		Lithium Carbonicum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CARBONATE	6	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-0936_e3de9925-99d5-a9e8-e053-2a95a90ab34f	37662-0936	HUMAN OTC DRUG	Lithium Carbonicum		Lithium Carbonicum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CARBONATE	12	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-0937_e3de9925-99d5-a9e8-e053-2a95a90ab34f	37662-0937	HUMAN OTC DRUG	Lithium Carbonicum		Lithium Carbonicum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CARBONATE	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-0938_e3de9925-99d5-a9e8-e053-2a95a90ab34f	37662-0938	HUMAN OTC DRUG	Lithium Carbonicum		Lithium Carbonicum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CARBONATE	100	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-0939_e3de9925-99d5-a9e8-e053-2a95a90ab34f	37662-0939	HUMAN OTC DRUG	Lithium Carbonicum		Lithium Carbonicum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CARBONATE	200	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-0940_e3de9925-99d5-a9e8-e053-2a95a90ab34f	37662-0940	HUMAN OTC DRUG	Lithium Carbonicum		Lithium Carbonicum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CARBONATE	500	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-0941_e3de9925-99d5-a9e8-e053-2a95a90ab34f	37662-0941	HUMAN OTC DRUG	Lithium Carbonicum		Lithium Carbonicum	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CARBONATE	1	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-0942_e3e02cf9-d65a-71cd-e053-2a95a90a5067	37662-0942	HUMAN OTC DRUG	Lemna Minor		Lemna Minor	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMNA MINOR	6	[hp_C]/1			N	20241231
37662-0943_e3e02cf9-d65a-71cd-e053-2a95a90a5067	37662-0943	HUMAN OTC DRUG	Lemna Minor		Lemna Minor	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMNA MINOR	12	[hp_C]/1			N	20241231
37662-0944_e3e02cf9-d65a-71cd-e053-2a95a90a5067	37662-0944	HUMAN OTC DRUG	Lemna Minor		Lemna Minor	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMNA MINOR	30	[hp_C]/1			N	20241231
37662-0945_e3e02cf9-d65a-71cd-e053-2a95a90a5067	37662-0945	HUMAN OTC DRUG	Lemna Minor		Lemna Minor	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMNA MINOR	100	[hp_C]/1			N	20241231
37662-0946_e3e02cf9-d65a-71cd-e053-2a95a90a5067	37662-0946	HUMAN OTC DRUG	Lemna Minor		Lemna Minor	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMNA MINOR	200	[hp_C]/1			N	20241231
37662-0947_e3e02cf9-d65a-71cd-e053-2a95a90a5067	37662-0947	HUMAN OTC DRUG	Lemna Minor		Lemna Minor	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMNA MINOR	500	[hp_C]/1			N	20241231
37662-0948_e3e02cf9-d65a-71cd-e053-2a95a90a5067	37662-0948	HUMAN OTC DRUG	Lemna Minor		Lemna Minor	PELLET	ORAL	20220715		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEMNA MINOR	1	[hp_M]/1			N	20241231
37662-0949_e41df23b-1102-68fa-e053-2995a90a667b	37662-0949	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	6	[hp_C]/1			N	20241231
37662-0950_e41df23b-1102-68fa-e053-2995a90a667b	37662-0950	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	12	[hp_C]/1			N	20241231
37662-0951_e41df23b-1102-68fa-e053-2995a90a667b	37662-0951	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	30	[hp_C]/1			N	20241231
37662-0952_e41df23b-1102-68fa-e053-2995a90a667b	37662-0952	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	100	[hp_C]/1			N	20241231
37662-0953_e41df23b-1102-68fa-e053-2995a90a667b	37662-0953	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	200	[hp_C]/1			N	20241231
37662-0954_e41df23b-1102-68fa-e053-2995a90a667b	37662-0954	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	500	[hp_C]/1			N	20241231
37662-0955_e41df23b-1102-68fa-e053-2995a90a667b	37662-0955	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	1	[hp_M]/1			N	20241231
37662-0956_e41df23b-1102-68fa-e053-2995a90a667b	37662-0956	HUMAN OTC DRUG	Cuprum Fluoratum		Cuprum Fluoratum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC FLUORIDE DIHYDRATE	1	[hp_Q]/1			N	20241231
37662-0957_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0957	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	6	[hp_C]/1			N	20241231
37662-0958_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0958	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	12	[hp_C]/1			N	20241231
37662-0959_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0959	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	30	[hp_C]/1			N	20241231
37662-0960_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0960	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	100	[hp_C]/1			N	20241231
37662-0961_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0961	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	200	[hp_C]/1			N	20241231
37662-0962_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0962	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	500	[hp_C]/1			N	20241231
37662-0963_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0963	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	1	[hp_M]/1			N	20241231
37662-0964_e41f9ab3-aff4-5a40-e053-2a95a90a15fe	37662-0964	HUMAN OTC DRUG	Cobaltum Bromatum		Cobaltum Bromatum	PELLET	ORAL	20220718		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS BROMIDE	1	[hp_Q]/1			N	20241231
37662-0965_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0965	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	6	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0966_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0966	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	12	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0967_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0967	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0968_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0968	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	100	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0969_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0969	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	200	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0970_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0970	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	500	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0971_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0971	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	1	[hp_M]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0972_e45bc2b0-72f5-42e1-e053-2995a90a0e66	37662-0972	HUMAN OTC DRUG	Magnesia Oxydata		Magnesia Oxydata	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM OXIDE	1	[hp_Q]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-0973_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0973	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	6	[hp_C]/1			N	20241231
37662-0974_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0974	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	12	[hp_C]/1			N	20241231
37662-0975_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0975	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	30	[hp_C]/1			N	20241231
37662-0976_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0976	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	100	[hp_C]/1			N	20241231
37662-0977_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0977	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	200	[hp_C]/1			N	20241231
37662-0978_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0978	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	500	[hp_C]/1			N	20241231
37662-0979_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0979	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	1	[hp_M]/1			N	20241231
37662-0980_e42ebbe6-1ef8-2d8d-e053-2a95a90a7794	37662-0980	HUMAN OTC DRUG	Acidum Fluoricum		Acidum Fluoricum	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROFLUORIC ACID	1	[hp_Q]/1			N	20241231
37662-0981_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0981	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	6	[hp_C]/1			N	20241231
37662-0982_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0982	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	12	[hp_C]/1			N	20241231
37662-0983_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0983	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	30	[hp_C]/1			N	20241231
37662-0984_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0984	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	100	[hp_C]/1			N	20241231
37662-0985_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0985	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	200	[hp_C]/1			N	20241231
37662-0986_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0986	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	500	[hp_C]/1			N	20241231
37662-0987_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0987	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	1	[hp_M]/1			N	20241231
37662-0988_e4310548-b363-a2c6-e053-2a95a90ac607	37662-0988	HUMAN OTC DRUG	Magnesia Carbonica		Magnesia Carbonica	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CARBONATE	1	[hp_Q]/1			N	20241231
37662-0989_e4329129-5c5c-7f0c-e053-2995a90aa921	37662-0989	HUMAN OTC DRUG	Dimethylum Flavus		Dimethylum Flavus	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	P-DIMETHYLAMINOAZOBENZENE	6	[hp_C]/1			N	20241231
37662-0990_e4329129-5c5c-7f0c-e053-2995a90aa921	37662-0990	HUMAN OTC DRUG	Dimethylum Flavus		Dimethylum Flavus	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	P-DIMETHYLAMINOAZOBENZENE	12	[hp_C]/1			N	20241231
37662-0991_e4329129-5c5c-7f0c-e053-2995a90aa921	37662-0991	HUMAN OTC DRUG	Dimethylum Flavus		Dimethylum Flavus	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	P-DIMETHYLAMINOAZOBENZENE	30	[hp_C]/1			N	20241231
37662-0992_e4329129-5c5c-7f0c-e053-2995a90aa921	37662-0992	HUMAN OTC DRUG	Dimethylum Flavus		Dimethylum Flavus	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	P-DIMETHYLAMINOAZOBENZENE	100	[hp_C]/1			N	20241231
37662-0993_e4329129-5c5c-7f0c-e053-2995a90aa921	37662-0993	HUMAN OTC DRUG	Dimethylum Flavus		Dimethylum Flavus	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	P-DIMETHYLAMINOAZOBENZENE	200	[hp_C]/1			N	20241231
37662-0994_e4329129-5c5c-7f0c-e053-2995a90aa921	37662-0994	HUMAN OTC DRUG	Dimethylum Flavus		Dimethylum Flavus	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	P-DIMETHYLAMINOAZOBENZENE	500	[hp_C]/1			N	20241231
37662-0995_e4329129-5c5c-7f0c-e053-2995a90aa921	37662-0995	HUMAN OTC DRUG	Dimethylum Flavus		Dimethylum Flavus	PELLET	ORAL	20220719		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	P-DIMETHYLAMINOAZOBENZENE	1	[hp_M]/1			N	20241231
37662-0996_e4434837-4541-94ff-e053-2a95a90aba6b	37662-0996	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	6	[hp_C]/1			N	20241231
37662-0997_e4434837-4541-94ff-e053-2a95a90aba6b	37662-0997	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	12	[hp_C]/1			N	20241231
37662-0998_e4434837-4541-94ff-e053-2a95a90aba6b	37662-0998	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	30	[hp_C]/1			N	20241231
37662-0999_e4434837-4541-94ff-e053-2a95a90aba6b	37662-0999	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	100	[hp_C]/1			N	20241231
37662-1000_e4434837-4541-94ff-e053-2a95a90aba6b	37662-1000	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	200	[hp_C]/1			N	20241231
37662-1001_e4434837-4541-94ff-e053-2a95a90aba6b	37662-1001	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	500	[hp_C]/1			N	20241231
37662-1002_e4434837-4541-94ff-e053-2a95a90aba6b	37662-1002	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	1	[hp_M]/1			N	20241231
37662-1003_e4434837-4541-94ff-e053-2a95a90aba6b	37662-1003	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	10	[hp_M]/1			N	20241231
37662-1004_e4434837-4541-94ff-e053-2a95a90aba6b	37662-1004	HUMAN OTC DRUG	Eupatorium Perfoliatum		Eupatorium Perfoliatum	PELLET	ORAL	20220720		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GENTIANELLA QUINQUEFOLIA	1	[hp_Q]/1			N	20241231
37662-1005_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1005	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	6	[hp_C]/1			N	20241231
37662-1006_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1006	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	12	[hp_C]/1			N	20241231
37662-1007_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1007	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	30	[hp_C]/1			N	20241231
37662-1008_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1008	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	100	[hp_C]/1			N	20241231
37662-1009_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1009	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	200	[hp_C]/1			N	20241231
37662-1010_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1010	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	500	[hp_C]/1			N	20241231
37662-1011_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1011	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	1	[hp_M]/1			N	20241231
37662-1012_e45833c5-ec2f-4ccf-e053-2a95a90ab36a	37662-1012	HUMAN OTC DRUG	Cobaltum Oxydatum		Cobaltum Oxydatum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALT OXIDE	1	[hp_Q]/1			N	20241231
37662-1013_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1013	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	6	[hp_C]/1			N	20241231
37662-1014_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1014	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	12	[hp_C]/1			N	20241231
37662-1015_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1015	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	30	[hp_C]/1			N	20241231
37662-1016_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1016	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	100	[hp_C]/1			N	20241231
37662-1017_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1017	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	200	[hp_C]/1			N	20241231
37662-1018_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1018	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	500	[hp_C]/1			N	20241231
37662-1019_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1019	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	1	[hp_M]/1			N	20241231
37662-1020_e45aac0a-8810-ad5b-e053-2a95a90a9892	37662-1020	HUMAN OTC DRUG	Cobaltum Carbonicum		Cobaltum Carbonicum	PELLET	ORAL	20220721		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS CARBONATE	1	[hp_Q]/1			N	20241231
37662-1021_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1021	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-1022_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1022	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-1023_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1023	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-1024_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1024	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-1025_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1025	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-1026_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1026	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-1027_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1027	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-1028_e45cf05f-7ca9-2654-e053-2a95a90a7425	37662-1028	HUMAN OTC DRUG	Magnesia Muriatica		Magnesia Muriatica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM CHLORIDE	1	[hp_Q]/1			N	20241231
37662-1029_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1029	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1030_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1030	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	12	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1031_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1031	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1032_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1032	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	100	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1033_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1033	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	200	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1034_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1034	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	500	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1035_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1035	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	1	[hp_M]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1036_e46cb756-bb04-4a99-e053-2a95a90a3fd5	37662-1036	HUMAN OTC DRUG	Magnesia Sulphurica		Magnesia Sulphurica	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	1	[hp_Q]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1037_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1037	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	6	[hp_C]/1			N	20241231
37662-1038_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1038	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	12	[hp_C]/1			N	20241231
37662-1039_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1039	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	30	[hp_C]/1			N	20241231
37662-1040_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1040	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	100	[hp_C]/1			N	20241231
37662-1041_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1041	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	200	[hp_C]/1			N	20241231
37662-1042_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1042	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	500	[hp_C]/1			N	20241231
37662-1043_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1043	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	1	[hp_M]/1			N	20241231
37662-1044_e46d7b97-594d-3492-e053-2995a90acd6d	37662-1044	HUMAN OTC DRUG	Lycopus Virginicus		Lycopus Virginicus	PELLET	ORAL	20220722		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPUS VIRGINICUS	1	[hp_Q]/1			N	20241231
37662-1045_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1045	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	6	[hp_C]/1			N	20241231
37662-1046_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1046	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	12	[hp_C]/1			N	20241231
37662-1047_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1047	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	30	[hp_C]/1			N	20241231
37662-1048_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1048	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	100	[hp_C]/1			N	20241231
37662-1049_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1049	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	200	[hp_C]/1			N	20241231
37662-1050_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1050	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	500	[hp_C]/1			N	20241231
37662-1051_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1051	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	1	[hp_M]/1			N	20241231
37662-1052_e4d0e7bb-e0ad-5bf2-e053-2a95a90aa219	37662-1052	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBELIA INFLATA	1	[hp_Q]/1			N	20241231
37662-1053_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1053	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	6	[hp_C]/1			N	20241231
37662-1054_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1054	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	12	[hp_C]/1			N	20241231
37662-1055_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1055	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	30	[hp_C]/1			N	20241231
37662-1056_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1056	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	100	[hp_C]/1			N	20241231
37662-1057_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1057	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	200	[hp_C]/1			N	20241231
37662-1058_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1058	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	500	[hp_C]/1			N	20241231
37662-1059_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1059	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	1	[hp_M]/1			N	20241231
37662-1060_e4d32e8a-8508-8bfd-e053-2995a90a5fe0	37662-1060	HUMAN OTC DRUG	Acidum Lacticum		Acidum Lacticum	PELLET	ORAL	20220727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTIC ACID, DL-	10	[hp_M]/1			N	20241231
37662-1061_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1061	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	6	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1062_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1062	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	12	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1063_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1063	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1064_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1064	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	100	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1065_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1065	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	200	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1066_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1066	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	500	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1067_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1067	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	1	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-1068_e4d4dc18-3e34-9d4c-e053-2995a90a15b4	37662-1068	HUMAN OTC DRUG	Lithium Bromatum		Lithium Bromatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM BROMIDE	1	[hp_Q]/1	Mood Stabilizer [EPC]		N	20241231
37662-1069_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1069	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	6	[hp_C]/1			N	20241231
37662-1070_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1070	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	12	[hp_C]/1			N	20241231
37662-1071_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1071	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	30	[hp_C]/1			N	20241231
37662-1072_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1072	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	100	[hp_C]/1			N	20241231
37662-1073_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1073	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	200	[hp_C]/1			N	20241231
37662-1074_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1074	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	500	[hp_C]/1			N	20241231
37662-1075_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1075	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	1	[hp_M]/1			N	20241231
37662-1076_e4e4c045-be83-74ae-e053-2a95a90a84d1	37662-1076	HUMAN OTC DRUG	Dysprosium Metallicum		Dysprosium Metallicum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPROSIUM	1	[hp_Q]/1			N	20241231
37662-1077_e4e5cfcf-a6fb-a6d8-e053-2995a90a4b4e	37662-1077	HUMAN OTC DRUG	Manganum Aceticum		Manganum Aceticum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE ACETATE TETRAHYDRATE	6	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1078_e4e5cfcf-a6fb-a6d8-e053-2995a90a4b4e	37662-1078	HUMAN OTC DRUG	Manganum Aceticum		Manganum Aceticum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE ACETATE TETRAHYDRATE	12	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1079_e4e5cfcf-a6fb-a6d8-e053-2995a90a4b4e	37662-1079	HUMAN OTC DRUG	Manganum Aceticum		Manganum Aceticum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE ACETATE TETRAHYDRATE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1080_e4e5cfcf-a6fb-a6d8-e053-2995a90a4b4e	37662-1080	HUMAN OTC DRUG	Manganum Aceticum		Manganum Aceticum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE ACETATE TETRAHYDRATE	100	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1081_e4e5cfcf-a6fb-a6d8-e053-2995a90a4b4e	37662-1081	HUMAN OTC DRUG	Manganum Aceticum		Manganum Aceticum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE ACETATE TETRAHYDRATE	200	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1082_e4e5cfcf-a6fb-a6d8-e053-2995a90a4b4e	37662-1082	HUMAN OTC DRUG	Manganum Aceticum		Manganum Aceticum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE ACETATE TETRAHYDRATE	500	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1083_e4e5cfcf-a6fb-a6d8-e053-2995a90a4b4e	37662-1083	HUMAN OTC DRUG	Manganum Aceticum		Manganum Aceticum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE ACETATE TETRAHYDRATE	1	[hp_M]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1084_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1084	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	6	[hp_C]/1			N	20241231
37662-1085_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1085	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	12	[hp_C]/1			N	20241231
37662-1086_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1086	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	30	[hp_C]/1			N	20241231
37662-1087_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1087	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	100	[hp_C]/1			N	20241231
37662-1088_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1088	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	200	[hp_C]/1			N	20241231
37662-1089_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1089	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	500	[hp_C]/1			N	20241231
37662-1090_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1090	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	1	[hp_M]/1			N	20241231
37662-1091_e4e80242-9a46-5166-e053-2995a90a55e8	37662-1091	HUMAN OTC DRUG	Cuprum Iodatum		Cuprum Iodatum	PELLET	ORAL	20220728		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPROUS IODIDE	1	[hp_Q]/1			N	20241231
37662-1092_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1092	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	6	[hp_C]/1			N	20241231
37662-1093_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1093	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	12	[hp_C]/1			N	20241231
37662-1094_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1094	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	30	[hp_C]/1			N	20241231
37662-1095_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1095	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	100	[hp_C]/1			N	20241231
37662-1096_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1096	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	200	[hp_C]/1			N	20241231
37662-1097_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1097	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	500	[hp_C]/1			N	20241231
37662-1098_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1098	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	1	[hp_M]/1			N	20241231
37662-1099_e4e98610-976d-2d0d-e053-2995a90a9e47	37662-1099	HUMAN OTC DRUG	Europium Metallicum		Europium Metallicum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	EUROPIUM	1	[hp_Q]/1			N	20241231
37662-1100_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1100	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	6	[hp_C]/1			N	20241231
37662-1101_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1101	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	12	[hp_C]/1			N	20241231
37662-1102_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1102	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	30	[hp_C]/1			N	20241231
37662-1103_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1103	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	100	[hp_C]/1			N	20241231
37662-1104_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1104	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	200	[hp_C]/1			N	20241231
37662-1105_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1105	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	500	[hp_C]/1			N	20241231
37662-1106_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1106	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	1	[hp_M]/1			N	20241231
37662-1107_e4f988c2-9d03-65fe-e053-2995a90aa8b4	37662-1107	HUMAN OTC DRUG	Ferrum Fluoratum		Ferrum Fluoratum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC FLUORIDE	1	[hp_Q]/1			N	20241231
37662-1108_e4fc7c46-39ef-7251-e053-2995a90ae464	37662-1108	HUMAN OTC DRUG	Natrum Nitricum		Natrum Nitricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NITRATE	6	[hp_C]/1			N	20241231
37662-1109_e4fc7c46-39ef-7251-e053-2995a90ae464	37662-1109	HUMAN OTC DRUG	Natrum Nitricum		Natrum Nitricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NITRATE	12	[hp_C]/1			N	20241231
37662-1110_e4fc7c46-39ef-7251-e053-2995a90ae464	37662-1110	HUMAN OTC DRUG	Natrum Nitricum		Natrum Nitricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NITRATE	30	[hp_C]/1			N	20241231
37662-1111_e4fc7c46-39ef-7251-e053-2995a90ae464	37662-1111	HUMAN OTC DRUG	Natrum Nitricum		Natrum Nitricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NITRATE	100	[hp_C]/1			N	20241231
37662-1112_e4fc7c46-39ef-7251-e053-2995a90ae464	37662-1112	HUMAN OTC DRUG	Natrum Nitricum		Natrum Nitricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NITRATE	200	[hp_C]/1			N	20241231
37662-1113_e4fc7c46-39ef-7251-e053-2995a90ae464	37662-1113	HUMAN OTC DRUG	Natrum Nitricum		Natrum Nitricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NITRATE	500	[hp_C]/1			N	20241231
37662-1114_e4fc7c46-39ef-7251-e053-2995a90ae464	37662-1114	HUMAN OTC DRUG	Natrum Nitricum		Natrum Nitricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NITRATE	1	[hp_M]/1			N	20241231
37662-1115_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1115	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	6	[hp_C]/1			N	20241231
37662-1116_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1116	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	12	[hp_C]/1			N	20241231
37662-1117_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1117	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	30	[hp_C]/1			N	20241231
37662-1118_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1118	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	100	[hp_C]/1			N	20241231
37662-1119_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1119	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	200	[hp_C]/1			N	20241231
37662-1120_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1120	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	500	[hp_C]/1			N	20241231
37662-1121_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1121	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	1	[hp_M]/1			N	20241231
37662-1122_e4fdabac-edc0-bb14-e053-2a95a90aab7e	37662-1122	HUMAN OTC DRUG	Cobaltum Phosphoricum		Cobaltum Phosphoricum	PELLET	ORAL	20220729		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS PHOSPHATE	1	[hp_Q]/1			N	20241231
37662-1123_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1123	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	6	[hp_C]/1			N	20241231
37662-1124_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1124	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	12	[hp_C]/1			N	20241231
37662-1125_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1125	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	30	[hp_C]/1			N	20241231
37662-1126_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1126	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	100	[hp_C]/1			N	20241231
37662-1127_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1127	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	200	[hp_C]/1			N	20241231
37662-1128_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1128	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	500	[hp_C]/1			N	20241231
37662-1129_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1129	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	1	[hp_M]/1			N	20241231
37662-1130_e5349a58-f0fe-8173-e053-2995a90adb7c	37662-1130	HUMAN OTC DRUG	Manganum Metallicum		Manganum Metallicum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE	1	[hp_Q]/1			N	20241231
37662-1131_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1131	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1132_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1132	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1133_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1133	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1134_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1134	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1135_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1135	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1136_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1136	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1137_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1137	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1138_e5367169-cdcc-dd6d-e053-2a95a90a5fa9	37662-1138	HUMAN OTC DRUG	Manganum Muriaticum		Manganum Muriaticum	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CHLORIDE	1	[hp_Q]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1139_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1139	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	6	[hp_C]/1			N	20241231
37662-1140_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1140	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	12	[hp_C]/1			N	20241231
37662-1141_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1141	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	30	[hp_C]/1			N	20241231
37662-1142_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1142	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	100	[hp_C]/1			N	20241231
37662-1143_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1143	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	200	[hp_C]/1			N	20241231
37662-1144_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1144	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	500	[hp_C]/1			N	20241231
37662-1145_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1145	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	1	[hp_M]/1			N	20241231
37662-1146_e537e1fc-3b8a-8ce1-e053-2a95a90a8005	37662-1146	HUMAN OTC DRUG	Melilotus Officinalis		Melilotus Officinalis	PELLET	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS OFFICINALIS TOP	1	[hp_Q]/1			N	20241231
37662-1147_e5494923-4ec0-46d4-e053-2a95a90a0161	37662-1147	HUMAN OTC DRUG	Natrum Salicylicum		Natrum Salicylicum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SALICYLATE	6	[hp_C]/1			N	20241231
37662-1148_e5494923-4ec0-46d4-e053-2a95a90a0161	37662-1148	HUMAN OTC DRUG	Natrum Salicylicum		Natrum Salicylicum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SALICYLATE	12	[hp_C]/1			N	20241231
37662-1149_e5494923-4ec0-46d4-e053-2a95a90a0161	37662-1149	HUMAN OTC DRUG	Natrum Salicylicum		Natrum Salicylicum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SALICYLATE	30	[hp_C]/1			N	20241231
37662-1150_e5494923-4ec0-46d4-e053-2a95a90a0161	37662-1150	HUMAN OTC DRUG	Natrum Salicylicum		Natrum Salicylicum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SALICYLATE	100	[hp_C]/1			N	20241231
37662-1151_e5494923-4ec0-46d4-e053-2a95a90a0161	37662-1151	HUMAN OTC DRUG	Natrum Salicylicum		Natrum Salicylicum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SALICYLATE	200	[hp_C]/1			N	20241231
37662-1152_e5494923-4ec0-46d4-e053-2a95a90a0161	37662-1152	HUMAN OTC DRUG	Natrum Salicylicum		Natrum Salicylicum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SALICYLATE	500	[hp_C]/1			N	20241231
37662-1153_e5494923-4ec0-46d4-e053-2a95a90a0161	37662-1153	HUMAN OTC DRUG	Natrum Salicylicum		Natrum Salicylicum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SALICYLATE	1	[hp_M]/1			N	20241231
37662-1154_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1154	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-1155_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1155	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-1156_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1156	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-1157_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1157	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-1158_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1158	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-1159_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1159	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-1160_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1160	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-1161_e54bdb28-890c-4869-e053-2995a90a8efd	37662-1161	HUMAN OTC DRUG	Natrum Fluoratum		Natrum Fluoratum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM FLUORIDE	1	[hp_Q]/1			N	20241231
37662-1162_e54d7f79-f98b-1011-e053-2a95a90a3745	37662-1162	HUMAN OTC DRUG	Niccolum Sulphuricum		Niccolum Sulphuricum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL SULFATE HEXAHYDRATE	6	[hp_C]/1			N	20241231
37662-1163_e54d7f79-f98b-1011-e053-2a95a90a3745	37662-1163	HUMAN OTC DRUG	Niccolum Sulphuricum		Niccolum Sulphuricum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL SULFATE HEXAHYDRATE	12	[hp_C]/1			N	20241231
37662-1164_e54d7f79-f98b-1011-e053-2a95a90a3745	37662-1164	HUMAN OTC DRUG	Niccolum Sulphuricum		Niccolum Sulphuricum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL SULFATE HEXAHYDRATE	30	[hp_C]/1			N	20241231
37662-1165_e54d7f79-f98b-1011-e053-2a95a90a3745	37662-1165	HUMAN OTC DRUG	Niccolum Sulphuricum		Niccolum Sulphuricum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL SULFATE HEXAHYDRATE	100	[hp_C]/1			N	20241231
37662-1166_e54d7f79-f98b-1011-e053-2a95a90a3745	37662-1166	HUMAN OTC DRUG	Niccolum Sulphuricum		Niccolum Sulphuricum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL SULFATE HEXAHYDRATE	200	[hp_C]/1			N	20241231
37662-1167_e54d7f79-f98b-1011-e053-2a95a90a3745	37662-1167	HUMAN OTC DRUG	Niccolum Sulphuricum		Niccolum Sulphuricum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL SULFATE HEXAHYDRATE	500	[hp_C]/1			N	20241231
37662-1168_e54d7f79-f98b-1011-e053-2a95a90a3745	37662-1168	HUMAN OTC DRUG	Niccolum Sulphuricum		Niccolum Sulphuricum	PELLET	ORAL	20220802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL SULFATE HEXAHYDRATE	1	[hp_M]/1			N	20241231
37662-1169_e55bf1b6-5482-3b3d-e053-2a95a90a8747	37662-1169	HUMAN OTC DRUG	Pareira Brava		Pareira Brava	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHONDRODENDRON TOMENTOSUM ROOT	6	[hp_C]/1			N	20241231
37662-1170_e55bf1b6-5482-3b3d-e053-2a95a90a8747	37662-1170	HUMAN OTC DRUG	Pareira Brava		Pareira Brava	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHONDRODENDRON TOMENTOSUM ROOT	12	[hp_C]/1			N	20241231
37662-1171_e55bf1b6-5482-3b3d-e053-2a95a90a8747	37662-1171	HUMAN OTC DRUG	Pareira Brava		Pareira Brava	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHONDRODENDRON TOMENTOSUM ROOT	30	[hp_C]/1			N	20241231
37662-1172_e55bf1b6-5482-3b3d-e053-2a95a90a8747	37662-1172	HUMAN OTC DRUG	Pareira Brava		Pareira Brava	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHONDRODENDRON TOMENTOSUM ROOT	100	[hp_C]/1			N	20241231
37662-1173_e55bf1b6-5482-3b3d-e053-2a95a90a8747	37662-1173	HUMAN OTC DRUG	Pareira Brava		Pareira Brava	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHONDRODENDRON TOMENTOSUM ROOT	200	[hp_C]/1			N	20241231
37662-1174_e55bf1b6-5482-3b3d-e053-2a95a90a8747	37662-1174	HUMAN OTC DRUG	Pareira Brava		Pareira Brava	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHONDRODENDRON TOMENTOSUM ROOT	500	[hp_C]/1			N	20241231
37662-1175_e55bf1b6-5482-3b3d-e053-2a95a90a8747	37662-1175	HUMAN OTC DRUG	Pareira Brava		Pareira Brava	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHONDRODENDRON TOMENTOSUM ROOT	1	[hp_M]/1			N	20241231
37662-1176_e55f6111-c940-26d0-e053-2995a90ae173	37662-1176	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	6	[hp_C]/1			N	20241231
37662-1177_e55f6111-c940-26d0-e053-2995a90ae173	37662-1177	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	12	[hp_C]/1			N	20241231
37662-1178_e55f6111-c940-26d0-e053-2995a90ae173	37662-1178	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	30	[hp_C]/1			N	20241231
37662-1179_e55f6111-c940-26d0-e053-2995a90ae173	37662-1179	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	100	[hp_C]/1			N	20241231
37662-1180_e55f6111-c940-26d0-e053-2995a90ae173	37662-1180	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	200	[hp_C]/1			N	20241231
37662-1181_e55f6111-c940-26d0-e053-2995a90ae173	37662-1181	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	500	[hp_C]/1			N	20241231
37662-1182_e55f6111-c940-26d0-e053-2995a90ae173	37662-1182	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	1	[hp_M]/1			N	20241231
37662-1183_e55f6111-c940-26d0-e053-2995a90ae173	37662-1183	HUMAN OTC DRUG	Natrum Sulphuratum		Natrum Sulphuratum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	1	[hp_Q]/1			N	20241231
37662-1184_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1184	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	6	[hp_C]/1			N	20241231
37662-1185_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1185	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	12	[hp_C]/1			N	20241231
37662-1186_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1186	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	30	[hp_C]/1			N	20241231
37662-1187_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1187	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	100	[hp_C]/1			N	20241231
37662-1188_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1188	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	200	[hp_C]/1			N	20241231
37662-1189_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1189	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	500	[hp_C]/1			N	20241231
37662-1190_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1190	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	1	[hp_M]/1			N	20241231
37662-1191_e5607f2a-28af-a442-e053-2995a90a01a3	37662-1191	HUMAN OTC DRUG	Nuphar Luteum		Nuphar Luteum	PELLET	ORAL	20220803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUPHAR LUTEUM ROOT	1	[hp_Q]/1			N	20241231
37662-1192_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1192	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1193_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1193	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1194_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1194	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1195_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1195	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1196_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1196	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1197_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1197	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1198_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1198	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1199_e56f33e8-bd96-3560-e053-2995a90a9b0d	37662-1199	HUMAN OTC DRUG	Salvia Officinalis		Salvia Officinalis	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAGE	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1200_e5718ce2-4f4f-7172-e053-2a95a90ad868	37662-1200	HUMAN OTC DRUG	Sabal Serrulata		Sabal Serrulata	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAW PALMETTO	6	[hp_C]/1			N	20241231
37662-1201_e5718ce2-4f4f-7172-e053-2a95a90ad868	37662-1201	HUMAN OTC DRUG	Sabal Serrulata		Sabal Serrulata	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAW PALMETTO	12	[hp_C]/1			N	20241231
37662-1202_e5718ce2-4f4f-7172-e053-2a95a90ad868	37662-1202	HUMAN OTC DRUG	Sabal Serrulata		Sabal Serrulata	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAW PALMETTO	30	[hp_C]/1			N	20241231
37662-1203_e5718ce2-4f4f-7172-e053-2a95a90ad868	37662-1203	HUMAN OTC DRUG	Sabal Serrulata		Sabal Serrulata	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAW PALMETTO	100	[hp_C]/1			N	20241231
37662-1204_e5718ce2-4f4f-7172-e053-2a95a90ad868	37662-1204	HUMAN OTC DRUG	Sabal Serrulata		Sabal Serrulata	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAW PALMETTO	200	[hp_C]/1			N	20241231
37662-1205_e5718ce2-4f4f-7172-e053-2a95a90ad868	37662-1205	HUMAN OTC DRUG	Sabal Serrulata		Sabal Serrulata	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAW PALMETTO	500	[hp_C]/1			N	20241231
37662-1206_e5718ce2-4f4f-7172-e053-2a95a90ad868	37662-1206	HUMAN OTC DRUG	Sabal Serrulata		Sabal Serrulata	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAW PALMETTO	1	[hp_M]/1			N	20241231
37662-1207_e572f913-9239-d58b-e053-2995a90af6ca	37662-1207	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-1208_e572f913-9239-d58b-e053-2995a90af6ca	37662-1208	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-1209_e572f913-9239-d58b-e053-2995a90af6ca	37662-1209	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-1210_e572f913-9239-d58b-e053-2995a90af6ca	37662-1210	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-1211_e572f913-9239-d58b-e053-2995a90af6ca	37662-1211	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-1212_e572f913-9239-d58b-e053-2995a90af6ca	37662-1212	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-1213_e572f913-9239-d58b-e053-2995a90af6ca	37662-1213	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-1214_e572f913-9239-d58b-e053-2995a90af6ca	37662-1214	HUMAN OTC DRUG	Sambucus Nigra		Sambucus Nigra	PELLET	ORAL	20220804		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMBUCUS NIGRA FLOWERING TOP	1	[hp_Q]/1			N	20241231
37662-1215_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1215	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	6	[hp_C]/1			N	20241231
37662-1216_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1216	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	12	[hp_C]/1			N	20241231
37662-1217_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1217	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	30	[hp_C]/1			N	20241231
37662-1218_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1218	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	100	[hp_C]/1			N	20241231
37662-1219_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1219	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	200	[hp_C]/1			N	20241231
37662-1220_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1220	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	500	[hp_C]/1			N	20241231
37662-1221_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1221	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	1	[hp_M]/1			N	20241231
37662-1222_e5bf009d-b80a-60f3-e053-2995a90a6d66	37662-1222	HUMAN OTC DRUG	Sabadilla		Sabadilla	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCHOENOCAULON OFFICINALE SEED	1	[hp_Q]/1			N	20241231
37662-1223_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1223	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	6	[hp_C]/1			N	20241231
37662-1224_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1224	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	12	[hp_C]/1			N	20241231
37662-1225_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1225	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	30	[hp_C]/1			N	20241231
37662-1226_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1226	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	100	[hp_C]/1			N	20241231
37662-1227_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1227	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	200	[hp_C]/1			N	20241231
37662-1228_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1228	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	500	[hp_C]/1			N	20241231
37662-1229_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1229	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	1	[hp_M]/1			N	20241231
37662-1230_e5c07422-c190-13f6-e053-2a95a90a04d6	37662-1230	HUMAN OTC DRUG	Scrophularia Nodosa		Scrophularia Nodosa	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCROPHULARIA NODOSA	1	[hp_Q]/1			N	20241231
37662-1231_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1231	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-1232_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1232	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-1233_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1233	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-1234_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1234	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-1235_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1235	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-1236_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1236	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-1237_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1237	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-1238_e5c2cbe2-7dbe-0f88-e053-2a95a90a134b	37662-1238	HUMAN OTC DRUG	Rosmarinus Officinalis		Rosmarinus Officinalis	PELLET	ORAL	20220808		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSMARINUS OFFICINALIS FLOWERING TOP	1	[hp_Q]/1			N	20241231
37662-1239_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1239	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	6	[hp_C]/1			N	20241231
37662-1240_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1240	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	12	[hp_C]/1			N	20241231
37662-1241_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1241	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	30	[hp_C]/1			N	20241231
37662-1242_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1242	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	100	[hp_C]/1			N	20241231
37662-1243_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1243	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	200	[hp_C]/1			N	20241231
37662-1244_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1244	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	500	[hp_C]/1			N	20241231
37662-1245_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1245	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	1	[hp_M]/1			N	20241231
37662-1246_e5d48085-ffbe-129c-e053-2995a90a034b	37662-1246	HUMAN OTC DRUG	Secale Cornutum		Secale Cornutum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CLAVICEPS PURPUREA SCLEROTIUM	1	[hp_Q]/1			N	20241231
37662-1247_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1247	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	6	[hp_C]/1			N	20241231
37662-1248_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1248	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	12	[hp_C]/1			N	20241231
37662-1249_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1249	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	30	[hp_C]/1			N	20241231
37662-1250_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1250	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	100	[hp_C]/1			N	20241231
37662-1251_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1251	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	200	[hp_C]/1			N	20241231
37662-1252_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1252	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	500	[hp_C]/1			N	20241231
37662-1253_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1253	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	1	[hp_M]/1			N	20241231
37662-1254_e5d5eaf6-b5d3-b483-e053-2995a90af117	37662-1254	HUMAN OTC DRUG	Selenium Metallicum		Selenium Metallicum	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM	1	[hp_Q]/1			N	20241231
37662-1255_e5d7dc1e-dda1-214c-e053-2a95a90adfcf	37662-1255	HUMAN OTC DRUG	Stellaria Media		Stellaria Media	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STELLARIA MEDIA	6	[hp_C]/1			N	20241231
37662-1256_e5d7dc1e-dda1-214c-e053-2a95a90adfcf	37662-1256	HUMAN OTC DRUG	Stellaria Media		Stellaria Media	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STELLARIA MEDIA	12	[hp_C]/1			N	20241231
37662-1257_e5d7dc1e-dda1-214c-e053-2a95a90adfcf	37662-1257	HUMAN OTC DRUG	Stellaria Media		Stellaria Media	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STELLARIA MEDIA	30	[hp_C]/1			N	20241231
37662-1258_e5d7dc1e-dda1-214c-e053-2a95a90adfcf	37662-1258	HUMAN OTC DRUG	Stellaria Media		Stellaria Media	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STELLARIA MEDIA	100	[hp_C]/1			N	20241231
37662-1259_e5d7dc1e-dda1-214c-e053-2a95a90adfcf	37662-1259	HUMAN OTC DRUG	Stellaria Media		Stellaria Media	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STELLARIA MEDIA	200	[hp_C]/1			N	20241231
37662-1260_e5d7dc1e-dda1-214c-e053-2a95a90adfcf	37662-1260	HUMAN OTC DRUG	Stellaria Media		Stellaria Media	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STELLARIA MEDIA	500	[hp_C]/1			N	20241231
37662-1261_e5d7dc1e-dda1-214c-e053-2a95a90adfcf	37662-1261	HUMAN OTC DRUG	Stellaria Media		Stellaria Media	PELLET	ORAL	20220809		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STELLARIA MEDIA	1	[hp_M]/1			N	20241231
37662-1262_e5e65c7a-55d7-2fde-e053-2995a90a5d14	37662-1262	HUMAN OTC DRUG	Strophanthus Hispidus		Strophanthus Hispidus	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STROPHANTHUS HISPIDUS SEED	6	[hp_C]/1			N	20241231
37662-1263_e5e65c7a-55d7-2fde-e053-2995a90a5d14	37662-1263	HUMAN OTC DRUG	Strophanthus Hispidus		Strophanthus Hispidus	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STROPHANTHUS HISPIDUS SEED	12	[hp_C]/1			N	20241231
37662-1264_e5e65c7a-55d7-2fde-e053-2995a90a5d14	37662-1264	HUMAN OTC DRUG	Strophanthus Hispidus		Strophanthus Hispidus	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STROPHANTHUS HISPIDUS SEED	30	[hp_C]/1			N	20241231
37662-1265_e5e65c7a-55d7-2fde-e053-2995a90a5d14	37662-1265	HUMAN OTC DRUG	Strophanthus Hispidus		Strophanthus Hispidus	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STROPHANTHUS HISPIDUS SEED	100	[hp_C]/1			N	20241231
37662-1266_e5e65c7a-55d7-2fde-e053-2995a90a5d14	37662-1266	HUMAN OTC DRUG	Strophanthus Hispidus		Strophanthus Hispidus	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STROPHANTHUS HISPIDUS SEED	200	[hp_C]/1			N	20241231
37662-1267_e5e65c7a-55d7-2fde-e053-2995a90a5d14	37662-1267	HUMAN OTC DRUG	Strophanthus Hispidus		Strophanthus Hispidus	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STROPHANTHUS HISPIDUS SEED	500	[hp_C]/1			N	20241231
37662-1268_e5e65c7a-55d7-2fde-e053-2995a90a5d14	37662-1268	HUMAN OTC DRUG	Strophanthus Hispidus		Strophanthus Hispidus	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STROPHANTHUS HISPIDUS SEED	1	[hp_M]/1			N	20241231
37662-1269_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1269	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	6	[hp_C]/1			N	20241231
37662-1270_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1270	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	12	[hp_C]/1			N	20241231
37662-1271_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1271	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	30	[hp_C]/1			N	20241231
37662-1272_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1272	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	100	[hp_C]/1			N	20241231
37662-1273_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1273	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	200	[hp_C]/1			N	20241231
37662-1274_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1274	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	500	[hp_C]/1			N	20241231
37662-1275_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1275	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	1	[hp_M]/1			N	20241231
37662-1276_e5e7d7bf-0389-4aa2-e053-2a95a90a1352	37662-1276	HUMAN OTC DRUG	Strontium Bromatum		Strontium Bromatum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM BROMIDE	1	[hp_Q]/1			N	20241231
37662-1277_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1277	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	6	[hp_C]/1			N	20241231
37662-1278_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1278	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	12	[hp_C]/1			N	20241231
37662-1279_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1279	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	30	[hp_C]/1			N	20241231
37662-1280_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1280	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	100	[hp_C]/1			N	20241231
37662-1281_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1281	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	200	[hp_C]/1			N	20241231
37662-1282_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1282	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	500	[hp_C]/1			N	20241231
37662-1283_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1283	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	1	[hp_M]/1			N	20241231
37662-1284_e5e8ac6c-aa31-202c-e053-2a95a90a5438	37662-1284	HUMAN OTC DRUG	Titanium Metallicum		Titanium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM	1	[hp_Q]/1			N	20241231
37662-1285_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1285	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	6	[hp_C]/1			N	20241231
37662-1286_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1286	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	12	[hp_C]/1			N	20241231
37662-1287_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1287	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	30	[hp_C]/1			N	20241231
37662-1288_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1288	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	100	[hp_C]/1			N	20241231
37662-1289_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1289	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	200	[hp_C]/1			N	20241231
37662-1290_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1290	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	500	[hp_C]/1			N	20241231
37662-1291_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1291	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	1	[hp_M]/1			N	20241231
37662-1292_e5e92ba0-7862-5117-e053-2a95a90a99d9	37662-1292	HUMAN OTC DRUG	Tellurium Metallicum		Tellurium Metallicum	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM	1	[hp_Q]/1			N	20241231
37662-1293_e5eb7691-0454-2987-e053-2995a90a8562	37662-1293	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	6	[hp_C]/1			N	20241231
37662-1294_e5eb7691-0454-2987-e053-2995a90a8562	37662-1294	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	12	[hp_C]/1			N	20241231
37662-1295_e5eb7691-0454-2987-e053-2995a90a8562	37662-1295	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	30	[hp_C]/1			N	20241231
37662-1296_e5eb7691-0454-2987-e053-2995a90a8562	37662-1296	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	100	[hp_C]/1			N	20241231
37662-1297_e5eb7691-0454-2987-e053-2995a90a8562	37662-1297	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	200	[hp_C]/1			N	20241231
37662-1298_e5eb7691-0454-2987-e053-2995a90a8562	37662-1298	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	500	[hp_C]/1			N	20241231
37662-1299_e5eb7691-0454-2987-e053-2995a90a8562	37662-1299	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	1	[hp_M]/1			N	20241231
37662-1300_e5eb7691-0454-2987-e053-2995a90a8562	37662-1300	HUMAN OTC DRUG	Taraxacum Officinale		Taraxacum Officinale	PELLET	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TARAXACUM OFFICINALE	1	[hp_Q]/1			N	20241231
37662-1301_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1301	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	6	[hp_C]/1			N	20241231
37662-1302_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1302	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	12	[hp_C]/1			N	20241231
37662-1303_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1303	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	30	[hp_C]/1			N	20241231
37662-1304_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1304	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	100	[hp_C]/1			N	20241231
37662-1305_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1305	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	200	[hp_C]/1			N	20241231
37662-1306_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1306	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	500	[hp_C]/1			N	20241231
37662-1307_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1307	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	1	[hp_M]/1			N	20241231
37662-1308_e5fafb25-a010-65ba-e053-2a95a90a4228	37662-1308	HUMAN OTC DRUG	Veratrum Album		Veratrum Album	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM ALBUM ROOT	1	[hp_Q]/1			N	20241231
37662-1309_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1309	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	6	[hp_C]/1			N	20241231
37662-1310_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1310	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	12	[hp_C]/1			N	20241231
37662-1311_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1311	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	30	[hp_C]/1			N	20241231
37662-1312_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1312	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	100	[hp_C]/1			N	20241231
37662-1313_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1313	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	200	[hp_C]/1			N	20241231
37662-1314_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1314	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	500	[hp_C]/1			N	20241231
37662-1315_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1315	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	1	[hp_M]/1			N	20241231
37662-1316_e5fd619f-60d9-c751-e053-2a95a90aa70c	37662-1316	HUMAN OTC DRUG	Veratrum Viride		Veratrum Viride	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM VIRIDE ROOT	1	[hp_Q]/1			N	20241231
37662-1317_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1317	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	6	[hp_C]/1			N	20241231
37662-1318_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1318	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	12	[hp_C]/1			N	20241231
37662-1319_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1319	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	30	[hp_C]/1			N	20241231
37662-1320_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1320	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	100	[hp_C]/1			N	20241231
37662-1321_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1321	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	200	[hp_C]/1			N	20241231
37662-1322_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1322	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	500	[hp_C]/1			N	20241231
37662-1323_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1323	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	1	[hp_M]/1			N	20241231
37662-1324_e5fe0aed-7a51-c606-e053-2995a90af8a7	37662-1324	HUMAN OTC DRUG	Vinca Minor		Vinca Minor	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VINCA MINOR	1	[hp_Q]/1			N	20241231
37662-1325_e60062b5-caef-192f-e053-2a95a90aacea	37662-1325	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	6	[hp_C]/1			N	20241231
37662-1326_e60062b5-caef-192f-e053-2a95a90aacea	37662-1326	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	12	[hp_C]/1			N	20241231
37662-1327_e60062b5-caef-192f-e053-2a95a90aacea	37662-1327	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	30	[hp_C]/1			N	20241231
37662-1328_e60062b5-caef-192f-e053-2a95a90aacea	37662-1328	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	100	[hp_C]/1			N	20241231
37662-1329_e60062b5-caef-192f-e053-2a95a90aacea	37662-1329	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	200	[hp_C]/1			N	20241231
37662-1330_e60062b5-caef-192f-e053-2a95a90aacea	37662-1330	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	500	[hp_C]/1			N	20241231
37662-1331_e60062b5-caef-192f-e053-2a95a90aacea	37662-1331	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	1	[hp_M]/1			N	20241231
37662-1332_e60062b5-caef-192f-e053-2a95a90aacea	37662-1332	HUMAN OTC DRUG	Viola Odorata		Viola Odorata	PELLET	ORAL	20220811		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA ODORATA	1	[hp_Q]/1			N	20241231
37662-1333_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1333	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	6	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1334_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1334	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	12	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1335_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1335	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	30	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1336_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1336	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	100	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1337_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1337	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	200	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1338_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1338	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	500	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1339_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1339	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	1	[hp_M]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1340_e601f6b4-8a47-3169-e053-2a95a90ab167	37662-1340	HUMAN OTC DRUG	Zincum Carbonicum		Zincum Carbonicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CARBONATE	1	[hp_Q]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-1341_e6115854-4d17-730a-e053-2a95a90a125a	37662-1341	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	6	[hp_C]/1			N	20241231
37662-1342_e6115854-4d17-730a-e053-2a95a90a125a	37662-1342	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	12	[hp_C]/1			N	20241231
37662-1343_e6115854-4d17-730a-e053-2a95a90a125a	37662-1343	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	30	[hp_C]/1			N	20241231
37662-1344_e6115854-4d17-730a-e053-2a95a90a125a	37662-1344	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	100	[hp_C]/1			N	20241231
37662-1345_e6115854-4d17-730a-e053-2a95a90a125a	37662-1345	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	200	[hp_C]/1			N	20241231
37662-1346_e6115854-4d17-730a-e053-2a95a90a125a	37662-1346	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	500	[hp_C]/1			N	20241231
37662-1347_e6115854-4d17-730a-e053-2a95a90a125a	37662-1347	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	1	[hp_M]/1			N	20241231
37662-1348_e6115854-4d17-730a-e053-2a95a90a125a	37662-1348	HUMAN OTC DRUG	Viburnum Opulus		Viburnum Opulus	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIBURNUM OPULUS BARK	1	[hp_Q]/1			N	20241231
37662-1349_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1349	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	6	[hp_C]/1			N	20241231
37662-1350_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1350	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	12	[hp_C]/1			N	20241231
37662-1351_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1351	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	30	[hp_C]/1			N	20241231
37662-1352_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1352	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	100	[hp_C]/1			N	20241231
37662-1353_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1353	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	200	[hp_C]/1			N	20241231
37662-1354_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1354	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	500	[hp_C]/1			N	20241231
37662-1355_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1355	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	1	[hp_M]/1			N	20241231
37662-1356_e61312a4-3caa-4f35-e053-2a95a90ac95c	37662-1356	HUMAN OTC DRUG	Vanadium Metallicum		Vanadium Metallicum	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM	1	[hp_Q]/1			N	20241231
37662-1357_e61531a6-8a75-5ec3-e053-2995a90a0a57	37662-1357	HUMAN OTC DRUG	Plantago Major		Plantago Major	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLANTAGO MAJOR	6	[hp_C]/1			N	20241231
37662-1358_e61531a6-8a75-5ec3-e053-2995a90a0a57	37662-1358	HUMAN OTC DRUG	Plantago Major		Plantago Major	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLANTAGO MAJOR	12	[hp_C]/1			N	20241231
37662-1359_e61531a6-8a75-5ec3-e053-2995a90a0a57	37662-1359	HUMAN OTC DRUG	Plantago Major		Plantago Major	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLANTAGO MAJOR	30	[hp_C]/1			N	20241231
37662-1360_e61531a6-8a75-5ec3-e053-2995a90a0a57	37662-1360	HUMAN OTC DRUG	Plantago Major		Plantago Major	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLANTAGO MAJOR	100	[hp_C]/1			N	20241231
37662-1361_e61531a6-8a75-5ec3-e053-2995a90a0a57	37662-1361	HUMAN OTC DRUG	Plantago Major		Plantago Major	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLANTAGO MAJOR	200	[hp_C]/1			N	20241231
37662-1362_e61531a6-8a75-5ec3-e053-2995a90a0a57	37662-1362	HUMAN OTC DRUG	Plantago Major		Plantago Major	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLANTAGO MAJOR	500	[hp_C]/1			N	20241231
37662-1363_e61531a6-8a75-5ec3-e053-2995a90a0a57	37662-1363	HUMAN OTC DRUG	Plantago Major		Plantago Major	PELLET	ORAL	20220812		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLANTAGO MAJOR	1	[hp_M]/1			N	20241231
37662-1364_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1364	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	6	[hp_C]/1			N	20241231
37662-1365_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1365	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	12	[hp_C]/1			N	20241231
37662-1366_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1366	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	30	[hp_C]/1			N	20241231
37662-1367_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1367	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	100	[hp_C]/1			N	20241231
37662-1368_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1368	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	200	[hp_C]/1			N	20241231
37662-1369_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1369	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	500	[hp_C]/1			N	20241231
37662-1370_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1370	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	1	[hp_M]/1			N	20241231
37662-1371_e68a82f1-8448-ef30-e053-2a95a90a9531	37662-1371	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS SPINOSA FLOWER BUD	1	[hp_Q]/1			N	20241231
37662-1372_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1372	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	6	[hp_C]/1			N	20241231
37662-1373_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1373	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	12	[hp_C]/1			N	20241231
37662-1374_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1374	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	30	[hp_C]/1			N	20241231
37662-1375_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1375	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	100	[hp_C]/1			N	20241231
37662-1376_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1376	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	200	[hp_C]/1			N	20241231
37662-1377_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1377	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	500	[hp_C]/1			N	20241231
37662-1378_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1378	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	1	[hp_M]/1			N	20241231
37662-1379_e68d0227-13a9-c6be-e053-2a95a90aacbd	37662-1379	HUMAN OTC DRUG	Rhus Glabra		Rhus Glabra	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHUS GLABRA TOP	1	[hp_Q]/1			N	20241231
37662-1380_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1380	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	6	[hp_C]/1			N	20241231
37662-1381_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1381	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	12	[hp_C]/1			N	20241231
37662-1382_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1382	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	30	[hp_C]/1			N	20241231
37662-1383_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1383	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	100	[hp_C]/1			N	20241231
37662-1384_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1384	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	200	[hp_C]/1			N	20241231
37662-1385_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1385	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	500	[hp_C]/1			N	20241231
37662-1386_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1386	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	1	[hp_M]/1			N	20241231
37662-1387_e68f80d1-d0dc-01bd-e053-2a95a90a101f	37662-1387	HUMAN OTC DRUG	Plumbum Metallicum		Plumbum Metallicum	PELLET	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD	1	[hp_Q]/1			N	20241231
37662-1388_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1388	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	6	[hp_C]/1			N	20241231
37662-1389_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1389	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	12	[hp_C]/1			N	20241231
37662-1390_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1390	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	30	[hp_C]/1			N	20241231
37662-1391_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1391	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	100	[hp_C]/1			N	20241231
37662-1392_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1392	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	200	[hp_C]/1			N	20241231
37662-1393_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1393	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	500	[hp_C]/1			N	20241231
37662-1394_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1394	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	1	[hp_M]/1			N	20241231
37662-1395_e69133b2-2979-c65f-e053-2a95a90a74bd	37662-1395	HUMAN OTC DRUG	Ricinus Communis		Ricinus Communis	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RICINUS COMMUNIS SEED	1	[hp_Q]/1			N	20241231
37662-1396_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1396	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	6	[hp_C]/1			N	20241231
37662-1397_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1397	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	12	[hp_C]/1			N	20241231
37662-1398_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1398	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	30	[hp_C]/1			N	20241231
37662-1399_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1399	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	100	[hp_C]/1			N	20241231
37662-1400_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1400	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	200	[hp_C]/1			N	20241231
37662-1401_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1401	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	500	[hp_C]/1			N	20241231
37662-1402_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1402	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	1	[hp_M]/1			N	20241231
37662-1403_e6cc5cff-74d0-6bb0-e053-2a95a90a382c	37662-1403	HUMAN OTC DRUG	Plumbum Iodatum		Plumbum Iodatum	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LEAD IODIDE	1	[hp_Q]/1			N	20241231
37662-1404_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1404	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	6	[hp_C]/1			N	20241231
37662-1405_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1405	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	12	[hp_C]/1			N	20241231
37662-1406_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1406	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	30	[hp_C]/1			N	20241231
37662-1407_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1407	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	100	[hp_C]/1			N	20241231
37662-1408_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1408	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	200	[hp_C]/1			N	20241231
37662-1409_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1409	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	500	[hp_C]/1			N	20241231
37662-1410_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1410	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	1	[hp_M]/1			N	20241231
37662-1411_e6ee6d0a-4b32-44f5-e053-2995a90a63db	37662-1411	HUMAN OTC DRUG	Ratanhia		Ratanhia	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KRAMERIA LAPPACEA ROOT	1	[hp_Q]/1			N	20241231
37662-1412_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1412	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	6	[hp_C]/1			N	20241231
37662-1413_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1413	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	12	[hp_C]/1			N	20241231
37662-1414_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1414	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	30	[hp_C]/1			N	20241231
37662-1415_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1415	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	100	[hp_C]/1			N	20241231
37662-1416_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1416	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	200	[hp_C]/1			N	20241231
37662-1417_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1417	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	500	[hp_C]/1			N	20241231
37662-1418_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1418	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	1	[hp_M]/1			N	20241231
37662-1419_e6f02163-2846-680d-e053-2a95a90ae43a	37662-1419	HUMAN OTC DRUG	Saccharum Lactis		Saccharum Lactis	PELLET	ORAL	20220823		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LACTOSE, UNSPECIFIED FORM	1	[hp_Q]/1			N	20241231
37662-1420_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1420	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	6	[hp_C]/1			N	20241231
37662-1421_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1421	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	12	[hp_C]/1			N	20241231
37662-1422_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1422	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	30	[hp_C]/1			N	20241231
37662-1423_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1423	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	100	[hp_C]/1			N	20241231
37662-1424_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1424	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	200	[hp_C]/1			N	20241231
37662-1425_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1425	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	500	[hp_C]/1			N	20241231
37662-1426_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1426	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	1	[hp_M]/1			N	20241231
37662-1427_e6f27046-663a-3f8a-e053-2a95a90ab197	37662-1427	HUMAN OTC DRUG	Ranunculus Bulbosus		Ranunculus Bulbosus	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RANUNCULUS BULBOSUS	1	[hp_Q]/1			N	20241231
37662-1428_e70519b5-2ea2-9f70-e053-2a95a90a8395	37662-1428	HUMAN OTC DRUG	Rauwolfia Serpentina		Rauwolfia Serpentina	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RAUWOLFIA SERPENTINA	6	[hp_C]/1			N	20241231
37662-1429_e70519b5-2ea2-9f70-e053-2a95a90a8395	37662-1429	HUMAN OTC DRUG	Rauwolfia Serpentina		Rauwolfia Serpentina	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RAUWOLFIA SERPENTINA	12	[hp_C]/1			N	20241231
37662-1430_e70519b5-2ea2-9f70-e053-2a95a90a8395	37662-1430	HUMAN OTC DRUG	Rauwolfia Serpentina		Rauwolfia Serpentina	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RAUWOLFIA SERPENTINA	30	[hp_C]/1			N	20241231
37662-1431_e70519b5-2ea2-9f70-e053-2a95a90a8395	37662-1431	HUMAN OTC DRUG	Rauwolfia Serpentina		Rauwolfia Serpentina	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RAUWOLFIA SERPENTINA	100	[hp_C]/1			N	20241231
37662-1432_e70519b5-2ea2-9f70-e053-2a95a90a8395	37662-1432	HUMAN OTC DRUG	Rauwolfia Serpentina		Rauwolfia Serpentina	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RAUWOLFIA SERPENTINA	200	[hp_C]/1			N	20241231
37662-1433_e70519b5-2ea2-9f70-e053-2a95a90a8395	37662-1433	HUMAN OTC DRUG	Rauwolfia Serpentina		Rauwolfia Serpentina	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RAUWOLFIA SERPENTINA	500	[hp_C]/1			N	20241231
37662-1434_e70519b5-2ea2-9f70-e053-2a95a90a8395	37662-1434	HUMAN OTC DRUG	Rauwolfia Serpentina		Rauwolfia Serpentina	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RAUWOLFIA SERPENTINA	1	[hp_M]/1			N	20241231
37662-1435_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1435	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	6	[hp_C]/1			N	20241231
37662-1436_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1436	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	12	[hp_C]/1			N	20241231
37662-1437_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1437	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	30	[hp_C]/1			N	20241231
37662-1438_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1438	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	100	[hp_C]/1			N	20241231
37662-1439_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1439	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	200	[hp_C]/1			N	20241231
37662-1440_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1440	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	500	[hp_C]/1			N	20241231
37662-1441_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1441	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	1	[hp_M]/1			N	20241231
37662-1442_e706a1e5-c78e-7464-e053-2995a90a35a5	37662-1442	HUMAN OTC DRUG	Phytolacca Decandra		Phytolacca Decandra	PELLET	ORAL	20220824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYTOLACCA AMERICANA ROOT	1	[hp_Q]/1			N	20241231
37662-1443_e71a5386-1992-f339-e053-2995a90ad921	37662-1443	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	6	[hp_C]/1			N	20241231
37662-1444_e71a5386-1992-f339-e053-2995a90ad921	37662-1444	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	12	[hp_C]/1			N	20241231
37662-1445_e71a5386-1992-f339-e053-2995a90ad921	37662-1445	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	30	[hp_C]/1			N	20241231
37662-1446_e71a5386-1992-f339-e053-2995a90ad921	37662-1446	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	100	[hp_C]/1			N	20241231
37662-1447_e71a5386-1992-f339-e053-2995a90ad921	37662-1447	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	200	[hp_C]/1			N	20241231
37662-1448_e71a5386-1992-f339-e053-2995a90ad921	37662-1448	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	500	[hp_C]/1			N	20241231
37662-1449_e71a5386-1992-f339-e053-2995a90ad921	37662-1449	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	1	[hp_M]/1			N	20241231
37662-1450_e71a5386-1992-f339-e053-2995a90ad921	37662-1450	HUMAN OTC DRUG	Spigelia Anthelmia		Spigelia Anthelmia	PELLET	ORAL	20220825		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPIGELIA ANTHELMIA	1	[hp_Q]/1			N	20241231
37662-1451_e76a4120-f732-a978-e053-2995a90a7ecf	37662-1451	HUMAN OTC DRUG	Ginkgo Biloba		Ginkgo Biloba	PELLET	ORAL	20220829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINKGO	6	[hp_C]/1			N	20241231
37662-1452_e76a4120-f732-a978-e053-2995a90a7ecf	37662-1452	HUMAN OTC DRUG	Ginkgo Biloba		Ginkgo Biloba	PELLET	ORAL	20220829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINKGO	12	[hp_C]/1			N	20241231
37662-1453_e76a4120-f732-a978-e053-2995a90a7ecf	37662-1453	HUMAN OTC DRUG	Ginkgo Biloba		Ginkgo Biloba	PELLET	ORAL	20220829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINKGO	30	[hp_C]/1			N	20241231
37662-1454_e76a4120-f732-a978-e053-2995a90a7ecf	37662-1454	HUMAN OTC DRUG	Ginkgo Biloba		Ginkgo Biloba	PELLET	ORAL	20220829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINKGO	100	[hp_C]/1			N	20241231
37662-1455_e76a4120-f732-a978-e053-2995a90a7ecf	37662-1455	HUMAN OTC DRUG	Ginkgo Biloba		Ginkgo Biloba	PELLET	ORAL	20220829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINKGO	200	[hp_C]/1			N	20241231
37662-1456_e76a4120-f732-a978-e053-2995a90a7ecf	37662-1456	HUMAN OTC DRUG	Ginkgo Biloba		Ginkgo Biloba	PELLET	ORAL	20220829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINKGO	500	[hp_C]/1			N	20241231
37662-1457_e76a4120-f732-a978-e053-2995a90a7ecf	37662-1457	HUMAN OTC DRUG	Ginkgo Biloba		Ginkgo Biloba	PELLET	ORAL	20220829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINKGO	1	[hp_M]/1			N	20241231
37662-1458_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1458	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	6	[hp_C]/1			N	20241231
37662-1459_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1459	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	12	[hp_C]/1			N	20241231
37662-1460_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1460	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	30	[hp_C]/1			N	20241231
37662-1461_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1461	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	100	[hp_C]/1			N	20241231
37662-1462_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1462	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	200	[hp_C]/1			N	20241231
37662-1463_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1463	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	500	[hp_C]/1			N	20241231
37662-1464_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1464	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	1	[hp_M]/1			N	20241231
37662-1465_e8196e26-a21e-a58f-e053-2995a90a36a9	37662-1465	HUMAN OTC DRUG	Illicium Verum		Illicium Verum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STAR ANISE	1	[hp_Q]/1			N	20241231
37662-1466_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1466	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	6	[hp_C]/1			N	20241231
37662-1467_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1467	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	12	[hp_C]/1			N	20241231
37662-1468_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1468	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	30	[hp_C]/1			N	20241231
37662-1469_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1469	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	100	[hp_C]/1			N	20241231
37662-1470_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1470	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	200	[hp_C]/1			N	20241231
37662-1471_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1471	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	500	[hp_C]/1			N	20241231
37662-1472_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1472	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	1	[hp_M]/1			N	20241231
37662-1473_e81be440-31a4-53e1-e053-2995a90ace9e	37662-1473	HUMAN OTC DRUG	Kali Bichromicum		Kali Bichromicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM DICHROMATE	10	[hp_M]/1			N	20241231
37662-1474_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1474	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	6	[hp_C]/1			N	20241231
37662-1475_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1475	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	12	[hp_C]/1			N	20241231
37662-1476_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1476	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	30	[hp_C]/1			N	20241231
37662-1477_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1477	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	100	[hp_C]/1			N	20241231
37662-1478_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1478	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	200	[hp_C]/1			N	20241231
37662-1479_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1479	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	500	[hp_C]/1			N	20241231
37662-1480_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1480	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	1	[hp_M]/1			N	20241231
37662-1481_e81dfcb9-ec13-64bf-e053-2995a90a7dd7	37662-1481	HUMAN OTC DRUG	Kali Carbonicum		Kali Carbonicum	PELLET	ORAL	20220907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CARBONATE	10	[hp_M]/1			N	20241231
37662-1482_e8207fc8-0b00-430b-e053-2995a90a9610	37662-1482	HUMAN OTC DRUG	Guaiacum		Guaiacum	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GUAIACUM OFFICINALE RESIN	6	[hp_C]/1			N	20241231
37662-1483_e8207fc8-0b00-430b-e053-2995a90a9610	37662-1483	HUMAN OTC DRUG	Guaiacum		Guaiacum	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GUAIACUM OFFICINALE RESIN	12	[hp_C]/1			N	20241231
37662-1484_e8207fc8-0b00-430b-e053-2995a90a9610	37662-1484	HUMAN OTC DRUG	Guaiacum		Guaiacum	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GUAIACUM OFFICINALE RESIN	30	[hp_C]/1			N	20241231
37662-1485_e8207fc8-0b00-430b-e053-2995a90a9610	37662-1485	HUMAN OTC DRUG	Guaiacum		Guaiacum	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GUAIACUM OFFICINALE RESIN	100	[hp_C]/1			N	20241231
37662-1486_e8207fc8-0b00-430b-e053-2995a90a9610	37662-1486	HUMAN OTC DRUG	Guaiacum		Guaiacum	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GUAIACUM OFFICINALE RESIN	200	[hp_C]/1			N	20241231
37662-1487_e8207fc8-0b00-430b-e053-2995a90a9610	37662-1487	HUMAN OTC DRUG	Guaiacum		Guaiacum	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GUAIACUM OFFICINALE RESIN	500	[hp_C]/1			N	20241231
37662-1488_e8207fc8-0b00-430b-e053-2995a90a9610	37662-1488	HUMAN OTC DRUG	Guaiacum		Guaiacum	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GUAIACUM OFFICINALE RESIN	1	[hp_M]/1			N	20241231
37662-1489_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1489	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	6	[hp_C]/1			N	20241231
37662-1490_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1490	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	12	[hp_C]/1			N	20241231
37662-1491_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1491	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	30	[hp_C]/1			N	20241231
37662-1492_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1492	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	100	[hp_C]/1			N	20241231
37662-1493_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1493	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	200	[hp_C]/1			N	20241231
37662-1494_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1494	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	500	[hp_C]/1			N	20241231
37662-1495_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1495	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	1	[hp_M]/1			N	20241231
37662-1496_e8320887-7971-0df5-e053-2a95a90a3ce2	37662-1496	HUMAN OTC DRUG	Kali Iodatum		Kali Iodatum	PELLET	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM IODIDE	10	[hp_M]/1			N	20241231
37662-1497_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1497	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	6	[hp_C]/1			N	20241231
37662-1498_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1498	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	12	[hp_C]/1			N	20241231
37662-1499_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1499	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	30	[hp_C]/1			N	20241231
37662-1500_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1500	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	100	[hp_C]/1			N	20241231
37662-1501_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1501	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	200	[hp_C]/1			N	20241231
37662-1502_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1502	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	500	[hp_C]/1			N	20241231
37662-1503_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1503	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	1	[hp_M]/1			N	20241231
37662-1504_e8805448-7be3-46d2-e053-2a95a90ae3f6	37662-1504	HUMAN OTC DRUG	Helonias Dioica		Helonias Dioica	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHAMAELIRIUM LUTEUM ROOT	10	[hp_M]/1			N	20241231
37662-1505_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1505	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1506_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1506	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1507_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1507	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1508_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1508	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1509_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1509	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1510_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1510	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1511_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1511	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1512_e8965e72-c365-0db3-e053-2a95a90ad1d3	37662-1512	HUMAN OTC DRUG	Linum Usitatissimum		Linum Usitatissimum	PELLET	ORAL	20220913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FLAX SEED	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1513_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1513	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	6	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1514_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1514	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	12	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1515_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1515	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1516_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1516	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	100	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1517_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1517	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	200	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1518_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1518	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	500	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-1519_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1519	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	1	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-1520_e8a665ae-8113-3cae-e053-2995a90a1fcd	37662-1520	HUMAN OTC DRUG	Lithium Muriaticum		Lithium Muriaticum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM CHLORIDE	1	[hp_Q]/1	Mood Stabilizer [EPC]		N	20241231
37662-1521_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1521	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	6	[hp_C]/1			N	20241231
37662-1522_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1522	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	12	[hp_C]/1			N	20241231
37662-1523_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1523	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	30	[hp_C]/1			N	20241231
37662-1524_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1524	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	100	[hp_C]/1			N	20241231
37662-1525_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1525	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	200	[hp_C]/1			N	20241231
37662-1526_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1526	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	500	[hp_C]/1			N	20241231
37662-1527_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1527	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	1	[hp_M]/1			N	20241231
37662-1528_e8a8ae26-41f0-39c8-e053-2995a90ab68a	37662-1528	HUMAN OTC DRUG	Magnesium Metallicum		Magnesium Metallicum	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM	1	[hp_Q]/1			N	20241231
37662-1529_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1529	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	6	[hp_C]/1			N	20241231
37662-1530_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1530	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	12	[hp_C]/1			N	20241231
37662-1531_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1531	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	30	[hp_C]/1			N	20241231
37662-1532_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1532	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	100	[hp_C]/1			N	20241231
37662-1533_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1533	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	200	[hp_C]/1			N	20241231
37662-1534_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1534	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	500	[hp_C]/1			N	20241231
37662-1535_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1535	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	1	[hp_M]/1			N	20241231
37662-1536_e8aa3522-98a6-0b3b-e053-2995a90a282e	37662-1536	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20220914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	1	[hp_Q]/1			N	20241231
37662-1537_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1537	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	6	[hp_C]/1			N	20241231
37662-1538_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1538	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	12	[hp_C]/1			N	20241231
37662-1539_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1539	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	30	[hp_C]/1			N	20241231
37662-1540_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1540	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	100	[hp_C]/1			N	20241231
37662-1541_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1541	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	200	[hp_C]/1			N	20241231
37662-1542_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1542	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	500	[hp_C]/1			N	20241231
37662-1543_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1543	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	1	[hp_M]/1			N	20241231
37662-1544_e8ad2a13-8e04-df98-e053-2a95a90ac791	37662-1544	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	1	[hp_Q]/1			N	20241231
37662-1545_e938679c-6159-cc55-e053-2995a90aa393	37662-1545	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1546_e938679c-6159-cc55-e053-2995a90aa393	37662-1546	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1547_e938679c-6159-cc55-e053-2995a90aa393	37662-1547	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1548_e938679c-6159-cc55-e053-2995a90aa393	37662-1548	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1549_e938679c-6159-cc55-e053-2995a90aa393	37662-1549	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1550_e938679c-6159-cc55-e053-2995a90aa393	37662-1550	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1551_e938679c-6159-cc55-e053-2995a90aa393	37662-1551	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1552_e938679c-6159-cc55-e053-2995a90aa393	37662-1552	HUMAN OTC DRUG	Manganum Phosphoricum		Manganum Phosphoricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE PHOSPHATE, DIBASIC	1	[hp_Q]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1553_e939792e-f82b-2cc1-e053-2995a90aac88	37662-1553	HUMAN OTC DRUG	Manganum Sulphuricum		Manganum Sulphuricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE SULFATE	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1554_e939792e-f82b-2cc1-e053-2995a90aac88	37662-1554	HUMAN OTC DRUG	Manganum Sulphuricum		Manganum Sulphuricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE SULFATE	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1555_e939792e-f82b-2cc1-e053-2995a90aac88	37662-1555	HUMAN OTC DRUG	Manganum Sulphuricum		Manganum Sulphuricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE SULFATE	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1556_e939792e-f82b-2cc1-e053-2995a90aac88	37662-1556	HUMAN OTC DRUG	Manganum Sulphuricum		Manganum Sulphuricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE SULFATE	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1557_e939792e-f82b-2cc1-e053-2995a90aac88	37662-1557	HUMAN OTC DRUG	Manganum Sulphuricum		Manganum Sulphuricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE SULFATE	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1558_e939792e-f82b-2cc1-e053-2995a90aac88	37662-1558	HUMAN OTC DRUG	Manganum Sulphuricum		Manganum Sulphuricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE SULFATE	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1559_e939792e-f82b-2cc1-e053-2995a90aac88	37662-1559	HUMAN OTC DRUG	Manganum Sulphuricum		Manganum Sulphuricum	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE SULFATE	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-1560_e93c0c70-0851-1d0a-e053-2a95a90aaf9f	37662-1560	HUMAN OTC DRUG	Myristica Sebifera		Myristica Sebifera	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIROLA SEBIFERA RESIN	6	[hp_C]/1			N	20241231
37662-1561_e93c0c70-0851-1d0a-e053-2a95a90aaf9f	37662-1561	HUMAN OTC DRUG	Myristica Sebifera		Myristica Sebifera	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIROLA SEBIFERA RESIN	12	[hp_C]/1			N	20241231
37662-1562_e93c0c70-0851-1d0a-e053-2a95a90aaf9f	37662-1562	HUMAN OTC DRUG	Myristica Sebifera		Myristica Sebifera	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIROLA SEBIFERA RESIN	30	[hp_C]/1			N	20241231
37662-1563_e93c0c70-0851-1d0a-e053-2a95a90aaf9f	37662-1563	HUMAN OTC DRUG	Myristica Sebifera		Myristica Sebifera	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIROLA SEBIFERA RESIN	100	[hp_C]/1			N	20241231
37662-1564_e93c0c70-0851-1d0a-e053-2a95a90aaf9f	37662-1564	HUMAN OTC DRUG	Myristica Sebifera		Myristica Sebifera	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIROLA SEBIFERA RESIN	200	[hp_C]/1			N	20241231
37662-1565_e93c0c70-0851-1d0a-e053-2a95a90aaf9f	37662-1565	HUMAN OTC DRUG	Myristica Sebifera		Myristica Sebifera	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIROLA SEBIFERA RESIN	500	[hp_C]/1			N	20241231
37662-1566_e93c0c70-0851-1d0a-e053-2a95a90aaf9f	37662-1566	HUMAN OTC DRUG	Myristica Sebifera		Myristica Sebifera	PELLET	ORAL	20220921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIROLA SEBIFERA RESIN	1	[hp_M]/1			N	20241231
37662-1567_e9724a43-6966-5150-e053-2995a90a19b3	37662-1567	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	6	[hp_C]/1			N	20241231
37662-1568_e9724a43-6966-5150-e053-2995a90a19b3	37662-1568	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	12	[hp_C]/1			N	20241231
37662-1569_e9724a43-6966-5150-e053-2995a90a19b3	37662-1569	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	30	[hp_C]/1			N	20241231
37662-1570_e9724a43-6966-5150-e053-2995a90a19b3	37662-1570	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	100	[hp_C]/1			N	20241231
37662-1571_e9724a43-6966-5150-e053-2995a90a19b3	37662-1571	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	200	[hp_C]/1			N	20241231
37662-1572_e9724a43-6966-5150-e053-2995a90a19b3	37662-1572	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	500	[hp_C]/1			N	20241231
37662-1573_e9724a43-6966-5150-e053-2995a90a19b3	37662-1573	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	1	[hp_M]/1			N	20241231
37662-1574_e9724a43-6966-5150-e053-2995a90a19b3	37662-1574	HUMAN OTC DRUG	Osmium Metallicum		Osmium Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OSMIUM	1	[hp_Q]/1			N	20241231
37662-1575_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1575	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	6	[hp_C]/1			N	20241231
37662-1576_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1576	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	12	[hp_C]/1			N	20241231
37662-1577_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1577	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	30	[hp_C]/1			N	20241231
37662-1578_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1578	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	100	[hp_C]/1			N	20241231
37662-1579_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1579	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	200	[hp_C]/1			N	20241231
37662-1580_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1580	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	500	[hp_C]/1			N	20241231
37662-1581_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1581	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	1	[hp_M]/1			N	20241231
37662-1582_e97409aa-a5d3-9395-e053-2995a90ab2cc	37662-1582	HUMAN OTC DRUG	Robinia Pseudacacia		Robinia Pseudacacia	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROBINIA PSEUDOACACIA BARK	1	[hp_Q]/1			N	20241231
37662-1583_e975ebff-ca51-1228-e053-2995a90addd1	37662-1583	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	6	[hp_C]/1			N	20241231
37662-1584_e975ebff-ca51-1228-e053-2995a90addd1	37662-1584	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	12	[hp_C]/1			N	20241231
37662-1585_e975ebff-ca51-1228-e053-2995a90addd1	37662-1585	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	30	[hp_C]/1			N	20241231
37662-1586_e975ebff-ca51-1228-e053-2995a90addd1	37662-1586	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	100	[hp_C]/1			N	20241231
37662-1587_e975ebff-ca51-1228-e053-2995a90addd1	37662-1587	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	200	[hp_C]/1			N	20241231
37662-1588_e975ebff-ca51-1228-e053-2995a90addd1	37662-1588	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	500	[hp_C]/1			N	20241231
37662-1589_e975ebff-ca51-1228-e053-2995a90addd1	37662-1589	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	1	[hp_M]/1			N	20241231
37662-1590_e975ebff-ca51-1228-e053-2995a90addd1	37662-1590	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	PELLET	ORAL	20220924		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN	1	[hp_Q]/1			N	20241231
37662-1591_e97842b9-bebc-fcb8-e053-2a95a90a87bc	37662-1591	HUMAN OTC DRUG	Senega Officinalis		Senega Officinalis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POLYGALA SENEGA ROOT	6	[hp_C]/1			N	20241231
37662-1592_e97842b9-bebc-fcb8-e053-2a95a90a87bc	37662-1592	HUMAN OTC DRUG	Senega Officinalis		Senega Officinalis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POLYGALA SENEGA ROOT	12	[hp_C]/1			N	20241231
37662-1593_e97842b9-bebc-fcb8-e053-2a95a90a87bc	37662-1593	HUMAN OTC DRUG	Senega Officinalis		Senega Officinalis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POLYGALA SENEGA ROOT	30	[hp_C]/1			N	20241231
37662-1594_e97842b9-bebc-fcb8-e053-2a95a90a87bc	37662-1594	HUMAN OTC DRUG	Senega Officinalis		Senega Officinalis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POLYGALA SENEGA ROOT	100	[hp_C]/1			N	20241231
37662-1595_e97842b9-bebc-fcb8-e053-2a95a90a87bc	37662-1595	HUMAN OTC DRUG	Senega Officinalis		Senega Officinalis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POLYGALA SENEGA ROOT	200	[hp_C]/1			N	20241231
37662-1596_e97842b9-bebc-fcb8-e053-2a95a90a87bc	37662-1596	HUMAN OTC DRUG	Senega Officinalis		Senega Officinalis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POLYGALA SENEGA ROOT	500	[hp_C]/1			N	20241231
37662-1597_e97842b9-bebc-fcb8-e053-2a95a90a87bc	37662-1597	HUMAN OTC DRUG	Senega Officinalis		Senega Officinalis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POLYGALA SENEGA ROOT	1	[hp_M]/1			N	20241231
37662-1598_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1598	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	6	[hp_C]/1			N	20241231
37662-1599_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1599	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	12	[hp_C]/1			N	20241231
37662-1600_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1600	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	30	[hp_C]/1			N	20241231
37662-1601_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1601	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	100	[hp_C]/1			N	20241231
37662-1602_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1602	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	200	[hp_C]/1			N	20241231
37662-1603_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1603	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	500	[hp_C]/1			N	20241231
37662-1604_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1604	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	1	[hp_M]/1			N	20241231
37662-1605_e98b4d58-fd7e-bfa6-e053-2995a90aba10	37662-1605	HUMAN OTC DRUG	Sticta Pulmonaria		Sticta Pulmonaria	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LOBARIA PULMONARIA	1	[hp_Q]/1			N	20241231
37662-1606_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1606	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	6	[hp_C]/1			N	20241231
37662-1607_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1607	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	12	[hp_C]/1			N	20241231
37662-1608_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1608	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	30	[hp_C]/1			N	20241231
37662-1609_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1609	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	100	[hp_C]/1			N	20241231
37662-1610_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1610	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	200	[hp_C]/1			N	20241231
37662-1611_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1611	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	500	[hp_C]/1			N	20241231
37662-1612_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1612	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	1	[hp_M]/1			N	20241231
37662-1613_e98d5ff1-ec13-5ad7-e053-2a95a90ad6d0	37662-1613	HUMAN OTC DRUG	Thea Sinensis		Thea Sinensis	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN TEA LEAF	1	[hp_Q]/1			N	20241231
37662-1614_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1614	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	6	[hp_C]/1			N	20241231
37662-1615_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1615	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	12	[hp_C]/1			N	20241231
37662-1616_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1616	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	30	[hp_C]/1			N	20241231
37662-1617_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1617	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	100	[hp_C]/1			N	20241231
37662-1618_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1618	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	200	[hp_C]/1			N	20241231
37662-1619_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1619	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	500	[hp_C]/1			N	20241231
37662-1620_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1620	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	1	[hp_M]/1			N	20241231
37662-1621_e98ed11e-79f2-23eb-e053-2995a90a1286	37662-1621	HUMAN OTC DRUG	Urtica Urens		Urtica Urens	PELLET	ORAL	20220925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	URTICA URENS	1	[hp_Q]/1			N	20241231
37662-1622_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1622	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	6	[hp_C]/1			N	20241231
37662-1623_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1623	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	12	[hp_C]/1			N	20241231
37662-1624_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1624	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	30	[hp_C]/1			N	20241231
37662-1625_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1625	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	100	[hp_C]/1			N	20241231
37662-1626_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1626	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	200	[hp_C]/1			N	20241231
37662-1627_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1627	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	500	[hp_C]/1			N	20241231
37662-1628_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1628	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	1	[hp_M]/1			N	20241231
37662-1629_e9c4851b-1216-3272-e053-2995a90a64a3	37662-1629	HUMAN OTC DRUG	Terebinthina		Terebinthina	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TURPENTINE OIL	1	[hp_Q]/1			N	20241231
37662-1630_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1630	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	6	[hp_C]/1			N	20241231
37662-1631_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1631	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	12	[hp_C]/1			N	20241231
37662-1632_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1632	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	30	[hp_C]/1			N	20241231
37662-1633_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1633	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	100	[hp_C]/1			N	20241231
37662-1634_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1634	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	200	[hp_C]/1			N	20241231
37662-1635_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1635	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	500	[hp_C]/1			N	20241231
37662-1636_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1636	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	1	[hp_M]/1			N	20241231
37662-1637_e9c5b157-c54d-789f-e053-2a95a90a7fce	37662-1637	HUMAN OTC DRUG	Verbascum Thapsus		Verbascum Thapsus	PELLET	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERBASCUM THAPSUS	1	[hp_Q]/1			N	20241231
37662-1638_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1638	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	6	[hp_C]/1			N	20241231
37662-1639_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1639	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	12	[hp_C]/1			N	20241231
37662-1640_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1640	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	30	[hp_C]/1			N	20241231
37662-1641_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1641	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	100	[hp_C]/1			N	20241231
37662-1642_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1642	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	200	[hp_C]/1			N	20241231
37662-1643_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1643	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	500	[hp_C]/1			N	20241231
37662-1644_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1644	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	1	[hp_M]/1			N	20241231
37662-1645_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1645	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	10	[hp_M]/1			N	20241231
37662-1646_e9c7e259-dbaf-271a-e053-2995a90aa178	37662-1646	HUMAN OTC DRUG	Dulcamara		Dulcamara	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM DULCAMARA TOP	1	[hp_Q]/1			N	20241231
37662-1647_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1647	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	6	[hp_C]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1648_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1648	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	12	[hp_C]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1649_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1649	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	30	[hp_C]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1650_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1650	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	100	[hp_C]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1651_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1651	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	200	[hp_C]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1652_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1652	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	500	[hp_C]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1653_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1653	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	1	[hp_M]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1654_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1654	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	10	[hp_M]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1655_ea2975ae-687c-500b-e053-2a95a90a2e32	37662-1655	HUMAN OTC DRUG	Glonoinum		Glonoinum	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITROGLYCERIN	1	[hp_Q]/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
37662-1656_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1656	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	6	[hp_C]/1			N	20241231
37662-1657_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1657	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	12	[hp_C]/1			N	20241231
37662-1658_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1658	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	30	[hp_C]/1			N	20241231
37662-1659_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1659	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	100	[hp_C]/1			N	20241231
37662-1660_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1660	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	200	[hp_C]/1			N	20241231
37662-1661_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1661	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	500	[hp_C]/1			N	20241231
37662-1662_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1662	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	1	[hp_M]/1			N	20241231
37662-1663_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1663	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	10	[hp_M]/1			N	20241231
37662-1664_ea2b8bdf-9421-626f-e053-2a95a90a5181	37662-1664	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HELLEBORUS NIGER ROOT	1	[hp_Q]/1			N	20241231
37662-1665_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1665	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	6	[hp_C]/1			N	20241231
37662-1666_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1666	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	12	[hp_C]/1			N	20241231
37662-1667_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1667	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	30	[hp_C]/1			N	20241231
37662-1668_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1668	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	100	[hp_C]/1			N	20241231
37662-1669_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1669	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	200	[hp_C]/1			N	20241231
37662-1670_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1670	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	500	[hp_C]/1			N	20241231
37662-1671_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1671	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	1	[hp_M]/1			N	20241231
37662-1672_ea2cc59f-4490-22f8-e053-2995a90a4a30	37662-1672	HUMAN OTC DRUG	Hydrastis Canadensis		Hydrastis Canadensis	PELLET	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GOLDENSEAL	1	[hp_Q]/1			N	20241231
37662-1673_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1673	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	6	[hp_C]/1			N	20241231
37662-1674_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1674	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	12	[hp_C]/1			N	20241231
37662-1675_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1675	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	30	[hp_C]/1			N	20241231
37662-1676_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1676	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	100	[hp_C]/1			N	20241231
37662-1677_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1677	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	200	[hp_C]/1			N	20241231
37662-1678_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1678	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	500	[hp_C]/1			N	20241231
37662-1679_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1679	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	1	[hp_M]/1			N	20241231
37662-1680_ea3cdd3e-3b30-1141-e053-2a95a90ac833	37662-1680	HUMAN OTC DRUG	Hafnium		Hafnium	PELLET	ORAL	20221004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAFNIUM	1	[hp_Q]/1			N	20241231
37662-1681_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1681	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	6	[hp_C]/1			N	20241231
37662-1682_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1682	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	12	[hp_C]/1			N	20241231
37662-1683_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1683	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	30	[hp_C]/1			N	20241231
37662-1684_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1684	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	100	[hp_C]/1			N	20241231
37662-1685_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1685	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	200	[hp_C]/1			N	20241231
37662-1686_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1686	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	500	[hp_C]/1			N	20241231
37662-1687_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1687	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	1	[hp_M]/1			N	20241231
37662-1688_eab5ec54-64ac-c7bd-e053-2995a90a5b18	37662-1688	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYOSCYAMUS NIGER	10	[hp_M]/1			N	20241231
37662-1689_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1689	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	6	[hp_C]/1			N	20241231
37662-1690_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1690	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	12	[hp_C]/1			N	20241231
37662-1691_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1691	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	30	[hp_C]/1			N	20241231
37662-1692_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1692	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	100	[hp_C]/1			N	20241231
37662-1693_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1693	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	200	[hp_C]/1			N	20241231
37662-1694_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1694	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	500	[hp_C]/1			N	20241231
37662-1695_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1695	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	1	[hp_M]/1			N	20241231
37662-1696_eab7d9fd-0df8-c9de-e053-2a95a90ad67b	37662-1696	HUMAN OTC DRUG	Hypericum Perforatum		Hypericum Perforatum	PELLET	ORAL	20221010		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYPERICUM PERFORATUM	10	[hp_M]/1			N	20241231
37662-1697_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1697	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	6	[hp_C]/1			N	20241231
37662-1698_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1698	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	12	[hp_C]/1			N	20241231
37662-1699_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1699	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	30	[hp_C]/1			N	20241231
37662-1700_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1700	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	100	[hp_C]/1			N	20241231
37662-1701_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1701	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	200	[hp_C]/1			N	20241231
37662-1702_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1702	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	500	[hp_C]/1			N	20241231
37662-1703_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1703	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	1	[hp_M]/1			N	20241231
37662-1704_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1704	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	10	[hp_M]/1			N	20241231
37662-1705_eab962ba-6f66-c509-e053-2a95a90a6b44	37662-1705	HUMAN OTC DRUG	Ignatia Amara		Ignatia Amara	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS IGNATII SEED	1	[hp_Q]/1			N	20241231
37662-1706_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1706	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	6	[hp_C]/1			N	20241231
37662-1707_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1707	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	12	[hp_C]/1			N	20241231
37662-1708_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1708	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	30	[hp_C]/1			N	20241231
37662-1709_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1709	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	100	[hp_C]/1			N	20241231
37662-1710_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1710	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	200	[hp_C]/1			N	20241231
37662-1711_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1711	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	500	[hp_C]/1			N	20241231
37662-1712_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1712	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	1	[hp_M]/1			N	20241231
37662-1713_eadf989b-0dad-0afc-e053-2a95a90adea3	37662-1713	HUMAN OTC DRUG	Iris Versicolor		Iris Versicolor	PELLET	ORAL	20221012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IRIS VERSICOLOR ROOT	10	[hp_M]/1			N	20241231
37662-1714_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1714	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	6	[hp_C]/1			N	20241231
37662-1715_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1715	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	12	[hp_C]/1			N	20241231
37662-1716_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1716	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	30	[hp_C]/1			N	20241231
37662-1717_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1717	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	100	[hp_C]/1			N	20241231
37662-1718_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1718	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	200	[hp_C]/1			N	20241231
37662-1719_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1719	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	500	[hp_C]/1			N	20241231
37662-1720_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1720	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	1	[hp_M]/1			N	20241231
37662-1721_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1721	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	10	[hp_M]/1			N	20241231
37662-1722_eae03e93-ff19-bff8-e053-2995a90abf44	37662-1722	HUMAN OTC DRUG	Iodium		Iodium	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IODINE	1	[hp_Q]/1			N	20241231
37662-1723_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1723	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	6	[hp_C]/1			N	20241231
37662-1724_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1724	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	12	[hp_C]/1			N	20241231
37662-1725_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1725	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	30	[hp_C]/1			N	20241231
37662-1726_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1726	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	100	[hp_C]/1			N	20241231
37662-1727_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1727	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	200	[hp_C]/1			N	20241231
37662-1728_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1728	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	500	[hp_C]/1			N	20241231
37662-1729_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1729	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	1	[hp_M]/1			N	20241231
37662-1730_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1730	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	10	[hp_M]/1			N	20241231
37662-1731_eb463b96-325d-5fb0-e053-2995a90a4581	37662-1731	HUMAN OTC DRUG	Ipecacuanha		Ipecacuanha	PELLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	IPECAC	1	[hp_Q]/1			N	20241231
37662-1732_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1732	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1733_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1733	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1734_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1734	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1735_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1735	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1736_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1736	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1737_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1737	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1738_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1738	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1739_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1739	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1740_eb6ac6ad-4678-1072-e053-2995a90a02e9	37662-1740	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIBASIC POTASSIUM PHOSPHATE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-1741_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1741	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	6	[hp_C]/1			N	20241231
37662-1742_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1742	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	12	[hp_C]/1			N	20241231
37662-1743_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1743	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	30	[hp_C]/1			N	20241231
37662-1744_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1744	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	100	[hp_C]/1			N	20241231
37662-1745_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1745	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	200	[hp_C]/1			N	20241231
37662-1746_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1746	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	500	[hp_C]/1			N	20241231
37662-1747_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1747	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	1	[hp_M]/1			N	20241231
37662-1748_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1748	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	10	[hp_M]/1			N	20241231
37662-1749_eb6c8282-a07c-db46-e053-2995a90a7ee4	37662-1749	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	PELLET	ORAL	20221019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON TOMENTOSUM LEAFY TWIG	1	[hp_Q]/1			N	20241231
37662-1750_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1750	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	6	[hp_C]/1			N	20241231
37662-1751_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1751	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	12	[hp_C]/1			N	20241231
37662-1752_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1752	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	30	[hp_C]/1			N	20241231
37662-1753_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1753	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	100	[hp_C]/1			N	20241231
37662-1754_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1754	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	200	[hp_C]/1			N	20241231
37662-1755_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1755	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	500	[hp_C]/1			N	20241231
37662-1756_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1756	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	1	[hp_M]/1			N	20241231
37662-1757_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1757	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	10	[hp_M]/1			N	20241231
37662-1758_ebcf970f-96ec-f0a7-e053-2995a90a07ad	37662-1758	HUMAN OTC DRUG	Laurocerasus		Laurocerasus	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRUNUS LAUROCERASUS LEAF	1	[hp_Q]/1			N	20241231
37662-1759_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1759	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	6	[hp_C]/1			N	20241231
37662-1760_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1760	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	12	[hp_C]/1			N	20241231
37662-1761_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1761	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	30	[hp_C]/1			N	20241231
37662-1762_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1762	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	100	[hp_C]/1			N	20241231
37662-1763_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1763	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	200	[hp_C]/1			N	20241231
37662-1764_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1764	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	500	[hp_C]/1			N	20241231
37662-1765_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1765	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	1	[hp_M]/1			N	20241231
37662-1766_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1766	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	10	[hp_M]/1			N	20241231
37662-1767_ebd17aeb-d7ee-4d07-e053-2a95a90af097	37662-1767	HUMAN OTC DRUG	Lilium Tigrinum		Lilium Tigrinum	PELLET	ORAL	20221024		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LANCIFOLIUM WHOLE FLOWERING	1	[hp_Q]/1			N	20241231
37662-1768_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1768	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	6	[hp_C]/1			N	20241231
37662-1769_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1769	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	12	[hp_C]/1			N	20241231
37662-1770_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1770	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	30	[hp_C]/1			N	20241231
37662-1771_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1771	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	100	[hp_C]/1			N	20241231
37662-1772_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1772	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	200	[hp_C]/1			N	20241231
37662-1773_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1773	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	500	[hp_C]/1			N	20241231
37662-1774_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1774	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	1	[hp_M]/1			N	20241231
37662-1775_ebd28cf1-cca6-539f-e053-2a95a90a4230	37662-1775	HUMAN OTC DRUG	Lutetium		Lutetium	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LUTETIUM	1	[hp_Q]/1			N	20241231
37662-1776_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1776	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	6	[hp_C]/1			N	20241231
37662-1777_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1777	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	12	[hp_C]/1			N	20241231
37662-1778_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1778	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	30	[hp_C]/1			N	20241231
37662-1779_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1779	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	100	[hp_C]/1			N	20241231
37662-1780_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1780	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	200	[hp_C]/1			N	20241231
37662-1781_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1781	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	500	[hp_C]/1			N	20241231
37662-1782_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1782	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	1	[hp_M]/1			N	20241231
37662-1783_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1783	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	10	[hp_M]/1			N	20241231
37662-1784_ec0c31ec-1971-7332-e053-2a95a90abc0a	37662-1784	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPODIUM CLAVATUM SPORE	1	[hp_Q]/1			N	20241231
37662-1785_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1785	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1786_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1786	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	12	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1787_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1787	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1788_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1788	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	100	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1789_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1789	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	200	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1790_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1790	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	500	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1791_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1791	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	1	[hp_M]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1792_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1792	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	10	[hp_M]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1793_ec0ddfa5-ad76-5afe-e053-2995a90a2b53	37662-1793	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	1	[hp_Q]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-1794_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1794	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	6	[hp_C]/1			N	20241231
37662-1795_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1795	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	12	[hp_C]/1			N	20241231
37662-1796_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1796	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	30	[hp_C]/1			N	20241231
37662-1797_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1797	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	100	[hp_C]/1			N	20241231
37662-1798_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1798	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	200	[hp_C]/1			N	20241231
37662-1799_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1799	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	500	[hp_C]/1			N	20241231
37662-1800_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1800	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	1	[hp_M]/1			N	20241231
37662-1801_ec5f11aa-e0df-2463-e053-2995a90a18e3	37662-1801	HUMAN OTC DRUG	Mercurius Corrosivus		Mercurius Corrosivus	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CHLORIDE	1	[hp_Q]/1			N	20241231
37662-1802_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1802	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	6	[hp_C]/1			N	20241231
37662-1803_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1803	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	12	[hp_C]/1			N	20241231
37662-1804_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1804	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	30	[hp_C]/1			N	20241231
37662-1805_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1805	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	100	[hp_C]/1			N	20241231
37662-1806_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1806	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	200	[hp_C]/1			N	20241231
37662-1807_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1807	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	500	[hp_C]/1			N	20241231
37662-1808_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1808	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	1	[hp_M]/1			N	20241231
37662-1809_ec5e44c6-be32-6e5c-e053-2a95a90a99db	37662-1809	HUMAN OTC DRUG	Medusa		Medusa	PELLET	ORAL	20221031		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSALIA PHYSALIS	10	[hp_M]/1			N	20241231
37662-1810_ec83c630-968b-76d4-e053-2995a90a59da	37662-1810	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	6	[hp_C]/1			N	20241231
37662-1811_ec83c630-968b-76d4-e053-2995a90a59da	37662-1811	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	12	[hp_C]/1			N	20241231
37662-1812_ec83c630-968b-76d4-e053-2995a90a59da	37662-1812	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	30	[hp_C]/1			N	20241231
37662-1813_ec83c630-968b-76d4-e053-2995a90a59da	37662-1813	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	100	[hp_C]/1			N	20241231
37662-1814_ec83c630-968b-76d4-e053-2995a90a59da	37662-1814	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	200	[hp_C]/1			N	20241231
37662-1815_ec83c630-968b-76d4-e053-2995a90a59da	37662-1815	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	500	[hp_C]/1			N	20241231
37662-1816_ec83c630-968b-76d4-e053-2995a90a59da	37662-1816	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	1	[hp_M]/1			N	20241231
37662-1817_ec83c630-968b-76d4-e053-2995a90a59da	37662-1817	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	1	[hp_Q]/1			N	20241231
37662-1818_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1818	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	6	[hp_C]/1			N	20241231
37662-1819_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1819	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	12	[hp_C]/1			N	20241231
37662-1820_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1820	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	30	[hp_C]/1			N	20241231
37662-1821_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1821	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	100	[hp_C]/1			N	20241231
37662-1822_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1822	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	200	[hp_C]/1			N	20241231
37662-1823_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1823	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	500	[hp_C]/1			N	20241231
37662-1824_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1824	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	1	[hp_M]/1			N	20241231
37662-1825_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1825	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	10	[hp_M]/1			N	20241231
37662-1826_ec851073-8b5a-cc21-e053-2a95a90adfe9	37662-1826	HUMAN OTC DRUG	Mercurius Dulcis		Mercurius Dulcis	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CALOMEL	1	[hp_Q]/1			N	20241231
37662-1827_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1827	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1828_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1828	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1829_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1829	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1830_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1830	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1831_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1831	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1832_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1832	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1833_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1833	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1834_ec86675f-d173-7810-e053-2a95a90a16bb	37662-1834	HUMAN OTC DRUG	Mercurius Sulphuricus		Mercurius Sulphuricus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC SULFATE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1835_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1835	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	6	[hp_C]/1			N	20241231
37662-1836_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1836	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	12	[hp_C]/1			N	20241231
37662-1837_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1837	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	30	[hp_C]/1			N	20241231
37662-1838_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1838	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	100	[hp_C]/1			N	20241231
37662-1839_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1839	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	200	[hp_C]/1			N	20241231
37662-1840_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1840	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	500	[hp_C]/1			N	20241231
37662-1841_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1841	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	1	[hp_M]/1			N	20241231
37662-1842_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1842	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	10	[hp_M]/1			N	20241231
37662-1843_ec890906-d387-1f5a-e053-2a95a90a68b6	37662-1843	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	PELLET	ORAL	20221102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURY	1	[hp_Q]/1			N	20241231
37662-1844_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1844	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	6	[hp_C]/1			N	20241231
37662-1845_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1845	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	12	[hp_C]/1			N	20241231
37662-1846_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1846	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	30	[hp_C]/1			N	20241231
37662-1847_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1847	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	100	[hp_C]/1			N	20241231
37662-1848_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1848	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	200	[hp_C]/1			N	20241231
37662-1849_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1849	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	500	[hp_C]/1			N	20241231
37662-1850_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1850	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	1	[hp_M]/1			N	20241231
37662-1851_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1851	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	10	[hp_M]/1			N	20241231
37662-1852_ece9a08e-e0e2-a5db-e053-2a95a90a1451	37662-1852	HUMAN OTC DRUG	Mezereum		Mezereum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DAPHNE MEZEREUM BARK	1	[hp_Q]/1			N	20241231
37662-1853_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1853	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	6	[hp_C]/1			N	20241231
37662-1854_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1854	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	12	[hp_C]/1			N	20241231
37662-1855_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1855	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	30	[hp_C]/1			N	20241231
37662-1856_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1856	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	100	[hp_C]/1			N	20241231
37662-1857_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1857	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	200	[hp_C]/1			N	20241231
37662-1858_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1858	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	500	[hp_C]/1			N	20241231
37662-1859_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1859	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	1	[hp_M]/1			N	20241231
37662-1860_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1860	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	10	[hp_M]/1			N	20241231
37662-1861_ecec0266-cf52-b1ec-e053-2995a90a2a86	37662-1861	HUMAN OTC DRUG	Natrum Arsenicicum		Natrum Arsenicicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	1	[hp_Q]/1			N	20241231
37662-1862_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1862	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	6	[hp_C]/1			N	20241231
37662-1863_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1863	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	12	[hp_C]/1			N	20241231
37662-1864_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1864	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	30	[hp_C]/1			N	20241231
37662-1865_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1865	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	100	[hp_C]/1			N	20241231
37662-1866_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1866	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	200	[hp_C]/1			N	20241231
37662-1867_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1867	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	500	[hp_C]/1			N	20241231
37662-1868_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1868	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	1	[hp_M]/1			N	20241231
37662-1869_ececf4c5-69e7-c2fd-e053-2995a90ab78e	37662-1869	HUMAN OTC DRUG	Natrum Bromatum		Natrum Bromatum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BROMIDE	1	[hp_Q]/1			N	20241231
37662-1870_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1870	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	6	[hp_C]/1			N	20241231
37662-1871_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1871	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	12	[hp_C]/1			N	20241231
37662-1872_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1872	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	30	[hp_C]/1			N	20241231
37662-1873_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1873	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	100	[hp_C]/1			N	20241231
37662-1874_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1874	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	200	[hp_C]/1			N	20241231
37662-1875_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1875	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	500	[hp_C]/1			N	20241231
37662-1876_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1876	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	1	[hp_M]/1			N	20241231
37662-1877_ecee3632-9ca2-6e93-e053-2a95a90afb58	37662-1877	HUMAN OTC DRUG	Natrum Carbonicum		Natrum Carbonicum	PELLET	ORAL	20221107		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CARBONATE	10	[hp_M]/1			N	20241231
37662-1878_ecf06f13-012d-212d-e053-2995a90a7198	37662-1878	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1879_ecf06f13-012d-212d-e053-2995a90a7198	37662-1879	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1880_ecf06f13-012d-212d-e053-2995a90a7198	37662-1880	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1881_ecf06f13-012d-212d-e053-2995a90a7198	37662-1881	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1882_ecf06f13-012d-212d-e053-2995a90a7198	37662-1882	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1883_ecf06f13-012d-212d-e053-2995a90a7198	37662-1883	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1884_ecf06f13-012d-212d-e053-2995a90a7198	37662-1884	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1885_ecf06f13-012d-212d-e053-2995a90a7198	37662-1885	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1886_ecf06f13-012d-212d-e053-2995a90a7198	37662-1886	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM CHLORIDE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1887_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1887	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1888_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1888	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1889_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1889	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1890_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1890	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1891_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1891	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1892_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1892	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1893_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1893	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1894_ed01509a-afb7-476f-e053-2995a90a5aa6	37662-1894	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-1895_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1895	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	6	[hp_C]/1			N	20241231
37662-1896_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1896	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	12	[hp_C]/1			N	20241231
37662-1897_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1897	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	30	[hp_C]/1			N	20241231
37662-1898_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1898	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	100	[hp_C]/1			N	20241231
37662-1899_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1899	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	200	[hp_C]/1			N	20241231
37662-1900_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1900	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	500	[hp_C]/1			N	20241231
37662-1901_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1901	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	1	[hp_M]/1			N	20241231
37662-1902_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1902	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	10	[hp_M]/1			N	20241231
37662-1903_ed024be8-873f-7ad6-e053-2995a90a3c84	37662-1903	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	PELLET	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM SULFATE	1	[hp_Q]/1			N	20241231
37662-1904_ed03a980-af18-59d4-e053-2995a90a583e	37662-1904	HUMAN OTC DRUG	Paeonia Officinalis		Paeonia Officinalis	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PAEONIA OFFICINALIS ROOT	6	[hp_C]/1			N	20241231
37662-1905_ed03a980-af18-59d4-e053-2995a90a583e	37662-1905	HUMAN OTC DRUG	Paeonia Officinalis		Paeonia Officinalis	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PAEONIA OFFICINALIS ROOT	12	[hp_C]/1			N	20241231
37662-1906_ed03a980-af18-59d4-e053-2995a90a583e	37662-1906	HUMAN OTC DRUG	Paeonia Officinalis		Paeonia Officinalis	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PAEONIA OFFICINALIS ROOT	30	[hp_C]/1			N	20241231
37662-1907_ed03a980-af18-59d4-e053-2995a90a583e	37662-1907	HUMAN OTC DRUG	Paeonia Officinalis		Paeonia Officinalis	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PAEONIA OFFICINALIS ROOT	100	[hp_C]/1			N	20241231
37662-1908_ed03a980-af18-59d4-e053-2995a90a583e	37662-1908	HUMAN OTC DRUG	Paeonia Officinalis		Paeonia Officinalis	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PAEONIA OFFICINALIS ROOT	200	[hp_C]/1			N	20241231
37662-1909_ed03a980-af18-59d4-e053-2995a90a583e	37662-1909	HUMAN OTC DRUG	Paeonia Officinalis		Paeonia Officinalis	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PAEONIA OFFICINALIS ROOT	500	[hp_C]/1			N	20241231
37662-1910_ed03a980-af18-59d4-e053-2995a90a583e	37662-1910	HUMAN OTC DRUG	Paeonia Officinalis		Paeonia Officinalis	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PAEONIA OFFICINALIS ROOT	1	[hp_M]/1			N	20241231
37662-1911_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1911	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1912_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1912	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1913_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1913	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1914_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1914	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1915_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1915	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1916_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1916	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1917_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1917	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1918_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1918	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1919_ed79003a-9a92-ca14-e053-2a95a90a1724	37662-1919	HUMAN OTC DRUG	Niccolum Metallicum		Niccolum Metallicum	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37662-1920_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1920	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1921_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1921	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1922_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1922	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1923_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1923	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1924_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1924	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1925_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1925	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1926_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1926	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1927_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1927	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1928_ed79cc77-8e3f-a92c-e053-2995a90a8d9f	37662-1928	HUMAN OTC DRUG	Nux Moschata		Nux Moschata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NUTMEG	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1929_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1929	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	6	[hp_C]/1			N	20241231
37662-1930_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1930	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	12	[hp_C]/1			N	20241231
37662-1931_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1931	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	30	[hp_C]/1			N	20241231
37662-1932_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1932	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	100	[hp_C]/1			N	20241231
37662-1933_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1933	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	200	[hp_C]/1			N	20241231
37662-1934_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1934	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	500	[hp_C]/1			N	20241231
37662-1935_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1935	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	1	[hp_M]/1			N	20241231
37662-1936_ed7b9fea-fbad-85a4-e053-2995a90a8521	37662-1936	HUMAN OTC DRUG	Ptelea Trifoliata		Ptelea Trifoliata	PELLET	ORAL	20221114		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PTELEA TRIFOLIATA BARK	1	[hp_Q]/1			N	20241231
37662-1937_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1937	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	6	[hp_C]/1			N	20241231
37662-1938_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1938	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	12	[hp_C]/1			N	20241231
37662-1939_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1939	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	30	[hp_C]/1			N	20241231
37662-1940_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1940	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	100	[hp_C]/1			N	20241231
37662-1941_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1941	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	200	[hp_C]/1			N	20241231
37662-1942_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1942	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	500	[hp_C]/1			N	20241231
37662-1943_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1943	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	1	[hp_M]/1			N	20241231
37662-1944_ed7dc116-4d60-e101-e053-2995a90a545d	37662-1944	HUMAN OTC DRUG	Rheum Officinale		Rheum Officinale	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHEUM OFFICINALE ROOT	1	[hp_Q]/1			N	20241231
37662-1945_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1945	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1946_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1946	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1947_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1947	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1948_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1948	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1949_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1949	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1950_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1950	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1951_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1951	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1952_ed8cddb2-9c87-47c3-e053-2a95a90a6fa0	37662-1952	HUMAN OTC DRUG	Raphanus Sativus		Raphanus Sativus	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RADISH	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
37662-1953_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1953	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1954_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1954	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1955_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1955	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1956_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1956	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1957_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1957	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1958_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1958	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1959_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1959	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1960_ed8e08ad-2185-13af-e053-2a95a90ade93	37662-1960	HUMAN OTC DRUG	Tabacum		Tabacum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOBACCO LEAF	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-1961_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1961	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	6	[hp_C]/1			N	20241231
37662-1962_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1962	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	12	[hp_C]/1			N	20241231
37662-1963_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1963	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	30	[hp_C]/1			N	20241231
37662-1964_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1964	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	100	[hp_C]/1			N	20241231
37662-1965_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1965	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	200	[hp_C]/1			N	20241231
37662-1966_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1966	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	500	[hp_C]/1			N	20241231
37662-1967_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1967	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	1	[hp_M]/1			N	20241231
37662-1968_ed8eaebd-a834-ff73-e053-2a95a90ab9ac	37662-1968	HUMAN OTC DRUG	Thulium Metallicum		Thulium Metallicum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THALLIUM	1	[hp_Q]/1			N	20241231
37662-1969_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1969	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	6	[hp_C]/1			N	20241231
37662-1970_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1970	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	12	[hp_C]/1			N	20241231
37662-1971_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1971	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	30	[hp_C]/1			N	20241231
37662-1972_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1972	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	100	[hp_C]/1			N	20241231
37662-1973_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1973	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	200	[hp_C]/1			N	20241231
37662-1974_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1974	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	500	[hp_C]/1			N	20241231
37662-1975_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1975	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	1	[hp_M]/1			N	20241231
37662-1976_ed8fd430-a1b4-b44a-e053-2995a90adbfb	37662-1976	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20221115		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	1	[hp_Q]/1			N	20241231
37662-1977_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1977	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1978_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1978	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1979_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1979	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1980_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1980	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1981_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1981	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1982_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1982	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1983_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1983	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1984_ee05578e-ca07-55c2-e053-2995a90af56f	37662-1984	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRYCHNOS NUX-VOMICA SEED	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
37662-1985_ee07f754-2b85-b456-e053-2995a90af841	37662-1985	HUMAN OTC DRUG	Oleander		Oleander	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NERIUM OLEANDER LEAF	6	[hp_C]/1			N	20241231
37662-1986_ee07f754-2b85-b456-e053-2995a90af841	37662-1986	HUMAN OTC DRUG	Oleander		Oleander	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NERIUM OLEANDER LEAF	12	[hp_C]/1			N	20241231
37662-1987_ee07f754-2b85-b456-e053-2995a90af841	37662-1987	HUMAN OTC DRUG	Oleander		Oleander	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NERIUM OLEANDER LEAF	30	[hp_C]/1			N	20241231
37662-1988_ee07f754-2b85-b456-e053-2995a90af841	37662-1988	HUMAN OTC DRUG	Oleander		Oleander	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NERIUM OLEANDER LEAF	100	[hp_C]/1			N	20241231
37662-1989_ee07f754-2b85-b456-e053-2995a90af841	37662-1989	HUMAN OTC DRUG	Oleander		Oleander	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NERIUM OLEANDER LEAF	200	[hp_C]/1			N	20241231
37662-1990_ee07f754-2b85-b456-e053-2995a90af841	37662-1990	HUMAN OTC DRUG	Oleander		Oleander	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NERIUM OLEANDER LEAF	500	[hp_C]/1			N	20241231
37662-1991_ee07f754-2b85-b456-e053-2995a90af841	37662-1991	HUMAN OTC DRUG	Oleander		Oleander	PELLET	ORAL	20221121		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NERIUM OLEANDER LEAF	1	[hp_M]/1			N	20241231
37662-1992_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1992	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	6	[hp_C]/1			N	20241231
37662-1993_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1993	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	12	[hp_C]/1			N	20241231
37662-1994_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1994	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	30	[hp_C]/1			N	20241231
37662-1995_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1995	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	100	[hp_C]/1			N	20241231
37662-1996_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1996	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	200	[hp_C]/1			N	20241231
37662-1997_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1997	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	500	[hp_C]/1			N	20241231
37662-1998_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1998	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	1	[hp_M]/1			N	20241231
37662-1999_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-1999	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	10	[hp_M]/1			N	20241231
37662-2000_ee18acd6-7738-3e53-e053-2a95a90afa71	37662-2000	HUMAN OTC DRUG	Palladium Metallicum		Palladium Metallicum	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PALLADIUM	1	[hp_Q]/1			N	20241231
37662-2001_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2001	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	6	[hp_C]/1			N	20241231
37662-2002_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2002	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	12	[hp_C]/1			N	20241231
37662-2003_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2003	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	30	[hp_C]/1			N	20241231
37662-2004_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2004	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	100	[hp_C]/1			N	20241231
37662-2005_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2005	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	200	[hp_C]/1			N	20241231
37662-2006_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2006	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	500	[hp_C]/1			N	20241231
37662-2007_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2007	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	1	[hp_M]/1			N	20241231
37662-2008_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2008	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	10	[hp_M]/1			N	20241231
37662-2009_ee1ad771-9548-4272-e053-2a95a90aacc4	37662-2009	HUMAN OTC DRUG	Rumex Crispus		Rumex Crispus	PELLET	ORAL	20221122		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUMEX CRISPUS ROOT	1	[hp_Q]/1			N	20241231
37662-2010_ee92aee2-6cff-05af-e053-2995a90a3201	37662-2010	HUMAN OTC DRUG	Viscum Album		Viscum Album	PELLET	ORAL	20221128		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VISCUM ALBUM FRUITING TOP	6	[hp_C]/1			N	20241231
37662-2011_ee92aee2-6cff-05af-e053-2995a90a3201	37662-2011	HUMAN OTC DRUG	Viscum Album		Viscum Album	PELLET	ORAL	20221128		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VISCUM ALBUM FRUITING TOP	12	[hp_C]/1			N	20241231
37662-2012_ee92aee2-6cff-05af-e053-2995a90a3201	37662-2012	HUMAN OTC DRUG	Viscum Album		Viscum Album	PELLET	ORAL	20221128		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VISCUM ALBUM FRUITING TOP	30	[hp_C]/1			N	20241231
37662-2013_ee92aee2-6cff-05af-e053-2995a90a3201	37662-2013	HUMAN OTC DRUG	Viscum Album		Viscum Album	PELLET	ORAL	20221128		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VISCUM ALBUM FRUITING TOP	100	[hp_C]/1			N	20241231
37662-2014_ee92aee2-6cff-05af-e053-2995a90a3201	37662-2014	HUMAN OTC DRUG	Viscum Album		Viscum Album	PELLET	ORAL	20221128		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VISCUM ALBUM FRUITING TOP	200	[hp_C]/1			N	20241231
37662-2015_ee92aee2-6cff-05af-e053-2995a90a3201	37662-2015	HUMAN OTC DRUG	Viscum Album		Viscum Album	PELLET	ORAL	20221128		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VISCUM ALBUM FRUITING TOP	500	[hp_C]/1			N	20241231
37662-2016_ee92aee2-6cff-05af-e053-2995a90a3201	37662-2016	HUMAN OTC DRUG	Viscum Album		Viscum Album	PELLET	ORAL	20221128		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VISCUM ALBUM FRUITING TOP	1	[hp_M]/1			N	20241231
37662-2017_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2017	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	6	[hp_C]/1			N	20241231
37662-2018_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2018	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	12	[hp_C]/1			N	20241231
37662-2019_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2019	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	30	[hp_C]/1			N	20241231
37662-2020_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2020	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	100	[hp_C]/1			N	20241231
37662-2021_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2021	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	200	[hp_C]/1			N	20241231
37662-2022_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2022	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	500	[hp_C]/1			N	20241231
37662-2023_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2023	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	1	[hp_M]/1			N	20241231
37662-2024_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2024	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	10	[hp_M]/1			N	20241231
37662-2025_eea42741-4b3b-737e-e053-2a95a90a7eff	37662-2025	HUMAN OTC DRUG	Viola Tricolor		Viola Tricolor	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VIOLA TRICOLOR WHOLE	1	[hp_Q]/1			N	20241231
37662-2026_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2026	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	6	[hp_C]/1			N	20241231
37662-2027_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2027	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	12	[hp_C]/1			N	20241231
37662-2028_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2028	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	30	[hp_C]/1			N	20241231
37662-2029_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2029	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	100	[hp_C]/1			N	20241231
37662-2030_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2030	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	200	[hp_C]/1			N	20241231
37662-2031_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2031	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	500	[hp_C]/1			N	20241231
37662-2032_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2032	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	1	[hp_M]/1			N	20241231
37662-2033_eea6bcec-a8b6-313a-e053-2995a90a8681	37662-2033	HUMAN OTC DRUG	Petroleum		Petroleum	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KEROSENE	1	[hp_Q]/1			N	20241231
37662-2034_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2034	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	6	[hp_C]/1			N	20241231
37662-2035_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2035	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	12	[hp_C]/1			N	20241231
37662-2036_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2036	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	30	[hp_C]/1			N	20241231
37662-2037_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2037	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	100	[hp_C]/1			N	20241231
37662-2038_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2038	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	200	[hp_C]/1			N	20241231
37662-2039_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2039	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	500	[hp_C]/1			N	20241231
37662-2040_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2040	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	1	[hp_M]/1			N	20241231
37662-2041_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2041	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	10	[hp_M]/1			N	20241231
37662-2042_eea7b314-3f7c-419d-e053-2a95a90a18d6	37662-2042	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	1	[hp_Q]/1			N	20241231
37662-2043_eea9fef2-6a31-5076-e053-2995a90a9074	37662-2043	HUMAN OTC DRUG	Ruthenium		Ruthenium	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM	6	[hp_C]/1			N	20241231
37662-2044_eea9fef2-6a31-5076-e053-2995a90a9074	37662-2044	HUMAN OTC DRUG	Ruthenium		Ruthenium	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM	12	[hp_C]/1			N	20241231
37662-2045_eea9fef2-6a31-5076-e053-2995a90a9074	37662-2045	HUMAN OTC DRUG	Ruthenium		Ruthenium	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM	30	[hp_C]/1			N	20241231
37662-2046_eea9fef2-6a31-5076-e053-2995a90a9074	37662-2046	HUMAN OTC DRUG	Ruthenium		Ruthenium	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM	100	[hp_C]/1			N	20241231
37662-2047_eea9fef2-6a31-5076-e053-2995a90a9074	37662-2047	HUMAN OTC DRUG	Ruthenium		Ruthenium	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM	200	[hp_C]/1			N	20241231
37662-2048_eea9fef2-6a31-5076-e053-2995a90a9074	37662-2048	HUMAN OTC DRUG	Ruthenium		Ruthenium	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM	500	[hp_C]/1			N	20241231
37662-2049_eea9fef2-6a31-5076-e053-2995a90a9074	37662-2049	HUMAN OTC DRUG	Ruthenium		Ruthenium	PELLET	ORAL	20221129		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM	1	[hp_M]/1			N	20241231
37662-2050_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2050	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	6	[hp_C]/1			N	20241231
37662-2051_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2051	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	12	[hp_C]/1			N	20241231
37662-2052_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2052	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	30	[hp_C]/1			N	20241231
37662-2053_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2053	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	100	[hp_C]/1			N	20241231
37662-2054_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2054	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	200	[hp_C]/1			N	20241231
37662-2055_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2055	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	500	[hp_C]/1			N	20241231
37662-2056_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2056	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	1	[hp_M]/1			N	20241231
37662-2057_ef2f96ac-47f6-6d16-e053-2995a90a8343	37662-2057	HUMAN OTC DRUG	Rhus Venenata		Rhus Venenata	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON VERNIX LEAFY TWIG	10	[hp_M]/1			N	20241231
37662-2058_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2058	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	6	[hp_C]/1			N	20241231
37662-2059_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2059	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	12	[hp_C]/1			N	20241231
37662-2060_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2060	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	30	[hp_C]/1			N	20241231
37662-2061_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2061	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	100	[hp_C]/1			N	20241231
37662-2062_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2062	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	200	[hp_C]/1			N	20241231
37662-2063_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2063	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	500	[hp_C]/1			N	20241231
37662-2064_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2064	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	1	[hp_M]/1			N	20241231
37662-2065_ef33c165-590f-493a-e053-2a95a90a6e1a	37662-2065	HUMAN OTC DRUG	Scilla Maritima		Scilla Maritima	PELLET	ORAL	20221206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DRIMIA MARITIMA BULB	10	[hp_M]/1			N	20241231
37662-2066_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2066	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	6	[hp_C]/1			N	20241231
37662-2067_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2067	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	12	[hp_C]/1			N	20241231
37662-2068_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2068	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	30	[hp_C]/1			N	20241231
37662-2069_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2069	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	100	[hp_C]/1			N	20241231
37662-2070_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2070	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	200	[hp_C]/1			N	20241231
37662-2071_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2071	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	500	[hp_C]/1			N	20241231
37662-2072_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2072	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	1	[hp_M]/1			N	20241231
37662-2073_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2073	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	10	[hp_M]/1			N	20241231
37662-2074_ef35e6ff-2a4a-0361-e053-2995a90a5ae9	37662-2074	HUMAN OTC DRUG	Platinum Metallicum		Platinum Metallicum	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLATINUM	1	[hp_Q]/1			N	20241231
37662-2075_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2075	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	6	[hp_C]/1			N	20241231
37662-2076_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2076	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	12	[hp_C]/1			N	20241231
37662-2077_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2077	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_C]/1			N	20241231
37662-2078_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2078	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	100	[hp_C]/1			N	20241231
37662-2079_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2079	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	200	[hp_C]/1			N	20241231
37662-2080_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2080	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	500	[hp_C]/1			N	20241231
37662-2081_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2081	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	1	[hp_M]/1			N	20241231
37662-2082_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2082	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	10	[hp_M]/1			N	20241231
37662-2083_ef46c97d-a25a-2949-e053-2a95a90aef6c	37662-2083	HUMAN OTC DRUG	Spongia Tosta		Spongia Tosta	PELLET	ORAL	20221207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SPONGIA OFFICINALIS SKELETON, ROASTED	1	[hp_Q]/1			N	20241231
37662-2088_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2088	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	6	[hp_C]/1			N	20241231
37662-2089_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2089	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	12	[hp_C]/1			N	20241231
37662-2090_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2090	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	30	[hp_C]/1			N	20241231
37662-2091_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2091	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	100	[hp_C]/1			N	20241231
37662-2092_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2092	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	200	[hp_C]/1			N	20241231
37662-2093_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2093	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	500	[hp_C]/1			N	20241231
37662-2094_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2094	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	1	[hp_M]/1			N	20241231
37662-2095_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2095	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	10	[hp_M]/1			N	20241231
37662-2096_efcdc393-5dac-38d1-e053-2995a90acb2e	37662-2096	HUMAN OTC DRUG	Silicea		Silicea	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON DIOXIDE	1	[hp_Q]/1			N	20241231
37662-2097_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2097	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	6	[hp_C]/1			N	20241231
37662-2098_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2098	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	12	[hp_C]/1			N	20241231
37662-2099_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2099	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	30	[hp_C]/1			N	20241231
37662-2100_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2100	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	100	[hp_C]/1			N	20241231
37662-2101_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2101	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	200	[hp_C]/1			N	20241231
37662-2102_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2102	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	500	[hp_C]/1			N	20241231
37662-2103_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2103	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	1	[hp_M]/1			N	20241231
37662-2104_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2104	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	10	[hp_M]/1			N	20241231
37662-2105_efd0b4af-a1b6-2e6c-e053-2995a90a70f0	37662-2105	HUMAN OTC DRUG	Sepia		Sepia	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEPIA OFFICINALIS JUICE	1	[hp_Q]/1			N	20241231
37662-2106_efd22340-1352-7f33-e053-2995a90abcb8	37662-2106	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2107_efd22340-1352-7f33-e053-2995a90abcb8	37662-2107	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2108_efd22340-1352-7f33-e053-2995a90abcb8	37662-2108	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2109_efd22340-1352-7f33-e053-2995a90abcb8	37662-2109	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2110_efd22340-1352-7f33-e053-2995a90abcb8	37662-2110	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2111_efd22340-1352-7f33-e053-2995a90abcb8	37662-2111	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2112_efd22340-1352-7f33-e053-2995a90abcb8	37662-2112	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2113_efd22340-1352-7f33-e053-2995a90abcb8	37662-2113	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2114_efd22340-1352-7f33-e053-2995a90abcb8	37662-2114	HUMAN OTC DRUG	Ustilago Maidis		Ustilago Maidis	PELLET	ORAL	20221214		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	USTILAGO MAYDIS	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
37662-2115_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2115	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	6	[hp_C]/1			N	20241231
37662-2116_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2116	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	12	[hp_C]/1			N	20241231
37662-2117_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2117	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	30	[hp_C]/1			N	20241231
37662-2118_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2118	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	100	[hp_C]/1			N	20241231
37662-2119_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2119	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	200	[hp_C]/1			N	20241231
37662-2120_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2120	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	500	[hp_C]/1			N	20241231
37662-2121_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2121	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	1	[hp_M]/1			N	20241231
37662-2122_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2122	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	10	[hp_M]/1			N	20241231
37662-2123_efd3ad9d-f570-914f-e053-2995a90a3ea7	37662-2123	HUMAN OTC DRUG	Symphytum Officinale		Symphytum Officinale	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COMFREY ROOT	1	[hp_Q]/1			N	20241231
37662-2124_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2124	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	6	[hp_C]/1			N	20241231
37662-2125_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2125	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	12	[hp_C]/1			N	20241231
37662-2126_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2126	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	30	[hp_C]/1			N	20241231
37662-2127_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2127	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	100	[hp_C]/1			N	20241231
37662-2128_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2128	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	200	[hp_C]/1			N	20241231
37662-2129_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2129	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	500	[hp_C]/1			N	20241231
37662-2130_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2130	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	1	[hp_M]/1			N	20241231
37662-2131_f034f7f8-b2c7-71ac-e053-2a95a90ad8bb	37662-2131	HUMAN OTC DRUG	Valeriana Officinalis		Valeriana Officinalis	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALERIAN	10	[hp_M]/1			N	20241231
37662-2132_f035e3fa-532a-79d5-e053-2995a90a2e9b	37662-2132	HUMAN OTC DRUG	Zincum Bromatum		Zincum Bromatum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC BROMIDE	6	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2133_f035e3fa-532a-79d5-e053-2995a90a2e9b	37662-2133	HUMAN OTC DRUG	Zincum Bromatum		Zincum Bromatum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC BROMIDE	12	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2134_f035e3fa-532a-79d5-e053-2995a90a2e9b	37662-2134	HUMAN OTC DRUG	Zincum Bromatum		Zincum Bromatum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC BROMIDE	30	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2135_f035e3fa-532a-79d5-e053-2995a90a2e9b	37662-2135	HUMAN OTC DRUG	Zincum Bromatum		Zincum Bromatum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC BROMIDE	100	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2136_f035e3fa-532a-79d5-e053-2995a90a2e9b	37662-2136	HUMAN OTC DRUG	Zincum Bromatum		Zincum Bromatum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC BROMIDE	200	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2137_f035e3fa-532a-79d5-e053-2995a90a2e9b	37662-2137	HUMAN OTC DRUG	Zincum Bromatum		Zincum Bromatum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC BROMIDE	500	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2138_f035e3fa-532a-79d5-e053-2995a90a2e9b	37662-2138	HUMAN OTC DRUG	Zincum Bromatum		Zincum Bromatum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC BROMIDE	1	[hp_M]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2139_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2139	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	6	[hp_C]/1			N	20241231
37662-2140_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2140	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	12	[hp_C]/1			N	20241231
37662-2141_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2141	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	30	[hp_C]/1			N	20241231
37662-2142_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2142	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	100	[hp_C]/1			N	20241231
37662-2143_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2143	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	200	[hp_C]/1			N	20241231
37662-2144_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2144	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	500	[hp_C]/1			N	20241231
37662-2145_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2145	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	1	[hp_M]/1			N	20241231
37662-2146_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2146	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	10	[hp_M]/1			N	20241231
37662-2147_f03748db-9f00-ea3e-e053-2995a90aaaff	37662-2147	HUMAN OTC DRUG	Zincum Metallicum		Zincum Metallicum	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC	1	[hp_Q]/1			N	20241231
37662-2148_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2148	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	6	[hp_C]/1			N	20241231
37662-2149_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2149	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	12	[hp_C]/1			N	20241231
37662-2150_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2150	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	30	[hp_C]/1			N	20241231
37662-2151_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2151	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	100	[hp_C]/1			N	20241231
37662-2152_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2152	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	200	[hp_C]/1			N	20241231
37662-2153_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2153	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	500	[hp_C]/1			N	20241231
37662-2154_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2154	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	1	[hp_M]/1			N	20241231
37662-2155_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2155	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	10	[hp_M]/1			N	20241231
37662-2156_f048c79d-019c-6ebc-e053-2a95a90a99c2	37662-2156	HUMAN OTC DRUG	Sarsaparilla		Sarsaparilla	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARSAPARILLA	1	[hp_Q]/1			N	20241231
37662-2157_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2157	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	6	[hp_C]/1			N	20241231
37662-2158_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2158	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	12	[hp_C]/1			N	20241231
37662-2159_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2159	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	30	[hp_C]/1			N	20241231
37662-2160_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2160	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	100	[hp_C]/1			N	20241231
37662-2161_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2161	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	200	[hp_C]/1			N	20241231
37662-2162_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2162	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	500	[hp_C]/1			N	20241231
37662-2163_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2163	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	1	[hp_M]/1			N	20241231
37662-2164_f04b0ab3-af1d-ec2d-e053-2995a90a7855	37662-2164	HUMAN OTC DRUG	Saccharum Officinale		Saccharum Officinale	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SUCROSE	10	[hp_M]/1			N	20241231
37662-2165_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2165	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	6	[hp_C]/1			N	20241231
37662-2166_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2166	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	12	[hp_C]/1			N	20241231
37662-2167_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2167	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	30	[hp_C]/1			N	20241231
37662-2168_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2168	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	100	[hp_C]/1			N	20241231
37662-2169_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2169	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	200	[hp_C]/1			N	20241231
37662-2170_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2170	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	500	[hp_C]/1			N	20241231
37662-2171_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2171	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	1	[hp_M]/1			N	20241231
37662-2172_f04c4aae-b795-1d15-e053-2a95a90a993f	37662-2172	HUMAN OTC DRUG	Stramonium		Stramonium	PELLET	ORAL	20221220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DATURA STRAMONIUM	10	[hp_M]/1			N	20241231
37662-2173_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2173	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	6	[hp_C]/1			N	20241231
37662-2174_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2174	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	12	[hp_C]/1			N	20241231
37662-2175_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2175	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	30	[hp_C]/1			N	20241231
37662-2176_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2176	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	100	[hp_C]/1			N	20241231
37662-2177_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2177	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	200	[hp_C]/1			N	20241231
37662-2178_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2178	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	500	[hp_C]/1			N	20241231
37662-2179_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2179	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	1	[hp_M]/1			N	20241231
37662-2180_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2180	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	10	[hp_M]/1			N	20241231
37662-2181_f05e7d86-4d91-ba11-e053-2a95a90a20c3	37662-2181	HUMAN OTC DRUG	Crocus Sativus		Crocus Sativus	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAFFRON	1	[hp_Q]/1			N	20241231
37662-2182_f060351b-1242-1e57-e053-2a95a90a5294	37662-2182	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2183_f060351b-1242-1e57-e053-2a95a90a5294	37662-2183	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2184_f060351b-1242-1e57-e053-2a95a90a5294	37662-2184	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2185_f060351b-1242-1e57-e053-2a95a90a5294	37662-2185	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2186_f060351b-1242-1e57-e053-2a95a90a5294	37662-2186	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2187_f060351b-1242-1e57-e053-2a95a90a5294	37662-2187	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2188_f060351b-1242-1e57-e053-2a95a90a5294	37662-2188	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2189_f060351b-1242-1e57-e053-2a95a90a5294	37662-2189	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20221221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2190_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2190	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2191_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2191	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2192_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2192	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2193_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2193	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2194_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2194	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2195_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2195	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2196_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2196	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2197_ec0ed752-e065-0d8b-e053-2995a90ab143	37662-2197	HUMAN OTC DRUG	Manganum Carbonicum		Manganum Carbonicum	PELLET	ORAL	20221027		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE CARBONATE	1	[hp_Q]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2198_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2198	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	6	[hp_C]/1			N	20241231
37662-2199_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2199	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	12	[hp_C]/1			N	20241231
37662-2200_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2200	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	30	[hp_C]/1			N	20241231
37662-2201_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2201	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	100	[hp_C]/1			N	20241231
37662-2202_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2202	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	200	[hp_C]/1			N	20241231
37662-2203_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2203	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	500	[hp_C]/1			N	20241231
37662-2204_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2204	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	1	[hp_M]/1			N	20241231
37662-2205_f062baf5-af5e-8425-e053-2995a90a79cb	37662-2205	HUMAN OTC DRUG	Cobaltum Sulphuricum		Cobaltum Sulphuricum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS SULFATE HEPTAHYDRATE	1	[hp_Q]/1			N	20241231
37662-2206_f0732b95-e72c-07e4-e053-2995a90a0613	37662-2206	HUMAN OTC DRUG	Crataegus		Crataegus	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAWTHORN LEAF WITH FLOWER	6	[hp_C]/1			N	20241231
37662-2207_f0732b95-e72c-07e4-e053-2995a90a0613	37662-2207	HUMAN OTC DRUG	Crataegus		Crataegus	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAWTHORN LEAF WITH FLOWER	12	[hp_C]/1			N	20241231
37662-2208_f0732b95-e72c-07e4-e053-2995a90a0613	37662-2208	HUMAN OTC DRUG	Crataegus		Crataegus	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAWTHORN LEAF WITH FLOWER	30	[hp_C]/1			N	20241231
37662-2209_f0732b95-e72c-07e4-e053-2995a90a0613	37662-2209	HUMAN OTC DRUG	Crataegus		Crataegus	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAWTHORN LEAF WITH FLOWER	100	[hp_C]/1			N	20241231
37662-2210_f0732b95-e72c-07e4-e053-2995a90a0613	37662-2210	HUMAN OTC DRUG	Crataegus		Crataegus	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAWTHORN LEAF WITH FLOWER	200	[hp_C]/1			N	20241231
37662-2211_f0732b95-e72c-07e4-e053-2995a90a0613	37662-2211	HUMAN OTC DRUG	Crataegus		Crataegus	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAWTHORN LEAF WITH FLOWER	500	[hp_C]/1			N	20241231
37662-2212_f0732b95-e72c-07e4-e053-2995a90a0613	37662-2212	HUMAN OTC DRUG	Crataegus		Crataegus	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAWTHORN LEAF WITH FLOWER	1	[hp_M]/1			N	20241231
37662-2213_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2213	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	6	[hp_C]/1			N	20241231
37662-2214_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2214	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	12	[hp_C]/1			N	20241231
37662-2215_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2215	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	30	[hp_C]/1			N	20241231
37662-2216_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2216	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	100	[hp_C]/1			N	20241231
37662-2217_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2217	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	200	[hp_C]/1			N	20241231
37662-2218_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2218	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	500	[hp_C]/1			N	20241231
37662-2219_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2219	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	1	[hp_M]/1			N	20241231
37662-2220_f0749d4d-497f-0059-e053-2995a90a4bbc	37662-2220	HUMAN OTC DRUG	Cobaltum Iodatum		Cobaltum Iodatum	PELLET	ORAL	20221222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS IODIDE	1	[hp_Q]/1			N	20241231
37662-2221_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2221	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	6	[hp_C]/1			N	20241231
37662-2222_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2222	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	12	[hp_C]/1			N	20241231
37662-2223_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2223	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	30	[hp_C]/1			N	20241231
37662-2224_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2224	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	100	[hp_C]/1			N	20241231
37662-2225_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2225	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	200	[hp_C]/1			N	20241231
37662-2226_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2226	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	500	[hp_C]/1			N	20241231
37662-2227_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2227	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	1	[hp_M]/1			N	20241231
37662-2228_f0761712-b228-05a5-e053-2a95a90a63f4	37662-2228	HUMAN OTC DRUG	Cuprum Bromatum		Cuprum Bromatum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC BROMIDE	1	[hp_Q]/1			N	20241231
37662-2229_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2229	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	6	[hp_C]/1			N	20241231
37662-2230_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2230	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	12	[hp_C]/1			N	20241231
37662-2231_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2231	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	30	[hp_C]/1			N	20241231
37662-2232_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2232	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	100	[hp_C]/1			N	20241231
37662-2233_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2233	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	200	[hp_C]/1			N	20241231
37662-2234_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2234	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	500	[hp_C]/1			N	20241231
37662-2235_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2235	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	1	[hp_M]/1			N	20241231
37662-2236_f166517a-76d5-cc19-e053-2995a90ae4f1	37662-2236	HUMAN OTC DRUG	Cuprum Phosphoricum		Cuprum Phosphoricum	PELLET	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC PHOSPHATE	1	[hp_Q]/1			N	20241231
37662-2237_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2237	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2238_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2238	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2239_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2239	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2240_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2240	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2241_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2241	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2242_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2242	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2243_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2243	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2244_f176bba9-acef-ccc0-e053-2a95a90aa506	37662-2244	HUMAN OTC DRUG	Kali Ferrocyanatum		Kali Ferrocyanatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FERROCYANIDE TRIHYDRATE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2245_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2245	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	6	[hp_C]/1			N	20241231
37662-2246_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2246	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	12	[hp_C]/1			N	20241231
37662-2247_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2247	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	30	[hp_C]/1			N	20241231
37662-2248_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2248	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	100	[hp_C]/1			N	20241231
37662-2249_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2249	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	200	[hp_C]/1			N	20241231
37662-2250_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2250	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	500	[hp_C]/1			N	20241231
37662-2251_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2251	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	1	[hp_M]/1			N	20241231
37662-2252_f178ed5b-c86a-3d20-e053-2a95a90a40d8	37662-2252	HUMAN OTC DRUG	Ornithogalum Umbellatum		Ornithogalum Umbellatum	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORNITHOGALUM UMBELLATUM	1	[hp_Q]/1			N	20241231
37662-2253_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2253	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	6	[hp_C]/1			N	20241231
37662-2254_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2254	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	12	[hp_C]/1			N	20241231
37662-2255_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2255	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	30	[hp_C]/1			N	20241231
37662-2256_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2256	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	100	[hp_C]/1			N	20241231
37662-2257_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2257	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	200	[hp_C]/1			N	20241231
37662-2258_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2258	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	500	[hp_C]/1			N	20241231
37662-2259_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2259	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	1	[hp_M]/1			N	20241231
37662-2260_f179fdc3-e594-b66e-e053-2995a90a5642	37662-2260	HUMAN OTC DRUG	Sanguinaria Canadensis		Sanguinaria Canadensis	PELLET	ORAL	20230104		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANGUINARIA CANADENSIS ROOT	1	[hp_Q]/1			N	20241231
37662-2261_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2261	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-2262_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2262	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-2263_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2263	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-2264_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2264	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-2265_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2265	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-2266_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2266	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-2267_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2267	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-2268_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2268	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	10	[hp_M]/1			N	20241231
37662-2269_f1a3bd93-80d5-be37-e053-2a95a90a3fd9	37662-2269	HUMAN OTC DRUG	Ruta Graveolens		Ruta Graveolens	PELLET	ORAL	20230106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTA GRAVEOLENS FLOWERING TOP	1	[hp_Q]/1			N	20241231
37662-2270_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2270	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	6	[hp_C]/1			N	20241231
37662-2271_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2271	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	12	[hp_C]/1			N	20241231
37662-2272_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2272	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	30	[hp_C]/1			N	20241231
37662-2273_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2273	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	100	[hp_C]/1			N	20241231
37662-2274_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2274	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	200	[hp_C]/1			N	20241231
37662-2275_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2275	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	500	[hp_C]/1			N	20241231
37662-2276_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2276	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	1	[hp_M]/1			N	20241231
37662-2277_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2277	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	10	[hp_M]/1			N	20241231
37662-2278_f1dd6d9b-f1d8-0820-e053-2a95a90a82a6	37662-2278	HUMAN OTC DRUG	Scutellaria Lateriflora		Scutellaria Lateriflora	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCUTELLARIA LATERIFLORA WHOLE	1	[hp_Q]/1			N	20241231
37662-2279_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2279	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	6	[hp_C]/1			N	20241231
37662-2280_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2280	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	12	[hp_C]/1			N	20241231
37662-2281_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2281	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	30	[hp_C]/1			N	20241231
37662-2282_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2282	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	100	[hp_C]/1			N	20241231
37662-2283_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2283	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	200	[hp_C]/1			N	20241231
37662-2284_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2284	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	500	[hp_C]/1			N	20241231
37662-2285_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2285	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	1	[hp_M]/1			N	20241231
37662-2286_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2286	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	10	[hp_M]/1			N	20241231
37662-2287_f1dfc1c1-7670-65c5-e053-2995a90a2220	37662-2287	HUMAN OTC DRUG	Staphysagria		Staphysagria	PELLET	ORAL	20230109		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DELPHINIUM STAPHISAGRIA SEED	1	[hp_Q]/1			N	20241231
37662-2288_f1f24797-3321-296d-e053-2995a90adf5a	37662-2288	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	6	[hp_C]/1			N	20241231
37662-2289_f1f24797-3321-296d-e053-2995a90adf5a	37662-2289	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	12	[hp_C]/1			N	20241231
37662-2290_f1f24797-3321-296d-e053-2995a90adf5a	37662-2290	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	30	[hp_C]/1			N	20241231
37662-2291_f1f24797-3321-296d-e053-2995a90adf5a	37662-2291	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	100	[hp_C]/1			N	20241231
37662-2292_f1f24797-3321-296d-e053-2995a90adf5a	37662-2292	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	200	[hp_C]/1			N	20241231
37662-2293_f1f24797-3321-296d-e053-2995a90adf5a	37662-2293	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	500	[hp_C]/1			N	20241231
37662-2294_f1f24797-3321-296d-e053-2995a90adf5a	37662-2294	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	1	[hp_M]/1			N	20241231
37662-2295_f1f24797-3321-296d-e053-2995a90adf5a	37662-2295	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	10	[hp_M]/1			N	20241231
37662-2296_f1f24797-3321-296d-e053-2995a90adf5a	37662-2296	HUMAN OTC DRUG	Strontium Carbonicum		Strontium Carbonicum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CARBONATE	1	[hp_Q]/1			N	20241231
37662-2297_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2297	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	6	[hp_C]/1			N	20241231
37662-2298_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2298	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	12	[hp_C]/1			N	20241231
37662-2299_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2299	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	30	[hp_C]/1			N	20241231
37662-2300_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2300	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	100	[hp_C]/1			N	20241231
37662-2301_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2301	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	200	[hp_C]/1			N	20241231
37662-2302_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2302	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	500	[hp_C]/1			N	20241231
37662-2303_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2303	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	1	[hp_M]/1			N	20241231
37662-2304_f1f51e7a-f305-72a7-e053-2a95a90a0756	37662-2304	HUMAN OTC DRUG	Syzygium Jambolanum		Syzygium Jambolanum	PELLET	ORAL	20230110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SYZYGIUM CUMINI SEED	10	[hp_M]/1			N	20241231
37662-2305_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2305	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	6	[hp_C]/1			N	20241231
37662-2306_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2306	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	12	[hp_C]/1			N	20241231
37662-2307_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2307	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	30	[hp_C]/1			N	20241231
37662-2308_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2308	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	100	[hp_C]/1			N	20241231
37662-2309_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2309	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	200	[hp_C]/1			N	20241231
37662-2310_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2310	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	500	[hp_C]/1			N	20241231
37662-2311_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2311	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	1	[hp_M]/1			N	20241231
37662-2312_f1f61f7e-bb41-4ee8-e053-2a95a90a08bd	37662-2312	HUMAN OTC DRUG	Thiosinaminum		Thiosinaminum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALLYLTHIOUREA	1	[hp_Q]/1			N	20241231
37662-2313_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2313	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	6	[hp_C]/1			N	20241231
37662-2314_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2314	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	12	[hp_C]/1			N	20241231
37662-2315_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2315	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	30	[hp_C]/1			N	20241231
37662-2316_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2316	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	100	[hp_C]/1			N	20241231
37662-2317_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2317	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	200	[hp_C]/1			N	20241231
37662-2318_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2318	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	500	[hp_C]/1			N	20241231
37662-2319_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2319	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	1	[hp_M]/1			N	20241231
37662-2320_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2320	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	10	[hp_M]/1			N	20241231
37662-2321_f208f88c-3c4e-f177-e053-2995a90aba01	37662-2321	HUMAN OTC DRUG	Sulphur		Sulphur	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFUR	1	[hp_Q]/1			N	20241231
37662-2322_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2322	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	6	[hp_C]/1			N	20241231
37662-2323_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2323	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	12	[hp_C]/1			N	20241231
37662-2324_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2324	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	30	[hp_C]/1			N	20241231
37662-2325_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2325	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	100	[hp_C]/1			N	20241231
37662-2326_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2326	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	200	[hp_C]/1			N	20241231
37662-2327_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2327	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	500	[hp_C]/1			N	20241231
37662-2328_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2328	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	1	[hp_M]/1			N	20241231
37662-2329_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2329	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	10	[hp_M]/1			N	20241231
37662-2330_f20a451d-1ce3-cc93-e053-2a95a90a5a15	37662-2330	HUMAN OTC DRUG	Paris Quadrifolia		Paris Quadrifolia	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PARIS QUADRIFOLIA	1	[hp_Q]/1			N	20241231
37662-2331_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2331	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	6	[hp_C]/1			N	20241231
37662-2332_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2332	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	12	[hp_C]/1			N	20241231
37662-2333_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2333	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	30	[hp_C]/1			N	20241231
37662-2334_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2334	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	100	[hp_C]/1			N	20241231
37662-2335_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2335	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	200	[hp_C]/1			N	20241231
37662-2336_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2336	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	500	[hp_C]/1			N	20241231
37662-2337_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2337	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	1	[hp_M]/1			N	20241231
37662-2338_f20ba449-8107-5c88-e053-2a95a90aa9de	37662-2338	HUMAN OTC DRUG	Petroselinum Sativum		Petroselinum Sativum	PELLET	ORAL	20230111		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PETROSELINUM CRISPUM	1	[hp_Q]/1			N	20241231
37662-2339_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2339	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	6	[hp_C]/1			N	20241231
37662-2340_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2340	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	12	[hp_C]/1			N	20241231
37662-2341_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2341	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	30	[hp_C]/1			N	20241231
37662-2342_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2342	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	100	[hp_C]/1			N	20241231
37662-2343_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2343	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	200	[hp_C]/1			N	20241231
37662-2344_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2344	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	500	[hp_C]/1			N	20241231
37662-2345_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2345	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	1	[hp_M]/1			N	20241231
37662-2346_f20c98a8-0bf3-07f4-e053-2a95a90a44ad	37662-2346	HUMAN OTC DRUG	Podophyllum Peltatum		Podophyllum Peltatum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PODOPHYLLUM	1	[hp_Q]/1			N	20241231
37662-2347_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2347	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	6	[hp_C]/1			N	20241231
37662-2348_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2348	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	12	[hp_C]/1			N	20241231
37662-2349_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2349	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	30	[hp_C]/1			N	20241231
37662-2350_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2350	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	100	[hp_C]/1			N	20241231
37662-2351_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2351	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	200	[hp_C]/1			N	20241231
37662-2352_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2352	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	500	[hp_C]/1			N	20241231
37662-2353_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2353	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	1	[hp_M]/1			N	20241231
37662-2354_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2354	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	10	[hp_M]/1			N	20241231
37662-2355_f21d8260-13b5-8f19-e053-2a95a90a0065	37662-2355	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	1	[hp_Q]/1			N	20241231
37662-2356_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2356	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	6	[hp_C]/1			N	20241231
37662-2357_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2357	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	12	[hp_C]/1			N	20241231
37662-2358_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2358	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	30	[hp_C]/1			N	20241231
37662-2359_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2359	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	100	[hp_C]/1			N	20241231
37662-2360_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2360	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	200	[hp_C]/1			N	20241231
37662-2361_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2361	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	500	[hp_C]/1			N	20241231
37662-2362_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2362	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	1	[hp_M]/1			N	20241231
37662-2363_f21de984-91f9-b4f0-e053-2995a90aab4f	37662-2363	HUMAN OTC DRUG	Acidum Picricum		Acidum Picricum	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PICRIC ACID	10	[hp_M]/1			N	20241231
37662-2364_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2364	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	6	[hp_C]/1			N	20241231
37662-2365_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2365	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	12	[hp_C]/1			N	20241231
37662-2366_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2366	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	30	[hp_C]/1			N	20241231
37662-2367_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2367	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	100	[hp_C]/1			N	20241231
37662-2368_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2368	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	200	[hp_C]/1			N	20241231
37662-2369_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2369	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	500	[hp_C]/1			N	20241231
37662-2370_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2370	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	1	[hp_M]/1			N	20241231
37662-2371_f21eceaf-b412-28a5-e053-2995a90a6fcd	37662-2371	HUMAN OTC DRUG	Sabina		Sabina	PELLET	ORAL	20230112		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	JUNIPERUS SABINA LEAFY TWIG	1	[hp_Q]/1			N	20241231
37662-2372_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2372	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2373_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2373	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2374_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2374	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2375_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2375	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2376_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2376	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2377_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2377	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2378_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2378	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2379_f27d73b2-2715-3a52-e053-2a95a90a8f05	37662-2379	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM SULFATE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-2380_f27fbace-3f51-d282-e053-2995a90a9649	37662-2380	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	6	[hp_C]/1			N	20241231
37662-2381_f27fbace-3f51-d282-e053-2995a90a9649	37662-2381	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	12	[hp_C]/1			N	20241231
37662-2382_f27fbace-3f51-d282-e053-2995a90a9649	37662-2382	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	30	[hp_C]/1			N	20241231
37662-2383_f27fbace-3f51-d282-e053-2995a90a9649	37662-2383	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	100	[hp_C]/1			N	20241231
37662-2384_f27fbace-3f51-d282-e053-2995a90a9649	37662-2384	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	200	[hp_C]/1			N	20241231
37662-2385_f27fbace-3f51-d282-e053-2995a90a9649	37662-2385	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	500	[hp_C]/1			N	20241231
37662-2386_f27fbace-3f51-d282-e053-2995a90a9649	37662-2386	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	1	[hp_M]/1			N	20241231
37662-2387_f27fbace-3f51-d282-e053-2995a90a9649	37662-2387	HUMAN OTC DRUG	Physostigma Venenosum		Physostigma Venenosum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHYSOSTIGMA VENENOSUM SEED	1	[hp_Q]/1			N	20241231
37662-2388_f2816d07-7110-335d-e053-2995a90a0e44	37662-2388	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	6	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2389_f2816d07-7110-335d-e053-2995a90a0e44	37662-2389	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	12	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2390_f2816d07-7110-335d-e053-2995a90a0e44	37662-2390	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	30	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2391_f2816d07-7110-335d-e053-2995a90a0e44	37662-2391	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	100	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2392_f2816d07-7110-335d-e053-2995a90a0e44	37662-2392	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	200	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2393_f2816d07-7110-335d-e053-2995a90a0e44	37662-2393	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	500	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2394_f2816d07-7110-335d-e053-2995a90a0e44	37662-2394	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	1	[hp_M]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2395_f2816d07-7110-335d-e053-2995a90a0e44	37662-2395	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	10	[hp_M]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2396_f2816d07-7110-335d-e053-2995a90a0e44	37662-2396	HUMAN OTC DRUG	Zincum Sulphuricum		Zincum Sulphuricum	PELLET	ORAL	20230117		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC SULFATE HEPTAHYDRATE	1	[hp_Q]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-2397_f29046e7-a00c-9401-e053-2a95a90afef6	37662-2397	HUMAN OTC DRUG	Xerophyllum Asphodeloides		Xerophyllum Asphodeloides	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	XEROPHYLLUM ASPHODELOIDES	6	[hp_C]/1			N	20241231
37662-2398_f29046e7-a00c-9401-e053-2a95a90afef6	37662-2398	HUMAN OTC DRUG	Xerophyllum Asphodeloides		Xerophyllum Asphodeloides	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	XEROPHYLLUM ASPHODELOIDES	12	[hp_C]/1			N	20241231
37662-2399_f29046e7-a00c-9401-e053-2a95a90afef6	37662-2399	HUMAN OTC DRUG	Xerophyllum Asphodeloides		Xerophyllum Asphodeloides	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	XEROPHYLLUM ASPHODELOIDES	30	[hp_C]/1			N	20241231
37662-2400_f29046e7-a00c-9401-e053-2a95a90afef6	37662-2400	HUMAN OTC DRUG	Xerophyllum Asphodeloides		Xerophyllum Asphodeloides	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	XEROPHYLLUM ASPHODELOIDES	100	[hp_C]/1			N	20241231
37662-2401_f29046e7-a00c-9401-e053-2a95a90afef6	37662-2401	HUMAN OTC DRUG	Xerophyllum Asphodeloides		Xerophyllum Asphodeloides	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	XEROPHYLLUM ASPHODELOIDES	200	[hp_C]/1			N	20241231
37662-2402_f29046e7-a00c-9401-e053-2a95a90afef6	37662-2402	HUMAN OTC DRUG	Xerophyllum Asphodeloides		Xerophyllum Asphodeloides	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	XEROPHYLLUM ASPHODELOIDES	500	[hp_C]/1			N	20241231
37662-2403_f29046e7-a00c-9401-e053-2a95a90afef6	37662-2403	HUMAN OTC DRUG	Xerophyllum Asphodeloides		Xerophyllum Asphodeloides	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	XEROPHYLLUM ASPHODELOIDES	1	[hp_M]/1			N	20241231
37662-2404_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2404	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	6	[hp_C]/1			N	20241231
37662-2405_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2405	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	12	[hp_C]/1			N	20241231
37662-2406_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2406	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	30	[hp_C]/1			N	20241231
37662-2407_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2407	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	100	[hp_C]/1			N	20241231
37662-2408_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2408	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	200	[hp_C]/1			N	20241231
37662-2409_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2409	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	500	[hp_C]/1			N	20241231
37662-2410_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2410	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	1	[hp_M]/1			N	20241231
37662-2411_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2411	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	10	[hp_M]/1			N	20241231
37662-2412_f2946bb3-57bc-216b-e053-2995a90ab015	37662-2412	HUMAN OTC DRUG	Xanthoxylum Fraxineum		Xanthoxylum Fraxineum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZANTHOXYLUM AMERICANUM BARK	1	[hp_Q]/1			N	20241231
37662-2413_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2413	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	6	[hp_C]/1			N	20241231
37662-2414_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2414	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	12	[hp_C]/1			N	20241231
37662-2415_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2415	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	30	[hp_C]/1			N	20241231
37662-2416_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2416	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	100	[hp_C]/1			N	20241231
37662-2417_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2417	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	200	[hp_C]/1			N	20241231
37662-2418_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2418	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	500	[hp_C]/1			N	20241231
37662-2419_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2419	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	1	[hp_M]/1			N	20241231
37662-2420_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2420	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	10	[hp_M]/1			N	20241231
37662-2421_f29571fd-07a0-a723-e053-2a95a90a48d3	37662-2421	HUMAN OTC DRUG	Acidum Nitricum		Acidum Nitricum	PELLET	ORAL	20230118		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NITRIC ACID	1	[hp_Q]/1			N	20241231
37662-2422_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2422	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	6	[hp_C]/1			N	20241231
37662-2423_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2423	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	12	[hp_C]/1			N	20241231
37662-2424_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2424	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	30	[hp_C]/1			N	20241231
37662-2425_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2425	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	100	[hp_C]/1			N	20241231
37662-2426_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2426	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	200	[hp_C]/1			N	20241231
37662-2427_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2427	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	500	[hp_C]/1			N	20241231
37662-2428_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2428	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	1	[hp_M]/1			N	20241231
37662-2429_f2a47b37-9849-0eac-e053-2995a90aadef	37662-2429	HUMAN OTC DRUG	Rhus Toxicodendron		Rhus Toxicodendron	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TOXICODENDRON PUBESCENS LEAF	1	[hp_Q]/1			N	20241231
37662-2430_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2430	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	6	[hp_C]/1			N	20241231
37662-2431_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2431	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	12	[hp_C]/1			N	20241231
37662-2432_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2432	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	30	[hp_C]/1			N	20241231
37662-2433_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2433	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	100	[hp_C]/1			N	20241231
37662-2434_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2434	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	200	[hp_C]/1			N	20241231
37662-2435_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2435	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	500	[hp_C]/1			N	20241231
37662-2436_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2436	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	1	[hp_M]/1			N	20241231
37662-2437_f2a6f5f9-54a1-d3c6-e053-2995a90a3bcd	37662-2437	HUMAN OTC DRUG	Mercurius Iodatus Flavus		Mercurius Iodatus Flavus	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS IODIDE	1	[hp_Q]/1			N	20241231
37662-2438_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2438	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	6	[hp_C]/1			N	20241231
37662-2439_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2439	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	12	[hp_C]/1			N	20241231
37662-2440_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2440	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	30	[hp_C]/1			N	20241231
37662-2441_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2441	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	100	[hp_C]/1			N	20241231
37662-2442_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2442	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	200	[hp_C]/1			N	20241231
37662-2443_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2443	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	500	[hp_C]/1			N	20241231
37662-2444_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2444	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	1	[hp_M]/1			N	20241231
37662-2445_f2aa1489-8e84-8f81-e053-2a95a90ad068	37662-2445	HUMAN OTC DRUG	Mercurius Iodatus Ruber		Mercurius Iodatus Ruber	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC IODIDE	1	[hp_Q]/1			N	20241231
37662-2446_f2aad04c-5152-6cab-e053-2a95a90ad3a7	37662-2446	HUMAN OTC DRUG	Acidum Muriaticum		Acidum Muriaticum	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROCHLORIC ACID	6	[hp_C]/1			N	20241231
37662-2447_f2aad04c-5152-6cab-e053-2a95a90ad3a7	37662-2447	HUMAN OTC DRUG	Acidum Muriaticum		Acidum Muriaticum	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROCHLORIC ACID	12	[hp_C]/1			N	20241231
37662-2448_f2aad04c-5152-6cab-e053-2a95a90ad3a7	37662-2448	HUMAN OTC DRUG	Acidum Muriaticum		Acidum Muriaticum	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROCHLORIC ACID	30	[hp_C]/1			N	20241231
37662-2449_f2aad04c-5152-6cab-e053-2a95a90ad3a7	37662-2449	HUMAN OTC DRUG	Acidum Muriaticum		Acidum Muriaticum	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROCHLORIC ACID	100	[hp_C]/1			N	20241231
37662-2450_f2aad04c-5152-6cab-e053-2a95a90ad3a7	37662-2450	HUMAN OTC DRUG	Acidum Muriaticum		Acidum Muriaticum	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROCHLORIC ACID	200	[hp_C]/1			N	20241231
37662-2451_f2aad04c-5152-6cab-e053-2a95a90ad3a7	37662-2451	HUMAN OTC DRUG	Acidum Muriaticum		Acidum Muriaticum	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROCHLORIC ACID	500	[hp_C]/1			N	20241231
37662-2452_f2aad04c-5152-6cab-e053-2a95a90ad3a7	37662-2452	HUMAN OTC DRUG	Acidum Muriaticum		Acidum Muriaticum	PELLET	ORAL	20230119		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROCHLORIC ACID	1	[hp_M]/1			N	20241231
37662-2453_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2453	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	6	[hp_C]/1			N	20241231
37662-2454_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2454	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	12	[hp_C]/1			N	20241231
37662-2455_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2455	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	30	[hp_C]/1			N	20241231
37662-2456_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2456	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	100	[hp_C]/1			N	20241231
37662-2457_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2457	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	200	[hp_C]/1			N	20241231
37662-2458_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2458	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	500	[hp_C]/1			N	20241231
37662-2459_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2459	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	1	[hp_M]/1			N	20241231
37662-2460_f2f5e4c5-4681-d3ae-e053-2a95a90a501c	37662-2460	HUMAN OTC DRUG	Germanium Metallicum		Germanium Metallicum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM	1	[hp_Q]/1			N	20241231
37662-2461_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2461	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	6	[hp_C]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2462_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2462	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	12	[hp_C]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2463_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2463	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	30	[hp_C]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2464_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2464	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	100	[hp_C]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2465_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2465	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	200	[hp_C]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2466_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2466	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	500	[hp_C]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2467_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2467	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	1	[hp_M]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2468_f2fb0248-1fcb-2b8b-e053-2995a90a5afa	37662-2468	HUMAN OTC DRUG	Kali Citricum		Kali Citricum	PELLET	ORAL	20230123		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CITRATE	1	[hp_Q]/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
37662-2469_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2469	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2470_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2470	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2471_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2471	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2472_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2472	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2473_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2473	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2474_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2474	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2475_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2475	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2476_f30b97cd-f720-25f0-e053-2995a90a0ea9	37662-2476	HUMAN OTC DRUG	Manganum Bromatum		Manganum Bromatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE BROMIDE	1	[hp_Q]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2477_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2477	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2478_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2478	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2479_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2479	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2480_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2480	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2481_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2481	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2482_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2482	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2483_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2483	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2484_f30d500b-2a6b-3c96-e053-2995a90a2b6e	37662-2484	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	1	[hp_Q]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2485_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2485	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2486_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2486	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2487_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2487	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2488_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2488	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2489_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2489	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2490_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2490	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2491_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2491	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2492_f30ed2e7-b0f7-58b3-e053-2a95a90a0d1c	37662-2492	HUMAN OTC DRUG	Manganum Iodatum		Manganum Iodatum	PELLET	ORAL	20230124		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE IODIDE	1	[hp_Q]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2493_f31d91d4-3254-7100-e053-2995a90a10f2	37662-2493	HUMAN OTC DRUG	Melilotus Alba		Melilotus Alba	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS ALBUS TOP	6	[hp_C]/1			N	20241231
37662-2494_f31d91d4-3254-7100-e053-2995a90a10f2	37662-2494	HUMAN OTC DRUG	Melilotus Alba		Melilotus Alba	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS ALBUS TOP	12	[hp_C]/1			N	20241231
37662-2495_f31d91d4-3254-7100-e053-2995a90a10f2	37662-2495	HUMAN OTC DRUG	Melilotus Alba		Melilotus Alba	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS ALBUS TOP	30	[hp_C]/1			N	20241231
37662-2496_f31d91d4-3254-7100-e053-2995a90a10f2	37662-2496	HUMAN OTC DRUG	Melilotus Alba		Melilotus Alba	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS ALBUS TOP	100	[hp_C]/1			N	20241231
37662-2497_f31d91d4-3254-7100-e053-2995a90a10f2	37662-2497	HUMAN OTC DRUG	Melilotus Alba		Melilotus Alba	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS ALBUS TOP	200	[hp_C]/1			N	20241231
37662-2498_f31d91d4-3254-7100-e053-2995a90a10f2	37662-2498	HUMAN OTC DRUG	Melilotus Alba		Melilotus Alba	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS ALBUS TOP	500	[hp_C]/1			N	20241231
37662-2499_f31d91d4-3254-7100-e053-2995a90a10f2	37662-2499	HUMAN OTC DRUG	Melilotus Alba		Melilotus Alba	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MELILOTUS ALBUS TOP	1	[hp_M]/1			N	20241231
37662-2500_f32148d6-5e37-91e1-e053-2a95a90a5f25	37662-2500	HUMAN OTC DRUG	Mercurius Bromatus		Mercurius Bromatus	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS BROMIDE	6	[hp_C]/1			N	20241231
37662-2501_f32148d6-5e37-91e1-e053-2a95a90a5f25	37662-2501	HUMAN OTC DRUG	Mercurius Bromatus		Mercurius Bromatus	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS BROMIDE	12	[hp_C]/1			N	20241231
37662-2502_f32148d6-5e37-91e1-e053-2a95a90a5f25	37662-2502	HUMAN OTC DRUG	Mercurius Bromatus		Mercurius Bromatus	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS BROMIDE	30	[hp_C]/1			N	20241231
37662-2503_f32148d6-5e37-91e1-e053-2a95a90a5f25	37662-2503	HUMAN OTC DRUG	Mercurius Bromatus		Mercurius Bromatus	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS BROMIDE	100	[hp_C]/1			N	20241231
37662-2504_f32148d6-5e37-91e1-e053-2a95a90a5f25	37662-2504	HUMAN OTC DRUG	Mercurius Bromatus		Mercurius Bromatus	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS BROMIDE	200	[hp_C]/1			N	20241231
37662-2505_f32148d6-5e37-91e1-e053-2a95a90a5f25	37662-2505	HUMAN OTC DRUG	Mercurius Bromatus		Mercurius Bromatus	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS BROMIDE	500	[hp_C]/1			N	20241231
37662-2506_f32148d6-5e37-91e1-e053-2a95a90a5f25	37662-2506	HUMAN OTC DRUG	Mercurius Bromatus		Mercurius Bromatus	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS BROMIDE	1	[hp_M]/1			N	20241231
37662-2507_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2507	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	6	[hp_C]/1			N	20241231
37662-2508_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2508	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	12	[hp_C]/1			N	20241231
37662-2509_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2509	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	30	[hp_C]/1			N	20241231
37662-2510_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2510	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	100	[hp_C]/1			N	20241231
37662-2511_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2511	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	200	[hp_C]/1			N	20241231
37662-2512_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2512	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	500	[hp_C]/1			N	20241231
37662-2513_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2513	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	1	[hp_M]/1			N	20241231
37662-2514_f3221c6a-cd18-8609-e053-2995a90a4787	37662-2514	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	1	[hp_Q]/1			N	20241231
37662-2515_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2515	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	6	[hp_C]/1			N	20241231
37662-2516_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2516	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	12	[hp_C]/1			N	20241231
37662-2517_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2517	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	30	[hp_C]/1			N	20241231
37662-2518_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2518	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	100	[hp_C]/1			N	20241231
37662-2519_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2519	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	200	[hp_C]/1			N	20241231
37662-2520_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2520	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	500	[hp_C]/1			N	20241231
37662-2521_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2521	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	1	[hp_M]/1			N	20241231
37662-2522_f323df0f-a3ff-6230-e053-2995a90a6252	37662-2522	HUMAN OTC DRUG	Acidum Oxalicum		Acidum Oxalicum	PELLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OXALIC ACID DIHYDRATE	1	[hp_Q]/1			N	20241231
37662-2523_f3328663-881a-7749-e053-2a95a90aff5c	37662-2523	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	6	[hp_C]/1			N	20241231
37662-2524_f3328663-881a-7749-e053-2a95a90aff5c	37662-2524	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	12	[hp_C]/1			N	20241231
37662-2525_f3328663-881a-7749-e053-2a95a90aff5c	37662-2525	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	30	[hp_C]/1			N	20241231
37662-2526_f3328663-881a-7749-e053-2a95a90aff5c	37662-2526	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	100	[hp_C]/1			N	20241231
37662-2527_f3328663-881a-7749-e053-2a95a90aff5c	37662-2527	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	200	[hp_C]/1			N	20241231
37662-2528_f3328663-881a-7749-e053-2a95a90aff5c	37662-2528	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	500	[hp_C]/1			N	20241231
37662-2529_f3328663-881a-7749-e053-2a95a90aff5c	37662-2529	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	1	[hp_M]/1			N	20241231
37662-2530_f3328663-881a-7749-e053-2a95a90aff5c	37662-2530	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230126		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	1	[hp_Q]/1			N	20241231
37662-2531_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2531	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	6	[hp_C]/1			N	20241231
37662-2532_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2532	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	12	[hp_C]/1			N	20241231
37662-2533_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2533	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	30	[hp_C]/1			N	20241231
37662-2534_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2534	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	100	[hp_C]/1			N	20241231
37662-2535_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2535	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	200	[hp_C]/1			N	20241231
37662-2536_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2536	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	500	[hp_C]/1			N	20241231
37662-2537_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2537	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	1	[hp_M]/1			N	20241231
37662-2538_f349d1ce-08ff-9fbc-e053-2995a90a81a1	37662-2538	HUMAN OTC DRUG	Piper Nigrum		Piper Nigrum	PELLET	ORAL	20230127		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GREEN PEPPERCORN	1	[hp_Q]/1			N	20241231
37662-2539_f382e454-6b5a-e1c9-e053-2a95a90a496e	37662-2539	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	6	[hp_C]/1			N	20241231
37662-2540_f382e454-6b5a-e1c9-e053-2a95a90a496e	37662-2540	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	12	[hp_C]/1			N	20241231
37662-2541_f382e454-6b5a-e1c9-e053-2a95a90a496e	37662-2541	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	30	[hp_C]/1			N	20241231
37662-2542_f382e454-6b5a-e1c9-e053-2a95a90a496e	37662-2542	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	100	[hp_C]/1			N	20241231
37662-2543_f382e454-6b5a-e1c9-e053-2a95a90a496e	37662-2543	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	200	[hp_C]/1			N	20241231
37662-2544_f382e454-6b5a-e1c9-e053-2a95a90a496e	37662-2544	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	500	[hp_C]/1			N	20241231
37662-2545_f382e454-6b5a-e1c9-e053-2a95a90a496e	37662-2545	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	1	[hp_M]/1			N	20241231
37662-2546_f384fd93-350c-7e26-e053-2995a90a4b56	37662-2546	HUMAN OTC DRUG	Ruthenium Muriaticum		Ruthenium Muriaticum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRICHLORIDE	6	[hp_C]/1			N	20241231
37662-2547_f384fd93-350c-7e26-e053-2995a90a4b56	37662-2547	HUMAN OTC DRUG	Ruthenium Muriaticum		Ruthenium Muriaticum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRICHLORIDE	12	[hp_C]/1			N	20241231
37662-2548_f384fd93-350c-7e26-e053-2995a90a4b56	37662-2548	HUMAN OTC DRUG	Ruthenium Muriaticum		Ruthenium Muriaticum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRICHLORIDE	30	[hp_C]/1			N	20241231
37662-2549_f384fd93-350c-7e26-e053-2995a90a4b56	37662-2549	HUMAN OTC DRUG	Ruthenium Muriaticum		Ruthenium Muriaticum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRICHLORIDE	100	[hp_C]/1			N	20241231
37662-2550_f384fd93-350c-7e26-e053-2995a90a4b56	37662-2550	HUMAN OTC DRUG	Ruthenium Muriaticum		Ruthenium Muriaticum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRICHLORIDE	200	[hp_C]/1			N	20241231
37662-2551_f384fd93-350c-7e26-e053-2995a90a4b56	37662-2551	HUMAN OTC DRUG	Ruthenium Muriaticum		Ruthenium Muriaticum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRICHLORIDE	500	[hp_C]/1			N	20241231
37662-2552_f384fd93-350c-7e26-e053-2995a90a4b56	37662-2552	HUMAN OTC DRUG	Ruthenium Muriaticum		Ruthenium Muriaticum	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRICHLORIDE	1	[hp_M]/1			N	20241231
37662-2553_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2553	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_C]/1			N	20241231
37662-2554_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2554	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	12	[hp_C]/1			N	20241231
37662-2555_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2555	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/1			N	20241231
37662-2556_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2556	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	100	[hp_C]/1			N	20241231
37662-2557_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2557	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	200	[hp_C]/1			N	20241231
37662-2558_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2558	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	500	[hp_C]/1			N	20241231
37662-2559_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2559	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	1	[hp_M]/1			N	20241231
37662-2560_f38860a7-f8c3-1593-e053-2995a90ad343	37662-2560	HUMAN OTC DRUG	Thuja Occidentalis		Thuja Occidentalis	PELLET	ORAL	20230130		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	THUJA OCCIDENTALIS LEAFY TWIG	1	[hp_Q]/1			N	20241231
37662-2561_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2561	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	6	[hp_C]/1			N	20241231
37662-2562_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2562	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	12	[hp_C]/1			N	20241231
37662-2563_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2563	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	30	[hp_C]/1			N	20241231
37662-2564_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2564	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	100	[hp_C]/1			N	20241231
37662-2565_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2565	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	200	[hp_C]/1			N	20241231
37662-2566_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2566	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	500	[hp_C]/1			N	20241231
37662-2567_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2567	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	1	[hp_M]/1			N	20241231
37662-2568_f3982a7b-c1e9-aa2e-e053-2995a90ad6bf	37662-2568	HUMAN OTC DRUG	Teucrium Marum Verum		Teucrium Marum Verum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TEUCRIUM MARUM	1	[hp_Q]/1			N	20241231
37662-2569_f3992295-d300-395a-e053-2a95a90acc10	37662-2569	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	6	[hp_C]/1			N	20241231
37662-2570_f3992295-d300-395a-e053-2a95a90acc10	37662-2570	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	12	[hp_C]/1			N	20241231
37662-2571_f3992295-d300-395a-e053-2a95a90acc10	37662-2571	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	30	[hp_C]/1			N	20241231
37662-2572_f3992295-d300-395a-e053-2a95a90acc10	37662-2572	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	100	[hp_C]/1			N	20241231
37662-2573_f3992295-d300-395a-e053-2a95a90acc10	37662-2573	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	200	[hp_C]/1			N	20241231
37662-2574_f3992295-d300-395a-e053-2a95a90acc10	37662-2574	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	500	[hp_C]/1			N	20241231
37662-2575_f3992295-d300-395a-e053-2a95a90acc10	37662-2575	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	1	[hp_M]/1			N	20241231
37662-2576_f3992295-d300-395a-e053-2a95a90acc10	37662-2576	HUMAN OTC DRUG	Thlaspi Bursa Pastoris		Thlaspi Bursa Pastoris	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAPSELLA BURSA-PASTORIS	1	[hp_Q]/1			N	20241231
37662-2577_f39ae58d-6e51-5a5d-e053-2a95a90a2959	37662-2577	HUMAN OTC DRUG	Etherum		Etherum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHER	6	[hp_C]/1			N	20241231
37662-2578_f39ae58d-6e51-5a5d-e053-2a95a90a2959	37662-2578	HUMAN OTC DRUG	Etherum		Etherum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHER	12	[hp_C]/1			N	20241231
37662-2579_f39ae58d-6e51-5a5d-e053-2a95a90a2959	37662-2579	HUMAN OTC DRUG	Etherum		Etherum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHER	30	[hp_C]/1			N	20241231
37662-2580_f39ae58d-6e51-5a5d-e053-2a95a90a2959	37662-2580	HUMAN OTC DRUG	Etherum		Etherum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHER	100	[hp_C]/1			N	20241231
37662-2581_f39ae58d-6e51-5a5d-e053-2a95a90a2959	37662-2581	HUMAN OTC DRUG	Etherum		Etherum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHER	200	[hp_C]/1			N	20241231
37662-2582_f39ae58d-6e51-5a5d-e053-2a95a90a2959	37662-2582	HUMAN OTC DRUG	Etherum		Etherum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHER	500	[hp_C]/1			N	20241231
37662-2583_f39ae58d-6e51-5a5d-e053-2a95a90a2959	37662-2583	HUMAN OTC DRUG	Etherum		Etherum	PELLET	ORAL	20230131		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHER	1	[hp_M]/1			N	20241231
37662-2584_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2584	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	6	[hp_C]/1			N	20241231
37662-2585_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2585	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	12	[hp_C]/1			N	20241231
37662-2586_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2586	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	30	[hp_C]/1			N	20241231
37662-2587_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2587	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	100	[hp_C]/1			N	20241231
37662-2588_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2588	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	200	[hp_C]/1			N	20241231
37662-2589_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2589	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	500	[hp_C]/1			N	20241231
37662-2590_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2590	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	1	[hp_M]/1			N	20241231
37662-2591_f39ccceb-d0b2-aabf-e053-2a95a90a3da7	37662-2591	HUMAN OTC DRUG	Gadolinium Metallicum		Gadolinium Metallicum	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GADOLINIUM	1	[hp_Q]/1			N	20241231
37662-2592_f3c363a2-8050-5c7f-e053-2a95a90aaebb	37662-2592	HUMAN OTC DRUG	Granatum Punica		Granatum Punica	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PUNICA GRANATUM ROOT BARK	6	[hp_C]/1			N	20241231
37662-2593_f3c363a2-8050-5c7f-e053-2a95a90aaebb	37662-2593	HUMAN OTC DRUG	Granatum Punica		Granatum Punica	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PUNICA GRANATUM ROOT BARK	12	[hp_C]/1			N	20241231
37662-2594_f3c363a2-8050-5c7f-e053-2a95a90aaebb	37662-2594	HUMAN OTC DRUG	Granatum Punica		Granatum Punica	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PUNICA GRANATUM ROOT BARK	30	[hp_C]/1			N	20241231
37662-2595_f3c363a2-8050-5c7f-e053-2a95a90aaebb	37662-2595	HUMAN OTC DRUG	Granatum Punica		Granatum Punica	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PUNICA GRANATUM ROOT BARK	100	[hp_C]/1			N	20241231
37662-2596_f3c363a2-8050-5c7f-e053-2a95a90aaebb	37662-2596	HUMAN OTC DRUG	Granatum Punica		Granatum Punica	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PUNICA GRANATUM ROOT BARK	200	[hp_C]/1			N	20241231
37662-2597_f3c363a2-8050-5c7f-e053-2a95a90aaebb	37662-2597	HUMAN OTC DRUG	Granatum Punica		Granatum Punica	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PUNICA GRANATUM ROOT BARK	500	[hp_C]/1			N	20241231
37662-2598_f3c363a2-8050-5c7f-e053-2a95a90aaebb	37662-2598	HUMAN OTC DRUG	Granatum Punica		Granatum Punica	PELLET	ORAL	20230202		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PUNICA GRANATUM ROOT BARK	1	[hp_M]/1			N	20241231
37662-2599_f3c56b4a-1e1c-1298-e053-2a95a90a8054	37662-2599	HUMAN OTC DRUG	Formalinum		Formalinum	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMALDEHYDE SOLUTION	6	[hp_C]/1			N	20241231
37662-2600_f3c56b4a-1e1c-1298-e053-2a95a90a8054	37662-2600	HUMAN OTC DRUG	Formalinum		Formalinum	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMALDEHYDE SOLUTION	12	[hp_C]/1			N	20241231
37662-2601_f3c56b4a-1e1c-1298-e053-2a95a90a8054	37662-2601	HUMAN OTC DRUG	Formalinum		Formalinum	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMALDEHYDE SOLUTION	30	[hp_C]/1			N	20241231
37662-2602_f3c56b4a-1e1c-1298-e053-2a95a90a8054	37662-2602	HUMAN OTC DRUG	Formalinum		Formalinum	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMALDEHYDE SOLUTION	100	[hp_C]/1			N	20241231
37662-2603_f3c56b4a-1e1c-1298-e053-2a95a90a8054	37662-2603	HUMAN OTC DRUG	Formalinum		Formalinum	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMALDEHYDE SOLUTION	200	[hp_C]/1			N	20241231
37662-2604_f3c56b4a-1e1c-1298-e053-2a95a90a8054	37662-2604	HUMAN OTC DRUG	Formalinum		Formalinum	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMALDEHYDE SOLUTION	500	[hp_C]/1			N	20241231
37662-2605_f3c56b4a-1e1c-1298-e053-2a95a90a8054	37662-2605	HUMAN OTC DRUG	Formalinum		Formalinum	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FORMALDEHYDE SOLUTION	1	[hp_M]/1			N	20241231
37662-2606_f3d612b0-008c-2bb6-e053-2a95a90a7a9e	37662-2606	HUMAN OTC DRUG	Hura Brasiliensis		Hura Brasiliensis	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HURA CREPITANS SAP	6	[hp_C]/1			N	20241231
37662-2607_f3d612b0-008c-2bb6-e053-2a95a90a7a9e	37662-2607	HUMAN OTC DRUG	Hura Brasiliensis		Hura Brasiliensis	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HURA CREPITANS SAP	12	[hp_C]/1			N	20241231
37662-2608_f3d612b0-008c-2bb6-e053-2a95a90a7a9e	37662-2608	HUMAN OTC DRUG	Hura Brasiliensis		Hura Brasiliensis	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HURA CREPITANS SAP	30	[hp_C]/1			N	20241231
37662-2609_f3d612b0-008c-2bb6-e053-2a95a90a7a9e	37662-2609	HUMAN OTC DRUG	Hura Brasiliensis		Hura Brasiliensis	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HURA CREPITANS SAP	100	[hp_C]/1			N	20241231
37662-2610_f3d612b0-008c-2bb6-e053-2a95a90a7a9e	37662-2610	HUMAN OTC DRUG	Hura Brasiliensis		Hura Brasiliensis	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HURA CREPITANS SAP	200	[hp_C]/1			N	20241231
37662-2611_f3d612b0-008c-2bb6-e053-2a95a90a7a9e	37662-2611	HUMAN OTC DRUG	Hura Brasiliensis		Hura Brasiliensis	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HURA CREPITANS SAP	500	[hp_C]/1			N	20241231
37662-2612_f3d612b0-008c-2bb6-e053-2a95a90a7a9e	37662-2612	HUMAN OTC DRUG	Hura Brasiliensis		Hura Brasiliensis	PELLET	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HURA CREPITANS SAP	1	[hp_M]/1			N	20241231
37662-2613_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2613	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	6	[hp_C]/1			N	20241231
37662-2614_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2614	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	12	[hp_C]/1			N	20241231
37662-2615_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2615	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	30	[hp_C]/1			N	20241231
37662-2616_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2616	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	100	[hp_C]/1			N	20241231
37662-2617_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2617	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	200	[hp_C]/1			N	20241231
37662-2618_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2618	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	500	[hp_C]/1			N	20241231
37662-2619_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2619	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	1	[hp_M]/1			N	20241231
37662-2620_f40f4f9d-9006-3f8c-e053-2a95a90a8a3e	37662-2620	HUMAN OTC DRUG	Gallium Arsenatum		Gallium Arsenatum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM ARSENIDE	1	[hp_Q]/1			N	20241231
37662-2621_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2621	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	6	[hp_C]/1			N	20241231
37662-2622_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2622	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	12	[hp_C]/1			N	20241231
37662-2623_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2623	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	30	[hp_C]/1			N	20241231
37662-2624_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2624	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	100	[hp_C]/1			N	20241231
37662-2625_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2625	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	200	[hp_C]/1			N	20241231
37662-2626_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2626	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	500	[hp_C]/1			N	20241231
37662-2627_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2627	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	1	[hp_M]/1			N	20241231
37662-2628_f4133b5c-25ca-5a33-e053-2a95a90a8681	37662-2628	HUMAN OTC DRUG	Gallium Fluoratum		Gallium Fluoratum	PELLET	ORAL	20230206		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM TRIFLUORIDE	1	[hp_Q]/1			N	20241231
37662-2629_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2629	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	6	[hp_C]/1			N	20241231
37662-2630_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2630	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	12	[hp_C]/1			N	20241231
37662-2631_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2631	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	30	[hp_C]/1			N	20241231
37662-2632_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2632	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	100	[hp_C]/1			N	20241231
37662-2633_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2633	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	200	[hp_C]/1			N	20241231
37662-2634_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2634	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	500	[hp_C]/1			N	20241231
37662-2635_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2635	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	1	[hp_M]/1			N	20241231
37662-2636_f4151f7f-cc31-ed01-e053-2995a90a9097	37662-2636	HUMAN OTC DRUG	Gallium Metallicum		Gallium Metallicum	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM	1	[hp_Q]/1			N	20241231
37662-2637_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2637	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	6	[hp_C]/1			N	20241231
37662-2638_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2638	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	12	[hp_C]/1			N	20241231
37662-2639_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2639	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	30	[hp_C]/1			N	20241231
37662-2640_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2640	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	100	[hp_C]/1			N	20241231
37662-2641_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2641	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	200	[hp_C]/1			N	20241231
37662-2642_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2642	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	500	[hp_C]/1			N	20241231
37662-2643_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2643	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	1	[hp_M]/1			N	20241231
37662-2644_f424da9c-521a-1d8d-e053-2a95a90a29fb	37662-2644	HUMAN OTC DRUG	Mancinella Venenata		Mancinella Venenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HIPPOMANE MANCINELLA FRUITING LEAFY TWIG	1	[hp_Q]/1			N	20241231
37662-2645_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2645	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	6	[hp_C]/1			N	20241231
37662-2646_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2646	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	12	[hp_C]/1			N	20241231
37662-2647_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2647	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	30	[hp_C]/1			N	20241231
37662-2648_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2648	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	100	[hp_C]/1			N	20241231
37662-2649_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2649	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	200	[hp_C]/1			N	20241231
37662-2650_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2650	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	500	[hp_C]/1			N	20241231
37662-2651_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2651	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	1	[hp_M]/1			N	20241231
37662-2652_f425d971-94c6-57c8-e053-2995a90aa8cd	37662-2652	HUMAN OTC DRUG	Magnesia Arsenata		Magnesia Arsenata	PELLET	ORAL	20230207		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ARSENATE	1	[hp_Q]/1			N	20241231
37662-2653_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2653	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	6	[hp_C]/1			N	20241231
37662-2654_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2654	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	12	[hp_C]/1			N	20241231
37662-2655_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2655	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	30	[hp_C]/1			N	20241231
37662-2656_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2656	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	100	[hp_C]/1			N	20241231
37662-2657_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2657	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	200	[hp_C]/1			N	20241231
37662-2658_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2658	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	500	[hp_C]/1			N	20241231
37662-2659_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2659	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	1	[hp_M]/1			N	20241231
37662-2660_f4289a6f-1ae4-72f8-e053-2995a90a0aa9	37662-2660	HUMAN OTC DRUG	Magnesia Iodata		Magnesia Iodata	PELLET	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM IODIDE	1	[hp_Q]/1			N	20241231
37662-2661_f44b5405-566f-6a32-e053-2995a90aa387	37662-2661	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-2662_f44b5405-566f-6a32-e053-2995a90aa387	37662-2662	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-2663_f44b5405-566f-6a32-e053-2995a90aa387	37662-2663	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-2664_f44b5405-566f-6a32-e053-2995a90aa387	37662-2664	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-2665_f44b5405-566f-6a32-e053-2995a90aa387	37662-2665	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-2666_f44b5405-566f-6a32-e053-2995a90aa387	37662-2666	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-2667_f44b5405-566f-6a32-e053-2995a90aa387	37662-2667	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-2668_f44b5405-566f-6a32-e053-2995a90aa387	37662-2668	HUMAN OTC DRUG	Magnesia Fluorata		Magnesia Fluorata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM FLUORIDE	1	[hp_Q]/1			N	20241231
37662-2669_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2669	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	6	[hp_C]/1			N	20241231
37662-2670_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2670	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	12	[hp_C]/1			N	20241231
37662-2671_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2671	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	30	[hp_C]/1			N	20241231
37662-2672_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2672	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	100	[hp_C]/1			N	20241231
37662-2673_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2673	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	200	[hp_C]/1			N	20241231
37662-2674_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2674	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	500	[hp_C]/1			N	20241231
37662-2675_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2675	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	1	[hp_M]/1			N	20241231
37662-2676_f44ed0ee-1e6c-2add-e053-2a95a90a1665	37662-2676	HUMAN OTC DRUG	Magnesia Bromata		Magnesia Bromata	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM BROMATE	1	[hp_Q]/1			N	20241231
37662-2677_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2677	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	6	[hp_C]/1			N	20241231
37662-2678_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2678	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	12	[hp_C]/1			N	20241231
37662-2679_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2679	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	30	[hp_C]/1			N	20241231
37662-2680_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2680	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	100	[hp_C]/1			N	20241231
37662-2681_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2681	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	200	[hp_C]/1			N	20241231
37662-2682_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2682	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	500	[hp_C]/1			N	20241231
37662-2683_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2683	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	1	[hp_M]/1			N	20241231
37662-2684_f450858c-a6d3-d5df-e053-2995a90ab1f7	37662-2684	HUMAN OTC DRUG	Lithium Oxydatum		Lithium Oxydatum	PELLET	ORAL	20230209		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM OXIDE	1	[hp_Q]/1			N	20241231
37662-2685_f4523119-e760-2242-e053-2995a90a21ab	37662-2685	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	6	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2686_f4523119-e760-2242-e053-2995a90a21ab	37662-2686	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	12	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2687_f4523119-e760-2242-e053-2995a90a21ab	37662-2687	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2688_f4523119-e760-2242-e053-2995a90a21ab	37662-2688	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	100	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2689_f4523119-e760-2242-e053-2995a90a21ab	37662-2689	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	200	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2690_f4523119-e760-2242-e053-2995a90a21ab	37662-2690	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	500	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2691_f4523119-e760-2242-e053-2995a90a21ab	37662-2691	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	1	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-2692_f4523119-e760-2242-e053-2995a90a21ab	37662-2692	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	10	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-2693_f4523119-e760-2242-e053-2995a90a21ab	37662-2693	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	1	[hp_Q]/1	Mood Stabilizer [EPC]		N	20241231
37662-2694_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2694	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	6	[hp_C]/1			N	20241231
37662-2695_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2695	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	12	[hp_C]/1			N	20241231
37662-2696_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2696	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	30	[hp_C]/1			N	20241231
37662-2697_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2697	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	100	[hp_C]/1			N	20241231
37662-2698_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2698	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	200	[hp_C]/1			N	20241231
37662-2699_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2699	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	500	[hp_C]/1			N	20241231
37662-2700_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2700	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	1	[hp_M]/1			N	20241231
37662-2701_f49f4a93-d9a7-0964-e053-2995a90a867e	37662-2701	HUMAN OTC DRUG	Aluminum Metallicum		Aluminum Metallicum	PELLET	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM	10	[hp_M]/1			N	20241231
37662-2702_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2702	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	6	[hp_C]/1			N	20241231
37662-2703_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2703	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	12	[hp_C]/1			N	20241231
37662-2704_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2704	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	30	[hp_C]/1			N	20241231
37662-2705_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2705	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	100	[hp_C]/1			N	20241231
37662-2706_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2706	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	200	[hp_C]/1			N	20241231
37662-2707_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2707	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	500	[hp_C]/1			N	20241231
37662-2708_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2708	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	1	[hp_M]/1			N	20241231
37662-2709_f56a0700-4416-2dbb-e053-2995a90a3a03	37662-2709	HUMAN OTC DRUG	Aluminum Muriaticum		Aluminum Muriaticum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CHLORIDE ANHYDROUS	10	[hp_M]/1			N	20241231
37662-2710_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2710	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	6	[hp_C]/1			N	20241231
37662-2711_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2711	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	12	[hp_C]/1			N	20241231
37662-2712_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2712	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	30	[hp_C]/1			N	20241231
37662-2713_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2713	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	100	[hp_C]/1			N	20241231
37662-2714_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2714	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	200	[hp_C]/1			N	20241231
37662-2715_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2715	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	500	[hp_C]/1			N	20241231
37662-2716_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2716	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	1	[hp_M]/1			N	20241231
37662-2717_f56d6068-958c-ccb7-e053-2a95a90a0d03	37662-2717	HUMAN OTC DRUG	Antimonium Metallicum		Antimonium Metallicum	PELLET	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANTIMONY	10	[hp_M]/1			N	20241231
37662-2718_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2718	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	6	[hp_C]/1			N	20241231
37662-2719_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2719	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	12	[hp_C]/1			N	20241231
37662-2720_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2720	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	30	[hp_C]/1			N	20241231
37662-2721_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2721	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	100	[hp_C]/1			N	20241231
37662-2722_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2722	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	200	[hp_C]/1			N	20241231
37662-2723_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2723	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	500	[hp_C]/1			N	20241231
37662-2724_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2724	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	1	[hp_M]/1			N	20241231
37662-2725_f57bac38-bbd1-74f3-e053-2a95a90a6761	37662-2725	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILVER IODIDE	10	[hp_M]/1			N	20241231
37662-2726_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2726	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	6	[hp_C]/1			N	20241231
37662-2727_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2727	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	12	[hp_C]/1			N	20241231
37662-2728_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2728	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	30	[hp_C]/1			N	20241231
37662-2729_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2729	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	100	[hp_C]/1			N	20241231
37662-2730_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2730	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	200	[hp_C]/1			N	20241231
37662-2731_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2731	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	500	[hp_C]/1			N	20241231
37662-2732_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2732	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	1	[hp_M]/1			N	20241231
37662-2733_f57e8e79-6209-2e88-e053-2995a90ab4cc	37662-2733	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM TETRACHLOROAURATE	10	[hp_M]/1			N	20241231
37662-2734_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2734	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	6	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2735_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2735	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	12	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2736_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2736	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	30	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2737_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2737	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	100	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2738_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2738	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	200	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2739_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2739	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	500	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2740_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2740	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	1	[hp_M]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2741_f5ce0f08-8907-1eb8-e053-2a95a90a0168	37662-2741	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	10	[hp_M]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
37662-2742_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2742	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	6	[hp_C]/1			N	20241231
37662-2743_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2743	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	12	[hp_C]/1			N	20241231
37662-2744_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2744	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	30	[hp_C]/1			N	20241231
37662-2745_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2745	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	100	[hp_C]/1			N	20241231
37662-2746_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2746	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	200	[hp_C]/1			N	20241231
37662-2747_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2747	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	500	[hp_C]/1			N	20241231
37662-2748_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2748	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	1	[hp_M]/1			N	20241231
37662-2749_f5cf9032-ab23-2853-e053-2995a90a244b	37662-2749	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20230228		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	10	[hp_M]/1			N	20241231
37662-2750_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2750	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-2751_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2751	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-2752_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2752	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-2753_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2753	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-2754_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2754	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-2755_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2755	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-2756_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2756	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-2757_f5f69745-7c95-7dcc-e053-2a95a90a35f7	37662-2757	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	10	[hp_M]/1			N	20241231
37662-2758_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2758	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2759_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2759	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2760_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2760	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2761_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2761	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2762_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2762	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2763_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2763	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2764_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2764	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2765_f60742dd-c083-3c50-e053-2a95a90ad96e	37662-2765	HUMAN OTC DRUG	Cinnamomum		Cinnamomum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CINNAMON	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-2766_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2766	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	6	[hp_C]/1			N	20241231
37662-2767_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2767	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	12	[hp_C]/1			N	20241231
37662-2768_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2768	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	30	[hp_C]/1			N	20241231
37662-2769_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2769	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	100	[hp_C]/1			N	20241231
37662-2770_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2770	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	200	[hp_C]/1			N	20241231
37662-2771_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2771	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	500	[hp_C]/1			N	20241231
37662-2772_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2772	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	1	[hp_M]/1			N	20241231
37662-2773_f65ae29b-f7b5-357c-e053-2a95a90a491c	37662-2773	HUMAN OTC DRUG	Cobaltum Nitricum		Cobaltum Nitricum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	COBALTOUS NITRATE HEXAHYDRATE	10	[hp_M]/1			N	20241231
37662-2774_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2774	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	6	[hp_C]/1			N	20241231
37662-2775_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2775	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	12	[hp_C]/1			N	20241231
37662-2776_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2776	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	30	[hp_C]/1			N	20241231
37662-2777_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2777	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	100	[hp_C]/1			N	20241231
37662-2778_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2778	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	200	[hp_C]/1			N	20241231
37662-2779_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2779	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	500	[hp_C]/1			N	20241231
37662-2780_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2780	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	1	[hp_M]/1			N	20241231
37662-2781_f65d84e6-61da-1469-e053-2a95a90adfb7	37662-2781	HUMAN OTC DRUG	Ferrum Bromatum		Ferrum Bromatum	PELLET	ORAL	20230307		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC BROMIDE	10	[hp_M]/1			N	20241231
37662-2782_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2782	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2783_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2783	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2784_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2784	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2785_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2785	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2786_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2786	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2787_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2787	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2788_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2788	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2789_f66e6f3f-499a-e60f-e053-2995a90ae5e0	37662-2789	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM PHOSPHATE, DIBASIC	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2790_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2790	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	6	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2791_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2791	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	12	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2792_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2792	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2793_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2793	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	100	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2794_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2794	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	200	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2795_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2795	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	500	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-2796_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2796	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	1	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-2797_f6718276-fef4-20cb-e053-2a95a90ad2bc	37662-2797	HUMAN OTC DRUG	Lithium Phosphoricum		Lithium Phosphoricum	PELLET	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM PHOSPHATE	10	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-2798_f6723f81-9065-dace-e053-2995a90a2f21	37662-2798	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	6	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2799_f6723f81-9065-dace-e053-2995a90a2f21	37662-2799	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	12	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2800_f6723f81-9065-dace-e053-2995a90a2f21	37662-2800	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2801_f6723f81-9065-dace-e053-2995a90a2f21	37662-2801	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	100	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2802_f6723f81-9065-dace-e053-2995a90a2f21	37662-2802	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	200	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2803_f6723f81-9065-dace-e053-2995a90a2f21	37662-2803	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	500	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2804_f6723f81-9065-dace-e053-2995a90a2f21	37662-2804	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	1	[hp_M]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2805_f6723f81-9065-dace-e053-2995a90a2f21	37662-2805	HUMAN OTC DRUG	Magnesia Acetica		Magnesia Acetica	PELLET	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM ACETATE TETRAHYDRATE	10	[hp_M]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37662-2806_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2806	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	6	[hp_C]/1			N	20241231
37662-2807_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2807	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	12	[hp_C]/1			N	20241231
37662-2808_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2808	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	30	[hp_C]/1			N	20241231
37662-2809_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2809	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	100	[hp_C]/1			N	20241231
37662-2810_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2810	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	200	[hp_C]/1			N	20241231
37662-2811_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2811	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	500	[hp_C]/1			N	20241231
37662-2812_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2812	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	1	[hp_M]/1			N	20241231
37662-2813_f6886714-1db6-4e9a-e053-2a95a90a2d3f	37662-2813	HUMAN OTC DRUG	Oenanthe Crocata		Oenanthe Crocata	PELLET	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	OENANTHE CROCATA ROOT	10	[hp_M]/1			N	20241231
37662-2814_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2814	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	6	[hp_C]/1			N	20241231
37662-2815_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2815	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	12	[hp_C]/1			N	20241231
37662-2816_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2816	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	30	[hp_C]/1			N	20241231
37662-2817_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2817	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	100	[hp_C]/1			N	20241231
37662-2818_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2818	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	200	[hp_C]/1			N	20241231
37662-2819_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2819	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	500	[hp_C]/1			N	20241231
37662-2820_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2820	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	1	[hp_M]/1			N	20241231
37662-2821_f75f2f43-6f50-8aec-e053-6394a90aab1f	37662-2821	HUMAN OTC DRUG	Piper Methysticum		Piper Methysticum	PELLET	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PIPER METHYSTICUM ROOT	10	[hp_M]/1			N	20241231
37662-2822_f773d667-6122-0909-e053-6294a90afb48	37662-2822	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	6	[hp_C]/1			N	20241231
37662-2823_f773d667-6122-0909-e053-6294a90afb48	37662-2823	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	12	[hp_C]/1			N	20241231
37662-2824_f773d667-6122-0909-e053-6294a90afb48	37662-2824	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	30	[hp_C]/1			N	20241231
37662-2825_f773d667-6122-0909-e053-6294a90afb48	37662-2825	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	100	[hp_C]/1			N	20241231
37662-2826_f773d667-6122-0909-e053-6294a90afb48	37662-2826	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	200	[hp_C]/1			N	20241231
37662-2827_f773d667-6122-0909-e053-6294a90afb48	37662-2827	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	500	[hp_C]/1			N	20241231
37662-2828_f773d667-6122-0909-e053-6294a90afb48	37662-2828	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	1	[hp_M]/1			N	20241231
37662-2829_f773d667-6122-0909-e053-6294a90afb48	37662-2829	HUMAN OTC DRUG	Rhamnus Cathartica		Rhamnus Cathartica	PELLET	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHAMNUS CATHARTICA FRUIT	10	[hp_M]/1			N	20241231
37662-2830_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2830	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	6	[hp_C]/1			N	20241231
37662-2831_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2831	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	12	[hp_C]/1			N	20241231
37662-2832_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2832	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	30	[hp_C]/1			N	20241231
37662-2833_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2833	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	100	[hp_C]/1			N	20241231
37662-2834_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2834	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	200	[hp_C]/1			N	20241231
37662-2835_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2835	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	500	[hp_C]/1			N	20241231
37662-2836_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2836	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	1	[hp_M]/1			N	20241231
37662-2837_f7751fe3-a683-e782-e053-6394a90a95fb	37662-2837	HUMAN OTC DRUG	Zincum Oxydatum		Zincum Oxydatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC OXIDE	10	[hp_M]/1			N	20241231
37662-2838_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2838	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	6	[hp_C]/1			N	20241231
37662-2839_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2839	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	12	[hp_C]/1			N	20241231
37662-2840_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2840	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	30	[hp_C]/1			N	20241231
37662-2841_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2841	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	100	[hp_C]/1			N	20241231
37662-2842_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2842	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	200	[hp_C]/1			N	20241231
37662-2843_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2843	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	500	[hp_C]/1			N	20241231
37662-2844_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2844	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	1	[hp_M]/1			N	20241231
37662-2845_f786d777-53ef-fc5a-e053-6294a90a1037	37662-2845	HUMAN OTC DRUG	Ruthenium Bromatum		Ruthenium Bromatum	PELLET	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUTHENIUM TRIBROMIDE	10	[hp_M]/1			N	20241231
37662-2846_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2846	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	6	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2847_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2847	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	12	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2848_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2848	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	30	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2849_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2849	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	100	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2850_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2850	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	200	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2851_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2851	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	500	[hp_C]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2852_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2852	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	1	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2853_f788fe1a-9b19-9f67-e053-6294a90ae563	37662-2853	HUMAN OTC DRUG	Manganum Fluoratum		Manganum Fluoratum	PELLET	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIFLUORIDE	10	[hp_M]/1	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
37662-2854_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2854	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	6	[hp_C]/1			N	20241231
37662-2855_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2855	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	12	[hp_C]/1			N	20241231
37662-2856_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2856	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	30	[hp_C]/1			N	20241231
37662-2857_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2857	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	100	[hp_C]/1			N	20241231
37662-2858_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2858	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	200	[hp_C]/1			N	20241231
37662-2859_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2859	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	500	[hp_C]/1			N	20241231
37662-2860_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2860	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	1	[hp_M]/1			N	20241231
37662-2861_f7f1948a-6d76-368b-e053-6294a90a39c6	37662-2861	HUMAN OTC DRUG	Manganum Oxydatum Nigrum		Manganum Oxydatum Nigrum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE DIOXIDE	10	[hp_M]/1			N	20241231
37662-2862_f7fec516-ec70-6248-e053-6294a90a3342	37662-2862	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	6	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2863_f7fec516-ec70-6248-e053-6294a90a3342	37662-2863	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	12	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2864_f7fec516-ec70-6248-e053-6294a90a3342	37662-2864	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	30	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2865_f7fec516-ec70-6248-e053-6294a90a3342	37662-2865	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	100	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2866_f7fec516-ec70-6248-e053-6294a90a3342	37662-2866	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	200	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2867_f7fec516-ec70-6248-e053-6294a90a3342	37662-2867	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	500	[hp_C]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2868_f7fec516-ec70-6248-e053-6294a90a3342	37662-2868	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	1	[hp_M]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2869_f7fec516-ec70-6248-e053-6294a90a3342	37662-2869	HUMAN OTC DRUG	Divalproex Sodium		Divalproex Sodium	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VALPROATE SODIUM	10	[hp_M]/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
37662-2870_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2870	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	6	[hp_C]/1			N	20241231
37662-2871_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2871	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	12	[hp_C]/1			N	20241231
37662-2872_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2872	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	30	[hp_C]/1			N	20241231
37662-2873_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2873	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	100	[hp_C]/1			N	20241231
37662-2874_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2874	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	200	[hp_C]/1			N	20241231
37662-2875_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2875	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	500	[hp_C]/1			N	20241231
37662-2876_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2876	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	1	[hp_M]/1			N	20241231
37662-2877_f802f1b1-2d42-a401-e053-6294a90a4796	37662-2877	HUMAN OTC DRUG	Mercurius Cyanatus		Mercurius Cyanatus	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC CYANIDE	10	[hp_M]/1			N	20241231
37662-2878_f8054332-7dda-7a05-e053-6294a90a8013	37662-2878	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2879_f8054332-7dda-7a05-e053-6294a90a8013	37662-2879	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2880_f8054332-7dda-7a05-e053-6294a90a8013	37662-2880	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2881_f8054332-7dda-7a05-e053-6294a90a8013	37662-2881	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2882_f8054332-7dda-7a05-e053-6294a90a8013	37662-2882	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2883_f8054332-7dda-7a05-e053-6294a90a8013	37662-2883	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2884_f8054332-7dda-7a05-e053-6294a90a8013	37662-2884	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2885_f8054332-7dda-7a05-e053-6294a90a8013	37662-2885	HUMAN OTC DRUG	Kali Aceticum		Kali Aceticum	PELLET	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM ACETATE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-2886_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2886	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	6	[hp_C]/1			N	20241231
37662-2887_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2887	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	12	[hp_C]/1			N	20241231
37662-2888_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2888	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	30	[hp_C]/1			N	20241231
37662-2889_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2889	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	100	[hp_C]/1			N	20241231
37662-2890_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2890	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	200	[hp_C]/1			N	20241231
37662-2891_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2891	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	500	[hp_C]/1			N	20241231
37662-2892_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2892	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	1	[hp_M]/1			N	20241231
37662-2893_f82c152a-0c32-8c01-e053-6294a90aa6e0	37662-2893	HUMAN OTC DRUG	Pix Liquida		Pix Liquida	PELLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PINE TAR	10	[hp_M]/1			N	20241231
37662-2894_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2894	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	6	[hp_C]/1			N	20241231
37662-2895_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2895	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	12	[hp_C]/1			N	20241231
37662-2896_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2896	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	30	[hp_C]/1			N	20241231
37662-2897_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2897	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	100	[hp_C]/1			N	20241231
37662-2898_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2898	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	200	[hp_C]/1			N	20241231
37662-2899_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2899	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	500	[hp_C]/1			N	20241231
37662-2900_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2900	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	1	[hp_M]/1			N	20241231
37662-2901_f82c4c19-c31c-55d8-e053-6294a90a9c3b	37662-2901	HUMAN OTC DRUG	Cuprum Sulphuricum		Cuprum Sulphuricum	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CUPRIC SULFATE	10	[hp_M]/1			N	20241231
37662-2902_f83d341b-10ff-573f-e053-6394a90a574e	37662-2902	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	6	[hp_C]/1			N	20241231
37662-2903_f83d341b-10ff-573f-e053-6394a90a574e	37662-2903	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	12	[hp_C]/1			N	20241231
37662-2904_f83d341b-10ff-573f-e053-6394a90a574e	37662-2904	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	30	[hp_C]/1			N	20241231
37662-2905_f83d341b-10ff-573f-e053-6394a90a574e	37662-2905	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	100	[hp_C]/1			N	20241231
37662-2906_f83d341b-10ff-573f-e053-6394a90a574e	37662-2906	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	200	[hp_C]/1			N	20241231
37662-2907_f83d341b-10ff-573f-e053-6394a90a574e	37662-2907	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	500	[hp_C]/1			N	20241231
37662-2908_f83d341b-10ff-573f-e053-6394a90a574e	37662-2908	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	1	[hp_M]/1			N	20241231
37662-2909_f83d341b-10ff-573f-e053-6394a90a574e	37662-2909	HUMAN OTC DRUG	Dipsacus Sylvestris		Dipsacus Sylvestris	PELLET	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIPSACUS FULLONUM WHOLE	10	[hp_M]/1			N	20241231
37662-2910_f83ebba7-4077-a586-e053-6394a90af083	37662-2910	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	6	[hp_C]/1			N	20241231
37662-2911_f83ebba7-4077-a586-e053-6394a90af083	37662-2911	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	12	[hp_C]/1			N	20241231
37662-2912_f83ebba7-4077-a586-e053-6394a90af083	37662-2912	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	30	[hp_C]/1			N	20241231
37662-2913_f83ebba7-4077-a586-e053-6394a90af083	37662-2913	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	100	[hp_C]/1			N	20241231
37662-2914_f83ebba7-4077-a586-e053-6394a90af083	37662-2914	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	200	[hp_C]/1			N	20241231
37662-2915_f83ebba7-4077-a586-e053-6394a90af083	37662-2915	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	500	[hp_C]/1			N	20241231
37662-2916_f83ebba7-4077-a586-e053-6394a90af083	37662-2916	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	1	[hp_M]/1			N	20241231
37662-2917_f83ebba7-4077-a586-e053-6394a90af083	37662-2917	HUMAN OTC DRUG	Elaeagnus Angustiflora		Elaeagnus Angustiflora	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ELAEAGNUS ANGUSTIFOLIA WHOLE	10	[hp_M]/1			N	20241231
37662-2918_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2918	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	6	[hp_C]/1			N	20241231
37662-2919_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2919	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	12	[hp_C]/1			N	20241231
37662-2920_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2920	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	30	[hp_C]/1			N	20241231
37662-2921_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2921	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	100	[hp_C]/1			N	20241231
37662-2922_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2922	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	200	[hp_C]/1			N	20241231
37662-2923_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2923	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	500	[hp_C]/1			N	20241231
37662-2924_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2924	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	1	[hp_M]/1			N	20241231
37662-2925_f8a19f14-edd5-d02c-e053-6394a90afc99	37662-2925	HUMAN OTC DRUG	Erbium Sulphuricum		Erbium Sulphuricum	PELLET	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ERBIUM SULFATE OCTAHYDRATE	1	[hp_Q]/1			N	20241231
37662-2926_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2926	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	6	[hp_C]/1			N	20241231
37662-2927_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2927	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	12	[hp_C]/1			N	20241231
37662-2928_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2928	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	30	[hp_C]/1			N	20241231
37662-2929_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2929	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	100	[hp_C]/1			N	20241231
37662-2930_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2930	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	200	[hp_C]/1			N	20241231
37662-2931_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2931	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	500	[hp_C]/1			N	20241231
37662-2932_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2932	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	1	[hp_M]/1			N	20241231
37662-2933_f8b52d3f-3fe3-a850-e053-6394a90a5d9f	37662-2933	HUMAN OTC DRUG	Ferrum Oxydatum		Ferrum Oxydatum	PELLET	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	FERRIC OXIDE RED	1	[hp_Q]/1			N	20241231
37662-2934_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2934	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	6	[hp_C]/1			N	20241231
37662-2935_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2935	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	12	[hp_C]/1			N	20241231
37662-2936_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2936	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	30	[hp_C]/1			N	20241231
37662-2937_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2937	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	100	[hp_C]/1			N	20241231
37662-2938_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2938	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	200	[hp_C]/1			N	20241231
37662-2939_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2939	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	500	[hp_C]/1			N	20241231
37662-2940_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2940	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	1	[hp_M]/1			N	20241231
37662-2941_f8b81c6a-2dd4-27e5-e053-6394a90af458	37662-2941	HUMAN OTC DRUG	Hamamelis Virginica		Hamamelis Virginica	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	1	[hp_Q]/1			N	20241231
37662-2942_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2942	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	6	[hp_C]/1			N	20241231
37662-2943_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2943	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	12	[hp_C]/1			N	20241231
37662-2944_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2944	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	30	[hp_C]/1			N	20241231
37662-2945_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2945	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	100	[hp_C]/1			N	20241231
37662-2946_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2946	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	200	[hp_C]/1			N	20241231
37662-2947_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2947	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	500	[hp_C]/1			N	20241231
37662-2948_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2948	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	1	[hp_M]/1			N	20241231
37662-2949_f8ccddaf-cccd-ba55-e053-6394a90a7612	37662-2949	HUMAN OTC DRUG	Holmium Metallicum		Holmium Metallicum	PELLET	ORAL	20230407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HOLMIUM	1	[hp_Q]/1			N	20241231
37662-2950_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2950	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	6	[hp_C]/1			N	20241231
37662-2951_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2951	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	12	[hp_C]/1			N	20241231
37662-2952_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2952	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	30	[hp_C]/1			N	20241231
37662-2953_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2953	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	100	[hp_C]/1			N	20241231
37662-2954_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2954	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	200	[hp_C]/1			N	20241231
37662-2955_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2955	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	500	[hp_C]/1			N	20241231
37662-2956_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2956	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	1	[hp_M]/1			N	20241231
37662-2957_f8ce2a14-5cbc-b277-e053-6294a90ac9f7	37662-2957	HUMAN OTC DRUG	Hydrobromicum Acidum		Hydrobromicum Acidum	PELLET	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYDROBROMIC ACID	1	[hp_Q]/1			N	20241231
37662-2958_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2958	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	6	[hp_C]/1			N	20241231
37662-2959_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2959	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	12	[hp_C]/1			N	20241231
37662-2960_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2960	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	30	[hp_C]/1			N	20241231
37662-2961_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2961	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	100	[hp_C]/1			N	20241231
37662-2962_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2962	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	200	[hp_C]/1			N	20241231
37662-2963_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2963	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	500	[hp_C]/1			N	20241231
37662-2964_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2964	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	1	[hp_M]/1			N	20241231
37662-2965_f90af565-8abb-44f2-e053-6394a90a0c84	37662-2965	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	1	[hp_Q]/1			N	20241231
37662-2966_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2966	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	6	[hp_C]/1			N	20241231
37662-2967_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2967	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	12	[hp_C]/1			N	20241231
37662-2968_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2968	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	30	[hp_C]/1			N	20241231
37662-2969_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2969	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	100	[hp_C]/1			N	20241231
37662-2970_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2970	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	200	[hp_C]/1			N	20241231
37662-2971_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2971	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	500	[hp_C]/1			N	20241231
37662-2972_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2972	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	1	[hp_M]/1			N	20241231
37662-2973_f9bcf569-7aa5-a0dd-e053-6394a90aeae1	37662-2973	HUMAN OTC DRUG	Titanium Oxydatum		Titanium Oxydatum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM OXYSULFATE	1	[hp_Q]/1			N	20241231
37662-2974_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2974	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	6	[hp_C]/1			N	20241231
37662-2975_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2975	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	12	[hp_C]/1			N	20241231
37662-2976_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2976	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	30	[hp_C]/1			N	20241231
37662-2977_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2977	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	100	[hp_C]/1			N	20241231
37662-2978_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2978	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	200	[hp_C]/1			N	20241231
37662-2979_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2979	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	500	[hp_C]/1			N	20241231
37662-2980_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2980	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	1	[hp_M]/1			N	20241231
37662-2981_f9bda25d-2a82-a951-e053-6394a90a8503	37662-2981	HUMAN OTC DRUG	Titanium Sulphuratum		Titanium Sulphuratum	PELLET	ORAL	20230419		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DISULFATE	1	[hp_Q]/1			N	20241231
37662-2982_f9cd7e8e-fa4e-03f2-e053-6294a90af8b6	37662-2982	HUMAN OTC DRUG	Acidum Salicylicum		Acidum Salicylicum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SALICYLIC ACID	6	[hp_C]/1			N	20241231
37662-2983_f9cd7e8e-fa4e-03f2-e053-6294a90af8b6	37662-2983	HUMAN OTC DRUG	Acidum Salicylicum		Acidum Salicylicum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SALICYLIC ACID	12	[hp_C]/1			N	20241231
37662-2984_f9cd7e8e-fa4e-03f2-e053-6294a90af8b6	37662-2984	HUMAN OTC DRUG	Acidum Salicylicum		Acidum Salicylicum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SALICYLIC ACID	30	[hp_C]/1			N	20241231
37662-2985_f9cd7e8e-fa4e-03f2-e053-6294a90af8b6	37662-2985	HUMAN OTC DRUG	Acidum Salicylicum		Acidum Salicylicum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SALICYLIC ACID	100	[hp_C]/1			N	20241231
37662-2986_f9cd7e8e-fa4e-03f2-e053-6294a90af8b6	37662-2986	HUMAN OTC DRUG	Acidum Salicylicum		Acidum Salicylicum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SALICYLIC ACID	200	[hp_C]/1			N	20241231
37662-2987_f9cd7e8e-fa4e-03f2-e053-6294a90af8b6	37662-2987	HUMAN OTC DRUG	Acidum Salicylicum		Acidum Salicylicum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SALICYLIC ACID	500	[hp_C]/1			N	20241231
37662-2988_f9cd7e8e-fa4e-03f2-e053-6294a90af8b6	37662-2988	HUMAN OTC DRUG	Acidum Salicylicum		Acidum Salicylicum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SALICYLIC ACID	1	[hp_M]/1			N	20241231
37662-2989_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2989	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	6	[hp_C]/1			N	20241231
37662-2990_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2990	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	12	[hp_C]/1			N	20241231
37662-2991_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2991	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	30	[hp_C]/1			N	20241231
37662-2992_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2992	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	100	[hp_C]/1			N	20241231
37662-2993_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2993	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	200	[hp_C]/1			N	20241231
37662-2994_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2994	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	500	[hp_C]/1			N	20241231
37662-2995_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2995	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	1	[hp_M]/1			N	20241231
37662-2996_f9d0b7ba-bf4d-fe21-e053-6394a90a0621	37662-2996	HUMAN OTC DRUG	Scandium Oxydatum		Scandium Oxydatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM OXIDE	1	[hp_Q]/1			N	20241231
37662-2997_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-2997	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	6	[hp_C]/1			N	20241231
37662-2998_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-2998	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	12	[hp_C]/1			N	20241231
37662-2999_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-2999	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	30	[hp_C]/1			N	20241231
37662-3000_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-3000	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	100	[hp_C]/1			N	20241231
37662-3001_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-3001	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	200	[hp_C]/1			N	20241231
37662-3002_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-3002	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	500	[hp_C]/1			N	20241231
37662-3003_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-3003	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	1	[hp_M]/1			N	20241231
37662-3004_f9d1c4a8-6533-7290-e053-6394a90a7af8	37662-3004	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	1	[hp_Q]/1			N	20241231
37662-3005_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3005	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	6	[hp_C]/1			N	20241231
37662-3006_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3006	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	12	[hp_C]/1			N	20241231
37662-3007_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3007	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	30	[hp_C]/1			N	20241231
37662-3008_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3008	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	100	[hp_C]/1			N	20241231
37662-3009_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3009	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	200	[hp_C]/1			N	20241231
37662-3010_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3010	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	500	[hp_C]/1			N	20241231
37662-3011_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3011	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	1	[hp_M]/1			N	20241231
37662-3012_f9dfa1b2-5d79-0c48-e053-6294a90ac63f	37662-3012	HUMAN OTC DRUG	Scandium Nitricum		Scandium Nitricum	PELLET	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM NITRATE	1	[hp_Q]/1			N	20241231
37662-3013_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3013	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	6	[hp_C]/1			N	20241231
37662-3014_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3014	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	12	[hp_C]/1			N	20241231
37662-3015_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3015	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	30	[hp_C]/1			N	20241231
37662-3016_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3016	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	100	[hp_C]/1			N	20241231
37662-3017_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3017	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	200	[hp_C]/1			N	20241231
37662-3018_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3018	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	500	[hp_C]/1			N	20241231
37662-3019_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3019	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	1	[hp_M]/1			N	20241231
37662-3020_f9e1b15a-7f2a-6a7a-e053-6394a90a760b	37662-3020	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	1	[hp_Q]/1			N	20241231
37662-3021_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3021	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	6	[hp_C]/1			N	20241231
37662-3022_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3022	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	12	[hp_C]/1			N	20241231
37662-3023_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3023	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	30	[hp_C]/1			N	20241231
37662-3024_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3024	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	100	[hp_C]/1			N	20241231
37662-3025_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3025	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	200	[hp_C]/1			N	20241231
37662-3026_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3026	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	500	[hp_C]/1			N	20241231
37662-3027_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3027	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	1	[hp_M]/1			N	20241231
37662-3028_fa208e9e-992d-1ea4-e053-6294a90a3621	37662-3028	HUMAN OTC DRUG	Samarium Metallicum		Samarium Metallicum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SAMARIUM	1	[hp_Q]/1			N	20241231
37662-3029_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3029	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	6	[hp_C]/1			N	20241231
37662-3030_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3030	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	12	[hp_C]/1			N	20241231
37662-3031_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3031	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	30	[hp_C]/1			N	20241231
37662-3032_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3032	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	100	[hp_C]/1			N	20241231
37662-3033_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3033	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	200	[hp_C]/1			N	20241231
37662-3034_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3034	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	500	[hp_C]/1			N	20241231
37662-3035_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3035	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	1	[hp_M]/1			N	20241231
37662-3036_fa217e9f-581d-6c6d-e053-6394a90a0905	37662-3036	HUMAN OTC DRUG	Rubidium Iodatum		Rubidium Iodatum	PELLET	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM IODIDE	1	[hp_Q]/1			N	20241231
37662-3037_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3037	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-3038_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3038	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-3039_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3039	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-3040_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3040	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-3041_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3041	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-3042_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3042	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-3043_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3043	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-3044_fa47c370-d4b3-9d82-e053-6294a90a8551	37662-3044	HUMAN OTC DRUG	Rubidium Fluoratum		Rubidium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM FLUORIDE	10	[hp_M]/1			N	20241231
37662-3045_fa59f46b-6651-17c9-e053-6394a90ace77	37662-3045	HUMAN OTC DRUG	Rosa Canina Flos		Rosa Canina Flos	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSA CANINA FLOWER	6	[hp_C]/1			N	20241231
37662-3046_fa59f46b-6651-17c9-e053-6394a90ace77	37662-3046	HUMAN OTC DRUG	Rosa Canina Flos		Rosa Canina Flos	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSA CANINA FLOWER	12	[hp_C]/1			N	20241231
37662-3047_fa59f46b-6651-17c9-e053-6394a90ace77	37662-3047	HUMAN OTC DRUG	Rosa Canina Flos		Rosa Canina Flos	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSA CANINA FLOWER	30	[hp_C]/1			N	20241231
37662-3048_fa59f46b-6651-17c9-e053-6394a90ace77	37662-3048	HUMAN OTC DRUG	Rosa Canina Flos		Rosa Canina Flos	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSA CANINA FLOWER	100	[hp_C]/1			N	20241231
37662-3049_fa59f46b-6651-17c9-e053-6394a90ace77	37662-3049	HUMAN OTC DRUG	Rosa Canina Flos		Rosa Canina Flos	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSA CANINA FLOWER	200	[hp_C]/1			N	20241231
37662-3050_fa59f46b-6651-17c9-e053-6394a90ace77	37662-3050	HUMAN OTC DRUG	Rosa Canina Flos		Rosa Canina Flos	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSA CANINA FLOWER	500	[hp_C]/1			N	20241231
37662-3051_fa59f46b-6651-17c9-e053-6394a90ace77	37662-3051	HUMAN OTC DRUG	Rosa Canina Flos		Rosa Canina Flos	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ROSA CANINA FLOWER	1	[hp_M]/1			N	20241231
37662-3052_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3052	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-3053_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3053	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-3054_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3054	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-3055_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3055	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-3056_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3056	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-3057_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3057	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-3058_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3058	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-3059_fa5b126b-5bc7-a682-e053-6294a90adb7f	37662-3059	HUMAN OTC DRUG	Strontium Fluoratum		Strontium Fluoratum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM FLUORIDE	1	[hp_Q]/1			N	20241231
37662-3060_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3060	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	6	[hp_C]/1			N	20241231
37662-3061_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3061	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	12	[hp_C]/1			N	20241231
37662-3062_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3062	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	30	[hp_C]/1			N	20241231
37662-3063_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3063	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	100	[hp_C]/1			N	20241231
37662-3064_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3064	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	200	[hp_C]/1			N	20241231
37662-3065_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3065	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	500	[hp_C]/1			N	20241231
37662-3066_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3066	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	1	[hp_M]/1			N	20241231
37662-3067_fa5d5d37-d4e6-20dc-e053-6294a90a344a	37662-3067	HUMAN OTC DRUG	Strontium Iodatum		Strontium Iodatum	PELLET	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM IODIDE	1	[hp_Q]/1			N	20241231
37662-3068_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3068	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	6	[hp_C]/1			N	20241231
37662-3069_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3069	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	12	[hp_C]/1			N	20241231
37662-3070_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3070	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	30	[hp_C]/1			N	20241231
37662-3071_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3071	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	100	[hp_C]/1			N	20241231
37662-3072_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3072	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	200	[hp_C]/1			N	20241231
37662-3073_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3073	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	500	[hp_C]/1			N	20241231
37662-3074_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3074	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	1	[hp_M]/1			N	20241231
37662-3075_fa6d4891-84f3-ae16-e053-6394a90a37e4	37662-3075	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230428		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	1	[hp_Q]/1			N	20241231
37662-3076_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3076	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	6	[hp_C]/1			N	20241231
37662-3077_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3077	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	12	[hp_C]/1			N	20241231
37662-3078_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3078	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	30	[hp_C]/1			N	20241231
37662-3079_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3079	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	100	[hp_C]/1			N	20241231
37662-3080_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3080	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	200	[hp_C]/1			N	20241231
37662-3081_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3081	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	500	[hp_C]/1			N	20241231
37662-3082_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3082	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	1	[hp_M]/1			N	20241231
37662-3083_faa8c4b4-55aa-e495-e053-6394a90a8879	37662-3083	HUMAN OTC DRUG	Strontium Phosphoricum		Strontium Phosphoricum	PELLET	ORAL	20230501		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM PHOSPHATE	1	[hp_Q]/1			N	20241231
37662-3084_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3084	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	6	[hp_C]/1			N	20241231
37662-3085_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3085	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	12	[hp_C]/1			N	20241231
37662-3086_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3086	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	30	[hp_C]/1			N	20241231
37662-3087_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3087	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	100	[hp_C]/1			N	20241231
37662-3088_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3088	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	200	[hp_C]/1			N	20241231
37662-3089_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3089	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	500	[hp_C]/1			N	20241231
37662-3090_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3090	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	1	[hp_M]/1			N	20241231
37662-3091_faac0d10-dbe0-f1b6-e053-6294a90abb8e	37662-3091	HUMAN OTC DRUG	Zirconium Metallicum		Zirconium Metallicum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM	1	[hp_Q]/1			N	20241231
37662-3092_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3092	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-3093_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3093	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-3094_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3094	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-3095_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3095	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-3096_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3096	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-3097_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3097	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-3098_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3098	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-3099_fac0d318-fd53-b2ce-e053-6394a90ad95c	37662-3099	HUMAN OTC DRUG	Zirconium Fluoratum		Zirconium Fluoratum	PELLET	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM FLUORIDE	1	[hp_Q]/1			N	20241231
37662-3100_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3100	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	6	[hp_C]/1			N	20241231
37662-3101_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3101	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	12	[hp_C]/1			N	20241231
37662-3102_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3102	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	30	[hp_C]/1			N	20241231
37662-3103_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3103	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	100	[hp_C]/1			N	20241231
37662-3104_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3104	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	200	[hp_C]/1			N	20241231
37662-3105_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3105	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	500	[hp_C]/1			N	20241231
37662-3106_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3106	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	1	[hp_M]/1			N	20241231
37662-3107_fac2c594-4dc2-e0b0-e053-6394a90ad885	37662-3107	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	1	[hp_Q]/1			N	20241231
37662-3108_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3108	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	6	[hp_C]/1			N	20241231
37662-3109_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3109	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	12	[hp_C]/1			N	20241231
37662-3110_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3110	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	30	[hp_C]/1			N	20241231
37662-3111_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3111	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	100	[hp_C]/1			N	20241231
37662-3112_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3112	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	200	[hp_C]/1			N	20241231
37662-3113_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3113	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	500	[hp_C]/1			N	20241231
37662-3114_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3114	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	1	[hp_M]/1			N	20241231
37662-3115_fad5c21a-2a28-702a-e053-6394a90a2e4a	37662-3115	HUMAN OTC DRUG	Zirconium Iodatum		Zirconium Iodatum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM IODIDE	1	[hp_Q]/1			N	20241231
37662-3116_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3116	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	6	[hp_C]/1			N	20241231
37662-3117_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3117	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	12	[hp_C]/1			N	20241231
37662-3118_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3118	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	30	[hp_C]/1			N	20241231
37662-3119_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3119	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	100	[hp_C]/1			N	20241231
37662-3120_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3120	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	200	[hp_C]/1			N	20241231
37662-3121_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3121	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	500	[hp_C]/1			N	20241231
37662-3122_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3122	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	1	[hp_M]/1			N	20241231
37662-3123_fad6f2a9-af5d-59ad-e053-6394a90a9deb	37662-3123	HUMAN OTC DRUG	Zirconium Sulphuricum		Zirconium Sulphuricum	PELLET	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM SULFATE	1	[hp_Q]/1			N	20241231
37662-3124_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3124	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	6	[hp_C]/1			N	20241231
37662-3125_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3125	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	12	[hp_C]/1			N	20241231
37662-3126_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3126	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	30	[hp_C]/1			N	20241231
37662-3127_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3127	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	100	[hp_C]/1			N	20241231
37662-3128_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3128	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	200	[hp_C]/1			N	20241231
37662-3129_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3129	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	500	[hp_C]/1			N	20241231
37662-3130_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3130	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	1	[hp_M]/1			N	20241231
37662-3131_fad8ac17-a1c3-8c6e-e053-6394a90afa09	37662-3131	HUMAN OTC DRUG	Zirconium Oxydatum		Zirconium Oxydatum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM OXIDE	1	[hp_Q]/1			N	20241231
37662-3132_fae8e59c-7990-8305-e053-6394a90ac405	37662-3132	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	6	[hp_C]/1			N	20241231
37662-3133_fae8e59c-7990-8305-e053-6394a90ac405	37662-3133	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	12	[hp_C]/1			N	20241231
37662-3134_fae8e59c-7990-8305-e053-6394a90ac405	37662-3134	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	30	[hp_C]/1			N	20241231
37662-3135_fae8e59c-7990-8305-e053-6394a90ac405	37662-3135	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	100	[hp_C]/1			N	20241231
37662-3136_fae8e59c-7990-8305-e053-6394a90ac405	37662-3136	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	200	[hp_C]/1			N	20241231
37662-3137_fae8e59c-7990-8305-e053-6394a90ac405	37662-3137	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	500	[hp_C]/1			N	20241231
37662-3138_fae8e59c-7990-8305-e053-6394a90ac405	37662-3138	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	1	[hp_M]/1			N	20241231
37662-3139_fae8e59c-7990-8305-e053-6394a90ac405	37662-3139	HUMAN OTC DRUG	Yttrium Metallicum		Yttrium Metallicum	PELLET	ORAL	20230504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM	1	[hp_Q]/1			N	20241231
37662-3140_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3140	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-3141_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3141	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-3142_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3142	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-3143_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3143	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-3144_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3144	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-3145_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3145	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-3146_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3146	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-3147_fae98b48-9bc9-4389-e053-6394a90a389a	37662-3147	HUMAN OTC DRUG	Yttrium Fluoratum		Yttrium Fluoratum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM FLUORIDE	1	[hp_Q]/1			N	20241231
37662-3148_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3148	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	6	[hp_C]/1			N	20241231
37662-3149_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3149	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	12	[hp_C]/1			N	20241231
37662-3150_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3150	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	30	[hp_C]/1			N	20241231
37662-3151_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3151	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	100	[hp_C]/1			N	20241231
37662-3152_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3152	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	200	[hp_C]/1			N	20241231
37662-3153_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3153	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	500	[hp_C]/1			N	20241231
37662-3154_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3154	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	1	[hp_M]/1			N	20241231
37662-3155_fb4c7a15-2d04-4318-e053-6294a90a5e72	37662-3155	HUMAN OTC DRUG	Yttrium Bromatum		Yttrium Bromatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM BROMIDE	1	[hp_Q]/1			N	20241231
37662-3156_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3156	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	6	[hp_C]/1			N	20241231
37662-3157_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3157	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	12	[hp_C]/1			N	20241231
37662-3158_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3158	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	30	[hp_C]/1			N	20241231
37662-3159_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3159	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	100	[hp_C]/1			N	20241231
37662-3160_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3160	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	200	[hp_C]/1			N	20241231
37662-3161_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3161	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	500	[hp_C]/1			N	20241231
37662-3162_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3162	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	1	[hp_M]/1			N	20241231
37662-3163_fb4d90fa-a23b-c08a-e053-6294a90a852d	37662-3163	HUMAN OTC DRUG	Yttrium Iodide		Yttrium Iodide	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM IODIDE	1	[hp_Q]/1			N	20241231
37662-3164_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3164	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	6	[hp_C]/1			N	20241231
37662-3165_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3165	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	12	[hp_C]/1			N	20241231
37662-3166_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3166	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	30	[hp_C]/1			N	20241231
37662-3167_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3167	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	100	[hp_C]/1			N	20241231
37662-3168_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3168	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	200	[hp_C]/1			N	20241231
37662-3169_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3169	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	500	[hp_C]/1			N	20241231
37662-3170_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3170	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	1	[hp_M]/1			N	20241231
37662-3171_fb4ecc38-3c65-946c-e053-6394a90adddb	37662-3171	HUMAN OTC DRUG	Yttrium Oxydatum		Yttrium Oxydatum	PELLET	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM OXIDE	1	[hp_Q]/1			N	20241231
37662-3172_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3172	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-3173_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3173	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-3174_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3174	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-3175_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3175	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-3176_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3176	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-3177_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3177	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-3178_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3178	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-3179_fb747ef8-3ce0-317b-e053-6394a90a704a	37662-3179	HUMAN OTC DRUG	Lithium Fluoratum		Lithium Fluoratum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM FLUORIDE	1	[hp_Q]/1			N	20241231
37662-3180_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3180	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	6	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3181_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3181	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	12	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3182_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3182	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3183_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3183	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	100	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3184_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3184	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	200	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3185_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3185	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	500	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3186_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3186	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	1	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-3187_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3187	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	10	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-3188_fbdc435e-2ad1-8663-e053-6294a90a4c18	37662-3188	HUMAN OTC DRUG	Lithium Metallicum		Lithium Metallicum	PELLET	ORAL	20230516		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM	1	[hp_Q]/1	Mood Stabilizer [EPC]		N	20241231
37662-3189_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3189	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	6	[hp_C]/1			N	20241231
37662-3190_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3190	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	12	[hp_C]/1			N	20241231
37662-3191_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3191	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	30	[hp_C]/1			N	20241231
37662-3192_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3192	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	100	[hp_C]/1			N	20241231
37662-3193_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3193	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	200	[hp_C]/1			N	20241231
37662-3194_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3194	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	500	[hp_C]/1			N	20241231
37662-3195_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3195	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	1	[hp_M]/1			N	20241231
37662-3196_fbdd130f-f8a6-cec0-e053-6394a90a6dc3	37662-3196	HUMAN OTC DRUG	Lanthanum Metallicum		Lanthanum Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LANTHANUM	1	[hp_Q]/1			N	20241231
37662-3197_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3197	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	6	[hp_C]/1			N	20241231
37662-3198_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3198	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	12	[hp_C]/1			N	20241231
37662-3199_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3199	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	30	[hp_C]/1			N	20241231
37662-3200_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3200	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	100	[hp_C]/1			N	20241231
37662-3201_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3201	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	200	[hp_C]/1			N	20241231
37662-3202_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3202	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	500	[hp_C]/1			N	20241231
37662-3203_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3203	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	1	[hp_M]/1			N	20241231
37662-3204_fbed7a68-25a8-c411-e053-6394a90acee7	37662-3204	HUMAN OTC DRUG	Magnesia Nitrica		Magnesia Nitrica	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MAGNESIUM NITRITE	1	[hp_Q]/1			N	20241231
37662-3205_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3205	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	6	[hp_C]/1			N	20241231
37662-3206_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3206	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	12	[hp_C]/1			N	20241231
37662-3207_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3207	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	30	[hp_C]/1			N	20241231
37662-3208_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3208	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	100	[hp_C]/1			N	20241231
37662-3209_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3209	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	200	[hp_C]/1			N	20241231
37662-3210_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3210	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	500	[hp_C]/1			N	20241231
37662-3211_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3211	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	1	[hp_M]/1			N	20241231
37662-3212_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3212	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	10	[hp_M]/1			N	20241231
37662-3213_fbf2c672-3f25-d664-e053-6394a90acfc5	37662-3213	HUMAN OTC DRUG	Niobium Metallicum		Niobium Metallicum	PELLET	ORAL	20230517		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM	1	[hp_Q]/1			N	20241231
37662-3214_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3214	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	6	[hp_C]/1			N	20241231
37662-3215_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3215	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	12	[hp_C]/1			N	20241231
37662-3216_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3216	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	30	[hp_C]/1			N	20241231
37662-3217_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3217	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	100	[hp_C]/1			N	20241231
37662-3218_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3218	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	200	[hp_C]/1			N	20241231
37662-3219_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3219	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	500	[hp_C]/1			N	20241231
37662-3220_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3220	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	1	[hp_M]/1			N	20241231
37662-3221_fc02106d-c222-95bb-e053-6294a90aab6e	37662-3221	HUMAN OTC DRUG	Neodymium Oxydatum		Neodymium Oxydatum	PELLET	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NEODYMIUM OXIDE	1	[hp_Q]/1			N	20241231
37662-3222_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3222	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3223_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3223	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3224_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3224	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3225_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3225	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3226_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3226	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3227_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3227	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3228_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3228	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3229_fc636b53-c038-2fef-e053-6394a90aaca6	37662-3229	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA BEAN	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3230_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3230	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	6	[hp_C]/1			N	20241231
37662-3231_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3231	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	12	[hp_C]/1			N	20241231
37662-3232_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3232	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	30	[hp_C]/1			N	20241231
37662-3233_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3233	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	100	[hp_C]/1			N	20241231
37662-3234_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3234	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	200	[hp_C]/1			N	20241231
37662-3235_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3235	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	500	[hp_C]/1			N	20241231
37662-3236_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3236	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	1	[hp_M]/1			N	20241231
37662-3237_fc6988dd-4c64-fde8-e053-6394a90aa428	37662-3237	HUMAN OTC DRUG	Praseodymium Metallicum		Praseodymium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PRASEODYMIUM	1	[hp_Q]/1			N	20241231
37662-3238_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3238	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	6	[hp_C]/1			N	20241231
37662-3239_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3239	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	12	[hp_C]/1			N	20241231
37662-3240_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3240	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	30	[hp_C]/1			N	20241231
37662-3241_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3241	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	100	[hp_C]/1			N	20241231
37662-3242_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3242	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	200	[hp_C]/1			N	20241231
37662-3243_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3243	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	500	[hp_C]/1			N	20241231
37662-3244_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3244	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	1	[hp_M]/1			N	20241231
37662-3245_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3245	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	10	[hp_M]/1			N	20241231
37662-3246_fc7cedf6-1588-1db6-e053-6394a90a80c0	37662-3246	HUMAN OTC DRUG	Scandium Metallicum		Scandium Metallicum	PELLET	ORAL	20230524		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM	1	[hp_Q]/1			N	20241231
37662-3247_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3247	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	6	[hp_C]/1			N	20241231
37662-3248_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3248	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	12	[hp_C]/1			N	20241231
37662-3249_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3249	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	30	[hp_C]/1			N	20241231
37662-3250_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3250	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	100	[hp_C]/1			N	20241231
37662-3251_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3251	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	200	[hp_C]/1			N	20241231
37662-3252_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3252	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	500	[hp_C]/1			N	20241231
37662-3253_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3253	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	1	[hp_M]/1			N	20241231
37662-3254_fc7d6de2-7ec9-ffd1-e053-6394a90a6757	37662-3254	HUMAN OTC DRUG	Strontium Metallicum		Strontium Metallicum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM	10	[hp_M]/1			N	20241231
37662-3255_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3255	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-3256_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3256	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-3257_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3257	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-3258_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3258	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-3259_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3259	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-3260_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3260	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-3261_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3261	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-3262_fc8bc578-45f0-53c3-e053-6394a90aa7df	37662-3262	HUMAN OTC DRUG	Veratrum Nigrum		Veratrum Nigrum	PELLET	ORAL	20230525		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VERATRUM NIGRUM FLOWERING TOP	10	[hp_M]/1			N	20241231
37662-3263_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3263	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	6	[hp_C]/1			N	20241231
37662-3264_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3264	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	12	[hp_C]/1			N	20241231
37662-3265_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3265	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	30	[hp_C]/1			N	20241231
37662-3266_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3266	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	100	[hp_C]/1			N	20241231
37662-3267_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3267	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	200	[hp_C]/1			N	20241231
37662-3268_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3268	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	500	[hp_C]/1			N	20241231
37662-3269_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3269	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	1	[hp_M]/1			N	20241231
37662-3270_fc90ec3b-c596-d201-e053-6294a90a0655	37662-3270	HUMAN OTC DRUG	Scandium Iodatum		Scandium Iodatum	PELLET	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM IODIDE	10	[hp_M]/1			N	20241231
37662-3271_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3271	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	6	[hp_C]/1			N	20241231
37662-3272_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3272	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	12	[hp_C]/1			N	20241231
37662-3273_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3273	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	30	[hp_C]/1			N	20241231
37662-3274_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3274	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	100	[hp_C]/1			N	20241231
37662-3275_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3275	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	200	[hp_C]/1			N	20241231
37662-3276_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3276	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	500	[hp_C]/1			N	20241231
37662-3277_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3277	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	1	[hp_M]/1			N	20241231
37662-3278_fca3756d-9b8f-4720-e053-6294a90a030d	37662-3278	HUMAN OTC DRUG	Zirconium Carbonicum		Zirconium Carbonicum	PELLET	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CARBONATE	10	[hp_M]/1			N	20241231
37662-3279_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3279	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	6	[hp_C]/1			N	20241231
37662-3280_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3280	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	12	[hp_C]/1			N	20241231
37662-3281_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3281	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	30	[hp_C]/1			N	20241231
37662-3282_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3282	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	100	[hp_C]/1			N	20241231
37662-3283_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3283	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	200	[hp_C]/1			N	20241231
37662-3284_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3284	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	500	[hp_C]/1			N	20241231
37662-3285_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3285	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	1	[hp_M]/1			N	20241231
37662-3286_fd08d4cd-ec71-5a6d-e053-6394a90a55f9	37662-3286	HUMAN OTC DRUG	Titanium Carbonatum		Titanium Carbonatum	PELLET	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM CARBIDE	10	[hp_M]/1			N	20241231
37662-3287_fd0c1104-0622-e706-e053-6294a90aec82	37662-3287	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3288_fd0c1104-0622-e706-e053-6294a90aec82	37662-3288	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3289_fd0c1104-0622-e706-e053-6294a90aec82	37662-3289	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3290_fd0c1104-0622-e706-e053-6294a90aec82	37662-3290	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3291_fd0c1104-0622-e706-e053-6294a90aec82	37662-3291	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3292_fd0c1104-0622-e706-e053-6294a90aec82	37662-3292	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3293_fd0c1104-0622-e706-e053-6294a90aec82	37662-3293	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3294_fd0c1104-0622-e706-e053-6294a90aec82	37662-3294	HUMAN OTC DRUG	Vanilla Planifolia		Vanilla Planifolia	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANILLA	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3295_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3295	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	6	[hp_C]/1			N	20241231
37662-3296_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3296	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	12	[hp_C]/1			N	20241231
37662-3297_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3297	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	30	[hp_C]/1			N	20241231
37662-3298_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3298	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	100	[hp_C]/1			N	20241231
37662-3299_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3299	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	200	[hp_C]/1			N	20241231
37662-3300_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3300	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	500	[hp_C]/1			N	20241231
37662-3301_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3301	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	1	[hp_M]/1			N	20241231
37662-3302_fd2ecde0-2970-060f-e053-6294a90afd98	37662-3302	HUMAN OTC DRUG	Quercus Rubra Glandium		Quercus Rubra Glandium	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	QUERCUS RUBRA WHOLE	10	[hp_M]/1			N	20241231
37662-3303_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3303	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	6	[hp_C]/1			N	20241231
37662-3304_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3304	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	12	[hp_C]/1			N	20241231
37662-3305_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3305	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	30	[hp_C]/1			N	20241231
37662-3306_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3306	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	100	[hp_C]/1			N	20241231
37662-3307_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3307	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	200	[hp_C]/1			N	20241231
37662-3308_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3308	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	500	[hp_C]/1			N	20241231
37662-3309_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3309	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	1	[hp_M]/1			N	20241231
37662-3310_fd31ca86-fd46-9902-e053-6294a90a624a	37662-3310	HUMAN OTC DRUG	Tellurium Muriaticum		Tellurium Muriaticum	PELLET	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TELLURIUM TETRACHLORIDE	10	[hp_M]/1			N	20241231
37662-3311_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3311	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	6	[hp_C]/1			N	20241231
37662-3312_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3312	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	12	[hp_C]/1			N	20241231
37662-3313_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3313	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	30	[hp_C]/1			N	20241231
37662-3314_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3314	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	100	[hp_C]/1			N	20241231
37662-3315_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3315	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	200	[hp_C]/1			N	20241231
37662-3316_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3316	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	500	[hp_C]/1			N	20241231
37662-3317_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3317	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	1	[hp_M]/1			N	20241231
37662-3318_fd69cceb-aebd-ee89-e053-6294a90affa6	37662-3318	HUMAN OTC DRUG	Gallium Nitricum		Gallium Nitricum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM NITRATE ANHYDROUS	1	[hp_Q]/1			N	20241231
37662-3319_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3319	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	6	[hp_C]/1			N	20241231
37662-3320_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3320	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	12	[hp_C]/1			N	20241231
37662-3321_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3321	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	30	[hp_C]/1			N	20241231
37662-3322_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3322	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	100	[hp_C]/1			N	20241231
37662-3323_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3323	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	200	[hp_C]/1			N	20241231
37662-3324_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3324	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	500	[hp_C]/1			N	20241231
37662-3325_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3325	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	1	[hp_M]/1			N	20241231
37662-3326_fd6bfc15-3915-e1dd-e053-6294a90a4b64	37662-3326	HUMAN OTC DRUG	Germanium Oxydatum		Germanium Oxydatum	PELLET	ORAL	20230605		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM DIOXIDE	10	[hp_M]/1			N	20241231
37662-3327_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3327	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3328_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3328	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3329_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3329	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3330_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3330	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3331_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3331	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3332_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3332	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3333_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3333	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3334_fd6e0302-d053-8d36-e053-6294a90aae49	37662-3334	HUMAN OTC DRUG	Kali Tartaricum		Kali Tartaricum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TARTRATE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3335_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3335	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3336_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3336	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3337_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3337	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3338_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3338	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3339_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3339	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3340_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3340	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3341_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3341	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3342_fda9b1e2-9b93-4782-e053-6394a90ac8d3	37662-3342	HUMAN OTC DRUG	Kali Telluricosum		Kali Telluricosum	PELLET	ORAL	20230608		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM TELLURITE	10	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3343_fe101e58-b959-14ec-e053-6294a90a6118	37662-3343	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	6	[hp_C]/1			N	20241231
37662-3344_fe101e58-b959-14ec-e053-6294a90a6118	37662-3344	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	12	[hp_C]/1			N	20241231
37662-3345_fe101e58-b959-14ec-e053-6294a90a6118	37662-3345	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	30	[hp_C]/1			N	20241231
37662-3346_fe101e58-b959-14ec-e053-6294a90a6118	37662-3346	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	100	[hp_C]/1			N	20241231
37662-3347_fe101e58-b959-14ec-e053-6294a90a6118	37662-3347	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	200	[hp_C]/1			N	20241231
37662-3348_fe101e58-b959-14ec-e053-6294a90a6118	37662-3348	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	500	[hp_C]/1			N	20241231
37662-3349_fe101e58-b959-14ec-e053-6294a90a6118	37662-3349	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	1	[hp_M]/1			N	20241231
37662-3350_fe101e58-b959-14ec-e053-6294a90a6118	37662-3350	HUMAN OTC DRUG	Plumeria Rubra		Plumeria Rubra	PELLET	ORAL	20230613		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLUMERIA RUBRA WHOLE	10	[hp_M]/1			N	20241231
37662-3351_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3351	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-3352_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3352	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-3353_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3353	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-3354_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3354	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-3355_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3355	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-3356_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3356	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-3357_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3357	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-3358_fe22487b-9621-f890-e053-6294a90a2dfa	37662-3358	HUMAN OTC DRUG	Scandium Muriaticum		Scandium Muriaticum	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SCANDIUM CHLORIDE	10	[hp_M]/1			N	20241231
37662-3359_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3359	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3360_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3360	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3361_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3361	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3362_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3362	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3363_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3363	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3364_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3364	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3365_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3365	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3366_fe2381b8-413c-f3c3-e053-6294a90a53ab	37662-3366	HUMAN OTC DRUG	Wheat Berry		Wheat Berry	PELLET	ORAL	20230614		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	WHEAT	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
37662-3367_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3367	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	6	[hp_C]/1			N	20241231
37662-3368_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3368	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	12	[hp_C]/1			N	20241231
37662-3369_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3369	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	30	[hp_C]/1			N	20241231
37662-3370_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3370	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	100	[hp_C]/1			N	20241231
37662-3371_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3371	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	200	[hp_C]/1			N	20241231
37662-3372_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3372	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	500	[hp_C]/1			N	20241231
37662-3373_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3373	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	1	[hp_M]/1			N	20241231
37662-3374_fe33f487-8e29-4c0c-e053-6394a90ac7f3	37662-3374	HUMAN OTC DRUG	Stannum Arsenatum		Stannum Arsenatum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TIN MONOARSENIDE	10	[hp_M]/1			N	20241231
37662-3375_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3375	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	6	[hp_C]/1			N	20241231
37662-3376_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3376	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	12	[hp_C]/1			N	20241231
37662-3377_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3377	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	30	[hp_C]/1			N	20241231
37662-3378_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3378	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	100	[hp_C]/1			N	20241231
37662-3379_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3379	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	200	[hp_C]/1			N	20241231
37662-3380_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3380	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	500	[hp_C]/1			N	20241231
37662-3381_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3381	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	1	[hp_M]/1			N	20241231
37662-3382_fe39dd17-4447-11c7-e053-6394a90a58d4	37662-3382	HUMAN OTC DRUG	Strontium Muriaticum		Strontium Muriaticum	PELLET	ORAL	20230615		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM CHLORIDE HEXAHYDRATE	10	[hp_M]/1			N	20241231
37662-3383_feaca19b-014e-044a-e053-6294a90a1350	37662-3383	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	6	[hp_C]/1			N	20241231
37662-3384_feaca19b-014e-044a-e053-6294a90a1350	37662-3384	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	12	[hp_C]/1			N	20241231
37662-3385_feaca19b-014e-044a-e053-6294a90a1350	37662-3385	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	30	[hp_C]/1			N	20241231
37662-3386_feaca19b-014e-044a-e053-6294a90a1350	37662-3386	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	100	[hp_C]/1			N	20241231
37662-3387_feaca19b-014e-044a-e053-6294a90a1350	37662-3387	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	200	[hp_C]/1			N	20241231
37662-3388_feaca19b-014e-044a-e053-6294a90a1350	37662-3388	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	500	[hp_C]/1			N	20241231
37662-3389_feaca19b-014e-044a-e053-6294a90a1350	37662-3389	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	1	[hp_M]/1			N	20241231
37662-3390_feaca19b-014e-044a-e053-6294a90a1350	37662-3390	HUMAN OTC DRUG	Silicium Muriaticum		Silicium Muriaticum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON TETRACHLORIDE	10	[hp_M]/1			N	20241231
37662-3391_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3391	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	6	[hp_C]/1			N	20241231
37662-3392_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3392	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	12	[hp_C]/1			N	20241231
37662-3393_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3393	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	30	[hp_C]/1			N	20241231
37662-3394_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3394	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	100	[hp_C]/1			N	20241231
37662-3395_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3395	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	200	[hp_C]/1			N	20241231
37662-3396_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3396	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	500	[hp_C]/1			N	20241231
37662-3397_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3397	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	1	[hp_M]/1			N	20241231
37662-3398_feadcb6c-c45e-404e-e053-6394a90a238a	37662-3398	HUMAN OTC DRUG	Silicium Nitricatum		Silicium Nitricatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON NITRIDE	10	[hp_M]/1			N	20241231
37662-3399_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3399	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	6	[hp_C]/1			N	20241231
37662-3400_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3400	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	12	[hp_C]/1			N	20241231
37662-3401_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3401	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	30	[hp_C]/1			N	20241231
37662-3402_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3402	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	100	[hp_C]/1			N	20241231
37662-3403_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3403	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	200	[hp_C]/1			N	20241231
37662-3404_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3404	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	500	[hp_C]/1			N	20241231
37662-3405_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3405	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	1	[hp_M]/1			N	20241231
37662-3406_feb25d2f-76fe-7e7e-e053-6394a90a5abe	37662-3406	HUMAN OTC DRUG	Tantalum Carbonatum		Tantalum Carbonatum	PELLET	ORAL	20230621		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TANTALUM CARBIDE	10	[hp_M]/1			N	20241231
37662-3407_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3407	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	6	[hp_C]/1			N	20241231
37662-3408_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3408	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	12	[hp_C]/1			N	20241231
37662-3409_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3409	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	30	[hp_C]/1			N	20241231
37662-3410_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3410	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	100	[hp_C]/1			N	20241231
37662-3411_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3411	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	200	[hp_C]/1			N	20241231
37662-3412_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3412	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	500	[hp_C]/1			N	20241231
37662-3413_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3413	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	1	[hp_M]/1			N	20241231
37662-3414_fed2e6e7-7171-42a2-e053-6394a90a6767	37662-3414	HUMAN OTC DRUG	Oleum Santali		Oleum Santali	PELLET	ORAL	20230623		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SANDALWOOD OIL	10	[hp_M]/1			N	20241231
37662-3415_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3415	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	6	[hp_C]/1			N	20241231
37662-3416_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3416	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	12	[hp_C]/1			N	20241231
37662-3417_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3417	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	30	[hp_C]/1			N	20241231
37662-3418_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3418	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	100	[hp_C]/1			N	20241231
37662-3419_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3419	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	200	[hp_C]/1			N	20241231
37662-3420_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3420	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	500	[hp_C]/1			N	20241231
37662-3421_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3421	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	1	[hp_M]/1			N	20241231
37662-3422_ff0d33fd-bdfb-96a9-e053-6394a90a27e2	37662-3422	HUMAN OTC DRUG	Zincum Iodatum		Zincum Iodatum	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC IODIDE	10	[hp_M]/1			N	20241231
37662-3423_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3423	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	6	[hp_C]/1			N	20241231
37662-3424_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3424	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	12	[hp_C]/1			N	20241231
37662-3425_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3425	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	30	[hp_C]/1			N	20241231
37662-3426_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3426	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	100	[hp_C]/1			N	20241231
37662-3427_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3427	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	200	[hp_C]/1			N	20241231
37662-3428_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3428	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	500	[hp_C]/1			N	20241231
37662-3429_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3429	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	1	[hp_M]/1			N	20241231
37662-3430_ff1086e6-c317-239a-e053-6394a90ade3b	37662-3430	HUMAN OTC DRUG	Nitri Spiritus Dulcis		Nitri Spiritus Dulcis	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ETHYL NITRITE	10	[hp_M]/1			N	20241231
37662-3431_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3431	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	6	[hp_C]/1			N	20241231
37662-3432_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3432	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	12	[hp_C]/1			N	20241231
37662-3433_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3433	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	30	[hp_C]/1			N	20241231
37662-3434_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3434	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	100	[hp_C]/1			N	20241231
37662-3435_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3435	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	200	[hp_C]/1			N	20241231
37662-3436_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3436	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	500	[hp_C]/1			N	20241231
37662-3437_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3437	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	1	[hp_M]/1			N	20241231
37662-3438_ff1398ab-0347-09dd-e053-6294a90a6360	37662-3438	HUMAN OTC DRUG	Agraphis Nutans		Agraphis Nutans	PELLET	ORAL	20230626		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HYACINTHOIDES NON-SCRIPTA	10	[hp_M]/1			N	20241231
37662-3439_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3439	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	6	[hp_C]/1			N	20241231
37662-3440_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3440	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	12	[hp_C]/1			N	20241231
37662-3441_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3441	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	30	[hp_C]/1			N	20241231
37662-3442_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3442	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	100	[hp_C]/1			N	20241231
37662-3443_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3443	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	200	[hp_C]/1			N	20241231
37662-3444_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3444	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	500	[hp_C]/1			N	20241231
37662-3445_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3445	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	1	[hp_M]/1			N	20241231
37662-3446_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3446	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	10	[hp_M]/1			N	20241231
37662-3447_fc6595c5-ce4b-92e0-e053-6394a90aa059	37662-3447	HUMAN OTC DRUG	Acidum Phosphoricum		Acidum Phosphoricum	PELLET	ORAL	20230523		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHORIC ACID	1	[hp_Q]/1			N	20241231
37662-3448_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3448	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	6	[hp_C]/1			N	20241231
37662-3449_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3449	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	12	[hp_C]/1			N	20241231
37662-3450_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3450	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	30	[hp_C]/1			N	20241231
37662-3451_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3451	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	100	[hp_C]/1			N	20241231
37662-3452_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3452	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	200	[hp_C]/1			N	20241231
37662-3453_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3453	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	500	[hp_C]/1			N	20241231
37662-3454_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3454	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	1	[hp_M]/1			N	20241231
37662-3455_ff3761ad-78e7-2dd7-e053-6394a90a8c31	37662-3455	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ARTEMISIA ABROTANUM FLOWERING TOP	10	[hp_M]/1			N	20241231
37662-3456_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3456	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	6	[hp_C]/1			N	20241231
37662-3457_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3457	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	12	[hp_C]/1			N	20241231
37662-3458_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3458	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	30	[hp_C]/1			N	20241231
37662-3459_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3459	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	100	[hp_C]/1			N	20241231
37662-3460_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3460	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	200	[hp_C]/1			N	20241231
37662-3461_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3461	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	500	[hp_C]/1			N	20241231
37662-3462_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3462	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	1	[hp_M]/1			N	20241231
37662-3463_ff3d269e-a041-2ffa-e053-6294a90a4089	37662-3463	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ACTAEA SPICATA ROOT	10	[hp_M]/1			N	20241231
37662-3464_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3464	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	6	[hp_C]/1			N	20241231
37662-3465_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3465	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	12	[hp_C]/1			N	20241231
37662-3466_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3466	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	30	[hp_C]/1			N	20241231
37662-3467_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3467	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	100	[hp_C]/1			N	20241231
37662-3468_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3468	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	200	[hp_C]/1			N	20241231
37662-3469_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3469	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	500	[hp_C]/1			N	20241231
37662-3470_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3470	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	1	[hp_M]/1			N	20241231
37662-3471_ff3f8db9-7589-dfb3-e053-6294a90a0875	37662-3471	HUMAN OTC DRUG	Agnus Castus		Agnus Castus	PELLET	ORAL	20230628		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHASTE TREE	10	[hp_M]/1			N	20241231
37662-3472_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3472	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	6	[hp_C]/1			N	20241231
37662-3473_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3473	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	12	[hp_C]/1			N	20241231
37662-3474_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3474	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	30	[hp_C]/1			N	20241231
37662-3475_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3475	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	100	[hp_C]/1			N	20241231
37662-3476_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3476	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	200	[hp_C]/1			N	20241231
37662-3477_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3477	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	500	[hp_C]/1			N	20241231
37662-3478_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3478	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	1	[hp_M]/1			N	20241231
37662-3479_ff494daa-87a6-a7a3-e053-6294a90a6b55	37662-3479	HUMAN OTC DRUG	Aluminium Iodatum		Aluminium Iodatum	PELLET	ORAL	20230629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM IODIDE	10	[hp_M]/1			N	20241231
37662-3480_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3480	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	6	[hp_C]/1			N	20241231
37662-3481_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3481	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	12	[hp_C]/1			N	20241231
37662-3482_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3482	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	30	[hp_C]/1			N	20241231
37662-3483_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3483	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	100	[hp_C]/1			N	20241231
37662-3484_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3484	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	200	[hp_C]/1			N	20241231
37662-3485_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3485	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	500	[hp_C]/1			N	20241231
37662-3486_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3486	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	1	[hp_M]/1			N	20241231
37662-3487_ff5bf20d-a32c-f924-e053-6294a90aee6d	37662-3487	HUMAN OTC DRUG	Aesculus Hippocastanum		Aesculus Hippocastanum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	HORSE CHESTNUT	10	[hp_M]/1			N	20241231
37662-3488_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3488	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	6	[hp_C]/1			N	20241231
37662-3489_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3489	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	12	[hp_C]/1			N	20241231
37662-3490_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3490	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	30	[hp_C]/1			N	20241231
37662-3491_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3491	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	100	[hp_C]/1			N	20241231
37662-3492_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3492	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	200	[hp_C]/1			N	20241231
37662-3493_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3493	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	500	[hp_C]/1			N	20241231
37662-3494_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3494	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	1	[hp_M]/1			N	20241231
37662-3495_ff5cb465-47b7-dc36-e053-6294a90a7a66	37662-3495	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANGOSTURA BARK	10	[hp_M]/1			N	20241231
37662-3496_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3496	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	6	[hp_C]/1			N	20241231
37662-3497_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3497	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	12	[hp_C]/1			N	20241231
37662-3498_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3498	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	30	[hp_C]/1			N	20241231
37662-3499_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3499	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	100	[hp_C]/1			N	20241231
37662-3500_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3500	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	200	[hp_C]/1			N	20241231
37662-3501_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3501	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	500	[hp_C]/1			N	20241231
37662-3502_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3502	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	1	[hp_M]/1			N	20241231
37662-3503_ff5f2a6f-d2f6-8862-e053-6294a90a30c6	37662-3503	HUMAN OTC DRUG	Ailanthus Glandulous		Ailanthus Glandulous	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AILANTHUS ALTISSIMA FLOWERING TWIG	10	[hp_M]/1			N	20241231
37662-3504_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3504	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	6	[hp_C]/1			N	20241231
37662-3505_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3505	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	12	[hp_C]/1			N	20241231
37662-3506_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3506	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	30	[hp_C]/1			N	20241231
37662-3507_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3507	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	100	[hp_C]/1			N	20241231
37662-3508_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3508	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	200	[hp_C]/1			N	20241231
37662-3509_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3509	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	500	[hp_C]/1			N	20241231
37662-3510_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3510	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	1	[hp_M]/1			N	20241231
37662-3511_ffc56a39-0f70-2879-e053-6394a90a3a4a	37662-3511	HUMAN OTC DRUG	Aluminium Carbonicum		Aluminium Carbonicum	PELLET	ORAL	20230630		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM CARBONATE	10	[hp_M]/1			N	20241231
37662-3512_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3512	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	6	[hp_C]/1			N	20241231
37662-3513_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3513	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	12	[hp_C]/1			N	20241231
37662-3514_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3514	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	30	[hp_C]/1			N	20241231
37662-3515_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3515	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	100	[hp_C]/1			N	20241231
37662-3516_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3516	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	200	[hp_C]/1			N	20241231
37662-3517_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3517	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	500	[hp_C]/1			N	20241231
37662-3518_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3518	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	1	[hp_M]/1			N	20241231
37662-3519_ffc66c2f-d6f9-0fd1-e053-6294a90a4001	37662-3519	HUMAN OTC DRUG	Alumina Silicata		Alumina Silicata	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	KAOLIN	10	[hp_M]/1			N	20241231
37662-3520_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3520	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	6	[hp_C]/1			N	20241231
37662-3521_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3521	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	12	[hp_C]/1			N	20241231
37662-3522_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3522	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	30	[hp_C]/1			N	20241231
37662-3523_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3523	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	100	[hp_C]/1			N	20241231
37662-3524_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3524	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	200	[hp_C]/1			N	20241231
37662-3525_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3525	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	500	[hp_C]/1			N	20241231
37662-3526_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3526	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	1	[hp_M]/1			N	20241231
37662-3527_ffc922f9-214e-6958-e053-6294a90a12e3	37662-3527	HUMAN OTC DRUG	Ancylostoma Caninum		Ancylostoma Caninum	PELLET	ORAL	20230705		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANCYLOSTOMA CANINUM	10	[hp_M]/1			N	20241231
37662-3528_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3528	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3529_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3529	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3530_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3530	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3531_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3531	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3532_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3532	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3533_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3533	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3534_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3534	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3535_ffd80d14-64ff-369e-e053-6394a90a373b	37662-3535	HUMAN OTC DRUG	Allium Sativum		Allium Sativum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GARLIC	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3536_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3536	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	6	[hp_C]/1			N	20241231
37662-3537_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3537	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	12	[hp_C]/1			N	20241231
37662-3538_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3538	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	30	[hp_C]/1			N	20241231
37662-3539_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3539	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	100	[hp_C]/1			N	20241231
37662-3540_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3540	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	200	[hp_C]/1			N	20241231
37662-3541_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3541	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	500	[hp_C]/1			N	20241231
37662-3542_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3542	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	1	[hp_M]/1			N	20241231
37662-3543_ffdb39ca-51a7-2267-e053-6394a90adf3f	37662-3543	HUMAN OTC DRUG	Aloe Socotrina		Aloe Socotrina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALOE	10	[hp_M]/1			N	20241231
37662-3544_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3544	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	6	[hp_C]/1			N	20241231
37662-3545_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3545	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	12	[hp_C]/1			N	20241231
37662-3546_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3546	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	30	[hp_C]/1			N	20241231
37662-3547_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3547	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	100	[hp_C]/1			N	20241231
37662-3548_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3548	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	200	[hp_C]/1			N	20241231
37662-3549_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3549	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	500	[hp_C]/1			N	20241231
37662-3550_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3550	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	1	[hp_M]/1			N	20241231
37662-3551_ffdbdb70-8667-f0c6-e053-6394a90a6596	37662-3551	HUMAN OTC DRUG	Alumina		Alumina	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM OXIDE	10	[hp_M]/1			N	20241231
37662-3552_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3552	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	6	[hp_C]/1			N	20241231
37662-3553_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3553	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	12	[hp_C]/1			N	20241231
37662-3554_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3554	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	30	[hp_C]/1			N	20241231
37662-3555_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3555	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	100	[hp_C]/1			N	20241231
37662-3556_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3556	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	200	[hp_C]/1			N	20241231
37662-3557_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3557	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	500	[hp_C]/1			N	20241231
37662-3558_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3558	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	1	[hp_M]/1			N	20241231
37662-3559_ffdcb856-da82-e409-e053-6394a90a80bd	37662-3559	HUMAN OTC DRUG	Aluminium Bromatum		Aluminium Bromatum	PELLET	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM BROMIDE	10	[hp_M]/1			N	20241231
37662-3560_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3560	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	6	[hp_C]/1			N	20241231
37662-3561_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3561	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	12	[hp_C]/1			N	20241231
37662-3562_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3562	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	30	[hp_C]/1			N	20241231
37662-3563_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3563	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	100	[hp_C]/1			N	20241231
37662-3564_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3564	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	200	[hp_C]/1			N	20241231
37662-3565_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3565	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	500	[hp_C]/1			N	20241231
37662-3566_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3566	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	1	[hp_M]/1			N	20241231
37662-3567_002ce4f0-e919-6409-e063-6394a90a99ed	37662-3567	HUMAN OTC DRUG	Aluminium Fluoratum		Aluminium Fluoratum	PELLET	ORAL	20230710		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM FLUORIDE	10	[hp_M]/1			N	20241231
37662-3568_00304cae-efb3-dafb-e063-6294a90a6579	37662-3568	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	6	[hp_C]/1			N	20241231
37662-3569_00304cae-efb3-dafb-e063-6294a90a6579	37662-3569	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	12	[hp_C]/1			N	20241231
37662-3570_00304cae-efb3-dafb-e063-6294a90a6579	37662-3570	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	30	[hp_C]/1			N	20241231
37662-3571_00304cae-efb3-dafb-e063-6294a90a6579	37662-3571	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	100	[hp_C]/1			N	20241231
37662-3572_00304cae-efb3-dafb-e063-6294a90a6579	37662-3572	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	200	[hp_C]/1			N	20241231
37662-3573_00304cae-efb3-dafb-e063-6294a90a6579	37662-3573	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	500	[hp_C]/1			N	20241231
37662-3574_00304cae-efb3-dafb-e063-6294a90a6579	37662-3574	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	1	[hp_M]/1			N	20241231
37662-3575_00304cae-efb3-dafb-e063-6294a90a6579	37662-3575	HUMAN OTC DRUG	Aluminium Nitricum		Aluminium Nitricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM NITRATE	10	[hp_M]/1			N	20241231
37662-3576_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3576	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	6	[hp_C]/1			N	20241231
37662-3577_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3577	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	12	[hp_C]/1			N	20241231
37662-3578_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3578	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	30	[hp_C]/1			N	20241231
37662-3579_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3579	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	100	[hp_C]/1			N	20241231
37662-3580_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3580	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	200	[hp_C]/1			N	20241231
37662-3581_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3581	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	500	[hp_C]/1			N	20241231
37662-3582_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3582	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	1	[hp_M]/1			N	20241231
37662-3583_003ea3bc-9e9b-00ab-e063-6394a90aac24	37662-3583	HUMAN OTC DRUG	Aluminium Phosphoricum		Aluminium Phosphoricum	PELLET	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM PHOSPHATE	10	[hp_M]/1			N	20241231
37662-3584_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3584	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	6	[hp_C]/1			N	20241231
37662-3585_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3585	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	12	[hp_C]/1			N	20241231
37662-3586_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3586	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	30	[hp_C]/1			N	20241231
37662-3587_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3587	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	100	[hp_C]/1			N	20241231
37662-3588_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3588	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	200	[hp_C]/1			N	20241231
37662-3589_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3589	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	500	[hp_C]/1			N	20241231
37662-3590_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3590	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	1	[hp_M]/1			N	20241231
37662-3591_0050fc1d-0cdf-9e78-e063-6394a90afa14	37662-3591	HUMAN OTC DRUG	Aluminium Sulphuricum		Aluminium Sulphuricum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ALUMINUM SULFATE	10	[hp_M]/1			N	20241231
37662-3592_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3592	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	6	[hp_C]/1			N	20241231
37662-3593_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3593	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	12	[hp_C]/1			N	20241231
37662-3594_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3594	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	30	[hp_C]/1			N	20241231
37662-3595_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3595	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	100	[hp_C]/1			N	20241231
37662-3596_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3596	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	200	[hp_C]/1			N	20241231
37662-3597_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3597	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	500	[hp_C]/1			N	20241231
37662-3598_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3598	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	1	[hp_M]/1			N	20241231
37662-3599_0051cc5e-802d-22b0-e063-6294a90a6b4f	37662-3599	HUMAN OTC DRUG	Amanita Pantherina		Amanita Pantherina	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMANITA PANTHERINA FRUITING BODY	10	[hp_M]/1			N	20241231
37662-3600_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3600	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	6	[hp_C]/1			N	20241231
37662-3601_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3601	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	12	[hp_C]/1			N	20241231
37662-3602_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3602	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	30	[hp_C]/1			N	20241231
37662-3603_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3603	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	100	[hp_C]/1			N	20241231
37662-3604_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3604	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	200	[hp_C]/1			N	20241231
37662-3605_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3605	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	500	[hp_C]/1			N	20241231
37662-3606_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3606	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	1	[hp_M]/1			N	20241231
37662-3607_00537772-4bd0-36ee-e063-6294a90a3d66	37662-3607	HUMAN OTC DRUG	Ammonium Bromatum		Ammonium Bromatum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM BROMIDE	10	[hp_M]/1			N	20241231
37662-3608_0053de7d-eeef-5489-e063-6294a90a0514	37662-3608	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	6	[hp_C]/1			N	20241231
37662-3609_0053de7d-eeef-5489-e063-6294a90a0514	37662-3609	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	12	[hp_C]/1			N	20241231
37662-3610_0053de7d-eeef-5489-e063-6294a90a0514	37662-3610	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	30	[hp_C]/1			N	20241231
37662-3611_0053de7d-eeef-5489-e063-6294a90a0514	37662-3611	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	100	[hp_C]/1			N	20241231
37662-3612_0053de7d-eeef-5489-e063-6294a90a0514	37662-3612	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	200	[hp_C]/1			N	20241231
37662-3613_0053de7d-eeef-5489-e063-6294a90a0514	37662-3613	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	500	[hp_C]/1			N	20241231
37662-3614_0053de7d-eeef-5489-e063-6294a90a0514	37662-3614	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	1	[hp_M]/1			N	20241231
37662-3615_0053de7d-eeef-5489-e063-6294a90a0514	37662-3615	HUMAN OTC DRUG	Ammonium Carbonicum		Ammonium Carbonicum	PELLET	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CARBONATE	10	[hp_M]/1			N	20241231
37662-3616_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3616	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	6	[hp_C]/1			N	20241231
37662-3617_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3617	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	12	[hp_C]/1			N	20241231
37662-3618_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3618	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	30	[hp_C]/1			N	20241231
37662-3619_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3619	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	100	[hp_C]/1			N	20241231
37662-3620_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3620	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	200	[hp_C]/1			N	20241231
37662-3621_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3621	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	500	[hp_C]/1			N	20241231
37662-3622_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3622	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	1	[hp_M]/1			N	20241231
37662-3623_00653070-bf0a-78d9-e063-6394a90a0bcf	37662-3623	HUMAN OTC DRUG	Ammonium Causticum		Ammonium Causticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIA	10	[hp_M]/1			N	20241231
37662-3624_0067f67a-daec-4b77-e063-6394a90ac331	37662-3624	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-3625_0067f67a-daec-4b77-e063-6394a90ac331	37662-3625	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-3626_0067f67a-daec-4b77-e063-6394a90ac331	37662-3626	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-3627_0067f67a-daec-4b77-e063-6394a90ac331	37662-3627	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-3628_0067f67a-daec-4b77-e063-6394a90ac331	37662-3628	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-3629_0067f67a-daec-4b77-e063-6394a90ac331	37662-3629	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-3630_0067f67a-daec-4b77-e063-6394a90ac331	37662-3630	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-3631_0067f67a-daec-4b77-e063-6394a90ac331	37662-3631	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM CHLORIDE	10	[hp_M]/1			N	20241231
37662-3632_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3632	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	6	[hp_C]/1			N	20241231
37662-3633_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3633	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	12	[hp_C]/1			N	20241231
37662-3634_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3634	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	30	[hp_C]/1			N	20241231
37662-3635_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3635	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	100	[hp_C]/1			N	20241231
37662-3636_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3636	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	200	[hp_C]/1			N	20241231
37662-3637_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3637	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	500	[hp_C]/1			N	20241231
37662-3638_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3638	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	1	[hp_M]/1			N	20241231
37662-3639_00682d09-bf61-7d6f-e063-6294a90a866b	37662-3639	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20230713		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	AMMONIUM PHOSPHATE, DIBASIC	10	[hp_M]/1			N	20241231
37662-3640_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3640	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	6	[hp_C]/1			N	20241231
37662-3641_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3641	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	12	[hp_C]/1			N	20241231
37662-3642_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3642	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	30	[hp_C]/1			N	20241231
37662-3643_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3643	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	100	[hp_C]/1			N	20241231
37662-3644_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3644	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	200	[hp_C]/1			N	20241231
37662-3645_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3645	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	500	[hp_C]/1			N	20241231
37662-3646_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3646	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	1	[hp_M]/1			N	20241231
37662-3647_016623fe-c451-4cb8-e063-6294a90aa70d	37662-3647	HUMAN OTC DRUG	Terbium Metallicum		Terbium Metallicum	PELLET	ORAL	20230727		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TERBIUM	1	[hp_Q]/1			N	20241231
37662-3648_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3648	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	6	[hp_C]/1			N	20241231
37662-3649_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3649	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	12	[hp_C]/1			N	20241231
37662-3650_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3650	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	30	[hp_C]/1			N	20241231
37662-3651_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3651	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	100	[hp_C]/1			N	20241231
37662-3652_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3652	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	200	[hp_C]/1			N	20241231
37662-3653_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3653	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	500	[hp_C]/1			N	20241231
37662-3654_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3654	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	1	[hp_M]/1			N	20241231
37662-3655_01e66d3c-0a9b-0871-e063-6394a90ae891	37662-3655	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANACARDIUM OCCIDENTALE FRUIT	10	[hp_M]/1			N	20241231
37662-3656_01e691d3-858d-f907-e063-6294a90a5d38	37662-3656	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	6	[hp_C]/1			N	20241231
37662-3657_01e691d3-858d-f907-e063-6294a90a5d38	37662-3657	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	12	[hp_C]/1			N	20241231
37662-3658_01e691d3-858d-f907-e063-6294a90a5d38	37662-3658	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	30	[hp_C]/1			N	20241231
37662-3659_01e691d3-858d-f907-e063-6294a90a5d38	37662-3659	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	100	[hp_C]/1			N	20241231
37662-3660_01e691d3-858d-f907-e063-6294a90a5d38	37662-3660	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	200	[hp_C]/1			N	20241231
37662-3661_01e691d3-858d-f907-e063-6294a90a5d38	37662-3661	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	500	[hp_C]/1			N	20241231
37662-3662_01e691d3-858d-f907-e063-6294a90a5d38	37662-3662	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	1	[hp_M]/1			N	20241231
37662-3663_01e691d3-858d-f907-e063-6294a90a5d38	37662-3663	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SEMECARPUS ANACARDIUM JUICE	10	[hp_M]/1			N	20241231
37662-3664_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3664	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	6	[hp_C]/1			N	20241231
37662-3665_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3665	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	12	[hp_C]/1			N	20241231
37662-3666_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3666	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	30	[hp_C]/1			N	20241231
37662-3667_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3667	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	100	[hp_C]/1			N	20241231
37662-3668_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3668	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	200	[hp_C]/1			N	20241231
37662-3669_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3669	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	500	[hp_C]/1			N	20241231
37662-3670_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3670	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	1	[hp_M]/1			N	20241231
37662-3671_01fa3e6c-b834-73c0-e063-6394a90ad949	37662-3671	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ANAGALLIS ARVENSIS WHOLE	10	[hp_M]/1			N	20241231
37662-3672_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3672	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3673_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3673	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3674_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3674	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3675_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3675	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3676_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3676	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3677_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3677	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3678_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3678	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3679_01fada8b-68c3-4e7a-e063-6394a90acee7	37662-3679	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DILL	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3680_020c59c1-f549-852a-e063-6294a90a9925	37662-3680	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	6	[hp_C]/1			N	20241231
37662-3681_020c59c1-f549-852a-e063-6294a90a9925	37662-3681	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	12	[hp_C]/1			N	20241231
37662-3682_020c59c1-f549-852a-e063-6294a90a9925	37662-3682	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	30	[hp_C]/1			N	20241231
37662-3683_020c59c1-f549-852a-e063-6294a90a9925	37662-3683	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	100	[hp_C]/1			N	20241231
37662-3684_020c59c1-f549-852a-e063-6294a90a9925	37662-3684	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	200	[hp_C]/1			N	20241231
37662-3685_020c59c1-f549-852a-e063-6294a90a9925	37662-3685	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	500	[hp_C]/1			N	20241231
37662-3686_020c59c1-f549-852a-e063-6294a90a9925	37662-3686	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	1	[hp_M]/1			N	20241231
37662-3687_020c59c1-f549-852a-e063-6294a90a9925	37662-3687	HUMAN OTC DRUG	Grindelia Robusta		Grindelia Robusta	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GRINDELIA HIRSUTULA WHOLE	1	[hp_Q]/1			N	20241231
37662-3688_021103af-6167-d747-e063-6394a90a9b4e	37662-3688	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	6	[hp_C]/1			N	20241231
37662-3689_021103af-6167-d747-e063-6394a90a9b4e	37662-3689	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	12	[hp_C]/1			N	20241231
37662-3690_021103af-6167-d747-e063-6394a90a9b4e	37662-3690	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	30	[hp_C]/1			N	20241231
37662-3691_021103af-6167-d747-e063-6394a90a9b4e	37662-3691	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	100	[hp_C]/1			N	20241231
37662-3692_021103af-6167-d747-e063-6394a90a9b4e	37662-3692	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	200	[hp_C]/1			N	20241231
37662-3693_021103af-6167-d747-e063-6394a90a9b4e	37662-3693	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	500	[hp_C]/1			N	20241231
37662-3694_021103af-6167-d747-e063-6394a90a9b4e	37662-3694	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	1	[hp_M]/1			N	20241231
37662-3695_021103af-6167-d747-e063-6394a90a9b4e	37662-3695	HUMAN OTC DRUG	Indigo		Indigo	PELLET	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	INDIGO	1	[hp_Q]/1			N	20241231
37662-3696_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3696	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3697_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3697	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3698_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3698	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3699_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3699	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3700_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3700	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3701_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3701	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3702_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3702	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3703_029f57e7-2d6c-769c-e063-6294a90ab215	37662-3703	HUMAN OTC DRUG	Zingiber Officinale		Zingiber Officinale	PELLET	ORAL	20230810		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GINGER	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
37662-3704_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3704	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	6	[hp_C]/1			N	20241231
37662-3705_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3705	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	12	[hp_C]/1			N	20241231
37662-3706_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3706	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	30	[hp_C]/1			N	20241231
37662-3707_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3707	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	100	[hp_C]/1			N	20241231
37662-3708_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3708	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	200	[hp_C]/1			N	20241231
37662-3709_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3709	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	500	[hp_C]/1			N	20241231
37662-3710_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3710	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	1	[hp_M]/1			N	20241231
37662-3711_02e9bc35-4a25-4ef5-e063-6394a90a3e42	37662-3711	HUMAN OTC DRUG	Tungsten Sulphuratum		Tungsten Sulphuratum	PELLET	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TUNGSTEN DISULFIDE	1	[hp_Q]/1			N	20241231
37662-3712_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3712	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	6	[hp_C]/1			N	20241231
37662-3713_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3713	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	12	[hp_C]/1			N	20241231
37662-3714_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3714	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	30	[hp_C]/1			N	20241231
37662-3715_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3715	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	100	[hp_C]/1			N	20241231
37662-3716_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3716	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	200	[hp_C]/1			N	20241231
37662-3717_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3717	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	500	[hp_C]/1			N	20241231
37662-3718_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3718	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	1	[hp_M]/1			N	20241231
37662-3719_030f8dbc-2958-8b81-e063-6294a90a7a57	37662-3719	HUMAN OTC DRUG	Rubidium Bromatum		Rubidium Bromatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM BROMIDE	1	[hp_Q]/1			N	20241231
37662-3720_031091ad-a398-26ae-e063-6394a90a8190	37662-3720	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	6	[hp_C]/1			N	20241231
37662-3721_031091ad-a398-26ae-e063-6394a90a8190	37662-3721	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	12	[hp_C]/1			N	20241231
37662-3722_031091ad-a398-26ae-e063-6394a90a8190	37662-3722	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	30	[hp_C]/1			N	20241231
37662-3723_031091ad-a398-26ae-e063-6394a90a8190	37662-3723	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	100	[hp_C]/1			N	20241231
37662-3724_031091ad-a398-26ae-e063-6394a90a8190	37662-3724	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	200	[hp_C]/1			N	20241231
37662-3725_031091ad-a398-26ae-e063-6394a90a8190	37662-3725	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	500	[hp_C]/1			N	20241231
37662-3726_031091ad-a398-26ae-e063-6394a90a8190	37662-3726	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	1	[hp_M]/1			N	20241231
37662-3727_031091ad-a398-26ae-e063-6394a90a8190	37662-3727	HUMAN OTC DRUG	Strontium Oxydatum		Strontium Oxydatum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM OXIDE	1	[hp_Q]/1			N	20241231
37662-3728_0312a5d3-7823-e841-e063-6294a90a8695	37662-3728	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	6	[hp_C]/1			N	20241231
37662-3729_0312a5d3-7823-e841-e063-6294a90a8695	37662-3729	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	12	[hp_C]/1			N	20241231
37662-3730_0312a5d3-7823-e841-e063-6294a90a8695	37662-3730	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	30	[hp_C]/1			N	20241231
37662-3731_0312a5d3-7823-e841-e063-6294a90a8695	37662-3731	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	100	[hp_C]/1			N	20241231
37662-3732_0312a5d3-7823-e841-e063-6294a90a8695	37662-3732	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	200	[hp_C]/1			N	20241231
37662-3733_0312a5d3-7823-e841-e063-6294a90a8695	37662-3733	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	500	[hp_C]/1			N	20241231
37662-3734_0312a5d3-7823-e841-e063-6294a90a8695	37662-3734	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	1	[hp_M]/1			N	20241231
37662-3735_0312a5d3-7823-e841-e063-6294a90a8695	37662-3735	HUMAN OTC DRUG	Ytterbium Metallicum		Ytterbium Metallicum	PELLET	ORAL	20230816		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTERBIUM	1	[hp_Q]/1			N	20241231
37662-3736_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3736	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	6	[hp_C]/1			N	20241231
37662-3737_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3737	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	12	[hp_C]/1			N	20241231
37662-3738_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3738	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	30	[hp_C]/1			N	20241231
37662-3739_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3739	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	100	[hp_C]/1			N	20241231
37662-3740_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3740	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	200	[hp_C]/1			N	20241231
37662-3741_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3741	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	500	[hp_C]/1			N	20241231
37662-3742_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3742	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	1	[hp_M]/1			N	20241231
37662-3743_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3743	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	10	[hp_M]/1			N	20241231
37662-3744_032507e2-c9fb-f285-e063-6394a90a0fbf	37662-3744	HUMAN OTC DRUG	Kali Cyanatum		Kali Cyanatum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM CYANIDE	1	[hp_Q]/1			N	20241231
37662-3745_0326769f-24a8-059b-e063-6294a90a0f76	37662-3745	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3746_0326769f-24a8-059b-e063-6294a90a0f76	37662-3746	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3747_0326769f-24a8-059b-e063-6294a90a0f76	37662-3747	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3748_0326769f-24a8-059b-e063-6294a90a0f76	37662-3748	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3749_0326769f-24a8-059b-e063-6294a90a0f76	37662-3749	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3750_0326769f-24a8-059b-e063-6294a90a0f76	37662-3750	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3751_0326769f-24a8-059b-e063-6294a90a0f76	37662-3751	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3752_0326769f-24a8-059b-e063-6294a90a0f76	37662-3752	HUMAN OTC DRUG	Kali Oxalicum		Kali Oxalicum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM OXALATE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3753_03280bb4-794e-57bb-e063-6394a90a854f	37662-3753	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	6	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3754_03280bb4-794e-57bb-e063-6394a90a854f	37662-3754	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	12	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3755_03280bb4-794e-57bb-e063-6394a90a854f	37662-3755	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3756_03280bb4-794e-57bb-e063-6394a90a854f	37662-3756	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	100	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3757_03280bb4-794e-57bb-e063-6394a90a854f	37662-3757	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	200	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3758_03280bb4-794e-57bb-e063-6394a90a854f	37662-3758	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	500	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
37662-3759_03280bb4-794e-57bb-e063-6394a90a854f	37662-3759	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	1	[hp_M]/1	Mood Stabilizer [EPC]		N	20241231
37662-3760_03280bb4-794e-57bb-e063-6394a90a854f	37662-3760	HUMAN OTC DRUG	Lithium Sulphuratum		Lithium Sulphuratum	PELLET	ORAL	20230817		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM SULFATE	1	[hp_Q]/1	Mood Stabilizer [EPC]		N	20241231
37662-3761_03389426-36db-99ad-e063-6394a90a8132	37662-3761	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	6	[hp_C]/1			N	20241231
37662-3762_03389426-36db-99ad-e063-6394a90a8132	37662-3762	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	12	[hp_C]/1			N	20241231
37662-3763_03389426-36db-99ad-e063-6394a90a8132	37662-3763	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	30	[hp_C]/1			N	20241231
37662-3764_03389426-36db-99ad-e063-6394a90a8132	37662-3764	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	100	[hp_C]/1			N	20241231
37662-3765_03389426-36db-99ad-e063-6394a90a8132	37662-3765	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	200	[hp_C]/1			N	20241231
37662-3766_03389426-36db-99ad-e063-6394a90a8132	37662-3766	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	500	[hp_C]/1			N	20241231
37662-3767_03389426-36db-99ad-e063-6394a90a8132	37662-3767	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	1	[hp_M]/1			N	20241231
37662-3768_03389426-36db-99ad-e063-6394a90a8132	37662-3768	HUMAN OTC DRUG	Lithium Iodatum		Lithium Iodatum	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LITHIUM IODATE	1	[hp_Q]/1			N	20241231
37662-3769_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3769	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	6	[hp_C]/1			N	20241231
37662-3770_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3770	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	12	[hp_C]/1			N	20241231
37662-3771_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3771	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	30	[hp_C]/1			N	20241231
37662-3772_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3772	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	100	[hp_C]/1			N	20241231
37662-3773_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3773	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	200	[hp_C]/1			N	20241231
37662-3774_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3774	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	500	[hp_C]/1			N	20241231
37662-3775_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3775	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	1	[hp_M]/1			N	20241231
37662-3776_0339ca5d-3c1f-2ea4-e063-6294a90a2d51	37662-3776	HUMAN OTC DRUG	Mercurius Aceticus		Mercurius Aceticus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCUROUS ACETATE	1	[hp_Q]/1			N	20241231
37662-3777_033bef09-be65-853f-e063-6394a90a06d6	37662-3777	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	6	[hp_C]/1			N	20241231
37662-3778_033bef09-be65-853f-e063-6394a90a06d6	37662-3778	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	12	[hp_C]/1			N	20241231
37662-3779_033bef09-be65-853f-e063-6394a90a06d6	37662-3779	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	30	[hp_C]/1			N	20241231
37662-3780_033bef09-be65-853f-e063-6394a90a06d6	37662-3780	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	100	[hp_C]/1			N	20241231
37662-3781_033bef09-be65-853f-e063-6394a90a06d6	37662-3781	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	200	[hp_C]/1			N	20241231
37662-3782_033bef09-be65-853f-e063-6394a90a06d6	37662-3782	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	500	[hp_C]/1			N	20241231
37662-3783_033bef09-be65-853f-e063-6394a90a06d6	37662-3783	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	1	[hp_M]/1			N	20241231
37662-3784_033bef09-be65-853f-e063-6394a90a06d6	37662-3784	HUMAN OTC DRUG	Mercurius Arsenicicus		Mercurius Arsenicicus	PELLET	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC ARSENATE	1	[hp_Q]/1			N	20241231
37662-3785_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3785	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3786_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3786	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3787_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3787	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3788_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3788	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3789_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3789	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3790_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3790	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3791_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3791	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3792_0372b7a4-be50-aff7-e063-6394a90ad8b3	37662-3792	HUMAN OTC DRUG	Niobium Oxydatum		Niobium Oxydatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM NIOBIUM(V) OXIDE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3793_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3793	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	6	[hp_C]/1			N	20241231
37662-3794_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3794	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	12	[hp_C]/1			N	20241231
37662-3795_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3795	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	30	[hp_C]/1			N	20241231
37662-3796_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3796	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	100	[hp_C]/1			N	20241231
37662-3797_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3797	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	200	[hp_C]/1			N	20241231
37662-3798_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3798	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	500	[hp_C]/1			N	20241231
37662-3799_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3799	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	1	[hp_M]/1			N	20241231
37662-3800_0374b198-f3a3-7ef1-e063-6394a90a8dbb	37662-3800	HUMAN OTC DRUG	Niccolum Iodatum		Niccolum Iodatum	PELLET	ORAL	20230821		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL IODIDE	1	[hp_Q]/1			N	20241231
37662-3801_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3801	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	6	[hp_C]/1			N	20241231
37662-3802_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3802	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	12	[hp_C]/1			N	20241231
37662-3803_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3803	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	30	[hp_C]/1			N	20241231
37662-3804_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3804	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	100	[hp_C]/1			N	20241231
37662-3805_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3805	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	200	[hp_C]/1			N	20241231
37662-3806_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3806	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	500	[hp_C]/1			N	20241231
37662-3807_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3807	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	1	[hp_M]/1			N	20241231
37662-3808_03882c67-4eb4-57c8-e063-6294a90aa972	37662-3808	HUMAN OTC DRUG	Origanum Majorana		Origanum Majorana	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ORIGANUM MAJORANA	1	[hp_Q]/1			N	20241231
37662-3809_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3809	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	6	[hp_C]/1			N	20241231
37662-3810_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3810	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	12	[hp_C]/1			N	20241231
37662-3811_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3811	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	30	[hp_C]/1			N	20241231
37662-3812_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3812	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	100	[hp_C]/1			N	20241231
37662-3813_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3813	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	200	[hp_C]/1			N	20241231
37662-3814_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3814	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	500	[hp_C]/1			N	20241231
37662-3815_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3815	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	1	[hp_M]/1			N	20241231
37662-3816_02f997d7-346d-f409-e063-6294a90ab2b8	37662-3816	HUMAN OTC DRUG	Sarracenia Purpurea		Sarracenia Purpurea	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SARRACENIA PURPUREA	1	[hp_Q]/1			N	20241231
37662-3817_038c2235-b114-963d-e063-6394a90a2b10	37662-3817	HUMAN OTC DRUG	Acidum Sulphuricum		Acidum Sulphuricum	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFURIC ACID	6	[hp_C]/1			N	20241231
37662-3818_038c2235-b114-963d-e063-6394a90a2b10	37662-3818	HUMAN OTC DRUG	Acidum Sulphuricum		Acidum Sulphuricum	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFURIC ACID	12	[hp_C]/1			N	20241231
37662-3819_038c2235-b114-963d-e063-6394a90a2b10	37662-3819	HUMAN OTC DRUG	Acidum Sulphuricum		Acidum Sulphuricum	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFURIC ACID	30	[hp_C]/1			N	20241231
37662-3820_038c2235-b114-963d-e063-6394a90a2b10	37662-3820	HUMAN OTC DRUG	Acidum Sulphuricum		Acidum Sulphuricum	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFURIC ACID	100	[hp_C]/1			N	20241231
37662-3821_038c2235-b114-963d-e063-6394a90a2b10	37662-3821	HUMAN OTC DRUG	Acidum Sulphuricum		Acidum Sulphuricum	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFURIC ACID	200	[hp_C]/1			N	20241231
37662-3822_038c2235-b114-963d-e063-6394a90a2b10	37662-3822	HUMAN OTC DRUG	Acidum Sulphuricum		Acidum Sulphuricum	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFURIC ACID	500	[hp_C]/1			N	20241231
37662-3823_038c2235-b114-963d-e063-6394a90a2b10	37662-3823	HUMAN OTC DRUG	Acidum Sulphuricum		Acidum Sulphuricum	PELLET	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SULFURIC ACID	1	[hp_M]/1			N	20241231
37662-3824_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3824	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	6	[hp_C]/1			N	20241231
37662-3825_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3825	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	12	[hp_C]/1			N	20241231
37662-3826_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3826	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	30	[hp_C]/1			N	20241231
37662-3827_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3827	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	100	[hp_C]/1			N	20241231
37662-3828_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3828	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	200	[hp_C]/1			N	20241231
37662-3829_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3829	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	500	[hp_C]/1			N	20241231
37662-3830_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3830	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	1	[hp_M]/1			N	20241231
37662-3831_03af4578-26c5-d92b-e063-6394a90a5ba8	37662-3831	HUMAN OTC DRUG	Vanadium Bromatum		Vanadium Bromatum	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(III) BROMIDE	1	[hp_Q]/1			N	20241231
37662-3832_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3832	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	6	[hp_C]/1			N	20241231
37662-3833_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3833	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	12	[hp_C]/1			N	20241231
37662-3834_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3834	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	30	[hp_C]/1			N	20241231
37662-3835_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3835	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	100	[hp_C]/1			N	20241231
37662-3836_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3836	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	200	[hp_C]/1			N	20241231
37662-3837_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3837	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	500	[hp_C]/1			N	20241231
37662-3838_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3838	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	1	[hp_M]/1			N	20241231
37662-3839_03b06183-12ec-70c5-e063-6294a90a55ac	37662-3839	HUMAN OTC DRUG	Lilium Stargazer		Lilium Stargazer	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LILIUM LONGIFLORUM BULB	1	[hp_Q]/1			N	20241231
37662-3840_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3840	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	6	[hp_C]/1			N	20241231
37662-3841_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3841	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	12	[hp_C]/1			N	20241231
37662-3842_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3842	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	30	[hp_C]/1			N	20241231
37662-3843_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3843	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	100	[hp_C]/1			N	20241231
37662-3844_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3844	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	200	[hp_C]/1			N	20241231
37662-3845_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3845	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	500	[hp_C]/1			N	20241231
37662-3846_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3846	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	1	[hp_M]/1			N	20241231
37662-3847_03b378d2-bbd7-7891-e063-6394a90a2722	37662-3847	HUMAN OTC DRUG	Mercurius Praecipitatus Ruber		Mercurius Praecipitatus Ruber	PELLET	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MERCURIC OXIDE	1	[hp_Q]/1			N	20241231
37662-3848_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3848	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3849_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3849	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3850_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3850	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3851_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3851	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3852_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3852	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3853_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3853	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3854_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3854	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3855_0416ce03-c344-9d9e-e063-6294a90ad940	37662-3855	HUMAN OTC DRUG	Natrum Oxydatum		Natrum Oxydatum	PELLET	ORAL	20230829		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM OXIDE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3856_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3856	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3857_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3857	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3858_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3858	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3859_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3859	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3860_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3860	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3861_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3861	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3862_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3862	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3863_042c3f88-0177-abb1-e063-6394a90a7e97	37662-3863	HUMAN OTC DRUG	Natrum Iodatum		Natrum Iodatum	PELLET	ORAL	20230830		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM IODATE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3864_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3864	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	6	[hp_C]/1			N	20241231
37662-3865_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3865	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	12	[hp_C]/1			N	20241231
37662-3866_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3866	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	30	[hp_C]/1			N	20241231
37662-3867_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3867	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	100	[hp_C]/1			N	20241231
37662-3868_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3868	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	200	[hp_C]/1			N	20241231
37662-3869_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3869	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	500	[hp_C]/1			N	20241231
37662-3870_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3870	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	1	[hp_M]/1			N	20241231
37662-3871_04ba7ec2-1ea0-b828-e063-6394a90abb12	37662-3871	HUMAN OTC DRUG	Gallium Oxydatum		Gallium Oxydatum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM OXIDE	1	[hp_Q]/1			N	20241231
37662-3872_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3872	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	6	[hp_C]/1			N	20241231
37662-3873_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3873	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	12	[hp_C]/1			N	20241231
37662-3874_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3874	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	30	[hp_C]/1			N	20241231
37662-3875_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3875	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	100	[hp_C]/1			N	20241231
37662-3876_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3876	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	200	[hp_C]/1			N	20241231
37662-3877_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3877	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	500	[hp_C]/1			N	20241231
37662-3878_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3878	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	1	[hp_M]/1			N	20241231
37662-3879_04bd07cf-3b87-c251-e063-6294a90ab4da	37662-3879	HUMAN OTC DRUG	Manganum Nitricum		Manganum Nitricum	PELLET	ORAL	20230906		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MANGANESE NITRATE TETRAHYDRATE	1	[hp_Q]/1			N	20241231
37662-3880_04cdea6c-8349-d855-e063-6294a90a6660	37662-3880	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3881_04cdea6c-8349-d855-e063-6294a90a6660	37662-3881	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3882_04cdea6c-8349-d855-e063-6294a90a6660	37662-3882	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3883_04cdea6c-8349-d855-e063-6294a90a6660	37662-3883	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3884_04cdea6c-8349-d855-e063-6294a90a6660	37662-3884	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3885_04cdea6c-8349-d855-e063-6294a90a6660	37662-3885	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3886_04cdea6c-8349-d855-e063-6294a90a6660	37662-3886	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3887_04cdea6c-8349-d855-e063-6294a90a6660	37662-3887	HUMAN OTC DRUG	Natrum Aceticum		Natrum Aceticum	PELLET	ORAL	20230907		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM ACETATE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
37662-3888_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3888	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	6	[hp_C]/1			N	20241231
37662-3889_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3889	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	12	[hp_C]/1			N	20241231
37662-3890_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3890	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	30	[hp_C]/1			N	20241231
37662-3891_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3891	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	100	[hp_C]/1			N	20241231
37662-3892_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3892	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	200	[hp_C]/1			N	20241231
37662-3893_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3893	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	500	[hp_C]/1			N	20241231
37662-3894_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3894	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	1	[hp_M]/1			N	20241231
37662-3895_04d0b06f-5dc7-0198-e063-6294a90a47aa	37662-3895	HUMAN OTC DRUG	Molybdenum Phosphoratum		Molybdenum Phosphoratum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PHOSPHOMOLYBDIC ACID	1	[hp_Q]/1			N	20241231
37662-3896_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3896	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	6	[hp_C]/1			N	20241231
37662-3897_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3897	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	12	[hp_C]/1			N	20241231
37662-3898_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3898	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	30	[hp_C]/1			N	20241231
37662-3899_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3899	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	100	[hp_C]/1			N	20241231
37662-3900_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3900	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	200	[hp_C]/1			N	20241231
37662-3901_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3901	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	500	[hp_C]/1			N	20241231
37662-3902_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3902	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	1	[hp_M]/1			N	20241231
37662-3903_04e2e4a0-96c7-f778-e063-6294a90ad37d	37662-3903	HUMAN OTC DRUG	Molybdenum Muriaticum		Molybdenum Muriaticum	PELLET	ORAL	20230908		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	MOLYBDENUM TRICHLORIDE	1	[hp_Q]/1			N	20241231
37662-3904_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3904	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-3905_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3905	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-3906_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3906	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-3907_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3907	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-3908_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3908	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-3909_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3909	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-3910_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3910	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-3911_054a68ec-d310-7fbc-e063-6294a90ac912	37662-3911	HUMAN OTC DRUG	Gallium Muriaticum		Gallium Muriaticum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM CHLORIDE	1	[hp_Q]/1			N	20241231
37662-3912_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3912	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	6	[hp_C]/1			N	20241231
37662-3913_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3913	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	12	[hp_C]/1			N	20241231
37662-3914_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3914	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	30	[hp_C]/1			N	20241231
37662-3915_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3915	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	100	[hp_C]/1			N	20241231
37662-3916_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3916	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	200	[hp_C]/1			N	20241231
37662-3917_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3917	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	500	[hp_C]/1			N	20241231
37662-3918_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3918	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	1	[hp_M]/1			N	20241231
37662-3919_054d034c-0c6b-1aea-e063-6394a90a90e9	37662-3919	HUMAN OTC DRUG	Gallium Phosphoricum		Gallium Phosphoricum	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GALLIUM PHOSPHIDE	1	[hp_Q]/1			N	20241231
37662-3920_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3920	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	6	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3921_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3921	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	12	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3922_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3922	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3923_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3923	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	100	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3924_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3924	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3925_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3925	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	500	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3926_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3926	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	1	[hp_M]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3927_055aa7ce-89e6-cd78-e063-6394a90a7da6	37662-3927	HUMAN OTC DRUG	Kali Fluoratum		Kali Fluoratum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	POTASSIUM FLUORIDE	1	[hp_Q]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
37662-3928_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3928	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	6	[hp_C]/1			N	20241231
37662-3929_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3929	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	12	[hp_C]/1			N	20241231
37662-3930_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3930	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	30	[hp_C]/1			N	20241231
37662-3931_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3931	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	100	[hp_C]/1			N	20241231
37662-3932_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3932	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	200	[hp_C]/1			N	20241231
37662-3933_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3933	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	500	[hp_C]/1			N	20241231
37662-3934_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3934	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	1	[hp_M]/1			N	20241231
37662-3935_055e1c60-97c3-dfed-e063-6294a90a56fe	37662-3935	HUMAN OTC DRUG	Niccolum Carbonicum		Niccolum Carbonicum	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CARBONATE HYDROXIDE TETRAHYDRATE	1	[hp_Q]/1			N	20241231
37662-3936_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3936	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	6	[hp_C]/1			N	20241231
37662-3937_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3937	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	12	[hp_C]/1			N	20241231
37662-3938_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3938	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	30	[hp_C]/1			N	20241231
37662-3939_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3939	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	100	[hp_C]/1			N	20241231
37662-3940_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3940	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	200	[hp_C]/1			N	20241231
37662-3941_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3941	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	500	[hp_C]/1			N	20241231
37662-3942_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3942	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	1	[hp_M]/1			N	20241231
37662-3943_05aa8458-56d0-4b52-e063-6294a90ac6d3	37662-3943	HUMAN OTC DRUG	Niccolum Fluoratum		Niccolum Fluoratum	PELLET	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL FLUORIDE	1	[hp_Q]/1			N	20241231
37662-3944_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3944	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	6	[hp_C]/1			N	20241231
37662-3945_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3945	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	12	[hp_C]/1			N	20241231
37662-3946_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3946	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	30	[hp_C]/1			N	20241231
37662-3947_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3947	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	100	[hp_C]/1			N	20241231
37662-3948_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3948	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	200	[hp_C]/1			N	20241231
37662-3949_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3949	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	500	[hp_C]/1			N	20241231
37662-3950_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3950	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	1	[hp_M]/1			N	20241231
37662-3951_05c10aa8-d013-f88f-e063-6294a90ab311	37662-3951	HUMAN OTC DRUG	Niccolum Arsenatum		Niccolum Arsenatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL ARSENIDE	1	[hp_Q]/1			N	20241231
37662-3952_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3952	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	6	[hp_C]/1			N	20241231
37662-3953_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3953	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	12	[hp_C]/1			N	20241231
37662-3954_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3954	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	30	[hp_C]/1			N	20241231
37662-3955_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3955	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	100	[hp_C]/1			N	20241231
37662-3956_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3956	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	200	[hp_C]/1			N	20241231
37662-3957_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3957	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	500	[hp_C]/1			N	20241231
37662-3958_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3958	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	1	[hp_M]/1			N	20241231
37662-3959_05c1d5d6-ead4-1270-e063-6394a90a660b	37662-3959	HUMAN OTC DRUG	Niccolum Bromatum		Niccolum Bromatum	PELLET	ORAL	20230919		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL BROMIDE	1	[hp_Q]/1			N	20241231
37662-3960_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3960	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	6	[hp_C]/1			N	20241231
37662-3961_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3961	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	12	[hp_C]/1			N	20241231
37662-3962_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3962	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	30	[hp_C]/1			N	20241231
37662-3963_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3963	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	100	[hp_C]/1			N	20241231
37662-3964_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3964	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	200	[hp_C]/1			N	20241231
37662-3965_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3965	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	500	[hp_C]/1			N	20241231
37662-3966_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3966	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	1	[hp_M]/1			N	20241231
37662-3967_05d2ce2c-258b-8c1a-e063-6394a90afa04	37662-3967	HUMAN OTC DRUG	Niccolum Nitricum		Niccolum Nitricum	PELLET	ORAL	20230920		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL NITRATE	1	[hp_Q]/1			N	20241231
37662-3968_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3968	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	6	[hp_C]/1			N	20241231
37662-3969_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3969	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	12	[hp_C]/1			N	20241231
37662-3970_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3970	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	30	[hp_C]/1			N	20241231
37662-3971_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3971	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	100	[hp_C]/1			N	20241231
37662-3972_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3972	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	200	[hp_C]/1			N	20241231
37662-3973_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3973	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	500	[hp_C]/1			N	20241231
37662-3974_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3974	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	1	[hp_M]/1			N	20241231
37662-3975_05e7605d-dc3f-628f-e063-6294a90ad273	37662-3975	HUMAN OTC DRUG	Niccolum Phosphoricum		Niccolum Phosphoricum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL PHOSPHATE	1	[hp_Q]/1			N	20241231
37662-3976_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3976	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	6	[hp_C]/1			N	20241231
37662-3977_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3977	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	12	[hp_C]/1			N	20241231
37662-3978_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3978	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	30	[hp_C]/1			N	20241231
37662-3979_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3979	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	100	[hp_C]/1			N	20241231
37662-3980_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3980	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	200	[hp_C]/1			N	20241231
37662-3981_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3981	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	500	[hp_C]/1			N	20241231
37662-3982_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3982	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	1	[hp_M]/1			N	20241231
37662-3983_05e7d37f-c37d-e84a-e063-6394a90a5503	37662-3983	HUMAN OTC DRUG	Niccolum Muriaticum		Niccolum Muriaticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL CHLORIDE	1	[hp_Q]/1			N	20241231
37662-3984_05e8564f-05da-2880-e063-6294a90a620e	37662-3984	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	6	[hp_C]/1			N	20241231
37662-3985_05e8564f-05da-2880-e063-6294a90a620e	37662-3985	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	12	[hp_C]/1			N	20241231
37662-3986_05e8564f-05da-2880-e063-6294a90a620e	37662-3986	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	30	[hp_C]/1			N	20241231
37662-3987_05e8564f-05da-2880-e063-6294a90a620e	37662-3987	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	100	[hp_C]/1			N	20241231
37662-3988_05e8564f-05da-2880-e063-6294a90a620e	37662-3988	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	200	[hp_C]/1			N	20241231
37662-3989_05e8564f-05da-2880-e063-6294a90a620e	37662-3989	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	500	[hp_C]/1			N	20241231
37662-3990_05e8564f-05da-2880-e063-6294a90a620e	37662-3990	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	1	[hp_M]/1			N	20241231
37662-3991_05e8564f-05da-2880-e063-6294a90a620e	37662-3991	HUMAN OTC DRUG	Niccolum Causticum		Niccolum Causticum	PELLET	ORAL	20230921		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NICKEL AMMONIUM SULFATE	1	[hp_Q]/1			N	20241231
37662-3992_05fb5bbf-f1c2-203d-e063-6294a90ab79e	37662-3992	HUMAN OTC DRUG	Petroleum Etherum		Petroleum Etherum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NAPHTHA	6	[hp_C]/1			N	20241231
37662-3993_05fb5bbf-f1c2-203d-e063-6294a90ab79e	37662-3993	HUMAN OTC DRUG	Petroleum Etherum		Petroleum Etherum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NAPHTHA	12	[hp_C]/1			N	20241231
37662-3994_05fb5bbf-f1c2-203d-e063-6294a90ab79e	37662-3994	HUMAN OTC DRUG	Petroleum Etherum		Petroleum Etherum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NAPHTHA	30	[hp_C]/1			N	20241231
37662-3995_05fb5bbf-f1c2-203d-e063-6294a90ab79e	37662-3995	HUMAN OTC DRUG	Petroleum Etherum		Petroleum Etherum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NAPHTHA	100	[hp_C]/1			N	20241231
37662-3996_05fb5bbf-f1c2-203d-e063-6294a90ab79e	37662-3996	HUMAN OTC DRUG	Petroleum Etherum		Petroleum Etherum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NAPHTHA	200	[hp_C]/1			N	20241231
37662-3997_05fb5bbf-f1c2-203d-e063-6294a90ab79e	37662-3997	HUMAN OTC DRUG	Petroleum Etherum		Petroleum Etherum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NAPHTHA	500	[hp_C]/1			N	20241231
37662-3998_05fb5bbf-f1c2-203d-e063-6294a90ab79e	37662-3998	HUMAN OTC DRUG	Petroleum Etherum		Petroleum Etherum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NAPHTHA	1	[hp_M]/1			N	20241231
37662-3999_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-3999	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	6	[hp_C]/1			N	20241231
37662-4000_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4000	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	12	[hp_C]/1			N	20241231
37662-4001_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4001	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	30	[hp_C]/1			N	20241231
37662-4002_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4002	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	100	[hp_C]/1			N	20241231
37662-4003_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4003	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	200	[hp_C]/1			N	20241231
37662-4004_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4004	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	500	[hp_C]/1			N	20241231
37662-4005_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4005	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	1	[hp_M]/1			N	20241231
37662-4006_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4006	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	10	[hp_M]/1			N	20241231
37662-4007_05fc5431-1b3d-a47a-e063-6394a90a8baf	37662-4007	HUMAN OTC DRUG	Rhododendron Chrysanthum		Rhododendron Chrysanthum	PELLET	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RHODODENDRON AUREUM LEAF	1	[hp_Q]/1			N	20241231
37662-4008_063730b1-dc38-3ec6-e063-6294a90aecc3	37662-4008	HUMAN OTC DRUG	Pleurotus Ostreatus		Pleurotus Ostreatus	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLEUROTUS OSTREATUS WHOLE	6	[hp_C]/1			N	20241231
37662-4009_063730b1-dc38-3ec6-e063-6294a90aecc3	37662-4009	HUMAN OTC DRUG	Pleurotus Ostreatus		Pleurotus Ostreatus	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLEUROTUS OSTREATUS WHOLE	12	[hp_C]/1			N	20241231
37662-4010_063730b1-dc38-3ec6-e063-6294a90aecc3	37662-4010	HUMAN OTC DRUG	Pleurotus Ostreatus		Pleurotus Ostreatus	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLEUROTUS OSTREATUS WHOLE	30	[hp_C]/1			N	20241231
37662-4011_063730b1-dc38-3ec6-e063-6294a90aecc3	37662-4011	HUMAN OTC DRUG	Pleurotus Ostreatus		Pleurotus Ostreatus	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLEUROTUS OSTREATUS WHOLE	100	[hp_C]/1			N	20241231
37662-4012_063730b1-dc38-3ec6-e063-6294a90aecc3	37662-4012	HUMAN OTC DRUG	Pleurotus Ostreatus		Pleurotus Ostreatus	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLEUROTUS OSTREATUS WHOLE	200	[hp_C]/1			N	20241231
37662-4013_063730b1-dc38-3ec6-e063-6294a90aecc3	37662-4013	HUMAN OTC DRUG	Pleurotus Ostreatus		Pleurotus Ostreatus	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLEUROTUS OSTREATUS WHOLE	500	[hp_C]/1			N	20241231
37662-4014_063730b1-dc38-3ec6-e063-6294a90aecc3	37662-4014	HUMAN OTC DRUG	Pleurotus Ostreatus		Pleurotus Ostreatus	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PLEUROTUS OSTREATUS WHOLE	1	[hp_M]/1			N	20241231
37662-4015_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4015	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	6	[hp_C]/1			N	20241231
37662-4016_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4016	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	12	[hp_C]/1			N	20241231
37662-4017_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4017	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	30	[hp_C]/1			N	20241231
37662-4018_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4018	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	100	[hp_C]/1			N	20241231
37662-4019_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4019	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	200	[hp_C]/1			N	20241231
37662-4020_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4020	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	500	[hp_C]/1			N	20241231
37662-4021_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4021	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	1	[hp_M]/1			N	20241231
37662-4022_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4022	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	10	[hp_M]/1			N	20241231
37662-4023_063800f4-7ae8-0e3f-e063-6294a90a537a	37662-4023	HUMAN OTC DRUG	Pulsatilla Nigricans		Pulsatilla Nigricans	PELLET	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	PULSATILLA PRATENSIS WHOLE	1	[hp_Q]/1			N	20241231
37662-4024_0663cace-3517-e497-e063-6394a90a9c68	37662-4024	HUMAN OTC DRUG	Rubidium Muriaticum		Rubidium Muriaticum	PELLET	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-4025_0663cace-3517-e497-e063-6394a90a9c68	37662-4025	HUMAN OTC DRUG	Rubidium Muriaticum		Rubidium Muriaticum	PELLET	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-4026_0663cace-3517-e497-e063-6394a90a9c68	37662-4026	HUMAN OTC DRUG	Rubidium Muriaticum		Rubidium Muriaticum	PELLET	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-4027_0663cace-3517-e497-e063-6394a90a9c68	37662-4027	HUMAN OTC DRUG	Rubidium Muriaticum		Rubidium Muriaticum	PELLET	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-4028_0663cace-3517-e497-e063-6394a90a9c68	37662-4028	HUMAN OTC DRUG	Rubidium Muriaticum		Rubidium Muriaticum	PELLET	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-4029_0663cace-3517-e497-e063-6394a90a9c68	37662-4029	HUMAN OTC DRUG	Rubidium Muriaticum		Rubidium Muriaticum	PELLET	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-4030_0663cace-3517-e497-e063-6394a90a9c68	37662-4030	HUMAN OTC DRUG	Rubidium Muriaticum		Rubidium Muriaticum	PELLET	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RUBIDIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-4031_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4031	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	6	[hp_C]/1			N	20241231
37662-4032_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4032	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	12	[hp_C]/1			N	20241231
37662-4033_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4033	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	30	[hp_C]/1			N	20241231
37662-4034_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4034	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	100	[hp_C]/1			N	20241231
37662-4035_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4035	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	200	[hp_C]/1			N	20241231
37662-4036_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4036	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	500	[hp_C]/1			N	20241231
37662-4037_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4037	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	1	[hp_M]/1			N	20241231
37662-4038_067316c0-40ef-8f92-e063-6394a90ad2e9	37662-4038	HUMAN OTC DRUG	Selenium Bromatum		Selenium Bromatum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENIUM TETRABROMIDE	1	[hp_Q]/1			N	20241231
37662-4039_06738254-9a74-f476-e063-6394a90a22e4	37662-4039	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	6	[hp_C]/1			N	20241231
37662-4040_06738254-9a74-f476-e063-6394a90a22e4	37662-4040	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	12	[hp_C]/1			N	20241231
37662-4041_06738254-9a74-f476-e063-6394a90a22e4	37662-4041	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	30	[hp_C]/1			N	20241231
37662-4042_06738254-9a74-f476-e063-6394a90a22e4	37662-4042	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	100	[hp_C]/1			N	20241231
37662-4043_06738254-9a74-f476-e063-6394a90a22e4	37662-4043	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	200	[hp_C]/1			N	20241231
37662-4044_06738254-9a74-f476-e063-6394a90a22e4	37662-4044	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	500	[hp_C]/1			N	20241231
37662-4045_06738254-9a74-f476-e063-6394a90a22e4	37662-4045	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	1	[hp_M]/1			N	20241231
37662-4046_06738254-9a74-f476-e063-6394a90a22e4	37662-4046	HUMAN OTC DRUG	Silicium Metallicum		Silicium Metallicum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON	1	[hp_Q]/1			N	20241231
37662-4047_06753763-01d9-d043-e063-6294a90a511f	37662-4047	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	6	[hp_C]/1			N	20241231
37662-4048_06753763-01d9-d043-e063-6294a90a511f	37662-4048	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	12	[hp_C]/1			N	20241231
37662-4049_06753763-01d9-d043-e063-6294a90a511f	37662-4049	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	30	[hp_C]/1			N	20241231
37662-4050_06753763-01d9-d043-e063-6294a90a511f	37662-4050	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	100	[hp_C]/1			N	20241231
37662-4051_06753763-01d9-d043-e063-6294a90a511f	37662-4051	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	200	[hp_C]/1			N	20241231
37662-4052_06753763-01d9-d043-e063-6294a90a511f	37662-4052	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	500	[hp_C]/1			N	20241231
37662-4053_06753763-01d9-d043-e063-6294a90a511f	37662-4053	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	1	[hp_M]/1			N	20241231
37662-4054_06753763-01d9-d043-e063-6294a90a511f	37662-4054	HUMAN OTC DRUG	Stannum Phosphoricum		Stannum Phosphoricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STANNIC HYDROGEN PHOSPHATE	1	[hp_Q]/1			N	20241231
37662-4055_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4055	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	6	[hp_C]/1			N	20241231
37662-4056_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4056	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	12	[hp_C]/1			N	20241231
37662-4057_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4057	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	30	[hp_C]/1			N	20241231
37662-4058_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4058	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	100	[hp_C]/1			N	20241231
37662-4059_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4059	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	200	[hp_C]/1			N	20241231
37662-4060_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4060	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	500	[hp_C]/1			N	20241231
37662-4061_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4061	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	1	[hp_M]/1			N	20241231
37662-4062_0675be77-6cc0-5126-e063-6394a90ad6ed	37662-4062	HUMAN OTC DRUG	Strontium Sulphuricum		Strontium Sulphuricum	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM SULFATE	1	[hp_Q]/1			N	20241231
37662-4063_06c71de2-661c-36e3-e063-6394a90ad264	37662-4063	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	6	[hp_C]/1			N	20241231
37662-4064_06c71de2-661c-36e3-e063-6394a90ad264	37662-4064	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	12	[hp_C]/1			N	20241231
37662-4065_06c71de2-661c-36e3-e063-6394a90ad264	37662-4065	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	30	[hp_C]/1			N	20241231
37662-4066_06c71de2-661c-36e3-e063-6394a90ad264	37662-4066	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	100	[hp_C]/1			N	20241231
37662-4067_06c71de2-661c-36e3-e063-6394a90ad264	37662-4067	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	200	[hp_C]/1			N	20241231
37662-4068_06c71de2-661c-36e3-e063-6394a90ad264	37662-4068	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	500	[hp_C]/1			N	20241231
37662-4069_06c71de2-661c-36e3-e063-6394a90ad264	37662-4069	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	1	[hp_M]/1			N	20241231
37662-4070_06c71de2-661c-36e3-e063-6394a90ad264	37662-4070	HUMAN OTC DRUG	Strontium Nitricum		Strontium Nitricum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	STRONTIUM NITRATE	1	[hp_Q]/1			N	20241231
37662-4071_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4071	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-4072_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4072	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-4073_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4073	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-4074_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4074	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-4075_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4075	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-4076_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4076	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-4077_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4077	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-4078_06c7f530-5252-8ec9-e063-6394a90a8396	37662-4078	HUMAN OTC DRUG	Zirconium Muriaticum		Zirconium Muriaticum	PELLET	ORAL	20231002		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZIRCONIUM CHLORIDE	1	[hp_Q]/1			N	20241231
37662-4079_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4079	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	6	[hp_C]/1			N	20241231
37662-4080_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4080	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	12	[hp_C]/1			N	20241231
37662-4081_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4081	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	30	[hp_C]/1			N	20241231
37662-4082_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4082	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	100	[hp_C]/1			N	20241231
37662-4083_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4083	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	200	[hp_C]/1			N	20241231
37662-4084_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4084	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	500	[hp_C]/1			N	20241231
37662-4085_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4085	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	1	[hp_M]/1			N	20241231
37662-4086_06ebaed3-b023-e651-e063-6394a90afc8a	37662-4086	HUMAN OTC DRUG	Yttrium Muriaticum		Yttrium Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	YTTRIUM CHLORIDE	1	[hp_Q]/1			N	20241231
37662-4087_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4087	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	6	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4088_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4088	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	12	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4089_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4089	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	30	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4090_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4090	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	100	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4091_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4091	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	200	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4092_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4092	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	500	[hp_C]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4093_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4093	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	1	[hp_M]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4094_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4094	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	10	[hp_M]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4095_06ecda16-b4b3-1b9e-e063-6294a90a4891	37662-4095	HUMAN OTC DRUG	Zincum Muriaticum		Zincum Muriaticum	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ZINC CHLORIDE	1	[hp_Q]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37662-4096_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4096	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	6	[hp_C]/1			N	20241231
37662-4097_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4097	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	12	[hp_C]/1			N	20241231
37662-4098_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4098	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	30	[hp_C]/1			N	20241231
37662-4099_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4099	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	100	[hp_C]/1			N	20241231
37662-4100_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4100	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	200	[hp_C]/1			N	20241231
37662-4101_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4101	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	500	[hp_C]/1			N	20241231
37662-4102_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4102	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	1	[hp_M]/1			N	20241231
37662-4103_0715b97d-d02c-1d5a-e063-6394a90aaf58	37662-4103	HUMAN OTC DRUG	Selenium Muriaticum		Selenium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DISELENIUM DICHLORIDE	1	[hp_Q]/1			N	20241231
37662-4104_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4104	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	6	[hp_C]/1			N	20241231
37662-4105_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4105	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	12	[hp_C]/1			N	20241231
37662-4106_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4106	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	30	[hp_C]/1			N	20241231
37662-4107_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4107	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	100	[hp_C]/1			N	20241231
37662-4108_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4108	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	200	[hp_C]/1			N	20241231
37662-4109_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4109	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	500	[hp_C]/1			N	20241231
37662-4110_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4110	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	1	[hp_M]/1			N	20241231
37662-4111_0715c85f-b4ee-cdb9-e063-6394a90a0507	37662-4111	HUMAN OTC DRUG	Titanium Muriaticum		Titanium Muriaticum	PELLET	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TITANIUM DICHLORIDE	1	[hp_Q]/1			N	20241231
37662-4112_07508699-02b9-ca6d-e063-6294a90adf05	37662-4112	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	6	[hp_C]/1			N	20241231
37662-4113_07508699-02b9-ca6d-e063-6294a90adf05	37662-4113	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	12	[hp_C]/1			N	20241231
37662-4114_07508699-02b9-ca6d-e063-6294a90adf05	37662-4114	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	30	[hp_C]/1			N	20241231
37662-4115_07508699-02b9-ca6d-e063-6294a90adf05	37662-4115	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	100	[hp_C]/1			N	20241231
37662-4116_07508699-02b9-ca6d-e063-6294a90adf05	37662-4116	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	200	[hp_C]/1			N	20241231
37662-4117_07508699-02b9-ca6d-e063-6294a90adf05	37662-4117	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	500	[hp_C]/1			N	20241231
37662-4118_07508699-02b9-ca6d-e063-6294a90adf05	37662-4118	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	1	[hp_M]/1			N	20241231
37662-4119_07508699-02b9-ca6d-e063-6294a90adf05	37662-4119	HUMAN OTC DRUG	Vanadium Muriaticum		Vanadium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	VANADIUM(II) CHLORIDE	1	[hp_Q]/1			N	20241231
37662-4120_07526641-587c-e5aa-e063-6294a90a7408	37662-4120	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	6	[hp_C]/1			N	20241231
37662-4121_07526641-587c-e5aa-e063-6294a90a7408	37662-4121	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	12	[hp_C]/1			N	20241231
37662-4122_07526641-587c-e5aa-e063-6294a90a7408	37662-4122	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	30	[hp_C]/1			N	20241231
37662-4123_07526641-587c-e5aa-e063-6294a90a7408	37662-4123	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	100	[hp_C]/1			N	20241231
37662-4124_07526641-587c-e5aa-e063-6294a90a7408	37662-4124	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	200	[hp_C]/1			N	20241231
37662-4125_07526641-587c-e5aa-e063-6294a90a7408	37662-4125	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	500	[hp_C]/1			N	20241231
37662-4126_07526641-587c-e5aa-e063-6294a90a7408	37662-4126	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	1	[hp_M]/1			N	20241231
37662-4127_07526641-587c-e5aa-e063-6294a90a7408	37662-4127	HUMAN OTC DRUG	Germanium Muriaticum		Germanium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	GERMANIUM TETRACHLORIDE	1	[hp_Q]/1			N	20241231
37662-4128_07532a14-7007-5d56-e063-6294a90af180	37662-4128	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	6	[hp_C]/1			N	20241231
37662-4129_07532a14-7007-5d56-e063-6294a90af180	37662-4129	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	12	[hp_C]/1			N	20241231
37662-4130_07532a14-7007-5d56-e063-6294a90af180	37662-4130	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	30	[hp_C]/1			N	20241231
37662-4131_07532a14-7007-5d56-e063-6294a90af180	37662-4131	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	100	[hp_C]/1			N	20241231
37662-4132_07532a14-7007-5d56-e063-6294a90af180	37662-4132	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	200	[hp_C]/1			N	20241231
37662-4133_07532a14-7007-5d56-e063-6294a90af180	37662-4133	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	500	[hp_C]/1			N	20241231
37662-4134_07532a14-7007-5d56-e063-6294a90af180	37662-4134	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	1	[hp_M]/1			N	20241231
37662-4135_07532a14-7007-5d56-e063-6294a90af180	37662-4135	HUMAN OTC DRUG	Niobium Muriaticum		Niobium Muriaticum	PELLET	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTACHLORIDE	1	[hp_Q]/1			N	20241231
37662-4136_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4136	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	6	[hp_C]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4137_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4137	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	12	[hp_C]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4138_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4138	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	30	[hp_C]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4139_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4139	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	100	[hp_C]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4140_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4140	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	200	[hp_C]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4141_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4141	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	500	[hp_C]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4142_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4142	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	1	[hp_M]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4143_078e2ef1-2e1e-f8c3-e063-6394a90a145e	37662-4143	HUMAN OTC DRUG	Ribavirinum		Ribavirinum	PELLET	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	RIBAVIRIN	1	[hp_Q]/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
37662-4144_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4144	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	6	[hp_C]/1			N	20241231
37662-4145_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4145	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	12	[hp_C]/1			N	20241231
37662-4146_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4146	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	30	[hp_C]/1			N	20241231
37662-4147_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4147	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	100	[hp_C]/1			N	20241231
37662-4148_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4148	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	200	[hp_C]/1			N	20241231
37662-4149_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4149	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	500	[hp_C]/1			N	20241231
37662-4150_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4150	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	1	[hp_M]/1			N	20241231
37662-4151_07d3a45c-90fe-3f23-e063-6294a90a793a	37662-4151	HUMAN OTC DRUG	Solanum Nigrum		Solanum Nigrum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SOLANUM NIGRUM WHOLE	1	[hp_Q]/1			N	20241231
37662-4152_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4152	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	6	[hp_C]/1			N	20241231
37662-4153_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4153	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	12	[hp_C]/1			N	20241231
37662-4154_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4154	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	30	[hp_C]/1			N	20241231
37662-4155_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4155	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	100	[hp_C]/1			N	20241231
37662-4156_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4156	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	200	[hp_C]/1			N	20241231
37662-4157_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4157	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	500	[hp_C]/1			N	20241231
37662-4158_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4158	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	1	[hp_M]/1			N	20241231
37662-4159_07e0937e-784e-0cf1-e063-6294a90a8a2a	37662-4159	HUMAN OTC DRUG	Silicium Oxydatum		Silicium Oxydatum	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SILICON MONOXIDE	1	[hp_Q]/1			N	20241231
37662-4160_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4160	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	6	[hp_C]/1			N	20241231
37662-4161_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4161	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	12	[hp_C]/1			N	20241231
37662-4162_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4162	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	30	[hp_C]/1			N	20241231
37662-4163_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4163	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	100	[hp_C]/1			N	20241231
37662-4164_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4164	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	200	[hp_C]/1			N	20241231
37662-4165_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4165	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	500	[hp_C]/1			N	20241231
37662-4166_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4166	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	1	[hp_M]/1			N	20241231
37662-4167_07e166ad-2970-cf66-e063-6394a90a08d9	37662-4167	HUMAN OTC DRUG	Sinapis Nigra		Sinapis Nigra	PELLET	ORAL	20231016		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLACK MUSTARD SEED	1	[hp_Q]/1			N	20241231
37662-4168_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4168	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	6	[hp_C]/1			N	20241231
37662-4169_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4169	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	12	[hp_C]/1			N	20241231
37662-4170_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4170	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	30	[hp_C]/1			N	20241231
37662-4171_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4171	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	100	[hp_C]/1			N	20241231
37662-4172_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4172	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	200	[hp_C]/1			N	20241231
37662-4173_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4173	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	500	[hp_C]/1			N	20241231
37662-4174_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4174	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	1	[hp_M]/1			N	20241231
37662-4175_081737c8-f0f7-f3a2-e063-6294a90a7a30	37662-4175	HUMAN OTC DRUG	Niobium Iodatum		Niobium Iodatum	PELLET	ORAL	20231019		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	NIOBIUM PENTAIODIDE	1	[hp_Q]/1			N	20241231
37662-4176_08677f2c-1456-86e9-e063-6394a90ac784	37662-4176	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	6	[hp_C]/1			N	20241231
37662-4177_08677f2c-1456-86e9-e063-6394a90ac784	37662-4177	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	12	[hp_C]/1			N	20241231
37662-4178_08677f2c-1456-86e9-e063-6394a90ac784	37662-4178	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	30	[hp_C]/1			N	20241231
37662-4179_08677f2c-1456-86e9-e063-6394a90ac784	37662-4179	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	100	[hp_C]/1			N	20241231
37662-4180_08677f2c-1456-86e9-e063-6394a90ac784	37662-4180	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	200	[hp_C]/1			N	20241231
37662-4181_08677f2c-1456-86e9-e063-6394a90ac784	37662-4181	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	500	[hp_C]/1			N	20241231
37662-4182_08677f2c-1456-86e9-e063-6394a90ac784	37662-4182	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	1	[hp_M]/1			N	20241231
37662-4183_08677f2c-1456-86e9-e063-6394a90ac784	37662-4183	HUMAN OTC DRUG	Trillium Pendulum		Trillium Pendulum	PELLET	ORAL	20231023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	TRILLIUM ERECTUM ROOT	1	[hp_Q]/1			N	20241231
37808-000_f58d328c-8b31-b4d4-e053-2a95a90adb59	37808-000	HUMAN OTC DRUG	HEB SPF 50 Kids Blue Mineral Sunscreen Stick Berry Scented		Zinc Oxide	STICK	TOPICAL	20210215		OTC MONOGRAPH FINAL	M020	H.E.B.	ZINC OXIDE	200	mg/g			N	20241231
37808-004_2b4e2ec2-874c-4a5f-8110-7af59d2af05e	37808-004	HUMAN OTC DRUG	nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20141202		OTC MONOGRAPH FINAL	part341	H E B	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
37808-005_f72c31b5-3a3d-43a5-a4ef-e406da5946fd	37808-005	HUMAN OTC DRUG	antibiotic		Neomycin, Polymyxin B, Pramoxine HCl	CREAM	TOPICAL	20150914		OTC MONOGRAPH FINAL	part333B	H E B	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
37808-006_a1cb61c0-e85e-b387-8850-f698bf5a33e6	37808-006	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160101		ANDA	ANDA078878	HEB	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-007_66766915-1aef-4c72-8f47-f6074d2ab1ac	37808-007	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190515		ANDA	ANDA077442	HEB	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-009_370abb73-d5df-44ed-9487-3860fe220d6f	37808-009	HUMAN OTC DRUG	Healing		petrolatum	OINTMENT	TOPICAL	20110415		OTC MONOGRAPH FINAL	part347	H E B	PETROLATUM	340	mg/g			N	20241231
37808-012_369c4c2a-756b-4684-894e-74a41822643a	37808-012	HUMAN OTC DRUG	Allergy	Childrens	Diphenhydramine Hydrochloride	LIQUID	ORAL	20160229		OTC MONOGRAPH FINAL	part341	H E B	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-013_e3972ebb-3fa2-446c-b72b-c218753cd5eb	37808-013	HUMAN OTC DRUG	Athletes Foot Ultra		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	H E B	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
37808-014_aaa20f93-6044-4e3e-8757-9e73a9701932	37808-014	HUMAN OTC DRUG	Infants Non-staining Gas relief		Simethicone	SOLUTION/ DROPS	ORAL	20211115		OTC MONOGRAPH DRUG	part332	H E B	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
37808-015_d990add0-aeba-45bf-83f3-bbb94fc5639b	37808-015	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20100729		OTC MONOGRAPH FINAL	part347	H E B	PETROLATUM	1	g/g			N	20241231
37808-016_8f4b61c7-718c-4468-8ac3-d762c3bb77c0	37808-016	HUMAN OTC DRUG	Flu Relief Therapy	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20160131	20251231	OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
37808-017_14f10cb0-df18-42e1-ae2c-61f672145258	37808-017	HUMAN OTC DRUG	Severe Cold and Cough Relief	Nighttime	Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20151031	20251031	OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
37808-019_d07197cb-9b10-82f5-e053-2995a90a1e3b	37808-019	HUMAN OTC DRUG	Nighttime Sleep Aid		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20191031		OTC MONOGRAPH FINAL	part338	HEB	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-020_61dadcba-591a-40e4-9c6f-0183f5c34db4	37808-020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	PASTE	TOPICAL	20100910		OTC MONOGRAPH FINAL	part347	H E B	ZINC OXIDE	400	mg/g			N	20241231
37808-021_7ab5bfe0-8dda-4c8c-9e8d-fc4391ea9957	37808-021	HUMAN OTC DRUG	nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20150203		OTC MONOGRAPH FINAL	part341	H E B	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
37808-022_8c74b0a5-6bbc-0f8d-bbda-46d6cb39aea6	37808-022	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20151221		ANDA	ANDA076667	HEB	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-023_b019f0be-e2f1-4c87-bc2b-cecc458cc88a	37808-023	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION	ORAL	20160301		ANDA	ANDA074937	H E B	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-024_ab24b4d9-091b-476c-bdfe-8affb19f64ef	37808-024	HUMAN OTC DRUG	Oral Sore Antiseptic		Hydrogen Peroxide, Menthol	LIQUID	ORAL	20200315		OTC MONOGRAPH NOT FINAL	part356	H E B	HYDROGEN PEROXIDE; MENTHOL	15; 1	mg/mL; mg/mL			N	20241231
37808-030_f58f0199-bf23-2197-e053-2995a90ae64f	37808-030	HUMAN OTC DRUG	HEB SPF 50 Mineral Sunscreen Stick		Zinc Oxide	STICK	TOPICAL	20200305		OTC MONOGRAPH FINAL	M020	H.E.B.	ZINC OXIDE	216	mg/g			N	20241231
37808-031_ce173be2-1f7f-4890-95d9-dcedfd210c80	37808-031	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19910915		OTC MONOGRAPH NOT FINAL	part343	H E B	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-032_08a09b5c-9551-8429-e063-6294a90a2e53	37808-032	HUMAN OTC DRUG	Menthol Cough Drop		Menthol	LOZENGE	ORAL	20130515		OTC MONOGRAPH DRUG	M012	HEB	MENTHOL	5.4	mg/1			N	20241231
37808-033_08a0b6f7-712e-18ab-e063-6394a90a436d	37808-033	HUMAN OTC DRUG	Cherry cough drop		Menthol	LOZENGE	ORAL	20130515		OTC MONOGRAPH DRUG	M012	HEB	MENTHOL	5.8	mg/1			N	20241231
37808-039_f58ecff4-f341-0f61-e053-2a95a90a12ed	37808-039	HUMAN OTC DRUG	HEB SPF 50 Kids Purple Mineral Sunscreen Stick Grape Scented		Zinc Oxide	STICK	TOPICAL	20210215		OTC MONOGRAPH FINAL	M020	H.E.B.	ZINC OXIDE	200	mg/g			N	20241231
37808-040_0ccb3da3-cd22-5dd2-e063-6294a90ab069	37808-040	HUMAN OTC DRUG	HEB Calaclear		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	H E B	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37808-041_f5930029-4c97-2576-e053-2995a90a7bed	37808-041	HUMAN OTC DRUG	HEB Shimmer Sunscreen SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200508		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-042_a9d9f6d3-9d98-4f42-bc1b-fa420fe93026	37808-042	HUMAN OTC DRUG	Acid Controller		Famotidine	TABLET, FILM COATED	ORAL	20160914		ANDA	ANDA077351	H E B	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
37808-043_f59363b2-49d4-6121-e053-2995a90a645b	37808-043	HUMAN OTC DRUG	HEB SPF 50 Pomegranate Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20200310		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-044_f59461e3-9522-6a7b-e053-2a95a90a73b8	37808-044	HUMAN OTC DRUG	HEB SPF 50 For Men Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20210322		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-045_0c730c1f-cbbe-0877-cd98-7371a55ad67d	37808-045	HUMAN OTC DRUG	Once Daily Relief		Olopatadine Hydrochloride Ophthalmic Solution	SOLUTION	OPHTHALMIC	20220307		ANDA	ANDA209752	H E B	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
37808-048_f5a2c266-6fca-21ae-e053-2995a90aec0e	37808-048	HUMAN OTC DRUG	HEB SPF 50 Pink Peony Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20210322		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-049_f0fcbeef-9c57-79cb-e053-2a95a90aa504	37808-049	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190101		NDA	NDA021920	HEB	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-051_06d15ae5-a920-ac3e-e063-6394a90a616e	37808-051	HUMAN OTC DRUG	SF Menthol Cough Drop		Menthol	LOZENGE	ORAL	20120629		OTC MONOGRAPH FINAL	part341	HEB	MENTHOL	5.8	mg/1			N	20241231
37808-053_06d17009-50c4-99f7-e063-6294a90a9ef0	37808-053	HUMAN OTC DRUG	SF Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20120629		OTC MONOGRAPH FINAL	part341	HEB	MENTHOL	7.6	mg/1			N	20241231
37808-053_08a0d254-b3e0-6abb-e063-6394a90ab84a	37808-053	HUMAN OTC DRUG	SF Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20120702	20240201	OTC MONOGRAPH DRUG	M012	HEB	MENTHOL	7.6	mg/1			N	
37808-055_c4934d07-44aa-49c2-bdda-6f62f1e4b9d1	37808-055	HUMAN OTC DRUG	Isopropyl		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20150313		OTC MONOGRAPH NOT FINAL	part333A	H-E-B	ISOPROPYL ALCOHOL	462	mg/mL			N	20241231
37808-056_8f8ed252-b20c-4b0c-9b96-7ddfa540cbbf	37808-056	HUMAN OTC DRUG	night time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20140414		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-057_b2cfae91-2360-445e-9933-78793d3b8854	37808-057	HUMAN OTC DRUG	ibuprofen	infants	ibuprofen	SUSPENSION	ORAL	20020618		ANDA	ANDA075217	H E B	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-058_06d17009-50c5-99f7-e063-6294a90a9ef0	37808-058	HUMAN OTC DRUG	Cherry Antacid Soft Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20120419		OTC MONOGRAPH FINAL	part331	HEB	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-060_08a154e3-eb64-9c5d-e063-6394a90a8df3	37808-060	HUMAN OTC DRUG	Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20130515		OTC MONOGRAPH DRUG	M012	HEB	MENTHOL	7.5	mg/1			N	20241231
37808-062_06d1650d-74da-d159-e063-6394a90a2a12	37808-062	HUMAN OTC DRUG	Mixed Berry Sore Throat and Cough Lozenges		Benzocaine	LOZENGE	ORAL	20160413		OTC MONOGRAPH NOT FINAL	part356	HEB	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-063_08a13b11-6f09-a07e-e063-6294a90a4070	37808-063	HUMAN OTC DRUG	Assorted Fruit Panned Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20150623		OTC MONOGRAPH DRUG	M001	HEB	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-063_08a143c6-b19c-3822-e063-6294a90a55f8	37808-063	HUMAN OTC DRUG	Assorted Fruit panned chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20160710		OTC MONOGRAPH DRUG	M001	HEB	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-064_0993b1ce-d4ae-6ac6-e063-6394a90a51fd	37808-064	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20200801		OTC MONOGRAPH DRUG	M007	H E B	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-068_cc1eb980-a014-48df-83cd-9cfa050b4414	37808-068	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET	ORAL	20150930		ANDA	ANDA079096	H E B	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-070_2931f640-37e7-4918-8ace-66fbebc37a53	37808-070	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20161021		OTC MONOGRAPH FINAL	part358H	HEB	PYRITHIONE ZINC	10	mg/mL			N	20241231
37808-072_dffaef83-bb3f-4cae-b535-285c34d5db7b	37808-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19950425		OTC MONOGRAPH NOT FINAL	part356	H-E-B	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-073_f5a27035-5a31-f928-e053-2995a90a72b9	37808-073	HUMAN OTC DRUG	HEB SPF 50 White Gardenia Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20210322		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-074_f5a33175-8ec6-1ce7-e053-2a95a90aec22	37808-074	HUMAN OTC DRUG	HEB SPF 50 Birthday Cake Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210322		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-076_f5b48733-a4a7-39e9-e053-2a95a90ab53a	37808-076	HUMAN OTC DRUG	HEB SPF 50 Pomegranate Continuous		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20200207		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-078_f5b689a2-7be5-08bc-e053-2995a90a68ce	37808-078	HUMAN OTC DRUG	HEB SPF 50 For Men Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210217		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-080_864a75dd-8000-40be-9070-cc919b6b9fda	37808-080	HUMAN OTC DRUG	Athletes Foot		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	H E B	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
37808-083_f5b6d53a-da4a-2fe0-e053-2995a90a384c	37808-083	HUMAN OTC DRUG	HEB SPF 50 White Gardenia Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210217		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-084_328e3405-965a-44cd-a4c6-b19f1c34ed1a	37808-084	HUMAN OTC DRUG	Stool Softener plus Stimulant Laxative		docusate sodium and sennosides	TABLET	ORAL	20160430	20251231	OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
37808-086_f5b71735-1e82-a36c-e053-2a95a90adb7a	37808-086	HUMAN OTC DRUG	HEB SPF 50 Pink Peony Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210217		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-087_a0bb2dd0-1a91-452e-83dd-61c717c39530	37808-087	HUMAN OTC DRUG	arthritis pain reliever		diclofenac sodium	GEL	TOPICAL	20200806		ANDA	ANDA211253	H E B	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-088_f5b74f1a-7343-0940-e053-2a95a90ae4c1	37808-088	HUMAN OTC DRUG	HEB SPF 50 Birthday Cake Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220321		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-089_f5b77b72-bf06-069c-e053-2995a90ad322	37808-089	HUMAN OTC DRUG	HEB SPF 50 Watermelon Serbert Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220321		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-093_e18e8bec-a950-3820-e053-2995a90a100f	37808-093	HUMAN OTC DRUG	Daytime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20220620		OTC MONOGRAPH FINAL	part341	H-E-B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-095_e18f01b4-3476-172d-e053-2995a90a9286	37808-095	HUMAN OTC DRUG	Nightime		Acetaminophen Dextromethorphan HBr Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20220620		OTC MONOGRAPH FINAL	part341	H-E-B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-098_0ccb529f-cac3-918f-e063-6294a90a5b0a	37808-098	HUMAN OTC DRUG	HEB Water Drying Aid		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20080101		OTC MONOGRAPH DRUG	M014	H E B	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
37808-099_0993e7da-7a54-748c-e063-6394a90a9a0f	37808-099	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID MINT		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M001	H E B	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-100_0cfaa286-19a1-c576-e063-6394a90a4af8	37808-100	HUMAN OTC DRUG	HEB Lubricant Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20190111		OTC MONOGRAPH DRUG	M018	HEB	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
37808-101_2c927822-ed49-4ff2-a13f-be94b06222ec	37808-101	HUMAN OTC DRUG	HEB Regular strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190305		OTC MONOGRAPH FINAL	part331	HEB	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-102_f3134d73-e830-4ceb-8bd4-57217d841ae4	37808-102	HUMAN OTC DRUG	HEB	Allergy Relief	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	H E B	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-103_7fd70e69-271c-4afd-8cfb-200cdeec2c43	37808-103	HUMAN OTC DRUG	HEB Antacid Calcium	Assorted Berry	calcium carbonate	TABLET, CHEWABLE	ORAL	20190304		OTC MONOGRAPH FINAL	part331	HEB	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-103_8e3b7c48-bd7b-414a-8e3b-5654e1406a2f	37808-103	HUMAN OTC DRUG	HEB Antacid Calcium	Assorted Berry	calcium carbonate	TABLET, CHEWABLE	ORAL	20190220		OTC MONOGRAPH FINAL	part331	HEB	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-105_0ccb54ad-71d7-795c-e063-6294a90a568d	37808-105	HUMAN OTC DRUG	HEB Camphor Phenol		Camphor 10.8% and Phenol 4.7%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	H E B	CAMPHOR (NATURAL); PHENOL	108; 47	mg/mL; mg/mL			N	20241231
37808-106_3e05caf8-84cf-478f-9401-762f51c9e796	37808-106	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	H E B	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-108_f5cba8e5-b09a-0bfe-e053-2995a90aa4a2	37808-108	HUMAN OTC DRUG	HEB SPF 50 Peach Bellini Scented Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20230125		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-109_941c137e-4bcd-388a-e053-2995a90aca79	37808-109	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20101201		ANDA	ANDA079174	HEB	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-111_c1c81cb9-1d96-44ad-97d1-001e26f06f6e	37808-111	HUMAN OTC DRUG	HEB Regular Strength	Peppermint Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190306		OTC MONOGRAPH FINAL	part331	HEB	CALCIUM CARBONATE	500	mg/1			N	20241231
37808-112_802279af-7334-4d92-a17d-3af025aa5cc6	37808-112	HUMAN OTC DRUG	Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	H E B	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-113_06d17009-50c3-99f7-e063-6294a90a9ef0	37808-113	HUMAN OTC DRUG	Strawberry Cough Drops		Menthol	LOZENGE	ORAL	20180921		OTC MONOGRAPH FINAL	part341	HEB	MENTHOL	2.7	mg/1			N	20241231
37808-114_f5cb5fa5-0097-e208-e053-2995a90aa4d2	37808-114	HUMAN OTC DRUG	HEB SPF 50 Strawberry Daquiri Scented Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20230125		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-115_395b1e8c-4b5a-e197-73e3-08fd2634837d	37808-115	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190324		ANDA	ANDA207673	HEB	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-116_f2151bf2-f796-5213-e053-2a95a90aaf2a	37808-116	HUMAN OTC DRUG	4x Medicated Toothache and Gum Cream		Benzocaine	CREAM	ORAL	20200602		OTC MONOGRAPH NOT FINAL	part356	HEB	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .25; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37808-118_f5d93cd2-208f-6231-e053-2995a90a44fe	37808-118	HUMAN OTC DRUG	HEB SPF 50 Cucumber Water Scented Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20230125		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-119_d4ccd305-c91c-4084-a19e-1f7955277c16	37808-119	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20210420		OTC MONOGRAPH FINAL	part355	H E Butt	SODIUM FLUORIDE	.02	mg/mL			N	20241231
37808-120_f924d0ab-cfa6-7dbe-e053-6394a90abc40	37808-120	HUMAN OTC DRUG	HEB		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200301		ANDA	ANDA211544	HEB	ACETAMINOPHEN	650	mg/1			N	20241231
37808-121_83f06741-c7c5-426a-9c4f-df1e051c128b	37808-121	HUMAN OTC DRUG	Dual Action Complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20160407		ANDA	ANDA077355	H E B	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-125_f5db82da-fc1a-a90b-e053-2a95a90aab6c	37808-125	HUMAN OTC DRUG	HEB SPF 50 Rosewater Scented Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20230125		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-126_3f0b2aba-9ee0-df9f-7479-a40a8f4b759b	37808-126	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20190615		ANDA	ANDA210375	HEB	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-127_0a387641-3b8a-38e0-e063-6294a90a81b3	37808-127	HUMAN OTC DRUG	HEB Solutions Sunscreen Face 50 Facial Mist Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20200302		OTC MONOGRAPH DRUG	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 25	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-129_f6ce4eac-27e3-c9b1-e053-6394a90ac061	37808-129	HUMAN OTC DRUG	HEB Oil Free Facial Moisturizer with Sunscreen Broad Spectrum SPF 15		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210226		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; OCTISALATE; OCTOCRYLENE	15; 50; 60	mg/mL; mg/mL; mg/mL			N	20241231
37808-130_b13a6dfe-ea1e-4c89-b205-71f4fcc9c84a	37808-130	HUMAN OTC DRUG	pain relief		Acetaminophen	SUSPENSION	ORAL	19960429		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	160	mg/5mL			N	20241231
37808-131_6f26c722-a050-48ef-8d2a-13812326f3a3	37808-131	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	H E B	LORATADINE	5	mg/5mL			N	20241231
37808-132_077d96b7-d452-4d07-b4ba-3b7cace9f591	37808-132	HUMAN OTC DRUG	HEB Extra Strength Smooth Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20181023		OTC MONOGRAPH FINAL	part331	H E B	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37808-135_643680c7-e529-46c2-bddc-bece693c6d41	37808-135	HUMAN OTC DRUG	HEB Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20181024		OTC MONOGRAPH FINAL	part331	H E B	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37808-136_dcfe4c81-b6e0-4a9b-a521-f3ad0c0a8e48	37808-136	HUMAN OTC DRUG	HEB Extra Stregth Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180926		OTC MONOGRAPH FINAL	part331	H E B	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37808-137_fef0f9d2-64a6-4291-8642-c901d9477738	37808-137	HUMAN OTC DRUG	HEB Extra Strength Smooth Antacid Assorted Fruits		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180926		OTC MONOGRAPH FINAL	part331	H E B	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37808-138_6a990c29-47cc-4794-8054-1dd61074bca6	37808-138	HUMAN OTC DRUG	Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20181008		OTC MONOGRAPH FINAL	part331	H E B	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-139_f6df3d87-e90b-7f40-e053-6294a90ae165	37808-139	HUMAN OTC DRUG	HEB SPF 50 Tattoo Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210113		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-142_f6dfefdf-7a44-e104-e053-6394a90a05bd	37808-142	HUMAN OTC DRUG	HEB SPF 50 Refine 50 Sunscreen with Niacinamide and Collagen Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220127		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-143_f6e0d6de-a7d7-3523-e053-6294a90a64ca	37808-143	HUMAN OTC DRUG	HEB SPF 50 Hydrate 50 Sunscreen with Hyaluronic Acid and Collagen Continuous Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220127		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-145_f6e1b3b0-e26b-7aaf-e053-6394a90aa25d	37808-145	HUMAN OTC DRUG	HEB Tinted 30 Mineral Sunscreen For Face		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210128		OTC MONOGRAPH FINAL	M020	H.E.B.	TITANIUM DIOXIDE; ZINC OXIDE	33.3; 35	mg/mL; mg/mL			N	20241231
37808-147_220a7510-013e-4a42-989f-d2b98f28d08f	37808-147	HUMAN OTC DRUG	HEB Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20180928		OTC MONOGRAPH FINAL	part335	H E B	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
37808-148_ea9323a2-e409-4e2b-92cb-6618e9f26110	37808-148	HUMAN OTC DRUG	HEB Stomach Relief Cherry		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20180928		OTC MONOGRAPH FINAL	part335	H E B	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
37808-149_c6177867-5006-4caf-8121-5ae5ca6bcc77	37808-149	HUMAN OTC DRUG	HEB Maximum strength Laxative pills		Sennosides	TABLET	ORAL	20180402		OTC MONOGRAPH NOT FINAL	part334	H E B	SENNOSIDES	25	mg/1			N	20241231
37808-150_f6e29c5b-71b2-2a67-e053-6394a90a6d29	37808-150	HUMAN OTC DRUG	HEB Face Primer 30 Sunscreen Face Primer SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220124		OTC MONOGRAPH FINAL	M020	H-E-B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 110; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-151_f6e3c883-0088-dcd6-e053-6394a90a1272	37808-151	HUMAN OTC DRUG	HEB Face 50 Clear Zinc Sunscreen		Octocrylene, Zinc Oxide	LOTION	TOPICAL	20200107		OTC MONOGRAPH FINAL	M020	H.E.B.	OCTOCRYLENE; ZINC OXIDE	40; 50	mg/g; mg/g			N	20241231
37808-152_277ec990-ec1a-4fe6-846c-012d9e27577e	37808-152	HUMAN OTC DRUG	HEB Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20180928		OTC MONOGRAPH FINAL	part335	H E B	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
37808-153_e1627476-5310-468c-bfd5-fa174342870c	37808-153	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20160926		OTC MONOGRAPH FINAL	part358H	HEB	PYRITHIONE ZINC	1	mg/mL			N	20241231
37808-155_b33a9c4c-4494-49c7-a012-15ba55606d80	37808-155	HUMAN OTC DRUG	HEB Gas Relief Extra Strength Peppermint		Simethicone	TABLET, CHEWABLE	ORAL	20180928		OTC MONOGRAPH FINAL	part332	H E B	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
37808-157_00c8fa16-db4c-46dc-ab0f-255a47330ed4	37808-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	H E B	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-158_7d88c73b-b8ae-44e3-b1dd-a6e5cd4b4009	37808-158	HUMAN OTC DRUG	Congestion Relief		Ibuprofen, phenylephrine HCl	TABLET, FILM COATED	ORAL	20160418		ANDA	ANDA203200	H E B	IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	200; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-161_a856d1db-eaea-4afe-8366-c5f170d19814	37808-161	HUMAN OTC DRUG	Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20111215		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	160	mg/5mL			N	20241231
37808-163_42dd2d9d-b35f-4364-9392-a78daff8a04c	37808-163	HUMAN OTC DRUG	Anticavity Fluoride Rinse		SODIUM FLUORIDE	MOUTHWASH	ORAL	20100929		OTC MONOGRAPH DRUG	M021	HEB	SODIUM FLUORIDE	1	mg/mL			N	20241231
37808-176_59443634-77c7-4cec-a287-c44187e1063e	37808-176	HUMAN OTC DRUG	all day Allergy Relief D		Cetirizine HCl, Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20080502		ANDA	ANDA077170	H E B	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-178_e9475408-2f77-53ab-e053-2995a90a402a	37808-178	HUMAN OTC DRUG	DAYTIME SEVERE COLD AND FLU	MAXIMUM STRENGTH	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160501		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-186_e7cc378a-59ad-4a98-ac16-67574712bc2b	37808-186	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20131030		OTC MONOGRAPH FINAL	part338	H E B	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-191_e18f1e6a-4802-d214-e053-2a95a90a8fc2	37808-191	HUMAN OTC DRUG	Daytime Nighttime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl and Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	KIT	ORAL	20220620		OTC MONOGRAPH FINAL	part341	H-E-B						N	20241231
37808-195_b9fd1e4e-5231-4bb8-acf6-ff5ea1226002	37808-195	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	H E B	ACETAMINOPHEN	500	mg/1			N	20241231
37808-199_a4b8e7c8-3d3e-4560-bf58-3acfe1266790	37808-199	HUMAN OTC DRUG	miconazole 1		Miconazole nitrate	KIT		20100607		ANDA	ANDA079114	H E B						N	20241231
37808-200_f0ab6ead-f34b-4fcb-8734-d17ca2137718	37808-200	HUMAN OTC DRUG	childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020619		ANDA	ANDA074937	H E B	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-202_d2915eda-7964-475a-9a86-088b194eadb8	37808-202	HUMAN OTC DRUG	Minoxidil		minoxidil	SOLUTION	TOPICAL	20110404		ANDA	ANDA075357	H E B	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
37808-203_d41dae7a-b5b3-4265-ba81-9580338c4d4a	37808-203	HUMAN OTC DRUG	HEB Ultra Strength	Assorted Fruits	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190305		OTC MONOGRAPH FINAL	part331	HEB	CALCIUM CARBONATE	1000	mg/1			N	20241231
37808-205_cf8364f9-b450-4996-9df9-3ee468fbd869	37808-205	HUMAN OTC DRUG	Nasopro 24		Fluticasone propionate	SPRAY, METERED	NASAL	20160530		ANDA	ANDA207957	H E B	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37808-209_b52df554-ae16-4bc9-a31c-a1e204593af0	37808-209	HUMAN OTC DRUG	Nasal Decongestant PE		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20160926		OTC MONOGRAPH FINAL	part341	H E B	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-212_cd9e4c0b-20f4-4081-9d34-60d395536cd7	37808-212	HUMAN OTC DRUG	HEB Extra Strength Antacid	Assorted Fruit Flavors	Antacid Tablets	TABLET, CHEWABLE	ORAL	20190304		OTC MONOGRAPH FINAL	part331	H-E-B	CALCIUM CARBONATE	750	mg/1			N	20241231
37808-213_ab088eb2-b600-449e-a1c2-86d7ea3e600d	37808-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20160621		OTC MONOGRAPH FINAL	part355	HEB	SODIUM FLUORIDE	.2	mg/mL			N	20241231
37808-219_c136e718-35fd-426f-b76e-e59baf76347b	37808-219	HUMAN OTC DRUG	Blackhead Clearing Scrub		Salicylic acid	GEL	TOPICAL	20090623		OTC MONOGRAPH FINAL	part333D	H E B	SALICYLIC ACID	19.4	mg/g			N	20241231
37808-221_c3db1a60-e4cb-45b9-97d6-5d543ae50859	37808-221	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180331	20251231	ANDA	ANDA202300	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
37808-222_0983c637-0c15-47be-9168-dcd2087b3d49	37808-222	HUMAN OTC DRUG	HEB Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20220302		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM	100	mg/1			N	20241231
37808-223_8b595acd-7818-4061-970f-e1b64f3e8284	37808-223	HUMAN OTC DRUG	Cold Sore Fever Blister		Docosanol	CREAM	TOPICAL	20210801		ANDA	ANDA208754	H E B	DOCOSANOL	100	mg/g			N	20241231
37808-229_362f386b-fa5f-4e04-a891-1b11ef714c81	37808-229	HUMAN OTC DRUG	Cold Sore Treatment		Docosanol	CREAM	TOPICAL	20200630		ANDA	ANDA208754	H E B	DOCOSANOL	100	mg/g			N	20241231
37808-230_f202f70a-2930-8a32-e053-2a95a90a5b68	37808-230	HUMAN OTC DRUG	H E B	Restore and Defend	Fluoride	PASTE, DENTIFRICE	DENTAL	20140701		OTC MONOGRAPH NOT FINAL	part356	HEB	STANNOUS FLUORIDE	.15	g/100g			N	20241231
37808-232_0ccb3962-d49d-0a6c-e063-6294a90a0d41	37808-232	HUMAN OTC DRUG	HEB Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	H E B	POVIDONE-IODINE	100	mg/mL			N	20241231
37808-242_129eabfc-74b1-4340-a3f8-ff77e13710e4	37808-242	HUMAN OTC DRUG	miconazole 3		Miconazole nitrate	KIT		20060314		ANDA	ANDA075329	H E B						N	20241231
37808-246_941ca260-7430-83ad-e053-2a95a90a93b2	37808-246	HUMAN OTC DRUG	Aspirin 81 mg	Low Dose	ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20100401		OTC MONOGRAPH NOT FINAL	part343	HEB	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-248_c11c9810-5a81-4f02-84a4-0431cc522eb3	37808-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20090123		OTC MONOGRAPH FINAL	part341	H E B	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
37808-249_fc2f4b0a-2e7a-4a94-9112-64947a61c4aa	37808-249	HUMAN OTC DRUG	Nighttime Cold and Flu Relief	Multi Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20200630	20241231	OTC MONOGRAPH DRUG	M012	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
37808-255_edea0019-eee0-4c6e-aafb-f8854d012b74	37808-255	HUMAN OTC DRUG	infants ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20050225		ANDA	ANDA075217	H E B	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-263_5bbc2aae-e549-4abd-a2ff-01d155b96480	37808-263	HUMAN OTC DRUG	Triple Antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20141014		OTC MONOGRAPH FINAL	part333B	H E B	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
37808-264_77ff501a-ceb9-44ac-86ba-ce45fa0cf9f0	37808-264	HUMAN OTC DRUG	naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20201013		ANDA	ANDA208499	H E B	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-273_f951904d-90ae-2720-e053-6394a90aca3a	37808-273	HUMAN OTC DRUG	Head Congestion plus Mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230414		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-278_841b18f5-c2c7-46d9-8791-8735f3741432	37808-278	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20160803		OTC MONOGRAPH NOT FINAL	part333A	HEB	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
37808-279_404198da-457d-4327-bd89-e1154aceac7a	37808-279	HUMAN OTC DRUG	hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140930		OTC MONOGRAPH FINAL	part346	H E B	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-281_a2afc2ed-de09-424f-843e-2e45ef7d2c3a	37808-281	HUMAN OTC DRUG	Dry Scalp Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20161026		OTC MONOGRAPH FINAL	part358H	HEB	PYRITHIONE ZINC	10	mg/mL			N	20241231
37808-285_8df4f403-45e4-4597-8184-3825816eba51	37808-285	HUMAN OTC DRUG	Pain Relief	Childrens Dye Free	Acetaminophen	SUSPENSION	ORAL	20170430		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	160	mg/5mL			N	20241231
37808-286_efcec44b-2dda-76c7-e053-2a95a90ac323	37808-286	HUMAN OTC DRUG	Cold Flu Severe Day Night		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20180301		OTC MONOGRAPH FINAL	part341	HEB						N	20241231
37808-287_c718cc27-9b0d-8117-e053-2995a90a0ed8	37808-287	HUMAN OTC DRUG	HAND SANITIZER	HILL COUNTRY FARE	ALCOHOL	AEROSOL, SPRAY	TOPICAL	20200414		OTC MONOGRAPH NOT FINAL	part333A	H.E.B	ALCOHOL	70	mg/100g			N	20241231
37808-288_c5be0d8e-93bc-46cf-9b9a-a0c9ac7f676b	37808-288	HUMAN OTC DRUG	Childrens mucus relief		Guaifenesin	SOLUTION	ORAL	20090105		OTC MONOGRAPH FINAL	part341	H E B	GUAIFENESIN	100	mg/5mL			N	20241231
37808-293_c939536c-3f16-4257-b760-c45bc3df0123	37808-293	HUMAN OTC DRUG	H E B Stool Softener	laxative	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20211014		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM	250	mg/1			N	20241231
37808-295_c5279c1c-998c-d01a-e053-2a95a90ad895	37808-295	HUMAN OTC DRUG	H.E.B. Mineral Sunscreen Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20200122		OTC MONOGRAPH NOT FINAL	part352	H.E.B.	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
37808-296_15db0a9a-c7bf-463b-9353-928c7d91ab68	37808-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20090515		OTC MONOGRAPH FINAL	part358H	HEB	PYRITHIONE ZINC	14	mg/mL			N	20241231
37808-298_c5edd4fa-7149-660d-e053-2a95a90a7576	37808-298	HUMAN OTC DRUG	WALGREEN SPORT SPF 70 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20130619		OTC MONOGRAPH NOT FINAL	part352	H.E.B.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-299_81557e3b-f56a-4f04-8913-73536991e191	37808-299	HUMAN OTC DRUG	Alcohol Free		Cetylpyridinium cloride	MOUTHWASH	ORAL	20090416		OTC MONOGRAPH NOT FINAL	part356	H-E-B	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
37808-301_b6d7707b-916f-4d1d-9d99-6193cf700edc	37808-301	HUMAN OTC DRUG	acid controller		Famotidine	TABLET, FILM COATED	ORAL	20151023		ANDA	ANDA075400	H E B	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
37808-305_a5b96d51-97c1-44a9-80d1-e20347329e8f	37808-305	HUMAN OTC DRUG	HEB	Antifungal	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	H E B	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
37808-306_093f90e9-170e-4e3c-8fa7-6bdcc51de1e2	37808-306	HUMAN OTC DRUG	clear lax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091008		ANDA	ANDA090685	H E B	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-307_c89b386a-1d3f-1404-e053-2995a90af08d	37808-307	HUMAN OTC DRUG	HILL COUNTRY FARE HAND SANITIZER WITH ALOE FRAGRANCE		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part333A	H.E.B	ALCOHOL	70	mg/100g			N	20241231
37808-312_f202ed09-ce2d-6f27-e053-2a95a90ad894	37808-312	HUMAN OTC DRUG	HEB Mouth Sore Relief		Benzalkonium chloride, benzocaine, zinc chloride	GEL	TOPICAL	20190219		OTC MONOGRAPH NOT FINAL	part356	HEB	BENZALKONIUM CHLORIDE; BENZOCAINE; ZINC CHLORIDE	.02; 20; .1	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37808-313_f2030113-fc98-6bee-e053-2995a90a10f6	37808-313	HUMAN OTC DRUG	HEB Severe Toothache and Gum Relief	Triple Medicated	Benzalkonium chloride, Benzocaine, Menthol	CREAM	TOPICAL	20190220		OTC MONOGRAPH NOT FINAL	part356	HEB	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL	.1; 20; .25	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37808-315_f2030113-fca7-6bee-e053-2995a90a10f6	37808-315	HUMAN OTC DRUG	HEB	Restore and Defend Sensitive	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190221		OTC MONOGRAPH NOT FINAL	part356	HEB	STANNOUS FLUORIDE	.454	g/100g			N	20241231
37808-316_0d19111b-d15e-4e5d-a9e1-5403e7509902	37808-316	HUMAN OTC DRUG	MAX Cold, Flu, and Sore Throat		ACETAMINOPHEN,DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN , PHENYLEPHRINE HCL	LIQUID	ORAL	20140305		OTC MONOGRAPH DRUG	M013	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-317_9f2c6806-1156-4c91-8581-68b7fcf039ec	37808-317	HUMAN OTC DRUG	H E B MAX SEVERE CONGESTION and COUGH	Maxium Strength	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20120914		OTC MONOGRAPH DRUG	M012	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-318_1ca9bfe0-aac4-4455-9daf-ed0c79896a14	37808-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20090521		OTC MONOGRAPH NOT FINAL	part356	HEB	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-319_4b99305c-99f7-4931-8a5f-dbfe4366b557	37808-319	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20150911		OTC MONOGRAPH NOT FINAL	part348	H E B	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37808-320_f202f70a-294f-8a32-e053-2a95a90a5b68	37808-320	HUMAN OTC DRUG	HEB Gleaming White	Arctic Mint	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190212		OTC MONOGRAPH FINAL	part355	HEB	SODIUM FLUORIDE	.243	g/100g			N	20241231
37808-323_0d3a5fa8-062b-4700-96fe-bb9d1c68765b	37808-323	HUMAN OTC DRUG	Infants Pain Relief	Dye Free	Acetaminophen	SUSPENSION	ORAL	20170531	20250531	OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	160	mg/5mL			N	
37808-327_f3f095e4-91e1-48c5-9223-b3e347fe2b87	37808-327	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	H E B	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-330_f204193e-9b43-099f-e053-2a95a90a2c4e	37808-330	HUMAN OTC DRUG	HEB Gleaming White	Fresh Mint	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190212		OTC MONOGRAPH FINAL	part355	HEB	SODIUM FLUORIDE	.243	g/100g			N	20241231
37808-331_f2041a56-651d-7b8a-e053-2a95a90a7f9e	37808-331	HUMAN OTC DRUG	HEB	Dry Mouth	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190220		OTC MONOGRAPH FINAL	part355	HEB	SODIUM FLUORIDE	.243	g/100g			N	20241231
37808-332_68fb0c6a-e58a-47e7-a6b1-76dd94bb6dfc	37808-332	HUMAN OTC DRUG	milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	19941014		OTC MONOGRAPH NOT FINAL	part334	H E B	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-334_c8ab2fef-4e74-787f-e053-2a95a90a6acb	37808-334	HUMAN OTC DRUG	HEB Citrus Hand Sanitizer		Alcohol	AEROSOL, SPRAY	TOPICAL	20201119		OTC MONOGRAPH NOT FINAL	part333A	H.E.B.	ALCOHOL	70	mg/100g			N	20241231
37808-335_46afffd0-ad20-4c34-8f47-77d969799186	37808-335	HUMAN OTC DRUG	night time	cold and flu	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20130207		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-336_f2041a56-652c-7b8a-e053-2a95a90a7f9e	37808-336	HUMAN OTC DRUG	HEB Enamel Protection	Multi Action	Potassium nitrate, sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190220		OTC MONOGRAPH NOT FINAL	part356	HEB	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
37808-337_c9741804-8c97-f851-e053-2995a90aa6f0	37808-337	HUMAN OTC DRUG	HEB BROAD SPECTRUM SPF 30 POMEGRANATE SCENTED SUNSCREEN LIP BALM		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20200110		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-338_de9933f3-ee77-4fec-e053-2995a90a483f	37808-338	HUMAN OTC DRUG	HEB Mineral Sunscreen SPF 50		Zinc Oxide	LOTION	TOPICAL	20200304		OTC MONOGRAPH NOT FINAL	part352	H.E.B.	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37808-340_556d117b-2624-48f7-ad9c-83b01588846c	37808-340	HUMAN OTC DRUG	Childrens Nasopro		fluticasone propionate	SPRAY, METERED	NASAL	20200414		ANDA	ANDA207957	H E B	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37808-341_e3518b76-54aa-4131-b2e2-f54497cc4604	37808-341	HUMAN OTC DRUG	HEB Extra Strength	Tropical Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190307		OTC MONOGRAPH FINAL	part331	H-E-B	CALCIUM CARBONATE	750	mg/1			N	20241231
37808-342_df2b546a-85fc-050e-e053-2995a90ab585	37808-342	HUMAN OTC DRUG	H.E.B. Oil Free Daily Acne Scrub		SALICYLIC ACID	CREAM	TOPICAL	20210226		OTC MONOGRAPH FINAL	part333D	H.E.B	SALICYLIC ACID	20	mg/mL			N	20241231
37808-345_dfb49f62-4738-736f-e053-2a95a90aa3c5	37808-345	HUMAN OTC DRUG	Hill Country Essentials Oil Free Daily Acne Scrub		SALICYLIC ACID	CREAM	TOPICAL	20110802		OTC MONOGRAPH FINAL	part333D	H.E.B	SALICYLIC ACID	20	mg/mL			N	20241231
37808-346_0a0d52c0-b040-4190-83e4-0243f46a0357	37808-346	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	TABLET	ORAL	20110506		OTC MONOGRAPH DRUG	M008	H E B	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
37808-350_dfb43fd0-8dc6-731c-e053-2a95a90a8cf7	37808-350	HUMAN OTC DRUG	HEB Sensitive 50 Mineral Sensitive Skin Sunscreen For Face		Zinc Oxide	LOTION	TOPICAL	20210128		OTC MONOGRAPH NOT FINAL	part352	H.E.B.	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37808-354_3dda06d1-dee4-45b6-9032-33bb4d22ab94	37808-354	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180305		NDA	NDA209400	H E B	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-355_161b4ab1-40b0-446b-a3a9-42b1c63d2792	37808-355	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200630		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
37808-356_09d6522d-cdd7-b627-e063-6294a90ab945	37808-356	HUMAN OTC DRUG	HEB 70 Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20150810		OTC MONOGRAPH DRUG	M003	HEB Grocery Company	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
37808-359_d1da766f-79d9-4fd6-a228-757aea65465d	37808-359	HUMAN OTC DRUG	Tussin DM		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19910809		OTC MONOGRAPH FINAL	part341	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-360_e0566f40-9000-24d6-e053-2a95a90afed5	37808-360	HUMAN OTC DRUG	Hill Country Essentials Apricot Scrub Blemish and Blackhead Control		SALICYLIC ACID	EMULSION	TOPICAL	20101111		OTC MONOGRAPH FINAL	part333D	H.E.B.	SALICYLIC ACID	20	mg/g			N	20241231
37808-363_9fbad9c2-23de-4cfa-8ba5-a620a53023fb	37808-363	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20020610		ANDA	ANDA074937	H E B	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-367_7e2ff9cf-a312-1fc2-e053-2a91aa0a4ede	37808-367	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20150401		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-369_08498129-7eab-451d-a88a-786d4a8f62a0	37808-369	HUMAN OTC DRUG	hydrocortisone	anti itch	Hydrocortisone	CREAM	TOPICAL	20100915		OTC MONOGRAPH NOT FINAL	part348	H E B	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37808-374_b0333ae3-4842-405c-b742-159bd06e90dd	37808-374	HUMAN OTC DRUG	migraine formula		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020515		ANDA	ANDA075794	H E B	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
37808-375_21390637-bbd6-402d-ac80-ff91aadcc9e9	37808-375	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	H E B	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
37808-379_397fcfb4-5977-4b73-b9bb-1c0448f6715f	37808-379	HUMAN OTC DRUG	Allergy		Diphenhydramine HCl	SOLUTION	ORAL	19870715		OTC MONOGRAPH FINAL	part341	H E B	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-383_fbecca27-2bc4-4673-ba65-b6fd6a446218	37808-383	HUMAN OTC DRUG	nicotine		nicotine	LOZENGE	ORAL	20190417		ANDA	ANDA090711	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-384_61d27534-1e81-457e-a16e-11df3a9c8118	37808-384	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120830		ANDA	ANDA091135	H E B	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-390_aed07ef6-7357-4200-9aa5-dc1029ed653d	37808-390	HUMAN OTC DRUG	Menstrual Complete	Maximum Strength	Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	H E B	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
37808-391_e051ce8b-3163-69b9-e053-2a95a90ab739	37808-391	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20220531		ANDA	ANDA211075	HEB	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-392_e051ea08-74a0-5897-e053-2a95a90a7efd	37808-392	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20220531		ANDA	ANDA211075	HEB	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-393_624f0a57-9687-4d20-8266-a5161dcfb495	37808-393	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-397_fad255f3-580e-47f9-b005-8dff485a2335	37808-397	HUMAN OTC DRUG	Vaproizing		Camphor	LIQUID	RESPIRATORY (INHALATION)	20101006		OTC MONOGRAPH FINAL	part341	H E B	CAMPHOR (NATURAL)	62	mg/mL			N	20241231
37808-398_0c000212-1d3f-0949-e063-6294a90a0ea0	37808-398	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20160923		OTC MONOGRAPH DRUG	M007	H E B	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37808-399_0c000c2f-9be1-c28c-e063-6394a90a455e	37808-399	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20160923		OTC MONOGRAPH DRUG	M007	H E B	GLYCERIN	1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37808-401_f0969896-db74-43a2-93bf-c26bb9bf6b13	37808-401	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150403		NDA	NDA022032	H E B	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-406_e57396ad-572c-4a19-894c-a4d7a3200f23	37808-406	HUMAN OTC DRUG	HEB Antacid Extra Strength	Assorted Berry	calcium carbonate	TABLET, CHEWABLE	ORAL	20190305		OTC MONOGRAPH FINAL	part331	HEB	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-409_abb60da2-4384-4fd4-9236-4614de58233f	37808-409	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	19960325		OTC MONOGRAPH FINAL	part340	H E B	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
37808-410_941c303a-c14e-6645-e053-2a95a90a59b2	37808-410	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20110101		ANDA	ANDA079174	HEB	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-421_f03090fa-f7e7-f53a-e053-2a95a90aa819	37808-421	HUMAN OTC DRUG	Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20110810		OTC MONOGRAPH FINAL	part343	H. E. Butt Grocery Company	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-425_570179ef-c32d-4afa-90cb-24966184041e	37808-425	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20110824		ANDA	ANDA076447	H E B	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-426_0c72d07d-86cc-443d-96a8-8ec00e1cfa7c	37808-426	HUMAN OTC DRUG	Tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20160509		ANDA	ANDA075915	H E B	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
37808-427_58f339ff-cf7c-4d4d-9437-07ec3e2818d5	37808-427	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		loratadine and pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180201		ANDA	ANDA076557	HEB	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-431_1472fb4a-5dcf-4e50-a6dc-c8997f5f8ed0	37808-431	HUMAN OTC DRUG	nighttime sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20091009		OTC MONOGRAPH FINAL	part338	H E B	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-434_2183fd8c-8865-41a0-bfe9-2db2a78a2316	37808-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20160627		OTC MONOGRAPH NOT FINAL	part356	HEB	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-435_966c27b8-fb86-4a2e-a31f-825b27b539b1	37808-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150821		OTC MONOGRAPH FINAL	part355	H-E-B	SODIUM FLUORIDE	.2	mg/mL			N	20241231
37808-439_fe0e39bc-f0e4-40e4-8980-4f321ee6a3a0	37808-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160804		OTC MONOGRAPH NOT FINAL	part333A	H E B	ALCOHOL	700	mg/mL			N	20241231
37808-443_0fe1a50c-d707-4479-9615-50f1f6ff02ab	37808-443	HUMAN OTC DRUG	Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170330		ANDA	ANDA078104	H E B	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37808-449_58f8b1cb-5be5-4125-a5aa-a4d8eb50c669	37808-449	HUMAN OTC DRUG	anti diarrheal		loperamide HCl	SOLUTION	ORAL	20180622		ANDA	ANDA091292	H E B	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
37808-453_b0ba8a1a-f7a9-4258-8a99-2260df287536	37808-453	HUMAN OTC DRUG	Nasal Decongestant PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	H E B	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-457_7f896296-9c3d-489c-916f-903c8b83c4d2	37808-457	HUMAN OTC DRUG	HEB Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20211104		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM	100	mg/1			N	20241231
37808-459_8c8d2a4c-7f19-4752-a301-90fc56698b0b	37808-459	HUMAN OTC DRUG	night time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20120204		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-460_005c1660-21b6-6067-e063-6294a90a7053	37808-460	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190222		ANDA	ANDA074612	H-E-B	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-461_005c1660-21b6-6067-e063-6294a90a7053	37808-461	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190222		ANDA	ANDA074612	H-E-B	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-464_08a17869-d449-18ce-e063-6394a90adbbb	37808-464	HUMAN OTC DRUG	HEB Lime and Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200531		OTC MONOGRAPH DRUG	M001	HEB	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-465_08a17869-d45b-18ce-e063-6394a90adbbb	37808-465	HUMAN OTC DRUG	HEB Lime and Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200531		OTC MONOGRAPH DRUG	M001	HEB	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
37808-466_e970aa41-d444-450e-ba3b-ed4cfdaabeeb	37808-466	HUMAN OTC DRUG	Sinus Congestion and Pain	Daytime Non-Drowsy	Acetaminophen, Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	H E B	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-471_73286d6b-f3c9-4221-962f-9c22ddb44f72	37808-471	HUMAN OTC DRUG	hydrocortisone		hydrocortisone	OINTMENT	TOPICAL	20140118		OTC MONOGRAPH NOT FINAL	part348	H E B	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37808-473_06d17b71-f9d1-e1f3-e063-6394a90aed38	37808-473	HUMAN OTC DRUG	HEB Cherry Cough Drops		Menthol	LOZENGE	ORAL	20210505		OTC MONOGRAPH FINAL	part341	HEB	MENTHOL	5.8	mg/1			N	20241231
37808-474_06d17009-50c7-99f7-e063-6294a90a9ef0	37808-474	HUMAN OTC DRUG	HEB Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20210505		OTC MONOGRAPH FINAL	part341	HEB	MENTHOL	7.5	mg/1			N	20241231
37808-475_06d1650d-74db-d159-e063-6394a90a2a12	37808-475	HUMAN OTC DRUG	HEB Menthol Cough Drops		Menthol	LOZENGE	ORAL	20210505		OTC MONOGRAPH FINAL	part341	HEB	MENTHOL	5.4	mg/1			N	20241231
37808-482_8d585eb7-dda8-4f0b-9b3d-9dc61b18543b	37808-482	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	SUSPENSION	ORAL	20150308		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	160	mg/5mL			N	20241231
37808-483_06d15d06-c7f1-8e85-e063-6294a90ab2a2	37808-483	HUMAN OTC DRUG	HEB SF Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20211112		OTC MONOGRAPH FINAL	part341	HEB	MENTHOL	7.6	mg/1			N	20241231
37808-487_8e66fdc0-970f-458d-8e5c-a3d75a457b20	37808-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20180731	20250731	OTC MONOGRAPH FINAL	part347	H E B	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
37808-492_8e0da72e-7b00-468c-8552-cffe75014ea3	37808-492	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20160430	20250430	OTC MONOGRAPH NOT FINAL	part334	H E B	SENNOSIDES	25	mg/1			N	
37808-496_8ea90ad2-ae81-4a8b-b130-f826468f0ed7	37808-496	HUMAN OTC DRUG	Dimethicone		Dimethicone	LOTION	TOPICAL	20230605		OTC MONOGRAPH FINAL	part347	H E B	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
37808-497_ef5805b4-d0d8-ed5c-e053-2a95a90a1839	37808-497	HUMAN OTC DRUG	Mucus Relief Cold, Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210427		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-499_2bd8ea5a-aad6-4f1f-8a93-f3c932b93a5c	37808-499	HUMAN OTC DRUG	Childrens Pain Reliever		Acetaminophen	TABLET, CHEWABLE	ORAL	20220209		OTC MONOGRAPH DRUG	M013	H E B	ACETAMINOPHEN	160	mg/1			N	20241231
37808-501_f8185acc-bd46-4832-8cc4-9eee48fa58e5	37808-501	HUMAN OTC DRUG	nausea relief		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20141104		UNAPPROVED DRUG OTHER		H E B	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
37808-502_13412038-eb64-4b5b-8333-d3ce839cc372	37808-502	HUMAN OTC DRUG	nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20150219		OTC MONOGRAPH FINAL	part341	H E B	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
37808-503_99131056-e43f-46ec-9b1a-716e3924f760	37808-503	HUMAN OTC DRUG	Dual Action Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160407		ANDA	ANDA077355	H E B	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-505_2a47e9fc-46a0-44c8-ba60-895f66fe524d	37808-505	HUMAN OTC DRUG	HEB Extra Strength	Original Flavor	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20190320		OTC MONOGRAPH FINAL	part331	HEB	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
37808-506_17e2e605-d5de-4d95-b5c8-710e56b61334	37808-506	HUMAN OTC DRUG	Childrens Allergy Relief		loratadine	TABLET, CHEWABLE	ORAL	20210819		ANDA	ANDA210033	H E B	LORATADINE	5	mg/1			N	20241231
37808-509_2c4e1692-877c-4c33-a9f8-73bbd9556f0a	37808-509	HUMAN OTC DRUG	Advanced Guard		Cetylpyridinium chloride	RINSE	ORAL	20130625		OTC MONOGRAPH NOT FINAL	part356	H-E-B	CETYLPYRIDINIUM CHLORIDE	1	mg/100mL			N	20241231
37808-512_f2f4edb0-0118-2e5d-e053-2a95a90a2555	37808-512	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171222		OTC MONOGRAPH NOT FINAL	part333A	HEB	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
37808-514_f2f4edb0-0119-2e5d-e053-2a95a90a2555	37808-514	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Spray	AEROSOL, SPRAY	TOPICAL	20120105		OTC MONOGRAPH FINAL	part333C	HEB	TOLNAFTATE	1.13	g/113g			N	20241231
37808-518_2fca47e4-dd71-483b-8569-ee29c7cd2e9f	37808-518	HUMAN OTC DRUG	Maximum Strength DM MAX		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	LIQUID	ORAL	20120914		OTC MONOGRAPH DRUG	M012	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-520_f2a38737-0640-2cfb-e053-2a95a90a920a	37808-520	HUMAN OTC DRUG	Miconazole Nitrate		Antifungal Liquid Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120117		OTC MONOGRAPH FINAL	part333C	HEB	MICONAZOLE NITRATE	3	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
37808-521_f2a35d13-54fd-40bd-e053-2a95a90a217d	37808-521	HUMAN OTC DRUG	Tolnaftate		Antifungal Continuous Liquid Spray	AEROSOL, SPRAY	TOPICAL	20171222		OTC MONOGRAPH FINAL	part333C	HEB	TOLNAFTATE	1.5	g/150g			N	20241231
37808-522_f2f4d087-49b2-dbc2-e053-2995a90a07d5	37808-522	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	HEB	SALICYLIC ACID	40	mg/41			N	20241231
37808-523_f2f492ef-286d-5732-e053-2a95a90a1bf3	37808-523	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	HEB	SALICYLIC ACID	40	mg/41			N	20241231
37808-525_f2f4d087-49b1-dbc2-e053-2995a90a07d5	37808-525	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	HEB	SALICYLIC ACID	40	mg/91			N	20241231
37808-526_f2a372c1-030a-e3a0-e053-2a95a90a1f64	37808-526	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief	SPRAY	TOPICAL	20171222		OTC MONOGRAPH NOT FINAL	part348	HEB	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-529_c624b449-9db2-4b2e-852f-28f745aa7e2a	37808-529	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20180201		ANDA	ANDA076134	HEB	LORATADINE	10	mg/1			N	20241231
37808-530_f2a38737-063f-2cfb-e053-2a95a90a920a	37808-530	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20171222		OTC MONOGRAPH FINAL	part333C	HEB	TOLNAFTATE	1.3	g/130g			N	20241231
37808-531_f951904d-90c4-2720-e053-6394a90aca3a	37808-531	HUMAN OTC DRUG	Sinus Congestion PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230414		OTC MONOGRAPH FINAL	part341	HEB	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-533_56f142f0-fb0c-4e01-91a0-50ce317d8962	37808-533	HUMAN OTC DRUG	nicotine		nicotine	LOZENGE	ORAL	20190416		ANDA	ANDA090711	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-536_149f6f1a-2b12-425b-b07f-ab56fa55b877	37808-536	HUMAN OTC DRUG	bacitracin		Bacitracin	OINTMENT	TOPICAL	19910615		OTC MONOGRAPH FINAL	part333B	H E B	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
37808-540_0ccec468-e0e2-c5bf-e063-6394a90a61cf	37808-540	HUMAN OTC DRUG	HEB Extra Strength Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20200625		OTC MONOGRAPH DRUG	505G(a)(3)	H. E. Butt Grocery Company	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 500; 1985	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-543_e8ac4332-2730-486c-9db1-fb7710b7bb8e	37808-543	HUMAN OTC DRUG	severe cold, flu and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20180320		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-549_d72e6407-e7e4-965b-e053-2995a90ae445	37808-549	HUMAN OTC DRUG	Stool Softener and Stimulant Laxative		Docusate Sodium, Sennosides	TABLET	ORAL	20220204		OTC MONOGRAPH NOT FINAL	part334	H-E-B	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
37808-552_151f75b0-6158-4c55-a537-72049fc3c3e9	37808-552	HUMAN OTC DRUG	Anti Diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20140501		ANDA	ANDA075232	H E B	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
37808-554_f294cf44-fb21-4b2e-8b7c-efd41416c6b2	37808-554	HUMAN OTC DRUG	Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20211213		OTC MONOGRAPH FINAL	part331	H E B	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-556_5eb944ec-c459-4f24-87d8-591ee8922262	37808-556	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	H E B	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-560_f344ff26-4cf6-2f7a-e053-2a95a90abfbf	37808-560	HUMAN OTC DRUG	HEB Eye Drops		glycerin, naphazoline hydrochloride	LIQUID	OPHTHALMIC	20201211		OTC MONOGRAPH FINAL	part349	H E B	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	2.5; .12	mg/15mL; mg/15mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37808-563_1fb02f5e-56af-47ef-a1bc-49a6d86cc70c	37808-563	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190401		ANDA	ANDA203690	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-564_d4c84444-d60d-40c5-b847-97c2fdbfe6de	37808-564	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20211015		ANDA	ANDA213105	H E B	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-571_0e4ad335-1644-4143-84f3-acccf9bc84f9	37808-571	HUMAN OTC DRUG	Allergy Relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110622		ANDA	ANDA076447	H E B	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-574_f9519812-a5cc-1a19-e053-6294a90a471d	37808-574	HUMAN OTC DRUG	Head Congestion plus Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230414		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-576_5535461d-443f-4b39-851b-82e32130ba17	37808-576	HUMAN OTC DRUG	Alcohol Free Refreshing Mint		Sodium fluoride	MOUTHWASH	ORAL	20150427		OTC MONOGRAPH FINAL	part355	HEB	SODIUM FLUORIDE	10.41	mg/mL			N	20241231
37808-578_976854e4-112c-4a25-af9e-f74313d2ca68	37808-578	HUMAN OTC DRUG	tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20060530		OTC MONOGRAPH FINAL	part341	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-583_f1ab1435-24ff-4dd6-81e8-7eb5ad60f3a9	37808-583	HUMAN OTC DRUG	allergy relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA078336	H E B	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-584_10b231ab-3f7e-4b1d-a3fc-91473c2558db	37808-584	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180930	20250930	OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM	100	mg/1			N	
37808-586_41d2e356-38dd-4c4e-a044-9e992954e52d	37808-586	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20210730		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
37808-587_98c7a61e-27d3-4a57-8d18-aeee3f4391b5	37808-587	HUMAN OTC DRUG	HEB Stomach Relief Cherry		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20210914		OTC MONOGRAPH FINAL	part335	H E B	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
37808-590_beb27cc4-53f4-52cf-e053-2a95a90ac678	37808-590	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210329		OTC MONOGRAPH FINAL	part341	HEB	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-594_3376e9d9-101a-4090-8f14-4d39f5ad2682	37808-594	HUMAN OTC DRUG	Mucus Relief Cough	Childrens	Dextromethorphan HBr, Guaifensin	LIQUID	ORAL	20160731		OTC MONOGRAPH FINAL	part341	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-597_0d1219bb-0fd7-4cad-bed6-a0e4f99063cb	37808-597	HUMAN OTC DRUG	Day Time Night Time Severe Cold and Flu		acetaminophen, dextromethorphan HBr, doxylamine succinate, guaifenesin, phenylephrine HCl	KIT		20160414		OTC MONOGRAPH FINAL	part341	H E B						N	20241231
37808-598_ef57d5d8-fd6e-5bcb-e053-2a95a90aaa47	37808-598	HUMAN OTC DRUG	Mucus Relief Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210427		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-600_1cdb6d50-46ab-4c2a-9663-7753b64b2770	37808-600	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	H E B	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-602_56c19244-7877-4555-92d5-b47528fd0072	37808-602	HUMAN OTC DRUG	daytime severe cold and flu nighttime severe cold, cough and flu		acetaminophen, dextromethorphan HBr, phenylephrine HCl, diphenhydramine HCl	KIT		20181210		OTC MONOGRAPH FINAL	part341	H E B						N	20241231
37808-603_e4f8b2f1-6b4c-4bb2-ba28-d131572e9b74	37808-603	HUMAN OTC DRUG	daytime severe cold and flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20160411		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-604_e6936e2d-4f10-41b2-adb2-2cf44cec7fc5	37808-604	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19890215		ANDA	ANDA072096	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-606_6b58c344-b53f-4f9a-bb62-a85afa118079	37808-606	HUMAN OTC DRUG	Nighttime		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20200330		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-607_1cf3cc71-50a2-4a0d-a948-7317b5950a1d	37808-607	HUMAN OTC DRUG	HEB Stomach Relief	Regular Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20190307		OTC MONOGRAPH FINAL	part335	H E B	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
37808-609_f0d58de7-acf0-393a-e053-2995a90a766f	37808-609	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210924		ANDA	ANDA078682	HEB	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-611_f016f66c-e5ca-4d67-8532-59ddd74ba66c	37808-611	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230731		ANDA	ANDA206393	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-612_d65c3ac3-f9aa-408e-94f0-36a8e5c99de2	37808-612	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20161019		OTC MONOGRAPH FINAL	part358H	H E B	PYRITHIONE ZINC	1	g/mL			N	20241231
37808-617_b1a13942-1fad-40da-8664-f70574b950d7	37808-617	HUMAN OTC DRUG	nicotine		nicotine polacrilex	LOZENGE	ORAL	20181108		ANDA	ANDA203690	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-619_ddf1c7c1-b121-485c-8f1c-07cfdd2929d6	37808-619	HUMAN OTC DRUG	severe cold and flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20180530		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-622_5b82d556-9e53-4588-9cd2-10b80ffadf7e	37808-622	HUMAN OTC DRUG	itch relief		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20100915		OTC MONOGRAPH NOT FINAL	part348	H E B	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-623_bd3099ea-673c-4145-96b1-8ca6cf21bde1	37808-623	HUMAN OTC DRUG	Childrens Allergy		Fexofenadine HCL	SUSPENSION	ORAL	20210430		ANDA	ANDA203330	H E B	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-628_d07197cb-9b23-82f5-e053-2995a90a1e3b	37808-628	HUMAN OTC DRUG	Allergy Multi Symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200731		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-630_74b441b2-69bc-4cac-82a3-f164cc350114	37808-630	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20210903		OTC MONOGRAPH FINAL	part343	H E B	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-631_bee5b90e-9646-439c-a0be-074d2552c527	37808-631	HUMAN OTC DRUG	naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20171114		ANDA	ANDA074661	H E B	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-632_b043321a-dd95-45ef-ab1b-87bde13ae0db	37808-632	HUMAN OTC DRUG	HEB Extra Strength	Cool Mint	aluminum hydroxide and magnesium carbonate	LIQUID	ORAL	20190425		OTC MONOGRAPH FINAL	part331	HEB	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
37808-637_f344f37e-0152-0ef2-e053-2995a90a49a7	37808-637	HUMAN OTC DRUG	Eye Lubricant		polyethylene glycol, propylene glycol	LIQUID	OPHTHALMIC	20121205		OTC MONOGRAPH FINAL	part349	H E B	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/15mL; mg/15mL			N	20241231
37808-639_e9440347-1869-4aad-a359-e8d2fa04dafb	37808-639	HUMAN OTC DRUG	tussin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180924		OTC MONOGRAPH FINAL	part341	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-645_1790afa2-8e6f-4f4d-b63e-81fd4706f05d	37808-645	HUMAN OTC DRUG	Loperamide Hydrochloride		loperamide HCl	SUSPENSION	ORAL	20120305		ANDA	ANDA091292	H E B	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
37808-647_f6c53ee6-426d-4595-a9e1-023724c9acd3	37808-647	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19910809		ANDA	ANDA072096	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-650_0cfaa641-21fc-e11b-e063-6394a90a69f2	37808-650	HUMAN OTC DRUG	HEB Lubricant Eye Drops Dry Eye Therapy		Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20200912		OTC MONOGRAPH DRUG	M018	HEB	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
37808-651_fbe66713-c00e-492d-8aa7-06b7f361cc27	37808-651	HUMAN OTC DRUG	allergy relief d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210218		ANDA	ANDA210719	H E B	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-652_cc2a79ea-1ae1-495d-a0f0-d220217a1264	37808-652	HUMAN OTC DRUG	naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20171114		ANDA	ANDA074661	H E B	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-654_90756334-554b-43f4-8b52-413c29e521c3	37808-654	HUMAN OTC DRUG	Children Allergy		Fexofenadine HCL	SUSPENSION	ORAL	20231031		ANDA	ANDA203330	H E B	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-656_f0e019de-ec79-41eb-95a6-1ae008d51928	37808-656	HUMAN OTC DRUG	DayTime		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20060802		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-658_8899311f-1df0-4c98-815c-f5da3c3486e5	37808-658	HUMAN OTC DRUG	Nicotine		nicotine	GUM, CHEWING	ORAL	20190503		ANDA	ANDA076779	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-661_f6fbc45a-94c8-44e4-9941-af1df66d5ce4	37808-661	HUMAN OTC DRUG	Cold Sore Fever Blister		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	H E B	DOCOSANOL	100	mg/g			N	20241231
37808-663_efb61ba8-9a8f-2917-e053-2a95a90a7698	37808-663	HUMAN OTC DRUG	Cold Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180501		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-664_20bc4d83-1e09-4e63-b4be-f4f71b14ae79	37808-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20090519		OTC MONOGRAPH NOT FINAL	part356	H-E-B	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-668_643ba188-7527-4ca4-aa3e-9d2e8d762cb8	37808-668	HUMAN OTC DRUG	night time	cough relief	Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20030225		OTC MONOGRAPH FINAL	part341	H E B	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-671_e5e7b796-c175-4122-9474-238e38990337	37808-671	HUMAN OTC DRUG	childrens allergy relief		cetirizine Hydrochloride	SOLUTION	ORAL	20180518		ANDA	ANDA090254	H E B	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-673_2b5240af-b78e-4955-baf9-521417ce33eb	37808-673	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	SOLUTION	ORAL	20210817		OTC MONOGRAPH NOT FINAL	part334	H E BUTT	MAGNESIUM CITRATE	.059	g/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-674_ff6a0b65-a65f-4e9b-8209-6e68756d2e01	37808-674	HUMAN OTC DRUG	nicotine lozenge		nicotine polacrilex	LOZENGE	ORAL	20190416		ANDA	ANDA077007	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-675_c1030cf0-771e-46bb-b73f-80c31a91e558	37808-675	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20220218		OTC MONOGRAPH NOT FINAL	part334	H E B	SENNOSIDES	8.6	mg/1			N	20241231
37808-676_dc7a78e9-245c-491e-9456-c3a326560957	37808-676	HUMAN OTC DRUG	Womens Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	H E B	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-679_3c05e2a6-5afe-4751-b811-6c2ea8890319	37808-679	HUMAN OTC DRUG	triple antibiotic plus	maximum strength	Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20101105		OTC MONOGRAPH FINAL	part333B	H E B	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
37808-681_a8d71149-3d27-a59b-e053-2995a90a8fab	37808-681	HUMAN OTC DRUG	HEB	Extra Whitening	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	HEB	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
37808-682_4acc0b0b-af88-4846-b952-7a1209360f2c	37808-682	HUMAN OTC DRUG	Nicotine		nicotine	GUM, CHEWING	ORAL	20190506		ANDA	ANDA076777	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-683_e68006cb-0b2b-4d1d-8f85-f48e9b1b64d3	37808-683	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190701		ANDA	ANDA206393	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-691_f2151bf2-f797-5213-e053-2a95a90aaf2a	37808-691	HUMAN OTC DRUG	3x Medicated Mouth Sore Gel		Benzocaine	GEL	ORAL	20200602		OTC MONOGRAPH NOT FINAL	part356	HEB	BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	20; .1; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
37808-695_8b1ce67c-291b-4ba8-8861-b9116d986059	37808-695	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20210908		OTC MONOGRAPH NOT FINAL	part334	H E BUTT	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-699_03df1826-0684-4375-8f71-3933e113fccc	37808-699	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180331		ANDA	ANDA078682	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-703_a3b976be-1b40-404f-9146-c5572c1e53f5	37808-703	HUMAN OTC DRUG	ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20180405		ANDA	ANDA079113	H E B	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-704_941bb9fc-ef1d-1969-e053-2995a90abbf0	37808-704	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20110101		OTC MONOGRAPH NOT FINAL	part343	HEB	ACETAMINOPHEN	500	mg/1			N	20241231
37808-706_a50d7b47-62f5-422e-b35e-2a425feb388c	37808-706	HUMAN OTC DRUG	Gas Relief	Infants	Simethicone	EMULSION	ORAL	20081011		OTC MONOGRAPH FINAL	part332	H E B	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
37808-707_87620a19-30df-4a8d-9bf0-f847eb7e84e4	37808-707	HUMAN OTC DRUG	Nicotine		nicotine	LOZENGE	ORAL	20181001		ANDA	ANDA203690	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-708_f42d45ba-fb0a-4fbd-a4df-1d99bf5930b6	37808-708	HUMAN OTC DRUG	tussin		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20210611		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-709_9180a3da-35f2-439d-9ad1-dae14e65900e	37808-709	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060704		ANDA	ANDA077349	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-711_ec401f8b-cf20-4f48-9c08-0688af2b8198	37808-711	HUMAN OTC DRUG	Nicotine		nicotine	GUM, CHEWING	ORAL	20190502		ANDA	ANDA206394	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-712_0c401b9b-eee2-41a7-e063-6394a90af6d5	37808-712	HUMAN OTC DRUG	Sennosides		Sennosides	CAPSULE, LIQUID FILLED	ORAL	20200731		OTC MONOGRAPH DRUG	M007	H E B	SENNOSIDES	17.2	mg/17.21			N	20241231
37808-713_c6386e91-c7b2-4be1-a4db-1c69d0e89dc2	37808-713	HUMAN OTC DRUG	naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20171003		ANDA	ANDA074661	H E B	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-714_3af0c45f-5eca-4739-8426-f959a5d9e5e5	37808-714	HUMAN OTC DRUG	anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181115		ANDA	ANDA209837	H E B	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
37808-716_39b76143-a0e1-4010-a242-eea4920849c3	37808-716	HUMAN OTC DRUG	HEB Fiber Therapy		methylcellulose	POWDER, FOR SOLUTION	ORAL	20190425		OTC MONOGRAPH NOT FINAL	part334	HEB	METHYLCELLULOSE (4000 MPA.S)	2	g/10.2g			N	20241231
37808-718_78e66372-225a-49b0-abf9-633410d64bb6	37808-718	HUMAN OTC DRUG	Daytime Severe Cold and Cough		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20230331		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-719_eda9c15d-ba33-4b39-96e3-bc170da9f7b5	37808-719	HUMAN OTC DRUG	Esomeprazole Magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200806		ANDA	ANDA207193	H E B	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-724_3e9fe73b-d3ee-4160-8dfa-8b099cd68e8a	37808-724	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		loratadine and pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180201		ANDA	ANDA076557	HEB	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-726_88331672-bf21-4a69-b082-c8be601d4298	37808-726	HUMAN OTC DRUG	Sunscreen		Octinoxate, Octisalate, zinc oxide	GEL	TOPICAL	20170606		OTC MONOGRAPH FINAL	part352	HEB	OCTINOXATE; OCTISALATE; ZINC OXIDE	562; 250; 1000	g/g; g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37808-728_574ce5c7-9de7-4a0c-bb0c-7f6c25221f6a	37808-728	HUMAN OTC DRUG	heb nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20190314		OTC MONOGRAPH FINAL	part341	H E B	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-730_432a0491-52da-437d-92cd-05aa01015bbd	37808-730	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20230315		ANDA	ANDA209692	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-731_15947d40-2434-451c-bbe5-59cdf3c9e044	37808-731	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20190228	20251231	OTC MONOGRAPH NOT FINAL	part334	H E B	SENNOSIDES	8.6	mg/1			N	
37808-732_e64a8f7d-a9cc-4abf-a050-44fa5ecc1209	37808-732	HUMAN OTC DRUG	Omeprazole and sodium bicarbonate		Omeprazole, sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20170825		ANDA	ANDA201361	H E B	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-733_87d238ac-dd23-4574-8533-c397f61c33c7	37808-733	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20230228		ANDA	ANDA209692	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-739_2d04d2f6-22b7-46c6-bf8e-0734d6cdbcf1	37808-739	HUMAN OTC DRUG	nicotine		nicotine	GUM, CHEWING	ORAL	20190501		ANDA	ANDA206393	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-741_61d3cea8-b7a1-43bc-ad65-e8ad40931559	37808-741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180331	20250331	ANDA	ANDA207235	H E B	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
37808-747_6b75a346-403e-45e1-a74d-21c0b8dcd8ed	37808-747	HUMAN OTC DRUG	Pain Relief 8 HR		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170224		ANDA	ANDA075077	H E B	ACETAMINOPHEN	650	mg/1			N	20241231
37808-748_0cfa87ca-f1da-c578-e063-6394a90a7626	37808-748	HUMAN OTC DRUG	HEB Dry Eye Eye Drops		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20230328		OTC MONOGRAPH DRUG	M018	HEB	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
37808-750_e469dc56-eaa5-47ba-8cda-c1bbcd9028af	37808-750	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180831	20250831	ANDA	ANDA206999	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
37808-752_149fa1ee-9162-43b8-bd90-7dcb763d70e6	37808-752	HUMAN OTC DRUG	nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20210611		OTC MONOGRAPH FINAL	part341	H E B	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
37808-753_f70627db-fcc2-4786-8da2-732293e33cb5	37808-753	HUMAN OTC DRUG	Nicotine		nicotine	GUM, CHEWING	ORAL	20190506		ANDA	ANDA078326	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-755_0427e266-6d64-4f89-8e1a-dae50a33c3be	37808-755	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190930		ANDA	ANDA203187	H E B	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-757_0cfaa641-21fd-e11b-e063-6394a90a69f2	37808-757	HUMAN OTC DRUG	HEB A.C. Eye Drops		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20230323		OTC MONOGRAPH DRUG	M018	HEB Grocery Company., LP	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37808-759_b264f3bc-74d7-40a3-ac4f-db519945b2f2	37808-759	HUMAN OTC DRUG	pain relief		Acetaminophen	SUSPENSION	ORAL	20110301		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	160	mg/5mL			N	20241231
37808-762_caba79ca-704b-4d8d-a2e1-94a41da8593f	37808-762	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20210802		ANDA	ANDA207342	H E B	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
37808-763_a7dcbac5-fa41-4497-abee-f7e369b5ea51	37808-763	HUMAN OTC DRUG	nighttime severe cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20160411		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-765_9ecb26a2-7d32-482b-8c7c-3051be0d63d6	37808-765	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230707		ANDA	ANDA212385	H E B	DOCOSANOL	100	mg/g			N	20241231
37808-768_c1337636-05c1-f945-e053-2a95a90a326c	37808-768	HUMAN OTC DRUG	Effervescent Orange Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20180130		OTC MONOGRAPH FINAL	part341	H. E. Butt Grocery Company	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-769_dabc14e4-440e-4d58-88a2-e1fdca6d3ed9	37808-769	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	SOLUTION	ORAL	20210907		OTC MONOGRAPH NOT FINAL	part334	H E Butt	MAGNESIUM CITRATE	.059	g/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-770_4652b438-62d0-45e6-bf14-c51f453c3b63	37808-770	HUMAN OTC DRUG	HEB Stomach Relief	Max Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20190423		OTC MONOGRAPH FINAL	part335	HEB	BISMUTH SUBSALICYLATE	1050	mg/30mL			N	20241231
37808-773_ee06a1b0-574b-4e15-e053-2995a90af4c9	37808-773	HUMAN OTC DRUG	Muscle Rub Ultra		Camphor,Menthol, methyl salicylate	CREAM	TOPICAL	20110725		OTC MONOGRAPH NOT FINAL	part348	H E B	CAMPHOR (NATURAL); MENTHOL; MENTHYL SALICYLATE, (+/-)-	4; 10; 30	g/100g; g/100g; g/100g			N	20241231
37808-775_efb634c7-6467-25b9-e053-2a95a90aec13	37808-775	HUMAN OTC DRUG	Cold Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180401		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-777_dfea6c4d-3e9c-4cbd-bca4-054ae6f92816	37808-777	HUMAN OTC DRUG	mucus relief d		Guaifenesin, pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180517		ANDA	ANDA091071	H E B	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-778_5a87b154-c1e9-41c1-84b3-3109be499b54	37808-778	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180930	20240930	OTC MONOGRAPH DRUG	M007	H E B	DOCUSATE SODIUM	100	mg/1			N	
37808-781_60911860-768e-4c6f-b1ed-1b0a18c65da0	37808-781	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190412		ANDA	ANDA076775	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-782_191643e3-78cf-4321-b1c6-f3aad13ff30b	37808-782	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20220218		OTC MONOGRAPH NOT FINAL	part334	H E B	SENNOSIDES	8.6	mg/1			N	20241231
37808-785_22d7a8b4-abcd-44ce-828c-4a34ab74f660	37808-785	HUMAN OTC DRUG	allergy relief d		Cetirizine HCl, Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20180119		ANDA	ANDA077170	H E B	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
37808-786_0cfaa641-21fe-e11b-e063-6394a90a69f2	37808-786	HUMAN OTC DRUG	HEB Advanced Eye Drops		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	HEB Grocery Company, LP	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
37808-792_941bd2de-0c0f-1901-e053-2995a90a89a0	37808-792	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20130201		OTC MONOGRAPH NOT FINAL	part343	HEB	ACETAMINOPHEN	500	mg/1			N	20241231
37808-795_941bf5b3-57a1-e844-e053-2a95a90a6b59	37808-795	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20130201		OTC MONOGRAPH FINAL	part341	HEB	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-796_8d025aba-2573-4c79-b58f-308275c07482	37808-796	HUMAN OTC DRUG	daytime severe		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20200320		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-797_39b9bbfc-6511-4c7f-8ffe-686a62c8cb44	37808-797	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH FINAL	part347	H E B	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
37808-798_838e8952-5079-4b72-9f33-d5b9a457c6a8	37808-798	HUMAN OTC DRUG	minoxidil	for men	Minoxidil	SOLUTION	TOPICAL	20100216		ANDA	ANDA075598	H E B	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
37808-803_18125abf-f3bd-4a71-b71b-da2e6662b39c	37808-803	HUMAN OTC DRUG	HEB Sore Throat	Cherry Flavor	Phenol	SPRAY	ORAL	20190417		OTC MONOGRAPH NOT FINAL	part356	HEB	PHENOL	1.4	g/100mL			N	20241231
37808-804_92601a2e-9a41-4c06-9753-4943601ddea0	37808-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20150113		OTC MONOGRAPH NOT FINAL	part333A	H-E-B	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
37808-805_b1aefe57-9ca5-40e1-8b20-ac49495de8d0	37808-805	HUMAN OTC DRUG	HEB Sore Throat	Menthol Flavor	Phenol	SPRAY	ORAL	20190514		OTC MONOGRAPH NOT FINAL	part356	HEB	PHENOL	1.4	g/100mL			N	20241231
37808-808_301256fc-764c-48ac-a00f-34e7fe417aaf	37808-808	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20100225		OTC MONOGRAPH FINAL	part355	H-E-B	SODIUM FLUORIDE	.2	mg/mL			N	20241231
37808-809_0d725299-0322-a239-e063-6294a90a2f7c	37808-809	HUMAN OTC DRUG	inControl alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20101101		OTC MONOGRAPH DRUG	M003	H-E-B	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
37808-810_1f710907-8025-435f-8a02-4f73e84cc314	37808-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20150618		OTC MONOGRAPH NOT FINAL	part333A	H-E-B	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
37808-811_72969570-b897-4df7-9408-51aad60a69b6	37808-811	HUMAN OTC DRUG	Mucus Relief Cough Cold Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20230430		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-812_da8f4a08-6e64-44f6-8830-705e3fbdc05e	37808-812	HUMAN OTC DRUG	mucus relief dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180625		ANDA	ANDA207602	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37808-813_9d9b932c-a2ec-40ec-8012-7e13e0b56c40	37808-813	HUMAN OTC DRUG	Maximum Strength Gas Relief Softgel-60ct		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230216		OTC MONOGRAPH FINAL	part332	HEB	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
37808-816_f5e9151d-7e4f-4739-ba70-d9c7c509a24a	37808-816	HUMAN OTC DRUG	Dandruff		Selenium sulfide	SHAMPOO	TOPICAL	20160925		OTC MONOGRAPH FINAL	part358H	HEB	SELENIUM SULFIDE	10	mg/mL			N	20241231
37808-820_c2c7788b-b88b-4e59-837d-4dab8ed1a4e2	37808-820	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20221028		ANDA	ANDA079216	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-821_c57e7009-7e43-48a7-b3f8-04b9dfbee6bf	37808-821	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20221028		ANDA	ANDA079219	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-822_4b076a42-7083-4b4c-b6b4-fc7e210d8e3d	37808-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20150618		OTC MONOGRAPH FINAL	part346	H-E-B	WITCH HAZEL	979	mg/mL			N	20241231
37808-825_154b2a8e-966f-4dd9-8ce8-30a5adb3aab5	37808-825	HUMAN OTC DRUG	miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20060109		ANDA	ANDA074760	H E B	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
37808-826_836963e8-97f4-4cde-862b-b73ccfe92703	37808-826	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190719		OTC MONOGRAPH NOT FINAL	part333A	H-E-B	ALCOHOL	62	mg/mL			N	20241231
37808-833_e7ab66f6-bf38-467d-bad7-c982573ff663	37808-833	HUMAN OTC DRUG	minoxidil		minoxidil	SOLUTION	TOPICAL	20210517		ANDA	ANDA075598	H E B	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
37808-847_5857482f-bc9f-472a-b86b-ec2e2b83f6dc	37808-847	HUMAN OTC DRUG	allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20211222		ANDA	ANDA212971	H E B	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-848_80138824-0f96-4387-9f38-5e13b5c8621d	37808-848	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20200630		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-849_ae4f362c-7bfd-4fc0-8c3a-a6a6f43818da	37808-849	HUMAN OTC DRUG	nicotine		nicotine	GUM, CHEWING	ORAL	20190416		ANDA	ANDA076789	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-853_5d911dd4-21c5-40c2-a406-a629d753e209	37808-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20211029		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM	100	mg/1			N	20241231
37808-855_b47b67fe-a0bd-47c7-884a-a0d30d860146	37808-855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20150427		OTC MONOGRAPH NOT FINAL	part356	HEB	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-856_785cc2f6-6621-4870-8b38-3525dbb3b84a	37808-856	HUMAN OTC DRUG	Acid Reducer		Esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20220331		ANDA	ANDA212088	H E B	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-860_3661a63f-6cb1-4f95-a002-7d062d53e6bd	37808-860	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20200529		OTC MONOGRAPH FINAL	part338	H E B	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-862_f55e7c6e-434d-42f7-a705-f89733165ac2	37808-862	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM	100	mg/1			N	20241231
37808-863_3a0437f4-b7ac-4acc-ae3e-4fbb5444b82d	37808-863	HUMAN OTC DRUG	HEB Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230628		ANDA	ANDA206394	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-864_fab8eb08-7278-40d1-9946-26c64179376e	37808-864	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160531		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-866_65951161-f9f3-41c0-b28e-7a2a2864658f	37808-866	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20200529	20240529	OTC MONOGRAPH FINAL	part336	H E B	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
37808-867_1db0082c-ccb8-4524-938f-c1146d3d426e	37808-867	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20200529		OTC MONOGRAPH FINAL	part343	H E B	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37808-871_f4f6d65d-d405-4904-9dcb-604b009b998f	37808-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20150715		OTC MONOGRAPH NOT FINAL	part333A	H-E-B	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
37808-874_6398a4cf-0332-4e84-83cb-cc06a48e7b74	37808-874	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20220225		OTC MONOGRAPH FINAL	part332	H E B	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
37808-875_f2f40bce-43ad-4311-81c5-cace1c50be71	37808-875	HUMAN OTC DRUG	Deep Cleaning Astringent		Salicylic Acid	LIQUID	TOPICAL	20120913		OTC MONOGRAPH FINAL	part333D	HEB	SALICYLIC ACID	5	mg/mL			N	20241231
37808-877_69e35220-2faf-4a4e-9bea-45ab6cc5ce7c	37808-877	HUMAN OTC DRUG	HEB Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20190605		OTC MONOGRAPH NOT FINAL	part334	H E B	BISACODYL	10	mg/2000mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-878_59065567-e358-4c5e-b25d-f05ec7526861	37808-878	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20210603		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
37808-879_2e318ae3-fec1-4b27-b378-38ff8793b555	37808-879	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	H E B	DOCUSATE SODIUM	250	mg/1			N	20241231
37808-883_4702106c-9774-462d-8d8a-9045f54e274d	37808-883	HUMAN OTC DRUG	HEB Anti Nausea		Dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20200420		UNAPPROVED DRUG OTHER		HEB	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
37808-886_0b659e1f-d43a-45ce-b9a6-dc3cb56ae881	37808-886	HUMAN OTC DRUG	Nighttime Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190715		ANDA	ANDA040564	H E B	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
37808-889_0993eb73-0600-48fb-e063-6294a90a65ae	37808-889	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M007	H E B	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-890_1b849ce3-7b16-41cf-81bf-4fbacd08e92c	37808-890	HUMAN OTC DRUG	Cold and Allergy Relief		Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20160831	20250831	OTC MONOGRAPH FINAL	part341	H E B	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
37808-896_f2041946-915c-7b8c-e053-2a95a90a22fb	37808-896	HUMAN OTC DRUG	HEB	Brilliant White	Fluoride	PASTE, DENTIFRICE	DENTAL	20121001		OTC MONOGRAPH FINAL	part355	HEB	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
37808-897_cec6ab78-18da-40cd-b32d-a8f86bee870d	37808-897	HUMAN OTC DRUG	rx act ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19990106		ANDA	ANDA074937	H E B	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-900_d8b682e6-2f84-4d2e-b2cd-5bd963dc5cff	37808-900	HUMAN OTC DRUG	Nicotine		nicotine	LOZENGE	ORAL	20180928		ANDA	ANDA203690	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-901_0993eb73-0601-48fb-e063-6294a90a65ae	37808-901	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20200801		OTC MONOGRAPH DRUG	M007	H E B	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
37808-903_5c71c88d-abfe-448a-b049-6a6931b4c237	37808-903	HUMAN OTC DRUG	Motion Sickness		Meclizine HCl	TABLET	ORAL	20190624		OTC MONOGRAPH DRUG	M009	H E B	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
37808-905_f4130277-ea9c-6b25-e053-2a95a90a59be	37808-905	HUMAN OTC DRUG	H-E-B SOLUTIONS SUNSCREEN COCONUT SPF 50 CONTINUOUS		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20190307		OTC MONOGRAPH FINAL	M020	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-907_d7862b65-ceb2-4c52-8641-b224ab96aeb8	37808-907	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20200429		OTC MONOGRAPH NOT FINAL	part333A	HEB	ALCOHOL	62	mg/mL			N	20241231
37808-908_f5660a97-57c9-61c7-e053-2995a90a0164	37808-908	HUMAN OTC DRUG	HEB SPF 55 Babies and Kids Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20190401		OTC MONOGRAPH FINAL	M020	H.E.B.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-909_406f2271-8af6-43b2-ad7b-d7236ddeb830	37808-909	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190626		ANDA	ANDA206394	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-911_8198a227-1e1b-4832-897e-657a413b0eb6	37808-911	HUMAN OTC DRUG	Nicotine		nicotine	GUM, CHEWING	ORAL	20190506		ANDA	ANDA078325	H E B	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-912_9c3680bc-296c-409e-9e5d-7867585fb76c	37808-912	HUMAN OTC DRUG	H.E.B		SPF 50 Sunscreen	AEROSOL, SPRAY	TOPICAL	20190307		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-913_abab0926-ab8a-4e0c-93d3-1e53eeb14c62	37808-913	HUMAN OTC DRUG	H.E.B BABY		SPF 50 Sunscreen	AEROSOL, SPRAY	TOPICAL	20190205		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-914_f8370b01-75d9-49cc-b644-95458541f721	37808-914	HUMAN OTC DRUG	H.E.B ULTRA		SPF 50 Sunscreen	AEROSOL, SPRAY	TOPICAL	20190205		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-915_27e7368a-4f9a-4f11-be77-6dfabfe3c672	37808-915	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080229		NDA	NDA022032	H E B	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37808-916_989ef0d8-20fb-413a-856b-61a0af6323a4	37808-916	HUMAN OTC DRUG	H.E.B MANGO		SPF 50 Sunscreen	LOTION	TOPICAL	20190207		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-918_59da94b1-7b09-4940-8522-dc6f45429fb7	37808-918	HUMAN OTC DRUG	H.E.B MANGO		SPF 50 Sunscreen	LOTION	TOPICAL	20190206		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-919_40cf8fcc-45b4-40aa-af28-af18373770b9	37808-919	HUMAN OTC DRUG	H.E.B BANANA		SPF 50 Sunscreen	LOTION	TOPICAL	20190206		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-921_51609e75-cfe1-4b45-9e2f-7b33a592c149	37808-921	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-922_78b3f713-7fe8-4c4d-9d83-821ef11f983c	37808-922	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	H E B	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
37808-924_703b49f8-e247-4391-8dd8-b5e9046d8ab8	37808-924	HUMAN OTC DRUG	H.E.B ULTRA		SPF 30 Sunscreen	AEROSOL, SPRAY	TOPICAL	20190424		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-925_799125c2-10fe-4f00-b4e3-7122933cd691	37808-925	HUMAN OTC DRUG	HILL COUNTRY ESSENTIALS		SPF 15	LOTION	TOPICAL	20180104		OTC MONOGRAPH NOT FINAL	part352	H.E.B	OCTINOXATE; OCTISALATE; OXYBENZONE	75; 50; 30	mg/mL; mg/mL; mg/mL			N	20241231
37808-928_6b7d09f4-b857-4e61-9541-2a143bd5a8ee	37808-928	HUMAN OTC DRUG	Miconazole		miconazole nitrate	CREAM	VAGINAL	20200317		ANDA	ANDA091366	H E B	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
37808-930_c6b7ad0c-2685-43df-e053-2995a90a7179	37808-930	HUMAN OTC DRUG	HEB BROAD SPECTRUM SPF 30 MANGO SCENTED SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-931_c6b7c7ec-fae8-ff39-e053-2a95a90ad604	37808-931	HUMAN OTC DRUG	HEB BROAD SPECTRUM SPF 30 COCONUT SCENTED SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20190326		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-932_3bc59d7a-3cda-492c-8476-2782959a5006	37808-932	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	H E B	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37808-933_c6b7ed91-4f27-7ac3-e053-2a95a90aa9ce	37808-933	HUMAN OTC DRUG	HEB BROAD SPECTRUM SPF 30 BANANA SCENTED SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-935_884b612b-7aff-4e32-aa00-a77e28346a7f	37808-935	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20210528		ANDA	ANDA207342	H E B	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
37808-937_6e2f3bf9-8d0e-4259-be85-ff191c406509	37808-937	HUMAN OTC DRUG	HEB Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20211021		OTC MONOGRAPH FINAL	part335	H E B	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
37808-941_ea2debcb-891e-339f-e053-2a95a90a4b18	37808-941	HUMAN OTC DRUG	HEB Solutions	Sunscreen Ultra 30	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20130206		OTC MONOGRAPH NOT FINAL	part352	H-E-B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 70; 50; 30; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-942_8f02eef5-3c65-46a5-8a2d-73a8aab789b8	37808-942	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20170117		OTC MONOGRAPH FINAL	part355	H-E-B	SODIUM FLUORIDE	.1	mg/mL			N	20241231
37808-943_6d323329-d284-45e6-aa8e-6c46579b2dc6	37808-943	HUMAN OTC DRUG	HEB		General Protection SPF 100 Lotion	LOTION	TOPICAL	20191112		OTC MONOGRAPH NOT FINAL	part352	H-E-B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-945_6cb77f79-6824-4dc1-aaa5-73b186ec622c	37808-945	HUMAN OTC DRUG	Pain Reliever	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	H E B	ACETAMINOPHEN	160	mg/1			N	20241231
37808-946_e3f9257a-b5a8-41c7-873a-95a6504f2ae6	37808-946	HUMAN OTC DRUG	pain and fever		Acetaminophen	SUSPENSION	ORAL	20111201		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	160	mg/5mL			N	20241231
37808-947_31fcf247-47a7-42ca-98c5-6f5a98771917	37808-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20150915		OTC MONOGRAPH FINAL	part333D	HEB	SALICYLIC ACID	20.6	mg/mL			N	20241231
37808-948_8783214d-7b03-410d-855a-4ae07c712d6e	37808-948	HUMAN OTC DRUG	nicotine polacrilex		nicotine	LOZENGE	ORAL	20190510		ANDA	ANDA077007	H E B	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
37808-951_c5ee6dea-38f7-5d5a-e053-2995a90a7d7e	37808-951	HUMAN OTC DRUG	HEB	Solutions Sunscreen	Sport SPF 100 Lotion	LOTION	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-952_4ba686a4-e6e9-4bf0-9369-f9e623906fe8	37808-952	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20160717		OTC MONOGRAPH NOT FINAL	part333A	Harmon Stores, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
37808-954_a87a2dc7-7d36-4326-8380-07dccee3ad17	37808-954	HUMAN OTC DRUG	H.E.B.	Solutions Sunscreen	Sport SPF 70 Lotion	LOTION	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-955_83ae2333-de43-4905-b0df-68ba696613cb	37808-955	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Kids SPF 70 Lotion	LOTION	TOPICAL	20120221		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-956_be07b3cf-05d6-4e94-8510-2cf744f766a1	37808-956	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Ultra SPF 50 Lotion	LOTION	TOPICAL	20120220		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 100; 50; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-958_1024ba27-ca1c-4545-ae7b-bcee8617f29f	37808-958	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Sport SPF 50 Lotion	LOTION	TOPICAL	20120218		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 100; 50; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-959_fa0f381b-daed-4525-81d4-0ff3d76a1c97	37808-959	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Face SPF 70 Lotion	LOTION	TOPICAL	20120216		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37808-960_711e8898-9637-411a-b53a-c45203b3cb22	37808-960	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20150715		OTC MONOGRAPH FINAL	part347	H-E-B	PETROLATUM	1	g/g			N	20241231
37808-961_f32ca4a4-3768-c9ec-e053-2995a90ab18a	37808-961	HUMAN OTC DRUG	HEB	Extra Whitening	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	HEB	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
37808-962_eff9399d-89a7-400e-abf9-70d9aef20f14	37808-962	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Coconut Pineapple Scented SPF 50 Stick	STICK	TOPICAL	20190227		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-965_663104c2-4f04-4290-a996-b02677879654	37808-965	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Ultra SPF 50 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 100; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-967_b795aca2-1176-4113-9d11-a72f34f13c94	37808-967	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Wet Protection Kids SPF 70 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-968_0ccb5970-3694-9097-e063-6294a90aa811	37808-968	HUMAN OTC DRUG	HEB Calagesic		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	H E B	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
37808-969_a0010d11-195a-4513-a917-e39769ea4249	37808-969	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Wet Protection Ultra SPF 85 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120203		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-971_ddf025dc-87e4-4fc1-a952-29cd17dd3e35	37808-971	HUMAN OTC DRUG	Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20160630	20250630	OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
37808-972_108771df-2eb4-4026-8ba1-b792c57f89ad	37808-972	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Cooling Sport SPF 50 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20140311		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-973_d002a9c8-96f0-4879-83fe-5bb98fa6dc8a	37808-973	HUMAN OTC DRUG	hydrocortisone		hydrocortisone	CREAM	TOPICAL	20100927		OTC MONOGRAPH NOT FINAL	part348	H E B	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37808-974_89eeaf63-2d6d-4703-ba41-e6af10c79e4b	37808-974	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Ultra SPF 50 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-975_6af1f19c-d797-4a09-9616-3257f345d4d9	37808-975	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Ultra SPF 70 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-976_7985ffb0-c05a-452e-91d9-1d973b0e9a8d	37808-976	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Sport SPF 30 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-978_c6b72109-361a-75fd-e053-2995a90a697b	37808-978	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Sport SPF 50 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120207		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-979_c8e5e096-6fcf-4f90-9cda-8e6c82042004	37808-979	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Sport SPF 70 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-980_125fdad3-68ee-4725-b156-2f785e39ad50	37808-980	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET	ORAL	19910615		OTC MONOGRAPH NOT FINAL	part343	H E B	ACETAMINOPHEN	500	mg/1			N	20241231
37808-981_c6b78cd4-dd9a-745c-e053-2995a90a3d48	37808-981	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Sport SPF 100 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120217		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-982_cba3d484-8d90-49cd-8567-12924ba102bf	37808-982	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Ultra SPF 100 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120120		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-983_ca08768d-26c2-4735-a975-89df8b7887ad	37808-983	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Kids SPF 50 Lotion Spray	AEROSOL, SPRAY	TOPICAL	20120209		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-984_42d96b1b-3e1c-4a1b-b94a-275854514fab	37808-984	HUMAN OTC DRUG	H.E.B	Solutions Sunscreen	Baby SPF 50 Lotion Spray	AEROSOL, SPRAY	TOPICAL	20190422		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
37808-985_b2ee3ec7-b26e-4651-904b-284ef8df9444	37808-985	HUMAN OTC DRUG	Hill Country Essentials		SPF 15 Moisturizing	LOTION	TOPICAL	20110709		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
37808-987_a0cbed7f-03cc-4dde-8071-4edfa19765ae	37808-987	HUMAN OTC DRUG	cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060921		OTC MONOGRAPH FINAL	part341	H E B	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-988_df62ad54-5aa3-4d05-e053-2a95a90aa48d	37808-988	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20181204		NDA	NDA021855	HEB	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
37808-989_7a4fded0-0ac6-42b0-804b-d63d5785e8a2	37808-989	HUMAN OTC DRUG	HEB READY TO USE	LAXATIVE	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20181025		OTC MONOGRAPH NOT FINAL	part334	HEB	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/133mL; g/133mL			N	20241231
37808-990_7a4fded0-0ac6-42b0-804b-d63d5785e8a2	37808-990	HUMAN OTC DRUG	HEB READY TO USE	LAXATIVE	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20181025		OTC MONOGRAPH NOT FINAL	part334	HEB	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/133mL; g/133mL			N	20241231
37808-991_d47d90ed-35a0-47c2-b164-f6ec9f71ab32	37808-991	HUMAN OTC DRUG	HEB Hemorrhoidal		Mineral Oil, Petrolatum, and Phenylephrine Hydrochloride	CREAM	RECTAL	20181023		OTC MONOGRAPH FINAL	part346	H-E-B	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-992_e18a9340-1aa9-4ab5-b0a3-e97246584fa9	37808-992	HUMAN OTC DRUG	HEB Maximum Strength Pain Relief Hemorrhoidal		glycerin, petrolatum, phenylephrine hydrochloride, and pramoxine hydrochloride	CREAM	TOPICAL	20181018		OTC MONOGRAPH FINAL	part346	HEB	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	.144; .15; .0025; .1	mg/2g; mg/2g; mg/2g; mg/2g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-993_cad6183e-2503-4cc9-904a-b7358fef652c	37808-993	HUMAN OTC DRUG	HEB HEMORRHOIDAL COOLING Gel		WITCH HAZEL and PHENYLEPHRINE HYDROCHLORIDE	CREAM	TOPICAL	20181018		OTC MONOGRAPH FINAL	part346	HEB	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	.0025; .5	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-994_e9043f66-a840-481e-9d2b-929184f740ba	37808-994	HUMAN OTC DRUG	day time		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20110727		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37808-995_c6b82e99-53ed-b57b-e053-2995a90adac4	37808-995	HUMAN OTC DRUG	Hill Country Essentials		Dimethicone	LOTION	TOPICAL	20100722		OTC MONOGRAPH FINAL	part347	H.E.B	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
37808-996_54d4e4de-90db-4d09-8c32-0071d21fff05	37808-996	HUMAN OTC DRUG	H.E.B		SPF 50 Sunscreen	AEROSOL, SPRAY	TOPICAL	20190424		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-997_caa10667-17ba-4b64-b8a3-1e6de9b62fb7	37808-997	HUMAN OTC DRUG	H.E.B		SPF 50 Sunscreen	AEROSOL, SPRAY	TOPICAL	20190426		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-998_c718b847-d225-8445-e053-2a95a90aadfa	37808-998	HUMAN OTC DRUG	H.E.B		SPF 50 Sunscreen	AEROSOL, SPRAY	TOPICAL	20190307		OTC MONOGRAPH NOT FINAL	part352	H.E.B	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
37808-999_1f6d54d4-f124-4194-b6dc-b9e37fd54faa	37808-999	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA090818	H E B	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
37835-001_92dc4ef5-9793-42ea-9eda-3a5dbce2a13d	37835-001	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20190930		ANDA	ANDA207891	BI-MART	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37835-003_84952de2-c0be-4bd1-b970-a1a3bf0a37f6	37835-003	HUMAN OTC DRUG	Antiseptic Rinse Spring Mint		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20100810		OTC MONOGRAPH NOT FINAL	part356	Bi-Mart	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37835-115_14bda69e-3974-40a5-8edf-569c8971d216	37835-115	HUMAN OTC DRUG	BI-MART Regular Strength Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190320		OTC MONOGRAPH FINAL	part331	Bi-Mart	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37835-126_ae37d5fb-e3c9-4037-bc4e-c86730835df6	37835-126	HUMAN OTC DRUG	BI-MART Regular Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190321		OTC MONOGRAPH FINAL	part331	Bi-Mart	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37835-127_c90f0e66-1cd8-4ff2-a33a-1c0586b89dac	37835-127	HUMAN OTC DRUG	Bi-Mart Extra Strength Antacid Assorted Fruit		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190315		OTC MONOGRAPH FINAL	part331	Bi-Mart	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37835-171_f1017f17-b70c-4fba-aa5f-65e48428646e	37835-171	HUMAN OTC DRUG	Bi-Mart Ultra Strength Antacid Assorted Fruit		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190319		OTC MONOGRAPH FINAL	part331	Bi-Mart	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37835-184_7c8443a4-fdd2-4209-bdba-e25491b7b8d9	37835-184	HUMAN OTC DRUG	Bi-Mart Extra Strength Antacid Assorted Berry		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180926		OTC MONOGRAPH FINAL	part331	Bi-Mart	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37835-189_75709b58-bc5c-443d-a699-7ab4d2411665	37835-189	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Bi-Mart	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
37835-318_62c132ef-da10-48b6-b4b0-4f5a5cc6de89	37835-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20100825		OTC MONOGRAPH NOT FINAL	part356	Bi-Mart	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
37835-319_7e421fbc-fad3-4b87-a9bc-2d3e15542ed3	37835-319	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20210429		OTC MONOGRAPH DRUG	M010	Bi-Mart	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
37835-471_7e0fbdc3-2612-40a3-9c85-db1f23d9980d	37835-471	HUMAN OTC DRUG	BI-MART Ultra Strength Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190321		OTC MONOGRAPH FINAL	part331	Bi-Mart	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
37835-524_3bdd9a40-3817-4a9a-bd31-c04f9d139354	37835-524	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20180618		OTC MONOGRAPH DRUG	M012	Bi-Mart	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
37835-526_a232712f-f7e0-4d96-8912-95f40f18c044	37835-526	HUMAN OTC DRUG	Cold and Flu	Daytime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20180618		OTC MONOGRAPH DRUG	M012	Bi-Mart	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
37835-738_ab92a57a-a920-4f17-8896-8e72d1a316c0	37835-738	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Bi-Mart	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
37835-901_cbb088fe-5c98-43ab-9ea1-7b056ca6d20e	37835-901	HUMAN OTC DRUG	Bi-Mart Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20200101	20240201	OTC MONOGRAPH DRUG	M004	Bi-Mart Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
37835-997_addbc1dc-5a62-4505-879d-6680f962edbd	37835-997	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20170517		ANDA	ANDA208150	Bi-Mart	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
37945-860_0c804d58-1443-eee4-e063-6294a90ac65b	37945-860	HUMAN OTC DRUG	PRO-TECT SUNSCREEN FOR PROFESSIONALS		Meradimate, Octinoxate, Octisalate, Oxybenzone	LOTION	CUTANEOUS	19801101		OTC MONOGRAPH DRUG	M020	Bio-Medical & Pharmaceutical Manufacturing Corporation	MERADIMATE; OCTINOXATE; OCTISALATE; OXYBENZONE	50; 75; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
37945-862_0c9399b1-9d16-f702-e063-6294a90a2802	37945-862	HUMAN OTC DRUG	PRO-TECT SPORTS SUNSCREEN		Meradimate, Octinoxate, Octisalate, Oxybenzone	LOTION	CUTANEOUS	20150205		OTC MONOGRAPH DRUG	M020	Bio-Medical & Pharmaceutical Manufacturing Corporation	MERADIMATE; OCTINOXATE; OCTISALATE; OXYBENZONE	50; 75; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
37945-862_0c943ad1-4656-b6b8-e063-6294a90a2b99	37945-862	HUMAN OTC DRUG	PRO-TECT SPORTS SUNSCREEN		Meradimate, Octinoxate, Octisalate, Oxybenzone	LOTION	CUTANEOUS	20150527		OTC MONOGRAPH DRUG	M020	Bio-Medical & Pharmaceutical Manufacturing Corporation	MERADIMATE; OCTINOXATE; OCTISALATE; OXYBENZONE	50; 75; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
37945-902_a346ebd2-fc2e-b574-e053-2995a90a0d3a	37945-902	HUMAN OTC DRUG	ANTIMICROBIAL FACE BODY WASH		benzethonium chloride liquid	LIQUID	TOPICAL	20151009		OTC MONOGRAPH NOT FINAL	part333E	Bio-Medical & Pharmaceutical Manufacturing Corporation	BENZETHONIUM CHLORIDE	.2	g/100g			N	20241231
39328-024_1c506667-9c89-4467-ac09-d1da6b67fd48	39328-024	HUMAN OTC DRUG	Lidocaine		Lidocaine	CREAM	TOPICAL	20181101		OTC MONOGRAPH FINAL	part348	Patrin Pharma Inc.	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
39328-025_a01912cb-9188-4002-8300-8daeaccf2539	39328-025	HUMAN OTC DRUG	Lidocaine Anorectal		Lidocaine	CREAM	RECTAL	20181101		OTC MONOGRAPH FINAL	part346	Patrin Pharma Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
39328-029_b44a8a6e-1239-4b41-8856-9d047ca77958	39328-029	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20220101		UNAPPROVED DRUG OTHER		Patrin Pharma Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
39328-054_604deb17-dd9e-4386-a52b-248b1d5cb6b7	39328-054	HUMAN PRESCRIPTION DRUG	Methylphenidate HCl		Methylphenidate HCl	SOLUTION	ORAL	20200423		ANDA	ANDA210764	Patrin Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
39328-079_5d3d3dcc-d669-40b4-8bed-48415a2a4df1	39328-079	HUMAN PRESCRIPTION DRUG	Flac Otic Oil		fluocinolone acetonide	OIL	AURICULAR (OTIC)	20180412		ANDA	ANDA210736	Patrin Pharma, Inc.	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
39328-090_3a08157d-abaf-445c-b333-c209ef961bc0	39328-090	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	SOLUTION	ORAL	20220614		ANDA	ANDA212604	Patrin Pharma, Inc.	PREGABALIN	20	mg/mL		CV	N	20241231
39328-106_3ca7c2e1-8af0-48ae-893a-8f4e06eac6a9	39328-106	HUMAN PRESCRIPTION DRUG	Prenatal Plus Vitamins		prenatal with ferrous fumarate and folic acid	TABLET	ORAL	20130401		UNAPPROVED DRUG OTHER		Patrin Pharma, Inc.	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; BETA CAROTENE; CALCIUM CARBONATE; CHOLECALCIFEROL; CUPRIC OXIDE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	10; 120; 276; 200; 10; 2; 12; 27; 1667; 20; 10; 3; 1.84; 924; 25	mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
39328-129_b44a8a6e-1239-4b41-8856-9d047ca77958	39328-129	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20220101		UNAPPROVED DRUG OTHER		Patrin Pharma Inc.	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
39328-154_604deb17-dd9e-4386-a52b-248b1d5cb6b7	39328-154	HUMAN PRESCRIPTION DRUG	Methylphenidate HCl		Methylphenidate HCl	SOLUTION	ORAL	20200423		ANDA	ANDA210764	Patrin Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
39328-530_6460efaa-d942-4481-953e-16db0ddbda30	39328-530	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		amantadine hydrochloride	SOLUTION	ORAL	20230811		ANDA	ANDA214178	Patrin Pharma, Inc.	AMANTADINE HYDROCHLORIDE	50	mg/5mL	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
39328-544_fcdc36f7-1523-46dc-a976-c3d150fae843	39328-544	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	SOLUTION	ORAL	20220215		ANDA	ANDA209108	Patrin Pharma, Inc.	CYPROHEPTADINE	2	mg/5mL			N	20241231
39765-008_3f6d4a90-5c86-4874-b63a-a48f9aea44b7	39765-008	HUMAN OTC DRUG	Heeltastic		DIMETHICONE	STICK	TOPICAL	20090630		OTC MONOGRAPH FINAL	part347	Neutraderm, Inc.	DIMETHICONE	1	g/100g	Skin Barrier Activity [PE]		N	20241231
39765-011_2e202a4c-12d0-4b5c-9392-4387a275c4cc	39765-011	HUMAN OTC DRUG	Hempvana	Pain Relief	Trolamine Salicylate	CREAM	TOPICAL	20190110		OTC MONOGRAPH NOT FINAL	part348	Neutraderm, Inc.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
39765-034_21c73db5-9dd9-4805-b894-11ce10ad31ae	39765-034	HUMAN OTC DRUG	24 Hour Acne Serum		Benzoyl Peroxide	GEL	TOPICAL	20190208		OTC MONOGRAPH FINAL	part333D	Neutraderm, Inc.	BENZOYL PEROXIDE	5	g/100g			N	20241231
39765-035_1638bba3-b0ce-43f9-8fcc-77902aad1e3d	39765-035	HUMAN OTC DRUG	Broad Spectrum SPF45		Zinc Oxide, Octinoxate	GEL	TOPICAL	20200106		OTC MONOGRAPH NOT FINAL	part352	Neutraderm, Inc.	OCTINOXATE; ZINC OXIDE	7.5; 12	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
39765-036_7ad72c6c-8991-4b24-a3b2-08008ab1c171	39765-036	HUMAN OTC DRUG	Tinted Moisturizer SPF 46 Universal Tint		Zinc oxide, Octinoxate	CREAM	TOPICAL	20200106		OTC MONOGRAPH NOT FINAL	part352	Neutraderm, Inc.	OCTINOXATE; ZINC OXIDE	7.5; 12	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
39822-0151_02f79412-2198-a8af-e063-6394a90a0853	39822-0151	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	INJECTION, SOLUTION	INTRAVENOUS	20050817		ANDA	ANDA076923	XGen Pharmaceuticals DJB, Inc.	LIOTHYRONINE SODIUM	10	ug/mL	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
39822-0166_eedc47c0-5580-3069-e053-2995a90a0226	39822-0166	HUMAN PRESCRIPTION DRUG	Polymyxin B		Polymyxin B	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	19940930		ANDA	ANDA063000	XGen Pharmaceuticals DJB, Inc.	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
39822-0190_0c55a4a9-31d6-5169-e063-6394a90a7c3d	39822-0190	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20081210		ANDA	ANDA040784	XGen Pharmaceuticals DJB, Inc.	ACETAZOLAMIDE SODIUM	500	mg/5mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
39822-0250_01654fd8-d2e3-aa70-e063-6294a90aa503	39822-0250	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		Cyclophosphamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; ORAL	20231219		ANDA	ANDA211757	XGen Pharmaceuticals DJB, Inc.	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
39822-0255_01654fd8-d2e3-aa70-e063-6294a90aa503	39822-0255	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		Cyclophosphamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; ORAL	20231219		ANDA	ANDA211757	XGen Pharmaceuticals DJB, Inc.	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
39822-0260_01654fd8-d2e3-aa70-e063-6294a90aa503	39822-0260	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		Cyclophosphamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; ORAL	20231219		ANDA	ANDA211757	XGen Pharmaceuticals DJB, Inc.	CYCLOPHOSPHAMIDE	2	g/150mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
39822-0310_f98e5359-9315-9f38-e053-6294a90a2ba0	39822-0310	HUMAN PRESCRIPTION DRUG	Neomycin Sulfate		Neomycin Sulfate	TABLET	ORAL	20100312		ANDA	ANDA065220	XGen Pharmaceuticals DJB, Inc.	NEOMYCIN SULFATE	500	mg/1	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
39822-0350_df369d62-f1a4-1a53-e053-2995a90abbf9	39822-0350	HUMAN PRESCRIPTION DRUG	Lincomycin		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20150705		ANDA	ANDA201746	XGen Pharmaceuticals DJB, Inc.	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
39822-0353_df369d62-f1a4-1a53-e053-2995a90abbf9	39822-0353	HUMAN PRESCRIPTION DRUG	Lincomycin		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20150705		ANDA	ANDA201746	XGen Pharmaceuticals DJB, Inc.	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
39822-0412_f7047d2d-2b45-7a75-e053-6294a90a49a0	39822-0412	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010817		ANDA	ANDA065013	XGen Pharmaceuticals DJB, Inc.	TOBRAMYCIN SULFATE	1.2	g/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
39822-0500_eedc429c-f1bd-6111-e053-2995a90a70b4	39822-0500	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150629		ANDA	ANDA203110	XGen Pharmaceuticals DJB, Inc.	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
39822-0615_eedca302-5a83-6a5c-e053-2a95a90a7144	39822-0615	HUMAN PRESCRIPTION DRUG	Colistimethate		Colistimethate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110101		ANDA	ANDA064216	XGen Pharmaceuticals DJB, Inc.	COLISTIMETHATE SODIUM	150	mg/2mL	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
39822-0706_02f9e270-6046-83b6-e063-6394a90afc27	39822-0706	HUMAN PRESCRIPTION DRUG	Streptomycin		Streptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	19980630		ANDA	ANDA064210	XGen Pharmaceuticals DJB, Inc.	STREPTOMYCIN SULFATE	1	g/1	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Antimycobacterial [EPC]		N	20241231
39822-1000_fd8f9b33-2451-7a8c-e053-6294a90a7b52	39822-1000	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20120518		ANDA	ANDA201580	XGen Pharmaceuticals DJB, Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
39822-1030_09c10e65-0cea-3052-e063-6394a90ae199	39822-1030	HUMAN PRESCRIPTION DRUG	Ibuprofen Lysine		Ibuprofen Lysine	SOLUTION	INTRAVENOUS	20160408		ANDA	ANDA202402	XGen Pharmaceuticals DJB, Inc.	IBUPROFEN LYSINE	10	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
39822-1055_ff6c6de5-ba12-4176-817f-359761f6e4bf	39822-1055	HUMAN PRESCRIPTION DRUG	Amphotericin B		Amphotericin B	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19920429		ANDA	ANDA063206	XGen Pharmaceuticals DJB, Inc.	AMPHOTERICIN B	50	mg/10mL	Lipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
39822-1077_0bb396c9-ff0e-ae6b-e063-6294a90a9d5d	39822-1077	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170309		NDA	NDA208562	XGen Pharmaceuticals DJB, Inc.	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
39822-1100_d8119fcc-f10c-7370-e053-2995a90ae251	39822-1100	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191117		ANDA	ANDA202522	XGen Pharmaceuticals DJB, Inc.	FOLIC ACID	5	mg/mL			N	20241231
39822-1201_0cc9b11c-90cb-c93a-e063-6294a90ab1eb	39822-1201	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates		Neomycin and Polymyxin B Sulfates	SOLUTION	IRRIGATION	20060119		ANDA	ANDA065106	XGen Pharmaceuticals DJB, Inc.	NEOMYCIN SULFATE; POLYMYXIN B SULFATE	40; 200000	mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
39822-1220_0cc9b11c-90cb-c93a-e063-6294a90ab1eb	39822-1220	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates		Neomycin and Polymyxin B Sulfates	SOLUTION	IRRIGATION	20060131		ANDA	ANDA065108	XGen Pharmaceuticals DJB, Inc.	NEOMYCIN SULFATE; POLYMYXIN B SULFATE	40; 200000	mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
39822-2000_0a5d4d36-551d-dc6b-e063-6294a90a876c	39822-2000	HUMAN PRESCRIPTION DRUG	Clonidine		Clonidine	INJECTION, SOLUTION	EPIDURAL	20131029		ANDA	ANDA203167	XGen Pharmaceuticals DJB, Inc.	CLONIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
39822-2010_0a5d4d36-551d-dc6b-e063-6294a90a876c	39822-2010	HUMAN PRESCRIPTION DRUG	Clonidine		Clonidine	INJECTION, SOLUTION	EPIDURAL	20131029		ANDA	ANDA203167	XGen Pharmaceuticals DJB, Inc.	CLONIDINE HYDROCHLORIDE	500	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
39822-2100_9560cbbf-7e51-416d-b956-a3c2f7d696e7	39822-2100	HUMAN PRESCRIPTION DRUG	dactinomycin		dactinomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190731		ANDA	ANDA203999	XGen Pharmaceuticals DJB, Inc.	DACTINOMYCIN	.5	mg/mL	Actinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]		N	20241231
39822-3015_eedc4d46-9206-09f1-e053-2995a90aecf6	39822-3015	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	POWDER	TOPICAL	20040830		ANDA	ANDA065175	XGen Pharmaceuticals DJB, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
39822-3030_f98e8708-12cb-1665-e053-6394a90ac799	39822-3030	HUMAN PRESCRIPTION DRUG	Pentamidine Isethionate		PENTAMIDINE ISETHIONATE	INHALANT	RESPIRATORY (INHALATION)	20230404		ANDA	ANDA206983	XGen Pharmaceuticals DJB, Inc.	PENTAMIDINE ISETHIONATE	300	mg/6mL	Antiprotozoal [EPC]		N	20241231
39822-3050_f913c6ad-1490-8fd8-e053-6294a90a6ab2	39822-3050	HUMAN PRESCRIPTION DRUG	PENTAMIDINE ISETHIONATE		PENTAMIDINE ISETHIONATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230404		ANDA	ANDA206982	XGen Pharmaceuticals DJB, Inc.	PENTAMIDINE ISETHIONATE	300	mg/3mL	Antiprotozoal [EPC]		N	20241231
39822-4000_eedc47c0-5515-3069-e053-2995a90a0226	39822-4000	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20110805		ANDA	ANDA091485	XGen Pharmaceuticals DJB, Inc.	LEVETIRACETAM	500	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
39822-4200_eedcfb07-4e23-3152-e053-2995a90a6e6a	39822-4200	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	SOLUTION	INTRAVENOUS	20121201		ANDA	ANDA091115	XGen Pharmaceuticals DJB, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
39822-5525_0a5d6842-824c-e8a2-e063-6294a90ae239	39822-5525	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150130		ANDA	ANDA040737	XGen Pharmaceuticals DJB, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
39822-5550_45f076b3-407e-4ee7-ad5b-b935c8495383	39822-5550	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150130		ANDA	ANDA040737	XGen Pharmaceuticals DJB, Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
39892-0100_0c109b56-96ec-6044-e063-6394a90a36f2	39892-0100	HUMAN OTC DRUG	MediChoice Antiseptic Isopropyl Alcohol Prep Pads		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20120920		OTC MONOGRAPH DRUG	M003	Owens & Minor, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
39892-0101_0c10b30a-fa78-f370-e063-6294a90a3765	39892-0101	HUMAN OTC DRUG	MediChoice Alcohol Prep Pads		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20190913		OTC MONOGRAPH DRUG	M003	Owens & Minor, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
39892-0304_0c839d40-f744-03a6-e063-6394a90a8098	39892-0304	HUMAN OTC DRUG	MediChoice BZK Antiseptic		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20170829		OTC MONOGRAPH DRUG	M003	Owens & Minor Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
39892-0305_0c4ffbb2-a89e-4904-e063-6394a90a2503	39892-0305	HUMAN OTC DRUG	MediChoice Cleansing		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20170829		OTC MONOGRAPH DRUG	M003	Owens & Minor Distribution, Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
39892-0306_0c1083e3-bac5-7844-e063-6394a90a440b	39892-0306	HUMAN OTC DRUG	MediChoice OB Cleansing		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20170829		OTC MONOGRAPH DRUG	M003	Owens & Minor Distribution, Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
39892-0400_0c1083e3-ba7a-7844-e063-6394a90a440b	39892-0400	HUMAN OTC DRUG	MediChoice Instant Hand Sanitizer	Honey scented	ALCOHOL	GEL	TOPICAL	20190121		OTC MONOGRAPH DRUG	505G(a)(3)	Owens & Minor Distribution, Inc.	ALCOHOL	700	mg/mL			N	20241231
39892-0401_0c104598-a43b-b5d6-e063-6294a90a6b93	39892-0401	HUMAN OTC DRUG	MediChoice Instant Hand Sanitizer	Fragrance free	ALCOHOL	GEL	TOPICAL	20190121		OTC MONOGRAPH DRUG	505G(a)(3)	Owens & Minor Distribution, Inc.	ALCOHOL	700	mg/mL			N	20241231
39892-0412_0c10a1dd-3a84-f7d3-e063-6294a90a3232	39892-0412	HUMAN OTC DRUG	Antiseptic Hand Rub		ALCOHOL	GEL	TOPICAL	20190301		OTC MONOGRAPH DRUG	505G(a)(3)	Owens & Minor Distribution, Inc.	ALCOHOL	620	mg/mL			N	20241231
39892-0500_0c108ed1-d54d-7739-e063-6394a90a8b9b	39892-0500	HUMAN OTC DRUG	MediChoice Isopropyl Rubbing Alcohol		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20190320		OTC MONOGRAPH DRUG	M003	Owens & Minor Distribution, Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
39892-0602_0c4ffbb2-a8a2-4904-e063-6394a90a2503	39892-0602	HUMAN OTC DRUG	MediChoice Fluoride		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20130301		OTC MONOGRAPH DRUG	M021	Owens & Minor Inc.	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
39892-0603_0c106d71-8478-47eb-e063-6394a90adc19	39892-0603	HUMAN OTC DRUG	MediChoice Premium Anticavity Fluoride		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20130301		OTC MONOGRAPH DRUG	M021	Owens & Minor	SODIUM FLUORIDE	2.43	mg/g			N	20241231
39892-0700_0c1083e3-ba89-7844-e063-6394a90a440b	39892-0700	HUMAN OTC DRUG	MediChoice of Hydrogen Peroxide 3 10 Volume		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20190320		OTC MONOGRAPH DRUG	M003	Owens & Minor Distribution, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
39892-0710_0c1083e3-baa9-7844-e063-6394a90a440b	39892-0710	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20190301		OTC MONOGRAPH DRUG	M003	Owens & Minor Distribution, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
39892-0801_0c1083e3-ba9a-7844-e063-6394a90a440b	39892-0801	HUMAN OTC DRUG	MediChoice Alcohol Swabstick		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20180608		OTC MONOGRAPH DRUG	M003	Owens & Minor, Inc	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
39892-0802_0c1069d3-14c6-9959-e063-6294a90a7d85	39892-0802	HUMAN OTC DRUG	MediChoice PVP Swabsticks		POVIDONE-IODINE	SWAB	TOPICAL	20130502		OTC MONOGRAPH DRUG	505G(a)(3)	Owens and Minor	POVIDONE-IODINE	10	g/100g			N	20241231
39892-0803_0c106c8a-d937-d143-e063-6294a90a1cdd	39892-0803	HUMAN OTC DRUG	MediChoice Alcohol Swabstick		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20130717		OTC MONOGRAPH DRUG	M003	Owens & Minor, Inc	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
39892-0804_0c10a1dd-3a77-f7d3-e063-6294a90a3232	39892-0804	HUMAN OTC DRUG	MediChoice PVP Swabsticks		POVIDONE-IODINE	SWAB	TOPICAL	20130502		OTC MONOGRAPH DRUG	505G(a)(3)	Owens and Minor	POVIDONE-IODINE	10	g/100g			N	20241231
39892-0807_0c108ed1-d55d-7739-e063-6394a90a8b9b	39892-0807	HUMAN OTC DRUG	Roll-On Antiperspirant Deodorant - Scented		ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20150924		OTC MONOGRAPH DRUG	M019	OWENS & MINOR	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
39892-0808_0c501699-fbcf-1c59-e063-6294a90ac8af	39892-0808	HUMAN OTC DRUG	MediChoice Povidone-Iodine Prep Pad		POVIDONE-IODINE	CLOTH	TOPICAL	20190304		OTC MONOGRAPH DRUG	505G(a)(3)	Owens & Minor Distribution, Inc.	POVIDONE-IODINE	100	mg/mL			N	20241231
39892-0809_0c10b072-dfc3-f83a-e063-6294a90af4cb	39892-0809	HUMAN OTC DRUG	Povidone-Iodine Prep		POVIDONE-IODINE	SOLUTION	TOPICAL	20190301		OTC MONOGRAPH DRUG	M005	Owens & Minor Distribution, Inc.	POVIDONE-IODINE	100	mg/mL			N	20241231
39892-0810_0c10ca9d-785c-0b7a-e063-6294a90a0859	39892-0810	HUMAN OTC DRUG	MediChoice Bacitracin		Bacitracin	OINTMENT	TOPICAL	20150326		OTC MONOGRAPH DRUG	M004	Owens & Minor, Inc	BACITRACIN	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
39892-0811_0c109b56-96dc-6044-e063-6394a90a36f2	39892-0811	HUMAN OTC DRUG	MediChoice PVP		POVIDONE-IODINE	SWAB	TOPICAL	20170829		OTC MONOGRAPH DRUG	505G(a)(3)	Owens & Minor Inc.	POVIDONE-IODINE	10	g/100g			N	20241231
39892-0812_0c10a1dd-3a66-f7d3-e063-6294a90a3232	39892-0812	HUMAN OTC DRUG	MediChoice PVP		POVIDONE-IODINE	SWAB	TOPICAL	20170829		OTC MONOGRAPH DRUG	505G(a)(3)	Owens & Minor Inc.	POVIDONE-IODINE	10	g/100g			N	20241231
39892-0820_0c1083e3-bab6-7844-e063-6394a90a440b	39892-0820	HUMAN OTC DRUG	MediChoice Povidone-Iodine		POVIDONE-IODINE	OINTMENT	TOPICAL	20190304		OTC MONOGRAPH DRUG	505G(a)(3)	Owens & Minor Distribution, Inc.	POVIDONE-IODINE	100	mg/g			N	20241231
39892-0830_0c1083e3-bad3-7844-e063-6394a90a440b	39892-0830	HUMAN OTC DRUG	MediChoice Triple Antibiotic		Bacitracin	OINTMENT	TOPICAL	20150327		OTC MONOGRAPH DRUG	M004	Owens & Minor Inc.	BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
39892-0900_0c106d71-8468-47eb-e063-6394a90adc19	39892-0900	HUMAN OTC DRUG	MediChoice Lip Balm	SPF 15	OXYBENZONE, OCTINOXATE	LIPSTICK	TOPICAL	20141222		OTC MONOGRAPH DRUG	M020	Owens & Minor Inc.	OCTINOXATE; OXYBENZONE	7.5; 3	g/100g; g/100g			N	20241231
39892-0940_08f1e954-4e1a-d5de-e063-6394a90a64eb	39892-0940	HUMAN OTC DRUG	MediChoice Moisturizing Lip Balm SPF15		AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20141222		OTC MONOGRAPH DRUG	M020	Owens & Minor Distribution, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 65; 50; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
40028-511_9ab6839d-b112-4b0c-a203-8051d61b6140	40028-511	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F 18	INJECTION, SOLUTION	INTRAVENOUS	20080729		ANDA	ANDA079086	PETNET Solutions, Inc.	FLUDEOXYGLUCOSE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
40028-512_52ee89ca-bc43-4561-84a0-e2cc503be997	40028-512	HUMAN PRESCRIPTION DRUG	Sodium Fluoride F 18		Sodium Fluoride F 18	INJECTION, SOLUTION	INTRAVENOUS	20110126		ANDA	ANDA203890	PETNET Solutions, Inc.	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
40028-513_ea72117c-68b3-4581-982a-38155344c06b	40028-513	HUMAN PRESCRIPTION DRUG	Ammonia N 13		Ammonia N-13	INJECTION	INTRAVENOUS	20070823		ANDA	ANDA204510	PETNET Solutions, Inc.	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
40032-016_878c2746-64ac-4cf5-a8d6-25b2799b5891	40032-016	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		DICLOFENAC SODIUM	SOLUTION	TOPICAL	20151209		ANDA	ANDA205878	Novel Laboratories, Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
40032-024_e89ba1da-1104-4402-b0c5-e5afe8373eea	40032-024	HUMAN PRESCRIPTION DRUG	Desoximetasone		desoximetasone	OINTMENT	TOPICAL	20160510		ANDA	ANDA206792	Novel Laboratories, Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
40032-026_09d4aa56-fa9a-4697-aeab-87ba2f0cca92	40032-026	HUMAN PRESCRIPTION DRUG	fluocinonide		fluocinonide	SOLUTION	TOPICAL	20170721		ANDA	ANDA206003	Novel Laboratories, Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
40032-028_47d04010-3bdd-4720-82bb-54db608ded8a	40032-028	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	SOLUTION	TOPICAL	20151123		ANDA	ANDA206075	Novel Laboratories, Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
40032-038_55941af1-d7bf-494a-b90f-9ef19bc76eba	40032-038	HUMAN PRESCRIPTION DRUG	VORICONAZOLE		voriconazole	SUSPENSION	ORAL	20160601		ANDA	ANDA206799	Novel Laboratories, Inc.	VORICONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
40032-090_dd003952-2ae1-4c8d-9f2e-8dd6ae470279	40032-090	HUMAN PRESCRIPTION DRUG	POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES		POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES	POWDER, FOR SOLUTION	ORAL	20090601		ANDA	ANDA090231	Novel Laboratories, Inc.	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
40032-096_3853a6ab-db3f-4b76-b323-d769289a33ff	40032-096	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	OINTMENT	TOPICAL	20161125		ANDA	ANDA208841	Novel Laboratories, Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
40032-118_ced58732-29db-4f15-a4d4-858f3e4ecc4e	40032-118	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		Hydrocodone Bitartrate and Homatropine Methylbromide	TABLET	ORAL	20140923		ANDA	ANDA091528	Novel Laboratories, Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-160_b702ac6b-e9de-04a9-e053-2995a90a908d	40032-160	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20120725		ANDA	ANDA091667	Novel Laboratories, Inc.	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
40032-161_b702ac6b-e9de-04a9-e053-2995a90a908d	40032-161	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20120725		ANDA	ANDA091667	Novel Laboratories, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
40032-168_69533b48-eb7a-4cca-b672-95b570bfd950	40032-168	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	SOLUTION	ORAL	20180924		ANDA	ANDA209786	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	1.3	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-169_69533b48-eb7a-4cca-b672-95b570bfd950	40032-169	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	SOLUTION	ORAL	20180924		ANDA	ANDA209786	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	2.6	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-194_2464d5be-aa5e-4a28-8f7d-032a28132d8d	40032-194	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	FOR SOLUTION	ORAL	20181121		ANDA	ANDA210241	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	1.5	g/1.54g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-330_63ba2637-37db-4f1e-b488-6e53466a5028	40032-330	HUMAN PRESCRIPTION DRUG	Trimethoprim		Trimethoprim	TABLET	ORAL	20140304		ANDA	ANDA091437	Novel Laboratories, Inc.	TRIMETHOPRIM	100	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
40032-351_d207a3f2-17b8-47f0-8b10-a6080abeb477	40032-351	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161114		ANDA	ANDA206142	Novel Laboratories, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-352_d207a3f2-17b8-47f0-8b10-a6080abeb477	40032-352	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161114		ANDA	ANDA206142	Novel Laboratories, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-353_d207a3f2-17b8-47f0-8b10-a6080abeb477	40032-353	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161114		ANDA	ANDA206142	Novel Laboratories, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-356_102fbf8d-aff3-4f1c-b75b-deb9e4e22329	40032-356	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Novel Laboratories, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-357_102fbf8d-aff3-4f1c-b75b-deb9e4e22329	40032-357	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Novel Laboratories, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-358_102fbf8d-aff3-4f1c-b75b-deb9e4e22329	40032-358	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Novel Laboratories, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-450_f62f5875-c0f1-4892-95c4-a811d8b6f1de	40032-450	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20140908		ANDA	ANDA201693	Novel Laboratories, Inc.	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
40032-540_45a60fd8-71d8-4bf4-9946-372f7b39b2b0	40032-540	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Novel Laboratories, Inc.	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
40032-541_45a60fd8-71d8-4bf4-9946-372f7b39b2b0	40032-541	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Novel Laboratories, Inc.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
40032-542_45a60fd8-71d8-4bf4-9946-372f7b39b2b0	40032-542	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Novel Laboratories, Inc.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
40032-543_45a60fd8-71d8-4bf4-9946-372f7b39b2b0	40032-543	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Novel Laboratories, Inc.	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
40032-544_45a60fd8-71d8-4bf4-9946-372f7b39b2b0	40032-544	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Novel Laboratories, Inc.	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
40032-570_7620b57a-02e8-4fe6-9cd1-0e07a6152636	40032-570	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20150225		ANDA	ANDA204115	Novel Laboratories, Inc.	METHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
40032-571_7620b57a-02e8-4fe6-9cd1-0e07a6152636	40032-571	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20150225		ANDA	ANDA204115	Novel Laboratories, Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
40032-572_7620b57a-02e8-4fe6-9cd1-0e07a6152636	40032-572	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20150225		ANDA	ANDA204115	Novel Laboratories, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
40032-622_af913ba6-b143-43c5-86fc-a36fd494b29d	40032-622	HUMAN PRESCRIPTION DRUG	Levonorgestrel		Levonorgestrel	TABLET	ORAL	20130215		ANDA	ANDA202508	Novel Laboratories, Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
40032-641_7372be05-1fb5-4d62-8380-6007f61c929b	40032-641	HUMAN PRESCRIPTION DRUG	Nitrofurantoin macrocrystals		Nitrofurantoin macrocrystals	CAPSULE	ORAL	20180709		ANDA	ANDA203233	Novel Laboratories, Inc.	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
40032-642_7372be05-1fb5-4d62-8380-6007f61c929b	40032-642	HUMAN PRESCRIPTION DRUG	Nitrofurantoin macrocrystals		Nitrofurantoin macrocrystals	CAPSULE	ORAL	20180709		ANDA	ANDA203233	Novel Laboratories, Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
40032-652_9a2d773a-3076-84c5-e053-2995a90a5864	40032-652	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20160308		ANDA	ANDA206793	Novel Laboratories, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
40032-653_9a2d773a-3076-84c5-e053-2995a90a5864	40032-653	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20160308		ANDA	ANDA206793	Novel Laboratories, Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
40032-700_dc9d6a79-3160-4122-a0d7-139148afe782	40032-700	HUMAN PRESCRIPTION DRUG	SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE		sodium sulfate, potassium sulfate, magnesium sulfate	SOLUTION	ORAL	20170223		ANDA	ANDA202511	Novel Laboratories, Inc.	MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE	1.6; 3.13; 17.5	g/177mL; g/177mL; g/177mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
40032-770_6e35eb2f-b8be-422e-adcd-c11a2a6e3cb4	40032-770	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170707		ANDA	ANDA204652	Novel Laboratories, Inc.	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
40032-771_6e35eb2f-b8be-422e-adcd-c11a2a6e3cb4	40032-771	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170707		ANDA	ANDA204652	Novel Laboratories, Inc.	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
40032-790_69d6f881-5c24-44c9-ae77-de969367ede4	40032-790	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Novel Laboratories, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
40032-791_69d6f881-5c24-44c9-ae77-de969367ede4	40032-791	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Novel Laboratories, Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
40032-792_69d6f881-5c24-44c9-ae77-de969367ede4	40032-792	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Novel Laboratories, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
40032-794_7511bdc8-a3f6-4f22-bad9-72d861c711c9	40032-794	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20170906		ANDA	ANDA207558	Novel Laboratories, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
40032-810_d4417a8f-2b85-4357-ac9e-f3a4ee0f335d	40032-810	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		Hydrocodone Bitartrate and Homatropine Methylbromide	SYRUP	ORAL	20170213		ANDA	ANDA203535	Novel Laboratories, Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
40032-910_4b78ca83-1687-4d09-b328-f62e12abeca8	40032-910	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20160815		ANDA	ANDA204828	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	8	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-911_4b78ca83-1687-4d09-b328-f62e12abeca8	40032-911	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20160815		ANDA	ANDA204828	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-912_40a8f62d-ea9b-4c51-a521-69362d46aa71	40032-912	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20160809		ANDA	ANDA206759	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	8	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-913_40a8f62d-ea9b-4c51-a521-69362d46aa71	40032-913	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20160809		ANDA	ANDA206759	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-915_1f2efdb4-0bce-41ab-beff-c9b682f93c84	40032-915	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20160121		ANDA	ANDA206347	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-917_1f2efdb4-0bce-41ab-beff-c9b682f93c84	40032-917	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20160121		ANDA	ANDA206347	Novel Laboratories, Inc.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
40032-950_65077bf1-49cf-4205-91f6-d6e2e81281ce	40032-950	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	CAPSULE	ORAL	20150824		ANDA	ANDA204752	Novel Laboratories, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
40032-980_79b1eb69-36b1-41ca-8ecd-a90bcc361ac7	40032-980	HUMAN PRESCRIPTION DRUG	Carbidopa		Carbidopa	TABLET	ORAL	20171020		ANDA	ANDA204763	Novel Laboratories, Inc.	CARBIDOPA	25	mg/1			N	20241231
40032-999_c42fae45-bbcf-40b6-911d-ebe3893f10ba	40032-999	HUMAN PRESCRIPTION DRUG	cevimeline hydrochloride		cevimeline hydrochloride	CAPSULE	ORAL	20161230		ANDA	ANDA204746	Novel Laboratories, Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
40046-0063_043cb9a7-5859-aafa-e063-6294a90ac910	40046-0063	HUMAN OTC DRUG	MAC PREP AND PRIME FACE PROTECT BROAD SPECTRUM SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	LOTION	TOPICAL	20120202		OTC MONOGRAPH FINAL	M020	MAKEUP ART COSMETICS	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 50; 27; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
40046-0065_043cc01d-6c56-aafd-e063-6294a90a91a4	40046-0065	HUMAN OTC DRUG	STUDIO SCULPT SPF 15 BROAD SPECTRUM FOUNDATION		OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20110901		OTC MONOGRAPH FINAL	M020	MAKEUP ART COSMETICS	OCTINOXATE; TITANIUM DIOXIDE	70; 20	mg/mL; mg/mL			N	20241231
40046-0072_043cfa0f-5975-17b9-e063-6394a90a31f3	40046-0072	HUMAN OTC DRUG	STUDIO FIX FLUID SPF 15 BROAD SPECTRUM		OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20051201		OTC MONOGRAPH FINAL	M020	MAKEUP ART COSMETICS	OCTINOXATE; TITANIUM DIOXIDE	25; 10	mg/mL; mg/mL			N	20241231
40046-0075_043d1192-3156-a513-e063-6294a90a9298	40046-0075	HUMAN OTC DRUG	MAC STUDIO WATERWEIGHT SPF 30 BROAD SPECTRUM FOUNDATION	SUNSCREEN	OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LIQUID	TOPICAL	20150801		OTC MONOGRAPH FINAL	M020	MAKEUP ART COSMETICS	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.05425; .03364; .02279	g/100mL; g/100mL; g/100mL			N	20241231
40046-0077_f059fd9f-3c1b-0be0-e053-2995a90a9502	40046-0077	HUMAN OTC DRUG	MAC LIGHTFUL Cplus CORAL GRASS TINTED WITH RADIANCE BOOSTER BROAD SPECTRUM SPF030		OCTINOXATE, OCTISALATE, OXYBENZONE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20171101		OTC MONOGRAPH FINAL	M020	MAKEUP ART COSMETICS	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	81.75; 43.6; 27.25; 11.99	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
40046-0078_04a0da49-e978-1c71-e063-6294a90ad1c9	40046-0078	HUMAN OTC DRUG	STUDIO FINISH CONCEALER BROAD SPECTRUM SPF 35		OCTINOXATE and TITANIUM DIOXIDE	PASTE	TOPICAL	20110808		OTC MONOGRAPH FINAL	M020	MAKEUP ART COSMETICS	OCTINOXATE; TITANIUM DIOXIDE	5; 2	g/100g; g/100g			N	20241231
40046-0082_fb59afc1-1dca-f783-e053-6394a90a196b	40046-0082	HUMAN OTC DRUG	STUDIO FIX FLUID BROAD SPECTRUM SPF 15		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230512		OTC MONOGRAPH FINAL	M020	MAKEUP ART COSMETICS	OCTINOXATE; TITANIUM DIOXIDE	30; 10	mg/mL; mg/mL			N	20241231
40054-1003_9d740de9-dc77-4903-afee-37485a69fa46	40054-1003	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20100101		UNAPPROVED MEDICAL GAS		Northeast Home Medical Supplies Inc.	OXYGEN	99	L/100L			N	20241231
40089-113_48cc7cd9-2b8c-45da-8561-eb8061a64d3d	40089-113	HUMAN PRESCRIPTION DRUG	Ammonia N 13		NH3N13	INJECTION	INTRAVENOUS	20120321		ANDA	ANDA204514	The Johns Hopkins University	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
40092-500_45be1209-9f1e-4d37-a019-293307118985	40092-500	HUMAN OTC DRUG	GOLDSHIELD 24	GS 24	BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20141121		OTC MONOGRAPH NOT FINAL	part333A	AP GOLDSHIELD LLC	BENZALKONIUM CHLORIDE	.001	g/g			N	20241231
40092-600_f742724a-bf0c-4032-ad6d-af5528ec2fd6	40092-600	HUMAN OTC DRUG	VETERAN SHIELD 24	VSH	BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20120615		OTC MONOGRAPH NOT FINAL	part333A	AP GOLDSHIELD LLC	BENZALKONIUM CHLORIDE	.001	g/g			N	20241231
40096-0051_db7fdd7f-84e1-4534-8336-ed5deb4dce88	40096-0051	HUMAN OTC DRUG	TOUGH GUY 821 Antimicrobial Liquid Ltion So ap		Chloroxylenol	LIQUID	TOPICAL	20081030		OTC MONOGRAPH NOT FINAL	part333E	W.W. GRAINGER, INC.	CHLOROXYLENOL	.003	mg/mL			N	20241231
40096-0080_14803f3d-1e3b-4e92-897c-183d0319e21d	40096-0080	HUMAN OTC DRUG	TOUGH GUY Antimicrobial Foam So ap		Chloroxylenol	LIQUID	TOPICAL	20070915		OTC MONOGRAPH NOT FINAL	part333E	W.W. GRAINGER, INC.	CHLOROXYLENOL	.003	mg/mL			N	20241231
40096-0081_fbe44ecc-c7c7-4197-a786-3b771f9b943a	40096-0081	HUMAN OTC DRUG	TOUGH GUY Antibacterial Foam Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20090415		OTC MONOGRAPH NOT FINAL	part333E	W.W. GRAINGER, INC.	CHLOROXYLENOL	.003	mg/mL			N	20241231
40096-0909_0670a414-60d5-b3af-e063-6394a90adfe7	40096-0909	HUMAN OTC DRUG	5EWA5 Antibacterial Hand Sanitizer Wipes		Hand Sanitizer Wipe	CLOTH	CUTANEOUS	20161001	20240228	OTC MONOGRAPH NOT FINAL	part333E	W.W. Grainger, Inc.	BENZALKONIUM CHLORIDE	.00097	g/mL			N	
40096-1909_06808b7c-a59e-8d45-e063-6394a90ac45f	40096-1909	HUMAN OTC DRUG	5EWA5 Antibacterial Hand Sanitizer Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20230913		OTC MONOGRAPH NOT FINAL	part333E	W.W. Grainger	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
40097-001_06d6632f-71bd-2cc5-e063-6394a90a3fcd	40097-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100830		UNAPPROVED MEDICAL GAS		Diamond Respiratory Care, Inc.	OXYGEN	99	L/100L			N	20241231
40098-101_ce69061e-3b04-77c9-e053-2995a90a84fc	40098-101	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F-18		Fludeoxyglucose F-18	INJECTION, SOLUTION	INTRAVENOUS	20141030		ANDA	ANDA203801	Trustees of the University of Pennsylvania	FLUDEOXYGLUCOSE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
40171-005_1169a6a1-89e8-4ced-bc61-cd4401da4954	40171-005	HUMAN OTC DRUG	blink tears		polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20160315		OTC MONOGRAPH FINAL	part349	Bausch & Lomb Incorporated	POLYETHYLENE GLYCOL 400	2.5	mg/mL			N	20241231
41163-001_616aa521-346f-4285-95cd-58ddb6f26ea4	41163-001	HUMAN OTC DRUG	equaline heartburn prevention		Famotidine	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA077351	United Natural Foods, Inc. dba UNFI	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41163-004_6601b51b-c5c0-4b3b-b747-b2a54288d4cd	41163-004	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20110817		OTC MONOGRAPH FINAL	part355	United Natural Foods, Inc. dba UNFI	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41163-005_771db722-84f3-4d89-aa17-9dd918e36edc	41163-005	HUMAN OTC DRUG	Saline Laxative		sodium phosphate	ENEMA	RECTAL	20120831		OTC MONOGRAPH NOT FINAL	part334	Supervalu Inc	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
41163-009_7653d8de-7049-4fb3-827a-eba572141178	41163-009	HUMAN OTC DRUG	Calamine		Calamine, Pramoxind HCl	LOTION	TOPICAL	20090521		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	8.6; 10; 20	mg/mL; mg/mL; mg/mL			N	20241231
41163-011_25724c58-b7de-447c-a28b-28ee3820d73b	41163-011	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20151218		OTC MONOGRAPH DRUG	M021	United Natural Foods, Inc. dba UNFI	SODIUM FLUORIDE	.1	mg/mL			N	20241231
41163-015_88f3c96e-7d16-476f-9d91-b3697172c461	41163-015	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130826		OTC MONOGRAPH NOT FINAL	part356	United Natural Foods, Inc. dba UNFI	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41163-020_c83f5ffb-c707-4a53-bb7b-57318306a6ec	41163-020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	OINTMENT	TOPICAL	20091118		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	ZINC OXIDE	400	mg/g			N	20241231
41163-023_0d103745-d0c1-488d-9a49-667e5287d7f3	41163-023	HUMAN OTC DRUG	Equaline Fluticasone Propionate		Fluticasone propionate	SPRAY, METERED	NASAL	20160531		ANDA	ANDA207957	United Natural Foods, Inc. dba UNFI	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41163-031_a81e66bd-017a-4b3f-92a3-d83537ef531d	41163-031	HUMAN OTC DRUG	Vapor Inhaler	levmetamfetamine nasal decongestant, Equaline	Levmetamfetamine	INHALANT	NASAL	20210224		OTC MONOGRAPH FINAL	part341	Supervalu Inc.	LEVMETAMFETAMINE	50	mg/1			N	20241231
41163-032_07a00775-6625-48de-9963-5626755d3a04	41163-032	HUMAN OTC DRUG	Equaline Tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20160308		ANDA	ANDA075915	United Natural Foods, Inc. dba UNFI	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41163-035_0bdb7693-bb5e-4243-a24f-ddd6d3a91c86	41163-035	HUMAN OTC DRUG	Mucus Relief	Cold Flu and Sore Throat Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141231		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-040_1beee14b-483f-4206-ab9f-54dd8c3cbaab	41163-040	HUMAN OTC DRUG	equaline first aid antibiotic		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20150402		OTC MONOGRAPH FINAL	part333B	United Natural Foods, Inc. dba UNFI	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
41163-041_262c6024-849b-4d98-9473-7228fd45c97b	41163-041	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20150706		OTC MONOGRAPH DRUG	M006	United Natural Foods, Inc. dba UNFI	SALICYLIC ACID	19.8	mg/g			N	20241231
41163-043_a1362df4-305c-43ef-93f0-791c59f2cba7	41163-043	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20090913		OTC MONOGRAPH DRUG	M021	United Natural Foods, Inc. dba UNFI	SODIUM FLUORIDE	.1	mg/mL			N	20241231
41163-045_b9a8787e-40e9-40ff-99d2-0c7caa2d570a	41163-045	HUMAN OTC DRUG	childrens acetaminophen		acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	160	mg/1			N	20241231
41163-047_b1aa59bc-0e5c-4262-86ff-9722a9102123	41163-047	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141130		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-050_240bca28-8f82-4586-9917-eac30577cd29	41163-050	HUMAN OTC DRUG	equaline ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20090302		ANDA	ANDA079113	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-053_e6b521b3-99a9-45e9-ab11-c48af79d7174	41163-053	HUMAN OTC DRUG	Severe Cold		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20230127		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-054_8f2a455a-ff19-4cea-8e88-f440971bfe58	41163-054	HUMAN OTC DRUG	Equaline 12 Hour Decongestant		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20040810		ANDA	ANDA075153	United Natural Foods, Inc. dba UNFI	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41163-055_a372b48f-81c2-4afc-b430-e967c1103a5d	41163-055	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19940729		OTC MONOGRAPH NOT FINAL	part356	United Natural Foods, Inc. dba UNFI	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41163-057_5dcc0fc7-3a53-4eed-8f69-5b783acbb8db	41163-057	HUMAN OTC DRUG	Equaline Ibuprofen		ibuprofen	SUSPENSION	ORAL	20040907		ANDA	ANDA075217	United Natural Foods, Inc. dba UNFI	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-058_8e9dac6c-a287-46da-97fa-a913c29454d1	41163-058	HUMAN OTC DRUG	Equaline Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20220105		OTC MONOGRAPH FINAL	part335	Supervalu Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
41163-061_c83b1030-5da4-4e4b-a4de-da070c5afad6	41163-061	HUMAN OTC DRUG	equaline nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20140715		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41163-065_d6b49f0a-cf05-4b1b-8cad-c5795aa31645	41163-065	HUMAN OTC DRUG	maximum strength antacid cherry		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20220610		OTC MONOGRAPH FINAL	part331	Supervalu Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41163-069_c99d23aa-3d3f-4678-8f2a-e1c15e2413c1	41163-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20090105		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	PETROLATUM	1	g/g			N	20241231
41163-072_e6f0e5a1-a08f-4cf4-ba4d-71a8a30b3f04	41163-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20041228		OTC MONOGRAPH NOT FINAL	part356	United Natural Foods, Inc. dba UNFI	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41163-073_f5e1f3da-da06-4b79-8773-b88781563d6f	41163-073	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20050620		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
41163-078_d15656c5-ea79-4daf-8b36-c5bd78c4336b	41163-078	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	20041216		OTC MONOGRAPH NOT FINAL	part334	United Natural Foods, Inc. dba UNFI	CASTOR OIL	1	mL/mL			N	20241231
41163-079_94ab3a89-85d0-4985-ad99-43bd7bbf9e48	41163-079	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190115		NDA	NDA021920	SUPERVALU INC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-081_c41cc9e9-be8c-434d-9120-e6735acb124a	41163-081	HUMAN OTC DRUG	Equaline Miconazole 3		Miconazole nitrate	KIT		20120116		ANDA	ANDA075329	United Natural Foods, Inc. dba UNFI						N	20241231
41163-086_a8685d1a-b703-46cf-8381-c8fbd169c245	41163-086	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20150116		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41163-087_3cb4f3b7-e9ce-4688-998f-4c993adda707	41163-087	HUMAN OTC DRUG	equaline arthritis pain relieving		diclofenac sodium	GEL	TOPICAL	20200902		ANDA	ANDA211253	United Natural Foods, Inc. dba UNFI	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-088_2cde3f3c-b411-4fd9-a78d-0aaa755f805e	41163-088	HUMAN OTC DRUG	Iodine		Iodine	LIQUID	TOPICAL	20050204		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	IODINE	20	mg/mL			N	20241231
41163-089_55bd8b87-c698-4095-85c9-920dafba6567	41163-089	HUMAN OTC DRUG	equaline	anti-itch	Diphenhydramine hydrochloride and Zinc acetate	CREAM	TOPICAL	20050920		OTC MONOGRAPH NOT FINAL	part348	Supervalu Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-096_a9902ba0-f239-4e66-8d66-7cef39a5fdc3	41163-096	HUMAN OTC DRUG	Infants Gas relief		Simethicone	SOLUTION/ DROPS	ORAL	20210826		OTC MONOGRAPH FINAL	part332	Supervalu Inc.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
41163-099_419323f9-dde4-44b0-b115-f734f2cc2fe8	41163-099	HUMAN OTC DRUG	Clear Anti Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20050402		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41163-101_c0c58736-b836-4dc0-a611-c4111be7efa4	41163-101	HUMAN OTC DRUG	EQUALINE regular strength antacid		Antacid	TABLET, CHEWABLE	ORAL	20150922		OTC MONOGRAPH FINAL	part331	SUPERVALU INC	CALCIUM CARBONATE	500	mg/1			N	20241231
41163-102_dc5e498a-2fcd-4a72-9510-773955d8568d	41163-102	HUMAN OTC DRUG	EQUALINE extra strength antacid		Antacid	TABLET, CHEWABLE	ORAL	20150928		OTC MONOGRAPH FINAL	part331	SUPERVALU INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41163-107_de0ad02e-7c89-4c63-a49c-1035cb30b9ca	41163-107	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20221230		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM	100	mg/1			N	20241231
41163-113_884d2e82-11b0-43d6-a406-10d8acfedbb5	41163-113	HUMAN OTC DRUG	Equaline Chest Congestion Relief		Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Supervalu Inc.	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41163-114_ea17e9b4-1433-42d1-b275-e7a0d51e9b61	41163-114	HUMAN OTC DRUG	Equaline Chest Congestion Relief DM	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Supervalu Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-116_fbe573b2-eb1c-af53-e053-6394a90a2dc9	41163-116	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200501		ANDA	ANDA202312	United Natural Foods, Inc. dba UNFI	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-119_9deda665-16bf-4afc-a11d-6beb51463d15	41163-119	HUMAN OTC DRUG	Equaline Night Time Sleep Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20140307		OTC MONOGRAPH FINAL	part338	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-135_f31e3744-6631-2fe3-e053-2995a90a8c00	41163-135	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20171227		OTC MONOGRAPH FINAL	part358F	SUPERVALU INC.	SALICYLIC ACID	40	mg/41			N	20241231
41163-136_f31e385e-a16f-2efd-e053-2995a90a20ab	41163-136	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171227		OTC MONOGRAPH FINAL	part358F	SUPERVALU INC	SALICYLIC ACID	40	mg/91			N	20241231
41163-137_fc74e2ba-eae1-28cc-e053-6394a90a5307	41163-137	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171227		OTC MONOGRAPH FINAL	part358F	United Natural Foods, Inc.	SALICYLIC ACID	.4	g/g			N	20241231
41163-138_fc750b10-d3ab-db6c-e053-6294a90a6ccb	41163-138	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20171227		OTC MONOGRAPH FINAL	part358F	United Natural Foods, Inc.	SALICYLIC ACID	.4	g/g			N	20241231
41163-147_89b1e278-3b6d-49d5-aedf-51bd05f248d8	41163-147	HUMAN OTC DRUG	Fiber Laxative		Calcium polycarbophil	TABLET	ORAL	20180824		OTC MONOGRAPH NOT FINAL	part334	Supervalu Inc.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
41163-150_8e0f1efe-3379-4625-925b-84758628c1f1	41163-150	HUMAN OTC DRUG	equaline lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210902		ANDA	ANDA202319	United Natural Foods, Inc. dba UNFI	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41163-153_7ad31eb7-ca68-4045-bc07-0d1177fd5679	41163-153	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20061026		OTC MONOGRAPH DRUG	M032	United Natural Foods, Inc. dba UNFI	PYRITHIONE ZINC	10	mg/mL			N	20241231
41163-157_0e6be75e-22df-4f5e-9a0b-f1419eaad024	41163-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20060210		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41163-158_dce4f370-16bd-4192-ab5c-bd74632c1c25	41163-158	HUMAN OTC DRUG	Equaline congestion relief		Ibuprofen, phenylephrine HCl	TABLET, FILM COATED	ORAL	20150717		ANDA	ANDA203200	United Natural Foods, Inc. dba UNFI	IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	200; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-166_e2f0adb1-c4b0-432b-87d1-5fc685040c8e	41163-166	HUMAN OTC DRUG	Equaline ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20041007		ANDA	ANDA074937	United Natural Foods, Inc. dba UNFI	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-185_fbe573b2-eb1f-af53-e053-6394a90a2dc9	41163-185	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180101		ANDA	ANDA079205	United Natural Foods, Inc. dba UNFI	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-186_a66b50f4-ccfc-4ccc-910c-e88a4ddd27cc	41163-186	HUMAN OTC DRUG	Equaline Night Time Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20130628		OTC MONOGRAPH FINAL	part338	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-188_ad2f876a-422f-4d14-b6bf-8b3c2503415a	41163-188	HUMAN OTC DRUG	Equaline Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20140110		OTC MONOGRAPH FINAL	part346	United Natural Foods, Inc. dba UNFI	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-192_fbe57746-3ad4-be0a-e053-6294a90a6af1	41163-192	HUMAN OTC DRUG	Acetaminophen Easy Tabs	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20131101	20250430	OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	500	mg/1			N	
41163-194_a281c4cf-4853-46f4-a229-b2cff95cc3bb	41163-194	HUMAN OTC DRUG	Allergy		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-195_8db37ac7-8bcc-40a3-94f3-1884092b1a93	41163-195	HUMAN OTC DRUG	Laxative	Enteric Coated	Bisacodyl	TABLET, COATED	ORAL	20130331	20241227	OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
41163-197_fbe573b2-eb20-af53-e053-6394a90a2dc9	41163-197	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20201022		ANDA	ANDA209274	United Natural Foods, Inc. dba UNFI	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-203_fbe58138-8e22-c4d9-e053-6294a90a3bd0	41163-203	HUMAN OTC DRUG	eight hour pain relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20220429		ANDA	ANDA211544	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	650	mg/1			N	20241231
41163-209_56b2534c-9070-4790-8802-4c93ee636ee2	41163-209	HUMAN OTC DRUG	equaline first aid antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20141124		OTC MONOGRAPH FINAL	part333B	United Natural Foods, Inc. dba UNFI	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
41163-210_878bc762-0471-4b01-94de-d0cab9f5af08	41163-210	HUMAN OTC DRUG	equaline loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20180521		ANDA	ANDA091292	United Natural Foods, Inc. dba UNFI	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41163-213_08df56da-9762-4ad2-8d0e-eb030bed08c4	41163-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20090514		OTC MONOGRAPH FINAL	part355	United Natural Foods, Inc. dba UNFI	SODIUM FLUORIDE	.5	mg/mL			N	20241231
41163-219_5f9eda18-b09e-4157-a91b-0f7f245046d8	41163-219	HUMAN OTC DRUG	all day allergy		Cetirizine HCl	CAPSULE	ORAL	20190115		NDA	NDA022429	SUPERVALU INC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-226_75861e5c-d145-408c-878c-c8ae7bd48002	41163-226	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	United Natural Foods, Inc. dba UNFI	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
41163-228_8cd494fb-cfd1-4c1e-bceb-1f1ce23065db	41163-228	HUMAN OTC DRUG	Acetaminophen PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20140829		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-241_5c236409-67bc-4a3d-83aa-a1e205b87614	41163-241	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM	100	mg/1			N	20241231
41163-247_96b2b5a3-d179-4fcb-b91a-35e7c9bb39e8	41163-247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20090105		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	PETROLATUM	410	mg/g			N	20241231
41163-248_0e38daa5-720d-4e16-8bc7-ee333fdb02d8	41163-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	CREAM	TOPICAL	20090112		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
41163-253_ef88bc67-703e-449b-b30d-815e12593da4	41163-253	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20150121		OTC MONOGRAPH DRUG	M032	United Natural Foods, Inc. dba UNFI	PYRITHIONE ZINC	10	mg/mL			N	20241231
41163-255_b54a7636-3b04-4611-a48c-8eea78bf1d8a	41163-255	HUMAN OTC DRUG	equaline ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20041222		ANDA	ANDA075217	United Natural Foods, Inc. dba UNFI	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-266_96db1604-2932-4b45-8ab4-a49609e71423	41163-266	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20210222		OTC MONOGRAPH DRUG	M032	United Natural Foods, Inc. dba UNFI	PYRITHIONE ZINC	10	mg/mL			N	20241231
41163-278_f2ee6f10-9239-45b6-9502-b327e602a200	41163-278	HUMAN OTC DRUG	Light Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20131101		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41163-279_85cdb84a-4367-4f73-8562-8e6c1d1ef7df	41163-279	HUMAN OTC DRUG	Equaline Hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140905		OTC MONOGRAPH FINAL	part346	United Natural Foods, Inc. dba UNFI	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-288_6decd5ef-e8e1-44ae-8465-6266cf18e81e	41163-288	HUMAN OTC DRUG	Soluble Fiber		Methylcellulose	TABLET	ORAL	20180824		OTC MONOGRAPH NOT FINAL	part334	Supervalu Inc.	METHYLCELLULOSE (4000 CPS)	500	mg/1			N	20241231
41163-290_fbe55a67-6cd3-6c28-e053-6394a90a2b24	41163-290	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20171201		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-292_fbe573d6-e133-8c02-e053-6294a90a3f1f	41163-292	HUMAN OTC DRUG	allergy relief		Fexofenadine Hydrochloride	TABLET	ORAL	20211029		ANDA	ANDA211075	United Natural Foods, Inc. dba UNFI	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-296_feb1fec9-1913-4ab8-9f5a-453596912ecc	41163-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20150119		OTC MONOGRAPH DRUG	M032	United Natural Foods, Inc. dba UNFI	PYRITHIONE ZINC	10	mg/mL			N	20241231
41163-299_2c761781-a2cc-420b-a4cf-130e8487189f	41163-299	HUMAN OTC DRUG	Equaline Multi-Action Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20070501		OTC MONOGRAPH NOT FINAL	part356	United Natural Foods, Inc. dba UNFI	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
41163-304_5d4ae0b9-8ed3-41e7-9074-fc8f41861a19	41163-304	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20020624		OTC MONOGRAPH DRUG	M009	United Natural Foods, Inc. dba UNFI	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
41163-306_ea8e5ed9-0754-4eae-8bf0-1416d5a7f943	41163-306	HUMAN OTC DRUG	equaline clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	United Natural Foods, Inc. dba UNFI	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41163-312_fbe573d6-e131-8c02-e053-6294a90a3f1f	41163-312	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200101		ANDA	ANDA202312	United Natural Foods, Inc. dba UNFI	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-313_a3ac1d4b-b97d-42e4-a53a-30683d8ab8fd	41163-313	HUMAN OTC DRUG	equaline heartburn prevention		Famotidine	TABLET, FILM COATED	ORAL	20090918		ANDA	ANDA075400	United Natural Foods, Inc. dba UNFI	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41163-318_615c32ac-18a9-43d2-9689-8e74024f5072	41163-318	HUMAN OTC DRUG	Mouth Rinse		EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL	MOUTHWASH	ORAL	20050104		OTC MONOGRAPH NOT FINAL	part356	United Natural Foods, Inc. dba UNFI	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41163-319_c86bb0ed-351c-41ea-a016-3a1d89b2d62c	41163-319	HUMAN OTC DRUG	equaline anti itch		Hydrocortisone	CREAM	TOPICAL	20101117		OTC MONOGRAPH NOT FINAL	part348	United Natural Foods, Inc. dba UNFI	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41163-321_44871ca3-3400-4bcd-8227-bd35f4bf4b21	41163-321	HUMAN OTC DRUG	equaline complete	dual action	famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20080902		ANDA	ANDA077355	United Natural Foods, Inc. dba UNFI	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41163-329_e2c03f04-f21b-4f70-849c-8b6ae5b6dc1b	41163-329	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-334_b4f3ad08-e699-4ef0-b0dd-11b111d22f4b	41163-334	HUMAN OTC DRUG	Headache Relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20171101		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
41163-335_19e406d9-4930-4b15-9ed1-d30bee3672d9	41163-335	HUMAN OTC DRUG	equaline nighttime cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20111017		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-338_0cfa84bd-0fca-c574-e063-6394a90aa9b2	41163-338	HUMAN OTC DRUG	Equaline Advanced Relief Eye Drops		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	United Natural Foods, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
41163-340_d450affe-7d13-4aa8-bff2-a19051923faf	41163-340	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20201123		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41163-343_6e35e4a4-2cfd-40c3-bae9-a461d576d857	41163-343	HUMAN OTC DRUG	Equaline Nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20160703		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41163-359_3746bc14-4937-4e84-839f-90ed5dd61cac	41163-359	HUMAN OTC DRUG	Equaline tussin	adult	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20040824		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-363_06ae1292-46b6-4859-976c-bcb85585c838	41163-363	HUMAN OTC DRUG	equaline acetaminophen		Acetaminophen	TABLET	ORAL	20170829		OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	500	mg/1			N	20241231
41163-364_0a4f60cb-fb2e-4b71-bad6-13d532f9821e	41163-364	HUMAN OTC DRUG	Equaline Childrens Allergy Relief		loratadine	TABLET, CHEWABLE	ORAL	20200102		ANDA	ANDA210033	United Natural Foods, Inc. dba UNFI	LORATADINE	5	mg/1			N	20241231
41163-367_b17a6bc1-6e2a-4441-997d-93270aab6a36	41163-367	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-369_d73d180f-2b8b-4b09-b1e2-b0770a4518c0	41163-369	HUMAN OTC DRUG	equaline anti itch	maximum strength	Hydrocortisone	CREAM	TOPICAL	20110225		OTC MONOGRAPH NOT FINAL	part348	United Natural Foods, Inc. dba UNFI	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41163-374_c8123dac-6bc5-4f29-9905-c792c9fc77e6	41163-374	HUMAN OTC DRUG	Equaline migraine formula		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20040903		ANDA	ANDA075794	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
41163-375_861c4277-f89c-49aa-80d4-f79fe181877e	41163-375	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	United Natural Foods, Inc. dba UNFI	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41163-376_6ca6da49-791c-4e77-a306-b77e97691b25	41163-376	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20180430		OTC MONOGRAPH NOT FINAL	part356	EQUALINE (SuperValu)	PHENOL	1.4	g/100mL			N	20241231
41163-379_514e8ee5-07f6-49a6-b227-53fa8d9ac90c	41163-379	HUMAN OTC DRUG	equaline allergy		Diphenhydramine HCl	SOLUTION	ORAL	20040810		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-384_0158079f-86a8-4a73-b5b9-7b15db902935	41163-384	HUMAN OTC DRUG	equaline cough dm		dextromethorphan polistirex	SUSPENSION	ORAL	20121019		ANDA	ANDA091135	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-388_925c0cf8-38b6-46d9-9ae9-c4b2429b4887	41163-388	HUMAN OTC DRUG	equaline tussin	multi symptom	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20140711		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-390_30a2d1f1-cbac-4bf1-a573-f651b9898024	41163-390	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength	Acetaminophen, Caffeine and Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
41163-405_ba673ec8-04e3-4a13-93ee-85ac4664ecfa	41163-405	HUMAN OTC DRUG	Equaline Aspirin		aspirin	TABLET, FILM COATED	ORAL	20210715	20240430	OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
41163-408_46985060-b921-4cd6-ad55-1f365bb9889e	41163-408	HUMAN OTC DRUG	gas relief		simethicone	TABLET, CHEWABLE	ORAL	20210223		OTC MONOGRAPH DRUG	M002	United Natural Foods, Inc. dba UNFI	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
41163-421_f0307c24-2d64-4691-e053-2995a90a55ca	41163-421	HUMAN OTC DRUG	Equaline Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20141116		OTC MONOGRAPH FINAL	part343	Supervalu Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41163-432_91e2a365-f40a-4271-a912-137dd17ea15f	41163-432	HUMAN OTC DRUG	equaline nasal decongestant	non drowsy maximum strength	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20040817		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41163-434_4e5a7c14-3be0-45f5-9e22-c8d423daba6f	41163-434	HUMAN OTC DRUG	Stay Awake	Maximum Strength	Caffeine	TABLET, FILM COATED	ORAL	19980414		OTC MONOGRAPH DRUG	M011	United Natural Foods, Inc. dba UNFI	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
41163-439_5d1ea229-081f-4949-9e00-c67f4c6a1320	41163-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20131018		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	ALCOHOL	70	mL/100mL			N	20241231
41163-443_df7f062e-6a83-421b-b16c-32db5a69926c	41163-443	HUMAN OTC DRUG	Equaline nasal allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20161229		ANDA	ANDA078104	United Natural Foods, Inc. dba UNFI	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41163-453_7168fec3-efaa-4bae-a400-3a4e2661f774	41163-453	HUMAN OTC DRUG	Nasal Decongestant PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-458_1146cdbb-e263-45bb-b8a5-d607b8dd5259	41163-458	HUMAN OTC DRUG	Equaline all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080123		ANDA	ANDA078336	United Natural Foods, Inc. dba UNFI	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-459_9e023c2a-c058-49a4-aff9-594154a426b4	41163-459	HUMAN OTC DRUG	equaline nighttime cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20111024		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-471_52c36987-3e92-4104-b58d-69183d0d47b3	41163-471	HUMAN OTC DRUG	equaline anti itch		hydrocortisone	OINTMENT	TOPICAL	20101203		OTC MONOGRAPH NOT FINAL	part348	United Natural Foods, Inc. dba UNFI	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41163-473_49e7f731-cb6d-4c46-be6e-ae46ee6a6174	41163-473	HUMAN OTC DRUG	equaline childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20141015		OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	160	mg/5mL			N	20241231
41163-475_6d6abd00-4018-4d88-8a7b-634ebde45299	41163-475	HUMAN OTC DRUG	Equaline childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20151117		ANDA	ANDA204226	United Natural Foods, Inc. dba UNFI	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-494_308abcfe-73a1-4360-b9da-6a15ba2f0fe1	41163-494	HUMAN OTC DRUG	childrens acetaminophen		acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	160	mg/1			N	20241231
41163-500_fbe56804-3ecd-af55-e053-6394a90a3fbc	41163-500	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20131101		OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	500	mg/1			N	20241231
41163-503_f3217f7a-221c-46db-81e3-e5a352a36786	41163-503	HUMAN OTC DRUG	daytime severe cold	multi-symptom	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-509_fbe573d6-e12f-8c02-e053-6294a90a3f1f	41163-509	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20181231		ANDA	ANDA079174	United Natural Foods, Inc. dba UNFI	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-511_a4a4ef0d-4f25-40d8-886c-83a57baee347	41163-511	HUMAN OTC DRUG	equaline naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140924		ANDA	ANDA074661	United Natural Foods, Inc. dba UNFI	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-512_e8b85171-dc32-3b61-e053-2a95a90a6bb2	41163-512	HUMAN OTC DRUG	Pressure and Pain PE Plus Mucus		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140801	20241231	OTC MONOGRAPH FINAL	part341	Supervalu Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
41163-513_e8b85171-dc34-3b61-e053-2a95a90a6bb2	41163-513	HUMAN OTC DRUG	Pressure and Pain PE Plus Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140801	20240930	OTC MONOGRAPH FINAL	part341	Supervalu Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41163-514_fbe52782-7669-6df1-e053-6294a90a0a6c	41163-514	HUMAN OTC DRUG	Acetaminophen	Regular Strength	Acetaminophen	TABLET	ORAL	20141101		OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	325	mg/1			N	20241231
41163-515_fbe58138-8e20-c4d9-e053-6294a90a3bd0	41163-515	HUMAN OTC DRUG	acetaminophen pm	extra strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20140901		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-518_db8ade65-29ef-5eb6-e053-2995a90ab570	41163-518	HUMAN OTC DRUG	Equaline Antifungal Cream		Tolnaftate	CREAM	TOPICAL	20201006		OTC MONOGRAPH FINAL	part333C	SUPERVALU INC	TOLNAFTATE	10	mg/g			N	20241231
41163-520_fbe573b2-eb1d-af53-e053-6394a90a2dc9	41163-520	HUMAN OTC DRUG	Acetaminophen Gelcaps	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20141001		OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	500	mg/1			N	20241231
41163-522_fbe55a89-12a8-be1d-e053-6294a90adee7	41163-522	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20141001		OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41163-529_7d029831-3862-462b-b0fc-0d73d2cafe40	41163-529	HUMAN OTC DRUG	Daytime Cold, Nighttime Cold	multi-symptom	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	KIT		20050721		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI						N	20241231
41163-530_9560907c-c096-485b-b67b-910c9170402e	41163-530	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20141130	20250131	OTC MONOGRAPH FINAL	part347	EQUALINE (SuperValu)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
41163-536_1f194e60-991f-4c4b-b33f-acbe829dc2aa	41163-536	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20090521		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
41163-539_d6c3277e-7617-4fa7-a915-5165b323f623	41163-539	HUMAN OTC DRUG	equaline esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170925		ANDA	ANDA207193	United Natural Foods, Inc. dba UNFI	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41163-540_0cfac3c3-6f4a-cc70-e063-6394a90a57b1	41163-540	HUMAN OTC DRUG	Equaline Eye Drops A.C.		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20230322		OTC MONOGRAPH DRUG	M018	United Natural Foods, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41163-551_3b982999-b76b-4976-bb97-bd43bff543a0	41163-551	HUMAN OTC DRUG	equaline nighttime cough relief		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20140520		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-553_5a7d980d-2386-4fa1-9f84-f6f242c4a90a	41163-553	HUMAN OTC DRUG	equaline anti diarrheal plus anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20191204		ANDA	ANDA209837	United Natural Foods, Inc. dba UNFI	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
41163-563_4dabf8f1-a283-4b5d-a0db-684d37c2557a	41163-563	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41163-566_47e997e5-aa0b-401e-b3ac-cdea39a4bd05	41163-566	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20140113		OTC MONOGRAPH DRUG	M016	United Natural Foods, Inc. dba UNFI	PETROLATUM	1	g/g			N	20241231
41163-567_16aa8cd3-9f63-4aa7-8916-0839c0d21784	41163-567	HUMAN OTC DRUG	equaline daytime and nighttime cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, phenylephrine HCl	KIT		20120814		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI						N	20241231
41163-575_33eef624-b6cb-432e-96be-ec1a4a848c75	41163-575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160205		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41163-581_a7e4b8a8-53f3-4e31-a0a4-1c37751efa9a	41163-581	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20201026		OTC MONOGRAPH DRUG	M021	United Natural Foods, Inc. dba UNFI	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41163-585_0c459e52-48ec-40ec-90aa-e06155fb00fe	41163-585	HUMAN OTC DRUG	allergy relief	Childrens	Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20090320		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-592_e8ce9208-e3cb-f34d-e053-2995a90aedf7	41163-592	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20220915		OTC MONOGRAPH NOT FINAL	part343	UNFI	ACETAMINOPHEN	500	mg/1			N	20241231
41163-593_ccf84fbc-929d-471c-998b-8cf12d942907	41163-593	HUMAN OTC DRUG	equaline naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20191217		ANDA	ANDA208499	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-597_eadb242d-8396-4239-84a0-be66b49b4baf	41163-597	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
41163-599_4fc293f4-69f6-4050-a780-bed58bb68671	41163-599	HUMAN OTC DRUG	equaline mucus dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200218		ANDA	ANDA207602	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-602_489b906f-ea4e-4985-b141-1ec1ae2182ef	41163-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20050321		OTC MONOGRAPH NOT FINAL	part334	United Natural Foods, Inc. dba UNFI	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41163-603_f3c3be79-098d-4e35-b7ce-529eeb3f092f	41163-603	HUMAN OTC DRUG	equaline daytime severe cold and flu relief		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20140728		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-604_fe9df752-f9c7-4830-a6c2-8f6e6342d8cc	41163-604	HUMAN OTC DRUG	equaline ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20040805		ANDA	ANDA072096	United Natural Foods, Inc. dba UNFI	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-607_b8450245-a77c-4bd5-a382-2838bad1ca00	41163-607	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20130401		OTC MONOGRAPH DRUG	505G(a)(3)	United Natural Foods, Inc. dba UNFI	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41163-612_8c4f5dcb-b0d0-4baa-a339-7112c5896e33	41163-612	HUMAN OTC DRUG	Equaline Allergy Relief		Loratadine	TABLET	ORAL	20050207		ANDA	ANDA076301	United Natural Foods, Inc. dba UNFI	LORATADINE	10	mg/1			N	20241231
41163-613_fbe57746-3ad8-be0a-e053-6294a90a6af1	41163-613	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20171101		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-625_f732fef2-5f58-4861-8a64-93d7baab1b3c	41163-625	HUMAN OTC DRUG	Laxative	Regular Strength, chocolated stimulant laxative sennosides, Equaline	Sennosides	TABLET, CHEWABLE	ORAL	20210224		OTC MONOGRAPH NOT FINAL	part334	Supervalu Inc.	SENNOSIDES	15	mg/1			N	20241231
41163-628_2a152c6f-aae7-4d8b-8812-48752e54358f	41163-628	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41163-631_8e2704ee-bda6-4ecb-8a18-5623e739f945	41163-631	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	SENNOSIDES	8.6	mg/1			N	20241231
41163-633_4bb35fff-a300-48dd-9ebe-d797364b4b78	41163-633	HUMAN OTC DRUG	Equaline Childrens Allergy Relief		loratadine	SOLUTION	ORAL	20190109		ANDA	ANDA075728	United Natural Foods, Inc. dba UNFI	LORATADINE	5	mg/5mL			N	20241231
41163-634_d806739f-7f7b-42ae-af48-d1b0b22d3eef	41163-634	HUMAN OTC DRUG	equaline omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20181011		NDA	NDA209400	United Natural Foods, Inc. dba UNFI	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41163-647_e8c152ea-3335-4b45-bf02-21a7bd872d6c	41163-647	HUMAN OTC DRUG	equaline ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20040817		ANDA	ANDA072096	United Natural Foods, Inc. dba UNFI	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-648_2aacacd5-cc94-4ca6-8a2a-7b16c697f65c	41163-648	HUMAN OTC DRUG	equaline nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20180726		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-656_84ee11f8-b7dd-48e7-9661-1f81de67e16e	41163-656	HUMAN OTC DRUG	equaline daytime cold and flu relief		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20111012		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-664_5eb743a2-84f4-45d5-9f39-afcc17d2ba91	41163-664	HUMAN OTC DRUG	Sinus Congestion and Pain	Daytime	Acetaminophen and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-666_e483c723-5703-4063-a57a-6f727819ff65	41163-666	HUMAN OTC DRUG	sinus plus allergy PE	maximum strength	chlorpheniramine maleate, phenylephrine HCl	TABLET	ORAL	20050609		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20251231
41163-669_328d078e-240a-40f3-b23a-787bd72d2930	41163-669	HUMAN OTC DRUG	Acetaminophen	Extended Release	Acetaminophen	TABLET	ORAL	20190930		ANDA	ANDA207035	EQUALINE (SuperValu)	ACETAMINOPHEN	650	mg/1			N	20241231
41163-685_dc890419-6c85-43d5-81c8-830d253d8af8	41163-685	HUMAN OTC DRUG	Equaline Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20100927		ANDA	ANDA074937	United Natural Foods, Inc. dba UNFI	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-698_1c63ccd2-6c1d-4876-a507-56375d65048a	41163-698	HUMAN OTC DRUG	cough and cold relief HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170331		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-701_51c5d25e-bdb7-4888-b446-e82f2aeac938	41163-701	HUMAN OTC DRUG	Equaline Tussin Mucus and Chest Congestion		Guaifenesin	SOLUTION	ORAL	20131006		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41163-703_4a6682df-6b16-46ec-b51f-0fe13e2f5eac	41163-703	HUMAN OTC DRUG	equaline nasal		Oxymetazoline HCl	SPRAY	NASAL	20180403		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41163-704_be65abb1-62be-4a19-95b4-957213117825	41163-704	HUMAN OTC DRUG	equaline tussin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180830		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-707_ad75c0a0-32bd-4f25-bef6-bc5ec8194be0	41163-707	HUMAN OTC DRUG	equaline naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140924		ANDA	ANDA074661	United Natural Foods, Inc. dba UNFI	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-709_856c771c-1e3e-44a4-a9d0-c2c015187ab2	41163-709	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	United Natural Foods, Inc. dba UNFI	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41163-710_647b0f2d-5130-45a6-bfc8-345bfbc8599d	41163-710	HUMAN OTC DRUG	equaline childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190610		ANDA	ANDA076359	United Natural Foods, Inc. dba UNFI	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-712_fbe573b2-eb1e-af53-e053-6394a90a2dc9	41163-712	HUMAN OTC DRUG	Head Congestion Plus Mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220819		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-713_fbe573d6-e132-8c02-e053-6294a90a3f1f	41163-713	HUMAN OTC DRUG	Head Congestion plus Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220819		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-717_e2c8d15c-3c7b-474a-96cc-ccc90b5ae07a	41163-717	HUMAN OTC DRUG	mucus relief cold, flu and sore throat		acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	TABLET, FILM COATED	ORAL	20201211		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-722_589f53a0-0e00-49ae-8c93-ddf112379253	41163-722	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20191030	20250228	ANDA	ANDA208754	United Natural Foods, Inc. dba UNFI	DOCOSANOL	100	mg/g			N	
41163-724_d32ff607-008e-46f3-94f8-918016489c62	41163-724	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20210601		ANDA	ANDA208754	EQUALINE (SuperValu)	DOCOSANOL	100	mg/g			N	20241231
41163-731_1cc1009f-4bb7-4eed-aa15-8dc46782d3ad	41163-731	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20180930		ANDA	ANDA207342	United Natural Foods, Inc. dba UNFI	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41163-734_c77abd1f-fd9c-4f2d-89ed-3c556de7f7de	41163-734	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20181231	20241227	OTC MONOGRAPH FINAL	part338	EQUALINE (SuperValu)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
41163-737_be535a56-1b95-424e-8197-566976ef2efa	41163-737	HUMAN OTC DRUG	Maximum Strength Mucus Relief Cold,Flu and Sore Throat		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin ,Phenylephrine HCL	LIQUID	ORAL	20170907		OTC MONOGRAPH FINAL	part341	SUPERVALU INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-738_3bb76952-15d8-4a36-a392-60f62b845f09	41163-738	HUMAN OTC DRUG	maximum strength mucus relief severe congestion and cough		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20170907		OTC MONOGRAPH FINAL	part341	SuperValu Inc.,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-744_2622ecb2-137f-4f3c-9417-0cd1b73b8dec	41163-744	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20180630	20240329	OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)						N	
41163-750_70edb6b9-cbb4-4c30-8081-a3453db29828	41163-750	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20140503		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
41163-755_5843bf64-4d90-401e-8cf4-980230ef5e79	41163-755	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41163-763_c65cf091-cd78-4ee9-a38b-f48b328a9a23	41163-763	HUMAN OTC DRUG	equaline nighttime severe cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20140731		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-768_c0f499c5-a219-6222-e053-2a95a90a91ac	41163-768	HUMAN OTC DRUG	Equaline Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20140529		OTC MONOGRAPH FINAL	part341	Supervalu Inc.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-769_020afa39-c3d5-495e-8363-b218a64d34a7	41163-769	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	United Natural Foods, Inc. dba UNFI	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41163-775_94fdb440-db27-4ea9-af77-d9289f0056dd	41163-775	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20211029		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	SENNOSIDES	8.6	mg/1			N	20241231
41163-778_d7005b29-53e2-4a11-9378-1ca1cf263709	41163-778	HUMAN OTC DRUG	Stool Softener	Plus Stimulant	docusate sodium and sennosides	TABLET	ORAL	20210625		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41163-781_1be0cd36-faee-424b-a667-39a1cefcf0ea	41163-781	HUMAN OTC DRUG	Equaline Mucus DM		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200224		ANDA	ANDA207602	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-782_656ab69f-1ef8-4c3b-a059-17a4212ac5bf	41163-782	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20211029		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	SENNOSIDES	8.6	mg/1			N	20241231
41163-797_fbd18bd3-f86d-4b27-8591-27d1ee116dc2	41163-797	HUMAN OTC DRUG	aspirin	chewable, low dose	aspirin	TABLET, CHEWABLE	ORAL	20010904		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41163-804_6b3c39cc-c2ef-431b-9a71-d5778017f70f	41163-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20050701		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
41163-813_6f0523c8-2188-4ce4-b788-4dc7679583db	41163-813	HUMAN OTC DRUG	equaline adult tussin		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220608		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-815_e871187f-2386-458a-9d0b-3e35026b8054	41163-815	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET	ORAL	20190228		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	SENNOSIDES	25	mg/1			N	20241231
41163-816_03b1b700-f955-46a2-e063-6294a90a29c9	41163-816	HUMAN OTC DRUG	Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20110406		OTC MONOGRAPH NOT FINAL	part333A	SuperValu, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
41163-817_7f14ecdc-0abd-4d08-a69e-dc81052d7673	41163-817	HUMAN OTC DRUG	mucus relief cold and flu		acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	TABLET, FILM COATED	ORAL	20201207		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-821_0cce2f1e-fcef-32db-e063-6294a90af85b	41163-821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20130226		OTC MONOGRAPH DRUG	M006	United Natural Foods, Inc. dba UNFI	SALICYLIC ACID	20	mg/mL			N	20241231
41163-822_7c36f02b-ec05-4161-b70e-2aecd0ab8ca9	41163-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	SOLUTION	TOPICAL	20090529		OTC MONOGRAPH FINAL	part347	United Natural Foods, Inc. dba UNFI	WITCH HAZEL	860	mg/mL			N	20241231
41163-825_4c7ab517-750f-4479-adaf-ed5e04765a52	41163-825	HUMAN OTC DRUG	Equaline Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20041110		ANDA	ANDA074760	United Natural Foods, Inc. dba UNFI	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41163-826_e735c4d8-ddc3-4a3a-a82c-62df69826450	41163-826	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20220413		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	ALCOHOL	62	mL/100mL			N	20241231
41163-829_807477a0-ae35-4752-8607-ec6e1461df86	41163-829	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41163-831_c4d775f0-aec1-4d4d-b560-d9eb2e289ea1	41163-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20041222		OTC MONOGRAPH NOT FINAL	part334	United Natural Foods, Inc. dba UNFI	MINERAL OIL	999	mg/mL			N	20241231
41163-832_97e146e0-4c79-407f-b849-abf642218513	41163-832	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20181231		OTC MONOGRAPH FINAL	part332	EQUALINE (SuperValu)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
41163-835_0c863def-7305-49f7-e063-6294a90a5d41	41163-835	HUMAN OTC DRUG	Equaline Earwax Removal Drops		CARBAMIDE PEROXIDE	LIQUID	TOPICAL	20210101		OTC MONOGRAPH DRUG	M014	United Natural Foods	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
41163-842_9e7ff7a6-1333-4faa-a00c-9a5b36c7a56a	41163-842	HUMAN OTC DRUG	Daytime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20180630	20240329	OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41163-845_92b4b427-17d0-4383-95f5-72a90ae7a561	41163-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20050729		OTC MONOGRAPH FINAL	part344	United Natural Foods, Inc. dba UNFI	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
41163-846_bb73432d-af7c-1506-e053-2a95a90a3def	41163-846	HUMAN OTC DRUG	Equaline Ear Relief Ear Drops		CHAMOMILE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20051201		UNAPPROVED HOMEOPATHIC		Supervalu Inc	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
41163-848_7f99b59d-d65f-4552-bf5e-7df20026880c	41163-848	HUMAN OTC DRUG	Daytime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-849_bc1da8b8-f196-4b52-8c48-d326957ea80c	41163-849	HUMAN OTC DRUG	Nighttime Cold and Flu Relief	Multi Symptom	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-850_8b3b508c-7327-4f15-976a-5060071048a6	41163-850	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20190930		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)						N	20241231
41163-853_d32b51d3-a168-458b-8142-10b4ab140f0b	41163-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM	100	mg/1			N	20241231
41163-855_5e45b0fa-b2ee-4d03-9aaa-687701d09f47	41163-855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20170120		OTC MONOGRAPH NOT FINAL	part356	United Natural Foods, Inc. dba UNFI	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41163-860_c4c22fca-8589-4c36-b9a5-8ae110bda7ed	41163-860	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCL	CAPSULE	ORAL	20191227		OTC MONOGRAPH FINAL	part338	EQUALINE (SuperValu)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-862_2d8222b6-833a-4ac9-8dd3-a3cc3a471b60	41163-862	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM	100	mg/1			N	20241231
41163-866_aa4e62c7-b557-46ba-8648-b5157a61fbd4	41163-866	HUMAN OTC DRUG	equaline lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070709		OTC MONOGRAPH FINAL	part358G	United Natural Foods, Inc. dba UNFI	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
41163-870_c6ec546c-33a7-4d48-bc91-901246809561	41163-870	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20130109		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	ALCOHOL	70	mL/100mL			N	20241231
41163-871_8a28bb65-c029-41de-a7ae-d071fe471d54	41163-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20050114		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
41163-872_decd2f16-5376-4fa3-a51d-9d321d9db68d	41163-872	HUMAN OTC DRUG	Equaline nighttime	cold and flu relief	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20120717		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-875_690c60d7-0223-4a9c-ab7d-9110ad0dcba5	41163-875	HUMAN OTC DRUG	Senna S		Docusate Sodium Sennosides	TABLET	ORAL	20191227	20250228	OTC MONOGRAPH DRUG	M007	United Natural Foods, Inc. dba UNFI	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
41163-876_96b41561-4ede-4b03-9687-d64fb1818277	41163-876	HUMAN OTC DRUG	Rubbing		Ethyl Alcohol	LIQUID	TOPICAL	20050803		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	ALCOHOL	70	mL/100mL			N	20241231
41163-878_257b4c39-70de-4c6e-96d4-357d6a7fe72d	41163-878	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170630	20250131	OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM	100	mg/1			N	
41163-883_59e588de-9aa6-4f6a-8e77-0bd759c25bed	41163-883	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	EQUALINE (SuperValu)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41163-888_ba241be8-130b-49ec-8b35-2aab3e919833	41163-888	HUMAN OTC DRUG	equaline acetaminophen	infants	Acetaminophen	SUSPENSION	ORAL	20141212		OTC MONOGRAPH NOT FINAL	part343	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN	160	mg/5mL			N	20241231
41163-897_cb2b46d7-00db-4344-9956-fa5e26a684e9	41163-897	HUMAN OTC DRUG	equaline ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20040830		ANDA	ANDA074937	United Natural Foods, Inc. dba UNFI	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41163-899_0d1c53fa-3213-41d0-949a-25073c6b063e	41163-899	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20210730		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41163-901_af3bb924-1ea6-4a24-9a54-35549b036a2b	41163-901	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20210730		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)						N	20241231
41163-907_a3977461-cccc-4deb-bf38-0539f3260c1f	41163-907	HUMAN OTC DRUG	Cold Relief		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20211215		OTC MONOGRAPH DRUG	M012	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-908_b87ed55f-9ebb-4c17-92ec-b2606527a6c9	41163-908	HUMAN OTC DRUG	equaline multi symptom flu and severe cold daytime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20160728		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-915_9cf01d8d-1fe8-4350-a23b-065f4d126547	41163-915	HUMAN OTC DRUG	equaline omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080222		NDA	NDA022032	United Natural Foods, Inc. dba UNFI	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41163-918_af3c4413-72ab-4815-ba96-a0b6fb16a74f	41163-918	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	19900912		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41163-936_97205baf-91bd-466c-895e-6ba0f15bdf5d	41163-936	HUMAN OTC DRUG	Equaline Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20180923		OTC MONOGRAPH FINAL	part335	Supervalu Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
41163-937_20f6499c-d78f-46d9-a3f4-32db00a403be	41163-937	HUMAN OTC DRUG	Equaline Maximum Strength Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20180923		OTC MONOGRAPH FINAL	part335	Supervalu Inc.	BISMUTH SUBSALICYLATE	1050	mg/30mL			N	20241231
41163-938_c45a5831-d63d-e0d0-edae-ccdadc661f8a	41163-938	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20181231		ANDA	ANDA210375	United Natural Foods, Inc. dba UNFI	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-941_b0435364-5cba-4d2f-93c7-f36d5b732242	41163-941	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160315		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41163-943_bc414041-e31e-710a-e053-2995a90afe04	41163-943	HUMAN OTC DRUG	Supervalue Equaline Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
41163-944_fba203c1-1c59-452c-a5ed-0824ba116425	41163-944	HUMAN OTC DRUG	Equaline Hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20080328		OTC MONOGRAPH FINAL	part346	United Natural Foods, Inc. dba UNFI	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-945_e47732eb-4c5a-4642-8fcf-cc2007923a28	41163-945	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20140725		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41163-947_2e596ed0-92be-4352-8b3a-75640dabbd9f	41163-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20110204		OTC MONOGRAPH FINAL	part333D	United Natural Foods, Inc. dba UNFI	SALICYLIC ACID	20.6	mg/mL			N	20241231
41163-948_d5655a3f-5dd8-d449-e053-2995a90a4d0f	41163-948	HUMAN OTC DRUG	Equaline Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20120427		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
41163-951_d61b7442-a7f9-62c4-e053-2a95a90ad9b4	41163-951	HUMAN OTC DRUG	Equaline Kids Continuous Sunscreen SPF 50		Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	SPRAY	TOPICAL	20111221		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41163-953_e46cb6e3-ea8e-3c2d-e053-2a95a90a0bf6	41163-953	HUMAN OTC DRUG	EQUALINE KIDS SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20201015		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
41163-954_e46d254a-c7b3-291f-e053-2995a90a8f3a	41163-954	HUMAN OTC DRUG	EQUALINE SPORT SUNSCREEN CONTINUOUS SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20201014		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
41163-956_f922e314-e001-4c57-b8ca-23b2f5f371ad	41163-956	HUMAN OTC DRUG	Acetaminophen PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41163-957_f0dda63c-08ce-6c3d-e053-2a95a90ab1fd	41163-957	HUMAN OTC DRUG	Equaline Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20201012		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
41163-960_5624859a-0751-40b9-9e8e-bdf70ebc99a6	41163-960	HUMAN OTC DRUG	Therapeutic T Plus		Coal Tar	SHAMPOO	TOPICAL	20200227		OTC MONOGRAPH FINAL	part358H	United Natural Foods, Inc. dba UNFI	COAL TAR	25	mg/mL			N	20241231
41163-961_f0e89a00-f78d-270e-e053-2a95a90a24e1	41163-961	HUMAN OTC DRUG	Equaline SPORT Sunscreen SPF 30		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20201012		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
41163-963_db8ab2f1-c086-adce-e053-2a95a90a0467	41163-963	HUMAN OTC DRUG	Equaline Antifungal Cream		Clotrimazole	CREAM	TOPICAL	20201006		OTC MONOGRAPH FINAL	part333C	SUPERVALU INC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41163-964_b2e3c09f-23a0-4370-979b-96f1c6bb5571	41163-964	HUMAN OTC DRUG	equaline flu and severe cold and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20110726		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-965_f116b6dd-3a25-6118-e053-2a95a90aa706	41163-965	HUMAN OTC DRUG	Equaline Ultra Protection Sunscreen SPF 50		Avobenzone Homosalate Octisalate Octocrylene	LOTION	TOPICAL	20201027		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41163-966_f13febac-d22e-3439-e053-2a95a90a8413	41163-966	HUMAN OTC DRUG	EQUALINE SPORT CONTINUOUS SUNSCREEN SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20201014		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
41163-967_f4235736-304f-1ee0-e053-2a95a90a421c	41163-967	HUMAN OTC DRUG	Equaline Ultra Protection Continuous Sunscreen SPF 50		Avobenzone Homosalate Octisalate Octocrylene	SPRAY	TOPICAL	20201014		OTC MONOGRAPH NOT FINAL	part352	SUPERVALU INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
41163-971_9e9c83ae-3158-4384-a6e2-30bafec7442e	41163-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20211001		OTC MONOGRAPH FINAL	part355	United Natural Foods, Inc. dba UNFI	SODIUM FLUORIDE	.1	mg/mL			N	20241231
41163-973_58867207-88de-4b17-b951-315e07f3f631	41163-973	HUMAN OTC DRUG	equaline anti itch	maximum strength	hydrocortisone	CREAM	TOPICAL	20101001		OTC MONOGRAPH NOT FINAL	part348	United Natural Foods, Inc. dba UNFI	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41163-975_e63de7e7-32b8-4488-919d-a0fcd737dfef	41163-975	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20230202		OTC MONOGRAPH NOT FINAL	part333A	United Natural Foods, Inc. dba UNFI	ALCOHOL	62	mL/100mL			N	20241231
41163-986_6288508e-0eae-4a78-8bfe-ca8076ed1e27	41163-986	HUMAN OTC DRUG	Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190630		ANDA	ANDA040564	SUPERVALU INC.	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
41163-987_e2a9fc2b-e353-4712-b7a7-42604bebda75	41163-987	HUMAN OTC DRUG	equaline childrens cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20120727		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc. dba UNFI	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41163-998_89638149-2dae-4dcb-bbda-b2b86ccc11f5	41163-998	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20210730		OTC MONOGRAPH FINAL	part341	EQUALINE (SuperValu)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41167-0014_3d26c6b3-81fb-4835-9c87-e13d5280c7c2	41167-0014	HUMAN OTC DRUG	Unisom SleepMelts Nighttime Sleep-Aid		Diphenhydramine Hydrochloride	TABLET, CHEWABLE	ORAL	20080101		OTC MONOGRAPH DRUG	M010	Chattem, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-0021_518886e1-8d58-48d0-a565-111b7462429f	41167-0021	HUMAN OTC DRUG	Cortizone-10 Soothing Aloe Creme		Hydrocortisone	CREAM	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0022_968f782a-fcf2-41c2-af88-f94ec3d47d5e	41167-0022	HUMAN OTC DRUG	Cortisone 10 Intensive Moisture Creme		Hydrocortisone	CREAM	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0027_90c7ef56-3f78-4f35-80b5-bdb366223228	41167-0027	HUMAN OTC DRUG	Cortizone 10 Ultra Soothing Creme		Hydrocortisone	CREAM	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0028_273f8648-7393-4fe0-a9e9-4a1f7ee34e1c	41167-0028	HUMAN OTC DRUG	Cortisone 10 Sensitive Skin Creme		Hydrocortisone	CREAM	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0032_0ab48f4a-086c-4c78-b1fa-ed8d5b3e479f	41167-0032	HUMAN OTC DRUG	Cortizone 10 Easy Relief		Hydrocortisone	LIQUID	TOPICAL	20081001		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0033_0640e34f-a935-4bab-a4ea-f8cfbe669289	41167-0033	HUMAN OTC DRUG	Cortizone 10 Cooling		Hydrocortisone	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0035_069e30ab-f9b6-43ad-816e-d84791ab2c0d	41167-0035	HUMAN OTC DRUG	Cortizone 10 Intensive Healing		hydrocortisone	CREAM	TOPICAL	20071201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0036_069e30ab-f9b6-43ad-816e-d84791ab2c0d	41167-0036	HUMAN OTC DRUG	Cortizone 10 Cooling Relief		Hydrocortisone	GEL	TOPICAL	20081001		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0039_069e30ab-f9b6-43ad-816e-d84791ab2c0d	41167-0039	HUMAN OTC DRUG	Cortizone 10		hydrocortisone	CREAM	TOPICAL	20070901		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0040_4610e25d-f72a-40b8-a755-d7a6e1cb43b9	41167-0040	HUMAN OTC DRUG	Unisom PM Pain Nighttime Sleep Aid and Pain Reliever		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20091201		OTC MONOGRAPH DRUG	M013	Chattem, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	325; 50	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-0061_d168834c-70ea-4f2c-9a77-bf8a2a7fb384	41167-0061	HUMAN OTC DRUG	Unisom SleepGels Nighttime Sleep-Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20070101		OTC MONOGRAPH DRUG	M010	Chattem, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-0063_6f3dfd05-67c1-45af-b227-982655eee4a8	41167-0063	HUMAN OTC DRUG	Unisom SleepTabs		Doxylamine Succinate	TABLET	ORAL	20160115		ANDA	ANDA040167	Chattem, Inc.	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
41167-0067_642938f2-c175-4b20-981e-8fa15db2c06f	41167-0067	HUMAN OTC DRUG	Unisom SleepMinis Nighttime Sleep-Aid		Diphenhydramine HCl	CAPSULE	ORAL	20150401		OTC MONOGRAPH DRUG	M010	Chattem, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-0073_ab7cc4f3-195c-4262-a01a-d127ab4fe91b	41167-0073	HUMAN OTC DRUG	Icy Hot Back and Large Areas		Menthol	PATCH	TOPICAL	20030301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	428.5	mg/1			N	20241231
41167-0074_caaebaa0-3611-494e-a613-28851f8ed870	41167-0074	HUMAN OTC DRUG	Icy Hot Pro Pain		Camphor and Menthol	PATCH	TOPICAL	20230115		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	180; 300	mg/1; mg/1			N	20241231
41167-0078_afc49db4-bad4-4822-84d6-c2f99295ad07	41167-0078	HUMAN OTC DRUG	Icy Hot Pro Pain Relief Cream w/ microbeads		Menthol, Camphor	CREAM	TOPICAL	20220221		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	.11; .16	g/g; g/g			N	20241231
41167-0079_4aba19d0-5cef-4509-b5ec-1f2eceb5796c	41167-0079	HUMAN OTC DRUG	Icy Hot Pro No-Mess		Camphor, Menthol	LIQUID	TOPICAL	20220221		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	11; 16	g/100g; g/100g			N	20241231
41167-0080_6be13653-63c1-4c4d-9142-f25e9934a993	41167-0080	HUMAN OTC DRUG	Icy Hot Pro Dry		Camphor, Menthol	SPRAY	TOPICAL	20220221		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	11; 16	g/100mL; g/100mL			N	20241231
41167-0083_ab7cc4f3-195c-4262-a01a-d127ab4fe91b	41167-0083	HUMAN OTC DRUG	Icy Hot Back and Large Areas		Menthol	PATCH	TOPICAL	20030301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	428.5	mg/1			N	20241231
41167-0084_ab7cc4f3-195c-4262-a01a-d127ab4fe91b	41167-0084	HUMAN OTC DRUG	Icy Hot Arm Neck Leg and Small Areas		Menthol	PATCH	TOPICAL	20001101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	205.5	mg/1			N	20241231
41167-0087_b2bfcda0-12d8-4f4c-8f05-c3c4512bede2	41167-0087	HUMAN OTC DRUG	Icy Hot	Pain Relieving Balm	Menthol and Methyl Salicylate	OINTMENT	TOPICAL	19910601		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL; METHYL SALICYLATE	7.6; 29	g/100g; g/100g			N	20241231
41167-0088_b2bfcda0-12d8-4f4c-8f05-c3c4512bede2	41167-0088	HUMAN OTC DRUG	Icy Hot	Pain Relieving Cream	Menthol and Methyl Salicylate	CREAM	TOPICAL	19910601		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL; METHYL SALICYLATE	10; 30	g/100g; g/100g			N	20241231
41167-0090_2ff31a3a-c167-46bd-a22c-4c2d07cacf12	41167-0090	HUMAN OTC DRUG	Icy Hot Original Foam		Menthol	LIQUID	TOPICAL	20210115		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	140.8	mg/mL			N	20241231
41167-0091_d03cf1ad-c135-4aa4-ab4e-5677deea4221	41167-0091	HUMAN OTC DRUG	Icy Hot Medicated No Mess Applicator		Menthol	LIQUID	TOPICAL	20091201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	.16	g/mL			N	20241231
41167-0092_1ff6b697-9749-450e-ac12-4b47e9019238	41167-0092	HUMAN OTC DRUG	Icy Hot Vanishing Scent		Menthol	GEL	TOPICAL	20070301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	.025	g/g			N	20241231
41167-0095_7794b9c0-aa06-4621-854e-7f841405d0f8	41167-0095	HUMAN OTC DRUG	IcyHot Medicated		Menthol	SPRAY	TOPICAL	20091201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	.16	g/mL			N	20241231
41167-0099_b5a33aca-e882-48d8-b7aa-416cc984c6c5	41167-0099	HUMAN OTC DRUG	Icy Hot Kids Pain Relief		Menthol	PATCH	TOPICAL	20230115		OTC MONOGRAPH NOT FINAL	part348	Chattem, Inc.	MENTHOL	5	g/1			N	20241231
41167-0101_8d9b9eeb-bd27-4cd7-b27b-656c560c63d4	41167-0101	HUMAN OTC DRUG	Dulcolax Simulant Laxative		Bisacodyl	TABLET, FILM COATED	ORAL	20210212		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0105_069e30ab-f9b6-43ad-816e-d84791ab2c0d	41167-0105	HUMAN OTC DRUG	Cortizone 10 Plus		Hydrocortisone	CREAM	TOPICAL	20070901		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0108_a76c32fc-3d03-4143-82a3-1ec18aa23db3	41167-0108	HUMAN OTC DRUG	Cortizone 10 Overnight Itch Relief		Hydrocortisone	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0109_008eb825-61d4-4d90-9815-53a396b79c76	41167-0109	HUMAN OTC DRUG	Cortisone 10 Overnight Creme		Hydrocortisone	CREAM	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0110_28a27e97-3dd9-481a-b7e0-e233121ffa5d	41167-0110	HUMAN OTC DRUG	Gold Bond Medicated Original Strength Body		Menthol	POWDER	TOPICAL	20210301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	.15	g/100g			N	20241231
41167-0171_44e4800a-74f1-401c-8e72-ef386bdeded4	41167-0171	HUMAN OTC DRUG	Gold Bond Medicated Maximum Strength Foot		Menthol	POWDER	TOPICAL	20210301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	1	g/100g			N	20241231
41167-0175_df28f8ce-7953-4d34-a110-6672c642c417	41167-0175	HUMAN OTC DRUG	Gold Bond Medicated Cracked Foot Skin Relief		Petrolatum	OINTMENT	TOPICAL	20210101		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	PETROLATUM	30	g/100g			N	20241231
41167-0200_7e511601-813e-4dda-adc0-9a39f500b0d8	41167-0200	HUMAN OTC DRUG	Dulcolax Stimulant Laxative		Bisacodyl	TABLET, COATED	ORAL	20190102		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0210_6ade4dc8-bdce-4db5-8f4c-64f6d806b97e	41167-0210	HUMAN OTC DRUG	Dulcolax Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20190604		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0221_5dfcb760-8f43-4d3d-b34e-d814ab5ee28b	41167-0221	HUMAN OTC DRUG	Dulcolax Stool Softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
41167-0256_a2365ab8-4512-4799-a9e5-63b0ec9fcd88	41167-0256	HUMAN OTC DRUG	Dulcolax Chewy Bites Assorted Fruits		Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20220606		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	MAGNESIUM HYDROXIDE	600	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0257_3b5ab5c8-9203-4c12-bf03-fa9b81deb66a	41167-0257	HUMAN OTC DRUG	Dulcolax Chewy Fruit Bites Cherry Berry		Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20220606		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	MAGNESIUM HYDROXIDE	600	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0259_6bc37b01-3db4-4f9b-88c1-879c9ba36d94	41167-0259	HUMAN OTC DRUG	Dulcolax Soft Chews Watermelon		Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20220301		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	MAGNESIUM HYDROXIDE	1200	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0260_ae40dcf3-329d-4964-84c2-4376026a6df9	41167-0260	HUMAN OTC DRUG	Dulcolax Soft Chews Black Cherry		MAGNESIUM HYDROXIDE	TABLET, CHEWABLE	ORAL	20220301		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	MAGNESIUM HYDROXIDE	1200	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0265_cbf7ad11-7c14-450f-85b8-eed3bc3a3c61	41167-0265	HUMAN OTC DRUG	Dulcolax Soft Chews Mixed Berry		MAGNESIUM HYDROXIDE	TABLET, CHEWABLE	ORAL	20200223		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	MAGNESIUM HYDROXIDE	1200	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0281_ee31e609-02c9-4127-a6ad-77c141c1ed49	41167-0281	HUMAN OTC DRUG	Dulcolax Pink Stool Softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20180218		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
41167-0290_0bd956d8-c69d-4923-8093-4203daaa30d5	41167-0290	HUMAN OTC DRUG	Dulcolax Pink Stimulant Laxative		Bisacodyl	TABLET, COATED	ORAL	20190121		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0291_80ad4646-b7ac-45d3-b30f-101aeef1633d	41167-0291	HUMAN OTC DRUG	Dulcolax	Liquid	Magnesium hydroxide	LIQUID	ORAL	20190301		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0292_8c402e50-5a97-42ad-a204-5128fc475091	41167-0292	HUMAN OTC DRUG	Dulcolax	Liquid	Magnesium hydroxide	LIQUID	ORAL	20190301		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0330_85ecb8b2-4556-4960-a800-3e0160209a94	41167-0330	HUMAN OTC DRUG	Cortizone 10 Feminine Itch Relief		Hydrocortisone	CREAM	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0331_ebd3de6b-7909-4b09-b3b8-be6060559dac	41167-0331	HUMAN OTC DRUG	Cortizone 10 Intensive Healing for Eczema		Hydrocortisone	LOTION	TOPICAL	20091208		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0335_bf17168c-170b-4f2b-a1d8-84e7ebd316ad	41167-0335	HUMAN OTC DRUG	Cortizone 10 Intensive Healing Feminine Itch Relief		Hydrocortisone	CREAM	TOPICAL	20140101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0336_98fa233b-02bc-4d91-bba5-481de61064f6	41167-0336	HUMAN OTC DRUG	Cortizone 10 Sensitive Skin Anti-itch Creme		Hydrocortisone	CREAM	TOPICAL	20220101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0338_8048b1af-5b6a-4582-9fb0-07fee1f83fd0	41167-0338	HUMAN OTC DRUG	Cortizone 10 Itch Relief Massaging Rollerball		Hydrocortisone	CREAM	TOPICAL	20230102		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0339_069e30ab-f9b6-43ad-816e-d84791ab2c0d	41167-0339	HUMAN OTC DRUG	Cortizone 10		Hydrocortisone	OINTMENT	TOPICAL	20070901		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0341_2bd766c5-cfbc-4930-a12d-2ede6ae884ae	41167-0341	HUMAN OTC DRUG	Cortizone 10 for Psoriasis		Hydrocortizone	LOTION	TOPICAL	20160115		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0342_1078e514-c373-4419-87cf-bb488a173c46	41167-0342	HUMAN OTC DRUG	Cortizone 10 Anti-itch for Diabetics Skin		Hydrocortisone	LOTION	TOPICAL	20141222		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0344_bfcf5fe6-e29a-4987-8f51-33da472ebb04	41167-0344	HUMAN OTC DRUG	Cortizone 10 Water Resistant		Hydrocortisone	OINTMENT	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-0360_11934068-b70b-4afe-aff8-82f2a79068b9	41167-0360	HUMAN OTC DRUG	Zantac 360		Famotidine	TABLET, FILM COATED	ORAL	20210412		ANDA	ANDA206531	Chattem, Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41167-0361_11934068-b70b-4afe-aff8-82f2a79068b9	41167-0361	HUMAN OTC DRUG	Zantac 360		Famotidine	TABLET, FILM COATED	ORAL	20210412		ANDA	ANDA206531	Chattem, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41167-0364_678cb1ad-bfb6-489e-b84a-29d305f31aaf	41167-0364	HUMAN OTC DRUG	Zantac 360 Cool Mint		Famotidine	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA206531	Chattem, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41167-0392_056e99e0-e877-4026-b45b-ef9aa88e1d07	41167-0392	HUMAN OTC DRUG	Gold Bond Medicated Advanced Healing		White Petrolatum	OINTMENT	TOPICAL	20210801		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	PETROLATUM	45	g/100g			N	20241231
41167-0400_7e511601-813e-4dda-adc0-9a39f500b0d8	41167-0400	HUMAN OTC DRUG	Dulcolax Stimulant Laxative		Bisacodyl	TABLET, COATED	ORAL	20190414		OTC MONOGRAPH DRUG	505G(a)(3)	Chattem, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-0410_63273329-b0f7-463f-96b6-dd4879a06ab1	41167-0410	HUMAN OTC DRUG	Gold Bond Medicated Extra Strength Body		Menthol	POWDER	TOPICAL	20210301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	.8	g/100g			N	20241231
41167-0412_fa473fe8-04fa-4cf7-b03e-0fa8ae9dd1b0	41167-0412	HUMAN OTC DRUG	Gold Bond Ultimate Psoriasis Relief Cream		Salicylic Acid	LOTION	TOPICAL	20160801		OTC MONOGRAPH DRUG	M032	Chattem, Inc.	SALICYLIC ACID	3	g/100g			N	20251231
41167-0437_dcdf46d6-53f8-4e98-964f-87e8b3db84c7	41167-0437	HUMAN OTC DRUG	Gold Bond Ultimate Age Defense Hand Cream with SPF 20		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M020	Chattem, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100g; g/100g; g/100g			N	20241231
41167-0501_c1777fa3-e052-432c-bacf-303dd1b46064	41167-0501	HUMAN OTC DRUG	Gold Bond Anti Itch		Menthol and Pramoxine Hydrochloride	CREAM	TOPICAL	19960401		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL; PRAMOXINE HYDROCHLORIDE	.01; .01	g/g; g/g			N	20241231
41167-0505_c1b8f43f-1db9-4659-a56a-0daf59d3baef	41167-0505	HUMAN OTC DRUG	Gold Bond Medicated Pain and Itch Relief		Lidocaine hydrochloride	CREAM	TOPICAL	20160115		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0507_a61606cb-1d7d-4b88-8c6d-15e813af7e0c	41167-0507	HUMAN OTC DRUG	Gold Bond Intensive Relief Anti-Itch		Pramoxine Hydrochloride, Menthol	LOTION	TOPICAL	20160426		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL; PRAMOXINE HYDROCHLORIDE	.5; 1	g/100g; g/100g			N	20241231
41167-0518_f4274005-b15f-4399-aac9-82ddd25234be	41167-0518	HUMAN OTC DRUG	Gold Bond Medicated Cracked Skin Fill and Protect		Petrolatum	CREAM	TOPICAL	20180213		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	PETROLATUM	30	g/100g			N	20241231
41167-0519_a1b6d685-9bc7-4566-8a28-6c3288d2b708	41167-0519	HUMAN OTC DRUG	Gold Bond Ultimate Cracked Skin Fill and Protect		Petrolatum	CREAM	TOPICAL	20181011		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	PETROLATUM	30	g/100g			N	20241231
41167-0529_f56c5846-03cf-4deb-a1c0-77d62212bbda	41167-0529	HUMAN OTC DRUG	Gold Bond Medicated Pain and Itch Relief		Lidocaine hydrochloride	CREAM	TOPICAL	20230301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0540_3d28b878-8933-41fa-afc2-ddf31eb0dc68	41167-0540	HUMAN OTC DRUG	Gold Bond Ultimate Diabetics		Dimethicone and White Petrolatum	CREAM	TOPICAL	19980203		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	DIMETHICONE; PETROLATUM	.03; .3	g/g; g/g	Skin Barrier Activity [PE]		N	20241231
41167-0566_5d33b744-3ac6-4184-b8a8-6a43248c7b56	41167-0566	HUMAN OTC DRUG	Aspercreme Lidocaine with Eucalyptus Essential Oil		Lidocaine HCl	CREAM	TOPICAL	20230115		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0567_c0fdd999-30cf-4141-8450-d3d4ac5a8993	41167-0567	HUMAN OTC DRUG	Gold Bond Medicated eczema relief		Colloidal oatmeal	CREAM	TOPICAL	20141222		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	OATMEAL	20	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
41167-0568_1157a750-3e9f-41c7-a55b-450f82411a09	41167-0568	HUMAN OTC DRUG	Aspercreme Lidocaine No-Mess plus Lavender		Lidocaine HCl	LIQUID	TOPICAL	20200120		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0570_1039e7c2-508f-40fc-8cb8-84017613d4bc	41167-0570	HUMAN OTC DRUG	Aspercreme Pain Relieving		Trolamine Salicylate	CREAM	TOPICAL	19981201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
41167-0573_276076f7-61e3-49ac-abab-589e3eb2bd93	41167-0573	HUMAN OTC DRUG	Aspercreme Arthritis		Diclofenac Sodium	GEL	TOPICAL	20210415		ANDA	ANDA211253	Chattem, Inc.	DICLOFENAC SODIUM	.01	g/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41167-0581_01ff7a0e-bd59-44a2-8a2d-a88be714e736	41167-0581	HUMAN OTC DRUG	Aspercreme with Lidocaine No-Mess Applicator		Lidocaine Hydrochloride	LIQUID	TOPICAL	20170301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0582_27787b51-fdf9-4ecd-bccd-ae154da024a0	41167-0582	HUMAN OTC DRUG	Aspercreme with Lidocaine Pain Relieving Creme		Lidocaine Hydrochloride	LOTION	TOPICAL	20141201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0583_5d139801-b31a-45c2-a36d-e24faeb45ca8	41167-0583	HUMAN OTC DRUG	Aspercreme with Lidocaine Dry		lidocaine	SPRAY	TOPICAL	20190102		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0585_2404fbd6-c25e-45da-beaa-6431f85e9ab5	41167-0585	HUMAN OTC DRUG	Aspercreme with Lidocaine	XL	Lidocaine	PATCH	TOPICAL	20171021		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE	422	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0586_8755dbba-8752-4210-bae5-d40fbaaff053	41167-0586	HUMAN OTC DRUG	Aspercreme with Lidocaine Foot Pain Creme		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0590_ca351930-d874-4080-801d-c6d522d7a16e	41167-0590	HUMAN OTC DRUG	Aspercreme Lidocaine No-Mess Bergamot Orange		Lidocaine Hydrochloride	LIQUID	TOPICAL	20200120		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0597_ddbc8249-6deb-4d72-8576-38e8a7bfba23	41167-0597	HUMAN OTC DRUG	Aspercreme Lidocaine Foot (Diabetic)		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0598_8a56fcf0-9c04-4f12-98af-9f88add5b0c3	41167-0598	HUMAN OTC DRUG	Aspercreme with Lidocaine Essential Oils Rosemary Mint		Lidocaine	LIQUID	TOPICAL	20210101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-0600_b1ee473f-ed30-4080-968a-1d3aa36be122	41167-0600	HUMAN OTC DRUG	Arthritis Hot		Menthol and Methyl Salicylate	CREAM	TOPICAL	19981201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
41167-0641_ce3d0863-716d-4e90-b3c9-d90183bf0f28	41167-0641	HUMAN OTC DRUG	Gold Bond Extra Strength		Menthol	LOTION	TOPICAL	20160311		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	.005	g/g			N	20241231
41167-0662_0c6ec588-6b62-4c3f-b616-73b56c873afc	41167-0662	HUMAN OTC DRUG	Gold Bond Ultimate Eczema Relief		Colloidal oatmeal	CREAM	TOPICAL	20131006		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	OATMEAL	20	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
41167-0663_f5297019-8690-4c60-8468-06369c8da835	41167-0663	HUMAN OTC DRUG	Gold Bond Ultimate Eczema Relief Hand		Colloidal oatmeal	CREAM	TOPICAL	20150105		OTC MONOGRAPH DRUG	M016	Chattem, Inc.	OATMEAL	.02	g/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
41167-0751_eab04e42-8e1d-420f-b059-04b1c87845df	41167-0751	HUMAN OTC DRUG	Gold Bond Hydrating Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20201015		OTC MONOGRAPH DRUG	M003	Chattem, Inc.	ALCOHOL	75	mL/100mL			N	20241231
41167-0799_63681345-a143-4ef9-8dab-c940a91cebf7	41167-0799	HUMAN OTC DRUG	Icy Hot Kids Pain Relief Roll-On		Menthol	LIQUID	TOPICAL	20230115		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	4	g/100mL			N	20241231
41167-0801_65491944-30db-4aa0-93c1-df22d52eb1e4	41167-0801	HUMAN OTC DRUG	Icy Hot Advanced Relief		Camphor and Menthol	CREAM	TOPICAL	20121201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	.11; .16	g/g; g/g			N	20241231
41167-0805_c5312d71-6a8a-4ddb-aa01-3f618fce770d	41167-0805	HUMAN OTC DRUG	Icy Hot Advanced Relief		Menthol Topical Analgesic	PATCH	TOPICAL	20121201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	210	mg/1			N	20241231
41167-0815_54f8f560-d72f-4a7f-aa9a-d64b16da5171	41167-0815	HUMAN OTC DRUG	Icy Hot Dry		Menthol	SPRAY	TOPICAL	20200101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	16	g/100g			N	20241231
41167-0843_ab7cc4f3-195c-4262-a01a-d127ab4fe91b	41167-0843	HUMAN OTC DRUG	Icy Hot Back and Large Areas		Menthol	PATCH	TOPICAL	20030301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	428.5	mg/1			N	20241231
41167-0847_ab7cc4f3-195c-4262-a01a-d127ab4fe91b	41167-0847	HUMAN OTC DRUG	Icy Hot XL Back and Large Areas		Menthol	PATCH	TOPICAL	20071201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	750	mg/1			N	20241231
41167-0915_bf3e7a31-8bdc-4912-bdf3-7639c54f5728	41167-0915	HUMAN OTC DRUG	ACT Kids Pure Protect Anticavity- Simply Strawberry		Sodium Fluoride	RINSE	ORAL	20240104		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.5	mg/mL			N	20251231
41167-0922_9773b518-2d77-43fa-bd2b-4f0726b781f3	41167-0922	HUMAN OTC DRUG	ACT Kids Anticavity Fluoride	Bubble Gum Blowout	sodium fluoride	PASTE	TOPICAL	20161101		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
41167-0924_4e31c80b-0f37-4b0a-b2db-d6f3e0a97696	41167-0924	HUMAN OTC DRUG	ACT Anticavity Fluoride Kids Wild Watermelon		sodium fluoride 0.24 (0.14 w/v fluoride ion)	PASTE	TOPICAL	20190521		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
41167-0926_a653daab-ba6a-47f2-9e6f-9acde3722e38	41167-0926	HUMAN OTC DRUG	ACT Kids Anticavity Fluoride Groovy Grape		Sodium Fluoride	PASTE, DENTIFRICE	TOPICAL	20210101		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
41167-0937_cb82dc10-d51d-495e-8a62-2ee27df17874	41167-0937	HUMAN OTC DRUG	ACT Anticavity Fluoride Arctic Blast		sodium fluoride	MOUTHWASH	TOPICAL	20190102		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0938_b0b16ac8-86d1-4b8a-b460-a21e9b4ba4cb	41167-0938	HUMAN OTC DRUG	ACT Kids Anticavity Fluoride	Wild Watermelon	sodium fluoride	RINSE	TOPICAL	20171201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.5	mg/mL			N	20241231
41167-0940_702b5a38-883d-4288-813d-ee4b883da27d	41167-0940	HUMAN OTC DRUG	ACT Anticavity Fluoride Cinnamon		Sodium fluoride	RINSE	TOPICAL	19940401		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0942_545cd9ce-548b-447f-985e-cd4f6a014968	41167-0942	HUMAN OTC DRUG	ACT Anticavity Fluoride Mint		Sodium Fluoride	RINSE	TOPICAL	19940401		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0943_5abe3091-4e9e-4670-a1d5-bc971752fb19	41167-0943	HUMAN OTC DRUG	Act Total Care Anticavity Fluoride Fresh Mint		sodium fluoride	RINSE	TOPICAL	20120101		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.09	mg/mL			N	20241231
41167-0944_86694de2-8762-4b0b-ba59-40f87932f824	41167-0944	HUMAN OTC DRUG	ACT Anticavity Fluoride Kids Bubblegum		Sodium fluoride	RINSE	TOPICAL	19930201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0945_5db218b4-db59-40ad-a605-b9ae1e312bca	41167-0945	HUMAN OTC DRUG	ACT Anticavity Fluoride Kids Groovy Grape		Sodium fluoride	RINSE	TOPICAL	20190401		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0952_afba70c6-ba82-4951-9169-2aad96769491	41167-0952	HUMAN OTC DRUG	ACT Braces Care Anticavity		sodium fluoride	MOUTHWASH	ORAL	20140203		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.09	mg/mL			N	20241231
41167-0953_f8380073-16d3-4b12-8503-9c5378b92368	41167-0953	HUMAN OTC DRUG	ACT Kids Anticavity Fluoride Pineapple Punch		sodium fluoride	MOUTHWASH	TOPICAL	20190102		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0957_47b67a86-a2b2-4d5b-86cb-eabfec708384	41167-0957	HUMAN OTC DRUG	ACT Restoring Anticavity Fluoride Cool Mint		sodium fluoride	MOUTHWASH	TOPICAL	20060201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0961_be533af6-0e6d-4066-b97d-219ec80caa76	41167-0961	HUMAN OTC DRUG	ACT Total Care Anticavity Fluoride Fresh Mint		sodium fluoride	RINSE	TOPICAL	20090201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20251231
41167-0964_77b8099d-8190-49fd-9c6e-9b3e94974c78	41167-0964	HUMAN OTC DRUG	ACT Total Care Sensitive Anticavity Mint Mouth		Sodium Fluoride	RINSE	TOPICAL	20120101		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.09	mg/mL			N	20241231
41167-0965_89dc53d4-aa9d-4982-94a0-b9de80e85718	41167-0965	HUMAN OTC DRUG	ACT Total Care Anticavity Fluoride Icy Clean Mint		sodium fluoride	MOUTHWASH	TOPICAL	20090201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0966_24d33c12-7963-4088-a36d-25c5b724ad3d	41167-0966	HUMAN OTC DRUG	ACT Total Care Anticavity Fluoride Icy Clean Mint		sodium fluoride	MOUTHWASH	TOPICAL	20090201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.09	mg/mL			N	20241231
41167-0968_e05fddfa-05a2-44c0-a7a7-2436f1b9ddc1	41167-0968	HUMAN OTC DRUG	ACT Total Care Dry Mouth Anticavity Mouth		Sodium Fluoride	RINSE	TOPICAL	20110201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.09	mg/mL			N	20241231
41167-0978_4dff73d9-10af-4169-8300-3a595066cdc6	41167-0978	HUMAN OTC DRUG	ACT Restoring Anticavity Fluoride Mint Burst		Sodium fluoride	MOUTHWASH	ORAL	20151216		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41167-0979_7e9adc2f-4a24-4cbf-8e1e-c350d3ef2bf7	41167-0979	HUMAN OTC DRUG	ACT Restoring Anticavity Fluoride Mint Burst		Sodium fluoride	MOUTHWASH	ORAL	20151216		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.5	mg/mL			N	20241231
41167-0981_e327e98d-fe24-4332-b52e-8eba9a27ba02	41167-0981	HUMAN OTC DRUG	ACT Restoring Anticavity Fluoride Cool Mint		sodium fluoride	MOUTHWASH	TOPICAL	20060201		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.09	mg/mL			N	20241231
41167-0983_a0c44cd8-2c6e-4599-a122-9e22022b3dd1	41167-0983	HUMAN OTC DRUG	ACT Whitening Anticavity Gentle Mint		sodium fluoride 0.02 (0.009 w/v fluoride ion)	MOUTHWASH	TOPICAL	20190301		OTC MONOGRAPH DRUG	M021	Chattem, Inc.	SODIUM FLUORIDE	.09	mg/mL			N	20241231
41167-1001_62a80a17-9298-4228-a1c0-d58266eff39b	41167-1001	HUMAN OTC DRUG	Rolaids Extra Strength Mint		Calcium carbonate and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20130901		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	675; 135	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-1002_6d863b7a-f08f-4c53-b3c8-1f67de4aa569	41167-1002	HUMAN OTC DRUG	Rolaids Extra Strength Fruit		Calcium carbonate and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20130901		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	675; 135	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-1003_f11c1c8a-714a-435c-9a87-9ceec8c0225b	41167-1003	HUMAN OTC DRUG	Rolaids Ultra Strength Mint		Calcium carbonate and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20130901		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	1000; 200	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-1004_cc08b1ec-6999-438b-b5df-492e99c7480c	41167-1004	HUMAN OTC DRUG	Rolaids Ultra Strength Fruit		Calcium carbonate and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20130901		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	1000; 200	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-1031_71c6acba-1c5c-4ee0-9b9c-1da7e9df09b7	41167-1031	HUMAN OTC DRUG	Rolaids Ultra Strength Antacid Strawberry		Calcium carbonate and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20141201		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	1330; 235	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41167-1040_3c0f0671-19d4-499e-bb3c-4af42241ff17	41167-1040	HUMAN OTC DRUG	Rolaids Advanced Antacid Anti-gas Mixed Berry		Calcium carbonate and Magnesium hydroxide and Simethicone	TABLET, CHEWABLE	ORAL	20150202		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1000; 40; 200	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-1041_284dd7b1-cac0-4a91-acad-8955c9602478	41167-1041	HUMAN OTC DRUG	Rolaids Advanced Antacid Anti-gas Wild Berry		Calcium carbonate and Magnesium hydroxide and Simethicone	TABLET, CHEWABLE	ORAL	20230201		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1000; 40; 200	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-1043_551df376-b811-4dc5-a6c4-8c024d34d95e	41167-1043	HUMAN OTC DRUG	Rolaids Advanced Softchews Mixed Berry		Calcium carbonate, Dimethicone and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20190301		OTC MONOGRAPH DRUG	M001	Chattem, Inc.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1330; 40; 235	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41167-1602_df7a7135-59a4-4574-93f1-01bdbbd7f661	41167-1602	HUMAN OTC DRUG	Flexall Pain Relieving		Menthol	GEL	TOPICAL	19970101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	MENTHOL	.16	g/g			N	20241231
41167-1651_92616652-9b63-4883-a829-88309ab41a72	41167-1651	HUMAN OTC DRUG	Selsun Blue 2-in-1		Selenium Sulfide	SHAMPOO	TOPICAL	20020401		OTC MONOGRAPH DRUG	M032	Chattem, Inc.	SELENIUM SULFIDE	1	g/100mL			N	20241231
41167-1710_8d241abc-b359-4c7f-9ba2-a2c5edce37e9	41167-1710	HUMAN OTC DRUG	Icy Hot with Lidocaine	Pain Relieving	Lidocaine HCl and Menthol	CREAM	TOPICAL	20160301		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE; MENTHOL	.4; .1	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-1711_f2393832-4a79-4ff7-9970-202cd6699b73	41167-1711	HUMAN OTC DRUG	Icy Hot Lidocaine No-Mess		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20220210		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-1715_9651e936-8241-449a-86e3-3b3f7b407061	41167-1715	HUMAN OTC DRUG	Icy Hot with Lidocaine No-Mess		menthol and lidocaine	LIQUID	TOPICAL	20180101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-1720_812f13d3-6c4a-4d3c-b1d0-83b90f7bf5bd	41167-1720	HUMAN OTC DRUG	Icy Hot with Lidocaine		lidocaine and menthol	PATCH	TOPICAL	20180218		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE; MENTHOL	240; 60	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-1740_7b0ddb6e-716f-42a9-8c1b-959910c1de2b	41167-1740	HUMAN OTC DRUG	Icy Hot Lidocaine Dry		lidocaine, menthol	SPRAY	TOPICAL	20190601		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	LIDOCAINE; MENTHOL	4; 1	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41167-3510_2f6d58ad-9f08-46ac-85f8-ce2dcea4651a	41167-3510	HUMAN OTC DRUG	Xyzal Allergy 24HR		Levocetirizine dihydrochloride	TABLET	ORAL	20170310		NDA	NDA209089	Chattem, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-3530_473ef9ed-1b34-48a3-9438-75ebf10c321a	41167-3530	HUMAN OTC DRUG	Childrens Xyzal Allergy		Levocetirizine dihydrochloride	SOLUTION	ORAL	20230201		NDA	NDA209090	Chattem, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	2.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-3535_473ef9ed-1b34-48a3-9438-75ebf10c321a	41167-3535	HUMAN OTC DRUG	Childrens Xyzal Allergy		Levocetirizine dihydrochloride	SOLUTION	ORAL	20230201		NDA	NDA209090	Chattem, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	2.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4120_0415bbb5-3fe7-4b8e-8140-59f82020d9f8	41167-4120	HUMAN OTC DRUG	Allegra Allergy		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110303		NDA	NDA020872	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4121_0415bbb5-3fe7-4b8e-8140-59f82020d9f8	41167-4121	HUMAN OTC DRUG	Allegra Allergy		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110303		NDA	NDA020872	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4122_7b02cf6b-1e6e-429f-997b-991fc71b852e	41167-4122	HUMAN OTC DRUG	Allegra Allergy		Fexofenadine Hydrochloride	TABLET, COATED	ORAL	20141217		NDA	NDA020872	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4124_0415bbb5-3fe7-4b8e-8140-59f82020d9f8	41167-4124	HUMAN OTC DRUG	Allegra Allergy		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20201001		NDA	NDA020872	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4126_6588f306-351d-4bbb-8dd5-4617ecb72404	41167-4126	HUMAN OTC DRUG	Allegra Hives 24hr		Fexofenadine Hydrochloride	TABLET, FILM COATED	ORAL	20220606		NDA	NDA020872	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4131_0415bbb5-3fe7-4b8e-8140-59f82020d9f8	41167-4131	HUMAN OTC DRUG	Allegra Allergy		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110303		NDA	NDA020872	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4232_97ef9dd3-6eba-4189-80d0-c861c1fcf16c	41167-4232	HUMAN OTC DRUG	Childrens Allegra Allergy		Fexofenadine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20140102		NDA	NDA021909	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	30	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4244_5b688de1-ef62-4f0d-bd39-da7072ae4290	41167-4244	HUMAN OTC DRUG	Childrens Allegra Allergy		Fexofenadine Hydrochloride	SUSPENSION	ORAL	20110303		NDA	NDA201373	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4246_5b688de1-ef62-4f0d-bd39-da7072ae4290	41167-4246	HUMAN OTC DRUG	Childrens Allegra Allergy		Fexofenadine Hydrochloride	SUSPENSION	ORAL	20110303		NDA	NDA201373	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41167-4310_ebb05cc9-3bff-4357-942c-d0ab0a276938	41167-4310	HUMAN OTC DRUG	Allegra-D Allergy and Congestion		fexofenadine hydrochloride and pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110303		NDA	NDA020786	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
41167-4320_f7a5258f-2add-41a4-90d8-386bf49039b2	41167-4320	HUMAN OTC DRUG	Allegra-D Allergy and Congestion		fexofenadine hydrochloride and pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110303		NDA	NDA021704	Chattem, Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
41167-5800_4e8f5b37-4d00-4c36-9932-76649da3d802	41167-5800	HUMAN OTC DRUG	Nasacort Allergy 24HR		Triamcinolone Acetonide	SPRAY, METERED	NASAL	20140203		NDA	NDA020468	Chattem, Inc.	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41167-6020_a9d959b1-9e86-48de-aa78-2079edddce5e	41167-6020	HUMAN OTC DRUG	Selsun Blue Itchy Dry Scalp		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20091201		OTC MONOGRAPH DRUG	M032	Chattem, Inc.	PYRITHIONE ZINC	.01	g/mL			N	20241231
41167-6032_92616652-9b63-4883-a829-88309ab41a72	41167-6032	HUMAN OTC DRUG	Selsun Blue Moisturizing		Selenium Sulfide	SHAMPOO	TOPICAL	20020401		OTC MONOGRAPH DRUG	M032	Chattem, Inc.	SELENIUM SULFIDE	1	g/100mL			N	20241231
41167-6061_92616652-9b63-4883-a829-88309ab41a72	41167-6061	HUMAN OTC DRUG	Selsun Blue Medicated		Selenium Sulfide	SHAMPOO	TOPICAL	20020401		OTC MONOGRAPH DRUG	M032	Chattem, Inc.	SELENIUM SULFIDE	1	g/100mL			N	20241231
41167-6180_6c4bb06e-3e96-4ae2-81d6-dfc74afe1e17	41167-6180	HUMAN OTC DRUG	Selsun Blue Naturals Itchy, Dry Scalp		Salicylic Acid	SHAMPOO	TOPICAL	20101101		OTC MONOGRAPH DRUG	M032	Chattem, Inc.	SALICYLIC ACID	.03	g/mL			N	20241231
41167-7300_814a50af-10dc-47ee-9f40-e7ccf08a2699	41167-7300	HUMAN OTC DRUG	Sportscreme		Trolamine Salicylate	CREAM	TOPICAL	19990101		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
41167-7449_d5e059da-3cc6-467b-88fa-b3f27ba299a7	41167-7449	HUMAN OTC DRUG	Kaopectate Extra Strength Peppermint Flavor Anti Diarrheal		bismuth subsalicylate	LIQUID	ORAL	20030401		OTC MONOGRAPH DRUG	M008	Chattem, Inc.	BISMUTH SUBSALICYLATE	35	mg/mL	Bismuth [CS], Bismuth [EPC]		N	20241231
41167-7514_6f3a0418-fd3a-471f-b157-e7e01221fc1f	41167-7514	HUMAN OTC DRUG	Capzasin HP Arthritis Pain Relief		Capsaicin	CREAM	TOPICAL	19981201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	CAPSAICIN	.001	g/g			N	20241231
41167-7516_8a70bec1-cc7f-4be7-aa10-87afdb0e3466	41167-7516	HUMAN OTC DRUG	Capzasin Quick Relief		Capsaicin and Menthol	GEL	TOPICAL	20081201		OTC MONOGRAPH DRUG	M017	Chattem, Inc.	CAPSAICIN; MENTHOL	.00025; .1	g/g; g/g			N	20241231
41190-041_c0bf341f-c272-471b-821b-26bd8900e22a	41190-041	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20101214		OTC MONOGRAPH FINAL	part333D	Wakefern Food Corp	SALICYLIC ACID	19.8	mg/g			N	20241231
41190-063_fc0218d7-2776-450e-a694-556d637050e3	41190-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	19890715		OTC MONOGRAPH FINAL	part347	Wakefern Food Corp	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL			N	20241231
41190-069_6986bcbb-0374-41b6-8759-6b218991ef2f	41190-069	HUMAN OTC DRUG	Petrolatum		White Petrolatum	JELLY	TOPICAL	20090116		OTC MONOGRAPH FINAL	part347	Wakefern Food Corporation	PETROLATUM	1	g/g			N	20241231
41190-072_1a39942d-7d78-475e-8214-f443a9f45dd0	41190-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol. Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19990528		OTC MONOGRAPH NOT FINAL	part356	Wakefern Food Corporation	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41190-124_5fca05ee-07e2-40db-819a-cf3aa12952a9	41190-124	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20090804		OTC MONOGRAPH NOT FINAL	part356	Wakefern Food Corp	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41190-133_f31e3744-662e-2fe3-e053-2995a90a8c00	41190-133	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20171227		OTC MONOGRAPH FINAL	part333C	Wakefern Food Corporation	TOLNAFTATE	1.5	g/150g			N	20241231
41190-134_f3965d92-2af5-8411-e053-2995a90a7e0e	41190-134	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Spray	AEROSOL, SPRAY	TOPICAL	20171227		OTC MONOGRAPH FINAL	part333C	Wakefern Food Corporation	TOLNAFTATE	1.13	g/113g			N	20241231
41190-135_f31deda9-f9db-66a3-e053-2a95a90a15ca	41190-135	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171227		OTC MONOGRAPH FINAL	part358F	Wakefern Food Corporation	SALICYLIC ACID	40	mg/91			N	20241231
41190-136_f31d4248-2d56-d7fd-e053-2a95a90af900	41190-136	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20171227		OTC MONOGRAPH FINAL	part358B	Wakefern Food Corporation	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
41190-278_3f493da0-c525-4562-9e6f-3bc9f88c37d2	41190-278	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20170710		OTC MONOGRAPH NOT FINAL	part333A	Wakefern Food Corp	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
41190-326_0a090b1d-aca5-61ab-e063-6294a90a05c3	41190-326	HUMAN OTC DRUG	Shoprite Liquid Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210130	20241201	OTC MONOGRAPH DRUG	M003	Wakefern Food Corp	ALCOHOL	80	mL/100mL			N	
41190-370_99ca0ebe-269a-46c4-97bd-4e4371235bdb	41190-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20150127		OTC MONOGRAPH NOT FINAL	part333A	Wakefern Food Corp.	ALCOHOL	70	mL/100mL			N	20241231
41190-439_68afb5b8-366e-4a84-8645-b1f83c693579	41190-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20150203		OTC MONOGRAPH NOT FINAL	part333A	Wakefern Food Corp	ALCOHOL	616	mL/mL			N	20241231
41190-466_b6ba66cb-8769-4f91-bb33-d5909b097b69	41190-466	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160217		OTC MONOGRAPH NOT FINAL	part333A	Wakefern Food Corp.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41190-503_5c64e91f-d7e3-46a1-af71-243192007ef0	41190-503	HUMAN OTC DRUG	Complete Beauty		Octinoxate, zinc oxide	LOTION	TOPICAL	20130109		OTC MONOGRAPH FINAL	part352	Wakefern Food Corporation	OCTINOXATE; ZINC OXIDE	60; 30	mg/mL; mg/mL			N	20241231
41190-575_1373ae4e-5d50-4835-aa65-61de021b3245	41190-575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20151228		OTC MONOGRAPH NOT FINAL	part333A	Wakefern Food Corp	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
41190-602_c8be39f1-ecfe-4c62-be45-2ffe9dd80ff0	41190-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20140501		OTC MONOGRAPH NOT FINAL	part334	Wakefern Food Corp	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41190-619_faef43c5-ea2a-4731-8678-75f31639377b	41190-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20100614		OTC MONOGRAPH FINAL	part347	Wakefern Food Corp	DIMETHICONE	1.3	kg/100mL	Skin Barrier Activity [PE]		N	20241231
41190-664_58c9e4e7-3117-4fcf-a02b-519b9d62ccfc	41190-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19951002		OTC MONOGRAPH NOT FINAL	part356	Wakefern Food Corporation	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41190-804_14fea2c6-c2b1-47c8-ac61-a5ef6a3bf3b3	41190-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20101130		OTC MONOGRAPH NOT FINAL	part333A	Wakefern Food Corp	ISOPROPYL ALCOHOL	.91	mg/mL			N	20241231
41190-822_0a2708e4-f630-4984-8201-b1a28cd15ca9	41190-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	19890715		OTC MONOGRAPH FINAL	part347	Wakefern Food Corp	WITCH HAZEL	86	kg/100L			N	20241231
41190-831_3438d402-a154-4621-89ab-0bed95de21cc	41190-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part334	WAKEFERN FOOD CORPORATION	MINERAL OIL	999	mg/mL			N	20241231
41190-849_2bcc9185-2305-44c6-a849-57ad897a3b1a	41190-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20220621		OTC MONOGRAPH NOT FINAL	part333A	Wakefern	ALCOHOL	62	mg/mL			N	20241231
41190-871_ff209f36-ad08-455f-a740-cc3ccf67f8d4	41190-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	LIQUID	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Wakefern Food Corporation	HYDROGEN PEROXIDE	.3	kg/100L			N	20241231
41190-941_c2df5c51-e8c4-4580-bca2-ad4936647753	41190-941	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20140716		OTC MONOGRAPH FINAL	part358H	Wakefern Food Corp	PYRITHIONE ZINC	1	g/mL			N	20241231
41226-003_a706c6a6-e716-9044-e053-2995a90a95dc	41226-003	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part334	KROGER COMPANY	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41226-151_a6bb346c-c9aa-5755-e053-2a95a90af77d	41226-151	HUMAN OTC DRUG	WOMENS LAXATIVE		BISACODYL	TABLET	ORAL	20200529		OTC MONOGRAPH NOT FINAL	part334	KROGER	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41226-160_bfc02efe-894c-40be-e053-2995a90aaaae	41226-160	HUMAN OTC DRUG	ALLERGY		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210511		OTC MONOGRAPH FINAL	part341	Kroger Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41226-192_a7087601-616f-1ee3-e053-2a95a90a67e4	41226-192	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM AND SENNOSIDES	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part334	KROGER	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41226-195_a7096cc1-5103-c17f-e053-2a95a90a7418	41226-195	HUMAN OTC DRUG	MAXIMUM STRENGTH LAXATIVE		SENNOSIDES	TABLET	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part334	Kroger Company	SENNOSIDES	25	mg/1			N	20241231
41226-209_a825b8c5-1abe-6c82-e053-2995a90ad523	41226-209	HUMAN OTC DRUG	STOOL SOFTENER-STIMULANT LAXATIVE		STOOL SOFTENER-STIMULANT LAXATIVE	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part334	Kroger Company	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41226-272_88f1545a-6dbd-54f8-e053-2995a90a4138	41226-272	HUMAN OTC DRUG	MUCUS RELIEF		Guaifenesin	TABLET	ORAL	20190603		OTC MONOGRAPH FINAL	part341	KROGER COMPANY	GUAIFENESIN	400	mg/1			N	20241231
41226-280_89697bdd-6c45-47bf-e053-2a95a90aa0ca	41226-280	HUMAN OTC DRUG	MUCUS RELIEF DM		DEXTROMETHORPHAN HBR/GUAIFENESIN	TABLET	ORAL	20190603		OTC MONOGRAPH FINAL	part341	KROGER COMPANY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41226-341_c403fab9-ac76-41f3-e053-2995a90aee3d	41226-341	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, COATED	ORAL	20210520		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	500	mg/1			N	20241231
41226-370_bf36c5e9-62b3-1b2d-e053-2a95a90a337c	41226-370	HUMAN OTC DRUG	HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN AND CAFFEINE	TABLET, COATED	ORAL	20210410		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
41226-481_c3c22911-74c1-4aeb-e053-2a95a90a95ef	41226-481	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20210410		OTC MONOGRAPH FINAL	part343	Kroger Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41226-600_0db48dfa-6ba5-67cd-e063-6394a90ad75d	41226-600	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20210612		ANDA	ANDA091239	Kroger Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41226-601_f158ad51-b771-257f-e053-2a95a90a5558	41226-601	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20210410		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41226-609_c3d6166b-be1b-328a-e053-2a95a90af589	41226-609	HUMAN OTC DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET, COATED	ORAL	20210612		ANDA	ANDA090545	Kroger Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41226-610_c39e4f66-f9c0-9607-e053-2a95a90ac2b6	41226-610	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20210612		ANDA	ANDA079205	Kroger Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41226-625_edfa3267-1612-1146-e053-2a95a90af44b	41226-625	HUMAN OTC DRUG	DAYTIME SEVERE COLD AND FLU		ACETAMINOPHEN, PHENYLEPHRINE HCL, DEXTROMETHORPHAN HBR, GUAIFENESIN	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH FINAL	part341	KROGER COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41226-626_a6a09903-d76f-855d-e053-2a95a90a2c99	41226-626	HUMAN OTC DRUG	NIGHTTIME SEVERE COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH FINAL	part341	KROGER	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41226-627_a692815e-8a78-e3f0-e053-2995a90a0e59	41226-627	HUMAN OTC DRUG	DAYTIME-NIGHTTIME SEVERE COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL	KIT	ORAL	20200529		OTC MONOGRAPH FINAL	part341	KROGER						N	20241231
41226-628_b6bc9701-6bd5-f19c-e053-2995a90a81f4	41226-628	HUMAN OTC DRUG	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAILFENESIN,PHENLYEPHRINE HCL		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAILFENESIN,PHENLYEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20201221		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41226-686_6c55f992-da92-5188-e053-2a91aa0a4551	41226-686	HUMAN OTC DRUG	LORATADINE		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20170426		ANDA	ANDA206214	KROGER COMPANY	LORATADINE	10	mg/1			N	20241231
41226-692_d41af1aa-3c12-c440-e053-2a95a90a05fc	41226-692	HUMAN OTC DRUG	ALLERGY		CETIRIZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA078933	Kroger Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41226-693_ed19f114-f0f6-29f7-e053-2995a90aeea9	41226-693	HUMAN OTC DRUG	DAYTIME COLD AND FLU		DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210511		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41226-694_ec79e945-d60d-7590-e053-2a95a90a5cc4	41226-694	HUMAN OTC DRUG	NIGHTTIME COLD AND FLU		DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20210511		OTC MONOGRAPH FINAL	part341	Kroger Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41226-697_bf48070c-ff49-2cdb-e053-2995a90ab06f	41226-697	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, COATED	ORAL	20210410		OTC MONOGRAPH NOT FINAL	part343	Kroger Company	ACETAMINOPHEN	500	mg/1			N	20241231
41226-714_a09dc4d1-23a8-4bcd-8bbe-9960a25ed983	41226-714	HUMAN OTC DRUG	Kroger Stool Softener	Fruit Punch	Docusate sodium	LIQUID	ORAL	20230327		OTC MONOGRAPH NOT FINAL	part334	KROGER COMPANY	DOCUSATE SODIUM	50	mg/5mL			N	20241231
41226-716_002fdf94-eba4-9115-e063-6294a90a1582	41226-716	HUMAN OTC DRUG	Dual Action		Acetaminophen, Ibuprofen	TABLET	ORAL	20230711		ANDA	ANDA216994	KROGER COMPANY	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41226-717_fa789d40-7a48-186d-e053-6394a90a449c	41226-717	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE	ORAL	20230505		OTC MONOGRAPH FINAL	M002	KROGER COMPANY	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
41226-719_fab3c321-167d-50cd-e053-6294a90a054a	41226-719	HUMAN OTC DRUG	Original strength heartburn prevention		Famotidine	TABLET	ORAL	20230505		ANDA	ANDA217543	KROGER COMPANY	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41226-722_fab0c1b9-96a4-df9c-e053-6294a90a8e28	41226-722	HUMAN OTC DRUG	Extra strength gas relief		Simethicone	CAPSULE	ORAL	20230505		OTC MONOGRAPH FINAL	part332	KROGER COMPANY	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
41250-004_ce08ac08-3a9f-4a43-90c6-882b5d959916	41250-004	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20020627		OTC MONOGRAPH DRUG	M021	Meijer Distribution, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41250-007_9315f093-e516-4423-8e01-ccd0c96d070a	41250-007	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20080815		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, Inc	SALICYLIC ACID	19.8	mg/g			N	20241231
41250-024_15c9a8f0-391a-47a0-bae2-dd1314b446d1	41250-024	HUMAN OTC DRUG	Vaporizing		Camphor	LIQUID	RESPIRATORY (INHALATION)	20110722		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	CAMPHOR (NATURAL)	62	mg/mL			N	20241231
41250-029_8dbc2981-0a8d-4a66-97f9-9c26c5d94ed0	41250-029	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050206		ANDA	ANDA076775	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-031_3777e445-3c1d-46a9-bde0-5cd4a8dae1bc	41250-031	HUMAN OTC DRUG	NiteTime Cough DayTime Cough		dextromethorphan hydrobromide, doxylamine succinate	KIT		20130213		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc						N	20241231
41250-040_0ac032e8-e64e-121c-e063-6294a90ac138	41250-040	HUMAN OTC DRUG	Alcohol	Extra-Thick	Isopropyl Alcohol	SWAB	TOPICAL	20110406		OTC MONOGRAPH DRUG	M003	Meijer Distribution Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
41250-043_54fd75c2-daac-4f8a-ac5d-f2564a6936a4	41250-043	HUMAN OTC DRUG	Body		Menthol	POWDER	TOPICAL	19871115		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, Inc	MENTHOL	1.5	mg/g			N	20241231
41250-044_8e5d018a-9050-4a62-b4ba-ebfbdd56efdc	41250-044	HUMAN OTC DRUG	nitetime sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20141204		OTC MONOGRAPH FINAL	part338	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-045_e194e530-3024-4067-8c93-01a8bbb4b93b	41250-045	HUMAN OTC DRUG	Clean Apple		Pyrithione zinc	SHAMPOO	TOPICAL	20131213		OTC MONOGRAPH FINAL	part358H	Meijer Distribution	PYRITHIONE ZINC	1	g/mL			N	20241231
41250-050_3efee381-4037-4e08-8ae5-d4a2185f02d0	41250-050	HUMAN OTC DRUG	Ibuprofen PM		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20090408		ANDA	ANDA079113	Meijer Distribution Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-051_f204332b-7f25-5ba7-e053-2a95a90aacc2	41250-051	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel	GEL	TOPICAL	20150615		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	.17	g/7g			N	20241231
41250-057_a0d52a96-9254-447f-b46b-c1534ccfe359	41250-057	HUMAN OTC DRUG	ibuprofen	infants	ibuprofen	SUSPENSION	ORAL	20000317		ANDA	ANDA075217	Meijer Distribution Inc	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-058_0eb35db8-7864-b6aa-e063-6394a90a7610	41250-058	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief	SPRAY	TOPICAL	20150915		OTC MONOGRAPH DRUG	M017	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
41250-059_3366fda3-687e-466c-a647-a9a7316fdd17	41250-059	HUMAN OTC DRUG	Healing		Petrolatum	OINTMENT	TOPICAL	20130801		OTC MONOGRAPH DRUG	M016	Meijer Distribution, Inc	PETROLATUM	410	mg/g			N	20241231
41250-064_7e5c4f4f-4ef5-156b-3236-94459e5747ce	41250-064	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20140922		ANDA	ANDA078878	Meijer Distribution Inc	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-065_593322f5-1d56-43e1-b44c-a3cd7bbfdae1	41250-065	HUMAN OTC DRUG	nasal	12 hour	Oxymetazoline HCl	SPRAY	NASAL	19940503		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41250-067_c3fdf5c7-b9a2-4d81-a00c-fc4dddf83f39	41250-067	HUMAN OTC DRUG	triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20150402		OTC MONOGRAPH FINAL	part333B	Meijer Distribution Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
41250-069_46dea7c6-88eb-463d-936a-c302d209c14a	41250-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	19950407		OTC MONOGRAPH FINAL	part347	Meijer Distribution Inc	PETROLATUM	1	g/g			N	20241231
41250-071_521ede02-a7dd-4700-855b-0e22ab7ea0a7	41250-071	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20150210		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41250-072_7bbe59f8-78ea-4a05-86fd-e98c5da71333	41250-072	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	19961223		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-073_1ab1e8f9-e364-4220-b1f7-8a531d931b1b	41250-073	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20140930	20240426	NDA	NDA021920	MEIJER, INC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
41250-074_06e2a025-460a-48c2-8e87-1de554609552	41250-074	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060621		ANDA	ANDA077349	Meijer Distribution Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-080_2b8593e8-6117-4718-b198-148617edb069	41250-080	HUMAN OTC DRUG	Antifungal		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Meijer Distribution Inc	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
41250-081_49ebf096-4934-4a76-8296-1b9d6b29b5f5	41250-081	HUMAN OTC DRUG	miconazole 3		Miconazole nitrate	KIT		20000204		ANDA	ANDA075329	Meijer Distribution Inc						N	20241231
41250-082_0024658a-0b44-790f-e063-6294a90aefe8	41250-082	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	LOZENGE	ORAL	20140609		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc.	MENTHOL	5.4	mg/1			N	20241231
41250-084_73cbb0b2-5bf9-44a9-afb6-f8e23e66bf4b	41250-084	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20151130	20241231	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
41250-086_c2885c84-e377-48d8-8e92-f32e755691cc	41250-086	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20160131	20241231	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	SENNOSIDES	8.6	mg/1			N	
41250-087_f204538e-0394-b450-e053-2a95a90a82b4	41250-087	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Pen	LIQUID	TOPICAL	20140319		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
41250-091_3612237c-d1df-4d80-9830-394d09c4acfb	41250-091	HUMAN OTC DRUG	Vitamin A D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20080408		OTC MONOGRAPH FINAL	part347	Meijer	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
41250-093_a377b091-402e-43fd-9e7e-4a51141d30b0	41250-093	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl	GEL	TOPICAL	20160829		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution	LIDOCAINE HYDROCHLORIDE	2.5	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-098_0e8b2109-84cc-2d92-e063-6394a90a5d16	41250-098	HUMAN OTC DRUG	Miconazole nitrate		Antifungal Miconazole Liquid Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120413		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc	MICONAZOLE NITRATE	3	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20251231
41250-101_6271b621-39e7-4808-b763-dbc0fa53c4a8	41250-101	HUMAN OTC DRUG	NiteTime Sinus		Acetaminophen, Doxylamine succinate and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20100914	20241231	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 6.25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41250-103_fb3d58d0-340a-4736-9357-594aba1f52a4	41250-103	HUMAN OTC DRUG	Meijer Sheer Moisturing SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20160310		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
41250-107_7fb45269-d882-4d21-9d29-9cb12e10cc5f	41250-107	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20160207		OTC MONOGRAPH FINAL	part338	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-108_08a326c5-825d-ee3b-e063-6294a90afb3c	41250-108	HUMAN OTC DRUG	Assorted Fruit Antacid Flavor Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20150210		OTC MONOGRAPH DRUG	M001	Meijer Distribution Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41250-109_002540dd-8b87-2512-e063-6294a90ae95e	41250-109	HUMAN OTC DRUG	Cherry Antacid Soft Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20140401		OTC MONOGRAPH FINAL	part331	Meijer Distribution Inc.	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41250-111_b11cce22-3ca0-4d5d-8844-7fd1b42c1ce6	41250-111	HUMAN OTC DRUG	Meijer Enema		Saline Laxative	ENEMA	RECTAL	20130510		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
41250-118_91d2e1d6-4cca-9b52-e053-2995a90a2dd4	41250-118	HUMAN OTC DRUG	Aspirin	Regular Strength	ASPIRIN	TABLET, COATED	ORAL	20150101		OTC MONOGRAPH NOT FINAL	part343	Meijer	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-119_ec95d37a-6d1e-4b0c-b56e-1328b5f6c238	41250-119	HUMAN OTC DRUG	Winter Apple		Hand Sanitizer	GEL	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	ALCOHOL	62	mg/mL			N	20241231
41250-122_fcd4ea83-9ece-4c49-aa66-de11c4466f5f	41250-122	HUMAN OTC DRUG	Cranberry Garland		Ethyl Alcohol	GEL	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Meijers Distribution, Inc	ALCOHOL	62	mg/mL			N	20241231
41250-123_efbbff87-116a-63ce-e053-2995a90a31f8	41250-123	HUMAN OTC DRUG	Effervescent Orange Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20130526		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-125_1f1b0f75-5d0a-4aa1-954c-babcc7ec778e	41250-125	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20100709	20250709	OTC MONOGRAPH FINAL	part332	MEIJER, INC.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
41250-127_f2045a02-6a67-55bf-e053-2a95a90af73c	41250-127	HUMAN OTC DRUG	Undecylenic Acid Liquid		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20140319		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	UNDECYLENIC ACID	7.5	g/30g			N	20241231
41250-128_f2046cf0-f3b0-13f8-e053-2a95a90a72e2	41250-128	HUMAN OTC DRUG	Salicylic Acid		Wart Removers	PATCH	TOPICAL	20090109		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	40	mg/181			N	20241231
41250-132_0eb3f784-3523-e108-e063-6394a90a6782	41250-132	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20120105		OTC MONOGRAPH DRUG	M003	Meijer Distribution Inc	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/10mL; mg/10mL			N	20251231
41250-135_08a31c88-c31c-ee3d-e063-6294a90a07c2	41250-135	HUMAN OTC DRUG	Antacid and Anti-Gas Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170405		OTC MONOGRAPH DRUG	M001	Meijer	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
41250-136_eefaefec-5deb-4964-9625-4f847ababf44	41250-136	HUMAN OTC DRUG	Mucus Relief	Cold and Sinus Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150430	20241231	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
41250-137_f6b45447-1204-4f11-8963-af22e5030db4	41250-137	HUMAN OTC DRUG	Mucus Relief	Severe Congestion and Cough	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150228	20241231	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41250-138_e95c4ccd-e0bd-9bc5-e053-2a95a90ad053	41250-138	HUMAN OTC DRUG	COLD RELIEF MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141107		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-142_fea9d886-0541-4c24-93cc-fd7b02bfd5e7	41250-142	HUMAN OTC DRUG	Vagicaine	Maximum Strength	Benzocaine, Resorcinol	CREAM	TOPICAL	20090515		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	BENZOCAINE; RESORCINOL	20; 3	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
41250-143_5f8d84b5-dfc5-4947-8219-1307151e75ac	41250-143	HUMAN OTC DRUG	Back and Body	Extra Strength	Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20140412		OTC MONOGRAPH DRUG	M013	Meijer Distribution Inc	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
41250-146_d070f686-4c8f-55d1-e053-2995a90af638	41250-146	HUMAN OTC DRUG	Aspirin 81mg	Adult Low Dose	ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20110401		OTC MONOGRAPH NOT FINAL	part343	Meijer	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-148_e27b820f-9f4b-4acd-9069-0f01cce40a89	41250-148	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET	ORAL	19930121		OTC MONOGRAPH DRUG	M013	Meijer Distribution Inc	ACETAMINOPHEN	500	mg/1			N	20241231
41250-149_ffec5f0c-d6cc-14ac-e053-6394a90a5d99	41250-149	HUMAN OTC DRUG	menthol cough drops		Menthol	LOZENGE	ORAL	20171016		OTC MONOGRAPH FINAL	part341	Meijer	MENTHOL	5.4	mg/1			N	20241231
41250-151_0024a9f1-4d6d-4591-e063-6394a90a9ede	41250-151	HUMAN OTC DRUG	cherry cough drops		Menthol	LOZENGE	ORAL	20171017		OTC MONOGRAPH FINAL	part341	Meijer	MENTHOL	5.8	mg/1			N	20241231
41250-152_0024d77c-9c6d-503d-e063-6294a90a3171	41250-152	HUMAN OTC DRUG	cherry cough drops		Menthol	LOZENGE	ORAL	20171017		OTC MONOGRAPH FINAL	part341	Meijer	MENTHOL	5.8	mg/1			N	20241231
41250-153_0bc550a7-0991-75e4-e063-6294a90a9fc1	41250-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH DRUG	M032	Meijer Distribution, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
41250-154_6e8fe95e-f77b-4f4a-a487-c0651e514aa9	41250-154	HUMAN OTC DRUG	Athletes Foot		tolnaftate	SPRAY	TOPICAL	20041026		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	TOLNAFTATE	1	g/100g			N	20241231
41250-155_0024d77c-9c71-503d-e063-6294a90a3171	41250-155	HUMAN OTC DRUG	honey lemon cough drops		Menthol	LOZENGE	ORAL	20171018		OTC MONOGRAPH FINAL	part341	Meijer	MENTHOL	7.5	mg/1			N	20241231
41250-156_0024fb1c-a46d-1269-e063-6394a90abafb	41250-156	HUMAN OTC DRUG	honey lemon cough drops		Menthol	LOZENGE	ORAL	20171018		OTC MONOGRAPH FINAL	part341	Meijer	MENTHOL	7.5	mg/1			N	20241231
41250-158_d7794f31-7ab8-4ca1-b01b-87b955d012e2	41250-158	HUMAN OTC DRUG	Congestion Relief		Ibuprofen, phenylephrine HCl	TABLET, FILM COATED	ORAL	20140917		ANDA	ANDA203200	Meijer Distribution Inc	IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	200; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-159_f1fed021-c353-be13-e053-2995a90a49e1	41250-159	HUMAN OTC DRUG	Meijer	Maximum Strength	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	Meijer	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
41250-160_f1fec2eb-752f-e8c8-e053-2995a90a340e	41250-160	HUMAN OTC DRUG	Meijer	Maximum Strength	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	Meijer	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
41250-161_a7028c4a-a39b-4e78-a04e-bd6d939da74d	41250-161	HUMAN OTC DRUG	Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20110826		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
41250-162_be61f223-e2a9-6b1b-e053-2995a90aac36	41250-162	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20140101		NDA	NDA019125	Meijer Distribution, Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
41250-164_3d32a576-d817-43cf-9e61-9163e86159de	41250-164	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140501	20241231	OTC MONOGRAPH NOT FINAL	part356	MEIJER, INC.	PHENOL	1.4	g/100mL			N	
41250-168_00250070-b1d5-c3cb-e063-6394a90a7116	41250-168	HUMAN OTC DRUG	sugar free menthol cough drops		Menthol	LOZENGE	ORAL	20171018		OTC MONOGRAPH FINAL	part341	Meijer	MENTHOL	5.8	mg/1			N	20241231
41250-169_08a30bce-5912-9d0b-e063-6294a90a7a6a	41250-169	HUMAN OTC DRUG	sugar free cherry cough drops		Menthol	LOZENGE	ORAL	20171018		OTC MONOGRAPH DRUG	M012	Meijer	MENTHOL	5.8	mg/1			N	20241231
41250-170_7041e744-f129-42d4-9f13-4308093983eb	41250-170	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050201		ANDA	ANDA076789	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-171_0025112b-20dd-94ab-e063-6394a90afbaf	41250-171	HUMAN OTC DRUG	sugar free honey lemon cough drops		Menthol	LOZENGE	ORAL	20171018		OTC MONOGRAPH FINAL	part341	Meijer	MENTHOL	7.6	mg/1			N	20241231
41250-172_0024fb1c-a4a0-1269-e063-6394a90abafb	41250-172	HUMAN OTC DRUG	SF Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20180713		OTC MONOGRAPH FINAL	part341	Meijer Distribution	MENTHOL	7.6	mg/1			N	20241231
41250-184_9daaf945-bc33-4981-8241-7cfe4dbc1b22	41250-184	HUMAN OTC DRUG	DayTime Cold and Flu	Non Drowsy	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20200601	20250601	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41250-188_9c150e5e-75a2-488b-9043-a8252b9f2c7a	41250-188	HUMAN OTC DRUG	hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20140305		OTC MONOGRAPH FINAL	part346	Meijer Distribution Inc	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-189_d9c5a7d0-e4c7-4702-b174-a86068a4f7cd	41250-189	HUMAN OTC DRUG	Childrens 24 Hour Allergy		Cetirizine HCl	SOLUTION	ORAL	20180522		ANDA	ANDA204226	Meijer Distribution Inc	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-190_45a6ace6-653f-4207-aadb-d2d696875b60	41250-190	HUMAN OTC DRUG	nicotine		Nicotine polacrilex	LOZENGE	ORAL	20090916		ANDA	ANDA090711	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-191_ffabafa0-93bb-4513-b98e-a7a5ad77b42b	41250-191	HUMAN OTC DRUG	Bisacody	Enteric Coated	Bisacodyl	TABLET, COATED	ORAL	20160531	20250531	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
41250-192_e05167ff-b7bd-1d04-e053-2995a90a66e8	41250-192	HUMAN OTC DRUG	pain relief		Acetaminophen	TABLET, COATED	ORAL	20200313		OTC MONOGRAPH NOT FINAL	part343	MEIJER	ACETAMINOPHEN	500	mg/1			N	20241231
41250-195_91d2d116-f61b-e3c1-e053-2995a90af20f	41250-195	HUMAN OTC DRUG	pain relief PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20170501		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-196_f2047f00-c3f6-3e18-e053-2a95a90af35f	41250-196	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Powder Spray Talc Free	AEROSOL, POWDER	TOPICAL	20180404		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41250-197_efb672ef-24b0-6806-e053-2a95a90a85b4	41250-197	HUMAN OTC DRUG	mucus relief cold flu and sore throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20190901		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-198_06311c14-061d-4a3f-b36d-f83cfa67d7d2	41250-198	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20100712	20240426	ANDA	ANDA078682	MEIJER, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
41250-199_8ec57750-0c0e-4518-bed7-72654586cbc8	41250-199	HUMAN OTC DRUG	miconazole 1		Miconazole nitrate	KIT		20100611		ANDA	ANDA079114	Meijer Distribution Inc						N	20241231
41250-201_066c6b3e-3cec-4dab-8679-f126388bddea	41250-201	HUMAN OTC DRUG	nicotine		Nicotine polarilex	LOZENGE	ORAL	20100115		ANDA	ANDA090821	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-203_46b38e91-a6be-48e5-aba3-2b83dbe598f6	41250-203	HUMAN OTC DRUG	Meijer Extra Strength	Tropical Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190329		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41250-205_042d546f-3933-4f2e-87c2-b653df5fba88	41250-205	HUMAN OTC DRUG	Athletes Foot		Tolnaftate	SPRAY	TOPICAL	20041026		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	TOLNAFTATE	1	g/100g			N	20241231
41250-206_9c9aa278-5e64-4071-9eff-6bafb2d9d425	41250-206	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050124		ANDA	ANDA078325	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-207_d070f686-4ca6-55d1-e053-2995a90af638	41250-207	HUMAN OTC DRUG	sinus pressure and pain PE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200710		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-209_007bb943-bc02-47ec-9071-d0536584735f	41250-209	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20170208		ANDA	ANDA206394	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-210_f0fea709-42d1-5ab3-e053-2a95a90a093e	41250-210	HUMAN OTC DRUG	anti-diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190201		NDA	NDA021855	MEIJER DISTRIBUTION INC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41250-211_f9a6ca2e-3030-453f-adab-2a5263ebef9f	41250-211	HUMAN OTC DRUG	Meijer Stomach Relief	Regular Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20170315		OTC MONOGRAPH DRUG	M008	MEIJER DISTRIBUTION INC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
41250-212_d6c9fc40-9071-4b97-a949-7ad074de6091	41250-212	HUMAN OTC DRUG	meijer Fiber Therapy		Methylcellulose	TABLET	ORAL	20170314		OTC MONOGRAPH DRUG	M007	MEIJER DISTRIBUTION INC	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
41250-213_66fb2ffe-ea31-4354-9d75-da906e971d5b	41250-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20020711		OTC MONOGRAPH DRUG	M021	Meijer Distribution, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41250-218_602cb3a0-2c0b-46b5-a5b5-973ac0699fe1	41250-218	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20090602		OTC MONOGRAPH NOT FINAL	part347	Meijer Distribution, Inc.	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41250-219_d0720ed2-15d7-99db-e053-2995a90ada08	41250-219	HUMAN OTC DRUG	sinus severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170401		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-221_feb17ea6-2587-4948-a96c-ab30a8fbf6b8	41250-221	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180331	20241231	ANDA	ANDA202300	MEIJER, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
41250-222_f03090cf-5a87-ca73-e053-2a95a90abc61	41250-222	HUMAN OTC DRUG	Meijer Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20130521		OTC MONOGRAPH FINAL	part343	Meijer Distribution Inc	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-224_15ae5599-be4c-4546-9743-ce85786ee97d	41250-224	HUMAN OTC DRUG	anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030305		ANDA	ANDA075232	Meijer Distribution Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41250-225_df636c3f-baa7-9044-e053-2995a90a16a0	41250-225	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190201		NDA	NDA021920	MEIJER DISTRIBUTION INC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-226_34e153e4-b80c-426e-9f6d-21a2d4886342	41250-226	HUMAN OTC DRUG	Baby Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	20110901		OTC MONOGRAPH FINAL	part347	Meijer Distribution, Inc	ZINC OXIDE	130	g/g			N	20241231
41250-227_048f5453-5702-4bc0-bdef-13a5e5f44d43	41250-227	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20050928		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	500	mg/1			N	20241231
41250-229_bc2dbb0b-384b-49f3-8f02-4ec72a66074c	41250-229	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20130715		OTC MONOGRAPH FINAL	part333D	Meijer	BENZOYL PEROXIDE	100	mg/g			N	20241231
41250-230_df755518-5096-475e-b6f5-c07d0fee9d90	41250-230	HUMAN OTC DRUG	meijer fiber laxative		Psyllium Husk	CAPSULE	ORAL	20170314		OTC MONOGRAPH NOT FINAL	part334	MEIJER DISTRIBUTION, INC	PSYLLIUM HUSK	.52	g/1			N	20241231
41250-231_91d2c679-5e03-86cf-e053-2a95a90ae3d9	41250-231	HUMAN OTC DRUG	nasal decongestant PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170401		OTC MONOGRAPH FINAL	part341	Meijer	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-232_d763775b-ed98-489d-a537-f8d0b637d97e	41250-232	HUMAN OTC DRUG	meijer Extra Strength Antacid	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170314		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41250-235_0eb3bc19-0d79-cffb-e063-6394a90a1edb	41250-235	HUMAN OTC DRUG	Calamine Plus Pramoxine HCL		Calamine Plus Spray	AEROSOL, SPRAY	TOPICAL	20200314		OTC MONOGRAPH DRUG	M017	Meijer Distribution Inc.	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g			N	20251231
41250-239_f4b96094-f1ed-4597-ba7a-17e7031d64d3	41250-239	HUMAN OTC DRUG	Allergy Relief-D	24 Hour	Loratadine and Pseudoephedrine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20160301	20240426	ANDA	ANDA075706	MEIJER, INC.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
41250-241_f2048b24-4340-98ba-e053-2995a90a5e85	41250-241	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20120306		OTC MONOGRAPH FINAL	part358F	Meijer Distribution Inc	SALICYLIC ACID	40	mg/91			N	20241231
41250-243_f216e896-1e45-5c49-e053-2995a90ab89b	41250-243	HUMAN OTC DRUG	Salicylic Acid		Medicated Plantar Wart Remover	PATCH	TOPICAL	20120105		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	40	mg/241			N	20241231
41250-244_3b3cb966-5bea-4445-b079-ef252c976d83	41250-244	HUMAN OTC DRUG	Children Pain and Fever Reliever		Acetaminophen	TABLET, CHEWABLE	ORAL	20200129		OTC MONOGRAPH DRUG	M013	MEIJER DISTRIBUTION INC	ACETAMINOPHEN	160	mg/1			N	20241231
41250-246_8bc2248f-a0c5-4b53-a769-ff9d90582ead	41250-246	HUMAN OTC DRUG	Meijer Childrens	Pain and Fever Reducer	Acetaminophen	TABLET, CHEWABLE	ORAL	20200129		OTC MONOGRAPH DRUG	M013	MEIJER DISTRIBUTION INC	ACETAMINOPHEN	160	mg/1			N	20241231
41250-249_c3a48e25-2eac-4bf2-865d-46b20a268d6c	41250-249	HUMAN OTC DRUG	Meijer T Plus Gel Coal Tar Anti-Dandruff		Coal Tar	SHAMPOO	TOPICAL	20150305		OTC MONOGRAPH FINAL	part358H	Meijer Distribution, INC	COAL TAR	5	mg/mL			N	20241231
41250-255_3cd552af-c6eb-4df0-8bdb-2e8ebe7182eb	41250-255	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20040418		ANDA	ANDA075217	Meijer Distribution Inc	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-257_c24a9123-36c5-4ebb-9e8d-fac7ffcab1b7	41250-257	HUMAN OTC DRUG	Meijer Extra Strength	Gas Relief	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20200129		OTC MONOGRAPH DRUG	M002	MEIJER DISTRIBUTION INC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
41250-258_0a45956e-863e-4869-8840-c2b2298512b0	41250-258	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20190131	20250131	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	DOCUSATE SODIUM	250	mg/1			N	
41250-259_db8ab2f1-c087-adce-e053-2a95a90a0467	41250-259	HUMAN OTC DRUG	Meijer Max. Strength Anti-Itch Cream Intensive Healing Formula		Hydrocortisone	CREAM	TOPICAL	20200716		OTC MONOGRAPH NOT FINAL	part348	MEIJER, INC.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41250-260_7c7bb34c-3bc4-4c6d-b453-a7c89cb6cfc2	41250-260	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20191129	20250131	OTC MONOGRAPH FINAL	part338	MEIJER, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
41250-261_46b9d3e1-a0d4-4db6-8110-27e4ac14862a	41250-261	HUMAN OTC DRUG	adult dm max cough and chest congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180709		OTC MONOGRAPH FINAL	part341	Meijer, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-264_ab8c083e-ac22-4cad-b1b1-690a7ba6db33	41250-264	HUMAN OTC DRUG	Acne Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20140218		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	BENZOYL PEROXIDE	100	mg/g			N	20241231
41250-265_bae53396-8a20-4acd-94cf-5eb130fc5804	41250-265	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20190630	20250630	OTC MONOGRAPH NOT FINAL	part333A	MEIJER, INC.	ISOPROPYL ALCOHOL	70	mL/100mL			N	
41250-267_91d2c7b3-ff4c-c281-e053-2995a90a76cc	41250-267	HUMAN OTC DRUG	mucus relief sinus severe congestion and pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170701		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-268_4872c297-fbd5-4021-a831-6ebae559ee5a	41250-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20190630		OTC MONOGRAPH DRUG	M022	MEIJER, INC.	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
41250-270_27ef21b8-2475-4011-bab2-ee17f8135a86	41250-270	HUMAN OTC DRUG	Meijer Regular strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41250-273_e95a71a1-7663-c46b-e053-2a95a90a0790	41250-273	HUMAN OTC DRUG	Mucus and Sinus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141107	20241231	OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
41250-274_1df9f9cb-102a-44d3-893c-d16b3478036a	41250-274	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19961126		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-275_d070f7d1-5448-4d9c-e053-2a95a90a973d	41250-275	HUMAN OTC DRUG	COLD RELIEF SEVERE HEAD CONGESTION		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141107		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-276_d7348d02-41ba-4a28-81ea-96fdd52e6956	41250-276	HUMAN OTC DRUG	Isopropyl Alcohol Wintergreen	70 percent Wintergreen	Isopropyl alcohol	LIQUID	TOPICAL	20190630	20250630	OTC MONOGRAPH NOT FINAL	part333A	MEIJER, INC.	ISOPROPYL ALCOHOL	70	mL/100mL			N	
41250-278_3daa2a04-fb34-4402-8413-87016d6dee88	41250-278	HUMAN OTC DRUG	Pain Relief	Adult Extra Strength	Acetaminophen	LIQUID	ORAL	20160229	20250228	OTC MONOGRAPH NOT FINAL	part343	MEIJER, INC.	ACETAMINOPHEN	500	mg/15mL			N	
41250-279_2234cdf7-6319-4d2a-bad8-c72afa125f9b	41250-279	HUMAN OTC DRUG	hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20141008		OTC MONOGRAPH FINAL	part346	Meijer Distribution Inc	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-280_cb29854a-58d4-41d6-a34d-cf8f24fa5cce	41250-280	HUMAN OTC DRUG	cough and chest congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20140715		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-281_0bc8d071-0313-24b7-e063-6394a90ae6f4	41250-281	HUMAN OTC DRUG	Dandruff		Pyrithione zinc 1%	SHAMPOO	TOPICAL	20020524		OTC MONOGRAPH DRUG	M032	Meijer Distribution, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
41250-282_0c8661ec-0c9f-22fe-e063-6394a90ae334	41250-282	HUMAN OTC DRUG	Meijer Earwax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20141127		OTC MONOGRAPH DRUG	M014	Meijer Distribution Inc	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
41250-284_50f026c2-d413-442e-872f-2627afabcecb	41250-284	HUMAN OTC DRUG	Dual Action Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160126		ANDA	ANDA077355	Meijer Distribution Inc	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-285_eb64f59f-eef1-8517-e053-2a95a90a3948	41250-285	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20210224		ANDA	ANDA090397	MEIJER DISTRIBUTION INC.	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-286_0d864453-d924-2e87-e063-6394a90a4b81	41250-286	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210224		ANDA	ANDA078682	MEIJER DISTRIBUTION INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-287_ef465d35-d627-442b-ba00-8a088a473ac4	41250-287	HUMAN OTC DRUG	Meijer Maximum strength	pain relieving cleansing	benzalkonium chloride and lidocaine hydrochloride	LIQUID	TOPICAL	20200120		OTC MONOGRAPH DRUG	M015	MEIJER DISTRIBUTION, INC.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-288_0276f847-7b44-4fb9-b9f5-9d9cfc7707ad	41250-288	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20191129		ANDA	ANDA091314	MEIJER, INC.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
41250-290_0e8bbb50-1589-e622-e063-6294a90a7c51	41250-290	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone Continuous Spray	AEROSOL, SPRAY	TOPICAL	20210301		OTC MONOGRAPH DRUG	M017	Meijer Distribution Inc.	HYDROCORTISONE	1.13	g/113g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
41250-292_f0d70d17-a79a-0e69-e053-2a95a90ad005	41250-292	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200319		ANDA	ANDA078682	MEIJER DISTRIBUTION INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-293_f0d7aad3-c5ac-198b-e053-2995a90ae346	41250-293	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200319		ANDA	ANDA078682	MEIJER DISTRIBUTION INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-294_419bdb2f-91e0-4fca-b660-11a23b2ad480	41250-294	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20120319		ANDA	ANDA091344	Meijer Distribution Inc	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
41250-295_eeaf12a0-d7e5-426e-96c3-407831576cd7	41250-295	HUMAN OTC DRUG	Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	18; 882	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-297_d3643788-3218-4dcb-b5cd-bb73a1db9e30	41250-297	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20191227	20250630	OTC MONOGRAPH FINAL	part347	MEIJER, INC.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
41250-298_7381e18c-3f13-40b5-be47-16300965f70b	41250-298	HUMAN OTC DRUG	Meijer Extra Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200128		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41250-304_f307e209-5b91-4edf-9401-f9bd2bdaa8da	41250-304	HUMAN OTC DRUG	nasal	12 hour	oxymetazoline hydrochloride	SPRAY	NASAL	19911206		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41250-305_0c90a498-08b1-1e70-e063-6394a90a66ce	41250-305	HUMAN OTC DRUG	meijer	Athletes Foot	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41250-306_664e13a5-da63-411c-a37f-59aaaff7688f	41250-306	HUMAN OTC DRUG	clear lax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091006		ANDA	ANDA090685	Meijer Distribution Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-309_9d1a7eea-b3ea-41a3-8ff4-f0d84d7d8266	41250-309	HUMAN OTC DRUG	Fresh Mint Dandruff		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20040821		OTC MONOGRAPH FINAL	part358H	Meijer Distribution, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
41250-311_0bc842a6-0311-effc-e063-6394a90aeead	41250-311	HUMAN OTC DRUG	Everyday Clean		Pyrithione Zinc	SHAMPOO	TOPICAL	20051011		OTC MONOGRAPH DRUG	M032	Meijer Distribution, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
41250-313_4bc7888b-722a-4fd4-b35a-2460f855820b	41250-313	HUMAN OTC DRUG	naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20040528		ANDA	ANDA074661	Meijer Distribution Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-317_f27e3acc-163d-4ae0-830f-802acef602cc	41250-317	HUMAN OTC DRUG	pain relief		Acetaminophen	TABLET, FILM COATED	ORAL	20200602		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	500	mg/1			N	20241231
41250-318_befc64b4-99fc-4c08-88a2-e8104e94c03a	41250-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL, menthol, Methyl salicylate, thymol	MOUTHWASH	ORAL	19900715		OTC MONOGRAPH NOT FINAL	part356	Meijer Distribution, Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-319_0d2273c9-17e1-0f0b-e063-6294a90a76da	41250-319	HUMAN OTC DRUG	Meijer Lubricant Eye Drops		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20200420		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
41250-320_08f31a2b-20e5-5ada-e063-6394a90a2407	41250-320	HUMAN OTC DRUG	stay awake		CAFFEINE	TABLET	ORAL	20110801	20250731	OTC MONOGRAPH DRUG	M011	Meijer	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
41250-324_178e9530-83ab-4604-9d83-83ccadbec7be	41250-324	HUMAN OTC DRUG	meijer stomach relief		Bismuth Subsalicylate	TABLET	ORAL	20170307		OTC MONOGRAPH DRUG	M008	Meijer Distribution Inc	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
41250-327_2047279e-7b76-4153-b1a2-4334b0fbbd64	41250-327	HUMAN OTC DRUG	Cold, Flu, and Sore Throat		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20190430		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-329_2ec7ca25-af79-4365-938b-67a85f18db57	41250-329	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-331_c8d9c8c6-20fa-4a18-af80-47e3ffd4272a	41250-331	HUMAN OTC DRUG	childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190517		ANDA	ANDA076359	Meijer Distribution Inc	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-332_8e23ab75-36d6-40a0-9825-a8a1604bd883	41250-332	HUMAN OTC DRUG	milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	19920826		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-333_3c28645b-5a40-4edd-bb22-d93ad1077bc1	41250-333	HUMAN OTC DRUG	Enema	mineral oil	Mineral Oil	LIQUID	RECTAL	19910808		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc	MINERAL OIL	100	g/100mL			N	20241231
41250-334_db067f65-37e6-4332-ac2b-a2671cb7d7aa	41250-334	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20080313		OTC MONOGRAPH DRUG	M013	Meijer Distribution Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
41250-335_0d5f76b8-b13a-47fb-bcf5-d8f1989b93d8	41250-335	HUMAN OTC DRUG	nitetime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110921		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-339_b8d01813-85a9-4b77-bbd4-b2cc7f6fc733	41250-339	HUMAN OTC DRUG	gentle laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20200629		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-340_b0a84105-2d93-45d3-888f-a3fa8f3733d4	41250-340	HUMAN OTC DRUG	antacid		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	19900815		OTC MONOGRAPH FINAL	part331	Meijer Distribution Inc	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-342_c87eb290-445d-42d3-8fbf-22502185160f	41250-342	HUMAN OTC DRUG	Meijer Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190829		UNAPPROVED DRUG OTHER		Meijer Distribution Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
41250-343_032513ef-e98f-4eea-a090-bc38e5798557	41250-343	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190228	20250228	OTC MONOGRAPH FINAL	part332	MEIJER, INC.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
41250-344_5e8a2acd-097f-4806-8d53-03100fb50791	41250-344	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060301		ANDA	ANDA077007	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-346_8d49f52a-575e-46a4-b7bd-73260d56ed35	41250-346	HUMAN OTC DRUG	Meijer oil Free Acne Wash Facial Cleanser Pink Grapefruit	Acne medication	Salicylic Acid	LOTION	TOPICAL	20110328		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	SALICYLIC ACID	20	mg/mL			N	20241231
41250-347_2395498e-4726-4cb6-beda-cba2b5b62273	41250-347	HUMAN OTC DRUG	Meijer Acne Treatment	Acne medication	Benzoyl Peroxide	GEL	TOPICAL	20190514		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	BENZOYL PEROXIDE	100	mg/g			N	20241231
41250-348_010d2521-8f0a-4d9c-b5e8-41aba13ac58c	41250-348	HUMAN OTC DRUG	Meijer Invisible Acne	Acne medication	Benzoyl Peroxide	CREAM	TOPICAL	20190603		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	BENZOYL PEROXIDE	100	mg/g			N	20241231
41250-349_196181dd-ca33-481c-87c0-d662346b7660	41250-349	HUMAN OTC DRUG	Omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180313		NDA	NDA209400	Meijer Distribution Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-350_053f640b-b258-479e-ac94-60229d14b2eb	41250-350	HUMAN OTC DRUG	Meijer Maximum Strength Pain Relieving	Analgesic	menthol, unspecified form	LIQUID	TOPICAL	20190224		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	MENTHOL, UNSPECIFIED FORM	160	mg/mL			N	20241231
41250-351_eb31b285-0463-4dcb-9768-98001e40726e	41250-351	HUMAN OTC DRUG	Meijer Odor Free Analgesic Pain Relieving	Topical Analgesic	LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20190227		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-354_026f3905-4ba8-4c97-941d-76e5500d14d5	41250-354	HUMAN OTC DRUG	Meijer Foaming Cleanser	Acne medication	Salicylic Acid	LOTION	TOPICAL	20110106		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	SALICYLIC ACID	5	mg/mL			N	20241231
41250-355_f334ecbb-c950-4051-bdcf-2117e152abbc	41250-355	HUMAN OTC DRUG	Meijer Cold and Hot Pain Relieving	Analgesic	Lidocaine Hydrochloride and MENTHOL, UNSPECIFIED FORM	CREAM	TOPICAL	20200420		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-356_8de66cec-14fd-4eaf-9905-c754eea856f4	41250-356	HUMAN OTC DRUG	Meijer Pain Relieving Balm	Analgesic	Trolamine Salicylate	CREAM	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	TROLAMINE SALICYLATE	10	mg/g			N	20241231
41250-360_25f5a29f-8969-4a9e-b6c3-205ac6462049	41250-360	HUMAN OTC DRUG	Meijer SPF 8		AVOBENZONE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20160216		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution Inc	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	.9; 2; 1.5	g/100g; g/100g; g/100g			N	20241231
41250-362_f05d712d-b82e-35e0-e053-2995a90a3b19	41250-362	HUMAN OTC DRUG	MEIJER KIDS BROAD SPECTRUM SPF 50 MINERAL BASED SUNSCREEN		OCTINOXATE, OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20181106		OTC MONOGRAPH NOT FINAL	part352	MEIJER DISTRIBUTION INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 145	mg/mL; mg/mL; mg/mL			N	20241231
41250-363_08a36887-399a-8fff-e063-6394a90ae9d5	41250-363	HUMAN OTC DRUG	Meijer Berry Antacid HBG		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210312		OTC MONOGRAPH DRUG	M001	Meijer	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
41250-365_f379af2c-aa65-4f8a-9618-d368c6d9074c	41250-365	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20111214	20241101	ANDA	ANDA091349	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
41250-367_4e0c2de6-4325-4a35-91d8-69d12aee4c4e	41250-367	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-369_fe3ebe86-3cf8-4228-9042-a9f7d017d7f0	41250-369	HUMAN OTC DRUG	anti itch		Hydrocortisone	CREAM	TOPICAL	20181220		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41250-370_45f7e46c-3a1b-4c16-8a49-62b1d67c6bce	41250-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	19920424		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	ALCOHOL	70	mL/100mL			N	20241231
41250-374_22236522-a426-4ec9-869e-d8e22cc45493	41250-374	HUMAN OTC DRUG	migraine formula		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020430		ANDA	ANDA075794	Meijer Distribution Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
41250-375_aaf9cd80-9ea0-4a58-89b2-5ca03360bba3	41250-375	HUMAN OTC DRUG	anti diarrheal plus anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181016		ANDA	ANDA209837	Meijer Distribution Inc	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
41250-376_759f3f3c-02e0-443f-a489-0b347b7d9ad0	41250-376	HUMAN OTC DRUG	Senna S		Docusate Sodium, Sennosides	TABLET	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41250-378_b6c0988e-6f57-45c0-9832-f3278abd2050	41250-378	HUMAN OTC DRUG	Meijer Extra Strength Cold And Hot TherapyPain Relieving	Topical Analgesic	menthol, unspecified form and methyl salicylate	CREAM	TOPICAL	20201130		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 300	mg/g; mg/g			N	20241231
41250-379_d9ac2b0a-1934-4312-80b4-cd33bd37bb21	41250-379	HUMAN OTC DRUG	allergy	childrens	Diphenhydramine Hydrochloride	SOLUTION	ORAL	19871115		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-383_0e8bbade-08bb-5431-e063-6394a90aca3c	41250-383	HUMAN OTC DRUG	Witch Hazel		Witch Hazel Spray	SPRAY	TOPICAL	20210301		OTC MONOGRAPH DRUG	M016	Meijer Distribution Inc	WITCH HAZEL	146	g/170g			N	20251231
41250-384_40d7ea7b-9d73-4f4f-8628-ca0ac15dcf41	41250-384	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120827		ANDA	ANDA091135	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-385_c709432c-5e4d-f2f0-e053-2a95a90a0af6	41250-385	HUMAN OTC DRUG	Meijer Sunscreen Broad Spectrum SPF 70 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151026		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-386_0e8b2109-8518-2d92-e063-6394a90a5d16	41250-386	HUMAN OTC DRUG	Tolnaftate		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20210406		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc.	TOLNAFTATE	.3	g/30mL			N	20251231
41250-388_fbdb0d8e-94e0-48b6-b331-d1726a0a449d	41250-388	HUMAN OTC DRUG	nasal		Oxymetazoline HCl	SPRAY	NASAL	20020911		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41250-390_622b7382-f1e6-445b-aa5e-9ccf5ef30f16	41250-390	HUMAN OTC DRUG	Menstrual Complete	Maximum Strength	Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	Meijer Distribution Inc	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
41250-391_39439edb-df3c-4c85-bcfd-c435f4fbbfd1	41250-391	HUMAN OTC DRUG	lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210607		ANDA	ANDA202319	Meijer Distribution Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-392_08a35e4e-97cd-fca6-e063-6394a90af82b	41250-392	HUMAN OTC DRUG	Meijer Lime/Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210301		OTC MONOGRAPH DRUG	M001	Meijer	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41250-395_08a36759-4ba3-09cd-e063-6294a90aafaa	41250-395	HUMAN OTC DRUG	Meijer Lime/Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210301		OTC MONOGRAPH DRUG	M001	Meijer	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41250-398_f20494e3-24a3-ad8b-e053-2995a90a153d	41250-398	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20150716		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	.17	mg/9.8g			N	20241231
41250-399_f20494e3-24a4-ad8b-e053-2995a90a153d	41250-399	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20150716		OTC MONOGRAPH FINAL	part358F	Meijer Distribution Inc	SALICYLIC ACID	.17	g/9mL			N	20241231
41250-401_ec55f1ae-0f93-4ab2-ab2d-61ae2f4968f5	41250-401	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150325		NDA	NDA022032	Meijer Distribution Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-409_08a35e4e-97d0-fca6-e063-6394a90af82b	41250-409	HUMAN OTC DRUG	Meijer Berry Antacid HBG		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210312		OTC MONOGRAPH DRUG	M001	Meijer	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
41250-411_b8981ec7-68c5-4b9a-b0a5-806d7f1c79b0	41250-411	HUMAN OTC DRUG	Maximum Strength Cold Sore Treatment		Camphor, Menthol, Phenol, White Petrolatum	GEL	TOPICAL	20190909		OTC MONOGRAPH NOT FINAL	part333E	Meijer Distribution Inc	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
41250-412_62799e96-ef81-436a-9c2c-3d31a14e09d9	41250-412	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	PASTE	TOPICAL	20120510		OTC MONOGRAPH FINAL	part347	Meijer Distribution, Inc	ZINC OXIDE	400	mg/g			N	20241231
41250-414_754a9cdc-82f5-4e1f-ba42-4e6288366e5c	41250-414	HUMAN OTC DRUG	meijer Natural Fiber		Psyllium Husk	POWDER	ORAL	20170314		OTC MONOGRAPH DRUG	M007	MEIJER DISTRIBUTION INC	PSYLLIUM HUSK	3.4	g/12g			N	20241231
41250-415_dadbb1fe-da8a-44b0-b36e-d3078548ffc5	41250-415	HUMAN OTC DRUG	Meijer Extra Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41250-417_a7164cdf-c48f-4a48-88d8-e2f61bbbfdc3	41250-417	HUMAN OTC DRUG	Sinus and Cold D		Naproxen sodium, Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130812		ANDA	ANDA076518	Meijer Distribution Inc	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
41250-418_22504b43-0415-4b81-9b0a-57727868fc4c	41250-418	HUMAN OTC DRUG	Meijer Analgesic with Aloe	Topical Analgesic	Trolamine Salicylate	CREAM	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	TROLAMINE SALICYLATE	100	mg/g			N	20241231
41250-419_ab84407e-b584-4df8-a214-e951c80b3db6	41250-419	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20140423		ANDA	ANDA074937	Meijer Distribution Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-420_6eb1ac60-8fef-42ec-a845-d2ea8e9d347a	41250-420	HUMAN OTC DRUG	Meijer Ultra Strength Antacid	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170321		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	1000	mg/1			N	20241231
41250-422_6ac5444c-199a-49ca-bcde-585f38e73fcf	41250-422	HUMAN OTC DRUG	nicotine	mint flavor	Nicotine Polacrilex	GUM, CHEWING	ORAL	20050124		ANDA	ANDA078326	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-424_ffd8d5ed-f288-489c-8e1f-85ad2ca5228a	41250-424	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20100115		ANDA	ANDA090821	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-426_1cf05527-7e96-478f-bb56-0607e0e00f8b	41250-426	HUMAN OTC DRUG	tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20080109		ANDA	ANDA075915	Meijer Distribution Inc	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41250-427_81d08442-0326-4b89-b803-e6e9ae649b81	41250-427	HUMAN OTC DRUG	Multi Symptom Antacid	Berry Flavor	Calcium carbonate ,Magnesium hydroxide,Simethicone	TABLET, CHEWABLE	ORAL	20170307		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION, INC	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	675; 60; 135	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-428_ec8b36de-4a10-4e52-b7a6-f8b3409f45a7	41250-428	HUMAN OTC DRUG	hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20210615		ANDA	ANDA075598	Meijer, Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
41250-432_a2e74f87-ab7f-4184-b215-e91d3ec105c5	41250-432	HUMAN OTC DRUG	nasal decongestant	maximum strength non drowsy	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19910215		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41250-433_2b5a873d-9e42-40c4-ac72-8052aac02ce3	41250-433	HUMAN OTC DRUG	triple antibiotic		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20171003		OTC MONOGRAPH FINAL	part333B	Meijer Distribution Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
41250-434_42ca6b67-0ef7-4be7-93bc-060a1bc7c2ce	41250-434	HUMAN OTC DRUG	Tartar control		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20140220		OTC MONOGRAPH NOT FINAL	part356	Meijer Distribution, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-435_504859cd-5fdb-4acc-8547-29cdf6cfb87e	41250-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150909		OTC MONOGRAPH DRUG	M021	Meijer Distribution, Inc	SODIUM FLUORIDE	.1	mg/mL			N	20241231
41250-436_74afb504-a970-4dc6-ac35-a9939cacf798	41250-436	HUMAN OTC DRUG	mucus relief dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200602		ANDA	ANDA207602	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-438_f8b3c850-224d-4474-8f0c-b2b8e21cf723	41250-438	HUMAN OTC DRUG	Meijer Oil Free Faces SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20160525		OTC MONOGRAPH NOT FINAL	part352	Meijer	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 13; 5; 2; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
41250-439_8bf55622-87ad-4ad5-924c-df92ca44aae4	41250-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20131213		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	ALCOHOL	616	mL/mL			N	20241231
41250-440_6cea0198-be31-4b02-a42f-09471b2128e3	41250-440	HUMAN OTC DRUG	Meijer Oil Free SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20160519		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 13; 5; 2; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
41250-443_de4d769d-69f3-4a6e-a223-e7cfe697c3c1	41250-443	HUMAN OTC DRUG	24 Hour Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170118		ANDA	ANDA078104	Meijer Distribution Inc	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41250-445_2366108c-d2e3-49d0-99f3-74b834d00ae2	41250-445	HUMAN OTC DRUG	Meijer Senna Laxative	Regular Strength	Sennosides	TABLET	ORAL	20200420		OTC MONOGRAPH DRUG	M007	MEIJER, INC.	SENNOSIDES	8.6	mg/1			N	20241231
41250-446_1832056a-f608-46b2-95c4-2913e02a5c8b	41250-446	HUMAN OTC DRUG	Meijer Maximum Strength Severe Congestion and Cough		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20200420		OTC MONOGRAPH DRUG	M012	MEIJER, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-454_0eed69c2-2ff1-4ac1-a514-354288301049	41250-454	HUMAN OTC DRUG	meijer Extra Strength Antacid	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170310		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41250-455_45d3adc7-8989-4636-89dd-03471af0fe52	41250-455	HUMAN OTC DRUG	meijer Natural Fiber		Psyllium Husk	POWDER	ORAL	20170314		OTC MONOGRAPH NOT FINAL	part334	MEIJER DISTRIBUTION INC	PSYLLIUM HUSK	3.4	g/12g			N	20241231
41250-456_f6922979-472e-4f47-a751-d5013f72f6ad	41250-456	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20061031		ANDA	ANDA076777	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-457_8b46b471-049b-4ac5-af43-1895a7f6a029	41250-457	HUMAN OTC DRUG	Meijer	Original	Nasal	SPRAY	NASAL	20200629		OTC MONOGRAPH DRUG	M012	MEIJER DISTRIBUTION INC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41250-458_47d85867-169d-45e2-b2b6-bd2bbf9d5409	41250-458	HUMAN OTC DRUG	24 hour allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	19970707		ANDA	ANDA078336	Meijer Distribution Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-459_2279b4a5-79ea-4fca-af83-6f6044306b35	41250-459	HUMAN OTC DRUG	nitetime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110909		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-463_0e8b66f3-2d9e-4fc2-e063-6394a90a5d32	41250-463	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20170101		OTC MONOGRAPH DRUG	M030	Meijer Distribution Inc	SALICYLIC ACID	40	mg/41			N	20251231
41250-467_441c95e6-4853-4dcc-b9a9-8530c17c69f8	41250-467	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19920827		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-469_63618bc1-1101-43f3-a3c3-d6dd452cb825	41250-469	HUMAN OTC DRUG	stomach relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20180930		OTC MONOGRAPH FINAL	part335	Meijer Distribution Inc	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
41250-470_2a8af1fd-d136-4943-92ae-b83834a5be30	41250-470	HUMAN OTC DRUG	Meijer Infants Gas Relief Drops		Simethicone	EMULSION	ORAL	20200629		OTC MONOGRAPH DRUG	M002	MEIJER DISTRIBUTION INC.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
41250-471_f18fe23c-2013-4bce-a16e-13aefcca5a07	41250-471	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20160331	20240426	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
41250-473_b3346ecd-5837-4d1c-aa9b-70ed7402d5a5	41250-473	HUMAN OTC DRUG	daytime cough	non drowsy	dextromethorphan hydrobromide	SOLUTION	ORAL	20070815		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/15mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-474_e95a2a65-9446-b5d9-e053-2995a90adb21	41250-474	HUMAN OTC DRUG	cold and sinus PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170401	20240930	OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41250-475_7689d6f5-51bf-4ea8-9f3c-af23f1639f8c	41250-475	HUMAN OTC DRUG	Childrens 24 Hour Allergy		Cetirizine HCl	SOLUTION	ORAL	20151202		ANDA	ANDA204226	Meijer Distribution Inc	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-477_f13a6f8e-3de1-4e02-9248-bf38fa267f64	41250-477	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA074661	Meijer Distribution Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-479_3678be2d-cf31-440c-9d56-abd956640817	41250-479	HUMAN OTC DRUG	allergy		Diphenhydramine Hydrochloride	TABLET	ORAL	19910906		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-481_43d85927-1d40-430d-b1cc-61cf3af51982	41250-481	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	20151031	20240426	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
41250-482_f0fe8e45-ff1b-478f-a3e1-6f2dad116f3f	41250-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20120222		OTC MONOGRAPH DRUG	M021	Meijer Distribution, Inc	SODIUM FLUORIDE	.1	mg/mL			N	20241231
41250-483_e2223122-80a5-4fb0-92f2-8043beaac210	41250-483	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41250-484_402fc645-05fa-4295-a204-78e8a2e64edf	41250-484	HUMAN OTC DRUG	pain relief		Acetaminophen	TABLET	ORAL	19870815		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	500	mg/1			N	20241231
41250-487_0fa6f7ea-9d3e-435c-b642-861b7062b5f4	41250-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160331	20250331	OTC MONOGRAPH FINAL	part347	MEIJER, INC.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
41250-488_6f8b6bab-ff27-4087-9e49-4c831d260194	41250-488	HUMAN OTC DRUG	Allergy Relief		levocetirizine dihydrochloride	TABLET, FILM COATED	ORAL	20200206		ANDA	ANDA211983	Meijer Distribution Inc	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-492_09f8ee76-d4f1-49ca-a61b-e417b0af43a7	41250-492	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20160331	20250331	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	SENNOSIDES	25	mg/1			N	
41250-493_37f1eeff-b2aa-4689-b050-a670d1570191	41250-493	HUMAN OTC DRUG	heartburn relief		famotidine	TABLET, FILM COATED	ORAL	20190417		ANDA	ANDA075400	Meijer Distribution Inc	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41250-494_fb17dc21-e631-484c-9cfc-6c2a7cfb134e	41250-494	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150326		ANDA	ANDA091135	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-495_eef9316c-273c-4e99-b0cd-402519c1bf17	41250-495	HUMAN OTC DRUG	Meijer Anti Nausea		Dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20200629		UNAPPROVED DRUG OTHER		MEIJER DISTRIBUTION, INC.	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
41250-497_6055eb2e-e5e2-41a0-aa89-57218ef185e5	41250-497	HUMAN OTC DRUG	Jock Itch Relief		Miconazole Nitrate	SPRAY	TOPICAL	20170329		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41250-499_0e4dd0b1-33ca-6ed9-e063-6394a90aae14	41250-499	HUMAN OTC DRUG	meijer	antifungal	Tolnaftate	CREAM	TOPICAL	20060217		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc	TOLNAFTATE	10	mg/g			N	20251231
41250-501_91d2ec38-7e88-2b3a-e053-2a95a90af3fd	41250-501	HUMAN OTC DRUG	Pain Relief	Regular Strength	Acetaminophen	TABLET	ORAL	20120301		OTC MONOGRAPH NOT FINAL	part343	Meijer	ACETAMINOPHEN	325	mg/1			N	20241231
41250-502_679e4162-d5de-4203-849b-c141e5a35815	41250-502	HUMAN OTC DRUG	Nausea Relief		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20141030		UNAPPROVED DRUG OTHER		Meijer Distribution Inc	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
41250-506_89728a96-0c5f-4453-9a51-8dd0d9a4ea64	41250-506	HUMAN OTC DRUG	Allergy Relief	non drowsy	Fexofenadine HCl	TABLET, COATED	ORAL	20180331		ANDA	ANDA204507	MEIJER, INC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-507_7c92afa0-dd2a-43c9-bf5a-9ea9db475420	41250-507	HUMAN OTC DRUG	mucus and chest congestion		Guaifenesin	SOLUTION	ORAL	20140715		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	GUAIFENESIN	200	mg/10mL			N	20241231
41250-508_3bdff7c3-c445-4410-bf60-ec13a43f8685	41250-508	HUMAN OTC DRUG	meijer fiber therapy		Psyllium Husk	POWDER	ORAL	20170314		OTC MONOGRAPH NOT FINAL	part334	MEIJER DISTRIBUTION INC	PSYLLIUM HUSK	3.4	g/5.79g			N	20241231
41250-510_dd33b774-f8b6-43bd-b61e-70098c63c106	41250-510	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170208		ANDA	ANDA206393	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-514_f1fec2eb-753a-e8c8-e053-2995a90a340e	41250-514	HUMAN OTC DRUG	Meijer Enamel Guard		Potassium nitrate, sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190225		OTC MONOGRAPH NOT FINAL	part356	Meijer Distribution Inc	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
41250-518_788f2f39-dd3f-45db-999c-49054d5e2320	41250-518	HUMAN OTC DRUG	Meijer Analgesic Lidocaine	Topical Analgesic	lidocaine hydrochloride	CREAM	TOPICAL	20180927		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-520_f895c55e-046a-4f1b-b3a7-558fff4cd524	41250-520	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160831	20240426	NDA	NDA021855	MEIJER, INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	
41250-524_d7df7cef-efb7-4592-9f98-3c02a0267dd8	41250-524	HUMAN OTC DRUG	Meijer Natural Daily Fiber Sugar Free	Berry Flavor	Psyllium Husk	POWDER	ORAL	20170317		OTC MONOGRAPH NOT FINAL	part334	MEIJER DISTRIBUTION INC	PSYLLIUM HUSK	3.4	g/5.78g			N	20241231
41250-526_57e4852c-fa51-410f-a9cd-e17c021ddca5	41250-526	HUMAN OTC DRUG	naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20200114		ANDA	ANDA208499	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-529_3135b5ad-cedf-489e-943e-99d5df2de092	41250-529	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20200630		ANDA	ANDA206394	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-530_f1fec2eb-754a-e8c8-e053-2995a90a340e	41250-530	HUMAN OTC DRUG	Meijer	Restore and Defend Sensitive	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190225		OTC MONOGRAPH NOT FINAL	part356	Meijer Distribution Inc	STANNOUS FLUORIDE	.454	g/100g			N	20241231
41250-531_f1fed72d-f6cd-5e5d-e053-2a95a90a053a	41250-531	HUMAN OTC DRUG	Meijer	Dry Mouth	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190225		OTC MONOGRAPH FINAL	part355	Meijer Distribution Inc	SODIUM FLUORIDE	.243	g/100g			N	20241231
41250-532_171b5616-fd3a-4318-9cce-19e2a88ffa2f	41250-532	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20061031		ANDA	ANDA076779	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-533_b5ce38d4-15e5-497a-8e57-1abdfff44edb	41250-533	HUMAN OTC DRUG	Mucus Relief DM		Dextromethorphan HBr and Guaifenesin	TABLET, FILM COATED	ORAL	20051231		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-534_dcf4675c-0cac-7d99-e053-2995a90a18bd	41250-534	HUMAN OTC DRUG	Sinus plus Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200710		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-538_d38d402f-1313-4e9b-bbfc-8e9b52207ca0	41250-538	HUMAN OTC DRUG	Morning Fresh Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20160121		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	ALCOHOL	558	mg/mL			N	20241231
41250-539_40ac8d6b-776d-4c02-a735-a81bfd0bc174	41250-539	HUMAN OTC DRUG	Allergy	Childrens	Loratadine	LIQUID	ORAL	20180228	20250228	ANDA	ANDA077421	MEIJER, INC.	LORATADINE	5	mg/5mL			N	
41250-544_93189a51-6f67-4dec-8632-0b4fa86bcdcb	41250-544	HUMAN OTC DRUG	arthritis pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20050326	20240430	ANDA	ANDA075077	Meijer Distribution Inc	ACETAMINOPHEN	650	mg/1			N	
41250-545_662cb937-5de3-4837-b5f1-f74e1bd43c82	41250-545	HUMAN OTC DRUG	Meijer Medicated Selenium Sulfide	Anti-Dandruff	Selenium Sulfide	SHAMPOO	TOPICAL	20100511		OTC MONOGRAPH FINAL	part358H	Meijer Distribution, INC	SELENIUM SULFIDE	10	mg/mL			N	20241231
41250-547_b632d655-4e9e-46b8-aaee-57fe7dc6b208	41250-547	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin, Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20070126		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	400; 40	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
41250-553_ac4e0ae7-4811-4e4f-9ea1-cee589498cf7	41250-553	HUMAN OTC DRUG	Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20170314		OTC MONOGRAPH DRUG	M001	Meijer Distribution Inc	CALCIUM CARBONATE	750	mg/1			N	20241231
41250-554_372a021e-681d-4b9c-9a1c-b8be39cbdd93	41250-554	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20140228		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
41250-555_a7202531-161e-7051-e053-2a95a90a6131	41250-555	HUMAN OTC DRUG	MEIJER	BROAD SPECTRUM SPF 30 SUNSCREEN	AVOBENZONE, HOMOSALATE, OCTISLATE, OCTOCRYLENE	LOTION	TOPICAL	20181211		OTC MONOGRAPH NOT FINAL	part352	MEIJER DISTRIBUTION. INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-557_e537e45e-2c53-419c-aea6-2ec60efbf7b2	41250-557	HUMAN OTC DRUG	Meijer Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		Meijer Distribution Inc.	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
41250-560_d4c47e83-29cf-08fa-e053-2995a90a8c96	41250-560	HUMAN OTC DRUG	ACNE TREATMENT	MEIJER	SALICYLIC ACID	GEL	TOPICAL	20130923		OTC MONOGRAPH FINAL	part333D	MEIJER DISTRIBUTION, INC.	SALICYLIC ACID	20	mg/mL			N	20241231
41250-561_a71bf00a-8371-6012-e053-2a95a90a7b7c	41250-561	HUMAN OTC DRUG	MEIJER BROAD SPECTRUM SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20181211		OTC MONOGRAPH NOT FINAL	part352	MEIJER DISTRIBUTION, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-562_0e8af45a-9164-cac8-e063-6394a90a9919	41250-562	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Powder Spray	AEROSOL, SPRAY	TOPICAL	20200801		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc.	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20251231
41250-563_0e8b407b-5538-461c-e063-6394a90ad843	41250-563	HUMAN OTC DRUG	Tolnaftate		Tolnaftate Jock Itch Powder Spray - Talc Free	AEROSOL, SPRAY	TOPICAL	20200919		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc	TOLNAFTATE	1.3	g/130g			N	20251231
41250-564_4788a376-f293-4c4d-8462-5c41e63a0007	41250-564	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20191001	20251001	ANDA	ANDA204097	MEIJER, INC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
41250-566_9dac8cb8-f37d-4673-9144-1b649c66a845	41250-566	HUMAN OTC DRUG	Meijer Extra Strength Smooth Antacid	Assorted Fruits	Calcium carbonate	TABLET, CHEWABLE	ORAL	20170314		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41250-567_f77f0fe8-79ae-08ab-e053-6294a90a5d78	41250-567	HUMAN OTC DRUG	Meijer 3 Step Acne System		Benzoyl Peroxide	KIT		20190201		OTC MONOGRAPH FINAL	M006	Meijer Distribution, Inc.						N	20241231
41250-568_af6425d7-98f9-4fc2-8ca9-8af8872d2c57	41250-568	HUMAN OTC DRUG	DayTime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20160331	20240426	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41250-569_1c866bda-cb43-463b-9d66-54c656fc143f	41250-569	HUMAN OTC DRUG	daytime cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20191107		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-570_e051ce8b-314e-69b9-e053-2a95a90ab739	41250-570	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20220531		OTC MONOGRAPH NOT FINAL	part343	MEIJER DISTRIBUTION INC	ACETAMINOPHEN	500	mg/1			N	20241231
41250-572_a69e168c-858b-4c81-b40f-7c825d3229f5	41250-572	HUMAN OTC DRUG	Tension Headache		Acetaminophen, Caffeine	TABLET, COATED	ORAL	20090209		OTC MONOGRAPH DRUG	M013	Meijer Distribution Inc	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
41250-573_e95c4ccd-e0a7-9bc5-e053-2a95a90ad053	41250-573	HUMAN OTC DRUG	head congestion plus mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220923		OTC MONOGRAPH FINAL	part341	MEIJER DISTRIBUTION INC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-574_e95c5119-3cad-d5cd-e053-2a95a90a20a3	41250-574	HUMAN OTC DRUG	head congestion plus flu severe PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220923		OTC MONOGRAPH FINAL	part341	MEIJER DISTRIBUTION INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-575_f204a9ea-3fd6-10f6-e053-2995a90ae9d9	41250-575	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20171201		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41250-576_154ec891-88ba-4455-93dd-c70c592f1be2	41250-576	HUMAN OTC DRUG	Oral Antivavity		Sodium fluoride	MOUTHWASH	ORAL	20150206		OTC MONOGRAPH DRUG	M021	Meijer Distribution, Inc	SODIUM FLUORIDE	.1	mg/mL			N	20241231
41250-581_b2b71319-861a-4f76-9b9b-3e8946e8e733	41250-581	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20161018		OTC MONOGRAPH DRUG	M021	Meijer Distribution, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
41250-584_efe75fd6-79e4-90a3-e053-2a95a90a6c6a	41250-584	HUMAN OTC DRUG	Meijer Maximum Strength Anti-itch Cream Ultra Moisturizing Formula 1oz		Hydrocortisone	CREAM	TOPICAL	20200713		OTC MONOGRAPH NOT FINAL	part348	MEIJER, INC.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41250-587_29782264-fc21-4308-95a4-234c9deb7ecb	41250-587	HUMAN OTC DRUG	mini nicotine		nicotine polacrilex	LOZENGE	ORAL	20190516		ANDA	ANDA203690	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-588_ab9b3b68-3a6e-4cf1-8019-d7643a4bfbc3	41250-588	HUMAN OTC DRUG	Antacid	Maximum Strength	Aluminum Hydroxide, Magnesium Hydroxide, Simethicone	SUSPENSION	ORAL	20051019		OTC MONOGRAPH FINAL	part332	Meijer Distribution Inc	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-589_4c53ea0e-e1d0-425c-9a6d-eb80c39a8663	41250-589	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	LIQUID	TOPICAL	20140610		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41250-590_2e1096ac-253a-42f1-8968-9f8494d8f042	41250-590	HUMAN OTC DRUG	pain and fever		acetaminophen	SUSPENSION	ORAL	19930723		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
41250-594_0d22d96b-d1b6-820b-e063-6394a90a046c	41250-594	HUMAN OTC DRUG	Meijer Advanced Redness and Irritation Relief		Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20200306		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
41250-596_f51faebd-5d80-409a-a7bf-c4e20dce9d82	41250-596	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20141006		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41250-597_9784e635-2dbc-4046-a18a-39e602dd35c1	41250-597	HUMAN OTC DRUG	NiteTime DayTime	Cold and Flu	acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20131230		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc						N	20241231
41250-598_0d22c2c2-a705-2509-e063-6294a90ae206	41250-598	HUMAN OTC DRUG	Meijer Seasonal Itching and Redness Relief		Tetrahydrozoline HCI, Zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20200310		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41250-599_ba8e7b3e-2fd3-47b4-ba42-c171d02ca0f7	41250-599	HUMAN OTC DRUG	Allergy Relief	Childrens	Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20110425		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-600_76fb7d5d-734c-47bc-991e-c80e9d3a59fd	41250-600	HUMAN OTC DRUG	Aspirin 81 mg	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Meijer Distribution Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-602_a090d81f-f7b3-448a-8034-abc917eb1fdf	41250-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20130426		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution, Inc	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-603_848c896d-2de4-406b-9db5-90017be5c7f0	41250-603	HUMAN OTC DRUG	Daytime Cold and Flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20131211		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-604_4e6148c7-fafa-4303-bc95-1dc96dee075d	41250-604	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880215		ANDA	ANDA072096	Meijer Distribution Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-605_97d4dcf4-0222-44bf-ac9a-e91a0827651f	41250-605	HUMAN OTC DRUG	multi symptom cold		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20140715		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-606_146aea1e-8f48-4f76-9d13-31f77917cd06	41250-606	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160311		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc.	ALCOHOL	63	mL/100mL			N	20241231
41250-610_c16c1cea-ac5f-451e-beae-43d905faca18	41250-610	HUMAN OTC DRUG	meijer fiber laxative		Psyllium Husk	CAPSULE	ORAL	20170307		OTC MONOGRAPH NOT FINAL	part334	MEIJER DISTRIBUTION, INC	PSYLLIUM HUSK	.52	g/1			N	20241231
41250-612_3f152b7a-dcd5-490a-858e-be46da264be4	41250-612	HUMAN OTC DRUG	allergy relief		Loratadine	TABLET	ORAL	20070418		ANDA	ANDA076301	Meijer Distribution Inc	LORATADINE	10	mg/1			N	20241231
41250-613_e07350fe-b907-4c5c-af1f-49e686c1a668	41250-613	HUMAN OTC DRUG	pain relief		Acetaminophen	TABLET	ORAL	20170712		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	500	mg/1			N	20241231
41250-614_0eb55bcc-382b-4e1a-b09e-fb057cc45356	41250-614	HUMAN OTC DRUG	allergy relief		diphenhydramine HCl	TABLET, FILM COATED	ORAL	20130207		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-618_6511653d-8712-4cd5-86bf-307042127dc7	41250-618	HUMAN OTC DRUG	24 hour allergy		Cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20200602		ANDA	ANDA207235	Meijer Distribution Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-619_7a92abbe-6c94-4ac9-92de-0759b3d70292	41250-619	HUMAN OTC DRUG	Daily Moisturizing		Daily Moisturizing	LOTION	TOPICAL	20060519		OTC MONOGRAPH FINAL	part347	Meijer	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
41250-620_fe515902-d7f2-45ea-b5cd-958c22497c98	41250-620	HUMAN OTC DRUG	Motion Sickness	Less Drowsy Formula	Meclizine HCl	TABLET	ORAL	20140328	20250328	OTC MONOGRAPH FINAL	part336	MEIJER, INC.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
41250-622_636db874-94be-46ac-8082-346ecc0d9c77	41250-622	HUMAN OTC DRUG	Anti Itch		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20100317		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-625_f204b4b3-1772-8839-e053-2a95a90a7115	41250-625	HUMAN OTC DRUG	MEIJER PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-627_ecb522c8-b5d2-4b6e-be30-adb96f60e2dd	41250-627	HUMAN OTC DRUG	Meijer Clarifying Body Wash	Acne Treatment	Salicylic Acid	LOTION	TOPICAL	20110106		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	SALICYLIC ACID	20	mg/mL			N	20241231
41250-628_d0ab2f94-e31a-44c9-b44f-b15599f2ea77	41250-628	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41250-629_f880d534-c56a-4cd3-acb8-170e0346f567	41250-629	HUMAN OTC DRUG	childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20190827		ANDA	ANDA210033	Meijer Distribution Inc	LORATADINE	5	mg/1			N	20241231
41250-631_d2bf9f1b-4f4a-4fd4-bafa-c550dc7ce0b7	41250-631	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	19980505		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
41250-632_5c9608e7-e2cb-4ef3-a123-d11cf0d687b4	41250-632	HUMAN OTC DRUG	Meijer Sore Throat		Phenol	SPRAY	ORAL	20200413		OTC MONOGRAPH DRUG	M022	MEIJER DISTRIBUTION INC.	PHENOL	1.4	g/100mL			N	20241231
41250-633_69443323-d4c7-43a6-a976-f897e883ef6b	41250-633	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190101	20250401	ANDA	ANDA209692	MEIJER, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
41250-634_8ab4c2ec-3288-4ed3-9341-22fa22d920ab	41250-634	HUMAN OTC DRUG	Allergy Relief		Fluticasone propionate	SPRAY, METERED	NASAL	20160527		ANDA	ANDA207957	Meijer Distribution Inc	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41250-635_0e8bb742-a436-53cc-e063-6394a90a2001	41250-635	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Powder Spray	AEROSOL, SPRAY	TOPICAL	20120105		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc	TOLNAFTATE	1.3	g/113g			N	20251231
41250-636_8556dc5f-b8f2-4857-b922-1344f6c70f3b	41250-636	HUMAN OTC DRUG	MEIJER Saline		Nasal	SPRAY	NASAL	20210217		OTC MONOGRAPH FINAL	part349	MEIJER	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
41250-637_426b2f92-561d-476b-959c-cdd0fa37be56	41250-637	HUMAN OTC DRUG	mini nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190516		ANDA	ANDA203690	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-638_b78faabf-403a-4c40-aa7f-ab0d0969189e	41250-638	HUMAN OTC DRUG	flu HBP	Maximum Strength	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20200228		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-643_0d4e4002-f533-47d0-90e9-98a07ee98a27	41250-643	HUMAN OTC DRUG	Cold and Flu	Daytime Severe	acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	TABLET, FILM COATED	ORAL	20200508		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-647_9c8b5f5a-a1f7-4c77-8ba2-4b6c880bbb26	41250-647	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19881115		ANDA	ANDA072096	Meijer Distribution Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-648_d5a3d7a3-e469-49b6-84ab-5cd37b86bf25	41250-648	HUMAN OTC DRUG	Nasal Four		Phenylephrine hydrochloride	SPRAY	NASAL	20030303		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-650_f55348e0-c999-41ab-93f0-8735b6f6abea	41250-650	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20131218		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
41250-653_00cbbd72-4188-45e3-983f-5e0a6d378c0f	41250-653	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20191129	20250530	OTC MONOGRAPH FINAL	part341	MEIJER, INC.						N	
41250-654_96ada583-51a5-42d2-9ab7-aea027f3f477	41250-654	HUMAN OTC DRUG	mucus relief		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210223		ANDA	ANDA213420	Meijer Distribution Inc	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41250-656_a6c0e0b1-4263-4d55-97ff-78882f586130	41250-656	HUMAN OTC DRUG	Daytime cold and flu	non drowsy	acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	19890915		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-657_456d050c-4b7d-49d8-aa32-f28a5e38870e	41250-657	HUMAN OTC DRUG	gas relief	ultra strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20020509		OTC MONOGRAPH FINAL	part332	Meijer Distribution Inc	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
41250-658_d070f7d1-5432-4d9c-e053-2a95a90a973d	41250-658	HUMAN OTC DRUG	arthritis pain relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200306		ANDA	ANDA211544	Meijer	ACETAMINOPHEN	650	mg/1			N	20241231
41250-659_076cff6d-8734-45a9-b2a9-92bda3c34313	41250-659	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine Hydrochloride	CAPSULE	ORAL	20190430	20241227	OTC MONOGRAPH FINAL	part338	MEIJER, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
41250-660_637c4a5a-541f-46b2-b40e-3badbbf2d9bf	41250-660	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20020319		ANDA	ANDA074937	Meijer Distribution Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-661_92d5dd20-ec84-43ff-9f97-9ec4daf46a3b	41250-661	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part333A	MEIJER DISTRIBUTION, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41250-663_d070f7d1-5460-4d9c-e053-2a95a90a973d	41250-663	HUMAN OTC DRUG	Cold and Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20150101		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-664_a8a2f277-1573-480a-a504-f414905c8712	41250-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19930811		OTC MONOGRAPH NOT FINAL	part356	Meijer Distribution Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-665_3a8f1975-891e-4c77-9f9c-b1877fff3102	41250-665	HUMAN OTC DRUG	Meijer Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20200226		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc.	BISACODYL	10	mg/2000mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-668_4fea6285-8867-4eea-94db-84a65ce2ace0	41250-668	HUMAN OTC DRUG	Nitetime Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20030303		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-669_e98fca33-2604-4429-9241-3b0e248a639a	41250-669	HUMAN OTC DRUG	meijer extra strength	Wintergreen Flavor	CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20170310		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41250-670_fffa5008-8adc-4aaa-9de1-fe0c849d29da	41250-670	HUMAN OTC DRUG	meijer stomach relief	regular strength	Bismuth subsalicylate	SUSPENSION	ORAL	20170307		OTC MONOGRAPH DRUG	M008	MEIJER DISTRIBUTION INC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
41250-671_bf5f86de-6cce-4eb3-9338-b81fcc021afd	41250-671	HUMAN OTC DRUG	meijer stomach relief	regular strength	Bismuth subsalicylate	SUSPENSION	ORAL	20170307		OTC MONOGRAPH DRUG	M008	MEIJER DISTRIBUTION INC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
41250-674_affacda5-9d7a-4133-b4d3-7d05b40308b1	41250-674	HUMAN OTC DRUG	arthritis pain relieving		diclofenac sodium	GEL	TOPICAL	20200901		ANDA	ANDA211253	Meijer Distribution Inc	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-675_dd77598b-c6d6-4af4-80e9-0e07f9e160a1	41250-675	HUMAN OTC DRUG	Meijer Extra Strength	Original Flavor	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20170316		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
41250-676_1187b3e4-3d98-4dea-8ab0-bfaa459bedaf	41250-676	HUMAN OTC DRUG	Womens gentle laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20190327		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-680_53b7d627-fe18-48e3-8173-5e11ac247f01	41250-680	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA074661	Meijer Distribution Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-681_9522c328-6502-7d01-e053-2995a90a2b33	41250-681	HUMAN OTC DRUG	Aspirin 325 mg		Aspirin	TABLET, DELAYED RELEASE	ORAL	20170601		OTC MONOGRAPH NOT FINAL	part343	Meijer	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-682_2efdb4f0-2e7d-4f39-a333-4ba18d05eea5	41250-682	HUMAN OTC DRUG	Mucus Relief	Maximum StrengthCold Flu and Sore Throat	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20180831	20250831	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41250-683_8a462bc4-298f-41ea-ab9f-acfef5b3cd3b	41250-683	HUMAN OTC DRUG	Senna S		Docusate Sodium Sennosides	TABLET	ORAL	20190131	20250131	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
41250-684_cdf9b4ab-f566-4657-9e45-eef33666b84a	41250-684	HUMAN OTC DRUG	mucus relief		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20200807		ANDA	ANDA078912	Meijer Distribution Inc	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41250-685_399240a3-8191-4fa8-bbb4-4d0118f8f7f7	41250-685	HUMAN OTC DRUG	childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20080903		ANDA	ANDA074937	Meijer Distribution Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-689_ab2d266e-33f6-42e4-8508-bcfdd57aa5eb	41250-689	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20191218		ANDA	ANDA206393	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-690_cbe147b7-adef-4a1c-af4d-a3bde200f472	41250-690	HUMAN OTC DRUG	Dual Action Complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20160126		ANDA	ANDA077355	Meijer Distribution Inc	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-691_f7a86cc9-3f8e-4665-9baa-3f9e4e60108d	41250-691	HUMAN OTC DRUG	Meijer Extra Strength	Tropical Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20170314		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41250-692_21c725af-65da-4c1b-9869-a96ff8d5c4b5	41250-692	HUMAN OTC DRUG	cold and flu HBP		Acetaminophen, Chlorpheniramine maleate	TABLET, FILM COATED	ORAL	20170716		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	325; 2	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-695_3619ed92-646c-493f-8311-a05cbd59f555	41250-695	HUMAN OTC DRUG	jock itch relief		Tolnaftate	SPRAY	TOPICAL	20170329		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	TOLNAFTATE	1	g/100g			N	20241231
41250-696_799eb28e-6f47-48b4-b7ea-2acfc6f7d93c	41250-696	HUMAN OTC DRUG	nighttime sleep aid		diphenhydramine hcl	CAPSULE, LIQUID FILLED	ORAL	20200602		OTC MONOGRAPH FINAL	part338	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-697_d4dc0896-2422-43fa-8745-745ebbbef2ea	41250-697	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140724		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc.	ALCOHOL	558	mg/mL			N	20241231
41250-700_fcb07234-8bff-4d29-8dc8-97d97886ab2f	41250-700	HUMAN OTC DRUG	nicotine		Nicotine polacrilex	LOZENGE	ORAL	20090911		ANDA	ANDA090711	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-704_a59423a3-fe82-4487-91ac-ac29e26e2fdb	41250-704	HUMAN OTC DRUG	cough and chest congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20140715		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-705_33740434-87f8-4b89-b984-4610c428f359	41250-705	HUMAN OTC DRUG	Meijer Baby Tear Free SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20160601		OTC MONOGRAPH NOT FINAL	part352	Meijer Distributing Inc.	TITANIUM DIOXIDE; ZINC OXIDE	3.2; 4	g/100g; g/100g			N	20241231
41250-707_c2ec20e7-0b89-408e-b78f-459c0c80ac02	41250-707	HUMAN OTC DRUG	Meijer Sheer SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160601		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 8; 5; 4; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
41250-708_64664e5f-d91d-4cb4-9fce-4bf8abee4134	41250-708	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution, Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-710_0c3ac88b-34b4-47ac-af73-932859e99121	41250-710	HUMAN OTC DRUG	Meijer Childrens Allergy Relief	Bubblegum flavor	Diphenhydramine HCl	LIQUID	ORAL	20170307		OTC MONOGRAPH DRUG	M012	MEIJER DISTRIBUTION INC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-711_c8b9c065-0caf-4144-b523-c3ade98c125f	41250-711	HUMAN OTC DRUG	Flu and Severe Cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20180724		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-712_dd24164b-cd4e-4c37-92d9-2310ba0f3442	41250-712	HUMAN OTC DRUG	heartburn relief		famotidine	TABLET, FILM COATED	ORAL	20190417		ANDA	ANDA077351	Meijer Distribution Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41250-713_4c8b4c05-8680-42cd-8b45-7a67698d166c	41250-713	HUMAN OTC DRUG	Meijer Chest Congestion Relief		Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc.	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41250-715_0d2273c9-17e2-0f0b-e063-6294a90a76da	41250-715	HUMAN OTC DRUG	Meijer Maximum Redness Relief and Lubricant		Glycerin, Naphazoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20200311		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
41250-716_c41d0ce4-a59e-465b-bb4a-c653c2a773fd	41250-716	HUMAN OTC DRUG	childrens allergy relief		Loratadine	SOLUTION	ORAL	20180724		ANDA	ANDA075728	Meijer, Inc.	LORATADINE	5	mg/5mL			N	20241231
41250-718_0d22e47a-248f-46d1-e063-6294a90ab3c2	41250-718	HUMAN OTC DRUG	Meijer Dry Eye Relief		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20200311		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
41250-720_c6b38106-5ce0-4cea-b89b-f558d4d46ed8	41250-720	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20110812		OTC MONOGRAPH NOT FINAL	part333E	Meijer Distribution, Inc	POVIDONE-IODINE	10	mg/mL			N	20241231
41250-723_687a243f-c95e-4f20-8b1a-377505d4f244	41250-723	HUMAN OTC DRUG	Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20170314		OTC MONOGRAPH DRUG	M001	Meijer Distribution Inc	CALCIUM CARBONATE	1000	mg/1			N	20241231
41250-724_e1ae1d85-8b3c-4a7a-b174-fcb30c3853c8	41250-724	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Meijer Distribution, Inc.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41250-726_4555fcb1-95a5-40a3-b86d-1e23299dd87c	41250-726	HUMAN OTC DRUG	childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190718		ANDA	ANDA076359	Meijer Distribution Inc	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-727_28b1fbd8-a31e-48a8-a5d8-3e50cda4ca54	41250-727	HUMAN OTC DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200317		ANDA	ANDA207193	Meijer Distribution Inc	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-728_431b0861-e653-4a2d-8721-408cf9fdb842	41250-728	HUMAN OTC DRUG	12 hour allergy d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200407		ANDA	ANDA210719	Meijer Distribution Inc	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
41250-729_27da9a1c-eb69-4162-b0ba-ecc9d80b7ab1	41250-729	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20190131	20250131	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
41250-731_fd3cb955-8bba-44cd-a718-610798c1b51d	41250-731	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20190131	20250131	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	SENNOSIDES	8.6	mg/1			N	
41250-732_870c2771-5fec-402e-a3f5-9d35f00ac1e5	41250-732	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180711	20250131	ANDA	ANDA207342	MEIJER, INC.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
41250-733_e4de07d5-6d2a-42ed-af77-58180179e06c	41250-733	HUMAN OTC DRUG	daytime nitetime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20121024		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc						N	20241231
41250-734_48b20c84-7612-4ba8-99c1-afcad2d1ccca	41250-734	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130118		ANDA	ANDA203690	Meijer Distribution Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-736_0c05f0ee-205f-9e91-e063-6394a90a00e5	41250-736	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200407		OTC MONOGRAPH DRUG	M002	Meijer Distribution Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
41250-738_77c2d51b-cf97-4196-a66b-b4814f86a7de	41250-738	HUMAN OTC DRUG	Meijer Nighttime Sleep-aid	Berry Flavor	Diphenhydramine hydrochloride	SOLUTION	ORAL	20170315		OTC MONOGRAPH DRUG	M010	MEIJER DISTRIBUTION INC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-739_0c064eef-0695-bbcb-e063-6394a90a6184	41250-739	HUMAN OTC DRUG	STOOL SOFTENER PLUS STIMULANT LAXATIVE		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20200407		OTC MONOGRAPH DRUG	M007	Meijer Distribution Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41250-741_e3fbd066-0ca5-4677-9bc4-c2e9f16c7f62	41250-741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180331	20250331	ANDA	ANDA207235	MEIJER, INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
41250-743_a630069c-1b64-4fc8-af60-508b9e2a2ea0	41250-743	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180930	20241227	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
41250-744_e12ccad1-092c-4992-b191-18e07d5fdf9f	41250-744	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20180630	20240426	OTC MONOGRAPH FINAL	part341	MEIJER, INC.						N	
41250-745_efe79fc5-7a0f-b9f8-e053-2995a90a1030	41250-745	HUMAN OTC DRUG	Meijer Athletes Foot Cream AF		Clotrimazole	CREAM	TOPICAL	20200717		OTC MONOGRAPH FINAL	part333C	MEIJER, INC.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41250-746_0c062410-352f-aebd-e063-6394a90a269a	41250-746	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM AND SENNOSIDES	TABLET	ORAL	20200407		OTC MONOGRAPH DRUG	M007	Meijer Distribution Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
41250-747_63119348-5895-45df-aa71-c9d00b000443	41250-747	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl, Menthol	GEL	TOPICAL	20160829		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution	LIDOCAINE HYDROCHLORIDE; MENTHOL	4.97; .4	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-748_76749966-b160-4eb7-a541-3aa9e8adbddb	41250-748	HUMAN OTC DRUG	Meijer Mucus Relief DM	Maximum Strength	Dextromethorphan HBr and Guaifenesin	SOLUTION	ORAL	20200420		OTC MONOGRAPH DRUG	M012	MEIJER, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-750_cb8eed95-4800-4f1f-8e3b-fbaace8efad3	41250-750	HUMAN OTC DRUG	Sore Mouth Cleanser		Hydrogen Peroxide	MOUTHWASH	TOPICAL	20171201		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
41250-752_5b43cca9-92fa-44fc-813f-4c3a787f631a	41250-752	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180731	20250731	ANDA	ANDA206999	MEIJER, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
41250-753_896923a9-a387-6d10-e053-2995a90ad8de	41250-753	HUMAN OTC DRUG	cold and flu severe daytime nighttime		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20190521		OTC MONOGRAPH FINAL	part341	MEIJER						N	20241231
41250-754_d6089b27-8094-7076-e053-2a95a90a2efd	41250-754	HUMAN OTC DRUG	Antibacterial Hand Tropical Twist		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333E	Meijer Distribution Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
41250-755_d608ae37-990c-d0b9-e053-2995a90ac494	41250-755	HUMAN OTC DRUG	Antibacterial Hand Unicorn Sprinkles		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333E	Meijer Distribution Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
41250-756_8ee4abf9-3c29-4879-af16-da104634df03	41250-756	HUMAN OTC DRUG	pain relief PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20200818		OTC MONOGRAPH DRUG	M013	Meijer Distribution Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-757_1c254253-4fa9-483c-94d3-53ed522b7559	41250-757	HUMAN OTC DRUG	Mucus Relief Congestion and Headache	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20180731	20250731	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
41250-758_8c00d7e5-b11d-4915-9a8c-a359e4dd4512	41250-758	HUMAN OTC DRUG	meijer Maximum Strength Nighttime Cough DM		dextromethorphan hydrobromide, doxylamine succinate	SOLUTION	ORAL	20170314		OTC MONOGRAPH DRUG	M010	MEIJER DISTRIBUTION INC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-761_d608ae37-990d-d0b9-e053-2995a90ac494	41250-761	HUMAN OTC DRUG	Antibacterial Hand Sugar Cookie		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333E	Meijer Distribution Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
41250-762_f1f051ad-7e81-9d1a-e053-2a95a90ac7d3	41250-762	HUMAN OTC DRUG	Cold and Flu	Daytime, Nighttime, Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	KIT		20200916		OTC MONOGRAPH FINAL	part341	MEIJER DISTRIBUTION, INC						N	20241231
41250-763_09d6a695-4de4-45b6-9907-c9e5379f9968	41250-763	HUMAN OTC DRUG	Nitetime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20131211		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-764_f2b61ff7-3cd1-40c7-982a-9e5bec23457c	41250-764	HUMAN OTC DRUG	meijer Maximum Strength Sore Throat Fast Relief		Phenol and Glycerin	SPRAY	ORAL	20170314		OTC MONOGRAPH DRUG	M022	MEIJER DISTRIBUTION INC	GLYCERIN; PHENOL	330; 15	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
41250-766_014c3e4f-ca72-4ac6-8981-9cfc7c676f1c	41250-766	HUMAN OTC DRUG	pain and fever		Acetaminophen	SUSPENSION	ORAL	20111104		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
41250-768_c1337938-3512-5756-e053-2a95a90adcf5	41250-768	HUMAN OTC DRUG	Meijer Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20140307		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-769_17991e1a-1370-4710-869b-1083de5c2356	41250-769	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution, Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-772_50053106-7ae8-47b2-9041-eb01850e698d	41250-772	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20160331	20240426	OTC MONOGRAPH FINAL	part341	MEIJER, INC.						N	
41250-773_0edfe952-abfe-4c24-89ea-3f4165f9aa64	41250-773	HUMAN OTC DRUG	Isopropyl Alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20190630		OTC MONOGRAPH NOT FINAL	part333A	MEIJER, INC.	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
41250-775_1394c42d-73f7-493a-9e3d-e6e905744dfe	41250-775	HUMAN OTC DRUG	Deep Cleaning Astringent		Salicylic Acid	LIQUID	TOPICAL	20130601		OTC MONOGRAPH FINAL	part333D	Meijer Distribution	SALICYLIC ACID	5	mg/mL			N	20241231
41250-776_caa28f87-5d01-43ea-8907-060c79712cee	41250-776	HUMAN OTC DRUG	Maximum Strength Mucus Relief Severe Congestion and Cough	Cooling Menthol	dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20170314		OTC MONOGRAPH DRUG	M012	MEIJER DISTRIBUTION INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-778_14430220-6703-4cd7-b515-d7327449f4c2	41250-778	HUMAN OTC DRUG	Stool Softener Laxative		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20171001	20250101	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	DOCUSATE SODIUM	100	mg/1			N	
41250-780_91d2e1d6-4cb4-9b52-e053-2995a90a2dd4	41250-780	HUMAN OTC DRUG	Aspirin 81 MG		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20110301		OTC MONOGRAPH NOT FINAL	part343	Meijer	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41250-784_c030ff76-0814-67bd-8ef3-1a765271c8ab	41250-784	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20141229		ANDA	ANDA076502	Meijer Distribution, Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-785_fe2bba19-2699-441f-a737-bd2ba2907b2c	41250-785	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20151231	20240426	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
41250-796_682512d7-1458-48d9-813e-cd07f74e23e1	41250-796	HUMAN OTC DRUG	Meijer Zinc SPF 50		Octocrylene, Zinc Oxide	LOTION	TOPICAL	20160310		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	OCTOCRYLENE; ZINC OXIDE	4; 5	g/100g; g/100g			N	20241231
41250-802_ca8b0135-3528-4821-8b8d-6cd3d1757606	41250-802	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170303		ANDA	ANDA075077	Meijer Distribution Inc	ACETAMINOPHEN	650	mg/1			N	20241231
41250-804_ac8b1ffd-43e1-4975-b459-60aef1b9bdf4	41250-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20131101		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
41250-809_464cefc1-9739-4d41-8b4b-cdd54dd9dea8	41250-809	HUMAN OTC DRUG	nasal decongestant		pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181128		ANDA	ANDA075153	Meijer Distribution Inc	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41250-810_686923a7-1636-41b0-99fd-dc3f0e74ca18	41250-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20090514		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
41250-811_99227df7-29b8-4c4a-9266-806b08833ee0	41250-811	HUMAN OTC DRUG	nitetime cold and flu		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20150723		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-812_881f88a1-11db-47b1-bd0d-b0f1ed602cf5	41250-812	HUMAN OTC DRUG	mucus dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180808		ANDA	ANDA207602	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-813_cd43e250-d8ac-4540-abe3-8659461a3f8d	41250-813	HUMAN OTC DRUG	loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20180710		ANDA	ANDA091292	Meijer Distribution Inc	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41250-814_0d22b5e8-d76b-ab3f-e063-6394a90a55da	41250-814	HUMAN OTC DRUG	Meijer Redness Relief		Tetrahydrozoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20200423		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
41250-815_ac92251c-1156-4610-beb2-ef6f34c68102	41250-815	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET	ORAL	20190131	20250131	OTC MONOGRAPH NOT FINAL	part334	MEIJER, INC.	SENNOSIDES	25	mg/1			N	
41250-816_680f3b52-49b4-4dad-9928-419b62e84b4a	41250-816	HUMAN OTC DRUG	Dandruff		Selenium sulfide	SHAMPOO	TOPICAL	20130601		OTC MONOGRAPH FINAL	part358H	Meijer Distribution	SELENIUM SULFIDE	10	mg/mL			N	20241231
41250-817_713cb54b-ce6e-4b00-986e-53f2b88d7529	41250-817	HUMAN OTC DRUG	Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	19961213		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41250-818_1dac11f0-9b10-4510-b48c-7d91de9702d9	41250-818	HUMAN OTC DRUG	naproxen sodium		naproxen sodium	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA074661	Meijer Distribution Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-819_0d22c2c2-a706-2509-e063-6294a90ae206	41250-819	HUMAN OTC DRUG	Meijer Artificial Tears		Polyvinyl alcohol, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20200421		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
41250-822_c5e52be5-ff3f-4f08-aa5f-ccc3d0011880	41250-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	19960315		OTC MONOGRAPH FINAL	part347	Meijer Distribution, Inc	WITCH HAZEL	86	kg/100L			N	20241231
41250-823_9dde41af-84d4-4866-ac42-6d04ef261855	41250-823	HUMAN OTC DRUG	lice treatment complete		piperonyl butoxide, pyrethrum extract	KIT		20181219		OTC MONOGRAPH FINAL	part358G	Meijer Distribution Inc						N	20241231
41250-824_5f34de44-1027-45ea-bedb-661b8d1c4f4a	41250-824	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	CREAM	TOPICAL	20100112		OTC MONOGRAPH FINAL	part341	Meijer Distribution.Inc	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
41250-825_a045e703-1c48-4efe-b2b3-37d9eb40839c	41250-825	HUMAN OTC DRUG	Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20000204		ANDA	ANDA074760	Meijer Distribution Inc	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41250-826_eecbadf4-62ee-4be9-970f-305a0dc1dd5a	41250-826	HUMAN OTC DRUG	Mint		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20090514		OTC MONOGRAPH DRUG	505G(a)(3)	MeijerDistribution, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
41250-831_a8c8f926-e91c-4550-8c72-5d3b502824ea	41250-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20041222		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc	MINERAL OIL	999	mg/mL			N	20241231
41250-833_f204ed3a-fdbb-ab55-e053-2995a90aa29f	41250-833	HUMAN OTC DRUG	Large Medicated Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
41250-834_f204c835-2fb3-27b1-e053-2995a90a43b9	41250-834	HUMAN OTC DRUG	Meijer Large Cold-Hot Medicated Patches		MENTHOL	PATCH	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	MENTHOL	5	g/1			N	20241231
41250-835_0c7cc58b-c84e-94c8-e063-6394a90abe86	41250-835	HUMAN OTC DRUG	Meijer Earwax Removal Kit		CARBAMIDE PEROXIDE	LIQUID	TOPICAL	20141127		OTC MONOGRAPH DRUG	M014	Meijer Distribution Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
41250-836_644a1c83-f536-4af8-8ab5-ec2df592deaa	41250-836	HUMAN OTC DRUG	Itchy Scalp		Pyrithione zinc	SHAMPOO	TOPICAL	20131213		OTC MONOGRAPH FINAL	part358H	Meijer Distribution, Inc	PYRITHIONE ZINC	10.3	mg/mL			N	20241231
41250-839_51f64bac-b58e-4674-b6bc-d01a88c982e1	41250-839	HUMAN OTC DRUG	childrens multi symptom cold		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20140917		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-840_d5fee372-4b88-4dc3-81e0-4d89ad715aea	41250-840	HUMAN OTC DRUG	DayTime/NiteTime Severe Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Doxylamine Succinate, Phenylephrine HCl	KIT		20150801		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc						N	20241231
41250-841_f204ed3a-fdc9-ab55-e053-2995a90aa29f	41250-841	HUMAN OTC DRUG	Maximun Strength Lidocaine Patch Plus Menthol		Lidocaine, Menthol	PATCH	TOPICAL	20180701		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-842_f204b6f6-9436-4261-e053-2995a90a963a	41250-842	HUMAN OTC DRUG	CAPSAICIN HEAT PATCHES BACK AND LARGE AREAS		CAPSAICIN	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	CAPSAICIN	.025	g/100g			N	20241231
41250-844_e95b55f8-aaff-4a52-b7df-db44e0e971d8	41250-844	HUMAN OTC DRUG	BACITRACIN		Bacitracin	OINTMENT	TOPICAL	20181024		OTC MONOGRAPH FINAL	part333B	Meijer Distribution Inc	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
41250-845_44cba26f-7516-4769-8699-da922bfc9878	41250-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20090514		OTC MONOGRAPH FINAL	part344	Meijer Distribution, Inc	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
41250-846_0d22c2c2-a707-2509-e063-6294a90ae206	41250-846	HUMAN OTC DRUG	Meijer Redness Relief		Glycerin, Naphazoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20200427		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
41250-847_73e56b4f-2a6b-41d5-90f3-6fadde861413	41250-847	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20191129	20250529	OTC MONOGRAPH FINAL	part341	MEIJER, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
41250-848_0753e77e-4148-4850-97b9-599f17957675	41250-848	HUMAN OTC DRUG	Severe Cough and Congestion and Cold and Flu	Daytime, Nighttime	Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20240103		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc						N	20251231
41250-848_d03a58d4-f8f1-49a7-847e-683e5e24e979	41250-848	HUMAN OTC DRUG	Severe Cough and Congestion and Cold and Flu	Daytime, Nighttime	Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20170701		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc						N	20241231
41250-849_8010d002-7b85-4cc1-ab97-0d0f7f5bfe58	41250-849	HUMAN OTC DRUG	Sinus and Headache		Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20170328		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-853_bce37a06-9de7-445e-9466-86d1ac1ba98f	41250-853	HUMAN OTC DRUG	Meijer Nighttime Sleep Aid	Non Habit Forming	DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20190425		OTC MONOGRAPH DRUG	M010	MEIJER DISTRIBUTION INC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-854_04e16c8d-0fd6-4b68-8316-e392b3dd502e	41250-854	HUMAN OTC DRUG	Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	19920221		ANDA	ANDA078546	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-855_2a03908e-66f3-4702-af24-76186c933ada	41250-855	HUMAN OTC DRUG	Tartar control		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20140220		OTC MONOGRAPH NOT FINAL	part356	Meijer Distribution, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-858_efe78e44-bc2a-4006-e053-2a95a90a45fa	41250-858	HUMAN OTC DRUG	Meijer Cold and Hot Therapy		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part348	Meijer, Inc.	MENTHOL; METHYL SALICYLATE	10; 30	g/100g; g/100g			N	20241231
41250-859_58d88467-31db-4f6d-986c-bef786e585fb	41250-859	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH DRUG	M007	MEIJER, INC.	DOCUSATE SODIUM	250	mg/1			N	20241231
41250-860_8ff0faa0-479e-e2c2-e053-2995a90a5270	41250-860	HUMAN OTC DRUG	Meijer Ear Relief Ear Drops		CHAMOMILE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20091001		UNAPPROVED HOMEOPATHIC		Meijer Distribution Inc	MATRICARIA CHAMOMILLA; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/12mL; [hp_X]/12mL; [hp_X]/12mL			N	20241231
41250-862_e930395a-655b-4e4b-8a54-d20704bf9ad7	41250-862	HUMAN OTC DRUG	Allergy and Sinus PE	Maximum Strength	Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20050609		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-863_68c6f0f8-a8a1-49cf-aeb4-698d10b86234	41250-863	HUMAN OTC DRUG	Octinoxate, Octisalate, Avobenzone		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20130225		OTC MONOGRAPH FINAL	part352	Meijer Distribution, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/mL; mg/mL; mg/mL			N	20241231
41250-864_f655af94-648c-3b21-e053-2a95a90aa1da	41250-864	HUMAN OTC DRUG	Meijer Cold Therapy Pain Relief		MENTHOL	GEL	TOPICAL	20181022	20251231	OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, Inc.	MENTHOL	40	mg/mL			N	
41250-865_8379da69-c4be-42cf-b6f6-56d991ee68a5	41250-865	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20141008		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	ISOPROPYL ALCOHOL	30	mg/mL			N	20241231
41250-866_74221a63-149c-4fbe-9254-f660296152ea	41250-866	HUMAN OTC DRUG	lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070815		OTC MONOGRAPH FINAL	part358G	Meijer Distribution Inc	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
41250-867_22326544-7a4b-47da-bc81-1dbdc8259dd1	41250-867	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20211231		ANDA	ANDA208754	MEIJER, INC.	DOCOSANOL	100	mg/g			N	20241231
41250-869_46210898-6a3c-43f3-949c-ce90d5bc9046	41250-869	HUMAN OTC DRUG	Meijer Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20200525		OTC MONOGRAPH DRUG	M012	MEIJER DISTRIBUTION INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-871_1a35425b-b462-4c44-af50-44c446793f30	41250-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
41250-872_b7f1129c-17cf-4760-a0a7-257a174f8646	41250-872	HUMAN OTC DRUG	nitetime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	19891215		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-873_ee1824fd-e5b8-4ce9-b560-211ca6b708e7	41250-873	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060301		ANDA	ANDA077007	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-874_f6566926-139d-158e-e053-2a95a90aeac7	41250-874	HUMAN OTC DRUG	Meijer Cold Therapy Roll On		MENTHOL	GEL	TOPICAL	20181022	20251231	OTC MONOGRAPH NOT FINAL	part348	Meijer Inc.	MENTHOL	40	mg/mL			N	
41250-877_ce598802-c009-48e8-9764-6687893e95c7	41250-877	HUMAN OTC DRUG	Nite time Severe Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20150801		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-878_7035cfc6-203e-42ac-bf00-a866aebe7503	41250-878	HUMAN OTC DRUG	meijer stomach relief		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20170314		OTC MONOGRAPH DRUG	M008	Meijer Distribution Inc	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
41250-879_5d2775f1-3c25-4b91-9955-84c86386df51	41250-879	HUMAN OTC DRUG	Meijer Blackhead Clearing Scrub	Acne medication	Salicylic Acid	CREAM	TOPICAL	20110106		OTC MONOGRAPH DRUG	M006	Meijer Distribution, INC	SALICYLIC ACID	20	mg/g			N	20241231
41250-882_2411fb20-bb8a-4e0f-b524-b1b0c4831e75	41250-882	HUMAN OTC DRUG	gas relief	infants	Simethicone	EMULSION	ORAL	19990201		OTC MONOGRAPH FINAL	part332	Meijer Distribution Inc	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
41250-887_db8ac9e8-013c-add5-e053-2a95a90aa6be	41250-887	HUMAN OTC DRUG	Meijer Maximum Strength Anti-itch		Hydrocortisone	OINTMENT	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part348	Meijer, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41250-888_51bff15a-73d6-4389-b863-c384c6636751	41250-888	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20090617		OTC MONOGRAPH FINAL	part347	Meijer Distribution	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
41250-889_e93e59b7-fe34-4e8e-a64a-bcda930d4394	41250-889	HUMAN OTC DRUG	daily moisturizer		Octinoxate, Octisalate	LOTION	TOPICAL	20180426		OTC MONOGRAPH FINAL	part352	Meijer Distribution, INC	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
41250-890_a2c799c3-e087-4f7c-a490-c6f34214fa30	41250-890	HUMAN OTC DRUG	non drowsy allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200923		ANDA	ANDA076011	Meijer Distribution Inc	LORATADINE	10	mg/1			N	20241231
41250-892_0c05ee1e-2121-9fa2-e063-6394a90a341f	41250-892	HUMAN OTC DRUG	Meijer Chest Congestion Relief		GUAIFENESIN	TABLET	ORAL	20200210		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc.	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41250-893_0c05e2a4-265d-76f1-e063-6294a90a8eb5	41250-893	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200210		OTC MONOGRAPH DRUG	M010	Meijer Distribution Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41250-897_3c936bda-a9ef-43d6-96c8-85ee957387df	41250-897	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19990105		ANDA	ANDA074937	Meijer Distribution Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-899_26c2345f-46b4-48b1-b25a-4463e4bde941	41250-899	HUMAN OTC DRUG	cough dm	childrens	Dextromethorphan polistirex	SUSPENSION	ORAL	20150325		ANDA	ANDA091135	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-900_da4bca7e-bf18-46a1-ad13-0a8b154d52e3	41250-900	HUMAN OTC DRUG	esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Meijer Distribution Inc	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-907_f204ed3a-fddb-ab55-e053-2995a90aa29f	41250-907	HUMAN OTC DRUG	Medicated Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
41250-909_aee10e8a-d185-4895-948a-c6dc94f92d19	41250-909	HUMAN OTC DRUG	Beauty Hydrating		Octinoxate, Zinc Oxide	LOTION	TOPICAL	20061108		OTC MONOGRAPH NOT FINAL	part352	Meijer	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41250-912_2e187e11-173b-44bb-84d3-0b92d7350830	41250-912	HUMAN OTC DRUG	Charcoal Blackhead Clearing Scrub		Salicylic Acid	CREAM	TOPICAL	20160301		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, Inc.	SALICYLIC ACID	20.6	mg/mL			N	20241231
41250-913_e02f4d3a-1e84-4ccb-9cfd-91ccef989349	41250-913	HUMAN OTC DRUG	cold and cough		Diphenhydramine HCl, Phenylephrine HCl	SOLUTION	ORAL	20071031		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-914_b75b2bdf-b0b8-4d76-8a4d-24454c00d527	41250-914	HUMAN OTC DRUG	meijer Natural Fiber		Psyllium Husk	POWDER	ORAL	20170314		OTC MONOGRAPH DRUG	M007	MEIJER DISTRIBUTION INC	PSYLLIUM HUSK	3.4	g/12g			N	20241231
41250-915_bf18bb74-8dd9-4c02-b4e0-e3938cbec377	41250-915	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080229		NDA	NDA022032	Meijer Distribution Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-919_b6bf3fc7-59a4-4c8c-9897-3fc3d17d2b22	41250-919	HUMAN OTC DRUG	DAYTIME COLD AND FLU NITETIME COLD AND FLU		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20190329		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc						N	20241231
41250-921_bfb8ca56-0bb9-4f00-986a-c7eb1e62339d	41250-921	HUMAN OTC DRUG	meijer Baby Tear Free SPF 50 CS		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20160311		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
41250-922_30b55268-f297-4218-bd20-fb0959a85333	41250-922	HUMAN OTC DRUG	Meijer Kids Tear Free SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20160602		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	3.2; 4	g/100g; g/100g			N	20241231
41250-924_25a440e2-1bfa-4137-aa38-f45d03f67497	41250-924	HUMAN OTC DRUG	Meijer Sport SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20160406		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
41250-925_31dcdddf-436d-4f21-bc79-fbff54595646	41250-925	HUMAN OTC DRUG	Meijer Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160310		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 11.7; 4.5; 4.5; 5.4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
41250-928_6b89beab-4f70-40c8-b96c-4b0c44767d6a	41250-928	HUMAN OTC DRUG	Meijer Kids Tear Free SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20160311		OTC MONOGRAPH NOT FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
41250-929_81e1256a-94a7-44e1-8229-a8dc57523325	41250-929	HUMAN OTC DRUG	Epsom Salt		MAGNESIUM SULFATE	GRANULE	ORAL	20130703		OTC MONOGRAPH NOT FINAL	part334	Meijer	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-930_12aa35dc-32de-44e0-8612-001871834fbf	41250-930	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20190327		OTC MONOGRAPH DRUG	M009	Meijer Distribution Inc	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
41250-932_1ce6bbf7-a3e7-425d-a9a1-c2fd52593b7a	41250-932	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20200401	20250401	ANDA	ANDA208754	MEIJER, INC.	DOCOSANOL	100	mg/g			N	
41250-934_dbefef55-4ff1-4a27-8df8-cdc47456cc82	41250-934	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20181105	20250430	ANDA	ANDA209692	MEIJER, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
41250-936_e25a739a-fa0a-4583-b3a8-44407a171a43	41250-936	HUMAN OTC DRUG	Meijer Cold Therapy	Citrus Flavor	ZINC GLUCONATE	TABLET	ORAL	20190418		UNAPPROVED HOMEOPATHIC		Meijer Distribution Inc	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41250-937_0d22c2c2-a708-2509-e063-6294a90ae206	41250-937	HUMAN OTC DRUG	Meijer Ultra Lubricant Eye Drops High Performance		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20200310		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
41250-938_a01d3c35-e6b0-43fa-b09d-cf0dd8e9280c	41250-938	HUMAN OTC DRUG	omeprazole and sodium bicarbonate		Omeprazole, sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20200403		ANDA	ANDA201361	Meijer Distribution Inc	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41250-941_695b27f2-6f0b-425e-8db9-4e1355144a88	41250-941	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20141217		OTC MONOGRAPH FINAL	part358H	Meijer Distribution, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
41250-942_d70edb36-cfe5-4bbb-8eff-fbf73cd51bfb	41250-942	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20140421		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution, Inc	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
41250-944_f3a5c401-3131-44ba-a78c-ddfa5bb57495	41250-944	HUMAN OTC DRUG	hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20080206		OTC MONOGRAPH FINAL	part346	Meijer Distribution Inc	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-946_56fd5b4a-0091-4b33-9d50-4b9db8b8194b	41250-946	HUMAN OTC DRUG	pain and fever		Acetaminophen	SUSPENSION	ORAL	20110826		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
41250-947_1e66671e-5f95-4652-8504-716720a58feb	41250-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20090514		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, Inc	SALICYLIC ACID	20.6	mg/mL			N	20241231
41250-949_7938100c-5edb-4a88-b427-175e68f184d1	41250-949	HUMAN OTC DRUG	Milk of Magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20041018		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-952_0bc9a266-1834-2e5c-e063-6294a90a7da6	41250-952	HUMAN OTC DRUG	Dry Scalp		Pyrithions Zinc	SHAMPOO	TOPICAL	19970916		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
41250-954_645aea78-2639-4902-bd0a-2dfac062d293	41250-954	HUMAN OTC DRUG	allergy relief d		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180612		ANDA	ANDA076050	Meijer Distribution Inc	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41250-955_961390e6-7623-4868-a00f-cd3854a3c91d	41250-955	HUMAN OTC DRUG	Complete Beauty		octinoxate, zinc oxide	LOTION	TOPICAL	20190505		OTC MONOGRAPH FINAL	part352	Meijer	OCTINOXATE; ZINC OXIDE	60; 30	mg/mL; mg/mL			N	20241231
41250-957_c0f1a0c4-802c-447a-abc9-66c6498919b3	41250-957	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130118		ANDA	ANDA203690	Meijer Distribution Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41250-958_48684fe4-f2be-4a51-b695-26db91bd806e	41250-958	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20130708		ANDA	ANDA091135	Meijer Distribution Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41250-963_f05a61dc-093b-1f69-e053-2a95a90a1413	41250-963	HUMAN OTC DRUG	Meijer	Oil Free Acne Wash Pink Grapefruit Foaming Scrub	Salicylic Acid	LOTION	TOPICAL	20141208		OTC MONOGRAPH FINAL	part333D	MEIJER DISTRIBUTION, INC	SALICYLIC ACID	20	mg/mL			N	20241231
41250-964_bc71e90a-3f6a-40c9-b359-c4002cf7312d	41250-964	HUMAN OTC DRUG	flu and severe cold and cough	night time	Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20100903		OTC MONOGRAPH DRUG	M012	Meijer Distribution Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-965_4fd27271-9606-4895-bc65-cbc0394f1f16	41250-965	HUMAN OTC DRUG	Meijer Regular Strength	Peppermint Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170314		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE	500	mg/1			N	20241231
41250-966_a80c0c5f-8bf9-4d1f-99cf-efd421d3db1a	41250-966	HUMAN OTC DRUG	arthritis pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070905		ANDA	ANDA075077	Meijer Distribution Inc	ACETAMINOPHEN	650	mg/1			N	20241231
41250-967_ea2e420e-6a10-3764-e053-2a95a90a1939	41250-967	HUMAN OTC DRUG	Meijer	SPF 30 Face	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20181010		OTC MONOGRAPH FINAL	part352	MEIJER DISTRIBUTION, INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	25; 50; 40; 30; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-971_e75c2a39-91ca-425d-8a2d-f7616394e02f	41250-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20130211		OTC MONOGRAPH FINAL	part355	Meijer Distribution, Inc	SODIUM FLUORIDE	.02	mg/mL			N	20241231
41250-972_f204b4b3-1773-8839-e053-2a95a90a7115	41250-972	HUMAN OTC DRUG	MEIJER PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41250-973_1067c880-554f-493c-90c4-d32fa0ead98e	41250-973	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20210503		ANDA	ANDA208077	MEIJER, INC.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-975_e633ea09-53a8-4c55-a38a-1854cbf0ae8e	41250-975	HUMAN OTC DRUG	pain relief		Acetaminophen	TABLET	ORAL	19950426		OTC MONOGRAPH NOT FINAL	part343	Meijer Distribution Inc	ACETAMINOPHEN	500	mg/1			N	20241231
41250-976_4699ce78-a252-40c9-a889-42e853bcad3d	41250-976	HUMAN OTC DRUG	Antibacterial		Benzalkonium chloride	SOAP	TOPICAL	20180426		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
41250-978_41d59774-60e7-407c-80a4-694a549f0afa	41250-978	HUMAN OTC DRUG	Meijer Extra Strength	Freshmint Flavor	Calcium Carbonate ,Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH DRUG	M001	MEIJER DISTRIBUTION INC	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	675; 135	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41250-979_efb686f5-374a-3873-e053-2a95a90a31db	41250-979	HUMAN OTC DRUG	mucus relief sinus pressure, pain and cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20190901		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-981_efb6b0a3-28e6-c020-e053-2995a90a3db6	41250-981	HUMAN OTC DRUG	mucus relief all in one cold and flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20190901		OTC MONOGRAPH FINAL	part341	Meijer	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-982_8137d2cc-c0fe-42c1-a35c-e281ce7678e0	41250-982	HUMAN OTC DRUG	Miconazole 3		Miconazole nitrate	KIT		20161012		ANDA	ANDA076357	Meijer Distribution Inc						N	20241231
41250-983_5c9eecd8-17fc-4d9b-a54f-1a37a2bce3e8	41250-983	HUMAN OTC DRUG	congestion and headache		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20170724		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-984_f32e6ab5-bee8-ea87-e053-2995a90a8203	41250-984	HUMAN OTC DRUG	Meijer	SPF 30 Ultra Dry Sheer	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20181010		OTC MONOGRAPH NOT FINAL	part352	MEIJER DISTRIBUTION, INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 80; 50; 40; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41250-985_ea2e9c3b-7530-2c2e-e053-2a95a90a9e81	41250-985	HUMAN OTC DRUG	Meijer	Skin Relieving Moisturizing	DIMETHICONE	LOTION	TOPICAL	20160707		OTC MONOGRAPH FINAL	part347	MEIJER DISTRIBUTION, INC	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
41250-986_36d84460-b652-4e4d-a3f9-9db760d2d903	41250-986	HUMAN OTC DRUG	Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190506		ANDA	ANDA040564	Meijer Distribution Inc	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
41250-987_6d802905-ed12-49cf-af59-9c855dfdcf00	41250-987	HUMAN OTC DRUG	cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060811		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41250-989_9641c25e-370c-4ef8-96e3-77e7ccfc9ec8	41250-989	HUMAN OTC DRUG	nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20181120		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41250-991_3c565c0b-4206-4b67-be75-53e02f0b3eda	41250-991	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Meijer Distribution Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-993_93756dc4-c722-4066-b462-1cbb16924fdf	41250-993	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Meijer Distribution Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41250-997_337ad2dc-b72d-4e34-bd6a-e1c02861af76	41250-997	HUMAN OTC DRUG	Healing for Babies		Petrolatum	OINTMENT	TOPICAL	20140219		OTC MONOGRAPH FINAL	part347	Meijer Distribution	PETROLATUM	410	mg/g			N	20241231
41250-998_1fbc3cca-a44e-44f9-9c10-5ba4f6827eee	41250-998	HUMAN OTC DRUG	Glazed Pear		Ethyl Alcohol	GEL	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distributioin, Inc	ALCOHOL	62	mg/mL			N	20241231
41366-056_dd009a3a-df4d-24b7-e053-2a95a90a0185	41366-056	HUMAN OTC DRUG	Foaming Hand		Foaming Hand Soap	LIQUID	EXTRACORPOREAL	20220418		UNAPPROVED DRUG OTHER		Zhejiang Meimi Technology Co., Ltd.	COCOYL METHYL MONOETHANOLAMINE; LAURAMIDOPROPYL BETAINE	1.2; 5	g/100mL; g/100mL			N	20241231
41415-007_08a3a4b6-c8bd-2283-e063-6394a90ab2ad	41415-007	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	LOZENGE	ORAL	20180306		OTC MONOGRAPH DRUG	M012	Publix	MENTHOL	5.4	mg/1			N	20241231
41415-008_06d249e8-6a8b-0973-e063-6294a90a09e7	41415-008	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20180307		OTC MONOGRAPH FINAL	part341	Publix	MENTHOL	5.8	mg/1			N	20241231
41415-009_06d25564-4c82-0b3a-e063-6294a90a38bf	41415-009	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20180308		OTC MONOGRAPH FINAL	part341	Publix	MENTHOL	7.5	mg/1			N	20241231
41415-010_08a3c05a-54eb-1296-e063-6294a90a065b	41415-010	HUMAN OTC DRUG	Sugar Free Menthol Cough Drops		Menthol	LOZENGE	ORAL	20180828		OTC MONOGRAPH DRUG	M012	Publix	MENTHOL	5.8	mg/1			N	20241231
41415-011_08a3d30c-f46b-e40e-e063-6294a90a5184	41415-011	HUMAN OTC DRUG	Sugar Free Cherry Cough Drops		Menthol	LOZENGE	ORAL	20180829		OTC MONOGRAPH DRUG	M012	Publix	MENTHOL	5.8	mg/1			N	20241231
41415-012_08a3c05a-54ec-1296-e063-6294a90a065b	41415-012	HUMAN OTC DRUG	Sugar Free Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20180829		OTC MONOGRAPH DRUG	M012	Publix	MENTHOL	7.6	mg/1			N	20241231
41415-021_21b6eb46-4e9c-41b5-9dab-5c6b0cf4f00f	41415-021	HUMAN OTC DRUG	PUBLIX		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20190521		OTC MONOGRAPH DRUG	M007	PUBLIX SUPER MARKETS, INC	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
41415-046_3e050d3c-fd69-4dd1-96c3-0fb477612b54	41415-046	HUMAN OTC DRUG	Publix	allergy	diphenhydramine hydrochloride and zinc acetate	CREAM	TOPICAL	20050920		OTC MONOGRAPH NOT FINAL	part348	Publix Super Markets Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41415-047_95ac798c-931c-4e70-897f-e6b56a569c52	41415-047	HUMAN OTC DRUG	Publix	Hydro	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Publix Super Markets Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41415-056_005a8878-29d1-42c6-be42-635ffdc1397e	41415-056	HUMAN OTC DRUG	Publix	athletic foot	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Publix Super Markets Inc	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41415-101_61d17ac2-e207-4f44-b8a4-7ef9a5cf7e14	41415-101	HUMAN OTC DRUG	Publix Regular Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190520		OTC MONOGRAPH DRUG	M001	PUBLIX SUPER MARKETS, INC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41415-102_c3e4d7d0-aa7a-469e-81ed-f20708292489	41415-102	HUMAN OTC DRUG	Publix Extra Strength	Assorted Berry	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190520		OTC MONOGRAPH DRUG	M001	PUBLIX SUPER MARKETS, INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41415-103_93dfffa0-5337-4b92-bca0-9fb9e68dacbe	41415-103	HUMAN OTC DRUG	Publix Ultra Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190521		OTC MONOGRAPH DRUG	M001	PUBLIX SUPER MARKETS, INC	CALCIUM CARBONATE	1000	mg/1			N	20241231
41415-110_558f9453-54fc-48c8-8589-c1400192fa5a	41415-110	HUMAN OTC DRUG	Extra Strength gas relief		Simethicone	TABLET, CHEWABLE	ORAL	20171114		OTC MONOGRAPH DRUG	M002	PUBLIX SUPER MARKETS, INC,	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
41415-111_b2184693-bf09-45d5-b408-ac37d7c80173	41415-111	HUMAN OTC DRUG	Publix Regular Strength	Peppermint Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190522		OTC MONOGRAPH DRUG	M001	PUBLIX SUPER MARKETS, INC	CALCIUM CARBONATE	500	mg/1			N	20241231
41415-113_f3ab08cf-cc43-4a72-abf0-91301665f920	41415-113	HUMAN OTC DRUG	PUBLIX	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190514		OTC MONOGRAPH DRUG	M002	PUBLIX SUPER MARKETS, INC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
41415-114_5efb4cfb-c0c7-41a9-b969-590365ab46f2	41415-114	HUMAN OTC DRUG	Publix Laxative	Maximum Strength	Calcium Sennosides	TABLET	ORAL	20190515		OTC MONOGRAPH DRUG	M007	PUBLIX SUPER MARKETS, INC	SENNOSIDES A AND B	25	mg/1			N	20241231
41415-116_3096b222-1b38-4349-8f5b-8d278475fee9	41415-116	HUMAN OTC DRUG	Publix	Stimulant Laxative	Bisacodyl	TABLET, COATED	ORAL	20190522		OTC MONOGRAPH DRUG	M007	PUBLIX SUPER MARKETS, INC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41415-119_cdd82eba-31bb-4dde-9aaa-7a95c52e3dee	41415-119	HUMAN OTC DRUG	PUBLIX		Psyllium Husk	CAPSULE	ORAL	20190521		OTC MONOGRAPH DRUG	M007	PUBLIX SUPER MARKETS, INC	PSYLLIUM HUSK	.52	g/1			N	20241231
41415-120_effdb170-ef26-4985-96c1-4c4650037001	41415-120	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Publix Super Markets Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
41415-121_498b52fd-47f3-4331-b896-9965f257cbd7	41415-121	HUMAN OTC DRUG	Publix Women	Laxative	Bisacodyl	TABLET	ORAL	20190522		OTC MONOGRAPH DRUG	M007	PUBLIX SUPER MARKETS, INC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41415-124_535adf80-01c4-45e3-84bb-4515abcad10a	41415-124	HUMAN OTC DRUG	Chewable Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20170630		OTC MONOGRAPH DRUG	M008	PUBLIX SUPER MARKETS INC,	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
41415-201_7044d805-9847-49b4-9f8e-9c211844e34d	41415-201	HUMAN OTC DRUG	Publix Extra Strength	Tropical Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190522		OTC MONOGRAPH DRUG	M001	PUBLIX SUPER MARKETS, INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41415-296_c3f79e79-ab30-46d0-8e14-4ba88cd54cae	41415-296	HUMAN OTC DRUG	Extra Strength Sugar Free	Orange Cream Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190523		OTC MONOGRAPH DRUG	M001	PUBLIX SUPER MARKETS, INC	CALCIUM CARBONATE	750	mg/1			N	20241231
41415-307_651d23f7-0a07-447a-8338-de0f47a7c063	41415-307	HUMAN OTC DRUG	PUBLIX Sore Throat	Menthol Flavor	Phenol	SPRAY	ORAL	20221101		OTC MONOGRAPH DRUG	M022	PUBLIX SUPER MARKETS, INC	PHENOL	1.4	g/100mL			N	20241231
41415-325_0ccb3962-d49e-0a6c-e063-6294a90a0d41	41415-325	HUMAN OTC DRUG	Publix Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Publix	POVIDONE-IODINE	100	mg/mL			N	20241231
41415-400_0ccb5970-3695-9097-e063-6294a90aa811	41415-400	HUMAN OTC DRUG	Publix Clear Anti-Itch		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Publix	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41415-420_0ccb3da3-cd23-5dd2-e063-6294a90ab069	41415-420	HUMAN OTC DRUG	Publix Calamine Medicated		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Publix	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
41415-477_93e66a67-c371-4ae0-a905-a45d045370e5	41415-477	HUMAN OTC DRUG	Saline		Nasal	SPRAY	NASAL	20210127		OTC MONOGRAPH DRUG	M022	PUBLIX SUPER MARKETS, INC	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
41415-513_f1c446a3-c90e-4820-a0e6-5d01da1b3688	41415-513	HUMAN OTC DRUG	Publix Fiber Therapy	Orange Smooth	Psyllium Husk	POWDER	ORAL	20190516		OTC MONOGRAPH DRUG	M007	PUBLIX SUPER MARKETS, INC	PSYLLIUM HUSK	3.4	g/12g			N	20241231
41415-515_c26b8dd8-2a50-42aa-9850-8b50e96628a2	41415-515	HUMAN OTC DRUG	Publix Fiber Therapy	Sugar Free	Psyllium Husk	POWDER	ORAL	20190520		OTC MONOGRAPH DRUG	M007	PUBLIX SUPER MARKETS, INC	PSYLLIUM HUSK	3.4	g/5.8g			N	20241231
41415-703_4fc2c07d-07b3-41e5-bae8-3784041a783d	41415-703	HUMAN OTC DRUG	PUBLIX Sore Throat Fast Relief Oral Anesthetic		Phenol	SPRAY	ORAL	20221024		OTC MONOGRAPH DRUG	M022	PUBLIX SUPER MARKETS, INC	PHENOL	1.4	g/100mL			N	20241231
41415-706_169dea4d-3c11-4d43-bbc6-68b7c43f6c91	41415-706	HUMAN OTC DRUG	PUBLIX Regular Strength	Pink Bismuth	Bismuth Subsalicylate	SUSPENSION	ORAL	20221024		OTC MONOGRAPH DRUG	M008	PUBLIX SUPER MARKETS, INC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
41415-707_84761784-dd84-47f1-8ffb-709c81561d69	41415-707	HUMAN OTC DRUG	PUBLIX Stomach Relief	Ultra Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20221024		OTC MONOGRAPH DRUG	M008	PUBLIX SUPER MARKETS, INC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
41415-709_d5dc23a7-36a4-44d4-9383-8a24c6cd0afd	41415-709	HUMAN OTC DRUG	Publix Infants Dye Free	Gas Relief	Simethicone	EMULSION	ORAL	20190517		OTC MONOGRAPH DRUG	M002	PUBLIX SUPER MARKETS, INC	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
41415-715_05ed7b63-271e-4535-89bf-d1e55b02c68b	41415-715	HUMAN OTC DRUG	Publix	Maximum Strength	oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH DRUG	M012	PUBLIX SUPER MARKETS, INC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41415-716_7d02e0eb-4670-4b19-9a4c-8f88398b9120	41415-716	HUMAN OTC DRUG	Publix		oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH DRUG	M012	PUBLIX SUPER MARKETS, INC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41415-720_4474cfd7-c814-4640-9367-f7459ea7ae2d	41415-720	HUMAN OTC DRUG	Publix Extra Moisturizing		oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH DRUG	M012	PUBLIX SUPER MARKETS, INC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41415-728_bd5e2d0b-cfd3-4132-9db0-f8c3cfbc8647	41415-728	HUMAN OTC DRUG	Publix		Phenylephrine hydrochloride	SPRAY	NASAL	20190520		OTC MONOGRAPH DRUG	M012	PUBLIX SUPER MARKETS, INC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41415-943_bc435d0c-c8a5-370d-e053-2a95a90ab463	41415-943	HUMAN OTC DRUG	Publix Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	PUBLIX SUPER MARKETS, INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
41415-994_a36d0524-b1d7-4daf-a62e-54f63168b0cd	41415-994	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine Hydrochloride		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220407		ANDA	ANDA212542	PUBLIX SUPER MARKETS, INC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
41415-995_9da8a36f-ad09-41c5-a47f-e82ba723d828	41415-995	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		fexofenadine hydrochloride and pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20211108		ANDA	ANDA090818	PUBLIX SUPER MARKETS, INC	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
41415-996_1ec2b7b7-830a-4e04-b738-baed27b47662	41415-996	HUMAN OTC DRUG	GUAIFENESIN		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180108		ANDA	ANDA209254	Publix Super Markets, Inc	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41415-997_36b48471-5ae5-4b36-82c9-62fa4f3602c6	41415-997	HUMAN OTC DRUG	Guaifenesin	Extended Release	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20171210		ANDA	ANDA209254	PUBLIX SUPER MARKETS, INC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41415-998_a99e6c2d-b159-4ac6-804f-3805de23f320	41415-998	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan Hbr	TABLET, EXTENDED RELEASE	ORAL	20210701		ANDA	ANDA214781	PUBLIX SUPER MARKETS, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41415-999_1f339b80-92ff-41e0-a8e9-99e44c9609d7	41415-999	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20210701		ANDA	ANDA214781	PUBLIX SUPER MARKETS, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-004_f10ecaea-8761-4f84-94eb-9706a1d17b65	41520-004	HUMAN OTC DRUG	careone hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20141221		OTC MONOGRAPH FINAL	part346	American Sales Company	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-009_06c1066e-9106-09c9-e063-6294a90abf9d	41520-009	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20160609		OTC MONOGRAPH FINAL	part341	American Sales	MENTHOL	5.4	mg/1			N	20241231
41520-011_06c1149d-23b1-d994-e063-6294a90a686e	41520-011	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20160622		OTC MONOGRAPH FINAL	part341	American Sales	MENTHOL	7.5	mg/1			N	20241231
41520-020_06c113f5-63bd-f431-e063-6294a90a7d4f	41520-020	HUMAN OTC DRUG	Sugar Free Menthol Cough Drops		Menthol	LOZENGE	ORAL	20160622		OTC MONOGRAPH FINAL	part341	American Sales	MENTHOL	5.8	mg/1			N	20241231
41520-023_8c242e34-89b8-4ea1-9077-6d4658a3d858	41520-023	HUMAN OTC DRUG	CareOne Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20160413		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-026_06c0fe9a-92f3-1679-e063-6394a90a4bf8	41520-026	HUMAN OTC DRUG	Cherry cough drop		Menthol	LOZENGE	ORAL	20160609		OTC MONOGRAPH FINAL	part341	American Sales	MENTHOL	5.8	mg/1			N	20241231
41520-031_06c0e63c-1d71-166c-e063-6394a90ad3a6	41520-031	HUMAN OTC DRUG	cherry antacid soft chew		calcium carbonate	TABLET, CHEWABLE	ORAL	20160622		OTC MONOGRAPH FINAL	part331	American Sales	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41520-032_e5a3db0c-c4c3-45b5-9b41-4a3c69ab9762	41520-032	HUMAN OTC DRUG	CareOne DayTime Cold and Flu		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20160412		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-033_b04e80c2-b833-46db-9b98-0be4ce2ac396	41520-033	HUMAN OTC DRUG	careone anti itch		hydrocortisone	CREAM	TOPICAL	20160519		OTC MONOGRAPH NOT FINAL	part348	American Sales Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41520-034_60dc9668-9af4-49ed-80bd-b6b1813f2f8d	41520-034	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	Care One (American Sales Company)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-035_0e87a45f-f5a5-a7f3-e063-6294a90af805	41520-035	HUMAN OTC DRUG	Antacid Fruit Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20160622		OTC MONOGRAPH DRUG	M001	American Sales	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20251231
41520-036_2385c488-dfba-4bf1-befa-68d0ed7cde9b	41520-036	HUMAN OTC DRUG	Mucus Relief	Cold Flu and Sore Throat Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141031		OTC MONOGRAPH FINAL	part341	Care One (American Sales Company)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-037_7c54acfe-c56c-4b73-b827-5ba66dfbbe0c	41520-037	HUMAN OTC DRUG	Mucus Relief	Maximum Strength Severe Congestion and Cough	dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20141031		OTC MONOGRAPH FINAL	part341	Care One (American Sales Company)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-043_06c10153-8fd8-3a81-e063-6394a90a8db2	41520-043	HUMAN OTC DRUG	Cherry Sore Throat Lozenge		Benzocaine	LOZENGE	ORAL	20160622		OTC MONOGRAPH NOT FINAL	part356	American Sales	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
41520-044_0e87aa19-bbe5-d384-e063-6294a90a9d0b	41520-044	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20160622		OTC MONOGRAPH DRUG	M012	American Sales	MENTHOL	5.8	mg/1			N	20251231
41520-045_06c13112-3006-c860-e063-6294a90a1cdb	41520-045	HUMAN OTC DRUG	Sugar Free Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20160622		OTC MONOGRAPH FINAL	part341	American Sales	MENTHOL	7.6	mg/1			N	20241231
41520-050_0d661d9b-b781-4183-914b-9191b122e98b	41520-050	HUMAN OTC DRUG	Care One Ibuprofen PM		diphenhydramine citrate and ibuprofen	TABLET, FILM COATED	ORAL	20090220		ANDA	ANDA079113	American Sales Company	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-052_e45bc005-c56a-474f-a13b-366a7b2ab824	41520-052	HUMAN OTC DRUG	CareOne Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20140128		OTC MONOGRAPH FINAL	part338	American Sales Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-057_f6a8255b-6788-4293-aa91-f5a42f5f6ce1	41520-057	HUMAN OTC DRUG	care one ibuprofen	infants	ibuprofen	SUSPENSION	ORAL	20040511		ANDA	ANDA075217	American Sales Company	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-064_0bc76f4e-c887-43bb-8aca-74f93f2465f9	41520-064	HUMAN OTC DRUG	CareOne Acetaminophen		Acetaminophen	TABLET	ORAL	20160720		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	500	mg/1			N	20241231
41520-065_4e13cce1-978c-4ef0-8296-36fde776c409	41520-065	HUMAN OTC DRUG	care one nasal	extra moisturizing	Oxymetazoline HCl	SPRAY	NASAL	20040601		OTC MONOGRAPH FINAL	part341	American Sales Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41520-067_a8bbe3cf-19b1-4144-bf60-1f4cefefdc76	41520-067	HUMAN OTC DRUG	careone triple antibiotic		bacitracin zinc, neomycin sulfate, polymyxin B sulfate	OINTMENT	TOPICAL	20191001		OTC MONOGRAPH FINAL	part333B	American Sales Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
41520-068_c6f3f506-8ef0-4900-80b9-c298f879534d	41520-068	HUMAN OTC DRUG	Multi-Symptom Cold and Flu	DayTime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20160731		OTC MONOGRAPH DRUG	M012	Care One (American Sales Company)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-082_f2170117-b26d-51f4-e053-2995a90abe94	41520-082	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20171219		OTC MONOGRAPH FINAL	part333C	Foodhold USA	TOLNAFTATE	1.5	g/150g			N	20241231
41520-084_e280cc3d-d0f2-4c07-b2fc-c077f8f78ebb	41520-084	HUMAN OTC DRUG	CareOne Night TIme Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20160411		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-086_f2174e72-5a0b-f2ae-e053-2995a90a2109	41520-086	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Spray	AEROSOL, SPRAY	TOPICAL	20171219		OTC MONOGRAPH FINAL	part333C	Foodhold USA	TOLNAFTATE	1.13	g/113g			N	20241231
41520-089_f21704f8-9424-6e20-e053-2995a90ab1a1	41520-089	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171219		OTC MONOGRAPH NOT FINAL	part333A	Foodhold USA	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
41520-094_bc2da048-4632-4719-8cb4-622a1b598da0	41520-094	HUMAN OTC DRUG	care one nasal decongestant pe	maximum strength non drowsy	Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20050517		OTC MONOGRAPH FINAL	part341	American Sales Company	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-097_3e17d865-424d-414d-83f5-4d89526d98da	41520-097	HUMAN OTC DRUG	CareOne Cold Sore Treatment		camphor, menthol, phenol, white petrolatum	GEL	TOPICAL	20200311		OTC MONOGRAPH NOT FINAL	part333E	American Sales Company	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
41520-108_392a8a6a-ea3a-4cd4-a58e-ce3cb5061c55	41520-108	HUMAN OTC DRUG	CareOne Severe Congestion Nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20160831		OTC MONOGRAPH FINAL	part341	American Sales Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41520-127_88c6dd39-271b-45d5-b4d6-51f24b1afb82	41520-127	HUMAN OTC DRUG	CareOne 8 Hour Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170416		ANDA	ANDA075077	American Sales Company	ACETAMINOPHEN	650	mg/1			N	20241231
41520-131_229d491b-2951-45db-ab03-d8f79e154885	41520-131	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	American Sales Company	LORATADINE	5	mg/5mL			N	20241231
41520-138_ebddd26e-fd09-20c9-e053-2995a90a8d27	41520-138	HUMAN OTC DRUG	Cold Multi-Symptom Daytime		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110901		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-154_350cccac-45a1-4f5b-b1fa-afcbd8cd95c2	41520-154	HUMAN OTC DRUG	CareOne Miconazole 3		Miconazole nitrate	KIT		20140413		ANDA	ANDA075329	American Sales Company						N	20241231
41520-157_fcde91f2-e336-4cf0-8d5c-edadcfb6e34f	41520-157	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	FOODHOLD U.S.A., LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41520-166_9f4874e0-68b5-49c8-89b1-63badcc69af1	41520-166	HUMAN OTC DRUG	care one ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20040428		ANDA	ANDA074937	American Sales Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-184_f2171733-5da6-6476-e053-2a95a90ae144	41520-184	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus Spray	AEROSOL, SPRAY	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part348	Foodhold USA	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g			N	20241231
41520-188_926691f4-44ae-4a5a-9810-2603e9344f6d	41520-188	HUMAN OTC DRUG	careone hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20140720		OTC MONOGRAPH FINAL	part346	American Sales Company	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-201_35018f2c-bc48-48b1-9077-618a737d5d75	41520-201	HUMAN OTC DRUG	careone hydrocortisone 1	maximum strength	hydrocortisone	OINTMENT	TOPICAL	20121017		OTC MONOGRAPH NOT FINAL	part348	American Sales Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41520-208_ce9dbebe-fcea-436a-a381-504e0903dd5b	41520-208	HUMAN OTC DRUG	CareOne Acetaminophen PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20160902		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-209_0907f435-4c07-4fec-bda3-c9e2b2c85729	41520-209	HUMAN OTC DRUG	CareOne Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20160421		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-217_0e0c1bb9-8d94-4f5b-be2d-0e2c3d140183	41520-217	HUMAN OTC DRUG	care one pain relief	8 hour	Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051129		ANDA	ANDA075077	American Sales Company	ACETAMINOPHEN	650	mg/1			N	20241231
41520-222_4820b043-32bf-4d18-9dcb-b29c9334807c	41520-222	HUMAN OTC DRUG	CareOne Miconazole 3		Miconazole nitrate	KIT		20161017		ANDA	ANDA076357	American Sales Company						N	20241231
41520-228_4ac68f4c-1acf-48c8-837b-fcf996adfb85	41520-228	HUMAN OTC DRUG	Aspirin	Enteric Safety Coated	Aspirin	TABLET	ORAL	20140430	20240329	OTC MONOGRAPH FINAL	part343	Care One (American Sales Company)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
41520-229_57501f04-ba3d-4e21-af64-60674a4c9256	41520-229	HUMAN OTC DRUG	CareOne Allergy Relief		fexofenadine hcl	TABLET, FILM COATED	ORAL	20161014		ANDA	ANDA076447	American Sales Company	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-255_39ee2c94-390a-4b8b-a0da-e2be85b8ec90	41520-255	HUMAN OTC DRUG	care one ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20060516		ANDA	ANDA075217	American Sales Company	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-264_65baf60d-f7f4-4482-a7a4-3aab220925e2	41520-264	HUMAN OTC DRUG	careone naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20200225		ANDA	ANDA208499	American Sales Company	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-270_5d5d6386-2eab-45bc-ac98-6ce1192b4407	41520-270	HUMAN OTC DRUG	Sinus Headache PE Non- Drowsy	Maximum Strength	Acetaminophen and Phenylephrine HCl	TABLET	ORAL	20140612	20240731	OTC MONOGRAPH DRUG	M013	American Sales Company	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41520-274_4da8cc0a-d0a4-4ab3-9d79-9f2ef106dbf8	41520-274	HUMAN OTC DRUG	careone aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20171009		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41520-288_04f5e6fe-2ee0-4740-8fde-9f58ce00d032	41520-288	HUMAN OTC DRUG	careone mucus relief	childrens	Guaifenesin	SOLUTION	ORAL	20070808		OTC MONOGRAPH FINAL	part341	American Sales Company	GUAIFENESIN	100	mg/5mL			N	20241231
41520-290_93dcfe40-76e9-5a83-e053-2a95a90ac135	41520-290	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20190801		OTC MONOGRAPH FINAL	part341	FOODHOLD U.S.A., LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-299_fac09410-3b76-4517-b60f-22cb2caadd75	41520-299	HUMAN OTC DRUG	Multi-Action Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20180425		OTC MONOGRAPH NOT FINAL	part356	American Sales Company	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
41520-301_06ab27a3-4359-465e-ab84-dcda6d25a31e	41520-301	HUMAN OTC DRUG	careone childrens allergy relief		Cetirizine HCl	SOLUTION	ORAL	20160406		ANDA	ANDA204226	American Sales Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-304_35c461f1-1dbf-4412-98a7-0d02bebe8656	41520-304	HUMAN OTC DRUG	care one nasal	original	oxymetazoline hydrochloride	SPRAY	NASAL	20040524		OTC MONOGRAPH FINAL	part341	American Sales Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41520-305_1d679f20-267c-4fae-a3c3-a9f0c3806d17	41520-305	HUMAN OTC DRUG	CAREONE	Clotrimazole	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	American Sales Company	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41520-306_f5f5ef9c-c86c-4797-97df-ca06d0f3ce83	41520-306	HUMAN OTC DRUG	care one clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA090685	American Sales Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41520-319_7465898d-3a0c-4f95-9897-9cc052694050	41520-319	HUMAN OTC DRUG	Care One hydrocortisone	maximum strength	Hydrocortisone	CREAM	TOPICAL	20100528		OTC MONOGRAPH NOT FINAL	part348	American Sales Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41520-334_b6ca4adf-b868-4822-8e37-3f532726aa09	41520-334	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	OIL	ORAL; TOPICAL	20161130	20250228	OTC MONOGRAPH NOT FINAL	part334	Care One (American Sales Company)	MINERAL OIL	100	mg/100mL			N	
41520-340_0ab65e90-95f5-4588-866f-1abb98fc670a	41520-340	HUMAN OTC DRUG	careone liquid antacid		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	20120927		OTC MONOGRAPH FINAL	part331	American Sales Company	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41520-349_0f8d7673-37d3-4a8b-98f6-8142cfea41dc	41520-349	HUMAN OTC DRUG	Care One Naproxen Sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20160613		ANDA	ANDA074661	American Sales Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-352_7919cccb-d459-42b8-9b7c-90d663011e3a	41520-352	HUMAN OTC DRUG	care one nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20080829		ANDA	ANDA078547	American Sales Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-357_5675723d-ba5b-456c-bee6-913de56c571d	41520-357	HUMAN OTC DRUG	careone antacid	regular strength	Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20121118		OTC MONOGRAPH FINAL	part331	American Sales Company	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41520-363_34d8f481-ff83-484f-96b0-bb2423ab819e	41520-363	HUMAN OTC DRUG	CareOne Infants Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20161214		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-372_6b8507fa-302f-440b-b66a-b46aa17e04b7	41520-372	HUMAN OTC DRUG	Stomach Relief	regular strength	Bismuth subsalicylate	LIQUID	ORAL	20180930		OTC MONOGRAPH DRUG	M008	Care One (American Sales Company)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
41520-374_03b9a29a-33c0-4c88-8026-7120da6c27e9	41520-374	HUMAN OTC DRUG	Care One migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20040413		ANDA	ANDA075794	American Sales Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
41520-384_ee23d1e6-bf24-4943-8d82-305b05a691e5	41520-384	HUMAN OTC DRUG	CareOne Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120830		ANDA	ANDA091135	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-388_2d338dbc-561c-4931-b5e5-918db2e0e01c	41520-388	HUMAN OTC DRUG	CARE ONE NASAL		Oxymetazoline HCl	SPRAY	NASAL	20040720		OTC MONOGRAPH FINAL	part341	American Sales Company	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
41520-396_c7498a9e-0dac-4414-b422-7119a1bebc18	41520-396	HUMAN OTC DRUG	careone milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20120805		OTC MONOGRAPH NOT FINAL	part334	American Sales Company	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41520-409_ecd7cf7d-b7dc-42b1-b955-7217d9cf3450	41520-409	HUMAN OTC DRUG	CareOne Acid Reducer Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160929		ANDA	ANDA077355	American Sales Company	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41520-413_e8dd6f2e-71e7-46be-adc3-cebdf6845ad1	41520-413	HUMAN OTC DRUG	careone ibuprofen pm		Diphenhydramine citrate, Ibuprofen	TABLET, FILM COATED	ORAL	20111208		ANDA	ANDA079113	American Sales Company	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-415_a8d6d0ff-86f4-68bf-e053-2a95a90ad7ef	41520-415	HUMAN OTC DRUG	Care One	Maximum Strength	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	American Sales	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
41520-419_29c9a5f3-8b94-4094-8a0f-f3c1bf74f593	41520-419	HUMAN OTC DRUG	careone childrens mucus relief		Dextromethorphan hbr, Guaifenesin	SOLUTION	ORAL	20070808		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-426_d1512cc6-e0ba-4ebd-a169-ece8535153c6	41520-426	HUMAN OTC DRUG	CareOne Tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20080107		ANDA	ANDA075915	American Sales Company	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41520-427_fe4e130a-b275-4314-94ad-305aafbf46ca	41520-427	HUMAN OTC DRUG	CareOne Daytime Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20161102		OTC MONOGRAPH FINAL	part341	American Sales Company						N	20241231
41520-428_a2f5a33c-9389-4fac-a470-89b089591e89	41520-428	HUMAN OTC DRUG	careone gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20171102		OTC MONOGRAPH FINAL	part332	American Sales Company	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
41520-429_383c261f-5641-4d16-b206-46b86d1d98e8	41520-429	HUMAN OTC DRUG	CareOne Nasal and Sinus Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160915		ANDA	ANDA075153	American Sales Company	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41520-431_a8399ab9-c2be-446c-94cb-aa1e61d236ed	41520-431	HUMAN OTC DRUG	careone nighttime sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20040413		OTC MONOGRAPH FINAL	part338	American Sales Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-443_a7052a4e-5b02-4ce1-8c3c-161cad881acc	41520-443	HUMAN OTC DRUG	CareOne Allergy Relief		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170612		ANDA	ANDA078104	American Sales Company	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41520-444_f0304779-5aeb-a289-e053-2a95a90a49b5	41520-444	HUMAN OTC DRUG	Care One Original Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20150217		OTC MONOGRAPH FINAL	part343	Foodhold U.S.A.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41520-463_6bdb46fa-81c0-49f0-bda7-01931b840b43	41520-463	HUMAN OTC DRUG	careone allergy relief		Chlorpheniramine Maleate	TABLET	ORAL	20040518		OTC MONOGRAPH FINAL	part341	American Sales Company	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-467_fd664658-e22f-496c-b75b-dfb46b49f856	41520-467	HUMAN OTC DRUG	care one aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20040601		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
41520-468_08b53483-7711-4a3e-b440-c35edf0bc8f2	41520-468	HUMAN OTC DRUG	care one calcium antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20040301		OTC MONOGRAPH FINAL	part331	American Sales Company	CALCIUM CARBONATE	750	mg/1			N	20241231
41520-483_a0467fb8-6b23-463d-9d39-5f440aeabeb8	41520-483	HUMAN OTC DRUG	CareOne Nighttime Severe Cold and Cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20180710		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-485_c7b96a45-bcf1-4ead-b447-9135a8573cfd	41520-485	HUMAN OTC DRUG	Care One Calcium Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20040301		OTC MONOGRAPH FINAL	part331	American Sales Company	CALCIUM CARBONATE	500	mg/1			N	20241231
41520-487_bbc8f12a-f075-4bc5-85af-93e18d67cb11	41520-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20161130	20250228	OTC MONOGRAPH FINAL	part347	Care One (American Sales Company)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
41520-492_82e9a243-8e33-4a65-bf68-32e923031d62	41520-492	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20160531	20250530	OTC MONOGRAPH NOT FINAL	part334	Care One (American Sales Company)	SENNOSIDES	25	mg/1			N	
41520-495_c7f23752-fd7f-4463-8a9f-e4a5c96e3efc	41520-495	HUMAN OTC DRUG	CareOne Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160720		ANDA	ANDA077349	American Sales Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-507_7a363bfd-14b6-4560-8897-3f8117b981e9	41520-507	HUMAN OTC DRUG	CareOne Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA074661	American Sales Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-510_bb4f118d-ddd4-407a-9a07-0660c6150ca6	41520-510	HUMAN OTC DRUG	careone allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20211108		ANDA	ANDA076011	American Sales Company	LORATADINE	10	mg/1			N	20241231
41520-514_bb5bc6ac-4d1d-45b1-8bb9-0f1a4589197e	41520-514	HUMAN OTC DRUG	CareOne Acetaminophen PM		Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20160902		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-519_7101f904-8723-42c7-adc3-95e59d3bd8ea	41520-519	HUMAN OTC DRUG	Petrolatum		White Petrolatum	JELLY	TOPICAL	19920715		OTC MONOGRAPH FINAL	part347	Amerian Sales	PETROLATUM	1	g/g			N	20241231
41520-520_358c89ad-4c0b-4288-b729-088840a0d3fe	41520-520	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20100805	20250530	NDA	NDA021855	Care One (American Sales Company)	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	
41520-531_f4ee870c-a1df-1d42-e053-2a95a90ada2d	41520-531	HUMAN OTC DRUG	Redness reliever		tetrahydrozoline HCl	LIQUID	OPHTHALMIC	20110906		OTC MONOGRAPH FINAL	part349	American Sales Company	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
41520-532_f4ee990c-0637-122a-e053-2995a90a948e	41520-532	HUMAN OTC DRUG	Advanced relief		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline HCl	LIQUID	OPHTHALMIC	20110907		OTC MONOGRAPH FINAL	part349	American Sales Company	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
41520-533_629cfdaf-d805-4b1e-a99d-92afafe8f2b3	41520-533	HUMAN OTC DRUG	Care One Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20160708		ANDA	ANDA074661	American Sales Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-534_d5394e98-99ed-4856-ac7b-0232b5fe3240	41520-534	HUMAN OTC DRUG	CareOne Tussin	Mucus Plus Chest Congestion	Guaifenesin	SOLUTION	ORAL	20160826		OTC MONOGRAPH FINAL	part341	American Sales Company	GUAIFENESIN	200	mg/10mL			N	20241231
41520-544_d7aeeeea-6f86-462b-b89e-9dd9ad246bfb	41520-544	HUMAN OTC DRUG	Care One arthritis pain relief	temporary minor	Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051122		ANDA	ANDA075077	American Sales Company	ACETAMINOPHEN	650	mg/1			N	20241231
41520-553_4d532547-e4b8-42b2-82f9-8a550cca9352	41520-553	HUMAN OTC DRUG	careone childrens allergy relief		Fluticasone Propionate	SPRAY, METERED	NASAL	20190823		ANDA	ANDA207957	American Sales Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41520-558_f21751a4-ce49-53ea-e053-2a95a90a1dff	41520-558	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171127		OTC MONOGRAPH FINAL	part358F	Foodhold USA	SALICYLIC ACID	40	mg/91			N	20241231
41520-561_8d2b194c-b04d-44e5-983b-6ae22847b4b5	41520-561	HUMAN OTC DRUG	CareOne Nighttime Severe Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20160411		OTC MONOGRAPH DRUG	M004	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-565_f217318a-b44b-8078-e053-2a95a90a2f24	41520-565	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Miconazole Athletes Foot Spray Talc Free	AEROSOL, POWDER	TOPICAL	20171020		OTC MONOGRAPH FINAL	part333C	Foodhold USA	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41520-566_f2171db7-f3c3-5416-e053-2a95a90ab151	41520-566	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray Talc Free	AEROSOL, SPRAY	TOPICAL	20171020		OTC MONOGRAPH FINAL	part333C	American Sales Company	MICONAZOLE NITRATE	1.3	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41520-568_f2170b3c-4cdb-29ab-e053-2a95a90a7b23	41520-568	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20171020		OTC MONOGRAPH FINAL	part358F	Foodhold USA	SALICYLIC ACID	.17	g/9mL			N	20241231
41520-569_f21704f8-9422-6e20-e053-2995a90ab1a1	41520-569	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20171020		OTC MONOGRAPH FINAL	part358B	Foodhold USA	SALICYLIC ACID	.17	mg/9.8g			N	20241231
41520-570_f2171733-5da7-6476-e053-2a95a90ae144	41520-570	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20171020		OTC MONOGRAPH FINAL	part358F	Foodhold USA	SALICYLIC ACID	40	mg/41			N	20241231
41520-582_f32ca617-66e6-41d8-e053-2a95a90ae40a	41520-582	HUMAN OTC DRUG	Care One	Maximum Strength	Fluoride	PASTE, DENTIFRICE	DENTAL	20130120		OTC MONOGRAPH NOT FINAL	part356	American Sales	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
41520-597_aaa60595-72a9-4371-874b-0c28e351eb4c	41520-597	HUMAN OTC DRUG	careone daytime nighttime severe cold and flu		acetaminophen, dextromethorphan HBr, doxylamine succinate, guaifenesin, phenylephrine HCl	KIT		20181001		OTC MONOGRAPH FINAL	part341	American Sales Company						N	20241231
41520-599_f49cf15f-553a-6fbd-e053-2a95a90a6bd8	41520-599	HUMAN OTC DRUG	Cold Multi-Symptom Nighttime		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110601	20241130	OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41520-603_ebdd7234-bfc4-2542-e053-2a95a90a466e	41520-603	HUMAN OTC DRUG	Cold Head Congestion Daytime		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20110901		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-604_eda004ed-3640-4e9a-9926-2eedccda65b3	41520-604	HUMAN OTC DRUG	care one ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20040413		ANDA	ANDA072096	American Sales Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-606_7e4240f8-d044-e59c-e053-2a91aa0af918	41520-606	HUMAN OTC DRUG	PAIN RELIEF	Regular Strength	Acetaminophen	TABLET	ORAL	20100801		OTC MONOGRAPH NOT FINAL	part343	AMERICAN SALES COMPANY	ACETAMINOPHEN	325	mg/1			N	20241231
41520-612_7bb3b2ce-5245-4225-9e45-98f1707d518f	41520-612	HUMAN OTC DRUG	CareOne Allergy Relief	24 Hour	Loratadine	TABLET	ORAL	20060602		ANDA	ANDA076301	American Sales Company	LORATADINE	10	mg/1			N	20241231
41520-615_469a5fb7-ea86-4d53-a5a4-3d85c13f9509	41520-615	HUMAN OTC DRUG	CareOne Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20160411		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-616_23802cdc-7a89-4009-af85-8ad1f1a3046d	41520-616	HUMAN OTC DRUG	careone miconazole 1		Miconazole nitrate	KIT		20200115		ANDA	ANDA079114	American Sales Company						N	20241231
41520-617_83f8d173-af41-4b1e-ae32-3762b62377fb	41520-617	HUMAN OTC DRUG	CareOne Acid Reducer Complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20161004		ANDA	ANDA077355	American Sales Company	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41520-624_d7102585-422e-48d8-889b-a7c3a325601d	41520-624	HUMAN OTC DRUG	careone childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-627_0a980bad-ae11-a2ce-e063-6394a90a5f98	41520-627	HUMAN OTC DRUG	4x Medicated Toothache and Gum Gel		Benzocaine	GEL	ORAL	20231120		OTC MONOGRAPH DRUG	M017	American Sales	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .5; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
41520-631_4e23d4ba-3c89-45b5-a635-d4a78e17da92	41520-631	HUMAN OTC DRUG	Senna laxative	Regular Strength	Sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH DRUG	M007	Care One (American Sales Company)	SENNOSIDES	8.6	mg/1			N	20241231
41520-632_fdbc59cc-7454-486c-9412-96cb37f7a2aa	41520-632	HUMAN OTC DRUG	CareOne Childrens Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20160412		OTC MONOGRAPH FINAL	part341	American Sales Company	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-633_7749876b-a057-49ad-b48e-36041657dfb3	41520-633	HUMAN OTC DRUG	careone childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190708		ANDA	ANDA076359	American Sales Company	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-634_189bed6a-f1b8-4448-8d28-d2ec75a1a29b	41520-634	HUMAN OTC DRUG	CareOne Nighttime Sleep Aid		Doxylamine succinate	TABLET	ORAL	20160506		ANDA	ANDA040167	American Sales Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
41520-636_05bd87e9-0e7a-4340-b518-3e495ba8d3d0	41520-636	HUMAN OTC DRUG	CareOne Tussin DM	cough plus chest congestion	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20160805		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-647_b289b1e3-854c-4d4e-b97d-16bdc5b1084c	41520-647	HUMAN OTC DRUG	care one ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20040413		ANDA	ANDA072096	American Sales Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-657_36e1d29f-857d-4baa-917d-ab7ae21c55f7	41520-657	HUMAN OTC DRUG	Care One Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20040301		OTC MONOGRAPH FINAL	part332	American Sales Company	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
41520-660_bb9cb0af-884c-4855-87c7-ca9ed68dab7f	41520-660	HUMAN OTC DRUG	care one ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20040504		ANDA	ANDA074937	American Sales Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-679_9df0c4c2-f045-4f25-878e-4d55a99b8df4	41520-679	HUMAN OTC DRUG	careone triple antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, Pramoxine Hydrochloride	OINTMENT	TOPICAL	20190926		OTC MONOGRAPH FINAL	part333B	American Sales Company	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
41520-684_0001bc58-144b-4216-8c95-f669a06ae34e	41520-684	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20171231	20240430	OTC MONOGRAPH NOT FINAL	part334	Care One (American Sales Company)	DOCUSATE SODIUM	100	mg/1			N	
41520-685_a7ab73c2-f902-4645-877c-222486373633	41520-685	HUMAN OTC DRUG	Care One ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20080801		ANDA	ANDA074937	American Sales Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-690_97b97293-a628-42c1-a843-3c820221899e	41520-690	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	American Sales Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
41520-701_e1e056f5-68b5-43fc-b469-f6e130a9aec2	41520-701	HUMAN OTC DRUG	careone nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060307		ANDA	ANDA077007	American Sales Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-702_367d0ffa-a7c5-4f6a-9140-83dd1e3b12d6	41520-702	HUMAN OTC DRUG	CareOne Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210122		ANDA	ANDA074661	American Sales Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-703_d476709d-e51e-456f-a141-ea837d72da92	41520-703	HUMAN OTC DRUG	CareOne Allergy Relief		Fluticasone propionate	SPRAY, METERED	NASAL	20160823		ANDA	ANDA207957	American Sales Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
41520-704_b7af203c-8046-42e8-8b4c-786bdae7c982	41520-704	HUMAN OTC DRUG	Childrens Plus Multi Symptom Cold		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	SUSPENSION	ORAL	20151031		OTC MONOGRAPH DRUG	M012	Care One (American Sales Company)	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-707_b7c2f253-ace9-4f31-9bfa-5bb5a21f83d5	41520-707	HUMAN OTC DRUG	CareOne Acid Relief		Famotidine	TABLET, FILM COATED	ORAL	20160922		ANDA	ANDA077351	American Sales Company	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41520-708_5c92de1e-9494-42be-a0b8-0fbc67341209	41520-708	HUMAN OTC DRUG	careone stay awake		Caffeine	TABLET	ORAL	20190201		OTC MONOGRAPH FINAL	part340	American Sales Company	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
41520-709_01c8fdd3-abff-4831-971e-a1f743cf6c4c	41520-709	HUMAN OTC DRUG	CareOne Infants Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20161214		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-711_5348e407-1f4e-4f06-bc9a-315095e88d42	41520-711	HUMAN OTC DRUG	careone nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20171113		ANDA	ANDA206394	American Sales Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-712_823f759b-6ba7-48fe-a9d1-8eb6baaf655f	41520-712	HUMAN OTC DRUG	CareOne Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20160415		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-713_f8f580a4-aa4d-4214-841a-aab0eeb96427	41520-713	HUMAN OTC DRUG	Careone daytime severe cold and flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20160524		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-714_e1d27e0d-e2e2-4239-a731-3ac132457b18	41520-714	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20161128		OTC MONOGRAPH FINAL	part352	American Sales Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.3; 101; 50.5; 101	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41520-715_ee2f07ef-66a7-476e-b4e5-ed887992bf9e	41520-715	HUMAN OTC DRUG	CareOne Allergy Relief		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210803		ANDA	ANDA207235	American Sales Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-716_567de4c6-c106-4597-9e1a-f43fbb1592d6	41520-716	HUMAN OTC DRUG	careone childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20190716		ANDA	ANDA210033	American Sales Company	LORATADINE	5	mg/1			N	20241231
41520-722_f32cb6ce-193c-7e0e-e053-2a95a90a0827	41520-722	HUMAN OTC DRUG	Care One Restore and Defend	Sensitive Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190211		OTC MONOGRAPH NOT FINAL	part356	Foodhold U.S.A.	STANNOUS FLUORIDE	.454	g/100g			N	20241231
41520-724_f32cc999-16dc-0bcb-e053-2a95a90a05b8	41520-724	HUMAN OTC DRUG	Natures Promise	Childrens Fluoride Strawberry	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20190211		OTC MONOGRAPH FINAL	part355	Foodhold U.S.A.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
41520-727_3e714d4c-b8e6-4e56-b3f0-7b5c770be0ba	41520-727	HUMAN OTC DRUG	careone esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170926		ANDA	ANDA207193	American Sales Company	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41520-729_5968018b-332a-4a27-84e8-acf65561cde6	41520-729	HUMAN OTC DRUG	CareOne Fast Acting Nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20161130		OTC MONOGRAPH FINAL	part341	American Sales Company	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-731_6f2f767f-fc84-4ac1-86fc-e27f3d46819b	41520-731	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20181231		ANDA	ANDA207342	Care One (American Sales Company)	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41520-732_72cc5e09-dd68-4158-935a-4fa739235045	41520-732	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20181231		ANDA	ANDA207342	Care One (American Sales Company)	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
41520-734_7e2a17fe-318d-4755-b48b-4d5bb1576288	41520-734	HUMAN OTC DRUG	CareOne Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130628		ANDA	ANDA203690	American Sales Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-741_6bca60f3-07a8-4ac0-85f7-1ecb70702a19	41520-741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180430		ANDA	ANDA207235	Care One (American Sales Company)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-745_2790ee9d-7db5-427c-ad2b-394dfaa55f9f	41520-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180430		ANDA	ANDA206568	Care One (American Sales Company)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-748_7aaea604-bfe6-43ec-bb8f-3ee11f20b9fe	41520-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	Care One (American Sales Company)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-767_3cbd17c0-6e94-4d97-aafa-4da2ca0ea4ec	41520-767	HUMAN OTC DRUG	CareOne Diarrhea Control		loperamide HCl	SUSPENSION	ORAL	20160920		ANDA	ANDA091292	American Sales Company	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41520-769_fc3f3509-0928-4acc-a0ec-9781a8f0a2df	41520-769	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	American Sales Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41520-772_a842d24a-824b-472f-8818-faf631126c13	41520-772	HUMAN OTC DRUG	CareOne Diarrhea and Gas Control		loperamide hydrochloride, simethicone	TABLET	ORAL	20190131		ANDA	ANDA209837	American Sales Company	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
41520-773_16ff0de7-bdbe-4d87-b2b7-88a9c4e9ee41	41520-773	HUMAN OTC DRUG	CareOne Severe Cold		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20160407		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-774_ebca4f41-8123-f322-e053-2a95a90ab007	41520-774	HUMAN OTC DRUG	Pressure and Pain and Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160801	20240930	OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
41520-778_b11d89b9-05eb-4e2a-a229-a292ffc0705c	41520-778	HUMAN OTC DRUG	careone allergy relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20170921		OTC MONOGRAPH FINAL	part341	American Sales Company	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-779_dc1e485b-8ddf-4f7b-a340-784bc0f24abe	41520-779	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180930	20241227	OTC MONOGRAPH NOT FINAL	part334	Care One (American Sales Company)	DOCUSATE SODIUM	100	mg/1			N	
41520-781_0fafab9b-e0ba-4012-afa8-67e566e8509c	41520-781	HUMAN OTC DRUG	CareOne Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20160929		ANDA	ANDA078336	American Sales Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-786_16f56d19-dba7-40ff-a9f9-67cc5105d5cf	41520-786	HUMAN OTC DRUG	careone acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20171221		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	500	mg/1			N	20241231
41520-788_35cb0cc5-004a-434a-91a4-e8cfc051cae2	41520-788	HUMAN OTC DRUG	CareOne arthritis pain relief		diclofenac sodium	GEL	TOPICAL	20201029		ANDA	ANDA211253	American Sales Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-789_aecbd15e-641a-492c-873d-826e31dd4ceb	41520-789	HUMAN OTC DRUG	careone lidocaine pain relief		lidocaine	PATCH	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part348	American Sales Company	LIDOCAINE	560	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
41520-790_d106316e-dcdd-08a5-e053-2a95a90a1e08	41520-790	HUMAN OTC DRUG	CareOne Maximum Strength Redness Relief		Glycerin, and Naphazoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20170518		OTC MONOGRAPH FINAL	part349	FOODHOLD U.S.A., LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.0025; .00015	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
41520-792_0f559acc-44c4-404f-ac46-ce7ce100b7e7	41520-792	HUMAN OTC DRUG	CareOne nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20171113		ANDA	ANDA076775	American Sales Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-800_1cafe826-be65-4216-a706-a99e865c51a7	41520-800	HUMAN OTC DRUG	CareOne Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20160408		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-802_21cb7078-eccd-43a9-a81a-ce46a69a8e84	41520-802	HUMAN OTC DRUG	careone omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20210311		NDA	NDA022032	American Sales Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41520-806_b152519f-0778-484d-b34a-ec5f52f5c939	41520-806	HUMAN OTC DRUG	CareOne sinus relief day time sinus relief night time		acetaminophen, guaifenesin, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20191008		OTC MONOGRAPH FINAL	part341	American Sales Company						N	20241231
41520-809_04111956-ec9a-62a1-e063-6294a90af2fd	41520-809	HUMAN OTC DRUG	Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20110408		OTC MONOGRAPH NOT FINAL	part333A	Foodhold U.S.A. LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
41520-813_dfcbb976-d2e0-4ee9-b071-f7d09d40df84	41520-813	HUMAN OTC DRUG	CareOne Diarrhea Control		Loperamide HCl	TABLET, FILM COATED	ORAL	20160914		ANDA	ANDA075232	American Sales Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41520-816_bb353f94-c96a-4322-bc2e-b2f652ca5b0a	41520-816	HUMAN OTC DRUG	CareOne Acid Reducer		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20161014		ANDA	ANDA202319	American Sales Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41520-818_7b8b8af1-7a23-4b70-a522-2c6e07bc4481	41520-818	HUMAN OTC DRUG	CareOne Infants Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20161214		OTC MONOGRAPH NOT FINAL	part343	American Sales Company	ACETAMINOPHEN	160	mg/5mL			N	20241231
41520-822_6fd08458-e905-4ea3-b70f-81054d8cbe84	41520-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20150324		OTC MONOGRAPH FINAL	part346	FOODHOLD U.S.A., LLC	WITCH HAZEL	979	mg/mL			N	20241231
41520-825_dd6f9159-8c07-49f6-a043-99222a327cba	41520-825	HUMAN OTC DRUG	Careone miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20190529		ANDA	ANDA074760	American Sales Company	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
41520-826_954fe703-9a10-4354-8b71-4d98a22a0b9f	41520-826	HUMAN OTC DRUG	careone tussin dm		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20181022		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-831_0f60cb21-8931-4f02-943f-4fc3d23f6545	41520-831	HUMAN OTC DRUG	CareOne Cold and Sinus		Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	20161020		OTC MONOGRAPH FINAL	part341	American Sales Company	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-833_d1219a27-94cc-4b35-8eb5-cd5659cdcdd8	41520-833	HUMAN OTC DRUG	CareOne Childrens Cold and Flu		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SUSPENSION	ORAL	20180801		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-835_368fea31-2b31-48cd-90b0-9cf996aeefe2	41520-835	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20180930	20241227	OTC MONOGRAPH FINAL	part338	Care One (American Sales Company)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
41520-839_2ce12594-fd7d-4fef-91b4-238f775a4fc9	41520-839	HUMAN OTC DRUG	CareOne Childrens Mucus Relief		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20140805		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-841_ab98e470-5785-4aaf-8aef-91d8d18ccccc	41520-841	HUMAN OTC DRUG	CareOne Diarrhea Control		Loperamide Hydrochloride	SUSPENSION	ORAL	20161123		ANDA	ANDA091292	American Sales Company	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
41520-843_896b3313-3469-4892-baf2-fb15d2cf3252	41520-843	HUMAN OTC DRUG	careone nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170929		ANDA	ANDA206393	American Sales Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-854_8e410015-fc80-4eb0-b30f-55f0fa753d32	41520-854	HUMAN OTC DRUG	Care One Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20080725		ANDA	ANDA078546	American Sales Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-858_e9197d76-647f-4118-8f60-318c6f8c24b7	41520-858	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate,Otisalate, Octocrylene	SPRAY	TOPICAL	20201028		OTC MONOGRAPH FINAL	part352	American Sales Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
41520-861_b07f66ac-c675-4191-8a2b-809d717f2042	41520-861	HUMAN OTC DRUG	careone daytime severe cold and cough		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20190805		OTC MONOGRAPH DRUG	M012	American Sales Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-866_f2cf9769-33ff-4d74-bfbe-a44979783b2d	41520-866	HUMAN OTC DRUG	care one lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070829		OTC MONOGRAPH FINAL	part358G	American Sales Company	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
41520-872_697806d9-7ded-4fd4-9b7e-6f5c6e54e553	41520-872	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20161130	20251130	OTC MONOGRAPH FINAL	part341	Care One (American Sales Company)						N	
41520-873_cb9f3baa-5250-4a13-ae9e-f8dc8a44c771	41520-873	HUMAN OTC DRUG	care one nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060307		ANDA	ANDA077007	American Sales Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-881_211ce678-77c0-48dc-8aff-33bc59311856	41520-881	HUMAN OTC DRUG	CareOne Nasal and Sinus Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20170925		OTC MONOGRAPH FINAL	part341	American Sales Company	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41520-891_3b528dc7-0033-4e8a-b913-7d14a7416b98	41520-891	HUMAN OTC DRUG	careone nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20171113		ANDA	ANDA076789	American Sales Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-894_56c4900b-2985-4afd-8d4d-2a9a7346ba05	41520-894	HUMAN OTC DRUG	careone complete kit lice		piperonyl butoxide, pyrethrum extract	KIT		20190126		OTC MONOGRAPH FINAL	part358G	American Sales Company						N	20241231
41520-897_c8ce1637-f151-4bce-84ac-6b14122f0a28	41520-897	HUMAN OTC DRUG	care one ibuprofen		Ibuprofen	SUSPENSION	ORAL	20040428		ANDA	ANDA074937	American Sales Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-901_6e86c968-a2ed-49c7-bb6a-2777627444f1	41520-901	HUMAN OTC DRUG	CareOne Acid Reducer		Famotidine	TABLET, FILM COATED	ORAL	20161004		ANDA	ANDA075400	American Sales Company	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
41520-902_d2628e81-5c0b-4b38-a92e-39452159202a	41520-902	HUMAN OTC DRUG	careone childrens allergy relief		Cetirizine HCl	SOLUTION	ORAL	20160623		ANDA	ANDA204226	American Sales Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-903_8849f4b9-484d-4f05-9c3b-93488fb8c1e8	41520-903	HUMAN OTC DRUG	careone tussin		Dextromethorphan Hydrobromide	SOLUTION	ORAL	20180208		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-905_8e73bd58-3068-411e-8c1e-98422373f568	41520-905	HUMAN OTC DRUG	CAREONE Extra Strength	Assorted Fruits	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190419		OTC MONOGRAPH FINAL	part331	FOODHOLD USA	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
41520-907_059234f3-5665-4a0d-8e42-1edff4910a32	41520-907	HUMAN OTC DRUG	CAREONE		Psyllium Husk	CAPSULE	ORAL	20190416		OTC MONOGRAPH NOT FINAL	part334	FOODHOLD USA	PSYLLIUM HUSK	.52	g/1			N	20241231
41520-913_9b827ae5-8c6c-46ea-89ab-d76dda3f0ed7	41520-913	HUMAN OTC DRUG	CareOne Triacting Night Time Cold and Cough	Childrens	Diphenhydramine HCl, Phenylephrine HCl	SOLUTION	ORAL	20090605		OTC MONOGRAPH FINAL	part341	American Sales Company	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-915_bfe9e274-24ba-4952-9f23-baffc40055b9	41520-915	HUMAN OTC DRUG	care one omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080229		NDA	NDA022032	American Sales Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41520-916_b1e11f62-0ed9-462b-8a9e-33b15e4e4b22	41520-916	HUMAN OTC DRUG	care one miconazole 1		Miconazole nitrate	KIT		20101119		ANDA	ANDA079114	American Sales Company						N	20241231
41520-918_996412b6-45c9-4f7b-b4b9-b34edad77557	41520-918	HUMAN OTC DRUG	careone allergy and congestion relief		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190307		ANDA	ANDA076050	American Sales Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
41520-919_f8fcbb38-fe9a-4a34-ab0f-6c17bef18275	41520-919	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	FOODHOLD U.S.A., LLC	ACETAMINOPHEN	500	mg/1			N	20241231
41520-929_e32f10a5-ee8e-5c60-e053-2a95a90ac53e	41520-929	HUMAN OTC DRUG	Soft Tip Neti Pot Sinus wash	CareOne	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		FOODHOLD U.S.A.						N	20241231
41520-931_0590cd98-baa3-40bd-b631-5fe636c0af3e	41520-931	HUMAN OTC DRUG	careone tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180920		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-937_76c9e270-34e9-4790-aea6-3730f3e98560	41520-937	HUMAN OTC DRUG	CareOne Tussin CF	Multi Symptom Cold	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20160805		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-938_e32f10a5-ee8d-5c60-e053-2a95a90ac53e	41520-938	HUMAN OTC DRUG	All natural Saline Packets	CareOne	SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20220108		UNAPPROVED DRUG OTHER		FOODHOLD U.S.A.	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
41520-939_76d47385-3b32-4995-98f4-484390ddd83a	41520-939	HUMAN OTC DRUG	careone omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180302		NDA	NDA209400	American Sales Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
41520-940_bc5acc60-f076-425f-9e19-9ee4f3b17538	41520-940	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190708		OTC MONOGRAPH FINAL	part352	American Sales Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
41520-943_db0db9be-08e8-4d54-8240-bf4c44f980a7	41520-943	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190228		ANDA	ANDA206568	Care One (American Sales Company)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
41520-947_95fc3982-b737-408f-b202-c34e11c67c8f	41520-947	HUMAN OTC DRUG	careone childrens multi symptom fever and cold		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SUSPENSION	ORAL	20180928		OTC MONOGRAPH FINAL	part341	American Sales Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-948_1a09ab01-efa3-4f96-b5ae-8e09f8c2a1bb	41520-948	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20141120		OTC MONOGRAPH FINAL	part333D	American Sales Company	SALICYLIC ACID	20	mg/mL			N	20241231
41520-949_81024d70-dda9-4aed-af97-de991e37b527	41520-949	HUMAN OTC DRUG	careone milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20120826		OTC MONOGRAPH NOT FINAL	part334	American Sales Company	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
41520-956_2f1de390-e711-40b8-8a1c-ca7e4ef63ec6	41520-956	HUMAN OTC DRUG	Acetaminophen PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	FOODHOLD U.S.A., LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-957_2f975f2a-9842-47a6-9fa7-03241c550644	41520-957	HUMAN OTC DRUG	CareOne Mini Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20130622		ANDA	ANDA203690	American Sales Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
41520-958_0b878421-e230-465d-bfd1-88bbe810149c	41520-958	HUMAN OTC DRUG	CareOne Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20130823		ANDA	ANDA091135	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-970_1fe501ee-b5aa-454f-b14c-2263686a3487	41520-970	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20151122		OTC MONOGRAPH NOT FINAL	part333A	Foodhold U.S.A. LLC	ALCOHOL	70	mL/100mL			N	20241231
41520-982_83ad6ce4-31cb-4966-8c60-3ac21edb0d47	41520-982	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20161003		OTC MONOGRAPH NOT FINAL	part343	FOODHOLD U.S.A., LLC	ACETAMINOPHEN	325	mg/1			N	20241231
41520-983_a94ce89b-b818-40a5-89eb-7bd4fda8feff	41520-983	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20161005		OTC MONOGRAPH FINAL	part332	FOODHOLD U.S.A., LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
41520-984_475e9b36-1c9f-4b6e-8433-9b003aefc9eb	41520-984	HUMAN OTC DRUG	COLD FLU and SORE THROAT RELIEF		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20161005		OTC MONOGRAPH FINAL	part341	FOODHOLD U.S.A., LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-985_fdc57c2b-b3d6-4bf2-aa9a-2eedef98d767	41520-985	HUMAN OTC DRUG	Severe sinus Congestion Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20161006		OTC MONOGRAPH FINAL	part341	FOODHOLD U.S.A., LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-986_bcce3646-e505-4324-bd93-2a85f3554b5b	41520-986	HUMAN OTC DRUG	TUSSIN DM		dextromethorphan hydrobromide, guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20161002		OTC MONOGRAPH FINAL	part341	FOODHOLD U.S.A., LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-987_07260d84-e644-4aaa-ab39-c6509720cc36	41520-987	HUMAN OTC DRUG	CareOne Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060907		OTC MONOGRAPH FINAL	part341	American Sales Company	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
41520-995_6f34b8f1-8723-49ce-8542-69ce0e219c6e	41520-995	HUMAN OTC DRUG	CareOne NightTime Cough		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20040518		OTC MONOGRAPH FINAL	part341	American Sales Company	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
41520-996_9c3b81eb-78de-4a39-a127-7875ee49d6e4	41520-996	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20161003		OTC MONOGRAPH FINAL	part341	FOODHOLD U.S.A., LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
41520-997_ba83fb48-bec5-4389-aa21-cd26230366bf	41520-997	HUMAN OTC DRUG	careone day severe cold night cold and flu		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl, doxylamine succinate	KIT		20170825		OTC MONOGRAPH FINAL	part341	American Sales Company						N	20241231
41595-5509_ca02d6a3-8e04-909a-e053-2a95a90a31c2	41595-5509	HUMAN OTC DRUG	Sure Invisible Solid Unscented		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20091222		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	19	g/100g			N	20241231
41595-5510_ca02d6a3-8e09-909a-e053-2a95a90a31c2	41595-5510	HUMAN OTC DRUG	Sure Invisible Solid Regular		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20091222		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	19	g/100g			N	20241231
41595-5512_ca02d6a3-8e07-909a-e053-2a95a90a31c2	41595-5512	HUMAN OTC DRUG	Sure Invisible Solid Powder Scent		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20091222		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	19	g/100g			N	20241231
41595-5513_ca02d161-ffbf-b6dd-e053-2995a90a4ccb	41595-5513	HUMAN OTC DRUG	Sure Original Solid Unscented		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20091222		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	16	g/100g			N	20241231
41595-5514_ca02d161-ffc0-b6dd-e053-2995a90a4ccb	41595-5514	HUMAN OTC DRUG	Sure Original Solid Regular		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20091222		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	16	g/100g			N	20241231
41595-5516_ca02d6a3-8e08-909a-e053-2a95a90a31c2	41595-5516	HUMAN OTC DRUG	Sure Original Solid Powder		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20091222		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	16	g/100g			N	20241231
41595-5517_f2b354b4-2a9b-6c41-e053-2a95a90a7891	41595-5517	HUMAN OTC DRUG	Sure Antiperspirant Deodorant Unscented		Aluminum Chlorohydrate	AEROSOL	TOPICAL	20080201		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM CHLOROHYDRATE	10	g/100g			N	20241231
41595-5518_f2b34728-3e46-0c1d-e053-2995a90a4f0e	41595-5518	HUMAN OTC DRUG	Sure Antiperspirant Deodorant Regular		Aluminum Chlorohydrate	AEROSOL	TOPICAL	20080201		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM CHLOROHYDRATE	10	g/100g			N	20241231
41595-5545_ca02d6a3-8e05-909a-e053-2a95a90a31c2	41595-5545	HUMAN OTC DRUG	Sure Invisible Solid Fresh and Cool		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20150101		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	19	g/100g			N	20241231
41595-5546_ca02d6a3-8e06-909a-e053-2a95a90a31c2	41595-5546	HUMAN OTC DRUG	Sure Original Solid Fresh and Cool		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20150101		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	16	g/100g			N	20241231
41595-5547_ca02d161-ffc1-b6dd-e053-2995a90a4ccb	41595-5547	HUMAN OTC DRUG	Sure Invisible Solid Nourishing Coconut		Aluminum Zirconium Tricholorohydrex GLY	STICK	TOPICAL	20190101		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	19	g/100g			N	20241231
41595-7014_ca02f5c8-6590-6124-e053-2995a90a0e05	41595-7014	HUMAN OTC DRUG	Brut Classic Anti-perspirant and Deodorant		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20101204		OTC MONOGRAPH FINAL	part350	Idelle Labs, Ltd	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
42007-0001_0ce46076-c2e9-251d-e063-6294a90a3d36	42007-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070917		UNAPPROVED MEDICAL GAS		Memorial Health System of East Texas dba Memorial Medical Center East Texas	OXYGEN	99	L/100L			N	20241231
42023-104_d8054592-defc-4aa5-9392-700090b9fb20	42023-104	HUMAN PRESCRIPTION DRUG	Aplisol		Tuberculin Purified Protein Derivative	INJECTION	INTRADERMAL	20080425		BLA	BLA103782	Par Pharmaceutical, Inc.	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	5	[iU]/.1mL	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
42023-105_6f36157b-6fae-4428-80b7-aee3842d21c6	42023-105	HUMAN PRESCRIPTION DRUG	Brevital Sodium		methohexital sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; RECTAL	20071101		NDA	NDA011559	Par Pharmaceutical, Inc.	METHOHEXITAL SODIUM	500	mg/1	Barbiturate [EPC], Barbiturates [CS]	CIV	N	20241231
42023-107_267f327e-917a-4d07-ab24-3c0ac7e514b9	42023-107	HUMAN PRESCRIPTION DRUG	Coly-Mycin	M	colistimethate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20071101		NDA	NDA050108	Par Pharmaceutical, Inc.	COLISTIMETHATE SODIUM	150	mg/2mL	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
42023-110_132be116-35a8-467c-8e9e-da721c2bcf0d	42023-110	HUMAN PRESCRIPTION DRUG	Delestrogen		estradiol valerate	INJECTION	INTRAMUSCULAR	20071101		NDA	NDA009402	Par Pharmaceutical, Inc.	ESTRADIOL VALERATE	10	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
42023-111_132be116-35a8-467c-8e9e-da721c2bcf0d	42023-111	HUMAN PRESCRIPTION DRUG	Delestrogen		estradiol valerate	INJECTION	INTRAMUSCULAR	20071101		NDA	NDA009402	Par Pharmaceutical, Inc.	ESTRADIOL VALERATE	20	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
42023-112_132be116-35a8-467c-8e9e-da721c2bcf0d	42023-112	HUMAN PRESCRIPTION DRUG	Delestrogen		estradiol valerate	INJECTION	INTRAMUSCULAR	20071101		NDA	NDA009402	Par Pharmaceutical, Inc.	ESTRADIOL VALERATE	40	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
42023-113_fb6a37cf-a12a-4c27-a2f8-e53017b7463a	42023-113	HUMAN PRESCRIPTION DRUG	Ketalar		ketamine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20071001		NDA	NDA016812	Par Pharmaceutical, Inc.	KETAMINE HYDROCHLORIDE	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
42023-114_fb6a37cf-a12a-4c27-a2f8-e53017b7463a	42023-114	HUMAN PRESCRIPTION DRUG	Ketalar		ketamine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20071001		NDA	NDA016812	Par Pharmaceutical, Inc.	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
42023-115_fb6a37cf-a12a-4c27-a2f8-e53017b7463a	42023-115	HUMAN PRESCRIPTION DRUG	Ketalar		ketamine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20071001		NDA	NDA016812	Par Pharmaceutical, Inc.	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
42023-116_cc3946a1-6045-43f8-bf0a-0f70e75a6c45	42023-116	HUMAN PRESCRIPTION DRUG	Pitocin		oxytocin	INJECTION	INTRAVENOUS	20231222		NDA	NDA018261	Par Pharmaceutical, Inc.	OXYTOCIN	10	[iU]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
42023-116_f86dd8cd-42e4-49b1-a759-de36d7e6e7e0	42023-116	HUMAN PRESCRIPTION DRUG	Pitocin		oxytocin	INJECTION	INTRAVENOUS	20080201		NDA	NDA018261	Par Pharmaceutical, Inc.	OXYTOCIN	10	[iU]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
42023-119_91f69d60-ed08-4cb0-a1b9-0847b2a9cd4c	42023-119	HUMAN PRESCRIPTION DRUG	Tigan		trimethobenzamide hydrochloride	INJECTION	INTRAMUSCULAR	20080801		NDA	NDA017530	Par Pharmaceutical, Inc.	TRIMETHOBENZAMIDE HYDROCHLORIDE	100	mg/mL	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
42023-123_44e02603-a1bb-439b-9b74-aa90bab5f472	42023-123	HUMAN PRESCRIPTION DRUG	Dantrium		dantrolene sodium	INJECTION	INTRAVENOUS	20090420		NDA	NDA018264	Par Pharmaceutical, Inc.	DANTROLENE SODIUM	20	mg/60mL	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
42023-124_ae3211d2-bff5-47ba-a683-331c32499f62	42023-124	HUMAN PRESCRIPTION DRUG	Dantrium		dantrolene sodium	CAPSULE	ORAL	20080801		NDA	NDA017443	Par Pharmaceutical, Inc.	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
42023-129_2add7ee3-68c2-4892-bf30-c00ef0693c91	42023-129	HUMAN PRESCRIPTION DRUG	Fluphenazine Decanoate		Fluphenazine Decanoate	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20180626		ANDA	ANDA203732	Par Pharmaceutical, Inc.	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
42023-129_8d5cc273-483c-4ba5-9e21-966578a0685c	42023-129	HUMAN PRESCRIPTION DRUG	Fluphenazine Decanoate		Fluphenazine Decanoate	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20140709		ANDA	ANDA203732	Par Pharmaceutical, Inc.	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
42023-130_f817f0ea-b84a-4f8d-b124-5241d244e247	42023-130	HUMAN PRESCRIPTION DRUG	Pitocin		oxytocin	INJECTION	INTRAVENOUS	20180501		NDA	NDA018261	Par Pharmaceutical, Inc.	OXYTOCIN	10	[iU]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
42023-146_ead5df8e-ba7b-4950-a358-76f555393965	42023-146	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140819		ANDA	ANDA203972	Par Pharmaceutical, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
42023-157_2121f7a3-6ecc-49c6-8a83-8ea5c09f792c	42023-157	HUMAN PRESCRIPTION DRUG	ETHACRYNATE SODIUM		ethacrynate sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20150730		ANDA	ANDA205473	Par Pharmaceutical, Inc.	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42023-157_e4271deb-64c5-4253-9303-d77952117df4	42023-157	HUMAN PRESCRIPTION DRUG	ETHACRYNATE SODIUM		ethacrynate sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160923		ANDA	ANDA205473	Par Pharmaceutical, Inc.	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42023-159_04a5b794-1e6d-4aa6-856c-7a8a9e159eed	42023-159	HUMAN PRESCRIPTION DRUG	Adrenalin		epinephrine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20130701		NDA	NDA204200	Par Pharmaceutical, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-164_0b559b32-e602-4316-8b52-f31fd0308c41	42023-164	HUMAN PRESCRIPTION DRUG	Vasostrict		Vasopressin	INJECTION	INTRAVENOUS	20221205		NDA	NDA204485	Par Pharmaceutical, Inc.	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
42023-164_a77d5136-3c3a-43ef-a80a-849fae5153a5	42023-164	HUMAN PRESCRIPTION DRUG	Vasostrict		Vasopressin	INJECTION	INTRAVENOUS	20141112		NDA	NDA204485	Par Pharmaceutical, Inc.	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
42023-168_04a5b794-1e6d-4aa6-856c-7a8a9e159eed	42023-168	HUMAN PRESCRIPTION DRUG	Adrenalin		epinephrine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20140301		NDA	NDA204640	Par Pharmaceutical, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-168_432969a5-c96f-4856-a95e-11247c2844c2	42023-168	HUMAN PRESCRIPTION DRUG	Adrenalin		epinephrine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20201204		NDA	NDA204640	Par Pharmaceutical, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-168_d27f3f17-c524-4e26-bb91-b3c2d08e6928	42023-168	HUMAN PRESCRIPTION DRUG	Adrenalin		epinephrine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20201204		NDA	NDA204640	Par Pharmaceutical, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-172_7122aeae-3183-48d2-90f2-5746ff7ca758	42023-172	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161028		ANDA	ANDA203575	Par Pharmaceutical, Inc.	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
42023-173_c78764e1-e468-4108-9d9b-2a719991fe72	42023-173	HUMAN PRESCRIPTION DRUG	Ganciclovir		Ganciclovir	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161206		ANDA	ANDA204950	Par Pharmaceutical, Inc.	GANCICLOVIR SODIUM	500	mg/10mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
42023-179_b134ed1d-b62e-4c37-857e-0378a0e1fcec	42023-179	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride		Buprenorphine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20150730		ANDA	ANDA206586	Par Pharmaceutical, Inc.	BUPRENORPHINE HYDROCHLORIDE	.324	mg/mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42023-182_5855a956-6af5-4072-8df3-4e6cdbbd44b7	42023-182	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION	INTRAVENOUS	20150601		ANDA	ANDA091665	Par Pharmaceutical, Inc.	ARGATROBAN	250	mg/2.5mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
42023-182_cc7c27e1-b4af-463d-a25b-0fbfa260d4b4	42023-182	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION	INTRAVENOUS	20150601		ANDA	ANDA091665	Par Pharmaceutical, Inc.	ARGATROBAN	250	mg/2.5mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
42023-186_ead5df8e-ba7b-4950-a358-76f555393965	42023-186	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201204		ANDA	ANDA208266	Par Pharmaceutical, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
42023-187_ead5df8e-ba7b-4950-a358-76f555393965	42023-187	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201204		ANDA	ANDA208266	Par Pharmaceutical, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
42023-188_800b16d2-741b-478e-9b0d-684931766c8d	42023-188	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20170426		ANDA	ANDA208405	Par Pharmaceutical, Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
42023-189_800b16d2-741b-478e-9b0d-684931766c8d	42023-189	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20170426		ANDA	ANDA208405	Par Pharmaceutical, Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
42023-190_a77d5136-3c3a-43ef-a80a-849fae5153a5	42023-190	HUMAN PRESCRIPTION DRUG	Vasostrict		Vasopressin	INJECTION	INTRAVENOUS	20170227		NDA	NDA204485	Par Pharmaceutical, Inc.	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
42023-195_06b2d1a6-72b8-4427-9a2b-6c4f74d2f5bd	42023-195	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	INJECTION	INTRAVENOUS	20230101		ANDA	ANDA208768	Par Pharmaceutical, Inc.	POSACONAZOLE	18	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
42023-196_aa6213f5-e549-4e42-a795-b791de8353b7	42023-196	HUMAN PRESCRIPTION DRUG	Corphedra		Ephedrine Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20170216		NDA	NDA208943	Par Pharmaceutical, Inc.	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-201_2b645c05-9276-4be2-805b-cf3a2a57b093	42023-201	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Par Pharmaceutical Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
42023-202_2b645c05-9276-4be2-805b-cf3a2a57b093	42023-202	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Par Pharmaceutical Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	200	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
42023-203_2b645c05-9276-4be2-805b-cf3a2a57b093	42023-203	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Par Pharmaceutical Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	500	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
42023-205_ce709efb-6b26-444c-8493-b6bc9f0b3fda	42023-205	HUMAN PRESCRIPTION DRUG	Calcitonin Salmon		Calcitonin Salmon	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20211110		ANDA	ANDA209358	Par Pharmaceutical, Inc.	CALCITONIN SALMON	200	[iU]/mL	Calcitonin [CS], Calcitonin [EPC]		N	20241231
42023-206_1798515a-9b6d-4718-b259-8f893c14b904	42023-206	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190925		ANDA	ANDA209382	Par Pharmaceutical, Inc.	TREPROSTINIL	1	mg/mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
42023-207_1798515a-9b6d-4718-b259-8f893c14b904	42023-207	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190925		ANDA	ANDA209382	Par Pharmaceutical, Inc.	TREPROSTINIL	2.5	mg/mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
42023-208_1798515a-9b6d-4718-b259-8f893c14b904	42023-208	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190925		ANDA	ANDA209382	Par Pharmaceutical, Inc.	TREPROSTINIL	5	mg/mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
42023-209_1798515a-9b6d-4718-b259-8f893c14b904	42023-209	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190925		ANDA	ANDA209382	Par Pharmaceutical, Inc.	TREPROSTINIL	10	mg/mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
42023-214_44f8368d-7235-48f3-b4fc-97dd7ddfa36c	42023-214	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20190717		ANDA	ANDA210025	Par Pharmaceutical, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
42023-215_44f8368d-7235-48f3-b4fc-97dd7ddfa36c	42023-215	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20190717		ANDA	ANDA210025	Par Pharmaceutical, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
42023-216_453fc694-09d2-4f04-9883-6f81eccf3656	42023-216	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20170216		NDA	NDA208943	Par Pharmaceutical, Inc.	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-216_6df5e5f1-6375-45ff-9905-f19927e92ee2	42023-216	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20180626		NDA	NDA208943	Par Pharmaceutical, Inc.	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-219_a77d5136-3c3a-43ef-a80a-849fae5153a5	42023-219	HUMAN PRESCRIPTION DRUG	Vasostrict		Vasopressin	INJECTION	INTRAVENOUS	20211215		NDA	NDA204485	Par Pharmaceutical, Inc.	VASOPRESSIN, UNSPECIFIED	.4	[USP'U]/mL			N	20241231
42023-221_8deb2b20-fee2-4134-80f8-b12eac47bae6	42023-221	HUMAN PRESCRIPTION DRUG	ERTAPENEM		ertapenem sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181101		NDA	NDA021337	Par Pharmaceutical Inc.	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
42023-229_d1ed890c-2d2e-4e45-bb19-cd0929a17e0b	42023-229	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210801		NDA	NDA212156	Par Pharmaceutical, Inc.	MICAFUNGIN SODIUM	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
42023-230_d1ed890c-2d2e-4e45-bb19-cd0929a17e0b	42023-230	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210801		NDA	NDA212156	Par Pharmaceutical, Inc.	MICAFUNGIN SODIUM	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
42023-233_aa6213f5-e549-4e42-a795-b791de8353b7	42023-233	HUMAN PRESCRIPTION DRUG	Corphedra		ephedrine sulfate	INJECTION, SOLUTION	INTRAVENOUS	20190118		NDA	NDA208943	Par Pharmaceutical, Inc.	EPHEDRINE SULFATE	500	mg/10mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-237_a77d5136-3c3a-43ef-a80a-849fae5153a5	42023-237	HUMAN PRESCRIPTION DRUG	Vasostrict		Vasopressin	INJECTION	INTRAVENOUS	20211215		NDA	NDA204485	Par Pharmaceutical, Inc.	VASOPRESSIN, UNSPECIFIED	.2	[USP'U]/mL			N	20241231
42023-238_d5577a8b-6d4c-45d2-9eec-1c9df9a461f0	42023-238	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE ACETATE		METHYLPREDNISOLONE ACETATE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMENINGEAL; SOFT TISSUE	20231102		ANDA	ANDA214297	Par Pharmaceutical, Inc.	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42023-239_d5577a8b-6d4c-45d2-9eec-1c9df9a461f0	42023-239	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE ACETATE		METHYLPREDNISOLONE ACETATE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20230512		ANDA	ANDA214297	Par Pharmaceutical, Inc.	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42023-240_d5577a8b-6d4c-45d2-9eec-1c9df9a461f0	42023-240	HUMAN PRESCRIPTION DRUG	Methylprednisolone Acetate		Methylprednisolone Acetate	INJECTION, SUSPENSION	INTRA-ARTERIAL; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20220630		ANDA	ANDA214297	Par Pharmaceutical, Inc.	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42023-243_ff906bee-e4eb-4800-b67d-8b0125beb7dd	42023-243	HUMAN PRESCRIPTION DRUG	EPHEDRINE SULFATE		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20210131		NDA	NDA213994	Par Pharmaceutical, Inc.	EPHEDRINE SULFATE	5	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-244_5f789662-c814-425c-b520-eb96f8ee2547	42023-244	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		Doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231101		ANDA	ANDA216690	Par Pharmaceutical, Inc.	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42023-253_ff906bee-e4eb-4800-b67d-8b0125beb7dd	42023-253	HUMAN PRESCRIPTION DRUG	EPHEDRINE SULFATE		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20220531		NDA	NDA213994	Par Pharmaceutical, Inc.	EPHEDRINE SULFATE	5	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42023-269_dd8ad38f-247b-4948-a13c-8f3a4921b4f1	42023-269	HUMAN PRESCRIPTION DRUG	PREVDUO		neostigmine methylsulfate and glycopyrrolate	INJECTION	INTRAVENOUS	20230515		NDA	NDA216903	PAR PHARMACEUTICAL, INC.	GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE	.2; 1	mg/mL; mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
42023-622_795a02e6-0e33-4b66-8c68-0782006bcf1e	42023-622	HUMAN PRESCRIPTION DRUG	Bivalirudin		Bivalirudin	INJECTION, SOLUTION	INTRAVENOUS	20230619		NDA	NDA211215	Par Pharmaceutical, Inc.	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
42068-001_07612f65-6238-5254-e063-6294a90ae02f	42068-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19730101		NDA	NDA205767	Jackson Welding Supply Co Inc.	OXYGEN	990	mL/L			N	20241231
42068-002_0761707a-69e5-8c1f-e063-6294a90a4d78	42068-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19730101		NDA	NDA205766	Jackson Welding Supply Co Inc.	NITROGEN	990	mL/L			N	20241231
42126-5200_b0439dd7-d670-4783-b794-721a157b9c44	42126-5200	HUMAN OTC DRUG	VISCO SHIELD	Lubricant	HYPROMELLOSE 2208 (15000 MPA.S)	SOLUTION/ DROPS	OPHTHALMIC	20140616		OTC MONOGRAPH FINAL	part349	OASIS Medical, Inc.	HYPROMELLOSE 2208 (15000 MPA.S)	17	mg/mL			N	20241231
42126-6100_1ef317c1-aad4-4b95-ac9e-14fde3028135	42126-6100	HUMAN OTC DRUG	OASIS Tears	Preservative-Free Lubricant Eye	Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20071101		OTC MONOGRAPH FINAL	part349	OASIS Medical, Inc.	GLYCERIN	.22	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
42126-6200_d2abd14a-25f3-40d1-b0eb-3678164c9e9e	42126-6200	HUMAN OTC DRUG	OASIS Tears Plus	Preservative-Free Lubricant Eye	Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20071101		OTC MONOGRAPH FINAL	part349	OASIS Medical, Inc.	GLYCERIN	.22	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
42126-6310_fdbf7d44-f8a3-4109-a9b2-3ee48b78b9df	42126-6310	HUMAN OTC DRUG	OASIS Tears	Lubricant Eye	Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20100109		OTC MONOGRAPH FINAL	part349	OASIS Medical, Inc.	GLYCERIN	2	g/1000mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
42126-6400_2b3a4d03-7ab0-4c66-80e0-b2611d2be0f9	42126-6400	HUMAN OTC DRUG	Oasis Tears PF	Preservative-Free Lubricant Eye	Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20150101		OTC MONOGRAPH FINAL	part349	OASIS Medical, Inc.	GLYCERIN	.25	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
42126-6500_df0ae8bb-543d-4681-823f-9a9c4ae90537	42126-6500	HUMAN OTC DRUG	Oasis TEARS PF PLUS	Preservative-Free Lubricant Eye	Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20210610		OTC MONOGRAPH FINAL	part349	OASIS Medical, Inc.	GLYCERIN	.25	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
42139-001_5201ea4b-9d9d-46e6-b978-4f59005d7667	42139-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19880101		NDA	NDA205767	Seaboard Welding Supply, Inc.	OXYGEN	99	L/100L			N	20241231
42192-104_0e76cbc6-8cf0-7dc8-e063-6294a90a815a	42192-104	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE and SULFUR	Wash	SODIUM SULFACETAMIDE and SULFUR	LIQUID	TOPICAL	20080604		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 10	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-112_d31c5bdb-a299-4263-8734-b612c062c953	42192-112	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	AEROSOL, FOAM	TOPICAL	20091112		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SALICYLIC ACID	6	g/100g			N	20251231
42192-115_776e46fc-8639-4780-af33-6afcdf818078	42192-115	HUMAN PRESCRIPTION DRUG	UREA HYDRATING TOPICAL		UREA	AEROSOL, FOAM	TOPICAL	20100521		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals	UREA	35	g/100g			N	20251231
42192-121_5f0c9397-a5f3-44d6-933e-10eda34274c2	42192-121	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE - SULFUR WASH		SODIUM SULFACETAMIDE, SULFUR	LIQUID	TOPICAL	20100916		UNAPPROVED DRUG OTHER		ACELLA PHARMACEUTICALS	SULFACETAMIDE; SULFUR	90; 40	mg/473.2mL; mg/473.2mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-129_49b06fdb-fd90-439d-b6a9-0a7c2a5951d1	42192-129	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE		SODIUM SULFACETAMIDE	LIQUID	TOPICAL	20110104		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-130_916862d9-9f2b-4646-9b3d-73ddae6b8a80	42192-130	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	AEROSOL, FOAM	TOPICAL	20110517		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SALICYLIC ACID	6	g/100g			N	20251231
42192-133_888fce7d-dc47-4d1b-9c39-9dfcaa051607	42192-133	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide and Sulfur		Sodium Sulfacetamide and Sulfur	SOLUTION	TOPICAL	20110513		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	80; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-134_82acb5c3-24e6-4417-808c-74ad6003e76d	42192-134	HUMAN PRESCRIPTION DRUG	Salicylic Acid		SALICYLIC ACID	GEL	TOPICAL	20110519		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SALICYLIC ACID	60	mg/g			N	20251231
42192-135_56e0544c-2352-4ee3-8a07-2936853ae97f	42192-135	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	LIQUID	TOPICAL	20111010		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SALICYLIC ACID	275	mg/mL			N	20251231
42192-136_679caef9-ee89-4c41-abfb-1987997729fc	42192-136	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10 Sulfur 5 Cleanser		Sulfacetamide Sodium and Sulfur	RINSE	TOPICAL	20120420		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	10; 5	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-139_db2b5db3-6b73-4292-874e-d1893b647429	42192-139	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		Sodium Sulfacetamide and Sulfur	CREAM	TOPICAL	20140611		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-143_104e24cf-eaf6-4d5e-827f-9251eb1e80c1	42192-143	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10% and Sulfur 5% Emollient Foam		Sulfacetamide Sodium and Sulfur	AEROSOL, FOAM	TOPICAL	20130416		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	10; 5	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-143_f8795341-2217-414c-a184-aec6432f2d3d	42192-143	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10% and Sulfur 5% Emollient Foam		Sulfacetamide Sodium and Sulfur	AEROSOL, FOAM	TOPICAL	20130618		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	10; 5	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-149_db2b5db3-6b73-4292-874e-d1893b647429	42192-149	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		Sodium Sulfacetamide and Sulfur	CREAM	TOPICAL	20140814		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20251231
42192-301_5c66f0de-f322-4042-b46f-84dfeacd21cb	42192-301	HUMAN PRESCRIPTION DRUG	BP Vit 3		folic acid, pyridoxine hydrochloride, cyanocobalamin, omega-3 fatty acids, doconexent, icosapent and .beta.-sitosterol	CAPSULE, COATED	ORAL	20090417		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	.BETA.-SITOSTEROL; CYANOCOBALAMIN; DOCONEXENT; FOLIC ACID; ICOSAPENT; OMEGA-3 FATTY ACIDS; PYRIDOXINE HYDROCHLORIDE	200; 500; 350; 1; 35; 500; 12.5	mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC]		N	20241231
42192-327_29661365-3cc9-4004-aa9f-976f5b97fdec	42192-327	HUMAN PRESCRIPTION DRUG	NP Thyroid 15		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20161116		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	LEVOTHYROXINE; LIOTHYRONINE	9.5; 2.25	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
42192-328_39b36c1b-bf2a-4889-9e01-f4fe86932eda	42192-328	HUMAN PRESCRIPTION DRUG	NP Thyroid 120		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20170612		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	LEVOTHYROXINE; LIOTHYRONINE	76; 18	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
42192-329_9f92a5fe-81ab-4f2e-80c3-0f0477ad42fa	42192-329	HUMAN PRESCRIPTION DRUG	NP Thyroid 30		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20110114		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	LEVOTHYROXINE; LIOTHYRONINE	19; 4.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
42192-330_ee291a98-f2b1-4329-8aae-93e7b0d67377	42192-330	HUMAN PRESCRIPTION DRUG	NP Thyroid 60		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20101111		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	LEVOTHYROXINE; LIOTHYRONINE	38; 9	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
42192-331_017fba91-92e4-4099-b9b6-67ecbc438f97	42192-331	HUMAN PRESCRIPTION DRUG	NP Thyroid 90		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20110203		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	LEVOTHYROXINE; LIOTHYRONINE	57; 13.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
42192-338_703427a9-aa68-4bca-9a94-3667c10fe790	42192-338	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate ODT		hyoscyamine sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20110519		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
42192-339_6f951a48-eb5c-40e9-b4c4-cca001d04942	42192-339	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate SL		hyoscyamine sulfate	TABLET	SUBLINGUAL	20110519		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
42192-340_681781aa-be59-40bc-99d8-944c610ebea5	42192-340	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate TAB		hyoscyamine sulfate	TABLET	ORAL	20110519		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
42192-374_2ab60950-553c-45c4-830a-03b60d9d7768	42192-374	HUMAN PRESCRIPTION DRUG	Nicotinamide		Nicotinamide	TABLET	ORAL	20210525		UNAPPROVED DRUG OTHER		Acella Pharmaceuticals, LLC	CHROMIUM; COPPER; FOLIC ACID; NIACINAMIDE; SELENIUM; ZINC	100; 2; 850; 750; 50; 27	ug/1; mg/1; ug/1; mg/1; ug/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
42192-501_075da728-77cd-4464-e063-6294a90ac0c7	42192-501	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20200821		ANDA	ANDA210664	Acella Pharmaceuticals, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42192-607_075d5bfb-bb2e-9971-e063-6294a90a2e5b	42192-607	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	SYRUP	ORAL	20160921		ANDA	ANDA203375	Acella Pharmaceuticals, LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
42192-608_075d80dd-02b5-0502-e063-6294a90a8983	42192-608	HUMAN PRESCRIPTION DRUG	Gabapentin		gabapentin	SOLUTION	ORAL	20121001		ANDA	ANDA076403	Acella Pharmaceuticals, LLC	GABAPENTIN	250	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42192-614_a6e2c6d9-fd28-4276-a578-976aba15cbf0	42192-614	HUMAN PRESCRIPTION DRUG	PHENYTOIN SODIUM		PHENYTOIN SODIUM	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211201		ANDA	ANDA040573	Acella Pharmaceuticals, LLC	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42192-617_06182aae-3281-4c5f-903a-7b30323c9ac7	42192-617	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210802		ANDA	ANDA091310	Acella Pharmaceuticals, LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20251231
42192-618_06182aae-3281-4c5f-903a-7b30323c9ac7	42192-618	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210802		ANDA	ANDA091310	Acella Pharmaceuticals, LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20251231
42192-619_6ea7034b-9615-40be-a9f9-c79d15103a0f	42192-619	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	SUSPENSION	ORAL	20201112		NDA AUTHORIZED GENERIC	NDA018965	Acella Pharmaceuticals, LLC	NAPROXEN	125	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42192-623_1e41b45c-f1c4-4007-ac32-fa62055184b0	42192-623	HUMAN PRESCRIPTION DRUG	levonorgestrel and ethinyl estradiol		levonorgestrel and ethinyl estradiol	KIT		20230821		NDA	NDA208612	Acella Pharmaceuticals						N	20241231
42192-626_074b1af6-991d-d376-e063-6394a90a26c7	42192-626	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		pyridostigmine bromide	SOLUTION	ORAL	20231009		ANDA	ANDA212405	Acella Pharmaceuticals, LLC	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
42195-128_f3baab1f-2f36-4a61-e053-2995a90a75ee	42195-128	HUMAN PRESCRIPTION DRUG	Ciprofloxacin and Fluocinolone Acetonide		ciprofloxacin and fluocinolone acetonide	SOLUTION	AURICULAR (OTIC)	20211004		NDA AUTHORIZED GENERIC	NDA208251	Xspire Pharma, LLC	CIPROFLOXACIN; FLUOCINOLONE ACETONIDE	.75; .0625	mg/.25mL; mg/.25mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
42195-308_079cb594-ac07-14e3-e063-6394a90aeb77	42195-308	HUMAN PRESCRIPTION DRUG	Nalfon		fenoprofen calcium	CAPSULE	ORAL	20120827		NDA	NDA017604	Xspire Pharma	FENOPROFEN CALCIUM	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42195-471_079e140a-b3a2-1c2e-e063-6394a90a8491	42195-471	HUMAN PRESCRIPTION DRUG	Fenoprofen Calcium		Fenoprofen Calcium	TABLET, FILM COATED	ORAL	20180212		ANDA	ANDA072267	Xspire Pharma, Llc	FENOPROFEN CALCIUM	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42195-600_079cb594-ac07-14e3-e063-6394a90aeb77	42195-600	HUMAN PRESCRIPTION DRUG	Nalfon		fenoprofen calcium	CAPSULE	ORAL	20120827		NDA	NDA017604	Xspire Pharma	FENOPROFEN CALCIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42195-688_079e260a-4bee-a423-e063-6394a90aaf0d	42195-688	HUMAN PRESCRIPTION DRUG	NALFON		Fenoprofen Calcium	TABLET, FILM COATED	ORAL	20180924		ANDA	ANDA072267	Xspire Pharma, LLC	FENOPROFEN CALCIUM	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42199-006_0b3e6b1d-3644-3f2c-e063-6394a90a25a1	42199-006	HUMAN OTC DRUG	Pearl White		Potassium nitrate, Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20170612	20261127	OTC MONOGRAPH DRUG	M022	Beyond International Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1	mg/g; mg/g			N	
42199-008_0b3eaa83-c1b4-6390-e063-6394a90ae1cc	42199-008	HUMAN OTC DRUG	Beyond Activated Coconut Charcoal and Sea Salt		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20211110	20261115	OTC MONOGRAPH DRUG	M021	Beyond International Inc	SODIUM FLUORIDE	.24	g/100g			N	
42213-370_f1b26eb5-bf86-1d24-e053-2a95a90a2f15	42213-370	HUMAN OTC DRUG	Advanced Hydrocortisone		hydrocortisone	CREAM	TOPICAL	20110405	20240701	OTC MONOGRAPH NOT FINAL	part348	Ultra Seal Corporation	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
42227-081_696969cf-1588-4eec-9874-7de096db04dd	42227-081	PLASMA DERIVATIVE	Cinryze		HUMAN C1-ESTERASE INHIBITOR	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20081201		BLA	BLA125267	Takeda Pharmaceuticals America, Inc.	HUMAN C1-ESTERASE INHIBITOR	500	[iU]/5mL	Decreased Vascular Permeability [PE], Human C1 Esterase Inhibitor [EPC], Kallikrein Inhibitors [MoA]		N	20241231
42227-083_696969cf-1588-4eec-9874-7de096db04dd	42227-083	PLASMA DERIVATIVE	Cinryze		HUMAN C1-ESTERASE INHIBITOR	KIT		20210115		BLA	BLA125267	Takeda Pharmaceuticals America, Inc.						N	20241231
42239-001_0aac7935-6b23-773e-e063-6394a90a8f3f	42239-001	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20231114		ANDA	ANDA214272	Abon Pharmaceuticals, LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
42241-001_080231bc-1a3e-ce09-e063-6294a90a5db4	42241-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20111101		NDA	NDA205767	- INDUSTRIAL WELDING SUPPLY CO. OF HARVEY, INC.	OXYGEN	995	mL/L			N	20241231
42241-002_08024afc-622c-fcf5-e063-6294a90afbf2	42241-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20111101		NDA	NDA205766	INDUSTRIAL WELDING SUPPLY CO. OF HARVEY, INC.	NITROGEN	995	mL/L			N	20241231
42241-003_0802489a-380f-cc8b-e063-6294a90a9b4e	42241-003	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20181217		NDA	NDA205767	- INDUSTRIAL WELDING SUPPLY CO. OF HARVEY, INC.	OXYGEN	235	mL/L			N	20241231
42281-001_f53988dc-9b5b-7c21-e053-2a95a90a1042	42281-001	HUMAN OTC DRUG	Belli Acne Control Spot Treatment		SULFUR	CREAM	TOPICAL	20120102		OTC MONOGRAPH FINAL	M006	BODY HALO LLC	SULFUR	30	mg/mL			N	20241231
42281-003_f5398b6a-a37b-4918-e053-2a95a90a3c52	42281-003	HUMAN OTC DRUG	Belli Pure Radiance Facial Sunscreen Tinted Protection SPF 25		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20130722		OTC MONOGRAPH FINAL	M020	BODY HALO LLC	TITANIUM DIOXIDE; ZINC OXIDE	70; 50	mg/mL; mg/mL			N	20241231
42291-009_0b384ccf-385d-fcf1-e063-6294a90ae53a	42291-009	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20231128		ANDA	ANDA075389	AvKARE	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
42291-010_fa40a564-a57a-15c1-e053-6294a90ad8e9	42291-010	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20230426		ANDA	ANDA075047	AvKARE	ACEBUTOLOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42291-011_fe91543e-a7df-6399-e053-6394a90af5e5	42291-011	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20230620		ANDA	ANDA202239	AvKARE	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-012_fe91543e-a7df-6399-e053-6394a90af5e5	42291-012	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20230620		ANDA	ANDA202239	AvKARE	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-013_fe91543e-a7df-6399-e053-6394a90af5e5	42291-013	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20230620		ANDA	ANDA202239	AvKARE	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-014_fe91543e-a7df-6399-e053-6394a90af5e5	42291-014	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20230620		ANDA	ANDA202239	AvKARE	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-015_fe91543e-a7df-6399-e053-6394a90af5e5	42291-015	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20230620		ANDA	ANDA202239	AvKARE	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-016_f40b9197-32f6-fde9-e053-2995a90a11a3	42291-016	HUMAN PRESCRIPTION DRUG	ANASTROZOLE		ANASTROZOLE	TABLET	ORAL	20230206		ANDA	ANDA079220	AvKARE	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
42291-017_0e8b3503-2369-af12-e063-6294a90af0c0	42291-017	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20190115		ANDA	ANDA075677	AvKARE	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
42291-024_0e8b3606-7e08-af78-e063-6294a90afbd2	42291-024	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone	TABLET	ORAL	20190114		ANDA	ANDA208327	AvKARE	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20251231
42291-025_feb94e91-2c00-6f80-e053-6394a90a612d	42291-025	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20230622		ANDA	ANDA076846	AvKARE	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-026_feb94e91-2c00-6f80-e053-6394a90a612d	42291-026	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20230622		ANDA	ANDA076846	AvKARE	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-027_feb94e91-2c00-6f80-e053-6394a90a612d	42291-027	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20230622		ANDA	ANDA076846	AvKARE	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-028_0416b0c0-255f-5f9d-e063-6294a90a8aef	42291-028	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride Extended-Release		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230829		ANDA	ANDA215775	AvKARE	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
42291-029_0416b0c0-255f-5f9d-e063-6294a90a8aef	42291-029	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride Extended-Release		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230829		ANDA	ANDA215775	AvKARE	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
42291-030_0416b0c0-255f-5f9d-e063-6294a90a8aef	42291-030	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride Extended-Release		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230130		ANDA	ANDA215775	AvKARE	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
42291-031_0a334eb9-cad0-f213-e063-6394a90a46da	42291-031	HUMAN PRESCRIPTION DRUG	Dutasteride and Tamsulosin Hydrochloride		Dutasteride and Tamsulosin Hydrochloride Capsules	CAPSULE	ORAL	20231115		ANDA	ANDA202509	AvKARE	DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE	.5; .4	mg/1; mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA], Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
42291-045_0e2402a0-f3b8-8f5c-e063-6294a90af13c	42291-045	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20240104		ANDA	ANDA204598	AvKARE	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
42291-046_0bc72bd8-1f34-b01c-e063-6394a90a77ea	42291-046	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE, LIQUID FILLED	ORAL	20231205		ANDA	ANDA209525	AvKARE	ICOSAPENT ETHYL	1	g/1			N	20241231
42291-047_0a341d0e-791b-85dd-e063-6294a90a42cb	42291-047	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		CHLOROQUINE PHOSPHATE	TABLET	ORAL	20231115		ANDA	ANDA040516	AvKARE	CHLOROQUINE PHOSPHATE	500	mg/1	Antimalarial [EPC]		N	20241231
42291-053_0995fc87-8581-8c9f-e063-6294a90ad91f	42291-053	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20231107		ANDA	ANDA205002	AvKARE	FESOTERODINE FUMARATE	4	mg/1			N	20241231
42291-054_0995fc87-8581-8c9f-e063-6294a90ad91f	42291-054	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20231107		ANDA	ANDA205002	AvKARE	FESOTERODINE FUMARATE	8	mg/1			N	20241231
42291-055_0416b0c0-2568-5f9d-e063-6294a90a8aef	42291-055	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac sodium	SOLUTION	TOPICAL	20230829		ANDA	ANDA212506	AvKARE	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42291-062_fdb4c51c-f465-92f0-e053-6294a90a504b	42291-062	HUMAN PRESCRIPTION DRUG	Isradipine		Isradipine	CAPSULE	ORAL	20230609		ANDA	ANDA077317	AvKARE	ISRADIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42291-063_f93d89e5-5f0c-15d6-e053-6394a90a8eed	42291-063	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20230413		ANDA	ANDA074069	AvKARE	AZATHIOPRINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
42291-064_0e8b3994-a060-af6e-e063-6294a90a60ad	42291-064	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20220412		ANDA	ANDA079022	AvKARE	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
42291-065_0e8b3994-a060-af6e-e063-6294a90a60ad	42291-065	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20220412		ANDA	ANDA079022	AvKARE	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
42291-066_0e8b3994-a060-af6e-e063-6294a90a60ad	42291-066	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20220412		ANDA	ANDA079022	AvKARE	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
42291-067_0e8b3994-a060-af6e-e063-6294a90a60ad	42291-067	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20220412		ANDA	ANDA079022	AvKARE	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
42291-068_0e8b3994-a060-af6e-e063-6294a90a60ad	42291-068	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20220412		ANDA	ANDA079022	AvKARE	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
42291-069_0e8b3994-a060-af6e-e063-6294a90a60ad	42291-069	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20220412		ANDA	ANDA079022	AvKARE	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
42291-070_0e8b3994-a060-af6e-e063-6294a90a60ad	42291-070	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20220412		ANDA	ANDA079022	AvKARE	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
42291-071_0e8b3b35-1b50-28bb-e063-6394a90a640c	42291-071	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20220104		ANDA	ANDA074069	AvKARE	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20251231
42291-072_f9514270-d6dc-89ca-e053-6294a90ad3da	42291-072	HUMAN PRESCRIPTION DRUG	Bexarotene		Bexarotene	CAPSULE	ORAL	20230414		ANDA	ANDA210105	AvKARE	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
42291-073_0e8b3606-7e09-af78-e063-6294a90afbd2	42291-073	HUMAN PRESCRIPTION DRUG	ABIRATERONE ACETATE		ABIRATERONE	TABLET	ORAL	20210429		ANDA	ANDA208327	AvKARE	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20251231
42291-076_0e8b3994-a061-af6e-e063-6294a90a60ad	42291-076	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20200618		ANDA	ANDA211256	AvKARE	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
42291-077_ff958b19-2ce4-442a-e053-6294a90a66a0	42291-077	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	OINTMENT	TOPICAL	20200618		ANDA	ANDA209701	AvKARE	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42291-078_0e8b3503-236f-af12-e063-6294a90af0c0	42291-078	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20221004		ANDA	ANDA208831	AvKARE	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
42291-079_0e8b3503-236f-af12-e063-6294a90af0c0	42291-079	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20221004		ANDA	ANDA208831	AvKARE	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
42291-080_0e8b3503-236f-af12-e063-6294a90af0c0	42291-080	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20221004		ANDA	ANDA208831	AvKARE	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
42291-081_0e8b3503-236f-af12-e063-6294a90af0c0	42291-081	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20221004		ANDA	ANDA208831	AvKARE	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
42291-082_0e8b3994-a062-af6e-e063-6294a90a60ad	42291-082	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA210000	AvKARE	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
42291-083_0e8b3994-a062-af6e-e063-6294a90a60ad	42291-083	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA210001	AvKARE	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
42291-084_0e8b3503-2370-af12-e063-6294a90af0c0	42291-084	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA209999	AvKARE	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
42291-085_0e8b3606-7e0a-af78-e063-6294a90afbd2	42291-085	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA078058	AvKARE	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20251231
42291-089_0e8b488d-f5aa-3055-e063-6394a90a605b	42291-089	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	TABLET	ORAL	20170518		ANDA	ANDA205530	AvKARE	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20251231
42291-090_0e8b488d-f5aa-3055-e063-6394a90a605b	42291-090	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	TABLET	ORAL	20170518		ANDA	ANDA205530	AvKARE	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20251231
42291-091_0b501298-298f-ef70-e063-6294a90a941d	42291-091	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20231129		ANDA	ANDA091133	AvKARE	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
42291-092_0b501298-298f-ef70-e063-6294a90a941d	42291-092	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20231129		ANDA	ANDA091133	AvKARE	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
42291-093_ff952234-87d7-da18-e053-6394a90aea48	42291-093	HUMAN PRESCRIPTION DRUG	Albendazole	200 mg	Albendazole	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA210011	AvKARE	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
42291-094_0e8b3b37-c0f4-3297-e063-6394a90ae2b0	42291-094	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		Azelastine	SPRAY, METERED	NASAL	20210303		ANDA	ANDA204660	AvKARE	AZELASTINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
42291-116_0e8b3994-a065-af6e-e063-6294a90a60ad	42291-116	HUMAN PRESCRIPTION DRUG	Aspirin and Extended-Release Dipyridamole		Aspirin and Extended-Release Dipyridamole	CAPSULE	ORAL	20170427		ANDA	ANDA206392	AvKARE	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20251231
42291-125_ec18f623-779a-3c3b-e053-2a95a90a4cb1	42291-125	HUMAN PRESCRIPTION DRUG	Amantadine HCl		AMANTADINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20130807		ANDA	ANDA078720	AvKARE	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
42291-130_0e1016e2-301c-0bec-e063-6294a90a6c87	42291-130	HUMAN PRESCRIPTION DRUG	acarbose		acarbose	TABLET	ORAL	20131224		ANDA	ANDA091343	AvKARE	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20251231
42291-147_0e8b3994-a066-af6e-e063-6294a90a60ad	42291-147	HUMAN PRESCRIPTION DRUG	Colesevelam Hydrochloride		COLESEVELAM HYDROCHLORIDE	TABLET, COATED	ORAL	20180618		ANDA	ANDA091600	AvKARE	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20251231
42291-154_d57990ab-c7fd-985f-e053-2995a90ac88a	42291-154	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20200403		ANDA	ANDA077563	AvKARE	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
42291-155_0e8b488d-f5ab-3055-e063-6394a90a605b	42291-155	HUMAN PRESCRIPTION DRUG	Dexamethasone		dexamethasone	TABLET	ORAL	20220831		ANDA	ANDA088481	AvKARE	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
42291-181_0e8c5472-74f3-6f18-e063-6294a90a6c04	42291-181	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	CAPSULE	ORAL	20141124		ANDA	ANDA040885	AvKARE	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20251231
42291-182_0e8c132f-f957-71f9-e063-6394a90a7392	42291-182	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221116	20250331	ANDA	ANDA077284	AvKARE	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
42291-183_0e8c132f-f957-71f9-e063-6394a90a7392	42291-183	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221116	20250228	ANDA	ANDA077284	AvKARE	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
42291-208_0e8c522a-7694-54c7-e063-6294a90a7e9d	42291-208	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110811		ANDA	ANDA062713	AvKARE	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
42291-209_0e8c522a-7694-54c7-e063-6294a90a7e9d	42291-209	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110811		ANDA	ANDA062713	AvKARE	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
42291-230_0e1022cc-8c1d-137f-e063-6294a90aef45	42291-230	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20110317		ANDA	ANDA075185	AvKARE	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-231_0e1022cc-8c1d-137f-e063-6294a90aef45	42291-231	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20110317		ANDA	ANDA075185	AvKARE	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-232_e7b66265-bdbe-1480-e053-2995a90add60	42291-232	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20121214		ANDA	ANDA201089	AvKARE	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
42291-233_e7b66265-bdbe-1480-e053-2995a90add60	42291-233	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20121214		ANDA	ANDA201089	AvKARE	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
42291-258_0e8c58bf-d628-5974-e063-6294a90a1a99	42291-258	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150409		ANDA	ANDA075580	AvKARE	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
42291-259_0e8c58bf-d628-5974-e063-6294a90a1a99	42291-259	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150409		ANDA	ANDA075580	AvKARE	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
42291-260_0e8c58bf-d628-5974-e063-6294a90a1a99	42291-260	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150409		ANDA	ANDA075580	AvKARE	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
42291-261_0e8c5472-74f5-6f18-e063-6294a90a6c04	42291-261	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA206652	AvKARE	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
42291-262_0e8c5472-74f5-6f18-e063-6294a90a6c04	42291-262	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA206652	AvKARE	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
42291-266_d57a8c18-a85d-e5cb-e053-2995a90a1a90	42291-266	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20150723		ANDA	ANDA080704	AvKARE	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
42291-281_0e8c5b30-e8ce-8d66-e063-6394a90a40a6	42291-281	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20130918		ANDA	ANDA075805	AvKARE	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
42291-282_0e8c5b30-e8ce-8d66-e063-6394a90a40a6	42291-282	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20151116		ANDA	ANDA075805	AvKARE	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
42291-305_0e8c5472-74f6-6f18-e063-6294a90a6c04	42291-305	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20130708		ANDA	ANDA077270	AvKARE	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
42291-306_0e8c5472-74f6-6f18-e063-6294a90a6c04	42291-306	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20130708		ANDA	ANDA077270	AvKARE	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
42291-321_d57ac4cd-47bf-488b-e053-2995a90a7c62	42291-321	HUMAN PRESCRIPTION DRUG	HYDROXYUREA		Hydroxyurea	CAPSULE	ORAL	20130723		ANDA	ANDA075143	AvKARE	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
42291-324_0e8c5472-74f7-6f18-e063-6294a90a6c04	42291-324	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150709		ANDA	ANDA200881	AvKARE	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-325_0e8c5472-74f7-6f18-e063-6294a90a6c04	42291-325	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150709		ANDA	ANDA200881	AvKARE	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-326_0e8c5472-74f7-6f18-e063-6294a90a6c04	42291-326	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150709		ANDA	ANDA200881	AvKARE	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-327_0e8c5472-74f7-6f18-e063-6294a90a6c04	42291-327	HUMAN PRESCRIPTION DRUG	guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150709		ANDA	ANDA200881	AvKARE	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-350_0e8c31f4-3b30-7e77-e063-6394a90a053d	42291-350	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	20160607		ANDA	ANDA087946	AvKARE	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
42291-366_d57af4f3-6350-5f6c-e053-2995a90a15a4	42291-366	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130410		ANDA	ANDA079132	AvKARE	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
42291-367_d57af4f3-6350-5f6c-e053-2995a90a15a4	42291-367	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130410		ANDA	ANDA079132	AvKARE	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
42291-368_d57af4f3-6350-5f6c-e053-2995a90a15a4	42291-368	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130410		ANDA	ANDA079132	AvKARE	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
42291-369_d57af4f3-6350-5f6c-e053-2995a90a15a4	42291-369	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130410		ANDA	ANDA079132	AvKARE	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
42291-374_0e21feb3-6512-846c-e063-6394a90a4395	42291-374	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA090289	AvKARE	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20251231
42291-378_6e2d4b5b-0ef8-4a0a-9cdd-19e782ca092d	42291-378	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20130325		ANDA	ANDA086724	AvKARE, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42291-396_0e8c6a44-afd3-872c-e063-6394a90afb60	42291-396	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20170814		ANDA	ANDA076001	AvKARE	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-397_0e8c6a44-afd3-872c-e063-6394a90afb60	42291-397	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20170814		ANDA	ANDA076001	AvKARE	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-398_0e8c6a44-afd4-872c-e063-6394a90afb60	42291-398	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20170814		ANDA	ANDA075452	AvKARE	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-404_0e8c58bf-d62c-5974-e063-6294a90a1a99	42291-404	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20170105		ANDA	ANDA075419	AvKARE	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-405_0e8c58bf-d62c-5974-e063-6294a90a1a99	42291-405	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20170105		ANDA	ANDA075419	AvKARE	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-414_0e8c71af-826d-8309-e063-6294a90a4342	42291-414	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20210519		ANDA	ANDA077487	AvKARE	FAMCICLOVIR	125	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
42291-415_0e8c71af-826d-8309-e063-6294a90a4342	42291-415	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20210519		ANDA	ANDA077487	AvKARE	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
42291-416_0e8c71af-826d-8309-e063-6294a90a4342	42291-416	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20210519		ANDA	ANDA077487	AvKARE	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
42291-420_0e8fcbb3-196d-92c2-e063-6294a90a392b	42291-420	HUMAN PRESCRIPTION DRUG	LEFLUNOMIDE		LEFLUNOMIDE	TABLET	ORAL	20190613		ANDA	ANDA077090	AvKARE	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20251231
42291-421_0e8fcbb3-196d-92c2-e063-6294a90a392b	42291-421	HUMAN PRESCRIPTION DRUG	LEFLUNOMIDE		LEFLUNOMIDE	TABLET	ORAL	20190613		ANDA	ANDA077090	AvKARE	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20251231
42291-426_0e8fc3b1-2e7a-ac30-e063-6394a90ad8cb	42291-426	HUMAN PRESCRIPTION DRUG	Estradiol Vaginal		Estradiol	CREAM	VAGINAL	20210216		ANDA	ANDA210194	AvKARE	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
42291-427_f669f428-f21e-4cc6-e053-2995a90aa1d1	42291-427	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20230308		ANDA	ANDA207803	AvKARE	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42291-439_0e8fcbb3-196e-92c2-e063-6294a90a392b	42291-439	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA209721	AvKARE	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20251231
42291-443_0e8fa652-212f-4339-e063-6294a90abce6	42291-443	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200522		ANDA	ANDA207497	AvKARE	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
42291-444_0e8fa652-212f-4339-e063-6294a90abce6	42291-444	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200522		ANDA	ANDA207497	AvKARE	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
42291-445_0e8fa652-212f-4339-e063-6294a90abce6	42291-445	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200522		ANDA	ANDA207497	AvKARE	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
42291-446_0e8fa652-212f-4339-e063-6294a90abce6	42291-446	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200522		ANDA	ANDA207497	AvKARE	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
42291-447_0e8fa652-212f-4339-e063-6294a90abce6	42291-447	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200522		ANDA	ANDA207497	AvKARE	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
42291-448_0e8fa652-212f-4339-e063-6294a90abce6	42291-448	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200522		ANDA	ANDA207497	AvKARE	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
42291-453_0e8fc3b1-2e7b-ac30-e063-6394a90ad8cb	42291-453	HUMAN PRESCRIPTION DRUG	cilostazol		cilostazol	TABLET	ORAL	20220412		ANDA	ANDA077030	AvKARE	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20251231
42291-454_0e8fcbb3-196f-92c2-e063-6294a90a392b	42291-454	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, COATED	ORAL	20220303		ANDA	ANDA207842	AvKARE	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
42291-455_0e8fcbb3-196f-92c2-e063-6294a90a392b	42291-455	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, COATED	ORAL	20220303		ANDA	ANDA207842	AvKARE	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
42291-459_0e8fd624-fbe3-c134-e063-6294a90a01e2	42291-459	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20210727		ANDA	ANDA206125	AvKARE	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20251231
42291-460_0e8fd624-fbe3-c134-e063-6294a90a01e2	42291-460	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20210727		ANDA	ANDA206125	AvKARE	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20251231
42291-461_0e8fd624-fbe3-c134-e063-6294a90a01e2	42291-461	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20210727		ANDA	ANDA206125	AvKARE	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20251231
42291-466_0e8ff8ef-59bb-df59-e063-6394a90a9e20	42291-466	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20210406	20241031	ANDA	ANDA074260	AvKARE	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
42291-467_0e8ff8ef-59bb-df59-e063-6394a90a9e20	42291-467	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20210406		ANDA	ANDA074260	AvKARE	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20251231
42291-468_0e8ff8ef-59bc-df59-e063-6394a90a9e20	42291-468	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20220104		ANDA	ANDA076796	AvKARE	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
42291-469_0e8ff8ef-59bc-df59-e063-6394a90a9e20	42291-469	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20220104		ANDA	ANDA076796	AvKARE	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
42291-470_0e8ff8ef-59bc-df59-e063-6394a90a9e20	42291-470	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20220104		ANDA	ANDA076796	AvKARE	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
42291-473_0e8ff8ef-59bf-df59-e063-6394a90a9e20	42291-473	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20221004		ANDA	ANDA214196	AvKARE	ETRAVIRINE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
42291-474_0e8ff8ef-59bf-df59-e063-6394a90a9e20	42291-474	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20221004		ANDA	ANDA214196	AvKARE	ETRAVIRINE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
42291-475_f7a613ca-8beb-ef3f-e053-6294a90a14e7	42291-475	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20230104		ANDA	ANDA209450	AvKARE	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
42291-476_f7a613ca-8beb-ef3f-e053-6294a90a14e7	42291-476	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20230104		ANDA	ANDA209450	AvKARE	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
42291-477_0a4c88f4-8ca1-6c7e-e063-6294a90a3c52	42291-477	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20231116		ANDA	ANDA206463	AvKARE	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42291-478_05e172aa-e18b-427b-e063-6294a90ae22f	42291-478	HUMAN PRESCRIPTION DRUG	Etonogestrel and Ethinyl Estradiol Vaginal		Etonogestrel and Ethinyl Estradiol Vaginal	RING	VAGINAL	20230921		ANDA	ANDA211157	AvKARE	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
42291-490_07ff6c11-3e6c-460a-e063-6294a90a6ec0	42291-490	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	CAPSULE	ORAL	20231018		ANDA	ANDA212569	AvKARE	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42291-491_080468d8-d76a-42a9-e063-6394a90a5353	42291-491	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20231018		ANDA	ANDA212570	AvKARE	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42291-492_080468d8-d76a-42a9-e063-6394a90a5353	42291-492	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20231018		ANDA	ANDA212570	AvKARE	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42291-494_0e90167d-1655-f3d6-e063-6394a90a17b0	42291-494	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20220802		ANDA	ANDA076541	AvKARE	MIRTAZAPINE	7.5	mg/1			N	20251231
42291-495_41ad2641-b79e-45db-8b2d-33b216b27a27	42291-495	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20221101		ANDA	ANDA200675	AVKARE	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42291-496_0e90176c-f81d-f913-e063-6394a90a5813	42291-496	HUMAN PRESCRIPTION DRUG	Lithium Carbonate	ER	Lithium Carbonate	TABLET	ORAL	20220225		ANDA	ANDA091616	AvKARE	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20251231
42291-497_0a4ce29e-780b-cdb6-e063-6394a90a077d	42291-497	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220328		ANDA	ANDA078596	AvKARE	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42291-497_fa2ccb14-6b86-764a-e053-6394a90ac4db	42291-497	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA078596	AvKARE	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42291-498_fa2ccb14-6b86-764a-e053-6394a90ac4db	42291-498	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA078596	AvKARE	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42291-502_e78b20f5-bcbf-4619-e053-2995a90ab600	42291-502	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220831		ANDA	ANDA201845	AvKARE	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-503_e78b20f5-bcbf-4619-e053-2995a90ab600	42291-503	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220831		ANDA	ANDA201845	AvKARE	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-504_e78b20f5-bcbf-4619-e053-2995a90ab600	42291-504	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220831		ANDA	ANDA201845	AvKARE	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-505_0e901544-2f8b-ce0f-e063-6294a90ae5a1	42291-505	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20201005		ANDA	ANDA210040	AvKARE	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
42291-506_0e901a2b-811b-f79c-e063-6394a90aebc0	42291-506	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190621		NDA	NDA019123	AvKARE	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
42291-507_0e90176c-f81e-f913-e063-6394a90a5813	42291-507	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20190619		ANDA	ANDA074726	AvKARE	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
42291-509_f32cd8c4-d205-77c3-e053-2a95a90a387f	42291-509	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20220322		ANDA	ANDA040866	AvKARE	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42291-510_0e902405-2b11-fc76-e063-6394a90ad984	42291-510	HUMAN PRESCRIPTION DRUG	PRIMAQUINE PHOSPHATE		PRIMAQUINE PHOSPHATE	TABLET, FILM COATED	ORAL	20190221		ANDA	ANDA206043	AvKARE	PRIMAQUINE PHOSPHATE	15	mg/1	Antimalarial [EPC]		N	20251231
42291-511_f32cd8c4-d205-77c3-e053-2a95a90a387f	42291-511	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20220322		ANDA	ANDA040866	AvKARE	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42291-516_0e901a2b-811e-f79c-e063-6394a90aebc0	42291-516	HUMAN PRESCRIPTION DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET	ORAL	20171030		ANDA	ANDA078432	AvKARE	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-517_0e901a2b-811e-f79c-e063-6394a90aebc0	42291-517	HUMAN PRESCRIPTION DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET	ORAL	20171030		ANDA	ANDA078432	AvKARE	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-522_0e902405-2b12-fc76-e063-6394a90ad984	42291-522	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170516		ANDA	ANDA078703	AvKARE	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
42291-523_0e902405-2b12-fc76-e063-6394a90ad984	42291-523	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170516		ANDA	ANDA078703	AvKARE	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
42291-524_0e902405-2b12-fc76-e063-6394a90ad984	42291-524	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170516		ANDA	ANDA078703	AvKARE	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
42291-525_0e902405-2b12-fc76-e063-6394a90ad984	42291-525	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170516		ANDA	ANDA078703	AvKARE	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
42291-553_0e9917ff-3789-1cfe-e063-6294a90a7a6f	42291-553	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and ethinyl estradiol	KIT		20200420		ANDA	ANDA090794	AvKARE						N	20251231
42291-560_08a48083-e5fc-5bd7-e063-6394a90a0daa	42291-560	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20170505		ANDA	ANDA077746	AvKARE	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
42291-561_08a48083-e5fc-5bd7-e063-6394a90a0daa	42291-561	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20170505		ANDA	ANDA077746	AvKARE	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
42291-562_08a48083-e5fc-5bd7-e063-6394a90a0daa	42291-562	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20170505		ANDA	ANDA077746	AvKARE	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
42291-565_0e9925c8-d7f8-5cea-e063-6294a90a50a2	42291-565	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		norgestimate and ethinyl estradiol	KIT		20200420		ANDA	ANDA091232	AvKARE						N	20251231
42291-566_04c71fbf-f074-ae73-e063-6294a90a3221	42291-566	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20230907		ANDA	ANDA209373	AvKARE	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
42291-567_f7a7d52e-3c06-40ba-e053-6294a90af0ed	42291-567	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	FOR SUSPENSION	ORAL	20190826		ANDA	ANDA210186	AvKARE	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
42291-568_0e9921e5-8ee5-5fe0-e063-6294a90a8765	42291-568	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180724		ANDA	ANDA207515	AvKARE	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
42291-569_0e9921e5-8ee5-5fe0-e063-6294a90a8765	42291-569	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180724		ANDA	ANDA207515	AvKARE	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
42291-570_0e9921e5-8ee5-5fe0-e063-6294a90a8765	42291-570	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180724		ANDA	ANDA207515	AvKARE	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
42291-571_0e9921e5-8ee5-5fe0-e063-6294a90a8765	42291-571	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180724		ANDA	ANDA207515	AvKARE	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
42291-589_0e99334f-dd11-5853-e063-6294a90ad0f2	42291-589	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline	TABLET	ORAL	20150508		ANDA	ANDA065131	AvKARE	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
42291-590_0e992dcf-9566-1fe5-e063-6394a90a0d20	42291-590	HUMAN PRESCRIPTION DRUG	norgestimate and ethinyl estradiol		norgestimate and ethinyl estradiol	KIT		20200420		ANDA	ANDA090793	AvKARE						N	20251231
42291-591_0e99334f-dd11-5853-e063-6294a90ad0f2	42291-591	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline	TABLET	ORAL	20150508		ANDA	ANDA065131	AvKARE	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
42291-596_0e9921e5-8ee6-5fe0-e063-6294a90a8765	42291-596	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20141001		ANDA	ANDA070184	AvKARE	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20251231
42291-609_fe90e7c0-73d4-d7f7-e053-6294a90a8ea2	42291-609	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20120511		ANDA	ANDA201451	AvKARE	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
42291-618_089f9ac0-43ca-f649-e063-6294a90a76b9	42291-618	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	20130801		ANDA	ANDA072708	AvKARE	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
42291-619_089f9ac0-43ca-f649-e063-6294a90a76b9	42291-619	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	20130801		ANDA	ANDA072709	AvKARE	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
42291-622_f16017c8-7714-6c17-e053-2a95a90a6fcf	42291-622	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20130104		ANDA	ANDA200405	AvKARE	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
42291-623_f16017c8-7714-6c17-e053-2a95a90a6fcf	42291-623	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20130104		ANDA	ANDA200405	AvKARE	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
42291-624_fb5bb759-3d7d-6205-e053-6294a90aebe9	42291-624	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20130709		ANDA	ANDA074377	AvKARE	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
42291-625_fb5bb759-3d7d-6205-e053-6294a90aebe9	42291-625	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20130709		ANDA	ANDA074377	AvKARE	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
42291-626_fb5bb759-3d7d-6205-e053-6294a90aebe9	42291-626	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20130709		ANDA	ANDA074377	AvKARE	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
42291-628_0e99334f-dd12-5853-e063-6294a90ad0f2	42291-628	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20130926		ANDA	ANDA075927	AvKARE	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-632_0e9921e5-8ee7-5fe0-e063-6294a90a8765	42291-632	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20150326		ANDA	ANDA075274	AvKARE	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
42291-633_d57e53ae-531f-964e-e053-2a95a90a2e0f	42291-633	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160309		ANDA	ANDA078503	AvKARE	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
42291-634_d57e53ae-531f-964e-e053-2a95a90a2e0f	42291-634	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160309		ANDA	ANDA078503	AvKARE	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
42291-635_d57e53ae-531f-964e-e053-2a95a90a2e0f	42291-635	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160309		ANDA	ANDA078503	AvKARE	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
42291-650_0e992dcf-9567-1fe5-e063-6394a90a0d20	42291-650	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate		Norethindrone	TABLET	ORAL	20130618		ANDA	ANDA200275	AvKARE	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20251231
42291-651_0e99334f-dd13-5853-e063-6294a90ad0f2	42291-651	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	TABLET, FILM COATED	ORAL	20140120		ANDA	ANDA062506	AvKARE	NYSTATIN	500000	[USP'U]/1	Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
42291-652_0e9921e5-8eea-5fe0-e063-6294a90a8765	42291-652	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20140121		ANDA	ANDA202074	AvKARE	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 3	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-653_0e9921e5-8eea-5fe0-e063-6294a90a8765	42291-653	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20140121		ANDA	ANDA077528	AvKARE	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 6	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-654_0e9921e5-8eea-5fe0-e063-6294a90a8765	42291-654	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20140121		ANDA	ANDA077528	AvKARE	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 6	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-655_0e9921e5-8eea-5fe0-e063-6294a90a8765	42291-655	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20140121		ANDA	ANDA077528	AvKARE	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 12	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-656_0e9921e5-8eea-5fe0-e063-6294a90a8765	42291-656	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		Olanzapine and Fluoxetine	CAPSULE	ORAL	20140121		ANDA	ANDA077528	AvKARE	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 12	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
42291-657_0e9925c8-d7fa-5cea-e063-6294a90a50a2	42291-657	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20150507		ANDA	ANDA090973	AvKARE	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20251231
42291-664_0e99334f-dd16-5853-e063-6294a90ad0f2	42291-664	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir	CAPSULE	ORAL	20170808		ANDA	ANDA209093	AvKARE	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20251231
42291-665_052ace3f-bc7f-4936-e063-6394a90acd3b	42291-665	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20140630		ANDA	ANDA076056	AvKARE	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42291-666_0e99334f-dd16-5853-e063-6294a90ad0f2	42291-666	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir	CAPSULE	ORAL	20170808		ANDA	ANDA209093	AvKARE	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20251231
42291-667_052ace3f-bc7f-4936-e063-6394a90acd3b	42291-667	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20140630		ANDA	ANDA076056	AvKARE	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42291-668_052ace3f-bc7f-4936-e063-6394a90acd3b	42291-668	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20140630		ANDA	ANDA076056	AvKARE	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42291-669_052ace3f-bc7f-4936-e063-6394a90acd3b	42291-669	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20140630		ANDA	ANDA077793	AvKARE	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42291-674_0e99334f-dd18-5853-e063-6294a90ad0f2	42291-674	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20130627		ANDA	ANDA074131	AvKARE	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-677_0e99334f-dd18-5853-e063-6294a90ad0f2	42291-677	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20130627		ANDA	ANDA074131	AvKARE	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
42291-679_d57ed5a6-e031-4c8f-e053-2995a90a2bdb	42291-679	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20130305		ANDA	ANDA077419	AvKARE	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
42291-695_f26368af-0bbf-2cc9-e053-2a95a90a2e44	42291-695	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA077745	AvKARE	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-696_f26368af-0bbf-2cc9-e053-2a95a90a2e44	42291-696	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA077745	AvKARE	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-697_f26368af-0bbf-2cc9-e053-2a95a90a2e44	42291-697	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA077745	AvKARE	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-698_f26368af-0bbf-2cc9-e053-2a95a90a2e44	42291-698	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA077745	AvKARE	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-699_f26368af-0bbf-2cc9-e053-2a95a90a2e44	42291-699	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA077745	AvKARE	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-700_f26368af-0bbf-2cc9-e053-2a95a90a2e44	42291-700	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA077745	AvKARE	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-713_2b70539d-b409-4570-a189-4ad9880f4581	42291-713	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		Ropinirole Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130913		ANDA	ANDA090869	AvKARE	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
42291-714_2b70539d-b409-4570-a189-4ad9880f4581	42291-714	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		Ropinirole Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130913		ANDA	ANDA090869	AvKARE	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
42291-715_2b70539d-b409-4570-a189-4ad9880f4581	42291-715	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		Ropinirole Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130913		ANDA	ANDA090869	AvKARE	ROPINIROLE HYDROCHLORIDE	6	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
42291-716_2b70539d-b409-4570-a189-4ad9880f4581	42291-716	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		Ropinirole Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130913		ANDA	ANDA090869	AvKARE	ROPINIROLE HYDROCHLORIDE	8	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
42291-717_2b70539d-b409-4570-a189-4ad9880f4581	42291-717	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		Ropinirole Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130913		ANDA	ANDA090869	AvKARE	ROPINIROLE HYDROCHLORIDE	12	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
42291-727_d5bf9b4d-804d-6196-e053-2a95a90a55bc	42291-727	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200204		ANDA	ANDA040362	AvKARE	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42291-739_0e99218f-04ce-60b0-e063-6294a90afb7f	42291-739	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succiate	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA210281	AvKARE	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
42291-740_0e99218f-04ce-60b0-e063-6294a90afb7f	42291-740	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA210281	AvKARE	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
42291-741_0e993cb8-eccc-240d-e063-6394a90a98e4	42291-741	HUMAN PRESCRIPTION DRUG	Sodium Flouride		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190920		UNAPPROVED DRUG OTHER		AvKARE	SODIUM FLUORIDE	5	mg/mL			N	20251231
42291-746_0e99468f-d948-951e-e063-6294a90a62d3	42291-746	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180529		ANDA	ANDA077342	AvKARE	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-747_0e99468f-d948-951e-e063-6294a90a62d3	42291-747	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180529		ANDA	ANDA077342	AvKARE	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-748_0e99468f-d948-951e-e063-6294a90a62d3	42291-748	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180529		ANDA	ANDA077342	AvKARE	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-758_0e9aacfd-d4d3-be6c-e063-6394a90a430b	42291-758	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20150805		ANDA	ANDA076899	AvKARE	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20251231
42291-759_0e9aacfd-d4d3-be6c-e063-6394a90a430b	42291-759	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20150805		ANDA	ANDA076899	AvKARE	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20251231
42291-764_0e9ab853-6d17-cd40-e063-6294a90aa1a1	42291-764	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		FLUDROCORTISONE ACETATE	TABLET	ORAL	20210113		ANDA	ANDA040431	AvKARE	FLUDROCORTISONE ACETATE	.1	mg/1			N	20251231
42291-765_ff958b19-2ce5-442a-e053-6294a90a66a0	42291-765	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20191021		ANDA	ANDA211368	AvKARE	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
42291-771_0e106675-cd9d-56c0-e063-6294a90acfac	42291-771	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200422		ANDA	ANDA211575	AvKARE	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
42291-772_0e9a9db7-6a6f-d144-e063-6394a90ad796	42291-772	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20200825		ANDA	ANDA040765	AvKARE	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
42291-773_0e9aba8f-2059-cea0-e063-6294a90a8241	42291-773	HUMAN PRESCRIPTION DRUG	Ranolazine		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201027		ANDA	ANDA212781	AvKARE	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
42291-774_0e9aba8f-2059-cea0-e063-6294a90a8241	42291-774	HUMAN PRESCRIPTION DRUG	Ranolazine		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201027		ANDA	ANDA212781	AvKARE	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
42291-775_0e9aa94f-fbd1-bee4-e063-6394a90a16c1	42291-775	HUMAN PRESCRIPTION DRUG	Riluzole		riluzole	TABLET, FILM COATED	ORAL	20201007		ANDA	ANDA206045	AvKARE	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20251231
42291-776_0e9aa94f-fbd2-bee4-e063-6394a90a16c1	42291-776	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20201221		ANDA	ANDA213186	AvKARE	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20251231
42291-777_0e9abeed-2337-d18a-e063-6394a90a4127	42291-777	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20221004		ANDA	ANDA209745	AvKARE	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
42291-778_0e9abeed-2337-d18a-e063-6394a90a4127	42291-778	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20221004		ANDA	ANDA209745	AvKARE	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
42291-780_0993a1f0-3792-f9aa-e063-6294a90a0960	42291-780	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20210520		NDA AUTHORIZED GENERIC	NDA021641	AvKARE	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
42291-781_0e9ac01f-7d10-e0c3-e063-6294a90aa5c7	42291-781	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate Oral	SUSPENSION	ORAL	20210416		ANDA	ANDA209356	AvKARE	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20251231
42291-783_f331ad24-f318-419a-e053-2995a90a0ffa	42291-783	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230126		ANDA	ANDA040362	AvKARE	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42291-790_0e9ac170-4a2f-d07c-e063-6394a90af8f4	42291-790	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20171220		ANDA	ANDA204415	AvKARE	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
42291-791_0e9ac170-4a2f-d07c-e063-6394a90af8f4	42291-791	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20171220		ANDA	ANDA204415	AvKARE	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
42291-792_0e9ac170-4a2f-d07c-e063-6394a90af8f4	42291-792	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20171220		ANDA	ANDA204415	AvKARE	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
42291-800_0e9aa072-4597-d186-e063-6394a90a21e2	42291-800	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20190110		ANDA	ANDA090636	AvKARE	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20251231
42291-804_0e9ac170-4a31-d07c-e063-6394a90af8f4	42291-804	HUMAN PRESCRIPTION DRUG	ALYQ		Tadalafil	TABLET, FILM COATED	ORAL	20190218		ANDA	ANDA209942	AvKARE	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-808_0e9aba8f-205a-cea0-e063-6294a90a8241	42291-808	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20150728		ANDA	ANDA076416	AvKARE	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-809_0e9aba8f-205a-cea0-e063-6294a90a8241	42291-809	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20150728		ANDA	ANDA076416	AvKARE	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-810_0e9ac170-4a35-d07c-e063-6394a90af8f4	42291-810	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20140620		ANDA	ANDA078868	AvKARE	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-811_0e9ac170-4a35-d07c-e063-6394a90af8f4	42291-811	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20140620		ANDA	ANDA078868	AvKARE	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-812_0e9ac170-4a35-d07c-e063-6394a90af8f4	42291-812	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20140620		ANDA	ANDA078868	AvKARE	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
42291-816_f6f60241-ad95-373c-e053-6294a90a3a73	42291-816	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20170403		ANDA	ANDA076346	AvKARE	TORSEMIDE	5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42291-817_f6f60241-ad95-373c-e053-6294a90a3a73	42291-817	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20170403		ANDA	ANDA076346	AvKARE	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42291-818_f6f60241-ad95-373c-e053-6294a90a3a73	42291-818	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20170403		ANDA	ANDA076346	AvKARE	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42291-819_f6f60241-ad95-373c-e053-6294a90a3a73	42291-819	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20141230		ANDA	ANDA076346	AvKARE	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42291-820_d5c9eac5-69d5-62be-e053-2a95a90a26a7	42291-820	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200330		ANDA	ANDA075317	AvKARE	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
42291-821_d5c9eac5-69d5-62be-e053-2a95a90a26a7	42291-821	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200330		ANDA	ANDA075317	AvKARE	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
42291-822_d5c9eac5-69d5-62be-e053-2a95a90a26a7	42291-822	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200330		ANDA	ANDA075317	AvKARE	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
42291-823_d5c9eac5-69d5-62be-e053-2a95a90a26a7	42291-823	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200330		ANDA	ANDA075317	AvKARE	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
42291-829_0e9ac170-4a36-d07c-e063-6394a90af8f4	42291-829	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200417		ANDA	ANDA071525	AvKARE	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20251231
42291-830_faa23f94-4013-1808-e053-6294a90aee89	42291-830	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230420		ANDA	ANDA209700	AvKARE	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
42291-831_faa23f94-4013-1808-e053-6294a90aee89	42291-831	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230420		ANDA	ANDA209700	AvKARE	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
42291-847_0e9abeab-80ce-d78f-e063-6394a90a1fba	42291-847	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20190131		ANDA	ANDA209057	AvKARE	VARDENAFIL HYDROCHLORIDE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-848_0e9abeab-80ce-d78f-e063-6394a90a1fba	42291-848	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20190131		ANDA	ANDA209057	AvKARE	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-849_0e9ac01f-7d14-e0c3-e063-6294a90aa5c7	42291-849	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20171106		UNAPPROVED DRUG OTHER		AvKARE	UREA	40	g/100g			N	20251231
42291-853_d5ca21ed-a3f0-b7dd-e053-2a95a90ac112	42291-853	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20200413		ANDA	ANDA071881	AvKARE	VERAPAMIL HYDROCHLORIDE	40	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
42291-854_d5ca21ed-a3f0-b7dd-e053-2a95a90ac112	42291-854	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20200413		ANDA	ANDA071881	AvKARE	VERAPAMIL HYDROCHLORIDE	80	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
42291-855_d5ca21ed-a3f0-b7dd-e053-2a95a90ac112	42291-855	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20200413		ANDA	ANDA071881	AvKARE	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
42291-856_0e9ac0eb-a9aa-d396-e063-6394a90a4764	42291-856	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20200623		ANDA	ANDA204011	AvKARE	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
42291-857_0e9ac0eb-a9aa-d396-e063-6394a90a4764	42291-857	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20200623		ANDA	ANDA204011	AvKARE	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
42291-858_0e9ac0eb-a9aa-d396-e063-6394a90a4764	42291-858	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20200623		ANDA	ANDA204011	AvKARE	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
42291-859_0e9ac0eb-a9aa-d396-e063-6394a90a4764	42291-859	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20200623		ANDA	ANDA204011	AvKARE	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
42291-860_0e9ae2d1-a9ca-d188-e063-6394a90a0213	42291-860	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220615		ANDA	ANDA204857	AvKARE	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20251231
42291-861_0e9ae2d1-a9ca-d188-e063-6394a90a0213	42291-861	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220615		ANDA	ANDA204857	AvKARE	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20251231
42291-862_0e9ae2d1-a9ca-d188-e063-6394a90a0213	42291-862	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220615		ANDA	ANDA204857	AvKARE	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20251231
42291-863_0e9ae2d1-a9ca-d188-e063-6394a90a0213	42291-863	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220615		ANDA	ANDA204857	AvKARE	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20251231
42291-864_0e9b0063-74ab-ec2a-e063-6394a90aac3b	42291-864	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA209744	AvKARE	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-865_0e9b0063-74ab-ec2a-e063-6394a90aac3b	42291-865	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA209744	AvKARE	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-866_0e9b0063-74ab-ec2a-e063-6394a90aac3b	42291-866	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA209744	AvKARE	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-867_0e9b0063-74ab-ec2a-e063-6394a90aac3b	42291-867	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA209744	AvKARE	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
42291-868_0e9b0642-5400-ec94-e063-6394a90aec3d	42291-868	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201106		ANDA	ANDA071523	AvKARE	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20251231
42291-869_0e9b0642-5400-ec94-e063-6394a90aec3d	42291-869	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201106		ANDA	ANDA071524	AvKARE	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20251231
42291-870_0e9ae2d1-a9cb-d188-e063-6394a90a0213	42291-870	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE	ORAL	20220223		ANDA	ANDA208279	AvKARE	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
42291-897_0e9b118a-3cea-f0d6-e063-6394a90affd8	42291-897	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130710		ANDA	ANDA076565	AvKARE	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
42291-898_0e9b118a-3cea-f0d6-e063-6394a90affd8	42291-898	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130710		ANDA	ANDA076565	AvKARE	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
42291-899_0e9b118a-3cea-f0d6-e063-6394a90affd8	42291-899	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130710		ANDA	ANDA076565	AvKARE	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
42291-901_0772f635-a03d-3c10-e063-6294a90a67ad	42291-901	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20231011		ANDA	ANDA213803	AvKARE	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42291-902_0772f635-a03d-3c10-e063-6294a90a67ad	42291-902	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20231011		ANDA	ANDA213803	AvKARE	SUNITINIB MALATE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42291-903_0772f635-a03d-3c10-e063-6294a90a67ad	42291-903	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20231011		ANDA	ANDA213803	AvKARE	SUNITINIB MALATE	37.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42291-904_0772f635-a03d-3c10-e063-6294a90a67ad	42291-904	HUMAN PRESCRIPTION DRUG	Sunitinib Malate		Sunitinib Malate	CAPSULE	ORAL	20231011		ANDA	ANDA213803	AvKARE	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42291-908_f1eb0066-a8da-7dd1-e053-2995a90af3f0	42291-908	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210922		ANDA	ANDA078071	AvKARE	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-908_f1eb12af-083e-13a0-e053-2a95a90a8e12	42291-908	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210910		ANDA	ANDA078071	AvKARE	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-909_f1eb0066-a8da-7dd1-e053-2995a90af3f0	42291-909	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210922		ANDA	ANDA078071	AvKARE	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-909_f1eb12af-083e-13a0-e053-2a95a90a8e12	42291-909	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210910		ANDA	ANDA078071	AvKARE	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-910_f1eb0066-a8da-7dd1-e053-2995a90af3f0	42291-910	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210922		ANDA	ANDA078071	AvKARE	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-910_f1eb12af-083e-13a0-e053-2a95a90a8e12	42291-910	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210910		ANDA	ANDA078071	AvKARE	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-911_f1eb0066-a8da-7dd1-e053-2995a90af3f0	42291-911	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210922		ANDA	ANDA078071	AvKARE	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-911_f1eb12af-083e-13a0-e053-2a95a90a8e12	42291-911	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210910		ANDA	ANDA078071	AvKARE	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-912_f1eb0066-a8da-7dd1-e053-2995a90af3f0	42291-912	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210922		ANDA	ANDA078071	AvKARE	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-912_f1eb12af-083e-13a0-e053-2a95a90a8e12	42291-912	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210910		ANDA	ANDA078071	AvKARE	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-913_f1eb0066-a8da-7dd1-e053-2995a90af3f0	42291-913	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210922		ANDA	ANDA078071	AvKARE	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-913_f1eb12af-083e-13a0-e053-2a95a90a8e12	42291-913	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210910		ANDA	ANDA078071	AvKARE	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-914_0e9ae0bc-3da5-cea2-e063-6294a90afff2	42291-914	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		oxybutynin chloride	TABLET	ORAL	20220930		ANDA	ANDA075079	AvKARE	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
42291-915_0291de42-f8b1-5ae5-e063-6294a90a601e	42291-915	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230728		ANDA	ANDA204707	AvKARE	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-916_0291de42-f8b1-5ae5-e063-6294a90a601e	42291-916	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230728		ANDA	ANDA204707	AvKARE	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-917_0291de42-f8b1-5ae5-e063-6294a90a601e	42291-917	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230728		ANDA	ANDA204707	AvKARE	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-918_0291de42-f8b1-5ae5-e063-6294a90a601e	42291-918	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230728		ANDA	ANDA204707	AvKARE	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42291-919_fa293151-c70c-bbf0-e053-6294a90a77aa	42291-919	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20230420		ANDA	ANDA216626	AvKARE	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
42291-920_f6cd8e3d-8b02-18e5-e053-6294a90a075f	42291-920	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride and Metformin Hydrochloride		Pioglitazone Hydrochloride and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA200823	AvKARE	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	500; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
42291-921_f6cd8e3d-8b02-18e5-e053-6294a90a075f	42291-921	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride and Metformin Hydrochloride		Pioglitazone Hydrochloride and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA200823	AvKARE	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	850; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
42291-922_f93e14dc-b2cc-a025-e053-6294a90a2a1d	42291-922	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20230413		ANDA	ANDA089763	AvKARE	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
42291-923_00c45ba8-b94f-f7b0-e063-6394a90affd0	42291-923	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20230718		NDA AUTHORIZED GENERIC	NDA019594	AvKARE	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
42291-924_030a6eab-af2d-3813-e063-6394a90a7731	42291-924	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil-hydrochlorothiazide		olmesartan medoxomil-hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230727		NDA	NDA021532	AvKARE	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-925_030a6eab-af2d-3813-e063-6394a90a7731	42291-925	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil-hydrochlorothiazide		olmesartan medoxomil-hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230727		NDA	NDA021532	AvKARE	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-926_030a6eab-af2d-3813-e063-6394a90a7731	42291-926	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil-hydrochlorothiazide		olmesartan medoxomil-hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230727		NDA	NDA021532	AvKARE	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-927_0552b8e6-579f-60f5-e063-6394a90ad1bf	42291-927	HUMAN PRESCRIPTION DRUG	varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20230914		ANDA	ANDA214557	AvKARE	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
42291-928_0552b8e6-579f-60f5-e063-6394a90ad1bf	42291-928	HUMAN PRESCRIPTION DRUG	varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20230914		ANDA	ANDA214557	AvKARE	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
42291-929_0552b8e6-579f-60f5-e063-6394a90ad1bf	42291-929	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline tartrate	KIT		20230914		ANDA	ANDA214557	AvKARE						N	20241231
42291-930_fbbd1f99-39fb-6335-e053-6394a90a45f3	42291-930	HUMAN PRESCRIPTION DRUG	ZAFEMY		Norelgestromin and Ethinyl Estradiol	PATCH	TRANSDERMAL	20230515		ANDA	ANDA213950	AvKARE	ETHINYL ESTRADIOL; NORELGESTROMIN	35; 150	ug/d; ug/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
42291-931_0c7e1aad-cc5e-ecd3-e063-6294a90ab9f9	42291-931	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20231214		ANDA	ANDA202540	AvKARE	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
42291-936_0909a2f4-ab61-2569-e063-6394a90acf6a	42291-936	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20231031		ANDA	ANDA215576	AvKARE	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
42291-962_0e9ae0bc-3da6-cea2-e063-6294a90afff2	42291-962	HUMAN PRESCRIPTION DRUG	Yuvafem		Estradiol	TABLET	VAGINAL	20161019		ANDA	ANDA205256	AvKARE	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
42291-963_0e9ae0bc-3da7-cea2-e063-6294a90afff2	42291-963	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20190221		ANDA	ANDA076410	AvKARE	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20251231
42291-964_0e9ae0bc-3da7-cea2-e063-6294a90afff2	42291-964	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20190221		ANDA	ANDA076410	AvKARE	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20251231
42291-965_05b9dcb6-6ebf-03cf-e063-6294a90a679c	42291-965	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230919		ANDA	ANDA204382	AvKARE	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-966_05b9dcb6-6ebf-03cf-e063-6294a90a679c	42291-966	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230919		ANDA	ANDA204382	AvKARE	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-967_05b9dcb6-6ebf-03cf-e063-6294a90a679c	42291-967	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230919		ANDA	ANDA204382	AvKARE	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-968_05b9dcb6-6ebf-03cf-e063-6294a90a679c	42291-968	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230919		ANDA	ANDA204382	AvKARE	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-969_05b9dcb6-6ebf-03cf-e063-6294a90a679c	42291-969	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230919		ANDA	ANDA204382	AvKARE	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42291-970_fa2bbd50-d0eb-d448-e053-6394a90a4152	42291-970	HUMAN PRESCRIPTION DRUG	Zafirlukast		zafirlukast	TABLET, COATED	ORAL	20230405		NDA	NDA020547	AvKARE	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
42291-971_fa2bbd50-d0eb-d448-e053-6394a90a4152	42291-971	HUMAN PRESCRIPTION DRUG	Zafirlukast		zafirlukast	TABLET, COATED	ORAL	20230405		NDA	NDA020547	AvKARE	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
42291-972_07eb7119-b679-5570-e063-6394a90a8038	42291-972	HUMAN PRESCRIPTION DRUG	Valganciclovir hydrochloride for Oral		Valganciclovir hydrochloride	POWDER, FOR SOLUTION	ORAL	20231017		ANDA	ANDA205220	AvKARE	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
42291-973_0d0b8a06-8587-2cfe-e063-6294a90af7a0	42291-973	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir hydrochloride	TABLET, FILM COATED	ORAL	20231221		ANDA	ANDA200790	AvKARE	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
42292-017_f8712884-9074-81f4-e053-6394a90aac8e	42292-017	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		spironolactone and hydrochlorothiazide	TABLET	ORAL	20170512	20240331	ANDA	ANDA086513	Mylan Institutional Inc.	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
42292-038_f4348cfd-4241-bfd4-e053-2995a90ab7ad	42292-038	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20170118		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
42292-039_f4348cfd-4241-bfd4-e053-2995a90ab7ad	42292-039	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20170119		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
42292-040_f4348cfd-4241-bfd4-e053-2995a90ab7ad	42292-040	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20170119		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
42292-041_f4348cfd-4241-bfd4-e053-2995a90ab7ad	42292-041	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20190114		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
42292-043_0d8146a4-3342-7683-e063-6294a90aa7cb	42292-043	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		imatinib	TABLET, FILM COATED	ORAL	20170907		ANDA	ANDA204644	Mylan Institutional Inc.	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
42292-044_0d8146a4-3342-7683-e063-6294a90aa7cb	42292-044	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		imatinib	TABLET, FILM COATED	ORAL	20170907		ANDA	ANDA204644	Mylan Institutional Inc.	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
42292-054_0e0f4d78-3a33-6fb6-e063-6394a90abdc2	42292-054	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20200430	20240331	ANDA	ANDA209470	Mylan Institutional Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	
42292-055_f0e73f03-8af4-d75f-e053-2995a90ae6f8	42292-055	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200306	20240130	ANDA	ANDA203802	Mylan Institutional Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	
42326-090_0c0e089a-b2fc-3fed-e063-6294a90a7078	42326-090	HUMAN OTC DRUG	HEALTH E Alcohol-Free Antiseptic		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200414		OTC MONOGRAPH DRUG	505G(a)(3)	Petra Hygienic Systems Int Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
42326-098_0c0e8f59-0e15-854a-e063-6294a90a7663	42326-098	HUMAN OTC DRUG	Club Wipes Alcohol Free Antimicrobial Cleaning Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200414		OTC MONOGRAPH DRUG	505G(a)(3)	Petra Hygienic Systems Int Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
42326-099_0c0e20d7-549f-801c-e063-6294a90ab84f	42326-099	HUMAN OTC DRUG	CLUB Wipes Sanitizing Wipes for Hands		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20230201		OTC MONOGRAPH DRUG	505G(a)(3)	Petra Hygienic Systems International Limited	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
42326-100_0c0e089a-b307-3fed-e063-6294a90a7078	42326-100	HUMAN OTC DRUG	Petra Health E Wipes Alcohol Free Antiseptic		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200514		OTC MONOGRAPH DRUG	505G(a)(3)	Petra Hygienic Systems Int Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
42326-580_0c0e9512-2d06-e1ff-e063-6294a90aea1a	42326-580	HUMAN OTC DRUG	Apres Foaming Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201207		OTC MONOGRAPH DRUG	505G(a)(3)	Petra Hygienic Systems International Limited	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
42339-001_c917a103-9722-22c9-e053-2a95a90a9779	42339-001	HUMAN OTC DRUG	Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20120218		OTC MONOGRAPH FINAL	part344	Shandong Haiyan Medical Manufacture Co., Ltd.	ISOPROPYL ALCOHOL	.7	mL/1			N	20241231
42339-003_c9185c17-2603-99e8-e053-2a95a90af9fb	42339-003	HUMAN OTC DRUG	Povidone-Iodine Pad		Povidone-Iodine	SWAB	TOPICAL	20120218		OTC MONOGRAPH FINAL	part333C	Shandong Haiyan Medical Manufacture Co., Ltd.	POVIDONE-IODINE	9.43	g/100g			N	20241231
42346-301_d246535b-bbe5-06a0-e053-2a95a90a9248	42346-301	HUMAN OTC DRUG	Frankincense and Myrrh Neuropathy		Aconitum Napellus, Bryonia Alba, Hypericum Perforatum	OIL	TOPICAL	20130611		UNAPPROVED HOMEOPATHIC		Wise Consumer Products	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; HYPERICUM PERFORATUM	3; 3; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
42346-519_f0d4b5b1-47d7-d381-e053-2a95a90a50e9	42346-519	HUMAN OTC DRUG	Frankincense and Myrrh		Intensive Foot Therapy Lotion	LOTION	TOPICAL	20200701		UNAPPROVED HOMEOPATHIC		Wise Consumer Products Co.	HYPERICUM PERFORATUM	3	[hp_X]/g			N	20241231
42346-725_f0d48b70-149a-4e74-e053-2a95a90a3063	42346-725	HUMAN OTC DRUG	Frankincense and Myrrh Arthritis Pain Relief		Aconitum napellus, Bryonia alba, Hypericum perforatum	OIL	TOPICAL	20211221		UNAPPROVED HOMEOPATHIC		Wise Consumer Products	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; HYPERICUM PERFORATUM	3; 3; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
42346-730_f0d48cd0-77f9-33b4-e053-2995a90afd67	42346-730	HUMAN OTC DRUG	Frankincense and Myrrh Arthritis Pain Therapy		Hypericum perforatum	LOTION	TOPICAL	20211221		UNAPPROVED HOMEOPATHIC		Wise Consumer Products Co.	HYPERICUM PERFORATUM	3	[hp_X]/85g			N	20241231
42355-265_5cca2d96-cc63-4bc3-b226-09978e97c1ea	42355-265	HUMAN OTC DRUG	All Stop Medicated Body Wash		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20171221		OTC MONOGRAPH NOT FINAL	part333E	Q-Based Solutions Inc	BENZALKONIUM CHLORIDE	25	mg/mL			N	20241231
42358-295_f2d66860-2840-4060-82ba-5fa50f4724c4	42358-295	HUMAN PRESCRIPTION DRUG	Nulibry		fosdenopterin hydrobromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210330		NDA	NDA214018	Sentynl Therapeutics, Inc.	FOSDENOPTERIN HYDROBROMIDE	9.5	mg/1	Cyclic Pyranopterin Monophosphate [EPC], Cyclic Pyranopterin Monophosphate [EXT]		N	20241231
42364-0011_491245d9-8bda-4cf3-a934-49757a54d81e	42364-0011	HUMAN OTC DRUG	vanquish		acetaminophen, aspirin, and caffeine	TABLET, COATED	ORAL	20180715		OTC MONOGRAPH DRUG	M013	DSE Healthcare Solutions, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	194; 227; 33	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
42367-521_37c52795-a06c-45ad-b496-930508048381	42367-521	HUMAN PRESCRIPTION DRUG	BELRAPZO		bendamustine hydrochloride	INJECTION	INTRAVENOUS	20190603		NDA	NDA205580	Eagle Pharmaceuticals, Inc	BENDAMUSTINE HYDROCHLORIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
42367-531_041cbcd7-a78a-47bd-8288-0e0b828f6706	42367-531	HUMAN PRESCRIPTION DRUG	Pemfexy		pemetrexed	INJECTION	INTRAVENOUS	20220201		NDA	NDA209472	Eagle Pharmaceuticals, Inc.	PEMETREXED MONOHYDRATE	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
42367-540_651d74ad-433d-4ac8-a7cd-7d79460b08ac	42367-540	HUMAN PRESCRIPTION DRUG	RYANODEX	dantrolene sodium	dantrolene sodium	INJECTION, SUSPENSION	INTRAVENOUS	20140723		NDA	NDA205579	Eagle Pharmaceuticals, Inc.	DANTROLENE SODIUM	250	mg/5mL	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
42367-570_bf43a24f-2cb9-4169-af3a-f892ad8772e2	42367-570	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION	PARENTERAL	20220110	20240630	ANDA	ANDA211538	Eagle Pharmaceuticals, Inc.	VASOPRESSIN	20	U/mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	
42385-915_aca22076-f435-4533-9fcf-566b0734c313	42385-915	HUMAN PRESCRIPTION DRUG	Efavirenz, emtricitabine and tenofovir disoproxil fumarate		Efavirenz, emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20211222		ANDA	ANDA213541	Laurus Labs Limited	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
42385-920_7d442858-8287-43ad-9bf7-990b1f3665be	42385-920	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20210430		ANDA	ANDA212579	Laurus Labs Limited	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
42385-921_7d442858-8287-43ad-9bf7-990b1f3665be	42385-921	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20210430		ANDA	ANDA212579	Laurus Labs Limited	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
42385-922_7d442858-8287-43ad-9bf7-990b1f3665be	42385-922	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20210430		ANDA	ANDA212579	Laurus Labs Limited	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
42385-923_cf17d5b2-c169-4671-a819-803409d48b1a	42385-923	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	CAPSULE	ORAL	20220719		ANDA	ANDA212724	Laurus Labs Limited	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42385-924_cf17d5b2-c169-4671-a819-803409d48b1a	42385-924	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220719		ANDA	ANDA212722	Laurus Labs Limited	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42385-925_cf17d5b2-c169-4671-a819-803409d48b1a	42385-925	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220719		ANDA	ANDA212722	Laurus Labs Limited	PIRFENIDONE	534	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42385-926_cf17d5b2-c169-4671-a819-803409d48b1a	42385-926	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220719		ANDA	ANDA212722	Laurus Labs Limited	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42385-927_6b2aac0f-56ba-455c-850b-d7e14ea8143f	42385-927	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20190905	20250228	ANDA	ANDA210959	Laurus Labs Limited	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	
42385-928_27623aed-629d-4406-a0bf-4f234fc4e6c6	42385-928	HUMAN PRESCRIPTION DRUG	Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate		Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20200514		ANDA	ANDA212786	Laurus Labs Limited	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	600; 300; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
42385-929_98342153-b9de-4318-aac4-9f8d19590cd7	42385-929	HUMAN PRESCRIPTION DRUG	Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate		Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20200514		ANDA	ANDA213038	Laurus Labs Limited	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	400; 300; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
42385-933_3a3c4164-da47-427d-9f12-6d1f73b0729d	42385-933	HUMAN PRESCRIPTION DRUG	Lopinavir and Ritonavir		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20220322		ANDA	ANDA213857	Laurus Labs Limited	LOPINAVIR; RITONAVIR	100; 25	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
42385-934_3a3c4164-da47-427d-9f12-6d1f73b0729d	42385-934	HUMAN PRESCRIPTION DRUG	Lopinavir and Ritonavir		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20220322		ANDA	ANDA213857	Laurus Labs Limited	LOPINAVIR; RITONAVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
42385-935_f0dfffd1-9c2c-0cbd-e053-2a95a90a908c	42385-935	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET, FILM COATED	ORAL	20200113		ANDA	ANDA210606	Laurus Labs Limited	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42385-936_f0dfffd1-9c2c-0cbd-e053-2a95a90a908c	42385-936	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET, FILM COATED	ORAL	20200113		ANDA	ANDA210606	Laurus Labs Limited	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42385-944_f0e00f9f-65f5-407a-e053-2a95a90a260f	42385-944	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID DELAYED-RELEASE		FENOFIBRIC ACID	CAPSULE, DELAYED RELEASE	ORAL	20200824		ANDA	ANDA211626	Laurus Labs Limited	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42385-945_f0e00f9f-65f5-407a-e053-2a95a90a260f	42385-945	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID DELAYED-RELEASE		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20200824		ANDA	ANDA211626	Laurus Labs Limited	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42385-946_6be8e383-37fa-4e0a-b9fc-3976a8be1d2f	42385-946	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20210417		ANDA	ANDA213200	Laurus Labs Limited	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
42385-947_ff7cc931-fed0-431d-b817-1c950b5159f8	42385-947	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	Laurus Labs Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42385-948_ff7cc931-fed0-431d-b817-1c950b5159f8	42385-948	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	Laurus Labs Limited	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42385-949_ff7cc931-fed0-431d-b817-1c950b5159f8	42385-949	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	Laurus Labs Limited	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42385-950_f0dd74ce-5a8e-07b1-e053-2a95a90af387	42385-950	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20200318		ANDA	ANDA211122	Laurus Labs Limited	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42385-951_f0dd74ce-5a8e-07b1-e053-2a95a90af387	42385-951	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20200318		ANDA	ANDA211122	Laurus Labs Limited	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42385-953_f87bdc93-cb49-4c2f-b8db-f8b8e57d0367	42385-953	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA212114	Laurus Labs Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
42385-954_cbdae2e4-1013-e3d8-e053-2995a90a625c	42385-954	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20210322		ANDA	ANDA090767	Laurus Generics Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42385-955_cbdae2e4-1013-e3d8-e053-2995a90a625c	42385-955	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20210322		ANDA	ANDA090767	Laurus Generics Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42385-956_cbdae2e4-1013-e3d8-e053-2995a90a625c	42385-956	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20210322		ANDA	ANDA090767	Laurus Generics Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42385-957_cbdae2e4-1013-e3d8-e053-2995a90a625c	42385-957	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20210322		ANDA	ANDA090767	Laurus Generics Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42385-962_0c1a2d90-e5e1-48ff-8e81-7d2bec0e50d0	42385-962	HUMAN PRESCRIPTION DRUG	Abacavir and Lamivudine		Abacavir and Lamivudine	TABLET, FILM COATED	ORAL	20220725		ANDA	ANDA216332	Laurus Labs Limited	ABACAVIR SULFATE; LAMIVUDINE	600; 300	mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
42385-963_dae26a01-bfd7-0432-e053-2995a90a88dd	42385-963	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220119		ANDA	ANDA214035	Laurus Generics Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
42385-964_dae26a01-bfd7-0432-e053-2995a90a88dd	42385-964	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220119		ANDA	ANDA214035	Laurus Generics Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
42385-972_07aa1bcc-df05-44fa-92d4-63894e0e6cd6	42385-972	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230513		ANDA	ANDA217546	Laurus Labs Limited	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42385-973_07aa1bcc-df05-44fa-92d4-63894e0e6cd6	42385-973	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230513		ANDA	ANDA217546	Laurus Labs Limited	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42385-974_07aa1bcc-df05-44fa-92d4-63894e0e6cd6	42385-974	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230513		ANDA	ANDA217546	Laurus Labs Limited	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42385-977_0e7b02cc-2ddc-4394-a80c-128e6452d697	42385-977	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20231006		ANDA	ANDA217631	Laurus Labs Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42385-978_0e7b02cc-2ddc-4394-a80c-128e6452d697	42385-978	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20231006		ANDA	ANDA217631	Laurus Labs Limited	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42388-011_e795674d-0cf9-4907-a097-eaf10a1b1dea	42388-011	HUMAN PRESCRIPTION DRUG	COMETRIQ		cabozantinib	KIT		20121129		NDA	NDA203756	Exelixis, Inc.						N	20241231
42388-012_e795674d-0cf9-4907-a097-eaf10a1b1dea	42388-012	HUMAN PRESCRIPTION DRUG	COMETRIQ		cabozantinib	KIT		20121129		NDA	NDA203756	Exelixis, Inc.						N	20241231
42388-013_e795674d-0cf9-4907-a097-eaf10a1b1dea	42388-013	HUMAN PRESCRIPTION DRUG	COMETRIQ		cabozantinib	CAPSULE	ORAL	20121129		NDA	NDA203756	Exelixis, Inc.	CABOZANTINIB S-MALATE	20	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42388-023_7ba5219b-5a32-42c9-a00a-6afc22f31bb1	42388-023	HUMAN PRESCRIPTION DRUG	CABOMETYX		cabozantinib	TABLET	ORAL	20160425		NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	60	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42388-024_7ba5219b-5a32-42c9-a00a-6afc22f31bb1	42388-024	HUMAN PRESCRIPTION DRUG	CABOMETYX		cabozantinib	TABLET	ORAL	20160425		NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	20	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42388-025_7ba5219b-5a32-42c9-a00a-6afc22f31bb1	42388-025	HUMAN PRESCRIPTION DRUG	CABOMETYX		cabozantinib	TABLET	ORAL	20160425		NDA	NDA208692	Exelixis, Inc.	CABOZANTINIB S-MALATE	40	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
42389-001_0712020c-f4ca-cdd3-e063-6294a90a8197	42389-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20071201		NDA	NDA205840	Carepro Health Risk Management	OXYGEN	990	mL/L			N	20241231
42423-271_972278f0-aacf-4b9e-aacf-c712ef8684b6	42423-271	HUMAN OTC DRUG	EasyTouch Alcohol Prep Pads	Sterile	Isopropyl Alcohol	SWAB	TOPICAL	20140401		OTC MONOGRAPH NOT FINAL	part333A	MHC Medical Products, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
42452-379_291a7722-a53d-4827-b9f6-897226369d92	42452-379	HUMAN OTC DRUG	Revalife Pain Relief Cream		Menthol, Methyl Salicylate	CREAM	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part348	International Nutraceutical Company of America, LLC	MENTHOL; METHYL SALICYLATE	.05; .075	kg/kg; kg/kg			N	20241231
42457-420_9f38e2db-d15b-4d17-951a-2e42ac87e43c	42457-420	HUMAN PRESCRIPTION DRUG	Endari		Glutamine	POWDER, FOR SOLUTION	ORAL	20170707		NDA	NDA208587	Emmaus Medical, Inc.	GLUTAMINE	5	g/1	Amino Acid [EPC], Amino Acids [CS]		N	20241231
42472-006_effabd46-34f6-16e7-e053-2995a90a6654	42472-006	HUMAN OTC DRUG	ARAMIS 24 HOUR HIGH PERFORMANCE ANTIPERSPIRANT		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20200409	20240630	OTC MONOGRAPH FINAL	M019	ARAMIS INC.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	186	mg/mL			N	
42472-010_fc5c91b3-cc8e-2fab-e053-6394a90ad94c	42472-010	HUMAN OTC DRUG	LAB SERIES DAY RESCUE DEFENSE BROAD SPECTRUM SPF 35		AVOBENZONE, HOMOSALATE, OCTISALATE, and OXYBENZONE	LOTION	TOPICAL	20161201		OTC MONOGRAPH FINAL	M020	Aramis Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	.03; .05; .045; .033	g/mL; g/mL; g/mL; g/mL			N	20241231
42472-011_fc5cc340-edf5-023e-e053-6394a90ae447	42472-011	HUMAN OTC DRUG	LAB SERIES SKINCARE FOR MEN	BB TINTED MOISTURIZER BROAD SPECTRUM SPF 35	OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE, and ZINC OXIDE	LIQUID	TOPICAL	20110424		OTC MONOGRAPH FINAL	M020	Aramis Inc.	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	75; 40; 25; 22; 20	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
42485-005_0c5b3fe9-1841-0f34-e063-6294a90ad802	42485-005	HUMAN OTC DRUG	Broad Spectrum SPF 30 Up The Anti		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20121114		OTC MONOGRAPH DRUG	M020	Biopelle, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	32; 60	mg/mL; mg/mL			N	20241231
42491-1100_2dd373d3-dd3e-4382-b695-9fcdc46e4b4b	42491-1100	HUMAN OTC DRUG	Tissen NF 10		Adenosine	LIQUID	TOPICAL	20191101		UNAPPROVED DRUG OTHER		Dalim Tissen	ADENOSINE	.012	g/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
42491-1200_f1deb5a1-8593-4db1-8ee0-985fa1b399ba	42491-1200	HUMAN OTC DRUG	Tissen ICM 10		Adenosine	LIQUID	TOPICAL	20191101		UNAPPROVED DRUG OTHER		Dalim Tissen	ADENOSINE	.005	g/13mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
42494-339_2a26a9f9-9188-4608-a587-77f76ec22b56	42494-339	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Cameron Pharmaceuticals, LLC	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
42494-340_2a26a9f9-9188-4608-a587-77f76ec22b56	42494-340	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Cameron Pharmaceuticals, LLC	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
42494-341_b9ed6ad3-0833-45c8-8f10-2e7675675b3f	42494-341	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20220401		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals, Limited Liability Company	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42494-342_2c55c436-1ae6-4008-bc58-739b43750a6f	42494-342	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20220401		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals, Limited Liability Company	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42494-415_c93382e0-88bd-46f2-a788-897de4b1d9b5	42494-415	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
42494-416_c93382e0-88bd-46f2-a788-897de4b1d9b5	42494-416	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
42494-419_15940c31-0dab-4058-a154-7a5a623e1ff5	42494-419	HUMAN PRESCRIPTION DRUG	Methylene Blue INJ		METHYLENE BLUE ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20230807		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	METHYLENE BLUE ANHYDROUS	10	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
42494-423_48e8b38f-e794-438f-bf24-66d0363e4829	42494-423	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	POWDER, FOR SOLUTION	RESPIRATORY (INHALATION)	20200415		NDA	NDA018859	Cameron Pharmaceuticals	RIBAVIRIN	6	g/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
42494-426_8dec023f-f9b0-497b-b339-16807411a6df	42494-426	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20191127		ANDA	ANDA212254	Cameron Pharmaceuticals	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
42494-432_016e6a8f-be63-40b3-83c1-ebed6586bd4f	42494-432	HUMAN PRESCRIPTION DRUG	Multi-Vit-Flor		SODIUM FLUORIDE, VITAMIN A ACETATE, SODIUM ASCORBATE, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE CALCIUM, and CYANOCOBALAMIN	TABLET, CHEWABLE	ORAL	20220202		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	.ALPHA.-TOCOPHEROL, D-; CHOLECALCIFEROL; CYANOCOBALAMIN; LEVOMEFOLATE CALCIUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A ACETATE	10; 10; 4.5; 230; 10; 1; 1.2; 60; 1; 1; 600	mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Folate Analog [EPC], Folic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
42494-433_016e6a8f-be63-40b3-83c1-ebed6586bd4f	42494-433	HUMAN PRESCRIPTION DRUG	Multi-Vit-Flor		SODIUM FLUORIDE, VITAMIN A ACETATE, SODIUM ASCORBATE, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE CALCIUM, and CYANOCOBALAMIN	TABLET, CHEWABLE	ORAL	20220202		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	.ALPHA.-TOCOPHEROL, D-; CHOLECALCIFEROL; CYANOCOBALAMIN; LEVOMEFOLATE CALCIUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A ACETATE	10; 10; 4.5; 230; 10; 1; 1.2; 60; .5; 1; 600	mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Folate Analog [EPC], Folic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
42494-434_016e6a8f-be63-40b3-83c1-ebed6586bd4f	42494-434	HUMAN PRESCRIPTION DRUG	Multi-Vit-Flor		SODIUM FLUORIDE, VITAMIN A ACETATE, SODIUM ASCORBATE, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, D-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLATE CALCIUM, and CYANOCOBALAMIN	TABLET, CHEWABLE	ORAL	20220202		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	.ALPHA.-TOCOPHEROL, D-; CHOLECALCIFEROL; CYANOCOBALAMIN; LEVOMEFOLATE CALCIUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A ACETATE	10; 10; 4.5; 230; 10; 1; 1.2; 60; .25; 1; 600	mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Folate Analog [EPC], Folic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
42494-441_027dbe7b-e75a-4cda-840d-297db9241ec1	42494-441	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		PHENOBARBITAL SODIUM	INJECTION	INTRAMUSCULAR	20230602		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
42494-442_027dbe7b-e75a-4cda-840d-297db9241ec1	42494-442	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		PHENOBARBITAL SODIUM	INJECTION	INTRAMUSCULAR	20230602		UNAPPROVED DRUG OTHER		Cameron Pharmaceuticals	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
42494-453_f5d320e2-0a9e-4794-8995-d8409953b9be	42494-453	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20231006		ANDA	ANDA091432	Cameron Pharmaceuticals	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42494-454_f5d320e2-0a9e-4794-8995-d8409953b9be	42494-454	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20230910		ANDA	ANDA091432	Cameron Pharmaceuticals	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42507-114_f2f51b6a-b984-cbcc-e053-2a95a90afec2	42507-114	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20120103		OTC MONOGRAPH FINAL	part358F	HY-VEE, INC	SALICYLIC ACID	40	mg/91			N	20241231
42507-115_f2f518cc-1fce-713c-e053-2a95a90a7217	42507-115	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	HY-VEE, INC	SALICYLIC ACID	40	mg/41			N	20241231
42507-133_f2f518cc-1fcf-713c-e053-2a95a90a7217	42507-133	HUMAN OTC DRUG	Salicylic acid		Wart Remover	PLASTER	TOPICAL	20171206		OTC MONOGRAPH FINAL	part358B	HY-VEE, INC	SALICYLIC ACID	.4	g/181			N	20241231
42507-134_f2f4f98d-b644-4adb-e053-2a95a90a7a33	42507-134	HUMAN OTC DRUG	Salicylic Acid		Medicated Plantar Wart Remover	PATCH	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358B	HY-VEE, INC	SALICYLIC ACID	40	mg/241			N	20241231
42507-136_f2f4f98d-b642-4adb-e053-2a95a90a7a33	42507-136	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20171222		OTC MONOGRAPH FINAL	part333C	HY-VEE, INC	TOLNAFTATE	1.5	g/150g			N	20241231
42507-137_f2f4f98d-b643-4adb-e053-2a95a90a7a33	42507-137	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20171222		OTC MONOGRAPH FINAL	part358F	HY-VEE, INC	SALICYLIC ACID	.17	g/9mL			N	20241231
42507-174_4b24c39e-11f4-4ab7-af26-30ebf2d89510	42507-174	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20140930	20240426	NDA	NDA021920	Hy-Vee	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
42507-281_345922e0-5caf-46e4-a0a5-38b4750888fe	42507-281	HUMAN OTC DRUG	Dry Scalp Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20020719		OTC MONOGRAPH FINAL	part358H	Hy-Vee, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
42507-336_bd0fa0e6-c088-461c-87a2-ed2f67673aa4	42507-336	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150331	20250331	OTC MONOGRAPH FINAL	part341	Hy-Vee	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
42507-492_fbc2f503-fd98-4226-9710-064bae77aa65	42507-492	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20160229	20250228	OTC MONOGRAPH NOT FINAL	part334	Hy-Vee	SENNOSIDES	25	mg/1			N	
42507-505_0c20ecde-be8d-432e-b398-3594a62cb380	42507-505	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160331	20250331	OTC MONOGRAPH FINAL	part341	Hy-Vee	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
42507-810_798a3cd5-1503-44dd-94da-e18d644d002e	42507-810	HUMAN OTC DRUG	Sinus and Allergy		Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20140228	20250228	OTC MONOGRAPH FINAL	part341	Hy-Vee	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
42507-825_3e85cf59-abcb-4b91-b00b-ff5dd61f5f40	42507-825	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20151031	20250131	OTC MONOGRAPH FINAL	part335	Hy-Vee	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
42507-930_c69f8a95-dd16-2942-e053-2a95a90a71e3	42507-930	HUMAN OTC DRUG	HyVee Blemish Controlling Apricot Scrub		SALICYLIC ACID	EMULSION	TOPICAL	20130925		OTC MONOGRAPH FINAL	part333D	HYVEE INC	SALICYLIC ACID	20	mg/g			N	20241231
42508-001_442c8e58-a22d-437e-a3b6-22935b19b9d6	42508-001	HUMAN OTC DRUG	Arbonne Got You Covered Mineral Foundation Broad Spectrum SPF 15 Sunscreen	Ivory	Titanium dioxide and Zinc oxide	POWDER	TOPICAL	20200301	20241001	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	220.8; 100	mg/g; mg/g			N	
42508-002_442c8e58-a22d-437e-a3b6-22935b19b9d6	42508-002	HUMAN OTC DRUG	Arbonne Got You Covered Mineral Foundation Broad Spectrum SPF 15 Sunscreen	Nude	Titanium dioxide and Zinc oxide	POWDER	TOPICAL	20200301	20241101	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	220.8; 100	mg/g; mg/g			N	
42508-003_442c8e58-a22d-437e-a3b6-22935b19b9d6	42508-003	HUMAN OTC DRUG	Arbonne Got You Covered Mineral Foundation Broad Spectrum SPF 15 Sunscreen	Beige	Titanium dioxide and Zinc oxide	POWDER	TOPICAL	20200301	20241001	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	220.8; 100	mg/g; mg/g			N	
42508-005_442c8e58-a22d-437e-a3b6-22935b19b9d6	42508-005	HUMAN OTC DRUG	Arbonne Got You Covered Mineral Foundation Broad Spectrum SPF 15 Sunscreen	Bisque	Titanium dioxide and Zinc oxide	POWDER	TOPICAL	20200301	20241101	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	220.8; 100	mg/g; mg/g			N	
42508-006_442c8e58-a22d-437e-a3b6-22935b19b9d6	42508-006	HUMAN OTC DRUG	Arbonne Got You Covered Mineral Foundation Broad Spectrum SPF 15 Sunscreen	Radiant	Titanium dioxide and Zinc oxide	POWDER	TOPICAL	20200301	20241101	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	220.8; 100	mg/g; mg/g			N	
42508-007_442c8e58-a22d-437e-a3b6-22935b19b9d6	42508-007	HUMAN OTC DRUG	Arbonne Got You Covered Mineral Foundation Broad Spectrum SPF 15 Sunscreen	Natural	Titanium dioxide and Zinc oxide	POWDER	TOPICAL	20200301	20241001	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	220.8; 100	mg/g; mg/g			N	
42508-013_f198eeed-1023-4bd5-ad25-671a6fe4df4c	42508-013	HUMAN OTC DRUG	Arbonne Setting Pretty Translucent Broad Spectrum SPF 15 Sunscreen		titanium dioxide and zinc oxide	POWDER	TOPICAL	20200501	20240801	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	19.2; 150	mg/g; mg/g			N	
42508-104_65fc57af-48dd-46c9-b92c-32f70d3afeb6	42508-104	HUMAN OTC DRUG	Clear Future Corrective Treatment		SALICYLIC ACID	CLOTH	TOPICAL	20150401		OTC MONOGRAPH FINAL	part333D	Arbonne International, LLC	SALICYLIC ACID	.5	mg/90mL			N	20241231
42508-210_e8686689-1d7d-4d87-8187-0cd6de346e2d	42508-210	HUMAN OTC DRUG	Clear Future Intensive Spot Treatment		SALICYLIC ACID	LOTION	TOPICAL	20150401		OTC MONOGRAPH FINAL	part333D	Arbonne International, LLC	SALICYLIC ACID	2	mg/15mL			N	20241231
42508-222_0b634b97-487e-1100-e063-6294a90aed19	42508-222	HUMAN OTC DRUG	Arbonne Intelligence Pollution Defense SPF30 CC Cream - Medium Shade		SPF30 CC Cream - Medium Shade	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	2.5; 7.2	mg/100mg; mg/100mg			N	20241231
42508-226_0b63555e-e5c5-92ee-e063-6394a90a34f2	42508-226	HUMAN OTC DRUG	Arbonne Intelligence Pollution Defense SPF30 CC Cream - Fair Shade		SPF30 CC Cream - Fair Shade	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	2.5; 7.2	mg/100mg; mg/100mg			N	20241231
42508-260_0b63555e-e5c4-92ee-e063-6394a90a34f2	42508-260	HUMAN OTC DRUG	Arbonne Intelligence Pollution Defense SPF30 CC Cream - Light Shade		SPF30 CC Cream - Light Shade	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	2.5; 7.2	mg/100mg; mg/100mg			N	20241231
42508-311_41c2107d-30aa-4f5f-8e1d-b6b3b5765270	42508-311	HUMAN OTC DRUG	Clear Future Mattifying Treatment		SALICYLIC ACID	LOTION	TOPICAL	20150401		OTC MONOGRAPH FINAL	part333D	Arbonne International, LLC	SALICYLIC ACID	.5	mg/50mL			N	20241231
42508-331_390da45e-7239-4296-a34d-1a37c04ef1eb	42508-331	HUMAN OTC DRUG	ABC Arbonne Baby Care Diaper Rash		DIMETHICONE and ZINC OXIDE	CREAM	TOPICAL	20230630		OTC MONOGRAPH DRUG	M016	Arbonne International, LLC	DIMETHICONE; ZINC OXIDE	10; 120	mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
42508-332_be7e3147-81c0-49a7-9e6a-cbc6fe69f50a	42508-332	HUMAN OTC DRUG	ABC Arbonne Baby Care Sunscreen Broad Spectrum SPF 30 Water-Resistant (40 Minutes)		Zinc Oxide	LOTION	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	ZINC OXIDE	144	mg/mL			N	20241231
42508-791_0cf71743-6e86-875e-e063-6394a90ad30a	42508-791	HUMAN OTC DRUG	LiftIntense Sculpting with Mineral Broad Spectrum SPF 15 Sunscreen		Zinc oxide	CREAM	TOPICAL	20210601	20250124	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	ZINC OXIDE	80	mg/g			N	
42508-805_0cf6a0da-4137-77ce-e063-6394a90a2012	42508-805	HUMAN OTC DRUG	Arbonne FunSun Mineral Sunscreen Broad Spectrum SPF 30		Zinc Oxide	LOTION	TOPICAL	20220307		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	ZINC OXIDE	190	mg/mL			N	20241231
42508-820_0cf853e4-fee6-fe90-e063-6394a90a9ece	42508-820	HUMAN OTC DRUG	Arbonne AgeWell Moisture Restoring Broad Spectrum SPF 15 Sunscreen		Zinc Oxide	CREAM	TOPICAL	20200513		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	ZINC OXIDE	49	mg/g			N	20241231
42508-827_0dc2e381-ae2f-b06f-e063-6394a90a1eda	42508-827	HUMAN OTC DRUG	GroomWell Weightless with Mineral Broad Spectrum SPF 15 Sunscreen		Zinc oxide	CREAM	TOPICAL	20210427		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	ZINC OXIDE	49.5	mg/g			N	20241231
42508-831_0dc341fc-d354-c47f-e063-6394a90a5b96	42508-831	HUMAN OTC DRUG	BrightenUp Illuminating with Mineral Broad Spectrum SPF 15 Sunscreen		zinc oxide	CREAM	TOPICAL	20210107	20250126	OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	ZINC OXIDE	49.5	mg/g			N	
42508-881_0dc3ca07-7abd-efae-e063-6394a90a406d	42508-881	HUMAN OTC DRUG	Arbonne Soft Focus Veil Broad Spectrum SPF 30 Sunscreen		titanium dioxide and zinc oxide	LOTION	TOPICAL	20230401		OTC MONOGRAPH DRUG	M020	Arbonne International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	26; 72	mg/mL; mg/mL			N	20241231
42508-904_d2e92c1d-2d4e-4111-97af-28fc8c526dc5	42508-904	HUMAN OTC DRUG	Clear Future Deep Pore Cleanser		SALICYLIC ACID	GEL	TOPICAL	20150401		OTC MONOGRAPH FINAL	part333D	Arbonne International, LLC	SALICYLIC ACID	.5	mg/118mL			N	20241231
42509-005_a6e75e18-c362-1241-e053-2995a90a27c7	42509-005	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333E	Wessco International	ALCOHOL	75	mL/100mL			N	20241231
42509-010_a738bdfd-cff5-b7c4-e053-2995a90af8f5	42509-010	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333E	Wessco International	ALCOHOL	75	mL/100mL			N	20241231
42509-013_08634f11-3d5d-9bdc-e063-6294a90a101b	42509-013	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210601		OTC MONOGRAPH DRUG	505G(a)(3)	Wessco International	ALCOHOL	75	mL/100mL			N	20241231
42509-020_a739b70b-ccb5-caaf-e053-2a95a90ad3a2	42509-020	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333E	Wessco International	ALCOHOL	75	mL/100mL			N	20241231
42509-034_a99de9b7-49ab-9509-e053-2995a90ada9c	42509-034	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part333E	Wessco International	ALCOHOL	70	mL/100mL			N	20241231
42509-134_08aaf4ce-9b3c-5491-e063-6294a90a8a4e	42509-134	HUMAN OTC DRUG	United Dental Kit		SODIUM MONOFLUOROPHOSPHATE	KIT		20230601		OTC MONOGRAPH DRUG	M021	Wessco International						N	20241231
42509-135_08ab1b81-1f73-8a8d-e063-6394a90aa816	42509-135	HUMAN OTC DRUG	United Airlines Therabody Polaris Kit		SODIUM MONOFLUOROPHOSPHATE	KIT		20230601		OTC MONOGRAPH DRUG	M021	Wessco International						N	20241231
42509-136_08aaf4ce-9b2f-5491-e063-6294a90a8a4e	42509-136	HUMAN OTC DRUG	United Airlines Therabody UPP Kit		SODIUM MONOFLUOROPHOSPHATE	KIT		20230601		OTC MONOGRAPH DRUG	M021	Wessco International						N	20241231
42515-002_f3d13c93-5fce-43db-b25f-8e1c8cd1dfb8	42515-002	VACCINE	IXIARO		Japanese Encephalitis Vaccine, Inactivated, Adsorbed	INJECTION, SUSPENSION	INTRAMUSCULAR	20090330		BLA	BLA125280	Valneva Scotland Ltd.	JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)	6	[arb'U]/.5mL	Actively Acquired Immunity [PE], Inactivated Japanese Encephalitis Virus Vaccine [EPC], Japanese Encephalitis Vaccines [CS], Vaccines, Inactivated [CS]		N	20241231
42536-6044_bb840351-2517-431d-8d46-c80ed7c4035d	42536-6044	HUMAN PRESCRIPTION DRUG	PYtest		Urea, C-14	CAPSULE	ORAL	19970509		NDA	NDA020617	Avent, Inc.	UREA C-14	1	uCi/1			N	20241231
42543-098_192e71b5-d399-4698-88bf-534ff69d7393	42543-098	HUMAN PRESCRIPTION DRUG	Butalbital, Aspirin and Caffeine		Butalbital, Aspirin and Caffeine	TABLET	ORAL	20170622		ANDA	ANDA204195	Vensun Pharmaceuticals, Inc.	ASPIRIN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	20241231
42543-114_bceebd41-54dd-4a1e-b250-f1e460bb903d	42543-114	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20170928		ANDA	ANDA206136	Vensun Pharmaceuticals, Inc.	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42543-115_bceebd41-54dd-4a1e-b250-f1e460bb903d	42543-115	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20170928		ANDA	ANDA206136	Vensun Pharmaceuticals, Inc.	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42543-406_67ba2683-6fb5-429e-ab39-6f004ac33f1b	42543-406	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE	EXTENDED RELEASE	POTASSIUM CITRATE	TABLET	ORAL	20171101		ANDA	ANDA206813	Strides Pharma Inc.	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
42543-407_67ba2683-6fb5-429e-ab39-6f004ac33f1b	42543-407	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE	EXTENDED RELEASE	POTASSIUM CITRATE	TABLET	ORAL	20171101		ANDA	ANDA206813	Strides Pharma Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
42543-408_67ba2683-6fb5-429e-ab39-6f004ac33f1b	42543-408	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE	EXTENDED RELEASE	POTASSIUM CITRATE	TABLET	ORAL	20171101		ANDA	ANDA206813	Strides Pharma Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
42543-493_aad88d8a-234e-425b-9910-6cc98e0dca64	42543-493	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20170731		ANDA	ANDA209047	Strides Pharma Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
42543-497_2af4babe-35db-41e6-abc8-514e10fa96e0	42543-497	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	TABLET	ORAL	20170804		ANDA	ANDA209035	Strides Pharma Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
42543-700_51dfd284-b3d8-4b5c-b8d4-b93a070ddb2e	42543-700	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140731		ANDA	ANDA203374	Vensun Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
42543-712_e0dc4ba0-8ea1-47c3-8bed-427969ca5c15	42543-712	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20141027		ANDA	ANDA203646	Vensun Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42543-713_4b480542-0dd3-4694-9d43-d5fdcdd64a0f	42543-713	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel	TABLET	ORAL	20141101		ANDA	ANDA204165	Vensun Pharmaceuticals, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
42543-714_4b480542-0dd3-4694-9d43-d5fdcdd64a0f	42543-714	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel	TABLET	ORAL	20141101		ANDA	ANDA204165	Vensun Pharmaceuticals, Inc.	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
42543-725_f1764ef9-4324-4e97-a72c-d54bb09245ba	42543-725	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Vensun Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42543-726_f1764ef9-4324-4e97-a72c-d54bb09245ba	42543-726	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Vensun Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42543-727_f1764ef9-4324-4e97-a72c-d54bb09245ba	42543-727	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Vensun Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42543-741_0d50eb55-824e-47ea-a72d-562c2c351dac	42543-741	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210401		ANDA	ANDA202330	Strides Pharma Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
42543-742_0d50eb55-824e-47ea-a72d-562c2c351dac	42543-742	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210401		ANDA	ANDA202330	Strides Pharma Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
42543-743_0d50eb55-824e-47ea-a72d-562c2c351dac	42543-743	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210401		ANDA	ANDA202330	Strides Pharma Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
42543-744_0d50eb55-824e-47ea-a72d-562c2c351dac	42543-744	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210401		ANDA	ANDA202330	Strides Pharma Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
42543-787_0d50eb55-824e-47ea-a72d-562c2c351dac	42543-787	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210401		ANDA	ANDA202330	Strides Pharma Inc.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
42543-889_de78e3e6-09a1-4b72-b05e-dc8d731bb737	42543-889	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	TABLET	ORAL	20210111		ANDA	ANDA204869	Strides Pharma Inc.	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
42543-961_41b403d3-1dbf-4860-a652-bbf57fcad25d	42543-961	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20200601		ANDA	ANDA209226	Strides Pharma Inc.	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
42543-962_41b403d3-1dbf-4860-a652-bbf57fcad25d	42543-962	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20200601		ANDA	ANDA209226	Strides Pharma Inc.	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
42543-963_41b403d3-1dbf-4860-a652-bbf57fcad25d	42543-963	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20200601		ANDA	ANDA209226	Strides Pharma Inc.	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
42543-964_8940718b-0808-42fc-a5fa-eb4500182bf6	42543-964	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	Strides Pharma Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42543-965_8940718b-0808-42fc-a5fa-eb4500182bf6	42543-965	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	Strides Pharma Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42543-966_8940718b-0808-42fc-a5fa-eb4500182bf6	42543-966	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	Strides Pharma Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42546-279_45777b6d-68da-4e50-9613-dfeb5633d965	42546-279	HUMAN PRESCRIPTION DRUG	Salicylic Acid 6 percent		Salicylic Acid	SHAMPOO	TOPICAL	20090101		UNAPPROVED DRUG OTHER		PruGen LLC	SALICYLIC ACID	6	mg/100mL			N	20241231
42546-771_68acdc1d-a4e9-48a8-b5d5-71a6681ae7ee	42546-771	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20121119		ANDA	ANDA202261	PruGen Pharmaceuticals	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42546-774_68acdc1d-a4e9-48a8-b5d5-71a6681ae7ee	42546-774	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20121119		ANDA	ANDA202261	PruGen Pharmaceuticals	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42546-777_68acdc1d-a4e9-48a8-b5d5-71a6681ae7ee	42546-777	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20121119		ANDA	ANDA202261	PruGen Pharmaceuticals	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42555-060_ff2f46d9-2e02-4dd7-b6bc-b79924992b00	42555-060	HUMAN OTC DRUG	Colgate Anticavity		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20090604		OTC MONOGRAPH FINAL	part355	COLGATE-PALMOLIVE (THAILAND) LIMITED	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
42558-123_0a22dc34-4080-ab14-e063-6294a90a966f	42558-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110831		UNAPPROVED MEDICAL GAS		Bozeman Deaconess Health Services	OXYGEN	99	L/100L			N	20241231
42571-005_0369d423-9ef2-0191-e063-6294a90a55e7	42571-005	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET	ORAL	20130613		ANDA	ANDA090383	Micro Labs Limited	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-010_0369d423-9ef2-0191-e063-6294a90a55e7	42571-010	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET	ORAL	20130613		ANDA	ANDA090383	Micro Labs Limited	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-020_0369d423-9ef2-0191-e063-6294a90a55e7	42571-020	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET	ORAL	20130613		ANDA	ANDA090383	Micro Labs Limited	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-040_0369d423-9ef2-0191-e063-6294a90a55e7	42571-040	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET	ORAL	20130613		ANDA	ANDA090383	Micro Labs Limited	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-080_0369d423-9ef2-0191-e063-6294a90a55e7	42571-080	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET	ORAL	20130613		ANDA	ANDA090383	Micro Labs Limited	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-100_d2282c3d-6897-e06f-e053-2a95a90a8945	42571-100	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	Micro Labs Limited	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
42571-101_d2282c3d-6897-e06f-e053-2a95a90a8945	42571-101	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	Micro Labs Limited	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
42571-102_d2282c3d-6897-e06f-e053-2a95a90a8945	42571-102	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	Micro Labs Limited	GLIMEPIRIDE	3	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
42571-103_d2282c3d-6897-e06f-e053-2a95a90a8945	42571-103	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	Micro Labs Limited	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
42571-104_d2282c3d-6897-e06f-e053-2a95a90a8945	42571-104	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	Micro Labs Limited	GLIMEPIRIDE	6	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
42571-105_d2282c3d-6897-e06f-e053-2a95a90a8945	42571-105	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20130613		ANDA	ANDA091220	Micro Labs Limited	GLIMEPIRIDE	8	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
42571-110_d279edfe-37b8-fbf9-e053-2995a90a0c24	42571-110	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		losartan potassium	TABLET, FILM COATED	ORAL	20121206		ANDA	ANDA091541	Micro Labs Limited	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-111_d279edfe-37b8-fbf9-e053-2995a90a0c24	42571-111	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		losartan potassium	TABLET, FILM COATED	ORAL	20121206		ANDA	ANDA091541	Micro Labs Limited	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-112_d279edfe-37b8-fbf9-e053-2995a90a0c24	42571-112	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		losartan potassium	TABLET, FILM COATED	ORAL	20121206		ANDA	ANDA091541	Micro Labs Limited	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-119_0d7d551e-1eea-18b1-e063-6394a90a8ec6	42571-119	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN		TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20121215		ANDA	ANDA201952	Micro Labs Limited	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
42571-122_d287a227-5efb-c36f-e053-2995a90a4a53	42571-122	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20130930		ANDA	ANDA202046	Micro Labs Limited	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42571-128_db6b4b3b-aced-169a-e053-2995a90a30ef	42571-128	HUMAN PRESCRIPTION DRUG	BIMATOPROST		BIMATOPROST	SOLUTION/ DROPS	OPHTHALMIC	20210315		ANDA	ANDA202505	Micro Labs Limited	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
42571-130_e60a9cb0-4c72-06f4-e053-2a95a90a0ddb	42571-130	HUMAN PRESCRIPTION DRUG	Travoprost Ophthalmic		Travoprost Ophthalmic Solution	SOLUTION	OPHTHALMIC	20210415		ANDA	ANDA203767	Micro Labs Limited	TRAVOPROST	.04	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
42571-131_e3d504ca-3118-4a93-e053-2995a90ae7ce	42571-131	HUMAN PRESCRIPTION DRUG	NEVIRAPINE		NEVIRAPINE	TABLET	ORAL	20120522		ANDA	ANDA203080	Micro Labs Limited	NEVIRAPINE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
42571-132_ee467dfb-c44b-b260-e053-2995a90a7271	42571-132	HUMAN PRESCRIPTION DRUG	CROMOLYN SODIUM		Cromolyn sodium	SOLUTION, CONCENTRATE	ORAL	20130504		ANDA	ANDA202745	Micro Labs Limited	CROMOLYN SODIUM	100	mg/5mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
42571-133_f17fa649-8277-3ae8-e053-2a95a90a3c5b	42571-133	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium/Misoprostol	DICLOFENAC-SODIUM-MISOPROSTOL	Diclofenac Sodium/Misoprostol	TABLET	ORAL	20210901		ANDA	ANDA204355	Micro Labs Limited	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
42571-134_f17fa649-8277-3ae8-e053-2a95a90a3c5b	42571-134	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium/Misoprostol	DICLOFENAC-SODIUM-MISOPROSTOL	Diclofenac Sodium/Misoprostol	TABLET	ORAL	20210901		ANDA	ANDA204355	Micro Labs Limited	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
42571-137_d1aee3bb-346e-b6e9-e053-2995a90ad789	42571-137	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	SOLUTION	OPHTHALMIC	20190603		ANDA	ANDA203410	Micro Labs Limited	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-141_d1aee3bb-3431-b6e9-e053-2995a90ad789	42571-141	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride Ophthalmic Solution		Dorzolamide Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20191111		ANDA	ANDA204778	Micro Labs Limited	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
42571-142_d9da6b1b-48f3-7924-e053-2995a90a894e	42571-142	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	Micro Labs Limited	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-143_d9da6b1b-48f3-7924-e053-2995a90a894e	42571-143	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	Micro Labs Limited	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-144_d9da6b1b-48f3-7924-e053-2995a90a894e	42571-144	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	Micro Labs Limited	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-145_d9da6b1b-48f3-7924-e053-2995a90a894e	42571-145	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	Micro Labs Limited	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-147_d19b20d8-5aa6-fc19-e053-2995a90ab5f7	42571-147	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20200615		ANDA	ANDA204777	Micro Labs Limited	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	22.3; 6.8	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42571-160_0b5d12f0-f60d-a002-e063-6394a90a0d80	42571-160	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA205707	Micro Labs Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
42571-161_0b5d12f0-f60d-a002-e063-6394a90a0d80	42571-161	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA205707	Micro Labs Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
42571-162_0b5d12f0-f60d-a002-e063-6394a90a0d80	42571-162	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA204755	Micro Labs Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
42571-163_ea2eae7c-e987-534c-e053-2a95a90a26c8	42571-163	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20210701		ANDA	ANDA205187	Micro Labs Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
42571-164_ea2eae7c-e987-534c-e053-2a95a90a26c8	42571-164	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20210701		ANDA	ANDA205187	Micro Labs Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
42571-168_833c5e2e-8b64-3b8f-e053-2a91aa0ab453	42571-168	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		Levofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20190416		ANDA	ANDA205600	Micro Labs Limited	LEVOFLOXACIN	15	mg/mL			N	20241231
42571-169_ee833395-f25e-768d-e053-2995a90a7bac	42571-169	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE		Diphenhydramine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181204		ANDA	ANDA205723	Micro Labs Limited	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42571-172_f141c43d-cf68-1472-e053-2a95a90ab672	42571-172	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200101		ANDA	ANDA205945	Micro Labs Limited	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-173_f141c43d-cf68-1472-e053-2a95a90ab672	42571-173	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200101		ANDA	ANDA205945	Micro Labs Limited	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-174_f141c43d-cf68-1472-e053-2a95a90ab672	42571-174	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200101		ANDA	ANDA205945	Micro Labs Limited	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-175_f141c43d-cf68-1472-e053-2a95a90ab672	42571-175	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200101		ANDA	ANDA205945	Micro Labs Limited	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42571-176_ef264a47-84e5-e910-e053-2995a90ae48b	42571-176	HUMAN PRESCRIPTION DRUG	PIROXICAM		Piroxicam	CAPSULE	ORAL	20180301		ANDA	ANDA206152	Micro Labs Limited	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-177_ef264a47-84e5-e910-e053-2995a90ae48b	42571-177	HUMAN PRESCRIPTION DRUG	PIROXICAM		Piroxicam	CAPSULE	ORAL	20180301		ANDA	ANDA206152	Micro Labs Limited	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-189_c4c7d076-acff-4ec7-e053-2995a90a1333	42571-189	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION	INTRAVENOUS	20170801		ANDA	ANDA206713	Micro Labs Limited	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
42571-201_d1aee355-45f4-1ff5-e053-2a95a90a9d2b	42571-201	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20200203		ANDA	ANDA206372	Micro Labs Limited	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-202_d1aee355-45f4-1ff5-e053-2a95a90a9d2b	42571-202	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20200203		ANDA	ANDA206372	Micro Labs Limited	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-203_d1aee355-45f4-1ff5-e053-2a95a90a9d2b	42571-203	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20200203		ANDA	ANDA206372	Micro Labs Limited	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-220_d277f481-a137-7df3-e053-2a95a90a664a	42571-220	HUMAN PRESCRIPTION DRUG	RASAGILINE		Rasagiline	TABLET	ORAL	20190403		ANDA	ANDA207004	Micro Labs Limited	RASAGILINE MESYLATE	.5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
42571-221_d277f481-a137-7df3-e053-2a95a90a664a	42571-221	HUMAN PRESCRIPTION DRUG	RASAGILINE		Rasagiline	TABLET	ORAL	20190403		ANDA	ANDA207004	Micro Labs Limited	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
42571-226_f2aa8284-f86c-3425-e053-2995a90a6dc6	42571-226	HUMAN PRESCRIPTION DRUG	TELMISARTAN		Telmisartan	TABLET	ORAL	20180101		ANDA	ANDA207016	Micro Labs Limited	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-227_f2aa8284-f86c-3425-e053-2995a90a6dc6	42571-227	HUMAN PRESCRIPTION DRUG	TELMISARTAN		Telmisartan	TABLET	ORAL	20180101		ANDA	ANDA207016	Micro Labs Limited	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-228_f2aa8284-f86c-3425-e053-2995a90a6dc6	42571-228	HUMAN PRESCRIPTION DRUG	TELMISARTAN		Telmisartan	TABLET	ORAL	20180101		ANDA	ANDA207016	Micro Labs Limited	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42571-233_e6974958-9205-bd29-e053-2a95a90aff73	42571-233	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		Amoxicillin	CAPSULE	ORAL	20221101		ANDA	ANDA207471	Micro Labs Limited	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42571-234_e6974958-9205-bd29-e053-2a95a90aff73	42571-234	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		Amoxicillin	CAPSULE	ORAL	20221101		ANDA	ANDA207471	Micro Labs Limited	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42571-235_d171c368-ee05-2397-e053-2995a90a7d2d	42571-235	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND OLMESARTAN MEDOXOMIL		Amlodipine and Olmesartan Medoxomil	TABLET	ORAL	20180101		ANDA	ANDA207435	Micro Labs Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42571-236_d171c368-ee05-2397-e053-2995a90a7d2d	42571-236	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND OLMESARTAN MEDOXOMIL		Amlodipine and Olmesartan Medoxomil	TABLET	ORAL	20180101		ANDA	ANDA207435	Micro Labs Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42571-237_d171c368-ee05-2397-e053-2995a90a7d2d	42571-237	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND OLMESARTAN MEDOXOMIL		Amlodipine and Olmesartan Medoxomil	TABLET	ORAL	20180101		ANDA	ANDA207435	Micro Labs Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42571-238_d171c368-ee05-2397-e053-2995a90a7d2d	42571-238	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND OLMESARTAN MEDOXOMIL		Amlodipine and Olmesartan Medoxomil	TABLET	ORAL	20180101		ANDA	ANDA207435	Micro Labs Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42571-239_9ebf7533-27e6-54c2-e053-2995a90ae560	42571-239	HUMAN PRESCRIPTION DRUG	METHAZOLAMIDE		Methazolamide	TABLET	ORAL	20190305		ANDA	ANDA207438	Micro Labs Limited	METHAZOLAMIDE	25	mg/1			N	20241231
42571-240_9ebf7533-27e6-54c2-e053-2995a90ae560	42571-240	HUMAN PRESCRIPTION DRUG	METHAZOLAMIDE		Methazolamide	TABLET	ORAL	20190305		ANDA	ANDA207438	Micro Labs Limited	METHAZOLAMIDE	50	mg/1			N	20241231
42571-241_f0ce1ca1-67e4-8c69-e053-2995a90aae76	42571-241	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20200701		ANDA	ANDA207403	Micro Labs Limited	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42571-242_f0ce1ca1-67e4-8c69-e053-2995a90aae76	42571-242	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20200701		ANDA	ANDA207403	Micro Labs Limited	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42571-243_dfba4fe1-a84c-e54a-e053-2a95a90a3023	42571-243	HUMAN PRESCRIPTION DRUG	ACETAZOLAMIDE EXTENDED-RELEASE		Acetazolamide Extended-Release	CAPSULE	ORAL	20201201		ANDA	ANDA207401	Micro Labs Limited	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
42571-244_a136688e-42a6-d318-e053-2995a90ac9d3	42571-244	HUMAN PRESCRIPTION DRUG	CAFFEINE CITRATE		Caffeine Citrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20171230		ANDA	ANDA207400	Micro Labs Limited	CAFFEINE CITRATE	60	mg/3mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
42571-250_e09d134a-2719-5b04-e053-2a95a90a236e	42571-250	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Micro Labs Limited	CLINDAMYCIN HYDROCHLORIDE	75	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
42571-251_e09d134a-2719-5b04-e053-2a95a90a236e	42571-251	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Micro Labs Limited	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
42571-252_e09d134a-2719-5b04-e053-2a95a90a236e	42571-252	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Micro Labs Limited	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
42571-253_ecee2036-76c1-3433-e053-2995a90a0f30	42571-253	HUMAN PRESCRIPTION DRUG	MISOPROSTOL		Misoprostol	TABLET	ORAL	20230101		ANDA	ANDA216872	Micro Labs Limited	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
42571-254_ecee2036-76c1-3433-e053-2995a90a0f30	42571-254	HUMAN PRESCRIPTION DRUG	MISOPROSTOL		Misoprostol	TABLET	ORAL	20230101		ANDA	ANDA216872	Micro Labs Limited	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
42571-258_f210df97-172c-31e9-e053-2995a90a00be	42571-258	HUMAN PRESCRIPTION DRUG	Mefenamic acid		Mefenamic acid	CAPSULE	ORAL	20101119		ANDA	ANDA090562	Micro Labs Limited	MEFENAMIC ACID	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42571-259_fa1415ba-cf19-8b70-e053-6394a90af9a6	42571-259	HUMAN PRESCRIPTION DRUG	ROFLUMILAST		Roflumilast	TABLET	ORAL	20221019		ANDA	ANDA208180	Micro Labs Limited	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
42571-264_e102c927-d0ea-b388-e053-2995a90aab46	42571-264	HUMAN PRESCRIPTION DRUG	tafluprost		tafluprost opthalmic	SOLUTION/ DROPS	OPHTHALMIC	20221118		ANDA	ANDA209051	Micro Labs Limited	TAFLUPROST	.0045	mg/.3mL	Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]		N	20241231
42571-265_9bb02a55-9e19-748b-e053-2995a90a900a	42571-265	HUMAN PRESCRIPTION DRUG	SODIUM NITROPRUSSIDE		SODIUM NITROPRUSSIDE	INJECTION	INTRAVENOUS	20171230		ANDA	ANDA209352	Micro Labs Limited	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
42571-274_ee82d0f1-56d0-10ec-e053-2995a90ac665	42571-274	HUMAN PRESCRIPTION DRUG	ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE		ASPIRIN and Extended-Release DIPYRIDAMOLE	CAPSULE, EXTENDED RELEASE	ORAL	20210816		ANDA	ANDA209929	Micro Labs Limited	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
42571-275_ee82b88c-e152-0978-e053-2a95a90ab5f1	42571-275	HUMAN PRESCRIPTION DRUG	DALFAMPRIDINE		DALFAMPRIDINE	TABLET, EXTENDED RELEASE	ORAL	20190321		ANDA	ANDA210158	Micro Labs Limited	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
42571-294_ed7a8636-e10f-71c6-e053-2995a90a728b	42571-294	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION	INTRAVENOUS	20210501		ANDA	ANDA210845	Micro Labs Limited	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
42571-302_f29c1a2e-70e3-1dc5-e053-2a95a90ae382	42571-302	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide and Amitriptyline Hydrochloride		Chlordiazepoxide and Amitriptyline Hydrochloride	TABLET	ORAL	20220401		ANDA	ANDA211925	Micro Labs Limited	AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE	5; 12.5	mg/1; mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Tricyclic Antidepressant [EPC]	CIV	N	20241231
42571-303_f29c1a2e-70e3-1dc5-e053-2a95a90ae382	42571-303	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide and Amitriptyline Hydrochloride		Chlordiazepoxide and Amitriptyline Hydrochloride	TABLET	ORAL	20220401		ANDA	ANDA211925	Micro Labs Limited	AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE	10; 25	mg/1; mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Tricyclic Antidepressant [EPC]	CIV	N	20241231
42571-312_96ce7d6a-5c89-b6fa-e053-2a95a90a918c	42571-312	HUMAN OTC DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20190201		ANDA	ANDA211551	Micro Labs Limited	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42571-313_874186a5-c314-9d21-e053-2995a90ae376	42571-313	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20190304		ANDA	ANDA211370	Micro Labs Limited	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
42571-314_c4c7d076-acff-4ec7-e053-2995a90a1333	42571-314	HUMAN PRESCRIPTION DRUG	TRANEXAMIC ACID		TRANEXAMIC ACID	INJECTION	INTRAVENOUS	20170801		ANDA	ANDA206713	Micro Labs Limited	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
42571-315_f42f340b-8775-51dc-e053-2a95a90a2062	42571-315	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20190402		ANDA	ANDA211711	Micro Labs Limited	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
42571-316_f42f340b-8775-51dc-e053-2a95a90a2062	42571-316	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20190402		ANDA	ANDA211711	Micro Labs Limited	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
42571-324_d172a3c8-ae0a-9ccb-e053-2a95a90a069e	42571-324	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20200601		ANDA	ANDA211745	Micro Labs Limited	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
42571-325_d172a3c8-ae0a-9ccb-e053-2a95a90a069e	42571-325	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20200601		ANDA	ANDA211745	Micro Labs Limited	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
42571-330_ed7a8636-e10f-71c6-e053-2995a90a728b	42571-330	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION	INTRAVENOUS	20210501		ANDA	ANDA210845	Micro Labs Limited	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
42571-331_06551dd6-d0e2-2852-e063-6394a90ac2fb	42571-331	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	INJECTION	INTRAVENOUS	20191004		ANDA	ANDA211954	Micro Labs Limited	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42571-332_d19b20d8-5a5d-fc19-e053-2995a90ab5f7	42571-332	HUMAN PRESCRIPTION DRUG	Methenamine Hippurate		Methenamine Hippurate	TABLET	ORAL	20190815		ANDA	ANDA212172	Micro Labs Limited	METHENAMINE HIPPURATE	1000	mg/1			N	20241231
42571-333_f20dafcf-7ee0-3608-e053-2995a90a8c47	42571-333	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230301		ANDA	ANDA212448	Micro Labs Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42571-334_f20dafcf-7ee0-3608-e053-2995a90a8c47	42571-334	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230301		ANDA	ANDA212448	Micro Labs Limited	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42571-335_fd363916-d208-9681-e053-6294a90a0b1e	42571-335	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA212680	Micro Labs Limited	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42571-336_fd363916-d208-9681-e053-6294a90a0b1e	42571-336	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA212680	Micro Labs Limited	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
42571-337_ee833395-f25e-768d-e053-2995a90a7bac	42571-337	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE		Diphenhydramine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191210		ANDA	ANDA205723	Micro Labs Limited	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42571-342_ee83212d-fdc1-cf00-e053-2995a90ac21b	42571-342	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20200901		ANDA	ANDA213219	Micro Labs Limited	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-343_ee83212d-fdc1-cf00-e053-2995a90ac21b	42571-343	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20200901		ANDA	ANDA213219	Micro Labs Limited	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-344_ee83212d-fdc1-cf00-e053-2995a90ac21b	42571-344	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20200901		ANDA	ANDA213219	Micro Labs Limited	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-346_9a944c51-5ad3-2dc8-e053-2a95a90a4fce	42571-346	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		Caffeine Citrate	SOLUTION	ORAL	20200201		ANDA	ANDA213202	Micro Labs Limited	CAFFEINE CITRATE	60	mg/3mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
42571-347_ee833c1c-286f-61c4-e053-2995a90a30f1	42571-347	HUMAN PRESCRIPTION DRUG	Fenofibric acid		Fenofibric acid	CAPSULE, DELAYED RELEASE	ORAL	20200901		ANDA	ANDA213450	Micro Labs Limited	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42571-348_ee833c1c-286f-61c4-e053-2995a90a30f1	42571-348	HUMAN PRESCRIPTION DRUG	Fenofibric acid		Fenofibric acid	CAPSULE, DELAYED RELEASE	ORAL	20200901		ANDA	ANDA213450	Micro Labs Limited	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42571-350_de292bdb-6079-23d6-e053-2995a90afd78	42571-350	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	INHALANT	INTRABRONCHIAL	20220601		ANDA	ANDA213658	Micro Labs Limited	CROMOLYN SODIUM	20	mg/2mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
42571-357_34b6d1d5-3724-4de2-b598-6a6b815fd882	42571-357	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20210521		ANDA	ANDA211648	MICRO LABS LIMITED	POTASSIUM CHLORIDE	1.5	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
42571-358_34b6d1d5-3724-4de2-b598-6a6b815fd882	42571-358	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20210521		ANDA	ANDA211648	MICRO LABS LIMITED	POTASSIUM CHLORIDE	3	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
42571-360_71823f89-ee1b-4fda-a16c-a2b22fde7de1	42571-360	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride Oral Solution		Metformin Hydrochloride	SOLUTION	ORAL	20200420		ANDA	ANDA211309	MICRO LABS LIMITED	METFORMIN HYDROCHLORIDE	500	mg/5mL	Biguanide [EPC], Biguanides [CS]		N	20241231
42571-362_c9436f21-16f0-41ba-8990-b5ee5507fb48	42571-362	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		clobetasol propionate	SOLUTION	TOPICAL	20191002		ANDA	ANDA211494	Micro Labs Limited	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42571-369_fa1415ba-cf19-8b70-e053-6394a90af9a6	42571-369	HUMAN PRESCRIPTION DRUG	ROFLUMILAST		ROFLUMILAST	TABLET	ORAL	20230501		ANDA	ANDA208180	Micro Labs Limited	ROFLUMILAST	250	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
42571-371_ed051eb0-a20f-20f9-e053-2a95a90af067	42571-371	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210301		ANDA	ANDA214879	Micro Labs Limited	SUCCINYLCHOLINE CHLORIDE	200	mg/10mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
42571-374_e2cf9f04-64e0-4a9c-e053-2a95a90a25ba	42571-374	HUMAN PRESCRIPTION DRUG	Lincomycin		Lincomycin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220201		ANDA	ANDA215082	Micro Labs Limited	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
42571-375_f4561217-1074-273d-e053-2995a90a2157	42571-375	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20230501		ANDA	ANDA215243	Micro Labs Limited	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
42571-378_d807f196-f1f8-0a8f-e053-2a95a90aab8d	42571-378	HUMAN PRESCRIPTION DRUG	SEVELAMER CARBONATE		SEVELAMER CARBONATE	TABLET	ORAL	20220501		ANDA	ANDA215537	Micro Labs Limited	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
42571-381_fa3753a6-a410-6ae8-e053-6394a90a0106	42571-381	HUMAN PRESCRIPTION DRUG	CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE		CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE	CAPSULE	ORAL	20221001		ANDA	ANDA215835	Micro Labs Limited	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
42571-382_0650384a-621f-6c0c-e063-6294a90a82f7	42571-382	HUMAN PRESCRIPTION DRUG	DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE		DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE	SOLUTION/ DROPS	OPHTHALMIC	20220215		ANDA	ANDA215936	Micro Labs Limited	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42571-384_ef68c009-7789-4c11-82e3-4200b9469987	42571-384	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	SOLUTION	TOPICAL	20210604		ANDA	ANDA062687	MICRO LABS LIMITED	ERYTHROMYCIN	20	mg/mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
42571-385_74570965-ebb6-417b-a84e-68a8956e9b52	42571-385	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	LOTION	TOPICAL	20210816		ANDA	ANDA040672	MICRO LABS LIMITED	TRIAMCINOLONE ACETONIDE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42571-387_0770266d-0043-f296-e063-6294a90a1d1c	42571-387	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20230101		ANDA	ANDA216232	Micro Labs Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42571-388_0770266d-0043-f296-e063-6294a90a1d1c	42571-388	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20230101		ANDA	ANDA216232	Micro Labs Limited	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42571-389_0770266d-0043-f296-e063-6294a90a1d1c	42571-389	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20230101		ANDA	ANDA216232	Micro Labs Limited	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42571-391_fbdca190-53fc-29e9-e053-6394a90abafe	42571-391	HUMAN PRESCRIPTION DRUG	RUFINAMIDE		RUFINAMIDE	TABLET	ORAL	20230701		ANDA	ANDA216688	Micro Labs Limited	RUFINAMIDE	200	mg/1			N	20241231
42571-392_fbdca190-53fc-29e9-e053-6394a90abafe	42571-392	HUMAN PRESCRIPTION DRUG	RUFINAMIDE		RUFINAMIDE	TABLET	ORAL	20230701		ANDA	ANDA216688	Micro Labs Limited	RUFINAMIDE	400	mg/1			N	20241231
42571-394_007019a4-32ef-56c9-e063-6294a90a7bbd	42571-394	HUMAN PRESCRIPTION DRUG	NICARDIPINE HYDROCHLORIDE		NICARDIPINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20231101		ANDA	ANDA216420	Micro Labs Limited	NICARDIPINE HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42571-398_e83cac2d-dac4-b4d0-e053-2a95a90acbd8	42571-398	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20230101		ANDA	ANDA216596	Micro Labs Limited	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42571-403_fe89ee54-4067-df4e-e053-6394a90aa1e4	42571-403	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20230801		ANDA	ANDA217343	Micro Labs Limited	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42571-404_fe89ee54-4067-df4e-e053-6394a90aa1e4	42571-404	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20230801		ANDA	ANDA217343	Micro Labs Limited	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42571-408_01d5a13f-7719-b208-e063-6294a90a560b	42571-408	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin solution	INHALANT	RESPIRATORY (INHALATION)	20240101		ANDA	ANDA217344	Micro Labs Limited	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
42571-414_03a665f9-f328-83d4-e063-6294a90a756a	42571-414	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20240101		ANDA	ANDA217504	Micro Labs Limited	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
42571-415_03a665f9-f328-83d4-e063-6294a90a756a	42571-415	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20240101		ANDA	ANDA217504	Micro Labs Limited	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
42571-420_ffb6da56-b51c-dd9b-e053-6394a90a366c	42571-420	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20240101		ANDA	ANDA217688	Micro Labs Limited	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-421_ffb6da56-b51c-dd9b-e053-6394a90a366c	42571-421	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20240101		ANDA	ANDA217688	Micro Labs Limited	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-422_ffb6da56-b51c-dd9b-e053-6394a90a366c	42571-422	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20240101		ANDA	ANDA217688	Micro Labs Limited	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-423_ffb6da56-b51c-dd9b-e053-6394a90a366c	42571-423	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20240101		ANDA	ANDA217688	Micro Labs Limited	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-424_ffb6da56-b51c-dd9b-e053-6394a90a366c	42571-424	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20240101		ANDA	ANDA217688	Micro Labs Limited	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42571-433_065703de-56a8-fcf1-e063-6294a90a91b7	42571-433	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	POWDER, FOR SUSPENSION	ORAL	20231201		ANDA	ANDA217842	Micro Labs Limited	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
42582-114_2623362f-c5cd-4880-bb49-2d64bedf7be0	42582-114	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160413		ANDA	ANDA090007	Bi-Coastal Pharma International LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42582-115_2623362f-c5cd-4880-bb49-2d64bedf7be0	42582-115	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160413		ANDA	ANDA090007	Bi-Coastal Pharma International LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42582-116_2623362f-c5cd-4880-bb49-2d64bedf7be0	42582-116	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160413		ANDA	ANDA090007	Bi-Coastal Pharma International LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42584-0080_7152ba10-c277-4967-974f-f611fbe31756	42584-0080	HUMAN OTC DRUG	RENOWN Antibacterial Foam		Chloroxylenol	LIQUID	TOPICAL	20200224		OTC MONOGRAPH NOT FINAL	part333E	Home Depot U.S.A., Inc.	CHLOROXYLENOL	.3	mg/100mL			N	20241231
42584-0081_5967c112-aa66-4364-b62e-b225847054b9	42584-0081	HUMAN OTC DRUG	RENOWN Antibacterial Foam Cleanser		Chloroxylenol	LIQUID	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333E	Home Depot U.S.A., Inc.	CHLOROXYLENOL	.3	mg/100mL			N	20241231
42584-0400_cde76bf7-9a4a-4b90-9bac-89937478e5b2	42584-0400	HUMAN OTC DRUG	RENOWN Antibacterial Plum Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part333E	Home Depot U.S.A., Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
42602-001_45a5f3e1-1d1e-449f-8ad1-052158378afa	42602-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20080901		NDA	NDA205820	Norco, Inc.	OXYGEN	999	L/1000L			N	20241231
42602-002_16b209e5-e5e4-4478-bc28-bd2c2adc94ac	42602-002	HUMAN PRESCRIPTION DRUG	HELIUM		HELIUM	GAS	RESPIRATORY (INHALATION)	20080901		NDA	NDA205819	Norco, Inc.	HELIUM	99	L/100L			N	20241231
42602-003_4d8cbbf6-d1f5-4b9b-9c06-cab4ab08c9e5	42602-003	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	20080901		NDA	NDA206009	Norco, Inc	NITROUS OXIDE	99	L/100L			N	20241231
42602-004_405385f7-64e4-49cf-abeb-01da8f5f70af	42602-004	HUMAN PRESCRIPTION DRUG	MEDICAL AIR		OXYGEN	GAS	RESPIRATORY (INHALATION)	20080901		NDA	NDA205820	Norco, Inc.	OXYGEN	23	L/100L			N	20241231
42602-005_c2f79fd6-c95e-49c4-abe0-df8e1f4e0bec	42602-005	HUMAN PRESCRIPTION DRUG	NITROGEN	NF	NITROGEN	GAS	RESPIRATORY (INHALATION)	20030227		NDA	NDA205805	Norco, Inc	NITROGEN	999	L/1000L			N	20241231
42602-006_82e62ec8-bba1-4cef-a2fc-59de4cb8a403	42602-006	HUMAN PRESCRIPTION DRUG	CARBON DIOXIDE		CARBON DIOXIDE	GAS	RESPIRATORY (INHALATION)	20080901		NDA	NDA205764	Norco, Inc	CARBON DIOXIDE	99	L/100L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
42602-007_fbf1d73e-a850-4f5c-9a2a-49250d9d974c	42602-007	HUMAN PRESCRIPTION DRUG	COMPRESSED Gas, N.O.S.		OXYGEN, HELIUM	GAS	RESPIRATORY (INHALATION)	20080901		UNAPPROVED MEDICAL GAS		Norco, Inc.	HELIUM; OXYGEN	79.6; 20.4	L/100L; L/100L			N	20241231
42602-008_bc5d2740-e16f-4476-b5e5-173e4c4fcfa0	42602-008	HUMAN PRESCRIPTION DRUG	COMPRESSED Gas OXIDIZING, N.O.S.		OXYGEN, HELIUM	GAS	RESPIRATORY (INHALATION)	20080901		UNAPPROVED MEDICAL GAS		Norco, Inc.	HELIUM; OXYGEN	70; 30	L/100L; L/100L			N	20241231
42627-254_ec2002b0-3529-6099-e053-2995a90ae314	42627-254	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Shell	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42627-255_ec1ff2fc-88ca-3feb-e053-2a95a90a18ac	42627-255	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Ivory	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42627-256_ec2013ba-0c90-5b46-e053-2a95a90a0e20	42627-256	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Light Beige	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42627-257_ec201f14-7537-2a44-e053-2995a90a7f2a	42627-257	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Sand	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42627-258_ec2024e4-22d8-df58-e053-2a95a90afe77	42627-258	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Beige	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42627-260_ec2027ec-00b4-06c9-e053-2a95a90a937a	42627-260	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Nude	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42627-261_ec2024e4-22e8-df58-e053-2a95a90afe77	42627-261	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Warm Ivory	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42627-264_ec20396d-3be1-6cdc-e053-2995a90a9f75	42627-264	HUMAN OTC DRUG	Illusion Tinted Moisturizer Broad Spectrum Golden	SPF 15	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part352	Kingdom Animalia, LLC DBA Hourglass Cosmetics	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7; 4; 4	g/100mL; g/100mL; g/100mL			N	20241231
42637-803_09148806-b5ab-03bd-e063-6294a90a27d5	42637-803	HUMAN OTC DRUG	Olbas Lozenges	Maximun Strength	Menthol	LOZENGE	ORAL	20100405		OTC MONOGRAPH DRUG	M012	Jakemans (Confectioners) Limited	MENTHOL	10	mg/1			N	20241231
42637-824_09148806-b5aa-03bd-e063-6294a90a27d5	42637-824	HUMAN OTC DRUG	Jakemans Throat and Chest Peppermint		Menthol	LOZENGE	ORAL	20131211		OTC MONOGRAPH DRUG	M012	Jakemans (Confectioners) Ltd.	MENTHOL	5	mg/1			N	20241231
42637-825_085f988a-27d1-bfc6-e063-6294a90a0e9d	42637-825	HUMAN OTC DRUG	Jakemans Throat and Chest Cherry		Menthol	LOZENGE	ORAL	20110713		OTC MONOGRAPH DRUG	M012	Jakemans (Confectioners) Limited	MENTHOL	5	mg/1			N	20241231
42637-826_085f9216-2855-c021-e063-6294a90a4ccb	42637-826	HUMAN OTC DRUG	Jakemans Throat and Chest Honey and Lemon		Menthol	LOZENGE	ORAL	20110713		OTC MONOGRAPH DRUG	M012	Jakemans (Confectioners) Limited	MENTHOL	5	mg/1			N	20241231
42637-827_085f6eec-cf92-05a3-e063-6394a90aeee8	42637-827	HUMAN OTC DRUG	Jakemans Throat and Chest Anise		Menthol	LOZENGE	ORAL	20110713		OTC MONOGRAPH DRUG	M012	Jakemans (Confectioners) Limited	MENTHOL	5	mg/1			N	20241231
42658-008_af836a30-5e58-5c97-e053-2995a90a15b9	42658-008	HUMAN PRESCRIPTION DRUG	Dactinomycin		dactinomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210101		ANDA	ANDA207232	Hisun Pharmaceuticals USA, Inc.	DACTINOMYCIN	.5	mg/1	Actinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]		N	20241231
42658-010_f538b1e1-8d47-4ad9-e053-2995a90a91db	42658-010	HUMAN PRESCRIPTION DRUG	Cladribine		Cladribine	INJECTION, SOLUTION	INTRAVENOUS	20200518		ANDA	ANDA210856	Hisun Pharmaceuticals USA, Inc.	CLADRIBINE	1	mg/mL	Purine Antimetabolite [EPC]		N	20241231
42658-019_ba721991-179e-273f-e053-2995a90a9236	42658-019	HUMAN PRESCRIPTION DRUG	Daunorubicin Hydrochloride		daunorubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200120		ANDA	ANDA208759	Hisun Pharmaceuticals USA, Inc.	DAUNORUBICIN HYDROCHLORIDE	5	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
42658-021_ba721991-179e-273f-e053-2995a90a9236	42658-021	HUMAN PRESCRIPTION DRUG	Daunorubicin Hydrochloride		daunorubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200120		ANDA	ANDA208759	Hisun Pharmaceuticals USA, Inc.	DAUNORUBICIN HYDROCHLORIDE	5	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
42658-021_f43105cb-1807-45f2-e053-2995a90a4d6b	42658-021	HUMAN PRESCRIPTION DRUG	Daunorubicin Hydrochloride		daunorubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200120		ANDA	ANDA208759	Hisun Pharmaceuticals USA, Inc.	DAUNORUBICIN HYDROCHLORIDE	5	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
42658-101_05211c2c-ee02-fcec-e063-6394a90a6f59	42658-101	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA204076	Hisun Pharmaceuticals USA, Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
42658-108_05996dbc-0aa7-0c1a-e063-6294a90a3b67	42658-108	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA206557	Hisun Pharmaceuticals USA, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42658-109_05996dbc-0aa7-0c1a-e063-6294a90a3b67	42658-109	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA206557	Hisun Pharmaceuticals USA, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42658-110_05996dbc-0aa7-0c1a-e063-6294a90a3b67	42658-110	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA206557	Hisun Pharmaceuticals USA, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42658-111_05996dbc-0aa7-0c1a-e063-6294a90a3b67	42658-111	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA206557	Hisun Pharmaceuticals USA, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42658-121_d05d838a-88eb-7e1b-e053-2995a90a5177	42658-121	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET, FILM COATED	ORAL	20170415		ANDA	ANDA206194	Hisun Pharmaceuticals USA Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42658-122_d05d838a-88eb-7e1b-e053-2995a90a5177	42658-122	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET, FILM COATED	ORAL	20170415		ANDA	ANDA206194	Hisun Pharmaceuticals USA Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42658-123_d05d838a-88eb-7e1b-e053-2995a90a5177	42658-123	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET, FILM COATED	ORAL	20170415		ANDA	ANDA206194	Hisun Pharmaceuticals USA Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42658-501_05211c2c-ee02-fcec-e063-6394a90a6f59	42658-501	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	CAPSULE	ORAL	20230901		ANDA	ANDA204077	Hisun Pharmaceuticals USA, Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
42667-5511_f032bccc-33cf-4e7d-e053-2995a90ac5ea	42667-5511	HUMAN PRESCRIPTION DRUG	Natesto	nasal gel	testosterone	GEL, METERED	NASAL	20200508		NDA	NDA205488	Acerus Pharmaceuticals Corporation	TESTOSTERONE	5.5	mg/.122g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
42669-015_fae30560-efb2-6209-e053-6394a90a7baf	42669-015	HUMAN OTC DRUG	Germ Eliminator		Ethyl Alcohol 62%	LIQUID	TOPICAL	20230504		OTC MONOGRAPH NOT FINAL	part333E	Davion, Inc	ALCOHOL	62	mL/100mL			N	20241231
42673-000_e9218bc1-d4a8-7c8d-e053-2995a90a4b9d	42673-000	HUMAN OTC DRUG	Epionce Renewal Calming Cream		OATMEAL	CREAM	TOPICAL	20180228	20241231	OTC MONOGRAPH FINAL	part347	Episciences, Inc.	OATMEAL	.03	g/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
42673-005_06bfa5e7-2ae9-b704-e063-6394a90ac4cd	42673-005	HUMAN OTC DRUG	Epionce Daily Shield	Tinted SPF 50	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20170227		OTC MONOGRAPH DRUG	M020	Episciences, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	.048; .093	g/g; g/g			N	20241231
42673-007_e08e64bb-bd7f-8949-e053-2995a90aa70a	42673-007	HUMAN OTC DRUG	Epionce Purifying Spot Gel		Sulfur	GEL	TOPICAL	20181002	20240531	OTC MONOGRAPH FINAL	part333D	Episciences, Inc.	SULFUR	.033	g/g			N	
42673-008_e9219278-9b6f-e7d8-e053-2995a90a6854	42673-008	HUMAN OTC DRUG	Epionce Purifying Wash		Salicylic Acid	GEL	TOPICAL	20181002	20240831	OTC MONOGRAPH FINAL	part333D	Episciences, Inc	SALICYLIC ACID	.006	g/g			N	
42673-009_e921b28d-776a-1cdc-e053-2995a90aeb07	42673-009	HUMAN OTC DRUG	Epionce Renewal Calming Cream		OATMEAL	CREAM	TOPICAL	20180924	20241231	OTC MONOGRAPH FINAL	part347	Episciences, Inc.	OATMEAL	.03	g/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
42673-011_e921a5c1-d0f7-0004-e053-2995a90af6e5	42673-011	HUMAN OTC DRUG	Epionce Ultra Shield		Homosalate, Octisalate, Zinc Oxide	LOTION	TOPICAL	20090406	20240831	OTC MONOGRAPH NOT FINAL	part352	Episciences, Inc.	HOMOSALATE; OCTISALATE; ZINC OXIDE	.1; .05; .101	g/g; g/g; g/g			N	
42677-301_0ea46597-f550-4ae6-e063-6394a90a3f03	42677-301	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220122		ANDA	ANDA207375	Shandong New Time Pharmaceutical Co., Ltd.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
42677-302_0ea46597-f550-4ae6-e063-6394a90a3f03	42677-302	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220122		ANDA	ANDA207375	Shandong New Time Pharmaceutical Co., Ltd.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
42677-307_0d24d7dd-03b9-21f0-e063-6294a90af6df	42677-307	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20220429		ANDA	ANDA214115	Shandong New Time Pharmaceutical Co., Ltd.	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
42677-308_0eb9fc59-7f8e-f64b-e063-6394a90a025e	42677-308	HUMAN PRESCRIPTION DRUG	Sevoflurane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20230818		ANDA	ANDA214382	Shandong New Time Pharmaceutical Co., Ltd.	SEVOFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20251231
42677-313_0e939452-59af-27fc-e063-6394a90a780c	42677-313	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20230228		ANDA	ANDA216373	Shandong New Time Pharmaceutical Co., Ltd.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20251231
42677-314_0e939452-59af-27fc-e063-6394a90a780c	42677-314	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20230301		ANDA	ANDA216373	Shandong New Time Pharmaceutical Co., Ltd.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20251231
42681-0001_9a822d2a-d9c2-4647-a74d-9641f949d96b	42681-0001	HUMAN OTC DRUG	365 Medicated Lip Balm		Medicated Lip Balm	STICK	TOPICAL	20190613		OTC MONOGRAPH DRUG	M017	Whole Foods Market, Inc.	CAMPHOR (NATURAL)	.0578	g/4.25g			N	20241231
42681-0002_8ad61adf-e90a-60bc-e053-2995a90a23c0	42681-0002	HUMAN OTC DRUG	Hand Sanitizer	Peppermint Vanilla	Ethyl Alcohol	GEL	TOPICAL	20190608	20250608	OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	
42681-0003_8ad5ef9d-859d-f9fe-e053-2995a90a2656	42681-0003	HUMAN OTC DRUG	Hand Sanitizer	Peppermint Vanilla	Ethyl Alcohol	GEL	TOPICAL	20190608	20250608	OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	
42681-0004_9cd42fcb-5eac-41e9-9dbf-123f1f6c3b89	42681-0004	HUMAN OTC DRUG	WHOLE FOODS MARKET Health Ultra Strength Natural Antacid	Peppermint Flavor	Antacid Tablets	TABLET, CHEWABLE	ORAL	20190805		OTC MONOGRAPH DRUG	M001	WHOLE FOODS MARKET, INC.	CALCIUM CARBONATE	1000	mg/1			N	20241231
42681-0006_0742f251-5fca-c015-e063-6394a90a79b1	42681-0006	HUMAN OTC DRUG	Hand Sanitizer	Lavender	Ethyl Alcohol	SPRAY	TOPICAL	20200101		OTC MONOGRAPH DRUG	M003	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	20241231
42681-0007_07434f9b-bc97-b099-e063-6394a90a2861	42681-0007	HUMAN OTC DRUG	Hand Sanitizer	Orange Blossom	Ethyl Alcohol	SPRAY	TOPICAL	20231009		OTC MONOGRAPH DRUG	M016	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	20241231
42681-0008_9d89e245-7069-fe1d-e053-2995a90ab420	42681-0008	HUMAN OTC DRUG	Hand Sanitizer	Mojito Mint	Organic Ethyl Alcohol	SPRAY	TOPICAL	20200101	20241231	OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	
42681-0009_07432a3e-3dc6-027d-e063-6294a90a5c5f	42681-0009	HUMAN OTC DRUG	Hand Sanitizer	Cucumber Aloe	Ethyl Alcohol	SPRAY	TOPICAL	20231009		OTC MONOGRAPH DRUG	M003	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	20241231
42681-0010_be1b5371-0bf6-7fb7-e053-2995a90a11a6	42681-0010	HUMAN OTC DRUG	Hand Sanitizer	Lavender	Ethyl Alcohol	GEL	TOPICAL	20200101	20241231	OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	
42681-0013_3f3fcba9-fdb9-46ce-a1dd-8271d2b3555c	42681-0013	HUMAN OTC DRUG	365 Everyday Value Aspirin		aspirin	TABLET, FILM COATED	ORAL	20210608		OTC MONOGRAPH NOT FINAL	part343	Whole Foods Market, INC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
42681-0019_0c6b7e41-fc9a-3c04-e063-6394a90a64af	42681-0019	HUMAN OTC DRUG	Spearmint Whitening with Hemp Oil		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20200429		OTC MONOGRAPH DRUG	M021	Whole Foods	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
42681-0023_715585a3-4285-4c08-bae3-ac88c5390b53	42681-0023	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
42681-0025_57f89574-98e5-40e5-8dd4-e868a668adaa	42681-0025	HUMAN OTC DRUG	365 everyday value acetaminophen		Acetaminophen	TABLET	ORAL	20200823		OTC MONOGRAPH NOT FINAL	part343	Whole Foods Market, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
42681-0026_b61a2293-6d35-4273-8a27-ccde1f987757	42681-0026	HUMAN OTC DRUG	365 everday value ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200824		ANDA	ANDA072096	Whole Foods Market, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42681-0028_bfd7d847-f87f-4337-a137-7441c208c7fe	42681-0028	HUMAN OTC DRUG	Whole Foods Market Regular Strength	Peppermint Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220124		OTC MONOGRAPH DRUG	M001	WHOLE FOODS MARKET, INC.	CALCIUM CARBONATE	500	mg/1			N	20241231
42681-0029_bcdc1c41-3769-41a4-8687-986e9fdfd749	42681-0029	HUMAN OTC DRUG	Whole Foods Market Regular Strength	Peppermint Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220124		OTC MONOGRAPH DRUG	M001	WHOLE FOODS MARKET, INC.	CALCIUM CARBONATE	500	mg/1			N	20241231
42681-0030_0c6b671d-56ab-6dd7-e063-6294a90a77d3	42681-0030	HUMAN OTC DRUG	AntiDandruffShampooConditioner		365 Anti Dandruff Shampoo Conditioner 2 in 1	SHAMPOO	TOPICAL	20210604		OTC MONOGRAPH DRUG	M032	Whole Foods Market, Inc.	SALICYLIC ACID	3	mg/100mL			N	20241231
42681-0031_0c6b89fc-062c-a83b-e063-6294a90ae3b1	42681-0031	HUMAN OTC DRUG	AntiDandruffShampoo		365 Anti Dandruff Shampoo	SHAMPOO	TOPICAL	20210604		OTC MONOGRAPH DRUG	M032	Whole Foods Market, Inc.	SALICYLIC ACID	30	mg/100mL			N	20241231
42681-0032_0c91a14a-1a9c-7231-e063-6294a90a6d06	42681-0032	HUMAN OTC DRUG	BabyDiaperCream		Baby Diaper Cream	CREAM	TOPICAL	20220101		OTC MONOGRAPH DRUG	M016	Whole Foods Market	ZINC OXIDE	14	g/100g			N	20241231
42681-0033_0bc809db-5be0-d962-e063-6394a90a6dca	42681-0033	HUMAN OTC DRUG	365 Chai Spice Hand Sanitizer Wipes		Alcohol Hand Sanitizer	CLOTH	TOPICAL	20210505		OTC MONOGRAPH DRUG	505G(a)(3)	Whole Foods Market, Inc.	ALCOHOL	65	mL/100mL			N	20241231
42681-0034_0bc849f1-734e-f7e6-e063-6394a90a5280	42681-0034	HUMAN OTC DRUG	365 Winterberry Hand Sanitizer Wipes		Alcohol Hand Sanitizer	CLOTH	TOPICAL	20210505		OTC MONOGRAPH DRUG	505G(a)(3)	Whole Foods Market, Inc.	ALCOHOL	65	mL/100mL			N	20241231
42681-0035_0bc6c62f-ef82-7f8b-e063-6394a90a0d26	42681-0035	HUMAN OTC DRUG	ANTISEPTIC WIPE		Alcohol Hand Sanitizer	CLOTH	TOPICAL	20210505		OTC MONOGRAPH DRUG	505G(a)(3)	Whole Foods Market, Inc.	ALCOHOL	65	mL/100mL			N	20241231
42681-0512_00c741d4-f9a5-b286-e063-6394a90adb2c	42681-0512	HUMAN OTC DRUG	365 Everyday Value Arnica		ARNICA MONTANA	GEL	TOPICAL	20080901		UNAPPROVED HOMEOPATHIC		WFM Private Label, LP	ARNICA MONTANA	1	[hp_X]/1			N	20241231
42681-5002_0c6b7ce7-8bcb-78cb-e063-6294a90aa3a3	42681-5002	HUMAN OTC DRUG	365 Everyday Value	Cavity Fighting and Whitening	Sodium monoflourophosphate	PASTE, DENTIFRICE	DENTAL	20190306		OTC MONOGRAPH DRUG	M021	Whole Foods Market, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
42681-5276_0c6b7ce7-8bc8-78cb-e063-6294a90aa3a3	42681-5276	HUMAN OTC DRUG	365 Everyday Value	Kids Flouride	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20190306		OTC MONOGRAPH DRUG	M021	Whole Foods Market, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
42681-6412_73eef043-4242-4cee-8761-d50165cc01bd	42681-6412	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE	ORAL; TOPICAL	20180228	20251231	OTC MONOGRAPH DRUG	M007	Whole Foods Market	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
42681-6413_1347381c-6f64-49c4-8b36-f9e6763b50a8	42681-6413	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20180228	20251231	OTC MONOGRAPH DRUG	M007	Whole Foods Market	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
42681-6414_74f1ef54-161f-480f-a876-a9d899414278	42681-6414	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20161130		OTC MONOGRAPH NOT FINAL	part356	Whole Foods Market	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
42681-6513_09803998-8c11-d251-e063-6294a90ab9af	42681-6513	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20200610		OTC MONOGRAPH DRUG	M012	Whole Foods	MENTHOL	7.5	mg/1			N	20241231
42681-6514_098015b2-3a4c-3175-e063-6394a90a1cde	42681-6514	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20170315		OTC MONOGRAPH DRUG	M012	Whole Foods Market	MENTHOL	5.8	mg/1			N	20241231
42681-6573_311d457a-96f5-4b7e-a24a-ddbdc1b3da9a	42681-6573	HUMAN OTC DRUG	50 percent Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20170531	20241231	OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market	ISOPROPYL ALCOHOL	50	mL/100mL			N	
42681-6808_0bc75804-aea1-3df1-e063-6294a90ac293	42681-6808	HUMAN OTC DRUG	Lavender Hand Sanitizer Wipes		Ethanol	CLOTH	TOPICAL	20210505		OTC MONOGRAPH DRUG	505G(a)(3)	Whole Foods Market, Inc.	ALCOHOL	65	mL/100mL			N	20241231
42681-6809_0bc61dd4-1dd6-4a31-e063-6394a90a2e17	42681-6809	HUMAN OTC DRUG	Lavender Hand Sanitizer Wipes		Ethanol	CLOTH	TOPICAL	20210505		OTC MONOGRAPH DRUG	505G(a)(3)	Whole Foods Market, Inc.	ALCOHOL	65	mL/100mL			N	20241231
42681-6810_0bc56e5b-6080-ff29-e063-6394a90ad815	42681-6810	HUMAN OTC DRUG	Lavender Hand Sanitizing Wipes		Ethanol	CLOTH	TOPICAL	20180201		OTC MONOGRAPH DRUG	505G(a)(3)	Whole Foods Market, Inc.	ALCOHOL	65	mL/100mL			N	20241231
42681-6892_9d8cb9b9-95bf-704f-e053-2a95a90a763a	42681-6892	HUMAN OTC DRUG	Hand Sanitizer	Lavender	Organic Ethyl Alcohol	GEL	TOPICAL	20200101	20241231	OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	
42681-6893_07f7090f-3016-247c-e063-6394a90ae397	42681-6893	HUMAN OTC DRUG	Hand Sanitizer	Orange Blossom	Organic Ethyl Alcohol	GEL	TOPICAL	20231009		OTC MONOGRAPH DRUG	M003	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	20241231
42681-6894_0588aeaf-c9ef-6e9d-e063-6394a90a0f65	42681-6894	HUMAN OTC DRUG	Hand Sanitizer	Cucumber Aloe	Organic Ethyl Alcohol	GEL	TOPICAL	20230922		OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	20241231
42681-6895_be1b787a-76ad-f7a9-e053-2a95a90a0204	42681-6895	HUMAN OTC DRUG	Hand Sanitizer	Mojito Mint	Organic Ethyl Alcohol	GEL	TOPICAL	20200101	20241231	OTC MONOGRAPH NOT FINAL	part333A	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	
42681-7048_bb60dd9f-a194-4eeb-8a1e-b7452cceba5b	42681-7048	HUMAN OTC DRUG	365 Everyday Value		Sport Lotion Mineral Sunscreen SPF 30	LOTION	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	Whole Foods Market, Inc.	ZINC OXIDE	8.25	g/44mL			N	20241231
42681-7049_fa1b83b4-9f38-4765-afa6-110068207878	42681-7049	HUMAN OTC DRUG	365 Everyday Value		Sport Lotion Mineral Sunscreen SPF 30	LOTION	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	Whole Foods Market, Inc.	ZINC OXIDE	33.18	g/177mL			N	20241231
42681-7066_0c6b48b8-8209-3944-e063-6394a90a5b4c	42681-7066	HUMAN OTC DRUG	365. Everyday Value		Hydrating Facial Lotion Mineral Sunscreen	LOTION	TOPICAL	20190520		OTC MONOGRAPH DRUG	M020	Whole Foods Market	ZINC OXIDE	6.6375	g/6.6375g			N	20241231
42681-7075_8e603505-2866-42a9-93af-ad30c3620c09	42681-7075	HUMAN OTC DRUG	365 everyday value aspirin		Aspirin	TABLET, FILM COATED	ORAL	20180823		OTC MONOGRAPH NOT FINAL	part343	Whole Foods Market, INC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
42681-7076_7b81017e-c94c-40fe-af24-0f598da95309	42681-7076	HUMAN OTC DRUG	365 everyday value acetaminophen		Acetaminophen	TABLET	ORAL	20180823		OTC MONOGRAPH NOT FINAL	part343	Whole Foods Market, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
42681-7077_cd5a9c83-3217-46fa-91f3-c3f1d981f40e	42681-7077	HUMAN OTC DRUG	365 everyday value ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180829		ANDA	ANDA072096	Whole Foods Market, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42681-7162_07f7e978-a1f4-71e9-e063-6394a90ae3d2	42681-7162	HUMAN OTC DRUG	Hand Sanitizer	Lavender	Ethyl Alcohol	GEL	TOPICAL	20231009		OTC MONOGRAPH DRUG	M003	Whole Foods Market, Inc.	ALCOHOL	62	mL/100mL			N	20241231
42681-7345_0c6b7869-fb6b-6fcd-e063-6294a90a9c6f	42681-7345	HUMAN OTC DRUG	Acne Care Charcoal Cleanser		Acne Care Charcoal Cleanser	LIQUID	TOPICAL	20190517		OTC MONOGRAPH DRUG	M006	Whole Foods Market	SALICYLIC ACID	3.61	g/3.61g			N	20241231
42681-7346_0c6b48b8-820a-3944-e063-6394a90a5b4c	42681-7346	HUMAN OTC DRUG	Acne Care Moisturizer		Acne Care Moisturizer	LOTION	TOPICAL	20190520		OTC MONOGRAPH DRUG	M006	Whole Foods Market	SALICYLIC ACID	1.18	g/1.18g			N	20241231
42681-7353_b48aabe8-3ab2-4536-9779-7551548a8f58	42681-7353	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20180331		OTC MONOGRAPH FINAL	part347	Whole Foods Market	WITCH HAZEL	842	mg/mL			N	20241231
42681-9032_f7059e6b-8aac-801c-e053-6294a90a3d5e	42681-9032	HUMAN OTC DRUG	365 Everyday Value Be Well Cough Ease		ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA, IPECAC, PULSATILLA VULGARIS, RUMEX CRISPUS ROOT, PONGIA OFFICINALIS SKELETON, ROASTED, LOBARIA PULMONARIA	SYRUP	ORAL	20110103		UNAPPROVED HOMEOPATHIC		WFM Private Label, LP	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC; LOBARIA PULMONARIA; PROTORTONIA CACTI; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 3; 3; 3; 3; 3; 6; 6; 3	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
42681-9033_06eae910-1e66-71c8-e063-6294a90a91cc	42681-9033	HUMAN OTC DRUG	365 Everyday Value Be Well Cough Ease for Kids		ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA, IPECAC, PULSATILLA VULGARIS, RUMEX CRISPUS ROOT, PONGIA OFFICINALIS SKELETON, ROASTED, LOBARIA PULMONARIA	SYRUP	ORAL	20110103		UNAPPROVED HOMEOPATHIC		WFM Private Label, LP	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC; LOBARIA PULMONARIA; PROTORTONIA CACTI; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 3; 3; 3; 3; 3; 6; 6; 3	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
42681-9280_06eae740-bd84-1bbe-e063-6394a90a9835	42681-9280	HUMAN OTC DRUG	Flu Ease		CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	PELLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		WFM Private Label, LP	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
42681-9281_06eae740-bd84-1bbe-e063-6394a90a9835	42681-9281	HUMAN OTC DRUG	Flu Ease		CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	PELLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		WFM Private Label, LP	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
42689-005_09441cd1-b37f-cc1d-e063-6294a90a2a32	42689-005	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20090407		ANDA	ANDA203158	Nortec Development Associates, Inc.	MORPHINE SULFATE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42689-006_09441cd1-b37f-cc1d-e063-6294a90a2a32	42689-006	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20090407		ANDA	ANDA203158	Nortec Development Associates, Inc.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42689-007_09441cd1-b37f-cc1d-e063-6294a90a2a32	42689-007	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20090407		ANDA	ANDA203158	Nortec Development Associates, Inc.	MORPHINE SULFATE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42689-008_09441cd1-b37f-cc1d-e063-6294a90a2a32	42689-008	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20090407		ANDA	ANDA203158	Nortec Development Associates, Inc.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42689-009_09441cd1-b37f-cc1d-e063-6294a90a2a32	42689-009	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20090407		ANDA	ANDA203158	Nortec Development Associates, Inc.	MORPHINE SULFATE	80	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42689-010_09441cd1-b37f-cc1d-e063-6294a90a2a32	42689-010	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		morphine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20090407		ANDA	ANDA203158	Nortec Development Associates, Inc.	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42689-011_0a5bc268-a231-1779-e063-6294a90aa769	42689-011	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150501		ANDA	ANDA078065	Nortec Development Associates, Inc	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42689-012_0a5bc268-a231-1779-e063-6294a90aa769	42689-012	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150501		ANDA	ANDA078065	Nortec Development Associates, Inc	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42689-013_0a5bc268-a231-1779-e063-6294a90aa769	42689-013	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150501		ANDA	ANDA078065	Nortec Development Associates, Inc	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42689-014_0a5bc268-a231-1779-e063-6294a90aa769	42689-014	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150501		ANDA	ANDA078065	Nortec Development Associates, Inc	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42702-102_ff463c02-5533-c9ad-e053-6294a90a7035	42702-102	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		phenylephrine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20130415		NDA	NDA203510	Paragon BioTeck, Inc.	PHENYLEPHRINE HYDROCHLORIDE	25	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
42702-103_ff463c02-5533-c9ad-e053-6294a90a7035	42702-103	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		phenylephrine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20130415		NDA	NDA203510	Paragon BioTeck, Inc.	PHENYLEPHRINE HYDROCHLORIDE	100	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
42708-002_f2682ce3-8cfd-df80-e053-2a95a90ac08a	42708-002	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20061101		ANDA	ANDA076794	QPharma Inc	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
42708-003_026f9d94-f6dd-6e03-e063-6294a90a96b2	42708-003	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	QPharma Inc	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-004_026f9d94-f6dd-6e03-e063-6294a90a96b2	42708-004	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	QPharma Inc	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-005_026f9d94-f6dd-6e03-e063-6294a90a96b2	42708-005	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	QPharma Inc	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-007_f28ba16d-cce7-31ef-e053-2995a90abde6	42708-007	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	QPharma Inc	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42708-009_f28c9a8d-2eb3-0e8e-e053-2a95a90aaf1a	42708-009	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	QPharma Inc	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42708-010_0258b81a-5eb2-08af-e063-6294a90affb4	42708-010	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19900930		ANDA	ANDA061926	QPharma Inc	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42708-012_f2645f03-e5b5-eabf-e053-2995a90a62ab	42708-012	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19950222		ANDA	ANDA074056	QPharma Inc	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42708-013_02569b60-18eb-b0ed-e063-6294a90a508f	42708-013	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	QPharma Inc	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-014_02569b60-18eb-b0ed-e063-6294a90a508f	42708-014	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	QPharma Inc	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-017_f266a9e4-50d3-0401-e053-2a95a90a1791	42708-017	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	QPharma Inc	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
42708-018_f28c9a8d-2eb3-0e8e-e053-2a95a90aaf1a	42708-018	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	QPharma Inc	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42708-019_f268d84a-e8b0-7803-e053-2995a90a86d1	42708-019	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	QPharma Inc	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-025_f2776b3b-1b21-7ac5-e053-2995a90ac4ad	42708-025	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	QPharma Inc	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-027_f277f43b-543d-c790-e053-2995a90aab7d	42708-027	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE, GELATIN COATED	ORAL	19961227		NDA AUTHORIZED GENERIC	NDA020504	QPharma Inc	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-028_f278153f-2a93-6e78-e053-2a95a90a9b60	42708-028	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19730112		ANDA	ANDA083177	QPharma Inc	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-031_f27a52d9-7058-ac2b-e053-2a95a90a32ac	42708-031	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	QPharma Inc	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-032_f27a52d9-7058-ac2b-e053-2a95a90a32ac	42708-032	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	QPharma Inc	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-033_f27a52d9-7058-ac2b-e053-2a95a90a32ac	42708-033	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	QPharma Inc	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-034_f27b52ee-982d-0947-e053-2a95a90a1e53	42708-034	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20020701		ANDA	ANDA076194	QPharma Inc	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-036_f28b2cdd-7ca2-8ef2-e053-2a95a90ad9f1	42708-036	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100406		ANDA	ANDA077157	QPharma Inc	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-041_f28cac98-e3e4-658c-e053-2a95a90a08af	42708-041	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	QPharma Inc	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42708-043_0335db7c-5cf8-645e-e063-6394a90a0172	42708-043	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	QPharma, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42708-044_f28e83ec-3bf9-5761-e053-2995a90af152	42708-044	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	QPharma Inc	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
42708-045_f28f7081-c253-4e6e-e053-2995a90a36bb	42708-045	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030213		ANDA	ANDA084122	QPharma Inc	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42708-053_f290fc76-a50c-6a78-e053-2a95a90a4b59	42708-053	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	QPharma Inc	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
42708-054_f2911854-ec4a-b360-e053-2a95a90a0878	42708-054	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	QPharma Inc	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
42708-055_f28ac2d2-782d-c055-e053-2995a90a7c1e	42708-055	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	QPharma Inc	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42708-059_f28ebcec-3ad4-bfe7-e053-2a95a90a67a0	42708-059	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	QPharma Inc	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
42708-066_f262e5a7-3c29-a6d8-e053-2995a90aacbc	42708-066	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	QPharma Inc	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42708-070_021d53c2-fc82-a254-e063-6294a90aa152	42708-070	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	QPharma Inc	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
42708-072_f26659dd-87bd-6aeb-e053-2a95a90a3003	42708-072	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070906		ANDA	ANDA076373	QPharma Inc	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
42708-076_026cfa20-755a-eb93-e063-6294a90ac87d	42708-076	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	QPharma Inc	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42708-077_0335f1b3-5c89-67b8-e063-6294a90a9847	42708-077	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	QPharma Inc	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-078_f263d209-e50d-8e47-e053-2995a90a06b8	42708-078	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	QPharma Inc	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42708-079_f277c1c9-bb02-a82e-e053-2a95a90a2cf6	42708-079	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	QPharma Inc	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-082_f2662bd9-22d6-c7c6-e053-2995a90a2626	42708-082	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040749	QPharma Inc	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
42708-086_f2785fee-45fc-057d-e053-2995a90adee1	42708-086	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20100315		ANDA	ANDA090510	QPharma Inc	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-088_0cca2b7c-dc30-17c8-e063-6394a90a7549	42708-088	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	QPharma Inc	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
42708-091_01f13040-1d38-64fc-e063-6394a90af046	42708-091	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	QPharma Inc	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-092_026ecad8-e07b-2dc5-e063-6294a90a88e6	42708-092	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	QPharma Inc	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-093_f28c55c8-2711-a44d-e053-2a95a90ae798	42708-093	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	QPharma Inc	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42708-094_f27a93d3-5241-6a1b-e053-2995a90a1a63	42708-094	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	QPharma Inc	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-096_f27ad5df-612c-3507-e053-2995a90aff4e	42708-096	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	QPharma Inc	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-097_0cf51e96-78cb-fb18-e063-6394a90a4590	42708-097	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20110228		ANDA	ANDA090796	QPharma Inc	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42708-098_f28f1c00-09dc-4d58-e053-2995a90a8b79	42708-098	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	QPharma Inc	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42708-100_f2676fc2-2613-558c-e053-2995a90a1974	42708-100	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	QPharma Inc	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
42708-101_f290d7a0-ab29-0480-e053-2995a90a31e8	42708-101	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	QPharma Inc	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
42708-102_f28b840a-3452-6e95-e053-2995a90ae46d	42708-102	HUMAN PRESCRIPTION DRUG	Meclizine Hydrocloride		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	QPharma Inc	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
42708-103_f29046e7-a00e-9401-e053-2a95a90afef6	42708-103	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	QPharma Inc	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
42708-104_f28efec4-2048-2736-e053-2a95a90a00d7	42708-104	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	QPharma Inc	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
42708-105_0c7f04af-9fe0-b1c4-e063-6294a90afd70	42708-105	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085161	QPharma Inc	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42708-108_02580f46-7a85-0dea-e063-6394a90a36d6	42708-108	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	QPharma Inc	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-109_f277ccc8-0acc-442c-e053-2995a90a2dc6	42708-109	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	QPharma Inc	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
42708-110_f28cfd9d-9bf2-cbe7-e053-2995a90a9660	42708-110	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	QPharma Inc	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42708-112_03360768-0eaa-b9ed-e063-6294a90ac375	42708-112	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20000926		ANDA	ANDA065056	QPharma, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42708-113_f28ae87f-38dd-04da-e053-2a95a90acf0f	42708-113	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	QPharma Inc	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42708-114_0c7f2066-d361-bee4-e063-6294a90a2b94	42708-114	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA080356	QPharma Inc	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42708-115_f28fa4c7-ae8a-6916-e053-2995a90a1edf	42708-115	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085162	QPharma Inc	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42708-123_00c2af2f-d8c8-9130-e063-6394a90ac9d4	42708-123	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	QPharma Inc	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42708-124_021e2cdc-3a9c-5dd5-e063-6394a90aa555	42708-124	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	QPharma Inc	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-125_f28b148c-4144-6bff-e053-2a95a90adb50	42708-125	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	QPharma Inc	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42708-126_02818b70-724f-29dc-e063-6294a90a746f	42708-126	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	QPharma Inc	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
42708-127_0c522451-2474-02a9-e063-6394a90a11a3	42708-127	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20100212		ANDA	ANDA201451	QPharma Inc	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
42708-136_f28fca38-274b-d665-e053-2995a90ab771	42708-136	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20190307		ANDA	ANDA080292	QPharma Inc	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42708-140_f28e5c86-da29-d5d9-e053-2995a90a3c72	42708-140	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	QPharma Inc	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42708-141_0cf3ee47-fa30-9cba-e063-6394a90aeecb	42708-141	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	QPharma Inc	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-142_f27ad62c-42a2-2c09-e053-2995a90a70b1	42708-142	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	QPharma Inc	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-143_f2650429-8707-3628-e053-2a95a90a26e5	42708-143	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	QPharma Inc	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42708-144_0cf3f866-24a9-9b3f-e063-6394a90ac58b	42708-144	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	QPharma, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-145_021dc31d-31a5-5640-e063-6394a90ae40c	42708-145	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	QPharma Inc	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
42708-146_f2689794-5454-4bf1-e053-2995a90ac272	42708-146	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	QPharma Inc	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
42708-147_f28d2816-b5af-7e98-e053-2995a90abd06	42708-147	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	QPharma Inc	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42708-148_026e7e0a-f7a0-e20b-e063-6294a90af6c8	42708-148	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	QPharma Inc	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-150_021dff9f-8fd3-1afd-e063-6294a90a2362	42708-150	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	QPharma Inc	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-151_f28c0224-7f92-cf34-e053-2a95a90a7ad4	42708-151	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	QPharma Inc	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42708-152_f28c25e4-556a-1654-e053-2995a90a1242	42708-152	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	QPharma Inc	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
42708-153_f263fdcc-1e9d-1f64-e053-2995a90ac7d2	42708-153	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	QPharma Inc	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
42708-154_f27b3518-d586-1229-e053-2a95a90ab56f	42708-154	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	QPharma Inc	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-155_f276e313-0903-e0d8-e053-2a95a90a52a5	42708-155	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	QPharma Inc	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-158_f5dcf323-b915-ed6d-e053-2a95a90ab926	42708-158	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	QPharma Inc	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
42708-159_025875fe-ae8b-6007-e063-6394a90a48a7	42708-159	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	QPharma Inc	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
42708-160_f5dd7fc7-89d7-1e41-e053-2995a90a3c05	42708-160	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	QPharma Inc	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
42708-162_f682d6ba-d2ed-f4ec-e053-2a95a90a86d7	42708-162	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071031		ANDA	ANDA078512	QPharma Inc	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42708-163_f682f991-1808-176a-e053-2995a90a3dfa	42708-163	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	QPharma Inc	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-164_021d7fda-6b7c-7aa6-e063-6294a90a6473	42708-164	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	QPharma Inc	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
42708-165_f6f6837e-b0fd-2daa-e053-6294a90afaac	42708-165	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	QPharma Inc	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-166_f795ea1d-f41b-6100-e053-6394a90a63a4	42708-166	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	QPharma Inc	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42708-167_f7961716-971d-04dd-e053-6294a90a4286	42708-167	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	QPharma Inc	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42708-168_f71f70fb-9ef3-049b-e053-6294a90afb63	42708-168	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	QPharma Inc	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-169_f71fc0b3-de1e-a7c6-e053-6294a90a07ff	42708-169	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	QPharma Inc	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
42708-170_f6f6ad19-ff28-7cd3-e053-6294a90ae1bf	42708-170	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190701		ANDA	ANDA075757	QPharma Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
42708-171_fbd07fb0-c49d-a838-e053-6394a90a5f0e	42708-171	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	QPharma Inc	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
42708-172_fbe6ae15-28ed-2acf-e053-6394a90a8d42	42708-172	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	QPharma Inc	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
42708-173_fbd0b0d8-7414-e779-e053-6394a90ac3cd	42708-173	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20030702		ANDA	ANDA065095	QPharma Inc	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42708-174_fbe71227-910d-43ed-e053-6294a90ac578	42708-174	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	QPharma Inc	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42708-175_fd8bae35-15a8-3e2d-e053-6394a90afdb6	42708-175	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	QPharma Inc	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42708-176_fbbff4eb-a642-b083-e053-6294a90a404a	42708-176	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210601		ANDA	ANDA077321	QPharma Inc	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42708-177_fc75c155-1f70-6596-e053-6394a90aac1a	42708-177	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20170117		ANDA	ANDA206553	QPharma Inc	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
42708-178_fbc05ceb-2e67-3c37-e053-6394a90ac4f4	42708-178	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	QPharma Inc	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
42708-179_fbe71312-0f9b-47c1-e053-6394a90a63a1	42708-179	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	QPharma Inc	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
42708-180_fbd03a5d-5abb-2942-e053-6394a90a9492	42708-180	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA090970	QPharma Inc	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
42708-181_01029181-9b54-99dd-e063-6294a90a58d5	42708-181	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20230804		ANDA	ANDA077614	QPharma Inc	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
42708-182_fc751cd6-704e-acbf-e053-6394a90a9d74	42708-182	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	QPharma Inc	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42708-183_fc756d84-ed65-f17f-e053-6294a90ae43f	42708-183	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate TAB		hyoscyamine sulfate	TABLET	ORAL	20110519		UNAPPROVED DRUG OTHER		QPharma Inc	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
42708-184_0554512f-74ba-f4ae-e063-6394a90a034a	42708-184	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20220222		ANDA	ANDA211013	QPharma Inc	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
42708-185_0e1ff179-0241-ed08-e063-6294a90a3513	42708-185	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	QPharma Inc	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
42731-033_0c4e4502-394a-2fed-e063-6294a90a7e0f	42731-033	HUMAN OTC DRUG	Triple Allergy Defense		Allium cepa, Ambrosia artemisiifolia, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Hydrastis canadensis, Lemna minor, Luffa operculata, Natrum muriaticum, Polyporus pinicola, Sabadilla	LIQUID	ORAL	20160901		UNAPPROVED HOMEOPATHIC		Nenningers Naturals, LLC	ALLIUM CEPA WHOLE; AMBROSIA ARTEMISIIFOLIA; EUPHRASIA STRICTA; FOMITOPSIS PINICOLA FRUITING BODY; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; HYDRASTIS CANADENSIS WHOLE; LEMNA MINOR; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL			N	20241231
42731-062_0c4e77f9-5297-e292-e063-6394a90adc4e	42731-062	HUMAN OTC DRUG	Dr. Nenninger Cold and Sinus Solution		Allium cepa, Hepar sulphuris calcareum, Hydrastis canadensis, Kali bichromicum, Kali iodatum, Natrum muriaticum, Pulsatilla	LIQUID	ORAL	20201201		UNAPPROVED HOMEOPATHIC		Nenningers Naturals, LLC	ANEMONE PULSATILLA; CALCIUM SULFIDE; GOLDENSEAL; ONION; POTASSIUM DICHROMATE; POTASSIUM IODIDE; SODIUM CHLORIDE	30; 30; 30; 30; 30; 30; 30	[hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_C]/60mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
42731-075_0c4e77f9-5298-e292-e063-6394a90adc4e	42731-075	HUMAN OTC DRUG	Nenningers Naturals		Bites Stings Ticks	LIQUID	ORAL	20210803		UNAPPROVED HOMEOPATHIC		Nenningers Naturals, LLC	APIS MELLIFERA; ARNICA MONTANA; LACHESIS MUTA VENOM; LEDUM PALUSTRE TWIG; LYTTA VESICATORIA; ST. JOHN'S WORT	30; 30; 30; 30; 30; 30	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
42731-076_0c4e4502-394e-2fed-e063-6294a90a7e0f	42731-076	HUMAN OTC DRUG	Nenningers Naturals		Cuts Bruises Wounds	LIQUID	ORAL	20210804		UNAPPROVED HOMEOPATHIC		Nenningers Naturals, LLC	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LACHESIS MUTA VENOM; LEDUM PALUSTRE TWIG; ST. JOHN'S WORT	30; 30; 30; 30; 30; 30	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL			N	20241231
42731-081_fed139a8-55d2-8a7c-e053-6294a90afb51	42731-081	HUMAN OTC DRUG	Triple Flu Defense		Homeopathic Flu Defense	LIQUID	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Nenningers Naturals, LLC	BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CALCIUM SULFIDE; CINCHONA OFFICINALIS BARK; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/COLORADO/06/2017 LIVE (ATTENUATED) ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN; IPECAC; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; PHYTOLACCA DODECANDRA WHOLE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL			N	20241231
42747-102_318f67b2-4862-49eb-802f-7ecf14def8bf	42747-102	HUMAN PRESCRIPTION DRUG	CRYSVITA		Burosumab	INJECTION	SUBCUTANEOUS	20180418		BLA	BLA761068	Kyowa Kirin, Inc.	BUROSUMAB	10	mg/mL			N	20241231
42747-203_318f67b2-4862-49eb-802f-7ecf14def8bf	42747-203	HUMAN PRESCRIPTION DRUG	CRYSVITA		Burosumab	INJECTION	SUBCUTANEOUS	20180418		BLA	BLA761068	Kyowa Kirin, Inc.	BUROSUMAB	20	mg/mL			N	20241231
42747-304_318f67b2-4862-49eb-802f-7ecf14def8bf	42747-304	HUMAN PRESCRIPTION DRUG	CRYSVITA		Burosumab	INJECTION	SUBCUTANEOUS	20180418		BLA	BLA761068	Kyowa Kirin, Inc.	BUROSUMAB	30	mg/mL			N	20241231
42747-327_105f2acb-bb04-4551-9ae3-3abbeacaba5e	42747-327	HUMAN PRESCRIPTION DRUG	Fareston		toremifene citrate	TABLET	ORAL	19970630		NDA	NDA020497	Kyowa Kirin, Inc.	TOREMIFENE CITRATE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
42747-602_4e2f357c-0318-41db-a830-313520ce182a	42747-602	HUMAN PRESCRIPTION DRUG	NOURIANZ		istradefylline	TABLET, FILM COATED	ORAL	20190827		NDA	NDA022075	Kyowa Kirin, Inc.	ISTRADEFYLLINE	20	mg/1			N	20241231
42747-604_4e2f357c-0318-41db-a830-313520ce182a	42747-604	HUMAN PRESCRIPTION DRUG	NOURIANZ		istradefylline	TABLET, FILM COATED	ORAL	20190827		NDA	NDA022075	Kyowa Kirin, Inc.	ISTRADEFYLLINE	40	mg/1			N	20241231
42747-726_20296b0f-9faf-4d20-8a5a-f631d743f7d1	42747-726	HUMAN PRESCRIPTION DRUG	SANCUSO		granisetron	PATCH	TRANSDERMAL	20080912		NDA	NDA022198	Kyowa Kirin, Inc.	GRANISETRON	3.1	mg/24h	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
42747-761_143e751e-e97a-4dc8-aac9-9aa202243d04	42747-761	HUMAN PRESCRIPTION DRUG	POTELIGEO		mogamulizumab-kpkc	INJECTION	INTRAVENOUS	20180808		BLA	BLA761051	Kyowa Kirin, Inc.	MOGAMULIZUMAB	4	mg/mL	Antibodies, Monoclonal [CS], Chemokine Receptor Type 4 Interaction [EPC], Chemokine Receptor Type 4 Interactions [MoA], Monoclonal Antibody [EPC]		N	20241231
42751-1073_0760dd72-2fe9-c8eb-e063-6294a90ad4be	42751-1073	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20180830		NDA	NDA205866	FULLERTON WELDING SUPPLY	NITROGEN	990	mL/L			N	20241231
42751-1074_0760c404-9d42-a7cc-e063-6294a90a6c7e	42751-1074	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20180830		NDA	NDA205866	FULLERTON WELDING SUPPLY	NITROGEN	990	mL/L			N	20241231
42756-1030_6dc8dd56-839d-42a7-b818-b4983b9a1c32	42756-1030	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine Bitartrate		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111107		ANDA	ANDA088390	IQ Dental	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
42756-1080_2cb0fd05-0e79-42d4-b5d3-caaab9e4f625	42756-1080	HUMAN PRESCRIPTION DRUG	IQ Dental Mepivacaine		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20120815		ANDA	ANDA088387	IQ Dental	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
42756-1100_d6943c2b-0e48-2afb-e053-2a95a90a575a	42756-1100	HUMAN PRESCRIPTION DRUG	NRG Hemo-Stat		Aluminum Chloride	SOLUTION	DENTAL	20141101		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	ALUMINUM CHLORIDE	7500	mg/30mL			N	20241231
42756-1101_d609a943-4dcb-f221-e053-2a95a90aa68e	42756-1101	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1102_d609a79b-4c76-66fd-e053-2995a90a77c1	42756-1102	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1103_d70cb731-806e-2237-e053-2a95a90ab2ea	42756-1103	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1104_d609519e-0fc4-83de-e053-2995a90aaaf7	42756-1104	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1105_d609b648-e10f-58d1-e053-2a95a90a34e9	42756-1105	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1106_d609b860-1224-286a-e053-2a95a90a297e	42756-1106	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1107_d609b139-9fbf-c28e-e053-2995a90a6a4b	42756-1107	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1108_d70cc9bc-b40f-3df4-e053-2a95a90a17c8	42756-1108	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1109_d70ccc3b-c075-251e-e053-2995a90ad9ad	42756-1109	HUMAN OTC DRUG	NRG Topical Anesthetic		Benzocaine	GEL	DENTAL	20130801		OTC MONOGRAPH NOT FINAL	part356	IQ Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42756-1110_d70c050a-116a-9015-e053-2a95a90a0163	42756-1110	HUMAN PRESCRIPTION DRUG	NRG APF		Sodium Fluoride	GEL	DENTAL	20130801		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
42756-1111_d609fe56-98dc-543f-e053-2a95a90a7b4c	42756-1111	HUMAN PRESCRIPTION DRUG	NRG APF		Sodium Fluoride	GEL	DENTAL	20130801		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
42756-1112_d609fe56-98d1-543f-e053-2a95a90a7b4c	42756-1112	HUMAN PRESCRIPTION DRUG	NRG APF		Sodium Fluoride	GEL	DENTAL	20130801		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
42756-1113_d70c625f-9fea-0539-e053-2a95a90a6fcd	42756-1113	HUMAN PRESCRIPTION DRUG	NRG APF		Sodium Fluoride	GEL	DENTAL	20130801		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
42756-1114_d60a32ab-8dec-f14a-e053-2995a90a19ec	42756-1114	HUMAN PRESCRIPTION DRUG	NRG APF		Sodium Fluoride	GEL	DENTAL	20130801		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
42756-1115_d60a2cad-b621-b7a0-e053-2a95a90a42c6	42756-1115	HUMAN PRESCRIPTION DRUG	NRG APF		Sodium Fluoride	GEL	DENTAL	20130801		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
42756-1116_d60a3e9d-e878-3b19-e053-2995a90a3e8d	42756-1116	HUMAN PRESCRIPTION DRUG	NRG APF		Sodium Fluoride	GEL	DENTAL	20130801		UNAPPROVED DRUG OTHER		IQ Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
42792-101_e71318cb-a690-517b-e053-2a95a90ac97b	42792-101	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20110309		UNAPPROVED DRUG OTHER		AUSTIN PHARMACEUTICALS, LLC	UREA	390	mg/g			N	20241231
42794-003_f7ac2b46-04c8-a739-e053-6394a90a7711	42794-003	HUMAN PRESCRIPTION DRUG	ADEFOVIR DIPIVOXIL		ADEFOVIR DIPIVOXIL	TABLET	ORAL	20130903		ANDA	ANDA202051	Sigmapharm Laboratories, LLC	ADEFOVIR DIPIVOXIL	10	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
42794-004_f1f190da-554e-55cb-e053-2a95a90a2871	42794-004	HUMAN PRESCRIPTION DRUG	Protriptyline Hydrochloride		Protriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20200302		ANDA	ANDA090462	Sigmapharm Laboratories, LLC	PROTRIPTYLINE HYDROCHLORIDE	5	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42794-005_f1f15fe7-63a8-4708-e053-2a95a90a7dea	42794-005	HUMAN PRESCRIPTION DRUG	Amiloride Hydrochloride		Amiloride Hydrochloride	TABLET	ORAL	20210614		ANDA	ANDA079133	Sigmapharm Laboratories, LLC	AMILORIDE HYDROCHLORIDE ANHYDROUS	5	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
42794-007_f1f190da-554e-55cb-e053-2a95a90a2871	42794-007	HUMAN PRESCRIPTION DRUG	Protriptyline Hydrochloride		Protriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20200302		ANDA	ANDA090462	Sigmapharm Laboratories, LLC	PROTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42794-009_f1f1b263-dcab-60e7-e053-2995a90ae493	42794-009	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20180601		ANDA	ANDA201566	Sigmapharm Laboratories, LLC	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
42794-010_f1f1b263-dcab-60e7-e053-2995a90ae493	42794-010	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20180601		ANDA	ANDA201566	Sigmapharm Laboratories, LLC	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
42794-012_e8a91e6c-8bed-66f5-e053-2a95a90aa489	42794-012	HUMAN PRESCRIPTION DRUG	Griseofulvin		Griseofulvin	TABLET	ORAL	20121206		ANDA	ANDA202482	Sigmapharm Laboratories, LLC	GRISEOFULVIN	500	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
42794-013_d58d8124-4925-b8a1-e053-2995a90ac4c5	42794-013	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Ultramicrosize Griseofulvin	TABLET	ORAL	20121115		ANDA	ANDA202545	Sigmapharm Laboratories, LLC	GRISEOFULVIN	125	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
42794-014_d58d8124-4925-b8a1-e053-2995a90ac4c5	42794-014	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Ultramicrosize Griseofulvin	TABLET	ORAL	20121115		ANDA	ANDA202545	Sigmapharm Laboratories, LLC	GRISEOFULVIN	250	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
42794-016_f1f1f3b2-6b49-a523-e053-2995a90ad0c9	42794-016	HUMAN PRESCRIPTION DRUG	ASENAPINE		ASENAPINE	TABLET	SUBLINGUAL	20201214		ANDA	ANDA206107	Sigmapharm Laboratories, LLC	ASENAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42794-017_f1f1f3b2-6b49-a523-e053-2995a90ad0c9	42794-017	HUMAN PRESCRIPTION DRUG	ASENAPINE		ASENAPINE	TABLET	SUBLINGUAL	20201214		ANDA	ANDA206107	Sigmapharm Laboratories, LLC	ASENAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
42794-018_f1f181e3-ceed-1d17-e053-2995a90af5cd	42794-018	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	SIGMAPHARM LABORATORIES, LLC	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
42794-019_f1f181e3-ceed-1d17-e053-2995a90af5cd	42794-019	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	SIGMAPHARM LABORATORIES, LLC	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
42794-020_f1f181e3-ceed-1d17-e053-2995a90af5cd	42794-020	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	SIGMAPHARM LABORATORIES, LLC	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
42794-028_d552f1c4-f0eb-029e-e053-2995a90ae79a	42794-028	HUMAN PRESCRIPTION DRUG	Disulfiram		Disulfiram	TABLET	ORAL	20211101		ANDA	ANDA091619	Sigmapharm Laboratories, LLC	DISULFIRAM	250	mg/1	Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]		N	20241231
42794-044_f1f1f93d-aee6-246f-e053-2a95a90a9eee	42794-044	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180611		ANDA	ANDA207746	Sigmapharm Laboratories, LLC	DOFETILIDE	125	ug/1	Antiarrhythmic [EPC]		N	20241231
42794-045_f1f1f93d-aee6-246f-e053-2a95a90a9eee	42794-045	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180611		ANDA	ANDA207746	Sigmapharm Laboratories, LLC	DOFETILIDE	250	ug/1	Antiarrhythmic [EPC]		N	20241231
42794-046_f1f1f93d-aee6-246f-e053-2a95a90a9eee	42794-046	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180611		ANDA	ANDA207746	Sigmapharm Laboratories, LLC	DOFETILIDE	500	ug/1	Antiarrhythmic [EPC]		N	20241231
42794-051_f1f20771-a78f-74cf-e053-2995a90a6adf	42794-051	HUMAN PRESCRIPTION DRUG	AMBRISENTAN		AMBRISENTAN	TABLET, FILM COATED	ORAL	20190410		ANDA	ANDA208354	Sigmapharm Laboratories, LLC	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
42794-052_f1f20771-a78f-74cf-e053-2995a90a6adf	42794-052	HUMAN PRESCRIPTION DRUG	AMBRISENTAN		AMBRISENTAN	TABLET, FILM COATED	ORAL	20190410		ANDA	ANDA208354	Sigmapharm Laboratories, LLC	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
42794-080_f1f1dd05-77f9-ff40-e053-2995a90a2e80	42794-080	HUMAN PRESCRIPTION DRUG	ACITRETIN		ACITRETIN	CAPSULE	ORAL	20150916		ANDA	ANDA204633	Sigmapharm Laboratories, LLC	ACITRETIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
42794-081_f1f1dd05-77f9-ff40-e053-2995a90a2e80	42794-081	HUMAN PRESCRIPTION DRUG	ACITRETIN		ACITRETIN	CAPSULE	ORAL	20150916		ANDA	ANDA204633	Sigmapharm Laboratories, LLC	ACITRETIN	17.5	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
42794-083_f1f1dd05-77f9-ff40-e053-2995a90a2e80	42794-083	HUMAN PRESCRIPTION DRUG	ACITRETIN		ACITRETIN	CAPSULE	ORAL	20150916		ANDA	ANDA204633	Sigmapharm Laboratories, LLC	ACITRETIN	25	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
42794-086_d70f7f7c-f27a-db94-e053-2995a90a6937	42794-086	HUMAN PRESCRIPTION DRUG	Sodium Phenylbutyrate		Sodium Phenylbutyrate	POWDER	ORAL	20130408		ANDA	ANDA202819	Sigmapharm Laboratories, LLC	SODIUM PHENYLBUTYRATE	.94	g/g	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
42799-054_c32edc1c-beb6-44eb-ac7d-f0b40ac42946	42799-054	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	TABLET	ORAL	20210602		ANDA	ANDA212110	Edenbridge Pharmaceuticals LLC.	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
42799-105_42dda043-7e70-4fcd-9fcc-96f70d751efa	42799-105	HUMAN PRESCRIPTION DRUG	Methenamine Mandelate		Methenamine Mandelate	TABLET	ORAL	20091215		UNAPPROVED DRUG OTHER		Edenbridge Pharmaceuticals LLC.	METHENAMINE MANDELATE	500	mg/1			N	20241231
42799-106_42dda043-7e70-4fcd-9fcc-96f70d751efa	42799-106	HUMAN PRESCRIPTION DRUG	Methenamine Mandelate		Methenamine Mandelate	TABLET	ORAL	20091215		UNAPPROVED DRUG OTHER		Edenbridge Pharmaceuticals LLC.	METHENAMINE MANDELATE	1000	mg/1			N	20241231
42799-110_db0f0b61-fc61-4b18-8b64-9e1c1ca47a81	42799-110	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET	ORAL	20190517		ANDA	ANDA211117	Edenbridge Pharmaceuticals LLC.	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
42799-111_5f1dcdf0-b824-4de7-87f6-fe5d0d5d885e	42799-111	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20181207		ANDA	ANDA209888	Edenbridge Pharmaceuticals LLC.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42799-112_5f1dcdf0-b824-4de7-87f6-fe5d0d5d885e	42799-112	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20181207		ANDA	ANDA209888	Edenbridge Pharmaceuticals LLC.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42799-118_bac5026a-a519-4abc-8041-2f4eb18ea9a1	42799-118	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	TABLET	ORAL	20220915		ANDA	ANDA212407	Edenbridge Pharmaceuticals LLC.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
42799-119_ab94447e-955c-428d-93c8-c8d440924e00	42799-119	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20151015		NDA AUTHORIZED GENERIC	NDA018225	Edenbridge Pharmaceuticals LLC.	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42799-120_ab94447e-955c-428d-93c8-c8d440924e00	42799-120	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20151015		NDA AUTHORIZED GENERIC	NDA018225	Edenbridge Pharmaceuticals LLC.	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42799-121_ab94447e-955c-428d-93c8-c8d440924e00	42799-121	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20151015		NDA AUTHORIZED GENERIC	NDA018225	Edenbridge Pharmaceuticals LLC.	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42799-123_56333c02-3c9c-4914-908b-460824178458	42799-123	HUMAN PRESCRIPTION DRUG	Carbidopa		Carbidopa	TABLET	ORAL	20160219		ANDA	ANDA205304	Edenbridge Pharmaceuticals LLC.	CARBIDOPA	25	mg/1			N	20241231
42799-129_5b90e43a-b550-4a28-b9f8-5f1b4663201a	42799-129	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20181029		ANDA	ANDA211596	Edenbridge Pharmaceuticals LLC.	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
42799-130_5b90e43a-b550-4a28-b9f8-5f1b4663201a	42799-130	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20181029		ANDA	ANDA211596	Edenbridge Pharmaceuticals LLC.	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
42799-131_5b90e43a-b550-4a28-b9f8-5f1b4663201a	42799-131	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20181029		ANDA	ANDA211596	Edenbridge Pharmaceuticals LLC.	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
42799-132_5b90e43a-b550-4a28-b9f8-5f1b4663201a	42799-132	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20181029		ANDA	ANDA211596	Edenbridge Pharmaceuticals LLC.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
42799-207_add34c39-01bd-4efb-b432-15df2a2d2816	42799-207	HUMAN PRESCRIPTION DRUG	Tinidazole		Tinidazole	TABLET	ORAL	20191220		ANDA	ANDA203808	Edenbridge Pharmaceuticals LLC.	TINIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
42799-208_add34c39-01bd-4efb-b432-15df2a2d2816	42799-208	HUMAN PRESCRIPTION DRUG	Tinidazole		Tinidazole	TABLET	ORAL	20191220		ANDA	ANDA203808	Edenbridge Pharmaceuticals LLC.	TINIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
42799-217_5b376952-010f-adfc-e053-2a91aa0ae464	42799-217	HUMAN PRESCRIPTION DRUG	Opium Tincture Deodorized		Morphine	TINCTURE	ORAL	20100715		UNAPPROVED DRUG OTHER		Edenbridge Pharmaceuticals, LLC	MORPHINE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42799-405_75100a82-9e46-46b2-9eb1-f0435143a978	42799-405	HUMAN PRESCRIPTION DRUG	Ethacrynic Acid		Ethacrynic Acid	TABLET	ORAL	20160701		ANDA	ANDA205609	Edenbridge Pharmaceuticals LLC.	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
42799-605_bcadcacf-74dd-446d-8bf5-293943e8306c	42799-605	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20200925		ANDA	ANDA215001	Edenbridge Pharmaceuticals LLC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
42799-709_0841c5c7-f6f9-4e2d-bca6-c5a9f76b5d81	42799-709	HUMAN PRESCRIPTION DRUG	Yargesa		Miglustat	CAPSULE	ORAL	20200806		ANDA	ANDA209821	Edenbridge Pharmaceuticals LLC.	MIGLUSTAT	100	mg/1	Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA]		N	20241231
42799-806_b33af21e-6113-45a7-8588-c85099beb506	42799-806	HUMAN PRESCRIPTION DRUG	Ivermectin		Ivermectin	TABLET	ORAL	20141115		ANDA	ANDA204154	Edenbridge Pharmaceuticals LLC.	IVERMECTIN	3	mg/1	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
42799-812_073536da-16a0-4c78-b4d4-95a1e3ad00d6	42799-812	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20111111		ANDA	ANDA203559	Edenbridge Pharmaceuticals LLC.	PREDNISOLONE SODIUM PHOSPHATE	10	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42799-813_073536da-16a0-4c78-b4d4-95a1e3ad00d6	42799-813	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20111111		ANDA	ANDA203559	Edenbridge Pharmaceuticals LLC.	PREDNISOLONE SODIUM PHOSPHATE	20	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42799-815_073536da-16a0-4c78-b4d4-95a1e3ad00d6	42799-815	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20231009		ANDA	ANDA203559	Edenbridge Pharmaceuticals LLC.	PREDNISOLONE SODIUM PHOSPHATE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42799-920_312e3d98-d5dd-4861-94e9-4d53a6450cbd	42799-920	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA212678	Edenbridge Pharmaceuticals LLC.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
42799-921_312e3d98-d5dd-4861-94e9-4d53a6450cbd	42799-921	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA212678	Edenbridge Pharmaceuticals LLC.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
42799-922_312e3d98-d5dd-4861-94e9-4d53a6450cbd	42799-922	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA212678	Edenbridge Pharmaceuticals LLC.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
42799-935_ce3c96ec-c8e5-4241-a32c-cdc3e67f3001	42799-935	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220502		ANDA	ANDA213796	Edenbridge Pharmaceuticals LLC.	DOXEPIN HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42799-950_93ba3894-fd97-4432-9f2d-e7050371e91f	42799-950	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	TABLET	ORAL	20220629		ANDA	ANDA215109	Edenbridge Pharmaceuticals LLC.	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
42799-952_c5aac605-24bf-42a8-a336-d7acbb81c925	42799-952	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	GRANULE, DELAYED RELEASE	ORAL	20230616		ANDA	ANDA216247	Edenbridge Pharmaceuticals LLC.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
42799-953_f17f2167-f47b-4497-ac37-a6ef59e45897	42799-953	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, EXTENDED RELEASE	ORAL	20021106		ANDA	ANDA076201	Edenbridge Pharmaceuticals LLC.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42799-954_11404dc3-1bde-4d4e-8386-006b67ee19dd	42799-954	HUMAN PRESCRIPTION DRUG	Donepezil hydrochloride		Donepezil hydrochloride	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA203713	Edenbridge Pharmaceuticals LLC.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
42799-958_0e3c4461-2e04-481f-a9e5-29f21cc71ec5	42799-958	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA075522	Edenbridge Pharmaceuticals LLC.	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
42799-959_0e3c4461-2e04-481f-a9e5-29f21cc71ec5	42799-959	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20100607		ANDA	ANDA075522	Edenbridge Pharmaceuticals LLC.	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
42799-960_0e3c4461-2e04-481f-a9e5-29f21cc71ec5	42799-960	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181115		ANDA	ANDA210822	Edenbridge Pharmaceuticals LLC.	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
42799-961_3504d573-890b-47a7-bde6-0831ff47a0d4	42799-961	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20230201		ANDA	ANDA213927	Edenbridge Pharmaceuticals LLC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
42799-962_9c56448e-7291-4e1e-a260-5c22f01c3448	42799-962	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride, extended release		venlafaxine hydrochloride, extended release	TABLET	ORAL	20230315		ANDA	ANDA209193	Edenbridge Pharmaceuticals LLC.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
42799-963_9c56448e-7291-4e1e-a260-5c22f01c3448	42799-963	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride, extended release		venlafaxine hydrochloride, extended release	TABLET	ORAL	20230315		ANDA	ANDA209193	Edenbridge Pharmaceuticals LLC.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
42806-005_5759388a-06ad-4a70-bd43-9c4abf69bc88	42806-005	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20150922		ANDA	ANDA202662	Epic Pharma, LLC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-006_5759388a-06ad-4a70-bd43-9c4abf69bc88	42806-006	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20150922		ANDA	ANDA202662	Epic Pharma, LLC	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-007_5759388a-06ad-4a70-bd43-9c4abf69bc88	42806-007	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20150922		ANDA	ANDA202662	Epic Pharma, LLC	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-008_5759388a-06ad-4a70-bd43-9c4abf69bc88	42806-008	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20150922		ANDA	ANDA202662	Epic Pharma, LLC	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-009_5759388a-06ad-4a70-bd43-9c4abf69bc88	42806-009	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20150922		ANDA	ANDA202662	Epic Pharma, LLC	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-011_6505b5a4-70c1-450c-acd8-99b6be4f6430	42806-011	HUMAN PRESCRIPTION DRUG	SULINDAC		SULINDAC	TABLET	ORAL	20100125		ANDA	ANDA072711	Epic Pharma, LLC	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42806-012_42600718-075b-481b-8fec-cb6cbadab7de	42806-012	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20120430		ANDA	ANDA200294	Epic Pharma LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
42806-013_b177069d-1a6b-490c-b17a-a2399d99685f	42806-013	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20140414		ANDA	ANDA202333	Epic Pharma, LLC	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
42806-014_42600718-075b-481b-8fec-cb6cbadab7de	42806-014	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20120430		ANDA	ANDA200294	Epic Pharma LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
42806-018_6505b5a4-70c1-450c-acd8-99b6be4f6430	42806-018	HUMAN PRESCRIPTION DRUG	SULINDAC		SULINDAC	TABLET	ORAL	20100125		ANDA	ANDA072710	Epic Pharma, LLC	SULINDAC	150	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42806-019_0d69db75-5e99-4ac9-9102-803e77f66dce	42806-019	HUMAN PRESCRIPTION DRUG	CITALOPRAM		citalopram	TABLET, FILM COATED	ORAL	20110520		ANDA	ANDA077045	Epic Pharma, LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42806-020_0d69db75-5e99-4ac9-9102-803e77f66dce	42806-020	HUMAN PRESCRIPTION DRUG	CITALOPRAM		citalopram	TABLET, FILM COATED	ORAL	20110520		ANDA	ANDA077045	Epic Pharma, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42806-021_0d69db75-5e99-4ac9-9102-803e77f66dce	42806-021	HUMAN PRESCRIPTION DRUG	CITALOPRAM		citalopram	TABLET, FILM COATED	ORAL	20110520		ANDA	ANDA077045	Epic Pharma, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42806-029_cb25710e-9669-4f21-a77c-2a5a013ec96f	42806-029	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20200918		ANDA	ANDA213980	Epic Pharma LLC	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42806-030_cb25710e-9669-4f21-a77c-2a5a013ec96f	42806-030	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20200918		ANDA	ANDA213980	Epic Pharma LLC	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42806-038_7e92fea8-e192-19b9-e053-2991aa0a6f99	42806-038	HUMAN PRESCRIPTION DRUG	Betaxolol		Betaxolol	TABLET, FILM COATED	ORAL	20100720		ANDA	ANDA075541	Epic Pharma LLC	BETAXOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42806-039_7e92fea8-e192-19b9-e053-2991aa0a6f99	42806-039	HUMAN PRESCRIPTION DRUG	Betaxolol		Betaxolol	TABLET, FILM COATED	ORAL	20100720		ANDA	ANDA075541	Epic Pharma LLC	BETAXOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42806-048_d0ca35de-12e8-4154-825a-c82eed36efd7	42806-048	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20131202		ANDA	ANDA074673	Epic Pharma, LLC	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
42806-050_f7bd1ebe-8512-4846-a8e5-445cd1f76b39	42806-050	HUMAN PRESCRIPTION DRUG	Meperidine Hydrochloride		Meperidine Hydrochloride	TABLET	ORAL	20110505		ANDA	ANDA040331	EPIC PHARMA, LLC	MEPERIDINE HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-051_f7bd1ebe-8512-4846-a8e5-445cd1f76b39	42806-051	HUMAN PRESCRIPTION DRUG	Meperidine Hydrochloride		Meperidine Hydrochloride	TABLET	ORAL	20110505		ANDA	ANDA040331	EPIC PHARMA, LLC	MEPERIDINE HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-052_71e96bed-1a18-49d6-e053-2995a90a3014	42806-052	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril Tablets	TABLET	ORAL	20150331		ANDA	ANDA078508	Epic Pharma, LLC	TRANDOLAPRIL	1	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42806-053_71e96bed-1a18-49d6-e053-2995a90a3014	42806-053	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril Tablets	TABLET	ORAL	20150331		ANDA	ANDA078508	Epic Pharma, LLC	TRANDOLAPRIL	2	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42806-054_71e96bed-1a18-49d6-e053-2995a90a3014	42806-054	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril Tablets	TABLET	ORAL	20150331		ANDA	ANDA078508	Epic Pharma, LLC	TRANDOLAPRIL	4	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
42806-055_4275a8ce-3151-44c0-a455-ab1f929c0443	42806-055	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110425		ANDA	ANDA078552	Epic Pharma, LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42806-056_4275a8ce-3151-44c0-a455-ab1f929c0443	42806-056	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110425		ANDA	ANDA078552	Epic Pharma, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42806-057_4275a8ce-3151-44c0-a455-ab1f929c0443	42806-057	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110425		ANDA	ANDA078552	Epic Pharma, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42806-058_6aeb8856-3df7-40a7-b03e-d855a58c8fa4	42806-058	HUMAN PRESCRIPTION DRUG	Flavoxate Hydrochloride		Flavoxate Hydrochloride	TABLET	ORAL	20110221		ANDA	ANDA076835	Epic Pharma, LLC	FLAVOXATE HYDROCHLORIDE	100	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
42806-061_3292a7c6-5ba3-4563-bc62-e43040634123	42806-061	HUMAN PRESCRIPTION DRUG	Oxycodone and Aspirin		Oxycodone and Aspirin	TABLET	ORAL	20200716		ANDA	ANDA040910	Epic Pharma, LLC	ASPIRIN; OXYCODONE HYDROCHLORIDE	325; 4.8355	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Full Opioid Agonists [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Platelet Aggregation Inhibitor [EPC]	CII	N	20241231
42806-081_b4e5d191-8cbf-4111-a07b-025b920269c4	42806-081	HUMAN PRESCRIPTION DRUG	Benzphetamine Hydrochloride		Benzphetamine Hydrochloride	TABLET, FILM COATED	ORAL	20151216		ANDA	ANDA090346	Epic Pharma, LLC	BENZPHETAMINE HYDROCHLORIDE	50	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
42806-082_02628a0c-bfdb-4a58-8e48-bcd8ca12d53b	42806-082	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190417		ANDA	ANDA208972	Epic Pharma, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
42806-083_02628a0c-bfdb-4a58-8e48-bcd8ca12d53b	42806-083	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190417		ANDA	ANDA208972	Epic Pharma, LLC	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
42806-084_02628a0c-bfdb-4a58-8e48-bcd8ca12d53b	42806-084	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190417		ANDA	ANDA208972	Epic Pharma, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
42806-085_02628a0c-bfdb-4a58-8e48-bcd8ca12d53b	42806-085	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190417		ANDA	ANDA208972	Epic Pharma, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
42806-086_02628a0c-bfdb-4a58-8e48-bcd8ca12d53b	42806-086	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190417		ANDA	ANDA208972	Epic Pharma, LLC	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
42806-087_40e24708-8521-49cb-91b5-15ea960a6afa	42806-087	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	EPIC PHARMA, LLC	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
42806-088_40e24708-8521-49cb-91b5-15ea960a6afa	42806-088	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	EPIC PHARMA, LLC	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
42806-089_40e24708-8521-49cb-91b5-15ea960a6afa	42806-089	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	EPIC PHARMA, LLC	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
42806-094_e172ab7f-3b5e-4ff8-8c5a-cc6396bbe042	42806-094	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	POWDER, FOR SOLUTION	ORAL	20181128		ANDA	ANDA210200	Epic Pharma, LLC	POTASSIUM CHLORIDE	1.5	g/1.77g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
42806-096_e68d74c7-1d6a-4453-bb46-0047047b7527	42806-096	HUMAN PRESCRIPTION DRUG	Protriptyline Hydrochloride		Protriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20130109		ANDA	ANDA202220	Epic Pharma, LLC	PROTRIPTYLINE HYDROCHLORIDE	5	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-097_e68d74c7-1d6a-4453-bb46-0047047b7527	42806-097	HUMAN PRESCRIPTION DRUG	Protriptyline Hydrochloride		Protriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20130109		ANDA	ANDA202220	Epic Pharma, LLC	PROTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-101_a5247287-041a-4548-9a24-aadbfd233459	42806-101	HUMAN PRESCRIPTION DRUG	ETHAMBUTOL HYDROCHLORIDE		ETHAMBUTOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20150318		ANDA	ANDA075095	Epic Pharma, LLC	ETHAMBUTOL HYDROCHLORIDE	100	mg/1	Antimycobacterial [EPC]		N	20241231
42806-102_a5247287-041a-4548-9a24-aadbfd233459	42806-102	HUMAN PRESCRIPTION DRUG	ETHAMBUTOL HYDROCHLORIDE		ETHAMBUTOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20150318		ANDA	ANDA075095	Epic Pharma, LLC	ETHAMBUTOL HYDROCHLORIDE	400	mg/1	Antimycobacterial [EPC]		N	20241231
42806-111_de4e6327-61aa-4e55-b55b-43c6bcf46d78	42806-111	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180402		ANDA	ANDA203863	Epic Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
42806-112_de4e6327-61aa-4e55-b55b-43c6bcf46d78	42806-112	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180402		ANDA	ANDA203863	Epic Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
42806-113_de4e6327-61aa-4e55-b55b-43c6bcf46d78	42806-113	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180402		ANDA	ANDA203863	Epic Pharma, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
42806-114_37d9023b-61a1-49f0-be46-606034e5d8f4	42806-114	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180702		ANDA	ANDA203864	Epic Pharma, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-115_37d9023b-61a1-49f0-be46-606034e5d8f4	42806-115	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180702		ANDA	ANDA203864	Epic Pharma, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-116_37d9023b-61a1-49f0-be46-606034e5d8f4	42806-116	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180702		ANDA	ANDA203864	Epic Pharma, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-121_f272cf6a-b757-41ea-83b1-f62b9ec5259e	42806-121	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20160104		ANDA	ANDA077070	Epic Pharma, LLC	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
42806-122_f272cf6a-b757-41ea-83b1-f62b9ec5259e	42806-122	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20160104		ANDA	ANDA077070	Epic Pharma, LLC	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
42806-123_f272cf6a-b757-41ea-83b1-f62b9ec5259e	42806-123	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20160104		ANDA	ANDA077070	Epic Pharma, LLC	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
42806-133_9db189e6-7ecc-465c-8197-c454350a45dc	42806-133	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20210101		ANDA	ANDA074544	Epic Pharma LLC	LEUCOVORIN CALCIUM	10	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
42806-134_9db189e6-7ecc-465c-8197-c454350a45dc	42806-134	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20210101		ANDA	ANDA074544	Epic Pharma LLC	LEUCOVORIN CALCIUM	15	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
42806-143_b84008e7-52db-4b3e-a12e-cb939852ff0f	42806-143	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline Hydrochloride	TABLET, FILM COATED	ORAL	20150202		ANDA	ANDA065447	Epic Pharma, LLC	DEMECLOCYCLINE HYDROCHLORIDE	150	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
42806-144_b84008e7-52db-4b3e-a12e-cb939852ff0f	42806-144	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline Hydrochloride	TABLET, FILM COATED	ORAL	20150202		ANDA	ANDA065447	Epic Pharma, LLC	DEMECLOCYCLINE HYDROCHLORIDE	300	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
42806-147_8982f18b-d818-43db-acbd-4ca06d36b967	42806-147	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		azithromycin	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	Epic Pharma, LLC	AZITHROMYCIN MONOHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
42806-149_8982f18b-d818-43db-acbd-4ca06d36b967	42806-149	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		azithromycin	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	Epic Pharma, LLC	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
42806-150_8982f18b-d818-43db-acbd-4ca06d36b967	42806-150	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		azithromycin	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	Epic Pharma, LLC	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
42806-151_8982f18b-d818-43db-acbd-4ca06d36b967	42806-151	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		azithromycin	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	Epic Pharma, LLC	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
42806-159_6252b8da-0d64-4e59-8617-85dbc57d602f	42806-159	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040600	Epic Pharma, LLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
42806-160_6252b8da-0d64-4e59-8617-85dbc57d602f	42806-160	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	Epic Pharma, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
42806-161_6252b8da-0d64-4e59-8617-85dbc57d602f	42806-161	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040604	Epic Pharma, LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
42806-178_eb386427-9b1d-4b13-9e18-0f9cc00b4cb7	42806-178	HUMAN PRESCRIPTION DRUG	Nystatin Topical Powder		Nystatin Topical Powder	POWDER	TOPICAL	20180502		ANDA	ANDA210532	Epic Pharma, LLC	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
42806-185_8723c280-f501-46c5-8be5-8a3e9cbd28b9	42806-185	HUMAN PRESCRIPTION DRUG	Nystatin Topical Powder		Nystatin Topical Powder	POWDER	TOPICAL	20230414		ANDA	ANDA210532	Epic Pharma, LLC	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
42806-186_0df13b1e-0e07-4123-a83a-1d7afb56170f	42806-186	HUMAN PRESCRIPTION DRUG	KLAYESTA		Nystatin Topical Powder	POWDER	TOPICAL	20230414		ANDA	ANDA210532	Epic Pharma, LLC	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
42806-260_a0376562-8af8-4fb9-9c67-7554e31179cd	42806-260	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		GEMFIBROZIL	TABLET	ORAL	20170323		ANDA	ANDA078012	Epic Pharma, LLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
42806-263_2495a640-8be1-4b9f-891e-8fc9fd5a2b48	42806-263	HUMAN PRESCRIPTION DRUG	Isradipine		Isradipine	CAPSULE	ORAL	20210315		ANDA	ANDA077169	Epic Pharma, LLC	ISRADIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42806-264_2495a640-8be1-4b9f-891e-8fc9fd5a2b48	42806-264	HUMAN PRESCRIPTION DRUG	Isradipine		Isradipine	CAPSULE	ORAL	20210315		ANDA	ANDA077169	Epic Pharma, LLC	ISRADIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42806-265_d02eca8c-18d4-4b11-bb16-08748543b04d	42806-265	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20211215		ANDA	ANDA074557	EPIC PHARMA, LLC	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
42806-266_2586c871-a6f1-4fab-87bf-c43b9e9fd092	42806-266	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20211215		ANDA	ANDA074557	EPIC PHARMA, LLC	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
42806-267_a67db31b-ed41-4d6d-b526-d6cdbf0ccb9e	42806-267	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20211215		ANDA	ANDA074557	EPIC PHARMA, LLC	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
42806-269_00990dec-7618-4cc8-9387-48c2cea8df1c	42806-269	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE LIGHT		cholestyramine light	POWDER, FOR SUSPENSION	ORAL	20211215		ANDA	ANDA074558	EPIC PHARMA, LLC	CHOLESTYRAMINE	4	g/5.7g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
42806-270_0e42f2cf-8083-4437-83d6-09335203e778	42806-270	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE LIGHT		cholestyramine light	POWDER, FOR SUSPENSION	ORAL	20211215		ANDA	ANDA074558	EPIC PHARMA, LLC	CHOLESTYRAMINE	4	g/5.7g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
42806-271_a04c5ed2-cb55-4c10-90f2-c7ea86b29b2e	42806-271	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE LIGHT		cholestyramine light	POWDER, FOR SUSPENSION	ORAL	20211215		ANDA	ANDA074558	EPIC PHARMA, LLC	CHOLESTYRAMINE	4	g/5.7g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
42806-296_d0ca35de-12e8-4154-825a-c82eed36efd7	42806-296	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20131202		ANDA	ANDA074673	Epic Pharma, LLC	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
42806-312_5a80562b-6db7-45b3-9285-d27e2353ba8d	42806-312	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA062269	Epic Pharma, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42806-313_b7b6b188-b148-4c9f-8e7b-1fad061209ea	42806-313	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20170313		ANDA	ANDA090564	Epic Pharma, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42806-314_b7b6b188-b148-4c9f-8e7b-1fad061209ea	42806-314	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20170313		ANDA	ANDA090564	Epic Pharma, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42806-315_b7b6b188-b148-4c9f-8e7b-1fad061209ea	42806-315	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20170313		ANDA	ANDA090564	Epic Pharma, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42806-317_6e8e00b0-1b6e-43dd-87ad-480bb8b09d34	42806-317	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20180611		ANDA	ANDA090065	Epic Pharma, LLC	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-318_6e8e00b0-1b6e-43dd-87ad-480bb8b09d34	42806-318	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20180611		ANDA	ANDA090065	Epic Pharma, LLC	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-327_b950655d-a9f8-4ace-bb56-0c7abbca231e	42806-327	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20210930		ANDA	ANDA212990	Epic Pharma, LLC	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42806-328_b950655d-a9f8-4ace-bb56-0c7abbca231e	42806-328	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20210930		ANDA	ANDA212990	Epic Pharma, LLC	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42806-329_b950655d-a9f8-4ace-bb56-0c7abbca231e	42806-329	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20210930		ANDA	ANDA212990	Epic Pharma, LLC	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
42806-330_d1991241-7c48-41dc-878c-fbc8b245b806	42806-330	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		Oxymorphone Hydrochloride	TABLET	ORAL	20190515		ANDA	ANDA201187	Epic Pharma, LLC	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-331_d1991241-7c48-41dc-878c-fbc8b245b806	42806-331	HUMAN PRESCRIPTION DRUG	Oxymorphone Hydrochloride		Oxymorphone Hydrochloride	TABLET	ORAL	20190515		ANDA	ANDA201187	Epic Pharma, LLC	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42806-336_b957cd51-22e2-4944-9653-704030fd0dfb	42806-336	HUMAN PRESCRIPTION DRUG	Molindone Hydrochloride		Molindone Hydrochloride	TABLET	ORAL	20181017		ANDA	ANDA090453	EPIC PHARMA, LLC	MOLINDONE HYDROCHLORIDE	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
42806-337_b957cd51-22e2-4944-9653-704030fd0dfb	42806-337	HUMAN PRESCRIPTION DRUG	Molindone Hydrochloride		Molindone Hydrochloride	TABLET	ORAL	20181017		ANDA	ANDA090453	EPIC PHARMA, LLC	MOLINDONE HYDROCHLORIDE	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
42806-338_b957cd51-22e2-4944-9653-704030fd0dfb	42806-338	HUMAN PRESCRIPTION DRUG	Molindone Hydrochloride		Molindone Hydrochloride	TABLET	ORAL	20181017		ANDA	ANDA090453	EPIC PHARMA, LLC	MOLINDONE HYDROCHLORIDE	25	mg/1	Typical Antipsychotic [EPC]		N	20241231
42806-339_f11301e2-3b5d-468d-b44c-45839e7e5dfb	42806-339	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20180817		ANDA	ANDA040444	Epic Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42806-341_f11301e2-3b5d-468d-b44c-45839e7e5dfb	42806-341	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190315		ANDA	ANDA040444	Epic Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42806-343_f11301e2-3b5d-468d-b44c-45839e7e5dfb	42806-343	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20180817		ANDA	ANDA040444	Epic Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42806-344_f11301e2-3b5d-468d-b44c-45839e7e5dfb	42806-344	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20190315		ANDA	ANDA040444	Epic Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42806-345_f11301e2-3b5d-468d-b44c-45839e7e5dfb	42806-345	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20180817		ANDA	ANDA040444	Epic Pharma, LLC	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42806-348_b271a757-875d-4349-8c40-a047c10cbd1b	42806-348	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171001		ANDA	ANDA207224	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-349_b271a757-875d-4349-8c40-a047c10cbd1b	42806-349	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171001		ANDA	ANDA207224	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-358_9db189e6-7ecc-465c-8197-c454350a45dc	42806-358	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20200416		ANDA	ANDA074544	Epic Pharma LLC	LEUCOVORIN CALCIUM	5	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
42806-359_9db189e6-7ecc-465c-8197-c454350a45dc	42806-359	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20200416		ANDA	ANDA074544	Epic Pharma LLC	LEUCOVORIN CALCIUM	25	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
42806-362_97ff76ed-f45f-4b11-b61f-78f8ea50f2fc	42806-362	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20190830		ANDA	ANDA065182	EPIC PHARMA, LLC	DOXYCYCLINE HYCLATE	20	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42806-363_11d06cd6-d46d-492c-ac8c-5f4d6df6d9e3	42806-363	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate for Oral Suspension		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20220802		ANDA	ANDA215538	EPIC PHARMA, LLC	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
42806-371_032860cb-ab2e-4fa7-aa43-672dee85e481	42806-371	HUMAN PRESCRIPTION DRUG	Deferasirox Oral Granules		deferasirox	GRANULE	ORAL	20221006		ANDA	ANDA214559	EPIC PHARMA, LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
42806-372_032860cb-ab2e-4fa7-aa43-672dee85e481	42806-372	HUMAN PRESCRIPTION DRUG	Deferasirox Oral Granules		deferasirox	GRANULE	ORAL	20221006		ANDA	ANDA214559	EPIC PHARMA, LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
42806-373_032860cb-ab2e-4fa7-aa43-672dee85e481	42806-373	HUMAN PRESCRIPTION DRUG	Deferasirox Oral Granules		deferasirox	GRANULE	ORAL	20221006		ANDA	ANDA214559	EPIC PHARMA, LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
42806-400_1a06b6b8-d81c-43a8-8d75-4685559a77b6	42806-400	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	Epic Pharma,LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42806-405_6f67d010-6cd8-461f-a71d-2dc689d54676	42806-405	HUMAN PRESCRIPTION DRUG	metformin hydrochloride		metformin hydrochloride tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190104		ANDA	ANDA209993	EPIC PHARMA, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42806-406_6f67d010-6cd8-461f-a71d-2dc689d54676	42806-406	HUMAN PRESCRIPTION DRUG	metformin hydrochloride		metformin hydrochloride tablet	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190104		ANDA	ANDA209993	EPIC PHARMA, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42806-410_c3910a83-8ab1-48f3-90d3-1e6a55524cb1	42806-410	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211215		ANDA	ANDA075932	Epic Pharma LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-411_c3910a83-8ab1-48f3-90d3-1e6a55524cb1	42806-411	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211215		ANDA	ANDA075932	Epic Pharma LLC	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-413_0c616c4e-b96d-8b5d-e063-6394a90adcae	42806-413	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230228		ANDA	ANDA216766	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-414_0bbe2ce1-be51-57c6-e063-6294a90accfc	42806-414	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230430		ANDA	ANDA210015	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-415_c3910a83-8ab1-48f3-90d3-1e6a55524cb1	42806-415	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211215		ANDA	ANDA075932	Epic Pharma LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-416_0bbe2ce1-be51-57c6-e063-6294a90accfc	42806-416	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230430		ANDA	ANDA210015	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-422_0bbe89e3-5885-ccca-e063-6394a90a328f	42806-422	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230807		ANDA	ANDA209314	Epic Pharma, LLC	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
42806-423_0bbe89e3-5885-ccca-e063-6394a90a328f	42806-423	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230807		ANDA	ANDA209314	Epic Pharma, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
42806-424_0be54d9c-5487-6c88-e063-6294a90ad626	42806-424	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230918		ANDA	ANDA211347	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-425_0be54d9c-5487-6c88-e063-6294a90ad626	42806-425	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230918		ANDA	ANDA211347	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-426_0be54d9c-5487-6c88-e063-6294a90ad626	42806-426	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230918		ANDA	ANDA211347	Epic Pharma, LLC	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
42806-501_cdaf4385-811f-4e33-9990-b4e2586b81b3	42806-501	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20100505		ANDA	ANDA074928	Epic Pharma, LLC	NICARDIPINE HYDROCHLORIDE	20	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42806-502_cdaf4385-811f-4e33-9990-b4e2586b81b3	42806-502	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20100505		ANDA	ANDA074928	Epic Pharma, LLC	NICARDIPINE HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
42806-503_9b63fd64-b261-4129-8583-f5a89dd284d2	42806-503	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20100716		ANDA	ANDA075517	Epic Pharma, LLC	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
42806-509_20f2898a-4fc1-450c-a7e8-36e3d8219ee0	42806-509	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170324		ANDA	ANDA207099	Epic Pharma, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42806-510_20f2898a-4fc1-450c-a7e8-36e3d8219ee0	42806-510	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170324		ANDA	ANDA207099	Epic Pharma, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42806-511_20f2898a-4fc1-450c-a7e8-36e3d8219ee0	42806-511	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170324		ANDA	ANDA207099	Epic Pharma, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42806-512_80df716e-b0d6-4b0f-b0f4-879874d7ed05	42806-512	HUMAN PRESCRIPTION DRUG	QUINIDINE SULFATE		quinidine sulfate tablet	TABLET	ORAL	20211215		ANDA	ANDA088072	EPIC PHARMA, LLC	QUINIDINE SULFATE	300	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
42806-513_80df716e-b0d6-4b0f-b0f4-879874d7ed05	42806-513	HUMAN PRESCRIPTION DRUG	QUINIDINE SULFATE		quinidine sulfate tablet	TABLET	ORAL	20211215		ANDA	ANDA088072	EPIC PHARMA, LLC	QUINIDINE SULFATE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
42806-524_eb0dd945-2ebd-422f-9228-7460f93d7889	42806-524	HUMAN PRESCRIPTION DRUG	PHENTERMINE HYDROCHLORIDE		PHENTERMINE HYDROCHLORIDE	CAPSULE	ORAL	20150415		ANDA	ANDA040228	Epic Pharma, LLC	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
42806-529_baef2304-82cb-41cc-b671-51b3b7886f55	42806-529	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170606		ANDA	ANDA210675	Epic Pharma, LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-530_baef2304-82cb-41cc-b671-51b3b7886f55	42806-530	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170606		ANDA	ANDA210675	Epic Pharma, LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-531_baef2304-82cb-41cc-b671-51b3b7886f55	42806-531	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220303		ANDA	ANDA210675	Epic Pharma, LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-532_baef2304-82cb-41cc-b671-51b3b7886f55	42806-532	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220303		ANDA	ANDA210675	Epic Pharma, LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-533_baef2304-82cb-41cc-b671-51b3b7886f55	42806-533	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170606		ANDA	ANDA210675	Epic Pharma, LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-547_5ad59ceb-a80c-4053-beaa-3ea86df31009	42806-547	HUMAN PRESCRIPTION DRUG	Ergocalciferol Capsules,		Ergocalciferol Capsules,	CAPSULE	ORAL	20181210		ANDA	ANDA204276	Epic Pharma LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
42806-549_3720bc10-a77d-4ffa-adcd-1920a4d8e970	42806-549	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20171128		ANDA	ANDA209909	Epic Pharma, LLC	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
42806-552_565240bb-7eb7-44fc-9b3f-2c40cc2156d1	42806-552	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		OMEGA-3-ACID ETHYL ESTERS	CAPSULE, LIQUID FILLED	ORAL	20200702		ANDA	ANDA210093	EPIC PHARMA, LLC	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
42806-553_141c4005-89de-447e-961f-3780f62eded4	42806-553	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	CAPSULE	ORAL	20211001		ANDA	ANDA215208	EPIC PHARMA, LLC	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
42806-554_141c4005-89de-447e-961f-3780f62eded4	42806-554	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	CAPSULE	ORAL	20211001		ANDA	ANDA215208	EPIC PHARMA, LLC	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
42806-555_141c4005-89de-447e-961f-3780f62eded4	42806-555	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	CAPSULE	ORAL	20211001		ANDA	ANDA215208	EPIC PHARMA, LLC	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
42806-562_eab706f9-1c3b-4be4-a118-4cfd55ce2c11	42806-562	HUMAN PRESCRIPTION DRUG	CHLORDIAZEPOXIDE HYDROCHLORIDE		CHLORDIAZEPOXIDE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20210511		ANDA	ANDA085472	Epic Pharma LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
42806-563_eab706f9-1c3b-4be4-a118-4cfd55ce2c11	42806-563	HUMAN PRESCRIPTION DRUG	CHLORDIAZEPOXIDE HYDROCHLORIDE		CHLORDIAZEPOXIDE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20210511		ANDA	ANDA085475	Epic Pharma LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
42806-564_d7a3306e-01d4-4966-a473-62136d81f959	42806-564	HUMAN PRESCRIPTION DRUG	CHLORDIAZEPOXIDE HYDROCHLORIDE		CHLORDIAZEPOXIDE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20211109		ANDA	ANDA085461	Epic Pharma, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
42806-565_d7a3306e-01d4-4966-a473-62136d81f959	42806-565	HUMAN PRESCRIPTION DRUG	CHLORDIAZEPOXIDE HYDROCHLORIDE		CHLORDIAZEPOXIDE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20210813		ANDA	ANDA085472	Epic Pharma, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
42806-566_d7a3306e-01d4-4966-a473-62136d81f959	42806-566	HUMAN PRESCRIPTION DRUG	CHLORDIAZEPOXIDE HYDROCHLORIDE		CHLORDIAZEPOXIDE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20210813		ANDA	ANDA085475	Epic Pharma, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
42806-600_e5150640-374a-4e7d-bac2-aabe50c07083	42806-600	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	SUSPENSION	ORAL	20230130		ANDA	ANDA215332	EPIC PHARMA, LLC	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42806-601_0c60dbaf-630c-bec4-e063-6294a90a7ea2	42806-601	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220907		ANDA	ANDA214654	Epic Pharma, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
42806-602_0c60dbaf-630c-bec4-e063-6294a90a7ea2	42806-602	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220907		ANDA	ANDA214654	Epic Pharma, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
42806-603_0c60dbaf-630c-bec4-e063-6294a90a7ea2	42806-603	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220907		ANDA	ANDA214654	Epic Pharma, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
42806-632_0bbf8c4c-2a56-2ced-e063-6394a90adb91	42806-632	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200708		ANDA	ANDA211052	Epic Pharma, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42806-633_0bbf8c4c-2a56-2ced-e063-6394a90adb91	42806-633	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200708		ANDA	ANDA211052	Epic Pharma, LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
42806-645_2cffb084-2b25-4e1b-846b-8681de7ea666	42806-645	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		doxyclycline hyclate	TABLET, COATED	ORAL	20201216		ANDA	ANDA214207	EPIC PHARMA, LLC	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42806-646_2cffb084-2b25-4e1b-846b-8681de7ea666	42806-646	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		doxyclycline hyclate	TABLET, COATED	ORAL	20201216		ANDA	ANDA214207	EPIC PHARMA, LLC	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
42806-648_92732b8c-9804-4019-bd6c-5cc5077b1b0e	42806-648	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20161122		OTC MONOGRAPH FINAL	part341	Epic Pharma, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42806-649_4884641f-c4af-4148-89c1-0e29c6ec6e5e	42806-649	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20161122		OTC MONOGRAPH FINAL	part341	Epic Pharma, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42806-658_6981fb54-6655-45d8-93bc-2e43a6f6eb41	42806-658	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20200602		ANDA	ANDA212126	EPIC PHARMA, LLC	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
42806-659_6981fb54-6655-45d8-93bc-2e43a6f6eb41	42806-659	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20200602		ANDA	ANDA212126	EPIC PHARMA, LLC	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
42806-662_4c360519-dcca-4a6b-a80b-87adaedd7d60	42806-662	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA202087	EPIC PHARMA, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
42806-663_4c360519-dcca-4a6b-a80b-87adaedd7d60	42806-663	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA202087	EPIC PHARMA, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
42806-664_4c360519-dcca-4a6b-a80b-87adaedd7d60	42806-664	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA202087	EPIC PHARMA, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
42806-665_4c360519-dcca-4a6b-a80b-87adaedd7d60	42806-665	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA202087	EPIC PHARMA, LLC	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
42806-708_f5295234-f25a-44c1-a761-2500d4db2312	42806-708	HUMAN PRESCRIPTION DRUG	Ethosuximide		Ethosuximide	CAPSULE	ORAL	20211112		ANDA	ANDA210654	Epic Pharma, LLC	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42806-711_f40654a9-2cf1-49a3-bddb-1f56460a67b8	42806-711	HUMAN PRESCRIPTION DRUG	Ethosuximide		Ethosuximide	CAPSULE	ORAL	20200316		ANDA	ANDA210654	Epic Pharma, LLC	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
42806-714_9b35e9d5-7d72-4f51-a245-ad2467ab40e9	42806-714	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Epic Pharma LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
42806-715_9b35e9d5-7d72-4f51-a245-ad2467ab40e9	42806-715	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Epic Pharma LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
42806-716_f0b6bd3f-e401-7607-e053-2a95a90a036c	42806-716	HUMAN PRESCRIPTION DRUG	amantadine hydrochloride		amantadine hydrochloride	CAPSULE	ORAL	20221230		ANDA	ANDA214580	EPIC PHARMA LLC	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
42806-720_57dbaf6f-f259-4179-87a8-426b0c6c94b9	42806-720	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201016		ANDA	ANDA207872	EPIC PHARMA, LLC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42806-721_57dbaf6f-f259-4179-87a8-426b0c6c94b9	42806-721	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201016		ANDA	ANDA207872	EPIC PHARMA, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42806-722_57dbaf6f-f259-4179-87a8-426b0c6c94b9	42806-722	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201016		ANDA	ANDA207872	EPIC PHARMA, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42806-723_57dbaf6f-f259-4179-87a8-426b0c6c94b9	42806-723	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201016		ANDA	ANDA207872	EPIC PHARMA, LLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42806-757_69f2d77c-8279-4524-93c2-f199e7973400	42806-757	HUMAN PRESCRIPTION DRUG	SULFADIAZINE		sulfadiazine	TABLET	ORAL	20211215		ANDA	ANDA040091	EPIC PHARMA, LLC	SULFADIAZINE	500	mg/1	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
42806-799_a4ac02e8-68ac-4e79-8ca5-0939dd002c87	42806-799	HUMAN PRESCRIPTION DRUG	RIFAMPIN		rifampin	CAPSULE	ORAL	20211215		ANDA	ANDA064150	EPIC PHARMA, LLC	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
42806-801_a4ac02e8-68ac-4e79-8ca5-0939dd002c87	42806-801	HUMAN PRESCRIPTION DRUG	RIFAMPIN		rifampin	CAPSULE	ORAL	20211215		ANDA	ANDA064150	EPIC PHARMA, LLC	RIFAMPIN	150	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
42806-802_c9cbd807-7a84-4285-928e-63bc11db6c9a	42806-802	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20210316		ANDA	ANDA077361	Epic Pharma, LLC	TRIMIPRAMINE MALEATE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-803_c9cbd807-7a84-4285-928e-63bc11db6c9a	42806-803	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20210316		ANDA	ANDA077361	Epic Pharma, LLC	TRIMIPRAMINE MALEATE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-804_c9cbd807-7a84-4285-928e-63bc11db6c9a	42806-804	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20210316		ANDA	ANDA077361	Epic Pharma, LLC	TRIMIPRAMINE MALEATE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42806-810_c05e4350-a70c-41d0-ac28-30b47133b0b8	42806-810	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20140501		ANDA	ANDA040190	Epic Pharma, LLC	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
42806-817_0c60915f-1782-4d29-e063-6394a90af71e	42806-817	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20220915		ANDA	ANDA215599	Epic Pharma, LLC	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
42806-818_0c60915f-1782-4d29-e063-6394a90af71e	42806-818	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20220915		ANDA	ANDA215599	Epic Pharma, LLC	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
42806-819_0c60915f-1782-4d29-e063-6394a90af71e	42806-819	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20220915		ANDA	ANDA215599	Epic Pharma, LLC	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
42808-103_086c6733-8023-d553-e063-6394a90a3cfd	42808-103	HUMAN PRESCRIPTION DRUG	Exact-Rx Sodium Sulfacetamide Wash 10%		SODIUM SULFACETAMIDE	LIQUID	TOPICAL	20110801		UNAPPROVED DRUG OTHER		Exact-Rx, Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
42808-113_09426e3a-88b1-3c76-e063-6394a90a483e	42808-113	HUMAN PRESCRIPTION DRUG	Exact-Rx SODIUM SULFACETAMIDE and SULFER 10%/5% Cleanser		SODIUM SULFACETAMIDE, SULFUR	LOTION	TOPICAL	20110801		UNAPPROVED DRUG OTHER		Exact-Rx, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
42808-202_09431b41-95aa-da6e-e063-6294a90ac22e	42808-202	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20110801		UNAPPROVED DRUG OTHER		Exact-Rx, Inc.	UREA	450	mg/g			N	20241231
42808-204_086b2d75-beb1-4856-e063-6294a90ad02e	42808-204	HUMAN PRESCRIPTION DRUG	Urea		Urea	GEL	TOPICAL	20110801		UNAPPROVED DRUG OTHER		Exact-Rx, Inc.	UREA	450	mg/mL			N	20241231
42809-0002_3b6b0469-bb49-4ac1-83d6-a5483f6c7a96	42809-0002	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19900101		UNAPPROVED MEDICAL GAS		Express Medical Inc	OXYGEN	99	L/100L			N	20241231
42821-001_0803345d-7814-bc21-e063-6394a90aa661	42821-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205767	T & C Flynn's Pharmacy Inc	OXYGEN	990	mL/L			N	20241231
42829-001_e5c5c2ee-fe5d-b29e-e053-2a95a90aa9f8	42829-001	HUMAN OTC DRUG	Sterile Saline Kids Mist	SinuCleanse Breathe	Sodium Chloride	SPRAY	NASAL	20220613		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.	SODIUM CHLORIDE	.9	g/100g			N	20241231
42829-002_0ac85b9a-3cfc-0c6a-e063-6294a90a479b	42829-002	HUMAN OTC DRUG	Antiseptic Wound Care	MediCleanse Healing	BENZETHONIUM CHLORIDE	SOLUTION	TOPICAL	20220628		OTC MONOGRAPH DRUG	505G(a)(3)	ASCENT CONSUMER PRODUCTS, INC	BENZETHONIUM CHLORIDE	1.3	mg/g			N	20241231
42829-003_e5c5b580-1da0-3081-e053-2995a90a8031	42829-003	HUMAN OTC DRUG	Sterile Saline Kids Mist	PediaMeds	Sodium Chloride	SPRAY	NASAL	20220613		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.	SODIUM CHLORIDE	.9	g/100g			N	20241231
42829-401_bbccd2ce-d9af-fb70-e053-2a95a90aa9bf	42829-401	HUMAN OTC DRUG	SinuCleanse		SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20150201		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
42829-402_effe6064-3bca-d188-e053-2a95a90a9c3c	42829-402	HUMAN OTC DRUG	SinuCleanse Neti-Pot		SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20150201		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.						N	20241231
42829-405_bbccd2ce-d9bd-fb70-e053-2a95a90aa9bf	42829-405	HUMAN OTC DRUG	SinuCleanse Squeeze		SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20150201		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.						N	20241231
42829-406_bbccc1b5-47cc-60bc-e053-2a95a90ae9a5	42829-406	HUMAN OTC DRUG	SinuCleanse Micro-Filtered Nasal Wash System		Sodium Chloride, Sodium Bicarbonate	KIT		20150701		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.						N	20241231
42829-407_d5129a91-50e8-6b94-e053-2a95a90a2b30	42829-407	HUMAN OTC DRUG	SinuCleanse Nasal Drip		Sodium Chloride	GEL	NASAL	20220108		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC	SODIUM CHLORIDE	.9	mg/100mL			N	20241231
42829-408_bbccf65a-37fe-eb10-e053-2a95a90ad979	42829-408	HUMAN OTC DRUG	SinuCleanse		SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20150201		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.	SODIUM BICARBONATE; SODIUM CHLORIDE	22.2; 77.8	mg/100mg; mg/100mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
42829-408_bbed82c3-6472-c141-e053-2a95a90a9320	42829-408	HUMAN OTC DRUG	SinuCleanse		SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20150201		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC.	SODIUM BICARBONATE; SODIUM CHLORIDE	22.2; 77.8	mg/100mg; mg/100mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
42829-504_d5131b0b-4c4f-1711-e053-2995a90a5390	42829-504	HUMAN OTC DRUG	SinuCleanse Sterile Saline Mist Daily Care		Sodium Chloride	SPRAY	NASAL	20220108		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC	SODIUM CHLORIDE	.9	g/100g			N	20241231
42829-505_d51264de-6134-310a-e053-2995a90a7084	42829-505	HUMAN OTC DRUG	SinuCleanse Sterile Saline Mist		Sodium Chloride	SPRAY	NASAL	20210313		UNAPPROVED DRUG OTHER		ASCENT CONSUMER PRODUCTS, INC	SODIUM CHLORIDE	3	g/100g			N	20241231
42847-103_1a9b50b3-afcb-4b7b-a891-5fd1da5709c8	42847-103	HUMAN PRESCRIPTION DRUG	Silenor		doxepin hydrochloride	TABLET	ORAL	20100801		NDA	NDA022036	Currax Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42847-106_1a9b50b3-afcb-4b7b-a891-5fd1da5709c8	42847-106	HUMAN PRESCRIPTION DRUG	Silenor		doxepin hydrochloride	TABLET	ORAL	20100801		NDA	NDA022036	Currax Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
42847-311_4e3e77c5-7f60-4205-b7c8-a048469c79ce	42847-311	HUMAN PRESCRIPTION DRUG	Onzetra Xsail		sumatriptan succinate	CAPSULE	NASAL	20151001		NDA	NDA206099	Currax Pharmaceuticals LLC	SUMATRIPTAN SUCCINATE	11	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
42847-850_b8ff8553-e8a3-478b-a79f-add4d4620e3c	42847-850	HUMAN PRESCRIPTION DRUG	Treximet		Sumatriptan Succinate and Naproxen Sodium	TABLET, FILM COATED	ORAL	20080425		NDA	NDA021926	Currax Pharmaceuticals LLC	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500; 85	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
42851-035_dd2fe1d6-cadc-4299-e053-2995a90a4f3e	42851-035	HUMAN PRESCRIPTION DRUG	ZO Skin Health Pigment Control plus Brightening Creme Hydroquinone plus Vitamin C		Hydroquinone	EMULSION	TOPICAL	20180501		UNAPPROVED DRUG OTHER		ZO Skin Health, Inc.	HYDROQUINONE	.04	mg/mL	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
42851-036_dd473419-8217-5f56-e053-2995a90ad156	42851-036	HUMAN PRESCRIPTION DRUG	ZO Skin Health Pigment Control Plus Blending Creme Hydroquinone		Hydroquinone	EMULSION	TOPICAL	20180501		UNAPPROVED DRUG OTHER		ZO Skin Health, Inc.	HYDROQUINONE	.04	g/mL	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
42851-037_dd47af61-3b0f-4e58-e053-2995a90a7d9c	42851-037	HUMAN PRESCRIPTION DRUG	ZO Skin Health Pigment Control Creme Hydroquinone		Hydroquinone	EMULSION	TOPICAL	20180415		UNAPPROVED DRUG OTHER		ZO Skin Health, Inc.	HYDROQUINONE	40	mg/mL	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
42851-038_dd82a6af-aa21-98ba-e053-2995a90a5540	42851-038	HUMAN OTC DRUG	ZO Skin Health Pigment Control Creme Hydroquinone		Hydroquinone	LOTION	TOPICAL	20181107		OTC MONOGRAPH NOT FINAL	part358A	ZO Skin Health, Inc.	HYDROQUINONE	20	mg/mL	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
42851-049_9a72cd81-ea7a-41fa-b6a4-c945d5671b4c	42851-049	HUMAN OTC DRUG	ZO Skin Health Sunscreen Plus Powder Broad-Spectrum SPF 45 (Light)		Zinc Oxide	POWDER	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	ZO Skin Health, Inc.	ZINC OXIDE	.675	mg/g			N	20241231
42851-055_dd09abaa-c8e1-5621-e053-2a95a90a6cbf	42851-055	HUMAN OTC DRUG	ZO Skin Health Smart Tone Broad-Spectrum Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220601		OTC MONOGRAPH FINAL	part352	ZO Skin Health, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
42851-060_077882d3-ccad-8cbb-e063-6394a90a45bd	42851-060	HUMAN OTC DRUG	ZO Skin Health Sunscreen Plus Primer Broad-Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20191031		OTC MONOGRAPH DRUG	M020	ZO Skin Health, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	10; 200	mg/mL; mg/mL			N	20241231
42851-064_e81c7511-8433-1d43-e053-2a95a90a008e	42851-064	HUMAN OTC DRUG	ZO Skin Health Broad-Spectrum Sunscreen SPF 50		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220815		OTC MONOGRAPH FINAL	part352	ZO Skin Health, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	7.552; 17.7	mg/118g; mg/118g			N	20241231
42851-068_3dc65043-d141-428d-8814-15f4f206498c	42851-068	HUMAN OTC DRUG	ZO Skin Health Sunscreen Plus Powder Broad-Spectrum SPF 45		Zinc Oxide	POWDER	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	ZO Skin Health, Inc.	ZINC OXIDE	.675	mg/2.7g			N	20241231
42851-069_5542d447-4fcd-4866-b4d8-ebf52f94abd2	42851-069	HUMAN OTC DRUG	Sunscreen Plus Powder Broad-Spectrum SPF 45		Zinc Oxide	POWDER	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	ZO Skin Health, Inc.	ZINC OXIDE	.675	mg/2.7g			N	20241231
42851-085_dd983d2c-f396-a9c5-e053-2995a90a1d12	42851-085	HUMAN OTC DRUG	ZO Skin Health Oil Control Pads Acne Treatment		Salicylic Acid	PATCH	TOPICAL	20171101		OTC MONOGRAPH FINAL	part333D	ZO Skin Health, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
42851-087_fcf13405-2f1a-a703-e053-6294a90a6947	42851-087	HUMAN OTC DRUG	ZO Skin Health Acne Control Benzoyl Peroxide		Benzoyl Peroxide	CREAM	TOPICAL	20230525		OTC MONOGRAPH FINAL	part333D	ZO Skin Health, Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
42851-090_ea51529d-5271-c941-e053-2a95a90ab8cd	42851-090	HUMAN OTC DRUG	ZO Skin Health Astringent Solution		Aluminum Acetate	POWDER	TOPICAL	20220221		OTC MONOGRAPH FINAL	part347	ZO Skin Health, Inc.	ALUMINUM ACETATE	4866	mg/6g			N	20241231
42851-091_f2a339ca-cdf4-1899-e053-2a95a90acbb7	42851-091	HUMAN OTC DRUG	ZO Skin Health Sheer Fluid Broad-Spectrum Sunscreen SPF 50		Zinc Oxide	LOTION	TOPICAL	20230401		OTC MONOGRAPH FINAL	M020	ZO Skin Health, Inc.	ZINC OXIDE	.225	g/50mL			N	20241231
42851-092_ecae2e4d-dfca-642c-e053-2995a90ac9b1	42851-092	HUMAN OTC DRUG	ZO Skin Health Gel Sunscreen Broad-Spectrum SPF 50		Avobenzone, Octisalate, Octocrylene	GEL	TOPICAL	20230401		OTC MONOGRAPH FINAL	M020	ZO Skin Health, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.35; 2.25; 4.5	g/45g; g/45g; g/45g			N	20241231
42851-094_f3a84c9a-3c45-3a86-e053-2a95a90a0b6e	42851-094	HUMAN OTC DRUG	ZO Skin Health Daily Sheer Broad-Spectrum Sunscreen SPF 45		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230801		OTC MONOGRAPH FINAL	M020	ZO Skin Health, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1350; 3060; 2250; 4500	mg/45mL; mg/45mL; mg/45mL; mg/45mL			N	20241231
42851-095_ffd6ce9d-be49-a5b8-e053-6394a90ac2da	42851-095	HUMAN OTC DRUG	ZO Skin Health Daily Sheer Broad-Spectrum Sunscreen SPF 50 Water Resistant (40 Minutes)		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20231001		OTC MONOGRAPH FINAL	M020	ZO Skin Health, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1350; 3060; 2250; 4500	mg/45mL; mg/45mL; mg/45mL; mg/45mL			N	20241231
42851-184_dd1a4fc8-0c2c-67a7-e053-2995a90ac05b	42851-184	HUMAN PRESCRIPTION DRUG	ZO Skin Health Pigment Control Program Plus Hydroquinone		Hydroquinone	KIT		20210309		UNAPPROVED DRUG OTHER		ZO Skin Health, Inc.						N	20241231
42851-187_0cce3690-f45a-9838-e063-6394a90a36ee	42851-187	HUMAN OTC DRUG	ZO Skin Health Post Procedure Program		ALUMINUM ACETATE	KIT		20190702		OTC MONOGRAPH DRUG	M016	ZO Skin Health, Inc.						N	20241231
42851-193_0ccf88c6-273b-0a37-e063-6294a90a679a	42851-193	HUMAN OTC DRUG	ZO Skin Health Post Procedure Recovery System		Aluminum Acetate	KIT		20190131		OTC MONOGRAPH DRUG	M016	ZO Skin Health, Inc.						N	20241231
42858-001_36e846be-d98d-4bb4-8078-c8955dd4532d	42858-001	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Rhodes Pharmaceuticals L.P.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-002_36e846be-d98d-4bb4-8078-c8955dd4532d	42858-002	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Rhodes Pharmaceuticals L.P.	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-003_36e846be-d98d-4bb4-8078-c8955dd4532d	42858-003	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Rhodes Pharmaceuticals L.P.	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-004_36e846be-d98d-4bb4-8078-c8955dd4532d	42858-004	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Rhodes Pharmaceuticals L.P.	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-005_36e846be-d98d-4bb4-8078-c8955dd4532d	42858-005	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Rhodes Pharmaceuticals L.P.	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-011_5c3a829d-205d-4ec7-b87b-ebe4dc754ac8	42858-011	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20171201	20240402	ANDA	ANDA208756	Rhodes Pharmaceuticals L.P.	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
42858-029_02c1dae3-bf64-4836-a7e5-3246ba1ead26	42858-029	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		Lidocaine and Prilocaine	CREAM	TOPICAL	20230416		ANDA	ANDA213253	Rhodes Pharmaceuticals L.P.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
42858-055_f39f8c3a-d21d-4599-856f-c8e3f909e5a8	42858-055	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20190822		ANDA	ANDA210651	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-067_d749dc50-3875-43fe-b137-e994d53d42b8	42858-067	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20170601		ANDA	ANDA075753	Rhodes Pharmaceuticals L.P.	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42858-075_313dd85a-d17b-49fd-ae59-47fbf49280f9	42858-075	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200401		NDA AUTHORIZED GENERIC	NDA205831	Rhodes Pharmaceuticals	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-076_313dd85a-d17b-49fd-ae59-47fbf49280f9	42858-076	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200401		NDA AUTHORIZED GENERIC	NDA205831	Rhodes Pharmaceuticals	METHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-077_313dd85a-d17b-49fd-ae59-47fbf49280f9	42858-077	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200401		NDA AUTHORIZED GENERIC	NDA205831	Rhodes Pharmaceuticals	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-078_313dd85a-d17b-49fd-ae59-47fbf49280f9	42858-078	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200401		NDA AUTHORIZED GENERIC	NDA205831	Rhodes Pharmaceuticals	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-079_313dd85a-d17b-49fd-ae59-47fbf49280f9	42858-079	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200401		NDA AUTHORIZED GENERIC	NDA205831	Rhodes Pharmaceuticals	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-080_313dd85a-d17b-49fd-ae59-47fbf49280f9	42858-080	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200401		NDA AUTHORIZED GENERIC	NDA205831	Rhodes Pharmaceuticals	METHYLPHENIDATE HYDROCHLORIDE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-081_313dd85a-d17b-49fd-ae59-47fbf49280f9	42858-081	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200401		NDA AUTHORIZED GENERIC	NDA205831	Rhodes Pharmaceuticals	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-094_174e9aa4-f38f-4fa9-af1e-db9bfe7aabb9	42858-094	HUMAN PRESCRIPTION DRUG	FORMOTEROL FUMARATE		formoterol fumarate dihydrate	SOLUTION	RESPIRATORY (INHALATION)	20231115		ANDA	ANDA215621	Rhodes Pharmaceuticals L.P.	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
42858-102_52c7325e-1d7f-4a2f-9839-eb47cc5b79da	42858-102	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Rhodes Pharmaceuticals L.P.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
42858-103_52c7325e-1d7f-4a2f-9839-eb47cc5b79da	42858-103	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Rhodes Pharmaceuticals L.P.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
42858-104_52c7325e-1d7f-4a2f-9839-eb47cc5b79da	42858-104	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Rhodes Pharmaceuticals L.P.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
42858-122_d1961f48-267b-481f-9d2a-ac5b33a10e44	42858-122	HUMAN PRESCRIPTION DRUG	Dilaudid		hydromorphone hydrochloride	TABLET	ORAL	20170515		NDA	NDA019892	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
42858-134_d749dc50-3875-43fe-b137-e994d53d42b8	42858-134	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20170601		ANDA	ANDA075753	Rhodes Pharmaceuticals L.P.	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42858-200_d749dc50-3875-43fe-b137-e994d53d42b8	42858-200	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20170601		ANDA	ANDA075753	Rhodes Pharmaceuticals L.P.	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42858-201_3846ca13-e311-46ea-b3fc-ccca91bba701	42858-201	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Rhodes Pharmaceuticals L.P.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
42858-202_3846ca13-e311-46ea-b3fc-ccca91bba701	42858-202	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Rhodes Pharmaceuticals L.P.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
42858-203_3846ca13-e311-46ea-b3fc-ccca91bba701	42858-203	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Rhodes Pharmaceuticals L.P.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
42858-215_f39f8c3a-d21d-4599-856f-c8e3f909e5a8	42858-215	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20190822		ANDA	ANDA210651	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-225_5c3a829d-205d-4ec7-b87b-ebe4dc754ac8	42858-225	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20171201	20240402	ANDA	ANDA208756	Rhodes Pharmaceuticals L.P.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
42858-234_d1961f48-267b-481f-9d2a-ac5b33a10e44	42858-234	HUMAN PRESCRIPTION DRUG	Dilaudid		hydromorphone hydrochloride	TABLET	ORAL	20170515		NDA	NDA019892	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
42858-301_a297f2f1-2b57-4eed-8ddd-8f3387010e74	42858-301	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091123		NDA AUTHORIZED GENERIC	NDA019892	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-302_a297f2f1-2b57-4eed-8ddd-8f3387010e74	42858-302	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091123		NDA AUTHORIZED GENERIC	NDA019892	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-303_a297f2f1-2b57-4eed-8ddd-8f3387010e74	42858-303	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091123		NDA AUTHORIZED GENERIC	NDA019892	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-304_a297f2f1-2b57-4eed-8ddd-8f3387010e74	42858-304	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	SOLUTION	ORAL	20120720		NDA AUTHORIZED GENERIC	NDA019891	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-325_f39f8c3a-d21d-4599-856f-c8e3f909e5a8	42858-325	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20190822		ANDA	ANDA210651	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-338_d1961f48-267b-481f-9d2a-ac5b33a10e44	42858-338	HUMAN PRESCRIPTION DRUG	Dilaudid		hydromorphone hydrochloride	TABLET	ORAL	20170515		NDA	NDA019892	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
42858-353_8dadad59-07b4-4a1c-9b9e-b7c3a6dbaafe	42858-353	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH	TRANSDERMAL	20170703		NDA AUTHORIZED GENERIC	NDA021306	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE	7.5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-401_1d11e318-755c-460d-9d69-eba3e754642b	42858-401	HUMAN PRESCRIPTION DRUG	APTENSIO XR		(methylphenidate hydrochloride)	CAPSULE, EXTENDED RELEASE	ORAL	20150417		NDA	NDA205831	Rhodes Pharmaceuticals L.P.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-402_1d11e318-755c-460d-9d69-eba3e754642b	42858-402	HUMAN PRESCRIPTION DRUG	APTENSIO XR		(methylphenidate hydrochloride)	CAPSULE, EXTENDED RELEASE	ORAL	20150417		NDA	NDA205831	Rhodes Pharmaceuticals L.P.	METHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-403_1d11e318-755c-460d-9d69-eba3e754642b	42858-403	HUMAN PRESCRIPTION DRUG	APTENSIO XR		(methylphenidate hydrochloride)	CAPSULE, EXTENDED RELEASE	ORAL	20150417		NDA	NDA205831	Rhodes Pharmaceuticals L.P.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-404_1d11e318-755c-460d-9d69-eba3e754642b	42858-404	HUMAN PRESCRIPTION DRUG	APTENSIO XR		(methylphenidate hydrochloride)	CAPSULE, EXTENDED RELEASE	ORAL	20150417		NDA	NDA205831	Rhodes Pharmaceuticals L.P.	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-405_1d11e318-755c-460d-9d69-eba3e754642b	42858-405	HUMAN PRESCRIPTION DRUG	APTENSIO XR		(methylphenidate hydrochloride)	CAPSULE, EXTENDED RELEASE	ORAL	20150417		NDA	NDA205831	Rhodes Pharmaceuticals L.P.	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-406_1d11e318-755c-460d-9d69-eba3e754642b	42858-406	HUMAN PRESCRIPTION DRUG	APTENSIO XR		(methylphenidate hydrochloride)	CAPSULE, EXTENDED RELEASE	ORAL	20150417		NDA	NDA205831	Rhodes Pharmaceuticals L.P.	METHYLPHENIDATE HYDROCHLORIDE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-407_1d11e318-755c-460d-9d69-eba3e754642b	42858-407	HUMAN PRESCRIPTION DRUG	APTENSIO XR		(methylphenidate hydrochloride)	CAPSULE, EXTENDED RELEASE	ORAL	20150417		NDA	NDA205831	Rhodes Pharmaceuticals L.P.	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-410_5c3a829d-205d-4ec7-b87b-ebe4dc754ac8	42858-410	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20171201	20240402	ANDA	ANDA208756	Rhodes Pharmaceuticals L.P.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
42858-416_d1961f48-267b-481f-9d2a-ac5b33a10e44	42858-416	HUMAN PRESCRIPTION DRUG	Dilaudid		hydromorphone hydrochloride	SOLUTION	ORAL	20170515		NDA	NDA019891	Rhodes Pharmaceuticals L.P.	HYDROMORPHONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
42858-454_e51a8147-e070-477e-a769-7b9419b98698	42858-454	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20170601		ANDA	ANDA076433	Rhodes Pharmaceuticals L.P.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42858-493_8dadad59-07b4-4a1c-9b9e-b7c3a6dbaafe	42858-493	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH	TRANSDERMAL	20170703		NDA AUTHORIZED GENERIC	NDA021306	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE	10	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-501_c100436c-620c-46fe-966f-0e23b074ace9	42858-501	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20171025		ANDA	ANDA207276	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-502_c100436c-620c-46fe-966f-0e23b074ace9	42858-502	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20171025		ANDA	ANDA207276	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-515_d6dc2105-2042-4b39-97bd-2d80e0114dcd	42858-515	HUMAN PRESCRIPTION DRUG	MS Contin		morphine sulfate	TABLET	ORAL	20170515		NDA	NDA019516	Rhodes Pharmaceuticals L.P.	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-586_8dadad59-07b4-4a1c-9b9e-b7c3a6dbaafe	42858-586	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH	TRANSDERMAL	20170703		NDA AUTHORIZED GENERIC	NDA021306	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE	15	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-601_e50a8997-6d4e-4ee0-9a5d-52be019c7c22	42858-601	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20200413		ANDA	ANDA205601	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-602_e50a8997-6d4e-4ee0-9a5d-52be019c7c22	42858-602	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20200413		ANDA	ANDA205601	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-610_f39f8c3a-d21d-4599-856f-c8e3f909e5a8	42858-610	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20190822		ANDA	ANDA210651	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-631_d6dc2105-2042-4b39-97bd-2d80e0114dcd	42858-631	HUMAN PRESCRIPTION DRUG	MS Contin		morphine sulfate	TABLET	ORAL	20170515		NDA	NDA019516	Rhodes Pharmaceuticals L.P.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-660_e51a8147-e070-477e-a769-7b9419b98698	42858-660	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20170601		ANDA	ANDA076433	Rhodes Pharmaceuticals L.P.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
42858-700_d33a56ff-af7b-41a0-9b44-0f58c7fa347a	42858-700	HUMAN PRESCRIPTION DRUG	THEOPHYLLINE		THEOPHYLLINE ANHYDROUS	TABLET, EXTENDED RELEASE	ORAL	20231215		ANDA	ANDA214113	Rhodes Pharmaceuticals	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
42858-701_69ebc57e-5b69-46e7-beaa-271cfce91391	42858-701	HUMAN PRESCRIPTION DRUG	Theophylline	Anhydrous	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20120202		ANDA	ANDA040086	Rhodes Pharmaceuticals L.P.	THEOPHYLLINE ANHYDROUS	400	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
42858-703_06f6d078-40c3-46f3-a245-28ad27f2dc37	42858-703	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE HYDROCHLORIDE HEMIHYDRATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180914		ANDA	ANDA209293	Rhodes Pharmaceuticals L.P.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42858-705_06f6d078-40c3-46f3-a245-28ad27f2dc37	42858-705	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE HYDROCHLORIDE HEMIHYDRATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180914		ANDA	ANDA209293	Rhodes Pharmaceuticals L.P.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42858-707_06f6d078-40c3-46f3-a245-28ad27f2dc37	42858-707	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE HYDROCHLORIDE HEMIHYDRATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180914		ANDA	ANDA209293	Rhodes Pharmaceuticals L.P.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
42858-720_f39f8c3a-d21d-4599-856f-c8e3f909e5a8	42858-720	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20190822		ANDA	ANDA210651	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-721_8ce3fe4e-f32a-4028-a920-86d638628cca	42858-721	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20210909		ANDA	ANDA213111	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-722_8ce3fe4e-f32a-4028-a920-86d638628cca	42858-722	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20210909		ANDA	ANDA213111	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-723_8ce3fe4e-f32a-4028-a920-86d638628cca	42858-723	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20210909		ANDA	ANDA213111	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-724_8ce3fe4e-f32a-4028-a920-86d638628cca	42858-724	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20210909		ANDA	ANDA213111	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-725_8ce3fe4e-f32a-4028-a920-86d638628cca	42858-725	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20210909		ANDA	ANDA213111	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-726_8ce3fe4e-f32a-4028-a920-86d638628cca	42858-726	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20210909		ANDA	ANDA213111	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-727_8ce3fe4e-f32a-4028-a920-86d638628cca	42858-727	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20210909		ANDA	ANDA213111	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42858-750_8dadad59-07b4-4a1c-9b9e-b7c3a6dbaafe	42858-750	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH	TRANSDERMAL	20170703		NDA AUTHORIZED GENERIC	NDA021306	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE	5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-760_d6dc2105-2042-4b39-97bd-2d80e0114dcd	42858-760	HUMAN PRESCRIPTION DRUG	MS Contin		morphine sulfate	TABLET	ORAL	20170515		NDA	NDA019516	Rhodes Pharmaceuticals L.P.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-799_d6dc2105-2042-4b39-97bd-2d80e0114dcd	42858-799	HUMAN PRESCRIPTION DRUG	MS Contin		morphine sulfate	TABLET	ORAL	20170515		NDA	NDA019516	Rhodes Pharmaceuticals L.P.	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-801_104fdbb1-7268-497e-aaed-b271dfc43dba	42858-801	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074862	Rhodes Pharmaceuticals L. P.	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-802_104fdbb1-7268-497e-aaed-b271dfc43dba	42858-802	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074862	Rhodes Pharmaceuticals L. P.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-803_104fdbb1-7268-497e-aaed-b271dfc43dba	42858-803	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074862	Rhodes Pharmaceuticals L. P.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-804_104fdbb1-7268-497e-aaed-b271dfc43dba	42858-804	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074769	Rhodes Pharmaceuticals L. P.	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-805_104fdbb1-7268-497e-aaed-b271dfc43dba	42858-805	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074769	Rhodes Pharmaceuticals L. P.	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-839_8dadad59-07b4-4a1c-9b9e-b7c3a6dbaafe	42858-839	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH	TRANSDERMAL	20170703		NDA AUTHORIZED GENERIC	NDA021306	Rhodes Pharmaceuticals L.P.	BUPRENORPHINE	20	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
42858-867_3b651e63-d7f6-4256-a7a8-d4ceb23aed92	42858-867	HUMAN PRESCRIPTION DRUG	DRONABINOL		DRONABINOL	CAPSULE	ORAL	20180626		ANDA	ANDA078292	Rhodes Pharmaceuticals L.P.	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
42858-868_3b651e63-d7f6-4256-a7a8-d4ceb23aed92	42858-868	HUMAN PRESCRIPTION DRUG	DRONABINOL		DRONABINOL	CAPSULE	ORAL	20180626		ANDA	ANDA078292	Rhodes Pharmaceuticals L.P.	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
42858-869_3b651e63-d7f6-4256-a7a8-d4ceb23aed92	42858-869	HUMAN PRESCRIPTION DRUG	DRONABINOL		DRONABINOL	CAPSULE	ORAL	20180626		ANDA	ANDA078292	Rhodes Pharmaceuticals L.P.	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
42858-900_d6dc2105-2042-4b39-97bd-2d80e0114dcd	42858-900	HUMAN PRESCRIPTION DRUG	MS Contin		morphine sulfate	TABLET	ORAL	20170515		NDA	NDA019516	Rhodes Pharmaceuticals L.P.	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
42858-930_f39f8c3a-d21d-4599-856f-c8e3f909e5a8	42858-930	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20190822		ANDA	ANDA210651	Rhodes Pharmaceuticals L.P.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
42887-001_b262ed56-c2e8-474f-a93b-559c21e75181	42887-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20010101		UNAPPROVED MEDICAL GAS		North Central Respiratory, Inc	OXYGEN	99	L/100L			N	20241231
42893-013_0cfce20b-9fd5-81b7-e063-6294a90a898e	42893-013	HUMAN OTC DRUG	CHANTECAILLE Ultra Sun Protection Sunscreen Broad Spectrum SPF 45		AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20140730		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 75; 50; 27.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
42893-014_0cfd060b-244e-91ee-e063-6294a90ae754	42893-014	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Aura		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-015_0cfd048f-8893-91a3-e063-6294a90a8d80	42893-015	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Alabaster		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-016_0cfcfbb0-66ef-a5d0-e063-6394a90a2aff	42893-016	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Bliss		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-017_0cfd2b50-61f7-8b7b-e063-6294a90a370e	42893-017	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Vanilla		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-018_0cfd2dd2-1334-9c16-e063-6294a90a16fb	42893-018	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Nude		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-019_0cfd1755-7cbe-8a88-e063-6294a90a056d	42893-019	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Glow		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-024_0cfd2819-014d-811d-e063-6294a90adbc3	42893-024	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Tan		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-025_0cff20a7-fade-8fee-e063-6394a90a4ea1	42893-025	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15 Shade Wheat		TITANIUM DIOXIDE	CREAM	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Chantecaille Beaute Inc	TITANIUM DIOXIDE	106.22	mg/g			N	20241231
42893-200_f3053378-3b25-287b-e053-2a95a90a4833	42893-200	HUMAN OTC DRUG	Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15		Chantecaille Just Skin Tinted Moisturizer Sunscreen Broad Spectrum SPF 15	LOTION	TOPICAL	20210105		OTC MONOGRAPH FINAL	part352	Chantecaille Beaute Inc.	TITANIUM DIOXIDE	10.622	g/100g			N	20241231
42893-328_f40eb4e3-6619-bb82-e053-2995a90a9b0c	42893-328	HUMAN OTC DRUG	Chantecaille SeaScreen 30 Mineral Broad-Spectrum Sunscreen Mist	SPF 30	Zinc Oxide	AEROSOL, SPRAY	TOPICAL	20211122		OTC MONOGRAPH FINAL	M020	Chantecaille Beaute Inc	ZINC OXIDE	15.2	g/100mL			N	20241231
42913-001_0949b0a5-290e-b0ad-e063-6394a90a2a3b	42913-001	HUMAN OTC DRUG	Power Stick XJ Coolblast Xtreme		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20141114		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	200	mg/g			N	20241231
42913-006_0949b0a5-2919-b0ad-e063-6394a90a2a3b	42913-006	HUMAN OTC DRUG	Power Stick XJ Intensity		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20141114		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	200	mg/g			N	20241231
42913-010_0949a165-7692-8fc6-e063-6294a90a9cb3	42913-010	HUMAN OTC DRUG	Soft Whisper Cucumber Green Tea		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20141114		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	200	mg/g			N	20241231
42913-025_0949e5cb-b9b8-cee1-e063-6394a90a5377	42913-025	HUMAN OTC DRUG	Power Stick for Her Powder Fresh		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20190213		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	200	mg/g			N	20241231
42913-026_0949c870-2c48-ac0d-e063-6294a90af59b	42913-026	HUMAN OTC DRUG	Power Stick for Her Shower Fresh		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20190213		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	200	mg/g			N	20241231
42913-038_0949e5cb-b9c7-cee1-e063-6394a90a5377	42913-038	HUMAN OTC DRUG	Power Stick For Her Roll- On Antiperspirant Deodorant Powder Fresh		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20230101		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	220	mg/mL			N	20241231
42913-039_0949ee74-d728-be55-e063-6294a90a72a6	42913-039	HUMAN OTC DRUG	Power Stick Invisible Protection Roll- On Antiperspirant Deodorant Spring Fresh		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20230101		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	250	mg/mL			N	20241231
42913-040_0949e5cb-b9d6-cee1-e063-6394a90a5377	42913-040	HUMAN OTC DRUG	Power Stick Original Nourishing Invisible Protection Roll- On Antiperspirant Deodorant		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20230101		OTC MONOGRAPH DRUG	M019	A.P. Deauville, LLC	ALUMINUM SESQUICHLOROHYDRATE	250	mg/mL			N	20241231
42914-001_d937eb1d-b680-44b3-820f-e987a053e6b6	42914-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20071215		NDA	NDA205862	Aspen Air U.S., LLC	OXYGEN	99	L/100L			N	20241231
42914-010_23b8111a-9d49-40b9-8a80-3f1c8db2ab48	42914-010	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20071215		NDA	NDA205863	Aspen Air U.S., LLC	NITROGEN	99	L/100L			N	20241231
42926-160_f18abfc7-2766-2298-e053-2995a90ad15a	42926-160	HUMAN OTC DRUG	Pomegranate Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140514	20240831	OTC MONOGRAPH NOT FINAL	part333E	Mangiacotti, Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	
42926-162_f18addd7-ece1-f89a-e053-2995a90a647e	42926-162	HUMAN OTC DRUG	Clementine Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140514	20240831	OTC MONOGRAPH NOT FINAL	part333E	Mangiacotti, Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	
42926-163_f18af79a-4949-2cf2-e053-2a95a90a0205	42926-163	HUMAN OTC DRUG	Ocean Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140514	20240831	OTC MONOGRAPH NOT FINAL	part333E	Mangiacotti, Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	
42926-164_f18b1905-825c-503b-e053-2a95a90a6e26	42926-164	HUMAN OTC DRUG	Lavender Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140514	20240831	OTC MONOGRAPH NOT FINAL	part333E	Mangiacotti, Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	
42926-165_f18b7603-1c1d-78ed-e053-2a95a90a7095	42926-165	HUMAN OTC DRUG	Lemon Verbena Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140508	20240831	OTC MONOGRAPH NOT FINAL	part333E	Mangiacotti, Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	
42926-166_f1993a34-ec39-264b-e053-2a95a90aaf29	42926-166	HUMAN OTC DRUG	Jasmine Plum Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180101	20240831	OTC MONOGRAPH NOT FINAL	part333E	Mangiacotti, Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	
42936-585_63466e18-e0c5-4da2-aa24-b353f802c04a	42936-585	HUMAN OTC DRUG	Foam San Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20190710		OTC MONOGRAPH NOT FINAL	part333E	Hill Manufacturing Co., Inc.	ALCOHOL	.62	mL/mL			N	20241231
42939-124_09461f7d-3438-e388-e063-6294a90a819b	42939-124	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-124_094621d8-5998-e852-e063-6294a90a76cf	42939-124	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-124_f0b8c495-704c-18cf-e053-2a95a90a1ba6	42939-124	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-125_09461c09-ae1a-f648-e063-6394a90ad893	42939-125	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-125_094621d8-599b-e852-e063-6294a90a76cf	42939-125	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-125_f0b8939f-2296-7446-e053-2995a90a075a	42939-125	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-127_09453bf6-92ac-4aa6-e063-6294a90a62b2	42939-127	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-127_f0b84004-24b2-f7b1-e053-2a95a90abd4a	42939-127	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-128_094536f1-3352-aa57-e063-6394a90a606a	42939-128	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42939-128_f0b8bb15-60ab-571d-e053-2a95a90a3d8c	42939-128	HUMAN OTC DRUG	Scrub, Scrub-Stat, Foam Safe, Micro-Guard		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	AVA, Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
42947-500_f3d8080f-4b80-c240-e053-2995a90a9df9	42947-500	HUMAN OTC DRUG	VIAMED Alcohol Prep Pad		ALCOHOL	SWAB	TOPICAL	20150910		OTC MONOGRAPH NOT FINAL	part333E	Wuxi Medical Instrument Factory	ALCOHOL	70	g/100g			N	20241231
42961-014_1224727f-9ec1-4ee9-9843-f273bf0ff5a5	42961-014	HUMAN OTC DRUG	Zee First Aid Cream		Benzalkonium Chloride, Lidocaine HCl	CREAM	TOPICAL	20220505		OTC MONOGRAPH DRUG	M003	Cintas Corporation No 2	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; .5	mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42961-015_8a3aaff8-ac21-473a-9b54-e0f7cad5e972	42961-015	HUMAN OTC DRUG	Zee Hydrocream		Hydrocortisone Cream	CREAM	TOPICAL	20220505		OTC MONOGRAPH DRUG	M017	Cintas Corp	HYDROCORTISONE ACETATE	1	mg/100mg	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42961-016_e8550953-125c-4c35-b175-f3feab3b64a7	42961-016	HUMAN OTC DRUG	Zee Hydrogen Peroxide		Hydrogen Peroxide	SPRAY	TOPICAL	20220121		OTC MONOGRAPH DRUG	M003	Cintas Corp	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
42961-017_7a387aab-e364-4b6c-b548-2ae7c798d7fb	42961-017	HUMAN OTC DRUG	Signature Series Enriched Foam Alcohol Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200508		OTC MONOGRAPH DRUG	M004	Cintas Corporation	ALCOHOL	75	mL/100mL			N	20241231
42961-020_4e694a90-bcd5-4874-9f67-41b6f8b19faf	42961-020	HUMAN OTC DRUG	Zee Insect Sting Relief Wipes		benzocaine, isopropyl alcohol	SPONGE	TOPICAL	20211020		OTC MONOGRAPH DRUG	M003	Cintas Corp	BENZOCAINE; ISOPROPYL ALCOHOL	6; 60	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42961-022_4d997074-f747-4625-b043-ac80101fd198	42961-022	HUMAN OTC DRUG	Xpect Antiseptic Wipes		Antiseptic Cleanser	SPONGE	TOPICAL	20201120		OTC MONOGRAPH DRUG	M003	Cintas Corporation	BENZALKONIUM CHLORIDE	.13	mg/.13mg			N	20241231
42961-023_392f43b9-bc95-4c09-abd4-81642178b9f9	42961-023	HUMAN OTC DRUG	Zee Povidone Iodine		Povidone Iodine 10% w/w (equivalent to iodine 1%)	SWAB	TOPICAL	20220512		OTC MONOGRAPH DRUG	M003	Cintas Corporation	POVIDONE-IODINE	10	mg/mL			N	20241231
42961-028_07a139e0-818f-40d3-8ab7-9c24fa050aa9	42961-028	HUMAN OTC DRUG	Zee First Aid Antiseptic		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20220216		OTC MONOGRAPH DRUG	M003	Cintas Corp	BENZALKONIUM CHLORIDE	26	mg/mL			N	20241231
42961-029_3c460bea-64b6-41af-b7f2-5e4dbe754f6f	42961-029	HUMAN OTC DRUG	Zee Antiseptic Wipes		Antiseptic Wipes	SPONGE	TOPICAL	20211022		OTC MONOGRAPH DRUG	M003	Cintas Corp	BENZALKONIUM CHLORIDE	.133	mg/1			N	20241231
42961-030_e3514712-01bf-443c-93dd-2607e1c35ff7	42961-030	HUMAN OTC DRUG	Zee Burn Relief		Burn Relief	SPRAY	TOPICAL	20220426		OTC MONOGRAPH DRUG	M003	Cintas Corp	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 2	mg/100mL; mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42961-031_54402b70-1657-42e3-96b7-a82f68919e61	42961-031	HUMAN OTC DRUG	Zee Blood Clotting Antiseptic		Benzethonium Chloride	SPRAY	TOPICAL	20220426		OTC MONOGRAPH DRUG	M003	Cintas Corp	BENZETHONIUM CHLORIDE; LIDOCAINE	.2; 4	mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42961-055_a7753910-2011-4432-a9b8-5ed44ddabfd7	42961-055	HUMAN OTC DRUG	cherry throat relief lozenges		benzocaine	LOZENGE	ORAL	20210107		OTC MONOGRAPH DRUG	M022	Cintas Corporation	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42961-056_8bd23b41-b798-41eb-ba99-ce069107e2b3	42961-056	HUMAN OTC DRUG	Isopropyl Alcohol		Alcohol	SPRAY	TOPICAL	20210413		OTC MONOGRAPH DRUG	M003	Cintas Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
42961-057_43c40271-8a5b-4d79-9a2f-a51c37ea2867	42961-057	HUMAN OTC DRUG	Zee Clean Wipes		Alcohol Wipes	SPONGE	TOPICAL	20230126		OTC MONOGRAPH NOT FINAL	part333A	Cintas Corporation	ISOPROPYL ALCOHOL	.7	mL/.7mL			N	20241231
42961-103_a6286ce6-e898-42a8-bc31-1508f329c986	42961-103	HUMAN OTC DRUG	First Aid Direct Anti-Diarrheal		First Aid Direct Anti-Diarrheal	CAPSULE	ORAL	20211020		ANDA	ANDA076497	Cintas Corp	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
42961-104_4a064a46-242b-462e-840f-7ce1cae05cf0	42961-104	HUMAN OTC DRUG	First Aid Direct Chewable Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20211025		OTC MONOGRAPH DRUG	M013	Cintas Corp	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
42961-105_d6122645-e9b4-4dac-8813-7c74ecece436	42961-105	HUMAN OTC DRUG	First Aid Direct Cold-EEZE Cold Remedy		Zinc Gluconate	LOZENGE	ORAL	20230720		UNAPPROVED HOMEOPATHIC		Cintas Corporation	ZINC GLUCONATE	2	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
42961-107_65797da8-3ffa-4d50-a42f-f1a712101565	42961-107	HUMAN OTC DRUG	First Aid Direct Soothe-A-Sting		benzocaine swab	SPONGE	TOPICAL	20220516		OTC MONOGRAPH DRUG	M017	Cintas Corporation	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	20; 1	mg/100mg; mg/100mg	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42961-109_511fbfff-6523-4fa2-b337-90c3808e2bd1	42961-109	HUMAN OTC DRUG	First Aid Direct Peptum Tabs		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20211025		OTC MONOGRAPH DRUG	M008	Cintas Corp	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
42961-110_9206a2e8-7a7c-4091-947f-a2739d058dd4	42961-110	HUMAN OTC DRUG	First Aid Direct Povidone Iodine		Povidone Iodine Antiseptic	SWAB	TOPICAL	20220516		OTC MONOGRAPH DRUG	M003	CINTAS CORPORATION	POVIDONE-IODINE	10	mg/100mg			N	20241231
42961-112_d4fcc094-9cb4-41ea-a967-ca6271ce448e	42961-112	HUMAN OTC DRUG	Xpect Cold Relief		Acetaminophen Guaifenesein Phenylephrine HCl	TABLET	ORAL	20210329		OTC MONOGRAPH DRUG	M013	Cintas Corporation	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
42961-120_8561fd56-a3ec-4b63-a295-4edab3ea2f88	42961-120	HUMAN OTC DRUG	First Aid Direct Allergy Relief		Loratadine Tablets	TABLET	ORAL	20211020		ANDA	ANDA210722	Cintas Corporation	LORATADINE	10	mg/1			N	20241231
42961-122_a2439a53-19d0-4fbd-a711-27bea00ccd13	42961-122	HUMAN OTC DRUG	First Aid Direct All Day Pain Relief		Naproxen Sodium	TABLET, COATED	ORAL	20230719		ANDA	ANDA204872	Cintas Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42961-123_65ce5a79-05b0-4319-b620-5742871574ef	42961-123	HUMAN OTC DRUG	First Aid Direct Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20230720		OTC MONOGRAPH NOT FINAL	part333E	Cintas Corporation	ALCOHOL	66.5	g/100g			N	20241231
42961-125_68b18e08-ad0c-45d8-9a69-6cde16594a35	42961-125	HUMAN OTC DRUG	First Aid Direct Nasal and Sinus Decongestant		Phenylephrine HCl	TABLET	ORAL	20230809		OTC MONOGRAPH FINAL	part341	Cintas Corporation	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
42961-126_05440b6e-ecd1-4cf7-8b3f-68e5594cb0db	42961-126	HUMAN OTC DRUG	First Aid Direct Headache and Congestion Sinus Relief		Acetaminophen Phenylephrine HCl	TABLET	ORAL	20230926		OTC MONOGRAPH FINAL	part341	Cintas Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
42961-127_39a0abb5-b751-41fb-ac35-9da97814fffc	42961-127	HUMAN OTC DRUG	First Aid Direct Antiseptic Wipe		BENZALKONIUM CHLORIDE	SPONGE	TOPICAL	20230928		OTC MONOGRAPH NOT FINAL	part333A	Cintas Corporation	BENZALKONIUM CHLORIDE	.133	mg/100mL			N	20241231
42961-128_64e28158-f051-44d9-a8f0-c2d8cf4b2aa6	42961-128	HUMAN OTC DRUG	First Aid Direct Alcohol Wipe		ISOPROPYL ALCOHOL	SPONGE	TOPICAL	20230928		OTC MONOGRAPH DRUG	M003	Cintas Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
42961-182_68eac69a-aec7-47f8-b177-703c0f5c7f64	42961-182	HUMAN OTC DRUG	Xpect Sting Wipes		Benzocaine 6%	SWAB	TOPICAL	20210330		OTC MONOGRAPH DRUG	M017	Cintas Corporation	BENZOCAINE	6	g/1001	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42961-201_1339f6ce-0b14-4c81-83e8-33f6080d75c9	42961-201	HUMAN OTC DRUG	Xpect Isopropyl Alcohol		Isopropyl Alcohol	SPRAY	TOPICAL	20220126		OTC MONOGRAPH DRUG	M003	Cintas Corp	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
42961-203_a84d688b-86e6-4c06-84fa-4f88ac54262e	42961-203	HUMAN OTC DRUG	Xpect Ibuprofen		Ibuprofen	TABLET	ORAL	20210227		ANDA	ANDA079174	Cintas Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
42961-208_7e8e012e-85a5-42e8-9eec-58255ec18556	42961-208	HUMAN OTC DRUG	Xpect Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210211		OTC MONOGRAPH FINAL	part331	Cintas Corporation	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
42961-213_55c1f55d-67e7-4a23-aad8-3094c60d7cf0	42961-213	HUMAN OTC DRUG	Xpect Burn Care		Burn Care	SPRAY	TOPICAL	20220127		OTC MONOGRAPH DRUG	M017	Cintas Corp	LIDOCAINE HYDROCHLORIDE	2	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42961-214_bb33559f-a307-4100-bfe2-26b430c4f724	42961-214	HUMAN OTC DRUG	Xpect First Aid Cream		benzalkonium chloride, lidocaine hcl	CREAM	TOPICAL	20220516		OTC MONOGRAPH DRUG	M003	Cintas Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42961-216_1ccc22d0-f6ab-4283-874f-032c71f1ad79	42961-216	HUMAN OTC DRUG	Xpect Hydrogen Peroxide		Hydrogen Peroxide	SPRAY	TOPICAL	20220516		OTC MONOGRAPH DRUG	M003	Cintas Corporation	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
42961-218_0fbfd731-c9b1-404e-bbc0-883dc358d576	42961-218	HUMAN OTC DRUG	Xpect Extra Strength Itch Relief		Diphenhydramine Hydrochloride	SPRAY	TOPICAL	20220516		OTC MONOGRAPH DRUG	M017	Cintas Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	2	mg/100mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
42961-219_45397a6c-f2fb-4ec0-9a03-0389802a0c45	42961-219	HUMAN OTC DRUG	First Aid Direct Industrial Eye Drops		Sterile Industrial Eye Drops	SOLUTION/ DROPS	OPHTHALMIC	20220128		OTC MONOGRAPH FINAL	part349	Cintas Corp	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	2.5; .132	mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
42961-220_d2261026-edc8-4ff9-bac8-07841fa0ff0b	42961-220	HUMAN OTC DRUG	Xpect Hydrocortisone		Anti-Itch	CREAM	TOPICAL	20220328		OTC MONOGRAPH DRUG	M017	Cintas Corp	HYDROCORTISONE ACETATE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42961-222_fabb41ee-73ed-46d5-a20e-fc383b8b5a02	42961-222	HUMAN OTC DRUG	Xpect Triple Antibiotic		bacitracin zinc, neomycin sulfate and polymyxin b sulfate	OINTMENT	TOPICAL	20220512		OTC MONOGRAPH DRUG	M004	Cintas Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
42961-223_1cc13b3c-2109-4d7c-9e80-415e31e63d46	42961-223	HUMAN OTC DRUG	Super-Stop BloodClotter		Blood Clotter	AEROSOL, SPRAY	TOPICAL	20220328		OTC MONOGRAPH DRUG	M003	Cintas Corp	BENZETHONIUM CHLORIDE; LIDOCAINE	.2; 4	mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
42961-224_4f3d72ef-b26b-45a9-b145-23367e956d10	42961-224	HUMAN OTC DRUG	Foaming Hand		Benzalkonium Chloride	LOTION	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333A	Cintas Corp	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
42961-226_af334987-1439-416c-8319-7a2b532ac4b3	42961-226	HUMAN OTC DRUG	Xpect Alcohol Wipes		Alcohol Wipes	SPONGE	TOPICAL	20200910		OTC MONOGRAPH NOT FINAL	part333A	Cintas Corporation	ISOPROPYL ALCOHOL	.7	mL/.7mL			N	20241231
42961-227_fac9a1b8-d2c7-4002-97b7-7522abc25c64	42961-227	HUMAN OTC DRUG	Xpect Antiseptic		benzalkonium chloride	SPRAY	TOPICAL	20230419		OTC MONOGRAPH NOT FINAL	part333A	Cintas Corporation	BENZALKONIUM CHLORIDE	.13	mg/mL			N	20241231
42961-231_7e94db94-278c-4e9c-b01e-65af3eaef915	42961-231	HUMAN OTC DRUG	Xpect Eyewash		Eyewash	SOLUTION	OPHTHALMIC	20230711		OTC MONOGRAPH FINAL	part349	Cintas Corporation	WATER	.984	mL/mL			N	20241231
42961-232_c09b78c6-ed0f-459e-833c-407da7c8be17	42961-232	HUMAN OTC DRUG	Xpect Cherry Cough Drops		Cherry Cough Drops	LOZENGE	ORAL	20230719		OTC MONOGRAPH FINAL	part341	Cintas Corporation	MENTHOL	7	mg/1			N	20241231
42961-233_dc11ddf0-63fb-419a-a6e9-dab450a6bf88	42961-233	HUMAN OTC DRUG	Xpect Honey Lemon Cough Drops		Honey Lemon Cough Drops	LOZENGE	ORAL	20230720		OTC MONOGRAPH FINAL	part341	Cintas Corporation	MENTHOL	9	mg/1			N	20241231
42961-234_9a0014c7-91ad-49c2-af03-55b6aa869fb6	42961-234	HUMAN OTC DRUG	Xpect Pain Away Extra Strength		Acetaminophen Aspirin Caffeine	TABLET	ORAL	20230726		OTC MONOGRAPH NOT FINAL	part343	Cintas Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
42961-236_585d3835-ac61-4081-9982-c383694ce71f	42961-236	HUMAN OTC DRUG	Xpect Triple Antibiotic		bacitracin zinc, neomycin sulfate, polymyxin b sulfate	OINTMENT	TOPICAL	20230913		OTC MONOGRAPH FINAL	part333B	Cintas Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
42961-237_e2bd362a-4efe-46c7-9274-55034505c2fe	42961-237	HUMAN OTC DRUG	Xpect Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20230912		OTC MONOGRAPH NOT FINAL	part348	Cintas Corporation	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
42961-255_0d291a5f-b631-380c-e063-6394a90a0310	42961-255	HUMAN OTC DRUG	Xpect Industrial Eye Relief		glycerin, naphazoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20220301		OTC MONOGRAPH DRUG	M018	Cintas Corporation	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
42961-399_e530813f-dc0b-45ee-8e7e-6f0aab1db6aa	42961-399	HUMAN OTC DRUG	Xpect Acetaminophen		Acetaminophen	TABLET	ORAL	20210330		OTC MONOGRAPH DRUG	M013	Cintas Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
42961-401_06c1149d-23b6-d994-e063-6294a90a686e	42961-401	HUMAN OTC DRUG	cherry throat relief lozenges		benzocaine	LOZENGE	ORAL	20150227		OTC MONOGRAPH NOT FINAL	part356	Cintas Corporation	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
42961-600_22ad4630-417a-4a0e-a85d-589f72295317	42961-600	HUMAN OTC DRUG	Alcohol Foam Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333A	Cintas Corporation	ALCOHOL	70	mg/100mL			N	20241231
42961-615_8590dacb-ee42-4d1e-960d-c1b1d3b503d4	42961-615	HUMAN OTC DRUG	Antibacterial Foaming Hand		Benzalkonium Chloride	SOAP	TOPICAL	20220601		OTC MONOGRAPH DRUG	M003	Cintas	BENZALKONIUM CHLORIDE	13	mg/10mL			N	20241231
42961-810_d06e2264-981a-4934-b949-aaca714a14b3	42961-810	HUMAN OTC DRUG	Dental Relief		benzocaine	LIQUID	TOPICAL	20210408		OTC MONOGRAPH DRUG	M022	Cintas Corporation	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43063-008_05b7adf3-2287-e3c8-e063-6294a90a3ab6	43063-008	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20190607		ANDA	ANDA078155	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-020_0643e771-24b4-a6e5-e063-6394a90a40ce	43063-020	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA073192	PD-Rx Pharmaceuticals, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
43063-033_fcffb6b1-1d40-aa38-e053-6294a90adaad	43063-033	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-041_04287686-ea06-4a56-e063-6394a90a54b5	43063-041	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43063-045_fb5bd34a-7e42-7e50-e053-6294a90ad399	43063-045	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19860730		ANDA	ANDA085223	PD-Rx Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43063-046_febc49d0-cb09-438c-e053-6394a90aacd2	43063-046	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760701		ANDA	ANDA084769	PD-Rx Pharmaceuticals, Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-060_05b76342-5994-fab8-e063-6394a90aa939	43063-060	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20060517		ANDA	ANDA040500	PD-Rx Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43063-063_0644012f-55b4-2d87-e063-6394a90aa1c6	43063-063	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20100406		ANDA	ANDA077289	PD-Rx Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-074_f8ff9bbf-6f17-f6a3-e053-6394a90a611a	43063-074	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-077_00b610eb-b9ce-de05-e063-6294a90aa7ca	43063-077	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065096	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
43063-080_06441212-4067-621e-e063-6394a90a754a	43063-080	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077752	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-086_0644012f-55b5-2d87-e063-6394a90aa1c6	43063-086	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	PD-Rx Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43063-112_0643e1cc-5e2a-1e73-e063-6394a90a4824	43063-112	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	PD-Rx Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43063-121_074fff28-13eb-938c-e063-6294a90a4c4a	43063-121	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-122_06849d08-62fc-1087-e063-6394a90a7658	43063-122	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-125_f928c9fc-38c3-fa41-e053-6294a90aedcc	43063-125	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	PD-Rx Pharmaceuticals, Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43063-126_f56420b6-16f2-3ff6-e053-2a95a90a00b5	43063-126	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	PD-Rx Pharmaceuticals, Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43063-129_f5643d2a-b4b5-5b73-e053-2995a90a739d	43063-129	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	PD-Rx Pharmaceuticals, Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43063-162_0643c07b-f871-2509-e063-6294a90a385b	43063-162	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077752	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-172_06e5462d-a954-13e8-e063-6294a90a0450	43063-172	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-176_fcff95fe-ad83-7236-e053-6294a90ae3bd	43063-176	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	PD-Rx Pharmaceuticals, Inc.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43063-180_06443161-d0de-d1cf-e063-6394a90ab7de	43063-180	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	PD-Rx Pharmaceuticals, Inc.	DICLOXACILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-182_fcffd390-8072-406c-e053-6294a90a54bf	43063-182	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120815		ANDA	ANDA040887	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-203_f5649216-0de3-db6e-e053-2a95a90a606b	43063-203	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20090127		ANDA	ANDA078947	PD-Rx Pharmaceuticals, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
43063-225_06443161-d0df-d1cf-e063-6394a90ab7de	43063-225	HUMAN PRESCRIPTION DRUG	Primaquine Phosphate		Primaquine Phosphate	TABLET, FILM COATED	ORAL	20110415		NDA	NDA008316	PD-Rx Pharmaceuticals, Inc.	PRIMAQUINE PHOSPHATE	15	mg/1	Antimalarial [EPC]		N	20241231
43063-238_f564d058-18e1-107b-e053-2995a90a4245	43063-238	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20090127		ANDA	ANDA078947	PD-Rx Pharmaceuticals, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
43063-248_f564eedb-0d1c-b6bc-e053-2a95a90a75f9	43063-248	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890228		ANDA	ANDA072575	PD-Rx Pharmaceuticals, Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43063-254_f564f5e5-dccf-2bda-e053-2995a90a3261	43063-254	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	PD-Rx Pharmaceuticals, Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43063-260_feba81e6-55c3-b43d-e053-6294a90abf41	43063-260	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890228		ANDA	ANDA072575	PD-Rx Pharmaceuticals, Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43063-264_0644012f-55bc-2d87-e063-6394a90aa1c6	43063-264	HUMAN PRESCRIPTION DRUG	Tamsulosin hydrochloride		Tamsulosin hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078801	PD-Rx Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43063-266_f161c099-7e1c-56b7-e053-2995a90ae1d0	43063-266	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19820826		ANDA	ANDA087916	PD-Rx Pharmaceuticals, Inc.	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43063-273_06445074-911c-4081-e063-6394a90a0c96	43063-273	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	PD-Rx Pharmaceuticals, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
43063-313_06445074-911f-4081-e063-6394a90a0c96	43063-313	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET, EXTENDED RELEASE	ORAL	19981030	20240331	ANDA	ANDA075155	PD-Rx Pharmaceuticals, Inc.	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
43063-328_093048c4-15d2-d6ff-e063-6294a90a46be	43063-328	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19961003		ANDA	ANDA074649	PD-Rx Pharmaceuticals, Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
43063-341_f5653ddd-0f33-a84c-e053-2995a90a923e	43063-341	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, CHEWABLE	ORAL	19930101		ANDA	ANDA064013	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-345_06446e9a-0e82-0623-e063-6294a90ac403	43063-345	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		PD-Rx Pharmaceuticals, Inc.	SUS SCROFA THYROID	30	mg/1			N	20241231
43063-348_f93c8383-c6a1-064d-e053-6294a90a1328	43063-348	HUMAN PRESCRIPTION DRUG	DIETHYLPROPION HYDROCHLORIDE		DIETHYLPROPION HYDROCHLORIDE	TABLET	ORAL	20101227		ANDA	ANDA201212	PD-Rx Pharmaceuticals, Inc.	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-352_06447e1a-1bd6-ba76-e063-6294a90aa5a3	43063-352	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-368_06444c81-d51b-137f-e063-6294a90a068e	43063-368	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	PD-Rx Pharmaceuticals, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-371_febabb00-8160-ee4b-e053-6394a90a27ce	43063-371	HUMAN PRESCRIPTION DRUG	Clopidogrel Bisulfate		Clopidogrel Bisulfate	TABLET	ORAL	20120517		ANDA	ANDA090844	PD-Rx Pharmaceuticals, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
43063-377_febbb30d-cb72-3a76-e053-6294a90a6d37	43063-377	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065096	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
43063-381_febbd8a4-b55a-0cd9-e053-6394a90afe34	43063-381	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA090984	PD-Rx Pharmaceuticals, Inc.	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
43063-383_f56572d6-7973-7c11-e053-2a95a90a2f06	43063-383	HUMAN PRESCRIPTION DRUG	ANASTROZOLE		ANASTROZOLE	TABLET	ORAL	20100628		ANDA	ANDA079220	PD-Rx Pharmaceuticals, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
43063-387_f577b2f4-0b48-7561-e053-2995a90a57a8	43063-387	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612		ANDA	ANDA077284	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43063-388_f577949f-5875-c0f8-e053-2a95a90ae941	43063-388	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612		ANDA	ANDA077284	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43063-392_febc186a-76cc-c3f8-e053-6394a90a1345	43063-392	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	PD-Rx Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
43063-393_06447d5e-b13e-7286-e063-6394a90a3dd9	43063-393	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		Atovaquone and Proguanil Hydrochloride	TABLET, FILM COATED	ORAL	20110915		ANDA	ANDA091211	PD-Rx Pharmaceuticals, Inc.	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
43063-395_febc1514-6590-7648-e053-6394a90a33c9	43063-395	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	PD-Rx Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-396_0bdc2526-19d9-99c9-e063-6394a90a7c7f	43063-396	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	PD-Rx Pharmaceuticals, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-400_06456ece-acc8-3882-e063-6294a90a8387	43063-400	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	PD-Rx Pharmaceuticals, Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
43063-401_f8394f09-200c-b75d-e053-6294a90a627c	43063-401	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	PD-Rx Pharmaceuticals, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-405_f578a88f-1c87-1833-e053-2995a90a81a0	43063-405	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20110303		ANDA	ANDA091179	PD-Rx Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43063-406_05bcd89f-38fc-a9c9-e063-6294a90a2c71	43063-406	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-407_f93c91b7-5392-c4ea-e053-6394a90ac0c9	43063-407	HUMAN PRESCRIPTION DRUG	ORPHENADRINE CITRATE		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	PD-Rx Pharmaceuticals, Inc.	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43063-410_06459744-5cf8-6377-e063-6294a90ae5fd	43063-410	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
43063-437_f8c25b48-4df5-68e0-e053-6294a90a8291	43063-437	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-443_f578e291-886d-6322-e053-2995a90a9d50	43063-443	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	PD-Rx Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-444_f578f498-ec2f-1100-e053-2a95a90a1688	43063-444	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	PD-Rx Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-447_f5790304-9579-b42a-e053-2995a90a4a50	43063-447	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20110303		ANDA	ANDA091179	PD-Rx Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43063-453_febcbab2-3318-5373-e053-6394a90a79a0	43063-453	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	PD-Rx Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-455_fa1b9058-470c-e172-e053-6394a90af3ad	43063-455	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	PD-Rx Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43063-457_f9156ad0-0d40-3c6e-e053-6294a90ab740	43063-457	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
43063-458_fb5bdef3-1308-9a52-e053-6294a90a1054	43063-458	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43063-459_06456ece-acca-3882-e063-6294a90a8387	43063-459	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	750	mg/1			N	20241231
43063-463_056a6c9f-6739-070c-e063-6394a90a5ac6	43063-463	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080937	PD-Rx Pharmaceuticals, Inc.	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
43063-467_f838f87c-ad2a-ef76-e053-6294a90a8de3	43063-467	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	PD-Rx Pharmaceuticals, Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-468_fa1b9aa0-5fb4-5420-e053-6394a90aebad	43063-468	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43063-473_06459f74-ca0e-d414-e063-6294a90a188a	43063-473	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	PD-Rx Pharmaceuticals, Inc.	DICLOXACILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-474_f5792dcb-0a69-194c-e053-2a95a90a3291	43063-474	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	PD-Rx Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-479_0645be57-dd11-102b-e063-6294a90adc16	43063-479	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20110906		ANDA	ANDA090199	PD-Rx Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
43063-480_febcf80e-4721-910f-e053-6294a90a7df8	43063-480	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113	20240331	ANDA	ANDA077321	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
43063-481_febdb463-6aa8-b854-e053-6394a90abbae	43063-481	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	PD-Rx Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-482_fb5bdef3-130a-9a52-e053-6294a90a1054	43063-482	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43063-487_0645ea10-d690-629f-e063-6294a90ad500	43063-487	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	PD-Rx Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-492_05b7aa44-cf93-d77a-e063-6394a90a850b	43063-492	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20091216		ANDA	ANDA040765	PD-Rx Pharmaceuticals, Inc.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-493_05b7d6fb-daa0-4159-e063-6394a90a0ad8	43063-493	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20080314		ANDA	ANDA078296	PD-Rx Pharmaceuticals, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-494_fcffc0f7-77a5-e410-e053-6294a90abb5a	43063-494	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43063-496_febe1478-d8f7-7d16-e053-6394a90a0472	43063-496	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	PD-Rx Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-497_f8c30e53-2e48-466b-e053-6394a90a2459	43063-497	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-499_febe9e9e-6e79-492d-e053-6294a90a6242	43063-499	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078858	PD-Rx Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-505_0646fb64-bd11-589e-e063-6394a90a0199	43063-505	HUMAN PRESCRIPTION DRUG	ZALEPLON		ZALEPLON	CAPSULE	ORAL	20080606		ANDA	ANDA078829	PD-Rx Pharmaceuticals, Inc.	ZALEPLON	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
43063-510_070d39d9-f03d-dc1e-e063-6394a90a813f	43063-510	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	PD-Rx Pharmaceuticals, Inc.	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
43063-516_0647173a-268e-07ad-e063-6294a90a2f81	43063-516	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43063-518_f604f079-dbc2-714c-e053-2a95a90aef6f	43063-518	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040787	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-519_f6060b10-fe5a-8fcc-e053-2a95a90a5e1f	43063-519	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040788	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-522_06471aaf-eb2a-9f20-e063-6294a90a75e5	43063-522	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil HCl		atovaquone and proguanil hydrochloride	TABLET, FILM COATED	ORAL	20120727		NDA AUTHORIZED GENERIC	NDA021078	PD-Rx Pharmaceuticals, Inc.	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
43063-527_064728af-6e94-5958-e063-6394a90a1813	43063-527	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43063-530_fc10f11a-0893-9fe4-e053-6394a90ab09c	43063-530	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20050825		ANDA	ANDA065136	PD-Rx Pharmaceuticals, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
43063-532_f928ca00-3e01-c1fd-e053-6294a90ad32b	43063-532	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride	ER	Diethylpropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111024		ANDA	ANDA091680	PD-Rx Pharmaceuticals, Inc.	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-533_06471aaf-eb44-9f20-e063-6294a90a75e5	43063-533	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	PD-Rx Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43063-536_f8ffb5d3-1c7e-114a-e053-6394a90a28ff	43063-536	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-541_f8c334d7-1b52-94a7-e053-6294a90a2aed	43063-541	HUMAN PRESCRIPTION DRUG	BENZPHETAMINE HYDROCHLORIDE		benzphetamine hydrochloride	TABLET	ORAL	20100721		ANDA	ANDA090968	PD-Rx Pharmaceuticals, Inc.	BENZPHETAMINE HYDROCHLORIDE	50	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
43063-544_0647672f-067b-079b-e063-6294a90adda7	43063-544	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43063-547_ff31af5a-1530-03a3-e053-6394a90a65c3	43063-547	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
43063-548_0bdc2526-19d4-99c9-e063-6394a90a7c7f	43063-548	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	PD-Rx Pharmaceuticals, Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-553_f8c34838-72a4-508c-e053-6294a90ad264	43063-553	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	PD-Rx Pharmaceuticals, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-557_0647672f-067c-079b-e063-6294a90adda7	43063-557	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-563_f605deef-6e40-6e90-e053-2995a90a8fb5	43063-563	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-564_052c64bc-d2b7-1a22-e063-6294a90a57a3	43063-564	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43063-569_06476b51-cfa9-8720-e063-6394a90a3661	43063-569	HUMAN PRESCRIPTION DRUG	ERY-TAB		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20110418		ANDA	ANDA062298	PD-Rx Pharmaceuticals, Inc.	ERYTHROMYCIN	333	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
43063-570_fbd57482-1b8b-c223-e053-6394a90ae6a0	43063-570	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	PD-Rx Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-574_f606163d-3512-b3d7-e053-2a95a90a3460	43063-574	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-576_f606447f-a277-2636-e053-2995a90a3494	43063-576	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-578_f606437d-ca5d-675e-e053-2a95a90ac492	43063-578	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	PD-Rx Pharmaceuticals, Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-582_0647763a-b326-8722-e063-6394a90aae96	43063-582	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	PD-Rx Pharmaceuticals, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
43063-584_0647672f-0681-079b-e063-6294a90adda7	43063-584	HUMAN PRESCRIPTION DRUG	cefuroxime axetil		cefuroxime axetil	TABLET	ORAL	20081008		ANDA	ANDA065135	PD-Rx Pharmaceuticals, Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-587_06478c59-e987-d74f-e063-6394a90aa8fc	43063-587	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-589_f8c305bf-831e-2056-e053-6294a90ad8c3	43063-589	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	PD-Rx Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
43063-595_09301c74-995f-bb84-e063-6394a90a1e6a	43063-595	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	PD-Rx Pharmaceuticals, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-596_0178ea2e-2c7a-b97b-e063-6394a90ac145	43063-596	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-600_fa1a05eb-c6cd-6d47-e053-6394a90a41e2	43063-600	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	PD-Rx Pharmaceuticals, Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-605_ff37a221-61fd-3a7e-e053-6394a90acef3	43063-605	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-609_ff49699c-cedc-13d2-e053-6394a90af079	43063-609	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	PD-Rx Pharmaceuticals, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-611_f67f2178-e7c1-6903-e053-2995a90a6c41	43063-611	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-612_ff49699c-cf1b-13d2-e053-6394a90af079	43063-612	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-614_f67f3a83-c2cd-cb27-e053-2995a90aba0d	43063-614	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-617_f67f5084-57ab-2f1d-e053-2995a90a6a4d	43063-617	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078154	PD-Rx Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-622_f67f547d-db5b-0e64-e053-2a95a90abd64	43063-622	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-623_06478845-7264-a312-e063-6294a90a302b	43063-623	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	PD-Rx Pharmaceuticals, Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-624_ff49883c-d826-2fef-e053-6294a90a880d	43063-624	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	PD-Rx Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-627_f67f6c63-ae04-0d27-e053-2a95a90a9c10	43063-627	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040786	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-629_0647732b-db67-6308-e063-6294a90ae8cd	43063-629	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	PD-Rx Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43063-630_0647abcf-743f-cbed-e063-6294a90ad272	43063-630	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-633_fb5c26b5-0005-1392-e053-6294a90a0add	43063-633	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	PD-Rx Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43063-634_0647abcf-7441-cbed-e063-6294a90ad272	43063-634	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-637_f67f7f0e-3867-0d25-e053-2a95a90a095e	43063-637	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20250731	ANDA	ANDA200839	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	
43063-638_f67f82da-cd68-5466-e053-2a95a90a57b6	43063-638	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20250731	ANDA	ANDA200839	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	
43063-639_f8729be3-9f7e-b256-e053-6294a90a2c05	43063-639	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	PD-Rx Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
43063-642_ff498c49-0dfb-10fd-e053-6394a90a12e3	43063-642	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	PD-Rx Pharmaceuticals, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43063-645_ff49699c-cf30-13d2-e053-6394a90af079	43063-645	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	PD-Rx Pharmaceuticals, Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43063-646_f928e00d-e5d5-1759-e053-6294a90a6c6d	43063-646	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-647_fe7cee16-331f-eed9-e053-6294a90a7f01	43063-647	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070219	PD-Rx Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-650_f91584da-324c-5601-e053-6294a90ae986	43063-650	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	PD-Rx Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-652_ff225b91-3aea-55c9-e053-6294a90af7bf	43063-652	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	PD-Rx Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
43063-654_06481823-1147-3129-e063-6294a90aad14	43063-654	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-656_f68f82f8-5468-566e-e053-2a95a90a119f	43063-656	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	PD-Rx Pharmaceuticals, Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-657_f68efd55-b94b-cf82-e053-2995a90ae41a	43063-657	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	PD-Rx Pharmaceuticals, Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-659_05b88fe1-d25f-caa7-e063-6394a90aa139	43063-659	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	PD-Rx Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43063-661_0647e41d-1661-e078-e063-6294a90a5616	43063-661	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	PD-Rx Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-668_f692cdfb-77da-599a-e053-2a95a90afa9f	43063-668	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20130531		ANDA	ANDA078380	PD-Rx Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43063-669_0647ef67-e7fa-a73e-e063-6294a90abe76	43063-669	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20150923		ANDA	ANDA207446	PD-Rx Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-670_f692d818-1622-126c-e053-2995a90ad54d	43063-670	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	PD-Rx Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-671_f98acaf6-d181-3c0c-e053-6394a90a62fe	43063-671	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	PD-Rx Pharmaceuticals, Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-673_f87318d1-da54-50c3-e053-6294a90ae63b	43063-673	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-676_05b88fe1-d28f-caa7-e063-6394a90aa139	43063-676	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103	20271031	ANDA	ANDA203814	PD-Rx Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
43063-677_01f5561c-cca1-3f68-e063-6294a90acc76	43063-677	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	PD-Rx Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43063-678_06483829-25fc-463b-e063-6394a90ae4de	43063-678	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-679_f28d8435-1637-9e94-e053-2995a90a9437	43063-679	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	PD-Rx Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43063-680_06485770-ff2b-aa7c-e063-6294a90a0b98	43063-680	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-683_ffbef8ba-f08c-3a1e-e053-6394a90a182e	43063-683	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	PD-Rx Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-692_01cacf24-9020-802e-e063-6294a90ac0ea	43063-692	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	PD-Rx Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-695_ffbf4c0e-e912-efab-e053-6394a90a1a2b	43063-695	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	PD-Rx Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43063-696_ffbf2c13-e63e-c764-e053-6294a90a0f66	43063-696	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	PD-Rx Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43063-697_f98ad801-9112-916e-e053-6294a90afcd2	43063-697	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-698_f98add3c-e829-990c-e053-6294a90a6be8	43063-698	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-699_f98add3c-e86d-990c-e053-6294a90a6be8	43063-699	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-702_f98bf124-5746-1eaa-e053-6294a90a71ac	43063-702	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43063-703_05b87b34-516b-dfbb-e063-6394a90a0104	43063-703	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	PD-Rx Pharmaceuticals, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43063-704_064813bd-d4b6-b0d5-e063-6294a90ac2ab	43063-704	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-707_06486557-5c74-6d58-e063-6394a90adbac	43063-707	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20120725		ANDA	ANDA091667	PD-Rx Pharmaceuticals, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
43063-711_0633280e-46c2-9e1c-e063-6394a90a9754	43063-711	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	PD-Rx Pharmaceuticals, Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
43063-712_f915cc9d-f5ad-cbd0-e053-6294a90a0e19	43063-712	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	PD-Rx Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-713_f98c15bd-a437-96ee-e053-6294a90a630b	43063-713	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818	20240731	ANDA	ANDA065399	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
43063-715_f98f0cfc-6535-63cf-e053-6394a90a0d13	43063-715	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818	20240731	ANDA	ANDA065399	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
43063-716_f99eece6-1b80-9866-e053-6394a90a23c6	43063-716	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43063-718_ffbf4c0e-e936-efab-e053-6394a90a1a2b	43063-718	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	PD-Rx Pharmaceuticals, Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-719_06486557-5c76-6d58-e063-6394a90adbac	43063-719	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	PD-Rx Pharmaceuticals, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
43063-720_06c1f8c3-968e-3c2c-e063-6294a90a50a2	43063-720	HUMAN OTC DRUG	Diphenhydramine HCL		diphenhydramine hcl	CAPSULE	ORAL	20091102		OTC MONOGRAPH DRUG	M012	PD-Rx Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
43063-721_fc110696-29e9-19e4-e053-6294a90a3b07	43063-721	HUMAN PRESCRIPTION DRUG	Primaquine Phosphate		Primaquine Phosphate	TABLET	ORAL	20140801		ANDA	ANDA204476	PD-Rx Pharmaceuticals, Inc.	PRIMAQUINE PHOSPHATE	15	mg/1	Antimalarial [EPC]		N	20241231
43063-722_06495af5-1327-b9e8-e063-6394a90a59fd	43063-722	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20160601		ANDA	ANDA073556	PD-Rx Pharmaceuticals, Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
43063-725_0658aaa9-2e1e-1577-e063-6294a90a9497	43063-725	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	PD-Rx Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43063-726_05b88fe1-d2bc-caa7-e063-6394a90aa139	43063-726	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-727_05b8ec4d-33fe-a7ca-e063-6394a90a089f	43063-727	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-728_f99f33e6-d606-cf88-e053-6294a90afd4a	43063-728	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818	20240731	ANDA	ANDA065398	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
43063-729_ffbfa36e-6492-8b35-e053-6394a90a9dfb	43063-729	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-730_ffbfa36e-64dc-8b35-e053-6394a90a9dfb	43063-730	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	PD-Rx Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
43063-733_05b8ed39-74cd-f32b-e063-6294a90a3895	43063-733	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-734_ffbfd97f-3917-c26f-e053-6294a90abc5a	43063-734	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-735_ffbfd97f-395f-c26f-e053-6294a90abc5a	43063-735	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-736_07ffe263-bfc3-3f5a-e063-6394a90a5e6a	43063-736	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	PD-Rx Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43063-738_0658b276-5ff8-19c8-e063-6294a90ae5a3	43063-738	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	PD-Rx Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
43063-739_ffbfd97f-39a8-c26f-e053-6294a90abc5a	43063-739	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	PD-Rx Pharmaceuticals, Inc.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43063-740_0658af56-5464-81c9-e063-6394a90a1710	43063-740	HUMAN PRESCRIPTION DRUG	METHSCOPOLAMINE BROMIDE		methscopolamine bromide	TABLET	ORAL	20131001		ANDA	ANDA200602	PD-Rx Pharmaceuticals, Inc.	METHSCOPOLAMINE BROMIDE	2.5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43063-741_0658aaa9-2e1f-1577-e063-6294a90a9497	43063-741	HUMAN PRESCRIPTION DRUG	METHSCOPOLAMINE BROMIDE		methscopolamine bromide	TABLET	ORAL	20131001		ANDA	ANDA200602	PD-Rx Pharmaceuticals, Inc.	METHSCOPOLAMINE BROMIDE	5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43063-742_0e771c1f-597d-e177-e063-6394a90a0b89	43063-742	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	PD-Rx Pharmaceuticals, Inc.	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
43063-743_f98f0cfc-656f-63cf-e053-6394a90a0d13	43063-743	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	PD-Rx Pharmaceuticals, Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43063-744_0658c12f-e7f2-829b-e063-6394a90a1aa2	43063-744	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE	SR	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160725		ANDA	ANDA206674	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43063-745_056958ca-c70e-9129-e063-6394a90ace38	43063-745	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20161013		ANDA	ANDA077836	PD-Rx Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
43063-746_0658cf65-3934-06ac-e063-6394a90a2bb4	43063-746	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	PD-Rx Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
43063-747_0658b08c-c495-9a6a-e063-6294a90a1283	43063-747	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43063-748_065931a9-473e-0e99-e063-6394a90a9423	43063-748	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	PD-Rx Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43063-752_f9a1d0bc-45ca-ca80-e053-6394a90a35f2	43063-752	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA203584	PD-Rx Pharmaceuticals, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
43063-754_065931a9-473f-0e99-e063-6394a90a9423	43063-754	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-755_065931a9-4740-0e99-e063-6394a90a9423	43063-755	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43063-761_ffc00092-9ca3-c4ba-e053-6394a90ada4c	43063-761	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	PD-Rx Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-762_06596989-9a1f-e3e2-e063-6294a90aef14	43063-762	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20130411		ANDA	ANDA202717	PD-Rx Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
43063-764_06593e4f-fde6-361b-e063-6394a90a3a3e	43063-764	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43063-765_06595750-1898-5f6a-e063-6394a90afc23	43063-765	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19950222		ANDA	ANDA074056	PD-Rx Pharmaceuticals, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-767_06596989-9a23-e3e2-e063-6294a90aef14	43063-767	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
43063-769_f8c32948-fc2f-1f64-e053-6294a90aa942	43063-769	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-770_065a1b49-0374-2df7-e063-6394a90a5870	43063-770	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077535	PD-Rx Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
43063-771_0996e643-e019-f68a-e063-6394a90a0b6d	43063-771	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	PD-Rx Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
43063-773_0569a0fa-4a3d-f20e-e063-6394a90a400c	43063-773	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20170622		ANDA	ANDA091240	PD-Rx Pharmaceuticals, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-777_f9b6e54f-e103-d1a8-e053-6294a90ab82f	43063-777	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	PD-Rx Pharmaceuticals, Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-778_f9b6b248-74ba-6246-e053-6394a90a217e	43063-778	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077135	PD-Rx Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
43063-779_065a24fc-b228-90d9-e063-6294a90a653b	43063-779	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-780_f9cbbfb8-62dc-09bd-e053-6394a90a2584	43063-780	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-783_065b01ed-7a80-4168-e063-6394a90a3b5e	43063-783	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20090505		ANDA	ANDA078989	PD-Rx Pharmaceuticals, Inc.	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
43063-785_f9cbc474-9714-c987-e053-6294a90a64c5	43063-785	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	PD-Rx Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
43063-786_fbd65717-b42a-892e-e053-6294a90acbc2	43063-786	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-788_ffc05799-7814-7c4f-e053-6394a90abd09	43063-788	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	PD-Rx Pharmaceuticals, Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-790_05ba40e0-8c40-127f-e063-6294a90a3636	43063-790	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	PD-Rx Pharmaceuticals, Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43063-791_fb5cebcb-4147-7991-e053-6394a90ae568	43063-791	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20150804		ANDA	ANDA204418	PD-Rx Pharmaceuticals, Inc.	FOLIC ACID	1	mg/1			N	20241231
43063-792_fe7d993d-6cb1-730d-e053-6294a90a29c3	43063-792	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	PD-Rx Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
43063-794_ffd76d09-080c-8a0f-e053-6394a90a5faa	43063-794	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	PD-Rx Pharmaceuticals, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-795_05ba12a9-806f-9532-e063-6294a90a0831	43063-795	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091124	PD-Rx Pharmaceuticals, Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
43063-796_ffd764e3-f7cc-75fa-e053-6394a90a59da	43063-796	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20251130	ANDA	ANDA200839	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	750	mg/1			N	
43063-797_ffd7be08-04c8-dfcb-e053-6394a90ad286	43063-797	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	PD-Rx Pharmaceuticals, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-800_fa1b4941-c10a-d840-e053-6394a90a399e	43063-800	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-801_06c3176d-e6f9-4231-e063-6394a90a694b	43063-801	HUMAN OTC DRUG	Guaifenesin DM		GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	TABLET	ORAL	20180402	20271130	OTC MONOGRAPH DRUG	M012	PD-Rx Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
43063-804_d2bca074-0ebd-0514-e053-2a95a90a36a5	43063-804	HUMAN OTC DRUG	Meclizine 25		MECLIZINE HYDROCHLORIDE	TABLET, CHEWABLE	ORAL	20171127	20271130	OTC MONOGRAPH FINAL	part336	PD-Rx Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
43063-805_fa1b60b1-49c5-1211-e053-6394a90a0a46	43063-805	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20041116		ANDA	ANDA074056	PD-Rx Pharmaceuticals, Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-806_065b0f93-2ce2-0633-e063-6394a90a0001	43063-806	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43063-807_f9cbdab1-0f3d-f4df-e053-6294a90a660d	43063-807	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	PD-Rx Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-808_f9cbe1d0-caec-1f39-e053-6294a90a9d6c	43063-808	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	PD-Rx Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-810_fa53f692-e653-97ed-e053-6294a90a1763	43063-810	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180105		ANDA	ANDA075743	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-811_fa53f692-e653-97ed-e053-6294a90a1763	43063-811	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-812_fa53f692-e653-97ed-e053-6294a90a1763	43063-812	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-813_fa53f692-e653-97ed-e053-6294a90a1763	43063-813	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-814_fa53f692-e653-97ed-e053-6294a90a1763	43063-814	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-815_fa53f692-e653-97ed-e053-6294a90a1763	43063-815	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43063-817_065b57dd-56ed-fbf8-e063-6394a90a0f2a	43063-817	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	PD-Rx Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43063-820_fa567cf4-9e81-b647-e053-6394a90a45e6	43063-820	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-821_05ba12a9-80b3-9532-e063-6294a90a0831	43063-821	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	PD-Rx Pharmaceuticals, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-822_fa69db8c-7af0-8f5b-e053-6294a90af7e1	43063-822	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085966	PD-Rx Pharmaceuticals, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
43063-823_05ba5966-f104-5360-e063-6294a90a0fc9	43063-823	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	PD-Rx Pharmaceuticals, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
43063-824_05baa054-796e-471b-e063-6394a90a84ae	43063-824	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20170501	20240229	ANDA	ANDA205085	PD-Rx Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	
43063-825_05bb0871-fe4c-e192-e063-6294a90a8fb3	43063-825	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150603		ANDA	ANDA204197	PD-Rx Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-826_fe467b2e-3fc7-ab94-e053-6294a90a07be	43063-826	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20060320		ANDA	ANDA075677	PD-Rx Pharmaceuticals, Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
43063-832_ffd8120d-fc3f-58f7-e053-6394a90a2430	43063-832	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	PD-Rx Pharmaceuticals, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
43063-833_0b28733a-1abf-5e20-e063-6394a90a41f6	43063-833	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	PD-Rx Pharmaceuticals, Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43063-834_065be877-4e82-e7c2-e063-6394a90a7985	43063-834	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, COATED	ORAL	20150420		ANDA	ANDA074903	PD-Rx Pharmaceuticals, Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-835_ffd8ac02-2f34-fe55-e053-6394a90af454	43063-835	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	PD-Rx Pharmaceuticals, Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
43063-836_fa69db8c-7b28-8f5b-e053-6294a90af7e1	43063-836	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771129		ANDA	ANDA085968	PD-Rx Pharmaceuticals, Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
43063-838_06d12bcf-db68-fe1b-e063-6294a90a6d1e	43063-838	HUMAN OTC DRUG	Senna Laxative		Senna	TABLET, FILM COATED	ORAL	20070124		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	SENNOSIDES A AND B	8.6	mg/1			N	20241231
43063-839_065c16b3-65d7-0bf3-e063-6394a90a2f65	43063-839	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20160129		ANDA	ANDA090223	PD-Rx Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-840_0996c85b-2a73-f59b-e063-6294a90ac732	43063-840	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071307	PD-Rx Pharmaceuticals, Inc.	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-841_065c2eac-49df-4ee2-e063-6294a90aef11	43063-841	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	PD-Rx Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-843_ffd8ddbd-d082-9957-e053-6394a90a42fa	43063-843	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-845_ffd85a45-d9d7-255f-e053-6294a90aad85	43063-845	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-847_ffd85a45-d9ec-255f-e053-6294a90aad85	43063-847	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-848_065c1306-232f-f932-e063-6394a90a53ef	43063-848	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	TABLET, FILM COATED	ORAL	19980811		ANDA	ANDA075219	PD-Rx Pharmaceuticals, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-849_fa6a68aa-b5bd-f542-e053-6394a90a6939	43063-849	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43063-851_065c1306-2330-f932-e063-6394a90a53ef	43063-851	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171222		ANDA	ANDA209335	PD-Rx Pharmaceuticals, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43063-854_0996ea60-fa2e-0294-e063-6294a90a3f84	43063-854	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43063-855_05bb0871-fe99-e192-e063-6294a90a8fb3	43063-855	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-856_fa6ac3cb-b98a-002a-e053-6294a90a694d	43063-856	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	PD-Rx Pharmaceuticals, Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-857_f8c4e860-e702-ade2-e053-6394a90a7c03	43063-857	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	PD-Rx Pharmaceuticals, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
43063-858_f76db82a-8271-92b0-e053-6294a90a8ec6	43063-858	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-861_0569976a-07d9-bdc4-e063-6294a90a23e1	43063-861	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	PD-Rx Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-862_06d13207-c1fc-8cee-e063-6394a90a21a0	43063-862	HUMAN OTC DRUG	Aspirin EC		Aspirin	TABLET, DELAYED RELEASE	ORAL	20070112		OTC MONOGRAPH DRUG	M013	PD-Rx Pharmaceuticals, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
43063-863_fa6a9a08-b514-4788-e053-6294a90a10f7	43063-863	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	PD-Rx Pharmaceuticals, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
43063-864_065c25f6-54b5-2127-e063-6394a90a6df7	43063-864	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	PD-Rx Pharmaceuticals, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
43063-865_065c25f6-54b5-2127-e063-6394a90a6df7	43063-865	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	PD-Rx Pharmaceuticals, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
43063-866_f8c59c61-5967-397f-e053-6394a90a144f	43063-866	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	PD-Rx Pharmaceuticals, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43063-867_08f0140d-d084-19fa-e063-6394a90a0e61	43063-867	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-868_faa86858-5b51-e354-e053-6294a90a5611	43063-868	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	PD-Rx Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43063-869_065c36c9-14e3-306a-e063-6394a90af8ff	43063-869	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
43063-870_f9296a5a-0cd6-92d0-e053-6294a90acee9	43063-870	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	PD-Rx Pharmaceuticals, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
43063-871_065c25f6-54b6-2127-e063-6394a90a6df7	43063-871	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursosiol	CAPSULE	ORAL	20180517		ANDA	ANDA210707	PD-Rx Pharmaceuticals, Inc.	URSADIOL	300	mg/1			N	20241231
43063-872_065c1306-2332-f932-e063-6394a90a53ef	43063-872	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-874_0bb3a84e-6b0a-30c5-e063-6394a90a7913	43063-874	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	PD-Rx Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43063-875_065c645d-9125-6060-e063-6294a90a6638	43063-875	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20070504		ANDA	ANDA040712	PD-Rx Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43063-876_065d1b2c-b058-a9eb-e063-6394a90ac06a	43063-876	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	PD-Rx Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43063-877_fa1a2c40-82be-4a6b-e053-6394a90ab5d4	43063-877	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	PD-Rx Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43063-878_f89d5d9d-a63d-3534-e053-6394a90a323c	43063-878	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	PD-Rx Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43063-880_faa8318f-0259-5133-e053-6394a90a662a	43063-880	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43063-884_faa87156-e49b-ab71-e053-6394a90a63a7	43063-884	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	PD-Rx Pharmaceuticals, Inc.	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
43063-885_faa8c4b4-5578-e495-e053-6394a90a8879	43063-885	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, COATED	ORAL	20060329		ANDA	ANDA065255	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-893_065df2c4-5b2c-1209-e063-6394a90ad421	43063-893	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20000427		ANDA	ANDA075731	PD-Rx Pharmaceuticals, Inc.	CLORAZEPATE DIPOTASSIUM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-897_0683a11b-1c2a-640f-e063-6294a90ab336	43063-897	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	PD-Rx Pharmaceuticals, Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
43063-899_fbd65717-b428-892e-e053-6294a90acbc2	43063-899	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	PD-Rx Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
43063-900_faa8c4b4-55ac-e495-e053-6394a90a8879	43063-900	HUMAN PRESCRIPTION DRUG	LAMIVUDINE and ZIDOVUDINE		LAMIVUDINE and ZIDOVUDINE	TABLET, FILM COATED	ORAL	20150918		ANDA	ANDA079124	PD-Rx Pharmaceuticals, Inc.	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
43063-901_05bb2f42-e5c4-6c1d-e063-6394a90aa81b	43063-901	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20040113		ANDA	ANDA076691	PD-Rx Pharmaceuticals, Inc.	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20241231
43063-902_0683b79e-b20b-b57f-e063-6394a90a53a0	43063-902	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43063-903_ffec24cf-7642-f9c2-e053-6394a90a3294	43063-903	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	PD-Rx Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43063-904_fe7d993d-6cb5-730d-e053-6294a90a29c3	43063-904	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	PD-Rx Pharmaceuticals, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-905_ffec48e6-a99b-6245-e053-6394a90ad47b	43063-905	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	PD-Rx Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43063-906_ffec24cf-7659-f9c2-e053-6394a90a3294	43063-906	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20101227		ANDA	ANDA077714	PD-Rx Pharmaceuticals, Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
43063-908_fbd635b8-af30-3ff1-e053-6294a90a8169	43063-908	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	PD-Rx Pharmaceuticals, Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43063-909_06e68891-351a-1caa-e063-6294a90aa572	43063-909	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140411		ANDA	ANDA074661	PD-Rx Pharmaceuticals, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-911_080454b1-0a4a-2c42-e063-6394a90a92c3	43063-911	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	PD-Rx Pharmaceuticals, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43063-912_0683b79e-b20c-b57f-e063-6394a90a53a0	43063-912	HUMAN PRESCRIPTION DRUG	Zaleplon		Zaleplon	CAPSULE	ORAL	20080606		ANDA	ANDA077237	PD-Rx Pharmaceuticals, Inc.	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
43063-913_f8398d11-7817-4840-e053-6294a90a80e2	43063-913	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43063-914_0683c980-0168-a797-e063-6294a90aee88	43063-914	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-915_faa8cfd1-206a-e287-e053-6394a90ae65e	43063-915	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-917_0683b79e-b20d-b57f-e063-6394a90a53a0	43063-917	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43063-920_f89d6aa6-a134-8113-e053-6294a90a33a8	43063-920	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	PD-Rx Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-921_faa8f5a5-70df-7a91-e053-6294a90a7452	43063-921	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		GEMFIBROZIL	TABLET	ORAL	20170323		ANDA	ANDA078012	PD-Rx Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
43063-923_0023a458-729b-669b-e063-6294a90a92b0	43063-923	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
43063-924_0683dac3-c82d-9bbf-e063-6394a90a965c	43063-924	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	PD-Rx Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43063-925_0683c980-0169-a797-e063-6294a90aee88	43063-925	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	PD-Rx Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43063-927_fa2b5e9e-404d-17e6-e053-6294a90a2358	43063-927	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	PD-Rx Pharmaceuticals, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-928_08f05543-4552-3907-e063-6294a90a4351	43063-928	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	PD-Rx Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
43063-929_f91652dd-da25-2a99-e053-6394a90aabae	43063-929	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	PD-Rx Pharmaceuticals, Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-930_0683b8d6-c8fa-9d59-e063-6394a90a11b0	43063-930	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	PD-Rx Pharmaceuticals, Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-931_0683c0b0-c289-1b86-e063-6394a90a4155	43063-931	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171222		ANDA	ANDA209335	PD-Rx Pharmaceuticals, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43063-933_074ed150-3b06-9f1e-e063-6294a90aaa07	43063-933	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43063-934_09303c2f-e32d-b079-e063-6394a90ab824	43063-934	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	PD-Rx Pharmaceuticals, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43063-935_0685f365-54e3-8145-e063-6294a90a55bc	43063-935	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	PD-Rx Pharmaceuticals, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43063-936_0685fc15-7ca6-b757-e063-6394a90ac07d	43063-936	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-937_0683c980-016a-a797-e063-6294a90aee88	43063-937	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	PD-Rx Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-938_fe7d9143-7d53-a9cc-e053-6394a90a7501	43063-938	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	PD-Rx Pharmaceuticals, Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-939_06840d52-970e-9f56-e063-6294a90a3cf8	43063-939	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	PD-Rx Pharmaceuticals, Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-940_fa5567f2-8782-8d2d-e053-6394a90a2907	43063-940	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA091448	PD-Rx Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43063-941_fa30f851-c74c-5bee-e053-6294a90ab229	43063-941	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA091448	PD-Rx Pharmaceuticals, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43063-942_00236314-8c81-42be-e063-6294a90a20ad	43063-942	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA208987	PD-Rx Pharmaceuticals, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
43063-943_fa556bcd-ae80-3ad1-e053-6294a90ac20d	43063-943	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040786	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-946_fabb3f7d-804d-4c95-e053-6394a90a8db5	43063-946	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43063-947_07ff2586-c83d-9cd1-e063-6394a90a8bf5	43063-947	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	PD-Rx Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43063-952_05bae424-ab4d-d837-e063-6394a90a0241	43063-952	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	PD-Rx Pharmaceuticals, Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43063-953_05bb0569-4ef1-2139-e063-6394a90acb6c	43063-953	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20170224	20251109	UNAPPROVED DRUG OTHER		PD-Rx Pharmaceuticals, Inc.	PHENOBARBITAL	32.4	mg/1		CIV	N	
43063-954_0684302b-33e5-e941-e063-6294a90a292c	43063-954	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43063-955_0684302b-33e6-e941-e063-6294a90a292c	43063-955	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43063-957_0024fb1c-a471-1269-e063-6394a90abafb	43063-957	HUMAN PRESCRIPTION DRUG	Diphenoxylate hydrochloride and atropine sulfate		Diphenoxylate hydrochloride and Atropine sulfate	TABLET	ORAL	20180831		ANDA	ANDA210571	PD-Rx Pharmaceuticals, Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
43063-958_06d13207-c1fe-8cee-e063-6394a90a21a0	43063-958	HUMAN OTC DRUG	Docusate Sodium With Sennosides		Docusate Sodium 50mg and Sennosides 8.6mg	TABLET, FILM COATED	ORAL	20181105		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
43063-959_00261ccc-88e4-ed9b-e063-6294a90a23b6	43063-959	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	PD-Rx Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-960_00261ccc-8927-ed9b-e063-6294a90a23b6	43063-960	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040786	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-961_068472e9-f0c5-7779-e063-6294a90aae2d	43063-961	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43063-962_00261ccc-8927-ed9b-e063-6294a90a23b6	43063-962	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040787	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-963_00261ccc-8927-ed9b-e063-6294a90a23b6	43063-963	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA040788	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43063-964_05bc7f9e-33e3-1177-e063-6294a90ac0be	43063-964	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	PD-Rx Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43063-967_fabd51de-fa59-daff-e053-6394a90af383	43063-967	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	PD-Rx Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-968_0076a89c-6935-4667-e063-6394a90a91a0	43063-968	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19720421		ANDA	ANDA080352	PD-Rx Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43063-969_f9296a5a-0cd5-92d0-e053-6294a90acee9	43063-969	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	PD-Rx Pharmaceuticals, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43063-970_fa1a2c40-82c1-4a6b-e053-6394a90ab5d4	43063-970	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	PD-Rx Pharmaceuticals, Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-972_0685a13d-a45b-609d-e063-6294a90a650b	43063-972	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA078671	PD-Rx Pharmaceuticals, Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-974_0076a89c-695c-4667-e063-6394a90a91a0	43063-974	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	PD-Rx Pharmaceuticals, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
43063-975_f8c60d6d-a114-d3f3-e053-6294a90aaaf9	43063-975	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	PD-Rx Pharmaceuticals, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43063-976_fa1afc76-0295-e443-e053-6394a90aba35	43063-976	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	PD-Rx Pharmaceuticals, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43063-979_00767a8a-9c07-26a0-e063-6294a90a312f	43063-979	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	PD-Rx Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
43063-980_00767a8a-9c07-26a0-e063-6294a90a312f	43063-980	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	PD-Rx Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
43063-982_056a5aec-4953-cc3e-e063-6294a90ad3e1	43063-982	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190501		ANDA	ANDA203963	PD-Rx Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43063-983_074ed3e5-7fe7-a81b-e063-6394a90afa79	43063-983	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	PD-Rx Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43063-986_0e76cbc6-8cee-7dc8-e063-6294a90a815a	43063-986	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
43063-987_07ffc7b1-97b8-09ba-e063-6294a90a521c	43063-987	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071322	PD-Rx Pharmaceuticals, Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-988_fadf7e0e-24f5-0afc-e053-6394a90a7044	43063-988	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20190607		ANDA	ANDA062396	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43063-992_f8395a5c-e5a3-3d70-e053-6394a90a02b5	43063-992	HUMAN PRESCRIPTION DRUG	Flurbiprofen		Flurbiprofen	TABLET, FILM COATED	ORAL	19950602		ANDA	ANDA074431	PD-Rx Pharmaceuticals, Inc.	FLURBIPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43063-993_fbd55a72-f757-bf9d-e053-6394a90a94e7	43063-993	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	PD-Rx Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43063-994_fadf9cac-587b-3440-e053-6394a90afda4	43063-994	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20190620		ANDA	ANDA206975	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43063-995_0c407522-5004-5b38-e063-6394a90ab4fe	43063-995	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20190724		ANDA	ANDA090549	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
43063-996_007700af-ce41-081a-e063-6294a90a0d75	43063-996	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20181029		ANDA	ANDA074224	PD-Rx Pharmaceuticals, Inc.	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43063-997_007729a5-b922-a402-e063-6394a90a848c	43063-997	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-998_007700af-ce75-081a-e063-6294a90a0d75	43063-998	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43063-999_00777001-0b70-d4cf-e063-6394a90a1c0a	43063-999	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19840507		ANDA	ANDA062396	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43066-001_111840d0-9952-4f48-9234-8f7d4e396a24	43066-001	HUMAN PRESCRIPTION DRUG	Docetaxel		docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20180219		NDA	NDA201525	Baxter Healthcare Corporation	DOCETAXEL	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43066-006_111840d0-9952-4f48-9234-8f7d4e396a24	43066-006	HUMAN PRESCRIPTION DRUG	Docetaxel		docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20180219		NDA	NDA201525	Baxter Healthcare Corporation	DOCETAXEL	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43066-007_c2ea7623-fbc9-41bd-83f3-32d67e8668ef	43066-007	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20190715		ANDA	ANDA091115	Baxter Healthcare Corporation	ROCURONIUM BROMIDE	50	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
43066-008_d16fa2b3-f9ba-4d64-b7b2-19f2a1a39ef3	43066-008	HUMAN PRESCRIPTION DRUG	TRANEXAMIC ACID		tranexamic acid	INJECTION	INTRAVENOUS	20200701		ANDA	ANDA212360	Baxter Healthcare Corporation	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
43066-009_f95d328e-964b-4540-9f59-0b1507b63947	43066-009	HUMAN PRESCRIPTION DRUG	CARDENE IV		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19920130		NDA	NDA019734	Baxter Healthcare Corporation	NICARDIPINE HYDROCHLORIDE	.1	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43066-010_111840d0-9952-4f48-9234-8f7d4e396a24	43066-010	HUMAN PRESCRIPTION DRUG	Docetaxel		docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20180219		NDA	NDA201525	Baxter Healthcare Corporation	DOCETAXEL	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43066-013_c2ea7623-fbc9-41bd-83f3-32d67e8668ef	43066-013	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20190715		ANDA	ANDA091115	Baxter Healthcare Corporation	ROCURONIUM BROMIDE	100	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
43066-014_e75a145f-a175-4f01-9313-1de8665ab926	43066-014	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20180219		ANDA	ANDA078817	Baxter Healthcare Corporation	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
43066-015_4157bbc3-8a96-4b79-890d-50ff00bdf4c9	43066-015	HUMAN PRESCRIPTION DRUG	ROPIVACAINE HYDROCHLORIDE		ropivacaine hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20200409		ANDA	ANDA212808	Baxter Healthcare Corporation	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
43066-016_f95d328e-964b-4540-9f59-0b1507b63947	43066-016	HUMAN PRESCRIPTION DRUG	CARDENE IV		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19920130		NDA	NDA019734	Baxter Healthcare Corporation	NICARDIPINE HYDROCHLORIDE	.2	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43066-018_e75a145f-a175-4f01-9313-1de8665ab926	43066-018	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20180219		ANDA	ANDA078817	Baxter Healthcare Corporation	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
43066-019_4157bbc3-8a96-4b79-890d-50ff00bdf4c9	43066-019	HUMAN PRESCRIPTION DRUG	ROPIVACAINE HYDROCHLORIDE		ropivacaine hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20200409		ANDA	ANDA212808	Baxter Healthcare Corporation	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
43066-021_ad0477ba-841a-4f1f-af14-2c3229e83541	43066-021	HUMAN PRESCRIPTION DRUG	Cardene IV		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19920130		NDA	NDA019734	Baxter Healthcare Corporation	NICARDIPINE HYDROCHLORIDE	.1	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43066-023_4157bbc3-8a96-4b79-890d-50ff00bdf4c9	43066-023	HUMAN PRESCRIPTION DRUG	ROPIVACAINE HYDROCHLORIDE		ropivacaine hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20200409		ANDA	ANDA212808	Baxter Healthcare Corporation	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
43066-024_ad0477ba-841a-4f1f-af14-2c3229e83541	43066-024	HUMAN PRESCRIPTION DRUG	Cardene IV		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19920130		NDA	NDA019734	Baxter Healthcare Corporation	NICARDIPINE HYDROCHLORIDE	.2	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43066-026_c0eb72b9-2afa-4939-be34-6968c887a18a	43066-026	HUMAN PRESCRIPTION DRUG	CARDENE IV		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19920130		NDA	NDA019734	Baxter Healthcare Corporation	NICARDIPINE HYDROCHLORIDE	.1	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43066-027_4157bbc3-8a96-4b79-890d-50ff00bdf4c9	43066-027	HUMAN PRESCRIPTION DRUG	ROPIVACAINE HYDROCHLORIDE		ropivacaine hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20200409		ANDA	ANDA212808	Baxter Healthcare Corporation	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
43066-028_c0eb72b9-2afa-4939-be34-6968c887a18a	43066-028	HUMAN PRESCRIPTION DRUG	CARDENE IV		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19920130		NDA	NDA019734	Baxter Healthcare Corporation	NICARDIPINE HYDROCHLORIDE	.2	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43066-031_6175dd75-09e6-4fdf-b7cc-4ac459f7e879	43066-031	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200325		ANDA	ANDA213232	Baxter Healthcare Corporation	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
43066-035_6175dd75-09e6-4fdf-b7cc-4ac459f7e879	43066-035	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200325		ANDA	ANDA213232	Baxter Healthcare Corporation	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
43066-089_d6ccbcf7-d858-4107-b8b2-5b9b3cc488ea	43066-089	HUMAN PRESCRIPTION DRUG	FOSCARNET SODIUM		foscarnet sodium	INJECTION, SOLUTION	INTRAVENOUS	20230828		ANDA	ANDA213001	Baxter Healthcare Corporation	FOSCARNET SODIUM	6000	mg/250mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
43066-090_e913c559-48fc-42e7-b8d0-de083005171f	43066-090	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE EDISYLATE		prochlorperazine edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210503		ANDA	ANDA214379	Baxter Healthcare Corporation	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43066-150_b3d4e148-3bc1-4c80-8df7-5006a77c813d	43066-150	HUMAN PRESCRIPTION DRUG	Nexterone		amiodarone hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20101116		NDA	NDA022325	Baxter Healthcare Corporation	AMIODARONE HYDROCHLORIDE	1.5	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
43066-152_e057aeb2-5125-490c-b691-847426fd42d0	43066-152	HUMAN PRESCRIPTION DRUG	ROPIVACAINE HYDROCHLORIDE		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20240101		ANDA	ANDA210102	Baxter Healthcare Corporation	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
43066-154_e057aeb2-5125-490c-b691-847426fd42d0	43066-154	HUMAN PRESCRIPTION DRUG	ROPIVACAINE HYDROCHLORIDE		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20240101		ANDA	ANDA210102	Baxter Healthcare Corporation	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
43066-360_b3d4e148-3bc1-4c80-8df7-5006a77c813d	43066-360	HUMAN PRESCRIPTION DRUG	Nexterone		amiodarone hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20101116		NDA	NDA022325	Baxter Healthcare Corporation	AMIODARONE HYDROCHLORIDE	1.8	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
43066-555_65a8c434-40f6-442a-9406-004f38d84fcf	43066-555	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE in 0.9% sodium chloride	INJECTION	INTRAVENOUS	20190827		ANDA	ANDA208532	Baxter Healthcare Corporation	DEXMEDETOMIDINE HYDROCHLORIDE	200	ug/50mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
43066-557_65a8c434-40f6-442a-9406-004f38d84fcf	43066-557	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE in 0.9% sodium chloride	INJECTION	INTRAVENOUS	20190827		ANDA	ANDA208532	Baxter Healthcare Corporation	DEXMEDETOMIDINE HYDROCHLORIDE	400	ug/100mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
43066-561_6b59b58e-3a4f-4c9d-bfdd-6419dbb54187	43066-561	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20190827		ANDA	ANDA208532	Baxter Healthcare Corporation	DEXMEDETOMIDINE HYDROCHLORIDE	200	ug/50mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
43066-565_6b59b58e-3a4f-4c9d-bfdd-6419dbb54187	43066-565	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20190827		ANDA	ANDA208532	Baxter Healthcare Corporation	DEXMEDETOMIDINE HYDROCHLORIDE	400	ug/100mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
43066-993_c82b7e0c-b3c4-46ae-a859-aac273937592	43066-993	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170628		ANDA	ANDA208084	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	600	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
43066-995_c82b7e0c-b3c4-46ae-a859-aac273937592	43066-995	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20170628		ANDA	ANDA208084	Baxter Healthcare Corporation	CLINDAMYCIN PHOSPHATE	900	mg/50mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
43066-997_34bce0e9-1c23-4860-a734-18b2b928a8a3	43066-997	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		norepinephrine bitartrate	INJECTION	INTRAVENOUS	20210506		ANDA	ANDA214323	Baxter Healthcare Corporation	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
43068-101_da8dc973-0388-406c-9228-332ba031d37c	43068-101	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20160501		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-102_da8dc973-0388-406c-9228-332ba031d37c	43068-102	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20160801		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-104_da8dc973-0388-406c-9228-332ba031d37c	43068-104	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20151215		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-106_da8dc973-0388-406c-9228-332ba031d37c	43068-106	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20160701		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-108_da8dc973-0388-406c-9228-332ba031d37c	43068-108	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20150915		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	8	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-110_da8dc973-0388-406c-9228-332ba031d37c	43068-110	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20160115		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-112_da8dc973-0388-406c-9228-332ba031d37c	43068-112	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20161015		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	12	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-113_da8dc973-0388-406c-9228-332ba031d37c	43068-113	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	KIT	ORAL	20151201		NDA	NDA022192	Vanda Pharmaceuticals Inc.						N	20241231
43068-220_3248eef5-6bad-4844-a6f9-2f5fddd39c8d	43068-220	HUMAN PRESCRIPTION DRUG	Hetlioz		tasimelteon	CAPSULE	ORAL	20140404		NDA	NDA205677	Vanda Pharmaceuticals Inc.	TASIMELTEON	20	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
43068-304_3248eef5-6bad-4844-a6f9-2f5fddd39c8d	43068-304	HUMAN PRESCRIPTION DRUG	Hetlioz	LQ	tasimelteon	SUSPENSION	ORAL	20201210		NDA	NDA214517	Vanda Pharmaceuticals Inc.	TASIMELTEON	4	mg/mL	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
43068-901_da8dc973-0388-406c-9228-332ba031d37c	43068-901	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20180924		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-902_da8dc973-0388-406c-9228-332ba031d37c	43068-902	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	TABLET	ORAL	20180924		NDA	NDA022192	Vanda Pharmaceuticals Inc.	ILOPERIDONE	8	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43068-903_da8dc973-0388-406c-9228-332ba031d37c	43068-903	HUMAN PRESCRIPTION DRUG	Fanapt		iloperidone	KIT	ORAL	20180924		NDA	NDA022192	Vanda Pharmaceuticals Inc.						N	20241231
43097-457_42c90f07-ebf1-49d6-a2a5-67b4f79c24ab	43097-457	HUMAN OTC DRUG	Puri-San Plus Instant Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20190220		OTC MONOGRAPH NOT FINAL	part333E	People's Janitorial Supply	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
43097-658_ece7cccc-933e-5b84-e053-2a95a90ae392	43097-658	HUMAN OTC DRUG	I-70 FOAMING		ALCOHOL	LIQUID	TOPICAL	20201110		OTC MONOGRAPH NOT FINAL	part333E	People's JanitorialSupply	ALCOHOL	.62	mL/mL			N	20241231
43097-876_ece7db27-1744-15b5-e053-2995a90a3710	43097-876	HUMAN OTC DRUG	FM-24 FOAMING		CHLOROXYLENOL	SOAP	TOPICAL	20201110		OTC MONOGRAPH NOT FINAL	part333E	People's Janitorial Supply	CHLOROXYLENOL	3	mg/mL			N	20241231
43115-123_0c5b67fe-1145-254e-e063-6394a90a07ce	43115-123	HUMAN OTC DRUG	NIA 24 SPF 30		HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE	LOTION	TOPICAL	20110609		OTC MONOGRAPH DRUG	M020	Niadyne Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 75; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
43116-031_020f8beb-46c7-2b1b-e063-6394a90a1d2f	43116-031	HUMAN OTC DRUG	CPAP WIPES		CPAP WIPES	CLOTH	CUTANEOUS	20230804		UNAPPROVED DRUG OTHER		Shenzhen Shierjie Biological Engineering Co., LTD	PHENOXYETHANOL	.3	g/1001			N	20241231
43116-032_0a91ce99-6b6f-bc62-e063-6394a90a2bba	43116-032	HUMAN OTC DRUG	Shierjie Hypochlorous Acid		Hypochlorous Acid	LIQUID	TOPICAL	20231119		OTC MONOGRAPH DRUG	M005	Shenzhen Shierjie Biological Engineering Co., LTD	HYPOCHLOROUS ACID	.02	g/100mL			N	20241231
43116-033_0ccb0278-213b-6b92-e063-6394a90aea16	43116-033	HUMAN OTC DRUG	ROUYUN Lavender essential oil portable body care wipes		ROUYUN Lavender essential oil portable body care wipes	CLOTH	TOPICAL	20231217		OTC MONOGRAPH DRUG	M005	Shenzhen Shierjie Biological Engineering Co., LTD	BENZALKONIUM CHLORIDE	.09	g/1001			N	20241231
43128-001_09449a7e-ca10-2c43-e063-6294a90ab21f	43128-001	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20140601		OTC MONOGRAPH DRUG	M003	NDC, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
43128-002_08b8bdab-eaad-bc6b-e063-6394a90a0f3e	43128-002	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20140601		OTC MONOGRAPH DRUG	M003	NDC, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
43128-005_09c56951-a603-4fcd-82f3-d15e05ae2d65	43128-005	HUMAN PRESCRIPTION DRUG	Mepivacaine		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20150410		ANDA	ANDA088387	NDC, Inc.	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
43128-028_d681185f-ffbd-50c8-e053-2995a90a3ca4	43128-028	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20191001		OTC MONOGRAPH NOT FINAL	part356	National Distribution & Contracting, Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43128-029_d681d1cc-7090-6da9-e053-2a95a90a49c6	43128-029	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20191001		OTC MONOGRAPH NOT FINAL	part356	National Distribution & Contracting, Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43128-031_d68308b6-7aa8-a14b-e053-2995a90a6038	43128-031	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20191001		OTC MONOGRAPH NOT FINAL	part356	National Distribution & Contracting, Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43128-032_d68320d9-f8c9-3cca-e053-2a95a90a53a1	43128-032	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20191001		OTC MONOGRAPH NOT FINAL	part356	National Distribution & Contracting, Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43128-033_d68348c8-e63e-a77b-e053-2995a90a336a	43128-033	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20191001		OTC MONOGRAPH NOT FINAL	part356	National Distribution & Contracting, Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43128-034_d683483c-6819-2895-e053-2a95a90ae524	43128-034	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20191001		OTC MONOGRAPH NOT FINAL	part356	National Distribution & Contracting, Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43128-050_f6f20cca-1cc5-7668-e053-6394a90a58b9	43128-050	HUMAN OTC DRUG	Alcohol Prep pad		Isopropyl Alcohol	SWAB	TOPICAL	20111215		OTC MONOGRAPH NOT FINAL	part333A	NDC National Distribution & Contracting, Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
43128-101_71791304-f900-4d7c-8379-24dddab2b2e2	43128-101	HUMAN PRESCRIPTION DRUG	ARTICAINE		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20150622		NDA AUTHORIZED GENERIC	NDA020971	NDC, Inc.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .01	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43128-102_af76c5d8-c475-48bb-beb8-2c5e33ba87ab	43128-102	HUMAN PRESCRIPTION DRUG	ARTICAINE		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20151204		NDA AUTHORIZED GENERIC	NDA020971	NDC, Inc.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43128-105_4dd4c646-af6c-4b77-bb05-32b0fd4798f8	43128-105	HUMAN PRESCRIPTION DRUG	LIDOCAINE		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20150410		ANDA	ANDA088390	NDC, Inc.	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43128-114_f6f20b8c-4c0f-92e8-e053-6294a90a1be3	43128-114	HUMAN OTC DRUG	Pro Advantage Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20130308		OTC MONOGRAPH NOT FINAL	part333E	NDC National Distribution & Contracting, Inc.	ALCOHOL	620	mg/mL			N	20241231
43128-118_f6f20d9a-72d4-5588-e053-6294a90a24eb	43128-118	HUMAN OTC DRUG	Pro Advantage Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20130308		OTC MONOGRAPH NOT FINAL	part333E	NDC National Distribution & Contracting, Inc.	ALCOHOL	620	mg/mL			N	20241231
43128-128_f6f1fede-12b8-767f-e053-6394a90a9dd6	43128-128	HUMAN OTC DRUG	Pro Advantage Antibacterial		TRICLOSAN	LIQUID	TOPICAL	20130424		OTC MONOGRAPH NOT FINAL	part333E	NDC National Distribution & Contracting, Inc.	TRICLOSAN	3	mg/.001L			N	20241231
43136-100_8f3c378a-e213-e822-e053-2995a90a53eb	43136-100	HUMAN OTC DRUG	AVON HeXashield Triple Antibiotic with Pain Relief		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCl	OINTMENT	TOPICAL	20190731		OTC MONOGRAPH FINAL	part333B	Tai Guk Pharm. Co., Ltd.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
43136-101_8f28883f-e460-b140-e053-2995a90aa903	43136-101	HUMAN OTC DRUG	AVON HeXashield Arthritis Pain Relief	Cream Capsaisin	CAPSAISIN	CREAM	TOPICAL	20190731		OTC MONOGRAPH NOT FINAL	part348	Tai Guk Pharm. Co., Ltd.	CAPSAICIN	.75	mg/g			N	20241231
43136-102_8f29ff63-ba5c-11b6-e053-2995a90a3ee1	43136-102	HUMAN OTC DRUG	AVON HeXashield Pain Relief for Muscle, Back and Joint	Cream	CAMPHOR, MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20190731		OTC MONOGRAPH NOT FINAL	part348	Tai Guk Pharm. Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
43136-103_8f2aa16d-3c3e-e947-e053-2995a90ab4ac	43136-103	HUMAN OTC DRUG	AVON HeXashield Anti Itch	Cream with Healing Aloe	HYDROCORTISONE	CREAM	TOPICAL	20190731		OTC MONOGRAPH NOT FINAL	part348	Tai Guk Pharm. Co., Ltd.	HYDROCORTISONE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43136-104_8f2b6a09-8caf-0d17-e053-2995a90aa07f	43136-104	HUMAN OTC DRUG	AVON HeXashield Athletes Foot	Cream	TOLNAFTATE	CREAM	TOPICAL	20190731		OTC MONOGRAPH FINAL	part333C	Tai Guk Pharm. Co., Ltd.	TOLNAFTATE	10	mg/g			N	20241231
43136-105_8f2c1590-b311-56d6-e053-2995a90a4ab2	43136-105	HUMAN OTC DRUG	AVON HeXashield Congestion Relief	Original	OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20190731		OTC MONOGRAPH FINAL	part341	Tai Guk Pharm. Co., Ltd.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
43136-203_b9d033f3-4d13-a2c8-e053-2995a90ac7f1	43136-203	HUMAN OTC DRUG	HeXashield Anti Itch	Cream with Healing Aloe	HYDROCORTISONE	CREAM	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part348	Tai Guk Pharm. Co., Ltd.	HYDROCORTISONE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43136-501_05a9cee1-bd6f-6b93-e063-6294a90a5c10	43136-501	HUMAN OTC DRUG	EUTHYMOL Extraordinary Pink Whitening		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-502_0a8b6c3b-b05b-9d40-e063-6394a90afa5f	43136-502	HUMAN OTC DRUG	EUTHYMOL Extraordinary Pink Whitening		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH DRUG	M021	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-511_05aba199-a503-de58-e063-6394a90a03f6	43136-511	HUMAN OTC DRUG	POP Hint Of Mint		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
43136-512_0abb7aa1-66d5-0cc3-e063-6394a90a7c46	43136-512	HUMAN OTC DRUG	POP Feeling Peachy		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20231117		OTC MONOGRAPH DRUG	M021	TAI GUK PHARM. CO., LTD	SODIUM FLUORIDE	1.4	mg/g			N	20241231
43136-521_05b18bb6-9fc1-469b-e063-6294a90a4f2f	43136-521	HUMAN OTC DRUG	POP Gel Pumpin Strawberry		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.3	mg/g			N	20241231
43136-522_05b18bb6-9fc0-469b-e063-6294a90a4f2f	43136-522	HUMAN OTC DRUG	POP Gel Whatzzup Watermelon		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.3	mg/g			N	20241231
43136-601_f4ef8ee7-7198-b3dc-e053-2a95a90a1c1b	43136-601	HUMAN OTC DRUG	PERIOE POP Sensitivity Care Prebiotic	Clean Mint	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20230217		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
43136-602_f546470a-7faf-4988-e053-2995a90ab61b	43136-602	HUMAN OTC DRUG	PERIOE POP Advanced Whitening Prebiotic	Cool Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230217		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-603_f547a468-d2fe-7176-e053-2995a90a5539	43136-603	HUMAN OTC DRUG	PERIOE POP Complete Protection Prebiotic	Mint Blast	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230217		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
43136-701_e8bdad5f-e844-3320-e053-2a95a90a4de2	43136-701	HUMAN OTC DRUG	Dr. Groot Anti-dandruff Scalp Care		Salicylic Acid	SHAMPOO	TOPICAL	20020915		OTC MONOGRAPH FINAL	part358H	TAI GUK PHARM. CO., LTD	SALICYLIC ACID	30	mg/mL			N	20241231
43136-702_e8bf37ee-1c1d-ef8c-e053-2a95a90a8c3a	43136-702	HUMAN OTC DRUG	Dr. Groot Anti-dandruff Scalp Care 2 in 1		Salicylic Acid	SHAMPOO	TOPICAL	20020915		OTC MONOGRAPH FINAL	part358H	TAI GUK PHARM. CO., LTD	SALICYLIC ACID	30	mg/mL			N	20241231
43136-801_9c820658-3d0f-5b7a-e053-2a95a90aea63	43136-801	HUMAN OTC DRUG	AVON Whitening Essentials	10X Charcoal Black Clean Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200120		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-802_a3b21156-d466-6cb0-e053-2995a90aa358	43136-802	HUMAN OTC DRUG	PERIOE Whitening Essentials	Fresh Aloe Green Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20200331		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-803_b45317e8-a766-08c1-e053-2a95a90ae73c	43136-803	HUMAN OTC DRUG	PERIOE Whitening Essentials	10X Charcoal Black Clean Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201120		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-810_de97dbea-dc8d-ebfa-e053-2995a90a2270	43136-810	HUMAN OTC DRUG	PERIOE Microbiome Whitening	Cool Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20220401		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-820_de99d950-9eff-9451-e053-2a95a90a9ec5	43136-820	HUMAN OTC DRUG	PERIOE Microbiome Total Care	Strong Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20220401		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
43136-830_dec403d2-dfae-d7f6-e053-2995a90a8a2b	43136-830	HUMAN OTC DRUG	PERIOE Microbiome Sensitive	Clean Mint	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20220511		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
43136-901_8e5dce76-df8c-5878-e053-2a95a90a3f04	43136-901	HUMAN OTC DRUG	AVON Whitening Essentials	Original Cool Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190731		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-902_8f27a488-4981-5a47-e053-2a95a90a4d11	43136-902	HUMAN OTC DRUG	AVON Whitening Essentials	Blanc Charcoal Fresh Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190731		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43136-903_99fff091-b3f5-2c4d-e053-2995a90a450d	43136-903	HUMAN OTC DRUG	AVON Whitening Essentials	Blanc Charcoal Fresh Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20191225		OTC MONOGRAPH FINAL	part355	Tai Guk Pharm. Co., Ltd.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
43203-852_36fd228c-a0de-42d9-90a4-c7b252a07571	43203-852	HUMAN PRESCRIPTION DRUG	Anticoagulant Citrate Dextrose A ACD-A		Anticoagulant Citrate Dextrose A ACD-A	INJECTION, SOLUTION	EXTRACORPOREAL	20110511		ANDA	BA110057	Arteriocyte Medical Systems, Inc.	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM	.08; .245; .22	g/10mL; g/10mL; g/10mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
43208-001_0940f26d-fa58-986a-e063-6394a90a8a8a	43208-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Currier Drug Inc.	OXYGEN	99	L/100L			N	20241231
43251-2400_f0372523-5731-407d-b221-e288d07339c8	43251-2400	HUMAN OTC DRUG	Flexitol Foot and Knee Pain Relief		Methyl Salicylate	GEL	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part348	LaCorium Health USA Inc.	METHYL SALICYLATE	100	mg/g			N	20241231
43251-4904_a4baec69-f891-4963-bb19-54396e515aef	43251-4904	HUMAN OTC DRUG	Flexitol Face and Eyelid Eczema		oatmeal	CREAM	TOPICAL	20220101		OTC MONOGRAPH FINAL	part347	LaCorium Health USA Inc.	OATMEAL	50	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43251-4927_0f6d122f-db98-45d7-b8c6-acac83045bf3	43251-4927	HUMAN OTC DRUG	Flexitol Happy Little Bodies Eczema Relief		oatmeal	CREAM	TOPICAL	20211129		OTC MONOGRAPH DRUG	M016	LaCorium Health USA Inc	OATMEAL	50	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43251-9020_ae10b2f5-0e99-4348-9a53-eb101b72da10	43251-9020	HUMAN OTC DRUG	Flexitol Eczema and Dermatitis		oatmeal	CREAM	TOPICAL	20200110		OTC MONOGRAPH DRUG	M016	LaCorium Health USA Inc	OATMEAL	50	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43305-0000_d5f6dbc2-c56d-fd87-e053-2a95a90aeac3	43305-0000	HUMAN PRESCRIPTION DRUG	Hemostat		Aluminum Chloride	SOLUTION	DENTAL	20130115		UNAPPROVED DRUG OTHER		Pearson Dental Supplies INC.	ALUMINUM CHLORIDE	7500	mg/30mL			N	20241231
43353-001_0b1c30af-8a82-417f-be0a-aa3ec324e0d0	43353-001	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20060510		ANDA	ANDA076635	Aphena Pharma Solutions - Tennessee, LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43353-004_02d04e01-a007-457d-9200-990cd737611e	43353-004	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090120	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-008_02d04e01-a007-457d-9200-990cd737611e	43353-008	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090120	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-009_c7e48d97-db9a-465d-938b-215db53d3f58	43353-009	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20140315		ANDA	ANDA203508	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-011_ba04e9ec-26d0-4ec3-ba89-9443def0c189	43353-011	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20140117		ANDA	ANDA077745	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-013_6ce6ad15-ef05-4056-a630-897f4cc6d903	43353-013	HUMAN PRESCRIPTION DRUG	tamsulosin hydrochloride		tamsulosin hydrochloride	CAPSULE	ORAL	20150105		ANDA	ANDA078015	Aphena Pharma Solutions - Tennessee, LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43353-018_6b8291f1-dcbd-4c61-92a4-9b1d35eeecdc	43353-018	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43353-019_e1806901-2386-4ada-84a9-f20bc3c0edf2	43353-019	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100715		ANDA	ANDA090931	Aphena Pharma Solutions - Tennessee, LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43353-021_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-021	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-023_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-023	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-025_88f5034d-3e54-49a5-b644-141e7bcdb7db	43353-025	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43353-027_2d3ce59f-9be8-43ca-bbf7-06ee7f55d047	43353-027	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Aphena Pharma Solutions - Tennessee, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43353-028_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-028	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-029_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-029	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-030_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-030	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-033_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-033	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-041_a33fd71a-4174-4989-82f2-6c8c39e187b3	43353-041	HUMAN OTC DRUG	Sodium Bicarbonate		sodium bicarbonate	TABLET, ORALLY DISINTEGRATING	ORAL	20120626		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	SODIUM BICARBONATE	650	mg/1			N	20241231
43353-051_185f5714-9f7b-4570-8047-0ba6994a6dc4	43353-051	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET	ORAL	20141212		NDA AUTHORIZED GENERIC	NDA009768	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
43353-053_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-053	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-054_41fc64c4-7edd-4a3c-b4e0-7da421e375de	43353-054	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
43353-059_0f5111d6-a380-40d6-ae3f-6fbcd975c962	43353-059	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA021283	Aphena Pharma Solutions - Tennessee, LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43353-060_fab5e5c3-4250-44c5-9a97-68a48e5330b2	43353-060	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20150209		ANDA	ANDA076008	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
43353-066_0f5111d6-a380-40d6-ae3f-6fbcd975c962	43353-066	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA021283	Aphena Pharma Solutions - Tennessee, LLC	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43353-067_0f5111d6-a380-40d6-ae3f-6fbcd975c962	43353-067	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20140707		NDA AUTHORIZED GENERIC	NDA021283	Aphena Pharma Solutions - Tennessee, LLC	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43353-069_13d5f0a8-f822-4190-99b3-32f2a1126caf	43353-069	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43353-075_c53f4d79-df8d-42b8-86e3-bd6181049abc	43353-075	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20100123		ANDA	ANDA075350	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-081_c53f4d79-df8d-42b8-86e3-bd6181049abc	43353-081	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140317		ANDA	ANDA075350	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-082_afc5f57d-e5ee-4eef-acb8-00c6fe16ce44	43353-082	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130911		ANDA	ANDA203769	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43353-083_a923a016-80b4-4a98-9494-ada455890843	43353-083	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		DIPHENOXYLATE HYDROCHLORIDE and ATROPINE SULFATE	TABLET	ORAL	20130227		NDA AUTHORIZED GENERIC	NDA012462	Aphena Pharma Solutions - Tennessee, LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
43353-084_39e1f574-b4d0-461a-9845-16f1ded3854a	43353-084	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Aphena Pharma Solutions - Tennessee, LLC	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43353-085_a83d04b7-84f7-4967-9721-a82a0fe8d83e	43353-085	HUMAN PRESCRIPTION DRUG	valproic acid		valproic acid	CAPSULE	ORAL	20111029		ANDA	ANDA073229	Aphena Pharma Solutions - Tennessee, LLC	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
43353-091_ed5be4fc-b241-4d4f-9c66-85d764eea8cd	43353-091	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20110101		ANDA	ANDA077534	Aphena Pharma Solutions - Tennessee, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-094_0fa7e671-91b0-4903-ad9a-11f538701b83	43353-094	HUMAN PRESCRIPTION DRUG	HYDROXYZINE PAMOATE		HYDROXYZINE PAMOATE	CAPSULE	ORAL	20140520		ANDA	ANDA201507	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43353-096_ed6d6ba2-96b7-4149-a6b8-85fe75f6f95a	43353-096	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20140201		ANDA	ANDA203769	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43353-097_fcdcacb3-f8a2-4cef-beb0-316dc7485002	43353-097	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140515		ANDA	ANDA091169	Aphena Pharma Solutions - Tennessee, LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
43353-101_fcdcacb3-f8a2-4cef-beb0-316dc7485002	43353-101	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140515		ANDA	ANDA091169	Aphena Pharma Solutions - Tennessee, LLC	ESZOPICLONE	2	mg/1		CIV	N	20241231
43353-105_a828bab2-c41b-4a57-9ec9-626114437f4f	43353-105	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19911230		ANDA	ANDA063065	Aphena Pharma Solutions - Tennessee, LLC	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43353-106_88f5034d-3e54-49a5-b644-141e7bcdb7db	43353-106	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43353-107_b6b43c41-f63d-4cff-930e-dc9ee7f9201e	43353-107	HUMAN PRESCRIPTION DRUG	Valproic		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20090908		ANDA	ANDA073229	Aphena Pharma Solutions - Tennessee, LLC	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
43353-112_15b2d425-9b35-4453-b086-2a77d1d5af33	43353-112	HUMAN PRESCRIPTION DRUG	CITALOPRAM HYDROBROMIDE		CITALOPRAM	TABLET	ORAL	20121001		ANDA	ANDA077534	Aphena Pharma Solutions - Tennessee, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-113_4caff724-4abc-435e-8e04-616f4d40f51c	43353-113	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA075743	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-114_54921df4-d3d6-4ab2-aaf9-9789679c9f99	43353-114	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43353-124_66435209-390b-4344-9b5b-47c9c2d92e2f	43353-124	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA089098	Aphena Pharma Solutions - Tennessee, LLC	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
43353-128_2ac9368a-7105-4d2a-a6d7-a8b9c5c9bfce	43353-128	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA091184	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43353-138_acc9691a-1f0d-4799-b4fa-35e480ef8538	43353-138	HUMAN PRESCRIPTION DRUG	CALCITRIOL		CALCITRIOL	CAPSULE	ORAL	20090826		NDA AUTHORIZED GENERIC	NDA018044	Aphena Pharma Solutions - Tennessee, LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
43353-139_2f4be110-f156-465a-861d-fe406e0fd037	43353-139	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	20150904		ANDA	ANDA086925	Aphena Pharma Solutions - Tennessee, LLC	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43353-141_2f4be110-f156-465a-861d-fe406e0fd037	43353-141	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	20150904		ANDA	ANDA087537	Aphena Pharma Solutions - Tennessee, LLC	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43353-152_7e272f5a-86d5-48f5-92b5-50bc33f351b3	43353-152	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20150325		ANDA	ANDA071457	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-162_36d1abdc-f28b-4c0d-98ea-07718706c695	43353-162	HUMAN OTC DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	TABLET	ORAL	20150501		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
43353-165_bd5eaa03-d2d2-4af4-855f-a3fa51a58b72	43353-165	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, COATED	ORAL	20151013		ANDA	ANDA200891	Aphena Pharma Solutions - Tennessee, LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
43353-167_e5134918-4fb4-4395-a5ec-8acb76d627d5	43353-167	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20040116		ANDA	ANDA076533	Aphena Pharma Solutions - Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43353-172_ed662f55-b226-4b47-8004-a5ff89f91003	43353-172	HUMAN PRESCRIPTION DRUG	Minocin		minocycline hydrochloride	CAPSULE, COATED PELLETS	ORAL	19900531		NDA	NDA050649	Aphena Pharma Solutions - Tennessee, LLC	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43353-186_8b90efb6-87d0-428c-b0ef-13237a009714	43353-186	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	19861024		ANDA	ANDA018659	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43353-199_f76944fe-c1e8-4cd6-a7ec-72b0a243c590	43353-199	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
43353-201_9d397bfd-f53e-42ca-8e0f-5392b6324e15	43353-201	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20120123		ANDA	ANDA091305	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43353-205_7ff2351c-0271-49c1-b5d4-cb73b76a508c	43353-205	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20160520		ANDA	ANDA090255	Aphena Pharma Solutions - Tennessee, LLC	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
43353-207_c6784fa1-f4f6-403b-bab4-2e681cf226eb	43353-207	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43353-208_15b2d425-9b35-4453-b086-2a77d1d5af33	43353-208	HUMAN PRESCRIPTION DRUG	CITALOPRAM HYDROBROMIDE		CITALOPRAM	TABLET	ORAL	20121001		ANDA	ANDA077534	Aphena Pharma Solutions - Tennessee, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-211_68ef14c5-d88d-4c95-b6d4-65606f4c11fa	43353-211	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20160610		ANDA	ANDA091305	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43353-216_68ef14c5-d88d-4c95-b6d4-65606f4c11fa	43353-216	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20160610		ANDA	ANDA091305	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43353-218_68ef14c5-d88d-4c95-b6d4-65606f4c11fa	43353-218	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20160610		ANDA	ANDA091305	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43353-219_7d5d42ee-0533-4ade-9d04-8a58ec77b8f7	43353-219	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE	ORAL	20111115		ANDA	ANDA040833	Aphena Pharma Solutions - Tennessee, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
43353-222_26c902cb-733e-4dcb-9a47-f5044956a503	43353-222	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20160601		ANDA	ANDA204074	Aphena Pharma Solutions - Tennessee, LLC	DAPSONE	25	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
43353-223_26c902cb-733e-4dcb-9a47-f5044956a503	43353-223	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20160601		ANDA	ANDA204074	Aphena Pharma Solutions - Tennessee, LLC	DAPSONE	100	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
43353-233_c0d29c8f-bd6a-4b5c-adba-7e5ebdd8029c	43353-233	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Aphena Pharma Solutions - Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43353-234_c0d29c8f-bd6a-4b5c-adba-7e5ebdd8029c	43353-234	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111123		ANDA	ANDA200834	Aphena Pharma Solutions - Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43353-238_88018fca-ced9-4936-8361-4276c737f6bd	43353-238	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20150723		ANDA	ANDA080704	Aphena Pharma Solutions - Tennessee, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
43353-240_e5f8cae3-76be-4f78-9b8a-690bacf28a09	43353-240	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20070301		ANDA	ANDA040702	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43353-253_293b1286-f467-418f-9b40-e5502c14c3b9	43353-253	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20150828		ANDA	ANDA204310	Aphena Pharma Solutions - Tennessee, LLC	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
43353-255_241fa37f-a839-42e7-8f99-7f33ea809be0	43353-255	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-257_e3381eee-5310-4f22-ae15-a059905f2c83	43353-257	HUMAN PRESCRIPTION DRUG	Celecoxib		celecoxib	CAPSULE	ORAL	20151109		ANDA	ANDA078857	Aphena Pharma Solutions - Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43353-258_137b8563-7235-4e5b-bcdf-68e788eb8d8b	43353-258	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		ropinirole	TABLET	ORAL	20160620		ANDA	ANDA078881	Aphena Pharma Solutions - Tennessee, LLC	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43353-259_7b7e9faa-ff3d-4886-a07e-63775e66f9f9	43353-259	HUMAN OTC DRUG	Loratadine	antihistamine	Loratadine	TABLET	ORAL	20081015		ANDA	ANDA076301	Aphena Pharma Solutions - Tennessee, LLC	LORATADINE	10	mg/1			N	20241231
43353-260_98a12b95-2697-4861-941c-581732972660	43353-260	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-263_46aed802-1b67-48f3-bf67-5a1c7a49cc46	43353-263	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
43353-264_46aed802-1b67-48f3-bf67-5a1c7a49cc46	43353-264	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
43353-265_137b8563-7235-4e5b-bcdf-68e788eb8d8b	43353-265	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		ropinirole	TABLET	ORAL	20160620		ANDA	ANDA078881	Aphena Pharma Solutions - Tennessee, LLC	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43353-266_137b8563-7235-4e5b-bcdf-68e788eb8d8b	43353-266	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		ropinirole	TABLET	ORAL	20160620		ANDA	ANDA078881	Aphena Pharma Solutions - Tennessee, LLC	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43353-267_137b8563-7235-4e5b-bcdf-68e788eb8d8b	43353-267	HUMAN PRESCRIPTION DRUG	Ropinirole Hydrochloride		ropinirole	TABLET	ORAL	20160620		ANDA	ANDA078881	Aphena Pharma Solutions - Tennessee, LLC	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43353-268_c0d29c8f-bd6a-4b5c-adba-7e5ebdd8029c	43353-268	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Aphena Pharma Solutions - Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43353-270_c7e48d97-db9a-465d-938b-215db53d3f58	43353-270	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20140315		ANDA	ANDA203508	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-271_c7e48d97-db9a-465d-938b-215db53d3f58	43353-271	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20140315		ANDA	ANDA203508	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-272_3e47ea73-8fb6-4624-9dad-de04d8d650de	43353-272	HUMAN PRESCRIPTION DRUG	Tricor		Fenofibrate	TABLET	ORAL	20160205		NDA	NDA021656	Aphena Pharma Solutions - Tennessee, LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43353-274_02044cca-72db-4876-8c73-8e623464bef4	43353-274	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20140930		ANDA	ANDA070184	Aphena Pharma Solutions - Tennessee, LLC	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
43353-276_adf69c69-e739-4ffc-9bad-0f269f804e8c	43353-276	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20160803		ANDA	ANDA071136	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-278_d316061b-b83d-4b0f-bc01-fce90149a2fa	43353-278	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20160803		ANDA	ANDA071135	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-279_1f5efbea-ccd0-4213-9324-769b0077144f	43353-279	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20160715		ANDA	ANDA073484	Aphena Pharma Solutions - Tennessee, LLC	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
43353-281_c97dc0e4-979e-4f8f-bf23-cc09993eb660	43353-281	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20160803		ANDA	ANDA071134	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-282_a9056bad-e15c-4be4-a63c-f51362e2f025	43353-282	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160309		ANDA	ANDA078503	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43353-284_a9056bad-e15c-4be4-a63c-f51362e2f025	43353-284	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160309		ANDA	ANDA078503	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43353-285_9eda2c93-de21-45ec-a9dc-1329d6d44be7	43353-285	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43353-288_b1b7dc90-3e5c-48cf-8a65-446c52e79d53	43353-288	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Aphena Pharma Solutions - Tennessee, LLC	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43353-292_b3048e2b-3ff7-4160-870f-147d792ec36c	43353-292	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Aphena Pharma Solutions - Tennessee, LLC	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43353-294_f7a2760f-2274-412b-8dc6-111f547e7e03	43353-294	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20170105		ANDA	ANDA075419	Aphena Pharma Solutions - Tennessee, LLC	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43353-296_f867ba88-a009-4f0e-8792-d9e0d416117d	43353-296	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20020301		NDA AUTHORIZED GENERIC	NDA021342	Aphena Pharma Solutions - Tennessee, LLC	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43353-297_50eb65e3-af02-4008-b713-b11f6f61e254	43353-297	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-298_c7e48d97-db9a-465d-938b-215db53d3f58	43353-298	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20140315		ANDA	ANDA203508	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-301_c7e48d97-db9a-465d-938b-215db53d3f58	43353-301	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20140315		ANDA	ANDA203508	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-312_98a12b95-2697-4861-941c-581732972660	43353-312	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-315_cd00a5cc-04b6-49cd-89d0-ae552b415f5d	43353-315	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20050303		ANDA	ANDA076943	Aphena Pharma Solutions - Tennessee, LLC	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43353-316_2bf1938a-b415-4fb4-bb25-c3fc89ed1462	43353-316	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070976	Aphena Pharma Solutions - Tennessee, LLC	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43353-317_815744b6-6096-4a89-8171-cdca95e10631	43353-317	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20151118		ANDA	ANDA090596	Aphena Pharma Solutions - Tennessee, LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
43353-322_a9056bad-e15c-4be4-a63c-f51362e2f025	43353-322	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160309		ANDA	ANDA078503	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43353-325_5fa3f583-8654-4f38-8014-34b792086809	43353-325	HUMAN OTC DRUG	Mi-Acid Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20110302		OTC MONOGRAPH FINAL	part332	Aphena Pharma Solutions - Tennessee, LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
43353-326_d6ad0b81-6658-4b27-adf1-0115af4c7471	43353-326	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride		Pioglitazone Hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	Aphena Pharma Solutions - Tennessee, LLC	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
43353-329_a3797445-680f-449e-8ffd-522445906bdb	43353-329	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Aphena Pharma Solutions - Tennessee, LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
43353-331_a3797445-680f-449e-8ffd-522445906bdb	43353-331	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Aphena Pharma Solutions - Tennessee, LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
43353-332_6398df0f-8c43-4428-b882-3f5efb53ae00	43353-332	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET	ORAL	20170202		ANDA	ANDA079170	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-339_6398df0f-8c43-4428-b882-3f5efb53ae00	43353-339	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET	ORAL	20170202		ANDA	ANDA079170	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-341_9307939d-4b16-42e8-a5eb-15dcc8295c44	43353-341	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43353-342_adc9595c-1b82-45f5-a679-ecf843d8baf2	43353-342	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	20130801		ANDA	ANDA072708	Aphena Pharma Solutions - Tennessee, LLC	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
43353-343_add29ca5-ecb5-4b8c-b35f-83a58dbd91bb	43353-343	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20160222		ANDA	ANDA077056	Aphena Pharma Solutions - Tennessee, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43353-345_c1c88939-6766-4d48-bf65-c0662f1472e4	43353-345	HUMAN PRESCRIPTION DRUG	Sildenafil		sildenafil citrate	TABLET, FILM COATED	ORAL	20120927		NDA AUTHORIZED GENERIC	NDA021845	Aphena Pharma Solutions - Tennessee, LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43353-352_6398df0f-8c43-4428-b882-3f5efb53ae00	43353-352	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET	ORAL	20170202		ANDA	ANDA079170	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-369_af280d57-ac35-48fa-ad26-93f91eb6c9eb	43353-369	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	19940510		ANDA	ANDA074226	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43353-378_4175874c-5e90-4788-b418-81c2ece96a7e	43353-378	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	30	mg/1			N	20241231
43353-379_2c861c05-b5b5-4ecf-a221-ad274df017e6	43353-379	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	19940510		ANDA	ANDA074226	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43353-412_2ea2de52-7580-4e06-a06d-dd57572cc4aa	43353-412	HUMAN PRESCRIPTION DRUG	Risperidone		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Aphena Pharma Solutions - Tennessee, LLC	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-413_46aed802-1b67-48f3-bf67-5a1c7a49cc46	43353-413	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
43353-414_46aed802-1b67-48f3-bf67-5a1c7a49cc46	43353-414	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
43353-432_050617b7-15e2-42b5-a541-f813e32824ca	43353-432	HUMAN PRESCRIPTION DRUG	Risperidone		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Aphena Pharma Solutions - Tennessee, LLC	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-445_515aa4a3-308a-4d12-915e-5684210081eb	43353-445	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20091216		ANDA	ANDA077824	Aphena Pharma Solutions - Tennessee, LLC	RANITIDINE HYDROCHLORIDE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43353-447_0b74d1f0-4bad-415a-a4b7-fe8a563b4d03	43353-447	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Aphena Pharma Solutions - Tennessee, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-451_fe714ed3-35c9-4c0c-b64c-d6e1ba0e685f	43353-451	HUMAN PRESCRIPTION DRUG	Triazolam		triazolam	TABLET	ORAL	19821115		NDA AUTHORIZED GENERIC	NDA017892	Aphena Pharma Solutions - Tennessee, LLC	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-501_8d93d4a2-8f24-4df0-a068-d49234766c97	43353-501	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091116		ANDA	ANDA078253	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43353-544_37d67ac2-1470-43aa-a06d-b24981539fd4	43353-544	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-554_37d67ac2-1470-43aa-a06d-b24981539fd4	43353-554	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-580_492e8cdc-125f-46b9-b95d-3c05ab07fe87	43353-580	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515		ANDA	ANDA204713	Aphena Pharma Solutions - Tennnessee, LLC	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
43353-594_ef69e563-7239-4c78-8fb4-3cd641fbff17	43353-594	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170620		ANDA	ANDA086727	Aphena Pharma Solutions - Tennessee, LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
43353-616_c68dff8e-c8ac-4ed4-8700-a70b920554a8	43353-616	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20031107		ANDA	ANDA075563	Aphena Pharma Solutions - Tennessee, LLC	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
43353-637_682046db-6afc-4387-9e0f-24fb0d06d436	43353-637	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	CAPSULE	ORAL	20010802		ANDA	ANDA075049	Aphena Pharma Solutions - Tennessee, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-643_ef026ab2-cba4-4528-b8b6-1f6f142405ad	43353-643	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA075743	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-646_30c400c9-6ac0-44c8-ab03-f18c634c23cf	43353-646	HUMAN PRESCRIPTION DRUG	Doxazosin Mesylate		Doxazosin Mesylate	TABLET	ORAL	20110720		ANDA	ANDA076161	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43353-662_ef026ab2-cba4-4528-b8b6-1f6f142405ad	43353-662	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA075743	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-675_46aed802-1b67-48f3-bf67-5a1c7a49cc46	43353-675	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	200	mg/1		CV	N	20241231
43353-684_1fb58ec3-f97b-443f-ada2-a8d4edaedef8	43353-684	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		amlodipine besylate	TABLET	ORAL	20100407		ANDA	ANDA078414	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43353-691_1fb58ec3-f97b-443f-ada2-a8d4edaedef8	43353-691	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		amlodipine besylate	TABLET	ORAL	20100407		ANDA	ANDA078414	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43353-695_20fe0892-ca2f-4934-83c2-c88c9d48189a	43353-695	HUMAN PRESCRIPTION DRUG	Topiramate		topiramate	TABLET	ORAL	20110708		ANDA	ANDA079162	Aphena Pharma Solutions - Tennessee, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-696_1166a6cd-e221-43fb-825f-9f1489ec967b	43353-696	HUMAN PRESCRIPTION DRUG	Topiramate		topiramate	TABLET	ORAL	20110708		ANDA	ANDA079162	Aphena Pharma Solutions - Tennessee, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-697_027d1527-b473-4d5d-9cc2-b541c0ad544f	43353-697	HUMAN PRESCRIPTION DRUG	Topiramate		topiramate	TABLET	ORAL	20110708		ANDA	ANDA079162	Aphena Pharma Solutions - Tennessee, LLC	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-699_e0078bdb-6976-4f1a-b2e8-c9c0fbc8360e	43353-699	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20020926		ANDA	ANDA085475	Aphena Pharma Solutions - Tennessee, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-713_85b2c456-e237-42da-aa5c-415dc3326154	43353-713	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-717_80c4cb36-638f-4d42-aa92-c5428ba5c547	43353-717	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19800107		ANDA	ANDA083177	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43353-719_80c4cb36-638f-4d42-aa92-c5428ba5c547	43353-719	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19730112		ANDA	ANDA083177	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43353-720_42231505-eb36-4128-829b-2a66dc8ad832	43353-720	HUMAN PRESCRIPTION DRUG	Risperidone		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Aphena Pharma Solutions - Tennessee, LLC	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-739_30c400c9-6ac0-44c8-ab03-f18c634c23cf	43353-739	HUMAN PRESCRIPTION DRUG	Doxazosin Mesylate		Doxazosin Mesylate	TABLET	ORAL	20110720		ANDA	ANDA076161	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43353-740_30c400c9-6ac0-44c8-ab03-f18c634c23cf	43353-740	HUMAN PRESCRIPTION DRUG	Doxazosin Mesylate		Doxazosin Mesylate	TABLET	ORAL	20110720		ANDA	ANDA076161	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43353-747_13d5f0a8-f822-4190-99b3-32f2a1126caf	43353-747	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43353-793_e756b759-f051-4dd1-a98f-f93931d3cd6a	43353-793	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA075743	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-798_ad3a32db-8ab9-402e-a263-33931bc29cd1	43353-798	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20120507		ANDA	ANDA079098	Aphena Pharma Solutions - Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43353-825_ab1a1c72-dcae-47ba-8f0e-aefb9b5143a0	43353-825	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071307	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-829_1b00384a-efea-458c-8485-5da3db9d28d6	43353-829	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090123		ANDA	ANDA075410	Aphena Pharma Solutions - Tennessee, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43353-832_c13aa0de-b0cb-47a8-a932-e093ea2d9526	43353-832	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43353-834_7eca20ff-75cb-402d-942a-7c4854718687	43353-834	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	20140220		ANDA	ANDA073457	Aphena Pharma Solutions - Tennessee, LLC	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43353-837_c13aa0de-b0cb-47a8-a932-e093ea2d9526	43353-837	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43353-838_c13aa0de-b0cb-47a8-a932-e093ea2d9526	43353-838	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43353-840_46aed802-1b67-48f3-bf67-5a1c7a49cc46	43353-840	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	300	mg/1		CV	N	20241231
43353-845_773d481a-a489-492b-a74e-eede0e3987da	43353-845	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-862_19801231-00a9-4772-b3b1-9be1ac7c1b86	43353-862	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-863_19801231-00a9-4772-b3b1-9be1ac7c1b86	43353-863	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-864_19801231-00a9-4772-b3b1-9be1ac7c1b86	43353-864	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43353-874_c13aa0de-b0cb-47a8-a932-e093ea2d9526	43353-874	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
43353-876_46aed802-1b67-48f3-bf67-5a1c7a49cc46	43353-876	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	225	mg/1		CV	N	20241231
43353-880_d39e6df1-44b6-46a3-9da7-250f6a589b01	43353-880	HUMAN PRESCRIPTION DRUG	Ranexa		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060127		NDA	NDA021526	Aphena Pharma Solutions - Tennessee, LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
43353-884_08025228-3c71-400b-95ff-80d6aea38f33	43353-884	HUMAN PRESCRIPTION DRUG	APRISO		mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20081031		NDA	NDA022301	Aphena Pharma Solutions - Tennessee, LLC	MESALAMINE	375	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
43353-890_5e3b0779-f81b-410e-820e-5cd76dad6bf5	43353-890	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	20040106		ANDA	ANDA076698	Aphena Pharma Solutions - Tennessee, LLC	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
43353-893_280bbc43-14a1-47e0-a702-8cd8117c2978	43353-893	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20120822		ANDA	ANDA077714	Aphena Pharma Solutions - Tennessee, LLC	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
43353-898_cd1cd9aa-0533-401b-b257-7f3a814c7ff7	43353-898	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20091222		ANDA	ANDA076520	Aphena Pharma Solutions - Tennessee, LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43353-899_45cfd34d-08ac-40a8-95b3-21d3fea687c3	43353-899	HUMAN PRESCRIPTION DRUG	CHANTIX		varenicline tartrate	TABLET, FILM COATED	ORAL	20060510		NDA	NDA021928	Aphena Pharma Solutions - Tennessee, LLC	VARENICLINE TARTRATE	1	mg/1	Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
43353-916_2d3ce59f-9be8-43ca-bbf7-06ee7f55d047	43353-916	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Aphena Pharma Solutions - Tennessee, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43353-925_01f751d9-8907-4a54-b2e9-f57a8f150920	43353-925	HUMAN PRESCRIPTION DRUG	modafinil		modafinil	TABLET	ORAL	20120329		NDA AUTHORIZED GENERIC	NDA020717	Aphena Pharma Solutions - Tennessee, LLC	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
43353-931_5e3b0779-f81b-410e-820e-5cd76dad6bf5	43353-931	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	20041019		ANDA	ANDA076698	Aphena Pharma Solutions - Tennessee, LLC	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
43353-945_15c875e9-bc9e-4d06-83f5-0cc5c6742302	43353-945	HUMAN PRESCRIPTION DRUG	Alfuzosin hydrochloride		Alfuzosin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20121002		ANDA	ANDA090284	Aphena Pharma Solutions - Tennessee, LLC	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
43353-951_d644a3db-506a-4d45-9cd3-519871c90eb2	43353-951	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20080130		NDA AUTHORIZED GENERIC	NDA020482	Aphena Pharma Solutions - Tennessee, LLC	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
43353-953_7c7b8491-2291-48de-8b76-bf2eca6c9d9c	43353-953	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20140307		ANDA	ANDA075948	Aphena Pharma Solutions - Tennessee, LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
43353-955_ba04e9ec-26d0-4ec3-ba89-9443def0c189	43353-955	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20140117		ANDA	ANDA077745	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-957_ba04e9ec-26d0-4ec3-ba89-9443def0c189	43353-957	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20140117		ANDA	ANDA077745	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43353-958_451f0be0-8e23-4426-a62f-73540f6f2d73	43353-958	HUMAN OTC DRUG	Rugby Calcium Carbonate 10 gr		Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	CALCIUM CARBONATE	648	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43353-959_73131824-586d-4048-879b-a4d3b7cbdf30	43353-959	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA077575	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-960_88f5034d-3e54-49a5-b644-141e7bcdb7db	43353-960	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43353-961_39e1f574-b4d0-461a-9845-16f1ded3854a	43353-961	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Aphena Pharma Solutions - Tennessee, LLC	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43353-964_0d6fa0b8-bef8-42ff-8b4e-ea21b291a8e2	43353-964	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20140617		ANDA	ANDA076056	Aphena Pharma Solutions - Tennessee, LLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-965_d630cdd9-fe25-4ea6-8a1f-0100bb6e6cb5	43353-965	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE	ORAL	19880419		ANDA	ANDA071813	Aphena Pharma Solutions - Tennessee, LLC	OXAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-966_0d6fa0b8-bef8-42ff-8b4e-ea21b291a8e2	43353-966	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20140617		ANDA	ANDA077793	Aphena Pharma Solutions - Tennessee, LLC	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-969_e0078bdb-6976-4f1a-b2e8-c9c0fbc8360e	43353-969	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20020926		ANDA	ANDA085472	Aphena Pharma Solutions - Tennessee, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-970_1e0a30cf-a624-4b41-aa91-c6fde1419cdf	43353-970	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20071018		ANDA	ANDA077397	Aphena Pharma Solutions - Tennessee, LLC	SERTRALINE HYDROCHLORIDE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-973_80bec5c1-751e-453c-b882-3dd39f349ef5	43353-973	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20140206		ANDA	ANDA071523	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
43353-974_80bec5c1-751e-453c-b882-3dd39f349ef5	43353-974	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20140206		ANDA	ANDA071524	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
43353-975_45771ade-45bd-48c0-9895-f38ff79766e6	43353-975	HUMAN PRESCRIPTION DRUG	Lisinopril with Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20020708		ANDA	ANDA076265	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43353-978_c8f0373d-45aa-49dc-8436-4fc1a9304a57	43353-978	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20111107		ANDA	ANDA074625	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43353-979_2de88d7c-3a87-4803-9650-a44353888f5d	43353-979	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Aphena Pharma Solutions - Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43353-980_d630cdd9-fe25-4ea6-8a1f-0100bb6e6cb5	43353-980	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE	ORAL	19880419		ANDA	ANDA071814	Aphena Pharma Solutions - Tennessee, LLC	OXAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43353-981_73131824-586d-4048-879b-a4d3b7cbdf30	43353-981	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA077575	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-982_afc5f57d-e5ee-4eef-acb8-00c6fe16ce44	43353-982	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130911		ANDA	ANDA203769	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43353-984_ee9210aa-aedf-4658-bd12-0710ee2e54b8	43353-984	HUMAN PRESCRIPTION DRUG	Galantamine hydrobromide		Galantamine hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20091215		ANDA	ANDA079028	Aphena Pharma Solutions - Tennessee, LLC	GALANTAMINE HYDROBROMIDE	16	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43353-986_7eca20ff-75cb-402d-942a-7c4854718687	43353-986	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	20140220		ANDA	ANDA073457	Aphena Pharma Solutions - Tennessee, LLC	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43353-987_afc5f57d-e5ee-4eef-acb8-00c6fe16ce44	43353-987	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130911		ANDA	ANDA203769	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43353-988_f5549749-851b-4814-88d4-38c9b52bf35c	43353-988	HUMAN PRESCRIPTION DRUG	KLOR-CON M		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20140901		ANDA	ANDA074726	Aphena Pharma Solutions - Tennessee, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43353-989_0e9a9053-4baf-4549-864b-4a35c92a7e06	43353-989	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20071102		ANDA	ANDA077955	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43353-990_f5549749-851b-4814-88d4-38c9b52bf35c	43353-990	HUMAN PRESCRIPTION DRUG	KLOR-CON M		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20140901		ANDA	ANDA074726	Aphena Pharma Solutions - Tennessee, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43353-992_c5f2cabc-76b1-4a50-b42d-bb938af891cf	43353-992	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20120101		ANDA	ANDA090529	Aphena Pharma Solutions - Tennessee, LLC	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
43353-993_d4004fc6-9440-4480-be75-8baa53b96090	43353-993	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA075743	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43353-994_75709904-fa17-4f01-9568-53bb3e2f6e80	43353-994	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43353-995_ca06eda8-31b3-4f42-a57a-630656336e73	43353-995	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20140624		ANDA	ANDA075828	Aphena Pharma Solutions - Tennessee, LLC	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43353-998_9bef390d-c6c4-4961-b030-0da3aa5a106a	43353-998	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20130529		ANDA	ANDA091174	Aphena Pharma Solutions - Tennessee, LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
43353-999_484ad518-75e8-4281-a8f2-17d745567d44	43353-999	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	19731127		NDA AUTHORIZED GENERIC	NDA017386	Aphena Pharma Solutions - Tennessee, LLC	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
43374-457_884bb3ec-0ba1-4728-adaf-dcd806eba413	43374-457	HUMAN OTC DRUG	Handy San Instant Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20200204		OTC MONOGRAPH NOT FINAL	part333E	Delta Foremost Chemical Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
43374-876_6f5d8f4b-775a-4593-8657-f60c1077eb63	43374-876	HUMAN OTC DRUG	Sani Foam Mango Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20180621		OTC MONOGRAPH NOT FINAL	part333E	Delta Foremost Chemical Corporation	CHLOROXYLENOL	3	mg/mL			N	20241231
43376-322_5dc79cac-29be-48b8-9dd1-0613731abc9d	43376-322	HUMAN PRESCRIPTION DRUG	Fintepla		fenfluramine	SOLUTION	ORAL	20200715		NDA	NDA212102	UCB, Inc.	FENFLURAMINE	2.2	mg/mL			N	20241231
43386-016_d85013c6-896b-4d20-976c-3a583ab4ba7c	43386-016	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		DICLOFENAC SODIUM	SOLUTION	TOPICAL	20151209		ANDA	ANDA205878	Lupin Pharmaceuticals,Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43386-022_1b1a31b3-0c84-4961-a0a5-4e3abfbe3a75	43386-022	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET	ORAL	20160822		ANDA	ANDA207526	Lupin Pharmaceuticals,Inc.	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
43386-026_465101b9-6374-4ce8-b64d-97e296f5c72a	43386-026	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	20170721		ANDA	ANDA206003	Lupin Pharmaceuticals,Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43386-028_bd7c8e56-cd90-47bc-bd02-d14c1ca6170a	43386-028	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	SOLUTION	TOPICAL	20151123		ANDA	ANDA206075	Lupin Pharmaceuticals,Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43386-030_b1062fe4-a424-4354-a204-f4dcefe33bf4	43386-030	HUMAN PRESCRIPTION DRUG	Monobasic Sodium Phosphate and Dibasic Sodium Phosphate		Monobasic Sodium Phosphate and Dibasic Sodium Phosphate	TABLET	ORAL	20120120		ANDA	ANDA079247	Lupin Pharmaceuticals,Inc.	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.398; 1.105	g/1; g/1	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
43386-038_feb682f8-db23-48d3-9544-183c16f67462	43386-038	HUMAN PRESCRIPTION DRUG	VORICONAZOLE		voriconazole	POWDER, FOR SUSPENSION	ORAL	20160601		ANDA	ANDA206799	Lupin Pharmaceuticals,Inc.	VORICONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43386-050_4dc13bff-b31b-4c32-ae98-9c467824a93d	43386-050	HUMAN PRESCRIPTION DRUG	GAVILYTE-N		polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate	POWDER, FOR SOLUTION	ORAL	20090528		ANDA	ANDA090019	Lupin Pharmaceuticals,Inc.	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	420; 1.48; 5.72; 11.2	g/438.4g; g/438.4g; g/438.4g; g/438.4g	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
43386-060_7af81acb-3c86-4089-93dc-2cf9a6fac42a	43386-060	HUMAN PRESCRIPTION DRUG	GaviLyte - C	TM	polyethylene glycol-3350 and electrolytes with Flavor Pack	POWDER, FOR SOLUTION	ORAL	20090106		ANDA	ANDA090186	Lupin Pharmaceuticals,Inc.	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	240; 2.98; 6.72; 5.84; 22.72	g/278.26g; g/278.26g; g/278.26g; g/278.26g; g/278.26g	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43386-069_15764733-88e0-40bf-ac92-ff4e3e35b15d	43386-069	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	SOLUTION	TOPICAL	20150902		ANDA	ANDA206422	Lupin Pharmaceuticals,Inc.	FLUOCINOLONE ACETONIDE	.1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43386-071_98bd30c9-6c0a-3b78-e053-2a95a90ab268	43386-071	HUMAN PRESCRIPTION DRUG	GaviLyte-H and Bisacodyl		Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet	KIT	ORAL	20150421		ANDA	ANDA202217	Lupin Pharmaceuticals, Inc.						N	20241231
43386-080_8d66a9ba-050e-4993-939b-f2c858760a0c	43386-080	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		amlodipine and valsartan	TABLET	ORAL	20150330		ANDA	ANDA202829	Lupin Pharmaceuticals,Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43386-081_8d66a9ba-050e-4993-939b-f2c858760a0c	43386-081	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		amlodipine and valsartan	TABLET	ORAL	20150330		ANDA	ANDA202829	Lupin Pharmaceuticals,Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43386-082_8d66a9ba-050e-4993-939b-f2c858760a0c	43386-082	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		amlodipine and valsartan	TABLET	ORAL	20150330		ANDA	ANDA202829	Lupin Pharmaceuticals,Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43386-083_8d66a9ba-050e-4993-939b-f2c858760a0c	43386-083	HUMAN PRESCRIPTION DRUG	AMLODIPINE AND VALSARTAN		Amlodipine and Valsartan	TABLET	ORAL	20150330		ANDA	ANDA202829	Lupin Pharmaceuticals,Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43386-088_ebafe2b8-ea7d-405e-afb6-10063ef18bb9	43386-088	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20160524		ANDA	ANDA207371	Lupin Pharmaceuticals,Inc.	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43386-089_ebafe2b8-ea7d-405e-afb6-10063ef18bb9	43386-089	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20160524		ANDA	ANDA207371	Lupin Pharmaceuticals,Inc.	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43386-090_cccea25c-6192-418e-a9ee-d97be10e7c69	43386-090	HUMAN PRESCRIPTION DRUG	GAVILYTE G	TM	polyethylene glycol-3350 and Electrolytes	POWDER, FOR SOLUTION	ORAL	20090601		ANDA	ANDA090231	Lupin Pharmaceuticals,Inc.	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43386-096_370129be-84f5-4edf-b821-ffbad2db8c66	43386-096	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	OINTMENT	TOPICAL	20180602		ANDA	ANDA208841	Lupin Pharmaceuticals,Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43386-118_cc0b2769-2881-46f9-9da2-ca325419a432	43386-118	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		Hydrocodone Bitartrate and Homatropine Methylbromide	TABLET	ORAL	20140923		ANDA	ANDA091528	Lupin Pharmaceuticals,Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
43386-160_b702aa1b-6c21-e44f-e053-2995a90a16f2	43386-160	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20120725		ANDA	ANDA091667	Lupin Pharmaceuticals,Inc.	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
43386-161_b702aa1b-6c21-e44f-e053-2995a90a16f2	43386-161	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20120725		ANDA	ANDA091667	Lupin Pharmaceuticals,Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
43386-168_b48fb85d-87f5-0c70-e053-2a95a90a7011	43386-168	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20180924		ANDA	ANDA209786	Lupin Pharmaceuticals,Inc.	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43386-169_b48fb85d-87f5-0c70-e053-2a95a90a7011	43386-169	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20180924		ANDA	ANDA209786	Lupin Pharmaceuticals,Inc.	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43386-194_21b5a86c-0f40-42f0-8e47-05062ce1f1f8	43386-194	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	FOR SOLUTION	ORAL	20181121		ANDA	ANDA210241	Lupin Pharmaceuticals,Inc.	POTASSIUM CHLORIDE	1.5	g/1.54g			N	20241231
43386-280_fdfd69c8-d9ae-4e4d-8927-7221f9e5f604	43386-280	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	GEL	RECTAL	20231030		ANDA	ANDA091076	Lupin Pharmaceuticals,Inc.	DIAZEPAM	10	mg/2g	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43386-281_fdfd69c8-d9ae-4e4d-8927-7221f9e5f604	43386-281	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	GEL	RECTAL	20231030		ANDA	ANDA091076	Lupin Pharmaceuticals,Inc.	DIAZEPAM	20	mg/4g	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43386-312_19242eae-03a4-4e7d-96e0-f942ed594a32	43386-312	HUMAN OTC DRUG	GAVILAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA091077	Lupin Pharmaceuticals,Inc.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43386-330_d891933b-5900-48e9-820b-28f21e86b4bc	43386-330	HUMAN PRESCRIPTION DRUG	Trimethoprim		Trimethoprim	TABLET	ORAL	20110624		ANDA	ANDA091437	Lupin Pharmaceuticals,Inc.	TRIMETHOPRIM	100	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
43386-351_322b2034-bf51-4765-a52b-43e3a4062135	43386-351	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161114		ANDA	ANDA206142	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
43386-352_322b2034-bf51-4765-a52b-43e3a4062135	43386-352	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161114		ANDA	ANDA206142	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
43386-353_322b2034-bf51-4765-a52b-43e3a4062135	43386-353	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161114		ANDA	ANDA206142	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
43386-356_689e6dcd-1bea-4400-ae49-47589f86f983	43386-356	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
43386-357_689e6dcd-1bea-4400-ae49-47589f86f983	43386-357	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
43386-358_689e6dcd-1bea-4400-ae49-47589f86f983	43386-358	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA206245	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
43386-360_1eb0b695-ce65-45c2-914a-87bc2105b139	43386-360	HUMAN PRESCRIPTION DRUG	Phenelzine Sulfate		Phenelzine Sulfate	TABLET	ORAL	20101214		ANDA	ANDA200181	Lupin Pharmaceuticals,Inc.	PHENELZINE SULFATE	15	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
43386-371_dfb57dd5-18ce-4491-a8eb-a5659756114a	43386-371	HUMAN PRESCRIPTION DRUG	MERZEE		NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	KIT		20220309		ANDA	ANDA212706	Lupin Pharmaceuticals, Inc.						N	20241231
43386-405_0bccdf51-18f8-2f82-e063-6294a90ab438	43386-405	HUMAN PRESCRIPTION DRUG	N/A		nitazoxanide	TABLET	ORAL	20210217		NDA AUTHORIZED GENERIC	NDA021497	Lupin Pharmaceuticals, Inc.	NITAZOXANIDE	500	mg/1	Antiprotozoal [EPC]		N	20241231
43386-430_5fe9f019-fa7e-4ca8-ae55-a5ac54f1c7c4	43386-430	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170612		ANDA	ANDA204021	Lupin Pharmaceuticals,Inc.	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-431_5fe9f019-fa7e-4ca8-ae55-a5ac54f1c7c4	43386-431	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170612		ANDA	ANDA204021	Lupin Pharmaceuticals,Inc.	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-432_5fe9f019-fa7e-4ca8-ae55-a5ac54f1c7c4	43386-432	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170612		ANDA	ANDA204021	Lupin Pharmaceuticals,Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-433_5fe9f019-fa7e-4ca8-ae55-a5ac54f1c7c4	43386-433	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170612		ANDA	ANDA204021	Lupin Pharmaceuticals,Inc.	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-434_5fe9f019-fa7e-4ca8-ae55-a5ac54f1c7c4	43386-434	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170612		ANDA	ANDA204021	Lupin Pharmaceuticals,Inc.	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-450_361dd255-19ba-453f-9b68-ade3185ff390	43386-450	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20150521		ANDA	ANDA201693	Lupin Pharmaceuticals,Inc.	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
43386-480_acc89d6c-4fe3-4770-b71a-bc8f1e93564c	43386-480	HUMAN PRESCRIPTION DRUG	ORPHENADRINE CITRATE		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	Lupin Pharmaceuticals, Inc.	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43386-490_19826532-ae1f-490a-9122-6536b110f153	43386-490	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170224		ANDA	ANDA204407	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-491_19826532-ae1f-490a-9122-6536b110f153	43386-491	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170224		ANDA	ANDA204407	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-492_19826532-ae1f-490a-9122-6536b110f153	43386-492	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170224		ANDA	ANDA204407	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-493_19826532-ae1f-490a-9122-6536b110f153	43386-493	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170224		ANDA	ANDA204407	Lupin Pharmaceuticals,Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-500_82462011-668a-4fbd-9653-48049901eacc	43386-500	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	FOR SUSPENSION	ORAL	20121217		ANDA	ANDA201695	Lupin Pharmaceuticals,Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43386-530_b0de02c7-980a-4947-ae03-f5ef52a4b06f	43386-530	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	POWDER	TOPICAL	20140926		ANDA	ANDA065138	Lupin Pharmaceuticals,Inc.	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
43386-540_ac0a5db2-f086-4e60-9fca-537796ea535d	43386-540	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Lupin Pharmaceuticals,Inc.	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-541_ac0a5db2-f086-4e60-9fca-537796ea535d	43386-541	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Lupin Pharmaceuticals,Inc.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-542_ac0a5db2-f086-4e60-9fca-537796ea535d	43386-542	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Lupin Pharmaceuticals,Inc.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-543_ac0a5db2-f086-4e60-9fca-537796ea535d	43386-543	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Lupin Pharmaceuticals,Inc.	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-544_ac0a5db2-f086-4e60-9fca-537796ea535d	43386-544	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151216		ANDA	ANDA203602	Lupin Pharmaceuticals,Inc.	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-550_98a66e10-fb32-46ce-a68b-c21d615f6621	43386-550	HUMAN PRESCRIPTION DRUG	Tinidazole		Tinidazole	TABLET	ORAL	20120430		ANDA	ANDA202044	Lupin Pharmaceuticals,Inc.	TINIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
43386-551_98a66e10-fb32-46ce-a68b-c21d615f6621	43386-551	HUMAN PRESCRIPTION DRUG	Tinidazole		Tinidazole	TABLET	ORAL	20120430		ANDA	ANDA202044	Lupin Pharmaceuticals,Inc.	TINIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
43386-570_c9e22f02-1ba0-41b6-ad52-181d18094553	43386-570	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20150406		ANDA	ANDA204115	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-571_c9e22f02-1ba0-41b6-ad52-181d18094553	43386-571	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20150406		ANDA	ANDA204115	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-572_c9e22f02-1ba0-41b6-ad52-181d18094553	43386-572	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20150406		ANDA	ANDA204115	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-573_9d03ed16-df52-43d1-a625-afd549ad8ad0	43386-573	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20160120		ANDA	ANDA207884	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-574_9d03ed16-df52-43d1-a625-afd549ad8ad0	43386-574	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20151113		ANDA	ANDA207884	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-575_9d03ed16-df52-43d1-a625-afd549ad8ad0	43386-575	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20151113		ANDA	ANDA207884	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-580_b5844be2-94b3-3e3f-e053-2995a90a6eb8	43386-580	HUMAN PRESCRIPTION DRUG	METOCLOPRAMIDE hydrochloride		Metoclopramide Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20150406		ANDA	ANDA202191	Lupin Pharmaceuticals,Inc.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
43386-581_b5844be2-94b3-3e3f-e053-2995a90a6eb8	43386-581	HUMAN PRESCRIPTION DRUG	METOCLOPRAMIDE hydrochloride		Metoclopramide Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20150406		ANDA	ANDA202191	Lupin Pharmaceuticals,Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
43386-622_6dce7821-019c-4344-9634-5a51060920d5	43386-622	HUMAN OTC DRUG	My Way		Levonorgestrel	TABLET	ORAL	20130215		ANDA	ANDA202508	Lupin Pharmaceuticals,Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
43386-641_7d737d0f-6dfc-4860-85c3-db22d43c21bd	43386-641	HUMAN PRESCRIPTION DRUG	Nitrofurantoin macrocrystals		Nitrofurantoin macrocrystals	CAPSULE	ORAL	20180709		ANDA	ANDA203233	Lupin Pharmaceuticals,Inc.	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
43386-642_7d737d0f-6dfc-4860-85c3-db22d43c21bd	43386-642	HUMAN PRESCRIPTION DRUG	Nitrofurantoin macrocrystals		Nitrofurantoin macrocrystals	CAPSULE	ORAL	20180709		ANDA	ANDA203233	Lupin Pharmaceuticals,Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
43386-660_465b720e-d68d-4903-ad9c-1174af923f41	43386-660	HUMAN PRESCRIPTION DRUG	Trimethobenzamide Hydrochloride		Trimethobenzamide Hydrochloride	CAPSULE	ORAL	20110117		ANDA	ANDA076546	Lupin Pharmaceuticals,Inc.	TRIMETHOBENZAMIDE HYDROCHLORIDE	300	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
43386-680_c20cf8d7-480d-4d2a-aa35-6465d1dafa2e	43386-680	HUMAN PRESCRIPTION DRUG	PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE		pentazocine hydrochloride and naloxone hydrochloride	TABLET	ORAL	20110511		ANDA	ANDA075735	Lupin Pharmaceuticals,Inc.	NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE	.5; 50	mg/1; mg/1	Competitive Opioid Antagonists [MoA], Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
43386-700_58ceb74b-a538-476d-a326-98ef0128a4c2	43386-700	HUMAN PRESCRIPTION DRUG	SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE		sodium sulfate, potassium sulfate, magnesium sulfate	SOLUTION	ORAL	20221230		ANDA	ANDA202511	Lupin Pharmaceuticals, Inc.	MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE	1.6; 3.13; 17.5	g/177mL; g/177mL; g/177mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43386-710_1f5e9cdc-ae57-4198-bb48-bd31efe86921	43386-710	HUMAN PRESCRIPTION DRUG	Quinapril HCL and Hydrochlorothiazide		Quinapril HCl and Hydrochlorothiazide	TABLET	ORAL	20110715		ANDA	ANDA076374	Lupin Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43386-711_1f5e9cdc-ae57-4198-bb48-bd31efe86921	43386-711	HUMAN PRESCRIPTION DRUG	Quinapril HCL and Hydrochlorothiazide		Quinapril HCL and Hydrochlorothiazide	TABLET	ORAL	20110715		ANDA	ANDA076374	Lupin Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43386-712_1f5e9cdc-ae57-4198-bb48-bd31efe86921	43386-712	HUMAN PRESCRIPTION DRUG	Quinapril HCL and Hydrochlorothiazide		Quinapril HCL and Hydrochlorothiazide	TABLET	ORAL	20110715		ANDA	ANDA076374	Lupin Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43386-761_b4684db4-fae2-5bc4-e053-2995a90a9cd1	43386-761	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	SUBLINGUAL	20160322		ANDA	ANDA204299	Lupin Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	3.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
43386-762_b4684db4-fae2-5bc4-e053-2995a90a9cd1	43386-762	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	SUBLINGUAL	20160322		ANDA	ANDA204299	Lupin Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	1.75	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
43386-770_23a1fa95-2d66-4e32-8dc6-ebfdb0fcac56	43386-770	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170707		ANDA	ANDA204652	Lupin Pharmaceuticals,Inc.	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
43386-771_23a1fa95-2d66-4e32-8dc6-ebfdb0fcac56	43386-771	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170707		ANDA	ANDA204652	Lupin Pharmaceuticals,Inc.	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
43386-790_0e276990-d1f0-43bb-8719-a5ddf616a201	43386-790	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20150708		ANDA	ANDA204446	Lupin Pharmaceuticals,Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43386-791_0e276990-d1f0-43bb-8719-a5ddf616a201	43386-791	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20150708		ANDA	ANDA204446	Lupin Pharmaceuticals,Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43386-792_0e276990-d1f0-43bb-8719-a5ddf616a201	43386-792	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20150708		ANDA	ANDA204446	Lupin Pharmaceuticals,Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43386-794_b48f9004-a576-5592-e053-2995a90a99fa	43386-794	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20170906		ANDA	ANDA207558	Lupin Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43386-860_b1300c71-14cf-482b-9f82-089e5d084939	43386-860	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20151204		ANDA	ANDA204534	Lupin Pharmaceuticals,Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-861_b1300c71-14cf-482b-9f82-089e5d084939	43386-861	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20151204		ANDA	ANDA204534	Lupin Pharmaceuticals,Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-862_b1300c71-14cf-482b-9f82-089e5d084939	43386-862	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20151204		ANDA	ANDA204534	Lupin Pharmaceuticals,Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-870_5ddb144c-152e-40ee-90ba-b01c91beb079	43386-870	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		dextroamphetamine sulfate	TABLET	ORAL	20160425		ANDA	ANDA204330	Lupin Pharmaceuticals,Inc.	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-871_5ddb144c-152e-40ee-90ba-b01c91beb079	43386-871	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		dextroamphetamine sulfate	TABLET	ORAL	20160425		ANDA	ANDA204330	Lupin Pharmaceuticals,Inc.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-915_5dc49f2a-1ad4-40d2-a648-8a9962a2c7bf	43386-915	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20160121		ANDA	ANDA206347	Lupin Pharmaceuticals,Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43386-917_5dc49f2a-1ad4-40d2-a648-8a9962a2c7bf	43386-917	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20160121		ANDA	ANDA206347	Lupin Pharmaceuticals,Inc.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43386-920_2ced98b8-fe3a-4a25-bdd1-ee168a30f428	43386-920	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20150429		ANDA	ANDA204603	Lupin Pharmaceuticals, Inc.	OXYCODONE HYDROCHLORIDE	20	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43386-930_69b5f215-076c-47d1-9250-1406016a5679	43386-930	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20151215		ANDA	ANDA204602	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-931_69b5f215-076c-47d1-9250-1406016a5679	43386-931	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20151215		ANDA	ANDA204602	Lupin Pharmaceuticals,Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43386-980_7b3079e3-d9db-41aa-886f-a9f95a828437	43386-980	HUMAN PRESCRIPTION DRUG	Carbidopa		Carbidopa	TABLET	ORAL	20171020		ANDA	ANDA204763	Lupin Pharmaceuticals,Inc.	CARBIDOPA	25	mg/1			N	20241231
43386-999_231fb8b5-e1b6-4ef7-bc2c-e895eea40b0d	43386-999	HUMAN PRESCRIPTION DRUG	cevimeline hydrochloride		cevimeline hydrochloride	CAPSULE	ORAL	20161230		ANDA	ANDA204746	Lupin Pharmaceuticals,Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
43393-001_f827a5f5-c021-61dd-e053-6294a90a94d9	43393-001	HUMAN PRESCRIPTION DRUG	Mifepristone		MIFEPRISTONE	TABLET	ORAL	20190501		ANDA	ANDA091178	GenBioPro, Inc.	MIFEPRISTONE	200	mg/1	Progestational Hormone Receptor Antagonists [MoA], Progestin Antagonist [EPC]		N	20241231
43393-020_0e8b8238-a4ba-e017-e063-6294a90ae331	43393-020	HUMAN PRESCRIPTION DRUG	misoprostol		MISOPROSTOL	TABLET	ORAL	20091227		NDA AUTHORIZED GENERIC	NDA019268	GenBioPro, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20251231
43393-022_0e8b81be-bfc1-dbb2-e063-6294a90a2ccf	43393-022	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20200427		ANDA	ANDA091667	GenBioPro, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20251231
43393-023_f19b951f-2e45-7072-e053-2a95a90ac730	43393-023	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20230101		ANDA	ANDA076095	GenBioPro, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
43405-005_da33ae72-a960-2252-e053-2a95a90aa90c	43405-005	HUMAN OTC DRUG	Eagle	Medicated	Menthol Methyl Salicylate	OIL	TOPICAL	20220304		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	MENTHOL; METHYL SALICYLATE	14.5; 30	g/100mL; g/100mL			N	20241231
43405-006_da340970-8286-8065-e053-2a95a90a57b3	43405-006	HUMAN OTC DRUG	Eagle	Medicated	Menthol Methyl Salicylate	OIL	TOPICAL	20220304		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	MENTHOL; METHYL SALICYLATE	14.5; 30	g/100mL; g/100mL			N	20241231
43405-007_88c76656-03a4-00ca-e053-2995a90af739	43405-007	HUMAN OTC DRUG	Muscular Balm		Capsaicin Menthol Methyl Salicylate	OINTMENT	TOPICAL	20100514		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.15; 13.5; 30	g/100g; g/100g; g/100g			N	20241231
43405-008_e2c5fde2-6887-6cb6-e053-2995a90a6714	43405-008	HUMAN OTC DRUG	Eagle	Medicated	Menthol Methyl Salicylate	OIL	TOPICAL	20120514		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	MENTHOL; METHYL SALICYLATE	14.5; 30	g/100mL; g/100mL			N	20241231
43405-009_e2ade1eb-0759-40aa-e053-2a95a90a3166	43405-009	HUMAN OTC DRUG	Eagle	Medicated Aromatic	Camphor Menthol Methyl Salicylate	OIL	TOPICAL	20150615		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	7; 16; 35	g/100mL; g/100mL; g/100mL			N	20241231
43405-010_eade2db4-2ba6-6004-e053-2a95a90aac62	43405-010	HUMAN OTC DRUG	Eagle	Extra Strength	Menthol Methyl Salicylate	LIQUID	TOPICAL	20150615		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	MENTHOL; METHYL SALICYLATE	14.5; 30	g/100mL; g/100mL			N	20241231
43405-011_08810cb0-6728-851a-e063-6294a90a53df	43405-011	HUMAN OTC DRUG	Eagle Brand	Muscle Rub	menthol, methyl salicylate	LIQUID	TOPICAL	20150515		OTC MONOGRAPH DRUG	M017	Borden Company (Private) Limited	MENTHOL; METHYL SALICYLATE	14.5; 30	g/100mL; g/100mL			N	20241231
43405-012_091451fb-e30b-0012-e063-6394a90a3ba8	43405-012	HUMAN OTC DRUG	Eagle Brand	Medicated Roll On Refresh	camphor, menthol	OIL	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Borden Company (Private) Limited	CAMPHOR (SYNTHETIC); MENTHOL	2.2; 14	g/100mL; g/100mL			N	20251231
43405-013_09243a23-1f18-f77b-e063-6394a90a0b22	43405-013	HUMAN OTC DRUG	Eagle Brand	Medicated Oil Refresh	camphor, menthol	OIL	TOPICAL	20231102		OTC MONOGRAPH DRUG	M017	Borden Company (Private) Limited	CAMPHOR (SYNTHETIC); MENTHOL	2.2; 14	g/100mL; g/100mL			N	20251231
43405-100_d00c5e1f-d869-c713-e053-2995a90ae49c	43405-100	HUMAN OTC DRUG	Eagle Green Balm		Camphor Menthol	OINTMENT	TOPICAL	20180514		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	CAMPHOR (SYNTHETIC); MENTHOL	11; 15	g/100g; g/100g			N	20241231
43405-102_e2ad1ff6-5ad7-0e1b-e053-2995a90a87fe	43405-102	HUMAN OTC DRUG	Eagle Medicated Oil	Refreshing	Menthol, Methyl Salicylate	OIL	TOPICAL	20210630		OTC MONOGRAPH NOT FINAL	part348	Borden Company (Private) Limited	MENTHOL; METHYL SALICYLATE	14; 15	g/100mL; g/100mL			N	20241231
43406-0001_590b80f7-4981-401e-b093-31510ac26afe	43406-0001	HUMAN OTC DRUG	ACNE HP		Carbo Animalis, Activated Charcoal, Potassium Dichromate, Sodium Chloride, Pulsatilla Vulgaris, Sepia Officinalis Juice, Silicon Dioxide, Sulfur, Zinc	LIQUID	ORAL	20160101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ACTIVATED CHARCOAL; CARBO ANIMALIS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS WHOLE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR; ZINC	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0002_398bc8c6-6c14-4776-bfc3-c9ce188fab3b	43406-0002	HUMAN OTC DRUG	Allergy HP		Onion, Ambrosia Artemisiifolia, Arsenic Trioxide, Activated Charcoal, Euphrasia Stricta, Strychnos Nux-Vomica Seed, Pulsatilla Vulgaris, Solidago Virgaurea Flowering Top, Sulfur	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ACTIVATED CHARCOAL; AMBROSIA ARTEMISIIFOLIA; ARSENIC TRIOXIDE; EUPHRASIA STRICTA; ONION; PULSATILLA VULGARIS; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
43406-0003_5650ff86-26eb-47a3-8d31-4051c8038fde	43406-0003	HUMAN OTC DRUG	Anxiety HP		Arsenic Trioxide, Calcium Carbonate, Strychnos Ignatii Seed, Potassium Carbonate, Lachesis Muta Venom, Sodium Chloride, Phosphorus, Pulsatilla	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE; CALCIUM CARBONATE; LACHESIS MUTA VENOM; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
43406-0004_38647534-fc40-4494-86d4-a5014f5034ab	43406-0004	HUMAN OTC DRUG	ANXIETY II HP		Aconitum Napellus, Arsenic Trioxide, Atropa Belladonna, Oyster Shell Calcium Carbonate, Crude, Activated Charcoal, Human Breast Tumor Cell, Causticum, Gelsemium Sempervirens Root, Lachesis Muta Venom, Mercury, Sodium Chloride, Nitric Acid, Phosphorus, Toxicodendron Pubescens Leaf	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ACONITUM NAPELLUS WHOLE; ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAUSTICUM; GELSEMIUM SEMPERVIRENS ROOT; HUMAN BREAST TUMOR CELL; LACHESIS MUTA VENOM; MERCURY; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0005_bb9fa20b-f24f-4753-a050-7a2aaf1fe980	43406-0005	HUMAN OTC DRUG	Arthritis HP		Apis Mellifera, Bryonia Alba Root, Causticum, Colchicum Autumnale Bulb, Kalmia Latifolia Leaf, Ledum Palustre Twig, Pulsatilla Vulgaris, Rhododenron Aureum LEaf, Toxicodendren Pubescens Leaf	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	APIS MELLIFERA; BRYONIA ALBA ROOT; CAUSTICUM; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; PULSATILLA VULGARIS; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43406-0010_a0376a11-bb91-4172-aefd-e11e97ec9355	43406-0010	HUMAN OTC DRUG	Bronchi HP		Activated Charcoal, Copper, Drosera Rotundifolia, Ipecac, Lachesis Muta Venom, Lobelia Inflata, Phosphorus, Pulsatilla Vulgaris, Rumex Crispus Root, Spongia Officinalis Skeleton, Roasted	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ACTIVATED CHARCOAL; COPPER; DROSERA ROTUNDIFOLIA; IPECAC; LACHESIS MUTA VENOM; LOBELIA INFLATA; PHOSPHORUS; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
43406-0014_bcc9b7d6-9ae7-40ea-874c-83f68f707c84	43406-0014	HUMAN OTC DRUG	Cough HP		Arsenicum Album, Bryonia Alba, Cuprum Acenticum, Drosera Rotundifolia, Ipecacuanha, Kali Carbonicum, Phosphorus, Pulsatilla, Spongia Tosta	LIQUID	ORAL	20011005		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CUPRIC ACETATE; DROSERA ROTUNDIFOLIA; IPECAC; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0015_93c2392d-93e4-4f7e-bf8d-c9d99572eb26	43406-0015	HUMAN OTC DRUG	CYSTOGES HP		Berberis Vulgaris Root Bark, Lytta Vesicatoria, Clematis Recta Flowering Top, Canis Lupus Familiaris Milk, Lycopodium Clavatum Spore, Pulsatilla Vulgaris, Sarsaparilla, Sepia Officinalis Juice, Delphinium Staphysagria Seed	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	BERBERIS VULGARIS ROOT BARK; CANIS LUPUS FAMILIARIS MILK; CLEMATIS RECTA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULSATILLA VULGARIS; SARSAPARILLA; SEPIA OFFICINALIS JUICE	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0017_48eb5948-1092-401e-bd95-fab236ddd06c	43406-0017	HUMAN OTC DRUG	DIZZINESS HP		Oyster Shell Calcium Carbonate Crude, Chenopodium Ambrosioides, Anamirta Cocculus Seed, Conium Maculatum Flowering Top, Strychnos Nux-Vomica Seed, Phosphorus, Pulsatilla Vulgaris, Silicon Dioxide	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANAMIRTA COCCULUS SEED; CHENOPODIUM AMBROSIOIDES; CONIUM MACULATUM FLOWERING TOP; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PULSATILLA VULGARIS; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0019_899a9516-b5ed-40d2-a044-a2cb4ddbc91a	43406-0019	HUMAN OTC DRUG	ECZEMA HP		Arsenic Trioxide 30X, Oyster Shell Calcium Carbonate, Crude 30X, Graphite 30X, Mercurius Solubilis 30X, Daphne Mezereum Bark 30X, Toxicodendron Pubescens Leaf 30X, Sepia Officinalis Juice 30X, Sulfur 30X	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE; DAPHNE MEZEREUM BARK; GRAPHITE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SULFUR; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0022_95c3991f-0887-4724-96fd-d69e8fc88556	43406-0022	HUMAN OTC DRUG	FLU HP		Aconitum Napellus, Arsenic Trioxide, Atropa Belladonna, Bryonia Alba Root, Eupatorium Perfoliatum Flowering Top, Ferrum Phosphoricum, Gelsemium Sempervirens Root	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERRUM PHOSPHORICUM; GELSEMIUM SEMPERVIRENS ROOT	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0025_7f7ac7fe-6a84-401c-abc0-9cddce1578cf	43406-0025	HUMAN OTC DRUG	HEADACHE HP		Silver Nitrate, Atropa Belladonna, Bryonia Alba Root, Gelsemium Sempervirens Root, Nitroglycerin, Lachesis Muta Venom, Lycopodium Clavatum Spore, Melilotus Officinalis Top, Sodium Chloride, Strychnos Nux-Vomica Seed, Silicon Dioxide, Spigelia Anthelmia	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ATROPA BELLADONNA; BRYONIA ALBA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MELILOTUS OFFICINALIS TOP; NITROGLYCERIN; SILICON DIOXIDE; SILVER NITRATE; SODIUM CHLORIDE; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
43406-0030_74ef510e-bc36-4f86-a0c6-51b9a5fb30f5	43406-0030	HUMAN OTC DRUG	MENOPAUSE HP		Atropa Belladonna, Black Cohosh, Lachesis Muta Venom, Strychnos Nux-Vomica Seed, Pulsatilla Vulgaris, Claviceps Purpurea Sclerotium, Sepia Officinalis Juice, Ustilago Maydis	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ATROPA BELLADONNA; BLACK COHOSH; CLAVICEPS PURPUREA SCLEROTIUM; LACHESIS MUTA VENOM; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; USTILAGO MAYDIS	30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0032_49646136-db1f-44a2-9b5e-4ed490793bd0	43406-0032	HUMAN OTC DRUG	NAUSEA VOMITING HP		Arsenic Trioxide, Anamirta Cocculus Seed, Ipeca, Wood Creasote, Kerosene, Pulsatilla Vulgaris, Sanguinaria Candensis Root, Tobacco Leaf	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANAMIRTA COCCULUS SEED; ARSENIC TRIOXIDE; IPECAC; KEROSENE; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; TOBACCO LEAF; WOOD CREOSOTE	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43406-0040_6615c08b-6408-42a7-ae49-a273f8c3e148	43406-0040	HUMAN OTC DRUG	PSORIASIS HP		Arsenicum Album, Arsenicum Iodatum, Borax, Calcarea Carbonica, Graphites, Mezereum, Proteus, Natrum Muriaticum, Phytolacca Decandra, Sepia, Silicea, Sulphur, Thyroidinum	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIIODIDE; ARSENIC TRIOXIDE; DAPHNE MEZEREUM BARK; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PROTEUS MORGANII; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CHLORIDE; SULFUR; THYROID, UNSPECIFIED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0043_1fe8f783-fdaa-4b04-bc17-3020faf440f0	43406-0043	HUMAN OTC DRUG	SCROPHULOUS HP		Barium Carbonate, Bromine, Oyster Shell Calcium Carbonate, Crude, Conium Maculatum Flowering Top, Ferrous Iodide, Mercurius Solubilis, Phytolacca Americana Root, Toxicodendron Pubescens Leaf, Silicon Dioxide	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	BARIUM CARBONATE; BROMINE; CONIUM MACULATUM FLOWERING TOP; FERROUS IODIDE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0045_07cd0eaa-0ce7-41ca-8400-c2252e529a87	43406-0045	HUMAN OTC DRUG	SINUS HP		Ambrosia Artemisiifolia, Arsenic Trioxide, Calcium Sulfide, Potassium Dichromate, Potassium Sulfate, Lycopodium Clavatum Spore, Mercurius Solubilis, Sodium Chloride, Phosphorus, Pulsatilla Vulgaris, Sepia Officinalis Juice, Silicon Dioxide, Thuja Occidentalis Leafy Twig	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	AMBROSIA ARTEMISIIFOLIA; ARSENIC TRIOXIDE; CALCIUM SULFIDE; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; PHOSPHORUS; POTASSIUM DICHROMATE; POTASSIUM SULFATE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
43406-0052_73a14648-c607-4bca-9500-43d5ac185fa4	43406-0052	HUMAN OTC DRUG	VIRAL HP		Arsenic Trioxide, Atropa Belladonna, Echinacea Angustifolia, Eupatorium Perfoliatum Flowering Top, Gelsemium Sempervirens Root, Lycopodium Clavatum Spore, Phosphoric Acid, Phosphorus, Rancid Beef, Toxicodendron Pubescens Leaf	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0053_5affda02-cfef-481d-934d-45549c0afe1e	43406-0053	HUMAN OTC DRUG	Weight Management HP		Arsenic Trioxide, Gold, Oyster Shell Calcium Carbonate, Crude, Iodine, Lycopodium Clavatum Spore, Sodium Chloride, Strychnos Nux-Vomica Seed, Phosphoric Acid, Phosphorus, Phytolacca Americana Root, Pulsatilla Vulgaris, Sepia Officinalis Juice, Sulfur	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE; GOLD; IODINE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43406-0056_d01271a6-becf-465b-86d6-1e4c51f97f0d	43406-0056	HUMAN OTC DRUG	COLIC CP		Aethusa Cynapium, Aluminum Oxide, Bryonia Alba Root, Oyster Shell Calcium Carbonate Crude, Matricaria Recutita, Lycopodium Clavatum Spore, Phosphorus, Anemone Pulsatilla, Silicon Dioxide, Sulfur.	LIQUID	ORAL	20100101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	AETHUSA CYNAPIUM; ALUMINUM OXIDE; ANEMONE PULSATILLA; BRYONIA ALBA ROOT; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SILICON DIOXIDE; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0057_384d29dc-dfcd-445d-acf8-d00397950a18	43406-0057	HUMAN OTC DRUG	CONSTIPATION CP		Aluminum Oxide, Bryonia Alba Root, Matricaria Recutita, Graphite, Lycopodium Clavatum Spore, Strychnos Nux-Vomica Seed, Silicon Dioxide, Sulfur, Sodium Chloride, Magnesium Chloride, Lead, Sepia Officinalis Juice.	LIQUID	ORAL	20100101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ALUMINUM OXIDE; BRYONIA ALBA ROOT; GRAPHITE; LEAD; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; MATRICARIA RECUTITA; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43406-0058_1de2deb3-d795-4b70-9a97-7296fe274c76	43406-0058	HUMAN OTC DRUG	CROUP CP		Aconitum Napellus, Calcarea Carbonica, Hepar Sulphuris Calcareum, Lachesis Mutus, Lycopodium Clavatum, Phosphorus, Pulsatilla, Sambucus Nigra, Spongia Tosta, Sulphur	LIQUID	ORAL	20020401		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACONITUM NAPELLUS; ANEMONE PULSATILLA; CALCIUM SULFIDE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP; SPONGIA OFFICINALIS SKELETON, ROASTED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0059_91998650-6631-4908-aeba-93743def92b9	43406-0059	HUMAN OTC DRUG	DIARRHEA CP		Aethusa Cynapium, Arsenic Trioxide, Oyster Shell Calicum Carbonate, Crude, Matricaria Chamomilla, Citrullus Colocynthis Fruit Pulp, Iron, Lycopodium Clavatum Spore, Mercurius Solobilis, Phosphorus, Podophyllum, Anemone Pulsatilla, Delphinium Straphisagria Seed, Sulfur	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	AETHUSA CYNAPIUM; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; DELPHINIUM STAPHISAGRIA SEED; IRON; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PODOPHYLLUM; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0063_b437fc67-3676-4895-a260-07869184f172	43406-0063	HUMAN OTC DRUG	Nausea CP		Aethusa Cynapium, Antimon Tart, Arsenicum Alb, Calc Carb, Chamomilla, Cinchona, Coccus, Cuprum Met, Ferrum Met, Ipecac, Kreosotum, Lycopodium, Petroleum, Pulsatilla, Silicea, Sulphur	LIQUID	ORAL	20130111		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	AETHUSA CYNAPIUM WHOLE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; COPPER; IPECAC; IRON; KEROSENE; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PROTORTONIA CACTI; PULSATILLA VULGARIS WHOLE; SILICON DIOXIDE; SULFUR; WOOD CREOSOTE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
43406-0089_a0657d2e-f195-4069-a835-874780641d3c	43406-0089	HUMAN OTC DRUG	Respirasode		Bryonia, Dulcamara, Kali Carb, Sanguinaria, Belladonna, Bromium, Candida Alb, Candida Parap, Conium, Lycopodium, Pulsatilla, Secale, Silicea, Sticta, Sulphur, Ustilago Maidis	LIQUID	ORAL	20120522		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ATROPA BELLADONNA; BROMINE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; LOBARIA PULMONARIA; LYCOPODIUM CLAVATUM SPORE; POTASSIUM CARBONATE; PULSATILLA VULGARIS WHOLE; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; SULFUR; USTILAGO MAYDIS	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43406-0093_75d3ece7-67a9-486f-9eb3-c013428b5e05	43406-0093	HUMAN OTC DRUG	Influenzinum		Influenzinum	LIQUID	ORAL	20010901		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) WHOLE; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) WHOLE; INFLUENZA B VIRUS B/IOWA/06/2017 WHOLE; INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE	1; 1; 1; 1	[hp_M]/mL; [hp_M]/mL; [hp_M]/mL; [hp_M]/mL			N	20241231
43406-0094_5328d876-9175-4106-b6b3-99ca92367c92	43406-0094	HUMAN OTC DRUG	KALI IODATUM 1X		Potassium Iodide	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	POTASSIUM IODIDE	1	[hp_X]/mL			N	20241231
43406-0099_2779f075-075c-413a-b4a9-e8e0f4c2d586	43406-0099	HUMAN OTC DRUG	MOTION SICKNESS HP		Arnica Montana, Bryonia Alba Root, Quinine Sulfate, Anamirta Cocculus Seed, Conium Maculatum Flowering Top, Strychnos Ignatii Seed, Ipecac, Potassium Carbonate, Strychnos Nux-Vomica Seed, Sepia Officinalis Juice, Tobacco Leaf, Veratrum Album Root	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANAMIRTA COCCULUS SEED; ARNICA MONTANA; BRYONIA ALBA ROOT; CONIUM MACULATUM FLOWERING TOP; IPECAC; POTASSIUM CARBONATE; QUININE SULFATE; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; VERATRUM ALBUM ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0100_adacf002-ce24-4cc2-9100-0bf490883941	43406-0100	HUMAN OTC DRUG	Weed Grass Antigen		Alopecurus Pratensis, Anthoxanthum, Cynodon, Melilotus Off, Phleum Pratense, Rumex Crisp, Secale Cereale, Solidago, Triticum Vulgare, Allium Cepa, Ambrosia, Arsenicum Alb, Nux Vomica, Pulsatilla	LIQUID	ORAL	20140718		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ALOPECURUS PRATENSIS; AMBROSIA ARTEMISIIFOLIA WHOLE; ANTHOXANTHUM ODORATUM WHOLE; ARSENIC TRIOXIDE; CYNODON DACTYLON WHOLE; MELILOTUS OFFICINALIS TOP; ONION; PHLEUM PRATENSE POLLEN; PULSATILLA VULGARIS WHOLE; RUMEX CRISPUS ROOT; SECALE CEREALE WHOLE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; WHEAT BRAN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
43406-0102_996160a6-4f76-4ae3-af2b-1e6bafbc4592	43406-0102	HUMAN OTC DRUG	Nasal		Arsenicum Album, Euphorbium Officinarum, Hepar Sulphuris Calcareum, Histaminum, Iodium, Lycopodium, Pulsatilla	LIQUID	ORAL	20110921		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; CALCIUM SULFIDE; EUPHORBIA RESINIFERA RESIN; HISTAMINE DIHYDROCHLORIDE; IODINE; LYCOPODIUM CLAVATUM SPORE	12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0106_62cd6b32-878a-4cd6-9305-b9e7da76498f	43406-0106	HUMAN OTC DRUG	ALLERGY NEW ENGLAND MIX		Betula Pubescens Bark, Artemisia Vulgaris Pollen, Plantago Lanceolata Pollen, Acer Pseudoplatanus Pollen, Betula Pubescens Bark, Evernia Prunastri Bark, Armaranthus Retroflexus Pollen, Pinus Massoniana Pollen, Tabuliformis Pollen, Ambrosia Artemisifolia Pollen,	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ACER PSEUDOPLATANUS POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; ARTEMISIA VULGARIS POLLEN; BETULA PUBESCENS BARK; EVERNIA PRUNASTRI; JUNIPERUS VIRGINIANA POLLEN; MORUS RUBRA POLLEN; PINUS MASSONIANA POLLEN; PINUS TABULIFORMIS POLLEN; PLANTAGO LANCEOLATA POLLEN; POPULUS ALBA POLLEN; RUMEX ACETOSELLA POLLEN	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Chemical Allergen [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
43406-0111_672a8322-35b1-4039-9191-09561dbacd1b	43406-0111	HUMAN OTC DRUG	RESCUE		Clematis Vitalba Flos, Helianthemum Nummularium Flos, Impatiens Glandulifera Flos, Ornithogalum Umbellatum Flos, Prunus Cerasifera Flos	LIQUID	ORAL	20100528		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER	200; 200; 200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0114_476b2f05-4797-4c56-b737-faef0e415697	43406-0114	HUMAN OTC DRUG	BITING INSECT ANTIGEN		Apis Mellifera, Arnica Montana, Blatta Orientalis, Dieffenbachia Seguine, Cimex Lectularius, Culex Pipiens, Formica Rufa, Hypericum Perforatum, Latrodectus Mactans, Ledum Palustre Twig, Loxosceles Reclusa, Pediculus Humanus Var. Capitis, Pulex Irritans, Delphinium Staphisagria Seed, Vespa Crabro.	LIQUID	ORAL	20100101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	APIS MELLIFERA; ARNICA MONTANA; BLATTA ORIENTALIS; CIMEX LECTULARIUS; CULEX PIPIENS; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; FORMICA RUFA; HYPERICUM PERFORATUM; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; LOXOSCELES RECLUSA; PEDICULUS HUMANUS VAR. CAPITIS; PULEX IRRITANS; VESPA CRABRO	12; 30; 30; 30; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43406-0120_a395af16-2095-4b8a-896f-7f91cd693cbe	43406-0120	HUMAN OTC DRUG	Fungus Nosode		Achorion Scho, Alternaria Alt, Aspergillus Fum, Aspergillus Niger, Boletus Sat, Botrytis Cin, Candida Parap, Cladosporium Met, Fusarium Oxy, Helminthosporium Sat, Microsporon Fur, Mucor Muecedo, Pullularia Pull, Rhizopus Nig, Saccharomyces Cer, Trichophyton Spp, Ustilago Maydis	LIQUID	ORAL	20111215		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOLETUS SATANAS FRUITING BODY; BOTRYTIS CINEREA; CANDIDA PARAPSILOSIS; COCHLIOBOLUS SATIVUS; EPIDERMOPHYTON FLOCCOSUM; FUSARIUM OXYSPORUM; HORTAEA WERNECKII; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE RNA; TRICHOPHYTON SCHOENLEINII; USTILAGO MAYDIS	200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43406-0124_3d257ccd-5bd0-462c-a9b3-76b7224f484e	43406-0124	HUMAN OTC DRUG	CENTROCODE		American Ginseng, Adenosine Triphosphate, Corticotropin, Alfalfa, Bos Taurus Hypothalamus, Phytolacca Americana Root, Bos Taurus Pituitary Gland Posterior, Thyroid Unspecified, Iodine, Silicon Dioxide, Oster Shell Calcium Carbonate Crude, Strychnos Ignatii Seed, Iridium, Lachesis Muta Venom, Lycopodium Clavatum Spore, Sodium Chloride, Strychnos Nux-Vomica Seed, Phosphorus, Selenium, Uranyl Nitrate Hexahydrate.	LIQUID	ORAL	20100101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ADENOSINE TRIPHOSPHATE; ALFALFA; AMERICAN GINSENG; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND, POSTERIOR; CORTICOTROPIN; IODINE; IRIDIUM; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; SELENIUM; SILICON DIOXIDE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; URANYL NITRATE HEXAHYDRATE	6; 6; 3; 6; 6; 6; 12; 30; 30; 30; 30; 30; 6; 30; 12; 30; 30; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0128_44b218c1-de39-4783-9aae-35680ad388e5	43406-0128	HUMAN PRESCRIPTION DRUG	ANIMAL ANTIGEN		FelisCatusHair,BosTaurusHair,BosTaurusSkin,GallusGallusFeather,CanisLupusFamiliarisSkin,CanisFamiliarisHair,AnasPlatyrhynchosFeather,AnserAnserFeather,CaviaPorcellusHair,CaviaPorcellusSkin,MesocricetusAuratusHair,MesocricetusAuratusSkin,SusScrofaHair,SusScrofaSkin,EquusCaballusHair,EquusCaballusDander,MusMusculusHair,MusMusculuasSkin,OryctolagusCuniculusSkin,OryctolagusCuniculusHair,OvisAriesWhole,MeleagrisGallopavoFeather,ArsenicTrioxide,BlattaOrientalis,StrychnosNux-VomicaSeed,Phosphorus,Pulsatilla,Sulfur	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANEMONE PULSATILLA; ANSER ANSER FEATHER; ARSENIC TRIOXIDE; BLATTA ORIENTALIS; BOS TAURUS HAIR; BOS TAURUS SKIN; CANIS LUPUS FAMILIARIS HAIR; CANIS LUPUS FAMILIARIS SKIN; CAVIA PORCELLUS HAIR; CAVIA PORCELLUS SKIN; EQUUS CABALLUS DANDER; EQUUS CABALLUS HAIR; FELIS CATUS HAIR; GALLUS GALLUS FEATHER; MELEAGRIS GALLOPAVO FEATHER; MESOCRICETUS AURATUS HAIR; MESOCRICETUS AURATUS SKIN; MUS MUSCULUS HAIR; MUS MUSCULUS SKIN; ORYCTOLAGUS CUNICULUS HAIR; ORYCTOLAGUS CUNICULUS SKIN; OVIS ARIES WHOLE; PHOSPHORUS; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA HAIR; SUS SCROFA SKIN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Dander [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
43406-0133_00435778-fa1c-4331-9df3-1a0a9d0779dd	43406-0133	HUMAN OTC DRUG	Vaccine Support CP		Belladonna, Calcarea Carbonica, Carcinosinum, Hypericum Perforatum, Ledum Palustre, Lycopodium Clavatum, Malandrinum, Mercurius Solubilis, Natrum Sulphuricum, Pyrogenium, Sarsaparilla, Silicea, Sulphur, Thuja Occidentalis	LIQUID	ORAL	20110829		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ATROPA BELLADONNA; HUMAN BREAST TUMOR CELL; HYPERICUM PERFORATUM WHOLE; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; RANCID BEEF; RHODODENDRON TOMENTOSUM LEAFY TWIG; SILICON DIOXIDE; SMILAX ORNATA ROOT; SODIUM SULFATE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0140_ec89c2e9-8a1e-4a93-a4cf-b7ed7bb27e76	43406-0140	HUMAN OTC DRUG	Dust Mix Antigen		Antimon Tart, Arsenicum Alb, Blatta Or, Bromium, Calc Carb, Cimex, Drosera, Hepar Sulph Calc, Ictodes Foetida, Lycopodium, Phos, Pulsatilla, Silicea Terra, Tabacum Fumus	LIQUID	ORAL	20120712		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BLATTA ORIENTALIS; BROMINE; CALCIUM SULFIDE; CIMEX LECTULARIUS; DROSERA ROTUNDIFOLIA; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PULSATILLA VULGARIS; SILICON DIOXIDE; SYMPLOCARPUS FOETIDUS ROOT; TOBACCO SMOKE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
43406-0149_f789289e-bdd2-4369-8683-4515aae0f638	43406-0149	HUMAN OTC DRUG	Thyroidinum 6X		Thyroidinum	LIQUID	ORAL	20120610		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	THYROID, PORCINE	6	[hp_X]/mL			N	20241231
43406-0152_b94996ce-3837-43d5-a284-62a14a3e5a2c	43406-0152	HUMAN PRESCRIPTION DRUG	STIFF JOINTS HP		Bryonia Alba Root, Colchicum Autumnale Bulb, Kalmia Latifolia Leaf, Ledum Palustre Twig, Lycopodium Clavatum Spore, Rhododendron Aureum Leaf, Toxicodendron Pubescens Leaf	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0159_af011067-478f-4d5e-8e3f-d98864508175	43406-0159	HUMAN OTC DRUG	Aconitum Napellus 200C		Aconitum Napellus	LIQUID	ORAL	20130226		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACONITUM NAPELLUS	200	[hp_C]/mL			N	20241231
43406-0160_c0a196a9-3da2-4ca1-a8dc-e77d72492f77	43406-0160	HUMAN OTC DRUG	Ignatia Amara 200C		Ignatia Amara	LIQUID	ORAL	20150615		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	STRYCHNOS IGNATII SEED	200	[hp_C]/mL			N	20241231
43406-0161_9048e16b-d4a8-4296-abc7-9a805625209e	43406-0161	HUMAN OTC DRUG	Apis Mellifica 30C		Apis Mellifica	LIQUID	ORAL	20100423		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	APIS MELLIFERA	30	[hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43406-0164_d5408058-d51f-4d10-af0d-381da9dedeef	43406-0164	HUMAN OTC DRUG	Thyroidinum 30C		Thyroidinum	LIQUID	ORAL	20120610		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	THYROID, PORCINE	30	[hp_C]/mL			N	20241231
43406-0167_862bad1d-0075-4b44-8adf-fb240fa38172	43406-0167	HUMAN OTC DRUG	Rhus Toxicodendron 30C		Rhus Toxicodendron	LIQUID	ORAL	20120518		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	TOXICODENDRON PUBESCENS LEAF	30	[hp_C]/mL			N	20241231
43406-0168_c59590ba-6ad8-462f-9ceb-d7cd1b6882f6	43406-0168	HUMAN OTC DRUG	Arsenicum Album 30C		Arsenic Trioxide	LIQUID	ORAL	20060701		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE	30	[hp_C]/mL			N	20241231
43406-0169_606eb79e-6325-44c3-804c-e2cc327f8343	43406-0169	HUMAN OTC DRUG	Berberis Vulgaris 30C		Berberis Vulgaris Root Bark	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	BERBERIS VULGARIS ROOT BARK	30	[hp_C]/mL			N	20241231
43406-0216_b2a280a9-9c9e-41c4-b83d-64335bad4778	43406-0216	HUMAN OTC DRUG	Rhus Tox 4X / 8X / 12X		Rhus Toxicodendron	LIQUID	ORAL	20090220		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	TOXICODENDRON PUBESCENS LEAF	12	[hp_X]/mL			N	20241231
43406-0217_22e73b00-2289-4fb8-bb98-1834d76bc1c8	43406-0217	HUMAN OTC DRUG	ARNICA MONTANA 30C		Arnica Montana	LIQUID	ORAL	20060701		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARNICA MONTANA	30	[hp_C]/mL			N	20241231
43406-0218_b284f015-6d59-4865-a9cb-bbbb61574d82	43406-0218	HUMAN OTC DRUG	Cinchona Officinalis 30C		Cinchona Officinalis	LIQUID	ORAL	20070508		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	CINCHONA OFFICINALIS BARK	30	[hp_C]/mL			N	20241231
43406-0219_6f2c4e49-0fec-4478-b2fe-64b5c620ec95	43406-0219	HUMAN OTC DRUG	Thuja Occidentalis 30C		Thuja Occidentalis	LIQUID	ORAL	20120604		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/mL			N	20241231
43406-0223_575a43ef-77d5-4348-bd98-a2a1df2db51c	43406-0223	HUMAN OTC DRUG	ALLERGY SOUTH EAST MIX		Birch Mix, Common Mugwort, English Plantain, Maple Mix, Pigweed Mix, Pine Mix, Ragweed Mix, Red Cedar, Red Mulberry, Sheep Sorrel, White Poplar	LIQUID	ORAL	20150817		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACER NEGUNDO WOOD; AMBROSIA CONFERTIFLORA WHOLE; ARTEMISIA VULGARIS POLLEN; BETULA PENDULA WHOLE; CHENOPODIUM ALBUM WHOLE; JUNIPERUS VIRGINIANA POLLEN; MORUS RUBRA WHOLE; PINUS SPP. WHOLE; PLANTAGO LANCEOLATA POLLEN; POPULUS ALBA WHOLE; QUERCUS SPP. WHOLE; RUMEX ACETOSELLA WHOLE	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
43406-0224_bb6579d3-ccc4-45d5-82c1-8076b267c578	43406-0224	HUMAN OTC DRUG	Nux Vomica 30C		Nux Vomica	LIQUID	ORAL	20160620		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0255_0427b31e-d04a-428b-87fb-ebe9f87401c9	43406-0255	HUMAN OTC DRUG	Rhus Toxicodendron 200C		Rhus Toxicodendron	LIQUID	ORAL	20120518		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	TOXICODENDRON PUBESCENS LEAF	200	[hp_C]/mL			N	20241231
43406-0257_a1af0c99-3e2a-4e1e-8a5f-70d90ba249e6	43406-0257	HUMAN OTC DRUG	Calcarea Carbonica 200C		Calcarea Carbonica	LIQUID	ORAL	20011204		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	OYSTER SHELL CALCIUM CARBONATE, CRUDE	200	[hp_C]/mL			N	20241231
43406-0258_66443525-1188-408b-a372-3427e59245fd	43406-0258	HUMAN OTC DRUG	Pulsatilla 200C		Pulsatilla	LIQUID	ORAL	20150413		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	PULSATILLA VULGARIS WHOLE	200	[hp_C]/mL			N	20241231
43406-0306_d0bc017e-cf83-4223-9f0d-d744584a1165	43406-0306	HUMAN OTC DRUG	Causticum 200C		Causticum	LIQUID	ORAL	20080408		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	CAUSTICUM	200	[hp_C]/mL			N	20241231
43406-0311_a38d1ef6-192a-4447-b254-d0f31b966dc1	43406-0311	HUMAN OTC DRUG	ARNICA MONTANA 200C		Arnica Montana	LIQUID	ORAL	20011203		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARNICA MONTANA	200	[hp_C]/mL			N	20241231
43406-0318_1faad233-11fd-43af-b57e-4123165b8dfd	43406-0318	HUMAN OTC DRUG	Arsenicum Album 200C		Arsenic Trioxide	LIQUID	ORAL	20011119		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE	200	[hp_C]/mL			N	20241231
43406-0319_6fb99f8b-1a5a-45ec-bc43-787c54ecb2fa	43406-0319	HUMAN OTC DRUG	BELLADONNA 30C		Atropa Belladonna	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ATROPA BELLADONNA	30	[hp_C]/mL			N	20241231
43406-0324_feea68b8-9178-4828-a2d0-d094d2ccc22c	43406-0324	HUMAN OTC DRUG	BELLADONNA 200C		Atropa Belladonna	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ATROPA BELLADONNA	200	[hp_C]/mL			N	20241231
43406-0346_9ab5b920-526e-4e53-af6f-fc3febbfa14d	43406-0346	HUMAN OTC DRUG	Staphysagria 200C		Staphysagria	LIQUID	ORAL	20150630		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	DELPHINIUM STAPHISAGRIA SEED	200	[hp_C]/mL			N	20241231
43406-0393_cf76a6a8-a2c7-4963-b4f2-64e107215730	43406-0393	HUMAN OTC DRUG	Carbo Vegetabilis 30C		Carbo Vegetabilis	LIQUID	ORAL	20070508		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACTIVATED CHARCOAL	30	[hp_C]/mL			N	20241231
43406-0398_57ee4288-9a85-4fc3-a19b-043a35dd1e6d	43406-0398	HUMAN OTC DRUG	Pyrogenium 30C		Pyrogenium	LIQUID	ORAL	20180627		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	RANCID BEEF	30	[hp_C]/mL			N	20241231
43406-0402_cfae6756-a606-4cfd-90c7-ca541a901309	43406-0402	HUMAN OTC DRUG	FERRUM PHOSPHORICUM 12X		FERRUM PHOSPHORICUM	LIQUID	ORAL	20140328		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	FERROSOFERRIC PHOSPHATE	12	[hp_X]/mL			N	20241231
43406-0411_0903ef74-d8c2-465e-914d-1291e04df7c1	43406-0411	HUMAN OTC DRUG	CINA 30C		Artemisia Cina Pre-Flowering Top	LIQUID	ORAL	20070507		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP	30	[hp_C]/mL			N	20241231
43406-0423_5b74bd81-581a-4d10-baa1-d1a98cf6e339	43406-0423	HUMAN OTC DRUG	BARYTA CARBONICA 30C		Barium Carbonate	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	BARIUM CARBONATE	30	[hp_C]/mL			N	20241231
43406-0461_a95fdebd-a638-46fe-b409-3d01bc093612	43406-0461	HUMAN OTC DRUG	CANTHARIS 30C		Lytta Vesicatoria	LIQUID	ORAL	20070507		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	LYTTA VESICATORIA	30	[hp_C]/mL			N	20241231
43406-0472_79e6debb-b348-4f5c-a177-ed059ba0406d	43406-0472	HUMAN OTC DRUG	Sulphur 30C		Sulphur	LIQUID	ORAL	20120618		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	SULFUR	30	[hp_C]/mL			N	20241231
43406-0527_4482fc25-290f-4e2a-8cf3-e773abca5ee8	43406-0527	HUMAN OTC DRUG	Scar		Calendula, Graphites, Hypericum Perforatum, Staphysagria, Silicea, Thiosinaminum	LIQUID	ORAL	20150401		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ALLYLTHIOUREA; CALENDULA OFFICINALIS FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; HYPERICUM PERFORATUM WHOLE; SILICON DIOXIDE	6; 6; 6; 6; 6; 6	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0546_63ac7b16-badf-46a5-b2c8-70b2c0b224dc	43406-0546	HUMAN OTC DRUG	Calcarea Carbonica 30C		Calcarea Carbonica	LIQUID	ORAL	20011204		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_C]/mL			N	20241231
43406-0587_a00c0c98-7625-4f43-8b7b-1d8a1b488a8d	43406-0587	HUMAN OTC DRUG	ALLERGY ATLANTIC MOLD MIX		Alternaria Alternata, Aspergillus Fumigatus, Botrytis Cinerea, Rhizopus Stolonifer, Ustilago Maydis	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; BOTRYTIS CINEREA; RHIZOPUS STOLONIFER; USTILAGO MAYDIS	8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43406-0588_cf3e478d-c7b5-4988-92df-fa23a29f5057	43406-0588	HUMAN OTC DRUG	ALLERGY POLLEN		Garlic, Echinacea Angustifolia, Solidago Virgaurea Flowering Top, Toxicodendron Pubescens Leaf, Onion, Ambrosia Artemisiifolia, Apis Mellifera, Arsenic TriOxide, Arsenic TriIodide, Euphrasia Stricta, Iodine, Histamine DiHydrochloride, Lycopodium Clavatum Spore, Mercurius Solubilis, Strychnos Nux-Vomica Seed, Sus Scrofa Pituitary Gland Posterior, Anemone Pulsatilla, Schoenocaulon Officinale Seed, Sulfur	LIQUID	ORAL	20150101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	AMBROSIA ARTEMISIIFOLIA; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIIODIDE; ARSENIC TRIOXIDE; ECHINACEA ANGUSTIFOLIA; EUPHRASIA STRICTA; GARLIC; HISTAMINE DIHYDROCHLORIDE; IODINE; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; ONION; SCHOENOCAULON OFFICINALE SEED; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA PITUITARY GLAND, POSTERIOR; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 8; 30; 8; 30; 30; 30; 30; 30; 30; 8; 30; 30; 30; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43406-0589_fd8082b7-dc24-4a5d-89ce-c840201cfd0c	43406-0589	HUMAN OTC DRUG	Mold Antigen		Alternaria Alternata, Aspergillus Fumigatus, Aspergillus Niger, Boletus Sat, Botrytis Cinerea, Cladosporium Metanigrum, Fusarium Oxysporum, Helminthosporium, Mucor Muecedo, Pullularia Pullulans, Rhizopus Nigricans, Ustilago Maydis, Arsenicum Alb, Candida Alb, Carbo An, Lachesis, Lycopodium, Merc Solub, Nitricum Ac, Phosphorus, Pulsatilla, Sepia, Silicea, Thuja Occ	LIQUID	ORAL	20151021		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ALTERNARIA ALTERNATA; ARSENIC TRIOXIDE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOLETUS SATANAS FRUITING BODY; BOTRYTIS CINEREA; CANDIDA ALBICANS; CARBO ANIMALIS; COCHLIOBOLUS SATIVUS; FUSARIUM OXYSPORUM; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NITRIC ACID; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; RHIZOPUS STOLONIFER; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; USTILAGO MAYDIS	200; 30; 200; 200; 200; 200; 200; 30; 30; 200; 200; 30; 30; 30; 30; 30; 30; 200; 30; 30; 30; 200	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43406-0592_eb719df3-e5a7-4c63-8c72-54d7166b5090	43406-0592	HUMAN OTC DRUG	Hydrate 2		BerberisAquifolium,BetaVulgaris,Boldo,ChelidoniumMajus,HordeumVulgare,IrisVersicolor,RosmarinusOfficinalis,CarduusMarianus,TaraxacumOfficinale,AvenaSativa,EleutherococcusSenticosus,XanthoxylumFraxineum,EquisetumHyemale,HypericumPerforatum,UlmusFulva,GettysburgAqua,GlycyrrhizaGlabra,WildbadAqua,CarlsbadAqua,ATP,Hydrogen,NatrumMuriaticum,Oxygen,Silicea,WiesbadenAqua	LIQUID	ORAL	20151123		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ADENOSINE TRIPHOSPHATE; AVENA SATIVA FLOWERING TOP; BERBERIS AQUIFOLIUM ROOT BARK; BETA VULGARIS; CHELIDONIUM MAJUS; ELEUTHEROCOCCUS SENTICOSUS WHOLE; EQUISETUM HYEMALE; GLYCYRRHIZA GLABRA; HORDEUM VULGARE WHOLE; HYDROGEN; HYPERICUM PERFORATUM; IRIS VERSICOLOR ROOT; MILK THISTLE; OXYGEN; PEUMUS BOLDUS LEAF; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SODIUM CHLORIDE; TARAXACUM OFFICINALE; ULMUS RUBRA BARK; ZANTHOXYLUM AMERICANUM BARK	30; 8; 8; 8; 8; 8; 8; 12; 8; 30; 8; 8; 8; 30; 8; 8; 30; 30; 8; 8; 8	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43406-0593_e9a334cc-3069-48c3-a62e-2a700547c1cb	43406-0593	HUMAN OTC DRUG	VIROSODE		Echinacea Angustifolia, Hydrastis Canadensis, Lomatium, Phytolacca Decandra, Aconitum Napellus, Arsenicum Album, Belladonna, Carcinosin, Coxsackie, Eupatorium Perfoliatum, Gelsemium Sempervirens, Herpes Zoster, Influenzinum, Morbillinum, Pertussin, Pyrogenium	LIQUID	ORAL	20151201		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HUMAN BREAST TUMOR CELL; HUMAN COXSACKIEVIRUS A; HUMAN HERPESVIRUS 3; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; INFLUENZA A VIRUS A/NORTH CAROLINA/04/2016 (H3N2) WHOLE; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) WHOLE; INFLUENZA B VIRUS B/IOWA/06/2017 WHOLE; INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 WHOLE; LOMATIUM DISSECTUM WHOLE; MEASLES VIRUS; PHYTOLACCA AMERICANA ROOT; RANCID BEEF	30; 30; 30; 8; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 8; 30; 8; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
43406-0595_b2dc6a65-fdc2-4662-b765-3df5a2c4d58b	43406-0595	HUMAN OTC DRUG	Tiny Tot Cough Syrup		Squilla, Antimonium Tart, Arsenicum Alb, Belladonna, Bryonia, Chamomilla, Cuprum Met, Drosera, Hepar Sulph Calc, Ipecacuanha, Kali Bic, Kali Carb, Phosphorus, Pulsatilla, Spongia	SYRUP	ORAL	20151111		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; COPPER; DRIMIA MARITIMA BULB; DROSERA ROTUNDIFOLIA WHOLE; IPECAC; MATRICARIA CHAMOMILLA WHOLE; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS WHOLE; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
43406-0603_94e7bb2b-fed9-47a9-a7b0-a8903c6070a7	43406-0603	HUMAN OTC DRUG	Injury		Calendula Officinalis, Symphytum Officinale, Arnica Montana, Bellis Perennis, Bryonia Alba, Hypericum Perforatum, Ledum Palustre, Phosphorus, Rhus Toxicodendron, Ruta Graveolens, Staphysagria, Pyrogenium	LIQUID	ORAL	20160114		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; DELPHINIUM STAPHISAGRIA SEED; HYPERICUM PERFORATUM WHOLE; PHOSPHORUS; RANCID BEEF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 6; 6; 12; 12; 12; 30; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0605_b1f04965-1554-487a-b1c9-70e115f27817	43406-0605	HUMAN OTC DRUG	Vitality Female		Aralia Quinquefolia, Avena Sativa, Berberis Vulgaris, Causticum, Graphites, Lachesis Mutus, Natrum Muriaticum, Phosphoricum Acidum, Phosphorus, Sepia	LIQUID	ORAL	20160114		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	AMERICAN GINSENG; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; CAUSTICUM; GRAPHITE; LACHESIS MUTA VENOM; PHOSPHORIC ACID; PHOSPHORUS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE	6; 6; 6; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0611_6379c1e2-3b90-4bf9-b40c-dc16b424a3f7	43406-0611	HUMAN OTC DRUG	BONE HP		Sodium Borate, Oyster Shell Calcium Carbonate Crude, Calcium Fluoride, Tribasic Calcium Phosphate, Eupatorium Perfoliatum Flowering Top, Iron, Hydrofluoric Acid, Hekla Lava, Toxicodendron Pubescens Leaf, Ruta Graveolens Flowering Top, Silicon Dioxide, Comfrey Root.	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	CALCIUM FLUORIDE; COMFREY ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; HEKLA LAVA; HYDROFLUORIC ACID; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; SODIUM BORATE; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43406-0612_2b02919f-d84a-4c9c-8b74-173ed40b2784	43406-0612	HUMAN OTC DRUG	STRESS / FATIGUE		Epinephrine, Thyroid Unspecified,Bos Taurus Pituitary Gland, Arsenic Trioxide, Oyster Shell Calcium Carbonate Crude, Conium Maculatum Flowering Top, Cortisone Acetate, Crotalus Horridus Horridus Venom, Iron, Strychnos Nux-Vomica Seed, Phosphoric Acid, Phosphorus, Selenium, Sepia Officinalis Juice, Zanthoxylum Americanum Bark	LIQUID	ORAL	20160101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE; BOS TAURUS PITUITARY GLAND; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; ZANTHOXYLUM AMERICANUM BARK	12; 6; 12; 12; 12; 6; 12; 12; 12; 12; 12; 12; 12; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43406-0613_f97dc02e-f47e-42a9-8cda-b96b2d4e0838	43406-0613	HUMAN OTC DRUG	GBLV HP		Atropa Belladonna, Berberis Vulgaris Root Bark, Milk Thistle, Chelidonium Majus, Citrullus Colocynthis Fruit Pulp, Dioscorea Villosa Tuber, Goldenseal, Lycopodium Clavatum Spore, Sodium Sulfate, Strychnos Nux-Vomica Seed, Phosphorus, Anemone Pulsatilla, Veratrum Album Root	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANEMONE PULSATILLA; ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CITRULLUS COLOCYNTHIS FRUIT PULP; DIOSCOREA VILLOSA TUBER; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHOSPHORUS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0616_6811b8a4-0c64-40f4-93d7-d16660ce78cc	43406-0616	HUMAN OTC DRUG	DANDI HP		Milk Thistle, Dysphania Ambrosioides, Bos Taurus Bile, Golden Seal, Potassium Tartrate HemiHydrate, Taraxacum Officinale, Iodine, Arsenic Trioxide, Oster SHell Calcium Carbonate, Crude, Lycopodium Clavatum Spore, Magnesium Chloride, Mercurius Solubilis, Sodium Sulfate, Strychnos Nux-Vomica Seed, Phosphorus	LIQUID	ORAL	20160630		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE; BOS TAURUS BILE; DYSPHANIA AMBROSIOIDES; GOLDENSEAL; IODINE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; MERCURIUS SOLUBILIS; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM TARTRATE HEMIHYDRATE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	30; 8; 8; 8; 6; 30; 30; 30; 8; 30; 30; 8; 30; 30; 8	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43406-0619_67d8d7d0-5618-47ed-b0ea-18f220803358	43406-0619	HUMAN OTC DRUG	Germasode		Arnica Montana, Echinacea Angustifolia, Arsenicum Album, Belladonna, Berberis Vulgaris, Borrelia, Chlamydia, Hydrastis Canadensis, Lachesis Mutus, Lymphogranuloma, Mercurius Solubilis, Oophorinum, Phosphorus, Pneumococcinum, Pyrogenium, Silicea Terra	LIQUID	ORAL	20160729		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; BORRELIA BURGDORFERI; CHLAMYDIA TRACHOMATIS; ECHINACEA ANGUSTIFOLIA WHOLE; GOLDENSEAL; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHOSPHORUS; RANCID BEEF; SILICON DIOXIDE; SUS SCROFA OVARY	8; 30; 30; 30; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0622_da1ae8e4-1c7a-4ac9-81d6-fca58a944d98	43406-0622	HUMAN OTC DRUG	BACK HP		Aconitum Napellus, Horse Chestnut, Colchicum Autumnale Bulb, Hypericum Perforatum, Magnesium Phosphate Dibasic Trihydrate, Lead, Toxicodendron Pubescens Leaf, Arnica Montana	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; COLCHICUM AUTUMNALE BULB; HORSE CHESTNUT; HYPERICUM PERFORATUM; LEAD; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43406-0623_471c8f40-310f-4860-b148-f0551029b59c	43406-0623	HUMAN OTC DRUG	GERM HP		Apis Mellifera, Arsenic Trioxide, Atropa Belladonna, Matricaria Recutita, Lachesis Muta Venom, Mercurius Solubilis, Pulsatilla Vulgaris, Toxicodendron Pubescens Leaf, Silicon Dioxide	LIQUID	ORAL	20160101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; PULSATILLA VULGARIS; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 300; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43406-0625_9838ec0b-1cac-4634-a14e-fd35fcbafc01	43406-0625	HUMAN OTC DRUG	BLISTER HP		Juglans Cinerea Branch Bark/Root Bark, Potassium Iodide, Lycopodium Clavatum Spore, Mercury, Sodium Chloride, Nitric Acid, Phosphorus, Ranunculus Bulbosus, Toxicodendron Pubescens Leaf, Sepia Officinalis Juice, Thuja Occidentalis Leafy Twig.	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	JUGLANS CINEREA BRANCH BARK/ROOT BARK; LYCOPODIUM CLAVATUM SPORE; MERCURY; NITRIC ACID; PHOSPHORUS; POTASSIUM IODIDE; RANUNCULUS BULBOSUS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0626_19cf1f09-c4e3-44da-a081-348742741950	43406-0626	HUMAN OTC DRUG	CONGESTION HP		Ammonium Chloride, Antimony Potassium Tartrate, Arsenic Trioxide, Oyster Shell Calcium Carbonate, Crude, Lobelia Inflata, Sodium Sulfate, Spongia Officinalis Skeleton, Roasted, Phosphorus	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	AMMONIUM CHLORIDE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; LOBELIA INFLATA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0627_92875cfb-2144-4616-9bbb-13cfa639f95a	43406-0627	HUMAN OTC DRUG	SWELLING HP		Apis Mellifera, Arsenic Trioxide, Cinchona Officinalis Bark, Digitalis, Lachesis Muta Venom, Lycopodium Clavatum Spore, Sodium Sulfate, Toxicodendron Pubescens Leaf, Sambucus Nigra Flowering Top, Strophanthus Hispidus Seed	LIQUID	ORAL	20070529		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; DIGITALIS; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE; STROPHANTHUS HISPIDUS SEED; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43406-0628_2359607e-7336-47b1-8142-6cc14083d908	43406-0628	HUMAN PRESCRIPTION DRUG	INJURY HP		Arnica Montana, Echinacea Angustifolia, Hypericum Perforatum, Phosphorus, Rancid Beef, Silicon Dioxide, Delphinium Staphisagria Seed, Comfrey Root	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARNICA MONTANA; COMFREY ROOT; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA ANGUSTIFOLIA; HYPERICUM PERFORATUM; PHOSPHORUS; RANCID BEEF; SILICON DIOXIDE	200; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0629_12213eb7-af6b-4e3b-b049-f660cd2b6470	43406-0629	HUMAN OTC DRUG	IODIUM HP		Barium Carbonate, Oyster Shell Calcium Carbonate, Crude, Fucus Vesiculosus, Iodine, Sodium Chloride, Pulsatilla Vulgaris, Spongia Officinalis Skeleton, Roasted, Thyroid	LIQUID	ORAL	20160101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	BARIUM CARBONATE; FUCUS VESICULOSUS; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS; SODIUM CHLORIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID, UNSPECIFIED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0631_b4511899-a483-4ce4-ab8d-401f28a71d06	43406-0631	HUMAN OTC DRUG	BURN RELIEF		Arsenic Trioxide, Atropa Belladonna, Lytta Vesicatoria, Causticum, Picric Acid, Urtica Urens, Hypericum Perforatum	SPRAY	TOPICAL	20161230		UNAPPROVED HOMEOPATHIC		Natrural Creations, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAUSTICUM; HYPERICUM PERFORATUM; LYTTA VESICATORIA; PICRIC ACID; URTICA URENS	12; 12; 12; 30; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0635_c4a4c825-0f15-4f60-902c-1cbf2c4f6b3b	43406-0635	HUMAN OTC DRUG	LYCOPODIUM HP		Amanita Muscaria Fruiting Body, Onion, Arnica Montana, Hypericum Perforatum, Lycopodium Clavatum Spore, Mercurius Solubilis, Phosphorus, Lead	LIQUID	ORAL	20160718		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	AMANITA MUSCARIA FRUITING BODY; ARNICA MONTANA; HYPERICUM PERFORATUM; LEAD; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; ONION; PHOSPHORUS	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43406-0636_90ff7b66-7958-4c78-b60d-33035274a5d1	43406-0636	HUMAN OTC DRUG	Uroflo HP		Clematis Erecta, Conium Maculatum, Lycopodium Clavatum, Mercurius Corrosivus, Pulsatilla, Sabal Serrulata, Selenium Metallicum, Sepia, Staphysagria, Thuja Occidentalis	LIQUID	ORAL	20160706		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; PULSATILLA VULGARIS WHOLE; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0637_8f685fed-7131-4592-9f6e-467fb3a91172	43406-0637	HUMAN OTC DRUG	BELLA HP		Atropa Belladonna, Conium Maculatum Flowering Top, Solanum Dulcamara Top, Calcium Sulfide, Potassium Dichromate, Mercurius Solubilis, Anemone Pulsatilla, Silicon Dioxide, Matricaria Recutita.	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANEMONE PULSATILLA; ATROPA BELLADONNA; CALCIUM SULFIDE; CONIUM MACULATUM FLOWERING TOP; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; POTASSIUM DICHROMATE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0641_28a2c34e-dce4-4e67-b1b7-5a75288bc0ef	43406-0641	HUMAN OTC DRUG	ALUMIZEN		Garlic, Avena Sativa Flowering Top, Berberis Vulgaris Root Bark, Arctium Lappa Root, Phytolacca Americana Root, Solidago Virgaurea Flowering Top, Aluminum Oxide, Silver Nitrate, Barium Carbonate, Beryllium, Cadmium, Copper, Hydrofluoric Acid, Indium, Iodine, Lithium Carbonate, Mercurius Solubilis, Nickel Carbonate Hydroxide Tetrahydrate, Nitrous Oxide, Lead, Selenium, Strontium Carbonate, Titanium, Arsenic Trioxide, Sodium Chloride, Strychnos Nux-Vomica Seed.	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ALUMINUM OXIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; CADMIUM; COPPER; GARLIC; HYDROFLUORIC ACID; INDIUM; IODINE; LEAD; LITHIUM CARBONATE; MERCURIUS SOLUBILIS; NICKEL CARBONATE HYDROXIDE TETRAHYDRATE; NITROUS OXIDE; PHYTOLACCA AMERICANA ROOT; SELENIUM; SILVER NITRATE; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TITANIUM	12; 6; 12; 6; 12; 6; 12; 12; 12; 6; 12; 12; 12; 12; 12; 12; 12; 12; 6; 12; 12; 12; 6; 12; 12; 12	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0657_e94cdca8-d57f-484a-aec3-09825479eb23	43406-0657	HUMAN OTC DRUG	Calcarea Phosphorica 30C		Calcarea Phosphorica	LIQUID	ORAL	20070508		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	TRIBASIC CALCIUM PHOSPHATE	30	[hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43406-0661_e996b687-e6a7-4366-a287-b7a96e3fb8bb	43406-0661	HUMAN OTC DRUG	ANAS BARBARIE HEPATIS ET 30C		Anas Barbarie Hepatis Et	LIQUID	ORAL	20170825		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	30	[hp_C]/mL			N	20241231
43406-0664_c6b3d70d-2a1b-4065-91c0-f07fbfa0a1bb	43406-0664	HUMAN OTC DRUG	Cough Syrup		Camphor (Natural), Arsenic Trioxide, Bryonia Alba Root, Drosera Rotundifolia, Ipecac, Potassium Carbonate, Phosphorus, Anemone Pulsatilla, Spongia Officinalis Skeleton, Roasted, Drimia Maritima Whole	SYRUP	ORAL	20070507		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); DRIMIA MARITIMA WHOLE; DROSERA ROTUNDIFOLIA; IPECAC; PHOSPHORUS; POTASSIUM CARBONATE; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43406-0669_05d23e4d-d629-44c0-8161-1b3a07c5493b	43406-0669	HUMAN OTC DRUG	Throat		Baptisia, Phytolacca, Hydrastis, Apis mel, Arg Nit, Belladonna, Hepar Sulph Calc, Kali Bic, Lac Can, Lachesis, Merc Solub	SPRAY	ORAL	20180403		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	APIS MELLIFERA; ATROPA BELLADONNA; BAPTISIA TINCTORIA WHOLE; CALCIUM SULFIDE; CANIS LUPUS FAMILIARIS MILK; GOLDENSEAL; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SILVER NITRATE	12; 12; 4; 12; 12; 6; 12; 12; 4; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43406-0670_c42fe24b-acdd-42f4-9403-9a1934e27ebb	43406-0670	HUMAN OTC DRUG	COLD/FLU HP		ArsenicTrioxide,BaptisiaTinctoriaRoot,BryoniaAlbaRoot,SolanumDulcamaraTop,EchinaceaAngustifolia,EchinaceaPurpurea,EupatoriumPerfoliatumFloweringTop,FerrosoferricPhosphate,GelsemiumSempervirensRoot,PotassiumChloride,Phosphorus,AnemonePulsatilla,Sulfur,ZincAcetateAnhydrous,ZincCarbonate,Zinc,ZincChloride,ZincOxide,ZincPicrateNonahyrdate,ZincValerateDihydrate,CairinaMoschataHeart/LiverAutolysate,Influenzinum	LIQUID	ORAL	20180301		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) WHOLE; PHOSPHORUS; POTASSIUM CHLORIDE; SOLANUM DULCAMARA TOP; SULFUR; ZINC; ZINC ACETATE ANHYDROUS; ZINC CARBONATE; ZINC CHLORIDE; ZINC OXIDE; ZINC PICRATE NONAHYDRATE; ZINC VALERATE DIHYDRATE	100; 100; 100; 100; 200; 100; 100; 100; 100; 100; 200; 100; 100; 100; 100; 100; 100; 100; 100; 100; 100; 100	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43406-0672_f5bb196e-3547-4d62-8ca7-92f0620c67d8	43406-0672	HUMAN OTC DRUG	Candida HP		Baptisia Tinctoria Root, Echinacea Purpurea, Glycyrrhiza Glabra, Astragalus Nuttallii Leaf, Candida Albicans, Sodium Borate, Oyster Shell Calcium Carbonate, Crude, Wood Creosote, Lycopodium Clavatum Spore, Strychnos Nux-Vomica Seed, Phosphoric Acid, Anemone Pulsatilla, Sepia Officinalis Juice, Thuja Occidentalis Leafy Twig, Sodium Phosphate, Dibasic, Heptahydrate, Nitric Acid	LIQUID	ORAL	20180101		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ASTRAGALUS NUTTALLII LEAF; BAPTISIA TINCTORIA ROOT; CANDIDA ALBICANS; ECHINACEA PURPUREA; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	6; 4; 200; 4; 4; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0674_3ed1e9de-89db-4a48-a636-6086fc40cf91	43406-0674	HUMAN OTC DRUG	Runny Nose CP		Allium Cepa, Calc Carb, Ferrum Phos, Hepar Sulph Calc, Lycopodium, Merc Solub, Pulsatilla, Silicea, Sulphur	LIQUID	ORAL	20180430		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; ONION; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS WHOLE; SILICON DIOXIDE; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43406-0675_e5125b5a-1992-430c-976a-e60bfaac66e2	43406-0675	HUMAN OTC DRUG	Sleepy Time CP		Aconitum, Arsenicum Alb, Calc Carb, Coffea Cruda, Magnesium Met, Nux Vom, Pulsatilla, Sepia, Sulphur	LIQUID	ORAL	20180430		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACONITUM NAPELLUS WHOLE; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; MAGNESIUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS WHOLE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0678_9e30d707-5cbe-4ee5-86c6-41dd8865d26a	43406-0678	HUMAN OTC DRUG	Digestion		Gentiana Lut, Sambucus Nig, Arsenicum Alb, Bismuth Sub, Carbo Veg, Kali Bic, Lycopodium, Nux Vom, Phosphorus, Pulsatilla	LIQUID	ORAL	20180502		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; BISMUTH SUBNITRATE; GENTIANA LUTEA ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS WHOLE; SAMBUCUS NIGRA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 4; 12; 12; 12; 12; 4; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0679_81a9ad6c-c27b-4b7c-a763-04c2b752f714	43406-0679	HUMAN OTC DRUG	Vermasode		Artemisia Vulgaris, Chelidonium Majus, Granatum, Spigelia Anthelmia, Ratanhia, Arsenicum Album, Ferrum Metallicum, Calcarea Carbonica, Cina, Gaertner Bacillus, Graphites, Mercurius Dulcis, Natrum Muriaticum, Natrum Phosphoricum, Vermin Nosode	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARSENIC TRIOXIDE; ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; CALOMEL; CHELIDONIUM MAJUS WHOLE; GRAPHITE; IRON; KRAMERIA LAPPACEA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PUNICA GRANATUM ROOT BARK; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SPIGELIA ANTHELMIA WHOLE	6; 12; 4; 12; 4; 12; 9; 4; 12; 4; 12; 12; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0680_c2598f59-f967-49f2-981d-7ee468f61aea	43406-0680	HUMAN OTC DRUG	Mood		Aralia Quin, Cimicifuga, Spigelia Anth, Arg Nit, Arsenicum Alb, Aurum Met, Ignatia Amara, Lachesis, Lycopodium, Nat Mur, Phosphoricum Ac, Platinum Met, Pulsatilla, Sepia, Thuja Occ	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	AMERICAN GINSENG; ARSENIC TRIOXIDE; BLACK COHOSH; GOLD; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PLATINUM; PULSATILLA VULGARIS WHOLE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; SPIGELIA ANTHELMIA WHOLE; STRYCHNOS IGNATII SEED; THUJA OCCIDENTALIS LEAFY TWIG	4; 12; 4; 12; 12; 12; 12; 12; 12; 12; 12; 12; 4; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43406-0681_b85fef1a-bdf2-4a5e-9def-07bcf2357f3b	43406-0681	HUMAN OTC DRUG	Hemorrhoid		Aesculus Hipp, Hamamelis, ALoe, Calc Phos, Carbo An, Carbo Veg, Lachesis, Lycopodium, Muriaticum Ac, Nitricum Ac, Nux Vom, Paeonia, Ratanhia, Sepia, Sulphur	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACTIVATED CHARCOAL; ALOE; CARBO ANIMALIS; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; HYDROCHLORIC ACID; KRAMERIA LAPPACEA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PAEONIA OFFICINALIS ROOT; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SULFUR; TRIBASIC CALCIUM PHOSPHATE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0685_689dde29-addf-4565-aec1-53d66cb27353	43406-0685	HUMAN OTC DRUG	Imucode		Astragalus, Hydrastis, Adrenalinum, Thyroidinum, Pituitarum Posterium, Arsenicum Alb, Baptisia, Baryta Carb, Baryta Mur, Bromium, Candida Alb, Ceanothus, Chininum Sulph, Conium, Hepar Sulph Calc, Ignatia, Indium, Iodium, Merc Solub, Phytolacca, Sulphur	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARSENIC TRIOXIDE; ASTRAGALUS NUTTALLII LEAF; BAPTISIA TINCTORIA WHOLE; BARIUM CARBONATE; BARIUM CHLORIDE DIHYDRATE; BROMINE; CALCIUM SULFIDE; CANDIDA ALBICANS; CEANOTHUS AMERICANUS LEAF; CONIUM MACULATUM FLOWERING TOP; EPINEPHRINE; GOLDENSEAL; INDIUM; IODINE; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; QUININE SULFATE; STRYCHNOS IGNATII SEED; SULFUR; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, PORCINE	30; 12; 12; 12; 12; 12; 12; 30; 12; 12; 9; 8; 12; 12; 30; 12; 12; 12; 12; 9; 9	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43406-0686_a9f04b29-8306-4955-aa12-00731a871230	43406-0686	HUMAN OTC DRUG	Panacode		Syzygium, Hydrastis, Adrenalinum, Pancreatinum, Pituitarum Posterium, Bovista, Insulin, Lycopersicum, Phosphoricum Ac, Phosphorus, Tarentula Hispana, Terebinthina, Uranium Nitricum	LIQUID	ORAL	20200211		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	EPINEPHRINE; GOLDENSEAL; INSULIN PORK; LYCOPERDON UTRIFORME FRUITING BODY; LYCOSA TARANTULA; PANCRELIPASE; PHOSPHORIC ACID; PHOSPHORUS; SOLANUM LYCOPERSICUM WHOLE; SUS SCROFA PITUITARY GLAND, POSTERIOR; SYZYGIUM CUMINI SEED; TURPENTINE OIL; URANYL NITRATE HEXAHYDRATE	9; 6; 12; 12; 12; 9; 12; 12; 12; 9; 4; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43406-0687_fd459d48-6086-470d-8d25-56a7c946a2de	43406-0687	HUMAN OTC DRUG	Vitalcode		Fucus, Spongia, Symphytum, Adrenalinum, Pituitaria Glandula, Thyroidinum, Arsenicum Iod, Baryta Carb, Calc Carb, Calc Fluor, Calc Phos, Crotalus Hor, Hekla Lava, Iodium Purum, Lycopus, Mang Mur, Silicea	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARSENIC TRIIODIDE; BARIUM CARBONATE; CALCIUM FLUORIDE; COMFREY ROOT; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; FUCUS VESICULOSUS; HEKLA LAVA; IODINE; LYCOPUS VIRGINICUS WHOLE; MANGANESE CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, PORCINE; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 8; 12; 9; 8; 12; 12; 12; 12; 12; 12; 8; 9; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43406-0688_96ae3b96-1aa1-43bb-a2ee-8c2896eb17d0	43406-0688	HUMAN OTC DRUG	Cold		Baptisia Tinctoria, Echinacea Angustifolia, Eupatorium Perfoliatum, Lomatium Dissectum, Pueraria Lobata, Trifolium Pratense, Phytolacca Decandra, Allium Cepa, Arsenicum Iodatum, Baryta Carbonica, Bromium, Calcarea Carbonica, Kali Muriaticum, Lachesis Mutus, Mercurius Solubilis, Silicea	LIQUID	ORAL	20190207		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARSENIC TRIIODIDE; BAPTISIA TINCTORIA WHOLE; BARIUM CARBONATE; BROMINE; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; LACHESIS MUTA VENOM; LOMATIUM DISSECTUM ROOT; MERCURIUS SOLUBILIS; ONION; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; PUERARIA MONTANA VAR. LOBATA WHOLE; SILICON DIOXIDE; TRIFOLIUM PRATENSE FLOWER	12; 4; 12; 12; 4; 4; 12; 4; 12; 12; 12; 6; 12; 4; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS]		N	20241231
43406-0689_6364c944-7fa6-447f-aa40-8ab5b6569073	43406-0689	HUMAN OTC DRUG	CONSTIPATION		Magnesia Carbonica, Magnesia Muriatica, Aesculus Hippocastanum, Alumen, Alumina, Bryonia Alba, Nux Vomica, Silicea	LIQUID	ORAL	20190305		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ALUMINUM OXIDE; BRYONIA ALBA ROOT; HORSE CHESTNUT; MAGNESIUM CARBONATE; MAGNESIUM CHLORIDE; POTASSIUM ALUM; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 9; 9; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43406-0690_04d47b51-3874-4b44-b195-dec9fffa00ea	43406-0690	HUMAN OTC DRUG	Gastrozen		Coffea Tosta, Glycyrrhiza, Phytolacca, Taraxacum, Hydrastis, Arsenicum Alb, Gelsemium, Merc Solub, Nitricum Ac, Nux Vom, Petroleum, Phosphoricum Ac, Phosphorus, Bromium, Cadmium Sulphuricum, Cinchona, Conium, Hydrogen, Iodium, Lachesis, Pulsatilla, Silicea, Sulphuricum Ac	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARSENIC TRIOXIDE; BROMINE; CADMIUM SULFATE; CINCHONA OFFICINALIS BARK; COFFEA ARABICA SEED, ROASTED; CONIUM MACULATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GLYCYRRHIZA GLABRA; GOLDENSEAL; HYDROGEN; IODINE; KEROSENE; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; NITRIC ACID; PHOSPHORIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS WHOLE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; TARAXACUM OFFICINALE	12; 30; 30; 30; 4; 30; 12; 4; 6; 30; 30; 12; 30; 12; 12; 12; 12; 4; 30; 30; 12; 30; 4	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0691_4b824b10-ee54-4105-b6cf-9441f75687fb	43406-0691	HUMAN OTC DRUG	Hives		Echinacea Ang, Apis Mel, Arsenicum Alb, Carbolicum Ac, Ledum, Rhus Tox, Sulphur, Urtica Urens	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	APIS MELLIFERA; ARSENIC TRIOXIDE; ECHINACEA ANGUSTIFOLIA WHOLE; PHENOL; RHODODENDRON TOMENTOSUM LEAFY TWIG; SULFUR; TOXICODENDRON PUBESCENS LEAF; URTICA URENS WHOLE	12; 12; 4; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43406-0693_f488ac0b-aa2f-4b24-850a-1898ed7930d3	43406-0693	HUMAN OTC DRUG	Nasal Decongestant		Camellia Sinensis, Ephedra Vulgaris, Belladonna, Arsenicum Album, Cinnabaris, Kali Bichromicum, Pulsatilla, Sepia, Calcarea Carbonica, Mercurius Solubilis, Sulphur	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAMELLIA SINENSIS WHOLE; EPHEDRA DISTACHYA FLOWERING TWIG; MERCURIC SULFIDE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS WHOLE; SEPIA OFFICINALIS JUICE; SULFUR	12; 4; 4; 4; 12; 30; 30; 12; 12; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0695_e9d313b3-54d4-49ee-b075-92668810128e	43406-0695	HUMAN OTC DRUG	STRESS / FATIGUE		Adrenalinum, Pituitarum Gland, Thyroidinum, Arsenicum Alb, Calc Carb, Conium, Cortisone Aceticum, Crotalus Hor, Ferrum Met, Nux Vomica, Phosphoricum Ac, Phosphorus, Selenium, Sepia, Xanthoxylum	LIQUID	ORAL	20180615		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ARSENIC TRIOXIDE; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, PORCINE; ZANTHOXYLUM AMERICANUM BARK	12; 12; 12; 12; 9; 12; 12; 12; 12; 12; 12; 12; 9; 9; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43406-0696_821d143a-a41c-4db7-84cc-abc9c45e9ef1	43406-0696	HUMAN OTC DRUG	FCS HP		Epinephrine,GlutamicAcid,MucunaPruriensSeed,Niacinamide,Serotonin,Ubidecarenone,Corticotropin,AdenosineTriphosphate,InsulinPork,SusScrofaParathyroidGland,SusScrofaPituitaryGland,ThiamineHydrochloride,Thyroid,AnhydrousCitricAcid,HerringSpermDNA,SaccharomycesCerevisiaeRNA,AnacardiumOccidentaleFruit,ArsenicTrioxide,AsparticAcid,BariumCarbonate,OysterShellCalciumCarbonateCrude,ClematisRectaFloweringTop,LycopodiumClavatumSpore,AnemonePulsatilla,DaturaStramonium,Sulfur	LIQUID	ORAL	20180601		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	ADENOSINE TRIPHOSPHATE; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; ANHYDROUS CITRIC ACID; ARSENIC TRIOXIDE; ASPARTIC ACID; BARIUM CARBONATE; CLEMATIS RECTA FLOWERING TOP; CORTICOTROPIN; DATURA STRAMONIUM; EPINEPHRINE; GLUTAMIC ACID; HERRING SPERM DNA; INSULIN PORK; LYCOPODIUM CLAVATUM SPORE; MUCUNA PRURIENS SEED; NIACINAMIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SACCHAROMYCES CEREVISIAE RNA; SEROTONIN; SULFUR; SUS SCROFA PARATHYROID GLAND; SUS SCROFA PITUITARY GLAND; THIAMINE HYDROCHLORIDE; THYROID, UNSPECIFIED; UBIDECARENONE	6; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 12; 6; 30; 30; 9; 30; 12; 30; 30; 6; 6; 6; 6; 9	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Acidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Decreased Coagulation Factor Activity [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43406-0697_2892f89a-f5af-4bbc-906b-94538db94881	43406-0697	HUMAN OTC DRUG	FCS CP		Corticotropin,GlutamicAcid,MucunaPuriensSeed,Serotonin,Epinephrine,Niacinamide,Ubidecarenone,AdenosineTriphosphate,InsulinPork,SusScrofaParathyroidGland,SusScrofaPituitaryGland,ThiamineHydrochloride,Thyroid,Unspecified,AnhydrousCitricAcid,HerringSpermDNA,SaccharomycesCerevisiaeRNA,AnacardiumOccidentaleFruit,ArsenicTrioxide,AsparticAcid,BariumCarbonate,OysterShellCalciumCarbonate,Crude,ClematisRectaFloweringTop,LycopodiumClavatumSpore,AnemonePulsatilla,DaturaStramonium,Sulfur	LIQUID	ORAL	20160701		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ADENOSINE TRIPHOSPHATE; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; ANHYDROUS CITRIC ACID; ARSENIC TRIOXIDE; ASPARTIC ACID; BARIUM CARBONATE; CLEMATIS RECTA FLOWERING TOP; CORTICOTROPIN; DATURA STRAMONIUM; EPINEPHRINE; GLUTAMIC ACID; HERRING SPERM DNA; INSULIN PORK; LYCOPODIUM CLAVATUM SPORE; MUCUNA PRURIENS SEED; NIACINAMIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SACCHAROMYCES CEREVISIAE RNA; SEROTONIN; SULFUR; SUS SCROFA PARATHYROID GLAND; SUS SCROFA PITUITARY GLAND; THIAMINE HYDROCHLORIDE; THYROID, UNSPECIFIED; UBIDECARENONE	6; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 12; 6; 30; 30; 8; 30; 12; 30; 30; 6; 6; 6; 6; 8	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Acidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Decreased Coagulation Factor Activity [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43406-0698_86b1882b-05dd-4722-b44a-260355e8a3b6	43406-0698	HUMAN OTC DRUG	Fever CP		Aconitum Napellus, Bryonia Alba, Calcarea Carbonica, Ferrum Phosphoricum, Lycopodium Clavatum, Phosphorus, Pulsatilla, Pyrogenium, Sulphur	LIQUID	ORAL	20180613		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACONITUM NAPELLUS WHOLE; BRYONIA ALBA ROOT; FERROSOFERRIC PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; RANCID BEEF; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0707_4919a13d-e595-4bb8-bc30-7ebf9cc74e95	43406-0707	HUMAN OTC DRUG	Injure Gel		Arnica Montana, Calendula Officinalis, Hypericum Perf, Symphytum Off, Bellis Per, Ledum Palustre, Sulphuricum Ac, Calc Fluor, Ferrum Phos, Rhus Tox, Nat Sulphuricum	GEL	TOPICAL	20190821		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; HYPERICUM PERFORATUM WHOLE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SODIUM SULFATE; SULFURIC ACID; TOXICODENDRON PUBESCENS LEAF	30; 12; 30; 4; 6; 30; 30; 12; 30; 12; 30	[hp_C]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_C]/g; [hp_X]/g; [hp_C]/g; [hp_X]/g; [hp_X]/g			N	20241231
43406-0709_a515d3ae-7a24-45b9-9bcf-a3ec565cd89c	43406-0709	HUMAN OTC DRUG	Hemorrhoid Gel		Achillea Millefolium, Aesculus Hippocastanum, Hamamelis Virginiana, Ruscus Aculeatus, Aloe Socotrina, Paeonia Officinalis, Ignatia Amara, Nitricum Acidum, Nux Vomica, Phosphorus, Podophyllum Peitatum, Pulsatilla, Ratanhia, Chelidonium Majus, Sulphur	GEL	TOPICAL	20190912		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ACHILLEA MILLEFOLIUM WHOLE; ALOE; CHELIDONIUM MAJUS WHOLE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; KRAMERIA LAPPACEA ROOT; NITRIC ACID; PAEONIA OFFICINALIS ROOT; PHOSPHORUS; PODOPHYLLUM; PULSATILLA VULGARIS WHOLE; RUSCUS ACULEATUS WHOLE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR	4; 6; 30; 4; 30; 30; 12; 6; 12; 12; 12; 4; 12; 12; 30	[hp_X]/g; [hp_X]/g; [hp_C]/g; [hp_X]/g; [hp_C]/g; [hp_C]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_C]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43406-0713_776270e1-b44a-47d8-8a5b-eafff4d03aa3	43406-0713	HUMAN OTC DRUG	Zincum Metallicum 12X		Zincum Metallicum	LIQUID	ORAL	20200813		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ZINC	12	[hp_X]/mL			N	20241231
43406-0714_d98dc8cf-516d-426b-bbdd-f6fdbc3ee473	43406-0714	HUMAN OTC DRUG	CONTACT ALLERGY ANTIGEN		Toxicodendron Diversilobum Leaf, Toxicodendron Pubescens Leaf, Toxicodendron Vernix Leafy Twig, Urtica Dioica, Semecarpus Anacardium Juice, Graphite, Daphne Mezereum Bark, Urtica Urens, Xerophyllum Asphodeloides	LIQUID	ORAL	20210727		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc.	DAPHNE MEZEREUM BARK; GRAPHITE; SEMECARPUS ANACARDIUM FRUIT; TOXICODENDRON DIVERSILOBUM LEAF; TOXICODENDRON PUBESCENS LEAF; TOXICODENDRON VERNIX LEAFY TWIG; URTICA DIOICA; URTICA URENS; XEROPHYLLUM ASPHODELOIDES	12; 12; 12; 30; 30; 30; 30; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43406-0715_3e0f7b0a-c29b-4b82-85cf-55c1aba825ff	43406-0715	HUMAN OTC DRUG	Hydrate 1		BerberisAqui,BetaVulgaris,Boldo,CarduusMarianus,ChelidoniumMajus,Eleutherococcus Senticosus,HordeumVulgare,IrisVersicolor,RosmarinusOfficinalis,TaraxacumOfficinale,XanthoxylumFraxineum,UlmusFulva,GlycyrrhizaGlabra,GettysburgAqua,WildbadAqua,CarlsbadAqua,ATP,NatrumMuriaticum,Oxygen,Silicea,WiesbadenAqua,Hydrogen	LIQUID	ORAL	20210602		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ADENOSINE TRIPHOSPHATE; BERBERIS AQUIFOLIUM ROOT BARK; BETA VULGARIS WHOLE; CHELIDONIUM MAJUS WHOLE; ELEUTHEROCOCCUS SENTICOSUS WHOLE; GLYCYRRHIZA GLABRA; HORDEUM VULGARE WHOLE; HYDROGEN; IRIS VERSICOLOR ROOT; MILK THISTLE; OXYGEN; PEUMUS BOLDUS LEAF; SALVIA ROSMARINUS FLOWERING TOP; SILICON DIOXIDE; SODIUM CHLORIDE; TARAXACUM OFFICINALE; ULMUS RUBRA BARK; ZANTHOXYLUM AMERICANUM BARK	30; 4; 4; 4; 4; 12; 4; 34; 4; 4; 30; 4; 4; 30; 30; 4; 6; 4	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43406-0716_215a5d1e-1b25-44bc-8f29-b606c7342526	43406-0716	HUMAN OTC DRUG	Hydrate 2		BerberisAquifolium,BetaVulgaris,Boldo,ChelidoniumMajus,HordeumVulgare,IrisVersicolor,RosmarinusOfficinalis,CarduusMarianus,TaraxacumOfficinale,AvenaSativa,EleutherococcusSenticosus,XanthoxylumFraxineum,EquisetumHyemale,HypericumPerforatum,UlmusFulva,GettysburgAqua,GlycyrrhizaGlabra,WildbadAqua,CarlsbadAqua,ATP,Hydrogen,NatrumMuriaticum,Oxygen,Silicea,WiesbadenAqua	LIQUID	ORAL	20151123		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	ADENOSINE TRIPHOSPHATE; AVENA SATIVA FLOWERING TOP; BERBERIS AQUIFOLIUM ROOT BARK; BETA VULGARIS; CHELIDONIUM MAJUS; ELEUTHEROCOCCUS SENTICOSUS WHOLE; EQUISETUM HYEMALE; GLYCYRRHIZA GLABRA; HORDEUM VULGARE WHOLE; HYDROGEN; HYPERICUM PERFORATUM; IRIS VERSICOLOR ROOT; MILK THISTLE; OXYGEN; PEUMUS BOLDUS LEAF; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SODIUM CHLORIDE; TARAXACUM OFFICINALE; ULMUS RUBRA BARK; ZANTHOXYLUM AMERICANUM BARK	30; 8; 8; 8; 8; 8; 8; 12; 8; 34; 8; 8; 8; 30; 8; 8; 30; 30; 8; 8; 8	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43406-0717_4b702cfd-e1ca-4920-b93b-2a8a53664b0e	43406-0717	HUMAN OTC DRUG	Stress		Aralia Quin, Passiflora, Scutellaria, Valeriana, Arsenicum Alb, Aur Met, Calc Carb, Coffea Cruda, Ignatia, Kali Phos, Lycopus, Phosphorus, Staphysagria	LIQUID	ORAL	20220818		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	AMERICAN GINSENG; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; DELPHINIUM STAPHISAGRIA SEED; DIBASIC POTASSIUM PHOSPHATE; GOLD; LYCOPUS VIRGINICUS WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; SCUTELLARIA LATERIFLORA WHOLE; STRYCHNOS IGNATII SEED; VALERIAN	6; 12; 12; 12; 12; 12; 12; 12; 6; 12; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43406-0718_d59e2f29-e84d-4751-a019-7b160b5199ad	43406-0718	HUMAN OTC DRUG	Throat		Baptisia, Phytolacca, Hydrastis, Apis mel, Arg Nit, Belladonna, Hepar Sulph Calc, Kali Bic, Lac Can, Lachesis, Merc Solub	SPRAY	ORAL	20221020		UNAPPROVED HOMEOPATHIC		Natural Creations, Inc	APIS MELLIFERA; ATROPA BELLADONNA; BAPTISIA TINCTORIA WHOLE; CALCIUM SULFIDE; CANIS LUPUS FAMILIARIS MILK; GOLDENSEAL; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SILVER NITRATE	12; 12; 6; 12; 12; 6; 12; 12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43419-075_0bf3980f-d110-afc9-e063-6294a90acbf5	43419-075	HUMAN OTC DRUG	SULWHASOO PERFECTING CUSHION NO. 15		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	20241231
43419-077_0bf3980f-d110-afc9-e063-6294a90acbf5	43419-077	HUMAN OTC DRUG	SULWHASOO PERFECTING CUSHION NO. 21		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	20241231
43419-078_0bf3980f-d110-afc9-e063-6294a90acbf5	43419-078	HUMAN OTC DRUG	SULWHASOO PERFECTING CUSHION NO. 23		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	20241231
43419-079_0bf3980f-d110-afc9-e063-6294a90acbf5	43419-079	HUMAN OTC DRUG	SULWHASOO PERFECTING CUSHION NO. 25		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	20241231
43419-085_0bf3e089-5edf-e8a7-e063-6294a90a6a02	43419-085	HUMAN OTC DRUG	Sulwhasoo UV Daily Cream		Avobenzone, Homosalate, Octisalate, Octocrylene Cream	CREAM	TOPICAL	20220531		OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1; 3.6; 1.8; 3.6	g/40mL; g/40mL; g/40mL; g/40mL			N	20241231
43419-403_0bf42e19-8b67-5241-e063-6394a90a5269	43419-403	HUMAN OTC DRUG	IOPE AIR CUSHION Cover 13 Ivory		ZINC OXIDE, OCTINOXATE, and TITANIUM DIOXIDE	LOTION	TOPICAL	20161226	20240229	OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	
43419-404_0bf42e19-8b67-5241-e063-6394a90a5269	43419-404	HUMAN OTC DRUG	IOPE AIR CUSHION Cover 21 Vanilla		ZINC OXIDE, OCTINOXATE, and TITANIUM DIOXIDE	LOTION	TOPICAL	20161226		OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	20241231
43419-405_0bf42e19-8b67-5241-e063-6394a90a5269	43419-405	HUMAN OTC DRUG	IOPE AIR CUSHION Cover 23 Beige		ZINC OXIDE, OCTINOXATE, and TITANIUM DIOXIDE	LOTION	TOPICAL	20161226		OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	20241231
43419-415_0b52046a-bddf-91b9-e063-6294a90a1fc7	43419-415	HUMAN OTC DRUG	IOPE PERFECT COVER CUSHION 13		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20200201	20240131	OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	1.797; .996; 1.764	mg/30g; mg/30g; mg/30g			N	
43419-416_0b52046a-bddf-91b9-e063-6294a90a1fc7	43419-416	HUMAN OTC DRUG	IOPE PERFECT COVER CUSHION 21		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20200201	20241031	OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	1.797; .996; 1.764	mg/30g; mg/30g; mg/30g			N	
43419-417_0b52046a-bddf-91b9-e063-6294a90a1fc7	43419-417	HUMAN OTC DRUG	IOPE PERFECT COVER CUSHION 23		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20200201	20240531	OTC MONOGRAPH DRUG	M020	Amorepacific Corporation	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	1.797; .996; 1.764	mg/30g; mg/30g; mg/30g			N	
43419-418_a085c09f-9d9c-0e5f-e053-2a95a90aae9b	43419-418	HUMAN OTC DRUG	IOPE UV DEFENSE SUN PROTECTOR EX		Avobenzone, Homosalate, Octocrylene, Octisalate Lotion	LOTION	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part352	Amorepacific Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.5; 5.4; 2.7; 5.4	mg/60mL; mg/60mL; mg/60mL; mg/60mL			N	20241231
43419-419_eea22274-5f09-62df-e053-2a95a90aa857	43419-419	HUMAN OTC DRUG	IOPE UV MEN DEFENSE SUN PROTECTOR EX		Avobenzone, Homosalate, Octocrylene, Octisalate Lotion	LOTION	TOPICAL	20200427	20240531	OTC MONOGRAPH NOT FINAL	part352	Amorepacific Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.25; 4.5; 2.25; 4.5	mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	
43419-511_0c69e4ce-6fc8-cd62-e063-6394a90a9e43	43419-511	HUMAN OTC DRUG	AMOREPACIFIC	COLOR CONTROL CUSHION COMPACT NO.104	OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20121205		OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	1.05; .6225; 1.47	g/15g; g/15g; g/15g			N	20241231
43419-512_0c69e4ce-6fc8-cd62-e063-6394a90a9e43	43419-512	HUMAN OTC DRUG	AMOREPACIFIC	COLOR CONTROL CUSHION COMPACT NO.106	OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20121205		OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	1.05; .6225; 1.47	g/15g; g/15g; g/15g			N	20241231
43419-513_0c69e4ce-6fc8-cd62-e063-6394a90a9e43	43419-513	HUMAN OTC DRUG	AMOREPACIFIC	COLOR CONTROL CUSHION COMPACT NO.204	OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20121205		OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	1.05; .6225; 1.47	g/15g; g/15g; g/15g			N	20241231
43419-514_0c69e4ce-6fc8-cd62-e063-6394a90a9e43	43419-514	HUMAN OTC DRUG	AMOREPACIFIC	COLOR CONTROL CUSHION COMPACT NO.208	OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20121205		OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	1.05; .6225; 1.47	g/15g; g/15g; g/15g			N	20241231
43419-528_0c69d3e7-5343-c52b-e063-6394a90a0aa5	43419-528	HUMAN OTC DRUG	AMOREPACIFIC COLOR CONTROL CUSHION COMPACT NO.102		ZINC OXIDE, OCTINOXATE, and TITANIUM DIOXIDE	LOTION	TOPICAL	20161226		OTC MONOGRAPH DRUG	M020	AMOREPACIFIC CORPORATION	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.1; 1.245; 2.94	g/30g; g/30g; g/30g			N	20241231
43419-768_f1ee6fef-bdbb-530e-e053-2a95a90a3159	43419-768	HUMAN OTC DRUG	Laneige Hydro UV Defense		Avobenzone, Homosalate, Octisalate, and Octocrylene Lotion	LOTION	TOPICAL	20211231		OTC MONOGRAPH NOT FINAL	part352	Amorepacific Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.25; 4.5; 2.25; 4.5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
43473-009_a9947922-889a-0d65-e053-2995a90a3666	43473-009	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-011_07b3a755-eef8-5405-e063-6394a90a0f32	43473-011	HUMAN OTC DRUG	EVERLIT CARE Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20231014		OTC MONOGRAPH DRUG	M005	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-012_07b3bb16-6261-e661-e063-6394a90a6eec	43473-012	HUMAN OTC DRUG	EVERLIT CARE Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20231014		OTC MONOGRAPH DRUG	M004	Nantong Health & Beyond Hygienic Products Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
43473-013_0814ce6b-2e9e-e68b-e063-6294a90a3daf	43473-013	HUMAN OTC DRUG	GENUINE FIRST AID Antiseptic Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20231019		OTC MONOGRAPH DRUG	M003	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	62	mL/100mL			N	20241231
43473-014_0814d789-8b7d-0be7-e063-6294a90a1e10	43473-014	HUMAN OTC DRUG	GENUINE FIRST AID Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20231018		OTC MONOGRAPH DRUG	M004	Nantong Health & Beyond Hygienic Products Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
43473-015_0814dd5c-45ab-739e-e063-6394a90ac8bc	43473-015	HUMAN OTC DRUG	GENUINE FIRST AID Antiseptic Pain Relieving		BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20231019		OTC MONOGRAPH DRUG	M017	Nantong Health & Beyond Hygienic Products Inc.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
43473-016_0a755b30-1d1a-b11f-e063-6394a90ab80f	43473-016	HUMAN OTC DRUG	FIRSTAR TRIPLE ANTIBIOTIC		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20231118		OTC MONOGRAPH DRUG	M004	Nantong Health & Beyond Hygienic Products Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
43473-034_a78e7b8d-7fd4-f9a1-e053-2995a90a3294	43473-034	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200608		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-049_fbbbd898-9534-ee72-e053-6294a90a643b	43473-049	HUMAN OTC DRUG	Hydrocortisone		HYDROCORTISONE	CREAM	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part348	Nantong Health & Beyond Hygienic Products Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43473-050_0070b925-796d-30fe-e063-6394a90ae793	43473-050	HUMAN OTC DRUG	health and .beyond Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230714		OTC MONOGRAPH FINAL	part333B	Nantong Health & Beyond Hygienic Products Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
43473-059_af0151c4-cea3-ca76-e053-2995a90ad9b2	43473-059	HUMAN OTC DRUG	INSTANT HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200911		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-060_af149936-a466-4571-e053-2995a90add14	43473-060	HUMAN OTC DRUG	INSTANT HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200911		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-102_a7760932-30ca-f5fe-e053-2a95a90a9d43	43473-102	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200608		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-104_847b8f7c-66f6-e56a-e053-2a91aa0a5f4b	43473-104	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	67	mL/100mL			N	20241231
43473-105_847b8f7c-6702-e56a-e053-2a91aa0a5f4b	43473-105	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	67	mL/100mL			N	20241231
43473-106_847c52b3-b6d7-0475-e053-2a91aa0a82d0	43473-106	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	67	mL/100mL			N	20241231
43473-115_b664b8c5-dd68-5bce-e053-2a95a90a0109	43473-115	HUMAN OTC DRUG	INSTANT HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201214		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-118_a78d5ed4-6ccf-112a-e053-2a95a90a03a8	43473-118	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200608		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-218_a3d6ad8f-e3ef-3797-e053-2a95a90a2f36	43473-218	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-219_a3d6c1c7-9f50-6937-e053-2a95a90a3d10	43473-219	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-220_a3d6e4b9-8714-d691-e053-2a95a90ac36e	43473-220	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-221_a3d6d499-d7c0-a346-e053-2a95a90a43d3	43473-221	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-222_a3d6f77a-41a4-7625-e053-2995a90a9918	43473-222	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	62	mL/100mL			N	20241231
43473-223_a3d72ce9-b821-6664-e053-2a95a90a3ac6	43473-223	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	62	mL/100mL			N	20241231
43473-224_a3d72ce9-b826-6664-e053-2a95a90a3ac6	43473-224	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	62	mL/100mL			N	20241231
43473-226_a3ed37ea-ecb1-6a52-e053-2a95a90a1d4e	43473-226	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	62	mL/100mL			N	20241231
43473-236_af15753f-db4d-c067-e053-2a95a90a47c1	43473-236	HUMAN OTC DRUG	INSTANT HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200911		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-262_a78d7e04-cfa6-94f0-e053-2a95a90a7c35	43473-262	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200608		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	62	mL/100mL			N	20241231
43473-269_a78d7e04-cf96-94f0-e053-2a95a90a7c35	43473-269	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200608		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-275_a78e2dde-8b72-1d5d-e053-2a95a90a13c1	43473-275	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200608		OTC MONOGRAPH NOT FINAL	part333E	Nantong Health & Beyond Hygienic Products Inc.	ALCOHOL	75	mL/100mL			N	20241231
43473-301_0e66af91-e0b5-827f-e063-6294a90a9847	43473-301	HUMAN OTC DRUG	Lightning X Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20240108		OTC MONOGRAPH DRUG	M004	Nantong Health & Beyond Hygienic Products Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
43473-302_0e69a971-0c6f-6ebe-e063-6394a90a0b33	43473-302	HUMAN OTC DRUG	Lightning X Burn		Lidocaine	SPRAY	TOPICAL	20240108		OTC MONOGRAPH DRUG	M017	Nantong Health & Beyond Hygienic Products Inc.	LIDOCAINE	2	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
43473-303_0e6b10e7-6e85-6bfc-e063-6294a90a8537	43473-303	HUMAN OTC DRUG	Lightning X Antiseptic		Benzalkonium Chloride	SPRAY	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	Nantong Health & Beyond Hygienic Products Inc.	BENZALKONIUM CHLORIDE	1.3	mg/100mL			N	20251231
43479-105_0e5e4315-4dcb-0fe6-e063-6294a90a3d65	43479-105	HUMAN OTC DRUG	ANTI BAC ACNE CLEARING		BENZOYL PEROXIDE	LOTION	TOPICAL	20140622		OTC MONOGRAPH DRUG	M006	KATE SOMERVILLE SKINCARE, LLC	BENZOYL PEROXIDE	5	g/100mL			N	20251231
43479-109_0e5ea8ed-e1ea-3734-e063-6294a90aed06	43479-109	HUMAN OTC DRUG	EradiKate Facial Mask		SULFUR	LOTION	TOPICAL	20140615		OTC MONOGRAPH DRUG	M006	Kate Somerville Skincare, LLC	SULFUR	5	g/100mL			N	20251231
43479-110_e54964f6-8981-d9bb-e053-2a95a90a6227	43479-110	HUMAN OTC DRUG	EradiKate Daily Foaming Cleanser	Acne Treatment	SULFUR	GEL	TOPICAL	20181012		OTC MONOGRAPH FINAL	part333D	Kate Somerville Skincare, LLC	SULFUR	3	g/100mL			N	20241231
43479-111_0e5e4315-4dcc-0fe6-e063-6294a90a3d65	43479-111	HUMAN OTC DRUG	ERADIKATE SALICYLIC ACID ACNE TREATMENT		SALICYLIC ACID	LOTION	TOPICAL	20181118		OTC MONOGRAPH DRUG	M006	KATE SOMERVILLE SKINCARE, LLC	SALICYLIC ACID	2	g/100mL			N	20251231
43479-112_0e5ea8ed-e1e7-3734-e063-6294a90aed06	43479-112	HUMAN OTC DRUG	ERADIKATE ACNE MARK FADING		SALICYLIC ACID	GEL	TOPICAL	20210401		OTC MONOGRAPH DRUG	M006	KATE SOMERVILLE SKINCARE, LLC	SALICYLIC ACID	2	g/100mL			N	20251231
43479-113_f58c511a-2e93-2ed7-e053-2995a90acf64	43479-113	HUMAN OTC DRUG	Eradikate Mattifying Acne		SALICYLIC ACID	CREAM	TOPICAL	20210401		OTC MONOGRAPH FINAL	M006	KATE SOMERVILLE SKINCARE, LLC	SALICYLIC ACID	1	g/100mL			N	20241231
43479-114_0e5ea8ed-e1e9-3734-e063-6294a90aed06	43479-114	HUMAN OTC DRUG	ERADIKATE CLARIFYING ACNE	CLEANSER	SALICYLIC ACID	GEL	TOPICAL	20210401		OTC MONOGRAPH DRUG	M006	KATE SOMERVILLE SKINCARE, LLC	SALICYLIC ACID	1	g/100mL			N	20251231
43479-208_0e5e829d-c147-37cc-e063-6294a90aa575	43479-208	HUMAN OTC DRUG	UNCOMPLIKATED MAKEUP SETTING	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20181118		OTC MONOGRAPH DRUG	M020	KATE SOMERVILLE SKINCARE LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 10; 5	g/100g; g/100g; g/100g; g/100g; g/100g			N	20251231
43479-209_0e5ea8ed-e1e6-3734-e063-6294a90aed06	43479-209	HUMAN OTC DRUG	DAILY DEFLECTOR MINERAL SUNSCREEN	SPF 40	ZINC OXIDE	LOTION	TOPICAL	20210108		OTC MONOGRAPH DRUG	M020	KATE SOMERVILLE SKINCARE LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 10; 5	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
43485-101_46576ffa-6af6-4d6c-8e83-62df0bbd7ca0	43485-101	HUMAN PRESCRIPTION DRUG	Spritam		levetiracetam	TABLET, FOR SUSPENSION	ORAL	20160205		NDA	NDA207958	Aprecia Pharmaceuticals, LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43485-102_46576ffa-6af6-4d6c-8e83-62df0bbd7ca0	43485-102	HUMAN PRESCRIPTION DRUG	Spritam		levetiracetam	TABLET, FOR SUSPENSION	ORAL	20160205		NDA	NDA207958	Aprecia Pharmaceuticals, LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43485-103_46576ffa-6af6-4d6c-8e83-62df0bbd7ca0	43485-103	HUMAN PRESCRIPTION DRUG	Spritam		levetiracetam	TABLET, FOR SUSPENSION	ORAL	20160205		NDA	NDA207958	Aprecia Pharmaceuticals, LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43485-104_46576ffa-6af6-4d6c-8e83-62df0bbd7ca0	43485-104	HUMAN PRESCRIPTION DRUG	Spritam		levetiracetam	TABLET, FOR SUSPENSION	ORAL	20160205		NDA	NDA207958	Aprecia Pharmaceuticals, LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43493-0000_f0572a47-3c93-34fc-e053-2995a90a2d63	43493-0000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Avaria Health & Beauty Corp	ALCOHOL	280	mL/400mL			N	20241231
43493-0003_f05746fd-7f52-77ac-e053-2a95a90aece8	43493-0003	HUMAN OTC DRUG	Kalaya Pain Relief 6X with Arnica		Pain Relief Cream	CREAM	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	Avaria Health & Beauty Corp	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	4; .5; 4; 11	g/100g; g/100g; g/100g; g/100g			N	20241231
43493-0004_f0574a43-981b-30a8-e053-2a95a90a8e81	43493-0004	HUMAN OTC DRUG	Kalaya Breathe Easy Vaporizing Rub		Vaporizing Rub	OINTMENT	TOPICAL	20181116		OTC MONOGRAPH FINAL	part341	Avaria Health & Beauty Corp	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	g/100g; g/100g; g/100g			N	20241231
43493-0005_f057426a-d671-6b61-e053-2a95a90a4d13	43493-0005	HUMAN OTC DRUG	Kalaya Breath Refresh		Mouthwash	LIQUID	ORAL	20181116		OTC MONOGRAPH NOT FINAL	part356	Avaria Health and Beauty Corp	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
43493-0007_f057426a-d67c-6b61-e053-2a95a90a4d13	43493-0007	HUMAN OTC DRUG	Kalaya Pain Relief		Methyl salicylate, Menthol, Camphor	LIQUID	TOPICAL	20210407		OTC MONOGRAPH NOT FINAL	part348	Avaria Health & Beauty Corp	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	10; 8; 25	g/100mL; g/100mL; g/100mL			N	20241231
43493-0008_f76a47b0-a53f-765f-e053-6394a90a397c	43493-0008	HUMAN OTC DRUG	KALAYA PAIN RELIEF 6X WITH ARNICA - Pain Relief		Methyl salicylate, Menthol, Camphor	CREAM	TOPICAL	20210407		OTC MONOGRAPH NOT FINAL	part348	Avaria Health & Beauty Corp	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	4; 4; 11	g/100g; g/100g; g/100g			N	20241231
43493-0009_f4d3adb7-b88c-5262-e053-2995a90a7fd9	43493-0009	HUMAN OTC DRUG	KALAYA BACK AND NECK PAIN RELIEF		methyl salicylate, menthol, camphor	LIQUID	TOPICAL	20230216		OTC MONOGRAPH NOT FINAL	part348	Avaria Health & Beauty Corp	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	11; 16; 25	g/100mL; g/100mL; g/100mL			N	20241231
43493-0010_f4bf6231-7351-4675-e053-2995a90a4fcf	43493-0010	HUMAN OTC DRUG	KALAYA EXTRA STRENGTH FOAMING PAIN RELIEF		methyl salicylate, menthol, camphor	LIQUID	TOPICAL	20230210		OTC MONOGRAPH NOT FINAL	part348	Avaria Health & Beauty Corp	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	3; 8; 15	g/100mL; g/100mL; g/100mL			N	20241231
43493-0011_f4bf64ae-4e8b-3498-e053-2a95a90a3a7d	43493-0011	HUMAN OTC DRUG	KALAYA FOAMING PAIN RELIEF		methyl salicylate, menthol, camphor	LIQUID	TOPICAL	20230210		OTC MONOGRAPH NOT FINAL	part348	Avaria Health & Beauty Corp	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	3; 8; 10	g/100mL; g/100mL; g/100mL			N	20241231
43493-0012_0aaf7cb2-779b-5304-e063-6394a90aec97	43493-0012	HUMAN OTC DRUG	Kalaya Extra Strength Pain Relief Gel with Arnica		methyl salicylate, menthol, camphor	GEL	TOPICAL	20230216		OTC MONOGRAPH DRUG	M017	Avaria Health & Beauty Corp	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	4; 4; 11	g/100g; g/100g; g/100g			N	20241231
43493-0013_0ab0b0a3-55c9-2837-e063-6294a90a570d	43493-0013	HUMAN OTC DRUG	Kalaya Extra Strength Pain Relief Cream with Hemp Seed Oil		methyl salicylate, menthol, camphor	CREAM	TOPICAL	20231201		OTC MONOGRAPH DRUG	M017	Avaria Health & Beauty Corp	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	4; 4; 11	g/100g; g/100g; g/100g			N	20241231
43498-100_d70d6555-4b3b-5832-e053-2995a90a1a55	43498-100	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-101_d70e3c83-4109-bb86-e053-2995a90a8a9a	43498-101	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-102_d66a3298-8b9b-2440-e053-2a95a90a2101	43498-102	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-103_d70e42c6-8627-53b4-e053-2a95a90a4971	43498-103	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-104_d70e4c68-dc7d-43e0-e053-2995a90acd86	43498-104	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-105_d70e56fb-58be-0593-e053-2a95a90a661a	43498-105	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-106_d70e56fb-58c7-0593-e053-2a95a90a661a	43498-106	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-107_d70e60bc-60c2-c66c-e053-2a95a90a106f	43498-107	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-108_d70dee10-cc1c-4db1-e053-2995a90a5c50	43498-108	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-109_d70e60bc-6104-c66c-e053-2a95a90a106f	43498-109	HUMAN PRESCRIPTION DRUG	Burkhart		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
43498-150_d70d52c0-65f1-f632-e053-2995a90a9291	43498-150	HUMAN PRESCRIPTION DRUG	Burkhart Neutral pH		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	4.086	g/454g			N	20241231
43498-151_d70d625c-edfa-6184-e053-2a95a90ac93a	43498-151	HUMAN PRESCRIPTION DRUG	Burkhart Neutral pH		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	SODIUM FLUORIDE	4.086	g/454g			N	20241231
43498-200_d70dcc83-25ca-3eb9-e053-2a95a90a5c02	43498-200	HUMAN PRESCRIPTION DRUG	Burkhart		Stannous Fluoride	CONCENTRATE	DENTAL	20130201		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	STANNOUS FLUORIDE	.3408	g/284g			N	20241231
43498-201_d70dc1ee-062b-64d4-e053-2995a90a7559	43498-201	HUMAN PRESCRIPTION DRUG	Burkhart		Stannous Fluoride	CONCENTRATE	DENTAL	20130201		UNAPPROVED DRUG OTHER		Burkhart Dental Supply Inc	STANNOUS FLUORIDE	.3408	g/284g			N	20241231
43498-250_d70dee10-cc10-4db1-e053-2995a90a5c50	43498-250	HUMAN OTC DRUG	Burkhart		Stannous Fluoride	GEL	DENTAL	20130105		OTC MONOGRAPH FINAL	part355	Burkhart Dental Supply Inc	STANNOUS FLUORIDE	.116	g/120g			N	20241231
43498-251_d70dfd34-b2a0-25ea-e053-2a95a90a69f5	43498-251	HUMAN OTC DRUG	Burkhart		Stannous Fluoride	GEL	DENTAL	20130105		OTC MONOGRAPH FINAL	part355	Burkhart Dental Supply Inc	STANNOUS FLUORIDE	.116	g/120g			N	20241231
43498-310_d655bfd3-a3a3-6c58-e053-2995a90a1c48	43498-310	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-311_d655bfd3-a3af-6c58-e053-2995a90a1c48	43498-311	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-312_d655ba29-3757-fb8a-e053-2995a90afd80	43498-312	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-313_d655bfd3-a3fb-6c58-e053-2995a90a1c48	43498-313	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-314_d655c91d-4582-2c95-e053-2a95a90a134a	43498-314	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-315_d655b0d2-0fc0-de6b-e053-2995a90a43f7	43498-315	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-316_d655c91d-458e-2c95-e053-2a95a90a134a	43498-316	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-317_d655cae9-253a-98ae-e053-2995a90a48bb	43498-317	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-318_d655d0ee-d5d6-555b-e053-2a95a90a1cfd	43498-318	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43498-319_d655d30d-d706-d85a-e053-2995a90a4540	43498-319	HUMAN OTC DRUG	Burkhart Topical Anesthetic		Benzocaine	GEL	DENTAL	20151101		OTC MONOGRAPH NOT FINAL	part356	Burkhart Dental Supply Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43528-003_f698a0e4-1e23-47f3-aee5-2d6c54131e5a	43528-003	VACCINE	HEPLISAV-B		Hepatitis B Vaccine (Recombinant) Adjuvanted	INJECTION, SOLUTION	INTRAMUSCULAR	20180101		BLA	BLA125428	Dynavax Technologies Corporation	HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN	20	ug/.5mL	Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
43538-100_10983826-2970-4ff2-87f6-6633c093843f	43538-100	HUMAN PRESCRIPTION DRUG	Sumaxin	Cleansing Pads	sulfacetamide sodium and Sulfur	CLOTH	TOPICAL	20090101		UNAPPROVED DRUG OTHER		Medimetriks Pharmaceuticals, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 40	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
43538-101_10983826-2970-4ff2-87f6-6633c093843f	43538-101	HUMAN PRESCRIPTION DRUG	Sumaxin CP		sulfacetamide sodium and sulfur	KIT		20110801		UNAPPROVED DRUG OTHER		Medimetriks Pharmaceuticals, Inc.						N	20241231
43538-170_46465f9a-1b07-4044-9598-55a211b95297	43538-170	HUMAN PRESCRIPTION DRUG	Clindacin P		clindamycin phosphate	SOLUTION	TOPICAL	20110220		ANDA	ANDA065049	Medimetriks Pharmaceuticals, Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
43538-172_0c940a5b-f099-4a5c-9ab7-7ad95a9e22f4	43538-172	HUMAN PRESCRIPTION DRUG	Clindacin ETZ		clindamycin phosphate	SWAB	TOPICAL	20130615		ANDA	ANDA065049	Medimetriks Pharmaceuticals, Inc.	CLINDAMYCIN PHOSPHATE	10	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
43538-173_0c940a5b-f099-4a5c-9ab7-7ad95a9e22f4	43538-173	HUMAN PRESCRIPTION DRUG	Clindacin ETZ		clindamycin phosphate	KIT		20130615		ANDA	ANDA065049	Medimetriks Pharmaceuticals, Inc.						N	20241231
43538-176_ea93a8c5-1172-4b62-9a28-33783fbca9fd	43538-176	HUMAN PRESCRIPTION DRUG	Neuac		clindamycin phosphate and benzoyl peroxide	GEL	TOPICAL	20140615		ANDA	ANDA090979	Medimetriks Pharmaceuticals	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
43538-179_391b4472-8468-4d6f-bab0-406d83655cd0	43538-179	HUMAN PRESCRIPTION DRUG	Clindacin		clindamycin phosphate	AEROSOL, FOAM	TOPICAL	20100321		ANDA	ANDA090785	Medimetriks Pharmaceuticals, Inc.	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
43538-500_9e5c8888-85f4-4f9c-b807-b30e66a3c4a8	43538-500	HUMAN PRESCRIPTION DRUG	Ciclodan		ciclopirox	SOLUTION	TOPICAL	20110410		ANDA	ANDA078233	Medimetriks Pharmaceuticals, Inc.	CICLOPIROX	2.28	g/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
43538-530_f3738f17-654e-419b-952c-ca3566550a9c	43538-530	HUMAN PRESCRIPTION DRUG	Ketodan		ketoconazole	AEROSOL, FOAM	TOPICAL	20120615		ANDA	ANDA091550	Medimetriks Pharmaceuticals, Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
43538-900_d7d379c8-6e10-4b06-b6f9-68f129c8edc7	43538-900	HUMAN PRESCRIPTION DRUG	Synalar		fluocinolone acetonide	CREAM	TOPICAL	20120927		NDA	NDA012787	Medimetriks Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43538-910_ba6591f7-ccd9-4269-a18f-d269f2714345	43538-910	HUMAN PRESCRIPTION DRUG	Synalar		fluocinolone acetonide	OINTMENT	TOPICAL	20120927		NDA	NDA013960	Medimetriks Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43538-940_4b6c5088-fd92-4793-8010-f2b20f9fe44a	43538-940	HUMAN PRESCRIPTION DRUG	Neo-Synalar		neomycin sulfate and fluocinolone acetonide	CREAM	TOPICAL	19630611		ANDA	ANDA060700	Medimetriks Pharmaceuticals	FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE	.25; 3.5	mg/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43538-950_d9fb3d50-fdde-4dc7-af7c-c8c2c039fc51	43538-950	HUMAN PRESCRIPTION DRUG	Clodan		clobetasol propionate	SHAMPOO	TOPICAL	20140622		ANDA	ANDA090974	Medimetriks Pharmaceuticals	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43538-952_efec5f5f-6098-480b-a95a-d46afd79fbcd	43538-952	HUMAN PRESCRIPTION DRUG	Tovet (emollient formulation)		CLOBETASOL PROPIONATE	AEROSOL, FOAM	TOPICAL	20130201		ANDA	ANDA201402	Medimetriks Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43547-001_3cd80c04-43a2-4be3-b831-ebccc273a0d2	43547-001	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230328		ANDA	ANDA214920	Solco Healthcare US LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43547-002_3cd80c04-43a2-4be3-b831-ebccc273a0d2	43547-002	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230328		ANDA	ANDA214920	Solco Healthcare US LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43547-003_41f4c122-d865-444c-9963-62e2bbee8f56	43547-003	HUMAN PRESCRIPTION DRUG	FINGOLIMOD		fingolimod	CAPSULE	ORAL	20200217		ANDA	ANDA208003	Solco Healthcare US, LLC	FINGOLIMOD	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
43547-005_4251c764-7224-4f94-9de7-b6c76cb1f5cd	43547-005	HUMAN PRESCRIPTION DRUG	ROFLUMILAST		roflumilast	TABLET	ORAL	20220510		ANDA	ANDA208299	Solco Healthcare US, LLC.	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
43547-019_b0cce89c-0e84-4f60-8e50-0e26c41c2613	43547-019	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220401		ANDA	ANDA208781	Solco Healthcare U.S., LLC	QUETIAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-020_b0cce89c-0e84-4f60-8e50-0e26c41c2613	43547-020	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220401		ANDA	ANDA208781	Solco Healthcare U.S., LLC	QUETIAPINE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-021_b0cce89c-0e84-4f60-8e50-0e26c41c2613	43547-021	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220401		ANDA	ANDA208781	Solco Healthcare U.S., LLC	QUETIAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-022_b0cce89c-0e84-4f60-8e50-0e26c41c2613	43547-022	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET, EXTENDED RELEASE	ORAL	20220401		ANDA	ANDA208781	Solco Healthcare U.S., LLC	QUETIAPINE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-024_93f3f082-5cf0-409d-a4db-33fdf1d035b3	43547-024	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20221018		ANDA	ANDA210414	Solco Healthcare US, LLC	DIMETHYL FUMARATE	120	mg/1			N	20241231
43547-025_93f3f082-5cf0-409d-a4db-33fdf1d035b3	43547-025	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20221018		ANDA	ANDA210414	Solco Healthcare US, LLC	DIMETHYL FUMARATE	240	mg/1			N	20241231
43547-047_430467ce-4e6d-4ded-aa75-692bc9579442	43547-047	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20220118		ANDA	ANDA210609	Solco Healthcare US, LLC	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43547-049_430467ce-4e6d-4ded-aa75-692bc9579442	43547-049	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20220118		ANDA	ANDA210609	Solco Healthcare US, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43547-050_430467ce-4e6d-4ded-aa75-692bc9579442	43547-050	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20220118		ANDA	ANDA210609	Solco Healthcare US, LLC	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43547-051_430467ce-4e6d-4ded-aa75-692bc9579442	43547-051	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20220118		ANDA	ANDA210609	Solco Healthcare US, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43547-221_02fa5302-3a0b-4315-abc6-a9706c7bef28	43547-221	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Solco Healthcare US, LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43547-222_02fa5302-3a0b-4315-abc6-a9706c7bef28	43547-222	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Solco Healthcare US, LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43547-223_02fa5302-3a0b-4315-abc6-a9706c7bef28	43547-223	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Solco Healthcare US, LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43547-224_02fa5302-3a0b-4315-abc6-a9706c7bef28	43547-224	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Solco Healthcare US, LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43547-226_9d9e4ccc-efc3-4d8e-9302-1cd4ed4eb25d	43547-226	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130115		ANDA	ANDA086988	Solco Healthcare LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43547-268_dbaf433c-9f03-4f89-bf32-6fbfc3d61f2f	43547-268	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-269_dbaf433c-9f03-4f89-bf32-6fbfc3d61f2f	43547-269	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-270_dbaf433c-9f03-4f89-bf32-6fbfc3d61f2f	43547-270	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-271_dbaf433c-9f03-4f89-bf32-6fbfc3d61f2f	43547-271	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-272_dbaf433c-9f03-4f89-bf32-6fbfc3d61f2f	43547-272	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-273_dbaf433c-9f03-4f89-bf32-6fbfc3d61f2f	43547-273	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-274_dbaf433c-9f03-4f89-bf32-6fbfc3d61f2f	43547-274	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-275_2ae1a4fe-ec65-4546-a4a7-1377ab1872bd	43547-275	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20111101		ANDA	ANDA200292	Solco Healthcare US, LLC	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43547-276_2ae1a4fe-ec65-4546-a4a7-1377ab1872bd	43547-276	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20111101		ANDA	ANDA200292	Solco Healthcare US, LLC	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43547-280_0d58a174-db77-4ba9-a188-b57678ab66bf	43547-280	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	SOLCO HEALTHCARE US, LLC	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
43547-281_0d58a174-db77-4ba9-a188-b57678ab66bf	43547-281	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	SOLCO HEALTHCARE US, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
43547-282_0d58a174-db77-4ba9-a188-b57678ab66bf	43547-282	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	SOLCO HEALTHCARE US, LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
43547-283_85d103f4-4fba-459a-841e-961926dee65d	43547-283	HUMAN PRESCRIPTION DRUG	TELMISARTAN		TELMISARTAN	TABLET	ORAL	20170820		ANDA	ANDA207882	Solco Healthcare US, LLC	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-284_85d103f4-4fba-459a-841e-961926dee65d	43547-284	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20170820		ANDA	ANDA207882	Solco Healthcare US, LLC	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-285_85d103f4-4fba-459a-841e-961926dee65d	43547-285	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20170820		ANDA	ANDA207882	Solco Healthcare US, LLC	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-288_8978516f-6290-434f-9166-ff3007f0881f	43547-288	HUMAN PRESCRIPTION DRUG	bupropion		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA202304	Solco Healthcare US LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43547-289_8978516f-6290-434f-9166-ff3007f0881f	43547-289	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA202304	Solco Healthcare US LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43547-290_8978516f-6290-434f-9166-ff3007f0881f	43547-290	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA202304	Solco Healthcare US LLC	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43547-295_53efc1f0-0df6-463d-bee2-a61e596d1e8a	43547-295	HUMAN PRESCRIPTION DRUG	FEBUXOSTAT		febuxostat	TABLET	ORAL	20220929		ANDA	ANDA206266	Solco Healthcare US LLC	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43547-296_53efc1f0-0df6-463d-bee2-a61e596d1e8a	43547-296	HUMAN PRESCRIPTION DRUG	FEBUXOSTAT		febuxostat	TABLET	ORAL	20221101		ANDA	ANDA206266	Solco Healthcare US LLC	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
43547-299_21c26510-42e0-4e52-ae81-6c45713906ae	43547-299	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET	ORAL	20220304		ANDA	ANDA206720	Solco Healthcare US, LLC.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-300_21c26510-42e0-4e52-ae81-6c45713906ae	43547-300	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET	ORAL	20220304		ANDA	ANDA206720	Solco Healthcare US, LLC.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-301_21c26510-42e0-4e52-ae81-6c45713906ae	43547-301	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET	ORAL	20220304		ANDA	ANDA206720	Solco Healthcare US, LLC.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-302_71684c41-433a-4d0a-b08b-cc7f13a408de	43547-302	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20171204		ANDA	ANDA205363	Solco Healthcare U.S., LLC	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-303_71684c41-433a-4d0a-b08b-cc7f13a408de	43547-303	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20171204		ANDA	ANDA205363	Solco Healthcare U.S., LLC	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-304_71684c41-433a-4d0a-b08b-cc7f13a408de	43547-304	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20171204		ANDA	ANDA205363	Solco Healthcare U.S., LLC	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-305_71684c41-433a-4d0a-b08b-cc7f13a408de	43547-305	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20171204		ANDA	ANDA205363	Solco Healthcare U.S., LLC	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-306_71684c41-433a-4d0a-b08b-cc7f13a408de	43547-306	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20171204		ANDA	ANDA205363	Solco Healthcare U.S., LLC	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-307_71684c41-433a-4d0a-b08b-cc7f13a408de	43547-307	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20170915		ANDA	ANDA205363	Solco Healthcare U.S., LLC	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-311_1b876e29-1212-4e28-8d3c-e2e717a8fe53	43547-311	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20151031		ANDA	ANDA206083	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-312_1b876e29-1212-4e28-8d3c-e2e717a8fe53	43547-312	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20151031		ANDA	ANDA206083	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-313_1b876e29-1212-4e28-8d3c-e2e717a8fe53	43547-313	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20151031		ANDA	ANDA206083	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-314_1b876e29-1212-4e28-8d3c-e2e717a8fe53	43547-314	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20151031		ANDA	ANDA206083	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-315_1b876e29-1212-4e28-8d3c-e2e717a8fe53	43547-315	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20151031		ANDA	ANDA206083	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-324_d9b62506-144a-4c0b-a550-b09bdf958c01	43547-324	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, DELAYED RELEASE	ORAL	20161128		ANDA	ANDA207494	Solco Healthcare US LLC	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43547-325_d9b62506-144a-4c0b-a550-b09bdf958c01	43547-325	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, DELAYED RELEASE	ORAL	20161128		ANDA	ANDA207494	Solco Healthcare US LLC	DOXYCYCLINE HYCLATE	200	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43547-330_4d6d7068-64e1-45e7-82e5-861935757086	43547-330	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20140301		ANDA	ANDA203072	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-331_4d6d7068-64e1-45e7-82e5-861935757086	43547-331	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20140301		ANDA	ANDA203072	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-335_51573661-8fd9-47e8-a404-05a25dbc8d21	43547-335	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Solco healthcare U.S., LLC	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-336_51573661-8fd9-47e8-a404-05a25dbc8d21	43547-336	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Solco healthcare U.S., LLC	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-337_51573661-8fd9-47e8-a404-05a25dbc8d21	43547-337	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Solco healthcare U.S., LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-338_51573661-8fd9-47e8-a404-05a25dbc8d21	43547-338	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Solco healthcare U.S., LLC	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-339_1f0a0598-13b3-4249-b483-92ccff6dcd5a	43547-339	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20140601		ANDA	ANDA077493	Solco Healthcare US, LLC	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-340_1f0a0598-13b3-4249-b483-92ccff6dcd5a	43547-340	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20140601		ANDA	ANDA077493	Solco Healthcare US, LLC	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-341_1f0a0598-13b3-4249-b483-92ccff6dcd5a	43547-341	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20140601		ANDA	ANDA077493	Solco Healthcare US, LLC	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-342_1f0a0598-13b3-4249-b483-92ccff6dcd5a	43547-342	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20140601		ANDA	ANDA077493	Solco Healthcare US, LLC	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-343_1f0a0598-13b3-4249-b483-92ccff6dcd5a	43547-343	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20140601		ANDA	ANDA077493	Solco Healthcare US, LLC	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-344_1f0a0598-13b3-4249-b483-92ccff6dcd5a	43547-344	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20140601		ANDA	ANDA077493	Solco Healthcare US, LLC	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-345_80de46c3-f9da-4994-b5ef-b470e83df205	43547-345	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140501		ANDA	ANDA203468	Solco healthcare U.S., LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43547-346_80de46c3-f9da-4994-b5ef-b470e83df205	43547-346	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140501		ANDA	ANDA203468	Solco healthcare U.S., LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43547-347_878bf293-7b01-4383-bcf5-11e25987c813	43547-347	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Solco Healthcare US, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43547-348_878bf293-7b01-4383-bcf5-11e25987c813	43547-348	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Solco Healthcare US, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43547-349_878bf293-7b01-4383-bcf5-11e25987c813	43547-349	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Solco Healthcare US, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43547-350_878bf293-7b01-4383-bcf5-11e25987c813	43547-350	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Solco Healthcare US, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43547-351_a5dd7612-fa64-461b-9c02-6da2adac49d0	43547-351	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Solco healthcare U.S., LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-352_a5dd7612-fa64-461b-9c02-6da2adac49d0	43547-352	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Solco healthcare U.S., LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-353_a5dd7612-fa64-461b-9c02-6da2adac49d0	43547-353	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Solco healthcare U.S., LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-354_a5dd7612-fa64-461b-9c02-6da2adac49d0	43547-354	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Solco healthcare U.S., LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-355_a5dd7612-fa64-461b-9c02-6da2adac49d0	43547-355	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Solco healthcare U.S., LLC	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-356_a5dd7612-fa64-461b-9c02-6da2adac49d0	43547-356	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Solco healthcare U.S., LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-360_151ed059-542f-4688-8cbd-779d5467f462	43547-360	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20110601		ANDA	ANDA091497	Solco Healthcare US, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-361_151ed059-542f-4688-8cbd-779d5467f462	43547-361	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Solco Healthcare US, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-362_151ed059-542f-4688-8cbd-779d5467f462	43547-362	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Solco Healthcare US, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-363_2d3779b0-83d9-4b6f-a043-f7768cd7fce6	43547-363	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Solco Healthcare US, LLC	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-364_2d3779b0-83d9-4b6f-a043-f7768cd7fce6	43547-364	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Solco Healthcare US, LLC	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-365_2d3779b0-83d9-4b6f-a043-f7768cd7fce6	43547-365	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Solco Healthcare US, LLC	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-366_2d3779b0-83d9-4b6f-a043-f7768cd7fce6	43547-366	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Solco Healthcare US, LLC	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-367_aa8d8f4b-1383-4b30-88f3-90e9aee11222	43547-367	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Solco Healthcare US, LLC	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-368_aa8d8f4b-1383-4b30-88f3-90e9aee11222	43547-368	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Solco Healthcare US, LLC	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-369_aa8d8f4b-1383-4b30-88f3-90e9aee11222	43547-369	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Solco Healthcare US, LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-370_aa8d8f4b-1383-4b30-88f3-90e9aee11222	43547-370	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Solco Healthcare US, LLC	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-374_fe8577a0-8afd-4c60-9618-126a096cfa47	43547-374	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20160613		ANDA	ANDA203071	Solco Healthcare U.S., LLC	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-375_fe8577a0-8afd-4c60-9618-126a096cfa47	43547-375	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20160613		ANDA	ANDA203071	Solco Healthcare U.S., LLC	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-376_fe8577a0-8afd-4c60-9618-126a096cfa47	43547-376	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20160613		ANDA	ANDA203071	Solco Healthcare U.S., LLC	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
43547-377_dc47845f-067b-42a7-b140-51898cb35b0c	43547-377	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, COATED	ORAL	20161028		ANDA	ANDA206654	Solco Healthcare U.S., LLC	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43547-378_dc47845f-067b-42a7-b140-51898cb35b0c	43547-378	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, COATED	ORAL	20161028		ANDA	ANDA206654	Solco Healthcare U.S., LLC	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43547-379_1b037cb5-9db9-44a6-89dd-1cf1dcf895fb	43547-379	HUMAN PRESCRIPTION DRUG	DULOXETINE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160120		ANDA	ANDA206653	Solco Healthcare US, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43547-380_1b037cb5-9db9-44a6-89dd-1cf1dcf895fb	43547-380	HUMAN PRESCRIPTION DRUG	DULOXETINE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160120		ANDA	ANDA206653	Solco Healthcare US, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43547-381_1b037cb5-9db9-44a6-89dd-1cf1dcf895fb	43547-381	HUMAN PRESCRIPTION DRUG	DULOXETINE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160120		ANDA	ANDA206653	Solco Healthcare US, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43547-382_0de518b0-75a0-466f-9e20-15c2e00aefbd	43547-382	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20161205		ANDA	ANDA203713	Solco Healthcare US, LLC	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43547-386_893dd5ed-1330-4f2f-a064-d95061e69fc3	43547-386	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		fosinopirl sodium	TABLET	ORAL	20171001		ANDA	ANDA205670	Solco Healthcare LLC	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-387_893dd5ed-1330-4f2f-a064-d95061e69fc3	43547-387	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		fosinopril sodium	TABLET	ORAL	20171001		ANDA	ANDA205670	Solco Healthcare LLC	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-388_893dd5ed-1330-4f2f-a064-d95061e69fc3	43547-388	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		fosinopril sodium	TABLET	ORAL	20171001		ANDA	ANDA205670	Solco Healthcare LLC	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-391_1b7ba94c-998a-491e-86d9-b7b2cc97a9eb	43547-391	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		olmesartan medoxomil and hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA207804	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-392_1b7ba94c-998a-491e-86d9-b7b2cc97a9eb	43547-392	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		olmesartan medoxomil and hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA207804	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-393_1b7ba94c-998a-491e-86d9-b7b2cc97a9eb	43547-393	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		olmesartan medoxomil and hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA207804	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-394_95a5568d-751c-4497-b70c-5cc358bbb2af	43547-394	HUMAN PRESCRIPTION DRUG	Glimepiride		glimepiride	TABLET	ORAL	20170130		ANDA	ANDA077370	Solco Healthcare U.S., LLC	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43547-395_95a5568d-751c-4497-b70c-5cc358bbb2af	43547-395	HUMAN PRESCRIPTION DRUG	Glimepiride		glimepiride	TABLET	ORAL	20170130		ANDA	ANDA077370	Solco Healthcare U.S., LLC	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43547-396_95a5568d-751c-4497-b70c-5cc358bbb2af	43547-396	HUMAN PRESCRIPTION DRUG	Glimepiride		glimepiride	TABLET	ORAL	20170130		ANDA	ANDA077370	Solco Healthcare U.S., LLC	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
43547-397_d8ce29b2-7f3a-4944-bf9e-0fcebb25d3c4	43547-397	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Solco Healthcare U.S., LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-398_d8ce29b2-7f3a-4944-bf9e-0fcebb25d3c4	43547-398	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Solco Healthcare U.S., LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-399_450dbde3-44c3-4b62-8cea-dc97ad7f1d20	43547-399	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Solco Healthcare U.S., LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43547-400_450dbde3-44c3-4b62-8cea-dc97ad7f1d20	43547-400	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Solco Healthcare U.S., LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43547-401_bc9c6c62-0d7a-4d1e-bed6-0796342bf87c	43547-401	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Solco Healthcare LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43547-402_bc9c6c62-0d7a-4d1e-bed6-0796342bf87c	43547-402	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Solco Healthcare LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43547-403_bc9c6c62-0d7a-4d1e-bed6-0796342bf87c	43547-403	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Solco Healthcare LLC	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
43547-404_a9f0be20-5e10-40fd-928a-4fb0909af8f5	43547-404	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20020104		ANDA	ANDA040377	Solco Healthcare U.S., LLC	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
43547-405_9d9e4ccc-efc3-4d8e-9302-1cd4ed4eb25d	43547-405	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20171215		ANDA	ANDA086989	Solco Healthcare LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43547-406_99293743-ec49-42ca-962f-11b58921ce64	43547-406	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Solco Healthcare LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43547-407_99293743-ec49-42ca-962f-11b58921ce64	43547-407	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Solco Healthcare LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43547-408_99293743-ec49-42ca-962f-11b58921ce64	43547-408	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Solco Healthcare LLC	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43547-409_3f62fbd7-8552-4f81-90f8-fb6b522ee1f2	43547-409	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine	CAPSULE	ORAL	20170815		ANDA	ANDA207188	Solco Healthcare LLC	PAROXETINE MESYLATE	7.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43547-410_b8f1731a-cbac-4f64-a8d4-320b80b335e1	43547-410	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20171110		ANDA	ANDA205823	Solco Healthcare US, LLC	QUINAPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-411_b8f1731a-cbac-4f64-a8d4-320b80b335e1	43547-411	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20171110		ANDA	ANDA205823	Solco Healthcare US, LLC	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-412_b8f1731a-cbac-4f64-a8d4-320b80b335e1	43547-412	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20171110		ANDA	ANDA205823	Solco Healthcare US, LLC	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-413_b8f1731a-cbac-4f64-a8d4-320b80b335e1	43547-413	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20160316		ANDA	ANDA205823	Solco Healthcare US, LLC	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-414_1ed80b02-cb3b-41c5-ab33-ff0106b8792d	43547-414	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Solco healthcare U.S., LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-415_1ed80b02-cb3b-41c5-ab33-ff0106b8792d	43547-415	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Solco healthcare U.S., LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-416_1ed80b02-cb3b-41c5-ab33-ff0106b8792d	43547-416	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Solco healthcare U.S., LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-417_1ed80b02-cb3b-41c5-ab33-ff0106b8792d	43547-417	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Solco healthcare U.S., LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-418_1ed80b02-cb3b-41c5-ab33-ff0106b8792d	43547-418	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Solco healthcare U.S., LLC	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-419_1ed80b02-cb3b-41c5-ab33-ff0106b8792d	43547-419	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Solco healthcare U.S., LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
43547-420_d4c1a1dd-0ff7-4c99-926c-3fc988dade79	43547-420	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Solco Healthcare LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-421_d4c1a1dd-0ff7-4c99-926c-3fc988dade79	43547-421	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Solco Healthcare LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-422_d4c1a1dd-0ff7-4c99-926c-3fc988dade79	43547-422	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Solco Healthcare LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-423_59da1fd1-5d2c-4a6c-9372-cc2fe0f86404	43547-423	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20180215		ANDA	ANDA204901	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-424_59da1fd1-5d2c-4a6c-9372-cc2fe0f86404	43547-424	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20180215		ANDA	ANDA204901	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-425_59da1fd1-5d2c-4a6c-9372-cc2fe0f86404	43547-425	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20180215		ANDA	ANDA204901	Solco Healthcare US, LLC	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-426_258c9ca5-41a1-44dc-8d3a-958bf6613e40	43547-426	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		Pioglitazone	TABLET	ORAL	20180520		ANDA	ANDA207806	Solco Healthcare LLC	PIOGLITAZONE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
43547-427_258c9ca5-41a1-44dc-8d3a-958bf6613e40	43547-427	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		Pioglitazone	TABLET	ORAL	20180520		ANDA	ANDA207806	Solco Healthcare LLC	PIOGLITAZONE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
43547-428_258c9ca5-41a1-44dc-8d3a-958bf6613e40	43547-428	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		Pioglitazone	TABLET	ORAL	20180520		ANDA	ANDA207806	Solco Healthcare LLC	PIOGLITAZONE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
43547-430_165e6912-1ca0-4fad-8c3c-97a927d0d249	43547-430	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		fenofibrate	TABLET	ORAL	20190220		ANDA	ANDA211080	Solco Healthcare US, LLC	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43547-431_165e6912-1ca0-4fad-8c3c-97a927d0d249	43547-431	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		fenofibrate	TABLET	ORAL	20190220		ANDA	ANDA211080	Solco Healthcare US, LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43547-435_7704af2a-3917-49bf-a416-3e57c819a6a9	43547-435	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180215		ANDA	ANDA209757	Solco Healthcare LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43547-436_8f7c60d0-b6eb-4325-ab48-d5748975c5dc	43547-436	HUMAN PRESCRIPTION DRUG	ENTECAVIR		ENTECAVIR	TABLET, FILM COATED	ORAL	20180401		ANDA	ANDA208782	Solco Healthcare LLC	ENTECAVIR ANHYDROUS	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
43547-437_8f7c60d0-b6eb-4325-ab48-d5748975c5dc	43547-437	HUMAN PRESCRIPTION DRUG	ENTECAVIR		ENTECAVIR	TABLET, FILM COATED	ORAL	20180401		ANDA	ANDA208782	Solco Healthcare LLC	ENTECAVIR ANHYDROUS	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
43547-441_a0a83c79-b565-4c82-a127-5e87816cbaef	43547-441	HUMAN PRESCRIPTION DRUG	TELMISARTAN AND HYDROCHLOROTHIAZIDE		telmisartan and hydrochlorothiazide	TABLET	ORAL	20180205		ANDA	ANDA209028	Solco Healthcare LLC	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-442_a0a83c79-b565-4c82-a127-5e87816cbaef	43547-442	HUMAN PRESCRIPTION DRUG	TELMISARTAN AND HYDROCHLOROTHIAZIDE		telmisartan and hydrochlorothiazide	TABLET	ORAL	20180205		ANDA	ANDA209028	Solco Healthcare LLC	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-443_a0a83c79-b565-4c82-a127-5e87816cbaef	43547-443	HUMAN PRESCRIPTION DRUG	TELMISARTAN AND HYDROCHLOROTHIAZIDE		telmisartan and hydrochlorothiazide	TABLET	ORAL	20180205		ANDA	ANDA209028	Solco Healthcare LLC	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-454_cfe618ae-f7de-43d8-a754-3ce0a08c48ee	43547-454	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		levetiracetam	INJECTION	INTRAVENOUS	20220411		ANDA	ANDA209474	Solco Healthcare US, LLC	LEVETIRACETAM	500	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43547-457_536d3653-93a1-4ae3-ac89-8fa23943bd96	43547-457	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200402		ANDA	ANDA211861	Solco Healthcare US, LLC	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-458_536d3653-93a1-4ae3-ac89-8fa23943bd96	43547-458	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200402		ANDA	ANDA211861	Solco Healthcare US, LLC	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-459_745438ab-c3fe-4da9-9548-730970399e0d	43547-459	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20171120		ANDA	ANDA207455	Solco Healthcare LLC	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-460_745438ab-c3fe-4da9-9548-730970399e0d	43547-460	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20171120		ANDA	ANDA207455	Solco Healthcare LLC	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-461_745438ab-c3fe-4da9-9548-730970399e0d	43547-461	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20171120		ANDA	ANDA207455	Solco Healthcare LLC	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 25	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
43547-462_d9b62506-144a-4c0b-a550-b09bdf958c01	43547-462	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, DELAYED RELEASE	ORAL	20181128		ANDA	ANDA207494	Solco Healthcare US LLC	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
43547-486_9b9363c0-b23f-4d57-b3dc-c4da1dff25eb	43547-486	HUMAN PRESCRIPTION DRUG	Methylphenidate hydrochloride		Methylphenidate hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA212697	Solco Healthcare US,LLC	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-487_9b9363c0-b23f-4d57-b3dc-c4da1dff25eb	43547-487	HUMAN PRESCRIPTION DRUG	Methylphenidate hydrochloride		Methylphenidate hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA212697	Solco Healthcare US,LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-488_9b9363c0-b23f-4d57-b3dc-c4da1dff25eb	43547-488	HUMAN PRESCRIPTION DRUG	Methylphenidate hydrochloride		Methylphenidate hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA212697	Solco Healthcare US,LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-499_a1d7b8ec-309d-447e-ae05-b9e89cc29948	43547-499	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		acyclovir	OINTMENT	TOPICAL	20211115		ANDA	ANDA212202	Solco Healthcare US, LLC	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
43547-503_1016cad7-2198-483c-893b-e25fd397a226	43547-503	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220531		ANDA	ANDA212681	Solco Healthcare US, LLC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43547-504_1016cad7-2198-483c-893b-e25fd397a226	43547-504	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220531		ANDA	ANDA212681	Solco Healthcare US, LLC.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
43547-506_085db834-3735-40d9-ac67-f9dbb82390c5	43547-506	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	25	mg/1		CV	N	20241231
43547-507_085db834-3735-40d9-ac67-f9dbb82390c5	43547-507	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	50	mg/1		CV	N	20241231
43547-508_085db834-3735-40d9-ac67-f9dbb82390c5	43547-508	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	75	mg/1		CV	N	20241231
43547-509_085db834-3735-40d9-ac67-f9dbb82390c5	43547-509	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	100	mg/1		CV	N	20241231
43547-510_085db834-3735-40d9-ac67-f9dbb82390c5	43547-510	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	150	mg/1		CV	N	20241231
43547-511_085db834-3735-40d9-ac67-f9dbb82390c5	43547-511	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	200	mg/1		CV	N	20241231
43547-512_085db834-3735-40d9-ac67-f9dbb82390c5	43547-512	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	225	mg/1		CV	N	20241231
43547-513_085db834-3735-40d9-ac67-f9dbb82390c5	43547-513	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20200615		ANDA	ANDA207883	Solco Healthcare US, LLC	PREGABALIN	300	mg/1		CV	N	20241231
43547-518_61b1230e-c0dc-46c6-a577-7d5dd2515eb7	43547-518	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET	ORAL	20220412		ANDA	ANDA206954	Solco Healthcare US, LLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-519_61b1230e-c0dc-46c6-a577-7d5dd2515eb7	43547-519	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET	ORAL	20220412		ANDA	ANDA206954	Solco Healthcare US, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-520_61b1230e-c0dc-46c6-a577-7d5dd2515eb7	43547-520	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET	ORAL	20220412		ANDA	ANDA206954	Solco Healthcare US, LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-521_61b1230e-c0dc-46c6-a577-7d5dd2515eb7	43547-521	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET	ORAL	20220412		ANDA	ANDA206954	Solco Healthcare US, LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-522_61b1230e-c0dc-46c6-a577-7d5dd2515eb7	43547-522	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET	ORAL	20220412		ANDA	ANDA206954	Solco Healthcare US, LLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-523_61b1230e-c0dc-46c6-a577-7d5dd2515eb7	43547-523	HUMAN PRESCRIPTION DRUG	QUETIAPINE		quetiapine	TABLET	ORAL	20220412		ANDA	ANDA206954	Solco Healthcare US, LLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43547-524_51d3f12f-94cc-4f58-94d3-61990e16adfc	43547-524	HUMAN PRESCRIPTION DRUG	NEBIVOLOL		nebivolol	TABLET	ORAL	20220214		ANDA	ANDA212682	Solco Healthcare US, LLC	NEBIVOLOL	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43547-525_51d3f12f-94cc-4f58-94d3-61990e16adfc	43547-525	HUMAN PRESCRIPTION DRUG	NEBIVOLOL		nebivolol	TABLET	ORAL	20220214		ANDA	ANDA212682	Solco Healthcare US, LLC	NEBIVOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43547-526_51d3f12f-94cc-4f58-94d3-61990e16adfc	43547-526	HUMAN PRESCRIPTION DRUG	NEBIVOLOL		nebibolol	TABLET	ORAL	20220214		ANDA	ANDA212682	Solco Healthcare US, LLC	NEBIVOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43547-527_51d3f12f-94cc-4f58-94d3-61990e16adfc	43547-527	HUMAN PRESCRIPTION DRUG	NEBIVOLOL		nebivolol	TABLET	ORAL	20220214		ANDA	ANDA212682	Solco Healthcare US, LLC	NEBIVOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43547-530_b7fba679-9c2d-4dac-af53-8c1331c966c3	43547-530	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		rocuronium bromide	INJECTION	INTRAVENOUS	20210725		ANDA	ANDA212668	Solco Healthcare US, LLC	ROCURONIUM BROMIDE	50	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
43547-531_b7fba679-9c2d-4dac-af53-8c1331c966c3	43547-531	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		rocuronium bromide	INJECTION	INTRAVENOUS	20210725		ANDA	ANDA212668	Solco Healthcare US, LLC	ROCURONIUM BROMIDE	100	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
43547-543_3707f06a-6cba-4f5c-86ab-fb95bc2a933c	43547-543	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190320		ANDA	ANDA210927	Solco Healthcare US, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43547-544_3707f06a-6cba-4f5c-86ab-fb95bc2a933c	43547-544	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190320		ANDA	ANDA210927	Solco Healthcare US, LLC	GLYCOPYRROLATE	.4	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43547-545_0c829189-fba2-48f8-a23f-d5471a0345f6	43547-545	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	Solco Healthcare US, LLC	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-546_0c829189-fba2-48f8-a23f-d5471a0345f6	43547-546	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	Solco Healthcare US, LLC	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-547_0c829189-fba2-48f8-a23f-d5471a0345f6	43547-547	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	Solco Healthcare US, LLC	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-548_0c829189-fba2-48f8-a23f-d5471a0345f6	43547-548	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	Solco Healthcare US, LLC	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43547-549_f704b746-ab75-4484-8704-5baa94a07750	43547-549	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		potassium chloride extended-release	TABLET	ORAL	20190430		ANDA	ANDA209922	Solco Healthcare LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43547-550_f704b746-ab75-4484-8704-5baa94a07750	43547-550	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		potassium chloride extended-release	TABLET	ORAL	20190430		ANDA	ANDA209922	Solco Healthcare LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43547-551_f704b746-ab75-4484-8704-5baa94a07750	43547-551	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		potassium chloride extended-release	TABLET	ORAL	20190430		ANDA	ANDA209922	Solco Healthcare LLC	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43547-552_3bdeb395-aa5c-4d49-98f9-fa14afc62968	43547-552	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	CAPSULE, EXTENDED RELEASE	ORAL	20190314		ANDA	ANDA209026	Solco Healthcare LLC	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43547-553_3bdeb395-aa5c-4d49-98f9-fa14afc62968	43547-553	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	CAPSULE, EXTENDED RELEASE	ORAL	20190430		ANDA	ANDA209026	Solco Healthcare LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43547-554_e8a53d53-1a48-4dbb-a98d-22e65cc645a6	43547-554	HUMAN PRESCRIPTION DRUG	ROPINIROLE		ropinirole	TABLET, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA204413	Solco Healthcare US, LLC	ROPINIROLE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-555_e8a53d53-1a48-4dbb-a98d-22e65cc645a6	43547-555	HUMAN PRESCRIPTION DRUG	ROPINIROLE		ropinirole	TABLET, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA204413	Solco Healthcare US, LLC	ROPINIROLE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-556_e8a53d53-1a48-4dbb-a98d-22e65cc645a6	43547-556	HUMAN PRESCRIPTION DRUG	ROPINIROLE		ropinirole	TABLET, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA204413	Solco Healthcare US, LLC	ROPINIROLE	6	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-557_e8a53d53-1a48-4dbb-a98d-22e65cc645a6	43547-557	HUMAN PRESCRIPTION DRUG	ROPINIROLE		ropinirole	TABLET, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA204413	Solco Healthcare US, LLC	ROPINIROLE	8	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-558_e8a53d53-1a48-4dbb-a98d-22e65cc645a6	43547-558	HUMAN PRESCRIPTION DRUG	ROPINIROLE		ropinirole	TABLET, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA204413	Solco Healthcare US, LLC	ROPINIROLE	12	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-565_d09551ff-dfac-4525-8122-97b4463e98ea	43547-565	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		clonidine hydrochloride	TABLET	ORAL	20230105		ANDA	ANDA077901	Solco Healthcare LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43547-566_d09551ff-dfac-4525-8122-97b4463e98ea	43547-566	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		clonidine hydrochloride	TABLET	ORAL	20230105		ANDA	ANDA077901	Solco Healthcare LLC	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43547-567_d09551ff-dfac-4525-8122-97b4463e98ea	43547-567	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		clonidine hydrochloride	TABLET	ORAL	20230105		ANDA	ANDA077901	Solco Healthcare LLC	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43547-591_ab55fc1d-c567-40bc-acbf-089c5a0cc091	43547-591	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		rosuvastatin calcium	TABLET, FILM COATED	ORAL	20210310		ANDA	ANDA212059	Solco Healthcare LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43547-592_ab55fc1d-c567-40bc-acbf-089c5a0cc091	43547-592	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		rosuvastatin calcium	TABLET, FILM COATED	ORAL	20210310		ANDA	ANDA212059	Solco Healthcare LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43547-593_ab55fc1d-c567-40bc-acbf-089c5a0cc091	43547-593	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		rosuvastatin calcium	TABLET, FILM COATED	ORAL	20210310		ANDA	ANDA212059	Solco Healthcare LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43547-594_ab55fc1d-c567-40bc-acbf-089c5a0cc091	43547-594	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		rosuvastatin calcium	TABLET, FILM COATED	ORAL	20210310		ANDA	ANDA212059	Solco Healthcare LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43547-595_202c65a8-538f-4a87-853e-f86f9aa79905	43547-595	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-596_202c65a8-538f-4a87-853e-f86f9aa79905	43547-596	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-597_202c65a8-538f-4a87-853e-f86f9aa79905	43547-597	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-598_202c65a8-538f-4a87-853e-f86f9aa79905	43547-598	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-599_202c65a8-538f-4a87-853e-f86f9aa79905	43547-599	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-600_202c65a8-538f-4a87-853e-f86f9aa79905	43547-600	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-601_202c65a8-538f-4a87-853e-f86f9aa79905	43547-601	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	SOLCO HEALTHCARE US, LLC	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
43547-602_7ed12fbd-7572-4bf1-b142-e05f81a7110e	43547-602	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine dimesylate		Lisdexamfetamine dimesylate capsules	CAPSULE	ORAL	20230901		ANDA	ANDA216266	Solco Healthcare US,LLC	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-603_7ed12fbd-7572-4bf1-b142-e05f81a7110e	43547-603	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine dimesylate		Lisdexamfetamine dimesylate capsules	CAPSULE	ORAL	20230901		ANDA	ANDA216266	Solco Healthcare US,LLC	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-604_7ed12fbd-7572-4bf1-b142-e05f81a7110e	43547-604	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine dimesylate		Lisdexamfetamine dimesylate capsules	CAPSULE	ORAL	20230901		ANDA	ANDA216266	Solco Healthcare US,LLC	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-605_7ed12fbd-7572-4bf1-b142-e05f81a7110e	43547-605	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine dimesylate		Lisdexamfetamine dimesylate capsules	CAPSULE	ORAL	20230901		ANDA	ANDA216266	Solco Healthcare US,LLC	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-606_7ed12fbd-7572-4bf1-b142-e05f81a7110e	43547-606	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine dimesylate		Lisdexamfetamine dimesylate capsules	CAPSULE	ORAL	20230901		ANDA	ANDA216266	Solco Healthcare US,LLC	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-607_7ed12fbd-7572-4bf1-b142-e05f81a7110e	43547-607	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine dimesylate		Lisdexamfetamine dimesylate capsules	CAPSULE	ORAL	20230901		ANDA	ANDA216266	Solco Healthcare US,LLC	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-608_7ed12fbd-7572-4bf1-b142-e05f81a7110e	43547-608	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine dimesylate		Lisdexamfetamine dimesylate capsules	CAPSULE	ORAL	20230901		ANDA	ANDA216266	Solco Healthcare US,LLC	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43547-611_0078e31a-bf4b-480f-b7d1-040352255081	43547-611	HUMAN PRESCRIPTION DRUG	Temazepam		temazepam	CAPSULE	ORAL	20230105		ANDA	ANDA201781	Solco Healthcare U.S., LLC	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43547-612_0078e31a-bf4b-480f-b7d1-040352255081	43547-612	HUMAN PRESCRIPTION DRUG	Temazepam		temazepam	CAPSULE	ORAL	20230105		ANDA	ANDA201781	Solco Healthcare U.S., LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43547-613_0078e31a-bf4b-480f-b7d1-040352255081	43547-613	HUMAN PRESCRIPTION DRUG	Temazepam		temazepam	CAPSULE	ORAL	20230105		ANDA	ANDA201781	Solco Healthcare U.S., LLC	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43547-614_0078e31a-bf4b-480f-b7d1-040352255081	43547-614	HUMAN PRESCRIPTION DRUG	Temazepam		temazepam	CAPSULE	ORAL	20230105		ANDA	ANDA201781	Solco Healthcare U.S., LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
43547-616_084308e4-3b8b-40d6-acbf-d775772a8a73	43547-616	HUMAN PRESCRIPTION DRUG	Bisoprolol fumarate		Bisoprolol fumarate	TABLET	ORAL	20220705		ANDA	ANDA217368	Solco Healthcare US, LLC	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43547-617_084308e4-3b8b-40d6-acbf-d775772a8a73	43547-617	HUMAN PRESCRIPTION DRUG	Bisoprolol fumarate		Bisoprolol fumarate	TABLET	ORAL	20220705		ANDA	ANDA217368	Solco Healthcare US, LLC	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43547-634_d0954a7a-812b-487e-8c22-2a2a58303277	43547-634	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	20220823		ANDA	ANDA217531	Solco Healthcare US,LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43547-639_2972f22e-378c-450b-8869-1354a9bd0ffc	43547-639	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190320		ANDA	ANDA210927	Solco Healthcare US, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43547-640_2972f22e-378c-450b-8869-1354a9bd0ffc	43547-640	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190320		ANDA	ANDA210927	Solco Healthcare US, LLC	GLYCOPYRROLATE	.4	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43547-686_734f9a6f-dfce-48c4-8d8b-513ba6458ac6	43547-686	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20231205		ANDA	ANDA214087	SOLCO HEALTHCARE US, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
43547-688_b6dcfcef-d4ec-4463-a6b5-192cd8c7c0c3	43547-688	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofolxacin	TABLET	ORAL	20231001		ANDA	ANDA208921	Solco Healthcare US, LLC	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
43547-689_b6dcfcef-d4ec-4463-a6b5-192cd8c7c0c3	43547-689	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofolxacin	TABLET	ORAL	20231001		ANDA	ANDA208921	Solco Healthcare US, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
43547-990_9489b635-385e-4a05-be02-df39fcafebe3	43547-990	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20210811		ANDA	ANDA210608	Solco Healthcare US, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43595-122_ec927771-a5ed-372e-e053-2995a90ad7ea	43595-122	HUMAN OTC DRUG	amekina Instant Hand Sanitizer Gel		ALCOHOL	GEL	TOPICAL	20221103		OTC MONOGRAPH NOT FINAL	part333E	Angelini Pharma Inc.	ALCOHOL	.7	mL/mL			N	20241231
43595-867_ec9310bb-a24f-7e06-e053-2a95a90a6070	43595-867	HUMAN OTC DRUG	amekina Instant Foaming Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20221103		OTC MONOGRAPH NOT FINAL	part333E	Angelini Pharma Inc.	ALCOHOL	.7	mL/mL			N	20241231
43598-008_2309a6e3-9a3e-f8dc-33b3-b4cf23d432b7	43598-008	HUMAN OTC DRUG	Guaifenesin 600 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220315		ANDA	ANDA215932	Dr. Reddys Laboratories Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
43598-009_2309a6e3-9a3e-f8dc-33b3-b4cf23d432b7	43598-009	HUMAN OTC DRUG	Guaifenesin 1200 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220315		ANDA	ANDA215932	Dr. Reddys Laboratories Inc.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
43598-027_8cfe480e-b9c5-db52-e4b7-2b61f32e91e2	43598-027	HUMAN PRESCRIPTION DRUG	Melphalan Hydrochloride		Melphalan Hydrochloride	KIT	INTRAVENOUS	20210426		ANDA	ANDA203655	Dr.Reddy's Laboratories Inc						N	20241231
43598-034_417c78e6-6b41-4949-8279-945b6451c7a9	43598-034	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210215		ANDA	ANDA214534	Dr. Reddys Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43598-035_417c78e6-6b41-4949-8279-945b6451c7a9	43598-035	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210215		ANDA	ANDA214534	Dr. Reddys Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43598-036_417c78e6-6b41-4949-8279-945b6451c7a9	43598-036	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210215		ANDA	ANDA214534	Dr. Reddys Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43598-037_417c78e6-6b41-4949-8279-945b6451c7a9	43598-037	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210215		ANDA	ANDA214534	Dr. Reddys Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43598-045_664e6a61-82ff-5756-1fc1-9266090d901e	43598-045	HUMAN PRESCRIPTION DRUG	SUNITINIB MALATE		SUNITINIB MALATE	CAPSULE	ORAL	20221130		ANDA	ANDA215843	Dr.Reddys Laboratories Inc	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
43598-046_664e6a61-82ff-5756-1fc1-9266090d901e	43598-046	HUMAN PRESCRIPTION DRUG	SUNITINIB MALATE		SUNITINIB MALATE	CAPSULE	ORAL	20221130		ANDA	ANDA215843	Dr.Reddys Laboratories Inc	SUNITINIB MALATE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
43598-047_664e6a61-82ff-5756-1fc1-9266090d901e	43598-047	HUMAN PRESCRIPTION DRUG	SUNITINIB MALATE		SUNITINIB MALATE	CAPSULE	ORAL	20221130		ANDA	ANDA215843	Dr.Reddys Laboratories Inc	SUNITINIB MALATE	37.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
43598-048_664e6a61-82ff-5756-1fc1-9266090d901e	43598-048	HUMAN PRESCRIPTION DRUG	SUNITINIB MALATE		SUNITINIB MALATE	CAPSULE	ORAL	20221130		ANDA	ANDA215843	Dr.Reddys Laboratories Inc	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
43598-050_253cd4f8-82f7-be9b-ace6-0e59b3326d88	43598-050	HUMAN PRESCRIPTION DRUG	Thiamine Hydrochloride		thiamine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230331		ANDA	ANDA080571	Dr. Reddy's Laboratories Inc.	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
43598-053_58e7affd-0fce-80fb-be3b-7f438f332011	43598-053	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220912		ANDA	ANDA215961	Dr. Reddy's Laboratories Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
43598-058_b7605466-c580-4c15-372a-17e4c54ee02c	43598-058	HUMAN OTC DRUG	Naproxen Sodium	Caplets	Naproxen Sodium	TABLET, COATED	ORAL	20210804		ANDA	ANDA075168	Dr Reddy's Laboratories Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-059_583abf1f-c5f3-baeb-3e5d-9e645247116d	43598-059	HUMAN OTC DRUG	Naproxen Sodium	Headache Pain Caplets	Naproxen Sodium	TABLET, COATED	ORAL	20210805		ANDA	ANDA075168	Dr.Reddy's Laboratories Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-060_583abf1f-c5f3-baeb-3e5d-9e645247116d	43598-060	HUMAN OTC DRUG	Naproxen Sodium	Back and Muscle Pain Caplets	Naproxen Sodium	TABLET, COATED	ORAL	20210805		ANDA	ANDA075168	Dr.Reddy's Laboratories Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-061_b94a787b-0592-ac3d-b887-c706d571f6e8	43598-061	HUMAN PRESCRIPTION DRUG	ziprasidone mesylate		ziprasidone mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20220322		ANDA	ANDA211908	Dr.Reddy's Laboratories, Inc.	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
43598-071_e944f1a0-dcbe-138e-6215-a35124ab36af	43598-071	HUMAN OTC DRUG	Naproxen Sodium	Headache Pain	Naproxen Sodium	TABLET, COATED	ORAL	20211210		ANDA	ANDA075168	Dr.Reddy's Laboratories Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-072_e944f1a0-dcbe-138e-6215-a35124ab36af	43598-072	HUMAN OTC DRUG	Naproxen Sodium	Headache Pain	Naproxen Sodium	TABLET, COATED	ORAL	20211210		ANDA	ANDA075168	Dr.Reddy's Laboratories Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-073_e944f1a0-dcbe-138e-6215-a35124ab36af	43598-073	HUMAN OTC DRUG	Naproxen Sodium	Back and Muscle Pain	Naproxen Sodium	TABLET, COATED	ORAL	20211210		ANDA	ANDA075168	Dr.Reddy's Laboratories Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-074_e944f1a0-dcbe-138e-6215-a35124ab36af	43598-074	HUMAN OTC DRUG	Naproxen Sodium	Back and Muscle Pain	Naproxen Sodium	TABLET, COATED	ORAL	20211210		ANDA	ANDA075168	Dr.Reddy's Laboratories Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-078_4a20e779-1cb3-d987-ab48-c2da16611d15	43598-078	HUMAN PRESCRIPTION DRUG	Enalaprilat		enalaprilat	INJECTION	INTRAVENOUS	20230606		ANDA	ANDA075578	Dr. Reddys Laboratories Inc	ENALAPRILAT	1.25	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43598-085_2a73cd4f-7e40-4cf5-a3e9-bce074403a70	43598-085	HUMAN PRESCRIPTION DRUG	Vasopressin		Vasopressin	INJECTION	INTRAVENOUS	20141112		NDA	NDA204485	DR. REDDYS LABORATORIES INC	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
43598-096_a9701d52-15de-5762-9bd5-651f4764f1c1	43598-096	HUMAN PRESCRIPTION DRUG	JAVYGTOR		Sapropterin Dihydrochloride	TABLET	ORAL	20221003		ANDA	ANDA207685	Dr. Reddys Laboratories Inc	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
43598-097_ecb86af2-3917-0f6e-b88c-b869f7350c0a	43598-097	HUMAN PRESCRIPTION DRUG	JAVYGTOR		Sapropterin Dihydrochloride	POWDER, FOR SOLUTION	ORAL	20220916		ANDA	ANDA209452	Dr. Reddys Laboratories Inc	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
43598-108_aef9a93b-9bb3-7b51-f163-14c2469872cf	43598-108	HUMAN OTC DRUG	Guaifenesin 1200 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215932	Dr. Reddy's Laboratories Inc.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
43598-109_b54b5c70-6021-84ea-3d19-20c6ea81248f	43598-109	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220412		ANDA	ANDA202194	Dr. Reddy's Laboratories Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-110_aef9a93b-9bb3-7b51-f163-14c2469872cf	43598-110	HUMAN OTC DRUG	Guaifenesin 600 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215932	Dr. Reddy's Laboratories Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
43598-114_c4b32a9e-981c-1f4f-944a-11ad9807caeb	43598-114	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBR		Guaifenesin and Dextromethorphan HBR	TABLET, EXTENDED RELEASE	ORAL	20230815		ANDA	ANDA217340	Dr. Reddy's Laboratories Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
43598-115_c4b32a9e-981c-1f4f-944a-11ad9807caeb	43598-115	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBR		Guaifenesin and Dextromethorphan HBR	TABLET, EXTENDED RELEASE	ORAL	20230815		ANDA	ANDA217340	Dr. Reddy's Laboratories Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
43598-126_f9dfb39a-c6af-441a-132d-31712621ba0e	43598-126	HUMAN PRESCRIPTION DRUG	Sterile Diluent for Treprostinil		water	INJECTION, SOLUTION	INTRAVENOUS	20230213		ANDA	ANDA210214	Dr.Reddy's Laboratories Inc.,	WATER	1	mL/mL			N	20241231
43598-127_10bfab92-d488-5162-05f6-4ae978439f7b	43598-127	HUMAN PRESCRIPTION DRUG	Methylprednisolone sodium succinate		Methylprednisolone sodium succinate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220324		ANDA	ANDA212396	Dr. Reddy's Laboratories Inc	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43598-128_10bfab92-d488-5162-05f6-4ae978439f7b	43598-128	HUMAN PRESCRIPTION DRUG	Methylprednisolone sodium succinate		Methylprednisolone sodium succinate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220324		ANDA	ANDA212396	Dr. Reddy's Laboratories Inc	METHYLPREDNISOLONE SODIUM SUCCINATE	500	mg/8mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43598-129_10bfab92-d488-5162-05f6-4ae978439f7b	43598-129	HUMAN PRESCRIPTION DRUG	Methylprednisolone sodium succinate		Methylprednisolone sodium succinate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220324		ANDA	ANDA212396	Dr. Reddy's Laboratories Inc	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43598-130_10bfab92-d488-5162-05f6-4ae978439f7b	43598-130	HUMAN PRESCRIPTION DRUG	Methylprednisolone sodium succinate		Methylprednisolone sodium succinate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220324		ANDA	ANDA212396	Dr. Reddy's Laboratories Inc	METHYLPREDNISOLONE SODIUM SUCCINATE	1	g/16mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43598-131_a2a0a639-561f-4b6b-bcc6-4f035cbca8d5	43598-131	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20221024		ANDA	ANDA210441	Dr. Reddy's Laboratories Inc.	HYDROXYCHLOROQUINE SULFATE	400	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
43598-132_a2a0a639-561f-4b6b-bcc6-4f035cbca8d5	43598-132	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20221024		ANDA	ANDA210441	Dr. Reddy's Laboratories Inc.	HYDROXYCHLOROQUINE SULFATE	300	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
43598-133_a2a0a639-561f-4b6b-bcc6-4f035cbca8d5	43598-133	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20221024		ANDA	ANDA210441	Dr. Reddy's Laboratories Inc.	HYDROXYCHLOROQUINE SULFATE	100	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
43598-139_9029e1f7-e5a9-4b9a-ac24-11ab314d94f1	43598-139	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20220523		ANDA	ANDA215788	DR. REDDY'S LABORATORIES, INC.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-142_542e953d-9288-a391-f4f0-6b005579f824	43598-142	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20230109		ANDA	ANDA216934	Dr. Reddy's Laboratories, Inc.	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-143_2903ee1b-a0d9-fc28-c8cc-7d54739963b6	43598-143	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220420		ANDA	ANDA207234	Dr. Reddy's Laboratories Inc.	AZACITIDINE	100	mg/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-160_21ff31d2-239a-4997-b999-3b7cc55994b9	43598-160	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20220725		ANDA	ANDA213062	Dr. Reddys Laboratories, Inc.	POTASSIUM CHLORIDE	40	meq/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43598-161_d03caae4-5e53-5f97-3848-bbbe514c9ed1	43598-161	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221001		ANDA	ANDA202194	Dr. Reddy's Laboratories Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-162_671e3289-1cf1-1f0d-0255-39042d55b800	43598-162	HUMAN PRESCRIPTION DRUG	JAVYGTOR		Sapropterin Dihydrochloride	POWDER, FOR SOLUTION	ORAL	20221116		ANDA	ANDA215798	Dr. Reddys Laboratories Inc	SAPROPTERIN DIHYDROCHLORIDE	500	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
43598-163_ecd72df6-8058-4e44-bcc6-2c0d8d0dfef7	43598-163	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Dr. Reddy's Laboratories Inc.	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
43598-164_c94eafdb-204e-99e2-9836-86e859b995f9	43598-164	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20131210		ANDA	ANDA076255	Dr. Reddy's Laboratories Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-165_c94eafdb-204e-99e2-9836-86e859b995f9	43598-165	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20131210		ANDA	ANDA076255	Dr. Reddy's Laboratories Inc.	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-166_c94eafdb-204e-99e2-9836-86e859b995f9	43598-166	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20131210		ANDA	ANDA076255	Dr. Reddy's Laboratories Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-167_bd2e4486-0720-4d09-b4f5-472c4478af0e	43598-167	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20221020		ANDA	ANDA210742	Dr. Reddy's Laboratories Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
43598-168_ecd72df6-8058-4e44-bcc6-2c0d8d0dfef7	43598-168	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Dr. Reddy's Laboratories Inc.	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
43598-169_4a20e779-1cb3-d987-ab48-c2da16611d15	43598-169	HUMAN PRESCRIPTION DRUG	Enalaprilat		enalaprilat	INJECTION	INTRAVENOUS	20230606		ANDA	ANDA075578	Dr. Reddys Laboratories Inc	ENALAPRILAT	2.5	mg/2mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
43598-170_bd2e4486-0720-4d09-b4f5-472c4478af0e	43598-170	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20221020		ANDA	ANDA210742	Dr. Reddy's Laboratories Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
43598-171_39da3f89-dda0-26cd-f641-0f7ea4e7616c	43598-171	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20221101		ANDA	ANDA214222	Dr.Reddy's Laboratories Inc.,	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
43598-172_8ac35170-ffb3-bab7-cc96-8c14253eff23	43598-172	HUMAN PRESCRIPTION DRUG	Biorphen		Phenylephrine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20221125		NDA	NDA212909	Dr. Reddy's Laboratories Inc.	PHENYLEPHRINE HYDROCHLORIDE	.1	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
43598-179_94e3f2f1-95a2-9129-fedc-4b681772a5b2	43598-179	HUMAN PRESCRIPTION DRUG	Carboprost Tromethamine		Carboprost Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20240112		ANDA	ANDA211941	Dr. Reddy's Laboratories Inc.	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20251231
43598-181_39988d93-955e-b4a2-40b5-d1678cf5aaf0	43598-181	HUMAN PRESCRIPTION DRUG	REZIPRES		ephedrine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20231221		NDA	NDA213536	Dr. Reddy's Laboratories Inc	EPHEDRINE HYDROCHLORIDE	47	mg/10mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43598-199_8ac35170-ffb3-bab7-cc96-8c14253eff23	43598-199	HUMAN PRESCRIPTION DRUG	Biorphen		Phenylephrine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20221125		NDA	NDA212909	Dr. Reddy's Laboratories Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
43598-210_13bd26c4-522e-3253-d05e-d48c367a800c	43598-210	HUMAN PRESCRIPTION DRUG	SSD Cream		Silver Sulfadiazine	CREAM	TOPICAL	20110504		NDA	NDA018578	Dr Reddys Laboratories Inc	SILVER SULFADIAZINE	10	g/1000g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
43598-230_1afa82f5-9ea2-5d75-688e-a44a867bd377	43598-230	HUMAN PRESCRIPTION DRUG	Colesevelam Hydrochloride		Colesevelam Hydrochloride	TABLET	ORAL	20181005		ANDA	ANDA210889	Dr.Reddys Laboratories Inc	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
43598-233_7b696ba3-6566-d179-d9fb-88cc3b6a51ba	43598-233	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230821		ANDA	ANDA091186	Dr. Reddy's Laboratories Inc.	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
43598-235_f87588c1-1380-ddad-0927-954cfad15ded	43598-235	HUMAN PRESCRIPTION DRUG	Cycloserine		Cycloserine	CAPSULE	ORAL	20230315		ANDA	ANDA060593	Dr. Reddys Laboratories, Inc.	CYCLOSERINE	250	mg/1			N	20241231
43598-247_b9770fc7-538d-8632-1196-578b426a0069	43598-247	HUMAN PRESCRIPTION DRUG	Fesoterodine fumarate		Fesoterodine fumarate	TABLET, EXTENDED RELEASE	ORAL	20220610		ANDA	ANDA204975	Dr.Reddy's Laboratories Inc.,	FESOTERODINE FUMARATE	4	mg/1			N	20241231
43598-248_b9770fc7-538d-8632-1196-578b426a0069	43598-248	HUMAN PRESCRIPTION DRUG	Fesoterodine fumarate		Fesoterodine fumarate	TABLET, EXTENDED RELEASE	ORAL	20220610		ANDA	ANDA204975	Dr.Reddy's Laboratories Inc.,	FESOTERODINE FUMARATE	8	mg/1			N	20241231
43598-255_9f84a6ad-be66-32f8-d1cc-cc0165058c27	43598-255	HUMAN PRESCRIPTION DRUG	Zoledronic acid		Zoledronic acid	INJECTION, SOLUTION	INTRAVENOUS	20190115		ANDA	ANDA204344	Dr. Reddy's Laboratories Inc	ZOLEDRONIC ACID	4	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
43598-258_b06584c8-f4fd-46dd-a1f2-0e3672b24938	43598-258	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20141110		ANDA	ANDA204193	Dr. Reddy's Laboratories Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43598-259_b06584c8-f4fd-46dd-a1f2-0e3672b24938	43598-259	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20141110		ANDA	ANDA204193	Dr. Reddy's Laboratories Inc.	DOCETAXEL	80	mg/4mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43598-262_795e1a0c-de9f-e3e2-ea1c-8fd8c752ed14	43598-262	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20200817		ANDA	ANDA209246	Dr.Reddy's Laboratories Inc	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
43598-265_b4a9147e-dfe3-229a-d8d7-6a84e6449f15	43598-265	HUMAN PRESCRIPTION DRUG	Propofol Injectable Emulsion		Propofol Injectable Emulsion	INJECTION, EMULSION	INTRAVENOUS	20181115		ANDA	ANDA205067	Dr. Reddy's Laboratories, Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
43598-267_d6afc522-23f4-025c-df81-109460653b4d	43598-267	HUMAN PRESCRIPTION DRUG	Icosapent		Icosapent Ethyl	CAPSULE	ORAL	20210621		ANDA	ANDA209499	Dr. Reddy's Laboratories, Inc.	ICOSAPENT ETHYL	1000	mg/1			N	20241231
43598-281_7d61060b-ddc4-d6fd-854a-62ef39f0936a	43598-281	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209623	Dr. Reddy's Laboratories Inc	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
43598-282_7d61060b-ddc4-d6fd-854a-62ef39f0936a	43598-282	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230324		ANDA	ANDA209623	Dr. Reddy's Laboratories Inc	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
43598-283_c879ca79-919e-693e-4712-72c8ccf42813	43598-283	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20170522		ANDA	ANDA208657	Dr. Reddy's Laboratories Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
43598-285_02da7ec9-5768-8114-0049-a32efc48a4f6	43598-285	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod	CAPSULE	ORAL	20221011		ANDA	ANDA208000	Dr. Reddy's Laboratories Inc	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
43598-286_375091c7-86fe-00dd-8dd8-7da0c6c42f07	43598-286	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20181106		ANDA	ANDA207740	Dr. Reddys Laboratories Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-291_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-291	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	25	mg/1		CV	N	20241231
43598-292_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-292	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	50	mg/1		CV	N	20241231
43598-293_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-293	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	75	mg/1		CV	N	20241231
43598-294_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-294	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	100	mg/1		CV	N	20241231
43598-295_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-295	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	150	mg/1		CV	N	20241231
43598-296_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-296	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	200	mg/1		CV	N	20241231
43598-297_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-297	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	225	mg/1		CV	N	20241231
43598-298_7971b1fe-948f-cacf-e675-fb3e061f4ed8	43598-298	HUMAN PRESCRIPTION DRUG	pregabalin		pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209664	Dr.Reddys Laboratories Inc	PREGABALIN	300	mg/1		CV	N	20241231
43598-303_7279f2c0-bb47-2a79-b3e1-5a5f25bcbedf	43598-303	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20121025		ANDA	ANDA090061	Dr Reddys Laboratories Inc	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
43598-304_e1612112-46cf-11c4-9e02-9178073b50ab	43598-304	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL, METERED	TRANSDERMAL	20190412		ANDA	ANDA208620	Dr. Reddy's Laboratories, Inc.	TESTOSTERONE	1.62	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
43598-305_7fd5dc53-d9f5-6b97-7039-2494d6d5462c	43598-305	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20130919		ANDA	ANDA201537	Dr. Reddy's Laboratories Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-308_8c557c5b-e6ce-1896-6411-58e4ff603765	43598-308	HUMAN PRESCRIPTION DRUG	Plerixafor		Plerixafor	SOLUTION	SUBCUTANEOUS	20231106		ANDA	ANDA205182	Dr. Reddy's Laboratories Inc	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
43598-309_2f7415ac-921e-cece-82ea-1793d2c60d52	43598-309	HUMAN PRESCRIPTION DRUG	Clofarabine		Clofarabine	INJECTION	INTRAVENOUS	20171108		ANDA	ANDA205375	Dr.Reddy's Laboratories Inc	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-313_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-313	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-314_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-314	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-315_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-315	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-316_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-316	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-317_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-317	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-318_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-318	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-319_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-319	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-320_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-320	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-321_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-321	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-322_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-322	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-323_54058ac6-94e2-d2d3-5c46-886b3478fc76	43598-323	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		Amlodipine besylate and Atorvastatin calcium	TABLET, FILM COATED	ORAL	20140317		ANDA	ANDA203874	Dr. Reddy's Laboratories Inc	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-326_b9e7833a-4bf3-df83-aef8-465d91c69c8e	43598-326	HUMAN PRESCRIPTION DRUG	Ciprofloxacin and Dexamethasone		Ciprofloxacin and Dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20200810		ANDA	ANDA205548	Dr. Reddy's Laboratories, Inc.	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
43598-330_f33ee816-0d98-0942-a19c-97e68d0870b4	43598-330	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20130819		ANDA	ANDA091186	Dr. Reddy's Laboratories Inc.	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
43598-331_d89899a3-8ada-0438-07b9-2164c640995a	43598-331	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20130819		ANDA	ANDA091363	Dr.Reddy's Laboratories Inc	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
43598-339_4483f2db-5250-45fd-e1b1-03ffa74a4eb1	43598-339	HUMAN PRESCRIPTION DRUG	Aspirin and Dipyridamole		Aspirin and Dipyridamole	CAPSULE, EXTENDED RELEASE	ORAL	20181010		ANDA	ANDA209048	Dr. Reddy's Laboratories Inc	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
43598-341_c476d39c-4622-e3bf-d781-a880816c4cbd	43598-341	HUMAN PRESCRIPTION DRUG	clocortolone pivalate		clocortolone pivalate	CREAM	TOPICAL	20140217		NDA AUTHORIZED GENERIC	NDA017765	Dr. Reddy's Laboratories Inc	CLOCORTOLONE PIVALATE	.001	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43598-344_d905cdb0-eca9-d4f8-d875-08cb6fd75327	43598-344	HUMAN PRESCRIPTION DRUG	Imatinib		Imatinib	TABLET	ORAL	20180813		ANDA	ANDA206547	Dr.Reddy's Laboratories Inc	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
43598-345_d905cdb0-eca9-d4f8-d875-08cb6fd75327	43598-345	HUMAN PRESCRIPTION DRUG	Imatinib		Imatinib	TABLET	ORAL	20180813		ANDA	ANDA206547	Dr.Reddy's Laboratories Inc	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
43598-348_86ae5ec4-f9af-4eff-ae01-e817fe1e8890	43598-348	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20130711		ANDA	ANDA203131	Dr. Reddy's Laboratories Inc.	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-349_fc45000e-71c9-c4b2-84c9-2f8f5c88e56a	43598-349	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20170325		ANDA	ANDA208801	Dr. Reddys Laboratories, Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
43598-350_fc45000e-71c9-c4b2-84c9-2f8f5c88e56a	43598-350	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20170325		ANDA	ANDA208801	Dr. Reddys Laboratories, Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
43598-351_fbf67aef-17be-f29a-d5ac-253d6fe54a91	43598-351	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208047	Dr. Reddys Laboratories Inc	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-352_fbf67aef-17be-f29a-d5ac-253d6fe54a91	43598-352	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208047	Dr. Reddys Laboratories Inc	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-353_fbf67aef-17be-f29a-d5ac-253d6fe54a91	43598-353	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208047	Dr. Reddys Laboratories Inc	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-354_fbf67aef-17be-f29a-d5ac-253d6fe54a91	43598-354	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208047	Dr. Reddys Laboratories Inc	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-355_a6742369-fc8f-d7cc-42c1-33c95d6946ef	43598-355	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208055	Dr. Reddys Laboratories Inc	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-356_2fbdd00d-733b-49f9-70b4-c1aefa75d6a4	43598-356	HUMAN PRESCRIPTION DRUG	valganciclovir hydrochloride		valganciclovir hydrochloride	TABLET	ORAL	20171212		ANDA	ANDA206876	Dr. Reddy's Laboratories Inc	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
43598-358_5e7f1aec-5727-4e71-1a05-55e8eef89e0a	43598-358	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone Acetate	TABLET	ORAL	20200519		ANDA	ANDA208416	Dr. Reddys Laboratories Inc	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
43598-367_e07f5026-c912-d0cd-0457-1649176c8b70	43598-367	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET	ORAL	20200918		ANDA	ANDA208368	Dr. Reddys Laboratories Inc	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
43598-368_e07f5026-c912-d0cd-0457-1649176c8b70	43598-368	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET	ORAL	20200918		ANDA	ANDA208368	Dr. Reddys Laboratories Inc	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
43598-369_e07f5026-c912-d0cd-0457-1649176c8b70	43598-369	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET	ORAL	20200918		ANDA	ANDA208368	Dr. Reddys Laboratories Inc	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
43598-370_ad279b3e-152b-998b-a0d8-f96ecff31439	43598-370	HUMAN PRESCRIPTION DRUG	Pemetrexed disodium		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA202596	Dr. Reddys Laboratories Inc	PEMETREXED DISODIUM	1	g/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
43598-372_4559a404-0737-6595-f732-531fe45a1606	43598-372	HUMAN PRESCRIPTION DRUG	colchicine		colchicine	TABLET	ORAL	20200611		ANDA	ANDA209876	Dr.Reddys Laboratories, Inc.	COLCHICINE	.6	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
43598-386_ad279b3e-152b-998b-a0d8-f96ecff31439	43598-386	HUMAN PRESCRIPTION DRUG	Pemetrexed disodium		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA202596	Dr. Reddys Laboratories Inc	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
43598-387_ad279b3e-152b-998b-a0d8-f96ecff31439	43598-387	HUMAN PRESCRIPTION DRUG	Pemetrexed disodium		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA202596	Dr. Reddys Laboratories Inc	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
43598-389_b06584c8-f4fd-46dd-a1f2-0e3672b24938	43598-389	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20190422		ANDA	ANDA204193	Dr. Reddy's Laboratories Inc.	DOCETAXEL	160	mg/8mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43598-390_1f8a2931-1197-c9d1-4ced-a2388ad6c3b6	43598-390	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20140610		ANDA	ANDA090060	Dr Reddys Laboratories Inc	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
43598-392_7f4cc8ff-4b1c-86d8-ea19-0bab41202737	43598-392	HUMAN PRESCRIPTION DRUG	Melphalan Hydrochloride		Melphalan Hydrochloride	KIT	INTRAVENOUS	20171218		ANDA	ANDA203655	Dr.Reddy's Laboratories Inc						N	20241231
43598-394_b3ddb23f-3cc7-7c18-982b-970f7acc8766	43598-394	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET	ORAL	20180108		ANDA	ANDA209284	Dr. Reddys Laboratories Inc	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
43598-395_b3ddb23f-3cc7-7c18-982b-970f7acc8766	43598-395	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET	ORAL	20180108		ANDA	ANDA209284	Dr. Reddys Laboratories Inc	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
43598-405_c4a2bf44-0ad2-c0d2-164f-562ba6df930c	43598-405	HUMAN PRESCRIPTION DRUG	PHYTONADIONE	PHYTONADIONE	PHYTONADIONE	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20190531		ANDA	ANDA207719	Dr.Reddy's Laboratories Inc	PHYTONADIONE	10	mg/mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
43598-407_1f7dc391-028d-a98f-7cc6-887f293caf06	43598-407	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180516		ANDA	ANDA207673	Dr. Reddy's Laboratories Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-409_3ec07be3-1e04-66a2-ffee-b4795006fae9	43598-409	HUMAN PRESCRIPTION DRUG	levalbuterol inhalation		levalbuterol inhalation 1.25mg/3mL	SOLUTION	RESPIRATORY (INHALATION)	20140916		ANDA	ANDA078171	Dr. Reddys Laboratories, Inc.	LEVALBUTEROL	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
43598-410_3ec07be3-1e04-66a2-ffee-b4795006fae9	43598-410	HUMAN PRESCRIPTION DRUG	levalbuterol inhalation		levalbuterol inhalation 0.63mg/3mL	SOLUTION	RESPIRATORY (INHALATION)	20140916		ANDA	ANDA078171	Dr. Reddys Laboratories, Inc.	LEVALBUTEROL	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
43598-412_3ec07be3-1e04-66a2-ffee-b4795006fae9	43598-412	HUMAN PRESCRIPTION DRUG	levalbuterol inhalation		levalbuterol inhalation 0.31mg/3mL	SOLUTION	RESPIRATORY (INHALATION)	20140916		ANDA	ANDA078171	Dr. Reddys Laboratories, Inc.	LEVALBUTEROL	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
43598-413_607d5de5-52c5-3cb7-0707-7535e1791027	43598-413	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190501		ANDA	ANDA208375	Dr.Reddy's Laboratories Inc.,	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
43598-426_76eb5589-db8b-643c-8a38-7e600c4aea71	43598-426	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortexomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220726		ANDA	ANDA202963	Dr.Reddy's Laboratories, Inc.	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
43598-427_542f8797-9e69-ef0d-4ec3-c12a79df816e	43598-427	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20141205		ANDA	ANDA203131	Dr. Reddy's Laboratories Inc.	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-429_2ff664b3-80c7-d562-634c-7ca3a6176433	43598-429	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210460	Dr. Reddy's Laboratories Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
43598-430_2ff664b3-80c7-d562-634c-7ca3a6176433	43598-430	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210460	Dr. Reddy's Laboratories Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
43598-431_1cc0dc64-6b2b-b35a-6381-af4d6ef3b09b	43598-431	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20161115		ANDA	ANDA208326	Dr. Reddy's Laboratories, Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
43598-435_91f7d356-54f1-5c86-7689-d7fd7d882ef7	43598-435	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160829		ANDA	ANDA208191	Dr. Reddys Laboratories Inc	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43598-436_91f7d356-54f1-5c86-7689-d7fd7d882ef7	43598-436	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160829		ANDA	ANDA208191	Dr. Reddys Laboratories Inc	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43598-437_91f7d356-54f1-5c86-7689-d7fd7d882ef7	43598-437	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160829		ANDA	ANDA208191	Dr. Reddys Laboratories Inc	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43598-438_b2e44e65-bff9-7e54-c9e9-6adf1b831b6f	43598-438	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA213473	Dr.Reddys Laboratories Inc	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43598-439_b2e44e65-bff9-7e54-c9e9-6adf1b831b6f	43598-439	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA213473	Dr.Reddys Laboratories Inc	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43598-440_b2e44e65-bff9-7e54-c9e9-6adf1b831b6f	43598-440	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA213473	Dr.Reddys Laboratories Inc	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43598-441_b2e44e65-bff9-7e54-c9e9-6adf1b831b6f	43598-441	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA213473	Dr.Reddys Laboratories Inc	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43598-445_5a4d5ef2-6f8d-987c-2c14-58cf1949a009	43598-445	HUMAN OTC DRUG	Nicotine	transdermal system	Nicotine	KIT	TRANSDERMAL	20150514		NDA	NDA020076	Dr. Reddy's Laboratories Inc.						N	20241231
43598-446_25ebdccc-d55a-64c8-451c-a4d511412634	43598-446	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150514		NDA	NDA020076	Dr. Reddy's Laboratories Inc.	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-447_25ebdccc-d55a-64c8-451c-a4d511412634	43598-447	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150514		NDA	NDA020076	Dr. Reddy's Laboratories Inc.	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-448_25ebdccc-d55a-64c8-451c-a4d511412634	43598-448	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150514		NDA	NDA020076	Dr. Reddy's Laboratories Inc.	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-452_370b6498-30f2-48a4-f32a-9ee671cf294e	43598-452	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET, FILM COATED	ORAL	20210126		ANDA	ANDA211034	Dr.Reddys Laboratories Inc	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
43598-458_8ad2e151-bfb3-30bc-f24b-928f5f626f1d	43598-458	HUMAN PRESCRIPTION DRUG	sorafenib		sorafenib	TABLET, FILM COATED	ORAL	20220608		ANDA	ANDA216073	Dr.Reddys Laboratories Inc	SORAFENIB TOSYLATE	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
43598-459_8ada4dd5-ebb4-7ae5-e9c3-69ab78d8509e	43598-459	HUMAN PRESCRIPTION DRUG	Trientine Hydrochloride		Trientine Hydrochloride	CAPSULE	ORAL	20190703		ANDA	ANDA211076	Dr.Reddys Laboratories Inc	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
43598-465_5f82ea4d-4722-6413-0c81-c46a5d757dbf	43598-465	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20150619		ANDA	ANDA201537	Dr. Reddy's Laboratories Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-468_5e7f1aec-5727-4e71-1a05-55e8eef89e0a	43598-468	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone Acetate	TABLET	ORAL	20230911		ANDA	ANDA208416	Dr. Reddys Laboratories Inc	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
43598-469_3fb729ea-a04a-bfdd-d564-7045771e1247	43598-469	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	TABLET, DELAYED RELEASE	ORAL	20201115		ANDA	ANDA211571	Dr. Reddys Laboratories Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-470_f2e0addb-4673-c334-740b-c067fe96858c	43598-470	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20220407		ANDA	ANDA212500	Dr.Reddys Laboratories Inc	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
43598-476_29677998-337b-a026-92f5-1a3958dec926	43598-476	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211004		ANDA	ANDA211403	Dr. Reddy's Laboratories Inc.,	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
43598-477_de177a71-0a19-b267-0676-34415c9d5fea	43598-477	HUMAN PRESCRIPTION DRUG	Sapropterin Dihydrochloride		Sapropterin Dihydrochloride	POWDER, FOR SOLUTION	ORAL	20210401		ANDA	ANDA209452	Dr. Reddys Laboratories Inc	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
43598-478_85e37025-d239-e504-38a0-c2db7ffa0100	43598-478	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate for Oral Suspension		Sevelamer Carbonate for Oral Suspension	POWDER, FOR SUSPENSION	ORAL	20181025		ANDA	ANDA210464	Dr. Reddys Laboratories Inc	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
43598-479_85e37025-d239-e504-38a0-c2db7ffa0100	43598-479	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate for Oral Suspension		Sevelamer Carbonate for Oral Suspension	POWDER, FOR SUSPENSION	ORAL	20181025		ANDA	ANDA210464	Dr. Reddys Laboratories Inc	SEVELAMER CARBONATE	2400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
43598-484_9097eb4b-8d29-26a5-f53e-186b6f95a81b	43598-484	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20200911		ANDA	ANDA212983	Dr. Reddy's Laboratories Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-485_9097eb4b-8d29-26a5-f53e-186b6f95a81b	43598-485	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20200911		ANDA	ANDA212983	Dr. Reddy's Laboratories Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-486_b2d97760-75da-e0fa-88d0-34f70545675f	43598-486	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20200609		ANDA	ANDA212796	Dr. Reddy's Laboratories Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-487_b2d97760-75da-e0fa-88d0-34f70545675f	43598-487	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20200609		ANDA	ANDA212796	Dr. Reddy's Laboratories Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-488_52fb82d1-7ad2-b908-1be0-0d0ce379a595	43598-488	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20201001		ANDA	ANDA213233	Dr. Reddy's Laboratories Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-489_52fb82d1-7ad2-b908-1be0-0d0ce379a595	43598-489	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20201001		ANDA	ANDA213233	Dr. Reddy's Laboratories Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-494_af97c508-eb76-9684-d903-746b311e0c4b	43598-494	HUMAN PRESCRIPTION DRUG	Naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA078486	Dr. Reddy's Laboratories Inc.	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-495_af97c508-eb76-9684-d903-746b311e0c4b	43598-495	HUMAN PRESCRIPTION DRUG	Naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA078486	Dr. Reddy's Laboratories Inc.	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-505_f08636b3-11f2-23f1-e053-2a95a90a12e5	43598-505	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, FILM COATED	ORAL	20161012		ANDA	ANDA206384	Dr.Reddys Laboratories Inc	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
43598-509_bc23d230-ec98-ff25-5296-39e31fe9b775	43598-509	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20151210		ANDA	ANDA078279	Dr. Reddy's Laboratories Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-510_bc23d230-ec98-ff25-5296-39e31fe9b775	43598-510	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20151210		ANDA	ANDA078279	Dr. Reddy's Laboratories Inc	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-511_023f2dc9-b878-9d13-44d0-894310c6b8da	43598-511	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220907		ANDA	ANDA209348	Dr. Reddy's Laboratories Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
43598-512_023f2dc9-b878-9d13-44d0-894310c6b8da	43598-512	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220907		ANDA	ANDA209348	Dr. Reddy's Laboratories Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
43598-513_023f2dc9-b878-9d13-44d0-894310c6b8da	43598-513	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220907		ANDA	ANDA209348	Dr. Reddy's Laboratories Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
43598-514_023f2dc9-b878-9d13-44d0-894310c6b8da	43598-514	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220907		ANDA	ANDA209348	Dr. Reddy's Laboratories Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
43598-515_023f2dc9-b878-9d13-44d0-894310c6b8da	43598-515	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220907		ANDA	ANDA209348	Dr. Reddy's Laboratories Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
43598-516_023f2dc9-b878-9d13-44d0-894310c6b8da	43598-516	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220907		ANDA	ANDA209348	Dr. Reddy's Laboratories Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
43598-528_649d8760-81df-13da-6556-14a0fdbc8b02	43598-528	HUMAN PRESCRIPTION DRUG	Neostigmine		Neostigmine	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA209135	Dr.Reddy's Laboratories Inc	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43598-529_649d8760-81df-13da-6556-14a0fdbc8b02	43598-529	HUMAN PRESCRIPTION DRUG	Neostigmine		Neostigmine	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA209135	Dr.Reddy's Laboratories Inc	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43598-536_6364d3de-085f-44f8-d1e4-e6bfc5a854a7	43598-536	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160801		ANDA	ANDA205794	Dr. Reddys Laboratories Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-537_6364d3de-085f-44f8-d1e4-e6bfc5a854a7	43598-537	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160801		ANDA	ANDA205794	Dr. Reddys Laboratories Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-538_6364d3de-085f-44f8-d1e4-e6bfc5a854a7	43598-538	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160801		ANDA	ANDA205794	Dr. Reddys Laboratories Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-541_c879ca79-919e-693e-4712-72c8ccf42813	43598-541	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20170522		ANDA	ANDA208657	Dr. Reddy's Laboratories Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
43598-546_f430020f-5a30-63e3-c72c-ce1736aa8061	43598-546	HUMAN PRESCRIPTION DRUG	oxycodone and acetaminophen		oxycodone and acetaminophen	TABLET	ORAL	20180709		ANDA	ANDA207510	Dr. Reddys Laboratories Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43598-547_f430020f-5a30-63e3-c72c-ce1736aa8061	43598-547	HUMAN PRESCRIPTION DRUG	oxycodone and acetaminophen		oxycodone and acetaminophen	TABLET	ORAL	20180709		ANDA	ANDA207510	Dr. Reddys Laboratories Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43598-548_b4a9147e-dfe3-229a-d8d7-6a84e6449f15	43598-548	HUMAN PRESCRIPTION DRUG	Propofol Injectable Emulsion		Propofol Injectable Emulsion	INJECTION, EMULSION	INTRAVENOUS	20181115		ANDA	ANDA205067	Dr. Reddy's Laboratories, Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
43598-549_b4a9147e-dfe3-229a-d8d7-6a84e6449f15	43598-549	HUMAN PRESCRIPTION DRUG	Propofol Injectable Emulsion		Propofol Injectable Emulsion	INJECTION, EMULSION	INTRAVENOUS	20181115		ANDA	ANDA205067	Dr. Reddy's Laboratories, Inc.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
43598-550_ec93a28c-634b-7717-e053-2a95a90ae08d	43598-550	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20160617		ANDA	ANDA206382	Dr. Reddys Laboratories Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
43598-551_ec93a28c-634b-7717-e053-2a95a90ae08d	43598-551	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20160617		ANDA	ANDA206382	Dr. Reddys Laboratories Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
43598-552_ec93a28c-634b-7717-e053-2a95a90ae08d	43598-552	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20160617		ANDA	ANDA206382	Dr. Reddys Laboratories Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
43598-553_ec93a28c-634b-7717-e053-2a95a90ae08d	43598-553	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20160617		ANDA	ANDA206382	Dr. Reddys Laboratories Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
43598-554_7b98f7e8-e2a3-4c6c-a47c-b40a6da85f4c	43598-554	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-555_7b98f7e8-e2a3-4c6c-a47c-b40a6da85f4c	43598-555	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-556_7b98f7e8-e2a3-4c6c-a47c-b40a6da85f4c	43598-556	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-557_7b98f7e8-e2a3-4c6c-a47c-b40a6da85f4c	43598-557	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-558_7b98f7e8-e2a3-4c6c-a47c-b40a6da85f4c	43598-558	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-559_7b98f7e8-e2a3-4c6c-a47c-b40a6da85f4c	43598-559	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-560_2154d0b1-eada-784d-5840-75d230a46e7f	43598-560	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20210201		ANDA	ANDA210465	Dr.Reddys Laboratories Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-561_2154d0b1-eada-784d-5840-75d230a46e7f	43598-561	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20210201		ANDA	ANDA210465	Dr.Reddys Laboratories Inc	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-562_8f09ecf2-4018-c4d9-2a67-b797baf3c742	43598-562	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	20160906		ANDA	ANDA204910	Dr. Reddy's Laboratories, Inc.	PARICALCITOL	5	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
43598-563_8f09ecf2-4018-c4d9-2a67-b797baf3c742	43598-563	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	20160906		ANDA	ANDA204910	Dr. Reddy's Laboratories, Inc.	PARICALCITOL	2	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
43598-564_8f09ecf2-4018-c4d9-2a67-b797baf3c742	43598-564	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	20160906		ANDA	ANDA204910	Dr. Reddy's Laboratories, Inc.	PARICALCITOL	5	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
43598-565_8f09ecf2-4018-c4d9-2a67-b797baf3c742	43598-565	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	20160906		ANDA	ANDA204910	Dr. Reddy's Laboratories, Inc.	PARICALCITOL	5	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
43598-566_5d9a91f6-93bc-2002-8876-20139830dbb1	43598-566	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20180508		ANDA	ANDA076006	Dr.Reddy's Laboratories Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43598-573_7d8af9db-e459-1195-41b8-67f96e390ef2	43598-573	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA210069	Dr.Reddys Laboratories Inc	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43598-574_7d8af9db-e459-1195-41b8-67f96e390ef2	43598-574	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA210069	Dr.Reddys Laboratories Inc	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43598-575_7d8af9db-e459-1195-41b8-67f96e390ef2	43598-575	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA210069	Dr.Reddys Laboratories Inc	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43598-576_7d8af9db-e459-1195-41b8-67f96e390ef2	43598-576	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA210069	Dr.Reddys Laboratories Inc	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43598-578_e0893959-da34-2bf9-3a3e-3b89974f13dd	43598-578	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190205		ANDA	ANDA210145	Dr.Reddys Laboratories Inc	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
43598-579_06eedb87-f2e6-d9f9-c23c-7b2c975239c7	43598-579	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20180614		ANDA	ANDA205299	Dr.Reddys Laboratories Inc	BUPRENORPHINE HYDROCHLORIDE; NALOXONE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
43598-580_f03b5cdf-b928-e6eb-aed0-64e6e7ad3212	43598-580	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20180614		ANDA	ANDA205806	Dr.Reddys Laboratories Inc	BUPRENORPHINE HYDROCHLORIDE; NALOXONE	4; 1	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
43598-581_f03b5cdf-b928-e6eb-aed0-64e6e7ad3212	43598-581	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20180614		ANDA	ANDA205806	Dr.Reddys Laboratories Inc	BUPRENORPHINE HYDROCHLORIDE; NALOXONE	12; 3	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
43598-582_06eedb87-f2e6-d9f9-c23c-7b2c975239c7	43598-582	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	FILM, SOLUBLE	BUCCAL; SUBLINGUAL	20180614		ANDA	ANDA205299	Dr.Reddys Laboratories Inc	BUPRENORPHINE HYDROCHLORIDE; NALOXONE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
43598-587_a8e46365-6bd9-b963-dd1c-b42398508a74	43598-587	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION, SOLUTION	INTRAVENOUS	20191217		ANDA	ANDA210114	Dr.Reddy's Laboratories Inc.,	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
43598-588_7f14adc1-845e-ad00-8cbe-cee1999db6c0	43598-588	HUMAN PRESCRIPTION DRUG	Difluprednate Ophthalmic Emulsion		Difluprednate Ophthalmic	EMULSION	OPHTHALMIC	20221225		ANDA	ANDA214894	Dr. Reddy's Laboratories Inc.	DIFLUPREDNATE	.5	mg/mL			N	20241231
43598-605_946d18e8-ea8f-97c0-f49b-ec4e286beede	43598-605	HUMAN PRESCRIPTION DRUG	Tobramycin Inhalation Solution		Tobramycin Inhalation Solution	INHALANT	RESPIRATORY (INHALATION)	20190514		ANDA	ANDA207080	Dr. Reddy's Laboratories Inc.	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
43598-606_a0391e02-8a69-6aa6-d687-f740a2a44bfa	43598-606	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20170727		ANDA	ANDA091316	Dr. Reddy's Laboratories Inc.	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
43598-607_a0391e02-8a69-6aa6-d687-f740a2a44bfa	43598-607	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20170727		ANDA	ANDA091316	Dr. Reddy's Laboratories Inc.	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
43598-608_a0391e02-8a69-6aa6-d687-f740a2a44bfa	43598-608	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20170727		ANDA	ANDA091316	Dr. Reddy's Laboratories Inc.	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
43598-609_a0391e02-8a69-6aa6-d687-f740a2a44bfa	43598-609	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20170727		ANDA	ANDA091316	Dr. Reddy's Laboratories Inc.	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
43598-610_948f7c4c-6a40-d240-3eb3-d9ae6e371429	43598-610	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20170822		ANDA	ANDA204193	Dr. Reddy's Laboratories Inc.	DOCETAXEL	80	mg/4mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43598-611_948f7c4c-6a40-d240-3eb3-d9ae6e371429	43598-611	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20170822		ANDA	ANDA204193	Dr. Reddy's Laboratories Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43598-616_4b43c865-fcdb-4e57-30a4-871e37e0e593	43598-616	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION	INTRAVENOUS	20230423		ANDA	ANDA213210	Dr. Reddy's Laboratories Inc.	REGADENOSON ANHYDROUS	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
43598-618_bb0a9e92-ffa9-e5ee-51d5-30e6c78fed45	43598-618	HUMAN PRESCRIPTION DRUG	Saxagliptin and Metformin Hydrochloride		Saxagliptin and Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230809		ANDA	ANDA207678	Dr.Reddys Laboratories Inc	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN	1000; 2.5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
43598-619_bb0a9e92-ffa9-e5ee-51d5-30e6c78fed45	43598-619	HUMAN PRESCRIPTION DRUG	Saxagliptin and Metformin Hydrochloride		Saxagliptin and Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230809		ANDA	ANDA207678	Dr.Reddys Laboratories Inc	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN	1000; 5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
43598-620_bb0a9e92-ffa9-e5ee-51d5-30e6c78fed45	43598-620	HUMAN PRESCRIPTION DRUG	Saxagliptin and Metformin Hydrochloride		Saxagliptin and Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230809		ANDA	ANDA207678	Dr.Reddys Laboratories Inc	METFORMIN HYDROCHLORIDE; SAXAGLIPTIN	500; 5	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
43598-628_4a27a35f-574e-e0d4-f083-ed2b34d5b939	43598-628	HUMAN PRESCRIPTION DRUG	carmustine		carmustine	KIT	INTRAVENOUS	20211004		ANDA	ANDA213207	Dr. Reddy's Laboratories Inc.						N	20241231
43598-632_5f7a910c-9d83-9a80-7565-cd2fb5b0caa1	43598-632	HUMAN PRESCRIPTION DRUG	Fluoxetine hydrochloride		Fluoxetine hydrochloride	TABLET, FILM COATED	ORAL	20190128		ANDA	ANDA211721	Dr. Reddy's Laboratories Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43598-634_95e0de3d-c587-1569-8808-6c419f7208ec	43598-634	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE, GELATIN COATED	ORAL	20200804		ANDA	ANDA211867	Dr. Reddy's Laboratories Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
43598-635_f5cfc6e1-79f3-bd25-5f66-9ea05bc47def	43598-635	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam Injection	INJECTION	INTRAVENOUS	20180608		ANDA	ANDA206880	Dr.Reddy's Laboratories Inc	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43598-636_f5cfc6e1-79f3-bd25-5f66-9ea05bc47def	43598-636	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam Injection	INJECTION	INTRAVENOUS	20180608		ANDA	ANDA206880	Dr.Reddy's Laboratories Inc	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43598-637_f5cfc6e1-79f3-bd25-5f66-9ea05bc47def	43598-637	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam Injection	INJECTION	INTRAVENOUS	20180608		ANDA	ANDA206880	Dr.Reddy's Laboratories Inc	LEVETIRACETAM	15	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43598-646_f9dfb39a-c6af-441a-132d-31712621ba0e	43598-646	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230213		ANDA	ANDA210214	Dr.Reddy's Laboratories Inc.,	TREPROSTINIL	50	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
43598-647_f9dfb39a-c6af-441a-132d-31712621ba0e	43598-647	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230213		ANDA	ANDA210214	Dr.Reddy's Laboratories Inc.,	TREPROSTINIL	100	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
43598-648_f9dfb39a-c6af-441a-132d-31712621ba0e	43598-648	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230213		ANDA	ANDA210214	Dr.Reddy's Laboratories Inc.,	TREPROSTINIL	200	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
43598-649_f9dfb39a-c6af-441a-132d-31712621ba0e	43598-649	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230213		ANDA	ANDA210214	Dr.Reddy's Laboratories Inc.,	TREPROSTINIL	20	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
43598-650_7cd11d83-8cc9-26f6-27e2-86b486232874	43598-650	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20180504		ANDA	ANDA210337	Dr.Reddy's Laboratories Inc.,	THIOTEPA	15	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
43598-651_f9d29bec-f73b-7dc9-5f1b-7857dc0fdb74	43598-651	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	TABLET, FILM COATED	ORAL	20210201		ANDA	ANDA211539	Dr. Reddys Laboratories Inc.,	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
43598-655_dc27d1dd-5931-08dc-e053-2995a90a21f0	43598-655	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	Dr Reddys Laboratories Inc	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-656_dc27d1dd-5931-08dc-e053-2995a90a21f0	43598-656	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	Dr Reddys Laboratories Inc	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-660_3312331b-207a-eb61-a6b4-6922d051ad06	43598-660	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20230724		NDA	NDA210852	Dr. Reddy's Laboratories Inc.	CYCLOPHOSPHAMIDE	500	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
43598-661_3312331b-207a-eb61-a6b4-6922d051ad06	43598-661	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20230724		NDA	NDA210852	Dr. Reddy's Laboratories Inc.	CYCLOPHOSPHAMIDE	1	g/2mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
43598-662_3312331b-207a-eb61-a6b4-6922d051ad06	43598-662	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20230724		NDA	NDA210852	Dr. Reddy's Laboratories Inc.	CYCLOPHOSPHAMIDE	2	g/4mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
43598-666_2e79c2bb-635f-1a41-943f-6f49937a63ec	43598-666	HUMAN PRESCRIPTION DRUG	Succinylcholine		Succinylcholine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201007		ANDA	ANDA210698	Dr.Reddy's Laboratories Inc.,	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
43598-672_eaf69850-6d69-7178-e1b9-0897caf031da	43598-672	HUMAN PRESCRIPTION DRUG	Pyrimethamine		pyrimethamine	TABLET	ORAL	20200316		ANDA	ANDA207127	DR.REDDYS LABORATORIES INC	PYRIMETHAMINE	25	mg/1	Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
43598-673_06f95483-707f-8e4b-e063-6294a90a1992	43598-673	HUMAN PRESCRIPTION DRUG	Cefixime		Cefixime	POWDER, FOR SUSPENSION	ORAL	20170803		ANDA	ANDA206938	Dr. Reddys Laboratories, Inc	CEFIXIME	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43598-674_06f95483-707f-8e4b-e063-6294a90a1992	43598-674	HUMAN PRESCRIPTION DRUG	Cefixime		Cefixime	POWDER, FOR SUSPENSION	ORAL	20170803		ANDA	ANDA206938	Dr. Reddys Laboratories, Inc	CEFIXIME	200	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
43598-678_b7d42845-1888-66b9-77a0-c6f4902e21ac	43598-678	HUMAN PRESCRIPTION DRUG	AZACITIDINE	AZACITIDINE	AZACITIDINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20171213		ANDA	ANDA207518	Dr. Reddy's Laboratories Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43598-682_4b74fe5f-bc0a-86e0-e5a0-35aa7da7a221	43598-682	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20180313		ANDA	ANDA208657	Dr. Reddy's Laboratories Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
43598-683_4b74fe5f-bc0a-86e0-e5a0-35aa7da7a221	43598-683	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20180313		ANDA	ANDA208657	Dr. Reddy's Laboratories Inc	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
43598-697_8e7a7bae-3a50-a61a-8ecb-b251dcb0573d	43598-697	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	POWDER, FOR SOLUTION	ORAL	20181121		ANDA	ANDA211481	Dr. Reddys Laboratories Inc.,	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
43598-698_94e3f2f1-95a2-9129-fedc-4b681772a5b2	43598-698	HUMAN PRESCRIPTION DRUG	Carboprost Tromethamine		Carboprost Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20190702		ANDA	ANDA211941	Dr. Reddy's Laboratories Inc.	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20251231
43598-704_82f022df-8075-b1cd-f33b-a5603365dcc2	43598-704	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231129		ANDA	ANDA211578	Dr.Reddys Laboratories Inc	DARUNAVIR	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
43598-705_82f022df-8075-b1cd-f33b-a5603365dcc2	43598-705	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231129		ANDA	ANDA211578	Dr.Reddys Laboratories Inc	DARUNAVIR	800	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
43598-706_ab488204-9ccf-695c-4576-7ebc12e60c33	43598-706	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20210510		ANDA	ANDA214698	Dr. Reddy's Laboratories Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
43598-707_2316deef-d945-4443-f3d3-dfca67b5439f	43598-707	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210519		ANDA	ANDA213294	Dr. Reddy's Laboratories Inc.	LORATADINE	10	mg/1			N	20241231
43598-719_46902081-6a2d-4489-b828-351a33d405b5	43598-719	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20181023		ANDA	ANDA210742	Dr. Reddy's Laboratories Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
43598-720_46902081-6a2d-4489-b828-351a33d405b5	43598-720	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20181023		ANDA	ANDA210742	Dr. Reddy's Laboratories Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
43598-721_a2a0a639-561f-4b6b-bcc6-4f035cbca8d5	43598-721	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20180501		ANDA	ANDA210441	Dr. Reddy's Laboratories Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
43598-725_574459ca-dc0a-9033-5364-a02153543d19	43598-725	HUMAN PRESCRIPTION DRUG	Ephedrine sulfate		Ephedrine sulfate	INJECTION	INTRAVENOUS	20211004		ANDA	ANDA212649	Dr. Reddy's Laboratories, Inc.	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43598-733_f086bb5a-627e-74fa-e053-2a95a90abd06	43598-733	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole orally disintegrating	TABLET	ORAL	20180515		ANDA	ANDA207240	Dr. Reddy's Laboratories Inc	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-734_f086bb5a-627e-74fa-e053-2a95a90abd06	43598-734	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole orally disintegrating	TABLET	ORAL	20180515		ANDA	ANDA207240	Dr. Reddy's Laboratories Inc	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-735_edb4b4ba-4dd4-93b3-d23f-29d2caeccadb	43598-735	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180312		ANDA	ANDA210375	Dr. Reddy's Laboratories Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
43598-741_8aede701-70ed-87f7-1e8b-5de1456d3bdc	43598-741	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20190722		ANDA	ANDA091693	Dr.Reddys Laboratories Inc	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
43598-742_74768125-2b19-53fc-b5a3-bca582ba1cf3	43598-742	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20181120		ANDA	ANDA200909	Dr.Reddys Laboratories Inc	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-743_74768125-2b19-53fc-b5a3-bca582ba1cf3	43598-743	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20181120		ANDA	ANDA200909	Dr.Reddys Laboratories Inc	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-744_74768125-2b19-53fc-b5a3-bca582ba1cf3	43598-744	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20181120		ANDA	ANDA200909	Dr.Reddys Laboratories Inc	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-745_74768125-2b19-53fc-b5a3-bca582ba1cf3	43598-745	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20181120		ANDA	ANDA200909	Dr.Reddys Laboratories Inc	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-746_c23214a0-3fde-a1b2-d1ed-e7f120af949a	43598-746	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE	ORAL	20230417		ANDA	ANDA209499	Dr. Reddy's Laboratories, Inc.	ICOSAPENT ETHYL	500	mg/1			N	20241231
43598-747_f6a2c7f9-3a4a-0cb1-96a7-50f3e708b8fa	43598-747	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution 0.25%		Timolol Maleate Ophthalmic Gel Forming Solution 0.25%	SOLUTION/ DROPS	OPHTHALMIC	20220501		ANDA	ANDA215733	Dr. Reddy's Laboratories, Inc.	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43598-748_f6a2c7f9-3a4a-0cb1-96a7-50f3e708b8fa	43598-748	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution 0.5%		Timolol Maleate Ophthalmic Gel Forming Solution 0.5%	SOLUTION/ DROPS	OPHTHALMIC	20221115		ANDA	ANDA215733	Dr. Reddy's Laboratories, Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
43598-749_2607ac79-fdb9-4688-b322-0c351d8eb20e	43598-749	HUMAN PRESCRIPTION DRUG	Sapropterin Dihydrochloride		Sapropterin Dihydrochloride	TABLET	ORAL	20201001		NDA	NDA022181	Dr. Reddys Laboratories Inc.	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
43598-750_86d1633b-bbdf-e3e2-749d-34bc4b021952	43598-750	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20200318		ANDA	ANDA213209	Dr. Reddys Laboratories, Inc.	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
43598-751_f7096480-651b-6498-e053-6394a90ae555	43598-751	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180515		ANDA	ANDA205794	Dr. Reddys Laboratories Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-752_f7096480-651b-6498-e053-6394a90ae555	43598-752	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180515		ANDA	ANDA205794	Dr. Reddys Laboratories Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-753_f7096480-651b-6498-e053-6394a90ae555	43598-753	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180515		ANDA	ANDA205794	Dr. Reddys Laboratories Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-755_b6d4150a-3849-e804-02cb-468a6593dd71	43598-755	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam Injection	INJECTION	INTRAVENOUS	20180608		ANDA	ANDA206880	Dr.Reddy's Laboratories Inc	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43598-756_33224371-b336-2c1e-63dd-7a8ce9d195ff	43598-756	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210519		ANDA	ANDA212795	Dr. Reddy's Laboratories Inc.	LORATADINE	5	mg/1			N	20241231
43598-757_b6d4150a-3849-e804-02cb-468a6593dd71	43598-757	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam Injection	INJECTION	INTRAVENOUS	20180608		ANDA	ANDA206880	Dr.Reddy's Laboratories Inc	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43598-758_2f67bf36-2053-dd83-afad-a64810fa9050	43598-758	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210519		ANDA	ANDA213294	Dr. Reddy's Laboratories Inc.	LORATADINE	10	mg/1			N	20241231
43598-759_b6d4150a-3849-e804-02cb-468a6593dd71	43598-759	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam Injection	INJECTION	INTRAVENOUS	20180608		ANDA	ANDA206880	Dr.Reddy's Laboratories Inc	LEVETIRACETAM	15	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43598-764_39e1386c-3328-1883-f690-ed3adb16da41	43598-764	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20200901		ANDA	ANDA209752	Dr. Reddy's Laboratories Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
43598-765_c920760f-2ec6-7d4d-acba-c5e0aa7d3c22	43598-765	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200901		ANDA	ANDA209619	Dr. Reddy's Laboratories Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
43598-768_7302d24d-c87b-e7c2-233e-ccadbbdcc10d	43598-768	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20230420		ANDA	ANDA090495	Dr. Reddys Laboratories Inc.,	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
43598-770_9e844085-911a-6aff-3f42-27056b1de246	43598-770	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20211022		ANDA	ANDA213070	Dr. Reddy's Laboratories Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
43598-771_2f5844a8-825f-6a4f-996e-17e21c369359	43598-771	HUMAN PRESCRIPTION DRUG	LEVOLEUCOVORIN		LEVOLEUCOVORIN	INJECTION, SOLUTION	INTRAVENOUS	20180926		ANDA	ANDA210892	Dr.Reddy's Laboratories Inc	LEVOLEUCOVORIN CALCIUM	175	mg/17.5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
43598-773_2f5844a8-825f-6a4f-996e-17e21c369359	43598-773	HUMAN PRESCRIPTION DRUG	LEVOLEUCOVORIN		LEVOLEUCOVORIN	INJECTION, SOLUTION	INTRAVENOUS	20180926		ANDA	ANDA210892	Dr.Reddy's Laboratories Inc	LEVOLEUCOVORIN CALCIUM	250	mg/25mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
43598-808_f6dfcff2-d313-5722-171d-8d4d5af59951	43598-808	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET, COATED	ORAL	20181226		ANDA	ANDA078192	Dr. Reddy's Laboratories Inc.	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43598-809_64d8c8e7-da38-46cf-b893-88c090668dbc	43598-809	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20181226		ANDA	ANDA076502	Dr. Reddy's Laboratories Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
43598-810_0b8fb64b-59ab-b342-8403-7a9afdfad6bb	43598-810	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20181226		ANDA	ANDA210375	Dr. Reddy's Laboratories Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
43598-811_6e5c090a-d8fd-717c-26a0-acfb071ba7f4	43598-811	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20181217		ANDA	ANDA078343	Dr. Reddy's Laboratories Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
43598-812_0c91c23c-54d5-1020-9667-e2c2162ed894	43598-812	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20181217		ANDA	ANDA207673	Dr. Reddy's Laboratories Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-813_63992387-2d2b-fe0b-fa8b-5c429b187981	43598-813	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20181226		ANDA	ANDA078878	Dr. Reddy's Laboratories Inc.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-823_d024126e-de41-3d5e-73d8-bbb2623037e6	43598-823	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20190718		ANDA	ANDA076667	Dr. Reddy's Laboratories Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
43598-824_f91b307e-58d4-d6e5-e6e0-68b2783a97e9	43598-824	HUMAN OTC DRUG	Acid Reducer	Original Strength	Famotidine	TABLET	ORAL	20200901		ANDA	ANDA077367	Dr.Reddys Laboratories Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43598-826_25cecc54-4a6f-e14e-69eb-da358331ef93	43598-826	HUMAN OTC DRUG	Eye Allergy Itch and Redness Relief	Twice Daily Relief	Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20201001		ANDA	ANDA209619	Dr. Reddy's Laboratories Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
43598-827_5bf29087-e4a8-d892-415a-d160f76a8cbd	43598-827	HUMAN OTC DRUG	Eye Allergy Itch Relief	Once Daily Relief	Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20201001		ANDA	ANDA209752	Dr. Reddy's Laboratories Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
43598-830_264d5d5d-4dad-9d4d-09d9-1e60f42f4998	43598-830	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	Dr. Reddy's Laboratories Inc	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-831_264d5d5d-4dad-9d4d-09d9-1e60f42f4998	43598-831	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	Dr. Reddy's Laboratories Inc	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-832_264d5d5d-4dad-9d4d-09d9-1e60f42f4998	43598-832	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	Dr. Reddy's Laboratories Inc	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-833_264d5d5d-4dad-9d4d-09d9-1e60f42f4998	43598-833	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	Dr. Reddy's Laboratories Inc	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
43598-839_87da81ae-2159-f914-da9a-e6de28a93433	43598-839	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190307		ANDA	ANDA211504	Dr.Reddys Laboratories Inc.,	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43598-841_e312954b-cba2-1967-0a6f-7592c31f9b35	43598-841	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20201001		ANDA	ANDA207740	Dr. Reddys Laboratories Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-848_44d8fcde-2e03-b6e8-d5dd-d062e075be8c	43598-848	HUMAN PRESCRIPTION DRUG	ziprasidone mesylate		ziprasidone mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20200224		ANDA	ANDA211908	Dr.Reddy's Laboratories, Inc.	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
43598-850_d5fd27c9-aafe-2928-e0d9-33cdeae52dff	43598-850	HUMAN PRESCRIPTION DRUG	DOXERCALCIFEROL		DOXERCALCIFEROL	INJECTION	INTRAVENOUS	20191113		ANDA	ANDA210452	Dr.Reddy's Laboratories Inc	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
43598-851_1dda7eef-29b4-4cca-0905-9ffe45da1505	43598-851	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20191120		ANDA	ANDA210945	Dr. Reddy's Laboratories Inc	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
43598-852_1dda7eef-29b4-4cca-0905-9ffe45da1505	43598-852	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20200625		ANDA	ANDA210945	Dr. Reddy's Laboratories Inc	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
43598-853_1dda7eef-29b4-4cca-0905-9ffe45da1505	43598-853	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20191120		ANDA	ANDA210945	Dr. Reddy's Laboratories Inc	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
43598-854_764cc47a-a6dc-3c11-cf22-c5d2f8db72dd	43598-854	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191120		ANDA	ANDA209878	Dr. Reddy's Laboratories Inc	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
43598-855_764cc47a-a6dc-3c11-cf22-c5d2f8db72dd	43598-855	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191120		ANDA	ANDA209878	Dr. Reddy's Laboratories Inc	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
43598-856_764cc47a-a6dc-3c11-cf22-c5d2f8db72dd	43598-856	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191120		ANDA	ANDA209878	Dr. Reddy's Laboratories Inc	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
43598-859_758fbfce-39fd-5a8e-e85f-c6656e03c242	43598-859	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190906		ANDA	ANDA209965	Dr. Reddy's Laboratories Inc.,	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
43598-863_d9b7f809-ada7-6a2b-e053-2995a90acc44	43598-863	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE (SR)		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160817		ANDA	ANDA206122	Dr. Reddy's Laboratories Inc	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43598-865_7da60d3a-de17-4a7b-662e-ebca9050d9bb	43598-865	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortexomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191101		NDA	NDA206927	Dr.Reddy's Laboratories Inc	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
43598-883_4ccf5ed3-aaf3-0ff8-adab-0f395e7bb7eb	43598-883	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190801		ANDA	ANDA202194	Dr. Reddy's Laboratories Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
43598-885_195f48e7-53f4-e6a7-a61e-f4a0b9e2a6a9	43598-885	HUMAN OTC DRUG	DICLOFENAC SODIUM		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20201214		ANDA	ANDA210986	Dr. Reddy's Laboratories Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-891_21ff31d2-239a-4997-b999-3b7cc55994b9	43598-891	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20220725		ANDA	ANDA213062	Dr. Reddys Laboratories, Inc.	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43598-892_178c2fc9-5fb7-96f9-83a8-735ac57b91c7	43598-892	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCl		Fexofenadine HCl and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20220517		ANDA	ANDA079043	Dr.Reddy's Laboratories Inc	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
43598-893_10b34299-d60a-f785-70d6-2e5cc344638c	43598-893	HUMAN PRESCRIPTION DRUG	Nitroglycerin Transdermal Infusion System		Nitroglycerin	PATCH	TRANSDERMAL	20200301		NDA AUTHORIZED GENERIC	NDA020145	Dr. Reddy's Laboratories, Inc.	NITROGLYCERIN	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43598-894_10b34299-d60a-f785-70d6-2e5cc344638c	43598-894	HUMAN PRESCRIPTION DRUG	Nitroglycerin Transdermal Infusion System		Nitroglycerin	PATCH	TRANSDERMAL	20200301		NDA AUTHORIZED GENERIC	NDA020145	Dr. Reddy's Laboratories, Inc.	NITROGLYCERIN	80	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43598-895_10b34299-d60a-f785-70d6-2e5cc344638c	43598-895	HUMAN PRESCRIPTION DRUG	Nitroglycerin Transdermal Infusion System		Nitroglycerin	PATCH	TRANSDERMAL	20200301		NDA AUTHORIZED GENERIC	NDA020145	Dr. Reddy's Laboratories, Inc.	NITROGLYCERIN	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43598-896_10b34299-d60a-f785-70d6-2e5cc344638c	43598-896	HUMAN PRESCRIPTION DRUG	Nitroglycerin Transdermal Infusion System		Nitroglycerin	PATCH	TRANSDERMAL	20200301		NDA AUTHORIZED GENERIC	NDA020145	Dr. Reddy's Laboratories, Inc.	NITROGLYCERIN	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43598-897_6804c1a2-f648-b841-1d39-74d8624881e0	43598-897	HUMAN PRESCRIPTION DRUG	Amphetamine sulfate		Amphetamine Sulfate Tablets	TABLET	ORAL	20200301		ANDA	ANDA212582	DR. REDDY'S LABORATORIES INC	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43598-898_6804c1a2-f648-b841-1d39-74d8624881e0	43598-898	HUMAN PRESCRIPTION DRUG	Amphetamine sulfate		Amphetamine Sulfate Tablets	TABLET	ORAL	20200301		ANDA	ANDA212582	DR. REDDY'S LABORATORIES INC	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43598-901_66a1b489-50a0-8863-407a-5fa217706601	43598-901	HUMAN PRESCRIPTION DRUG	ERTAPENEM SODIUM		Ertapenem	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210429		ANDA	ANDA212040	Dr.Reddys Laboratories Inc.,	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
43598-909_f1aa7987-8d7b-4df7-81e1-884966cf0173	43598-909	HUMAN PRESCRIPTION DRUG	Fenofibrate		FENOFIBRATE	TABLET, FILM COATED	ORAL	20200131		ANDA	ANDA210670	Dr. Reddy's Laboratories Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43598-910_f1aa7987-8d7b-4df7-81e1-884966cf0173	43598-910	HUMAN PRESCRIPTION DRUG	Fenofibrate		FENOFIBRATE	TABLET, FILM COATED	ORAL	20200131		ANDA	ANDA210670	Dr. Reddy's Laboratories Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43598-917_e7281ee1-e9cc-0a66-ee35-b632108e15b0	43598-917	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20200204		ANDA	ANDA211941	Dr. Reddys Laboratories Inc.	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
43598-919_7026ffd6-b29b-6b2f-9176-e411bded1d69	43598-919	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20200204		ANDA	ANDA211941	Dr. Reddys Laboratories Inc.	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
43598-921_289aa34b-1563-86b0-34c6-6ce335b3f127	43598-921	HUMAN PRESCRIPTION DRUG	Xeglyze		abametapir	LOTION	TOPICAL	20210129		NDA	NDA206966	Dr. Reddy's Laboratories Inc.	ABAMETAPIR	.74	g/100g			N	20241231
43598-931_bf0a845a-fd5e-48e2-f068-1d080d97ff40	43598-931	HUMAN PRESCRIPTION DRUG	DESMOPRESSIN ACETATE		DESMOPRESSIN ACETATE	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20200403		ANDA	ANDA210218	Dr.Reddys' Laboratories Inc	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
43598-936_da202795-625c-5037-1cfd-6d68724ca8d9	43598-936	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20201201		ANDA	ANDA076502	Dr. Reddy's Laboratories Inc.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
43598-943_06148e7a-2f37-4731-9f20-fc19427eaf6d	43598-943	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210920		ANDA	ANDA214609	Dr. Reddy's Laboratories Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43598-944_06148e7a-2f37-4731-9f20-fc19427eaf6d	43598-944	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210920		ANDA	ANDA214609	Dr. Reddy's Laboratories Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43598-945_44dd76ad-df65-d827-1a7f-db3bcfab9d06	43598-945	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20220725		ANDA	ANDA216291	Dr.Reddys Laboratories Inc	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43598-948_947d6239-8b25-5225-b257-71e8a98b5aae	43598-948	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200701		ANDA	ANDA209965	Dr. Reddy's Laboratories Inc.,	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
43598-960_f91b307e-58d4-d6e5-e6e0-68b2783a97e9	43598-960	HUMAN OTC DRUG	Acid Reducer	Maximum Strength	Famotidine	TABLET	ORAL	20200901		ANDA	ANDA077367	Dr.Reddys Laboratories Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43598-965_f529227e-40ff-fc0b-e053-2a95a90a8c50	43598-965	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200316		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-966_f529227e-40ff-fc0b-e053-2a95a90a8c50	43598-966	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200316		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-967_f529227e-40ff-fc0b-e053-2a95a90a8c50	43598-967	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200316		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-968_f529227e-40ff-fc0b-e053-2a95a90a8c50	43598-968	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200316		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-969_f529227e-40ff-fc0b-e053-2a95a90a8c50	43598-969	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200316		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-970_f529227e-40ff-fc0b-e053-2a95a90a8c50	43598-970	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200316		ANDA	ANDA206383	Dr.Reddys Laboratories Inc	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43598-975_079da288-33ea-0240-9d07-bc04c118919b	43598-975	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200817		ANDA	ANDA209307	Dr.Reddy's Laboratories Inc	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
43598-976_079da288-33ea-0240-9d07-bc04c118919b	43598-976	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200817		ANDA	ANDA209307	Dr.Reddy's Laboratories Inc	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
43598-977_3cedceee-935b-4ad4-3a4b-b091fba59b0e	43598-977	HUMAN OTC DRUG	DICLOFENAC SODIUM		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20200914		ANDA	ANDA210986	Dr. Reddy's Laboratories Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43598-982_79949dc5-8655-8e15-4fa1-fe47e989681f	43598-982	HUMAN OTC DRUG	Habitrol Lozenge	Original Flavor	Nicotine Polacrilex	LOZENGE	ORAL	20220401		ANDA	ANDA212983	Dr. Reddy's Laboratories Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-983_79949dc5-8655-8e15-4fa1-fe47e989681f	43598-983	HUMAN OTC DRUG	Habitrol Lozenge	Original Flavor	Nicotine Polacrilex	LOZENGE	ORAL	20220401		ANDA	ANDA212983	Dr. Reddy's Laboratories Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-984_a64c05de-3eb1-0a94-bcf8-449bd68c9313	43598-984	HUMAN OTC DRUG	Habitrol Lozenge	Cherry	Nicotine Polacrilex	LOZENGE	ORAL	20211130		ANDA	ANDA213233	Dr. Reddy's Laboratories Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-985_a64c05de-3eb1-0a94-bcf8-449bd68c9313	43598-985	HUMAN OTC DRUG	Habitrol Lozenge	Cherry	Nicotine Polacrilex	LOZENGE	ORAL	20210820		ANDA	ANDA213233	Dr. Reddy's Laboratories Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-986_817c3437-a067-1beb-0797-0211ad1c7218	43598-986	HUMAN OTC DRUG	Habitrol	Nicotine Polacrilex Lozenge Mint	Nicotine Polacrilex Lozenge 2 mg	LOZENGE	ORAL	20210521		ANDA	ANDA212796	Dr. Reddy's Laboratories Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43598-987_817c3437-a067-1beb-0797-0211ad1c7218	43598-987	HUMAN OTC DRUG	Habitrol	Nicotine Polacrilex Lozenge Mint	Nicotine Polacrilex Lozenge 4 mg	LOZENGE	ORAL	20210521		ANDA	ANDA212796	Dr. Reddy's Laboratories Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
43602-177_eadd6980-7aad-464b-9ce8-cf7b1a20064d	43602-177	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20210129		ANDA	ANDA207417	Ascent Pharmaceuticals, Inc.	METHYLPHENIDATE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-178_eadd6980-7aad-464b-9ce8-cf7b1a20064d	43602-178	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20210129		ANDA	ANDA207417	Ascent Pharmaceuticals, Inc.	METHYLPHENIDATE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-266_728caa01-5e35-4d0e-b15a-d716cd48c34f	43602-266	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Ascent Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43602-267_728caa01-5e35-4d0e-b15a-d716cd48c34f	43602-267	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Ascent Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	12	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43602-268_728caa01-5e35-4d0e-b15a-d716cd48c34f	43602-268	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Ascent Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	16	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43602-269_728caa01-5e35-4d0e-b15a-d716cd48c34f	43602-269	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	Ascent Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	32	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
43602-283_ddde8a6a-992e-4bc4-9fc6-da9dfc08e092	43602-283	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201230		ANDA	ANDA214422	Ascent Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43602-284_ddde8a6a-992e-4bc4-9fc6-da9dfc08e092	43602-284	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20201230		ANDA	ANDA214422	Ascent Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43602-285_ddde8a6a-992e-4bc4-9fc6-da9dfc08e092	43602-285	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20201230		ANDA	ANDA214422	Ascent Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43602-294_d89a471e-16b5-4292-b681-65f4f0aa6883	43602-294	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230823		ANDA	ANDA216174	Ascent Pharmaceuticals, Inc.	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43602-295_d89a471e-16b5-4292-b681-65f4f0aa6883	43602-295	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230823		ANDA	ANDA216174	Ascent Pharmaceuticals, Inc.	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43602-296_d89a471e-16b5-4292-b681-65f4f0aa6883	43602-296	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230823		ANDA	ANDA216174	Ascent Pharmaceuticals, Inc.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43602-297_d89a471e-16b5-4292-b681-65f4f0aa6883	43602-297	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20230823		ANDA	ANDA216174	Ascent Pharmaceuticals, Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43602-306_9d8b3568-308c-4b1b-9dc1-f836544b97da	43602-306	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		Lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA217442	Ascent Pharmaceuticals, Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-307_9d8b3568-308c-4b1b-9dc1-f836544b97da	43602-307	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		Lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA217442	Ascent Pharmaceuticals, Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-308_9d8b3568-308c-4b1b-9dc1-f836544b97da	43602-308	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		Lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA217442	Ascent Pharmaceuticals, Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-309_9d8b3568-308c-4b1b-9dc1-f836544b97da	43602-309	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		Lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA217442	Ascent Pharmaceuticals, Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-310_9d8b3568-308c-4b1b-9dc1-f836544b97da	43602-310	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		Lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA217442	Ascent Pharmaceuticals, Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-311_9d8b3568-308c-4b1b-9dc1-f836544b97da	43602-311	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		Lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA217442	Ascent Pharmaceuticals, Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-312_9d8b3568-308c-4b1b-9dc1-f836544b97da	43602-312	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		Lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA217442	Ascent Pharmaceuticals, Inc.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-316_d83a3b23-e47e-4f28-9e87-8a0a7e1b127a	43602-316	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-317_d83a3b23-e47e-4f28-9e87-8a0a7e1b127a	43602-317	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-318_d83a3b23-e47e-4f28-9e87-8a0a7e1b127a	43602-318	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-319_d83a3b23-e47e-4f28-9e87-8a0a7e1b127a	43602-319	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-320_d83a3b23-e47e-4f28-9e87-8a0a7e1b127a	43602-320	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-321_d83a3b23-e47e-4f28-9e87-8a0a7e1b127a	43602-321	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20210929		ANDA	ANDA214959	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-327_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-327	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-328_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-328	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-329_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-329	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-330_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-330	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-331_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-331	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-332_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-332	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-333_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-333	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-334_47833074-8691-4e8b-9f72-7bb4efda36a8	43602-334	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211208		ANDA	ANDA215523	Ascent Pharmaceuticals, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-370_82f79db6-1962-4374-8510-0bbf73709a58	43602-370	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-371_82f79db6-1962-4374-8510-0bbf73709a58	43602-371	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-372_82f79db6-1962-4374-8510-0bbf73709a58	43602-372	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	10; 10; 10; 10	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-373_82f79db6-1962-4374-8510-0bbf73709a58	43602-373	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	12.5; 12.5; 12.5; 12.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-374_82f79db6-1962-4374-8510-0bbf73709a58	43602-374	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	15; 15; 15; 15	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-375_82f79db6-1962-4374-8510-0bbf73709a58	43602-375	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	20; 20; 20; 20	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-376_82f79db6-1962-4374-8510-0bbf73709a58	43602-376	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	30; 30; 30; 30	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-392_01685dfa-31a2-4b5a-a4d7-bf4a27e19f56	43602-392	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Ascent Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43602-393_01685dfa-31a2-4b5a-a4d7-bf4a27e19f56	43602-393	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Ascent Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43602-394_01685dfa-31a2-4b5a-a4d7-bf4a27e19f56	43602-394	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Ascent Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43602-395_01685dfa-31a2-4b5a-a4d7-bf4a27e19f56	43602-395	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20201023		ANDA	ANDA214419	Ascent Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
43602-399_e66721be-46fd-4d8b-a622-c357bb785e0f	43602-399	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Ascent Pharmaceuticals Inc	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
43602-400_e66721be-46fd-4d8b-a622-c357bb785e0f	43602-400	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Ascent Pharmaceuticals Inc	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
43602-401_e66721be-46fd-4d8b-a622-c357bb785e0f	43602-401	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Ascent Pharmaceuticals Inc	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
43602-417_466c6396-380c-4144-bd77-a73e028e559b	43602-417	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-418_466c6396-380c-4144-bd77-a73e028e559b	43602-418	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-419_466c6396-380c-4144-bd77-a73e028e559b	43602-419	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-420_466c6396-380c-4144-bd77-a73e028e559b	43602-420	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-421_466c6396-380c-4144-bd77-a73e028e559b	43602-421	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-422_466c6396-380c-4144-bd77-a73e028e559b	43602-422	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-423_466c6396-380c-4144-bd77-a73e028e559b	43602-423	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-424_466c6396-380c-4144-bd77-a73e028e559b	43602-424	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-425_466c6396-380c-4144-bd77-a73e028e559b	43602-425	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-426_466c6396-380c-4144-bd77-a73e028e559b	43602-426	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-427_466c6396-380c-4144-bd77-a73e028e559b	43602-427	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.2	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-428_466c6396-380c-4144-bd77-a73e028e559b	43602-428	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	Ascent Pharmaceuticals, Inc	LEVOTHYROXINE SODIUM	.3	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43602-452_7eda8527-3245-4dbf-b057-af88b97b31ad	43602-452	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210113		ANDA	ANDA214603	Ascent Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
43602-457_aae1df09-1482-4aef-a038-11295c610473	43602-457	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210826		ANDA	ANDA215414	Ascent Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-458_aae1df09-1482-4aef-a038-11295c610473	43602-458	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210826		ANDA	ANDA215414	Ascent Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-459_aae1df09-1482-4aef-a038-11295c610473	43602-459	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210826		ANDA	ANDA215414	Ascent Pharmaceuticals, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-460_aae1df09-1482-4aef-a038-11295c610473	43602-460	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		Topiramate	TABLET	ORAL	20210826		ANDA	ANDA215414	Ascent Pharmaceuticals, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-466_dc5d1f9f-b231-4320-aade-f051a8f4deed	43602-466	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Ascent Pharmaceuticals, Inc	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-467_dc5d1f9f-b231-4320-aade-f051a8f4deed	43602-467	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Ascent Pharmaceuticals, Inc	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-469_f2b29432-5b8e-4cd0-93f6-5dd626087eb4	43602-469	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Ascent Pharmaceuticals, Inc	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-470_f2b29432-5b8e-4cd0-93f6-5dd626087eb4	43602-470	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Ascent Pharmaceuticals, Inc	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-471_f2b29432-5b8e-4cd0-93f6-5dd626087eb4	43602-471	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Ascent Pharmaceuticals, Inc	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
43602-501_979f9de7-3cc6-4f7f-aaed-96ee208606b6	43602-501	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		Famotidine	TABLET, FILM COATED	ORAL	20211015		ANDA	ANDA215689	Ascent Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43602-502_979f9de7-3cc6-4f7f-aaed-96ee208606b6	43602-502	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		Famotidine	TABLET, FILM COATED	ORAL	20211015		ANDA	ANDA215689	Ascent Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43602-511_a2adad08-283e-4617-b3db-1eade7f5b296	43602-511	HUMAN OTC DRUG	FAMOTIDINE		Famotidine	TABLET	ORAL	20211103		ANDA	ANDA216030	Ascent Pharmaceuticals, Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43602-544_97d403fb-8a67-483d-8f9c-45dd16a31689	43602-544	HUMAN PRESCRIPTION DRUG	IBUPROFEN AND FAMOTIDINE		Ibuprofen and famotidine	TABLET	ORAL	20221006		ANDA	ANDA216814	Ascent Pharmaceuticals, Inc.	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43602-547_3e8c1490-7494-4d84-842b-553a189f1a3e	43602-547	HUMAN PRESCRIPTION DRUG	ICOSAPENT ETHYL		Icosapent ethyl	CAPSULE	ORAL	20220902		ANDA	ANDA216811	Ascent Pharmaceuticals, Inc	ICOSAPENT ETHYL	.5	g/1			N	20241231
43602-551_e824ad0c-9811-4866-95e6-e837b38b4352	43602-551	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		lisdexamfetamine dimesylate	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA217068	Ascent Pharmaceuticals, Inc	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-552_e824ad0c-9811-4866-95e6-e837b38b4352	43602-552	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		lisdexamfetamine dimesylate	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA217068	Ascent Pharmaceuticals, Inc	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-553_e824ad0c-9811-4866-95e6-e837b38b4352	43602-553	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		lisdexamfetamine dimesylate	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA217068	Ascent Pharmaceuticals, Inc	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-554_e824ad0c-9811-4866-95e6-e837b38b4352	43602-554	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		lisdexamfetamine dimesylate	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA217068	Ascent Pharmaceuticals, Inc	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-555_e824ad0c-9811-4866-95e6-e837b38b4352	43602-555	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		lisdexamfetamine dimesylate	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA217068	Ascent Pharmaceuticals, Inc	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-556_e824ad0c-9811-4866-95e6-e837b38b4352	43602-556	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		lisdexamfetamine dimesylate	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA217068	Ascent Pharmaceuticals, Inc	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-602_a2adad08-283e-4617-b3db-1eade7f5b296	43602-602	HUMAN OTC DRUG	FAMOTIDINE		Famotidine	TABLET	ORAL	20211103		ANDA	ANDA216030	Ascent Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
43602-623_1bbba2dd-563e-44e8-843a-95ea09ffc871	43602-623	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20230608		ANDA	ANDA217579	Ascent Pharmaceuticals, Inc	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43602-624_1bbba2dd-563e-44e8-843a-95ea09ffc871	43602-624	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20230608		ANDA	ANDA217579	Ascent Pharmaceuticals, Inc	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
43602-979_91447af3-b3d6-4ffe-8c89-1869a22373ba	43602-979	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	Ascent Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43602-980_91447af3-b3d6-4ffe-8c89-1869a22373ba	43602-980	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	Ascent Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43602-981_91447af3-b3d6-4ffe-8c89-1869a22373ba	43602-981	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	Ascent Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
43602-982_5c2a8c35-d15b-44d5-8909-301221a1936c	43602-982	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-983_5c2a8c35-d15b-44d5-8909-301221a1936c	43602-983	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-984_5c2a8c35-d15b-44d5-8909-301221a1936c	43602-984	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-985_5c2a8c35-d15b-44d5-8909-301221a1936c	43602-985	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-986_5c2a8c35-d15b-44d5-8909-301221a1936c	43602-986	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-987_5c2a8c35-d15b-44d5-8909-301221a1936c	43602-987	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43602-988_5c2a8c35-d15b-44d5-8909-301221a1936c	43602-988	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate	TABLET	ORAL	20210422		ANDA	ANDA213709	Ascent Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43621-001_0760bb5f-85a6-c294-e063-6394a90aa71d	43621-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205712	DJB Gas Services, Inc	OXYGEN	990	mL/L			N	20241231
43621-002_0760a704-e7ad-6d7f-e063-6294a90a72b5	43621-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20160304		NDA	NDA205713	DJB Gas Services, Inc	NITROGEN	990	mL/L			N	20241231
43621-003_076098ff-73ee-4d5f-e063-6294a90aeef4	43621-003	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20160912		NDA	NDA205704	DJB Gas Services, Inc	NITROUS OXIDE	990	mL/L			N	20241231
43621-004_0760b970-1afd-dbf1-e063-6394a90a9eec	43621-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20171107		NDA	NDA205712	DJB Gas Services, Inc	OXYGEN	210	mL/L			N	20241231
43624-002_0ac2e24a-5da3-6e69-e063-6394a90a0af1	43624-002	HUMAN PRESCRIPTION DRUG	Halaven		eribulin mesylate	INJECTION	INTRAVENOUS	20170421		NDA	NDA201532	BSP Pharmaceuticals SpA	ERIBULIN MESYLATE	.5	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
43655-1111_f942c4fb-ba14-4f75-95f9-45654689d648	43655-1111	HUMAN OTC DRUG	GNC Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part333A	GNC Holdings LLC	ALCOHOL	66.5	mL/100mL			N	20241231
43655-3111_8c3ea1ca-fcef-49e0-ade5-c3702691a4cb	43655-3111	HUMAN OTC DRUG	GNC Antimicrobial Hand Wipes		Alcohol	CLOTH	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part333A	GNC Holdings LLC	ALCOHOL	66.5	mL/100mL			N	20241231
43689-0013_ffdcb688-1e28-493b-bef5-2dd3162f949c	43689-0013	HUMAN OTC DRUG	Leg and Back Pain Relief		Capsicum Annuum, Colocynthis, Gnaphalium Polycephalum, Magnesia Phosphorica	TABLET	ORAL	20150611		UNAPPROVED HOMEOPATHIC		The Magni Company	CAPSICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM	6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
43689-0015_ec83ed89-ee4e-408e-8dcf-244a762a5e9b	43689-0015	HUMAN OTC DRUG	Pain and Fatigue Relief		Aconitum Napellus, Arsenicum Album, Belladonna, Coniinum, Gelsemium Sempervirens, Hypericum Perforatum, Kali Bichromicum, Lacticum Acidum, Phosphoricum Acidum, Rhus Tox, Uricum Acidum	TABLET	ORAL	20150612	20270420	UNAPPROVED HOMEOPATHIC		The Magni Company	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CONIINE; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM WHOLE; LACTIC ACID, DL-; PHOSPHORIC ACID; POTASSIUM DICHROMATE; TOXICODENDRON PUBESCENS LEAF; URIC ACID	30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	
43689-0018_a34ebc40-4dfa-4cbf-8937-c8732954ea09	43689-0018	HUMAN OTC DRUG	Sleep Assist		Chamomilla, Coffea Cruda, Avena Sativa, Nux Vomica, Passiflora Incarnata	TABLET, ORALLY DISINTEGRATING	ORAL	20230619		UNAPPROVED HOMEOPATHIC		The Magni Company	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED	4; 6; 4; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43689-0024_08857028-7123-8ae6-e063-6394a90aa6c0	43689-0024	HUMAN OTC DRUG	Diabetics Dry Skin Relief		DIMETHICONE	CREAM	TOPICAL	20170512		OTC MONOGRAPH DRUG	M016	The Magni Group Inc	DIMETHICONE	10	mg/g	Skin Barrier Activity [PE]		N	20241231
43689-0025_08854bfe-b2c1-e134-e063-6394a90a773f	43689-0025	HUMAN OTC DRUG	DB Antifungal foot		MICONAZOLE NITRATE	CREAM	TOPICAL	20170427		OTC MONOGRAPH DRUG	M005	The Magni Group Inc	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
43689-0028_ed7df275-cd17-3b65-e053-2995a90ab93c	43689-0028	HUMAN OTC DRUG	Relaxing Leg Homeopathic		CAUSTICUM, PSEUDOGNAPHALIUM OBTUSIFOLIUM	CREAM	TOPICAL	20170525		UNAPPROVED HOMEOPATHIC		The Magni Group Inc	CAUSTICUM; PSEUDOGNAPHALIUM OBTUSIFOLIUM	8; 6	[hp_X]/113g; [hp_X]/113g			N	20241231
43689-0029_ed7e00eb-696c-b78f-e053-2a95a90a3f46	43689-0029	HUMAN OTC DRUG	PAIN AND ITCH RELIEF		DAPHNE MEZEREUM BARK, GELSEMIUM SEMPERVIRENS ROOT	GEL	TOPICAL	20170706		UNAPPROVED HOMEOPATHIC		Magni Group	DAPHNE MEZEREUM BARK; GELSEMIUM SEMPERVIRENS ROOT	6; 6	[hp_X]/51g; [hp_X]/51g			N	20241231
43689-0031_ed7e0c7f-2dd0-bee9-e053-2995a90a8512	43689-0031	HUMAN OTC DRUG	Leg and Back Pain Relief		ATROPA BELLADONNA,CAPSICUM,CITRULLUS COLOCYNTHIS FRUIT PULP,MAGNESIUM PHOSPHATE, DIBASIC,TOXICODENDRON RADICANS LEAF,HYPERICUM PERFORATUM	CREAM	TOPICAL	20170608		UNAPPROVED HOMEOPATHIC		The Magni Group Inc	ATROPA BELLADONNA; CAPSICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC; TOXICODENDRON RADICANS LEAF	3; 3; 3; 3; 3; 3	[hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
43689-0032_ed7e1a08-2c6a-5354-e053-2a95a90aad49	43689-0032	HUMAN OTC DRUG	Breathe Easy Chest		ARSENIC TRIOXIDE, IPECAC, PHOSPHORUS, POLYGALA SENEGA ROOT, ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA WHOLE	CREAM	TOPICAL	20170716		UNAPPROVED HOMEOPATHIC		Magni Group	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA WHOLE; IPECAC; PHOSPHORUS; POLYGALA SENEGA ROOT	6; 6; 3; 3; 6; 3	[hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g			N	20241231
43689-0033_ed7e33e0-44fb-51ed-e053-2a95a90a6648	43689-0033	HUMAN OTC DRUG	Pain Relieving Foot		APIS MELLIFERA, PSEUDOGNAPHALIUM OBTUSIFOLIUM, GELSEMIUM SEMPERVIRENS ROOT	CREAM	TOPICAL	20170505		UNAPPROVED HOMEOPATHIC		The Magni Group Inc	APIS MELLIFERA; GELSEMIUM SEMPERVIRENS ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM	3; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43689-0034_ed7e2848-d523-6639-e053-2995a90a1722	43689-0034	HUMAN OTC DRUG	Arnica Pain Relief		ARNICA MONTANA	GEL	TOPICAL	20170620		UNAPPROVED HOMEOPATHIC		Magni Group	ARNICA MONTANA	3	[hp_X]/113g			N	20241231
43689-0055_d825893d-e904-75d9-e053-2a95a90a477f	43689-0055	HUMAN OTC DRUG	Magnilife Knee pain relief gel		ARNICA MONTANA FLOWER, TOXICODENDRON PUBESCENS LEAF	GEL	TOPICAL	20220210		UNAPPROVED HOMEOPATHIC		The Magni Company	ARNICA MONTANA FLOWER; TOXICODENDRON PUBESCENS LEAF	1; 4	[hp_X]/g; [hp_X]/g			N	20241231
43689-0058_e6315067-f0fb-4589-8c61-da2bd5563daf	43689-0058	HUMAN OTC DRUG	Fibromyalgia Support		Aconitum Napellus, Arsenicum Album, Belladonna, Coniinum, Gelsemium Sempervirens, Hypericum Perforatum, Kali Bichromicum, Lacticum Acidum, Phosphoricum Acidum, Rhus Tox, Uricum Acidum	TABLET	ORAL	20230125		UNAPPROVED HOMEOPATHIC		The Magni Company	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CONIINE; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM WHOLE; LACTIC ACID, DL-; PHOSPHORIC ACID; POTASSIUM DICHROMATE; TOXICODENDRON PUBESCENS LEAF; URIC ACID	30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
43695-0010_22533e1e-86d1-4867-8842-d50533b49152	43695-0010	HUMAN OTC DRUG	Oxyhives		Apis Mellifica, Arnica Montana, Hepar Suis, Ichthyolum, Lachesis Mutus, Mercurius Solubilis, Rhus Tox, Urtica Urens	SPRAY	ORAL	20150326		UNAPPROVED HOMEOPATHIC		Global Naturals, Inc.	APIS MELLIFERA; ARNICA MONTANA; ICHTHAMMOL; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PORK LIVER; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	200; 6; 6; 30; 200; 6; 200; 200	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43695-0012_4fbbe1d5-822c-4108-bef5-dd7cc29f0f8f	43695-0012	HUMAN OTC DRUG	BoilX		Anthracinum, Baptisia Tinctoria, Calcarea Picrata, Echinacea (Angustifolia), Hepar Sulphuris Calcareum, Mercurius Corrosivus, Pyrogenium	SPRAY	ORAL	20180601		UNAPPROVED HOMEOPATHIC		Global Naturals, Inc.	BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; CALCIUM PICRATE; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; MERCURIC CHLORIDE; RANCID BEEF	30; 3; 10; 200; 3; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43713-001_07ead125-ab6c-b16f-e063-6394a90ae37f	43713-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100831		UNAPPROVED MEDICAL GAS		Trico Oxygen	OXYGEN	99	L/100L			N	20241231
43742-0015_cb327c06-d9b6-40d0-bb3c-ffb4ca237c02	43742-0015	HUMAN OTC DRUG	Biological Complex	III	Anthracinum, Arsenicum album, Botulinum, Calcarea hypophosphorosa, Coxiella burnetii, Dysentery bacillus, Francisella tularensis, Gaertner bacillus, Kali sulphuricum, Lac caninum, Malaria officinalis, Mutabile bacillus, Pertussinum, Pestinum, Pyrogenium, Typhoid fever,	LIQUID	ORAL	20120426		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BOTULINUM TOXIN TYPE A; CALCIUM HYPOPHOSPHITE; CANIS LUPUS FAMILIARIS MILK; COXIELLA BURNETII; ESCHERICHIA COLI; FRANCISELLA TULARENSIS; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; PLASMODIUM MALARIAE; POTASSIUM SULFATE; RANCID BEEF; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SHIGELLA DYSENTERIAE; YERSINIA PESTIS	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
43742-0057_ad3f8c41-8ce8-4888-9dff-733225e94c18	43742-0057	HUMAN OTC DRUG	Stress	EZ	Aralia Quinquefolia, Ginkgo Biloba, Hydrocotyle Asiatica, Lomatium Dissectum, Cobaltum Metallicum, Cuprum Metallicum, Gelsemium Sempervirens, Iodium, Vanadium Metallicum, Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos	LIQUID	ORAL	20120605	20270103	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMERICAN GINSENG; CENTELLA ASIATICA; CLEMATIS VITALBA FLOWER; COBALT; COPPER; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; IODINE; LOMATIUM DISSECTUM ROOT; ORNITHOGALUM UMBELLATUM; PRUNUS CERASIFERA FLOWER; VANADIUM	3; 3; 30; 12; 12; 12; 3; 30; 30; 12; 3; 30; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	
43742-0066_9f8595be-f24f-433b-9368-6347e67033dd	43742-0066	HUMAN OTC DRUG	Estrogen		Folliculinum, Oophorinum,	LIQUID	ORAL	20120710		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ESTRONE; SUS SCROFA OVARY	8; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
43742-0217_cd703286-4402-499a-89c5-03390999d55a	43742-0217	HUMAN OTC DRUG	Quercetin		Quercetin	LIQUID	ORAL	20130411		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	QUERCETIN	6	[hp_X]/mL			N	20241231
43742-0248_19fd35fa-afa8-44f3-a0d8-965b26005b26	43742-0248	HUMAN PRESCRIPTION DRUG	Gyno Complex		Viburnum Opulus, Magnesia Phosphorica, Folliculinum, Pulsatilla, Borax, Mercurius Solubilis, Nitricum Acidum, Silicea, Thuja Occidentalis	LIQUID	ORAL	20130820	20240801	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ESTRONE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; NITRIC ACID; PULSATILLA VULGARIS; SILICON DIOXIDE; SODIUM BORATE; THUJA OCCIDENTALIS LEAF; VIBURNUM OPULUS BARK	12; 8; 30; 30; 12; 30; 30; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-0292_2d40f125-a3a2-420b-9d97-5312e4c60a59	43742-0292	HUMAN OTC DRUG	Enviro	II	Potassium Gluconate, Glandula Suprarenalis Suis, Hepar Suis, Canary Feathers, Standardized Cat Hair, Cattle Epithelia, Chicken Feathers, Dog Epithelia, Duck Feathers, Gerbil Epithelia, Goat Epithelia, Goose Feathers, Guinea Pig Epithelia, Hamster Epithelia, Hog Epithelia, Horse Epithelia, Mouse Epithelia, Parakeet Feathers, Rabbit Epithelia, Rat Epithelia, House, Mattress, Rug, Upholstery, Barley, Corn, Oat, Wheat, Rice, Millet, Milo, Dust Mite, Alfalfa, Golden Rod (Solidago Virguarea), Red Clover	LIQUID	ORAL	20130923	20240130	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ACER NEGUNDO POLLEN; AGROSTIS GIGANTEA POLLEN; ALFALFA; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; ARSENIC TRIOXIDE; BARLEY; BETULA OCCIDENTALIS POLLEN; BOS TAURUS SKIN; BROWN RICE; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS SKIN; CARYA OVATA POLLEN; CAVIA PORCELLUS SKIN; CORN GRAIN; DACTYLIS GLOMERATA TOP; DERMATOPHAGOIDES FARINAE; EQUUS CABALLUS SKIN; FAGUS GRANDIFOLIA POLLEN; FELIS CATUS HAIR; FRAXINUS AMERICANA POLLEN; GALLUS GALLUS FEATHER; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; HYALURONIDASE; INTERFERON .GAMMA. PORCINE RECOMBINANT; IRIDIUM; JUGLANS NIGRA POLLEN; MELOPSITTACUS UNDULATUS FEATHER; MERIONES UNGUICULATUS SKIN; MESOCRICETUS AURATUS SKIN; MILLET; MUS MUSCULUS SKIN; OAT; ORYCTOLAGUS CUNICULUS SKIN; PHLEUM PRATENSE TOP; PHOSPHORUS; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS TOP; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; PORK LIVER; POTASSIUM GLUCONATE; QUERCUS RUBRA POLLEN; RATTUS NORVEGICUS SKIN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS TOP; SALIX NIGRA POLLEN; SELENIUM; SERINUS CANARIA FEATHER; SEROTONIN HYDROCHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SORGHUM BICOLOR WHOLE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA SKIN; TRIFOLIUM PRATENSE FLOWER; ULMUS AMERICANA POLLEN; WHEAT	9; 9; 9; 9; 9; 9; 9; 9; 9; 12; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 30; 9; 30; 30; 12; 9; 9; 9; 9; 9; 9; 9; 9; 9; 12; 9; 9; 9; 8; 6; 9; 9; 9; 9; 9; 12; 9; 30; 9; 9; 12; 8; 9; 9; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Endoglycosidase [EPC], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Glycoside Hydrolases [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE]		N	
43742-0323_f889db83-2a93-45df-a646-5de72ce0cf85	43742-0323	HUMAN OTC DRUG	Bug Bouncer		Grindelia (Robusta), Urtica Urens, Ledum Palustre, Staphysagria, Cedron	LIQUID	ORAL	20140612	20241107	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	DELPHINIUM STAPHISAGRIA SEED; GRINDELIA HIRSUTULA WHOLE; LEDUM PALUSTRE TWIG; SIMABA CEDRON SEED; URTICA URENS	4; 1; 4; 6; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	
43742-0490_d8930949-819a-438c-9c13-5d19235a47cd	43742-0490	HUMAN OTC DRUG	Liver Drainage		Chelidonium Majus, Carduus Marianus, Schisandra Chinensis, Taraxacum Officinale, Berberis Vulgaris, Neopicrorhiza Scrophulariiflora, Raphanus Sativus, Viscum Album, Chromium Gluconate, Cobalt Gluconate, Copper Gluconate, Magnesium Gluconate, Natrum Sulphuricum, Ptelea Trifoliate, Sarcolacticum Acidum, Sulphur Iodatum, Carbolicum Acidum, Cichorium Intybus, Flos, Gallbladder (Suis), Hepar Suis, Nux Vomica, Pancreas Suis, Vanadium Metallicum, Verbena Officinalis, Flos	LIQUID	ORAL	20140621	20240531	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CHROMIUM GLUCONATE; CICHORIUM INTYBUS FLOWER; COBALTOUS GLUCONATE; COPPER GLUCONATE; LACTIC ACID, L-; MAGNESIUM GLUCONATE; MILK THISTLE; NEOPICRORHIZA SCROPHULARIIFLORA ROOT; PHENOL; PORK LIVER; PTELEA TRIFOLIATA BARK; RADISH; SCHISANDRA CHINENSIS FRUIT; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; SUS SCROFA GALLBLADDER; SUS SCROFA PANCREAS; TARAXACUM OFFICINALE; VANADIUM; VERBENA OFFICINALIS FLOWERING TOP; VISCUM ALBUM FRUITING TOP	3; 1; 6; 8; 6; 6; 6; 6; 2; 3; 8; 8; 6; 3; 2; 6; 8; 6; 8; 8; 2; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	
43742-0577_f4bb323b-5515-46a1-91c2-e4e3ba33c443	43742-0577	HUMAN OTC DRUG	Sugar and Food Additive Allergen Mix		Cinnamic Acid, Phloridzinum, Aspartame, Ileum (Suis), Jejunum (Suis), Stomach (Suis), Malvin (Chloride), Adenosinum Triphosphoricum Dinatrum, Argentum Nitricum, Fructose, Glucose, Lycopodium Clavatum, Sarcolacticum Acidum, Saccharum Lactis, Saccharum Officinale, Adrenocorticotrophin, High Fructose Corn Syrup, Dysentary Bacillus, Maple Sugar, Morgan Gaertner	LIQUID	ORAL	20150506	20240725	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACER SACCHARUM SAP; ADENOSINE TRIPHOSPHATE DISODIUM; ASPARTAME; CINNAMIC ACID; CORTICOTROPIN; DEXTROSE; FRUCTOSE; HIGH FRUCTOSE CORN SYRUP; LACTIC ACID, L-; LACTOSE; LYCOPODIUM CLAVATUM SPORE; MALVIN; PHLORIZIN; PROTEUS MORGANII; SHIGELLA DYSENTERIAE; SILVER NITRATE; SUCROSE; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA STOMACH	30; 6; 6; 6; 8; 6; 6; 9; 6; 6; 6; 15; 6; 30; 30; 6; 6; 8; 8; 8	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	
43742-0578_1c2634a4-8595-4ff8-a19a-6f65bd6a12dd	43742-0578	HUMAN OTC DRUG	Egg Allergen Mix		Adenosinum Triphosphoricum Dinatrum, L-Asparagine (Monohydrate), Phenylalanine, Quercetin, Ileum (Suis), Jejunum (Suis), Stomach (Suis), Canary Feathers, Cattle Epithelia, Chicken Feathers, Dog Epithelia, Duck Feathers, Gerbil Epithelia, Goat Epithelia, Goose Feathers, Guinea Pig Epithelia, Hamster Epithelia, Hog Epithelia, Horse Epithelia, Mouse Epithelia, Parakeet Feathers, Rabbit Epithelia, Rat Epithelia, Standardized Cat Hair, Ascorbicum Acidum, Calcarea Carbonica, Ferrum Iodatum, Tetracycline, Egg	LIQUID	ORAL	20150506	20240807	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; ASCORBIC ACID; ASPARAGINE MONOHYDRATE; BOS TAURUS SKIN; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS SKIN; CAVIA PORCELLUS SKIN; EGG; EQUUS CABALLUS SKIN; FELIS CATUS HAIR; FERROUS IODIDE; GALLUS GALLUS FEATHER; MELOPSITTACUS UNDULATUS FEATHER; MERIONES UNGUICULATUS SKIN; MESOCRICETUS AURATUS SKIN; MUS MUSCULUS SKIN; ORYCTOLAGUS CUNICULUS SKIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHENYLALANINE; PROTEUS MORGANII; QUERCETIN; RATTUS NORVEGICUS SKIN; SERINUS CANARIA FEATHER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA SKIN; SUS SCROFA STOMACH; TETRACYCLINE	4; 9; 9; 6; 6; 9; 9; 9; 9; 28; 9; 9; 6; 9; 9; 9; 9; 9; 9; 6; 6; 30; 6; 9; 9; 8; 8; 9; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Salivary Proteins and Peptides [CS], Standardized Animal Hair Allergenic Extract [EPC], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS], Vitamin C [EPC]		N	
43742-0600_12ccd251-0c46-41aa-8518-83f8033d4759	43742-0600	HUMAN OTC DRUG	Professional Weight Support		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Gambogia, Graphites, Nux Vomica, Phytolacca Decandra, 7-Oxo-Dehydroepiandrosterone 3-Acetate, Adenosinum Triphosphoricum Dinatrum, Glucagon, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20150728	20240314	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GLUCAGON; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA HYPOTHALAMUS	30; 30; 6; 6; 12; 30; 12; 30; 30; 8; 12; 8; 8; 30; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antihypoglycemic Agent [EPC], Cell-mediated Immunity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-0652_defa12ca-652a-44f6-889d-dd3c8e4a03a8	43742-0652	HUMAN OTC DRUG	Pericardium Triple Warmer	Meridian Opener	Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Calcarea Carbonica, Glonoinum, Iodium, Kali Iodatum, Lachesis Mutus, Lithium Carbonicum, Mercurius Solubilis, Naja Tripudians, Phosphoricum Acidum, Phosphorus, Sepia, Spongia Tosta, Tabacum, Thyroidinum (Suis)	LIQUID	ORAL	20151117		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; BARIUM CARBONATE; GOLD; IODINE; LACHESIS MUTA VENOM; LITHIUM CARBONATE; MERCURIUS SOLUBILIS; NAJA NAJA VENOM; NITROGLYCERIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; POTASSIUM IODIDE; SEPIA OFFICINALIS JUICE; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID; TOBACCO LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
43742-0660_5005e6bc-3ce5-4966-a61d-b8fbf8591556	43742-0660	HUMAN OTC DRUG	Arthritis Joints		Gnaphalium Polycephalum, Berberis Vulgaris, Cimicifuga Racemosa, Cinchona Officinalis, Colocynthis, Ledum Palustre, Ranunculus Bulbosus, Aesculus Hippocastanum, Borax, Cuprum Aceticum, Kali Carbonicum, Pulsatilla (Vulgaris), Secale Cornutum, Ammonium Muriaticum, Silicea, Argentum Metallicum, Calcarea Phosphorica, Glandula Suprarenalis Suis, Mercurius Praecipitatus Ruber, Sepia, Zincum Metallicum, Palladium Metallicum, Picricum Acidum, Sulphur, Cartilago Suis, Intervertebral Disc (Suis), Medulla Ossis Suis	LIQUID	ORAL	20151111		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMMONIUM CHLORIDE; BERBERIS VULGARIS ROOT BARK; BLACK COHOSH; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC ACETATE; HORSE CHESTNUT; LEDUM PALUSTRE TWIG; MERCURIC OXIDE; PALLADIUM; PICRIC ACID; POTASSIUM CARBONATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; PULSATILLA VULGARIS; RANUNCULUS BULBOSUS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SILVER; SODIUM BORATE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA CARTILAGE; SUS SCROFA INTERVERTEBRAL DISC; TRIBASIC CALCIUM PHOSPHATE; ZINC	8; 4; 4; 4; 4; 6; 6; 6; 4; 10; 12; 12; 6; 3; 6; 4; 10; 8; 10; 6; 30; 10; 12; 12; 12; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43742-0678_ff80e434-e772-4640-a069-b24a1fbc572b	43742-0678	HUMAN OTC DRUG	Rocky Mountain Spotted Fever Remedy		Rickettsia Nosode	LIQUID	ORAL	20151120		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	RICKETTSIA RICKETTSII	10	[hp_C]/mL			N	20241231
43742-0705_77aeb389-9888-41bc-9e98-340ee75de2d5	43742-0705	HUMAN OTC DRUG	Prostate		Petroselinum Sativum, Populus Tremuloides, Sabal Serrulata, Chimaphila Umbellata, Adenosinum Triphosphoricum Dinatrum, Equol, Kreosotum, Nadidum, Testosterone, Prostate (Suis), Succinicum Acidum, Hepar Sulphuris Calcareum, Conium Maculatum, Proteus (Mirabilis), Proteus (Vulgaris)	LIQUID	ORAL	20160217	20280424	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; CALCIUM SULFIDE; CHIMAPHILA UMBELLATA; CONIUM MACULATUM FLOWERING TOP; EQUOL, (+/-)-; NADIDE; PETROSELINUM CRISPUM; POPULUS TREMULOIDES BARK; POPULUS TREMULOIDES LEAF; PROTEUS MIRABILIS; PROTEUS VULGARIS; SAW PALMETTO; SUCCINIC ACID; SUS SCROFA PROSTATE; TESTOSTERONE; WOOD CREOSOTE	6; 10; 5; 30; 6; 6; 4; 4; 4; 30; 30; 4; 8; 8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	
43742-0729_9b04d5fc-f7bb-4720-a105-6e00b15ef900	43742-0729	HUMAN OTC DRUG	Perfect Sleep		Adenosinum Triphosphoricum Dinatrum, Pantothenic Acid, Pineal Gland (Suis), Sarcolacticum Acidum, Ubidecarenonum, L-Tryptophan, Melatonin, Pyrrole, Arsenicum Album, Avena Sativa, Chamomilla, Coffea Cruda, Mercurius Corrosivus, Passiflora Incarnata, Silicea, Zincum Valerianicum, Dysentery Bacillus, Gaertner Bacillus (Bach)	LIQUID	ORAL	20160412		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE PHOSPHATE DISODIUM; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; LACTIC ACID, L-; MATRICARIA CHAMOMILLA WHOLE; MELATONIN; MERCURIC CHLORIDE; PANTOTHENIC ACID; PASSIFLORA INCARNATA FLOWERING TOP; PYRROLE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SHIGELLA DYSENTERIAE; SILICON DIOXIDE; SUS SCROFA PINEAL GLAND; TRYPTOPHAN; UBIDECARENONE; ZINC VALERATE DIHYDRATE	8; 10; 10; 10; 8; 10; 8; 10; 8; 10; 8; 30; 30; 10; 8; 8; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-0734_d5682a09-e35a-4df5-8068-a3915c57e2f2	43742-0734	HUMAN OTC DRUG	Glucagon		Glucagon	LIQUID	ORAL	20160413	20240806	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	GLUCAGON	8	[hp_X]/mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	
43742-0745_e4031432-8615-4ecd-93cb-d700f7a2744a	43742-0745	HUMAN OTC DRUG	Sulphur Remedy		Sulphur, Asclepias Tuberosa, Bryonia, Dulcamara	LIQUID	ORAL	20160504		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ASCLEPIAS TUBEROSA ROOT; BRYONIA ALBA ROOT; SOLANUM DULCAMARA STEM; SULFUR	6; 10; 10; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-0756_43bfc7f6-39d4-4088-addf-5dd02883fed0	43742-0756	HUMAN OTC DRUG	Energy Catalyst		Viscum Album, Cobalt Gluconate, Cuprum Sulphuricum, Ferrous Fumarate, Magnesium Aspartate, Manganese Gluconate, Phosphorus, Potassium Aspartate, Sodium Molybdate, Adenosinum, Cyclophosphoricum, Cerium Oxalicum, Nickel Acetate, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Bromium, Cadmium Metallicum, Cerium Metallicum, Cesium Chloride, Dysprosium Metallicum, Erbium Metallicum	LIQUID	ORAL	20160602	20250831	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE CYCLIC PHOSPHATE; ALUMINUM; ALUMINUM OXIDE; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BROMINE; CADMIUM; CERIUM; CEROUS OXALATE NONAHYDRATE; CESIUM CHLORIDE; CHOLECALCIFEROL; CHROMIUM; COBALT; COBALTOUS GLUCONATE; COPPER; CUPRIC SULFATE; DYSPROSIUM; ERBIUM; EUROPIUM; FERROUS FUMARATE; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; INDIUM; IODINE; IRIDIUM; IRON; LANTHANUM; LEAD; LITHIUM; MAGNESIUM; MAGNESIUM ASPARTATE; MANGANESE; MANGANESE GLUCONATE; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NICKEL ACETATE; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POTASSIUM ASPARTATE; POTASSIUM CARBONATE; PRASEODYMIUM; PROTEUS MORGANII; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SILVER; SODIUM CHLORIDE; SODIUM MOLYBDATE; STRONTIUM; SULFUR; TANTALUM; TERBIUM; THALLIUM; TIN; TRIBASIC CALCIUM PHOSPHATE; URANIUM; VANADIUM; VISCUM ALBUM FRUITING TOP; YTTERBIUM OXIDE; ZINC	8; 12; 30; 12; 1000; 12; 12; 12; 12; 12; 12; 8; 12; 8; 8; 8; 6; 8; 6; 12; 12; 12; 6; 12; 12; 12; 12; 12; 8; 8; 8; 14; 1000; 8; 8; 6; 8; 6; 30; 1000; 8; 12; 12; 8; 30; 12; 12; 6; 12; 6; 8; 12; 30; 12; 12; 12; 8; 12; 8; 6; 8; 8; 30; 12; 12; 12; 8; 12; 8; 3; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin D [CS], Vitamin D [EPC]		N	
43742-0764_5a3c65d6-295f-4c0c-9e34-fb2be5bfa60d	43742-0764	HUMAN OTC DRUG	Caffeic Acid		Caffeic Acid	LIQUID	ORAL	20160607		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CAFFEIC ACID	6	[hp_X]/mL			N	20241231
43742-0769_6d40ffd0-8ebf-4315-ba31-81273bea8644	43742-0769	HUMAN OTC DRUG	Insect Bite		Hypericum Perforatum, Ledum Palustre, Latrodectus Mactans, Tarentula Cubensis, Tarentula Hispana, Lachesis Mutus, Lycopus Virginicus, Theridion, Cimex Lectularius, Formica Rufa, Pulex Irritans, Vespa Crabro, Loxosceles Reclusa	LIQUID	ORAL	20160607		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CIMEX LECTULARIUS; CITHARACANTHUS SPINICRUS; FORMICA RUFA; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; LOXOSCELES RECLUSA; LYCOPUS VIRGINICUS; LYCOSA TARANTULA; PULEX IRRITANS; THERIDION CURASSAVICUM; VESPA CRABRO	15; 8; 15; 3; 10; 8; 4; 12; 12; 8; 15; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-0770_86054b65-6085-46a3-b047-de678d3a2ce2	43742-0770	HUMAN OTC DRUG	Tryptophan		Tryptophan	LIQUID	ORAL	20160608		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	TRYPTOPHAN	6	[hp_X]/mL			N	20241231
43742-0771_981563a9-8070-4fe0-b69d-e01d08e8b402	43742-0771	HUMAN OTC DRUG	Melatonin		Melatonin	LIQUID	ORAL	20160608		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	MELATONIN	6	[hp_X]/mL			N	20241231
43742-0779_5115097f-294c-4443-bee5-868202bae1c4	43742-0779	HUMAN OTC DRUG	HA2CG Evolution		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gambogia, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, 7-Oxo-Dehydroepiandrosterone 3-Acetate, Adenosinum Triphosphoricum Dinatrum, Glucagon, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20160609	20241021	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GLUCAGON; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	30; 30; 8; 8; 6; 6; 12; 12; 30; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antihypoglycemic Agent [EPC], Cell-mediated Immunity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-0780_99bb8f23-0574-46bb-877f-8b4f1a32eeec	43742-0780	HUMAN OTC DRUG	Enviro	I	Potassium Gluconate, Glandula Suprarenalis Suis, Hepar Suis, Bamboo, Barley, California Poppy, Corn, Flax, Levant Cotton, Millet, Milo, Avena Sativa, Oryza Sativa, Rye, Safflower, Sesame, Sorghum, Soy Bean, Sugarcane, Sunflower, Wheat, Coffea Tosta, Thea Sinensis, Carbo Vegetabilis, Ferrum Iodatum, Ferrum Metallicum, Gelsemium Sempervirens, Iodium, Iridium Metallicum, Lycopodium Clavatum, Pulsatilla (Vulgaris), Selenium Metallicum, Zincum Metallicum, Allium Cepa, Amygdala Amara,	LIQUID	ORAL	20160628	20240408	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALMOND; ANEMONE PULSATILLA; APPLE; AVENA SATIVA FLOWERING TOP; BAMBUSA VULGARIS LEAF; BANANA; BARLEY; BEEF; BLACK PEPPER; BLACK WALNUT; BRAZIL NUT; CASEIN, STREPTOCOCCUS THERMOPHILUS CULTURED, PROPIONIBACTERIUM FREUDENREICHII SUBSP. SHERMANII CULTURED, AGED; CASHEW; CHICKEN BREAST; COCOA; COCONUT; COFFEA ARABICA SEED, ROASTED; CORN; CORTISONE ACETATE; COTTON SEED; COW MILK; EGG; EGGPLANT; ENGLISH WALNUT; FERROUS IODIDE; FLAX SEED; FRAGARIA VESCA FRUIT; GELSEMIUM SEMPERVIRENS ROOT; GREEN TEA LEAF; HELIANTHUS ANNUUS FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; HYALURONIDASE; INTERFERON .GAMMA. PORCINE RECOMBINANT; IODINE; IRIDIUM; IRON; KIDNEY BEAN; LAMB; LIMULUS POLYPHEMUS; LYCOPODIUM CLAVATUM SPORE; MILLET; ONION; ORANGE; ORYZA SATIVA WHOLE; OYSTER, UNSPECIFIED; PACIFIC COD; PEANUT; PECAN; POPPY SEED; PORK; PORK LIVER; POTASSIUM GLUCONATE; POTATO; RYE; SAFFLOWER; SALMON, UNSPECIFIED; SELENIUM; SEROTONIN HYDROCHLORIDE; SESAME SEED; SHRIMP, UNSPECIFIED; SORGHUM; SOYBEAN; SUGARCANE; SUS SCROFA ADRENAL GLAND; TOMATO; TUNA, UNSPECIFIED; WHEAT; ZINC	12; 12; 12; 12; 9; 9; 12; 9; 12; 12; 12; 12; 12; 12; 12; 10; 12; 10; 9; 30; 9; 12; 12; 12; 12; 12; 9; 12; 12; 10; 9; 30; 30; 30; 12; 12; 12; 12; 12; 12; 12; 9; 12; 12; 9; 12; 12; 12; 12; 9; 12; 8; 6; 12; 9; 9; 12; 12; 30; 9; 12; 9; 9; 9; 8; 12; 12; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Endoglycosidase [EPC], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Glycoside Hydrolases [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]	CII	N	
43742-0781_40dd015b-02b6-4dae-a802-6efa7a10ef0d	43742-0781	HUMAN OTC DRUG	Apiol		Apiolum	LIQUID	ORAL	20160629		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIOLE (PARSLEY)	6	[hp_X]/mL			N	20241231
43742-0783_817cbad3-d118-4572-b20b-1ba4bedba396	43742-0783	HUMAN OTC DRUG	Multiple Miasm		Arsenicum Album, Lycopodium Clavatum, Sulphur, Aloe, Carcinosin, Nitricum Acidum, Silicea, Thuja Occidentalis	LIQUID	ORAL	20160627		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALOE; ARSENIC TRIOXIDE; HUMAN BREAST TUMOR CELL; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; SILICON DIOXIDE; SULFUR; THUJA OCCIDENTALIS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43742-0787_0c4df2ba-c8ea-435f-867c-1fa73d9af15f	43742-0787	HUMAN OTC DRUG	Metab		Ascorbicum Acidum, Cysteinum, Manganese Gluconate, alpha-Ketoglutaricum Acidum, Fumaricum Acidum, Germanium Sesquioxide, Iodium, Magnesium Metallicum, Natrum Oxalaceticum, Pulsatilla (Vulgaris), Thyroidinum (Suis), Vanadium Metallicum	LIQUID	ORAL	20160627	20240328	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ANEMONE PULSATILLA; ASCORBIC ACID; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; IODINE; MAGNESIUM; MANGANESE GLUCONATE; OXOGLURIC ACID; SODIUM DIETHYL OXALACETATE; SUS SCROFA THYROID; VANADIUM	12; 6; 9; 12; 12; 12; 12; 10; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Vitamin C [EPC]		N	
43742-0803_794b3376-bbb9-4901-8fd1-6ab78900240f	43742-0803	HUMAN OTC DRUG	Eye Sarcode		Eye (Suis)	LIQUID	ORAL	20160706	20271229	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	SUS SCROFA EYE	30	[hp_C]/mL			N	
43742-0813_48312450-17a0-4afb-8061-46b72851288a	43742-0813	HUMAN OTC DRUG	Streptococcus Homochord		Enterococcus Faecalis, Pheumococcinum, Streptococcus Viridans, Streptococcus Mutans	LIQUID	ORAL	20160726	20250722	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ENTEROCOCCUS FAECALIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	15; 15; 15; 15	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-0817_337d8fc9-4fb1-4f27-938f-1f2d4fd2e7f7	43742-0817	HUMAN OTC DRUG	Acetylcholine Chloride		Acetylcholine Chloride	LIQUID	ORAL	20160721		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYLCHOLINE CHLORIDE	6	[hp_X]/mL	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
43742-0821_29d69105-c611-4c5b-9b4e-11163825481f	43742-0821	HUMAN OTC DRUG	Ileocecal Valve Support		Iodium, Hypophysis Suis, Thyroidinum, (Suis), Glandula Suprarenalis Suis, Fel Tauri, Taraxacum Officinale, Bryonia (Alba), Carbo Vegetabilis, Colocynthis, Indolum, Lycopodium Clavatum, Mercurius Corrosivus, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris)	LIQUID	ORAL	20160803	20240807	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; BOS TAURUS BILE; BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; INDOLE; IODINE; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; PHOSPHORUS; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; TARAXACUM OFFICINALE	30; 12; 30; 30; 30; 6; 30; 30; 30; 30; 30; 10; 8; 8; 12	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-0825_fe0f9cf5-b9a1-450a-b2e2-917ab1f84cf3	43742-0825	HUMAN OTC DRUG	Epstein-Barr Virus Homochord		Epstein-Barr Virus Nosode	LIQUID	ORAL	20160804	20240730	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN HERPESVIRUS 4	15	[hp_X]/mL			N	
43742-0830_424b5187-bf9b-4cab-bab4-6a7dbe891048	43742-0830	HUMAN OTC DRUG	Candida		Candida Albicans	LIQUID	ORAL	20160817	20250617	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CANDIDA ALBICANS	1	[hp_M]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-0833_66da4447-8959-4132-ae6f-0c914c0af2a2	43742-0833	HUMAN OTC DRUG	Herpes Zoster Homochord		Herpes Zoster Nosode	LIQUID	ORAL	20160818	20250630	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN HERPESVIRUS 3	15	[hp_X]/mL			N	
43742-0835_2bf8b043-bb71-4c27-a707-5c231c17ea7e	43742-0835	HUMAN OTC DRUG	Gallic Acid		Gallicum Acidum	LIQUID	ORAL	20160907	20260902	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	GALLIC ACID	6	[hp_X]/mL			N	
43742-0836_f2425fb6-123c-464d-95a7-2a52e21a2c49	43742-0836	HUMAN OTC DRUG	Bladder Kidney Meridian Opener		Apis Mellifica, Argentum Nitricum, Berberis Vulgaris, Cantharis, Equisetum Arvense, Kali Bichromicum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Phosphorus, Rhus Tox, Sepia, Terebinthina, Thuja Occidentalis	LIQUID	ORAL	20160819		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; EQUISETUM ARVENSE TOP; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; MERCURIUS SOLUBILIS; PHOSPHORUS; POTASSIUM DICHROMATE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAF; TOXICODENDRON PUBESCENS LEAF; TURPENTINE OIL	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-0840_e59d768e-1292-4945-81bc-719e74b6e7fa	43742-0840	HUMAN OTC DRUG	Bartonella Homochord		Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis	LIQUID	ORAL	20160907	20250921	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BARTONELLA BACILLIFORMIS; BARTONELLA CLARRIDGEIAE; BARTONELLA ELIZABETHAE; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BARTONELLA VINSONII; BARTONELLA WASHOENSIS	15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-0842_0be78845-3c40-435d-9d77-6f1af57c3a41	43742-0842	HUMAN OTC DRUG	Coxsackie Homochord		Coxsackie Nosode A2, Coxsackie Nosode A7, Coxsackie Nosode B1, Coxsackie Nosode B3, Coxsackie Nosode B4	LIQUID	ORAL	20160907	20240522	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4	7; 7; 7; 7; 7	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-0843_bbb02edd-bf0c-4e72-a36a-1dec003a4a18	43742-0843	HUMAN OTC DRUG	Mycoplasma Homochord		Mycoplasma Pneumoniae	LIQUID	ORAL	20160908	20250707	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	MYCOPLASMA PNEUMONIAE	15	[hp_X]/mL			N	
43742-0849_506d1b99-d904-4760-8a3c-74fb915df067	43742-0849	HUMAN OTC DRUG	Inflammation	II	Asafoetida, Kalmia Latifolia, Causticum, Colchicum Autumnale, Ferrum Metallicum, Gnaphalium Polycephalum, Lithium Benzoicum, Mercurius Praecipitatus Ruber, Rhus Tox, Spiraea Ulmaria	LIQUID	ORAL	20160915		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CAUSTICUM; COLCHICUM AUTUMNALE BULB; FERULA ASSA-FOETIDA RESIN; FILIPENDULA ULMARIA ROOT; IRON; KALMIA LATIFOLIA LEAF; LITHIUM BENZOATE; MERCURIC OXIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF	10; 10; 8; 10; 10; 8; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Mood Stabilizer [EPC]		N	20241231
43742-0850_548bbf1a-985c-4c93-ac6f-6d052f9b72cd	43742-0850	HUMAN OTC DRUG	Gallbladder Liver Meridian Opener		Arsenicum Album, Berberis Vulgaris, Bryonia (Alba), Calcarea Carbonica, Carduus Marianus, Cinchona Officinalis, Kali Carbonicum, Lycopodium Clavatum, Natrum Sulphuricum, Nux Vomica, Phosphorus	LIQUID	ORAL	20160915		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-0851_9cd59bf8-d133-4cec-a7ed-d8a4e0e5786f	43742-0851	HUMAN OTC DRUG	Progesterone		Progesterone	LIQUID	ORAL	20160919		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	PROGESTERONE	6	[hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
43742-0857_ec6d087f-c399-44bb-8a61-b1cac2e85411	43742-0857	HUMAN OTC DRUG	Osteoreg		Asafoetida, Kali Iodatum, Natrum Sulphuricum, Stillingia Sylvatica, Aranea Diadema, Vitamin D3, Hydrocortisone (Cortisol), Mercurius Praecipitatus Ruber, Calcarea Phosphorica, Hekla Lava, Parathyroid Gland (Bovine), Aurum Metallicum, Lycopodium Clavatum, Gaertner Bacillus (Bach)	LIQUID	ORAL	20160921		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARANEUS DIADEMATUS; ASAFETIDA; BOS TAURUS PARATHYROID GLAND; CHOLECALCIFEROL; GOLD; HEKLA LAVA; HYDROCORTISONE; LYCOPODIUM CLAVATUM SPORE; MERCURIC OXIDE; POTASSIUM IODIDE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM SULFATE; STILLINGIA SYLVATICA ROOT; TRIBASIC CALCIUM PHOSPHATE	6; 4; 8; 6; 12; 8; 6; 30; 8; 4; 30; 4; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
43742-0863_6c0fef95-ba9e-4b55-a0dd-82bcd069d3b3	43742-0863	HUMAN OTC DRUG	Candida Albicans Homochord		Candida Albicans	LIQUID	ORAL	20161005	20250821	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CANDIDA ALBICANS	15	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-0866_7b284a85-6acc-467b-89cc-ac4cd2fd9538	43742-0866	HUMAN OTC DRUG	Cytomegalovirus Homochord		Cytomegalovirus Nosode	LIQUID	ORAL	20161005	20250721	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	HUMAN HERPESVIRUS 5	18	[hp_X]/mL			N	
43742-0894_28965c90-e51f-4cce-b188-8891fcfef8a3	43742-0894	HUMAN OTC DRUG	Brucella Homochord		Brucella Melitensis	LIQUID	ORAL	20161028		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BRUCELLA MELITENSIS	11	[hp_C]/mL			N	20241231
43742-0898_4c41260c-42c7-4fe6-9f86-a728b784e76e	43742-0898	HUMAN OTC DRUG	Herpes Simplex Homochord		Herpes Simplex I, Herpes Simplex II	LIQUID	ORAL	20161117	20250616	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2	15; 15	[hp_X]/mL; [hp_X]/mL			N	
43742-0900_b98b3eef-b8ce-4242-a3fc-48f720ae01ec	43742-0900	HUMAN OTC DRUG	Peptostrep Homochord		Peptostreptococcus Anaerobius	LIQUID	ORAL	20161117	20250707	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	PEPTOSTREPTOCOCCUS ANAEROBIUS	19	[hp_X]/mL			N	
43742-0901_1f281ab8-5f0a-4666-a517-b56539835891	43742-0901	HUMAN OTC DRUG	H. Pylori Homochord		Helicobacter Pylori	LIQUID	ORAL	20161110	20250720	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HELICOBACTER PYLORI	15	[hp_X]/mL			N	
43742-0915_122f7dfb-0f15-45fb-8d5a-06dc6994b107	43742-0915	HUMAN OTC DRUG	Petrochemical Detox		Chelidonium Majus, Symphytum Officinale, Taraxacum Officinale, Trifolium Pratense, Acetone, Sodium Tripolyphosphate, Propylene Glycol, Sodium Benzene Sulfonate, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Arsenicum Album, Cadmium Sulphuratum, Gelsemium Sempervirens, Iridium Metallicum, Lycopodium Clavatum, Mercurius Solubilis, Nitricum Acidum, Nitricum Acidum, Nux Vomica, Petroleum, Phosphoricum Acidum, Platinum Metallicum, Latrodectus Mactans	LIQUID	ORAL	20161128	20240410	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETONE; AMMONIUM CHLORIDE; ARSENIC TRIOXIDE; CADMIUM SULFIDE; CHELIDONIUM MAJUS; COMFREY ROOT; GELSEMIUM SEMPERVIRENS ROOT; IRIDIUM; KEROSENE; LATRODECTUS MACTANS; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NITRIC ACID; PHOSPHORIC ACID; PLATINUM; PROPYLENE GLYCOL; SODIUM BENZENESULFONATE; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; TURPENTINE OIL	9; 9; 12; 12; 3; 6; 12; 12; 12; 15; 12; 12; 12; 12; 12; 9; 9; 9; 9; 12; 3; 6; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-0944_839cbcc2-0326-4783-8c45-a4599e4f3d14	43742-0944	HUMAN OTC DRUG	Oratox		Fucus Vesiculosus, Lymph Node (Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum	LIQUID	ORAL	20161227		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CALCIUM CHLORIDE; COPPER; EUGENOL; FORMALDEHYDE; FUCUS VESICULOSUS; GOLD; IODINE; LIDOCAINE; MERCURIUS SOLUBILIS; MOLYBDENUM; NICKEL; PALLADIUM; SELENIUM; SILVER; SODIUM CHLORIDE; SODIUM FLUORIDE; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA THYMUS; SUS SCROFA THYROID; TIN; TITANIUM; VANADIUM; ZINC	12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 8; 8; 8; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43742-0945_859dc18e-2e0d-4614-9d66-299e725d76b1	43742-0945	HUMAN OTC DRUG	Radiation Plus		Chondrus Crispus, Fucus Vesiculosus, Thyroidinum (Suis), Cadmium Iodatum, Cadmium Sulphuratum, Iodium, Radium Bromatum, Strontium Carbonicum, Uranium Nitricum, X-Ray, Arnica Montana	LIQUID	ORAL	20161228	20271011	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); ARNICA MONTANA; CADMIUM IODIDE; CADMIUM SULFIDE; CHONDRUS CRISPUS; FUCUS VESICULOSUS; IODINE; RADIUM BROMIDE; STRONTIUM CARBONATE; SUS SCROFA THYROID; URANYL NITRATE HEXAHYDRATE	30; 30; 12; 12; 3; 3; 12; 12; 12; 8; 12	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-0949_6aec5184-56dd-44a7-ad8a-f90284b97a50	43742-0949	HUMAN OTC DRUG	Lymphoplus		Trifolium Pratense, Lymph Node (Suis), Spleen (Suis), Conium Maculatum, Echinacea (Angustifolia), Lycopodium Clavatum, Myrrha, Phytolacca Decandra, Selenium Metallicum, Silicea	LIQUID	ORAL	20161229		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; LYCOPODIUM CLAVATUM SPORE; MYRRH; PHYTOLACCA AMERICANA ROOT; SELENIUM; SILICON DIOXIDE; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; TRIFOLIUM PRATENSE FLOWER	12; 12; 12; 12; 12; 12; 12; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-0955_36f7f484-6d7b-4fe6-9c0a-c0355fb77371	43742-0955	HUMAN OTC DRUG	Levothyroxine		Levothyroxine	LIQUID	ORAL	20170106	20260118	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	LEVOTHYROXINE	16	[hp_X]/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	
43742-0958_7cd0b3c0-cbb9-49ca-aae4-758cf4125831	43742-0958	HUMAN OTC DRUG	Upper Respiratory Staph Strep Combination		Staphylococcus Aureus, Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Streptococcus Viridans	LIQUID	ORAL	20170106	20240328	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE TYPE B; KLEBSIELLA PNEUMONIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	12; 12; 15; 15; 12; 12; 12; 36	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43742-0962_56022332-01ae-4ca4-8833-03d642841791	43742-0962	HUMAN OTC DRUG	Rocky Mountain Spotted Fever Homochord		Rickettsia Prowazekii	LIQUID	ORAL	20170109	20250902	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	RICKETTSIA PROWAZEKII	10	[hp_C]/mL			N	
43742-0969_213020c5-9b19-430b-904d-a282021047bf	43742-0969	HUMAN OTC DRUG	Human Parvovirus Homochord		Parvovirus Nosode	LIQUID	ORAL	20170208	20240815	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN PARVOVIRUS B19	15	[hp_X]/mL			N	
43742-0970_85f2eb31-a973-43b2-b161-5e80f662405b	43742-0970	HUMAN OTC DRUG	Biological Complex	I	Variolinum	LIQUID	ORAL	20170208		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN	30	[hp_C]/mL	Actively Acquired Immunity [PE], Live Vaccinia Virus Vaccine [EPC], Smallpox Vaccine [CS], Vaccines, Live, Unattenuated [CS]		N	20241231
43742-0985_3136bd82-1ef8-4e03-8758-9e82a3dc6dd3	43742-0985	HUMAN OTC DRUG	Candida		Candida Albicans	LIQUID	ORAL	20170221	20251013	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CANDIDA ALBICANS	200	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-0991_e056c4ab-43eb-46dc-a1a4-e2f5b90fdeb3	43742-0991	HUMAN OTC DRUG	Biological Complex	II	Anthracinum	LIQUID	ORAL	20170309		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BACILLUS ANTHRACIS IMMUNOSERUM RABBIT	30	[hp_C]/mL			N	20241231
43742-0998_00d16142-f4ad-4b7f-bb39-e6b0a8f3bece	43742-0998	HUMAN OTC DRUG	Perfect Sleep		Adenosinum Triphosphoricum Dinatrum, Pantothenic Acid, Ubidecarenonum, Pineal Gland (Suis), Sarcolacticum Acidum, Melatonin, Pyrrole, Tryptophan, Arsenicum Album, Avena Sativa, Chamomilla, Coffea Cruda, Mercurius Corrosivus, Passiflora Incarnata, Silicea, Zincum Valerianicum, Dysentery Bacillus, Gaertner Bacillus	LIQUID	ORAL	20170417	20261230	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; LACTIC ACID, L-; MATRICARIA RECUTITA; MELATONIN; MERCURIC CHLORIDE; PANTOTHENIC ACID; PASSIFLORA INCARNATA FLOWERING TOP; PYRROLE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SHIGELLA DYSENTERIAE; SILICON DIOXIDE; SUS SCROFA PINEAL GLAND; TRYPTOPHAN; UBIDECARENONE; ZINC VALERATE DIHYDRATE	8; 10; 10; 10; 8; 10; 8; 10; 8; 10; 8; 30; 30; 10; 8; 8; 8; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1002_f4b9f9d0-8506-4fe5-8c26-6685f1323d4f	43742-1002	HUMAN OTC DRUG	Giardia Lamblia Homochord		Giardia Lamblia	LIQUID	ORAL	20170501	20250227	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	GIARDIA LAMBLIA	11	[hp_C]/mL			N	
43742-1009_3563c0f7-8682-4558-8bda-3aa8bfb931b8	43742-1009	HUMAN OTC DRUG	Heart Small Intestine Meridian Opener		Arsenicum Album, Aurum Metallicum, Cactus Grandiflorus, Cinchona Officinalis, Digitalis Purpurea, Kali Carbonicum, Lithium Carbonicum, Lycopodium Clavatum, Mercurius Solubilis, Naja Tripudians, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris), Pyrogenium, Spigelia Anthelmia	LIQUID	ORAL	20170525	20240624	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; DIGITALIS; GOLD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NAJA NAJA VENOM; PHOSPHORUS; POTASSIUM CARBONATE; RANCID BEEF; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	
43742-1010_a782e082-868d-4106-95b5-a19ac57b36c4	43742-1010	HUMAN OTC DRUG	Thyroplus		Fucus Vesiculosus, Spongia Tosta, Phosphoricum Acidum, Hypophysis (Suis), Thyroidinum (Suis), Calcarea Carbonica, Iodium, Iridium Metallicum	LIQUID	ORAL	20170809		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	FUCUS VESICULOSUS; IODINE; IRIDIUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; THYROID	3; 12; 12; 12; 6; 4; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1012_aeba8e77-7194-42d2-8fa5-68bdfc248d30	43742-1012	HUMAN OTC DRUG	Chlamydia Homochord		Chlamydia Trachomatis	LIQUID	ORAL	20170525	20250616	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CHLAMYDIA TRACHOMATIS	12	[hp_X]/mL			N	
43742-1015_e1ae8e5e-df79-4897-991f-a59ca8eeb773	43742-1015	HUMAN OTC DRUG	Upper Respiratory Staph/Strep Combination		Staphylococcus Aureus, Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Streptococcus Viridans	TABLET	ORAL	20170531	20250505	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE TYPE B; KLEBSIELLA PNEUMONIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	12; 12; 15; 15; 12; 12; 12; 36	[hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	
43742-1017_74406d95-821d-42e3-a131-331dced508b6	43742-1017	HUMAN OTC DRUG	Skin Infections		Ailanthus Glandulosus, Echinacea (Angustifolia), Phytolacca Decandra, Hepar Sulphuris Calcareum, Mercurius Solubilis, Mezereum, Arsenicum Album, Lachesis Mutus, Herpes Simplex 1 and 2 Nosode, Herpes Zoster Nosode	LIQUID	ORAL	20180116	20240416	UNAPPROVED HOMEOPATHIC		Deseret Biologials, Inc.	AILANTHUS ALTISSIMA FLOWERING TWIG; ARSENIC TRIOXIDE; CALCIUM SULFIDE; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT	3; 12; 8; 9; 3; 15; 15; 15; 12; 8; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1018_7392f949-f127-43d8-93e2-66c86c886a17	43742-1018	HUMAN OTC DRUG	Pre-Dental Visit		Scrophularia Nodosa, Teucrium Scorodonia, Veronica Officinalis, Equisetum Arvense, Fumaria Officinalis, Geranium Robertianum, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Gentiana Lutea, Juglans Regia, Sarsaparilla (Smilax Regelii), Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos, Myosotis Arvensis, Aranea Diadema, Calcarea Phosphorica, Ferrum Iodatum, Lymph Node (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20180116	20240618	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARANEUS DIADEMATUS; CLEMATIS VITALBA FLOWER; EQUISETUM ARVENSE TOP; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PINUS SYLVESTRIS LEAFY TWIG; PRUNUS CERASIFERA FLOWER; SARSAPARILLA; SCROPHULARIA NODOSA; SODIUM SULFATE; SUS SCROFA LYMPH; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	12; 8; 4; 12; 4; 5; 4; 8; 8; 5; 5; 9; 4; 8; 4; 8; 6; 3; 4; 12; 12; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
43742-1019_267f36d4-6003-4ed9-b9d2-e248003d1eba	43742-1019	HUMAN OTC DRUG	Upper Respiratory Support		Allium Cepa, Echinacea (Angustifolia), Eucalyptus Globulus, Salvia Officinalis, Dulcamara, Euphrasia Officinalis, Hydrastis Canadensis, Natrum Muriaticum, Sabadilla, Viscum Album, Mucosa Nasalis Suis, Aconitum Napellus, Ammonium Carbonicum, Arsenicum Iodatum, Bryonia (Alba), Gelsemium Sempervirens, Kali Bichromicum, Mercurius Vivus, Nux Vomica, Pulsatilla (Pratensis), Rhus Tox	LIQUID	ORAL	20170606		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; AMMONIUM CARBONATE; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA; EUCALYPTUS GLOBULUS LEAF; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; MERCURY; ONION; POTASSIUM DICHROMATE; SAGE; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA NASAL MUCOSA; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 12; 3; 3; 6; 12; 6; 12; 3; 12; 3; 6; 6; 6; 12; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
43742-1035_09a53249-d7a3-45f2-ae6b-f8a98ea78d9f	43742-1035	HUMAN OTC DRUG	Bio Lymph Phase		Scrophularia Nodosa, Teucrium Scorodonia, Veronica Officinalis, Equisetum Hyemale, Fumaria Officinalis, Geranium Robertianum, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Gentiana Lutea, Juglans Regia, Aranea Diadema, Sarsaparilla (Smilax Regelii), Ascorbicum Acidum, Quercetin, Myosotis Arvensis, Calcarea Phosphorica, Ferrum Iodatum, Thyroidinum (Suis), Gaertner Bacillus	LIQUID	ORAL	20170720	20240723	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARANEUS DIADEMATUS; ASCORBIC ACID; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; QUERCETIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	6; 6; 4; 12; 4; 5; 4; 5; 5; 9; 4; 4; 6; 30; 3; 6; 4; 12; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Vitamin C [EPC]		N	
43742-1036_3a0fd953-cbb6-4652-a05c-93d38384d715	43742-1036	HUMAN OTC DRUG	Elevate		Lycopodium Clavatum, Natrum Muriaticum, Sepia, Causticum, Phosphorus, Sulphur, 5-Hydroxytryptophan, Alumina, Silicea, Acetylcholine Chloride, Dopamine Hydrochloride, Norepinephrine, Phenylethylamine (Hydrochloride), Serotonin (Hydrochloride), Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Funiculus Umbilicalis Suis, Pantothenic Acid, Pineal Gland (Suis), Sarcolacticum Acidum, Faecalis (Alkaligenes), Gaertner Bacillus (Bach), Proteus (Vulgaris)	LIQUID	ORAL	20170720	20240204	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYLCHOLINE CHLORIDE; ADENOSINE CYCLIC PHOSPHATE; ALCALIGENES FAECALIS; ALUMINUM OXIDE; CAUSTICUM; DOPAMINE HYDROCHLORIDE; LACTIC ACID, L-; LYCOPODIUM CLAVATUM SPORE; NOREPINEPHRINE; OXITRIPTAN; PANTOTHENIC ACID; PHENETHYLAMINE HYDROCHLORIDE; PHOSPHORUS; PROTEUS VULGARIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEPIA OFFICINALIS JUICE; SEROTONIN HYDROCHLORIDE; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA UMBILICAL CORD	8; 10; 30; 8; 4; 8; 10; 3; 8; 6; 10; 8; 4; 30; 30; 3; 8; 8; 3; 4; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	
43742-1047_046ce759-71e7-4b8e-a080-748f6b337d77	43742-1047	HUMAN OTC DRUG	Herpes Simplex Plus		Allium Sativum, Calendula Officinalis, Sambucus Nigra, Clematis Erecta, Dulcamara, Petroleum, Sarsaparilla (Smilax Regelii), Graphites, Arsenicum Album, Croton Tiglium, Mercurius Sulphuratus Ruber, Natrum Muriaticum, Nitricum Acidum, Rhus Tox, Sepia, Thuja Occidentalis	LIQUID	ORAL	20170731	20240501	UNAPPROVED HOMEOPATHIC		Deseret Biologicals,Inc.	ARSENIC TRIOXIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS RECTA FLOWERING TOP; CROTON TIGLIUM SEED; GARLIC; GRAPHITE; KEROSENE; MERCURIC SULFIDE; NITRIC ACID; SAMBUCUS NIGRA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 2; 6; 12; 2; 8; 6; 12; 12; 3; 12; 6; 12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1060_073e9a9c-7896-470f-9dd6-40cd0b9d0b7b	43742-1060	HUMAN OTC DRUG	Clostridium Difficile Homochord		Clostridium Difficile	LIQUID	ORAL	20170912	20250504	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CLOSTRIDIUM DIFFICILE	15	[hp_X]/mL			N	
43742-1089_a1ee91c3-0ca9-4129-9e5d-aa26669f24bf	43742-1089	HUMAN OTC DRUG	Pertussis		Aconitum Napellus, Bryonia (Alba), Hyoscyamus Niger, Ipecacuanha, Sticta Pulmonaria, Tabacum, Phosphorus, Antimonium Tartaricum, Kreosotum, Silicea, Pertussinum, Tetanus Toxin	LIQUID	ORAL	20171031		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CLOSTRIDIUM TETANI; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYOSCYAMUS NIGER; IPECAC; LOBARIA PULMONARIA; PHOSPHORUS; SILICON DIOXIDE; TOBACCO LEAF; WOOD CREOSOTE	4; 6; 4; 30; 30; 4; 4; 4; 5; 8; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43742-1113_23bb14ef-c47a-465e-a4f4-e1aa500c5ce9	43742-1113	HUMAN OTC DRUG	Sore Throat		Myosotis Arvensis, Scrophularia Nodosa, Teucrium Scorodonia, Veronica Officinalis, Equisetum Hyemale, Fumaria Officinalis, Geranium Robertianum, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Gentiana Lutea, Juglans Regia, Aranea Diadema, Sarsaparilla (Smilax Regelii), Calcarea Phosphorica, Ferrum Iodatum, Lymph Nose (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20171129	20240415	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARANEUS DIADEMATUS; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA LYMPH; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	6; 4; 12; 4; 5; 4; 5; 5; 9; 4; 4; 3; 6; 4; 12; 12; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
43742-1121_6eecb3c6-7665-43fc-9bdf-1b1cc1eab90d	43742-1121	HUMAN OTC DRUG	Esteem		Ambra Grisea, Lilium Tigrinum, Lycopodium Clavatum, Natrum Carbonicum, Viscum Album, Thuja Occidentalis, Hypothalamus Suis, Cubeba Officinalis, Agnus Castus, Anacardium Orientale, Baryta Iodata, Lac Caninum, Lac Felinum, Naja Tripudians, Rhus Glabra, Rosa Damascena, Sabadilla, Aurum Metallicum, Magnesium Iodide, Carcinosin	LIQUID	ORAL	20171219		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMBERGRIS; BARIUM IODIDE; CANIS LUPUS FAMILIARIS MILK; CHASTE TREE; FELIS CATUS MILK; GOLD; HUMAN BREAST TUMOR CELL; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM IODIDE; NAJA NAJA VENOM; PIPER CUBEBA FRUIT; RHUS GLABRA TOP; ROSA X DAMASCENA FLOWERING TOP; SCHOENOCAULON OFFICINALE SEED; SEMECARPUS ANACARDIUM JUICE; SODIUM CARBONATE; SUS SCROFA HYPOTHALAMUS; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP	6; 12; 12; 12; 12; 12; 30; 6; 6; 16; 12; 9; 12; 12; 12; 12; 6; 8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43742-1133_82bcbc32-6ae9-4667-8875-37fba1e71ea3	43742-1133	HUMAN OTC DRUG	Toxoplasma Gondii Homochord		Toxoplasma Gondii	LIQUID	ORAL	20171229	20250228	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	TOXOPLASMA GONDII	15	[hp_X]/mL			N	
43742-1149_3ac21c28-e1af-4c9b-ae04-e11989a656b9	43742-1149	HUMAN OTC DRUG	Amoeba		Baptisia Tinctoria, Cajuputum, Capsicum Annuum, Fragaria Vesca, Frasera Caroliniensis, Hamamelis Virginiana, Quassia (Amara), Senna (Cassia Angustifolia), Hydrastis Canadensis, Ipecacuanha, Hepar Suis, Pancreas Suis, Spleen (Suis), Cinchona Officinalis, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Selenium Metallicum, Blastocystis Hominis, Cryptosporidium Parvum, Entamoeba Histolytica, Giardia Lamblia, Brugia Malayi	LIQUID	ORAL	20180111	20240219	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALPINE STRAWBERRY; BAPTISIA TINCTORIA ROOT; BLASTOCYSTIS HOMINIS; BRUGIA MALAYI; CAJUPUT OIL; CAPSICUM; CINCHONA OFFICINALIS BARK; CRYPTOSPORIDIUM PARVUM; ENTAMOEBA HISTOLYTICA; FRASERA CAROLINIENSIS ROOT; GIARDIA LAMBLIA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; IPECAC; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PORK LIVER; QUASSIA AMARA WOOD; SELENIUM; SENNA LEAF; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN	3; 3; 12; 39; 3; 3; 12; 12; 12; 3; 12; 6; 3; 6; 12; 12; 12; 8; 3; 12; 3; 12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-1170_c1ecefa2-d637-4d59-a749-4bc66d88fc27	43742-1170	HUMAN OTC DRUG	Progenite		Ammonium Carbonicum, Baryta Muriatica, Borax, Caulophyllum Thalictroides, Natrum Carbonicum, Sabal Serrulata, Sabina, Sulphuricum Acidum, Thiosinaminum, Folliculinum, Tuba Uterina Suis, Uterus Suis, Hypothalamus (Suis), Thyroidinum (Suis), Agnus Castus, Conium Maculatum, Graphites, Hyoscyamus Niger, Sepia, Selenium Metallicum, X-Ray	LIQUID	ORAL	20180219	20280601	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ALCOHOL, X-RAY EXPOSED (1000 RAD); ALLYLTHIOUREA; AMMONIUM CARBONATE; BARIUM CHLORIDE DIHYDRATE; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE; CONIUM MACULATUM FLOWERING TOP; ESTRONE; GRAPHITE; HYOSCYAMUS NIGER; JUNIPERUS SABINA LEAFY TWIG; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CARBONATE; SULFURIC ACID; SUS SCROFA FALLOPIAN TUBE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA UTERUS; THYROID	12; 6; 6; 6; 6; 12; 12; 6; 12; 12; 6; 6; 12; 12; 6; 6; 6; 6; 8; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1171_cd73cf65-2c9d-4dcd-8e11-849f66f50453	43742-1171	HUMAN OTC DRUG	H. Pylori Plus		Angelica Archangelica, Geranium Maculatum, Hydrastis Canadensis, Sinapis Nigra, Symphytum Officinale, Ratanhia, Aceticum Acidum, Carbolicum Acidum, Ornithogalum Umbellatum, Abies Canadensis, Anacardium Orientale, Bismuthum Subnitricum, Condurango, Graphites, Iris Versicolor, Lycopodium Clavatum, Mezereum, Uranium Nitricum, Euphorbium Officinarum, Nux Vomica	LIQUID	ORAL	20180306	20250720	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ANGELICA ARCHANGELICA ROOT; BISMUTH SUBNITRATE; BLACK MUSTARD SEED; COMFREY ROOT; DAPHNE MEZEREUM BARK; EUPHORBIA RESINIFERA RESIN; GERANIUM MACULATUM ROOT; GOLDENSEAL; GRAPHITE; IRIS VERSICOLOR ROOT; KRAMERIA LAPPACEA ROOT; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; ORNITHOGALUM UMBELLATUM; PHENOL; SEMECARPUS ANACARDIUM JUICE; STRYCHNOS NUX-VOMICA SEED; TSUGA CANADENSIS BARK; TSUGA CANADENSIS FLOWER BUD; URANYL NITRATE HEXAHYDRATE	9; 6; 12; 6; 6; 12; 12; 6; 6; 12; 12; 6; 12; 12; 10; 9; 12; 12; 10; 10; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1172_582c0495-845c-4b6b-99f3-4a89ac704851	43742-1172	HUMAN OTC DRUG	Strep Plus/PANDAS		Allium Sativum, Echinacea (Angustifolia), Chamomilla, Kali Iodatum, Lac Caninum, Agaricus Muscarius, Ailanthus Glandulosus, Apis Mellifica, Argentum Nitricum, Baptisia Tinctoria, Baryta Muriatica, Calcarea Carbonica, Causticum, Hepar Sulphuris Calcareum, Lachesis Mutus, Mercurius Corrosivus, Stramonium, Aconitum Napellus, Gelsemium Sempervirens, Phytolacca Decandra	LIQUID	ORAL	20180219	20250722	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; AILANTHUS ALTISSIMA FLOWERING TWIG; AMANITA MUSCARIA FRUITING BODY; APIS MELLIFERA; BAPTISIA TINCTORIA ROOT; BARIUM CHLORIDE DIHYDRATE; CALCIUM SULFIDE; CANIS LUPUS FAMILIARIS MILK; CAUSTICUM; DATURA STRAMONIUM; ECHINACEA ANGUSTIFOLIA; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA; MERCURIC CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM IODIDE; SILVER NITRATE	12; 12; 12; 12; 12; 12; 12; 10; 12; 12; 3; 3; 12; 12; 6; 12; 12; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1177_d1c4ceb6-8627-496e-b632-402fe68c2d49	43742-1177	HUMAN OTC DRUG	Spectric		Ethylicum, Kali Bromatum, Aspartic Acid, L-Dopa, Serotonin (Hydrochloride), Cerebrum Suis, Placenta Totalis Suis, Agaricus Muscarius, Bufo Rana, Helleborus Niger, Hyoscyamus Niger, Olibanum (Boswellia Serrata), Stramonium, Thuja Occidentalis, Helium, Neon, Carcinosin, Hydrogen	LIQUID	ORAL	20180220	20270701	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ALCOHOL; AMANITA MUSCARIA FRUITING BODY; ASPARTIC ACID; BUFO BUFO CUTANEOUS GLAND; DATURA STRAMONIUM; HELIUM; HELLEBORUS NIGER ROOT; HUMAN BREAST TUMOR CELL; HYDROGEN; HYOSCYAMUS NIGER; INDIAN FRANKINCENSE; LEVODOPA; NEON; POTASSIUM BROMIDE; SEROTONIN HYDROCHLORIDE; SUS SCROFA CEREBRUM; SUS SCROFA PLACENTA; THUJA OCCIDENTALIS LEAFY TWIG	6; 12; 6; 12; 12; 16; 12; 30; 12; 12; 12; 6; 16; 6; 6; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
43742-1178_bb6dfec2-8050-4897-9862-1e602232b82f	43742-1178	HUMAN OTC DRUG	Bartonella Plus		Arnica Montana, Echinacea (Angustifolia), Glycyrrhiza Glabra, Hydrastis Canadensis, Ledum Palustre, Thyroidinum (Suis), Arbutus Andrachne, Apis Mellifica, Arsenicum Album, Cocculus Indicus, Gunpowder, Hepar Sulphuris Calcareum, Kalmia Latifolia, Lac Caninum, Lycopodium Clavatum, Veratrum Album, Aconitum Napellus, Stramonium, Tellurium Metallicum	LIQUID	ORAL	20180316	20250904	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ACTIVATED CHARCOAL; ANAMIRTA COCCULUS SEED; APIS MELLIFERA; ARBUTUS ANDRACHNE LEAFY SHOOT; ARNICA MONTANA; ARSENIC TRIOXIDE; CALCIUM SULFIDE; CANIS LUPUS FAMILIARIS MILK; DATURA STRAMONIUM; ECHINACEA ANGUSTIFOLIA; GLYCYRRHIZA GLABRA; GOLDENSEAL; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; POTASSIUM NITRATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SULFUR; TELLURIUM; THYROID, PORCINE; VERATRUM ALBUM ROOT	12; 12; 12; 12; 10; 3; 12; 12; 12; 12; 3; 6; 6; 12; 12; 12; 6; 12; 16; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1180_c9848d0f-c079-4dc6-bcf1-18bc5233e404	43742-1180	HUMAN OTC DRUG	Co-InfXn		Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Encephalitis Nosode, Mycoplasma Pneumoniae, Meningococcus Nosode, Hepatitis B Nosode	LIQUID	ORAL	20180226	20240416	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BABESIA MICROTI; BARTONELLA HENSELAE; BORRELIA BURGDORFERI; EHRLICHIA CANIS; HEPATITIS B VIRUS; JAPANESE ENCEPHALITIS VIRUS; MYCOPLASMA PNEUMONIAE; NEISSERIA MENINGITIDIS	15; 15; 15; 15; 15; 15; 15; 21	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1183_5c156101-796c-43e3-943f-41aff011f2b0	43742-1183	HUMAN OTC DRUG	Lyme Plus		Arnica Montana, Echinacea (Angustifolia), Taraxacum Officinale, Trifolium Pratense, Glycyrrhiza Glabra, Hydrastis Canadensis, Kalmia Latifolia, Ledum Palustre, Gunpowder, Adrenalinum, Thyroidinum (Suis), Arbutus Andrachne, Arsenicum Album, Cocculus Indicus, Lac Caninum, Lycopodium Clavatum, Phosphorus, Rhus Tox, Tellurium Metallicum	LIQUID	ORAL	20180315	20251019	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ANAMIRTA COCCULUS SEED; ARBUTUS ANDRACHNE LEAFY SHOOT; ARNICA MONTANA; ARSENIC TRIOXIDE; CANIS LUPUS FAMILIARIS MILK; ECHINACEA ANGUSTIFOLIA; EPINEPHRINE; GLYCYRRHIZA GLABRA; GOLDENSEAL; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; POTASSIUM NITRATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SULFUR; SUS SCROFA THYROID; TARAXACUM OFFICINALE; TELLURIUM; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER	8; 12; 12; 3; 12; 12; 3; 8; 6; 6; 6; 12; 12; 8; 6; 8; 8; 3; 16; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1184_3bc0d6b6-272a-4006-9078-9a02d02a21a6	43742-1184	HUMAN OTC DRUG	EBV/CFS Plus		Carduus Marianus, Cistus Canadensis, Dulcamara, Galium Aparine, Magnesia Muriatica, Natrum Sulphuricum, Viscum Album, Muriaticum Acidum, Folliculinum, Aqua Marina, Ailanthus Glandulosa, Baryta Muriatica, Cadmium Metallicum, Ceanothus Americanus, Cocculus Indicus, Iridium Metallicum, Thuja Occidentalis, Cinchona Officinalis, Calcarea Carbonica, Crotalus Cascavella	LIQUID	ORAL	20180315	20250610	UNAPPROVED DRUG OTHER		Deseret Biologicals, Inc.	AILANTHUS ALTISSIMA FLOWERING TWIG; ANAMIRTA COCCULUS SEED; BARIUM CHLORIDE DIHYDRATE; CADMIUM; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; CROTALUS DURISSUS TERRIFICUS VENOM; ESTRONE; GALIUM APARINE; HELIANTHEMUM CANADENSE; HYDROCHLORIC ACID; IRIDIUM; MAGNESIUM CHLORIDE; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE; SODIUM SULFATE; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 12; 12; 16; 8; 6; 6; 6; 12; 6; 6; 12; 10; 6; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-1201_323b0074-0b6b-411e-8f3e-f8f52092c1a6	43742-1201	HUMAN OTC DRUG	Focus		Ginkgo Biloba, Alpha-Ketoglutaricum Acidum, Iodium, Phosphorus, Sarcolacticum Acid, Saccharum Officinale, Adenosinum Cyclophosphoricum, Cerebrum Suis, Hypothalamus Suis, Silicea, Adrenalinum, Ambra Grisea, Carboneum Sulphuratum, Tarentula Hispana, Aethusa Cynapium, Baryta Carbonica, Helleborus Niger, Veratrum Album, Candida Albicans, Hyoscyamus Niger	LIQUID	ORAL	20180524		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE CYCLIC PHOSPHATE; AETHUSA CYNAPIUM; AMBERGRIS; BARIUM CARBONATE; CANDIDA ALBICANS; CARBON DISULFIDE; EPINEPHRINE; GINKGO; HELLEBORUS NIGER ROOT; HYOSCYAMUS NIGER; IODINE; LACTIC ACID, L-; LYCOSA TARANTULA; OXOGLURIC ACID; PHOSPHORUS; SILICON DIOXIDE; SUCROSE; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; VERATRUM ALBUM ROOT	8; 12; 9; 12; 12; 9; 8; 3; 12; 12; 6; 6; 10; 6; 6; 8; 6; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1202_9ae90d8c-cf6f-4638-89a5-401b3b6df63c	43742-1202	HUMAN OTC DRUG	Candida Spp		Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Pullularia Pullulans, Rhizopus Nigricans, Torula Cerevisiae, Candida Krusei, Candida Tropicalis	LIQUID	ORAL	20180409	20240815	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS WHOLE; MUCOR RACEMOSUS; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE	12; 12; 12; 12; 12; 31; 15; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-1221_715e3bc9-2a15-481d-b4b3-1abbf7ed5676	43742-1221	HUMAN OTC DRUG	Rheumatism		Benzoicum Acidum, Rhododendron Chrysanthum, Spiraea Ulmaria, Aconitum Napellus, Dulcamara, Ledum Palustre, Pulsatilla (Vulgaris), Asclepias Tuberosa, Lithium Benzoicum, Euphorbium Officinarum	LIQUID	ORAL	20180529	20241121	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ASCLEPIAS TUBEROSA ROOT; BENZOIC ACID; EUPHORBIA RESINIFERA RESIN; FILIPENDULA ULMARIA ROOT; LITHIUM BENZOATE; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; SOLANUM DULCAMARA TOP	4; 4; 6; 3; 9; 3; 8; 10; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ammonium Ion Binding Activity [MoA], Mood Stabilizer [EPC], Nitrogen Binding Agent [EPC]		N	
43742-1228_b7dc66c0-fa69-446f-8b4d-75bfdae2456a	43742-1228	HUMAN OTC DRUG	Human Papilloma Virus Homochord		Human Papilloma Nosode	LIQUID	ORAL	20180601	20250616	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN PAPILLOMAVIRUS	15	[hp_X]/mL			N	
43742-1242_5d746f29-7912-420b-bb2a-d07e1722789f	43742-1242	HUMAN OTC DRUG	Testosterone		Testosterone	LIQUID	ORAL	20180618		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	TESTOSTERONE	8	[hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
43742-1243_8f341e02-6074-4ca2-aca1-55ff02dfd13b	43742-1243	HUMAN OTC DRUG	Epinephrine		Adrenalinum	LIQUID	ORAL	20180710		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	EPINEPHRINE	6	[hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1244_1fdebd1a-db6f-4b86-aa09-49fe5ade6402	43742-1244	HUMAN OTC DRUG	Gum Therapy		Calendula Officinalis, Eugenia Caryophyllata, Plantago Major, Arnica Montana, Phytolacca Decandra, Phosphorus, Peptostreptococcus Anaerobius, Carbo Vegetabilis, Hepar Sulphuris Calcareum, Lachesis Mutus, Mercurius Solubilis	LIQUID	ORAL	20180710	20240801	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ACTIVATED CHARCOAL; ARNICA MONTANA; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLOVE; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PEPTOSTREPTOCOCCUS ANAEROBIUS; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR	30; 3; 30; 1; 1; 30; 30; 15; 12; 8; 1	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1246_8dd90663-9e67-4395-8903-83253d1820b7	43742-1246	HUMAN OTC DRUG	Acetaldehyde		Acetaldehyde	LIQUID	ORAL	20180828		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE	8	[hp_X]/mL			N	20241231
43742-1247_e0dbd732-e711-4ce8-946a-96827e8b26e1	43742-1247	HUMAN OTC DRUG	Adrenal Support		Aralia Quinquefolia, Humulus Lupulus, Adrenalinum, Cortisone Aceticum, Selenium Metallicum, Thyroidinum (Suis), Arsenicum Album, Calcarea Carbonica, Convallaria Majalis, Crotalus Horridus, Ferrum Metallicum, Nux Vomica, Phosphorus, Sepia, Phosphoricum Acidum	LIQUID	ORAL	20180824	20270322	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMERICAN GINSENG; ARSENIC TRIOXIDE; CONVALLARIA MAJALIS; CORTISONE ACETATE; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; HOPS; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA THYROID	3; 12; 12; 8; 12; 8; 3; 12; 12; 30; 12; 8; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1248_d6541d82-b5df-4dac-a1e8-9465e1ac31ed	43742-1248	HUMAN OTC DRUG	Adrenal Support		Aralia Quinquefolia, Humulus Lupulus, Adrenalinum, Cortisone Aceticum, Selenium Metallicum, Thyroidinum (Suis), Arsenicum Album, Calcarea Carbonica, Convallaria Majalis, Crotalus Horridus, Ferrum Metallicum, Nux Vomica, Phosphorus, Sepia, Phosphoricum Acidum	LIQUID	ORAL	20180914		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMERICAN GINSENG; ARSENIC TRIOXIDE; CONVALLARIA MAJALIS; CORTISONE ACETATE; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; HOPS; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; THYROID, PORCINE	3; 12; 12; 8; 12; 8; 3; 12; 12; 30; 12; 8; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1249_6f6c26d1-f442-4313-a1d2-0f78caf4421e	43742-1249	HUMAN OTC DRUG	Allergy Rescue		Acetylcholine Chloride, Histaminum Hydrochloricum, Serotonin (Hydrochloride)	LIQUID	ORAL	20180823		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYLCHOLINE CHLORIDE; HISTAMINE DIHYDROCHLORIDE; SEROTONIN HYDROCHLORIDE	6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
43742-1250_d5e987a7-c46a-4ee8-aaf5-a8d4bb8768ce	43742-1250	HUMAN OTC DRUG	Allermilk		Taraxacum Officinale, Hydrastis Canadensis, Apiolum, Benzoicum Acidum, Cholinum, Cinnamic Acid, Eugenol, Folic Acid, Histaminum Hydrochloricum, L-Asparagine, Menadione, Octopamine, Oophorinum (Suis), Phenyl Isothiocyanate, Piperine, Progesterone, Quercetin, Rutin, Saccharum Lactis, Vanillylamine, Xanthine, Coumarinum, Folliculinum, Formalinum, GABA (Gamma-Aminobutyric Acid).	LIQUID	ORAL	20181109	20240415	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; APIOLE (PARSLEY); ASPARAGINE; BENZOIC ACID; CHOLINE HYDROXIDE; CINNAMIC ACID; COUMARIN; ESTRONE; EUGENOL; FOLIC ACID; FORMALDEHYDE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; LACTOSE, UNSPECIFIED FORM; MENADIONE; OCTOPAMINE HYDROCHLORIDE; PHENYL ISOTHIOCYANATE; PIPERINE; PROGESTERONE; QUERCETIN; RUTIN; SUS SCROFA OVARY; TARAXACUM OFFICINALE; VANILLYLAMINE; XANTHINE	8; 6; 6; 6; 6; 6; 8; 8; 6; 6; 8; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 3; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Progesterone [CS], Progesterone [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43742-1251_f7a72680-13c6-4eb6-95e1-81ea135f2388	43742-1251	HUMAN OTC DRUG	Appetite Control		Acetyl Coenzyme A, Adenosinum Triphosphoricum Dinatrum, Adrenal Cortex (Suis), Bacopa Speciosa, Equol, Gambogia, Oxytocin Acetate, Rhodiola, Stomach (Suis), Chininum Sulphuricum, Iodium, Lycopodium Clavatum, Phosphorus, Dopamine Hydrochloride, Thyroidinum (Suis), Cina, Serotonin (Hydrochloride), Morgan Gaertner	LIQUID	ORAL	20180831	20240401	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE DISODIUM; ARTEMISIA CINA PRE-FLOWERING TOP; BACOPA MONNIERI WHOLE; DOPAMINE HYDROCHLORIDE; EQUOL, (+/-)-; IODINE; LYCOPODIUM CLAVATUM SPORE; OXYTOCIN ACETATE; PHOSPHORUS; QUININE SULFATE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEDUM ROSEUM ROOT; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL CORTEX; SUS SCROFA STOMACH; SUS SCROFA THYROID	6; 6; 8; 6; 8; 6; 6; 6; 6; 6; 6; 30; 6; 8; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	
43742-1252_140eff28-8b25-470b-b90c-ad2652da2849	43742-1252	HUMAN OTC DRUG	Aspartame/MSG Detox		Chelidonium Majus, Arnica Montana, Phytolacca Decandra, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum, Bisphenol A (BPA), Dextrose, Maltodextrin, Sucralose, Aspartic Acid, Diketopiperazine, Dopamine Hydrochloride, Formalinum, Formicum Acidum, L-Phenylalanine, Methyl Alcohol, Monosodium Glutamate	LIQUID	ORAL	20181105		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	2,5-PIPERAZINEDIONE; ARNICA MONTANA; ASPARTIC ACID; BISPHENOL A; CHELIDONIUM MAJUS; DEXTROSE MONOHYDRATE; DOPAMINE HYDROCHLORIDE; FORMALDEHYDE; FORMIC ACID; MALTODEXTRIN; METHYL ALCOHOL; MONOSODIUM GLUTAMATE; NITRIC ACID; PHENYLALANINE; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; STRYCHNOS NUX-VOMICA SEED; SUCRALOSE	30; 6; 30; 12; 3; 12; 30; 30; 30; 12; 30; 30; 12; 30; 12; 8; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43742-1253_ce084235-fbd4-4a5f-9413-5e5fa70e303e	43742-1253	HUMAN OTC DRUG	Asthma Plus		Ribes Nigrum, Viburnum Opulus, Quebracho, Blatta Orientalis, Pothos Foetidus, Cinnamic Acid, Gallicum Acidum, Indolum, Quercetin, Rutin, Arsenicum Iodatum, Naphthalinum, Coumarinum, Dust Mite Allersode, Oxygenium, Malvin	LIQUID	ORAL	20180831	20240722	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIIODIDE; BLATTA ORIENTALIS; CINNAMIC ACID; COUMARIN; DERMATOPHAGOIDES FARINAE; GALLIC ACID; INDOLE; MALVIN; NAPHTHALENE; OXYGEN; QUEBRACHO BARK; QUERCETIN; RIBES NIGRUM LEAF; RUTIN; SYMPLOCARPUS FOETIDUS ROOT; VIBURNUM OPULUS BARK	8; 6; 6; 8; 9; 6; 6; 12; 8; 12; 5; 6; 3; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	
43742-1254_c9db2466-671a-4502-93a8-394d787cdb8c	43742-1254	HUMAN OTC DRUG	Bio Co-Enzyme Phase		Beta Vulgaris, Ascorbicum Acidum, Cysteinum, Natrum Oxalaceticum, Nicotinamidum, Pulsatilla (Vulgaris), Pyridoxinum, Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Adrenalinum, Aconiticum Acidum, Cis-, alpha-Ketoglutaricum Acidum, alpha-Lipoicum Acidum, Cerium Oxalicum, Citricum Acidum, Fumaricum Acidum, Magnesium Oroticum Dihydricum, Malicum Acidum, Nadidum, Natrum Pyruvicum, Pantothenic Acid, Succinicum Acidum, Adenosinum Triphosphoricum Dinatrum, Hepar Sulphuris Calcareum, Sulphur	LIQUID	ORAL	20180720	20241118	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITIC ACID, (Z)-; ADENOSINE TRIPHOSPHATE DISODIUM; ANEMONE PULSATILLA; ANHYDROUS CITRIC ACID; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BETA VULGARIS; CALCIUM SULFIDE; CEROUS OXALATE NONAHYDRATE; CYSTEINE; EPINEPHRINE; FUMARIC ACID; MAGNESIUM OROTATE DIHYDRATE; MALIC ACID; MANGANESE PHOSPHATE, DIBASIC; NADIDE; NIACINAMIDE; OXOGLURIC ACID; PANTOTHENIC ACID; PROTEUS MORGANII; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SULFUR; THIAMINE HYDROCHLORIDE; THIOCTIC ACID	8; 10; 6; 8; 6; 30; 4; 10; 8; 6; 8; 8; 8; 8; 16; 8; 6; 8; 8; 34; 6; 6; 6; 8; 8; 10; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Decreased Coagulation Factor Activity [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1256_0119d480-f2d5-4237-9d15-26052b0f8b7b	43742-1256	HUMAN OTC DRUG	Bio Galium Phase		Betula (Pendula), Cortex, Caltha Palustris, Clematis Erecta, Galium Aparine, Hedera Helix, Juniperus Communis, Sedum Acre, Sempervivum Tectorum, Thuja Occidentalis, Urtica Urens, Echinacea (Angustifolia), Cortisone Aceticum, Argentum Metallicum, Calcarea Fluorica, Nitricum Acidum, Phosphorus, Aurum Metallicum, Ononis Spinosa, Gaertner Bacillus (Bach)	LIQUID	ORAL	20180716	20240304	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; BETULA PENDULA BARK; CALCIUM FLUORIDE; CALTHA PALUSTRIS; CLEMATIS RECTA FLOWERING TOP; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; GOLD; HEDERA HELIX FLOWERING TWIG; JUNIPER BERRY; NITRIC ACID; ONONIS SPINOSA WHOLE; PHOSPHORUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEDUM ACRE; SEMPERVIVUM TECTORUM LEAF; SILVER; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS	12; 4; 8; 4; 4; 8; 5; 4; 10; 4; 4; 8; 5; 8; 30; 4; 4; 8; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1257_3185c5f1-d036-49bb-b575-1ce52387ca5e	43742-1257	HUMAN OTC DRUG	Bio Glyoxal Phase		Arnica Montana, Baptisia Tinctoria, Echinacea (Angustifolia), Sanguinaria Canadensis, Eupatorium Perfoliatum, Euphorbium Officinarum, Dopamine Hydrochloride, Phytolacca Decandra, Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Mercurius Corrosivus, Phosphorus, Pulsatilla (Pratensis), Rhus Tox, Sulphur, Thuja Occidentalis, Cortisone Aceticum, Acetaldehyde, Formalinum, Hepar Sulphuris Calcareum, Lachesis Mutus, Zincum Metallicum	LIQUID	ORAL	20190607		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; ACONITUM NAPELLUS; ANEMONE PRATENSIS; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; DOPAMINE HYDROCHLORIDE; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; FORMALDEHYDE; GELSEMIUM SEMPERVIRENS ROOT; LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 8; 8; 4; 8; 4; 8; 10; 8; 6; 5; 6; 6; 10; 8; 10; 8; 8; 7; 5; 8; 8; 8; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43742-1258_cd05f528-e7a4-4200-b35f-fff640fc8608	43742-1258	HUMAN OTC DRUG	Bio Mood Phase		Cortisone Aceticum, Adrenalinum, Chininum Arsenicosum, Helonias Dioica, Hypericum Perforatum, Kali Phosphoricum, Nux Vomica, Selenium Metallicum, Aurum Metallicum, Bacillus 7 (Enterobacter Cloacae)	LIQUID	ORAL	20180911		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CHAMAELIRIUM LUTEUM ROOT; CORTISONE ACETATE; DIBASIC POTASSIUM PHOSPHATE; ENTEROBACTER CLOACAE; EPINEPHRINE; GOLD; HYPERICUM PERFORATUM; QUININE ARSENATE; SELENIUM; STRYCHNOS NUX-VOMICA SEED	10; 8; 10; 30; 8; 10; 10; 10; 10; 10	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1259_a7a2e53f-2397-4be3-930f-8c667f580e8c	43742-1259	HUMAN OTC DRUG	Bio Placenta Phase		Aesculus Hippocastanum, Sarcolacticum Acidum, Cuprum Sulphuricum, Melilotus Officinalis, Placenta Totalis Suis, Solanum Nigrum, Strophanthus Hispidus, DHEA (Dehydroepiandrosterone), Quercetin, Rutin, Natrum Pyruvicum, Secale Cornutum, Vena Suis, Arteria Suis, Funiculus Umbilicalis Suis, Tabacum, Vipera Berus, Baryta Carbonica, Plumbum Iodatum, Astragalus Exscapus, Proteus (Vulgaris)	LIQUID	ORAL	20180910	20250513	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ASTRAGALUS EXSCAPUS WHOLE FLOWERING/FRUITING; BARIUM CARBONATE; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC SULFATE; HORSE CHESTNUT; LACTIC ACID, L-; LEAD IODIDE; MELILOTUS OFFICINALIS TOP; PRASTERONE; PROTEUS VULGARIS; QUERCETIN; RUTIN; SODIUM PYRUVATE; SOLANUM NIGRUM WHOLE; STROPHANTHUS HISPIDUS SEED; SUS SCROFA ARTERY; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA VEIN; TOBACCO LEAF; VIPERA BERUS VENOM	6; 13; 8; 6; 4; 4; 18; 6; 6; 30; 6; 6; 8; 6; 6; 8; 6; 10; 8; 10; 10	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1260_4e6b8a08-23df-44e9-8df7-fa0927caed5e	43742-1260	HUMAN OTC DRUG	Bio Thalamus Phase		Adenosinum Cyclophosphoricum, Apiolum, Melatonin, Pineal Gland (Suis), Thalamus Opticus (Suis), L-DOPA, Viscum Album	LIQUID	ORAL	20180820	20240730	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE CYCLIC PHOSPHATE; APIOLE (PARSLEY); LEVODOPA; MELATONIN; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; VISCUM ALBUM FRUITING TOP	6; 6; 8; 6; 8; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
43742-1261_bc18ab03-8ee0-489b-95f4-3c3f5021dc48	43742-1261	HUMAN OTC DRUG	Bio Tonsilla Phase		Dulcamara, Echinacea (Angustifolia), Aesculus Hippocastanum, Antimonium Tartaricum, Ascorbicum Acidum, Coccus Cacti, Galium Aparine, Gentiana Lutea, Geranium Robertianum, Pulsatilla (Vulgaris), Sarcolacticum Acidum, Acetylcholine Chloride, Mannan, Conium Maculatum, Lymph Node (Suis), Sulphur, Calcarea Phosphorica, Ferrum Phosphoricum, Funiculus Umbilicalis Suis, Hepar Suis, Hypothalamus Suis, Medulla Ossis Suis, Spleen (Spleen), Cortisone Aceticum, Glandula Suprarenalis Suis, Mercurius Solubilis,	LIQUID	ORAL	20181206	20240201	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYLCHOLINE CHLORIDE; ANTIMONY POTASSIUM TARTRATE; ASCORBIC ACID; BARIUM CARBONATE; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; GALIUM APARINE; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; HORSE CHESTNUT; LACTIC ACID, L-; MERCURIUS SOLUBILIS; PORK LIVER; PROTORTONIA CACTI; PULSATILLA VULGARIS; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYROID; SUS SCROFA TONSIL; SUS SCROFA UMBILICAL CORD; TRIBASIC CALCIUM PHOSPHATE; YEAST MANNAN	6; 6; 6; 28; 8; 13; 4; 10; 6; 6; 6; 6; 6; 13; 10; 6; 6; 4; 8; 13; 10; 10; 8; 10; 13; 28; 10; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Coagulation Factor Activity [PE], Vitamin C [EPC]		N	
43742-1262_7397fbd7-29a7-4373-b5fa-b5eeef040b13	43742-1262	HUMAN OTC DRUG	Bio Viscum Phase		Viscum Album, L-Tryptophan, Adenosinum Cyclophosphoricum, Serotonin (Hydrochloride), Mercurius Iodatus Flavus	LIQUID	ORAL	20180720		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE CYCLIC PHOSPHATE; MERCUROUS IODIDE; SEROTONIN HYDROCHLORIDE; TRYPTOPHAN; VISCUM ALBUM FRUITING TOP	8; 10; 6; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1263_cc5a6fd6-9ed7-4f4f-93c6-4dd9c86ac772	43742-1263	HUMAN OTC DRUG	Breathe		Argentum Nitricum, Natrum Muriaticum, Sulphur, Aconitum Napellus, Arsenicum Album, Rhus Tox, Adenosinum Cyclophosphoricum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Lung (Suis), Mucosa Nasalis Suis, Pantothenic Acid, Sarcolacticum Acidum, Acetylcholine Chloride, Coumarinum, Malvin, Dysentery Bacillus, Proteus (Morgani)	LIQUID	ORAL	20181114		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ACETYLCHOLINE CHLORIDE; ACONITUM NAPELLUS; ADENOSINE CYCLIC PHOSPHATE; ARSENIC TRIOXIDE; COUMARIN; LACTIC ACID, L-; MALVIN; PANTOTHENIC ACID; PROTEUS MORGANII; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM CHLORIDE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	6; 8; 10; 8; 6; 10; 15; 10; 30; 30; 6; 6; 6; 10; 10; 10; 10; 8	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
43742-1264_3f920c83-eb18-4827-9d6a-77a4360179c7	43742-1264	HUMAN OTC DRUG	Bronchial Cough		Coccus Cacti, Drosera (Rotundifolia), Scilla Maritima, Sticta Pulmonaria, Causticum, Cuprum Aceticum, Arsenicum Iodatum, Carbo Vegetabilis, Kali Carbonicum, Lachesis Mutus	LIQUID	ORAL	20181022	20251125	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIIODIDE; CAUSTICUM; CUPRIC ACETATE; DRIMIA MARITIMA BULB; DROSERA ROTUNDIFOLIA; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; POTASSIUM CARBONATE; PROTORTONIA CACTI	12; 8; 6; 6; 4; 4; 12; 4; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1266_d3316246-675e-45cc-afea-5964287b4390	43742-1266	HUMAN OTC DRUG	Candida Plus		Echinacea (Angustifolia), Allium Sativum, Asafoetida, Hydrastis Canadensis, Berberis Vulgaris, Borax, Saccharum Officinale, Caffeinum, Gallicum Acidum, Indolum, Acetaldehyde, Folliculinum, Lycopodium Clavatum, Phytolacca Decandra, Pulsatilla (Pratensis), Sepia, Ustilago Maidis, Torula Cerevisiae	LIQUID	ORAL	20180629	20240218	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; ANEMONE PRATENSIS; BERBERIS VULGARIS ROOT BARK; CAFFEINE; ECHINACEA ANGUSTIFOLIA; ESTRONE; FERULA ASSA-FOETIDA RESIN; GALLIC ACID MONOHYDRATE; GARLIC; GOLDENSEAL; INDOLE; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SUCROSE; USTILAGO MAYDIS	8; 12; 6; 6; 3; 12; 3; 6; 3; 5; 6; 12; 12; 60; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Plant Proteins [CS], Xanthines [CS]		N	
43742-1267_cb64bb09-f810-4f09-82ef-ab438cc3671c	43742-1267	HUMAN OTC DRUG	Celeragesic		Echinacea (Angustifolia), Calendula Officinalis, Hamamelis Virginiana, Echinacea Purpurea, Bellis Perennis, Chamomilla, Hypericum Perforatum, Millefolium, Ledum Palustre, Arnica Montana, Bryonia (Alba), Hepar Sulphuris Calcareum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Symphytum Officinale, Rhus Tox, Aconitum Napellus, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis	LIQUID	ORAL	20180904		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LACTIC ACID, L-; MATRICARIA RECUTITA; NADIDE; PANTOTHENIC ACID; RHODODENDRON TOMENTOSUM LEAFY TWIG; SUS SCROFA ADRENAL GLAND; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	3; 12; 4; 2; 8; 8; 1; 8; 1; 2; 1; 3; 8; 3; 8; 8; 4; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1272_e2c33fb3-c706-4a92-a4b5-175968f4122e	43742-1272	HUMAN OTC DRUG	Cholesterol		Cholesterinum	LIQUID	ORAL	20181002		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CHOLESTEROL	8	[hp_X]/mL			N	20241231
43742-1273_02cfc91a-856d-4fb2-8520-f7e43526e960	43742-1273	HUMAN OTC DRUG	Chronagesic		Arnica Montana, Cinnamomum, Dulcamara, Funiculus Umbilicalis Suis, Nadidum, Natrum Oxalaceticum, Pantothenic Acid, Placenta Totalis Suis, Sanguinaria Canadensis, Sulphur, Apiolum, Piper Nigrum, Alpha-Lipoicum Acidum, Cartilago Suis, Rhus Tox, Silicea, Symphytum Officinale, Thuja Occidentalis	LIQUID	ORAL	20180820	20250421	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-LIPOIC ACID; APIOLE (PARSLEY); ARNICA MONTANA; CINNAMON; COMFREY ROOT; GREEN PEPPERCORN; NADIDE; PANTOTHENIC ACID; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SODIUM DIETHYL OXALACETATE; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	8; 6; 3; 6; 8; 6; 6; 6; 6; 8; 6; 6; 6; 8; 6; 6; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1275_ca3d9ff7-59cd-4715-bf3f-6d26cde66e51	43742-1275	HUMAN OTC DRUG	Cortisol		Hydrocortisone	LIQUID	ORAL	20180720		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HYDROCORTISONE	8	[hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43742-1276_371a0719-3529-4493-86e0-6d4bc0281d45	43742-1276	HUMAN OTC DRUG	Lymph/Spleen Combo		Juniperus Communis, Quercus Glandium Spiritus, Myosotis Arvensis, Natrum Sulphuricum, Ceanothus Americanus, Helianthus Annuus, Natrum Muriaticum, Phytolacca Decandra, Lymph Node (Suis), Spleen (Suis), Thymus (Suis), Chininum Arsenicosum, Adenosinum Triphosphoricum Dinatrum, Ubidecarenonum, Ferrum Metallicum, Succinum, Castanea Vesca, Apis Mellifica	LIQUID	ORAL	20181105	20250821	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; AMBER; APIS MELLIFERA; CASTANEA SATIVA LEAF; CEANOTHUS AMERICANUS LEAF; HELIANTHUS ANNUUS FLOWERING TOP; IRON; JUNIPERUS COMMUNIS WHOLE; MYOSOTIS ARVENSIS; PHYTOLACCA AMERICANA ROOT; QUERCUS ROBUR NUT; QUININE ARSENATE; SODIUM CHLORIDE; SODIUM SULFATE; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; UBIDECARENONE	12; 30; 200; 4; 6; 6; 30; 3; 6; 8; 4; 8; 6; 6; 8; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1277_8e05dfed-90b2-4f6f-a616-da89d64a1c7e	43742-1277	HUMAN OTC DRUG	Dairy Allergen Mix		Adenosinum Triphosphoricum Dinatrum, Apiolum, Benzoicum Acidum, Cholinum, Cinnamic Acid, Eugenol, Folic Acid, Formalinum, Histaminum Hydrochloricum, L-Asparagine (Monohydrate), Lac Defloratum, Lac Vaccinum, Menadione, Oophorinum (Suis), Phenyl Isothiocyanate, Quercetin, Rutin, Saccharum Lactis, Ileum (Suis), Jejunum (Suis), Stomach (Suis), Coumarinum, Folliculinum, GABA (Gamma-Aminobutyric Acid), Sarcolacticum Acidum, Lac Caninum, Lac Felinum, Lac Humanum, Piperine, Calcarea Carbonica, Calcarea Fluorica,	LIQUID	ORAL	20181231	20250217	UNAPPROVED DRUG OTHER		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACTIVATED CHARCOAL; ADENOSINE TRIPHOSPHATE DISODIUM; APIOLE (PARSLEY); ASPARAGINE MONOHYDRATE; BENZOIC ACID; CALCIUM CITRATE; CALCIUM FLUORIDE; CALCIUM GLUCONATE; CANIS LUPUS FAMILIARIS MILK; CHOLINE HYDROXIDE; CINNAMIC ACID; COUMARIN; COW MILK; ESTRONE; EUGENOL; FELIS CATUS MILK; FOLIC ACID; FORMALDEHYDE; HISTAMINE DIHYDROCHLORIDE; HUMAN MILK; LACTIC ACID, L-; LACTOSE, UNSPECIFIED FORM; MATRICARIA RECUTITA; MENADIONE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHENYL ISOTHIOCYANATE; PIPERINE; QUERCETIN; RUTIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SKIM MILK; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA OVARY; SUS SCROFA STOMACH; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	8; 6; 4; 6; 6; 6; 6; 6; 6; 30; 6; 6; 8; 6; 8; 6; 30; 6; 6; 6; 30; 8; 6; 6; 6; 6; 6; 30; 6; 6; 6; 6; 8; 8; 6; 8; 6; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43742-1278_143b308d-ffea-4c0e-a0b3-6172a7a5944c	43742-1278	HUMAN OTC DRUG	Detox	I	Carduus Marianus, Chelidonium Majus, Lycopodium Clavatum, Taraxacum Officinale, Avena Sativa, Cynara Scolymus, Methylcobalamin, Menadione, Alpha-Lipoicum Acidum, Cinchona Officinalis, Hepar Suis, Veratrum Album, Colon (Suis), Duodenum (Suis), Gallbladder (Suis), Intestine (Suis), Lymph Node (Suis), Pancreas Suis, Thymus (Suis), Alpha-Ketoglutaricum Acidum, Cholesterinum, Formicum Acidum, Glyoxal Trimer Dihydrate, Histaminum Hydrochloricum, Malic Acid, Natrum Oxalaceticum, Sulphur	LIQUID	ORAL	20180726	20240715	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; AVENA SATIVA FLOWERING TOP; CHELIDONIUM MAJUS; CHOLESTEROL; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; FORMIC ACID; GLYOXAL TRIMER DIHYDRATE; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; MALIC ACID; MENADIONE; METHYLCOBALAMIN; MILK THISTLE; OROTIC ACID MONOHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK INTESTINE; PORK LIVER; PROTEUS MORGANII; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA GALLBLADDER; SUS SCROFA LYMPH; SUS SCROFA PANCREAS; SUS SCROFA THYMUS; TARAXACUM OFFICINALE; VERATRUM ALBUM ROOT	10; 8; 6; 4; 10; 8; 6; 10; 10; 10; 4; 10; 6; 6; 3; 7; 28; 8; 8; 30; 30; 10; 13; 8; 8; 8; 8; 8; 8; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1279_f9c38565-016c-4c2e-a530-f56104ef4484	43742-1279	HUMAN OTC DRUG	Detox	II	Solidago Virgaurea, Baptisia Tinctoria, Berberis Vulgaris, Equisetum Hyemale, Argentum Nitricum, Cantharis, Capsicum Annuum, Cuprum Sulphuricum, Orthosiphon Stamineus, Pareira Brava, Sarsaparilla (Smilax Regelii), Apis Venenum Purum, Barosma (Betulina), Mercurius Corrosivus, Pyelon (Suis), Terebinthina, Ureter (Suis), Urethra (Suis), Urinary Bladder (Suis), Glyoxal Trimer Dihydrate, Hepar Sulphuris Calcareum, Natrum Pyruvicum, Quercetin, Colibacillinum Cum Natrum Muriaticum, Dysentery Bacillus	LIQUID	ORAL	20180925	20240508	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AGATHOSMA BETULINA LEAF; APIS MELLIFERA VENOM; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CAPSICUM; CHONDRODENDRON TOMENTOSUM ROOT; CUPRIC SULFATE; EQUISETUM HYEMALE; ESCHERICHIA COLI; GLYOXAL TRIMER DIHYDRATE; LYTTA VESICATORIA; MERCURIC CHLORIDE; ORTHOSIPHON ARISTATUS WHOLE; QUERCETIN; SHIGELLA DYSENTERIAE; SILVER NITRATE; SMILAX ORNATA ROOT; SODIUM PYRUVATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA RENAL PELVIS; SUS SCROFA URETER; SUS SCROFA URETHRA; SUS SCROFA URINARY BLADDER; TURPENTINE OIL	8; 6; 4; 4; 10; 6; 6; 6; 4; 15; 8; 6; 8; 6; 10; 30; 6; 6; 10; 3; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
43742-1280_94140fb7-f444-4cc1-90e2-ecdaf94b78d1	43742-1280	HUMAN OTC DRUG	Detox	III	Dulcamara, Echinacea (Angustifolia), Aesculus Hippocastanum, Antimonium Tartaricum, Ascorbic Acid, Coccus Cacti, Galium Aparine, Gentiana Lutea, Geranium Robertianum, Pulsatilla (Vulgaris), Sarcolacticum Acidum, Conium Maculatum, Lymph Node (Suis), Sulphur, Glandula Suprarenalis Suis, L-Phenylalanine, Calcarea Phosphorica, Ferrum Phosphoricum, Hepar Suis, Hypothalamus Suis, Spleen (Suis), Cortisone Aceticum, Mercurius Solubilis, Baryta Carbonica, Glyphosate, Funiculus Umbilicalis Suis	LIQUID	ORAL	20181031	20250616	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY POTASSIUM TARTRATE; ASCORBIC ACID; BARIUM CARBONATE; BISPHENOL A; BROMINE; CHLORINE; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; FERRUM PHOSPHORICUM; GALIUM APARINE; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; GLYPHOSATE; HORSE CHESTNUT; HYDROFLUORIC ACID; IODINE; LACTIC ACID, L-; LIOTHYRONINE; MERCURIUS SOLUBILIS; PHENYLALANINE; PORK LIVER; PROTORTONIA CACTI; PULSATILLA VULGARIS WHOLE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA TONSIL; SUS SCROFA UMBILICAL CORD; TRIBASIC CALCIUM PHOSPHATE	6; 6; 28; 12; 12; 12; 8; 13; 4; 30; 10; 6; 6; 6; 1000; 6; 12; 12; 6; 10; 13; 8; 10; 6; 6; 9; 4; 8; 8; 12; 10; 8; 10; 6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Coagulation Factor Activity [PE], Triiodothyronine [CS], Vitamin C [EPC], l-Triiodothyronine [EPC]		N	
43742-1281_8cf752d8-1148-4807-87ad-730c6a6270cb	43742-1281	HUMAN OTC DRUG	Dopamine		Dopamine Hydrochloride	LIQUID	ORAL	20180727		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	DOPAMINE HYDROCHLORIDE	8	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
43742-1282_170457eb-a256-4fd5-9dd0-ae18cf2595f3	43742-1282	HUMAN OTC DRUG	Energize		Sarcolacticum Acidum, Viscum Album, Iodium, Fucus Vesiculosus, Galium Aparine, Natrum Oxalaceticum, Thyroidinum (Suis), DHEA (Dehydroepiandrosterone), Phenyl Isothiocyanate, Tri-Iodothyronine, Tyramine, Alpha-Ketoglutaricum Acidum, Adenosinum Triphosphoricum Dinatrum, Fumaricum Acidum, Malic Acid, Colchicum Autumnale, Conium Maculatum, Funiculus Umbilicalis Suis, Hepar Suis, Medulla Ossis Suis, Pineal Gland (Suis), Spleen (Suis), Thymus (Suis), Calcarea Fluorica, Pulsatilla (Vulgaris), Spongia Tosta	LIQUID	ORAL	20181022	20240823	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-KETOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; ANEMONE PULSATILLA; CALCIUM FLUORIDE; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ESCHERICHIA COLI; FUCUS VESICULOSUS; FUMARIC ACID; GALIUM APARINE; IODINE; LACTIC ACID, L-; LIOTHYRONINE; MALIC ACID; MERCURIC CHLORIDE; PHENYL ISOTHIOCYANATE; PORK LIVER; PRASTERONE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA BONE MARROW; SUS SCROFA PINEAL GLAND; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; SUS SCROFA UMBILICAL CORD; THYROID, PORCINE; TYRAMINE; VISCUM ALBUM FRUITING TOP	7; 7; 12; 12; 8; 8; 30; 30; 6; 7; 6; 3; 3; 6; 7; 60; 6; 8; 6; 30; 6; 12; 8; 8; 8; 8; 8; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	
43742-1283_51796af6-81fa-448e-b35a-ec2609438f74	43742-1283	HUMAN OTC DRUG	Enviroclenz		Berberis Vulgaris, Carduus Marianus, Chelidonium Majus, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Stillingia Sylvatica, Taraxacum Officinale, Trifolium Pratense, Germanium Sesquioxide, Phytolacca Decandra, Benzinum, Chlorinum, Acetone, Ammonium Muriaticum, Propylene Glycol, Sodium Benzene Sulfonate, Sodium Lauryl Sulfate, Sodium Tripolyphosphate, Terebinthina, Methanol, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum	LIQUID	ORAL	20180731	20240903	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETONE; AMMONIUM CHLORIDE; ARCTIUM LAPPA ROOT; BENZENE; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CHLORINE; FRANGULA ALNUS BARK; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; METHYL ALCOHOL; MILK THISTLE; NITRIC ACID; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PROPYLENE GLYCOL; SODIUM BENZENESULFONATE; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE FLOWERING TOP; TRIFOLIUM PRATENSE LEAF; TURPENTINE OIL	9; 9; 3; 9; 3; 3; 10; 3; 8; 3; 12; 12; 9; 3; 12; 12; 8; 9; 9; 9; 9; 3; 12; 3; 3; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1285_4f0abe14-7f21-4c85-842a-1b0ada66a283	43742-1285	HUMAN OTC DRUG	FNG		Berberis Vulgaris, Cochlearia Armoracia, Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Suis, Tabebuia Impetiginosa, Thymus (Suis), Formalinum, Ferrum Metallicum, Iridium Metallicum, Lycopodium Clavatum, Phosphoricum Acidum, Pulsatilla (Vulgaris), Selenium Metallicum, Zincum Metallicum, Adenosinum Triphosphoricum Dinatrum, Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Pullularia Pullulans	LIQUID	ORAL	20180816	20240806	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ALTERNARIA ALTERNATA; ANEMONE PULSATILLA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BERBERIS VULGARIS ROOT BARK; BRUGIA MALAYI; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; FORMALDEHYDE; GOLDENSEAL; HORSERADISH; IRIDIUM; IRON; LACTIC ACID, L-; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; METHYLCOBALAMIN; MUCOR RACEMOSUS; MYRRH; PHOSPHORIC ACID; PROPOLIS WAX; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SELENIUM; STACHYBOTRYS CHARTARUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK; ZINC	12; 12; 12; 12; 12; 3; 39; 12; 12; 3; 30; 8; 6; 3; 12; 8; 12; 3; 12; 12; 12; 3; 12; 6; 12; 12; 12; 12; 6; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	
43742-1288_21f2a0d7-f35a-4327-925e-8fc94ddd653d	43742-1288	HUMAN OTC DRUG	Formaldehyde		Formalinum	LIQUID	ORAL	20180831		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	FORMALDEHYDE	8	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43742-1289_2f620e4a-9896-45e4-881f-bd88816e6687	43742-1289	HUMAN OTC DRUG	Free Radical		Alfalfa, Ascorbyl Palmitate, Cysteinum, Hordeum Vulgare, Laminaria Digitata, Manganese Gluconate, L-Methionine, Nasturtium Aquaticum, Dimethyl Glycine, Quercetin, Raphanus Sativus, Sodium Selenite, Triticum Aestivum, Ubidecarenonum, GABA (Gamma Aminobutyric Acid), alpha-Lipoicum Acidum, Oryza Sativa, Tocopherol, Zinc Picolinate, Cobaltum Metallicum, Ferrum Metallicum, Glutathione, Magnesium Fluoratum, Selenium Metallicum, Zincum Metallicum, alpha-Ketoglutaricum Acidum, Glyoxal Trimer Dihydrate	LIQUID	ORAL	20181130	20240201	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; .GAMMA.-AMINOBUTYRIC ACID; ALFALFA; ASCORBYL PALMITATE; BARLEY; COBALT; CYSTEINE; GLUTATHIONE; GLYOXAL TRIMER DIHYDRATE; IRON; LAMINARIA DIGITATA; MAGNESIUM FLUORIDE; MANGANESE GLUCONATE; METHIONINE; N,N-DIMETHYLGLYCINE; NASTURTIUM OFFICINALE; ORYZA SATIVA WHOLE; QUERCETIN; RAPHANUS SATIVUS; SELENIUM; SODIUM SELENITE; TOCOPHEROL; UBIDECARENONE; WHEAT; ZINC; ZINC PICOLINATE	30; 8; 8; 6; 6; 6; 12; 6; 12; 30; 12; 6; 12; 6; 6; 6; 6; 8; 6; 6; 12; 6; 8; 6; 6; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC]		N	
43742-1290_4d875267-2ff6-43d5-a4c6-2cca24d1277e	43742-1290	HUMAN OTC DRUG	GI Drainage		Cinnamomum, Gentiana Lutea, Syzygium Jambolanum, Argentum Nitricum, Colchicum Autumnale, Colostrum, Copper Gluconate, Lappa Major, Lycopodium Clavatum, Magnesium Gluconate, Manganese Gluconate, Pancreas Suis, Potassium Gluconate, Rumex Crispus, Schrophularia Nodosa, Stomach (Suis), Aurum Metallicum, Calcarea Carbonica, Carbo Vegetabilis, Intestine (Suis), Malus Pumila, Flos, Nitricum Acidum, Prunus Cerasifera, Flos, Rock Water, Fagus Sylvatica, Flos	LIQUID	ORAL	20180831	20241203	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ARCTIUM LAPPA ROOT; BOS TAURUS COLOSTRUM; CINNAMON; COLCHICUM AUTUMNALE BULB; COPPER GLUCONATE; FAGUS SYLVATICA FLOWERING TOP; GENTIANA LUTEA ROOT; GOLD; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM GLUCONATE; MALUS PUMILA FLOWER; MANGANESE GLUCONATE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK INTESTINE; POTASSIUM GLUCONATE; PRUNUS CERASIFERA FLOWER; RUMEX CRISPUS ROOT; SCROPHULARIA NODOSA; SILVER NITRATE; SUS SCROFA PANCREAS; SUS SCROFA STOMACH; SYZYGIUM CUMINI SEED; WATER	8; 6; 6; 3; 6; 6; 12; 3; 8; 6; 6; 8; 6; 8; 8; 8; 6; 8; 6; 6; 6; 6; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-1291_5939a5fb-2139-495b-a8f8-fb24282c2627	43742-1291	HUMAN OTC DRUG	Glucoreg		Ascorbicum Acidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, DHEA (Dehydroepiandrosterone), Phloridzinum, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Citricum Acidum, Fumaricum Acidum, Glyoxal Trimer Dihydrate, Nadidum, Pantothenic Acid, Acetaldehyde, Insulinum (Suis), Hepar Suis, Pancreas Suis, Glucagon, Baryta Oxalica, Alloxanum, Berberis Vulgaris, Carcinosin, Lycopodium Clavatum, Momordica Balsamina, Phosphoricum Acidum, Phosphorus	LIQUID	ORAL	20181101	20240404	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; ADENOSINE TRIPHOSPHATE DISODIUM; ALLOXAN; ASCORBIC ACID; BARIUM OXALATE; BERBERIS VULGARIS ROOT BARK; CITRIC ACID MONOHYDRATE; FUMARIC ACID; GLUCAGON; GLYOXAL TRIMER DIHYDRATE; GYMNEMA SYLVESTRE LEAF; HUMAN BREAST TUMOR CELL; INSULIN PORK; LACTIC ACID, L-; LYCOPODIUM CLAVATUM SPORE; MOMORDICA BALSAMINA IMMATURE FRUIT; NADIDE; PANTOTHENIC ACID; PHLORIZIN; PHOSPHORIC ACID; PHOSPHORUS; PORK LIVER; PRASTERONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SUS SCROFA PANCREAS; SYZYGIUM CUMINI SEED; THIAMINE HYDROCHLORIDE; THIOCTIC ACID; TRIGONELLA FOENUM-GRAECUM WHOLE	8; 8; 6; 6; 6; 6; 8; 8; 12; 8; 30; 6; 8; 6; 6; 6; 8; 8; 6; 6; 6; 10; 6; 6; 6; 30; 10; 6; 6; 8; 30	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Acidifying Activity [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Antihypoglycemic Agent [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	
43742-1293_05fb67f4-4547-4142-8633-fff3a87226a1	43742-1293	HUMAN OTC DRUG	Headache		Cimicifuga Racemosa, Gelsemium Sempervirens, Rhus Tox	LIQUID	ORAL	20180816		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BLACK COHOSH; GELSEMIUM SEMPERVIRENS ROOT; TOXICODENDRON PUBESCENS LEAF	1; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1295_ce26b50f-09ed-4153-9db6-89aa996d494f	43742-1295	HUMAN OTC DRUG	Heart/Fatigue		Kali Carbonicum, Arnica Montana, Cactus Grandiflorus, Castoreum, Ranunculus Bulbosus, Gelsemium Sempervirens, Glonoinum, Heart (Suis), Spigelia Anthelmia, Abrotanum, Sulphur	LIQUID	ORAL	20180904		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARNICA MONTANA; ARTEMISIA ABROTANUM FLOWERING TOP; CASTOR CANADENSIS SCENT GLAND SECRETION; GELSEMIUM SEMPERVIRENS ROOT; NITROGLYCERIN; PORK HEART; POTASSIUM CARBONATE; RANUNCULUS BULBOSUS; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA; SULFUR	4; 12; 6; 8; 8; 8; 3; 6; 4; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43742-1296_b4a19c47-fbeb-4d62-b8c8-2b3e821030a7	43742-1296	HUMAN OTC DRUG	Herpes Zoster Plus		Cistus Canadensis, Clematis Erecta, Croton Tiglium, Dolichos Pruriens, Iris Versicolor, Prunus Spinosa, Ranunculus Bulbosus, Kali Bichromicum, Zincum Phosphoratum, Arsenicum Album, Comocladia Dentata, Graphites, Kalmia Latifolia, Lachesis Mutus, Mezereum, Rhus Tox, Thallium Metallicum	LIQUID	ORAL	20190514	20250303	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; CLEMATIS RECTA FLOWERING TOP; COMOCLADIA DENTATA BARK/LEAF; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; GRAPHITE; HELIANTHEMUM CANADENSE; IRIS VERSICOLOR ROOT; KALMIA LATIFOLIA LEAF; LACHESIS MUTA VENOM; MUCUNA PRURIENS FRUIT TRICHOME; POTASSIUM DICHROMATE; PRUNUS SPINOSA FLOWER BUD; RANUNCULUS BULBOSUS; THALLIUM; TOXICODENDRON PUBESCENS LEAF; ZINC PHOSPHIDE	12; 6; 12; 6; 12; 12; 6; 6; 12; 12; 6; 8; 6; 6; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1297_9e9f548b-e553-4312-92bc-7cc747e6042b	43742-1297	HUMAN OTC DRUG	HerX		Echinacea (Angustifolia), Arnica Montana, Hydrastis Canadensis, Ledum Palustre, Magnesia Sulphurica, Kalmia Latifolia, Arsenicum Album, Cocculus Indicus, Phosphorus	LIQUID	ORAL	20180716		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ANAMIRTA COCCULUS SEED; ARNICA MONTANA; ARSENIC TRIOXIDE; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; KALMIA LATIFOLIA LEAF; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG	12; 6; 12; 3; 6; 8; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1298_8e40131c-e4f9-409f-862e-6b9eaced9613	43742-1298	HUMAN OTC DRUG	HGH Vitality		Agnus Castus, Ambra Grisea, Apiolum, Estradiol, Estriol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone,	LIQUID	ORAL	20180827	20240624	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-LIPOIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; CHASTE TREE; ESTRADIOL; ESTRIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 6; 8; 6; 6; 6; 8; 8; 6; 6; 8; 8; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
43742-1299_bd2c1674-96dd-48f9-b2ba-e2054169406c	43742-1299	HUMAN OTC DRUG	HGH Vitality		Agnus Castus, Ambra Grisea, Apiolum, Estradiol, Estriol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus (Suis), Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone, Proteus	TABLET	ORAL	20190314	20240416	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	.ALPHA.-LIPOIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; CHASTE TREE; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 6; 8; 6; 8; 6; 6; 8; 8; 6; 6; 8; 8; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
43742-1300_2dcb1f9a-db16-4d71-89b2-befc57a15ed4	43742-1300	HUMAN OTC DRUG	Hormone Combination		Salsolinol (Hydrochloride), Cholesterinum, DHEA (Dehydroepiandrosterone), 7-Oxo- Dehydroepiandrosterone 3-Acetate, Folliculinum, Oophorinum (Suis), Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating Hormone	LIQUID	ORAL	20180629	20250721	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	7-KETO-DEHYDROEPIANDROSTERONE; ALDOSTERONE; ANDROSTERONE; CHOLESTEROL; CORTISONE ACETATE; ESTRONE; FOLLITROPIN; PRASTERONE; PROGESTERONE; SALSOLINOL HYDROCHLORIDE, (+/-)-; SUS SCROFA OVARY; TESTOSTERONE	8; 12; 12; 8; 12; 8; 12; 6; 8; 6; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Gonadotropin [EPC], Gonadotropins [CS], Progesterone [CS], Progesterone [EPC]	CIII	N	
43742-1302_0020d8e1-ee47-4b87-81d2-ed75d193cb11	43742-1302	HUMAN OTC DRUG	Immune Support		Echinacea (Angustifolia), Arnica Montana, Baptisia Tinctoria, Sanguinaria Canadensis, Aristolochia Clematitis, Eupatorium Perfoliatum, Euphorbium Officinarum, Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Mercurius Corrosivus, Phosphorus, Phytolacca Decandra, Pulsatilla (Vulgaris), Rhus Tox, Sulphur, Thuja Occidentalis, Hepar Sulphuris Calcareum, Lachesis Mutus, Zincum Metallicum, Astragalus Menziesii, Influenzinum (2017-2018), Spleen (Suis), Thymus (Suis)	LIQUID	ORAL	20181107	20240416	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARISTOLOCHIA CLEMATITIS ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; ASTRAGALUS NUTTALLII LEAF; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; SULFUR; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP; ZINC	8; 8; 6; 4; 8; 12; 4; 8; 10; 13; 1; 6; 6; 8; 12; 12; 12; 12; 10; 8; 8; 8; 200; 4; 8; 8; 12; 12; 8; 8; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
43742-1303_d93a8ccf-e6aa-458e-9c75-4a7506738faa	43742-1303	HUMAN OTC DRUG	Inflammation		Arnica Montana, Benzoicum Acidum, Echinacea (Angustifolia), Apis Mellifica, Baptisia Tinctoria, Dulcamara, Eucalyptus Globulus, Solanum Nigrum, Eupatorium Perfoliatum, Bryonia (Alba), Colchicum Autumnale, Mercurialis Perennis, Rhus Tox	LIQUID	ORAL	20180710		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; ARNICA MONTANA; BAPTISIA TINCTORIA ROOT; BENZOIC ACID; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; MERCURIALIS PERENNIS; SOLANUM DULCAMARA TOP; SOLANUM NIGRUM WHOLE; TOXICODENDRON PUBESCENS LEAF	4; 3; 4; 3; 8; 8; 3; 4; 6; 8; 4; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1304_11d118f6-e8d6-4398-bc07-4425207bcd7a	43742-1304	HUMAN OTC DRUG	GI Distress		Echinacea (Angustifolia), Natrum Phosphoricum, Colchicum Autumnale, Arsenicum Album, Colocynthis, Croton Tiglium, Gambogia, Aceticum Acidum, Antimonium Crudum, Bismuthum Subnitricum, Cinchona Officinalis, Ferrum Metallicum, Iris Versicolor, Lac Defloratum, Mercurius Vivus, Nux Vomica, Ricinus Communis, Veratrum Album, Colibacillinum Cum Natrum Muriaticum, Proteus (Mirabilis)	LIQUID	ORAL	20180926		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BISMUTH SUBNITRATE; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; CROTON TIGLIUM SEED; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; GAMBOGE; IRIS VERSICOLOR ROOT; IRON; MERCURY; PROTEUS MIRABILIS; RICINUS COMMUNIS SEED; SKIM MILK; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	12; 12; 8; 12; 12; 9; 8; 9; 3; 16; 9; 12; 12; 12; 16; 12; 12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1305_ce174ee7-88c7-49d6-9f42-5165d39f14f7	43742-1305	HUMAN OTC DRUG	Kidney Drainage		Solidago Virgaurea, Asparagus Officinalis, Juniperus Communis, Sabal Serrulata, Uva Ursi, Berberis Vulgaris, Equisetum Arvense, Urtica Dioica, Rubia Tinctorum, Staphysagria, Cantharis, Cobaltum Metallicum, Fagus Sylvatica Flos, Glandula Suprarenalis Suis, Hepar Sulphuris Calcareum, Kidney (Suis), Larix Decidua Flos, Manganum Metallicum, Mimulus Guttatus Flos, Nitricum Acidum, Rhus Aromatica, Silicea, Ulex Europaeus Flos, Benzoicum Acidum	LIQUID	ORAL	20180904	20240528	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; ASPARAGUS; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; COBALT; DELPHINIUM STAPHISAGRIA SEED; EQUISETUM ARVENSE TOP; FAGUS SYLVATICA FLOWERING TOP; JUNIPERUS COMMUNIS WHOLE; LARIX DECIDUA FLOWERING TOP; LYTTA VESICATORIA; MANGANESE; MIMULUS GUTTATUS FLOWERING TOP; NITRIC ACID; PORK KIDNEY; RHUS AROMATICA ROOT BARK; RUBIA TINCTORUM ROOT; SAW PALMETTO; SILICON DIOXIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; ULEX EUROPAEUS FLOWER; URTICA DIOICA	2; 2; 12; 3; 8; 8; 6; 3; 8; 2; 8; 8; 8; 8; 8; 8; 8; 6; 2; 8; 1; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	
43742-1306_95ae2407-6788-4a13-8f52-eefdc2c6106e	43742-1306	HUMAN OTC DRUG	Kidney/Bladder Support		Equisetum Hyemale, Solidago Virgaurea, Cantharis, Kidney (Suis), Berberis Vulgaris, Calcarea Carbonica, Terebinthina, Apis Mellifica, Pulsatilla (Vulgaris), Sepia, Staphysagria	LIQUID	ORAL	20180925	20240528	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; DELPHINIUM STAPHISAGRIA SEED; EQUISETUM HYEMALE; LYTTA VESICATORIA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK KIDNEY; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SOLIDAGO VIRGAUREA FLOWERING TOP; TURPENTINE OIL	30; 12; 30; 3; 8; 12; 8; 30; 30; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1307_16b08bd8-6364-4713-a3f4-448f59920e34	43742-1307	HUMAN OTC DRUG	L-Dopa		L-Dopa	LIQUID	ORAL	20180820		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	LEVODOPA	8	[hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
43742-1308_48cf6774-f192-4fbb-8f9e-418580f09827	43742-1308	HUMAN OTC DRUG	Lymph Drainage		Citrus Limonum, Echinacea (Angustifolia), Scrophularia Nodosa, Teucrium Scorodonia, Baptisia Tinctoria, Pinus Sylvestris, Zincum Gluconicum, Thuja Occidentalis, Capsicum Annuum, Copper Gluconate, Manganese Gluconate, Aranea Diadema, Arsenicum Iodatum, Carpinus Betulus, Flos, Centaurium Umbellatum, Flos, Larix Decidua, Flos, Lymph Node (Suis), Phytolacca Decandra, Spleen (Suis), Thymus (Suis), Tabacum, Lachesis Mutus	LIQUID	ORAL	20180827	20250715	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ARANEUS DIADEMATUS; ARSENIC TRIIODIDE; BAPTISIA TINCTORIA ROOT; CAPSICUM; CARPINUS BETULUS FLOWER; CENTAURIUM ERYTHRAEA FLOWER; COPPER GLUCONATE; ECHINACEA ANGUSTIFOLIA; LACHESIS MUTA VENOM; LARIX DECIDUA FLOWERING TOP; LEMON JUICE; MANGANESE GLUCONATE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; TEUCRIUM SCORODONIA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; TOBACCO LEAF; ZINC GLUCONATE	8; 8; 1; 6; 8; 8; 6; 1; 12; 8; 1; 6; 8; 3; 1; 8; 8; 8; 1; 4; 9; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS]		N	
43742-1310_a67488eb-3a62-4049-9ae4-09b060481eab	43742-1310	HUMAN OTC DRUG	Matrix Support		Ceanothus Americanus, Anacardium Orientale, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Oxalis Acetosella, Pulsatilla (Vulgaris), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Pancreas Suis, Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Veratrum Album, Mannan,	LIQUID	ORAL	20180911	20240311	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CEANOTHUS AMERICANUS LEAF; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; MANDRAGORA OFFICINARUM ROOT; MARSDENIA CONDURANGO BARK; MOMORDICA BALSAMINA IMMATURE FRUIT; OXALIS ACETOSELLA LEAF; PHOSPHORUS; PORK INTESTINE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SEMECARPUS ANACARDIUM JUICE; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA BILE DUCT; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA EYE; SUS SCROFA GALLBLADDER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA ORAL MUCOSA; SUS SCROFA PANCREAS; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; VERATRUM ALBUM ROOT; WOOD CREOSOTE; YEAST MANNAN	4; 6; 8; 10; 10; 6; 6; 6; 8; 8; 8; 6; 6; 30; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8; 10; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1311_1a0da555-74bc-41c3-93ac-39abc32895c6	43742-1311	HUMAN OTC DRUG	Menopause Relief		Sanguinaria Canadensis, Sepia, Adenosinum Triphosphoricum Dinatrum, Cedron, DIM (3,3-Diindolymethane), Equol, Sulphur, Apiolum, Bryonia (Alba), Ignatia Amara, Lachesis Mutus, Stannum Metallicum, Faecalis (Alkaligenes)	LIQUID	ORAL	20180828	20240305	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	3,3'-DIINDOLYLMETHANE; ADENOSINE TRIPHOSPHATE DISODIUM; ALCALIGENES FAECALIS; APIOLE (PARSLEY); BRYONIA ALBA ROOT; EQUOL, (-)-; LACHESIS MUTA VENOM; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SIMABA CEDRON SEED; STRYCHNOS IGNATII SEED; SULFUR; TIN	6; 6; 30; 6; 8; 6; 12; 3; 4; 6; 8; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1312_eeaeada9-a6da-4648-842b-8ab21134079b	43742-1312	HUMAN OTC DRUG	Metox		Allium Sativum, Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Stillingia Sylvatica, Trifolium Pratense, Ascorbicum Acidum, Cysteinum, L-Methionine, Phytolacca Decandra, Thyroidinum (Suis), Carbolicum Acidum, Formalinum, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Carbolicum Acidum, Formalinum	LIQUID	ORAL	20180727		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALUMINUM; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; ASCORBIC ACID; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; COBALT; COPPER; CYSTEINE; DYSPROSIUM; ERBIUM; EUROPIUM; FORMALDEHYDE; GADOLINIUM; GARLIC; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; GOLD; HOLMIUM; INDIUM; IODINE; IRIDIUM; IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MERCURIUS SOLUBILIS; METHIONINE; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHENOL; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PLATINUM; POTASSIUM CARBONATE; PRASEODYMIUM; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SILVER; SODIUM CHLORIDE; STILLINGIA SYLVATICA ROOT; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA THYROID; TANTALUM; TERBIUM; THALLIUM; TIN; TRIBASIC CALCIUM PHOSPHATE; TRIFOLIUM PRATENSE FLOWER; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 3; 12; 6; 12; 3; 12; 12; 12; 12; 12; 12; 12; 8; 8; 8; 6; 12; 12; 12; 12; 12; 3; 12; 3; 12; 12; 12; 8; 8; 8; 14; 12; 8; 12; 8; 8; 12; 8; 8; 12; 12; 30; 12; 12; 12; 8; 8; 12; 8; 12; 12; 12; 12; 8; 12; 8; 3; 8; 12; 8; 8; 30; 12; 12; 12; 8; 3; 12; 8; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vitamin C [EPC]		N	20241231
43742-1314_be2f5366-0c20-4c01-8682-80038f7152f4	43742-1314	HUMAN OTC DRUG	Nausia		Zingiber Officinale, Ipecacuanha, Iris Versicolor, Lac Defloratum, Lacticum Acidum, Cyclamen Europaeum, Petroleum, Tabacum, Arsenicum Album, Bryonia (Alba), Cadmium Sulphuratum, Cocculus Indicus, Colchicum Autumnale, Conium Maculatum, Ferrum Metallicum, Nux Vomica, Pulsatilla (Pratensis), Sepia, Theridion, Euphorbia Corollata	LIQUID	ORAL	20181108	20240121	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANAMIRTA COCCULUS SEED; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CADMIUM SULFIDE; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; CYCLAMEN PURPURASCENS TUBER; EUPHORBIA COROLLATA ROOT; GINGER; IPECAC; IRIS VERSICOLOR ROOT; IRON; KEROSENE; LACTIC ACID, DL-; SEPIA OFFICINALIS JUICE; SKIM MILK; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; TOBACCO LEAF	12; 12; 12; 12; 12; 12; 12; 8; 24; 3; 6; 6; 12; 8; 6; 12; 6; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1315_03928d96-f7b3-4cf9-8de1-e9ee1c78f32e	43742-1315	HUMAN OTC DRUG	Nerve Z		Condurango, Echinacea (Angustifolia), Ginkgo Biloba, Ligusticum Porteri, Myrrha, Phytolacca Decandra, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Suis, Spleen (Suis), Tabebuia Impetiginosa, Thymus (Suis), Thyroidinum (Suis), Gelsemium Sempervirens, Lycopodium Clavatum, Nux Vomica, Selenium Metallicum, Pyrogenium	LIQUID	ORAL	20190110		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; GOLDENSEAL; LIGUSTICUM PORTERI ROOT; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; MYRRH; PHYTOLACCA AMERICANA ROOT; PROPOLIS WAX; RANCID BEEF; SELENIUM; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA SPLEEN; SUS SCROFA THYROID; TABEBUIA IMPETIGINOSA BARK	3; 12; 3; 6; 3; 12; 3; 3; 4; 6; 30; 12; 12; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1317_64e7e601-2764-447e-8e97-bf2bf2de4c44	43742-1317	HUMAN OTC DRUG	Neuro	I	Taraxacum Officinale, Hydrastis Canadensis, Melatonin, Dopamine Hydrochloride, L-Dopa, Serotonin (Hydrochloride)	LIQUID	ORAL	20180727		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	DOPAMINE HYDROCHLORIDE; GOLDENSEAL; LEVODOPA; MELATONIN; SEROTONIN HYDROCHLORIDE; TARAXACUM OFFICINALE	8; 6; 8; 6; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catecholamine [EPC], Catecholamines [CS]		N	20241231
43742-1318_86d9a27f-6870-4434-a958-b3ac9e5e716c	43742-1318	HUMAN OTC DRUG	Neuro	II	Taraxacum Officinale, Hydrastis Canadensis, Acetylcholine Chloride, Histaminum Hydrochloricum, Adrenalinum, GABA (Gamma-Aminobutyric Acid), Norepinephrine, Tyramine	LIQUID	ORAL	20180829	20240117	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; EPINEPHRINE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; NOREPINEPHRINE; TARAXACUM OFFICINALE; TYRAMINE	8; 6; 8; 6; 6; 8; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1319_6eae03af-c907-4651-85b2-7a6bcb2c9974	43742-1319	HUMAN OTC DRUG	Norepinephrine		Norepinephrine	LIQUID	ORAL	20180919	20240204	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	NOREPINEPHRINE	8	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	
43742-1320_1ab03905-9088-4cfe-bac8-b57ce2c82163	43742-1320	HUMAN OTC DRUG	Pertussis		Ipecacuanha, Sticta Pulmonaria, Phosphorus, Antimonium Tartaricum, Kreosotum, Aconitum Napellus, Bryonia (Alba), Hyoscyamus Niger, Silicea, Tabacum, Pertussinum, Tetanus Toxin	LIQUID	ORAL	20180904	20250513	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CLOSTRIDIUM TETANI; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYOSCYAMUS NIGER; IPECAC; LOBARIA PULMONARIA; PHOSPHORUS; SILICON DIOXIDE; TOBACCO LEAF; WOOD CREOSOTE	8; 6; 8; 30; 30; 8; 4; 4; 5; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1321_46b38e0f-6cfa-464b-97ef-3749fdb85947	43742-1321	HUMAN OTC DRUG	Post-Dental Visit		Chamomilla, Echinacea (Angustifolia), Hamamelis Virginiana, Hypericum Perforatum, Millefolium, Calendula Officinalis, Arnica Montana, Bellis Perennis, Rhus Tox, Bryonia (Alba), Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Hepar Sulphuris Calcareum, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos, Carbo Vegetabilis	LIQUID	ORAL	20181207	20240820	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS VITALBA FLOWER; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HELIANTHEMUM NUMMULARIUM FLOWER; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA RECUTITA; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER; TOXICODENDRON PUBESCENS LEAF	3; 12; 4; 6; 8; 8; 4; 8; 3; 3; 8; 3; 8; 3; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1322_22475aba-1142-4e5f-a66a-0cb95ce2ba44	43742-1322	HUMAN OTC DRUG	PTS/Stress Remedy		Kali Phosphoricum, Ambra Grisea, Cacao, Phosphoricum Acidum, Arnica Montana, Calcarea Carbonica, Cerebrum Suis, Glandula Suprarenalis Suis, Lithium Carbonicum, Aconitum Napellus, Argemone Mexicana, Arsenicum Album, Cicuta Virosa, Hyoscyamus Niger, Ignatia Tigrinum, Natrum Muriaticum, Tarentula Hispanica, Stramonium, Buthus Australis	LIQUID	ORAL	20180828		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; AMBERGRIS; ANDROCTONUS AUSTRALIS VENOM; ARGEMONE MEXICANA; ARNICA MONTANA; ARSENIC TRIOXIDE; CICUTA VIROSA ROOT; COCOA; DATURA STRAMONIUM; DIBASIC POTASSIUM PHOSPHATE; HYOSCYAMUS NIGER; LILIUM LANCIFOLIUM WHOLE FLOWERING; LITHIUM CARBONATE; LYCOSA TARANTULA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA CEREBRUM	8; 6; 6; 12; 6; 12; 12; 6; 12; 3; 12; 12; 8; 12; 8; 6; 12; 12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43742-1323_37f827d9-5b14-4114-8f32-f8ca635ef749	43742-1323	HUMAN OTC DRUG	Pyrrole		Pyrrole	LIQUID	ORAL	20200318	20250326	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	PYRROLE	8	[hp_X]/mL			N	
43742-1324_33af8b07-1412-42fd-be4a-b468252e313b	43742-1324	HUMAN OTC DRUG	Reflux		Acetyl Coenzyme A, Adenosinum Triphosphoricum Dinatrum, Nadidum, Argentum Nitricum, Ipecacuanha, Robinia Pseudoacacia, Sulphur, Origanum Vulgare, Duodenum (Suis), Esophagus (Suis), Funiculus Umbilicalis Suis, Stomach (Suis), Nux Vomica, Coumarinum, Erythraea Centaurium, Pepsinum, Muriaticum Acidum, Citricum Acidum, Formicum Acidum, Sarcolacticum Acidum, Proteus (Morgani)	LIQUID	ORAL	20180919		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS CITRIC ACID; CENTAURIUM ERYTHRAEA; COUMARIN; FORMIC ACID; HYDROCHLORIC ACID; IPECAC; LACTIC ACID, L-; NADIDE; OREGANO; PEPSIN; PROTEUS MORGANII; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA STOMACH; SUS SCROFA UMBILICAL CORD	6; 6; 6; 10; 8; 6; 6; 6; 6; 6; 6; 12; 30; 6; 6; 8; 6; 8; 8; 8; 8	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1325_7a6de289-6e15-4fc7-a168-395aa5380637	43742-1325	HUMAN OTC DRUG	Rheumagesic		Arnica Montana, Apis Mellifica, Benzoicum Acidum, Cartilago Suis, Ledum Palustre, Pantothenic Acid, Ruta Graveolens, Rhododendron Chrysanthum, Causticum, Formica Rufa, Sepia, alpha-Lipoicum Acidum, Aurum Metallicum, Calcarea Phosphorica, Colchicum Autumnale, Phytolacca Decandra, Radium Bromatum, Rhus Venenata, Thuja Occidentalis, Lac Caninum	LIQUID	ORAL	20190109	20251008	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; ARNICA MONTANA; BENZOIC ACID; CANIS LUPUS FAMILIARIS MILK; CAUSTICUM; COLCHICUM AUTUMNALE BULB; FORMICA RUFA; GOLD; PANTOTHENIC ACID; PHYTOLACCA AMERICANA ROOT; RADIUM BROMIDE; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SEPIA OFFICINALIS JUICE; SUS SCROFA CARTILAGE; THIOCTIC ACID; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON VERNIX LEAFY TWIG; TRIBASIC CALCIUM PHOSPHATE	6; 3; 6; 16; 10; 12; 10; 12; 6; 12; 12; 8; 6; 6; 10; 6; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1326_8f39458f-3d4e-43f7-bb0f-33ddb99ad025	43742-1326	HUMAN OTC DRUG	Spinalmax		Berberis Vulgaris, Cimicifuga Racemosa, Cinchona Officinalis, Colocynthis, Ledum Palustre, Ranunculus Bulbosus, Aesculus Hippocastanum, Cuprum Aceticum, Nadidum, Natrum Oxalaceticum, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Alpha-Lipoicum Acidum, Ammonium Muriaticum, Cartilago Suis, Discus Intervertebralis (Suis), Picricum Acidum, Silicea, Argentum Metallicum, Calcarea Phosphorica, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Gnaphalium Polycephalum	LIQUID	ORAL	20190517		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALPHA LIPOIC ACID; AMMONIUM CHLORIDE; BERBERIS VULGARIS ROOT BARK; BLACK COHOSH; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; ENTEROBACTER CLOACAE; HORSE CHESTNUT; MERCURIC OXIDE; NADIDE; NIACINAMIDE; PANTOTHENIC ACID; PICRIC ACID; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; PYRIDOXINE HYDROCHLORIDE; RANUNCULUS BULBOSUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SILICON DIOXIDE; SILVER; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA CARTILAGE; SUS SCROFA INTERVERTEBRAL DISC; SUS SCROFA UMBILICAL CORD; THIAMINE HYDROCHLORIDE; TRIBASIC CALCIUM PHOSPHATE	8; 8; 4; 4; 4; 4; 6; 30; 6; 10; 6; 6; 10; 8; 30; 30; 10; 6; 4; 4; 6; 30; 8; 10; 6; 28; 10; 10; 8; 8; 10; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
43742-1327_575dcd24-3ffd-4aa2-8b54-91de03a0c251	43742-1327	HUMAN OTC DRUG	ENT Support		Pulsatilla (Vulgaris), Euphorbium Officinarum, Luffa Operculata, Mercurius Iodatus Ruber, Argentum Nitricum, Hepar Sulphuris Calcareum, Influenzinum (2018-2019), Sinusitisinum, Aspergillus Niger, Candida Albicans, Gallicum Acidum, Mucor Racemosus, Mutabile Bacillus (Bach)	LIQUID	ORAL	20181112	20240226	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; PULSATILLA VULGARIS; SILVER NITRATE; SINUSITISINUM	10; 10; 10; 30; 6; 10; 12; 12; 12; 12; 6; 8; 10; 4; 10; 17	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-1328_61503271-e3d0-47d7-bc3d-1c3885d72f2d	43742-1328	HUMAN OTC DRUG	Systemic Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Sarsaparilla (Smilax Regelii), Gelsemium Sempervirens, Veratrum Album, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Vulgaris), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20180716	20240529	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BETA VULGARIS; CHELIDONIUM MAJUS; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PULSATILLA VULGARIS; SARSAPARILLA; SELENIUM; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	3; 3; 8; 12; 12; 12; 3; 12; 6; 12; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1330_fb06ed6b-2c3d-4d29-b137-7488ee0d522d	43742-1330	HUMAN OTC DRUG	Systemic Drainage		Alfalfa, Avena Sativa, Citrus Limonum, Glycyrrhiza Glabra, Uva-Ursi, Taraxacum Officinale, Galium Aparine, Schisandra Chinensis, Solidago Virgaurea, Tylophora Asthmatica, Tabacum, Berberis Vulgaris, Chelidonium Majus, Hepar Suis, Intestine (Suis), Kidney (Suis), Lung (Suis), Lymph Node (Suis), Magnesium Gluconate, Potassium Gluconate, Zincum Gluconicum, Nux Vomica, Sarcolacticum Acidum, Lacticum Acidum	LIQUID	ORAL	20190517	20251125	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALFALFA; ARCTOSTAPHYLOS UVA-URSI LEAF; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; GALIUM APARINE; GLYCYRRHIZA GLABRA; LACTIC ACID, DL-; LACTIC ACID, L-; LEMON JUICE; MAGNESIUM GLUCONATE; PORK INTESTINE; PORK KIDNEY; PORK LIVER; POTASSIUM GLUCONATE; SCHISANDRA CHINENSIS FRUIT; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LUNG; SUS SCROFA LYMPH; TARAXACUM OFFICINALE; TOBACCO LEAF; TYLOPHORA INDICA LEAF; ZINC GLUCONATE	1; 1; 1; 6; 6; 3; 1; 12; 8; 1; 6; 6; 6; 6; 6; 3; 3; 8; 6; 6; 2; 4; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-1331_f5ea829d-4d2c-4e5d-9edd-33cf0a6fea77	43742-1331	HUMAN OTC DRUG	Tobacco		Avena Sativa, Lobelia Inflata, Cactus Grandiflorus, Tabacum, Gelsemium Sempervirens, Selenium Metallicum, Staphysagria, Vanadium Metallicum	LIQUID	ORAL	20200608	20250716	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AVENA SATIVA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; LOBELIA INFLATA WHOLE; SELENICEREUS GRANDIFLORUS STEM; SELENIUM; TOBACCO LEAF; VANADIUM	1; 12; 12; 3; 4; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1333_8cd5e887-d035-486d-bdec-0aad6d389cdb	43742-1333	HUMAN OTC DRUG	Trauma Relief		Chamomilla, Echinacea (Angustifolia), Hamamelis Virginiana, Hypericum Perforatum, Millefolium, Calendula Officinalis, Arnica Montana, Belladonna, Bellis Perennis, Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos, Symphytum Officinale, Rhus Tox, Bryonia (Alba), Hepar Sulphuris Calcareum, Carbo Vegetabilis	LIQUID	TOPICAL	20181207		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HELIANTHEMUM NUMMULARIUM FLOWER; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA RECUTITA; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER; TOXICODENDRON PUBESCENS LEAF	3; 12; 4; 6; 6; 8; 8; 4; 6; 3; 3; 6; 3; 6; 3; 6; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
43742-1334_333a1b1f-4618-4620-8dcb-3b0faa8ba934	43742-1334	HUMAN OTC DRUG	Trauma Remedy		Chamomilla, Echinacea (Angustifolia), Hamamelis Virginiana, Hypericum Perforatum, Millefolium, Calendula Officinalis, Arnica Montana, Bellis Perennis, Rhus Tox, Bryonia (Alba), Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Hepar Sulphuris Calcareum, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos, Carbo Vegetabilis	LIQUID	ORAL	20180831	20240521	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS VITALBA FLOWER; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HELIANTHEMUM NUMMULARIUM FLOWER; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA RECUTITA; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER; TOXICODENDRON PUBESCENS LEAF	3; 12; 4; 6; 8; 8; 4; 8; 3; 3; 8; 3; 8; 3; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1336_8310545b-c959-4653-8d12-21f32d71cdc8	43742-1336	HUMAN OTC DRUG	Vascuflow		Melatonin, L-Arginine, L-Citrulline, Ubidecarenonum, Lanosterol, Mevalonolactone, Squalene, Calcarea Carbonica, Cholesterinum, Coumarinum, Formalinum, Gelsemium Sempervirens, Alpha-Lipoicum Acidum, Mercurius Corrosivus, Plumbum Metallicum, Pantothenic Acid, Glonoinum, Lycopodium Clavatum, Phosphorus, Berberis Vulgaris, Red Yeast Rice, Nitric Oxide, Proteus (Morgani), Rhus Tox	LIQUID	ORAL	20180920	20240305	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARGININE; BERBERIS VULGARIS ROOT BARK; CHOLESTEROL; CITRULLINE; COUMARIN; FORMALDEHYDE; GELSEMIUM SEMPERVIRENS ROOT; LANOSTEROL; LEAD; LYCOPODIUM CLAVATUM SPORE; MELATONIN; MERCURIC CHLORIDE; MEVALONOLACTONE; NITRIC OXIDE; NITROGLYCERIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PANTOTHENIC ACID; PHOSPHORUS; PROTEUS MORGANII; RED YEAST; SQUALENE; THIOCTIC ACID; TOXICODENDRON PUBESCENS LEAF; UBIDECARENONE	6; 8; 8; 6; 8; 8; 8; 8; 8; 6; 6; 8; 8; 12; 6; 8; 10; 6; 30; 8; 8; 8; 30; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE], Vasodilation [PE], Vasodilator [EPC]		N	
43742-1337_36302411-ef71-429d-8605-6be4bae2e5dd	43742-1337	HUMAN OTC DRUG	Vax Reaction		Thuja Occidentalis, Mezereum, Silicea, Calcarea Carbonica, Morbillinum, Parotidinum, Pertussinum, Poliomyelitis Nosode, Rubella Nosode, Tetanus Toxin, Carcinosin, Antimonium Crudum, Ledum Palustre, Thimerosal	LIQUID	ORAL	20181023	20240821	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY TRISULFIDE; BORDETELLA PERTUSSIS; CLOSTRIDIUM TETANI; DAPHNE MEZEREUM BARK; HUMAN BREAST TUMOR CELL; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MUMPS VIRUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POLIOVIRUS; RUBELLA VIRUS; SILICON DIOXIDE; THIMEROSAL; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 8; 15; 30; 30; 30; 30; 30; 30; 8; 30; 6	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43742-1338_be6e651e-dc7b-419f-87f0-fbab08ee315c	43742-1338	HUMAN OTC DRUG	Ver		Artemisia Vulgaris, Melilotus Officinalis, Quassia (Amara), Teucrium Marum, Thymus Serpyllum, Filix Mas, Cina, Silicea, Spigelia Anthelmia, Calcarea Carbonica, Graphites, Iodium, Mercurius Corrosivus, Sabadilla, Ascaris Lumbricoides, Trichinella Spiralis, Enterobius Vermicularis, Taenia Solium, Trichomonas Vaginalis, Giardia Lamblia, Cryptosporidium Parvum, Taenia Saginata, Brugia Malayi	LIQUID	ORAL	20180730	20240826	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; ASCARIS LUMBRICOIDES; BRUGIA MALAYI; CRYPTOSPORIDIUM PARVUM; DRYOPTERIS FILIX-MAS ROOT; ENTEROBIUS VERMICULARIS; GIARDIA LAMBLIA; GRAPHITE; IODINE; MELILOTUS OFFICINALIS TOP; MERCURIC CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; QUASSIA AMARA WOOD; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SPIGELIA ANTHELMIA; TAENIA SAGINATA; TAENIA SOLIUM; TEUCRIUM MARUM; THYMUS SERPYLLUM; TRICHINELLA SPIRALIS; TRICHOMONAS VAGINALIS	8; 2; 15; 39; 20; 4; 33; 18; 12; 12; 3; 12; 12; 3; 12; 8; 8; 20; 12; 3; 3; 15; 13	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	
43742-1340_65840681-22ed-48d0-a317-de16bbe925e9	43742-1340	HUMAN OTC DRUG	Vertigone		Natrum Salicylicum, Cerebellum (Suis), Bryonia (Alba), Petroleum, Tabacum, Ambra Grisea, Cyclamen Europaeum, Argentum Nitricum, Asarum Canadense, Calcarea Sulphurica, Carboneum Sulphuratum, Chininum Sulphuricum, Cocculus Indicus, Conium Maculatum, Digitalis Purpurea, Gelsemium Sempervirens, Phosphorus, Piper Methysticum, Silicea, Theridion	LIQUID	ORAL	20190528	20250120	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMBERGRIS; ANAMIRTA COCCULUS SEED; ASARUM CANADENSE ROOT; BRYONIA ALBA ROOT; CALCIUM SULFATE ANHYDROUS; CARBON DISULFIDE; CONIUM MACULATUM FLOWERING TOP; CYCLAMEN PURPURASCENS TUBER; DIGITALIS; GELSEMIUM SEMPERVIRENS ROOT; KEROSENE; MACROPIPER METHYSTICUM ROOT; PHOSPHORUS; QUININE SULFATE; SILICON DIOXIDE; SILVER NITRATE; SODIUM SALICYLATE; SUS SCROFA CEREBELLUM; THERIDION CURASSAVICUM; TOBACCO LEAF	9; 12; 12; 8; 12; 12; 12; 9; 12; 12; 8; 12; 12; 12; 12; 12; 3; 6; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antimalarial [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1355_e430b1b0-08ed-499a-89e7-6fc75f8f8ed9	43742-1355	HUMAN OTC DRUG	Leaky Gut Formula		Alfalfa, Fragaria Vesca, Glycyrrhiza Glabra, Aloe, Astacus Fluviatilis, Berberis Aquifolium, Lac Defloratum, Natrum Carbonicum, Saccharum Officinale, Fel Tauri, Pancreas Suis, Pepsinum, Antimonium Crudum, Carbo Vegetabilis, Euphorbium Officinarum, Lycopodium Clavatum, Magnesia Carbonica, Zincum Metallicum, Colibacillinum Cum Natrum Muriaticum, Proteus (Mirabilis)	LIQUID	ORAL	20180719	20251130	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALFALFA; ALOE; ALPINE STRAWBERRY; ANTIMONY TRISULFIDE; ASTACUS ASTACUS; BERBERIS AQUIFOLIUM ROOT BARK; BOS TAURUS BILE; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; PEPSIN; PROTEUS MIRABILIS; SKIM MILK; SODIUM CARBONATE; SUCROSE; SUS SCROFA PANCREAS; ZINC	12; 3; 4; 3; 12; 6; 6; 8; 15; 12; 3; 12; 12; 8; 15; 6; 6; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1369_981bda0e-558a-447f-bf75-e5d2c286d3f7	43742-1369	HUMAN OTC DRUG	Female Support		Chamomilla, Cimicifuga Racemosa, Crocus Sativus, Helonias Dioica, Mentha Piperita, Senna (Cassia Angustifolia), Valeriana Officinalis, Viola Odorata, Agnus Castus, Ledum Palustre, Lilium Tigrinum, Staphysagria, Hydrastis Canadensis, Cinchona Officinalis, Convallaria Majalis, Cyclamen Europaeum, Cinnamomum, Murex Purpurea, Naja Tripudians	LIQUID	ORAL	20180828	20240408	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BLACK COHOSH; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; CINNAMON; CONVALLARIA MAJALIS; CYCLAMEN PURPURASCENS TUBER; DELPHINIUM STAPHISAGRIA SEED; GOLDENSEAL; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LEDUM PALUSTRE TWIG; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA RECUTITA; MENTHA PIPERITA; NAJA NAJA VENOM; SAFFRON; SENNA LEAF; VALERIAN; VIOLA ODORATA	3; 3; 4; 8; 12; 8; 8; 4; 6; 12; 4; 4; 3; 3; 15; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1371_a54fa531-60b3-4632-a239-ae7c293b7da9	43742-1371	HUMAN OTC DRUG	Female Stimulant		Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Apiolum, Apis Venenum Purum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Kreosotum, Oophorinum (Suis), Uterus (Suis), Folliculinum, Aconiticum Acidum, CIS-, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (Suis), Hypophysis Suis, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Bacillus Faecalis, Mutabile Bacillus (Bach)	LIQUID	ORAL	20190517	20251023	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITIC ACID, (Z)-; ALCALIGENES FAECALIS; APIOLE (PARSLEY); APIS MELLIFERA VENOM; AQUILEGIA VULGARIS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; GOLDENSEAL; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PORK HEART; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; TESTOSTERONE; WOOD CREOSOTE	10; 30; 6; 8; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 10; 8; 30; 10; 8; 8; 12; 13; 6; 8; 8; 30; 8	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]	CIII	N	
43742-1372_374e7620-b152-4e05-9585-68f7e7fe6611	43742-1372	HUMAN OTC DRUG	GABA		GABA	LIQUID	ORAL	20180823		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID	8	[hp_X]/mL			N	20241231
43742-1377_607d9cfc-29f0-4e06-be83-4a609e83ef48	43742-1377	HUMAN OTC DRUG	Addiclenz		Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Bisphenol A, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Phosphoricum Acidum, Selenium Metallicum, Zincum Metallicum, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methyl Paraben, Propyl Paraben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum, Bacillus Thuringiensis (BT Toxin)	LIQUID	ORAL	20180828	20240618	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; ASPARTAME; BACILLUS THURINGIENSIS; BENZALKONIUM CHLORIDE; BETA VULGARIS; BISPHENOL A; CHELIDONIUM MAJUS; COBALT; COPPER; FORMALDEHYDE; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE	12; 30; 14; 30; 3; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43742-1379_a2562d5b-2209-44a4-98e3-69853aa2d4b1	43742-1379	HUMAN OTC DRUG	Male Stimulant		Aralia Quinquefolia, Agnus Castus, Ascorbicum Acidum, Caladium Seguinum, Kali Bromatum, Cantharis, Damiana, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hypophysis Suis, Orchitinum (Suis), Prostate (Suis), Strychninum Phosphoricum, Conium Maculatum, Diencephalon (Suis), Heart (Suis), Ferrum Phosphoricum, Magnesia Phosphorica, Selenium Metallicum, Zincum Metallicum, Pineal Gland (Suis), Cortisone Aceticum, Manganum Phosphoricum, Lycopodium Clavatum, Testosterone, Morgan Gaertner	LIQUID	ORAL	20180905		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMERICAN GINSENG; ASCORBIC ACID; CHASTE TREE; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; DIEFFENBACHIA SEGUINE; FERROSOFERRIC PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE PHOSPHATE, DIBASIC; PORK HEART; POTASSIUM BROMIDE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SELENIUM; STRYCHNINE PHOSPHATE DIHYDRATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PROSTATE; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; TURNERA DIFFUSA LEAFY TWIG; ZINC	4; 6; 6; 8; 13; 6; 10; 28; 8; 10; 20; 8; 6; 30; 10; 8; 8; 8; 12; 8; 8; 8; 8; 30; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin C [EPC]	CIII	N	20241231
43742-1383_0fdd8f5d-f961-4a9d-adeb-bbcc45f9ab75	43742-1383	HUMAN OTC DRUG	Viril		Benzoicum Acidum, Caladium Seguinum, Chimaphila Umbellata, Clematis Erecta, Rhododendron, Sabal Serrulata, Natrum Muriaticum, Cortisone Aceticum, Hypothalamus Suis, Prostate (Suis), Testosterone, Agnus Castus, Aurum Metallicum, Bryonia (Alba), Conium Maculatum, Lycopodium Clavatum, Selenium Metallicum, Sepia, Thuja Occidentalis, Kali Arsenicosum, Bufo Rana	LIQUID	ORAL	20180905	20260304	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BENZOIC ACID; BRYONIA ALBA ROOT; BUFO BUFO CUTANEOUS GLAND; CHASTE TREE; CHIMAPHILA UMBELLATA; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; DIEFFENBACHIA SEGUINE; GOLD; LYCOPODIUM CLAVATUM SPORE; POTASSIUM ARSENITE ANHYDROUS; RHODODENDRON AUREUM LEAF; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PROSTATE; TESTOSTERONE; THUJA OCCIDENTALIS LEAFY TWIG	6; 12; 16; 12; 6; 6; 12; 8; 6; 12; 12; 15; 6; 6; 12; 12; 6; 8; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC]	CIII	N	
43742-1406_3b14fb2d-a7c6-459b-bf48-9bf09b85260a	43742-1406	HUMAN OTC DRUG	Electrolyte Plus		Boron Gluconate, Calcium Gluconate, Chromium Gluconate, Cobalt Gluconate, Copper Gluconate, Ferrous Gluconate, Magnesium Gluconicum Dihydricum, Manganese Gluconate, Potassium Gluconate, Selenium Dioxide, Sodium Gluconate, Zincum Gluconicum, Kali Phosphoricum, Niccolum Metallicum, Vanadium Metallicum, Calcarea Phosphorica	LIQUID	ORAL	20181102	20240213	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BORON GLUCONATE; CALCIUM GLUCONATE; CHROMIUM GLUCONATE; COBALTOUS GLUCONATE; COPPER GLUCONATE; FERROUS GLUCONATE; MAGNESIUM GLUCONATE; MANGANESE GLUCONATE; NICKEL; POTASSIUM GLUCONATE; POTASSIUM PHOSPHATE, DIBASIC; SELENIUM DIOXIDE; SODIUM GLUCONATE; TRIBASIC CALCIUM PHOSPHATE; VANADIUM; ZINC GLUCONATE	6; 6; 6; 6; 6; 6; 6; 6; 8; 6; 8; 6; 6; 9; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-1412_b10b976a-f2e8-43f5-97d2-86a550d0502e	43742-1412	HUMAN OTC DRUG	Mycocombo		Allium Cepa, Echinacea (Echinacea Angustifolia), Natrum Sulphuricum, Kali Carbonicum, Mephitis Mephitica, Sanguinaria Canadensis, Blatta Orientalis, Agaricus Muscarius, Antimonium Tartaricum, Arsenicum Iodatum, Carbolicum Acidum, Cinchona Officinalis, Ferrum Metallicum, Phytolacca Decandra, Secale Cornutum, Sulphuricum Acidum, Thuja Occidentalis, Ammonium Carbonicum, Aspergillus Niger	LIQUID	ORAL	20181212	20251009	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMANITA MUSCARIA FRUITING BODY; AMMONIUM CARBONATE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIIODIDE; ASPERGILLUS NIGER VAR. NIGER; BLATTA ORIENTALIS; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; ECHINACEA ANGUSTIFOLIA; IRON; MEPHITIS MEPHITIS ANAL GLAND FLUID; ONION; PHENOL; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SANGUINARIA CANADENSIS ROOT; SODIUM SULFATE; SULFURIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 12; 12; 15; 8; 12; 12; 6; 12; 8; 6; 12; 12; 8; 8; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Vegetable Proteins [CS]		N	
43742-1413_ac81ad7c-173f-45dc-99d4-3e7e9cb08042	43742-1413	HUMAN OTC DRUG	Itch Formula		Calendula Officinalis, Apis Mellifica, Natrum Muriaticum, Urtica Urens, Histaminum Hydrochloricum, Ledum Palustre, Sulphur, Copaiva Officinalis, Cantharis, Croton Tiglium, Graphites, Mezereum, Petroleum, Rhus Venenata, Staphysagria, Antipyrinum	LIQUID	ORAL	20181206		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIPYRINE; APIS MELLIFERA; CALENDULA OFFICINALIS FLOWERING TOP; COPAIFERA OFFICINALIS RESIN; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; KEROSENE; LYTTA VESICATORIA; RHODODENDRON TOMENTOSUM LEAFY TWIG; SODIUM CHLORIDE; SULFUR; TOXICODENDRON VERNIX LEAFY TWIG	16; 6; 3; 8; 12; 12; 12; 12; 6; 12; 10; 6; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1414_271b0818-ab9f-4668-9f71-10ea1709c223	43742-1414	HUMAN OTC DRUG	BP Reg		Allium Sativum, Adrenalinum, Arteria Suis, Cortisone Aceticum, Thyroidinum (Suis), Vena Suis, Formalinum, Kali Chloricum, alpha-Lipoicum Acidum, Aurum Metallicum, Cactus Grandiflorus, Cholesterinum, Coumarinum, Ephedra Vulgaris, Glonoinum, Lachesis Mutus, Rauwolfia Serpentina, Strontium Carbonicum, Sulphur, Veratrum Album, Proteus (Vulgaris)	LIQUID	ORAL	20181206		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CHOLESTEROL; CORTISONE ACETATE; COUMARIN; EPHEDRA DISTACHYA FLOWERING TWIG; EPINEPHRINE; FORMALDEHYDE; GARLIC; GOLD; LACHESIS MUTA VENOM; NITROGLYCERIN; POTASSIUM CHLORATE; PROTEUS VULGARIS; RAUWOLFIA SERPENTINA; SELENICEREUS GRANDIFLORUS STEM; STRONTIUM CARBONATE; SULFUR; SUS SCROFA ARTERY; SUS SCROFA VEIN; THIOCTIC ACID; THYROID, PORCINE; VERATRUM ALBUM ROOT	12; 8; 12; 12; 8; 9; 6; 12; 12; 12; 9; 16; 12; 12; 12; 12; 8; 8; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vasodilation [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1415_5d3c264c-0f40-46d4-a4bd-9118a3d3c172	43742-1415	HUMAN OTC DRUG	Virus Combination		Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode	LIQUID	ORAL	20181207	20240416	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); NORWALK VIRUS	30; 15; 15; 15; 18; 33; 18; 12; 12; 12; 12; 30	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1416_506542cf-0832-4309-9943-eac26428fdff	43742-1416	HUMAN OTC DRUG	Chemtox		Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Stillingia Sylvatica, Trifolium Pratense, Hepar Suis, Phytolacca Decandra, Glandula Suprarenalis Suis, Thyroidinum (Suis), Arsenicum Album, Asarum Canadense, Carbolicum Acidum, Carboneum Sulphuratum, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphorus, Selenium Metallicum, Sulphuricum Acidum, Chlorinum, Butylbenzene, Petroleum, Sorbitol	LIQUID	ORAL	20190102		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; ASARUM CANADENSE ROOT; BERBERIS VULGARIS ROOT BARK; BUTYLBENZENE; CARBON DISULFIDE; CHLORINE; GLYCYRRHIZA GLABRA; IRIDIUM; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PHENOL; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PORK LIVER; SELENIUM; SORBITOL; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYROID; TRIFOLIUM PRATENSE FLOWER	3; 12; 12; 3; 30; 12; 12; 3; 12; 30; 12; 12; 12; 12; 8; 8; 12; 30; 3; 12; 12; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1417_55a863d0-8ea2-48d1-aaea-b227e53c5eed	43742-1417	HUMAN OTC DRUG	Grain and Soy Allergen Mix		Adenosinum Triphosphoricum Dinatrum, Quercetin, Rutin, Ileum (Suis), Jejunum (Suis) Stomach (Suis), Bamboo, Barley, Poppy Seed, Corn, Flax Seed, Cotton Seed, Millet, Milo, Oat, Rice, Rye, Safflower, Sesame, Sorghum, Soy Bean, Sugarcane, Sunflower, Wheat, Bacillus Thuringiensis (BT Toxin), Gluten, Amaranth, Avena Sativa, Natrum Sulphuricum, Sarcolacticum Acidum, Triticum Repens, Adrenocorticotrophin, Glyphosate, Sycotic Co Bacillus	LIQUID	ORAL	20190102	20250225	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; AMARANTH; AVENA SATIVA FLOWERING TOP; BACILLUS THURINGIENSIS; BAMBUSA VULGARIS LEAF; BARLEY; BROWN RICE; CORN; CORTICOTROPIN; ELYMUS REPENS ROOT; ENTEROCOCCUS FAECALIS; FLAX SEED; GLYPHOSATE; LACTIC ACID, L-; LEVANT COTTON SEED; MILLET; OAT; POPPY SEED; QUERCETIN; RUTIN; RYE; SAFFLOWER; SESAME SEED; SODIUM SULFATE; SORGHUM; SORGHUM BICOLOR WHOLE; SOYBEAN; SUGARCANE; SUNFLOWER SEED; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA STOMACH; WHEAT; WHEAT GLUTEN	4; 6; 6; 10; 9; 9; 9; 9; 8; 6; 30; 9; 12; 6; 9; 9; 9; 9; 6; 6; 9; 9; 9; 6; 9; 9; 9; 9; 9; 8; 8; 8; 9; 30	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]	CII	N	
43742-1419_26a539f0-eb80-475b-a45a-5d59629489ac	43742-1419	HUMAN OTC DRUG	Bacteria Combination		Adenosinum Triphosphoricum Dinatrum, Malic Acid, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Apiolum, Cinnamic Acid, Streptococcus Viridans, Pneumococcinum, Colibacillinum Cum Natrum Muriaticum, Echinacea (Angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (Mirabilis), Proteus (Vulgaris), Pseudomonas Aeruginosa, Yersinia Enterocolitica, Streptococcus Agalactiae, Legionella Pneumophila, Enterococcus Faecalis, Streptococcus Mutans, Listeria Monocytogenes, Dysentery Bacillus,	LIQUID	ORAL	20190603	20250720	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE PHOSPHATE DISODIUM; APIOLE (PARSLEY); CINNAMIC ACID; ECHINACEA ANGUSTIFOLIA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HELICOBACTER PYLORI; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; MALIC ACID; MYCOPLASMA PNEUMONIAE; OROTIC ACID; PROTEUS MIRABILIS; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RIBOFLAVIN; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; SODIUM DIETHYL OXALACETATE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS UBERIS; STREPTOCOCCUS VIRIDANS GROUP; YERSINIA ENTEROCOLITICA	6; 6; 6; 15; 13; 15; 15; 11; 14; 6; 15; 6; 15; 30; 15; 15; 6; 15; 15; 6; 9; 15; 32; 13; 15; 15; 12; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1420_cb83ae31-37a0-450c-a07b-34d4b6552e3e	43742-1420	HUMAN OTC DRUG	Healing Support		Betula (Pendula) Cortex, Caltha Palustris, Galium Aparine, Thuja Occidentalis, Urtica Urens, Clematis Erecta, Hedera Helix, Juniperus Communis, Quillaja Saponaria, Sempervivum Tectorum, Echinacea (Angustifolia), Argentum Metallicum, Calcarea Fluorica, Nitricum Acidum, Sedum Acre, Phosphorus, Apis Mellifica, Pyrogenium, Ononis Spinosa	LIQUID	ORAL	20190110	20250820	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; BETULA PENDULA BARK; CALCIUM FLUORIDE; CALTHA PALUSTRIS; CLEMATIS RECTA FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; GARLIC; HEDERA HELIX FLOWERING TWIG; JUNIPER BERRY; NITRIC ACID; ONONIS SPINOSA WHOLE; PHOSPHORUS; RANCID BEEF; SEDUM ACRE; SEMPERVIVUM TECTORUM LEAF; SILVER; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS	12; 1; 8; 3; 4; 5; 3; 6; 4; 4; 8; 5; 9; 12; 8; 4; 8; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1421_f7a18cc2-4492-4561-b393-4e00164fbcbe	43742-1421	HUMAN OTC DRUG	DysBio Plus		Echinacea (Angustifolia), Aloe, Colchicum Autumnale, Colocynthis, Mercurius Corrosivus, Nux Vomica, Arsenicum Album, Clostridium Difficile, Aceticum Acidum, Chininum Sulphuricum, Cholera Nosode, Proteus (Vulgaris), Colibacillinum Cum Natrum Muriaticum, Helicobacter Pylori, Yersinia Enterocolitica, Botulinum Nosode, Salmonella Typhi Nosode, Brugia Malayi	LIQUID	ORAL	20190103	20251111	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ALOE; ARSENIC TRIOXIDE; BOTULINUM TOXIN TYPE A; BRUGIA MALAYI; CITRULLUS COLOCYNTHIS FRUIT PULP; CLOSTRIDIUM DIFFICILE; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; HELICOBACTER PYLORI; MERCURIC CHLORIDE; PROTEUS VULGARIS; QUININE SULFATE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; STRYCHNOS NUX-VOMICA SEED; VIBRIO CHOLERAE; YERSINIA ENTEROCOLITICA	12; 6; 8; 30; 39; 8; 8; 8; 3; 30; 30; 8; 16; 12; 33; 8; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1422_b6b5c21a-f9c8-453f-9234-f3fa31ea1e62	43742-1422	HUMAN OTC DRUG	Influenza Plus		Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Influenzinum, Respiratory Syncytial Virus Nosode (RSV), Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20190116	20250617	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN); VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 8; 8; 8; 8; 3; 9; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43742-1423_2368f2bf-3741-4a8e-ab57-690e738132db	43742-1423	HUMAN OTC DRUG	Cerebromax		Acetylcholine Chloride, Octopamine (Hydrochloride), Taurine, Adenosinum Cyclophosphoricum, Cerebrum Suis, Diencephalon (Suis), Pineal Gland (Suis), Thalamus Opticus (Suis), Adrenalinum, Dopamine Hydrochloride, GABA (Gamma-Aminobutyric Acid), Norepinephrine (Bitartrate), Serotonin (Hydrochloride)	LIQUID	ORAL	20190129	20250731	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; ADENOSINE CYCLIC PHOSPHATE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; NOREPINEPHRINE BITARTRATE; OCTOPAMINE HYDROCHLORIDE; SEROTONIN HYDROCHLORIDE; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; TAURINE	8; 6; 8; 8; 8; 8; 6; 8; 8; 8; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1434_3fb6c408-3222-4be6-a1ae-b32ed97cd86a	43742-1434	HUMAN OTC DRUG	Brucella Homochord		Brucella Melitensis	LIQUID	ORAL	20190213	20240505	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BRUCELLA MELITENSIS	14	[hp_C]/mL			N	
43742-1435_ac4c1528-0972-4089-af1a-f2785da5c55a	43742-1435	HUMAN OTC DRUG	SinusitX		Plantago Major, Pulsatilla (Vulgaris), Luffa Operculata, Mercurius Iodatus Ruber, Mucosa Nasalis Suis, Euphorbium Officinarum, Argentum Nitricum, Hepar Sulphuris Calcareum, Calcarea Carbonica, Natrum Muriaticum, Sinusitisinum	LIQUID	ORAL	20190221	20250707	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PULSATILLA; CALCIUM SULFIDE; EUPHORBIA RESINIFERA RESIN; LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PLANTAGO MAJOR; SILVER NITRATE; SINUSITISINUM; SODIUM CHLORIDE; SUS SCROFA NASAL MUCOSA	4; 10; 9; 6; 8; 12; 3; 10; 20; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1438_435b99ad-9aee-4871-a0c9-6ec922aca3c6	43742-1438	HUMAN OTC DRUG	AnXious		Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Passiflora Incarnata, Angelica Sinensis, Argentum Nitricum, Cacao, Lithium Carbonicum, Prunus Cerasifera, Flos, Valeriana Officinalis, Piper Methysticum, Glandula Suprarenalis Suis, Aconitum Napellus, Anacardium Orientale, Arsenicum Album, Calcarea Carbonica, Cocculus Indicus, Ignatia Amara, Gelsemium Sempervirens	LIQUID	ORAL	20190222		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANAMIRTA COCCULUS SEED; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; CLEMATIS VITALBA FLOWER; COCOA; GELSEMIUM SEMPERVIRENS ROOT; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; LITHIUM CARBONATE; MACROPIPER METHYSTICUM ROOT; ORNITHOGALUM UMBELLATUM FLOWERING TOP; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PRUNUS CERASIFERA FLOWER; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; STRYCHNOS IGNATII SEED; SUS SCROFA ADRENAL GLAND; VALERIAN	12; 12; 6; 12; 3; 6; 12; 3; 3; 6; 7; 3; 12; 3; 6; 12; 6; 12; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43742-1449_b3ad9e13-d5aa-4b3f-8aff-5db5c773c073	43742-1449	HUMAN OTC DRUG	Neuro	II	Taraxacum Officinale, Hydrastis Canadensis, Acetylcholine Chloride, Histaminum Hydrochloricum, Adrenalinum, GABA (Gamma-Aminobutyric Acid), Norepinephrine (Bitartrate), Tyramine	LIQUID	ORAL	20190222		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; EPINEPHRINE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; NOREPINEPHRINE BITARTRATE; TARAXACUM OFFICINALE; TYRAMINE	8; 6; 8; 6; 6; 8; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1451_6aaa1369-94a9-48df-bcc1-4f56b9febad8	43742-1451	HUMAN OTC DRUG	Dynamic Brain		Argentum Nitricum, Cuprum Aceticum, Ginkgo Biloba, Kali Phosphoricum, Lycopodium Clavatum, Phosphoricum Acidum, Thiaminum Hydrochloricum, Cerebrum Suis, Ambra Grisea, Picricum Acidum, Agnus Castus, Alumina, Anacardium Orientale, Baryta Carbonica, Cicuta Virosa, Conium Maculatum, Helleborus Niger, Plumbum Metallicum, Selenium Metallicum, Zincum Metallicum	LIQUID	ORAL	20190315		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALUMINUM OXIDE; AMBERGRIS; BARIUM CARBONATE; CHASTE TREE FRUIT; CICUTA VIROSA ROOT; CONIUM MACULATUM FLOWERING TOP; CUPRIC ACETATE; DIBASIC POTASSIUM PHOSPHATE; GINKGO; HELLEBORUS NIGER ROOT; LEAD; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PICRIC ACID; SELENIUM; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; SUS SCROFA CEREBRUM; THIAMINE HYDROCHLORIDE; ZINC	12; 9; 12; 12; 12; 12; 6; 6; 6; 12; 12; 6; 6; 10; 12; 12; 6; 8; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1452_610e475e-a7d9-41c8-8083-2812164d1475	43742-1452	HUMAN OTC DRUG	Elevate		Lycopodium Clavatum, Natrum Muriaticum, Sepia, Causticum, Phosphorus, Sulphur, 5-Hydroxytryptophan, Alumina, Silicea, Acetylcholine Chloride, Dopamine Hydrochloride, Norepinephrine (Bitartrate), Phenylethylamine (Hydrochloride), Serotonin (Hydrochloride), Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Funiculus Umbilicalis Suis, Pantothenic Acid, Pineal Gland (Suis), Sarcolacticum Acidum, Faecalis (Alkaligenes), Gaertner Bacillus (Bach), Proteus (Vulgaris)	LIQUID	ORAL	20190315		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYLCHOLINE CHLORIDE; ADENOSINE CYCLIC PHOSPHATE; ALCALIGENES FAECALIS; ALUMINUM OXIDE; CAUSTICUM; DOPAMINE HYDROCHLORIDE; LACTIC ACID, L-; LYCOPODIUM CLAVATUM SPORE; NOREPINEPHRINE BITARTRATE; OXITRIPTAN; PANTOTHENIC ACID; PHENETHYLAMINE HYDROCHLORIDE; PHOSPHORUS; PROTEUS VULGARIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEPIA OFFICINALIS JUICE; SEROTONIN HYDROCHLORIDE; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA UMBILICAL CORD	8; 10; 30; 8; 4; 8; 10; 3; 8; 6; 10; 8; 4; 30; 30; 3; 8; 8; 3; 4; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
43742-1453_96968744-c1ac-45af-879d-d45edc4dc3ae	43742-1453	HUMAN OTC DRUG	Household Detox		Ptelea Trifoliata, Allium Sativum, Petroleum, Carboneum Sulphuratum, Alumina, Benzinum, Bisphenol A, Carbolicum Acidum, Formalinum, Glyphosate, Methylparaben, Naphthalinum, Paraffinum, Phenacetinum, Sodium Carboxymethyl Cellulose, Folliculinum, Antipyrinum, Dioxin, Diethylstilbestrol, Teflon	LIQUID	ORAL	20190319		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; ALUMINUM OXIDE; ANTIPYRINE; BENZENE; BISPHENOL A; CARBON DISULFIDE; CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM; DIETHYLSTILBESTROL; ESTRONE; FORMALDEHYDE; GARLIC; GLYPHOSATE; KEROSENE; METHYLPARABEN; NAPHTHALENE; PARAFFIN; PHENACETIN; PHENOL; POLYTETRAFLUOROETHYLENE; PTELEA TRIFOLIATA BARK	36; 12; 16; 12; 12; 9; 12; 15; 12; 12; 6; 12; 8; 12; 12; 12; 12; 12; 33; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43742-1454_4b256d37-4db2-40bb-845d-0515eb7250dc	43742-1454	HUMAN OTC DRUG	Matrix Support		Ceanothus Americanus, Veratrum Album, Anacardium Orientale, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Oxalis Acetosella, Pulsatilla (Vulgaris), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Mannan,	LIQUID	ORAL	20190401	20240408	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CEANOTHUS AMERICANUS LEAF; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; MANDRAGORA OFFICINARUM ROOT; MARSDENIA CONDURANGO BARK; MOMORDICA BALSAMINA IMMATURE FRUIT; OXALIS ACETOSELLA LEAF; PHOSPHORUS; PORK INTESTINE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SEMECARPUS ANACARDIUM JUICE; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA BILE DUCT; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA EYE; SUS SCROFA GALLBLADDER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA ORAL MUCOSA; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; VERATRUM ALBUM ROOT; WOOD CREOSOTE; YEAST MANNAN	4; 6; 8; 10; 10; 6; 6; 6; 8; 8; 8; 6; 6; 30; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8; 10; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1455_4a30b420-7c06-46fe-be6d-b0a7d2c7e390	43742-1455	HUMAN OTC DRUG	Leaky Gut Formula		Alfalfa, Fragaria Vesca, Glycyrrhiza Glabra, Aloe, Astacus Fluviatilis, Berberis Aquifolium, Lac Defloratum, Natrum Carbonicum, Saccharum Officinale, Fel Tauri, Pancreas Suis, Pepsinum, Antimonium Crudum, Carbo Vegetabilis, Euphorbium Officinarum, Lycopodium Clavatum, Magnesia Carbonica, Zincum Metallicum, Colibacillinum Cum Natrum Muriaticum, Proteus (Vulgaris)	LIQUID	ORAL	20190404	20240404	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALFALFA; ALOE; ALPINE STRAWBERRY; ANTIMONY TRISULFIDE; ASTACUS ASTACUS; BERBERIS AQUIFOLIUM ROOT BARK; BOS TAURUS BILE; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; PEPSIN; PROTEUS VULGARIS; SKIM MILK; SODIUM CARBONATE; SUCROSE; SUS SCROFA PANCREAS; ZINC	12; 3; 4; 3; 12; 6; 6; 8; 15; 12; 3; 12; 12; 8; 15; 6; 6; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1456_4945fc12-dd2c-420e-8501-c6d61cca4555	43742-1456	HUMAN OTC DRUG	Candida Plus		Hydrastis Canadensis, Berberis Vulgaris, Borax, Saccharum Officinale, Caffeinum, Gallicum Acidum, Indolum, Allium Sativum, Echinacea (Angustifolia), Asafoetida, Acetaldehyde, Folliculinum, Lycopodium Clavatum, Phytolacca Decandra, Pulsatilla (Pratensis), Sepia, Ustilago Maidis, Torula Cerevisiae	LIQUID	ORAL	20190508	20250908	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; ANEMONE PRATENSIS; BERBERIS VULGARIS ROOT BARK; CAFFEINE; ECHINACEA ANGUSTIFOLIA; ESTRONE; FERULA ASSA-FOETIDA RESIN; GALLIC ACID MONOHYDRATE; GARLIC; GOLDENSEAL; INDOLE; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SUCROSE; USTILAGO MAYDIS	8; 12; 6; 6; 8; 12; 8; 6; 8; 5; 6; 12; 12; 60; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Plant Proteins [CS], Xanthines [CS]		N	
43742-1477_684589e9-7d73-4bc5-9628-e80c33425de6	43742-1477	HUMAN OTC DRUG	Detox	I	Carduus Marianus, Chelidonium Majus, Lycopodium Clavatum, Taraxacum Officinale, Avena Sativa, Cynara Scolymus, Methylcobalamin, Menadione, alpha-Lipoicum Acidum, Cinchona Officinalis, Hepar Suis, Veratrum Album, Colon (Suis), Duodenum (Suis), Gallbladder (Suis), Intestine (Suis), Lymph Node (Suis), Thymus (Suis), alpha-Ketoglutaricum Acidum, Cholesterinum, Formicum Acidum, Glyoxal Trimer Dihydrate, Histaminum Hydrochloricum, Malic Acid, Natrum Oxalaceticum, Sulphur	LIQUID	ORAL	20190424	20240507	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; AVENA SATIVA FLOWERING TOP; CHELIDONIUM MAJUS; CHOLESTEROL; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; FORMIC ACID; GLYOXAL TRIMER DIHYDRATE; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; MALIC ACID; MENADIONE; METHYLCOBALAMIN; MILK THISTLE; OROTIC ACID MONOHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK INTESTINE; PORK LIVER; PROTEUS MORGANII; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA GALLBLADDER; SUS SCROFA LYMPH; SUS SCROFA THYMUS; TARAXACUM OFFICINALE; VERATRUM ALBUM ROOT	10; 8; 6; 4; 10; 8; 6; 10; 10; 10; 4; 10; 6; 6; 3; 7; 28; 8; 8; 30; 30; 10; 13; 8; 8; 8; 8; 8; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1478_b097f77e-5b4c-4136-ba05-28be421ac93f	43742-1478	HUMAN OTC DRUG	Liver Drainage		Chelidonium Majus, Carduus Marianus, Schisandra Chinensis, Taraxacum Officinale, Berberis Vulgaris, Neopicrorhiza Scrophulariiflora, Raphanus Sativus, Viscum Album, Chromium Gluconate, Cobalt Gluconate, Copper Gluconate, Magnesium Gluconate, Natrum Sulphuricum, Ptelea Trifoliate, Sarcolacticum Acidum, Sulphur Iodatum, Carbolicum Acidum, Cichorium Intybus, Flos, Gallbladder (Suis), Hepar Suis, Nux Vomica, Vanadium Metallicum, Verbena Officinalis, Flos	LIQUID	ORAL	20190430	20240528	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CHROMIUM GLUCONATE; CICHORIUM INTYBUS FLOWER; COBALTOUS GLUCONATE; COPPER GLUCONATE; LACTIC ACID, L-; MAGNESIUM GLUCONATE; MILK THISTLE; NEOPICRORHIZA SCROPHULARIIFLORA ROOT; PHENOL; PORK LIVER; PTELEA TRIFOLIATA BARK; RADISH; SCHISANDRA CHINENSIS FRUIT; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; SUS SCROFA GALLBLADDER; TARAXACUM OFFICINALE; VANADIUM; VERBENA OFFICINALIS FLOWERING TOP; VISCUM ALBUM FRUITING TOP	3; 1; 6; 8; 6; 6; 6; 6; 2; 3; 8; 8; 6; 3; 2; 6; 8; 6; 8; 3; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	
43742-1479_4d7c9216-af0e-4d25-816a-5057c6624102	43742-1479	HUMAN OTC DRUG	GI Drainage		Cinnamomum, Gentiana Lutea, Syzygium Jambolanum, Argentum Nitricum, Colchicum Autumnale, Colostrum, Copper Gluconate, Lappa Major, Lycopodium Clavatum, Magnesium Gluconate, Manganese Gluconate, Potassium Gluconate, Rumex Crispus, Scrophularia Nodosa, Stomach (Suis), Aurum Metallicum, Calcarea Carbonica, Carbo Vegetabilis, Intestine (Suis), Malus Pumila, Flos, Nitricum Acidum, Prunus Cerasifera, Flos, Rock Water, Fagus Sylvatica, Flos	LIQUID	ORAL	20190513	20240530	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ARCTIUM LAPPA ROOT; BOS TAURUS COLOSTRUM; CINNAMON; COLCHICUM AUTUMNALE BULB; COPPER GLUCONATE; FAGUS SYLVATICA FLOWERING TOP; GENTIANA LUTEA ROOT; GOLD; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM GLUCONATE; MALUS PUMILA FLOWER; MANGANESE GLUCONATE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK INTESTINE; POTASSIUM GLUCONATE; PRUNUS CERASIFERA FLOWER; RUMEX CRISPUS ROOT; SCROPHULARIA NODOSA; SILVER NITRATE; SUS SCROFA STOMACH; SYZYGIUM CUMINI SEED; WATER	8; 6; 6; 3; 6; 6; 12; 3; 8; 6; 6; 8; 6; 8; 8; 8; 6; 8; 6; 6; 6; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-1480_527ec264-21c5-4615-a32b-2ce97c9ac5c9	43742-1480	HUMAN OTC DRUG	Viracomp		Allium Sativum, Echinacea (Angustifolia), Ginkgo Biloba, Viscum Album, Hamamelis Virginiana, Aconitum Napellus, Allium Cepa, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Gelsemium Sempervirens, Mercurius Vivus, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Influenzinum, Morbillinum	LIQUID	ORAL	20190424	20250115	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); MEASLES VIRUS; MERCURY; ONION; SELENIUM; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 3; 3; 12; 3; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-1481_52b9861f-816c-4947-b18b-2bbd7f61394c	43742-1481	HUMAN OTC DRUG	Herpes Simplex Plus		Allium Sativum, Calendula Officinalis, Sambucus Nigra, Clematis Erecta, Dulcamara, Sarsaparilla (Smilax Regelii), Graphites, Petroleum, Arsenicum Album, Croton Tiglium, Mercurius Sulphuratus Ruber, Natrum Muriaticum, Nitricum Acidum, Rhus Tox, Sepia, Thuja Occidentalis	LIQUID	ORAL	20190514	20240823	UNAPPROVED HOMEOPATHIC		Deseret Biologicals,Inc.	ARSENIC TRIOXIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS RECTA FLOWERING TOP; CROTON TIGLIUM SEED; GARLIC; GRAPHITE; KEROSENE; MERCURIC SULFIDE; NITRIC ACID; SAMBUCUS NIGRA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 2; 6; 12; 2; 8; 8; 12; 12; 3; 12; 6; 12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1482_7751eb20-e68e-4faf-a9ba-54dc90b24d1d	43742-1482	HUMAN OTC DRUG	Co-InfXn		Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Encephalitis Nosode, Mycoplasma Pneumoniae, Meningococcus Nosode, Hepatitis B Nosode	LIQUID	ORAL	20190514	20240918	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANAPLASMA PHAGOCYTOPHILUM; BABESIA MICROTI; BARTONELLA HENSELAE; BORRELIA BURGDORFERI; EHRLICHIA CANIS; HEPATITIS B VIRUS; JAPANESE ENCEPHALITIS VIRUS; MYCOPLASMA PNEUMONIAE; NEISSERIA MENINGITIDIS	15; 15; 15; 15; 15; 15; 15; 15; 21	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1483_31373f3b-9089-4340-9b68-c072c5c5fe8d	43742-1483	HUMAN OTC DRUG	Virus Combination		Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode	LIQUID	ORAL	20190502	20250710	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); NORWALK VIRUS	33; 15; 15; 15; 15; 18; 18; 15; 12; 12; 12; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1484_a2f76ef9-6c60-415e-a6a8-cbf46772debe	43742-1484	HUMAN OTC DRUG	Appetite Control		Acetyl Coenzyme A, Adenosinum Triphosphoricum Dinatrum, Adrenal Cortex (Suis), Bacopa Speciosa, Equol, Gambogia, Oxytocin Acetate, Rhodiola, Stomach (Suis), Chininum Sulphuricum, Iodium, Lycopodium Clavatum, Phosphorus, Dopamine Hydrochloride, Thyroidinum (Suis), Cina, Serotonin (Hydrochloride), Morgan Gaertner	LIQUID	ORAL	20190507	20250706	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE DISODIUM; ARTEMISIA CINA PRE-FLOWERING TOP; BACOPA MONNIERI WHOLE; DOPAMINE HYDROCHLORIDE; EQUOL, (+/-)-; GAMBOGE; IODINE; LYCOPODIUM CLAVATUM SPORE; OXYTOCIN ACETATE; PHOSPHORUS; QUININE SULFATE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEDUM ROSEUM ROOT; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL CORTEX; SUS SCROFA STOMACH; SUS SCROFA THYROID	6; 6; 8; 6; 8; 6; 14; 6; 6; 6; 6; 6; 30; 6; 8; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	
43742-1486_c8057f7e-5903-4fcb-8af0-3e8c7427fdab	43742-1486	HUMAN OTC DRUG	Cerebromax		Acetylcholine Chloride, Taurine, Adenosinum Cyclophosphoricum, Cerebrum Suis, Diencephalon (Suis), Pineal Gland (Suis), Thalamus Opticus (Suis), Adrenalinum, Dopamine Hydrochloride, GABA (Gamma-Aminobutyric Acid), Norepinephrine (Bitartrate), Serotonin (Hydrochloride), Tyramine	LIQUID	ORAL	20190517		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; ADENOSINE CYCLIC PHOSPHATE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; NOREPINEPHRINE BITARTRATE; SEROTONIN HYDROCHLORIDE; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; TAURINE; TYRAMINE	8; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1487_ce3e1c90-7da7-4700-8cc9-f352d63d55c4	43742-1487	HUMAN OTC DRUG	Matrix Support		Ceanothus Americanus, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Pulsatilla (Pratensis), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Pancreas Suis, Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Veratrum Album, Mannose, Anacardium Orientale, Kreosotum,	LIQUID	ORAL	20190516	20250204	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; CEANOTHUS AMERICANUS LEAF; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; MANDRAGORA OFFICINARUM ROOT; MANNOSE, D-; MARSDENIA CONDURANGO BARK; MOMORDICA BALSAMINA IMMATURE FRUIT; OXALIS ACETOSELLA LEAF; PHOSPHORUS; PORK INTESTINE; POTASSIUM DICHROMATE; SEMECARPUS ANACARDIUM JUICE; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA BILE DUCT; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA EYE; SUS SCROFA GALLBLADDER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA ORAL MUCOSA; SUS SCROFA PANCREAS; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; VERATRUM ALBUM ROOT; WOOD CREOSOTE	6; 4; 6; 8; 10; 10; 8; 6; 6; 10; 8; 8; 8; 9; 30; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1488_031c6f06-aeef-4fed-889b-7a762379ec9b	43742-1488	HUMAN OTC DRUG	Detox	I	Carduus Marianus, Chelidonium Majus, Lycopodium Clavatum, Taraxacum Officinale, Avena Sativa, Cynara Scolymus, Methylcobalamin, Menadione, alpha-Lipoicum Acidum, Cinchona Officinalis, Hepar Suis, Veratrum Album, Colon (Suis), Duodenum (Suis), Gallbladder (Suis), Intestine (Suis), Lymph Node (Suis), Pancreas Suis, Thymus (Suis), Acetaldehyde, alpha-Ketoglutaricum Acidum, Cholesterinum, Formicum Acidum, Histaminum Hydrochloricum, Malic Acid, Natrum Oxalaceticum, Sulphur, Calcarea Carbonica,	LIQUID	ORAL	20190722		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; ACETALDEHYDE; AVENA SATIVA FLOWERING TOP; CHELIDONIUM MAJUS WHOLE; CHOLESTEROL; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; FORMIC ACID; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; MALIC ACID; MENADIONE; METHYLCOBALAMIN; MILK THISTLE; OROTIC ACID MONOHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK INTESTINE; PORK LIVER; PROTEUS MORGANII; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA GALLBLADDER; SUS SCROFA LYMPH; SUS SCROFA PANCREAS; SUS SCROFA THYMUS; TARAXACUM OFFICINALE; VERATRUM ALBUM ROOT	10; 8; 10; 6; 4; 10; 8; 6; 10; 10; 4; 10; 6; 6; 3; 7; 28; 8; 8; 30; 30; 10; 13; 8; 8; 8; 8; 8; 8; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1489_a61e9472-9464-4461-a331-5a0c8d8c8b58	43742-1489	HUMAN OTC DRUG	Norepinephrine		Norepinephrine (Bitartrate)	LIQUID	ORAL	20190528		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	NOREPINEPHRINE BITARTRATE	8	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
43742-1490_3c7bd156-e5a6-4b66-ad6a-22836f864f84	43742-1490	HUMAN OTC DRUG	Detox	II	Solidago Virgaurea, Baptisia Tinctoria, Berberis Vulgaris, Equisetum Hyemale, Argentum Nitricum, Cantharis, Capsicum Annuum, Cuprum Sulphuricum, Orthosiphon Stamineus, Pareira Brava, Sarsaparilla (Smilax Regelii), Barosma (Betulina), Mercurius Corrosivus, Pyelon (Suis), Terebinthina, Ureter (Suis), Urethra (Suis), Urinary Bladder (Suis), Acetaldehyde, Hepar Sulphuris Calcareum, Natrum Pyruvicum, Quercetin, Colibacillinum Cum Natrum Muriaticum, Apis Venenum Purum, Dysentery Bacillus	LIQUID	ORAL	20190528	20260707	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; AGATHOSMA BETULINA LEAF; APIS MELLIFERA VENOM; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CAPSICUM; CHONDRODENDRON TOMENTOSUM ROOT; CUPRIC SULFATE; EQUISETUM HYEMALE; ESCHERICHIA COLI; LYTTA VESICATORIA; MERCURIC CHLORIDE; ORTHOSIPHON ARISTATUS WHOLE; QUERCETIN; SHIGELLA DYSENTERIAE; SILVER NITRATE; SMILAX ORNATA ROOT; SODIUM PYRUVATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA RENAL PELVIS; SUS SCROFA URETER; SUS SCROFA URETHRA; SUS SCROFA URINARY BLADDER; TURPENTINE OIL	10; 8; 18; 4; 4; 10; 6; 6; 6; 4; 15; 6; 8; 6; 10; 30; 6; 6; 10; 3; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
43742-1492_94ef3f9e-bfe9-4a23-b797-393ee27c6d02	43742-1492	HUMAN OTC DRUG	Staph/Strep Combination		Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Staphylococcus Aureus, Streptococcus Viridans	LIQUID	ORAL	20190723	20250727	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE TYPE B; KLEBSIELLA PNEUMONIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	12; 12; 15; 15; 12; 12; 12; 36	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43742-1493_c001761a-01bd-4147-8776-faa5a9ba8c1c	43742-1493	HUMAN OTC DRUG	Bio Cytotox Phase		Podophyllum Peltatum, Ascorbicum Acidum, Galium Aparine, Hydrastis Canadensis, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, alpha-Lipoicum Acidum, Colchicum Autumnale, Conium Maculatum, Natrum Oxalaceticum, Sulphur, Vaccinium Myrtillus, Norepinephrine, Acetylsalicylicum Acidum, Adenosinum Triphosphoricum Dinatrum, Anthrachinonum, Histaminum Hydrochloricum, Magnesium Gluconicum Dihydricum, Nadidum, Naphthochinonum, Pantothenic Acid, Ubidecarenonum,	LIQUID	ORAL	20190709		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ANTHRAQUINONE; ASCORBIC ACID; ASPIRIN; BILBERRY; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; GALIUM APARINE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; HYDROQUINONE; LACTIC ACID, L-; MAGNESIUM GLUCONATE; MANGANESE PHOSPHATE, DIBASIC; NADIDE; NAPHTHOQUINE; NIACINAMIDE; NOREPINEPHRINE BITARTRATE; PANTOTHENIC ACID; PODOPHYLLUM; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SULFUR; THIAMINE HYDROCHLORIDE; THIOCTIC ACID; UBIDECARENONE	10; 10; 6; 10; 8; 8; 8; 6; 6; 10; 3; 6; 10; 15; 10; 10; 6; 10; 10; 5; 6; 6; 30; 8; 8; 6; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Anti-Inflammatory Agents, Non-Steroidal [CS], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Depigmenting Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Platelet Aggregation Inhibitor [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
43742-1504_ba1950cd-e831-4d95-afb7-33301da5aa63	43742-1504	HUMAN OTC DRUG	HA2CG Evolution		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, Gambogia, 7-Oxo-Dehydroepiandrosterone 3-Acetate, Adenosinum Triphosphoricum Dinatrum, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20190723	20270607	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	30; 30; 8; 8; 6; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1505_735a5872-76b0-42f1-a840-488f437ec6cd	43742-1505	HUMAN OTC DRUG	ENT Support		Pulsatilla (Pratensis), Euphorbium Officinarum, Luffa Operculata, Mercurius Iodatus Ruber, Argentum Nitricum, Hepar Sulphuris Calcareum, Influenzinum (2018-2019), Sinusitisinum, Aspergillus Niger, Candida Albicans, Gallicum Acidum, Mucor Racemosus, Mutabile Bacillus (Bach)	LIQUID	ORAL	20190725	20240725	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; SILVER NITRATE; SINUSITISINUM	4; 10; 10; 10; 30; 6; 10; 12; 12; 12; 12; 6; 8; 10; 10; 17	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-1506_5a42f188-f269-4269-bca8-8000f7bd497d	43742-1506	HUMAN OTC DRUG	Rage		Apis Mellifica, Cantharis, Chamomilla, Adrenalinum, Cerebrum Suis, Hypophysis Suis, Aconitum Napellus, Agaricus Muscarius, Atropinum, Causticum, Cicuta Virosa, Cuprum Metallicum, Hyoscyamus Niger, Lac Caninum, Moschus, Stramonium, Tarentula Hispana, Veratrum Album, Homarus, Camphora	LIQUID	ORAL	20190725		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; AMANITA MUSCARIA FRUITING BODY; APIS MELLIFERA; ATROPINE; CAMPHOR (NATURAL); CANIS LUPUS FAMILIARIS MILK; CAUSTICUM; CICUTA VIROSA ROOT; COPPER; DATURA STRAMONIUM; EPINEPHRINE; HOMARUS AMERICANUS DIGESTIVE FLUID; HYOSCYAMUS NIGER; LYCOSA TARANTULA; LYTTA VESICATORIA; MATRICARIA CHAMOMILLA; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; SUS SCROFA CEREBRUM; SUS SCROFA PITUITARY GLAND; VERATRUM ALBUM ROOT	12; 12; 6; 12; 30; 12; 12; 12; 12; 12; 8; 17; 12; 12; 6; 6; 12; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Anticholinergic [EPC], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Standardized Insect Venom Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1507_37f2bec1-99cb-4698-8c89-2ddf552d31a9	43742-1507	HUMAN OTC DRUG	Female Stimulant		Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Kreosotum, Oophorinum (Suis), Uterus (Suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (Suis), Hypophysis Suis, Aconiticum Acidum CIS-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (Alkaligenes), Mutabile Bacillus (Bach)	LIQUID	ORAL	20190820		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITIC ACID, (Z)-; ALCALIGENES FAECALIS; APIS MELLIFERA VENOM; AQUILEGIA VULGARIS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; GOLDENSEAL; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PETROSELINUM CRISPUM; PORK HEART; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; TESTOSTERONE; WOOD CREOSOTE	10; 30; 18; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 12; 6; 8; 30; 13; 8; 8; 16; 10; 6; 8; 8; 30; 8	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]	CIII	N	20241231
43742-1508_5b4da384-70d1-47b1-9b85-3b8a1428fe88	43742-1508	HUMAN OTC DRUG	Grain and Soy Allergen Mix		Adenosinum Triphosphoricum Dinatrum, Quercetin, Rutin, Ileum (Suis), Jejunum (Suis) Stomach (Suis), Bacillus Thuringiensis (BT Toxin), Gluten, Amaranth, Avena Sativa, Natrum Sulphuricum, Sarcolacticum Acidum, Triticum Repens, Cortisone Aceticum, Glyphosate, Sycotic Co Bacillus	LIQUID	ORAL	20190820	20250217	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; AMARANTH; AVENA SATIVA FLOWERING TOP; CORTICOTROPIN; ELYMUS REPENS ROOT; ENTEROCOCCUS FAECALIS; GLYPHOSATE; LACTIC ACID, L-; QUERCETIN; RUTIN; SODIUM CARBONATE; SODIUM SULFATE; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA STOMACH; WHEAT GLUTEN	4; 6; 6; 8; 6; 30; 12; 6; 6; 6; 6; 6; 8; 8; 8; 30	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1509_d9c12636-2f2a-4677-94e9-eb2c33768804	43742-1509	HUMAN OTC DRUG	Gum Therapy		Calendula Officinalis, Kali Phosphoricum, Natrum Muriaticum, Arnica Montana, Agave Americana, Cistus Canadensis, Kreosotum, Myrrha, Calcarea Fluorica, Aconitum Napellus, Bismuthum Subnitricum, Sepia, Hepar Sulphuris Calcareum, Mercurius Vivus	LIQUID	ORAL	20190820	20270425	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ACONITUM NAPELLUS; AGAVE AMERICANA LEAF; ARNICA MONTANA; BISMUTH SUBNITRATE; CALCIUM FLUORIDE; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; DIBASIC POTASSIUM PHOSPHATE; HELIANTHEMUM CANADENSE; MERCURY; MYRRH; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; WOOD CREOSOTE	12; 6; 6; 12; 12; 12; 1; 3; 6; 12; 8; 12; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Bismuth [CS], Bismuth [EPC]		N	
43742-1510_eb18ade3-2670-49a0-a51f-9d19cae0fb2d	43742-1510	HUMAN OTC DRUG	Circulation		Cactus Grandiflorus, Kali Carbonicum, Kalmia Latifolia, Arnica Montana, Glonoinum, Ignatia Amara, Lacticum Acidum, Ranunculus Bulbosus, Alpha-Ketoglutaricum Acidum, Arsenicum Album, Fumaricum Acidum, Heart (Suis), Hepar Suis, Malicum Acidum, Natrum Oxalaceticum, Phosphorus, Strophanthus Hispidus, Spigelia Anthelmia, Carbo Vegetabilis, Naja Tripudians, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode	LIQUID	ORAL	20190725		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ARNICA MONTANA; ARSENIC TRIOXIDE; FUMARIC ACID; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; KALMIA LATIFOLIA LEAF; LACTIC ACID; MALIC ACID; NAJA NAJA VENOM; NITROGLYCERIN; OXOGLURIC ACID; PHOSPHORUS; PORK HEART; PORK LIVER; POTASSIUM CARBONATE; RANUNCULUS BULBOSUS; SELENICEREUS GRANDIFLORUS STEM; SODIUM DIETHYL OXALACETATE; SPIGELIA ANTHELMIA; STROPHANTHUS HISPIDUS SEED; STRYCHNOS IGNATII SEED	12; 6; 8; 8; 17; 17; 8; 6; 8; 15; 8; 8; 8; 8; 8; 4; 6; 3; 8; 10; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
43742-1511_aa8abc78-8cad-43d1-919e-714b5b5580f1	43742-1511	HUMAN OTC DRUG	Oral Health		Borax, Bryonia (Alba), Echinacea Purpurea, Juglans Cinerea, Kali Muriaticum, Magnesia Muriatica, Muriaticum Acidum, Discus Intervertebralis Suis, Oral Mucosa (Suis), Antimonium Crudum, Arsenicum Album, Bismuthum Subnitricum, Chamomilla, Cinchona Officinalis, Nux Moschata, Sambucus Nigra, Sepia, Mercurius Solubilis, Calcarea Phosphorica, Ignatia Amara, Oxygenium, Candida Albicans	LIQUID	ORAL	20190820	20241022	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BISMUTH SUBNITRATE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CINCHONA OFFICINALIS BARK; ECHINACEA PURPUREA; HYDROCHLORIC ACID; JUGLANS CINEREA BRANCH BARK/ROOT BARK; MAGNESIUM CHLORIDE; MATRICARIA CHAMOMILLA; MERCURIUS SOLUBILIS; NUTMEG; OXYGEN; POTASSIUM CHLORIDE; SAMBUCUS NIGRA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SODIUM BORATE; STRYCHNOS IGNATII SEED; SUS SCROFA INTERVERTEBRAL DISC; SUS SCROFA ORAL MUCOSA; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 6; 16; 12; 6; 6; 6; 6; 12; 12; 12; 16; 6; 12; 12; 6; 12; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bismuth [CS], Bismuth [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-1512_eaa730f8-8b4b-4371-92c6-f5863564f29d	43742-1512	HUMAN OTC DRUG	Mood Swings		Camphora, Cimicifuga Racemosa, Crocus Sativus, Kali Bromatum, Lithium Carbonicum, Adrenalinum, Dopamine Hydrochloride, Hypothalamus Suis, Serotonin (Hydrochloride), Thyroidinum (Suis), Aconitum Napellus, Hyoscyamus Niger, Ignatia Amara, Oenanthe Crocata, Pulsatilla (Pratensis), Stramonium, Tarentula Hispana, Zincum Metallicum, Lachesis Mutus, Platinum Metallicum	LIQUID	ORAL	20190725	20241209	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANEMONE PRATENSIS; BLACK COHOSH; CAMPHOR (NATURAL); DATURA STRAMONIUM; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; HYOSCYAMUS NIGER; LACHESIS MUTA VENOM; LITHIUM CARBONATE; LYCOSA TARANTULA; OENANTHE CROCATA ROOT; PLATINUM; POTASSIUM BROMIDE; SAFFRON; SEROTONIN HYDROCHLORIDE; STRYCHNOS IGNATII SEED; SUS SCROFA HYPOTHALAMUS; THYROID, PORCINE; ZINC	12; 12; 6; 6; 12; 8; 8; 12; 12; 8; 12; 12; 18; 6; 6; 8; 12; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Mood Stabilizer [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1513_869ddebb-6e32-4d2b-9b95-97f7d35214d4	43742-1513	HUMAN OTC DRUG	Grief		Cimicifuga Racemosa, Natrum Sulphuricum, Phosphoricum Acidum, Sepia, Cerebrum Suis, Ignatia Amara, Natrum Muriaticum, Ambra Grisea, DNA, Aurum Metallicum, Cocculus Indicus, Digitalis Purpurea, Helleborus Niger, Lycopodium Clavatum, Staphysagria	LIQUID	ORAL	20190726		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMBERGRIS; ANAMIRTA COCCULUS SEED; BLACK COHOSH; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; GOLD; HELLEBORUS NIGER ROOT; HERRING SPERM DNA; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SODIUM SULFATE; STRYCHNOS IGNATII SEED; SUS SCROFA CEREBRUM	9; 12; 6; 12; 12; 12; 12; 10; 12; 6; 8; 8; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43742-1514_3f4241dd-7ea9-48d6-9add-05a96da4361d	43742-1514	HUMAN OTC DRUG	HP Axis		Argentum Nitricum, Berberis Vulgaris, Iodium, Kali Carbonicum, Natrum Muriaticum, Adrenalinum, Cortisone Aceticum, DHEA, Glandula Suprarenalis Suis, Hypophysis Suis, Hypothalamus Suis, Melatonin, Testosterone, Arsenicum Album, Phosphorus, Proteus (Vulgaris), Sepia, Silicea, Alloxanum, Corticotropin Releasing Hormone, Adrenocorticotrophin, Aldosterone	LIQUID	ORAL	20190726		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALDOSTERONE; ALLOXAN; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; CORTICORELIN; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; IODINE; MELATONIN; PHOSPHORUS; POTASSIUM CARBONATE; PRASTERONE; PROTEUS VULGARIS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SILVER NITRATE; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND; TESTOSTERONE	15; 18; 12; 6; 12; 15; 8; 8; 6; 8; 12; 6; 8; 12; 12; 12; 6; 6; 8; 8; 8; 8	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Catecholamine [EPC], Catecholamines [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]	CIII	N	20241231
43742-1516_762c7ffb-6fc5-420f-972c-473a8169d92d	43742-1516	HUMAN OTC DRUG	Electrolyte Plus		Boron Citrate, Calcium Gluconate, Chromium Picolinate, Cobalt Gluconate, Copper Gluconate, Ferrous Muriaticum, Magnesium Gluconicum Dihydricum, Manganese Gluconate, Potassium Gluconate, Selenium Dioxide, Sodium Gluconate, Zincum Gluconicum, Kali Phosphoricum, Niccolum Metallicum, Vanadium Metallicum, Calcarea Phosphorica	LIQUID	ORAL	20190821	20270316	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BORON CITRATE; CALCIUM GLUCONATE; CHROMIUM PICOLINATE; COBALTOUS GLUCONATE; COPPER GLUCONATE; DIBASIC POTASSIUM PHOSPHATE; FERRIC CHLORIDE HEXAHYDRATE; MAGNESIUM GLUCONATE; MANGANESE GLUCONATE; NICKEL; POTASSIUM GLUCONATE; SELENIUM DIOXIDE; SODIUM GLUCONATE; TRIBASIC CALCIUM PHOSPHATE; VANADIUM; ZINC GLUCONATE	6; 6; 6; 6; 6; 8; 6; 6; 6; 8; 6; 6; 6; 9; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Iron [CS], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43742-1517_f6f02673-27e8-49d1-87db-7957f5f6cd63	43742-1517	HUMAN OTC DRUG	Epstein-Barr Virus Homochord		Epstein-Barr Virus Nosode	LIQUID	ORAL	20190821	20250714	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN HERPESVIRUS 4	15	[hp_C]/mL			N	
43742-1518_f36422e3-26c6-4973-a5b7-b7367504e7b1	43742-1518	HUMAN OTC DRUG	Hormone Combination		Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo- Dehydroepiandrosterone 3-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating Hormone	LIQUID	ORAL	20190821		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	7-KETO-DEHYDROEPIANDROSTERONE; ACETALDEHYDE; ALDOSTERONE; ANDROSTERONE; CHOLESTEROL; CORTISONE ACETATE; DOPAMINE HYDROCHLORIDE; ESTRONE; FOLLITROPIN; PRASTERONE; PROGESTERONE; SUS SCROFA OVARY; TESTOSTERONE	6; 6; 12; 12; 8; 12; 6; 8; 12; 6; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Catecholamine [EPC], Catecholamines [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Gonadotropin [EPC], Gonadotropins [CS], Progesterone [CS], Progesterone [EPC]	CIII	N	20241231
43742-1519_76e2840c-42f0-4d67-a8a9-450ddba89bdf	43742-1519	HUMAN OTC DRUG	Kidney/Bladder Support		Equisetum Hyemale, Solidago Virgaurea, Cantharis, Kidney (Suis), Berberis Vulgaris, Calcarea Carbonica, Terebinthina, Apis Mellifica, Pulsatilla (Pratensis), Sepia, Staphysagria	LIQUID	ORAL	20190821		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; DELPHINIUM STAPHISAGRIA SEED; EQUISETUM HYEMALE; LYTTA VESICATORIA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK KIDNEY; SEPIA OFFICINALIS JUICE; SOLIDAGO VIRGAUREA FLOWERING TOP; TURPENTINE OIL	30; 30; 12; 30; 3; 8; 12; 8; 30; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1520_7f8ff591-2863-4069-a48a-74bfe770d510	43742-1520	HUMAN OTC DRUG	Coxsackie Homochord		Coxsackie Nosode A2, Coxsackie Nosode A7, Coxsackie Nosode B1, Coxsackie Nosode B3, Coxsackie Nosode B4	LIQUID	ORAL	20190821	20241126	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4	15; 45; 15; 15; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43742-1521_5fbbd815-8b11-473f-bc3f-8dca5806811d	43742-1521	HUMAN OTC DRUG	Governing Vessel Conception Vessel Meridian Opener		Apis Mellifica, Arsenicum Album, Baryta Carbonica, Calcarea Carbonica, Cicuta Virosa, Conium Maculatum, Ferrum Metallicum, Lachesis Mutus, Lycopodium Clavatum, Mercurius Solubilis, Natrum Sulphuricum, Phosphorus, Pulsatilla (Pratensis), Sepia, Tarentula Hispana, Thuja Occidentalis	LIQUID	ORAL	20190821		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; APIS MELLIFERA; ARSENIC TRIOXIDE; BARIUM CARBONATE; CICUTA VIROSA ROOT; CONIUM MACULATUM FLOWERING TOP; IRON; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SEPIA OFFICINALIS JUICE; SODIUM SULFATE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1523_ab3059bc-b78a-48e0-82c2-aacf15e96e46	43742-1523	HUMAN OTC DRUG	Dental Pain		Aceticum Acidum, Calendula Officinalis, Zingiber Officinale, Bryonia (Alba), Coffea Tosta, Ledum Palustre, Phosphorus, Plantago Major, Spigelia Anthelmia, Arnica Montana, Chamomilla, Hepar Sulphuris Calcareum, Hypericum Perforatum, Aconitum Napellus, Antimonium Crudum, Mezereum, Sepia, Staphysagria, Magnesia Phosphorica	LIQUID	ORAL	20190821		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ACONITUM NAPELLUS; ANTIMONY TRISULFIDE; ARNICA MONTANA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COFFEA ARABICA SEED, ROASTED; DAPHNE MEZEREUM BARK; DELPHINIUM STAPHISAGRIA SEED; GINGER; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; PHOSPHORUS; PLANTAGO MAJOR; RHODODENDRON TOMENTOSUM LEAFY TWIG; SEPIA OFFICINALIS JUICE; SPIGELIA ANTHELMIA	3; 12; 12; 6; 6; 8; 3; 6; 12; 12; 3; 8; 12; 6; 6; 6; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1526_e97db930-bb7d-4f17-81a2-099c2bca27c0	43742-1526	HUMAN OTC DRUG	Immune Support		Echinacea (Angustifolia), Arnica Montana, Baptisia Tinctoria, Sanguinaria Canadensis, Aristolochia Clematitis, Eupatorium Perfoliatum, Euphorbium Officinarum, Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Mercurius Corrosivus, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhus Tox, Sulphur, Thuja Occidentalis, Hepar Sulphuris Calcareum, Lachesis Mutus, Zincum Metallicum, Astragalus Menziesii, Influenzinum (2018-2019), Spleen (Suis), Thymus (Suis)	LIQUID	ORAL	20190821	20250316	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANEMONE PRATENSIS; ARISTOLOCHIA CLEMATITIS ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; ASTRAGALUS PROPINQUUS ROOT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; SULFUR; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP; ZINC	8; 8; 6; 4; 8; 12; 4; 8; 10; 13; 1; 6; 6; 8; 12; 12; 12; 12; 10; 8; 8; 8; 200; 4; 8; 8; 12; 12; 8; 8; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
43742-1527_ad3a2809-fa06-48ee-bb3c-d871ea7d81cc	43742-1527	HUMAN OTC DRUG	Virus Combination		Influenzinum (2018-2019), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode	LIQUID	ORAL	20190821	20250710	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12; 12	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1528_62ef0b17-9730-4347-95b0-cd5842435ad8	43742-1528	HUMAN OTC DRUG	Amoeba		Baptisia Tinctoria, Cajuputum, Capsicum Annuum, Fragaria Vesca, Hamamelis Virginiana, Quassia (Amara), Senna (Cassia Angustifolia), Hydrastis Canadensis, Ipecacuanha, Hepar Suis, Pancreas Suis, Spleen (Suis), Cinchona Officinalis, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Selenium Metallicum, Blastocystis Hominis, Cryptosporidium Parvum, Giardia Lamblia, Entamoeba Histolytica, Brugia Malayi	LIQUID	ORAL	20190821	20240821	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALPINE STRAWBERRY; BAPTISIA TINCTORIA ROOT; BLASTOCYSTIS HOMINIS; BRUGIA MALAYI; CAJUPUT OIL; CAPSICUM; CINCHONA OFFICINALIS BARK; CRYPTOSPORIDIUM PARVUM; ENTAMOEBA HISTOLYTICA; GIARDIA LAMBLIA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; IPECAC; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PORK LIVER; QUASSIA AMARA WOOD; SELENIUM; SENNA LEAF; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN	3; 3; 12; 39; 3; 3; 12; 12; 18; 12; 6; 3; 6; 12; 12; 12; 8; 3; 12; 3; 12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-1529_ba3ba8fa-182f-4597-9a9c-b33399a13626	43742-1529	HUMAN OTC DRUG	Asthma Plus		Ribes Nigrum, Viburnum Opulus, Quebracho, Blatta Orientalis, Pothos Foetidus, Cinnamic Acid, Gallicum Acidum, Indolum, Quercetin, Rutin, Arsenicum Iodatum, Naphthalinum, Coumarinum, House Dust Mite, Oxygenium, Malvin	LIQUID	ORAL	20190905	20250908	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIIODIDE; BLATTA ORIENTALIS; CINNAMIC ACID; COUMARIN; DERMATOPHAGOIDES FARINAE; GALLIC ACID; INDOLE; MALVIN; NAPHTHALENE; OXYGEN; QUEBRACHO BARK; QUERCETIN; RIBES NIGRUM LEAF; RUTIN; SYMPLOCARPUS FOETIDUS ROOT; VIBURNUM OPULUS BARK	8; 6; 6; 8; 9; 6; 6; 12; 8; 12; 5; 6; 3; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	
43742-1531_cfaaa754-08a4-4cf8-9495-bbbadf298e60	43742-1531	HUMAN OTC DRUG	Professional Weight Support		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Gambogia, Graphites, Nux Vomica, Phytolacca Decandra, 7-Oxo-Dehydroepiandrosterone 3-Acetate, Adenosinum Triphosphoricum Dinatrum, Insulinum (Suis), Pancreas Suis, Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20190822		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS	30; 30; 6; 6; 12; 12; 30; 30; 8; 12; 8; 8; 30; 12; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1532_64bdbe6d-0a39-4b25-9f33-6ce4c8742428	43742-1532	HUMAN OTC DRUG	Systemic Drainage		Alfalfa, Avena Sativa, Citrus Limonum, Glycyrrhiza Glabra, Uva-Ursi, Taraxacum Officinale, Galium Aparine, Schisandra Chinensis, Solidago Virgaurea, Tabacum, Berberis Vulgaris, Chelidonium Majus, Hepar Suis, Intestine (Suis), Kidney (Suis), Lung (Suis), Lymph Node (Suis), Magnesium Gluconate, Potassium Gluconate, Zincum Gluconicum, Nux Vomica, Sarcolacticum Acidum, Lacticum Acidum, Tylophora Asthmatica	LIQUID	ORAL	20191009		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS WHOLE; GALIUM APARINE WHOLE; GLYCYRRHIZA GLABRA; LACTIC ACID, DL-; LACTIC ACID, L-; LEMON JUICE; MAGNESIUM GLUCONATE; MEDICAGO SATIVA WHOLE; PORK INTESTINE; PORK KIDNEY; PORK LIVER; POTASSIUM GLUCONATE; SCHISANDRA CHINENSIS FRUIT; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LUNG; SUS SCROFA LYMPH; TARAXACUM OFFICINALE; TOBACCO LEAF; TYLOPHORA INDICA LEAF; ZINC GLUCONATE	1; 1; 6; 6; 3; 1; 12; 8; 1; 6; 1; 6; 6; 6; 6; 3; 3; 8; 6; 6; 2; 4; 16; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1534_cfe44bd2-bd78-4987-803a-b2f3b70d9ffe	43742-1534	HUMAN OTC DRUG	Appetite Control		Adenosinum Triphosphoricum Dinatrum, Adrenal Cortex (Suis), Bacopa Speciosa, Equol, Pantothenic Acid, Gambogia, Oxytocin, Rhodiola, Stomach (Suis), Chininum Sulphuricum, Iodium, Lycopodium Clavatum, Phosphorus, Dopamine Hydrochloride, Thyroidinum (Suis), Cina, Serotonin (Hydrochloride), Morgan Gaertner	LIQUID	ORAL	20190822	20280512	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARTEMISIA CINA PRE-FLOWERING TOP; BACOPA MONNIERI WHOLE; DOPAMINE HYDROCHLORIDE; EQUOL, (+/-)-; GAMBOGE; IODINE; LYCOPODIUM CLAVATUM SPORE; OXYTOCIN; PANTOTHENIC ACID; PHOSPHORUS; QUININE SULFATE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEDUM ROSEUM ROOT; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL CORTEX; SUS SCROFA STOMACH; THYROID	6; 8; 6; 8; 6; 14; 6; 6; 12; 6; 6; 6; 30; 6; 8; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	
43742-1535_89f9a0e3-575a-4cb3-ac45-328a64d3f02d	43742-1535	HUMAN OTC DRUG	Leaky Gut Formula		Alfalfa, Glycyrrhiza Glabra, Aloe, Astacus Fluviatilis, Berberis Aquifolium, Lac Defloratum, Natrum Carbonicum, Saccharum Officinale, Fel Tauri, Pancreas Suis, Pancreatinum, Fragaria Vesca, Antimonium Crudum, Carbo Vegetabilis, Euphorbium Officinarum, Lycopodium Clavatum, Magnesia Carbonica, Zincum Metallicum, Colibacillinum Cum Natrum Muriaticum, Proteus (Vulgaris)	LIQUID	ORAL	20190822	20250505	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALFALFA; ALOE; ALPINE STRAWBERRY; ANTIMONY TRISULFIDE; ASTACUS ASTACUS; BERBERIS AQUIFOLIUM ROOT BARK; BOS TAURUS BILE; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; PANCRELIPASE; PROTEUS VULGARIS; SKIM MILK; SODIUM CARBONATE; SUCROSE; SUS SCROFA PANCREAS; ZINC	12; 3; 4; 9; 12; 6; 6; 8; 15; 12; 3; 12; 12; 8; 15; 6; 6; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1536_455f9f60-73b4-4da6-9604-efa303637ed4	43742-1536	HUMAN OTC DRUG	Trauma Remedy		Chamomilla, Echinacea (Angustifolia), Hamamelis Virginiana, Hypericum Perforatum, Millefolium, Calendula Officinalis, Arnica Montana, Bellis Perennis, Rhus Tox, Bryonia (Alba), Clematis Vitalba, Folia, Hepar Sulphuris Calcareum, Ornithogalum Umbellatum, Prunus Cerasifera, Flos, Carbo Vegetabilis	LIQUID	ORAL	20190822		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS VITALBA TOP; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; ORNITHOGALUM UMBELLATUM; PRUNUS CERASIFERA FLOWER; TOXICODENDRON PUBESCENS LEAF	3; 12; 4; 6; 8; 8; 4; 8; 3; 3; 3; 3; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1537_befa1fe4-ae5b-452b-8744-13b61b162b2d	43742-1537	HUMAN OTC DRUG	Liver Drainage		Chelidonium Majus, Carduus Marianus, Schisandra Chinensis, Taraxacum Officinale, Berberis Vulgaris, Neopicrorhiza Scrophulariiflora, Raphanus Sativus, Viscum Album, Chromium Picolinate, Cobalt Gluconate, Copper Gluconate, Magnesium Gluconate, Natrum Sulphuricum, Ptelea Trifoliate, Sarcolacticum Acidum, Sulphur Iodatum, Carbolicum Acidum, Cichorium Intybus, Flos, Gallbladder (Suis), Hepar Suis, Nux Vomica, Pancreas Suis, Vanadium Metallicum, Verbena Officinalis, Flos	LIQUID	ORAL	20190822	20260401	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CHROMIUM PICOLINATE; CICHORIUM INTYBUS FLOWER; COBALTOUS GLUCONATE; COPPER GLUCONATE; LACTIC ACID, L-; MAGNESIUM GLUCONATE; MILK THISTLE; NEOPICRORHIZA SCROPHULARIIFLORA ROOT; PHENOL; PORK LIVER; PTELEA TRIFOLIATA BARK; RADISH; SCHISANDRA CHINENSIS FRUIT; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; SUS SCROFA GALLBLADDER; SUS SCROFA PANCREAS; TARAXACUM OFFICINALE; VANADIUM; VERBENA OFFICINALIS FLOWERING TOP; VISCUM ALBUM FRUITING TOP	3; 1; 6; 8; 6; 6; 6; 6; 2; 3; 8; 8; 6; 3; 2; 6; 8; 6; 8; 8; 2; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	
43742-1538_856999a7-1fb9-4bcf-91e0-de26fdf00d49	43742-1538	HUMAN OTC DRUG	Skin Infections		Echinacea (Angustifolia), Phytolacca Decandra, Hepar Sulphuris Calcareum, Mercurius Solubilis, Mezereum, Ailanthus Glandulosus, Arsenicum Album, Lachesis Mutus, Herpes Simplex I and II Nosode, Herpes Zoster Nosode	LIQUID	ORAL	20190822		UNAPPROVED HOMEOPATHIC		Deseret Biologials, Inc.	AILANTHUS ALTISSIMA FLOWERING TWIG; ARSENIC TRIOXIDE; CALCIUM SULFIDE; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT	10; 12; 8; 9; 3; 15; 15; 15; 12; 8; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1540_5f7c5244-5005-4d78-bbc1-8f414a8d5b11	43742-1540	HUMAN OTC DRUG	SinusitX		Plantago Major, Pulsatilla (Pratensis), Luffa Operculata, Mercurius Iodatus Ruber, Mucosa Nasalis Suis, Euphorbium Officinarum, Argentum Nitricum, Hepar Sulphuris Calcareum, Calcarea Carbonica, Natrum Muriaticum, Sinusitisinum	LIQUID	ORAL	20190823	20250707	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; CALCIUM SULFIDE; EUPHORBIA RESINIFERA RESIN; LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PLANTAGO MAJOR; SILVER NITRATE; SINUSITISINUM; SODIUM CHLORIDE; SUS SCROFA NASAL MUCOSA	4; 10; 9; 6; 8; 12; 3; 10; 20; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1542_9cb3ba5e-5f2e-4ac2-a1b3-e7ae2ec8d570	43742-1542	HUMAN OTC DRUG	HHV-6 Homochord		Human Herpesvirus 6A, 6B	LIQUID	ORAL	20190823	20250721	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN HERPESVIRUS 6	15	[hp_X]/mL			N	
43742-1543_b827d18a-5d52-41aa-b494-934ccca69c28	43742-1543	HUMAN OTC DRUG	Anaplasma Homochord		Anaplasma Phagocytophilum	LIQUID	ORAL	20190823	20250609	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANAPLASMA PHAGOCYTOPHILUM	15	[hp_X]/mL			N	
43742-1548_c473cde6-2737-4dcd-b07f-f2e10b56d29e	43742-1548	HUMAN OTC DRUG	Pest and Dustmite Formula		Amyl Nitrosum, Euphrasia Officinalis, Kali Muriaticum, Wyethia Helenoides, Histaminum Hydrochloricum, Lac Caninum, Glandula Suprarenalis Suis, Mucosa Nasalis Suis, Allium Cepa, Arsenicum Album, Blatta Americana, Iridium Metallicum, Sabadilla, Selenium Metallicum, Lac Felinum, Hyaluronidase, Interferon (Suis), Serotonin (Hydrochloride), House Dust Mite	LIQUID	ORAL	20190919		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMYL NITRITE; ARSENIC TRIOXIDE; CANIS LUPUS FAMILIARIS MILK; DERMATOPHAGOIDES FARINAE; EUPHRASIA STRICTA; FELIS CATUS MILK; HISTAMINE DIHYDROCHLORIDE; HYALURONIDASE; INTERFERON .GAMMA. PORCINE RECOMBINANT; IRIDIUM; ONION; PERIPLANETA AMERICANA; POTASSIUM CHLORIDE; SCHOENOCAULON OFFICINALE SEED; SELENIUM; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA NASAL MUCOSA; WYETHIA HELENIOIDES ROOT	6; 12; 6; 9; 6; 12; 6; 30; 30; 12; 12; 12; 6; 12; 12; 30; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Endoglycosidase [EPC], Glycoside Hydrolases [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Insect Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43742-1553_cb398267-797d-4d35-b226-e401a98932fb	43742-1553	HUMAN OTC DRUG	Reflux		Adenosinum Triphosphoricum Dinatrum, Nadidum, Argentum Nitricum, Ipecacuanha, Robinia Pseudoacacia, Sulphur, Origanum Vulgare, Duodenum (Suis), Esophagus (Suis), Funiculus Umbilicalis Suis, Stomach (Suis), Nux Vomica, Coumarinum, Erythraea Centaurium, Pancreatinum, Muriaticum Acidum, Citricum Acidum, Formicum Acidum, Sarcolacticum Acidum, Coenzyme A, Proteus (Morgani)	LIQUID	ORAL	20190827	20240827	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS CITRIC ACID; CENTAURIUM ERYTHRAEA; COENZYME A; COUMARIN; FORMIC ACID; HYDROCHLORIC ACID; IPECAC; LACTIC ACID, L-; NADIDE; OREGANO; PANCRELIPASE; PROTEUS MORGANII; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA STOMACH; SUS SCROFA UMBILICAL CORD	6; 6; 10; 8; 8; 6; 6; 6; 6; 6; 6; 12; 30; 6; 6; 8; 6; 8; 8; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1554_65029079-7bf1-4ffc-86cf-bba25e3baa7f	43742-1554	HUMAN OTC DRUG	Vascuflow		Melatonin, L-Arginine, L-Citrulline, Ubidecarenonum, Squalene, Calcarea Carbonica, Cholesterinum, Coumarinum, Formalinum, Gelsemium Sempervirens, Alpha-Lipoicum Acidum, Mercurius Corrosivus, Plumbum Metallicum, Pantothenic Acid, Glonoinum, Lycopodium Clavatum, Phosphorus, Berberis Vulgaris, Red Yeast Rice, Nitric Oxide, Proteus (Morgani), Rhus Tox	LIQUID	ORAL	20190906		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARGININE; BERBERIS VULGARIS ROOT BARK; CHOLESTEROL; CITRULLINE; COUMARIN; FORMALDEHYDE; GELSEMIUM SEMPERVIRENS ROOT; LEAD; LYCOPODIUM CLAVATUM SPORE; MELATONIN; MERCURIC CHLORIDE; NITRIC OXIDE; NITROGLYCERIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PANTOTHENIC ACID; PHOSPHORUS; PROTEUS MORGANII; RED YEAST; SQUALENE; THIOCTIC ACID; TOXICODENDRON PUBESCENS LEAF; UBIDECARENONE	6; 8; 8; 6; 8; 8; 8; 8; 6; 6; 8; 12; 6; 8; 10; 6; 30; 8; 8; 8; 30; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE], Vasodilation [PE], Vasodilator [EPC]		N	20241231
43742-1555_0c1fe331-8dd8-478e-be44-0c709289a11a	43742-1555	HUMAN OTC DRUG	Systemic Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Sarsaparilla (Smilax Medica), Gelsemium Sempervirens, Veratrum Album, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Pratensis), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20190827	20240827	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; BETA VULGARIS; CHELIDONIUM MAJUS; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; SELENIUM; SMILAX ARISTOLOCHIIFOLIA ROOT; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	12; 3; 3; 8; 12; 12; 12; 3; 12; 6; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1557_cd79a505-a39c-4450-a6ed-1baa7ca401e4	43742-1557	HUMAN OTC DRUG	Bio Lymph Phase		Scrophularia Nodosa, Teucrium Scorodonia, Veronica Officinalis, Equisetum Hyemale, Fumaria Officinalis, Geranium Robertianum, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Gentiana Lutea, Juglans Regia, Aranea Diadema, Sarsaparilla (Smilax Medica), Ascorbicum Acidum, Quercetin, Myosotis Arvensis, Calcarea Phosphorica, Ferrum Iodatum, Thyroidinum (Suis), Gaertner Bacillus	LIQUID	ORAL	20190905	20240905	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARANEUS DIADEMATUS; ASCORBIC ACID; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; QUERCETIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SCROPHULARIA NODOSA; SMILAX ARISTOLOCHIIFOLIA ROOT; SODIUM SULFATE; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	6; 6; 4; 12; 4; 5; 4; 5; 5; 9; 4; 4; 6; 30; 3; 6; 4; 12; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Vitamin C [EPC]		N	
43742-1558_4be4bd6f-aa0b-46e1-8e57-ba38a4fb86e1	43742-1558	HUMAN OTC DRUG	Addiclenz		Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Bisphenol A, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Phosphoricum Acidum, Selenium Metallicum, Zincum Metallicum, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methyl Paraben, Propyl Paraben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum	LIQUID	ORAL	20190913	20261101	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BETA VULGARIS; BISPHENOL A; CHELIDONIUM MAJUS; COBALT; COPPER; FORMALDEHYDE; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE	12; 30; 30; 3; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43742-1559_def6ff1e-b69f-4ee4-a9b9-f4bcd8266597	43742-1559	HUMAN OTC DRUG	Influenza Plus		Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Influenzinum 2018-2019, Adenoviren Nosode, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20190910	20240912	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 9; 9; 8; 8; 8; 8; 3; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1560_6b4cd44a-756d-4d79-99a0-5e75a8a83585	43742-1560	HUMAN OTC DRUG	Enviro	I	Potassium Gluconate, Glandula Suprarenalis Suis, Hepar Suis, Coffea Tosta, Thea Sinensis, Carbo Vegetabilis, Ferrum Iodatum, Ferrum Metallicum, Gelsemium Sempervirens, Iodium, Iridium Metallicum, Lycopodium Clavatum, Pulsatilla (Vulgaris), Selenium Metallicum, Zincum Metallicum, Peanut, Black Walnut, English Walnut, Almond, Cashew, Coconut, Pecan, Brazil Nut, Tomato, Potato, Black Pepper, Eggplant, Rape Seed Oil, Sesame, Seed, Cheese (Stilton), Lac Vaccinum, Beef, Lamb, Pork, Chicken, Egg (Whole), Phaseolus	LIQUID	ORAL	20190905	20240912	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALMOND; ANEMONE PRATENSIS; APPLE; ATLANTIC COD; ATLANTIC SALMON; BANANA; BEEF; BLACK PEPPER; BLACK WALNUT; BRAZIL NUT; CANOLA OIL; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM ROQUEFORTI CULTURED, AGED; CASHEW; CHICKEN; COCOA; COCONUT; COFFEA ARABICA SEED, ROASTED; COMMON SHRIMP; CORTISONE ACETATE; COW MILK; EDIBLE ROCK CRAB; EGG; EGGPLANT; ENGLISH WALNUT; FERROUS IODIDE; FLAX SEED; GELSEMIUM SEMPERVIRENS ROOT; GREEN TEA LEAF; HISTAMINE DIHYDROCHLORIDE; HYALURONIDASE; INTERFERON .GAMMA. PORCINE RECOMBINANT; IODINE; IRIDIUM; IRON; KIDNEY BEAN; LAMB; LYCOPODIUM CLAVATUM SPORE; NORTHERN BLUEFIN TUNA; ONION; ORANGE; PACIFIC OYSTER; PEANUT; PECAN; PORK; PORK LIVER; POTASSIUM GLUCONATE; POTATO; SELENIUM; SEROTONIN HYDROCHLORIDE; SESAME SEED; STRAWBERRY; SUS SCROFA ADRENAL GLAND; TOMATO; WHEAT; ZINC	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 10; 12; 10; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 10; 30; 30; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 6; 12; 12; 30; 12; 12; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Endoglycosidase [EPC], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Glycoside Hydrolases [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Meat Proteins [EXT], Meat Proteins [EXT], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1561_5dac7e3b-f355-4eab-9550-9dc60f4a452a	43742-1561	HUMAN OTC DRUG	Free Radical		Alfalfa, Ascorbyl Palmitate, Cysteinum, Dimethyl Glycine, Fucus Vesiculosus, Hordeum Vulgare, L-Methionine, Manganese Gluconate, Nasturtium Aquaticum, Quercetin, Raphanus Sativus, Sodium Selenite, Triticum Aestivum, Ubidecarenonum, alpha-Lipoicum Acidum, GABA (Gamma Aminobutyric Acid), Oryza Sativa, Vitamin E, Zinc Picolinate, Cobaltum Metallicum, Ferrum Metallicum, Glutathione, Magnesium Fluoratum, Selenium Metallicum, Zincum Metallicum, alpha-Ketoglutaricum Acidum	LIQUID	ORAL	20190906		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; .ALPHA.-TOCOPHEROL; .GAMMA.-AMINOBUTYRIC ACID; ACETALDEHYDE; ALFALFA; ASCORBYL PALMITATE; BARLEY; COBALT; CYSTEINE; FUCUS VESICULOSUS; GLUTATHIONE; IRON; MAGNESIUM FLUORIDE; MANGANESE GLUCONATE; METHIONINE; N,N-DIMETHYLGLYCINE; NASTURTIUM OFFICINALE; ORYZA SATIVA WHOLE; QUERCETIN; RAPHANUS SATIVUS; SELENIUM; SODIUM SELENITE; UBIDECARENONE; WHEAT; ZINC; ZINC PICOLINATE	30; 8; 8; 8; 30; 6; 6; 6; 12; 6; 6; 12; 12; 12; 6; 6; 6; 6; 8; 6; 6; 12; 6; 6; 6; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43742-1562_b13c2a35-64eb-4147-9499-8b5fafef1602	43742-1562	HUMAN OTC DRUG	Lymph/Spleen Combo		Juniperus Communis, Quercus Glandium Spiritus, Myosotis Arvensis, Natrum Sulphuricum, Ceanothus Americanus, Helianthus Annuus, Natrum Muriaticum, Phytolacca Decandra, Lymph Node (Suis), Spleen (Suis), Thymus (Suis), Chininum Arsenicosum, Adenosinum Triphosphoricum Dinatrum, Ubidecarenonum, Ferrum Metallicum, Succinum, Castanea Vesca, Apis Mellifica	LIQUID	ORAL	20190911		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; AMBER; APIS MELLIFERA; CASTANEA SATIVA LEAF; CEANOTHUS AMERICANUS LEAF; HELIANTHUS ANNUUS FLOWERING TOP; IRON; JUNIPERUS COMMUNIS WHOLE; MYOSOTIS ARVENSIS; PHYTOLACCA AMERICANA ROOT; QUERCUS ROBUR NUT; QUININE ARSENATE; SODIUM CHLORIDE; SODIUM SULFATE; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; UBIDECARENONE	12; 30; 200; 4; 6; 12; 30; 3; 6; 8; 4; 8; 6; 6; 8; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1563_974da0ba-3093-4d24-8074-8ea54c4130e0	43742-1563	HUMAN OTC DRUG	HGH Vitality		Agnus Castus, Ambra Grisea, Petroselinum Sativum, Estradiol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone,	LIQUID	ORAL	20190919	20250904	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-LIPOIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; CHASTE TREE; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 14; 8; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
43742-1564_d83c0ba4-7829-482a-a764-fd9d150298d7	43742-1564	HUMAN PRESCRIPTION DRUG	Kidney Drainage		Solidago Virgaurea, Asparagus Officinalis, Juniperus Communis, Sabal Serrulata, Uva-Ursi, Berberis Vulgaris, Equisetum Arvense, Urtica Dioica, Rubia Tinctorum, Staphysagria, Cantharis, Fagus Sylvatica, Flos, Glandula Suprarenalis Suis, Hepar Sulphuris Calcareum, Kidney (Suis), Larix Decidua, Flos, Manganum Metallicum, Mimulus Guttatus, Flos, Nitricum Acidum, Rhus Aromatica, Silicea, Ulex Europaeus, Flos, Benzoicum Acidum, Cobaltum Metallicum	LIQUID	ORAL	20190917	20280215	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; ASPARAGUS; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; COBALT; DELPHINIUM STAPHISAGRIA SEED; EQUISETUM ARVENSE TOP; FAGUS SYLVATICA FLOWERING TOP; JUNIPERUS COMMUNIS WHOLE; LARIX DECIDUA FLOWERING TOP; LYTTA VESICATORIA; MANGANESE; MIMULUS GUTTATUS FLOWERING TOP; NITRIC ACID; PORK KIDNEY; RHUS AROMATICA ROOT BARK; RUBIA TINCTORUM ROOT; SAW PALMETTO; SILICON DIOXIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; ULEX EUROPAEUS FLOWER; URTICA DIOICA	2; 2; 12; 3; 8; 16; 6; 3; 8; 2; 8; 8; 8; 8; 8; 8; 8; 6; 2; 8; 1; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	
43742-1565_29d8f7b8-2070-4c00-8465-7dd27ea5e4c4	43742-1565	HUMAN OTC DRUG	Candida Spp		Alternaria Tenuis Nees, Aspergillus Niger, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Rhizopus Nigricans, Candida Krusei, Candida Tropicalis	LIQUID	ORAL	20190911	20250716	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS WHOLE; MUCOR RACEMOSUS; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE	12; 12; 15; 15; 31; 15; 16; 14; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-1566_fa7c29e7-20b8-4b99-a017-c300e9c502ae	43742-1566	HUMAN OTC DRUG	Glucoreg		Ascorbicum Acidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, DHEA (Dehydroepiandrosterone), Phloridzinum, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Citricum Acidum, Fumaricum Acidum, Nadidum, Pantothenic Acid, Acetaldehyde, Insulinum (Suis), Insulinum (Human), Hepar Suis, Pancreas Suis, Phloridzinum, Baryta Oxalica, Alloxanum, Berberis Vulgaris, Carcinosin, Lycopodium Clavatum, Momordica Balsamina, Phosphoricum Acidum, Phosphorus,	LIQUID	ORAL	20190924	20270712	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; ADENOSINE TRIPHOSPHATE DISODIUM; ALLOXAN; ANHYDROUS CITRIC ACID; ASCORBIC ACID; BARIUM OXALATE; BERBERIS VULGARIS ROOT BARK; FUMARIC ACID; GYMNEMA SYLVESTRE LEAF; HUMAN BREAST TUMOR CELL; INSULIN HUMAN; INSULIN PORK; LACTIC ACID, L-; LYCOPODIUM CLAVATUM SPORE; MOMORDICA BALSAMINA IMMATURE FRUIT; NADIDE; PANTOTHENIC ACID; PHLORIZIN; PHOSPHORIC ACID; PHOSPHORUS; PORK LIVER; PRASTERONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SUS SCROFA PANCREAS; SYZYGIUM CUMINI SEED; THIAMINE HYDROCHLORIDE; THIOCTIC ACID; TRIGONELLA FOENUM-GRAECUM WHOLE	8; 8; 6; 8; 6; 6; 6; 8; 30; 6; 12; 8; 6; 6; 6; 8; 8; 16; 6; 6; 10; 6; 6; 6; 30; 10; 6; 6; 8; 30	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Acidifying Activity [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Insulin [CS], Insulin [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	
43742-1567_a3f530e2-965c-440c-b88d-08b2c107fa9c	43742-1567	HUMAN OTC DRUG	Viracomp		Allium Sativum, Echinacea (Angustifolia), Ginkgo Biloba, Viscum Album, Hamamelis Virginiana, Aconitum Napellus, Allium Cepa, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Gelsemium Sempervirens, Mercurius Vivus, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Influenzinum, Morbillinum	LIQUID	ORAL	20200103	20250513	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); MEASLES VIRUS; MERCURY; ONION; SELENIUM; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 3; 3; 12; 3; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-1569_155ae77e-7cc7-435b-a101-6ac691a76e75	43742-1569	HUMAN OTC DRUG	Ileocecal Valve Support		Iodium, Hypophysis Suis, Thyroidinum, (Suis), Glandula Suprarenalis Suis, Fel Tauri, Taraxacum Officinale, Bryonia (Alba), Carbo Vegetabilis, Colocynthis, Indolum, Lycopodium Clavatum, Mercurius Corrosivus, Nux Vomica, Phosphorus, Pulsatilla (Pratensis)	LIQUID	ORAL	20191002		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; BOS TAURUS BILE; BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; INDOLE; IODINE; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; PHOSPHORUS; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; TARAXACUM OFFICINALE	30; 12; 30; 30; 30; 6; 30; 30; 30; 30; 30; 10; 8; 8; 12	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1570_47984cbf-e26a-429c-be77-cef142d81610	43742-1570	HUMAN OTC DRUG	Co-InfXn		Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Mycoplasma Pneumoniae, Morbillinum, Meningococcus Nosode, Hepatitis B Nosode	LIQUID	ORAL	20191002	20250909	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANAPLASMA PHAGOCYTOPHILUM; BABESIA MICROTI; BARTONELLA HENSELAE; BORRELIA BURGDORFERI; EHRLICHIA CANIS; HEPATITIS B VIRUS; MEASLES VIRUS; MYCOPLASMA PNEUMONIAE; NEISSERIA MENINGITIDIS	15; 15; 15; 15; 15; 15; 16; 15; 27	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-1571_e45bddcb-4ec3-4ce8-b545-6958869e3a18	43742-1571	HUMAN OTC DRUG	Enviroclenz		Berberis Vulgaris, Carduus Marianus, Chelidonium Majus, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Stillingia Sylvatica, Taraxacum Officinale, Trifolium Pratense, Germanium Sesquioxide, Phytolacca Decandra, Acetone, Ammonium Muriaticum, Benzinum, Propylene Glycol, Sodium Lauryl Sulfate, Sodium Tripolyphosphate, Terebinthina, Methanol, Chlorinum, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum	LIQUID	ORAL	20190927		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETONE; AMMONIUM CHLORIDE; ARCTIUM LAPPA ROOT; BENZENE; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CHLORINE; FRANGULA ALNUS BARK; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; METHYL ALCOHOL; MILK THISTLE; NITRIC ACID; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PROPYLENE GLYCOL; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE FLOWERING TOP; TRIFOLIUM PRATENSE LEAF; TURPENTINE OIL	9; 9; 3; 9; 3; 3; 10; 3; 8; 3; 12; 12; 9; 3; 12; 12; 8; 9; 9; 9; 3; 12; 3; 3; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1572_705ea4de-1ae7-4ce3-92eb-c911cfef6f71	43742-1572	HUMAN OTC DRUG	Stomach Spleen Meridian Opener		Arsenicum Album, Calcarea Carbonica, Carduus Marianus, Ceanothus Americanus, Cinchona Officinalis, Digitalis Purpurea, Ignatia Amara, Kali Bichromicum, Lycopodium Clavatum, Phosphorus, Plumbum Metallicum, Pulsatilla (Pratensis), Ranunculus Bulbosus, Veratrum Viride	LIQUID	ORAL	20191007		UNAPPROVED HOMEOPATHIC		Desert Biologicals, Inc.	ANEMONE PRATENSIS; ARSENIC TRIOXIDE; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; DIGITALIS; LEAD; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM DICHROMATE; RANUNCULUS BULBOSUS; SILYBUM MARIANUM SEED; STRYCHNOS IGNATII SEED; VERATRUM VIRIDE ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43742-1573_df0ef2a8-5436-4bed-ba84-b63c806f84bf	43742-1573	HUMAN OTC DRUG	Heart Small Intestine Meridian Opener		Arsenicum Album, Aurum Metallicum, Belladonna, Cactus Grandiflorus, Cinchona Officinalis, Digitalis Purpurea, Kali Carbonicum, Lithium Carbonicum, Lycopodium Clavatum, Mercurius Solubilis, Naja Tripudians, Nux Vomica, Phosphorus, Pulsatilla (Pratensis), Pyrogenium, Spigelia Anthelmia	LIQUID	ORAL	20191004		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CINCHONA OFFICINALIS BARK; DIGITALIS; GOLD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NAJA NAJA VENOM; PHOSPHORUS; POTASSIUM CARBONATE; RANCID BEEF; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43742-1574_69ab26b2-6adc-4e7e-a7df-ffef3fcf3e88	43742-1574	HUMAN OTC DRUG	Vax Reaction		Thuja Occidentalis, Mezereum, Silicea, Calcarea Carbonica, Morbillinum, Parotidinum, Pertussinum, Poliomyelitis Nosode, Rubella Nosode, Tetanus Toxin, Carcinosin, Antimonium Crudum, Ledum Palustre, Thimerosal, Poliomyelitis Nosode	LIQUID	ORAL	20191004	20250921	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY TRISULFIDE; BORDETELLA PERTUSSIS; CLOSTRIDIUM TETANI; DAPHNE MEZEREUM BARK; HUMAN BREAST TUMOR CELL; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MUMPS VIRUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POLIOVIRUS; RUBELLA VIRUS; SILICON DIOXIDE; THIMEROSAL; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 8; 15; 30; 30; 30; 30; 30; 30; 8; 30; 6	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	
43742-1575_1c3d5284-5fa2-4fa0-bab7-d522ff61b56e	43742-1575	HUMAN OTC DRUG	FNG		Berberis Vulgaris, Cochlearia Armoracia, Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Suis, Tabebuia Impetiginosa, Thymus (Suis), Formalinum, Carbolicum Acidum, Ferrum Metallicum, Iridium Metallicum, Lycopodium Clavatum, Phosphoricum Acidum, Pulsatilla (Prastensis), Selenium Metallicum, Zincum Metallicum, Adenosinum Triphosphoricum Dinatrum, Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Torula Cerevisiae,	LIQUID	ORAL	20191001	20241001	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ALTERNARIA ALTERNATA; ANEMONE PRATENSIS; ASPERGILLUS NIGER VAR. NIGER; BERBERIS VULGARIS ROOT BARK; BRUGIA MALAYI; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; FORMALDEHYDE; GOLDENSEAL; HORSERADISH; IRIDIUM; IRON; LACTIC ACID, L-; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; METHYLCOBALAMIN; MUCOR RACEMOSUS; MYRRH; PHENOL; PHOSPHORIC ACID; PROPOLIS WAX; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SELENIUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK; ZINC	12; 12; 12; 12; 3; 39; 12; 12; 3; 30; 8; 6; 3; 12; 12; 12; 3; 12; 12; 16; 3; 12; 12; 6; 14; 12; 12; 8; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	
43742-1579_a1663e3e-f20b-486d-a84b-ad32cff9f15d	43742-1579	HUMAN OTC DRUG	Metab		Ascorbicum Acidum, Cysteinum, Manganese Gluconate, alpha-Ketoglutaricum Acidum, Fumaricum Acidum, Germanium Sesquioxide, Iodium, Magnesium Metallicum, Natrum Oxalaceticum, Pulsatilla (Pratensis), Thyroidinum (Suis), Vanadium Metallicum	LIQUID	ORAL	20191007		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ANEMONE PRATENSIS; ASCORBIC ACID; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; IODINE; MAGNESIUM; MANGANESE GLUCONATE; OXOGLURIC ACID; SODIUM DIETHYL OXALACETATE; SUS SCROFA THYROID; VANADIUM	12; 6; 9; 12; 12; 12; 12; 10; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Vitamin C [EPC]		N	20241231
43742-1580_847dd29c-6db4-4ea8-9975-234cd267cf8b	43742-1580	HUMAN OTC DRUG	Petrochemical Detox		Chelidonium Majus, Taraxacum Officinale, Trifolium Pratense, Symphytum Officinale, Acetone, Sodium Tripolyphosphate, Propylene Glycol, Benzinum, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Arsenicum Album, Cadmium Sulphuratum, Gelsemium Sempervirens, Iridium Metallicum, Lycopodium Clavatum, Mercurius Solubilis, Nitricum Acidum, Nux Vomica, Petroleum, Phosphoricum Acidum, Platinum Metallicum, Latrodectus Mactans	LIQUID	ORAL	20191004		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETONE; AMMONIUM CHLORIDE; ARSENIC TRIOXIDE; BENZENE; CADMIUM SULFIDE; CHELIDONIUM MAJUS; COMFREY ROOT; GELSEMIUM SEMPERVIRENS ROOT; IRIDIUM; KEROSENE; LATRODECTUS MACTANS; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NITRIC ACID; PHOSPHORIC ACID; PLATINUM; PROPYLENE GLYCOL; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; TURPENTINE OIL	9; 12; 12; 12; 12; 3; 6; 12; 12; 12; 15; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-1581_adaab137-4604-4aec-8191-d7a2a3fb2b4c	43742-1581	HUMAN OTC DRUG	Sugar and Food Additive Allergen Mix		Cinnamic Acid, Aspartame, Ileum (Suis), Jejunum (Suis), Stomach (Suis), Phloridzinum, Adenosinum Triphosphoricum Dinatrum, Argentum Nitricum, Fructose, Glucose, Lycopodium Clavatum, Saccharum Lactis, Saccharum Officinale, Sarcolacticum Acidum, High Fructose Corn Syrup, Malvin, Adrenocorticotrophin, Dysentery Bacillus, Maple Sugar, Morgan Gaertner	LIQUID	ORAL	20191004	20250616	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACER SACCHARUM SAP; ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS DEXTROSE; ASPARTAME; CINNAMIC ACID; CORTICOTROPIN; FRUCTOSE; HIGH FRUCTOSE CORN SYRUP; LACTIC ACID, L-; LACTOSE; LYCOPODIUM CLAVATUM SPORE; MALVIN; PHLORIZIN; PROTEUS MORGANII; SHIGELLA DYSENTERIAE; SILVER NITRATE; SUCROSE; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA STOMACH	30; 6; 6; 6; 6; 16; 6; 9; 6; 6; 6; 15; 12; 30; 30; 6; 6; 8; 8; 8	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	
43742-1582_5d748510-05b1-4c04-9f4f-b99cb2850a5d	43742-1582	HUMAN OTC DRUG	Bio Lymph Phase		Scrophularia Nodosa, Teucrium Scorodonia, Veronica Officinalis, Equisetum Hyemale, Fumaria Officinalis, Geranium Robertianum, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Gentiana Lutea, Juglans Regia, Aranea Diadema, Sarsaparilla (Smilax Regelii), Ascorbicum Acidum, Quercetin, Myosotis Arvensis, Calcarea Phosphorica, Ferrum Iodatum, Thyroidinum (Suis), Gaertner Bacillus (Bach)	LIQUID	ORAL	20200114	20250102	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARANEUS DIADEMATUS; ASCORBIC ACID; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA LEAF; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; QUERCETIN; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; THYROID, PORCINE; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	6; 6; 4; 12; 4; 5; 4; 5; 9; 4; 4; 6; 30; 3; 6; 4; 3; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Vitamin C [EPC]		N	
43742-1584_60ebd336-8483-4ff3-8f68-5c92e432f64b	43742-1584	HUMAN OTC DRUG	Female Support		Chamomilla, Cimicifuga Racemosa, Helonias Dioica, Mentha Piperita, Senna (Cassia Angustifolia), Valeriana Officinalis, Viola Odorata, Agnus Castus, Ledum Palustre, Lilium Tigrinum, Staphysagria, Crocus Sativus, Hydrastis Canadensis, Cinchona Officinalis, Convallaria Majalis, Cyclamen Europaeum, Cinnamomum, Murex Purpurea, Naja Tripudians	LIQUID	ORAL	20191003	20250323	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BLACK COHOSH; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CINNAMON; CONVALLARIA MAJALIS; CYCLAMEN PURPURASCENS TUBER; DELPHINIUM STAPHISAGRIA SEED; GOLDENSEAL; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LEDUM PALUSTRE TWIG; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA RECUTITA; MENTHA PIPERITA; NAJA NAJA VENOM; SAFFRON; SENNA LEAF; VALERIAN; VIOLA ODORATA	3; 3; 4; 8; 12; 8; 8; 4; 6; 12; 4; 4; 3; 3; 15; 6; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1585_4a0ff05b-b051-4fe0-8a3d-4eb136735a5c	43742-1585	HUMAN OTC DRUG	Gyno Complex		Viburnum Opulus, Magnesia Phosphorica, Folliculinum, Pulsatilla (Pratensis), Borax, Mercurius Solubilis, Nitricum Acidum, Silicea, Thuja Occidentalis	LIQUID	ORAL	20191010		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ANEMONE PRATENSIS; ESTRONE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; NITRIC ACID; SILICON DIOXIDE; SODIUM BORATE; THUJA OCCIDENTALIS LEAF; VIBURNUM OPULUS BARK	12; 12; 8; 30; 30; 30; 30; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1586_33825d85-931e-4e29-b472-7d7f367995bb	43742-1586	HUMAN OTC DRUG	Virus Combination		Influenzinum (2019-2020), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode	LIQUID	ORAL	20191025	20250908	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED)	33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1587_e357ad88-3b57-490f-bbc7-b425eb7ba9d7	43742-1587	HUMAN OTC DRUG	Bacteria Combination		Adenosinum Triphosphoricum Dinatrum, Malicum Acidum, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Cinnamic Acid, Petroselinum Sativum, Colibacillinum Cum Natrum Muriaticum, Echinacea (Angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (Mirabilis), Proteus (Vulgaris), Pseudomonas Aeruginosa, Salmonella Typhi Nosode, Enterococcus Faecalis, Streptococcus Mutans, Pneumococcinum, Streptococcus Agalactiae, Legionella Pneumophila, Listeria Monocytogenes, Dysentery Bacillus, Shigella Sonnei,	LIQUID	ORAL	20191118	20250720	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE PHOSPHATE DISODIUM; CINNAMIC ACID; ECHINACEA ANGUSTIFOLIA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HELICOBACTER PYLORI; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; MALIC ACID; MYCOPLASMA PNEUMONIAE; OROTIC ACID MONOHYDRATE; PETROSELINUM CRISPUM; PROTEUS MIRABILIS; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RIBOFLAVIN; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; SODIUM DIETHYL OXALACETATE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS UBERIS; STREPTOCOCCUS VIRIDANS GROUP	6; 6; 15; 13; 15; 15; 14; 14; 6; 15; 6; 6; 15; 30; 15; 15; 6; 17; 15; 15; 6; 14; 15; 15; 13; 13; 32; 38	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43742-1588_1f554240-5708-4fdb-8327-6b79edac2816	43742-1588	HUMAN OTC DRUG	Sore Throat		Scrophularia Nodosa, Teucrium Scorodonia, Veronica Officinalis, Equisetum Hyemale, Fumaria Officinalis, Geranium Robertianum, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Gentiana Lutea, Sarsaparilla (Smilax Regelii), Myosotis Arvensis, Aranea Diadema, Juglans Regia, Calcarea Phosphorica, Ferrum Iodatum, Lymph Nose (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20200319	20250128	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARANEUS DIADEMATUS; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA LYMPH; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	10; 4; 12; 4; 5; 4; 10; 10; 9; 4; 4; 3; 6; 4; 12; 12; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
43742-1589_7eb76642-9a9d-4b35-a5d1-aa5357e8f04a	43742-1589	HUMAN OTC DRUG	Dairy Allergen Mix		Adenosinum Triphosphoricum Dinatrum, Benzoicum Acidum, Cholinum, Cinnamic Acid, Eugenol, Folic Acid, Formalinum, Histaminum Hydrochloricum, L-Asparagine (Monohydrate), Lac Defloratum, Lac Vaccinum, Menadione, Oophorinum (Suis), Petroselinum Sativum, Phenyl Isothiocyanate, Quercetin, Rutin, Saccharum Lactis, Ileum (Suis), Jejunum (Suis), Stomach (Suis), Coumarinum, Folliculinum, GABA (Gamma-Aminobutyric Acid), Sarcolacticum Acidum, Lac Caninum, Lac Felinum, Lac Humanum, Piperine, Calcarea Carbonica,	LIQUID	ORAL	20191025		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACTIVATED CHARCOAL; ADENOSINE TRIPHOSPHATE DISODIUM; ASPARAGINE MONOHYDRATE; BENZOIC ACID; CALCIUM CITRATE; CALCIUM FLUORIDE; CALCIUM GLUCONATE; CANIS LUPUS FAMILIARIS MILK; CHOLINE HYDROXIDE; CINNAMIC ACID; COUMARIN; COW MILK; ESTRONE; EUGENOL; FELIS CATUS MILK; FOLIC ACID; FORMALDEHYDE; HISTAMINE DIHYDROCHLORIDE; HUMAN MILK; LACTIC ACID, L-; LACTOSE, UNSPECIFIED FORM; MATRICARIA RECUTITA; MENADIONE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PETROSELINUM CRISPUM; PHENYL ISOTHIOCYANATE; PIPERINE; QUERCETIN; RUTIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SKIM MILK; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA OVARY; SUS SCROFA STOMACH; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	8; 6; 4; 6; 6; 6; 6; 6; 30; 6; 6; 8; 6; 8; 6; 30; 6; 6; 6; 30; 8; 6; 6; 6; 6; 6; 6; 30; 6; 6; 6; 6; 8; 8; 6; 8; 6; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43742-1590_2e8667c9-13d9-4a4c-8ccb-4a1b5a04f89b	43742-1590	HUMAN OTC DRUG	Menopause Relief		Sanguinaria Canadensis, Sepia, Adenosinum Triphosphoricum Dinatrum, DIM (3, 3-Diindolymethane), Equol, Sulphur, Petroselinum Sativum, Bryonia (Alba), Ignatia Amara, Cedron, Lachesis Mutus, Stannum Metallicum, Faecalis (Alkaligenes)	LIQUID	ORAL	20191114		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	3,3'-DIINDOLYLMETHANE; ADENOSINE TRIPHOSPHATE DISODIUM; ALCALIGENES FAECALIS; BRYONIA ALBA ROOT; EQUOL, (-)-; LACHESIS MUTA VENOM; PETROSELINUM CRISPUM; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SIMABA CEDRON SEED; STRYCHNOS IGNATII SEED; SULFUR; TIN	6; 6; 30; 8; 6; 12; 6; 3; 4; 11; 8; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1591_85a49d35-eea9-4a19-b8b3-a125b6ed1f90	43742-1591	HUMAN OTC DRUG	Allermilk		Taraxacum Officinale, Hydrastis Canadensis, Benzoicum Acidum, Cholinum, Cinnamic Acid, Eugenol, Folic Acid, Histaminum Hydrochloricum, L-Asparagine (Monohydrate), Menadione, Oophorinum (Suis), Phenyl Isothiocyanate, Piperine, Progesterone, Quercetin, Rutin, Saccharum Lactis, Tyramine, Xanthine, Coumarinum, Folliculinum, Formalinum, GABA (Gamma-Aminobutyric Acid), Vanillylamine, Apiolum	LIQUID	ORAL	20191121		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; APIOLE (PARSLEY); ASPARAGINE; BENZOIC ACID; CHOLINE HYDROXIDE; CINNAMIC ACID; COUMARIN; ESTRONE; EUGENOL; FOLIC ACID; FORMALDEHYDE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; LACTOSE, UNSPECIFIED FORM; MENADIONE; PHENYL ISOTHIOCYANATE; PIPERINE; PROGESTERONE; QUERCETIN; RUTIN; SUS SCROFA OVARY; TARAXACUM OFFICINALE; TYRAMINE; VANILLYLAMINE; XANTHINE	8; 15; 6; 6; 6; 6; 8; 8; 6; 6; 8; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 3; 6; 16; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Progesterone [CS], Progesterone [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43742-1592_5acac7f9-80ab-4004-8630-94d404b63a8c	43742-1592	HUMAN OTC DRUG	Oral Health		Borax, Bryonia (Alba), Echinacea Purpurea, Juglans Cinerea, Kali Muriaticum, Magnesia Muriatica, Muriaticum Acidum, Discus Intervertebralis Suis, Oral Mucosa (Suis), Antimonium Crudum, Arsenicum Album, Bismuthum Subnitricum, Chamomilla, Cinchona Officinalis, Nux Moschata, Sambucus Nigra, Sepia, Mercurius Solubilis, Calcarea Phosphorica, Ignatia Amara, Oxygenium, Candida Albicans, Staphylococcus Aureus, Streptococcus Mutans	LIQUID	ORAL	20200219		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BISMUTH SUBNITRATE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CINCHONA OFFICINALIS BARK; ECHINACEA PURPUREA WHOLE; HYDROCHLORIC ACID; JUGLANS CINEREA BRANCH BARK/ROOT BARK; MAGNESIUM CHLORIDE; MATRICARIA CHAMOMILLA WHOLE; MERCURIUS SOLUBILIS; NUTMEG; OXYGEN; POTASSIUM CHLORIDE; SAMBUCUS NIGRA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SODIUM BORATE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS; STRYCHNOS IGNATII SEED; SUS SCROFA INTERVERTEBRAL DISC; SUS SCROFA ORAL MUCOSA; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 6; 16; 12; 6; 6; 6; 6; 12; 12; 12; 16; 6; 12; 12; 6; 12; 12; 12; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bismuth [CS], Bismuth [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1593_3974b578-f77d-45ca-876e-39adf452bacc	43742-1593	HUMAN OTC DRUG	NephroVesic		Uva-Ursi, Berberis Vulgaris, Chimaphila Umbellata, Equisetum Hyemale, Hydrangea Arborescens, Petroselinum Sativum, Cantharis, Ocimum Sanctum, Calcarea Carbonica, Apis Mellifica, Causticum, Lycopodium Clavatum, Mercurius Corrosivus, Nux Vomica, Pulsatilla (Pratensis), Terebinthina	LIQUID	ORAL	20191028	20241126	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; CAUSTICUM; CHIMAPHILA UMBELLATA; EQUISETUM HYEMALE; HYDRANGEA ARBORESCENS ROOT; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; MERCURIC CHLORIDE; OCIMUM TENUIFLORUM TOP; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PETROSELINUM CRISPUM; STRYCHNOS NUX-VOMICA SEED; TURPENTINE OIL	12; 12; 3; 6; 12; 6; 6; 6; 12; 6; 12; 10; 10; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1594_c6437bf9-4914-487a-864c-a2d82f04a365	43742-1594	HUMAN OTC DRUG	EMF Protect and Balance		Alfalfa, Fucus Vesiculosus, Kali Phosphoricum, Symphytum Officinale, Calcarea Carbonica, Ferrum Metallicum, Cadmium Sulphuratum, Hypericum Perforatum, Magnesia Phosphorica, Manganum Metallicum, Mercurius Vivus, Plumbum Metallicum, Ytterbium Oxide, Tarentula Cubensis, X-Ray, Cuprum Metallicum, Silicea	LIQUID	ORAL	20200108		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); ALFALFA; CADMIUM SULFIDE; CITHARACANTHUS SPINICRUS; COMFREY ROOT; COPPER; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; HYPERICUM PERFORATUM; IRON; LEAD; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; MERCURY; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; YTTERBIUM OXIDE	16; 3; 12; 15; 6; 30; 3; 3; 12; 8; 12; 12; 12; 12; 8; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1595_77f20218-fa8a-4a9b-a642-a134ff0fbd9a	43742-1595	HUMAN OTC DRUG	DysBio Plus		Echinacea (Angustifolia), Aloe, Colchicum Autumnale, Colocynthis, Mercurius Corrosivus, Nux Vomica, Arsenicum Album, Aceticum Acidum, Chininum Sulphuricum, Cholera Nosode, Proteus (Vulgaris), Colibacillinum Cum Natrum Muriaticum, Helicobacter Pylori, Botulinum, Salmonella Typhi Nosode, Morgan Gaertner, Clostridium Difficile, Brugia Malayi	LIQUID	ORAL	20191029	20260406	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ALOE; ARSENIC TRIOXIDE; BOTULINUM TOXIN TYPE A; BRUGIA MALAYI; CITRULLUS COLOCYNTHIS FRUIT PULP; CLOSTRIDIUM DIFFICILE; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; HELICOBACTER PYLORI; MERCURIC CHLORIDE; PROTEUS VULGARIS; QUININE SULFATE; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; STRYCHNOS NUX-VOMICA SEED; VIBRIO CHOLERAE	12; 6; 8; 30; 39; 8; 30; 8; 3; 30; 30; 8; 16; 12; 30; 33; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1596_42ad319c-cd79-48ca-a538-06d2a9a88b5b	43742-1596	HUMAN OTC DRUG	Amoeba		Baptisia Tinctoria, Cajuputum, Capsicum Annuum, Fragaria Vesca, Hamamelis Virginiana, Quassia (Amara), Senna (Cassia Angustifolia), Hydrastis Canadensis, Hepar Suis, Pancreas Suis, Spleen (Suis), Cinchona Officinalis, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Selenium Metallicum, Blastocystis Hominis, Cryptosporidium Parvum, Giardia Lamblia, Entamoeba Histolytica, Brugia Malayi	LIQUID	ORAL	20191029	20250820	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALPINE STRAWBERRY; BAPTISIA TINCTORIA ROOT; BLASTOCYSTIS HOMINIS; BRUGIA MALAYI; CAJUPUT OIL; CAPSICUM; CINCHONA OFFICINALIS BARK; CRYPTOSPORIDIUM PARVUM; ENTAMOEBA HISTOLYTICA; GIARDIA LAMBLIA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PORK LIVER; QUASSIA AMARA WOOD; SELENIUM; SENNA LEAF; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN	3; 3; 12; 39; 3; 3; 12; 12; 18; 12; 6; 3; 12; 12; 12; 8; 3; 12; 3; 12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-1597_a215629b-b206-4bda-b140-47eb1f6c1b40	43742-1597	HUMAN OTC DRUG	Influenza Plus		Eucalyptus Globulus, Aconitum Napellus, Influenzinum 2018-2019, Adenoviren Nosode, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20191029	20241118	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 9; 9; 8; 8; 8; 8; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1598_b6f7a5f2-f35c-4bbe-9ca4-afcc76136711	43742-1598	HUMAN OTC DRUG	Hydration Complex		Beta Vulgaris, Boldo, Carduus Benedictus, Chelidonium Majus, Equisetum Arvense, Petroselinum Sativum, Taraxacum Officinale, Ginkgo Biloba, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Germanium Sesquioxide, Silicea, Calcarea Fluorica, Calcarea Phosphorica	LIQUID	ORAL	20191029	20240119	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BETA VULGARIS; CALCIUM FLUORIDE; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; EQUISETUM ARVENSE TOP; GERMANIUM SESQUIOXIDE; GINKGO; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; TARAXACUM OFFICINALE; TRIBASIC CALCIUM PHOSPHATE	1; 8; 1; 1; 1; 8; 6; 1; 1; 6; 6; 6; 8; 1; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	
43742-1599_49d35ef3-8303-4c83-8ba7-d44e978224a4	43742-1599	HUMAN OTC DRUG	Herpes Simplex Plus		Allium Sativum, Calendula Officinalis, Sambucus Nigra, Clematis Erecta, Dulcamara, Graphites, Petroleum, Arsenicum Album, Croton Tiglium, Mercurius Sulphuratus Ruber, Natrum Muriaticum, Nitricum Acidum, Rhus Tox, Sepia, Thuja Occidentalis	LIQUID	ORAL	20191029	20250102	UNAPPROVED HOMEOPATHIC		Deseret Biologicals,Inc.	ARSENIC TRIOXIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS RECTA FLOWERING TOP; CROTON TIGLIUM SEED; GARLIC; GRAPHITE; KEROSENE; MERCURIC SULFIDE; NITRIC ACID; SAMBUCUS NIGRA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 2; 6; 12; 2; 8; 8; 12; 12; 3; 12; 12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1600_d2efef41-2d4f-4447-b2e4-88c494858794	43742-1600	HUMAN OTC DRUG	Bio Tonsilla Phase		Dulcamara, Echinacea (Angustifolia), Aesculus Hippocastanum, Antimonium Tartaricum, Ascorbicum Acidum, Coccus Cacti, Galium Aparine, Gentiana Lutea, Geranium Robertianum, Pulsatilla (Pratensis), Sarcolacticum Acidum, Acetylcholine Chloride, Mannose, Conium Maculatum, Lymph Node (Suis), Sulphur, Calcarea Phosphorica, Funiculus Umbilicalis Suis, Hepar Suis, Hypothalamus Suis, Medulla Ossis Suis, Spleen (Suis), Cortisone Aceticum, Glandula Suprarenalis Suis, Mercurius Solubilis, Thyroidinum (suis),	LIQUID	ORAL	20191029		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETYLCHOLINE CHLORIDE; ANEMONE PRATENSIS; ANTIMONY POTASSIUM TARTRATE; ASCORBIC ACID; BARIUM CARBONATE; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; HORSE CHESTNUT; LACTIC ACID, L-; MANNOSE, D-; MERCURIUS SOLUBILIS; PORK LIVER; PROTORTONIA CACTI; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYROID; SUS SCROFA TONSIL; SUS SCROFA UMBILICAL CORD; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6; 6; 28; 8; 13; 4; 6; 6; 6; 6; 6; 6; 13; 10; 6; 4; 8; 13; 10; 10; 8; 10; 13; 28; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Coagulation Factor Activity [PE], Vitamin C [EPC]		N	20241231
43742-1601_4a36ef9d-87e7-4c4d-bc61-421f0a7b68cb	43742-1601	HUMAN OTC DRUG	Enviro	I	Potassium Gluconate, Glandula Suprarenalis Suis, Hepar Suis, Coffea Tosta, Thea Sinensis, Carbo Vegetabilis, Ferrum Iodatum, Ferrum Metallicum, Gelsemium Sempervirens, Iodium, Iridium Metallicum, Lycopodium Clavatum, Pulsatilla (Pratensis), Selenium Metallicum, Zincum Metallicum, Peanut, Black Walnut, English Walnut, Almond, Cashew, Coconut, Pecan, Brazil Nut, Tomato, Potato, Black Pepper, Eggplant, Rape Seed Oil, Flax Seed, Sesame, Seed, Cheese (Stilton), Lac Vaccinum, Beef, Lamb, Pork, Chicken,	LIQUID	ORAL	20191030	20241202	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALMOND; ANEMONE PRATENSIS; APPLE; ATLANTIC COD; ATLANTIC SALMON; BANANA; BEEF; BLACK PEPPER; BLACK WALNUT; BRAZIL NUT; CANOLA OIL; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM ROQUEFORTI CULTURED, AGED; CASHEW; CHICKEN; COCOA; COCONUT; COFFEA ARABICA SEED, ROASTED; COMMON SHRIMP; CORTISONE ACETATE; COW MILK; EDIBLE ROCK CRAB; EGG; EGGPLANT; ENGLISH WALNUT; FERROUS IODIDE; FLAX SEED; GELSEMIUM SEMPERVIRENS ROOT; GREEN TEA LEAF; HISTAMINE DIHYDROCHLORIDE; HYALURONIDASE; INTERFERON .GAMMA. PORCINE RECOMBINANT; IODINE; IRIDIUM; IRON; KIDNEY BEAN; LAMB; LYCOPODIUM CLAVATUM SPORE; NORTHERN BLUEFIN TUNA; ONION; ORANGE; PACIFIC OYSTER; PEANUT; PECAN; PORK; PORK LIVER; POTASSIUM GLUCONATE; POTATO; SELENIUM; SEROTONIN HYDROCHLORIDE; SESAME SEED; STRAWBERRY; SUS SCROFA ADRENAL GLAND; TOMATO; WHEAT; ZINC	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 10; 12; 10; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 10; 30; 30; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 6; 12; 12; 30; 12; 12; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Endoglycosidase [EPC], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Glycoside Hydrolases [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Meat Proteins [EXT], Meat Proteins [EXT], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1602_e8c0cc6c-ce98-4d65-9d4e-be2da6fd75b7	43742-1602	HUMAN OTC DRUG	Bio Galium Phase		Caltha Palustris, Clematis Erecta, Galium Aparine, Hedera Helix, Juniperus Communis, Sedum Acre, Sempervivum Tectorum, Thuja Occidentalis, Urtica Urens, Echinacea (Angustifolia), Argentum Metallicum, Calcarea Fluorica, Nitricum Acidum, Phosphorus, Cortisone Aceticum, Aurum Metallicum, Apis Mellifica, Ononis Spinosa, Gaertner Bacillus (Bach)	LIQUID	ORAL	20191030		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; CALCIUM FLUORIDE; CALTHA PALUSTRIS; CLEMATIS RECTA FLOWERING TOP; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; GOLD; HEDERA HELIX FLOWERING TWIG; JUNIPER BERRY; NITRIC ACID; ONONIS SPINOSA WHOLE; PHOSPHORUS; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SEDUM ACRE; SEMPERVIVUM TECTORUM LEAF; SILVER; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS	12; 8; 4; 4; 8; 5; 4; 10; 4; 4; 8; 5; 8; 30; 4; 4; 8; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1604_274da1c0-2d94-460b-b33c-cc6db2e3a4ff	43742-1604	HUMAN OTC DRUG	Female Support		Chamomilla, Cimicifuga Racemosa, Mentha Piperita, Senna (Cassia Angustifolia), Valeriana Officinalis, Viola Odorata, Agnus Castus, Ledum Palustre, Lilium Tigrinum, Staphysagria, Crocus Sativus, Hydrastis Canadensis, Cinchona Officinalis, Convallaria Majalis, Cyclamen Europaeum, Cinnamomum, Murex Purpurea, Naja Tripudians	LIQUID	ORAL	20191104	20241126	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BLACK COHOSH; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CINNAMON; CONVALLARIA MAJALIS; CYCLAMEN PURPURASCENS TUBER; DELPHINIUM STAPHISAGRIA SEED; GOLDENSEAL; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LEDUM PALUSTRE TWIG; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA RECUTITA; MENTHA PIPERITA; NAJA NAJA VENOM; SAFFRON; SENNA LEAF; VALERIAN; VIOLA ODORATA	3; 4; 8; 12; 8; 8; 4; 6; 12; 4; 4; 3; 3; 15; 6; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1605_0a74828e-7d63-4955-a438-de933a0604c5	43742-1605	HUMAN OTC DRUG	Mood Swings		Camphora, Cimicifuga Racemosa, Kali Bromatum, Lithium Carbonicum, Adrenalinum, Dopamine Hydrochloride, Hypothalamus Suis, Serotonin (Hydrochloride), Thyroidinum (Suis), Aconitum Napellus, Hyoscyamus Niger, Ignatia Amara, Oenanthe Crocata, Pulsatilla (Pratensis), Stramonium, Tarentula Hispana, Zincum Metallicum, Lachesis Mutus, Platinum Metallicum	LIQUID	ORAL	20191104	20241209	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; ANEMONE PRATENSIS; BLACK COHOSH; CAMPHOR (NATURAL); DATURA STRAMONIUM; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; HYOSCYAMUS NIGER; LACHESIS MUTA VENOM; LITHIUM CARBONATE; LYCOSA TARANTULA; OENANTHE CROCATA ROOT; PLATINUM; POTASSIUM BROMIDE; SEROTONIN HYDROCHLORIDE; STRYCHNOS IGNATII SEED; SUS SCROFA HYPOTHALAMUS; THYROID, PORCINE; ZINC	12; 12; 6; 6; 12; 8; 8; 12; 12; 8; 12; 12; 18; 6; 8; 12; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Mood Stabilizer [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1606_f656d753-8672-4695-94fd-d674823c6cde	43742-1606	HUMAN OTC DRUG	Reflux		Adenosinum Triphosphoricum Dinatrum, Nadidum, Argentum Nitricum, Robinia Pseudoacacia, Sulphur, Origanum Vulgare, Duodenum (Suis), Esophagus (Suis), Funiculus Umbilicalis Suis, Stomach (Suis), Nux Vomica, Coumarinum, Pancreatinum, Muriaticum Acidum, Citricum Acidum, Formicum Acidum, Sarcolacticum Acidum, Coenzyme A, Proteus (Morgani)	LIQUID	ORAL	20191104	20241202	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS CITRIC ACID; COENZYME A; COUMARIN; FORMIC ACID; HYDROCHLORIC ACID; LACTIC ACID, L-; NADIDE; OREGANO; PANCRELIPASE; PROTEUS MORGANII; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA STOMACH; SUS SCROFA UMBILICAL CORD	6; 6; 8; 8; 6; 6; 6; 6; 6; 12; 30; 6; 6; 8; 6; 8; 8; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1607_5291f262-dc7e-4781-beba-88e6273548e1	43742-1607	HUMAN OTC DRUG	Systemic Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Gelsemium Sempervirens, Veratrum Album, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Pratensis), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20191114	20250630	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; BETA VULGARIS; CHELIDONIUM MAJUS; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; SELENIUM; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	12; 3; 3; 8; 12; 12; 12; 3; 12; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1608_814b055b-73ed-4950-b07d-0628b71e12a8	43742-1608	HUMAN OTC DRUG	Nausia		Zingiber Officinale, Iris Versicolor, Lac Defloratum, Lacticum Acidum, Cyclamen Europaeum, Petroleum, Tabacum, Arsenicum Album, Bryonia (Alba), Cadmium Sulphuratum, Cocculus Indicus, Colchicum Autumnale, Conium Maculatum, Ferrum Metallicum, Nux Vomica, Pulsatilla (Pratensis), Sepia, Theridion, Euphorbia Corollata	LIQUID	ORAL	20191114	20240820	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANAMIRTA COCCULUS SEED; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CADMIUM SULFIDE; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; CYCLAMEN PURPURASCENS TUBER; EUPHORBIA COROLLATA ROOT; GINGER; IRIS VERSICOLOR ROOT; IRON; KEROSENE; LACTIC ACID, DL-; SEPIA OFFICINALIS JUICE; SKIM MILK; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; TOBACCO LEAF	12; 12; 12; 12; 12; 12; 12; 8; 24; 3; 6; 12; 8; 6; 12; 6; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1609_31be0c7e-f7ee-4063-a821-cdda7008e669	43742-1609	HUMAN OTC DRUG	Healing Support		Caltha Palustris, Galium Aparine, Thuja Occidentalis, Urtica Urens, Clematis Erecta, Hedera Helix, Juniperus Communis, Juniperus Communis, Sempervivum Tectorum, Echinacea (Angustifolia), Allium Sativum, Argentum Metallicum, Calcarea Fluorica, Nitricum Acidum, Sedum Acre, Phosphorus, Apis Mellifica, Pyrogenium, Ononis Spinosa	LIQUID	ORAL	20200224	20260427	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; CALCIUM FLUORIDE; CALTHA PALUSTRIS; CLEMATIS RECTA FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; GARLIC; HEDERA HELIX FLOWERING TWIG; JUNIPER BERRY; NITRIC ACID; ONONIS SPINOSA WHOLE; PHOSPHORUS; RANCID BEEF; SEDUM ACRE; SEMPERVIVUM TECTORUM LEAF; SILVER; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS	12; 8; 3; 4; 5; 3; 6; 4; 4; 8; 5; 9; 12; 8; 4; 8; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	
43742-1620_f114f690-2fd6-4ca9-998d-505d05f722f3	43742-1620	HUMAN OTC DRUG	Intimate		Natrum Carbonicum, Saccharum Officinale, Lithium Carbonicum, Placenta Totalis Suis, Lac Caninum, Anacardium Orientale, Aurum Muriaticum Natronatum, Camphora, Germanium Metallicum, Helleborus Niger, Magnesia Oxydata, Rhus Glabra, Stramonium, Thuja Occidentalis, DNA (Human), Oxytocin, Hydrogen, Neon, Lac Materna Humanum	LIQUID	ORAL	20200309		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CAMPHOR (NATURAL); CANIS LUPUS FAMILIARIS MILK; DATURA STRAMONIUM; GERMANIUM SESQUIOXIDE; HELLEBORUS NIGER ROOT; HERRING SPERM DNA; HUMAN MILK; HYDROGEN; LITHIUM CARBONATE; MAGNESIUM OXIDE; NEON; OXYTOCIN; RHUS GLABRA TOP; SEMECARPUS ANACARDIUM JUICE; SODIUM CARBONATE; SODIUM TETRACHLOROAURATE; SUCROSE; SUS SCROFA PLACENTA; THUJA OCCIDENTALIS LEAFY TWIG	12; 10; 12; 12; 12; 12; 16; 16; 8; 12; 16; 12; 12; 12; 6; 12; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Uterine Smooth Muscle Contraction or Tone [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxytocic [EPC], Oxytocin [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1621_4980ae88-f2b2-4ab6-9286-4bef59d924fc	43742-1621	HUMAN OTC DRUG	Ver		Artemisia Vulgaris, Melilotus Officinalis, Quassia (Amara), Teucrium Marum, Thymus Serpyllum, Filix Mas, Cina, Silicea, Spigelia Anthelmia, Calcarea Carbonica, Graphites, Iodium, Mercurius Corrosivus, Sabadilla, Ascaris Lumbricoides, Trichinella Spiralis, Enterobius Vermicularis, Taenia Solium, Trichomonas Vaginalis, Giardia Lamblia, Cryptosporidium Parvum, Taenia Saginata, Brugia Malayi	LIQUID	ORAL	20200227	20260525	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; ASCARIS LUMBRICOIDES; BRUGIA MALAYI; CRYPTOSPORIDIUM PARVUM; DRYOPTERIS FILIX-MAS ROOT; ENTEROBIUS VERMICULARIS; GIARDIA LAMBLIA; GRAPHITE; IODINE; MELILOTUS OFFICINALIS TOP; MERCURIC CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; QUASSIA AMARA WOOD; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SPIGELIA ANTHELMIA; TAENIA SAGINATA; TAENIA SOLIUM; TEUCRIUM MARUM; THYMUS SERPYLLUM; TRICHINELLA SPIRALIS; TRICHOMONAS VAGINALIS	8; 2; 15; 39; 20; 7; 33; 18; 12; 12; 3; 12; 12; 3; 12; 8; 8; 20; 12; 3; 3; 15; 13	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	
43742-1622_21ad3671-74e0-4fc4-ac08-9c490e7893fd	43742-1622	HUMAN OTC DRUG	FNG		Berberis Vulgaris, Cochlearia Armoracia, Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Suis, Tabebuia Impetiginosa, Thymus (Suis), Formalinum, Carbolicum Acidum, Ferrum Metallicum, Iridium Metallicum, Lycopodium Clavatum, Phosphoricum Acidum, Pulsatilla (Prastensis), Selenium Metallicum, Zincum Metallicum, Adenosinum Triphosphoricum Dinatrum, Methylcobalamin, Sarcolacticum Acidum, Mucor Racemosus, Alternaria Tenuis Nees, Aspergillus Niger,	LIQUID	ORAL	20200115		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; BERBERIS VULGARIS ROOT BARK; BRUGIA MALAYI; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ECHINACEA ANGUSTIFOLIA WHOLE; ESCHERICHIA COLI; FORMALDEHYDE; GOLDENSEAL; HORSERADISH; IRIDIUM; IRON; LACTIC ACID, L-; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; METHYLCOBALAMIN; MUCOR RACEMOSUS; MYRRH; PHENOL; PHOSPHORIC ACID; PROPOLIS WAX; PULSATILLA PRATENSIS WHOLE; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SELENIUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK; ZINC	12; 16; 16; 3; 39; 12; 12; 3; 30; 8; 6; 3; 12; 12; 12; 3; 12; 12; 16; 3; 12; 12; 6; 12; 14; 12; 12; 8; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43742-1623_956219e2-891a-437a-88bd-1c7bb14801eb	43742-1623	HUMAN OTC DRUG	Influenza Plus		Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2019-2020, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20200303	20250617	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 9; 10; 10; 10; 3; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1624_f4d98bb8-4530-49d1-93a0-b56626a17472	43742-1624	HUMAN OTC DRUG	ENT Support		Pulsatilla (Pratensis), Euphorbium Officinarum, Luffa Operculata, Mercurius Iodatus Ruber, Argentum Nitricum, Hepar Sulphuris Calcareum, Influenzinum (2019-2020), Sinusitisinum, Aspergillus Niger, Candida Albicans, Gallicum Acidum, Mucor Racemosus, Mutabile Bacillus (Bach)	LIQUID	ORAL	20200304	20251110	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANEMONE PRATENSIS; ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; SILVER NITRATE; SINUSITISINUM	4; 10; 10; 10; 30; 6; 10; 12; 12; 12; 6; 8; 10; 10; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-1625_7f219fe6-9189-4869-9307-a33357d18d33	43742-1625	HUMAN OTC DRUG	Bio Thalamus Phase		Adenosinum Cyclophosphoricum, Petroselinum sativum, Melatonin, Pineal Gland (Suis), Thalamus Opticus (Suis), L-Dopa, Viscum Album, Apiolum	LIQUID	ORAL	20200309		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE CYCLIC PHOSPHATE; APIOLE (PARSLEY); LEVODOPA; MELATONIN; PETROSELINUM CRISPUM WHOLE; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; VISCUM ALBUM FRUITING TOP	6; 15; 8; 6; 6; 8; 8; 10	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
43742-1626_28d4d875-8e23-479c-8fbb-3def2662513b	43742-1626	HUMAN OTC DRUG	Bug Bouncer		Grindelia (Robusta), Urtica Urens, Ledum Palustre, Staphysagria, Cedron	LIQUID	ORAL	20200306		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	DELPHINIUM STAPHISAGRIA SEED; GRINDELIA HIRSUTULA WHOLE; LEDUM PALUSTRE TWIG; SIMABA CEDRON SEED; URTICA URENS	4; 1; 4; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
43742-1628_87de21ea-bb4d-4f4e-b5fe-475682c0ad08	43742-1628	HUMAN OTC DRUG	Motivation		Dioscorea Villosa, Lecithin, sepia, Viola Odorata, Adrenalinum, Lithium Carbonicum, Thyroidinum (Bovine), Placenta Totalis Suis, Guaiacum, Solanum Tuberosum, Antimonium Crudum, Aurum Sulphuratum, Baryta Carbonica, Chininum Sulphuricum, Conium Maculatum, Graphites, Lilium Tigrinum, Rhus Venenata, Selenium Metallicum, Alumina	LIQUID	ORAL	20200317		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALUMINUM OXIDE; ANTIMONY TRISULFIDE; BARIUM CARBONATE; CONIUM MACULATUM FLOWERING TOP; DIOSCOREA VILLOSA TUBER; EGG PHOSPHOLIPIDS; EPINEPHRINE; GOLD MONOSULFIDE; GRAPHITE; GUAIACUM OFFICINALE RESIN; LILIUM LANCIFOLIUM WHOLE FLOWERING; LITHIUM CARBONATE; QUININE SULFATE; SELENIUM; SEPIA OFFICINALIS JUICE; SOLANUM TUBEROSUM WHOLE; SUS SCROFA PLACENTA; THYROID, BOVINE; TOXICODENDRON VERNIX LEAFY TWIG; VIOLA ODORATA WHOLE	12; 12; 12; 12; 6; 6; 8; 12; 12; 10; 12; 8; 12; 12; 6; 10; 8; 8; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Mood Stabilizer [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1629_08406fe1-f100-406a-80a8-3b9ea454d445	43742-1629	HUMAN PRESCRIPTION DRUG	Female Support		Chamomilla, Cimicifuga Racemosa, Helonias Dioica, Mentha Piperita, Senna (Cassia Angustifolia), Valeriana Officinalis, Viola Odorata, Agnus Castus, Ledum Palustre, Lilium Tigrinum, Staphysagria, Crocus Sativus, Hydrastis Canadensis, Cinchona Officinalis, Convallaria Majalis, Cyclamen Europaeum, Cinnamomum, Murex Purpurea, Naja Tripudians	LIQUID	ORAL	20200318	20260422	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BLACK COHOSH; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CINNAMON; CONVALLARIA MAJALIS; CYCLAMEN PURPURASCENS TUBER; DELPHINIUM STAPHISAGRIA SEED; GOLDENSEAL; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LEDUM PALUSTRE TWIG; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA RECUTITA; MENTHA PIPERITA; NAJA NAJA VENOM; SAFFRON; SENNA LEAF; VALERIAN; VIOLA ODORATA	3; 3; 4; 8; 12; 8; 8; 4; 6; 12; 4; 4; 3; 3; 15; 6; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	
43742-1630_2d947b58-2f33-44d8-97cb-a4d5ae0b7db2	43742-1630	HUMAN OTC DRUG	Reflux		Adenosinum Triphosphoricum Dinatrum, Nadidum, Argentum Nitricum, Ipecacuanha, Robinia Pseudoacacia, Sulphur, Origanum Vulgare, Duodenum (Suis), Esophagus (Suis), Funiculus Umbilicalis Suis, Stomach (Suis), Nux Vomica, Coumarinum, Erythraea Centaurium, Pancreatinum, Muriaticum Acidum, Citricum Acidum, Formicum Acidum, Sarcolacticum Acidum, Coenzyme A, Proteus (Morgani)	LIQUID	ORAL	20200327	20251022	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS CITRIC ACID; CENTAURIUM ERYTHRAEA; COENZYME A; COUMARIN; FORMIC ACID; HYDROCHLORIC ACID; IPECAC; LACTIC ACID, L-; NADIDE; OREGANO; PANCRELIPASE; PROTEUS MORGANII; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA STOMACH; SUS SCROFA UMBILICAL CORD	6; 6; 10; 8; 8; 6; 6; 6; 6; 6; 6; 12; 30; 6; 6; 8; 6; 8; 8; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1631_cf7d3aec-21af-42e6-b477-b11e98c18484	43742-1631	HUMAN OTC DRUG	Hydration Complex		Beta Vulgaris, Boldo, Carduus Benedictus, Chelidonium Majus, Coffea Tosta, Equisetum Arvense, Petroselinum Sativum, Taraxacum Officinale, Hypericum Perforatum, Ginkgo Biloba, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Germanium Sesquioxide, Silicea, Calcarea Fluorica, Calcarea Phosphorica	LIQUID	ORAL	20200324	20260526	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BETA VULGARIS; CALCIUM FLUORIDE; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; COFFEA ARABICA SEED, ROASTED; DIBASIC POTASSIUM PHOSPHATE; EQUISETUM ARVENSE TOP; GERMANIUM SESQUIOXIDE; GINKGO; HYPERICUM PERFORATUM WHOLE; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; TARAXACUM OFFICINALE; TRIBASIC CALCIUM PHOSPHATE	1; 8; 1; 1; 1; 6; 1; 8; 6; 3; 1; 1; 6; 6; 8; 1; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	
43742-1642_c68ed65b-6733-455f-b17e-4a205525ae82	43742-1642	HUMAN OTC DRUG	Brucella Homochord		Brucella Melitensis	LIQUID	ORAL	20200331	20250331	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BRUCELLA MELITENSIS	18	[hp_C]/mL			N	
43742-1645_ca271103-d6f0-4e81-8664-08dee373b53c	43742-1645	HUMAN OTC DRUG	Immune Support		Echinacea (Angustifolia), Arnica Montana, Baptisia Tinctoria, Sanguinaria Canadensis, Aristolochia Clematitis, Eupatorium Perfoliatum, Euphorbium Officinarum, Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Mercurius Corrosivus, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhus Tox, Sulphur, Thuja Occidentalis, Hepar Sulphuris Calcareum, Lachesis Mutus, Zincum Metallicum, Astragalus Membranaceus, Influenzinum (2019-2020), Spleen (Suis), Pyrogenium,	LIQUID	ORAL	20200519	20250908	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARISTOLOCHIA CLEMATITIS ROOT; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASTRAGALUS PROPINQUUS ROOT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA PRATENSIS WHOLE; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; SULFUR; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP; ZINC	8; 6; 4; 8; 12; 4; 8; 10; 13; 1; 6; 6; 8; 12; 12; 12; 10; 8; 8; 8; 8; 200; 4; 8; 8; 12; 12; 8; 8; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
43742-1646_65c8fd27-99d4-42dc-9108-f3442df82afb	43742-1646	HUMAN OTC DRUG	TinitX		Allium Cepa, Argentum Nitricum, Chenopodium Anthelminticum, Dulcamara, Ginkgo Biloba, Chininum Sulphuricum, Cartilago Suis, Mucosa Nasalis Suis, Asarum Canadense, Onosmodium Virginianum, Natrum Salicylicum, Carbo Vegetabilis, Carboneum Sulphuratum, Cyclamen Europaeum, Gossypium Herbaceum, Graphites, Kreosotum, Phosphorus, Plumbum Metallicum, Theridion, Zincum Metallicum	LIQUID	ORAL	20200529	20251014	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ASARUM CANADENSE ROOT; CARBON DISULFIDE; CYCLAMEN PURPURASCENS TUBER; DYSPHANIA AMBROSIOIDES WHOLE; GINKGO; GOSSYPIUM HERBACEUM ROOT BARK; GRAPHITE; LEAD; ONION; ONOSMODIUM VIRGINIANUM; PHOSPHORUS; QUININE SULFATE; SILVER NITRATE; SODIUM SALICYLATE; SOLANUM DULCAMARA TOP; SUS SCROFA CARTILAGE; SUS SCROFA NASAL MUCOSA; THERIDION CURASSAVICUM; WOOD CREOSOTE; ZINC	12; 9; 12; 12; 6; 6; 12; 12; 12; 6; 10; 12; 6; 6; 10; 6; 8; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	
43742-1660_ec70c9b8-a5a8-4130-911d-fad31622c447	43742-1660	HUMAN OTC DRUG	Systemic Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Sarsaparilla (Smilax Regelii), Gelsemium Sempervirens, Veratrum Album, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Pratensis), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20201005	20261012	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BETA VULGARIS; CHELIDONIUM MAJUS; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PULSATILLA PRATENSIS WHOLE; SELENIUM; SMILAX ORNATA WHOLE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	3; 3; 8; 12; 12; 12; 3; 12; 12; 6; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1661_37f9d039-404c-4c9d-b8cd-3cc4e34d9b66	43742-1661	HUMAN OTC DRUG	Bio Co-Enzyme Phase		Beta Vulgaris, Ascorbicum Acidum, Cysteinum, Natrum Oxalaceticum, Nicotinamidum, Pulsatilla (Pratensis), Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Alpha-Ketoglutaricum Acidum, Alpha-Lipoicum Acidum, Cerium Oxalicum, Citricum Acidum, Fumaricum Acidum, Magnesium Oroticum Dihydricum, Malicum Acidum, Nadidum, Natrum Pyruvicum, Pantothenic Acid, Succinicum Acidum, Adrenalinum, Adenosinum Triphosphoricum Dinatrum, Hepar Sulphuris Calcareum, Sulphur, Aconiticum Acidum, Cis-,	LIQUID	ORAL	20200608	20261015	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; ANHYDROUS CITRIC ACID; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BETA VULGARIS WHOLE; CALCIUM SULFIDE; CEROUS OXALATE NONAHYDRATE; CYSTEINE; EPINEPHRINE; FUMARIC ACID; MAGNESIUM OROTATE DIHYDRATE; MALIC ACID; MANGANESE PHOSPHATE, DIBASIC; NADIDE; NIACINAMIDE; OXOGLURIC ACID; PANTOTHENIC ACID; PROTEUS MORGANII; PULSATILLA PRATENSIS WHOLE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SULFUR; THIAMINE HYDROCHLORIDE	16; 10; 8; 8; 6; 34; 4; 10; 8; 6; 8; 8; 8; 8; 16; 8; 6; 8; 8; 30; 6; 6; 6; 6; 8; 8; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Decreased Coagulation Factor Activity [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-1662_a0aee502-5a9e-4610-af34-a1a105aaf330	43742-1662	HUMAN OTC DRUG	Herpes Simplex Plus		Allium Sativum, Calendula Officinalis, Sambucus Nigra, Clematis Erecta, Dulcamara, Sarsaparilla (Smilax Regelii), Graphites, Petroleum, Arsenicum Album, Croton Tiglium, Mercurius Sulphuratus Ruber, Natrum Muriaticum, Nitricum Acidum, Rhus Tox, Sepia, Thuja Occidentalis	LIQUID	ORAL	20200629	20250901	UNAPPROVED HOMEOPATHIC		Deseret Biologicals,Inc.	ARSENIC TRIOXIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS RECTA FLOWERING TOP; CROTON TIGLIUM SEED; GARLIC; GRAPHITE; KEROSENE; MERCURIC SULFIDE; NITRIC ACID; SAMBUCUS NIGRA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 2; 6; 12; 2; 8; 8; 12; 12; 3; 12; 6; 12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1664_48da4c48-8cc0-49bd-97e1-d34b72d95c58	43742-1664	HUMAN OTC DRUG	Matrix Support		Ceanothus Americanus, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Pulsatilla (Pratensis), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Pancreas Suis, Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Veratrum Album, Mannose, Anacardium Orientale, Kreosotum,	LIQUID	ORAL	20200629		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CEANOTHUS AMERICANUS LEAF; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; MANDRAGORA OFFICINARUM ROOT; MANNOSE, D-; MARSDENIA CONDURANGO BARK; MOMORDICA BALSAMINA IMMATURE FRUIT; OXALIS ACETOSELLA LEAF; PHOSPHORUS; PORK INTESTINE; POTASSIUM DICHROMATE; PULSATILLA PRATENSIS WHOLE; SEMECARPUS ANACARDIUM JUICE; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA BILE DUCT; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA EYE; SUS SCROFA GALLBLADDER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA ORAL MUCOSA; SUS SCROFA PANCREAS; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; VERATRUM ALBUM ROOT; WOOD CREOSOTE	4; 6; 8; 10; 16; 8; 6; 6; 10; 8; 8; 8; 6; 9; 30; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1666_79cff166-b898-4da9-997d-6c8413374c91	43742-1666	HUMAN OTC DRUG	Lymph Drainage		Citrus Limonum, Echinacea (Angustifolia), Teucrium Scorodonia, Baptisia Tinctoria, Pinus Sylvestris, Zincum Gluconicum, Thuja Occidentalis, Capsicum Annuum, Copper Gluconate, Manganese Gluconate, Aranea Diadema, Arsenicum Iodatum, Carpinus Betulus, Flos, Centaurium Umbellatum, Flos, Larix Decidua, Flos, Lymph Node (Suis), Phytolacca Decandra, Scrophularia Nodosa, Spleen (Suis), Thymus (Suis), Tabacum, Lachesis Mutus	LIQUID	ORAL	20200619		UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ARANEUS DIADEMATUS; ARSENIC TRIIODIDE; BAPTISIA TINCTORIA ROOT; CAPSICUM; CARPINUS BETULUS FLOWERING TOP; CENTAURIUM ERYTHRAEA FLOWER; COPPER GLUCONATE; ECHINACEA ANGUSTIFOLIA WHOLE; LACHESIS MUTA VENOM; LARIX DECIDUA FLOWERING TOP; LEMON JUICE; MANGANESE GLUCONATE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA WHOLE; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; TEUCRIUM SCORODONIA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; TOBACCO LEAF; ZINC GLUCONATE	8; 8; 1; 6; 8; 8; 6; 1; 12; 8; 1; 6; 8; 3; 8; 8; 8; 8; 1; 4; 9; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
43742-1673_8d6e9dc6-d289-43f8-817f-13339abbd7b5	43742-1673	HUMAN OTC DRUG	Tobacco		Chamomilla, Passiflora Incarnata, Valeriana Officinalis, Allium Sativum, Argentum Nitricum, Avena Sativa, Caladium Seguinum, Kali Bichromicum, Lobelia Inflata, Lycopodium Clavatum, Serotonin (Hydrochloride), Tabacum, Adrenalinum, Ammoniacum Gummi, Balsamum Peruvianum, Cactus Cacti, Selenium Metallicum	LIQUID	ORAL	20201208		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AVENA SATIVA FLOWERING TOP; BALSAM PERU; DIEFFENBACHIA SEGUINE WHOLE; EPINEPHRINE; FERULA AMMONIACUM RESIN; GARLIC; LOBELIA INFLATA WHOLE; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM DICHROMATE; PROTORTONIA CACTI; SELENIUM; SEROTONIN HYDROCHLORIDE; SILVER NITRATE; TOBACCO LEAF; VALERIAN	6; 12; 6; 10; 12; 6; 6; 6; 3; 3; 6; 12; 12; 6; 6; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1676_bfce9acf-49f0-4b15-a230-91c23bfcbc14	43742-1676	HUMAN OTC DRUG	High Vitality Tab		Agnus Castus, Ambra Grisea, Estradiol, L-Dopa, Melatonin, Petroselinum Sativum, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Testosterone, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus (Suis), Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone,	TABLET	ORAL	20210106	20260107	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMBERGRIS; BARIUM CARBONATE; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM WHOLE; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 8; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
43742-1678_8414eb84-336e-49f7-9dfd-e3c3169dcd6f	43742-1678	HUMAN OTC DRUG	Leaky Gut Formula		Glycyrrhiza Glabra, Aloe, Astacus Fluviatilis, Berberis Aquifolium, Lac Defloratum, Natrum Carbonicum, Saccharum Officinale, Fel Tauri, Pancreas Suis, Pancreatinum, Fragaria Vesca, Antimonium Crudum, Carbo Vegetabilis, Euphorbium Officinarum, Lycopodium Clavatum, Magnesia Carbonica, Zincum Metallicum, Colibacillinum Cum Natrum Muriaticum, Proteus (Vulgaris)	LIQUID	ORAL	20200928	20251130	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALOE; ANTIMONY TRISULFIDE; ASTACUS ASTACUS; BERBERIS AQUIFOLIUM ROOT BARK; BOS TAURUS BILE; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; FRAGARIA VESCA FRUIT; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; PANCRELIPASE; PROTEUS INCONSTANS; SKIM MILK; SODIUM CARBONATE; SUCROSE; SUS SCROFA PANCREAS; ZINC	12; 4; 12; 6; 6; 8; 15; 12; 9; 3; 12; 12; 8; 15; 6; 6; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1681_85e3c899-dc81-4514-8f4a-dd62676d8dad	43742-1681	HUMAN OTC DRUG	Amoe Combination		Baptisia Tinctoria, Cajuputum, Capsicum Annuum, Fragaria Vesca, Hamamelis Virginiana, Quassia (Amara), Senna (Cassia Angustifolia), Hydrastis Canadensis, Hepar Suis, Pancreas Suis, Spleen (Suis), Cinchona Officinalis, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Selenium Metallicum, Blastocystis Hominis, Cryptosporidium Parvum, Giardia Lamblia, Entamoeba Histolytica, Brugia Malayi	LIQUID	ORAL	20210514		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BAPTISIA TINCTORIA ROOT; BLASTOCYSTIS HOMINIS; BRUGIA MALAYI; CAJUPUT OIL; CAPSICUM; CINCHONA OFFICINALIS BARK; CRYPTOSPORIDIUM PARVUM; ENTAMOEBA HISTOLYTICA; FRAGARIA VESCA FRUIT; GIARDIA LAMBLIA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PORK LIVER; QUASSIA AMARA WOOD; SELENIUM; SENNA LEAF; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN	3; 12; 39; 3; 3; 12; 12; 18; 3; 12; 6; 3; 12; 12; 12; 8; 3; 12; 3; 12; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
43742-1682_e5d9ff16-4b05-4e6d-8047-7688a5d21764	43742-1682	HUMAN OTC DRUG	ANAP HOMO		Anaplasma Phagocytophilum	LIQUID	ORAL	20201002		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANAPLASMA PHAGOCYTOPHILUM	15	[hp_X]/mL			N	20241231
43742-1698_695f0793-a900-4da0-8af5-ef9ab7562ffc	43742-1698	HUMAN OTC DRUG	BACT COMBINATION		Adenosinum Triphosphoricum Dinatrum, Malicum Acidum, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Cinnamic Acid, Petroselinum Sativum, Colibacillinum Cum Natrum Muriaticum, Echinacea (Angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (Mirabilis), Proteus (Vulgaris), Pseudomonas Aeruginosa, Salmonella Typhi Nosode, Enterococcus Faecalis, Streptococcus Mutans, Pneumococcinum, Streptococcus Agalactiae, Legionella Pneumophila, Listeria Monocytogenes, Dysentery Bacillus, Shigella Sonnei,	LIQUID	ORAL	20201201		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE PHOSPHATE DISODIUM; CINNAMIC ACID; ECHINACEA ANGUSTIFOLIA WHOLE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HELICOBACTER PYLORI; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; MALIC ACID; MYCOPLASMA PNEUMONIAE; OROTIC ACID MONOHYDRATE; PETROSELINUM CRISPUM WHOLE; PROTEUS MIRABILIS; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RIBOFLAVIN; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; SODIUM DIETHYL OXALACETATE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS UBERIS; STREPTOCOCCUS VIRIDANS GROUP	6; 6; 15; 13; 15; 15; 14; 14; 6; 15; 6; 6; 15; 30; 15; 15; 6; 17; 15; 15; 6; 14; 15; 32; 13; 13; 32; 38	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43742-1700_5341d590-262c-4937-831a-f0f1a45c2fc5	43742-1700	HUMAN OTC DRUG	Bart Homo		Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis	LIQUID	ORAL	20200928		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BARTONELLA BACILLIFORMIS; BARTONELLA CLARRIDGEIAE; BARTONELLA ELIZABETHAE; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BARTONELLA VINSONII; BARTONELLA WASHOENSIS	15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1701_508c8488-2851-426f-aef6-7df619d37f2f	43742-1701	HUMAN OTC DRUG	BART PLUS		Arnica Montana, Echinacea (Angustifolia), Glycyrrhiza Glabra, Hydrastis Canadensis, Ledum Palustre, Thyroidinum (Suis), Arbutus Andrachne, Apis Mellifica, Arsenicum Album, Cocculus Indicus, Gunpowder, Hepar Sulphuris Calcareum, Kalmia Latifolia, Lac Caninum, Lycopodium Clavatum, Veratrum Album, Aconitum Napellus, Stramonium, Tellurium Metallicum	LIQUID	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ACTIVATED CHARCOAL; ANAMIRTA COCCULUS SEED; APIS MELLIFERA; ARBUTUS ANDRACHNE LEAFY SHOOT; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; CALCIUM SULFIDE; CANIS LUPUS FAMILIARIS MILK; DATURA STRAMONIUM; ECHINACEA ANGUSTIFOLIA WHOLE; GLYCYRRHIZA GLABRA; GOLDENSEAL; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; RHODODENDRON TOMENTOSUM LEAFY TWIG; TELLURIUM; THYROID, PORCINE; VERATRUM ALBUM ROOT	12; 12; 12; 12; 10; 3; 12; 12; 12; 12; 3; 6; 6; 12; 12; 6; 16; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1716_9e01945d-75af-4506-953d-74abc0a5425c	43742-1716	HUMAN OTC DRUG	BOBA HOMO		Babesia Microti, Borrelia Burgdorferi Nosode	LIQUID	ORAL	20201007		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BABESIA MICROTI; BORRELIA BURGDORFERI	15; 15	[hp_X]/mL; [hp_X]/mL			N	20241231
43742-1729_9b25a958-49d2-431a-a9f8-471e6456ed5f	43742-1729	HUMAN OTC DRUG	BRUC HOMO		Brucella Melitensis	LIQUID	ORAL	20201002		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BRUCELLA MELITENSIS	18	[hp_C]/mL			N	20241231
43742-1741_d4c66e4e-13ef-41cd-ab4a-5cf7c0277c69	43742-1741	HUMAN OTC DRUG	CAN1 PC		Candida Albicans	LIQUID	ORAL	20210412		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CANDIDA ALBICANS	1	[hp_M]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43742-1743_d27f9ff5-e5b9-4ca9-8b77-54b4512d2b97	43742-1743	HUMAN OTC DRUG	CAN200 PC		Candida Albicans	LIQUID	ORAL	20210514		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CANDIDA ALBICANS	200	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43742-1745_640047a3-fa2a-45e4-a07c-89cdae3fe017	43742-1745	HUMAN OTC DRUG	CAND HOMO		Candida Albicans	LIQUID	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CANDIDA ALBICANS	15	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43742-1759_5a9c60d9-0519-42c2-923e-3931f1964427	43742-1759	HUMAN OTC DRUG	Cand Plus		Hydrastis Canadensis, Berberis Vulgaris, Borax, Saccharum Officinale, Caffeinum, Gallicum Acidum, Indolum, Allium Sativum, Echinacea (Angustifolia), Asafoetida, Acetaldehyde, Folliculinum, Lycopodium Clavatum, Phytolacca Decandra, Pulsatilla (Pratensis), Sepia, Ustilago Maidis, Torula Cerevisiae	LIQUID	ORAL	20200922		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; BERBERIS VULGARIS ROOT BARK; CAFFEINE; ECHINACEA ANGUSTIFOLIA WHOLE; ESTRONE; FERULA ASSA-FOETIDA RESIN; GALLIC ACID MONOHYDRATE; GARLIC; GOLDENSEAL; INDOLE; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; PULSATILLA PRATENSIS WHOLE; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SUCROSE; USTILAGO MAYDIS	8; 6; 6; 8; 12; 8; 6; 8; 5; 6; 12; 12; 12; 60; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Plant Proteins [CS], Xanthines [CS]		N	20241231
43742-1771_378f24a3-42b9-4025-a05c-ad4bcd990c72	43742-1771	HUMAN OTC DRUG	CHLA HOMO		Chlamydia Trachomatis	LIQUID	ORAL	20210226		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CHLAMYDIA TRACHOMATIS	12	[hp_X]/mL			N	20241231
43742-1774_90b8e6d6-17b9-483c-8b06-11c55999c8d7	43742-1774	HUMAN OTC DRUG	CDIF HOMO		Clostridium Difficile	LIQUID	ORAL	20201007		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CLOSTRIDIUM DIFFICILE	15	[hp_X]/mL			N	20241231
43742-1787_485032da-51bb-45d0-a70a-d5bcb1854e24	43742-1787	HUMAN OTC DRUG	Lym Combination		Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Mycoplasma Pneumoniae, Morbillinum, Meningococcus Nosode, Hepatitis B Nosode	LIQUID	ORAL	20210514		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANAPLASMA PHAGOCYTOPHILUM; BABESIA MICROTI; BARTONELLA HENSELAE; BORRELIA BURGDORFERI; EHRLICHIA CANIS; HEPATITIS B VIRUS; MEASLES VIRUS; MYCOPLASMA PNEUMONIAE; NEISSERIA MENINGITIDIS	15; 15; 15; 15; 15; 15; 16; 15; 27	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1807_f4c7f1ba-69a6-4bf3-a2c7-052fd6240903	43742-1807	HUMAN OTC DRUG	CYTO HOMO		Cytomegalovirus Nosode	LIQUID	ORAL	20210514		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	HUMAN HERPESVIRUS 5	18	[hp_X]/mL			N	20241231
43742-1821_0b724525-8dd1-43a3-a34b-ce964dd9cd95	43742-1821	HUMAN OTC DRUG	EPST PLUS		Carduus Marianus, Cistus Canadensis, Dulcamara, Galium Aparine, Magnesia Muriatica, Natrum Sulphuricum, Viscum Album, Muriaticum Acidum, Folliculinum, Aqua Marina, Ailanthus Glandulosus, Baryta Muriatica, Cadmium Metallicum, Ceanothus Americanus, Cocculus Indicus, Iridium Metallicum, Thuja Occidentalis, Cinchona Officinalis, Calcarea Carbonica, Crotalus Cascavella	LIQUID	ORAL	20201007		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AILANTHUS ALTISSIMA FLOWERING TWIG; ANAMIRTA COCCULUS SEED; BARIUM CHLORIDE DIHYDRATE; CADMIUM; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; CROTALUS DURISSUS TERRIFICUS VENOM; ESTRONE; GALIUM APARINE WHOLE; HELIANTHEMUM CANADENSE; HYDROCHLORIC ACID; IRIDIUM; MAGNESIUM CHLORIDE; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE; SODIUM SULFATE; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 12; 12; 16; 8; 6; 6; 6; 12; 6; 6; 12; 10; 6; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1822_736ba712-b2ef-470f-8c18-82f07699a5e2	43742-1822	HUMAN OTC DRUG	Epst Homo		Epstein-Barr Virus Nosode	LIQUID	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN HERPESVIRUS 4	15	[hp_C]/mL			N	20241231
43742-1835_65ab3c53-1f32-4553-8818-86590696cee8	43742-1835	HUMAN OTC DRUG	GIAR HOMO		Giardia Lamblia	LIQUID	ORAL	20201007		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	GIARDIA LAMBLIA	11	[hp_C]/mL			N	20241231
43742-1848_c5d783df-36ae-4079-944b-decd221233e5	43742-1848	HUMAN OTC DRUG	HPYL HOMO		Helicobacter Pylori	LIQUID	ORAL	20201026		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HELICOBACTER PYLORI	15	[hp_X]/mL			N	20241231
43742-1849_b993a2f1-3b14-4e3c-806d-e9f17d274451	43742-1849	HUMAN OTC DRUG	HPYL PLUS		Angelica Archangelica, Geranium Maculatum, Hydrastis Canadensis, Sinapis Nigra, Symphytum Officinale, Ratanhia, Aceticum Acidum, Carbolicum Acidum, Ornithogalum Umbellatum, Abies Canadensis, Anacardium Orientale, Bismuthum Subnitricum, Condurango, Graphites, Iris Versicolor, Lycopodium Clavatum, Mezereum, Uranium Nitricum, Euphorbium Officinarum, Nux Vomica	LIQUID	ORAL	20201026	20270620	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ANGELICA ARCHANGELICA ROOT; BISMUTH SUBNITRATE; BLACK MUSTARD SEED; COMFREY ROOT; DAPHNE MEZEREUM BARK; EUPHORBIA RESINIFERA RESIN; GERANIUM MACULATUM ROOT; GOLDENSEAL; GRAPHITE; IRIS VERSICOLOR ROOT; KRAMERIA LAPPACEA ROOT; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; ORNITHOGALUM UMBELLATUM; PHENOL; SEMECARPUS ANACARDIUM JUICE; STRYCHNOS NUX-VOMICA SEED; TSUGA CANADENSIS WHOLE; URANYL NITRATE HEXAHYDRATE	9; 6; 12; 6; 6; 12; 12; 6; 6; 12; 12; 6; 12; 12; 10; 9; 12; 12; 10; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1903_9fcb2b7a-778d-4826-ac32-5e7827b70bc1	43742-1903	HUMAN OTC DRUG	Leaky Gut Formula		Alfalfa, Glycyrrhiza Glabra, Aloe, Astacus Fluviatilis, Berberis Aquifolium, Lac Defloratum, Natrum Carbonicum, Saccharum Officinale, Fel Tauri, Pancreas Suis, Pancreatinum, Fragaria Vesca, Antimonium Crudum, Carbo Vegetabilis, Euphorbium Officinarum, Lycopodium Clavatum, Magnesia Carbonica, Zincum Metallicum, Colibacillinum Cum Natrum Muriaticum, Proteus (Vulgaris)	LIQUID	ORAL	20201023	20251202	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALOE; ANTIMONY TRISULFIDE; ASTACUS ASTACUS; BERBERIS AQUIFOLIUM ROOT BARK; BOS TAURUS BILE; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; FRAGARIA VESCA FRUIT; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MEDICAGO SATIVA WHOLE; PANCRELIPASE; PROTEUS INCONSTANS; SKIM MILK; SODIUM CARBONATE; SUCROSE; SUS SCROFA PANCREAS; ZINC	12; 4; 12; 6; 6; 8; 15; 12; 9; 3; 12; 12; 3; 8; 15; 6; 6; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-1904_9aaeae16-bfb3-491b-80b9-bb892dfb14a8	43742-1904	HUMAN OTC DRUG	HGH Vitality		Agnus Castus, Ambra Grisea, Petroselinum Sativum, Estradiol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone,	LIQUID	ORAL	20210324	20270102	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.ALPHA.-LIPOIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM WHOLE; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 14; 8; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
43742-1905_80829322-e5bb-4d66-9c78-c3a935f57157	43742-1905	HUMAN OTC DRUG	HV 6 HOMO		Human Herpesvirus 6A, 6B	LIQUID	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HUMAN HERPESVIRUS 6	15	[hp_X]/mL			N	20241231
43742-1931_c1e13257-5a51-4409-a2c1-d5415644e558	43742-1931	HUMAN OTC DRUG	Glyreg		Aceticum Acidum, Cacao, Magnesia Sulphurica, Natrum Sulphuricum, Verbascum Thapsus, Glandula Suprarenalis Suis, Pancreas Suis, Cortisone Aceticum, Thyroidinum (Suis), Iodium, Lycopodium Clavatum, Phosphorus, Ranunculus Bulbosus, Saccharum Officinale, Vanadium Metallicum, Zincum Metallicum, Chromium Acidum, Culex Musca	LIQUID	ORAL	20201026		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc	ACETIC ACID; CHROMIUM TRIOXIDE; COCOA; CORTISONE ACETATE; CULEX PIPIENS; IODINE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; RANUNCULUS BULBOSUS WHOLE; SODIUM SULFATE; SUCROSE; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; THYROID, PORCINE; VANADIUM; VERBASCUM THAPSUS WHOLE; ZINC	3; 16; 6; 8; 16; 12; 12; 6; 12; 12; 6; 12; 8; 8; 8; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43742-1932_50415041-4139-4844-a184-12b0dd4df3e7	43742-1932	HUMAN OTC DRUG	INFL Combination		Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2019-2020, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20210324	20251125	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 9; 10; 10; 10; 3; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1933_d9b5145d-4ef7-4bbb-b588-baa80f0a24df	43742-1933	HUMAN OTC DRUG	BORR PLUS		Arnica Montana, Echinacea (Angustifolia), Taraxacum Officinale, Trifolium Pratense, Glycyrrhiza Glabra, Hydrastis Canadensis, Kalmia Latifolia, Ledum Palustre, Gunpowder, Adrenalinum, Thyroidinum (Suis), Arbutus Andrachne, Arsenicum Album, Cocculus Indicus, Lac Caninum, Lycopodium Clavatum, Phosphorus, Rhus Tox, Tellurium Metallicum	LIQUID	ORAL	20210420		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ANAMIRTA COCCULUS SEED; ARBUTUS ANDRACHNE LEAFY SHOOT; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; CANIS LUPUS FAMILIARIS MILK; ECHINACEA ANGUSTIFOLIA WHOLE; EPINEPHRINE; GLYCYRRHIZA GLABRA; GOLDENSEAL; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; SUS SCROFA THYROID; TARAXACUM OFFICINALE; TELLURIUM; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER	8; 12; 12; 3; 12; 12; 3; 8; 6; 6; 6; 12; 12; 6; 8; 3; 16; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1934_b1db4354-95ca-4b26-a46f-69e8b47fd8a7	43742-1934	HUMAN OTC DRUG	MYCCombination		Allium Cepa, Echinacea (Echinacea Angustifolia), Natrum Sulphuricum, Kali Carbonicum, Mephitis Mephitica, Sanguinaria Canadensis, Blatta Orientalis, Agaricus Muscarius, Antimonium Tartaricum, Arsenicum Iodatum, Carbolicum Acidum, Cinchona Officinalis, Ferrum Metallicum, Phytolacca Decandra, Secale Cornutum, Sulphuricum Acidum, Thuja Occidentalis, Ammonium Carbonicum, Aspergillus Niger	LIQUID	ORAL	20200921	20280707	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMANITA MUSCARIA FRUITING BODY; AMMONIUM CARBONATE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIIODIDE; ASPERGILLUS NIGER VAR. NIGER; BLATTA ORIENTALIS; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; ECHINACEA ANGUSTIFOLIA WHOLE; IRON; MEPHITIS MEPHITIS ANAL GLAND FLUID; ONION; PHENOL; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SANGUINARIA CANADENSIS ROOT; SODIUM SULFATE; SULFURIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 12; 12; 15; 8; 12; 12; 6; 12; 8; 6; 12; 12; 8; 8; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Vegetable Proteins [CS]		N	
43742-1935_b533fc14-9413-4705-b1b4-7bd9ffe76630	43742-1935	HUMAN OTC DRUG	MYCO HOMO		Mycoplasma Pneumoniae	LIQUID	ORAL	20210420		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	MYCOPLASMA PNEUMONIAE	15	[hp_X]/mL			N	20241231
43742-1948_27f12d1f-cc6d-40c2-bbd4-60e836d2286f	43742-1948	HUMAN OTC DRUG	Energy Catalyst		Viscum Album, Cobalt Gluconate, Cuprum Sulphuricum, Ferrous Fumarate, Magnesium Aspartate, Manganese Gluconate, Phosphorus, Potassium Aspartate, Sodium Molybdate, Adenosinum, Cyclophosphoricum, Cerium Oxalicum, Nickel Acetate, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Bromium, Cadmium Metallicum, Cerium Metallicum, Cesium Chloride, Dysprosium Metallicum, Erbium Metallicum, Alumina,	LIQUID	ORAL	20210315		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE CYCLIC PHOSPHATE; ALUMINUM; ALUMINUM OXIDE; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BROMINE; CADMIUM; CERIUM; CEROUS OXALATE NONAHYDRATE; CESIUM CHLORIDE; CHOLECALCIFEROL; CHROMIUM; COBALT; COBALTOUS GLUCONATE; COPPER; CUPRIC SULFATE; DYSPROSIUM; ERBIUM; EUROPIUM; FERROUS FUMARATE; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; INDIUM; IODINE; IRIDIUM; IRON; LANTHANUM; LEAD; LITHIUM; MAGNESIUM; MAGNESIUM ASPARTATE; MANGANESE; MANGANESE GLUCONATE; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NICKEL ACETATE; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POTASSIUM ASPARTATE; POTASSIUM CARBONATE; PRASEODYMIUM; PROTEUS MORGANII; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SILVER; SODIUM CHLORIDE; SODIUM MOLYBDATE; STRONTIUM; SULFUR; TANTALUM; TERBIUM; THALLIUM; TIN; TRIBASIC CALCIUM PHOSPHATE; URANIUM; VANADIUM; VISCUM ALBUM FRUITING TOP; YTTERBIUM OXIDE; ZINC	8; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 8; 12; 8; 8; 8; 6; 8; 6; 12; 12; 12; 6; 12; 12; 12; 12; 12; 8; 8; 8; 14; 12; 8; 8; 6; 8; 6; 30; 12; 8; 12; 12; 8; 30; 12; 12; 6; 12; 6; 8; 12; 30; 12; 12; 12; 8; 12; 8; 6; 8; 8; 30; 12; 12; 12; 8; 12; 8; 3; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin D [CS], Vitamin D [EPC]		N	20241231
43742-1949_7ea18e49-4c16-4002-8e8a-36e9539d276e	43742-1949	HUMAN OTC DRUG	Mood Swings		Camphora, Cimicifuga Racemosa, Crocus Sativus, Kali Bromatum, Lithium Carbonicum, Adrenalinum, Dopamine Hydrochloride, Hypothalamus Suis, Serotonin (Hydrochloride), Thyroidinum (Suis), Aconitum Napellus, Hyoscyamus Niger, Ignatia Amara, Oenanthe Crocata, Pulsatilla (Pratensis), Stramonium, Tarentula Hispana, Zincum Metallicum, Lachesis Mutus, Platinum Metallicum	LIQUID	ORAL	20210422		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS; BLACK COHOSH; CAMPHOR (NATURAL); DATURA STRAMONIUM; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; HYOSCYAMUS NIGER; LACHESIS MUTA VENOM; LITHIUM CARBONATE; LYCOSA TARANTULA; OENANTHE CROCATA ROOT; PLATINUM; POTASSIUM BROMIDE; PULSATILLA PRATENSIS WHOLE; SAFFRON; SEROTONIN HYDROCHLORIDE; STRYCHNOS IGNATII SEED; SUS SCROFA HYPOTHALAMUS; THYROID, PORCINE; ZINC	12; 6; 6; 12; 8; 8; 12; 12; 8; 12; 12; 18; 6; 12; 6; 8; 12; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Mood Stabilizer [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-1950_c1f37d29-e7d4-4550-928f-b15a797d407e	43742-1950	HUMAN OTC DRUG	Enviro I		Potassium Gluconate, Glandula Suprarenalis Suis, Hepar Suis, Coffea Tosta, Thea Sinensis, Carbo Vegetabilis, Ferrum Iodatum, Ferrum Metallicum, Gelsemium Sempervirens, Iodium, Iridium Metallicum, Lycopodium Clavatum, Pulsatilla (Pratensis), Selenium Metallicum, Zincum Metallicum, Peanut, Black Walnut, English Walnut, Amygdala Amara, Cashew, Coconut, Pecan, Brazil Nut, Tomato, Solanum Tuberosum, Piper Nigrum, Eggplant, Rape Seed Oil, Linum Usitatissimum, Sesame, Seed, Cheese (Stilton), Lac Vaccinum, Beef,	LIQUID	ORAL	20210226		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ANEMONE PRATENSIS; APPLE; ATLANTIC COD; ATLANTIC SALMON; BANANA; BEEF; BITTER ALMOND; BLACK WALNUT; BRAZIL NUT; CANOLA OIL; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM ROQUEFORTI CULTURED, AGED; CASHEW; CHICKEN; COCOA; COCONUT; COFFEA ARABICA SEED, ROASTED; COMMON SHRIMP; CORTISONE ACETATE; COW MILK; EDIBLE ROCK CRAB; EGG; EGGPLANT; ENGLISH WALNUT; FERROUS IODIDE; FLAX SEED; FRAGARIA VESCA FRUIT; GELSEMIUM SEMPERVIRENS ROOT; GREEN PEPPERCORN; GREEN TEA LEAF; HISTAMINE DIHYDROCHLORIDE; HYALURONIDASE; INTERFERON .GAMMA. PORCINE RECOMBINANT; IODINE; IRIDIUM; IRON; KIDNEY BEAN; LAMB; LYCOPODIUM CLAVATUM SPORE; NORTHERN BLUEFIN TUNA; ONION; ORANGE; PACIFIC OYSTER; PEANUT; PECAN; PORK; PORK LIVER; POTASSIUM GLUCONATE; SELENIUM; SEROTONIN HYDROCHLORIDE; SESAME SEED; SOLANUM TUBEROSUM WHOLE; SUS SCROFA ADRENAL GLAND; TOMATO; WHEAT; ZINC	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 10; 12; 10; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 10; 30; 30; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 6; 12; 30; 12; 12; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Endoglycosidase [EPC], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Glycoside Hydrolases [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Meat Proteins [EXT], Meat Proteins [EXT], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
43742-1951_1047fa05-94d6-4834-9fa9-9d00f2eb8fcd	43742-1951	HUMAN OTC DRUG	Metox		Allium Sativum, Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Stillingia Sylvatica, Trifolium Pratense, Ascorbicum Acidum, Cysteinum, L-Methionine, Phytolacca Decandra, Thyroidinum (Suis), Carbolicum Acidum, Formalinum, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Boron, Arsenicum Album, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Mercurius Solubilis, Plumbum Metallicum, Lanthanum Metallicum, Niobium Metallicum, Niobium,	LIQUID	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALUMINUM; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; ASCORBIC ACID; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; COBALT; COPPER; CYSTEINE; DYSPROSIUM; ERBIUM; EUROPIUM; FORMALDEHYDE; GADOLINIUM; GARLIC; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; GOLD; HOLMIUM; INDIUM; IODINE; IRIDIUM; IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MERCURIUS SOLUBILIS; METHIONINE; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHENOL; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PLATINUM; POTASSIUM CARBONATE; PRASEODYMIUM; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SILVER; SODIUM CHLORIDE; STILLINGIA SYLVATICA ROOT; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA THYROID; TANTALUM; TERBIUM; THALLIUM; TIN; TRIBASIC CALCIUM PHOSPHATE; TRIFOLIUM PRATENSE FLOWER; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 3; 12; 6; 12; 3; 12; 12; 12; 12; 12; 12; 12; 8; 8; 8; 6; 12; 12; 12; 12; 12; 3; 12; 3; 12; 12; 12; 8; 8; 8; 14; 12; 8; 12; 8; 8; 12; 8; 8; 12; 12; 30; 12; 12; 12; 8; 8; 12; 8; 12; 12; 12; 12; 8; 12; 8; 3; 8; 12; 8; 8; 30; 12; 12; 12; 8; 3; 12; 8; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vitamin C [EPC]		N	20241231
43742-1952_0f03c0a0-32f9-4dec-b22d-581676b14916	43742-1952	HUMAN OTC DRUG	Immune Support		Echinacea (Angustifolia), Arnica Montana, Baptisia Tinctoria, Sanguinaria Canadensis, Aristolochia Clematitis, Eupatorium Perfoliatum, Euphorbium Officinarum, Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Mercurius Corrosivus, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhus Tox, Sulphur, Thuja Occidentalis, Hepar Sulphuris Calcareum, Lachesis Mutus, Zincum Metallicum, Astragalus Membranaceus, Influenzinum (2020-2021), Spleen (Suis), Thymus,	LIQUID	ORAL	20210503	20260908	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARISTOLOCHIA CLEMATITIS ROOT; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASTRAGALUS PROPINQUUS ROOT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA PRATENSIS WHOLE; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; SULFUR; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP; ZINC	8; 6; 4; 8; 12; 4; 8; 10; 13; 1; 6; 6; 8; 12; 12; 12; 12; 10; 8; 8; 8; 8; 200; 4; 8; 8; 12; 12; 8; 8; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
43742-1953_495c4779-82ef-4d31-9149-4445dc3695bc	43742-1953	HUMAN OTC DRUG	INFL Combination		Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2020-2021, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20210603	20270105	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 9; 10; 10; 10; 10; 3; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-1954_646d2ae6-b96f-421b-a412-18f5d59d8d96	43742-1954	HUMAN OTC DRUG	Bio Placenta Phase		Aesculus Hippocastanum, Sarcolacticum Acidum, Cuprum Sulphuricum, Melilotus Officinalis, Placenta Totalis Suis, Solanum Nigrum, Strophanthus Hispidus, DHEA (Dehydroepiandrosterone), Quercetin, Rutin, Natrum Pyruvicum, Secale Cornutum, Vena Suis, Arteria Suis, Funiculus Umbilicalis Suis, Tabacum, Baryta Carbonica, Vipera Berus, Plumbum Iodatum, Astragalus Exscapus, Proteus (Vulgaris)	LIQUID	ORAL	20210503		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ASTRAGALUS EXSCAPUS WHOLE FLOWERING/FRUITING; BARIUM CARBONATE; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC SULFATE; HORSE CHESTNUT; LACTIC ACID, L-; LEAD IODIDE; MELILOTUS OFFICINALIS TOP; PRASTERONE; PROTEUS VULGARIS; QUERCETIN; RUTIN; SODIUM PYRUVATE; SOLANUM NIGRUM WHOLE; STROPHANTHUS HISPIDUS SEED; SUS SCROFA ARTERY; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA VEIN; TOBACCO LEAF; VIPERA BERUS VENOM	6; 13; 8; 6; 4; 4; 18; 6; 6; 30; 6; 6; 8; 6; 6; 10; 6; 10; 8; 10; 14	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43742-1955_3672a87c-22cd-4457-83da-86acdb4df951	43742-1955	HUMAN OTC DRUG	ENT Support		Pulsatilla (Pratensis), Euphorbium Officinarum, Luffa Operculata, Mercurius Iodatus Ruber, Argentum Nitricum, Hepar Sulphuris Calcareum, Influenzinum (2020-2021), Sinusitisinum, Aspergillus Niger, Candida Albicans, Gallicum Acidum, Mucor Racemosus, Mutabile Bacillus (Bach)	LIQUID	ORAL	20210607	20260802	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; SINUSITISINUM	10; 10; 10; 30; 6; 10; 12; 12; 12; 12; 6; 8; 10; 4; 10; 17	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-1956_0abd5317-05f9-44f7-938c-e1bc0c49e7ae	43742-1956	HUMAN OTC DRUG	Liver Drainage		Chelidonium Majus, Carduus Marianus, Schisandra Chinensis, Taraxacum Officinale, Berberis Vulgaris, Raphanus Sativus, Viscum Album, Chromium Picolinate, Cobalt Gluconate, Copper Gluconate, Magnesium Gluconate, Natrum Sulphuricum, Ptelea Trifoliate, Sarcolacticum Acidum, Sulphur Iodatum, Carbolicum Acidum, Cichorium Intybus, Flos, Gallbladder (Suis), Hepar Suis, Nux Vomica, Pancreas Suis, Vanadium Metallicum, Verbena Officinalis, Flos, Picrorhiza Kurroa	LIQUID	ORAL	20210615		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS WHOLE; CHROMIUM PICOLINATE; CICHORIUM INTYBUS FLOWER; COBALTOUS GLUCONATE; COPPER GLUCONATE; LACTIC ACID, L-; MAGNESIUM GLUCONATE; MILK THISTLE; PHENOL; PICRORHIZA KURROA WHOLE; PORK LIVER; PTELEA TRIFOLIATA BARK; RADISH; SCHISANDRA CHINENSIS FRUIT; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; SUS SCROFA GALLBLADDER; SUS SCROFA PANCREAS; TARAXACUM OFFICINALE; VANADIUM; VERBENA OFFICINALIS FLOWERING TOP; VISCUM ALBUM FRUITING TOP	3; 1; 6; 8; 6; 6; 6; 6; 2; 8; 10; 8; 6; 3; 2; 6; 8; 6; 8; 8; 2; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
43742-1967_34a01caa-95f5-4892-afa0-72c3b2b26c5b	43742-1967	HUMAN OTC DRUG	PEPT HOMO		Peptostreptococcus Anaerobius DNA	LIQUID	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	PEPTOSTREPTOCOCCUS ANAEROBIUS DNA	19	[hp_X]/mL			N	20241231
43742-1968_eb23d63f-e788-453e-a948-006944a3a3b4	43742-1968	HUMAN OTC DRUG	Cough		Ipecacuanha, Sticta Pulmonaria, Phosphorus, Antimonium Tartaricum, Kreosotum, Aconitum Napellus, Bryonia (Alba), Hyoscyamus Niger, Silicea, Tabacum, Pertussinum, Tetanus Toxin	LIQUID	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYOSCYAMUS NIGER; IPECAC; LOBARIA PULMONARIA; PHOSPHORUS; SILICON DIOXIDE; TETANUS TOXIN; TOBACCO LEAF; WOOD CREOSOTE	8; 6; 8; 30; 8; 4; 4; 5; 8; 30; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43742-1969_70493e78-cf8f-4f53-b3b9-a8549d0e9243	43742-1969	HUMAN OTC DRUG	REFL HS		Adenosinum Triphosphoricum Dinatrum, Nadidum, Argentum Nitricum, Ipecacuanha, Robinia Pseudoacacia, Sulphur, Origanum Vulgare, Duodenum (Suis), Esophagus (Suis), Funiculus Umbilicalis Suis, Stomach (Suis), Nux Vomica, Coumarinum, Erythraea Centaurium, Pancreatinum, Muriaticum Acidum, Citricum Acidum, Formicum Acidum, Sarcolacticum Acidum, Coenzyme A, Proteus (Morgani)	LIQUID	ORAL	20210423	20280426	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS CITRIC ACID; CENTAURIUM ERYTHRAEA; COENZYME A; COUMARIN; FORMIC ACID; HYDROCHLORIC ACID; IPECAC; LACTIC ACID, L-; NADIDE; OREGANO; PANCRELIPASE; PROTEUS MORGANII; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA STOMACH; SUS SCROFA UMBILICAL CORD	6; 6; 10; 8; 8; 6; 6; 6; 6; 6; 6; 12; 30; 6; 6; 8; 6; 8; 8; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-1970_82900b81-b2bf-42b1-bc08-5be3eb8c487f	43742-1970	HUMAN OTC DRUG	Detox	III	Dulcamara, Echinacea (Angustifolia), Aesculus Hippocastanum, Antimonium Tartaricum, Ascorbicum Acidum, Coccus Cacti, Galium Aparine, Gentiana Lutea, Geranium Robertianum, Pulsatilla (Pratensis), Sarcolacticum Acidum, Conium Maculatum, Lymph Node (Suis), Sulphur, Glandula Suprarenalis Suis, L-Phenylalanine, Calcarea Phosphorica, Ferrum Phosphoricum, Hepar Suis, Hypothalamus Suis, Spleen (Suis), Cortisone Aceticum, Mercurius Solubilis, Baryta Carbonica, Glyphosate, Funiculus Umbilicalis Suis,Tonsil (Suis),	LIQUID	ORAL	20201202		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY POTASSIUM TARTRATE; ASCORBIC ACID; BARIUM CARBONATE; BISPHENOL A; BROMINE; CHLORINE; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA WHOLE; ESCHERICHIA COLI; FERROSOFERRIC PHOSPHATE; GALIUM APARINE WHOLE; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM WHOLE; GLYPHOSATE; HORSE CHESTNUT; HYDROFLUORIC ACID; IODINE; LACTIC ACID, L-; LIOTHYRONINE; MERCURIUS SOLUBILIS; PHENYLALANINE; PORK LIVER; PROTORTONIA CACTI; PULSATILLA PRATENSIS WHOLE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA TONSIL; SUS SCROFA UMBILICAL CORD; TRIBASIC CALCIUM PHOSPHATE	6; 6; 28; 12; 12; 12; 8; 13; 4; 30; 10; 6; 6; 6; 1000; 6; 12; 12; 6; 18; 13; 8; 10; 6; 6; 9; 4; 8; 8; 12; 10; 8; 10; 6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Triiodothyronine [CS], Vitamin C [EPC], l-Triiodothyronine [EPC]		N	20241231
43742-1971_fb4f20aa-b580-44bc-b50f-7d50156334cb	43742-1971	HUMAN OTC DRUG	Immunogesic		Arnica Montana, Apis Mellifica, Benzoicum Acidum, Cartilago Suis, Ledum Palustre, Pantothenic Acid, Ruta Graveolens, Rhododendron Chrysanthum, Causticum, Formica Rufa, Sepia, Alpha-Lipoicum Acidum, Aurum Metallicum, Calcarea Phosphorica, Colchicum Autumnale, Phytolacca Decandra, Radium Bromatum, Rhus Venenata, Thuja Occidentalis, Lac Caninum	LIQUID	ORAL	20201005		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALPHA LIPOIC ACID; APIS MELLIFERA; ARNICA MONTANA WHOLE; BENZOIC ACID; CANIS LUPUS FAMILIARIS MILK; CAUSTICUM; COLCHICUM AUTUMNALE BULB; FORMICA RUFA; GOLD; PANTOTHENIC ACID; PHYTOLACCA AMERICANA ROOT; RADIUM BROMIDE; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SEPIA OFFICINALIS JUICE; SUS SCROFA CARTILAGE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON VERNIX LEAFY TWIG; TRIBASIC CALCIUM PHOSPHATE	12; 6; 3; 6; 16; 10; 12; 10; 12; 6; 12; 12; 8; 6; 6; 10; 6; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43742-1985_7ed8fddf-2141-46d6-8cb6-c998465a1105	43742-1985	HUMAN OTC DRUG	SINU HC		Plantago Major, Pulsatilla (Pratensis), Luffa Operculata, Mercurius Iodatus Ruber, Mucosa Nasalis Suis, Euphorbium Officinarum, Argentum Nitricum, Hepar Sulphuris Calcareum, Calcarea Carbonica, Natrum Muriaticum, Sinusitisinum	LIQUID	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CALCIUM SULFIDE; EUPHORBIA RESINIFERA RESIN; LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PLANTAGO MAJOR WHOLE; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; SINUSITISINUM; SODIUM CHLORIDE; SUS SCROFA NASAL MUCOSA	10; 9; 6; 8; 12; 3; 4; 10; 20; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-1986_584f142e-5f81-41d6-a3ff-903f47ff6248	43742-1986	HUMAN OTC DRUG	Stap Combination		Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Staphylococcus Aureus, Streptococcus Viridans	LIQUID	ORAL	20210514		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE TYPE B; KLEBSIELLA PNEUMONIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	12; 12; 15; 15; 12; 12; 12; 36	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43742-1988_0c0ad1de-a605-4c73-bb8a-e1bff1170b24	43742-1988	HUMAN OTC DRUG	STRE HOMO		Enterococcus Faecalis, Pheumococcinum, Streptococcus Viridans, Streptococcus Mutans	LIQUID	ORAL	20210420		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ENTEROCOCCUS FAECALIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	15; 15; 15; 15	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-2002_82ab84ae-ba82-4d84-97a1-51b26f455cdf	43742-2002	HUMAN OTC DRUG	TOXO HOMO		TOXOPLASMA GONDII DNA	LIQUID	ORAL	20201221		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	TOXOPLASMA GONDII DNA	15	[hp_X]/mL			N	20241231
43742-2015_4b729089-2968-40a8-b39f-2456f22ed22b	43742-2015	HUMAN OTC DRUG	STAP TAB		Staphylococcus Aureus, Klebsiella Pneumoniae, Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Mutans, Haemophilus Influenzae B, Streptococcus Viridans	TABLET	ORAL	20210729	20261130	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE TYPE B; KLEBSIELLA PNEUMONIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	15; 12; 15; 15; 15; 15; 12; 38	[hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	
43742-2018_fb25c700-12f7-4786-8759-89b7b6c11133	43742-2018	HUMAN OTC DRUG	VAXR HC		Thuja Occidentalis, Mezereum, Silicea, Calcarea Carbonica, Morbillinum, Parotidinum, Pertussinum, Rubella Nosode, Tetanus Toxin, Carcinosin, Antimonium Crudum, Ledum Palustre, Thimerosal, Poliomyelitis Nosode	LIQUID	ORAL	20201221		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY TRISULFIDE; BORDETELLA PERTUSSIS; CLOSTRIDIUM TETANI; DAPHNE MEZEREUM BARK; HUMAN BREAST TUMOR CELL; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MUMPS VIRUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POLIOVIRUS; RUBELLA VIRUS; SILICON DIOXIDE; THIMEROSAL; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 8; 15; 30; 30; 30; 30; 30; 30; 8; 30; 6	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
43742-2019_eba4ef3d-e1b6-4c9b-a504-e58fa82f605a	43742-2019	HUMAN OTC DRUG	Leaky Gut Formula		Alfalfa, Glycyrrhiza Glabra, Astacus Fluviatilis, Berberis Aquifolium, Lac Defloratum, Natrum Carbonicum, Saccharum Officinale, Aloe, Fel Tauri, Pancreas Suis, Pancreatinum, Fragaria Vesca, Antimonium Crudum, Carbo Vegetabilis, Euphorbium Officinarum, Lycopodium Clavatum, Magnesia Carbonica, Zincum Metallicum, Colibacillinum Cum Natrum Muriaticum, Proteus (Vulgaris)	LIQUID	ORAL	20210618	20280531	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALOE; ANTIMONY TRISULFIDE; ASTACUS ASTACUS; BERBERIS AQUIFOLIUM ROOT BARK; BOS TAURUS BILE; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; FRAGARIA VESCA FRUIT; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MEDICAGO SATIVA WHOLE; PANCRELIPASE; PROTEUS VULGARIS; SKIM MILK; SODIUM CARBONATE; SUCROSE; SUS SCROFA PANCREAS; ZINC	12; 7; 12; 6; 6; 8; 15; 12; 9; 3; 12; 12; 3; 8; 15; 6; 6; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43742-2020_583e8b58-b22e-4b85-bfcb-e44502c8f106	43742-2020	HUMAN OTC DRUG	Virimmune		Allium Sativum, Echinacea (Angustifolia), Ginkgo Biloba, Viscum Album, Hamamelis Virginiana, Aconitum Napellus, Allium Cepa, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Gelsemium Sempervirens, Mercurius Vivus, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Influenzinum, Morbillinum	LIQUID	ORAL	20210329	20260413	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS WHOLE; ECHINACEA ANGUSTIFOLIA WHOLE; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); MEASLES VIRUS; MERCURY; ONION; SELENIUM; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 3; 3; 12; 3; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-2021_644e91cf-eaa3-431e-81b9-81815e3e2a50	43742-2021	HUMAN OTC DRUG	DysBio Plus		Echinacea (Angustifolia), Aloe, Colchicum Autumnale, Colocynthis, Mercurius Corrosivus, Nux Vomica, Arsenicum Album, Aceticum Acidum, Chininum Sulphuricum, Cholera Nosode, Proteus (Vulgaris), Colibacillinum Cum Natrum Muriaticum, Helicobacter Pylori, Botulinum, Salmonella Typhi Nosode, Morgan Gaertner, Clostridium Difficile, Brugia Malayi	LIQUID	ORAL	20210628	20270926	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ALOE; ARSENIC TRIOXIDE; BOTULINUM TOXIN TYPE A; BRUGIA MALAYI; CITRULLUS COLOCYNTHIS FRUIT PULP; CLOSTRIDIUM DIFFICILE; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA WHOLE; ESCHERICHIA COLI; HELICOBACTER PYLORI; MERCURIC CHLORIDE; PROTEUS VULGARIS; QUININE SULFATE; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; STRYCHNOS NUX-VOMICA SEED; VIBRIO CHOLERAE	12; 7; 8; 30; 39; 8; 30; 8; 3; 30; 30; 8; 16; 12; 30; 33; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-2022_1c6082ef-d671-4c6f-ab37-0f71379ed579	43742-2022	HUMAN OTC DRUG	VIR Combination		Influenzinum (2019-2020), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode	LIQUID	ORAL	20200922	20260127	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED)	33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-2034_b26773cb-526e-4be5-9d36-569e45e2db89	43742-2034	HUMAN OTC DRUG	Bronchial Cough		Coccus Cacti, Drosera (Rotundifolia), Scilla Maritima, Sticta Pulmonaria, Causticum, Cuprum Aceticum, Arsenicum Iodatum, Carbo Vegetabilis, Kali Carbonicum, Lachesis Mutus	LIQUID	ORAL	20210803		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIIODIDE; CAUSTICUM; CUPRIC ACETATE; DRIMIA MARITIMA BULB; DROSERA ROTUNDIFOLIA WHOLE; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; POTASSIUM CARBONATE; PROTORTONIA CACTI	12; 8; 6; 6; 5; 4; 12; 4; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-2035_306992e3-5fb0-43fc-8d3c-273f0c4fd270	43742-2035	HUMAN OTC DRUG	Virimmune		Allium Sativum, Echinacea (Angustifolia), Ginkgo Biloba, Viscum Album, Hamamelis Virginiana, Aconitum Napellus, Allium Cepa, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Gelsemium Sempervirens, Mercurius Vivus, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Influenzinum (2020-2021), Morbillinum	LIQUID	ORAL	20210722	20260928	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS WHOLE; ECHINACEA ANGUSTIFOLIA WHOLE; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); MEASLES VIRUS; MERCURY; ONION; SELENIUM; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 3; 3; 12; 3; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-2036_8df251cd-be49-44d3-b456-badf4ba1c4af	43742-2036	HUMAN OTC DRUG	Vir Combination		Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode	LIQUID	ORAL	20210909	20261001	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-2037_f516cd17-9902-4963-b60e-0ed77c033c53	43742-2037	HUMAN OTC DRUG	Pollutox		Sulphuricum Acidum, Berberis Vulgaris, Arsenicum Album, Benzinum, Cadmium Sulphuratum, Hydrofluoricum Acidum, Melatonin, Nitrogenum Oxygenatum, Nux Vomica, Petroleum, Plumbum Metallicum, Stannum Metallicum, Toluene, Acetone, Carbon Dioxide, Chlorinum, Mercurius Solubilis, Uranium Nitricum, Ozone	LIQUID	ORAL	20230721	20270718	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETONE; ARSENIC TRIOXIDE; BENZENE; BERBERIS VULGARIS ROOT BARK; CADMIUM SULFIDE; CARBON DIOXIDE; CHLORINE; HYDROFLUORIC ACID; KEROSENE; LEAD; MELATONIN; MERCURIUS SOLUBILIS; NITROUS OXIDE; OZONE; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; TIN; TOLUENE; URANYL NITRATE HEXAHYDRATE	12; 12; 12; 8; 12; 12; 12; 12; 12; 12; 12; 12; 12; 16; 12; 6; 12; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Radiographic Contrast Agent [EPC], Seed Storage Proteins [CS], X-Ray Contrast Activity [MoA]		N	
43742-2038_87a350b4-4d14-487f-83f8-cae4728fb498	43742-2038	HUMAN OTC DRUG	Detox	II	Solidago Virgaurea, Baptisia Tinctoria, Berberis Vulgaris, Equisetum Hyemale, Argentum Nitricum, Cantharis, Capsicum Annuum, Cuprum Sulphuricum, Orthosiphon Stamineus, Sarsaparilla (Smilax Regelii), Barosma (Betulina), Mercurius Corrosivus, Pareira Brava, Pyelon (Suis), Terebinthina, Ureter (Suis), Urethra (Suis), Urinary Bladder (Suis), Acetaldehyde, Hepar Sulphuris Calcareum, Natrum Pyruvicum, Quercetin, Colibacillinum Cum Natrum Muriaticum, Apis Venenum Purum, Dysentery Bacillus	LIQUID	ORAL	20211004		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETALDEHYDE; AGATHOSMA BETULINA LEAF; APIS MELLIFERA VENOM; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CAPSICUM; CHONDRODENDRON TOMENTOSUM ROOT; CUPRIC SULFATE; EQUISETUM HYEMALE WHOLE; ESCHERICHIA COLI; LYTTA VESICATORIA; MERCURIC CHLORIDE; ORTHOSIPHON ARISTATUS WHOLE; QUERCETIN; SHIGELLA DYSENTERIAE; SILVER NITRATE; SMILAX ORNATA ROOT; SODIUM PYRUVATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA RENAL PELVIS; SUS SCROFA URETER; SUS SCROFA URETHRA; SUS SCROFA URINARY BLADDER; TURPENTINE OIL	10; 8; 18; 4; 4; 10; 6; 8; 6; 4; 15; 6; 8; 6; 10; 30; 6; 6; 10; 3; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
43742-2039_daed2a82-7ae8-4d71-aebc-ead613329e70	43742-2039	HUMAN OTC DRUG	VACC HC		Hepar Suis, Histaminum Hydrochloricum, Thuja Occidentalis, RNA, Echinacea (Angustifolia), Ledum Palustre, Mezereum, Silicea, Influenzinum (2021-2022), Antimonium Tartaricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Hyoscyamus Niger, Lac Felinum, Mercurius Solubilis, Nicotinamidum, Senega Officinalis, Spigelia Anthelmia, Sulphur, Zincum Metallicum	LIQUID	ORAL	20211101	20270418	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA WHOLE; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA WHOLE; FELIS CATUS MILK; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; HYOSCYAMUS NIGER; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); MERCURIUS SOLUBILIS; NIACINAMIDE; POLYGALA SENEGA ROOT; PORK LIVER; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SPIGELIA ANTHELMIA WHOLE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; ZINC	30; 30; 30; 12; 12; 30; 30; 6; 30; 12; 12; 12; 12; 30; 30; 30; 6; 12; 10; 12; 30; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43742-2040_730cbe69-d67d-4041-bb71-46cc2829bcda	43742-2040	HUMAN OTC DRUG	Vir Combination		Influenzinum (2021-2022), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode	LIQUID	ORAL	20220202	20270823	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12; 12	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-2041_fd47b576-5f8b-4032-8795-968f13d6615b	43742-2041	HUMAN OTC DRUG	ENT Support		Pulsatilla (Pratensis), Euphorbium Officinarum, Luffa Operculata, Mercurius Iodatus Ruber, Argentum Nitricum, Hepar Sulphuris Calcareum, Influenzinum (2021-2022), Sinusitisinum, Aspergillus Niger, Candida Albicans, Gallicum Acidum, Mucor Racemosus, Mutabile Bacillus (Bach)	LIQUID	ORAL	20211122	20270805	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; SINUSITISINUM	10; 10; 10; 30; 6; 10; 12; 12; 12; 12; 6; 8; 10; 4; 10; 17	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43742-2042_b71e5b3f-2264-4aed-b290-f9dfe897c548	43742-2042	HUMAN OTC DRUG	Immune Support		Echinacea (Angustifolia), Arnica Montana, Baptisia Tinctoria, Sanguinaria Canadensis, Aristolochia Clematitis, Eupatorium Perfoliatum, Euphorbium Officinarum, Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Mercurius Corrosivus, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhus Tox, Sulphur, Thuja Occidentalis, Hepar Sulphuris Calcareum, Lachesis Mutus, Zincum Metallicum, Astragalus Membranaceus, Influenzinum (2021-2022), Spleen (Suis), Thymus,	LIQUID	ORAL	20211123	20270719	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARISTOLOCHIA CLEMATITIS ROOT; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASTRAGALUS PROPINQUUS ROOT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA PRATENSIS WHOLE; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; SULFUR; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP; ZINC	8; 6; 4; 8; 12; 4; 8; 10; 13; 1; 6; 6; 8; 12; 12; 12; 12; 10; 8; 8; 8; 8; 200; 4; 8; 8; 12; 12; 8; 8; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
43742-2043_70f8f3c4-f666-41a0-bded-65f469bfa33b	43742-2043	HUMAN OTC DRUG	Ver		Artemisia Vulgaris, Ascaris Lumbricoides, Brugia Malayi, Calcarea Carbonica, Cina, Cryptosporidium Parvum, Enterobius Vermicularis, Filix Mas, Giardia Lamblia, Graphites, Iodium, Mercurius Corrosivus, Quassia (Amara), Sabadilla, Silicea, Spigelia Anthelmia, Taenia Saginata, Taenia Solium, Teucrium Marum, Thymus Serpyllum, Trichinella Spiralis, Trichomonas Vaginalis	LIQUID	ORAL	20230310		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; ASCARIS LUMBRICOIDES; BRUGIA MALAYI; CRYPTOSPORIDIUM PARVUM; DRYOPTERIS FILIX-MAS ROOT; ENTEROBIUS VERMICULARIS; GIARDIA LAMBLIA; GRAPHITE; IODINE; MERCURIC CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; QUASSIA AMARA WOOD; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SPIGELIA ANTHELMIA WHOLE; TAENIA SAGINATA; TAENIA SOLIUM; TEUCRIUM MARUM WHOLE; THYMUS SERPYLLUM WHOLE; TRICHINELLA SPIRALIS; TRICHOMONAS VAGINALIS	8; 2; 15; 39; 20; 7; 33; 18; 12; 12; 12; 12; 3; 12; 8; 8; 20; 12; 3; 3; 15; 13	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
43742-2044_08746abb-f4e4-4077-adbd-88bb0ef08285	43742-2044	HUMAN OTC DRUG	Virimmune		Allium Sativum, Echinacea (Angustifolia), Ginkgo Biloba, Viscum Album, Hamamelis Virginiana, Aconitum Napellus, Allium Cepa, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Gelsemium Sempervirens, Mercurius Vivus, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Influenzinum (2021-2022), Morbillinum	LIQUID	ORAL	20220301	20270927	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS WHOLE; ECHINACEA ANGUSTIFOLIA WHOLE; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); MEASLES VIRUS; MERCURY; ONION; SELENIUM; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 3; 3; 12; 3; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43742-2045_1edbe15b-3773-4eb3-a02d-7cfb3d8ca251	43742-2045	HUMAN OTC DRUG	INFL Combination		Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2021-2022, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20220202	20271004	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 9; 10; 10; 30; 10; 3; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	
43742-2046_91fbebb5-5a50-4ba7-aac7-58eb44ecd96a	43742-2046	HUMAN OTC DRUG	High Vitality Tab		Agnus Castus, Ambra Grisea, Estradiol, L-Dopa, Melatonin, Petroselinum Sativum, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Testosterone, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone,	TABLET	ORAL	20220210	20270201	UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMBERGRIS; BARIUM CARBONATE; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM WHOLE; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 8; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
43742-2051_ad9bd876-5db2-4805-a8a8-e3000ba4e30a	43742-2051	HUMAN OTC DRUG	High Vitality		Agnus Castus, Ambra Grisea, Petroselinum Sativum, Estradiol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, GABA, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Apiolum,	LIQUID	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM WHOLE; PORK LIVER; PROTEUS MORGANII; SELENIUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	30; 8; 8; 6; 14; 8; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]	CIII	N	20241231
43742-2052_d2ad486a-44c3-4ea5-b464-87dd6c02deff	43742-2052	HUMAN OTC DRUG	Systemic Detox		Boldo, Carduus Marianus, Chelidonium Majus, Sarsaparilla (Smilax Regelii), Gelsemium Sempervirens, Veratrum Album, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Pratensis), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20220621	20270803	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CHELIDONIUM MAJUS WHOLE; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PEUMUS BOLDUS LEAF; PULSATILLA PRATENSIS WHOLE; SELENIUM; SMILAX ORNATA ROOT; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	3; 8; 12; 12; 12; 3; 3; 12; 12; 6; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-2055_1b9a0e3a-e90e-48b7-b801-d9de31a90d5a	43742-2055	HUMAN OTC DRUG	Addiclenz		Boldo, Carduus Marianus, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Bisphenol A, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Phosphoricum Acidum, Selenium Metallicum, Zincum Metallicum, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methyl Paraben, Propyl Paraben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum	LIQUID	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BISPHENOL A; CHELIDONIUM MAJUS WHOLE; COBALT; COPPER; FORMALDEHYDE SOLUTION; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; MILK THISTLE; PETROSELINUM CRISPUM WHOLE; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE, UNSPECIFIED FORM; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE	12; 30; 30; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43742-2057_491f8f1a-e83d-41ff-b5c0-221a24da91fc	43742-2057	HUMAN OTC DRUG	Stress	EZ	Ginkgo Biloba, Hydrocotyle Asiatica, Lomatium Dissectum, Cobaltum Metallicum, Cuprum Metallicum, Gelsemium Sempervirens, Iodium, Vanadium Metallicum, Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos	LIQUID	ORAL	20220714	20270627	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	CENTELLA ASIATICA WHOLE; CLEMATIS VITALBA FLOWER; COBALT; COPPER; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; IODINE; LOMATIUM DISSECTUM ROOT; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER; VANADIUM	3; 30; 12; 12; 12; 3; 30; 30; 12; 3; 30; 30; 12	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	
43742-2058_5c32e0c9-168b-4f41-b3db-ba24f651e7bd	43742-2058	HUMAN OTC DRUG	Adrenal Support		Humulus Lupulus, Adrenalinum, Cortisone Aceticum, Selenium Metallicum, Thyroidinum (Suis), Arsenicum Album, Calcarea Carbonica, Convallaria Majalis, Crotalus Horridus, Ferrum Metallicum, Nux Vomica, Phosphorus, Sepia, Phosphoricum Acidum	LIQUID	ORAL	20220621	20270628	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARSENIC TRIOXIDE; CONVALLARIA MAJALIS; CORTISONE ACETATE; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; HOPS; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; THYROID, PORCINE	12; 12; 8; 12; 8; 3; 12; 12; 30; 12; 8; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43742-2060_7b0019f9-c865-4843-a231-590914aec772	43742-2060	HUMAN OTC DRUG	Systemic Detox		Boldo, Chelidonium Majus, Sarsaparilla (Smilax Regelii), Gelsemium Sempervirens, Veratrum Album,Beta Vulgaris, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Pratensis), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BETA VULGARIS WHOLE; CHELIDONIUM MAJUS WHOLE; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PULSATILLA PRATENSIS WHOLE; SELENIUM; SMILAX ORNATA WHOLE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	12; 3; 8; 12; 12; 12; 3; 12; 12; 6; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-2063_01b2162a-9b3a-4eed-b3ad-c69cca1c6431	43742-2063	HUMAN OTC DRUG	Adrenal Support		Aralia Quinquefolia, Humulus Lupulus, Adrenalinum, Cortisone Aceticum, Selenium Metallicum, Thyroidinum (Suis), Arsenicum Album, Calcarea Carbonica, Convallaria Majalis, Crotalus Horridus, Ferrum Metallicum, Nux Vomica, Phosphorus, Sepia, Phosphoricum Acidum	LIQUID	ORAL	20221108		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMERICAN GINSENG; ARSENIC TRIOXIDE; CONVALLARIA MAJALIS; CORTISONE ACETATE; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; HOPS; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; THYROID	3; 12; 12; 8; 12; 8; 3; 12; 12; 30; 12; 8; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43742-2065_20566c13-1623-4c8a-bdf5-8a8bd1bc5185	43742-2065	HUMAN OTC DRUG	Immune Support		Echinacea (Angustifolia), Arnica Montana, Baptisia Tinctoria, Sanguinaria Canadensis, Aristolochia Clematitis, Eupatorium Perfoliatum, Euphorbium Officinarum, Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Mercurius Corrosivus, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhus Tox, Sulphur, Thuja Occidentalis, Hepar Sulphuris Calcareum, Lachesis Mutus, Zincum Metallicum, Astragalus Membranaceus, Influenzinum (2022-2023), Spleen (Suis), Thymus,	LIQUID	ORAL	20221229		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARISTOLOCHIA CLEMATITIS ROOT; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASTRAGALUS MONGHOLICUS ROOT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA PRATENSIS WHOLE; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; SILVER NITRATE; SULFUR; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP; ZINC	8; 6; 4; 8; 12; 4; 8; 10; 13; 1; 6; 6; 8; 12; 12; 12; 12; 10; 8; 8; 8; 8; 200; 4; 8; 8; 12; 12; 8; 8; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43742-2067_ebe1feb9-f9a3-416e-9491-7aa70cd2011d	43742-2067	HUMAN OTC DRUG	Virimmune		Allium Sativum, Echinacea (Angustifolia), Ginkgo Biloba, Viscum Album, Hamamelis Virginiana, Aconitum Napellus, Allium Cepa, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Gelsemium Sempervirens, Mercurius Vivus, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Influenzinum (2022-2023), Morbillinum	LIQUID	ORAL	20221229		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS WHOLE; ECHINACEA ANGUSTIFOLIA WHOLE; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); MEASLES VIRUS; MERCURY; ONION; SELENIUM; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 3; 3; 12; 3; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
43742-2077_5b85850b-e67e-480f-b9f0-23626b32fc1d	43742-2077	HUMAN OTC DRUG	Female Support		Chamomilla, Cimicifuga Racemosa, Helonias Dioica, Mentha Piperita, Senna (Cassia Angustifolia), Valeriana Officinalis, Viola Odorata, Agnus Castus, Ledum Palustre, Lilium Tigrinum, Staphysagria, Crocus Sativus, Hydrastis Canadensis, Cinchona Officinalis, Convallaria Majalis, Cyclamen Europaeum, Cinnamomum, Murex Purpurea, Naja Tripudians	LIQUID	ORAL	20230203		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	BLACK COHOSH; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CINNAMON; CONVALLARIA MAJALIS; CYCLAMEN PURPURASCENS TUBER; DELPHINIUM STAPHISAGRIA SEED; GOLDENSEAL; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA CHAMOMILLA WHOLE; MENTHA X PIPERITA WHOLE; NAJA NAJA VENOM; RHODODENDRON TOMENTOSUM LEAFY TWIG; SAFFRON; SENNA LEAF; VALERIAN; VIOLA ODORATA WHOLE	3; 3; 4; 8; 12; 8; 8; 4; 6; 12; 4; 3; 3; 15; 4; 6; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
43742-2078_4fd5ecae-90c9-4801-8c70-4a91424934a3	43742-2078	HUMAN OTC DRUG	Perfect Sleep		Adenosinum Triphosphoricum Dinatrum, Pantothenic Acid, Pineal Gland (Suis), Sarcolacticum Acidum, Ubidecarenonum, L-Tryptophan, Melatonin, Pyrrole, Arsenicum Album, Avena Sativa, Chamomilla, Coffea Cruda, Mercurius Corrosivus, Passiflora Incarnata, Silicea, Zincum Valerianicum, Dysentery Bacillus, Gaertner Bacillus	TABLET	ORAL	20230220		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; LACTIC ACID, L-; MATRICARIA CHAMOMILLA WHOLE; MELATONIN; MERCURIC CHLORIDE; PANTOTHENIC ACID; PASSIFLORA INCARNATA FLOWERING TOP; PYRROLE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SHIGELLA DYSENTERIAE; SILICON DIOXIDE; SUS SCROFA PINEAL GLAND; TRYPTOPHAN; UBIDECARENONE; ZINC VALERATE DIHYDRATE	8; 10; 10; 10; 8; 10; 8; 10; 8; 10; 8; 30; 30; 10; 8; 8; 8; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-2079_83a1759f-f2de-4ef4-874a-75e73a8b7824	43742-2079	HUMAN OTC DRUG	INFL Combination		Eucalyptus Globulus, Ipecacuanha, Aconitum Napellus, Adenoviren Nosode, Influenzinum 2022-2023, Bryonia, Eupatorium Perfoliatum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride	LIQUID	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACONITUM NAPELLUS WHOLE; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); IPECAC; VERATRUM VIRIDE ROOT; WOOD CREOSOTE	6; 30; 2; 30; 30; 9; 10; 10; 10; 10; 3; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	20241231
43742-2080_357a8667-22a8-4c7f-8e34-a897f3dac3b4	43742-2080	HUMAN OTC DRUG	Radiation Plus		Fucus Vesiculosus, Thyroidinum (Suis), Cadmium Sulphuratum, Colchicum Autumnale, DNA, Iodium, Plumbum Metallicum, Radium Bromatum, Strontium Carbonicum, Viscum Album, X-Ray, Arnica Montana	LIQUID	ORAL	20230411		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); ARNICA MONTANA WHOLE; CADMIUM SULFIDE; COLCHICUM AUTUMNALE BULB; FUCUS VESICULOSUS; HERRING SPERM DNA; IODINE; LEAD; RADIUM BROMIDE; STRONTIUM CARBONATE; THYROID, PORCINE; VISCUM ALBUM FRUITING TOP	30; 30; 12; 12; 3; 12; 12; 12; 12; 12; 8; 12	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-2081_f61aa359-ee46-4734-8f79-353d123a0ee6	43742-2081	HUMAN OTC DRUG	HPYL PLUS		Angelica Archangelica, Geranium Maculatum, Hydrastis Canadensis, Sinapis Nigra, Symphytum Officinale, Ratanhia, Aceticum Acidum, Carbolicum Acidum, Ornithogalum Umbellatum, Abies Canadensis, Anacardium Orientale, Bismuthum Subnitricum, Condurango, Graphites, Iris Versicolor, Kali Bichromicum, Lycopodium Clavatum, Mezereum, Euphorbium Officinarum, Nux Vomica	LIQUID	ORAL	20230410	20280315	UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ANGELICA ARCHANGELICA ROOT; BISMUTH SUBNITRATE; BLACK MUSTARD SEED; COMFREY ROOT; DAPHNE MEZEREUM BARK; EUPHORBIA RESINIFERA RESIN; GERANIUM MACULATUM ROOT; GOLDENSEAL; GRAPHITE; IRIS VERSICOLOR ROOT; KRAMERIA LAPPACEA ROOT; LYCOPODIUM CLAVATUM SPORE; ORNITHOGALUM UMBELLATUM WHOLE; PHENOL; POTASSIUM DICHROMATE; RUEHSSIA CUNDURANGO BARK; SEMECARPUS ANACARDIUM JUICE; STRYCHNOS NUX-VOMICA SEED; TSUGA CANADENSIS FLOWER BUD	9; 6; 12; 6; 6; 12; 12; 6; 6; 12; 12; 6; 12; 10; 9; 12; 12; 12; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43742-2082_fb3013de-ec20-45b9-bd18-db4799494297	43742-2082	HUMAN OTC DRUG	Electrolyte Plus		Kali Muriaticum, L-Arginine, L-Carnitine, L-Leucine, L-Ornithine, L-Valine, Magnesia Muriatica, Ascorbicum Acidum, Borax, Chromium Oxydatum, Ferrum Muriaticum, Kali Carbonicum, Magnesium Gluconicum Dihydricum, Natrum Muriaticum, Zincum Gluconicum, Cuprum Metallicum, Kali Phosphoricum, Niccolum Metallicum, Selenium Metallicum, Vanadium Metallicum, Calcarea Carbonica, Calcarea Phosphorica, Manganum Carbonicum	LIQUID	ORAL	20231010		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARGININE; ASCORBIC ACID; CHROMIC OXIDE; COPPER; DIBASIC POTASSIUM PHOSPHATE; FERRIC CHLORIDE HEXAHYDRATE; LEUCINE; LEVOCARNITINE; MAGNESIUM CHLORIDE; MAGNESIUM GLUCONATE; MANGANESE CARBONATE; NICKEL; ORNITHINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; SELENIUM; SODIUM BORATE; SODIUM CHLORIDE; TRIBASIC CALCIUM PHOSPHATE; VALINE; VANADIUM; ZINC GLUCONATE	3; 6; 6; 8; 8; 6; 3; 3; 3; 6; 9; 8; 3; 9; 6; 3; 8; 6; 6; 9; 3; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Carnitine Analog [EPC], Carnitine [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Iron [CS], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin C [EPC]		N	20241231
43742-2083_aa7e82cf-62d9-44d9-9632-3b1d66b7e87b	43742-2083	HUMAN OTC DRUG	Eye Support		Allium Cepa, Symphytum Officinale, Argentum Nitricum, Eye (Suis), Vaccinium Myrtillus, Apis Mellifica, Calcarea Fluorica, Carboneum Sulphuratum, Cedron, Gelsemium Sempervirens, Kali Iodatum, Nux Moschata, Phosphorus, Physostigma Venenosum, Staphysagria	LIQUID	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	APIS MELLIFERA; BILBERRY; CALCIUM FLUORIDE; CARBON DISULFIDE; COMFREY ROOT; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; HOMALOLEPIS CEDRON SEED; NUTMEG; ONION; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; POTASSIUM IODIDE; SILVER NITRATE; SUS SCROFA EYE	12; 6; 12; 12; 6; 12; 12; 12; 12; 6; 12; 12; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43742-2084_b85333c6-adcb-4bca-b260-9e78274da8c5	43742-2084	HUMAN OTC DRUG	Dysbio Plus		Echinacea (Angustifolia), Aloe, Colchicum Autumnale, Colocynthis, Mercurius Corrosivus, Nux Vomica, Arsenicum Album, Aceticum Acidum, Chininum Sulphuricum, Cholera Nosode, Proteus (Vulgaris), Colibacillinum Cum Natrum Muriaticum, Helicobacter Pylori, Botulinum, Salmonella Typhi Nosode, Morgan Gaertner, Clostridium Difficile, Brugia Malayi	LIQUID	ORAL	20230418		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ALOE; ARSENIC TRIOXIDE; BRUGIA MALAYI; CITRULLUS COLOCYNTHIS FRUIT PULP; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM DIFFICILE; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA WHOLE; ESCHERICHIA COLI; HELICOBACTER PYLORI; MERCURIC CHLORIDE; PROTEUS VULGARIS; QUININE SULFATE; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; STRYCHNOS NUX-VOMICA SEED; VIBRIO CHOLERAE	12; 7; 8; 39; 8; 30; 30; 8; 3; 30; 30; 8; 16; 12; 30; 33; 8; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-2085_e45af173-6f1c-48f0-929e-8c862d408935	43742-2085	HUMAN OTC DRUG	HA2CG Evolution		7-Oxo-Dehydroepiandrosterone 3-Acetate, AACG-A, AACG-B, Adenosinum Triphosphoricum Dinatrum, Asclepias Vincetoxicum, Calcarea Carbonica, Cerebrum Suis, Echinacea (Angustifolia), Gambogia, Gelsemium Sempervirens, Graphites, Hepar Suis, Hypothalamus (Suis), Insulinum (Suis), Kidney (Suis), Methylcobalamin, Nux Vomica, Pancreas Suis, Phytolacca Decandra, Proteus (Vulgaris), Sarcolacticum Acidum, Stomach (Suis)	LIQUID	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; ECHINACEA ANGUSTIFOLIA WHOLE; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH; VINCETOXICUM HIRUNDINARIA ROOT	30; 30; 8; 8; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 12; 6; 8; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-2086_80a7791e-f08d-46eb-925b-483b6d063503	43742-2086	HUMAN OTC DRUG	Kidney Drainage		Solidago Virgaurea, Asparagus Officinalis, Juniperus Communis, Sabal Serrulata, Uva-Ursi, Berberis Vulgaris, Equisetum Arvense, Urtica Dioica, Rubia Tinctorum, Staphysagria, Cantharis, Fagus Sylvatica, Flos, Glandula Suprarenalis Suis, Hepar Sulphuris Calcareum, Kidney (Suis), Larix Decidua, Flos, Manganum Metallicum, Mimulus Guttatus, Flos, Nitricum Acidum, Rhus Aromatica, Silicea, Ulex Europaeus, Flos, Benzoicum Acidum, Cobaltum Metallicum	LIQUID	ORAL	20230627		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; ASPARAGUS; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; COBALT; DELPHINIUM STAPHISAGRIA SEED; EQUISETUM ARVENSE TOP; FAGUS SYLVATICA FLOWERING TOP; JUNIPER BERRY; LARIX DECIDUA FLOWERING TOP; LYTTA VESICATORIA; MANGANESE; MIMULUS GUTTATUS FLOWERING TOP; NITRIC ACID; PORK KIDNEY; RHUS AROMATICA ROOT BARK; RUBIA TINCTORUM ROOT; SAW PALMETTO; SILICON DIOXIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; ULEX EUROPAEUS FLOWER; URTICA DIOICA WHOLE	2; 2; 12; 3; 8; 16; 6; 3; 8; 2; 8; 8; 8; 8; 8; 8; 8; 6; 2; 8; 1; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
43742-2087_6a8d4c04-0dad-43ad-8868-a85b806e4666	43742-2087	HUMAN OTC DRUG	VACC HC		Hepar Suis, Histaminum Hydrochloricum, Thuja Occidentalis, RNA, Echinacea (Angustifolia), Ledum Palustre, Mezereum, Silicea, Influenzinum, Antimonium Tartaricum, Arsenicum Album, Bryonia (Alba), Gelsemium Sempervirens, Hyoscyamus Niger, Lac Felinum, Mercurius Solubilis, Nicotinamidum, Senega Officinalis, Spigelia Anthelmia, Sulphur, Zincum Metallicum	LIQUID	ORAL	20230718		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA WHOLE; FELIS CATUS MILK; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; HYOSCYAMUS NIGER; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); MERCURIUS SOLUBILIS; NIACINAMIDE; POLYGALA SENEGA ROOT; PORK LIVER; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SPIGELIA ANTHELMIA WHOLE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; ZINC	30; 30; 30; 12; 12; 30; 30; 6; 30; 12; 12; 12; 12; 30; 30; 30; 6; 12; 10; 12; 30; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43742-2088_743a5183-1c70-4a47-9945-f6f41eea0531	43742-2088	HUMAN OTC DRUG	Gum Therapy		Calendula Officinalis, Kali Phosphoricum, Natrum Muriaticum, Arnica Montana, Borax, Cistus Canadensis, Kreosotum, Myrrha, Calcarea Fluorica, Aconitum Napellus, Bismuthum Subnitricum, Sepia, Hepar Sulphuris Calcareum, Mercurius Vivus	LIQUID	ORAL	20230719		UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; BISMUTH SUBNITRATE; CALCIUM FLUORIDE; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; DIBASIC POTASSIUM PHOSPHATE; HELIANTHEMUM CANADENSE; MERCURY; MYRRH; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CHLORIDE; WOOD CREOSOTE	12; 3; 12; 8; 12; 1; 3; 6; 12; 6; 12; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Bismuth [CS], Bismuth [EPC]		N	20241231
43742-2089_6bac1cc6-55be-4c8e-afe8-407c8675d08a	43742-2089	HUMAN OTC DRUG	Control		Anacardium Orientale, Aqua Marina, Argentum Nitricum, Asarum Canadense, Blatta Orientalis, Bufo Rana, Cerebrum Suis, Clematis Erecta, Cuprum Aceticum, Hypothalamus Suis, Ignatia Amara, Kali Phosphoricum, Lachesis Mutus, Mercurius Solubilis, Natrum Sulphuricum, Placenta Totalis Suis, Rhus Tox, Thuja Occidentalis, Thymolum, Valeriana Officinalis	LIQUID	ORAL	20230823		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ASARUM CANADENSE ROOT; BLATTA ORIENTALIS; BUFO BUFO CUTANEOUS GLAND; CLEMATIS RECTA FLOWERING TOP; CUPRIC ACETATE; DIBASIC POTASSIUM PHOSPHATE; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; SODIUM CHLORIDE; SODIUM SULFATE; STRYCHNOS IGNATII SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PLACENTA; THUJA OCCIDENTALIS LEAFY TWIG; THYMOL; TOXICODENDRON PUBESCENS LEAF; VALERIAN	12; 12; 12; 6; 6; 6; 12; 12; 12; 6; 6; 6; 12; 6; 8; 8; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
43742-2090_2bd661e9-dacf-414c-86b4-580ff4236694	43742-2090	HUMAN OTC DRUG	REFL HS		Adenosinum Triphosphoricum Dinatrum, Nadidum, Argentum Nitricum, Ipecacuanha, Robinia Pseudoacacia, Sulphur, Origanum Vulgare, Duodenum (Suis), Esophagus (Suis), Funiculus Umbilicalis Suis, Stomach (Suis), Nux Vomica, Coumarinum, Erythraea Centaurium, Pancreas Suis, Muriaticum Acidum, Citricum Acidum, Formicum Acidum, Sarcolacticum Acidum, Coenzyme A, Proteus (Morgani)	LIQUID	ORAL	20230714		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS CITRIC ACID; CENTAURIUM ERYTHRAEA; COENZYME A; COUMARIN; FORMIC ACID; HYDROCHLORIC ACID; IPECAC; LACTIC ACID, L-; NADIDE; OREGANO; PROTEUS INCONSTANS; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH; SUS SCROFA UMBILICAL CORD	6; 6; 10; 8; 8; 6; 6; 6; 6; 6; 6; 30; 6; 6; 8; 6; 8; 8; 12; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-2091_725ddb09-6f72-44d1-bdf9-dbe3c088f1fa	43742-2091	HUMAN OTC DRUG	Leaky Gut Formula		Alfalfa, Glycyrrhiza Glabra, Astacus Fluviatilis, Berberis Aquifolium, Lac Defloratum, Natrum Carbonicum, Saccharum Officinale, Aloe, Fel Tauri, Pancreas Suis, Fragaria Vesca, Antimonium Crudum, Carbo Vegetabilis, Euphorbium Officinarum, Lycopodium Clavatum, Magnesia Carbonica, Zincum Metallicum, Colibacillinum Cum Natrum Muriaticum, Proteus (Vulgaris)	LIQUID	ORAL	20230714		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACTIVATED CHARCOAL; ALOE; ANTIMONY TRISULFIDE; ASTACUS ASTACUS; BERBERIS AQUIFOLIUM ROOT BARK; BOS TAURUS BILE; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; FRAGARIA VESCA FRUIT; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MEDICAGO SATIVA WHOLE; PROTEUS INCONSTANS; SKIM MILK; SODIUM CARBONATE; SUCROSE; SUS SCROFA PANCREAS; ZINC	12; 7; 12; 6; 6; 8; 15; 12; 9; 3; 12; 12; 3; 15; 6; 6; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43742-2092_ca349b23-d54d-453a-ac27-d09e811469e1	43742-2092	HUMAN OTC DRUG	Prostate		Petroselinum Sativum, Populus Tremuloides, Sabal Serrulata, Chimaphila Umbellata, Adenosinum Triphosphoricum Dinatrum, Equol, Kreosotum, Nadidum, Testosterone, Prostate (Suis), Succinicum Acidum, Hepar Sulphuris Calcareum, Conium Maculatum, Proteus (Mirabilis), Proteus (Vulgaris)	LIQUID	ORAL	20231011		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; CALCIUM SULFIDE; CHIMAPHILA UMBELLATA WHOLE; CONIUM MACULATUM FLOWERING TOP; EQUOL; NADIDE; PETROSELINUM CRISPUM WHOLE; POPULUS TREMULOIDES BARK; POPULUS TREMULOIDES LEAF; PROTEUS MIRABILIS; PROTEUS VULGARIS; SAW PALMETTO; SUCCINIC ACID; SUS SCROFA PROSTATE; TESTOSTERONE; WOOD CREOSOTE	6; 10; 5; 30; 6; 6; 4; 4; 4; 30; 30; 4; 8; 8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
43742-2093_656ff175-81dc-4705-a683-17f588f9ca56	43742-2093	HUMAN OTC DRUG	HPYL PLUS		Angelica Archangelica, Geranium Maculatum, Hydrastis Canadensis, Sinapis Nigra, Symphytum Officinale, Ratanhia, Aceticum Acidum, Carbolicum Acidum, Ornithogalum Umbellatum, Abies Canadensis, Anacardium Orientale, Bismuthum Subnitricum, Condurango, Graphites, Iris Versicolor, Lycopodium Clavatum, Mezereum, Euphorbium Officinarum, Nux Vomica, Uranium Nitricum	LIQUID	ORAL	20231012		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETIC ACID; ANGELICA ARCHANGELICA ROOT; BISMUTH SUBNITRATE; BLACK MUSTARD SEED; COMFREY ROOT; DAPHNE MEZEREUM BARK; EUPHORBIA RESINIFERA RESIN; GERANIUM MACULATUM ROOT; GOLDENSEAL; GRAPHITE; IRIS VERSICOLOR ROOT; KRAMERIA LAPPACEA ROOT; LYCOPODIUM CLAVATUM SPORE; ORNITHOGALUM UMBELLATUM WHOLE; PHENOL; RUEHSSIA CUNDURANGO BARK; SEMECARPUS ANACARDIUM JUICE; STRYCHNOS NUX-VOMICA SEED; TSUGA CANADENSIS BARK; TSUGA CANADENSIS FLOWER BUD; URANYL NITRATE HEXAHYDRATE	9; 6; 12; 6; 6; 12; 12; 6; 6; 12; 12; 6; 12; 10; 9; 12; 12; 12; 10; 10; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43742-2094_033cd2ca-04ae-4684-b078-a7f7d55d0eb8	43742-2094	HUMAN OTC DRUG	Appetite Control		Adenosinum Triphosphoricum Dinatrum, Adrenal Cortex (Suis), Bacopa Speciosa, Chininum Sulphuricum, Cina, Dopamine Hydrochloride, Equol, Gambogia, Iodium, Lycopodium Clavatum, Morgan Gaertner, Oxytocin, Pantothenic Acid, Phosphorus, Rhodiola, Serotonin (Hydrochloride), Stomach (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20231026		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARTEMISIA CINA PRE-FLOWERING TOP; BACOPA MONNIERA LEAF; DOPAMINE HYDROCHLORIDE; EQUOL; GAMBOGE; IODINE; LYCOPODIUM CLAVATUM SPORE; OXYTOCIN; PANTOTHENIC ACID; PHOSPHORUS; QUININE SULFATE; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SEDUM ROSEUM ROOT; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL CORTEX; SUS SCROFA STOMACH; THYROID	6; 8; 6; 8; 6; 14; 6; 6; 12; 6; 6; 6; 30; 6; 8; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
43742-2095_58a6d6f8-caed-48e7-8217-5c148b86ef35	43742-2095	HUMAN OTC DRUG	Pollutox		Sulphuricum Acidum, Berberis Vulgaris, Arsenicum Album, Benzinum, Cadmium Sulphuratum, Hydrofluoricum Acidum, Melatonin, Nitrogenum Oxygenatum, Nux Vomica, Petroleum, Plumbum Metallicum, Stannum Metallicum, Toluene, Acetone, Carbon Dioxide, Chlorinum, Mercurius Solubilis, Ozone, Uranium Nitricum	LIQUID	ORAL	20231013		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	ACETONE; ARSENIC TRIOXIDE; BENZENE; BERBERIS VULGARIS ROOT BARK; CADMIUM SULFIDE; CARBON DIOXIDE; CHLORINE; HYDROFLUORIC ACID; KEROSENE; LEAD; MELATONIN; MERCURIUS SOLUBILIS; NITROUS OXIDE; OZONE; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; TIN; TOLUENE; URANYL NITRATE HEXAHYDRATE	12; 12; 12; 8; 12; 12; 12; 12; 12; 12; 12; 12; 12; 16; 12; 6; 12; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Radiographic Contrast Agent [EPC], Seed Storage Proteins [CS], X-Ray Contrast Activity [MoA]		N	20241231
43742-2108_1ef8099f-8dd1-41e2-8c2b-79c03ee99479	43742-2108	HUMAN OTC DRUG	MYCCombination		Allium Cepa, Echinacea (Echinacea Angustifolia), Natrum Sulphuricum, Kali Carbonicum, Sanguinaria Canadensis, Agaricus Muscarius, Antimonium Tartaricum, Arsenicum Iodatum, Carbolicum Acidum, Cinchona Officinalis, Ferrum Metallicum, Phytolacca Decandra, Secale Cornutum, Sulphuricum Acidum, Thuja Occidentalis, Ammonium Carbonicum, Aspergillus Niger, Blatta Orientalis, Mephitis Mephitica	LIQUID	ORAL	20231220		UNAPPROVED HOMEOPATHIC		Deseret Biologicals, Inc.	AMANITA MUSCARIA FRUITING BODY; AMMONIUM CARBONATE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIIODIDE; ASPERGILLUS NIGER VAR. NIGER; BLATTA ORIENTALIS; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; ECHINACEA ANGUSTIFOLIA WHOLE; IRON; MEPHITIS MEPHITIS ANAL GLAND FLUID; ONION; PHENOL; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SANGUINARIA CANADENSIS ROOT; SODIUM SULFATE; SULFURIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 12; 12; 15; 9; 12; 12; 6; 12; 12; 6; 12; 12; 8; 8; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43742-2110_59d9f991-fc81-4668-b4c7-c69c72cf705c	43742-2110	HUMAN OTC DRUG	High Vitality Tab		Agnus Castus, Ambra Grisea, Estradiol, L-Dopa, Melatonin, Petroselinum Sativum, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Testosterone, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Proteus (Morgani)	TABLET	ORAL	20231222		UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMBERGRIS; BARIUM CARBONATE; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM WHOLE; PORK LIVER; PROTEUS MORGANII; SELENIUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 8; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]	CIII	N	20241231
43742-2126_e30cdb3e-749d-4b0b-8c89-d74c24671c3f	43742-2126	HUMAN OTC DRUG	Progenite		Ammonium Carbonicum, Baryta Muriatica, Borax, Caulophyllum Thalictroides, Natrum Carbonicum, Sabal Serrulata, Sabina, Sulphuricum Acidum, Thiosinaminum, Folliculinum, Tuba Uterina Suis, Uterus Suis, Hypothalamus (Suis), Thyroidinum (Suis), Agnus Castus, Conium Maculatum, Graphites, Hyoscyamus Niger, Sepia, Selenium Metallicum, X-Ray	LIQUID	ORAL	20231221		UNAPPROVED HOMEOPATHIC		Deseret Biologicals	ALCOHOL, X-RAY EXPOSED (1000 RAD); ALLYLTHIOUREA; AMMONIUM CARBONATE; BARIUM CHLORIDE DIHYDRATE; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; ESTRONE; GRAPHITE; HYOSCYAMUS NIGER; JUNIPERUS SABINA LEAFY TWIG; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CARBONATE; SULFURIC ACID; SUS SCROFA FALLOPIAN TUBE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA UTERUS; THYROID	20; 6; 6; 6; 6; 12; 12; 6; 12; 12; 6; 6; 12; 12; 6; 6; 6; 6; 8; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43749-110_f28f8a35-cbb1-21bc-e053-2995a90adb2c	43749-110	HUMAN OTC DRUG	Avedana Medicated Chest Rub		Camphor Eucalyptus Menthol	OINTMENT	TOPICAL	20140903		OTC MONOGRAPH NOT FINAL	part348	Unipack LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
43749-230_921f72a8-c8b7-4ab3-b9fa-cb28cfa23afa	43749-230	HUMAN OTC DRUG	Natures Choice Vitamins A and D		A and D Ointment	OINTMENT	TOPICAL	20140918		OTC MONOGRAPH FINAL	part347	Unipack, Inc.	PETROLATUM	99.397	g/100g			N	20241231
43749-250_0e2394cc-d9f3-1d41-e063-6394a90a42d0	43749-250	HUMAN OTC DRUG	Avedana Hydrocortisone	Maximum Strength	Hydrocortisone	OINTMENT	TOPICAL	20180203		OTC MONOGRAPH DRUG	M017	Unipack LLC	HYDROCORTISONE	.0102	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
43749-321_1850af06-be68-45cd-a107-604506bef374	43749-321	HUMAN OTC DRUG	Avedana Cool Hot Ice		Menthol	GEL	TOPICAL	20171104		OTC MONOGRAPH NOT FINAL	part348	Unipack, Inc.	MENTHOL	2	g/100g			N	20241231
43749-330_f29005e2-5ca7-1421-e053-2a95a90a519a	43749-330	HUMAN OTC DRUG	Natures Choice Vitamins A and D		A and D Ointment	OINTMENT	TOPICAL	20140918		OTC MONOGRAPH FINAL	part347	Unipack LLC	PETROLATUM	98.3	g/100g			N	20241231
43749-330_f29005e2-5cb9-1421-e053-2a95a90a519a	43749-330	HUMAN OTC DRUG	Natures Choice Vitamins A and D		A and D Ointment	OINTMENT	TOPICAL	20140918		OTC MONOGRAPH FINAL	part347	Unipack LLC	PETROLATUM	98.3	g/100g			N	20241231
43749-430_f265e7a5-711f-c5bd-e053-2a95a90a4667	43749-430	HUMAN OTC DRUG	Avedana Hemorrhoidal		Hemorrhoidal Rectal Suppositories	SUPPOSITORY	RECTAL	20140918		OTC MONOGRAPH FINAL	M015	Unipack LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.25	mg/1; g/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
43749-430_f2687ce5-cd32-882a-e053-2a95a90a9922	43749-430	HUMAN OTC DRUG	Avedana Hemorrhoidal		Hemorrhoidal Rectal Suppositories	SUPPOSITORY	RECTAL	20201026		OTC MONOGRAPH FINAL	M015	Unipack LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.25	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
43749-440_0e239b53-79e2-8bd2-e063-6294a90ab85e	43749-440	HUMAN OTC DRUG	Avedana Glycerin	Laxative	Glycerin	SUPPOSITORY	RECTAL	20170917		OTC MONOGRAPH DRUG	M007	Unipack LLC	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20251231
43749-440_0e23b761-33bc-a425-e063-6294a90abb7c	43749-440	HUMAN OTC DRUG	Avedana Glycerin	Laxative	Glycerin	SUPPOSITORY	RECTAL	20140918		OTC MONOGRAPH DRUG	M007	Unipack LLC	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20251231
43749-450_f28f21dc-a989-638d-e053-2995a90ae0e9	43749-450	HUMAN OTC DRUG	Avedana HEMORRHOIDAL COOLING Gel		Phenylephrine HCl, Witch Hazel	GEL	TOPICAL	20040101		OTC MONOGRAPH FINAL	part346	Unipack LLC	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	2.5; 500	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
43749-460_0e23b510-8245-a4c7-e063-6294a90a55b4	43749-460	HUMAN OTC DRUG	Avedana Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20170917		OTC MONOGRAPH DRUG	M007	Unipack LLC	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
43749-470_f28f8618-610b-7440-e053-2995a90a1f2b	43749-470	HUMAN OTC DRUG	Avedana Hemorrhoidal	Maximum Strength	Hemorrhoidal	CREAM	TOPICAL	20201104		OTC MONOGRAPH FINAL	part346	Unipack LLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	144; 150; 25; 10	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
43749-480_f28f24d3-cf95-e27d-e053-2a95a90aae7b	43749-480	HUMAN OTC DRUG	Avedana Hemorrhoidal Pain Relief		Mineral Oil, Petrolatum, Phenylephrine HCl	OINTMENT	TOPICAL	20040301		OTC MONOGRAPH FINAL	part346	Unipack LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
43749-510_0e23c0a8-e981-27e1-e063-6394a90ae5db	43749-510	HUMAN OTC DRUG	Avedana Pain Relief		Menthol	SPRAY	TOPICAL	20140929		OTC MONOGRAPH DRUG	M017	Unipack LLC	MENTHOL	9	g/100mL			N	20251231
43749-620_0e23b510-8249-a4c7-e063-6294a90a55b4	43749-620	HUMAN OTC DRUG	Avedana Hydrocortisone Cream with Aloe		Hydrocortisone	CREAM	TOPICAL	20160407		OTC MONOGRAPH DRUG	M017	Unipack LLC	HYDROCORTISONE	10.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
43749-621_f28f8618-610c-7440-e053-2995a90a1f2b	43749-621	HUMAN OTC DRUG	Avedana Hydrocortisone Cream with Aloe		Hydrocortisone	CREAM	TOPICAL	20210827		OTC MONOGRAPH NOT FINAL	part348	Unipack LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
43817-133_bc9b4f29-1581-cc17-e053-2a95a90a9cc8	43817-133	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20170117		ANDA	ANDA204722	Panacea Biotec Limited	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
43817-135_bc9b4f29-1581-cc17-e053-2a95a90a9cc8	43817-135	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20170117		ANDA	ANDA204722	Panacea Biotec Limited	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
43817-239_29da9cfc-814c-448a-afc2-f7c7ccd518b5	43817-239	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20171016		ANDA	ANDA205897	Panacea Biotec Limited	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
43817-240_29da9cfc-814c-448a-afc2-f7c7ccd518b5	43817-240	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20171016		ANDA	ANDA205897	Panacea Biotec Limited	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
43817-421_b7490022-d96c-7547-e053-2a95a90af51b	43817-421	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	20160226		ANDA	ANDA090802	Panacea Biotec Limited	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
43817-422_b7490022-d96c-7547-e053-2a95a90af51b	43817-422	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	20160226		ANDA	ANDA090802	Panacea Biotec Limited	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
43817-423_b7490022-d96c-7547-e053-2a95a90af51b	43817-423	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	20160226		ANDA	ANDA090802	Panacea Biotec Limited	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
43817-906_dcfb97f4-4218-4d97-ba28-4f97dabe4ac0	43817-906	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20190506		ANDA	ANDA207234	Panacea Biotec Limited	AZACITIDINE	100	mg/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
43825-200_1b6ef855-cd47-4dcc-818f-5c0bc8783e16	43825-200	HUMAN PRESCRIPTION DRUG	Terlivaz		Terlipressin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220914		NDA	NDA022231	Mallinckrodt Hospital Products Inc.	TERLIPRESSIN	.85	mg/5mL			N	20241231
43826-027_0534ca3a-9698-d216-e063-6294a90ad235	43826-027	HUMAN PRESCRIPTION DRUG	COLESTIPOL HYDROCHLORIDE		COLESTIPOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA216517	Bora Pharmaceuticals Laboratories Inc.	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
43826-029_0cec5933-85f1-ae18-e063-6294a90a984c	43826-029	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA200959	Bora Pharmaceutical Laboratories Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
43826-030_0d612796-c988-9ae5-e063-6394a90a4f59	43826-030	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Bora Pharmaceutical Laboratories Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43826-031_0d612796-c988-9ae5-e063-6394a90a4f59	43826-031	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Bora Pharmaceutical Laboratories Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43826-032_0d612796-c988-9ae5-e063-6394a90a4f59	43826-032	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Bora Pharmaceutical Laboratories Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
43826-033_0cfd6e8b-0a91-cf21-e063-6394a90ab4b6	43826-033	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-034_0cfd6e8b-0a91-cf21-e063-6394a90ab4b6	43826-034	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-035_0cfd6e8b-0a91-cf21-e063-6394a90ab4b6	43826-035	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-036_0cfd6e8b-0a91-cf21-e063-6394a90ab4b6	43826-036	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-037_0cfd6e8b-0a91-cf21-e063-6394a90ab4b6	43826-037	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-038_0d0112b8-3ddc-6746-e063-6294a90a58d1	43826-038	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Bora Pharmaceutical Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43826-039_0d0112b8-3ddc-6746-e063-6294a90a58d1	43826-039	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Bora Pharmaceutical Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43826-040_0d0112b8-3ddc-6746-e063-6294a90a58d1	43826-040	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Bora Pharmaceutical Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43826-041_0d0112b8-3ddc-6746-e063-6294a90a58d1	43826-041	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Bora Pharmaceutical Laboratories Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
43826-042_0cedfec2-1553-43e3-e063-6394a90a7f3e	43826-042	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230201		ANDA	ANDA217054	Bora Pharmaceutical Laboratories Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43826-043_0cee17ae-45aa-46bf-e063-6394a90a7cd2	43826-043	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20230701		ANDA	ANDA216782	Bora Pharmaceutical Laboratories Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
43826-044_0d01a05c-01c0-7195-e063-6394a90a7623	43826-044	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20220901		ANDA	ANDA216399	Bora Pharmaceutical Laboratories Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43826-045_0d01a05c-01c0-7195-e063-6394a90a7623	43826-045	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20220901		ANDA	ANDA216399	Bora Pharmaceutical Laboratories Inc.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
43826-046_0d62bfcd-52f9-51f8-e063-6394a90ac826	43826-046	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20200713		ANDA	ANDA211832	Bora Pharmaceutical Laboratories Inc.	TERBUTALINE SULFATE	2.5	mg/1			N	20241231
43826-047_0d62bfcd-52f9-51f8-e063-6394a90ac826	43826-047	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20200713		ANDA	ANDA211832	Bora Pharmaceutical Laboratories Inc.	TERBUTALINE SULFATE	5	mg/1			N	20241231
43826-048_0d616415-6be6-b417-e063-6394a90a6498	43826-048	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	Bora Pharmaceutical Laboratories Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
43826-049_0d616415-6be6-b417-e063-6394a90a6498	43826-049	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	Bora Pharmaceutical Laboratories Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
43826-050_0d616415-6be6-b417-e063-6394a90a6498	43826-050	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	Bora Pharmaceutical Laboratories Inc.	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
43826-051_0ced8e01-8997-521f-e063-6294a90a11d0	43826-051	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		ANDA	ANDA091281	Bora Pharmaceutical Laboratories Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43826-052_0ced8e01-8997-521f-e063-6294a90a11d0	43826-052	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		ANDA	ANDA091281	Bora Pharmaceutical Laboratories Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	30	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
43826-055_0d018b4b-1679-8ea3-e063-6294a90a18ba	43826-055	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20201201		ANDA	ANDA210382	Bora Pharmaceutical Laboratories Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
43826-056_0d018b4b-1679-8ea3-e063-6294a90a18ba	43826-056	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20201201		ANDA	ANDA210382	Bora Pharmaceutical Laboratories Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
43826-057_0cfd6e8b-0a63-cf21-e063-6394a90ab4b6	43826-057	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20150301		ANDA	ANDA203104	Bora Pharmaceutical Laboratories Inc.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
43826-058_0d00a798-a551-39f9-e063-6394a90a9f1b	43826-058	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA217377	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-059_0d00a798-a551-39f9-e063-6394a90a9f1b	43826-059	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA217377	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-060_0d00a798-a551-39f9-e063-6394a90a9f1b	43826-060	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230501		ANDA	ANDA217377	Bora Pharmaceutical Laboratories Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
43826-061_0d61114d-802b-9cdf-e063-6394a90ac84c	43826-061	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20150301		ANDA	ANDA203139	Bora Pharmaceutical Laboratories Inc.	MEGESTROL ACETATE	125	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
43826-062_0d612796-c94b-9ae5-e063-6394a90a4f59	43826-062	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20211108		ANDA	ANDA214289	Bora Pharmaceutical Laboratories Inc.	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
43826-063_0d612796-c94b-9ae5-e063-6394a90a4f59	43826-063	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20211108		ANDA	ANDA214289	Bora Pharmaceutical Laboratories Inc.	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
43826-064_0d018f81-cc47-75f4-e063-6394a90a3406	43826-064	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA209688	Bora Pharmaceutical Laboratories Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43826-065_0d018f81-cc47-75f4-e063-6394a90a3406	43826-065	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA209688	Bora Pharmaceutical Laboratories Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43826-066_0d61926f-f94f-fa84-e063-6294a90a14e2	43826-066	HUMAN PRESCRIPTION DRUG	sorafenib		sorafenib	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA209050	Bora Pharmaceutical Laboratories Inc.	SORAFENIB	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
43826-067_0ced30ec-9a8d-1e7d-e063-6294a90ab7ce	43826-067	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	Bora Pharmaceutical Laboratories Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43826-068_0ced30ec-9a8d-1e7d-e063-6294a90ab7ce	43826-068	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	Bora Pharmaceutical Laboratories Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
43846-0008_37bfe6a8-7239-47cb-bf28-1559f019d833	43846-0008	HUMAN OTC DRUG	Eczema Rescue		Carbolicum Acidum, Fagopyrum Esculentum, Hydrastis Canadensis, Hydrocotyle Asiatica, Juglans Regia, Vinca Minor	LOTION	TOPICAL	20130319		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	CENTELLA ASIATICA; FAGOPYRUM ESCULENTUM; GOLDENSEAL; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; PHENOL; VINCA MINOR	30; 30; 30; 30; 30; 30; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
43846-0017_f034aeb8-147d-4fa4-a874-9db319a0d046	43846-0017	HUMAN OTC DRUG	Eczema Rescue		Carbolicum Acidum, Fagopyrum Esculentum, Hydrastis Canadensis, Hydrocotyle Asiatica, Juglans Regia, Vinca Minor	LOTION	TOPICAL	20120914		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	CENTELLA ASIATICA; FAGOPYRUM ESCULENTUM; GOLDENSEAL; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; PHENOL; VINCA MINOR	30; 30; 30; 30; 30; 30; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
43846-0039_4301f4e3-3dde-4df2-b3bf-0ce5f1ab5d86	43846-0039	HUMAN OTC DRUG	Acne Rescue		Borax, Carbo Vegetabilis, Carboneum Sulphuratum, Causticum, Natrum Muriaticum, Silicea	GEL	TOPICAL	20141229		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	ACTIVATED CHARCOAL; CARBON DISULFIDE; CAUSTICUM; SILICON DIOXIDE; SODIUM BORATE; SODIUM CHLORIDE	12; 12; 12; 30; 30; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
43846-0059_2c6a8c16-b524-4219-90a3-c1e6a1c23bb8	43846-0059	HUMAN OTC DRUG	Shingles Pain Relief		Calendula Officinalis, Croton Tiglium, Natrum Muriaticum, Plantago Major, Rhus Tox, Sarsaparilla (Smilax Regelii)	LIQUID	TOPICAL	20160324	20240904	UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	CALENDULA OFFICINALIS FLOWERING TOP; CROTON TIGLIUM SEED; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	12; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43846-0062_6c9b7477-d1e5-4879-927c-f96a3e580c43	43846-0062	HUMAN OTC DRUG	Arnica Plus		Arnica Montana, Hamamelis Virginiana, Rhus Tox, Whey Protein	GEL	TOPICAL	20160719		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	ARNICA MONTANA; HAMAMELIS VIRGINIANA BARK; TOXICODENDRON PUBESCENS LEAF; WHEY	6; 6; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
43846-0065_f08bdda0-7eda-4ded-98e3-0d42d3a87e72	43846-0065	HUMAN OTC DRUG	Arnica Plus		Arnica Montana, Hamamelis Virginiana, Rhus Tox, Whey Protein	GEL	TOPICAL	20160720		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	ARNICA MONTANA; HAMAMELIS VIRGINIANA BARK; TOXICODENDRON PUBESCENS LEAF; WHEY	6; 6; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
43846-0069_e0f4ef27-5d40-4050-b06c-09440b03fa8f	43846-0069	HUMAN OTC DRUG	Arnica Plus		Arnica Montana, Hamamelis Virginiana, Rhus Tox, Whey Protein	GEL	TOPICAL	20180209		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	ARNICA MONTANA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; TOXICODENDRON PUBESCENS LEAF; WHEY	6; 6; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
43846-0075_a2f9f847-67dd-4824-acc1-650d5b05af94	43846-0075	HUMAN OTC DRUG	Arnica Plus		Arnica Montana, Hamamelis Virginiana, Rhus Tox	GEL	TOPICAL	20181114		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	ARNICA MONTANA WHOLE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; TOXICODENDRON PUBESCENS LEAF	6; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
43846-0077_6cad809c-44e5-49f8-95c0-6bab13e86e71	43846-0077	HUMAN OTC DRUG	Joint and Tendon Rescue		Bryonia (Alba), Ruta Graveolens, Bellis Perennis, Capsicum Annuum, Ledum Palustre, Symphytum Officinale, Colchicum Autumnale, Rhododendron Chrysanthum, Argentum Metallicum	GEL	TOPICAL	20181212		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	BELLIS PERENNIS; BRYONIA ALBA ROOT; CAPSICUM; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; LEDUM PALUSTRE TWIG; RHODODENDRON AUREUM LEAF; RUTA GRAVEOLENS FLOWERING TOP; WHEY	6; 3; 6; 12; 6; 6; 30; 3; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
43846-0081_574a773c-8a7f-4738-ac37-8cfe80d42734	43846-0081	HUMAN OTC DRUG	Hot Flash Rescue		Capsicum Annuum, Pulsatilla Pratensis), Sanguinaria Canadensis	SPRAY	TOPICAL	20210318		UNAPPROVED HOMEOPATHIC		Peaceful Mountain, Inc.	CAPSICUM; PULSATILLA PRATENSIS WHOLE; SANGUINARIA CANADENSIS ROOT	3; 4; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
43853-0013_e78878c8-6130-46fe-9812-f0b646416135	43853-0013	HUMAN OTC DRUG	HGH		Human Growth Hormone (2 Parts), Hypophysis Suis (2 Parts), Hepar Suis (1 Part)	SPRAY	ORAL	20161123		UNAPPROVED HOMEOPATHIC		ProBLEN	PORK LIVER; SOMATROPIN; SUS SCROFA PITUITARY GLAND	6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
43853-0014_28033bb9-bd2c-4223-a7e7-b7fd11286091	43853-0014	HUMAN OTC DRUG	DNA RNA		Arnica Montana, Avena Sativa, Damiana, DNA, Hypophysis Suis, Oleum Animale, Panax Ginseng, RNA, Thuja Occidentalis	SPRAY	ORAL	20161123		UNAPPROVED HOMEOPATHIC		ProBLEN	ARNICA MONTANA; ASIAN GINSENG; AVENA SATIVA FLOWERING TOP; CERVUS ELAPHUS HORN OIL; HERRING SPERM DNA; SACCHAROMYCES CEREVISIAE RNA; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG	6; 3; 3; 6; 9; 9; 5; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43853-0017_31103d8c-5ee4-483e-bd45-aac9eda84b68	43853-0017	HUMAN OTC DRUG	Estrogen and Progesterone		Agnus Castus, Angelica Sinensis, Apis Mellifica, Arnica Montana, Cimicifuga Racemosa, Estradiol, Estriol, Folliculinum, Galium Aparine, Glycyrrhiza Glabra, Korean Ginseng, Oophorinum (Suis), Progesterone, Sepia, Thuja Occidentalis, Viscum Album	SPRAY	ORAL	20170112		UNAPPROVED HOMEOPATHIC		ProBLEN	ANGELICA SINENSIS ROOT; APIS MELLIFERA; ARNICA MONTANA; ASIAN GINSENG; BLACK COHOSH; CHASTE TREE; ESTRADIOL; ESTRIOL; ESTRONE; GALIUM APARINE; GLYCYRRHIZA GLABRA; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP	3; 6; 6; 3; 3; 3; 9; 9; 9; 3; 3; 6; 30; 30; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Progesterone [CS], Progesterone [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43853-0019_b8f74cc1-afc6-61ed-e053-2a95a90a9515	43853-0019	HUMAN OTC DRUG	Libido		Damiana, Galium, Glandula Suprarenalis, Hepar, Hypophysis, Korean Ginseng, Nuphar, Orchitinum, Phosphoricum ac, Populus Trem, Testosterone.	LIQUID	ORAL	20170509		UNAPPROVED HOMEOPATHIC		ProBlen	ASIAN GINSENG; GALIUM APARINE; NUPHAR LUTEA ROOT; PHOSPHORIC ACID; POPULUS TREMULOIDES WHOLE; PORK LIVER; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA TESTICLE; TESTOSTERONE; TURNERA DIFFUSA LEAFY TWIG	1; 3; 2; 200; 3; 6; 12; 12; 6; 30; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
43853-0020_a808f440-abf4-4652-8ac6-f0dce3212a86	43853-0020	HUMAN OTC DRUG	Adrenal and DHEA		Aralia Quinquefolia, Ashwagandha, Avena Sativa, Carduus Marianus, Dhea, Glandula Suprarenalis Suis, L-Arginine, Natrum Muriaticum, Phosphoricum Acidum, Rhodiola.	LIQUID	ORAL	20170509		UNAPPROVED HOMEOPATHIC		ProBLEN	AMERICAN GINSENG; ARGININE; AVENA SATIVA FLOWERING TOP; MILK THISTLE; PHOSPHORIC ACID; PRASTERONE; RHODIOLA KIRILOWII ROOT; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; WITHANIA SOMNIFERA ROOT	3; 6; 3; 3; 200; 6; 3; 30; 12; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
43853-0023_eeb420f0-c924-0d96-e053-2a95a90afe36	43853-0023	HUMAN OTC DRUG	HGH		Human growth hormone	LIQUID	ORAL	20170509		UNAPPROVED HOMEOPATHIC		ProBLEN	SOMATROPIN	30	[hp_X]/30mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
43853-0027_eeb4227f-1264-6f43-e053-2a95a90a2fec	43853-0027	HUMAN OTC DRUG	Telomere - DNA		CA98, Carotenoid, DNA, Glutathione, Omega 3, Pituitarum, RNA, Vitamin B complex, Vitamin C, Vitamin D3, Vitamin E	SPRAY	ORAL	20191101		UNAPPROVED HOMEOPATHIC		ProBLEN	.ALPHA.-TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CHOLECALCIFEROL; CYANOCOBALAMIN; CYCLOASTRAGENOL; GLUTATHIONE; HERRING SPERM DNA; OMEGA-3 FATTY ACIDS; PANTOTHENIC ACID; RIBOFLAVIN; SACCHAROMYCES CEREVISIAE RNA; SUS SCROFA PITUITARY GLAND, POSTERIOR; THIAMINE	12; 12; 12; 12; 12; 12; 12; 9; 12; 12; 12; 9; 5; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL	Ascorbic Acid [CS], Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
43853-0028_6652723f-d9ef-47c2-bdfe-acf4f6d32fb3	43853-0028	HUMAN OTC DRUG	HGH Plus		Alpha GPC, Deer Antler Velvet, Hepar Suis, HGH, IGF-1, IGF-2, Pituitarum Post	SPRAY	ORAL	20170509		UNAPPROVED HOMEOPATHIC		ProBlen	ALPHA; CERVUS ELAPHUS VELVET; DALOTUZUMAB; INSULIN-LIKE GROWTH FACTOR-2; PORK LIVER; SOMATROPIN; SUS SCROFA PITUITARY GLAND, POSTERIOR	8; 6; 12; 12; 6; 12; 5	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
43853-0032_eeb42bff-7f13-7138-e053-2a95a90a2eee	43853-0032	HUMAN OTC DRUG	HGH COMPLEX		Arginine pyroglutamate, Coleus forskohlii, Glutamine, Glycine, Lysine, Mucuna pruriens, Ornithine alpha-ketoglutarate, Tribulus terrestris, Tyrosine, CDP-choline, GABA	SPRAY	ORAL	20200110		UNAPPROVED HOMEOPATHIC		ProBlen	.GAMMA.-AMINOBUTYRIC ACID; ARGININE PIDOLATE; CITICOLINE; DIORNITHINE OXOGLURATE; GLUTAMINE; GLYCINE; LYSINE; MUCUNA PRURIENS SEED; PLECTRANTHUS BARBATUS ROOT; TRIBULUS TERRESTRIS WHOLE; TYROSINE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
43853-0035_eeb44298-3678-344e-e053-2a95a90a8f5f	43853-0035	HUMAN OTC DRUG	TestoPRO		Avena sativa, Damiana, Hamamelis virginiana, Korean ginseng, Populus tremuloides, Baryta carbonica, Hepar suis, Nuphar luteum, Orchitinum suis, Phosphoricum acidum, Sabal serulata, Selenium metallicum, Testosterone, Tribulus terrestris, Horny goat weed, Tongkat ali, Fenugreek	SPRAY	ORAL	20170628		UNAPPROVED HOMEOPATHIC		ProBlen	ASIAN GINSENG; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; EPIMEDIUM GRANDIFLORUM TOP; EURYCOMA LONGIFOLIA WHOLE; FENUGREEK SEED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; NUPHAR LUTEA ROOT; PHOSPHORIC ACID; POPULUS TREMULOIDES WHOLE; PORK LIVER; SAW PALMETTO; SELENIUM; SUS SCROFA TESTICLE; TESTOSTERONE; TRIBULUS TERRESTRIS WHOLE; TURNERA DIFFUSA LEAFY TWIG	1; 1; 8; 6; 6; 3; 1; 3; 12; 1; 6; 6; 12; 6; 30; 6; 1	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
43853-0037_eeb40b29-d0a5-282e-e053-2995a90a5c3e	43853-0037	HUMAN OTC DRUG	LIBIDOPRO		Damiana, Galium, Glandula Suprarenalis, Hepar, Hypophysis, Korean Ginseng, Nuphar, Orchitinum, Phosphoricum ac, Populus Trem, Testosterone	LIQUID	ORAL	20211210		UNAPPROVED HOMEOPATHIC		ProBlen	ASIAN GINSENG; BOS TAURUS TESTICLE; GALLIUM; NUPHAR LUTEA LEAF; PHOSPHORIC ACID; POPULUS TREMULA FLOWERING TOP; PORK LIVER; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; TESTOSTERONE; TURNERA DIFFUSA LEAFY TWIG	1; 2; 3; 2; 200; 3; 6; 12; 12; 30; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
43853-0040_eeb3d0e2-fd99-3ad5-e053-2a95a90a3231	43853-0040	HUMAN OTC DRUG	THYROPRO		Calcarea iodata, Ferrum iodatum, Kali iodatum, Spongia tosta, Fucus vesiculosus, Thyroidinum, Glandula suprarenalis, Hypophysis, Lapis albus, Hydrofluoricum acidum	LIQUID	ORAL	20211210		UNAPPROVED HOMEOPATHIC		ProBlen	CALCIUM HEXAFLUOROSILICATE; CALCIUM IODIDE; FERROUS IODIDE; FUCUS VESICULOSUS; HYDROFLUORIC ACID; POTASSIUM IODIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; THYROID, UNSPECIFIED	30; 12; 12; 3; 12; 6; 6; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43853-0041_eeb45706-9e3c-ee28-e053-2a95a90ae758	43853-0041	HUMAN OTC DRUG	Metals Detox		Alumina, Arsenicum metallicum, Mercurius corrosivus, Niccolum metallicum, Plumbum metallicum, Radium bromatum, Stannum metallicum	LIQUID	ORAL	20210415		UNAPPROVED HOMEOPATHIC		ProBLEN	ALUMINUM OXIDE; LEAD; MERCURIC CHLORIDE; NICKEL; RADIUM BROMIDE; TIN	30; 30; 30; 30; 30; 30	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43853-0042_eeb45ede-aec6-2289-e053-2995a90af21a	43853-0042	HUMAN OTC DRUG	Lung Detox		Argentum nitricum, Arsenicum album, Carduus marianus, Hepar suis, Mercurius corrosivus, Plumbum metallicum	LIQUID	ORAL	20210415		UNAPPROVED HOMEOPATHIC		ProBLEN	ARSENIC TRIOXIDE; LEAD; MERCURIC CHLORIDE; MILK THISTLE; PORK LIVER; SILVER NITRATE	200; 200; 200; 1; 6; 200	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL			N	20241231
43853-0043_eeb45706-9e48-ee28-e053-2a95a90ae758	43853-0043	HUMAN OTC DRUG	Immune Support		Arsenicum album, Rumex, Squilla maritima, Bryonia alba, Kali carbonicum, Glutathione, Vitamin C, Vitamin C, Zinc picolinate, Vitamin B, Vitamin E, Beta Glucan, Curcumin, Grapefruit seed, Oregano leaf, Garlic bulb, Olive leaf, Apple cider vinegar, Astragalus root, Maitake mushroom, Cats claw bark	LIQUID	ORAL	20210415		UNAPPROVED HOMEOPATHIC		ProBLEN	.ALPHA.-TOCOPHEROL; APPLE CIDER VINEGAR; ARSENIC TRIOXIDE; ASCORBIC ACID; ASCORBYL PALMITATE; ASTRAGALUS PROPINQUUS ROOT; BIANCAEA DECAPETALA ROOT BARK; BRYONIA ALBA ROOT; CITRUS PARADISI SEED; CURCUMIN; CURDLAN; DRIMIA MARITIMA BULB; GARLIC; GLUTATHIONE; MAITAKE; OLEA EUROPAEA LEAF; OREGANO; POTASSIUM CARBONATE; PYRIDOXINE; RUMEX CRISPUS ROOT; ZINC PICOLINATE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
43857-0001_cb2bdc15-3f93-45c9-9807-ebae2dc8ab08	43857-0001	HUMAN OTC DRUG	Ligatone		Arnica Montana, Bryonia, Calcarea Phosphorica, Causticum, Kali Carbonicum, Manganese Gluconate, Mezereum, Rhus Tox, Ruta Graveolens, Silicea	LIQUID	ORAL	20120413		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; BRYONIA ALBA ROOT; CAUSTICUM; DAPHNE MEZEREUM BARK; MANGANESE GLUCONATE; POTASSIUM CARBONATE; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
43857-0006_97e1cb68-2204-4e16-bdf3-d6800294fd37	43857-0006	HUMAN OTC DRUG	Pituitary Forte		Hypophysis Suis, Hypothalamus (Suis), Pineal (Suis)	SPRAY	ORAL	20120417		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND, POSTERIOR	8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0007_5ed3a398-7e23-483e-a40d-be6de2cdec1e	43857-0007	HUMAN OTC DRUG	Pollen Mix		Alfalfa, American Elm, Sycamore, Ash, Beech, Black Walnut, Black Willow, Box Elder, Eastern Cottonwood, False Ragweed, Giant Ragweed, Goldenrod, Kentucky Bluegrass, Orchard Grass, Red Birch, Red Clover, Red Oak, Redtop Grass, Hickory, Sheep Sorrel, Short Ragweed, Timothy Grass, Western Ragweed, Yellow Dock	LIQUID	ORAL	20130114	20240306	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACER NEGUNDO POLLEN; AGROSTIS GIGANTEA TOP; ALFALFA; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA; AMBROSIA PSILOSTACHYA TOP; AMBROSIA TRIFIDA POLLEN; BETULA OCCIDENTALIS POLLEN; CARYA OVATA POLLEN; DACTYLIS GLOMERATA TOP; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PHLEUM PRATENSE TOP; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS TOP; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS TOP; SALIX NIGRA POLLEN; SOLIDAGO VIRGAUREA FLOWERING TOP; TRIFOLIUM PRATENSE FLOWER; ULMUS AMERICANA POLLEN	9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	
43857-0010_33bc9bbd-68e3-461a-a96d-ce9773d8baf9	43857-0010	HUMAN OTC DRUG	Thyrotox		Chondrus Crispus, Fucus Vesiculosus, Thyroidinum, Belladonna, Calcarea Carbonica, Conium Maculatum, Iodium, Kali Carbonicum, Phosphorus, Pulsatilla (Vulgaris), Silicea	LIQUID	ORAL	20130116		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; CHONDRUS CRISPUS; CONIUM MACULATUM FLOWERING TOP; FUCUS VESICULOSUS; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SILICON DIOXIDE; SUS SCROFA THYROID	12; 3; 12; 3; 12; 12; 12; 12; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0011_b5a512d0-78b3-4638-919c-b33837329ab6	43857-0011	HUMAN OTC DRUG	Candida Combo		Candida Albicans	LIQUID	ORAL	20130116	20250127	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43857-0012_02b725de-210b-48f8-8d39-4b3902aebaae	43857-0012	HUMAN OTC DRUG	Sciatica	HP	Aconitum Napellus, Aesculus Hippocastanum, Colchicum Autumnale, Hypericum Perforatum, Magnesia Phosphorica, Plumbum Metallicum, Rhus Tox, Arnica Montana	LIQUID	ORAL	20130117	20250722	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; COLCHICUM AUTUMNALE BULB; HORSE CHESTNUT; HYPERICUM PERFORATUM; LEAD; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43857-0016_20cc2718-815f-4773-b1fb-e1e06b873ac9	43857-0016	HUMAN OTC DRUG	Allerforce		Chondrus Crispus, Glycyrrhiza Glabra, Sarsaparilla, Zingiber Officinale, Adrenalinum, Allium Cepa, Aralia Racemosa, Arsenicum Album, Calcarea Carbonica, Cantharis, Iodium, Natrum Carbonicum, Rhus Tox,	LIQUID	ORAL	20130219		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARALIA RACEMOSA ROOT; ARSENIC TRIOXIDE; CHONDRUS CRISPUS; EPINEPHRINE; GINGER; GLYCYRRHIZA GLABRA; IODINE; LYTTA VESICATORIA; ONION; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SMILAX ORNATA ROOT; SODIUM CARBONATE; TOXICODENDRON PUBESCENS LEAF	12; 12; 3; 8; 3; 3; 12; 12; 12; 12; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43857-0020_0eb0a737-d850-4241-a0e9-e0c63dda2c3a	43857-0020	HUMAN OTC DRUG	Melatonin Forte		Melatonin, Nadidum, Niacin, Pyridoxinum Hydrochloricum, Zincum Sulphuricum, Hypophysis Suis, Hypothalamus (Suis), Lithium Carbonicum, Magnesia Carbonica, Pineal (Suis)	SPRAY	ORAL	20120504		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	LITHIUM CARBONATE; MAGNESIUM CARBONATE; MELATONIN; NADIDE; NIACIN; PYRIDOXINE HYDROCHLORIDE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; ZINC SULFATE HEPTAHYDRATE	8; 8; 6; 6; 6; 6; 8; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Mood Stabilizer [EPC], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
43857-0023_3077d00e-7e8d-4ab2-ba00-f1b3719942f4	43857-0023	HUMAN OTC DRUG	NADH Plus		Nadidum, Adenosinum Cyclophosphoricum, Calcium D-Pantothenate, Cholinum, Riboflavinum, Ubidecarenonum, Dimethyl Glycine	SPRAY	ORAL	20120531		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	ADENOSINE CYCLIC PHOSPHATE; CALCIUM PANTOTHENATE; CHOLINE HYDROXIDE; N,N-DIMETHYLGLYCINE; NADIDE; RIBOFLAVIN; UBIDECARENONE	6; 6; 6; 7; 4; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0025_e6de2eb6-d157-4984-82ef-9f0e248e5b87	43857-0025	HUMAN OTC DRUG	Hemoforce		Urtica Urens, Ferrum Muriaticum, Aranea Diadema, Aurum Metallicum, Cinchona Officinalis, Cobaltum Gluconate, Phosphorus	LIQUID	ORAL	20130121		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARANEUS DIADEMATUS; CINCHONA OFFICINALIS BARK; COBALTOUS GLUCONATE; FERRIC CHLORIDE HEXAHYDRATE; GOLD; PHOSPHORUS; URTICA URENS	12; 12; 12; 6; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC]		N	20241231
43857-0031_376d66f4-32ce-4595-b033-ce79b7bdd396	43857-0031	HUMAN OTC DRUG	Hypopituitaryplex		Aralia Quinquefolia, Hydrocotyle Asiatica, Polygonum Multiflorum, Hypophysis Suis, Hypothalamus Suis, Germanium Sesquioxide, Pineal Gland (Suis)	LIQUID	ORAL	20130121		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMERICAN GINSENG; CENTELLA ASIATICA; FALLOPIA MULTIFLORA ROOT; GERMANIUM SESQUIOXIDE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND	3; 3; 3; 12; 8; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0032_6d0bb145-0c40-47b6-9bb9-adb5b6859dc1	43857-0032	HUMAN OTC DRUG	Asthmaforce		Arnica montana, Asclepias tuberosa, Eriodictyon californicum, Eucalyptus globulus, Lobelia inflata, Plantago major, Trifolium pratense, Arsenicum album, Belladonna, Bryonia, Carbo vegetabilis, Grindelia, Kali carbonicum, Natrum sulphuricum, Pulsatilla,	LIQUID	ORAL	20120601	20240401	UNAPPROVED HOMEOPATHIC		BioActive Nutritional	ACTIVATED CHARCOAL; ARNICA MONTANA; ARSENIC TRIOXIDE; ASCLEPIAS TUBEROSA ROOT; ATROPA BELLADONNA; BRYONIA ALBA ROOT; ERIODICTYON CALIFORNICUM LEAF; EUCALYPTUS GLOBULUS LEAF; GRINDELIA HIRSUTULA FLOWERING TOP; LOBELIA INFLATA; PLANTAGO MAJOR; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SODIUM SULFATE; TRIFOLIUM PRATENSE FLOWER	12; 3; 12; 3; 12; 12; 3; 3; 12; 3; 3; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0033_24deb803-ab80-49ec-81e5-4ef5ce24fcf5	43857-0033	HUMAN OTC DRUG	Gynobalance		Dehydroepiandrosterone, Estradiol, Pregnenolone, Progesterone, Testosterone	LIQUID	ORAL	20130118		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ESTRADIOL; PRASTERONE; PREGNENOLONE; PROGESTERONE; TESTOSTERONE	8; 6; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone [CS], Progesterone [EPC]	CIII	N	20241231
43857-0034_5335f231-9d84-43b4-9320-4f3622964fb2	43857-0034	HUMAN OTC DRUG	Otoflam	HP	Belladonna, Conium Maculatum, Dulcamara, Hepar Sulphuris Calcareum, Kali Bichromicum, Mercurius Solubilis, Pulsatilla (Vulgaris), Silicea, Chamomilla	LIQUID	ORAL	20120713		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; CALCIUM SULFIDE; CONIUM MACULATUM FLOWERING TOP; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILICON DIOXIDE; SOLANUM DULCAMARA TOP	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0037_7dccd1d9-3940-43a1-81b2-3e5f6ff11d68	43857-0037	HUMAN OTC DRUG	Thyroid HP		Baryta Carbonica, Calcarea Carbonica, Fucus Vesiculosus, Iodium, Natrum Muriaticum, Pulsatilla, Spongia Tosta, Thyroidinum (Suis)	LIQUID	ORAL	20130124		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BARIUM CARBONATE; FUCUS VESICULOSUS; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS; SODIUM CHLORIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA THYROID	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0041_8307ff37-f16d-4890-9a51-95b4dd25af16	43857-0041	HUMAN OTC DRUG	ANX HP		Arsenicum Album, Calcarea Carbonica, Ignatia Amara, Kali Carbonicum, Lachesis Mutus, Natrum Muriaticum	LIQUID	ORAL	20130124		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0045_4bbbfc7d-afbe-4e41-a18d-5028cec3dfc6	43857-0045	HUMAN OTC DRUG	LGB	HP	Belladonna, Chelidonium Majus, Colocynthis, Lycopodium Clavatum, Natrum Sulphuricum, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris), Veratrum Album	LIQUID	ORAL	20130123		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA WHOLE; CHELIDONIUM MAJUS; CITRULLUS COLOCYNTHIS FRUIT PULP; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PULSATILLA VULGARIS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0047_06dd437c-6dea-4b95-b475-ba00088b3afb	43857-0047	HUMAN OTC DRUG	Chlorogenic Acid		Chlorogenic acid,	LIQUID	ORAL	20120626	20240311	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CHLOROGENIC ACID	6	[hp_X]/mL			N	
43857-0048_df848b06-d4c7-4576-9ab3-3643f421082a	43857-0048	HUMAN OTC DRUG	Diabenex	HP	Colchicum Autumnale, Lacticum Acidum, Lycopodium Clavatum, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum, Uranium Nitricum	LIQUID	ORAL	20130118	20240619	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	COLCHICUM AUTUMNALE BULB; LACTIC ACID, DL-; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; SYZYGIUM CUMINI SEED; URANYL NITRATE HEXAHYDRATE	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0052_22cd0355-dccf-41af-993e-2b8e6b4ccfea	43857-0052	HUMAN OTC DRUG	DHEA Forte		Dehydroepiandrosterone (DHEA), Pregnenolone, Progesterone,	LIQUID	ORAL	20120807		UNAPPROVED HOMEOPATHIC		BioActive Nutritionals, Inc.	PRASTERONE; PREGNENOLONE; PROGESTERONE	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
43857-0057_cd143c46-7a09-4fba-a53a-610541ccf702	43857-0057	HUMAN OTC DRUG	Adrenal Tonic		Aralia Quinquefolia, Glycyrrhiza Glabra, Sarsaparilla, Avena Sativa, Glandula Suprarenalis Bovine, Adrenalinum, Arsenicum Album, Kali Phosphoricum, Natrum Muriaticum, Nux Vomica, Phosphoricum Acidum, Veratrum Album	LIQUID	ORAL	20160523		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMERICAN GINSENG; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BOS TAURUS ADRENAL GLAND; EPINEPHRINE; GLYCYRRHIZA GLABRA; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SMILAX ORNATA ROOT; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	1; 12; 3; 8; 12; 1; 12; 12; 1; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43857-0058_2a31540e-3c93-469f-be33-550b9e960425	43857-0058	HUMAN OTC DRUG	Allerpoll	HP	Allium Cepa, Ambrosia Artemisiaefolia, Arsenicum Album, Euphrasia Officinalis, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris), Solidago Virgaurea, Sulphur	LIQUID	ORAL	20120820		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMBROSIA ARTEMISIIFOLIA; ARSENIC TRIOXIDE; EUPHRASIA STRICTA; ONION; PHOSPHORUS; PULSATILLA VULGARIS; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
43857-0061_33d4f8d9-ca3b-46bb-b0ab-b150f4317872	43857-0061	HUMAN OTC DRUG	Pre Post Surgery		Hypericum Perforatum, Symphytum Officinale, Arnica Montana	LIQUID	ORAL	20130124		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; COMFREY ROOT; HYPERICUM PERFORATUM	200; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0063_42b63272-f78b-4141-8a3d-940035147b95	43857-0063	HUMAN OTC DRUG	Hypothalamus	HP	Aralia Quinquefolia, Germanium Sesquioxide, Hydrocotyle Asiatica, Hypophysis Suis, Hypothalamus Suis, Pineal Gland (Suis), Polygonum Multiflorum, Carcinosin	LIQUID	ORAL	20120824		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMERICAN GINSENG; CENTELLA ASIATICA; FALLOPIA MULTIFLORA ROOT; GERMANIUM SESQUIOXIDE; HUMAN BREAST TUMOR CELL; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND	30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43857-0064_37aac024-fed0-44f3-a85b-cb5415e87375	43857-0064	HUMAN OTC DRUG	Cystoges	HP	Berberis Vulgaris, Cantharis, Clematis Erecta, Lac Caninum, Lycopodium Clavatum, Pulsatilla (Vulgaris), Sarsaparilla, Sepia, Staphysagria	LIQUID	ORAL	20121026		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BERBERIS VULGARIS ROOT BARK; CANIS LUPUS FAMILIARIS MILK; CLEMATIS RECTA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULSATILLA VULGARIS WHOLE; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0067_895c9e1a-0505-4957-8d06-74b07173f470	43857-0067	HUMAN OTC DRUG	Quercetin		Quercetin	LIQUID	ORAL	20130124		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	QUERCETIN	6	[hp_X]/mL			N	20241231
43857-0070_08227eaf-52f4-423c-8fa5-91f2a2e4b489	43857-0070	HUMAN OTC DRUG	Arnica		Arnica Montana	LIQUID	ORAL	20121008		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA ROOT	3	[hp_X]/mL			N	20241231
43857-0073_9f11c01e-e753-4231-a254-f66c404597cd	43857-0073	HUMAN OTC DRUG	Cardio Tonic		Kali Muriaticum, Kali Phosphoricum, Plantago Major, Cactus Grandiflorus, Digitalis Purpurea, Heart (Bovine), L-Carnitine, L-Valine, Thyroidinum (Suis), Abrotanum (Artemisia Abrotanum), Iodium, Lecithin, Spigelia Anthelmia	LIQUID	ORAL	20130117		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP; BEEF HEART; DIGITALIS; EGG PHOSPHOLIPIDS; IODINE; LEVOCARNITINE; PLANTAGO MAJOR; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA; SUS SCROFA THYROID; VALINE	12; 6; 6; 12; 12; 6; 3; 3; 3; 5; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Carnitine Analog [EPC], Carnitine [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43857-0074_04f495a9-53fd-4b77-bf4a-0007e7fb9212	43857-0074	HUMAN OTC DRUG	Estrogen		Folliculinum, Oophorinum	LIQUID	ORAL	20121008		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ESTRONE; SUS SCROFA OVARY	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
43857-0075_8659c999-8b66-49df-befb-051e03f2a0a6	43857-0075	HUMAN OTC DRUG	Cough HP		Arsenicum Album, Bryonia (Alba), Cuprum Aceticum, Drosera (Rotundifolia), Ipecacuanha, Kali Carbonicum, Phosphorus, Pulsatilla (Vulgaris), Spongia Tosta	LIQUID	ORAL	20130125		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CUPRIC ACETATE; DROSERA ROTUNDIFOLIA; IPECAC; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0076_f4534484-7778-491b-a157-aced89ed90b6	43857-0076	HUMAN OTC DRUG	Shark Cartilage		Shark Cartilage	LIQUID	ORAL	20121008	20240311	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SHARK CARTILAGE	12	[hp_X]/mL			N	
43857-0079_5261b655-0d30-453f-86f7-2bcbd52eb945	43857-0079	HUMAN OTC DRUG	Relaxoforce		Humulus Lupulus, Passiflora Incarnata, Valeriana Officinalis, Calcarea Carbonica, Coffea Tosta, Ignatia Amara, Kali Phosphoricum, Moschus, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris)	LIQUID	ORAL	20130123	20240128	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	COFFEA ARABICA SEED, ROASTED; HOPS; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; POTASSIUM PHOSPHATE, DIBASIC; PULSATILLA VULGARIS; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VALERIAN	12; 3; 12; 12; 3; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0080_7bf668c6-531a-4c35-adfd-89295fe1e85c	43857-0080	HUMAN OTC DRUG	Hydrate	II	Coffea Tosta, Avena Sativa, Equisetum Hyemale, Hypericum Performatum, Ginkgo Biloba, Germanium Sesquioxide, Silicea	LIQUID	ORAL	20130218		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AVENA SATIVA FLOWERING TOP; COFFEA ARABICA SEED, ROASTED; EQUISETUM HYEMALE WHOLE; GERMANIUM SESQUIOXIDE; GINKGO; HYPERICUM PERFORATUM WHOLE; SILICON DIOXIDE	3; 1; 3; 8; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0083_396a6cab-02fa-4875-9c4f-d549a9ea9ce8	43857-0083	HUMAN OTC DRUG	Bronchiforce		Althaea Officinalis, Lobelia Inflata, Rheum (Officinale), Verbascum Thapsus, Belladonna, Cuprum Aceticum, Drosera (Rotundifolia), Ipecacuanha, Spongia Tosta, Sticta Pulmonaria	LIQUID	ORAL	20130213	20241112	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALTHAEA OFFICINALIS ROOT; ATROPA BELLADONNA WHOLE; CUPRIC ACETATE; DROSERA ROTUNDIFOLIA; IPECAC; LOBARIA PULMONARIA; LOBELIA INFLATA; RHEUM OFFICINALE ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; VERBASCUM THAPSUS	3; 12; 12; 12; 12; 12; 3; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0084_8b849aec-1118-4097-8728-75396aa1e457	43857-0084	HUMAN OTC DRUG	Natural Progesterone		Progesterone	SPRAY	ORAL	20140709		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	PROGESTERONE	8	[hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
43857-0086_e189499d-9da3-43fc-8a0b-9d5dd0923b11	43857-0086	HUMAN OTC DRUG	Melatonin		Melatonin	LIQUID	ORAL	20130213		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	MELATONIN	6	[hp_X]/mL			N	20241231
43857-0088_0326104f-0ea0-48d1-8b1e-e0fb7b1a49f7	43857-0088	HUMAN OTC DRUG	Bio Iodine		Iodium	LIQUID	ORAL	20130213		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	IODINE	6	[hp_X]/mL			N	20241231
43857-0090_d83ecc37-859d-449c-9220-ba4921f9adbc	43857-0090	HUMAN OTC DRUG	Stomaplex		Carduus Marianus, Gentiana Lutea, Sambucus Nigra, Senna (Cassia Angustifolia), Stomach (Bovine), Arsenicum Album, Atropinum Sulphuricum, Carbo Vegetabilis, Lycopodium Clavatum, Nux Vomica, Phosphorus	LIQUID	ORAL	20130219	20260219	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; ATROPINE SULFATE; GENTIANA LUTEA ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP; SENNA LEAF; SILYBUM MARIANUM SEED; STRYCHNOS NUX-VOMICA SEED; TRIPE	12; 12; 12; 3; 12; 12; 3; 3; 3; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Anticholinergic [EPC], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0093_c1e5b50b-8635-496c-9a10-d12ebe2ad709	43857-0093	HUMAN OTC DRUG	Dentaforce		Antimonium Crudum, Belladonna, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Hekla Lava, Mercurius Solubilis, Plumbum Metallicum, Sepia, Silicea, Hydrofluoricum Acidum	LIQUID	ORAL	20130910		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANTIMONY TRISULFIDE; ATROPA BELLADONNA; CALCIUM FLUORIDE; HEKLA LAVA; HYDROFLUORIC ACID; LEAD; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43857-0097_6262d15f-e7d4-4403-a77a-f9b5fe7cb428	43857-0097	HUMAN OTC DRUG	Anxiety	II HP	Aconitum Napellus, Arsenicum Album, Belladonna, Calcarea Carbonica, Carcinosin, Causticum, Gelsemium Sempervirens, Lachesis Mutus, Mercurius Vivus, Nitricum Acidum, Phosphorus, Rhus Tox	SPRAY	ORAL	20121109		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAUSTICUM; GELSEMIUM SEMPERVIRENS ROOT; HUMAN BREAST TUMOR CELL; LACHESIS MUTA VENOM; MERCURY; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43857-0100_8753c8fb-ce47-46db-ac3b-95eec1aab688	43857-0100	HUMAN OTC DRUG	Pneumoforce		Althaea Officinalis, Natrum Carbonicum, Rheum (Officinale), Verbascum Thapsus, Zingiber Officinale, Aconitum Napellus, Drosera (Rotundifolia), Kali Bichromicum, Lobelia Inflata, Phosphorus	LIQUID	ORAL	20130212	20240307	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS; ALTHAEA OFFICINALIS ROOT; DROSERA ROTUNDIFOLIA; GINGER; LOBELIA INFLATA; PHOSPHORUS; POTASSIUM DICHROMATE; RHEUM OFFICINALE ROOT; SODIUM CARBONATE; VERBASCUM THAPSUS	12; 3; 12; 3; 12; 12; 12; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43857-0103_0fbb882f-ea06-4d40-be08-8fef05705c57	43857-0103	HUMAN OTC DRUG	Progesterone		Progesterone	LIQUID	ORAL	20130212		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	PROGESTERONE	6	[hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
43857-0108_1865ac26-9e8e-4039-bf92-bd74cf8e5b8d	43857-0108	HUMAN OTC DRUG	Bio Res Q		Clematis Vitalba Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos	LIQUID	ORAL	20140903		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER	6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0109_86d58480-746d-42a5-828d-56eee3fb266b	43857-0109	HUMAN OTC DRUG	Viscumforce		Passiflora Incarnata, Valeriana Officinalis, Aurum Metallicum, Baryta Carbonica, Glonoinum, Phosphorus, Plumbum Metallicum, Viscum Album	LIQUID	ORAL	20130211		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BARIUM CARBONATE; GOLD; LEAD; NITROGLYCERIN; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; VALERIAN; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 3; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
43857-0110_aa83accc-ad3e-4f93-a23f-b77618f8972e	43857-0110	HUMAN OTC DRUG	Hepataplex		Beta Vulgaris, Boldo, Carduus Marianus, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Glutathione, Hepar suis, Lycopodium clavatum, Nux vomica, Phosphorus	LIQUID	ORAL	20130211	20260525	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BETA VULGARIS; CHELIDONIUM MAJUS; GLUTATHIONE; LYCOPODIUM CLAVATUM SPORE; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; PHOSPHORUS; PORK LIVER; SILYBUM MARIANUM SEED; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	3; 3; 6; 12; 3; 3; 12; 6; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0111_e951e1e5-bf9d-4ca4-82fd-090e6e2039a7	43857-0111	HUMAN OTC DRUG	Coxsackie		Coxsackie B1, B4	LIQUID	ORAL	20121009		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4	200; 200	[hp_C]/mL; [hp_C]/mL			N	20241231
43857-0115_487a750f-661b-43d3-ac8a-fb0bb90ff51a	43857-0115	HUMAN OTC DRUG	Bone Repair	HP	Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Fluoricum Acidum, Hekla Lava, Rhus Tox, Silicea, Symphytum Officinale	LIQUID	ORAL	20130130	20241024	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CALCIUM FLUORIDE; COMFREY ROOT; HEKLA LAVA; HYDROFLUORIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
43857-0116_3a7a505d-8c2c-4e81-ba7f-87ebf4248360	43857-0116	HUMAN OTC DRUG	Kidney Tonic I		Echinacea (Angustifolia), Petroselinum Sativum, Solidago Virgaurea, Uva-Ursi, Pareira Brava, Glutathione, Kidney (Suis), Cantharis, Lycopodium Clavatum	LIQUID	ORAL	20121217	20240325	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; CHONDRODENDRON TOMENTOSUM ROOT; ECHINACEA ANGUSTIFOLIA; GLUTATHIONE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PETROSELINUM CRISPUM; PORK KIDNEY; SOLIDAGO VIRGAUREA FLOWERING TOP	1; 3; 1; 6; 12; 12; 1; 8; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0117_787dc812-6bbe-4e1a-a13e-f530256ea0ad	43857-0117	HUMAN OTC DRUG	Bio Cherry Plum		Prunus Cerasifera, Flos	LIQUID	ORAL	20130130		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	PRUNUS CERASIFERA FLOWER	6	[hp_X]/mL			N	20241231
43857-0119_558bd339-b742-44a0-b279-7091ed50ad45	43857-0119	HUMAN OTC DRUG	Spleen		Spleen (bovine)	LIQUID	ORAL	20121008		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BOS TAURUS SPLEEN	6	[hp_X]/mL			N	20241231
43857-0120_d1fed1b0-6ed3-44da-a68e-e0c73097b541	43857-0120	HUMAN OTC DRUG	Progesterone		Progesterone	LIQUID	ORAL	20121009		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	PROGESTERONE	6	[hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
43857-0121_26d649fc-4cb0-4cf2-8527-bf08919f92b5	43857-0121	HUMAN OTC DRUG	Bio Electrolyte		Boron Gluconate, Calcium Gluconate, Chromium Gluconate, Cobalt Gluconate, Copper Gluconate, Ferrous Gluconate, Magnesium Gluconicum Dihydrate, Manganese Gluconate, Nickel Gluconate, Potassium Gluconate, Selenium Gluconate, Zincum Gluconicum, Kali Phosphoricum, Vanadium Metallicum, Calcarea Phosphorica	LIQUID	ORAL	20130129	20240802	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BORON GLUCONATE; CALCIUM GLUCONATE; CHROMIUM GLUCONATE; COBALTOUS GLUCONATE; COPPER GLUCONATE; DIBASIC POTASSIUM PHOSPHATE; FERROUS GLUCONATE; MAGNESIUM GLUCONATE; MANGANESE GLUCONATE; NICKEL GLUCONATE; POTASSIUM GLUCONATE; SELENIUM DIOXIDE; SODIUM GLUCONATE; TRIBASIC CALCIUM PHOSPHATE; VANADIUM; ZINC GLUCONATE	6; 6; 6; 6; 6; 8; 6; 6; 6; 6; 6; 6; 6; 9; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43857-0123_24c12661-ff0c-40a0-a64e-038e1e0a491c	43857-0123	HUMAN OTC DRUG	GABA		Gaba (Gamma-Aminobutyric Acid)	LIQUID	ORAL	20141003		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	.GAMMA.-AMINOBUTYRIC ACID	6	[hp_X]/mL			N	20241231
43857-0126_5a80f8c8-b8fa-4b4e-b288-ff2796bdd7c2	43857-0126	HUMAN OTC DRUG	Histamine		Histaminum Hydrochloricum	LIQUID	ORAL	20130307		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	HISTAMINE DIHYDROCHLORIDE	6	[hp_X]/mL			N	20241231
43857-0127_903a2dae-39ac-4d13-8290-8ab6469c3a25	43857-0127	HUMAN OTC DRUG	Anti Hive		Ammonium Carbonicum, Apis Mellifica, Argentum Metallicum, Arsenicum Album, Dulcamara, Mezereum, Rhus Tox, Urtica Urens	LIQUID	ORAL	20130307		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMMONIUM CARBONATE; APIS MELLIFERA; ARSENIC TRIOXIDE; DAPHNE MEZEREUM BARK; SILVER; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0129_fda88d2d-0e7a-4f86-942b-aad9e43b51b3	43857-0129	HUMAN OTC DRUG	Bio Impatiens		Impatiens Glandulifera, Flos	LIQUID	ORAL	20130311		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	IMPATIENS GLANDULIFERA FLOWER	6	[hp_X]/mL			N	20241231
43857-0130_58ab93af-c7a8-4010-a051-d7ef51ccff8b	43857-0130	HUMAN OTC DRUG	Glutathione		Glutathione	LIQUID	ORAL	20130228		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	GLUTATHIONE	6	[hp_X]/mL			N	20241231
43857-0131_adc55c3b-41ea-4f4f-b14f-443542d19b6d	43857-0131	HUMAN OTC DRUG	Arthritis	HP	Apis Mellifica, Bryonia, Causticum, Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Pulsatilla, Rhododendron Chrysanthum, Rhus Tox	LIQUID	ORAL	20130220	20240814	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; BRYONIA ALBA ROOT; CAUSTICUM; COLCHICUM AUTUMNALE BULB; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; PULSATILLA VULGARIS; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
43857-0134_f3ecb03e-f67e-4189-86a4-3446980a0316	43857-0134	HUMAN OTC DRUG	Bio Mimulus		Mimulus Guttatus, Flos	LIQUID	ORAL	20130311		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	MIMULUS GUTTATUS FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0136_fd6b4539-44c5-414d-8134-1ba1f7c12053	43857-0136	HUMAN OTC DRUG	Nephroplex		Berberis Vulgaris, Hydrangea Arborescens, Petroselinum Sativum, Solidago Virgaurea, Uva Ursi, Rubia Tinctorum, Glutathione, Kidney (Suis), Bryonia (Alba), Eupatorium Purpureum, Mercurius Corrosivus	LIQUID	ORAL	20130114		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; EUTROCHIUM PURPUREUM ROOT; GLUTATHIONE; HYDRANGEA ARBORESCENS ROOT; MERCURIC CHLORIDE; PETROSELINUM CRISPUM; PORK KIDNEY; RUBIA TINCTORUM ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP	3; 3; 12; 12; 6; 3; 12; 3; 6; 5; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0138_88b92968-2286-444b-a39c-c7ac8492e821	43857-0138	HUMAN OTC DRUG	Acetylcholine Chloride		Acetylcholine Chloride	LIQUID	ORAL	20130228		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACETYLCHOLINE CHLORIDE	6	[hp_X]/mL	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
43857-0142_58e83756-3f61-475b-86af-984d8cd71199	43857-0142	HUMAN OTC DRUG	Insomnia	HP	Arsenicum Album, Coffea Cruda, Kali Carbonicum, Magnesia Carbonica, Nux Vomica, Passiflora Incarnata, Sepia, Valeriana Officinalis	LIQUID	ORAL	20130409		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; MAGNESIUM CARBONATE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; VALERIAN	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0145_a6309dc3-326d-4f2b-b728-eeb041acb975	43857-0145	HUMAN OTC DRUG	Allergen	II	Kali Gluconicum, Adrenalinum, Hepar, Sheep Sorrel, Yellow Dock, Kentucky Blue Grass, Orchard Grass, Red Top Grass, Timothy Grass, Goldenrod, Red Clover, False Ragweed, Short Ragweed, Tall Ragweed, Western Ragweed, Ash, Beech, Red Birch, Box Elder, Cottonwood, Elm, Hickory, Red Oak, Sycamore, Black Walnut, Black Willow, Arsenicum Album, Phosphorus, Pulsatilla, Sulphur, Histaminum Hydrochloricum	LIQUID	ORAL	20120222	20240325	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACER NEGUNDO POLLEN; AGROSTIS GIGANTEA POLLEN; ALFALFA; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ARSENIC TRIOXIDE; BEEF LIVER; BETULA OCCIDENTALIS POLLEN; CARYA OVATA POLLEN; DACTYLIS GLOMERATA TOP; EPINEPHRINE; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; HISTAMINE DIHYDROCHLORIDE; JUGLANS NIGRA POLLEN; PHLEUM PRATENSE TOP; PHOSPHORUS; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS TOP; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POTASSIUM GLUCONATE; PULSATILLA VULGARIS; QUERCUS RUBRA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS TOP; SALIX NIGRA POLLEN; SOLIDAGO VIRGAUREA FLOWERING TOP; SULFUR; TRIFOLIUM PRATENSE FLOWER; ULMUS AMERICANA POLLEN	9; 9; 9; 9; 9; 9; 9; 12; 8; 9; 9; 9; 8; 9; 9; 30; 9; 9; 12; 9; 9; 9; 6; 12; 9; 9; 9; 9; 9; 12; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Pollen Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
43857-0148_48384b25-12ba-4098-855d-f375e0c0fe2f	43857-0148	HUMAN OTC DRUG	Diathesis	III	Heart (Suis), Small Intestine (Suis), Germanium Sesquioxide, Cobaltum Metallicum, Cysteinum, Manganum Metallicum, Manganese Gluconate, alpha-Ketoglutaricum Acidum, Arsenicum Album, Aurum Metallicum, Fumaricum Acidum, Natrum Oxalaceticum, Phosphorus	LIQUID	ORAL	20130416		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	.ALPHA.-KETOGLUTARIC ACID; ARSENIC TRIOXIDE; COBALT; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GOLD; MANGANESE; MANGANESE GLUCONATE; PHOSPHORUS; PORK HEART; PORK INTESTINE; SODIUM DIETHYL OXALACETATE	12; 12; 9; 9; 12; 8; 12; 9; 10; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0149_edc54e45-9589-4d49-ab67-0df094edddf6	43857-0149	HUMAN OTC DRUG	Gaba		Gaba	LIQUID	ORAL	20130910		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	.GAMMA.-AMINOBUTYRIC ACID	6	[hp_X]/mL			N	20241231
43857-0150_f57f2fdf-83fd-4400-9f42-28710cda6fba	43857-0150	HUMAN OTC DRUG	Estrogen		Folliculinum, Oophorinum (Suis)	LIQUID	ORAL	20130404		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ESTRONE; SUS SCROFA OVARY	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
43857-0151_d8c3ce0f-e576-4e06-a4d8-60378802df4b	43857-0151	HUMAN OTC DRUG	Naja Forte X		Naja Tripudians	LIQUID	ORAL	20130403		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	NAJA NAJA VENOM	9	[hp_X]/mL			N	20241231
43857-0152_885577e1-59ea-479b-9015-2ee58620e1bf	43857-0152	HUMAN OTC DRUG	HZ	HP	Lycopodium Clavatum, Natrum Muriaticum, Nitricum Acidum, Ranunculus Bulbosus, Rhus Tox, Sepia, Thuja Occidentalis	LIQUID	ORAL	20130404		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; RANUNCULUS BULBOSUS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0156_9d5ff5a5-aa57-431d-8387-ee37ee42827d	43857-0156	HUMAN OTC DRUG	Bio Mustard		Sinapis Arvensis, Flos	LIQUID	ORAL	20121009		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	SINAPIS ARVENSIS FLOWERING/FRUITING TOP	6	[hp_X]/mL			N	20241231
43857-0159_89910b9e-d250-4bc3-b982-e33a11ba28ee	43857-0159	HUMAN OTC DRUG	Arterioforce	I	Arnica Montana, Lilium Tigrinum, Aurum Muriaticum, Cactus Grandiflorus, Digitalis Purpurea, Glonoinum, Nux Vomica, Veratrum Album	LIQUID	ORAL	20130417		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; DIGITALIS; GOLD TRICHLORIDE; LILIUM LANCIFOLIUM WHOLE FLOWERING; NITROGLYCERIN; SELENICEREUS GRANDIFLORUS STEM; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	3; 12; 12; 4; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
43857-0161_6c128790-08ca-418e-a2c8-e6fda37a620f	43857-0161	HUMAN OTC DRUG	Norepinephrine		Norepinephrine	LIQUID	ORAL	20130417		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	NOREPINEPHRINE	6	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
43857-0164_9b7ff634-0c8f-4107-af04-80f9afe98b2a	43857-0164	HUMAN OTC DRUG	Circulatone		Fagopyrum Esculentum, Magnesia Muriatica, Citrus Bioflavonoids, Heart (Suis), Thyroidinum (Suis), Arsenicum Iodatum, Aurum Muriaticum, Baryta Muriatica, Calcarea Iodata, Cholesterinum, Conium Maculatum, Kali Iodatum, Plumbum Metallicum, Arnica Montana, Phosphorus	LIQUID	ORAL	20130422		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; ARSENIC TRIIODIDE; BARIUM CHLORIDE DIHYDRATE; CALCIUM IODIDE; CHOLESTEROL; CITRUS BIOFLAVONOIDS; CONIUM MACULATUM FLOWERING TOP; FAGOPYRUM ESCULENTUM; GOLD TRICHLORIDE; LEAD; MAGNESIUM CHLORIDE; PHOSPHORUS; PORK HEART; POTASSIUM IODIDE; SUS SCROFA THYROID	30; 12; 12; 12; 12; 8; 12; 3; 12; 12; 3; 30; 8; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0165_568944d6-2efe-4a6c-8882-05011a8fe69b	43857-0165	HUMAN OTC DRUG	Gynetox		Angelica Archangelica, Cimicifuga Racemosa, Zincum Gluconicum, Funiculus Umbilicalis Suis, Lymph Node (Suis), Oophorinum (Suis), Uterus (Suis), Glandula Suprarenalis Suis, Thyroidinum Suis, Boricum Acidum, Kreosotum, Mercurius Solubilis, Pulsatilla, Sepia, Calcarea Carbonica, Phosphorus, Sabina, Candida Albicans, Herpes Simplex 1 And 2 Nosode, Human Papilloma Virus Nosode	LIQUID	ORAL	20140903	20250904	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANEMONE PULSATILLA; ANGELICA ARCHANGELICA ROOT; BLACK COHOSH; BORIC ACID; CANDIDA ALBICANS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN PAPILLOMAVIRUS; JUNIPERUS SABINA LEAFY TWIG; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA THYROID; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; WOOD CREOSOTE; ZINC GLUCONATE	12; 3; 3; 12; 30; 30; 30; 30; 30; 12; 30; 30; 12; 9; 8; 8; 9; 8; 8; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43857-0168_4af75847-5944-45b7-95d6-efa3369c29ab	43857-0168	HUMAN OTC DRUG	Food Additives		Berberis Vulgaris, Chelidonium Majus, Trifolium Pratense, Glycyrrhiza Glabra, Lappa Major, Phytolacca Decandra, Rhamnus Frangula, Rhamnus Purshiana, Stillingia Sylvatica, Xanthoxylum Fraxineum, Arsenicum Album, Belladonna, Lycopodium Clavatum, Natrum Sulphuricum, Phosphoricum Acidum	LIQUID	ORAL	20130516		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; ATROPA BELLADONNA WHOLE; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; FRANGULA ALNUS BARK; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; SODIUM SULFATE; STILLINGIA SYLVATICA ROOT; TRIFOLIUM PRATENSE FLOWER; ZANTHOXYLUM AMERICANUM BARK	4; 12; 12; 3; 3; 4; 4; 4; 12; 12; 4; 12; 4; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43857-0170_11a03722-d294-4c99-b234-579722745c5b	43857-0170	HUMAN OTC DRUG	Cystoforce		Sarsaparilla, Solidago Virgaurea, Uva Ursi, Apis Mellifica, Arsenicum Album, Cantharis, Hepar Sulphuris Calcareum	LIQUID	ORAL	20130605		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIOXIDE; CALCIUM SULFIDE; LYTTA VESICATORIA; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 3; 12; 12; 12; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0171_ef3fa1f6-a7ec-4fba-b593-57df454867d0	43857-0171	HUMAN OTC DRUG	Bio Argimony		Agrimonia Eupatoria, Flos (Agrimony)	LIQUID	ORAL	20140826		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AGRIMONIA EUPATORIA FLOWER	6	[hp_X]/mL			N	20241231
43857-0172_a38f0abb-4b64-4120-bd4f-08cae1f2ec47	43857-0172	HUMAN OTC DRUG	Diathesis	V 1	Ginkgo Biloba, Pancreas (Suis), Spleen (Suis), Stomach (Suis), Germanium Sesquioxide, Cuprum Metallicum, Cysteinum, Zincum Metallicum, Manganese Gluconate, Alpha-Ketoglutaricum Acidum, Fumaricum Acidum, Natrum Oxalaceticum	LIQUID	ORAL	20130516		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	.ALPHA.-KETOGLUTARIC ACID; COPPER; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; MANGANESE GLUCONATE; SODIUM DIETHYL OXALACETATE; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA STOMACH; ZINC	12; 9; 9; 12; 8; 6; 10; 12; 6; 6; 6; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
43857-0173_a1982d80-6241-4308-b2c9-8c4267c9a056	43857-0173	HUMAN OTC DRUG	TREE ANTIGEN		American Beech, American Elm, Black Walnut, Black Willow, Negundo, Eastern Cottonwood, Hickory, Red Birch, Red Oak, Platanus, Fraxinus Americana, Melaleuca Blossom, Arsenicum Album, Lycopodium Clavatum, Pulsatilla Vulgaris	LIQUID	ORAL	20130807	20240218	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACER NEGUNDO POLLEN; ARSENIC TRIOXIDE; BETULA OCCIDENTALIS POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; LYCOPODIUM CLAVATUM SPORE; MELALEUCA ALTERNIFOLIA FLOWERING TOP; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; PULSATILLA VULGARIS; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	6; 12; 6; 6; 6; 6; 6; 12; 6; 6; 6; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	
43857-0174_120a9d7d-6176-4d25-9dc3-4d3b7dc8efcc	43857-0174	HUMAN OTC DRUG	Bronci	HP	Carbo Vegetabilis, Cuprum Metallicum, Drosera (Rotundifolia), Ipecacuanha, Lachesis Mutus, Lobelia Inflata, Phosphorus, Pulsatilla (Vulgaris), Rumex Crispus, Spongia Tosta	LIQUID	ORAL	20130611	20250630	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACTIVATED CHARCOAL; COPPER; DROSERA ROTUNDIFOLIA; IPECAC; LACHESIS MUTA VENOM; LOBELIA INFLATA; PHOSPHORUS; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	
43857-0176_a42075b1-fa82-486b-9ec4-a0882c1fc1fe	43857-0176	HUMAN OTC DRUG	Cerebroforce		Capsicum Annuum, Ginkgo Biloba, Gelsemium Sempervirens, Kali Phosphoricum, Lycopodium Clavatum, Phosphorus, Arsenicum Album	LIQUID	ORAL	20130910		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc	ARSENIC TRIOXIDE; CAPSICUM; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; POTASSIUM PHOSPHATE, DIBASIC	30; 3; 12; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
43857-0177_0b1fd8a7-b47c-4705-b7d0-8b85476dd92e	43857-0177	HUMAN OTC DRUG	Candida		Candida Albicans	LIQUID	ORAL	20130910		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0178_edc0a842-5b2e-44de-9686-5d0bd0f28680	43857-0178	HUMAN OTC DRUG	Bio Elm		Ulmus Procera, Flos	LIQUID	ORAL	20130611		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ULMUS PROCERA FLOWERING TWIG	6	[hp_X]/mL			N	20241231
43857-0180_3391c38f-2ed1-4b6e-835a-fbd382f90bdb	43857-0180	HUMAN OTC DRUG	FEMALE BALANCE		Folliculinum, Progesterone	LIQUID	ORAL	20130801		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ESTRONE; PROGESTERONE	6; 6	[hp_X]/mL; [hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
43857-0181_623163f1-9a5f-43ef-841e-6108b43d95f1	43857-0181	HUMAN OTC DRUG	Hypert	HP	Arnica Montana, Aurum Metallicum, Cactus Grandiflorus, Calcarea Carbonica, Natrum Muriaticum, Nux Vomica, Phosphorus, Solidago Virgaurea	LIQUID	ORAL	20130612	20240807	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; GOLD; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SELENICEREUS GRANDIFLORUS STEM; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	
43857-0182_64fbb371-c22d-472b-8595-f5f96ffe4307	43857-0182	HUMAN OTC DRUG	Bio Wild Oat		Bromus Ramosus, Flos	LIQUID	ORAL	20130612		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BROMUS RAMOSUS FLOWER	6	[hp_X]/mL			N	20241231
43857-0183_9412044f-f6c6-4206-a26f-90f44ed9d232	43857-0183	HUMAN OTC DRUG	Bio Centaury		Centaurium Umbellatum, Flos	LIQUID	ORAL	20130613		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CENTAURIUM ERYTHRAEA	6	[hp_X]/mL			N	20241231
43857-0184_c3bb6040-8b39-4fe6-b5dc-50f2efee6b0c	43857-0184	HUMAN OTC DRUG	Candida Alb		Candida Albicans	LIQUID	ORAL	20130612		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	500	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0185_330f69bb-17d7-4646-af3e-6916c3d63a0e	43857-0185	HUMAN OTC DRUG	Candida Alb		Candida Albicans	LIQUID	ORAL	20130612		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0187_1cc46acd-4c59-4f83-80f5-09fbbe42d509	43857-0187	HUMAN OTC DRUG	Neurotone		Passiflora Incarnata, Glandula Suprarenalis Suis, Thyroidinum (Suis), Arnica Montana, Hypericum Perforatum, Lachesis Mutus, Muira Puama	LIQUID	ORAL	20130611		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; PASSIFLORA INCARNATA FLOWERING TOP; PTYCHOPETALUM OLACOIDES ROOT; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYROID	12; 12; 12; 3; 15; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0188_0f19abb3-2421-4f9c-8639-84abb1c5d9d2	43857-0188	HUMAN OTC DRUG	ASTH-HP		Arsenicum Album, Belladonna, Ipecacuanha, Kali Carbonicum, Lobelia Inflata, Natrum Sulphuricum, Silicea	LIQUID	ORAL	20130806	20250124	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; IPECAC; LOBELIA INFLATA; POTASSIUM CARBONATE; SILICON DIOXIDE; SODIUM SULFATE	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0189_45dba434-3776-4d07-9311-9b5002e46891	43857-0189	HUMAN OTC DRUG	BIO BEECH		Fagus Sylvatica, Flos	LIQUID	ORAL	20130806		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	FAGUS SYLVATICA FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0201_001d43aa-c707-4589-a300-25f23ccd7f46	43857-0201	HUMAN OTC DRUG	VERTIFORCE		Leonurus Cardiaca, Agaricus Muscarius, Arsenicum Album, Cocculus Indicus, Conium Maculatum, Petroleum, Phosphorus, Pulsatilla, Tabacum, Theridion	LIQUID	ORAL	20130812	20240725	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMANITA MUSCARIA FRUITING BODY; ANAMIRTA COCCULUS SEED; ARSENIC TRIOXIDE; CONIUM MACULATUM FLOWERING TOP; KEROSENE; LEONURUS CARDIACA; PHOSPHORUS; PULSATILLA VULGARIS; THERIDION CURASSAVICUM; TOBACCO LEAF	12; 12; 12; 12; 12; 3; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43857-0202_536fd716-a488-4ac3-b2f7-3b84f57d75f5	43857-0202	HUMAN OTC DRUG	Grippe HP		Aconitum Napellus, Arsenicum Album, Belladonna, Bryonia, Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens	LIQUID	ORAL	20130911	20250629	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERRUM PHOSPHORICUM; GELSEMIUM SEMPERVIRENS ROOT	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0203_6951631d-2627-410f-b803-8b5d7e116f1e	43857-0203	HUMAN OTC DRUG	Menopause HP		Belladonna, Lachesis Mutus, Nux Vomica, Pulsatilla (Vulgaris), Secale Cornutum, Sepia, Ustilago Maidis	LIQUID	ORAL	20130911		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; CLAVICEPS PURPUREA SCLEROTIUM; LACHESIS MUTA VENOM; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; USTILAGO MAYDIS	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0204_448f788c-f956-40eb-aa08-8fdff5e95c1e	43857-0204	HUMAN OTC DRUG	Ovaplex		Angelica Archangelica, Caulophyllum Thalictroides, Dioscorea Villosa, Hypophysis Suis, Oophorinum (Suis) Thyroidinum (Suis), Uterus Suis, Zincum Gluconicum, Apis Mellifica, Belladonna, Cimicifuga Racemosa, Magnesia Phosphorica, Sepia	LIQUID	ORAL	20130821		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANGELICA ARCHANGELICA ROOT; APIS MELLIFERA; ATROPA BELLADONNA; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; DIOSCOREA VILLOSA TUBER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; SUS SCROFA UTERUS; ZINC GLUCONATE	3; 12; 12; 12; 3; 3; 12; 12; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0205_c1f990cb-c09c-4f1c-b2ba-0231b0eaaaa4	43857-0205	HUMAN OTC DRUG	Parathyroplex		Parathyroid Gland (Bovine), Baryta Carbonica, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Cuprum Metallicum, Magnesia Phosphorica, Manganum Metallicum, Rhus Tox, Silicea	LIQUID	ORAL	20130821		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BARIUM CARBONATE; BOS TAURUS PARATHYROID GLAND; CALCIUM FLUORIDE; COPPER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	12; 6; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0213_becaaf29-a0a8-4d09-96e9-532867121a91	43857-0213	HUMAN OTC DRUG	Pneumo	HP	Ammonium Muriaticum, Antimonium Tartaricum, Arsenicum Album, Calcarea Carbonica, Lobelia Inflata, Natrum Sulphuricum, Spongia Tosta, Phosphorus,	LIQUID	ORAL	20140122		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMMONIUM CHLORIDE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; LOBELIA INFLATA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0214_5ed0f9ca-2eac-459e-8305-4e167e4c7f10	43857-0214	HUMAN OTC DRUG	Influaforce Plus		Bryonia (Alba), Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens, Kreosotum, Veratrum Viride, Avian Flu Virus Nosode	LIQUID	ORAL	20141002	20250514	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERRUM PHOSPHORICUM; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/VIETNAM/1203/2004 (H5N1, CLADE 1) ANTIGEN (FORMALDEHYDE INACTIVATED); VERATRUM VIRIDE ROOT; WOOD CREOSOTE	30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43857-0216_1adec121-e5a8-461d-9123-314ed2433a5c	43857-0216	HUMAN OTC DRUG	Depressoforce		Picricum acidum, Arsenicum album, Aurum metallicum, Ignatia amara, Natrum muriaticum, Nitricum acidum, Pulsatilla (Vulgaris), Sepia,	LIQUID	ORAL	20140616	20240611	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; GOLD; NITRIC ACID; PICRIC ACID; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	30; 30; 30; 12; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
43857-0217_99a44b58-29e7-4016-ba9a-d883823a0589	43857-0217	HUMAN OTC DRUG	Enuresis		Equisetum Hyemale, Solidago Virgaurea, Uva-Ursi, Argentum Metallicum, Causticum, Kreosotum, Nitricum Acidum, Sepia, Thuja Occidentalis	LIQUID	ORAL	20150401		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; CAUSTICUM; EQUISETUM HYEMALE; NITRIC ACID; SEPIA OFFICINALIS JUICE; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	3; 12; 3; 12; 12; 12; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0219_e35dd05d-0c32-459a-b98b-a27e22c15b27	43857-0219	HUMAN OTC DRUG	Bio Aspen		Aspen	LIQUID	ORAL	20130830		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	POPULUS TREMULA FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0220_119c2eb2-f316-4b5a-b994-1fec67c7ba3b	43857-0220	HUMAN OTC DRUG	Bio Rock Water		Rock Water	LIQUID	ORAL	20130829		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	WATER	6	[hp_X]/mL			N	20241231
43857-0221_35e1ce43-a3e1-42fc-b425-ca1e9f550f5b	43857-0221	HUMAN OTC DRUG	NV-HP		Arsenicum Album, Cocculus Indicus, Ipecacuanha, Kerosotum, Petroleum, Pulsatilla, Sanguinaria Canadensis, Tabacum	LIQUID	ORAL	20130917		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANAMIRTA COCCULUS SEED; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; IPECAC; KEROSENE; SANGUINARIA CANADENSIS ROOT; TOBACCO LEAF; WOOD CREOSOTE	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43857-0222_59c48e81-ad44-4d68-92e5-936d6de9eab5	43857-0222	HUMAN OTC DRUG	Animal Antigens		Canary Feathers, Cat Hair, Cattle Epithelia, Chicken Feathers, Dog Epithelia, Duck Feathers, Gerbil Epithelia, Goat Epithelia, Goose Feathers, Guinea Pig Epithelia, Hamster Epithelia, Hog Epithelia, Horse Epithelia, Mouse Epithelia, Parakeet Feathers, Rabbit Epithelia, Rat Epithelia, Arsenicum Album, Nux Vomica, Phosphorus	LIQUID	ORAL	20130919	20250820	UNAPPROVED HOMEOPATHIC		BioActive Nutritional	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; ARSENIC TRIOXIDE; BOS TAURUS SKIN; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS SKIN; CAVIA PORCELLUS SKIN; EQUUS CABALLUS SKIN; FELIS CATUS HAIR; GALLUS GALLUS FEATHER; MELOPSITTACUS UNDULATUS FEATHER; MERIONES UNGUICULATUS SKIN; MESOCRICETUS AURATUS SKIN; MUS MUSCULUS SKIN; ORYCTOLAGUS CUNICULUS SKIN; PHOSPHORUS; RATTUS NORVEGICUS SKIN; SERINUS CANARIA FEATHER; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA SKIN	9; 9; 12; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 12; 9; 9; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	
43857-0226_37e29af7-2896-47d1-8f2e-d9ccd03108d6	43857-0226	HUMAN OTC DRUG	L-Dopa		L-Dopa	LIQUID	ORAL	20150327		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	LEVODOPA	6	[hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
43857-0227_842929a8-8e58-4c45-89c9-56d39127ac8e	43857-0227	HUMAN OTC DRUG	Colloidal Silver		Colloidal Silver	LIQUID	ORAL	20150401		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SILVER	6	[hp_X]/mL			N	20241231
43857-0229_242ee500-e8a9-4f8d-aebc-97d9e052aad2	43857-0229	HUMAN OTC DRUG	Taurine		Taurine	LIQUID	ORAL	20130923		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	TAURINE	6	[hp_X]/mL			N	20241231
43857-0231_c15fc262-73ed-49dd-b340-0af171aec314	43857-0231	HUMAN OTC DRUG	Hepataforce		Carduus Marianus, Chelidonium Majus, Taraxacum Officinale, Lycopodium Clavatum, Magnesia Phosphorica, Natrum Sulphuricum	LIQUID	ORAL	20130925		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	CHELIDONIUM MAJUS; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MILK THISTLE; SODIUM SULFATE; TARAXACUM OFFICINALE	3; 12; 12; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0232_0bf65e6f-1631-44ce-94c9-29c249826aea	43857-0232	HUMAN OTC DRUG	Tryptophan		L-Tryptophan	LIQUID	ORAL	20130925		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	TRYPTOPHAN	6	[hp_X]/mL			N	20241231
43857-0235_23e967b9-2246-49d3-b0bf-042bf8c43892	43857-0235	HUMAN OTC DRUG	Bio Larch		Larix Decidua, Flos	LIQUID	ORAL	20131002		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	LARIX DECIDUA FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0236_04a8669c-c144-4d82-b5e3-a7adad10b541	43857-0236	HUMAN OTC DRUG	Bio Olive		Olea Europaea,Flos	LIQUID	ORAL	20131002		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	OLEA EUROPAEA FLOWER	6	[hp_X]/mL			N	20241231
43857-0237_97a11238-ab8c-4ead-8f06-9f8248146cfd	43857-0237	HUMAN OTC DRUG	Bio Pine		Pinus Sylvestris	LIQUID	ORAL	20131002		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	PINUS SYLVESTRIS FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0238_8b867853-f85c-4eb7-82fe-c20a89cdfdc1	43857-0238	HUMAN OTC DRUG	Bio Vervain		Verbena Officinalis, Flos	LIQUID	ORAL	20140822		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	VERBENA OFFICINALIS FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0239_08da90b8-c059-42c0-9cf3-2414a4f894f6	43857-0239	HUMAN OTC DRUG	Bio White Chestnut		Aesculus Hippocastanum, Flos	LIQUID	ORAL	20140826		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AESCULUS HIPPOCASTANUM FLOWER	6	[hp_X]/mL			N	20241231
43857-0240_96ef367d-bfdc-49ab-b5f0-26f09b05c8c2	43857-0240	HUMAN OTC DRUG	Bio Willow		Salix Vitellina, Flos	LIQUID	ORAL	20131002		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SALIX ALBA FLOWER	6	[hp_X]/mL			N	20241231
43857-0242_74a18921-f988-421a-b3c0-12229d607ab9	43857-0242	HUMAN OTC DRUG	Serotonin		Serotonin (Hydrochloride)	LIQUID	ORAL	20130925		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	SEROTONIN HYDROCHLORIDE	6	[hp_X]/mL			N	20241231
43857-0243_9258dcbb-cfec-414e-9ad6-4acb30634988	43857-0243	HUMAN OTC DRUG	Serotonin		Serotonin	LIQUID	ORAL	20160523		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	SEROTONIN HYDROCHLORIDE	6	[hp_X]/mL			N	20241231
43857-0245_2fd1d86e-78d3-4db5-891f-b325f6280a02	43857-0245	HUMAN OTC DRUG	Serotonin		Serotonin (Hydrochloride)	LIQUID	ORAL	20130930		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SEROTONIN HYDROCHLORIDE	6	[hp_X]/mL			N	20241231
43857-0247_fc175c6d-4af7-414e-a8ea-cc5ba17336dd	43857-0247	HUMAN OTC DRUG	Candida Alb		Candida Albicans	LIQUID	ORAL	20131003		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	30	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0249_8abac30f-8abf-4d91-88b6-f4361ca97586	43857-0249	HUMAN OTC DRUG	Diathesis	I	Manganum Metallicum, Germanium Sesquioxide, Fel Tauri, Hepar Suis, Ginkgo Biloba, Cysteinum, Manganese Gluconate, Alpha-Ketoglutaricum Acidum, Arsenicum Album, Fumaricum Acidum, Phosphorus, Sodium Oxalate, Sulphur	LIQUID	ORAL	20140109		UNAPPROVED HOMEOPATHIC		BioActive Nutritionals, Inc.	.ALPHA.-KETOGLUTARIC ACID; ARSENIC TRIOXIDE; BOS TAURUS BILE; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; MANGANESE; MANGANESE GLUCONATE; PHOSPHORUS; PORK LIVER; SODIUM OXALATE; SULFUR	12; 12; 6; 9; 12; 8; 6; 9; 10; 12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
43857-0250_be74e7e2-3aee-450f-b7a1-778185edc3fd	43857-0250	HUMAN OTC DRUG	Diathesis V 2		Ginkgo Biloba, Pancreas Suis, Spleen (Suis), Stomach (Suis), Germanium Sesquioxide, Cobaltum Metallicum, Cysteinum, Niccolum Metallicum, Zincum Metallicum, Manganese Gluconate, Alpha-Ketoglutaricum Acidum, Baryta Carbonica, Fumaricum Acidum, Phosphoricum Acidum, Phosphorus, Sodium Oxalate	LIQUID	ORAL	20170209		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BARIUM CARBONATE; COBALT; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; MANGANESE GLUCONATE; NICKEL; OXOGLURIC ACID; PHOSPHORIC ACID; PHOSPHORUS; SODIUM OXALATE; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA STOMACH; ZINC	12; 9; 9; 12; 8; 6; 10; 9; 12; 12; 12; 12; 6; 6; 6; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0254_fb3f2ef5-8647-4b6c-83aa-146f94d1754a	43857-0254	HUMAN OTC DRUG	Senility HP		Anacardium Orientale, Belladonna, Hyoscyamus Niger, Veratrum Album, Baryta Carbonica, Lachesis Mutus, Phosphorus, Stramonium	LIQUID	ORAL	20140113		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; BARIUM CARBONATE; DATURA STRAMONIUM; HYOSCYAMUS NIGER; LACHESIS MUTA VENOM; PHOSPHORUS; SEMECARPUS ANACARDIUM JUICE; VERATRUM ALBUM ROOT	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0255_aa921ea5-1692-41f0-821b-8c0b7943a705	43857-0255	HUMAN OTC DRUG	Eczema	HP	Arsenicum Album, Calcarea Carbonica, Graphites, Mercurius Solubilis, Mezereum, Rhus Tox, Sepia, Sulphur	LIQUID	ORAL	20140804	20250608	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; DAPHNE MEZEREUM BARK; GRAPHITE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SULFUR; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0258_aafb17d3-7e22-4f6b-a349-23d8f7bfe9d0	43857-0258	HUMAN OTC DRUG	Cardioforce	I	Arnica Montana, Cactus Grandiflorus, Capsicum Annuum, Spigelia Anthelmia, Digitalis Purpurea, Kali Phosphoricum, Laurocerasus, Tabacum, Aconitum napellus, Agaricus muscarius, Aurum muriaticum, Glonoinum, Ignatia amara, Kalmia latifolia, Latrodectus Mactans, Valeriana officinalis	LIQUID	ORAL	20140611		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS; AMANITA MUSCARIA FRUITING BODY; ARNICA MONTANA; CAPSICUM; DIGITALIS; GOLD TRICHLORIDE; KALMIA LATIFOLIA LEAF; LATRODECTUS MACTANS; NITROGLYCERIN; POTASSIUM PHOSPHATE, DIBASIC; PRUNUS LAUROCERASUS LEAF; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA; STRYCHNOS IGNATII SEED; TOBACCO LEAF; VALERIAN	12; 12; 3; 3; 6; 12; 12; 12; 12; 6; 6; 3; 3; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
43857-0260_bb5375e4-8c27-4594-b1f1-6e6fc93413da	43857-0260	HUMAN OTC DRUG	Norepinephrine		Norepinephrine	LIQUID	ORAL	20150327		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	NOREPINEPHRINE	6	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
43857-0262_77373d4f-a057-4c63-af16-25e9a7f8dd79	43857-0262	HUMAN OTC DRUG	Psorinum Complex		Phosphorus, Silicea, Sulphur, Aloe	LIQUID	ORAL	20140822		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALOE; PHOSPHORUS; SILICON DIOXIDE; SULFUR	30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
43857-0263_637b1682-6eb6-4a77-9c8c-4955a7fae96d	43857-0263	HUMAN OTC DRUG	Biting Insect Antigens		Apis Mellifica, Hypericum Perforatum, Ledum Palustre, Cimex Lectularius (Bed Bug), Formica Rufa (Red Wood Ants), Pulex Irritans (Human Flea), Vespa Crabro (Hornet, Wasp)	LIQUID	ORAL	20140616		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; CIMEX LECTULARIUS; FORMICA RUFA; HYPERICUM PERFORATUM WHOLE; PULEX IRRITANS; RHODODENDRON TOMENTOSUM LEAFY TWIG; VESPA CRABRO	12; 15; 15; 12; 15; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0266_7728da6d-7023-46f6-b36f-982c6ebb4836	43857-0266	HUMAN OTC DRUG	Rheumatism	HP	Bryonia (Alba), Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Rhododendron Chrysanthum, Rhus Tox	LIQUID	ORAL	20140822	20250511	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0267_155a3af0-5884-448c-b5b3-642b7dc84ac9	43857-0267	HUMAN OTC DRUG	SCROPHULOUS	HP	Baryta Carbonica, Bromium, Calcarea Carbonica, Ferrum Iodatum, Mercurius Solubilis, Phytolacca Decandra, Rhus Tox, Silicea	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BARIUM CARBONATE; BROMINE; FERROUS IODIDE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0269_783730d4-aa9c-4e58-8109-a2b2d980b442	43857-0269	HUMAN OTC DRUG	Bio Star of Bethlehem		Ornithogallum Umbellatum, Flos	LIQUID	ORAL	20140702		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ORNITHOGALUM UMBELLATUM FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0270_43df6026-ff5d-4f83-ae90-b2d24b01d910	43857-0270	HUMAN OTC DRUG	Acetylcholine Chloride		Acetylcholine Chloride	LIQUID	ORAL	20140822		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACETYLCHOLINE CHLORIDE	6	[hp_X]/mL	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
43857-0275_b8fda148-adeb-4579-8e74-cde068479c3b	43857-0275	HUMAN OTC DRUG	Acne	HP	Carbo Animalis, Carbo Vegetabilis, Kali Bichromicum, Natrum Muriaticum, Pulsatilla (Vulgaris), Sepia, Silicea, Sulphur, Zincum Metallicum	LIQUID	ORAL	20140804		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACTIVATED CHARCOAL; CARBO ANIMALIS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR; ZINC	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0276_b673eca2-d926-41eb-826c-c88ee2d73154	43857-0276	HUMAN OTC DRUG	Bio Rock Rose		Helianthemum Nummularium, Flos	LIQUID	ORAL	20140805		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	HELIANTHEMUM NUMMULARIUM FLOWER	6	[hp_X]/mL			N	20241231
43857-0278_b762c0b1-76fc-443b-9961-152cb06eaf51	43857-0278	HUMAN OTC DRUG	PSORIASIS	HP	Arsenicum Album, Borax, Graphites, Natrum Muriaticum, Sepia, Sulphur	LIQUID	ORAL	20150130	20240416	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; GRAPHITE; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CHLORIDE; SULFUR	30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0279_a4a6b2ad-4b70-44e7-be0b-b20684aed52b	43857-0279	HUMAN OTC DRUG	Dopamine		Dopamine Hydrochloride	LIQUID	ORAL	20140612		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	DOPAMINE HYDROCHLORIDE	6	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
43857-0284_7d2d1ee4-5a71-4eb5-a989-9577cd116ce0	43857-0284	HUMAN OTC DRUG	Androbalance		DHEA (Dehydroepiandrosterone) Pregnenolone, Progesterone, Testosterone	SPRAY	ORAL	20140224		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	PRASTERONE; PREGNENOLONE; PROGESTERONE; TESTOSTERONE	6; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Progesterone [CS], Progesterone [EPC]	CIII	N	20241231
43857-0285_2a7cee16-82ee-436e-8fec-c22681b40d36	43857-0285	HUMAN OTC DRUG	HA HP		Belladonna, Bryonia (Alba), Gelsemium Sempervirens, Glonoinum, Melilotus Officinalis, Nux Vomica, Silicea, Spigelia Anthelmia	LIQUID	ORAL	20140822		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; MELILOTUS OFFICINALIS TOP; NITROGLYCERIN; SILICON DIOXIDE; SODIUM CHLORIDE; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
43857-0287_40fdc438-e248-42bf-a6e0-1c36f8dd6f45	43857-0287	HUMAN OTC DRUG	Res Balancer		Spleen (Bovine), Thymus (Bovine)	SPRAY	ORAL	20140818		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BOS TAURUS SPLEEN; BOS TAURUS THYMUS	8; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
43857-0294_a6a6df11-2370-470b-8475-78d0a0a85fb3	43857-0294	HUMAN OTC DRUG	Lymphoplex		Myrrha, Trigonella Foenum-Graecum, Pinus Sylvestris, Lymph (Suis), Spleen (Suis), Conium Maculatum, Echinacea (Angustifolia), Hepar Sulphuris Calcareum, Hydrangea Arborescens, Phytolacca Decandra, Silicea	LIQUID	ORAL	20140425		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CALCIUM SULFIDE; CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; FENUGREEK SEED; HYDRANGEA ARBORESCENS ROOT; MYRRH; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SILICON DIOXIDE; SUS SCROFA LYMPH; SUS SCROFA SPLEEN	12; 12; 12; 3; 12; 3; 12; 6; 12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0300_d534b472-9b59-4ab1-9a0c-d96cc35aceda	43857-0300	HUMAN OTC DRUG	Cardiotone		Adonis Vernalis, Adenosinum Triphosphoricum Dinatrum, Cactus Grandiflorus, Convallaria Majalis, Heart (Suis), Magnesium Gluconate, Potassium Gluconate, Thyroidinum (Suis), Ubidecarenonum, Germanium Sesquioxide, Strophanthus Hispidus, Digitalis Purpurea	LIQUID	ORAL	20140604	20240318	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ADENOSINE TRIPHOSPHATE; ADONIS VERNALIS; CONVALLARIA MAJALIS; DIGITALIS; GERMANIUM SESQUIOXIDE; MAGNESIUM GLUCONATE; PORK HEART; POTASSIUM GLUCONATE; SELENICEREUS GRANDIFLORUS STEM; STROPHANTHUS HISPIDUS SEED; SUS SCROFA THYROID; UBIDECARENONE	6; 3; 6; 12; 8; 6; 6; 6; 6; 10; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43857-0301_b970d215-aace-4bbd-9073-b11b64500d48	43857-0301	HUMAN OTC DRUG	V HP		Arsenicum Album, Belladonna, Echinacea (Angustifolia), Eupatorium Perfoliatum, Gelsemium Sempervirens, Lycopodium Clavatum, Phosphoricum Acidum, Phosphorus, Pyrogenium, Rhus Tox	LIQUID	ORAL	20140903	20250520	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC ACID; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0303_5cd2fd2a-5c70-421e-bba1-d2cfe180cbd9	43857-0303	HUMAN OTC DRUG	CANDIDA ALB		Candida Albicans	LIQUID	ORAL	20140702		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	60	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0305_586b5837-c2a2-4a87-b333-4c8c637a8bac	43857-0305	HUMAN OTC DRUG	Bio Gentian		Gentianella Amarella, Flos	LIQUID	ORAL	20140703		UNAPPROVED HOMEOPATHIC		BioActive Nutritional Inc .	GENTIANELLA AMARELLA FLOWER	6	[hp_X]/mL			N	20241231
43857-0306_ad1d83d2-ba5d-4161-ba38-625ba1dea12d	43857-0306	HUMAN OTC DRUG	Bio Hornbeam		Carpinus Betulus, Flos	LIQUID	ORAL	20140703		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CARPINUS BETULUS FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0307_2d8012be-f305-4e46-8e83-b4814d7f42f4	43857-0307	HUMAN OTC DRUG	Bio Scleranthus		Scleranthus Annuus, Flos	LIQUID	ORAL	20140703		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SCLERANTHUS ANNUUS FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0308_7068573f-2038-4d58-8243-f4b2d553a62a	43857-0308	HUMAN OTC DRUG	Bio Gorse		Ulex Europaeus, Flos	LIQUID	ORAL	20140703		UNAPPROVED HOMEOPATHIC		BioActive Nutritional Inc.	ULEX EUROPAEUS FLOWER	6	[hp_X]/mL			N	20241231
43857-0312_5f52b7e0-b9ee-4f2c-8b17-bbea9e72681f	43857-0312	HUMAN OTC DRUG	Toxodetox		Toxoplasma Gondii	LIQUID	ORAL	20140711		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	TOXOPLASMA GONDII	12	[hp_X]/mL			N	20241231
43857-0328_7e3e2ce2-4659-426c-8ac9-fc2fce550a6d	43857-0328	HUMAN OTC DRUG	Liver Tonic	II	Boldo, Carduus Marianus, Curcuma Longa, Echinacea (Angustifolia), Taraxacum Officinale Magnesia Phosphorica, Gallbladder (Bovine), Hepar Bovine, Ammi Visnaga, Atropinum Sulphuricum, Chelidonium Majus, Leptandra Virginica, Podophyllinum	LIQUID	ORAL	20140825		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMMI VISNAGA FRUIT; ATROPINE SULFATE; BEEF LIVER; BOS TAURUS GALLBLADDER; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MILK THISTLE; PEUMUS BOLDUS LEAF; PODOPHYLLUM RESIN; TARAXACUM OFFICINALE; TURMERIC; VERONICASTRUM VIRGINICUM ROOT	12; 12; 8; 8; 12; 1; 8; 1; 1; 12; 1; 1; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0331_16c1f72a-893f-4d9b-b219-e32bf1cee81e	43857-0331	HUMAN OTC DRUG	ADRENOPLEX		Chelidonium Majus, Echinacea (Angustifolia), Glandula Suprarenalis Bovine, Spleen (Suis), Carduus Marianus, Lycopodium Clavatum, Natrum Muriaticum, Phosphoricum Acidum	LIQUID	ORAL	20140902		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BOS TAURUS ADRENAL GLAND; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHOSPHORIC ACID; SODIUM CHLORIDE; SUS SCROFA SPLEEN	8; 3; 3; 12; 12; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0332_e6fde8d0-57b8-4638-85e3-39c2038c7277	43857-0332	HUMAN OTC DRUG	Albuminuriaforce		Equisetum Hyemale, Solidago Virgaurea, Apis Mellifica, Mercurius Corrosivus, Nux Moschata, Phosphorus, Terebinthina	LIQUID	ORAL	20140903	20240328	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; EQUISETUM HYEMALE; MERCURIC CHLORIDE; NUTMEG; PHOSPHORUS; SOLIDAGO VIRGAUREA FLOWERING TOP; TURPENTINE OIL	12; 3; 12; 12; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	
43857-0333_aeae3eec-af1f-4f14-a8d3-ec8ec881914a	43857-0333	HUMAN OTC DRUG	Female Tonic		Condurango, Humulus Lupulus, Agnus Castus, Caulophyllum Thalictroides, Iris Versicolor, Lilium Tigrinum, Asterias Rubens, Apis Mellifica, Calcarea Fluorica, Conium Maculatum, Ignatia Amara, Lac Caninum, Lachesis Mutus, Sepia Cyclamen Europaeum	LIQUID	ORAL	20140902		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; ASTERIAS RUBENS; CALCIUM FLUORIDE; CANIS LUPUS FAMILIARIS MILK; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE; CONIUM MACULATUM FLOWERING TOP; CYCLAMEN PURPURASCENS TUBER; HOPS; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; MARSDENIA CONDURANGO BARK; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED	12; 6; 12; 12; 3; 3; 12; 15; 1; 3; 12; 3; 1; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0335_5ca1ebc0-39d8-4789-b07f-9999e236f832	43857-0335	HUMAN OTC DRUG	Flu Tonic		Echinacea (Angustifolia), Uva-Ursi, Baptisia Tinctoria, Convallaria Majalis, Kali Muriaticum, Pinus Sylvestris, Thuja Occidentalis, Bryonia (Alba), Condurango, Crotalus Horridus, Ginkgo Biloba, Lachesis Mutus, Selenium Metallicum, Tabebuia Impetiginosa, Viscum Album	LIQUID	ORAL	20140911	20250610	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; GINKGO; LACHESIS MUTA VENOM; MARSDENIA CONDURANGO BARK; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM CHLORIDE; SELENIUM; TABEBUIA IMPETIGINOSA BARK; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP	1; 3; 12; 6; 12; 1; 12; 12; 12; 6; 6; 12; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
43857-0340_fe58d4a0-2153-429b-9e49-1c7354fec2c8	43857-0340	HUMAN OTC DRUG	RENAFORCE		Berberis Vulgaris, Echinacea (Angustifolia), Coccus Cacti, Kali Muriaticum, Lycopodium Clavatum, Nitricum Acidum	LIQUID	ORAL	20141015		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BERBERIS VULGARIS ROOT BARK; ECHINACEA ANGUSTIFOLIA; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; POTASSIUM CHLORIDE; PROTORTONIA CACTI	3; 3; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43857-0341_32809a68-f774-4bb3-bdc2-3d12345d18f2	43857-0341	HUMAN OTC DRUG	VARICO HP		Calcarea Fluorica, Carbo Vegetabilis, Hamamelis Virginiana, Lachesis Mutus, Lycopodium Clavatum, Pulsatilla (Vulgaris), Secale Cornutum, Staphysagria, Zincum Metallicum	LIQUID	ORAL	20141020		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACTIVATED CHARCOAL; ANEMONE PULSATILLA; CALCIUM FLUORIDE; CLAVICEPS PURPUREA SCLEROTIUM; DELPHINIUM STAPHISAGRIA SEED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; ZINC	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0343_f1f1a191-57a6-4f5c-9c85-fe8ea05a8eed	43857-0343	HUMAN OTC DRUG	DV HP		Not Applicable	LIQUID	ORAL	20141125	20260426	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; DYSPHANIA AMBROSIOIDES; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PULSATILLA VULGARIS; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0345_e035bf23-b17e-47c8-a17d-6e10c071bf02	43857-0345	HUMAN OTC DRUG	LIVER TONIC	I	Carduus Marianus, Chelidonium Majus, Taraxacum Officinale, Chionanthus Virginica, Quassia (Amara), Hepar Bovine, Ceanothus Americanus Colocynthis, Leptandra Virginica, Natrum Sulphuricum, Nux Vomica, Phosphorus, Teucrium Marum	LIQUID	ORAL	20141125		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BEEF LIVER; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; MILK THISTLE; PHOSPHORUS; QUASSIA AMARA WOOD; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TEUCRIUM MARUM; VERONICASTRUM VIRGINICUM ROOT	8; 12; 1; 3; 12; 1; 12; 3; 12; 12; 1; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0351_75d71207-90ce-4a73-961d-5bfe34e20daf	43857-0351	HUMAN OTC DRUG	Osteoforce		Medulla Ossis Suis, Calcarea Carbonica, Calcarea Fluorica, Causticum, Cocculus Indicus, Ledum Palustre, Phosphoricum Acidum, Rhus Tox	LIQUID	ORAL	20141204		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANAMIRTA COCCULUS SEED; CALCIUM FLUORIDE; CAUSTICUM; LEDUM PALUSTRE TWIG; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; SUS SCROFA BONE MARROW; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0354_ee82b2b0-cee4-4023-906d-5f925c2a4442	43857-0354	HUMAN OTC DRUG	THYRO TONIC		Chelidonium Majus, Spongia Tosta, Lac Defloratum, Fucus Vesiculosus, Hepar Suis, Hypophysis Suis, Thyroidinum (Suis), Calcarea Carbonica, Ferrum Iodatum, Iodium, Kali Iodatum, Molybdenum, Pulsatilla (Vulgaris)	LIQUID	ORAL	20150116	20240130	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CHELIDONIUM MAJUS; FERROUS IODIDE; FUCUS VESICULOSUS; IODINE; MOLYBDENUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK LIVER; POTASSIUM IODIDE; PULSATILLA VULGARIS; SKIM MILK; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID	3; 12; 6; 12; 12; 12; 8; 12; 12; 4; 3; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0358_65397d05-f66e-4d96-b783-4a8b9ad1046c	43857-0358	HUMAN OTC DRUG	ACETALDEHYDE		Acetaldehyde	LIQUID	ORAL	20150202		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACETALDEHYDE	6	[hp_X]/mL			N	20241231
43857-0364_7330a031-5ae1-4a3a-8b18-af1fc035af0d	43857-0364	HUMAN OTC DRUG	Bio Holly		Ilex Aquifolium (Holly), Flos	LIQUID	ORAL	20150401	20251103	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ILEX AQUIFOLIUM FRUITING TOP	6	[hp_X]/mL			N	
43857-0366_5f43b3f3-7e32-41b1-9597-805945fdf04c	43857-0366	HUMAN OTC DRUG	Bio Sweet Chestnut		Castanea Sativa (Sweet Chestnut), Flos	LIQUID	ORAL	20150428	20240520	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CASTANEA SATIVA FLOWER	6	[hp_X]/mL			N	
43857-0372_e9e9be76-4b66-42b5-80de-bea58b041b1b	43857-0372	HUMAN OTC DRUG	Diathesis	II	Germanium Sesquioxide, Cuprum Metallicum, Manganum Metallicum, Intestine (Suis), Lung (Suis), Cysteinum, Manganese Gluconate, alpha-Ketoglutaricum Acidum, Arsenicum Album, Calcarea Carbonica, Fumaricum Acidum, Natrum Oxalaceticum, Phosphorus	LIQUID	ORAL	20150709		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; COPPER; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; MANGANESE; MANGANESE GLUCONATE; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PORK INTESTINE; SODIUM DIETHYL OXALACETATE; SUS SCROFA LUNG	12; 8; 9; 12; 8; 8; 10; 12; 12; 12; 8; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
43857-0376_89180ded-82eb-4043-9155-c88c175dabd9	43857-0376	HUMAN OTC DRUG	Energy		Boldo, Chelidonium Majus, Ginkgo Biloba, Glycyrrhiza Glabra, Hydrocotyle Asiatica, Copper Gluconate, Germanium Sesquioxide	LIQUID	ORAL	20150812		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CENTELLA ASIATICA; CHELIDONIUM MAJUS; COPPER GLUCONATE; GERMANIUM SESQUIOXIDE; GINKGO; GLYCYRRHIZA GLABRA; PEUMUS BOLDUS LEAF	3; 3; 12; 12; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43857-0377_2e524de1-ddd0-449c-9cac-7c3a40fa96cb	43857-0377	HUMAN OTC DRUG	Lym D	HP	Arsenicum Album, Borrelia Burgdorferi Nosode, Chelidonium Majus, Coccus Cacti, Echinacea (Angustifolia), Hydrastis Canadensis, Lycopodium Clavatum, Nasturtium Aquaticum, Phosphorus, Rhus Tox, Taraxacum Officinale, Thymus (Suis), Thyroidinum (Suis), Trifolium Pratense, Urtica Dioica	LIQUID	ORAL	20151002	20240730	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; BORRELIA BURGDORFERI; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; NASTURTIUM OFFICINALE; PHOSPHORUS; PROTORTONIA CACTI; SUS SCROFA THYMUS; TARAXACUM OFFICINALE; THYROID, PORCINE; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; URTICA DIOICA	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
43857-0379_4ab87088-52c2-4ea7-af56-069ffd566cb1	43857-0379	HUMAN OTC DRUG	Somineze		Humulus Lupulus, Passiflora Incarnata, Valeriana Officinalis, Ambrosia Artemisiaefolia, Arsenicum Album, Coffea Tosta, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Silicea	LIQUID	ORAL	20151014		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMBROSIA ARTEMISIIFOLIA; ARSENIC TRIOXIDE; COFFEA ARABICA SEED, ROASTED; HOPS; LYCOPODIUM CLAVATUM SPORE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORIC ACID; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; VALERIAN	12; 12; 12; 3; 12; 3; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0381_074e4da3-ca01-42b0-88da-a2a0da804fd1	43857-0381	HUMAN OTC DRUG	Neuralgia	HP	Agaricus Muscarius, Allium Cepa, Arnica Montana, Hypericum Perforatum, Lycopodium Clavatum, Mercurius Solubilis, Phosphorus, Plumbum Metallicum	LIQUID	ORAL	20151020		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMANITA MUSCARIA FRUITING BODY; ARNICA MONTANA; HYPERICUM PERFORATUM; LEAD; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; ONION; PHOSPHORUS	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43857-0382_aad81b8a-24ca-4cb5-ae60-9de02b2caccd	43857-0382	HUMAN OTC DRUG	Rheumatic Tonic	I	Ginkgo Biloba, Dioscorea Villosa, Glycyrrhiza Glabra, Viscum Album, Pinus Sylvestris, Apis Mellifica, Dulcamara, Kalmia Latifolia, Lycopodium Clavatum, Sulphur	LIQUID	ORAL	20151111		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; DIOSCOREA VILLOSA TUBER; GINKGO; GLYCYRRHIZA GLABRA; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; PINUS SYLVESTRIS LEAFY TWIG; SOLANUM DULCAMARA TOP; SULFUR; VISCUM ALBUM FRUITING TOP	12; 1; 1; 3; 12; 12; 6; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0392_863a9d6e-f34f-4e12-8fcb-70c481b0f9f4	43857-0392	HUMAN OTC DRUG	Prostatone	HP	Clematis Erecta, Conium Maculatum, Lycopodium Clavatum, Mercurius Corrosivus, Pulsatilla (Vulgaris), Sabal Serrulata, Selenium Metallicum, Sepia, Staphysagria, Thuja Occidentalis	LIQUID	ORAL	20160426		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc	CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; PULSATILLA VULGARIS; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0393_f04ef438-e0ff-40bc-9cfe-dae2a42cc249	43857-0393	HUMAN OTC DRUG	EVTOX		Cochlearia Officinalis, Echinacea (Angustifolia), Hydrastis Canadensis, Lomatium Dissectum, Tabebuia Impetiginosa, Propolis, Glandula Suprarenalis Suis, Thymus (Suis), Aranea Diadema, Ipecacuanha, Lycopodium Clavatum, Muriaticum Acidum, Nitricum Acidum, Rhus Tox, Silicea, EBV Nosode,	LIQUID	ORAL	20160503	20240301	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARANEUS DIADEMATUS; COCHLEARIA OFFICINALIS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HUMAN HERPESVIRUS 4; HYDROCHLORIC ACID; IPECAC; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PROPOLIS WAX; SILICON DIOXIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK; TOXICODENDRON PUBESCENS LEAF	12; 3; 3; 5; 30; 12; 12; 3; 12; 12; 6; 12; 8; 8; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0395_dd5344c1-5a59-416a-bd14-936f7c1c73f4	43857-0395	HUMAN OTC DRUG	Edemaforce		Cactus Grandiflorus, Calendula Officinalis, Dulcamara, Leptandra Virginica, Solidago Virgaurea, Convallaria Majalis, Apis Mellifica, Arnica Montana, Berberis Vulgaris, Bryonia (Alba), Chelidonium Majus, Lycopodium Clavatum, Plumbum Metallicum, Sambucus Nigra	LIQUID	ORAL	20160531		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; ARNICA MONTANA; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; CONVALLARIA MAJALIS; LEAD; LYCOPODIUM CLAVATUM SPORE; SAMBUCUS NIGRA FLOWERING TOP; SELENICEREUS GRANDIFLORUS STEM; SOLANUM DULCAMARA TOP; SOLIDAGO VIRGAUREA FLOWERING TOP; VERONICASTRUM VIRGINICUM ROOT	12; 12; 12; 12; 3; 12; 4; 12; 12; 12; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0396_50615e36-20f1-442a-8fa7-6659839ce45c	43857-0396	HUMAN OTC DRUG	Arterioforce	II	Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Myrrha, Nasturtium Aquaticum, Trigonella Foenum-Graecum, Hydrastis Canadensis, Kali Iodatum, Arnica Montana, Cactus Grandiflorus, Propolis, Baryta Carbonica, Conium Maculatum, Secale Cornutum	LIQUID	ORAL	20160531		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; FENUGREEK SEED; GOLDENSEAL; MYRRH; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; POTASSIUM IODIDE; PROPOLIS WAX; SELENICEREUS GRANDIFLORUS STEM	6; 3; 12; 12; 12; 3; 4; 5; 4; 4; 3; 5; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0397_91df2fc9-0a35-4cbd-bb1f-d2c4588d01a8	43857-0397	HUMAN OTC DRUG	FNG	I	Echinacea (Angustifolia), Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Condurango, Ginkgo Biloba, Ligusticum Porteri, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Bovine, Thymus (Bovine), Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phytolacca Decandra, Sepia, Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Pullularia Pullulans, Rhizopus Nigricans, Torula Cerevisiae	LIQUID	ORAL	20160614	20240911	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; ASTRAGALUS PROPINQUUS ROOT; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOS TAURUS ADRENAL GLAND; BOS TAURUS THYMUS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ECHINACEA ANGUSTIFOLIA; GINKGO; GOLDENSEAL; LIGUSTICUM PORTERI ROOT; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; MUCOR RACEMOSUS; NASTURTIUM OFFICINALE; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PROPOLIS WAX; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; TABEBUIA IMPETIGINOSA BARK	12; 12; 6; 12; 8; 8; 12; 12; 3; 4; 5; 4; 3; 12; 4; 12; 3; 12; 12; 6; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0398_0b6d08ad-8853-4053-8171-319d0dace9bc	43857-0398	HUMAN OTC DRUG	Cerebraplex		Avena Sativa, Capsicum Annuum, Ginkgo Biloba, Hydrocotyle Asiatica, Polygonum Multiflorum, Rosmarinus Officinalis, Vinca Minor, Cerebrum Suis, Baryta Carbonica, Belladonna, Germanium Sesquioxide, Kali Phosphoricum, Stramonium	LIQUID	ORAL	20160606		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; CAPSICUM; CENTELLA ASIATICA; DATURA STRAMONIUM; FALLOPIA MULTIFLORA ROOT; GERMANIUM SESQUIOXIDE; GINKGO; POTASSIUM PHOSPHATE, DIBASIC; ROSMARINUS OFFICINALIS FLOWERING TOP; SUS SCROFA CEREBRUM; VINCA MINOR	12; 3; 12; 3; 3; 12; 3; 12; 3; 12; 3; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
43857-0400_b8928bcd-3b83-4712-b810-ee61389f8d11	43857-0400	HUMAN OTC DRUG	Injury Topical		Calendula Officinalis, Arnica Montana, Hypericum Perforatum, Symphytum Officinale, Bellis Perennis, Carbo Vegetabilis, Hamamelis Virginiana, Millefolium, Rhus Tox, Ruta Graveolens, Veratrum Album	GEL	TOPICAL	20160901	20240708	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARNICA MONTANA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	12; 12; 1; 12; 1; 6; 12; 3; 12; 12; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	
43857-0401_cb074d46-85dd-411a-bea6-fa62a21045ff	43857-0401	HUMAN OTC DRUG	LYM D		Chelidonium Majus, Echinacea (Angustifolia), Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Urtica Dioica, Hydrastis Canadensis, Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Coccus Cacti, Lycopodium Clavatum, Phosphorus, Rhus Tox, Borrelia Burgdorferi Nosode, Ledum Palustre	LIQUID	ORAL	20160627	20250224	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; BORRELIA BURGDORFERI; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; NASTURTIUM OFFICINALE; PHOSPHORUS; PROTORTONIA CACTI; SUS SCROFA THYMUS; SUS SCROFA THYROID; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; URTICA DIOICA	12; 12; 3; 3; 5; 200; 12; 3; 12; 12; 8; 8; 3; 12; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0404_71fc8181-3b75-4c30-be38-a690d1960413	43857-0404	HUMAN OTC DRUG	Injury		Arnica Montana, Calendula Officinalis, Hypericum Perforatum, Symphytum Officinale, Belladonna, Bellis Perennis, Carbo Vegetabilis, Hamamelis Virginiana, Millefolium, Rhus Tox, Ruta Graveolens, Veratrum Album	LIQUID	ORAL	20160708		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARNICA MONTANA; ATROPA BELLADONNA WHOLE; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	12; 12; 3; 12; 12; 3; 6; 12; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0406_f00e158b-3a49-4114-a9aa-738ce56d74ad	43857-0406	HUMAN OTC DRUG	Teething		Arnica Montana, Trifolium Pratense, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Chamomilla, Kreosotum, Silicea	LIQUID	ORAL	20160727		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; CALCIUM FLUORIDE; MATRICARIA RECUTITA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE; TRIFOLIUM PRATENSE FLOWER; WOOD CREOSOTE	3; 12; 12; 12; 12; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43857-0407_4d621a86-10a2-42c0-a778-49968f18d678	43857-0407	HUMAN OTC DRUG	Intestaforce		Althaea Officinalis, Capsicum Annuum, Foeniculum Vulgare, Symphytum Officinale, Argentum Nitricum, Ferrum Phosphoricum, Magnesia Phosphorica, Mercurius Solubilis	LIQUID	ORAL	20160811		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALTHAEA OFFICINALIS ROOT; CAPSICUM; COMFREY ROOT; FENNEL SEED; FERRUM PHOSPHORICUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; SILVER NITRATE	3; 3; 6; 3; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
43857-0408_4c5db5f2-f9f0-4d47-b5d8-136cc06a1d3b	43857-0408	HUMAN OTC DRUG	Apizelen		Alfalfa, Avena Sativa, Chelidonium Majus, Aralia Quinquefolia, Beta Vulgaris, Calendula Officinalis, Echinacea (Angustifolia), Natrum Muriaticum, Oxalis Acetosella, Paloondo, Phytolacca Decandra, Trifolium Pratense, Urtica Dioica, Viscum Album, Cobalt Acetate, Cobalt Gluconate, Copper Gluconate, Cuprum Aceticum, Glutathione, Magnesium Gluconicum Dihydricum, Ganoderma Lucidum, Ubidecarenonum, Argentum Metallicum, Germanium Metallicum	LIQUID	ORAL	20160727		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALFALFA; AMERICAN GINSENG; AVENA SATIVA FLOWERING TOP; BETA VULGARIS; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; COBALTOUS ACETATE; COBALTOUS GLUCONATE; COPPER GLUCONATE; CUPRIC ACETATE; ECHINACEA ANGUSTIFOLIA; GERMANIUM; GLUTATHIONE; LARREA TRIDENTATA LEAF; MAGNESIUM GLUCONATE; OXALIS ACETOSELLA LEAF; PHYTOLACCA AMERICANA ROOT; REISHI; SILVER; SODIUM CHLORIDE; TRIFOLIUM PRATENSE FLOWER; UBIDECARENONE; URTICA DIOICA; VISCUM ALBUM FRUITING TOP	1; 2; 1; 2; 2; 1; 3; 3; 3; 3; 2; 8; 3; 2; 3; 2; 2; 5; 8; 2; 2; 5; 2; 2	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0409_469a6bad-6ff6-4368-bd0b-9fd55a5ec379	43857-0409	HUMAN OTC DRUG	Amoebatox		Triticum Aestivum, Baptisia Tinctoria, Capsicum Annuum, Frasera Caroliniensis, Hamamelis Virginiana, Hydrastis Canadensis, Quassia Amara, Senna, Hydrastis Canadensis, Hepar Bovine, Pancreas Suis, Spleen (Bovine), Belladonna, Cinchona Officinalis, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Entamoeba Histolytica, Giardia Lamblia30	LIQUID	ORAL	20160818	20240218	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALPINE STRAWBERRY; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BEEF LIVER; BOS TAURUS SPLEEN; CAPSICUM; CINCHONA OFFICINALIS BARK; ENTAMOEBA HISTOLYTICA; FRASERA CAROLINIENSIS ROOT; GIARDIA LAMBLIA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; QUASSIA AMARA WOOD; SENNA LEAF; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; TRITICUM AESTIVUM WHOLE	3; 12; 3; 8; 8; 3; 12; 15; 3; 15; 5; 3; 12; 12; 3; 3; 12; 8; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43857-0410_8b5b7b18-6359-45d6-9a8f-49574d936835	43857-0410	HUMAN OTC DRUG	Bio Walnut		Juglans Regia, Flos	LIQUID	ORAL	20160811		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	JUGLANS REGIA FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0411_85f721d6-aee5-47e1-8232-1da1e15bca7e	43857-0411	HUMAN OTC DRUG	Virotox		Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Glandula Suprarenalis Bovine, Thymus (Bovine), Belladonna, Gelsemium Sempervirens, Lycopodium Clavatum, Nux Vomica, Pyrogenium	LIQUID	ORAL	20160818	20250518	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; BOS TAURUS ADRENAL GLAND; BOS TAURUS THYMUS; ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; MYRRH; NASTURTIUM OFFICINALE; RANCID BEEF; STRYCHNOS NUX-VOMICA SEED; TABEBUIA IMPETIGINOSA BARK	12; 8; 8; 3; 12; 5; 3; 12; 3; 3; 30; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0412_727ccac0-3f68-41f5-be37-26c5b55fd848	43857-0412	HUMAN OTC DRUG	Dopamine		Dopamine Hydrochloride	LIQUID	ORAL	20160816		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	DOPAMINE HYDROCHLORIDE	6	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
43857-0413_7c629ce8-9dcb-4750-b23d-d40c12f62954	43857-0413	HUMAN OTC DRUG	Enuresis	HP	Argentum Nitricum, Belladonna, Causticum, Equisetum Hyemale, Kreosotum, Nitricum Acidum, Pulsatilla (Vulgaris), Thuja Occidentalis	LIQUID	ORAL	20160907		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; CAUSTICUM; EQUISETUM HYEMALE; NITRIC ACID; PULSATILLA VULGARIS; SILVER NITRATE; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0415_ad50fc9b-277f-4386-a7f0-b045bb43ea1a	43857-0415	HUMAN OTC DRUG	Candida Alb		Candida Albicans	LIQUID	ORAL	20160908		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	100	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0416_5fcfeed5-7357-461f-96e0-c8066e1541d9	43857-0416	HUMAN OTC DRUG	Tryptophan		L-Tryptophan	LIQUID	ORAL	20160929		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	TRYPTOPHAN	6	[hp_X]/mL			N	20241231
43857-0417_6b54713f-6236-46e6-9652-aaffb2715397	43857-0417	HUMAN OTC DRUG	Endoplex F		Cimicifuga Racemosa, Fucus Vesiculosus, Glycyrrhiza Glabra, Xanthoxylum Fraxineum, Adrenalinum, Cerebrum Suis, Hypophysis Suis, Hypothalamus (Suis), Oophorinum (Suis), Pineal (Suis), Thyroidinum (Suis), Pulsatilla (Vulgaris), Sepia	LIQUID	ORAL	20160929		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BLACK COHOSH; EPINEPHRINE; FUCUS VESICULOSUS; GLYCYRRHIZA GLABRA; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; ZANTHOXYLUM AMERICANUM BARK	3; 8; 3; 3; 12; 12; 8; 8; 8; 8; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43857-0418_00a77fb6-d971-4b37-8d0b-eb11407d7a79	43857-0418	HUMAN OTC DRUG	Inflammation II		Astragalus Membranaceus, Echinacea (Angustifolia), Sarsaparilla (Smilax Regelii), Tabebuia Impetiginosa, Hydrastis Canadensis, Thyroidinum (Suis), Aurum Metallicum, Carbo Animalis, Causticum, Gelsemium Sempervirens, Natrum Sulphuricum, Phosphorus, Sulphur, Thuja Occidentalis	LIQUID	ORAL	20161004		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACTIVATED CHARCOAL; ASTRAGALUS PROPINQUUS ROOT; CAUSTICUM; ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; GOLD; GOLDENSEAL; PHOSPHORUS; SARSAPARILLA; SODIUM SULFATE; SULFUR; SUS SCROFA THYROID; TABEBUIA IMPETIGINOSA BARK; THUJA OCCIDENTALIS LEAFY TWIG	12; 3; 12; 3; 30; 12; 6; 30; 3; 30; 30; 8; 3; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43857-0419_564e2c7e-8ce5-4abd-8bec-684a36751643	43857-0419	HUMAN OTC DRUG	Sinus Tonic		Echinacea (Angustifolia), Baptisia Tinctoria, Thiaminum Hydrochloricum, Hydrastis Canadensis, Pyridoxinum Hydrochloricum, Spongia Tosta, Apis Mellifica, Ascorbic Acid, Hepar Sulphuris Calcareum, Kali Bichromicum, Lachesis Mutus, Mercurius Iodatus Ruber, Mercurius Sulphuratus Ruber, Pulsatilla (Vulgaris), Silicea, Sinusitisinum, Pantothenic Acid	LIQUID	ORAL	20161028	20240311	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ASCORBIC ACID; BAPTISIA TINCTORIA ROOT; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; LACHESIS MUTA VENOM; MERCURIC IODIDE; MERCURIC SULFIDE; PANTOTHENIC ACID; POTASSIUM DICHROMATE; PYRIDOXINE HYDROCHLORIDE; SILICON DIOXIDE; SINUSITISINUM; SPONGIA OFFICINALIS SKELETON, ROASTED; THIAMINE HYDROCHLORIDE	12; 12; 12; 3; 12; 1; 5; 12; 12; 12; 28; 12; 6; 12; 30; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	
43857-0420_bc11d133-fc34-48a0-8dc7-1f5144decc65	43857-0420	HUMAN OTC DRUG	BAC		Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Suis, Lymph Node (Suis), Spleen (Suis), Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Belladonna, Hypericum Perforatum, Phosphorus, Botulinum, Escherichia Coli, Proteus (Vulgaris), Pseudomonas Aeruginosa, Yersinia Enterocolitica, Salmonella Typhi Nosode, Clostridium Perfringens	LIQUID	ORAL	20161116	20240417	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; BOTULINUM TOXIN TYPE A; CLOSTRIDIUM PERFRINGENS; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; GOLDENSEAL; HYPERICUM PERFORATUM; LOMATIUM DISSECTUM ROOT; MYRRH; NASTURTIUM OFFICINALE; PHOSPHORUS; PROPOLIS WAX; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; SUS SCROFA THYROID; TABEBUIA IMPETIGINOSA BARK; YERSINIA ENTEROCOLITICA	12; 12; 30; 15; 3; 30; 5; 12; 3; 3; 3; 12; 6; 30; 30; 33; 8; 8; 8; 8; 8; 3; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	
43857-0423_61f8cec9-1e33-4eff-aa16-af2d3ca36644	43857-0423	HUMAN OTC DRUG	Sinuforce		Echinacea (Angustifolia), Nux Moschata, Trigonella Foenum Graecum, Hydrastis Canadensis, Arsenicum Album, Kali Bichromicum, Mercurius Sulphuratus Ruber, Pulsatilla (Vulgaris), Sepia, Mercurius Solubilis	LIQUID	ORAL	20170104	20250428	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; ECHINACEA ANGUSTIFOLIA; FENUGREEK SEED; GOLDENSEAL; MERCURIC SULFIDE; MERCURIUS SOLUBILIS; NUTMEG; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE	12; 3; 3; 5; 12; 30; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0424_4e8887a0-b21d-4480-9c5f-ee239a75f7fd	43857-0424	HUMAN OTC DRUG	FNG	II	Echinacea (Angustifolia), Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Iodium, Adrenalinum, Argentum Metallicum, Thymus (Suis), Thyroidinum (Suis), Phosphoricum Acidum, Candida Albicans, Lycopodium Clavatum, Pulsatilla (Vulgaris), Sepia	LIQUID	ORAL	20161220		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS; ECHINACEA ANGUSTIFOLIA; EPINEPHRINE; GOLDENSEAL; IODINE; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; NASTURTIUM OFFICINALE; PHOSPHORIC ACID; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SILVER; SUS SCROFA THYMUS; SUS SCROFA THYROID; TABEBUIA IMPETIGINOSA BARK	12; 3; 8; 5; 6; 3; 30; 3; 12; 30; 30; 8; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43857-0425_96cfead1-a1ea-4953-aea8-fd9ca2ff0435	43857-0425	HUMAN OTC DRUG	Cesium Chloride		Cesium Chloride	LIQUID	ORAL	20170119		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CESIUM CHLORIDE	6	[hp_X]/mL			N	20241231
43857-0426_b771f9ee-6d61-40ae-a224-4a5b47bfd668	43857-0426	HUMAN OTC DRUG	ASP		Echinacea (Angustifolia), Tabebuia Impetiginosa, Hydrastis Canadensis, Glandula Suprarenalis Suis, Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Bryonia (Alba), Cocculus Indicus, Colchicum Autumnale, Ledum Palustre, Mercurius Cyanatus, Natrum Sulphuricum, Pulsatilla (Vulgaris) Sepia, Silicea, Aspergillus Flavus	LIQUID	ORAL	20170124	20240218	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANAMIRTA COCCULUS SEED; ARSENIC TRIOXIDE; ASPERGILLUS FLAVUS; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HANDROANTHUS IMPETIGINOSUS BARK; LEDUM PALUSTRE TWIG; MERCURIC CYANIDE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM SULFATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYMUS; SUS SCROFA THYROID	12; 12; 30; 12; 12; 3; 5; 3; 12; 12; 12; 12; 12; 12; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
43857-0427_03cdcde5-8ea0-4deb-ad34-8d0c39403216	43857-0427	HUMAN OTC DRUG	Pacreaplex		Chelidonium Majus, Glycyrrhiza Glabra, Nux Moschata, Rheum (Officinale), Syzygium Jambolanum, Taraxacum Officinale, Zingiber Officinale, Hydrastis Canadensis, Glandula Suprarenalis Suis, Hepar Suis, Hypophysis Suis, Pancreas Suis, Thyroidinum (Suis), Phaseolus, Phosphoricum Acidum, Phosphorus	LIQUID	ORAL	20170124	20240827	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CHELIDONIUM MAJUS; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; KIDNEY BEAN; NUTMEG; PHOSPHORIC ACID; PHOSPHORUS; PORK LIVER; RHEUM OFFICINALE ROOT; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; SYZYGIUM CUMINI SEED; TARAXACUM OFFICINALE	3; 3; 3; 5; 12; 3; 12; 12; 6; 3; 6; 6; 6; 8; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43857-0433_c1d4830d-3b43-43d8-af89-a5a6f3dcc0f3	43857-0433	HUMAN OTC DRUG	Arrhythmiaforce		Juglans Nigra, Leonurus Cardiaca, Adonis Vernalis, Convallaria Majalis, Magnesia Sulphurica, Kali Chloricum, Digitalis Purpurea, Lycopus Virginicus, Phosphorus	LIQUID	ORAL	20170228	20240315	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ADONIS VERNALIS; BLACK WALNUT; CONVALLARIA MAJALIS; DIGITALIS; IBERIS AMARA SEED; LEONURUS CARDIACA; LYCOPUS VIRGINICUS; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; POTASSIUM CHLORATE	4; 3; 4; 12; 6; 3; 12; 4; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43857-0434_fa1aa211-2180-4e63-a986-a3e4760685bc	43857-0434	HUMAN OTC DRUG	Lumbagoforce		Arnica Montana, Hypericum Perforatum, Gnaphalium Polycephalum, Symphytum Officinale, Colocynthis, Formica Rufa, Rhus Tox	LIQUID	ORAL	20170301		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA; CITRULLUS COLOCYNTHIS FRUIT PULP; COMFREY ROOT; FORMICA RUFA; HYPERICUM PERFORATUM; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF	3; 12; 6; 12; 3; 5; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0437_ed9a2948-e84d-4aae-ba4d-edaa28909969	43857-0437	HUMAN OTC DRUG	Cardioforce	II	Abrotanum, Boldo, Cimicifuga Racemosa, Kali Phosphoricum, Taraxacum Officinale, Convallaria Majalis, Magnesia Sulphurica, Oleander, Natrum Muriaticum, Bellis Perennis	LIQUID	ORAL	20170302		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP; BELLIS PERENNIS; BLACK COHOSH; CONVALLARIA MAJALIS; MAGNESIUM SULFATE HEPTAHYDRATE; NERIUM OLEANDER LEAF; PEUMUS BOLDUS LEAF; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; TARAXACUM OFFICINALE	3; 30; 3; 4; 5; 8; 3; 3; 12; 3	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0438_10fd5b19-9aa0-4bae-9d42-299b1cae89cf	43857-0438	HUMAN OTC DRUG	Bio Chestnut Bud		Aesculus Hippocastanum Flower, Aesculus Hippocastanum Leaf	LIQUID	ORAL	20170302		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc	AESCULUS HIPPOCASTANUM FLOWER; AESCULUS HIPPOCASTANUM LEAF	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
43857-0439_5e3a9bf0-5d17-46f8-a181-948c4f3f3113	43857-0439	HUMAN OTC DRUG	Phenylalanine		L-Phenylalanine	LIQUID	ORAL	20170309		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	PHENYLALANINE	6	[hp_X]/mL			N	20241231
43857-0442_c65f863e-ea55-471f-9079-58f05faf3d03	43857-0442	HUMAN OTC DRUG	Cardioforce	I	Arnica Montana, Cactus Grandiflorus, Capsicum Annuum, Digitalis Purpurea, Kali Phosphoricum, Laurocerasus, Spigelia Anthelmia, Tabacum, Aconitum Napellus, Agaricus Muscarius, Aurum Muriaticum, Glonoinum, Ignatia Amara, Kalmia Latifolia, Latrodectus Mactans, Valeriana Officinalis	LIQUID	ORAL	20170508		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS; AMANITA MUSCARIA FRUITING BODY; ARNICA MONTANA; CAPSICUM; DIGITALIS; GOLD TRICHLORIDE; KALMIA LATIFOLIA LEAF; LATRODECTUS MACTANS; NITROGLYCERIN; POTASSIUM PHOSPHATE, DIBASIC; PRUNUS LAUROCERASUS LEAF; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA; STRYCHNOS IGNATII SEED; TOBACCO LEAF; VALERIAN	12; 12; 3; 3; 6; 12; 12; 12; 12; 6; 6; 3; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
43857-0443_c1449004-ae9f-4417-b1bb-30c71fd53c17	43857-0443	HUMAN OTC DRUG	Bio Myelin Protein		Cerebrum Suis	SPRAY	ORAL	20170519		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SUS SCROFA CEREBRUM	6	[hp_X]/mL			N	20241231
43857-0446_551bbf17-56e6-4197-aa31-7539ea5f3b87	43857-0446	HUMAN OTC DRUG	Menopause		Angelica Archangelica, Aralia Quinquefolia, Cimicifuga Racemosa, Hydrastis Canadensis, Pulsatilla, Sabina, Sepia, Sulphuricum Acidum, Lachesis Mutus	LIQUID	ORAL	20170518		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMERICAN GINSENG; ANEMONE PULSATILLA; ANGELICA ARCHANGELICA ROOT; BLACK COHOSH; GOLDENSEAL; JUNIPERUS SABINA LEAFY TWIG; LACHESIS MUTA VENOM; SEPIA OFFICINALIS JUICE; SULFURIC ACID	3; 12; 3; 3; 5; 12; 15; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0447_562a6e71-7273-4b9f-a4da-d6998baff786	43857-0447	HUMAN OTC DRUG	Teething-HP		Borax, Calcarea Carbonica, Calcarea Phosphorica, Chamomilla, Passiflora Incarnata, Podophyllinum, Silicea	LIQUID	ORAL	20170616		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PODOPHYLLUM; SILICON DIOXIDE; SODIUM BORATE; TRIBASIC CALCIUM PHOSPHATE	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
43857-0450_1293d52a-ac96-4912-8874-161bac1461af	43857-0450	HUMAN OTC DRUG	Bio Red Chestnut		Aesculus Carnea, Flos	LIQUID	ORAL	20170615		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc	AESCULUS X CARNEA FLOWER	6	[hp_X]/mL			N	20241231
43857-0451_95551b61-d8b5-4487-ac58-b7f368f609a6	43857-0451	HUMAN OTC DRUG	Industrotox		Glycyrrhiza Glabra, Plantago Major, Stillingia Sylvatica, Trifolium Pratense, Arnica Montana, Asclepias Tuberosa, Berberis Vulgaris, Calendula Officinalis, Chamomilla, Chelidonium Majus, Echinacea (Angustifolia), Eucalyptus Globulus, Lappa Major, Nasturtium Aquaticum, Phytolacca Decandra, Rhamnus Frangula, Rhamnus Purshiana, Taraxacum Officinale, Trigonella Foenum-Graecum, Urtica Dioica, Xanthoxylum Fraxineum, Symphytum Officinale, Hepar Suis, Lung (Suis), Lymph Node (Suis)	LIQUID	ORAL	20170616		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTIUM LAPPA ROOT; ARNICA MONTANA; ASCLEPIAS TUBEROSA ROOT; ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; EUCALYPTUS GLOBULUS LEAF; FENUGREEK SEED; FRANGULA ALNUS BARK; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; NASTURTIUM OFFICINALE; NITRIC ACID; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR; PORK LIVER; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LUNG; SUS SCROFA LYMPH; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; URTICA DIOICA; ZANTHOXYLUM AMERICANUM BARK	4; 3; 4; 12; 4; 4; 4; 6; 4; 4; 4; 4; 4; 3; 12; 4; 4; 12; 12; 4; 3; 8; 3; 12; 8; 8; 4; 3; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0452_029304f4-c605-451c-84ec-d537fa1e016d	43857-0452	HUMAN OTC DRUG	Ricetsotox		Rickettsia Nosode	LIQUID	ORAL	20170619		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	RICKETTSIA PROWAZEKII	16	[hp_X]/mL			N	20241231
43857-0453_1322732d-5d86-4b79-bd55-91aebccb013d	43857-0453	HUMAN OTC DRUG	VAX		Baptisia Tinctoria, Echinacea (Angustifolia), Tabebuia Impetiginosa, Trifolium Pratense, Arnica Montana, Calendula Officinalis, Chelidonium Majus, Leptandra Virginica, Ligusticum Porteri, Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Taraxacum Officinale, Trigonella Foenum-Graecum, Urtica Dioica, Hydrastis Canadensis, Astragalus Membranaceus, Propolis, Glandula Suprarenalis Suis, Thymus (Suis), Arsenicum Album, Belladonna, Chamomilla, Lycopodium Clavatum, Rhus Tox, Silicea,	LIQUID	ORAL	20170720		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANTIMONY TRISULFIDE; ARNICA MONTANA; ARSENIC TRIOXIDE; ASTRAGALUS PROPINQUUS ROOT; ATROPA BELLADONNA; BAPTISIA TINCTORIA; BORDETELLA PERTUSSIS; CALENDULA OFFICINALIS FLOWERING TOP; CHAMOMILE; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; FENUGREEK SEED; GOLDENSEAL; LIGUSTICUM PORTERI ROOT; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; MYRRH; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; PROPOLIS WAX; SILICON DIOXIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK; TARAXACUM OFFICINALE; TETANUS TOXIN; THIMEROSAL; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; URTICA DIOICA; VERONICASTRUM VIRGINICUM ROOT	30; 4; 12; 6; 12; 3; 30; 4; 12; 4; 3; 4; 5; 4; 4; 12; 4; 4; 4; 6; 30; 8; 8; 3; 4; 30; 30; 30; 12; 3; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0454_bd68b3fa-7005-4741-9c99-6fb275318754	43857-0454	HUMAN OTC DRUG	Immuno Fortifier		Echinacea (Angustifolia), Hydrastis Canadensis, Ligusticum Porteri, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Trigonella Foenum-Graecum, Ascorbic Acid, Pinus Sylvestris, Lymph (Suis), Medulla Ossis Suis, Spleen (Suis), Thymus (Suis), Hepar Sulphuris Calcareum, Phosphoricum Acidum, Silicea	LIQUID	ORAL	20170721		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ASCORBIC ACID; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; FENUGREEK SEED; GOLDENSEAL; LIGUSTICUM PORTERI ROOT; MYRRH; NASTURTIUM OFFICINALE; PHOSPHORIC ACID; PINUS SYLVESTRIS LEAFY TWIG; SILICON DIOXIDE; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK	6; 12; 3; 3; 5; 3; 3; 3; 12; 6; 12; 8; 8; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Vitamin C [EPC]		N	20241231
43857-0455_0670c14d-98a7-4e04-a67c-d25e1bb17406	43857-0455	HUMAN OTC DRUG	Thyroplex		Fucus Vesiculosus, Spongia Tosta, Iodium, Pulsatilla (Vulgaris), Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Liothyronine Sodium, Calcarea Carbonica, Ferrum Iodatum, Kali Iodatum, Lycopus Virginicus, Phosphoricum Acidum	LIQUID	ORAL	20170803	20240904	UNAPPROVED HOMEOPATHIC		BioActive Nutritional	ANEMONE PULSATILLA; FERROUS IODIDE; FUCUS VESICULOSUS; IODINE; LIOTHYRONINE SODIUM; LYCOPUS VIRGINICUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; POTASSIUM IODIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; THYROID, PORCINE	6; 12; 3; 6; 10; 12; 12; 12; 12; 3; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	
43857-0457_c4c611f8-2d01-4a6f-8caa-a7e891f9e236	43857-0457	HUMAN OTC DRUG	Neuroforce		Echinacea (Angustifolia), Hypericum Perforatum, Arnica Montana, Symphytum Officinale, Agaricus Muscarius, Arsenicum Album, Gelsemium Sempervirens, Plumbum Metallicum, Rhus tox	LIQUID	ORAL	20170728		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMANITA MUSCARIA FRUITING BODY; ARNICA MONTANA; ARSENIC TRIOXIDE; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LEAD; TOXICODENDRON PUBESCENS LEAF	12; 3; 12; 6; 3; 12; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0458_a7ff4e0a-b652-4386-944d-558d47ab8641	43857-0458	HUMAN OTC DRUG	Gastrotone		Capsicum Annuum, Foeniculum Vulgare, Symphytum Officinale, Argentum Nitricum, Arsenicum Album, Magnesia Phosphorica, Pulsatilla (Vulgaris)	LIQUID	ORAL	20170905		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; CAPSICUM; COMFREY ROOT; FENNEL SEED; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS; SILVER NITRATE	12; 3; 6; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
43857-0460_baec17ce-577d-4693-ad1e-1bb2edec7a64	43857-0460	HUMAN OTC DRUG	OB Metab		Fucus Vesiculosus, Capsicum Annuum, Nicotinamidum, Spongia Tosta, Croton Tiglium, Hypophysis Suis, L-Arginine, L-Ornithine, L-Tyrosine, Thyroidinum (Suis), Calcarea Carbonica, Graphites, Kali Carbonicum	LIQUID	ORAL	20170908		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARGININE; CAPSICUM; CROTON TIGLIUM SEED; FUCUS VESICULOSUS; GRAPHITE; NIACINAMIDE; ORNITHINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; TYROSINE	6; 3; 6; 1; 12; 5; 6; 12; 12; 5; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
43857-0463_25558fd8-03f7-41b0-9314-12a13705461d	43857-0463	HUMAN OTC DRUG	Venoforce	I	Aesculus Hippocastanum, Collinsonia Canadensis, Echinacea (Angustifolia), Hamamelis Virginiana, Pulsatilla (Vulgaris), Arnica Montana, Carbo Vegetabilis, Graphites, Hydrofluoricum Acidum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Paeonia Officinalis, Sepia	LIQUID	ORAL	20170921		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACTIVATED CHARCOAL; ANEMONE PULSATILLA; ARNICA MONTANA; COLLINSONIA CANADENSIS ROOT; ECHINACEA ANGUSTIFOLIA; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; HYDROFLUORIC ACID; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PAEONIA OFFICINALIS ROOT; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED	12; 3; 12; 3; 3; 12; 3; 3; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0469_8477555b-7bdb-4f49-ba02-cab4b51c9750	43857-0469	HUMAN OTC DRUG	Psoriaforce		Baptisia Tinctoria, Berberis Vulgaris, Echinacea (Angustifolia), Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Rhamnus Purshiana, Trifolium Pratense, Xanthoxylum Fraxineum, Phytolacca Decandra, Hydrastis Canadensis, Arsenicum Iodatum, Calcarea Carbonica, Clematis Erecta, Graphites, Kali Muriaticum, Kali Sulphuricum, Mezereum, Petroleum, Sepia	LIQUID	ORAL	20180223		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTIUM LAPPA ROOT; ARSENIC TRIIODIDE; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CLEMATIS RECTA FLOWERING TOP; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA; FRANGULA ALNUS BARK; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA; GOLDENSEAL; GRAPHITE; KEROSENE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SEPIA OFFICINALIS JUICE; TRIFOLIUM PRATENSE FLOWER; ZANTHOXYLUM AMERICANUM BARK	3; 12; 3; 3; 12; 12; 3; 3; 3; 3; 5; 12; 12; 12; 4; 12; 12; 12; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
43857-0470_a693512f-9c03-4eeb-b74a-b83e31f9e55d	43857-0470	HUMAN OTC DRUG	Inflammation	I	Echinacea (Angustifolia), Nasturtium Aquaticum, Phytolacca Decandra, Hydrastis Canadensis, Apis Mellifica, Belladonna, Ferrum Phosphoricum, Nitricum Acidum, Oleander, Silicea	LIQUID	ORAL	20180306		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; NASTURTIUM OFFICINALE; NERIUM OLEANDER LEAF; NITRIC ACID; PHYTOLACCA AMERICANA ROOT; SILICON DIOXIDE	12; 12; 3; 12; 5; 3; 12; 12; 4; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0473_71e389fc-f380-4950-beac-aa236ec45b68	43857-0473	HUMAN OTC DRUG	Ear		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Hydrastis Canadensis, Capsicum Annuum, Chamomilla, Ferrum Phosphoricum, Kali Muriaticum, Plantago Major, Pulsatilla (Vulgaris)	LIQUID	ORAL	20180322	20240225	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BAPTISIA TINCTORIA ROOT; CAPSICUM; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; MATRICARIA RECUTITA; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR; POTASSIUM CHLORIDE; PULSATILLA VULGARIS	3; 12; 3; 12; 5; 12; 4; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS]		N	
43857-0474_c2658bac-ad37-46f7-8e93-d3f6c3846eb5	43857-0474	HUMAN OTC DRUG	Bio Wild Rose		Rosa Canina, Flos	LIQUID	ORAL	20180322		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ROSA CANINA FLOWER	6	[hp_X]/mL			N	20241231
43857-0477_ec615ed2-6e43-40ed-a4f8-9a823cbdc2f0	43857-0477	HUMAN OTC DRUG	Lymph	I	Echinacea (Angustifolia), Kali Iodatum, Phytolacca Decandra, Pinus Sylvestris, Hypophysis Suis, Apis Mellifica, Aranea Diadema, Belladonna, Calcarea Carbonica, Clematis Erecta, Conium Maculatum, Galium Aparine, Graphites, Lachesis Mutus, Mercurius Praecipitatus Ruber, Myristica Sebifera, Phosphorus, Rhus Tox, Scrophularia Nodosa, Sulphur, Thyroidinum (Suis), Vespa Crabro	LIQUID	ORAL	20180424		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; ARANEUS DIADEMATUS; ATROPA BELLADONNA; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; GRAPHITE; LACHESIS MUTA VENOM; MERCURIC OXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM IODIDE; SCROPHULARIA NODOSA; SULFUR; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; TOXICODENDRON PUBESCENS LEAF; VESPA CRABRO; VIROLA SEBIFERA RESIN	12; 12; 12; 12; 12; 1; 12; 12; 12; 12; 12; 12; 4; 6; 3; 12; 12; 8; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0481_48f12f83-62cf-4a78-a033-a5daacb443d8	43857-0481	HUMAN OTC DRUG	Free Radical		Triticum Aestivum, Alfalfa, Fucus Vesiculosus, Laminaria Digitata, Nasturtium Aquaticum, Oryza Sativa, Raphanus Sativus, Symphytum Officinale, Hordeum Vulgare, Asparagus Officinalis, Manganese Gluconate, Ferrum Phosphoricum, Arnica Montana, Cuprum Metallicum, Ubidecarenonum, Alpha-Ketoglutaricum Acidum, Glyoxal Trimer Dihydrate, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium	LIQUID	ORAL	20180522		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	.ALPHA.-KETOGLUTARIC ACID; ALFALFA; ALUMINUM; ANTIMONY TRISULFIDE; ARNICA MONTANA; ARSENIC TRIOXIDE; ASPARAGUS; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BORON; BROMINE; BROWN RICE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; COBALT; COMFREY ROOT; COPPER; DYSPROSIUM; ERBIUM; EUROPIUM; FERROSOFERRIC PHOSPHATE; FUCUS VESICULOSUS; GADOLINIUM; GERMANIUM SESQUIOXIDE; GLYOXAL TRIMER DIHYDRATE; GOLD; HOLMIUM; HORDEUM VULGARE TOP; INDIUM; IRON; LAMINARIA DIGITATA; LANTHANUM; LEAD; LITHIUM CARBONATE; MAGNESIUM; MANGANESE; MANGANESE GLUCONATE; MERCURIUS SOLUBILIS; MOLYBDENUM; NASTURTIUM OFFICINALE; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PLATINUM; PRASEODYMIUM; RADISH; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SILVER; STRONTIUM CARBONATE; TANTALUM; TERBIUM; THALLIUM; TIN; TRITICUM AESTIVUM WHOLE; UBIDECARENONE; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	30; 3; 12; 12; 12; 12; 6; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 6; 12; 12; 12; 12; 8; 3; 12; 12; 30; 12; 12; 3; 12; 12; 3; 14; 12; 12; 12; 12; 6; 12; 12; 3; 12; 12; 30; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 1; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Magnetic Resonance Contrast Activity [MoA], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
43857-0483_2a4d6ae0-78c7-4c8f-9daf-9b098147577f	43857-0483	HUMAN OTC DRUG	Vermex		Artemisia Vulgaris, Cina, Teucrium Marum, Filix Mas, Spigelia Anthelmia, Calcarea Carbonica, Graphites, Mercurius Corrosivus, Sabadilla, Silicea, Tanacetum Vulgare, Taenia Solium, Ascaris Lumbricoides	LIQUID	ORAL	20180611	20241209	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; ASCARIS LUMBRICOIDES; DRYOPTERIS FILIX-MAS ROOT; GRAPHITE; MERCURIC CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SPIGELIA ANTHELMIA; TAENIA SOLIUM; TANACETUM VULGARE TOP; TEUCRIUM MARUM	3; 3; 30; 4; 12; 12; 12; 12; 12; 6; 30; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0484_8698510f-0654-422d-b3f6-72ee17925b90	43857-0484	HUMAN OTC DRUG	Throat Formula		Baptisia Tinctoria, Phytolacca Decandra, Apis Mellifica, Belladonna, Lachesis Mutus, Mercurius Solubilis, Hepar Sulphuris Calcareum	SPRAY	ORAL	20180615		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; ATROPA BELLADONNA; BAPTISIA TINCTORIA; CALCIUM SULFIDE; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT	12; 12; 3; 15; 12; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0485_2670cc07-b0c1-4102-90e2-f146fb93014e	43857-0485	HUMAN OTC DRUG	Metalogin		Allium Sativum, Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Stillingia Sylvatica, Trifolium Pratense, Phytolacca Decandra, L-Methionine, Thyroidinum (Suis), Selenium Dioxide, Lycopodium Clavatum, Nux Vomica, Lanthanum Oxide, Niobium Metallicum, Tantalum Metallicum, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum	LIQUID	ORAL	20180629	20251014	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALUMINUM; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM; CHROMIUM; COBALT; COPPER; DYSPROSIUM; ERBIUM; EUROPIUM; FRANGULA ALNUS BARK; GADOLINIUM; GARLIC; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; GOLD; HOLMIUM; IRIDIUM; IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MERCURIUS SOLUBILIS; METHIONINE; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHYTOLACCA AMERICANA ROOT; PLATINUM; PRASEODYMIUM; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SELENIUM DIOXIDE; SILVER; STILLINGIA SYLVATICA ROOT; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA THYROID; TANTALUM; TERBIUM; THALLIUM; TIN; TRIFOLIUM PRATENSE FLOWER; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 3; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 12; 14; 12; 12; 12; 12; 12; 12; 6; 12; 12; 12; 30; 12; 12; 4; 12; 12; 12; 12; 12; 12; 8; 12; 3; 12; 12; 6; 30; 12; 12; 12; 3; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43857-0486_f5884a60-2a40-4568-968d-5a58e3eeb0bf	43857-0486	HUMAN OTC DRUG	Nut Antigens		Arsenicum Album, Lycopodium Clavatum, Pulsatilla (Pratensis), Sulphur, Almond (Nut), Cashew (Nut), Black Walnut (Nut), Pecan (Nut), Coconut, Oleum Olea Europaea, Chestnut (Nut), Water Chestnut (Nut), Pinenut (Nut), Macadamia (Nut), Pistachio (Nut), Peanut (Nut), English Walnut (Nut), Brazil Nut (Nut), Hazelnut (Nut), Carya Alba	LIQUID	ORAL	20180710		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALMOND; AMERICAN HAZELNUT; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; BLACK WALNUT; BRAZIL NUT; CASHEW; CHINESE CHESTNUT; COCONUT; ENGLISH WALNUT; LYCOPODIUM CLAVATUM SPORE; MACADAMIA NUT; MOCKERNUT; OLIVE OIL; PEANUT; PECAN; PINE NUT; PISTACHIO; SULFUR; TRAPA BICORNIS SEED	12; 15; 12; 12; 12; 15; 12; 12; 12; 15; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Lipid Emulsion [EPC], Lipids [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Plant Proteins [CS]		N	20241231
43857-0487_e095c202-fcfe-4cc8-8985-4e6c3a0f35b0	43857-0487	HUMAN OTC DRUG	Additox		Trifolium Pratense, Xanthoxylum Fraxineum, Phytolacca Decandra, Arsenicum Album, Belladonna, Chelidonium Majus, Lycopodium Clavatum, Phosphoricum Acidum, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum	LIQUID	ORAL	20180718		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; ASPARTAME; ATROPA BELLADONNA; BENZALKONIUM CHLORIDE; CHELIDONIUM MAJUS; FORMALDEHYDE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PROPYLPARABEN; SODIUM BENZOATE; SODIUM CITRATE; TITANIUM DIOXIDE; TRIFOLIUM PRATENSE FLOWER; ZANTHOXYLUM AMERICANUM BARK; ZINC OXIDE	12; 30; 12; 30; 12; 30; 12; 30; 30; 12; 4; 30; 30; 30; 30; 3; 3; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0489_169e62cc-2ea3-4607-9d0c-3d6371ffc235	43857-0489	HUMAN OTC DRUG	Drainage		Echinacea (Angustifolia), Trifolium Pratense, Phytolacca Decandra, Calcarea Iodata, Kali Muriaticum, Nitricum Acidum, Phosphoricum Acidum, Sulphur Iodatum	LIQUID	ORAL	20180802		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CALCIUM IODIDE; ECHINACEA ANGUSTIFOLIA; NITRIC ACID; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; SULFUR IODIDE; TRIFOLIUM PRATENSE FLOWER	12; 3; 12; 12; 4; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
43857-0490_abb9e2e2-ae38-48f8-8e97-3e9e23caabc4	43857-0490	HUMAN OTC DRUG	Apizelen		Alfalfa, Aralia Quinquefolia, Avena Sativa, Beta Vulgaris, Calendula Officinalis, Chelidonium Majus, Echinacea (Angustifolia), Natrum Muriaticum, Oxalis Acetosella, Paloondo, Phytolacca Decandra, Trifolium Pratense, Urtica Dioica, Viscum Album, Cobalt Acetate, Cobalt Gluconate, Copper Gluconate, Cuprum Aceticum, Glutathione, Magnesium Gluconicum Dihydricum, Ganoderma Lucidum, Ubidecarenonum, Argentum Metallicum, Germanium Metallicum	LIQUID	ORAL	20180910		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALFALFA; AMERICAN GINSENG; AVENA SATIVA FLOWERING TOP; BETA VULGARIS; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; COBALTOUS ACETATE; COBALTOUS GLUCONATE; COPPER GLUCONATE; CUPRIC ACETATE; ECHINACEA ANGUSTIFOLIA; GERMANIUM; GLUTATHIONE; LARREA TRIDENTATA LEAF; MAGNESIUM GLUCONATE; OXALIS ACETOSELLA LEAF; PHYTOLACCA AMERICANA ROOT; REISHI; SILVER; SODIUM CHLORIDE; TRIFOLIUM PRATENSE FLOWER; UBIDECARENONE; URTICA DIOICA; VISCUM ALBUM FRUITING TOP	2; 2; 2; 2; 2; 2; 3; 3; 3; 3; 2; 8; 3; 2; 3; 2; 2; 5; 8; 2; 2; 5; 2; 2	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0491_6b0d449c-6c34-4842-b4b1-997f7bf1e804	43857-0491	HUMAN OTC DRUG	Bio Heather		Calluna Vulgaris, Flos	LIQUID	ORAL	20180820		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CALLUNA VULGARIS FLOWERING TOP	6	[hp_X]/mL			N	20241231
43857-0492_5671bc49-3057-4144-a497-90d69eaad973	43857-0492	HUMAN OTC DRUG	Prostatone		Echinacea (Angustifolia), Sabal Serrulata, Sarsaparilla (Smilax Regelii), Solidago Virgaurea, Zincum Sulphuricum, Phytolacca Decandra, Hydrastis Canadensis, Orchitinum (Suis), Prostate (Suis), Clematis Erecta, Phosphoricum Acidum, Pulsatilla (Vulgaris)	LIQUID	ORAL	20180829		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CLEMATIS RECTA FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; SARSAPARILLA; SAW PALMETTO; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA PROSTATE; SUS SCROFA TESTICLE; ZINC SULFATE HEPTAHYDRATE	12; 3; 5; 12; 4; 12; 3; 3; 3; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
43857-0494_445393e9-40f5-4e5c-8286-76834cf63eaf	43857-0494	HUMAN OTC DRUG	Pancreaforce		Lappa Major, Rhamnus Purshiana, Syzygium Jambolanum, Chelidonium Majus, Juniperus Virginiana, Lycopodium Clavatum, Myrtus Communis, Natrum Sulphuricum, Phosphoricum Acidum, Phosphorus, Tarentula Cubensis	LIQUID	ORAL	20180831		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTIUM LAPPA ROOT; CHELIDONIUM MAJUS; CITHARACANTHUS SPINICRUS; FRANGULA PURSHIANA BARK; JUNIPERUS VIRGINIANA TWIG; LYCOPODIUM CLAVATUM SPORE; MYRTUS COMMUNIS TOP; PHOSPHORIC ACID; PHOSPHORUS; SODIUM SULFATE; SYZYGIUM CUMINI SEED	3; 12; 12; 3; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0495_8007e762-cd10-44cc-86ea-3da8a102a113	43857-0495	HUMAN OTC DRUG	Bio Chicory		Cichorium Intybus, Flos	LIQUID	ORAL	20180904		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CICHORIUM INTYBUS FLOWER	6	[hp_X]/mL			N	20241231
43857-0496_ccbf796b-3f47-4512-b0ad-8c67be8057b0	43857-0496	HUMAN OTC DRUG	Nightshade Antigen		Capsicum Annuum, Solanum Tuberosum, Tabacum, Lycopersicum Esculentum, Solanum Melongena, Aluminum Metallicum, Arsenicum Album, Nux Vomica, Phosphorus, Pulsatilla (Pratensis)	LIQUID	ORAL	20180925		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALUMINUM; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; CAPSICUM; EGGPLANT; PHOSPHORUS; POTATO; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOMATO	9; 12; 12; 9; 9; 12; 9; 12; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
43857-0497_17c54366-8d22-410e-b6c6-a6bfe2cbf9d0	43857-0497	HUMAN OTC DRUG	Eczemaforce		Lappa Major, Phytolacca Decandra, Trifolium Pratense, Hydrocotyle Asiatica, Arsenicum Album, Graphites, Mezereum	LIQUID	ORAL	20181002	20240814	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; CENTELLA ASIATICA; DAPHNE MEZEREUM BARK; GRAPHITE; PHYTOLACCA AMERICANA ROOT; TRIFOLIUM PRATENSE FLOWER	3; 12; 6; 12; 12; 4; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0498_62da68f1-9102-4c23-9460-2fb1edfe20df	43857-0498	HUMAN OTC DRUG	Mammaryplex		Echinacea (Angustifolia), Myrrha, Trigonella Foenum-Graecum, Phytolacca Decandra, Hydrastis Canadensis, Lymph (Suis), Spleen (Suis), Bryonia (Alba), Conium Maculatum, Lac Caninum, Lachesis Mutus, Silicea, Bufo Rana, Mammary Gland (Bovine)	LIQUID	ORAL	20181011		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BOS TAURUS MAMMARY GLAND; BRYONIA ALBA ROOT; BUFO BUFO CUTANEOUS GLAND; CANIS LUPUS FAMILIARIS MILK; CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; FENUGREEK SEED; GOLDENSEAL; LACHESIS MUTA VENOM; MYRRH; PHYTOLACCA AMERICANA ROOT; SILICON DIOXIDE; SUS SCROFA LYMPH; SUS SCROFA SPLEEN	36; 12; 14; 12; 12; 3; 3; 5; 12; 3; 4; 12; 8; 8	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0499_2d8bd20c-4033-47e4-a679-8b38ed3ff030	43857-0499	HUMAN OTC DRUG	Lymph	III	Echinacea (Angustifolia), Phytolacca Decandra, Boldo, Pinus Sylvestris, Thyroidinum (Suis), Germanium Sesquioxide, Arnica Montana, Calcarea Iodata, Hamamelis Virginiana, Hepar Sulphuris Calcareum, Adenosinum Triphosphoricum Dinatrum, Ubidecarenonum, Naja Tripudians, Calcarea Phosphorica, Influenzinum, Natrum Sulphuricum, Pyrogenium, Sulphur, Carcinosin	LIQUID	ORAL	20190423	20240501	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARNICA MONTANA; CALCIUM IODIDE; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; GERMANIUM SESQUIOXIDE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HUMAN BREAST TUMOR CELL; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); NAJA NAJA VENOM; PEUMUS BOLDUS LEAF; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; RANCID BEEF; SODIUM SULFATE; SULFUR; SUS SCROFA THYROID; TRIBASIC CALCIUM PHOSPHATE; UBIDECARENONE	12; 12; 12; 12; 1; 8; 12; 200; 30; 30; 30; 30; 15; 3; 4; 6; 30; 30; 30; 6; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE]		N	
43857-0500_f0ada671-af38-4824-a55e-6389ac8f9bf1	43857-0500	HUMAN OTC DRUG	Lymph	II	Echinacea (Angustifolia), Collinsonia Canadensis, Phytolacca Decandra, Kali Iodatum, Pinus Sylvestris, Pix Liquida, Ferrum Phosphoricum, Aesculus Hippocastanum, Baryta Carbonica, Berberis Vulgaris, Calcarea Carbonica, Calcarea Phosphorica, Causticum, Hepar Sulphuris Calcareum, Kreosotum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Nitricum Acidum, Phosphorus, Pulsatilla (Vulgaris), Silicea, Stellaria Media, Sulphur, Terebinthina, Thuja Occidentalis, Bufo Rana	LIQUID	ORAL	20190524	20240730	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANEMONE PULSATILLA; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BUFO BUFO CUTANEOUS GLAND; CALCIUM SULFIDE; CAUSTICUM; COLLINSONIA CANADENSIS ROOT; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; HORSE CHESTNUT; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PINE TAR; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM IODIDE; SILICON DIOXIDE; SODIUM CHLORIDE; STELLARIA MEDIA; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TRIBASIC CALCIUM PHOSPHATE; TURPENTINE OIL; WOOD CREOSOTE	12; 12; 12; 14; 12; 12; 3; 3; 8; 12; 12; 12; 12; 12; 12; 4; 6; 6; 6; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
43857-0501_642aeb8b-bbf2-4fed-9a4b-0fe9562961a9	43857-0501	HUMAN OTC DRUG	Salsolinol		Salsolinol (Hydrochloride)	LIQUID	ORAL	20181207		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SALSOLINOL HYDROCHLORIDE, (+/-)-	6	[hp_X]/mL			N	20241231
43857-0502_3ee5275c-0ad0-46c8-a0a6-698acb5e7698	43857-0502	HUMAN OTC DRUG	Renotox		Triticum Aestivum, Asparagus Officinalis, Berberis Vulgaris, Echinacea (Angustifolia), Kali Muriaticum, Petroselinum Sativum, Sabal Serrulata, Solidago Virgaurea, Taraxacum Officinale, Uva-Ursi, Barosma (Betulina), Eupatorium Purpureum, Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum,	LIQUID	ORAL	20190108	20240225	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AGATHOSMA BETULINA LEAF; ALUMINUM; ANTIMONY TRISULFIDE; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIOXIDE; ASPARAGUS; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BOTULINUM TOXIN TYPE A; BROMINE; BRYONIA ALBA ROOT; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CLOSTRIDIUM PERFRINGENS; COBALT; COPPER; DYSPROSIUM; ECHINACEA ANGUSTIFOLIA; ERBIUM; ESCHERICHIA COLI; EUROPIUM; EUTROCHIUM PURPUREUM ROOT; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PETROSELINUM CRISPUM; PLATINUM; POLIOVIRUS; PORK KIDNEY; POTASSIUM CHLORIDE; PRASEODYMIUM; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SAW PALMETTO; SELENIUM; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; TANTALUM; TARAXACUM OFFICINALE; TERBIUM; THALLIUM; TIN; TRITICUM AESTIVUM WHOLE; URANYL NITRATE HEXAHYDRATE; VANADIUM; YERSINIA ENTEROCOLITICA; YTTERBIUM OXIDE; ZINC	5; 12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 15; 12; 12; 12; 3; 12; 30; 12; 6; 12; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 12; 12; 3; 12; 30; 8; 3; 12; 30; 30; 12; 12; 33; 12; 3; 12; 12; 3; 12; 30; 3; 12; 12; 12; 1; 12; 12; 30; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Mood Stabilizer [EPC], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	
43857-0503_92b732e2-0397-4f11-9860-3c1206016bd0	43857-0503	HUMAN OTC DRUG	Octopamine		Octopamine Hydrochloride	LIQUID	ORAL	20190109	20240227	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	OCTOPAMINE HYDROCHLORIDE	6	[hp_X]/mL			N	
43857-0504_b80c1c0d-78ea-48ac-b8e9-bc4bc5b94919	43857-0504	HUMAN OTC DRUG	Mentox	HP	Baryta Carbonica, Calcarea Carbonica, Lachesis Mutus, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phosphorus	LIQUID	ORAL	20190118	20240311	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BARIUM CARBONATE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0505_0635b8a0-5f34-4558-aaa2-207af2923fa6	43857-0505	HUMAN OTC DRUG	Prostoforce		Aralia Quinquefolia, Damiana, Hydrocotyle Asiatica, Pareira Brava, Sabal Serrulata, Thuja Occidentalis, Clematis Erecta, Conium Maculatum, Juniperus Virginiana, Pulsatilla (Vulgaris)	LIQUID	ORAL	20190123	20240311	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMERICAN GINSENG; ANEMONE PULSATILLA; CENTELLA ASIATICA; CHONDRODENDRON TOMENTOSUM ROOT; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; JUNIPERUS VIRGINIANA TWIG; SAW PALMETTO; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG	3; 12; 3; 3; 12; 12; 12; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0514_f6584708-c855-4d93-99a7-d253f5dfc63d	43857-0514	HUMAN OTC DRUG	CVTOX		Cochlearia Armoracia, Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Bovine, Thymus (Suis), Aranea Diadema, Ipecacuanha, Lycopodium Clavatum, Muriaticum Acidum, Nitricum Acidum, Phosphoricum Acidum, Rhus Tox, Silicea, Epstein-Barr Virus Nosode, Herpes Zoster Nosode, Morbillinum, Poliomyelitis Nosode, Hepatitis B Nosode, Coxsackie B1 Nosode, Coxsackie B4 Nosode, Cytomegalovirus Nosode	LIQUID	ORAL	20190514	20240722	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARANEUS DIADEMATUS; BOS TAURUS ADRENAL GLAND; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HEPATITIS B VIRUS; HORSERADISH; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HYDROCHLORIC ACID; IPECAC; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; MEASLES VIRUS; NITRIC ACID; PHOSPHORIC ACID; POLIOVIRUS; PROPOLIS WAX; SILICON DIOXIDE; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK; TOXICODENDRON PUBESCENS LEAF	12; 8; 3; 5; 33; 3; 15; 15; 30; 30; 16; 12; 12; 3; 12; 30; 12; 12; 30; 6; 12; 8; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
43857-0515_a9f86fd3-836d-409e-ab02-ae16b42c9d55	43857-0515	HUMAN OTC DRUG	Oligo Bio Iodine		Chelidonium Majus, Spongia Tosta, Iodium, Lycopus Virginicus, Ginkgo Biloba, Pinus Sylvestris, Fucus Vesiculosus, Germanium Sesquioxide, Hypophysis Suis, Thyroidinum (Suis), Cysteinum, Manganese Gluconate, alpha-Ketoglutaricum Acidum, Calcarea Carbonica, Ferrum Iodatum, Fumaricum Acidum, Kali Iodatum, Natrum Oxalaceticum, Pulsatilla (Vulgaris), Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum,	LIQUID	ORAL	20190627	20241106	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANEMONE PULSATILLA; CHELIDONIUM MAJUS; COPPER; CYSTEINE; EUGENOL; FERROUS IODIDE; FORMALDEHYDE; FUCUS VESICULOSUS; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4; IODINE; LIDOCAINE; LYCOPUS VIRGINICUS; MANGANESE GLUCONATE; MERCURIUS SOLUBILIS; MOLYBDENUM; MUMPS VIRUS; NICKEL; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PALLADIUM; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM IODIDE; RUBELLA VIRUS; SILVER; SODIUM DIETHYL OXALACETATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; TIN; TITANIUM; ZINC	12; 3; 12; 9; 12; 12; 12; 6; 12; 8; 6; 12; 33; 33; 33; 33; 33; 4; 12; 4; 10; 12; 12; 30; 12; 12; 12; 12; 6; 12; 12; 12; 12; 3; 8; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Local Anesthesia [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43857-0517_f5ad6638-3a2d-45a7-99c9-dfb398ed7a02	43857-0517	HUMAN OTC DRUG	Amoebatox		Triticum Aestivum, Baptisia Tinctoria, Capsicum Annuum, Fragaria Vesca, Hamamelis Virginiana, Quassia Amara, Senna, Hydrastis Canadensis, Podophyllum Peltatum, Hepar Bovine, Pancreas Suis, Spleen (Bovine), Belladonna, Cinchona Officinalis, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Giardia Lamblia, Entamoeba Histolytica	LIQUID	ORAL	20190806	20241209	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALPINE STRAWBERRY; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BEEF LIVER; BOS TAURUS SPLEEN; CAPSICUM; CINCHONA OFFICINALIS BARK; ENTAMOEBA HISTOLYTICA; GIARDIA LAMBLIA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PODOPHYLLUM; QUASSIA AMARA WOOD; SENNA LEAF; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; TRITICUM AESTIVUM WHOLE	3; 12; 3; 8; 8; 3; 12; 15; 18; 5; 3; 12; 12; 6; 3; 3; 12; 8; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43857-0518_235422be-3720-4a55-be72-ab2595877550	43857-0518	HUMAN OTC DRUG	Neurotox		Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Lycopodium Clavatum, Phosphorus, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum Cerium Metallicum, Cesium Chloride, Chromium, Cobaltum Metallicum, Cuprum Metallicum, Dysprosium Metallicum, Erbium Metallicum, Europium Metallicum, Ferrum Metallicum, Gadolinium Metallicum, Germanium Sesquioxide, Holmium Metallicum,	LIQUID	ORAL	20190905	20241120	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALUMINUM; AMANITA MUSCARIA FRUITING BODY; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CITHARACANTHUS SPINICRUS; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM PERFRINGENS; COBALT; CONIUM MACULATUM FLOWERING TOP; COPPER; DYSPROSIUM; ERBIUM; ESCHERICHIA COLI; EUROPIUM; GADOLINIUM; GELSEMIUM SEMPERVIRENS ROOT; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LATRODECTUS MACTANS; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POLIOVIRUS; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PROTORTONIA CACTI; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SELENIUM; SILVER; STRONTIUM CARBONATE; TANTALUM; TERBIUM; THALLIUM; TIN; TOXICODENDRON PUBESCENS LEAF; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 30; 15; 12; 12; 12; 12; 12; 30; 12; 12; 30; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 30; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 30; 30; 12; 30; 12; 12; 33; 12; 12; 12; 12; 30; 12; 12; 12; 30; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43857-0520_0d6a889b-4780-48b6-a730-f3ee58c18d0f	43857-0520	HUMAN OTC DRUG	Tree Antigen		Tea Tree Essential Oil, Arsenicum Album, Lycopodium Clavatum, Pulsatilla (Pratensis).	LIQUID	ORAL	20190808		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; LYCOPODIUM CLAVATUM SPORE; PULSATILLA PRATENSIS WHOLE; TEA TREE OIL	12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0522_dd83ce09-8eb1-4217-a39b-bf7782cfabed	43857-0522	HUMAN OTC DRUG	Weed and Grass Antigen		Allium Cepa, Arsenicum Album, Nux Vomica, Pulsatilla Pratensis	LIQUID	ORAL	20190829	20250821	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANEMONE PRATENSIS; ARSENIC TRIOXIDE; ONION; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
43857-0523_7517aa39-3fcc-4b14-836f-29c04c6de480	43857-0523	HUMAN OTC DRUG	Androtox		Echinacea (Angustifolia), Hydrocotyle Asiatica, Sabal Serrulata, Tabebuia Impetiginosa, Thuja Occidentalis, Astragalus Membranaceus, Glandula Suprarenalis Suis, Lymph Node (Suis), Zincum Gluconicum, Juniperus Virginiana, Mercurius Solubilis, Natrum Sulphuricum, Orchitinum (Suis), Prostate (Suis), Pulsatilla (Pratensis), Rhododendron Chrysanthum, Spongia Tosta, Calcarea Sulphurica, Lycopodium Clavatum, Phosphorus, Botulinum, Escherichia Coli, Proteus (Vulgaris), Pseudomonas Aeruginosa, Salmonella TyphiNosode	LIQUID	ORAL	20190829		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ASTRAGALUS PROPINQUUS ROOT; BOTULINUM TOXIN TYPE A; CALCIUM SULFATE ANHYDROUS; CENTELLA ASIATICA WHOLE; ECHINACEA ANGUSTIFOLIA WHOLE; ESCHERICHIA COLI; JUNIPERUS VIRGINIANA TWIG; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; PHOSPHORUS; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; PULSATILLA PRATENSIS WHOLE; RHODODENDRON AUREUM LEAF; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAW PALMETTO; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH; SUS SCROFA PROSTATE; SUS SCROFA TESTICLE; TABEBUIA IMPETIGINOSA BARK; THUJA OCCIDENTALIS LEAFY TWIG; ZINC GLUCONATE	6; 30; 30; 3; 3; 30; 8; 30; 12; 30; 30; 30; 30; 12; 12; 33; 3; 12; 12; 6; 6; 12; 12; 3; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
43857-0524_ce4e8e15-9461-4185-8e9f-e427bcb19de1	43857-0524	HUMAN OTC DRUG	BAC	HP	Apis Mellifica, Arsenicum Album, Belladonna, Chamomilla, Lachesis Mutus, Mercurius Solubilis, Pulsatilla (Pratensis), Rhus Tox, Silicea	LIQUID	ORAL	20191227	20241022	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANEMONE PRATENSIS; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
43857-0525_b492ea77-75f1-4a90-86d5-b4982cb3ed12	43857-0525	HUMAN OTC DRUG	Mold Mix Antigens		Arsenicum Album, Phosphorus, Pulsatilla (Pratensis), Sepia, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Torula Cerevisiae, Alternaria Tenuis Nees, Mucor Racemosus, Candida Krusei, Rhizopus Nigricans	LIQUID	ORAL	20190829		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALTERNARIA ALTERNATA; ARSENIC TRIOXIDE; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ISSATCHENKIA ORIENTALIS WHOLE; MUCOR RACEMOSUS; PHOSPHORUS; PULSATILLA PRATENSIS WHOLE; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE	16; 12; 12; 12; 12; 14; 16; 12; 12; 14; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0526_8b507a8e-a00d-4c32-bcbc-ccadabd597ef	43857-0526	HUMAN OTC DRUG	Allergen	I	Potassium Gluconate, Glandula Suprarenalis Bovine, Hepar Bovine, Arsenicum Album, Lycopodium Clavatum, Nux Vomica, Phosphorus, Peanut, Black Walnut, English Walnut, Almond, Cashew, Pecan, Brazil Nut, Tomato, Potato (Solanum Tuberosum), Black Pepper, Eggplant (Solanum Melongena), Rape Seed Oil, Cheese (Stilton), Lac Vaccinum, Beef, Lamb, Pork, Chicken, Egg (Whole), Phaseolus, Allium Cepa, Apple, Wheat, Banana, Strawberry, Orange, Cod (Gadus Morhua), Tuna (Thunnus Thynnus),	LIQUID	ORAL	20200102	20241209	UNAPPROVED HOMEOPATHIC		BioActive Nutritional	ALMOND; APPLE; ARSENIC TRIOXIDE; ATLANTIC COD; ATLANTIC SALMON; BANANA; BEEF; BEEF LIVER; BLACK PEPPER; BLACK WALNUT; BOS TAURUS ADRENAL GLAND; BRAZIL NUT; CANOLA OIL; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM ROQUEFORTI CULTURED, AGED; CASHEW; CHICKEN; COMMON SHRIMP; CORTISONE ACETATE; COW MILK; EDIBLE ROCK CRAB; EGG; EGGPLANT; ENGLISH WALNUT; HISTAMINE DIHYDROCHLORIDE; HYALURONIDASE; INTERFERON .GAMMA. PORCINE RECOMBINANT; KIDNEY BEAN; LAMB; LYCOPODIUM CLAVATUM SPORE; NORTHERN BLUEFIN TUNA; ONION; ORANGE; PACIFIC OYSTER; PEANUT; PECAN; PHOSPHORUS; PORK; POTASSIUM GLUCONATE; POTATO; SEROTONIN HYDROCHLORIDE; STRAWBERRY; STRYCHNOS NUX-VOMICA SEED; TOMATO; WHEAT	12; 12; 12; 12; 12; 12; 12; 8; 12; 12; 8; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 30; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 6; 12; 30; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Endoglycosidase [EPC], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Glycoside Hydrolases [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Meat Proteins [EXT], Meat Proteins [EXT], Meat Proteins [EXT], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	
43857-0527_63c92870-a04e-483e-937b-73e1a2bda952	43857-0527	HUMAN OTC DRUG	Renotox		Triticum Aestivum, Asparagus Officinalis, Berberis Vulgaris, Echinacea (Angustifolia), Kali Muriaticum, Petroselinum Sativum, Sabal Serrulata, Solidago Virgaurea, Taraxacum Officinale, Uva-Ursi, Barosma (Betulina), Eupatorium Purpureum, Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum,	LIQUID	ORAL	20190913	20241203	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AGATHOSMA BETULINA LEAF; ALUMINUM; ANTIMONY TRISULFIDE; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIOXIDE; ASPARAGUS; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BOTULINUM TOXIN TYPE A; BROMINE; BRYONIA ALBA ROOT; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CLOSTRIDIUM PERFRINGENS; COBALT; COPPER; DYSPROSIUM; ECHINACEA ANGUSTIFOLIA; ERBIUM; ESCHERICHIA COLI; EUROPIUM; EUTROCHIUM PURPUREUM ROOT; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PETROSELINUM CRISPUM; PLATINUM; POLIOVIRUS; PORK KIDNEY; POTASSIUM CHLORIDE; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SAW PALMETTO; SELENIUM; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; TANTALUM; TARAXACUM OFFICINALE; TERBIUM; THALLIUM; TIN; TRITICUM AESTIVUM WHOLE; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	5; 12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 15; 12; 12; 12; 3; 12; 30; 12; 6; 12; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 12; 12; 3; 12; 30; 8; 3; 12; 30; 30; 30; 12; 12; 33; 12; 3; 12; 12; 3; 12; 30; 3; 12; 12; 12; 1; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Mood Stabilizer [EPC], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	
43857-0528_3a2b9d94-ae3d-4aaf-8ecf-021675bcd435	43857-0528	HUMAN OTC DRUG	Envirotox		Triticum Aestivum, Berberis Vulgaris, Lappa Major, Rhamnus Cathartica, Rhamnus Purshiana, Phytolacca Decandra, Glycyrrhiza Glabra, Stillingia Sylvatica, Trifolium Pratense, Xanthoxylum Fraxineum, Acetonum Acetone, Sodium Tripolyphosphate, Propylene Glycol, Benzinum, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Belladonna, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum	LIQUID	ORAL	20191223	20250107	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACETONE; AMMONIUM CHLORIDE; ARCTIUM LAPPA ROOT; ATROPA BELLADONNA WHOLE; BENZENE; BERBERIS VULGARIS ROOT BARK; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PROPYLENE GLYCOL; RHAMNUS CATHARTICA FRUIT; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; TRIFOLIUM PRATENSE FLOWER; TRITICUM AESTIVUM WHOLE; TURPENTINE OIL; ZANTHOXYLUM AMERICANUM BARK	9; 9; 3; 12; 9; 3; 3; 6; 12; 12; 12; 4; 9; 3; 9; 9; 6; 12; 6; 1; 9; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
43857-0530_ffdca3ab-76e7-440e-b1c5-9e93bf2e91c2	43857-0530	HUMAN OTC DRUG	BAC		Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Suis, Lymph Node (Suis), Spleen (Suis), Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Belladonna, Hypericum Perforatum, Phosphorus, Botulinum, Escherichia Coli, Proteus (Vulgaris), Pseudomonas Aeruginosa, Proteus (Morgani), Salmonella Typhi Nosode, Clostridium Perfringens	LIQUID	ORAL	20191226	20250515	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; BOTULINUM TOXIN TYPE A; CLOSTRIDIUM PERFRINGENS; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; GOLDENSEAL; HYPERICUM PERFORATUM; LOMATIUM DISSECTUM ROOT; MYRRH; NASTURTIUM OFFICINALE; PHOSPHORUS; PROPOLIS WAX; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; SUS SCROFA THYROID; TABEBUIA IMPETIGINOSA BARK	12; 12; 30; 15; 3; 30; 5; 12; 3; 3; 3; 12; 6; 30; 30; 30; 33; 8; 8; 8; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	
43857-0533_4c238e58-9f3d-4061-beb8-fd1a7107061e	43857-0533	HUMAN OTC DRUG	Pneumotox		Triticum Aestivum, Alfalfa, Arnica Montana, Asclepias Tuberosa, Chamomilla, Echinacea (Angustifolia), Eucalyptus Globulus, Fucus Vesiculosus, Hordeum Vulgare, Iodium, Nasturtium Aquaticum, Plantago Major, Raphanus Sativus, Trifolium Pratense, Trigonella Foenum-Graecum, Symphytum Officinale, Lung (Suis), Oryza Sativa, Silicea, Acetone, Sodium Tripolyphosphate, Propylene Glycol, Benzinum, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Arsenicum Album, Natrum Muriaticum, Nitricum Acidum,	LIQUID	ORAL	20191002		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACETONE; ALFALFA; AMMONIUM CHLORIDE; ARNICA MONTANA; ARSENIC TRIOXIDE; ASCLEPIAS TUBEROSA ROOT; BENZENE; DAIKON; ECHINACEA ANGUSTIFOLIA WHOLE; EUCALYPTUS GLOBULUS LEAF; FUCUS VESICULOSUS; HORDEUM VULGARE TOP; IODINE; MATRICARIA RECUTITA; NASTURTIUM OFFICINALE; NITRIC ACID; OENANTHE AQUATICA FRUIT; ORYZA SATIVA WHOLE; PHOSPHORIC ACID; PHOSPHORUS; PLANTAGO MAJOR; PROPYLENE GLYCOL; PULSATILLA PRATENSIS WHOLE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; SUS SCROFA LUNG; SYMPHYTUM OFFICINALE WHOLE; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; TRIGONELLA FOENUM-GRAECUM WHOLE; TRITICUM AESTIVUM WHOLE; TURPENTINE OIL	9; 3; 9; 3; 12; 3; 9; 3; 3; 3; 3; 3; 3; 3; 3; 12; 12; 8; 12; 12; 3; 9; 12; 8; 12; 9; 9; 8; 6; 12; 3; 3; 1; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0537_b5ddb5d9-54f6-49d8-abdf-01b080b7e3ed	43857-0537	HUMAN OTC DRUG	Household Antigens		Acetone, Sodium Tripolyphosphate, Propylene Glycol, Benzinum, Ammonium Muriaticum, Sodium Lauryl Sulfate, Terebinthina, Anacardium Orientale, Graphites, Nitricum Acidum, Pulsatilla (Pratensis), Sulphur	LIQUID	ORAL	20191008		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	ACETONE; AMMONIUM CHLORIDE; BENZENE; GRAPHITE; NITRIC ACID; PROPYLENE GLYCOL; PULSATILLA PRATENSIS WHOLE; SEMECARPUS ANACARDIUM JUICE; SODIUM LAURYL SULFATE; SODIUM TRIPOLYPHOSPHATE; SULFUR; TURPENTINE OIL	9; 9; 9; 12; 12; 9; 12; 12; 9; 9; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0538_2b3b1bb0-ac74-4a63-bc1e-9aeda4bc10ef	43857-0538	HUMAN OTC DRUG	Depressoforce		Picricum acidum, Arsenicum album, Aurum metallicum, Ignatia amara, Natrum muriaticum, Nitricum acidum, Pulsatilla (Pratensis), Sepia	LIQUID	ORAL	20191025		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; GOLD; NITRIC ACID; PICRIC ACID; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	30; 30; 30; 12; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
43857-0539_203fdd03-48d8-4ef0-ae5f-8e0f38c8e900	43857-0539	HUMAN OTC DRUG	Ear		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Hydrastis Canadensis, Capsicum Annuum, Chamomilla, Ferrum Phosphoricum, Kali Muriaticum, Plantago Major, Pulsatilla (Pratensis)	LIQUID	ORAL	20191024		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BAPTISIA TINCTORIA ROOT; CAPSICUM; ECHINACEA ANGUSTIFOLIA WHOLE; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; MATRICARIA CHAMOMILLA WHOLE; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR WHOLE; POTASSIUM CHLORIDE; PULSATILLA PRATENSIS WHOLE	3; 12; 3; 12; 5; 12; 4; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS]		N	20251231
43857-0541_7042f927-8a49-48aa-a0d6-5132f25fcd0e	43857-0541	HUMAN OTC DRUG	Oligo Bio Iodine		Chelidonium Majus, Iodium, Lycopus Virginicus, Ginkgo Biloba, Pinus Sylvestris, Fucus Vesiculosus, Spongia Tosta, Germanium Sesquioxide, Hypophysis Suis, Thyroidinum (Suis), Cysteinum, Manganese Gluconate, Alpha-Ketoglutaricum Acidum, Calcarea Carbonica, Ferrum Iodatum, Fumaricum Acidum, Kali Iodatum, Natrum Oxalaceticum, Pulsatilla (Vulgaris), Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum,	LIQUID	ORAL	20191121		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CHELIDONIUM MAJUS WHOLE; COPPER; CYSTEINE; EUGENOL; FERROUS IODIDE; FORMALDEHYDE; FUCUS VESICULOSUS; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4; IODINE; LIDOCAINE; LYCOPUS VIRGINICUS WHOLE; MANGANESE GLUCONATE; MERCURIUS SOLUBILIS; MOLYBDENUM; MUMPS VIRUS; NICKEL; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PALLADIUM; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM IODIDE; PULSATILLA VULGARIS WHOLE; RUBELLA VIRUS; SILVER; SODIUM DIETHYL OXALACETATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; THYROID; TIN; TITANIUM; ZINC	3; 12; 9; 12; 12; 12; 6; 12; 8; 6; 12; 16; 16; 16; 16; 16; 4; 12; 4; 10; 12; 12; 30; 12; 12; 12; 12; 6; 12; 12; 16; 12; 12; 7; 8; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Local Anesthesia [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0542_31b72b0c-f121-4204-a4ee-7b3e86908a20	43857-0542	HUMAN OTC DRUG	Dust Mix Antigens		Arsenicum Album, Drosera (Rotundifolia), Lycopodium Clavatum, Pothos Foetidus, Pulsatilla (Pratensis), Barley, Corn, House, Millet, Milo, Oat, Rice, Rug, Upholstery, Wheat	LIQUID	ORAL	20191230	20250102	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANEMONE PRATENSIS; ARSENIC TRIOXIDE; BARLEY; CORN; DROSERA ROTUNDIFOLIA; HOUSE DUST; LYCOPODIUM CLAVATUM SPORE; MILLET; OAT; SORGHUM BICOLOR WHOLE; SYMPLOCARPUS FOETIDUS ROOT; WHEAT; WHITE RICE	12; 12; 9; 9; 12; 9; 12; 9; 9; 9; 12; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC]		N	
43857-0543_c02affcc-c0ce-4ee4-969b-f7da2e428cd0	43857-0543	HUMAN OTC DRUG	Hepatatox		Triticum Aestivum, Chelidonium Majus, Taraxacum Officinale, Glutathione, Hepar Suis, Thyroidinum (Suis), Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Adrenocorticotrophin, Salicylicum Acidum, Cortisone Aceticum, Eugenol, Stearyl Alcohol, Xylitol, Folliculinum, Benzoicum Acidum, Chlorinum Potassium Sorbate, Sorbitol, Resorcinum, Benzyl Alcohol, Lacticum Acidum, Isopropyl Palmitate, Boricum Acidum, Aceticum Acidum, Phenyl Butazone, Petroleum Jelly, Plumbum Metallicum	LIQUID	ORAL	20200220		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc	ACETIC ACID; BENZOIC ACID; BENZYL ALCOHOL; BORIC ACID; CHELIDONIUM MAJUS WHOLE; CHLORINE; CORTICOTROPIN; CORTISONE ACETATE; ESTRONE; EUGENOL; GLUTATHIONE; ISOPROPYL PALMITATE; LACTIC ACID, DL-; LEAD; LYCOPODIUM CLAVATUM SPORE; PETROLATUM; PHENYLBUTAZONE; PHOSPHORIC ACID; PORK LIVER; POTASSIUM SORBATE; RESORCINOL; SALICYLIC ACID; SORBITOL; STEARYL ALCOHOL; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; THYROID; TRITICUM AESTIVUM WHOLE; XYLITOL	30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 6; 30; 30; 30; 12; 30; 30; 12; 8; 30; 30; 30; 30; 30; 12; 3; 8; 1; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Pediculicide [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43857-0544_a7d0e4ba-40b6-470e-8428-2430505a924e	43857-0544	HUMAN OTC DRUG	Bronchiforce		Althaea Officinalis, Lobelia Inflata, Rheum (Palmatum), Verbascum Thapsus, Belladonna, Cuprum Aceticum, Drosera (Rotundifolia), Ipecacuanha, Spongia Tosta, Sticta Pulmonaria	LIQUID	ORAL	20191209		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALTHAEA OFFICINALIS ROOT; ATROPA BELLADONNA WHOLE; CUPRIC ACETATE; DROSERA ROTUNDIFOLIA WHOLE; IPECAC; LOBARIA PULMONARIA; LOBELIA INFLATA WHOLE; RHEUM PALMATUM ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; VERBASCUM THAPSUS WHOLE	3; 12; 12; 12; 12; 12; 3; 3; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0545_d10a9ed5-2b5e-470e-a15d-8240e1b2d88e	43857-0545	HUMAN OTC DRUG	Relaxoforce		Humulus Lupulus, Passiflora Incarnata, Valeriana Officinalis, Calcarea Carbonica, Coffea Tosta, Ignatia Amara, Kali Phosphoricum, Moschus, Nux Vomica, Phosphorus, Pulsatilla (Pratensis)	LIQUID	ORAL	20200219		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	COFFEA ARABICA SEED, ROASTED; DIBASIC POTASSIUM PHOSPHATE; HOPS; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PULSATILLA PRATENSIS WHOLE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VALERIAN	12; 12; 3; 12; 12; 3; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0546_1ba28daf-7bf8-4143-8fe0-aa993c9ea0c2	43857-0546	HUMAN OTC DRUG	Chemtox		Triticum Aestivum, Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Rhamnus Purshiana, Stillingia Sylvatica, Trifolium Pratense, Xanthoxylum Fraxineum, Phytolacca Decandra, Glandula Suprarenalis Suis, Hepar Suis, Lymph Node (suis), Thyroidinum (suis), Belladonna, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Salicylicum Acidum, Cortisone Aceticum, Eugenol, Stearyl Alcohol, Xylitol, Folliculinum, Benzoicum Acidum, Chlorinum, Potassium Sorbate,	LIQUID	ORAL	20191226		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACETIC ACID; ARCTIUM LAPPA ROOT; ATROPA BELLADONNA WHOLE; BENZOIC ACID; BENZYL ALCOHOL; BERBERIS VULGARIS ROOT BARK; BORIC ACID; CHLORINE; CORTICOTROPIN; CORTISONE ACETATE; ESTRONE; EUGENOL; FRANGULA ALNUS BARK; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA; ISOPROPYL PALMITATE; LACTIC ACID, DL-; LEAD; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PETROLATUM; PHENYLBUTAZONE; PHOSPHORIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PORK LIVER; POTASSIUM SORBATE; RESORCINOL; SALICYLIC ACID; SORBITOL; STEARYL ALCOHOL; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH; SUS SCROFA THYROID; TRIFOLIUM PRATENSE FLOWER; TRITICUM AESTIVUM WHOLE; XYLITOL; ZANTHOXYLUM AMERICANUM BARK	30; 3; 12; 30; 30; 3; 30; 30; 30; 30; 30; 30; 3; 3; 3; 30; 30; 30; 12; 12; 30; 30; 12; 12; 4; 8; 30; 30; 30; 30; 30; 3; 12; 8; 8; 8; 3; 1; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Pediculicide [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43857-0548_dee49bf1-2692-4b6f-ad0b-4c76659076b6	43857-0548	HUMAN OTC DRUG	Cough Syrup Formula		Drosera (Rotundifolia), Coccus Cacti, Spongia Tosta, Belladonna, Cuprum Aceticum, Kali Carbonicum, Mentha Piperita, Phosphorus	LIQUID	ORAL	20200225		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; CUPRIC ACETATE; DROSERA ROTUNDIFOLIA WHOLE; MENTHA X PIPERITA WHOLE; PHOSPHORUS; POTASSIUM CARBONATE; PROTORTONIA CACTI; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 12; 4; 12; 12; 12; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
43857-0551_6f70138f-e984-4270-9a1d-fae0292d9758	43857-0551	HUMAN OTC DRUG	Pneumoforce		Althaea Officinalis, Natrum Carbonicum, Rheum (Palmatum), Verbascum Thapsus, Zingiber Officinale, Aconitum Napellus, Drosera (Rotundifolia), Kali Bichromicum, Lobelia Inflata, Phosphorus	LIQUID	ORAL	20200306		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS WHOLE; ALTHAEA OFFICINALIS ROOT; DROSERA ROTUNDIFOLIA WHOLE; GINGER; LOBELIA INFLATA WHOLE; PHOSPHORUS; POTASSIUM DICHROMATE; RHEUM PALMATUM ROOT; SODIUM CARBONATE; VERBASCUM THAPSUS WHOLE	12; 3; 12; 3; 12; 12; 12; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43857-0556_fc5c9f14-3bd5-4a96-986a-b57d6db6522f	43857-0556	HUMAN OTC DRUG	Arrhythmiaforce		Juglans Nigra, Leonurus Cardiaca, Convallaria Majalis, Magnesia Sulphurica, Iberis Amara, Kali Chloricum, Adonis Vernalis, Digitalis Purpurea, Lycopus Virginicus, Phosphorus	LIQUID	ORAL	20200427	20250514	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ADONIS VERNALIS WHOLE; BLACK WALNUT; CONVALLARIA MAJALIS; DIGITALIS; IBERIS AMARA SEED; LEONURUS CARDIACA WHOLE; LYCOPUS VIRGINICUS WHOLE; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; POTASSIUM CHLORATE	10; 3; 4; 12; 6; 3; 12; 4; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
43857-0557_d46c8440-f512-4247-9eb0-8a7b4f165bb3	43857-0557	HUMAN OTC DRUG	Allergen	II	Potassium Gluconate, Adrenalinum, Hepar Bovine, Arsenicum Album, Phosphorus, Pulsatilla (Pratensis), Sulphur, Ambrosia Artemisiaefolia, Kentucky Bluegrass, Orchard Grass, Bermuda Grass, Johnson Grass, Rye Grass, Vernal Grass, Bahia Grass, Timothy Grass, Histaminum Hydrochloricum	LIQUID	ORAL	20200430		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; ANTHOXANTHUM ODORATUM; ARSENIC TRIOXIDE; BEEF LIVER; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA TOP; EPINEPHRINE; HISTAMINE DIHYDROCHLORIDE; LOLIUM PERENNE POLLEN; PASPALUM NOTATUM POLLEN; PHLEUM PRATENSE TOP; PHOSPHORUS; POA PRATENSIS TOP; POTASSIUM GLUCONATE; PULSATILLA PRATENSIS WHOLE; SORGHUM HALEPENSE POLLEN; SULFUR	16; 16; 12; 8; 16; 16; 8; 30; 16; 16; 16; 12; 16; 6; 12; 16; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Pollen Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
43857-0558_fab1f141-a014-4739-94a2-142682f36651	43857-0558	HUMAN OTC DRUG	Lymph	III	Echinacea (Angustifolia), Boldo, Phytolacca Decandra, Pinus Sylvestris, Thyroidinum (Suis), Germanium Sesquioxide, Arnica Montana, Calcarea Iodata, Hamamelis Virginiana, Hepar Sulphuris Calcareum, Adenosinum Triphosphoricum Dinatrum, Ubidecarenonum, Naja Tripudians, Calcarea Phosphorica, Influenzinum (2019-2020), Natrum Sulphuricum, Pyrogenium, Sulphur, Carcinosin	LIQUID	ORAL	20200716	20250629	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARNICA MONTANA WHOLE; CALCIUM IODIDE; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA WHOLE; GERMANIUM SESQUIOXIDE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HUMAN BREAST TUMOR CELL; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); NAJA NAJA VENOM; PEUMUS BOLDUS LEAF; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; RANCID BEEF; SODIUM SULFATE; SULFUR; SUS SCROFA THYROID; TRIBASIC CALCIUM PHOSPHATE; UBIDECARENONE	12; 12; 12; 12; 1; 8; 12; 200; 30; 30; 30; 15; 3; 4; 6; 30; 30; 30; 6; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE]		N	
43857-0559_8f935564-6146-4fd1-ba33-850042b06581	43857-0559	HUMAN OTC DRUG	Kidney Tonic	I	Echinacea (Angustifolia), Petroselinum Sativum, Solidago Virgaurea, Uva-Ursi, Glutathione, Pareira Brava, Kidney (Suis), Cantharis, Lycopodium Clavatum	LIQUID	ORAL	20200518		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; CHONDRODENDRON TOMENTOSUM ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; GLUTATHIONE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PETROSELINUM CRISPUM WHOLE; PORK KIDNEY; SOLIDAGO VIRGAUREA FLOWERING TOP	1; 8; 1; 6; 12; 12; 1; 8; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0561_26b7af9f-af34-400d-80de-935f4a380422	43857-0561	HUMAN OTC DRUG	Influaforce		Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Bryonia (Alba), Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens, Ipecacuanha, Mercurius Corrosivus, Pyrogenium, Influenzinum (2019-2020)	LIQUID	ORAL	20200716	20250616	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; LOMATIUM DISSECTUM ROOT; MERCURIC CHLORIDE; MYRRH; NASTURTIUM OFFICINALE; PROPOLIS WAX; RANCID BEEF; TABEBUIA IMPETIGINOSA BARK	12; 3; 12; 12; 12; 5; 10; 10; 10; 12; 3; 12; 3; 3; 6; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
43857-0562_b09fd433-1944-4f0d-a34d-bcf7650acfce	43857-0562	HUMAN OTC DRUG	Weed and Grass Antigen		Allium Cepa, Arsenicum Album, Nux Vomica, Pulsatilla Pratensis, Kentucky Bluegrass, Orchard Grass, Bermuda Grass, Johnson Grass, Rye Grass, Vernal Grass, Bahia Grass, Timothy Grass	LIQUID	ORAL	20201006		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANTHOXANTHUM ODORATUM POLLEN; ARSENIC TRIOXIDE; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA TOP; LOLIUM PERENNE POLLEN; ONION; PASPALUM NOTATUM POLLEN; PHLEUM PRATENSE TOP; POA PRATENSIS POLLEN; PULSATILLA PRATENSIS WHOLE; SORGHUM HALEPENSE POLLEN; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Plant Proteins [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Seed Storage Proteins [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
43857-0563_06d3c1d7-85ea-4cf5-9fe5-4f3ee6ff38b9	43857-0563	HUMAN OTC DRUG	Animal Antigens		Arsenicum Album, Nux Vomica, Phosphorus, Canary Feathers, Cat Hair Mix, Chicken Feathers, Cow Hair, Dog Hair Mix, Guinea Pig Hair, Hamster Hair, Horse Dander, Mus Musculus, Pig Hair, Rat Hair, Duck Feathers, Goose Feathers, Rabbit Fur	LIQUID	ORAL	20201006		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; ARSENIC TRIOXIDE; BOS TAURUS HAIR; CANIS LUPUS FAMILIARIS HAIR; CAVIA PORCELLUS HAIR; EQUUS CABALLUS DANDER; FELIS CATUS HAIR; GALLUS GALLUS FEATHER; MESOCRICETUS AURATUS SKIN; MUS MUSCULUS HAIR; ORYCTOLAGUS CUNICULUS HAIR; PHOSPHORUS; RATTUS NORVEGICUS HAIR; SERINUS CANARIA FEATHER; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA HAIR	18; 18; 12; 15; 15; 15; 15; 15; 15; 15; 15; 39; 12; 15; 15; 12; 15	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Dander [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
43857-0566_26cec7f6-c059-4328-b193-308e6324cb1c	43857-0566	HUMAN OTC DRUG	Grain and Seed Antigens		Bamboo, Barley, Poppy Seed, Corn, Flax Seed, Buckwheat, Millet, Milo, Oat, Rice, Rye, Lentils, Sesame, Amaranth, Soy Bean, Sugarcane, Sunflower Seed, Wheat, Arsenicum Album, Lycopodium Clavatum, Natrum Muriaticum, Sulphur	LIQUID	ORAL	20210416	20260329	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMARANTH; ARSENIC TRIOXIDE; BAMBUSA VULGARIS LEAF; BARLEY; BROWN RICE; BUCKWHEAT; CORN; FLAX SEED; LENTIL; LYCOPODIUM CLAVATUM SPORE; MILLET; OAT; POPPY SEED; RYE; SESAME SEED; SODIUM CHLORIDE; SORGHUM BICOLOR WHOLE; SOYBEAN; SUGARCANE; SULFUR; SUNFLOWER SEED; WHEAT	9; 12; 9; 9; 9; 9; 9; 9; 9; 12; 9; 9; 9; 9; 9; 12; 9; 9; 9; 12; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]	CII	N	
43857-0567_4721f373-874b-411c-a702-cd61900fe56d	43857-0567	HUMAN OTC DRUG	Bio Electrolyte		Boron Citrate, Calcium Gluconate, Chromium Picolinate, Cobalt Gluconate, Copper Gluconate, Magnesium Gluconicum Dihydricum, Manganese Gluconate, Nickel Acetate, Potassium Gluconate, Selenium Dioxide, Sodium Gluconate, Zincum Gluconicum, Ferrum Sulphuricum, Kali Phosphoricum, Vanadium Metallicum, Calcarea Phosphorica	LIQUID	ORAL	20201228		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BORON CITRATE; CALCIUM GLUCONATE; CHROMIUM PICOLINATE; COBALTOUS GLUCONATE; COPPER GLUCONATE; DIBASIC POTASSIUM PHOSPHATE; FERROUS SULFATE; MAGNESIUM GLUCONATE; MANGANESE GLUCONATE; NICKEL ACETATE; POTASSIUM GLUCONATE; SELENIUM DIOXIDE; SODIUM GLUCONATE; TRIBASIC CALCIUM PHOSPHATE; VANADIUM; ZINC GLUCONATE	6; 6; 6; 6; 6; 8; 8; 6; 6; 6; 6; 6; 6; 9; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0568_efde3f6a-b913-4b86-82f5-de8fe460d0d9	43857-0568	HUMAN OTC DRUG	Arterioforce	II	Baptisia Tinctoria, Echinacea (Angustifolia), Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Trigonella Foenum-Graecum, Hydrastis Canadensis, Kali Iodatum, Arnica Montana, Cactus Grandiflorus, Propolis, Baryta Carbonica, Conium Maculatum, Secale Cornutum	LIQUID	ORAL	20210419		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA WHOLE; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA WHOLE; FENUGREEK SEED; GOLDENSEAL; MYRRH; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; POTASSIUM IODIDE; PROPOLIS WAX; SELENICEREUS GRANDIFLORUS STEM	6; 3; 12; 12; 12; 3; 4; 5; 4; 4; 4; 5; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0569_2ab86649-6b5a-4e77-867b-5f7dd0774872	43857-0569	HUMAN OTC DRUG	Calciforce		Arnica Montana, Chamomilla, Echinacea (Angustifolia), Boron Citrate, Symphytum Officinale, Calcarea Fluorica, Calcarea Phosphorica, Hekla Lava, Lycopodium Clavatum, Silicea, Calcarea Carbonica	LIQUID	ORAL	20210104		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA WHOLE; BORON CITRATE; CALCIUM FLUORIDE; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; HEKLA LAVA; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE	3; 6; 12; 6; 3; 12; 12; 3; 30; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
43857-0570_12d3b396-dfe4-45d4-9677-2950141ab2f8	43857-0570	HUMAN OTC DRUG	Epiforce E		Lappa Major, Phytolacca Decandra, Trifolium Pratense, Hydrocotyle Asiatica, Arsenicum Album, Graphites, Mezereum	LIQUID	ORAL	20210218		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; CENTELLA ASIATICA WHOLE; DAPHNE MEZEREUM BARK; GRAPHITE; PHYTOLACCA AMERICANA ROOT; TRIFOLIUM PRATENSE FLOWER	3; 12; 6; 12; 12; 4; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0571_8a3b0b47-51cb-4ff6-a25e-b56a9e09b990	43857-0571	HUMAN OTC DRUG	V Force		Echinacea Angustifolia, Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Glandula Suprarenalis Bovine, Thymus (Bovine), Belladonna, Gelsemium Sempervirens, Lycopodium Clavatum, Nux Vomica, Pyrogenium	LIQUID	ORAL	20210504		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ATROPA BELLADONNA; BOS TAURUS ADRENAL GLAND; BOS TAURUS THYMUS; ECHINACEA ANGUSTIFOLIA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HANDROANTHUS IMPETIGINOSUS BARK; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; MYRRH; NASTURTIUM OFFICINALE; RANCID BEEF; STRYCHNOS NUX-VOMICA SEED	12; 8; 8; 3; 12; 5; 3; 3; 12; 3; 3; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0572_09369c0e-c1f5-4ebf-9a49-094a2db74c15	43857-0572	HUMAN OTC DRUG	Albuforce		Equisetum Hyemale, Solidago Virgaurea, Apis Mellifica, Mercurius Corrosivus, Nux Moschata, Phosphorus, Terebinthina	LIQUID	ORAL	20210222		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; EQUISETUM HYEMALE WHOLE; MERCURIC CHLORIDE; NUTMEG; PHOSPHORUS; SOLIDAGO VIRGAUREA FLOWERING TOP; TURPENTINE OIL	12; 3; 12; 12; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0573_4985f159-8527-4bb8-a653-85038a88686b	43857-0573	HUMAN OTC DRUG	Candida Alb Combo		Candida Albicans	LIQUID	ORAL	20210222		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
43857-0574_9d71dd18-741d-408c-91f7-8ae7f8095744	43857-0574	HUMAN OTC DRUG	B Force HP		Apis Mellifica, Arsenicum Album, Belladonna, Chamomilla, Lachesis Mutus, Mercurius Solubilis, Pulsatilla (Pratensis), Rhus Tox, Silicea	LIQUID	ORAL	20210218		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; PULSATILLA PRATENSIS WHOLE; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
43857-0578_a670670e-5e6c-4298-9e86-2ed48a3bd73f	43857-0578	HUMAN OTC DRUG	Tobaccotox		Avena Sativa, Kali Phosphoricum, Cactus Grandiflorus, Eucalyptus Globulus, Lobelia Inflata, Daphne Indica, Mentholum, Ignatia Amara, Nux Vomica, Staphysagria, Tabacum, Benzinum, Naphthalinum	LIQUID	ORAL	20210218		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AVENA SATIVA FLOWERING TOP; BENZENE; DAPHNE ODORA BARK; DELPHINIUM STAPHISAGRIA SEED; DIBASIC POTASSIUM PHOSPHATE; EUCALYPTUS GLOBULUS LEAF; LOBELIA INFLATA WHOLE; MENTHOL, UNSPECIFIED FORM; NAPHTHALENE; SELENICEREUS GRANDIFLORUS STEM; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	1; 15; 4; 12; 2; 3; 3; 4; 15; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0582_a813310b-deea-4938-9fd1-0f4512d3d491	43857-0582	HUMAN OTC DRUG	Renotox		Triticum Aestivum, Asparagus Officinalis, Berberis Vulgaris, Echinacea (Angustifolia), Kali Muriaticum, Petroselinum Sativum, Sabal Serrulata, Solidago Virgaurea, Taraxacum Officinale, Uva-Ursi, Barosma (Betulina), Eupatorium Purpureum, Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum,	LIQUID	ORAL	20210521	20270111	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AGATHOSMA BETULINA LEAF; ALUMINUM; ANTIMONY TRISULFIDE; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIOXIDE; ASPARAGUS; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BOTULINUM TOXIN TYPE A; BROMINE; BRYONIA ALBA ROOT; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CLOSTRIDIUM PERFRINGENS; COBALT; COPPER; DYSPROSIUM; ECHINACEA ANGUSTIFOLIA WHOLE; ERBIUM; ESCHERICHIA COLI; EUROPIUM; EUTROCHIUM PURPUREUM ROOT; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PETROSELINUM CRISPUM WHOLE; PLATINUM; POLIOVIRUS; PORK KIDNEY; POTASSIUM CHLORIDE; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SAW PALMETTO; SELENIUM; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; TANTALUM; TARAXACUM OFFICINALE; TERBIUM; THALLIUM; TIN; TRITICUM AESTIVUM WHOLE; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	5; 12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 15; 12; 12; 12; 3; 12; 30; 12; 6; 12; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 12; 12; 3; 12; 30; 8; 3; 12; 30; 30; 30; 12; 12; 33; 12; 3; 12; 12; 3; 12; 30; 3; 12; 12; 12; 1; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Mood Stabilizer [EPC], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	
43857-0586_01f41908-811f-4b13-9dc7-f1ddd49bcbb9	43857-0586	HUMAN OTC DRUG	Kidneyforce-HP		Arnica Montana, Aurum Metallicum, Cactus Grandiflorus, Calcarea Carbonica, Natrum Muriaticum, Nux Vomica, Phosphorus, Solidago Virgaurea	LIQUID	ORAL	20210510		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARNICA MONTANA WHOLE; GOLD; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SELENICEREUS GRANDIFLORUS STEM; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43857-0590_d142f5b9-1469-4cf8-be03-68cbdde67285	43857-0590	HUMAN OTC DRUG	Pancreaplex		Chelidonium Majus, Glycyrrhiza Glabra, Nux Moschata, Rheum (Palmatum), Syzygium Jambolanum, Taraxacum Officinale, Zingiber Officinale, Hydrastis Canadensis, Glandula Suprarenalis Suis, Hepar Suis, Hypophysis Suis, Pancreas Suis, Thyroidinum (Suis), Phaseolus, Phosphoricum Acidum, Phosphorus	LIQUID	ORAL	20230605		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CHELIDONIUM MAJUS WHOLE; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; KIDNEY BEAN; NUTMEG; PHOSPHORIC ACID; PHOSPHORUS; PORK LIVER; RHEUM PALMATUM ROOT; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SYZYGIUM CUMINI SEED; TARAXACUM OFFICINALE; THYROID	3; 3; 3; 5; 12; 3; 12; 12; 6; 3; 6; 6; 6; 3; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
43857-0591_64643242-e685-42f3-96d6-05ccefe2c9b2	43857-0591	HUMAN OTC DRUG	Boneforce	HP	Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Hekla Lava, Hydrofluoricum Acidum, Rhus Tox, Silicea, Symphytum Officinale	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CALCIUM FLUORIDE; COMFREY ROOT; HEKLA LAVA; HYDROFLUORIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
43857-0592_086cfd19-cd43-4621-9ea3-a4ee0cff2a7e	43857-0592	HUMAN OTC DRUG	Balanceforce V		Leonurus Cardiaca, Agaricus Muscarius, Arsenicum Album, Cocculus Indicus, Conium Maculatum, Petroleum, Phosphorus, Pulsatilla (Vulgaris), Tabacum, Theridion	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMANITA MUSCARIA FRUITING BODY; ANAMIRTA COCCULUS SEED; ARSENIC TRIOXIDE; CONIUM MACULATUM FLOWERING TOP; KEROSENE; LEONURUS CARDIACA WHOLE; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; THERIDION CURASSAVICUM; TOBACCO LEAF	12; 12; 12; 12; 12; 3; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43857-0593_eeed1c47-1eec-4476-8f38-d538b67ee4c0	43857-0593	HUMAN OTC DRUG	Dentox		Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Stillingia Sylvatica, Trifolium Pratense, Phytolacca Decandra, Lymph Node(Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Fluorica, Natrum Fluoratum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum	LIQUID	ORAL	20230214		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARCTIUM LAPPA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM FLUORIDE; COPPER; EUGENOL; FORMALDEHYDE SOLUTION; GLYCYRRHIZA GLABRA; GOLD; LIDOCAINE; MERCURIUS SOLUBILIS; MOLYBDENUM; NICKEL; PALLADIUM; PHYTOLACCA AMERICANA ROOT; SILVER; SODIUM FLUORIDE; STILLINGIA SYLVATICA ROOT; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA THYMUS; THYROID, PORCINE; TIN; TITANIUM; TRIFOLIUM PRATENSE FLOWER; ZINC	3; 3; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 4; 12; 12; 3; 8; 8; 8; 8; 12; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Local Anesthesia [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0594_2c93d95d-5305-4195-9958-93ff1ca67c05	43857-0594	HUMAN OTC DRUG	FNG	I	Echinacea (Angustifolia), Lomatium Dissectum, Nasturtium Aquaticum, Tabebuia Impetiginosa, Condurango, Ginkgo Biloba, Ligusticum Porteri, Hydrastis Canadensis, Astragalus Membranaceus, Propolis, Glandula Suprarenalis Bovine, Thymus (Bovine), Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phytolacca Decandra, Sepia, Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Torula Cerevisiae, Mucor Racemosus, Rhizopus Nigricans.	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; ASTRAGALUS PROPINQUUS ROOT; BOS TAURUS ADRENAL GLAND; BOS TAURUS THYMUS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ECHINACEA ANGUSTIFOLIA WHOLE; GINKGO; GOLDENSEAL; LIGUSTICUM PORTERI ROOT; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; MUCOR RACEMOSUS; NASTURTIUM OFFICINALE; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PROPOLIS WAX; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; TABEBUIA IMPETIGINOSA BARK	30; 30; 6; 8; 8; 30; 30; 3; 4; 5; 4; 3; 12; 4; 30; 3; 12; 12; 6; 30; 30; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0595_f08b5e6f-4064-4a75-8fba-21c53e80fb3a	43857-0595	HUMAN OTC DRUG	LYMPH III		Echinacea (Angustifolia), Boldo, Phytolacca Decandra, Pinus Sylvestris, Thyroidinum (Suis), Germanium Sesquioxide, Arnica Montana, Calcarea Iodata, Hamamelis Virginiana, Hepar Sulphuris Calcareum, Adenosinum Triphosphoricum Dinatrum, Ubidecarenonum, Naja Tripudians, Calcarea Phosphorica, Influenzinum (2020-2021), Natrum Sulphuricum, Pyrogenium, Sulphur, Carcinosin	LIQUID	ORAL	20210520	20260402	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARNICA MONTANA WHOLE; CALCIUM IODIDE; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA WHOLE; GERMANIUM SESQUIOXIDE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HUMAN BREAST TUMOR CELL; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); NAJA NAJA VENOM; PEUMUS BOLDUS LEAF; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; RANCID BEEF; SODIUM SULFATE; SULFUR; SUS SCROFA THYROID; TRIBASIC CALCIUM PHOSPHATE; UBIDECARENONE	12; 12; 12; 12; 1; 8; 12; 200; 30; 30; 30; 30; 15; 3; 4; 6; 30; 30; 30; 6; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE]		N	
43857-0596_6a40a2f1-2f5e-404a-87a4-7da43d675724	43857-0596	HUMAN PRESCRIPTION DRUG	Neurotox		Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Lycopodium Clavatum, Phosphorus, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum Cerium Metallicum, Cesium Chloride, Chromium, Cobaltum Metallicum, Cuprum Metallicum, Dysprosium Metallicum, Erbium Metallicum, Europium Metallicum, Ferrum Metallicum, Gadolinium Metallicum, Germanium Sesquioxide, Holmium Metallicum,	LIQUID	ORAL	20210520	20260426	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALUMINUM; AMANITA MUSCARIA FRUITING BODY; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CITHARACANTHUS SPINICRUS; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM PERFRINGENS; COBALT; CONIUM MACULATUM FLOWERING TOP; COPPER; DYSPROSIUM; ERBIUM; ESCHERICHIA COLI; EUROPIUM; GADOLINIUM; GELSEMIUM SEMPERVIRENS ROOT; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LATRODECTUS MACTANS; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POLIOVIRUS; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PROTORTONIA CACTI; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SELENIUM; SILVER; STRONTIUM CARBONATE; TANTALUM; TERBIUM; THALLIUM; TIN; TOXICODENDRON PUBESCENS LEAF; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 30; 15; 12; 12; 12; 12; 12; 30; 12; 12; 30; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 30; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 30; 30; 12; 30; 12; 12; 33; 12; 12; 12; 12; 30; 12; 12; 12; 30; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43857-0602_5278f25b-6724-4840-a4bc-e9badf46d8ae	43857-0602	HUMAN OTC DRUG	Jointforce R		Chondrus Crispus, Cimicifuga Racemosa, Spiraea Ulmaria, Trifolium Pratense, Urtica Urens, Xanthoxylum Fraxineum, Symphytum Officinale, Colchicum Autumnale, Ferrum Phosphoricum, Formica Rufa, Lithium Carbonicum, Natrum Sulphuricum, Rhododendron Chrysanthemum, Rhus Tox	LIQUID	ORAL	20210617		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BLACK COHOSH; CHONDRUS CRISPUS; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; FILIPENDULA ULMARIA ROOT; FORMICA RUFA; LITHIUM CARBONATE; RHODODENDRON AUREUM LEAF; SODIUM SULFATE; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; URTICA URENS WHOLE; ZANTHOXYLUM AMERICANUM BARK	3; 3; 12; 6; 12; 9; 12; 12; 12; 12; 12; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Mood Stabilizer [EPC]		N	20241231
43857-0603_b7b1fe9e-9916-45d6-96ae-36ad5e28a1e3	43857-0603	HUMAN OTC DRUG	Oligo Bio Iodine		Chelidonium Majus, Iodium, Lycopus Virginicus, Ginkgo Biloba, Pinus Sylvestris, Fucus Vesiculosus, Spongia Tosta, Germanium Sesquioxide, Hypophysis Suis, Thyroidinum (Suis), Cysteinum, Manganese Gluconate, Alpha-Ketoglutaricum Acidum, Calcarea Carbonica, Ferrum Iodatum, Fumaricum Acidum, Kali Iodatum, Natrum Oxalaceticum, Pulsatilla (Vulgaris), Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum,	LIQUID	ORAL	20210616		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CHELIDONIUM MAJUS WHOLE; COPPER; CYSTEINE; EUGENOL; FERROUS IODIDE; FORMALDEHYDE; FUCUS VESICULOSUS; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4; IODINE; LIDOCAINE; LYCOPUS VIRGINICUS WHOLE; MANGANESE GLUCONATE; MERCURIUS SOLUBILIS; MOLYBDENUM; MUMPS VIRUS; NICKEL; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PALLADIUM; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM IODIDE; PULSATILLA VULGARIS WHOLE; RUBELLA VIRUS; SILVER; SODIUM DIETHYL OXALACETATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID; TIN; TITANIUM; ZINC	3; 12; 9; 12; 12; 12; 6; 12; 8; 6; 12; 16; 16; 16; 16; 16; 4; 12; 4; 10; 12; 12; 30; 12; 12; 12; 12; 6; 12; 12; 16; 12; 12; 7; 8; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Local Anesthesia [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0604_6524482b-75e7-4ff4-a534-f7ab7e69595e	43857-0604	HUMAN OTC DRUG	Epiforce P-HP		Arsenicum Album, Borax, Graphites, Natrum Muriaticum, Sepia, Sulphur	LIQUID	ORAL	20210615		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; GRAPHITE; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CHLORIDE; SULFUR	30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0605_9df3a5bf-e495-4b00-be98-07a1ae252062	43857-0605	HUMAN OTC DRUG	Spineforce S-HP		Aconitum Napellus, Aesculus Hippocastanum, Colchicum Autumnale, Hypericum Perforatum, Magnesia Phosphorica, Plumbum Metallicum, Rhus Tox, Arnica Montana	LIQUID	ORAL	20210615		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; COLCHICUM AUTUMNALE BULB; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; LEAD; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0606_e6e4e848-fea9-42c4-bef3-f8b7a4ab96f7	43857-0606	HUMAN OTC DRUG	Vermex		Artemisia Vulgaris, Cina, Teucrium Marum, Spigelia Anthelmia, Filix Mas, Calcarea Carbonica, Graphites, Mercurius Corrosivus, Sabadilla, Silicea, Tanacetum Vulgare, Ascaris Lumbricoides, Taenia Solium	LIQUID	ORAL	20210621		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; ASCARIS LUMBRICOIDES; DRYOPTERIS FILIX-MAS ROOT; GRAPHITE; MERCURIC CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SPIGELIA ANTHELMIA WHOLE; TAENIA SOLIUM; TANACETUM VULGARE TOP; TEUCRIUM MARUM WHOLE	3; 3; 30; 7; 12; 12; 12; 12; 12; 6; 30; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0607_c99ad3f8-709f-4653-9a31-65b5fc1cd918	43857-0607	HUMAN OTC DRUG	Cardiacforce		Juglans Nigra, Leonurus Cardiaca, Convallaria Majalis, Magnesia Sulphurica, Iberis Amara, Kali Chloricum, Adonis Vernalis, Digitalis Purpurea, Lycopus Virginicus, Phosphorus	LIQUID	ORAL	20210621		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ADONIS VERNALIS WHOLE; BLACK WALNUT; CONVALLARIA MAJALIS; DIGITALIS; IBERIS AMARA SEED; LEONURUS CARDIACA WHOLE; LYCOPUS VIRGINICUS WHOLE; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; POTASSIUM CHLORATE	10; 3; 4; 12; 6; 3; 12; 4; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
43857-0610_03ded7c3-432a-465e-aaca-42988ff959a4	43857-0610	HUMAN OTC DRUG	DV HP		CALCAREA CARBONICA, CHENOPODIUM ANTHELMINTICUM, COCCULUS INDICUS, CONIUM MACULATUM, NUX VOMICA, PHOSPHORUS, PULSATILLA (VULGARIS), SILICEA	LIQUID	ORAL	20210603		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; DYSPHANIA AMBROSIOIDES WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
43857-0612_ba5d0bdb-6140-4aab-b43d-dcd9346af2ae	43857-0612	HUMAN OTC DRUG	Respiforce A-HP		Arsenicum Album, Belladonna, Ipecacuanha, Kali Carbonicum, Lobelia Inflata, Natrum Sulphuricum, Silicea	LIQUID	ORAL	20210903		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; IPECAC; LOBELIA INFLATA WHOLE; POTASSIUM CARBONATE; SILICON DIOXIDE; SODIUM SULFATE	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
43857-0613_0f8f8c96-d128-4488-b2c4-b099ce604316	43857-0613	HUMAN OTC DRUG	Bio Chem Detox		Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Rhamnus Purshiana, Stillingia Sylvatica, Trifolium Pratense, Triticum Aestivum, Xanthoxylum Fraxineum, Phytolacca Decandra, Glandula Suprarenalis Suis, Hepar Suis, Lymph Node (Suis), Thyroidinum (Suis), Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Aconitum Napellus, Arsenicum Album, Belladonna, Carbo Vegetabilis, Cinchona Officinalis, Conium Maculatum, Mercurius Corrosivus, Phosphorus, Sulphur, Tabacum, Nitricum Acidum, Agaricus Muscarius,	SPRAY	ORAL	20210902		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACONITUM NAPELLUS WHOLE; ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; NITRIC ACID; PHOSPHORIC ACID; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; PHYTOLACCA AMERICANA ROOT; PORK LIVER; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH; SUS SCROFA THYROID; TOBACCO LEAF; TRIFOLIUM PRATENSE FLOWER; TRITICUM AESTIVUM WHOLE; TUBOCURARINE CHLORIDE; ZANTHOXYLUM AMERICANUM BARK	12; 12; 30; 3; 12; 12; 3; 12; 12; 3; 3; 30; 12; 12; 12; 12; 12; 30; 4; 6; 3; 12; 12; 6; 6; 6; 12; 3; 3; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0614_54675edd-b68a-48f9-8550-20753ba5e35a	43857-0614	HUMAN OTC DRUG	Thyroplex		Fucus Vesiculosus, Spongia Tosta, Iodium, Pulsatilla (Vulgaris), Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Levothyroxinum, Calcarea Carbonica, Ferrum Iodatum, Kali Iodatum, Lycopus Virginicus, Phosphoricum Acidum	LIQUID	ORAL	20210729		UNAPPROVED HOMEOPATHIC		BioActive Nutritional	FERROUS IODIDE; FUCUS VESICULOSUS; IODINE; LEVOTHYROXINE; LYCOPUS VIRGINICUS WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; POTASSIUM IODIDE; PULSATILLA VULGARIS WHOLE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; THYROID	12; 3; 6; 10; 12; 12; 12; 12; 6; 3; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
43857-0615_c289422f-6136-4807-b6c4-9f5f242ed7b4	43857-0615	HUMAN OTC DRUG	Neurotox		Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Lycopodium Clavatum, Phosphorus, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum Cerium Metallicum, Cesium Chloride, Chromium, Cobaltum Metallicum, Cuprum Metallicum, Dysprosium Metallicum, Erbium Metallicum, Europium Metallicum, Ferrum Metallicum, Gadolinium Metallicum, Germanium Sesquioxide, Holmium Metallicum,	LIQUID	ORAL	20210722	20260426	UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALUMINUM; AMANITA MUSCARIA FRUITING BODY; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BORON; BOTULINUM TOXIN TYPE A; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CITHARACANTHUS SPINICRUS; CLOSTRIDIUM PERFRINGENS; COBALT; CONIUM MACULATUM FLOWERING TOP; COPPER; DYSPROSIUM; ERBIUM; ESCHERICHIA COLI; EUROPIUM; GADOLINIUM; GELSEMIUM SEMPERVIRENS ROOT; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LATRODECTUS MACTANS; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POLIOVIRUS; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PROTORTONIA CACTI; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SELENIUM; SILVER; STRONTIUM CARBONATE; TANTALUM; TERBIUM; THALLIUM; TIN; TOXICODENDRON PUBESCENS LEAF; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 15; 12; 12; 12; 12; 12; 30; 12; 12; 30; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 30; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 30; 30; 12; 30; 12; 12; 33; 12; 12; 12; 12; 30; 12; 12; 12; 30; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
43857-0617_95895f56-f39d-4813-a21c-bab95a79d582	43857-0617	HUMAN OTC DRUG	Metalogin		Allium Sativum, Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Stillingia Sylvatica, Trifolium Pratense, Phytolacca Decandra, L-Methionine, Thyroidinum (Suis), Selenium Dioxide, Lycopodium Clavatum, Nux Vomica, Lanthanum Oxide, Niobium Metallicum, Tantalum Metallicum, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum	LIQUID	ORAL	20211223		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALUMINUM; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; COBALT; COPPER; DYSPROSIUM; ERBIUM; EUROPIUM; FRANGULA ALNUS BARK; GADOLINIUM; GARLIC; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; GOLD; HOLMIUM; INDIUM; IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MERCURIUS SOLUBILIS; METHIONINE; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHYTOLACCA AMERICANA ROOT; PLATINUM; PRASEODYMIUM; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SELENIUM DIOXIDE; SILVER; STILLINGIA SYLVATICA ROOT; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TANTALUM; TERBIUM; THALLIUM; THYROID; TIN; TRIFOLIUM PRATENSE FLOWER; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 3; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 12; 14; 12; 12; 12; 12; 12; 12; 6; 12; 12; 12; 30; 12; 12; 4; 12; 12; 12; 12; 12; 12; 8; 12; 3; 12; 12; 30; 12; 12; 6; 12; 3; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0619_383829c7-5dba-45f6-bcb0-15f10c742dba	43857-0619	HUMAN OTC DRUG	STOMAPLEX		Carduus Marianus, Gentiana Lutea, Sambucus Nigra, Senna (Cassia Angustifolia), Stomach (Bovine), Arsenicum Album, Atropinum Sulphuricum, Carbo Vegetabilis, Lycopodium Clavatum, Nux Vomica, Phosphorus	LIQUID	ORAL	20211101		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; ATROPINE SULFATE; GENTIANA LUTEA ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP; SENNA LEAF; SILYBUM MARIANUM SEED; STRYCHNOS NUX-VOMICA SEED; TRIPE	12; 12; 12; 3; 12; 12; 3; 3; 3; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Anticholinergic [EPC], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
43857-0629_ec54a5b1-a400-4022-8452-cbb85f0396c3	43857-0629	HUMAN OTC DRUG	Vitalizer		Echinacea (Angustifolia), Iodium, Arsenicum Album, Aurum Metallicum, Calcarea Fluorica, Gallicum Acidum, Hekla Lava, Niccolum Sulphuricum, Phosphorus, Sedum Acre, Sempervivum Tectorum, Senecio Aureus, Blatta Americana, Onosmodium Virginianum	LIQUID	ORAL	20230406		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARSENIC TRIOXIDE; CALCIUM FLUORIDE; ECHINACEA ANGUSTIFOLIA WHOLE; GALLIC ACID MONOHYDRATE; GOLD; HEKLA LAVA; IODINE; NICKEL SULFATE HEXAHYDRATE; ONOSMODIUM VIRGINIANUM; PACKERA AUREA WHOLE; PERIPLANETA AMERICANA; PHOSPHORUS; SEDUM ACRE WHOLE; SEMPERVIVUM TECTORUM LEAF	12; 12; 3; 12; 12; 12; 6; 12; 30; 12; 16; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0630_412443e8-ed75-4750-8449-134d455001b0	43857-0630	HUMAN OTC DRUG	Enviroforce		Sarsaparilla (Smilax Regelii), Xanthoxylum Fraxineum, Phytolacca Decandra, Hydrastis Canadensis, Aurum Metallicum, Carbo Animalis, Causticum, Iodium, Sulphur, Thuja Occidentalis	LIQUID	ORAL	20230410		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	CARBO ANIMALIS; CAUSTICUM; GOLD; GOLDENSEAL; IODINE; PHYTOLACCA AMERICANA ROOT; SMILAX ORNATA ROOT; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; ZANTHOXYLUM AMERICANUM BARK	12; 12; 12; 5; 12; 4; 3; 30; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
43857-0631_610e5fa0-b73b-4643-9f99-bd65d59f8b3f	43857-0631	HUMAN OTC DRUG	Diathesis	IV	Ginkgo Biloba, Fel Tauri, Kidney (Suis), Germanium Sesquioxide, Argentum Metallicum, Cuprum Metallicum, Cysteinum, Aurum Metallicum, Manganese Gluconate, Alpha-Ketoglutaricum Acidum, Fumaricum Acidum, Mercurius Solubilis, Natrum Oxalaceticum, Nux Vomica, Phosphoricum Acidum	LIQUID	ORAL	20230413		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	BOS TAURUS BILE; COPPER; CYSTEINE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; MANGANESE GLUCONATE; MERCURIUS SOLUBILIS; OXOGLURIC ACID; PHOSPHORIC ACID; PORK KIDNEY; SILVER; SODIUM DIETHYL OXALACETATE; STRYCHNOS NUX-VOMICA SEED	6; 9; 9; 12; 8; 6; 9; 10; 12; 12; 12; 6; 9; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
43857-0632_dee504ef-252b-4362-ab03-54f560e3ff92	43857-0632	HUMAN OTC DRUG	Neurotox		Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Lycopodium Clavatum, Phosphorus, Aluminium Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum, Cesium Chloride, Chromium, Cobaltum Metallicum, Cuprum Metallicum, Dysprosium Metallicum, Erbium Metallicum, Europium Metallicum, Ferrum Metallicum, Gadolinium Metallicum, Germanium Sesquioxide,	LIQUID	ORAL	20230809		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ALUMINUM; AMANITA MUSCARIA FRUITING BODY; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BORON; BOTULINUM TOXIN TYPE A; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CITHARACANTHUS SPINICRUS; CLOSTRIDIUM PERFRINGENS; COBALT; CONIUM MACULATUM FLOWERING TOP; COPPER; DYSPROSIUM; ERBIUM; ESCHERICHIA COLI; EUROPIUM; GADOLINIUM; GELSEMIUM SEMPERVIRENS ROOT; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LATRODECTUS MACTANS; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POLIOVIRUS; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PROTORTONIA CACTI; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SAMARIUM; SELENIUM; SILVER; STRONTIUM CARBONATE; TANTALUM; TERBIUM; THALLIUM; TIN; TOXICODENDRON PUBESCENS LEAF; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 15; 12; 12; 12; 12; 12; 30; 12; 12; 30; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 30; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 12; 12; 12; 30; 12; 30; 30; 12; 30; 12; 12; 33; 12; 12; 12; 12; 30; 12; 12; 12; 30; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0633_c9e5e6c3-5ce6-419c-a8e6-33442e1378a9	43857-0633	HUMAN OTC DRUG	Shark Cartilage	12C	Shark Cartilage	LIQUID	ORAL	20230411		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	SHARK CARTILAGE	12	[hp_C]/mL			N	20241231
43857-0634_43082aeb-6e31-4d9e-8dce-a5fd80fe1090	43857-0634	HUMAN OTC DRUG	Renotox		Triticum Aestivum, Asparagus Officinalis, Berberis Vulgaris, Echinacea (Angustifolia), Kali Muriaticum, Petroselinum Sativum, Sabal Serrulata, Solidago Virgaurea, Taraxacum Officinale, Uva-Ursi, Barosma (Betulina), Eupatorium Purpureum, Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum,	LIQUID	ORAL	20231116		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AGATHOSMA BETULINA LEAF; ALUMINUM; ANTIMONY TRISULFIDE; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIOXIDE; ASPARAGUS; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BOTULINUM TOXIN TYPE A; BROMINE; BRYONIA ALBA ROOT; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; CLOSTRIDIUM PERFRINGENS; COBALT; COPPER; DYSPROSIUM; ECHINACEA ANGUSTIFOLIA WHOLE; ERBIUM; ESCHERICHIA COLI; EUROPIUM; EUTROCHIUM PURPUREUM ROOT; GADOLINIUM; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; HUMAN HERPESVIRUS 4; INDIUM; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; MAGNESIUM; MANGANESE; MEASLES VIRUS; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PETROSELINUM CRISPUM WHOLE; PLATINUM; POLIOVIRUS; PORK KIDNEY; POTASSIUM CHLORIDE; PRASEODYMIUM; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RHODIUM; RUBIDIUM NITRITE; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; SAMARIUM; SAW PALMETTO; SELENIUM; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; TANTALUM; TARAXACUM OFFICINALE; TERBIUM; THALLIUM; TIN; TRITICUM AESTIVUM WHOLE; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	5; 12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 19; 12; 12; 12; 3; 12; 30; 12; 6; 12; 12; 12; 12; 30; 12; 30; 30; 30; 30; 12; 14; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 30; 12; 12; 3; 12; 30; 8; 3; 12; 30; 30; 30; 12; 12; 33; 12; 3; 12; 12; 3; 12; 30; 3; 12; 12; 12; 1; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Mood Stabilizer [EPC], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
43857-0635_e43fdffb-1196-4de8-b788-a9bd91458b27	43857-0635	HUMAN OTC DRUG	Grain and Seed Antigens		Amaranth, Bamboo, Barley, Buckwheat, Corn, Flax Seed, Lentils, Millet, Milo, Oat, Poppy Seed, Rice, Rye, Sesame, Soybean, Sugarcane, Sunflower Seed, Wheat, Arsenicum Album, Lycopodium Clavatum, Natrum Muriaticum, Sulphur	LIQUID	ORAL	20230620		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	AMARANTHUS CRUENTUS SEED; ARSENIC TRIOXIDE; BAMBUSA VULGARIS STEM; BARLEY; BUCKWHEAT; CORN; FLAX SEED; LENTIL; LYCOPODIUM CLAVATUM SPORE; MILLET; OAT; POPPY SEED; RYE; SESAME SEED; SODIUM CHLORIDE; SORGHUM BICOLOR WHOLE; SOYBEAN; SUCROSE; SULFUR; SUNFLOWER SEED; WHEAT; WHITE RICE	9; 12; 9; 9; 9; 9; 9; 9; 12; 9; 9; 9; 9; 9; 12; 9; 9; 9; 12; 9; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]	CII	N	20241231
43857-0636_c6b2d570-cc46-41fc-97f8-2734223ad76e	43857-0636	HUMAN OTC DRUG	Lipotox		Squalene, Cholesterinum, Estradiol, Progesterone, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum, Arsenicum Album, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Aceticum Acidum, Benzoicum Acidum, Benzyl Alcohol, Boricum Acidum, Chlorinum, Cortisone Aceticum, Eugenol, Folliculinum, Isopropyl Palmitate, Lacticum Acidum, Petroleum Jelly, Phenyl Butazone, Plumbum Metallicum,	LIQUID	ORAL	20230905		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ACETIC ACID; ANHYDROUS TRISODIUM CITRATE; ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BENZOIC ACID; BENZYL ALCOHOL; BORIC ACID; CHLORINE; CHOLESTEROL; CORTICOTROPIN; CORTISONE ACETATE; ESTRADIOL; ESTRONE; EUGENOL; FORMALDEHYDE SOLUTION; ISOPROPYL PALMITATE; LACTIC ACID, DL-; LEAD; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROLATUM; PHENYLBUTAZONE; PHOSPHORIC ACID; PHOSPHORUS; POTASSIUM SORBATE; PROGESTERONE; PROPYLPARABEN; RESORCINOL; SALICYLIC ACID; SODIUM BENZOATE; SORBITOL; SQUALENE; STEARYL ALCOHOL; STRYCHNOS NUX-VOMICA SEED; TITANIUM DIOXIDE; XYLITOL; ZINC OXIDE	30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 30; 30; 30; 8; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Pediculicide [EPC], Plant Proteins [CS], Progesterone [CS], Progesterone [EPC], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
43857-0637_32191a56-ab8f-4c57-a02f-3ba568affcb3	43857-0637	HUMAN OTC DRUG	CV TOX		Cochlearia Armoracia, Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Bovine, Thymus (Suis), Aranea Diadema, Ipecacuanha, Lycopodium Clavatum, Muriaticum Acidum, Nitricum Acidum, Phosphoricum Acidum, Rhus Tox, Silicea, Epstein-Barr Virus Nosode, Herpes Zoster Nosode, Morbillinum, Poliomyelitis Nosode, Hepatitis B Nosode, Coxsackie B1 Nosode, Cytomegalovirus Nosode, Coxsackie B4 Nosode, Epstein Barr Virus Nosode	LIQUID	ORAL	20231107		UNAPPROVED HOMEOPATHIC		BioActive Nutritional, Inc.	ARANEUS DIADEMATUS; BOS TAURUS ADRENAL GLAND; ECHINACEA ANGUSTIFOLIA WHOLE; GOLDENSEAL; HANDROANTHUS IMPETIGINOSUS BARK; HEPATITIS B VIRUS; HORSERADISH; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HYDROCHLORIC ACID; IPECAC; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; MEASLES VIRUS; NITRIC ACID; PHOSPHORIC ACID; POLIOVIRUS; PROPOLIS WAX; SILICON DIOXIDE; SUS SCROFA THYMUS; TOXICODENDRON PUBESCENS LEAF	12; 8; 3; 5; 3; 33; 3; 15; 24; 30; 30; 16; 12; 12; 3; 12; 30; 12; 12; 30; 6; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
43975-277_f64f7541-e9b1-4c3c-8bc5-378e25f590ee	43975-277	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	ANI Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43975-278_f64f7541-e9b1-4c3c-8bc5-378e25f590ee	43975-278	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	ANI Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43975-279_f64f7541-e9b1-4c3c-8bc5-378e25f590ee	43975-279	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	ANI Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43975-280_f64f7541-e9b1-4c3c-8bc5-378e25f590ee	43975-280	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	ANI Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43975-281_f64f7541-e9b1-4c3c-8bc5-378e25f590ee	43975-281	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	ANI Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43975-282_f64f7541-e9b1-4c3c-8bc5-378e25f590ee	43975-282	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	ANI Pharmaceuticals, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
43975-305_da322eb5-597d-4419-98b9-e38a369a9b32	43975-305	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180501		ANDA	ANDA209504	ANI Pharmaceuticals, Inc.	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43975-306_da322eb5-597d-4419-98b9-e38a369a9b32	43975-306	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180501		ANDA	ANDA209504	ANI Pharmaceuticals, Inc.	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
43975-310_24d74b6d-77d6-4804-a0f4-7b936ca7e4dc	43975-310	HUMAN PRESCRIPTION DRUG	MIGLUSTAT		MIGLUSTAT	CAPSULE	ORAL	20180417		ANDA	ANDA208342	ANI Pharmaceuticals, Inc.	MIGLUSTAT	100	mg/1	Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA]		N	20241231
43975-315_35ec854a-af3a-46a0-9c06-171a522628e4	43975-315	HUMAN PRESCRIPTION DRUG	Bexarotene		Bexarotene	CAPSULE, LIQUID FILLED	ORAL	20180510		ANDA	ANDA209861	ANI Pharmaceuticals, Inc.	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
43975-322_ba54a9d0-25e3-406f-b721-58e4fa2d8cb0	43975-322	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20190829		ANDA	ANDA204562	ANI Pharmaceuticals, Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43975-323_ba54a9d0-25e3-406f-b721-58e4fa2d8cb0	43975-323	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20190829		ANDA	ANDA204562	ANI Pharmaceuticals, Inc.	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
43975-349_2f74d7e1-f10c-460d-9a71-a136ba5e2f05	43975-349	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		PALIPERIDONE	TABLET, EXTENDED RELEASE	ORAL	20191127		ANDA	ANDA204452	ANI Pharmaceuticals, Inc.	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43975-350_2f74d7e1-f10c-460d-9a71-a136ba5e2f05	43975-350	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		PALIPERIDONE	TABLET, EXTENDED RELEASE	ORAL	20191127		ANDA	ANDA204452	ANI Pharmaceuticals, Inc.	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43975-351_2f74d7e1-f10c-460d-9a71-a136ba5e2f05	43975-351	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		PALIPERIDONE	TABLET, EXTENDED RELEASE	ORAL	20191127		ANDA	ANDA204452	ANI Pharmaceuticals, Inc.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43975-352_2f74d7e1-f10c-460d-9a71-a136ba5e2f05	43975-352	HUMAN PRESCRIPTION DRUG	PALIPERIDONE		PALIPERIDONE	TABLET, EXTENDED RELEASE	ORAL	20191127		ANDA	ANDA204452	ANI Pharmaceuticals, Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
43975-444_da322eb5-597d-4419-98b9-e38a369a9b32	43975-444	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180501		ANDA	ANDA209504	ANI Pharmaceuticals, Inc.	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
44076-006_07110cac-0e92-4e2f-e063-6394a90ae84d	44076-006	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20070401		NDA	NDA205839	American Welding & Gas	NITROGEN	990	mL/L			N	20241231
44076-010_0710d07a-abdf-b460-e063-6294a90a62d2	44076-010	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19870401		NDA	NDA205840	American Welding & Gas, Inc.	OXYGEN	990	mL/L			N	20241231
44076-012_07111e28-b594-502d-e063-6394a90a60fa	44076-012	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20140501		NDA	NDA205704	American Welding & Gas	NITROUS OXIDE	990	mL/L			N	20241231
44076-020_0710e208-5b33-3c72-e063-6394a90a4dac	44076-020	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20061101		NDA	NDA205821	American Welding & Gas, Inc.	AIR	1000	mL/L			N	20241231
44076-021_0710c649-799d-25b5-e063-6294a90a82bb	44076-021	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20131017		NDA	NDA205846	American Welding & Gas, Inc.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
44076-107_07111e28-b593-502d-e063-6394a90a60fa	44076-107	HUMAN PRESCRIPTION DRUG	reconstituted Air		reconstituted Air	GAS	RESPIRATORY (INHALATION)	20190213		NDA	NDA205865	AMERICAN WELDING & GAS, INC.	OXYGEN	210	mL/L			N	20241231
44087-0004_40a8b335-3874-4c7c-a332-ae94dd7a48e8	44087-0004	HUMAN PRESCRIPTION DRUG	Serostim		somatropin	KIT	SUBCUTANEOUS	19970725		BLA	BLA020604	EMD Serono, Inc.						N	20241231
44087-0005_40a8b335-3874-4c7c-a332-ae94dd7a48e8	44087-0005	HUMAN PRESCRIPTION DRUG	Serostim		somatropin	KIT	SUBCUTANEOUS	19960823		BLA	BLA020604	EMD Serono, Inc.						N	20241231
44087-0006_40a8b335-3874-4c7c-a332-ae94dd7a48e8	44087-0006	HUMAN PRESCRIPTION DRUG	Serostim		somatropin	KIT	SUBCUTANEOUS	19960823		BLA	BLA020604	EMD Serono, Inc.						N	20241231
44087-0022_348c7db6-5713-4329-83ca-14925b9b1d69	44087-0022	HUMAN PRESCRIPTION DRUG	REBIF		INTERFERON BETA-1A	INJECTION, SOLUTION	SUBCUTANEOUS	20020307		BLA	BLA103780	EMD Serono, Inc.	INTERFERON BETA-1A	22	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
44087-0044_348c7db6-5713-4329-83ca-14925b9b1d69	44087-0044	HUMAN PRESCRIPTION DRUG	REBIF		interferon beta-1a	INJECTION, SOLUTION	SUBCUTANEOUS	20020307		BLA	BLA103780	EMD Serono, Inc.	INTERFERON BETA-1A	44	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
44087-0188_348c7db6-5713-4329-83ca-14925b9b1d69	44087-0188	HUMAN PRESCRIPTION DRUG	REBIF REBIDOSE		INTERFERON BETA-1A	KIT	SUBCUTANEOUS	20121221		BLA	BLA103780	EMD Serono, Inc.						N	20241231
44087-1005_72b22c05-86fd-4b4e-bb7b-ec7e4fb40316	44087-1005	HUMAN PRESCRIPTION DRUG	Saizen		somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	19961008	20241031	BLA	BLA019764	EMD Serono, Inc.						N	
44087-1088_72b22c05-86fd-4b4e-bb7b-ec7e4fb40316	44087-1088	HUMAN PRESCRIPTION DRUG	Saizen		somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20000829	20240331	BLA	BLA019764	EMD Serono, Inc.						N	
44087-1115_9eed7780-b44a-4b04-999e-3561e2d1f7bc	44087-1115	HUMAN PRESCRIPTION DRUG	Gonal-f RFF Redi-ject		FOLLITROPIN	INJECTION, SOLUTION	SUBCUTANEOUS	20131016		BLA	BLA021684	EMD Serono, Inc.	FOLLITROPIN	300	[iU]/.5mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
44087-1116_9eed7780-b44a-4b04-999e-3561e2d1f7bc	44087-1116	HUMAN PRESCRIPTION DRUG	Gonal-f RFF Redi-ject		FOLLITROPIN	INJECTION, SOLUTION	SUBCUTANEOUS	20131016		BLA	BLA021684	EMD Serono, Inc.	FOLLITROPIN	450	[iU]/.75mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
44087-1117_9eed7780-b44a-4b04-999e-3561e2d1f7bc	44087-1117	HUMAN PRESCRIPTION DRUG	Gonal-f RFF Redi-ject		FOLLITROPIN	INJECTION, SOLUTION	SUBCUTANEOUS	20131016		BLA	BLA021684	EMD Serono, Inc.	FOLLITROPIN	900	[iU]/1.5mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
44087-1150_59d39f88-54fb-480a-979b-4d3d2c7c2cd4	44087-1150	HUMAN PRESCRIPTION DRUG	Ovidrel		choriogonadotropin alfa	INJECTION, SOLUTION	SUBCUTANEOUS	20031006		BLA	BLA021149	EMD Serono, Inc.	CHORIOGONADOTROPIN ALFA	250	ug/.5mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
44087-1225_a8b8db6f-e44f-438b-a40f-82107b88ef17	44087-1225	HUMAN PRESCRIPTION DRUG	Cetrotide		cetrorelix acetate	KIT	SUBCUTANEOUS	20000811		NDA	NDA021197	EMD Serono, Inc.						N	20241231
44087-3322_348c7db6-5713-4329-83ca-14925b9b1d69	44087-3322	HUMAN PRESCRIPTION DRUG	REBIF REBIDOSE		INTERFERON BETA-1A	INJECTION, SOLUTION	SUBCUTANEOUS	20121221		BLA	BLA103780	EMD Serono, Inc.	INTERFERON BETA-1A	22	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
44087-3344_348c7db6-5713-4329-83ca-14925b9b1d69	44087-3344	HUMAN PRESCRIPTION DRUG	REBIF REBIDOSE		INTERFERON BETA-1A	INJECTION, SOLUTION	SUBCUTANEOUS	20121221		BLA	BLA103780	EMD Serono, Inc.	INTERFERON BETA-1A	44	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
44087-3535_6e2d43a3-17bf-4023-9969-67077115fb13	44087-3535	HUMAN PRESCRIPTION DRUG	BAVENCIO		avelumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170323		BLA	BLA761049	EMD Serono, Inc.	AVELUMAB	20	mg/mL	Antibodies, Monoclonal [CS], Programmed Death Ligand-1 Antagonists [MoA], Programmed Death Ligand-1 Blocker [EPC], Programmed Death Ligand-1-directed Antibody Interactions [MoA]		N	20241231
44087-4000_2d9dd367-e8c5-4a72-b4d2-ac0ee19d79e7	44087-4000	HUMAN PRESCRIPTION DRUG	Mavenclad		Cladribine	TABLET	ORAL	20190401		NDA	NDA022561	EMD Serono, Inc.	CLADRIBINE	10	mg/1	Purine Antimetabolite [EPC]		N	20241231
44087-5000_62f8cbc0-f0de-4ba0-a355-a0b01331e02f	44087-5000	HUMAN PRESCRIPTION DRUG	TEPMETKO		Tepotinib Hydrochloride	TABLET	ORAL	20210203		NDA	NDA214096	EMD Serono, Inc.	TEPOTINIB HYDROCHLORIDE	225	mg/1	Kinase Inhibitor [EPC], Mesenchymal Epithelial Transition Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
44087-8822_348c7db6-5713-4329-83ca-14925b9b1d69	44087-8822	HUMAN PRESCRIPTION DRUG	Rebif		interferon beta-1a	KIT	SUBCUTANEOUS	20041217		BLA	BLA103780	EMD Serono, Inc.						N	20241231
44087-9005_44049ae1-852a-4342-9505-7216f0c28d1c	44087-9005	HUMAN PRESCRIPTION DRUG	GONAL-F RFF		follitropin alfa	KIT	SUBCUTANEOUS	20040325		BLA	BLA021765	EMD Serono, Inc.						N	20241231
44087-9030_90675969-128b-48cd-8011-725c0e975405	44087-9030	HUMAN PRESCRIPTION DRUG	Gonal-f		follitropin alfa	KIT	SUBCUTANEOUS	20040325		BLA	BLA020378	EMD Serono, Inc.						N	20241231
44087-9070_90675969-128b-48cd-8011-725c0e975405	44087-9070	HUMAN PRESCRIPTION DRUG	Gonal-f		follitropin alfa	KIT	SUBCUTANEOUS	20040325		BLA	BLA020378	EMD Serono, Inc.						N	20241231
44099-011_087b1d76-5fcc-25ac-e063-6394a90a822f	44099-011	HUMAN OTC DRUG	skin MD		octinoxate, octisalate, homosalate	LOTION	TOPICAL	20080819		OTC MONOGRAPH DRUG	M020	21st Century Formulations	HOMOSALATE; OCTINOXATE; OCTISALATE	3; 7; 5	mg/100mL; mg/100mL; mg/100mL			N	20241231
44117-0002_0d0022f3-9676-4fa7-b349-8d0ce26d1f1f	44117-0002	HUMAN OTC DRUG	Testosterone		Testosterone,	TABLET	ORAL	20140429		UNAPPROVED HOMEOPATHIC		Zoe Processing	TESTOSTERONE	30	[hp_X]/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
44118-700_d91769aa-ca47-567f-e053-2a95a90a664b	44118-700	HUMAN PRESCRIPTION DRUG	Plexion		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20220228		UNAPPROVED DRUG OTHER		Eckson Labs, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44118-701_db71ee55-bbde-0996-e053-2a95a90a5687	44118-701	HUMAN PRESCRIPTION DRUG	Plexion		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20220330		UNAPPROVED DRUG OTHER		Eckson Labs LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44118-702_db7601fa-a47c-bb58-e053-2995a90aa123	44118-702	HUMAN PRESCRIPTION DRUG	Plexion		SULFACETAMIDE SODIUM, SULFUR	CLOTH	TOPICAL	20220330		UNAPPROVED DRUG OTHER		Eckson Labs LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44118-703_db747368-d45e-64e3-e053-2995a90a1fb8	44118-703	HUMAN PRESCRIPTION DRUG	Plexion		SULFACETAMIDE SODIUM, SULFUR	LOTION	TOPICAL	20220330		UNAPPROVED DRUG OTHER		Eckson Labs LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44118-704_db751fea-59d8-314c-e053-2a95a90ae382	44118-704	HUMAN PRESCRIPTION DRUG	Vytone		HYDROCORTISONE ACETATE, IODOQUINOL	CREAM	TOPICAL	20220330		UNAPPROVED DRUG OTHER		Eckson Labs LLC	HYDROCORTISONE ACETATE; IODOQUINOL	19; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
44118-712_d7af39fc-190c-6c97-e053-2995a90adc80	44118-712	HUMAN PRESCRIPTION DRUG	PLEXION NS		SULFACETAMIDE SODIUM	SHAMPOO	TOPICAL	20211006		UNAPPROVED DRUG OTHER		Eckson Labs, LLC	SULFACETAMIDE SODIUM	98	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44118-807_04c70e1e-a02c-879a-e063-6394a90a13fb	44118-807	HUMAN PRESCRIPTION DRUG	Duet DHA	400	.BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, IRON, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC OXIDE, IODINE, OMEGA-3 FATTY ACIDS	KIT	ORAL	20110909	20240430	UNAPPROVED DRUG OTHER		Eckson Labs, LLC						N	
44118-902_04c70780-c6d6-8843-e063-6394a90a7caf	44118-902	HUMAN PRESCRIPTION DRUG	NataChew		.BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, D-, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, IRON, NIACINAMIDE	TABLET, CHEWABLE	ORAL	20121015	20240731	UNAPPROVED DRUG OTHER		Eckson Labs, LLC	.ALPHA.-TOCOPHEROL ACETATE, D-; .BETA.-CAROTENE; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; IRON; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE	20; 2700; 120; 400; 12; 1; 28; 20; 10; 3; 2	[iU]/1; [iU]/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	
44119-012_0bd687c7-383d-067f-e063-6294a90a3ede	44119-012	HUMAN OTC DRUG	Antibacterial Hand Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210401		OTC MONOGRAPH DRUG	505G(a)(3)	Peachtree Playthings, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
44183-103_d37c2dc8-b1d0-480e-9116-a6a3b1763a56	44183-103	HUMAN PRESCRIPTION DRUG	doxepin hydrochloride		doxepin hydrochloride	TABLET	ORAL	20100801		NDA AUTHORIZED GENERIC	NDA022036	Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
44183-106_d37c2dc8-b1d0-480e-9116-a6a3b1763a56	44183-106	HUMAN PRESCRIPTION DRUG	doxepin hydrochloride		doxepin hydrochloride	TABLET	ORAL	20100801		NDA AUTHORIZED GENERIC	NDA022036	Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
44183-850_b5658abd-46a6-4927-8824-ea7cfe83141a	44183-850	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate and Naproxen Sodium		sumatriptan succinate and naproxen sodium	TABLET	ORAL	20150514		NDA AUTHORIZED GENERIC	NDA021926	Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500; 85	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
44206-251_4ab3fa50-584a-43fd-a729-472240f3dc3f	44206-251	PLASMA DERIVATIVE	AlbuRx		ALBUMIN (HUMAN)	SOLUTION	INTRAVENOUS	20090106		BLA	BLA102366	CSL Behring AG	ALBUMIN HUMAN	12.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
44206-300_c700c02c-6b75-40f0-be58-0bbd38beda68	44206-300	PLASMA DERIVATIVE	Rhophylac		HUMAN RHO(D) IMMUNE GLOBULIN	SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20090106		BLA	BLA125070	CSL Behring AG	HUMAN RHO(D) IMMUNE GLOBULIN	1500	[iU]/2mL	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-310_570bfd23-8f64-45f1-9ad4-c07a6e310c12	44206-310	PLASMA DERIVATIVE	ALBURX		ALBUMIN (HUMAN)	SOLUTION	INTRAVENOUS	20090106		BLA	BLA102366	CSL Behring AG	ALBUMIN HUMAN	12.5	g/250mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
44206-436_d824e968-5441-417e-be92-0b74bbfb78cc	44206-436	PLASMA DERIVATIVE	Privigen		Human Immunoglobulin G	LIQUID	INTRAVENOUS	20090120		BLA	BLA125201	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	5	g/50mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-437_d824e968-5441-417e-be92-0b74bbfb78cc	44206-437	PLASMA DERIVATIVE	Privigen		Human Immunoglobulin G	LIQUID	INTRAVENOUS	20090120		BLA	BLA125201	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	10	g/100mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-438_d824e968-5441-417e-be92-0b74bbfb78cc	44206-438	PLASMA DERIVATIVE	Privigen		Human Immunoglobulin G	LIQUID	INTRAVENOUS	20090120		BLA	BLA125201	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	20	g/200mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-439_d824e968-5441-417e-be92-0b74bbfb78cc	44206-439	PLASMA DERIVATIVE	Privigen		Human Immunoglobulin G	LIQUID	INTRAVENOUS	20090120		BLA	BLA125201	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	40	g/400mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-451_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264	44206-451	PLASMA DERIVATIVE	Hizentra		HUMAN IMMUNOGLOBULIN G	LIQUID	SUBCUTANEOUS	20111003		BLA	BLA125350	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	.2	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-452_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264	44206-452	PLASMA DERIVATIVE	Hizentra		HUMAN IMMUNOGLOBULIN G	LIQUID	SUBCUTANEOUS	20111003		BLA	BLA125350	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	.2	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-454_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264	44206-454	PLASMA DERIVATIVE	Hizentra		HUMAN IMMUNOGLOBULIN G	LIQUID	SUBCUTANEOUS	20111003		BLA	BLA125350	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	.2	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-455_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264	44206-455	PLASMA DERIVATIVE	Hizentra		HUMAN IMMUNOGLOBULIN G	LIQUID	SUBCUTANEOUS	20111003		BLA	BLA125350	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	.2	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-456_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264	44206-456	PLASMA DERIVATIVE	Hizentra		HUMAN IMMUNOGLOBULIN G	LIQUID	SUBCUTANEOUS	20200101		BLA	BLA125350	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	.2	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-457_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264	44206-457	PLASMA DERIVATIVE	Hizentra		HUMAN IMMUNOGLOBULIN G	LIQUID	SUBCUTANEOUS	20200101		BLA	BLA125350	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	.2	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44206-458_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264	44206-458	PLASMA DERIVATIVE	Hizentra		HUMAN IMMUNOGLOBULIN G	LIQUID	SUBCUTANEOUS	20200101		BLA	BLA125350	CSL Behring AG	HUMAN IMMUNOGLOBULIN G	.2	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
44224-0156_0d708d7f-42ef-5db7-e063-6294a90ac34e	44224-0156	HUMAN OTC DRUG	After Bite Outdoor		Diphenhydramine HCl	GEL	TOPICAL	20180301	20241231	OTC MONOGRAPH DRUG	M017	Tender Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	20	mg/g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
44224-0160_0ab01ace-ca88-9d6e-e063-6294a90aeab4	44224-0160	HUMAN OTC DRUG	Easy Care First Aid Eyewash		Water	SOLUTION	OPHTHALMIC	20110912		NDA	NDA022305	Tender Corporation	WATER	929	g/946mL			N	20241231
44224-0166_f2a30cca-7ee5-6d2d-e053-2a95a90ad511	44224-0166	HUMAN OTC DRUG	After Bite Natural		OATMEAL, CAMPHOR (NATURAL)	SALVE	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part348	Adventure Ready Brands	CAMPHOR (NATURAL); OATMEAL	10; 100	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
44224-0176_0d706571-03d0-3bd1-e063-6394a90a11ae	44224-0176	HUMAN OTC DRUG	After Bite Plus		Diphenhydramine HCl	GEL	TOPICAL	20180301	20241231	OTC MONOGRAPH DRUG	M017	Tender Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	20	mg/g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
44224-0240_0d70baea-34d8-4d7a-e063-6394a90a1e0b	44224-0240	HUMAN OTC DRUG	The Itch Eraser		Diphenhydramine HCl	GEL	TOPICAL	20180301	20241231	OTC MONOGRAPH DRUG	M017	Tender Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	20	mg/g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
44224-1040_f2a339ca-cdf2-1899-e053-2a95a90acbb7	44224-1040	HUMAN OTC DRUG	After Bite X Tech		SODIUM BICARBONATE	LIQUID	TOPICAL	20230101		OTC MONOGRAPH FINAL	M016	Adventure Ready Brands	SODIUM BICARBONATE	50	mg/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
44278-025_bae5580d-5d5e-716c-e053-2a95a90ac2c3	44278-025	HUMAN PRESCRIPTION DRUG	Exemestane		EXEMESTANE	TABLET	ORAL	20131122		ANDA	ANDA200898	Eirgen Pharma Ltd	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
44356-0001_0a978e6e-ff40-3415-e063-6294a90ad828	44356-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20090926		UNAPPROVED MEDICAL GAS		Dona Ana Medical Supply	OXYGEN	99	L/100L			N	20241231
44363-1815_24a0b7ca-e72c-4fbb-acf8-5c7ea431ab71	44363-1815	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19880101		NDA	NDA205767	Institutional Care Pharmacy	OXYGEN	99	L/100L			N	20241231
44385-7014_c77b5070-4650-77d1-e053-2a95a90a779d	44385-7014	HUMAN OTC DRUG	Nice n Clean Wipes Sani-Hands Antibacterial Hand Wipes		Benzalkonium Chloride Hand Wipes	SWAB	TOPICAL	20201220		OTC MONOGRAPH NOT FINAL	part333A	Nice-Pak Products, Inc.	BENZALKONIUM CHLORIDE	.13	mg/mL			N	20241231
44385-7022_fceaa382-4843-6cda-e053-6294a90ab6b5	44385-7022	HUMAN OTC DRUG	NICE N CLEAN WIPES SANI-HANDS SANITIZING HAND WIPES		ALCOHOL	SWAB	TOPICAL	20210322		OTC MONOGRAPH NOT FINAL	part333E	Nice-Pak Products, Inc.	ALCOHOL	.7	mL/mL			N	20241231
44517-001_e1ca81a7-7796-4dab-bf48-ca66dca5a90b	44517-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20081201		NDA	NDA205889	Corrigan Propane LLC dba Blue Water Industrial Products	OXYGEN	99	L/100L			N	20241231
44517-010_e6a021a2-ae66-4ac2-a2e4-51617c089bbb	44517-010	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20081201		NDA	NDA205891	Corrigan Propane LLC dba Blue Water Industrial Products	NITROGEN	99	L/100L			N	20241231
44517-020_ec1098d3-11e4-47c4-ae10-013af31ccfd0	44517-020	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	20081201		NDA	NDA209989	Corrigan Propane LLC dba Blue Water Industrial Products	NITROUS OXIDE	99	L/100L			N	20241231
44523-120_0983c0a4-94fd-eaa8-e063-6394a90a5238	44523-120	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	SOLUTION	ORAL	20231130		ANDA	ANDA078974	BioComp Pharma, Inc.	GABAPENTIN	250	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
44523-510_f7e4da5a-b00f-c32c-e053-6294a90a74aa	44523-510	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide		Sodium Sulfacetamide	SHAMPOO	TOPICAL	20110915		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-520_f7988dc4-d3ab-6b5c-e053-6294a90a038f	44523-520	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide, Sulfur		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20110915		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-535_09921c9b-ad4d-c843-e063-6394a90a3dc3	44523-535	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide, Sulfur		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20110915		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-542_f7986b08-7653-ebba-e053-6294a90a0206	44523-542	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide, Sulfur		SULFACETAMIDE SODIUM	CREAM	TOPICAL	20110915		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-550_f798f8d7-639f-2a12-e053-6294a90a00fb	44523-550	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide, Sulfur		SULFACETAMIDE SODIUM, SULFUR	EMULSION	TOPICAL	20110915		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-560_09910b22-d48a-4d9b-e063-6394a90a50ea	44523-560	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM, SULFUR		SULFACETAMIDE SODIUM, SULFUR	EMULSION	TOPICAL	20110915		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-568_f79829b8-9eab-703f-e053-6294a90aaf15	44523-568	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM		SULFACETAMIDE SODIUM	LIQUID	TOPICAL	20110915		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-602_f7993689-bf1d-56b7-e053-6394a90af46b	44523-602	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE AND SULFUR		SULFACETAMIDE SODIUM, SULFUR	LOTION	TOPICAL	20110430		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-603_f7992356-ed95-ad2f-e053-6294a90a8281	44523-603	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE AND SULFUR		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20110430		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-604_f79914d3-c3c4-8601-e053-6294a90aefb3	44523-604	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		sulfacetamide sodium, sulfur	SUSPENSION	TOPICAL	20110604		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-605_f7e45f8b-a93c-26b4-e053-6394a90a841e	44523-605	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE AND SULFUR		sodium sulfacetamide, sulfur	LOTION	TOPICAL	20110415		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM; SULFUR	90; 45	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44523-613_f7e4cac5-e0b3-b203-e053-6294a90ac08b	44523-613	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE		SODIUM SULFACETAMIDE	LIQUID	TOPICAL	20110907		UNAPPROVED DRUG OTHER		BioComp Pharma, Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
44567-101_5a2e3b50-6f08-4a78-9cb2-d60b63cef5c9	44567-101	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120510		ANDA	ANDA062772	WG Critical Care, LLC	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-102_5a2e3b50-6f08-4a78-9cb2-d60b63cef5c9	44567-102	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120510		ANDA	ANDA062772	WG Critical Care, LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-103_5a2e3b50-6f08-4a78-9cb2-d60b63cef5c9	44567-103	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120510		ANDA	ANDA062772	WG Critical Care, LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-104_32e9c928-ae3c-444c-8240-2c72542181fb	44567-104	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120510		ANDA	ANDA063142	WG Critical Care, LLC	AMPICILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-120_e1a06916-d1e5-4abe-8702-1c1f6136e51b	44567-120	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190423		ANDA	ANDA065303	WG Critical Care, LLC	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-130_a58c99bd-b70a-4a7f-be6c-d08c36104899	44567-130	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210331		ANDA	ANDA065441	WG Critical Care, LLC	CEFEPIME HYDROCHLORIDE	1	g/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-131_a58c99bd-b70a-4a7f-be6c-d08c36104899	44567-131	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210331		ANDA	ANDA065441	WG Critical Care, LLC	CEFEPIME HYDROCHLORIDE	2	g/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-145_11738a60-a608-4ca0-87da-fd4afeae86f1	44567-145	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210630		ANDA	ANDA210773	WG Critical Care, LLC	MEROPENEM	500	mg/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
44567-146_11738a60-a608-4ca0-87da-fd4afeae86f1	44567-146	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210630		ANDA	ANDA210773	WG Critical Care, LLC	MEROPENEM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
44567-150_2dcc80dc-0d0b-4463-b8b0-e20d9337570b	44567-150	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20211130		ANDA	ANDA201406	WG Critical Care, LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-210_e9b60100-c832-41d8-9fd6-74e3a41b0e7a	44567-210	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051130		ANDA	ANDA065176	WG Critical Care, LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-211_e9b60100-c832-41d8-9fd6-74e3a41b0e7a	44567-211	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051130		ANDA	ANDA065176	WG Critical Care, LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-212_25b5e3a6-c538-4e84-b524-6e93d60ef4d4	44567-212	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20051125		ANDA	ANDA065188	WG Critical Care, LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	10; 5	g/100mL; g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-221_1d3972eb-3c35-4e3f-81b7-0a28b58c75a4	44567-221	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130118		ANDA	ANDA090560	WG Critical Care, LLC	NAFCILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-222_1d3972eb-3c35-4e3f-81b7-0a28b58c75a4	44567-222	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130118		ANDA	ANDA090560	WG Critical Care, LLC	NAFCILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-223_c7d4ca5b-202d-4ba3-adfa-4eccf19d2d47	44567-223	HUMAN PRESCRIPTION DRUG	Nafcillin		NAFCILLIN	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20110427		ANDA	ANDA090005	WG Critical Care, LLC	NAFCILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-235_fa5dc130-c774-440f-94f6-ea404c0e5ddb	44567-235	HUMAN PRESCRIPTION DRUG	Ceftazidime		Ceftazidime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130131		ANDA	ANDA062640	WG Critical Care, LLC	CEFTAZIDIME	1	g/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-236_fa5dc130-c774-440f-94f6-ea404c0e5ddb	44567-236	HUMAN PRESCRIPTION DRUG	Ceftazidime		Ceftazidime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20130131		ANDA	ANDA062640	WG Critical Care, LLC	CEFTAZIDIME	2	g/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-237_a225696b-a8e8-45cc-a329-9f312e03ea1a	44567-237	HUMAN PRESCRIPTION DRUG	Ceftazidime		Ceftazidime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20130131		ANDA	ANDA062640	WG Critical Care, LLC	CEFTAZIDIME	6	g/100mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-240_73cdc3cc-f577-4701-b3d9-0e74f75ea395	44567-240	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20141010		ANDA	ANDA065441	WG Critical Care, LLC	CEFEPIME HYDROCHLORIDE	1	g/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-241_73cdc3cc-f577-4701-b3d9-0e74f75ea395	44567-241	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20141010		ANDA	ANDA065441	WG Critical Care, LLC	CEFEPIME HYDROCHLORIDE	2	g/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-245_ef372f1b-7f38-45fc-a84d-bafd41970b87	44567-245	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170710		ANDA	ANDA065414	WG Critical Care, LLC	CEFOXITIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-245_fa6d5377-af57-45a8-aa38-685877c809a7	44567-245	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20150218		ANDA	ANDA065414	WG Critical Care, LLC	CEFOXITIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-246_ef372f1b-7f38-45fc-a84d-bafd41970b87	44567-246	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170710		ANDA	ANDA065414	WG Critical Care, LLC	CEFOXITIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-246_fa6d5377-af57-45a8-aa38-685877c809a7	44567-246	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20150218		ANDA	ANDA065414	WG Critical Care, LLC	CEFOXITIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-247_eaa65075-3ed9-4a2c-9aa5-2f24a34bf5b2	44567-247	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20131001		ANDA	ANDA065415	WG Critical Care, LLC	CEFOXITIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-310_8d598421-c4ac-4673-b7bc-a6d56a654e67	44567-310	HUMAN PRESCRIPTION DRUG	Penicillin G Potassium		Penicillin G Potassium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120510		ANDA	ANDA065149	WG Critical Care, LLC	PENICILLIN G POTASSIUM	1000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-311_8d598421-c4ac-4673-b7bc-a6d56a654e67	44567-311	HUMAN PRESCRIPTION DRUG	Penicillin G Potassium		Penicillin G Potassium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120510		ANDA	ANDA065149	WG Critical Care, LLC	PENICILLIN G POTASSIUM	5000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-312_8d598421-c4ac-4673-b7bc-a6d56a654e67	44567-312	HUMAN PRESCRIPTION DRUG	Penicillin G Potassium		Penicillin G Potassium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120510		ANDA	ANDA065149	WG Critical Care, LLC	PENICILLIN G POTASSIUM	20000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
44567-340_6ddea73e-4eb6-4136-99fb-2536fd277ab1	44567-340	HUMAN PRESCRIPTION DRUG	Acetaminophen		acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20230503		ANDA	ANDA215403	WG Critical Care, LLC	ACETAMINOPHEN	10	mg/mL			N	20241231
44567-400_f832894b-c857-4975-8bf9-b2865df4a0f1	44567-400	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20200109		ANDA	ANDA210773	WG Critical Care, LLC	MEROPENEM	500	mg/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
44567-401_f832894b-c857-4975-8bf9-b2865df4a0f1	44567-401	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20200109		ANDA	ANDA210773	WG Critical Care, LLC	MEROPENEM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
44567-402_d0522d6b-aceb-4cc9-8b25-0dd563930d47	44567-402	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20230908		NDA	NDA215212	WG Critical Care, LLC	MEROPENEM	2	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
44567-410_2bb880cf-2841-4c1a-a72a-5cf5e506a41c	44567-410	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Dextrose		Magnesium Sulfate	INJECTION	INTRAVENOUS	20160308		ANDA	ANDA207349	WG Critical Care, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44567-420_c9c163e2-f368-4481-a24c-f0df8f92732e	44567-420	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION	INTRAVENOUS	20180109		ANDA	ANDA207350	WG Critical Care, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	2	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44567-421_c9c163e2-f368-4481-a24c-f0df8f92732e	44567-421	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION	INTRAVENOUS	20180109		ANDA	ANDA207350	WG Critical Care, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44567-422_c9c163e2-f368-4481-a24c-f0df8f92732e	44567-422	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION	INTRAVENOUS	20180109		ANDA	ANDA207350	WG Critical Care, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	20	g/500mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44567-423_c9c163e2-f368-4481-a24c-f0df8f92732e	44567-423	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION	INTRAVENOUS	20180109		ANDA	ANDA207350	WG Critical Care, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	40	g/1000mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44567-424_c9c163e2-f368-4481-a24c-f0df8f92732e	44567-424	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION	INTRAVENOUS	20180109		ANDA	ANDA207350	WG Critical Care, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44567-435_30b692d0-ff58-4160-ad6b-1f8cec8bb210	44567-435	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20160414		ANDA	ANDA090343	WG Critical Care, LLC	LEVOFLOXACIN	5	mg/mL			N	20241231
44567-436_30b692d0-ff58-4160-ad6b-1f8cec8bb210	44567-436	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20160414		ANDA	ANDA090343	WG Critical Care, LLC	LEVOFLOXACIN	5	mg/mL			N	20241231
44567-437_30b692d0-ff58-4160-ad6b-1f8cec8bb210	44567-437	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20160414		ANDA	ANDA090343	WG Critical Care, LLC	LEVOFLOXACIN	5	mg/mL			N	20241231
44567-450_91e6e87e-28fe-453b-bb43-d46734e00150	44567-450	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride in Sodium Chloride	INJECTION	INTRAVENOUS	20221207		ANDA	ANDA214172	WG Critical Care, LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
44567-451_91e6e87e-28fe-453b-bb43-d46734e00150	44567-451	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride in Sodium Chloride	INJECTION	INTRAVENOUS	20221207		ANDA	ANDA214172	WG Critical Care, LLC	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
44567-500_30a6beb4-f575-469a-a211-8fd0c7732857	44567-500	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20200824		NDA	NDA202543	WG Critical Care, LLC	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
44567-501_29ae4b2d-00fa-4c2a-b4c5-f37608b59b31	44567-501	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20200824		NDA	NDA202543	WG Critical Care, LLC	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
44567-501_30a6beb4-f575-469a-a211-8fd0c7732857	44567-501	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20200824		NDA	NDA202543	WG Critical Care, LLC	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
44567-502_29ae4b2d-00fa-4c2a-b4c5-f37608b59b31	44567-502	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20200824		NDA	NDA202543	WG Critical Care, LLC	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
44567-502_30a6beb4-f575-469a-a211-8fd0c7732857	44567-502	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20200824		NDA	NDA202543	WG Critical Care, LLC	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
44567-503_30a6beb4-f575-469a-a211-8fd0c7732857	44567-503	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20200824		NDA	NDA202543	WG Critical Care, LLC	LEVETIRACETAM	15	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
44567-509_dd45d777-d4c1-40ee-b4f0-c9e001a15a8c	44567-509	HUMAN PRESCRIPTION DRUG	CISplatin		CISplatin	INJECTION, SOLUTION	INTRAVENOUS	20120113		NDA	NDA018057	WG Critical Care, LLC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
44567-510_dd45d777-d4c1-40ee-b4f0-c9e001a15a8c	44567-510	HUMAN PRESCRIPTION DRUG	CISplatin		CISplatin	INJECTION, SOLUTION	INTRAVENOUS	20120113		NDA	NDA018057	WG Critical Care, LLC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
44567-511_dd45d777-d4c1-40ee-b4f0-c9e001a15a8c	44567-511	HUMAN PRESCRIPTION DRUG	CISplatin		CISplatin	INJECTION, SOLUTION	INTRAVENOUS	20150415		NDA	NDA018057	WG Critical Care, LLC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
44567-530_a66eda32-1164-439a-ac8e-73138365ec06	44567-530	HUMAN PRESCRIPTION DRUG	Cisplatin		cisplatin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190405		NDA	NDA018057	WG Critical Care, LLC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
44567-600_85bceaaf-f32f-4ca4-b779-7b1c99a635e5	44567-600	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160419		NDA	NDA206628	WG Critical Care, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
44567-601_85bceaaf-f32f-4ca4-b779-7b1c99a635e5	44567-601	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160419		NDA	NDA206628	WG Critical Care, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
44567-602_85bceaaf-f32f-4ca4-b779-7b1c99a635e5	44567-602	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION	INTRAVENOUS	20160419		NDA	NDA206628	WG Critical Care, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
44567-603_85bceaaf-f32f-4ca4-b779-7b1c99a635e5	44567-603	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION	INTRAVENOUS	20160419		NDA	NDA206628	WG Critical Care, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
44567-610_c5b05f02-c673-42cf-b668-7302517ba3c6	44567-610	HUMAN PRESCRIPTION DRUG	MIDAZOLAM HYDROCHLORIDE		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201231		NDA	NDA211844	WG Critical Care, LLC.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
44567-611_c5b05f02-c673-42cf-b668-7302517ba3c6	44567-611	HUMAN PRESCRIPTION DRUG	MIDAZOLAM HYDROCHLORIDE		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201231		NDA	NDA211844	WG Critical Care, LLC.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
44567-620_27755a79-0f5c-455e-9239-d506dc3983b7	44567-620	HUMAN PRESCRIPTION DRUG	Calcium Gluconate in Sodium Chloride		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20181026		NDA	NDA210906	WG Critical Care, LLC	CALCIUM GLUCONATE MONOHYDRATE	20	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
44567-621_27755a79-0f5c-455e-9239-d506dc3983b7	44567-621	HUMAN PRESCRIPTION DRUG	Calcium Gluconate in Sodium Chloride		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20181026		NDA	NDA210906	WG Critical Care, LLC	CALCIUM GLUCONATE MONOHYDRATE	20	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
44567-622_27755a79-0f5c-455e-9239-d506dc3983b7	44567-622	HUMAN PRESCRIPTION DRUG	Calcium Gluconate in Sodium Chloride		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20210713		NDA	NDA210906	WG Critical Care, LLC	CALCIUM GLUCONATE MONOHYDRATE	10	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
44567-640_03fe8775-935a-4ebe-bf6d-81e54307503f	44567-640	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		NOREPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20220915		NDA	NDA215700	WG Critical Care, LLC	NOREPINEPHRINE BITARTRATE	.016	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20251231
44567-641_03fe8775-935a-4ebe-bf6d-81e54307503f	44567-641	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		NOREPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20220915		NDA	NDA215700	WG Critical Care, LLC	NOREPINEPHRINE BITARTRATE	.032	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20251231
44567-642_03fe8775-935a-4ebe-bf6d-81e54307503f	44567-642	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		NOREPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20220915		NDA	NDA215700	WG Critical Care, LLC	NOREPINEPHRINE BITARTRATE	.064	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20251231
44567-700_c6cefc85-a3b8-4a04-bbe4-afe570c3b5b1	44567-700	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080724		ANDA	ANDA065329	WG Critical Care, LLC	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-701_388addd3-03a0-4c5a-b2ab-7386bea970a0	44567-701	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080724		ANDA	ANDA065329	WG Critical Care, LLC	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-701_c6cefc85-a3b8-4a04-bbe4-afe570c3b5b1	44567-701	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080724		ANDA	ANDA065329	WG Critical Care, LLC	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-702_388addd3-03a0-4c5a-b2ab-7386bea970a0	44567-702	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080724		ANDA	ANDA065329	WG Critical Care, LLC	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-702_c6cefc85-a3b8-4a04-bbe4-afe570c3b5b1	44567-702	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080724		ANDA	ANDA065329	WG Critical Care, LLC	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-703_25b246f3-2324-45b8-94f3-657774b7cb62	44567-703	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20080724		ANDA	ANDA065328	WG Critical Care, LLC	CEFTRIAXONE SODIUM	10	g/100mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-705_28caf104-1a13-436f-ae55-1e41da3dd481	44567-705	HUMAN PRESCRIPTION DRUG	Imipenem and Cilastatin		Imipenem and Cilastatin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210309		ANDA	ANDA207594	WG Critical Care, LLC	CILASTATIN SODIUM; IMIPENEM ANHYDROUS	500; 500	mg/1; mg/1	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
44567-706_6998c2bb-57f1-4e29-965f-06f972192c69	44567-706	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150306		ANDA	ANDA065303	WG Critical Care, LLC	CEFAZOLIN SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-707_6998c2bb-57f1-4e29-965f-06f972192c69	44567-707	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150306		ANDA	ANDA065303	WG Critical Care, LLC	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-708_d94c6e64-269c-4cbb-b5e5-77a338d8c7f3	44567-708	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20150306		ANDA	ANDA065306	WG Critical Care, LLC	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44567-801_d5216ac2-2d38-49e1-a20a-137e7e0d6e11	44567-801	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	WG Critical Care, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-802_d5216ac2-2d38-49e1-a20a-137e7e0d6e11	44567-802	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	WG Critical Care, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-803_d5216ac2-2d38-49e1-a20a-137e7e0d6e11	44567-803	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	WG Critical Care, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-804_031717c4-0190-4914-b029-61b3f9652d1f	44567-804	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091020		ANDA	ANDA090498	WG Critical Care, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
44567-811_88447929-a6ff-47dd-9755-b7ebc038e118	44567-811	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	20171204		NDA	NDA205703	WG Critical Care, LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
44567-812_88447929-a6ff-47dd-9755-b7ebc038e118	44567-812	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	20171204		NDA	NDA205703	WG Critical Care, LLC	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
44567-820_befbf704-5aae-474b-8457-c77b2ab7835e	44567-820	HUMAN PRESCRIPTION DRUG	ertapenem		ertapenem	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200107		ANDA	ANDA208790	WG Critical Care, LLC	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
44567-840_90715b14-cf75-44e3-b31a-69976f5639dd	44567-840	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20230518		NDA	NDA211413	WG Critical Care, LLC	CEFAZOLIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
44577-001_0973b73d-5dc0-0986-e063-6294a90a5917	44577-001	HUMAN OTC DRUG	CLARUS Antifungal		TOLNAFTATE	CREAM	TOPICAL	20120607		OTC MONOGRAPH DRUG	M005	Clinical Therapeutic Solutions	TOLNAFTATE	1	g/100g			N	20241231
44577-002_09740b13-55d0-2604-e063-6294a90a158c	44577-002	HUMAN OTC DRUG	CLARUS Antifungal		TOLNAFTATE	SOLUTION	TOPICAL	20120607		OTC MONOGRAPH DRUG	M005	Clinical Therapeutic Solutions	TOLNAFTATE	1	g/100mL			N	20241231
44577-020_0973a822-e689-feb3-e063-6294a90ab132	44577-020	HUMAN OTC DRUG	VerruStat Wart Remover		SALICYLIC ACID	LIQUID	TOPICAL	20131016		OTC MONOGRAPH DRUG	M028	Clinical Therapeutic Solutions	SALICYLIC ACID	170	mg/mL			N	20241231
44577-128_09d7052e-ec64-ef60-e063-6294a90af214	44577-128	HUMAN OTC DRUG	CLARUS AC Antifungal Solution		TOLNAFTATE	LIQUID	TOPICAL	20210301		OTC MONOGRAPH DRUG	M005	Clinical Therapeutic Solutions	TOLNAFTATE	10	mg/g			N	20241231
44577-205_0973aae6-55b5-5f1a-e063-6394a90a9848	44577-205	HUMAN OTC DRUG	MacerRx Web		MICONAZOLE NITRATE	CREAM	TOPICAL	20130606		OTC MONOGRAPH DRUG	M005	Clinical Therapeutic Solutions	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
44577-623_09d72089-c2ef-70f3-e063-6394a90a65ad	44577-623	HUMAN OTC DRUG	KERA HC		HYDROCORTISONE	CREAM	TOPICAL	20121017		OTC MONOGRAPH DRUG	M017	Clinical Therapeutic Solutions	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
44577-704_0973ba09-954a-0fb9-e063-6294a90a4d13	44577-704	HUMAN OTC DRUG	LidoStat		LIDOCAINE HCL	CREAM	TOPICAL	20130619		OTC MONOGRAPH DRUG	M017	Clinical Therapeutic Solutions	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
44577-711_0973c7d8-bd6d-e83b-e063-6294a90acf55	44577-711	HUMAN OTC DRUG	TRI-SOFT SOFTENING		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20121206		OTC MONOGRAPH DRUG	505G(a)(3)	Clinical Therapeutic Solutions	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
44647-051_0b211a36-8d30-fb5e-e063-6294a90af3de	44647-051	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190319		ANDA	ANDA207647	Savior Lifetec Corporation	ERTAPENEM SODIUM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
44668-001_06d64666-6a21-2027-e063-6294a90a3966	44668-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		H & H Drug Stores Inc., DBA Western Drug Medical Supply	OXYGEN	99	L/100L			N	20241231
44717-062_e895d590-80ad-cc41-e053-2a95a90a7c04	44717-062	HUMAN OTC DRUG	Wonderscreen Broad Spectrum SPF 30		Zinc Oxide	CREAM	TOPICAL	20220225		OTC MONOGRAPH FINAL	M020	Wasatch Product Development, LLC.	ZINC OXIDE	19	g/100g			N	20241231
44717-068_f4206da0-df2b-2419-e053-2a95a90aaa33	44717-068	HUMAN OTC DRUG	Premium Moisturizing Sunscreen Broad Spectrum SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	M020	Wasatch Product Development, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 3; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
44717-069_f43408a7-8f85-3a41-e053-2995a90a0bdb	44717-069	HUMAN OTC DRUG	Premium Moisturizing Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	M020	Wasatch Product Development, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
44717-070_f411a763-6f9f-9566-e053-2995a90a0a01	44717-070	HUMAN OTC DRUG	Premium Moisturizing Sunscreen Broad Spectrum SPF 70		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	M020	Wasatch Product Development, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
44717-072_f4346f7a-3643-05d8-e053-2a95a90a013d	44717-072	HUMAN OTC DRUG	Premium Moisturizing Sunscreen Broad Spectrum SPF 15		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	M020	Wasatch Product Development, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5; 2; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
44717-080_f4ac746a-a50b-8041-e053-2a95a90a8ea6	44717-080	HUMAN OTC DRUG	Sun Bum Face 50 Premium Sunscreen SPF 50		Avobenzone, Homosalte, Octisalate, Octocrylene	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	M020	Wasatch Product Development, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
44717-539_eeb9a4b6-f5e2-bd04-e053-2995a90aa99c	44717-539	HUMAN OTC DRUG	Te-Fu Recovery Massage		Menthol, Methyl Salicylate	LOTION	TOPICAL	20181128		OTC MONOGRAPH NOT FINAL	part348	Wasatch Product Development	MENTHOL; METHYL SALICYLATE	5; 10	g/100mL; g/100mL			N	20241231
44873-007_0a33e170-e8a6-25a8-e063-6394a90addf5	44873-007	HUMAN OTC DRUG	Go Smile	RELAX	SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	ORAL	20110505		OTC MONOGRAPH DRUG	M021	Go Smile, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
44873-008_0a33d2ce-d5a3-1f75-e063-6394a90a0d1b	44873-008	HUMAN OTC DRUG	Go Smile	MINT	SODIUM FLUORIDE	PASTE, DENTIFRICE	ORAL	20160504		OTC MONOGRAPH DRUG	M021	Go Smile, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
44873-106_0a33e794-1f0d-2717-e063-6394a90a2c0b	44873-106	HUMAN OTC DRUG	GO SMILE LUXURY	AM	SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	ORAL	20151027		OTC MONOGRAPH DRUG	M021	Go Smile, Inc.	SODIUM MONOFLUOROPHOSPHATE	.13	g/100g			N	20241231
44911-0002_bfebd549-37ed-4001-86aa-61194b19e57b	44911-0002	HUMAN OTC DRUG	GABA Phenolic		Gamma-Aminobutyric Acid	LIQUID	ORAL	20120427		UNAPPROVED HOMEOPATHIC		Energique, Inc.	.GAMMA.-AMINOBUTYRIC ACID	6	[hp_X]/mL			N	20241231
44911-0003_fdb75ed1-8442-42d6-aca5-4df923ff0549	44911-0003	HUMAN OTC DRUG	Grippe	HP	Aconitum Napellus, Arsenicum Album, Baptisia Tinctoria, Belladonna, Bryonia (Alba), Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens	LIQUID	ORAL	20120427	20250324	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0006_20815c95-76e4-4170-8c97-d538406a89e3	44911-0006	HUMAN OTC DRUG	Dust Mix Antigens		Barley, Corn, House, Mattress, Millet, Milo, Oat, Rice, Rug, Upholstery, Wheat, Arsenicum album, Blatta orientalis, Drosera, Lycopodium clavatum, Pothos foetidus, Pulsatilla,	LIQUID	ORAL	20120504	20240218	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BARLEY; BLATTA ORIENTALIS; BROWN RICE; CORN; DROSERA ROTUNDIFOLIA; HOUSE DUST; LYCOPODIUM CLAVATUM SPORE; MILLET; OAT; SORGHUM; SYMPLOCARPUS FOETIDUS ROOT; WHEAT	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	
44911-0028_2604a23f-48d8-433c-a3fc-af6e01536f46	44911-0028	HUMAN OTC DRUG	Bronchitone		Echinacea, Lobelia Inflata, Antimonium Tartaricum, Aralia Racemosa, Drosera (Rotundifolia), Ipecacuanha, Kali Carbonicum, Phosphorus, Spongia Tosta	LIQUID	ORAL	20121107	20241202	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANTIMONY POTASSIUM TARTRATE; ARALIA RACEMOSA ROOT; DROSERA ROTUNDIFOLIA; ECHINACEA ANGUSTIFOLIA; IPECAC; LOBELIA INFLATA; PHOSPHORUS; POTASSIUM CARBONATE; SPONGIA OFFICINALIS SKELETON, ROASTED	12; 12; 12; 3; 12; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0035_ebc767db-aa3d-4be9-ab55-36407840fc26	44911-0035	HUMAN OTC DRUG	L-Dopa Phenolic		L-Dopa	LIQUID	ORAL	20130219		UNAPPROVED HOMEOPATHIC		Energique, Inc.	LEVODOPA	6	[hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
44911-0037_122799c5-9bc4-49ca-8935-f31d0db3dbee	44911-0037	HUMAN OTC DRUG	Adrenapar		Aralia Quinquefolia, Avena Sativa, Glandula Suprarenalis Suis, Arsenicum Iodatum, Ignatia Amara, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Zincum Metallicum	LIQUID	ORAL	20121004	20270113	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMERICAN GINSENG; ARSENIC TRIIODIDE; AVENA SATIVA FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; ZINC	3; 12; 3; 12; 12; 12; 12; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0038_cac0d588-5bc6-431e-ab1d-71e88d5a4f3f	44911-0038	HUMAN OTC DRUG	Anxiety		Aconitum Napellus, Arsenicum Album, Belladonna, Calcarea Carbonica, Carcinosin, Causticum, Gelsemium Sempervirens, Lachesis Mutus, Mercurius Vivus, Nitricum Acidum, Phosphorus, Rhus Tox	SPRAY	ORAL	20121016	20260810	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAUSTICUM; GELSEMIUM SEMPERVIRENS ROOT; HUMAN BREAST TUMOR CELL; LACHESIS MUTA VENOM; MERCURY; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0043_d25e7e16-8030-41d3-9c05-c17914433633	44911-0043	HUMAN OTC DRUG	Diabenex HP		Aceticum Acidum, Colchicum Autumnale, Lacticum Acidum, Lycopodium Clavatum, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum, Uranium Nitricum	LIQUID	ORAL	20121005	20240429	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACETIC ACID; COLCHICUM AUTUMNALE BULB; LACTIC ACID, DL-; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; SYZYGIUM CUMINI SEED; URANYL NITRATE HEXAHYDRATE	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0052_41230ecd-d5cb-44c5-9e49-4b420918e044	44911-0052	HUMAN OTC DRUG	Infect	HP	Aconitum Napellus, Arsenicum Album, Baptisia Tinctoria, Belladonna, Bryonia, Causticum, Echinacea, Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens, Hydrastis Canadensis, Hypericum Perforatum, Kali Carbonicum, Lachesis Mutus, Lobelia Inflata, Lomatium Dissectum, Lung, Natrum Sulphuricum, Phosphorus, Phytolacca Decandra, Pulsatilla, Pyrogenium, Rhus Tox, Silicea, Sulphur, Symphytum Officinale	LIQUID	ORAL	20121217	20240531	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA WHOLE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAUSTICUM; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LOBELIA INFLATA; LOMATIUM DISSECTUM ROOT; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; PULSATILLA VULGARIS; RANCID BEEF; SILICON DIOXIDE; SODIUM SULFATE; SULFUR; SUS SCROFA LUNG; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0060_2ab831f0-38d0-427b-bd27-a003a31df5eb	44911-0060	HUMAN OTC DRUG	HZ HP		Lycopodicum Clavatum, Mezereum, Natrum Muriaticum, Nitricum Acidum, Ranunculus Bulbosus, Rhus Tox, Sepia, Thuja Occidentalis	LIQUID	ORAL	20121219	20240809	UNAPPROVED HOMEOPATHIC		Energique, Inc.	DAPHNE MEZEREUM BARK; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; RANUNCULUS BULBOSUS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0068_b724bed9-1268-4aeb-b8e8-fb08b8899f00	44911-0068	HUMAN OTC DRUG	Allerpoll HP		Allium Cepa, Ambrosia Artemisiaefolia, Apis Mellfica, Arsenicum Album, Euphrasia Officinalis, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris), Solidago Virgaurea, Sulphur	LIQUID	ORAL	20130912	20250629	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMBROSIA ARTEMISIIFOLIA; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; EUPHRASIA STRICTA; ONION; PHOSPHORUS; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	
44911-0086_c75e90f6-faa0-4eb4-ace8-e98a148d8473	44911-0086	HUMAN OTC DRUG	Cystotone		Sarsaparilla, Uva-Ursi, Arsenicum Album, Cantharis, Pareira Brava, Pulsatilla, Sepia, Terebinthina, Populus Tremuloides	LIQUID	ORAL	20130815	20240228	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PULSATILLA; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIOXIDE; CHONDRODENDRON TOMENTOSUM ROOT; LYTTA VESICATORIA; POPULUS TREMULOIDES BARK; POPULUS TREMULOIDES LEAF; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT; TURPENTINE OIL	12; 3; 12; 12; 12; 15; 15; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0097_0e27dae5-db51-4f1a-b12c-c3d8b3576a11	44911-0097	HUMAN PRESCRIPTION DRUG	Psorinum		Psorinum	LIQUID	ORAL	20141209	20250922	UNAPPROVED HOMEOPATHIC		Energique, Inc.	SCABIES LESION LYSATE (HUMAN)	7	[hp_X]/mL			N	
44911-0119_cda34e50-0e47-471a-a677-76fd4cc718ee	44911-0119	HUMAN OTC DRUG	Fungustat	I	Echinacea (Angustifolia), Tabebuia impetiginosa, Abies nigra, Lycopodium clavatum, Nux vomica, Phosphorus, Pulsatilla (Vulgaris), Sepia, Skatolum, Canadida albicans,	LIQUID	ORAL	20140505	20250715	UNAPPROVED HOMEOPATHIC		Energique, Inc	CANDIDA ALBICANS; ECHINACEA ANGUSTIFOLIA; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PICEA MARIANA RESIN; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SKATOLE; STRYCHNOS NUX-VOMICA SEED; TABEBUIA IMPETIGINOSA BARK	30; 3; 12; 12; 12; 12; 12; 15; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0121_74a81199-f9a3-4c0e-9dec-2aa26b9abbff	44911-0121	HUMAN OTC DRUG	Candida Cord		Candida Albicans	LIQUID	ORAL	20140708		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
44911-0126_229ebf1a-109b-475c-b57f-ff006bed28dd	44911-0126	HUMAN OTC DRUG	Male Balance		Avena Sativa, Hepar Suis, Orchitinum (Suis), Testosterone, Agnus Castus, Damiana, Ginkgo Biloba, Hypothalamus (Suis), Lycopodium Clabatum, Spermidine, Spermine, Human Growth Hormone, Epimedium Grandiflorum, Serotonin (Hydrochloride)	LIQUID	ORAL	20140915	20250130	UNAPPROVED HOMEOPATHIC		Energique,Inc.	AVENA SATIVA FLOWERING TOP; CHASTE TREE; EPIMEDIUM GRANDIFLORUM TOP; GINKGO; LYCOPODIUM CLAVATUM SPORE; PORK LIVER; SEROTONIN HYDROCHLORIDE; SOMATROPIN; SPERMIDINE; SPERMINE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA TESTICLE; TESTOSTERONE; TURNERA DIFFUSA LEAFY TWIG	6; 12; 30; 12; 12; 6; 30; 26; 12; 12; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
44911-0146_db64c186-94e8-489c-972c-c482b404a094	44911-0146	HUMAN OTC DRUG	Ars Alb		Arsenicum Album	LIQUID	ORAL	20150512		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE	30	[hp_C]/mL			N	20241231
44911-0153_6a6fc5ba-8360-48de-8908-fbf32e4b99a6	44911-0153	HUMAN OTC DRUG	Enuresis	HP	Argentum Nitricum, Belladonna, Causticum, Equisetum Hyemale, Ferrum Phosphoricum, Kreosotum, Nitricum Acidum, Pulsatilla (Pratensis), Thuja Occidentalis, Thyroidinum (Suis)	LIQUID	ORAL	20150514		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ATROPA BELLADONNA; CAUSTICUM; EQUISETUM HYEMALE WHOLE; FERROSOFERRIC PHOSPHATE; NITRIC ACID; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID; WOOD CREOSOTE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0154_231480e4-5ce2-4a03-afe4-533681f13050	44911-0154	HUMAN OTC DRUG	Drainpar		Propolis, Solidago Virgaurea, Trifolium Pratense, Hepar (Suis), Kidney (Suis), Lymph Node (Suis), Berberis Vulgaris, Bryonia (Alba), Ceanothus Americanus, Chelidonium Majus, Nux Vomica	LIQUID	ORAL	20150514	20240603	UNAPPROVED HOMEOPATHIC		Energique, Inc.	BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; PORK KIDNEY; PORK LIVER; PROPOLIS WAX; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LYMPH; TRIFOLIUM PRATENSE FLOWER	10; 10; 10; 10; 6; 6; 2; 2; 10; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0156_4906610c-6c3c-4086-80f1-08f49052811b	44911-0156	HUMAN OTC DRUG	Thuja		Thuja Occidentalis	LIQUID	ORAL	20150514	20260611	UNAPPROVED HOMEOPATHIC		Energique, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/mL			N	
44911-0157_7cc0cb21-48fe-4df5-97e6-76fb52450230	44911-0157	HUMAN OTC DRUG	Cystoges	HP	Berberis Vulgaris, Cantharis, Clematis Erecta, Equisetum Hyemale, Lac Caninum, Lycopodium Clavatum, Pulsatilla (Pratensis), Sarsaparilla (Smilax Regelii), Sepia, Staphysagria	LIQUID	ORAL	20150519	20240814	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; BERBERIS VULGARIS ROOT BARK; CANIS LUPUS FAMILIARIS MILK; CLEMATIS RECTA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; EQUISETUM HYEMALE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0158_53ad35ac-1433-4737-811f-54382a7cab59	44911-0158	HUMAN OTC DRUG	Pre/Post Surgetone		Hypericum Perforatum, Symphytum Officinale, Arnica Montana	LIQUID	ORAL	20150519	20250212	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARNICA MONTANA; COMFREY ROOT; HYPERICUM PERFORATUM	200; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0159_38919897-50a6-454f-bf27-32ec7db1593f	44911-0159	HUMAN OTC DRUG	Nat Mur		Natrum Muriaticum	LIQUID	ORAL	20150519		UNAPPROVED HOMEOPATHIC		Energique, Inc.	SODIUM CHLORIDE	30	[hp_C]/mL			N	20241231
44911-0161_2272876c-0eb3-41a0-8f71-86006eb29c16	44911-0161	HUMAN OTC DRUG	Elm		Ulmus Procera, Flos	LIQUID	ORAL	20150519	20250203	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ULMUS PROCERA FLOWERING TWIG	30	[hp_C]/mL			N	
44911-0163_aa8b6039-63e4-4b0b-9c2d-b4c0a220a080	44911-0163	HUMAN OTC DRUG	Allertone		Allium Sativum, Baptisia Tinctoria, Echinacea (Angustifolia), Allium Cepa, Ambrosia Artemisiaefolia, Arsenicum Album, Phosphorus, Pulsatilla (Pratensis), Solidago Virgaurea	LIQUID	ORAL	20150519	20240131	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMBROSIA ARTEMISIIFOLIA; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; GARLIC; ONION; PHOSPHORUS; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 3; 3; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
44911-0164_8cca59e6-9711-43fd-be04-a5d375213763	44911-0164	HUMAN OTC DRUG	Dairy Antigens		American Cheese, Blue Cheese, Brie Cheese, Cheddar Cheese, Cottage Cheese, Goat Milk, Lac Vaccinum, Swiss Cheese, Calcarea Carbonica, Sepia, Sulphur	LIQUID	ORAL	20150706	20261222	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CASEIN, EMMENTAL CULTURED; CASEIN, LACTOCOCCUS LACTIS CULTURED; CASEIN, LACTOCOCCUS LACTIS CULTURED, AGED; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM CAMEMBERTI CULTURED, AGED; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM ROQUEFORTI CULTURED, AGED; COW MILK; GOAT MILK; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SULFUR; WHEY	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Milk Proteins [CS], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	
44911-0166_e0456aa8-e11c-4b9c-8e0a-32cae2d40afd	44911-0166	HUMAN OTC DRUG	Kali Mur		Kali Muriaticum	LIQUID	ORAL	20150520		UNAPPROVED HOMEOPATHIC		Energique, Inc.	POTASSIUM CHLORIDE	200	[hp_C]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
44911-0169_361440be-ddaf-4c8b-a817-2c0e5ab2d2e3	44911-0169	HUMAN OTC DRUG	Pneumo	HP	Ammonium Muriaticum, Antimonium Tartaricum, Arsenicum Album, Bryonia (Alba), Calcarea Carbonica, Lobelia Inflata, Natrum Sulphuricum, Phosphorus, Spongia Tosta	LIQUID	ORAL	20150617	20250330	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMMONIUM CHLORIDE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; LOBELIA INFLATA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0174_fefcd563-0299-438a-8940-e67daf391fbe	44911-0174	HUMAN OTC DRUG	Rheumatism	HP	Bryonia (Alba), Colchicum Autumnale, Formica Rufa, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Rhododendron Chrysanthum, Rhus Tox	LIQUID	ORAL	20150707	20240923	UNAPPROVED HOMEOPATHIC		Energique, Inc.	BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; FORMICA RUFA; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0176_6a242e54-1296-4352-a0f6-d666364ab3c0	44911-0176	HUMAN OTC DRUG	Zinc Met		Zincum metallicum	LIQUID	ORAL	20150708		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ZINC	30	[hp_X]/mL			N	20241231
44911-0179_73ace75c-fa50-4018-ba9e-9869a9e028f7	44911-0179	HUMAN OTC DRUG	Acetaldehyde Phenolic		Acetaldehyde	LIQUID	ORAL	20150708		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACETALDEHYDE	6	[hp_X]/mL			N	20241231
44911-0180_0e76d501-a583-477d-9430-ca4ba8ebb9a9	44911-0180	HUMAN OTC DRUG	Cancordistat		Mercurius Solubilis, Candida Albicans	LIQUID	ORAL	20150708	20240826	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CANDIDA ALBICANS; MERCURIUS SOLUBILIS	12; 12	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
44911-0189_26bd9355-532f-464c-9fc1-7b66301b5185	44911-0189	HUMAN OTC DRUG	H. Pylori		Helicobacter Pylori	LIQUID	ORAL	20150708	20250303	UNAPPROVED HOMEOPATHIC		Energique, Inc.	HELICOBACTER PYLORI	12	[hp_X]/mL			N	
44911-0190_7c8fa016-41f0-41e4-8b1c-1533e6d7aa36	44911-0190	HUMAN OTC DRUG	Glutathione		Glutathione	LIQUID	ORAL	20150709		UNAPPROVED HOMEOPATHIC		Energique, Inc.	GLUTATHIONE	5	[hp_X]/mL			N	20241231
44911-0197_239ae127-0a44-4632-94b9-70269cf0ac9b	44911-0197	HUMAN OTC DRUG	HYPERT HP		Arnica montana, Aurum metallicum, Cactus grandiflorus, Calcarea carbonica, Lachesis mutus, Natrum muriaticum, Nux vomica, Phosphorus, Solidago virgaurea,	LIQUID	ORAL	20150709	20240814	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARNICA MONTANA; GOLD; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SELENICEREUS GRANDIFLORUS STEM; SODIUM CHLORIDE; SOLIDAGO CANADENSIS FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	
44911-0205_fc34afa4-4a6f-4107-a28f-b3831a221063	44911-0205	HUMAN OTC DRUG	Histamine Phenolic		Histaminum Hydrochloricum	LIQUID	ORAL	20150727		UNAPPROVED HOMEOPATHIC		Energique, Inc.	HISTAMINE DIHYDROCHLORIDE	6	[hp_X]/mL			N	20241231
44911-0206_f13d9115-9272-4b04-ae59-82e3161cf381	44911-0206	HUMAN OTC DRUG	Calc Phos		Calcarea Phosphorica	LIQUID	ORAL	20150709		UNAPPROVED HOMEOPATHIC		Energique, Inc.	TRIBASIC CALCIUM PHOSPHATE	200	[hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
44911-0209_04259ae1-7e7d-4018-9866-9b0f378b2cfc	44911-0209	HUMAN OTC DRUG	ACONITE		Aconitum napellus	LIQUID	ORAL	20150715		UNAPPROVED HOMEOPATHIC		ENERGIQUE, INC.	ACONITUM NAPELLUS WHOLE	200	[hp_C]/mL			N	20241231
44911-0210_1d1f51f8-b89b-4d4e-be82-1fbfbe983c50	44911-0210	HUMAN OTC DRUG	PSORIASIS	HP	Arsenicum iodatum, Borax, Graphites, Lycopodium clavatum, Natrum muriaticum, Petroleum, Sepia, Sulphur	LIQUID	ORAL	20150715	20240801	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIIODIDE; GRAPHITE; KEROSENE; LYCOPODIUM CLAVATUM SPORE; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CHLORIDE; SULFUR	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0214_1b7f0a90-97db-4696-9ec5-979f266996ef	44911-0214	HUMAN OTC DRUG	E-COLI		Colibacillinum cum natrum muriaticum	LIQUID	ORAL	20150715	20250611	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ESCHERICHIA COLI	30	[hp_C]/mL			N	
44911-0215_dcbd2321-a2d8-433a-88b3-bc12fa9b9e4f	44911-0215	HUMAN OTC DRUG	Sciatica	HP	Aconitum Napellus, Aesculus Hippocastanum, Colocynthis, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Plumbum Metallicum, Rhus Tox, Arnica Montana	LIQUID	ORAL	20150714	20250430	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; CITRULLUS COLOCYNTHIS FRUIT PULP; HORSE CHESTNUT; HYPERICUM PERFORATUM; LEAD; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
44911-0216_96628717-f386-4a0f-899c-a7fdcda3d03f	44911-0216	HUMAN OTC DRUG	Estrogens		Estradiol, Estriol, Folliculinum	LIQUID	ORAL	20150723	20240225	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ESTRADIOL; ESTRIOL; ESTRONE	200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	
44911-0217_44c8fe18-b564-4961-9d51-5a7fc8ae3031	44911-0217	HUMAN OTC DRUG	Neurostat		Cimicifuga Racemosa, Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Cuprum Metallicum, Gelsemium Sempervirens, Lycopodium Clavatum, Phosphorus, Rhus Tox, Tarentula Cubensis, Latrodectus Mactans, Pyrogenium	LIQUID	ORAL	20150715		UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMANITA MUSCARIA FRUITING BODY; BLACK COHOSH; CITHARACANTHUS SPINICRUS; CONIUM MACULATUM FLOWERING TOP; COPPER; GELSEMIUM SEMPERVIRENS ROOT; LATRODECTUS MACTANS; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PROTORTONIA CACTI; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	12; 3; 12; 12; 12; 12; 15; 12; 12; 12; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
44911-0219_d04d946e-fe3f-4b37-9c7b-869296421f07	44911-0219	HUMAN OTC DRUG	EASTER LILY		Lilium longiflorum	LIQUID	ORAL	20150715		UNAPPROVED HOMEOPATHIC		Energique, Inc.	LILIUM LONGIFLORUM BULB	12	[hp_X]/mL			N	20241231
44911-0224_40544ccc-bd66-46fa-925d-8029f0acf637	44911-0224	HUMAN OTC DRUG	Impatiens		Impatiens Glandulifera, Flos	LIQUID	ORAL	20150723	20240325	UNAPPROVED HOMEOPATHIC		Energique, Inc.	IMPATIENS GLANDULIFERA FLOWER	30	[hp_C]/mL			N	
44911-0225_c31b106a-def6-4353-a05c-11bba9321b71	44911-0225	HUMAN OTC DRUG	Rescue 5		Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos	LIQUID	ORAL	20150724		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER	200; 200; 200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
44911-0226_9bab0e8a-3886-4a1e-8467-f858015703f7	44911-0226	HUMAN OTC DRUG	Drainpar		Propolis, Solidago Virgaurea, Trifolium Pratense, Hepar (Suis), Kidney (Suis), Lymph Node (Suis), Berberis Vulgaris, Bryonia (Alba), Ceanothus Americanus, Chelidonium Majus, Nux Vomica	LIQUID	ORAL	20150724	20250513	UNAPPROVED HOMEOPATHIC		Energique, Inc.	BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; PORK KIDNEY; PORK LIVER; PROPOLIS WAX; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LYMPH; TRIFOLIUM PRATENSE FLOWER	10; 10; 10; 10; 6; 6; 2; 2; 10; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0227_75a85a26-6c27-4a4c-a299-b1857aeff558	44911-0227	HUMAN OTC DRUG	Varico	HP	Calcarea Fluorica, Carbo Vegetabilis, Carduus Marianus, Hamamelis Virginiana, Lachesis Mutus, Lycopodium Clavatum, Pulsatilla (Pratensis), Secale Cornutum, Staphysagria, Zincum Metallicum	LIQUID	ORAL	20150724	20251021	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; CALCIUM FLUORIDE; CLAVICEPS PURPUREA SCLEROTIUM; DELPHINIUM STAPHISAGRIA SEED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PULSATILLA PRATENSIS WHOLE; ZINC	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0237_9e8c90ff-d31a-4456-8ca9-5fd2126c335a	44911-0237	HUMAN OTC DRUG	Candida Albicans Phenolic		Candida Albicans	LIQUID	ORAL	20150819		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
44911-0238_db45fbaf-9aa5-4b15-95b3-27de7f0f6f30	44911-0238	HUMAN OTC DRUG	Rescue 5		Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos	LIQUID	ORAL	20150730		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER	30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
44911-0241_2924f180-600e-479f-9b97-831d824a00c7	44911-0241	HUMAN OTC DRUG	Arnica		Arnica Montana	LIQUID	ORAL	20150811		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARNICA MONTANA	200	[hp_C]/mL			N	20241231
44911-0250_eead77a9-43bb-4070-bae3-cfaa1af5c35d	44911-0250	HUMAN OTC DRUG	Coxsackie Cord		Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5	LIQUID	ORAL	20150923	20250317	UNAPPROVED HOMEOPATHIC		Energique, Inc.	HUMAN COXSACKIEVIRUS A; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3	6; 6; 6; 6; 6	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0254_aebd2125-c67c-4022-b2fe-17b738ab69df	44911-0254	HUMAN OTC DRUG	Pneumotone		Lobelia Inflata, Verbascum Thapsus, Balsamum Peruvianum, Antimonium Tartaricum, Arsenicum Album, Drosera (Rotundifolia), Kali Bichromicum, Kali Carbonicum, Natrum Sulphuricum, Phosphorous, Spongia Tosta	LIQUID	ORAL	20150831	20250330	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BALSAM PERU; DROSERA ROTUNDIFOLIA; LOBELIA INFLATA; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; VERBASCUM THAPSUS	12; 12; 6; 12; 3; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
44911-0256_7249b982-1a4d-4f7c-bda3-072a383cc576	44911-0256	HUMAN OTC DRUG	Gallbladderpar		Carduus Marianus, Fel Tauri, Taraxacum Officinale, Chelidonium Majus, Lycopodium Clavatum, Magnesia Phosphorica, Natrum Sulphuricum, Nux Vomica, Phosphorus, Sanguinaria Canadensis, Gallbladder (Suis)	LIQUID	ORAL	20150903		UNAPPROVED HOMEOPATHIC		Energique, Inc.	BOS TAURUS BILE; CHELIDONIUM MAJUS WHOLE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MILK THISTLE; PHOSPHORUS; SANGUINARIA CANADENSIS ROOT; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA GALLBLADDER; TARAXACUM OFFICINALE	6; 12; 12; 12; 3; 12; 12; 12; 12; 30; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44911-0260_3c61f56d-8c54-41ce-a0b6-6351e56f1c66	44911-0260	HUMAN OTC DRUG	Shark Cartilage Cord		Shark Cartilage	LIQUID	ORAL	20150904	20270511	UNAPPROVED HOMEOPATHIC		Energique, Inc.	SHARK CARTILAGE	6	[hp_C]/mL			N	
44911-0264_6ea5eb78-0153-4a82-bc04-5c73e6d2f45a	44911-0264	HUMAN OTC DRUG	5-HTP Phenolic		5-Hydroxytryptophan	LIQUID	ORAL	20150908		UNAPPROVED HOMEOPATHIC		Energique, Inc.	OXITRIPTAN	6	[hp_X]/mL			N	20241231
44911-0265_6ef884e2-3306-4e62-af35-761b6809bbff	44911-0265	HUMAN OTC DRUG	Parasite Infection		Arsenicum Album, Baptisia Tinctoria, Lachesis Mutus, Pulsatilla (Pratensis), Rhus Tox	LIQUID	ORAL	20150908	20240801	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; LACHESIS MUTA VENOM; PULSATILLA PRATENSIS; TOXICODENDRON PUBESCENS LEAF	10; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0266_630ce8b7-1624-47f7-8fc9-6026e66a9ac1	44911-0266	HUMAN OTC DRUG	Pituistat		Aralia quinquefolia, Ginkgo biloba, Arsenicum iodatum, Avena sativa, Baryta carbonica, Phosphorus, Silicea, Thyroidinum (suis), Aluminum, Antimony, Barium, Beryllium, Bismuth, Boron, Bromine, Calcium, Carbon, Cerium, Cesium, Chloride, Chromium, Cobalt, Copper, Dysprosium, Erbium, Europium, Fluoride, Gadolinium, Gallium, Germanium, Gold, Hafnium, Holmium, Indium, Iodine, Iridium, Iron, Lanthanum, Lithium, Lutetium, Magnesium, Manganese, Molybdenum, Neodymium, Nickel, Niobium, Osmium, Palladium	LIQUID	ORAL	20150924		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; ALUMINUM; AMERICAN GINSENG; ANTIMONY; ARSENIC TRIIODIDE; AVENA SATIVA FLOWERING TOP; BARIUM; BARIUM CARBONATE; BERYLLIUM; BISMUTH; BORON; BROMINE; CALCIUM; CERIUM; CESIUM; CHLORIDE ION; CHROMIUM; COBALT; COPPER; DYSPROSIUM; ERBIUM; EUROPIUM; FLUORIDE ION; GADOLINIUM; GALLIUM; GERMANIUM; GINKGO; GOLD; HAFNIUM; HOLMIUM; INDIUM; IODINE; IRIDIUM; IRON; LANTHANUM; LITHIUM; LUTETIUM; MAGNESIUM; MANGANESE; MOLYBDENUM; NEODYMIUM; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHOSPHORUS; PLATINUM; POTASSIUM; PRASEODYMIUM; RHENIUM; RHODIUM; RUBIDIUM; RUTHENIUM; SAMARIUM; SCANDIUM; SELENIUM; SILICON; SILICON DIOXIDE; SILVER; SODIUM; STRONTIUM; SULFUR; TANTALUM; TELLURIUM; TERBIUM; THALLIUM; THORIUM; THULIUM; THYROID; TIN; TITANIUM; TUNGSTEN; VANADIUM; YTTERBIUM; YTTRIUM; ZINC; ZIRCONIUM	12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Calcium [CS], Calcium [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
44911-0267_dcb736fd-29df-4942-923e-668df0f9cebf	44911-0267	HUMAN OTC DRUG	Neuralgia	HP	Aconitum napellus, Agaricus muscarius, Allium cepa, Arnica montana, Coffea cruda, Hypericum perforatum, Lycopodium clavatum, Mercurius solubilis, Phosphorus, Plumbum metallicum	LIQUID	ORAL	20150923	20250304	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS WHOLE; AMANITA MUSCARIA FRUITING BODY; ARABICA COFFEE BEAN; ARNICA MONTANA WHOLE; HYPERICUM PERFORATUM WHOLE; LEAD; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; ONION; PHOSPHORUS	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
44911-0268_6db4d5b8-9c7b-4c96-9f14-61d87068dbae	44911-0268	HUMAN OTC DRUG	Allerstat	I	Chelidonium Majus, Echinacea (Angustifolia), Gentiana Lutea, Arsenicum Album, Carbo Vegetabilis, Lycopodium Clavatum, Nux Vomica, Phosphorus, Pulsatilla (Pratensis)	LIQUID	ORAL	20151020	20250217	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GENTIANA LUTEA ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 3; 3; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0270_2ede411f-1237-4dc1-a602-7bd35741c192	44911-0270	HUMAN OTC DRUG	Psora Miasm		Eggshell Membrane, Whey Protein, Arsenicum Album, Croton Tiglium, Hydrocotyle Asiatica, Natrum Muriaticum	LIQUID	ORAL	20150929	20260322	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; CENTELLA ASIATICA; CROTON TIGLIUM SEED; EGG SHELL MEMBRANE; SODIUM CHLORIDE; WHEY	12; 12; 12; 6; 12; 6	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	
44911-0271_e400431d-6aca-499d-823d-25732c5bb317	44911-0271	HUMAN OTC DRUG	Calc Fluor		Calcarea Fluorica	LIQUID	ORAL	20150930		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CALCIUM FLUORIDE	200	[hp_C]/mL			N	20241231
44911-0275_7c0c49ea-413a-451f-b0bb-a2eb8150b90d	44911-0275	HUMAN OTC DRUG	Cortisol Phenolic		Hydrocortisone	LIQUID	ORAL	20151001		UNAPPROVED HOMEOPATHIC		Energique, Inc.	HYDROCORTISONE	6	[hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
44911-0277_87c92297-c20d-41c7-b8b5-f780c10cd84a	44911-0277	HUMAN OTC DRUG	Nux Vom		Nux Vomica	LIQUID	ORAL	20151001	20251013	UNAPPROVED HOMEOPATHIC		Energique, Inc.	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0280_b1e23b09-f362-494c-8bf4-700edfe80d43	44911-0280	HUMAN OTC DRUG	Renapar		Pareira Brava, Petroselinum Sativum, Sarsaparilla (Smilax Regelii), Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Rubia Tinctorum, Solidago Virgaurea, Triticum Repens	LIQUID	ORAL	20151023	20240429	UNAPPROVED HOMEOPATHIC		Energique, Inc.	BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; ELYMUS REPENS ROOT; MERCURIC CHLORIDE; PETROSELINUM CRISPUM; PORK KIDNEY; RUBIA TINCTORUM ROOT; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 3; 12; 12; 3; 6; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0285_2250606a-d5f8-4475-9491-c5de55d22057	44911-0285	HUMAN OTC DRUG	V	HP	Arsenicum Album, Belladonna, Carcinosin, Echinacea (Angustifolia), Eupatorium Perfoliatum, Gelsemium Sempervirens, Lycopodium Clavatum, Phosphoricum Acidum, Phosphorus, Pyrogenium, Rhus Tox	LIQUID	ORAL	20151026	20270329	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN BREAST TUMOR CELL; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0288_620b3f9c-06e0-4e24-8f86-9d9eb42dd075	44911-0288	HUMAN OTC DRUG	Prostex	HP	Baryta Carbonica, Clematis Erecta, Conium Maculatum, Lycopodium Clavatum, Mercurius Corrosivus, Pulsatilla (Pratensis), Sabal Serrulata, Selenium Metallicum, Sepia, Staphysagria, Thuja Occidentalis	LIQUID	ORAL	20151028		UNAPPROVED HOMEOPATHIC		Energique, Inc.	BARIUM CARBONATE; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; PULSATILLA PRATENSIS WHOLE; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0289_9a932caf-bbea-4edd-a08c-128f29d91e89	44911-0289	HUMAN OTC DRUG	Addastat		Trifolium Pratense, Petroleum, Phytolacca Decandra, Arsenicum Album, Chelidonium Majus, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Nitricum Acidum	LIQUID	ORAL	20151028	20250114	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; CHELIDONIUM MAJUS; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PHOSPHORIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; STRYCHNOS NUX-VOMICA SEED; TRIFOLIUM PRATENSE FLOWER	12; 12; 6; 12; 12; 12; 12; 6; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0295_348c43f4-5937-4d46-b7c8-cd0779eb2fb0	44911-0295	HUMAN OTC DRUG	Rescue 5		Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos	LIQUID	ORAL	20151111		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER	30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
44911-0301_a7d07d6b-af03-420b-a29b-c3822bed1830	44911-0301	HUMAN OTC DRUG	Acne	HP	Carbo Animalis, Carbo Vegetabilis, Kali Bichromicum, Kali Iodatum, Natrum Muriaticum, Pulsatilla (Pratensis), Sepia, Silicea, Sulphur, Zincum Metallicum	LIQUID	ORAL	20151118	20251109	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; CARBO ANIMALIS; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SULFUR; ZINC	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0308_87d22a70-0356-477c-9085-9a7d351bbfc8	44911-0308	HUMAN OTC DRUG	Endopar	F	Cimicifuga Racemosa, Fucus Vesiculosus, Oophorinum (Suis), Hypophysis Suis, Thyroidinum (Suis), Graphites, Lachesis Mutus, Natrum Muriaticum, Pulsatilla (Pratensis), Sepia	LIQUID	ORAL	20151130		UNAPPROVED HOMEOPATHIC		Energique, Inc.	BLACK COHOSH; FUCUS VESICULOSUS; GRAPHITE; LACHESIS MUTA VENOM; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND; THYROID	3; 3; 12; 12; 12; 12; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0310_90889b93-a718-4cd6-a3c4-384c31555680	44911-0310	HUMAN OTC DRUG	Rescue 5		Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos	LIQUID	ORAL	20151204	20260610	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER	2; 2; 2; 2; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0320_2bd7b88b-6263-4336-be0a-e78857d275cf	44911-0320	HUMAN OTC DRUG	Hemotone		Urtica Urens, Ferrum Metallicum, Aranea Diadema, Arsenicum Album, Indium Metallicum, Lachesis Mutus, Natrum Muriaticum, Phosphorus	LIQUID	ORAL	20160112	20250629	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARANEUS DIADEMATUS; ARSENIC TRIOXIDE; INDIUM; IRON; LACHESIS MUTA VENOM; PHOSPHORUS; SODIUM CHLORIDE; URTICA URENS	12; 12; 12; 8; 12; 12; 12; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0323_3a1f6462-2770-454c-b2de-60ac23407e75	44911-0323	HUMAN OTC DRUG	Intestipar		Gentiana Lutea, Arsenicum Album, Cinchona Officinalis, Colocynthis, Nux Vomica, Phosphorus, Small Intestine (Suis)	LIQUID	ORAL	20160212		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; GENTIANA LUTEA ROOT; PHOSPHORUS; PORK INTESTINE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 3; 12; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
44911-0324_595e64b3-3b1a-4e21-a293-403693601908	44911-0324	HUMAN OTC DRUG	Flower Antigens		Arsenicum Album, Lycopodium Clavatum, Pulsatilla (Pratensis), Bellis Perennis, Calendula Officinalis, Camellia Japonica, Chrysanthemum Coronarium, Chrysanthemum Leucanthemum, Convallaria Majalis, Gardenia Jasminoides, Impatiens Glandulifera, Flos, Iris Tenax, Lilium Tigrinum, Narcissus Pseudo-Narcissus, Rosa Damascena, Syringa Vulgaris	LIQUID	ORAL	20160708		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BELLIS PERENNIS WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; CAMELLIA JAPONICA FLOWER; CONVALLARIA MAJALIS; GARDENIA JASMINOIDES FLOWER; GLEBIONIS CORONARIA WHOLE; IMPATIENS GLANDULIFERA FLOWER; IRIS TENAX WHOLE; LEUCANTHEMUM VULGARE WHOLE; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; NARCISSUS PSEUDONARCISSUS FLOWER; PULSATILLA PRATENSIS WHOLE; ROSA DAMASCENA FLOWERING TOP; SYRINGA VULGARIS FLOWER	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
44911-0334_1ce2a71f-1c53-4ca6-a20f-253a42690368	44911-0334	HUMAN OTC DRUG	Shingles Pain Relief		Calendula Officinalis, Croton Tiglium, Natrum Muriaticum, Plantago Major, Rhus Tox, Sarsaparilla (Smilax Regelii)	SPRAY	TOPICAL	20160323	20250427	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CALENDULA OFFICINALIS FLOWERING TOP; CROTON TIGLIUM SEED; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	12; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; a/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0335_1148fa93-c689-48b4-93d5-c07ee221468c	44911-0335	HUMAN OTC DRUG	Scrophularitone		Baptisia Tinctoria, Echinacea (Angustifolia), Trifolium Pratense, Phytolacca Decandra, Arsenicum Iodatum, Baryta Carbonica, Bromium, Calcarea Carbonica, Kali Muriaticum, Lachesis Mutus, Mercurius Solubilis	LIQUID	ORAL	20160330	20241024	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIIODIDE; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; BROMINE; ECHINACEA ANGUSTIFOLIA; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; TRIFOLIUM PRATENSE FLOWER	12; 3; 12; 12; 3; 12; 12; 6; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
44911-0337_cdbbcbdf-0794-418d-9a5c-4e38bcae7423	44911-0337	HUMAN OTC DRUG	Acnetone		Berberis Vulgaris, Cimicifuga Racemosa, Antimonium Crudum, Carbo Vegetabilis, Hepar Sulphuris Calcareum, Kali Iodatum, Lycopodium Clavatum, Sepia, Sulphur	LIQUID	ORAL	20160330	20240117	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; BERBERIS VULGARIS ROOT BARK; BLACK COHOSH; CALCIUM SULFIDE; LYCOPODIUM CLAVATUM SPORE; POTASSIUM IODIDE; SEPIA OFFICINALIS JUICE; SULFUR	12; 12; 3; 3; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0344_c2f124dd-9db3-4aa3-9974-f9adc0215ea4	44911-0344	HUMAN OTC DRUG	Hypericum		Hypericum Perforatum	LIQUID	ORAL	20160412	20260420	UNAPPROVED HOMEOPATHIC		Energique, Inc	HYPERICUM PERFORATUM	200	[hp_C]/mL			N	
44911-0346_e41d4612-7969-4fcd-aee2-5c5a8b24601e	44911-0346	HUMAN OTC DRUG	Lycopodium		Lycopodium Clavatum	LIQUID	ORAL	20160412	20260413	UNAPPROVED HOMEOPATHIC		Energique, Inc.	LYCOPODIUM CLAVATUM SPORE	200	[hp_C]/mL			N	
44911-0347_4d124af0-8096-48bd-ba90-ef08ccd61972	44911-0347	HUMAN OTC DRUG	Psychypar		Cerebrum Suis, Baryta Carbonica, Calcarea Carbonica, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Pulsatilla (Pratensis), Sepia, Silicea	LIQUID	ORAL	20160419	20240606	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; BARIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0349_0a80006b-cb39-45c7-a7ae-b287105db0f2	44911-0349	HUMAN OTC DRUG	Apizastat		Avena Sativa, Beta Vulgaris, Alfalfa, Chelidonium Majus, Oxalis Acetosella, Paloondo, Phytolacca Decandra, Urtica Dioica, Verbascum Thapsus, Viscum Album, Argentum Metallicum, Calcarea Fluorica, Thuja Occidentalis, Thymolum, Anthracinum, Baptisia Tinctoria, Paronichia Illecebrum, X-Ray	LIQUID	ORAL	20160414	20240306	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); ALFALFA; ALTERNANTHERA SESSILIS; AVENA SATIVA FLOWERING TOP; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BETA VULGARIS; CALCIUM FLUORIDE; CHELIDONIUM MAJUS; LARREA TRIDENTATA LEAF; OXALIS ACETOSELLA LEAF; PHYTOLACCA AMERICANA ROOT; SILVER; THUJA OCCIDENTALIS LEAFY TWIG; THYMOL; URTICA DIOICA; VERBASCUM THAPSUS; VISCUM ALBUM FRUITING TOP	12; 2; 12; 1; 12; 12; 1; 6; 2; 2; 2; 2; 6; 6; 7; 2; 2; 2	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0350_15670839-0ad5-4d6e-9f70-40f0f60ed6f5	44911-0350	HUMAN OTC DRUG	Nightshade Antigens		Capsicum Annuum, Lycopersicum Esculentum, Solanum Melongena, Solanum Tuberosum, Tabacum, Alumina, Arsenicum Album, Nux Vomica, Phosphorus, Pulsatilla (Pratensis)	LIQUID	ORAL	20160419	20250317	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALUMINUM OXIDE; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; CAPSICUM; EGGPLANT; PHOSPHORUS; SOLANUM LYCOPERSICUM; SOLANUM TUBEROSUM; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	12; 12; 12; 9; 9; 12; 9; 9; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	
44911-0353_afb5b63f-bad3-4ed6-84d9-86e7aab24462	44911-0353	HUMAN OTC DRUG	Mag Phos		Magnesia Phosphorica	LIQUID	ORAL	20160420	20261026	UNAPPROVED HOMEOPATHIC		Energique, Inc.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_C]/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
44911-0355_9f8d1f0d-2729-48d0-bdd1-57d137d2893f	44911-0355	HUMAN OTC DRUG	Allerphenex	II	Acetylcholine Chloride, Acetaldehyde, Adrenalinum, Caffeic Acid, Candida Albicans, Chlorogenic Acid, Cinnamic Acid, Coumarinum, Cysteinum, Gallicum Acidum, Hepar Suis, Histaminum Hydrochloricum, Indolum, Malvin, Mannan, Menadione, Norepinephrine, Octopamine (Hydrochloride), Pancreas Suis, Phenyl Isothiocyanate, Phloridzinum, Quercetin, Salsolinol, Serotonin (Hydrochloride)	LIQUID	ORAL	20160420	20240225	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACETALDEHYDE; ACETYLCHOLINE CHLORIDE; CAFFEIC ACID; CANDIDA ALBICANS; CHLOROGENIC ACID; CINNAMIC ACID; COUMARIN; CYSTEINE; EPINEPHRINE; GALLIC ACID MONOHYDRATE; HISTAMINE DIHYDROCHLORIDE; INDOLE; MALVIN; MENADIONE; NOREPINEPHRINE; OCTOPAMINE HYDROCHLORIDE; PHENYL ISOTHIOCYANATE; PHLORIZIN; PORK LIVER; QUERCETIN; SALSOLINOL HYDROCHLORIDE; SEROTONIN HYDROCHLORIDE; SUS SCROFA PANCREAS; YEAST MANNAN	200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
44911-0361_87dde3a8-7137-46bf-9b1d-87661eee9320	44911-0361	HUMAN OTC DRUG	Vegetable Antigens		Allium Cepa, Allium Sativum, Apium Graveolens, Beta Vulgaris, Brassica Oleracea Var. Botrytis, Brassica Oleracea Var. Capitata, Brassica Oleracea Var. Italica, Brassica Oleracea Var. Sabellica, Brassica Rapa Var. Rapa, Cicer Arietinum, Cucumis Staivus, Glycine Max, Lactuca Sativa, Lens Culinaris, Pastinaca Sativa, Phaseolus, Phaseolus Lunatus, Phaseolus Vulgaris, Raphanus Sativus, Spinacia Oleracea, Arsenicum Album, Bryonia (Alba), Helleborus Niger, Lycopodium Clavatum, Petroleum	LIQUID	ORAL	20160601	20250210	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BEET; BROCCOLI; BRYONIA ALBA ROOT; CABBAGE; CAULIFLOWER; CELERY SEED; CHICKPEA; CUCUMBER; GARLIC; HELLEBORUS NIGER ROOT; KALE; KEROSENE; KIDNEY BEAN; LENTIL; LETTUCE; LIMA BEAN; LYCOPODIUM CLAVATUM SPORE; ONION; PARSNIP; RADISH; SOYBEAN; SPINACH; STRING BEAN; TURNIP	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	
44911-0363_87539fa3-9552-4d86-b63f-fd9b531b5957	44911-0363	HUMAN OTC DRUG	Lymestat		Chelidonium Majus, Echinacea (Angustifolia), Hydrastis Canadensis, Arsenicum Album, Bryonia (Alba), Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Phosphorus, Rhus Tox	LIQUID	ORAL	20160602	20241022	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	12; 12; 3; 12; 3; 6; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0364_e93c96c8-7875-42ae-9182-d554dae967ea	44911-0364	HUMAN OTC DRUG	HZ Neurapain	HP	Echinacea (Angustifolia), Kali Phosphoricum, Sarracenia Purpurea, Arsenicum Album, Causticum, Dolichos Pruriens, Hypericum Perforatum, Mezereum, Ranunculus Bulbosus, Rhus Tox	LIQUID	ORAL	20160615	20240723	UNAPPROVED HOMEOPATHIC		Energique, Inc	ARSENIC TRIOXIDE; CAUSTICUM; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA; HYPERICUM PERFORATUM; MUCUNA PRURIENS FRUIT TRICHOME; POTASSIUM PHOSPHATE, DIBASIC; RANUNCULUS BULBOSUS; SARRACENIA PURPUREA; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 6; 30; 30; 6; 30; 9; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0369_7b901352-ee6b-47d8-b819-6728b25407ec	44911-0369	HUMAN OTC DRUG	Rheumatone		Cimicifuga Racemosa, Lappa Major, Trifolium Pratense, Colchicum Autumnale, Dulcamara, Lycopodium Clavatum, Pulsatilla (Pratensis), Rhododendron Chrysanthum, Rhus Tox	LIQUID	ORAL	20160616	20241022	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; ARCTIUM LAPPA ROOT; BLACK COHOSH; COLCHICUM AUTUMNALE BULB; LYCOPODIUM CLAVATUM SPORE; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER	12; 3; 3; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0371_d73db230-c7b0-474b-8a1b-bbd2dab59c92	44911-0371	HUMAN OTC DRUG	HZ Stat		Astragalus Membranaceus, Echinacea (Angustifolia), Hypericum Perforatum, Hydrastis Canadensis, Dulcamara, Gelsemium Sempervirens, Nitricum Acidum, Ranunculus Bulbosus, Thuja Occidentalis	LIQUID	ORAL	20160616	20240930	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ASTRAGALUS PROPINQUUS ROOT; ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HYPERICUM PERFORATUM; NITRIC ACID; RANUNCULUS BULBOSUS; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG	3; 3; 12; 6; 3; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0373_919fd182-8ae4-4c74-bcaa-79482a2a5c9b	44911-0373	HUMAN OTC DRUG	Thyroxine Cord		Levothyroxinum	LIQUID	ORAL	20160621		UNAPPROVED HOMEOPATHIC		Energique, Inc.	LEVOTHYROXINE	12	[hp_X]/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
44911-0374_b0282e4a-7670-4a1a-a687-938a1f8baf9d	44911-0374	HUMAN OTC DRUG	Pneumopar		Lobelia Inflata, Lung (Suis), Symphytum Officinale, Arsenicum Album, Blatta Orientalis, Bryonia (Alba), Phosphorus, Silicea, Sulphur	LIQUID	ORAL	20160726	20250324	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BLATTA ORIENTALIS; BRYONIA ALBA ROOT; COMFREY ROOT; LOBELIA INFLATA; PHOSPHORUS; SILICON DIOXIDE; SULFUR; SUS SCROFA LUNG	12; 12; 12; 6; 3; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	
44911-0378_f193c9d5-2942-4d93-9ffe-158b01687d80	44911-0378	HUMAN OTC DRUG	Septastat		Baptisia Tinctoria, Echinacea (Angustifolia), Anthracinum, Arsenicum Album, Belladonna, Crotalus Horridus, Hyoscyamus Niger, Lachesis Mutus, Pyrogenium, Tarentula Cubensis	LIQUID	ORAL	20160727	20240319	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; CITHARACANTHUS SPINICRUS; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; HYOSCYAMUS NIGER; LACHESIS MUTA VENOM; RANCID BEEF	12; 12; 12; 3; 12; 12; 3; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0379_eee7a9ff-4e00-4c5b-8e00-8f803acb6558	44911-0379	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	LIQUID	ORAL	20160816	20260805	UNAPPROVED HOMEOPATHIC		Energique, Inc.	SILVER NITRATE	200	[hp_C]/mL			N	
44911-0380_92936356-7c29-4c29-b61b-65b0a883b5d9	44911-0380	HUMAN OTC DRUG	Aurum Met		Aurum Metallicum	LIQUID	ORAL	20160816		UNAPPROVED HOMEOPATHIC		Energique, Inc.	GOLD	200	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
44911-0381_feb53596-a827-4718-ad0d-701a36415281	44911-0381	HUMAN OTC DRUG	Belladonna		Belladonna	LIQUID	ORAL	20160819		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ATROPA BELLADONNA	200	[hp_C]/mL			N	20241231
44911-0383_e7050c69-e7fa-4974-8c79-87efdf196256	44911-0383	HUMAN OTC DRUG	Calc Carb		Calcarea Carbonica	LIQUID	ORAL	20160822	20260413	UNAPPROVED HOMEOPATHIC		Energique, Inc.	OYSTER SHELL CALCIUM CARBONATE, CRUDE	200	[hp_C]/mL			N	
44911-0385_a35364b5-6390-4891-8903-dc1632b5e92c	44911-0385	HUMAN OTC DRUG	Chamomilla		Chamomilla	LIQUID	ORAL	20160822		UNAPPROVED HOMEOPATHIC		Energique, Inc.	MATRICARIA RECUTITA	200	[hp_C]/mL			N	20241231
44911-0391_b416d318-bfcc-47ec-b412-26ba8eb33fc7	44911-0391	HUMAN OTC DRUG	Sepia		Sepia	LIQUID	ORAL	20160822	20250423	UNAPPROVED HOMEOPATHIC		Energique, Inc.	SEPIA OFFICINALIS JUICE	200	[hp_C]/mL			N	
44911-0405_ccac0adf-04a3-4859-9e30-e49d24bfe95a	44911-0405	HUMAN OTC DRUG	Gonadal Homeopathic		Capsicum Annuum, Oophorinum (Suis), Ferrum Metallicum, Lachesis Mutus, Sepia, Lac Caninum	LIQUID	ORAL	20161130	20240820	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CANIS LUPUS FAMILIARIS MILK; CAPSICUM; IRON; LACHESIS MUTA VENOM; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY	16; 6; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
44911-0413_206b6204-26e0-4c15-8b1f-eaabded62a23	44911-0413	HUMAN OTC DRUG	Virustat		Echinacea (Angustifolia), Lomatium Dissectum, Hydrastis Canadensis, Aconitum Napellus, Arsenicum Album, Belladonna, Eupatorium Perfoliatum, Gelsemium Sempervirens, Lachesis Mutus, Rhus Tox, Pyrogenium	LIQUID	ORAL	20170109	20250401	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; LACHESIS MUTA VENOM; LOMATIUM DISSECTUM ROOT; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 3; 12; 12; 6; 12; 3; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0417_742f40ae-c48e-4b1c-a41b-4b1ea787428c	44911-0417	HUMAN OTC DRUG	Grain and Seed Antigens		Bamboo, Barley, Corn, Cotton Seed, Flax Seed (Linum Usitatissimum), Millet, Milo, Oat, Poppy Seed, Rice, Rye, Safflower, Sesame, Sorghum, Soy Bean, Sugarcane, Sunflower (Helianthus Annuus), Wheat, Arsenicum Album, Lycopodium Clavatum, Natrum Muriaticum, Sulphur	LIQUID	ORAL	20170208	20240528	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BAMBUSA VULGARIS TOP; BARLEY; BROWN RICE; CORN; COTTON SEED; FLAX SEED; HELIANTHUS ANNUUS FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; MILLET; OAT; POPPY SEED; RYE; SAFFLOWER; SESAME SEED; SODIUM CHLORIDE; SORGHUM; SOYBEAN; SUGARCANE; SULFUR; WHEAT	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]	CII	N	
44911-0419_eeacc3c5-b06d-467d-b422-1c9f101149a9	44911-0419	HUMAN OTC DRUG	Liverex I		Ginkgo Biloba, Fel Tauri, Gallbladder (Suis), Hepar Suis), Thyroidinum (Suis), Germanium Sesquioxide, Alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Malicum Acidum, Manganum Metallicum, Pyruvic Acid, Succinicum Acidum, Naphthochinonum, Arsenicum Metallicum, Sulphur, Aconiticum Acidum, Cis, Lycopodium Clavatum, Natrum Oxalaceticum, Phosphorus	LIQUID	ORAL	20170228		UNAPPROVED HOMEOPATHIC		Energique, Inc.	1,4-NAPHTHOQUINONE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; ARSENIC; BOS TAURUS BILE; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; LYCOPODIUM CLAVATUM SPORE; MALIC ACID; MANGANESE; OXOGLURIC ACID; PHOSPHORUS; PORK LIVER; PYRUVIC ACID; SODIUM DIETHYL OXALACETATE; SUCCINIC ACID; SULFUR; SUS SCROFA GALLBLADDER; THYROID	9; 12; 8; 12; 6; 8; 8; 6; 12; 8; 8; 8; 12; 6; 8; 12; 8; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
44911-0420_c2dcad60-9715-4366-af68-043bcc679745	44911-0420	HUMAN OTC DRUG	Pancreapar		Syzygium Jambolanum, Glandula Suprarenalis Suis, Hydrastis Canadensis, Hypophysis Suis, Pancreas Suis, Phaseolus, Aceticum Acidum, Lacticum Acidum, Phosphoricum Acidum, Phosphorus, Uranium Nitricum	LIQUID	ORAL	20170804	20261014	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACETIC ACID; GOLDENSEAL; KIDNEY BEAN; LACTIC ACID; PHOSPHORIC ACID; PHOSPHORUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SYZYGIUM CUMINI SEED; URANYL NITRATE HEXAHYDRATE	12; 6; 9; 12; 12; 12; 6; 6; 6; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
44911-0423_1ed14579-60a6-4fc1-a7db-76fe91796ed5	44911-0423	HUMAN OTC DRUG	Phenylisothiocyanate Phenolic		Phenyl Isothiocyanate	LIQUID	ORAL	20170502	20250429	UNAPPROVED HOMEOPATHIC		Energique, Inc.	PHENYL ISOTHIOCYANATE	6	[hp_X]/mL			N	
44911-0430_272661c5-f5fe-4d09-9e7e-aea49022f4dd	44911-0430	HUMAN OTC DRUG	Glutenstat		Alfalfa, Cinchona Officinalis, Zingiber Officinale, Hydrastis Canadensis, Barley (Grain), Carbo Vegetabilis, Glyphosate, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Oat (Grain), Pulsatilla (Vulgaris), Rye (Grain), Wheat (Grain), Gluten	LIQUID	ORAL	20170621	20260930	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; ALFALFA; ANEMONE PULSATILLA; BARLEY; CINCHONA OFFICINALIS BARK; GINGER; GLYPHOSATE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; OATMEAL; RYE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; WHEAT; WHEAT GLUTEN	12; 4; 12; 12; 4; 4; 12; 6; 12; 12; 12; 12; 12; 12; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0431_b25a901c-22fe-4f78-80d3-100cf59ead61	44911-0431	HUMAN OTC DRUG	Pneumostat		Echinacea (Angustifolia), Hydrastis Canadensis, Hypericum Perforatum, Symphytum Officinale, Arsenicum Album, Causticum, Kali Carbonicum, Natrum Sulphuricum, Phosphorus, Pulsatilla (Pratensis), Silicea	LIQUID	ORAL	20170620	20240319	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; CAUSTICUM; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HYPERICUM PERFORATUM; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA PRATENSIS; SILICON DIOXIDE; SODIUM SULFATE	12; 12; 6; 3; 3; 6; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0433_ffd3cf10-43ee-4771-9628-9ef267a16637	44911-0433	HUMAN OTC DRUG	Virustat		Echinacea (Angustifolia), Lomatium Dissectum, Hydrastis Canadensis, Aconitum Napellus, Arsenicum Album, Belladonna, Eupatorium Perfoliatum, Gelsemium Sempervirens, Lachesis Mutus, Rhus Tox, Pyrogenium	LIQUID	ORAL	20170724	20250415	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; LACHESIS MUTA VENOM; LOMATIUM DISSECTUM ROOT; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 3; 12; 12; 6; 12; 3; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0437_cb401183-25a2-4a43-a58f-fc8b45e6832e	44911-0437	HUMAN OTC DRUG	Fungustat	II	Echinacea (Angustifolia), Fucus Vesiculosus, Hydrastis Canadensis, Phytolacca Decandra, Kreosotum, Natrum Muriaticum, Candida Albicans, Lycopodium Clavatum, Pulsatilla (Pratensis), Sepia	LIQUID	ORAL	20170905	20250413	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; CANDIDA ALBICANS; ECHINACEA ANGUSTIFOLIA; FUCUS VESICULOSUS; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; WOOD CREOSOTE	30; 12; 3; 3; 6; 30; 6; 30; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
44911-0440_934e2722-e570-4979-a279-73112634d788	44911-0440	HUMAN OTC DRUG	Endopar		Glandula Suprarenalis Suis, Hypophysis Suis, Hypothalamus Suis, Oophorinum (Suis), Orchitinum (Bovine), Pineal Gland, Thyroidinum, Arsenicum Album, Baryta Carbonica, Natrum Muriaticum, Phosphoricum Acidum, Pulsatilla (Pratensis)	LIQUID	ORAL	20180719		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BARIUM CARBONATE; BOS TAURUS TESTICLE; PHOSPHORIC ACID; PULSATILLA PRATENSIS WHOLE; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; THYROID	12; 12; 8; 12; 12; 12; 8; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0441_418f132e-da8b-4dbe-8595-2f12575d6a4f	44911-0441	HUMAN OTC DRUG	Kidnex	IV	Ginkgo Biloba, Kidney (Suis), Lymph Node (Suis), Urinary Bladder (Suis), Germanium Sesquioxide, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Mercurius Vivus, alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Malicum Acidum, Pyruvic Acid, Succinicum Acidum, Naphthochinonum, Nux Vomica, Aconiticum Acidum, Cis-, Natrum Oxalaceticum, Phosphorus	LIQUID	ORAL	20170921	20240925	UNAPPROVED HOMEOPATHIC		Energique, Inc.	1,2-NAPHTHOQUINONE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; COPPER; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; MALIC ACID; MERCURY; OXOGLURIC ACID; PHOSPHORUS; PORK KIDNEY; PYRUVIC ACID; SILVER; SODIUM DIETHYL OXALACETATE; STRYCHNOS NUX-VOMICA SEED; SUCCINIC ACID; SUS SCROFA LYMPH; SUS SCROFA URINARY BLADDER	9; 12; 8; 8; 8; 8; 6; 8; 8; 8; 8; 12; 6; 8; 8; 12; 12; 8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	
44911-0443_58818186-7b29-40e4-9548-5d89dc0fd305	44911-0443	HUMAN OTC DRUG	Vaccistat		Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Antimonium Tartaricum, Mezereum, Mercurius Solubilis, Silicea, Thuja Occidentalis, Malandrinum, Variolinum	LIQUID	ORAL	20170928	20250120	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANTIMONY POTASSIUM TARTRATE; BAPTISIA TINCTORIA ROOT; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; MERCURIUS SOLUBILIS; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; VACCINIA VIRUS; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN	12; 3; 12; 3; 6; 30; 30; 30; 60; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Live Vaccinia Virus Vaccine [EPC], Smallpox Vaccine [CS], Vaccines, Live, Unattenuated [CS]		N	
44911-0445_2456ba9f-417b-4d37-8bc2-37a3629dd4e9	44911-0445	HUMAN OTC DRUG	Vaccistat		Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Antimonium Tartaricum, Mezereum, Mercurius Solubilis, Silicea, Thuja Occidentalis, Malandrinum, Variolinum	LIQUID	ORAL	20170929	20240311	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANTIMONY POTASSIUM TARTRATE; BAPTISIA TINCTORIA ROOT; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; MERCURIUS SOLUBILIS; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; VACCINIA VIRUS; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN	12; 3; 12; 3; 6; 30; 30; 30; 60; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Actively Acquired Immunity [PE], Live Vaccinia Virus Vaccine [EPC], Smallpox Vaccine [CS], Vaccines, Live, Unattenuated [CS]		N	
44911-0446_a953cf42-4285-40cb-a1fe-f84a6b365987	44911-0446	HUMAN OTC DRUG	Trauma plus Gel		Calendula Officinalis, Arnica Montana, Hypericum Perforatum, Symphytum Officinale, Bellis Perennis, Ledum Palustre, Sulphuricum Acidum, Calcarea Fluorica, Ferrum Phosphoricum, Rhus Tox, Ruta Graveolens, Natrum Sulphuricum	GEL	TOPICAL	20180208		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARNICA MONTANA; BELLIS PERENNIS; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; RUTA GRAVEOLENS FLOWERING TOP; SODIUM SULFATE; SULFURIC ACID; TOXICODENDRON PUBESCENS LEAF	1; 12; 30; 1; 6; 30; 1; 12; 30; 30; 12; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_C]/g; [hp_X]/g; [hp_X]/g			N	20241231
44911-0447_40f6d914-5191-4ce5-a618-cbe7d81472f6	44911-0447	HUMAN OTC DRUG	Osteotone		Symphytum Officinale, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Causticum, Hekla Lava, Pulsatilla (Pratensis), Rhus Tox, Silicea, Strontium Carbonicum	LIQUID	ORAL	20171129	20240801	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CALCIUM FLUORIDE; CAUSTICUM; COMFREY ROOT; HEKLA LAVA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA PRATENSIS WHOLE; SILICON DIOXIDE; STRONTIUM CARBONATE; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	12; 12; 6; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
44911-0449_babfa6e6-4ea6-4937-af61-795cc3cb257e	44911-0449	HUMAN OTC DRUG	Systemistat		Berberis Vulgaris, Chelidonium Majus, Lappa Major, Hydrastis Canadensis, Hepar Sulphuris Calcareum, Lycopodium Clavatum, Sulphur, Calcarea Carbonica, Mercurius Solubilis, Thuja Occidentalis	LIQUID	ORAL	20180306		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARCTIUM LAPPA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CHELIDONIUM MAJUS WHOLE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	3; 3; 12; 3; 5; 12; 30; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0451_12e6b8f2-bec0-4b69-aaef-2c9182693a27	44911-0451	HUMAN OTC DRUG	Recovatone		Glycyrrhiza Glabra, Kali Muriaticum, Zincum Gluconicum, Kali Phosphoricum, Iodium, Phosphorus, Adrenocorticotrophin, Ascorbicum Acidum, Calcium Gluconate, L-Arginine, L-Carnitine, L-Ornithine, Magnesia Muriatica, Magnesium Gluconicum, Dihydricum, Manganese Gluconate, Natrum Muriaticum, Adrenalinum, Cobalt Gluconate, Copper Gluconate, Creatine, Ferrous Gluconate, Glutamine, L-Leucine, L-Valine, Potassium Gluconate, Selenium Dioxide, Boron, Calcarea Phosphorica, Chromium, Molybdenum, Niccolum Metallicum	LIQUID	ORAL	20180402	20240917	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARGININE; ASCORBIC ACID; BORON; CALCIUM GLUCONATE; CARNITINE; CHROMIUM; COBALTOUS GLUCONATE; COPPER GLUCONATE; CORTICOTROPIN; CREATINE; DIBASIC POTASSIUM PHOSPHATE; EPINEPHRINE; FERROUS GLUCONATE; GLUTAMINE; GLYCYRRHIZA GLABRA; IODINE; LEUCINE; MAGNESIUM CHLORIDE; MAGNESIUM GLUCONATE; MANGANESE GLUCONATE; MOLYBDENUM; NICKEL; ORNITHINE; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM GLUCONATE; SELENIUM; SELENIUM DIOXIDE; SODIUM CHLORIDE; STRONTIUM CARBONATE; TRIBASIC CALCIUM PHOSPHATE; VALINE; VANADIUM; ZINC GLUCONATE	6; 6; 12; 6; 6; 14; 8; 8; 6; 8; 3; 8; 10; 8; 1; 4; 8; 6; 6; 6; 12; 12; 6; 5; 2; 8; 12; 8; 6; 12; 12; 8; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acids [CS], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin C [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
44911-0452_dffe4384-07aa-4ecc-a7d9-9feba4e20d35	44911-0452	HUMAN OTC DRUG	Animal Antigens		Canary Feathers, Cat Hair, Cattle Epithelia, Chicken Feathers, Dog Epithelia, Duck Feathers, Gerbil Epithelia, Goat Epithelia, Goose Feathers, Guinea Pig Epithelia, Hamster Epithelia, Hog Epithelia, Horse Epithelia, Mouse Epithelia, Parakeet Feathers, Rabbit Epithelia, Rat Epithelia, Arsenicum Album, Nux Vomica, Phosphorus	LIQUID	ORAL	20180718		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; ARSENIC TRIOXIDE; BOS TAURUS SKIN; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS SKIN; CAVIA PORCELLUS SKIN; EQUUS CABALLUS SKIN; FELIS CATUS HAIR; GALLUS GALLUS FEATHER; MELOPSITTACUS UNDULATUS FEATHER; MERIONES UNGUICULATUS SKIN; MESOCRICETUS AURATUS SKIN; MUS MUSCULUS SKIN; ORYCTOLAGUS CUNICULUS SKIN; PHOSPHORUS; RATTUS NORVEGICUS SKIN; SERINUS CANARIA FEATHER; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA SKIN	9; 9; 12; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 9; 12; 9; 9; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
44911-0454_0da8289e-50ee-4334-b1cf-2a975b3ac129	44911-0454	HUMAN OTC DRUG	CMV Stat		Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Phytolacca Decandra, Aranea Diadema, Ipecacuanha, Iridium Metallicum, Lachesis Mutus, Muriaticum Acidum, Rhus Tox, Epstein-Barr Virus Nosode	LIQUID	ORAL	20180508	20240304	UNAPPROVED HOMEOPATHIC		Energique, Inc	ARANEUS DIADEMATUS; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HUMAN HERPESVIRUS 4; HYDROCHLORIC ACID; IPECAC; IRIDIUM; LACHESIS MUTA VENOM; LOMATIUM DISSECTUM ROOT; PHYTOLACCA AMERICANA ROOT; TABEBUIA IMPETIGINOSA BARK; TOXICODENDRON PUBESCENS LEAF	12; 3; 6; 30; 12; 12; 12; 12; 3; 6; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0455_0007cd0a-4506-4d05-bc9a-d834ac7b5963	44911-0455	HUMAN OTC DRUG	Gastrotone		Gentiana Lutea, Sambucus Nigra, Arsenicum Album, Kali Bichromicum, Lycopodium Clavatum, Phosphorus, Pulsatilla (Vulgaris), Bismuthum Subnitricum	LIQUID	ORAL	20180508	20251103	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BISMUTH SUBNITRATE; GENTIANA LUTEA ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; POTASSIUM DICHROMATE; SAMBUCUS NIGRA FLOWERING TOP	12; 12; 15; 3; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Bismuth [CS], Bismuth [EPC]		N	
44911-0458_ca5753fd-d64b-4c4e-9bdb-7082e91ffc9d	44911-0458	HUMAN OTC DRUG	Tobaccostat		Avena Sativa, Valeriana Officinalis, Capsicum Annuum, Paullinia Sorbilis, Lobelia Inflata, Tabacum, Cadmium Sulphuratum, Caladium Seguinum, Daphne Indica, Nux Vomica, Phosphoricum Acidum, Spigelia Anthelmia, Staphysagria	LIQUID	ORAL	20180615		UNAPPROVED HOMEOPATHIC		Energique, Inc.	AVENA SATIVA FLOWERING TOP; CADMIUM SULFIDE; CAPSICUM; DAPHNE ODORA BARK; DIEFFENBACHIA SEGUINE; LOBELIA INFLATA WHOLE; PAULLINIA CUPANA SEED; PHOSPHORIC ACID; SPIGELIA ANTHELMIA WHOLE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; VALERIAN	1; 12; 3; 12; 12; 3; 3; 12; 12; 12; 4; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
44911-0479_b5fab510-abd1-4af8-a653-3b9297f91370	44911-0479	HUMAN OTC DRUG	Bactestat		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Aconitum Napellus, Arsenicum Album, Belladonna, Ferrum Phosphoricum, Lachesis Mutus, Phosphorus	LIQUID	ORAL	20181015	20241126	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT	12; 12; 12; 3; 3; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0480_ff2e913b-186b-45d1-8160-9c754827a9ce	44911-0480	HUMAN OTC DRUG	Influenzinum		Influenzinum (2018-2019)	LIQUID	ORAL	20181101	20240218	UNAPPROVED HOMEOPATHIC		Energique, Inc.	INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	200; 200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0481_e074842c-f9a0-445f-8fbc-a493e7714fc6	44911-0481	HUMAN OTC DRUG	Bio-Immune		Chelidonium Majus, Lobelia Inflata, Rumex Crispus, Sambucus Nigra, Scrophularia Nodosa, Senega Officinalis, Spongia Tosta, Taraxacum Officinale, Myristica Sebifera, Sticta Pulmonaria, Sulphur, Ustilago Maidis, Polyporus Officinalis, Candida Albicans, Carduus Marianus, Crotalus Horridus, Agaricus Muscarius, Bovista, Secale Cornutum, Anas Barbariae, Hepatis Et Cordis Extractum, Anthracinum, Arsenicum Album, Baptisia Tinctoria, Berberis Vulgaris, Botulinum, Dysentery Bacillus, Gaertner Bacillus (Bach),	LIQUID	ORAL	20181109	20240306	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMANITA MUSCARIA FRUITING BODY; ARSENIC TRIOXIDE; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CANDIDA ALBICANS; CHELIDONIUM MAJUS; CLAVICEPS PURPUREA SCLEROTIUM; CLOSTRIDIUM BOTULINUM; CROTALUS HORRIDUS HORRIDUS VENOM; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); LARICIFOMES OFFICINALIS FRUITING BODY; LOBARIA PULMONARIA; LOBELIA INFLATA; LYCOPERDON UTRIFORME FRUITING BODY; MILK THISTLE; POLYGALA SENEGA ROOT; RANCID BEEF; RUMEX CRISPUS ROOT; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SAMBUCUS NIGRA FLOWERING TOP; SCROPHULARIA NODOSA; SHIGELLA DYSENTERIAE; SPONGIA OFFICINALIS SKELETON, ROASTED; STREPTOCOCCUS PNEUMONIAE; SULFUR; TARAXACUM OFFICINALE; USTILAGO MAYDIS; VACCINIA VIRUS; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN; VIROLA SEBIFERA RESIN	10; 30; 30; 30; 30; 30; 12; 3; 10; 30; 12; 30; 30; 30; 30; 30; 8; 6; 3; 10; 12; 3; 30; 3; 30; 3; 3; 30; 3; 30; 6; 3; 6; 30; 30; 6	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Live Vaccinia Virus Vaccine [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Smallpox Vaccine [CS], Vaccines, Live, Unattenuated [CS]		N	
44911-0483_162c13d2-d756-4de5-8bf7-7fb46d5dcbd2	44911-0483	HUMAN OTC DRUG	Envirostat		Berberis Vulgaris, Chelidonium Majus, Lappa Major, Phytolacca Decandra, Calcarea Fluorica, Carbo Animalis, Nux Vomica, Phosphorus, Sepia, Sulphur, Thuja Occidentalis	LIQUID	ORAL	20181129		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARCTIUM LAPPA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM FLUORIDE; CARBO ANIMALIS; CHELIDONIUM MAJUS WHOLE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAF	3; 3; 12; 12; 3; 12; 6; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
44911-0485_c4afeea6-3f4d-4e04-9edf-177e84cab120	44911-0485	HUMAN OTC DRUG	Bactestat		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Aconitum Napellus, Arsenicum Album, Belladonna, Ferrum Phosphoricum, Lachesis Mutus, Phosphorus	LIQUID	ORAL	20190110	20250626	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT	12; 12; 12; 3; 3; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0486_6b1f910c-3f72-4133-b26a-9aa796758894	44911-0486	HUMAN OTC DRUG	EBV Stat		Astragalus Membranaceus, Echinacea (Angustifolia), Phytolacca Decandra, Hydrastis Canadensis, Aranea Diadema, Iridium Metallicum, Lycopodium Clavatum, Rhus Tox, Silicea, Sepia, Epstein-Barr Virus Nosode	LIQUID	ORAL	20190117	20240313	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARANEUS DIADEMATUS; ASTRAGALUS PROPINQUUS ROOT; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HUMAN HERPESVIRUS 4; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	12; 3; 3; 6; 30; 12; 12; 4; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0487_78a8b670-69cb-4256-9136-2f796b12904f	44911-0487	HUMAN OTC DRUG	Parastat		Artemisia Vulgaris, Cina, Sabadilla, Spigelia Anthelmia, Filix Mas, Baryta Carbonica, Calcarea Carbonica, Sulphur, Terebinthina	LIQUID	ORAL	20190201	20250420	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; BARIUM CARBONATE; DRYOPTERIS FILIX-MAS ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SCHOENOCAULON OFFICINALE SEED; SPIGELIA ANTHELMIA; SULFUR; TURPENTINE OIL	3; 3; 12; 4; 12; 3; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0488_fddfa4f5-e354-49fc-ac87-1e2d94a592f2	44911-0488	HUMAN OTC DRUG	Thyrostat		Fucus Vesiculosus, Spongia Tosta, Hypophysis Suis, Thyroidinum (Suis), Arsenicum Iodatum, Baryta Carbonica, Iodium, Lycopus Virginicus, Natrum Muriaticum	LIQUID	ORAL	20190222		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIIODIDE; BARIUM CARBONATE; FUCUS VESICULOSUS; IODINE; LYCOPUS VIRGINICUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; THYROID	12; 12; 3; 12; 12; 12; 12; 3; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0489_7d40d6e1-7d4a-4a51-800f-091ae350628d	44911-0489	HUMAN OTC DRUG	Multi-Phenolic		Serotonin Hydrochloride, 5-Hydroxytryptophan, Acetaldehyde, Acetylcholine Chloride, Apiolum, Ascorbic Acid, Aspartame, Butylated Hydroxytoluene, Caffeic Acid, Chlorogenic Acid, Cinnamic Acid, Coniferyl Alcohol, Coumarinum, Dopamine Hydrochloride, Estradiol, Gallicum Acidum, GABA (Gamma-Aminobutyric Acid), Histaminum Hydrochloricum, Hydrocortisone (Cortisol), Indolum, L-Dopa, L-Phenylalanine, Malvin, Mannan, Melatonin, Menadione, Norepinephrine (Bitartrate), Octopamine (Hydrochloride), Phenyl Isothiocyanate,	LIQUID	ORAL	20190319	20240701	UNAPPROVED HOMEOPATHIC		Energique, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETALDEHYDE; ACETYLCHOLINE CHLORIDE; APIOLE (PARSLEY); ASCORBIC ACID; ASPARTAME; BUTYLATED HYDROXYTOLUENE; CAFFEIC ACID; CANDIDA ALBICANS; CHLOROGENIC ACID; CINNAMIC ACID; CONIFERYL ALCOHOL; COUMARIN; DOPAMINE HYDROCHLORIDE; ESTRADIOL; GALLIC ACID MONOHYDRATE; HISTAMINE DIHYDROCHLORIDE; HYDROCORTISONE; INDOLE; LEVODOPA; MALVIN; MELATONIN; MENADIONE; NOREPINEPHRINE BITARTRATE; OCTOPAMINE HYDROCHLORIDE; OXITRIPTAN; PHENYL ISOTHIOCYANATE; PHENYLALANINE; PHLORIZIN; PIPERINE; PROGESTERONE; PYRROLE; QUERCETIN; RUTIN; SALSOLINOL HYDROCHLORIDE; SEROTONIN HYDROCHLORIDE; TAURINE; YEAST MANNAN	6; 6; 6; 6; 6; 6; 6; 6; 12; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 4; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Ascorbic Acid [CS], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Progesterone [CS], Progesterone [EPC], Vitamin C [EPC]		N	
44911-0492_3c9639f9-8476-4390-882b-7a5b5d2524db	44911-0492	HUMAN OTC DRUG	Lyme	HP	Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Borrelia Burgdorferi Nosode, Babesia Microti, Ehrlichia Nosode (Canine), Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Nosode, Arsenicum Album, Bryonia (Alba), Chelidonium Majus, Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Phosphorus, Rhus Tox	LIQUID	ORAL	20190327	20240626	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BABESIA MICROTI; BAPTISIA TINCTORIA ROOT; BORRELIA BURGDORFERI; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; EHRLICHIA CANIS; GOLDENSEAL; HEPATITIS B VIRUS; JAPANESE ENCEPHALITIS VIRUS; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; NEISSERIA MENINGITIDIS; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	30; 20; 3; 12; 30; 30; 30; 3; 20; 6; 38; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0496_268aa51f-5eaa-4c09-b998-1aca994c8c30	44911-0496	HUMAN OTC DRUG	Infectone		Astragalus Membranaceus, Scrophularia Nodosa, Baptisia Tinctoria, Phytolacca Decandra, Aconitum Napellus, Arnica Montana, Lachesis Mutus, Pyrogenium	LIQUID	ORAL	20200228	20250304	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; ASTRAGALUS PROPINQUUS ROOT; BAPTISIA TINCTORIA ROOT; LACHESIS MUTA VENOM; PHYTOLACCA AMERICANA ROOT; RANCID BEEF; SCROPHULARIA NODOSA	12; 12; 3; 3; 12; 4; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0497_00dff638-e674-46a1-9bff-55b422f30e97	44911-0497	HUMAN OTC DRUG	Fungustat	I	Echinacea (Angustifolia), Tabebuia Impetiginosa, Abies Nigra, Lycopodium Clavatum, Nux Vomica, Phosphorus, Pulsatilla (Pratensis), Sepia, Skatolum, Candida Albicans	LIQUID	ORAL	20190515	20240723	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CANDIDA ALBICANS; ECHINACEA ANGUSTIFOLIA WHOLE; HANDROANTHUS IMPETIGINOSUS BARK; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PICEA MARIANA RESIN; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; SKATOLE; STRYCHNOS NUX-VOMICA SEED	30; 3; 3; 12; 12; 12; 12; 12; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0500_bdfbe914-ba46-48a2-885f-a5c8b74c8f7b	44911-0500	HUMAN OTC DRUG	Melatonin Pro		Calcarea Carbonica, Chamomilla, Cocculus Indicus, Coffea Cruda, Ferrum Phosphoricum, Kali Phosphoricum, Magnesia Carbonica, Melatonin, Natrum Muriaticum, Nux Vomica, Pulsatilla (Pratensis)	TABLET	ORAL	20190607		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANAMIRTA COCCULUS SEED; ARABICA COFFEE BEAN; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; MELATONIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA PRATENSIS WHOLE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
44911-0501_d900fb46-958e-4f0e-beef-04b239bdb46f	44911-0501	HUMAN OTC DRUG	Lyme	HP	Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Borrelia Burgdorferi Nosode, Babesia Microti, Ehrlichia Nosode (Canine), Meningococcus Nosode, Hepatitis B Nosode, Arsenicum Album, Bryonia (Alba), Chelidonium Majus, Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Phosphorus, Rhus Tox	LIQUID	ORAL	20190711	20240807	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BABESIA MICROTI; BAPTISIA TINCTORIA ROOT; BORRELIA BURGDORFERI; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; EHRLICHIA CANIS; GOLDENSEAL; HEPATITIS B VIRUS; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; NEISSERIA MENINGITIDIS; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	30; 20; 3; 12; 30; 30; 30; 3; 20; 6; 38; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0502_d45c906d-31b1-4019-a302-97a8214a8262	44911-0502	HUMAN OTC DRUG	Liquid B		Hordeum Vulgare, Hepar Suis, Heart (Suis), Torula Cerevisiae	LIQUID	ORAL	20190606		UNAPPROVED HOMEOPATHIC		Energique, Inc.	HORDEUM VULGARE TOP; PORK HEART; PORK LIVER; SACCHAROMYCES CEREVISIAE	2; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
44911-0503_51cbef26-8412-4669-83c2-e41bab7c4cc4	44911-0503	HUMAN OTC DRUG	Lymphdrainex		Geranium Robertianum, Nasturtium Aquaticum, Scrophularia Nodosa, Teucrium Scorodonia, Apis Mellifica, Equisetum Hyemale, Fumaria Officinalis, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Veronica Officinalis, Aloe, Gentiana Lutea, Juglans Regia, Myosotis Arvensis, Sarsaparilla (Smilax Regelii), Baryta Carbonica, Hepar Sulphuris Calcareum, Mercurius Cyanatus, Ferrum Iodatum, Aranea Diadema, Calcarea Phosphorica, Parathyroid Gland (Bovine), Thymus (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20200114	20241127	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALOE; APIS MELLIFERA; ARANEUS DIADEMATUS; BARIUM CARBONATE; BOS TAURUS PARATHYROID GLAND; CALCIUM SULFIDE; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA FRUIT RIND, IMMATURE; MERCURIC CYANIDE; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA THYMUS; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	4; 4; 12; 8; 12; 8; 4; 8; 4; 5; 3; 6; 8; 6; 3; 4; 4; 3; 6; 4; 12; 12; 3; 12; 4	[hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
44911-0504_decef499-5b2b-4898-9bbe-b5df843c59ff	44911-0504	HUMAN OTC DRUG	Infectistat		Baptisia Tinctoria, Echinacea (Angustifolia), Lobelia Inflata, Lomatium Dissectum, Hydrastis Canadensis, Lung (Suis), Phytolacca Decandra, Symphytum Officinale, Aconitum Napellus, Arsenicum Album, Belladonna, Bryonia (Alba), Causticum, Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens, Hypericum Perforatum, Kali Carbonicum, Lachesis Mutus, Natrum Sulphuricum, Phosphorus, Pulsatilla (Pratensis), Rhus Tox, Silicea, Sulphur, Pyrogenium	LIQUID	ORAL	20190801	20241024	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAUSTICUM; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LOBELIA INFLATA; LOMATIUM DISSECTUM ROOT; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; RANCID BEEF; SILICON DIOXIDE; SODIUM SULFATE; SULFUR; SUS SCROFA LUNG; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 3; 12; 12; 6; 3; 12; 12; 12; 6; 12; 12; 3; 3; 12; 6; 12; 30; 12; 12; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0505_8b35263a-1c4c-46e0-a9b5-710851af4af7	44911-0505	HUMAN OTC DRUG	Thyroid Homeopathic		Capsicum Annuum, Thyroidinum (Suis), Ferrum Metallicum, Baryta Carbonica, Iodium, Pulsatilla (Pratensis)	LIQUID	ORAL	20190801		UNAPPROVED HOMEOPATHIC		Energique, Inc.	BARIUM CARBONATE; CAPSICUM; IODINE; IRON; PULSATILLA PRATENSIS WHOLE; SUS SCROFA THYROID	12; 6; 12; 8; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
44911-0506_5f86be1e-a717-4c47-af5d-d820eceb392b	44911-0506	HUMAN OTC DRUG	Liver Gallbladder	HP	Belladonna, Carduus Marianus, Chelidonium Majus, Colocynthis, Lycopodium Clavatum, Natrum Sulphuricum, Nux Vomica, Phosphorus, Pulsatilla (Pratensis), Veratrum Album	LIQUID	ORAL	20190805	20261223	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; ATROPA BELLADONNA; CHELIDONIUM MAJUS; CITRULLUS COLOCYNTHIS FRUIT PULP; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; SILYBUM MARIANUM SEED; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
44911-0507_8590d09d-142d-4b29-9db3-abaf6b348989	44911-0507	HUMAN OTC DRUG	Allerphenex	I	Acetaldehyde, Acetylcholine Chloride, Adrenalinum, Caffeic Acid, Cinnamic Acid, Coumarinum, Cysteinum, Dopamine Hydrochloride, Gallicum Acidum, Hepar Suis, Histaminum Hydrochloricum, Indolum, Mannose, Menadione, Norepinephrine (Bitartrate), Pancreas Suis, Phenyl Isothiocyanate, Quercetin, Serotonin (Hydrochloride), Tyramine, Candida Albicans, Chlorogenic Acid, Phloridzinum, Malvin	LIQUID	ORAL	20190813	20241127	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACETALDEHYDE; ACETYLCHOLINE CHLORIDE; CAFFEIC ACID; CANDIDA ALBICANS; CHLOROGENIC ACID; CINNAMIC ACID; COUMARIN; CYSTEINE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; GALLIC ACID MONOHYDRATE; HISTAMINE DIHYDROCHLORIDE; INDOLE; MALVIN; MANNOSE, D-; MENADIONE; NOREPINEPHRINE BITARTRATE; PHENYL ISOTHIOCYANATE; PHLORIZIN; PORK LIVER; QUERCETIN; SEROTONIN HYDROCHLORIDE; SUS SCROFA PANCREAS; TYRAMINE	6; 6; 6; 12; 12; 6; 6; 6; 6; 6; 6; 6; 6; 12; 6; 6; 6; 6; 12; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
44911-0510_51e182c6-26b2-45a4-b59e-0f72551996f2	44911-0510	HUMAN OTC DRUG	Infectistat		Baptisia Tinctoria, Echinacea (Angustifolia), Lobelia Inflata, Lomatium Dissectum, Hydrastis Canadensis, Lung (Suis), Phytolacca Decandra, Symphytum Officinale, Aconitum Napellus, Arsenicum Album, Belladonna, Bryonia (Alba), Causticum, Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens, Hypericum Perforatum, Kali Carbonicum, Lachesis Mutus, Natrum Sulphuricum, Phosphorus, Pulsatilla (Pratensis), Rhus Tox, Silicea, Sulphur, Pyrogenium	LIQUID	ORAL	20190913	20250331	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAUSTICUM; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LOBELIA INFLATA; LOMATIUM DISSECTUM ROOT; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; RANCID BEEF; SILICON DIOXIDE; SODIUM SULFATE; SULFUR; SUS SCROFA LUNG; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 3; 12; 12; 6; 3; 12; 12; 12; 6; 12; 12; 3; 3; 12; 6; 12; 30; 12; 12; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0511_5933d813-b86c-480c-85b4-53852036086e	44911-0511	HUMAN OTC DRUG	Anxiety	HP	Arsenicum Album, Calcarea Carbonica, Ignatia Amara, Kali Carbonicum, Lachesis Mutus, Natrum Muriaticum, Phosphorus, Pulsatilla (Pratensis), Staphysagria	LIQUID	ORAL	20191203	20260823	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; DELPHINIUM STAPHISAGRIA SEED; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA PRATENSIS WHOLE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0517_fa57f2f9-2353-48ab-ad5a-c51b9675632e	44911-0517	HUMAN OTC DRUG	CMV Stat		Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Hydrastis Canadensis, Phytolacca Decandra, Aranea Diadema, Ipecacuanha, Iridium Metallicum, Lachesis Mutus, Muriaticum Acidum, Rhus Tox, Cytomegalovirus Nosode	LIQUID	ORAL	20191028	20250203	UNAPPROVED HOMEOPATHIC		Energique, Inc	ARANEUS DIADEMATUS; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HUMAN HERPESVIRUS 5; HYDROCHLORIC ACID; IPECAC; IRIDIUM; LACHESIS MUTA VENOM; LOMATIUM DISSECTUM ROOT; PHYTOLACCA AMERICANA ROOT; TABEBUIA IMPETIGINOSA BARK; TOXICODENDRON PUBESCENS LEAF	12; 3; 6; 30; 12; 12; 12; 12; 3; 6; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0518_cd080db8-d243-496c-9f76-5b1ae9cb981c	44911-0518	HUMAN OTC DRUG	Influenzinum		Influenzinum (2019-2020)	LIQUID	ORAL	20191025	20250413	UNAPPROVED HOMEOPATHIC		Energique, Inc.	INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED)	200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0519_52c6be33-8041-4ad7-957d-81b47ddb0c29	44911-0519	HUMAN OTC DRUG	Metabatone		Aralia Racemosa, Avena Sativa, Berberis Vulgaris, Capsicum Annuum, Ginkgo Biloba, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Fel Tauri, Hyaluronidase, Pancreas Suis, Pancreatinum, Papain, Stomach (Suis), L-Alanine, L- Arginine, L-Carnitine, Cysteinum, L-Glutamine, L-Histidine, L-Isoleucine, L-Leucine, L-Lysine, L-Methionine, L-Ornithine, L-Proline, L-Serine, L-Tryptophan, L-Tyrosine, L-Valine, Calcarea Carbonica, Calcarea Phosphorica, Hepar Sulphuris Calcareum, Lycopodium Clavatum,	LIQUID	ORAL	20200311	20250316	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ALANINE; ARALIA RACEMOSA ROOT; ARGININE; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; BOS TAURUS BILE; BROMELAINS; CALCIUM SULFIDE; CAPSICUM; CARNITINE; CYSTEINE; GINKGO; GLUTAMINE; HISTIDINE; HYALURONIDASE; IODINE; ISOLEUCINE; LEUCINE; LYCOPODIUM CLAVATUM SPORE; LYSINE; MAGNESIUM CARBONATE; METHIONINE; ORNITHINE; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PANCRELIPASE; PAPAIN; PROLINE; SERINE; SODIUM CHLORIDE; SUS SCROFA PANCREAS; SUS SCROFA STOMACH; TRIBASIC CALCIUM PHOSPHATE; TRYPTOPHAN; TYROSINE; VALINE	9; 12; 3; 12; 3; 3; 9; 9; 12; 3; 12; 12; 3; 12; 12; 9; 12; 12; 12; 12; 12; 12; 12; 12; 9; 12; 9; 9; 12; 12; 12; 9; 9; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Endoglycosidase [EPC], Glycoside Hydrolases [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
44911-0520_aacaa774-0e0d-49da-85f0-023aeb49f339	44911-0520	HUMAN OTC DRUG	Genstat		Aesculus Hippocastanum, Equisetum Hyemale, Fumaria Officinalis, Hydrocotyle Asiatica, Oleum Olea Europaea, Passiflora Incarnata, Ribes Nigrum, Solidago Virgaurea, Ononis Spinosa	LIQUID	ORAL	20191025		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CENTELLA ASIATICA WHOLE; EQUISETUM HYEMALE WHOLE; FUMARIA OFFICINALIS FLOWERING TOP; HORSE CHESTNUT; OLIVE OIL; ONONIS SPINOSA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; RIBES NIGRUM LEAF; SOLIDAGO VIRGAUREA FLOWERING TOP	6; 6; 6; 6; 6; 14; 6; 7; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
44911-0521_a06c3051-5a03-4601-9587-3aeb7f06bf07	44911-0521	HUMAN OTC DRUG	Allerstat	II	Baptisia Tinctoria, Echinacea (Angustifolia), Allium Cepa, Ambrosia Artemisiaefolia, Arsenicum Album, Euphrasia Officinalis, Natrum Sulphuricum, Nux Vomica, Phosphorus, Pulsatilla (Pratensis), Solidago Virgaurea, Sulphur	LIQUID	ORAL	20200220	20250211	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMBROSIA ARTEMISIIFOLIA; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; EUPHRASIA STRICTA; ONION; PHOSPHORUS; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	12; 12; 12; 3; 3; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
44911-0522_657b4199-ba53-45d3-a2e5-53ca66dd6d52	44911-0522	HUMAN OTC DRUG	Terrestristat		Alfalfa, Avena Sativa, Fucus Vesiculosus, Aralia Quinquefolia, Natrum Carbonicum, Thyroidinum (Suis), Pineal Gland (Suis), Rhododendron Chrysanthum, Agate, Argentum Nitricum, Cadmium Iodatum, Calcarea Phosphorica, Cuprum Metallicum, Mercurius Corrosivus, Phosphoricum Acidum, Phosphorus, Quartz, Silicea, Strontium Carbonicum, Holmium Metallicum, Radium Bromatum, Tarentula Cubensis, Uranium Nitricum, X-Ray	LIQUID	ORAL	20200219	20261005	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); ALFALFA; AMERICAN GINSENG; AVENA SATIVA FLOWERING TOP; CADMIUM IODIDE; CITHARACANTHUS SPINICRUS; COPPER; FUCUS VESICULOSUS; HOLMIUM; MERCURIC CHLORIDE; PHOSPHORIC ACID; PHOSPHORUS; RADIUM BROMIDE; RHODODENDRON AUREUM LEAF; SILICON DIOXIDE; SILVER NITRATE; SODIUM CARBONATE; STRONTIUM CARBONATE; SUS SCROFA PINEAL GLAND; SUS SCROFA THYROID; TRIBASIC CALCIUM PHOSPHATE; URANYL NITRATE HEXAHYDRATE	30; 3; 6; 3; 12; 16; 12; 3; 16; 12; 12; 12; 16; 10; 12; 12; 6; 12; 8; 6; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Inhibit Ovum Fertilization [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
44911-0523_6eed96f6-639a-4325-9eae-f735d6241043	44911-0523	HUMAN OTC DRUG	Organdrainex		Allium Cepa, Allium Sativum, Ambrosia Artemisiaefolia, Berberis Vulgaris, Chelidonium Majus, Collinsonia Canadensis, Cynara Scolymus, Petroselinum Sativum, Trifolium Pratense, Methylcobalamin, Aloe, Alpha-Lipoicum Acidum, Palladium Metallicum	LIQUID	ORAL	20200129	20250303	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALOE; ALPHA LIPOIC ACID; AMBROSIA ARTEMISIIFOLIA WHOLE; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS WHOLE; COLLINSONIA CANADENSIS ROOT; CYNARA SCOLYMUS LEAF; GARLIC; METHYLCOBALAMIN; ONION; PALLADIUM; PETROSELINUM CRISPUM WHOLE; TRIFOLIUM PRATENSE FLOWER	6; 12; 3; 3; 3; 3; 3; 3; 4; 3; 12; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
44911-0524_77fb698b-cb0b-4930-9942-5486a28555f5	44911-0524	HUMAN OTC DRUG	EBV Stat		Astragalus Membranaceus, Echinacea (Angustifolia), Phytolacca Decandra, Hydrastis Canadensis, Aranea Diadema, Iridium Metallicum, Lycopodium Clavatum, Rhus Tox, Silicea, Sepia, Epstein-Barr Virus Nosode	LIQUID	ORAL	20200224	20250217	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARANEUS DIADEMATUS; ASTRAGALUS PROPINQUUS ROOT; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HUMAN HERPESVIRUS 4; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	12; 3; 3; 6; 30; 12; 12; 4; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0525_ecdef486-9d14-4945-85da-de3bf8370ee6	44911-0525	HUMAN OTC DRUG	Sinuchron	HP	Arsenicum Album, Hepar Sulphuris Calcareum, Hydrastis Canadensis, Kali Bichromicum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Phosphorus, Pulsatilla (Pratensis), Sepia, Thuja Occidentalis	LIQUID	ORAL	20200224	20250217	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; ARSENIC TRIOXIDE; CALCIUM SULFIDE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; PHOSPHORUS; POTASSIUM DICHROMATE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0526_8d0fadcd-80ec-4913-b16a-a96e95868588	44911-0526	HUMAN OTC DRUG	Anpituapar		Hypophysis Suis, Agnus Castus, Baryta Carbonica, Calcarea Carbonica, Iodium, Natrum Muriaticum, Phosphoricum Acidum, Sepia, Thyroidinum (Suis), Lac Caninum, Adrenocorticotrophin	LIQUID	ORAL	20200225		UNAPPROVED HOMEOPATHIC		Energique, Inc.	BARIUM CARBONATE; CANIS LUPUS FAMILIARIS MILK; CHASTE TREE FRUIT; CORTICOTROPIN; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SUS SCROFA PITUITARY GLAND; THYROID	12; 16; 12; 15; 12; 12; 12; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
44911-0527_e81f53e7-8866-4d97-824a-bb05a7edd17e	44911-0527	HUMAN OTC DRUG	Multi-Phenolic		Serotonin Hydrochloride, 5-Hydroxytryptophan, Acetaldehyde, Acetylcholine Chloride, Apiolum, Ascorbic Acid, Aspartame, Butylated Hydroxytoluene, Caffeic Acid, Cinnamic Acid, Coniferyl Alcohol, Coumarinum, Dopamine Hydrochloride, Estradiol, GABA (Gamma-Aminobutyric Acid), Gallicum Acidum, Histaminum Hydrochloricum, Hydrocortisone (Cortisol), Indolum, L-Dopa, L-Phenylalanine, Malvin, Mannan, Melatonin, Menadione, Norepinephrine, Octopamine (Hydrochloride), Phenyl Isothiocyanate, Phloridzinum, Piperine,	LIQUID	ORAL	20200306	20260129	UNAPPROVED HOMEOPATHIC		Energique, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETALDEHYDE; ACETYLCHOLINE CHLORIDE; APIOLE (PARSLEY); ASCORBIC ACID; ASPARTAME; BUTYLATED HYDROXYTOLUENE; CAFFEIC ACID; CANDIDA ALBICANS; CHLOROGENIC ACID; CINNAMIC ACID; CONIFERYL ALCOHOL; COUMARIN; DOPAMINE HYDROCHLORIDE; ESTRADIOL; GALLIC ACID MONOHYDRATE; HISTAMINE DIHYDROCHLORIDE; HYDROCORTISONE; INDOLE; LEVODOPA; MALVIN; MELATONIN; MENADIONE; NOREPINEPHRINE BITARTRATE; OCTOPAMINE HYDROCHLORIDE; OXITRIPTAN; PHENYL ISOTHIOCYANATE; PHENYLALANINE; PHLORIZIN; PIPERINE; PROGESTERONE; PYRROLE; QUERCETIN; RUTIN; SALSOLINOL HYDROCHLORIDE; SEROTONIN HYDROCHLORIDE; TAURINE; YEAST MANNAN	6; 6; 6; 6; 6; 6; 6; 6; 12; 12; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 4; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Ascorbic Acid [CS], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Progesterone [CS], Progesterone [EPC], Vitamin C [EPC]		N	
44911-0532_ee5e31e6-7482-446a-a39b-24b9db738f00	44911-0532	HUMAN OTC DRUG	Cardiopar		Convallaria Majalis, Apocynum Cannabinum, Arteria Suis, Heart (Suis), Thyroidinum (Suis), Adonis Vernalis, Cactus Grandiflorus, Digitalis Purpurea, Lycopus Virginicus	LIQUID	ORAL	20200226		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ADONIS VERNALIS WHOLE; APOCYNUM CANNABINUM ROOT; CONVALLARIA MAJALIS; DIGITALIS; LYCOPUS VIRGINICUS WHOLE; PORK HEART; SELENICEREUS GRANDIFLORUS STEM; SUS SCROFA ARTERY; THYROID	10; 6; 4; 12; 12; 8; 12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0533_fed4ad0c-e899-4113-ab93-44c97e5f5239	44911-0533	HUMAN OTC DRUG	Lymphdrainex		Geranium Robertianum, Nasturtium Aquaticum, Scrophularia Nodosa, Teucrium Scorodonia, Apis Mellifica, Equisetum Hyemale, Fumaria Officinalis, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Veronica Officinalis, Aloe, Gentiana Lutea, Sarsaparilla (Smilax Regelii), Baryta Carbonica, Hepar Sulphuris Calcareum, Mercurius Cyanatus, Ferrum Iodatum, Myosotis Arvensis, Aranea Diadema, Calcarea Phosphorica, Juglans Regia, Parathyroid Gland (Bovine), Thymus (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20200226	20250224	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALOE; APIS MELLIFERA; ARANEUS DIADEMATUS; BARIUM CARBONATE; BOS TAURUS PARATHYROID GLAND; CALCIUM SULFIDE; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA LEAF; MERCURIC CYANIDE; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SMILAX ORNATA WHOLE; SODIUM SULFATE; SUS SCROFA THYMUS; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	4; 4; 12; 8; 12; 8; 4; 8; 4; 5; 3; 12; 8; 10; 3; 4; 4; 3; 6; 4; 12; 12; 3; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
44911-0535_1387214b-6ef9-4562-aa90-3a7c31bd7c61	44911-0535	HUMAN OTC DRUG	Thyropar		Fucus Vesiculosus, Spongia Tosta, Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Bromium, Calcarea Carbonica, Iodium, Lachesis Mutus, Pulsatilla (Pratensis)	LIQUID	ORAL	20200302	20261207	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; BROMINE; FUCUS VESICULOSUS; IODINE; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID	12; 12; 3; 12; 12; 12; 3; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0537_020e3001-6ad2-40b4-9307-0564d2822542	44911-0537	HUMAN OTC DRUG	BAC	HP	Apis Mellifica, Arsenicum Album, Belladonna, Chamomilla, Echinacea (Angustifolia), Lachesis Mutus, Mercurius Solubilis, Pulsatilla (Pratensis), Pyrogenium, Rhus Tox, Silicea	LIQUID	ORAL	20200327	20250414	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA WHOLE; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA WHOLE; MERCURIUS SOLUBILIS; RANCID BEEF; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
44911-0538_458b9734-bde4-40b9-8742-4bceccaf6efe	44911-0538	HUMAN OTC DRUG	Arthritis	HP	Apis Mellifica, Bryonia (Alba), Causticum, Colchicum Autumnale, Kali Carbonicum, Kalmia Latifolia, Ledum Palustre, Pulsatilla (Pratensis), Rhododendron Chrysanthum, Rhus Tox	LIQUID	ORAL	20200325	20250416	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANEMONE PRATENSIS; APIS MELLIFERA; BRYONIA ALBA ROOT; CAUSTICUM; COLCHICUM AUTUMNALE BULB; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; POTASSIUM CARBONATE; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
44911-0546_a44fdb6c-4ce6-48c8-b1ed-4949a896b932	44911-0546	HUMAN OTC DRUG	Bio-Immune		Chelidonium Majus, Lobelia Inflata, Rumex Crispus, Sambucus Nigra, Senega Officinalis, Spongia Tosta, Taraxacum Officinale, Myristica Sebifera, Sticta Pulmonaria, Sulphur, Ustilago Maidis, Polyporus Officinalis, Candida Albicans, Carduus Marianus, Crotalus Horridus, Scrophularia Nodosa, Agaricus Muscarius, Bovista, Secale Cornutum, Anas Barbariae, Hepatis Et Cordis Extractum, Anthracinum, Arsenicum Album, Baptisia Tinctoria, Berberis Vulgaris, Botulinum, Dysentery Bacillus, Gaertner Bacillus (Bach),	LIQUID	ORAL	20200401	20250422	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMANITA MUSCARIA FRUITING BODY; ARSENIC TRIOXIDE; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CANDIDA ALBICANS; CHELIDONIUM MAJUS WHOLE; CLAVICEPS PURPUREA SCLEROTIUM; CLOSTRIDIUM BOTULINUM; CROTALUS HORRIDUS HORRIDUS VENOM; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); LARICIFOMES OFFICINALIS FRUITING BODY; LOBARIA PULMONARIA; LOBELIA INFLATA WHOLE; LYCOPERDON UTRIFORME FRUITING BODY; MILK THISTLE; POLYGALA SENEGA ROOT; RANCID BEEF; RUMEX CRISPUS ROOT; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SAMBUCUS NIGRA FLOWERING TOP; SCROPHULARIA NODOSA WHOLE; SHIGELLA DYSENTERIAE; SPONGIA OFFICINALIS SKELETON, ROASTED; STREPTOCOCCUS PNEUMONIAE; SULFUR; TARAXACUM OFFICINALE; USTILAGO MAYDIS; VACCINIA VIRUS; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN; VIROLA SEBIFERA RESIN	10; 30; 30; 30; 30; 30; 12; 3; 10; 30; 12; 30; 30; 30; 30; 8; 6; 3; 10; 12; 3; 30; 3; 30; 3; 12; 30; 3; 30; 6; 3; 6; 30; 30; 6	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Live Vaccinia Virus Vaccine [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Smallpox Vaccine [CS], Vaccines, Live, Unattenuated [CS]		N	
44911-0548_27c2a32c-051e-4baf-ac2b-35a4b276feac	44911-0548	HUMAN OTC DRUG	Mold Antigens		Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Torula Cerevisiae, Mucor Racemosus, Arsenicum Album, Phosphorus, Pulsatilla (Pratensis), Sepia, Rhizopus Nigricans	LIQUID	ORAL	20200528	20270412	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALTERNARIA ALTERNATA; ARSENIC TRIOXIDE; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; MUCOR RACEMOSUS; PHOSPHORUS; PULSATILLA PRATENSIS WHOLE; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE	30; 12; 30; 30; 30; 30; 12; 12; 30; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	
44911-0552_ac359f38-feb3-49b4-b9b0-6a291ec67aa6	44911-0552	HUMAN OTC DRUG	Erogetone		Aralia Quinquefolia, Berberis Vulgaris, Causticum, Conium Maculatum, Damiana, Graphites, Lachesis Mutus, Natrum Muriaticum, Phosphoricum Acidum, Phosphorus, Sepia	LIQUID	ORAL	20201006	20261026	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMERICAN GINSENG; BERBERIS VULGARIS ROOT BARK; CAUSTICUM; CONIUM MACULATUM FLOWERING TOP; GRAPHITE; LACHESIS MUTA VENOM; PHOSPHORIC ACID; PHOSPHORUS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; TURNERA DIFFUSA LEAFY TWIG	3; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0554_6abf27e9-e8ac-4fc6-9643-0c9e463cf619	44911-0554	HUMAN OTC DRUG	Inflammation Miasm		Astragalus Membranaceus, Echinacea (Angustifolia), Tabebuia Impetiginosa, Scrophularia Nodosa, Thyroidinum (Suis), Formicum Acidum, Phosphorus, Silicea, Sulphur, Thuja Occidentalis, Aurum Metallicum	LIQUID	ORAL	20200807	20250825	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ASTRAGALUS PROPINQUUS ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; FORMIC ACID; GOLD; HANDROANTHUS IMPETIGINOSUS BARK; PHOSPHORUS; SCROPHULARIA NODOSA WHOLE; SILICON DIOXIDE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, PORCINE	3; 3; 10; 12; 3; 10; 8; 10; 10; 10; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
44911-0555_cd186625-adaf-4614-abb3-6d10ddfd1956	44911-0555	HUMAN OTC DRUG	Dentastat		Allium Sativum, Berberis Vulgaris, Fucus Vesiculosus, Phytolacca Decandra, Argentum Metallicum, Aurum Metallicum, Calcarea Fluorica, Calcarea Phosphorica, Iodium, Mercurius Solubilis, Niccolum Metallicum, Silicea, Zincum Metallicum, Platinum Metallicum	LIQUID	ORAL	20200812	20250825	UNAPPROVED HOMEOPATHIC		Energique, Inc.	BERBERIS VULGARIS ROOT BARK; CALCIUM FLUORIDE; FUCUS VESICULOSUS; GARLIC; GOLD; IODINE; MERCURIUS SOLUBILIS; NICKEL; PHYTOLACCA AMERICANA ROOT; PLATINUM; SILICON DIOXIDE; SILVER; TRIBASIC CALCIUM PHOSPHATE; ZINC	3; 12; 3; 3; 12; 12; 12; 12; 6; 16; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
44911-0558_6b650ed5-c4ee-4928-9b9b-981a9e7abb83	44911-0558	HUMAN OTC DRUG	ADD HP		GABA (Gamma-Aminobutyric Acid), L-Dopa, Norepinephrine (Bitartrate), Serotonin (Hydrochloride), Adrenocorticotrophin, Anacardium Orientale, Arsenicum Album, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Hyoscyamus Niger, Lycopodium Clavatum, Stramonium	LIQUID	ORAL	20200924	20251021	UNAPPROVED HOMEOPATHIC		Engergique, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ARSENIC TRIOXIDE; BARIUM CARBONATE; CORTICOTROPIN; DATURA STRAMONIUM; HYOSCYAMUS NIGER; LEVODOPA; LYCOPODIUM CLAVATUM SPORE; NOREPINEPHRINE BITARTRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEMECARPUS ANACARDIUM JUICE; SEROTONIN HYDROCHLORIDE; TRIBASIC CALCIUM PHOSPHATE	6; 30; 30; 15; 30; 30; 6; 30; 6; 30; 30; 6; 30	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
44911-0560_804ebc9a-72d3-46c0-a4b7-216760b97df2	44911-0560	HUMAN OTC DRUG	Lyme	HP	Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Borrelia Burgdorferi Nosode, Babesia Microti, Ehrlichia Nosode (Canine), Hepatitis B Nosode, Meningococcus Nosode, Arsenicum Album, Bryonia (Alba), Chelidonium Majus, Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Phosphorus, Rhus Tox	LIQUID	ORAL	20201022	20251103	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BABESIA MICROTI; BAPTISIA TINCTORIA ROOT; BORRELIA BURGDORFERI; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA WHOLE; EHRLICHIA CANIS; GOLDENSEAL; HEPATITIS B VIRUS; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; NEISSERIA MENINGITIDIS; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	30; 20; 3; 12; 30; 30; 30; 3; 20; 6; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0577_1f880e8f-1596-4c21-bb40-e5dad673ceb9	44911-0577	HUMAN OTC DRUG	Histastat Pollen		Baptisia Tinctoria, Echinacea (Angustifolia), Allium Cepa, Ambrosia Artemisiaefolia, Arsenicum Album, Euphrasia Officinalis, Histaminum Hydrochloricum, Natrum Muriaticum, Natrum Sulphuricum, Nux Vomica, Phosphorus, Pulsatilla (Pratensis), Solidago Virgaurea, Sulphur	LIQUID	ORAL	20210420	20260108	UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; PHOSPHORUS; PULSATILLA PRATENSIS WHOLE; SODIUM CHLORIDE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	12; 12; 3; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
44911-0581_0423d7c4-f5f6-4968-8014-f5d02d9dd0b2	44911-0581	HUMAN OTC DRUG	Histapoll HP		Allium Cepa, Ambrosia Artemisiaefolia, Apis Mellfica, Arsenicum Album, Euphrasia Officinalis, Nux Vomica, Phosphorus, Pulsatilla (Vulgaris), Solidago Virgaurea, Sulphur	LIQUID	ORAL	20210104		UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMBROSIA ARTEMISIIFOLIA; APIS MELLIFERA; ARSENIC TRIOXIDE; EUPHRASIA STRICTA; ONION; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
44911-0587_3e2c6f05-ef33-468a-aa73-2e8e64f3a44b	44911-0587	HUMAN OTC DRUG	Joint Tone AI		Cimicifuga Racemosa, Lappa Major, Trifolium Pratense, Colchicum Autumnale, Dulcamara, Lycopodium Clavatum, Pulsatilla (Pratensis), Rhododendron Chrysanthum, Rhus Tox	LIQUID	ORAL	20210621		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARCTIUM LAPPA ROOT; BLACK COHOSH; COLCHICUM AUTUMNALE BULB; LYCOPODIUM CLAVATUM SPORE; PULSATILLA PRATENSIS WHOLE; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER	3; 3; 12; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0588_47c64e74-ff74-46dc-a2c7-9574586ed7cb	44911-0588	HUMAN OTC DRUG	JOINTOX BB		Baptisia Tinctoria, Echinacea (Angustifolia), Hydrastis Canadensis, Borrelia Burgdorferi Nosode, Babesia Microti, Ehrlichia Nosode (Canine), Meningococcus Nosode, Hepatitis B Nosode, Arsenicum Album, Bryonia (Alba), Chelidonium Majus, Colchicum Autumnale, Kalmia Latifolia, Ledum Palustre, Lycopodium Clavatum, Phosphorus, Rhus Tox	LIQUID	ORAL	20210526		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BABESIA MICROTI; BAPTISIA TINCTORIA ROOT; BORRELIA BURGDORFERI; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS WHOLE; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA WHOLE; EHRLICHIA CANIS; GOLDENSEAL; HEPATITIS B VIRUS; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; NEISSERIA MENINGITIDIS; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	30; 20; 3; 12; 30; 30; 30; 3; 20; 6; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
44911-0590_f5157189-1447-4dd3-b342-0c14ccaffcef	44911-0590	HUMAN OTC DRUG	Breathtone		Lobelia Inflata, Verbascum Thapsus, Balsamum Peruvianum, Antimonium Tartaricum, Arsenicum Album, Drosera (Rotundifolia), Kali Bichromicum, Kali Carbonicum, Natrum Sulphuricum, Phosphorous, Spongia Tosta	LIQUID	ORAL	20210527		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BALSAM PERU; DROSERA ROTUNDIFOLIA WHOLE; LOBELIA INFLATA WHOLE; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; VERBASCUM THAPSUS WHOLE	12; 12; 6; 12; 3; 12; 12; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
44911-0602_4b541be3-a334-4264-b7e9-eb054516dee7	44911-0602	HUMAN OTC DRUG	Candida Albicans 30C		Candida Albicans	LIQUID	ORAL	20210621		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CANDIDA ALBICANS	30	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
44911-0606_7b52e448-b2dd-4840-aa67-a723d7924173	44911-0606	HUMAN OTC DRUG	Femstat C		Echinacea (Angustifolia), Fucus Vesiculosus, Hydrastis Canadensis, Phytolacca Decandra, Kreosotum, Natrum Muriaticum, Candida Albicans, Lycopodium Clavatum, Pulsatilla (Pratensis), Sepia	LIQUID	ORAL	20210526		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CANDIDA ALBICANS; ECHINACEA ANGUSTIFOLIA WHOLE; FUCUS VESICULOSUS; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; WOOD CREOSOTE	12; 3; 3; 6; 30; 6; 30; 30; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
44911-0611_7879f1b8-4d66-4b1c-924e-a726cbba1d9a	44911-0611	HUMAN OTC DRUG	GI Clear P		Arsenicum Album, Baptisia Tinctoria, Lachesis Mutus, Pulsatilla (Pratensis), Rhus Tox	LIQUID	ORAL	20210621		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; LACHESIS MUTA VENOM; PULSATILLA PRATENSIS WHOLE; TOXICODENDRON PUBESCENS LEAF	10; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0612_2baae2c8-8206-475b-91c7-913f2df0c4e0	44911-0612	HUMAN OTC DRUG	Vermistat		Artemisia Vulgaris, Cina, Sabadilla, Spigelia Anthelmia, Filix Mas, Baryta Carbonica, Calcarea Carbonica, Sulphur, Terebinthina	LIQUID	ORAL	20210526	20261122	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; BARIUM CARBONATE; DRYOPTERIS FILIX-MAS ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SCHOENOCAULON OFFICINALE SEED; SPIGELIA ANTHELMIA; SULFUR; TURPENTINE OIL	3; 3; 12; 4; 12; 3; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0617_dd9b5159-7800-4482-a11c-1b0f85326798	44911-0617	HUMAN OTC DRUG	Lymphastat B		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Aconitum Napellus, Arsenicum Album, Belladonna, Ferrum Phosphoricum, Lachesis Mutus, Phosphorus	LIQUID	ORAL	20210524	20270111	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT	12; 12; 12; 3; 3; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0618_5e69908a-b018-4f83-b529-04d9b20ac6ce	44911-0618	HUMAN OTC DRUG	Lymphastat B		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Aconitum Napellus, Arsenicum Album, Belladonna, Ferrum Phosphoricum, Lachesis Mutus, Phosphorus	LIQUID	ORAL	20201222	20251211	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT	12; 12; 12; 3; 3; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
44911-0619_0169a2a5-a49f-435d-9796-72dce540134c	44911-0619	HUMAN OTC DRUG	B HP		Apis Mellifica, Arsenicum Album, Belladonna, Chamomilla, Echinacea (Angustifolia), Lachesis Mutus, Mercurius Solubilis, Pulsatilla (Vulgaris), Pyrogenium, Rhus Tox, Silicea	LIQUID	ORAL	20210520		UNAPPROVED HOMEOPATHIC		Energique, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA WHOLE; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA WHOLE; MERCURIUS SOLUBILIS; PULSATILLA VULGARIS WHOLE; RANCID BEEF; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
44911-0624_7561e824-ceb3-4d2c-8090-748a858daf10	44911-0624	HUMAN PRESCRIPTION DRUG	Back and Leg HP		Aconitum Napellus, Aesculus Hippocastanum, Colocynthis, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Plumbum Metallicum, Rhus Tox, Arnica Montana	LIQUID	ORAL	20210527		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; CITRULLUS COLOCYNTHIS FRUIT PULP; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; LEAD; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
44911-0626_dfb88b6d-ce5b-4ee0-9fca-6a7946664679	44911-0626	HUMAN OTC DRUG	Ring HP		Ginkgo Biloba, Chininum Sulphuricum, Cinchona Officinalis, Graphites, Natrum Salicylicum, Plumbum Metallicum, Salicylicum acidum, Spigelia Anthelmia, Thiosinaminum	LIQUID	ORAL	20201221		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALLYLTHIOUREA; CINCHONA OFFICINALIS BARK; GINKGO; GRAPHITE; LEAD; QUININE SULFATE; SALICYLIC ACID; SODIUM SALICYLATE; SPIGELIA ANTHELMIA WHOLE	30; 30; 6; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC]		N	20241231
44911-0627_312141f6-7344-4a0f-83dc-f96fcdb86883	44911-0627	HUMAN OTC DRUG	Bone Support	HP	Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Hekla Lava, Hydrofluoricum Acidum, Magnesia Phosphorica, Rhus Tox, Ruta Graveolens, Silicea, Symphytum Officinale	LIQUID	ORAL	20210519	20260420	UNAPPROVED HOMEOPATHIC		Energique, Inc.	CALCIUM FLUORIDE; COMFREY ROOT; HEKLA LAVA; HYDROFLUORIC ACID; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
44911-0629_e3aed212-d893-4692-9c03-6798939838f3	44911-0629	HUMAN OTC DRUG	Sinus HP		Arsenicum Album, Hepar Sulphuris Calcareum, Hydrastis Canadensis, Kali Bichromicum, Lycopodium Clavatum, Mercurius Solubilis, Natrum Muriaticum, Phosphorus, Pulsatilla (Pratensis), Sepia, Thuja Occidentalis	LIQUID	ORAL	20210601		UNAPPROVED DRUG OTHER		Energique, Inc.	ARSENIC TRIOXIDE; CALCIUM SULFIDE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0631_685ce6cf-ed03-4913-85bb-f6de4585a001	44911-0631	HUMAN OTC DRUG	Influenzinum 200C		Influenzinum (2020-2021)	LIQUID	ORAL	20201230	20260105	UNAPPROVED HOMEOPATHIC		Energique, Inc.	INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	200; 200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0638_729979f0-a987-443e-87bd-88ce9a1307de	44911-0638	HUMAN OTC DRUG	LYMPHDRAINEX		Geranium Robertianum, Nasturtium Aquaticum, Teucrium Scorodonia, Apis Mellifica, Equisetum Hyemale, Fumaria Officinalis, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Veronica Officinalis, Gentiana Lutea, Sarsaparilla (Smilax Regelii), Baryta Carbonica, Hepar Sulphuris Calcareum, Mercurius Cyanatus, Scrophularia Nodosa, Aloe, Ferrum Iodatum, Myosotis Arvensis, Aranea Diadema, Calcarea Phosphorica, Juglans Regia, Parathyroid Gland (Bovine), Thymus (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20210622	20260611	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALOE; APIS MELLIFERA; ARANEUS DIADEMATUS; BARIUM CARBONATE; BOS TAURUS PARATHYROID GLAND; CALCIUM SULFIDE; EQUISETUM HYEMALE WHOLE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM WHOLE; JUGLANS REGIA LEAF; MERCURIC CYANIDE; MYOSOTIS ARVENSIS WHOLE; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA WHOLE; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA THYMUS; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	8; 4; 12; 8; 12; 8; 4; 8; 4; 5; 3; 12; 8; 10; 3; 4; 4; 8; 6; 4; 12; 12; 3; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Insect Venom Allergenic Extract [EPC]		N	
44911-0641_c7b9e887-b6eb-4a7b-9db3-0ec22baf4c8b	44911-0641	HUMAN OTC DRUG	Renapar		Pareira Brava, Petroselinum Sativum, Sarsaparilla (Smilax Regelii), Kidney (Suis), Bryonia (Alba), Mercurius Corrosivus, Rubia Tinctorum, Solidago Virgaurea, Triticum Repens	LIQUID	ORAL	20210607		UNAPPROVED HOMEOPATHIC		Energique, Inc.	BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; ELYMUS REPENS ROOT; MERCURIC CHLORIDE; PETROSELINUM CRISPUM WHOLE; PORK KIDNEY; RUBIA TINCTORUM ROOT; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 8; 12; 12; 3; 6; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0646_eba049f5-934c-4e75-9ccf-614c251cb83c	44911-0646	HUMAN OTC DRUG	Kidnex	IV	Ginkgo Biloba, Alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Malicum Acidum, Pyruvic Acid, Succinicum Acidum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Germanium Sesquioxide, Mercurius Vivus, Nux Vomica, Kidney (Suis), Lymph Node (Suis), Naphthochinonum, Natrum Oxalaceticum, Phosphorus, Urinary Bladder (Suis), Aconiticum Acidum, Cis-	LIQUID	ORAL	20210823		UNAPPROVED HOMEOPATHIC		Energique, Inc.	1,2-NAPHTHOQUINONE; ACONITIC ACID, (Z)-; ANHYDROUS CITRIC ACID; COPPER; FUMARIC ACID; GERMANIUM SESQUIOXIDE; GINKGO; GOLD; MALIC ACID; MERCURY; OXOGLURIC ACID; PHOSPHORUS; PORK KIDNEY; PYRUVIC ACID; SILVER; SODIUM DIETHYL OXALACETATE; STRYCHNOS NUX-VOMICA SEED; SUCCINIC ACID; SUS SCROFA LYMPH; SUS SCROFA URINARY BLADDER	12; 30; 8; 12; 8; 12; 6; 12; 8; 12; 8; 12; 12; 8; 12; 12; 12; 8; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
44911-0647_2b6df607-6386-4f3d-a87a-8f9902efe97f	44911-0647	HUMAN OTC DRUG	Lymphdrainex		Geranium Robertianum, Nasturtium Aquaticum, Scrophularia Nodosa, Teucrium Scorodonia, Apis Mellifica, Equisetum Hyemale, Fumaria Officinalis, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Veronica Officinalis, Aloe, Gentiana Lutea, Juglans Regia, Myosotis Arvensis, Sarsaparilla (Smilax Regelii), Baryta Carbonica, Hepar Sulphuris Calcareum, Mercurius Cyanatus, Ferrum Iodatum, Aranea Diadema, Calcarea Phosphorica, Parathyroid Gland (Bovine), Thymus (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20211006	20261006	UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALOE; APIS MELLIFERA; ARANEUS DIADEMATUS; BARIUM CARBONATE; BOS TAURUS PARATHYROID GLAND; CALCIUM SULFIDE; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA FRUIT RIND, IMMATURE; MERCURIC CYANIDE; MYOSOTIS ARVENSIS WHOLE; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA WHOLE; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA THYMUS; SUS SCROFA THYROID; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	8; 4; 12; 8; 12; 8; 4; 8; 4; 5; 3; 12; 8; 10; 3; 4; 4; 8; 6; 4; 12; 12; 3; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Insect Venom Allergenic Extract [EPC]		N	
44911-0648_0237873c-bf25-4d31-b166-ad3196948922	44911-0648	HUMAN OTC DRUG	Biting Insect Antigens		Apis Mellifica, Culex Musca, Hypericum Perforatum, Ledum Palustre, Pediculus Capitis, Cimex Lectularius, Formica Rufa, Pulex Irritans, Vespa Crabro	LIQUID	ORAL	20211007		UNAPPROVED HOMEOPATHIC		Energique, Inc.	APIS MELLIFERA; CIMEX LECTULARIUS; CULEX PIPIENS; FORMICA RUFA; HYPERICUM PERFORATUM WHOLE; PEDICULUS HUMANUS VAR. CAPITIS; PULEX IRRITANS WHOLE; RHODODENDRON TOMENTOSUM LEAFY TWIG; VESPA CRABRO	12; 15; 12; 15; 12; 12; 15; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
44911-0652_9577b1f9-bb12-4371-b692-759612382fbf	44911-0652	HUMAN OTC DRUG	Influenzinum 200C		Influenzinum (2021-2022)	LIQUID	ORAL	20220215	20270330	UNAPPROVED HOMEOPATHIC		Energique, Inc.	INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	200; 200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
44911-0664_98bf0f3c-1216-4f98-9342-bdac8a80736b	44911-0664	HUMAN OTC DRUG	Influenzinum 200C		Influenzinum (2022-2023)	LIQUID	ORAL	20221229		UNAPPROVED HOMEOPATHIC		Energique, Inc.	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	200; 200; 200; 200	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
44911-0665_984f1f53-962f-4e0d-bda9-bc67fb461c1a	44911-0665	HUMAN OTC DRUG	Metabatone		Aralia Racemosa, Avena Sativa, Berberis Vulgaris, Capsicum Annuum, Ginkgo Biloba, Phytolacca Decandra, Hypothalamus Suis, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Fel Tauri, Hyaluronidase, Pancreas Suis, Pancreatinum, Papain, Stomach (Suis), L-Alanine, L- Arginine, L-Carnitine, Cysteinum, L-Glutamine, L-Histidine, L-Isoleucine, L-Leucine, L-Lysine, L-Methionine, L-Ornithine, L-Proline, L-Serine, L-Tryptophan, L-Tyrosine, L-Valine, Calcarea Carbonica, Calcarea Phosphorica, Iodium,	LIQUID	ORAL	20221228		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ALANINE; ARALIA RACEMOSA ROOT; ARGININE; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; BOS TAURUS BILE; BROMELAINS; CALCIUM SULFIDE; CAPSICUM; CYSTEINE; GINKGO; GLUTAMINE; GRAPHITE; HISTIDINE; HYALURONIDASE (BOVINE); IODINE; ISOLEUCINE; LEUCINE; LEVOCARNITINE; LYCOPODIUM CLAVATUM SPORE; LYSINE; MAGNESIUM CARBONATE; METHIONINE; ORNITHINE; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PANCRELIPASE; PAPAIN; PHYTOLACCA AMERICANA ROOT; PROLINE; SERINE; SODIUM CHLORIDE; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SUS SCROFA STOMACH; TRIBASIC CALCIUM PHOSPHATE; TRYPTOPHAN; TYROSINE; VALINE	9; 12; 3; 12; 3; 3; 9; 9; 12; 3; 12; 3; 12; 12; 12; 9; 12; 12; 12; 12; 12; 12; 12; 12; 12; 9; 12; 9; 9; 5; 12; 12; 12; 9; 9; 9; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Carnitine Analog [EPC], Carnitine [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Endoglycosidase [EPC], Glycoside Hydrolases [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
44911-0667_d63320b4-4be0-4ed3-a234-8f5b030c0826	44911-0667	HUMAN OTC DRUG	Varico	HP	Aesculus Hippocastanum, Calcarea Fluorica, Carbo Vegetabilis, Carduus Marianus, Hamamelis Virginiana, Lachesis Mutus, Lycopodium Clavatum, Paeonia Officinalis, Pulsatilla (Pratensis), Secale Cornutum, Sepia, Staphysagria, Zincum Metallicum	LIQUID	ORAL	20230103		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; CALCIUM FLUORIDE; CLAVICEPS PURPUREA SCLEROTIUM; DELPHINIUM STAPHISAGRIA SEED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PAEONIA OFFICINALIS ROOT; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; ZINC	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0668_f81e9498-0e64-4c2e-8e29-75248cb7b701	44911-0668	HUMAN OTC DRUG	Psora Miasm		Eggshell Membrane, Whey Protein, Calcarea Carbonica, Lycopodium Clavatum, Sulphur, Arsenicum Album, Fagopyrum Esculentum, Graphites, Hydrocotyle Asiatica, Natrum Muriaticum	LIQUID	ORAL	20230315		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; CENTELLA ASIATICA WHOLE; EGG SHELL MEMBRANE; FAGOPYRUM ESCULENTUM WHOLE; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE; SULFUR; WHEY	12; 12; 6; 12; 12; 30; 30; 12; 30; 6	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
44911-0669_140139c1-8dc4-4b35-b50e-806cac188663	44911-0669	HUMAN OTC DRUG	Norepinephrine Phenolic		Norepinephrine (Bitartrate)	LIQUID	ORAL	20230412		UNAPPROVED HOMEOPATHIC		Energique, Inc.	NOREPINEPHRINE BITARTRATE	6	[hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
44911-0670_4884ad84-694d-41dc-9946-63e1cf2696b7	44911-0670	HUMAN OTC DRUG	Glutenstat		Alfalfa, Zingiber Officinale, Cinchona Officinalis, Hydrastis Canadensis, Barley (Grain), Carbo Vegetabilis, Glyphosate, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Oat (Grain), Pulsatilla (Vulgaris), Rye (Grain), Wheat (Grain), Gluten	LIQUID	ORAL	20230405		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACTIVATED CHARCOAL; BARLEY; CINCHONA OFFICINALIS BARK; GINGER; GLYPHOSATE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MEDICAGO SATIVA WHOLE; OAT; PULSATILLA VULGARIS WHOLE; RYE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; WHEAT; WHEAT GLUTEN	12; 12; 6; 4; 12; 6; 12; 4; 12; 12; 12; 12; 12; 12; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
44911-0671_7c5edff5-09a7-4cd4-9bbe-88fcc3c1aa03	44911-0671	HUMAN OTC DRUG	Cosmestat		Alfalfa, Avena Sativa, Iodium, Bovista, Formalinum, Hypophysis Suis, Manganum Aceticum, Natrum Muriaticum, Petroleum, Pulsatilla (Pratensis), Rhus Tox, Terebinthina, Thyroidinum (Bovine), Cortisone Aceticum	LIQUID	ORAL	20230417		UNAPPROVED HOMEOPATHIC		Energique, Inc.	AVENA SATIVA FLOWERING TOP; CORTISONE ACETATE; FORMALDEHYDE SOLUTION; IODINE; KEROSENE; LYCOPERDON UTRIFORME FRUITING BODY; MANGANESE ACETATE TETRAHYDRATE; MEDICAGO SATIVA WHOLE; PULSATILLA PRATENSIS WHOLE; SODIUM CHLORIDE; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE; TOXICODENDRON PUBESCENS LEAF; TURPENTINE OIL	3; 30; 12; 6; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
44911-0672_17e93e7a-4799-45ce-8666-3b8920b2f2c5	44911-0672	HUMAN OTC DRUG	Neurotransmitter Pro		Aethusa Cynapium, Ginkgo Biloba, Kali Phosphoricum, Cerebrum Suis, Hypothalamus Suis, Adenosinum Triphosphoricum Dinatrum, Alumina, Anacardium Orientale, Arsenicum Album, Cortisone Aceticum, Levothyroxinum, Lycopodium Clavatum, Nadidum, Phosphorus, Ubidecarenonum, Zincum Metallicum, Acetylcholine Chloride, Dopamine Hydrochloride, Gaba (Gamma-Aminobutyric Acid), Histaminum Hydrochloricum, Melatonin, Norepinephrine (Bitartrate), Oxytocin, Serotonin (Hydrochloride)	LIQUID	ORAL	20230531		UNAPPROVED HOMEOPATHIC		Energique, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; ADENOSINE TRIPHOSPHATE DISODIUM; AETHUSA CYNAPIUM WHOLE; ALUMINUM OXIDE; ARSENIC TRIOXIDE; CORTISONE ACETATE; DIBASIC POTASSIUM PHOSPHATE; DOPAMINE HYDROCHLORIDE; GINKGO; HISTAMINE DIHYDROCHLORIDE; LEVOTHYROXINE; LYCOPODIUM CLAVATUM SPORE; MELATONIN; NADIDE; NOREPINEPHRINE BITARTRATE; OXYTOCIN; PHOSPHORUS; SEMECARPUS ANACARDIUM JUICE; SEROTONIN HYDROCHLORIDE; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; UBIDECARENONE; ZINC	30; 30; 12; 6; 12; 12; 12; 6; 30; 6; 30; 12; 12; 30; 12; 30; 30; 12; 12; 30; 8; 8; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS], Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
44911-0673_3adfbd87-bd52-41e3-98a7-e94d28ad765b	44911-0673	HUMAN OTC DRUG	Shark Cartilage Cord		Shark Cartilage	LIQUID	ORAL	20230411		UNAPPROVED HOMEOPATHIC		Energique, Inc.	SHARK CARTILAGE	12	[hp_C]/mL			N	20241231
44911-0674_cb42e9ee-cc8f-417e-8d39-3e4a72e8204d	44911-0674	HUMAN OTC DRUG	Histastat Pollen		Baptisia Tinctoria, Echinacea (Angustifolia), Adrenalinum, Allium Cepa, Ambrosia Artemisiaefolia, Arsenicum Album, Euphrasia Officinalis, Histaminum Hydrochloricum, Natrum Muriaticum, Natrum Sulphuricum, Nux Vomica, Phosphorus, Pulsatilla (Pratensis), Sabadilla, Sinapis Nigra, Solidago Virgaurea, Sulphur, Wyethia Helenioides	LIQUID	ORAL	20230512		UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BLACK MUSTARD SEED; ECHINACEA ANGUSTIFOLIA WHOLE; EPINEPHRINE; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; ONION; PHOSPHORUS; PULSATILLA PRATENSIS WHOLE; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; WYETHIA HELENIOIDES ROOT	12; 12; 3; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
44911-0675_1d9ab663-57a9-44c6-9d28-866c4711a52b	44911-0675	HUMAN OTC DRUG	Anxiety	HP	Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Calcarea Carbonica, Ignatia Amara, Kali Carbonicum, Lachesis Mutus, Natrum Muriaticum, Phosphorus, Pulsatilla (Pratensis), Staphysagria, Stramonium	LIQUID	ORAL	20230609		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0676_09f87d38-290a-4931-b5df-bd6a895f2866	44911-0676	HUMAN OTC DRUG	Lymphastat B		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Aconitum Napellus, Arsenicum Album, Belladonna, Ferrum Phosphoricum, Lachesis Mutus, Mercurius Corrosivus, Phosphorus, Colibacillinum Cum Natrum Muriaticum, Pyrogenium	LIQUID	ORAL	20230718		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; ESCHERICHIA COLI; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RANCID BEEF	12; 12; 12; 3; 3; 30; 12; 12; 12; 12; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0677_a7ece306-3ce3-4bae-b410-4ae48239524d	44911-0677	HUMAN OTC DRUG	Terrestristat		Alfalfa, Avena Sativa, Fucus Vesiculosus, Aralia Quinquefolia, Natrum Carbonicum, Thyroidinum (Suis), Cerebrum Suis, Pineal Gland (Suis), Rhododendron Chrysanthum, Agate, Argentum Nitricum, Cadmium Iodatum, Calcarea Phosphorica, Coffea Cruda, Cuprum Metallicum, Mercurius Corrosivus, Phosphoricum Acidum, Phosphorus, Quartz, Silicea, Strontium Carbonicum, Radium Bromatum, Carcinosin, Tarentula Cubensis, X-Ray, Holmium Metallicum, Uranium Nitricum.	LIQUID	ORAL	20231117		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); AMERICAN GINSENG; ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; CADMIUM IODIDE; CITHARACANTHUS SPINICRUS; COPPER; FUCUS VESICULOSUS; HOLMIUM; HUMAN BREAST TUMOR CELL; MEDICAGO SATIVA WHOLE; MERCURIC CHLORIDE; PHOSPHORIC ACID; PHOSPHORUS; RADIUM BROMIDE; RHODODENDRON AUREUM LEAF; SILICON DIOXIDE; SILVER NITRATE; SODIUM CARBONATE; STRONTIUM CARBONATE; SUS SCROFA CEREBRUM; SUS SCROFA PINEAL GLAND; THYROID; TRIBASIC CALCIUM PHOSPHATE; URANYL NITRATE HEXAHYDRATE	30; 6; 12; 3; 12; 30; 12; 3; 12; 30; 3; 12; 12; 12; 16; 10; 12; 12; 6; 12; 8; 8; 6; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
44911-0678_f117d17c-0889-4542-b603-ab9c812856f5	44911-0678	HUMAN OTC DRUG	Adrenapar		Aralia Quinquefolia, Avena Sativa, Glandula Suprarenalis Suis, Hypothalamus Suis, Arsenicum Iodatum, Calcarea Carbonica, Ignatia Amara, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Zincum Metallicum	LIQUID	ORAL	20230720		UNAPPROVED HOMEOPATHIC		Energique, Inc.	AMERICAN GINSENG; ARSENIC TRIIODIDE; AVENA SATIVA FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; ZINC	3; 12; 3; 12; 12; 12; 12; 12; 12; 12; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
44911-0679_e69fa62b-7fb4-4783-b5f5-56240295ae99	44911-0679	HUMAN OTC DRUG	Liver Gallbladder	HP	Belladonna, Carduus Marianus, Chelidonium Majus, Chionanthus Virginica, Cinchona Officinalis, Colocynthis, Leptandra Virginica, Lycopodium Clavatum, Natrum Sulphuricum, Nux Vomica, Phosphorus, Ptelea Trifoliata, Pulsatilla (Pratensis), Veratrum Album	LIQUID	ORAL	20230804		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ATROPA BELLADONNA; CHELIDONIUM MAJUS WHOLE; CHIONANTHUS VIRGINICUS ROOT BARK; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHOSPHORUS; PTELEA TRIFOLIATA BARK; PULSATILLA PRATENSIS WHOLE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT; VERONICASTRUM VIRGINICUM ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
44911-0680_958da3e2-e289-469d-9770-938d2ebf7d07	44911-0680	HUMAN OTC DRUG	V	HP	Anas Barbariae, Hepatis ET Cordis Extractum, Arsenicum Album, Belladonna, Bryonia (Alba), Carcinosin, Echinacea (Angustifolia), Eupatorium Perfoliatum, Gelsemium Sempervirens, Lycopodium Clavatum, Natrum Muriaticum, Phosphoricum Acidum, Phosphorus, Pyrogenium, Rhus Tox, Sulphur	LIQUID	ORAL	20230823		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HUMAN BREAST TUMOR CELL; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; RANCID BEEF; SODIUM CHLORIDE; SULFUR; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0681_373c3034-7f21-4ca8-b09e-469e3e85f899	44911-0681	HUMAN OTC DRUG	Pancreapar		Syzygium Jambolanum, Glandula Suprarenalis Suis, Hydrastis Canadensis, Hypophysis Suis, Pancreas Suis, Phaseolus, Aceticum Acidum, Lacticum Acidum, Phosphoricum Acidum, Phosphorus, Uranium Nitricum	LIQUID	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACETIC ACID; GOLDENSEAL; KIDNEY BEAN; LACTIC ACID, DL-; PHOSPHORIC ACID; PHOSPHORUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SYZYGIUM CUMINI SEED; URANYL NITRATE HEXAHYDRATE	12; 6; 9; 12; 12; 12; 6; 6; 6; 3; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
44911-0682_d790debb-55ca-4b7a-b18c-2795de873fdd	44911-0682	HUMAN OTC DRUG	Lymphastat B		Baptisia Tinctoria, Echinacea (Angustifolia), Phytolacca Decandra, Aconitum Napellus, Arsenicum Album, Belladonna, Ferrum Phosphoricum, Lachesis Mutus, Mercurius Corrosivus, Phosphorus, Colibacillinum Cum Natrum Muriaticum, Pyrogenium	LIQUID	ORAL	20231010		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; ESCHERICHIA COLI; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; MERCURIC CHLORIDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RANCID BEEF	12; 12; 12; 3; 3; 30; 12; 12; 12; 12; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0683_52ebd972-f911-4929-83a6-e4f68d143808	44911-0683	HUMAN OTC DRUG	Thyropar		Fucus Vesiculosus, Spongia Tosta, Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Bromium, Calcarea Carbonica, Graphites, Iodium, Lachesis Mutus, Levothyroxinum, Pulsatilla (Pratensis), Selenium Metallicum	LIQUID	ORAL	20231026		UNAPPROVED HOMEOPATHIC		Energique, Inc.	BROMINE; FUCUS VESICULOSUS; GRAPHITE; IODINE; LACHESIS MUTA VENOM; LEVOTHYROXINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA PRATENSIS WHOLE; SELENIUM; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; THYROID	12; 3; 12; 12; 12; 12; 12; 12; 12; 3; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
44911-0684_c0bf44fd-c222-4ddc-8ce4-b76b7458a1d8	44911-0684	HUMAN OTC DRUG	Vermistat		Artemisia Vulgaris, Cina, Sabadilla, Spigelia Anthelmia, Filix Mas, Baryta Carbonica, Calcarea Carbonica, Cinchona Officinalis, Natrum Phosphoricum, Sulphur, Terebinthina, Proteus (Vulgaris)	LIQUID	ORAL	20231102		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; BARIUM CARBONATE; CINCHONA OFFICINALIS BARK; DRYOPTERIS FILIX-MAS ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PROTEUS VULGARIS; SCHOENOCAULON OFFICINALE SEED; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SPIGELIA ANTHELMIA WHOLE; SULFUR; TURPENTINE OIL	3; 3; 12; 12; 4; 12; 30; 3; 12; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
44911-0685_e3298788-5ff2-48bb-8064-cd5610f0f111	44911-0685	HUMAN OTC DRUG	Anxiety		Aconitum Napellus, Argentum Nitricum, Arsenicum Album, Belladonna, Calcarea Carbonica, Carcinosin, Causticum, Gelsemium Sempervirens, Lachesis Mutus, Lithium Carbonicum, Lycopodium Clavatum, Mercurius Vivus, Nitricum Acidum, Phosphorus, Rhus Tox	SPRAY	ORAL	20231103		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAUSTICUM; GELSEMIUM SEMPERVIRENS ROOT; HUMAN BREAST TUMOR CELL; LACHESIS MUTA VENOM; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MERCURY; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SILVER NITRATE; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [kp_C]/mL	Mood Stabilizer [EPC]		N	20241231
44911-0686_153e1395-614e-4747-bdc5-0dc6fc8af35d	44911-0686	HUMAN OTC DRUG	Lymphdrainex		Geranium Robertianum, Nasturtium Aquaticum, Teucrium Scorodonia, Equisetum Hyemale, Fumaria Officinalis, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Veronica Officinalis, Baptisia Tinctoria, Galium Aparine, Gentiana Lutea, Apis Mellifica, Sarsaparilla (Smilax Regelii), Baryta Carbonica, Hepar Sulphuris Calcareum, Mercurius Cyanatus, Scrophularia Nodosa, Aloe, Ferrum Iodatum, Myosotis Arvensis, Aranea Diadema, Calcarea Phosphorica, Juglans Regia, Parathyroid Gland (Bovine), Silicea,	LIQUID	ORAL	20231220		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALOE; APIS MELLIFERA; ARANEUS DIADEMATUS; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; BOS TAURUS PARATHYROID GLAND; CALCIUM SULFIDE; EQUISETUM HYEMALE WHOLE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GALIUM APARINE WHOLE; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM WHOLE; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MERCURIC CYANIDE; MYOSOTIS ARVENSIS WHOLE; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA WHOLE; SILICON DIOXIDE; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA THYMUS; TEUCRIUM SCORODONIA FLOWERING TOP; THYROID; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	8; 6; 12; 5; 8; 12; 8; 4; 8; 4; 5; 5; 3; 12; 12; 8; 10; 3; 4; 4; 8; 12; 6; 4; 12; 3; 12; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
44911-0687_c43a4f2f-a174-472a-b572-6a5ba7b6ba1c	44911-0687	HUMAN OTC DRUG	Dairy Antigens		Calcarea Carbonica, Sepia, Sulphur, American Cheese, Cheese (Stilton), Cheese3 (Camembert), Cheddar Cheese, Cottage Cheese, Lac Caprinum, Lac Vaccinum, Swiss Cheese	LIQUID	ORAL	20231220		UNAPPROVED HOMEOPATHIC		Energique, Inc.	CASEIN, EMMENTAL CULTURED; CASEIN, LACTOCOCCUS LACTIS CULTURED; CASEIN, LACTOCOCCUS LACTIS CULTURED, AGED; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM CAMEMBERTI CULTURED, AGED; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM ROQUEFORTI CULTURED, AGED; COW MILK; GOAT MILK; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SULFUR; WHEY	12; 12; 12; 15; 15; 12; 15; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Milk Proteins [CS], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
44911-0689_7f1207cb-b9bf-4e68-b79d-3e9059fa9ffc	44911-0689	HUMAN OTC DRUG	Lymphdrainex		Geranium Robertianum, Nasturtium Aquaticum, Teucrium Scorodonia, Equisetum Hyemale, Fumaria Officinalis, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Veronica Officinalis, Baptisia Tinctoria, Galium Aparine, Gentiana Lutea, Apis Mellifica, Sarsaparilla (Smilax Regelii), Baryta Carbonica, Hepar Sulphuris Calcareum, Mercurius Cyanatus, Scrophularia Nodosa, Aloe, Ferrum Iodatum, Myosotis Arvensis, Aranea Diadema, Calcarea Phosphorica, Juglans Regia, Parathyroid Gland (Bovine), Silicea,	LIQUID	ORAL	20231228		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALOE; APIS MELLIFERA; ARANEUS DIADEMATUS; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; BOS TAURUS PARATHYROID GLAND; CALCIUM SULFIDE; EQUISETUM HYEMALE WHOLE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GALIUM APARINE WHOLE; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM WHOLE; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MERCURIC CYANIDE; MYOSOTIS ARVENSIS WHOLE; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA WHOLE; SILICON DIOXIDE; SMILAX ORNATA ROOT; SODIUM SULFATE; SUS SCROFA THYMUS; TEUCRIUM SCORODONIA FLOWERING TOP; THYROID; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	8; 6; 12; 5; 8; 12; 8; 4; 8; 4; 5; 5; 3; 12; 12; 8; 10; 3; 4; 4; 8; 12; 6; 4; 12; 3; 12; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
44911-0690_bfdb4938-95c6-4581-b36f-c92776bffb74	44911-0690	HUMAN OTC DRUG	Apis	30C	Apis Mellifica	LIQUID	ORAL	20240104		UNAPPROVED HOMEOPATHIC		Energique, Inc.	APIS MELLIFERA	30	[hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
44911-0691_366c36e7-9f9d-4e55-8ee5-9f23bf92ffe6	44911-0691	HUMAN OTC DRUG	Ars Alb	30C	Arsenicum Album	LIQUID	ORAL	20240105		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ARSENIC TRIOXIDE	30	[hp_C]/mL			N	20251231
44911-0692_6393a37e-9ebc-4cc7-a893-5a349efd74ea	44911-0692	HUMAN OTC DRUG	Calc Carb	30C	Calcarea Carbonica	LIQUID	ORAL	20240104		UNAPPROVED HOMEOPATHIC		Energique, Inc.	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_C]/mL			N	20251231
44911-0693_497b7763-3523-4bae-be75-6d93732ac7d8	44911-0693	HUMAN OTC DRUG	Mag Phos	30C	Magnesia Phosphorica	LIQUID	ORAL	20240104		UNAPPROVED HOMEOPATHIC		Energique, Inc.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_C]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
44911-0694_6ee5d857-7df6-4abf-8b23-e758bf978477	44911-0694	HUMAN OTC DRUG	Nat Mur	30C	Natrum Muriaticum	LIQUID	ORAL	20240104		UNAPPROVED HOMEOPATHIC		Energique, Inc.	SODIUM CHLORIDE	30	[hp_C]/mL			N	20251231
44911-0695_52a674e7-8cd7-4d29-b690-fa62982968ee	44911-0695	HUMAN OTC DRUG	Nux Vom	30C	Nux Vomica	LIQUID	ORAL	20240105		UNAPPROVED HOMEOPATHIC		Energique, Inc.	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
44911-0696_7990817b-5880-4132-ac43-f45e5031cff2	44911-0696	HUMAN OTC DRUG	Pulsatilla	30C	Pulsatilla (Vulgaris)	LIQUID	ORAL	20240104		UNAPPROVED HOMEOPATHIC		Energique, Inc.	PULSATILLA VULGARIS WHOLE	30	[hp_C]/mL			N	20251231
44911-0697_63fbb345-2ec6-44ed-9fa4-da43da5bf07d	44911-0697	HUMAN OTC DRUG	Rhus Tox	30C	Rhus Tox	LIQUID	ORAL	20231219		UNAPPROVED HOMEOPATHIC		Energique, Inc.	TOXICODENDRON PUBESCENS LEAF	30	[hp_C]/mL			N	20241231
44911-0698_38a18166-56ea-4bab-ac45-9e30b0ec5840	44911-0698	HUMAN OTC DRUG	Sepia	30C	Sepia	LIQUID	ORAL	20231204		UNAPPROVED HOMEOPATHIC		Energique, Inc.	SEPIA OFFICINALIS JUICE	30	[hp_C]/mL			N	20241231
44911-0699_341944bb-a85b-4b38-a870-db87096998f4	44911-0699	HUMAN OTC DRUG	Silicea	30C	Silicea	LIQUID	ORAL	20231128		UNAPPROVED HOMEOPATHIC		Energique, Inc.	SILICON DIOXIDE	30	[hp_C]/mL			N	20241231
44911-0700_e5bafebb-9c96-4d89-bed5-49a77af04553	44911-0700	HUMAN OTC DRUG	Sulphur	30C	Sulphur	LIQUID	ORAL	20231128		UNAPPROVED HOMEOPATHIC		Energique, Inc.	SULFUR	30	[hp_C]/mL			N	20241231
44911-0701_fa0f29bb-c632-4de2-b19c-8c0532684183	44911-0701	HUMAN OTC DRUG	Thuja	30C	Thuja Occidentalis	LIQUID	ORAL	20231127		UNAPPROVED HOMEOPATHIC		Energique, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/mL			N	20241231
44911-0702_bf0d8789-1708-47b8-a3b5-b2dca9e2a591	44911-0702	HUMAN OTC DRUG	Mold Antigens		Arsenicum Album, Histaminum Hydrochloricum, Natrum Sulphuricum, Phosphorus, Pulsatilla (Pratensis), Sepia, Thuja Occidentalis, Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Torula Cerevisiae, Mucor Racemosus, Rhizopus Nigricans	LIQUID	ORAL	20231222		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ALTERNARIA ALTERNATA; ARSENIC TRIOXIDE; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; HISTAMINE DIHYDROCHLORIDE; MUCOR RACEMOSUS; PHOSPHORUS; PULSATILLA PRATENSIS WHOLE; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM SULFATE; THUJA OCCIDENTALIS LEAFY TWIG	30; 12; 30; 30; 30; 12; 30; 12; 12; 30; 30; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
44911-0703_9afcd035-6123-4574-9c5d-85d7c85b0a8d	44911-0703	HUMAN OTC DRUG	Mitochondria PRO		Aralia Quinquefolia, Arnica Montana, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Ascorbicum Acidum, Alpha-Lipoicum Acidum, Calcarea Carbonica, Citricum Acidum, Cuprum Metallicum, Cysteinum, Ferrum Metallicum, Iodium, Levothyroxinum, Magnesium Gluconicum Dihydricum, Malicum Acidum, Manganum Aceticum, Nadidum, Natrum Pyruvicum, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Selenium Metallicum, Sulphur, Thiaminum Hydrochloricum, Ubidecarenonum, Zincum Metallicum,	LIQUID	ORAL	20231228		UNAPPROVED HOMEOPATHIC		Energique, Inc.	ACONITIC ACID, (Z)-; ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; AMERICAN GINSENG; ANHYDROUS CITRIC ACID; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; COPPER; CYSTEINE; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LEVOTHYROXINE; MAGNESIUM GLUCONATE; MALIC ACID; MANGANESE ACETATE TETRAHYDRATE; MERCURIUS SOLUBILIS; NADIDE; NIACINAMIDE; OXOGLURIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; SILICON DIOXIDE; SODIUM PYRUVATE; SULFUR; THIAMINE HYDROCHLORIDE; UBIDECARENONE; ZINC	16; 12; 12; 6; 12; 6; 30; 12; 35; 30; 30; 30; 12; 12; 30; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Thyroxine [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], l-Thyroxine [EPC]		N	20251231
44924-901_d09ab135-8ca6-74ab-e053-2995a90a18bd	44924-901	HUMAN OTC DRUG	Doctor Babor Protect Rx Mineral Sunscreen SPF 30		Zinc Oxide	CREAM	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part352	BABOR Cosmetics America Corp	ZINC OXIDE	182.2	mg/mL			N	20241231
45043-001_38a644dd-9f4b-45f4-b41b-d8c237be95d7	45043-001	HUMAN PRESCRIPTION DRUG	Cholbam		Cholic Acid	CAPSULE	ORAL	20150331		NDA	NDA205750	Manchester Pharmaceuticals, LLC	CHOLIC ACID	50	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
45043-002_38a644dd-9f4b-45f4-b41b-d8c237be95d7	45043-002	HUMAN PRESCRIPTION DRUG	Cholbam		Cholic Acid	CAPSULE	ORAL	20150331		NDA	NDA205750	Manchester Pharmaceuticals, LLC	CHOLIC ACID	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
45146-110_df09bf36-46b3-4edf-9a11-9d12bb7e12b3	45146-110	HUMAN PRESCRIPTION DRUG	Orabloc		articaine hydrochloride and epinephrine bitartrate	INJECTION	SUBMUCOSAL	20110301		NDA	NDA022466	Pierrel S.p.A.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; 10	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
45146-120_df09bf36-46b3-4edf-9a11-9d12bb7e12b3	45146-120	HUMAN PRESCRIPTION DRUG	Orabloc		articaine hydrochloride and epinephrine bitartrate	INJECTION	SUBMUCOSAL	20110301		NDA	NDA022466	Pierrel S.p.A.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
45149-014_c2e3749e-63bf-464b-866e-de5960840d2e	45149-014	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19650101		NDA	NDA205815	Messer Merchant Production LLC	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
45334-206_d9e02590-19a1-f0d8-e053-2a95a90a8e2a	45334-206	HUMAN OTC DRUG	Vanicream		Pyrithione Zinc	SHAMPOO	TOPICAL	20220103		OTC MONOGRAPH DRUG	M032	Pharmaceutical Specialties, Inc.	PYRITHIONE ZINC	2	g/100mL			N	20241231
45334-305_08676fab-a5ba-94a8-e063-6294a90aa861	45334-305	HUMAN OTC DRUG	Vanicream Anti-perspirant/Deodorant		Aluminum zirconium trichlorohydrex gly	STICK	TOPICAL	20161111		OTC MONOGRAPH DRUG	M019	Pharmaceutical Specialties, Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	12.8	g/64g			N	20241231
45334-325_0c0226b5-f524-6bc6-e063-6394a90a995f	45334-325	HUMAN OTC DRUG	Vanicream Facial Moisturizer Broad Spectrum SPF30		zinc oxide	CREAM	TOPICAL	20220315		OTC MONOGRAPH DRUG	M020	Pharmaceutical Specialties Inc	ZINC OXIDE	19.5	g/100g			N	20241231
45334-327_08679c4b-6af2-149c-e063-6294a90a1b40	45334-327	HUMAN OTC DRUG	Vanicream HC Anti-Itch		Hydrocortisone	CREAM	TOPICAL	20160126		OTC MONOGRAPH DRUG	M017	Pharmaceutical Specialties, Inc.	HYDROCORTISONE ACETATE	1.12	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45334-331_09ab033c-2737-c85b-e063-6294a90a00cb	45334-331	HUMAN OTC DRUG	Vanicream Sunscreen Sport Broad Spectrum SPF 35		Zinc oxide	CREAM	TOPICAL	20210427	20241130	OTC MONOGRAPH DRUG	M020	Pharmaceutical Specialties, Inc.	ZINC OXIDE	12	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
45334-332_08677f2c-1457-86e9-e063-6394a90ac784	45334-332	HUMAN OTC DRUG	Vanicream Sunscreen Broad Spectrum SPF 50		Zinc Oxide	CREAM	TOPICAL	20210405		OTC MONOGRAPH DRUG	M020	Pharmaceutical Specialties, Inc.	ZINC OXIDE	12	g/100g			N	20241231
45334-350_d9e0464f-e94c-91dc-e053-2995a90a91b7	45334-350	HUMAN OTC DRUG	Vanicream Lip Protectant/Sunscreen		Dimethicone, Titanium dioxide, Zinc oxide	OINTMENT	TOPICAL	20140902	20240430	OTC MONOGRAPH FINAL	part352	Pharmaceutical Specialties, Inc.	DIMETHICONE; TITANIUM DIOXIDE; ZINC OXIDE	12; 15; 150	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Skin Barrier Activity [PE]		N	
45334-391_f3bd9ae1-7001-057b-e053-2a95a90a800a	45334-391	HUMAN OTC DRUG	Vanicream Z-Bar		Pyrithione Zinc	SOAP	TOPICAL	20210101	20240131	OTC MONOGRAPH FINAL	M032	Pharmaceutical Specialties, Inc.	PYRITHIONE ZINC	2	g/100g			N	
45341-0001_e642ba0e-75b9-47e6-9e32-be8e99db7891	45341-0001	HUMAN OTC DRUG	Artalgia		Carduus Marianus, Arnica Montana, Agaricus Muscarius, Baryta Carbonica, Bellis Perennis, Glonoinum, Hamamelis Virginiana	LIQUID	ORAL	20120928		UNAPPROVED HOMEOPATHIC		Todd Horton DPM	ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; ARNICA MONTANA; BARIUM CARBONATE; BELLIS PERENNIS; CLAVICEPS PURPUREA SCLEROTIUM; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LEAD; MERCURIUS SOLUBILIS; NITROGLYCERIN; PHOSPHORUS; PULSATILLA VULGARIS; SILYBUM MARIANUM SEED OIL; TOXICODENDRON PUBESCENS LEAF; VANADIUM	30; 12; 3; 12; 12; 12; 12; 30; 12; 12; 12; 30; 30; 3; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
45341-0002_2c53f257-54a1-4a2b-aac3-6eaffea91603	45341-0002	HUMAN OTC DRUG	Artalgia		Carduus Marianus, Arnica Montana, Agaricus Muscarius, Baryta Carbonica, Bellis Perennis, Glonoinum, Hamamelis Virginiana, Mercurius Solubilis, Plumbum Metallicum, Secale Cornutum, Vanadium Metallicum, Carbo Vegetabilis, Hypericum Perforatum, Phosphorus Pulsatilla (Pratensis), Rhus Tox	LIQUID	ORAL	20200715		UNAPPROVED HOMEOPATHIC		Todd Horton DPM	ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; ARNICA MONTANA WHOLE; BARIUM CARBONATE; BELLIS PERENNIS WHOLE; CLAVICEPS PURPUREA SCLEROTIUM; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM WHOLE; LEAD; MERCURIUS SOLUBILIS; MILK THISTLE; NITROGLYCERIN; PHOSPHORUS; PULSATILLA PRATENSIS WHOLE; TOXICODENDRON PUBESCENS LEAF; VANADIUM	30; 12; 3; 12; 12; 12; 12; 30; 12; 12; 3; 12; 30; 30; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
45545-001_0bc64a52-e57f-34e7-e063-6294a90a9517	45545-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		InHome Oxygen & Medical Supplies, Inc.	OXYGEN	99	L/100L			N	20241231
45548-141_b089044e-6c93-4941-94e7-55786e5b57b8	45548-141	HUMAN PRESCRIPTION DRUG	TECHNETIUM TC 99M SESTAMIBI		Technetium TC 99m Sestamibi	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20090701		ANDA	ANDA078806	Jubilant Draximage (USA) Inc.	TECHNETIUM TC-99M SESTAMIBI	1	mg/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
45567-0030_875742de-1b2c-4733-accf-f67dbc5cda8a	45567-0030	HUMAN PRESCRIPTION DRUG	Kit for the Prepartion of Technetium Tc99m Sulfur Colloid		Technetium Tc 99m Sulfur Colloid	KIT		19780419		NDA	NDA017858	Sun Pharmaceutical Industries, Inc.						N	20241231
45567-0040_d39456d5-f3a9-4537-b8b8-19fa62e2590e	45567-0040	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc 99M Medronate		TC 99M MEDRONATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19790829		NDA	NDA018124	Sun Pharmaceutical Industries, Inc.	TECHNETIUM TC-99M MEDRONATE	20	mg/10mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
45567-0060_451249c9-0512-49f1-b04b-58a7dde3f43f	45567-0060	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc99m Pyrophosphate		Technetium Tc99m Pyrophosphate	INJECTION	INTRAVENOUS	19870630		NDA	NDA019039	Sun Pharmaceutical Industries, Inc.	TECHNETIUM TC-99M PYROPHOSPHATE	12	mg/10mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
45567-0455_cdf001df-1d72-4c44-abee-1daaedc215c7	45567-0455	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc 99m Mebrofenin		Kit for the Preparation of Technetium Tc 99m Mebrofenin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20080129		ANDA	ANDA078242	Sun Pharmaceutical Industries, Inc.	MEBROFENIN	45	mg/10mL			N	20241231
45567-0555_da951b14-fe9d-492c-950f-8a17e44dab31	45567-0555	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc99m Sestamibi		TECHNETIUM TC-99M SESTAMIBI	INJECTION	INTRAVENOUS	20090710		ANDA	ANDA079157	Sun Pharmaceutical Industries, Inc.	TECHNETIUM TC-99M SESTAMIBI	1	mg/10mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
45567-0655_ba5a4d75-eb0b-410b-acb2-330fc8dd91e7	45567-0655	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc99m Mertiatide		Betiatide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190902		ANDA	ANDA208994	Sun Pharmaceutical Industries, Inc.	BETIATIDE	1	mg/1			N	20241231
45591-002_0ccb5970-3696-9097-e063-6294a90aa811	45591-002	HUMAN OTC DRUG	Chigg Away		Benzocaine	LOTION	TOPICAL	20061201		OTC MONOGRAPH DRUG	M017	Pierson Laboratories, Inc.	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
45629-089_22d362c3-0746-49c4-8109-6f30bfc86cb8	45629-089	HUMAN PRESCRIPTION DRUG	FOTIVDA		Tivozanib	CAPSULE	ORAL	20210310		NDA	NDA212904	AVEO Pharmaceuticals, Inc.	TIVOZANIB HYDROCHLORIDE	.89	mg/1	Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
45629-134_22d362c3-0746-49c4-8109-6f30bfc86cb8	45629-134	HUMAN PRESCRIPTION DRUG	FOTIVDA		Tivozanib	CAPSULE	ORAL	20210310		NDA	NDA212904	AVEO Pharmaceuticals, Inc.	TIVOZANIB HYDROCHLORIDE	1.34	mg/1	Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
45634-137_0022e63f-612d-29f0-e063-6294a90aff98	45634-137	HUMAN OTC DRUG	HIGH POTENCY CLASSICS Face Finishing and Firming Tinted Moisturizer SPF 30		Titanium Dioxide	CREAM	TOPICAL	20220404		OTC MONOGRAPH FINAL	M020	N.V Perricone LLC	TITANIUM DIOXIDE	2.478	g/59g			N	20241231
45634-167_049e0989-2f9d-514b-e063-6294a90a44fc	45634-167	HUMAN OTC DRUG	Cold Plasma Plus Neck and Chest SPF25		titanium dioxide	CREAM	TOPICAL	20220401		OTC MONOGRAPH FINAL	M020	NV Perricone LLC	TITANIUM DIOXIDE	1.26	g/30g			N	20241231
45634-251_00246f6f-a987-e2c3-e063-6394a90aa27d	45634-251	HUMAN OTC DRUG	VITAMIN C ESTER PHOTO-BRIGHTROAD SPECTRUM SPF 30 59ml		TITANIUM DIOXIDE	CREAM	TOPICAL	20220728		OTC MONOGRAPH FINAL	M020	N.V Perricone LLC	TITANIUM DIOXIDE	2.48	g/59g			N	20241231
45634-252_0024163a-7904-053e-e063-6394a90a75df	45634-252	HUMAN OTC DRUG	VITAMIN C ESTER PHOTO-BRIGHTROAD SPECTRUM SPF 30 30ml		TITANIUM DIOXIDE	CREAM	TOPICAL	20220728		OTC MONOGRAPH FINAL	M020	N.V Perricone LLC	TITANIUM DIOXIDE	2.48	g/59g			N	20241231
45634-253_00242727-5d15-5ab1-e063-6394a90ac6ba	45634-253	HUMAN OTC DRUG	VITAMIN C ESTER PHOTO-BRIGHTROAD SPECTRUM SPF 30	15ml	TITANIUM DIOXIDE	CREAM	TOPICAL	20220728		OTC MONOGRAPH FINAL	M020	N.V Perricone LLC	TITANIUM DIOXIDE	2.48	g/59g			N	20241231
45634-254_00235822-ef50-6fb5-e063-6394a90a0864	45634-254	HUMAN OTC DRUG	VITAMIN C ESTER PHOTO-BRIGHTENING MOISTURIZER BROAD SPECTRUM SPF 30 59mL		TITANIUM DIOXIDE	CREAM	TOPICAL	20220728		OTC MONOGRAPH FINAL	M020	N.V Perricone LLC	TITANIUM DIOXIDE	2.48	g/59g			N	20241231
45634-711_00232275-64d4-9d37-e063-6294a90a1acb	45634-711	HUMAN OTC DRUG	No Makeup Bronzer SPF15		Zinc Oxide	LIQUID	TOPICAL	20220503		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	1.38	g/10g			N	20241231
45634-712_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-712	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Buff		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-715_04c1538c-2db8-f441-e063-6394a90a3367	45634-715	HUMAN OTC DRUG	HYPOALLERGENIC CBD SENSITIVE SKIN THERAPY Ultra-Lightweight Calming Veil SPF 35		Zinc Oxide	CREAM	TOPICAL	20230905		OTC MONOGRAPH FINAL	M020	NV Perricone LLC	ZINC OXIDE	7.725	mg/50mg			N	20241231
45634-716_04b1a617-e188-9f04-e063-6394a90a7c9c	45634-716	HUMAN OTC DRUG	HYPOALLERGENIC CBD SENSITIVE SKIN THERAPY Ultra-Lightweight Calming Veil SPF 35		Zinc Oxide	CREAM	TOPICAL	20230905		OTC MONOGRAPH FINAL	M020	NV Perricone LLC	ZINC OXIDE	2.3175	g/15g			N	20241231
45634-720_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-720	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Nude		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-721_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-721	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Ivory		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-723_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-723	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Beige		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-724_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-724	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Golden		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-725_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-725	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Tan		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-726_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-726	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Rich		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-729_0036d6fc-eed8-ee87-e063-6294a90a8022	45634-729	HUMAN OTC DRUG	Perricone MD No Make Up Foundation Serum SPF 20 - Porcelain		Zinc Oxide	LIQUID	TOPICAL	20220413		OTC MONOGRAPH FINAL	part352	N.V Perricone LLC	ZINC OXIDE	2.478	g/30g			N	20241231
45634-730_0022e63f-614f-29f0-e063-6294a90aff98	45634-730	HUMAN OTC DRUG	No Makeup Concealer (Light) SPF 20		ZINC OXIDE	EMULSION	TOPICAL	20220426		OTC MONOGRAPH FINAL	part352	N.V. Perricone LLC	ZINC OXIDE	.7434	g/9g			N	20241231
45634-731_00232275-64d7-9d37-e063-6294a90a1acb	45634-731	HUMAN OTC DRUG	No Makeup Concealer (Medium) SPF 20		ZINC OXIDE	EMULSION	TOPICAL	20220426		OTC MONOGRAPH FINAL	part352	N.V. Perricone LLC	ZINC OXIDE	.7434	g/9g			N	20241231
45634-732_00232275-64d8-9d37-e063-6294a90a1acb	45634-732	HUMAN OTC DRUG	No Makeup Concealer (Tan) SPF 20		ZINC OXIDE	EMULSION	TOPICAL	20220426		OTC MONOGRAPH FINAL	part352	N.V. Perricone LLC	ZINC OXIDE	.7434	g/9g			N	20241231
45634-733_00232275-64d5-9d37-e063-6294a90a1acb	45634-733	HUMAN OTC DRUG	No Makeup Concealer (Deep) SPF 20		ZINC OXIDE	EMULSION	TOPICAL	20220426		OTC MONOGRAPH FINAL	part352	N.V. Perricone LLC	ZINC OXIDE	.7434	g/9g			N	20241231
45634-793_00232275-64d6-9d37-e063-6294a90a1acb	45634-793	HUMAN OTC DRUG	No Makeup Concealer (Fair) SPF 20		ZINC OXIDE	EMULSION	TOPICAL	20220426		OTC MONOGRAPH FINAL	part352	N.V. Perricone LLC	ZINC OXIDE	.7434	g/9g			N	20241231
45728-444_0ccb64df-0691-12f4-e063-6294a90aca99	45728-444	HUMAN OTC DRUG	Father Johns Medicine		Dextromethorphan HBr	LIQUID	ORAL	20190617		OTC MONOGRAPH DRUG	M012	Oakhurst Company	DEXTROMETHORPHAN HYDROBROMIDE	10	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
45728-445_0ccb5970-3697-9097-e063-6294a90aa811	45728-445	HUMAN OTC DRUG	Father Johns Cough Medicine Plus		Nasal Decongestant	LIQUID	ORAL	20190617		OTC MONOGRAPH DRUG	M012	Oakhurst Company	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 10; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-203_5ebcff2f-3f3a-436a-8ab1-44928941f2a1	45737-203	HUMAN OTC DRUG	BIO Dtuss	DMX	Brompheniramine Maleate, Dextromethorphan, Pseudoephedrine	LIQUID	ORAL	20111201		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	1; 20; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45737-205_b3ffc52b-e4ae-4132-b066-5f11ac2a304e	45737-205	HUMAN OTC DRUG	BioGtuss		Dextromethorphan, Guaifenesin, Phenylephrine	LIQUID	ORAL	20091001		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	15; 300; 15	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-206_cfe6e1fc-d158-4e7e-b071-c6d7bd236a8b	45737-206	HUMAN OTC DRUG	Bionel		Dextromethorphan, Guaifenesin, Pseudoephedrine Hydrochloride	LIQUID	ORAL	20091001		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	15; 200; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45737-207_27ff6a28-8f3a-4a42-9cc9-0fe1afb85799	45737-207	HUMAN OTC DRUG	Bionel	Pediatric	Dextromethorphan, Guaifenesin, Pseudoephedrine Hydrochloride	LIQUID	ORAL	20091001		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 50; 15	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45737-208_09f2b66a-cbe2-4baf-a9a6-a55f0426cdd7	45737-208	HUMAN OTC DRUG	Biocotron-D		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SUSPENSION/ DROPS	ORAL	20130301		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-209_6064d4a6-914d-4c9b-847a-f6da938540ab	45737-209	HUMAN OTC DRUG	Biocotron		Dextromethorphan, Guaifenesin	LIQUID	ORAL	20090101		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
45737-210_2c36395e-c0a5-42a6-ba75-977b33b65aac	45737-210	HUMAN OTC DRUG	Bionatuss	DXP	Dexbrompheniramine Maleate, Dextromethorphan, Phenylephrine	LIQUID	ORAL	20091001		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 20; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-211_5c91244c-f997-481e-b9f2-b2814efc6e7d	45737-211	HUMAN OTC DRUG	Biospec	DMX	Dextromethorphan, Guaifenesin	LIQUID	ORAL	20091001		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	15; 25	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
45737-221_fe676580-acff-42f8-bc7a-076af73dd1b4	45737-221	HUMAN OTC DRUG	Biodesp	DM	Dextromethorphan, Guaifenesin, Phenylephrine	LIQUID	ORAL	20090101		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	15; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-230_b4c750b5-60bd-4135-a52f-529f315f3847	45737-230	HUMAN OTC DRUG	Bio-S-Pres	DX	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20130301		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-239_5f3d7e22-595d-4d3f-90b9-49f9a7f69b18	45737-239	HUMAN OTC DRUG	BIO-CNEX		Dexbrompheniramine Maleate, Pseudoephedrine HCl	LIQUID	ORAL	20170101		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	1; 30	mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45737-240_7d649187-a213-4d0d-be73-571cca8a19d5	45737-240	HUMAN OTC DRUG	Bio-G-Tuss	Pediatric Drops	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20160401		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	7.5; 88; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-242_20a2b312-cedb-44e7-ae7b-c945c5000ab3	45737-242	HUMAN OTC DRUG	BioGtuss	NF	Dextromethorphan, Guaifenesin, Phenylephrine	LIQUID	ORAL	20100901		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	28; 388; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-249_e0c8cde4-ca2e-4859-8bc3-37e21d932b9e	45737-249	HUMAN OTC DRUG	Biocof		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HCL	LIQUID	ORAL	20120701		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-250_42971dd8-e7b7-4696-8082-158e4ee51e4e	45737-250	HUMAN OTC DRUG	BIO-RYTUSS		CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-251_53d4ff7d-71b0-413a-9605-c1c8d3d29a77	45737-251	HUMAN OTC DRUG	Bio-Z-Cough		Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20120701		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
45737-261_465fc4d2-eac7-4b1e-9096-9b2d4f5851fc	45737-261	HUMAN OTC DRUG	Biocotron	PED	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150301		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	15; 350; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-263_01e61e17-30cb-4c85-a365-b1d68514c06f	45737-263	HUMAN OTC DRUG	Biodesp	DM NF	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150301		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	15; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-264_2a2354c5-aee5-4dc9-b397-3d10c72a9b58	45737-264	HUMAN OTC DRUG	Biospec	DMX	Dextromethorphan, Guaifenesin	LIQUID	ORAL	20150301		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 187	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
45737-605_ba0e6be6-75a0-4449-b4cd-3538d17b461c	45737-605	HUMAN OTC DRUG	Biogtuss	TR	Guaifenesin, Phenylephrine HCl, Dextromethorphan HBr	TABLET	ORAL	20140401		OTC MONOGRAPH FINAL	part341	Advanced Generic Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	28; 388; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45737-610_8c3e3753-dfc7-4cfe-9c04-b7f8a8cfd75f	45737-610	HUMAN OTC DRUG	Biogesic		Acetaminophen, Dexbrompheniramine Maleate	TABLET	ORAL	20170101		OTC MONOGRAPH NOT FINAL	part343	Advanced Generic Corporation	ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE	500; 1	mg/1; mg/1			N	20241231
45737-701_56418335-c450-468d-8ff1-37747778a7f6	45737-701	HUMAN OTC DRUG	BioDCream		Zinc Oxide	CREAM	TOPICAL	20160401		OTC MONOGRAPH FINAL	part347	Advanced Generic Corporation	ZINC OXIDE	15.25	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
45802-001_e918cc06-b6e1-4e66-b892-88d9114747c8	45802-001	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20140409	20250101	ANDA	ANDA078326	Padagis Israel Pharmaceuticals Ltd	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
45802-004_15138d09-8d0b-4627-a4ac-2df7e7e1c87a	45802-004	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-009_411adaf8-ab23-416a-b452-84ae6ee836e1	45802-009	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	SOLUTION/ DROPS	AURICULAR (OTIC)	20171004		ANDA	ANDA202849	Padagis Israel Pharmaceuticals Ltd	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-014_15138d09-8d0b-4627-a4ac-2df7e7e1c87a	45802-014	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20060613		ANDA	ANDA085027	Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-018_fbf2e020-49a6-4529-9bce-4650423239e7	45802-018	HUMAN PRESCRIPTION DRUG	MUPIROCIN		mupirocin	CREAM	TOPICAL	20220906	20240731	ANDA	ANDA212465	Padagis Israel Pharmaceuticals Ltd	MUPIROCIN CALCIUM	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	
45802-021_b6334b53-e40c-4c23-b051-0b1ab4a3c284	45802-021	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	LOTION	TOPICAL	20060630		ANDA	ANDA072538	Padagis Israel Pharmaceuticals Ltd	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-026_13a7f4f6-f9ad-4072-a70b-b80c4c24059f	45802-026	HUMAN PRESCRIPTION DRUG	azelastine hcl nasal		Azelastine HCl	SPRAY	NASAL	20140509		ANDA	ANDA202743	Padagis Israel Pharmaceuticals Ltd	AZELASTINE HYDROCHLORIDE	205.5	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45802-038_22fd6fa6-2fdf-4e0d-b51a-89bd44e4ecf0	45802-038	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	SOLUTION	TOPICAL	20111219		ANDA	ANDA063038	Padagis Israel Pharmaceuticals Ltd	ERYTHROMYCIN	20	mg/mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
45802-040_c9ad94f9-06a1-4079-886c-a5b159e214a2	45802-040	HUMAN PRESCRIPTION DRUG	SELENIUM SULFIDE		SELENIUM SULFIDE	LOTION	TOPICAL	20060925		ANDA	ANDA089996	Padagis Israel Pharmaceuticals Ltd	SELENIUM SULFIDE	2.5	mg/100mL			N	20241231
45802-042_8b0f9cbc-5e92-4583-a6a3-f7524a4cb3da	45802-042	HUMAN PRESCRIPTION DRUG	Clindesse		clindamycin phosphate	CREAM	VAGINAL	20150703		NDA	NDA050793	Padagis Israel Pharmaceuticals Ltd	CLINDAMYCIN PHOSPHATE	100	mg/5g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
45802-044_783fd153-9d5f-4296-a8da-f62d9fbdc5d3	45802-044	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CREAM	TOPICAL	20190211		ANDA	ANDA208702	Padagis Israel Pharmaceuticals Ltd	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
45802-045_b6d9aaf4-144a-4fb8-89f0-21daa68dbf5c	45802-045	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	AEROSOL, SPRAY	TOPICAL	20150417		ANDA	ANDA205782	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	.147	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-046_7709f999-b7b3-4def-ab9d-501e5eb3c09f	45802-046	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	OINTMENT	TOPICAL	20060710		ANDA	ANDA062351	Padagis Israel Pharmaceuticals Ltd	GENTAMICIN SULFATE	1	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
45802-048_1302b644-f700-40c7-8917-806b5ce94279	45802-048	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20060915		ANDA	ANDA062472	Padagis Israel Pharmaceuticals Ltd	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
45802-049_13c13dae-7f5d-4b1f-af06-c62dfdcf8f1c	45802-049	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20061110		ANDA	ANDA087385	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-050_d3df1be8-40f1-4ee7-8abc-649e9aeeee9a	45802-050	HUMAN OTC DRUG	dibucaine		dibucaine	OINTMENT	TOPICAL	20110620		OTC MONOGRAPH FINAL	part346	Padagis Israel Pharmaceuticals Ltd	DIBUCAINE	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
45802-053_bc56ee3f-ab35-46a1-8127-f3929766a6a8	45802-053	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	AEROSOL, FOAM	TOPICAL	20130115		ANDA	ANDA078337	Padagis Israel Pharmaceuticals Ltd	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-054_13c13dae-7f5d-4b1f-af06-c62dfdcf8f1c	45802-054	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20060512		ANDA	ANDA087385	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-055_13c13dae-7f5d-4b1f-af06-c62dfdcf8f1c	45802-055	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20060804		ANDA	ANDA087385	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-056_fdd54ecd-6312-47ad-bf76-162972f01c53	45802-056	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	CREAM	TOPICAL	20060823		ANDA	ANDA062307	Padagis Israel Pharmaceuticals Ltd	GENTAMICIN SULFATE	1	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
45802-057_195eac27-a311-4d14-9764-18e3ed73ee9d	45802-057	HUMAN OTC DRUG	Ibuprofen		ibuprofen	SUSPENSION	ORAL	20140409		ANDA	ANDA075217	Padagis Israel Pharmaceuticals Ltd	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-059_0743d7e6-4ae3-4933-bde5-4e4edeedb9d7	45802-059	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20060921		ANDA	ANDA062225	Padagis Israel Pharmaceuticals Ltd	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
45802-060_bba42abe-613c-4d5b-9eee-bb73e8ca6674	45802-060	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20110620		OTC MONOGRAPH FINAL	part333B	Padagis Israel Pharmaceuticals Ltd	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
45802-063_0e403a2d-2ea3-45fd-a88c-fd76d3f93514	45802-063	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20061009		ANDA	ANDA086413	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-064_0e403a2d-2ea3-45fd-a88c-fd76d3f93514	45802-064	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20060928		ANDA	ANDA086413	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-065_0e403a2d-2ea3-45fd-a88c-fd76d3f93514	45802-065	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20060517		ANDA	ANDA086413	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-066_693e7eea-6603-4393-9b74-27c583dc8f9e	45802-066	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE		azelastine hydrochloride, fluticasone propionate	SPRAY, METERED	NASAL	20210301		ANDA	ANDA208111	Padagis Israel Pharmaceuticals Ltd	AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE	137; 50	ug/1; ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45802-078_a2c74527-fc36-4141-a382-02fb06d6c0c8	45802-078	HUMAN PRESCRIPTION DRUG	BRIMONIDINE		brimonidine	GEL	TOPICAL	20230101		ANDA	ANDA209158	Padagis Israel Pharmaceuticals Ltd	BRIMONIDINE TARTRATE	5	mg/g	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45802-087_7255a53b-e2f0-466a-9ce7-d1df7babc9c1	45802-087	HUMAN PRESCRIPTION DRUG	Alogliptin		Alogliptin	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022271	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE	6.25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
45802-088_39364d69-14eb-4546-9ceb-12b27d008d7f	45802-088	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200226		ANDA	ANDA203760	Padagis Israel Pharmaceuticals Ltd	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
45802-089_365ced3c-1cba-43a1-9b6e-346532d5bfa6	45802-089	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20160708		ANDA	ANDA203690	Padagis Israel Pharmaceuticals Ltd	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
45802-097_21863c5c-acca-485c-9517-41a9f16e7591	45802-097	HUMAN PRESCRIPTION DRUG	Estradiol Vaginal		Estradiol	CREAM	VAGINAL	20210106		ANDA	ANDA210194	Padagis Israel Pharmaceuticals Ltd	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
45802-098_94e1b5cd-8927-4fb6-aeb3-baf0d6a4784c	45802-098	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	ENEMA	RECTAL	20071011		ANDA	ANDA076751	Padagis Israel Pharmaceuticals Ltd	MESALAMINE	4	g/60mL	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20251231
45802-101_009311c3-6c1e-4513-a6b6-7779d8db4f07	45802-101	HUMAN OTC DRUG	benzoyl peroxide		Benzoyl peroxide	GEL	TOPICAL	20120313		OTC MONOGRAPH FINAL	part333D	Padagis Israel Pharmaceuticals Ltd	BENZOYL PEROXIDE	2.5	g/100g			N	20241231
45802-102_9da7f6b6-f1cd-4058-a995-ca23c776fda8	45802-102	HUMAN PRESCRIPTION DRUG	Ivermectin		Ivermectin	CREAM	TOPICAL	20240108		ANDA	ANDA210225	Padagis Israel Pharmaceuticals Ltd	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20251231
45802-103_7255a53b-e2f0-466a-9ce7-d1df7babc9c1	45802-103	HUMAN PRESCRIPTION DRUG	Alogliptin		Alogliptin	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022271	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE	12.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
45802-104_2ea8fc33-9ced-4274-bab5-ae4284745931	45802-104	HUMAN PRESCRIPTION DRUG	olopatadine hydrochloride		Olopatadine Hydrochloride	SPRAY	NASAL	20170614		ANDA	ANDA202853	Padagis Israel Pharmaceuticals Ltd	OLOPATADINE HYDROCHLORIDE	665	ug/1	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
45802-107_545032a9-6307-402e-9cb4-1cf5174679c7	45802-107	HUMAN OTC DRUG	pseudoephedrine hydrochloride		Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140524		ANDA	ANDA075153	Padagis Israel Pharmaceuticals Ltd	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45802-109_6144fe71-93f5-4b2d-a3f2-8be6cd67e32c	45802-109	HUMAN OTC DRUG	Triamcinolone Acetonide Nasal		Triamcinolone acetonide	SPRAY, METERED	NASAL	20170328		ANDA	ANDA078104	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-111_8de722de-1521-4432-a1a6-dc4184027e05	45802-111	HUMAN PRESCRIPTION DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20181127		ANDA	ANDA210893	Padagis Israel Pharmaceuticals Ltd	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-112_0f1bb661-e86e-4a5d-b235-131962e64023	45802-112	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20091030		ANDA	ANDA065123	Padagis Israel Pharmaceuticals Ltd	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
45802-118_fe1488ac-a59e-4396-846f-d97b41ae7924	45802-118	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	SOLUTION	TOPICAL	20081211		ANDA	ANDA077180	Padagis Israel Pharmaceuticals Ltd	MOMETASONE FUROATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-119_e2f50925-5313-4067-b05c-e24a0e1fc52c	45802-119	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20080718		ANDA	ANDA076067	Padagis Israel Pharmaceuticals Ltd	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-122_dc002897-0153-4c05-b0cc-053fa439b791	45802-122	HUMAN OTC DRUG	loratadine D		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180410		ANDA	ANDA076050	Padagis Israel Pharmaceuticals Ltd	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45802-124_063887e2-1227-4ec9-8728-27821095a483	45802-124	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate pramoxine HCl		Hydrocortisone Acetate, Pramoxine HCl	CREAM	TOPICAL	20110329		UNAPPROVED DRUG OTHER		Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-128_96701f36-10ab-44c4-95d2-1f9dcee53b70	45802-128	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	LOTION	TOPICAL	20210331		ANDA	ANDA214604	Padagis Israel Pharmaceuticals Ltd	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
45802-129_4f3d068f-2393-41c4-9d14-47106cd5c6a0	45802-129	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	CREAM	TOPICAL	20080804		ANDA	ANDA077123	Padagis Israel Pharmaceuticals Ltd	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
45802-131_e8fe3dee-f2c5-45be-8608-8a1b0b2aef39	45802-131	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	OINTMENT	TOPICAL	20090205		ANDA	ANDA076872	Padagis Israel Pharmaceuticals Ltd	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-133_4a8c9af9-8570-4ea5-8c35-168d3e3b0982	45802-133	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20140409		ANDA	ANDA074937	Padagis Israel Pharmaceuticals Ltd	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-134_40076df8-0d46-42f4-b704-e4b74bace9a9	45802-134	HUMAN PRESCRIPTION DRUG	ESTRADIOL		estradiol	GEL	TOPICAL	20231207		ANDA	ANDA216524	Padagis Israel Pharmaceuticals Ltd	ESTRADIOL	.25	mg/.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
45802-138_b2f59056-96e5-49f9-8f56-522d0970f121	45802-138	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	CREAM	TOPICAL	20060719		ANDA	ANDA077364	Padagis Israel Pharmaceuticals Ltd	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
45802-139_ac51fedf-e650-40c6-a92f-d33d6f32e54b	45802-139	HUMAN PRESCRIPTION DRUG	metronidazole vaginal		metronidazole	GEL	VAGINAL	20190708		ANDA	ANDA211786	Padagis Israel Pharmaceuticals Ltd	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
45802-140_30b20ad0-0368-4d9b-bf31-f1d7626fbc27	45802-140	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20140409		ANDA	ANDA074937	Padagis Israel Pharmaceuticals Ltd	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-141_35caab7d-7077-4610-937a-8b593875d0b7	45802-141	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SOLUTION	TOPICAL	20070919		ANDA	ANDA077623	Padagis Israel Pharmaceuticals Ltd	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
45802-143_dcf538de-596c-4411-9eb5-c27f40c5644c	45802-143	HUMAN OTC DRUG	triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20140520		OTC MONOGRAPH FINAL	part333B	Padagis Israel Pharmaceuticals Ltd	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
45802-144_0d1c272f-d1a7-4f2e-b2a3-961746ae0e3e	45802-144	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate pramoxine hcl		hydrocortisone acetate pramoxine hcl	CREAM	TOPICAL	20100413		ANDA	ANDA085368	Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	1; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-147_37c10c35-1b9b-495b-9218-21735dabbd8c	45802-147	HUMAN OTC DRUG	Cetirizine hydrochloride and Pseudoephedrine hydrochloride		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200331		ANDA	ANDA210719	Padagis Israel Pharmaceuticals Ltd	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
45802-150_7255a53b-e2f0-466a-9ce7-d1df7babc9c1	45802-150	HUMAN PRESCRIPTION DRUG	Alogliptin		Alogliptin	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022271	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
45802-151_72c72409-e1bc-4058-8957-4361d7f94d22	45802-151	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20140114		ANDA	ANDA090256	Padagis Israel Pharmaceuticals Ltd	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-160_32c069b2-a11b-4df3-907c-8faaa43144f2	45802-160	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20190520	20250501	ANDA	ANDA211253	Padagis Israel Pharmaceuticals Ltd	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
45802-169_8b580d35-0095-4c68-94d0-afc3c4be4f22	45802-169	HUMAN PRESCRIPTION DRUG	alogliptin and metformin hydrochloride		alogliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA203414	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE	12.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
45802-174_04ef342d-042e-42c9-a400-0ad2549a3e72	45802-174	HUMAN OTC DRUG	Muscle Rub		Menthol, Methyl salicylate	CREAM	TOPICAL	20110303		OTC MONOGRAPH NOT FINAL	part348	Padagis Israel Pharmaceuticals Ltd	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
45802-188_1b107433-faf1-45b2-a175-bf2301060be0	45802-188	HUMAN OTC DRUG	Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20131101		OTC MONOGRAPH FINAL	part346	Padagis Israel Pharmaceuticals Ltd	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
45802-201_759204ba-544d-4f3f-af64-4171c98a5f3c	45802-201	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20140409		OTC MONOGRAPH NOT FINAL	part343	Padagis Israel Pharmaceuticals Ltd	ACETAMINOPHEN	160	mg/5mL			N	20241231
45802-202_40076df8-0d46-42f4-b704-e4b74bace9a9	45802-202	HUMAN PRESCRIPTION DRUG	ESTRADIOL		estradiol	GEL	TOPICAL	20231207		ANDA	ANDA216524	Padagis Israel Pharmaceuticals Ltd	ESTRADIOL	.5	mg/.5g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
45802-203_086b478d-2edc-477f-90ef-5986af3ebad1	45802-203	HUMAN OTC DRUG	childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20140409		OTC MONOGRAPH NOT FINAL	part343	Padagis Israel Pharmaceuticals Ltd	ACETAMINOPHEN	160	mg/5mL			N	20241231
45802-206_7e77ea19-41a3-4329-b157-6778ff8f267b	45802-206	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20140409	20241101	ANDA	ANDA078325	Padagis Israel Pharmaceuticals Ltd	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
45802-210_e75425f2-a532-4b73-9b24-258a7dcc34b9	45802-210	HUMAN PRESCRIPTION DRUG	nitroglycerin lingual		Nitroglycerin	SPRAY	ORAL	20130920		ANDA	ANDA091496	Padagis Israel Pharmaceuticals Ltd	NITROGLYCERIN	400	ug/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
45802-211_8b580d35-0095-4c68-94d0-afc3c4be4f22	45802-211	HUMAN PRESCRIPTION DRUG	alogliptin and metformin hydrochloride		alogliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA203414	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE	12.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
45802-216_55454ffb-5ad4-4964-9de2-0490c124b116	45802-216	HUMAN OTC DRUG	benzoyl peroxide		BENZOYL PEROXIDE	GEL	TOPICAL	20120313		OTC MONOGRAPH FINAL	part333D	Padagis Israel Pharmaceuticals Ltd	BENZOYL PEROXIDE	5	g/100g			N	20241231
45802-221_4f58fb74-b55e-4235-bd68-46a3871d2292	45802-221	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	OINTMENT	TOPICAL	20070709		ANDA	ANDA076668	Padagis Israel Pharmaceuticals Ltd	FLUTICASONE PROPIONATE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-222_0e72832d-bcac-47b4-a085-0f8002c2118a	45802-222	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	CREAM	TOPICAL	20060913		ANDA	ANDA076793	Padagis Israel Pharmaceuticals Ltd	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-238_35a2f49d-f0e8-4e6a-a9ae-a37484c0e7e7	45802-238	HUMAN PRESCRIPTION DRUG	Alogliptin and Pioglitazone		Alogliptin Benzoate and Pioglitazone hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022426	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	12.5; 15	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
45802-244_5797c2ea-37cd-4a6f-87ce-030df00cb949	45802-244	HUMAN PRESCRIPTION DRUG	nystatin and triamcinolone acetonide		nystatin and triamcinolone acetonide	OINTMENT	TOPICAL	20171018		ANDA	ANDA207380	Padagis Israel Pharmaceuticals Ltd	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
45802-245_9aaa8c78-11a3-4e9a-b044-9eda38fa6620	45802-245	HUMAN OTC DRUG	lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120807		ANDA	ANDA202319	Padagis Israel Pharmaceuticals Ltd	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45802-257_34076a1a-b6a3-498f-b8a3-6498a5c42fe8	45802-257	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20041221		ANDA	ANDA076679	Padagis Israel Pharmaceuticals Ltd	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-260_35a2f49d-f0e8-4e6a-a9ae-a37484c0e7e7	45802-260	HUMAN PRESCRIPTION DRUG	Alogliptin and Pioglitazone		Alogliptin Benzoate and Pioglitazone hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022426	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	12.5; 30	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
45802-263_e92b0367-c4ed-4147-b5f5-0c6afa71b1bd	45802-263	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20060531		ANDA	ANDA065049	Padagis Israel Pharmaceuticals Ltd	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
45802-269_329bfb32-8709-4e59-bae4-dbc7557ab049	45802-269	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin	CREAM	TOPICAL	20060811		ANDA	ANDA076369	Padagis Israel Pharmaceuticals Ltd	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
45802-276_816d7daf-3405-4b15-ae14-11e6fc3a0f65	45802-276	HUMAN OTC DRUG	hydrocortisone		hydrocortisone	OINTMENT	TOPICAL	20110818		OTC MONOGRAPH NOT FINAL	part348	Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-280_9ad048a0-effd-431b-87ce-7412d45f2c5d	45802-280	HUMAN OTC DRUG	benzoyl peroxide		BENZOYL PEROXIDE	LIQUID	TOPICAL	20130124		OTC MONOGRAPH FINAL	part333D	Padagis Israel Pharmaceuticals Ltd	BENZOYL PEROXIDE	5	g/100g			N	20241231
45802-281_3f080bb5-5452-44dc-86fe-a4b70fd975e7	45802-281	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20190627		ANDA	ANDA205781	Padagis Israel Pharmaceuticals Ltd	TESTOSTERONE	20.25	mg/1.25g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
45802-304_35a2f49d-f0e8-4e6a-a9ae-a37484c0e7e7	45802-304	HUMAN PRESCRIPTION DRUG	Alogliptin and Pioglitazone		Alogliptin Benzoate and Pioglitazone hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022426	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	12.5; 45	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
45802-308_beeb9707-38b2-49c8-87e8-ab543c3e3603	45802-308	HUMAN OTC DRUG	benzoyl peroxide		BENZOYL PEROXIDE	GEL	TOPICAL	20120406		OTC MONOGRAPH FINAL	part333D	Padagis Israel Pharmaceuticals Ltd	BENZOYL PEROXIDE	10	g/100g			N	20241231
45802-310_40076df8-0d46-42f4-b704-e4b74bace9a9	45802-310	HUMAN PRESCRIPTION DRUG	ESTRADIOL		estradiol	GEL	TOPICAL	20231207		ANDA	ANDA216524	Padagis Israel Pharmaceuticals Ltd	ESTRADIOL	.75	mg/.75g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
45802-318_7abae268-fd9b-4b16-aaa8-641cb9b0a58f	45802-318	HUMAN OTC DRUG	benzoyl peroxide		BENZOYL PEROXIDE	SUSPENSION	TOPICAL	20130220		OTC MONOGRAPH FINAL	part333D	Padagis Israel Pharmaceuticals Ltd	BENZOYL PEROXIDE	10	g/100g			N	20241231
45802-344_307d0eb4-30e2-40cb-9e79-8e6a2001b5fb	45802-344	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20140331		ANDA	ANDA077007	Padagis Israel Pharmaceuticals Ltd	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
45802-351_35a2f49d-f0e8-4e6a-a9ae-a37484c0e7e7	45802-351	HUMAN PRESCRIPTION DRUG	Alogliptin and Pioglitazone		Alogliptin Benzoate and Pioglitazone hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022426	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	25; 15	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
45802-358_56c0e2a9-71f4-4959-9244-98002453609f	45802-358	HUMAN OTC DRUG	diphenhydramine hcl and zinc acetate		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20051205		OTC MONOGRAPH NOT FINAL	part348	Padagis Israel Pharmaceuticals Ltd	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45802-366_3f080bb5-5452-44dc-86fe-a4b70fd975e7	45802-366	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20190606		ANDA	ANDA205781	Padagis Israel Pharmaceuticals Ltd	TESTOSTERONE	40.5	mg/2.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
45802-368_d4dfa9c0-c880-43eb-9c4b-8fa5e7d38395	45802-368	HUMAN PRESCRIPTION DRUG	Imiquimod		Imiquimod	CREAM	TOPICAL	20101109		ANDA	ANDA078837	Padagis Israel Pharmaceuticals Ltd	IMIQUIMOD	12.5	mg/.25g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
45802-376_7c95b6de-0d41-40b6-a7a3-3953facf094b	45802-376	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20060928		ANDA	ANDA076592	Padagis Israel Pharmaceuticals Ltd	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-390_ca08f41f-bc87-45bb-91b8-1d89adfba78f	45802-390	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	OINTMENT	TOPICAL	20141120		NDA	NDA050777	Padagis Israel Pharmaceuticals Ltd	TACROLIMUS	.3	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
45802-396_3953738b-1476-4a24-9e07-a7d3866d76a8	45802-396	HUMAN PRESCRIPTION DRUG	gynazole 1		butoconazole nitrate	CREAM	VAGINAL	20150429		ANDA	ANDA200923	Padagis Israel Pharmaceuticals Ltd	BUTOCONAZOLE NITRATE	100	mg/5g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
45802-400_945c33d7-b24a-4301-9064-732ee81bd093	45802-400	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	SUSPENSION	TOPICAL	20061229		ANDA	ANDA077676	Padagis Israel Pharmaceuticals Ltd	CICLOPIROX OLAMINE	7.7	mg/100mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
45802-401_8f74f30b-0371-43c4-a7fe-2369879accdd	45802-401	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SHAMPOO	TOPICAL	20100217		ANDA	ANDA078594	Padagis Israel Pharmaceuticals Ltd	CICLOPIROX	1	g/100mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
45802-402_35a2f49d-f0e8-4e6a-a9ae-a37484c0e7e7	45802-402	HUMAN PRESCRIPTION DRUG	Alogliptin and Pioglitazone		Alogliptin Benzoate and Pioglitazone hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022426	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	25; 30	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
45802-410_2e17d138-f4a7-4f1a-b7f8-7ec77e591263	45802-410	HUMAN OTC DRUG	oxymetazoline hcl		oxymetazoline hydrochloride	SPRAY	NASAL	20051205		OTC MONOGRAPH FINAL	part341	Padagis Israel Pharmaceuticals Ltd	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
45802-419_dc36085c-21d3-41e5-875c-685f3ef840f1	45802-419	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	LOTION	TOPICAL	20060620		ANDA	ANDA075570	Padagis Israel Pharmaceuticals Ltd	AMMONIUM LACTATE	12	g/100g	Acidifying Activity [MoA]		N	20241231
45802-423_9d27c98f-5df2-45c7-a479-a4a04128e6b6	45802-423	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	OINTMENT	TOPICAL	20060822		NDA	NDA017426	Padagis Israel Pharmaceuticals Ltd	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-432_8e029c00-20be-4bf2-a05a-2e82ef973935	45802-432	HUMAN OTC DRUG	pseudoephedrine hydrochloride		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20081017		OTC MONOGRAPH FINAL	part341	Padagis Israel Pharmaceuticals Ltd	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
45802-433_d58d9232-d3e8-46fa-adac-a5ff81d79c7b	45802-433	HUMAN OTC DRUG	dextromethorphan polistirex extended release		dextromethorphan polistirex	SUSPENSION	ORAL	20120910		ANDA	ANDA091135	Padagis Israel Pharmaceuticals Ltd	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
45802-434_3c4930b8-dc88-4075-9232-8dd99ab097da	45802-434	HUMAN OTC DRUG	clotrimazole		Clotrimazole	CREAM	TOPICAL	20110603		OTC MONOGRAPH FINAL	part333C	Padagis Israel Pharmaceuticals Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
45802-436_cb71f814-6c05-474c-8dd0-27f5398871ff	45802-436	HUMAN PRESCRIPTION DRUG	TAZAROTENE		tazarotene	GEL	TOPICAL	20230605		ANDA	ANDA213079	Padagis Israel Pharmaceuticals Ltd	TAZAROTENE	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
45802-437_b6daaa57-be91-4dc3-9cc4-aeb6402241ec	45802-437	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol propionate	AEROSOL, FOAM	TOPICAL	20080320		ANDA	ANDA077763	Padagis Israel Pharmaceuticals Ltd	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-438_9ac2242d-ac10-45ea-86d6-0ded80dfd988	45802-438	HUMAN OTC DRUG	hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20110413		OTC MONOGRAPH NOT FINAL	part348	Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-441_527c0560-e7da-4740-a7f6-951fe2749f8d	45802-441	HUMAN PRESCRIPTION DRUG	fluticasone propionate		fluticasone propionate	LOTION	TOPICAL	20130808		ANDA	ANDA091553	Padagis Israel Pharmaceuticals Ltd	FLUTICASONE PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-442_cb71f814-6c05-474c-8dd0-27f5398871ff	45802-442	HUMAN PRESCRIPTION DRUG	TAZAROTENE		tazarotene	GEL	TOPICAL	20230605		ANDA	ANDA213079	Padagis Israel Pharmaceuticals Ltd	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
45802-452_40076df8-0d46-42f4-b704-e4b74bace9a9	45802-452	HUMAN PRESCRIPTION DRUG	ESTRADIOL		estradiol	GEL	TOPICAL	20231207		ANDA	ANDA216524	Padagis Israel Pharmaceuticals Ltd	ESTRADIOL	1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
45802-453_0a564c3c-85dd-4fb8-8bb8-27a9e24c5723	45802-453	HUMAN PRESCRIPTION DRUG	Adapalene		Adapalene	CREAM	TOPICAL	20101026		NDA AUTHORIZED GENERIC	NDA020748	Padagis Israel Pharmaceuticals Ltd	ADAPALENE	.1	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
45802-465_270fb948-dc97-43ab-9936-38f3952aeff3	45802-465	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	SHAMPOO, SUSPENSION	TOPICAL	20100119		ANDA	ANDA076419	Padagis Israel Pharmaceuticals Ltd	KETOCONAZOLE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
45802-466_40af878e-bd3f-40c7-9022-73a294ae5f6e	45802-466	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20060808		ANDA	ANDA076479	Padagis Israel Pharmaceuticals Ltd	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
45802-472_105cdafb-b9f9-430d-94eb-1f680ab5e1a6	45802-472	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate Pramoxine Hcl		Hydrocortisone Acetate Pramoxine Hcl	CREAM	TOPICAL	19960927		UNAPPROVED DRUG OTHER		Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-485_9b55952b-7500-40f8-bbe7-88adbaa3a66d	45802-485	HUMAN PRESCRIPTION DRUG	Fluocinolone acetonide		Fluocinolone acetonide	OIL	TOPICAL	20170614		ANDA	ANDA202848	Padagis Israel Pharmaceuticals Ltd	FLUOCINOLONE ACETONIDE	.01	mg/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-486_76cf96e3-77e6-4616-924c-717bc101e438	45802-486	HUMAN OTC DRUG	Docusate Sodium		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20081028		OTC MONOGRAPH NOT FINAL	part334	Padagis Israel Pharmaceuticals Ltd	DOCUSATE SODIUM	100	mg/1			N	20241231
45802-490_4c16edda-e3ef-4c7d-8424-08628309556c	45802-490	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140411		ANDA	ANDA074661	Padagis Israel Pharmaceuticals Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-491_4cf650d9-6d6c-4112-88f2-cd2e94f1f416	45802-491	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	SPRAY	NASAL	20231228		ANDA	ANDA212458	Padagis Israel Pharmaceuticals Ltd	CYANOCOBALAMIN	500	ug/1	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20251231
45802-493_5b291cbb-d47e-4aa7-ad5d-c43a05d7ba4f	45802-493	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	CREAM	TOPICAL	20060816		ANDA	ANDA075774	Padagis Israel Pharmaceuticals Ltd	AMMONIUM LACTATE	12	g/100g	Acidifying Activity [MoA]		N	20241231
45802-495_e06c158f-a1f1-4964-afc9-1966d6800080	45802-495	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20061024		ANDA	ANDA076510	Padagis Israel Pharmaceuticals Ltd	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-496_1a568211-3bfc-4591-b8b7-36c2e3a4d24f	45802-496	HUMAN PRESCRIPTION DRUG	desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20150514		ANDA	ANDA077770	Padagis Israel Pharmaceuticals Ltd	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-499_35a2f49d-f0e8-4e6a-a9ae-a37484c0e7e7	45802-499	HUMAN PRESCRIPTION DRUG	Alogliptin and Pioglitazone		Alogliptin Benzoate and Pioglitazone hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022426	Padagis Israel Pharmaceuticals Ltd	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	25; 45	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
45802-505_2b7eb30b-edaf-4305-baa8-b6a7dcf48ec4	45802-505	HUMAN PRESCRIPTION DRUG	BETAMETHASONE DIPROPIONATE		betamethasone dipropionate	OINTMENT	TOPICAL	20220520		ANDA	ANDA215847	Padagis Israel Pharmaceuticals Ltd	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-507_3d75ed15-f8a8-4317-b949-992be4c2a7bd	45802-507	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN AND BENZOYL PEROXIDE		clindamycin and benzoyl peroxide	KIT		20150922		ANDA	ANDA202440	Padagis Israel Pharmaceuticals Ltd						N	20241231
45802-507_3ee59808-7869-47e4-b6e5-9c154dfcfe71	45802-507	HUMAN PRESCRIPTION DRUG	clindamycin and benzoyl peroxide		clindamycin and benzoyl peroxide	KIT		20160426		ANDA	ANDA202440	Padagis Israel Pharmaceuticals Ltd						N	20241231
45802-509_bae79e41-1b56-4bcc-9635-ffcf85fa0fde	45802-509	HUMAN PRESCRIPTION DRUG	clindamycin and benzoyl peroxide		clindamycin and benzoyl peroxide	KIT		20210203		ANDA	ANDA202440	Padagis Israel Pharmaceuticals Ltd						N	20241231
45802-510_84f65326-838e-412d-a5b4-44a28cea1415	45802-510	HUMAN PRESCRIPTION DRUG	clindamycin and benzoyl peroxide		clindamycin and benzoyl peroxide	KIT		20210308		ANDA	ANDA202440	Padagis Israel Pharmaceuticals Ltd						N	20241231
45802-532_291dbf6c-7104-4d9d-a0d7-cf32e5ee92b7	45802-532	HUMAN PRESCRIPTION DRUG	ketoconazole		ketoconazole	AEROSOL, FOAM	TOPICAL	20110830		ANDA	ANDA091550	Padagis Israel Pharmaceuticals Ltd	KETOCONAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
45802-562_e9efa7c9-d611-4ff9-a05e-868a68018d08	45802-562	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20130917		ANDA	ANDA064050	Padagis Israel Pharmaceuticals Ltd	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
45802-573_40076df8-0d46-42f4-b704-e4b74bace9a9	45802-573	HUMAN PRESCRIPTION DRUG	ESTRADIOL		estradiol	GEL	TOPICAL	20231207		ANDA	ANDA216524	Padagis Israel Pharmaceuticals Ltd	ESTRADIOL	1.25	mg/1.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
45802-578_b5d40220-f194-4835-b70c-f304ecb222d5	45802-578	HUMAN OTC DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	SPRAY	NASAL	20230730		ANDA	ANDA211951	Padagis Israel Pharmaceuticals Ltd	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
45802-580_ffccef4e-1775-f875-e053-6294a90a76cc	45802-580	HUMAN PRESCRIPTION DRUG	Scopolamine Trandermal System		scolopamine transdermal system	PATCH, EXTENDED RELEASE	TRANSDERMAL	20170613		ANDA	ANDA078830	Padagis Israel Pharmaceuticals Ltd	SCOPOLAMINE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
45802-597_fc3fe08e-5d69-42c0-bbdd-887ff1d944a6	45802-597	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate, Benzoyl Peroxide	GEL	TOPICAL	20190912		ANDA	ANDA205397	Padagis Israel Pharmaceuticals Ltd	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	25; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
45802-598_ad04acff-e168-419b-a127-ee66e9bb9b8d	45802-598	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	SPRAY	NASAL	20201004		ANDA	ANDA213465	Padagis Israel Pharmaceuticals Ltd	SUMATRIPTAN	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
45802-608_d1600f2d-9c61-486e-9ef0-54160ef6adc3	45802-608	HUMAN PRESCRIPTION DRUG	calcitriol		calcitriol	OINTMENT	TOPICAL	20120308		NDA AUTHORIZED GENERIC	NDA022087	Padagis Israel Pharmaceuticals Ltd	CALCITRIOL	3	ug/g	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
45802-610_90f87098-c973-4f63-9e6b-d029bf0dec4d	45802-610	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	SOLUTION	TOPICAL	20170628		ANDA	ANDA204255	Padagis Israel Pharmaceuticals Ltd	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
45802-619_ad04acff-e168-419b-a127-ee66e9bb9b8d	45802-619	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	SPRAY	NASAL	20201004		ANDA	ANDA213465	Padagis Israel Pharmaceuticals Ltd	SUMATRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
45802-626_a97f7672-8cb3-4629-a54e-d7cf72aaf3ce	45802-626	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine hydrochloride	SOLUTION	ORAL	20080724		ANDA	ANDA078398	Padagis Israel Pharmaceuticals Ltd	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45802-627_ad4a68e7-9200-4f05-8058-714d5d8900f8	45802-627	HUMAN PRESCRIPTION DRUG	BUDESONIDE		budesonide	AEROSOL, FOAM	RECTAL	20230417		ANDA	ANDA215328	Padagis Israel Pharmaceuticals Ltd	BUDESONIDE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-637_f17b5df7-574a-482e-93f3-246640cf3466	45802-637	HUMAN PRESCRIPTION DRUG	clobetasol propionate	emollient formulation	clobetasol propionate	AEROSOL, FOAM	TOPICAL	20130201		ANDA	ANDA201402	Padagis Israel Pharmaceuticals Ltd	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-650_4f7517ac-f9f3-40cd-b0c9-0b5ae2463701	45802-650	HUMAN OTC DRUG	Loratadine	antihistamine	Loratadine	TABLET	ORAL	20081015		ANDA	ANDA076301	Padagis Israel Pharmaceuticals Ltd	LORATADINE	10	mg/1			N	20241231
45802-651_26edb714-656d-49ca-b875-28972c490e5f	45802-651	HUMAN OTC DRUG	NICOTINE		nicotine polacrilex	GUM, CHEWING	ORAL	20230814		ANDA	ANDA206393	Padagis Israel Pharmaceuticals Ltd	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
45802-660_5c4e6dd8-1cba-471e-ae54-220717472f41	45802-660	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	AEROSOL, FOAM	TOPICAL	20100331		ANDA	ANDA090785	Padagis Israel Pharmaceuticals Ltd	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
45802-680_6b5f49f0-c974-47f1-a5c9-59b68623c122	45802-680	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		Levocetirizine dihydrochloride	SOLUTION	ORAL	20111107		ANDA	ANDA091263	Padagis Israel Pharmaceuticals Ltd	LEVOCETIRIZINE DIHYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45802-700_ca08f41f-bc87-45bb-91b8-1d89adfba78f	45802-700	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	OINTMENT	TOPICAL	20141120		NDA	NDA050777	Padagis Israel Pharmaceuticals Ltd	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
45802-711_670da414-66ad-4c5f-b218-f4958daae12c	45802-711	HUMAN PRESCRIPTION DRUG	zolmitriptan		zolmitriptan	SPRAY	NASAL	20211116		ANDA	ANDA212469	Padagis Israel Pharmaceuticals Ltd	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
45802-717_e873e5f0-ffa5-4827-b79b-b9973d6ad0d6	45802-717	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	SUPPOSITORY	VAGINAL	20060828		ANDA	ANDA077149	Padagis Israel Pharmaceuticals Ltd	TERCONAZOLE	80	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
45802-730_4ee4558c-bd55-4abf-9210-db4a178dade3	45802-730	HUMAN OTC DRUG	acetaminophen	pain reliever fever reducer	Acetaminophen	SUPPOSITORY	RECTAL	20101028		ANDA	ANDA070608	Padagis Israel Pharmaceuticals Ltd	ACETAMINOPHEN	650	mg/1			N	20241231
45802-732_8700eaea-4a54-42f0-81f3-88036f77f6a5	45802-732	HUMAN OTC DRUG	acetaminophen	for children	Acetaminophen	SUPPOSITORY	RECTAL	20101214		ANDA	ANDA070607	Padagis Israel Pharmaceuticals Ltd	ACETAMINOPHEN	120	mg/1			N	20241231
45802-736_4934962f-c507-4b32-9196-dded1e01eed1	45802-736	HUMAN PRESCRIPTION DRUG	clindamycin phosphate and benzoyl peroxide		Clindamycin, Benzoyl Peroxide	GEL	TOPICAL	20120626		ANDA	ANDA090979	Padagis Israel Pharmaceuticals Ltd	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
45802-754_3f080bb5-5452-44dc-86fe-a4b70fd975e7	45802-754	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20181012		ANDA	ANDA204268	Padagis Israel Pharmaceuticals Ltd	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
45802-758_7925cce4-282f-4445-a4d7-2803d2c7f749	45802-758	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20060627		ANDA	ANDA040500	Padagis Israel Pharmaceuticals Ltd	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
45802-759_7925cce4-282f-4445-a4d7-2803d2c7f749	45802-759	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20060517		ANDA	ANDA040500	Padagis Israel Pharmaceuticals Ltd	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
45802-807_482a4c6a-ae95-4885-8546-e1811290d2b7	45802-807	HUMAN PRESCRIPTION DRUG	desoximetasone		desoximetasone	SPRAY	TOPICAL	20181206		ANDA	ANDA206441	Padagis Israel Pharmaceuticals Ltd	DESOXIMETASONE	2.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-811_2af7a8dc-350f-4865-b1b9-d5b1201b340d	45802-811	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	SPRAY	NASAL	20220621		ANDA	ANDA211951	Padagis Israel Pharmaceuticals Ltd	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
45802-816_73f92653-6dc4-4846-8138-98cf2f6367fe	45802-816	HUMAN PRESCRIPTION DRUG	Calcipotriene and Betamethasone Dipropionate		Calcipotriene, Betamethasone Dipropionate	OINTMENT	TOPICAL	20200130		ANDA	ANDA200174	Padagis Israel Pharmaceuticals Ltd	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	.643; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
45802-817_716e9913-40cd-455c-81b3-5ee3677ec3f8	45802-817	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	20210301		ANDA	ANDA212460	Padagis Israel Pharmaceuticals Ltd	TRIAMCINOLONE ACETONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-827_f9759891-7d3d-4714-8f8b-92d0a499e52e	45802-827	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230522		ANDA	ANDA206394	Padagis Israel Pharmaceuticals Ltd	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
45802-846_37897e79-49a5-4230-ba34-bd25f2e7d66d	45802-846	HUMAN PRESCRIPTION DRUG	adapalene and benzoyl peroxide		Adapalene and Benzoyl Peroxide	GEL	TOPICAL	20180124		ANDA	ANDA205033	Padagis Israel Pharmaceuticals Ltd	ADAPALENE; BENZOYL PEROXIDE	.1; 2.5	g/100g; g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
45802-847_e43b561e-d68a-47af-be93-d710f0f77505	45802-847	HUMAN OTC DRUG	Fexofenadine Hydrochloride		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20220107		ANDA	ANDA212971	Padagis Israel Pharmaceuticals Ltd	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45802-853_92dcba02-f42f-482d-8cd5-2b5ab8fa540a	45802-853	HUMAN PRESCRIPTION DRUG	ADAPALENE AND BENZOYL PEROXIDE		adapalene and benzoyl peroxide	GEL	TOPICAL	20220602		ANDA	ANDA212464	Padagis Israel Pharmaceuticals Ltd	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
45802-868_1a88ad2b-b557-4991-aff2-a1f96159bbdc	45802-868	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091013		ANDA	ANDA090685	Padagis Israel Pharmaceuticals Ltd	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
45802-873_8adc9051-111c-4b0d-a752-232708b0552f	45802-873	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20140331		ANDA	ANDA077007	Padagis Israel Pharmaceuticals Ltd	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
45802-878_37ecaf01-d69b-491c-968c-9c984ac3fb54	45802-878	HUMAN OTC DRUG	lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210729		ANDA	ANDA202319	Padagis Israel Pharmaceuticals Ltd	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45802-880_3f4fba52-76cc-4ac5-aee1-e562d5c37a64	45802-880	HUMAN PRESCRIPTION DRUG	NYSTATIN AND TRIAMCINOLONE ACETONIDE		nystatin, triamcinolone acetonide	CREAM	TOPICAL	20171127		ANDA	ANDA208479	Padagis Israel Pharmaceuticals Ltd	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
45802-887_876bfe8b-0b6c-4fd8-b004-371e3cb55605	45802-887	HUMAN PRESCRIPTION DRUG	fluocinolone acetonide		fluocinolone acetonide	OIL	TOPICAL	20170614		ANDA	ANDA202847	Padagis Israel Pharmaceuticals Ltd	FLUOCINOLONE ACETONIDE	.01	mg/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-888_a60a6990-f019-428a-a9bb-bb76ecbe8650	45802-888	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080225		NDA	NDA022032	Padagis Israel Pharmaceuticals Ltd	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45802-889_a98abae8-6ddd-4215-8b45-f2241442b385	45802-889	HUMAN PRESCRIPTION DRUG	calcipotriene and betamethasone dipropionate		calcipotriene and betamethasone dipropionate	SUSPENSION	TOPICAL	20201009		ANDA	ANDA212367	Padagis Israel Pharmaceuticals Ltd	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
45802-896_3f519405-874b-4d4e-b09f-c376e3920694	45802-896	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		Sulfacetamide Sodium	LOTION	TOPICAL	20121017		ANDA	ANDA078649	Padagis Israel Pharmaceuticals Ltd	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
45802-897_c2f99be1-5d84-4bb9-bc17-779ef475003f	45802-897	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION	ORAL	20111117		ANDA	ANDA074937	Padagis Israel Pharmaceuticals Ltd	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-900_435a43c6-e6a0-447c-bd8e-a072fd096120	45802-900	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PHOSPHATE		clindamycin phosphate	GEL	TOPICAL	20210120		ANDA	ANDA212104	Padagis Israel Pharmaceuticals Ltd	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
45802-919_255264fa-71e6-4a62-ab0f-3b6f17871472	45802-919	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA078336	Padagis Israel Pharmaceuticals Ltd	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45802-923_b483157a-6e6d-4848-ad1c-d1e1c5cbfa8c	45802-923	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	KIT		20090901		ANDA	ANDA076751	Padagis Israel Pharmaceuticals Ltd						N	20251231
45802-925_596d1122-15bb-4b30-b175-457ba7933a6e	45802-925	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol propionate	GEL	TOPICAL	20080730		ANDA	ANDA075027	Padagis Israel Pharmaceuticals Ltd	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-928_a5be325d-6006-40c1-bace-5adcf29548e5	45802-928	HUMAN PRESCRIPTION DRUG	Flurandrenolide		Flurandrenolide	LOTION	TOPICAL	20161006		ANDA	ANDA207133	Padagis Israel Pharmaceuticals Ltd	FLURANDRENOLIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-929_90f45592-1b29-441b-9528-14c91cccbcbc	45802-929	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	KIT		20180802		ANDA	ANDA076751	Padagis Israel Pharmaceuticals Ltd						N	20251231
45802-937_a1f930e7-bda5-4fe9-9b79-f7beb5a4e428	45802-937	HUMAN PRESCRIPTION DRUG	hydrocortisone		hydrocortisone	LOTION	TOPICAL	20080523		ANDA	ANDA089074	Padagis Israel Pharmaceuticals Ltd	HYDROCORTISONE	25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-952_15a6f93b-09bb-4f62-9cf6-36846f060c8e	45802-952	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20041208		ANDA	ANDA076925	Padagis Israel Pharmaceuticals Ltd	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-953_d17d09af-9d75-4c5d-953c-97c7a52d69a5	45802-953	HUMAN OTC DRUG	Diclofenac Sodium		diclofenac sodium	GEL	TOPICAL	20200709		ANDA	ANDA211253	Padagis Israel Pharmaceuticals Ltd	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45802-957_492f928d-6aed-4301-9008-e6fde76c3dbf	45802-957	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20160708		ANDA	ANDA203690	Padagis Israel Pharmaceuticals Ltd	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
45802-961_dcc6d9aa-8fca-4a4b-abef-381a596c79cb	45802-961	HUMAN PRESCRIPTION DRUG	clobetasol propionate		Clobetasol Propionate	SHAMPOO	TOPICAL	20120810		ANDA	ANDA090974	Padagis Israel Pharmaceuticals Ltd	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45802-962_02f703fe-50b5-45dc-bfbb-fb0ef4784bcc	45802-962	HUMAN PRESCRIPTION DRUG	Ery		Erythromycin	SWAB	TOPICAL	20080707		ANDA	ANDA064126	Padagis Israel Pharmaceuticals Ltd	ERYTHROMYCIN	20	mg/mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
45802-966_f0ad2ff7-eaa9-4cfe-9949-5b35208c07d1	45802-966	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	GEL	TOPICAL	20080612		ANDA	ANDA063211	Padagis Israel Pharmaceuticals Ltd	ERYTHROMYCIN	20	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
45802-974_4ab6acdb-a469-4da0-9127-c75b5be16131	45802-974	HUMAN OTC DRUG	cetirizine hydrochloride		cetirizine hydrochloride	SOLUTION	ORAL	20080415		ANDA	ANDA090254	Padagis Israel Pharmaceuticals Ltd	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45865-100_b7685a89-1d11-f795-e053-2995a90af2be	45865-100	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20200703		ANDA	ANDA208507	Medsource Pharmaceuticals	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
45865-101_b77a3ea3-95a4-3b71-e053-2a95a90a0da5	45865-101	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20200703		ANDA	ANDA203536	Medsource Pharmaceuticals	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
45865-103_b59becdb-e73d-2d27-e053-2995a90aa946	45865-103	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200701		ANDA	ANDA211603	Medsource Pharmaceuticals	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45865-104_b5a60209-13e1-4931-e053-2995a90a8474	45865-104	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040194	Medsource Pharmaceuticals	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45865-105_b72d3b7f-bff3-3ec4-e053-2995a90a67b0	45865-105	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20200702		ANDA	ANDA090469	Medsource Pharmaceuticals	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
45865-111_b523dbfe-898f-c75b-e053-2a95a90a7ea2	45865-111	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20200701		ANDA	ANDA078420	Medsource Pharmaceuticals	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-114_b530ba76-e3b9-6925-e053-2995a90a2cf0	45865-114	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20200701		ANDA	ANDA091367	Medsource Pharmaceuticals	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
45865-115_b53300b2-8582-284c-e053-2995a90a83d0	45865-115	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA075964	Medsource Pharmaceuticals	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
45865-116_b429a1e9-5bbc-8b27-e053-2a95a90a089f	45865-116	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	20200701		ANDA	ANDA062500	Medsource Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
45865-117_b42e36f4-ff24-0b5a-e053-2a95a90ac629	45865-117	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20200701		ANDA	ANDA090796	Medsource Pharmaceuticals	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-118_b42e8082-557c-ab2b-e053-2995a90a622c	45865-118	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20200701		ANDA	ANDA203818	Medsource Pharmaceuticals	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-119_b37ce61e-5c75-0ac2-e053-2a95a90a318e	45865-119	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20170628		ANDA	ANDA207444	Medsource Pharmaceuticals	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
45865-120_b3e144e2-1118-65a5-e053-2995a90a1202	45865-120	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20200601		ANDA	ANDA075964	Medsource Pharmaceuticals	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
45865-121_b41b1b81-5d8d-48a9-e053-2a95a90a6ef6	45865-121	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20200701		ANDA	ANDA077259	Medsource Pharmaceuticals	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
45865-122_b2757fb9-1777-f115-e053-2995a90acddf	45865-122	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Medsource Pharmaceuticals	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45865-123_b28a6a10-6b16-d888-e053-2a95a90a1424	45865-123	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	Medsource Pharmaceuticals	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-136_b0f4df02-b66b-c914-e053-2995a90a85db	45865-136	HUMAN OTC DRUG	Acetaminophen	PAIN RELIEVER,FEVER REDUCER 500 mg	Acetaminophen	TABLET	ORAL	20201001		OTC MONOGRAPH NOT FINAL	part343	Medsouce Pharmaceuticals	ACETAMINOPHEN	500	mg/1			N	20241231
45865-137_b274a730-27e2-8e9e-e053-2995a90ae24b	45865-137	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20201022		ANDA	ANDA076921	Medsource Pharmaceuticals	MIRTAZAPINE	15	mg/1			N	20241231
45865-140_afdf1b5c-1031-7742-e053-2a95a90a6dec	45865-140	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071136	Medsource Pharmaceuticals	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-355_9adb5c2f-69b8-4c26-e053-2995a90aa4af	45865-355	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051201		ANDA	ANDA077241	Medsource Pharmaceuticals	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
45865-356_9700d830-6f75-d9c6-e053-2a95a90ab4f9	45865-356	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401		ANDA	ANDA077662	Medsource Pharmaceuticals	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45865-360_71666808-1994-6aa9-e053-2a95a90a8d25	45865-360	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Medsource Pharmaceuticals	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-382_9701f4c5-12e4-1b12-e053-2a95a90a4dd1	45865-382	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Medsource Pharmaceuticals	MIRTAZAPINE	15	mg/1			N	20241231
45865-402_9ab200ad-fc48-aa27-e053-2995a90ab079	45865-402	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	19970605		ANDA	ANDA074821	Medsource Pharmaceuticals	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
45865-404_715df815-c9c6-0972-e053-2a95a90a0e85	45865-404	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Medsource Pharmaceuticals	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
45865-405_7203ebe3-1693-9273-e053-2995a90a04c5	45865-405	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401		ANDA	ANDA077662	Medsource Pharmaceuticals	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45865-409_72046304-31f0-9043-e053-2995a90a57ea	45865-409	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Medsource Pharmaceuticals	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
45865-413_1b65880c-3eac-4d7f-e054-00144ff88e88	45865-413	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Medsource Pharmaceuticals	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
45865-416_9ab204d5-bc25-a818-e053-2995a90ad0da	45865-416	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20091216		ANDA	ANDA077824	Medsource Pharmaceuticals	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
45865-417_72046304-3204-9043-e053-2995a90a57ea	45865-417	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	Medsource Pharmaceuticals	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45865-418_9ab204d5-bc31-a818-e053-2995a90ad0da	45865-418	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	Medsource Pharmaceuticals	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
45865-423_7203845f-7cf8-a0d4-e053-2a95a90a37db	45865-423	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20160803		ANDA	ANDA071136	Medsource Pharmaceuticals	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-424_1b66047b-478c-4808-e054-00144ff8d46c	45865-424	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	20080925		ANDA	ANDA078491	Medsource Pharmaceuticals	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-428_9ab1fdd1-ec80-6939-e053-2a95a90ad46f	45865-428	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	Medsource Pharmaceuticals	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
45865-431_9ab233e3-aa99-452a-e053-2995a90abc2d	45865-431	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	20100530		ANDA	ANDA072192	Medsource Pharmaceuticals	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
45865-432_9ab201fe-69d9-69f8-e053-2a95a90a34fc	45865-432	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Medsource Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45865-433_9ab23898-fc51-6937-e053-2a95a90ab577	45865-433	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET	ORAL	20120402		ANDA	ANDA090478	Medsource Pharmaceuticals	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
45865-434_720357e2-6f15-737d-e053-2a95a90ae54b	45865-434	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	Medsource Pharmaceuticals	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
45865-436_9adbe070-47a0-0df4-e053-2995a90a71e2	45865-436	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	Medsource pharmaceuticals	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-439_71c7a685-c60b-d801-e053-2a95a90aec5f	45865-439	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	Medsource Pharmaceuticals	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
45865-441_9ab23521-8eee-5740-e053-2a95a90a1411	45865-441	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Medsource Pharmaceuticals	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
45865-443_71c7a685-c653-d801-e053-2a95a90aec5f	45865-443	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Medsource Pharmaceuticals	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
45865-444_9ab23cb0-303b-f6f9-e053-2a95a90a7147	45865-444	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19860710		ANDA	ANDA062676	Medsource Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
45865-452_71cad25b-9c6d-6797-e053-2a95a90a7b19	45865-452	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Medsource Pharmaceuticals	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
45865-464_9ab28852-3dee-308b-e053-2a95a90ae192	45865-464	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20080301		ANDA	ANDA078671	Medsource Pharmaceuticals	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-466_71c6f45f-af61-0c1e-e053-2a95a90ac402	45865-466	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	Medsource Pharmaceuticals	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
45865-471_9ab29dc3-533a-9ae9-e053-2a95a90a7c58	45865-471	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Medsource Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
45865-474_9ab2a40b-54a5-3088-e053-2a95a90a233c	45865-474	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Medsource Pharmaceuticals	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-475_718c0dfc-15c1-92e0-e053-2995a90a3051	45865-475	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	Medsource Pharmaceuticals	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
45865-482_718c0dfc-15fa-92e0-e053-2995a90a3051	45865-482	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20160803		ANDA	ANDA071135	Medsource Pharmaceuticals	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-483_718c3ca4-cb96-432e-e053-2a95a90a8130	45865-483	HUMAN OTC DRUG	SENEXON		SENNA	TABLET, COATED	ORAL	20060209		OTC MONOGRAPH NOT FINAL	part334	Medsource Pharmaceuticals	SENNOSIDES A AND B	8.6	mg/1			N	20241231
45865-485_7176c8c1-1fc8-88c1-e053-2a95a90a89f0	45865-485	HUMAN PRESCRIPTION DRUG	Ketoprofen		Ketoprofen	CAPSULE	ORAL	19930101		ANDA	ANDA073516	Medsource Pharmaceuticals	KETOPROFEN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-498_9ab2a4d1-59f1-1d78-e053-2995a90a6535	45865-498	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20100517		ANDA	ANDA090705	Medsource Pharmaceuticals	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45865-499_71770241-8e61-c120-e053-2a95a90a107b	45865-499	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20070103		ANDA	ANDA071403	Medsource Pharmaceuticals	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-503_7df08284-2357-0914-e053-2991aa0aa0fa	45865-503	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	medsource pharmaceutocals	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
45865-509_7df08e42-5ebe-3938-e053-2991aa0a4cf9	45865-509	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	medsource pharmaceuticals	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
45865-517_7176a5f6-65e9-7ccf-e053-2a95a90a1b43	45865-517	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET	ORAL	20100422		ANDA	ANDA090564	Medsource Pharmaceuticals	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
45865-518_9ab2e27f-3bec-2a90-e053-2995a90a4d3f	45865-518	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20071018		ANDA	ANDA077397	Medsource Pharmaceuticals	SERTRALINE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
45865-519_9ab2e268-cd9d-8932-e053-2a95a90ad7a6	45865-519	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20070801		ANDA	ANDA078314	Medsource Pharmaceuticals	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-530_9adbe53e-3512-4013-e053-2a95a90a36d3	45865-530	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Medsource Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
45865-536_1eb8084b-68e2-3178-e054-00144ff88e88	45865-536	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065225	Medsource Pharmaceuticals	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
45865-541_9ab2d412-2c8d-5772-e053-2a95a90a83c1	45865-541	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20090505		ANDA	ANDA078989	medsource pharmaceuticals	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
45865-549_7d63c12e-fc0b-6620-e053-2a91aa0a0732	45865-549	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	medsource pharmaceuticals	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45865-551_7d62746b-f8db-32de-e053-2a91aa0add64	45865-551	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	medsource pharmaceuticals	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45865-556_7d633912-6179-b99b-e053-2a91aa0af59a	45865-556	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20170321		ANDA	ANDA203068	medsource pharmaceuticals	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
45865-563_9ab32a0e-d268-0c50-e053-2a95a90abb20	45865-563	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Medsource Pharmaceuticals	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
45865-570_9ab32ff5-af87-2d1f-e053-2a95a90a592b	45865-570	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Medsource Pharmaceuticals	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
45865-575_9ab32ff5-aff0-2d1f-e053-2a95a90a592b	45865-575	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20090213		ANDA	ANDA074869	Medsource Pharmaceuticals	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-581_7d634e58-bdb2-14b0-e053-2a91aa0a50d9	45865-581	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	medsource pharmaceuticals	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-583_7d6268c7-b2aa-1bbf-e053-2a91aa0a5d32	45865-583	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	medsource pharmaceuticals	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
45865-592_7df0a51f-ea75-754b-e053-2991aa0a5e6c	45865-592	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	medsource pharmaceuticals	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
45865-605_7e03e84b-fe41-aba1-e053-2991aa0af9c8	45865-605	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate And Acetaminophen		Hydrocodone Bitartrate And Acetaminophen	TABLET	ORAL	20060119		ANDA	ANDA040655	Medsource Pharmaceticals	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
45865-610_9ab33b7d-7094-51b3-e053-2a95a90ad2aa	45865-610	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Medsource Pharmaceuticals	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-613_7d62291a-6194-458a-e053-2a91aa0a1af7	45865-613	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20091207		ANDA	ANDA076109	Medsource Pharmaceuticals	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-622_9ab34397-58b8-74c5-e053-2995a90abd86	45865-622	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20071221		ANDA	ANDA077056	Medsource Pharmaceuticals	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-624_7d623352-7831-8765-e053-2991aa0aae94	45865-624	HUMAN OTC DRUG	SENNA		SENNA	TABLET, COATED	ORAL	20150609		OTC MONOGRAPH NOT FINAL	part334	medsource pharmaceuticals	SENNOSIDES A AND B	8.6	mg/1			N	20241231
45865-630_7df0b4ca-2f58-e8e5-e053-2991aa0af9ee	45865-630	HUMAN OTC DRUG	Hydrocortisone	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	19970701		OTC MONOGRAPH NOT FINAL	part348	medsource pharmaceuticals	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45865-632_9ab34379-9dc6-7398-e053-2995a90a7336	45865-632	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		BUPROPION HYDROCHLORIDE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090501		ANDA	ANDA077415	Medsource Pharmaceuticals	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
45865-633_72061450-5715-acb4-e053-2a95a90a0a99	45865-633	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE (SR)		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160725		ANDA	ANDA206674	Medsource Pharmaceuticals	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
45865-639_9ab35c58-b4ed-7327-e053-2995a90a8275	45865-639	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		OTC MONOGRAPH NOT FINAL	part343	Medsource Pharmaceuticals	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-640_72061450-572d-acb4-e053-2a95a90a0a99	45865-640	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate	OINTMENT	TOPICAL	19970501		OTC MONOGRAPH FINAL	part333B	Medsource Pharmaceuticals	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
45865-642_7205c0e2-d7be-3451-e053-2a95a90a69b0	45865-642	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Medsource Pharmaceuticals	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
45865-643_9ab35ec5-4dd6-d09d-e053-2a95a90a2fa8	45865-643	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110610		NDA AUTHORIZED GENERIC	NDA020699	Medsource Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
45865-647_9ab35ec5-4dd6-d09d-e053-2a95a90a2fa8	45865-647	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110610		NDA AUTHORIZED GENERIC	NDA020699	Medsource Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
45865-648_9ab35d14-5adc-51a8-e053-2a95a90ada8d	45865-648	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085969	Medsource Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45865-656_72053f9e-cca8-7e8a-e053-2995a90a99f0	45865-656	HUMAN OTC DRUG	Extra Strength Mapap		ACETAMINOPHEN	TABLET	ORAL	20110504		OTC MONOGRAPH NOT FINAL	part343	Medsource Pharmaceuticals	ACETAMINOPHEN	500	mg/1			N	20241231
45865-666_7d788106-81dc-3026-e053-2991aa0ab45d	45865-666	HUMAN OTC DRUG	naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20150902		ANDA	ANDA074661	medsource pharmaceuticals	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-670_9ab32ff5-b028-2d1f-e053-2a95a90a592b	45865-670	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Medsource Pharmaceuticals	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45865-672_9ab3823b-9674-f077-e053-2995a90a740b	45865-672	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19940511		ANDA	ANDA064048	Medsource Pharmaceuticals	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
45865-676_9adc585b-0718-4980-e053-2a95a90afebb	45865-676	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20160620		ANDA	ANDA205119	medsource pharmaceuticals	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-687_7d789f3b-68f1-33c7-e053-2991aa0a0330	45865-687	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA090467	medsource pharmaceuticals	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
45865-699_7d791794-736b-9aaf-e053-2a91aa0a5572	45865-699	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	medsource pharmaceuticals	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
45865-709_9ab3fb67-c23c-40a8-e053-2a95a90aac04	45865-709	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20120314		NDA	NDA022370	Medsource Pharmaceuticals	TRAMADOL HYDROCHLORIDE	150	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
45865-717_9adc9cc1-0877-62b9-e053-2a95a90aee4a	45865-717	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	medsource pharmaceuticals	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
45865-721_9ab3a33e-7965-7c71-e053-2a95a90a7a0c	45865-721	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		CIPROFLOXACIN HYDROCHLORIDE	SOLUTION/ DROPS	TOPICAL	20080320		ANDA	ANDA077689	Medsource Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	3.5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
45865-722_1fc12db9-6581-509b-e054-00144ff88e88	45865-722	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20031107		ANDA	ANDA065085	Medsource Pharmaceuticals	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
45865-744_7d77bb22-3b4b-867d-e053-2a91aa0aee65	45865-744	HUMAN OTC DRUG	Artifical Tears		Polyvinyl alcohol, and Povidone	SOLUTION/ DROPS	OPHTHALMIC	20160404		OTC MONOGRAPH FINAL	part349	medsource pharmaceuticals	POLYVINYL ALCOHOL; POVIDONE	.05; .06	g/mL; g/mL			N	20241231
45865-748_7d77bb0b-6552-904d-e053-2a91aa0a5543	45865-748	HUMAN OTC DRUG	Terocin		Methyl Salicylate, Capsaicin, and Menthol	LOTION	TOPICAL	20130313		OTC MONOGRAPH NOT FINAL	part348	medsource pharmaceuticals	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.025; 10; 25	g/100mL; g/100mL; g/100mL			N	20241231
45865-758_9ab3a76c-4ca4-76d4-e053-2a95a90a0a64	45865-758	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA076361	Medsource Pharmaceuticals	LEVOFLOXACIN	500	mg/1			N	20241231
45865-759_7d7776f2-9e7c-2e52-e053-2a91aa0ad300	45865-759	HUMAN OTC DRUG	Terocin		Lidocaine, Menthol	PATCH	TOPICAL	20130501		OTC MONOGRAPH NOT FINAL	part348	medsource pharmaceuticals	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	600; 600	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-772_9ab40b20-86fb-6593-e053-2a95a90a1994	45865-772	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	SOLUTION/ DROPS	OPHTHALMIC; TOPICAL	20050121		ANDA	ANDA076673	Medsource Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
45865-773_7d772113-5b4b-3465-e053-2991aa0a1687	45865-773	HUMAN OTC DRUG	Rugby Capsaicin	External Analgesic	Capsaicin	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part348	medsource pharmaceuticals	CAPSAICIN	.025	g/100g			N	20241231
45865-775_9ab40f3c-d66a-e12a-e053-2995a90a2b3e	45865-775	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Medsource Pharmaceuticals	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45865-785_7d772e48-fd28-219f-e053-2991aa0af282	45865-785	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	medsource pharmaceuticals	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-796_7df0c910-93ce-65a6-e053-2991aa0aeb4c	45865-796	HUMAN PRESCRIPTION DRUG	Neomycin Polymyxin B Sulfates and Dexamethasone		Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19950913		ANDA	ANDA064135	medsource pharmaceuticals	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
45865-797_7d64e589-c07d-143c-e053-2991aa0a6ca3	45865-797	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	medsource pharmaceuticals	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
45865-801_7dca1d1e-ce33-2025-e053-2a91aa0afdf3	45865-801	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	medsource pharmaceuticals	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
45865-802_7dc9ffa8-9d11-b5a3-e053-2991aa0a5118	45865-802	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		RABEPRAZOLE SODIUM	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA078964	medsource pharmaceuticals	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-813_9ab40f3c-d695-e12a-e053-2995a90a2b3e	45865-813	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140618		ANDA	ANDA090723	Medsource Pharmaceuticals	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
45865-815_7dc9638a-dbbb-c190-e053-2a91aa0a1be9	45865-815	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	medsource pharmaceuticals	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
45865-828_9ab48833-f4f1-89fc-e053-2995a90a7d67	45865-828	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091103	Medsource Pharmaceuticals	ESZOPICLONE	3	mg/1		CIV	N	20241231
45865-829_9ab48833-f4f1-89fc-e053-2995a90a7d67	45865-829	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091103	Medsource Pharmaceuticals	ESZOPICLONE	2	mg/1		CIV	N	20241231
45865-830_9ab48833-f4f1-89fc-e053-2995a90a7d67	45865-830	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091103	Medsource Pharmaceuticals	ESZOPICLONE	1	mg/1		CIV	N	20241231
45865-833_7dc93e98-6c70-c094-e053-2991aa0a19fc	45865-833	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103		ANDA	ANDA203814	Medsource Pharmaceuticals	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
45865-836_7df0b5b1-1972-3f2a-e053-2a91aa0ad45e	45865-836	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160625		ANDA	ANDA202130	medsource pharmaceuticals	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
45865-837_7dc949d8-58cc-666b-e053-2a91aa0aba43	45865-837	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20120312		ANDA	ANDA040911	medsource pharmaceuticals	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-870_7dc856b1-0c47-94d6-e053-2991aa0aea16	45865-870	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021127		ANDA	ANDA065117	medsource pharmaceuticals	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
45865-876_7dc86b58-bb29-ac70-e053-2a91aa0af0dc	45865-876	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	medsource pharmaceuticals	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
45865-877_7dc89dd0-9bae-2639-e053-2a91aa0ad4d5	45865-877	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	medsource pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
45865-878_7dc7fb31-3324-7672-e053-2991aa0abff5	45865-878	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION/ DROPS	TRANSDERMAL	20150820		ANDA	ANDA204132	medsource pharmaceuticals	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-879_7dcbbe7b-4edb-440a-e053-2a91aa0a41c1	45865-879	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	medsource pharmaceuticals	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-892_7df002ca-e0b0-24fe-e053-2991aa0ab75f	45865-892	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160421		ANDA	ANDA205606	medsourcer pharmaceuticals	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-897_7d64b023-f33e-444b-e053-2a91aa0a5ed2	45865-897	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part348	medsource pharmaceuticals	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-898_7d645ac8-e2f7-3276-e053-2a91aa0a5835	45865-898	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	medsource pharmaceuticals	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45865-900_7d6438eb-89e6-6171-e053-2991aa0aa8bc	45865-900	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	medsource pharmaceuticals	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
45865-901_7d641e3c-5d84-dd95-e053-2991aa0a9423	45865-901	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA091154	medsource pharmaceuticals	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
45865-903_7d64c5d3-d8f4-4075-e053-2991aa0aeaa8	45865-903	HUMAN OTC DRUG	LidoPro Patch		Lidocaine, Menthol, and Methyl Salicylate	PATCH	TOPICAL	20141202		OTC MONOGRAPH NOT FINAL	part348	medsource pharmaceuticals	LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	4; 5; 4	mg/100mg; mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-906_7d647b90-9e19-d650-e053-2991aa0aa676	45865-906	HUMAN OTC DRUG	Hydrocortisone	Maximum Strength	Hydrocortisone	OINTMENT	TOPICAL	19980721		OTC MONOGRAPH NOT FINAL	part348	medsource pharmaceuticals	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45865-911_7d78ed75-2999-6fa3-e053-2991aa0a5b2c	45865-911	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20120312		ANDA	ANDA040911	medsource pharmaceuticals	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-912_7d78d50e-b62c-09de-e053-2991aa0ad9bf	45865-912	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20130915		ANDA	ANDA200675	medsource pharmaceuticals	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-913_7df0e98a-07c6-94d8-e053-2a91aa0ab227	45865-913	HUMAN OTC DRUG	Senna/Docusate Sodium		Docusate sodium and Sennosides	TABLET, FILM COATED	ORAL	20100101		OTC MONOGRAPH NOT FINAL	part334	medsource pharmaceuticals	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
45865-922_7df3366d-af02-9352-e053-2991aa0a8cab	45865-922	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20130325		ANDA	ANDA086724	medsource pharmaceuticals	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-923_7df356fc-4477-2d5a-e053-2991aa0a4a16	45865-923	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170815		ANDA	ANDA207807	medsource pharmaceuticals	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
45865-927_9adcc2c9-5222-2582-e053-2995a90ab208	45865-927	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	POWDER, FOR SUSPENSION	ORAL	20040813		ANDA	ANDA065098	medsource pharmaceuticals	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
45865-935_7df356fc-4477-2d5a-e053-2991aa0a4a16	45865-935	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170815		ANDA	ANDA207807	medsource pharmaceuticals	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
45865-938_9adcfbfc-babf-6c14-e053-2995a90aa22f	45865-938	HUMAN OTC DRUG	Senna Plus	Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each	DOCUSATE SODIUM,SENNOSIDES	TABLET, FILM COATED	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part334	medsource pharmaceuticals	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
45865-942_9adcfb31-33cf-6b70-e053-2995a90af3eb	45865-942	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	medsource pharmaceuticals	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
45865-943_9add4144-5840-6d3a-e053-2995a90ac3c9	45865-943	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	medsource pharmaceuticals	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-945_9add4144-5841-6d3a-e053-2995a90ac3c9	45865-945	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	medsource pharmaceuticals	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-947_9add4144-5842-6d3a-e053-2995a90ac3c9	45865-947	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170815		ANDA	ANDA207807	medsource pharmaceuticals	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
45865-948_9add85b6-a077-b8dc-e053-2a95a90a28ed	45865-948	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	20160705		ANDA	ANDA091432	medsource pharmaceuticals	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-950_9addc6af-dff7-0942-e053-2a95a90ac997	45865-950	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20150810		ANDA	ANDA206297	medsource pharmaceuticals	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-954_9addc6af-dffb-0942-e053-2a95a90ac997	45865-954	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20120206		ANDA	ANDA078868	medsource pharmaceuticals	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
45865-956_9ade007c-bc12-e4b1-e053-2a95a90a8c54	45865-956	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090107	medsource pharmaceuticals	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
45865-962_9aef7721-3553-8eb1-e053-2995a90acfe6	45865-962	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	medsource pharmaceuticals	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
45865-964_9aefc063-74ab-7ccb-e053-2995a90a6706	45865-964	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20151104		ANDA	ANDA202769	medsource pharmaceuticals	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-965_9aefefe6-9608-368b-e053-2995a90a0de7	45865-965	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20160331		OTC MONOGRAPH NOT FINAL	part334	medsource pharmaceuticals	SENNOSIDES	8.6	mg/1			N	20241231
45865-966_9aefefe6-9666-368b-e053-2995a90a0de7	45865-966	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	medsource pharmaceuticals	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
45865-968_9af00e2c-7557-4bcf-e053-2995a90a96f9	45865-968	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170901		ANDA	ANDA071422	medsource pharmaceuticals	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45865-969_9af04fba-ba9e-3691-e053-2995a90a12e2	45865-969	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	medsource pharmaceuticals	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
45865-970_9af06651-d73c-2269-e053-2a95a90a1c56	45865-970	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	medsource pharmaceuticals	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-971_9af0b870-0df4-9692-e053-2995a90ac5ab	45865-971	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20180801		OTC MONOGRAPH NOT FINAL	part334	medsource pharmaceuticals	SENNOSIDES A AND B	8.6	mg/1			N	20241231
45865-972_9af0c7e6-fa5b-1d9f-e053-2995a90aaa51	45865-972	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	medsource pharmaceuticals	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-974_9af07c77-15d8-f91a-e053-2995a90a0e09	45865-974	HUMAN OTC DRUG	Senna	Standardized Senna Concentrate 8.6 mg Sennosides Each	SENNOSIDES	TABLET, FILM COATED	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part334	medsource pharmaceuticals	SENNOSIDES	8.6	mg/1			N	20241231
45865-975_9af0fadd-0efa-2317-e053-2a95a90a9a88	45865-975	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	medsource pharmaceuticals	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
45865-976_9af0e4c1-acb0-c57c-e053-2995a90ae1e8	45865-976	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	medsource pharmaceuticals	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
45865-980_9af147ca-cb10-3194-e053-2a95a90aa0a8	45865-980	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20160823		ANDA	ANDA203824	medsource pharmaceuticals	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
45865-983_9af147ca-cb18-3194-e053-2a95a90aa0a8	45865-983	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Topical Solution		Diclofenac Sodium	SOLUTION	TOPICAL	20171101		ANDA	ANDA206715	medsource pharmaceuticals	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-984_9af1661c-46f5-a6a6-e053-2a95a90afefe	45865-984	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	medsource pharmaceuticals	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
45865-985_9af18dc9-fcef-fde1-e053-2995a90a4087	45865-985	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170619		ANDA	ANDA203695	medsource pharmaceuticals	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
45865-987_9af24216-c452-376c-e053-2a95a90aa613	45865-987	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	medsource pharmaceuticals	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
45865-989_9af254db-932f-ea2e-e053-2a95a90a047b	45865-989	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	medsource pharmaceuticals	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
45865-990_9af2a701-6607-1e46-e053-2995a90a070d	45865-990	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20160701		ANDA	ANDA206498	medsource pharmaceuticals	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
45865-991_9af2bdf7-addf-83f7-e053-2995a90a3c79	45865-991	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA210420	medsource pharmaceuticals	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
45865-992_9af2f05c-0e3d-716c-e053-2a95a90a3d45	45865-992	HUMAN OTC DRUG	Senna	Standardized Senna Concentrate 8.6 mg Sennosides Each	SENNOSIDES	TABLET, FILM COATED	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part334	medsource pharmaceuticals	SENNOSIDES	8.6	mg/1			N	20241231
45865-993_9af2f55c-f625-6fe9-e053-2a95a90ace0c	45865-993	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	medsource pharmaceuticals	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
45865-994_9af322d9-0754-6159-e053-2a95a90a63df	45865-994	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20181101		ANDA	ANDA077568	medsource pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
45865-996_9af36b29-ebbf-3148-e053-2995a90af655	45865-996	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	medsource pharmaceuticals	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
45865-997_9af395be-165c-634d-e053-2995a90a072b	45865-997	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20010926		ANDA	ANDA075189	medsource pharmaceuticals	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45865-999_9af3a740-ef83-26ce-e053-2a95a90a0ee1	45865-999	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	medsource pharmaceuticals	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
45932-0027_66be4797-d16e-460f-a636-d711d3866fe8	45932-0027	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAVENOUS	20140410		ANDA	ANDA205685	Xellia Pharmaceuticals ApS	TOBRAMYCIN SULFATE	1200	mg/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
45942-1629_0159d857-ae42-4623-9318-8c5797924532	45942-1629	HUMAN OTC DRUG	Refresh Sanitizing Towlette	Organic Grapefruit Splash	BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20100120		OTC MONOGRAPH NOT FINAL	part333A	GIOVANNI COSMETICS INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
45942-1630_9528c478-d754-4f0b-9924-af69cb933141	45942-1630	HUMAN OTC DRUG	Recharge Sanitizing Towlette	Organic Peppermint Surge	BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20100120		OTC MONOGRAPH NOT FINAL	part333A	GIOVANNI COSMETICS INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
45942-1631_b61dc84c-f940-4ea5-871f-7228bb889e25	45942-1631	HUMAN OTC DRUG	Relax Sanitizing Towlette	Organic Lavender Calm	BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20100120		OTC MONOGRAPH NOT FINAL	part333A	GIOVANNI COSMETICS INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
45942-1632_6ef8bf6c-c623-4c41-b1b4-7b39b379d8b8	45942-1632	HUMAN OTC DRUG	Mixed Sanitizing Towlettes	Grapefruit Splash, Lavender Calm, Peppermint Surge	Benzalkonium Chloride	KIT		20140120		OTC MONOGRAPH NOT FINAL	part333A	GIOVANNI COSMETICS INC						N	20241231
45963-142_7f58f460-2e82-41de-a694-ae74e81d43c0	45963-142	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150217		ANDA	ANDA077285	Actavis Pharma, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
45963-303_50d301c0-547c-4881-b618-c32987ca1f2a	45963-303	HUMAN PRESCRIPTION DRUG	dextroamphetamine sulfate		dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140619		ANDA	ANDA203901	Actavis Pharma, Inc.	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
45963-304_50d301c0-547c-4881-b618-c32987ca1f2a	45963-304	HUMAN PRESCRIPTION DRUG	dextroamphetamine sulfate		dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140619		ANDA	ANDA203901	Actavis Pharma, Inc.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
45963-305_50d301c0-547c-4881-b618-c32987ca1f2a	45963-305	HUMAN PRESCRIPTION DRUG	dextroamphetamine sulfate		dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20140619		ANDA	ANDA203901	Actavis Pharma, Inc.	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
45963-341_bdef07b9-40c2-4982-a9aa-344fd408aa02	45963-341	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	20060509		ANDA	ANDA074430	Actavis Pharma, Inc.	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45963-342_bdef07b9-40c2-4982-a9aa-344fd408aa02	45963-342	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	20060501		ANDA	ANDA071601	Actavis Pharma, Inc.	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45963-343_bdef07b9-40c2-4982-a9aa-344fd408aa02	45963-343	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	20060604		ANDA	ANDA071588	Actavis Pharma, Inc.	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45963-344_bdef07b9-40c2-4982-a9aa-344fd408aa02	45963-344	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	20060508		ANDA	ANDA071602	Actavis Pharma, Inc.	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45963-345_bdef07b9-40c2-4982-a9aa-344fd408aa02	45963-345	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	20060719		ANDA	ANDA071766	Actavis Pharma, Inc.	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45963-346_bdef07b9-40c2-4982-a9aa-344fd408aa02	45963-346	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET, FILM COATED	ORAL	20060509		ANDA	ANDA074430	Actavis Pharma, Inc.	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
45963-418_720cd924-0a15-4534-9c7b-50a2e66605ef	45963-418	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190528		ANDA	ANDA208862	Actavis Pharma, Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
45963-419_720cd924-0a15-4534-9c7b-50a2e66605ef	45963-419	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190528		ANDA	ANDA208862	Actavis Pharma, Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
45963-438_bda4ccaa-fa33-4911-b3bd-12391c365f47	45963-438	HUMAN PRESCRIPTION DRUG	Enulose		Lactulose	SOLUTION	ORAL; RECTAL	20110228		ANDA	ANDA090502	Actavis Pharma, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
45963-439_7fd63ff0-fccd-408a-9c56-2c2fefdb74fc	45963-439	HUMAN PRESCRIPTION DRUG	Constulose		Lactulose	SOLUTION	ORAL	20110228		ANDA	ANDA090503	Actavis Pharma, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
45963-454_ff13b6ff-e95c-47ed-b21b-6cac71aff318	45963-454	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20190322		ANDA	ANDA203560	Actavis Pharma, Inc.	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
45963-455_ff13b6ff-e95c-47ed-b21b-6cac71aff318	45963-455	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20190322		ANDA	ANDA203560	Actavis Pharma, Inc.	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
45963-456_ff13b6ff-e95c-47ed-b21b-6cac71aff318	45963-456	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20190322		ANDA	ANDA203560	Actavis Pharma, Inc.	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
45963-479_f3901408-f557-aacf-e053-2995a90ad9d8	45963-479	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride		alosetron hydrochloride	TABLET	ORAL	20150526		NDA AUTHORIZED GENERIC	NDA021107	Actavis Pharma, Inc.	ALOSETRON HYDROCHLORIDE	.5	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
45963-480_f3901408-f557-aacf-e053-2995a90ad9d8	45963-480	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride		alosetron hydrochloride	TABLET	ORAL	20150526		NDA AUTHORIZED GENERIC	NDA021107	Actavis Pharma, Inc.	ALOSETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
45963-555_f742f453-684c-4d77-99f9-46525149e390	45963-555	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140423		ANDA	ANDA075350	Actavis Pharma, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45963-556_f742f453-684c-4d77-99f9-46525149e390	45963-556	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	Actavis Pharma, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45963-557_f742f453-684c-4d77-99f9-46525149e390	45963-557	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	Actavis Pharma, Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
45963-565_ea5eedea-08bf-4180-8119-ed74e6365fae	45963-565	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA202968	Actavis Pharma, Inc.	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
45963-566_ea5eedea-08bf-4180-8119-ed74e6365fae	45963-566	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA202968	Actavis Pharma, Inc.	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
45963-567_ea5eedea-08bf-4180-8119-ed74e6365fae	45963-567	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA202968	Actavis Pharma, Inc.	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
45963-568_ea5eedea-08bf-4180-8119-ed74e6365fae	45963-568	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA202968	Actavis Pharma, Inc.	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
45963-607_1a467892-817b-4ff8-a58e-b69e0c3462cc	45963-607	HUMAN PRESCRIPTION DRUG	Vinorelbine		Vinorelbine	INJECTION, SOLUTION	INTRAVENOUS	20150301		ANDA	ANDA078011	Actavis Pharma, Inc.	VINORELBINE TARTRATE	10	mg/mL	Vinca Alkaloid [EPC], Vinca Alkaloids [CS]		N	20241231
45963-609_13fec225-ce1e-4855-936d-7166a066ba9a	45963-609	HUMAN PRESCRIPTION DRUG	Fludarabine phosphate		Fludarabine phosphate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150105		ANDA	ANDA078610	Actavis Pharma, Inc.	FLUDARABINE PHOSPHATE	50	mg/2mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
45963-611_f32f6b99-5065-44ad-8714-869821c5640a	45963-611	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150105		ANDA	ANDA078803	Actavis Pharma, Inc.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
45963-614_ddf510c7-0652-4cb7-93aa-67510de8ac61	45963-614	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloride		Irinotecan hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20150312		ANDA	ANDA078589	Actavis Pharma, Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
45963-615_0edbf531-9ae9-4f9d-a606-f8f56768ce9d	45963-615	HUMAN PRESCRIPTION DRUG	Topotecan hydrochloride		Topotecan hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150105		ANDA	ANDA090620	Actavis Pharma, Inc.	TOPOTECAN HYDROCHLORIDE	4	mg/4mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
45963-676_c8558afe-cb56-4d94-a966-5440dce9c387	45963-676	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200203		ANDA	ANDA204161	Actavis Pharma, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
45963-677_c8558afe-cb56-4d94-a966-5440dce9c387	45963-677	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191023		ANDA	ANDA204161	Actavis Pharma, Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
45963-678_c8558afe-cb56-4d94-a966-5440dce9c387	45963-678	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191023		ANDA	ANDA204161	Actavis Pharma, Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
45963-686_dd6b608a-f0de-469b-9dfe-a3be05c3c79f	45963-686	HUMAN PRESCRIPTION DRUG	Melphalan Hydrochloride		Melphalan Hydrochloride	KIT	INTRAVENOUS	20170113		ANDA	ANDA206018	Actavis Pharma, Inc.						N	20241231
45963-709_c8558afe-cb56-4d94-a966-5440dce9c387	45963-709	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191023		ANDA	ANDA204161	Actavis Pharma, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
45963-733_3996c08b-6e50-4705-8e84-ccc99887399b	45963-733	HUMAN PRESCRIPTION DRUG	Doxorubicin hydrochloride		Doxorubicin hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20141101		ANDA	ANDA203622	Actavis Pharma, Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
45963-734_579fd04d-100e-4887-8d85-b95c3c3e28ea	45963-734	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140901		NDA	NDA203551	Actavis Pharma, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
45963-765_579fd04d-100e-4887-8d85-b95c3c3e28ea	45963-765	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140901		NDA	NDA203551	Actavis Pharma, Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
46007-102_06fe5332-1f48-5084-e063-6394a90a888e	46007-102	HUMAN OTC DRUG	CLARIFYING PEEL		SALICYLIC ACID	GEL	TOPICAL	20120419		OTC MONOGRAPH DRUG	M006	Skin Authority LLC	SALICYLIC ACID	2	g/100mL			N	20241231
46007-201_06fe648d-7a4d-9165-e063-6294a90a5f68	46007-201	HUMAN OTC DRUG	AGE DEFYING HYDRATING SUNSCREEN	SPF 30	AVOBENZONE OCTINOXATE OCTISALATE OXYBENZONE HOMOSALATE OCTOCRYLENE	LOTION	TOPICAL	20120419		OTC MONOGRAPH DRUG	M020	Skin Authority LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 7; 7.5; 5; 3; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
46007-202_06fe623e-dc0e-530e-e063-6394a90a479a	46007-202	HUMAN OTC DRUG	AGE DEFYING MOISTURIZER	SPF 18	AVOBENZONE OCTINOXATE OCTISALATE OXYBENZONE	LOTION	TOPICAL	20120419		OTC MONOGRAPH DRUG	M020	Skin Authority LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	2; 7.5; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
46007-203_06fe49cf-6c88-81d9-e063-6294a90a6af2	46007-203	HUMAN OTC DRUG	SUNSCREEN MOISTURIZER	SPF 30	AVOBENZONE OCTINOXATE OCTISALATE OXYBENZONE HOMOSALATE OCTOCRYLENE	LOTION	TOPICAL	20120419		OTC MONOGRAPH DRUG	M020	Skin Authority LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 7; 7.5; 5; 3; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
46007-204_06fe48ef-fbfd-30dc-e063-6394a90a4a20	46007-204	HUMAN OTC DRUG	SKINSUIT FACE	SPF 50	ZINC OXIDE	LOTION	TOPICAL	20120419		OTC MONOGRAPH DRUG	M020	Skin Authority LLC	ZINC OXIDE	12	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
46007-205_06fe55f3-566e-1955-e063-6394a90a1291	46007-205	HUMAN OTC DRUG	SKINSUIT LIP	SPF 30	ZINC OXIDE	GEL	TOPICAL	20200102		OTC MONOGRAPH DRUG	M020	Skin Authority LLC	ZINC OXIDE	10	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
46063-552_692ad959-7088-4fe5-9ff7-66b1e26f517f	46063-552	HUMAN OTC DRUG	Relispray Antifungal Powder		Miconazole Nitrate	AEROSOL, SPRAY	TOPICAL	20220301		OTC MONOGRAPH FINAL	part333C	Midas-Care Pharmaceuticals Pvt. Ltd.	MICONAZOLE NITRATE	.02	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
46063-810_db53482a-fdb4-4130-85b4-23604ded9996	46063-810	HUMAN OTC DRUG	Relispray Antifungal Liquid		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20220301		OTC MONOGRAPH FINAL	part333C	Midas-Care Pharmaceuticals Pvt. Ltd.	TOLNAFTATE	.01	g/g			N	20241231
46122-007_541a8e91-9438-4ebd-8bfc-a2674f6a9c4a	46122-007	HUMAN OTC DRUG	Extra Strength sugar free Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20210526		OTC MONOGRAPH FINAL	part331	Amerisource Bergen	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
46122-014_d3310994-ca89-4900-bb9d-2d7ab8cb6f0c	46122-014	HUMAN OTC DRUG	Good Neighbor Pharmacy ClearLax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091019		ANDA	ANDA090685	Amerisource Bergen	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-020_d7fedf98-fb45-4f1b-8896-a3a7d057de0d	46122-020	HUMAN OTC DRUG	Good Neighbor Pharmacy Allergy	childrens all day	cetirizine Hydrochloride	SOLUTION	ORAL	20101029		ANDA	ANDA090254	Amerisource Bergen	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-029_480ffc1e-52b4-470c-aad8-43fae3641f88	46122-029	HUMAN OTC DRUG	good neighbor pharmacy omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080227		NDA	NDA022032	Amerisource Bergen	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-042_4874ac40-ef8c-460d-885d-2483d383c4d8	46122-042	HUMAN OTC DRUG	good neighbor pharmacy pain and fever		Acetaminophen	SUSPENSION	ORAL	20110828		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-043_092d3bf5-9db7-2a06-e063-6394a90ab170	46122-043	HUMAN OTC DRUG	Good Neighbor Pharmacy Alcohol Antiseptic Skin Cleanser		Isopropyl Alcohol	SWAB	TOPICAL	20110801		OTC MONOGRAPH DRUG	M003	Amerisouce Bergen	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
46122-056_ec4b8f47-6ec1-42ed-b196-cce21cd9ccf8	46122-056	HUMAN OTC DRUG	good neighbor pharmacy Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20110828		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-062_d0ea1815-1f04-4c23-9761-307116c04b63	46122-062	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Amerisource Bergen	ACETAMINOPHEN	650	mg/1			N	20241231
46122-101_659426e2-438c-40c1-8bb6-bb036168f8b6	46122-101	HUMAN OTC DRUG	All Day	Allergy	Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	Amerisource Bergen	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-107_6d29baf4-bf74-4394-b246-797f1261acd5	46122-107	HUMAN OTC DRUG	Good Neighbor Pharmacy Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120531		ANDA	ANDA202319	Amerisource Bergen	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-108_654ef9d6-0a29-4168-877b-542f2a8a382a	46122-108	HUMAN OTC DRUG	good neighbor pharmacy lice treatment		Permethrin	LOTION	TOPICAL	20120307		ANDA	ANDA076090	Amerisource Bergen	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
46122-110_5ed935b6-4798-4a77-b4d0-e0530a4e6892	46122-110	HUMAN OTC DRUG	good neighbor pharmacy childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020402		ANDA	ANDA074937	Amerisource Bergen	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-136_3e7c68f8-d4eb-468f-ac03-b83196c1e7bb	46122-136	HUMAN OTC DRUG	good neighbor pharmacy night time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110828		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-137_7e7c3128-d19d-8a4a-e053-2991aa0a770e	46122-137	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20130401		NDA	NDA019125	AmerisourceBergen Drug Corporation	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
46122-141_04706a99-20bf-4e9a-82d7-9c91fc5bbfe7	46122-141	HUMAN OTC DRUG	Good Neighbor Pharmacy Cough DM ER		dextromethorphan polistirex	SUSPENSION	ORAL	20120830		ANDA	ANDA091135	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-149_0b6bc3e9-8acc-41cd-ae27-e17dc89b040f	46122-149	HUMAN OTC DRUG	Good Neighbor Pharmacy Fast Acting Nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20120925		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-150_bd661dbf-ed9b-4e8c-9cc3-948e18d01a36	46122-150	HUMAN OTC DRUG	GOOD NEIGHBOR PHARMACY Antacid Extra Strength		aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20121023		OTC MONOGRAPH FINAL	part331	Amerisource Bergen	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
46122-151_7b2d8732-ed77-44b9-93d7-49659f13d6e8	46122-151	HUMAN OTC DRUG	Good Neighbor Pharmacy Antacid and Anti Gas Maximum Strength		Antacid and Antigas	TABLET, CHEWABLE	ORAL	20120924		OTC MONOGRAPH FINAL	part332	Amerisource Bergen	CALCIUM CARBONATE; DIMETHICONE	1000; 60	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
46122-157_e3da0e68-f86d-4505-a792-96dfe7e5548d	46122-157	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20090908		OTC MONOGRAPH FINAL	part341	AmersourceBergen	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
46122-165_681f75ae-01ef-4e91-a6b2-22e3619dc9e2	46122-165	HUMAN OTC DRUG	good neighbor pharmacy nasal		oxymetazoline hydrochloride	SPRAY	NASAL	19900115		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
46122-166_8b44b9ef-7b42-44da-b3cf-ad53f2a2ecdd	46122-166	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	Amerisource Bergen	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-167_747b20a8-c3a3-45dd-9212-f5074a010c6c	46122-167	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Amerisource Bergen	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-168_e5f19576-19b4-4edd-ba10-567a8b062f4d	46122-168	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20130501		ANDA	ANDA090283	AMERISOURCE BERGEN	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
46122-170_c7cc85d7-e528-4cdc-8550-7e431c10c3a5	46122-170	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Amerisource Bergen	ACETAMINOPHEN	650	mg/1			N	20241231
46122-171_c0baa772-c557-4aa1-b79d-90e489fc703e	46122-171	HUMAN OTC DRUG	Good Neighbor Pharmacy Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20140123		ANDA	ANDA078325	Amerisource Bergen	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-172_fabf5910-e360-4a50-aade-8c4fcea428be	46122-172	HUMAN OTC DRUG	Good Neighbor Pharmacy Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20140123		ANDA	ANDA078326	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-173_a3f28a37-27be-4bc5-a30f-625d4f10c044	46122-173	HUMAN OTC DRUG	Good Neighbor Pharmacy Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20130722		ANDA	ANDA076775	Amerisource Bergen	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-174_a498f86e-436c-4c3e-8335-d4722d696ac1	46122-174	HUMAN OTC DRUG	good neighbor pharmacy nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050831		ANDA	ANDA076789	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-176_106f58f3-ea8f-4eb4-bb15-f7d0e9e37cf1	46122-176	HUMAN OTC DRUG	Good Neighbor Pharmacy Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130802		ANDA	ANDA077007	Amerisource Bergen	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-177_90f161fc-8be5-4d04-a5c2-b6fa92b29a22	46122-177	HUMAN OTC DRUG	Good Neighbor Pharmacy Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20140319		ANDA	ANDA077007	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-195_832c5d97-77a9-4c5d-8320-9dd4e398995c	46122-195	HUMAN OTC DRUG	good neighbor pharmacy lubricating plus		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20130517		OTC MONOGRAPH FINAL	part349	Amerisource Bergen	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
46122-198_a0384570-83fb-4642-8dfa-e99fb3e3df5a	46122-198	HUMAN OTC DRUG	good neighbor pharmacy night time	cold and flu	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20111016		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-203_7926dfc2-37fa-453b-89a0-e1ee1addf216	46122-203	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20151110		ANDA	ANDA204226	Amerisource Bergen	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-209_465ea5e7-b7a1-45d4-8407-5592c607d9c5	46122-209	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20130815		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-210_9f3ddbb4-fa60-4754-be13-6628f9df97ca	46122-210	HUMAN OTC DRUG	good neighbor pharmacy childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19931012		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-211_0549ad28-9385-4b30-ae19-4e6b526908d2	46122-211	HUMAN OTC DRUG	Good Neighbor Pharmacy childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19980312		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-212_72f19b60-3563-44b2-b7a7-29558d110a7f	46122-212	HUMAN OTC DRUG	good neighbor pharmacy childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20110201		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-221_0c00af03-7be5-94d9-e063-6294a90a3090	46122-221	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20130912		OTC MONOGRAPH DRUG	M007	Amerisource Bergen/Good Neighbor Pharmacy	GLYCERIN	2.1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
46122-222_0c006801-5c14-68ae-e063-6294a90aa1b5	46122-222	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20130912		OTC MONOGRAPH DRUG	M007	Amerisource Bergen/Good Neighbor Pharmacy	GLYCERIN	1.2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
46122-225_3d21bb13-60f1-427b-a9c1-52c5fd9b2eaf	46122-225	HUMAN OTC DRUG	Good Neighbor Extra Strength	Assorted Fruits	Calcium carbonate	TABLET, CHEWABLE	ORAL	20140221		OTC MONOGRAPH FINAL	part331	AMERISOURCE BERGEN	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
46122-244_e9ed5187-6f84-4f59-b339-d932aa5aa51a	46122-244	HUMAN OTC DRUG	Good Neighbor Pharmacy Antibiotic and Pain Relief		Neomycin, Polymyxin B, Pramoxine HCl	CREAM	TOPICAL	20140211		OTC MONOGRAPH FINAL	part333B	Amerisource Bergen	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
46122-245_98c6433f-c0b4-49c2-a19a-d277d8de0325	46122-245	HUMAN OTC DRUG	Good Neighbor Pharmacy Night Time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20140306		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-254_9cd187e1-1b9e-44f9-8e0b-4efeff78fcb4	46122-254	HUMAN OTC DRUG	Good Neighbor Pharmacy Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20140814		ANDA	ANDA203690	Amerisource Bergen	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-255_61d63c9b-b25d-4458-9508-f32aebe26df4	46122-255	HUMAN OTC DRUG	good neighbor pharmacy nicotine mini		Nicotine Polacrilex	LOZENGE	ORAL	20140907		ANDA	ANDA203690	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-265_55379d7b-0586-45a2-adc7-6477b1409204	46122-265	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140731		OTC MONOGRAPH NOT FINAL	part356	AmerisourceBergen (Good Neighbor Pharmacy) 46122	PHENOL	1.4	g/100mL			N	20241231
46122-278_bb8fa7aa-0038-4b9b-b68c-992c95c2f094	46122-278	HUMAN OTC DRUG	Sore Throat	Menthol	Phenol	LIQUID	ORAL	20140831		OTC MONOGRAPH NOT FINAL	part356	AmerisourceBergen (Good Neighbor Pharmacy) 46122	PHENOL	1.4	g/100mL			N	20241231
46122-281_f8450f59-9629-41d2-92eb-9ac30593ea31	46122-281	HUMAN OTC DRUG	good neighbor pharmacy omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150325		NDA	NDA022032	Amerisource Bergen	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-284_10466f1d-d669-4d46-b2b6-7152e85689e1	46122-284	HUMAN OTC DRUG	good neighbor pharmacy nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20141202		ANDA	ANDA076777	Amerisource Bergen	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-286_85e7d0b2-157d-4638-8ce9-15a6b461be82	46122-286	HUMAN OTC DRUG	good neighbor pharmacy nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20141022		ANDA	ANDA076779	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-292_5b728d84-dea8-4ca6-a13b-dbf6c231b1a7	46122-292	HUMAN OTC DRUG	Good Neighbor Pharmacy Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20150220		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-296_0a371128-5a30-4eaa-b503-1d93db7f288b	46122-296	HUMAN OTC DRUG	Good Neighbor Pharmacy Nausea Relief		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20160509		UNAPPROVED DRUG OTHER		Amerisource Bergen	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
46122-299_9f80a702-def8-4a34-8158-a60aa41bb7bf	46122-299	HUMAN OTC DRUG	Good Neighbor Pharmacy Tussin		Guaifenesin	SOLUTION	ORAL	20150624		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	GUAIFENESIN	200	mg/10mL			N	20241231
46122-303_1e2bba8f-5574-453d-be66-a0ca287c6dda	46122-303	HUMAN OTC DRUG	Mucus Relief	Cold Flu and Sore Throat Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150731		OTC MONOGRAPH FINAL	part341	AmerisourceBergen (Good Neighbor Pharmacy) 46122	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-308_e69b9af5-6a3e-4309-bae8-7b3ab212680e	46122-308	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20150930	20240930	OTC MONOGRAPH FINAL	part335	AmerisourceBergen (Good Neighbor Pharmacy) 46122	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
46122-312_6509831e-6268-4ef6-b82e-c05a8e87cd2e	46122-312	HUMAN OTC DRUG	Good Neighbor Pharmacy Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20151109		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	500	mg/1			N	20241231
46122-322_aa3ef59a-1d56-4be6-a69f-142f3044f47f	46122-322	HUMAN OTC DRUG	good neighbor pharmacy pain and fever	childrens	Acetaminophen	SUSPENSION	ORAL	20150923		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-329_0c827e0d-14a3-ad56-e063-6394a90a0de5	46122-329	HUMAN OTC DRUG	GNP Ethyl Rubbing Alcohol 70 Percent		ethyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Amerisource Bergen	ALCOHOL	700	mg/mL			N	20241231
46122-331_0c82455f-5209-fa88-e063-6294a90a2518	46122-331	HUMAN OTC DRUG	GNP Isopropyl Alcohol 70 Percent With Wintergreen Oil		isopropyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Amerisource Bergen	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
46122-332_0c822f72-cc77-b188-e063-6394a90a272b	46122-332	HUMAN OTC DRUG	GNP Isopropyl Alcohol 91 Percent		isopropyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Amerisource Bergen	ISOPROPYL ALCOHOL	910	mg/mL			N	20241231
46122-334_0c82455f-520b-fa88-e063-6294a90a2518	46122-334	HUMAN OTC DRUG	GNP Hydrogen Peroxide 3 Percent		hydrogen peroxide	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Amerisource Bergen	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
46122-335_0c82455f-5208-fa88-e063-6294a90a2518	46122-335	HUMAN OTC DRUG	GNP Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M016	Amerisource Bergen	WITCH HAZEL	855	mg/mL			N	20241231
46122-337_abe00692-14e8-4849-9946-abd8bec7b9b3	46122-337	HUMAN OTC DRUG	Good Neighbor Pharmacy Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20160128		UNAPPROVED DRUG OTHER		AmerisourceBergen Drug Corp	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
46122-343_03ab0a6a-7d72-4994-987a-9f193818a0b6	46122-343	HUMAN OTC DRUG	Senna Plus		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20160131	20241227	OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
46122-345_4dcd662d-a4ab-4f78-ba5d-e05ca4504542	46122-345	HUMAN OTC DRUG	Good Neighbor Pharmacy Dual Action Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160129		ANDA	ANDA077355	Amerisource Bergen	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-346_55cd26ae-c883-4526-9130-ae6d6b975277	46122-346	HUMAN OTC DRUG	Good Neighbor Pharmacy Dual Action Complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20160129		ANDA	ANDA077355	Amerisource Bergen	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-352_005baca2-3dbc-45a8-e063-6394a90afa22	46122-352	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160720		ANDA	ANDA074612	AmerisourceBergen Drug Corporation	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-353_005baca2-3dbc-45a8-e063-6394a90afa22	46122-353	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160720		ANDA	ANDA074612	AmerisourceBergen Drug Corporation	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-354_005baca2-3dbc-45a8-e063-6394a90afa22	46122-354	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160720		ANDA	ANDA074612	AmerisourceBergen Drug Corporation	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-362_f28c0dc5-a8d5-e5af-e053-2995a90a1f3f	46122-362	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20160701		OTC MONOGRAPH FINAL	part358F	AmerisourceBergen Drug Corporation	SALICYLIC ACID	.17	g/9mL			N	20241231
46122-371_7628d6bb-b390-4095-a82f-8de487d91aa1	46122-371	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160531		OTC MONOGRAPH FINAL	part341	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-382_b80184b0-189f-4f9f-8afa-a1aa6e1aa297	46122-382	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160930	20240930	OTC MONOGRAPH NOT FINAL	part343	AmerisourceBergen (Good Neighbor Pharmacy) 46122	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
46122-383_39ace1fb-0f76-4ff6-8846-e6316ee972e5	46122-383	HUMAN OTC DRUG	Loratadine and Pseudoephedrine		loratadine and pseudoephedrine	TABLET, EXTENDED RELEASE	ORAL	20170802		ANDA	ANDA076557	AMERISOURCE BERGEN	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-385_5b225e95-6419-46eb-84ba-7287c8d96f3a	46122-385	HUMAN OTC DRUG	Good Neighbor Pharmacy 24 Hour Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20161024		ANDA	ANDA078104	Amerisource Bergen	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
46122-386_313bdfde-395c-4d96-8ee7-ef47a22812cb	46122-386	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20161010		ANDA	ANDA207957	Amerisource Bergen	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
46122-389_ad00cf96-8698-0af0-ee8a-523d9adf13b0	46122-389	HUMAN OTC DRUG	Budesonide		Budesonide	SPRAY, METERED	NASAL	20160915		ANDA	ANDA078949	Amerisource Bergen	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
46122-390_fe3f1add-c012-eb36-e053-6394a90a15cd	46122-390	HUMAN OTC DRUG	Pain Relief	Regular Strength	Acetaminophen	TABLET	ORAL	20170228		OTC MONOGRAPH NOT FINAL	part343	AmeriSource Bergen	ACETAMINOPHEN	325	mg/1			N	20241231
46122-392_eff78ff9-baaf-2793-e053-2995a90aa37d	46122-392	HUMAN OTC DRUG	Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
46122-394_a9d9591c-2945-4e59-96aa-7bd67b8c086c	46122-394	HUMAN OTC DRUG	Good Neighbor Pharmacy Acid Reducer		Famotidine	TABLET, FILM COATED	ORAL	20161212		ANDA	ANDA075400	Amerisource Bergen	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
46122-395_41bfa6e2-691f-44f8-9437-951402a0d819	46122-395	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	OIL	ORAL; TOPICAL	20161130		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	MINERAL OIL	100	mg/100mL			N	20241231
46122-410_e557c9bb-9b30-5ae1-e053-2995a90a7bdd	46122-410	HUMAN OTC DRUG	Cold Max		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180701		OTC MONOGRAPH FINAL	part341	AmeriSource Bergen	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-411_e557d1b3-3162-1c6c-e053-2995a90a1232	46122-411	HUMAN OTC DRUG	Cold Max Day and Night		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	KIT		20180801		OTC MONOGRAPH FINAL	part341	AmeriSource Bergen						N	20241231
46122-412_fe3f2602-d3e8-2bb2-e053-6294a90a6649	46122-412	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180920		OTC MONOGRAPH FINAL	part341	AmeriSource Bergen	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-414_b0c9e6cc-8bf8-46ed-888d-c022858dd2b0	46122-414	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	AmerisourceBergen	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
46122-415_e557d1b3-3136-1c6c-e053-2995a90a1232	46122-415	HUMAN OTC DRUG	Cold Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180201		OTC MONOGRAPH FINAL	part341	AmeriSource Bergen	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-418_e557d1b3-314c-1c6c-e053-2995a90a1232	46122-418	HUMAN OTC DRUG	Cold Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180701		OTC MONOGRAPH FINAL	part341	AmeriSource Bergen	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-420_59ff2a9d-3180-41b5-9a63-98ae793a8a0f	46122-420	HUMAN OTC DRUG	Mucus DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-423_f8905ca0-2fa9-422e-a42d-7d2b99a07775	46122-423	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	AmerisourceBergen	LORATADINE	5	mg/5mL			N	20241231
46122-424_6e836ddd-f20e-46b3-a578-fa0e9dbbd4b5	46122-424	HUMAN OTC DRUG	Pain Relief	Childrens	acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	Amerisource Bergen	ACETAMINOPHEN	160	mg/1			N	20241231
46122-425_61b41488-1719-410a-b482-156e53f3cd25	46122-425	HUMAN OTC DRUG	Allergy Relief	Childrens	diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20110425		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-428_a7834559-a16f-4f80-923b-44033f9dadc6	46122-428	HUMAN OTC DRUG	Nasal Decongestant	Maximum Strength, Non-Drowsy	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-429_7c94c551-9548-4252-9f33-f4dfa0fe2e74	46122-429	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20130401		OTC MONOGRAPH DRUG	505G(a)(3)	Amerisource Bergen	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-430_3989c325-c1bd-496c-9670-6b597d73bfc7	46122-430	HUMAN OTC DRUG	Acetaminophen	Regular Strength	Acetaminophen	TABLET, COATED	ORAL	20150724		OTC MONOGRAPH DRUG	M013	Amerisource Bergen	ACETAMINOPHEN	325	mg/1			N	20241231
46122-431_09937f20-1e6e-5b50-e063-6394a90a133d	46122-431	HUMAN OTC DRUG	ANTACID ANTIGAS	NTA	aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20170901		OTC MONOGRAPH DRUG	M001	AMERISOURCEBERGEN DRUG CORPORATION	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-432_09935a81-941e-1499-e063-6294a90a049c	46122-432	HUMAN OTC DRUG	ANTACID ANTIGAS	NTA	aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20170901		OTC MONOGRAPH DRUG	M001	AMERISOURCEBERGEN DRUG CORPORATION	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-433_0993837b-838b-4a83-e063-6394a90a437e	46122-433	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20000101		OTC MONOGRAPH DRUG	M001	AMERISOURCEBERGEN DRUG CORPORATION	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-434_09937f20-1e6d-5b50-e063-6394a90a133d	46122-434	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20170901		OTC MONOGRAPH DRUG	M001	AMERISOURCEBERGEN DRUG CORPORATION	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-435_09935f6d-4286-4f4c-e063-6394a90a940a	46122-435	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20170901		OTC MONOGRAPH DRUG	M007	AMERISOURCEBERGEN DRUG CORPORATION	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-436_09935f6d-4285-4f4c-e063-6394a90a940a	46122-436	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	LIQUID	ORAL	20170901		OTC MONOGRAPH DRUG	M007	AMERISOURCEBERGEN DRUG CORPORATION	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-437_09935a74-34b2-0e7c-e063-6294a90a7c83	46122-437	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	LIQUID	ORAL	20170901		OTC MONOGRAPH DRUG	M007	AMERISOURCEBERGEN DRUG CORPORATION	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-440_4c3ba5e9-aa36-41d5-9ec2-b1e85ddbaec4	46122-440	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	19900315		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-441_05832170-4e35-4073-8bf0-e1e803b21efa	46122-441	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-443_c18e4957-192f-4677-850c-e32b799c596e	46122-443	HUMAN OTC DRUG	Sinus Pressure Pain	Maximum Strength, Non-Drowsy	Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20050623		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-444_f28c0a58-8fc9-8f22-e053-2a95a90ad041	46122-444	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20170808		OTC MONOGRAPH FINAL	part333C	AmerisourceBergen Drug Corporation	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
46122-448_89743874-4ca5-40ec-958a-76975b3fe62b	46122-448	HUMAN OTC DRUG	Nicotine Polacrilex	coated ice mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180109		ANDA	ANDA204794	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-449_89743874-4ca5-40ec-958a-76975b3fe62b	46122-449	HUMAN OTC DRUG	Nicotine Polacrilex	coated ice mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180109		ANDA	ANDA204833	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-452_e29de5ab-e8fe-4d85-99fa-f867dd10273c	46122-452	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA090818	AmeriSource Bergen	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-455_5d58750d-d914-49e3-be5b-4a1acd0f4c58	46122-455	HUMAN OTC DRUG	good neighbor pharmacy loratadine d		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180423		ANDA	ANDA076050	Amerisource Bergen	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-456_0c5a42e8-8903-4d45-b000-320b877e5d28	46122-456	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen, Aspirin, Diphenhydramine citrate	TABLET, FILM COATED	ORAL	20160831		OTC MONOGRAPH DRUG	M013	Amerisource Bergen	ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE	250; 250; 38	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-457_866d1fef-ba37-46e1-8c81-d459f3f5c896	46122-457	HUMAN OTC DRUG	Alert Aid		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	Amerisource Bergen	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
46122-461_5ede8fe5-5996-406e-be9c-344d1b1bed6a	46122-461	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20180430		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-462_c8a7fe64-daff-3548-d0e0-a877f8a9d75b	46122-462	HUMAN OTC DRUG	Allergy Relief		Fexofenadine hydrochloride	TABLET	ORAL	20180220		ANDA	ANDA076502	AMERISOURCEBERGEN DRUG CORPORATION	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-524_f28c0dc5-a8d8-e5af-e053-2995a90a1f3f	46122-524	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20171221		OTC MONOGRAPH FINAL	part358F	AmerisourceBergen Drug Corporation	SALICYLIC ACID	40	mg/41			N	20241231
46122-525_f28c1222-500d-ab06-e053-2995a90ad004	46122-525	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171221		OTC MONOGRAPH NOT FINAL	part333A	AmerisourceBergen Drug Corporation	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
46122-526_f28c0dc5-a8d9-e5af-e053-2995a90a1f3f	46122-526	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171221		OTC MONOGRAPH FINAL	part358F	AmerisourceBergen Drug Corporation	SALICYLIC ACID	40	mg/91			N	20241231
46122-529_f453a7ab-e809-4b23-ada5-4b4b75e6b294	46122-529	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Amerisource Bergen	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
46122-530_6e4cecd5-881e-454b-8b84-28e0139c2bd6	46122-530	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228	20240228	ANDA	ANDA206568	AmerisourceBergen (Good Neighbor Pharmacy) 46122	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
46122-531_7ac146e8-8009-f57f-2966-5fac830d67b9	46122-531	HUMAN OTC DRUG	Allergy Relief		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180420		ANDA	ANDA210375	AMERISOURCEBERGEN DRUG CORPORATION	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-534_79acd71c-4714-4814-8338-c84dc2548f6e	46122-534	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-535_440e2e58-5bcc-4ba3-9275-273a7040e457	46122-535	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20020624		OTC MONOGRAPH DRUG	M009	Amerisource Bergen	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
46122-536_7af9d8a3-4ca5-4079-98f9-dc69d34759e9	46122-536	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	Amerisource Bergen	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-538_6919f6f4-9f1a-4c3c-ac91-589881a6ceb5	46122-538	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016	20240229	ANDA	ANDA209339	Amerisource Bergen	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
46122-539_64ce24cf-4a83-4d87-a5c8-0e9a7589fb13	46122-539	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180709		ANDA	ANDA208477	Amerisource Bergen	LORATADINE	10	mg/1			N	20241231
46122-540_585f03ef-6ddc-48d7-97fe-3504128c42bb	46122-540	HUMAN OTC DRUG	Zinc Cold Therapy		ZINC GLUCONATE	TABLET	ORAL	20180626		UNAPPROVED HOMEOPATHIC		Amerisource Bergen	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
46122-541_58687394-b6d2-4d51-bde0-8f2cfa3fe909	46122-541	HUMAN OTC DRUG	good neighbor pharmacy tussin dm max		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20181011		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-544_14bdfbed-3437-4020-ab60-771f5f574b93	46122-544	HUMAN OTC DRUG	good neighbor pharmacy loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20180813		ANDA	ANDA091292	Amerisource Bergen	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
46122-547_00c51ee1-d7ea-17f1-e063-6394a90ac336	46122-547	HUMAN OTC DRUG	INFANT GAS RELIEF		Simethicone	SUSPENSION/ DROPS	ORAL	20180601		OTC MONOGRAPH DRUG	M002	AMERISOURCEBERGEN DRUG CORPORATION	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
46122-548_92c05b55-b844-4bfe-a424-5481897936b6	46122-548	HUMAN OTC DRUG	Good neighbor pharmacy ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180716		ANDA	ANDA072096	Amerisource Bergen	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-550_974fbe97-a712-4675-b438-afb924c92b28	46122-550	HUMAN OTC DRUG	Childrens Loratadine		LORATADINE	TABLET, CHEWABLE	ORAL	20180701		ANDA	ANDA210088	Amerisource Bergen	LORATADINE	5	mg/1			N	20241231
46122-552_8cff4f6b-154c-40b6-8b17-58c6f648c82f	46122-552	HUMAN OTC DRUG	good neighbor pharmacy infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20180730		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ACETAMINOPHEN	160	mg/5mL			N	20241231
46122-555_f28b9230-315b-8c78-e053-2995a90a7c40	46122-555	HUMAN OTC DRUG	Burn Relief		Lidocaine	AEROSOL, SPRAY	TOPICAL	20181025		OTC MONOGRAPH NOT FINAL	part348	AmerisourceBergen Drug Corporation	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
46122-556_0c8655bc-43c2-2b67-e063-6394a90aafa3	46122-556	HUMAN OTC DRUG	Good Neighbor Pharmacy Earwax Removal		CARBAMIDE PEROXIDE	KIT		20190101		OTC MONOGRAPH DRUG	M014	Amerisource Bergen						N	20241231
46122-557_0c8655bc-43d3-2b67-e063-6394a90aafa3	46122-557	HUMAN OTC DRUG	Good Neighbor Pharmacy Earwax Removal Drops		CARBAMIDE PEROXIDE	LIQUID	TOPICAL	20190101		OTC MONOGRAPH DRUG	M014	Amerisource Bergen	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
46122-562_dd3ac49c-a345-40d3-884c-cfa79d12acbc	46122-562	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190201		ANDA	ANDA204872	Amerisource Bergen	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-564_bc04a5e1-ca96-4279-a509-9fe82246db16	46122-564	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190201		ANDA	ANDA204872	Amerisource Bergen	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-568_005baca2-3dbc-45a8-e063-6394a90afa22	46122-568	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190402		ANDA	ANDA074612	AmerisourceBergen Drug Corporation	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-570_8b7a3a54-e084-47dd-95dc-b43c526e330c	46122-570	HUMAN OTC DRUG	AntiGas	ultra strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20181231		OTC MONOGRAPH FINAL	part332	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
46122-572_c4478eb1-b9e8-3989-e053-2a95a90af5be	46122-572	HUMAN OTC DRUG	Good neighbor Pharmacy Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20140414		OTC MONOGRAPH NOT FINAL	part348	AMERISOURCEBERGEN DRUG CORPORATION	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-573_b4f2d6f7-2288-47d8-e053-2995a90ae335	46122-573	HUMAN OTC DRUG	GNP Anti Itch		Camphor, Menthol	LOTION	TOPICAL	20201125		OTC MONOGRAPH NOT FINAL	part348	AMERISOURCEBERGEN DRUG CORPORATION	CAMPHOR (SYNTHETIC); MENTHOL	.5; .5	g/100g; g/100g			N	20241231
46122-574_eff7c88d-1768-96d1-e053-2a95a90a29ac	46122-574	HUMAN OTC DRUG	Lidocaine Menthol Pain Relief		Lidocaine, Menthol	PATCH	TOPICAL	20180701		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
46122-575_4fe1a63a-6467-4cc0-a6cf-56c75ed2ed44	46122-575	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20190131	20241231	OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	SENNOSIDES	8.6	mg/1			N	
46122-577_4088284d-3532-4f6f-9a1e-51ccd92a061d	46122-577	HUMAN OTC DRUG	Good Neighbor Pharmacy Miconazole 1		Miconazole nitrate	KIT		20190211		ANDA	ANDA079114	Amerisource Bergen						N	20241231
46122-580_f034d7ba-a9fd-44cb-e053-2a95a90ae79b	46122-580	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190301		ANDA	ANDA078682	AMERISOURCE BERGEN	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-581_da57d294-64fd-f68f-e053-2a95a90ad396	46122-581	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190215		NDA	NDA021855	AMERISOURCE BERGEN	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
46122-593_e6dd0090-77f8-1985-e053-2a95a90ab25b	46122-593	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190301		ANDA	ANDA078682	AMERISOURCE BERGEN	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-596_0adbaaa1-c0b7-425e-9794-c5c2c22a82c4	46122-596	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20190601		OTC MONOGRAPH DRUG	M013	Amerisource Bergen	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-598_7c0131ad-9ccf-40d2-aa19-e67f325fd92a	46122-598	HUMAN OTC DRUG	Aspirin 81		Aspirin	TABLET, DELAYED RELEASE	ORAL	20190531		OTC MONOGRAPH DRUG	M013	Amerisource Bergen	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-602_0d291a5f-b634-380c-e063-6394a90a0310	46122-602	HUMAN OTC DRUG	GNP Eye Drops Seasonal Relief		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20190828		OTC MONOGRAPH DRUG	M018	AmerisourceBergen	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
46122-603_0d291a5f-b635-380c-e063-6394a90a0310	46122-603	HUMAN OTC DRUG	GNP EyeDrops Maximum Redness Relief		glycerin, naphazoline HCl	SOLUTION	OPHTHALMIC	20190905		OTC MONOGRAPH DRUG	M018	AmerisourceBergen	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
46122-605_0d292b5f-0247-304b-e063-6394a90abd23	46122-605	HUMAN OTC DRUG	GNP Eye Drops Dry Eye Relief		glycerin, hypromellose, polyethylene glycol 400	SOLUTION	OPHTHALMIC	20190827		OTC MONOGRAPH DRUG	M018	AmerisourceBergen	GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
46122-606_0d291a5f-b636-380c-e063-6394a90a0310	46122-606	HUMAN OTC DRUG	GNP Eye Drops Redness and Dry Eye Relief		glycerin, naphazoline HCl	SOLUTION	OPHTHALMIC	20190827		OTC MONOGRAPH DRUG	M018	AmerisourceBergen	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
46122-607_0d2930af-1ea4-deee-e063-6294a90a418d	46122-607	HUMAN OTC DRUG	GNP Eye Drops Long Lasting		Polyethylene glycol 400, propylene glycol	SOLUTION	OPHTHALMIC	20190812		OTC MONOGRAPH DRUG	M018	AmerisourceBergen	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
46122-608_938d42ff-cfb9-4111-8df9-4ddf5b11b9eb	46122-608	HUMAN OTC DRUG	Good Neighbor Pharmacy Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20190626		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen Drug Corp	BISACODYL	10	mg/2000mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-609_7569aff6-da0d-46b9-b7c4-bf2766827013	46122-609	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine HCl		Ibuprofen and Pseudoephedrine HCl	CAPSULE, LIQUID FILLED	ORAL	20171201		ANDA	ANDA209235	Amerisource Bergen	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-613_df610219-ee3e-1e7e-e053-2995a90a94a3	46122-613	HUMAN OTC DRUG	Cetirizine HCl		Cetirizine HCl	CAPSULE	ORAL	20190618		NDA	NDA022429	AMERISOURCE BERGEN	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-614_0befe1f8-16a2-2256-e063-6394a90a6680	46122-614	HUMAN OTC DRUG	GNP Lidocaine	Maximum Strength	Lidocaine HCl	CREAM	TOPICAL	20200224		OTC MONOGRAPH DRUG	M017	AMERISOURCE BERGEN	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
46122-615_169771b2-da86-4919-9c05-abcea50f21a0	46122-615	HUMAN OTC DRUG	Aspirin	Enteric Safety-Coated	Aspirin	TABLET	ORAL	20190531		OTC MONOGRAPH NOT FINAL	part343	AmerisourceBergen (Good Neighbor Pharmacy) 46122	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-616_94a5c724-ee04-45a5-ad87-c3a5a165a143	46122-616	HUMAN OTC DRUG	good neighbor pharmacy omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20190911		NDA	NDA209400	Amerisource Bergen	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-617_9e811fdb-8b33-4dff-b5a6-101826edd5c2	46122-617	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20190731		ANDA	ANDA076359	Amerisource Bergen	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-618_da981561-7d6d-476f-9c43-8f284e6bce09	46122-618	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	20190729		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-620_7c34093f-b736-466b-8d9a-b2e7b7093f8b	46122-620	HUMAN OTC DRUG	good neighbor pharmacy anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20190924		ANDA	ANDA209837	Amerisource Bergen	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
46122-622_168f3fb8-5b8d-4aa6-8e93-6541d8019fe3	46122-622	HUMAN OTC DRUG	Good Neighbor Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20191123		UNAPPROVED DRUG OTHER		AmerisourceBergen Drug Corp	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
46122-624_e1ac36dc-6a40-463c-b0f5-127e508d3793	46122-624	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20191030		ANDA	ANDA208754	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DOCOSANOL	100	mg/g			N	20241231
46122-625_c69a0375-df6c-4104-bb10-170943bfeb94	46122-625	HUMAN OTC DRUG	Senna Plus		Docusate Sodium, Sennosides	TABLET	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
46122-626_40f9f191-61e3-4f21-9326-09c026cdda24	46122-626	HUMAN OTC DRUG	good neighbor pharmacy all day allergy d		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200330		ANDA	ANDA210719	Amerisource Bergen	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-628_3340c17a-405e-44c7-a58e-241a5b02f880	46122-628	HUMAN OTC DRUG	Good Neighbor Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20200702		UNAPPROVED DRUG OTHER		AmerisourceBergen Drug Corp	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
46122-629_090568cf-d90d-2f8a-e063-6394a90a0136	46122-629	HUMAN OTC DRUG	8 Hour Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200113		ANDA	ANDA211544	AMERISOURCE BERGEN	ACETAMINOPHEN	650	mg/1			N	20241231
46122-630_f7e282e1-44dd-4c86-e053-6394a90aaa73	46122-630	HUMAN OTC DRUG	8 Hour Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200113		ANDA	ANDA211544	AMERISOURCE BERGEN	ACETAMINOPHEN	650	mg/1			N	20241231
46122-632_7a314b7f-91d6-4196-bd96-2470ff7b0b25	46122-632	HUMAN OTC DRUG	good neighbor pharmacy childrens ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20200114		ANDA	ANDA076359	Amerisource Bergen	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-635_e27e28ef-e00c-4354-b579-6b2898bd1500	46122-635	HUMAN OTC DRUG	good neighbor pharmacy aspirin		aspirin	TABLET, FILM COATED	ORAL	20210704		OTC MONOGRAPH NOT FINAL	part343	Amerisource Bergen	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-637_f7925a6b-7029-4389-bf1b-8c0f5e79b950	46122-637	HUMAN OTC DRUG	good neighbor pharmacy mucus dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200108		ANDA	ANDA207602	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-639_d384758c-0053-4dfc-88aa-bcddefcf2fdb	46122-639	HUMAN OTC DRUG	Stomach Relief Ultra		Bismuth subsalicylate	LIQUID	ORAL	20200706		OTC MONOGRAPH FINAL	part335	AmerisourceBergen (Good Neighbor Pharmacy) 46122	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
46122-641_b596055c-98b2-47b1-b174-ae7ad3ba97ee	46122-641	HUMAN OTC DRUG	Good Neighbor Pharmacy Esomeprazole Magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200313		ANDA	ANDA207193	Amerisource Bergen	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-643_f3edaa57-ef80-49c7-b15a-48facc2f4e30	46122-643	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen, Diphenhydramine HCL	TABLET, COATED	ORAL	20191227		OTC MONOGRAPH FINAL	part341	AmerisourceBergen (Good Neighbor Pharmacy) 46122	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-645_eff7eb41-671e-5ed3-e053-2a95a90a35d5	46122-645	HUMAN OTC DRUG	Large Medicate Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
46122-646_a5cbee68-5362-4e28-abdb-8cc2ad8e75ac	46122-646	HUMAN OTC DRUG	good neighbor pharmacy arthritis pain		diclofenac sodium	GEL	TOPICAL	20200831		ANDA	ANDA211253	Amerisource Bergen	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-648_41bc3a63-d31c-431b-9955-6b87a4bf8fae	46122-648	HUMAN OTC DRUG	good neighbor pharmacy esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200624		ANDA	ANDA207193	Amerisource Bergen	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-650_7fffbf36-082c-43dd-a202-1825e8de1180	46122-650	HUMAN OTC DRUG	Nasal Decongestant		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200717		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-651_20ceb8c1-33e2-4339-af87-b3ef89011675	46122-651	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20200729		OTC MONOGRAPH DRUG	M010	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-658_fe3f9956-1fe1-81d4-e053-6294a90a4e9e	46122-658	HUMAN OTC DRUG	Sinus and Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201015		OTC MONOGRAPH FINAL	part341	AMERISOURCE BERGEN	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-659_b1030a94-28eb-36bf-e053-2a95a90a315a	46122-659	HUMAN OTC DRUG	Antiseptic Skin Cleanser		2% Chlorhexidine Gluconate Solution	SOLUTION	TOPICAL	20201001		NDA	NDA019422	AmerisourceBergen Drug Corporation	CHLORHEXIDINE GLUCONATE	2	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
46122-660_fe3f1cdf-77d5-7d7e-e053-6394a90a6ef1	46122-660	HUMAN OTC DRUG	Allergy Multi Symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201113		OTC MONOGRAPH FINAL	part341	AMERISOURCE BERGEN	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-662_f4b149ea-68d5-4917-a8dc-1f91ac20c0f0	46122-662	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH FINAL	part332	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
46122-663_dbeb67f2-f1a8-458a-b369-81ecfc4ad499	46122-663	HUMAN OTC DRUG	good neighbor pharmacy nicotine		nicotine polacrilex	LOZENGE	ORAL	20201123		ANDA	ANDA203690	Amerisource Bergen	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-664_7b6b0162-70ce-4092-ad0f-bf05adb73716	46122-664	HUMAN OTC DRUG	good neighbor pharmacy nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201008		ANDA	ANDA078547	Amerisource Bergen	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-665_522ca787-e978-467b-8113-2f241e17acee	46122-665	HUMAN OTC DRUG	good neighbor pharmacy nicotine mini		Nicotine Polacrilex	LOZENGE	ORAL	20201204		ANDA	ANDA203690	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-666_f0c53506-50a6-463b-91eb-017c14cdd005	46122-666	HUMAN OTC DRUG	good neighbor pharmacy nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20201008		ANDA	ANDA078546	Amerisource Bergen	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-669_5ff28d6f-00ff-439d-bf11-9a9c69a23f07	46122-669	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
46122-670_122dc4e5-a259-4f2d-903b-462235a6ed6c	46122-670	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200730	20240430	OTC MONOGRAPH NOT FINAL	part343	AmerisourceBergen (Good Neighbor Pharmacy) 46122	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
46122-671_1f56c080-a9b4-46ba-882b-3d3d92138ce6	46122-671	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20210119		ANDA	ANDA209995	Amerisource Bergen	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
46122-672_7420f7f2-f791-4d48-8f17-a9916bd8aa4b	46122-672	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20210120		ANDA	ANDA204812	Amerisource Bergen	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
46122-674_f246e2c0-8a1b-406a-a7dd-3e57223b9d74	46122-674	HUMAN OTC DRUG	Allergy Relief	Childrens	Diphenhydramine Hydrochloride	LIQUID	ORAL	20210326		OTC MONOGRAPH FINAL	part341	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-676_febabad6-0bf3-a3f8-e053-6294a90a3aeb	46122-676	HUMAN OTC DRUG	Good Neighbor Pharmacy Skin Protectant		Zinc Oxide	OINTMENT	TOPICAL	20210517		OTC MONOGRAPH FINAL	part347	AMERISOURCE BERGEN	ZINC OXIDE	.2	g/g			N	20241231
46122-677_febabb00-819d-ee4b-e053-6394a90a27ce	46122-677	HUMAN OTC DRUG	GNP Hemorrhoidal		Mineral oil, Petrolatum, Phenylephrine, HCL	OINTMENT	TOPICAL	20210126		OTC MONOGRAPH FINAL	part346	Amerisource Bergen	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-681_01816c02-c228-4380-a4dc-8baa382a636c	46122-681	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20210528		ANDA	ANDA208754	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DOCOSANOL	100	mg/g			N	20241231
46122-683_4aecc3f9-11b2-4670-8de4-e2790023ba49	46122-683	HUMAN OTC DRUG	good neighbor pharmacy mucus er		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210329		ANDA	ANDA213420	Amerisource Bergen	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
46122-684_73e06703-a59e-4bee-be96-97d720e5dd82	46122-684	HUMAN OTC DRUG	good neighbor pharmacy fluticasone propionate		Fluticasone propionate	SPRAY, METERED	NASAL	20210126		ANDA	ANDA207957	Amerisource Bergen	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
46122-685_8dd3578b-fe29-444a-a149-f8f8ec44fd84	46122-685	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20210126		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/20mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-686_47dce86f-d184-44cf-8ee3-18dad7f401b8	46122-686	HUMAN OTC DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE	ORAL	20210331		ANDA	ANDA210593	AMERISOURCE BERGEN	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-687_4ededbfe-d905-41e1-885b-d9ecddded997	46122-687	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210129		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DOCUSATE SODIUM	100	mg/1			N	20241231
46122-688_9deed483-fb0f-4150-be3c-0d1a233c9c66	46122-688	HUMAN OTC DRUG	Good Neighbor Pharmacy Stool Softener		Docusate Calcium	CAPSULE, LIQUID FILLED	ORAL	20210513		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen Drug Corp	DOCUSATE CALCIUM	240	mg/1			N	20241231
46122-689_a3d637dc-d957-458c-8a75-f948601a31aa	46122-689	HUMAN OTC DRUG	good neighbor pharmacy nasal four		Phenylephrine hydrochloride	SPRAY	NASAL	20210415		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-690_0d257242-4828-4a33-9665-d2ce9f3c1421	46122-690	HUMAN OTC DRUG	Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210311		OTC MONOGRAPH DRUG	M013	Amerisource Bergen	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
46122-691_d0330c0c-e801-4fe6-bbac-8f1f0114cf5b	46122-691	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20210310		OTC MONOGRAPH DRUG	M013	Amerisource Bergen	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-692_4da6c394-bb98-4a8f-ae29-de9596fd0bab	46122-692	HUMAN OTC DRUG	Good Neighbor Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210728		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen Drug Corp	DOCUSATE SODIUM	100	mg/1			N	20241231
46122-693_d7366344-c470-4953-a53e-1dec4879408d	46122-693	HUMAN OTC DRUG	Good Neighbor Stool Softener	laxative	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210713		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen Drug Corp	DOCUSATE SODIUM	250	mg/1			N	20241231
46122-694_e1aa7e23-30a8-46dd-bfaa-ef3428447c60	46122-694	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA090818	AmeriSource Bergen	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
46122-695_0762f686-d0ef-cd1f-e063-6394a90a2af9	46122-695	HUMAN OTC DRUG	Nighttime Sleep-Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210715		OTC MONOGRAPH DRUG	M010	AMERISOURCE BERGEN	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-696_fe3f1b2a-87c7-5f54-e053-6394a90add27	46122-696	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20210913		OTC MONOGRAPH NOT FINAL	part343	AMERISOURCE BERGEN	ACETAMINOPHEN	500	mg/1			N	20241231
46122-697_d81e24ec-66df-327d-e053-2995a90a2622	46122-697	HUMAN OTC DRUG	Good Neighbor Pharmacy Medicated Chest Rub		camphor, menthol, eucalyptus oil	OINTMENT	TOPICAL	20210501		OTC MONOGRAPH FINAL	part341	AMERISOURCE BERGEN	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
46122-698_f99ca5a2-78bb-4965-b1d8-4ae12e3eb170	46122-698	HUMAN OTC DRUG	good neighbor pharmacy lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210709		ANDA	ANDA202319	Amerisource Bergen	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-699_a2e715bf-e350-47c5-8f1d-111c7613de96	46122-699	HUMAN OTC DRUG	Good Neighbor Allergy Relief		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20211020		OTC MONOGRAPH FINAL	part341	AmerisourceBergen Drug Corp	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-700_b8ceed18-8a8c-41e8-94bb-bf555d0fe20f	46122-700	HUMAN OTC DRUG	GNP Mucus Relief	PE	Guaifenesin/phenylephrine	TABLET	ORAL	20220113		OTC MONOGRAPH FINAL	part341	AmerisourceBergen Drug Corp	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-701_f696a151-4c97-485b-b049-a2fc57620d3f	46122-701	HUMAN OTC DRUG	GNP Pink Bismuth		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20210916		OTC MONOGRAPH FINAL	part335	Amerisource Bergen	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
46122-702_97167ae6-2734-4bd2-af3c-aadcdef5d9eb	46122-702	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20211008		OTC MONOGRAPH NOT FINAL	part334	AmerisourceBergen (Good Neighbor Pharmacy) 46122	SENNOSIDES	8.6	mg/1			N	20241231
46122-703_ead13b6b-de37-49f9-b18e-68096651d47e	46122-703	HUMAN OTC DRUG	GNP Stomach Relief		Bismuth subsalicylate 525 mg	LIQUID	ORAL	20220630		OTC MONOGRAPH FINAL	part335	Amerisource Bergen	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
46122-704_ced71993-f535-4e28-bc1d-3fcb7d86e9b7	46122-704	HUMAN OTC DRUG	good neighbor pharmacy adult tussin DM		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220504		OTC MONOGRAPH FINAL	part341	Amerisource Bergen	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-705_a2129581-bf6d-47ce-a120-93015d2daaf4	46122-705	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20211110		OTC MONOGRAPH DRUG	M012	Amerisource Bergen	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46122-707_081540c1-317b-7873-e063-6394a90a0738	46122-707	HUMAN OTC DRUG	Extra Strength Night Time Pain Relief		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20220601		OTC MONOGRAPH DRUG	M013	AMERISOURCE BERGEN	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-708_2829ee62-7685-4dbb-9f61-4ee0fb19e4c6	46122-708	HUMAN OTC DRUG	good neighbor pharmacy ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA079113	Amerisource Bergen	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-712_f6cbe742-c5e0-1a6f-e053-6394a90a983b	46122-712	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion and Pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220930		OTC MONOGRAPH FINAL	part341	AMERISOURCE BERGEN	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-713_f5dbe0d0-7435-579e-e053-2995a90a220f	46122-713	HUMAN OTC DRUG	Good Neighbor Pharmacy Arthritis Cream		Trolamine Salicylate	CREAM	TOPICAL	20020601		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	TROLAMINE SALICYLATE	10	g/100g			N	20241231
46122-714_f1f0be1e-39c2-a6d4-e053-2a95a90af0b6	46122-714	HUMAN OTC DRUG	Good Neighbor Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20220801		OTC MONOGRAPH FINAL	part347	AmerisourceBergen	PETROLATUM	100	g/100g			N	20241231
46122-715_57ac2e5a-6e8a-4a62-8d74-21e6a1c1ae8b	46122-715	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20230206		ANDA	ANDA207868	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-716_7f4562a5-49ed-4fd4-a59e-97613cea0c50	46122-716	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20230208		ANDA	ANDA207868	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-717_179749e9-569f-4477-938e-4c9de66e2b09	46122-717	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20220930		ANDA	ANDA078699	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-718_1c0f00e7-8a81-4f2d-9f2d-de1a166a7297	46122-718	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230222		ANDA	ANDA078697	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-719_17316526-1060-4759-af1b-a48b512cf047	46122-719	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20220930		ANDA	ANDA074507	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-720_95dce899-42b0-45d6-8b6d-a28c2bc6754b	46122-720	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230214		ANDA	ANDA076568	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-724_4c10f6c6-4db1-4f0d-8043-0e40af7e3983	46122-724	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230213		ANDA	ANDA076569	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-725_8319e140-314a-4209-acb4-1181b5fb5481	46122-725	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230210		ANDA	ANDA076568	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-726_f204ced9-4612-0544-e053-2a95a90ac1f3	46122-726	HUMAN OTC DRUG	Good Neighbor Pharmacy Vitamin A and D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20221001		OTC MONOGRAPH FINAL	part347	Amerisource Bergen	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
46122-729_15ccef8f-841c-479b-ac1f-fc9922c086d6	46122-729	HUMAN OTC DRUG	Good Neighbor Anti Nausea	Cherry Flavor	dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20230501		UNAPPROVED DRUG OTHER		AMERISOURCE BERGEN	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
46122-731_792c1910-8dc2-492f-85df-4888b4b306a4	46122-731	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20230221		ANDA	ANDA207868	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-732_5699ce88-9073-4eb4-bb93-baa9f2d87fb2	46122-732	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20230224		ANDA	ANDA209206	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-733_a08de0f1-43e6-4959-a03b-1c480e3075a9	46122-733	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20220930		ANDA	ANDA074707	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-734_eddf063a-fcc1-4eec-8222-48f6dfac5e7c	46122-734	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20230223		ANDA	ANDA209206	AmerisourceBergen (Good Neighbor Pharmacy) 46122	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
46122-735_a5d88925-efca-4240-9eb5-6a9d0ac7a67e	46122-735	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230321		ANDA	ANDA206531	Amerisource Bergen	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
46122-736_c94eb997-07d4-4d2e-b213-9a0d51db41c0	46122-736	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230321		ANDA	ANDA209339	Amerisource Bergen	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-737_d8df03ab-7c5c-4c8b-a3fb-6c6081e081e7	46122-737	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230321		ANDA	ANDA206531	Amerisource Bergen	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
46122-738_6c15f077-9f90-4262-9c17-a1ac70e45f57	46122-738	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	20230321		ANDA	ANDA206548	Amerisource Bergen	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
46122-739_87938c81-d60d-f568-06ed-e7272cbb9e1e	46122-739	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20181106		ANDA	ANDA207740	AMERISOURCEBERGEN DRUG CORPORATION	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-740_f384089c-1a7a-7415-e053-2a95a90ace95	46122-740	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230131		OTC MONOGRAPH NOT FINAL	part334	AMERISOURCE BERGEN	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-741_f3847b0f-802e-73d7-e053-2a95a90a5bbe	46122-741	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230131		OTC MONOGRAPH NOT FINAL	part334	AMERISOURCE BERGEN	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
46122-742_04dc3397-5feb-da11-e063-6394a90aacea	46122-742	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET, FILM COATED	ORAL	20230908		ANDA	ANDA216999	AMERISOURCE BERGEN	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-743_f2bb0e98-51eb-2b92-e053-2995a90a3db2	46122-743	HUMAN OTC DRUG	Cool and Heat		Menthol	LIQUID	TOPICAL	20230315		OTC MONOGRAPH NOT FINAL	part348	AMERISOURCE BERGEN	MENTHOL	16	mg/100mL			N	20241231
46122-744_c1e859b9-4a93-7d62-6fd6-382d745d9aba	46122-744	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220412		ANDA	ANDA202194	AMERISOURCEBERGEN DRUG CORPORATION	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
46122-745_f161e151-4fac-2fbc-e053-2a95a90a5437	46122-745	HUMAN OTC DRUG	Calamine Plus		Calamine Plus Pramoxine HCl	AEROSOL, SPRAY	TOPICAL	20230103		OTC MONOGRAPH NOT FINAL	part348	AmerisourceBergen Drug Corporation	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g			N	20241231
46122-747_71c30b10-db24-4a42-a4f4-db552e3d5fe6	46122-747	HUMAN OTC DRUG	Good Neighbor Ultra Strength	Stomach Relief	Bismuth subsalicylate	SUSPENSION	ORAL	20230123		OTC MONOGRAPH FINAL	part335	AMERISOURCE BERGEN	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
46122-748_aa8fb8ff-61c7-41ba-9a23-1052e2b6cd7f	46122-748	HUMAN OTC DRUG	Good Neighbor Sore Throat	Cherry Flavor	Phenol	SPRAY	ORAL	20230123		OTC MONOGRAPH NOT FINAL	part356	AMERISOURCE BERGEN	PHENOL	1.4	g/100mL			N	20241231
46122-749_9d9baf58-4790-4ff4-a462-5eb70c0e80c5	46122-749	HUMAN OTC DRUG	ABC Sore Throat	Menthol Flavor	Phenol	SPRAY	ORAL	20230123		OTC MONOGRAPH NOT FINAL	part356	AMERISOURCE BERGEN	PHENOL	1.4	g/100mL			N	20241231
46122-750_61d84e6e-eae0-4ee6-87c4-5c0ab15bc38d	46122-750	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230811		ANDA	ANDA209254	AMERISOURCE BERGEN	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
46122-751_fc117ab6-2d94-e358-e053-6294a90a926c	46122-751	HUMAN OTC DRUG	Good Neighbor Pharmacy Cold Therapy Pain Relief Patch		Menthol	PATCH	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	MENTHOL	5	g/100g			N	20241231
46122-752_64583277-4362-4eeb-90a9-e22d75377ff4	46122-752	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20230401		ANDA	ANDA208077	AmerisourceBergen (Good Neighbor Pharmacy) 46122	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46122-753_fadf58e6-92d2-d87b-e053-6394a90a966f	46122-753	HUMAN OTC DRUG	Good Neighbor Capsaicin Heat Patch for Back		Capsaicin	PATCH	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Amerisource Bergen	CAPSAICIN	.025	g/100g			N	20241231
46122-754_4b15027b-5923-4aaf-9007-ad38ddd875f1	46122-754	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20230914		OTC MONOGRAPH DRUG	M010	Amerisource Bergen	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46122-756_0d3833f2-09ae-7818-e063-6294a90abe9c	46122-756	HUMAN OTC DRUG	Good Neighbor Pharmacy Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20230601		OTC MONOGRAPH DRUG	M018	Amerisource Bergen Drug Corp.	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
46122-757_0d3833f2-09af-7818-e063-6294a90abe9c	46122-757	HUMAN OTC DRUG	Nighttime Relief Lubricant		Light Mineral Oil, White Petrolatum	OINTMENT	OPHTHALMIC	20230605		OTC MONOGRAPH DRUG	M018	Amerisource Bergen Drug Corp.	LIGHT MINERAL OIL; WHITE PETROLATUM	425; 573	mg/g; mg/g			N	20241231
46122-758_0d3842c0-149d-b681-e063-6394a90a52ed	46122-758	HUMAN OTC DRUG	Good Neighbor Pharmacy Eye Drops Multi-Symptom Relief		Polyethylene glycol 400, Tetrahydrozoline HCl, Zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20230605		OTC MONOGRAPH DRUG	M018	Amerisource Bergen Drug Corp.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	1; .05; .25	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
46122-759_0bc99e09-9c8f-529e-e063-6394a90a9b5f	46122-759	HUMAN OTC DRUG	GNP Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	AmerisourceBergen Drug Corporation	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
46122-760_dabdf9b4-23ca-45f8-8494-9b7189717e3b	46122-760	HUMAN OTC DRUG	Good Neighbor Pharmacy Dye Free Severe Cold	Multi-Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	POWDER, FOR SOLUTION	ORAL	20230724		OTC MONOGRAPH FINAL	part341	AMERISOURCE BERGEN	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46122-761_e7fe9142-2b25-44a5-9d21-4f460ae78cc1	46122-761	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20230615		OTC MONOGRAPH FINAL	part343	AmerisourceBergen (Good Neighbor Pharmacy) 46122	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46122-762_0bcc557c-6034-bb32-e063-6294a90ae728	46122-762	HUMAN OTC DRUG	GNP Vapor Steam camphor (synthetic)		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20230902		OTC MONOGRAPH DRUG	M012	AmerisourceBergen	CAMPHOR (SYNTHETIC)	.062	g/mL			N	20241231
46122-943_bc41a9a0-c74c-9916-e053-2a95a90aea21	46122-943	HUMAN OTC DRUG	Amerisource Bergen Good Neighbor Pharmacy Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	Amerisource Bergen	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
46122-944_d56655a4-c318-c9f4-e053-2a95a90a8f68	46122-944	HUMAN OTC DRUG	Good Neighbor Pharmacy Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20120426		OTC MONOGRAPH NOT FINAL	part352	Amerisource Bergen	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
46122-945_d61fee8e-aae7-39e1-e053-2995a90a5033	46122-945	HUMAN OTC DRUG	Good Neighbor Pharmacy Kids Sunscreen Broad Spectrum SPF 50		Homosalate, Octisalate, Oxybenzone, Octocrylene, Avobenzone	SPRAY	TOPICAL	20120426		OTC MONOGRAPH NOT FINAL	part352	Amerisource Bergen	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
46122-946_e46af432-2005-4a9e-e053-2995a90aec77	46122-946	HUMAN OTC DRUG	GOOD NEIGHBOR PHARMACY KIDS SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210419		OTC MONOGRAPH NOT FINAL	part352	Amerisource Bergen	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
46122-947_e46b2722-6730-04b8-e053-2995a90ae7ee	46122-947	HUMAN OTC DRUG	GOOD NEIGHBOR PHARMACY SPORT SUNSCREEN CONTINUOUS SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20200819		OTC MONOGRAPH NOT FINAL	part352	Amerisource Bergen	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
46122-948_f1401d5c-1ce8-a541-e053-2a95a90a87b3	46122-948	HUMAN OTC DRUG	GOOD NEIGHBORHOOD PHARMACY SPORT SUNSCREEN BROAD SPECTRUM SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part352	Amerisource Bergen	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
46123-001_0a4a90f7-b32a-ef0f-e063-6394a90a8ba0	46123-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19670101		NDA	NDA205849	Roberts Oxygen Company, Inc.	OXYGEN	990	mL/L			N	20241231
46123-002_0a4a9aed-5ef0-f648-e063-6394a90a1d76	46123-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19670101		NDA	NDA205849	Roberts Oxygen Company, Inc.	OXYGEN	990	mL/L			N	20241231
46123-003_0a4a9aed-5eef-f648-e063-6394a90a1d76	46123-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19670101		NDA	NDA205850	Roberts Oxygen Company, Inc	NITROGEN	990	mL/L			N	20241231
46123-004_0a4a94aa-6dd1-6d1a-e063-6294a90afbff	46123-004	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19670101		NDA	NDA205850	Roberts Oxygen Company, Inc	NITROGEN	990	mL/L			N	20241231
46123-006_0a4a95ed-fd1a-edd2-e063-6394a90a59e4	46123-006	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19670101		NDA	NDA206009	Roberts Oxygen Company, Inc.	NITROUS OXIDE	990	mL/L			N	20241231
46123-007_0a4a9410-cce7-efc2-e063-6394a90a76ab	46123-007	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19670101		NDA	NDA206009	Roberts Oxygen Company, Inc.	NITROUS OXIDE	990	mL/L			N	20241231
46123-016_0a4a9410-cce6-efc2-e063-6394a90a76ab	46123-016	HUMAN PRESCRIPTION DRUG	Carbon Dioxide-Air Mixture		Carbon Dioxide-Air Mixture	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205849	Roberts Oxygen Company, Inc.	CARBON DIOXIDE; OXYGEN	70; 210	mL/L; mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
46123-045_0a4a94aa-6dd2-6d1a-e063-6294a90afbff	46123-045	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140101		NDA	NDA205849	Roberts Oxygen Company, Inc.	OXYGEN	990	mL/L			N	20241231
46123-109_0a4a971d-6fd4-6cfb-e063-6294a90a678b	46123-109	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19670101		NDA	NDA205849	Roberts Oxygen Company, Inc.	OXYGEN	210	mL/L			N	20241231
46123-115_0a4a9aed-5eee-f648-e063-6394a90a1d76	46123-115	HUMAN PRESCRIPTION DRUG	Carbon Dioxide-Air Mixture		Carbon Dioxide-Air Mixture	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205849	Roberts Oxygen Company, Inc.	CARBON DIOXIDE; OXYGEN	50; 210	mL/L; mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
46123-117_0a4a971d-6fd5-6cfb-e063-6294a90a678b	46123-117	HUMAN PRESCRIPTION DRUG	Carbon Dioxide-Air Mixture		Carbon Dioxide-Air Mixture	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205849	Roberts Oxygen Company, Inc.	CARBON DIOXIDE; OXYGEN	80; 210	mL/L; mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
46123-120_0a4a94aa-6dd3-6d1a-e063-6294a90afbff	46123-120	HUMAN PRESCRIPTION DRUG	Carbon Dioxide-Oxygen Mixture		Carbon Dioxide-Oxygen Mixture	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205849	Roberts Oxygen Company, Inc.	CARBON DIOXIDE; OXYGEN	70; 930	mL/L; mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
46123-123_0a4a94aa-6dd4-6d1a-e063-6294a90afbff	46123-123	HUMAN PRESCRIPTION DRUG	Carbon Dioxide-Oxygen Mixture		Carbon Dioxide-Oxygen Mixture	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205849	Roberts Oxygen Company, Inc.	CARBON DIOXIDE; OXYGEN	150; 850	mL/L; mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
46123-124_0a4a971d-6fd6-6cfb-e063-6294a90a678b	46123-124	HUMAN PRESCRIPTION DRUG	Carbon Dioxide-Oxygen Mixture		Carbon Dioxide-Oxygen Mixture	GAS	RESPIRATORY (INHALATION)	19660101		NDA	NDA205849	Roberts Oxygen Company, Inc.	CARBON DIOXIDE; OXYGEN	200; 800	mL/L; mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
46163-300_0801932c-8861-35d8-e063-6294a90a67c1	46163-300	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	20070412		ANDA	ANDA078177	Fresenius Medical Care de Mexico, S.A. de C.V.	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
46287-006_233303fe-cee1-420f-bf82-aaeb7850b01f	46287-006	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		sodium polystyrene sulfonate	SUSPENSION	ORAL; RECTAL	19821208		ANDA	ANDA087859	CMP Pharma, Inc.	SODIUM POLYSTYRENE SULFONATE	15	g/60mL			N	20241231
46287-009_75907d04-0c9d-4a6a-b8c0-7d88ab5ad337	46287-009	HUMAN PRESCRIPTION DRUG	Isoniazid		isoniazid	SOLUTION	ORAL	19831111		ANDA	ANDA088235	CMP Pharma, Inc.	ISONIAZID	50	mg/5mL	Antimycobacterial [EPC]		N	20241231
46287-010_647c8a0c-803a-4efb-9c31-1269512aa1f9	46287-010	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20210823		ANDA	ANDA089595	CMP Pharma, Inc.	TRIAMCINOLONE ACETONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
46287-012_ad780ec6-1a7e-4838-b833-6adb6bdbdb9a	46287-012	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	19890119		ANDA	ANDA089910	CMP Pharma, Inc.	SODIUM POLYSTYRENE SULFONATE	1	g/g			N	20241231
46287-014_8691f6bc-18e9-4336-8e10-c702ecace00a	46287-014	HUMAN PRESCRIPTION DRUG	Oracit		Citric Acid and Sodium Citrate	SOLUTION	ORAL	19840515		UNAPPROVED DRUG OTHER		CMP Pharma, Inc.	CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	640; 490	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
46287-020_92dba216-23f2-4d90-82bd-583afa6d1fc7	46287-020	HUMAN PRESCRIPTION DRUG	CaroSpir		CaroSpir	SUSPENSION	ORAL	20170804		NDA	NDA209478	CMP Pharma, Inc.	SPIRONOLACTONE	25	mg/5mL	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
46287-030_6efeeae4-a15b-4a7b-8b10-6930534a92ea	46287-030	HUMAN PRESCRIPTION DRUG	ATORVALIQ		ATORVALIQ	SUSPENSION	ORAL	20230301		NDA	NDA213260	CMP Pharma, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/5mL	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
46287-035_63a6bb49-fb68-4351-be5f-a6b6e8f6b540	46287-035	HUMAN PRESCRIPTION DRUG	NORLIQVA		amlodipine	SOLUTION	ORAL	20220415		NDA	NDA214439	CMP Pharma, Inc.	AMLODIPINE	1	mg/mL	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46287-045_8389ef2b-e4b4-4fa2-8d1a-157f514d7786	46287-045	HUMAN PRESCRIPTION DRUG	TADLIQ		Tadalafil	SUSPENSION	ORAL	20220830		NDA	NDA214522	CMP Pharma, Inc.	TADALAFIL	20	mg/5mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46287-055_fea042e2-5fee-4dad-8a1c-ff5930d2e55a	46287-055	HUMAN PRESCRIPTION DRUG	Liqrev		sildenafil	SUSPENSION	ORAL	20230430		NDA	NDA214952	CMP Pharma, Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46324-2421_fe2f6deb-f097-e0c8-e053-6394a90a692a	46324-2421	HUMAN OTC DRUG	Control Anti-Dandruff		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20111028	20241031	OTC MONOGRAPH FINAL	part358H	AG Hair Ltd.	PYRITHIONE ZINC	20	mg/mL			N	
46324-2422_fe1d0a62-851f-25a8-e053-6394a90a7597	46324-2422	HUMAN OTC DRUG	CONTROL Anti-Dandruff		PYRITHIONE ZINC	SHAMPOO, SUSPENSION	TOPICAL	20220901	20240807	OTC MONOGRAPH FINAL	part358H	AG Hair Ltd	PYRITHIONE ZINC	20	mg/mL			N	
46362-001_080308f6-2f6f-4f66-e063-6394a90a7b9d	46362-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA205865	Red Ball Oxygen Co., Inc.	OXYGEN	992	mL/L			N	20241231
46362-002_0802ee08-d62e-ad56-e063-6294a90a7ad9	46362-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA205866	Red Ball Oxygen Co., Inc.	NITROGEN	992	mL/L			N	20241231
46362-003_08030415-31e8-bb6f-e063-6294a90ac561	46362-003	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA206009	Red Ball Oxygen Co., Inc.	NITROUS OXIDE	992	mL/L			N	20241231
46362-004_0802ee08-d62d-ad56-e063-6294a90a7ad9	46362-004	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20110401		NDA	NDA205846	Red Ball Oxygen Co., Inc.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
46414-2040_696bc572-65fb-483b-9d84-adef41d1440c	46414-2040	HUMAN OTC DRUG	Medicaine Sting and Bite		Benzocaine	SWAB	TOPICAL	19861115		OTC MONOGRAPH NOT FINAL	part348	James Alexander Corporation	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	.12; .006	g/.6mL; g/.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
46414-2222_eb6e373b-5b5d-46ea-90bd-f2dc8d813b13	46414-2222	HUMAN PRESCRIPTION DRUG	Amyl Nitrite		Amyl Nitrite	INHALANT	RESPIRATORY (INHALATION)	19790207		UNAPPROVED DRUG OTHER		James Alexander Corporation	AMYL NITRITE	.3	g/.3mL			N	20241231
46414-3333_a4d241dd-e857-4978-9112-0463a1fcf7d2	46414-3333	HUMAN OTC DRUG	Ammonia Inhalants		Ammonia Inhalants	INHALANT	RESPIRATORY (INHALATION)	19760214		UNAPPROVED DRUG OTHER		James Alexander Corporation	AMMONIA	.045	g/.3mL			N	20241231
46414-7777_e3f403b7-abfb-49b1-86c0-ac3a4156c6f6	46414-7777	HUMAN OTC DRUG	POVIDONE-IODINE		POVIDONE-IODINE	SOLUTION	TOPICAL	19760214		OTC MONOGRAPH DRUG	M003	James Alexander Corporation	POVIDONE-IODINE	10	mg/mL			N	20241231
46414-8888_a293bdae-e65f-4a0c-afe7-bfaf37b2cff8	46414-8888	HUMAN OTC DRUG	Benzoin		Benzoin	SWAB	TOPICAL	19761025	20250228	UNAPPROVED DRUG OTHER		James Alexander Corporation	ALOE; BENZOIN, (+/-)-; LIQUIDAMBAR STYRACIFLUA RESIN; TOLU BALSAM	.12; .6; .48; .24	g/.6mL; g/.6mL; g/.6mL; g/.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
46581-110_e67a9c77-2cd4-4d0b-9d94-9ad02b026faf	46581-110	HUMAN OTC DRUG	Salonpas		Camphor, Menthol, Methyl salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20150601		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu Pharmaceutical Co., Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	21.56; 41.73; 69.55	mg/1; mg/1; mg/1			N	20241231
46581-210_e9abe597-0a45-4d29-bb23-8b98dbfef8c7	46581-210	HUMAN OTC DRUG	Salonpas		Camphor, Menthol, Methyl salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20160517		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu Pharmaceutical Co., Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	86.24; 166.92; 278.2	mg/1; mg/1; mg/1			N	20241231
46581-440_3404befb-6a84-45ed-8e42-5d7007651700	46581-440	HUMAN OTC DRUG	Salonpas pain relieving JET		Menthol, Methyl salicylate	AEROSOL, SPRAY	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20110501		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu Pharmaceutical Co., Inc.	MENTHOL; METHYL SALICYLATE	3; 10	g/100g; g/100g			N	20241231
46581-670_34749e27-1251-4cca-9ad3-b4b2b0f06767	46581-670	HUMAN OTC DRUG	Salonpas Pain Relief		Menthol, Methyl Salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20080425		NDA	NDA022029	Hisamitsu Pharmaceutical Co., Inc.	MENTHOL; METHYL SALICYLATE	31.5; 105	mg/1; mg/1			N	20241231
46581-675_f74235b4-c91a-49d3-a02b-891a5ba2e068	46581-675	HUMAN OTC DRUG	Salonpas Pain Relief		Menthol, Methyl Salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20180601		NDA	NDA022029	Hisamitsu Pharmaceutical Co., Inc.	MENTHOL; METHYL SALICYLATE	63; 210	mg/1; mg/1			N	20241231
46581-680_2d1a3b39-cab5-4f95-9c5a-5ce0e590c472	46581-680	HUMAN OTC DRUG	Salonpas Arthritis Pain		Menthol, Methyl Salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20080425		NDA	NDA022029	Hisamitsu Pharmaceutical Co., Inc.	MENTHOL; METHYL SALICYLATE	31.5; 105	mg/1; mg/1			N	20241231
46581-700_650404ee-18d8-4ed1-a516-d7bbd7776c91	46581-700	HUMAN OTC DRUG	SALONPAS-HOT CAPSICUM		Capsaicin	PATCH	TOPICAL	19981126		OTC MONOGRAPH DRUG	M017	Hisamitsu Pharmaceutical Co., Inc.	CAPSICUM	.025	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
46581-830_39b310ac-4be6-4b3d-85a7-7d30c99ba7d1	46581-830	HUMAN OTC DRUG	Salonpas LIDOCAINE Pain Relieving		Lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20160801		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu Pharmaceutical Co., Inc.	LIDOCAINE	560	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
46581-840_b6d9b7ea-aad9-436f-81e8-46a89737fb30	46581-840	HUMAN OTC DRUG	Salonpas Pain Relieving LIDOCAINE 4% FLEX		Lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20220301		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu Pharmaceutical Co., Inc.	LIDOCAINE	42	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
46581-871_82aac54e-e8ab-4f3d-aad9-74939d7b0e26	46581-871	HUMAN OTC DRUG	Salonpas	pain relieving hot	Capsaicin, Menthol	PATCH	TOPICAL	20180101		OTC MONOGRAPH DRUG	M017	Hisamitsu Pharmaceutical Co., Inc.	CAPSICUM; MENTHOL	.025; 1.25	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
46672-053_0e845d26-e49d-1fad-e063-6294a90ad864	46672-053	HUMAN PRESCRIPTION DRUG	butalbital, acetaminophen and caffeine		butalbital, acetaminophen and caffeine	TABLET	ORAL	19870121		ANDA	ANDA089175	Mikart, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20251231
46708-003_92f6ef1e-3256-45a7-a409-80dd85e95187	46708-003	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-004_92f6ef1e-3256-45a7-a409-80dd85e95187	46708-004	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-005_92f6ef1e-3256-45a7-a409-80dd85e95187	46708-005	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-006_92f6ef1e-3256-45a7-a409-80dd85e95187	46708-006	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-007_92f6ef1e-3256-45a7-a409-80dd85e95187	46708-007	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-019_8c5c7ad8-a128-4243-bd03-0e7057295b3f	46708-019	HUMAN PRESCRIPTION DRUG	MEPROBAMATE		MEPROBAMATE	TABLET	ORAL	20130723		ANDA	ANDA090122	Alembic Pharmaceuticals Limited	MEPROBAMATE	200	mg/1		CIV	N	20241231
46708-020_8c5c7ad8-a128-4243-bd03-0e7057295b3f	46708-020	HUMAN PRESCRIPTION DRUG	MEPROBAMATE		MEPROBAMATE	TABLET	ORAL	20130723		ANDA	ANDA090122	Alembic Pharmaceuticals Limited	MEPROBAMATE	400	mg/1		CIV	N	20241231
46708-021_1e73c48c-80c3-4565-b11e-65e992c3c03a	46708-021	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100507		ANDA	ANDA090222	Alembic Pharmaceuticals Limited	METRONIDAZOLE	750	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
46708-025_0d340b17-907e-4c38-bbd6-c4740495a55a	46708-025	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20101101		ANDA	ANDA090430	Alembic Pharmaceuticals Limited	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
46708-026_0d340b17-907e-4c38-bbd6-c4740495a55a	46708-026	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20101101		ANDA	ANDA090430	Alembic Pharmaceuticals Limited	THEOPHYLLINE ANHYDROUS	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
46708-030_091670a3-3f00-4f03-9127-3792f22efddb	46708-030	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20130912		ANDA	ANDA090429	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-031_091670a3-3f00-4f03-9127-3792f22efddb	46708-031	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20130912		ANDA	ANDA090429	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-032_091670a3-3f00-4f03-9127-3792f22efddb	46708-032	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20130912		ANDA	ANDA090429	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-033_091670a3-3f00-4f03-9127-3792f22efddb	46708-033	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20130912		ANDA	ANDA090429	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-034_091670a3-3f00-4f03-9127-3792f22efddb	46708-034	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20130912		ANDA	ANDA090429	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-035_091670a3-3f00-4f03-9127-3792f22efddb	46708-035	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20130912		ANDA	ANDA090429	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-036_091670a3-3f00-4f03-9127-3792f22efddb	46708-036	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20130912		ANDA	ANDA090429	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-044_3c6999e0-a1f1-40f0-8a6e-f3513410fd5d	46708-044	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20150106		ANDA	ANDA091367	Alembic Pharmaceuticals Limited	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-045_3c6999e0-a1f1-40f0-8a6e-f3513410fd5d	46708-045	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20150106		ANDA	ANDA091367	Alembic Pharmaceuticals Limited	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-046_3c6999e0-a1f1-40f0-8a6e-f3513410fd5d	46708-046	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20150106		ANDA	ANDA091367	Alembic Pharmaceuticals Limited	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-047_3c6999e0-a1f1-40f0-8a6e-f3513410fd5d	46708-047	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20150106		ANDA	ANDA091367	Alembic Pharmaceuticals Limited	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-057_bb31fbb2-b157-4333-ac3b-5f3d65039890	46708-057	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20200129		ANDA	ANDA211791	Alembic Pharmaceuticals Limited	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
46708-058_ea5ea4f7-a4ce-4644-860a-942898f50a8a	46708-058	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20200129		ANDA	ANDA211792	Alembic Pharmaceuticals Limited	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
46708-060_048b90e3-9511-49be-8513-ebd0bde1e03c	46708-060	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20170621		ANDA	ANDA209119	Alembic Pharmaceuticals Limited	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-063_1ff4407e-25ad-4fa7-95dd-859e6589d5d1	46708-063	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613		ANDA	ANDA091689	Alembic Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
46708-064_1ff4407e-25ad-4fa7-95dd-859e6589d5d1	46708-064	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613		ANDA	ANDA091689	Alembic Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
46708-065_1ff4407e-25ad-4fa7-95dd-859e6589d5d1	46708-065	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613		ANDA	ANDA091689	Alembic Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
46708-066_1ff4407e-25ad-4fa7-95dd-859e6589d5d1	46708-066	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613		ANDA	ANDA091689	Alembic Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
46708-084_2e637d10-c15a-48f8-9261-13b3df419c85	46708-084	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20201022		ANDA	ANDA213842	Alembic Pharmaceuticals Limited	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-085_2e637d10-c15a-48f8-9261-13b3df419c85	46708-085	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20201022		ANDA	ANDA213842	Alembic Pharmaceuticals Limited	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-086_2e637d10-c15a-48f8-9261-13b3df419c85	46708-086	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20201022		ANDA	ANDA213842	Alembic Pharmaceuticals Limited	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-095_4ea08829-6e98-4a5f-97d0-da2d1ac96dc1	46708-095	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine chewable dispersible	TABLET, FOR SUSPENSION	ORAL	20160129		ANDA	ANDA201168	Alembic Pharmaceuticals Limited	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
46708-096_4ea08829-6e98-4a5f-97d0-da2d1ac96dc1	46708-096	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine chewable dispersible	TABLET, FOR SUSPENSION	ORAL	20160129		ANDA	ANDA201168	Alembic Pharmaceuticals Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
46708-115_5afb35ed-f222-47c7-ac02-3b1d062b09d2	46708-115	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20130917		ANDA	ANDA202870	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 50	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
46708-116_5afb35ed-f222-47c7-ac02-3b1d062b09d2	46708-116	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20130917		ANDA	ANDA202870	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
46708-117_5afb35ed-f222-47c7-ac02-3b1d062b09d2	46708-117	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20130917		ANDA	ANDA202870	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	50; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
46708-118_b09bdaa7-0871-4741-b5cd-dd30d683613c	46708-118	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20180618		ANDA	ANDA203013	Alembic Pharmaceuticals Limited	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
46708-119_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-119	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	25	mg/1		CV	N	20241231
46708-120_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-120	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	50	mg/1		CV	N	20241231
46708-121_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-121	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	75	mg/1		CV	N	20241231
46708-122_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-122	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	100	mg/1		CV	N	20241231
46708-123_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-123	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	150	mg/1		CV	N	20241231
46708-124_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-124	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	200	mg/1		CV	N	20241231
46708-125_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-125	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	225	mg/1		CV	N	20241231
46708-126_b746d2ae-57e4-4a36-9524-35c4aa6b4ef2	46708-126	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Limited	PREGABALIN	300	mg/1		CV	N	20241231
46708-127_b09bdaa7-0871-4741-b5cd-dd30d683613c	46708-127	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20180618		ANDA	ANDA203013	Alembic Pharmaceuticals Limited	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
46708-131_03dfb859-492b-4154-8fc7-dc4fa90cbf59	46708-131	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA203012	Alembic Pharmaceuticals Limited	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-132_03dfb859-492b-4154-8fc7-dc4fa90cbf59	46708-132	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA203012	Alembic Pharmaceuticals Limited	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-133_03dfb859-492b-4154-8fc7-dc4fa90cbf59	46708-133	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA203012	Alembic Pharmaceuticals Limited	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-134_1b3c037f-0cff-49a4-9ef2-5e19fdd21bc6	46708-134	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, FILM COATED	ORAL	20170221		ANDA	ANDA203390	Alembic Pharmaceuticals Limited	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-135_1b3c037f-0cff-49a4-9ef2-5e19fdd21bc6	46708-135	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, FILM COATED	ORAL	20170221		ANDA	ANDA203390	Alembic Pharmaceuticals Limited	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-136_1b3c037f-0cff-49a4-9ef2-5e19fdd21bc6	46708-136	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, FILM COATED	ORAL	20170221		ANDA	ANDA203390	Alembic Pharmaceuticals Limited	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-137_1b3c037f-0cff-49a4-9ef2-5e19fdd21bc6	46708-137	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, FILM COATED	ORAL	20170221		ANDA	ANDA203390	Alembic Pharmaceuticals Limited	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-138_1b3c037f-0cff-49a4-9ef2-5e19fdd21bc6	46708-138	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, FILM COATED	ORAL	20170221		ANDA	ANDA203390	Alembic Pharmaceuticals Limited	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-139_1b3c037f-0cff-49a4-9ef2-5e19fdd21bc6	46708-139	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, FILM COATED	ORAL	20170221		ANDA	ANDA203390	Alembic Pharmaceuticals Limited	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-148_fa1dd72f-c205-4377-881e-836882c4de47	46708-148	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20170221		ANDA	ANDA204445	Alembic Pharmaceuticals Limited	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
46708-149_b993c27f-9ada-45be-bb55-245e11564d83	46708-149	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA204233	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-150_b993c27f-9ada-45be-bb55-245e11564d83	46708-150	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA204233	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-151_b993c27f-9ada-45be-bb55-245e11564d83	46708-151	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA204233	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-152_6ebe192e-2b88-43fc-a2c8-db2c42bc5a43	46708-152	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20130305		NDA	NDA204150	Alembic Pharmaceuticals Limited	DESVENLAFAXINE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-153_6ebe192e-2b88-43fc-a2c8-db2c42bc5a43	46708-153	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20130305		NDA	NDA204150	Alembic Pharmaceuticals Limited	DESVENLAFAXINE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-171_7dafef1c-ba47-4562-aaa5-671105136aa6	46708-171	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Limited	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
46708-172_7dafef1c-ba47-4562-aaa5-671105136aa6	46708-172	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Limited	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
46708-173_7dafef1c-ba47-4562-aaa5-671105136aa6	46708-173	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Limited	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
46708-174_7dafef1c-ba47-4562-aaa5-671105136aa6	46708-174	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Limited	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
46708-175_571147f2-e182-44b5-9d0b-ecfc3265cc2d	46708-175	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106		ANDA	ANDA204973	Alembic Pharmaceuticals Limited	FESOTERODINE FUMARATE	4	mg/1			N	20241231
46708-176_571147f2-e182-44b5-9d0b-ecfc3265cc2d	46708-176	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106		ANDA	ANDA204973	Alembic Pharmaceuticals Limited	FESOTERODINE FUMARATE	8	mg/1			N	20241231
46708-177_5618f41d-2b71-4fc6-a0f4-6923ca1517e4	46708-177	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Limited	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-178_5618f41d-2b71-4fc6-a0f4-6923ca1517e4	46708-178	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Limited	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-179_5618f41d-2b71-4fc6-a0f4-6923ca1517e4	46708-179	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Limited	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-180_5618f41d-2b71-4fc6-a0f4-6923ca1517e4	46708-180	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-181_3cc676a6-0307-46a0-b208-b0109a087d1b	46708-181	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20161201		ANDA	ANDA205074	Alembic Pharmaceuticals Limited	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
46708-182_3cc676a6-0307-46a0-b208-b0109a087d1b	46708-182	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20161201		ANDA	ANDA205074	Alembic Pharmaceuticals Limited	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
46708-183_9ce8d5c0-4471-43ca-a988-f8b741b44178	46708-183	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA205233	Alembic Pharmaceuticals Limited	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
46708-184_f0d9160e-9405-435e-9f36-75c537267221	46708-184	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		Telmisartan and Amlodipine	TABLET	ORAL	20161122		ANDA	ANDA205234	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; TELMISARTAN	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-185_f0d9160e-9405-435e-9f36-75c537267221	46708-185	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		Telmisartan and Amlodipine	TABLET	ORAL	20161122		ANDA	ANDA205234	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; TELMISARTAN	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-186_f0d9160e-9405-435e-9f36-75c537267221	46708-186	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		Telmisartan and Amlodipine	TABLET	ORAL	20161122		ANDA	ANDA205234	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; TELMISARTAN	5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-187_f0d9160e-9405-435e-9f36-75c537267221	46708-187	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		Telmisartan and Amlodipine	TABLET	ORAL	20161122		ANDA	ANDA205234	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; TELMISARTAN	10; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-190_1d0ffd95-5afe-4f03-8ac9-706187144e98	46708-190	HUMAN PRESCRIPTION DRUG	Febuxostat		febuxostat	TABLET, COATED	ORAL	20190701		ANDA	ANDA205421	Alembic Pharmaceuticals Limited	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
46708-191_1d0ffd95-5afe-4f03-8ac9-706187144e98	46708-191	HUMAN PRESCRIPTION DRUG	Febuxostat		febuxostat	TABLET, COATED	ORAL	20190701		ANDA	ANDA205421	Alembic Pharmaceuticals Limited	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
46708-192_aea71cde-6d62-4f8d-b813-47064cb213d9	46708-192	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, COATED	ORAL	20190520		ANDA	ANDA205575	Alembic Pharmaceuticals Limited	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
46708-193_aea71cde-6d62-4f8d-b813-47064cb213d9	46708-193	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, COATED	ORAL	20190520		ANDA	ANDA205575	Alembic Pharmaceuticals Limited	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
46708-198_b8b5c58b-40db-4b6f-b53d-f11a842bcf28	46708-198	HUMAN PRESCRIPTION DRUG	Asenapine		Asenapine	TABLET	SUBLINGUAL	20201210		ANDA	ANDA206098	Alembic Pharmaceuticals Limited	ASENAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-199_b8b5c58b-40db-4b6f-b53d-f11a842bcf28	46708-199	HUMAN PRESCRIPTION DRUG	Asenapine		Asenapine	TABLET	SUBLINGUAL	20201210		ANDA	ANDA206098	Alembic Pharmaceuticals Limited	ASENAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-204_13a86518-48bc-421b-ad49-c253bd65b488	46708-204	HUMAN PRESCRIPTION DRUG	ITRACONAZOLE		itraconazole	CAPSULE	ORAL	20161216		ANDA	ANDA206741	Alembic Pharmaceuticals Limited	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
46708-209_7c37a82a-77c2-4d49-84ee-ee4f70b4ec93	46708-209	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20140314		ANDA	ANDA203010	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-210_7c37a82a-77c2-4d49-84ee-ee4f70b4ec93	46708-210	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20140314		ANDA	ANDA203010	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-211_7c37a82a-77c2-4d49-84ee-ee4f70b4ec93	46708-211	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20140314		ANDA	ANDA203010	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-212_cbb564d2-add9-430a-a36b-45147d417138	46708-212	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-213_cbb564d2-add9-430a-a36b-45147d417138	46708-213	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-214_cbb564d2-add9-430a-a36b-45147d417138	46708-214	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-215_cbb564d2-add9-430a-a36b-45147d417138	46708-215	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-223_70d8a245-0125-4c31-b941-2137d96c43c3	46708-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN		DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212		ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
46708-224_70d8a245-0125-4c31-b941-2137d96c43c3	46708-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN		DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212		ANDA	ANDA207681	Alembic Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
46708-232_900c5751-06b2-49b5-86a0-275d75eef7f8	46708-232	HUMAN PRESCRIPTION DRUG	VILAZODONE HYDROCHLORIDE		VILAZODONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220604		ANDA	ANDA208202	Alembic Pharmaceuticals Limited	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
46708-233_900c5751-06b2-49b5-86a0-275d75eef7f8	46708-233	HUMAN PRESCRIPTION DRUG	VILAZODONE HYDROCHLORIDE		VILAZODONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220604		ANDA	ANDA208202	Alembic Pharmaceuticals Limited	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
46708-234_900c5751-06b2-49b5-86a0-275d75eef7f8	46708-234	HUMAN PRESCRIPTION DRUG	VILAZODONE HYDROCHLORIDE		VILAZODONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220604		ANDA	ANDA208202	Alembic Pharmaceuticals Limited	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
46708-235_2ca8929b-0b62-4302-9ab4-60ad3768e803	46708-235	HUMAN PRESCRIPTION DRUG	Vardenafil		Vardenafil	TABLET, ORALLY DISINTEGRATING	ORAL	20181120		ANDA	ANDA208324	Alembic Pharmaceuticals Limited	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-236_f87ba545-36e3-4d7d-aa52-3976a44e1719	46708-236	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Limited	VARDENAFIL HYDROCHLORIDE	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-237_f87ba545-36e3-4d7d-aa52-3976a44e1719	46708-237	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Limited	VARDENAFIL HYDROCHLORIDE	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-238_f87ba545-36e3-4d7d-aa52-3976a44e1719	46708-238	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Limited	VARDENAFIL HYDROCHLORIDE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-239_f87ba545-36e3-4d7d-aa52-3976a44e1719	46708-239	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Limited	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
46708-242_563f5910-59e7-46c6-9b3d-d9c9b0efb350	46708-242	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET, FILM COATED	ORAL	20170415		ANDA	ANDA208698	Alembic Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
46708-243_563f5910-59e7-46c6-9b3d-d9c9b0efb350	46708-243	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET, FILM COATED	ORAL	20170415		ANDA	ANDA208698	Alembic Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
46708-244_4f5277a1-2983-4cf9-b589-714d5fc586c0	46708-244	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20170515		ANDA	ANDA208705	Alembic Pharmaceuticals Limited	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-245_4f5277a1-2983-4cf9-b589-714d5fc586c0	46708-245	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20170518		ANDA	ANDA208705	Alembic Pharmaceuticals Limited	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-246_db464488-fe29-445d-b8c1-b93554371798	46708-246	HUMAN PRESCRIPTION DRUG	amantadine		amantadine	CAPSULE	ORAL	20170622		ANDA	ANDA208966	Alembic Pharmaceuticals Limited	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
46708-249_7bd9362d-42fd-4f01-bed9-3797d0c1d6ee	46708-249	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20170731		ANDA	ANDA209165	Alembic Pharmaceuticals Limited	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-250_7bd9362d-42fd-4f01-bed9-3797d0c1d6ee	46708-250	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20170731		ANDA	ANDA209165	Alembic Pharmaceuticals Limited	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-253_6a2f7a6c-a45d-448d-8f56-5bd7a5309a2d	46708-253	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	TABLET, FILM COATED	ORAL	20200128		ANDA	ANDA211793	Alembic Pharmaceuticals Limited	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
46708-254_5108607e-5633-4b19-82f9-6c48720960c4	46708-254	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA202101	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-255_5108607e-5633-4b19-82f9-6c48720960c4	46708-255	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA202101	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-256_5108607e-5633-4b19-82f9-6c48720960c4	46708-256	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA202101	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-257_5108607e-5633-4b19-82f9-6c48720960c4	46708-257	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA202101	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-258_5108607e-5633-4b19-82f9-6c48720960c4	46708-258	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA202101	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-259_5108607e-5633-4b19-82f9-6c48720960c4	46708-259	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA202101	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-260_1ea06df8-17dc-46eb-921a-2b52d41ea622	46708-260	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20150521		ANDA	ANDA202102	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-261_1ea06df8-17dc-46eb-921a-2b52d41ea622	46708-261	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20150521		ANDA	ANDA202102	Alembic Pharmaceuticals Limited	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-262_a1e5da4e-74fc-4482-8e15-599c665f2c2f	46708-262	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130314		ANDA	ANDA202786	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-263_a1e5da4e-74fc-4482-8e15-599c665f2c2f	46708-263	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130314		ANDA	ANDA202786	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-264_a1e5da4e-74fc-4482-8e15-599c665f2c2f	46708-264	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130314		ANDA	ANDA202786	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	6	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-265_a1e5da4e-74fc-4482-8e15-599c665f2c2f	46708-265	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130314		ANDA	ANDA202786	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	8	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-266_a1e5da4e-74fc-4482-8e15-599c665f2c2f	46708-266	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130314		ANDA	ANDA202786	Alembic Pharmaceuticals Limited	ROPINIROLE HYDROCHLORIDE	12	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-267_ab19002d-09b5-4690-9fc5-745023403707	46708-267	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150822		ANDA	ANDA204519	Alembic Pharmaceuticals Limited	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46708-268_ab19002d-09b5-4690-9fc5-745023403707	46708-268	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150822		ANDA	ANDA204519	Alembic Pharmaceuticals Limited	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46708-269_ab19002d-09b5-4690-9fc5-745023403707	46708-269	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150822		ANDA	ANDA204519	Alembic Pharmaceuticals Limited	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46708-270_ab19002d-09b5-4690-9fc5-745023403707	46708-270	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150822		ANDA	ANDA204519	Alembic Pharmaceuticals Limited	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46708-271_168a74a5-392a-4677-8188-2cc73f28437d	46708-271	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20090701		ANDA	ANDA090223	Alembic Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
46708-272_168a74a5-392a-4677-8188-2cc73f28437d	46708-272	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20090701		ANDA	ANDA090223	Alembic Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
46708-273_168a74a5-392a-4677-8188-2cc73f28437d	46708-273	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20090701		ANDA	ANDA090223	Alembic Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
46708-274_1f960fe8-22d3-4836-9d4e-f53d74a6c590	46708-274	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130101		ANDA	ANDA090607	Alembic Pharmaceuticals Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
46708-275_1f960fe8-22d3-4836-9d4e-f53d74a6c590	46708-275	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130101		ANDA	ANDA090607	Alembic Pharmaceuticals Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
46708-276_1f960fe8-22d3-4836-9d4e-f53d74a6c590	46708-276	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130101		ANDA	ANDA090607	Alembic Pharmaceuticals Limited	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
46708-277_1f960fe8-22d3-4836-9d4e-f53d74a6c590	46708-277	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20130101		ANDA	ANDA090607	Alembic Pharmaceuticals Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
46708-278_5d679070-7ef4-48c0-a86b-59ed0a606fef	46708-278	HUMAN PRESCRIPTION DRUG	DULOXETINE HYDROCHLORIDE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140609		ANDA	ANDA202949	Alembic Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-279_5d679070-7ef4-48c0-a86b-59ed0a606fef	46708-279	HUMAN PRESCRIPTION DRUG	DULOXETINE HYDROCHLORIDE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140609		ANDA	ANDA202949	Alembic Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-280_5d679070-7ef4-48c0-a86b-59ed0a606fef	46708-280	HUMAN PRESCRIPTION DRUG	DULOXETINE HYDROCHLORIDE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140609		ANDA	ANDA202949	Alembic Pharmaceuticals Limited	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-290_f31d2aef-f902-4984-803c-5bdb015e9253	46708-290	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20130722		ANDA	ANDA202871	Alembic Pharmaceuticals Limited	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-291_f31d2aef-f902-4984-803c-5bdb015e9253	46708-291	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20130722		ANDA	ANDA202871	Alembic Pharmaceuticals Limited	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-292_f31d2aef-f902-4984-803c-5bdb015e9253	46708-292	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20130722		ANDA	ANDA202871	Alembic Pharmaceuticals Limited	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-293_bf3c42c7-d400-43a9-ad49-baaf3f8d29b5	46708-293	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Alembic Pharmaceuticals Limited	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
46708-294_bf3c42c7-d400-43a9-ad49-baaf3f8d29b5	46708-294	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Alembic Pharmaceuticals Limited	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
46708-295_f0627628-81b1-4b14-b49d-1e68b350146f	46708-295	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA201724	Alembic Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
46708-296_f0627628-81b1-4b14-b49d-1e68b350146f	46708-296	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA201724	Alembic Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
46708-303_f4a09dd5-000a-48d2-9681-d5bc360164f1	46708-303	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20161227		ANDA	ANDA079159	Alembic Pharmaceuticals Limited	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
46708-304_f4a09dd5-000a-48d2-9681-d5bc360164f1	46708-304	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20161227		ANDA	ANDA079159	Alembic Pharmaceuticals Limited	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
46708-305_f4a09dd5-000a-48d2-9681-d5bc360164f1	46708-305	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20161227		ANDA	ANDA079159	Alembic Pharmaceuticals Limited	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
46708-306_f2ae3ce9-d436-4616-a3eb-7838af98b9a6	46708-306	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Alembic Pharmaceuticals Limited	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-307_f2ae3ce9-d436-4616-a3eb-7838af98b9a6	46708-307	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Alembic Pharmaceuticals Limited	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-308_f2ae3ce9-d436-4616-a3eb-7838af98b9a6	46708-308	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Alembic Pharmaceuticals Limited	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-313_5c2a05ed-ff36-4dce-97e9-77b2d948b4f0	46708-313	HUMAN PRESCRIPTION DRUG	TERIFLUNOMIDE		TERIFLUNOMIDE	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA209572	Alembic Pharmaceuticals Limited	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
46708-314_5c2a05ed-ff36-4dce-97e9-77b2d948b4f0	46708-314	HUMAN PRESCRIPTION DRUG	TERIFLUNOMIDE		TERIFLUNOMIDE	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA209572	Alembic Pharmaceuticals Limited	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
46708-315_878a2586-20af-4f35-8908-82474cc732a3	46708-315	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Limited	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-316_878a2586-20af-4f35-8908-82474cc732a3	46708-316	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Limited	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-317_878a2586-20af-4f35-8908-82474cc732a3	46708-317	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Limited	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-318_878a2586-20af-4f35-8908-82474cc732a3	46708-318	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Limited	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-319_878a2586-20af-4f35-8908-82474cc732a3	46708-319	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Limited	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-320_878a2586-20af-4f35-8908-82474cc732a3	46708-320	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Limited	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-324_3b7b2b3c-507c-4ea9-a45d-f5e38f9e1b80	46708-324	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121		ANDA	ANDA210060	Alembic Pharmaceuticals Limited	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
46708-325_3b7b2b3c-507c-4ea9-a45d-f5e38f9e1b80	46708-325	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121		ANDA	ANDA210060	Alembic Pharmaceuticals Limited	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
46708-326_3b7b2b3c-507c-4ea9-a45d-f5e38f9e1b80	46708-326	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121		ANDA	ANDA210060	Alembic Pharmaceuticals Limited	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
46708-332_a85a56c5-44dd-41d4-ac1c-bdc4758406a4	46708-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606		ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
46708-333_a85a56c5-44dd-41d4-ac1c-bdc4758406a4	46708-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606		ANDA	ANDA210341	Alembic Pharmaceuticals Limited	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
46708-338_38173ca4-7b7e-4c91-b12c-7cce5bfaba84	46708-338	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	Alembic Pharmaceuticals Limited	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46708-339_38173ca4-7b7e-4c91-b12c-7cce5bfaba84	46708-339	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	Alembic Pharmaceuticals Limited	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46708-340_38173ca4-7b7e-4c91-b12c-7cce5bfaba84	46708-340	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	Alembic Pharmaceuticals Limited	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46708-341_aaa63206-6c7d-4996-8991-91bfdb69b821	46708-341	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20181205		ANDA	ANDA210302	Alembic Pharmaceuticals Limited	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-342_aaa63206-6c7d-4996-8991-91bfdb69b821	46708-342	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20181205		ANDA	ANDA210302	Alembic Pharmaceuticals Limited	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-343_aaa63206-6c7d-4996-8991-91bfdb69b821	46708-343	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20181205		ANDA	ANDA210302	Alembic Pharmaceuticals Limited	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-344_17817dba-4183-4a14-a55f-3e1240ea03a1	46708-344	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20220201		ANDA	ANDA210459	Alembic Pharmaceuticals Limited	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
46708-345_17817dba-4183-4a14-a55f-3e1240ea03a1	46708-345	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20220201		ANDA	ANDA210459	Alembic Pharmaceuticals Limited	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
46708-349_d9c1cc75-4e3d-4eaf-87c5-d5942a843818	46708-349	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20190220		ANDA	ANDA210423	Alembic Pharmaceuticals Limited	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
46708-350_8250e3fe-6420-401e-af14-45662b8a7b48	46708-350	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200123		ANDA	ANDA213252	Alembic Pharmaceuticals Limited	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-351_8250e3fe-6420-401e-af14-45662b8a7b48	46708-351	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200123		ANDA	ANDA213252	Alembic Pharmaceuticals Limited	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-352_994cfe3e-3b42-4837-b9fc-c88ba7484e51	46708-352	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200305		ANDA	ANDA210537	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	20	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-353_8a6d5c0f-9b8e-444e-882e-8a2264410c02	46708-353	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA210536	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-360_6d6a19bf-2b8a-411a-bd8e-94ae6fadd31f	46708-360	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA210476	Alembic Pharmaceuticals Limited	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-361_6d6a19bf-2b8a-411a-bd8e-94ae6fadd31f	46708-361	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA210476	Alembic Pharmaceuticals Limited	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-362_aec76b17-b6ca-41f3-b39b-65b7b3dd5972	46708-362	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	20180618		ANDA	ANDA210527	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-363_aec76b17-b6ca-41f3-b39b-65b7b3dd5972	46708-363	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	20180618		ANDA	ANDA210527	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-364_e19dd42d-3043-4605-9adf-001741e03942	46708-364	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Limited	CLONAZEPAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-365_e19dd42d-3043-4605-9adf-001741e03942	46708-365	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Limited	CLONAZEPAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-366_e19dd42d-3043-4605-9adf-001741e03942	46708-366	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Limited	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-367_e19dd42d-3043-4605-9adf-001741e03942	46708-367	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Limited	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-368_e19dd42d-3043-4605-9adf-001741e03942	46708-368	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Limited	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-379_387adad5-eb5e-429f-bc8a-b9ace387bc3f	46708-379	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Limited	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-380_387adad5-eb5e-429f-bc8a-b9ace387bc3f	46708-380	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Limited	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-381_387adad5-eb5e-429f-bc8a-b9ace387bc3f	46708-381	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Limited	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-382_387adad5-eb5e-429f-bc8a-b9ace387bc3f	46708-382	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Limited	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
46708-385_975cac47-5a4b-4a5d-a8c5-2aea808f30ca	46708-385	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20170630		ANDA	ANDA202700	Alembic Pharmaceuticals Limited	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
46708-386_975cac47-5a4b-4a5d-a8c5-2aea808f30ca	46708-386	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20170630		ANDA	ANDA202700	Alembic Pharmaceuticals Limited	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
46708-387_8becf01f-63de-4cf3-881e-94d18fe9274c	46708-387	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA211744	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-388_8becf01f-63de-4cf3-881e-94d18fe9274c	46708-388	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA211744	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-389_dacd91fc-bf3f-4ff3-a2ae-c0210796af47	46708-389	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	CAPSULE	ORAL	20210701		ANDA	ANDA211935	Alembic Pharmaceuticals Limited	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
46708-390_dacd91fc-bf3f-4ff3-a2ae-c0210796af47	46708-390	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	CAPSULE	ORAL	20210701		ANDA	ANDA211935	Alembic Pharmaceuticals Limited	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
46708-391_dacd91fc-bf3f-4ff3-a2ae-c0210796af47	46708-391	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	CAPSULE	ORAL	20210701		ANDA	ANDA211935	Alembic Pharmaceuticals Limited	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
46708-397_904b9ab6-9a2a-47f3-8a38-04920ce696e0	46708-397	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230828		ANDA	ANDA215661	Alembic Pharmaceuticals Limited	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
46708-398_904b9ab6-9a2a-47f3-8a38-04920ce696e0	46708-398	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230828		ANDA	ANDA215661	Alembic Pharmaceuticals Limited	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
46708-402_0bd202e3-c673-4945-b828-1a5bc6a896ae	46708-402	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20230608		ANDA	ANDA211763	Alembic Pharmaceuticals Limited	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-403_0bd202e3-c673-4945-b828-1a5bc6a896ae	46708-403	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20230608		ANDA	ANDA211763	Alembic Pharmaceuticals Limited	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-404_0bd202e3-c673-4945-b828-1a5bc6a896ae	46708-404	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20230608		ANDA	ANDA211763	Alembic Pharmaceuticals Limited	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-405_74147395-217c-4a7c-8acf-92a95ca7b7d4	46708-405	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20191125		ANDA	ANDA211731	Alembic Pharmaceuticals Limited	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
46708-406_74147395-217c-4a7c-8acf-92a95ca7b7d4	46708-406	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20191125		ANDA	ANDA211731	Alembic Pharmaceuticals Limited	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
46708-407_d6ecf659-e7e9-404b-98c0-999c30d485eb	46708-407	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20210805		ANDA	ANDA211822	Alembic Pharmaceuticals Limited	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-408_d6ecf659-e7e9-404b-98c0-999c30d485eb	46708-408	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20210805		ANDA	ANDA211822	Alembic Pharmaceuticals Limited	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-409_d6ecf659-e7e9-404b-98c0-999c30d485eb	46708-409	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20210805		ANDA	ANDA211822	Alembic Pharmaceuticals Limited	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-410_d58c204e-f996-4969-85c7-3fbe078bf6a8	46708-410	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211824	Alembic Pharmaceuticals Limited	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
46708-411_d58c204e-f996-4969-85c7-3fbe078bf6a8	46708-411	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20200615		ANDA	ANDA211824	Alembic Pharmaceuticals Limited	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
46708-412_d58c204e-f996-4969-85c7-3fbe078bf6a8	46708-412	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211824	Alembic Pharmaceuticals Limited	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
46708-413_d5e4bb9c-4af2-407a-8c7d-d4c9cb5117f5	46708-413	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR		OSELTAMIVIR	CAPSULE	ORAL	20190625		ANDA	ANDA211823	Alembic Pharmaceuticals Limited	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
46708-414_d5e4bb9c-4af2-407a-8c7d-d4c9cb5117f5	46708-414	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR		OSELTAMIVIR	CAPSULE	ORAL	20190625		ANDA	ANDA211823	Alembic Pharmaceuticals Limited	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
46708-415_d5e4bb9c-4af2-407a-8c7d-d4c9cb5117f5	46708-415	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR		OSELTAMIVIR	CAPSULE	ORAL	20190625		ANDA	ANDA211823	Alembic Pharmaceuticals Limited	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
46708-428_68765ffa-e238-40bb-8235-4ae53fb292e9	46708-428	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161201		ANDA	ANDA079067	Alembic Pharmaceuticals Limited	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
46708-429_68765ffa-e238-40bb-8235-4ae53fb292e9	46708-429	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161201		ANDA	ANDA079067	Alembic Pharmaceuticals Limited	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
46708-430_47576e3f-2b6d-4334-8733-748687e5b784	46708-430	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-431_47576e3f-2b6d-4334-8733-748687e5b784	46708-431	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-432_47576e3f-2b6d-4334-8733-748687e5b784	46708-432	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-433_47576e3f-2b6d-4334-8733-748687e5b784	46708-433	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-434_47576e3f-2b6d-4334-8733-748687e5b784	46708-434	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-435_73035cba-781b-4d60-80bb-8f8ff273a0a1	46708-435	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	CAPSULE	ORAL	20161209		ANDA	ANDA079065	Alembic Pharmaceuticals Limited	METRONIDAZOLE	375	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
46708-436_aa5c1860-7668-433b-bc17-c6de2b772e0f	46708-436	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20161201		ANDA	ANDA091369	Alembic Pharmaceuticals Limited	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
46708-437_aa5c1860-7668-433b-bc17-c6de2b772e0f	46708-437	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20161201		ANDA	ANDA091369	Alembic Pharmaceuticals Limited	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
46708-438_8ed60738-80b1-4c2d-a0f1-cf5fa17f8308	46708-438	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20170302		ANDA	ANDA200645	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-439_2efa4733-b806-42ee-b587-cae816493fa7	46708-439	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20160701		ANDA	ANDA091236	Alembic Pharmaceuticals Limited	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-440_2efa4733-b806-42ee-b587-cae816493fa7	46708-440	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20160701		ANDA	ANDA091236	Alembic Pharmaceuticals Limited	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-441_2efa4733-b806-42ee-b587-cae816493fa7	46708-441	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20160701		ANDA	ANDA091236	Alembic Pharmaceuticals Limited	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-442_bbfa2906-f126-40a2-a5c4-8cbe19388fcc	46708-442	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20160523		ANDA	ANDA091370	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-443_bbfa2906-f126-40a2-a5c4-8cbe19388fcc	46708-443	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20160523		ANDA	ANDA091370	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-444_bbfa2906-f126-40a2-a5c4-8cbe19388fcc	46708-444	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20160523		ANDA	ANDA091370	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	25; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-445_fed6ce57-7f32-48d0-a07e-82454736f587	46708-445	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	Alembic Pharmaceuticals Limited	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-446_fed6ce57-7f32-48d0-a07e-82454736f587	46708-446	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	Alembic Pharmaceuticals Limited	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-447_fed6ce57-7f32-48d0-a07e-82454736f587	46708-447	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	Alembic Pharmaceuticals Limited	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-448_0e751336-0818-42aa-8ee5-7ca8ff391a13	46708-448	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-449_0e751336-0818-42aa-8ee5-7ca8ff391a13	46708-449	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-450_0e751336-0818-42aa-8ee5-7ca8ff391a13	46708-450	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-451_3d66d5be-d570-4041-82bf-6b6f4eef9ed8	46708-451	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, COATED	ORAL	20151013		ANDA	ANDA200891	Alembic Pharmaceuticals Limited	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
46708-452_3d66d5be-d570-4041-82bf-6b6f4eef9ed8	46708-452	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, COATED	ORAL	20151013		ANDA	ANDA200891	Alembic Pharmaceuticals Limited	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
46708-453_7fb28413-d2ab-4534-8f12-48ce33bbc6a9	46708-453	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-454_7fb28413-d2ab-4534-8f12-48ce33bbc6a9	46708-454	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-455_7fb28413-d2ab-4534-8f12-48ce33bbc6a9	46708-455	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-456_7fb28413-d2ab-4534-8f12-48ce33bbc6a9	46708-456	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-457_7fb28413-d2ab-4534-8f12-48ce33bbc6a9	46708-457	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
46708-458_3fb35d37-f05c-44ff-be96-076adaa6da32	46708-458	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-459_3fb35d37-f05c-44ff-be96-076adaa6da32	46708-459	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-460_3fb35d37-f05c-44ff-be96-076adaa6da32	46708-460	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-461_3fb35d37-f05c-44ff-be96-076adaa6da32	46708-461	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Limited	AMLODIPINE BESYLATE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-462_edab3a0b-baf7-422c-be76-2638914d62f6	46708-462	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160104		ANDA	ANDA204232	Alembic Pharmaceuticals Limited	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
46708-463_edab3a0b-baf7-422c-be76-2638914d62f6	46708-463	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160104		ANDA	ANDA204232	Alembic Pharmaceuticals Limited	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
46708-478_49e45c73-b4c8-4f0e-8ad7-5a025ca5d5c8	46708-478	HUMAN PRESCRIPTION DRUG	ENTACAPONE		ENTACAPONE	TABLET, FILM COATED	ORAL	20220106		ANDA	ANDA212601	Alembic Pharmaceuticals Limited	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20251231
46708-479_5dd2966d-35b0-4a80-a677-bca6f4c69311	46708-479	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220610		ANDA	ANDA212708	Alembic Pharmaceuticals Limited	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
46708-480_5dd2966d-35b0-4a80-a677-bca6f4c69311	46708-480	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220610		ANDA	ANDA212708	Alembic Pharmaceuticals Limited	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
46708-481_e1387662-e286-469d-b85f-60344918a17b	46708-481	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-482_e1387662-e286-469d-b85f-60344918a17b	46708-482	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-483_e1387662-e286-469d-b85f-60344918a17b	46708-483	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-484_e1387662-e286-469d-b85f-60344918a17b	46708-484	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	200	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-491_cf7c5bb7-d94b-4c98-a4a2-e6a917e4165b	46708-491	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200115		ANDA	ANDA213223	Alembic Pharmaceuticals Limited	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-492_cf7c5bb7-d94b-4c98-a4a2-e6a917e4165b	46708-492	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200115		ANDA	ANDA213223	Alembic Pharmaceuticals Limited	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-493_cf7c5bb7-d94b-4c98-a4a2-e6a917e4165b	46708-493	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200115		ANDA	ANDA213223	Alembic Pharmaceuticals Limited	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-494_a4f0715d-590f-4b13-bb72-19cdca95aa01	46708-494	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-495_a4f0715d-590f-4b13-bb72-19cdca95aa01	46708-495	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-496_a4f0715d-590f-4b13-bb72-19cdca95aa01	46708-496	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-497_a4f0715d-590f-4b13-bb72-19cdca95aa01	46708-497	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-498_a4f0715d-590f-4b13-bb72-19cdca95aa01	46708-498	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Limited	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-499_8a6d5c0f-9b8e-444e-882e-8a2264410c02	46708-499	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20210915		ANDA	ANDA210536	Alembic Pharmaceuticals Limited	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
46708-507_f471cb1d-57c7-4556-99af-68f8c96059fd	46708-507	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20190412		ANDA	ANDA210263	Alembic Pharmaceuticals Limited	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
46708-508_013005e8-214b-41dc-b766-c0c57027487c	46708-508	HUMAN PRESCRIPTION DRUG	bromfenac		bromfenac	SOLUTION/ DROPS	OPHTHALMIC	20221110		ANDA	ANDA210560	Alembic Pharmaceuticals Limited	BROMFENAC SODIUM	1.035	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46708-511_2b4107e4-c108-4ed5-b7e8-253b74f2ff25	46708-511	HUMAN PRESCRIPTION DRUG	bimatoprost		bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20230721		ANDA	ANDA210515	Alembic Pharmaceuticals Limited	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
46708-532_5cae055b-b14c-4098-9d41-8f29adfd9f38	46708-532	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Alembic Pharmaceuticals Limited	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
46708-533_5cae055b-b14c-4098-9d41-8f29adfd9f38	46708-533	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Alembic Pharmaceuticals Limited	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
46708-534_5cae055b-b14c-4098-9d41-8f29adfd9f38	46708-534	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Alembic Pharmaceuticals Limited	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
46708-540_162ec8ed-f695-4db2-badf-4afb6b9e1cba	46708-540	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	Alembic Pharmaceuticals Limited	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-541_162ec8ed-f695-4db2-badf-4afb6b9e1cba	46708-541	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	Alembic Pharmaceuticals Limited	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-542_162ec8ed-f695-4db2-badf-4afb6b9e1cba	46708-542	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20180914		ANDA	ANDA204003	Alembic Pharmaceuticals Limited	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
46708-544_b8b5c58b-40db-4b6f-b53d-f11a842bcf28	46708-544	HUMAN PRESCRIPTION DRUG	Asenapine		Asenapine	TABLET	SUBLINGUAL	20210720		ANDA	ANDA206098	Alembic Pharmaceuticals Limited	ASENAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
46708-554_037d6074-3c99-4fdc-99f0-f0b58bdbb874	46708-554	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA209660	Alembic Pharmaceuticals Limited	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-555_037d6074-3c99-4fdc-99f0-f0b58bdbb874	46708-555	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA209660	Alembic Pharmaceuticals Limited	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
46708-565_dc2236ad-53b0-43fa-8d0f-d7d644e4cca9	46708-565	HUMAN PRESCRIPTION DRUG	ERLOTINIB HYDROCHLORIDE		ERLOTINIB HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210709		ANDA	ANDA214719	Alembic Pharmaceuticals Limited	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
46708-566_dc2236ad-53b0-43fa-8d0f-d7d644e4cca9	46708-566	HUMAN PRESCRIPTION DRUG	ERLOTINIB HYDROCHLORIDE		ERLOTINIB HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210709		ANDA	ANDA214719	Alembic Pharmaceuticals Limited	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
46708-567_dc2236ad-53b0-43fa-8d0f-d7d644e4cca9	46708-567	HUMAN PRESCRIPTION DRUG	ERLOTINIB HYDROCHLORIDE		ERLOTINIB HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210709		ANDA	ANDA214719	Alembic Pharmaceuticals Limited	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
46708-574_c9aa6022-4a1b-4fd5-a7ba-04158d9b5a05	46708-574	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-575_c9aa6022-4a1b-4fd5-a7ba-04158d9b5a05	46708-575	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-576_c9aa6022-4a1b-4fd5-a7ba-04158d9b5a05	46708-576	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-577_c9aa6022-4a1b-4fd5-a7ba-04158d9b5a05	46708-577	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-578_c9aa6022-4a1b-4fd5-a7ba-04158d9b5a05	46708-578	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-579_c9aa6022-4a1b-4fd5-a7ba-04158d9b5a05	46708-579	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	3.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-580_c9aa6022-4a1b-4fd5-a7ba-04158d9b5a05	46708-580	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-586_1ca812f6-6983-4d9a-b08e-a8f7e50054b8	46708-586	HUMAN PRESCRIPTION DRUG	Amantadine		Amantadine	TABLET	ORAL	20201020		ANDA	ANDA214284	Alembic Pharmaceuticals Limited	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
46708-598_de111d74-c740-47b3-adc7-4b855df2c561	46708-598	HUMAN PRESCRIPTION DRUG	Bepotastine Besilate Ophthalmic Solution 1.5%		Bepotastine Besilate Ophthalmic Solution 1.5%	SOLUTION/ DROPS	OPHTHALMIC	20230405		ANDA	ANDA214588	Alembic Pharmaceuticals Limited	BEPOTASTINE BESILATE	15	mg/mL	Histamine-1 Receptor Antagonist [EPC]		N	20241231
46708-603_ae10b8e1-557d-4437-8a1d-89d7844122c8	46708-603	HUMAN PRESCRIPTION DRUG	BISOPROLOL FUMARATE		BISOPROLOL FUMARATE	TABLET, FILM COATED	ORAL	20190911		ANDA	ANDA204891	Alembic Pharmaceuticals Limited	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-604_ae10b8e1-557d-4437-8a1d-89d7844122c8	46708-604	HUMAN PRESCRIPTION DRUG	BISOPROLOL FUMARATE		BISOPROLOL FUMARATE	TABLET, FILM COATED	ORAL	20190911		ANDA	ANDA204891	Alembic Pharmaceuticals Limited	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
46708-608_ae0d2b4e-7cf3-481b-9fc7-002c00214a56	46708-608	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160625		ANDA	ANDA202130	Alembic Pharmaceuticals Limited	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-609_ae0d2b4e-7cf3-481b-9fc7-002c00214a56	46708-609	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160625		ANDA	ANDA202130	Alembic Pharmaceuticals Limited	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-610_ae0d2b4e-7cf3-481b-9fc7-002c00214a56	46708-610	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160625		ANDA	ANDA202130	Alembic Pharmaceuticals Limited	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
46708-611_43b3cc2f-5e67-4440-a896-69f9be384e33	46708-611	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-612_43b3cc2f-5e67-4440-a896-69f9be384e33	46708-612	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-613_43b3cc2f-5e67-4440-a896-69f9be384e33	46708-613	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-614_43b3cc2f-5e67-4440-a896-69f9be384e33	46708-614	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-615_43b3cc2f-5e67-4440-a896-69f9be384e33	46708-615	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
46708-618_9e699cf7-860e-4c03-9760-0c24d56df2de	46708-618	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20221123		ANDA	ANDA215892	Alembic Pharmaceuticals Limited	CYCLOPHOSPHAMIDE	25	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
46708-619_9e699cf7-860e-4c03-9760-0c24d56df2de	46708-619	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20221123		ANDA	ANDA215892	Alembic Pharmaceuticals Limited	CYCLOPHOSPHAMIDE	50	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
46708-620_6d04b514-c85c-4db1-919e-21dd98172791	46708-620	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION	INTRAVENOUS	20221020		ANDA	ANDA216874	Alembic Pharmaceuticals Limited	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
46708-621_6d04b514-c85c-4db1-919e-21dd98172791	46708-621	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION	INTRAVENOUS	20221020		ANDA	ANDA216874	Alembic Pharmaceuticals Limited	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
46708-622_6d04b514-c85c-4db1-919e-21dd98172791	46708-622	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION	INTRAVENOUS	20221020		ANDA	ANDA216874	Alembic Pharmaceuticals Limited	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
46708-637_5c5c56f2-76f7-41b1-8eb5-40dc4cd4ac6a	46708-637	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Limited	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-638_5c5c56f2-76f7-41b1-8eb5-40dc4cd4ac6a	46708-638	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Limited	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-639_5c5c56f2-76f7-41b1-8eb5-40dc4cd4ac6a	46708-639	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Limited	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-640_5c5c56f2-76f7-41b1-8eb5-40dc4cd4ac6a	46708-640	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Limited	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-645_5c5c56f2-76f7-41b1-8eb5-40dc4cd4ac6a	46708-645	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Limited	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
46708-659_6e0cfe79-6998-45b2-bceb-f8848624be5a	46708-659	HUMAN PRESCRIPTION DRUG	Carmustine		Carmustine	KIT		20231020		ANDA	ANDA215730	Alembic Pharmaceuticals Limited						N	20241231
46708-661_e1ea003e-3dd9-41c7-9119-d1f209b9820b	46708-661	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate ophthalmic solution, 0.15%		Brimonidine Tartrate ophthalmic solution, 0.15%	SOLUTION/ DROPS	OPHTHALMIC	20230329		ANDA	ANDA215225	Alembic Pharmaceuticals Limited	BRIMONIDINE TARTRATE	1.5	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46708-676_1b98d1a1-9d3d-41d2-a5e9-744b851d30d4	46708-676	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE	CHLORTHALIDONE	CHLORTHALIDONE	TABLET	ORAL	20220829		ANDA	ANDA216262	Alembic Pharmaceuticals Limited	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
46708-677_1b98d1a1-9d3d-41d2-a5e9-744b851d30d4	46708-677	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE	CHLORTHALIDONE	CHLORTHALIDONE	TABLET	ORAL	20220829		ANDA	ANDA216262	Alembic Pharmaceuticals Limited	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
46708-678_682a0b1a-3277-4718-a94e-9645633062bf	46708-678	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20230228		ANDA	ANDA215744	Alembic Pharmaceuticals Limited	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
46708-691_fea187a3-ee8b-4463-8485-3b1de1504609	46708-691	HUMAN PRESCRIPTION DRUG	PRAZOSIN HYDROCHLORIDE		PRAZOSIN HYDROCHLORIDE	CAPSULE	ORAL	20230309		ANDA	ANDA217268	Alembic Pharmaceuticals Limited	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
46708-692_fea187a3-ee8b-4463-8485-3b1de1504609	46708-692	HUMAN PRESCRIPTION DRUG	PRAZOSIN HYDROCHLORIDE		PRAZOSIN HYDROCHLORIDE	CAPSULE	ORAL	20230309		ANDA	ANDA217268	Alembic Pharmaceuticals Limited	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
46708-693_fea187a3-ee8b-4463-8485-3b1de1504609	46708-693	HUMAN PRESCRIPTION DRUG	PRAZOSIN HYDROCHLORIDE		PRAZOSIN HYDROCHLORIDE	CAPSULE	ORAL	20230309		ANDA	ANDA217268	Alembic Pharmaceuticals Limited	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
46708-706_b5d560b6-847e-4f09-b1ef-22e4deb8a206	46708-706	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate and Timolol Maleate		Brimonidine Tartrate and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20230825		ANDA	ANDA215230	Alembic Pharmaceuticals Limited	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
46708-724_4ef59b85-e5a5-479f-a1fe-e1cee4d87670	46708-724	HUMAN PRESCRIPTION DRUG	MESALAMINE		MESALAMINE	CAPSULE, EXTENDED RELEASE	ORAL	20221103		ANDA	ANDA216967	Alembic Pharmaceuticals Limited	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
46708-732_1486f187-0ec6-4c70-8991-02c1493912b4	46708-732	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20221123		ANDA	ANDA216896	Alembic Pharmaceuticals Limited	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-733_1486f187-0ec6-4c70-8991-02c1493912b4	46708-733	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20221123		ANDA	ANDA216896	Alembic Pharmaceuticals Limited	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-734_1486f187-0ec6-4c70-8991-02c1493912b4	46708-734	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20221123		ANDA	ANDA216896	Alembic Pharmaceuticals Limited	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
46708-735_1f9751ff-33da-44be-9c1f-9bbf88ac543b	46708-735	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Limited	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
46708-736_1f9751ff-33da-44be-9c1f-9bbf88ac543b	46708-736	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Limited	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
46708-737_1f9751ff-33da-44be-9c1f-9bbf88ac543b	46708-737	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Limited	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
46708-738_1f9751ff-33da-44be-9c1f-9bbf88ac543b	46708-738	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Limited	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
46708-739_1f9751ff-33da-44be-9c1f-9bbf88ac543b	46708-739	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Limited	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
46708-744_398931c6-4954-4bbc-8b63-ea382e5864fc	46708-744	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide hydrochloride and clidinium bromide		Chlordiazepoxide hydrochloride and clidinium bromide	CAPSULE	ORAL	20231004		ANDA	ANDA216969	Alembic Pharmaceuticals Limited	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
46708-745_983b3157-cbea-435d-ba32-9ee7ef95226a	46708-745	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Limited	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-746_983b3157-cbea-435d-ba32-9ee7ef95226a	46708-746	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Limited	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-747_983b3157-cbea-435d-ba32-9ee7ef95226a	46708-747	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Limited	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-748_983b3157-cbea-435d-ba32-9ee7ef95226a	46708-748	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Limited	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
46708-749_ee26e0c9-a169-4842-ab0f-3c718bb14018	46708-749	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION/ DROPS	OPHTHALMIC	20230801		ANDA	ANDA216909	Alembic Pharmaceuticals Limited	BRIMONIDINE TARTRATE	1	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
46708-751_d10f12a2-7b38-4351-93df-1e8444d2a9e4	46708-751	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20230303		ANDA	ANDA217295	Alembic Pharmaceuticals Limited	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
46708-779_b6b0d9e2-c6f0-4523-a33b-b958d32d3a28	46708-779	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20231018		ANDA	ANDA217676	Alembic Pharmaceuticals Limited	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
46783-002_801c7ff6-75ce-4c4c-91ed-ad3b06e8c49b	46783-002	HUMAN OTC DRUG	Journee Bio-restorative Day Balm Broad-spectrum Suncreen SPF 30		OCTINOXATE and ZINC OXIDE	LOTION	TOPICAL	20110401		OTC MONOGRAPH FINAL	part352	Merz North America, Inc.	OCTINOXATE; ZINC OXIDE	75; 73	mg/mL; mg/mL			N	20241231
46783-004_5703bbff-1f78-46fa-beba-5bcfb1f7f2b7	46783-004	HUMAN OTC DRUG	AFTER CARE		DIMETHICONE	CREAM	TOPICAL	20190401		OTC MONOGRAPH FINAL	part347	Merz North America	DIMETHICONE	4	mg/mL	Skin Barrier Activity [PE]		N	20241231
46783-100_6c0a1c72-e85b-455d-91ec-3587a4fbd785	46783-100	HUMAN OTC DRUG	Journee Firm Broad Spectrum Sunscreen SPF 30		TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	Merz North America, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	12.25; 10.2	mg/mL; mg/mL			N	20241231
46783-110_5a7d1b35-68f1-4128-84e2-e2fb02787989	46783-110	HUMAN OTC DRUG	Journee Firm Riche Broad Spectrum Sunscreen SPF 30		TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20230315		OTC MONOGRAPH DRUG	M020	Merz North America, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	12.25; 10.2	mg/mL; mg/mL			N	20241231
46783-160_b10a6813-7c18-4ee8-8728-3a749f3d4b53	46783-160	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20110801		BLA	BLA125360	Merz North America, Inc.	BOTULINUM TOXIN TYPE A	100	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
46783-161_b10a6813-7c18-4ee8-8728-3a749f3d4b53	46783-161	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20110801		BLA	BLA125360	Merz North America, Inc.	BOTULINUM TOXIN TYPE A	50	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
46783-165_b10a6813-7c18-4ee8-8728-3a749f3d4b53	46783-165	HUMAN PRESCRIPTION DRUG	Xeomin		incobotulinumtoxinA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20110801		BLA	BLA125360	Merz North America, Inc.	BOTULINUM TOXIN TYPE A	50	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
46783-173_ec4a7869-c831-47e7-8c12-352a16a2424b	46783-173	HUMAN OTC DRUG	Micro Day Rejuvenating Broad-spectrum Sunscreen SPF 30		OCTINOXATE and ZINC OXIDE	LOTION	TOPICAL	20150323	20241031	OTC MONOGRAPH FINAL	part352	Merz North America, Inc.	OCTINOXATE; ZINC OXIDE	75; 73	mg/mL; mg/mL			N	
46783-222_45aafa11-426d-41b9-b27e-be10aec3c586	46783-222	HUMAN OTC DRUG	Reactive Plus Anti-Oxidant Serum plus Broad-spectrum SPF 45		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	Merz North America, Inc	OCTINOXATE; ZINC OXIDE	50; 51	mg/mL; mg/mL			N	20241231
46994-069_0a20c0bc-a38b-4710-acc2-4c30d9c243a6	46994-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20141108		OTC MONOGRAPH FINAL	part347	Moran Foods Inc	PETROLATUM	1	g/g			N	20241231
46994-157_4a62f604-2e73-4ec1-84ce-8dcd6179b83a	46994-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	SAVE-A-LOT FOOD STORES, LTD.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
46994-291_355c4942-cb3f-4888-9887-85c3f1a6fed3	46994-291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	SAVE-A-LOT FOOD STORES, LTD.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
46994-311_f572b120-8570-4b6a-80bb-6752c283d4c5	46994-311	HUMAN OTC DRUG	Everyday Clean		Pyrithione Zinc	SHAMPOO	TOPICAL	20110401		OTC MONOGRAPH FINAL	part358H	Moran Foods, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
46994-344_fc4bfc03-0564-458f-893f-6782d71825ad	46994-344	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20190830		OTC MONOGRAPH FINAL	part341	Being Well	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46994-370_de6c0a93-7dba-4bc7-8d39-dd19431db10b	46994-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20151122		OTC MONOGRAPH NOT FINAL	part333A	Save-A-Lot Food Stores, LTD	ALCOHOL	70	mL/100mL			N	20241231
46994-385_90fbf574-3481-4bfa-802b-430be245e626	46994-385	HUMAN OTC DRUG	Tussin DM Cough and Chest Congestion		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20190830		OTC MONOGRAPH FINAL	part341	Being Well	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
46994-568_ee07fffb-df2f-42a8-984c-2a17a19f1071	46994-568	HUMAN OTC DRUG	Ultra Dish		chloroxylenol 0.30%	LIQUID	TOPICAL	20160711		OTC MONOGRAPH NOT FINAL	part333A	Save A Lot	CHLOROXYLENOL	3.06	mg/mL			N	20241231
46994-658_0c072553-ff69-904b-e063-6294a90a9d51	46994-658	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA077829	SAVE-A-LOT FOOD STORES, LTD.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46994-659_0c06f429-27df-71fa-e063-6294a90a8e13	46994-659	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200313		OTC MONOGRAPH DRUG	M012	SAVE-A-LOT FOOD STORES, LTD.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
46994-660_0c06e3d2-447d-f4b5-e063-6394a90a0608	46994-660	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20200313		OTC MONOGRAPH DRUG	M012	SAVE-A-LOT FOOD STORES, LTD.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46994-663_0c06dc59-fcce-f09b-e063-6394a90a3629	46994-663	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20200313		OTC MONOGRAPH DRUG	M013	SAVE-A-LOT FOOD STORES, LTD.	ACETAMINOPHEN	500	mg/1			N	20241231
46994-664_098f1daa-44d1-406a-acc1-9d6926cb5ef6	46994-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20100617		OTC MONOGRAPH NOT FINAL	part356	Save A Lot Food Stores LTD	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
46994-711_3c456e31-398d-4819-944f-665f46cfd4bf	46994-711	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	Moran Foods, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.9; 133.9; 51.5; 72.1; 41.2	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
46994-714_5d344a12-3dac-457a-81a2-4645af4ce8b2	46994-714	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20161128		OTC MONOGRAPH FINAL	part352	Moran Foods, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.3; 101; 50.5; 101	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
46994-724_38d6c59a-fa5f-4c91-aaaf-091207fad024	46994-724	HUMAN OTC DRUG	Digestive Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20190930		OTC MONOGRAPH FINAL	part335	Being Well	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
46994-752_6681e784-3de0-487c-9640-82baa2d40ac9	46994-752	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20180501		OTC MONOGRAPH FINAL	part352	Moran Foods, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.9; 133.9; 51.5; 72.1; 41.2	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
46994-764_05c5d08b-72ac-4158-abf3-9ce270871a6a	46994-764	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	Moran Foods, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.6; 119; 45.9; 45.9; 55.08	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
46994-769_c584f4a8-fdb0-42a0-bc49-f3be2c1fb8ec	46994-769	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	Moran Foods, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30.3; 101; 30.3	mg/mL; mg/mL; mg/mL			N	20241231
46994-810_87c27f23-1546-4256-b141-dee61ba00fa1	46994-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20160214		OTC MONOGRAPH NOT FINAL	part333A	Moran Foods, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
46994-871_995295e4-30b2-4e59-a021-b1970d676231	46994-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Moran Foods, LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
46994-935_5d564918-c092-4cea-83e0-97176c8cf068	46994-935	HUMAN OTC DRUG	Acetaminophen	Extra Strength PM	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19940515		OTC MONOGRAPH DRUG	M013	SAVE-A-LOT FOOD STORES, LTD.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
46994-953_4baeee1d-b83f-4da2-ad87-58d8fa87325a	46994-953	HUMAN OTC DRUG	Congestion	PE	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20191018		OTC MONOGRAPH DRUG	M012	SAVE-A-LOT FOOD STORES, LTD.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47047-0001_081d148d-c127-b86f-e063-6394a90aebf1	47047-0001	HUMAN OTC DRUG	ChigaRid		CAMPHOR (SYNTHETIC), PHENOL, MENTHOL	SOLUTION	TOPICAL	20110707		OTC MONOGRAPH DRUG	M017	Colgin Inc	CAMPHOR (SYNTHETIC); MENTHOL; PHENOL	26; 1; 15	mg/mL; mg/mL; mg/mL			N	20241231
47124-072_19211f1b-7ee0-4c85-aab7-ccd91b526e4f	47124-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19960108		OTC MONOGRAPH NOT FINAL	part356	Topco	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
47124-120_bfe23b21-a424-9f57-e053-2a95a90a0366	47124-120	HUMAN OTC DRUG	MINERAL SUNSCREEN SPF 50		ZINC OXIDE, TITANIUM DIOXIDE	STICK	TOPICAL	20201019		OTC MONOGRAPH NOT FINAL	part352	WEGMANS FOOD MARKETS INC	TITANIUM DIOXIDE; ZINC OXIDE	70; 47	mg/g; mg/g			N	20241231
47124-121_e4b7df52-2bca-1afc-e053-2a95a90a4f87	47124-121	HUMAN OTC DRUG	WEGMANS SPORT CLEAR CONTINUOUS SUNSCREEN SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20190110		OTC MONOGRAPH NOT FINAL	part352	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
47124-122_e7174ca0-ac4a-46b7-e053-2995a90aa863	47124-122	HUMAN OTC DRUG	Wegmans Sport Broad Spectrum SPF 70 Clear Continuous Sunscreen		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20190626		OTC MONOGRAPH NOT FINAL	part352	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
47124-123_f12c2d94-50df-3e39-e053-2a95a90a345e	47124-123	HUMAN OTC DRUG	Wegmans SPORT BROAD SPECTRUM SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20190620		OTC MONOGRAPH NOT FINAL	part352	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
47124-124_f33248fa-695b-fbef-e053-2a95a90abe35	47124-124	HUMAN OTC DRUG	Wegmans Sheer Broad Spectrum SPF 30 Dry Touch Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190225		OTC MONOGRAPH FINAL	part352	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
47124-125_f3463fd0-3e6c-2356-e053-2a95a90a01e6	47124-125	HUMAN OTC DRUG	Wegmans Kids and Sport Broad Spectrum SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190116		OTC MONOGRAPH NOT FINAL	part352	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
47124-126_f558c679-86b2-7693-e053-2a95a90a0f70	47124-126	HUMAN OTC DRUG	Wegmans Sport and Kids Clear Continuous Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190110		OTC MONOGRAPH FINAL	M020	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
47124-127_f5671a83-32b1-0422-e053-2995a90ab0f6	47124-127	HUMAN OTC DRUG	Wegmans Sport Sunscreen Stick SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20190218		OTC MONOGRAPH FINAL	M020	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
47124-128_f57775d3-3fb0-fd12-e053-2a95a90a5992	47124-128	HUMAN OTC DRUG	Wegmans Kids Sunscreen Stick SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20190213		OTC MONOGRAPH FINAL	M020	WEGMANS FOOD MARKETS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
47124-129_f70bc442-dd29-0a52-e053-6294a90a2b06	47124-129	HUMAN OTC DRUG	Wegmans Aloe After Sun Gel with Lidocaine HCl External Analgesic		Lidocaine Hydrochloride	GEL	TOPICAL	20190206		OTC MONOGRAPH NOT FINAL	part348	WEGMANS FOOD MARKETS INC	LIDOCAINE HYDROCHLORIDE	8	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
47124-326_b60677a2-94e8-4cda-9eb2-66b8d0bae4cc	47124-326	HUMAN OTC DRUG	Tartar Control Plus		eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20140203		OTC MONOGRAPH NOT FINAL	part356	Wegmans Food Markets	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
47124-434_40dbd62a-7cba-4a03-b50b-05590065eb3f	47124-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20131122		OTC MONOGRAPH NOT FINAL	part356	Wegmans Food Markets, inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
47124-664_c68c893b-5f37-4251-858e-e50e459809dc	47124-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20100617		OTC MONOGRAPH NOT FINAL	part356	Topco	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
47133-574_be26dd04-d8a3-42c3-ab44-210dff9a0e3b	47133-574	HUMAN PRESCRIPTION DRUG	Elepsia XR		Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20190517		NDA	NDA204417	Sun Pharma Advanced Research Company Limited	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47133-575_be26dd04-d8a3-42c3-ab44-210dff9a0e3b	47133-575	HUMAN PRESCRIPTION DRUG	Elepsia XR		Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20190517		NDA	NDA204417	Sun Pharma Advanced Research Company Limited	LEVETIRACETAM	1500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47335-007_5330dfe5-b7e1-4813-bf9f-b3e932e61796	47335-007	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET, FILM COATED	ORAL	20130401		NDA AUTHORIZED GENERIC	NDA020796	Sun Pharmaceutical Industries, Inc.	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
47335-009_5f176ab2-0dba-4418-8aee-27a110ed6396	47335-009	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA208934	Sun Pharmaceutical Industries, Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
47335-010_5f176ab2-0dba-4418-8aee-27a110ed6396	47335-010	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA208934	Sun Pharmaceutical Industries, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
47335-011_5f176ab2-0dba-4418-8aee-27a110ed6396	47335-011	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA208934	Sun Pharmaceutical Industries, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
47335-012_5f176ab2-0dba-4418-8aee-27a110ed6396	47335-012	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA208934	Sun Pharmaceutical Industries, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
47335-031_1f7269e6-8156-45be-ba04-9f81cfe7e409	47335-031	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130614		ANDA	ANDA205905	Sun Pharmaceutical Industries, Inc.	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
47335-032_1f7269e6-8156-45be-ba04-9f81cfe7e409	47335-032	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130614		ANDA	ANDA205905	Sun Pharmaceutical Industries, Inc.	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
47335-033_1f7269e6-8156-45be-ba04-9f81cfe7e409	47335-033	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130614		ANDA	ANDA205905	Sun Pharmaceutical Industries, Inc.	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
47335-034_1f7269e6-8156-45be-ba04-9f81cfe7e409	47335-034	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130614		ANDA	ANDA205905	Sun Pharmaceutical Industries, Inc.	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
47335-037_dd6cda1c-d74f-4cc0-8027-bc2af7c1b1f6	47335-037	HUMAN PRESCRIPTION DRUG	HYDROXYPROGESTERONE CAPROATE		HYDROXYPROGESTERONE CAPROATE	INJECTION	INTRAMUSCULAR	20190701		ANDA	ANDA208381	Sun Pharmaceutical Industries, Inc.	HYDROXYPROGESTERONE CAPROATE	250	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
47335-038_a2bb0923-e59a-485a-ad65-06b97e0a2e1d	47335-038	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA209324	Sun Pharmaceutical Industries, Inc.	BOSENTAN	62.5	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
47335-039_a2bb0923-e59a-485a-ad65-06b97e0a2e1d	47335-039	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA209324	Sun Pharmaceutical Industries, Inc.	BOSENTAN	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
47335-049_b97ae977-5695-41c4-aa71-527c08d56b85	47335-049	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20130205		ANDA	ANDA203263	Sun Pharmaceutical Industries, Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
47335-050_b97ae977-5695-41c4-aa71-527c08d56b85	47335-050	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20130205		ANDA	ANDA203263	Sun Pharmaceutical Industries, Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
47335-061_3ea6a12b-26de-4858-aebe-4f8902cc560f	47335-061	HUMAN PRESCRIPTION DRUG	DOFETILIDE		DOFETILIDE	CAPSULE	ORAL	20181011		ANDA	ANDA210466	Sun Pharmaceutical Industries, Inc.	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
47335-062_3ea6a12b-26de-4858-aebe-4f8902cc560f	47335-062	HUMAN PRESCRIPTION DRUG	DOFETILIDE		DOFETILIDE	CAPSULE	ORAL	20181011		ANDA	ANDA210466	Sun Pharmaceutical Industries, Inc.	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
47335-063_3ea6a12b-26de-4858-aebe-4f8902cc560f	47335-063	HUMAN PRESCRIPTION DRUG	DOFETILIDE		DOFETILIDE	CAPSULE	ORAL	20181011		ANDA	ANDA210466	Sun Pharmaceutical Industries, Inc.	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
47335-171_fcccf0aa-4457-4836-a74f-594614cbb4a3	47335-171	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20200228		ANDA	ANDA207136	Sun Pharmaceutical Industries, Inc.	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
47335-177_e811aee5-936e-46a9-bb7d-9a387bdb505f	47335-177	HUMAN PRESCRIPTION DRUG	ILUMYA		tildrakizumab-asmn	INJECTION, SOLUTION	SUBCUTANEOUS	20180806		BLA	BLA761067	Sun Pharmaceutical Industries, Inc.	TILDRAKIZUMAB	100	mg/mL	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20241231
47335-179_86ebe1dd-8c77-4615-8a4c-1e8ec4dc0098	47335-179	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET	ORAL	20150817		ANDA	ANDA206129	Sun Pharmaceutical Industries, Inc.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
47335-186_eb06b9a0-d6cb-4293-8de4-62d9205ec365	47335-186	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET, ORALLY DISINTEGRATING	ORAL	20141215		ANDA	ANDA078690	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
47335-187_eb06b9a0-d6cb-4293-8de4-62d9205ec365	47335-187	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET, ORALLY DISINTEGRATING	ORAL	20141215		ANDA	ANDA078690	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
47335-188_eb06b9a0-d6cb-4293-8de4-62d9205ec365	47335-188	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET, ORALLY DISINTEGRATING	ORAL	20141215		ANDA	ANDA078690	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
47335-219_26b840cb-75b8-41f1-bcbb-287a0b2eca52	47335-219	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20180313		ANDA	ANDA090017	Sun Pharmaceutical Industries, Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47335-220_26b840cb-75b8-41f1-bcbb-287a0b2eca52	47335-220	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20180313		ANDA	ANDA090017	Sun Pharmaceutical Industries, Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47335-221_26b840cb-75b8-41f1-bcbb-287a0b2eca52	47335-221	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20180313		ANDA	ANDA090017	Sun Pharmaceutical Industries, Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47335-235_15524c15-09e2-4eb2-bba7-a5e51d8ead07	47335-235	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate Sodium	TABLET	ORAL	20171110		ANDA	ANDA201749	Sun Pharmaceutical Industries, Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
47335-236_884d2d52-fa1a-4895-823c-e62916bffefe	47335-236	HUMAN PRESCRIPTION DRUG	ambrisentan		ambrisentan	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA210784	Sun Pharmaceutical Industries, Inc.	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
47335-237_884d2d52-fa1a-4895-823c-e62916bffefe	47335-237	HUMAN PRESCRIPTION DRUG	ambrisentan		ambrisentan	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA210784	Sun Pharmaceutical Industries, Inc.	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
47335-276_76d6f706-19c4-452f-a0cc-db656b6a0266	47335-276	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20110622		ANDA	ANDA090358	Sun Pharmaceutical Industries, Inc.	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
47335-277_86ebe1dd-8c77-4615-8a4c-1e8ec4dc0098	47335-277	HUMAN PRESCRIPTION DRUG	Tetrabenazine		Tetrabenazine	TABLET	ORAL	20150817		ANDA	ANDA206129	Sun Pharmaceutical Industries, Inc.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
47335-289_f32e4ba0-3e6d-41b3-95f3-67b040cd4529	47335-289	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		Caffeine Citrate	INJECTION	INTRAVENOUS	20140605		ANDA	ANDA090077	Sun Pharmaceutical Industries, Inc.	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
47335-290_dd824465-e6da-459b-9f40-2ddb0fd98cb0	47335-290	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		Caffeine Citrate	SOLUTION	ORAL	20210301		ANDA	ANDA090357	Sun Pharmaceutical Industries, Inc.	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
47335-303_a2951b0d-10fe-447c-8f83-2c244fbc8815	47335-303	HUMAN PRESCRIPTION DRUG	Odomzo		sonidegib	CAPSULE	ORAL	20170921		NDA	NDA205266	Sun Pharmaceutical Industries, Inc.	SONIDEGIB PHOSPHATE	200	mg/1	Hedgehog Pathway Inhibitor [EPC], Smoothened Receptor Antagonists [MoA]		N	20251231
47335-305_33ab529d-b535-4138-9c3d-dbde05d702c9	47335-305	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180522		ANDA	ANDA202917	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
47335-306_33ab529d-b535-4138-9c3d-dbde05d702c9	47335-306	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180522		ANDA	ANDA202917	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
47335-307_4a5c474b-e752-4d01-be37-a66e7c9bf62e	47335-307	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		ANDA	ANDA204170	Sun Pharmaceutical Industries, Inc.	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
47335-308_4a5c474b-e752-4d01-be37-a66e7c9bf62e	47335-308	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		ANDA	ANDA204170	Sun Pharmaceutical Industries, Inc.	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
47335-317_c866d64c-e5c1-4ae5-b023-957d0211581d	47335-317	HUMAN PRESCRIPTION DRUG	XELPROS		latanoprost	SOLUTION/ DROPS	OPHTHALMIC; TOPICAL	20180912		NDA	NDA206185	Sun Pharmaceutical Industries, Inc.	LATANOPROST	.05	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
47335-321_81ca8cbf-7854-43a2-bd0b-1dbaf4709a42	47335-321	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20150711		ANDA	ANDA090058	Sun Pharmaceutical Industries, Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
47335-322_81ca8cbf-7854-43a2-bd0b-1dbaf4709a42	47335-322	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20150711		ANDA	ANDA090058	Sun Pharmaceutical Industries, Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
47335-323_9a0d7b91-4324-4e19-9cd8-eb19266e771a	47335-323	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20201126		NDA	NDA022534	Sun Pharmaceutical Industries, Inc.	DOCETAXEL ANHYDROUS	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
47335-326_b0c2b60a-dc96-483b-933e-2fed58b64372	47335-326	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		NALTREXONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120229		ANDA	ANDA090356	Sun Pharmaceutical Industries, Inc.	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
47335-330_8ea1e7fe-7bb3-42b3-9a24-5ea2f2c09715	47335-330	HUMAN PRESCRIPTION DRUG	CHLOROTHIAZIDE SODIUM		CHLOROTHIAZIDE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160825		ANDA	ANDA091546	Sun Pharmaceutical Industries, Inc.	CHLOROTHIAZIDE SODIUM	500	mg/18mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
47335-343_358269d0-02b4-4efe-8acb-1a3e77a47e7e	47335-343	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20110909		ANDA	ANDA090142	Sun Pharmaceutical Industries, Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47335-343_82a6bc4d-2eed-434f-931a-ba338706ebbb	47335-343	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20110926		ANDA	ANDA090142	Sun Pharmaceutical Industries, Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47335-344_358269d0-02b4-4efe-8acb-1a3e77a47e7e	47335-344	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20110909		ANDA	ANDA090142	Sun Pharmaceutical Industries, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47335-344_82a6bc4d-2eed-434f-931a-ba338706ebbb	47335-344	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20110926		ANDA	ANDA090142	Sun Pharmaceutical Industries, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47335-361_ddc155a1-509c-4d7e-bab1-fa5891ef354e	47335-361	HUMAN PRESCRIPTION DRUG	decitabine		decitabine	KIT		20140124		NDA	NDA205582	Sun Pharmaceutical Industries, Inc.						N	20241231
47335-379_fb601aec-aba6-4bec-a98d-51e556fef95c	47335-379	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190515		ANDA	ANDA207008	Sun Pharmaceutical Industries, Inc.	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
47335-380_fb601aec-aba6-4bec-a98d-51e556fef95c	47335-380	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190515		ANDA	ANDA207008	Sun Pharmaceutical Industries, Inc.	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
47335-381_cec0154d-5c8c-496d-89bd-ba2a93aee774	47335-381	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090745	Sun Pharmaceutical Industries, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-382_cec0154d-5c8c-496d-89bd-ba2a93aee774	47335-382	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090745	Sun Pharmaceutical Industries, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-383_cec0154d-5c8c-496d-89bd-ba2a93aee774	47335-383	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090745	Sun Pharmaceutical Industries, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-401_2bfc9d4d-6445-4228-8fe5-acb108de89db	47335-401	HUMAN PRESCRIPTION DRUG	YONSA		abiraterone acetate	TABLET	ORAL	20180522		NDA	NDA210308	Sun Pharmaceutical Industries, Inc.	ABIRATERONE ACETATE	125	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
47335-410_e0e3ea6e-7931-4279-880d-9d4f7d340acf	47335-410	HUMAN PRESCRIPTION DRUG	Sumatriptan and Naproxen Sodium		Sumatriptan and Naproxen Sodium	TABLET, FILM COATED	ORAL	20180720		ANDA	ANDA202803	Sun Pharmaceutical Industries, Inc.	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500; 85	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
47335-472_ad13dbca-474d-4492-9c25-e0e175143d8c	47335-472	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078340	Sun Pharmaceutical Industries, Inc.	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
47335-475_ad13dbca-474d-4492-9c25-e0e175143d8c	47335-475	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078340	Sun Pharmaceutical Industries, Inc.	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
47335-485_03950328-e671-448e-af60-14af3c9725f0	47335-485	HUMAN PRESCRIPTION DRUG	bicalutamide		bicalutamide	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA079110	Sun Pharmaceutical Industries, Inc.	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
47335-506_44371b0e-995a-4747-9414-daa3f5312f77	47335-506	HUMAN PRESCRIPTION DRUG	CEQUA		cyclosporine	SOLUTION/ DROPS	OPHTHALMIC; TOPICAL	20180815		NDA	NDA210913	Sun Pharmaceutical Industries, Inc.	CYCLOSPORINE	.0009	g/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
47335-507_44371b0e-995a-4747-9414-daa3f5312f77	47335-507	HUMAN PRESCRIPTION DRUG	CEQUA		cyclosporine	SOLUTION/ DROPS	OPHTHALMIC; TOPICAL	20180815		NDA	NDA210913	Sun Pharmaceutical Industries, Inc.	CYCLOSPORINE	.0009	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
47335-531_2122faf1-b357-4a4d-b732-60ddb96a507d	47335-531	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111230		ANDA	ANDA091607	Sun Pharmaceutical Industries, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
47335-533_2122faf1-b357-4a4d-b732-60ddb96a507d	47335-533	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111230		ANDA	ANDA091607	Sun Pharmaceutical Industries, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
47335-537_2122faf1-b357-4a4d-b732-60ddb96a507d	47335-537	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111230		ANDA	ANDA091607	Sun Pharmaceutical Industries, Inc.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
47335-539_bc18daa3-5321-43bd-9d00-dabd9adac571	47335-539	HUMAN PRESCRIPTION DRUG	NIACIN		NIACIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140627		ANDA	ANDA200484	Sun Pharmaceutical Industries, Inc.	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
47335-578_0d26f1ea-7eef-4d0a-9905-fd88daa35b65	47335-578	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208066	Sun Pharmaceutical Industries, Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-579_0d26f1ea-7eef-4d0a-9905-fd88daa35b65	47335-579	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208066	Sun Pharmaceutical Industries, Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-582_20ea7bbd-b500-46cd-bbfa-6d0a3347c10e	47335-582	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20210301		ANDA	ANDA079169	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-583_20ea7bbd-b500-46cd-bbfa-6d0a3347c10e	47335-583	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20210301		ANDA	ANDA079169	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-584_20ea7bbd-b500-46cd-bbfa-6d0a3347c10e	47335-584	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20210301		ANDA	ANDA079169	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-585_20ea7bbd-b500-46cd-bbfa-6d0a3347c10e	47335-585	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20210301		ANDA	ANDA079169	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-586_95e952a3-5a7d-4b4c-9ac8-b5256a4371c3	47335-586	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091103	Sun Pharmaceutical Industries, Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
47335-587_95e952a3-5a7d-4b4c-9ac8-b5256a4371c3	47335-587	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091103	Sun Pharmaceutical Industries, Inc.	ESZOPICLONE	2	mg/1		CIV	N	20241231
47335-588_95e952a3-5a7d-4b4c-9ac8-b5256a4371c3	47335-588	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091103	Sun Pharmaceutical Industries, Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
47335-600_fb601aec-aba6-4bec-a98d-51e556fef95c	47335-600	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190515		ANDA	ANDA207008	Sun Pharmaceutical Industries, Inc.	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
47335-613_bc18daa3-5321-43bd-9d00-dabd9adac571	47335-613	HUMAN PRESCRIPTION DRUG	NIACIN		NIACIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140627		ANDA	ANDA200484	Sun Pharmaceutical Industries, Inc.	NIACIN	1000	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
47335-614_bc18daa3-5321-43bd-9d00-dabd9adac571	47335-614	HUMAN PRESCRIPTION DRUG	NIACIN		NIACIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140627		ANDA	ANDA201273	Sun Pharmaceutical Industries, Inc.	NIACIN	750	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
47335-615_4bb42f07-a41e-42f3-92e7-dab665584f84	47335-615	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		NOREPINEPHRINE BITARTRATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210701		ANDA	ANDA211980	Sun Pharmaceutical Industries, Inc.	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
47335-616_8e6793fa-1e04-4212-88b9-b53f7a42ae8d	47335-616	HUMAN PRESCRIPTION DRUG	DRIZALMA SPRINKLE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190801		NDA	NDA212516	SUN PHARMACEUTICAL INDUSTRIES, INC.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-617_8e6793fa-1e04-4212-88b9-b53f7a42ae8d	47335-617	HUMAN PRESCRIPTION DRUG	DRIZALMA SPRINKLE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190801		NDA	NDA212516	SUN PHARMACEUTICAL INDUSTRIES, INC.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-618_8e6793fa-1e04-4212-88b9-b53f7a42ae8d	47335-618	HUMAN PRESCRIPTION DRUG	DRIZALMA SPRINKLE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190801		NDA	NDA212516	SUN PHARMACEUTICAL INDUSTRIES, INC.	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-619_8e6793fa-1e04-4212-88b9-b53f7a42ae8d	47335-619	HUMAN PRESCRIPTION DRUG	DRIZALMA SPRINKLE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190801		NDA	NDA212516	SUN PHARMACEUTICAL INDUSTRIES, INC.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-624_110acc77-c51e-465f-8d01-2c01f69af87b	47335-624	HUMAN PRESCRIPTION DRUG	ASPRUZYO SPRINKLE		Ranolazine	GRANULE	ORAL	20220228		NDA	NDA216018	SUN PHARMACEUTICAL INDUSTRIES, INC.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
47335-625_110acc77-c51e-465f-8d01-2c01f69af87b	47335-625	HUMAN PRESCRIPTION DRUG	ASPRUZYO SPRINKLE		Ranolazine	GRANULE	ORAL	20220228		NDA	NDA216018	SUN PHARMACEUTICAL INDUSTRIES, INC.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
47335-631_bd3a9267-8719-4d38-bcb3-6001792d06c7	47335-631	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20210501		ANDA	ANDA211922	Sun Pharmaceutical Industries, Inc.	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47335-632_bd3a9267-8719-4d38-bcb3-6001792d06c7	47335-632	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20210501		ANDA	ANDA211922	Sun Pharmaceutical Industries, Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47335-633_bd3a9267-8719-4d38-bcb3-6001792d06c7	47335-633	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20210501		ANDA	ANDA211922	Sun Pharmaceutical Industries, Inc.	BUDESONIDE	1	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47335-639_0d26f1ea-7eef-4d0a-9905-fd88daa35b65	47335-639	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208066	Sun Pharmaceutical Industries, Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-666_d9f1a2ae-b089-400c-b9f5-e06b058d767d	47335-666	HUMAN PRESCRIPTION DRUG	risedronate sodium		risedronate sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA090886	Sun Pharmaceutical Industries, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE	5	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
47335-667_d9f1a2ae-b089-400c-b9f5-e06b058d767d	47335-667	HUMAN PRESCRIPTION DRUG	risedronate sodium		risedronate sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA090886	Sun Pharmaceutical Industries, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE	30	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
47335-668_d9f1a2ae-b089-400c-b9f5-e06b058d767d	47335-668	HUMAN PRESCRIPTION DRUG	risedronate sodium		risedronate sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA090886	Sun Pharmaceutical Industries, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
47335-669_ecddf1f1-b8e7-4a08-8f00-6cc484092a5f	47335-669	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20101115		ANDA	ANDA090421	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
47335-670_ecddf1f1-b8e7-4a08-8f00-6cc484092a5f	47335-670	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20101115		ANDA	ANDA090421	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
47335-671_ecddf1f1-b8e7-4a08-8f00-6cc484092a5f	47335-671	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20101115		ANDA	ANDA090421	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
47335-672_ecddf1f1-b8e7-4a08-8f00-6cc484092a5f	47335-672	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20101115		ANDA	ANDA090421	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
47335-673_ecddf1f1-b8e7-4a08-8f00-6cc484092a5f	47335-673	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20101115		ANDA	ANDA090421	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
47335-675_3c94f868-93d3-4b36-8420-b2903a0bd79a	47335-675	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090492	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
47335-676_3c94f868-93d3-4b36-8420-b2903a0bd79a	47335-676	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090492	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
47335-677_3c94f868-93d3-4b36-8420-b2903a0bd79a	47335-677	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090492	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
47335-678_3c94f868-93d3-4b36-8420-b2903a0bd79a	47335-678	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090492	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
47335-679_3c94f868-93d3-4b36-8420-b2903a0bd79a	47335-679	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090492	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
47335-684_0d26f1ea-7eef-4d0a-9905-fd88daa35b65	47335-684	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208066	Sun Pharmaceutical Industries, Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-685_0d26f1ea-7eef-4d0a-9905-fd88daa35b65	47335-685	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208066	Sun Pharmaceutical Industries, Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-686_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-686	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
47335-687_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-687	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
47335-688_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-688	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
47335-689_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-689	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
47335-690_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-690	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
47335-691_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-691	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
47335-692_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-692	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	225	mg/1		CV	N	20241231
47335-693_0bbf728e-61b6-4050-a7fc-ca5862dcb87e	47335-693	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191204		ANDA	ANDA091157	Sun Pharmaceutical Industries, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
47335-703_2833984c-f479-4e90-b947-80df3d3111f7	47335-703	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		albuterol sulfate	SOLUTION	RESPIRATORY (INHALATION)	20210611		ANDA	ANDA207857	Sun Pharmaceutical Industries, Inc.	ALBUTEROL SULFATE	.83	mg/mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
47335-706_147b55d9-c9f9-4a22-814a-acf834a1864d	47335-706	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20200204		ANDA	ANDA207903	Sun Pharmaceutical Industries, Inc.	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
47335-707_a93bac64-4496-4496-b710-8ee8ffd8cc59	47335-707	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47335-710_a93bac64-4496-4496-b710-8ee8ffd8cc59	47335-710	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47335-711_a93bac64-4496-4496-b710-8ee8ffd8cc59	47335-711	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47335-712_a93bac64-4496-4496-b710-8ee8ffd8cc59	47335-712	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47335-714_3fb7fc89-95b5-4c8a-9b1c-dd509cadb4eb	47335-714	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20221123		ANDA	ANDA090508	Sun Pharmaceutical Industries, Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
47335-715_4e0042bf-4c11-4c49-98c1-27c714e17149	47335-715	HUMAN PRESCRIPTION DRUG	FINASTERIDE		FINASTERIDE	TABLET, FILM COATED	ORAL	20221125		ANDA	ANDA090507	Sun Pharmaceutical Industries, Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
47335-721_53dfe063-e9bf-4069-b4cc-5a83a27d18ec	47335-721	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20190705		ANDA	ANDA205467	Sun Pharmaceutical Industries, Inc.	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
47335-722_53dfe063-e9bf-4069-b4cc-5a83a27d18ec	47335-722	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20190705		ANDA	ANDA205467	Sun Pharmaceutical Industries, Inc.	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
47335-724_500a47c2-26a8-4dce-9e99-a7c9b69e84c1	47335-724	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA090818	Sun Pharmaceutical Industries, Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
47335-727_d9f1a2ae-b089-400c-b9f5-e06b058d767d	47335-727	HUMAN PRESCRIPTION DRUG	risedronate sodium		risedronate sodium	TABLET, FILM COATED	ORAL	20140611		ANDA	ANDA090886	Sun Pharmaceutical Industries, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE	75	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
47335-736_c6713a20-9f4d-4823-9e61-6b49bf962fe7	47335-736	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200301		ANDA	ANDA078866	Sun Pharmaceutical Industries, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
47335-737_c6713a20-9f4d-4823-9e61-6b49bf962fe7	47335-737	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200301		ANDA	ANDA078866	Sun Pharmaceutical Industries, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
47335-738_c6713a20-9f4d-4823-9e61-6b49bf962fe7	47335-738	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200301		ANDA	ANDA078866	Sun Pharmaceutical Industries, Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
47335-743_f264b091-1414-4e44-abae-d0b787c94397	47335-743	HUMAN PRESCRIPTION DRUG	Levalbuterol Inhalation Solution		Levalbuterol Inhalation Solution	SOLUTION	RESPIRATORY (INHALATION)	20181201		ANDA	ANDA207820	Sun Pharmaceutical Industries, Inc.	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
47335-744_3cd6c22e-945d-4231-9c3c-9a728868b442	47335-744	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA205618	Sun Pharmaceutical Industries, Inc.	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-746_f264b091-1414-4e44-abae-d0b787c94397	47335-746	HUMAN PRESCRIPTION DRUG	Levalbuterol Inhalation Solution		Levalbuterol Inhalation Solution	SOLUTION	RESPIRATORY (INHALATION)	20181201		ANDA	ANDA207820	Sun Pharmaceutical Industries, Inc.	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
47335-753_f264b091-1414-4e44-abae-d0b787c94397	47335-753	HUMAN PRESCRIPTION DRUG	Levalbuterol Inhalation Solution		Levalbuterol Inhalation Solution	SOLUTION	RESPIRATORY (INHALATION)	20181201		ANDA	ANDA207820	Sun Pharmaceutical Industries, Inc.	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
47335-756_c9e56721-a62e-4703-8ea6-20bf51f244a6	47335-756	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20211115		ANDA	ANDA207875	Sun Pharmaceutical Industries, Inc.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
47335-758_dae15132-d26b-4ea9-b937-da9c282ada48	47335-758	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141215		ANDA	ANDA091272	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-759_dae15132-d26b-4ea9-b937-da9c282ada48	47335-759	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141215		ANDA	ANDA091272	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-760_dae15132-d26b-4ea9-b937-da9c282ada48	47335-760	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141215		ANDA	ANDA091272	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-765_3cd6c22e-945d-4231-9c3c-9a728868b442	47335-765	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA205618	Sun Pharmaceutical Industries, Inc.	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-766_3cd6c22e-945d-4231-9c3c-9a728868b442	47335-766	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA205618	Sun Pharmaceutical Industries, Inc.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-767_3cd6c22e-945d-4231-9c3c-9a728868b442	47335-767	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA205618	Sun Pharmaceutical Industries, Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-779_09652cb1-7315-4188-9f36-4e2b50fb764d	47335-779	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		Azelastine Hydrochloride	SPRAY, METERED	NASAL	20120524		ANDA	ANDA090423	Sun Pharmaceutical Industries, Inc.	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47335-794_dae15132-d26b-4ea9-b937-da9c282ada48	47335-794	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190215		ANDA	ANDA091272	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
47335-835_3ddec6e9-e082-4c2d-a026-aee87736ef80	47335-835	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Sun Pharmaceutical Industries, Inc.	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
47335-836_3ddec6e9-e082-4c2d-a026-aee87736ef80	47335-836	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Sun Pharmaceutical Industries, Inc.	GALANTAMINE HYDROBROMIDE	16	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
47335-837_3ddec6e9-e082-4c2d-a026-aee87736ef80	47335-837	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Sun Pharmaceutical Industries, Inc.	GALANTAMINE HYDROBROMIDE	24	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
47335-859_e0d3db7a-edb2-4a1b-b7db-cd6aef8e550c	47335-859	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Sun Pharmaceutical Industries, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
47335-860_e0d3db7a-edb2-4a1b-b7db-cd6aef8e550c	47335-860	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Sun Pharmaceutical Industries, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
47335-861_e0d3db7a-edb2-4a1b-b7db-cd6aef8e550c	47335-861	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Sun Pharmaceutical Industries, Inc.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
47335-890_3f33dbae-6f6d-4863-8d02-cc8bd27bc795	47335-890	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20140213		ANDA	ANDA201742	Sun Pharmaceutical Industries, Inc.	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
47335-891_3f33dbae-6f6d-4863-8d02-cc8bd27bc795	47335-891	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20140213		ANDA	ANDA201742	Sun Pharmaceutical Industries, Inc.	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
47335-892_3f33dbae-6f6d-4863-8d02-cc8bd27bc795	47335-892	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20140213		ANDA	ANDA201742	Sun Pharmaceutical Industries, Inc.	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
47335-893_3f33dbae-6f6d-4863-8d02-cc8bd27bc795	47335-893	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20140213		ANDA	ANDA201742	Sun Pharmaceutical Industries, Inc.	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
47335-894_2de2d0fb-68e7-4a22-8da8-be7658468f15	47335-894	HUMAN PRESCRIPTION DRUG	Clopidogrel Bisulfate		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120518		ANDA	ANDA090494	Sun Pharmaceutical Industries, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
47335-895_9a0d7b91-4324-4e19-9cd8-eb19266e771a	47335-895	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20201126		NDA	NDA022534	Sun Pharmaceutical Industries, Inc.	DOCETAXEL ANHYDROUS	80	mg/4mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
47335-902_7d9c9071-2f8a-471b-9e80-5d2e18cae951	47335-902	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Sun Pharmaceutical Industries, Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-903_7d9c9071-2f8a-471b-9e80-5d2e18cae951	47335-903	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Sun Pharmaceutical Industries, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-904_7d9c9071-2f8a-471b-9e80-5d2e18cae951	47335-904	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Sun Pharmaceutical Industries, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-905_7d9c9071-2f8a-471b-9e80-5d2e18cae951	47335-905	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Sun Pharmaceutical Industries, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-906_7d9c9071-2f8a-471b-9e80-5d2e18cae951	47335-906	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Sun Pharmaceutical Industries, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-907_7d9c9071-2f8a-471b-9e80-5d2e18cae951	47335-907	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Sun Pharmaceutical Industries, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
47335-918_4bfda9bf-5a78-47a6-9d71-48f3a080dc7e	47335-918	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA205031	Sun Pharmaceutical Industries, Inc.	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
47335-922_4bfda9bf-5a78-47a6-9d71-48f3a080dc7e	47335-922	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA205031	Sun Pharmaceutical Industries, Inc.	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
47335-928_d9f1a2ae-b089-400c-b9f5-e06b058d767d	47335-928	HUMAN PRESCRIPTION DRUG	risedronate sodium		risedronate sodium	TABLET, FILM COATED	ORAL	20140611		ANDA	ANDA090886	Sun Pharmaceutical Industries, Inc.	RISEDRONATE SODIUM HEMI-PENTAHYDRATE	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
47335-929_3f33dbae-6f6d-4863-8d02-cc8bd27bc795	47335-929	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20140213		ANDA	ANDA201742	Sun Pharmaceutical Industries, Inc.	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
47335-930_3f33dbae-6f6d-4863-8d02-cc8bd27bc795	47335-930	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20140213		ANDA	ANDA201742	Sun Pharmaceutical Industries, Inc.	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
47335-931_82d6bc45-04a5-409a-9223-da1884b2468f	47335-931	HUMAN PRESCRIPTION DRUG	vecuronium bromide		vecuronium bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20141215		ANDA	ANDA079001	Sun Pharmaceutical Industries, Inc.	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
47335-932_82d6bc45-04a5-409a-9223-da1884b2468f	47335-932	HUMAN PRESCRIPTION DRUG	vecuronium bromide		vecuronium bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20141215		ANDA	ANDA079001	Sun Pharmaceutical Industries, Inc.	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
47335-933_ab3baa8c-d041-4e72-bf0a-a5dbb15c0955	47335-933	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221225		ANDA	ANDA078737	Sun Pharmaceutical Industries, Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47335-934_ab3baa8c-d041-4e72-bf0a-a5dbb15c0955	47335-934	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221225		ANDA	ANDA078737	Sun Pharmaceutical Industries, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47335-935_ab3baa8c-d041-4e72-bf0a-a5dbb15c0955	47335-935	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION	INTRAMUSCULAR	20221225		ANDA	ANDA078737	Sun Pharmaceutical Industries, Inc.	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47335-936_2d16e44a-9d54-4c1a-ab3d-6265827b0435	47335-936	HUMAN PRESCRIPTION DRUG	leuprolide acetate		leuprolide acetate	KIT		20141215		ANDA	ANDA078885	Sun Pharmaceutical Industries, Inc.						N	20241231
47335-938_b2bdb49f-ef3d-467d-aa3b-d7ab72162f4b	47335-938	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		Azelastine Hydrochloride	SOLUTION/ DROPS	INTRAOCULAR	20100531		ANDA	ANDA078738	Sun Pharmaceutical Industries, Inc.	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47335-939_9a0d7b91-4324-4e19-9cd8-eb19266e771a	47335-939	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20201126		NDA	NDA022534	Sun Pharmaceutical Industries, Inc.	DOCETAXEL ANHYDROUS	160	mg/8mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
47335-943_4bfda9bf-5a78-47a6-9d71-48f3a080dc7e	47335-943	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA205031	Sun Pharmaceutical Industries, Inc.	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
47335-954_5054c941-5817-4666-b562-800de8be86b2	47335-954	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141225		ANDA	ANDA200695	Sun Pharmaceutical Industries, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
47335-956_d40e11c0-3d00-4493-8916-ffc48d1b60d4	47335-956	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111122		ANDA	ANDA079057	Sun Pharmaceutical Industries, Inc.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
47335-980_4bfda9bf-5a78-47a6-9d71-48f3a080dc7e	47335-980	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA205031	Sun Pharmaceutical Industries, Inc.	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
47335-984_a0b982dc-e829-436e-88c6-c2e77eac37f0	47335-984	HUMAN PRESCRIPTION DRUG	EZALLOR SPRINKLE		ROSUVASTATIN	CAPSULE	ORAL	20190504		NDA	NDA208647	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-985_a0b982dc-e829-436e-88c6-c2e77eac37f0	47335-985	HUMAN PRESCRIPTION DRUG	EZALLOR SPRINKLE		ROSUVASTATIN	CAPSULE	ORAL	20190504		NDA	NDA208647	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-986_a0b982dc-e829-436e-88c6-c2e77eac37f0	47335-986	HUMAN PRESCRIPTION DRUG	EZALLOR SPRINKLE		ROSUVASTATIN	CAPSULE	ORAL	20190504		NDA	NDA208647	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-987_a0b982dc-e829-436e-88c6-c2e77eac37f0	47335-987	HUMAN PRESCRIPTION DRUG	EZALLOR SPRINKLE		ROSUVASTATIN	CAPSULE	ORAL	20190504		NDA	NDA208647	Sun Pharmaceutical Industries, Inc.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
47335-992_efadcb55-f935-4c60-b2e2-0a76b9194b50	47335-992	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		magnesium sulfate heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20210801		ANDA	ANDA213917	Sun Pharmaceutical Industries, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
47335-993_30c23dd8-4214-4d45-afc2-95d36ca4674e	47335-993	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		metronidazole	INJECTION, SOLUTION	INTRAVENOUS	20210810		ANDA	ANDA212435	Sun Pharmaceutical Industries, Inc.	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
47335-994_d78b5354-95c8-4bba-99a5-9cb339735547	47335-994	HUMAN PRESCRIPTION DRUG	Winlevi		Clascoterone	CREAM	TOPICAL	20211004		NDA	NDA213433	Sun Pharmaceutical Industries, Inc.	CLASCOTERONE	1	g/100g	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
47426-101_495b6512-53e3-4b64-a08a-45958b08bfd0	47426-101	HUMAN PRESCRIPTION DRUG	SUSTOL		granisetron	INJECTION	SUBCUTANEOUS	20160809		NDA	NDA022445	Heron Therapeutics, Inc.	GRANISETRON	10	mg/.4mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
47426-201_a4cb8b73-5995-4bac-a0b2-df9119f896d9	47426-201	HUMAN PRESCRIPTION DRUG	CINVANTI		aprepitant	INJECTION, EMULSION	INTRAVENOUS	20180103		NDA	NDA209296	Heron Therapeutics, Inc.	APREPITANT	130	mg/18mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
47426-301_ecef2459-9a3e-4a90-b95b-75b94ead9cf1	47426-301	HUMAN PRESCRIPTION DRUG	ZYNRELEF		BUPIVACAINE and MELOXICAM	SOLUTION	INFILTRATION	20210701		NDA	NDA211988	Heron Therapeutics, Inc.	BUPIVACAINE; MELOXICAM	400; 12	mg/14mL; mg/14mL	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47426-302_ecef2459-9a3e-4a90-b95b-75b94ead9cf1	47426-302	HUMAN PRESCRIPTION DRUG	ZYNRELEF		BUPIVACAINE and MELOXICAM	SOLUTION	INFILTRATION	20210701		NDA	NDA211988	Heron Therapeutics, Inc.	BUPIVACAINE; MELOXICAM	300; 9	mg/10.5mL; mg/10.5mL	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47426-303_ecef2459-9a3e-4a90-b95b-75b94ead9cf1	47426-303	HUMAN PRESCRIPTION DRUG	ZYNRELEF		BUPIVACAINE and MELOXICAM	SOLUTION	INFILTRATION	20210701		NDA	NDA211988	Heron Therapeutics, Inc.	BUPIVACAINE; MELOXICAM	200; 6	mg/7mL; mg/7mL	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47426-304_ecef2459-9a3e-4a90-b95b-75b94ead9cf1	47426-304	HUMAN PRESCRIPTION DRUG	ZYNRELEF		BUPIVACAINE and MELOXICAM	SOLUTION	INFILTRATION	20210701		NDA	NDA211988	Heron Therapeutics, Inc.	BUPIVACAINE; MELOXICAM	60; 1.8	mg/2.3mL; mg/2.3mL	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47426-401_c6481359-0722-4eb7-ba2b-7d62a01ddbeb	47426-401	HUMAN PRESCRIPTION DRUG	APONVIE		APREPITANT	EMULSION	INTRAVENOUS	20230306		NDA	NDA216457	Heron Therapeutics, Inc.	APREPITANT	32	mg/4.4mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
47444-001_71b1c54e-ad10-4ebf-84cf-3972ec31a5a8	47444-001	HUMAN OTC DRUG	Salicylic Acid		Bosye Benefiting Hair Lotion	LOTION	TOPICAL	20090101		UNAPPROVED DRUG OTHER		Bejing Rimeng Biological Technology Co Ltd	SALICYLIC ACID	.5	g/60mL			N	20241231
47593-264_13ab8384-c4e0-4e40-86b0-60f5dcacc56d	47593-264	HUMAN OTC DRUG	Endure 300 Cida Rinse Gel	Antimicrobial Hand Rinse	Antiseptic handwash	SOLUTION	TOPICAL	19991122		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	70	mL/100mL			N	20241231
47593-275_d7ded465-43de-4a5d-8e0e-6d2ba21d38df	47593-275	HUMAN OTC DRUG	EcoCare 360		Benzalkonium	SOLUTION	TOPICAL	19990223		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	.1	mg/100mL			N	20241231
47593-305_b111925a-97d6-4ddc-b941-ebf6f47f8e37	47593-305	HUMAN OTC DRUG	DigiClean E		Triclosan	SOLUTION	TOPICAL	19990526		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	TRICLOSAN	3	mg/mL			N	20241231
47593-308_d0201181-ae00-4f30-b5dd-1a6e1fa3f6f4	47593-308	HUMAN OTC DRUG	DigiClean E		Chloroxylenol	SOLUTION	TOPICAL	19990526		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	1	mg/100mL			N	20241231
47593-341_4029e567-a194-4959-aa16-4a821606f944	47593-341	HUMAN OTC DRUG	Keystone		triclosan	SOLUTION	TOPICAL	20000726		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	TRICLOSAN	.3	mg/100mL			N	20241231
47593-359_ae1e06e6-f1cf-4dd2-8d0e-068ea26eb3bb	47593-359	HUMAN OTC DRUG	Keystone		Benzalkonium Chloride	SOLUTION	TOPICAL	20020726		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	.1	mg/100mL			N	20241231
47593-360_7bc16011-4425-435d-a9e8-095d7d79c56f	47593-360	HUMAN OTC DRUG	EcoCare 250		Triclosan	SOLUTION	TOPICAL	20020831		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	TRICLOSAN	3	mg/mL			N	20241231
47593-362_f658a380-3764-4766-a9c4-a1c3157ba3d2	47593-362	HUMAN OTC DRUG	EcoCare 270		Chloroxylenol	SOLUTION	TOPICAL	20020831		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	9	mg/mL			N	20241231
47593-363_dda01c25-1b79-408a-8d75-ada8c0c84a5c	47593-363	HUMAN OTC DRUG	EcoCare 350		Isopropyl Alcohol	SOLUTION	TOPICAL	20021226		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ISOPROPYL ALCOHOL	80	mL/100mL			N	20241231
47593-404_0dec3d17-c3c6-45db-b29f-963099e51e4b	47593-404	HUMAN OTC DRUG	DigiSan E		Benzalkonium chloride	SOLUTION	TOPICAL	20031104		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-406_935aa6d6-d058-459b-b895-0082e822a5b8	47593-406	HUMAN OTC DRUG	Clean Force		Ethyl Alcohol	SOLUTION	TOPICAL	20031027		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	60	mL/100mL			N	20241231
47593-463_65b68f17-3da5-46fb-8a76-44b3c0af756d	47593-463	HUMAN OTC DRUG	Scrub-Stat		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	Ecolab Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
47593-464_b91c9711-a915-40a6-830e-7ad492eab8b6	47593-464	HUMAN OTC DRUG	Scrub-Stat		Chlorhexidine gluconate	SOLUTION	TOPICAL	19860722		NDA	NDA019258	Ecolab Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
47593-465_e75fa36d-ef76-4f6d-8163-5c06de0a8a41	47593-465	HUMAN OTC DRUG	Ecolab	Keystone	Chloroxylenol	SOLUTION	TOPICAL	20100526		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	5	mg/mL			N	20241231
47593-466_57be4035-8037-4679-8d91-49c45bf55bf0	47593-466	HUMAN OTC DRUG	Keystone Liquid Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20100526		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	60	mL/100mL			N	20241231
47593-467_f5a13774-e84c-40e9-a922-cb97f8250482	47593-467	HUMAN OTC DRUG	Scrub-Stat		Chlorhexidine gluconate	SOLUTION	TOPICAL	20110303		NDA	NDA019258	Ecolab Inc.	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
47593-468_092b0488-aaad-43b1-81c7-d19be8947eb7	47593-468	HUMAN OTC DRUG	Scrub-Stat		Chlorhexidine gluconate	SOLUTION	TOPICAL	20110303		NDA	NDA019258	Ecolab Inc.	CHLORHEXIDINE GLUCONATE	40	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
47593-469_5d246f42-0fe2-4429-92c0-eb07c133dbd7	47593-469	HUMAN OTC DRUG	Ecolab		Triclosan	SOLUTION	TOPICAL	20110124		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	TRICLOSAN	3	mg/mL			N	20241231
47593-470_4374c02b-5062-4b3f-9c6f-0282bf93ec42	47593-470	HUMAN OTC DRUG	Foodservice Foam Hand Sanitizer		Benzalkonium chloride	SOLUTION	TOPICAL	20101208		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	.1	mg/100mL			N	20241231
47593-472_57d358ed-34ab-463b-a18f-2401a6fa03bc	47593-472	HUMAN OTC DRUG	Ecolab		Alcohol	SOLUTION	TOPICAL	20101116		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	62	mL/100mL			N	20241231
47593-473_ae8fc39f-5145-4458-8eed-0d0de37d84a9	47593-473	HUMAN OTC DRUG	Pureforce		Alcohol	SOLUTION	TOPICAL	20110427		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	60	mL/100mL			N	20241231
47593-477_fdbe5720-f0e4-4b23-893f-1a8c371f1422	47593-477	HUMAN OTC DRUG	Sysco	Reliance	Chloroxylenol	SOLUTION	TOPICAL	20110405		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	.5	mg/100mL			N	20241231
47593-478_0f15c1f5-8030-418b-b394-31c150ec3651	47593-478	HUMAN OTC DRUG	Reliance Hand Saniziter		Benzalkonium chloride	SOLUTION	TOPICAL	20110330		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	.1	mg/100mL			N	20241231
47593-479_53dc44c5-e4da-42c0-92aa-3c02a525e653	47593-479	HUMAN OTC DRUG	Sysco		chloroxylenol	SOLUTION	TOPICAL	20110331		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	.5	mg/100mL			N	20241231
47593-480_741a4128-dcb5-4b3b-bc6a-612cd8e4be92	47593-480	HUMAN OTC DRUG	Sysco Reliance		alcohol	SOLUTION	TOPICAL	20110401		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	60	mL/100mL			N	20241231
47593-487_83b12858-4f7f-4a56-bace-47f1a2c7d7d4	47593-487	HUMAN OTC DRUG	Ecolab		Alcohol	SOLUTION	TOPICAL	20121128		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	589.4	mg/mL			N	20241231
47593-488_3cd32307-5c34-4f90-899c-fff580db578f	47593-488	HUMAN OTC DRUG	Advanced Gel Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20121130		OTC MONOGRAPH DRUG	505G(a)(3)	Ecolab Inc.	ALCOHOL	70	mL/100mL			N	20241231
47593-489_515276db-4498-4ce2-8350-7ea61b7a0ea1	47593-489	HUMAN OTC DRUG	Ecolab		Ethyl Alcohol	SOLUTION	TOPICAL	20131207		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	620	mg/mL			N	20241231
47593-490_badb8f6e-9402-4447-94c0-ce5f55db6a3b	47593-490	HUMAN OTC DRUG	Quik-Care		Ethyl Alcohol	SOLUTION	TOPICAL	20121010		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	54.7	g/100g			N	20241231
47593-491_56965145-e0f9-43b5-8efd-e1c9dcd10b1f	47593-491	HUMAN OTC DRUG	Quik-Care		Ethyl Alcohol	SOLUTION	TOPICAL	20130619		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	539.71	mg/mL			N	20241231
47593-493_2454eaac-1c72-422b-9beb-3e98c35653b8	47593-493	HUMAN OTC DRUG	EcoCare 275		Chloroxylenol	SOLUTION	TOPICAL	20160622		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	100	mg/mL			N	20241231
47593-498_7d0cebe8-8022-49da-b811-2be993855417	47593-498	HUMAN OTC DRUG	PureForce		Alcohol	SOLUTION	TOPICAL	20120823		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	534	mg/mL			N	20241231
47593-500_b241329d-641a-4ee7-9668-106030856830	47593-500	HUMAN OTC DRUG	Quik-Care		Alcohol	SOLUTION	TOPICAL	20130201		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	539.4	mg/mL			N	20241231
47593-501_3f084139-0d3b-49f0-97c9-a0ce7e386c01	47593-501	HUMAN OTC DRUG	Ecolab		Chloroxylenol	SOLUTION	TOPICAL	20121024		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	5.2	mg/mL			N	20241231
47593-502_b6a9a83d-63c1-42dc-8898-f30a07f6824c	47593-502	HUMAN OTC DRUG	Ecolab		Alcohol	SOLUTION	TOPICAL	20130326		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	598.5	mg/mL			N	20241231
47593-503_db9830ba-4faa-4f49-b6ac-879f4db52b35	47593-503	HUMAN OTC DRUG	Ecolab Inc.		Chloroxylenol	LIQUID	TOPICAL	20131027		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	5	mg/mL			N	20241231
47593-504_10f40864-fc35-4c79-a366-c25647789af4	47593-504	HUMAN OTC DRUG	Pure Force		Benzalkonium chloride	LIQUID	TOPICAL	20131028		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-506_8074fbe1-10d7-480b-aa39-91b532e6b70a	47593-506	HUMAN OTC DRUG	Ecolab		Chloroxylenol	LIQUID	TOPICAL	20140321		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	10	mg/mL			N	20241231
47593-507_6bf567de-2c5d-4a5c-848d-b379ff7bb0bd	47593-507	HUMAN OTC DRUG	Ecolab		Alcohol	LIQUID	TOPICAL	20131031		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	60	mL/100mL			N	20241231
47593-508_fd6c9591-d469-41b6-880c-d9c4a7d0a67a	47593-508	HUMAN OTC DRUG	Ecolab	Facilipro	Alcohol	LIQUID	TOPICAL	20140202		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	60	mL/100mL			N	20241231
47593-509_85d7ceff-0217-4b12-816b-ec3ddcb149fe	47593-509	HUMAN OTC DRUG	Ecolab		Alcohol	LIQUID	TOPICAL	20140305		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	700	mg/mL			N	20241231
47593-511_0bbfdd08-77ae-4071-8a4b-c434cef6ac01	47593-511	HUMAN OTC DRUG	Ecolab Inc.		Benzalkonium chloride	SOLUTION	TOPICAL	20150226		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	8.9	mg/mL			N	20241231
47593-512_62364e80-8880-4523-a2c8-1e91afc79320	47593-512	HUMAN OTC DRUG	Ecolab Inc.		Benzalkonium chloride	SOLUTION	TOPICAL	20150302		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	8.9	mg/mL			N	20241231
47593-513_3f5f4a52-4eb8-48f1-a57c-faa3bd6a8a46	47593-513	HUMAN OTC DRUG	Ecolab Inc.		Benzalkonium chloride	SOLUTION	TOPICAL	20150226		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	8.9	mg/mL			N	20241231
47593-514_9464c589-170a-4f14-b7bb-dd2517fbe9da	47593-514	HUMAN OTC DRUG	Ecolab Inc.		Benzalkonium chloride	SOLUTION	TOPICAL	20150302		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	8.9	mg/mL			N	20241231
47593-515_6ffecb5d-d138-4fef-8801-2d2548c5617a	47593-515	HUMAN OTC DRUG	Ecolab Clean Force		Chloroxylenol	SOLUTION	TOPICAL	20150803		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	5	mg/mL			N	20241231
47593-521_d4ca2dbb-4f28-4113-ae4a-42b01d3b6cde	47593-521	HUMAN OTC DRUG	Ecolab		Benzalkonium chloride	SOLUTION	TOPICAL	20140915		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5.5	mg/mL			N	20241231
47593-532_947a7fdd-ca7d-4c42-880a-2133dc9b6d25	47593-532	HUMAN OTC DRUG	Ecolab		Benzalkonium chloride	SOLUTION	TOPICAL	20160428		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5.5	mg/mL			N	20241231
47593-543_fbd40e6a-5b95-40ef-a1b3-6936148f6c58	47593-543	HUMAN OTC DRUG	Advanced Antibacterial Foaming Hand Soap		Benzalkonium Chloride	SOLUTION	TOPICAL	20150812		OTC MONOGRAPH DRUG	505G(a)(3)	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-561_10c9cda4-4725-41ab-9a46-38569a492732	47593-561	HUMAN OTC DRUG	Keystone		Benzalkonium Chloride	SOLUTION	TOPICAL	20161221		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-563_51ff219c-cdbb-4495-8828-47fc99e4332f	47593-563	HUMAN OTC DRUG	Facilipro		Ethyl Alcohol	SOLUTION	TOPICAL	20101203		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	620	mg/mL			N	20241231
47593-565_9c971f6d-42fe-4563-b650-badedb8bdd1b	47593-565	HUMAN OTC DRUG	Facilipro		Benzalkonium chloride	SOLUTION	TOPICAL	20160329		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5.5	mg/mL			N	20241231
47593-566_c200fe86-abf5-4622-b669-d4d8f63358bd	47593-566	HUMAN OTC DRUG	Facilipro		Benzalkonium Chloride	SOLUTION	TOPICAL	20160523		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-567_e7222f32-fed4-4ba0-8c98-5d15de8456cf	47593-567	HUMAN OTC DRUG	PureForce		Benzalkonium chloride	SOLUTION	TOPICAL	20160614		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-568_5fbcbdca-f3b3-4225-bba5-39739a7a4b98	47593-568	HUMAN OTC DRUG	PureForce		Benzalkonium Chloride	SOLUTION	TOPICAL	20160726		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-571_306e08f0-eb04-4c4c-b0b7-b1c040ba63fe	47593-571	HUMAN OTC DRUG	PureForce		Chloroxylenol	SOLUTION	TOPICAL	20160727		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	5	mg/mL			N	20241231
47593-572_671c2e7c-14a5-41b9-95e7-455f81372814	47593-572	HUMAN OTC DRUG	Members Mark		Benzalkonium Chloride	SOLUTION	TOPICAL	20160729		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-573_07087ad6-ec13-4677-997a-dae07194da58	47593-573	HUMAN OTC DRUG	Members Mark		Chloroxylenol	SOLUTION	TOPICAL	20160728		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	CHLOROXYLENOL	5	mg/mL			N	20241231
47593-575_987398a4-434c-4b8c-bb86-c08a7a41acf2	47593-575	HUMAN OTC DRUG	Advanced Antibacterial Clean and Smooth		Benzalkonium chloride	SOLUTION	TOPICAL	20170525		OTC MONOGRAPH DRUG	505G(a)(3)	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-576_250bfa9a-7565-49e0-84e9-30d37022dc0d	47593-576	HUMAN OTC DRUG	Swisher		Benzalkonium chloride	SOLUTION	TOPICAL	20160908		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-581_3ec296d6-278a-465d-9957-0ed4adfb8553	47593-581	HUMAN OTC DRUG	Ecolab		Benzalkonium chloride	SOLUTION	TOPICAL	20170518		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-582_a4d38793-d365-44b2-9eea-4fec8ff3067e	47593-582	HUMAN OTC DRUG	Equi-Mild		Benzalkonium Chloride	SOLUTION	TOPICAL	20170622		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-584_efb4e796-7214-4491-8ab5-c2513c208d20	47593-584	HUMAN OTC DRUG	Clean Force		Benzalkonium Chloride	SOLUTION	TOPICAL	20170630		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-585_ae073f3f-933e-47d3-b493-693dbf4bc436	47593-585	HUMAN OTC DRUG	Equi-Stat		Benzalkonium chloride	SOLUTION	TOPICAL	20171220		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-586_dbba121e-f9fd-4444-aaec-d7029816ecbf	47593-586	HUMAN OTC DRUG	Clean Force		Benzalkonium chloride	LIQUID	TOPICAL	20171220		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-591_7b66083b-c3e0-4727-9160-55d16bd9c151	47593-591	HUMAN OTC DRUG	Swisher		Benzalkonium Chloride	SOLUTION	TOPICAL	20180620		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-592_007c812c-824d-40f2-ae79-695bc8757906	47593-592	HUMAN OTC DRUG	Swisher		Benzalkonium chloride	LIQUID	TOPICAL	20180615		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-593_8d999000-919f-4867-979d-8480a6e5ff14	47593-593	HUMAN OTC DRUG	Ecolab		Benzalkonium Chloride	SOLUTION	TOPICAL	20180516		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5.5	mg/mL			N	20241231
47593-594_fa375333-8e87-4db0-a1b1-d83f3fefa3a5	47593-594	HUMAN OTC DRUG	Keystone		Benzalkonium chloride	SOLUTION	TOPICAL	20180906		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-595_327005f8-f49f-4468-b1b7-5c8d0877252f	47593-595	HUMAN OTC DRUG	Keystone		Benzalkonium Chloride	SOLUTION	TOPICAL	20180920		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-601_65a263b5-902d-422f-909f-8f99acfff70a	47593-601	HUMAN OTC DRUG	Swisher TF		Benzalkonium Chloride	SOLUTION	TOPICAL	20190115		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
47593-602_e8822cdf-6cc6-4dc2-bb6f-a4c86c42c2a5	47593-602	HUMAN OTC DRUG	PROCLEAN		Benzalkonium Chloride	SOLUTION	TOPICAL	20181029		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-611_77995cd3-c024-4f41-966c-4f33e9b4d768	47593-611	HUMAN OTC DRUG	Protecting FHS		Alcohol	SOLUTION	TOPICAL	20190918		OTC MONOGRAPH NOT FINAL	part333E	Ecolab	ALCOHOL	73.8	mL/mL			N	20241231
47593-612_1a12accf-a7d4-4ffb-9fd7-b70f8fb78938	47593-612	HUMAN OTC DRUG	Facilipro Protecting FHS		Alcohol	SOLUTION	TOPICAL	20190918		OTC MONOGRAPH NOT FINAL	part333E	Ecolab	ALCOHOL	73.8	mL/mL			N	20241231
47593-613_16c183b4-c09c-49a8-b990-b126da090380	47593-613	HUMAN OTC DRUG	Ecolab		Benzalkonium Chloride	SOLUTION	TOPICAL	20190619		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-617_224b26af-5c98-446a-b087-a753f97d9d2e	47593-617	HUMAN OTC DRUG	DigiSan		Alcohol	SOLUTION	TOPICAL	20010110	20250125	OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	.547	mg/mg			N	
47593-618_41004450-fab2-44df-9341-15d80042fef5	47593-618	HUMAN OTC DRUG	DigiSan		Alcohol	AEROSOL, FOAM	TOPICAL	20031031		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	.547	mg/mg			N	20241231
47593-624_e6e4d1a8-ad09-4d4a-87cc-d869d6fe4f39	47593-624	HUMAN OTC DRUG	Alcohol Antiseptic 80% Topical Solution		Alcohol	SOLUTION	TOPICAL	20200414	20240331	OTC MONOGRAPH NOT FINAL	part333A	Ecolab Inc.	ALCOHOL	80	L/100L			N	
47593-635_69bdd789-efdb-4180-a960-5fc04c33ddba	47593-635	HUMAN OTC DRUG	Ecolab Gel Hand Sanitizer LS		Alcohol	SOLUTION	TOPICAL	20200413		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	67	mL/100mL			N	20241231
47593-636_d52ce692-c540-4e26-b815-a9cb1e21ea4b	47593-636	HUMAN OTC DRUG	Ecolab Advanced Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200717		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	70	mL/100mL			N	20241231
47593-637_918e5310-fb5a-4bad-b1d2-5c2220b78906	47593-637	HUMAN OTC DRUG	Ecolab Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200723		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	70	mL/100mL			N	20241231
47593-638_cdc68a10-17da-47f7-a28e-87ea327c1db1	47593-638	HUMAN OTC DRUG	ECOLAB CLEAR		Alcohol	LIQUID	TOPICAL	20210426		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	ALCOHOL	60	mL/100mL			N	20241231
47593-645_1faad659-7d82-4e2e-969d-baf9da8fdb6a	47593-645	HUMAN OTC DRUG	Proclean Foaming Antibacterial Nexa		Benzalkonium Chloride	SOLUTION	TOPICAL	20220302		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47593-646_8abe5c3a-59f1-4cd8-a79b-4b86d32b0e85	47593-646	HUMAN OTC DRUG	EcoCare 280		Benzalkonium chloride	SOLUTION	TOPICAL	20220207		OTC MONOGRAPH NOT FINAL	part333E	Ecolab Inc.	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
47632-0003_d830ba02-37cc-47e7-b83f-40c88b529cab	47632-0003	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19881215		NDA	NDA205766	O.E. Meyer Company	NITROGEN	99	L/100L			N	20241231
47632-0025_fc29f4ac-16da-4bf3-a51f-bd9bb1feb8a4	47632-0025	HUMAN PRESCRIPTION DRUG	AIR COMPRESSED		AIR COMPRESSED	GAS	RESPIRATORY (INHALATION)	19881215		NDA	NDA205765	O.E. Meyer Company	OXYGEN	20	L/100L			N	20241231
47632-0029_ed65568b-29b9-46d0-976e-4e426b8e47a6	47632-0029	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19881215		NDA	NDA205767	O.E. Meyer Company	OXYGEN	99	L/100L			N	20241231
47632-0030_ed65568b-29b9-46d0-976e-4e426b8e47a6	47632-0030	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19881215		NDA	NDA205767	O.E. Meyer Company	OXYGEN	99	L/100L			N	20241231
47649-1201_f3ace331-4bc8-0b32-e053-2995a90a8823	47649-1201	HUMAN OTC DRUG	Dr.Whitiss 20%		CARBAMIDE PEROXIDE	GEL, DENTIFRICE	DENTAL	20150607		OTC MONOGRAPH NOT FINAL	part356	Nibec Co., Ltd	CARBAMIDE PEROXIDE	20	g/100g			N	20241231
47649-1401_f3ac966f-c614-3898-e053-2995a90a49c4	47649-1401	HUMAN OTC DRUG	Dr.Whitiss 15%		CARBAMIDE PEROXIDE, SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20150607		OTC MONOGRAPH NOT FINAL	part356	NIBEC Co., Ltd.	CARBAMIDE PEROXIDE; SODIUM FLUORIDE	150; 2.5	mg/g; mg/g			N	20241231
47682-001_f78351e2-3659-b295-e053-6394a90a6e2e	47682-001	HUMAN OTC DRUG	Green Guard Advanced Sinus Relief		ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-002_f793cdb3-9fc5-79e1-e053-6394a90ae08b	47682-002	HUMAN OTC DRUG	Green Guard Advanced Sinus Relief		ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20081230	20240701	OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
47682-003_f561711b-0111-2650-e053-2995a90a3be4	47682-003	HUMAN OTC DRUG	Green Guard Pain and Ache Relief		ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE	TABLET	ORAL	20081230	20240301	OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE	110; 162; 32.4; 152	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
47682-009_f794e775-23b7-8611-e053-6294a90ae616	47682-009	HUMAN OTC DRUG	Green Guard Maximum Non-Aspirin		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-017_da4514d5-0998-0f9e-e053-2a95a90adfd0	47682-017	HUMAN OTC DRUG	Green Guard Allergy 2 Relief		PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-018_da456b1e-c70b-984f-e053-2a95a90a3753	47682-018	HUMAN OTC DRUG	Green Guard Cough Drop Relief		Menthol	LOZENGE	ORAL	20111101		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	7.6	mg/1			N	20241231
47682-037_ebf3deb7-0831-d81b-e053-2a95a90ae3be	47682-037	HUMAN OTC DRUG	Belmora Flanax		Naproxen Sodium	TABLET, FILM COATED	ORAL	20081230		ANDA	ANDA079096	Unifirst First Aid Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-040_ec6bd5e6-9e7a-4f1a-e053-2a95a90a2a4f	47682-040	HUMAN OTC DRUG	Green Guard Honey Lemon Cough Drop		Menthol 8.6 mg	LOZENGE	ORAL	20190701		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	8.6	mg/1			N	20241231
47682-050_f704c707-a66a-d962-e053-6294a90a15dd	47682-050	HUMAN OTC DRUG	MEDIQUE Medikoff Drops		MENTHOL	LOZENGE	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	7.6	mg/1			N	20241231
47682-108_efa796e8-62a5-6c20-e053-2a95a90aef6f	47682-108	HUMAN OTC DRUG	Medique Cold Cough Product		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl ,	TABLET, FILM COATED	ORAL	20220926		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-110_f7a5b544-e21d-e6cf-e053-6294a90a681c	47682-110	HUMAN OTC DRUG	Medique Sugar Free Medikoff Drops		Menthol	LOZENGE	ORAL	20111101		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	5.8	mg/1			N	20241231
47682-120_da833cb5-92ec-28a6-e053-2995a90a8315	47682-120	HUMAN OTC DRUG	Medique Medicidin D		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-135_0bc88fc0-ce9b-13b4-e063-6394a90a61c1	47682-135	HUMAN OTC DRUG	Medique Medi Seltzer		aspirin, citric acid, sodium bicarbonate	TABLET, EFFERVESCENT	ORAL	20081230		OTC MONOGRAPH DRUG	M013	Unifirst First Aid Corporation	ASPIRIN; CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE	325; 1000; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-145_f188085b-61de-21c1-e053-2a95a90aff97	47682-145	HUMAN OTC DRUG	MEDIQUE APAP		Acetaminophen	TABLET, COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	325	mg/1			N	20241231
47682-161_da45030a-aa85-5d9d-e053-2a95a90a4cb2	47682-161	HUMAN OTC DRUG	Medique Medi-Phenyl		PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-162_da45030a-aa85-5d9d-e053-2a95a90a4cb2	47682-162	HUMAN OTC DRUG	Dover Sudanyl PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-166_da6d6132-2796-2bb8-e053-2995a90ae5e0	47682-166	HUMAN OTC DRUG	Medique at Home Diphen		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210201		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47682-167_da445fa6-f486-8210-e053-2995a90ae205	47682-167	HUMAN OTC DRUG	Medique Diphen		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120101		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
47682-170_f77c9554-d1c3-1682-e053-6294a90ac572	47682-170	HUMAN OTC DRUG	Green Guard Maximum Strength Non-Aspirin		Acetaminophen	TABLET	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-172_f77f8ef5-4aa9-fa80-e053-6394a90a70c2	47682-172	HUMAN OTC DRUG	Medique Extra Strength APAP		Acetaminophen	TABLET	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-173_f77f8ef5-4aa9-fa80-e053-6394a90a70c2	47682-173	HUMAN OTC DRUG	Medi-First Extra Strength Non Aspirin		Acetaminophen	TABLET	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-174_f77f8ef5-4aa9-fa80-e053-6394a90a70c2	47682-174	HUMAN OTC DRUG	Medi-First Plus Extra Strength Non Aspirin		Acetaminophen	TABLET	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-175_f7a66ce8-7a28-9b8f-e053-6394a90a6db8	47682-175	HUMAN OTC DRUG	MEDIQUE APAP Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-201_ded30d4a-d38e-4a8a-e053-2995a90a65c5	47682-201	HUMAN OTC DRUG	Medique Alcalak		calcium carbonate	TABLET, CHEWABLE	ORAL	20140615		OTC MONOGRAPH FINAL	part331	Unifirst First Aid Corporation	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
47682-203_f98c7ced-13a2-d2e6-e053-6394a90a645b	47682-203	HUMAN OTC DRUG	MEDIQUE Loradamed		Loratadine	TABLET, FILM COATED	ORAL	20081230		ANDA	ANDA076134	Unifirst First Aid Corporation	LORATADINE	10	mg/1			N	20241231
47682-210_de59b6e2-9822-6895-e053-2995a90afe06	47682-210	HUMAN OTC DRUG	Medique Diotame		BISMUTH SUBSALICYLATE	TABLET, CHEWABLE	ORAL	20140401		OTC MONOGRAPH FINAL	part335	Unifirst First Aid Corporation	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
47682-285_e39dc218-767c-8af4-e053-2a95a90ad2ab	47682-285	HUMAN OTC DRUG	Medique Ban-acid	Maximum Strength 750	calcium carbonate	TABLET, CHEWABLE	ORAL	20140701		OTC MONOGRAPH FINAL	part331	Unifirst First Aid Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
47682-303_f188085b-61de-21c1-e053-2a95a90aff97	47682-303	HUMAN OTC DRUG	Dover Aminophen		Acetaminophen	TABLET, COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	325	mg/1			N	20241231
47682-331_f5d6ee54-1fa1-c87b-e053-2a95a90a14ec	47682-331	HUMAN OTC DRUG	Medi-First Alcohol Wipes		Isopropyl Alcohol, 70%	SWAB	TOPICAL	20200701	20250401	OTC MONOGRAPH NOT FINAL	part333A	Unifirst First Aid Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	
47682-345_f3baf4c9-080a-a258-e053-2a95a90ae1a7	47682-345	HUMAN OTC DRUG	Mediqe Medi-Mucus		Dextromethorphan HBr, Guaifenesin	TABLET	ORAL	20190603	20240701	OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
47682-391_02ab23d4-85d0-495c-e063-6294a90a0543	47682-391	HUMAN OTC DRUG	Green Guard Triple Antibiotic		bacitracin zinc, neomycin sulfate, polymyxin b sulfate	OINTMENT	TOPICAL	20180604	20240331	OTC MONOGRAPH FINAL	part333B	Unifirst First Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
47682-403_f98a45fd-cda9-4884-e053-6294a90a57b5	47682-403	HUMAN OTC DRUG	Medique Loradamed		Loratadine	TABLET	ORAL	20230601		ANDA	ANDA210722	Unifirst First Aid Corporation	LORATADINE	10	mg/1			N	20241231
47682-406_da590e4a-9848-687e-e053-2995a90a16ec	47682-406	HUMAN OTC DRUG	Medi-First Pep-T-Med		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20111201		OTC MONOGRAPH FINAL	part335	Unifirst First Aid Corporation	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
47682-432_f3bb862a-9cb9-f644-e053-2a95a90a5f4f	47682-432	HUMAN OTC DRUG	Medique Medi-Mucus		Dextromethorphan HBr, Guaifenesin	TABLET	ORAL	20230501		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
47682-433_fda4845b-0eea-472a-e053-6294a90a9767	47682-433	HUMAN OTC DRUG	Medique at Home APAP Extra Strength		Acetaminophen 500 mg	TABLET, FILM COATED	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-434_f5d84b66-9a75-0b52-e053-2995a90a8eb6	47682-434	HUMAN OTC DRUG	Medique at Home APAP		Acetaminophen	TABLET, COATED	ORAL	20210401		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	325	mg/1			N	20241231
47682-509_f264ee6b-f293-2000-e053-2995a90ad005	47682-509	HUMAN OTC DRUG	Otis Clapp Mygrex		ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-533_b5a469c1-9ab5-5bd7-e053-2995a90a86d1	47682-533	HUMAN OTC DRUG	Medique at Home Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-543_da833cb5-92ec-28a6-e053-2995a90a8315	47682-543	HUMAN OTC DRUG	Otis Clapp Valihist		ACETAMINOPHEN,CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-600_f212bb08-0562-050e-e053-2a95a90a0866	47682-600	HUMAN OTC DRUG	Medique Iprin		Ibuprofen	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA075010	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-608_f212bb08-0562-050e-e053-2a95a90a0866	47682-608	HUMAN OTC DRUG	Medi-First Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA075010	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-609_f212bb08-0562-050e-e053-2a95a90a0866	47682-609	HUMAN OTC DRUG	Medi-First Plus Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA075010	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-611_029524b2-5ac3-392f-e063-6394a90ac963	47682-611	HUMAN OTC DRUG	Medi-First Hydrocortisone		1 % Hydrocortisone	CREAM	TOPICAL	20200101	20241201	OTC MONOGRAPH NOT FINAL	part348	Unifirst First Aid Corporation	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
47682-614_f212bb08-0562-050e-e053-2a95a90a0866	47682-614	HUMAN OTC DRUG	Dover Addaprin		Ibuprofen	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA075010	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-616_f175268b-741b-e9ad-e053-2995a90ad2ea	47682-616	HUMAN OTC DRUG	Medique Products Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200720		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-617_f175268b-741b-e9ad-e053-2995a90ad2ea	47682-617	HUMAN OTC DRUG	Medi-First Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200720		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-618_f175268b-741b-e9ad-e053-2995a90ad2ea	47682-618	HUMAN OTC DRUG	Medi-First Plus Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200720		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-620_f175268b-741b-e9ad-e053-2995a90ad2ea	47682-620	HUMAN OTC DRUG	Medique Products Aspirin		Aspirin	TABLET, COATED	ORAL	20210104		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-621_f175268b-741b-e9ad-e053-2995a90ad2ea	47682-621	HUMAN OTC DRUG	Medi-First Aspirin		Aspirin	TABLET, COATED	ORAL	20210104		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-622_f175268b-741b-e9ad-e053-2995a90ad2ea	47682-622	HUMAN OTC DRUG	Medi-First Plus Aspirin		Aspirin	TABLET, COATED	ORAL	20210104		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
47682-633_029524b2-5ac3-392f-e063-6394a90ac963	47682-633	HUMAN OTC DRUG	Medi-First Plus Hydrocortisone		1 % Hydrocortisone	CREAM	TOPICAL	20200101	20241201	OTC MONOGRAPH NOT FINAL	part348	Unifirst First Aid Corporation	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
47682-700_f2129bde-d0c0-b403-e053-2a95a90a5b1d	47682-700	HUMAN OTC DRUG	Medique Iprin		Ibuprofen	TABLET, COATED	ORAL	20170126		ANDA	ANDA079174	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-709_f2129bde-d0c0-b403-e053-2a95a90a5b1d	47682-709	HUMAN OTC DRUG	Medi-First Plus Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170126		ANDA	ANDA079174	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-714_f2129bde-d0c0-b403-e053-2a95a90a5b1d	47682-714	HUMAN OTC DRUG	Dover Addaprin		Ibuprofen	TABLET, COATED	ORAL	20170126		ANDA	ANDA079174	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-718_f2129bde-d0c0-b403-e053-2a95a90a5b1d	47682-718	HUMAN OTC DRUG	Medi-First Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170126		ANDA	ANDA079174	Unifirst First Aid Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47682-723_f7831900-33d3-b4db-e053-6394a90a0254	47682-723	HUMAN OTC DRUG	Medi First Plus PMS Relief		Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET, COATED	ORAL	20220926		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
47682-803_f188085b-61de-21c1-e053-2a95a90aff97	47682-803	HUMAN OTC DRUG	MEDI-FIRST Non-Aspirin		Acetaminophen	TABLET, COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	325	mg/1			N	20241231
47682-804_f7a66ce8-7a28-9b8f-e053-6394a90a6db8	47682-804	HUMAN OTC DRUG	MEDI-FIRST Non-Aspirin Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-809_da556d22-e560-f4a8-e053-2995a90afcdd	47682-809	HUMAN OTC DRUG	Medi-First Sinus Decongestant		PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-811_f5633c0d-bcef-b9f6-e053-2a95a90a9353	47682-811	HUMAN OTC DRUG	Medi First Pain Relief		ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE	TABLET	ORAL	20081230	20240301	OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE	110; 162; 32.4; 152	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
47682-815_f704c707-a66a-d962-e053-6294a90a15dd	47682-815	HUMAN OTC DRUG	MEDI-FIRST Cherry Cough Drops		MENTHOL	LOZENGE	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	7.6	mg/1			N	20241231
47682-819_f264ee6b-f293-2000-e053-2995a90ad005	47682-819	HUMAN OTC DRUG	Medi First Sinus Pain and Pressure		ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-820_ded30d4a-d38e-4a8a-e053-2995a90a65c5	47682-820	HUMAN OTC DRUG	Medi-First Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20140615		OTC MONOGRAPH FINAL	part331	Unifirst First Aid Corporation	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
47682-823_f7831900-33d3-b4db-e053-6394a90a0254	47682-823	HUMAN OTC DRUG	Medi First PMS Relief		Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET, COATED	ORAL	20220926		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
47682-840_da454739-60b3-28ae-e053-2a95a90a84ed	47682-840	HUMAN OTC DRUG	Medi-First Honey Lemon Cough Drops		Menthol 8.6 mg	LOZENGE	ORAL	20190318		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	8.6	mg/1			N	20241231
47682-841_da454739-60b3-28ae-e053-2a95a90a84ed	47682-841	HUMAN OTC DRUG	Medi-First Plus Honey Lemon Cough Drops		Menthol 8.6 mg	LOZENGE	ORAL	20190318		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	8.6	mg/1			N	20241231
47682-850_e6866c9f-b303-4892-e053-2995a90ac773	47682-850	HUMAN OTC DRUG	Green Guard Maximum Strength Stomach Relief		Calcium Carbonate 750 mg	TABLET, CHEWABLE	ORAL	20180409		OTC MONOGRAPH FINAL	part331	Unifirst First Aid Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
47682-859_da5b0190-06c5-5f11-e053-2995a90af073	47682-859	HUMAN OTC DRUG	Medique Medi-lax Enteric Coated		Bisacodyl 5 mg	TABLET, SUGAR COATED	ORAL	20200701		OTC MONOGRAPH NOT FINAL	part334	Unifirst First Aid Corporation	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
47682-903_f188085b-61de-21c1-e053-2a95a90aff97	47682-903	HUMAN OTC DRUG	Medi First Plus Non-Aspirin		Acetaminophen	TABLET, COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	325	mg/1			N	20241231
47682-904_f7a66ce8-7a28-9b8f-e053-6394a90a6db8	47682-904	HUMAN OTC DRUG	Medi First Plus Non-Aspirin Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
47682-911_f5633c0d-bcef-b9f6-e053-2a95a90a9353	47682-911	HUMAN OTC DRUG	Medi First Plus Pain Zapper		ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE	TABLET	ORAL	20081230	20240301	OTC MONOGRAPH NOT FINAL	part343	Unifirst First Aid Corporation	ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE	110; 162; 32.4; 152	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
47682-912_f98a45fd-cda9-4884-e053-6294a90a57b5	47682-912	HUMAN OTC DRUG	Medi-First Plus Allery Relief		Loratadine	TABLET	ORAL	20230601		ANDA	ANDA210722	Unifirst First Aid Corporation	LORATADINE	10	mg/1			N	20241231
47682-913_f98c7ced-13a2-d2e6-e053-6394a90a645b	47682-913	HUMAN OTC DRUG	Medi First Plus Allergy Relief		Loratadine	TABLET, FILM COATED	ORAL	20190423		ANDA	ANDA076134	Unifirst First Aid Corporation	LORATADINE	10	mg/1			N	20241231
47682-915_f704c707-a66a-d962-e053-6294a90a15dd	47682-915	HUMAN OTC DRUG	Medi First Plus Cherry Cough Drops		MENTHOL	LOZENGE	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	MENTHOL	7.6	mg/1			N	20241231
47682-919_f264ee6b-f293-2000-e053-2995a90ad005	47682-919	HUMAN OTC DRUG	Medi First Plus Sinus Pain and Pressure		ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20081230		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47682-920_ded30d4a-d38e-4a8a-e053-2995a90a65c5	47682-920	HUMAN OTC DRUG	Medi-First Plus Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20140615		OTC MONOGRAPH FINAL	part331	Unifirst First Aid Corporation	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
47682-980_f2b46d69-1c22-5ae9-e053-2a95a90a60a9	47682-980	HUMAN OTC DRUG	Medi-First Hydrocortisone 1%		Hydrocortisone acetate 1%	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Unifirst First Aid Corporation	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47682-981_f2b46d69-1c22-5ae9-e053-2a95a90a60a9	47682-981	HUMAN OTC DRUG	Medi-First Plus Hydrocortisone 1%		Hydrocortisone acetate 1%	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Unifirst First Aid Corporation	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47682-982_f2f0a1da-3e34-3c1a-e053-2a95a90a12b1	47682-982	HUMAN OTC DRUG	Medi-First Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230401		OTC MONOGRAPH FINAL	part333B	Unifirst First Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
47682-983_f2f0a1da-3e34-3c1a-e053-2a95a90a12b1	47682-983	HUMAN OTC DRUG	Medi-First Plus Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230401		OTC MONOGRAPH FINAL	part333B	Unifirst First Aid Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
47682-984_f2b7e1c4-636a-9efa-e053-2a95a90a8212	47682-984	HUMAN OTC DRUG	Medi-First Burn with Lidocaine		Benzalkonium Chloride, Lidocaine	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Unifirst First Aid Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
47682-985_f2b7e1c4-636a-9efa-e053-2a95a90a8212	47682-985	HUMAN OTC DRUG	Medi-First Plus Burn with Lidocaine		Benzalkonium Chloride, Lidocaine	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Unifirst First Aid Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
47682-990_da556d22-e560-f4a8-e053-2995a90afcdd	47682-990	HUMAN OTC DRUG	Medi-First Plus Sinus Decongestant		PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190418		OTC MONOGRAPH FINAL	part341	Unifirst First Aid Corporation	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
47781-011_2b748b0b-6f80-c404-d9a2-c58ca79834c4	47781-011	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL; SUBLINGUAL	20220307		UNAPPROVED DRUG OTHER		Alvogen Inc.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
47781-012_007ca0f4-9e3b-e225-f22f-4ad3571caec8	47781-012	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20220307		UNAPPROVED DRUG OTHER		Alvogen Inc.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
47781-013_bd14d323-7176-abaf-caa5-e3cb4841023e	47781-013	HUMAN PRESCRIPTION DRUG	hyoscyamine sulfate		hyoscyamine sulfate	TABLET	ORAL	20220126		UNAPPROVED DRUG OTHER		Alvogen Inc.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
47781-014_a62c7c6b-59e3-2426-d799-802d5b276ce9	47781-014	HUMAN PRESCRIPTION DRUG	hyoscyamine sulfate		hyoscyamine sulfate	TABLET, EXTENDED RELEASE	ORAL	20220131		UNAPPROVED DRUG OTHER		Alvogen Inc.	HYOSCYAMINE SULFATE	.375	mg/1			N	20241231
47781-103_a9a34956-2167-670a-da19-9fa3689b09b1	47781-103	HUMAN PRESCRIPTION DRUG	IBANDRONATE SODIUM		IBANDRONATE SODIUM	TABLET	ORAL	20140501		ANDA	ANDA078998	Alvogen Inc.	IBANDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
47781-104_128c6398-d4c5-f537-c829-cab235306889	47781-104	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	CREAM	VAGINAL	20180305		ANDA	ANDA209767	Alvogen Inc.	ESTRADIOL HEMIHYDRATE	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
47781-153_74bb33fa-a1b3-156a-b6b2-f60275e04c7f	47781-153	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150311		NDA AUTHORIZED GENERIC	NDA020353	Alvogen Inc.	NAPROXEN SODIUM	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47781-154_74bb33fa-a1b3-156a-b6b2-f60275e04c7f	47781-154	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150311		NDA AUTHORIZED GENERIC	NDA020353	Alvogen Inc.	NAPROXEN SODIUM	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47781-155_74bb33fa-a1b3-156a-b6b2-f60275e04c7f	47781-155	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150311		NDA AUTHORIZED GENERIC	NDA020353	Alvogen Inc.	NAPROXEN SODIUM	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
47781-174_eb08d7cb-de94-8c18-7e55-292b7c6946a5	47781-174	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 5 mg,Cll	TABLET	ORAL	20170728		ANDA	ANDA207388	Alvogen Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
47781-176_eb08d7cb-de94-8c18-7e55-292b7c6946a5	47781-176	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 10 mg,Cll	TABLET	ORAL	20170728		ANDA	ANDA207388	Alvogen Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
47781-178_eb08d7cb-de94-8c18-7e55-292b7c6946a5	47781-178	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 15 mg,Cll	TABLET	ORAL	20170728		ANDA	ANDA207388	Alvogen Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
47781-179_eb08d7cb-de94-8c18-7e55-292b7c6946a5	47781-179	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 20 mg,Cll	TABLET	ORAL	20170728		ANDA	ANDA207388	Alvogen Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
47781-180_eb08d7cb-de94-8c18-7e55-292b7c6946a5	47781-180	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 30 mg,Cll	TABLET	ORAL	20170728		ANDA	ANDA207388	Alvogen Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
47781-196_78eea6d0-505c-5d95-035f-bc533541ad83	47781-196	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20160309		ANDA	ANDA202677	Alvogen, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-200_07bf6eb3-d646-e207-7c43-034774e094ce	47781-200	HUMAN PRESCRIPTION DRUG	Melphalan		Melphalan USP, 2 mg	TABLET	ORAL	20170322		ANDA	ANDA207809	Alvogen Inc.	MELPHALAN	2	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
47781-229_78eea6d0-505c-5d95-035f-bc533541ad83	47781-229	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20120117		ANDA	ANDA202677	Alvogen, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-230_78eea6d0-505c-5d95-035f-bc533541ad83	47781-230	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20120117		ANDA	ANDA202677	Alvogen, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-263_29cb5662-c011-cb05-36d9-56a25ce93aef	47781-263	HUMAN PRESCRIPTION DRUG	Oxycodone hydrochloride		Oxycodone hydrochloride	TABLET	ORAL	20111230		ANDA	ANDA202116	Alvogen, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-264_29cb5662-c011-cb05-36d9-56a25ce93aef	47781-264	HUMAN PRESCRIPTION DRUG	Oxycodone hydrochloride		Oxycodone hydrochloride	TABLET	ORAL	20111230		ANDA	ANDA202116	Alvogen, Inc.	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-265_29cb5662-c011-cb05-36d9-56a25ce93aef	47781-265	HUMAN PRESCRIPTION DRUG	Oxycodone hydrochloride		Oxycodone hydrochloride	TABLET	ORAL	20111230		ANDA	ANDA202116	Alvogen, Inc.	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-303_2444eb50-fc82-6185-ee6b-5163178e9555	47781-303	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	Alvogen Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
47781-304_ba92f242-fdc3-c9e9-71ce-0f2a7be4c1d0	47781-304	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150904		ANDA	ANDA204403	Alvogen Inc.	RIVASTIGMINE	4.6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
47781-305_ba92f242-fdc3-c9e9-71ce-0f2a7be4c1d0	47781-305	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150904		ANDA	ANDA204403	Alvogen Inc.	RIVASTIGMINE	9.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
47781-306_550fc2ff-6d06-f9f3-ebfa-c9b2a6900a7a	47781-306	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Alvogen Inc.	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
47781-307_550fc2ff-6d06-f9f3-ebfa-c9b2a6900a7a	47781-307	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Alvogen Inc.	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
47781-308_550fc2ff-6d06-f9f3-ebfa-c9b2a6900a7a	47781-308	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Alvogen Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
47781-332_6a00e01f-b2c4-4470-ef1c-dff518a77ea7	47781-332	HUMAN PRESCRIPTION DRUG	Carbidopa Tablets, 25 mg		Carbidopa Tablets, 25 mg	TABLET	ORAL	20160125		ANDA	ANDA204291	Alvogen Inc.	CARBIDOPA	25	mg/1			N	20241231
47781-335_210210e1-a038-858e-25e7-ba24b5206234	47781-335	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		Pyridostigmine Bromide	TABLET, EXTENDED RELEASE	ORAL	20150629		ANDA	ANDA204737	Alvogen, Inc.	PYRIDOSTIGMINE BROMIDE	180	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
47781-355_932ccd8e-f055-9145-4495-066d3fc19098	47781-355	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	Sublingual Film	Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20190211		ANDA	ANDA205954	Alvogen Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-356_932ccd8e-f055-9145-4495-066d3fc19098	47781-356	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	Sublingual Film	Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20190211		ANDA	ANDA205954	Alvogen Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	4; 1	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-357_932ccd8e-f055-9145-4495-066d3fc19098	47781-357	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	Sublingual Film	Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20190211		ANDA	ANDA205954	Alvogen Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-358_932ccd8e-f055-9145-4495-066d3fc19098	47781-358	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone	Sublingual Film	Buprenorphine and Naloxone	FILM	BUCCAL; SUBLINGUAL	20190211		ANDA	ANDA205954	Alvogen Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	12; 3	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-379_9a2ec469-2eba-8583-4dc2-ee26273fe975	47781-379	HUMAN PRESCRIPTION DRUG	Pregabalin Extended Release		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210414		ANDA	ANDA211593	Alvogen Inc.	PREGABALIN	82.5	mg/1		CV	N	20241231
47781-380_9a2ec469-2eba-8583-4dc2-ee26273fe975	47781-380	HUMAN PRESCRIPTION DRUG	Pregabalin Extended Release		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210414		ANDA	ANDA211593	Alvogen Inc.	PREGABALIN	165	mg/1		CV	N	20241231
47781-381_9a2ec469-2eba-8583-4dc2-ee26273fe975	47781-381	HUMAN PRESCRIPTION DRUG	Pregabalin Extended Release		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210414		ANDA	ANDA211593	Alvogen Inc.	PREGABALIN	330	mg/1		CV	N	20241231
47781-384_864f8878-2922-79e3-8a37-f4f5e6f9d2c1	47781-384	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate for Oral Suspension		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20171101		ANDA	ANDA208823	Alvogen Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
47781-392_ca1e12ee-5cca-c1d2-509f-ed171902d723	47781-392	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	TABLET, EXTENDED RELEASE	ORAL	20210303		ANDA	ANDA208269	Alvogen Inc.	HYDROCODONE BITARTRATE	20	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-393_ca1e12ee-5cca-c1d2-509f-ed171902d723	47781-393	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	TABLET, EXTENDED RELEASE	ORAL	20210303		ANDA	ANDA208269	Alvogen Inc.	HYDROCODONE BITARTRATE	30	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-394_ca1e12ee-5cca-c1d2-509f-ed171902d723	47781-394	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	TABLET, EXTENDED RELEASE	ORAL	20210303		ANDA	ANDA208269	Alvogen Inc.	HYDROCODONE BITARTRATE	40	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-395_ca1e12ee-5cca-c1d2-509f-ed171902d723	47781-395	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	TABLET, EXTENDED RELEASE	ORAL	20210303		ANDA	ANDA208269	Alvogen Inc.	HYDROCODONE BITARTRATE	60	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-396_ca1e12ee-5cca-c1d2-509f-ed171902d723	47781-396	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	TABLET, EXTENDED RELEASE	ORAL	20210303		ANDA	ANDA208269	Alvogen Inc.	HYDROCODONE BITARTRATE	80	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-397_ca1e12ee-5cca-c1d2-509f-ed171902d723	47781-397	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	TABLET, EXTENDED RELEASE	ORAL	20210303		ANDA	ANDA208269	Alvogen Inc.	HYDROCODONE BITARTRATE	100	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-398_ca1e12ee-5cca-c1d2-509f-ed171902d723	47781-398	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	TABLET, EXTENDED RELEASE	ORAL	20210303		ANDA	ANDA208269	Alvogen Inc.	HYDROCODONE BITARTRATE	120	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-405_ba92f242-fdc3-c9e9-71ce-0f2a7be4c1d0	47781-405	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150902		ANDA	ANDA204403	Alvogen Inc.	RIVASTIGMINE	13.3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
47781-406_78a881af-7a7f-0a76-b997-0ff28f209d03	47781-406	HUMAN PRESCRIPTION DRUG	buprenorphine transdermal system		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20220517		ANDA	ANDA207490	Alvogen Inc.	BUPRENORPHINE	5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-407_78a881af-7a7f-0a76-b997-0ff28f209d03	47781-407	HUMAN PRESCRIPTION DRUG	buprenorphine transdermal system		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20220517		ANDA	ANDA207490	Alvogen Inc.	BUPRENORPHINE	10	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-408_78a881af-7a7f-0a76-b997-0ff28f209d03	47781-408	HUMAN PRESCRIPTION DRUG	buprenorphine transdermal system		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20220517		ANDA	ANDA207490	Alvogen Inc.	BUPRENORPHINE	20	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-409_34e5bc3d-3268-c39f-a85e-fc52156df997	47781-409	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200121		ANDA	ANDA206986	Alvogen Inc.	HYDROCODONE BITARTRATE	10	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-410_34e5bc3d-3268-c39f-a85e-fc52156df997	47781-410	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200121		ANDA	ANDA206986	Alvogen Inc.	HYDROCODONE BITARTRATE	15	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-411_34e5bc3d-3268-c39f-a85e-fc52156df997	47781-411	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200121		ANDA	ANDA206986	Alvogen Inc.	HYDROCODONE BITARTRATE	20	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-412_34e5bc3d-3268-c39f-a85e-fc52156df997	47781-412	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200121		ANDA	ANDA206986	Alvogen Inc.	HYDROCODONE BITARTRATE	30	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-413_34e5bc3d-3268-c39f-a85e-fc52156df997	47781-413	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200121		ANDA	ANDA206986	Alvogen Inc.	HYDROCODONE BITARTRATE	40	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-414_34e5bc3d-3268-c39f-a85e-fc52156df997	47781-414	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate		Hydrocodone Bitartrate	CAPSULE, EXTENDED RELEASE	ORAL	20200121		ANDA	ANDA206986	Alvogen Inc.	HYDROCODONE BITARTRATE	50	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
47781-419_78a881af-7a7f-0a76-b997-0ff28f209d03	47781-419	HUMAN PRESCRIPTION DRUG	buprenorphine transdermal system		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20220517		ANDA	ANDA207490	Alvogen Inc.	BUPRENORPHINE	15	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
47781-423_fd7b3810-c7b5-4e37-e053-6294a90aa338	47781-423	HUMAN PRESCRIPTION DRUG	Fentanyl system		Fentanyl	PATCH	TRANSDERMAL	20161104		ANDA	ANDA202097	ALVOGEN	FENTANYL	12.5	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-424_fd7b3810-c7b5-4e37-e053-6294a90aa338	47781-424	HUMAN PRESCRIPTION DRUG	Fentanyl system		Fentanyl	PATCH	TRANSDERMAL	20161104		ANDA	ANDA202097	ALVOGEN	FENTANYL	25	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-426_fd7b3810-c7b5-4e37-e053-6294a90aa338	47781-426	HUMAN PRESCRIPTION DRUG	Fentanyl system		Fentanyl	PATCH	TRANSDERMAL	20161104		ANDA	ANDA202097	ALVOGEN	FENTANYL	50	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-427_fd7b3810-c7b5-4e37-e053-6294a90aa338	47781-427	HUMAN PRESCRIPTION DRUG	Fentanyl system		Fentanyl	PATCH	TRANSDERMAL	20161104		ANDA	ANDA202097	ALVOGEN	FENTANYL	75	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-428_fd7b3810-c7b5-4e37-e053-6294a90aa338	47781-428	HUMAN PRESCRIPTION DRUG	Fentanyl system		Fentanyl	PATCH	TRANSDERMAL	20161104		ANDA	ANDA202097	ALVOGEN	FENTANYL	100	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
47781-456_161c015a-aec1-c56a-2b58-98572cab765b	47781-456	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430	20240601	ANDA	ANDA211604	Alvogen Inc.	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
47781-457_161c015a-aec1-c56a-2b58-98572cab765b	47781-457	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430	20240601	ANDA	ANDA211604	Alvogen Inc.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
47781-458_161c015a-aec1-c56a-2b58-98572cab765b	47781-458	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430	20240601	ANDA	ANDA211604	Alvogen Inc.	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
47781-466_e69ad463-c235-71be-9c67-f0fadf5aa516	47781-466	HUMAN PRESCRIPTION DRUG	VORICONAZOLE		VORICONAZOLE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160808		ANDA	ANDA206398	Alvogen Inc.	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
47781-468_eb1d1ab9-4d3f-0e86-2594-1227ccbc249c	47781-468	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20161212		ANDA	ANDA202595	Alvogen Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
47781-469_eb1d1ab9-4d3f-0e86-2594-1227ccbc249c	47781-469	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20161212		ANDA	ANDA202595	Alvogen Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
47781-470_eb1d1ab9-4d3f-0e86-2594-1227ccbc249c	47781-470	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20161212		ANDA	ANDA202595	Alvogen Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
47781-483_2a9c80e9-1fdc-7f73-d2cb-84d7c2399691	47781-483	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA210480	Alvogen, Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
47781-484_2a9c80e9-1fdc-7f73-d2cb-84d7c2399691	47781-484	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		Lenalidomide	CAPSULE	ORAL	20220903		ANDA	ANDA210480	Alvogen, Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
47781-485_2a9c80e9-1fdc-7f73-d2cb-84d7c2399691	47781-485	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		Lenalidomide	CAPSULE	ORAL	20220903		ANDA	ANDA210480	Alvogen, Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
47781-486_2a9c80e9-1fdc-7f73-d2cb-84d7c2399691	47781-486	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		Lenalidomide	CAPSULE	ORAL	20220903		ANDA	ANDA210480	Alvogen, Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
47781-487_2a9c80e9-1fdc-7f73-d2cb-84d7c2399691	47781-487	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA210480	Alvogen, Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
47781-488_2a9c80e9-1fdc-7f73-d2cb-84d7c2399691	47781-488	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		Lenalidomide	CAPSULE	ORAL	20220903		ANDA	ANDA210480	Alvogen, Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
47781-533_40a91708-d8ad-427f-8cf9-3fe49be8248c	47781-533	HUMAN PRESCRIPTION DRUG	Fluocinonide Gel		Fluocinonide Gel	GEL	TOPICAL	20170214	20240501	NDA	NDA017373	Alvogen Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
47781-562_1cb8b80e-fe98-4b0b-5ae5-d4b3d09793e9	47781-562	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Alvogen Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
47781-563_1cb8b80e-fe98-4b0b-5ae5-d4b3d09793e9	47781-563	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Alvogen Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
47781-564_1cb8b80e-fe98-4b0b-5ae5-d4b3d09793e9	47781-564	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Alvogen Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
47781-565_1cb8b80e-fe98-4b0b-5ae5-d4b3d09793e9	47781-565	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Alvogen Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
47781-566_1cb8b80e-fe98-4b0b-5ae5-d4b3d09793e9	47781-566	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Alvogen Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
47781-567_1cb8b80e-fe98-4b0b-5ae5-d4b3d09793e9	47781-567	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Alvogen Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
47781-568_1cb8b80e-fe98-4b0b-5ae5-d4b3d09793e9	47781-568	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Alvogen Inc.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
47781-569_9769cea5-24f2-1374-f146-782a46136461	47781-569	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20171002	20241101	NDA	NDA016909	Alvogen Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
47781-577_19758169-748f-c93a-1bde-b41ab8be1146	47781-577	HUMAN PRESCRIPTION DRUG	Methenamine Hippurate		Methenamine Hippurate	TABLET	ORAL	20100503		NDA	NDA016151	Alvogen Inc.	METHENAMINE HIPPURATE	1	g/1			N	20241231
47781-586_d59ca248-8648-4aa8-87b4-a6de2f7d14e6	47781-586	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	20170601		ANDA	ANDA090699	Alvogen Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
47781-595_069e086b-1cd0-f698-c6f0-3335b7a60f2f	47781-595	HUMAN PRESCRIPTION DRUG	Paclitaxel		paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20171227		ANDA	ANDA207326	Alvogen Inc.	PACLITAXEL	300	mg/50mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
47781-600_1466518f-9c70-d6d5-e86b-961df5baab85	47781-600	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET, FILM COATED	ORAL	20170901		NDA AUTHORIZED GENERIC	NDA202133	Alvogen Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
47781-607_afd51429-bbfd-267d-3299-f17e6bfea1e2	47781-607	HUMAN PRESCRIPTION DRUG	Disulfiram		Disulfiram	TABLET	ORAL	20130809		ANDA	ANDA091681	Alvogen Inc.	DISULFIRAM	250	mg/1	Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]		N	20241231
47781-624_c44165ae-1159-8e15-908b-b5a2b2201cf3	47781-624	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate		Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180324		ANDA	ANDA207384	Alvogen Inc.	DEFEROXAMINE MESYLATE	2	g/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
47781-627_fcc557ec-9cae-85b0-c3f3-d5bed71ed9f1	47781-627	HUMAN PRESCRIPTION DRUG	Felbamate		felbamate	TABLET	ORAL	20181201		ANDA	ANDA204595	Alvogen Inc.	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47781-630_fcc557ec-9cae-85b0-c3f3-d5bed71ed9f1	47781-630	HUMAN PRESCRIPTION DRUG	Felbamate		felbamate	TABLET	ORAL	20181201		ANDA	ANDA204595	Alvogen Inc.	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
47781-637_ff963f16-8f76-66a6-25aa-fe2020be1fb0	47781-637	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride		bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180928		NDA AUTHORIZED GENERIC	NDA022497	Alvogen Inc.	BUPROPION HYDROCHLORIDE	450	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
47781-640_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-640	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-643_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-643	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-646_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-646	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-649_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-649	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-651_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-651	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-652_749baee6-aee0-e1e1-a9f3-4755dbbf6a37	47781-652	HUMAN PRESCRIPTION DRUG	teriparatide		teriparatide	INJECTION, SOLUTION	SUBCUTANEOUS	20191114		NDA	NDA211939	Alvogen, Inc.	TERIPARATIDE	250	ug/mL	Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]		N	20241231
47781-654_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-654	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-657_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-657	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-659_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-659	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-662_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-662	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-665_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-665	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-668_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-668	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-671_049b22fc-354f-f5f8-625a-9b99d48f90b3	47781-671	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Alvogen, Inc.	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
47781-683_cd461dbf-4155-fd7f-1815-5dd5d2cdfc94	47781-683	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20190301		ANDA	ANDA201970	Alvogen, Inc.	RASAGILINE MESYLATE	.5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
47781-690_cd461dbf-4155-fd7f-1815-5dd5d2cdfc94	47781-690	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20190301		ANDA	ANDA201970	Alvogen, Inc.	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
47781-729_7d215494-5257-ab5f-ab0f-71894cf0b21c	47781-729	HUMAN PRESCRIPTION DRUG	vancomycin hydrochloride		vancomycin hydrochloride	CAPSULE	ORAL	20120409	20250101	ANDA	ANDA065490	Alvogen Inc.	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	
47781-730_7d215494-5257-ab5f-ab0f-71894cf0b21c	47781-730	HUMAN PRESCRIPTION DRUG	vancomycin hydrochloride		vancomycin hydrochloride	CAPSULE	ORAL	20120409	20240901	ANDA	ANDA065490	Alvogen Inc.	VANCOMYCIN HYDROCHLORIDE	250	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	
47781-910_a8b5ee51-ba17-909a-bbb8-cf14c265e1a2	47781-910	HUMAN PRESCRIPTION DRUG	testosterone cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20221102		ANDA	ANDA207742	Alvogen Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
47781-911_a8b5ee51-ba17-909a-bbb8-cf14c265e1a2	47781-911	HUMAN PRESCRIPTION DRUG	testosterone cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20221102		ANDA	ANDA207742	Alvogen Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
47781-914_415ca184-6711-b52c-96ac-0a2efd15ef4d	47781-914	HUMAN PRESCRIPTION DRUG	Dexamethasone		dexamethasone	TABLET	ORAL	20210628		ANDA	ANDA088481	Alvogen Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47781-916_415ca184-6711-b52c-96ac-0a2efd15ef4d	47781-916	HUMAN PRESCRIPTION DRUG	Dexamethasone		dexamethasone	TABLET	ORAL	20210628		ANDA	ANDA088481	Alvogen Inc.	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47781-925_d72499da-4d6d-48f6-cd6d-4351ac2a1433	47781-925	HUMAN PRESCRIPTION DRUG	pyrimethamine		pyrimethamine	TABLET	ORAL	20210917		ANDA	ANDA211271	Alvogen Inc.	PYRIMETHAMINE	25	mg/1	Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
47783-101_18790228-a777-4dc5-a566-aafa7cdeff36	47783-101	HUMAN PRESCRIPTION DRUG	Kalbitor		Ecallantide	INJECTION, SOLUTION	SUBCUTANEOUS	20100202		BLA	BLA125277	Takeda Pharmaceuticals America, Inc.	ECALLANTIDE	10	mg/mL	Kallikrein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]		N	20241231
47783-644_7b67bee7-cd75-431e-949e-39399e849426	47783-644	HUMAN PRESCRIPTION DRUG	TAKHZYRO		lanadelumab-flyo	INJECTION, SOLUTION	SUBCUTANEOUS	20180824		BLA	BLA761090	Takeda Pharmaceuticals America, Inc.	LANADELUMAB	300	mg/2mL	Kallikrein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]		N	20241231
47783-645_7b67bee7-cd75-431e-949e-39399e849426	47783-645	HUMAN PRESCRIPTION DRUG	TAKHZYRO		lanadelumab-flyo	SOLUTION	SUBCUTANEOUS	20230203		BLA	BLA761090	Takeda Pharmaceuticals America, Inc.	LANADELUMAB	150	mg/mL	Kallikrein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]		N	20241231
47783-646_7b67bee7-cd75-431e-949e-39399e849426	47783-646	HUMAN PRESCRIPTION DRUG	TAKHZYRO		lanadelumab-flyo	SOLUTION	SUBCUTANEOUS	20220208		BLA	BLA761090	Takeda Pharmaceuticals America, Inc.	LANADELUMAB	300	mg/2mL	Kallikrein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]		N	20241231
47832-071_c44f9882-db75-469f-a447-565a8f957645	47832-071	HUMAN OTC DRUG	JOCK-EZE		CLOTRIMAZOLE	CREAM	TOPICAL	20200121		OTC MONOGRAPH DRUG	M005	Bentlin Products LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
47832-205_1054b185-9c83-4935-a364-9b6ce657edbc	47832-205	HUMAN OTC DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	CREAM	TOPICAL	20070124		OTC MONOGRAPH DRUG	M017	Bentlin Products LLC	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
47918-874_590032d0-a528-4d1e-ad37-bd33398f1fe8	47918-874	HUMAN PRESCRIPTION DRUG	AFREZZA		INSULIN HUMAN	POWDER, METERED	RESPIRATORY (INHALATION)	20150121		BLA	BLA022472	Mannkind Corporation	INSULIN HUMAN	4	[arb'U]/1	Insulin [CS], Insulin [EPC]		N	20241231
47918-878_590032d0-a528-4d1e-ad37-bd33398f1fe8	47918-878	HUMAN PRESCRIPTION DRUG	AFREZZA		INSULIN HUMAN	POWDER, METERED	RESPIRATORY (INHALATION)	20170701		BLA	BLA022472	Mannkind Corporation	INSULIN HUMAN	8	[arb'U]/1	Insulin [CS], Insulin [EPC]		N	20241231
47918-880_590032d0-a528-4d1e-ad37-bd33398f1fe8	47918-880	HUMAN PRESCRIPTION DRUG	AFREZZA		INSULIN HUMAN	KIT	RESPIRATORY (INHALATION)	20160701		BLA	BLA022472	Mannkind Corporation						N	20241231
47918-891_590032d0-a528-4d1e-ad37-bd33398f1fe8	47918-891	HUMAN PRESCRIPTION DRUG	AFREZZA		INSULIN HUMAN	POWDER, METERED	RESPIRATORY (INHALATION)	20170701		BLA	BLA022472	Mannkind Corporation	INSULIN HUMAN	12	[arb'U]/1	Insulin [CS], Insulin [EPC]		N	20241231
47918-898_590032d0-a528-4d1e-ad37-bd33398f1fe8	47918-898	HUMAN PRESCRIPTION DRUG	AFREZZA		INSULIN HUMAN	KIT	RESPIRATORY (INHALATION)	20181204		BLA	BLA022472	Mannkind Corporation						N	20241231
47918-902_590032d0-a528-4d1e-ad37-bd33398f1fe8	47918-902	HUMAN PRESCRIPTION DRUG	AFREZZA		INSULIN HUMAN	KIT	RESPIRATORY (INHALATION)	20170110		BLA	BLA022472	Mannkind Corporation						N	20241231
47918-903_590032d0-a528-4d1e-ad37-bd33398f1fe8	47918-903	HUMAN PRESCRIPTION DRUG	AFREZZA		INSULIN HUMAN	KIT	RESPIRATORY (INHALATION)	20201109		BLA	BLA022472	Mannkind Corporation						N	20241231
47993-201_5fa3f98d-87bc-075e-e053-2a91aa0a2af4	47993-201	HUMAN OTC DRUG	Hand Sanitizer Spraying		ALCOHOL	SPRAY	TOPICAL	20140503		OTC MONOGRAPH NOT FINAL	part333E	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/100g			N	20241231
47993-203_a3dd4a6c-dc82-d0e4-e053-2995a90ae06e	47993-203	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	LIQUID	TOPICAL	20141008		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/100g			N	20241231
47993-204_5fa964bb-55a7-1f45-e053-2a91aa0ad913	47993-204	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	LIQUID	TOPICAL	20160926		OTC MONOGRAPH NOT FINAL	part356	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	CITRIC ACID MONOHYDRATE; COCAMIDOPROPYL BETAINE	.3; 5	g/100g; 1/100g	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
47993-217_b2cb3fad-a9fe-f79d-e053-2a95a90ad691	47993-217	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-218_b2cb9bf2-8011-3fba-e053-2995a90a58bb	47993-218	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200403		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-226_b33fb1b8-1a0b-17da-e053-2a95a90ac2d9	47993-226	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200411		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-238_b342bbda-3b94-58cd-e053-2a95a90a7b13	47993-238	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200422		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-240_9579016a-881e-8f86-e053-2a95a90af3e2	47993-240	HUMAN OTC DRUG	anti-frizz sheets		anti-frizz sheets	SWAB	TOPICAL	20150915		OTC MONOGRAPH NOT FINAL	part352	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	SULISOBENZONE	2	g/100g			N	20241231
47993-243_b343b992-d68a-5fa8-e053-2995a90a7813	47993-243	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	65	g/112mL			N	20241231
47993-245_b343ae8e-9c91-a0b4-e053-2a95a90a7a6d	47993-245	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-246_b3434027-508a-6c60-e053-2995a90ab20f	47993-246	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	g/112mL			N	20241231
47993-247_b34416ad-b23f-0fa3-e053-2a95a90ac49d	47993-247	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200519		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-248_b34416ad-b240-0fa3-e053-2a95a90ac49d	47993-248	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200519		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-260_b346e070-d641-aeab-e053-2995a90a8a01	47993-260	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200515		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-265_b346efa4-05c6-2b2d-e053-2995a90add4e	47993-265	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-266_b347320d-39c9-b28a-e053-2995a90a6fb4	47993-266	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-267_b3478e43-3d4d-1a83-e053-2995a90a6752	47993-267	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-276_b35679d6-3417-35db-e053-2995a90a13d0	47993-276	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-277_b3566df4-d219-5f7d-e053-2a95a90adae6	47993-277	HUMAN OTC DRUG	Antibacterial HandSoap with Moisturizer		CHLOROXYLENOL	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	CHLOROXYLENOL	.3	g/100mL			N	20241231
47993-278_b357014d-8903-0bcc-e053-2a95a90a9c67	47993-278	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	g/112mL			N	20241231
47993-279_b357014d-8904-0bcc-e053-2a95a90a9c67	47993-279	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200616		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	65	g/112mL			N	20241231
47993-286_b35721fc-09ff-0bce-e053-2a95a90a0cb2	47993-286	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200623		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-287_b35721fc-0a00-0bce-e053-2a95a90a0cb2	47993-287	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200623		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-291_b357c7fc-f692-4f7e-e053-2995a90a46e1	47993-291	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-293_b3583573-5cab-0dd4-e053-2995a90ac806	47993-293	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-297_b3584abc-dc8b-5475-e053-2a95a90af775	47993-297	HUMAN OTC DRUG	SANITIZER		ethyl alcohol	GEL	TOPICAL	20200714		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	g/112mL			N	20241231
47993-298_b366dc55-6f82-6d56-e053-2995a90a20a3	47993-298	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200714		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	g/112mL			N	20241231
47993-299_b366dc55-6f83-6d56-e053-2995a90a20a3	47993-299	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200724		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-300_b366dc55-6f84-6d56-e053-2995a90a20a3	47993-300	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200724		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-301_5fb74303-319a-738e-e053-2a91aa0a37cf	47993-301	HUMAN OTC DRUG	HAND SANITIZER WITH VE		ALCOHOL	LIQUID	TOPICAL	20141008		OTC MONOGRAPH NOT FINAL	part333E	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	.ALPHA.-TOCOPHEROL ACETATE, DL-; ALCOHOL	1.5; 62	g/100g; g/100g			N	20241231
47993-303_b366dc55-6f85-6d56-e053-2995a90a20a3	47993-303	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZERSPRAY		ethyl alcohol	GEL	TOPICAL	20200724		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-311_b36740fa-658d-5b27-e053-2995a90a7c6d	47993-311	HUMAN OTC DRUG	HAND SURFACE SPRAYSANITIZER		ethyl alcohol	LIQUID	TOPICAL	20200731		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20241231
47993-313_b367b1b1-8563-638d-e053-2995a90a1e87	47993-313	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20200818		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	g/112mL			N	20241231
47993-314_b367ba8d-16ae-3ec8-e053-2a95a90a4183	47993-314	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZERSPRAY		ethyl alcohol	LIQUID	TOPICAL	20200818		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	g/112mL			N	20241231
47993-315_b367b371-1e9a-6383-e053-2995a90aeb38	47993-315	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20200902		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
47993-319_b32d52dc-6683-4dcc-e053-2995a90a5206	47993-319	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	75	mL/100mL			N	20241231
47993-321_b4ef0c8a-9862-f723-e053-2a95a90ac1b3	47993-321	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20201125		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	70	g/112mL			N	20241231
47993-323_be1e49d3-925c-e474-e053-2a95a90a0c59	47993-323	HUMAN OTC DRUG	HAND SANITIZER		Benzalkonium Chloride	GEL	TOPICAL	20210322		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	BENZALKONIUM CHLORIDE	.3	g/100mL			N	20241231
47993-324_c42df83a-be30-c4ff-e053-2a95a90aa81d	47993-324	HUMAN OTC DRUG	HANDSOAP		CHLOROXYLENOL	GEL	TOPICAL	20210607		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	CHLOROXYLENOL	.3	g/100mL			N	20241231
47993-325_c4f12df0-da51-d05b-e053-2a95a90a1a8b	47993-325	HUMAN OTC DRUG	ANTIMICROBIALSOAP		CHLOROXYLENOL	GEL	TOPICAL	20210615		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	CHLOROXYLENOL	.75	g/100mL			N	20241231
47993-326_c4f1422b-b877-5f56-e053-2a95a90ab2ce	47993-326	HUMAN OTC DRUG	HANDSOAP		CHLOROXYLENOL	GEL	TOPICAL	20210615		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	CHLOROXYLENOL	.3	g/100mL			N	20241231
47993-327_c4f14787-9e1d-ffbb-e053-2a95a90a89b8	47993-327	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20210616		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	64	g/112mL			N	20241231
47993-328_c4f14cb7-3da9-2272-e053-2995a90ab24f	47993-328	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	LIQUID	TOPICAL	20210616		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	71	mL/100mL			N	20241231
47993-329_c4f14922-709c-59c6-e053-2995a90a065e	47993-329	HUMAN OTC DRUG	HAND SANITIZER		ethyl alcohol	GEL	TOPICAL	20210616		OTC MONOGRAPH NOT FINAL	part333A	INGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	71	mL/100mL			N	20241231
47993-330_e5b1c9f8-85c0-5da3-e053-2995a90ada38	47993-330	HUMAN OTC DRUG	HAND SANITIZER		HAND SANITIZER	GEL	TOPICAL	20220804		OTC MONOGRAPH NOT FINAL	part333A	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	71	mL/100mL			N	20241231
47993-331_ec8ba47c-d22d-bfbf-e053-2a95a90ac99d	47993-331	HUMAN OTC DRUG	aluminum chlorohydrate		aluminum chlorohydrate	GEL	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALUMINUM CHLOROHYDRATE	5.67	g/56.7g			N	20241231
47993-360_0e149f84-e27f-1a96-e063-6294a90abfb5	47993-360	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanizizer	GEL	TOPICAL	20231215		OTC MONOGRAPH DRUG	M	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20251231
47993-361_0e1430ca-d113-2a09-e063-6394a90a0013	47993-361	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanizizer	GEL	TOPICAL	20231215		OTC MONOGRAPH DRUG	M	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20251231
47993-362_0e143e17-ca46-f248-e063-6294a90a199e	47993-362	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Spray.		Antibacterial Hand Sanitizer Spray.	LIQUID	TOPICAL	20231215		OTC MONOGRAPH DRUG	M	NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD	ALCOHOL	62	g/112mL			N	20251231
48102-053_81a1b057-dad2-414f-9b62-e3285869bebb	48102-053	HUMAN PRESCRIPTION DRUG	Phospholine Iodide		echothiophate iodide for ophthalmic solution	KIT	OPHTHALMIC	20211117		NDA	NDA011963	Fera Pharmaceuticals, LLC						N	20241231
48102-057_25650692-bc31-4626-a795-998e9746a9bf	48102-057	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	20230927		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Fera Pharmaceuticals, LLC	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
48201-001_031f33d4-5d53-3809-e063-6294a90a89be	48201-001	HUMAN OTC DRUG	Sanaflu Xtra		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20150430		OTC MONOGRAPH FINAL	part341	Grandall Distributing Co., Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
48201-004_031f6392-1d7b-8e4f-e063-6294a90a7863	48201-004	HUMAN OTC DRUG	CALMADOL		Camphor, Menthol, Methyl Salicylate	LINIMENT	TOPICAL	20150708		OTC MONOGRAPH NOT FINAL	part348	Grandall Distributing Co., Inc.	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	6; 1.9; 10	g/100g; g/100g; g/100g			N	20241231
48201-006_031f2c20-417b-0a75-e063-6394a90af2a7	48201-006	HUMAN OTC DRUG	Mata Piojos Lice		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20150709		OTC MONOGRAPH FINAL	part358G	Grandall Distributing Co., Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
48201-007_031f6392-1d8a-8e4f-e063-6294a90a7863	48201-007	HUMAN OTC DRUG	CALMADOL PAIN RELIEVER		Naproxen Sodium	TABLET	ORAL	20150331		ANDA	ANDA090545	Grandall Distributing Co., Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
48201-012_087d5101-9e54-703c-e063-6394a90a8780	48201-012	HUMAN OTC DRUG	Cherry Throat Drops		Benzocaine	LOZENGE	ORAL	20180807		OTC MONOGRAPH DRUG	M012	Grandall Distributing	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48201-013_087d6642-688f-0839-e063-6294a90a9659	48201-013	HUMAN OTC DRUG	Honey Lemon Sore Throat Lozenges		Benzocaine	LOZENGE	ORAL	20180807		OTC MONOGRAPH DRUG	M012	Grandall Distributing	BENZOCAINE; MENTHOL	15; 2.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48201-014_031ecf22-6a6d-3ff8-e063-6394a90aae71	48201-014	HUMAN OTC DRUG	Angidol	Honey-Lime	BENZOCAINE, MENTHOL	LOZENGE	ORAL	20230324		OTC MONOGRAPH NOT FINAL	part356	Grandall Distributing Co., Inc.	BENZOCAINE; MENTHOL	15; 2.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48201-015_031ecc85-8328-4505-e063-6294a90a580b	48201-015	HUMAN OTC DRUG	Angidol	Raspberry	BENZOCAINE, MENTHOL	LOZENGE	ORAL	20230324		OTC MONOGRAPH NOT FINAL	part356	Grandall Distributing Co., Inc.	BENZOCAINE; MENTHOL	15; 2.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48201-103_031f4df4-dcff-63f5-e063-6294a90a3444	48201-103	HUMAN OTC DRUG	POMADA SULFA FIRST AID ANTIBIOTIC		NEOMYCIN SULFATE	OINTMENT	TOPICAL	20200206		OTC MONOGRAPH FINAL	part333B	Grandall Distributing Co., Inc.	NEOMYCIN SULFATE	.5	g/100g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
48256-0002_06c7f530-5253-8ec9-e063-6394a90a8396	48256-0002	HUMAN OTC DRUG	WHITE FLOWER ANALGESIC BALM		CAMPHOR, MENTHOL AND METHYL SALICYLATE	OIL	TOPICAL	20100611		OTC MONOGRAPH DRUG	M017	HOE HIN PAK FAH YEOW MANUFACTORY LTD	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	6; 14.5; 40.02	g/100mL; g/100mL; g/100mL			N	20241231
48256-0011_06c8a808-955c-6bd6-e063-6294a90a40fd	48256-0011	HUMAN OTC DRUG	WHITE FLOWER ANALGESIC BALM FLORAL SCENTED		CAMPHOR, MENTHOL AND METHYL SALICYLATE	OIL	TOPICAL	20100730		OTC MONOGRAPH DRUG	M017	HOE HIN PAK FAH YEOW MANUFACTORY LTD	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	5.4; 13; 35.8	g/100mL; g/100mL; g/100mL			N	20241231
48256-0041_06c87533-3e09-9c43-e063-6394a90aca74	48256-0041	HUMAN OTC DRUG	WHITE FLOWER STRAIN RELIEF		CAMPHOR, MENTHOL AND METHYL SALICYLATE	OIL	TOPICAL	20120307		OTC MONOGRAPH DRUG	M017	HOE HIN PAK FAH YEOW MANUFACTORY LTD	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	10.2; 15.3; 49.1	g/100mL; g/100mL; g/100mL			N	20241231
48273-001_076171d0-7306-d126-e063-6394a90afafd	48273-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20190101		NDA	NDA205767	Keen Compressed Gas Co. Inc.	OXYGEN	99	L/100L			N	20241231
48273-002_07617a70-ccd0-b9ef-e063-6394a90aad8c	48273-002	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	20190101		NDA	NDA206009	Keen Compressed Gas Co. Inc.	NITROUS OXIDE	99	L/100L			N	20241231
48273-006_076177e4-8ccd-3644-e063-6294a90a02a4	48273-006	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19700101		NDA	NDA205766	Keen Compressed Gas Co. Inc.	NITROGEN	99	L/100L			N	20241231
48273-010_07617a70-cccd-b9ef-e063-6394a90aad8c	48273-010	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20190611		NDA	NDA205764	Keen Compressed Gas Co. Inc.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
48273-011_07617bf4-1bf4-c8a7-e063-6294a90a485b	48273-011	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	20190611		NDA	NDA206826	Keen Compressed Gas Co. Inc.	HELIUM	990	mL/L			N	20241231
48273-012_0761707a-69e7-8c1f-e063-6294a90a4d78	48273-012	HUMAN PRESCRIPTION DRUG	Medical Air		Medical Air	GAS	RESPIRATORY (INHALATION)	20190101		NDA	NDA206023	Keen Compressed Gas Co. Inc.	OXYGEN	210	mL/L			N	20241231
48324-693_bd310bb2-37e4-1ed7-e053-2995a90a36b4	48324-693	HUMAN OTC DRUG	Instant		Instant	LIQUID	TOPICAL	20200514		OTC MONOGRAPH NOT FINAL	part333A	Unlimited Sales	ALCOHOL	67	mL/100mL			N	20241231
48404-050_0930bf8b-2181-fadc-e063-6394a90adc78	48404-050	HUMAN OTC DRUG	pre fense unscented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200515		OTC MONOGRAPH DRUG	505G(a)(3)	Prefense LLC	BENZALKONIUM CHLORIDE	120	mg/100mL			N	20241231
48404-051_09308c19-8bcb-f20d-e063-6394a90a92a6	48404-051	HUMAN OTC DRUG	pre fense		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200511		OTC MONOGRAPH DRUG	505G(a)(3)	Prefense LLC	BENZALKONIUM CHLORIDE	120	mg/100mL			N	20241231
48433-101_3c42dd05-b2d9-411b-8ef2-63baa98ebe3b	48433-101	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000501		OTC MONOGRAPH NOT FINAL	part334	Safecor Health, LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
48433-106_2a94a14b-9339-4f5b-8428-d4e24c0aac35	48433-106	HUMAN OTC DRUG	Calcium Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20140825		OTC MONOGRAPH FINAL	part331	Safecor Health, LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
48433-115_3faad38f-c24b-4bcc-a602-a6d1dc99bfbf	48433-115	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151201		ANDA	ANDA078583	Safecor Health, LLC	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
48433-116_3faad38f-c24b-4bcc-a602-a6d1dc99bfbf	48433-116	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151201		ANDA	ANDA078583	Safecor Health, LLC	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
48433-117_3faad38f-c24b-4bcc-a602-a6d1dc99bfbf	48433-117	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151201		ANDA	ANDA078583	Safecor Health, LLC	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
48433-118_3faad38f-c24b-4bcc-a602-a6d1dc99bfbf	48433-118	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151201		ANDA	ANDA078583	Safecor Health, LLC	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
48433-119_3faad38f-c24b-4bcc-a602-a6d1dc99bfbf	48433-119	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151201		ANDA	ANDA078583	Safecor Health, LLC	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
48433-120_3faad38f-c24b-4bcc-a602-a6d1dc99bfbf	48433-120	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151201		ANDA	ANDA078583	Safecor Health, LLC	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
48433-127_2b96078c-0b5d-48a7-bbc3-19209568a118	48433-127	HUMAN OTC DRUG	Bismuth		Bismuth subsalicylate	TABLET	ORAL	20200801		OTC MONOGRAPH FINAL	part335	Safecor Health, LLC	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
48433-129_1421e480-ad49-41c1-86d8-cc6b2be39e23	48433-129	HUMAN OTC DRUG	Aspirin	Chewable	Aspirin 81 mg	TABLET	ORAL	20221101		OTC MONOGRAPH NOT FINAL	part343	Safecor Health, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
48433-130_15709bf4-4414-45e7-99c6-aeab03b190c4	48433-130	HUMAN OTC DRUG	Senna		Sennosides 8.6mg	TABLET	ORAL	20221201		OTC MONOGRAPH NOT FINAL	part334	Safecor Health, LLC	SENNOSIDES	8.6	mg/1			N	20241231
48433-202_2adb5217-ebbe-408a-a271-2bd8a5f282f2	48433-202	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	SOLUTION	ORAL	20141001		OTC MONOGRAPH NOT FINAL	part334	Safecor Health, LLC	MINERAL OIL	1000	mg/mL			N	20241231
48433-219_3fab5a34-d4b8-4f6a-ac20-b0aa147b5c8d	48433-219	HUMAN OTC DRUG	Senna Syrup		Sennosides	LIQUID	ORAL	20200301		OTC MONOGRAPH NOT FINAL	part334	Safecor Health, LLC	SENNOSIDES	8.8	mg/5mL			N	20241231
48433-220_2d0f2890-e03c-4adb-a45e-6f948f6cf030	48433-220	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	LIQUID	ORAL	20210901		OTC MONOGRAPH NOT FINAL	part334	Safecor Health, LLC	DOCUSATE SODIUM	50	mg/5mL			N	20241231
48433-222_2b10fac7-8e9b-40fd-a004-1160886d35e3	48433-222	HUMAN OTC DRUG	Senna Syrup		Sennosides	LIQUID	ORAL	20230807		OTC MONOGRAPH NOT FINAL	part334	Safecor Health, LLC	SENNOSIDES	8.8	mg/5mL			N	20241231
48433-230_2c84b0d0-e460-45d9-abad-f7bfb2a561b9	48433-230	HUMAN PRESCRIPTION DRUG	Strong Iodine Solution		Strong Iodine Solution	SOLUTION/ DROPS	ORAL	20080920		UNAPPROVED DRUG OTHER		Safecor Health, LLC	IODINE; POTASSIUM IODIDE	700; 1400	mg/mL; mg/mL			N	20241231
48433-401_178825f0-6fc4-479d-9715-a1a7036ef025	48433-401	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	LIQUID	ORAL	20221101		OTC MONOGRAPH NOT FINAL	part343	Safecor Health, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
48546-0001_f38cde59-66aa-4d2f-951a-ad00741b4575	48546-0001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205767	Indiana Oxygen Company Inc	OXYGEN	99	L/100L			N	20241231
48546-0002_f38cde59-66aa-4d2f-951a-ad00741b4575	48546-0002	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19610101		NDA	NDA205767	Indiana Oxygen Company Inc	OXYGEN	99.5	L/100L			N	20241231
48546-0003_9fd3494b-c018-422a-817f-e9d5499311cd	48546-0003	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205766	Indiana Oxygen Company Inc	NITROGEN	99	L/100L			N	20241231
48546-0004_f38cde59-66aa-4d2f-951a-ad00741b4575	48546-0004	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19610101		NDA	NDA205767	Indiana Oxygen Company Inc	OXYGEN	99.6	L/100L			N	20241231
48546-0005_9fd3494b-c018-422a-817f-e9d5499311cd	48546-0005	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205766	Indiana Oxygen Company Inc	NITROGEN	99.1	L/100L			N	20241231
48546-0006_f38cde59-66aa-4d2f-951a-ad00741b4575	48546-0006	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19610101		NDA	NDA205767	Indiana Oxygen Company Inc	OXYGEN	99	L/100L			N	20241231
48599-002_d443ffc3-f804-4aba-9972-6b26dcb01686	48599-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	CUTANEOUS; RESPIRATORY (INHALATION)	20160701		NDA	NDA205766	Airweld, Inc	NITROGEN	99	L/100L			N	20241231
48599-345_f3676790-12a4-4ba1-a266-630c5bcdb2f4	48599-345	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	NASAL	19650101		NDA	NDA205767	Airweld, Inc.	OXYGEN	99	L/100L			N	20241231
48663-0001_0bb6ce39-b781-86ce-e063-6294a90a4c84	48663-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20090415		UNAPPROVED MEDICAL GAS		Respiratory Medical Services	OXYGEN	99	L/100L			N	20241231
48783-112_f76a4462-42e1-985d-e053-6294a90aacc2	48783-112	HUMAN PRESCRIPTION DRUG	Monsels Solution		Ferric Subsulfate	PASTE	TOPICAL	20140610		UNAPPROVED DRUG OTHER		Premier Dental Products Company	FERRIC SUBSULFATE	210	mg/g	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
48783-500_e0789a71-7346-4525-e053-2995a90a2059	48783-500	HUMAN OTC DRUG	Enamelon Preventive Treatment		stannous fluoride	GEL	DENTAL	20140101		OTC MONOGRAPH FINAL	part355	Premier Dental Products Company	STANNOUS FLUORIDE	.004	g/g			N	20241231
48783-520_e07b44db-7c5b-34fe-e053-2a95a90a4d3c	48783-520	HUMAN OTC DRUG	Enamelon		stannous fluoride	PASTE, DENTIFRICE	DENTAL	20140101		OTC MONOGRAPH FINAL	part355	Premier Dental Products Company	STANNOUS FLUORIDE	.00454	g/g			N	20241231
48815-1001_c07d2306-68cc-4c33-9b6f-4750c0edf625	48815-1001	HUMAN PRESCRIPTION DRUG	Sodium Iodide I 123		Sodium Iodide I 123	CAPSULE, GELATIN COATED	ORAL	20030102		NDA	NDA018671	Cardinal Health 418, Inc	SODIUM IODIDE I-123	100	uCi/1			N	20241231
48815-1002_c07d2306-68cc-4c33-9b6f-4750c0edf625	48815-1002	HUMAN PRESCRIPTION DRUG	Sodium Iodide I 123		Sodium Iodide I 123	CAPSULE, GELATIN COATED	ORAL	20030102		NDA	NDA018671	Cardinal Health 418, Inc	SODIUM IODIDE I-123	200	uCi/1			N	20241231
48818-001_6fd56180-47a2-4a9c-9f37-3088aa77b131	48818-001	HUMAN PRESCRIPTION DRUG	Folotyn		pralatrexate	INJECTION	INTRAVENOUS	20090924		NDA	NDA022468	Acrotech Biopharma Inc	PRALATREXATE	20	mg/mL	Folate Analog Metabolic Inhibitor [EPC]		N	20241231
48848-001_08f63077-5b84-dd40-e063-6394a90a419b	48848-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190130		UNAPPROVED MEDICAL GAS		Strate Welding Supply Co, Inc.	OXYGEN	99	L/100L			N	20241231
48878-0231_9a6c41a2-f87f-42b4-84e1-6509920f7330	48878-0231	HUMAN OTC DRUG	Avagard D		Alcohol	LOTION	TOPICAL	19991001		OTC MONOGRAPH NOT FINAL	part333E	3M ESPE Dental Products	ALCOHOL	530.7	mg/mL			N	20241231
48878-0620_c16fa4f7-aae9-42a3-ae90-837bd0a6bbb2	48878-0620	HUMAN PRESCRIPTION DRUG	Peridex		chlorhexidine gluconate	RINSE	ORAL	19860813		NDA	NDA019028	3M ESPE Dental Products	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
48878-3120_c7976c5b-f25a-4724-836e-04d25d441d26	48878-3120	HUMAN PRESCRIPTION DRUG	Clinpro 5000		sodium fluoride	PASTE, DENTIFRICE	ORAL	20090101		UNAPPROVED DRUG OTHER		3M ESPE Dental Products	SODIUM FLUORIDE	5	mg/g			N	20241231
48878-3130_c7976c5b-f25a-4724-836e-04d25d441d26	48878-3130	HUMAN PRESCRIPTION DRUG	Clinpro 5000		sodium fluoride	PASTE, DENTIFRICE	ORAL	20101015		UNAPPROVED DRUG OTHER		3M ESPE Dental Products	SODIUM FLUORIDE	5	mg/g			N	20241231
48878-3140_c7976c5b-f25a-4724-836e-04d25d441d26	48878-3140	HUMAN PRESCRIPTION DRUG	Clinpro 5000		sodium fluoride	PASTE, DENTIFRICE	ORAL	20110107		UNAPPROVED DRUG OTHER		3M ESPE Dental Products	SODIUM FLUORIDE	5	mg/g			N	20241231
48878-3150_47362d79-d214-4468-a858-c78916e91132	48878-3150	HUMAN OTC DRUG	Clinpro Tooth Creme		sodium fluoride	PASTE, DENTIFRICE	ORAL	20130718		OTC MONOGRAPH FINAL	part355	3M ESPE Dental Products	SODIUM FLUORIDE	.95	mg/g			N	20241231
48878-3315_020022a2-f258-49c2-b361-c7434ad6b8b4	48878-3315	HUMAN OTC DRUG	PerioMed		stannous fluoride	RINSE	ORAL	19670701		OTC MONOGRAPH FINAL	part355	3M ESPE Dental Products	STANNOUS FLUORIDE	1.53	mg/g			N	20241231
48878-3317_020022a2-f258-49c2-b361-c7434ad6b8b4	48878-3317	HUMAN OTC DRUG	PerioMed		stannous fluoride	RINSE	ORAL	19670701		OTC MONOGRAPH FINAL	part355	3M ESPE Dental Products	STANNOUS FLUORIDE	1.53	mg/g			N	20241231
48878-4020_3f618a29-cbbb-4b39-930b-a742c89ce40c	48878-4020	HUMAN OTC DRUG	Just For Kids		stannous fluoride	GEL	ORAL	19970701		OTC MONOGRAPH FINAL	part355	3M ESPE Dental Products	STANNOUS FLUORIDE	.969	mg/g			N	20241231
48878-4061_5539e66a-f111-4d1d-b4fd-6d0eaab84a84	48878-4061	HUMAN OTC DRUG	OMNI		stannous fluoride	GEL	ORAL	19980201		OTC MONOGRAPH FINAL	part355	3M ESPE Dental Products	STANNOUS FLUORIDE	.969	mg/g			N	20241231
48878-4070_3f618a29-cbbb-4b39-930b-a742c89ce40c	48878-4070	HUMAN OTC DRUG	Just For Kids		stannous fluoride	GEL	ORAL	19970701		OTC MONOGRAPH FINAL	part355	3M ESPE Dental Products	STANNOUS FLUORIDE	.969	mg/g			N	20241231
48951-1001_6bddd185-bd73-eae7-e053-2a91aa0a75f6	48951-1001	HUMAN OTC DRUG	Viscum Abietis		VISCUM ALBUM FRUITING TOP	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-1002_6bdf230e-99f4-cada-e053-2a91aa0a0c8a	48951-1002	HUMAN OTC DRUG	Viscum Crataegi		VISCUM ALBUM FRUITING TOP	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-1003_6bef9269-99b2-d792-e053-2a91aa0a8581	48951-1003	HUMAN OTC DRUG	Viscum Mali		VISCUM ALBUM FRUITING TOP	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-1004_6c2e7386-8fc7-be84-e053-2991aa0ae7d7	48951-1004	HUMAN OTC DRUG	Viscum Pini		VISCUM ALBUM FRUITING TOP	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-1005_6c2a387f-845b-7c3d-e053-2991aa0a79c4	48951-1005	HUMAN OTC DRUG	Viscum Populi		VISCUM ALBUM FRUITING TOP	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-1008_6c2b935c-0dfd-5dea-e053-2a91aa0a1b1f	48951-1008	HUMAN OTC DRUG	Viscum Tiliae		VISCUM ALBUM FRUITING TOP	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-1010_8b20b33a-3b6f-8ab0-e053-2a95a90ae039	48951-1010	HUMAN OTC DRUG	Adonis Crataegus Special Order		Adonis Crataegus Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ADONIS VERNALIS FLOWERING TOP; HAWTHORN LEAF WITH FLOWER; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	3; 3; 4; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1011_6d853b54-f0e1-8d03-e053-2991aa0a30ac	48951-1011	HUMAN OTC DRUG	Adonis Crataegus		Adonis Crataegus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ADONIS VERNALIS FLOWERING TOP; HAWTHORN LEAF WITH FLOWER; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	3; 3; 4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1021_69fa02b0-1f64-b968-e053-2991aa0adebe	48951-1021	HUMAN OTC DRUG	Apis Rhus		Apis Rhus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BRYONIA ALBA ROOT; TOXICODENDRON PUBESCENS LEAF	2; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1022_69826906-232f-31f4-e053-2991aa0a03c5	48951-1022	HUMAN OTC DRUG	Agaricus Phosphorus		Agaricus Phosphorus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMANITA MUSCARIA FRUITING BODY; DRYOPTERIS FILIX-MAS ROOT; OSTREA EDULIS SHELL; PHOSPHORUS; SILVER FLUORIDE	8; 3; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1023_6d847268-055b-df99-e053-2a91aa0afd79	48951-1023	HUMAN OTC DRUG	Agaricus Phosphorus		Agaricus Phosphorus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMANITA MUSCARIA FRUITING BODY; DRYOPTERIS FILIX-MAS ROOT; OSTREA EDULIS SHELL; PHOSPHORUS; SILVER FLUORIDE	8; 3; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1024_6a0c4b5c-0848-590c-e053-2991aa0a806b	48951-1024	HUMAN OTC DRUG	Agnus castus e sem. 4		Agnus castus e sem. 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACMELLA OLERACEA WHOLE; ANGELICA ARCHANGELICA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CUPRIC ACETATE; ECHINACEA, UNSPECIFIED; INULA HELENIUM ROOT; LEVISTICUM OFFICINALE ROOT; PLANTAGO MAJOR LEAF; VERBASCUM DENSIFLORUM LEAF	2; 1; 3; 3; 1; 6; 2; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1027_0e9c2d93-7a91-3c03-e063-6394a90acd4f	48951-1027	HUMAN OTC DRUG	Ammi Nicotiana Adult Size		Ammi Nicotiana Adult Size	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMMI VISNAGA FRUIT; ATROPA BELLADONNA; MATRICARIA CHAMOMILLA; TOBACCO LEAF	1; 1; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
48951-1028_69836294-cb89-54d5-e053-2991aa0a53de	48951-1028	HUMAN OTC DRUG	Amnion 30		Amnion 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMNIOTIC FLUID (BOVINE)	30	[hp_X]/mL			N	20241231
48951-1030_69833818-fe17-7046-e053-2a91aa0a88e5	48951-1030	HUMAN OTC DRUG	Anagallis Taraxacum		Anagallis Taraxacum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANAGALLIS ARVENSIS; CICHORIUM INTYBUS WHOLE; FRAGARIA VESCA WHOLE; MILK THISTLE; POTASSIUM CARBONATE; TARAXACUM PALUSTRE ROOT; VITIS VINIFERA LEAF	5; 7; 5; 5; 7; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1031_6d849d46-8958-7319-e053-2a91aa0ac75b	48951-1031	HUMAN OTC DRUG	Anagallis Taraxacum		Aanagallis Taraxacum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANAGALLIS ARVENSIS; CICHORIUM INTYBUS WHOLE; FRAGARIA VESCA WHOLE; MILK THISTLE; POTASSIUM CARBONATE; TARAXACUM PALUSTRE ROOT; VITIS VINIFERA LEAF	3; 6; 5; 3; 6; 3; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1033_554d8cc9-981d-2579-e054-00144ff8d46c	48951-1033	HUMAN OTC DRUG	Ananassa Resina		Ananassa Resina	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LARIX DECIDUA RESIN; PINEAPPLE; SILICON DIOXIDE	2; 2; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1034_6d8452a7-5d0c-f1f9-e053-2a91aa0a15b0	48951-1034	HUMAN OTC DRUG	Ananassa Resina		Ananassa Resina	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LARIX DECIDUA RESIN; PINEAPPLE; SILICON DIOXIDE	30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1035_6983a08d-9df5-8cce-e053-2991aa0a46db	48951-1035	HUMAN OTC DRUG	Angelica Comp.		Angelica Comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACMELLA OLERACEA WHOLE; ANGELICA ARCHANGELICA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CUPRIC ACETATE; ECHINACEA ANGUSTIFOLIA; INULA HELENIUM ROOT; LEVISTICUM OFFICINALE ROOT; PLANTAGO MAJOR LEAF; VERBASCUM DENSIFLORUM LEAF	2; 1; 3; 3; 1; 6; 2; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1036_6d83f608-daaf-5a75-e053-2991aa0a1e90	48951-1036	HUMAN OTC DRUG	Anise Pyrite		Anise Pyrite	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANISE; FERROUS DISULFIDE; SUCROSE	3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-1037_6983c4f2-0167-ba15-e053-2991aa0a3625	48951-1037	HUMAN OTC DRUG	Antimonite Belladonna		Antimonite Belladonna	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY TRISULFIDE; ATROPA BELLADONNA; BISMUTH SUBNITRATE; MATRICARIA RECUTITA	3; 4; 6; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Bismuth [CS], Bismuth [EPC]		N	20241231
48951-1041_698408a5-520d-2854-e053-2991aa0a53f8	48951-1041	HUMAN OTC DRUG	Apatite Cucurbita		Apatite Cucurbita	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUCURBITA PEPO FLOWER; FLUORAPATITE	3; 6	g/g; g/g			N	20241231
48951-1042_9842561e-c79f-fa31-e053-2a95a90aa90f	48951-1042	HUMAN OTC DRUG	Apis Aconitum		Apis Aconitum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; ATROPA BELLADONNA	12; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1043_6a0c988f-013a-e757-e053-2a91aa0a0824	48951-1043	HUMAN OTC DRUG	Apis Arnica		Apis Arnica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA	3; 3	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1044_6cbc75b7-0172-1970-e053-2a91aa0a5f2b	48951-1044	HUMAN OTC DRUG	Apis Arnica		Apis Arnica	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA	3; 3	[hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1045_6a0c111d-1bbe-72d1-e053-2a91aa0a47ff	48951-1045	HUMAN OTC DRUG	Apis Belladonna		Apis Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA	5; 4	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1049_6d83eb16-00dc-c8d1-e053-2991aa0ab1f3	48951-1049	HUMAN OTC DRUG	Apis Belladonna Mercurius		Apis Belladonna Mercurius	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA; MERCURIUS SOLUBILIS	5; 4; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1050_553d7690-fab3-2d4f-e054-00144ff88e88	48951-1050	HUMAN OTC DRUG	Apis Bryonia		Apis Bryonia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BRYONIA ALBA ROOT	3; 3	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1053_553ca1b5-b871-0e7c-e054-00144ff88e88	48951-1053	HUMAN OTC DRUG	Apis ex animale 30		Apis ex animale 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA	30	[hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1054_69f95ee5-2bbf-532f-e053-2991aa0a85ca	48951-1054	HUMAN OTC DRUG	Apis ex animale 30 Special Order		Apis ex animale 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA	30	[hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1057_69f95ee5-2bcc-532f-e053-2991aa0a85ca	48951-1057	HUMAN OTC DRUG	Apis Gelsemium		Apis Gelsemium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA ROOT; BERBERIS VULGARIS ROOT BARK; COLCHICUM AUTUMNALE FLOWER; FORMICA RUFA; GELSEMIUM SEMPERVIRENS ROOT; PSEUDOGNAPHALIUM LUTEOALBUM LEAF	4; 10; 3; 5; 5; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1058_08f4d57e-97e0-1a63-e063-6294a90a7d5f	48951-1058	HUMAN OTC DRUG	Apis Levisticum		Apis Levisticum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; LEVISTICUM OFFICINALE ROOT	3; 3	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1061_69f9cab4-11ea-dd03-e053-2a91aa0acc8f	48951-1061	HUMAN OTC DRUG	Apis Regina Cerebri		Apis Regina Cerebri	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASTRAGALUS PROPINQUUS ROOT; BOS TAURUS BRAINSTEM; ROYAL JELLY	20; 8; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1062_6d826c17-39ab-0d22-e053-2991aa0aaec0	48951-1062	HUMAN OTC DRUG	Apis regina Cerebri		Apis regina Cerebri	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA ROOT; BOS TAURUS BRAINSTEM; ROYAL JELLY	20; 8; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1063_6a0c02df-2e32-b86d-e053-2a91aa0a832d	48951-1063	HUMAN OTC DRUG	Agaricus e pl. tota 6 Special Order		Agaricus e pl. tota 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMANITA MUSCARIA FRUITING BODY	6	[hp_X]/mL			N	20241231
48951-1064_69fa21db-96b5-f096-e053-2991aa0a7283	48951-1064	HUMAN OTC DRUG	Apis venenum purum 5		Apis venenum purum 5	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA VENOM	5	[hp_X]/mL			N	20241231
48951-1065_69fa1c9d-5e6f-4593-e053-2a91aa0a7690	48951-1065	HUMAN OTC DRUG	Aquavit 1		Aquavit 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBERGRIS; ANGELICA ARCHANGELICA ROOT; ANISE; BLACK PEPPER; CALENDULA OFFICINALIS FLOWERING TOP; CARAWAY SEED; CARDAMOM; CENTAURIUM ERYTHRAEA FLOWERING TOP; CHAMOMILE; CINNAMON; COLA NUT; CORIANDER OIL; EQUISETUM ARVENSE TOP; FENNEL SEED; FERRIC OXIDE RED; FERROUS ARSENATE; FUMARIA OFFICINALIS FLOWERING TOP; GINGER; GOLD; HONEY; HYSSOPUS OFFICINALIS WHOLE; IMPERATORIA OSTRUTHIA ROOT; JUNIPER BERRY; LAVANDULA ANGUSTIFOLIA FLOWER; LESSER GALANGAL ROOT; LITSEA CUBEBA FRUIT; LONG PEPPER; MYRISTICA FRAGRANS WHOLE; OREGANO; PRUNUS SPINOSA FLOWER BUD; QUILLAJA SAPONARIA BARK; ROSA RUGOSA FLOWER; ROSMARINUS OFFICINALIS FLOWERING TOP; SAFFRON; ST. JOHN'S WORT; SWEET MARJORAM; SYZYGIUM AROMATICUM FRUIT; TANGERINE; THYME; VANILLA	10; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 11; 8; 4; 4; 12; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 11; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-1067_553eb5ab-5499-4fd6-e054-00144ff8d46c	48951-1067	HUMAN OTC DRUG	Aquilinum Taraxicum		Aquilinum Taraxicum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASPLENIUM SCOLOPENDRIUM TOP; CHELIDONIUM MAJUS; DRYOPTERIS FILIX-MAS ROOT; PTERIDIUM AQUILINUM WHOLE; SALIX PURPUREA BARK; SOLIDAGO CANADENSIS FLOWERING TOP; TARAXACUM PALUSTRE ROOT	5; 5; 5; 5; 5; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1068_57962ea7-9b9b-8666-e053-2991aa0ae35f	48951-1068	HUMAN OTC DRUG	Aquilinum Taraxacum		Aquilinum Taraxacum	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASPLENIUM SCOLOPENDRIUM TOP; CHELIDONIUM MAJUS; DRYOPTERIS FILIX-MAS ROOT; PTERIDIUM AQUILINUM WHOLE; SALIX PURPUREA BARK; SOLIDAGO CANADENSIS FLOWERING TOP; TARAXACUM PALUSTRE ROOT; WILLOW BARK	3; 3; 3; 3; 3; 3; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1069_69fa9f0c-8ca6-2bc5-e053-2991aa0a1f13	48951-1069	HUMAN OTC DRUG	Aquilinum Taraxacum		Aquilinum Taraxacum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASPLENIUM SCOLOPENDRIUM TOP; CHELIDONIUM MAJUS; DRYOPTERIS FILIX-MAS ROOT; PTERIDIUM AQUILINUM WHOLE; SALIX ALBA FLOWER; SALIX PURPUREA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM PALUSTRE ROOT; WILLOW BARK	5; 5; 5; 5; 5; 5; 5; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1070_6d826c17-399f-0d22-e053-2991aa0aaec0	48951-1070	HUMAN OTC DRUG	Aquilinum Taraxicum		Aquilinum Taraxicum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASPLENIUM SCOLOPENDRIUM TOP; CHELIDONIUM MAJUS; DRYOPTERIS FILIX-MAS ROOT; PTERIDIUM AQUILINUM WHOLE; SALIX ALBA FLOWER; SALIX PURPUREA BARK; SOLIDAGO CANADENSIS FLOWERING TOP; TARAXACUM PALUSTRE ROOT; WILLOW BARK	3; 3; 3; 3; 3; 3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1072_82f8c241-84f3-7cc1-e053-2a91aa0ac6d0	48951-1072	HUMAN OTC DRUG	Archangelica Eucalyptus		Archangelica Eucalyptus	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANGELICA ARCHANGELICA ROOT; EUCALYPTUS OIL	1; 1	[hp_X]/100g; [hp_X]/100g			N	20241231
48951-1074_7809cd18-7e80-ec0f-e053-2991aa0a0cfe	48951-1074	HUMAN OTC DRUG	Argentum 0.4		Argentum 0.4	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	1	[hp_X]/g			N	20241231
48951-1079_553ed9a5-6b01-5cfb-e054-00144ff88e88	48951-1079	HUMAN OTC DRUG	Argentum 17 Special Order		Argentum 17 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	17	[hp_X]/mL			N	20241231
48951-1083_9454d261-30d2-7fb8-e053-2a95a90ae699	48951-1083	HUMAN OTC DRUG	Argentum 30		Argentum 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	30	[hp_X]/mL			N	20241231
48951-1084_8b0e6f5b-3be4-7a6b-e053-2a95a90ad9ba	48951-1084	HUMAN OTC DRUG	Argentum 5		Argentum 5	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	5	[hp_X]/g			N	20241231
48951-1085_69fbf9d1-da80-8614-e053-2a91aa0a750f	48951-1085	HUMAN OTC DRUG	Argentum 6		Argentum 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	6	[hp_X]/mL			N	20241231
48951-1087_69fc11e4-fd7e-c4b4-e053-2a91aa0aa4db	48951-1087	HUMAN OTC DRUG	Argentum 8		Argentum 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	8	[hp_X]/mL			N	20241231
48951-1090_6d828ce5-f7fc-b14b-e053-2a91aa0abbcd	48951-1090	HUMAN OTC DRUG	Argentum Bryophyllum		Argentum Bryophyllum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; SILVER	6; 10	[hp_X]/1; [hp_X]/1			N	20241231
48951-1097_6d823054-10fb-8f32-e053-2991aa0a88d0	48951-1097	HUMAN OTC DRUG	Argentum Quartz		Argentum Quartz	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE; SILVER	30; 20	[hp_X]/1; [hp_X]/1			N	20241231
48951-1098_69fcd5ab-ab8c-9e64-e053-2991aa0a44be	48951-1098	HUMAN OTC DRUG	Argentum Quartz		Argentum Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE; SILVER	30; 20	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-1103_6d81c53d-9b81-14dc-e053-2991aa0a451d	48951-1103	HUMAN OTC DRUG	Arnica Aconitum		Arnica Aconitum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA FLOWER; BETULA PUBESCENS LEAF; MANDRAGORA OFFICINARUM ROOT	4; 1; 2; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1106_69fd6877-e25d-e5c3-e053-2a91aa0ac017	48951-1106	HUMAN OTC DRUG	Arnica Aurum 20/30		Arnica Aurum 20/30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	20; 30; 4; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1107_6d81d420-9a74-fe83-e053-2a91aa0a65d3	48951-1107	HUMAN OTC DRUG	Arnica Aurum 20/30		Arnica Aurum 20/30	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	20; 30; 4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1108_69fd4724-e115-9e0f-e053-2a91aa0a1401	48951-1108	HUMAN OTC DRUG	Arnica Aurum 6 10		Arnica Aurum 6 10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	6; 10; 4; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1109_6c447c8c-5a64-0f60-e053-2a91aa0aa014	48951-1109	HUMAN OTC DRUG	Arnica Aurum 6/10		Arnica Aurum 6/10	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	6; 10; 4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1111_69fd7580-aaa8-33fa-e053-2991aa0a0aa4	48951-1111	HUMAN OTC DRUG	Arnica Aurum Equisetum		Arnica Aurum Equisetum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; EQUISETUM ARVENSE TOP; GOLD	3; 15; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1112_6d81f605-6e7e-a2f3-e053-2a91aa0a2baa	48951-1112	HUMAN OTC DRUG	Arnica Aurum Equisetum		Arnica Aurum Equisetum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; EQUISETUM ARVENSE TOP; GOLD	3; 15; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1113_6d821cfd-b52e-520e-e053-2a91aa0ad330	48951-1113	HUMAN OTC DRUG	Arnica Berberis Teucrium		Arnica Berberis Teucrium	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BERBERIS VULGARIS ROOT BARK; TEUCRIUM SCORODONIA WHOLE	4; 2; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1115_6ce16c04-c3f9-42dc-e053-2a91aa0aafd9	48951-1115	HUMAN OTC DRUG	Arnica Betula A		Arnica Betula A	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS EYE; BOS TAURUS NERVE; BOS TAURUS PITUITARY GLAND; LEAD; SILICON DIOXIDE; SUS SCROFA THALAMUS	30; 4; 3; 17; 17; 17; 17; 17; 30; 30; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1116_69fd9c1d-c7a0-0eb7-e053-2991aa0aa070	48951-1116	HUMAN OTC DRUG	Arnica Betula B		Arnica Betula B	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; BIFENTHRIN; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS NERVE; BOS TAURUS PINEAL GLAND; HONEY; LEAD; SUS SCROFA EAR	30; 4; 3; 30; 17; 17; 17; 17; 30; 30; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1117_6d81b3a7-8213-b194-e053-2a91aa0a3934	48951-1117	HUMAN OTC DRUG	Arnica Betula B		Arnica Betula B	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; BIFENTHRIN; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS NERVE; BOS TAURUS PINEAL GLAND; HONEY; LEAD; SUS SCROFA EAR	30; 4; 3; 30; 17; 17; 17; 17; 30; 30; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1126_6a0d4e5a-c65f-67f9-e053-2991aa0af1d0	48951-1126	HUMAN OTC DRUG	Arnica e pl. tota 3		Arnica e pl. tota 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	3	[hp_X]/mL			N	20241231
48951-1128_6d816e6a-ce28-471d-e053-2a91aa0a1473	48951-1128	HUMAN OTC DRUG	Arnica e pl. tota 3		Arnica e pl. tota 3	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	3	[hp_X]/1			N	20241231
48951-1129_6c7bf385-e03c-194f-e053-2991aa0a19bb	48951-1129	HUMAN OTC DRUG	Arnica e pl. tota 30		Arnica e pl. tota 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	30	[hp_X]/mL			N	20241231
48951-1131_6d8145ca-e72d-5ed4-e053-2a91aa0a7835	48951-1131	HUMAN OTC DRUG	Arnica e pl. tota 30		Arnica e pl. tota 30	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	30	[hp_X]/1			N	20241231
48951-1132_54997f39-b3e2-60a0-e054-00144ff8d46c	48951-1132	HUMAN OTC DRUG	Arnica e pl. tota 6		Arnica e pl. tota 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	6	[hp_X]/mL			N	20241231
48951-1134_6d816e6a-ce1a-471d-e053-2a91aa0a1473	48951-1134	HUMAN OTC DRUG	Arnica e pl. tota 6		Arnica e pl. tota 6	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	6	[hp_X]/1			N	20241231
48951-1135_6d80e52a-ad92-b8f2-e053-2a91aa0ac605	48951-1135	HUMAN OTC DRUG	Arnica e rad. 12		Arnica e rad. 12	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA ROOT	12	[hp_X]/1			N	20241231
48951-1137_6d8129f8-0502-6724-e053-2991aa0a4e6d	48951-1137	HUMAN OTC DRUG	Arnica e rad. 6 Special Order		Arnica e rad. 6 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA ROOT	6	[hp_X]/1			N	20241231
48951-1141_0b517f3d-d053-3d53-e063-6394a90a8c3c	48951-1141	HUMAN OTC DRUG	Arnica Echinacea		Arnica Echinacea	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA LEAF; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; ST. JOHN'S WORT	6; 6; 6; 6; 5; 9; 6; 9; 5; 5; 6; 9; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1144_554e309d-b909-062e-e054-00144ff88e88	48951-1144	HUMAN OTC DRUG	Arnica		Arnica	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER	1	[hp_X]/mL			N	20241231
48951-1146_54c1a4ce-e569-112e-e054-00144ff8d46c	48951-1146	HUMAN OTC DRUG	Arnica Forte		Arnica Forte	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER	1	[hp_X]/g			N	20241231
48951-1152_6c7c446e-43d2-ef04-e053-2a91aa0aabab	48951-1152	HUMAN OTC DRUG	Arnica Plumbum Mel		Arnica Plumbum Mel	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; HONEY; LEAD	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1153_6d8066d6-f942-5297-e053-2a91aa0a9614	48951-1153	HUMAN OTC DRUG	Arnica Plumbum Mel		Arnica Plumbum Mel	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; HONEY; LEAD	30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1154_6c7bf385-e049-194f-e053-2991aa0a19bb	48951-1154	HUMAN OTC DRUG	Arnica Retina		Arnica Retina	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BOS TAURUS EYE; EQUISETUM ARVENSE TOP	20; 10; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1155_6c7b93ca-ee8e-3c2e-e053-2a91aa0ad23e	48951-1155	HUMAN OTC DRUG	Arnica Scorodite		Arnica Scorodite	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BOS TAURUS CEREBELLUM; FERROUS ARSENATE; FLUORAPATITE; LEVISTICUM OFFICINALE ROOT; ORCHIS MASCULA TUBER; OSTREA EDULIS SHELL; SILICON DIOXIDE; SODIUM CARBONATE	6; 8; 7; 7; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1156_6ce311c8-0d7c-51da-e053-2a91aa0a7875	48951-1156	HUMAN OTC DRUG	Arnica Scorodite		Arnica Scorodite	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BOS TAURUS CEREBELLUM; FERROUS ARSENATE; FLUORAPATITE; LEVISTICUM OFFICINALE ROOT; ORCHIS MASCULA TUBER; OSTREA EDULIS SHELL; SILICON DIOXIDE; SODIUM CARBONATE	6; 8; 7; 7; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1157_0ac2e24a-5d9f-6e69-e063-6394a90a0af1	48951-1157	HUMAN OTC DRUG	Arnica Stannum		Arnica Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BOS TAURUS BONE; BOS TAURUS TENDON; COMFREY ROOT; ONION; RUTA GRAVEOLENS FLOWERING TOP; TIN	6; 17; 17; 6; 6; 6; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-1158_6d8066d6-f94f-5297-e053-2a91aa0a9614	48951-1158	HUMAN OTC DRUG	Arnica Stannum		Arnica Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BOS TAURUS BONE; BOS TAURUS TENDON; COMFREY ROOT; ONION; RUTA GRAVEOLENS FLOWERING TOP; TIN	6; 17; 17; 6; 6; 6; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-1161_6d726a30-ca64-dfef-e053-2991aa0ab109	48951-1161	HUMAN OTC DRUG	Arsenicum album 30		Arsenicum album 30	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE	30	[hp_X]/1			N	20241231
48951-1163_6c6a0daa-de23-5455-e053-2991aa0a4cf8	48951-1163	HUMAN OTC DRUG	Arsenicum Cerebrum		Arsenicum Cerebrum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA ROOT; ARSENIC TRIOXIDE; BOS TAURUS BRAIN; BOS TAURUS FRONTAL LOBE; SILVER SULFIDE; SUS SCROFA TEMPORAL LOBE	6; 30; 8; 8; 20; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1169_6c698a0e-3414-4dc0-e053-2991aa0a1888	48951-1169	HUMAN OTC DRUG	Articulatio humeri 6 Special Order		Articulatio humeri 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS JOINT CAPSULE	6	[hp_X]/mL			N	20241231
48951-1170_6c7c9125-5b77-7c97-e053-2991aa0a33ae	48951-1170	HUMAN OTC DRUG	Articulatio interphalangea 17 Special Order		Articulatio interphalangea 17 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF	17	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1171_6a0f035f-a3d3-def4-e053-2a91aa0a97a6	48951-1171	HUMAN OTC DRUG	Astragalus Arnica		Astragalus Arnica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; ASTRAGALUS PROPINQUUS ROOT	30; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-1173_6c6980b6-8e6d-5b39-e053-2a91aa0a3d14	48951-1173	HUMAN OTC DRUG	Astragalus e rad. 3		Astragalus e rad. 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASTRAGALUS PROPINQUUS ROOT	3	[hp_X]/mL			N	20241231
48951-1174_6c7c9fd6-bea1-6f52-e053-2a91aa0aab2c	48951-1174	HUMAN OTC DRUG	Astragalus Formica		Astragalus Formica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; ASTRAGALUS PROPINQUUS ROOT; FORMICA RUFA; SILVER	3; 3; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1177_6b502268-3e81-7fcb-e053-2991aa0aabdc	48951-1177	HUMAN OTC DRUG	Aurum 20		Aurum 20	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	20	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1178_09a8c775-e1c4-ec01-e063-6394a90a69b0	48951-1178	HUMAN OTC DRUG	Aurum 30		Aurum 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	30	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1180_7aa22457-c32b-3cd5-e053-2991aa0a87a1	48951-1180	HUMAN OTC DRUG	Aurum 5		Aurum 5	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	5	[hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1181_6c6980b6-8e61-5b39-e053-2a91aa0a3d14	48951-1181	HUMAN OTC DRUG	Aurum 6		Aurum 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	6	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1184_6a104bc5-cec4-fb6e-e053-2a91aa0a3684	48951-1184	HUMAN OTC DRUG	Aurum Crataegus		Aurum Crataegus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CAMPHOR (NATURAL); GOLD; HAWTHORN LEAF WITH FLOWER; SELENICEREUS GRANDIFLORUS STEM; STROPHANTHUS KOMBE WHOLE; TARAXACUM PALUSTRE ROOT; VALERIAN	4; 10; 3; 4; 6; 2; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1186_eeb2b5ea-474d-33c4-e053-2a95a90a8511	48951-1186	HUMAN OTC DRUG	Aurum Equisetum A		Aurum Equisetum A	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; EQUISETUM ARVENSE TOP; GOLD; PORK KIDNEY	8; 17; 10; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1187_6d71cacc-313d-de67-e053-2a91aa0a5a91	48951-1187	HUMAN OTC DRUG	Aurum Equisetum A		Aurum Equisetum A	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; EQUISETUM ARVENSE TOP; GOLD; PORK KIDNEY	8; 17; 10; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1188_6c689177-addd-55f3-e053-2991aa0a171d	48951-1188	HUMAN OTC DRUG	Aurum Equisetum B		Aurum Equisetum B	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; GOLD	17; 30	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1189_6c43d82c-f7b6-5765-e053-2991aa0afc75	48951-1189	HUMAN OTC DRUG	Aurum Equisetum B		Aurum Equisetum B	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; GOLD	17; 30	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1190_6a105cb3-2167-b8cc-e053-2991aa0a5e1e	48951-1190	HUMAN OTC DRUG	Aurum Hypericum		Aurum Hypericum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AVENA SATIVA FLOWERING TOP; GOLD TRICHLORIDE; MAGNESIUM HYDROXIDE; MAMMAL LIVER; PHOSPHORIC ACID; ROYAL JELLY; SILICON DIOXIDE; ST. JOHN'S WORT; STRYCHNOS IGNATII SEED	3; 7; 4; 4; 5; 6; 7; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-1192_6d718999-1087-6467-e053-2991aa0afc25	48951-1192	HUMAN OTC DRUG	Aurum Hypericum Stibium		Aurum Hypericum Stibium	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; ST. JOHN'S WORT	10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1195_57d2de67-dfcd-3215-e053-2a91aa0aaccd	48951-1195	HUMAN OTC DRUG	Aurum Lavender Rose		Aurum Lavender Rose	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; FRANKINCENSE; GOLD; HORSE CHESTNUT; MYRRH; ST. JOHN'S WORT	3; 10; 13; 3; 10; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1196_6c687ac1-6885-f7d0-e053-2991aa0afe6e	48951-1196	HUMAN OTC DRUG	Aurum Olibanum Myrrha		Aurum Olibanum Myrrha	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FRANKINCENSE; GOLD; MYRRH	7; 10; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1199_6c688c44-cfeb-c8f9-e053-2991aa0a2ecf	48951-1199	HUMAN OTC DRUG	Aurum Onopordon		Aurum Onopordon	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; FORMICA RUFA; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	10; 10; 10; 4; 2; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1200_6a84d9c2-eb3d-2e81-e053-2a91aa0ae883	48951-1200	HUMAN OTC DRUG	Aurum Plumbum		Aurum Plumbum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; GOLD; HONEY; LEAD	10; 10; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1201_6d718999-1074-6467-e053-2991aa0afc25	48951-1201	HUMAN OTC DRUG	Aurum Plumbum		Aurum Plumbum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; GOLD; LEAD	10; 10; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1202_6c69360b-2c2e-25a3-e053-2991aa0a6429	48951-1202	HUMAN OTC DRUG	Aurum Prunus		Aurum Prunus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD; SLOE	10; 6	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1203_6a10217e-c0c4-4f4c-e053-2991aa0a3fcd	48951-1203	HUMAN OTC DRUG	Aurum Prunus		Aurum Prunus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD; SLOE	10; 6	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1204_6d71942f-3113-8f2d-e053-2991aa0a029b	48951-1204	HUMAN OTC DRUG	Aurum Prunus		Aurum Prunus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD; SLOE	10; 6	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1205_0a4a5d34-76d1-e0c9-e063-6394a90a78b8	48951-1205	HUMAN OTC DRUG	Aurum Stibium Hyoscyamus		Aurum Stibium Hyoscyamus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	8; 10; 4; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1206_6a346e13-ada3-be3a-e053-2991aa0abba6	48951-1206	HUMAN OTC DRUG	AURUM STIBIUM HYOSCYAMUS		AURUM STIBIUM HYOSCYAMUS	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		URIEL PHARMACY INC.	ANTIMONY; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	8; 10; 4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1208_6d71a428-6ba6-92ae-e053-2a91aa0a3db8	48951-1208	HUMAN OTC DRUG	Aurum Stibium Special Order		Aurum Stibium Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD	8; 10	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1211_6c69bd38-d485-fbe8-e053-2a91aa0a3fe0	48951-1211	HUMAN OTC DRUG	Avena Valeriana		Avena Valeriana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AVENA SATIVA FLOWERING TOP; OSTREA EDULIS SHELL; PHOSPHORUS; SULFUR; VALERIAN	6; 7; 30; 30; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1214_698459af-8578-55f5-e053-2a91aa0aac82	48951-1214	HUMAN OTC DRUG	Apis Belladonna Mercurius		Apis Belladonna Mercurius	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA; MERCURIUS SOLUBILIS	5; 4; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1221_69fbd7ab-f148-7f90-e053-2a91aa0a6b9d	48951-1221	HUMAN OTC DRUG	Argentum 0.4 Adult Size (cocoa butter) Special Order		Argentum 0.4 Adult Size (cocoa butter) Special Order	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	1	[hp_X]/g			N	20241231
48951-1224_8afba694-148d-5571-e053-2a95a90a3e19	48951-1224	HUMAN OTC DRUG	Astragalus Formica Special Order		Astragalus Formica Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; ASTRAGALUS PROPINQUUS ROOT; FORMICA RUFA; SILVER	3; 3; 6; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1226_6d83d3db-d2c5-106a-e053-2a91aa0aeb7d	48951-1226	HUMAN OTC DRUG	Apis Eucalyptus Special Order		Apis Eucalyptus Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA; EUCALYPTUS GUM	3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1227_553f8af1-435b-7247-e054-00144ff8d46c	48951-1227	HUMAN OTC DRUG	Arnica Apis Nervus trigeminus Special Order		Arnica Apis Nervus trigeminus Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA; BOS TAURUS NERVE	20; 20; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1228_69fd4724-e120-9e0f-e053-2a91aa0a1401	48951-1228	HUMAN OTC DRUG	Arnica Aurum 15/10 Special Order		Arnica Aurum 15/10 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; GOLD	15; 10	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1230_6c689177-adcd-55f3-e053-2991aa0a171d	48951-1230	HUMAN OTC DRUG	Aurum Hypericum Stibium Special Order		Aurum Hypericum Stibium Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; ST. JOHN'S WORT	10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1231_6a0d288e-c2f4-7389-e053-2991aa0afc05	48951-1231	HUMAN OTC DRUG	Arnica Carbo Special Order		Arnica Carbo Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; ARNICA MONTANA ROOT; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MELILOTUS INDICUS SEED	10; 6; 6; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1234_69fc8b9f-0ddd-5d25-e053-2a91aa0a6884	48951-1234	HUMAN OTC DRUG	Argentum carbonicum 6 Special Order		Argentum carbonicum 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER CARBONATE	6	[hp_X]/mL			N	20241231
48951-1235_69f8d71f-7b80-1ebb-e053-2a91aa0aedad	48951-1235	HUMAN OTC DRUG	Apis ex animale 4 Special Order		Apis ex animale 4 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA	4	[hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1241_553c8a15-23eb-3bd7-e054-00144ff8d46c	48951-1241	HUMAN OTC DRUG	Antimonite Echincea Special Order		Antimonite Echincea Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY TRISULFIDE; BEEF; BOS TAURUS OVARY; ECHINACEA, UNSPECIFIED; SUS SCROFA FALLOPIAN TUBE	8; 6; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1250_6c69bd38-d494-fbe8-e053-2a91aa0a3fe0	48951-1250	HUMAN OTC DRUG	Aurum Equisetum 10/15 Special Order		Aurum Equisetum 10/15 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; GOLD	15; 10	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1252_55517295-1285-4930-e054-00144ff8d46c	48951-1252	HUMAN OTC DRUG	Arnica Retina Quartz Special Order		Arnica Retina Quartz Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY TRISULFIDE; ARNICA MONTANA; BOS TAURUS EYE; EQUISETUM ARVENSE TOP; SILICON DIOXIDE	10; 20; 10; 20; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1256_6a0c4b5c-0855-590c-e053-2991aa0a806b	48951-1256	HUMAN OTC DRUG	Allium Cuprum comp. Special Order		Allium Cuprum comp. Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC SULFATE; GARLIC; ONION	3; 2; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-1257_6d8363d8-8b2b-c36f-e053-2a91aa0a3ce4	48951-1257	HUMAN OTC DRUG	Apis ex animale 30 Special Order		Apis ex animale 30 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA	30	[hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1259_6a0ea8fc-1cbc-6413-e053-2a91aa0a1e5c	48951-1259	HUMAN OTC DRUG	Arsenicum Cerebrum Special Order		Arsenicum Cerebrum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA ROOT; ARSENIC TRIOXIDE; BOS TAURUS BRAIN; BOS TAURUS FRONTAL LOBE; SILVER SULFIDE; SUS SCROFA TEMPORAL LOBE	6; 30; 8; 8; 20; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1260_6a0eaf5e-3f0e-1d8a-e053-2991aa0aef85	48951-1260	HUMAN OTC DRUG	Artemesia absinthium 5 Special Order		Artemesia absinthium 5 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	WORMWOOD	1	[hp_X]/mL			N	20241231
48951-1261_6a0ed1ed-f2a7-45b9-e053-2991aa0a7b99	48951-1261	HUMAN OTC DRUG	Arum maculatum Pteridium 5/5 Special Order		Arum maculatum Pteridium 5/5 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARUM MACULATUM ROOT; PTERIDIUM AQUILINUM WHOLE	5; 5	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-1262_6d724769-e8fa-935a-e053-2991aa0af7e7	48951-1262	HUMAN OTC DRUG	Aurum Belladonna Special Order		Aurum Belladonna Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; FRANKINCENSE; GOLD; MYRRH	8; 7; 10; 7	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1266_6a1027d7-0621-c551-e053-2a91aa0a1853	48951-1266	HUMAN OTC DRUG	Aurum Stibium Special Order		Aurum Stibium Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD	8; 10	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1270_7cc2ff8e-b639-b8d6-e053-2a91aa0a2b87	48951-1270	HUMAN OTC DRUG	Amber Amethyst		Amber Amethyst	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBER; EQUISETUM ARVENSE TOP; HORSE CHESTNUT; SILICON DIOXIDE	3; 2; 2; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1273_6d83d3db-d2d2-106a-e053-2a91aa0aeb7d	48951-1273	HUMAN OTC DRUG	Apis Belladonna		Apis Belladonna	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	APIS MELLIFERA; ATROPA BELLADONNA	5; 4	[hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1274_994a17d8-842b-3bd2-e053-2a95a90a243a	48951-1274	HUMAN OTC DRUG	Argentum Calendula		Argentum Calendula	OINTMENT	VAGINAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS OVARY; CALENDULA OFFICINALIS FLOWERING TOP; SILVER; SLOE	7; 1; 3; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1275_0b60d65b-4a9d-cdca-e063-6294a90a6593	48951-1275	HUMAN OTC DRUG	Apis Levisticum		Apis Levisticum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	APIS MELLIFERA; LEVISTICUM OFFICINALE LEAF	3; 3	[hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1276_69706e43-761f-0ef3-e053-2a91aa0ae715	48951-1276	HUMAN OTC DRUG	Aquavit		Aquavit	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ANGELICA ARCHANGELICA ROOT; ANISE; BLACK PEPPER; CALENDULA OFFICINALIS FLOWERING TOP; CARAWAY SEED; CINCHONA OFFICINALIS BARK; EQUISETUM ARVENSE TOP; GINGER; GOLD; HYPERICUM PERFORATUM; JUNIPER BERRY; MATRICARIA RECUTITA; MELISSA OFFICINALIS; ORIGANUM MAJORANA; PRUNUS SPINOSA BUDDING TOP; ROSE PETAL EXTRACT; ROSEMARY; SAGE	1; 1; 1; 1; 1; 2; 1; 1; 3; 3; 1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-1277_6d80a06a-6e85-f3c9-e053-2991aa0ab178	48951-1277	HUMAN OTC DRUG	Arnica Echinacea		Arnica Echinacea	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; ST. JOHN'S WORT	6; 6; 6; 6; 5; 9; 6; 9; 5; 5; 6; 9; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1278_6d71cacc-3157-de67-e053-2a91aa0a5a91	48951-1278	HUMAN OTC DRUG	Aurum Crataegus		Aurum Crataegus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	CAMPHOR (SYNTHETIC); GOLD; HAWTHORN LEAF WITH FLOWER; SELENICEREUS GRANDIFLORUS STEM; STROPHANTHUS HISPIDUS SEED; TARAXACUM OFFICINALE; VALERIAN	4; 10; 3; 4; 6; 2; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1279_6d7204ad-ad9a-345e-e053-2a91aa0af8f4	48951-1279	HUMAN OTC DRUG	Avena Valeriana		Avena Valeriana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	AVENA SATIVA FLOWERING TOP; OSTREA EDULIS SHELL; PHOSPHORUS; SULFUR; VALERIAN	3; 7; 30; 30; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1280_6e0e9ba8-2c0c-0e2f-e053-2991aa0aa488	48951-1280	HUMAN OTC DRUG	Threefold Balance		Threefold Balance	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	GOLD; MYRRH	10; 7	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1281_6d72373c-e954-27e1-e053-2a91aa0a6d41	48951-1281	HUMAN OTC DRUG	Aurum Hypericum		Aurum Hypericum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	APIS MELLIFERA; GOLD TRICHLORIDE; HYPERICUM PERFORATUM; MAGNESIUM; MAMMAL LIVER; OAT; PHOSPHORIC ACID; SILICON DIOXIDE; STRYCHNOS IGNATII SEED	6; 7; 3; 5; 5; 3; 5; 7; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1282_6a0e116f-b768-056c-e053-2991aa0afa35	48951-1282	HUMAN OTC DRUG	Arnica Nettle Burn and Bite		Arnica Nettle Burn and Bite	SPRAY	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; LARIX DECIDUA RESIN; LYTTA VESICATORIA; SILVER; THUJA OCCIDENTALIS WHOLE; URTICA URENS	1; 2; 2; 2; 7; 8; 2; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1283_8b211ae0-9462-7e77-e053-2995a90acc54	48951-1283	HUMAN OTC DRUG	Argentum Malachite		Argentum Malachite	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AZADIRACHTA INDICA FLOWER; CUPRIC CATION; MERCURY; SILVER	2; 3; 6; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1285_6b3ec25a-65b0-de80-e053-2991aa0aa70d	48951-1285	HUMAN OTC DRUG	Aquilinum Taraxacum Ampules		Aquilinum Taraxacum Ampules	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASPLENIUM SCOLOPENDRIUM TOP; CHELIDONIUM MAJUS; DRYOPTERIS FILIX-MAS ROOT; PTERIDIUM AQUILINUM WHOLE; SALIX ALBA FLOWER; SALIX PURPUREA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM PALUSTRE ROOT; WILLOW BARK	5; 5; 5; 5; 5; 5; 5; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1287_6b3e87de-23e1-7b89-e053-2991aa0aef43	48951-1287	HUMAN OTC DRUG	Arnica Aurum Special Order		Arnica Aurum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; GOLD	20; 30	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1288_6b3ec25a-65bc-de80-e053-2991aa0aa70d	48951-1288	HUMAN OTC DRUG	Arnica Bryonia Special Order		Arnica Bryonia Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BRYONIA ALBA ROOT	4; 2; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1289_6b3f6c79-1b8f-3bf3-e053-2991aa0a3fc1	48951-1289	HUMAN OTC DRUG	Arnica Cordifolia Essence		Arnica Cordifolia Essence	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA CORDIFOLIA WHOLE	1	[hp_X]/mL			N	20241231
48951-1291_6b4e86e1-b370-634a-e053-2a91aa0aeb35	48951-1291	HUMAN OTC DRUG	Arsenicum 6/12/30 Special Order		Arsenicum 6/12/30 Special Order	SPRAY	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE	6	[hp_X]/mL			N	20241231
48951-1292_6b4f9b22-c4b2-1459-e053-2a91aa0af412	48951-1292	HUMAN OTC DRUG	Aurum 6 Special Order		Aurum 6 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	6	[hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1294_6b5033d9-681a-9ce8-e053-2991aa0a0da3	48951-1294	HUMAN OTC DRUG	Aurum Hypericum Special Order		Aurum Hypericum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AVENA SATIVA FLOWERING TOP; GOLD TRICHLORIDE; MAGNESIUM HYDROXIDE; MAMMAL LIVER; PHOSPHORIC ACID; ROYAL JELLY; SILICON DIOXIDE; ST. JOHN'S WORT; STRYCHNOS IGNATII SEED	3; 7; 5; 5; 5; 6; 7; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-1299_6c538f50-fd8d-272b-e053-2a91aa0a31bc	48951-1299	HUMAN OTC DRUG	Aurum Stibium Hyoscyamus		Aurum Stibium Hyoscyamus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	8; 10; 4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1308_77f72303-08a7-a101-e053-2991aa0a62eb	48951-1308	HUMAN OTC DRUG	Arnica Forte		Arnica Forte	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER	1	[hp_X]/g			N	20241231
48951-1309_8b21311e-a453-3086-e053-2995a90a0814	48951-1309	HUMAN OTC DRUG	Argentum Malachite		Argentum Malachite	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AZADIRACHTA INDICA FLOWER; CUPRIC CATION; MERCURY; SILVER	2; 3; 6; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1310_7ab5dccb-c570-3d10-e053-2991aa0a422c	48951-1310	HUMAN OTC DRUG	Ananassa Arnica		Ananassa Arnica	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; LARIX DECIDUA RESIN; PINEAPPLE; SILICON DIOXIDE	3; 2; 2; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1311_7acbf92b-c919-20ba-e053-2991aa0a4e66	48951-1311	HUMAN OTC DRUG	Aquilinum Taraxacum		Aquilinum Taraxacum	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASPLENIUM SCOLOPENDRIUM TOP; CHELIDONIUM MAJUS; DRYOPTERIS FILIX-MAS ROOT; PTERIDIUM AQUILINUM WHOLE; SALIX ALBA FLOWER; SALIX PURPUREA BARK; SOLIDAGO CANADENSIS FLOWERING TOP; TARAXACUM PALUSTRE ROOT; WILLOW BARK	3; 3; 3; 3; 3; 3; 3; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1313_7ef670a1-b87b-f187-e053-2a91aa0a9f9c	48951-1313	HUMAN OTC DRUG	Argentum Viscum		Argentum Viscum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS EYE; SILVER CHLORIDE; VISCUM ALBUM FRUITING TOP	8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1314_81a2e5a8-8241-7ddd-e053-2a91aa0a86e8	48951-1314	HUMAN OTC DRUG	Arnica Hypericum Special Order		Arnica Hypericum Special Order	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ANTIMONY; ARNICA MONTANA FLOWER; GOLD; OXALIS STRICTA WHOLE; PENOXSULAM; SEDUM ROSEUM WHOLE; ST. JOHN'S WORT; URTICA DIOICA	6; 6; 6; 6; 6; 12; 12; 5; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1317_8afcd2a3-38d7-2f96-e053-2995a90afc06	48951-1317	HUMAN OTC DRUG	Argentum Nitricum 4X		Argentum Nitricum 4X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	4	[hp_X]/mL			N	20241231
48951-1318_93f243c0-b964-9ea0-e053-2995a90aa852	48951-1318	HUMAN OTC DRUG	Aurum 21X		Aurum 21X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	21	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1319_93f29db8-7355-1ee9-e053-2995a90a2a7d	48951-1319	HUMAN OTC DRUG	Aurum 8X		Aurum 8X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	8	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1320_9404af09-a5f0-4a26-e053-2995a90aa0ff	48951-1320	HUMAN OTC DRUG	Aurum 21X Special Order		Aurum 21X Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	21	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1321_94063fee-1d9b-11d4-e053-2995a90ab0d1	48951-1321	HUMAN OTC DRUG	Argentum 12X		Argentum 12X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	12	[hp_X]/mL			N	20241231
48951-1322_9406b88e-1a67-39ec-e053-2a95a90aa6f4	48951-1322	HUMAN OTC DRUG	Argentum 21X		Argentum 21X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	21	[hp_X]/mL			N	20241231
48951-1323_9455b992-37bc-4357-e053-2995a90abfce	48951-1323	HUMAN OTC DRUG	Aurum 12X		Aurum 12X	LIQUID	ORAL	20191007		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1324_09a874aa-9be3-322a-e063-6294a90a4944	48951-1324	HUMAN OTC DRUG	Aurum 30X		Aurum 30X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	30	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1325_94576211-8b7a-03b1-e053-2a95a90a93df	48951-1325	HUMAN OTC DRUG	Argentum 6X		Argentum 6X	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	6	[hp_X]/1			N	20241231
48951-1326_9457a21c-83dc-5149-e053-2995a90a886e	48951-1326	HUMAN OTC DRUG	Aurum 6X		Aurum 6X	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	6	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1327_953266cc-52ee-1c4a-e053-2995a90a4372	48951-1327	HUMAN OTC DRUG	Arnica Rosa		Arnica Rosa	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BOS TAURUS BRAIN; BOS TAURUS EYE; BOS TAURUS NERVE; SILICON DIOXIDE	17; 7; 6; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1328_969c0200-c8a6-0517-e053-2a95a90aa264	48951-1328	HUMAN OTC DRUG	Argentum 21X		Argentum 21X	LIQUID	ORAL	20191105		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER	21	[hp_X]/mL			N	20241231
48951-1329_96c7bd49-27cc-574f-e053-2a95a90ac334	48951-1329	HUMAN OTC DRUG	Argentum Saccharum Special Order		Argentum Saccharum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS STRICTA WHOLE; SILVER; SUGARCANE	6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1330_96b1e2b2-9e71-3489-e053-2995a90a0eb8	48951-1330	HUMAN OTC DRUG	Ananassa Resina		Ananassa Resina	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LARIX DECIDUA RESIN; PINEAPPLE; SILICON DIOXIDE	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1331_96b174e1-405a-9932-e053-2995a90ac5f3	48951-1331	HUMAN OTC DRUG	Ananassa Resina		Ananassa Resina	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LARIX DECIDUA RESIN; PINEAPPLE; SILICON DIOXIDE	2; 2; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1333_982f7873-09ae-2bef-e053-2a95a90ac783	48951-1333	HUMAN OTC DRUG	Arnica e pl. tota 10X Special Order		Arnica e pl. tota 10X Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	10	[hp_X]/mL			N	20241231
48951-1334_6a0ea8fc-1cae-6413-e053-2a91aa0a1e5c	48951-1334	HUMAN OTC DRUG	Arsenicum album 30X Special Order		Arsenicum album 30XSpecial Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE	30	[hp_X]/mL			N	20241231
48951-1335_98308659-49ed-1c15-e053-2995a90a7bda	48951-1335	HUMAN OTC DRUG	Arsenicum album 6X Special Order		Arsenicum album 6X Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE	6	[hp_X]/mL			N	20241231
48951-1336_983203fc-5c51-2888-e053-2995a90a6d67	48951-1336	HUMAN OTC DRUG	Arnica e rad. 20X		Arnica e rad. 20X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA ROOT	20	[hp_X]/mL			N	20241231
48951-1337_6a0db083-3391-b3ab-e053-2a91aa0a1dd5	48951-1337	HUMAN OTC DRUG	Arnica e pl. tota 20X Special Order		Arnica e pl. tota 20X Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	20	[hp_X]/mL			N	20241231
48951-1339_b6acddc9-b4f4-4b25-e053-2995a90a175e	48951-1339	HUMAN OTC DRUG	Arnica comp.		Arnica comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA; BAPTISIA AUSTRALIS ROOT; BENZOIC ACID; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE WHOLE; ECHINACEA, UNSPECIFIED; EUCALYPTUS GUM; EUPATORIUM CANNABINUM FLOWERING TOP; MERCURIALIS PERENNIS; SOLANUM DULCAMARA FLOWER; SOLANUM LYCOPERSICUM FRUITING TOP; SOLANUM NIGRUM FRUIT; TOXICODENDRON PUBESCENS LEAF	5; 4; 5; 6; 5; 5; 4; 5; 5; 4; 5; 4; 8; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1340_de5d3f29-19b4-379b-e053-2a95a90a0ae8	48951-1340	HUMAN OTC DRUG	Aurum Hypericum Stibium		Aurum Hypericum Stibium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; ST. JOHN'S WORT	10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1341_b6fbe2d9-dd42-375d-e053-2a95a90ac263	48951-1341	HUMAN OTC DRUG	Aurum Strophanthus		Aurum Strophanthus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD; STROPHANTHUS KOMBE WHOLE	12; 6	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1342_b7004cae-4ada-2291-e053-2a95a90a5d43	48951-1342	HUMAN OTC DRUG	Arnica 10%		Arnica 10%	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER	1	[hp_X]/g			N	20241231
48951-1343_b71241d5-556a-1491-e053-2a95a90a35dc	48951-1343	HUMAN OTC DRUG	Apis Bryonia		Apis Bryonia	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BRYONIA ALBA ROOT	3; 3	[hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1344_b712c185-71d6-62e7-e053-2a95a90a1dc7	48951-1344	HUMAN OTC DRUG	Argentum Saccharum		Argentum Saccharum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS ACETOSELLA LEAF; SILVER; SUGARCANE	6; 6; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-1346_bd35c88f-c647-4136-e053-2a95a90a0cc1	48951-1346	HUMAN OTC DRUG	Aurum Stibium		Aurum Stibium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD	8; 10	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1347_0bc9785e-681d-58be-e063-6394a90ab576	48951-1347	HUMAN OTC DRUG	Aquavit		Aquavit	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBERGRIS; ANGELICA ARCHANGELICA ROOT; ANISE; BLACK PEPPER; CALENDULA OFFICINALIS FLOWERING TOP; CARAWAY SEED; CARDAMOM; CENTAURIUM ERYTHRAEA FLOWERING TOP; CHAMOMILE; CINNAMON; COLA NITIDA SEED; CORIANDER OIL; EQUISETUM ARVENSE TOP; FENNEL SEED; FERRIC OXIDE RED; FERROUS ARSENATE; FUMARIA OFFICINALIS FLOWERING TOP; GINGER; GOLD; HONEY; HYSSOPUS OFFICINALIS WHOLE; IMPERATORIA OSTRUTHIA ROOT; JUNIPER BERRY; LAVANDULA ANGUSTIFOLIA FLOWER; LESSER GALANGAL ROOT; LITSEA CUBEBA FRUIT; LONG PEPPER; MYRISTICA FRAGRANS WHOLE; NUTMEG; OREGANO; PRUNUS SPINOSA FLOWER BUD; QUILLAJA SAPONARIA BARK; ROSMARINUS OFFICINALIS FLOWERING TOP; SAFFRON; SEDUM ROSEUM WHOLE; ST. JOHN'S WORT; SWEET MARJORAM; SYZYGIUM AROMATICUM FRUIT; TANGERINE; THYME; VANILLA BEAN; WHITE PEPPER	11; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 9; 6; 2; 2; 10; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 9; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-1348_c675c885-7b2a-1346-e053-2995a90a47d0	48951-1348	HUMAN OTC DRUG	Arnica Nettle		Arnica Nettle	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; LARIX DECIDUA RESIN; LYTTA VESICATORIA; SILVER; THUJA OCCIDENTALIS WHOLE; URTICA URENS	1; 2; 2; 2; 7; 8; 2; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1349_c706aaf0-a97b-7848-e053-2995a90a0aca	48951-1349	HUMAN OTC DRUG	Aurum 10X		Aurum 10X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD	10	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1350_c8c1e7ab-5477-ffb2-e053-2995a90ae1fb	48951-1350	HUMAN OTC DRUG	Arnica Hypericum DKS		Arnica Hypericum DKS	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACONITUM NAPELLUS; ANTIMONY; ARNICA MONTANA FLOWER; GOLD; OXALIS STRICTA WHOLE; PENOXSULAM; SEDUM ROSEUM WHOLE; ST. JOHN'S WORT; URTICA DIOICA	6; 6; 6; 6; 6; 12; 6; 5; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1352_0a2151ce-82f2-629a-e063-6394a90a7e1b	48951-1352	HUMAN OTC DRUG	Arnica Betula A		Arnica Betula A	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; BETULA PENDULA LEAF; BETULA PUBESCENS BARK; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS EYE; BOS TAURUS NERVE; BOS TAURUS PITUITARY GLAND; C12-17 ALKANE; FORMICA RUFA; HONEY; LEAD; SILICON DIOXIDE; SUS SCROFA THALAMUS	30; 3; 4; 17; 17; 17; 17; 17; 17; 30; 30; 30; 30; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-1353_d2d18086-8f38-1acf-e053-2a95a90ac9e3	48951-1353	HUMAN OTC DRUG	Apis Phosphorus		Apis Phosphorus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	APIS MELLIFERA; PHOSPHORUS; SILVER SULFIDE	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1354_d694f7c5-050b-1883-e053-2995a90afc79	48951-1354	HUMAN OTC DRUG	Arnica Nettle		Arnica Nettle	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; LYTTA VESICATORIA; THUJA OCCIDENTALIS WHOLE; URTICA URENS	1; 1; 1; 3; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1355_d8a24966-49da-fb8c-e053-2995a90a535f	48951-1355	HUMAN OTC DRUG	Apis Bryonia		Apis Bryonia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BRYONIA ALBA ROOT	3; 3	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-1356_de5e946e-e066-2af5-e053-2a95a90aeb01	48951-1356	HUMAN OTC DRUG	Aurum Ferrum Sidereum 10/10		Aurum Ferrum Sidereum 10/10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	GOLD; IRON	10; 10	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-1358_eac58c77-dbf6-c9ee-e053-2a95a90a70e1	48951-1358	HUMAN OTC DRUG	Argentum Veratrum		Argentum Veratrum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	APIS MELLIFERA; BOS TAURUS PARATHYROID GLAND; CUPRIC SULFATE; GOLD; MAGNESIUM SULFATE, UNSPECIFIED; PHOSPHORUS; ROYAL JELLY; SILVER; SUGARCANE; SUS SCROFA PANCREAS; TARAXACUM PALUSTRE ROOT; URTICA DIOICA; VERATRUM ALBUM ROOT	5; 8; 4; 9; 4; 6; 5; 6; 5; 5; 2; 2; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-1359_ed38a70c-9874-8823-e053-2a95a90aad06	48951-1359	HUMAN OTC DRUG	Aconitum Bryonia		Aconitum Bryonia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT	3; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-1361_f9c7dc5c-1310-3790-e053-6294a90aa437	48951-1361	HUMAN OTC DRUG	Amethyst Rosa		Amethyst Rosa	CAPSULE	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; FUMARIA OFFICINALIS FLOWERING TOP; GRAPHITE; SILICON DIOXIDE	2; 5; 3; 15; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1362_0b606911-13ce-87a2-e063-6294a90abef0	48951-1362	HUMAN OTC DRUG	Arnica Echinacea		Arnica Echinacea	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ARNICA MONTANA FLOWER; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CHAMOMILE; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA TOP; MERCURY; ST. JOHN'S WORT	6; 6; 6; 3; 6; 5; 9; 6; 6; 9; 5; 5; 9; 5	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1363_05d0d352-ad34-fc60-e063-6394a90ab0c5	48951-1363	HUMAN OTC DRUG	Amethyst Rosa		Amethyst Rosa	CAPSULE	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACORUS CALAMUS ROOT; ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; BETULA PUBESCENS BARK; BLACK PEPPER; CHAMOMILE; COCHLEARIA OFFICINALIS FLOWERING TOP; FERRIC OXIDE RED; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GEUM URBANUM ROOT; GINGER; GRAPHITE; OXALIS STRICTA WHOLE; ROSA RUGOSA FLOWER; SEDUM ROSEUM WHOLE; SILICON DIOXIDE; URTICA DIOICA; WORMWOOD	4; 2; 5; 4; 5; 4; 4; 6; 3; 4; 4; 4; 15; 4; 4; 4; 2; 4; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-1364_05f59510-8570-6889-e063-6294a90ac147	48951-1364	HUMAN OTC DRUG	Argentum Calendula		Argentum Calendula	OINTMENT	VAGINAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS OVARY; CALENDULA OFFICINALIS FLOWERING TOP; SILVER; SLOE	6; 1; 3; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-1365_06eacfa6-d100-1bd2-e063-6394a90a08b5	48951-1365	HUMAN OTC DRUG	Arsenicum album 30X		Arsenicum album 30X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ARSENIC TRIOXIDE	30	[hp_X]/mL			N	20241231
48951-1366_06f9bf42-b42f-f5e8-e063-6394a90ad421	48951-1366	HUMAN OTC DRUG	Articulatio coxae 8X		Articulatio coxae 8X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF	8	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-1367_0c7dc8ac-5119-db15-e063-6294a90a774e	48951-1367	HUMAN OTC DRUG	Arnica e pl. tota 30X		Arnica e pl. tota 30X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ARNICA MONTANA	30	[hp_X]/mL			N	20241231
48951-1368_0c93390b-bc9a-9c43-e063-6294a90aeffb	48951-1368	HUMAN OTC DRUG	Aurum Hypericum		Aurum Hypericum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AVENA SATIVA FLOWERING TOP; GOLD TRICHLORIDE; MAGNESIUM HYDROXIDE; MAMMAL LIVER; PHOSPHORIC ACID; ROYAL JELLY; SILICON DIOXIDE; ST. JOHN'S WORT; STRYCHNOS IGNATII SEED	3; 7; 4; 4; 5; 6; 7; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-2002_6c7c9fd6-beb5-6f52-e053-2a91aa0aab2c	48951-2002	HUMAN OTC DRUG	Bambusa Aesculus		Bambusa Aesculus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; HORSE CHESTNUT; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS	20; 6; 8; 7; 50; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2003_b6bf71c5-f0e9-b311-e053-2a95a90a5546	48951-2003	HUMAN OTC DRUG	BAMBUSA AESCULUS		BAMBUSA AESCULUS	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		URIEL PHARMACY INC.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; HORSE CHESTNUT; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS	20; 6; 8; 7; 50; 6; 12; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-2004_6d94a285-d90c-5e9b-e053-2991aa0aaf2d	48951-2004	HUMAN OTC DRUG	Bambusa Aesculus		Bambusa Aesculus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; HORSE CHESTNUT; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS	20; 6; 8; 7; 50; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2005_0b65697d-327f-e958-e063-6394a90a7575	48951-2005	HUMAN OTC DRUG	Bambusa Argentum		Bambusa Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; STACHYS OFFICINALIS	20; 6; 8; 7; 6; 17; 20; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2007_6ce05eb8-7e3e-f063-e053-2a91aa0a7a45	48951-2007	HUMAN OTC DRUG	Bambusa Argentum		Bambusa Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; STACHYS OFFICINALIS	20; 6; 8; 7; 6; 17; 20; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2009_6d94a285-d8fc-5e9b-e053-2991aa0aaf2d	48951-2009	HUMAN OTC DRUG	Bambusa Aurum		Bambusa Aurum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; GOLD; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS	20; 6; 6; 5; 16; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-2011_09931f37-eb92-fa98-e063-6294a90ab8ae	48951-2011	HUMAN OTC DRUG	Bambusa Nicotiana		Bambusa Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; BOS TAURUS PITUITARY GLAND; EQUISETUM ARVENSE TOP; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS; TIN; TOBACCO LEAF	6; 8; 8; 15; 7; 6; 12; 6; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-2013_6d94860c-b034-2a99-e053-2991aa0a9718	48951-2013	HUMAN OTC DRUG	Bambusa Nicotiana		Bambusa Nicotiana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; BOS TAURUS PITUITARY GLAND; EQUISETUM ARVENSE TOP; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS; TIN; TOBACCO LEAF	6; 8; 8; 15; 7; 6; 12; 6; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-2014_6c7cf17f-e569-574a-e053-2991aa0a0818	48951-2014	HUMAN OTC DRUG	Bambusa Pulsatilla		Bambusa Pulsatilla	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; EQUISETUM ARVENSE TOP; FERROSOFERRIC PHOSPHATE; FORMICA RUFA; PULSATILLA VULGARIS; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS; TIN; VISCUM ALBUM FRUITING TOP	6; 6; 5; 7; 5; 5; 6; 12; 6; 7; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2016_6c7c9fd6-bec1-6f52-e053-2a91aa0aab2c	48951-2016	HUMAN OTC DRUG	Bambusa Rhus		Bambusa Rhus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; GELSEMIUM SEMPERVIRENS ROOT; MANDRAGORA OFFICINARUM ROOT; PENOXSULAM; PSEUDOGNAPHALIUM LUTEOALBUM LEAF; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; STACHYS OFFICINALIS; TOXICODENDRON PUBESCENS LEAF	6; 20; 6; 8; 7; 4; 6; 10; 4; 6; 12; 20; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2017_6d85b29e-84b1-76fa-e053-2991aa0a8674	48951-2017	HUMAN OTC DRUG	Bambusa Rhus		Bambusa Rhus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; GELSEMIUM SEMPERVIRENS ROOT; MANDRAGORA OFFICINARUM ROOT; PENOXSULAM; PSEUDOGNAPHALIUM LUTEOALBUM LEAF; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; STACHYS OFFICINALIS; TOXICODENDRON PUBESCENS LEAF	6; 20; 6; 8; 7; 4; 6; 10; 4; 6; 12; 20; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2018_6c7cf17f-e55b-574a-e053-2991aa0a0818	48951-2018	HUMAN OTC DRUG	Bambusa Stannum		Bambusa Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; EQUISETUM ARVENSE TOP; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS; TIN	6; 6; 15; 7; 6; 12; 6; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2019_6ce2328d-1bf2-fd07-e053-2a91aa0a351c	48951-2019	HUMAN OTC DRUG	Bambusa Stannum		Bambusa Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; EQUISETUM ARVENSE TOP; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS; TIN	6; 6; 15; 7; 6; 12; 6; 7	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2020_6c7cc7b1-9468-fda5-e053-2991aa0a7f5c	48951-2020	HUMAN OTC DRUG	Bambusa Stibium		Bambusa Stibium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS	8; 20; 6; 6; 7; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2021_0b659abd-33fb-0404-e063-6394a90a427a	48951-2021	HUMAN OTC DRUG	Bambusa Stibium		Bambusa Stibium	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS	8; 20; 6; 6; 7; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2023_6c7c9c28-3256-4953-e053-2a91aa0a3635	48951-2023	HUMAN OTC DRUG	Bambusa Viscum Stannum		Bambusa Viscum Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; EQUISETUM ARVENSE TOP; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS; TIN; VISCUM ALBUM FRUITING TOP	6; 6; 15; 5; 6; 12; 6; 7; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2024_6a10d1e7-f569-6511-e053-2991aa0a3005	48951-2024	HUMAN OTC DRUG	Bambusa Viscum Stannum		Bambusa Viscum Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; EQUISETUM ARVENSE TOP; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STACHYS OFFICINALIS; TIN; VISCUM ALBUM FRUITING TOP	6; 6; 15; 5; 6; 12; 6; 7; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2026_56e16db3-dbba-494c-e054-00144ff8d46c	48951-2026	HUMAN OTC DRUG	Barium Conchae		Barium Conchae	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BARIUM CITRATE; BARIUM IODATE; BERBERIS VULGARIS ROOT BARK; FERROUS ARSENATE; MERCURIC SULFIDE; OSTREA EDULIS SHELL	8; 4; 4; 6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2031_6a34e72c-5721-6996-e053-2991aa0a72aa	48951-2031	HUMAN OTC DRUG	Belladonna ex herba 30 Special Order		Belladonna ex herba 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA	30	[hp_X]/mL			N	20241231
48951-2033_b48d0436-ae1c-1105-e053-2995a90a0940	48951-2033	HUMAN OTC DRUG	Belladonna ex herba 6		Belladonna ex herba 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA	6	[hp_X]/mL			N	20241231
48951-2036_6d94e5f7-065e-658b-e053-2991aa0acfdf	48951-2036	HUMAN OTC DRUG	Berberis Aurum Special Order		Berberis Aurum Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BOS TAURUS PLACENTA; GOLD; KALANCHOE DAIGREMONTIANA LEAF; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; URTICA URENS	2; 6; 10; 3; 5; 4; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-2037_8b101c33-4e16-634b-e053-2995a90abbdd	48951-2037	HUMAN OTC DRUG	Berberis e fruct. 10% Special Order		Berberis e fruct. 10% Special Order	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK	1	[hp_X]/g			N	20241231
48951-2040_559db667-45cc-6ed0-e054-00144ff8d46c	48951-2040	HUMAN OTC DRUG	Berberis e rad. 2 Special Order		Berberis e rad. 2 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK	2	[hp_X]/mL			N	20241231
48951-2042_6cb8e31b-5222-aac5-e053-2a91aa0aa2fc	48951-2042	HUMAN OTC DRUG	Berberis Larix		Berberis Larix	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACHILLEA MILLEFOLIUM; APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; EQUISETUM ARVENSE TOP; FERROUS DISULFIDE; LARIX DECIDUA RESIN; LYTTA VESICATORIA; SUS SCROFA URINARY BLADDER	3; 8; 3; 3; 8; 8; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2047_6cb813bc-e132-a226-e053-2991aa0a6313	48951-2047	HUMAN OTC DRUG	Berberis Populus		Berberis Populus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BLACK PEPPER; LARIX DECIDUA RESIN; POPULUS TREMULA WHOLE; SAW PALMETTO; URTICA URENS	2; 17; 8; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-2048_6d8643f0-c711-56e6-e053-2991aa0aaac9	48951-2048	HUMAN OTC DRUG	Berberis Populus		Berberis Populus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BLACK PEPPER; LARIX DECIDUA RESIN; POPULUS TREMULA WHOLE; SAW PALMETTO; URTICA URENS	1; 17; 8; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-2052_6cb9f706-f1c4-08ed-e053-2991aa0a9934	48951-2052	HUMAN OTC DRUG	Berberis Pyrite Special Order		Berberis Pyrite Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; FERROUS DISULFIDE; MERCURIC SULFIDE; SAGE	3; 3; 8; 20; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2054_6cb7e1f8-ecf5-df39-e053-2a91aa0ac352	48951-2054	HUMAN OTC DRUG	Berberis Quartz		Berberis Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BOS TAURUS NASAL MUCOSA; SILICON DIOXIDE	3; 7; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2055_6d94f4d0-0a6d-b284-e053-2a91aa0ab707	48951-2055	HUMAN OTC DRUG	BERBERIS QUARTZ		BERBERIS QUARTZ	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		URIEL PHARMACY INC.	BERBERIS VULGARIS ROOT BARK; BOS TAURUS NASAL MUCOSA; SILICON DIOXIDE	3; 7; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2057_0b65ba1a-6267-1013-e063-6394a90aa330	48951-2057	HUMAN OTC DRUG	Berberis Urtica		Berberis Urtica	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; URTICA URENS	1; 2	[hp_X]/1; [hp_X]/1			N	20241231
48951-2058_5563f530-4fcf-3d7d-e054-00144ff88e88	48951-2058	HUMAN OTC DRUG	Berberis Viscum		Berberis Viscum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ALUMINUM OXIDE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS OVARY; BOS TAURUS UTERUS; MAGNESIUM SULFATE, UNSPECIFIED; OXALIS ACETOSELLA LEAF; PENOXSULAM; URTICA URENS; VISCUM ALBUM FRUITING TOP	6; 2; 6; 6; 6; 3; 10; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-2059_6d868019-64f3-8eda-e053-2991aa0af44a	48951-2059	HUMAN OTC DRUG	Berberis Viscum		Berberis Viscum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ALUMINUM OXIDE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS OVARY; BOS TAURUS UTERUS; MAGNESIUM SULFATE, UNSPECIFIED; OXALIS ACETOSELLA LEAF; PENOXSULAM; URTICA URENS; VISCUM ALBUM FRUITING TOP	6; 1; 6; 6; 6; 3; 10; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-2062_6c7de07f-5f0e-4c2b-e053-2991aa0a3a6c	48951-2062	HUMAN OTC DRUG	Betonica Rosmarinus		Betonica Rosmarinus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ROSMARINUS OFFICINALIS FLOWERING TOP; STACHYS OFFICINALIS	3; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-2063_6a85cd07-ce72-550a-e053-2991aa0ae511	48951-2063	HUMAN OTC DRUG	Betula Argentum		Betula Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; FORMICA RUFA; SILVER	3; 17; 3; 3; 7; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2064_6d86672e-b53e-2007-e053-2a91aa0ada70	48951-2064	HUMAN OTC DRUG	Betula Argentum		Betula Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; FORMICA RUFA; SILVER	6; 17; 1; 1; 7; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2068_6c7e63c2-42a1-2be2-e053-2a91aa0a6af3	48951-2068	HUMAN OTC DRUG	Betula Spiraea		Betula spiraea	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; EQUISETUM ARVENSE TOP; FILIPENDULA ULMARIA ROOT; FORMICA RUFA; LEAD; MANDRAGORA OFFICINARUM ROOT	17; 3; 3; 17; 3; 10; 7; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2069_6d86921f-ad04-31a5-e053-2a91aa0a6a25	48951-2069	HUMAN OTC DRUG	Betula Spiraea		Betula Spiraea	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; EQUISETUM ARVENSE TOP; FILIPENDULA ULMARIA ROOT; FORMICA RUFA; LEAD SULFIDE; MANDRAGORA OFFICINARUM ROOT	17; 3; 3; 17; 3; 10; 7; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2077_6c7d910a-e0f8-191a-e053-2991aa0ae605	48951-2077	HUMAN OTC DRUG	Borago Nicotiana		Borago Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ALUMINUM OXIDE; BORAGE; CENTAUREA BENEDICTA; FERROUS ARSENATE; HAMAMELIS VIRGINIANA LEAF; HORSE CHESTNUT; TOBACCO LEAF	8; 3; 3; 10; 3; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-2078_6d86921f-ad11-31a5-e053-2a91aa0a6a25	48951-2078	HUMAN OTC DRUG	Borago Nicotiana		Borago Nicotiana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ALUMINUM OXIDE; BORAGO OFFICINALIS WHOLE; CENTAUREA BENEDICTA; FERROUS ARSENATE; HAMAMELIS VIRGINIANA LEAF; HORSE CHESTNUT; TOBACCO LEAF	8; 3; 3; 10; 3; 10; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-2080_6c7d6124-2f2f-c592-e053-2991aa0a0512	48951-2080	HUMAN OTC DRUG	Bronchi 17 Special Order		Bronchi 17 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LUNG	17	[hp_X]/mL			N	20241231
48951-2082_55a063cc-7623-6156-e054-00144ff88e88	48951-2082	HUMAN OTC DRUG	Bryonia Apis Special Order		Bryonia Apis Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA; BOS TAURUS OVARY; BRYONIA ALBA ROOT; PULSATILLA VULGARIS; SUS SCROFA FALLOPIAN TUBE	8; 6; 20; 6; 6; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2083_6d9542e5-3f0e-3fc6-e053-2991aa0aac53	48951-2083	HUMAN OTC DRUG	Bryonia Apis Special Order		Bryonia Apis Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA; BOS TAURUS OVARY; BRYONIA ALBA ROOT; PULSATILLA VULGARIS; SUS SCROFA FALLOPIAN TUBE	8; 6; 20; 6; 6; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2085_6a860aaa-1934-7bc8-e053-2a91aa0a6ca1	48951-2085	HUMAN OTC DRUG	Bryonia Spongia		Bryonia Spongia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA; BRYONIA ALBA ROOT; SPONGIA OFFICINALIS WHOLE	4; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2086_6c7d9173-6897-3d99-e053-2a91aa0a9a3d	48951-2086	HUMAN OTC DRUG	Bryonia Stannum		Bryonia Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BRYONIA ALBA ROOT; TIN	3; 17	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-2087_6d860c51-3c82-23d2-e053-2991aa0ae66a	48951-2087	HUMAN OTC DRUG	Bryonia Stannum		Bryonia Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BRYONIA ALBA ROOT; TIN	3; 17	[hp_X]/1; [hp_X]/1			N	20241231
48951-2088_6cb86761-361e-37a3-e053-2991aa0a05ef	48951-2088	HUMAN OTC DRUG	Bryophyllum Argentum		Bryophyllum Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS UTERUS; KALANCHOE DAIGREMONTIANA LEAF; SILVER	8; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2089_6d97ed27-d115-01ce-e053-2991aa0a2447	48951-2089	HUMAN OTC DRUG	Bryophyllum Argentum		Bryophyllum Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS UTERUS; KALANCHOE DAIGREMONTIANA LEAF; SILVER	8; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2090_0a2132cb-07ce-8c92-e063-6294a90a97fd	48951-2090	HUMAN OTC DRUG	Bryophyllum Avena		Bryophyllum Avena	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AVENA SATIVA FLOWERING TOP; KALANCHOE DAIGREMONTIANA LEAF; OSTREA EDULIS SHELL; PHOSPHORUS; SULFUR; VALERIAN	6; 3; 7; 30; 30; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2092_6d953400-42a3-20b2-e053-2991aa0a7af3	48951-2092	HUMAN OTC DRUG	Bryophyllum Conchae		Bryophyllum Conchae	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; OSTREA EDULIS SHELL	5; 7	[hp_X]/1; [hp_X]/1			N	20241231
48951-2094_6aad6481-757d-4ba1-e053-2991aa0a712e	48951-2094	HUMAN OTC DRUG	Bryophyllum e fol. 10		Bryophyllum e fol. 10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF	1	[hp_X]/mL			N	20241231
48951-2095_6d97b3ee-6463-9b7e-e053-2991aa0aa1b3	48951-2095	HUMAN OTC DRUG	Bryophyllum e fol. 10		Bryophyllum e fol. 10	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF	1	[hp_X]/1			N	20241231
48951-2099_6cb9cf84-c5a0-3557-e053-2991aa0a1b73	48951-2099	HUMAN OTC DRUG	Bryophyllum e fol. 5%		Bryophyllum e fol. 5%	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF	1	[hp_X]/mL			N	20241231
48951-2102_0aacfb0a-d1f6-e5d2-e063-6294a90ada1a	48951-2102	HUMAN OTC DRUG	Citrus Cydonia 1		Citrus Cydonia 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEMON; QUINCE	1; 1	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-2104_6d94a285-d919-5e9b-e053-2991aa0aaf2d	48951-2104	HUMAN OTC DRUG	Barium Conchae Mercurius Special Order		Barium Conchae Mercurius Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BARIUM CITRATE; BARIUM IODATE; BERBERIS VULGARIS ROOT BARK; FERROUS ARSENATE; MERCURIC SULFIDE; MERCURY; OSTREA EDULIS SHELL	8; 4; 4; 6; 6; 14; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
48951-2105_6cb9c065-f443-3ca0-e053-2a91aa0aba45	48951-2105	HUMAN OTC DRUG	Bryophyllum Conchae Special Order		Bryophyllum Conchae Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; OSTREA EDULIS SHELL	5; 7	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-2106_6cb97027-6d85-bed5-e053-2a91aa0a77c1	48951-2106	HUMAN OTC DRUG	Belladonna ex herba 3 Special Order		Belladonna ex herba 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA	3	[hp_X]/mL			N	20241231
48951-2112_6cb87e0a-2b76-5f08-e053-2a91aa0a8b2e	48951-2112	HUMAN OTC DRUG	Betula e cort. 2 Special Order		Betula e cort. 2 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BETULA PUBESCENS BARK	2	[hp_X]/mL			N	20241231
48951-2113_6d853b54-f0f0-8d03-e053-2991aa0a30ac	48951-2113	HUMAN OTC DRUG	Bryophyllum Quartz		Bryophyllum Quartz	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; OSTREA EDULIS SHELL; SILICON DIOXIDE; SILVER	4; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2114_7aa5965b-5073-4535-e053-2a91aa0aa36d	48951-2114	HUMAN OTC DRUG	Betula Rhus Special Order		Betula Rhus Special Order	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BETULA PUBESCENS BARK; COLCHICUM AUTUMNALE WHOLE; FILIPENDULA ULMARIA ROOT; FORMICA RUFA; SAGE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	3; 4; 2; 5; 2; 10; 2; 12; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-2117_0eb0909f-f09b-a1cc-e063-6394a90a1868	48951-2117	HUMAN OTC DRUG	Berberis Oxalis		Berberis Oxalis	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BOS TAURUS PROSTATE GLAND; FERROUS PICRATE; MAGNESIUM SULFATE, UNSPECIFIED; OXALIS STRICTA WHOLE; PENOXSULAM; SAW PALMETTO; URTICA URENS; VISCUM ALBUM FRUITING TOP	1; 8; 8; 6; 3; 10; 3; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
48951-2118_6cb9f706-f1b9-08ed-e053-2991aa0a9934	48951-2118	HUMAN OTC DRUG	Berberis Oxalis		Berberis Oxalis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BOS TAURUS PROSTATE GLAND; MAGNESIUM SULFATE, UNSPECIFIED FORM; OXALIS STRICTA WHOLE; PENOXSULAM; SAW PALMETTO; URTICA URENS; VISCUM ALBUM FRUITING TOP	2; 8; 6; 3; 10; 3; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-2119_6d94f4d0-0a7a-b284-e053-2a91aa0ab707	48951-2119	HUMAN OTC DRUG	Berberis Larix		Berberis Larix	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ACHILLEA MILLEFOLIUM; APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; EQUISETUM ARVENSE TOP; LARIX DECIDUA RESIN; LYTTA VESICATORIA	3; 8; 3; 3; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-2123_6b533ec9-3769-f1a6-e053-2991aa0a2277	48951-2123	HUMAN OTC DRUG	Belladonna ex herba 12 Special Order		Belladonna ex herba 12 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA	12	[hp_X]/mL			N	20241231
48951-2124_6b614691-b02a-60bd-e053-2991aa0ab5f0	48951-2124	HUMAN OTC DRUG	Betula e fol. 4 Special Order		Betula e fol. 4 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BETULA PUBESCENS LEAF	2	[hp_X]/mL			N	20241231
48951-2125_6b61c742-3a7e-a6e4-e053-2a91aa0a3e79	48951-2125	HUMAN OTC DRUG	Bryophyllum e fol. 50% Special Order		Bryophyllum e fol. 50% Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF	1	[hp_X]/mL			N	20241231
48951-2128_6d953400-42b0-20b2-e053-2991aa0a7af3	48951-2128	HUMAN OTC DRUG	Berberis Sambucus Special Order		Berberis Sambucus Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP; TEUCRIUM SCORODONIA WHOLE	6; 6; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2129_7744bafb-7561-29a2-e053-2991aa0a86a9	48951-2129	HUMAN OTC DRUG	Bryophyllum Argentum Special Order		Bryophyllum Argentum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS UTERUS; KALANCHOE DAIGREMONTIANA LEAF; SILVER	8; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2130_7a914c56-ade0-cca2-e053-2a91aa0adb22	48951-2130	HUMAN OTC DRUG	Bamboo Rosemary		Bamboo Rosemary	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; EQUISETUM ARVENSE TOP; FORMICA RUFA; ROSEMARY OIL; TIN; VISCUM ALBUM FRUITING TOP	3; 5; 3; 5; 2; 7; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-2131_7cae5327-51e2-5548-e053-2a91aa0abd7a	48951-2131	HUMAN OTC DRUG	Berberis Populus		Berberis Populus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; LARIX DECIDUA RESIN; POPULUS TREMULOIDES POLLEN; SAW PALMETTO; URTICA URENS; WHITE PEPPER	2; 8; 3; 3; 3; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
48951-2133_92aec9ba-4322-ecdd-e053-2995a90a6c23	48951-2133	HUMAN OTC DRUG	Belladonna Betula Formica		Belladonna Betula Formica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; BETULA PENDULA LEAF; FORMICA RUFA	6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2134_b6af6fce-e027-254f-e053-2a95a90a324b	48951-2134	HUMAN OTC DRUG	Bambusa Formica		Bambusa Formica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS EYE; EQUISETUM ARVENSE TOP; FORMICA RUFA; TIN; VISCUM ALBUM FRUITING TOP	6; 8; 15; 7; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2135_97b6f7c6-1b53-e4bd-e053-2a95a90afe81	48951-2135	HUMAN OTC DRUG	Bambusa Argentum		Bambusa Argentum	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; FORMICA RUFA; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; STACHYS OFFICINALIS; VISCUM ALBUM FRUITING TOP	22; 8; 10; 9; 8; 19; 22; 8; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-2136_97b65c02-122a-07db-e053-2a95a90ac4fe	48951-2136	HUMAN OTC DRUG	Bryonia Eucalyptus		Bryonia Eucalyptus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GUM; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; QUILLAJA SAPONARIA BARK	3; 3; 3; 3; 7; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-2137_0a20de78-d1fa-5932-e063-6294a90a4e3f	48951-2137	HUMAN OTC DRUG	Bryophyllum Avena		Bryophyllum Avena	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	KALANCHOE DAIGREMONTIANA LEAF; OAT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SULFUR; VALERIAN	1; 3; 7; 30; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-2138_b70fd0b9-22bb-a955-e053-2a95a90ab672	48951-2138	HUMAN OTC DRUG	Bambusa Argentum		Bambusa Argentum	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; COPPER; GOLD; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; STACHYS OFFICINALIS	22; 8; 10; 11; 9; 8; 19; 22; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-2139_982eeb0f-4870-835d-e053-2a95a90ae9da	48951-2139	HUMAN OTC DRUG	Berberis Oxalis Special Order		Berberis Oxalis Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BOS TAURUS PROSTATE GLAND; MAGNESIUM SULFATE, UNSPECIFIED FORM; OXALIS STRICTA WHOLE; PENOXSULAM; SAW PALMETTO; URTICA URENS; VISCUM ALBUM FRUITING TOP	2; 8; 6; 3; 10; 3; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-2140_c3df8739-02dc-0134-e053-2a95a90abe26	48951-2140	HUMAN OTC DRUG	Berberis Prunus		Berberis Prunus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS FRUIT; BOS TAURUS NASAL MUCOSA; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; SILICON DIOXIDE; SILVER; SLOE	2; 8; 2; 6; 30; 8; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-2143_cf5b6661-8a2e-2084-e053-2a95a90a1c92	48951-2143	HUMAN OTC DRUG	Borago Lavender cum Cupro		Borago Lavender cum Cupro	LOTION	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	BORAGE; CUPRIC SULFATE; HORSE CHESTNUT; MELILOTUS INDICUS SEED	1; 2; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-2144_d2bb5092-2b3a-77d3-e053-2a95a90a3d4b	48951-2144	HUMAN OTC DRUG	Borago Lavender		Borago Lavender	LOTION	TOPICAL	20211209		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BORAGE; HORSE CHESTNUT; MELILOTUS INDICUS SEED	1; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-2145_d31e0920-431b-1e0c-e053-2a95a90aebeb	48951-2145	HUMAN OTC DRUG	Birch Juniper Rejuvenation		Birch Juniper Rejuvenation	LIQUID	ORAL	20211103		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	BETULA PENDULA BARK; JUNIPER BERRY	1; 1	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-2146_0681572d-7fa9-0ad4-e063-6394a90a823d	48951-2146	HUMAN OTC DRUG	Berberis Populus Adult Size		Berberis Populus Adult Size	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; BLACK PEPPER; LARIX DECIDUA RESIN; POPULUS TREMULA WHOLE; SAW PALMETTO; URTICA URENS	3; 17; 8; 3; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-3001_6d980e68-f936-629b-e053-2991aa0a87d2	48951-3001	HUMAN OTC DRUG	Cactus Cinis Avenae		Cactus Cinis Avenae	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; HAWTHORN LEAF WITH FLOWER; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; SELENICEREUS GRANDIFLORUS STEM	20; 3; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-3002_6cba4e4a-0224-08eb-e053-2991aa0ad8cf	48951-3002	HUMAN OTC DRUG	Cactus Cinis Avenae Special Order		Cactus Cinis Avenae Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; HAWTHORN LEAF WITH FLOWER; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; SELENICEREUS GRANDIFLORUS STEM	20; 3; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-3003_6cba5356-7c27-d595-e053-2a91aa0abe0f	48951-3003	HUMAN OTC DRUG	Cactus Crataegus Special Order		Cactus Crataegus Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HAWTHORN LEAF WITH FLOWER; MELISSA OFFICINALIS; SELENICEREUS GRANDIFLORUS STEM	3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3005_6d97e1e0-ba1a-0610-e053-2a91aa0af072	48951-3005	HUMAN OTC DRUG	Cactus Crataegus		Cactus Crataegus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HAWTHORN LEAF WITH FLOWER; MELISSA OFFICINALIS; SELENICEREUS GRANDIFLORUS STEM	3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3006_6a87a1fc-d9ea-af54-e053-2a91aa0a1351	48951-3006	HUMAN OTC DRUG	Calcium carb. Cortex Quercus 30 Special Order		Calcium carb. Cortex Quercus 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CARBONATE ION; QUERCUS ROBUR WHOLE	30; 30	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3007_6a87656c-640b-33d4-e053-2a91aa0a0d75	48951-3007	HUMAN OTC DRUG	Calcium carbonicum 3 Special Order		Calcium carbonicum 3 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CARBONATE ION	3	[hp_X]/g			N	20241231
48951-3008_6a88bce9-7289-0638-e053-2991aa0a4e50	48951-3008	HUMAN OTC DRUG	Calcium Carbonicum 30 Special Order		Calcium Carbonicum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CARBONATE ION	30	[hp_X]/mL			N	20241231
48951-3015_57970b4e-b681-2c59-e053-2991aa0a683f	48951-3015	HUMAN OTC DRUG	Calendula Stibium		Calendula Stibium	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; CALENDULA OFFICINALIS FLOWERING TOP	3; 2	[hp_X]/g; [hp_X]/g			N	20241231
48951-3018_559e353c-2dd4-16ba-e054-00144ff8d46c	48951-3018	HUMAN OTC DRUG	Capsicum Chamomilla Special Order		Capsicum Chamomilla Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROSOFERRIC PHOSPHATE; LEVISTICUM OFFICINALE ROOT; MATRICARIA RECUTITA; MERCURIC IODIDE; PAPRIKA; PULSATILLA VULGARIS	12; 2; 3; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3020_6a89a525-6c9d-4ad2-e053-2a91aa0afeb9	48951-3020	HUMAN OTC DRUG	Carbo Betulae 20 Special Order		Carbo Betulae 20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL	20	[hp_X]/mL			N	20241231
48951-3021_6a89d447-9812-8813-e053-2a91aa0adc99	48951-3021	HUMAN OTC DRUG	Carbo Betulae 30 Special Order		Carbo Betulae 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL	30	[hp_X]/mL			N	20241231
48951-3025_6a9a62ef-b710-1377-e053-2991aa0a56a8	48951-3025	HUMAN OTC DRUG	Carbo Sulfur		Carbo Sulfur	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; SULFUR	2; 2	[hp_X]/g; [hp_X]/g			N	20241231
48951-3030_6a9ab41c-d8ea-b95a-e053-2991aa0aae9a	48951-3030	HUMAN OTC DRUG	Carduus Oxalis		Carduus Oxalis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MILK THISTLE; OXALIS ACETOSELLA LEAF	1; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3032_6c6a35e2-bd3a-35f6-e053-2a91aa0a9e27	48951-3032	HUMAN OTC DRUG	Carduus Viscum		Carduus Viscum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAMMAL LIVER; MILK THISTLE; VISCUM ALBUM FRUITING TOP	8; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3034_6a9afb0c-2b5e-34fc-e053-2a91aa0a5aed	48951-3034	HUMAN OTC DRUG	Carpellum Mali Comp.		Carpellum Mali Comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ENGLISH WALNUT; MALUS DOMESTICA WHOLE	4; 4	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
48951-3035_6c58d689-5481-1df4-e053-2991aa0af12b	48951-3035	HUMAN OTC DRUG	Cartilago Argentum		Cartilago Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ANTIMONY TRISULFIDE; ARNICA MONTANA; BETULA PUBESCENS LEAF; BOS TAURUS CARTILAGE; MANDRAGORA OFFICINARUM ROOT; SILVER	6; 6; 6; 6; 6; 5; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3036_6a9b38f3-d1de-752e-e053-2991aa0a5d3e	48951-3036	HUMAN OTC DRUG	Cartilago Argentum Joint Support		Cartilago Argentum Joint Support	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ANTIMONY TRISULFIDE; ARNICA MONTANA; BETULA PUBESCENS LEAF; BOS TAURUS CARTILAGE; MANDRAGORA OFFICINARUM ROOT; SILVER	6; 5; 6; 3; 6; 3; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-3039_0e9e95c3-4ac7-5962-e063-6294a90a0c02	48951-3039	HUMAN OTC DRUG	Cartilago Betula		Cartilago Betula	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BETULA PUBESCENS LEAF; BOS TAURUS CARTILAGE; FORMICA RUFA; GOLD; ONION; TIN	6; 6; 5; 8; 17; 10; 17; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20251231
48951-3040_6e73ee84-40f7-0e05-e053-2991aa0a04fd	48951-3040	HUMAN OTC DRUG	Cartilago Betula		Cartilago Betula	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BETULA PUBESCENS LEAF; BOS TAURUS CARTILAGE; FORMICA RUFA; GOLD; ONION; TIN	6; 6; 3; 6; 7; 10; 3; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-3041_6d9852b6-68ae-6ca8-e053-2991aa0aeb0a	48951-3041	HUMAN OTC DRUG	Cartilago Betula		Cartilago Betula	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BETULA PUBESCENS LEAF; BOS TAURUS CARTILAGE; FORMICA RUFA; GOLD; ONION; TIN	6; 6; 5; 8; 17; 10; 17; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-3042_6c58a833-e415-64ad-e053-2a91aa0a5a78	48951-3042	HUMAN OTC DRUG	Cartilago Quartz		Cartilago Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF; ECHINACEA ANGUSTIFOLIA; SILICON DIOXIDE	30; 3; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3043_57970b4e-b65d-2c59-e053-2991aa0a683f	48951-3043	HUMAN OTC DRUG	Cartilago Quartz		Cartilago Quartz	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF; ECHINACEA, UNSPECIFIED; SILICON DIOXIDE	30; 2; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3044_6d98215a-1bf6-8953-e053-2a91aa0a03f6	48951-3044	HUMAN OTC DRUG	Cartilago Quartz		Cartilago Quartz	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF; ECHINACEA ANGUSTIFOLIA; SILICON DIOXIDE	30; 2; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3045_6c57be27-47d7-3cc1-e053-2a91aa0a9b9c	48951-3045	HUMAN OTC DRUG	Cavum Tympani 8 Special Order		Cavum Tympani 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF	8	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3047_6c586097-e61f-ac66-e053-2991aa0ac432	48951-3047	HUMAN OTC DRUG	Cerebellum 4 Special Order		Cerebellum 4 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS CEREBELLUM	4	[hp_X]/mL			N	20241231
48951-3048_559e18a4-d335-1054-e054-00144ff8d46c	48951-3048	HUMAN OTC DRUG	Cerebellum Thalamus A		Cerebellum Thalamus A	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS EYE; BOS TAURUS NERVE; BOS TAURUS PITUITARY GLAND; SILICON DIOXIDE; SUS SCROFA THALAMUS	8; 8; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3049_6d996ed0-6e62-0311-e053-2a91aa0ada14	48951-3049	HUMAN OTC DRUG	Cerebellum Thalamus A		Cerebellum Thalamus A	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS EYE; BOS TAURUS PITUITARY GLAND; SILICON DIOXIDE; SUS SCROFA THALAMUS	8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3050_6c6a900f-7651-a7b7-e053-2991aa0ac60b	48951-3050	HUMAN OTC DRUG	Cerebellum Thalamus A Aurm		Cerebellum Thalamus A Aurum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS EYE; BOS TAURUS NERVE; BOS TAURUS PITUITARY GLAND; FRANKINCENSE; GOLD; MYRRH; SILICON DIOXIDE; SUS SCROFA THALAMUS	8; 8; 8; 8; 8; 7; 10; 7; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3051_6d98e2b4-ba56-07a5-e053-2991aa0a6328	48951-3051	HUMAN OTC DRUG	Cerebellum Thalamus A Aurum		Cerebellum Thalamus A Aurum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS EYE; BOS TAURUS PITUITARY GLAND; FRANKINCENSE; GOLD; MYRRH; SILICON DIOXIDE; SUS SCROFA THALAMUS	8; 8; 8; 8; 7; 10; 7; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3052_6c6a4889-ed35-6195-e053-2991aa0a1beb	48951-3052	HUMAN OTC DRUG	Cerebellum Thalamus B		Cerebellum Thalamus B	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BIFENTHRIN; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS NERVE; BOS TAURUS PINEAL GLAND; SUS SCROFA EAR; SUS SCROFA THALAMUS	8; 8; 8; 8; 8; 17; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3053_6d993b73-94bd-f1cd-e053-2a91aa0a6980	48951-3053	HUMAN OTC DRUG	Cerebellum Thalamus B		Cerebellum Thalamus B	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BIFENTHRIN; BOS TAURUS BONE; BOS TAURUS BRAIN; BOS TAURUS NERVE; SUS SCROFA EAR; SUS SCROFA THALAMUS; VISCUM ALBUM FRUITING TOP	8; 8; 8; 8; 17; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3054_6c6a900f-765f-a7b7-e053-2991aa0ac60b	48951-3054	HUMAN OTC DRUG	Cerebellum Thalamus B Aurum		Cerebellum Thalamus B Aurum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BIFENTHRIN; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS NERVE; BOS TAURUS PINEAL GLAND; FRANKINCENSE; GOLD; MYRRH; SUS SCROFA EAR; SUS SCROFA THALAMUS	8; 8; 8; 8; 8; 7; 10; 7; 17; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3055_6d9a3ef6-8194-43bd-e053-2991aa0ae8f5	48951-3055	HUMAN OTC DRUG	Cerebellum Thalamus B Aurum		Cerebellum Thalamus B Aurum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BIFENTHRIN; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS NERVE; BOS TAURUS PINEAL GLAND; FRANKINCENSE; GOLD; MYRRH; SUS SCROFA EAR; SUS SCROFA THALAMUS	8; 8; 8; 8; 8; 7; 10; 7; 12; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3056_6c56a45f-58cc-6181-e053-2991aa0ab872	48951-3056	HUMAN OTC DRUG	Cerussite 8		Cerussite 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD CARBONATE	8	[hp_X]/mL			N	20241231
48951-3064_6c564d61-9aeb-194b-e053-2991aa0ae0d0	48951-3064	HUMAN OTC DRUG	Chamomilla Cupro 3 Special Order		Chamomilla Cupro 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER; MATRICARIA RECUTITA	3; 3	[hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3065_559ff7bd-fc1c-5406-e054-00144ff88e88	48951-3065	HUMAN OTC DRUG	Chamomilla e pl. tota 15 Special Order		Chamomilla e pl. tota 15 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MATRICARIA RECUTITA	15	[hp_X]/mL			N	20241231
48951-3066_6c56d3b0-01dd-d776-e053-2991aa0af9b5	48951-3066	HUMAN OTC DRUG	Chamomilla e pl. tota 3 Special Order		Chamomilla e pl. tota 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MATRICARIA RECUTITA	3	[hp_X]/mL			N	20241231
48951-3067_6c57f235-f323-973c-e053-2a91aa0ab720	48951-3067	HUMAN OTC DRUG	Chamomilla e pl. tota 30 Special Order		Chamomilla e pl. tota 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MATRICARIA RECUTITA	30	[hp_X]/mL			N	20241231
48951-3070_6c57faf8-faee-0c57-e053-2991aa0a28d8	48951-3070	HUMAN OTC DRUG	Chamomilla e rad. 20 Special Order		Chamomilla e rad. 20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MATRICARIA RECUTITA	20	[hp_X]/mL			N	20241231
48951-3072_6c57faf8-fae0-0c57-e053-2991aa0a28d8	48951-3072	HUMAN OTC DRUG	Chamomilla e rad. 6 Special Order		Chamomilla e rad. 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MATRICARIA RECUTITA	6	[hp_X]/mL			N	20241231
48951-3075_6d9a8165-a5f6-0bd0-e053-2991aa0a88e2	48951-3075	HUMAN OTC DRUG	Chelidonium Colocynthis Special Order		Chelidonium Colocynthis Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS; CITRULLUS COLOCYNTHIS FRUIT	2; 3	[hp_X]/1; [hp_X]/1			N	20241231
48951-3076_6a9dbf2c-6211-5b35-e053-2a91aa0a9245	48951-3076	HUMAN OTC DRUG	Chelidonium Curcuma		Chelidonium Curcuma	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS ROOT; TURMERIC	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3077_6d9a7bb8-13ef-4516-e053-2991aa0ac4ec	48951-3077	HUMAN OTC DRUG	Chelidonium Curcuma		Chelidonium Curcuma	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS ROOT; TURMERIC	3; 3	[hp_X]/1; [hp_X]/1			N	20241231
48951-3078_6a9df35e-6900-6759-e053-2a91aa0afc2a	48951-3078	HUMAN OTC DRUG	Chelidonium Curcuma Thuja		Chelidonium Curcuma Thuja	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS ROOT; THUJA OCCIDENTALIS WHOLE; TURMERIC	1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3079_6c5662a1-df20-a627-e053-2a91aa0a7844	48951-3079	HUMAN OTC DRUG	Chelidonium Ferro 3		Chelidonium Ferro 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS ROOT	3	[hp_X]/mL			N	20241231
48951-3086_6c564645-6e33-1948-e053-2991aa0a862c	48951-3086	HUMAN OTC DRUG	Chrysolith Retina		Chrysolith Retina	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS EYE; LARIX DECIDUA RESIN; SILICON DIOXIDE	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3087_6d9a7bb8-140c-4516-e053-2991aa0ac4ec	48951-3087	HUMAN OTC DRUG	Chrysolith Retina		Chrysolith Retina	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS EYE; LARIX DECIDUA RESIN; SILICON DIOXIDE	30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3088_6c5676fb-d2a8-8817-e053-2a91aa0a2247	48951-3088	HUMAN OTC DRUG	Chrysosplenium Chamomilla		Chrysosplenium Chamomilla	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHRYSOSPLENETIN; CICHORIUM INTYBUS WHOLE; MATRICARIA RECUTITA; TARAXACUM PALUSTRE ROOT	3; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3089_6d9ac076-1dfd-ef71-e053-2991aa0af8a1	48951-3089	HUMAN OTC DRUG	Chrysosplenium Chamomilla		Chrysosplenium Chamomilla	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHRYSOSPLENETIN; CICHORIUM INTYBUS WHOLE; MATRICARIA RECUTITA; TARAXACUM PALUSTRE ROOT	3; 6; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3091_559efa5b-91c5-2b52-e054-00144ff88e88	48951-3091	HUMAN OTC DRUG	Cichorium Oxalis		Cichorium Oxalis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; BARIUM CITRATE; CICHORIUM INTYBUS WHOLE; IRON; OXALIS ACETOSELLA LEAF; SUS SCROFA PANCREAS	6; 10; 3; 20; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
48951-3092_6d9ac076-1e0c-ef71-e053-2991aa0af8a1	48951-3092	HUMAN OTC DRUG	Cichorium Oxalis Special Order		Cichorium Oxalis Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; BARIUM CITRATE; CICHORIUM INTYBUS WHOLE; IRON; OXALIS ACETOSELLA LEAF; SUS SCROFA PANCREAS	6; 10; 3; 20; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3093_6c55b030-e56c-bc0c-e053-2a91aa0a015a	48951-3093	HUMAN OTC DRUG	Cichorium Stibium Special Order		Cichorium Stibium Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; CICHORIUM INTYBUS WHOLE; SUS SCROFA PANCREAS; TOBACCO LEAF	6; 4; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3094_6d9ac076-1e1e-ef71-e053-2991aa0af8a1	48951-3094	HUMAN OTC DRUG	Cichorium Stibium		Cichorium Stibium	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; CICHORIUM INTYBUS WHOLE; SUS SCROFA PANCREAS; TOBACCO LEAF	6; 4; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3096_6a8944f6-747e-c3cf-e053-2991aa0ac19b	48951-3096	HUMAN OTC DRUG	Caraway Oil 1 Special Order		Caraway Oil 1 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CARAWAY OIL	2	[hp_X]/g			N	20241231
48951-3097_6aacd1b1-d169-0788-e053-2a91aa0a8027	48951-3097	HUMAN OTC DRUG	Cinis Quercus 3 Special Order		Cinis Quercus 3 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	QUERCUS ROBUR WHOLE	3	[hp_X]/g			N	20241231
48951-3100_6dd0e062-96b8-5ea0-e053-2a91aa0a6df3	48951-3100	HUMAN OTC DRUG	Cinnabar comp.		Cinnabar comp.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA VENOM; ATROPA BELLADONNA; MERCURIC SULFIDE	6; 6; 7	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3101_0ac26ffb-1359-6332-e063-6294a90a194b	48951-3101	HUMAN OTC DRUG	Cinnabar Dandelion		Cinnabar Dandelion	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CARBONATE ION; ELYMUS REPENS ROOT; FERROUS DISULFIDE; MERCURIC CATION; TARAXACUM PALUSTRE ROOT	10; 3; 8; 20; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3103_6c556dbe-6707-907c-e053-2991aa0a475d	48951-3103	HUMAN OTC DRUG	Citrus Cydonia 3		Citrus Cydonia 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEMON; QUINCE	1; 1	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3104_6cd18bf8-2d3c-37b6-e053-2a91aa0a663d	48951-3104	HUMAN OTC DRUG	Citrus Cydonia 5%		CITRUS CYDONIA 5%	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEMON; QUINCE	1; 1	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3106_6cd1568e-f78f-a25b-e053-2991aa0ab1bd	48951-3106	HUMAN OTC DRUG	Citrus Cydonia 7		Citrus Cydonia 7	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEMON; QUINCE	1; 1	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3107_6cd0e405-f323-4599-e053-2a91aa0a39d7	48951-3107	HUMAN OTC DRUG	Citrus Quartz		Citrus Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AGROPYRON FRAGILE WHOLE; LARIX DECIDUA RESIN; LEMON; QUINCE; SAMBUCUS CANADENSIS FLOWER; SILICON DIOXIDE; TILIA AMERICANA FLOWER	5; 10; 2; 2; 5; 20; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3108_6cd08de1-4686-4776-e053-2a91aa0ab611	48951-3108	HUMAN OTC DRUG	Cocculus Conium Special Order		Cocculus Conium Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBERGRIS; ANAMIRTA COCCULUS WHOLE; CONIUM MACULATUM ROOT; LIQUID PETROLEUM	7; 4; 4; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3109_6dd0d15f-ad9a-7f08-e053-2a91aa0a9a6d	48951-3109	HUMAN OTC DRUG	Cocculus Conium		Cocculus Conium	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBERGRIS; ANAMIRTA COCCULUS WHOLE; CONIUM MACULATUM ROOT; LIQUID PETROLEUM	7; 4; 4; 9	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3112_08f536eb-21fc-3a9e-e063-6294a90ae5df	48951-3112	HUMAN OTC DRUG	Colchicum Chelidonium		Colchicum Chelidonium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS; COLCHICUM AUTUMNALE WHOLE	3; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3114_6ccf5931-eb58-a25f-e053-2991aa0ac0be	48951-3114	HUMAN OTC DRUG	Colon 6		Colon 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS COLON	6	[hp_X]/mL			N	20241231
48951-3116_6aad3463-56a0-fd1f-e053-2991aa0ab8ef	48951-3116	HUMAN OTC DRUG	Conchae 5 comp.		Conchae 5 comp.	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OSTREA EDULIS SHELL; QUERCUS ROBUR WHOLE	1; 4	[hp_X]/g; [hp_X]/g			N	20241231
48951-3117_0943fea0-2a36-bb05-e063-6394a90a02a0	48951-3117	HUMAN OTC DRUG	Conchae Argentum		Conchae Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMANITA MUSCARIA FRUITING BODY; ASPLENIUM SCOLOPENDRIUM WHOLE; DRYOPTERIS FILIX-MAS ROOT; OSTREA EDULIS SHELL; PTERIDIUM AQUILINUM WHOLE; SILVER	7; 3; 3; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3118_6dd14441-a236-d531-e053-2a91aa0a2b3e	48951-3118	HUMAN OTC DRUG	Conchae Argentum		Conchae Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMANITA MUSCARIA FRUITING BODY; ASPLENIUM SCOLOPENDRIUM TOP; DRYOPTERIS FILIX-MAS ROOT; OSTREA EDULIS SHELL; PTERIDIUM AQUILINUM WHOLE; SILVER	7; 3; 3; 6; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3119_6dd0e062-96cc-5ea0-e053-2a91aa0a6df3	48951-3119	HUMAN OTC DRUG	Conchae Urtica Special Order		Conchae Urtica Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMANITA MUSCARIA FRUITING BODY; EQUISETUM ARVENSE TOP; FORMICA RUFA; LEVISTICUM OFFICINALE ROOT; MAMMAL LIVER; MERCURY; OSTREA EDULIS SHELL; PORK KIDNEY; SILICON DIOXIDE; SILVER; SLOE; THUJA OCCIDENTALIS WHOLE; URTICA DIOICA ROOT	7; 2; 2; 2; 4; 14; 5; 4; 12; 5; 2; 6; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3121_55a00928-4322-5525-e054-00144ff88e88	48951-3121	HUMAN OTC DRUG	Conjunctiva Argentum Special Order		Conjunctiva Argentum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; BOS TAURUS EYE; ECHINACEA, UNSPECIFIED; SILICON DIOXIDE; SILVER	20; 30; 3; 20; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3122_6cdf6c99-6620-750e-e053-2a91aa0aac4c	48951-3122	HUMAN OTC DRUG	Conjunctiva Argentum		Conjunctiva Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; BOS TAURUS EYE; ECHINACEA, UNSPECIFIED; SILICON DIOXIDE; SILVER	20; 30; 3; 20; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3124_0e9ce591-dafb-73d6-e063-6394a90a3968	48951-3124	HUMAN OTC DRUG	Copper Oxide 0.4		Copper Oxide 0.4	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC OXIDE	1	[hp_X]/g			N	20251231
48951-3125_6cd04b85-bb2c-9630-e053-2a91aa0adb34	48951-3125	HUMAN OTC DRUG	Cor 5 Special Order		Cor 5 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART	5	[hp_X]/mL			N	20241231
48951-3126_6ccebb3f-bf89-413e-e053-2a91aa0a4a7a	48951-3126	HUMAN OTC DRUG	Cor 8 Special Order		Cor 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART	8	[hp_X]/mL			N	20241231
48951-3127_08f4bd3b-823d-fcf9-e063-6294a90aab40	48951-3127	HUMAN OTC DRUG	Cor Aurum 17/10		Cor Aurum 17/10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	17; 10; 4; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3133_6ccdb407-2c23-7ccc-e053-2991aa0a5eec	48951-3133	HUMAN OTC DRUG	Cortisonum 30 Special Order		Cortisonum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CORTISONE	30	[hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
48951-3134_0a1fb6ac-606f-ca01-e063-6394a90a4df8	48951-3134	HUMAN OTC DRUG	Crataegus Nicotiana		Crataegus Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; CERIUM; HAWTHORN LEAF WITH FLOWER; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; TOBACCO LEAF	6; 6; 3; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-3135_6dd17c05-1ad9-6a73-e053-2a91aa0a1191	48951-3135	HUMAN OTC DRUG	Crataegus Nicotiana		Crataegus Nicotiana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; CERIUM; HAWTHORN LEAF WITH FLOWER; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; TOBACCO LEAF	6; 6; 1; 6; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-3136_6aadd3a0-800f-6582-e053-2991aa0a3939	48951-3136	HUMAN OTC DRUG	Crataegus Onopordon		Crataegus Onopordon	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; GOLD; HAWTHORN LEAF WITH FLOWER; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; SELENICEREUS GRANDIFLORUS STEM	6; 15; 3; 3; 2; 2; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3137_6aade953-e8cb-765b-e053-2a91aa0a20af	48951-3137	HUMAN OTC DRUG	Cuprite 3 Special Order		Cuprite 3 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC OXIDE	3	[hp_X]/g			N	20241231
48951-3138_6eb37ecd-bffc-99c4-e053-2a91aa0a61b5	48951-3138	HUMAN OTC DRUG	Cuprum 5		Cuprum 5	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER	5	[hp_X]/g	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3139_6aae10db-25da-cb66-e053-2991aa0a2a30	48951-3139	HUMAN OTC DRUG	Cuprum Aceticum 3		Cuprum Aceticum 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC ACETATE	3	[hp_X]/mL			N	20241231
48951-3140_6dd1b709-53e8-da4d-e053-2a91aa0a6d5c	48951-3140	HUMAN OTC DRUG	Cuprum aceticum 4 Special Order		Cuprum aceticum 4 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC ACETATE	4	[hp_X]/1			N	20241231
48951-3141_5498dc41-9e13-3dad-e054-00144ff8d46c	48951-3141	HUMAN OTC DRUG	Cuprum aceticum Nicotiana		Cuprum aceticum Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE; CUPRIC ACETATE; LOBELIA SPICATA LEAF; PORK KIDNEY; TOBACCO LEAF	12; 6; 6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3142_6dd22ca7-d942-9629-e053-2991aa0a4649	48951-3142	HUMAN OTC DRUG	Cuprum aceticum Nicotiana		Cuprum aceticum Nicotiana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE; CUPRIC ACETATE; LOBELIA SPICATA LEAF; PORK KIDNEY; TOBACCO LEAF	12; 6; 6; 6; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3143_6aae39b6-be83-c9b5-e053-2991aa0a7d89	48951-3143	HUMAN OTC DRUG	Cuprum aceticum Zincum valerianicum		Cuprum aceticum Zincum valerianicum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC ACETATE; ZINC VALERATE DIHYDRATE	5; 5	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3144_57d39a95-de76-83c0-e053-2991aa0a6a4c	48951-3144	HUMAN OTC DRUG	Cuprum Nicotiana		Cuprum Nicotiana	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC OXIDE; MATRICARIA RECUTITA; TOBACCO LEAF	1; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3145_0a211dcc-e3c8-7311-e063-6294a90a7e5c	48951-3145	HUMAN OTC DRUG	Cuprum Stannum		Cuprum Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER; NITRIC ACID; POTASSIUM ALUM; SULFURIC ACID; TIN	3; 2; 3; 2; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3146_6aaeab59-d842-a66c-e053-2a91aa0a71ec	48951-3146	HUMAN OTC DRUG	Cuprum sulfuricum 6		Cuprum sulfuricum 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC SULFATE	6	[hp_X]/mL			N	20241231
48951-3152_57d39a95-de68-83c0-e053-2991aa0a6a4c	48951-3152	HUMAN OTC DRUG	Cuprum Quartz (Red)		Cuprum Quartz (Red)	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC OXIDE; SILICON DIOXIDE	1; 1	[hp_X]/g; [hp_X]/g			N	20241231
48951-3154_6a9df35e-68f2-6759-e053-2a91aa0afc2a	48951-3154	HUMAN OTC DRUG	Chelidonium Curcuma P		Chelidonium Curcuma P	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS ROOT; TURMERIC	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3156_6aad1434-3464-c352-e053-2991aa0ad952	48951-3156	HUMAN OTC DRUG	Citrus Urtica comp. Special Order		Citrus Urtica comp. Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; LARIX DECIDUA RESIN; LEMON; QUINCE; SILICON DIOXIDE; URTICA URENS; WORMWOOD	3; 3; 2; 2; 20; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3157_6dd20ee1-7396-a4ba-e053-2991aa0a7a5b	48951-3157	HUMAN OTC DRUG	Cor Aurum 6/10 Special Order		Cor Aurum 6/10 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	6; 10; 4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3163_6ccf9240-257e-77e1-e053-2991aa0a7e67	48951-3163	HUMAN OTC DRUG	Colchicum e tub. 4 Special Order		Colchicum e tub. 4 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COLCHICUM AUTUMNALE WHOLE	4	[hp_X]/mL			N	20241231
48951-3166_6ccdb407-2c05-7ccc-e053-2991aa0a5eec	48951-3166	HUMAN OTC DRUG	Cuprum 17 Special Order		Cuprum 17 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER	17	[hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3167_6c6bbee7-ab15-3d0c-e053-2991aa0a7427	48951-3167	HUMAN OTC DRUG	Calc. carb. Cortex Quercus Special Order		Calc. carb. Cortex Quercus Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CARBONATE ION; QUERCUS ROBUR WHOLE	30; 30	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3168_6a893a14-f480-b700-e053-2991aa0adf8f	48951-3168	HUMAN OTC DRUG	Calendula Thuja Adult Size		Calendula Thuja Adult Size	SUPPOSITORY	VAGINAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALENDULA OFFICINALIS FLOWERING TOP; CANDIDA ALBICANS; ECHINACEA, UNSPECIFIED; LILIUM LANCIFOLIUM WHOLE FLOWERING; PULSATILLA VULGARIS; SILVER; SWEET MARJORAM; THUJA OCCIDENTALIS WHOLE; WOOD CREOSOTE	2; 33; 2; 3; 6; 7; 2; 3; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
48951-3170_6cccccc4-d077-ddc9-e053-2a91aa0aa932	48951-3170	HUMAN OTC DRUG	Cuprum 8 Special Order		Cuprum 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER	8	[hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3171_6cbaf12b-c50e-5548-e053-2a91aa0a2639	48951-3171	HUMAN OTC DRUG	Carbo Equiseti 6 Special Order		Carbo Equiseti 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL	6	[hp_X]/mL			N	20241231
48951-3174_6cd10fa9-9569-6aa4-e053-2991aa0a2d12	48951-3174	HUMAN OTC DRUG	Citrus pericarpium 10% Special Order		Citrus pericarpium 10% Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEMON PEEL	1	[hp_X]/mL			N	20241231
48951-3178_6aac90dd-7175-40e3-e053-2991aa0aba6b	48951-3178	HUMAN OTC DRUG	Cinis comp A 21 Special Order		Cinis comp A 21 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	21	[hp_X]/mL			N	20241231
48951-3184_6ac5773c-9801-86ad-e053-2991aa0a0e96	48951-3184	HUMAN OTC DRUG	Jasper 17 Special Order		Jasper 17 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	17	[hp_X]/mL			N	20241231
48951-3187_6ccfae22-b0af-3e07-e053-2991aa0a4051	48951-3187	HUMAN OTC DRUG	Connective Tissue 6 Special Order		Connective Tissue 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS CONJUNCTIVA	6	[hp_X]/mL			N	20241231
48951-3189_6dd14441-a22c-d531-e053-2a91aa0a2b3e	48951-3189	HUMAN OTC DRUG	Coffea tosta 30 Special Order		Coffea tosta 30 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COFFEA ARABICA SEED, ROASTED	30	[hp_X]/1			N	20241231
48951-3191_6b250584-d577-5166-e053-2991aa0af862	48951-3191	HUMAN OTC DRUG	Sapphire 30 Special Order		Sapphire 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ALUMINUM OXIDE	30	[hp_X]/mL			N	20241231
48951-3193_6dd14441-a211-d531-e053-2a91aa0a2b3e	48951-3193	HUMAN OTC DRUG	Colchicum Sabina Special Order		Colchicum Sabina Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COLCHICUM AUTUMNALE WHOLE; JUNIPER BERRY	4; 3	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3194_6cd08de1-4698-4776-e053-2a91aa0ab611	48951-3194	HUMAN OTC DRUG	Citrus Quartz Special Order		Citrus Quartz Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ELYMUS REPENS ROOT; LARIX DECIDUA RESIN; LEMON; LINDEN LEAF; QUINCE; SAMBUCUS NIGRA FLOWERING TOP; SILICON DIOXIDE	4; 6; 2; 4; 2; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3196_6aacd1b1-d176-0788-e053-2a91aa0a8027	48951-3196	HUMAN OTC DRUG	Cinis Quercus 17 Special Order		Cinis Quercus 17 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	QUERCUS ROBUR WHOLE	17	[hp_X]/mL			N	20241231
48951-3197_6d9a1754-8d2e-054f-e053-2991aa0a4653	48951-3197	HUMAN OTC DRUG	Chamomilla e rad. 12 Special Order		Chamomilla e rad. 12 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MATRICARIA RECUTITA	12	[hp_X]/1			N	20241231
48951-3200_6a9b73e6-d61e-58c6-e053-2991aa0a6bd0	48951-3200	HUMAN OTC DRUG	Cartilago Betula Adult Size Special Order		Cartilago Betula Adult Size Special Order	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BETULA PUBESCENS LEAF; BOS TAURUS CARTILAGE; FORMICA RUFA; GOLD; ONION; TIN	5; 6; 15; 10; 15; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-3201_6c58a08d-e57a-545d-e053-2a91aa0a8b22	48951-3201	HUMAN OTC DRUG	Cartilago comp. Special Order		Cartilago comp. Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS CARTILAGE; ECHINACEA, UNSPECIFIED; EQUISETUM ARVENSE TOP; MANDRAGORA OFFICINARUM ROOT; TIN	5; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3209_6b63a29c-98e0-46b3-e053-2991aa0a70f7	48951-3209	HUMAN OTC DRUG	Cichorium e rad. 30 Special Order		Cichorium e rad. 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CICHORIUM INTYBUS WHOLE	30	[hp_X]/mL			N	20241231
48951-3210_6b640949-88d9-3cef-e053-2991aa0a316a	48951-3210	HUMAN OTC DRUG	Cinis comp. CI 6 Special Order		Cinis comp. CI 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	6	[hp_X]/mL			N	20241231
48951-3212_6b64e2f0-0afd-200d-e053-2991aa0a220c	48951-3212	HUMAN OTC DRUG	Crataegus e fol. et. fruct. 1% Special Order		Crataegus e fol. et. fruct. 1% Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HAWTHORN LEAF WITH FLOWER	2	[hp_X]/mL			N	20241231
48951-3213_6b6544ca-f9a8-cd7e-e053-2a91aa0ad479	48951-3213	HUMAN OTC DRUG	Cuprum 21 Special Order		Cuprum 21 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER	21	[hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3214_6b6573b4-c857-8996-e053-2a91aa0ab1a9	48951-3214	HUMAN OTC DRUG	Cuprum Aceticum Nicotiana Special Order		Cuprum Aceticum Nicotiana Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE; CUPRIC ACETATE; LOBELIA SPICATA LEAF; PORK KIDNEY; TOBACCO LEAF	12; 6; 6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3215_6bb46614-a14d-a3dd-e053-2a91aa0a11c4	48951-3215	HUMAN OTC DRUG	Calendula 5% Special Order		Calendula 5% Special Order	SPRAY	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/mL			N	20241231
48951-3216_0a4c3cc0-0ed7-92d6-e063-6394a90a0a84	48951-3216	HUMAN OTC DRUG	Carbo Chamomilla		Carbo Chamomilla	CAPSULE	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACORUS CALAMUS ROOT; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BLACK PEPPER; GENTIANA LUTEA ROOT; GEUM URBANUM ROOT; GINGER; MATRICARIA RECUTITA; WORMWOOD	6; 3; 6; 7; 5; 3; 5; 3; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-3218_6c57b631-c160-c139-e053-2991aa0a819e	48951-3218	HUMAN OTC DRUG	Chamomilla e rad. 3 Special Order		Chamomilla e rad. 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MATRICARIA RECUTITA	3	[hp_X]/mL			N	20241231
48951-3219_6c6a8c03-299b-9b1a-e053-2a91aa0aa0c0	48951-3219	HUMAN OTC DRUG	Carduus Paeonia Special Order		Carduus Paeonia Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CENTAUREA BENEDICTA; PAEONIA OFFICINALIS ROOT	2; 2	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3220_6cba5356-7c3e-d595-e053-2a91aa0abe0f	48951-3220	HUMAN OTC DRUG	Carbo Betulae 8 Special Order		Carbo Betulae 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL	8	[hp_X]/mL			N	20241231
48951-3221_6ccfe633-ad84-84bd-e053-2991aa0aa48d	48951-3221	HUMAN OTC DRUG	Corallium rubrum 6 Special Order		Corallium rubrum 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CORALLIUM RUBRUM EXOSKELETON	6	[hp_X]/mL			N	20241231
48951-3222_6cd0e405-f332-4599-e053-2a91aa0a39d7	48951-3222	HUMAN OTC DRUG	Cutis 8 Special Order		Cutis 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SUS SCROFA SKIN	8	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
48951-3223_6d997973-2020-5b58-e053-2a91aa0a21c3	48951-3223	HUMAN OTC DRUG	Chamomilla Belladonna		Chamomilla Belladonna	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; MATRICARIA RECUTITA; TOBACCO LEAF	6; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3224_6d99d288-acff-38e6-e053-2991aa0aa20a	48951-3224	HUMAN OTC DRUG	Carbo Betulae 30 Special Order		Carbo Betulae 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL	30	[hp_X]/mL			N	20241231
48951-3225_0ac22946-6d9b-2f46-e063-6294a90a6688	48951-3225	HUMAN OTC DRUG	Cinnabar Dandelion		Cinnabar Dandelion	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CARBONATE ION; ELYMUS REPENS ROOT; FERROUS CATION; MERCURIC CATION; TARAXACUM OFFICINALE	10; 3; 3; 20; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3226_7acca117-84c1-251d-e053-2a91aa0a4546	48951-3226	HUMAN OTC DRUG	Cartilago Argentum		Cartilago Argentum	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ANTIMONY TRISULFIDE; ARNICA MONTANA; BETULA PUBESCENS LEAF; BOS TAURUS CARTILAGE; MANDRAGORA OFFICINARUM ROOT; SILVER	6; 5; 6; 3; 6; 3; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-3228_0aad75f9-d7f0-08fc-e063-6394a90a29ce	48951-3228	HUMAN OTC DRUG	Citrus Cydonia 1%		Citrus Cydonia 1%	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEMON; QUINCE	1; 1	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-3232_969eefb2-a802-6374-e053-2a95a90ac464	48951-3232	HUMAN OTC DRUG	Cartilago Argentum		Cartilago Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ANTIMONY TRISULFIDE; ARNICA MONTANA FLOWER; BETULA PUBESCENS BARK; BOS TAURUS CARTILAGE; MANDRAGORA OFFICINARUM ROOT; SILVER	6; 6; 6; 6; 8; 5; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3233_99496bc5-bd8d-7ca4-e053-2995a90a7bc0	48951-3233	HUMAN OTC DRUG	Cuprum 21X		Cuprum 21X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER	21	[hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3235_0e9cb2cf-9a06-48f6-e063-6294a90a3acc	48951-3235	HUMAN OTC DRUG	Cinis Equiseti 6		Cinis Equiseti 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP	6	[hp_X]/mL			N	20251231
48951-3238_b684a828-3265-87f6-e053-2a95a90a984b	48951-3238	HUMAN OTC DRUG	Cuprum 12		Cuprum 12	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER	12	[hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-3239_b6c13079-0ed0-0d79-e053-2a95a90a8d7c	48951-3239	HUMAN OTC DRUG	Cactus Cinis Avenae		Cactus Cinis Avenae	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; HAWTHORN LEAF WITH FLOWER; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; SELENICEREUS GRANDIFLORUS STEM	20; 3; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-3241_bcb9049c-a1de-7dd8-e053-2a95a90aa5e3	48951-3241	HUMAN OTC DRUG	Colon 8X		Colon 8X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS COLON	8	[hp_X]/mL			N	20241231
48951-3242_bcb9d2bc-1493-6aff-e053-2995a90a1e44	48951-3242	HUMAN OTC DRUG	Cinis comp.		Cinis comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; QUERCUS ROBUR WHOLE; TOBACCO LEAF	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-3243_bd2058f0-9773-6aa1-e053-2a95a90a1f48	48951-3243	HUMAN OTC DRUG	Cinis Equiseti 6X Cinis Avenae 6X		Cinis Equiseti 6X Cinis Avenae 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE	6; 6	[hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-3244_c9ec3a6e-ec2d-fa26-e053-2a95a90a76f7	48951-3244	HUMAN OTC DRUG	Cinis equiseti 6X/Cinis Avenae 6X		Cinis equiseti 6X/Cinis Avenae 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE	6; 6	[hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-3245_0b63555e-e5c2-92ee-e063-6394a90a34f2	48951-3245	HUMAN OTC DRUG	Chrysolith 6X		Chrysolith 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	6	[hp_X]/mL			N	20241231
48951-3247_c707325f-c2f6-f508-e053-2995a90a9248	48951-3247	HUMAN OTC DRUG	Calendula 3X		Calendula 3X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALENDULA OFFICINALIS FLOWERING TOP	3	[hp_X]/mL			N	20241231
48951-3248_c9da739a-0224-7d97-e053-2995a90a6bfa	48951-3248	HUMAN OTC DRUG	Celandine Honey		Celandine Honey	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHELIDONIUM MAJUS; HONEY	4; 4	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-3249_cf45a45f-f8cd-b544-e053-2a95a90a1e8b	48951-3249	HUMAN OTC DRUG	Crotalus terrificus 30X		Crotalus terrificus 30X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	CROTALUS DURISSUS TERRIFICUS VENOM	30	[hp_X]/mL			N	20241231
48951-3251_cfbb1c5a-6a35-bf50-e053-2a95a90a126b	48951-3251	HUMAN OTC DRUG	Chicory Ginger Bitters		Chicory Ginger Bitters	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACORUS CALAMUS ROOT; BLACK PEPPER; CHELIDONIUM MAJUS; CICHORIUM INTYBUS WHOLE; GENTIANA LUTEA ROOT; GINGER; MILK THISTLE; TURMERIC; WORMWOOD	1; 1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-3252_0541ee8a-92e6-657b-e063-6394a90a9a1d	48951-3252	HUMAN OTC DRUG	Chelidonium Cichorium		Chelidonium Cichorium	CAPSULE	ORAL	20230404		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	BOS TAURUS GALLBLADDER; CHELIDONIUM MAJUS; CICHORIUM INTYBUS WHOLE; CITRULLUS COLOCYNTHIS FRUIT; IRON	6; 4; 4; 4; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-3253_06318bef-290e-08ac-e063-6294a90a8ee0	48951-3253	HUMAN OTC DRUG	Calendula Thuja		Calendula Thuja	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALENDULA OFFICINALIS FLOWERING TOP; CANDIDA ALBICANS; ECHINACEA, UNSPECIFIED; LILIUM LANCIFOLIUM WHOLE FLOWERING; ORIGANUM MAJORANA WHOLE; PULSATILLA VULGARIS; SILVER; THUJA OCCIDENTALIS WHOLE; WOOD CREOSOTE	2; 30; 2; 3; 2; 6; 7; 3; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
48951-3254_06beaf35-f817-bf9b-e063-6294a90aec8c	48951-3254	HUMAN OTC DRUG	Cera Aesculus DKS		Cera Aesculus DKS	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; BRYONIA ALBA ROOT; EQUISETUM ARVENSE TOP; FORMICA RUFA; GOLD; HORSE CHESTNUT; SEDUM ROSEUM WHOLE; TIN; VESPA CRABRO	8; 3; 2; 5; 8; 1; 6; 8; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-3255_06fca76d-9a37-0bb9-e063-6394a90a64a6	48951-3255	HUMAN OTC DRUG	Cinis Equiseti		Cinis Equiseti	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	EQUISETUM ARVENSE TOP	6	[hp_X]/mL			N	20241231
48951-3256_0a5ba8c4-d5dd-a8af-e063-6394a90a90d3	48951-3256	HUMAN OTC DRUG	Calendula Essence		Calendula Essence	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/mL			N	20241231
48951-3257_0a5bc83c-6878-22e6-e063-6294a90a081c	48951-3257	HUMAN OTC DRUG	Carbo Chamomilla		Carbo Chamomilla	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ACORUS CALAMUS ROOT; ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BLACK PEPPER; GENTIANA LUTEA ROOT; GEUM URBANUM ROOT; GINGER; MATRICARIA RECUTITA; WORMWOOD	4; 2; 4; 6; 5; 3; 3; 3; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-3258_0b622c0a-9864-1223-e063-6294a90a95a1	48951-3258	HUMAN OTC DRUG	Conchae Argentum		Conchae Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	AMANITA MUSCARIA FRUITING BODY; ASPLENIUM SCOLOPENDRIUM TOP; DRYOPTERIS FILIX-MAS ROOT; OSTREA EDULIS SHELL; PTERIDIUM AQUILINUM WHOLE; SILVER	7; 3; 3; 8; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-3259_0bb1d5e8-8d66-dcf5-e063-6294a90a915b	48951-3259	HUMAN OTC DRUG	Carbo betulae cum methano 3X		Carbo betulae cum methano 3X	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL	3	[hp_X]/g			N	20241231
48951-4001_55a0dee7-d93d-7072-e054-00144ff8d46c	48951-4001	HUMAN OTC DRUG	Daphne Mezereum 30 Special Order		Daphne Mezereum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	DAPHNE MEZEREUM WHOLE	30	[hp_X]/mL			N	20241231
48951-4002_55a03e62-0828-6e95-e054-00144ff8d46c	48951-4002	HUMAN OTC DRUG	Daphne mezereum 4		Daphne mezereum 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	DAPHNE MEZEREUM WHOLE	4	[hp_X]/mL			N	20241231
48951-4009_6aaf20bc-356c-4851-e053-2a91aa0a56a8	48951-4009	HUMAN OTC DRUG	Drosera comp.		Drosera comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; DROSERA ROTUNDIFOLIA; HELLEBORUS FOETIDUS ROOT; IPECAC; MEPHITIS MEPHITIS ANAL GLAND FLUID; PROTORTONIA CACTI; QUILLAJA SAPONARIA BARK; VERATRUM ALBUM ROOT	4; 3; 4; 4; 4; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4010_6aaf294b-dd3c-75f4-e053-2a91aa0acae1	48951-4010	HUMAN OTC DRUG	Dulcamara comp.		Dulcamara comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE; BOS TAURUS ADRENAL GLAND; LOBELIA SPICATA LEAF; SOLANUM DULCAMARA TOP	6; 5; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4011_6aaf0ad0-1e44-d54d-e053-2991aa0a2b77	48951-4011	HUMAN OTC DRUG	Ear Formula		Ear Formula	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; LEVISTICUM OFFICINALE ROOT; PAPRIKA; PULSATILLA VULGARIS; SILICON DIOXIDE	8; 6; 2; 3; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-4012_c4d09d08-61ac-020b-e053-2a95a90a3c3d	48951-4012	HUMAN OTC DRUG	Echinacea Apis Child Size		Echinacea Apis Child Size	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; MERCURIUS SOLUBILIS; SILVER	3; 3; 3; 17; 20	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-4014_6c6c3cea-851e-6b60-e053-2a91aa0a60e7	48951-4014	HUMAN OTC DRUG	Echinacea Argentum		Echinacea Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA, UNSPECIFIED; SILVER	3; 30	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4015_6dd2e25c-adee-4499-e053-2991aa0a9d60	48951-4015	HUMAN OTC DRUG	Echinacea Argentum		Echinacea Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA, UNSPECIFIED; SILVER	2; 30	[hp_X]/1; [hp_X]/1			N	20241231
48951-4018_6aaf84b2-0ae3-71ee-e053-2a91aa0a3a93	48951-4018	HUMAN OTC DRUG	Echinacea Essence		Echinacea Essence	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA ANGUSTIFOLIA	1	[hp_X]/mL			N	20241231
48951-4021_6aafffe4-5fde-049c-e053-2991aa0aced6	48951-4021	HUMAN OTC DRUG	Echinacea Thuja		Echinacea Thuja	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; CHLOROPHYLL; ECHINACEA, UNSPECIFIED; EUCALYPTUS GUM; SILVER; THUJA OCCIDENTALIS WHOLE	6; 3; 3; 1; 20; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-4024_6dd3296b-e79e-148d-e053-2991aa0a5050	48951-4024	HUMAN OTC DRUG	Endometrium Argentum Special Order		Endometrium Argentum Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF; ECHINACEA, UNSPECIFIED; SILICON DIOXIDE; SILVER	30; 2; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-4026_6c6c2f09-5275-d49c-e053-2a91aa0af717	48951-4026	HUMAN OTC DRUG	Epiphysis 8		Epiphysis 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PINEAL GLAND	8	[hp_X]/mL			N	20241231
48951-4027_6c6bbef4-ff3d-614f-e053-2a91aa0a1852	48951-4027	HUMAN OTC DRUG	Epiphysis Plumbum		Epiphysis Plumbum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PINEAL GLAND; HONEY; LEAD	8; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4028_6dd368fd-6873-ce38-e053-2a91aa0a301a	48951-4028	HUMAN OTC DRUG	Epiphysis Plumbum		Epiphysis Plumbum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PINEAL GLAND; HONEY; LEAD	8; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-4032_55a2ff2e-bbc6-6e8f-e054-00144ff8d46c	48951-4032	HUMAN OTC DRUG	Ferrum phosphoricum 8 Special Order		Ferrum phosphoricum 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROSOFERRIC PHOSPHATE	8	[hp_X]/mL			N	20241231
48951-4034_6c6c1350-3115-38a0-e053-2991aa0a4143	48951-4034	HUMAN OTC DRUG	Equisetum ex herba 15 Special Order		Equisetum ex herba 15 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP	15	[hp_X]/mL			N	20241231
48951-4035_6ab1034f-5507-b79a-e053-2991aa0af4d2	48951-4035	HUMAN OTC DRUG	Equisetum Formica		Equisetum Formica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; FORMICA RUFA	17; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4036_6dd3c22a-3112-60c9-e053-2a91aa0af562	48951-4036	HUMAN OTC DRUG	Equisetum Formica		Equisetum Formica	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; FORMICA RUFA	17; 6	[hp_X]/1; [hp_X]/1			N	20241231
48951-4038_6c6c3cea-8514-6b60-e053-2a91aa0a60e7	48951-4038	HUMAN OTC DRUG	Equisetum limosum Rubellite 30		Equisetum limosum Rubellite 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; SILICON DIOXIDE	30; 30	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4039_6ab11021-0a81-bc66-e053-2a91aa0ac89c	48951-4039	HUMAN OTC DRUG	Equisetum Silicea		Equisetum Silicea	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; SILICON DIOXIDE	3; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4040_6c6c59cb-c52d-4899-e053-2991aa0a897d	48951-4040	HUMAN OTC DRUG	Equisetum Stannum		Equisetum Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; TIN	17; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4043_6ab1293a-5258-1a64-e053-2a91aa0a8493	48951-4043	HUMAN OTC DRUG	Equisetum Viscum		Equisetum Viscum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; PORK KIDNEY; VISCUM ALBUM FRUITING TOP	6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-4046_6dd3c22a-3129-60c9-e053-2a91aa0af562	48951-4046	HUMAN OTC DRUG	Eucalyptus Cuprum sulf.		Eucalyptus Cuprum sulf.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC SULFATE; EUCALYPTUS GUM	5; 1	[hp_X]/1; [hp_X]/1			N	20241231
48951-4049_6c6cf5c9-fd8c-c0ca-e053-2a91aa0a1044	48951-4049	HUMAN OTC DRUG	Eupatorium comp.		Eupatorium comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; LACHESIS MUTA VENOM; PHOSPHORUS	6; 6; 5; 12; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4054_7aa2d73d-bc47-fc0b-e053-2a91aa0a0caa	48951-4054	HUMAN OTC DRUG	Ferrum 5		Ferrum 5	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	5	[hp_X]/g			N	20241231
48951-4056_55a2ff2e-bb6f-6e8f-e054-00144ff8d46c	48951-4056	HUMAN OTC DRUG	Ferrum arsenicosum 30 Special Order		Ferrum arsenicosum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROUS ARSENATE	30	[hp_X]/mL			N	20241231
48951-4057_6ab14206-d66d-441a-e053-2a91aa0a0052	48951-4057	HUMAN OTC DRUG	Ferrum arsenicosum 6		Ferrum arsenicosum 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROUS ARSENATE	6	[hp_X]/mL			N	20241231
48951-4059_6ab171c7-7798-728e-e053-2a91aa0ad4e2	48951-4059	HUMAN OTC DRUG	Ferrum phosphoricum 6		Ferrum phosphoricum 6	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROSOFERRIC PHOSPHATE	6	[hp_X]/g			N	20241231
48951-4060_0a6036db-1c91-4c03-e063-6294a90a9bd8	48951-4060	HUMAN OTC DRUG	Equisetum cum sulfure tosta 6		Equisetum cum sulfure tosta 6	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; SULFUR	6; 6	[hp_X]/1; [hp_X]/1			N	20241231
48951-4062_6c7dcc74-a254-27b8-e053-2991aa0a9813	48951-4062	HUMAN OTC DRUG	Ferrum Quartz		Ferrum Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SULFUR	8; 6; 20; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4064_6ab179ce-66f1-0ba0-e053-2a91aa0aec52	48951-4064	HUMAN OTC DRUG	Ferrum rosatum Graphites		Ferrum rosatum Graphites	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERRIC OXIDE RED; GRAPHITE; IRON; SEDUM ROSEUM WHOLE	3; 17; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4065_6ac10e8a-8453-625c-e053-2a91aa0a92e9	48951-4065	HUMAN OTC DRUG	Ferrum sidereum Pancreas 10/4		Ferrum sidereum Pancreas 10/4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; SUS SCROFA PANCREAS	10; 4	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4067_55a3a9b3-bf90-5f67-e054-00144ff88e88	48951-4067	HUMAN OTC DRUG	Ferrum sidereum 21 Special Order		Ferrum sidereum 21 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	21	[hp_X]/mL			N	20241231
48951-4068_6ab16af9-5168-1344-e053-2991aa0a0906	48951-4068	HUMAN OTC DRUG	Ferrum sidereum 30 Special Order		Ferrum sidereum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	30	[hp_X]/mL			N	20241231
48951-4070_6c7e1fa3-5f42-10f7-e053-2a91aa0a3895	48951-4070	HUMAN OTC DRUG	Ferrum sidereum 6		Ferrum sidereum 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	6	[hp_X]/mL			N	20241231
48951-4071_6c7e3c06-5b81-3614-e053-2a91aa0ac0a0	48951-4071	HUMAN OTC DRUG	Ferrum sidereum Sulfur		Ferrum sidereum Sulfur	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; SILICON DIOXIDE; SULFUR	8; 20; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4072_6ac0d533-2c99-1c89-e053-2a91aa0a8935	48951-4072	HUMAN OTC DRUG	Ferrum sidereum 21 Special Order		Ferrum sidereum 21 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	21	[hp_X]/mL			N	20241231
48951-4073_08f3c4b2-fa65-f559-e063-6394a90a12f5	48951-4073	HUMAN OTC DRUG	Ferrum sidereum 6		Ferrum sidereum 6	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	6	[hp_X]/g			N	20241231
48951-4077_6ac145d1-9821-bdd6-e053-2a91aa0a6798	48951-4077	HUMAN OTC DRUG	Flores Formica		Flores Formica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA; VESPA CRABRO; WHEAT	6; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-4082_6ac17bad-7480-fc50-e053-2a91aa0af1f4	48951-4082	HUMAN OTC DRUG	Formica 3		Formica 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA	3	[hp_X]/mL			N	20241231
48951-4083_6ac18c95-89a8-76f6-e053-2991aa0aeef6	48951-4083	HUMAN OTC DRUG	Fomica 7 Special Order		Fomica 7 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA	7	[hp_X]/mL			N	20241231
48951-4084_6c800d6e-7d33-6b53-e053-2991aa0af30e	48951-4084	HUMAN OTC DRUG	Formica Apis		Formica Apis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; FORMICA RUFA	3; 3	[hp_X]/mL; 1/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-4085_6dd498f6-8435-26cd-e053-2a91aa0a21e0	48951-4085	HUMAN OTC DRUG	Formica Apis		Formica Apis	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; FORMICA RUFA	3; 3	[hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-4086_6c800d6e-7d3f-6b53-e053-2991aa0af30e	48951-4086	HUMAN OTC DRUG	Formica Arnica		Formica Arnica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; FORMICA RUFA; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE	3; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-4087_6ac1c145-94a8-472b-e053-2991aa0a9fe6	48951-4087	HUMAN OTC DRUG	Formica Arnica		Formica Arnica	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; FORMICA RUFA; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE	3; 4; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-4088_6c7e63c2-42b7-2be2-e053-2a91aa0a6af3	48951-4088	HUMAN OTC DRUG	Formica ex animale 4		Formica ex animale 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA	4	[hp_X]/mL			N	20241231
48951-4089_55b2af63-81b1-5c82-e054-00144ff88e88	48951-4089	HUMAN OTC DRUG	Formica Oxalis		Formica Oxalis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA; OXALIS ACETOSELLA LEAF	5; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4090_6dd4dbe0-aedd-5d6a-e053-2a91aa0aa106	48951-4090	HUMAN OTC DRUG	Formica Oxalis		Formica Oxalis	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA; OXALIS ACETOSELLA LEAF	5; 3	[hp_X]/1; [hp_X]/1			N	20241231
48951-4095_6ab1a8a1-d7a3-7459-e053-2991aa0a9d2f	48951-4095	HUMAN OTC DRUG	Ferrum sidereum 20		Ferrum sidereum 20	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	20	[hp_X]/g			N	20241231
48951-4096_6c80412c-9b37-8f19-e053-2a91aa0a9d03	48951-4096	HUMAN OTC DRUG	Formica ex animale 3/15		Formica ex animale 3/15	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA	3	[hp_X]/mL			N	20241231
48951-4098_6aaef9f0-b83a-b936-e053-2991aa0aa436	48951-4098	HUMAN OTC DRUG	Dioscorea batata 16 Special Order		Dioscorea batata 16 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHINESE YAM	16	[hp_X]/1			N	20241231
48951-4102_6ac1cba3-ea3b-0d77-e053-2a91aa0a247c	48951-4102	HUMAN OTC DRUG	Formica Stibium comp. Special Order		Formica Stibium comp. Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; FORMICA RUFA; SILICON DIOXIDE; SUS SCROFA LUNG	8; 15; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4104_6c6d0ecd-4074-06a5-e053-2991aa0a63fc	48951-4104	HUMAN OTC DRUG	Ferrum 8 Special Order		Ferrum 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	8	[hp_X]/mL			N	20241231
48951-4105_57e549a7-b159-e5b1-e053-2a91aa0aee56	48951-4105	HUMAN OTC DRUG	Eucalyptus comp. Special Order		Eucalyptus comp. Special Order	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	DROSERA ROTUNDIFOLIA; PETASITES HYBRIDUS ROOT; PLANTAGO MAJOR LEAF	1; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-4107_6c7fea5e-9cfe-364c-e053-2a91aa0a53e3	48951-4107	HUMAN OTC DRUG	Formica 60 Special Order		Formica 60 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA	60	[hp_X]/mL			N	20241231
48951-4109_55a26c8f-19e1-4c96-e054-00144ff8d46c	48951-4109	HUMAN OTC DRUG	Equisetum ex herba 30 Special Order		Equisetum ex herba 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP	30	[hp_X]/mL			N	20241231
48951-4111_55b270f8-f94d-4e6a-e054-00144ff88e88	48951-4111	HUMAN OTC DRUG	Funiculus umbilicalis 30 Special Order		Funiculus umbilicalis 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SUS SCROFA UMBILICAL CORD	30	[hp_X]/mL			N	20241231
48951-4114_6dd4141f-f417-72d4-e053-2991aa0aca72	48951-4114	HUMAN OTC DRUG	Ferrum 8 Special Order		Ferrum 8 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	8	[hp_X]/1			N	20241231
48951-4118_6dd3296b-e790-148d-e053-2991aa0a5050	48951-4118	HUMAN OTC DRUG	Echinacea e rad. 3 Special Order		Echinacea e rad. 3 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA ANGUSTIFOLIA	3	[hp_X]/1			N	20241231
48951-4119_6c797cc7-f90a-71b9-e053-2991aa0aecc5	48951-4119	HUMAN OTC DRUG	Femur 9 Special Order		Femur 9 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BONE	9	[hp_X]/mL			N	20241231
48951-4121_55a39ec3-beb6-158d-e054-00144ff8d46c	48951-4121	HUMAN OTC DRUG	Formica 3 Special Order		Formica 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA	3	[hp_X]/mL			N	20241231
48951-4122_6ac218b0-2be2-242a-e053-2991aa0a0c7d	48951-4122	HUMAN OTC DRUG	Funiculus umbilicalis 6 Special Order		Funiculus umbilicalis 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SUS SCROFA UMBILICAL CORD	6	[hp_X]/mL			N	20241231
48951-4129_6eaeca91-3e72-520c-e053-2a91aa0a1bc8	48951-4129	HUMAN OTC DRUG	Equisteum Iris		Equisteum Iris	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	C12-17 ALKANE; CALENDULA OFFICINALIS FLOWERING TOP; EQUISETUM ARVENSE TOP; SULFUR	2; 2; 2; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-4132_6dd44d2a-b5b2-1d57-e053-2a91aa0abb61	48951-4132	HUMAN OTC DRUG	Ferrum Quartz Pellets		Ferrum Quartz Pellets	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	IRON; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SULFUR	8; 6; 20; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-4133_6c538b15-7b2a-dd7d-e053-2991aa0aeb07	48951-4133	HUMAN OTC DRUG	Echinacea Thuja		Echinacea Thuja	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	APIS MELLIFERA; ECHINACEA PALLIDA; EUCALYPTUS GLOBULUS LEAF; SILVER NITRATE; THUJA OCCIDENTALIS LEAFY TWIG	6; 3; 1; 20; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-4136_6b66699b-e594-3265-e053-2a91aa0a9db3	48951-4136	HUMAN OTC DRUG	Equisetum Essence Special Order		Equisetum Essence Special Order	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP	1	[hp_X]/mL			N	20241231
48951-4137_6b658f98-d6e8-9ac9-e053-2991aa0ab3b0	48951-4137	HUMAN OTC DRUG	Dyscrasite 30 Special Order		Dyscrasite 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Dyscrasite 30 Special Order	SILVER SULFIDE	30	[hp_X]/mL			N	20241231
48951-4138_6b670483-0b3b-6a0b-e053-2991aa0a4066	48951-4138	HUMAN OTC DRUG	Equisetum ex herba 1% Special Order		Equisetum ex herba 1% Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP	2	[hp_X]/mL			N	20241231
48951-4139_6b6741df-9dd8-2fe9-e053-2a91aa0ae398	48951-4139	HUMAN OTC DRUG	Ferrum Acidum cholalicum 4 Special Order		Ferrum Acidum cholalicum 4 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHOLIC ACID; FERROUS GLUCONATE; HONEY	4; 4; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
48951-4145_6dd368fd-687e-ce38-e053-2a91aa0a301a	48951-4145	HUMAN OTC DRUG	Equisetum 1% Special Order		Equisetum 1% Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP	2	[hp_X]/1			N	20241231
48951-4149_7626cfbb-a9ce-9517-e053-2a91aa0a733d	48951-4149	HUMAN OTC DRUG	Formica 20X Special Order		Formica 20X Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA	20	[hp_X]/mL			N	20241231
48951-4151_76a02b08-0d58-198c-e053-2a91aa0aedb9	48951-4151	HUMAN OTC DRUG	Ferrum phos. 6X		Ferrum phos. 6X	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	6	[hp_X]/1			N	20241231
48951-4152_780b6833-64b1-41d3-e053-2a91aa0acfa9	48951-4152	HUMAN OTC DRUG	Flores Formica Special Order		Flores Formica Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FORMICA RUFA; VESPA CRABRO; WHEAT	6; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-4153_8b219989-c05f-8af7-e053-2a95a90a811d	48951-4153	HUMAN OTC DRUG	Formica 2X Special Order		Formica 2X Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	FORMICA RUFA	2	[hp_X]/mL			N	20241231
48951-4154_908e68c0-766b-2e3b-e053-2995a90af710	48951-4154	HUMAN OTC DRUG	Ferrum Sidereum 8X		Ferrum Sidereum 8X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	8	[hp_X]/mL			N	20241231
48951-4156_93ca023f-bbd0-cd38-e053-2a95a90a7d46	48951-4156	HUMAN OTC DRUG	Euphrasia 3X		Euphrasia 3X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EUPHRASIA STRICTA	3	[hp_X]/mL			N	20241231
48951-4157_940612af-ec33-09f6-e053-2a95a90a6641	48951-4157	HUMAN OTC DRUG	Ferrum 12X		Ferrum 12X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	12	[hp_X]/mL			N	20241231
48951-4159_97de5f48-094d-796c-e053-2a95a90a4069	48951-4159	HUMAN OTC DRUG	Ferrum 21X		Ferrum 21X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	21	[hp_X]/mL			N	20241231
48951-4161_b68685e5-e96e-10df-e053-2995a90a6878	48951-4161	HUMAN OTC DRUG	Ferrum 6		Ferrum 6	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON	6	[hp_X]/1			N	20241231
48951-4164_bd212235-529f-df7d-e053-2995a90ac214	48951-4164	HUMAN OTC DRUG	Echinacea Calendula		Echinacea Calendula	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PLACENTA; CALENDULA OFFICINALIS FLOWERING TOP; CUPRIC ACETATE; ECHINACEA, UNSPECIFIED; LARIX DECIDUA RESIN; SILVER; SUS SCROFA SKIN; SUS SCROFA UMBILICAL CORD; VISCUM ALBUM FRUITING TOP	12; 1; 6; 1; 1; 7; 8; 8; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
48951-4165_c19b1db8-df52-e8fc-e053-2a95a90aee03	48951-4165	HUMAN OTC DRUG	Calendula 10%		Calendula 10%	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/g			N	20241231
48951-4166_c1acc2cf-a81a-60b3-e053-2a95a90a502e	48951-4166	HUMAN OTC DRUG	Echinacea Argentum		Echinacea Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; ECHINACEA, UNSPECIFIED; SILICON DIOXIDE; SILVER	20; 3; 20; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-4168_d2d1428a-c8b6-9529-e053-2995a90a2343	48951-4168	HUMAN OTC DRUG	Endometrium Argentum		Endometrium Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	BEEF; ECHINACEA, UNSPECIFIED; SILICON DIOXIDE; SILVER	30; 2; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-4169_d321ce4e-ae9e-7c75-e053-2a95a90ae2e1	48951-4169	HUMAN OTC DRUG	Fragaria Vitis		Fragaria Vitis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	FRAGARIA VESCA WHOLE; VITIS VINIFERA LEAF	2; 2	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-4171_09a766af-8689-9ccd-e063-6294a90a8f59	48951-4171	HUMAN OTC DRUG	Fragaria Vitis		Fragaria Vitis	TABLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc	FRAGARIA VESCA WHOLE; VITIS VINIFERA LEAF	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
48951-4172_0647398f-ecaf-ad51-e063-6394a90a2ce2	48951-4172	HUMAN OTC DRUG	Echinacea Quartz		Echinacea Quartz	GEL	TOPICAL	20220628		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ALTHAEA OFFICINALIS ROOT; ANTIMONY TRISULFIDE; ATROPA BELLADONNA; ECHINACEA, UNSPECIFIED; SILICON DIOXIDE; SILVER	2; 5; 20; 2; 20; 20	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-4174_0bc9a266-1832-2e5c-e063-6294a90a7da6	48951-4174	HUMAN OTC DRUG	Ferrum Quartz		Ferrum Quartz	TABLET	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	FERROUS SULFATE; SULFUR	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
48951-4175_0647398f-ecae-ad51-e063-6394a90a2ce2	48951-4175	HUMAN OTC DRUG	Echinacea Calendula		Echinacea Calendula	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PLACENTA; CALENDULA OFFICINALIS FLOWERING TOP; CUPRIC ACETATE; ECHINACEA, UNSPECIFIED; LARIX DECIDUA RESIN; SILVER; SUS SCROFA SKIN; SUS SCROFA UMBILICAL CORD; VISCUM ALBUM FRUITING TOP	8; 1; 6; 1; 1; 7; 8; 8; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
48951-4176_09826d9f-fcd8-613a-e063-6394a90a262f	48951-4176	HUMAN OTC DRUG	Ferrum Silicicum Urtica		Ferrum Silicicum Urtica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANISE; FERRIC OXIDE RED; SILICON DIOXIDE; URTICA DIOICA	1; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-4177_098310bc-856b-a0a2-e063-6394a90ab498	48951-4177	HUMAN OTC DRUG	Ferrum silicicum Urtica		Ferrum silicicum Urtica	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANISE; FERRIC OXIDE RED; SILICON DIOXIDE; URTICA DIOICA ROOT	1; 6; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-4178_0d98c946-5ebe-3043-e063-6294a90a9a28	48951-4178	HUMAN OTC DRUG	Dioscorea batata		Dioscorea batata	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CHINESE YAM; FRANKINCENSE; GOLD; MYRRH	16; 9; 12; 9	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-4179_0bb14e22-95cc-7c6c-e063-6394a90a9b6e	48951-4179	HUMAN OTC DRUG	Equisetum Stannum		Equisetum Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; TIN	17; 8	[hp_X]/1; [hp_X]/1			N	20241231
48951-4180_0ccdf366-0876-7dce-e063-6394a90a0c39	48951-4180	HUMAN OTC DRUG	Ferrum arsenicosum 12X		Ferrum arsenicosum 12X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	FERROUS ARSENATE	12	[hp_X]/mL			N	20241231
48951-4181_0e9dc74d-a428-e67b-e063-6294a90a7e53	48951-4181	HUMAN OTC DRUG	Disci Viscum Comp.cum Stanno DKS Special Order		Disci Viscum Comp. cum Stanno DKS Special Order	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BAMBUSA VULGARIS WHOLE; BOS TAURUS INTERVERTEBRAL DISC; COPPER; EQUISETUM ARVENSE TOP; FORMICA RUFA; TIN; URTICA DIOICA; VESPA CRABRO; VISCUM ALBUM FRUITING TOP	12; 12; 8; 12; 3; 12; 3; 6; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20251231
48951-5001_6ac24b6c-2548-203b-e053-2a91aa0a9373	48951-5001	HUMAN OTC DRUG	Galena Larix Special Order		Galena Larix Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS EYE; CLAVICEPS PURPUREA SCLEROTIUM; LARIX DECIDUA RESIN; LEAD SULFIDE	12; 6; 10; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5004_6c806c76-f44f-29dd-e053-2991aa0a9d9e	48951-5004	HUMAN OTC DRUG	Gelsemium Bryonia		Gelsemium Bryonia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BRYONIA ALBA ROOT; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT	3; 7; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5006_df5e8e31-148f-8e81-e053-2a95a90a733a	48951-5006	HUMAN OTC DRUG	Gentian Ginger Bitters		Gentian Ginger Bitters	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACORUS CALAMUS ROOT; GENTIANA LUTEA ROOT; GINGER; WHITE PEPPER; WORMWOOD	1; 1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-5007_55b289e4-f1e5-57f5-e054-00144ff88e88	48951-5007	HUMAN OTC DRUG	Gentiana Absinthium		Gentiana Absinthium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GENTIANA LUTEA ROOT; STRYCHNOS NUX-VOMICA SEED; TARAXACUM PALUSTRE ROOT; WORMWOOD	3; 6; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-5008_6dd51ffd-40c5-0bea-e053-2991aa0ae974	48951-5008	HUMAN OTC DRUG	Gentiana Absinthium		Gentiana Absinthium	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GENTIANA LUTEA ROOT; STRYCHNOS NUX-VOMICA SEED; TARAXACUM PALUSTRE ROOT; WORMWOOD	1; 5; 2; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-5011_6ac24b6c-2562-203b-e053-2a91aa0a9373	48951-5011	HUMAN OTC DRUG	Gl. suprarenales Gl. thyreoidea Hypophysis		Gl. suprarenales Gl. thyreoidea Hypophysis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PITUITARY GLAND; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYROID	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5012_6ac2ae68-4a75-6c90-e053-2991aa0a42cb	48951-5012	HUMAN OTC DRUG	Glandula Thymus 4		Glandula Thymus 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS THYMUS	4	[hp_X]/mL			N	20241231
48951-5013_55b475df-9612-2746-e054-00144ff88e88	48951-5013	HUMAN OTC DRUG	Glandula thymus 6 Special Order		Glandula thymus 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy inc.	BOS TAURUS THYMUS	6	[hp_X]/mL			N	20241231
48951-5014_6ac2ea84-c4a4-8e59-e053-2a91aa0ac2c8	48951-5014	HUMAN OTC DRUG	Glandula thyreoidea 3 Special Order		Glandula thyreoidea 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	THYROID, UNSPECIFIED	3	[hp_X]/mL			N	20241231
48951-5019_6cbb4369-a668-5a1f-e053-2991aa0a5c73	48951-5019	HUMAN OTC DRUG	Glandulae suprarenales 4		Glandulae suprarenales 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND	4	[hp_X]/mL			N	20241231
48951-5020_6ac35551-cb64-080b-e053-2991aa0a9ea6	48951-5020	HUMAN OTC DRUG	Glandulae suprarenales 6 Special Order		Glandulae suprarenales 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND	6	[hp_X]/mL			N	20241231
48951-5021_6cbb20d7-6253-bf35-e053-2a91aa0a69be	48951-5021	HUMAN OTC DRUG	Glandulae suprarenales 6		Glandulae suprarenales 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND	6	[hp_X]/mL			N	20241231
48951-5022_55b31f2f-1c58-5cbd-e054-00144ff88e88	48951-5022	HUMAN OTC DRUG	Glandulae suprarenales 8 Special Order		Glandulae suprarenales 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND	8	[hp_X]/mL			N	20241231
48951-5023_c4e53e07-f88a-f8a4-e053-2995a90ac453	48951-5023	HUMAN OTC DRUG	Glandulae Suprarenales Lien		Glandulae Suprarenales Lien	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS GALLBLADDER; BOS TAURUS SPLEEN	8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5024_6c52ef10-1d75-6767-e053-2991aa0a7d1e	48951-5024	HUMAN OTC DRUG	Glandulae suprarenales Lien		Glandulae suprarenales Lien	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS BILE; BOS TAURUS SPLEEN	8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-5027_6cbcf4d7-85b9-f744-e053-2a91aa0a2ae1	48951-5027	HUMAN OTC DRUG	Gnaphalium Stannum		Gnaphalium Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BIFENTHRIN; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS NERVE; BOS TAURUS PINEAL GLAND; PSEUDOGNAPHALIUM LUTEOALBUM LEAF; SUS SCROFA EAR; TIN	20; 17; 17; 17; 17; 17; 17; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5028_6ac35978-cc15-080d-e053-2991aa0ac0ea	48951-5028	HUMAN OTC DRUG	Gnaphalium Stannum		Gnaphalium Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BIFENTHRIN; BOS TAURUS BRAIN; BOS TAURUS CEREBELLUM; BOS TAURUS NERVE; BOS TAURUS PINEAL GLAND; PSEUDOGNAPHALIUM LUTEOALBUM LEAF; SUS SCROFA EAR; TIN	20; 17; 17; 17; 17; 17; 17; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-5031_6ccb45b2-6811-f1eb-e053-2a91aa0a2de1	48951-5031	HUMAN OTC DRUG	Hamamelis Aesculus		Hamamelis Aesculus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HAMAMELIS VIRGINIANA TOP; HIRUDIN; HORSE CHESTNUT; MERCURY; PAEONIA OFFICINALIS ROOT; PULSATILLA VULGARIS	3; 6; 3; 17; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5032_6e759f79-b6e4-683b-e053-2a91aa0ae75b	48951-5032	HUMAN OTC DRUG	Hamamelis Aesculus		Hamamelis Aesculus	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; ARNICA MONTANA; CALCIUM FLUORIDE; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; KRAMERIA LAPPACEA WHOLE; MILK THISTLE; NITRIC ACID; SEPIA OFFICINALIS JUICE	11; 7; 9; 2; 2; 2; 2; 2; 7; 9	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-5036_6dd63c1f-e59f-e73f-e053-2a91aa0af677	48951-5036	HUMAN OTC DRUG	Helleborus Berberis Special Order		Helleborus Berberis Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARISTOLOCHIA CLEMATITIS WHOLE; BERBERIS VULGARIS ROOT BARK; HELLEBORUS FOETIDUS ROOT; POTASSIUM ALUM	3; 3; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-5037_0abf7def-2775-6a94-e063-6394a90a9cd3	48951-5037	HUMAN OTC DRUG	Helleborus e pl. tota 2		Helleborus e pl. tota 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HELLEBORUS FOETIDUS ROOT	2	[hp_X]/mL			N	20241231
48951-5038_6ccb8d0f-6c01-26ae-e053-2991aa0abeb8	48951-5038	HUMAN OTC DRUG	Helleborus e pl. tota 4		Helleborus e pl. tota 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HELLEBORUS FOETIDUS ROOT	4	[hp_X]/mL			N	20241231
48951-5041_6ccc080f-e373-ec66-e053-2a91aa0ac3b4	48951-5041	HUMAN OTC DRUG	Hepar Magnesium 4		Hepar Magnesium 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM HYDROXIDE; MAMMAL LIVER	4; 4	[hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5042_6ac3af31-3c4e-7fd4-e053-2991aa0a736b	48951-5042	HUMAN OTC DRUG	Hepar Magnesium 4		Hepar Magnesium 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM CATION; MAMMAL LIVER	4; 4	[hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5044_6ac3e6c4-15a1-f975-e053-2991aa0a4b4b	48951-5044	HUMAN OTC DRUG	Hepar Magnesium Taraxicum 4		Hepar Magnesium 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM HYDROXIDE; MAMMAL LIVER; TARAXACUM PALUSTRE ROOT	4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5045_6ccc47cd-6540-5153-e053-2a91aa0aed88	48951-5045	HUMAN OTC DRUG	Hepar Stannum 17/20		Hepar Stannum 17/20	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAMMAL LIVER; TIN	17; 20	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-5046_6dd6597f-d435-3182-e053-2a91aa0acad7	48951-5046	HUMAN OTC DRUG	Hepar Stannum 17/20		Hepar Stannum 17/20	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAMMAL LIVER; TIN	17; 20	[hp_X]/1; [hp_X]/1			N	20241231
48951-5047_6ccc080f-e381-ec66-e053-2a91aa0ac3b4	48951-5047	HUMAN OTC DRUG	Hepar Stannum 6/10		Heppar Stannum 6/10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAMMAL LIVER; TIN	6; 10	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-5048_6ce0f0bb-2f52-06b0-e053-2991aa0a8a15	48951-5048	HUMAN OTC DRUG	Hepar Stannum 6/10		Hepar Stannum 6/10	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAMMAL LIVER; TIN	6; 10	[hp_X]/1; [hp_X]/1			N	20241231
48951-5050_6dd6f3c8-d724-589a-e053-2991aa0ab449	48951-5050	HUMAN OTC DRUG	Hepar sulfuris Sinus		Hepar sulfuris Sinus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS NASAL MUCOSA; CALCIUM SULFIDE	8; 6	[hp_X]/1; [hp_X]/1			N	20241231
48951-5053_6ac3e6c4-158f-f975-e053-2991aa0a4b4b	48951-5053	HUMAN OTC DRUG	Hepar Magnesium 6 Special Order		Hepar Magnesium 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM HYDROXIDE; MAMMAL LIVER	6; 6	[hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5060_6ac41eb4-9268-6189-e053-2991aa0aefb1	48951-5060	HUMAN OTC DRUG	Hypericum Bryophyllum		Hypericum Bryophyllum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MILK THISTLE; ST. JOHN'S WORT	2; 6; 6; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5061_6c43bc9d-1a24-2e2a-e053-2991aa0a8060	48951-5061	HUMAN OTC DRUG	Hypericum Bryophyllum		Hypericum Bryophyllum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MILK THISTLE; ST. JOHN'S WORT	2; 6; 6; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5062_0a0ba528-9eb7-5356-e063-6394a90a71f9	48951-5062	HUMAN OTC DRUG	Hypericum ex herba 3		Hypericum ex herba 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ST. JOHN'S WORT	3	[hp_X]/mL			N	20241231
48951-5067_6de4f853-bed0-1120-e053-2991aa0a9c3b	48951-5067	HUMAN OTC DRUG	Hypophysis Stannum		Hypophysis Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PITUITARY GLAND; TIN	8; 20	[hp_X]/1; [hp_X]/1			N	20241231
48951-5068_0a0c0c92-8fd3-7637-e063-6394a90a2995	48951-5068	HUMAN OTC DRUG	Ignatia Bryophyllum		Ignatia Bryophyllum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; LACHESIS MUTA VENOM; SILVER; STRYCHNOS IGNATII SEED	3; 12; 10; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5069_6ce1e6f9-6bb3-8bee-e053-2991aa0ac157	48951-5069	HUMAN OTC DRUG	Ignatia Bryophyllum		Ignatia Bryophyllum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; LACHESIS MUTA VENOM; SILVER; STRYCHNOS IGNATII SEED	3; 12; 10; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-5072_6ac5930a-b41e-f40c-e053-2a91aa0afee3	48951-5072	HUMAN OTC DRUG	Iris germanica comp.		Iris germanica comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BEEF HEART; C12-17 ALKANE; CENTAUREA BENEDICTA; GOLD; HAWTHORN LEAF WITH FLOWER; PAEONIA OFFICINALIS ROOT; POTASSIUM CARBONATE	15; 6; 4; 4; 10; 3; 4; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-5073_6ac2ea84-c4bf-8e59-e053-2a91aa0ac2c8	48951-5073	HUMAN OTC DRUG	Glandula thyreoidea 6 Special Order		Glandula thyreoidea 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	THYROID, UNSPECIFIED	6	[hp_X]/mL			N	20241231
48951-5076_6de4f853-bec4-1120-e053-2991aa0a9c3b	48951-5076	HUMAN OTC DRUG	Hypophysis 7 Special Order		Hypophysis 7 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PITUITARY GLAND	7	[hp_X]/1			N	20241231
48951-5077_6dd644fb-2a13-044e-e053-2a91aa0a5fb6	48951-5077	HUMAN OTC DRUG	Helleborus e pl. tota 3 Special Order		Helleborus e pl. tota 3 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HELLEBORUS FOETIDUS ROOT	3	[hp_X]/1			N	20241231
48951-5078_6dd5153f-0e2d-bb2b-e053-2a91aa0aa291	48951-5078	HUMAN OTC DRUG	Geum Gentian 1 Special Order		Geum Gentian 1 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GENTIANA LUTEA ROOT; GEUM URBANUM ROOT	1; 1	[hp_Q]/1; [hp_Q]/1			N	20241231
48951-5079_6dd69f2c-6f8d-6ac7-e053-2a91aa0a807d	48951-5079	HUMAN OTC DRUG	Hyoscyamus 2 Special Order		Hyoscyamus 2 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HYOSCYAMUS NIGER LEAF	2	[hp_X]/1			N	20241231
48951-5084_55b289e4-f1f6-57f5-e054-00144ff88e88	48951-5084	HUMAN OTC DRUG	Glandulae suprarenales 30 Special Order		Glandulae suprarenales 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND	30	[hp_X]/mL			N	20241231
48951-5086_6ac3af31-3c41-7fd4-e053-2991aa0a736b	48951-5086	HUMAN OTC DRUG	HCG 30/15/8 Special Order		HCG 30/15/8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GONADOTROPHIN, CHORIONIC	8	1/mL			N	20241231
48951-5087_6ac4da8f-5c50-11ed-e053-2991aa0aa1e0	48951-5087	HUMAN OTC DRUG	Hypophysis Mel Special Order		Hypophysis Mel Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PITUITARY GLAND; HONEY	10; 10	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-5088_6ac33a10-5e10-41d2-e053-2991aa0abdf2	48951-5088	HUMAN OTC DRUG	Glandulae suprarenales 3 Special Order		Glandulae suprarenales 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND	3	[hp_X]/mL			N	20241231
48951-5089_6dd67848-2069-40de-e053-2a91aa0a39d1	48951-5089	HUMAN OTC DRUG	Hepar mag. Pulsatilla Tormentilla 6/12/30 Special Order		Hepar mag. Pulsatilla Tormentilla 6/12/30 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM HYDROXIDE; MAMMAL LIVER; POTENTILLA ERECTA ROOT; PULSATILLA VULGARIS	6; 6; 30; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5090_6dd725a3-e538-b4a8-e053-2991aa0aa153	48951-5090	HUMAN OTC DRUG	Hypericum 6 Special Order		Hypericum 6 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ST. JOHN'S WORT	6	[hp_X]/1			N	20241231
48951-5091_7be7d427-0d0d-4b04-e053-2a91aa0ac8cc	48951-5091	HUMAN OTC DRUG	Glandulae suprarenales Lien Special Order		Glandulae suprarenales Lien Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS BILE; BOS TAURUS SPLEEN	8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5092_6ac41eb4-925b-6189-e053-2991aa0aefb1	48951-5092	HUMAN OTC DRUG	Hepar sulfuris 30 Special Order		Hepar sulfuris 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM SULFIDE	30	[hp_X]/mL			N	20241231
48951-5093_6ac436cd-41d3-beb0-e053-2a91aa0a5769	48951-5093	HUMAN OTC DRUG	Hypericum ex herba 30 Special Order		Hypericum ex herba 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ST. JOHN'S WORT	30	[hp_X]/mL			N	20241231
48951-5097_6dd5153f-0e04-bb2b-e053-2a91aa0aa291	48951-5097	HUMAN OTC DRUG	Gelsemium Bryonia		Gelsemium Bryonia	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	BRYONIA CRETICA SUBSP. DIOICA ROOT; GELSEMIUM SEMPERVIRENS ROOT	3; 3	[hp_X]/1; [hp_X]/1			N	20241231
48951-5098_6cdfd785-c78f-80ca-e053-2991aa0a8bfe	48951-5098	HUMAN OTC DRUG	Hypericum Kali Phos.		Hypericum Kali Phos.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	BERBERIS VULGARIS FRUIT; HYPERICUM PERFORATUM; POTASSIUM PHOSPHATE, UNSPECIFIED FORM	3; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-5099_6b9db7ed-3511-7a6d-e053-2a91aa0ac1d9	48951-5099	HUMAN OTC DRUG	Hypericum 30 Special Order		Hypericum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ST. JOHN'S WORT	30	[hp_X]/mL			N	20241231
48951-5103_6b9f51b6-7ef9-2358-e053-2a91aa0ae4d8	48951-5103	HUMAN OTC DRUG	Iris Germanica 2 Special Order		Iris Germanica 2 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	C12-17 ALKANE	2	[hp_X]/mL			N	20241231
48951-5104_6cb75b69-e5da-1bb5-e053-2a91aa0a6e1c	48951-5104	HUMAN OTC DRUG	Glandula thyreoidea 60 Special Order		Glandula thyreoidea 60 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	THYROID, UNSPECIFIED	60	[hp_X]/mL			N	20241231
48951-5105_6cbb63fa-7a1b-2b58-e053-2a91aa0aaadc	48951-5105	HUMAN OTC DRUG	Glandulae supra. Lien Solutio Ferri Special Order		Glandulae supra. Lien Solutio Ferri Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BILE; BOS TAURUS SPLEEN	8; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-5108_6ccb8d0f-6c0c-26ae-e053-2991aa0abeb8	48951-5108	HUMAN OTC DRUG	Helleborus e pl. tota 12		Helleborus e pl. tota 12	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HELLEBORUS FOETIDUS ROOT	12	[hp_X]/mL			N	20241231
48951-5112_54c6038f-1738-7417-e054-00144ff8d46c	48951-5112	HUMAN OTC DRUG	Hamamelis Aesculus		Hamamelis Aesculus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	AESCULUS GLABRA NUT; DESIRUDIN; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MERCURY; PAEONIA OFFICINALIS ROOT; PULSATILLA VULGARIS	3; 6; 3; 17; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
48951-5113_7cc10c1b-fe0f-7d4c-e053-2a91aa0a2377	48951-5113	HUMAN OTC DRUG	Glandula thyreoidea 6 Special Order		Glandula thyreoidea 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	THYROID, UNSPECIFIED	6	[hp_X]/mL			N	20241231
48951-5115_0aac9dcd-c4e2-84d9-e063-6294a90a0376	48951-5115	HUMAN OTC DRUG	Helleborus comp. B		Helleborus comp. B	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; BOS TAURUS SPLEEN; COLCHICUM AUTUMNALE WHOLE; EQUISETUM ARVENSE TOP; FORMICA RUFA; HELLEBORUS FOETIDUS ROOT; LEAD; PHOSPHORUS; SILVER	17; 8; 4; 20; 20; 4; 30; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5117_8f636d53-b434-57c7-e053-2995a90a0ad3	48951-5117	HUMAN OTC DRUG	Helleborus comp. D		Helleborus comp. D	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LIVER; GOLD; HELLEBORUS NIGER ROOT; HYOSCYAMUS NIGER LEAF; IRON; SLOE	6; 10; 6; 4; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC]		N	20241231
48951-5118_8f76596c-9025-7660-e053-2995a90aff34	48951-5118	HUMAN OTC DRUG	Helleborus comp. D		Helleborus comp. D	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LIVER; GOLD; HELLEBORUS NIGER ROOT; HYOSCYAMUS NIGER LEAF; IRON; MAGNESIUM CATION; SLOE	6; 10; 6; 4; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5119_8f77df41-58c0-8267-e053-2995a90a90e2	48951-5119	HUMAN OTC DRUG	Helleborus comp. C		Helleborus comp. C	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; BOS TAURUS SPLEEN; CHELIDONIUM MAJUS; FORMICA RUFA; HELLEBORUS NIGER ROOT; LEAD; SILVER	12; 8; 4; 6; 12; 30; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5120_902ac093-cfb3-277f-e053-2995a90a8348	48951-5120	HUMAN OTC DRUG	Helleborus comp. E		Helleborus comp. E	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; CHINESE YAM; GOLD; HELLEBORUS FOETIDUS ROOT; HELLEBORUS NIGER ROOT; KALANCHOE DAIGREMONTIANA LEAF; LEAD; ROSMARINUS OFFICINALIS FLOWERING TOP	30; 3; 12; 12; 21; 2; 20; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-5121_97df45bd-27e8-2fc1-e053-2a95a90a8792	48951-5121	HUMAN OTC DRUG	Helleborus comp. E		Helleborus comp. E	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; CHINESE YAM; GOLD; HELLEBORUS FOETIDUS ROOT; HELLEBORUS NIGER ROOT; KALANCHOE DAIGREMONTIANA LEAF; LEAD; ROSMARINUS OFFICINALIS FLOWERING TOP	30; 3; 12; 12; 21; 2; 20; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-5122_bd490a1c-9c75-4585-e053-2995a90a4785	48951-5122	HUMAN OTC DRUG	Helleborus comp. A		Helleborus comp. A	LIQUID	ORAL	20210311		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; ARSENIC TRIOXIDE; FORMICA RUFA; HELLEBORUS NIGER ROOT; LEAD MONOSILICATE; PHOSPHORUS; SILVER	6; 17; 6; 3; 20; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5123_c69f7fe0-5930-b50c-e053-2995a90a3ca6	48951-5123	HUMAN OTC DRUG	Helleborus niger 3		Helleborus niger 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HELLEBORUS NIGER ROOT	3	[hp_X]/mL			N	20241231
48951-5124_0aab8547-2c4b-aff4-e063-6394a90affa7	48951-5124	HUMAN OTC DRUG	Helleborus niger 6X		Helleborus niger 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HELLEBORUS NIGER ROOT	6	[hp_X]/mL			N	20241231
48951-5125_0c3ff8de-f86f-0ab6-e063-6294a90ae621	48951-5125	HUMAN OTC DRUG	Helleborus niger 12X		Helleborus niger 12X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HELLEBORUS NIGER ROOT	12	[hp_X]/mL			N	20241231
48951-5126_cf338901-6b23-4cd3-e053-2995a90a1060	48951-5126	HUMAN OTC DRUG	Graphite Belladonna		Graphite Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	AMANITA MUSCARIA FRUITING BODY; ATROPA BELLADONNA; BOS TAURUS BRAIN; GRAPHITE; HELLEBORUS NIGER ROOT; SILVER SULFIDE; TIN	6; 30; 6; 30; 4; 6; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5127_d657e0e3-fb86-48e5-e053-2a95a90aaec7	48951-5127	HUMAN OTC DRUG	Hypophysis comp.		Hypophysis comp.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS HYPOTHALAMUS; BOS TAURUS PINEAL GLAND; BOS TAURUS PITUITARY GLAND	30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-5128_d66d2369-d5c7-f118-e053-2995a90a9d0f	48951-5128	HUMAN OTC DRUG	Hepar Magnesium 10X		Hepar Magnesium 10X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LIVER; MAGNESIUM HYDROXIDE	10; 10	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-5130_de5f6103-a9f0-b06b-e053-2a95a90a8301	48951-5130	HUMAN OTC DRUG	Helleborus comp. F		Helleborus comp. F	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ARNICA MONTANA; BOS TAURUS NASAL MUCOSA; BOS TAURUS OLFACTORY BULB; HELLEBORUS NIGER ROOT; SILICON DIOXIDE	12; 12; 8; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-5131_056bf303-e833-ed7f-e063-6294a90a2b7d	48951-5131	HUMAN OTC DRUG	GI. suprarenales GI. thyreoidea Hypophysis 6x6x8x		GI. suprarenales GI. thyreoidea Hypophysis 6x6x8x	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS PITUITARY GLAND; THYROID, UNSPECIFIED	6; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-5132_0b3d5569-03f6-6e0f-e063-6294a90ad872	48951-5132	HUMAN OTC DRUG	Helleborus foetidus 6X		Helleborus foetidus 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	HELLEBORUS FOETIDUS WHOLE	6	[hp_X]/mL			N	20241231
48951-5133_0c931a56-b7d8-c70e-e063-6394a90a2c4a	48951-5133	HUMAN OTC DRUG	Gentian Ginger Bitters		Gentian Ginger Bitters	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACORUS CALAMUS ROOT; BLACK PEPPER; GENTIANA LUTEA ROOT; GINGER; WORMWOOD	1; 1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-5134_0ccec871-c8fc-87b6-e063-6294a90a9c0f	48951-5134	HUMAN OTC DRUG	Helleborus comp. A		Helleborus comp. A	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ANTIMONY; ARSENIC TRIOXIDE; FORMICA RUFA; HELLEBORUS FOETIDUS ROOT; JUGLANS REGIA LEAF; LEAD MONOSILICATE; PHOSPHORUS; POTASSIUM PHOSPHATE, MONOBASIC; SILVER; TIN	6; 17; 6; 3; 7; 20; 12; 6; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6000_55c76edd-531d-3409-e054-00144ff88e88	48951-6000	HUMAN OTC DRUG	Juglans Stannum Special Order		Juglans Stannum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	JUGLANS REGIA LEAF; POTASSIUM PHOSPHATE, MONOBASIC; TIN	4; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6001_6de506a6-d929-cd0a-e053-2a91aa0a8ed3	48951-6001	HUMAN OTC DRUG	Juglans Stannum Special Order		Juglans Stannum Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	JUGLANS REGIA LEAF; POTASSIUM PHOSPHATE, MONOBASIC; TIN	12; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6004_6ac65534-fa20-379f-e053-2991aa0a3955	48951-6004	HUMAN OTC DRUG	Kalium aceticum comp. 6		Kalium aceticum comp. 6	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY TRISULFIDE; CORALLIUM RUBRUM EXOSKELETON; POTASSIUM ACETATE; SAFFRON	6; 6; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
48951-6006_6ac63abb-fb8c-78ec-e053-2991aa0a5dbf	48951-6006	HUMAN OTC DRUG	Kalium aceticum comp. 6		Kalium aceticum comp. 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY TRISULFIDE; CORALLIUM RUBRUM EXOSKELETON; POTASSIUM ACETATE; SAFFRON	6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
48951-6011_7cb0c15d-ee97-4d78-e053-2a91aa0aea1c	48951-6011	HUMAN OTC DRUG	Kali phos. Aurum		Kali phos. Aurum	TABLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROUS SULFATE; GOLD; POTASSIUM PHOSPHATE, MONOBASIC; SILICON DIOXIDE	5; 10; 6; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-6012_0a0c48f9-6f95-99a3-e063-6394a90a139c	48951-6012	HUMAN OTC DRUG	Lachesis Belladonna		Lachesis Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; CALCIUM SULFIDE; LACHESIS MUTA VENOM; MERCURIALIS PERENNIS	4; 7; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6013_6ad48609-b130-ecf3-e053-2991aa0ad704	48951-6013	HUMAN OTC DRUG	Lachesis Belladonna		Lachesis Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; CALCIUM SULFIDE; LACHESIS MUTA VENOM; MERCURIALIS PERENNIS	4; 6; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6014_6de5a51a-67ac-31ce-e053-2991aa0afb4d	48951-6014	HUMAN OTC DRUG	Lachesis Belladonna		Lachesis Belladonna	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; CALCIUM SULFIDE; LACHESIS MUTA VENOM; MERCURIALIS PERENNIS	4; 6; 12; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6015_6d6dbfb9-e99e-7cb7-e053-2991aa0a435c	48951-6015	HUMAN OTC DRUG	Larynx Bryonia Special Order		Larynx Bryonia Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BOS TAURUS NERVE; BRYONIA ALBA ROOT; LEVISTICUM OFFICINALE ROOT; THYROID, BOVINE	20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-6016_6de5a51a-67b9-31ce-e053-2991aa0afb4d	48951-6016	HUMAN OTC DRUG	Larynx Bryonia		Larynx Bryonia	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BOS TAURUS NERVE; BRYONIA ALBA ROOT; LEVISTICUM OFFICINALE ROOT; THYROID, BOVINE	20; 20; 20; 20; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-6018_6de5ad5f-9d26-72a0-e053-2991aa0af5b5	48951-6018	HUMAN OTC DRUG	Larynx Levisticum		Larynx Levisticum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BOS TAURUS NERVE; BRYONIA ALBA ROOT; LEVISTICUM OFFICINALE ROOT; THYROID, BOVINE	6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-6021_6ad52cac-df9c-76dd-e053-2991aa0a1c20	48951-6021	HUMAN OTC DRUG	Lavender Quartz Ear Oil		Lavender Quartz Ear Oil	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; CAMPHOR (NATURAL); GARLIC; LEVISTICUM OFFICINALE ROOT; SILICON DIOXIDE; ST. JOHN'S WORT; TOXICODENDRON PUBESCENS LEAF; VERBASCUM DENSIFLORUM LEAF	30; 30; 2; 2; 2; 30; 1; 30; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-6026_6d6d1d4f-c2a3-39f5-e053-2991aa0a107a	48951-6026	HUMAN OTC DRUG	Levico Prunus		Levico Prunus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERRIC OXIDE RED; FERROUS ARSENATE; PRUNUS SPINOSA FLOWER BUD; ST. JOHN'S WORT	6; 3; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6027_6de6195a-d254-05a7-e053-2a91aa0a2d6d	48951-6027	HUMAN OTC DRUG	Levico Prunus		Levico Prunus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERRIC OXIDE RED; FERROUS ARSENATE; SLOE; ST. JOHN'S WORT	3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6029_0eaebab2-2fbc-e88c-e063-6294a90ae4c3	48951-6029	HUMAN OTC DRUG	Levisticum e rad. 3		Levisticum e rad. 3	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEVISTICUM OFFICINALE ROOT	3	[hp_X]/1			N	20251231
48951-6032_6de61cd6-ce00-467f-e053-2991aa0a183d	48951-6032	HUMAN OTC DRUG	Levisticum Quercus		Levisticum Quercus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS EYE; LEVISTICUM OFFICINALE ROOT; QUERCUS ROBUR WHOLE	6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6033_0993e809-acbf-7481-e063-6394a90ae3f7	48951-6033	HUMAN OTC DRUG	Lien Cichorium		Lien Cichorium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS CARTILAGE; BOS TAURUS SPLEEN; CICHORIUM INTYBUS WHOLE; EQUISETUM ARVENSE TOP; PORK KIDNEY	8; 6; 20; 20; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6034_0993e833-a144-7485-e063-6394a90a73ac	48951-6034	HUMAN OTC DRUG	Lien Cichorium		Lien Cichorium	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS CARTILAGE; BOS TAURUS SPLEEN; CICHORIUM INTYBUS WHOLE; EQUISETUM ARVENSE TOP; PORK KIDNEY	8; 6; 20; 20; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6035_6d6ee75f-8dc5-a114-e053-2991aa0aee87	48951-6035	HUMAN OTC DRUG	Lien Plumbum		Lien Plumbum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS SPLEEN; LEAD	6; 30	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-6036_6de65da5-6adf-4d92-e053-2991aa0a67e2	48951-6036	HUMAN OTC DRUG	Lien Plumbum Special Order		Lien Plumbum Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS SPLEEN; LEAD	6; 30	[hp_X]/1; [hp_X]/1			N	20241231
48951-6044_0aac7617-8cc0-7962-e063-6394a90a1821	48951-6044	HUMAN OTC DRUG	Liver comp.		Liver comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM CATION; MAMMAL LIVER; MILK THISTLE; TIN	4; 4; 3; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-6045_6d6e20a3-878a-3e86-e053-2a91aa0a4aea	48951-6045	HUMAN OTC DRUG	Lobelia Quercus		Lobelia Quercus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD; LOBELIA SPICATA LEAF; QUERCUS ROBUR WHOLE; VERONICA OFFICINALIS FLOWERING TOP	17; 6; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6046_6ad58928-f21c-0673-e053-2a91aa0af990	48951-6046	HUMAN OTC DRUG	Lobelia Quercus		Lobelia Quercus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD; LOBELIA SPICATA LEAF; QUERCUS ROBUR WHOLE; VERONICA OFFICINALIS FLOWERING TOP	17; 6; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6047_6de6cdf3-51b8-0840-e053-2a91aa0af59a	48951-6047	HUMAN OTC DRUG	Lobelia Quercus		Lobelia Quercus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD; LOBELIA SPICATA LEAF; QUERCUS ROBUR WHOLE; VERONICA OFFICINALIS FLOWERING TOP	17; 6; 4; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6048_6cdf5e31-a6f0-0ba4-e053-2991aa0ab184	48951-6048	HUMAN OTC DRUG	Lycopodium Berberis		Lycopodium Berberis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; CALOMEL; CHELIDONIUM MAJUS ROOT; FRAGARIA VESCA WHOLE; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; SULFIDE ION; TURMERIC; VITIS VINIFERA LEAF	3; 10; 5; 5; 5; 4; 6; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6049_6ad5b667-3fe3-9545-e053-2a91aa0a8c94	48951-6049	HUMAN OTC DRUG	Lycopodium Berberis		Lycopodium Berberis	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; CALOMEL; CHELIDONIUM MAJUS ROOT; FRAGARIA VESCA WHOLE; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; SULFIDE ION; TURMERIC; VITIS VINIFERA LEAF	3; 10; 5; 5; 3; 1; 6; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6050_6ad5ecf2-21f3-4b20-e053-2991aa0a4028	48951-6050	HUMAN OTC DRUG	Lymphocytes 8		Lymphocytes 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUINE THYMOCYTE IMMUNE GLOBULIN	8	[hp_X]/mL	Antibody-Surface Protein Interactions [MoA], Immunoglobulin G [EPC], Immunoglobulins [CS], Increased T Lymphocyte Destruction [PE], Lymphocyte Function Alteration [PE]		N	20241231
48951-6051_6ad5ecf2-2204-4b20-e053-2991aa0a4028	48951-6051	HUMAN OTC DRUG	Lysimachia Solanum 5		Lysimachia Solanum 5	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LYSIMACHIA NUMMULARIA; SOLANUM DULCAMARA FLOWER	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-6060_55c834d5-2f38-4020-e054-00144ff8d46c	48951-6060	HUMAN OTC DRUG	Lymphocytes 30 Special Order		Lymphocytes 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUINE THYMOCYTE IMMUNE GLOBULIN	30	[hp_X]/mL	Antibody-Surface Protein Interactions [MoA], Immunoglobulin G [EPC], Immunoglobulins [CS], Increased T Lymphocyte Destruction [PE], Lymphocyte Function Alteration [PE]		N	20241231
48951-6061_6ccc1c4f-9073-17d1-e053-2991aa0a4c6a	48951-6061	HUMAN OTC DRUG	Lycopodium e pl tota. 8 Special Order		Lycopodium e pl tota. 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LYCOPODIUM CLAVATUM SPORE	8	[hp_X]/mL			N	20241231
48951-6062_6d6f2f5b-732e-0630-e053-2991aa0ac6dc	48951-6062	HUMAN OTC DRUG	Lycopodium e pl. tota 3 Special Order		Lycopodium e pl. tota 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LYCOPODIUM CLAVATUM SPORE	3	[hp_X]/mL			N	20241231
48951-6063_55c77d78-d2b8-28bf-e054-00144ff8d46c	48951-6063	HUMAN OTC DRUG	Kalium phosphoricum 6 Special Order		Kalium phosphoricum 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	POTASSIUM PHOSPHATE, MONOBASIC	6	[hp_X]/mL			N	20241231
48951-6067_6ad48609-b121-ecf3-e053-2991aa0ad704	48951-6067	HUMAN OTC DRUG	Kalium carbonicum 12 Special Order		Kalium carbonicum 12 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	POTASSIUM CARBONATE	12	[hp_X]/mL			N	20241231
48951-6068_0eb26ca1-bcd4-3e01-e063-6294a90a9dfe	48951-6068	HUMAN OTC DRUG	Lemon Quince		Lemon Quince	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	BERBERIS VULGARIS FRUIT; CHAENOMELES SINENSIS FRUIT; LEMON; SILICON DIOXIDE	3; 2; 2; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20251231
48951-6069_6b9fdd07-a3ae-2409-e053-2991aa0a0ff1	48951-6069	HUMAN OTC DRUG	Juglans regia e testa 14 Special Order		Juglans regia e testa 14 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ENGLISH WALNUT	14	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
48951-6070_6ba0247b-f252-91c6-e053-2a91aa0ab9c7	48951-6070	HUMAN OTC DRUG	Juglans regia e testa 30 Special Order		Juglans regia e testa 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ENGLISH WALNUT	30	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
48951-6071_6ba0600c-03c3-e39b-e053-2a91aa0a6234	48951-6071	HUMAN OTC DRUG	Kalium Sulfuratum Bath Essence		Kalium Sulfuratum Bath Essence	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SULFUR	1	[hp_X]/mL			N	20241231
48951-6072_6ba1268a-a3b2-6a3c-e053-2a91aa0a0add	48951-6072	HUMAN OTC DRUG	Lycopodium 5% Special Order		Lycopodium 5% Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LYCOPODIUM CLAVATUM SPORE	1	[hp_X]/mL			N	20241231
48951-6075_6d6d6521-7236-b0ce-e053-2991aa0aeb9c	48951-6075	HUMAN OTC DRUG	Ledum palustre 6 Special Order		Ledum palustre 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEDUM PALUSTRE TWIG	6	[hp_X]/mL			N	20241231
48951-6077_0b3b62fc-676c-576d-e063-6394a90a2f7b	48951-6077	HUMAN OTC DRUG	Levisticum Quercus		Levisticum Quercus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS EYE; BOS TAURUS NERVE; BOS TAURUS PARASYMPATHETIC NERVE; LEVISTICUM OFFICINALE ROOT; QUERCUS ALBA BARK; QUERCUS ROBUR WHOLE	8; 8; 8; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6078_c3649cbe-f30d-972a-e053-2a95a90a1dd7	48951-6078	HUMAN OTC DRUG	Juglans Stannum		Juglans Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	JUGLANS REGIA LEAF; POTASSIUM PHOSPHATE, MONOBASIC; TIN	5; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-6079_c9edf485-e2ec-1605-e053-2a95a90aff2d	48951-6079	HUMAN OTC DRUG	Kalium aceticum comp 6		Kalium aceticum comp 6	PELLET	ORAL	20210819		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY TRISULFIDE; CORALLIUM RUBRUM EXOSKELETON; POTASSIUM ACETATE; SAFFRON	6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
48951-6080_cc6f3978-cc52-a9d6-e053-2a95a90a7ce4	48951-6080	HUMAN OTC DRUG	Lymphocytes 6X		Lymphocytes 6X	LIQUID	ORAL	20210920		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUINE THYMOCYTE IMMUNE GLOBULIN	6	[hp_X]/mL	Antibody-Surface Protein Interactions [MoA], Immunoglobulin G [EPC], Immunoglobulins [CS], Increased T Lymphocyte Destruction [PE], Lymphocyte Function Alteration [PE]		N	20241231
48951-6081_d697009f-156d-6dde-e053-2a95a90a1254	48951-6081	HUMAN OTC DRUG	Hepar Magnesium 6		Hepar Magnesium 6	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LIVER; MAGNESIUM HYDROXIDE	6; 6	[hp_X]/1; [hp_X]/1	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-6082_05182654-5b51-c78a-e063-6394a90abfab	48951-6082	HUMAN OTC DRUG	Juniperus Eucalyptus		Juniperus Eucalyptus	CAPSULE, LIQUID FILLED	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ACORUS CALAMUS ROOT; BERBERIS VULGARIS ROOT BARK; C12-17 ALKANE; CAMPHOR (NATURAL); LARIX DECIDUA RESIN; SOLIDAGO VIRGAUREA FLOWERING TOP	3; 1; 3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-6083_0aac557d-6dd0-be58-e063-6294a90a5353	48951-6083	HUMAN OTC DRUG	Liver comp.		Liver comp.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM HYDROXIDE; MAMMAL LIVER; MILK THISTLE; TIN	4; 4; 3; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-6084_0ccf88c6-2738-0a37-e063-6294a90a679a	48951-6084	HUMAN OTC DRUG	Ledum palustre 30X		Ledum palustre 30X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	RHODODENDRON TOMENTOSUM LEAFY TWIG	30	[hp_X]/mL			N	20241231
48951-6086_0eb1e9d4-3ca3-0f9e-e063-6394a90a6d87	48951-6086	HUMAN OTC DRUG	Lemon Quince		Lemon Quince	SPRAY	NASAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; LEMON JUICE; QUINCE; SILICON DIOXIDE	3; 2; 2; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20251231
48951-7000_6d5af629-de1e-c2ab-e053-2a91aa0a45d9	48951-7000	HUMAN OTC DRUG	Magnesite Viscum		Magnesite Viscum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BOS TAURUS MAMMARY GLAND; BOS TAURUS PITUITARY GLAND; MAGNESITE; SUS SCROFA UMBILICAL CORD; VISCUM ALBUM FRUITING TOP	6; 6; 6; 8; 6; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-7002_6ad6072a-daa3-6c09-e053-2991aa0a47e2	48951-7002	HUMAN OTC DRUG	Magnesium carbonicum 6		Magnesium carbonicum 6	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM CARBONATE	6	[hp_X]/g			N	20241231
48951-7004_6ce0e10c-20bc-4e52-e053-2991aa0acce5	48951-7004	HUMAN OTC DRUG	Magnesium sulf. Bryonia		Magnesium sulf. Bryonia	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA; BOS TAURUS OVARY; BOS TAURUS PITUITARY GLAND; BRYONIA ALBA ROOT; MAGNESIUM CATION; SILICON DIOXIDE; SUS SCROFA UMBILICAL CORD; TIN; VESPA CRABRO; VISCUM ALBUM FRUITING TOP	5; 3; 6; 6; 3; 6; 6; 6; 10; 5; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-7009_6d5b2167-8b07-7b71-e053-2991aa0aedf0	48951-7009	HUMAN OTC DRUG	Mamma (dextra) 6		Mamma (dextra) 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS MAMMARY GLAND	6	[hp_X]/mL			N	20241231
48951-7010_6d5b6741-0334-886e-e053-2991aa0a4d73	48951-7010	HUMAN OTC DRUG	Mamma (sinistra) 6		Mamma (sinistra) 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS MAMMARY GLAND	6	[hp_X]/mL			N	20241231
48951-7013_55da9353-8722-3f5d-e054-00144ff88e88	48951-7013	HUMAN OTC DRUG	Mandragora e rad. 2		Mandragora e rad. 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MANDRAGORA OFFICINARUM ROOT	2	[hp_X]/mL			N	20241231
48951-7015_0ac1d262-5a34-f7ba-e063-6294a90a7726	48951-7015	HUMAN OTC DRUG	Mandragora Rheum		Mandragora Rheum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BONE; BOVINE TYPE I COLLAGEN; FORMICA RUFA; MANDRAGORA OFFICINARUM ROOT; SILVER; SUS SCROFA PANCREAS; TARAXACUM PALUSTRE ROOT	8; 6; 6; 3; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allogeneic Cultured Cell Scaffold [EPC], Collagen [CS]		N	20241231
48951-7016_0ac21f80-e655-0da2-e063-6294a90a5c26	48951-7016	HUMAN OTC DRUG	Mandragora Rheum		Mandragora Rheum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BONE; BOVINE TYPE I COLLAGEN; FORMICA RUFA; MANDRAGORA OFFICINARUM ROOT; SILVER; SUS SCROFA PANCREAS; TARAXACUM PALUSTRE ROOT	8; 6; 6; 3; 6; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allogeneic Cultured Cell Scaffold [EPC], Collagen [CS]		N	20241231
48951-7019_d335bbc8-25b2-88c3-e053-2995a90ae113	48951-7019	HUMAN OTC DRUG	Marjoram Quercus		Marjoram Quercus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ACHILLEA MILLEFOLIUM; CAPSELLA BURSA-PASTORIS; QUERCUS ROBUR WHOLE; SWEET MARJORAM; URTICA DIOICA LEAF	1; 1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7020_d7854cd7-239b-ef7f-e053-2995a90a2969	48951-7020	HUMAN OTC DRUG	Marjoram Quercus		Marjoram Quercus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACHILLEA MILLEFOLIUM; CAPSELLA BURSA-PASTORIS; QUERCUS ROBUR WHOLE; SWEET MARJORAM; URTICA DIOICA LEAF	1; 1; 1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7022_6de75df0-eba1-49e1-e053-2991aa0a2db1	48951-7022	HUMAN OTC DRUG	Medulla Arnica		Medulla Arnica	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; ARNICA MONTANA; BETULA PUBESCENS BARK; BOS TAURUS SPINAL CORD; CERVUS ELAPHUS WHOLE; GOLD; SILICON DIOXIDE	8; 20; 10; 8; 8; 10; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-7023_6d5dd521-53a9-0073-e053-2991aa0abd87	48951-7023	HUMAN OTC DRUG	Medulla ossium 8		Medulla ossium 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BONE MARROW	8	[hp_X]/mL			N	20241231
48951-7038_55dac11c-a7bc-5a71-e054-00144ff8d46c	48951-7038	HUMAN OTC DRUG	Mercurius auratus 15 Special Order		Mercurius auratus 15 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY	15	[hp_X]/mL			N	20241231
48951-7040_6ad62085-07f3-134e-e053-2a91aa0af5b1	48951-7040	HUMAN OTC DRUG	Mercurius auratus Pulmo		Mercurius auratus Pulmo	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY; SUS SCROFA LUNG	15; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-7042_6ad6d8e5-af27-100a-e053-2991aa0af784	48951-7042	HUMAN OTC DRUG	Mercurius cyanatus 6		Mercurius cyanatus 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURIC CYANIDE	6	[hp_X]/mL			N	20241231
48951-7044_6d5d4380-05e1-504d-e053-2991aa0aa3b7	48951-7044	HUMAN OTC DRUG	Mercurius vivus 8		Mercurius vivus 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY	8	[hp_X]/mL			N	20241231
48951-7046_6d5c9c18-2e9f-b562-e053-2a91aa0a283b	48951-7046	HUMAN OTC DRUG	Mesenchyme Quercus		Mesenchyme Quercus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; BOS TAURUS CARTILAGE; MAMMAL LIVER; PORK KIDNEY; QUERCUS ROBUR WHOLE; SUS SCROFA LUNG; SUS SCROFA PANCREAS	6; 8; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7047_57976239-91bc-9e21-e053-2991aa0a2a13	48951-7047	HUMAN OTC DRUG	Mesenchyme Quercus		Mesenchyme Quercus	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; BOS TAURUS CARTILAGE; MAMMAL LIVER; PORK KIDNEY; QUERCUS ROBUR WHOLE; SUS SCROFA LUNG; SUS SCROFA PANCREAS	8; 10; 8; 8; 8; 8; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-7048_6de8c607-340c-d6b8-e053-2991aa0abab4	48951-7048	HUMAN OTC DRUG	Mesenchyme Quercus		Mesenchyme Quercus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; BOS TAURUS CARTILAGE; MAMMAL LIVER; PORK KIDNEY; QUERCUS ROBUR WHOLE; SUS SCROFA LUNG; SUS SCROFA PANCREAS	6; 8; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7051_6d5d26b8-c77e-282c-e053-2a91aa0a153d	48951-7051	HUMAN OTC DRUG	Meteoric Iron Phosphorus Quartz		Meteoric Iron Phosphorus Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; PHOSPHORUS; SILICON DIOXIDE	12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7052_6d5c7660-4b06-37e8-e053-2991aa0a155c	48951-7052	HUMAN OTC DRUG	Meteoric Iron Prunus		Meteoric Iron Prunus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA, UNSPECIFIED; IRON; PHOSPHORUS; SILICON DIOXIDE; SLOE	3; 12; 6; 12; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7054_6ad7438d-5aec-d2a5-e053-2991aa0afb52	48951-7054	HUMAN OTC DRUG	Meteoric Iron Prunus		Meteoric Iron Prunus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA, UNSPECIFIED; IRON; PHOSPHORUS; SILICON DIOXIDE; SLOE	3; 12; 6; 12; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7055_6de8cba6-2014-76e1-e053-2a91aa0a71f5	48951-7055	HUMAN OTC DRUG	Mezereum Comp.		Mezereum Comp.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CROTON TIGLIUM WHOLE; DAPHNE MEZEREUM WHOLE; LYTTA VESICATORIA; SILVER; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7058_6d5c2e52-9e29-ab67-e053-2991aa0a5095	48951-7058	HUMAN OTC DRUG	Musculus deltoides comp. 12 Special Order		Musculus deltoides comp. 12 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-7062_6d5b5a29-fc95-683d-e053-2991aa0a9945	48951-7062	HUMAN OTC DRUG	Myristica Argentum		Myristica Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS NASAL MUCOSA; DICHROMATE ION; SILVER; VIROLA SEBIFERA RESIN	7; 6; 20; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7064_55dc0a98-1473-187b-e054-00144ff8d46c	48951-7064	HUMAN OTC DRUG	Naja e veneno 10		Naja e veneno 10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	NAJA NAJA VENOM	10	[hp_X]/mL			N	20241231
48951-7069_55dc40db-0c75-04ff-e054-00144ff88e88	48951-7069	HUMAN OTC DRUG	Nervus trigeminus 30 Special Order		Nervus trigeminus 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS NERVE	30	[hp_X]/mL			N	20241231
48951-7072_6de91052-2234-8d43-e053-2a91aa0ad157	48951-7072	HUMAN OTC DRUG	Nicotiana Carbo		Nicotiana Carbo	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; LOBELIA SPICATA LEAF; MATRICARIA RECUTITA; TOBACCO LEAF	20; 12; 6; 3; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-7074_6d5a3005-8c8f-d74f-e053-2a91aa0a3c49	48951-7074	HUMAN OTC DRUG	Nicotiana e fol. 6		Nicotiana e fol. 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TOBACCO LEAF	6	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-7075_55dc93ad-c54d-234f-e054-00144ff8d46c	48951-7075	HUMAN OTC DRUG	Nicotiana Pulsatilla Special Order		Nicotiana Pulsatilla Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; PULSATILLA VULGARIS; TOBACCO LEAF	3; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-7076_6de93cf9-8416-4b09-e053-2991aa0a85b7	48951-7076	HUMAN OTC DRUG	Nicotiana Pulsatilla		Nicotiana Pulsatilla	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; PULSATILLA VULGARIS; TOBACCO LEAF	3; 4; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-7077_55dc93ad-c558-234f-e054-00144ff8d46c	48951-7077	HUMAN OTC DRUG	Nodi Lymphatici 8		Nodi Lymphatici 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS LYMPH VESSEL	8	[hp_X]/mL			N	20241231
48951-7080_6d5acdf0-813f-5680-e053-2a91aa0a7e67	48951-7080	HUMAN OTC DRUG	Nux vomica Chamomilla		Nux vomica Chamomilla	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; MATRICARIA RECUTITA; PORK KIDNEY; ROBINIA PSEUDOACACIA BARK; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	20; 3; 7; 6; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-7081_6ad7af3e-86d2-14ab-e053-2a91aa0abf67	48951-7081	HUMAN OTC DRUG	Nux vomica Chamomilla		Nux vomica Chamomilla	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; CHELIDONIUM MAJUS ROOT; PORK KIDNEY; ROBINIA PSEUDOACACIA BARK; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	20; 3; 7; 6; 8; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-7084_55dcdcdb-61d6-339d-e054-00144ff8d46c	48951-7084	HUMAN OTC DRUG	Olivenite 6 Special Order		Olivenite 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER ARSENATE	6	[hp_X]/mL			N	20241231
48951-7086_55dcd063-5673-35aa-e054-00144ff8d46c	48951-7086	HUMAN OTC DRUG	Olivenite Stannum Special Order		Olivenite Stannum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER ARSENATE; FERROSOFERRIC PHOSPHATE; JACOBAEA VULGARIS; PULSATILLA VULGARIS; SPINACIA OLERACEA ROOT; TIN	6; 7; 3; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7087_6ce0e10c-20ae-4e52-e053-2991aa0acce5	48951-7087	HUMAN OTC DRUG	Olivenite Stannum		Olivenite Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPRIC ARSENATE; FERROSOFERRIC PHOSPHATE; JACOBAEA VULGARIS; PULSATILLA VULGARIS; SPINACIA OLERACEA ROOT; TIN	6; 7; 3; 6; 3; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-7088_6ad86aae-da3e-073d-e053-2a91aa0a651d	48951-7088	HUMAN OTC DRUG	Onopordon Aurum		Onopordon Aurum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	10; 3; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-7089_6ad919fe-d07a-71b9-e053-2991aa0a46bb	48951-7089	HUMAN OTC DRUG	Onopordon comp.		Onopordon comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	3; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7090_6de986ff-0b83-f4cc-e053-2991aa0a160e	48951-7090	HUMAN OTC DRUG	Onopordon comp.		Onopordon comp.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	4; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7092_6ad919fe-d06a-71b9-e053-2991aa0a46bb	48951-7092	HUMAN OTC DRUG	Onopordon Comp.		Onopordon Comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	3; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7094_6d581f92-f934-8c28-e053-2a91aa0a3ba5	48951-7094	HUMAN OTC DRUG	Organoplex		Organoplex	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; MAMMAL LIVER; PORK KIDNEY; SUS SCROFA LUNG	8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7095_6de98572-7ee3-e2a2-e053-2991aa0aec2b	48951-7095	HUMAN OTC DRUG	Organoplex		Organoplex	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; MAMMAL LIVER; PORK KIDNEY; SUS SCROFA LUNG	8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7098_6d581f92-f93f-8c28-e053-2a91aa0a3ba5	48951-7098	HUMAN OTC DRUG	Ovaria Apis Special Order		Ovaria Apis Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS OVARY; ROYAL JELLY; SILVER	8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7099_6dea1e52-7f54-8439-e053-2991aa0ad83e	48951-7099	HUMAN OTC DRUG	Ovaria Apis		Ovaria Apis	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS OVARY; ROYAL JELLY; SILVER	8; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7102_57d213e3-fdb4-70b1-e053-2991aa0a2e9b	48951-7102	HUMAN OTC DRUG	Oxalis 10		Oxalis 10	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS ACETOSELLA LEAF	1	[hp_X]/g			N	20241231
48951-7106_57974c81-7483-682e-e053-2a91aa0a84b1	48951-7106	HUMAN OTC DRUG	Oxalis 5		Oxalis 5	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS ACETOSELLA LEAF	5	[hp_X]/g			N	20241231
48951-7107_55de705b-a09c-5519-e054-00144ff88e88	48951-7107	HUMAN OTC DRUG	Oxalis Belladonna Special Order		Oxalis Belladonna Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; CHELIDONIUM MAJUS ROOT; GELSEMIUM SEMPERVIRENS ROOT; OXALIS ACETOSELLA LEAF; SANGUINARIA CANADENSIS ROOT	4; 4; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7108_6ad9a552-12c1-381e-e053-2991aa0a8b90	48951-7108	HUMAN OTC DRUG	Oxalis Belladonna		Oxalis Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA RECUTITA; OXALIS ACETOSELLA LEAF; SANGUINARIA CANADENSIS ROOT	4; 4; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7109_55de705b-a0a7-5519-e054-00144ff88e88	48951-7109	HUMAN OTC DRUG	Oxalis e pl. tota 3		Oxalis e pl. tota 3	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS ACETOSELLA LEAF	3	[hp_X]/mL			N	20241231
48951-7115_6ad9967f-be68-1066-e053-2a91aa0abd95	48951-7115	HUMAN OTC DRUG	Osteodoron AM Special Formula		Osteodoron AM Special Formula	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM FLUORIDE; CUCURBITA PEPO FLOWER; FLUORAPATITE; LEAD CARBONATE; SILICON DIOXIDE	6; 3; 6; 8; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-7117_6de8c607-3459-d6b8-e053-2991aa0abab4	48951-7117	HUMAN OTC DRUG	Musculus deltoideus comp. 8 Special Order		Musculus deltoideus comp. 8 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF	8	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-7120_6d5d5d8a-b2ea-12fb-e053-2a91aa0a179f	48951-7120	HUMAN OTC DRUG	Mercurius vivus 10/20/30 Special Order		Mercurius vivus 10/20/30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY	10	[hp_X]/mL			N	20241231
48951-7122_6d5e2e14-f166-5069-e053-2a91aa0a2045	48951-7122	HUMAN OTC DRUG	Magnesium phosphoricum 6 Special Order		Magnesium phosphoricum 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-7123_55dae099-0014-4b76-e054-00144ff88e88	48951-7123	HUMAN OTC DRUG	Mercurius solubilis 12 Special Order		Mercurius solubilis 12 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURIUS SOLUBILIS	12	[hp_X]/mL			N	20241231
48951-7134_6ad81326-94ce-9ac8-e053-2991aa0a9e7f	48951-7134	HUMAN OTC DRUG	Nux vomica e sem. 6 Special Order		Nux vomica e sem. 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	STRYCHNOS NUX-VOMICA SEED	6	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-7137_6ad6af83-0f1f-72d9-e053-2991aa0aa995	48951-7137	HUMAN OTC DRUG	Mercurius auratus Pulmo Special Order		Mercurius auratus Pulmo Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY; SUS SCROFA LUNG	15; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-7142_55dacc7e-15c9-42a4-e054-00144ff88e88	48951-7142	HUMAN OTC DRUG	Mercurius cyanatus 8		Mercurius cyanatus 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURIC CYANIDE	8	[hp_X]/mL			N	20241231
48951-7144_6ad7af3e-86bf-14ab-e053-2a91aa0abf67	48951-7144	HUMAN OTC DRUG	Myristica Argentum Special Order		Myristica Argentum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS NASAL MUCOSA; DICHROMATE ION; SILVER; VIROLA SEBIFERA RESIN	7; 6; 20; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7152_6de716db-41bc-6504-e053-2a91aa0a2f17	48951-7152	HUMAN OTC DRUG	Melissa Chamomilla		Melissa Chamomilla	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ACONITUM NAPELLUS ROOT; LACHESIS MUTA VENOM; MATRICARIA RECUTITA; MELISSA OFFICINALIS	10; 12; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7153_54c69554-0af3-27e7-e054-00144ff8d46c	48951-7153	HUMAN OTC DRUG	Myristica Argentum		Myristica Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	BOS TAURUS NASAL MUCOSA; POTASSIUM DICHROMATE; SILVER; VIROLA SEBIFERA RESIN	7; 6; 20; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7155_6ba27224-150b-9402-e053-2a91aa0a4bfc	48951-7155	HUMAN OTC DRUG	Melissa Marjoram 20/20 Special Order		Melissa Marjoram 20/20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MELISSA OFFICINALIS; SWEET MARJORAM	2; 2	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-7156_6ba2caa4-cfea-0b34-e053-2a91aa0ab08b	48951-7156	HUMAN OTC DRUG	Mercurius Vivus 6 Special Order		Mercurius Vivus 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY	6	[hp_X]/mL			N	20241231
48951-7158_6ba3647d-b758-dddd-e053-2991aa0a58e0	48951-7158	HUMAN OTC DRUG	Olivenite 6 Special Order		Olivenite 6 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER ARSENATE	6	[hp_X]/g			N	20241231
48951-7159_6ba3beef-200d-c2ea-e053-2a91aa0a75aa	48951-7159	HUMAN OTC DRUG	Onyx 6 Special Order		Onyx 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BIFENTHRIN	6	[hp_X]/mL			N	20241231
48951-7160_6bb0f068-79a2-face-e053-2a91aa0a7cac	48951-7160	HUMAN OTC DRUG	Oxalis 10% Essence		Oxalis 10% Essence	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS STRICTA WHOLE	1	[hp_X]/mL			N	20241231
48951-7161_6bb1d864-6349-6b0c-e053-2991aa0ab4c9	48951-7161	HUMAN OTC DRUG	Osteodoron PM Special Formula		Osteodoron PM Special Formula	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM FLUORIDE; LEAD CARBONATE; OSTREA EDULIS SHELL; QUERCUS ROBUR WHOLE; SILICON DIOXIDE	6; 8; 1; 4; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-7162_6bca3a18-a0aa-def0-e053-2991aa0ac417	48951-7162	HUMAN OTC DRUG	Mercurius 10X Special Order		Mercurius 10X Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURIALIS PERENNIS	10	[hp_X]/mL			N	20241231
48951-7168_6d595964-0bff-16e1-e053-2991aa0a21c5	48951-7168	HUMAN OTC DRUG	Nervus stat. 8 Special Order		Nervus stat. 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS NERVE	8	[hp_X]/mL			N	20241231
48951-7172_6de7f476-90c9-176f-e053-2a91aa0a3655	48951-7172	HUMAN OTC DRUG	Mercurius vivus 12 Special Order		Mercurius vivus 12 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY	12	[hp_X]/1			N	20241231
48951-7174_6dea3e61-f0a6-f755-e053-2991aa0a32a9	48951-7174	HUMAN OTC DRUG	Oxalis 3 Special Order		Oxalis 3 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS STRICTA WHOLE	3	[hp_X]/1			N	20241231
48951-7175_6e7708f6-0c05-6143-e053-2a91aa0ad949	48951-7175	HUMAN OTC DRUG	Mercurialis Calendula DKS Special Order		Mercurialis Calendula DKS Special Order	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; CALENDULA OFFICINALIS FLOWERING TOP; GOLD; MERCURIALIS PERENNIS; ONION; URTICA DIOICA	8; 1; 8; 1; 1; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-7177_76517086-fd7f-3872-e053-2a91aa0adc97	48951-7177	HUMAN OTC DRUG	Mandragora Arnica Special Order		Mandragora Arnica Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PENDULA LEAF; EQUISETUM ARVENSE TOP; FORMICA RUFA; MANDRAGORA OFFICINARUM ROOT; SUS SCROFA MENISCUS	15; 3; 15; 10; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7180_81404737-8f10-6dce-e053-2a91aa0a1478	48951-7180	HUMAN OTC DRUG	Oxalis 20		Oxalis 20	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS ACETOSELLA LEAF	1	[hp_X]/g			N	20241231
48951-7185_9418bb05-afd2-fc80-e053-2a95a90a33a2	48951-7185	HUMAN OTC DRUG	Magnesium sulf. Bryonia		Magnesium sulf. Bryonia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ARNICA MONTANA; BOS TAURUS OVARY; BOS TAURUS PITUITARY GLAND; BRYONIA ALBA ROOT; MAGNESIUM SULFATE, UNSPECIFIED; SILICON DIOXIDE; SUS SCROFA UMBILICAL CORD; TIN; VESPA CRABRO; VISCUM ALBUM FRUITING TOP	5; 3; 6; 8; 3; 8; 8; 6; 10; 5; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-7187_969b16f7-cfd1-9a26-e053-2995a90a9aa2	48951-7187	HUMAN OTC DRUG	Nicotiana Carbo		Nicotiana Carbo	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; MATRICARIA RECUTITA; TOBACCO LEAF	20; 3; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-7188_6ad75c70-d9e7-ffc8-e053-2991aa0a6702	48951-7188	HUMAN OTC DRUG	Meteoric Iron Prunus		Meteoric Iron Prunus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ECHINACEA PALLIDA; IRON; PHOSPHORUS; PRUNUS SPINOSA FLOWER BUD; SILICON DIOXIDE	3; 12; 6; 2; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7189_97b5eef4-aa4d-91a4-e053-2995a90a767e	48951-7189	HUMAN OTC DRUG	Meteoric iron Phosphorus Quartz		Meteoric iron Phosphorus Quartz	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; PHOSPHORUS; SILICON DIOXIDE	12; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-7190_0aaeda02-cd68-f1fa-e063-6394a90a0283	48951-7190	HUMAN OTC DRUG	Osteodoron AM		Osteodoron AM	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM FLUORIDE; CUCURBITA PEPO FLOWER; FLUORAPATITE; SILICON DIOXIDE	6; 3; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-7191_97dec905-12d7-4b5d-e053-2a95a90a6bac	48951-7191	HUMAN OTC DRUG	Osteodoron PM		Osteodoron PM	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM FLUORIDE; OSTREA EDULIS SHELL; QUERCUS ROBUR WHOLE; SILICON DIOXIDE	6; 1; 4; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-7194_b6fea972-8e2e-3f7d-e053-2a95a90af1bd	48951-7194	HUMAN OTC DRUG	Mygale Agaricus		Mygale Agaricus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMANITA MUSCARIA FRUITING BODY; AVICULARIA AVICULARIA; DATURA STRAMONIUM	4; 8; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7195_b711f4ef-084c-01b7-e053-2995a90aab9d	48951-7195	HUMAN OTC DRUG	Melissa Chamomilla		Melissa Chamomilla	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; KALANCHOE DAIGREMONTIANA LEAF; LACHESIS MUTA VENOM; MATRICARIA RECUTITA; MELISSA OFFICINALIS; SEPIA OFFICINALIS JUICE	10; 3; 12; 3; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7196_c77ed985-3404-d67c-e053-2995a90a17fa	48951-7196	HUMAN OTC DRUG	Melissa Chamomilla		Melissa Chamomilla	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; KALANCHOE DAIGREMONTIANA LEAF; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA; MELISSA OFFICINALIS; SEPIA OFFICINALIS JUICE	8; 1; 10; 1; 1; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-7197_c85b6d79-41cf-97da-e053-2995a90ae7c2	48951-7197	HUMAN OTC DRUG	Marjoram Melissa Adult Size		Marjoram Melissa Adult Size	SUPPOSITORY	VAGINAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MELISSA OFFICINALIS; SWEET MARJORAM	1; 1	[hp_X]/g; [hp_X]/g			N	20241231
48951-7198_cf32aa91-9c59-1e02-e053-2a95a90ab611	48951-7198	HUMAN OTC DRUG	Oxalis 20%		Oxalis 20%	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS STRICTA WHOLE	1	[hp_X]/g			N	20241231
48951-7199_cf56d1a3-7c79-c231-e053-2995a90a25e7	48951-7199	HUMAN OTC DRUG	Melissa		Melissa	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; MELISSA OFFICINALIS; TOXICODENDRON PUBESCENS LEAF	30; 30; 1; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-7200_dfb07548-ba83-15bb-e053-2a95a90a5043	48951-7200	HUMAN OTC DRUG	Mandragora Arnica		Mandragora Arnica	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ARNICA MONTANA WHOLE; BETULA PUBESCENS LEAF; EQUISETUM ARVENSE TOP; FORMICA RUFA; MANDRAGORA OFFICINARUM ROOT; SUS SCROFA MENISCUS	15; 3; 15; 10; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-7201_0683038c-f52d-cc4a-e063-6294a90acc2f	48951-7201	HUMAN OTC DRUG	Nervus Vagus 6X		Nervus Vagus 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PARASYMPATHETIC NERVE	6	[hp_X]/mL			N	20241231
48951-8000_6d08eda2-6b54-0a62-e053-2a91aa0ae4c3	48951-8000	HUMAN OTC DRUG	Pancreas Argentum		Pancreas Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA ANGUSTIFOLIA; SILVER; SUS SCROFA PANCREAS	3; 30; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8002_6ce13d4d-1331-1997-e053-2a91aa0ac476	48951-8002	HUMAN OTC DRUG	Pancreas Equisetum		Pancreas Equisetum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; QUERCUS ROBUR WHOLE; SUS SCROFA PANCREAS	6; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8003_6dea8117-f532-2a75-e053-2991aa0adea4	48951-8003	HUMAN OTC DRUG	Pancreas Equisetum		Pancreas Equisetum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; QUERCUS ROBUR WHOLE; SUS SCROFA PANCREAS	5; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8004_6cdf5e31-a6e4-0ba4-e053-2991aa0ab184	48951-8004	HUMAN OTC DRUG	Pancreas Meteoric Iron		Pancreas Meteoric Iron	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; ROSMARINUS OFFICINALIS FLOWERING TOP; SUS SCROFA PANCREAS	20; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8005_6ad9ecf6-9610-c638-e053-2a91aa0a1f2b	48951-8005	HUMAN OTC DRUG	Pancreas Meteoric Iron		Pancreas Meteoric Iron	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; ROSMARINUS OFFICINALIS FLOWERING TOP; SUS SCROFA PANCREAS	20; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8006_6ad9dd5e-8ea2-5d68-e053-2a91aa0ad259	48951-8006	HUMAN OTC DRUG	Pandanus Calc. carb.		Pandanus Calc. carb.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM CARBONATE; PANDANUS TECTORIUS ROOT	6; 6	[hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
48951-8007_6deac4bb-e31d-a719-e053-2991aa0a8d8c	48951-8007	HUMAN OTC DRUG	Pandanus Calc. Carb		Pandanus Calc. Carb	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM CARBONATE; PANDANUS TECTORIUS ROOT	1; 6	[hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
48951-8008_55dec89e-05b3-5f55-e054-00144ff88e88	48951-8008	HUMAN OTC DRUG	Parathyreoidea Aurum Special Order		Parathyreoidea Aurum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PARATHYROID GLAND; GOLD; SLOE	8; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8011_6d0992bd-fcaf-4070-e053-2991aa0a58af	48951-8011	HUMAN OTC DRUG	Passiflora Crataegus		Passiflora Crataegus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HAWTHORN LEAF WITH FLOWER; KALANCHOE DAIGREMONTIANA LEAF; PASSIFLORA INCARNATA FLOWERING TOP; SALIX ALBA FLOWER	3; 2; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8012_6ada7a4c-6b1a-7c7c-e053-2991aa0a6de3	48951-8012	HUMAN OTC DRUG	Passiflora Crataegus		Passiflora Crataegus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HAWTHORN LEAF WITH FLOWER; KALANCHOE DAIGREMONTIANA LEAF; PASSIFLORA INCARNATA FLOWERING TOP; SALIX ALBA FLOWER	3; 2; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8013_6ad9ecf6-9627-c638-e053-2a91aa0a1f2b	48951-8013	HUMAN OTC DRUG	Passiflora ex herba 1 Special Order		Passiflora ex herba 1 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PASSIFLORA INCARNATA FLOWERING TOP	2	[hp_X]/mL			N	20241231
48951-8016_6d08e600-4c1f-4fdf-e053-2991aa0aa78d	48951-8016	HUMAN OTC DRUG	Periodontium Hypophysis		Periodontium Hypophysis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF TONGUE; BOS TAURUS BONE; BOS TAURUS PITUITARY GLAND; SUS SCROFA TOOTH; TIN	8; 8; 8; 8; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8017_6d08e600-4c06-4fdf-e053-2991aa0aa78d	48951-8017	HUMAN OTC DRUG	Periodontium Quartz		Periodontium Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; BEEF TONGUE; BOS TAURUS BONE; CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; SUS SCROFA TOOTH	17; 17; 17; 3; 30; 20; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8018_6b10c7aa-6028-3d89-e053-2991aa0ae718	48951-8018	HUMAN OTC DRUG	Petasites e rad. 1 Special Order		Petasites e rad. 1 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PETASITES HYBRIDUS ROOT	1	[hp_X]/mL			N	20241231
48951-8021_08f1d844-199a-ce3b-e063-6394a90a4c80	48951-8021	HUMAN OTC DRUG	Petasites Quercus		Petasites Quercus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ABIES ALBA LEAFY TWIG; PETASITES HYBRIDUS ROOT; PLANTAGO MAJOR; QUERCUS ROBUR WHOLE	3; 3; 4; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8022_08f1c9dd-6224-2250-e063-6294a90ac875	48951-8022	HUMAN OTC DRUG	Petasites Veronica		Petasites Veronica	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ABIES ALBA LEAFY TWIG; PETASITES HYBRIDUS ROOT; PLANTAGO MAJOR LEAF; VERONICA OFFICINALIS FLOWERING TOP	3; 3; 4; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8023_6b10d657-8eac-2222-e053-2a91aa0a654f	48951-8023	HUMAN OTC DRUG	Phosphorus 30		Phosphorus 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PHOSPHORUS	30	[hp_X]/mL			N	20241231
48951-8024_6b10ffbe-35f4-523f-e053-2a91aa0a2516	48951-8024	HUMAN OTC DRUG	Phosphorus 30 Special Order		Phosphorus 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PHOSPHORUS	30	[hp_X]/mL			N	20241231
48951-8025_6dfae32e-1595-e464-e053-2a91aa0abb6e	48951-8025	HUMAN OTC DRUG	Phosphorus 30 Special Order		Phosphorus 30 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PHOSPHORUS	30	[hp_X]/1			N	20241231
48951-8026_6b10d657-8e9e-2222-e053-2a91aa0a654f	48951-8026	HUMAN OTC DRUG	Phosphorus 6		Phosphorus 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PHOSPHORUS	6	[hp_X]/mL			N	20241231
48951-8027_6d08e600-4beb-4fdf-e053-2991aa0aa78d	48951-8027	HUMAN OTC DRUG	Phosphorus 8		Phosphorus 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PHOSPHORUS	8	[hp_X]/mL			N	20241231
48951-8029_6d088ab6-ce97-58ab-e053-2a91aa0aafb6	48951-8029	HUMAN OTC DRUG	Phosphorus comp.		Phosphorus comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBER; CUPRIC SULFATE; PHOSPHORUS; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; SUS SCROFA PANCREAS	6; 4; 6; 6; 12; 30; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8030_6b10ffbe-3602-523f-e053-2a91aa0a2516	48951-8030	HUMAN OTC DRUG	Phosphorus comp.		Phosphorus comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBER; CUPRIC SULFATE; PHOSPHORUS; ROSMARINUS OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; SUS SCROFA PANCREAS	6; 4; 6; 6; 12; 30; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8031_6b114788-74c5-4bfa-e053-2a91aa0a89f1	48951-8031	HUMAN OTC DRUG	Phosphorus Tartarus		Phosphorus Tartarus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY POTASSIUM TARTRATE; PHOSPHORUS	3; 6	1/mL; 1/mL			N	20241231
48951-8032_6d0992bd-fd2b-4070-e053-2991aa0a58af	48951-8032	HUMAN OTC DRUG	Placenta (bovis) 6 Special Order		Placenta (bovis) 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PLACENTA	6	[hp_X]/mL			N	20241231
48951-8034_6b117d91-5aa6-1472-e053-2991aa0aacfd	48951-8034	HUMAN OTC DRUG	Plantago Primula		Plantago Primula	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HYOSCYAMUS NIGER LEAF; PLANTAGO MAJOR LEAF; PRIMULA VERIS FLOWER	3; 2; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8036_06bf5ae8-3ca1-d38b-e063-6294a90a80e2	48951-8036	HUMAN OTC DRUG	Plantago Pyrite		Plantago Pyrite	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ABIES ALBA LEAFY TWIG; BEEF LUNG; BOS TAURUS NASAL MUCOSA; BRYONIA ALBA ROOT; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; FERROUS DISULFIDE; PLANTAGO MAJOR LEAF; SAGE; THYROID, BOVINE	6; 17; 17; 8; 3; 8; 7; 17; 6; 6; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8037_6dfb41b0-b647-60db-e053-2991aa0a95a3	48951-8037	HUMAN OTC DRUG	Plantago Pyrite		Plantago Pyrite	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LUNG; BOS TAURUS NASAL MUCOSA; BRYONIA ALBA ROOT; ECHINACEA, UNSPECIFIED; EUPATORIUM CANNABINUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; FERROUS DISULFIDE; PICEA ABIES LEAF; PLANTAGO MAJOR LEAF; SAGE; THYROID, BOVINE	17; 17; 8; 3; 8; 7; 17; 6; 6; 6; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8038_6b11eb80-16d9-ab65-e053-2991aa0ad52f	48951-8038	HUMAN OTC DRUG	Plantain Beeswax Cough Relief		Plantain Beeswax Cough Relief	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	DROSERA ROTUNDIFOLIA; LARIX DECIDUA RESIN; PETASITES HYBRIDUS ROOT; PLANTAGO MAJOR LEAF; SAGE	4; 1; 4; 4; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8042_55df46f4-c00f-2896-e054-00144ff8d46c	48951-8042	HUMAN OTC DRUG	Platinum Cichorium		Platinum Cichorium	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; CICHORIUM INTYBUS WHOLE; OXALIS ACETOSELLA LEAF; PLATINUM; ROSMARINUS OFFICINALIS FLOWERING TOP; SUS SCROFA PANCREAS	6; 3; 3; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8046_55defaf3-8ccd-17d7-e054-00144ff8d46c	48951-8046	HUMAN OTC DRUG	Plexus coeliacus 6 Special Order		Plexus coeliacus 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS NERVE	6	[hp_X]/mL			N	20241231
48951-8051_b70ff176-39c4-2106-e053-2a95a90a7a8a	48951-8051	HUMAN OTC DRUG	Plumbum 30		Plumbum 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD	30	[hp_X]/mL			N	20241231
48951-8052_7b07a176-95d1-97be-e053-2991aa0ac59d	48951-8052	HUMAN OTC DRUG	Plumbum 5		Plumbum 5	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD	5	[hp_X]/g			N	20241231
48951-8053_55df9be2-da69-09e7-e054-00144ff88e88	48951-8053	HUMAN OTC DRUG	Plumbum 8 Special Order		Plumbum 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD	8	[hp_X]/mL			N	20241231
48951-8057_55e0248f-232e-1ea6-e054-00144ff88e88	48951-8057	HUMAN OTC DRUG	Plumbum mellitum 8		Plumbum mellitum 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HONEY; LEAD	8; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8058_6b1292da-47cc-4e6f-e053-2991aa0a31e2	48951-8058	HUMAN OTC DRUG	Plumbum silicicum 20 Special Order		Plumbum silicicum 20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD MONOSILICATE	20	[hp_X]/mL			N	20241231
48951-8067_55e04410-c923-201b-e054-00144ff88e88	48951-8067	HUMAN OTC DRUG	Primula Scilla Special Order		Primula Scilla Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; CONVALLARIA MAJALIS; DRIMIA MARITIMA BULB; HAWTHORN LEAF WITH FLOWER; HYOSCYAMUS NIGER LEAF; MELISSA OFFICINALIS; ONOPORDUM ACANTHIUM FLOWER; OSTREA EDULIS SHELL; PRIMULA VERIS FLOWER; SELENICEREUS GRANDIFLORUS STEM	6; 3; 3; 3; 4; 3; 3; 10; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8068_6dfbb8ba-0cce-57a2-e053-2991aa0a54e0	48951-8068	HUMAN OTC DRUG	Primula Scilla		Primula Scilla	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; CONVALLARIA MAJALIS; DRIMIA MARITIMA BULB; HAWTHORN LEAF WITH FLOWER; HYOSCYAMUS NIGER LEAF; MELISSA OFFICINALIS; ONOPORDUM ACANTHIUM FLOWER; OSTREA EDULIS SHELL; PRIMULA VERIS FLOWER; SELENICEREUS GRANDIFLORUS STEM	6; 3; 3; 3; 4; 3; 3; 10; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8077_6b12fd30-fc30-6ad0-e053-2a91aa0ad8c9	48951-8077	HUMAN OTC DRUG	Prunus Iron		Prunus Iron	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERRIC OXIDE RED; SLOE	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8079_6d0c170a-b7ee-de72-e053-2991aa0a5553	48951-8079	HUMAN OTC DRUG	Prunus spinosa e flor. et summ. 5		Prunus spinosa e flor. et summ. 5	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SLOE	1	[hp_X]/mL			N	20241231
48951-8081_6b12fd30-fc40-6ad0-e053-2a91aa0ad8c9	48951-8081	HUMAN OTC DRUG	Prunus spinosa e flor. et summ. 6 Special Order		Prunus spinosa e flor. et summ. 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SLOE	6	[hp_X]/mL			N	20241231
48951-8082_6b139bac-888f-4b86-e053-2991aa0a5cbe	48951-8082	HUMAN OTC DRUG	Prunus spinosa e summ 10%		Prunus spinosa e summ 10%	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PRUNUS SPINOSA WHOLE	10	g/1			N	20241231
48951-8083_0d0ba436-28e9-1db4-e063-6394a90a99a8	48951-8083	HUMAN OTC DRUG	Pulmo 8		Pulmo 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SUS SCROFA LUNG	8	[hp_X]/mL			N	20241231
48951-8084_6d0c3e0f-c8bd-f2de-e053-2a91aa0a8b4d	48951-8084	HUMAN OTC DRUG	Pulmo Bryonia		Pulmo Bryonia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; SUS SCROFA LUNG	8; 6; 8; 6; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8085_6d0c0948-928c-9bb8-e053-2a91aa0abf3a	48951-8085	HUMAN OTC DRUG	Pulmo Echinacea		Pulmo Echinacea	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASTRAGALUS PROPINQUUS ROOT; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; SILVER; SUS SCROFA LUNG; TARAXACUM PALUSTRE ROOT	3; 3; 2; 6; 12; 30; 17; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8086_6b134edd-cf35-6aca-e053-2a91aa0a0f9b	48951-8086	HUMAN OTC DRUG	Pulmo Echinacea		Pulmo Echinacea	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASTRAGALUS PROPINQUUS ROOT; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; SILVER; SUS SCROFA LUNG; TARAXACUM PALUSTRE ROOT	3; 3; 2; 6; 12; 30; 17; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8087_6d0be942-fb09-9723-e053-2991aa0a131e	48951-8087	HUMAN OTC DRUG	Pulmo Ferrum		Pulmo Ferrum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; SUS SCROFA LUNG	8; 17	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8088_6dfb9f86-ad85-ab5a-e053-2a91aa0abdd0	48951-8088	HUMAN OTC DRUG	Pulmo Ferrum		Pulmo Ferrum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; SUS SCROFA LUNG	8; 17	[hp_X]/1; [hp_X]/1			N	20241231
48951-8089_6d0be942-fafc-9723-e053-2991aa0a131e	48951-8089	HUMAN OTC DRUG	Pulmo Mercurius		Pulmo Mercurius	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY; SUS SCROFA LUNG	17; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8092_6d0be942-faf0-9723-e053-2991aa0a131e	48951-8092	HUMAN OTC DRUG	Pulmo Tartarus 6/8		Pulmo Tartarus 6/8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY POTASSIUM TARTRATE; SUS SCROFA LUNG	8; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8093_6dfc3753-236f-4473-e053-2a91aa0a56f2	48951-8093	HUMAN OTC DRUG	Pulmo Tartarus 6/8		Pulmo Tartarus 6/8	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY POTASSIUM TARTRATE; IRON; SUS SCROFA LUNG	8; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8098_6b1393e6-68ce-653b-e053-2991aa0afc9b	48951-8098	HUMAN OTC DRUG	Pulsatilla Tormentilla		Pulsatilla Tormentilla	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM HYDROXIDE; MAMMAL LIVER; POTENTILLA ERECTA ROOT; PULSATILLA VULGARIS	4; 4; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-8099_6b1422ef-3da0-6227-e053-2a91aa0ac046	48951-8099	HUMAN OTC DRUG	Pulsatilla Tormentilla		Pulsatilla Tormentilla	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MAGNESIUM HYDROXIDE; MAMMAL LIVER; POTENTILLA ERECTA ROOT; PULSATILLA VULGARIS	4; 4; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-8103_09a82d6c-91c3-2f86-e063-6394a90a07bd	48951-8103	HUMAN OTC DRUG	Pyrite Salvia		Pyrite Salvia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANGELICA ARCHANGELICA ROOT; FERROUS DISULFIDE; HYACINTHUS ORIENTALIS WHOLE; HYOSCYAMUS NIGER LEAF; SAGE; SILVER	5; 7; 17; 7; 3; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8104_6b1449b0-2a27-780a-e053-2991aa0a0c1b	48951-8104	HUMAN OTC DRUG	Pyrite Salvia		Pyrite Salvia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANGELICA ARCHANGELICA ROOT; FERROUS DISULFIDE; HYACINTHUS ORIENTALIS WHOLE; HYOSCYAMUS NIGER LEAF; SAGE; SILVER	5; 7; 17; 7; 3; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8108_6d081f78-e318-4f22-e053-2991aa0a565d	48951-8108	HUMAN OTC DRUG	Quartz 30		Quartz 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	30	[hp_X]/mL			N	20241231
48951-8109_6d081611-a636-feff-e053-2991aa0a0a39	48951-8109	HUMAN OTC DRUG	Quartz 8		Quartz 8	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	8	[hp_X]/mL			N	20241231
48951-8111_55ef60e5-bc07-313f-e054-00144ff88e88	48951-8111	HUMAN OTC DRUG	Quartz Oxalis Nicotiana		Quartz Oxalis Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OXALIS ACETOSELLA LEAF; SILICON DIOXIDE; SILVER; TOBACCO LEAF	30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8113_57e549a7-b0f7-e5b1-e053-2a91aa0aee56	48951-8113	HUMAN OTC DRUG	Quercus 5		Quercus 5	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	QUERCUS ROBUR WHOLE	1	[hp_X]/g			N	20241231
48951-8115_6b14a572-a0fb-03e6-e053-2991aa0a8e2c	48951-8115	HUMAN OTC DRUG	Quercus Borago Adult Size		Quercus Borago Adult Size	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AESCULUS HIPPOCASTANUM BARK; ANTIMONY; BORAGE; HAMAMELIS VIRGINIANA LEAF; MERCURIALIS PERENNIS; MILK THISTLE; QUERCUS ROBUR WHOLE	3; 3; 3; 3; 2; 3; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-8117_6b15706b-197d-beba-e053-2991aa0a1734	48951-8117	HUMAN OTC DRUG	Quercus Cinis		Quercus Cinis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	QUERCUS ROBUR WHOLE	5	[hp_X]/mL			N	20241231
48951-8119_09a879e7-e07c-28b4-e063-6294a90acf3d	48951-8119	HUMAN OTC DRUG	Quercus Essence		Quercus Essence	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	QUERCUS ROBUR WHOLE	1	[hp_X]/mL			N	20241231
48951-8122_06e81c98-d6db-d54a-e063-6394a90a04e0	48951-8122	HUMAN OTC DRUG	Regio substantiae nigrae 6X		Regio substantiae nigrae 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAIN	6	[hp_X]/mL			N	20241231
48951-8124_6cf88a35-a221-e54d-e053-2991aa0a7f37	48951-8124	HUMAN OTC DRUG	Renes Argentum nitricum		Renes Argentum nitricum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PORK KIDNEY; SILVER	17; 20	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8125_c6768621-eb87-f7df-e053-2995a90a7543	48951-8125	HUMAN OTC DRUG	Renes Betula		Renes Betula	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; BETULA PUBESCENS LEAF; CAPSELLA BURSA-PASTORIS; COPPER; CYTISUS SCOPARIUS FLOWERING TOP; ELYMUS REPENS ROOT; EQUISETUM ARVENSE TOP; ONONIS REPENS ROOT; PARSLEY; PETROSELINUM CRISPUM ROOT; PORK KIDNEY; SOLIDAGO VIRGAUREA FLOWERING TOP	2; 4; 2; 8; 3; 4; 3; 2; 2; 2; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-8126_6b1600b4-62e3-f12d-e053-2a91aa0a658e	48951-8126	HUMAN OTC DRUG	Renes Carbo		Renes Carbo	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; PORK KIDNEY	20; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8127_6cf93a07-3f43-a052-e053-2991aa0a5c09	48951-8127	HUMAN OTC DRUG	Renes Cuprum		Renes Cuprum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND; COPPER; PORK KIDNEY	6; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-8128_6b1600b4-62ee-f12d-e053-2a91aa0a658e	48951-8128	HUMAN OTC DRUG	Renes Cuprum Special Order		Renes Cuprum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER; PORK KIDNEY	8; 6	[hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-8129_6ce01eea-d22d-11cd-e053-2991aa0a15bc	48951-8129	HUMAN OTC DRUG	Renes Cuprum		Renes Cuprum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ADRENAL GLAND; COPPER; PORK KIDNEY	6; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
48951-8130_6cf88a35-a22c-e54d-e053-2991aa0a7f37	48951-8130	HUMAN OTC DRUG	Renes Mesenchyme		Renes Mesenchyme	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BORAGE; BOS TAURUS CARTILAGE; BOS TAURUS CONJUNCTIVA; BOS TAURUS LYMPH VESSEL; CUPRIC ACETATE; PORK KIDNEY; SUS SCROFA UMBILICAL CORD; VISCUM ALBUM FRUITING TOP	6; 8; 8; 8; 6; 8; 8; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8132_6cf88a35-a237-e54d-e053-2991aa0a7f37	48951-8132	HUMAN OTC DRUG	Renes Veratrum		Renes Veratrum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; EQUISETUM ARVENSE TOP; PORK KIDNEY; VERATRUM ALBUM ROOT; VISCUM ALBUM FRUITING TOP	30; 20; 7; 6; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-8133_6dfe0215-7194-6903-e053-2991aa0aa4cd	48951-8133	HUMAN OTC DRUG	Renes Veratrum		Renes Veratrum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; EQUISETUM ARVENSE TOP; PORK KIDNEY; VERATRUM ALBUM ROOT; VISCUM ALBUM FRUITING TOP	30; 20; 7; 6; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-8140_6cf96c90-8ad8-48a4-e053-2991aa0a97d1	48951-8140	HUMAN OTC DRUG	Rhus Aconitum		Rhus Aconitum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; GELSEMIUM SEMPERVIRENS ROOT; MANDRAGORA OFFICINARUM ROOT; PENOXSULAM; PSEUDOGNAPHALIUM LUTEOALBUM LEAF; TOXICODENDRON PUBESCENS LEAF	6; 6; 4; 6; 10; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8142_6dfce8dd-f5fa-fdaf-e053-2a91aa0a9bff	48951-8142	HUMAN OTC DRUG	Rhus Aconitum		Rhus Aconitum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; GELSEMIUM SEMPERVIRENS ROOT; MANDRAGORA OFFICINARUM ROOT; PENOXSULAM; PSEUDOGNAPHALIUM LUTEOALBUM LEAF; TOXICODENDRON PUBESCENS LEAF	4; 6; 3; 4; 10; 4; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8143_6cf96c90-8afa-48a4-e053-2991aa0a97d1	48951-8143	HUMAN OTC DRUG	Rhus Tox. e fol. 4		Rhus Tox. e fol. 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TOXICODENDRON PUBESCENS LEAF	4	[hp_X]/mL			N	20241231
48951-8150_6cbbf428-bdb0-2bb0-e053-2991aa0a1328	48951-8150	HUMAN OTC DRUG	Rose iron Graphite		Rose iron Graphite	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERRIC OXIDE RED; GRAPHITE; SEDUM ROSEUM WHOLE	6; 17; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8154_6cf9e5c8-7213-b2d2-e053-2991aa0af621	48951-8154	HUMAN OTC DRUG	Rosmarinus Argentum		Rosmarinus Argentum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBER; ROSMARINUS OFFICINALIS FLOWERING TOP; SILVER; TARAXACUM OFFICINALE ROOT	6; 6; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8155_6d07ab42-4d64-a092-e053-2991aa0a090c	48951-8155	HUMAN OTC DRUG	Rosmarinus e fol. 1% Special Order		Rosmarinus e fol. 1% Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ROSMARINUS OFFICINALIS FLOWERING TOP	2	[hp_X]/mL			N	20241231
48951-8156_55f06e08-1d60-2b5f-e054-00144ff8d46c	48951-8156	HUMAN OTC DRUG	Rosmarinus ex herba 3 Special Order		Rosmarinus ex herba 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ROSMARINUS OFFICINALIS FLOWERING TOP	3	[hp_X]/mL			N	20241231
48951-8159_6dfe3af6-3f74-7ffc-e053-2a91aa0aa2c2	48951-8159	HUMAN OTC DRUG	Sabal Populus		Sabal Populus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; MAGNESITE; POPULUS TREMULA WHOLE; SAW PALMETTO; SOLIDAGO VIRGAUREA FLOWERING TOP; THUJA OCCIDENTALIS WHOLE	3; 12; 3; 3; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8161_6cf487e7-7cf1-27c9-e053-2991aa0af305	48951-8161	HUMAN OTC DRUG	Sabal Populus		Sabal Populus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERBERIS VULGARIS ROOT BARK; MAGNESITE; POPULUS TREMULA WHOLE; SAW PALMETTO; SOLIDAGO VIRGAUREA FLOWERING TOP; THUJA OCCIDENTALIS WHOLE	3; 12; 3; 3; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8162_6cf487e7-7d05-27c9-e053-2991aa0af305	48951-8162	HUMAN OTC DRUG	Sambucus Larix		Sambucus Larix	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BLACK COHOSH; LARIX DECIDUA RESIN; SAMBUCUS NIGRA FLOWERING TOP	3; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8163_6dfe6ef7-56f5-204f-e053-2991aa0a9d3b	48951-8163	HUMAN OTC DRUG	Sambucus Larix		Sambucus Larix	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BLACK COHOSH; LARIX DECIDUA RESIN; SAMBUCUS NIGRA FLOWERING TOP	3; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8164_6cf4d9fd-632d-659d-e053-2a91aa0a4497	48951-8164	HUMAN OTC DRUG	Sarothamnus Aurum Special Order		Sarothamnus Aurum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERYLLIUM; CAMPHOR (NATURAL); CYTISUS SCOPARIUS FLOWER; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; SELENICEREUS GRANDIFLORUS STEM	17; 4; 3; 17; 4; 3; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8165_6dfe8b17-cd09-3143-e053-2991aa0a5fd5	48951-8165	HUMAN OTC DRUG	Sarothamnus Aurum		Sarothamnus Aurum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BERYLLIUM; CAMPHOR (NATURAL); CYTISUS SCOPARIUS FLOWER; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; SELENICEREUS GRANDIFLORUS STEM	17; 4; 3; 17; 4; 3; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8166_6cf4d3d5-de5f-760e-e053-2991aa0a0c69	48951-8166	HUMAN OTC DRUG	Scilla Crataegus		Scilla Crataegus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ADONIS VERNALIS FLOWERING TOP; CONVALLARIA MAJALIS; DRIMIA MARITIMA BULB; HAWTHORN LEAF WITH FLOWER; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	3; 4; 4; 3; 4; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8168_6c5309d1-1d53-0945-e053-2991aa0a4048	48951-8168	HUMAN OTC DRUG	Scorodite Prunus		Scorodite Prunus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PITUITARY GLAND; CAMPHOR (NATURAL); FERROUS ARSENATE; GOLD; SLOE; VERATRUM ALBUM ROOT	8; 4; 6; 10; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8169_6dfeb1ce-37cd-228f-e053-2a91aa0ac12a	48951-8169	HUMAN OTC DRUG	Scorodite Prunus		Scorodite Prunus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PITUITARY GLAND; CAMPHOR (NATURAL); FERROUS ARSENATE; GOLD; SLOE; VERATRUM ALBUM ROOT	8; 4; 6; 10; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8170_56cbdbfe-8f0e-13fe-e054-00144ff88e88	48951-8170	HUMAN OTC DRUG	Scorodite Saccharum Special Order		Scorodite Saccharum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PARATHYROID GLAND; FERROUS ARSENATE; OXALIS ACETOSELLA LEAF; SUGARCANE	6; 6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8172_6cf4d9fd-6340-659d-e053-2a91aa0a4497	48951-8172	HUMAN OTC DRUG	Secale Argentum Special Order		Secale Argentum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARISTOLOCHIA CLEMATITIS WHOLE; CLAVICEPS PURPUREA SCLEROTIUM; PULSATILLA VULGARIS; SILVER	3; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8175_0da9dc01-fd6e-24d3-e063-6294a90acca6	48951-8175	HUMAN OTC DRUG	Secale Betula		Secale Betula	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; BOS TAURUS EYE; CLAVICEPS PURPUREA SCLEROTIUM; LEAD SULFIDE; LEVISTICUM OFFICINALE ROOT; TOBACCO LEAF	12; 4; 3; 8; 6; 8; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Iron [CS], Non-Standardized Plant Allergenic Extract [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS]		N	20241231
48951-8176_0774bbd4-2a30-1a5c-e063-6394a90a4964	48951-8176	HUMAN OTC DRUG	Secale Nicotiana		Secale Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; BOS TAURUS ARTERY; CLAVICEPS PURPUREA SCLEROTIUM; LEAD SULFIDE; TOBACCO LEAF	4; 3; 8; 6; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8177_09a8f31d-ade0-88eb-e063-6294a90a140b	48951-8177	HUMAN OTC DRUG	Secale Nicotiana		Secale Nicotiana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; BOS TAURUS ARTERY; CLAVICEPS PURPUREA SCLEROTIUM; LEAD SULFIDE; TOBACCO LEAF	4; 3; 8; 6; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8178_6cf55114-f692-b8fd-e053-2991aa0a16d2	48951-8178	HUMAN OTC DRUG	Secale Quartz		Secale Quartz	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CLAVICEPS PURPUREA SCLEROTIUM; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE	6; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8180_6b2560a1-1689-eda0-e053-2991aa0aa895	48951-8180	HUMAN OTC DRUG	Secale Quartz		Secale Quartz	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CLAVICEPS PURPUREA SCLEROTIUM; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE	6; 6; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8183_6b25c6c9-e32e-bbd3-e053-2a91aa0a3254	48951-8183	HUMAN OTC DRUG	Silica 20 Special Order		Silica 20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	20	[hp_X]/mL			N	20241231
48951-8187_6cf60c87-8989-755a-e053-2a91aa0a15c5	48951-8187	HUMAN OTC DRUG	Silicea Belladonna		Silicea Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; SILICON DIOXIDE; SILVER	20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8189_6e0d7760-42b3-ebfd-e053-2a91aa0a54bf	48951-8189	HUMAN OTC DRUG	Silicea Belladonna		Silicea Belladonna	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; SILICON DIOXIDE; SILVER	20; 20; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8193_0a48b109-90df-e80e-e063-6394a90a5094	48951-8193	HUMAN OTC DRUG	Solum Aesculus		Solum Aesculus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; HORSE CHESTNUT; SPHAGNUM SQUARROSUM PEAT; ST. JOHN'S WORT	3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8201_6e0d7760-42cd-ebfd-e053-2a91aa0a54bf	48951-8201	HUMAN OTC DRUG	Spongia Aurum		Spongia Aurum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM CARBONATE; GOLD; PRUNUS SPINOSA FLOWER BUD; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUGARCANE	12; 12; 6; 7; 7; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8203_6e0dcb18-e8be-fb3c-e053-2991aa0a84d4	48951-8203	HUMAN OTC DRUG	Spongia Ovi		Spongia Ovi	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CALCIUM CARBONATE; CHELIDONIUM MAJUS; COLCHICUM AUTUMNALE WHOLE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUGARCANE	6; 3; 3; 1; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
48951-8206_6b273585-2e9a-fd2b-e053-2a91aa0a94e5	48951-8206	HUMAN OTC DRUG	Stannum 5		Stannum 5	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	5	[hp_X]/g			N	20241231
48951-8207_7f712e7d-4013-803e-e053-2a91aa0a62e5	48951-8207	HUMAN OTC DRUG	Stannum 5		Stannum 5	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	1	[hp_X]/g			N	20241231
48951-8210_57e5ed64-134c-658e-e053-2a91aa0aff82	48951-8210	HUMAN OTC DRUG	Stannum 0.4		Stannum 0.4	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	1	[hp_X]/g			N	20241231
48951-8211_6cf757ad-5f2b-7175-e053-2991aa0a2f0d	48951-8211	HUMAN OTC DRUG	Stibium 20		Stibium 20	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY	20	[hp_X]/mL			N	20241231
48951-8213_6cf757ad-5f20-7175-e053-2991aa0a2f0d	48951-8213	HUMAN OTC DRUG	Stibium 6		Stibium 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY	6	[hp_X]/mL			N	20241231
48951-8216_0ac19437-e925-c11e-e063-6294a90acc16	48951-8216	HUMAN OTC DRUG	Strophanthus Aurum		Strophanthus Aurum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; STROPHANTHUS KOMBE WHOLE	8; 10; 4; 3; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8217_0ac1c9b1-4152-bb71-e063-6394a90aa45e	48951-8217	HUMAN OTC DRUG	Strophanthus Aurum		Strophanthus Aurum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; STROPHANTHUS KOMBE WHOLE	8; 10; 4; 3; 3; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8218_6cf8bdf1-3a14-6a4d-e053-2991aa0a450f	48951-8218	HUMAN OTC DRUG	Strophanthus Nicotiana		Strophanthus Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HONEY; LEAD; STROPHANTHUS HISPIDUS SEED; TOBACCO LEAF	30; 30; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8219_6e0dfcee-ff51-7871-e053-2a91aa0ac76f	48951-8219	HUMAN OTC DRUG	Strophanthus Nicotiana		Strophanthus Nicotiana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HONEY; LEAD; STROPHANTHUS HISPIDUS SEED; TOBACCO LEAF	15; 15; 6; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8220_6b288fb7-f4cf-6ff2-e053-2991aa0acb61	48951-8220	HUMAN OTC DRUG	Sulfur 30 Special Order		Sulfur 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SULFUR	30	[hp_X]/mL			N	20241231
48951-8221_6b288fb7-f4ab-6ff2-e053-2991aa0acb61	48951-8221	HUMAN OTC DRUG	Sulfur 6		Sulfur 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SULFUR	6	[hp_X]/mL			N	20241231
48951-8222_0b3aad69-9803-fa0a-e063-6294a90a06bf	48951-8222	HUMAN OTC DRUG	Symphytum Hamamelis		Symphytum Hamamelis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; HAMAMELIS VIRGINIANA TOP; ONION; RUTA GRAVEOLENS FLOWERING TOP	4; 4; 3; 2; 3; 4; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-8223_6cf8c234-f02f-cd1b-e053-2a91aa0a1bc0	48951-8223	HUMAN OTC DRUG	Symphytum Stannum		Symphytum Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; COMFREY ROOT; ONION; TIN	3; 3; 3; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-8224_6e0dcb18-e8c8-fb3c-e053-2991aa0a84d4	48951-8224	HUMAN OTC DRUG	Symphytum Stannum Bone Support		Symphytum Stannum Bone Support	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; COMFREY ROOT; ONION; TIN	3; 3; 3; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-8225_57e61a89-a11e-621c-e053-2991aa0a1c3e	48951-8225	HUMAN OTC DRUG	Stibium 0.4		Stibium 0.4	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY	1	[hp_X]/g			N	20241231
48951-8226_6b2560a1-1697-eda0-e053-2991aa0aa895	48951-8226	HUMAN OTC DRUG	Sepia comp.		Sepia comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OSTREA EDULIS SHELL; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED	8; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8229_6b1393e6-689b-653b-e053-2991aa0afc9b	48951-8229	HUMAN OTC DRUG	Pulmo Mercurius Special Order		Pulmo Mercurius Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	MERCURY; SUS SCROFA LUNG	17; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8230_6b27a36a-c005-0880-e053-2991aa0adb53	48951-8230	HUMAN OTC DRUG	Stibium 20 Special Order		Stibium 20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY	20	[hp_X]/mL			N	20241231
48951-8231_6b25fd03-f316-5b9b-e053-2a91aa0a247e	48951-8231	HUMAN OTC DRUG	Silica 30 Special Order		Silica 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	30	[hp_X]/mL			N	20241231
48951-8232_6cf853ca-f0f7-4603-e053-2a91aa0a33f7	48951-8232	HUMAN OTC DRUG	Regio substantiae nigrae 6 Special Order		Regio substantiae nigrae 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAIN	6	[hp_X]/mL			N	20241231
48951-8234_6de9155b-7080-38fd-e053-2a91aa0af6f6	48951-8234	HUMAN OTC DRUG	Periodontium Quartz Special Order		Periodontium Quartz Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; BEEF TONGUE; BOS TAURUS BONE; CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; SUS SCROFA TOOTH	17; 17; 17; 3; 30; 20; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8235_6dfce49e-b8a2-7b80-e053-2991aa0a79f9	48951-8235	HUMAN OTC DRUG	Renes Betula Special Order		Renes Betula Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; BETULA PUBESCENS LEAF; CAPSELLA BURSA-PASTORIS; COPPER; CYTISUS SCOPARIUS FLOWERING TOP; ELYMUS REPENS TOP; EQUISETUM ARVENSE TOP; ONONIS REPENS ROOT; PARSLEY; PORK KIDNEY; SOLIDAGO VIRGAUREA FLOWERING TOP	3; 4; 3; 9; 4; 3; 4; 3; 3; 4; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
48951-8236_6dfd13f6-b9d5-3686-e053-2991aa0aa027	48951-8236	HUMAN OTC DRUG	Renes Carbo Special Order		Renes Carbo Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; PORK KIDNEY	20; 6	[hp_X]/1; [hp_X]/1			N	20241231
48951-8237_6dfe0215-71da-6903-e053-2991aa0aa4cd	48951-8237	HUMAN OTC DRUG	Reticuloendothelial system 8 Special Order		Reticuloendothelial system 8 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LIVER	8	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-8238_6dea8117-f540-2a75-e053-2991aa0adea4	48951-8238	HUMAN OTC DRUG	Pancreas Meteoric Iron Special Order		Pancreas Meteoric Iron Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; ROSMARINUS OFFICINALIS FLOWERING TOP; SUS SCROFA PANCREAS	20; 4; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8241_6d084f32-5799-51e1-e053-2991aa0a6aca	48951-8241	HUMAN OTC DRUG	Quartz 60 Special Order		Quartz 60 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	60	[hp_X]/mL			N	20241231
48951-8248_6e0dfcee-ff85-7871-e053-2a91aa0ac76f	48951-8248	HUMAN OTC DRUG	Sulfur 30 Special Order		Sulfur 30 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SULFUR	30	[hp_X]/1			N	20241231
48951-8250_6b28453d-ca04-0ebf-e053-2991aa0ab9da	48951-8250	HUMAN OTC DRUG	Strophanthus Aurum Special Order		Strophanthus Aurum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; STROPHANTHUS KOMBE WHOLE	8; 10; 4; 3; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8261_55df1359-3bc1-20bf-e054-00144ff8d46c	48951-8261	HUMAN OTC DRUG	Pharynx 8 Special Order		Pharynx 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS ESOPHAGUS	8	[hp_X]/mL			N	20241231
48951-8263_6b1622e9-29da-6942-e053-2a91aa0ab6dc	48951-8263	HUMAN OTC DRUG	Renes Pulmo 8/8/12 Special Order		Renes Pulmo 8/8/12 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PORK KIDNEY; SUS SCROFA LUNG	8; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8266_55df5bca-a808-03e1-e054-00144ff88e88	48951-8266	HUMAN OTC DRUG	Plantago e fol. 4 Special Order		Plantago e fol. 4 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PLANTAGO MAJOR LEAF	4	[hp_X]/mL			N	20241231
48951-8269_6adac776-8ebd-6268-e053-2991aa0a7d19	48951-8269	HUMAN OTC DRUG	Periodontium Quartz Special Order		Periodontium Quartz Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; BEEF TONGUE; BOS TAURUS BONE; CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; SILVER; SUS SCROFA TOOTH	17; 17; 17; 3; 30; 20; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8273_6dff2eb7-5b1b-1834-e053-2991aa0a31f1	48951-8273	HUMAN OTC DRUG	Sepia comp Special Order		Sepia comp Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OSTREA EDULIS SHELL; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED	8; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8275_6b125183-5ad2-7360-e053-2991aa0ab15f	48951-8275	HUMAN OTC DRUG	Plumbum mellitum 30 Special Order		Plumbum mellitum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HONEY; LEAD	30; 30	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8278_6b1642e1-7109-e3cc-e053-2a91aa0ae867	48951-8278	HUMAN OTC DRUG	Rhus tox. e fol. 30 Special Order		Rhus tox. e fol. 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TOXICODENDRON PUBESCENS LEAF	30	[hp_X]/mL			N	20241231
48951-8283_6b117d91-5a97-1472-e053-2991aa0aacfd	48951-8283	HUMAN OTC DRUG	Piper nigrum e fruct. 6 Special Order		Piper nigrum e fruct. 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BLACK PEPPER	6	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-8285_6b26b91d-c77f-5b0a-e053-2a91aa0a1bee	48951-8285	HUMAN OTC DRUG	Silicea Belladonna Special Order		Silicea Belladonna Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; SILICON DIOXIDE; SILVER	20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8288_6dfbb8ba-0cde-57a2-e053-2991aa0a54e0	48951-8288	HUMAN OTC DRUG	Prunus spinosa e flor. et summ. 2 Special Order		Prunus spinosa e flor. et summ. 2 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SLOE	2	[hp_X]/1			N	20241231
48951-8289_6b2445e3-31a5-2c8d-e053-2a91aa0a3504	48951-8289	HUMAN OTC DRUG	Secale Nicotiana Special Order		Secale Nicotiana Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BETULA PUBESCENS BARK; BETULA PUBESCENS LEAF; BOS TAURUS ARTERY; CLAVICEPS PURPUREA SCLEROTIUM; LEAD SULFIDE; TOBACCO LEAF	4; 3; 8; 6; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8290_6d0a51bd-2c8d-1d53-e053-2991aa0a4f9f	48951-8290	HUMAN OTC DRUG	Primula Auro culta 3 Special Order		Primula Auro culta 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PRIMULA VERIS FLOWER	3	[hp_X]/mL			N	20241231
48951-8292_6b27af4a-ce02-6d50-e053-2991aa0a204c	48951-8292	HUMAN OTC DRUG	Stibium 0.4 Adult Size Special Order		Stibium 0.4 Adult Size Special Order	SUPPOSITORY	RECTAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY	3	[hp_X]/g			N	20241231
48951-8296_6b1449b0-2a19-780a-e053-2991aa0a0c1b	48951-8296	HUMAN OTC DRUG	Pyrargyrite 6 Special Order		Pyrargyrite 6 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILVER SULFIDE	6	[hp_X]/g			N	20241231
48951-8306_6ac52a4d-c11a-560e-e053-2a91aa0a12b7	48951-8306	HUMAN OTC DRUG	Ignatia Bryophyllum		Ignatia Bryophyllum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; LACHESIS MUTA VENOM; SILVER; STRYCHNOS IGNATII SEED	3; 12; 10; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8307_6a85e3c9-7a54-0672-e053-2a91aa0a680a	48951-8307	HUMAN OTC DRUG	Bismuth Magnesite comp.		Bismuth Magnesite comp.	POWDER	ORAL	20090109		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY TRISULFIDE; BISMUTH; CORALLIUM RUBRUM EXOSKELETON; MAGNESITE; POTASSIUM ACETATE; SAFFRON	6; 3; 6; 3; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
48951-8309_860a6c70-bcc7-e593-e053-2991aa0a701d	48951-8309	HUMAN OTC DRUG	Rose Quartz		Rose Quartz	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	KALANCHOE DAIGREMONTIANA LEAF; SILICON DIOXIDE	2; 32	[hp_X]/g; [hp_X]/g			N	20241231
48951-8313_6b172c79-6478-22cc-e053-2a91aa0afc45	48951-8313	HUMAN OTC DRUG	Sabadilla Eucalyptus		Sabadilla Eucalyptus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GUM; EUPATORIUM PERFOLIATUM FLOWERING TOP; PHOSPHORUS; SCHOENOCAULON OFFICINALE SEED	4; 3; 3; 3; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8314_6dfb6620-c0ba-3a34-e053-2a91aa0a95d2	48951-8314	HUMAN OTC DRUG	Primula Onopordon		Primula Onopordon	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	HYOSCYAMUS NIGER; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS	4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8315_6dfc60ef-1d38-3ce8-e053-2991aa0a02ba	48951-8315	HUMAN OTC DRUG	Pyrite Salvia		Pyrite Salvia	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ANGELICA ARCHANGELICA ROOT; HYOSCYAMUS NIGER; SAGE; SILVER NITRATE	3; 7; 3; 15	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8316_6dfc5cb4-af1b-56c9-e053-2a91aa0a5d56	48951-8316	HUMAN OTC DRUG	Quercus Cinis		Quercus Cinis	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	WHITE OAK BARK	5	[hp_X]/1			N	20241231
48951-8317_551153e9-cc50-5cb8-e054-00144ff88e88	48951-8317	HUMAN OTC DRUG	Silica		Silica	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	EQUISETUM ARVENSE TOP; MAMMAL LIVER; WHITE OAK BARK	5; 9; 9	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8318_55134586-07b9-2b76-e054-00144ff8d46c	48951-8318	HUMAN OTC DRUG	Purple Coneflower		Purple Coneflower	SPRAY	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ATROPA BELLADONNA; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA PALLIDA; EUCALYPTUS GLOBULUS LEAF; MERCURIC CYANIDE; SAGE; SILICON DIOXIDE; SILVER NITRATE	20; 1; 1; 1; 8; 1; 20; 20	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8319_0b60c232-7132-cadd-e063-6294a90a872a	48951-8319	HUMAN OTC DRUG	Solum Aesculus		Solum Aesculus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; HORSE CHESTNUT; SPHAGNUM SQUARROSUM PEAT; ST. JOHN'S WORT	3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8320_6bb2b659-2327-5828-e053-2991aa0ab792	48951-8320	HUMAN OTC DRUG	Plumbum mellitum 14		Plumbum mellitum 14	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HONEY; LEAD	14; 14	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8321_6bb36301-c2b7-5b17-e053-2a91aa0a8e06	48951-8321	HUMAN OTC DRUG	Plumbum met. 30 Special Order		Plumbum met. 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD	30	[hp_X]/mL			N	20241231
48951-8325_6bb510ca-2e9b-063a-e053-2a91aa0a1d82	48951-8325	HUMAN OTC DRUG	Renes Veratrum Special Order		Renes Veratrum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; EQUISETUM ARVENSE TOP; PORK KIDNEY; VERATRUM ALBUM ROOT; VISCUM ALBUM FRUITING TOP	30; 20; 7; 6; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-8326_6bb54934-f604-0276-e053-2991aa0acb07	48951-8326	HUMAN OTC DRUG	Resina Laricis Bath Milk		Resina Laricis Bath Milk	LIQUID	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LARIX DECIDUA RESIN	1	[hp_X]/mL			N	20241231
48951-8327_08f198fc-6d44-c5fe-e063-6394a90a6a7d	48951-8327	HUMAN OTC DRUG	Silica comp.		Silica comp.	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART; BOS TAURUS CARTILAGE; EQUISETUM ARVENSE TOP; MAMMAL LIVER; PORK KIDNEY; QUERCUS ROBUR WHOLE; SUS SCROFA LUNG; SUS SCROFA PANCREAS	9; 11; 5; 9; 9; 9; 9; 9	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-8329_6bb7f6f9-50fe-3054-e053-2a91aa0aa8a9	48951-8329	HUMAN OTC DRUG	Stannum 5% Special Order		Stannum 5% Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	1	[hp_X]/g			N	20241231
48951-8331_6bc5f90e-97e3-7d2a-e053-2991aa0a7125	48951-8331	HUMAN OTC DRUG	Strophanthus 4 Special Order		Strophanthus 4 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	STROPHANTHUS HISPIDUS SEED	6	[hp_X]/mL			N	20241231
48951-8332_6bc69401-3afc-f9ca-e053-2991aa0ad337	48951-8332	HUMAN OTC DRUG	Sulfur 3 Special Order		Sulfur 3 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SULFUR	3	[hp_X]/g			N	20241231
48951-8333_6bcb40e7-426d-058e-e053-2991aa0ad7c7	48951-8333	HUMAN OTC DRUG	Prunus Iron Special Order		Prunus Iron Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERRIC OXIDE RED; PRUNUS SPINOSA FLOWER BUD	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8334_6bcb9dec-c713-7ba7-e053-2991aa0af89c	48951-8334	HUMAN OTC DRUG	Silica 6 Special Order		Silica 6 Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	6	[hp_X]/g			N	20241231
48951-8339_6e8c4603-82f9-6f62-e053-2991aa0a7252	48951-8339	HUMAN OTC DRUG	Strophanthus 3 Special Order		Strophanthus 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	STROPHANTHUS HISPIDUS SEED	3	[hp_X]/mL			N	20241231
48951-8340_6cf88437-522d-6c2f-e053-2a91aa0adac2	48951-8340	HUMAN OTC DRUG	Strophanthus e sem. 6 Special Order		Strophanthus e sem. 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	STROPHANTHUS HISPIDUS SEED	6	[hp_X]/mL			N	20241231
48951-8341_6d0aa18c-56ca-1e07-e053-2a91aa0aac92	48951-8341	HUMAN OTC DRUG	Plumbum met. 20 Special Order		Plumbum met. 20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD	20	[hp_X]/mL			N	20241231
48951-8343_6e0cd2d6-866f-6d5d-e053-2991aa0aaad9	48951-8343	HUMAN OTC DRUG	Silica 30 Special Order		Silica 30 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SILICON DIOXIDE	30	[hp_X]/1			N	20241231
48951-8345_731936c2-07e4-25db-e053-2991aa0addf6	48951-8345	HUMAN OTC DRUG	Stibium 6X Special Order		Stibium 6X Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY	6	[hp_X]/1			N	20241231
48951-8346_57e5517f-afba-540c-e053-2991aa0a6a07	48951-8346	HUMAN OTC DRUG	Rheuma DKS Special Order		Rheuma DKS Special Order	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; COMFREY ROOT; EQUISETUM ARVENSE TOP; FORMICA RUFA; ONION; TIN	1; 1; 5; 4; 1; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-8348_73543aeb-46d7-0d3d-e053-2991aa0a5c5c	48951-8348	HUMAN OTC DRUG	Rose Copper		Rose Copper	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	CUPROUS OXIDE	1	[hp_X]/g			N	20241231
48951-8350_77f9073d-62d8-7d71-e053-2991aa0a51c9	48951-8350	HUMAN OTC DRUG	Rheuma		Rheuma	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA FLOWER; COMFREY ROOT; ONION	1; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
48951-8351_7a8e2137-c841-37f9-e053-2991aa0ace59	48951-8351	HUMAN OTC DRUG	Stannum 5X		Stannum 5X	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	5	[hp_X]/g			N	20241231
48951-8352_8243228b-89ed-2b53-e053-2a91aa0a0f38	48951-8352	HUMAN OTC DRUG	Quercus Borago		Quercus Borago	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; BORAGE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; MERCURIALIS PERENNIS; MILK THISTLE; QUERCUS ROBUR WHOLE	3; 1; 1; 1; 1; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-8354_9407124a-0d59-09d2-e053-2995a90a2549	48951-8354	HUMAN OTC DRUG	Stannum 21X		Stannum 21X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	21	[hp_X]/mL			N	20241231
48951-8355_941ae14b-17e3-277a-e053-2a95a90ac837	48951-8355	HUMAN OTC DRUG	Plantain Beeswax Mild		Plantain Beeswax Mild	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	DROSERA ROTUNDIFOLIA; LARIX DECIDUA RESIN; PETASITES HYBRIDUS ROOT; PLANTAGO MAJOR LEAF; SAGE	4; 1; 4; 4; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8356_c5d79da6-5a3f-2cab-e053-2a95a90a9dd8	48951-8356	HUMAN OTC DRUG	Stannum 30X		Stannum 30X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	30	[hp_X]/mL			N	20241231
48951-8358_94f50c6d-2f32-7fd4-e053-2a95a90abadc	48951-8358	HUMAN OTC DRUG	Polygonatum Cepa		Polygonatum Cepa	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BARIUM CITRATE; BOS TAURUS CARTILAGE; BOS TAURUS PLACENTA; COPPER; ECHINACEA ANGUSTIFOLIA; GOLD; GRAPHITE; HIRUDIN; ONION; POLYGONATUM CYRTONEMA ROOT; SILICON DIOXIDE; SILVER; SUS SCROFA SKIN; THUJA OCCIDENTALIS WHOLE; VESPA CRABRO	12; 10; 8; 8; 2; 8; 17; 4; 2; 4; 8; 12; 8; 8; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
48951-8359_95c0a9e8-6d86-9510-e053-2a95a90afe2a	48951-8359	HUMAN OTC DRUG	Stannum 8X		Stannum 8X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	8	[hp_X]/mL			N	20241231
48951-8360_964c9c6c-8e87-4699-e053-2a95a90a55e6	48951-8360	HUMAN OTC DRUG	Pulsatilla Tormentilla		Pulsatilla Tormentilla	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF LIVER; HYDROXIDE ION; POTENTILLA ERECTA ROOT; PULSATILLA VULGARIS	4; 4; 30; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-8361_969cb4b7-c1c3-0577-e053-2a95a90a4e2c	48951-8361	HUMAN OTC DRUG	Stannum 21X		Stannum 21X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TIN	21	[hp_X]/mL			N	20241231
48951-8362_994b027a-d7d3-7fb1-e053-2a95a90a3f96	48951-8362	HUMAN OTC DRUG	Plumbum 8X		Plumbum 8X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	LEAD	8	[hp_X]/mL			N	20241231
48951-8363_994b65d2-4393-6d87-e053-2a95a90a1fc3	48951-8363	HUMAN OTC DRUG	Scorodite 6X Special Order		Scorodite 6X Special Order	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROUS ARSENATE	6	[hp_X]/g			N	20241231
48951-8365_b70f7b60-4239-11be-e053-2a95a90a49fb	48951-8365	HUMAN OTC DRUG	Stannum Succinum		Stannum Succinum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	AMBER; TIN	6; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8368_b699ea99-a012-2ecb-e053-2a95a90a6c29	48951-8368	HUMAN OTC DRUG	Spigelia comp		Spigelia comp	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ARNICA MONTANA FLOWER; PHOSPHORUS; SILVER NITRATE; SODIUM NITRITE; SPIGELIA MARILANDICA ROOT	8; 8; 12; 10; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8369_b710f4e6-3266-5353-e053-2995a90ad567	48951-8369	HUMAN OTC DRUG	Rhus tox. 10%		Rhus tox. 10%	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TOXICODENDRON PUBESCENS LEAF	1	[hp_X]/g			N	20241231
48951-8371_06bfb874-3a63-4c57-e063-6294a90aaba1	48951-8371	HUMAN OTC DRUG	Renes 5X		Renes 5X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PORK KIDNEY	5	[hp_X]/mL			N	20241231
48951-8374_c364e01a-5e57-509e-e053-2a95a90a3c89	48951-8374	HUMAN OTC DRUG	Robinia Nicotiana		Robinia Nicotiana	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	COPPER; ROBINIA PSEUDOACACIA BARK; SILVER; SODIUM PHOSPHATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; TOBACCO LEAF	8; 4; 6; 10; 6; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-8375_c3cc9a0f-7502-a0a5-e053-2995a90a767a	48951-8375	HUMAN OTC DRUG	Rosmarinus Lavandula		Rosmarinus Lavandula	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF; BOS TAURUS PLACENTA; BOS TAURUS SOMATIC NERVE; OSTREA EDULIS SHELL; SLOE; SUS SCROFA SKIN; SUS SCROFA UMBILICAL CORD; TIN; URTICA URENS	8; 11; 8; 8; 2; 8; 8; 8; 5	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Meat Proteins [EXT], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-8376_d79dad79-724e-e4ca-e053-2a95a90ae433	48951-8376	HUMAN OTC DRUG	Prunus spinosa e summ 30		Prunus spinosa e summ 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SLOE	1	[hp_X]/mL			N	20241231
48951-8377_c85c853f-d818-c72f-e053-2a95a90a18d5	48951-8377	HUMAN OTC DRUG	Sulfur 3X		Sulfur 3X	POWDER	TOPICAL	20090909		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SULFUR	3	[hp_X]/g			N	20241231
48951-8378_c70507f3-b221-66e7-e053-2a95a90adeae	48951-8378	HUMAN OTC DRUG	Arnica e pl. tota 6X		Arnica e pl. tota 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA	6	[hp_X]/mL			N	20241231
48951-8379_c85bc036-7a64-7033-e053-2a95a90a03e5	48951-8379	HUMAN OTC DRUG	Secale Betula		Secale Betula	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; BETULA PENDULA BARK; BETULA PENDULA LEAF; BOS TAURUS EYE; CLAVICEPS PURPUREA SCLEROTIUM; LEAD SULFIDE; LEVISTICUM OFFICINALE ROOT; TOBACCO LEAF	12; 4; 3; 8; 6; 8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-8380_0eaf75bd-f0cf-4bc1-e063-6394a90aa7d1	48951-8380	HUMAN OTC DRUG	Pancreas Argentum		Pancreas Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA, UNSPECIFIED; SILVER; SUS SCROFA PANCREAS	3; 30; 17	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20251231
48951-8381_c85d3605-583d-135a-e053-2a95a90acb8c	48951-8381	HUMAN OTC DRUG	Renes Mesenchyme		Renes Mesenchyme	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BORAGE; BOS TAURUS CARTILAGE; BOS TAURUS CONJUNCTIVA; BOS TAURUS LYMPH VESSEL; CUPRIC ACETATE; PORK KIDNEY; SUS SCROFA UMBILICAL CORD; VISCUM ALBUM FRUITING TOP	6; 8; 8; 8; 6; 8; 8; 15	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8382_c8989cce-551b-1de4-e053-2995a90a9976	48951-8382	HUMAN OTC DRUG	Scilla Crataegus		Scilla Crataegus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ADONIS VERNALIS FLOWERING TOP; CONVALLARIA MAJALIS; DRIMIA MARITIMA BULB; HAWTHORN LEAF WITH FLOWER; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	3; 4; 4; 3; 4; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8383_c8be6955-2642-0e9a-e053-2995a90a9a27	48951-8383	HUMAN OTC DRUG	Secale Argentum		Secale Argentum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARISTOLOCHIA CLEMATITIS WHOLE; CLAVICEPS PURPUREA SCLEROTIUM; PULSATILLA VULGARIS; SILVER	3; 6; 6; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-8384_cf447223-1552-59cc-e053-2a95a90adb2f	48951-8384	HUMAN OTC DRUG	Rectum 6X		Rectum 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	SUS SCROFA RECTUM	6	[hp_X]/mL			N	20241231
48951-8389_0d0c42f2-4f58-9ed0-e063-6294a90a252f	48951-8389	HUMAN OTC DRUG	Plantain Spruce Cough		Plantain Spruce Cough	LIQUID	ORAL	20220112		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; CINCHONA OFFICINALIS BARK; DROSERA ROTUNDIFOLIA; HELLEBORUS NIGER ROOT; IPECAC; MEPHITIS MEPHITIS ANAL GLAND FLUID; PETASITES HYBRIDUS ROOT; PICEA ABIES WHOLE; PLANTAGO LANCEOLATA WHOLE; PROTORTONIA CACTI; SLOE; VERATRUM ALBUM ROOT	5; 5; 4; 5; 5; 7; 1; 1; 1; 5; 1; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8390_0d982e3e-262a-c04c-e063-6394a90a7df3	48951-8390	HUMAN OTC DRUG	Plantain Spruce Cough		Plantain Spruce Cough	LIQUID	ORAL	20220112		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ATROPA BELLADONNA; CINCHONA OFFICINALIS BARK; DROSERA ROTUNDIFOLIA; HELLEBORUS NIGER ROOT; IPECAC; MEPHITIS MEPHITIS ANAL GLAND FLUID; PETASITES HYBRIDUS ROOT; PICEA ABIES WHOLE; PLANTAGO LANCEOLATA WHOLE; PROTORTONIA CACTI; SLOE; VERATRUM ALBUM ROOT	5; 5; 4; 5; 5; 7; 1; 1; 1; 5; 1; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8391_0d991cac-3ed0-4d0b-e063-6294a90ab18a	48951-8391	HUMAN OTC DRUG	Rose Copper Viscum DKS		Rose Copper Viscum DKS	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; FORMICA RUFA; VISCUM ALBUM FRUITING TOP	19; 8; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-8392_d79f76e2-23ad-49e0-e053-2a95a90a6e04	48951-8392	HUMAN OTC DRUG	Phosphorus 8		Phosphorus 8	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PHOSPHORUS	8	[hp_X]/1			N	20241231
48951-8393_db61db73-b7aa-2372-e053-2a95a90a2d12	48951-8393	HUMAN OTC DRUG	Plumbum mellitum 12X		Plumbum mellitum 12X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HONEY; LEAD	12; 12	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-8395_eadc50f4-5722-2a2a-e053-2995a90a8559	48951-8395	HUMAN OTC DRUG	Robinia Nicotiana		Robinia Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	BOS TAURUS ADRENAL GLAND; COPPER; ROBINIA PSEUDOACACIA BARK; SILVER; SODIUM PHOSPHATE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	8; 8; 4; 6; 10; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-8396_eac885e5-e8fe-a7c9-e053-2995a90a566a	48951-8396	HUMAN OTC DRUG	Reynoutria Lyme		Reynoutria Lyme	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	APIS MELLIFERA; ASTRAGALUS CHINENSIS SEED; ASTRAGALUS PROPINQUUS ROOT; COPPER; DIPSACUS FULLONUM WHOLE; GOLD; HELLEBORUS NIGER ROOT; REYNOUTRIA JAPONICA LEAF; SILICON DIOXIDE; SILVER	21; 30; 6; 17; 4; 30; 4; 3; 17; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-8397_0945d7ce-ca9f-b45a-e063-6294a90a6a54	48951-8397	HUMAN OTC DRUG	Robinia Nicotiana		Robinia Nicotiana	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	BOS TAURUS ADRENAL GLAND; COPPER; ROBINIA PSEUDOACACIA BARK; SILVER; SODIUM PHOSPHATE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	8; 8; 4; 6; 10; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
48951-8398_06ea42b9-11fc-e981-e063-6294a90a46dc	48951-8398	HUMAN OTC DRUG	Primula Onopordon		Primula Onopordon	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER	4; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8399_06fab6b8-3166-5a1c-e063-6394a90a696a	48951-8399	HUMAN OTC DRUG	Prostata 8X		Prostata 8X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS PROSTATE GLAND	8	[hp_X]/mL			N	20241231
48951-8400_06fb73a5-10fc-1a7a-e063-6394a90a9809	48951-8400	HUMAN OTC DRUG	Plantago Primula		Plantago Primula	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	HYOSCYAMUS NIGER LEAF; PLANTAGO MAJOR LEAF; PRIMULA VERIS FLOWER	4; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-8401_0a1f3256-dc5e-91b7-e063-6394a90a0de4	48951-8401	HUMAN OTC DRUG	Stibium 6X		Stibium 6X	POWDER	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY	6	[hp_X]/g			N	20241231
48951-8402_0a21913f-4e5b-f0ec-e063-6294a90ad9dd	48951-8402	HUMAN OTC DRUG	Phytolacca e rad 6X		Phytolacca e rad 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	PHYTOLACCA AMERICANA ROOT	6	[hp_X]/mL			N	20241231
48951-8403_0ac187cb-d052-cb60-e063-6394a90a183c	48951-8403	HUMAN OTC DRUG	Strophanthus Aurum		Strophanthus Aurum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; STROPHANTHUS KOMBE WHOLE	8; 10; 4; 3; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-8404_0ccd6c80-8601-493b-e063-6394a90a1390	48951-8404	HUMAN OTC DRUG	Sarothamnus Aurum		Sarothamnus Aurum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	CAMPHOR (NATURAL); CYTISUS SCOPARIUS FLOWER; GOLD; HYOSCYAMUS NIGER LEAF; ONOPORDUM ACANTHIUM FLOWER; PRIMULA VERIS FLOWER; SELENICEREUS GRANDIFLORUS STEM	4; 3; 17; 4; 3; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9001_0bb1c443-0d7a-9260-e063-6394a90ae1c9	48951-9001	HUMAN OTC DRUG	Testes Apis		Testes Apis	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS TESTICLE; ROYAL JELLY; SILVER	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9002_6e0e1dc6-975c-41fe-e053-2991aa0ae246	48951-9002	HUMAN OTC DRUG	Testes Apis		Testes Apis	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; BOS TAURUS TESTICLE; SILVER	6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-9003_6ce530a9-4d9b-6f4a-e053-2a91aa0a96e5	48951-9003	HUMAN OTC DRUG	Thrombocytes 6		Thrombocytes 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUUS CABALLUS WHOLE	6	[hp_X]/mL			N	20241231
48951-9008_0abfbf1c-2746-a358-e063-6394a90a64b7	48951-9008	HUMAN OTC DRUG	Thymus Mercurius		Thymus Mercurius	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS THYMUS; MERCURY	8; 20	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-9009_0ac01bf8-0f6f-121a-e063-6294a90a970d	48951-9009	HUMAN OTC DRUG	Thymus Mercurius		Thymus Mercurius	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS THYMUS; MERCURY	8; 20	[hp_X]/1; [hp_X]/1			N	20241231
48951-9012_6c448a40-bd5f-660a-e053-2991aa0a906a	48951-9012	HUMAN OTC DRUG	Thyreoidea Ferrum		Thyreoidea Ferrum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; THYROID, UNSPECIFIED	12; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-9014_6ce59d2e-2a7b-4951-e053-2a91aa0a25f7	48951-9014	HUMAN OTC DRUG	Thyreoidea Melissa		Thyreoidea Melissa	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARSENIC TRIOXIDE; BOS TAURUS PITUITARY GLAND; BOS TAURUS THYMUS; CUPRIC SULFATE; FUCUS VESICULOSUS; LYCOPUS VIRGINICUS; MELISSA OFFICINALIS; THYROID, UNSPECIFIED; VESPA CRABRO	6; 20; 5; 6; 3; 3; 3; 30; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9016_6cf40d7c-3430-67bb-e053-2a91aa0afc3f	48951-9016	HUMAN OTC DRUG	Tormentilla Cochlearia		Tormentilla Cochlearia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; COCHLEARIA OFFICINALIS FLOWERING TOP; POTENTILLA ERECTA ROOT	6; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9020_0b3b0eac-9360-f44a-e063-6394a90a604e	48951-9020	HUMAN OTC DRUG	Triticum Cerebri		Triticum Cerebri	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAINSTEM; WHEAT SPROUT	8; 20	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-9021_0b3b5ca7-2094-2c5d-e063-6394a90a8ffb	48951-9021	HUMAN OTC DRUG	Triticum Cerebri		Triticum Cerebri	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BRAINSTEM; WHEAT	8; 6	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-9026_6b2aa499-a000-d825-e053-2a91aa0abeef	48951-9026	HUMAN OTC DRUG	Urtica Conchae Special Order		Urtica Conchae Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OSTREA EDULIS SHELL; TIN; URTICA URENS	6; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9027_6e10cc1b-1e7f-457d-e053-2a91aa0a1db3	48951-9027	HUMAN OTC DRUG	Urtica Conchae		Urtica Conchae	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OSTREA EDULIS SHELL; TIN; URTICA URENS	2; 12; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-9034_6ce0e10c-20a4-4e52-e053-2991aa0acce5	48951-9034	HUMAN OTC DRUG	Valeriana Conchae		Valeriana Conchae	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	OSTREA EDULIS SHELL; PHOSPHORUS; SULFUR; VALERIAN	6; 30; 30; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-9037_56cde38c-99e5-645a-e054-00144ff8d46c	48951-9037	HUMAN OTC DRUG	Veratrum Chamomilla		Veratrum Chamomilla	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; ATROPA BELLADONNA; BOS TAURUS NERVE; CUPRIC SULFATE; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MATRICARIA RECUTITA; PRUNUS SPINOSA FLOWER BUD; VERATRUM ALBUM ROOT	6; 3; 6; 6; 6; 3; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-9038_6c43bc9d-1a37-2e2a-e053-2991aa0a8060	48951-9038	HUMAN OTC DRUG	Veratrum Chamomilla		Veratrum Chamomilla	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; ATROPA BELLADONNA; BOS TAURUS NERVE; CUPRIC SULFATE; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MATRICARIA RECUTITA; SLOE; VERATRUM ALBUM ROOT	6; 3; 6; 6; 6; 3; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-9039_6b394a7a-b4fe-48e1-e053-2991aa0ac763	48951-9039	HUMAN OTC DRUG	Vertebra thoracica 6 Special Order		Vertebra thoracica 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS BONE	6	[hp_X]/mL			N	20241231
48951-9041_6b39ce18-d809-7f50-e053-2991aa0abc8c	48951-9041	HUMAN OTC DRUG	Vesica fellea Ferrum 17/20 Special Order		Vesica fellea Ferrum 17/20 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS GALLBLADDER; ECHINACEA ANGUSTIFOLIA; IRON; SILVER	17; 3; 20; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9042_6e10d8c4-7d97-52ee-e053-2991aa0ab790	48951-9042	HUMAN OTC DRUG	Vesica fellea Ferrum 17/20 Special Order		Vesica fellea Ferrum 17/20 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS GALLBLADDER; IRON	17; 20	[hp_X]/1; [hp_X]/1			N	20241231
48951-9044_6b394a7a-b50b-48e1-e053-2991aa0ac763	48951-9044	HUMAN OTC DRUG	Vesica fellea 6 Special Order		Vesica fellea 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS GALLBLADDER	6	[hp_X]/mL			N	20241231
48951-9045_6b3a1a17-ae42-eb3b-e053-2a91aa0a08b8	48951-9045	HUMAN OTC DRUG	Vespa crabro ex animale 6 Special Order		Vespa crabro ex animale 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VESPA CRABRO	6	[hp_X]/mL			N	20241231
48951-9049_76503711-03c2-5956-e053-2991aa0ad0a4	48951-9049	HUMAN OTC DRUG	Viscum 3		Viscum 3	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/g			N	20241231
48951-9050_0aaeaa08-d65e-cb12-e063-6394a90a9163	48951-9050	HUMAN OTC DRUG	Viscum 10		Viscum 10	CREAM	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/g			N	20241231
48951-9060_6bdea63f-4ec3-0b69-e053-2991aa0a7b7c	48951-9060	HUMAN OTC DRUG	Viscum album 1 Special Order		Viscum album 1 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9061_6bdedfe9-9a62-5cfb-e053-2991aa0af7cf	48951-9061	HUMAN OTC DRUG	Viscum Belladonna		Viscum Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; ATROPA BELLADONNA; GOLD; VISCUM ALBUM FRUITING TOP	6; 12; 10; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9062_6bdef179-212c-e6e5-e053-2a91aa0ad12f	48951-9062	HUMAN OTC DRUG	Viscum Belladonna		Viscum Belladonna	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ARNICA MONTANA; ATROPA BELLADONNA; GOLD; VISCUM ALBUM FRUITING TOP	6; 12; 10; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9072_8b20ba02-fc7b-e9a3-e053-2a95a90a42e6	48951-9072	HUMAN OTC DRUG	Viscum Crataegus		Viscum Crataegus	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; GOLD; HAWTHORN LEAF WITH FLOWER; VISCUM ALBUM FRUITING TOP	17; 10; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9073_6e10ae8a-82a5-0bc8-e053-2991aa0a169b	48951-9073	HUMAN OTC DRUG	Viscum Crataegus		Viscum Crataegus	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUISETUM ARVENSE TOP; GOLD; HAWTHORN LEAF WITH FLOWER; VISCUM ALBUM FRUITING TOP	17; 10; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9074_6c547b69-6b6b-3ba3-e053-2991aa0a9f2d	48951-9074	HUMAN OTC DRUG	Viscum Echinacea		Viscum Echinacea	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA, UNSPECIFIED; FORMICA RUFA; VISCUM ALBUM FRUITING TOP	2; 3; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9075_6bdfd433-0056-7654-e053-2a91aa0aefc7	48951-9075	HUMAN OTC DRUG	Viscum Echinacea		Viscum Echinacea	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ECHINACEA, UNSPECIFIED; FORMICA RUFA; VISCUM ALBUM FRUITING TOP	2; 3; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-9085_6e113871-2d59-3c8d-e053-2991aa0af340	48951-9085	HUMAN OTC DRUG	Viscum Mali e pl. tota 5%		Viscum Mali e pl. tota 5%	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/1			N	20241231
48951-9091_6c66ae66-0704-41d2-e053-2991aa0a0858	48951-9091	HUMAN OTC DRUG	Viscum Mali e pl. tota 30		Viscum Mali e pl. tota 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	30	[hp_X]/mL			N	20241231
48951-9092_6c547b69-6b5e-3ba3-e053-2991aa0a9f2d	48951-9092	HUMAN OTC DRUG	Viscum Mali e pl. tota 4		Viscum Mali e pl. tota 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	4	[hp_X]/mL			N	20241231
48951-9093_6befe9b3-b55e-3ca9-e053-2a91aa0a2916	48951-9093	HUMAN OTC DRUG	Viscum Mali e pl. tota 6		Viscum Mali e pl. tota 6	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9105_6bf2f5de-e669-1716-e053-2991aa0a459b	48951-9105	HUMAN OTC DRUG	Viscum Pini e pl. tota 4		Viscum Pini e pl. tota 4	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	4	[hp_X]/mL			N	20241231
48951-9122_6bdee429-9b24-956d-e053-2a91aa0a5205	48951-9122	HUMAN OTC DRUG	Viscum comp.		Viscum comp.	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; PHOSPHORUS; VISCUM ALBUM FRUITING TOP	8; 30; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9144_6c2b8ac2-7fbc-4848-e053-2a91aa0a06b3	48951-9144	HUMAN OTC DRUG	Viscum Stannum		Viscum Stannum	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF; BRYONIA ALBA ROOT; MAMMAL LIVER; TIN; VISCUM ALBUM FRUITING TOP	8; 3; 6; 10; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-9145_6e116923-50da-2263-e053-2991aa0abbc3	48951-9145	HUMAN OTC DRUG	Viscum Stannum		Viscum Stannum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF; BRYONIA ALBA ROOT; MAMMAL LIVER; TIN; VISCUM ALBUM FRUITING TOP	8; 3; 6; 10; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-9160_6e120fc6-23f9-8dae-e053-2a91aa0a8f89	48951-9160	HUMAN OTC DRUG	Willow Fern		Willow Fern	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ASPLENIUM SCOLOPENDRIUM TOP; DRYOPTERIS FILIX-MAS ROOT; PTERIDIUM AQUILINUM WHOLE; SALIX ALBA FLOWER; SALIX PURPUREA BARK; WILLOW BARK	3; 3; 3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-9166_0995e648-9f31-9d3f-e063-6394a90ab072	48951-9166	HUMAN OTC DRUG	Aconitum Belladonna		Aconitum Belladonna	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	APIS MELLIFERA; ATROPA BELLADONNA	5; 4	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
48951-9167_0995afe5-df09-8725-e063-6394a90af3d7	48951-9167	HUMAN OTC DRUG	Aconitum Belladonna		Aconitum Belladonna	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; TOXICODENDRON PUBESCENS LEAF	30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-9170_69803f70-5821-5af6-e053-2991aa0a9763	48951-9170	HUMAN OTC DRUG	Aconitum Bryonia		Aconitum Bryonia	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT	3; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-9171_c68ebe6c-88a0-12ee-e053-2a95a90a97e4	48951-9171	HUMAN OTC DRUG	Aconitum e tub. 30		Aconitum e tub. 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACONITUM NAPELLUS	30	[hp_X]/mL			N	20241231
48951-9179_6ce570d7-bcfb-24cb-e053-2991aa0a0c91	48951-9179	HUMAN OTC DRUG	Thuja e summ. 6 Special Order		Thuja e summ. 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	THUJA OCCIDENTALIS WHOLE	6	[hp_X]/mL			N	20241231
48951-9180_6b3902d6-585d-8e12-e053-2a91aa0a687c	48951-9180	HUMAN OTC DRUG	Valvula aortae 6 Special Order		Valvula aortae 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BEEF HEART	6	[hp_X]/mL			N	20241231
48951-9181_6b3a1e84-cbe7-646f-e053-2991aa0a780e	48951-9181	HUMAN OTC DRUG	Vespa crabro 15 Special Order		Vespa crabro 15 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VESPA CRABRO	15	[hp_X]/mL			N	20241231
48951-9182_6ce570d7-bcf0-24cb-e053-2991aa0a0c91	48951-9182	HUMAN OTC DRUG	Thrombocytes 30 Special Order		Thrombocytes 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	EQUUS CABALLUS WHOLE	30	[hp_X]/mL			N	20241231
48951-9183_6b2aa499-9ff1-d825-e053-2a91aa0abeef	48951-9183	HUMAN OTC DRUG	Tourmaline 30 Special Order		Tourmaline 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SCHORL TOURMALINE	30	[hp_X]/mL			N	20241231
48951-9189_6b2ae27e-e843-d1b0-e053-2991aa0add64	48951-9189	HUMAN OTC DRUG	Urtica dioica ex herba Essence Special Order		Urtica dioica ex herba Essence Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	URTICA DIOICA LEAF	1	[hp_X]/mL			N	20241231
48951-9190_6b29a03f-a471-579f-e053-2991aa0a4c64	48951-9190	HUMAN OTC DRUG	Thalamus 8 Special Order		Thalamus 8 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	SUS SCROFA THALAMUS	8	[hp_X]/mL			N	20241231
48951-9193_6e1104b3-923f-d3c2-e053-2991aa0ad3fe	48951-9193	HUMAN OTC DRUG	Vesica fellea Ferrum 6/8 Special Order		Vesica fellea Ferrum 6/8 Special Order	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS GALLBLADDER; IRON	6; 8	[hp_X]/1; [hp_X]/1			N	20241231
48951-9195_6ce3793f-a1c1-6ab9-e053-2991aa0a9b41	48951-9195	HUMAN OTC DRUG	Taraxacum e pl. tota 2 Special Order		Taraxacum e pl. tota 2 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	TARAXACUM PALUSTRE ROOT	2	[hp_X]/mL			N	20241231
48951-9196_6b298aff-9520-f80a-e053-2a91aa0afb43	48951-9196	HUMAN OTC DRUG	Testes Apis Special Order		Testes Apis Special Order	CAPSULE	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS TESTICLE; ROYAL JELLY; SILVER	6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-9197_6b29cc49-7430-963b-e053-2991aa0ae30d	48951-9197	HUMAN OTC DRUG	Thuja e summ. 3 Special Order		Thuja e summ. 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	THUJA OCCIDENTALIS WHOLE	3	[hp_X]/mL			N	20241231
48951-9198_6c2ae50a-8a20-ddbf-e053-2991aa0afe45	48951-9198	HUMAN OTC DRUG	Viscum Quercus 6 Special Order		Viscum Quercus 6 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9205_0b27559c-883a-b387-e063-6394a90a0a74	48951-9205	HUMAN OTC DRUG	Viscum Abietis Series 1		Viscum Abietis Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9206_0c04acfa-89b7-55d7-e063-6294a90a97f5	48951-9206	HUMAN OTC DRUG	Viscum Abietis Series 2		Viscum Abietis Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9207_0da991af-1d3d-0483-e063-6294a90aca54	48951-9207	HUMAN OTC DRUG	Viscum Crataegi Series 1		Viscum Crataegi Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9208_0da9679a-04de-4a5b-e063-6394a90a2415	48951-9208	HUMAN OTC DRUG	Viscum Crataegi Series 2		Viscum Crataegi Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9209_0c04ef09-108f-4c9f-e063-6394a90a3bbf	48951-9209	HUMAN OTC DRUG	Viscum Mali Series 1		Viscum Mali Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9210_0b392a16-a834-0ca4-e063-6394a90ab730	48951-9210	HUMAN OTC DRUG	Viscum Mali Series 2		Viscum Mali Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9211_0b27559c-882d-b387-e063-6394a90a0a74	48951-9211	HUMAN OTC DRUG	Viscum Pini Series 1		Viscum Pini Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9212_0b26eab7-345b-17b1-e063-6394a90ad27e	48951-9212	HUMAN OTC DRUG	Viscum Pini Series 2		Viscum Pini Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9213_0da96a93-01f8-d8c0-e063-6294a90af8a4	48951-9213	HUMAN OTC DRUG	Viscum Populi Series 1		Viscum Populi Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9214_0da941b8-87f6-45e7-e063-6394a90a4f48	48951-9214	HUMAN OTC DRUG	Viscum Populi Series 2		Viscum Populi Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9217_0da93fbb-830a-2cba-e063-6394a90abca8	48951-9217	HUMAN OTC DRUG	Viscum Salicis Series 1		Viscum Salicis Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9218_0da921cd-b454-340f-e063-6394a90a9d3e	48951-9218	HUMAN OTC DRUG	Viscum Salicis Series 2		Viscum Salicis Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9219_0bdc20a9-7922-9a06-e063-6394a90a84cc	48951-9219	HUMAN OTC DRUG	Viscum Tiliae Series 1		Viscum Tiliae Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	6	[hp_X]/mL			N	20241231
48951-9220_0bdc16f4-dff8-cd74-e063-6294a90a8f65	48951-9220	HUMAN OTC DRUG	Viscum Tiliae Series 2		Viscum Tiliae Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9242_0bde5824-61c5-3b48-e063-6394a90a4d64	48951-9242	HUMAN OTC DRUG	Viscum Abietis Series 1 7ml		Viscum Abietis Series 1 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9248_0b4f6c20-f94e-7bae-e063-6294a90a5246	48951-9248	HUMAN OTC DRUG	Viscum Mali Series 1 7ml		Viscum Mali Series 1 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9249_0b3965d5-8e77-0605-e063-6394a90a1193	48951-9249	HUMAN OTC DRUG	Viscum Mali Series 2 7ml		Viscum Mali Series 2 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9256_0b27aade-f2ba-66f8-e063-6294a90a0fb2	48951-9256	HUMAN OTC DRUG	Viscum Pini Series 1 7ml		Viscum Pini Series 1 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9257_0b271a34-cadc-85ed-e063-6394a90ae233	48951-9257	HUMAN OTC DRUG	Viscum Pini Series 2 7ml		Viscum Pini Series 2 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9258_0da8289c-33a0-ccc4-e063-6294a90ad740	48951-9258	HUMAN OTC DRUG	Viscum Pini Series 3 7ml		Viscum Pini Series 3 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9264_0bdde46e-4e33-2552-e063-6394a90a6305	48951-9264	HUMAN OTC DRUG	Viscum Abietis Series 2 7ml		Viscum Abietis Series 2 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9265_0bde709f-0975-599a-e063-6394a90a6739	48951-9265	HUMAN OTC DRUG	Viscum Abietis Series 3 7ml		Viscum Abietis Series 3 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9266_0bde8c09-5f6c-5c07-e063-6394a90ab48c	48951-9266	HUMAN OTC DRUG	Viscum Abietis Series 4 7ml		Viscum Abietis Series 4 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9272_c68c09cf-41f1-6db8-e053-2995a90ad996	48951-9272	HUMAN OTC DRUG	Viscum Pini Series 4 7ml		Viscum Pini Series 4 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9279_6c2c4793-6ce2-4257-e053-2991aa0a1cb3	48951-9279	HUMAN OTC DRUG	Wild Yam Ginger		Wild Yam Ginger	SPRAY	NASAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	DIOSCOREA VILLOSA ROOT; GINGER	2; 2	[hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-9280_0a97e646-0394-9614-e063-6294a90a4ab9	48951-9280	HUMAN OTC DRUG	Travel Remedy		Travel Remedy	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ANTIMONY; ARNICA MONTANA; BELLIS PERENNIS; GOLD; HYOSCYAMUS NIGER; IPECAC; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; ONOPORDUM; PRIMULA VERIS	8; 30; 30; 10; 4; 30; 30; 30; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9281_6e10252c-3c54-7231-e053-2991aa0a2502	48951-9281	HUMAN OTC DRUG	Tormentilla Cochlearia		Tormentilla Cochlearia	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc	ACHILLEA MILLEFOLIUM; ANTIMONY; HORSERADISH	3; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
48951-9291_65049d3d-75fc-186f-e053-2991aa0aa108	48951-9291	HUMAN OTC DRUG	Visconsin Mali 0.1		Visconsin Mali 0.1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	4	[hp_X]/mL			N	20241231
48951-9292_6bcc1a02-d106-25a2-e053-2a91aa0aeaed	48951-9292	HUMAN OTC DRUG	Visconsin Mali 1		Visconsin Mali 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	3	[hp_X]/mL			N	20241231
48951-9293_6bd96e6b-883b-6f53-e053-2a91aa0abb91	48951-9293	HUMAN OTC DRUG	Visconsin Mali 5		Visconsin Mali 5	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9294_6bda6007-a586-2b08-e053-2991aa0a9224	48951-9294	HUMAN OTC DRUG	Visconsin Mali 10		Visconsin Mali 10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9295_6bda95a3-b3f2-0e97-e053-2a91aa0a10a2	48951-9295	HUMAN OTC DRUG	Visconsin Mali 20		Visconsin Mali 20	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9296_6bda4098-ab6e-69e1-e053-2991aa0a4ab2	48951-9296	HUMAN OTC DRUG	Visconsin Mali 30		Visconsin Mali 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9297_6bdac64a-165f-2617-e053-2a91aa0a0fe7	48951-9297	HUMAN OTC DRUG	Visconsin Mali 50		Visconsin Mali 50	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9299_6bc71437-29d9-6b92-e053-2991aa0a01a5	48951-9299	HUMAN OTC DRUG	Urtica Ferro 3 Special Order		Urtica Ferro 3 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	IRON; URTICA DIOICA	3; 3	[hp_X]/mL; [hp_X]/mL			N	20241231
48951-9300_6bc79b7a-c28d-71ed-e053-2a91aa0a186d	48951-9300	HUMAN OTC DRUG	Vaginae synovialis tendinum 30 Special Order		Vaginae synovialis tendinum 30 Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	BOS TAURUS TENDON	30	[hp_X]/mL			N	20241231
48951-9301_0bb316a1-7729-0d1a-e063-6394a90ad41f	48951-9301	HUMAN OTC DRUG	Viscum Abietis 1		Viscum Abietis 1	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	3	[hp_X]/mL			N	20241231
48951-9302_0bb3c6e4-1300-3371-e063-6394a90a42b0	48951-9302	HUMAN OTC DRUG	Viscum Abietis 5		Viscum Abietis 5	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9303_0bb2f3d6-f975-07d8-e063-6294a90abfb8	48951-9303	HUMAN OTC DRUG	Viscum Abietis 20		Viscum Abietis 20	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9304_0b245831-43dd-d48f-e063-6394a90a35de	48951-9304	HUMAN OTC DRUG	Viscum Abietis 10		Viscum Abietis 10	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9305_0bb3e1a6-5f92-514a-e063-6394a90a04c9	48951-9305	HUMAN OTC DRUG	Viscum Abietis 30		Viscum Abietis 30	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9306_0bdc16f4-dff6-cd74-e063-6294a90a8f65	48951-9306	HUMAN OTC DRUG	Viscum Abietis 50		Viscum Abietis 50	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9307_0b2534ed-30bb-3a23-e063-6294a90aaa31	48951-9307	HUMAN OTC DRUG	Viscum Abietis 100		Viscum Abietis 100	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9308_0da90003-2ccb-8f05-e063-6294a90ad4f2	48951-9308	HUMAN OTC DRUG	Viscum Mali 1		Viscum Mali 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	3	[hp_X]/mL			N	20241231
48951-9309_0da8cf48-9335-8921-e063-6294a90af690	48951-9309	HUMAN OTC DRUG	Viscum Mali 5		Viscum Mali 5	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9310_6bed63a6-1e10-3ed1-e053-2991aa0a4f55	48951-9310	HUMAN OTC DRUG	Viscum Mali 10		Viscum Mali 10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9311_0b251e46-f8df-211e-e063-6294a90a91a3	48951-9311	HUMAN OTC DRUG	Viscum Mali 20		Viscum Mali 20	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9312_0bb2e4ee-95b3-ab43-e063-6394a90a626b	48951-9312	HUMAN OTC DRUG	Viscum Mali 30		Viscum Mali 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9313_0b621c28-eab7-088d-e063-6294a90aabb6	48951-9313	HUMAN OTC DRUG	Viscum Mali 50		Viscum Mali 50	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9314_0ac2fc5c-c5f1-3dfb-e063-6394a90a4a58	48951-9314	HUMAN OTC DRUG	Viscum Mali 100		Viscum Mali 100	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9315_0ab006cb-c9c6-929e-e063-6294a90af0e1	48951-9315	HUMAN OTC DRUG	Viscum Pini 1		Viscum Pini 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	3	[hp_X]/mL			N	20241231
48951-9316_0b2677e2-7d55-0324-e063-6394a90a1116	48951-9316	HUMAN OTC DRUG	Viscum Pini 5		Viscum Pini 5	LIQUID	ORAL	20140801		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9317_0da895b0-6936-1963-e063-6394a90a5cce	48951-9317	HUMAN OTC DRUG	Viscum Pini 10		Viscum Pini 10	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9318_0da89529-83da-6070-e063-6294a90a55fd	48951-9318	HUMAN OTC DRUG	Viscum Pini 20		Viscum Pini 20	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9319_0b264af1-205d-2c71-e063-6294a90a783a	48951-9319	HUMAN OTC DRUG	Viscum Pini 30		Viscum Pini 30	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9320_0da82dc3-07ba-d426-e063-6294a90a5cf9	48951-9320	HUMAN OTC DRUG	Viscum Pini 50		Viscum Pini 50	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9321_0b2677e2-7d59-0324-e063-6394a90a1116	48951-9321	HUMAN OTC DRUG	Viscum Pini 100		Viscum Pini 100	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9322_6c2a8386-cb0b-745e-e053-2a91aa0af0af	48951-9322	HUMAN OTC DRUG	Viscum Quercus 1%		Viscum Quercus 1%	SPRAY	NASAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9325_6c2d7070-ef05-fd04-e053-2a91aa0a0108	48951-9325	HUMAN OTC DRUG	Viscum Abietis 12.5		Viscum Abietis 12.5	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9327_6c2f3305-fa39-7bd4-e053-2991aa0a1fa0	48951-9327	HUMAN OTC DRUG	Viscum Mali Special Series 1 7ml		Viscum Mali Special Series 1 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9328_6c2fe3ca-a4b2-2cac-e053-2a91aa0aa4be	48951-9328	HUMAN OTC DRUG	Viscum Pini Special Series 2		Viscum Pini Special Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	3	[hp_X]/mL			N	20241231
48951-9329_6c303517-4663-6533-e053-2991aa0a4c40	48951-9329	HUMAN OTC DRUG	Viscum Tiliae Special Series 2		Viscum Tiliae Special Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	3	[hp_X]/mL			N	20241231
48951-9330_6c53d03a-84c5-dc8b-e053-2991aa0aa1e3	48951-9330	HUMAN OTC DRUG	Viscum Special Series C		Viscum Special Series C	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	7	[hp_X]/mL			N	20241231
48951-9336_6c66e32c-51af-c70b-e053-2991aa0ab258	48951-9336	HUMAN OTC DRUG	Viscum Mali Special Series 1		Viscum Mali Special Series 1	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	10	[hp_X]/mL			N	20241231
48951-9339_6c67a057-57bd-268d-e053-2a91aa0afce8	48951-9339	HUMAN OTC DRUG	Viscum Pini Special Series 4 7ml		Viscum Pini Special Series 4 7ml	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	1	[hp_X]/mL			N	20241231
48951-9340_6c67fe9d-55ab-0d5e-e053-2991aa0a09bc	48951-9340	HUMAN OTC DRUG	Viscum Crataegi Special Series 2		Viscum Crataegi Special Series 2	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VISCUM ALBUM FRUITING TOP	2	[hp_X]/mL			N	20241231
48951-9353_95a9ab2f-8755-dbda-e053-2a95a90adea0	48951-9353	HUMAN OTC DRUG	Thyreoidea Ferrum		Thyreoidea Ferrum	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROUS ARSENATE; FUCUS VESICULOSUS; IRON; THYROID, UNSPECIFIED; URTICA DIOICA	6; 3; 6; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
48951-9354_95c070f4-b4c7-40e2-e053-2995a90a98d1	48951-9354	HUMAN OTC DRUG	Thyreoidea Ferrum Special Order		Thyreoidea Ferrum Special Order	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	FERROUS ARSENATE; FUCUS VESICULOSUS; IRON; THYROID, UNSPECIFIED; URTICA DIOICA	6; 3; 6; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9356_0a5e5933-4139-18e2-e063-6394a90a7d58	48951-9356	HUMAN OTC DRUG	Thyreoidea Belladonna		Thyreoidea Belladonna	PELLET	ORAL	20231117		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ATROPA BELLADONNA; CHAMOMILE; CUPRIC SULFATE; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; OSTREA EDULIS SHELL; THYROID, UNSPECIFIED	4; 3; 7; 6; 7; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
48951-9359_0996d446-1c32-f98f-e063-6394a90af8b8	48951-9359	HUMAN OTC DRUG	Viola comp.		Viola comp.	GEL	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; SAMBUCUS NIGRA FLOWERING TOP; URTICA DIOICA; VIOLA ODORATA FLOWERING TOP	5; 2; 1; 1	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
48951-9361_cf5aff6e-7abf-4de9-e053-2a95a90a6b1a	48951-9361	HUMAN OTC DRUG	Thuja e summ. 6X		Thuja e summ. 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	THUJA OCCIDENTALIS WHOLE	6	[hp_X]/mL			N	20241231
48951-9362_c3688cef-dc50-3c4c-e053-2995a90af2d8	48951-9362	HUMAN OTC DRUG	Thuja Thymus comp.		Thuja Thymus comp.	PELLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; ASPLENIUM SCOLOPENDRIUM TOP; BEEF LIVER; BOS TAURUS THYMUS; DRYOPTERIS FILIX-MAS ROOT; EQUISETUM ARVENSE TOP; FORMICA RUFA; LEVISTICUM OFFICINALE ROOT; MERCURY; OSTREA EDULIS SHELL; PORK KIDNEY; PTERIDIUM AQUILINUM WHOLE; SILICON DIOXIDE; SILVER; SLOE; THUJA OCCIDENTALIS WHOLE; URTICA DIOICA	20; 7; 3; 4; 4; 3; 2; 4; 2; 14; 5; 6; 3; 12; 6; 2; 6; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-9363_c3697270-e231-97b8-e053-2995a90ae572	48951-9363	HUMAN OTC DRUG	Thuja Thymus comp.		Thuja Thymus comp	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; ASPLENIUM SCOLOPENDRIUM TOP; BEEF LIVER; BOS TAURUS THYMUS; DRYOPTERIS FILIX-MAS ROOT; EQUISETUM ARVENSE TOP; FORMICA RUFA; LEVISTICUM OFFICINALE ROOT; MERCURY; OSTREA EDULIS SHELL; PORK KIDNEY; PTERIDIUM AQUILINUM WHOLE; SILICON DIOXIDE; SILVER; SLOE; THUJA OCCIDENTALIS WHOLE; URTICA DIOICA	20; 7; 3; 4; 4; 3; 2; 5; 2; 14; 5; 6; 3; 12; 6; 2; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
48951-9364_de5bb0ae-ea91-d8df-e053-2a95a90ae964	48951-9364	HUMAN OTC DRUG	Threefold Balance		Threefold Balance	TABLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	FRANKINCENSE; GOLD; MYRRH	2; 6; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9367_ed730437-f719-4bd2-e053-2a95a90af6b4	48951-9367	HUMAN OTC DRUG	Vitis Stibium		Vitis Stibium	TABLET	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ANTIMONY; CALCIUM FORMATE; FRAGARIA VESCA WHOLE; VITIS VINIFERA LEAF	5; 3; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
48951-9368_0682403f-a6f3-b64f-e063-6294a90af987	48951-9368	HUMAN OTC DRUG	Thuja e summ. 6X		Thuja e summ. 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	THUJA OCCIDENTALIS WHOLE	6	[hp_X]/mL			N	20241231
48951-9369_06e79a65-1452-804e-e063-6394a90a2f3d	48951-9369	HUMAN OTC DRUG	Vespa crabro ex animale 6X		Vespa crabro ex animale 6X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	VESPA CRABRO	6	[hp_X]/mL			N	20241231
48951-9370_06e9eee6-8391-7d95-e063-6294a90a6556	48951-9370	HUMAN OTC DRUG	Vespa Crabro DKS		Vespa Crabro DKS	OINTMENT	TOPICAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy Inc.	ANTIMONY; BOS TAURUS PLACENTA; COPPER; GOLD; ROYAL JELLY; SEDUM ROSEUM WHOLE; TIN; URTICA DIOICA; VESPA CRABRO; VISCUM ALBUM FRUITING TOP	6; 8; 15; 10; 6; 10; 6; 8; 6; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
48951-9371_074ec180-e1cb-7a22-e063-6394a90a7c0e	48951-9371	HUMAN OTC DRUG	Taraxacum Stanno culta 3X		Taraxacum Stanno culta 3X	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	TARAXACUM PALUSTRE ROOT	3	[hp_X]/mL			N	20241231
48951-9374_0c665726-d6c1-1d6f-e063-6294a90a71c3	48951-9374	HUMAN OTC DRUG	Viscum Immune Support		Viscum Immune Support	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	ATROPA BELLADONNA; BOS TAURUS THYMUS; FORMICA RUFA; GLUTATHIONE; KALANCHOE DAIGREMONTIANA LEAF; LEDUM PALUSTRE TWIG; OXALIS STRICTA WHOLE; THUJA OCCIDENTALIS WHOLE; VISCUM ALBUM FRUITING TOP	8; 10; 8; 21; 10; 30; 8; 20; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
48951-9375_0c672256-0b3f-e556-e063-6394a90a9ec6	48951-9375	HUMAN OTC DRUG	Viscum Vitalizer		Viscum Vitalizer	LIQUID	ORAL	20090901		UNAPPROVED HOMEOPATHIC		Uriel Pharmacy, Inc.	APIS MELLIFERA; BEEF LIVER; COPPER; EQUISETUM ARVENSE TOP; FORMICA RUFA; FRANKINCENSE; GOLD; HAWTHORN LEAF WITH FLOWER; KALANCHOE DAIGREMONTIANA LEAF; LEAD; MAGNESIUM HYDROXIDE; MYRRH; OXALIS STRICTA WHOLE; PHORADENDRON LEUCARPUM FRUITING TOP; PHOSPHORUS; SILICON DIOXIDE; SILVER; SLOE; VISCUM ALBUM FRUITING TOP	21; 6; 8; 6; 6; 7; 10; 12; 6; 20; 6; 7; 6; 20; 8; 6; 30; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-001_561bfa23-3720-4533-b568-6b6a68ad64b9	49035-001	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	CREAM	TOPICAL	19940131		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores Inc	ZINC OXIDE	130	mg/g			N	20241231
49035-002_6ad13634-b165-4af4-9804-1bc7dd2613aa	49035-002	HUMAN OTC DRUG	Equate Ready-to-Use Enema	Laxative	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20170401		OTC MONOGRAPH NOT FINAL	part334	WalMart	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
49035-003_8205d231-43f1-4aa5-ae66-92a1dcf2a059	49035-003	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20050620		OTC MONOGRAPH FINAL	part333D	Wal-Mart Stores Inc	SALICYLIC ACID	19.8	mg/g			N	20241231
49035-004_2466823b-3ffb-44b5-ab1c-7f23a400fcf0	49035-004	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20040406		OTC MONOGRAPH FINAL	part355	Wal Mart	SODIUM FLUORIDE	.2	mg/mL			N	20241231
49035-009_50509be3-fd7d-42db-b117-f3299125157d	49035-009	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20050208		OTC MONOGRAPH FINAL	part358H	Wal-Mart Stores, Inc	COAL TAR	25	mg/mL			N	20241231
49035-011_f31e8b52-8b5a-57de-e053-2a95a90a08a9	49035-011	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone Continuous Spray	AEROSOL, SPRAY	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	HYDROCORTISONE	1.13	g/113g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-012_06e68891-3518-1caa-e063-6294a90aa572	49035-012	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20160426		OTC MONOGRAPH FINAL	part341	Walmart Stores Inc.	MENTHOL	5.8	mg/1			N	20241231
49035-012_06e68891-3519-1caa-e063-6294a90aa572	49035-012	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20160428		OTC MONOGRAPH FINAL	part341	Walmart Stores Inc.	MENTHOL	5.8	mg/1			N	20241231
49035-015_f31e9cec-b67e-1c72-e053-2995a90aaa90	49035-015	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Anti-Itch Continuous Spray	AEROSOL, SPRAY	TOPICAL	20130303		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.5; .075	g/88mL; g/88mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-016_b8cce573-6300-4919-aead-0563d2abbd96	49035-016	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	19951214		OTC MONOGRAPH FINAL	part333B	Wal-Mart Stores, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49035-017_f31e9cec-b67f-1c72-e053-2995a90aaa90	49035-017	HUMAN OTC DRUG	Maximum Strength Wart Remover with Salicylic Acid		Wart Remover with Salicylic Acid	LIQUID	TOPICAL	20111231		OTC MONOGRAPH FINAL	part358B	Wal-Mart Stores, Inc.	SALICYLIC ACID	17	mg/100mg			N	20241231
49035-018_f3971580-671b-0f46-e053-2a95a90a2716	49035-018	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20140304		OTC MONOGRAPH FINAL	part358F	Wal-Mart Stores, Inc.	SALICYLIC ACID	.17	g/g			N	20241231
49035-019_f31ecb42-3d5d-1b99-e053-2995a90a7da7	49035-019	HUMAN OTC DRUG	Extra Thick Callus Removers		Extra Thick Callus Removers with Salicylic Acid	PATCH	TOPICAL	20130801		OTC MONOGRAPH FINAL	part358F	Wal-Mart Stores, Inc.	SALICYLIC ACID	40	mg/100mg			N	20241231
49035-027_06e680d7-6d81-0b54-e063-6294a90a14a1	49035-027	HUMAN OTC DRUG	Honey Lemon cough drops		menthol	LOZENGE	ORAL	20160427		OTC MONOGRAPH FINAL	part341	Walmart Stores Inc.	MENTHOL	7.5	mg/1			N	20241231
49035-028_bdfdea84-6d78-4914-a3d7-162ae8c40212	49035-028	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20141031	20250131	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49035-029_2a88f31a-a0b5-4e30-a807-088426f29e57	49035-029	HUMAN OTC DRUG	Equate nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050309		ANDA	ANDA076775	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-030_f31e966c-4c01-f5f3-e053-2995a90a09d3	49035-030	HUMAN OTC DRUG	Calamine Plus		FERRIC OXIDE RED, PRAMOXINE HYDROCHLORIDE, ZINC OXIDE	AEROSOL, SPRAY	TOPICAL	20130303		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores, Inc.	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/mL; mg/mL; mg/mL			N	20241231
49035-031_097ef1e4-1c05-3059-e063-6294a90ad9fb	49035-031	HUMAN OTC DRUG	Herbal Cough Drops		Menthol	LOZENGE	ORAL	20180208		OTC MONOGRAPH DRUG	M012	Walmart	MENTHOL	4.8	mg/1			N	20241231
49035-035_55f17dfa-d64f-4818-8cdf-80b63cbd857b	49035-035	HUMAN OTC DRUG	Mineral oil		Mineral oil	OIL	ORAL	20141031		OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	MINERAL OIL	100	mg/100mL			N	20241231
49035-038_26ca96e2-a884-4268-a256-cef2a9108f61	49035-038	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	19900415		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores, Inc	PETROLATUM	1	g/g			N	20241231
49035-039_4120178a-6086-4d1c-9240-ebf28b332d82	49035-039	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20140530		OTC MONOGRAPH FINAL	part347	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	WITCH HAZEL	842	mg/mL			N	20241231
49035-040_097f079e-aba5-bcac-e063-6394a90abb5c	49035-040	HUMAN OTC DRUG	Sugar Free Menthol Cough Drops		Menthol	LOZENGE	ORAL	20140730		OTC MONOGRAPH DRUG	M012	Walmart Stores Inc	MENTHOL	5.8	mg/1			N	20241231
49035-042_859c5841-0c5b-45e4-896a-12519f5e3b23	49035-042	HUMAN OTC DRUG	equate pain and fever	childrens	Acetaminophen	SUSPENSION	ORAL	20151106		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
49035-044_90f4798e-3dc4-46d8-a2db-8d31c74e0c0a	49035-044	HUMAN OTC DRUG	NiteTime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20141231		OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-046_06e690bc-2618-2987-e063-6394a90a17a4	49035-046	HUMAN OTC DRUG	Cherry Antacid Soft Chews		calcium carbonate	TABLET, CHEWABLE	ORAL	20161110		OTC MONOGRAPH FINAL	part331	Walmart Stores Inc.	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-047_9892e677-e524-4c06-9ff8-79834b46c55c	49035-047	HUMAN OTC DRUG	Acetaminophen PM	Extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20141130	20241129	OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49035-048_06e66fa7-b3be-1734-e063-6294a90a7864	49035-048	HUMAN OTC DRUG	Assorted Fruit Antacid Flavor Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181009		OTC MONOGRAPH FINAL	part331	Walmart	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-048_06e692c9-e746-5917-e063-6394a90ab15e	49035-048	HUMAN OTC DRUG	Assorted Fruit Antacid Flavor Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181009		OTC MONOGRAPH FINAL	part331	Walmart	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-050_84183e64-b074-4eef-91fb-a2cdf033f904	49035-050	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20100203		OTC MONOGRAPH NOT FINAL	part333E	Wal-Mart Stores, Inc.	POVIDONE-IODINE	10	mg/mL			N	20241231
49035-053_6e1f8100-9c7c-4470-9d1a-4b23e4759a52	49035-053	HUMAN OTC DRUG	Cold and Flu	severe	Acetaminophen,Dextromethorphan HBr,Guaifenesin,Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-057_c8ad60e2-f392-9d3b-e053-2a95a90a2135	49035-057	HUMAN OTC DRUG	Itch and Bite Relief First Aid Kit		Hydrocortisone and Diphenhydramine	KIT		20200909	20250312	OTC MONOGRAPH FINAL	part348	WAL-MART STORES, INC.						N	
49035-058_06e67cfe-f0ac-2976-e063-6394a90a82a5	49035-058	HUMAN OTC DRUG	Mixed Berry Antacid and Anti-Gas Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20160830		OTC MONOGRAPH FINAL	part331	Walmart Stores	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
49035-061_fdf600f7-5fc6-4fa2-8d40-29b38db62e02	49035-061	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Wal-Mart Stores Inc	LORATADINE	5	mg/5mL			N	20241231
49035-063_a265a327-b895-de8b-9334-5aadf9b8057c	49035-063	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20171011		ANDA	ANDA208150	Walmart	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-065_1b5dbbc9-023b-481e-be91-954e7e375cb5	49035-065	HUMAN OTC DRUG	Ibuprofen and Diphenhydramine HCl		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20151231	20240426	ANDA	ANDA090397	EQUATE (Wal-Mart Stores, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
49035-067_c8068143-b6fe-4cdd-b493-7b9fe7e48c81	49035-067	HUMAN OTC DRUG	EQUATE Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20100831		OTC MONOGRAPH DRUG	M004	Wal-Mart Stores Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49035-072_4fc35e9d-38c3-4efa-a31d-c1c27396bf19	49035-072	HUMAN OTC DRUG	Antiseptic Mouthrinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	19891111		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores, Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-073_3d5c7546-8eb1-4b6a-b42e-f43df8958366	49035-073	HUMAN OTC DRUG	Body Wash		Salicylic Acid	GEL	TOPICAL	20150115		OTC MONOGRAPH FINAL	part333D	Wal-Mart Stores, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49035-076_b99e75a8-26f3-4dbe-bbf6-f7529c7cbad0	49035-076	HUMAN OTC DRUG	Isopropyl alcohol	70 percent Wintergreen	Isopropyl alcohol	LIQUID	TOPICAL	20140530		OTC MONOGRAPH NOT FINAL	part333A	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
49035-078_31feba78-43d0-41c1-b3e1-e95bcabfb235	49035-078	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20171231	20241231	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	100	mg/1			N	
49035-080_b4d171d1-ad66-494f-9da1-6c692ab72906	49035-080	HUMAN OTC DRUG	equate	Athletes Foot	Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Wal-Mart Stores Inc	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
49035-082_752c9412-377d-47cf-8e9a-3595591f4449	49035-082	HUMAN OTC DRUG	equate childrens cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060812		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-085_df34afde-7394-4560-b31a-f7cbb626b385	49035-085	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20151231	20250131	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
49035-097_06e690bc-2619-2987-e063-6394a90a17a4	49035-097	HUMAN OTC DRUG	Sugar Free Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20180314		OTC MONOGRAPH FINAL	part341	Walmart	MENTHOL	7.6	mg/1			N	20241231
49035-099_2a5c1251-8881-423f-9fd8-33d5953f5b8f	49035-099	HUMAN OTC DRUG	Vaporizing		Camphor	INHALANT	RESPIRATORY (INHALATION)	20140307		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores, Inc	CAMPHOR (SYNTHETIC)	62	mg/mL			N	20241231
49035-101_67275bcc-77f5-49bd-b019-4269ad02aec3	49035-101	HUMAN OTC DRUG	equate Ultra Strength Antacid	Peppermint Flavor	Antacid Tablets	TABLET, CHEWABLE	ORAL	20151012		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	1000	mg/1			N	20241231
49035-105_2152f94b-e199-4538-9363-541771542722	49035-105	HUMAN OTC DRUG	equate Extra Strength Antacid		aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20151020		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
49035-106_26f1efff-e30b-4c6b-b1d1-51be507fbef1	49035-106	HUMAN OTC DRUG	Childrens	Allergy Relief	Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	Wal-Mart Stores Inc	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-118_cc861603-d1e2-9af2-3b81-f1e9cae7c71d	49035-118	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20120705		ANDA	ANDA077367	Wal-Mart Stores Inc	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-119_2b360745-20e3-4188-956b-204b35d72f35	49035-119	HUMAN OTC DRUG	equate omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150902		NDA	NDA022032	Wal-Mart Stores Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-122_7551e75b-f7de-45ed-9985-d9d0af0bc784	49035-122	HUMAN OTC DRUG	Equate Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20110501		OTC MONOGRAPH FINAL	part335	Wal-Mart Stores, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
49035-124_853e0097-c2c8-4869-8a20-980b1b7f449d	49035-124	HUMAN OTC DRUG	equate nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20090910		ANDA	ANDA090711	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-131_04ff8857-8512-4130-a213-b488617ad55e	49035-131	HUMAN OTC DRUG	Equate Suphedrine PE		Phenylephrine Hydrochloride	TABLET	ORAL	20140321		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-135_f39beeb3-3fdb-fa82-e053-2a95a90ad3f4	49035-135	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20190228		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc.	MICONAZOLE NITRATE	1.3	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49035-136_f204fd34-e9f1-1868-e053-2995a90a82a6	49035-136	HUMAN OTC DRUG	PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part348	WALMART STORES INC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49035-139_c7433d49-32a4-0c01-e053-2a95a90a2d48	49035-139	HUMAN OTC DRUG	Equate	SPF 50 Sport Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20120706		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49035-147_f034c4eb-1df9-46f9-b266-eb79ad70cf46	49035-147	HUMAN OTC DRUG	Fiber Therapy		Calcium polycarbophil	TABLET	ORAL	20131101		OTC MONOGRAPH NOT FINAL	part334	Wal-Mart Stores, Inc.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
49035-155_f31ec594-5f2e-87a8-e053-2a95a90ada3f	49035-155	HUMAN OTC DRUG	Salicylic acid		Medicated Corn Removers	PATCH	TOPICAL	20190315		OTC MONOGRAPH FINAL	part358F	Wal-Mart Stores Inc	SALICYLIC ACID	40	mg/91			N	20241231
49035-156_b6f8e977-4f1f-41a7-9a15-14b9898079cf	49035-156	HUMAN OTC DRUG	Equate Barrier Cream		Barrier Cream	CREAM	TOPICAL	20170228		OTC MONOGRAPH FINAL	part347	WALMART STORES INC	MENTHOL; ZINC OXIDE	4.5; 200	mg/g; mg/g			N	20241231
49035-157_ad758781-c35f-4c8d-9b28-9c46a1e166c3	49035-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49035-163_8b2b638c-cac7-43d9-aafb-1964050c54f6	49035-163	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20060513		OTC MONOGRAPH DRUG	M021	Wal-Mart	SODIUM FLUORIDE	.1	mg/mL			N	20241231
49035-164_f503a7fb-5af7-4ef5-9976-674bf69bb54a	49035-164	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCI	TABLET, FILM COATED	ORAL	20180815		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-165_ddf863e8-fd59-4ffa-8d7d-1dd113381c4d	49035-165	HUMAN OTC DRUG	Severe Congestion Relief	Maximum Strength Sinus	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20140630		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-166_60730a7e-ad03-4cba-8329-f1892a171ddb	49035-166	HUMAN OTC DRUG	equate ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20020416		ANDA	ANDA074937	Wal-Mart Stores Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-167_8ad324cf-763e-4c6e-b383-556b3cba7219	49035-167	HUMAN OTC DRUG	Ultra Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191118		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-170_e3662240-1aba-48ae-a1d1-e3909361a03c	49035-170	HUMAN OTC DRUG	Equate nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050322		ANDA	ANDA076789	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-175_648ad7a3-f1c6-42cf-bf0e-1b7de4245959	49035-175	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN	500	mg/1			N	20241231
49035-178_db3fd7a4-9c4e-4db3-b5ac-cc75fe1ecc9e	49035-178	HUMAN OTC DRUG	Butenafine Hydrochloride	Jock Itch	Butenafine Hydrochloride	CREAM	TOPICAL	20171116		ANDA	ANDA205181	Wal-Mart Stores Inc	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
49035-180_79979474-d172-4e23-b7b2-c7ef0c4dd2cd	49035-180	HUMAN OTC DRUG	Healing		Healing Ointment	OINTMENT	TOPICAL	20071202		OTC MONOGRAPH FINAL	part347	Wal Mart	PETROLATUM	41	kg/g			N	20241231
49035-181_0c6ab614-2c36-131e-e063-6394a90aacb4	49035-181	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191004		ANDA	ANDA211544	WAL-MART STORES INC	ACETAMINOPHEN	650	mg/1			N	20241231
49035-182_95e01367-e49b-4198-bc3f-78e40e02b244	49035-182	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190930	20240930	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	100	mg/1			N	
49035-184_6d63e25c-8dd3-42aa-95ef-935973e4ca04	49035-184	HUMAN OTC DRUG	Equate Everyday Clean 2 in 1 Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20181217		OTC MONOGRAPH DRUG	M032	Walmart Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-185_4e7ee2c6-e6e2-4b3f-a026-11c1e768d63e	49035-185	HUMAN OTC DRUG	Equate Everyday Clean Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20181217		OTC MONOGRAPH DRUG	M032	Walmart Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-188_380a4199-482d-4238-a5ce-5c5672c74e9b	49035-188	HUMAN OTC DRUG	Equate Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20140102		OTC MONOGRAPH FINAL	part346	Wal-Mart Stores Inc	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-190_e56b903c-4989-447b-9613-ce4e46679641	49035-190	HUMAN OTC DRUG	Equate Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20090910		ANDA	ANDA090711	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-192_b2838e6e-9937-423d-81aa-edc82d7706e0	49035-192	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20200130		OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)						N	20241231
49035-193_6af3d6d4-13d8-4a3c-acb7-dbee9d469d1a	49035-193	HUMAN OTC DRUG	Cold and Flu	Daytime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20200130		OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-199_200df9fe-0ae1-48b0-9a64-140e3ff9dd11	49035-199	HUMAN OTC DRUG	equate miconazole 1		Miconazole nitrate	KIT		20100609		ANDA	ANDA079114	Wal-Mart Stores Inc						N	20241231
49035-200_96cd2ff1-aba9-4897-91a7-d5814ddad916	49035-200	HUMAN OTC DRUG	equate allergy relief		Fluticasone propionate	SPRAY, METERED	NASAL	20160528		ANDA	ANDA207957	Wal-Mart Stores Inc	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-201_542314e5-6b18-4fb8-b661-2bb2f1f2c499	49035-201	HUMAN OTC DRUG	Equate Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20161011		ANDA	ANDA090821	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-203_097edeb2-ad48-1035-e063-6294a90a82fa	49035-203	HUMAN OTC DRUG	Honey Cough Drops		Menthol	LOZENGE	ORAL	20180314		OTC MONOGRAPH DRUG	M012	Walmart	MENTHOL	2.7	mg/1			N	20241231
49035-206_5b6a4cd4-cb4b-4841-bd19-13137c570d12	49035-206	HUMAN OTC DRUG	equate nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050308		ANDA	ANDA078325	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-207_57bfeb10-5eaf-4230-9b88-1d2bffb65975	49035-207	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE	ORAL	20191030	20250131	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	100	mg/1			N	
49035-208_b407f021-be2e-4c6e-aef6-583778b4681b	49035-208	HUMAN OTC DRUG	Childrens Allergy		Fexofenadine HCL	SUSPENSION	ORAL	20200701		ANDA	ANDA203330	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-213_a31c8079-cd84-40dd-bcbd-779ef6c4ab19	49035-213	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20010806		OTC MONOGRAPH FINAL	part355	Wal-Mart	SODIUM FLUORIDE	.2	mg/mL			N	20241231
49035-225_02469600-e153-416a-b16a-bde30c4bb2e8	49035-225	HUMAN OTC DRUG	Athletes Foot Ultra		Butenafine Hydrochloride	CREAM	TOPICAL	20171116		ANDA	ANDA205181	Wal-Mart Stores Inc	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
49035-226_947b4aee-cb63-41f1-bb19-c83fe82fbf98	49035-226	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	Wal-Mart Stores Inc	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
49035-228_38fe09a8-38d9-49e2-a951-d70aa7907e48	49035-228	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190814		ANDA	ANDA078682	Wal-Mart Stores, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-229_29b39377-a7b2-4bde-812c-1bf2f7c9d3ce	49035-229	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20150106		OTC MONOGRAPH FINAL	part333D	Wal-Mart Stores, Inc	BENZOYL PEROXIDE	100	mg/g			N	20241231
49035-231_23a94887-f625-4a01-bcda-131ca5286372	49035-231	HUMAN OTC DRUG	Equate Eye Itch Relief		ketotifen fumarate	SOLUTION	OPHTHALMIC	20160101		NDA	NDA021996	Wal-Mart Stores, Inc.	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
49035-237_b65203a1-0b17-493b-a0f3-b8315d739bf7	49035-237	HUMAN OTC DRUG	NIGHTTIME SLEEP AID Maximum Strength		DIPHENHYDRAMINE HYDROCHLORIDE 50 mg	CAPSULE, LIQUID FILLED	ORAL	20131031		OTC MONOGRAPH FINAL	part341	EQUATE (Walmart Stores, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-243_0d293bad-3889-0566-e063-6294a90ad581	49035-243	HUMAN OTC DRUG	Equate Lubricant Eye Drops Restorative Performance		Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20191101		OTC MONOGRAPH DRUG	M018	Wal-Mart Stores, Inc.	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
49035-245_0d293bad-388b-0566-e063-6294a90ad581	49035-245	HUMAN OTC DRUG	Equate Lubricant Eye Drops Preservative-Free		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20191101		OTC MONOGRAPH DRUG	M018	Wal-Mart Stores, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
49035-249_26ca504e-bc52-4289-bfb5-3e1ac2a4e1fe	49035-249	HUMAN OTC DRUG	Equate Dry Scalp 2 in 1 Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20181217		OTC MONOGRAPH FINAL	part358H	Wal-Mart Stores, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-250_7c8c465a-d4e5-4662-b6b2-7f813abbd1db	49035-250	HUMAN OTC DRUG	Equate Dry Scalp 2 in 1 Dandruff SH and COND	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20190131		OTC MONOGRAPH DRUG	M032	Walmart Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-251_75ba77ab-5c50-43ac-aa6d-24df0f7f0460	49035-251	HUMAN OTC DRUG	arthricream		Trolamine Salicylate	CREAM	TOPICAL	20090425		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	TROLAMINE SALICYLATE	10	g/100g			N	20241231
49035-252_76f204ca-6d4d-4587-ba84-d50281043413	49035-252	HUMAN OTC DRUG	Equate Athletes Foot		TOLNAFTATE	CREAM	TOPICAL	20160831		OTC MONOGRAPH FINAL	part333C	WALMART STORES INC	TOLNAFTATE	10	mg/g			N	20241231
49035-253_3ba229d0-b0cd-4aa4-b1f1-c81b17a743ed	49035-253	HUMAN OTC DRUG	Equate Jock Itch		CLOTRIMAZOLE	CREAM	TOPICAL	20160831		OTC MONOGRAPH FINAL	part333C	WALMART STORES INC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49035-256_f6c81c7f-fc86-4b3f-97a0-f6e002607dd0	49035-256	HUMAN OTC DRUG	Equate Dry Scalp 2 in 1 Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20181217		OTC MONOGRAPH DRUG	M032	Wal-Mart Stores, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-257_f32cd367-d0e7-212b-e053-2995a90ad731	49035-257	HUMAN OTC DRUG	equate Sensitive		Potassium nitrate, Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20181102		OTC MONOGRAPH NOT FINAL	part356	Wal-Mart Stores Inc	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
49035-259_9c4e2aa8-f9ab-459e-8825-1aa771f5463b	49035-259	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20200106		ANDA	ANDA208754	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCOSANOL	100	mg/g			N	20241231
49035-261_42abf75f-dc60-d3ed-fb1d-be9c33dc97f0	49035-261	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20200403		ANDA	ANDA208369	Wal-mart Stores, Inc.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
49035-262_e1af0005-e677-473d-bd3b-9d4d1a1a261d	49035-262	HUMAN OTC DRUG	equate arthritis pain		diclofenac sodium	GEL	TOPICAL	20200817		ANDA	ANDA211253	Wal-Mart Stores Inc	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-263_d19477bc-124a-4a58-8b2c-5fab69966b8b	49035-263	HUMAN OTC DRUG	Equate Everyday Clean Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20181217		OTC MONOGRAPH DRUG	M032	Walmart Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-264_46aba811-e817-451e-a941-aab32e0f6152	49035-264	HUMAN OTC DRUG	Acne Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20140218		OTC MONOGRAPH FINAL	part333D	Wal-Mart Stores, Inc	BENZOYL PEROXIDE	100	mg/g			N	20241231
49035-265_5ed19189-cb00-40e9-97e6-f67ad0b30ea4	49035-265	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20191231		ANDA	ANDA206568	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-266_86e0fb5d-5332-475f-b848-8a6fbbec41bb	49035-266	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20191030		OTC MONOGRAPH DRUG	M016	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
49035-267_8f67fa61-4454-40c9-9bd5-f4209f529ea7	49035-267	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20170630	20250630	OTC MONOGRAPH NOT FINAL	part333A	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	HYDROGEN PEROXIDE	2.65	mL/100mL			N	
49035-268_a7fb37a8-855d-495b-886d-45491cd2ee90	49035-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20140530		OTC MONOGRAPH NOT FINAL	part356	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
49035-269_6657f28e-6f37-4499-9695-bcded504f1b6	49035-269	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20210503		ANDA	ANDA208077	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-270_b9323093-7454-4f86-824a-c9648b4a3298	49035-270	HUMAN OTC DRUG	Sool Softener Laxative		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20200901		OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
49035-271_2fef85c5-af13-413e-97e6-ad41b6ee76e8	49035-271	HUMAN OTC DRUG	Isopropyl alcohol	50 percent	Isopropyl alcohol	LIQUID	TOPICAL	20170630		OTC MONOGRAPH NOT FINAL	part333A	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
49035-272_e06dee71-4b80-41af-89af-f98efcff377c	49035-272	HUMAN OTC DRUG	Isopropyl alcohol	50 percent	Isopropyl alcohol	LIQUID	TOPICAL	20160229		OTC MONOGRAPH NOT FINAL	part333A	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
49035-273_89a65237-243f-d6ec-f917-07450a7670b2	49035-273	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20191231		ANDA	ANDA076667	Wal-mart Stores Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
49035-274_eb4fa990-b60f-42af-8c82-5ed7ff39c889	49035-274	HUMAN OTC DRUG	equate aspirin	chewable	Aspirin	TABLET, CHEWABLE	ORAL	20030306		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49035-275_7404ae7a-00d2-493a-b6ee-a159bb4e1379	49035-275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20140530		OTC MONOGRAPH NOT FINAL	part333A	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
49035-276_8d295913-8dd6-43cd-ae46-9b5a8ba2e60d	49035-276	HUMAN OTC DRUG	Equate	Childrens Allergy Relief	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Wal-Mart Stores Inc	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-277_0afaf57f-9f1f-43ab-8742-78187c426026	49035-277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20140530		OTC MONOGRAPH NOT FINAL	part333A	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
49035-278_50d3c81f-0699-43a0-8712-d0108e2af7a8	49035-278	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	LIQUID	ORAL	20151231		OTC MONOGRAPH NOT FINAL	part343	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN	500	mg/15mL			N	20241231
49035-279_d21f06aa-6350-44c7-91ee-b2cf4485aeb1	49035-279	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20131101		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
49035-280_0d291a5f-b639-380c-e063-6394a90a0310	49035-280	HUMAN OTC DRUG	Equate Eye Drops Dry Eye Relief		Glycerin, Hypromellose, Polyethylene Glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20191101		OTC MONOGRAPH DRUG	M018	Wal-Mart Stores, Inc.	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
49035-282_0d295173-cadb-510d-e063-6394a90a6068	49035-282	HUMAN OTC DRUG	Equate Lubricant Eye Drops High Performance		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20191101		OTC MONOGRAPH DRUG	M018	Wal-Mart Stores, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
49035-293_fea616e4-1917-4a3f-a7d7-8a757e716825	49035-293	HUMAN OTC DRUG	Stomach Relief Ultra		Bismuth subsalicylate	LIQUID	ORAL	20200201		OTC MONOGRAPH FINAL	part335	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
49035-294_f8f753c5-178c-4ae7-85a8-d7ac660a962c	49035-294	HUMAN OTC DRUG	equate hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20120301		ANDA	ANDA091344	Wal-Mart Stores Inc	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
49035-295_3af6617c-2131-49d5-8c3d-99d27cd3c253	49035-295	HUMAN OTC DRUG	Medicated Body	Powder	MENTHOL, ZINC OXIDE	POWDER	TOPICAL	20090901		OTC MONOGRAPH NOT FINAL	part348	Walmart Stores Inc	MENTHOL; ZINC OXIDE	3; 20	mg/2g; mg/2g			N	20241231
49035-297_aaa1117e-e091-4ed2-968c-e89acf41764f	49035-297	HUMAN OTC DRUG	Walmart Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20191010		UNAPPROVED DRUG OTHER		Walmart	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
49035-299_0e18c398-a919-45c7-b0f0-e553d2f9055c	49035-299	HUMAN OTC DRUG	Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20080222		OTC MONOGRAPH NOT FINAL	part356	Wal-Mart Stores, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
49035-301_0ee04a36-804e-47f4-9c98-fe72963f3808	49035-301	HUMAN OTC DRUG	Blackhead Clearing Scrug		Salicylic acid	GEL	TOPICAL	20070813		OTC MONOGRAPH FINAL	part333D	Wal Mart	SALICYLIC ACID	19.4	mg/g			N	20241231
49035-303_95878365-80e6-46ad-a432-16daed666fc9	49035-303	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20180705		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-304_650435ca-d8da-4105-908e-1b388be489cc	49035-304	HUMAN OTC DRUG	equate nasal	original	oxymetazoline hydrochloride	SPRAY	NASAL	19900815		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
49035-306_6faea458-4757-4d09-bcb8-a6ca456260c9	49035-306	HUMAN OTC DRUG	equate clear lax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091008		ANDA	ANDA090685	Wal-Mart Stores Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-307_59b779ae-9ee1-4865-8377-12efef3cf0b1	49035-307	HUMAN OTC DRUG	Childrens Oral Saline Laxative		Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20200310		OTC MONOGRAPH DRUG	M007	WAL-MART STORES,INC.,	MAGNESIUM HYDROXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-308_75629915-26db-4eed-93d6-6d73c6eebedd	49035-308	HUMAN OTC DRUG	equate pain reliever		Acetaminophen	TABLET	ORAL	20190123		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	500	mg/1			N	20241231
49035-309_6568be60-6d35-4aaf-8937-1c61fa231e1d	49035-309	HUMAN OTC DRUG	equate nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20200325		ANDA	ANDA206393	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-313_c83226c1-4a66-4c8c-9e8a-5753c306c66f	49035-313	HUMAN OTC DRUG	Equate Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20131208		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
49035-314_097f079e-abb8-bcac-e063-6394a90abb5c	49035-314	HUMAN OTC DRUG	Equate Sore Throat Pops		Pectin	LOZENGE	ORAL	20190418		OTC MONOGRAPH DRUG	M012	Walmart	PECTIN	10	mg/1			N	20241231
49035-315_6511bedc-9275-4b4d-be3a-0d90d5414605	49035-315	HUMAN OTC DRUG	Day and Night Cold and Flu Formula		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20170823		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc						N	20241231
49035-321_c83a9037-6e0c-4414-9b06-1f1889f6915f	49035-321	HUMAN OTC DRUG	Equate Acid Reducer Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20080808		ANDA	ANDA077355	Wal-Mart Stores Inc	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-322_aef853df-6163-495f-9fc1-5a9c79b32582	49035-322	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20180705		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-324_0d979969-f41c-4700-bdaf-cb7b7bc73a78	49035-324	HUMAN OTC DRUG	equate nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	SOLUTION	ORAL	20200117		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-327_71a26b21-d6af-4f6b-8d9b-6330c3060b39	49035-327	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Wal-Mart Stores Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-329_07603772-adc9-4dca-9be4-1b15a3b6de08	49035-329	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20141031	20250131	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49035-330_9995a687-2bd1-42a4-8327-a6f7f64e1434	49035-330	HUMAN OTC DRUG	Nighttime Sleep Aid	Alcohol Free	Diphenhydramine HCl	SOLUTION	ORAL	20160912		OTC MONOGRAPH DRUG	M010	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-332_f76ee2d8-c710-4df1-abed-bdf3f6cf7767	49035-332	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ALCOHOL	62	mL/100mL			N	20241231
49035-335_2fae1029-1959-48ba-a67b-d50b02832068	49035-335	HUMAN OTC DRUG	equate nitetime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110806		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-336_cddfdc17-6c9f-45e5-b799-9fbf4868f0bd	49035-336	HUMAN OTC DRUG	Mucus Relief	Cold Flu and Sore Throat Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20180430		OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-338_c8edb4a8-8c75-470a-ab8e-c7e7ad765b99	49035-338	HUMAN OTC DRUG	Naturally Beaming		Avobenzone, Octinoxate, Octisalate	LOTION	TOPICAL	20100117		OTC MONOGRAPH FINAL	part352	Wal-Mart	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
49035-343_7a8ec088-38e3-4515-935a-0bf11c566e17	49035-343	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ALCOHOL	62	mL/100mL			N	20241231
49035-345_26697178-bcf0-46c8-a0af-d2fa6968200c	49035-345	HUMAN OTC DRUG	Miconazole 3 Combination Pack		Miconazole Nitrate	KIT		20200501		ANDA	ANDA074926	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)						N	20241231
49035-346_1e87a559-5dfd-40f7-a49c-f91528f92d92	49035-346	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	TABLET	ORAL	20190730		OTC MONOGRAPH DRUG	M008	Wal-Mart Stores Inc	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
49035-347_f2244fad-4ecc-47cb-b137-b136f17008bf	49035-347	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20200501		ANDA	ANDA074164	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	MICONAZOLE NITRATE	100	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49035-348_8317c5aa-c86c-49e3-8bd9-f6c87a486f11	49035-348	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, SUGAR COATED	ORAL	20030102	20240309	OTC MONOGRAPH DRUG	505G(a)(3)	Wal-Mart Stores Inc	SENNOSIDES	25	mg/1			N	
49035-349_a95be37b-54f2-4e33-8edf-970d773c0fcb	49035-349	HUMAN OTC DRUG	Chocolate Laxative	Regular strength, Sennosides Stimulant Laxative, equate	Sennosides	TABLET, CHEWABLE	ORAL	20210223		OTC MONOGRAPH NOT FINAL	part334	Wal-Mart Stores Inc	SENNOSIDES	15	mg/1			N	20241231
49035-352_d4d2f1de-a7b2-4f48-a7d3-519fce2179e8	49035-352	HUMAN OTC DRUG	Equate nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20081014		ANDA	ANDA078547	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-355_caeff985-d339-4c0d-9f35-25de1e55cb94	49035-355	HUMAN OTC DRUG	equate aspirin		aspirin	TABLET, FILM COATED	ORAL	20201209	20240501	OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
49035-356_e1dda8a7-963c-408e-bf78-3876c267a9c0	49035-356	HUMAN OTC DRUG	Day and Night Sinus		Acetaminophen, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20201023		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc						N	20241231
49035-359_67205588-aa34-4130-ab18-992491dc7f63	49035-359	HUMAN OTC DRUG	Equate Tussin DM	adult	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19920603		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-360_c8683112-b650-4d3d-99fa-756ca991016b	49035-360	HUMAN OTC DRUG	Laxative and Stool Softener		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20200901		OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
49035-362_89d55883-51f9-118d-8097-b42adfec34b1	49035-362	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20171023		ANDA	ANDA208150	Walmart	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-363_c6a4f49f-7b75-4e72-9f69-ea4a469bb433	49035-363	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part343	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-364_0715f00b-468e-4468-89a6-0968bae26140	49035-364	HUMAN OTC DRUG	50% Isopropyl Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20190308		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
49035-365_4d778cb5-3881-4c31-b3c4-96e699ec67c8	49035-365	HUMAN OTC DRUG	equate nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20111004		ANDA	ANDA091349	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-366_fc139800-7403-a90b-e053-6294a90ae397	49035-366	HUMAN OTC DRUG	equate allergy relief		fexofenadine hydrochloride	TABLET	ORAL	20110414		ANDA	ANDA204097	Walmart Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-367_02d5d7e6-16d9-434f-be53-264a83d7464b	49035-367	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-369_f243aeeb-c152-45b8-9bfa-72bcd4a937bd	49035-369	HUMAN OTC DRUG	Equate Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20090121		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-371_246b70af-17e7-4385-aeda-06af000ad234	49035-371	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20141031	20241031	OTC MONOGRAPH FINAL	part335	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
49035-372_e1e0d724-a81f-4858-8bdb-cef6d6493066	49035-372	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20141130	20240426	OTC MONOGRAPH FINAL	part335	EQUATE (Wal-Mart Stores, Inc.)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
49035-373_541f5b17-f2fe-428c-bf83-01d59bba6a97	49035-373	HUMAN OTC DRUG	equate lansoprazole		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20190319		NDA	NDA208025	Wal-Mart Stores Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-375_5c981487-cda5-447a-ab17-85b5d615b224	49035-375	HUMAN OTC DRUG	Anti Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	Wal-Mart Stores Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
49035-376_b92ac8d0-2eed-434a-b8b5-09f335e487a3	49035-376	HUMAN OTC DRUG	Sore Throat		Phenol	SPRAY	ORAL	20140731		OTC MONOGRAPH NOT FINAL	part356	EQUATE (Wal-Mart Stores, Inc.)	PHENOL	1.4	g/100mL			N	20241231
49035-377_6123eba6-00fd-40c1-970e-da9e2541145e	49035-377	HUMAN OTC DRUG	Senna S Laxative		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20190201	20250201	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
49035-378_6880d97d-63ec-4ddf-99f6-bb4fdc0c01d3	49035-378	HUMAN OTC DRUG	Stool Softener	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200901		OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	250	mg/1			N	20241231
49035-379_72fb0d5d-855b-41e7-8009-1c64fcc3a3b0	49035-379	HUMAN OTC DRUG	equate allergy relief		Diphenhydramine Hydrochloride	SOLUTION	ORAL	19900815		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-381_f0ead829-5869-cae5-e053-2a95a90a4581	49035-381	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200211		ANDA	ANDA078682	Wal-Mart Stores, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-382_f0fb53cd-5c61-6417-e053-2995a90a6c61	49035-382	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20200301		NDA	NDA021920	Wal-Mart Stores, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-384_42e472a6-ea98-46f0-95c2-539f14942b26	49035-384	HUMAN OTC DRUG	Equate Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120829		ANDA	ANDA091135	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-385_755c1523-7774-4a82-862a-ee4cb16195b9	49035-385	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20200901		OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	100	mg/1			N	20241231
49035-387_f502c4e0-a47d-4428-b6e3-a1a3767299e2	49035-387	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201001	20241001	ANDA	ANDA079216	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
49035-388_19d53811-19a4-47f0-bfd9-e7f133af4844	49035-388	HUMAN OTC DRUG	Equate Nasal		Oxymetazoline HCl	SPRAY	NASAL	20070727		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
49035-389_0d2940ee-e127-56cc-e063-6394a90aaa51	49035-389	HUMAN OTC DRUG	Equate Restore Plus Lubricant Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20200304		OTC MONOGRAPH DRUG	M018	Walmart, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
49035-390_7a072487-f5a3-4585-ba51-1371355a37fd	49035-390	HUMAN OTC DRUG	Menstrual Complete	Maximum Strength	Acetaminophen, Caffeine and Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
49035-391_69e2fa4a-aa0d-4d53-ac4d-7d6fe7bfaf85	49035-391	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201001	20241001	ANDA	ANDA079219	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
49035-395_44b77f8e-dd0d-48fc-b358-273287f6148c	49035-395	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20161130	20250328	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49035-396_d7da749a-a780-d5b0-3f09-05d3c661aa72	49035-396	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20111104		ANDA	ANDA077367	Walmart Stores Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f	49035-397	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium 20.6mg Capsules	CAPSULE, DELAYED RELEASE	ORAL	20100115		ANDA	ANDA078878	Wal-Mart Stores Inc	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-402_0ce5624e-220b-3882-e063-6294a90a1827	49035-402	HUMAN OTC DRUG	Calaclear		Pramoxine Hydrochloride and Zinc Acetate	LOTION	TOPICAL	20180103		OTC MONOGRAPH DRUG	M016	Wal-Mart Stores, Inc.	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-403_1e22e2e1-1ece-43e8-a22c-bb92f17dc856	49035-403	HUMAN OTC DRUG	Less Drowsy Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20020624		OTC MONOGRAPH DRUG	M009	Wal-Mart Stores Inc	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
49035-404_6267de8a-45b2-3d63-b86d-bd2dd5cd2078	49035-404	HUMAN OTC DRUG	Ranitidine 150		Ranitidine Hydrochloride Tablets 150mg	TABLET, COATED	ORAL	20100105		ANDA	ANDA078192	Walmart Stores Inc.	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-408_db6e33b5-3867-498f-9c82-c9d47b3d683f	49035-408	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20161231	20250131	ANDA	ANDA078682	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
49035-411_c77bb311-5eed-4a6b-8f0f-09371f123e92	49035-411	HUMAN OTC DRUG	equate lansoprazole delayed release		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20140505		ANDA	ANDA202319	Wal-Mart Stores Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-413_0ce56647-4353-5868-e063-6294a90a8d19	49035-413	HUMAN OTC DRUG	Calamine		Calamine and Zinc Oxide	LOTION	TOPICAL	20171230		OTC MONOGRAPH DRUG	M016	Wal-Mart Stores, Inc.	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-415_0e9f41d4-a12e-44fc-8ae4-0953d2424551	49035-415	HUMAN OTC DRUG	equate nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20200404		ANDA	ANDA206394	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-417_adf0ca3e-d461-45da-93d8-5b8c9e58cfc8	49035-417	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20200103		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-418_d7cd84e5-deaf-4858-a6a1-869e4b0162d3	49035-418	HUMAN OTC DRUG	Ethyl alcohol		Ethyl alcohol	GEL	TOPICAL	20191203		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	62	mL/100mL			N	20241231
49035-420_6c4091aa-1442-4765-987d-1776a9e2a8d4	49035-420	HUMAN OTC DRUG	Ethyl alcohol		Ethyl alcohol	GEL	TOPICAL	20191203		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-421_f0308c07-301d-2752-e053-2995a90a09e0	49035-421	HUMAN OTC DRUG	Equate Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20110923		OTC MONOGRAPH FINAL	part343	Walmart	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49035-422_9da2afe4-d13e-48ec-8bdd-1d81fe5266c5	49035-422	HUMAN OTC DRUG	equate nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050308		ANDA	ANDA078326	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-426_e3bc779e-c779-45e1-b529-69d5848615e8	49035-426	HUMAN OTC DRUG	Equate tioconazole 1 day		Tioconazole	OINTMENT	VAGINAL	20071101		ANDA	ANDA075915	Wal-Mart Stores Inc	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49035-430_e3cef1db-322d-45e0-b39f-442af74ee5b7	49035-430	HUMAN OTC DRUG	Eye Allergy Relief		Pheniramine Maleate and Naphazoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20100831		NDA	NDA020065	Wal-Mart Stores Inc	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.2675; 3.15	mg/mL; mg/mL			N	20241231
49035-433_0e81794f-1ea5-48b7-96d0-743416670a92	49035-433	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin and Caffeine	TABLET, FILM COATED	ORAL	20080313		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
49035-435_8e5ba75b-b3df-4c37-b497-7effe721df59	49035-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150601		OTC MONOGRAPH FINAL	part355	Wal-Mart Stores, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
49035-436_0db43109-59fb-4f28-9599-39ff4ab24d45	49035-436	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210115	20250115	ANDA	ANDA207868	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
49035-438_4aa0be80-2147-4cf9-9fa7-c7648f0d1043	49035-438	HUMAN OTC DRUG	Ibuprofen	Dye-Free	Ibuprofen	TABLET, FILM COATED	ORAL	20040311		ANDA	ANDA075139	Wal-Mart Stores Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-442_16f04b46-f620-4177-b461-fae04037716b	49035-442	HUMAN OTC DRUG	equate Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	19900615		ANDA	ANDA091354	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-443_3afc9315-e1f3-404a-a99e-fd6fff236edd	49035-443	HUMAN OTC DRUG	Equate Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20160417		ANDA	ANDA078104	Wal-Mart Stores Inc	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-444_25269c5f-95f3-46f6-9901-ad3c4f08959a	49035-444	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20180619		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
49035-446_832828e3-4af3-4f19-b90f-5e9f099f3efa	49035-446	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
49035-448_d178bfb4-29d7-4299-9dd0-816d50f80f42	49035-448	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190719		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ALCOHOL	62	mg/mL			N	20241231
49035-451_996e00cf-bfa2-4ef0-ac11-2cbd8096ef88	49035-451	HUMAN OTC DRUG	Equate Loperamide Hydrochloride		loperamide HCl	SUSPENSION	ORAL	20180710		ANDA	ANDA091292	Wal-Mart Stores Inc	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
49035-454_c6a0c85b-af66-4c33-9a86-2d84850398a1	49035-454	HUMAN OTC DRUG	Artifical Tears		Glycerin and Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20100901		OTC MONOGRAPH FINAL	part349	Wal-Mart Stores Inc	GLYCERIN; PROPYLENE GLYCOL	3; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
49035-455_a631e032-2823-473c-b5ef-ffc3ad0f48ed	49035-455	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN	160	mg/1			N	20241231
49035-456_bf4d0ded-4b84-4b28-9ba5-cf331e172cbc	49035-456	HUMAN OTC DRUG	Equate Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20070509		ANDA	ANDA076777	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-458_ba95cf48-677b-4c03-8091-dd6fe165674f	49035-458	HUMAN OTC DRUG	equate allergy relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080109		ANDA	ANDA078336	Wal-Mart Stores Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-461_d8d498cd-c2ba-4b5b-8fae-dbca31e3ee30	49035-461	HUMAN OTC DRUG	Mucus Relief Nighttime Congestion Cough	Maximum Strength	Acetaminophen Diphenhydramine HCI Phenylephrine HCI	LIQUID	ORAL	20180430	20250430	OTC MONOGRAPH DRUG	M012	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
49035-463_5e131b39-fe65-4b88-b003-0843cce43138	49035-463	HUMAN OTC DRUG	equate hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140523		OTC MONOGRAPH FINAL	part346	Wal-Mart Stores Inc	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-466_d0846d3b-0e3d-41d4-ab47-c42f7ec18378	49035-466	HUMAN OTC DRUG	Daytime Cold and Flu	Non drowsy	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-467_ecdf54e5-5606-45b1-991a-ec9361853c3f	49035-467	HUMAN OTC DRUG	equate aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20030319		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49035-470_f41e2b78-4eb2-63d6-e053-2995a90ab516	49035-470	HUMAN OTC DRUG	Equate Cool and Heat		Menthol, Methyl salicylate	CREAM	TOPICAL	20180917		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 300	mg/g; mg/g			N	20241231
49035-476_f154ff12-5049-4155-80b8-8ee7d5e59f53	49035-476	HUMAN OTC DRUG	equate daytime cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20190924		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-478_55b04bee-d821-4be2-b106-6988a8d41635	49035-478	HUMAN OTC DRUG	Severe Congestion and Sinus Relief	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20180430		OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-483_f0feada3-d253-2da9-e053-2a95a90a178e	49035-483	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190101		NDA	NDA021855	Wal-Mart Stores, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
49035-486_12d98939-7eb0-4aba-8f58-850d91fda142	49035-486	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ALCOHOL	62	mL/100mL			N	20241231
49035-487_25293f0d-fde1-4bf4-b7b7-12a1bebe57f9	49035-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160331	20250331	OTC MONOGRAPH FINAL	part347	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
49035-491_33bca576-5b63-4edc-839c-abfcb427b2ac	49035-491	HUMAN OTC DRUG	Pain Reliever	Regular Strength	Acetaminophen	TABLET	ORAL	20151031	20250131	OTC MONOGRAPH NOT FINAL	part343	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN	325	mg/1			N	
49035-492_c76c65f1-9704-ec0a-015e-e4333bc34dad	49035-492	HUMAN OTC DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET, COATED	ORAL	20190726		ANDA	ANDA210375	Wal-Mart Stores Inc	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-493_5f950d46-eb21-4d1f-8391-bb07a85caf5b	49035-493	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20210115		ANDA	ANDA207868	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-494_492c57f6-bff2-4d15-83a1-94c9e8c282bb	49035-494	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20140501	20250131	OTC MONOGRAPH NOT FINAL	part343	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN	500	mg/1			N	
49035-495_ea265dfa-115f-4f26-8d44-205c74a28e95	49035-495	HUMAN OTC DRUG	Equate Beauty Daily Moisturizer SPF-30	Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20190709		OTC MONOGRAPH FINAL	part352	Walmart, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 30; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-496_3da7bd55-05dc-4e8c-b2c2-9f7451af4e07	49035-496	HUMAN OTC DRUG	Daily Baby		Dimethicone	LOTION	TOPICAL	20160428		OTC MONOGRAPH FINAL	part347	Wal-Mart	DIMETHICONE	12.12	mg/mL	Skin Barrier Activity [PE]		N	20241231
49035-497_fb82bef6-4386-4816-b613-fed8f72a032f	49035-497	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20110831		OTC MONOGRAPH FINAL	part358H	Wal-Mart	COAL TAR	1	g/100mL			N	20241231
49035-499_a25ac6a8-c431-41f2-bc7e-aa5f14b3bf9e	49035-499	HUMAN OTC DRUG	equate	Athletes Foot	Tolnaftate	CREAM	TOPICAL	20060217		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores Inc	TOLNAFTATE	10	mg/g			N	20241231
49035-504_8f2e210b-ed42-4ab0-94ac-1f2671875db3	49035-504	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCL	TABLET, COATED	ORAL	20191001		ANDA	ANDA204097	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-505_a61dc99a-794f-4c3d-be53-91ed96d70565	49035-505	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Wal-Mart Stores, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-506_6f470463-2d29-42e1-945a-bbf69fc31a8c	49035-506	HUMAN OTC DRUG	citroma		Magesium Citrate	LIQUID	ORAL	20190429		OTC MONOGRAPH NOT FINAL	part334	Walmart, Inc.,	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-507_1a2437e3-3c75-49ff-9b6f-8f181064b8b4	49035-507	HUMAN OTC DRUG	Equate Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160104		ANDA	ANDA075400	Wal-Mart Stores Inc	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-508_52e79cd0-d53f-4a80-9b55-a680f45a9685	49035-508	HUMAN OTC DRUG	equate sinus 12 hour		pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200624		ANDA	ANDA075153	Wal-Mart Stores Inc	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
49035-510_f7e8a5a9-b5e2-452b-adf4-0b5a5e025e56	49035-510	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20170807		OTC MONOGRAPH FINAL	part333B	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
49035-512_43c699c4-a278-4ac7-a705-18ea03c16248	49035-512	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Ice Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20161001	20240726	ANDA	ANDA204794	EQUATE (Wal-Mart Stores, Inc.)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
49035-514_61bfaaf0-aa8f-4f3c-962d-37546a9e9281	49035-514	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20210131	20251231	OTC MONOGRAPH NOT FINAL	part343	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN	500	mg/1			N	
49035-517_93225c7f-2084-413c-87b4-380340d54119	49035-517	HUMAN OTC DRUG	Equate Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160302		ANDA	ANDA077349	Wal-Mart Stores Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-518_e142cf87-9b6f-4970-8f5e-4a2660f25d87	49035-518	HUMAN OTC DRUG	White Petrolatum		White Petrolatum	JELLY	TOPICAL	20090512		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores, Inc.	PETROLATUM	100	g/100g			N	20241231
49035-521_6c61a167-d7fe-49a1-ad04-596a1c2bae7e	49035-521	HUMAN OTC DRUG	equate ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20111025		ANDA	ANDA076359	Wal-Mart Stores Inc	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-523_63deb9a0-e0f0-4159-8d0e-d8fdfba91c47	49035-523	HUMAN OTC DRUG	Equate Acetaminophen		Acetaminophen	TABLET	ORAL	19890915		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	325	mg/1			N	20241231
49035-524_b51250d0-b684-4fa4-9f02-11cf31955d4c	49035-524	HUMAN OTC DRUG	equate childrens multi symptom cold		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20200810		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-526_0a1fa935-1baf-4e2c-bcd6-31eed8731921	49035-526	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210131		OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	100	mg/1			N	20241231
49035-527_2c06270c-1bee-4803-8653-d240246fb629	49035-527	HUMAN OTC DRUG	Sinus Congestion and Pain	Severe	Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-528_0d295927-09c7-5b68-e063-6394a90a965f	49035-528	HUMAN OTC DRUG	Equate Lubricant Eye Drops		Polyethylene glycol 400, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190709		OTC MONOGRAPH DRUG	M018	Wal-Mart Stores, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
49035-531_b675f6b8-633e-44e1-9889-62bd90d501d0	49035-531	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	20051211		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN	500	mg/1			N	20241231
49035-532_6769030c-76cc-4681-bf56-be820961e6db	49035-532	HUMAN OTC DRUG	Equate nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20070509		ANDA	ANDA076779	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-534_432a7e34-3a1d-4b7f-97bb-0db2743daa03	49035-534	HUMAN OTC DRUG	Equate Medicated Dandruff	Anti-Dandruff	Selenium Sulfide	SHAMPOO	TOPICAL	20181217		OTC MONOGRAPH FINAL	part358H	Wal-Mart Stores, Inc.	SELENIUM SULFIDE	10	mg/mL			N	20241231
49035-535_f19e44c8-fb9c-57a7-e053-2a95a90afd7a	49035-535	HUMAN OTC DRUG	Equate Anticavity Oral Rinse		Fluoride	LIQUID	ORAL	20170105		OTC MONOGRAPH FINAL	part355	Wal-Mart Stores, Inc.	SODIUM FLUORIDE	.021	g/mL			N	20241231
49035-536_f19e3ed9-e98e-0b9b-e053-2995a90a5d92	49035-536	HUMAN OTC DRUG	Equate Tartar Control Plus		Eucalyptol, Menthol, Methyl Salicylate, Thymol	LIQUID	ORAL	20170105		OTC MONOGRAPH NOT FINAL	part356	Wal-Mart Stores, Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.092; .042; .06; .064	g/mL; g/mL; g/mL; g/mL			N	20241231
49035-538_6ee5b7e9-711d-4d18-9cea-09a4d19d4332	49035-538	HUMAN OTC DRUG	Childrens Allergy		Loratadine	SOLUTION	ORAL	20161208		ANDA	ANDA201865	Wal-Mart Stores Inc	LORATADINE	5	mg/5mL			N	20241231
49035-542_fc0ae3ea-8ac8-4a76-b117-46286b99534f	49035-542	HUMAN OTC DRUG	Cold and Flu	Daytime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20181215	20241227	OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49035-543_967a022c-a577-4725-b656-923498c0352d	49035-543	HUMAN OTC DRUG	Severe Allergy Plus Sinus Headache		Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20070627		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-545_8172142f-4181-44c8-9624-1819274ab2fd	49035-545	HUMAN OTC DRUG	Nighttime Childrens Multi Symptoms	Cold and Cough Multi-Symptom Relief	Chlorpheniramine maleate and Dextromethorphan Hydrobromide	SOLUTION	ORAL	20200330		OTC MONOGRAPH DRUG	M012	WAL-MART STORES,INC.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/15mL; mg/15mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-546_31398a41-4713-44d6-9a03-8db9e5165d0b	49035-546	HUMAN OTC DRUG	Equate Acid Reducer Complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20080808		ANDA	ANDA077355	Wal-Mart Stores Inc	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-549_bab62830-ed57-4b2c-8d90-3dec10dbaa60	49035-549	HUMAN OTC DRUG	equate anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181230		ANDA	ANDA209837	Wal-Mart Stores Inc	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
49035-553_638704c1-cbea-4893-bf46-f2e6e75a2f17	49035-553	HUMAN OTC DRUG	Equate Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20130813		ANDA	ANDA072096	Wal-Mart Stores Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-558_4ab4314e-ac81-4c34-a368-36582f53e360	49035-558	HUMAN OTC DRUG	Sinus Congestion and Pain	Daytime	Acetaminophen and Phenylephrine HCl	TABLET	ORAL	20080317	20251231	OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49035-563_f00f392e-564c-4984-be66-9c972c197a0b	49035-563	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49035-564_cebc37a2-360a-e68d-e053-2a95a90a2ab8	49035-564	HUMAN OTC DRUG	Equate ZIinc Sunscreen ULTRA Broad Spectrum		Octinoxate, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190220		OTC MONOGRAPH NOT FINAL	part352	Walmart Stores Inc.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	40; 50; 91	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-566_f114cece-5d87-360c-e053-2a95a90ab3cc	49035-566	HUMAN OTC DRUG	Sunscreen ULTRA Broad Spectrum	Equate	Avobenzone Homosalate Octisalate Octocrylene	LOTION	TOPICAL	20190221		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-569_f2f22e2d-ba00-d9a5-e053-2a95a90ab970	49035-569	HUMAN OTC DRUG	4X Medicated Toothache and Gum Gel		Benzocaine	GEL	ORAL	20200518		OTC MONOGRAPH NOT FINAL	part356	Walmart	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL; ZINC CHLORIDE	.13; 20; .5; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
49035-575_c6b3112a-a2cb-fd98-e053-2995a90aef66	49035-575	HUMAN OTC DRUG	Equate Daily Moisturizing Dimethicone Skin Protectant		Dimethicone	LOTION	TOPICAL	20190207		OTC MONOGRAPH FINAL	part347	Walmart Stores Inc.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
49035-576_475da1ae-556b-43c7-ba75-73cd403bd3d3	49035-576	HUMAN OTC DRUG	Oral Antivavity		Sodium fluoride	MOUTHWASH	ORAL	20150108		OTC MONOGRAPH FINAL	part355	Wal-Mart Stores, Inc	SODIUM FLUORIDE	10.41	mg/mL			N	20241231
49035-581_048e1eed-83ea-4fef-b4ab-c2509c40253e	49035-581	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20160925		OTC MONOGRAPH FINAL	part355	Wal-Mart Stores, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
49035-582_a0028c55-a5fd-4ad5-b895-cfa92bb97662	49035-582	HUMAN OTC DRUG	equate vitamins a and d		Lanolin, Petrolatum	OINTMENT	TOPICAL	20050629		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores Inc	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
49035-583_005e7f3d-55d0-48e3-809c-113e709184fc	49035-583	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20170818		OTC MONOGRAPH FINAL	part332	Wal-Mart Stores Inc	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
49035-584_786ad1ac-0c46-4f74-afad-3d3958c34440	49035-584	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20180131	20250131	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	100	mg/1			N	
49035-585_a1c5ded6-8796-4f12-820f-0177c281506c	49035-585	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20171024		OTC MONOGRAPH FINAL	part332	Wal-Mart Stores Inc	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
49035-586_972cbbbf-97de-4814-805f-793bc8ff93e5	49035-586	HUMAN OTC DRUG	Day Severe Cold and Night Cold and Flu	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20180131		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores, Inc.						N	20241231
49035-587_422cbae2-ca60-4a0a-a63d-9016ca40c3c3	49035-587	HUMAN OTC DRUG	Day and Night Sinus Relief	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20180131		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores, Inc.						N	20241231
49035-588_c8ad60e2-f392-9d3b-e053-2a95a90a2135	49035-588	HUMAN OTC DRUG	Itch and Bite Relief First Aid Kit		Hydrocortisone and Diphenhydramine Hydrochloride	KIT		20191030	20250312	OTC MONOGRAPH NOT FINAL	part348	WAL-MART STORES, INC.						N	
49035-589_cf5fa8a1-32c4-4e85-a4a9-a9cf1f55654c	49035-589	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20200624		ANDA	ANDA206531	Wal-Mart Stores, Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-592_ee71cb44-834b-489a-af33-483d63b9ed80	49035-592	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20190506		OTC MONOGRAPH NOT FINAL	part334	Walmart Inc.,	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-593_b56239e1-8071-4460-b94b-04b5e332febf	49035-593	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20190501		OTC MONOGRAPH NOT FINAL	part334	Wal-Mart Stores, Inc.,	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-596_1f91d82f-4ebe-4d95-9239-b8968950e5c0	49035-596	HUMAN OTC DRUG	Childrens Stomach Relief		calcium carbonate	TABLET, CHEWABLE	ORAL	20190701		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores Inc	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-598_b1c5d520-aef8-4ac9-b9cd-578179b22d65	49035-598	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228	20240426	ANDA	ANDA078682	EQUATE (Wal-Mart Stores, Inc.)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
49035-599_a064d863-9243-4fe5-b7b1-5dbf6683627e	49035-599	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20110425		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-600_464b3e42-7db7-42d5-970b-a0bdf5f22350	49035-600	HUMAN OTC DRUG	Dye Free Childrens Allergy Relief		Diphenhydramine hydrochloride	SOLUTION	ORAL	20200309		OTC MONOGRAPH DRUG	M012	WAL-MART STORES INC.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-601_3252d5dd-78ff-43b1-bc6c-7c12f523da81	49035-601	HUMAN OTC DRUG	parents choice infants ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20170712		ANDA	ANDA075217	Wal-Mart Stores Inc	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-602_0e675be5-d7a9-4178-a794-4bcb03f7eec1	49035-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20190311		OTC MONOGRAPH NOT FINAL	part334	Walmart, Inc	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-604_57f3f4ce-6109-49a8-a369-5b87eaba74b5	49035-604	HUMAN OTC DRUG	equate ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19891015		ANDA	ANDA072096	Wal-Mart Stores Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-609_551679d6-6a72-431a-8152-98421549af2a	49035-609	HUMAN OTC DRUG	equate nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	SOLUTION	ORAL	20191021		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-611_5603d5e1-8d95-44b9-aceb-4bc37b162ab1	49035-611	HUMAN OTC DRUG	equate childrens allergy		Loratadine	SOLUTION	ORAL	20180622		ANDA	ANDA075728	Wal-Mart Stores Inc	LORATADINE	5	mg/5mL			N	20241231
49035-612_ee35ff28-273b-4264-bef1-4a759d86a8be	49035-612	HUMAN OTC DRUG	equate allergy relief		Loratadine	TABLET	ORAL	20070427		ANDA	ANDA076301	Wal-Mart Stores Inc	LORATADINE	10	mg/1			N	20241231
49035-613_eaa13062-d5ee-4267-aee0-4ed20c9429f4	49035-613	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20161001	20240726	ANDA	ANDA204833	EQUATE (Wal-Mart Stores, Inc.)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
49035-619_a5c52c41-a749-495d-8814-5275d89f88ff	49035-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20100222		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores, Inc	DIMETHICONE	13.13	mg/mL	Skin Barrier Activity [PE]		N	20241231
49035-622_0f95d05b-3fa0-4d5a-a0d1-550adbf51dcc	49035-622	HUMAN OTC DRUG	Equate Anti Itch		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20050629		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-623_fc6a8bc7-27b6-46b7-8f44-aab2ee55006b	49035-623	HUMAN OTC DRUG	Equate Childrens Multi symptom Cold Nighttime		Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20170801		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-625_0ce57040-019c-0c43-e063-6394a90a52eb	49035-625	HUMAN OTC DRUG	Equate Itch Relief Gel		Itch Relief Gel	GEL	TOPICAL	20181220		OTC MONOGRAPH DRUG	M017	Walmart, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	2	mg/100mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-626_44e76a5d-70ee-472e-8ddd-bacb1e2251bd	49035-626	HUMAN OTC DRUG	equate first aid antibiotic pain relieving		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20170324		OTC MONOGRAPH FINAL	part333B	Wal-Mart Stores Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49035-628_c87f4160-b0ab-479c-bd2d-d24a68e82004	49035-628	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160914		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
49035-629_f11825f9-c629-a954-e053-2995a90a81be	49035-629	HUMAN OTC DRUG	Equate Beauty Ultra Light Sunscreen SPF70	Broad spectrum	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20131126		OTC MONOGRAPH NOT FINAL	part352	WALMART STORES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-630_c6b3388d-443d-9d2e-e053-2a95a90a75b9	49035-630	HUMAN OTC DRUG	Equate Beauty	Ultra Light SPF 100	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151216		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-631_5c407220-d772-4c47-9427-442fcdd837e2	49035-631	HUMAN OTC DRUG	equate lice treatment kit		piperonyl butoxide, pyrethrum extract	KIT		20180831		OTC MONOGRAPH FINAL	part358G	Wal-Mart Stores Inc						N	20241231
49035-632_c6a4a336-faf8-66a4-e053-2a95a90a956f	49035-632	HUMAN OTC DRUG	Equate Sunscreen Mineral Broadspectrum SPF 50 BABY ZINC		Zinc Oxide	LOTION	TOPICAL	20171213		OTC MONOGRAPH NOT FINAL	part352	Walmart	ZINC OXIDE	216	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-633_c2900edd-6d8d-4997-b921-e527c8528394	49035-633	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20161221		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.,	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
49035-634_0ce5731a-7e1f-654e-e063-6294a90a2b5c	49035-634	HUMAN OTC DRUG	Equate Pain Relief Cream		4% Lidocaine HCl	LIQUID	TOPICAL	20181221		OTC MONOGRAPH DRUG	M017	Walmart, Inc	LIDOCAINE HYDROCHLORIDE	4	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49035-635_ad449225-ed60-4c66-9fd6-34bef9a4b42e	49035-635	HUMAN OTC DRUG	Concentrated ibuprofen infants		Ibuprofen	SUSPENSION/ DROPS	ORAL	20190620		ANDA	ANDA210755	Wal-Mart Stores, Inc.	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-636_091c024a-c65c-209a-e063-6394a90a749f	49035-636	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20140801		OTC MONOGRAPH DRUG	M007	Wal-Mart Stores, Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-638_091be2dc-5225-f35e-e063-6394a90a8b34	49035-638	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID CHERRY		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	20140901		OTC MONOGRAPH DRUG	M001	WAL-MART STORES, INC.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-642_da650c10-3037-424d-91b5-a40dce3f91e0	49035-642	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20190331	20250331	OTC MONOGRAPH FINAL	part335	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
49035-643_28b88cc1-55cc-4478-944f-cad80d654393	49035-643	HUMAN OTC DRUG	equate allergy and congestion relief		loratadine, pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200724		ANDA	ANDA076050	Wal-Mart Stores Inc	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
49035-647_31e0f074-cbf1-4762-91df-326d9642b533	49035-647	HUMAN OTC DRUG	equate ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19890915		ANDA	ANDA072096	Wal-Mart Stores Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-648_29bc3e37-3849-4036-b7da-6542255dc392	49035-648	HUMAN OTC DRUG	Equate Nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20020724		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-649_091b907f-544f-86c9-e063-6294a90a5d87	49035-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20110801		OTC MONOGRAPH DRUG	M007	Wal-Mart Stores, Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-650_820ac09a-1026-4a27-a9eb-5c6420ef52b1	49035-650	HUMAN OTC DRUG	Equate Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20070502		ANDA	ANDA077351	Wal-Mart Stores Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-651_5e26c390-36a6-4866-b837-198263a3529a	49035-651	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH FINAL	part344	Wal-Mart Stores, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
49035-653_3dd68f3b-b4c6-469e-8a5d-71e5615c8dc4	49035-653	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20190308		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores, Inc.	WITCH HAZEL	860	mg/mL			N	20241231
49035-657_6be3d3c3-8bb2-033a-e053-2a91aa0a3046	49035-657	HUMAN OTC DRUG	Equate Restore Plus Lubricant Eye		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20130905		OTC MONOGRAPH FINAL	part349	Wal-Mart Stores Inc.	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
49035-660_4360205c-32dd-4b39-85c4-b5e2ded1234e	49035-660	HUMAN OTC DRUG	equate ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20100819		ANDA	ANDA074937	Wal-Mart Stores Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-662_853828a8-924b-4221-989d-d9008b5d8867	49035-662	HUMAN OTC DRUG	Isopropyl		Isopropyl Alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
49035-664_031b2b80-f489-46e2-8c0a-91e7b0d318da	49035-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19920915		OTC MONOGRAPH NOT FINAL	part356	Wal-Mart Stores, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-666_689936ec-e0db-487b-8f49-a8daf2f26a66	49035-666	HUMAN OTC DRUG	Quick Action		Salicylic acid	SWAB	TOPICAL	20160621		OTC MONOGRAPH FINAL	part333D	Equate	SALICYLIC ACID	2	g/100mL			N	20241231
49035-670_f0ea4f2d-a5ea-374f-e053-2995a90a5d27	49035-670	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190401		ANDA	ANDA090397	Wal-Mart Stores, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-672_8399ba24-f1c0-452e-88e1-5035f0bb254f	49035-672	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20150724		OTC MONOGRAPH DRUG	M010	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-673_cbe817f6-21b2-42c3-9f49-65ee717519f2	49035-673	HUMAN OTC DRUG	Equate Arnica Pain Relieving		ARNICA MONTANA WHOLE	GEL	TOPICAL	20200430		UNAPPROVED HOMEOPATHIC		Walmart, Inc.	ARNICA MONTANA WHOLE	70	mg/g			N	20241231
49035-674_0bde7bd2-8a63-57b4-e063-6394a90a00d2	49035-674	HUMAN OTC DRUG	Maximum Strength Non Drowsy Day and Night Cold and Flu		Maximum Strength Non Drowsy Day and Night Cold and Flu	KIT		20201116		OTC MONOGRAPH DRUG	M012	WAL-MART STORES INC						N	20241231
49035-675_8f854387-8040-4a28-8af3-c20ec13efe10	49035-675	HUMAN OTC DRUG	EZ Nite Sleep Aid		Diphenhydramine HCl	LIQUID	ORAL	20151031	20250131	OTC MONOGRAPH FINAL	part338	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49035-681_091bb1ac-aa8d-a8f5-e063-6394a90af9b3	49035-681	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20110501		OTC MONOGRAPH DRUG	M001	WAL-MART STORES, INC.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-683_f9170863-5682-45b8-85c0-9a5b3d7cb1ec	49035-683	HUMAN OTC DRUG	Equate Green Apple 2 in 1 Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20181217		OTC MONOGRAPH DRUG	M032	Walmart Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-684_4b03aa7c-0aca-4a33-b6d3-1b378b38a230	49035-684	HUMAN OTC DRUG	equate ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20201229		ANDA	ANDA202312	Wal-Mart Stores Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-690_edf16e0b-3836-4133-a260-777f8024c9e7	49035-690	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ALCOHOL	62	mL/100mL			N	20241231
49035-691_debf024e-926d-408a-a132-a96e0bb7ad2e	49035-691	HUMAN OTC DRUG	70% Isopropyl Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
49035-693_0a949868-ae85-42fa-b1f1-1c2c155fb00d	49035-693	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170627		ANDA	ANDA209207	EQUATE (WAL-MART STORES, INC.)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-694_20bd775a-f4a0-45f2-ba4e-0e8ade824233	49035-694	HUMAN OTC DRUG	Ethyl alcohol		Ethyl alcohol	GEL	TOPICAL	20200103		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-695_c9488849-349f-4ce9-a2a6-d2140f80c094	49035-695	HUMAN OTC DRUG	equate diarrhea control		Loperamide HCl	SUSPENSION	ORAL	20200903		ANDA	ANDA091292	Wal-Mart Stores Inc	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
49035-696_8b3c2a18-590e-4edb-a326-cfa1729780c2	49035-696	HUMAN OTC DRUG	Ethyl alcohol		Ethyl alcohol	GEL	TOPICAL	20200207		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-697_9e1e7a09-d3dc-4d32-a3e3-be257fcfe5a4	49035-697	HUMAN OTC DRUG	equate nighttime vapor ice cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20191007		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-699_55abb369-e555-4465-877e-bfbca34e394c	49035-699	HUMAN OTC DRUG	equate ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20090415		ANDA	ANDA079113	Wal-Mart Stores Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-700_f41e24f9-c4c6-5500-e053-2995a90ad4c6	49035-700	HUMAN OTC DRUG	Equate Pain Relieving	Ultra Strength	Camphor, Menthol, Methyl salicylate	CREAM	TOPICAL	20110613		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
49035-702_8038fc3a-3ff9-4ab6-8717-1abfae0518a5	49035-702	HUMAN OTC DRUG	Equate Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20161007		ANDA	ANDA090821	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-703_63a55221-ee51-c24c-7f01-a4abc84ed770	49035-703	HUMAN OTC DRUG	Budesonide		Budesonide	SPRAY, METERED	NASAL	20160822		ANDA	ANDA078949	Walmart	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-704_3864c1de-a394-45c9-abfe-f86610f9c4d8	49035-704	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20190318		OTC MONOGRAPH DRUG	M010	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-705_30b6744e-f1d1-4ed6-8ada-7a4177e76849	49035-705	HUMAN OTC DRUG	equate adult tussin dm max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20181002		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-706_b7fd9d59-1a55-446b-9ff9-1c459cad56eb	49035-706	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20191217		OTC MONOGRAPH DRUG	505G(a)(3)	Wal-Mart Stores Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-707_0aceaaaa-08d7-4816-ac08-bee323c4b541	49035-707	HUMAN OTC DRUG	equate hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20120313		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-708_4eda6b4b-af6b-43f1-bbf2-454f40270517	49035-708	HUMAN OTC DRUG	equate vapor ice cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20200714		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-709_2c51d17d-58bc-4429-802f-4053753ee356	49035-709	HUMAN OTC DRUG	Infants Gas Relief Drops		Simethicone	EMULSION	ORAL	20171016		OTC MONOGRAPH DRUG	M002	Wal-Mart Stores,Inc.,	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
49035-710_67183d9e-3831-445a-82d0-34ef417b30f8	49035-710	HUMAN OTC DRUG	dishwashing		chloroxylenol	LIQUID	TOPICAL	20170114		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores Inc.,	CHLOROXYLENOL	3	mg/mL			N	20241231
49035-711_9f33c33a-1eb1-4c3b-97b0-a77d181d6ba9	49035-711	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20160531	20240126	NDA	NDA022429	EQUATE (Wal-Mart Stores, Inc.)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49035-712_6eb98daf-a324-4f9c-ba0b-8f3f09bb2d6a	49035-712	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.,	ALCOHOL	620	mg/mL			N	20241231
49035-713_6fc0bf8a-7726-4a11-b635-116eb0412ace	49035-713	HUMAN OTC DRUG	dishwashing		chloroxylenol	LIQUID	TOPICAL	20170114		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores Inc.,	CHLOROXYLENOL	3.09	mg/mL			N	20241231
49035-714_9039613b-7d21-4656-b830-19be81d76c76	49035-714	HUMAN OTC DRUG	Equate Daytime Nighttime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20200318		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc						N	20241231
49035-715_84c9df98-894c-432b-86b6-c03506eb14d5	49035-715	HUMAN OTC DRUG	Childrens Multi-symptom Cold		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141001		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-716_eb420354-f305-4be1-bf99-9a715027591f	49035-716	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20180226		ANDA	ANDA074916	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-717_3a0a9d45-d4be-452b-a617-5c65fa3900c9	49035-717	HUMAN OTC DRUG	Hemorrhoid Relief Cream		Lidocaine	CREAM	TOPICAL	20190430		OTC MONOGRAPH DRUG	M015	Wal-Mart Stores Inc	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49035-718_aae76b2a-8aa3-4a72-82cf-59920c6f4aab	49035-718	HUMAN OTC DRUG	equate daytime cold and flu nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20200421		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc						N	20241231
49035-720_333b6afd-baeb-4c33-85c5-c8585a7c67fb	49035-720	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.,	ALCOHOL	620	mg/mL			N	20241231
49035-725_e2c76f0b-8a4f-4f12-b652-9a5fa565e22d	49035-725	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20200201		OTC MONOGRAPH FINAL	part335	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
49035-726_022ecd99-7387-4458-9912-2107df6d4165	49035-726	HUMAN OTC DRUG	equate daytime cold and flu		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	SOLUTION	ORAL	20190924		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-727_4fe532c4-c665-4fd5-ab20-e4131029baf8	49035-727	HUMAN OTC DRUG	equate all night pain relief		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20200420		ANDA	ANDA208499	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-728_16f47f5c-76cd-43a3-bfac-7a9a66a24aa9	49035-728	HUMAN OTC DRUG	Equate Everyday Clean 2 in 1 Dandruff SH and COND	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20190131		OTC MONOGRAPH DRUG	M032	Walmart Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
49035-730_f529b113-8fe9-4694-bafd-a0c2177a391f	49035-730	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20080303	20240303	ANDA	ANDA074164	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
49035-731_cc4f0b8d-f084-473e-94ed-dd682d14b2f1	49035-731	HUMAN OTC DRUG	Miconazole 3 Combination Pack		Miconazole Nitrate	KIT		20070611	20250611	ANDA	ANDA074926	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)						N	
49035-732_fa1f0735-d3d6-46d2-8f81-0e1d3562366d	49035-732	HUMAN OTC DRUG	Hydrocortisone anti-itch plus		Hydrocortisone	CREAM	TOPICAL	20100601		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-733_3f71bea6-96d8-4b10-bcca-b67276a2c17e	49035-733	HUMAN OTC DRUG	Equate NiteTime DayTime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20130815		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc						N	20241231
49035-734_9e477213-5437-4b15-b165-24bc7c50520e	49035-734	HUMAN OTC DRUG	Equate Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130214		ANDA	ANDA203690	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-736_94a5fb9b-5130-48c1-9a86-d30d5a90e222	49035-736	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCL	CAPSULE	ORAL	20200131		OTC MONOGRAPH FINAL	part338	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-739_3a306bc1-5faa-c59d-6725-652b1ed8638a	49035-739	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120518		ANDA	ANDA202194	Wal-Mart Stores Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-740_c587536f-dce1-46b9-aa5c-a81e1f3a4f12	49035-740	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20180705		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-741_04101ff0-48de-44b8-9aa4-680a0346b64a	49035-741	HUMAN OTC DRUG	Equate 8HR Arthritis Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160718		ANDA	ANDA075077	Wal-Mart Stores Inc	ACETAMINOPHEN	650	mg/1			N	20241231
49035-744_3c39059f-d90a-42ad-b1f6-dcc156701d98	49035-744	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20181215	20241227	OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)						N	
49035-745_002eacd4-9581-472a-a667-c7f85659b20a	49035-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180331	20250331	ANDA	ANDA206568	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
49035-746_9733338f-e914-4c9b-bb11-e040f792e8aa	49035-746	HUMAN OTC DRUG	equate hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20210914		ANDA	ANDA075598	Wal-Mart Stores Inc	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
49035-747_8e3ac4e6-8615-4484-a81c-f9fed24d9591	49035-747	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20180705		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-748_a111bf65-174b-455e-b192-19c16882f5d4	49035-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-750_e0e849e4-108c-4edf-b286-a8384dc236e5	49035-750	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.,	ALCOHOL	620	mg/mL			N	20241231
49035-753_ec23b466-92c2-a8cf-e053-2995a90a9053	49035-753	HUMAN OTC DRUG	Equate	SPF 50 Ultra Zinc Sunscreen	Octocrylene, Zinc Oxide	LOTION	TOPICAL	20190812		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	OCTOCRYLENE; ZINC OXIDE	40; 50.2125	mg/mL; mg/mL			N	20241231
49035-754_9da7c5a1-6f58-4cce-a114-cf25f983d6fa	49035-754	HUMAN OTC DRUG	equate all day pain relief		naproxen sodium	TABLET, FILM COATED	ORAL	20181102		ANDA	ANDA074661	Wal-Mart Stores Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-755_9a163290-216e-bf74-e053-2995a90a7341	49035-755	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, COATED	ORAL	20200103		OTC MONOGRAPH NOT FINAL	part343	WAL-MART STORES INC	ACETAMINOPHEN	500	mg/1			N	20241231
49035-756_6bee7d2e-2ce7-4501-be40-6779e1ada70b	49035-756	HUMAN OTC DRUG	equate Fiber Therapy		Methylcellulose	TABLET	ORAL	20170830		OTC MONOGRAPH DRUG	M007	Wal-Mart Stores,Inc.,	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
49035-757_ec24568d-508b-af55-e053-2a95a90af5c6	49035-757	HUMAN OTC DRUG	Equate	SPF 50 Ultra Sunscreen Continuous	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190812		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
49035-759_ec252c89-6ee9-d521-e053-2a95a90aae9b	49035-759	HUMAN OTC DRUG	Equate	SPF 50 Ultra Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190604		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-760_ec25f956-0368-b449-e053-2995a90a657a	49035-760	HUMAN OTC DRUG	Equate	SPF 70 Ultra Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20190604		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-764_fe994701-5c84-4b79-ad39-300833eeb577	49035-764	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20181231	20251231	ANDA	ANDA204507	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49035-765_ec365186-0378-5ee0-e053-2995a90a9d6d	49035-765	HUMAN OTC DRUG	Equate	SPF 70 Ultra Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20190812		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49035-766_7e8d9f4d-9eb7-406b-b000-ecc45b09aa80	49035-766	HUMAN OTC DRUG	Parents Choice Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20170707		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
49035-767_dc7d2202-24b8-4fc6-b363-32f1f49ceded	49035-767	HUMAN OTC DRUG	equate all day pain relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20181024		ANDA	ANDA074661	Wal-Mart Stores Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-768_c0e35029-ea1b-7107-e053-2a95a90a020a	49035-768	HUMAN OTC DRUG	Equate Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20171102		OTC MONOGRAPH FINAL	part341	Walmart	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-769_825a8d68-9f19-425f-b0d1-694f8ecbceff	49035-769	HUMAN OTC DRUG	Anti-Diarrheal	Maximum Strength	Bismuth Subsalicylate	TABLET	ORAL	20200406		OTC MONOGRAPH DRUG	M008	Wal-Mart Stores Inc	BISMUTH SUBSALICYLATE	525	mg/1			N	20241231
49035-770_f41de0a9-e18a-86b5-e053-2995a90a8b2e	49035-770	HUMAN OTC DRUG	Equate Childrens Vaporizing		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20180901		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
49035-771_8cd65689-04f2-4229-81d6-63496f570938	49035-771	HUMAN OTC DRUG	Maximum Strength Mucus Relief Cold,Flu and Sore Throat		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin ,Phenylephrine HCL	LIQUID	ORAL	20170906		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores,Inc.,	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-772_7bf30c75-e867-4a2f-a481-702d7aa96c23	49035-772	HUMAN OTC DRUG	Childrens Multi-symptom Cold and Fever Liquid		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20170801		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-773_e9e83de6-534c-40fe-ba8d-d3070e655ff7	49035-773	HUMAN OTC DRUG	Childrens Cough		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20170801		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-774_127db33b-a3d4-4d37-88a6-bd4e00c2007b	49035-774	HUMAN OTC DRUG	Maximum Strength Mucus Relief Severe Congestion and Cough		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20180501		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores,Inc.,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-774_b6e472f6-8638-4ce1-9220-801227864d28	49035-774	HUMAN OTC DRUG	Maximum Strength Mucus Relief Severe Congestion and Cough		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20170808		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores,Inc.,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-775_5c0186cb-3520-4c4a-92d8-7ea6c4982f4b	49035-775	HUMAN OTC DRUG	Salicylic Acid		Astringent	LIQUID	TOPICAL	20170318		OTC MONOGRAPH FINAL	part333D	Wal-Mart	SALICYLIC ACID	5	mg/mL			N	20241231
49035-777_4474ebd1-1735-41b0-ba85-75c1bef11bc1	49035-777	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN	160	mg/1			N	20241231
49035-778_cdfe5c95-3f90-4620-a618-18bac0471c3e	49035-778	HUMAN OTC DRUG	Equate Ultra Stregth Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20170801		OTC MONOGRAPH FINAL	part331	Wal-Mart Stores, Inc.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
49035-779_1be819ac-2b8c-4c3d-9a91-2042e6c6c665	49035-779	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20180705		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-780_93573258-17ab-4a77-aca1-f25c4648155c	49035-780	HUMAN OTC DRUG	Sinus and Congestion	Non-Drowsy	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20200715		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
49035-782_3cba1faa-2084-e02f-2d7c-efbbeb587153	49035-782	HUMAN OTC DRUG	Nicotine	transdermal	Nicotine	KIT	TRANSDERMAL	20200130		NDA	NDA020076	Wal-mart Stores Inc						N	20241231
49035-784_f2bead8f-c5b4-3bef-9a4b-7b90f5b95994	49035-784	HUMAN OTC DRUG	Allergy Relief		Fexofenadine hydrochloride	TABLET	ORAL	20110413		ANDA	ANDA076502	Wal-Mart Stores, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-785_c67bef0a-432f-3c50-e053-2995a90a7b04	49035-785	HUMAN OTC DRUG	Equate Ultra Light Sunscreen MIST SPF70		Avobenzone Homosalate Octisalate Octocrylene Oxybenzone	SPRAY	TOPICAL	20160106		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49035-786_e30b82dc-0975-42e0-8a27-5ffa357f5779	49035-786	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20180228		OTC MONOGRAPH NOT FINAL	part343	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
49035-787_ec36d6a7-f2e0-24e5-e053-2a95a90aa11a	49035-787	HUMAN OTC DRUG	EQUATE Tanning Sunscreen Dry oil UVB Protection SPF10		Homosalate, Octisalate	SPRAY	TOPICAL	20190418		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	HOMOSALATE; OCTISALATE	70; 50	mg/g; mg/g			N	20241231
49035-788_d505ee00-21bb-55cc-e053-2a95a90aea04	49035-788	HUMAN OTC DRUG	EQUATE Sunburn relief with Aloe After Sun		Lidocaine	GEL	TOPICAL	20171108		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	LIDOCAINE	8	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49035-789_f05e60b3-7c62-7c87-e053-2a95a90a93bd	49035-789	HUMAN OTC DRUG	Equate Sunscreen SPORT SPF 100		Avobenzone Homosalate Octisalate Octocrylene Oxybenzone	LOTION	TOPICAL	20171108		OTC MONOGRAPH NOT FINAL	part352	Walmart Stores Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-791_f8a6c2f1-4557-4121-a2ae-92002ccbe3f2	49035-791	HUMAN OTC DRUG	equate nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190401		ANDA	ANDA203690	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-792_0c4746b2-71d3-4269-81a2-3fb341e0bedb	49035-792	HUMAN OTC DRUG	equate sinus and cold d		naproxen sodium, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200724		ANDA	ANDA076518	Wal-Mart Stores Inc	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
49035-793_d228464b-7469-e968-e053-2995a90aa27a	49035-793	HUMAN OTC DRUG	Equate Hemorrhoidal Medicated Wipes		Witch Hazel	CLOTH	TOPICAL	20100101		OTC MONOGRAPH FINAL	part346	Wal-Mart Stores, Inc.	WITCH HAZEL	.5	mg/mL			N	20241231
49035-795_b0794d48-eb8c-55c9-e053-2995a90a5b38	49035-795	HUMAN OTC DRUG	Maximum Strength Medicated Foot Powder		Medicated Foot Powder	POWDER	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part348	Walmart Stores Inc	MENTHOL	.1	g/g			N	20241231
49035-796_08e74a8d-8e8d-4cda-9adc-ea2ff4068353	49035-796	HUMAN OTC DRUG	Equate daytime severe vaporice cold and flu nighttime severe vapor ice cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20200714		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc						N	20241231
49035-797_ec39773f-8176-059b-e053-2995a90a1d71	49035-797	HUMAN OTC DRUG	Equate Sunscreen SPF 50 SPORT	Broad Spectrum	Avobenzone, Homosalate, Octisalate, Octocrylene.	LOTION	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-803_f9b198b9-7493-4f74-919a-d810cbe2dbfe	49035-803	HUMAN OTC DRUG	Ultra Strength Antacid	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190409		OTC MONOGRAPH DRUG	M001	WAL-MART STORES INC.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-804_1fb8f952-0ba5-40df-b0c6-9fe02ce1096f	49035-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
49035-806_709bec0b-3800-4fe1-96ae-2b100cbac13d	49035-806	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	Wal-Mart Stores, Inc.	LORATADINE	10	mg/1			N	20241231
49035-806_f4838dba-ad33-4f62-8544-6776be255229	49035-806	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	Wal-Mart Stores, Inc.	LORATADINE	10	mg/1			N	20241231
49035-807_2303048f-cfbe-412d-82e2-8673b2c12f02	49035-807	HUMAN OTC DRUG	equate nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20191001		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-808_cdb0ec30-d10b-426e-9f20-9afee86e00b8	49035-808	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	TABLET	ORAL	20180907	20240726	OTC MONOGRAPH FINAL	part338	EQUATE (Wal-Mart Stores, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49035-810_d92b4a3b-aa9b-4b0d-a4ec-5fbcb56380c6	49035-810	HUMAN OTC DRUG	Extra Strength Smooth Antacid		Antacid Tablets	TABLET, CHEWABLE	ORAL	20160315		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-810_f964dacd-083e-4346-9b8e-6c7e48c79aac	49035-810	HUMAN OTC DRUG	Extra Strength Smooth Antacid		Antacid Tablets	TABLET, CHEWABLE	ORAL	20170403		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-812_c677492b-7c56-412c-b62b-c2b9a65c22c8	49035-812	HUMAN OTC DRUG	Clotrimazole	Athletes Foot	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49035-813_ee8aceae-6874-4057-a964-6c03f7b2017c	49035-813	HUMAN OTC DRUG	equate vapor ice cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20200716		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-814_03b179c9-960b-38a6-e063-6394a90aff1a	49035-814	HUMAN OTC DRUG	Walmart		Isopropyl Alcohol	SWAB	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Walmart Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
49035-815_3e84b786-e5c6-4426-a3a6-c8d18df46970	49035-815	HUMAN OTC DRUG	equate Extra Strength Smooth Antacid	Assorted Berries	Antacid Tablets	TABLET, CHEWABLE	ORAL	20151028		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49035-817_364bbd4b-5074-4dbe-a2a7-3d94d6235ebd	49035-817	HUMAN OTC DRUG	Cold, Flu and Sore Throat	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20201022		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-819_f0cb138e-2a6f-4c75-a10f-214564487963	49035-819	HUMAN OTC DRUG	equate daytime vapor ice cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20191003		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-820_4c4930d7-ec4b-45eb-8706-d06523a0d198	49035-820	HUMAN OTC DRUG	Equate Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20060927		ANDA	ANDA075285	Wal-Mart Stores Inc	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49035-821_394e7fc6-aa59-4595-b4c4-6fceaad61112	49035-821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20150115		OTC MONOGRAPH FINAL	part333D	Wal-Mart Stores, Inc	SALICYLIC ACID	21	mg/mL			N	20241231
49035-822_b0786418-7b29-d316-e053-2995a90a3ab5	49035-822	HUMAN OTC DRUG	Medicated Body Extra Strength	Powder	MENTHOL 0.80%	POWDER	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part348	Walmart Stores Inc	MENTHOL	2.26	g/283g			N	20241231
49035-824_edba26a9-5636-4b1b-8971-52d3be8de257	49035-824	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20191129		ANDA	ANDA209692	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-825_b6f0d5d5-9371-4344-857a-42212866a507	49035-825	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20191129	20250425	ANDA	ANDA209692	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49035-826_a8611620-9ee9-47b7-90c8-7cc706643518	49035-826	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20170719		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ALCOHOL	62	mg/mL			N	20241231
49035-827_c7f55b5b-feb8-450d-90d6-0c7e26e8233e	49035-827	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20170719		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	ALCOHOL	63	mg/mL			N	20241231
49035-828_4321e115-efea-4e1c-b4a9-47c6b97bb6ae	49035-828	HUMAN OTC DRUG	Stool Softener Plus Stimulant Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20190228	20250228	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
49035-837_61f6ec19-fcd9-4dcb-84f7-a7f713b64515	49035-837	HUMAN OTC DRUG	Jock Itch	Clotrimazole Antifungal	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Walmart	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49035-838_969d0bb3-056f-4cce-aa08-07a05234dd05	49035-838	HUMAN OTC DRUG	Equate Scar	Topical	Allantoin	CREAM	TOPICAL	20181018		OTC MONOGRAPH FINAL	part347	Wal-Mart	ALLANTOIN	.005	mg/g			N	20241231
49035-839_97bacb8f-c672-40cd-9f9d-f2aced8c7283	49035-839	HUMAN OTC DRUG	Maximum Strength Mucus Relief DM		Dextromethorphan hydrobromide and Guaifenesin	LIQUID	ORAL	20180501		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores,Inc.,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-840_1162952f-3a6c-4414-b748-47480296f8dd	49035-840	HUMAN OTC DRUG	Equate First Aid Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	CREAM	TOPICAL	20181018		OTC MONOGRAPH FINAL	part333B	Wal-Mart	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49035-841_f925dad4-141f-4db7-add2-ea19435f7857	49035-841	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180331		ANDA	ANDA207235	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-843_ec39eb1f-22cc-6b32-e053-2995a90aef1b	49035-843	HUMAN OTC DRUG	Equate SUNSCREEN spf 50 SPORT	broadspectrum	Avobenzone,Homosalate,Octisalate,Octocrylene	SPRAY	TOPICAL	20190129		OTC MONOGRAPH NOT FINAL	part352	Walmart	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
49035-844_ec430169-d2c1-0741-e053-2995a90a7267	49035-844	HUMAN OTC DRUG	Equate Sunscreen SPF 70 SPORT	Broad spectrum	Avobenzone Homosalate Octisalate Octocrylene Oxybenzone	SPRAY	TOPICAL	20171108		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49035-845_c6a4b4e3-206b-b354-e053-2a95a90a88e0	49035-845	HUMAN OTC DRUG	Equate Sunscreen KIDS SPF50	Broad Spectrum	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
49035-846_e3de5415-5cbd-5d03-e053-2a95a90a9d93	49035-846	HUMAN OTC DRUG	Equate Sunscreen SPF 30 SPORT	Broad Spectrum	Avobenzone, Homosalate,Octisalate,Octocrylene	SPRAY	TOPICAL	20190128		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
49035-847_c848ec9e-68b7-4b8f-bd0d-0e49f3a2ab91	49035-847	HUMAN OTC DRUG	Equate Antibiotic Plus Pain Relief		Neomycin sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	CREAM	TOPICAL	20181018		OTC MONOGRAPH FINAL	part333B	WalMart	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49035-848_2f2c159f-95e5-45ec-9981-6e68a83385d0	49035-848	HUMAN OTC DRUG	Stool Softener	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190201	20250201	OTC MONOGRAPH NOT FINAL	part334	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DOCUSATE SODIUM	250	mg/1			N	
49035-849_ec4479f0-2dda-72b5-e053-2995a90aa7c1	49035-849	HUMAN OTC DRUG	Equate Sunscreen SPF70 ULTRA	Broad spectrum	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20171108		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49035-854_cb5005f0-ba07-495a-81d1-6142c9145fc3	49035-854	HUMAN OTC DRUG	Equate Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20081014		ANDA	ANDA078546	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-855_8d58ae2e-c3b7-4309-b3ae-07076d7165ae	49035-855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20160910		OTC MONOGRAPH NOT FINAL	part356	Wal-Mart Stores, Inc.,	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49035-857_c6791c59-bbd7-7294-e053-2a95a90ab019	49035-857	HUMAN OTC DRUG	Equate Sunscreen SPF100 SPORT	Broad Spectrum	Avobenzone Homosalate Octisalate Octocrylene Oxybenzone	SPRAY	TOPICAL	20190130		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49035-858_0f485898-4845-46ca-be51-a289dd648a73	49035-858	HUMAN OTC DRUG	Ibuprofen and Diphenhydramine HCl		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20180430	20240426	ANDA	ANDA200888	EQUATE (Wal-Mart Stores, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
49035-859_c72e227a-e28e-8eb9-e053-2a95a90a6ad7	49035-859	HUMAN OTC DRUG	Equate Beauty Ultra Light Sunscreen SPF 70		Avobenzone, Homosalate,Octisalate,Octocrylene,Oxybenzone	STICK	TOPICAL	20161206		OTC MONOGRAPH NOT FINAL	part352	Walmart Stores Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49035-860_f41e3c2b-9504-aa85-e053-2995a90a0bcc	49035-860	HUMAN OTC DRUG	Equate Pain Relieving Cream Lidocaine		Lidocaine	CREAM	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49035-861_f32cf2b1-c83b-a1a0-e053-2995a90a77cd	49035-861	HUMAN OTC DRUG	equate beauty Enamel Protection Gentle Whitening For Sensitive Teeth		potassium nitrate, sodium fluoride	PASTE	DENTAL	20181102		OTC MONOGRAPH NOT FINAL	part356	Wal-Mart Stores Inc	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
49035-862_28736548-09b6-4dcb-acdf-00ae56a6b3f4	49035-862	HUMAN OTC DRUG	Ear Wax Removal Drops	Equate	Carbamide Peroxide - 6.5%	SOLUTION/ DROPS	TOPICAL	20190301		OTC MONOGRAPH FINAL	part344	WALMART STORES INC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
49035-865_17ca31b4-0f66-4bf4-bb2d-da9a7fa4001a	49035-865	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190501	20250131	ANDA	ANDA206999	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
49035-866_f213d2cb-e135-48e6-9ddf-0524198e42f0	49035-866	HUMAN OTC DRUG	equate lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070708		OTC MONOGRAPH DRUG	M031	Wal-Mart Stores Inc	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
49035-868_c50c5c0b-5371-9d37-e053-2995a90a795c	49035-868	HUMAN OTC DRUG	Equate Sunscreen SPF 50 KIDS	Broad Spectrum	Titanium Dioxide, Zinc oxide	LOTION	TOPICAL	20190123		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC	TITANIUM DIOXIDE; ZINC OXIDE	31; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-869_f4b691ca-e06b-72dd-e053-2a95a90ab1b0	49035-869	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH NOT FINAL	part343	WAL-MART STORES INC	ACETAMINOPHEN	500	mg/1			N	20241231
49035-870_f94d5836-153b-f987-e053-6394a90afac6	49035-870	HUMAN OTC DRUG	Equate Menthol Pain Relieving		menthol	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	MENTHOL, UNSPECIFIED FORM	50	mg/1			N	20241231
49035-871_e33e987c-8a00-406b-ad2d-e1a4b8b3b404	49035-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20170709		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
49035-872_f41e4ca5-1623-e4c4-e053-2a95a90a58eb	49035-872	HUMAN OTC DRUG	Equate Vaporizing		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20070112		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
49035-873_14f9542a-d2d3-4450-87ff-4abbb482d4eb	49035-873	HUMAN OTC DRUG	equate nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20061215		ANDA	ANDA077007	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-875_390bdb8a-01b8-4b5f-b392-ce93d71d849e	49035-875	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20130827		OTC MONOGRAPH FINAL	part347	Equate	PETROLATUM	340	mg/100g			N	20241231
49035-881_1dcaeff5-7720-4799-843e-f3b0acb0dc80	49035-881	HUMAN OTC DRUG	Zinc		ZINC GLUCONATE	TABLET	ORAL	20171030		UNAPPROVED HOMEOPATHIC		Wal-Mart Stores,Inc.,	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-888_f41e00ec-bb5d-507d-e053-2995a90a5b36	49035-888	HUMAN OTC DRUG	Equate Cool and Heat	Extra Strength	Menthol	PATCH	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	MENTHOL, UNSPECIFIED FORM	50	mg/1			N	20241231
49035-889_6f81a5b0-ae5c-4e18-95a2-b4fbe3dcfe51	49035-889	HUMAN OTC DRUG	Regular Strength Antacid		Antacid	TABLET, CHEWABLE	ORAL	20170830		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	500	mg/1			N	20241231
49035-890_f41e5794-d519-dd5b-e053-2995a90a033a	49035-890	HUMAN OTC DRUG	Equate Capsaicin Pain Relieving		capsaicin	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc	CAPSAICIN	.25	mg/g			N	20241231
49035-893_ec44433a-a66a-2762-e053-2995a90acd62	49035-893	HUMAN OTC DRUG	Equate Sunscreen SPF 50 BABY	Broad Spectrum	Avobenzone, Homosalate,Octisalate,Octocrylene	SPRAY	TOPICAL	20161111		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 130; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
49035-897_9209eb73-0cfe-408b-9caa-7759d5984371	49035-897	HUMAN OTC DRUG	equate ibuprofen		Ibuprofen	SUSPENSION	ORAL	19990202		ANDA	ANDA074937	Wal-Mart Stores Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-899_5c36736b-ee13-4a7e-9c9e-ae14e4c72d52	49035-899	HUMAN OTC DRUG	equate cough dm		Dextromethorphan polistirex	SUSPENSION	ORAL	20150721		ANDA	ANDA091135	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-900_c51f869a-0bce-4dd1-add0-a44f9e326972	49035-900	HUMAN OTC DRUG	Equate nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190401		ANDA	ANDA203690	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-901_085fa28a-202f-4bd3-bc4a-eeb1648314c7	49035-901	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	19900315		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-902_4a8382d6-5a50-4743-98fe-5a424a44807a	49035-902	HUMAN OTC DRUG	equate Sugar Free Extra Strength Antacid	Orange Cream Flavor	Antacid	TABLET, CHEWABLE	ORAL	20150916		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	750	mg/1			N	20241231
49035-905_ee41e9a0-2175-4b30-9f0f-a0fbf586e27f	49035-905	HUMAN OTC DRUG	equate hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20171226		ANDA	ANDA091344	Wal-Mart Stores Inc	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
49035-906_c01171b9-c68f-419b-a9ad-c22b99d8f777	49035-906	HUMAN OTC DRUG	Mix-In Laxative Packets		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20191028		ANDA	ANDA203928	Wal-Mart Stores Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49035-907_6290340a-7fdd-4824-99ce-ff8edf21804a	49035-907	HUMAN OTC DRUG	Equate Severe Cold Multi Symptom		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20160718		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-909_01da2c6b-4832-410d-9f20-6b5f2cc097c5	49035-909	HUMAN OTC DRUG	All Day Moisture		Octinoxate, Zinc Oxide	LOTION	TOPICAL	20090512		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-910_c01d8355-369c-41c2-84dd-72ad4db59688	49035-910	HUMAN OTC DRUG	Extra Strength Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20151027		OTC MONOGRAPH DRUG	M002	Wal-Mart Stores,Inc.,	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
49035-911_fa102ba2-d76f-4bee-8074-7ecf4a4ba436	49035-911	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180206	20240426	NDA	NDA022429	EQUATE (Wal-Mart Stores, Inc.)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49035-912_382b4a80-7cac-4484-8528-f7e8d1d1be5e	49035-912	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Wal-Mart Stores Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49035-915_6b3dd6f7-7b86-433c-a125-816e7b68115d	49035-915	HUMAN OTC DRUG	Equate omeprazole delayed release	acid reducer	Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080227		NDA	NDA022032	Wal-Mart Stores Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-919_2ccf5c47-c9ca-4781-b70f-80d22ef14487	49035-919	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20191126		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN	500	mg/1			N	20241231
49035-925_efe14f46-c91e-aea4-e053-2a95a90aad5f	49035-925	HUMAN OTC DRUG	Childrens Cold and Cough Day and Night Twin Pack		ONION,MATRICARIA CHAMOMILLA,ARABICA COFFEE BEAN,CALCIUM SULFIDE,GOLDENSEAL,SODIUM CHLORIDE,PHOSPHORUS,ANEMONE PULSATILLA and SULFUR	KIT		20180701		UNAPPROVED HOMEOPATHIC		Wal-Mart Stores, Inc						N	20241231
49035-927_efe0c151-5402-04ae-e053-2995a90a026a	49035-927	HUMAN OTC DRUG	Cold and Cough		onion, calcium sulfide, sodium chloride, phosphorus, pulsatilla vulgaris, sulfur, and goldenseal	LIQUID	ORAL	20180601		UNAPPROVED HOMEOPATHIC		Wal-Mart Stores, Inc.	ANEMONE PULSATILLA; CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 12; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
49035-929_8850543f-9dfc-4eab-938f-9b16b7bb6a3a	49035-929	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-930_99e8a585-5faf-4aa3-af34-e9bbb96b8ed5	49035-930	HUMAN OTC DRUG	Tussin DM Max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180815		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-931_e6d7e156-0463-4434-b3f7-c00a671d980e	49035-931	HUMAN OTC DRUG	Cold Multi-Symptom		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	KIT		20050721		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc						N	20241231
49035-934_eb8925fd-dceb-46e3-8518-e66530076c96	49035-934	HUMAN OTC DRUG	Quick Action		Salicylic acid	LIQUID	TOPICAL	20170621		OTC MONOGRAPH FINAL	part333D	Equate	SALICYLIC ACID	2	g/100mL			N	20241231
49035-935_d7d59113-ba37-431c-950a-39ef82307131	49035-935	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20180228	20241227	OTC MONOGRAPH FINAL	part341	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49035-942_6d0660c2-e90e-4074-a5f7-2cf95dd30d96	49035-942	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20170113		OTC MONOGRAPH FINAL	part355	Wal-Mart Stores, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
49035-943_f00372d8-3f42-4223-bd26-ed230a286676	49035-943	HUMAN OTC DRUG	Tussin DM Max	Nighttime	Dextromethorphan HBr, Doxylamine Succinate	SOLUTION	ORAL	20180815		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-944_74326085-ef80-4c8e-a726-c528ff0a6ee6	49035-944	HUMAN OTC DRUG	equate hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20070925		OTC MONOGRAPH FINAL	part346	Wal-Mart Stores Inc	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-945_a9cddf67-364b-4501-9719-f0a2c4971fc3	49035-945	HUMAN OTC DRUG	Severe Cold and Flu		Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20180815		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc						N	20241231
49035-946_43cc496e-fa4e-483f-8b0a-c25f4ccc810f	49035-946	HUMAN OTC DRUG	equate pain and fever	infants	Acetaminophen	SUSPENSION	ORAL	20110808		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
49035-947_d7afc612-57d5-4562-9f2b-d7b670fd3919	49035-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20090512		OTC MONOGRAPH FINAL	part333D	Wal-Mart	SALICYLIC ACID	20.6	mg/mL			N	20241231
49035-948_0b42971b-27b0-4393-b247-d00c75557669	49035-948	HUMAN OTC DRUG	Multi Symptom Severe Cold and Nighttime Severe Cold and Cough		Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Phenylephrine HCl	KIT		20190701		OTC MONOGRAPH DRUG	M012	WAL-MART STORES INC						N	20241231
49035-952_9f03edea-0703-4094-8391-412d73817784	49035-952	HUMAN OTC DRUG	Diaper Rash		ZINC OXIDE	PASTE	TOPICAL	20160309		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores	ZINC OXIDE	400	mg/g			N	20241231
49035-953_0ea6cbb4-1105-fecf-e063-6394a90a513b	49035-953	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20180501		ANDA	ANDA210088	Wal-Mart Stores, Inc	LORATADINE	5	mg/1			N	20251231
49035-956_36508f89-27d1-4076-b633-2ab0d28d735c	49035-956	HUMAN OTC DRUG	Maximum Strength Mucus Relief DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Wal-Mart Stores, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-957_c74d4446-f7dd-4089-9da8-bd9e29118c99	49035-957	HUMAN OTC DRUG	Equate Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130214		ANDA	ANDA203690	Wal-Mart Stores Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49035-959_0e5351c8-1bcb-4f9f-b7bc-7f4f73e6e11c	49035-959	HUMAN OTC DRUG	equate childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20120124		OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
49035-960_e4470d80-6024-414e-9875-188e81ea627f	49035-960	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Wal-Mart Stores, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-962_c6b34a92-eff7-4d77-e053-2a95a90a683f	49035-962	HUMAN OTC DRUG	Equate Sunscreen Mineral Based KIDS Broad Spectrum spf 50		Homosalate , Octocrylene, Zinc Oxide	STICK	TOPICAL	20190326		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	HOMOSALATE; OCTOCRYLENE; ZINC OXIDE	50; 100; 150	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49035-963_f0e82f62-84dd-2b8c-e053-2a95a90aa1b1	49035-963	HUMAN OTC DRUG	EQUATE Sunscreen SPORT Broad Spectrum SPF 30		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20171108		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
49035-964_3fe55d68-929b-4eba-9fd5-7c2605481b7b	49035-964	HUMAN OTC DRUG	Equate Flu and Severe Cold and Cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20110711		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-965_43d4d54f-dac8-4b2b-82a3-81422fc15732	49035-965	HUMAN OTC DRUG	Soothing Moisturizing		Colloidal oatmeal	CREAM	TOPICAL	20140422		OTC MONOGRAPH FINAL	part347	Wal-Mart Stores, Inc	OATMEAL	10.4	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
49035-968_6910fe10-c0fb-42fa-8a21-f81dffe5eb27	49035-968	HUMAN OTC DRUG	Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190715		ANDA	ANDA040564	Wal-Mart Stores Inc	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
49035-969_ec45595a-6d40-e79e-e053-2a95a90a5ce3	49035-969	HUMAN OTC DRUG	EQUATE Sunscreen BABY Broad Spectrum SPF 50		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
49035-970_f31ed84d-7bb1-db54-e053-2a95a90a2f89	49035-970	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Pen	LIQUID	TOPICAL	20170501		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc.	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
49035-971_382d0662-9c97-4773-9932-f8a604f1bae9	49035-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20150114		OTC MONOGRAPH FINAL	part355	Wal-Mart Stores, Inc	SODIUM FLUORIDE	.02	mg/mL			N	20241231
49035-973_cb100245-af2d-4f3a-83b0-749fc76283e6	49035-973	HUMAN OTC DRUG	Equate Hydrocortisone	Intensive Healing Formula	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49035-974_5c5ecb71-c56e-49f8-a8ea-99639cb11a06	49035-974	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180206	20240426	NDA	NDA021920	EQUATE (Wal-Mart Stores, Inc.)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
49035-976_63e3aef6-92ca-4ade-9533-c199256f8d6c	49035-976	HUMAN OTC DRUG	Maximum Strength Mucus Relief Severe Congestion and Cough		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20180502		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores,Inc.,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49035-978_02a2bf15-8c06-4d64-b535-63115bb0fb64	49035-978	HUMAN OTC DRUG	NiteTime Cold/Flu, Multi-Symptom Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20160309		OTC MONOGRAPH FINAL	part341	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49035-979_f422749b-1964-672e-e053-2a95a90af655	49035-979	HUMAN OTC DRUG	Equate-Sunscreen Broad Spectrum SPF 50 ULTRA		Avobenzone Homosalate Octisalate Octocrylene	SPRAY	TOPICAL	20190328		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
49035-980_c29c11ae-2ff7-4653-9dd8-d25175cb9201	49035-980	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016		ANDA	ANDA209339	Wal-Mart Stores, Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-981_09353c74-d158-4926-9fdf-09806e336a1f	49035-981	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	Wal-Mart Stores Inc	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49035-983_e5dbd600-223b-4e6a-8a28-2fcaacdb1dce	49035-983	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Wal-Mart Stores, Inc.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49035-984_dcbc55c7-7ec8-4152-a498-277aa4d98f3b	49035-984	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20190417	20240912	OTC MONOGRAPH NOT FINAL	part343	Wal-Mart Stores Inc	ACETAMINOPHEN	500	mg/1			N	
49035-989_0ce57521-f388-2c51-e063-6394a90a3b10	49035-989	HUMAN OTC DRUG	Equate Swimmers Instant Ear Dry		Equate Swimmers Instant Ear Dry	LIQUID	AURICULAR (OTIC)	20180925		OTC MONOGRAPH DRUG	M014	Walmart Stores, Inc	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
49035-990_f31e8b52-8b59-57de-e053-2a95a90a08a9	49035-990	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Liquid	LIQUID	TOPICAL	20140508		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc.	UNDECYLENIC ACID	.25	g/mL			N	20241231
49035-991_e4e4d623-97e6-4165-90ee-640d6d71e046	49035-991	HUMAN OTC DRUG	No Drip Nasal Mist Nasal Decongestant Severe Congestion		oxymetazoline hydrochloride	SPRAY	NASAL	20170821		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores,Inc.,	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
49035-993_e645f9a1-ac28-4082-a8dc-27f8dc9e2bb4	49035-993	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	GEL	TOPICAL	20180705		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	ALCOHOL	620	mg/mL			N	20241231
49035-998_3af06efb-ad66-40ed-9e09-55d30d753e6e	49035-998	HUMAN OTC DRUG	Equate Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20061215		ANDA	ANDA077007	Wal-Mart Stores Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49204-001_0802129d-1bc0-2371-e063-6394a90aa730	49204-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19770701		NDA	NDA205712	HARTMAN BROTHERS, INC.	OXYGEN	990	mL/L			N	20241231
49204-002_080231bc-1a33-ce09-e063-6294a90a5db4	49204-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19770701		NDA	NDA205713	HARTMAN BROTHERS, INC.	NITROGEN	990	mL/L			N	20241231
49204-004_080216bf-b979-8e8d-e063-6294a90ac8de	49204-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19770701		NDA	NDA205712	HARTMAN BROTHERS, INC.	OXYGEN	210	mL/L			N	20241231
49215-0006_f6a74f50-a725-4b29-8772-a18e76911ca7	49215-0006	HUMAN OTC DRUG	Test Flex		Avena Sativa, Calcarea Carbonica, Damiana, Glandula Suprarenalis Suis, Hypophysis Suis, Magnesia Carbonica, Millefolium, Sabal Serrulata, Thuja Occidentalis, Urtica Urens	SPRAY	ORAL	20170817		UNAPPROVED HOMEOPATHIC		Safe Anabolic Sciences	ACHILLEA MILLEFOLIUM; AVENA SATIVA FLOWERING TOP; MAGNESIUM CARBONATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SAW PALMETTO; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAF; TURNERA DIFFUSA LEAFY TWIG; URTICA URENS	6; 3; 8; 8; 3; 6; 12; 6; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
49215-0009_728bfbc4-7d9b-4210-89b9-4ea0433ff84a	49215-0009	HUMAN OTC DRUG	G7 Flex		Arnica Montana, Carduus Marianus, Hepar Suis, Hypophysis Suis, Panax Ginseng, Phosphoricum Acidum	LIQUID	ORAL	20180504		UNAPPROVED HOMEOPATHIC		Safe Anabolic Sciences	ARNICA MONTANA; ASIAN GINSENG; MILK THISTLE; PHOSPHORIC ACID; PORK LIVER; SUS SCROFA PITUITARY GLAND	3; 1; 1; 3; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
49221-0025_baa126d8-0a62-4b19-a6ee-a4765fe67632	49221-0025	HUMAN PRESCRIPTION DRUG	MEDICAL AIR		AIR	GAS	RESPIRATORY (INHALATION)	19490101		NDA	NDA205765	Strate Welding Supply Co., Inc.	OXYGEN	21	L/100L			N	20241231
49221-0030_50027943-809e-4aae-9a6a-93ef46e0e6ae	49221-0030	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19490101		NDA	NDA205767	Strate Welding Supply Co., Inc.	OXYGEN	99	L/100L			N	20241231
49221-0042_b930014d-33c5-4369-b165-12623b930969	49221-0042	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19490101		NDA	NDA205766	Strate Welding Supply Co., Inc.	NITROGEN	99	L/100L			N	20241231
49221-3000_03cee808-a6ef-42a6-a6c6-379be8031506	49221-3000	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19490101		NDA	NDA205767	Strate Welding Supply Co., Inc.	OXYGEN	99	L/100L			N	20241231
49230-188_081757dd-3a78-2449-e063-6394a90a9c56	49230-188	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19841130		NDA	NDA018883	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 1.5; 15.2; 567; 392	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-191_081757dd-3a78-2449-e063-6394a90a9c56	49230-191	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19841130		NDA	NDA018883	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	25.7; 2.5; 15.2; 567; 392	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-206_08175c01-cebf-c71c-e063-6294a90af632	49230-206	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19920819		NDA	NDA020171	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 1.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-206_08178908-65c0-4b2a-e063-6394a90a8c5b	49230-206	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19920819		NDA	NDA020171	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 1.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-209_08175c01-cebf-c71c-e063-6294a90af632	49230-209	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19920819		NDA	NDA020171	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 2.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-209_08178908-65c0-4b2a-e063-6394a90a8c5b	49230-209	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19920819		NDA	NDA020171	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 2.5; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-212_08175c01-cebf-c71c-e063-6294a90af632	49230-212	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19920819		NDA	NDA020171	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 4.25; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-212_08178908-65c0-4b2a-e063-6394a90a8c5b	49230-212	HUMAN PRESCRIPTION DRUG	DELFLEX		Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	SOLUTION	INTRAPERITONEAL	19920819		NDA	NDA020171	Fresenius Medical Care North America	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	18.4; 4.25; 5.08; 538; 448	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49230-300_08017754-a404-f680-e063-6394a90abdd9	49230-300	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	20070412		ANDA	ANDA078177	Fresenius Medical Care North America	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
49230-530_a21a525d-9e5a-41e1-9415-bf362352f4b5	49230-530	HUMAN PRESCRIPTION DRUG	Venofer		iron sucrose	INJECTION, SOLUTION	INTRAVENOUS	20110127		NDA	NDA021135	Fresenius Medical Care Holdings, Inc.	IRON SUCROSE	20	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49230-534_a21a525d-9e5a-41e1-9415-bf362352f4b5	49230-534	HUMAN PRESCRIPTION DRUG	Venofer		iron sucrose	INJECTION, SOLUTION	INTRAVENOUS	20081104		NDA	NDA021135	Fresenius Medical Care Holdings, Inc.	IRON SUCROSE	20	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49230-645_080016c5-1e57-94fe-e063-6294a90aed68	49230-645	HUMAN PRESCRIPTION DRUG	Velphoro		sucroferric oxyhydroxide	TABLET, CHEWABLE	ORAL	20131127		NDA	NDA205109	Fresenius Medical Care North America	FERRIC OXYHYDROXIDE	500	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49252-007_9f2a12d3-495e-46ec-9aa9-8802ec487133	49252-007	HUMAN PRESCRIPTION DRUG	duloxetine		duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20151205		ANDA	ANDA202336	Inventia Healthcare Private Limited	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
49252-008_9f2a12d3-495e-46ec-9aa9-8802ec487133	49252-008	HUMAN PRESCRIPTION DRUG	duloxetine		duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20151205		ANDA	ANDA202336	Inventia Healthcare Private Limited	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
49252-009_9f2a12d3-495e-46ec-9aa9-8802ec487133	49252-009	HUMAN PRESCRIPTION DRUG	duloxetine		duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20151205		ANDA	ANDA202336	Inventia Healthcare Private Limited	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
49252-065_f29310d1-7b00-4057-9dd1-d9a69f542d5e	49252-065	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET, COATED	ORAL	20200529		ANDA	ANDA208659	Inventia Healthcare Limited	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
49252-066_f29310d1-7b00-4057-9dd1-d9a69f542d5e	49252-066	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		olmesartan medoxomil	TABLET, COATED	ORAL	20200529		ANDA	ANDA208659	Inventia Healthcare Limited	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
49252-067_f29310d1-7b00-4057-9dd1-d9a69f542d5e	49252-067	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		OLMESARTAN MEDOXOMIL	TABLET, COATED	ORAL	20200529		ANDA	ANDA208659	Inventia Healthcare Limited	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
49264-4274_c4844727-e8d3-4ad2-8919-0cc787dfff5c	49264-4274	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20231201		ANDA	ANDA211355	Procaps S A	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
49281-123_02ba091b-bc87-4561-a762-90710478fb5e	49281-123	VACCINE	Fluzone High-Dose Quadrivalent Northern Hemisphere		INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230630	20240630	BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	60; 60; 60; 60	ug/.7mL; ug/.7mL; ug/.7mL; ug/.7mL			N	
49281-190_8026005f-7587-47fe-bb78-ec6247a3434b	49281-190	PLASMA DERIVATIVE	IMOGAM RABIES-HT		HUMAN RABIES VIRUS IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR	19840427		BLA	BLA103932	Sanofi Pasteur Inc.	HUMAN RABIES VIRUS IMMUNE GLOBULIN	150	[iU]/mL			N	20241231
49281-215_39537b07-13b5-4db4-9a35-3bd6954b11de	49281-215	VACCINE	TENIVAC		CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20101208		BLA	BLA103171	Sanofi Pasteur Inc.	CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	5; 2	[Lf]/.5mL; [Lf]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-225_c05b35c2-928a-4388-84ed-051ea390f18e	49281-225	VACCINE	DIPHTHERIA AND TETANUS TOXOIDS ADSORBED		CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20100329		BLA	BLA103944	Sanofi Pasteur Inc.	CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	5; 25	[Lf]/.5mL; [Lf]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-252_f6b45065-e416-4389-bfe3-adf8235326ea	49281-252	VACCINE	IMOVAX RABIES		RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER	KIT		20191025		BLA	BLA103931	Sanofi Pasteur Inc.						N	20241231
49281-286_1b345e6e-c841-46a9-9703-941eeff80684	49281-286	VACCINE	DAPTACEL		corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen	INJECTION, SUSPENSION	INTRAMUSCULAR	20020514		BLA	BLA103666	Sanofi Pasteur Inc.	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	5; 5; 3; 10; 5; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-400_54c1ecd8-c9cc-4c58-b42d-345d03eb5e5b	49281-400	VACCINE	Adacel	TDaP	CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN	INJECTION, SUSPENSION	INTRAMUSCULAR	20050610		BLA	BLA125111	Sanofi Pasteur Inc.	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	5; 5; 3; 2.5; 5; 2	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-403_a1291f5b-2485-423a-b128-a3bc75ab738a	49281-403	VACCINE	FLUZONE High-Dose		influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/maryland/15/2016 bx-69a (a b/colorado/6/2017-like virus) antigen (formaldehyde inactivated)	INJECTION, SUSPENSION	INTRAMUSCULAR	20180629		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)	60; 60; 60	ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-405_a1291f5b-2485-423a-b128-a3bc75ab738a	49281-405	VACCINE	FLUZONE High-Dose		influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/maryland/15/2016 bx-69a (a b/colorado/6/2017-like virus) antigen (formaldehyde inactivated)	INJECTION, SUSPENSION	INTRAMUSCULAR	20190701		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)	60; 60; 60	ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-418_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-418	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20190123		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-420_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-420	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20200702		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-421_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-421	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20210702		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-422_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-422	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20220701		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-423_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-423	VACCINE	Fluzone Quadrivalent Northern Hemisphere		INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230630	20240630	BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
49281-511_bb37d588-7335-4257-af91-4eb54e96e00e	49281-511	VACCINE	PENTACEL		DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE	KIT		20080620		BLA	BLA125145	Sanofi Pasteur Inc.						N	20241231
49281-519_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-519	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20190701		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	7.5; 7.5; 7.5; 7.5	ug/.25mL; ug/.25mL; ug/.25mL; ug/.25mL			N	20241231
49281-545_17a63642-4ae1-4d16-ad54-e8e0c33acbd4	49281-545	VACCINE	ActHIB		HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN	KIT		19930330		BLA	BLA103935	Sanofi Pasteur Inc.						N	20241231
49281-562_60aec2d6-d1ff-4a83-844e-7c4b1f934bf7	49281-562	VACCINE	QUADRACEL		diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20150324		BLA	BLA125525	Sanofi Pasteur Inc.	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	20; 5; 3; 20; 5; 15; 40; 8; 32	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-564_36dac28e-f95b-4c27-a9f7-0d3a37e67bf3	49281-564	VACCINE	QUADRACEL		diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20150324		BLA	BLA125525	Sanofi Pasteur Inc.	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	20; 5; 3; 20; 5; 15; 29; 7; 26	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-574_68042e47-6495-4b99-a244-3360c4e5ce06	49281-574	HUMAN PRESCRIPTION DRUG	BEYFORTUS		nirsevimab	INJECTION	INTRAMUSCULAR	20230718		BLA	BLA761328	Sanofi Pasteur Inc.	NIRSEVIMAB	100	mg/mL	Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]		N	20241231
49281-575_68042e47-6495-4b99-a244-3360c4e5ce06	49281-575	HUMAN PRESCRIPTION DRUG	BEYFORTUS		nirsevimab	INJECTION	INTRAMUSCULAR	20230718		BLA	BLA761328	Sanofi Pasteur Inc.	NIRSEVIMAB	50	mg/.5mL	Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]		N	20241231
49281-589_ebc98cee-030f-46c1-8d1b-87da533152d9	49281-589	VACCINE	Menactra		NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN	INJECTION, SOLUTION	INTRAMUSCULAR	20050114		BLA	BLA125089	Sanofi Pasteur Inc.	NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN	4; 4; 4; 4	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-590_2c61477d-7c6b-498c-b465-49d666ac2fb9	49281-590	VACCINE	MenQuadfi		NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN	INJECTION, SOLUTION	INTRAMUSCULAR	20230630		BLA	BLA125701	Sanofi Pasteur Inc.	NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN	10; 10; 10; 10	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20251231
49281-605_55e1d28d-def8-45b8-9ed1-5769bdfe28e1	49281-605	VACCINE	Dengvaxia		Dengue Tetravalent Vaccine, Live	KIT		20190501		BLA	BLA125682	Sanofi Pasteur Inc.						N	20241231
49281-629_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-629	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20190123		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/MICHIGAN/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-631_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-631	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20190701		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-633_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-633	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20200702		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-635_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-635	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20210702		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-637_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-637	VACCINE	FLUZONE QUADRIVALENT NORTHERN HEMISPHERE		INFLUENZA A VIRUS A/Victoria/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20220701		BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-639_630e666a-9196-4d8c-9b96-7ee44f4daf5f	49281-639	VACCINE	Fluzone Quadrivalent Northern Hemisphere		INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230630	20240630	BLA	BLA103914	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
49281-722_f44f01fb-1905-4ead-8d1a-7362ef09797b	49281-722	VACCINE	Flublok Quadrivalent Northern Hemisphere		INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN	INJECTION	INTRAMUSCULAR	20220701		BLA	BLA125285	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN	45; 45; 45; 45	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
49281-723_f44f01fb-1905-4ead-8d1a-7362ef09797b	49281-723	VACCINE	Flublok Quadrivalent Northern Hemisphere		INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN	INJECTION	INTRAMUSCULAR	20230630	20240630	BLA	BLA125285	Sanofi Pasteur Inc.	INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN	45; 45; 45; 45	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
49281-752_d8ef50f2-09ec-415e-b837-4221a9b3aaa5	49281-752	HUMAN PRESCRIPTION DRUG	TUBERSOL		Tuberculin Purified Protein Derivative	INJECTION, SOLUTION	INTRADERMAL	19560815		BLA	BLA103941	Sanofi Pasteur Inc.	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	5	[iU]/.1mL	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
49281-790_fa4e39b2-950e-41f1-851b-c12f3f781ff8	49281-790	VACCINE	Typhim Vi		SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN	INJECTION, SOLUTION	INTRAMUSCULAR	19941128		BLA	BLA103936	Sanofi Pasteur Inc.	SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN	25	ug/.5mL	Actively Acquired Immunity [PE], Inactivated Salmonella Typhi Vaccine [EPC], Polysaccharides, Bacterial [CS], Vaccines, Inactivated [CS], Vaccines, Typhoid [CS]		N	20241231
49281-860_9465189c-18c9-4f3c-8ab8-75679348a8e4	49281-860	VACCINE	IPOL		POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	19901221		BLA	BLA103930	Sanofi Pasteur Inc.	POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	40; 8; 32	[D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
49281-912_9602be97-8fc3-4f87-b3d9-e22179bfa228	49281-912	VACCINE	Diluent		Sodium Chloride	INJECTION	SUBCUTANEOUS	19530522		BLA	BLA103915	Sanofi Pasteur Inc.	SODIUM CHLORIDE	4.5	mg/.5mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
49281-913_08093d34-773d-5e71-e063-6394a90a2de3	49281-913	VACCINE	STAMARIL		YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN	KIT		20160927		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Sanofi Pasteur Inc.						N	20241231
49281-915_9602be97-8fc3-4f87-b3d9-e22179bfa228	49281-915	VACCINE	YF-VAX		YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	SUBCUTANEOUS	19530522		BLA	BLA103915	Sanofi Pasteur Inc.	YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN	4.74	[PFU]/.5mL	Actively Acquired Immunity [PE], Live Attenuated Yellow Fever Virus Vaccine [EPC], Vaccines, Attenuated [CS], Yellow Fever Vaccine [CS]		N	20241231
49283-001_056a6c9f-673b-070c-e063-6394a90a5ac6	49283-001	HUMAN OTC DRUG	GELLE-N-DETOX - LAVENDER AND ROSEMARY MASSAGE		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20230118		OTC MONOGRAPH NOT FINAL	part333A	CHEMCO CORPORATION	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
49283-025_0bc72bd8-1f30-b01c-e063-6394a90a77ea	49283-025	HUMAN OTC DRUG	Undecylenic Acid		Undecylenic Acid	LIQUID	TOPICAL	20180816		OTC MONOGRAPH DRUG	M005	Chemco Corporation	UNDECYLENIC ACID	25	g/100mL			N	20241231
49283-101_f27b3518-d5c3-1229-e053-2a95a90ab56f	49283-101	HUMAN OTC DRUG	SPAREDI MINT AND EUCALYPTUS MASK		BENZALKONIUM CHLORIDE	CREAM	TOPICAL	20230117		OTC MONOGRAPH NOT FINAL	part333A	CHEMCO CORPORATION	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
49283-110_05e115a5-4d49-43d6-e063-6294a90a07c5	49283-110	HUMAN OTC DRUG	GELLE-N-DETOX ICE MINT AND EUCALYPTUS MASSAGE		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20230119		OTC MONOGRAPH NOT FINAL	part333A	CHEMCO CORPORATION	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
49283-145_05574941-6443-c7ad-e063-6394a90a6986	49283-145	HUMAN OTC DRUG	ALFLEXIL ZERO PAIN		CAMPHOR, LIDOCAINE HCL, MENTHOL	GEL	TOPICAL	20231018		OTC MONOGRAPH DRUG	M017	CHEMCO CORPORATION	CAMPHOR (SYNTHETIC); LIDOCAINE HYDROCHLORIDE; MENTHOL	.5; 4; 1	g/100g; g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49283-541_08024946-586b-992e-e063-6294a90a055f	49283-541	HUMAN OTC DRUG	MENTHOL, LIDOCAINE, CAMPHOR		MENTHOL, LIDOCAINE, CAMPHOR	GEL	TOPICAL	20210727	20241205	OTC MONOGRAPH DRUG	M017	CHEMCO CORPORATION	CAMPHOR (SYNTHETIC); LIDOCAINE; MENTHOL	.5; 4; 11	g/100g; g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
49283-707_04de86a2-835e-cbce-e063-6294a90a4956	49283-707	HUMAN OTC DRUG	FOOTSPA PEDI		ALCOHOL	SPRAY	TOPICAL	20210317		OTC MONOGRAPH NOT FINAL	part333A	CHEMCO CORPORATION	ALCOHOL	70	mL/100mL			N	20241231
49295-0001_2d9d93ea-a9c4-4601-aacd-eeba8efe2728	49295-0001	HUMAN OTC DRUG	GH		Human Growth Hormone, Pituitaria Glandula, Hepar Suis	SPRAY	ORAL	20140714		UNAPPROVED HOMEOPATHIC		Oxylife Nutritional Supplements Inc	PORK LIVER; SOMATROPIN; SUS SCROFA PITUITARY GLAND	6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
49309-001_7c481f92-32e0-44ff-8679-25cbe5928ecd	49309-001	HUMAN OTC DRUG	Devrom		bismuth subgallate	TABLET, CHEWABLE	ORAL	20181201		OTC MONOGRAPH FINAL	part357I	The Parthenon Co., Inc.	BISMUTH SUBGALLATE	200	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
49309-002_40024c94-09ca-4462-bbed-402bb1ac5b4c	49309-002	HUMAN OTC DRUG	Devrom		bismuth subgallate	CAPSULE	ORAL	20181201		OTC MONOGRAPH FINAL	part357I	The Parthenon Co., Inc.	BISMUTH SUBGALLATE	200	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
49314-0001_f72851cd-bb96-8b3d-e053-6394a90a907c	49314-0001	HUMAN OTC DRUG	First Aid Antispetic		Benzalkonium Chloride	SPRAY	TOPICAL	20230320		OTC MONOGRAPH NOT FINAL	part333A	Unishield	BENZALKONIUM CHLORIDE	.13	mg/mL			N	20241231
49314-0002_f729c666-669e-4605-e053-6394a90a426e	49314-0002	HUMAN OTC DRUG	UniShield First Aid Burn		Lidocaine HCL	SPRAY	TOPICAL	20230320		OTC MONOGRAPH NOT FINAL	part348	Unishield	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49314-0003_f86f7bb2-4c49-a087-e053-6394a90af969	49314-0003	HUMAN OTC DRUG	FIRST SHIELD		Benzalkonium Chloride, Lidocaine HCI	CREAM	TOPICAL	20230403		OTC MONOGRAPH NOT FINAL	part348	Unishield	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49314-0004_0a3a4738-5990-0d5a-e063-6294a90a87d9	49314-0004	HUMAN OTC DRUG	Unishield Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20231115		OTC MONOGRAPH DRUG	M005	Unishield	ALCOHOL	75	mL/100mL			N	20241231
49314-0005_0a3a836a-a193-b951-e063-6294a90a182d	49314-0005	HUMAN OTC DRUG	Unishield 1%		HYDROCORTISONE	CREAM	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	Unishield	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49314-0505_da45d49e-f07d-1939-e053-2a95a90a9673	49314-0505	HUMAN OTC DRUG	Unishield Cherry Cough		Menthol	LOZENGE	ORAL	20210301		OTC MONOGRAPH FINAL	part341	Unishield	MENTHOL, UNSPECIFIED FORM	7.6	mg/1			N	20241231
49314-1013_0d81e6b9-06e2-36f9-e063-6294a90a257d	49314-1013	HUMAN OTC DRUG	Unishield Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210301		OTC MONOGRAPH DRUG	M001	Unishield	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
49314-1163_02e68ed7-4c1b-644f-e063-6294a90a180e	49314-1163	HUMAN OTC DRUG	Unishield Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20210301		OTC MONOGRAPH NOT FINAL	part343	Unishield	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49314-1173_02e68ed7-4c1b-644f-e063-6294a90a180e	49314-1173	HUMAN OTC DRUG	Unishield Aspirin		Aspirin	TABLET, COATED	ORAL	20210301	20240401	OTC MONOGRAPH NOT FINAL	part343	Unishield	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
49314-1763_f6010d2d-5b99-3816-e053-2995a90a23b1	49314-1763	HUMAN OTC DRUG	Unishield Extra Strength Non-Aspirin		Acetaminophen	TABLET, FILM COATED	ORAL	20210301		OTC MONOGRAPH NOT FINAL	part343	Unishield	ACETAMINOPHEN	500	mg/1			N	20241231
49314-2083_da55994d-b70c-29c0-e053-2995a90a2e0e	49314-2083	HUMAN OTC DRUG	Unishield Sinus Decongestant		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210301		OTC MONOGRAPH FINAL	part341	Unishield	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49315-003_a6a1f86a-61c0-4769-8f6a-2b7af01c1410	49315-003	HUMAN PRESCRIPTION DRUG	CLOFARABINE		clofarabine	INJECTION	INTRAVENOUS	20170510		ANDA	ANDA204029	Zydus Lifesciences Limited	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
49315-005_a8f76ffc-24cf-4d5b-9bd2-1ace0c66eec5	49315-005	HUMAN PRESCRIPTION DRUG	Arsenic trioxide		Arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20181114		ANDA	ANDA206228	Zydus Lifesciences Limited	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
49315-007_e80b0973-e6e5-4914-b5f0-4528d7fa7285	49315-007	HUMAN PRESCRIPTION DRUG	Arsenic trioxide		Arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20190903		ANDA	ANDA206228	Zydus Lifesciences Limited	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
49315-008_2c0f5abf-ca66-445c-9a35-e39b2111911e	49315-008	HUMAN PRESCRIPTION DRUG	DOXORUBICIN HYDROCHLORIDE		doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20200914		ANDA	ANDA212299	Zydus Lifesciences Limited	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
49315-009_2c0f5abf-ca66-445c-9a35-e39b2111911e	49315-009	HUMAN PRESCRIPTION DRUG	DOXORUBICIN HYDROCHLORIDE		doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20200914		ANDA	ANDA212299	Zydus Lifesciences Limited	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
49344-0001_078a93ce-2f9c-f3ea-e063-6394a90a437c	49344-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091030		UNAPPROVED MEDICAL GAS		Westmoreland Medical Equipment Company	OXYGEN	99	L/100L			N	20241231
49348-011_0ce55ce7-d70e-5b31-e063-6294a90a7ab7	49348-011	HUMAN OTC DRUG	Sunmark Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	Strategic Sourcing Services LLC	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49348-017_2428f13d-ee43-4c43-b982-88bb7e393cf3	49348-017	HUMAN OTC DRUG	Sun Mark Tussin DM	cough and chest congestion	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20030627		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49348-028_9193775f-9fcd-4991-a383-1b393b4a0b09	49348-028	HUMAN OTC DRUG	Sunmark Nasal	Original	oxymetazoline hydrochloride	SPRAY	NASAL	20030627		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
49348-030_0ce55ce7-d70f-5b31-e063-6294a90a7ab7	49348-030	HUMAN OTC DRUG	sunmark Isopropyl Rubbing Alcohol		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20120628		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ISOPROPYL ALCOHOL	70	L/100L			N	20241231
49348-032_23e471c9-e055-488a-b4b9-2315fbbe1f3b	49348-032	HUMAN OTC DRUG	gentle laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325	20250504	OTC MONOGRAPH DRUG	505G(a)(3)	Strategic Sourcing Services, LLC (Sunmark)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49348-037_0d295927-09c8-5b68-e063-6394a90a965f	49348-037	HUMAN OTC DRUG	Sunmark Eye Drops Original Formula		Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20070301		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
49348-042_c323f511-a3b0-419a-aead-ca02ccc5c2c3	49348-042	HUMAN OTC DRUG	Sunmark pain reliever	extra strength	Acetaminophen	TABLET	ORAL	20030811		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
49348-045_02a343a4-0767-45e8-9c6f-095be70c5831	49348-045	HUMAN OTC DRUG	Sunmark Allergy Relief	Antihistamine	Diphenhydramine Hydrochloride	SOLUTION	ORAL	20030821		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49348-055_63f9d734-98d4-46d0-82f5-2259521acb67	49348-055	HUMAN OTC DRUG	SUNMARK Calcium Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190924		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
49348-061_a3f52424-ad93-4418-b9aa-edbdc537267d	49348-061	HUMAN OTC DRUG	sunmark nite time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20111121		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49348-076_3d0ce492-4edc-4461-8d05-94c0212e849b	49348-076	HUMAN OTC DRUG	Sunmark Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Strategic Sourcing Services LLC	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
49348-093_f6470ebc-6439-456d-a20e-89dddb655595	49348-093	HUMAN OTC DRUG	Sunmark childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20140124		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49348-095_0d2968de-d653-21f7-e063-6294a90a6bf7	49348-095	HUMAN OTC DRUG	Sunmark Dry Eye Relief		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20130501		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
49348-104_38834076-7b26-457b-b450-90fd9f03327a	49348-104	HUMAN OTC DRUG	sunmark cold and flu severe		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20080319		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49348-115_b2bcd6dc-84f3-fb0a-e053-2995a90ac62d	49348-115	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20140220		NDA	NDA019125	Strategic Sourcing Services, LLC	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
49348-116_08f3ae4b-b862-56a3-e063-6294a90aa760	49348-116	HUMAN OTC DRUG	Pain Reliever Rapid Release		Acetaminophen	TABLET, COATED	ORAL	20141024	20250331	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	
49348-117_08f38579-748b-c6d6-e063-6394a90a3081	49348-117	HUMAN OTC DRUG	Sinus Congestion and Pain Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141027	20250630	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
49348-119_b0994c40-4f38-436f-8ef8-23799e9d9ce5	49348-119	HUMAN OTC DRUG	sunmark childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20140428		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49348-123_13c6afaf-6f92-4479-b2f6-a8ce8889cc0c	49348-123	HUMAN OTC DRUG	Sunmark Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20140519		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49348-128_646e3d4d-6e53-44fc-a343-6294c0d97aa0	49348-128	HUMAN OTC DRUG	sunmark acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20090910		ANDA	ANDA075400	Strategic Sourcing Services LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49348-130_adb918ac-e3e2-4996-9d6c-c8563df7b05f	49348-130	HUMAN OTC DRUG	sunmark nasal		Oxymetazoline HCl	SPRAY	NASAL	20140926		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
49348-133_0ce55ce7-d710-5b31-e063-6294a90a7ab7	49348-133	HUMAN OTC DRUG	Sunmark Iodine		IODINE, SODIUM IODIDE, ALCOHOL	TINCTURE	TOPICAL	20120628		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 24	mg/mL; mg/mL; mg/mL			N	20241231
49348-135_ed2b44d3-8568-46e6-a618-63e6ec9eaab4	49348-135	HUMAN OTC DRUG	sunmark tussin		Guaifenesin	SOLUTION	ORAL	20140917		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	GUAIFENESIN	200	mg/10mL			N	20241231
49348-138_0ce57521-f389-2c51-e063-6394a90a3b10	49348-138	HUMAN OTC DRUG	Sunmark Benzoin Compound Tincture		Benzoin Resin	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M022	Strategic Sourcing Services LLC	BENZOIN RESIN	1000	mg/mL			N	20241231
49348-140_a6417c2a-a47d-4b26-8f2c-3b23b7299443	49348-140	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20141231	20241231	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
49348-143_ee3b33e5-c477-d243-e053-2995a90a3669	49348-143	HUMAN OTC DRUG	CLEARLAX		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20160701		ANDA	ANDA090812	STRATEGIC SOURCING SERVICES LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49348-147_08a1ff0f-27de-3b7b-e063-6394a90a9bb1	49348-147	HUMAN OTC DRUG	GAS RELIEF		Simethicone	TABLET, CHEWABLE	ORAL	20160401		OTC MONOGRAPH DRUG	M002	STRATEGIC SOURCING SERVICES LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
49348-148_0ce56aeb-f940-fa74-e063-6294a90aa548	49348-148	HUMAN OTC DRUG	Sunmark Camphor Spirit		Camphor 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Strategic Sourcing Services LLC	CAMPHOR (NATURAL)	100	mg/mL			N	20241231
49348-149_0d297793-9714-6382-e063-6394a90a7d3e	49348-149	HUMAN OTC DRUG	Sunmark Lubricating Tears		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20130501		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
49348-150_832d576d-33f3-439f-a580-355fd63bc8d6	49348-150	HUMAN OTC DRUG	sunmark lice treatment		Permethrin	LOTION	TOPICAL	20150803		ANDA	ANDA076090	Strategic Sourcing Services LLC	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
49348-153_091c6971-5cf4-3eec-e063-6294a90a0276	49348-153	HUMAN OTC DRUG	ADVANCED ANTACID REGULAR STRENGTH		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20120601	20250101	OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49348-154_99776353-c820-4fce-a9d0-ad13892d6617	49348-154	HUMAN OTC DRUG	antibiotic	Bacitracin Zinc	Bacitracin Zinc	OINTMENT	TOPICAL	20060511		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
49348-155_cad520b3-5aa8-48c3-a743-4dd0ab759392	49348-155	HUMAN OTC DRUG	sunmark	antifungal	Tolnaftate	CREAM	TOPICAL	20060217		OTC MONOGRAPH FINAL	part333C	Strategic Sourcing Services LLC	TOLNAFTATE	10	mg/g			N	20241231
49348-167_08665d14-be97-d6d0-e063-6394a90a5781	49348-167	HUMAN OTC DRUG	STOOL SOFTENER		docusate sodium	TABLET	ORAL	20160301		OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
49348-171_091c0eed-30b1-31ba-e063-6394a90afbd0	49348-171	HUMAN OTC DRUG	SUNMARK MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	LIQUID	ORAL	20120401	20250701	OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49348-174_0ce5731a-7e20-654e-e063-6294a90a2b5c	49348-174	HUMAN OTC DRUG	Sunmark Isopropyl Alcohol 91 Percent		isopropyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ISOPROPYL ALCOHOL	910	mg/mL			N	20241231
49348-175_0ce57040-019d-0c43-e063-6394a90a52eb	49348-175	HUMAN OTC DRUG	Sunmark Isopropyl Alcohol 70 Percent With Wintergreen Oil		isopropyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
49348-179_0ce59406-2d7b-73db-e063-6294a90a0f1e	49348-179	HUMAN OTC DRUG	Sunmark Hydrogen Peroxide 3 Percent		hydrogen peroxide	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
49348-181_0ce5bdec-f4fd-73d9-e063-6294a90a6a87	49348-181	HUMAN OTC DRUG	Sunmark Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M016	Strategic Sourcing Services LLC	WITCH HAZEL	855	mg/mL			N	20241231
49348-182_956f83eb-5e14-4972-b969-51be6da6b590	49348-182	HUMAN OTC DRUG	SunMark allergy relief nasal 24 hr		Fluticasone propionate	SPRAY, METERED	NASAL	20160529		ANDA	ANDA207957	Strategic Sourcing Services LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49348-185_0994aef8-e264-4a79-be5e-3deb037cabd0	49348-185	HUMAN OTC DRUG	Sunmark Mineral Oil	Laxative	Mineral Oil	ENEMA	RECTAL	20021113		OTC MONOGRAPH NOT FINAL	part334	McKesson	MINERAL OIL	118	g/118mL			N	20241231
49348-186_449d8174-1ca9-497e-a897-fd307482aceb	49348-186	HUMAN OTC DRUG	Sunmark Saline Single	Laxative	Sodium Phosphate, Dibasic and Sodium Phosphate, Monobasic, Unspecified Form	ENEMA	RECTAL	20130306		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
49348-188_08a20e5b-ddd0-5cd1-e063-6294a90a7204	49348-188	HUMAN OTC DRUG	GAS RELIEF		Simethicone	TABLET, CHEWABLE	ORAL	20160401		OTC MONOGRAPH DRUG	M002	STRATEGIC SOURCING SERVICES LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
49348-190_2116967b-ab23-4a8a-80e3-dab749390ba4	49348-190	HUMAN OTC DRUG	Fiber Caplets		CALCIUM POLYCARBOPHIL	TABLET	ORAL	20190918		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
49348-191_ca2e25f0-7d88-467c-951c-39358c3b7db5	49348-191	HUMAN OTC DRUG	sunmark aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20030906		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49348-196_dbc8bf08-a838-462a-80ae-d7a3155e6679	49348-196	HUMAN OTC DRUG	sunmark ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20030624		ANDA	ANDA072096	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-197_d3fc4610-3632-4408-bac8-14cfe80aac74	49348-197	HUMAN OTC DRUG	Sunmark Nose		Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	20030821		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49348-198_4b42d6cd-f4cd-439d-b9ee-8750abb322ab	49348-198	HUMAN OTC DRUG	Sunmark Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20160725		OTC MONOGRAPH FINAL	part346	Strategic Sourcing Services LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49348-229_62a7f514-790a-40f0-bec1-6ec46cf93cc0	49348-229	HUMAN OTC DRUG	sunmark ibuprofen		Ibuprofen	SUSPENSION	ORAL	20030919		ANDA	ANDA074937	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-230_822fb906-b2b4-4079-bb95-beabed7e5644	49348-230	HUMAN OTC DRUG	sunmark nasal		Oxymetazoline HCl	SPRAY	NASAL	20030919		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
49348-231_d703993b-4723-4778-a5f1-b0a6d6eac7c1	49348-231	HUMAN OTC DRUG	Sunmark Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20030624		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
49348-246_9365412b-ed13-4ed9-8252-f5c2f0e61049	49348-246	HUMAN OTC DRUG	SunMark heartburn relief	acid reducer	Cimetidine	TABLET, FILM COATED	ORAL	20030919		ANDA	ANDA075285	Strategic Sourcing Services LLC	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49348-274_5f05bab8-0348-4745-9973-917084329f7a	49348-274	HUMAN OTC DRUG	sunmark	double antibiotic	Bacitracin zinc and Polymyxin B sulfate	OINTMENT	TOPICAL	19901205		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49348-279_181ecc4e-d333-44ce-b8ec-514876c073f3	49348-279	HUMAN OTC DRUG	SUNMARK CLOTRIMAZOLE		Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	Strategic Sourcing Services LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-301_0257b87a-67c6-45ac-98c5-743ff20d1520	49348-301	HUMAN OTC DRUG	sunmark lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120521		ANDA	ANDA202319	Strategic Sourcing Services LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49348-302_091c76f7-a887-3f20-e063-6294a90ad1d0	49348-302	HUMAN OTC DRUG	SUNMARK ANTACID MAXIMUM STRENGTH CHERRY		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20120601	20240901	OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49348-303_091c6971-5cf3-3eec-e063-6294a90a0276	49348-303	HUMAN OTC DRUG	ANTACID MAXIMUM STRENGTH		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20120601	20250301	OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49348-305_091c0eed-30b3-31ba-e063-6394a90afbd0	49348-305	HUMAN OTC DRUG	SUNMARK MILK OF MAGNESIA MINT		magnesium hydroxide	LIQUID	ORAL	20120401	20250201	OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49348-306_5abef9e9-06f6-44a0-8d66-b3efb95d1320	49348-306	HUMAN OTC DRUG	Sunmark Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20030811		ANDA	ANDA074661	Strategic Sourcing Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-325_3cbd3dcf-0e90-49eb-bc3c-cde47a574572	49348-325	HUMAN OTC DRUG	Sunmark pain and fever	childrens	Acetaminophen	SUSPENSION	ORAL	20130117		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49348-329_af196572-2edf-44ca-9fa8-920f14205820	49348-329	HUMAN OTC DRUG	Sunmark Lubricating Plus		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20130606		OTC MONOGRAPH FINAL	part349	Strategic Sourcing Services LLC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
49348-355_b0fa9f9d-9a31-41f6-8cdf-575818147fc5	49348-355	HUMAN OTC DRUG	sunmark miconazole 3		Miconazole nitrate	KIT		20030905		ANDA	ANDA075329	Strategic Sourcing Services LLC						N	20241231
49348-374_557e6ae7-b2bb-47b2-9eea-d8769e2ab6ba	49348-374	HUMAN OTC DRUG	sunmark ibuprofen	infants	ibuprofen	SUSPENSION	ORAL	20030828		ANDA	ANDA075217	Strategic Sourcing Services LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-379_93126403-13fc-45c3-9605-bbdde72a1a2f	49348-379	HUMAN OTC DRUG	sunmark	Clotrimazole 3	Clotrimazole	CREAM	VAGINAL	20000412		NDA	NDA021143	Strategic Sourcing Services LLC	CLOTRIMAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-398_930d30d1-d7c8-45ca-8a7b-a0e6d8b106c3	49348-398	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20090109		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
49348-405_d481aee7-d815-4def-882b-d75070246d11	49348-405	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20130121		OTC MONOGRAPH NOT FINAL	part333A	STRATEGIC SOURCING SERVICES LLC	ALCOHOL	70	mL/100mL			N	20241231
49348-430_89bbd5b9-4e68-4f41-a7a4-2bf32e731d09	49348-430	HUMAN OTC DRUG	Sunmark Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20110926		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49348-441_c7ea187c-b69a-44b8-b0f3-d12197c9c267	49348-441	HUMAN OTC DRUG	SUNMARK HYDROCORTISONE PLUS		Hydrocortisone	CREAM	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49348-443_dd6455b7-210a-4b74-876d-2d6d5f23503e	49348-443	HUMAN OTC DRUG	Sunmark Lice Killing	Maximum Strength Lice Treatment	Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20070727		OTC MONOGRAPH FINAL	part358G	Strategic Sourcing Services LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
49348-477_da7b22ea-7790-440e-90b9-643d4665931a	49348-477	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20121217		OTC MONOGRAPH NOT FINAL	part333A	STRATEGIC SOURCING SERVICES LLC	ALCOHOL	700	mg/mL			N	20241231
49348-499_267afdaf-0170-4a9f-871c-74e740b39503	49348-499	HUMAN OTC DRUG	Sunmark ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20030906		ANDA	ANDA074937	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-500_4a85df99-4f30-4d01-bccd-09d1f6e84ac4	49348-500	HUMAN OTC DRUG	Sunmark ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20030624		ANDA	ANDA074937	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-508_8582c0d6-12e3-4cb0-88f6-9dc38f6b9876	49348-508	HUMAN OTC DRUG	SUNMARK TIOCONAZOLE 1		Tioconazole	OINTMENT	VAGINAL	20071218		ANDA	ANDA075915	Strategic Sourcing Services LLC	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-511_66109236-d86e-4fd3-937d-8067fa43a34c	49348-511	HUMAN OTC DRUG	Stomach relief		Bismuth subsalicylate	TABLET	ORAL	20190927		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
49348-521_6927ae99-b678-41a6-b1cb-b548fce8c565	49348-521	HUMAN OTC DRUG	Sunmark Hydrocortisone with Aloe	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49348-522_0490487f-9bb5-49ca-8db2-4495211f639d	49348-522	HUMAN OTC DRUG	sunmark	Hydrocortisone	Hydrocortisone	OINTMENT	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49348-529_627a7e28-0bf0-4e01-b6a2-7e7e7e2ebbbd	49348-529	HUMAN OTC DRUG	sunmark anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030627		ANDA	ANDA075232	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
49348-530_c271896e-5b14-4589-85d9-55fa7b0e57b7	49348-530	HUMAN OTC DRUG	Sunmark Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20030731		ANDA	ANDA074760	Strategic Sourcing Services LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-541_85aff42b-4bd8-481b-ae16-6d968c386502	49348-541	HUMAN OTC DRUG	Sunmark fiber laxative		Methylcellulose	TABLET	ORAL	20190926		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	METHYLCELLULOSE (4000 CPS)	500	mg/1			N	20241231
49348-543_6459b34c-2237-4931-af7a-507effd2daf0	49348-543	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	STRATEGIC SOURCING SERVICES	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
49348-572_179d7248-c3fa-45c0-9b67-8e20ee1cc0ee	49348-572	HUMAN OTC DRUG	Sunmark Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050618		ANDA	ANDA076789	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-573_8056965e-f1cc-486e-bf5d-c6e867b5ba33	49348-573	HUMAN OTC DRUG	sunmark nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050618		ANDA	ANDA076775	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-600_f48c17ce-818c-45e3-a525-ce3c7c142528	49348-600	HUMAN OTC DRUG	sunmark	triple antibiotic plus pain relief	polymyxin B sulfate, bacitracin zinc, neomycin sulfate, and pramoxine hydrochloride	OINTMENT	TOPICAL	20120331		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49348-602_d4bf7fc5-721a-4ec3-a020-ccfb121bd9ee	49348-602	HUMAN OTC DRUG	Anti-Dandruff		Coal Tar	SHAMPOO	TOPICAL	20050521		OTC MONOGRAPH FINAL	part358H	Strategic Sourcing Services LLC	COAL TAR	25	mg/mL			N	20241231
49348-610_0ce5bdec-f4fe-73d9-e063-6294a90a6a87	49348-610	HUMAN OTC DRUG	Sunmark Caldyphen Clear		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Strategic Sourcing Services LLC	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49348-622_0ce5be01-e0b9-7245-e063-6294a90acccf	49348-622	HUMAN OTC DRUG	sunmark Povidone-Iodine Topical		POVIDONE-IODINE	SOLUTION	TOPICAL	20120628		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
49348-636_01e3d93a-0977-47a5-a983-f523681eb12f	49348-636	HUMAN OTC DRUG	Sunmark	childrens loratadine	Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	Strategic Sourcing Services LLC	LORATADINE	5	mg/5mL			N	20241231
49348-642_3e6182d1-c8ae-4c78-94d2-f7e72a187f80	49348-642	HUMAN OTC DRUG	sunmark ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20040429		ANDA	ANDA075217	Strategic Sourcing Services LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-645_0d9cb558-ac48-4e8e-842e-5d7f0482a60d	49348-645	HUMAN OTC DRUG	sunmark miconazole 3		Miconazole nitrate	KIT		20040720		ANDA	ANDA076357	Strategic Sourcing Services LLC						N	20241231
49348-689_7de1accb-52dc-47ab-a690-17da115b4b1c	49348-689	HUMAN OTC DRUG	SUNMARK MICONAZOLE NITRATE	antifungal	Miconazole Nitrate	CREAM	TOPICAL	19911001		OTC MONOGRAPH FINAL	part333C	Strategic Sourcing Services LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-690_936c668e-6f45-421f-83e6-ea942ed0bc02	49348-690	HUMAN OTC DRUG	sunmark	antibiotic plus pain relief	Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	CREAM	TOPICAL	20120321		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
49348-691_0ca1e74e-f5a1-42e1-8e17-13ab08466655	49348-691	HUMAN OTC DRUG	Sunmark Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050623		ANDA	ANDA078325	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-692_495c82be-a7a1-4bee-af1f-611e88c97549	49348-692	HUMAN OTC DRUG	Sunmark Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050623		ANDA	ANDA078326	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-697_0d2942e7-fe3a-4dd4-e063-6394a90a020f	49348-697	HUMAN OTC DRUG	Sunmark Eye Drops Advanced Moisturizer/Lubricant		Dextran, Polyethylene glycol 400, Povidone, Tetrahydrozoline	SOLUTION/ DROPS	OPHTHALMIC	20070301		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
49348-700_06a40e28-bd73-4556-a977-787747522d59	49348-700	HUMAN OTC DRUG	sunmark nasal decongestant pe	maximum strength	Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20050214		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49348-706_e56971b6-6be1-44c0-9979-a05b7320c8f1	49348-706	HUMAN OTC DRUG	sunmark ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20030624		ANDA	ANDA072096	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-711_0ce5bdec-f4ff-73d9-e063-6294a90a6a87	49348-711	HUMAN OTC DRUG	Sunmark Iodides Tincture		Ethyl Alcohol	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ALCOHOL	.45	mL/mL			N	20241231
49348-727_0524397b-2fdd-4b93-96ca-b85c6596cb40	49348-727	HUMAN OTC DRUG	sunmark ibuprofen ib		Ibuprofen	TABLET, FILM COATED	ORAL	20060428		ANDA	ANDA077349	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-728_ae2f0bf5-1409-48c3-950b-d89e055e7103	49348-728	HUMAN OTC DRUG	Sunmark Chest Congestion Relief DM	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49348-729_9f73801b-d293-447b-b70e-4cebc7c41702	49348-729	HUMAN OTC DRUG	Chest Congestion Relief		Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
49348-737_e89c2cf2-b2f6-452a-ac0b-b4fcfc542022	49348-737	HUMAN OTC DRUG	SUNMARK TUSSIN CF		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20060502		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49348-740_fe94ed44-7e66-46fb-856d-c37281f0ffba	49348-740	HUMAN OTC DRUG	gas relief drops infants		simethicone	EMULSION	ORAL	20190926		OTC MONOGRAPH FINAL	part332	Strategic Sourcing Services LLC	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
49348-753_ea76c696-5497-4282-9865-2a9b1fc19a02	49348-753	HUMAN OTC DRUG	Sunmark Day time	cold and flu	acetaminophen, dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060609		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49348-757_0cfe9a86-12a4-40a6-9d92-9552a75c1ca2	49348-757	HUMAN OTC DRUG	Sunmark Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20030821		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49348-774_9bac885a-f6c4-46c8-96be-ecdef84c0e76	49348-774	HUMAN OTC DRUG	Sunmark Chest Congestion Relief PE	PE	Guaifenesin/phenylephrine	TABLET	ORAL	20060605		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49348-787_7669c2f7-10d4-4c94-96a5-438f898a072d	49348-787	HUMAN OTC DRUG	Sunmark Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20061221		ANDA	ANDA076777	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-788_505b7af2-3404-41bf-a101-0e02ba536149	49348-788	HUMAN OTC DRUG	Sunmark Nicotine		Nicotine	GUM, CHEWING	ORAL	20061221		ANDA	ANDA076779	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-790_0ea76a56-c88a-4c83-e063-6394a90ad422	49348-790	HUMAN OTC DRUG	Athletes Foot		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702	20241231	ANDA	ANDA077511	Strategic Sourcing Services LLC	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	
49348-793_05ab3ed5-f375-4c2d-92fe-467144c3ddb0	49348-793	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	19930719		ANDA	ANDA074165	Strategic Sourcing Services LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-802_0ce5c95c-a899-9b32-e063-6294a90a86b9	49348-802	HUMAN OTC DRUG	Sunmark Phenolated Calamine		Calamine and Zinc Oxide and Phenol	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Strategic Sourcing Services LLC	PHENOL; ZINC OXIDE	10; 160	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49348-817_2741ee59-0c08-4971-8884-3c63d297158b	49348-817	HUMAN OTC DRUG	SunMark Acid Reducer	maximum strength	Famotidine	TABLET, FILM COATED	ORAL	20070618		ANDA	ANDA077351	Strategic Sourcing Services LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49348-818_b14990f8-9e84-4d8a-8e28-a9f2271254f7	49348-818	HUMAN OTC DRUG	Sunmark Loratadine		Loratadine	TABLET	ORAL	20070621		ANDA	ANDA076301	Strategic Sourcing Services LLC	LORATADINE	10	mg/1			N	20241231
49348-828_27e91d77-b359-4ce8-952b-a813f1817e84	49348-828	HUMAN OTC DRUG	Sun Mark Mucus Relief Cough	Childrens	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20071012		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49348-831_a0f6454d-16f0-4473-ad5f-fb3e6cb7a03c	49348-831	HUMAN OTC DRUG	Sunmark		Mineral	OIL	ORAL	20021113		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	MINERAL OIL	999	mg/mL			N	20241231
49348-833_6e7caa6d-bb98-4586-8a0b-998afb5744da	49348-833	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	SUPPOSITORY	VAGINAL	20111209		ANDA	ANDA073507	Strategic Sourcing Services LLC	MICONAZOLE NITRATE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-846_c8cf49ab-7f9e-4ec4-a2a4-e79c29056cd5	49348-846	HUMAN OTC DRUG	sunmark omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080226		NDA	NDA022032	Strategic Sourcing Services LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49348-852_4c099d2c-14f8-4865-9730-cc5acfe37fce	49348-852	HUMAN OTC DRUG	Sunmark Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20080507		ANDA	ANDA077007	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-853_90b18737-2e04-4ad6-958e-2bb0714d78f3	49348-853	HUMAN OTC DRUG	Sunmark Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20080430		ANDA	ANDA077007	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
49348-854_94550a66-f531-4f29-896a-839b248c78a6	49348-854	HUMAN OTC DRUG	SUNMARK	ANTI-ITCH	diphenhydramine hydrochloride and zinc acetate	CREAM	TOPICAL	20050920		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49348-861_b23c9564-19c9-42b9-86d1-babee2b4fa35	49348-861	HUMAN OTC DRUG	sunmark tussin dm	sugar free	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20030624		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49348-863_49a1150d-e7cb-4de1-92c4-fb4c713f9676	49348-863	HUMAN OTC DRUG	gas relief		simethicone	TABLET, CHEWABLE	ORAL	20121001		OTC MONOGRAPH FINAL	part332	Strategic Sourcing Services LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
49348-872_a41336a0-d399-485f-9ed6-295e030602bf	49348-872	HUMAN OTC DRUG	sunmark miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20031125		ANDA	ANDA074760	Strategic Sourcing Services LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49348-873_ecacf39d-3cba-406e-af9d-3d5c8a439cb5	49348-873	HUMAN OTC DRUG	sunmark ibuprofen pm		diphenhydramine citrate and ibuprofen	TABLET, FILM COATED	ORAL	20090218		ANDA	ANDA079113	Strategic Sourcing Services LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-876_baf2f7f9-5c99-414e-89b3-60bb4f1bf63d	49348-876	HUMAN OTC DRUG	Sunmark ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20090401		ANDA	ANDA074937	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-883_558f0da5-74bc-4edc-b290-4a22b8278b9b	49348-883	HUMAN OTC DRUG	sunmark arthricream rub		Trolamine Salicylate	CREAM	TOPICAL	20090610		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	TROLAMINE SALICYLATE	10	g/100g			N	20241231
49348-893_fb2bd65f-ef43-4ed1-91c3-248687ae6a10	49348-893	HUMAN OTC DRUG	sunmark clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49348-927_ef713d42-5595-487a-869f-c704f0ba0a7f	49348-927	HUMAN OTC DRUG	Sunmark ibuprofen ib		Ibuprofen	TABLET, FILM COATED	ORAL	20060320		ANDA	ANDA077349	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49348-934_18c9ff05-74fd-403e-a494-dceb0667a0f0	49348-934	HUMAN OTC DRUG	sunmark childrens all day allergy		cetirizine Hydrochloride	SOLUTION	ORAL	20100909		ANDA	ANDA090254	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49348-947_0d295927-09ca-5b68-e063-6394a90a965f	49348-947	HUMAN OTC DRUG	Sunmark Lubricant Eye Drops		Polypropylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20101201		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
49348-953_a8dc8bda-40d3-456c-853f-d972b920741e	49348-953	HUMAN OTC DRUG	Sunmark Stomach relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20190924		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
49348-968_a4ce640d-7433-42ea-99c0-c5d7a5e69879	49348-968	HUMAN OTC DRUG	sunmark fexofenadine hydrochloride		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110414		ANDA	ANDA076447	Strategic Sourcing Services LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49348-973_08f386aa-23a9-5b18-e063-6294a90a2997	49348-973	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20121213	20250930	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	325	mg/1			N	
49348-975_a250eed6-113b-4ff2-9c4c-f9e4668e1ac4	49348-975	HUMAN OTC DRUG	sunmark nite time		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20111121		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49348-980_efba6920-d220-7cf8-e053-2a95a90ab4d1	49348-980	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20121215	20240930	OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
49348-981_08f38d50-4913-56d9-e063-6294a90a4dea	49348-981	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20121215	20251030	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
49348-991_a456cda4-cd0f-4e24-a359-bbd01d0351b8	49348-991	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140930	20250829	OTC MONOGRAPH NOT FINAL	part356	Strategic Sourcing Services LLC	PHENOL	1.4	g/100mL			N	
49348-998_0e757235-1024-0f72-e063-6294a90adff6	49348-998	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20121213	20250831	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	
49351-103_9b00ff37-ffca-f9cb-e053-2995a90a114d	49351-103	HUMAN OTC DRUG	Tork Hand Sanitizer Alcohol Free Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20140812		OTC MONOGRAPH NOT FINAL	part333E	Essity Professional Hygiene North America LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
49351-104_a1395cd3-9c1c-80b7-e053-2a95a90a7c8a	49351-104	HUMAN OTC DRUG	Tork Foam Antibacterial		benzalkonium chloride	SOAP	TOPICAL	20170315		OTC MONOGRAPH NOT FINAL	part333A	Essity Professional Hygiene North America LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
49351-105_f05632ee-a649-7e11-e053-2995a90a3227	49351-105	HUMAN OTC DRUG	Tork Hand Sanitizer Alcohol Gel		ethyl alcohol	GEL	TOPICAL	20191023		OTC MONOGRAPH NOT FINAL	part333A	Essity Professional Hygiene North America LLC	ALCOHOL	70	mL/100mL			N	20241231
49351-301_0e7362f2-db11-8f4c-e063-6394a90a3643	49351-301	HUMAN OTC DRUG	Tork Hand Sanitizing Alcohol Foam		Alcohol	LIQUID	TOPICAL	20200106		OTC MONOGRAPH DRUG	505G(a)(3)	Essity Professional Hygiene North America LLC	ALCOHOL	70	mL/100mL			N	20251231
49351-303_cff27015-1e40-43ca-9f15-a046fc047d8e	49351-303	HUMAN OTC DRUG	Tork Hand Sanitizing Alcohol-Free Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20221218		OTC MONOGRAPH NOT FINAL	part333A	Essity Professional Hygiene North America LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
49351-304_0e73d361-cfdb-1dd0-e063-6294a90a9fc2	49351-304	HUMAN OTC DRUG	Tork Hand Washing Antibacterial Foam		Benzalkonium Chloride	SOAP	TOPICAL	20230427		OTC MONOGRAPH DRUG	505G(a)(3)	Essity Professional Hygiene North America LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20251231
49354-055_08bf2eb5-b432-0ce8-e063-6294a90af3a0	49354-055	HUMAN OTC DRUG	X3 Clean Foaming Hand Sanitizer		BENZALKONIUM CHLORIDE	AEROSOL, FOAM	TOPICAL	20190501		OTC MONOGRAPH DRUG	505G(a)(3)	HK Kolmar Canada, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
49354-130_08bf29ff-1c69-1547-e063-6294a90ac7ee	49354-130	HUMAN OTC DRUG	Compound W Total Care Wart and Skin Kit		SALICYLIC ACID	KIT		20221205		OTC MONOGRAPH DRUG	M032	HK Kolmar Canada, Inc						N	20241231
49358-570_9e5fc151-4bed-4633-a4d8-69021f00f257	49358-570	HUMAN OTC DRUG	Mineral Creme SPF 50	Mineral Creme SPF 50 Broad Spectrum UVA-UVB Sunscreen Water Resistant (80 min)	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	20; 170	mg/mL; mg/mL			N	20241231
49358-571_44b1f7d2-5e79-4aab-82d0-85351e43aef3	49358-571	HUMAN OTC DRUG	Mineral Tinted SPF 30	Mineral Tinted SPF 30 Broad Spectrum Sunscreen Water Resistant (80 min)	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	20; 170	mg/mL; mg/mL			N	20241231
49358-572_60bcb9d5-b965-40ca-979a-19b7f4fe5a31	49358-572	HUMAN OTC DRUG	MD Mineral BB Creme	Broad Spectrum SPF 50 Water Resistant (80min) Mineral Sunscreen LIGHT	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	2; 17	g/100g; g/100g			N	20241231
49358-573_60bcb9d5-b965-40ca-979a-19b7f4fe5a31	49358-573	HUMAN OTC DRUG	MD Mineral BB Creme	Broad Spectrum SPF 50 Water Resistant (80min) Mineral Sunscreen MEDIUM	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	2; 17	g/100g; g/100g			N	20241231
49358-574_60bcb9d5-b965-40ca-979a-19b7f4fe5a31	49358-574	HUMAN OTC DRUG	MD Mineral BB Creme	Broad Spectrum SPF 50 Water Resistant (80min) Mineral Sunscreen DARK	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	2; 17	g/100g; g/100g			N	20241231
49358-575_60bcb9d5-b965-40ca-979a-19b7f4fe5a31	49358-575	HUMAN OTC DRUG	MD Mineral BB Creme	Broad Spectrum SPF 50 Water Resistant (80min) Mineral Sunscreen DEEP	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	2; 17	g/100g; g/100g			N	20241231
49358-576_74acfa9c-1efd-4569-9598-75cf5cc2a901	49358-576	HUMAN OTC DRUG	Mineral KidStick SPF 40	Mineral Broad Spectrum SPF 40 Sunscreen UVA-UVB Suncreen	Titanium Dioxide and Zinc Oxide	STICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	81; 60	mg/g; mg/g			N	20241231
49358-577_f3ce60d4-3208-4ba5-af74-1c5ac0429476	49358-577	HUMAN OTC DRUG	Solar SPF 40	Broad Spectrum SPF 40 Water Resistant (80 min) Mineral Suncreen	Titanium Dioxide and Zinc Oxide	STICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	81; 60	mg/g; mg/g			N	20241231
49358-578_3647ffa2-6b60-4f11-97ff-e3d6bf0310e0	49358-578	HUMAN OTC DRUG	Solar stick Tinted SPF 40	Tinted Broad Spectrum SPF 40 Water Resistant (80 min) Mineral Suncreen	Titanium Dioxide and Zinc Oxide	STICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	81; 60	mg/g; mg/g			N	20241231
49358-579_8df0c895-d3c1-4d76-9765-8d95ae394888	49358-579	HUMAN OTC DRUG	MD Daily Perfecting Moisturizer SPF 30.	SPF 30 Broad Spectrum Sunscreen UVA-UVB	Avobenzone, Octocrylene, and Octisalate	LOTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 27.5	mg/mL; mg/mL; mg/mL			N	20241231
49358-580_5737c5ed-567b-4054-8cc5-8f1163b26671	49358-580	HUMAN OTC DRUG	Daily Antioxidant Moisturizer SPF 30.	SPF 30 Broad Spectrum Sunscreen UVA-UVB	Avobenzone, Octocrylene, and Octisalate	LOTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 27.5	mg/mL; mg/mL; mg/mL			N	20241231
49358-581_fbf7908c-0c9c-4dde-a8e9-8f0fbc5f4299	49358-581	HUMAN OTC DRUG	Gleam plus Glow SPF 50.	SPF 50 Broad Spectrum Sunscreen UVA-UVB Sheer Glow Tint	Avobenzone, Octisalate, and Octocrylene	LOTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 27.5	mg/mL; mg/mL; mg/mL			N	20241231
49358-582_9a2168cf-0e43-493e-9457-fe6efb25aabb	49358-582	HUMAN OTC DRUG	Tint plus Tone SPF 50.	SPF 50 Broad Spectrum Sunscreen Sheer Tinted Moisturizer	Avobenzone, Octisalate, and Octocrylene	LOTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 27.5	mg/mL; mg/mL; mg/mL			N	20241231
49358-583_fb6abd00-fbea-475b-bb6d-4b4f89f1c11f	49358-583	HUMAN OTC DRUG	Mineral Moisture Defense SPF 50		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	20; 170	mg/mL; mg/mL			N	20241231
49358-584_b5c1967b-a290-49de-bde9-c0980f1e62b9	49358-584	HUMAN OTC DRUG	Mineral KidCreme SPF 50		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	TITANIUM DIOXIDE; ZINC OXIDE	20; 170	mg/mL; mg/mL			N	20241231
49358-600_9883f7bb-a679-4f29-b3f7-32ef5c0fee0d	49358-600	HUMAN OTC DRUG	Hydrating Sheer Lip Balm SPF 30 -Crystal	Broad Spectrum SPF 30 UVA-UVB Sunscreen	Avobenzone, Octisalate, and Homosalate	LIPSTICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
49358-601_9883f7bb-a679-4f29-b3f7-32ef5c0fee0d	49358-601	HUMAN OTC DRUG	Hydrating Sheer Lip Balm SPF 30 - BARE	Broad Spectrum SPF 30 UVA-UVB Sunscreen	Avobenzone, Octisalate, and Homosalate	LIPSTICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
49358-602_9883f7bb-a679-4f29-b3f7-32ef5c0fee0d	49358-602	HUMAN OTC DRUG	Hydrating Sheer Lip Balm SPF 30 - BLUSH	Broad Spectrum SPF 30 UVA-UVB Sunscreen	Avobenzone, Octisalate, and Homosalate	LIPSTICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
49358-603_9883f7bb-a679-4f29-b3f7-32ef5c0fee0d	49358-603	HUMAN OTC DRUG	Hydrating Sheer Lip Balm SPF 30 - RUBY	Broad Spectrum SPF 30 UVA-UVB Sunscreen	Avobenzone, Octisalate, and Homosalate	LIPSTICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
49358-604_9883f7bb-a679-4f29-b3f7-32ef5c0fee0d	49358-604	HUMAN OTC DRUG	Hydrating Sheer Lip Balm SPF 30 - SHIMMER	Broad Spectrum SPF 30 UVA-UVB Sunscreen	Avobenzone, Octisalate, and Homosalate	LIPSTICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
49358-605_9883f7bb-a679-4f29-b3f7-32ef5c0fee0d	49358-605	HUMAN OTC DRUG	Hydrating Sheer Lip Balm SPF 30 - SPICE	Broad Spectrum SPF 30 UVA-UVB Sunscreen	Avobenzone, Octisalate, and Homosalate	LIPSTICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
49358-606_9883f7bb-a679-4f29-b3f7-32ef5c0fee0d	49358-606	HUMAN OTC DRUG	Hydrating Sheer Lip Balm SPF 30 - DREAM	Broad Spectrum SPF 30 UVA-UVB Sunscreen	Avobenzone, Octisalate, and Homosalate	LIPSTICK	TOPICAL	20230701		OTC MONOGRAPH FINAL	part352	MDSolarSciences	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
49396-6601_efb90d91-f985-294d-e053-2a95a90ad3c4	49396-6601	HUMAN PRESCRIPTION DRUG	POSIMIR		Bupivacaine	INJECTION	INFILTRATION	20220531		NDA	NDA204803	Renaissance Lakewood, LLC	BUPIVACAINE	660	mg/5mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
49401-088_f5718e70-a617-4c71-9543-42fce2db0506	49401-088	HUMAN PRESCRIPTION DRUG	BENLYSTA		belimumab	SOLUTION	SUBCUTANEOUS	20170720		BLA	BLA761043	GlaxoSmithKline LLC	BELIMUMAB	200	mg/mL	B Lymphocyte Stimulator-directed Antibody Interactions [MoA], B Lymphocyte Stimulator-specific Inhibitor [EPC], Decreased B Lymphocyte Activation [PE]		N	20241231
49401-101_f5718e70-a617-4c71-9543-42fce2db0506	49401-101	HUMAN PRESCRIPTION DRUG	BENLYSTA		belimumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110310		BLA	BLA125370	GlaxoSmithKline LLC	BELIMUMAB	120	mg/1.5mL	B Lymphocyte Stimulator-directed Antibody Interactions [MoA], B Lymphocyte Stimulator-specific Inhibitor [EPC], Decreased B Lymphocyte Activation [PE]		N	20241231
49401-102_f5718e70-a617-4c71-9543-42fce2db0506	49401-102	HUMAN PRESCRIPTION DRUG	BENLYSTA		belimumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110310		BLA	BLA125370	GlaxoSmithKline LLC	BELIMUMAB	400	mg/5mL	B Lymphocyte Stimulator-directed Antibody Interactions [MoA], B Lymphocyte Stimulator-specific Inhibitor [EPC], Decreased B Lymphocyte Activation [PE]		N	20241231
49404-137_070ca63e-a395-2d33-e063-6394a90aecde	49404-137	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm 01 Light medium		Titanium Dioxide, Octinoxate, Zinc Oxide, Octisalate	CREAM	TOPICAL	20180426		OTC MONOGRAPH DRUG	M020	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	2.716; 1.8; 3.18; 2	mg/40mL; mg/40mL; mg/40mL; mg/40mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-138_f05d3d17-6ee9-464b-e053-2995a90aaa76	49404-138	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm 02 Medium deep		Octinoxate, Octisalate	CREAM	TOPICAL	20180108		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	2.716; 1.8; 3.18; 2	mg/40mL; mg/40mL; mg/40mL; mg/40mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-139_f05dd396-fb6f-593d-e053-2995a90a4894	49404-139	HUMAN OTC DRUG	Dr.Jart Black Label Detox Beauty Balm		Titanium Dioxide, Octinoxate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20180502		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	2.4; .8; 3.328; .784	mg/40mL; mg/40mL; mg/40mL; mg/40mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-141_f05dc4dd-5d84-cba1-e053-2a95a90a9636	49404-141	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm 03 Deep		Titanium Dioxide, Zinc Oxide, Octinoxate, Octisalate	CREAM	TOPICAL	20180911		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	2.716; 1.8; 2.32; 2	mg/40mL; mg/40mL; mg/40mL; mg/40mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-142_f05dd0e0-0376-78d5-e053-2995a90a99e2	49404-142	HUMAN OTC DRUG	Dr.Jart Cicapair Tiger Grass Camo Drops		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20190515		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	1.284; .864	mg/30mL; mg/30mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-143_f05dcd4e-dea8-75be-e053-2a95a90a34d3	49404-143	HUMAN OTC DRUG	Dr.Jart Every Sun Day Mineral Sun Screen		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20191031		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	2.05; 5.75	mg/50mL; mg/50mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-144_f05dd0e0-0381-78d5-e053-2995a90a99e2	49404-144	HUMAN OTC DRUG	Dr.Jart Every Sun Day Sun Fluid		Homosalate, Octinoxate, Octisalate, Octocrylene, Avobenzone	LIQUID	TOPICAL	20191031		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.9; 9; 6.8; 4.5; 4	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
49404-145_f05dd9d9-e599-61ab-e053-2a95a90acbe0	49404-145	HUMAN OTC DRUG	Dr.Jart Dis-A-Pore Beauty Balm 01		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20191107		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.996; 1.2; 6.388	mg/40mL; mg/40mL; mg/40mL			N	20241231
49404-146_f05db458-9ad5-e766-e053-2995a90a8b30	49404-146	HUMAN OTC DRUG	Dr.Jart Dis-A-Pore Beauty Balm 02		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20191107		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.996; 1.2; 6.388	mg/40mL; mg/40mL; mg/40mL			N	20241231
49404-147_f05dd0e0-038d-78d5-e053-2995a90a99e2	49404-147	HUMAN OTC DRUG	Dr.Jart Cicapair Tiger Grass Color Correcting Treatment		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20211028		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	2.8; 5.8	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-148_dd823868-aa09-b488-e053-2a95a90abc88	49404-148	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Fair-Light		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20220425		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	6.8; 4.5; 4.8; 5	g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-149_dd824969-e571-631d-e053-2995a90ae173	49404-149	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Light Medium-Medium		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20220425		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	6.8; 4.5; 4.8; 5	g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-150_dd8289f1-2026-a548-e053-2a95a90a3b09	49404-150	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Medium-Tan		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20220425		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	6.8; 4.5; 4.8; 5	g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-151_dd82a6af-aa31-98ba-e053-2995a90a5540	49404-151	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Deep Tan-Deep		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20220425		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	6.8; 4.5; 4.8; 5	g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49404-152_f06348f5-4ebd-325b-e053-2a95a90ada52	49404-152	HUMAN OTC DRUG	DR.JART CICAPAIR TIGER GRASS CAMO DROPS		zinc oxide, titanium dioxide	CREAM	TOPICAL	20221221		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	19; 29	mg/mL; mg/mL			N	20241231
49404-153_f06c31b4-da60-6495-e053-2995a90ae67c	49404-153	HUMAN OTC DRUG	DR.JART EVERY SUN DAY MINERAL SUN SCREEN		Titanium dioxide, Zinc Oxide	CREAM	TOPICAL	20221222		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	41; 115	mg/mL; mg/mL			N	20241231
49404-154_f06d8f90-f3e0-6d76-e053-2a95a90af1f8	49404-154	HUMAN OTC DRUG	DR.JART EVERY SUN DAY SUN FLUID		homosalate, octinoxate, octisalate, octocrylene, avobenzone	LIQUID	TOPICAL	20221222		OTC MONOGRAPH NOT FINAL	part352	Have & Be Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	29; 90; 68; 45; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49404-300_02aa02d8-4927-e96a-e063-6394a90a2b3e	49404-300	HUMAN OTC DRUG	DR.JART CICAPAIR TIGER GRASS COLOR CORRECTING TREATMENT		zinc oxide, titanium dioxide	CREAM	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	28; 58	mg/mL; mg/mL			N	20241231
49404-301_02a80d8e-29d0-a339-e063-6294a90a0c35	49404-301	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Fair-Light		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	68; 45; 48; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49404-302_02a8914d-f8b8-4e4b-e063-6294a90a8682	49404-302	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Light Medium-Medium		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	68; 45; 48; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49404-303_02a8b96b-790c-9c21-e063-6294a90aec38	49404-303	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Medium-Tan		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	68; 45; 48; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49404-304_02e22590-d1fe-31a4-e063-6294a90abd77	49404-304	HUMAN OTC DRUG	Dr.Jart Premium Beauty Balm Deep Tan-Deep		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20230814		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	68; 45; 48; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49404-305_02aa0728-a69e-35af-e063-6394a90a8852	49404-305	HUMAN OTC DRUG	Dr.Jart Cicapair Tiger Grass Camo Drops		zinc oxide, titanium dioxide	CREAM	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	19; 29	mg/mL; mg/mL			N	20241231
49404-306_02a7e7c7-62c2-3cf4-e063-6394a90a40f4	49404-306	HUMAN OTC DRUG	DR.JART EVERY SUN DAY MINERAL SUN SCREEN		titanium dioxide, zinc oxide	CREAM	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	41; 115	mg/mL; mg/mL			N	20241231
49404-307_02a72c6d-da43-14b2-e063-6394a90af5cb	49404-307	HUMAN OTC DRUG	DR.JART EVERY SUN DAY SUN FLUID		homosalate, octinoxate, octisalate, octocrylene, avobenzone	LIQUID	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Have & Be Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	29; 90; 68; 45; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49406-003_0786b213-548d-3c8f-e063-6394a90a9809	49406-003	HUMAN OTC DRUG	Formula 3		TOLNAFTATE	SOLUTION	TOPICAL	20121030		OTC MONOGRAPH DRUG	M005	The Tetra Corporation	TOLNAFTATE	10	mg/mL			N	20241231
49406-004_0786f8cb-fb7c-0851-e063-6394a90a2334	49406-004	HUMAN OTC DRUG	FungiFoam		TOLNAFTATE	AEROSOL, FOAM	TOPICAL	20200713		OTC MONOGRAPH DRUG	M005	The Tetra Corporation	TOLNAFTATE	10	mg/mL			N	20241231
49406-007_0786f8cb-fb88-0851-e063-6394a90a2334	49406-007	HUMAN OTC DRUG	Formula 7 - The Solution		Tolnaftate	SOLUTION	TOPICAL	20180613		OTC MONOGRAPH DRUG	M005	The Tetra Corporation	TOLNAFTATE	1	g/100g			N	20241231
49406-008_0786f8cb-fb97-0851-e063-6394a90a2334	49406-008	HUMAN OTC DRUG	Formula 7 THEGEL		Tolnaftate	GEL	TOPICAL	20180613		OTC MONOGRAPH DRUG	M005	The Tetra Corporation	TOLNAFTATE	1	g/100g			N	20241231
49406-009_07870fce-1434-cd3c-e063-6294a90ad2f7	49406-009	HUMAN OTC DRUG	GlyCylic		Salicylic Acid	LIQUID	TOPICAL	20220701		OTC MONOGRAPH DRUG	M005	The Tetra Corporation	SALICYLIC ACID	17	g/100mL			N	20241231
49411-050_bcb6223c-cffb-4b9f-9688-9e670d1bb21b	49411-050	HUMAN PRESCRIPTION DRUG	AMICAR		Aminocaproic Acid	TABLET	ORAL	20150601		NDA	NDA015197	Akorn Operating Company LLC	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
49411-051_bcb6223c-cffb-4b9f-9688-9e670d1bb21b	49411-051	HUMAN PRESCRIPTION DRUG	AMICAR		Aminocaproic Acid	TABLET	ORAL	20150601		NDA	NDA015197	Akorn Operating Company LLC	AMINOCAPROIC ACID	1000	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
49411-052_bcb6223c-cffb-4b9f-9688-9e670d1bb21b	49411-052	HUMAN PRESCRIPTION DRUG	AMICAR		Aminocaproic Acid	SOLUTION	ORAL	20150601		NDA	NDA015230	Akorn Operating Company LLC	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
49415-0004_3657946e-bbf6-4e78-aef0-5cd6393accbe	49415-0004	HUMAN OTC DRUG	HGH Complex		Arnica Montana, Carduus Marianus, Hepar Suis, Hypophysis Suis, Panax Ginseng, Phosphoricum Acidum	SPRAY	ORAL	20170801		UNAPPROVED HOMEOPATHIC		Maximum Results Solution, Inc.	ARNICA MONTANA; ASIAN GINSENG; PHOSPHORIC ACID; PORK LIVER; SILYBUM MARIANUM SEED; SUS SCROFA PITUITARY GLAND	3; 1; 3; 6; 1; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
49415-0005_6554d405-8bc0-4a13-839e-64a4d5a253c2	49415-0005	HUMAN OTC DRUG	H7 Complex		Arnica Montana, Carduus Marianus, Hepar Suis, Hypophysis Suis, Panax Ginseng, Phosphoricum Acidum	SPRAY	ORAL	20171129		UNAPPROVED HOMEOPATHIC		Maximum Results Solution, Inc.	ARNICA MONTANA; ASIAN GINSENG; PHOSPHORIC ACID; PORK LIVER; SILYBUM MARIANUM SEED; SUS SCROFA PITUITARY GLAND	3; 1; 3; 6; 1; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
49436-099_b78e9e98-056e-4556-925e-e68792d50b14	49436-099	HUMAN OTC DRUG	Recovery Numb		LIDOCAINE 4%	CREAM	TOPICAL	20191210		OTC MONOGRAPH DRUG	M017	PURKLENZ FORMULATIONS INC.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49436-291_bf8cd2f4-9694-483b-a4fa-f5ace4419755	49436-291	HUMAN OTC DRUG	PurKlenz		CHLOROXYLENOL	LIQUID	TOPICAL	20120501		OTC MONOGRAPH DRUG	M003	PurKlenz Formulations Inc.	CHLOROXYLENOL	2.949	g/100mL			N	20241231
49436-377_cac1894b-770c-4ea0-a8cb-6f618b866e40	49436-377	HUMAN OTC DRUG	Recovery Antiseptic Skin Prep		CHLOROXYLENOL	LOTION	TOPICAL	20201026		OTC MONOGRAPH DRUG	M003	PURKLENZ FORMULATIONS INC.	CHLOROXYLENOL	3	g/100mL			N	20241231
49449-100_8be7307b-f1fa-440e-864e-7c1101a56e68	49449-100	HUMAN OTC DRUG	TCX Skincare		Colloidal Oatmeal	CREAM	TOPICAL	20120517		OTC MONOGRAPH DRUG	M016	Theraceutix, LLC	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
49467-104_f44fafc4-59c1-be97-e053-2a95a90a1162	49467-104	HUMAN OTC DRUG	NAUS-EASE		MECLIZINE HYDROCHLORIDE	FILM, SOLUBLE	ORAL	20120416		OTC MONOGRAPH FINAL	part336	Sunascen Therapeutics LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
49467-124_f397aa41-4084-de07-e053-2a95a90a862a	49467-124	HUMAN OTC DRUG	NAUS-EASE		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20120416		ANDA	ANDA040659	Sunascen Therapeutics LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
49467-210_f397d737-a688-c4e3-e053-2a95a90ac146	49467-210	HUMAN OTC DRUG	MYGRIN Roll-On		Menthol	GEL	TOPICAL	20180205		OTC MONOGRAPH NOT FINAL	part348	Sunascen Therapeutics LLC	MENTHOL	35	mg/mL			N	20241231
49467-230_f44f322f-c170-1d60-e053-2995a90aff57	49467-230	HUMAN OTC DRUG	MYGRIN Nighttime		Acetaminophen, Aspirin (NSAID), and Diphenhydramine Citrate	TABLET, FILM COATED	ORAL	20180205		OTC MONOGRAPH NOT FINAL	part343	Sunascen Therapeutics LLC	ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE	250; 250; 38	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49479-500_0bc82258-3d54-f51f-e063-6294a90a7973	49479-500	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20130628		NDA	NDA205985	Linde Canada Inc.	NITROGEN	990	mL/L			N	20241231
49479-722_0bc82773-ef6a-ef2a-e063-6394a90a9167	49479-722	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130628		NDA	NDA205986	Linde Canada Inc.	OXYGEN	990	mL/L			N	20241231
49483-003_938bf8c5-6834-6362-e053-2995a90aa7e6	49483-003	HUMAN OTC DRUG	STIMULANT LAXATIVE		BISACODYL	TABLET, DELAYED RELEASE	ORAL	20140401		OTC MONOGRAPH NOT FINAL	part334	TIME CAP LABORATORIES, INC.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49483-011_0acac93d-0f05-0658-e063-6294a90a83c3	49483-011	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20140402		OTC MONOGRAPH DRUG	M013	TIME CAP LABS INC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-061_f4b5e5bc-c56b-bb42-e053-2995a90a0b09	49483-061	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120501		OTC MONOGRAPH FINAL	part341	TIME CAP LABORATORIES, INC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49483-079_97f141d0-789f-8d30-e053-2a95a90ac315	49483-079	HUMAN OTC DRUG	SENNOSIDES		SENNOSIDES	TABLET, SUGAR COATED	ORAL	20180830		OTC MONOGRAPH NOT FINAL	part334	TIME CAP LABORATORIES, INC	SENNOSIDES A AND B	15	mg/1			N	20241231
49483-080_fb676ad3-115d-7cf1-e053-6394a90a682c	49483-080	HUMAN OTC DRUG	SENNA TIME		SENNOSIDES	TABLET, COATED	ORAL	20120514		OTC MONOGRAPH NOT FINAL	part334	TIME CAP LABORATORIES, INC	SENNOSIDES A AND B	8.6	mg/1			N	20241231
49483-081_d42e00f7-ef36-9efc-e053-2995a90a94fe	49483-081	HUMAN OTC DRUG	SENNA TIME S		DOCUSATE SODIUM-SENNOSIDES	TABLET, FILM COATED	ORAL	20120514		OTC MONOGRAPH NOT FINAL	part334	TIME CAP LABORATORIES, INC	DOCUSATE SODIUM; SENNOSIDES A AND B	50; 8.6	mg/1; min/1			N	20241231
49483-083_f4b65706-1160-2b88-e053-2a95a90a0922	49483-083	HUMAN OTC DRUG	LAX-TIME		SENNOSIDES	TABLET, SUGAR COATED	ORAL	20180830		OTC MONOGRAPH NOT FINAL	part334	TIME CAP LABORATORIES, INC	SENNOSIDES A AND B	25	mg/1			N	20241231
49483-097_d15fb4b1-7dbc-0dec-e053-2a95a90ade85	49483-097	HUMAN OTC DRUG	SENNOSIDES AND DOCUSATE SODIUM		SENNOSIDES AND DOCUSATE SODIUM	TABLET, FILM COATED	ORAL	20100101		OTC MONOGRAPH NOT FINAL	part334	TIME CAP LABORATORIES, INC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
49483-114_0aca78a6-495e-bdd8-e063-6294a90ad0b3	49483-114	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160322		ANDA	ANDA091239	TIME CAP LABORATORIES,INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-133_059c51fc-6904-a427-e063-6294a90a7f69	49483-133	HUMAN OTC DRUG	Ibuprofen		Ibuprofen Capsules 200 mg	CAPSULE, LIQUID FILLED	ORAL	20210727		ANDA	ANDA079205	TIME CAP LABORATORIES, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-221_77d1e7a4-7b10-2f06-e053-2991aa0a2527	49483-221	HUMAN PRESCRIPTION DRUG	NITRO-TIME		NITROGLYCERIN	CAPSULE	ORAL	20140619		UNAPPROVED DRUG OTHER		TIME CAP LABORATORIES, INC	NITROGLYCERIN	2.5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49483-222_77d1e7a4-7b10-2f06-e053-2991aa0a2527	49483-222	HUMAN PRESCRIPTION DRUG	NITRO-TIME		NITROGLYCERIN	CAPSULE	ORAL	20140619		UNAPPROVED DRUG OTHER		TIME CAP LABORATORIES, INC	NITROGLYCERIN	6.5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49483-223_77d1e7a4-7b10-2f06-e053-2991aa0a2527	49483-223	HUMAN PRESCRIPTION DRUG	NITRO-TIME		NITROGLYCERIN	CAPSULE	ORAL	20140619		UNAPPROVED DRUG OTHER		TIME CAP LABORATORIES, INC	NITROGLYCERIN	9	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49483-234_7d0279a6-3a55-e7e4-e053-2a91aa0a1df7	49483-234	HUMAN OTC DRUG	PSEUDO TIME PE		PHENYLEPHRINE HCHLORIDE	TABLET, FILM COATED	ORAL	20120514		OTC MONOGRAPH FINAL	part341	TIME CAP LABORATORIES, INC.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49483-242_7d393588-61e4-0606-e053-2a91aa0a83b2	49483-242	HUMAN OTC DRUG	Allergy Time		Chlorpheniramine Maleate	TABLET	ORAL	20110208		OTC MONOGRAPH FINAL	part341	Time Cap Labs Inc	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49483-272_092526a7-c2e1-4cb5-e063-6394a90ac509	49483-272	HUMAN OTC DRUG	MUCOSA		GUAIFENESIN	TABLET	ORAL	20120416		OTC MONOGRAPH DRUG	M012	TIME CAP LABORATORIES,INC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
49483-280_059abb7a-9449-e088-e063-6394a90a4b2d	49483-280	HUMAN OTC DRUG	MUCOSA DM		GUAIFENESIN DEXTROMETHORPHAN	TABLET	ORAL	20120417		OTC MONOGRAPH FINAL	part341	TIME CAP LABORATORIES, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49483-328_7d3b6a67-60c8-162a-e053-2991aa0a7164	49483-328	HUMAN OTC DRUG	Low Dose Aspirin	Enteric Safety Coated	Aspirin	TABLET, DELAYED RELEASE	ORAL	20100811		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-329_7d3b9a35-9e04-4289-e053-2a91aa0a5042	49483-329	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20100301		OTC MONOGRAPH FINAL	part341	Time-Cap Labs, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49483-330_7d5fb951-93ac-12fa-e053-2991aa0abbf3	49483-330	HUMAN OTC DRUG	Low Dose Miniprin	Enteric Safety Coated	Aspirin	TABLET, DELAYED RELEASE	ORAL	20100811		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-331_cd865e39-baff-da9b-e053-2995a90a9547	49483-331	HUMAN OTC DRUG	Enteric Coated Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110104		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	325	mg/3251	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-333_7d3bf3b4-998d-e1df-e053-2991aa0a471c	49483-333	HUMAN OTC DRUG	Motion-Time	Chewable	Meclizine HCl	TABLET, CHEWABLE	ORAL	20100809		OTC MONOGRAPH FINAL	part336	Time-Cap Labs, Inc	MECLIZINE HYDROCHLORIDE	25	mg/251	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
49483-334_7d3d1e93-a7f9-92d4-e053-2a91aa0a7dbd	49483-334	HUMAN OTC DRUG	aspirin	low dose chewable	aspirin	TABLET, CHEWABLE	ORAL	20100716		OTC MONOGRAPH NOT FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-340_f7f6569d-0d88-0aa4-e053-6394a90a71be	49483-340	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20111215		OTC MONOGRAPH NOT FINAL	part343	TIME CAP LABS INC	ACETAMINOPHEN	325	mg/1			N	20241231
49483-341_08aca495-24f0-9caa-e063-6294a90a4096	49483-341	HUMAN OTC DRUG	ACETAMINOPHEN	Extra Strength	ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20110718		OTC MONOGRAPH DRUG	M013	TIME CAP LABS INC	ACETAMINOPHEN	500	mg/1			N	20241231
49483-342_7d3e2e18-1dee-4000-e053-2a91aa0aeefe	49483-342	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20120501		OTC MONOGRAPH NOT FINAL	part343	TIME CAP LABORATORIES, INC	ACETAMINOPHEN	500	mg/1			N	20241231
49483-343_7d3e5e3c-3199-5637-e053-2991aa0a0d27	49483-343	HUMAN OTC DRUG	Alert		Caffeine	TABLET, FILM COATED	ORAL	20111130		OTC MONOGRAPH FINAL	part340	Time Cap Labs, Inc	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
49483-347_7cfef4a4-ab1d-2dd4-e053-2991aa0a56c5	49483-347	HUMAN OTC DRUG	Comfort-Time		Acetaminophen, Caffeine, and Pyrilamine Maleate	TABLET, FILM COATED	ORAL	20111130		OTC MONOGRAPH NOT FINAL	part343	Time Cap Labs, Inc	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
49483-349_7cff0ad4-677a-03f7-e053-2a91aa0af7ae	49483-349	HUMAN OTC DRUG	Aspirin	Delayed Release	Aspirin	TABLET, DELAYED RELEASE	ORAL	20101223		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	81	mg/811	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-370_059c3ce8-e373-fece-e063-6394a90a0c4e	49483-370	HUMAN OTC DRUG	EXTRA PAIN RELIEF		ACETAMINOPHEN, ASPIRIN AND CAFFEINE	TABLET, FILM COATED	ORAL	20131101		OTC MONOGRAPH NOT FINAL	part343	TIME CAP LABS	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
49483-373_05364eb4-07a2-a4d9-e063-6294a90a47e5	49483-373	HUMAN OTC DRUG	Tension Headache Relief		Acetaminophen, Caffeine	TABLET	ORAL	20210616		OTC MONOGRAPH NOT FINAL	part343	TIME CAP LABS INC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
49483-381_7d3eb3e0-2eaa-1536-e053-2a91aa0a228b	49483-381	HUMAN OTC DRUG	Low Dose Aspirin	Enteric Safety Coated	Aspirin	TABLET, DELAYED RELEASE	ORAL	20100810		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-382_7d3ee158-5996-c9c6-e053-2991aa0a844a	49483-382	HUMAN OTC DRUG	ASPIRIN	EXTRA STRENGTH	Aspirin	TABLET, COATED	ORAL	20130211		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	500	mg/5001	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-387_7d3f2035-b032-633c-e053-2991aa0a59f2	49483-387	HUMAN OTC DRUG	aspirin	low dose enteric coated	aspirin	TABLET, COATED	ORAL	20100628		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-390_7d3f7c1d-79ea-acce-e053-2a91aa0acd38	49483-390	HUMAN OTC DRUG	aspirin	low dose enteric coated	aspirin	TABLET	ORAL	20100716		OTC MONOGRAPH FINAL	part343	Time-Cap Labs, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-430_010c5c98-fc68-a9c3-e063-6394a90aa640	49483-430	HUMAN OTC DRUG	Extra strength Acetaminophen PM		Acetaminophen 500mg/ Diphenhydramine HCl 25mg	TABLET	ORAL	20230722		OTC MONOGRAPH NOT FINAL	part343	TIME CAP LABS INC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49483-481_0db42a3e-0e86-1b7c-e063-6294a90a59f5	49483-481	HUMAN OTC DRUG	LOW DOSE ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20150619		OTC MONOGRAPH DRUG	M013	TIME CAP LABORATORIES, INC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49483-600_0aca78a6-495e-bdd8-e063-6294a90ad0b3	49483-600	HUMAN OTC DRUG	IBUPROFEN		IBUPFROFEN	TABLET, FILM COATED	ORAL	20160322		ANDA	ANDA091239	TIME CAP LABORATORIES,INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-601_0aca78a6-495e-bdd8-e063-6294a90ad0b3	49483-601	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20160322		ANDA	ANDA091239	TIME CAP LABORATORIES,INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-602_9af0c38e-0340-926c-e053-2995a90a30c8	49483-602	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	TIME CAP LABORATORIES, INC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-603_9af0c38e-0340-926c-e053-2995a90a30c8	49483-603	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	TIME CAP LABORATORIES, INC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-604_9af0c38e-0340-926c-e053-2995a90a30c8	49483-604	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	TIME CAP LABORATORIES, INC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-605_c0288657-2288-173a-e053-2a95a90a6636	49483-605	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	TIME CAP LABORATORIES, INC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
49483-606_c0288657-2288-173a-e053-2a95a90a6636	49483-606	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	TIME CAP LABORATORIES, INC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
49483-607_c0288657-2288-173a-e053-2a95a90a6636	49483-607	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	TIME CAP LABORATORIES, INC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
49483-608_0538c5c7-c559-4ea9-e063-6294a90aec21	49483-608	HUMAN OTC DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET, FILM COATED	ORAL	20160328		ANDA	ANDA090545	TIME CAP LABORATORIES, INC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-609_cbf198fe-25e4-694c-e053-2995a90aae22	49483-609	HUMAN OTC DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET, FILM COATED	ORAL	20160328		ANDA	ANDA090545	TIME CAP LABORATORIES, INC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-611_3aacf896-adf0-47fb-9cc4-a85ee9f61367	49483-611	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20161116		ANDA	ANDA091237	TIME CAP LABORATORIES,INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-612_3aacf896-adf0-47fb-9cc4-a85ee9f61367	49483-612	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20161116		ANDA	ANDA091237	TIME CAP LABORATORIES,INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-617_77d2030d-4699-2117-e053-2a91aa0a6dc8	49483-617	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	TIME CAP LABORATORIES	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-618_77d2030d-4699-2117-e053-2a91aa0a6dc8	49483-618	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	TIME CAP LABORATORIES	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-619_77d2030d-4699-2117-e053-2a91aa0a6dc8	49483-619	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	TIME CAP LABORATORIES	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-620_9af12167-4e7a-8e00-e053-2a95a90a270d	49483-620	HUMAN PRESCRIPTION DRUG	METFORMIN HCL		METFORMIN HCL	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA090888	TIME CAP LABORATORIES, INC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
49483-621_9af12167-4e7a-8e00-e053-2a95a90a270d	49483-621	HUMAN PRESCRIPTION DRUG	METFORMIN HCL		METFORMIN HCL	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA090888	TIME CAP LABORATORIES, INC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
49483-622_9af12167-4e7a-8e00-e053-2a95a90a270d	49483-622	HUMAN PRESCRIPTION DRUG	METFORMIN HCL		METFORMIN HCL	TABLET, FILM COATED	ORAL	20161114		ANDA	ANDA090888	TIME CAP LABORATORIES, INC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
49483-623_91e37851-9134-2578-e053-2a95a90a989c	49483-623	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	TIME CAP LABORATORIES, INC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
49483-624_91e37851-9134-2578-e053-2a95a90a989c	49483-624	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	TIME CAP LABORATORIES, INC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
49483-682_dfbdaf6a-c5e8-c5f9-e053-2995a90ae2c6	49483-682	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20220530		ANDA	ANDA078933	TIME CAP LABORATORIES, INC.	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49483-686_6c562c37-86ca-42c2-e053-2a91aa0a8a8a	49483-686	HUMAN OTC DRUG	LORATADINE		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20161013		ANDA	ANDA206214	TIME CAP LABORATORIES INC	LORATADINE	10	mg/1			N	20241231
49483-687_eed565d0-059d-eef6-e053-2a95a90ac962	49483-687	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20170103		ANDA	ANDA204948	TIME CAP LABORATORIES, INC	PARICALCITOL	1	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
49483-688_eed565d0-059d-eef6-e053-2a95a90ac962	49483-688	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20151230		ANDA	ANDA204948	TIME CAP LABORATORIES, INC	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
49483-689_eed565d0-059d-eef6-e053-2a95a90ac962	49483-689	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20170103		ANDA	ANDA204948	TIME CAP LABORATORIES, INC	PARICALCITOL	4	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
49483-690_c715d9f2-9fe1-0bdd-e053-2a95a90aecf2	49483-690	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET	ORAL	20210714		ANDA	ANDA079012	TIME CAP LABORATORIES, INC.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
49483-691_c715d9f2-9fe1-0bdd-e053-2a95a90aecf2	49483-691	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET	ORAL	20210714		ANDA	ANDA079012	TIME CAP LABORATORIES, INC.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
49483-692_f2843e12-4147-75a6-e053-2995a90ad661	49483-692	HUMAN OTC DRUG	Cetirizine Hydrochloride Tablets,10 mg		Cetirizine Hydrochloride	TABLET	ORAL	20220212		ANDA	ANDA078933	TIME CAP LABORATORIES, INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49483-693_fd24653e-c4fb-3c09-e053-6394a90aaa9e	49483-693	HUMAN OTC DRUG	Daytime cold and flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCI 325, 10, 5 mg softgels	CAPSULE, LIQUID FILLED	ORAL	20230706		OTC MONOGRAPH FINAL	part341	TIME CAP LABORATORIES, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49483-695_fd81dd4b-9618-f4c1-e053-6394a90a5e72	49483-695	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCI, Doxylamine Succinate 325, 10/15, 5, 6.25 mg softgels	KIT	ORAL	20230607		OTC MONOGRAPH FINAL	part341	TIME CAP LABORATORIES INC.						N	20241231
49483-697_d780e21d-d903-7c09-e053-2a95a90a3c57	49483-697	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		Acetaminophen	TABLET	ORAL	20220211		OTC MONOGRAPH NOT FINAL	part343	TIME CAP LABORATORIES, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
49483-699_eb0bcd1a-2f6b-5e5e-e053-2995a90ab995	49483-699	HUMAN OTC DRUG	Acetaminophen		Acetaminophen tablet extended release	TABLET, EXTENDED RELEASE	ORAL	20211004		ANDA	ANDA215486	TIME CAP LABORATORIES, INC.	ACETAMINOPHEN	650	mg/1			N	20241231
49483-700_059cb22f-f6dc-5d03-e063-6294a90a9ec1	49483-700	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20231023		ANDA	ANDA079205	TIME CAP LABORATORIES, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-701_e1794947-4c24-2c93-e053-2a95a90a3fe2	49483-701	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220212		ANDA	ANDA075465	TIME CAP LABORATORIES, INC.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49483-702_e1794947-4c24-2c93-e053-2a95a90a3fe2	49483-702	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220212		ANDA	ANDA075465	TIME CAP LABORATORIES, INC.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49483-703_e1794947-4c24-2c93-e053-2a95a90a3fe2	49483-703	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220212		ANDA	ANDA075465	TIME CAP LABORATORIES, INC.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49483-704_eb0bcd1a-2f6b-5e5e-e053-2995a90ab995	49483-704	HUMAN OTC DRUG	Muscle Aches and Pains Acetaminophen extended release		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA215486	TIME CAP LABORATORIES, INC.	ACETAMINOPHEN	650	mg/1			N	20241231
49483-716_08acd3bf-ad0d-f693-e063-6394a90ad8c2	49483-716	HUMAN OTC DRUG	Dual Action Pain Relief		Acetaminophen, Ibuprofen	TABLET	ORAL	20231013		ANDA	ANDA216994	TIME CAP LABORATORIES, INC.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49483-718_08ad180e-e87a-ba6f-e063-6394a90a2bc7	49483-718	HUMAN OTC DRUG	Esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20231114		ANDA	ANDA217264	TIME CAP LABORATORIES, INC.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49483-720_0b1af6f7-fecd-e0a5-e063-6394a90a7535	49483-720	HUMAN OTC DRUG	Maximum Strength Acid Reducer		Famotidine	TABLET	ORAL	20230615		ANDA	ANDA217543	TIME CAP LABORATORIES,INC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
49483-726_fff69901-965d-5372-e053-6394a90a29c2	49483-726	HUMAN OTC DRUG	Maximum strength Day cold and flu and Night severe cold and flu		Acetaminophe, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, Triprolidine HCl Tablets	KIT		20230921		OTC MONOGRAPH DRUG	M012	TIME CAP LABORATORIES,INC						N	20241231
49502-101_34f5aa96-1aab-4ddd-83dc-b8be2907d227	49502-101	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR	20161215		NDA AUTHORIZED GENERIC	NDA019430	Mylan Specialty L.P.	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
49502-102_34f5aa96-1aab-4ddd-83dc-b8be2907d227	49502-102	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR	20161215		NDA AUTHORIZED GENERIC	NDA019430	Mylan Specialty L.P.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
49502-250_b48ff049-2c9c-4143-88c9-22e628281502	49502-250	HUMAN PRESCRIPTION DRUG	SEMGLEE		insulin glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20211115		BLA	BLA761201	Mylan Specialty L.P.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
49502-251_b48ff049-2c9c-4143-88c9-22e628281502	49502-251	HUMAN PRESCRIPTION DRUG	SEMGLEE		insulin glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20211115		BLA	BLA761201	Mylan Specialty L.P.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
49502-345_8061b21d-5a04-48c1-b0fe-f769560f4a59	49502-345	HUMAN PRESCRIPTION DRUG	TOBI		Tobramycin	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20220623		NDA	NDA050753	Mylan Specialty L.P.	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
49502-378_5bbfafaa-e558-45f5-9ae4-c26aecb5815c	49502-378	HUMAN PRESCRIPTION DRUG	ERMEZA		levothyroxine sodium	SOLUTION	ORAL	20221214		NDA	NDA215809	Mylan Specialty L.P.	LEVOTHYROXINE SODIUM	30	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
49502-380_73e7b7ec-0cf7-40fb-a7c2-1ebaf8e92bf1	49502-380	HUMAN PRESCRIPTION DRUG	HULIO		adalimumab	KIT		20230701		BLA	BLA761154	Mylan Specialty L.P.						N	20241231
49502-381_73e7b7ec-0cf7-40fb-a7c2-1ebaf8e92bf1	49502-381	HUMAN PRESCRIPTION DRUG	HULIO		adalimumab	KIT		20230701		BLA	BLA761154	Mylan Specialty L.P.						N	20241231
49502-382_73e7b7ec-0cf7-40fb-a7c2-1ebaf8e92bf1	49502-382	HUMAN PRESCRIPTION DRUG	HULIO		adalimumab	KIT		20230701		BLA	BLA761154	Mylan Specialty L.P.						N	20241231
49502-393_4ad0964c-21f9-4fd0-a8ed-c0202d1b4fce	49502-393	HUMAN PRESCRIPTION DRUG	Insulin Glargine		insulin glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20211116		BLA	BLA761201	Mylan Specialty L.P.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
49502-394_4ad0964c-21f9-4fd0-a8ed-c0202d1b4fce	49502-394	HUMAN PRESCRIPTION DRUG	Insulin Glargine		insulin glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20211116		BLA	BLA761201	Mylan Specialty L.P.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
49502-401_0fd51b21-02ae-4b86-a817-4352a9899256	49502-401	HUMAN PRESCRIPTION DRUG	TOBI Podhaler		Tobramycin	CAPSULE	ORAL; RESPIRATORY (INHALATION)	20210901	20261231	NDA	NDA201688	Mylan Specialty L.P.	TOBRAMYCIN	28	mg/1	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	
49502-416_68c2c569-f3f3-4b33-8d4b-a164e78a1ae2	49502-416	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab	KIT		20230702		BLA	BLA761154	Mylan Specialty L.P.						N	20241231
49502-417_68c2c569-f3f3-4b33-8d4b-a164e78a1ae2	49502-417	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab	KIT		20230702		BLA	BLA761154	Mylan Specialty L.P.						N	20241231
49502-418_68c2c569-f3f3-4b33-8d4b-a164e78a1ae2	49502-418	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab	KIT		20230702		BLA	BLA761154	Mylan Specialty L.P.						N	20241231
49502-425_b3c95eed-7579-40b4-bf99-1530b71a975a	49502-425	HUMAN PRESCRIPTION DRUG	SYMFI LO		Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180313		NDA	NDA208255	Mylan Specialty L.P.	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	400; 300; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
49502-450_6e54ea13-a4be-4744-b1d6-e444181c0741	49502-450	HUMAN PRESCRIPTION DRUG	CIMDUO		Lamivudine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180625		NDA	NDA022141	Mylan Specialty L.P.	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	300; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
49502-475_d0b5030f-af79-4f3b-afe6-169ffc8ff276	49502-475	HUMAN PRESCRIPTION DRUG	SYMFI		Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180425		NDA	NDA022142	Mylan Specialty L.P.	EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	600; 300; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
49502-476_5dd0a13a-c8f0-413f-8306-92c479195e0f	49502-476	HUMAN PRESCRIPTION DRUG	Pretomanid		Pretomanid	TABLET	ORAL	20191107		NDA	NDA212862	Mylan Specialty L.P.	PRETOMANID	200	mg/1			N	20241231
49502-500_43cac57b-eee5-49ac-85c3-5c34069e610b	49502-500	HUMAN PRESCRIPTION DRUG	EPIPEN		epinephrine	INJECTION	INTRAMUSCULAR	19871222		NDA	NDA019430	Mylan Specialty L.P.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
49502-501_43cac57b-eee5-49ac-85c3-5c34069e610b	49502-501	HUMAN PRESCRIPTION DRUG	EPIPEN JR		epinephrine	INJECTION	INTRAMUSCULAR	19871222		NDA	NDA019430	Mylan Specialty L.P.	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
49502-605_e5b5d4fc-4d7c-40c5-adcc-662c711832a1	49502-605	HUMAN PRESCRIPTION DRUG	Perforomist		formoterol fumarate dihydrate	SOLUTION	RESPIRATORY (INHALATION)	20071001		NDA	NDA022007	Mylan Specialty L.P.	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
49502-806_10a82af1-5439-42be-b133-7ac409784ea9	49502-806	HUMAN PRESCRIPTION DRUG	YUPELRI		revefenacin	SOLUTION	RESPIRATORY (INHALATION)	20181203		NDA	NDA210598	Mylan Specialty L.P.	REVEFENACIN	175	ug/3mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
49502-900_cd3db8f7-5826-4db3-8db0-4bfca69288fe	49502-900	HUMAN PRESCRIPTION DRUG	EMSAM		selegiline	PATCH	TRANSDERMAL	20060227		NDA	NDA021336	Mylan Specialty L.P.	SELEGILINE	6	mg/24h	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
49502-901_cd3db8f7-5826-4db3-8db0-4bfca69288fe	49502-901	HUMAN PRESCRIPTION DRUG	EMSAM		selegiline	PATCH	TRANSDERMAL	20060227		NDA	NDA021336	Mylan Specialty L.P.	SELEGILINE	9	mg/24h	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
49502-902_cd3db8f7-5826-4db3-8db0-4bfca69288fe	49502-902	HUMAN PRESCRIPTION DRUG	EMSAM		selegiline	PATCH	TRANSDERMAL	20060227		NDA	NDA021336	Mylan Specialty L.P.	SELEGILINE	12	mg/24h	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
49514-051_0f867bca-4698-40c6-8293-c349c4708962	49514-051	HUMAN OTC DRUG	BRIGHTON PROFESSIONAL Antibacterial Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20060430		OTC MONOGRAPH NOT FINAL	part333E	Staples	CHLOROXYLENOL	.003	mg/mL			N	20241231
49514-080_f4398700-81d1-43e3-908d-8f0eb0376fcf	49514-080	HUMAN OTC DRUG	BRIGHTON PROFESSIONAL Antibacterial Foaming Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20060530		OTC MONOGRAPH NOT FINAL	part333E	Staples	CHLOROXYLENOL	.003	mg/mL			N	20241231
49514-081_ca29b8c4-82ba-45e2-8247-cbf897bddd43	49514-081	HUMAN OTC DRUG	BRIGHTON PROFESSIONAL Premium Antibacterial Foam So ap		Chloroxylenol	LIQUID	TOPICAL	20070330		OTC MONOGRAPH NOT FINAL	part333E	Staples	CHLOROXYLENOL	.003	mg/mL			N	20241231
49514-230_b44eae5e-ddca-483e-92ed-c0ed7f50ad69	49514-230	HUMAN OTC DRUG	Perk Hand Sanitizer		alcohol	GEL	TOPICAL	20190425	20240401	OTC MONOGRAPH NOT FINAL	part333E	Staples	ALCOHOL	.7	mL/mL			N	
49514-280_6a3727c0-76aa-4a32-9730-212e81f2f945	49514-280	HUMAN OTC DRUG	Perk Hand Sanitizer Moisturizing Gel		ALCOHOL	GEL	TOPICAL	20190425	20240401	OTC MONOGRAPH NOT FINAL	part333E	Staples	ALCOHOL	.7	mL/mL			N	
49514-400_7795c541-d287-4600-af1c-a50a4bb09390	49514-400	HUMAN OTC DRUG	BRIGHTON PROFESSIONAL Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Staples	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
49514-472_3955ee75-2ab3-4ea2-887d-1bb0a271b63b	49514-472	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160616		OTC MONOGRAPH NOT FINAL	part333A	Staples the Office Superstore, LLC	ALCOHOL	545	mg/mL			N	20241231
49527-017_017ad17c-87b5-dc4e-e063-6294a90ac5e0	49527-017	HUMAN OTC DRUG	REPAIRWEAR	UPLIFTING FIRMING BROAD SPECTRUM SPF 15 DRY	OCTINOXATE, OCTISALATE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20120502		OTC MONOGRAPH FINAL	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	75; 35; 17	mg/mL; mg/mL; mg/mL			N	20241231
49527-019_04a34025-eae3-0729-e063-6394a90a9f31	49527-019	HUMAN OTC DRUG	REDNESS solutions DAILY PROTECTIVE BASE BROAD SPECTRUM SPF 15		TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20111201		OTC MONOGRAPH FINAL	M020	CLINIQUE LABORATORIES LLC	TITANIUM DIOXIDE; ZINC OXIDE	65; 25	mg/mL; mg/mL			N	20241231
49527-022_0b77670a-ddb0-258f-e063-6394a90abe1f	49527-022	HUMAN OTC DRUG	REPAIRWEAR UPLIFTING FIRMING	BROAD SPECTUM SPF 15 - NORMAL COMBO TO COMBINATION oily	OCTINOXATE, OCTISALATE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20121001		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	75; 35; 17	mg/mL; mg/mL; mg/mL			N	20241231
49527-023_018f476d-eb92-6bcf-e063-6394a90a8ec4	49527-023	HUMAN OTC DRUG	CITY BLOCK SHEER Oil FREE DAILY FACE PROTECTOR BROAD SPECTRUM SPF 25		TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20191219		OTC MONOGRAPH FINAL	M020	CLINIQUE LABORATORIES LLC	TITANIUM DIOXIDE; ZINC OXIDE	73; 69	mg/mL; mg/mL			N	20241231
49527-025_0e87fa56-f2c2-f99b-e063-6294a90a94da	49527-025	HUMAN OTC DRUG	EVEN BETTER MAKEUP	BROAD SPECTRUM SPF 15	OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	59; 35; 28	mg/mL; mg/mL; mg/mL			N	20251231
49527-029_0e8855e7-139e-59ca-e063-6294a90a9f4e	49527-029	HUMAN OTC DRUG	MOISTURE SURGE CC	BROAD SPECTRUM SPF 30 HYDRATING COLOUR CORRECTOR	OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20221005		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 50; 52; 32	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49527-030_fa587115-3fba-40b2-e053-6394a90a7796	49527-030	HUMAN OTC DRUG	AGE DEFENSE BB BROAD SPECTRUM SPF 30 ALL SKIN TYPES		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20130501		OTC MONOGRAPH FINAL	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44; 35; 22	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-041_0190664c-6a4c-e654-e063-6394a90a2cbf	49527-041	HUMAN OTC DRUG	CLINIQUE TARGETED PROTECTION SPF 45 BROAD SPECTRUM SUNSCREEN		HOMOSALATE, OCTISALATE, and AVOBENZONE	STICK	TOPICAL	20081201		OTC MONOGRAPH FINAL	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 5; 5	g/100g; g/100g; g/100g			N	20241231
49527-045_0426793e-20f4-f176-e063-6294a90a601a	49527-045	HUMAN OTC DRUG	ACNE CLEANSING		SALICYLIC ACID	GEL	TOPICAL	20141001		OTC MONOGRAPH DRUG	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	20	mg/mL			N	20241231
49527-048_06fabe70-22e7-4814-e063-6394a90aead5	49527-048	HUMAN OTC DRUG	CLINIQUE SMART CUSTOM REPAIR MOISTURIZER BROAD SPECTRUM SPF 15 - VERY DRY/DRY		AVOBENZONE and OCTISALATE	CREAM	TOPICAL	20151201		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
49527-049_06fabf1e-a8ce-d8fe-e063-6294a90ae07b	49527-049	HUMAN OTC DRUG	REPAIRWEAR LASER FOCUS LINE SMOOTHING BROAD SPECTRUM SPF 15 -VERY DRY TO DRY COMBINATION		OCTINOXATE, OCTISALATE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20151001		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	.076125; .03745; .015225	g/100mL; g/100mL; g/100mL			N	20241231
49527-050_06fbb01f-2c86-510c-e063-6394a90a6516	49527-050	HUMAN OTC DRUG	CLINIQUE SMART CUSTOM REPAIR MOISTURIZER BROAD SPECTRUM SPF 15 - COMBINATION/OILY TO OILY		AVOBENZONE and OCTISALATE	CREAM	TOPICAL	20151201		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
49527-051_0d0dced8-4ba0-0cb3-e063-6394a90ad037	49527-051	HUMAN OTC DRUG	CLINIQUE SMART BROAD SPECTRUM SPF 15 CUSTOM-REPAIR MOISTURIZER DRY COMBINATION		avobenzone and octisalate	CREAM	TOPICAL	20151001		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
49527-053_06fcc643-ca45-6857-e063-6394a90a67e1	49527-053	HUMAN OTC DRUG	ACNE AND LINE CORRECTING SERUM		SALICYLIC ACID	LOTION	TOPICAL	20160815		OTC MONOGRAPH DRUG	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	10	mg/mL			N	20241231
49527-056_06fd451b-ef6f-137f-e063-6394a90a8a2c	49527-056	HUMAN OTC DRUG	EVEN BETTER GLOW LIGHT REFLECTING MAKEUP BROAD SPECTRUM SPF 15		Octinoxate, Titanium Dioxide, and Zinc Oxide	LOTION	TOPICAL	20170320		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	60; 38; 30	mg/mL; mg/mL; mg/mL			N	20241231
49527-060_07748d10-b322-1b5c-e063-6394a90ab245	49527-060	HUMAN OTC DRUG	ALMOST powder MAKEUP BROAD SPECTRUM SPF 18		OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20180301		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; TITANIUM DIOXIDE	2; 1.2	g/100g; g/100g			N	20241231
49527-061_f1d9957a-d2df-7ef5-e053-2a95a90a7488	49527-061	HUMAN OTC DRUG	blackhead solutions self-heating blackhead extractor acne medication		Salicylic acid	CREAM	TOPICAL	20180830		OTC MONOGRAPH FINAL	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	10	mg/mL			N	20241231
49527-062_f1d98e2c-f59c-3d49-e053-2995a90afaf7	49527-062	HUMAN OTC DRUG	blackhead solutions 7 day deep pore cleanse and scrub acne medication		Salicylic acid	CREAM	TOPICAL	20180830		OTC MONOGRAPH FINAL	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	10	mg/mL			N	20241231
49527-063_0799f11b-4622-0a97-e063-6394a90a17ed	49527-063	HUMAN OTC DRUG	CLINIQUE FOR MEN SUPER ENGERGIZER ANTI -FATIGUE HYDRATING Concentrate BROAD SPECTRUM SPF 25		AVOBENZONE and OCTISALATE	CREAM	TOPICAL	20181001		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
49527-065_079b3675-615e-1aac-e063-6394a90abb95	49527-065	HUMAN OTC DRUG	CLINIQUE BROAD SPECTRUM SPF 50 SUNSCREEN FACE WITH SOLAR SMART		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20100901		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 50; 27; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-067_079b699b-fbb1-0136-e063-6294a90a1447	49527-067	HUMAN OTC DRUG	Clinique Broad Spectrum SPF 30 Oil Free Face With Solar Smart		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20170101		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 45; 46; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-069_079bb65e-7a67-6c0a-e063-6294a90ab33a	49527-069	HUMAN OTC DRUG	CLINIQUE BROAD SPECTRUM SPF 50 SUNSCREEN BODY WITH SOLAR SMART		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20110601		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 50; 27; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-070_079bb65e-7a6e-6c0a-e063-6294a90ab33a	49527-070	HUMAN OTC DRUG	REDNESS solutions MAKEUP BROAD SPECTRUM SPF 15 WITH PROBIOTIC TECHNOLOGY		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20111201		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	59; 37; 29	mg/mL; mg/mL; mg/mL			N	20241231
49527-073_079bb7e2-552c-cf0e-e063-6394a90a74c8	49527-073	HUMAN OTC DRUG	PEP-STAR DAILY UV PROTECTOR BROAD SPECTRUM SPF 50		TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20170101		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	TITANIUM DIOXIDE; ZINC OXIDE	63; 40	mg/mL; mg/mL			N	20241231
49527-074_079c68e7-7fd2-9bb9-e063-6394a90a5f8e	49527-074	HUMAN OTC DRUG	MOISTURE SURGE SHEERTINT HYDRATOR BROAD SPECTRUM SPF 25		OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20191016		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 45; 38; 36	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-075_051ae0f1-bce0-6836-e063-6394a90aa4ab	49527-075	HUMAN OTC DRUG	SUPERDEFENSE BROAD SPECTRUM SPF 25 FATIGUE plus 1ST SIGNS OF AGE MULTI-CORRECTING		AVOBENZONE and OCTISALATE	CREAM	TOPICAL	20191121		OTC MONOGRAPH FINAL	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; OCTISALATE	.0306; .051	g/mL; g/mL			N	20241231
49527-076_08167b1b-2efd-1256-e063-6394a90a3eaf	49527-076	HUMAN OTC DRUG	ANTIPERSPIRANT-DEODORANT ROLL-ON		Aluminum chlorohydrate	LIQUID	TOPICAL	20200115		OTC MONOGRAPH DRUG	M019	CLINIQUE LABORATORIES LLC	ALUMINUM CHLOROHYDRATE	182	mg/mL			N	20241231
49527-077_0817d141-8c8f-3e19-e063-6394a90a8311	49527-077	HUMAN OTC DRUG	SUPERDEFENSE BROAD SPECTRUM SPF 25 FATIGUE PLUS 1ST SIGNS OF AGE MULTI-CORRECTING VERY DRY TO DRY COMBINATION		AVOBENZONE, HOMOSALATE, and OCTISALATE	CREAM	TOPICAL	20200128		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
49527-078_0d0e08b5-1d53-f62b-e063-6294a90ace87	49527-078	HUMAN OTC DRUG	CLINIQUE SUPER DEFENSE CITY BLOCK DAILY ENERGY PLUS FACE PROTECTOR BROAD SPECTRUM SPF 50		OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE	LOTION	TOPICAL	20200625		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	50; 32; 36	mg/mL; mg/mL; mg/mL			N	20241231
49527-079_0e88852d-7325-3002-e063-6394a90a0369	49527-079	HUMAN OTC DRUG	CLINIQUE ACNE SOLUTIONS CLEANSING FOAM		SALICYLIC ACID	LIQUID	TOPICAL	20200721		OTC MONOGRAPH DRUG	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	20	mg/mL			N	20251231
49527-080_0818396d-cc21-00ac-e063-6394a90a5d82	49527-080	HUMAN OTC DRUG	CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25		TITANIUM DIOXIDE, ZINC OXIDE	LIQUID	TOPICAL	20200924		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	TITANIUM DIOXIDE; ZINC OXIDE	24; 59	mg/mL; mg/mL			N	20241231
49527-081_0828eba6-8d0e-9a5a-e063-6394a90a2fca	49527-081	HUMAN OTC DRUG	CLINIQUE FOR MEN BROAD SPECTRUM SPF 21 MOISTURIZER		AVOBENZONE, OCTINOXATE, OCTISALATE, and OXYBENZONE	LOTION	TOPICAL	20210721		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	30; 74; 50; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-082_082a55c3-be0e-c10b-e063-6394a90a11ae	49527-082	HUMAN OTC DRUG	EVEN BETTER SKIN TONE CORRECTING MOISTURIZER	BROAD SPECTRUM SPF 20	AVOBENZONE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20120601		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 28	mg/mL; mg/mL; mg/mL			N	20241231
49527-083_0a35474f-c644-433e-e063-6294a90a3a75	49527-083	HUMAN OTC DRUG	SMART CLINICAL REPAIR BROAD SPECTRUM SPF 30		AVOBENZONE,HOMOSALATE,OCTINOXATE,OCTISALATE	CREAM	TOPICAL	20230512		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	30; 70; 35; 45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-084_0d0d82be-a504-a563-e063-6294a90a2fba	49527-084	HUMAN OTC DRUG	MOISTURE SURGE SPF		AVOBENZONE,HOMOSALATE,OCTINOXATE,OCTISALATE	CREAM	TOPICAL	20221107		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	30; 70; 70; 45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49527-113_082b297e-d1da-16b2-e063-6294a90a2ffd	49527-113	HUMAN OTC DRUG	CL EB MATTE MAKEUP BROAD SPECTRUM SPF 15		ZINC OXIDE AND TITANIUM DIOXIDE	EMULSION	TOPICAL	20231020		OTC MONOGRAPH DRUG	M020	CLINIQUE LABORATORIES LLC	TITANIUM DIOXIDE; ZINC OXIDE	24; 59	mg/mL; mg/mL			N	20241231
49527-114_04dc3397-6030-da11-e063-6394a90aacea	49527-114	HUMAN OTC DRUG	EVEN BETTER CLINICAL ACNE SOLUTIONS		SALICYLIC ACID	LIQUID	TOPICAL	20230908		OTC MONOGRAPH FINAL	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	5	mg/mL			N	20241231
49527-116_0d0c746a-cbc0-6152-e063-6394a90a0790	49527-116	HUMAN OTC DRUG	ACNE SOLUTIONS	CLINICAL CLEARING gel	SALICYLIC ACID	GEL	TOPICAL	20231221		OTC MONOGRAPH DRUG	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	10	mg/mL			N	20241231
49527-117_0d0d0309-99f1-6d78-e063-6294a90a5bf0	49527-117	HUMAN OTC DRUG	ACNE SOLUTIONS	ALL-OVER CLEARING TREATMENT	BENZOYL PEROXIDE	LOTION	TOPICAL	20231221		OTC MONOGRAPH DRUG	M006	CLINIQUE LABORATORIES LLC	BENZOYL PEROXIDE	25	mg/mL			N	20241231
49527-713_fa575923-5423-a04b-e053-6294a90a6284	49527-713	HUMAN OTC DRUG	ACNE solutions oil CONTROL CLEANSING MASK	ACNE MEDICATION ALL SKIN TYPES	SALICYLIC ACID	CREAM	TOPICAL	20201210		OTC MONOGRAPH FINAL	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	10	mg/mL			N	20241231
49527-723_0d0e0de0-5c59-1cf0-e063-6394a90a222d	49527-723	HUMAN OTC DRUG	ACNE solutions CLARIFYING		SALICYLIC ACID	LIQUID	TOPICAL	20060901		OTC MONOGRAPH DRUG	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	15	mg/mL			N	20241231
49527-751_fa546665-0b12-3365-e053-6294a90a63ce	49527-751	HUMAN OTC DRUG	ACNE solutions liquid MAKEUP	SALICYLIC ACID ACNE TREATMENT	SALICYLIC ACID	LIQUID	TOPICAL	20201204		OTC MONOGRAPH FINAL	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	5	mg/mL			N	20241231
49527-752_f1e9db9c-d185-21da-e053-2a95a90acf90	49527-752	HUMAN OTC DRUG	CLINIQUE SPF 50 BROAD SPECTRUM MINERAL SUNSCREEN FLUID FOR FACE		TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20160601		OTC MONOGRAPH FINAL	M020	CLINIQUE LABORATORIES LLC	TITANIUM DIOXIDE; ZINC OXIDE	63; 40	mg/mL; mg/mL			N	20241231
49527-999_031f2c20-4175-0a75-e063-6394a90af2a7	49527-999	HUMAN OTC DRUG	ACNE solutions	CLEANSING BAR FOR FACE AND BODY	salicylic acid	SOAP	TOPICAL	20060401	20260415	OTC MONOGRAPH DRUG	M006	CLINIQUE LABORATORIES LLC	SALICYLIC ACID	2	g/100g			N	
49539-001_f1e964cb-33eb-61b4-e053-2a95a90a7183	49539-001	HUMAN OTC DRUG	5% Minoxidil Topical Solution		Minoxidil	SOLUTION	TOPICAL	20190401		ANDA	ANDA076239	AVACOR PRODUCTS, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
49542-001_0d98e989-8cd2-5dd3-e063-6294a90a258c	49542-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130531		UNAPPROVED MEDICAL GAS		Southern Tier Home Medical Supplies Inc	OXYGEN	99	L/100L			N	20241231
49543-783_5d1393c7-4ec7-4b19-9399-fc80a0e80081	49543-783	HUMAN OTC DRUG	Hand Sanitizer Wipes		ALCOHOL	CLOTH	TOPICAL	20171219		OTC MONOGRAPH NOT FINAL	part333E	Nexgen	ALCOHOL	620	mg/g			N	20241231
49546-106_615438f4-7824-4367-e053-2a91aa0a7e3c	49546-106	HUMAN OTC DRUG	Ivy-Dry Super		BENZYL ALCOHOL, CAMPHOR, MENTHOL	SPRAY	TOPICAL	20120521		OTC MONOGRAPH NOT FINAL	part348	Ivy-Dry, Inc.	BENZYL ALCOHOL; CAMPHOR (SYNTHETIC); MENTHOL	100; 5; 2.5	mg/mL; mg/mL; mg/mL	Pediculicide [EPC]		N	20241231
49557-701_09d2bc09-6d90-bcf9-e063-6294a90af0a2	49557-701	HUMAN OTC DRUG	High Five Antibacterial Hand		Chloroxylenol	SOAP	TOPICAL	20230308		OTC MONOGRAPH DRUG	505G(a)(3)	Janisource, LLC	CHLOROXYLENOL	1	g/L			N	20241231
49575-001_0c037778-ca3a-30b3-e063-6294a90ac2cf	49575-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19990615		NDA	NDA205767	Machine & Welding Supply Company dba Arc3 Gases South	OXYGEN	992	mL/L			N	20241231
49575-002_0c038c62-d3b2-e343-e063-6394a90a4ae2	49575-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19990615		NDA	NDA205766	Machine & Welding Supply Company dba Arc3 Gases South	NITROGEN	990	mL/L			N	20241231
49575-003_0c0391f6-ba02-d841-e063-6394a90a248a	49575-003	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19900615		NDA	NDA205704	Machine & Welding Supply Company dba Arc3 Gases South	NITROUS OXIDE	990	mL/L			N	20241231
49575-004_0c03671e-ca51-29a2-e063-6294a90a8fb2	49575-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19990615		NDA	NDA205796	Machine & Welding Supply Company dba Arc3 Gases South	AIR	1000	mL/L			N	20241231
49575-005_0c037404-ac08-c7db-e063-6394a90ad86e	49575-005	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20190520		NDA	NDA205764	Machine & Welding Supply Company dba Arc3 Gases South	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
49575-020_0c0390bb-8381-43c4-e063-6294a90af977	49575-020	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	20220201		NDA	NDA205851	Machine & Welding Supply Company dba Arc3 Gases South	HELIUM	990	mL/L			N	20241231
49580-0268_ae80b39f-2126-462a-ab24-cc68ba20bc37	49580-0268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent ReadyInCase	Hydrogen Peroxide	LIQUID	TOPICAL	20140831		OTC MONOGRAPH NOT FINAL	part356	P & L Development, LLC	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
49580-0271_3e2ce4c3-e4ce-4d92-992f-9476f04707bc	49580-0271	HUMAN OTC DRUG	Isopropyl alcohol	50 percent ReadyInCase	Isopropyl alcohol	LIQUID	TOPICAL	20140630	20241231	OTC MONOGRAPH NOT FINAL	part333A	P & L Development, LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	
49580-0272_659f0e71-c048-4e82-91a8-8caa358de6c5	49580-0272	HUMAN OTC DRUG	Isopropyl alcohol	50 percent Wintergreen ReadyInCase	Isopropyl alcohol	LIQUID	TOPICAL	20140630		OTC MONOGRAPH NOT FINAL	part333A	P & L Development, LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
49580-0275_1db51251-f9de-4cab-b4d7-679cf73ade08	49580-0275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent ReadyInCase	Isopropyl alcohol	LIQUID	TOPICAL	20140630		OTC MONOGRAPH NOT FINAL	part333A	P & L Development, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
49580-0276_87ace905-bd32-4dc7-b9b1-e5fa129d07ff	49580-0276	HUMAN OTC DRUG	Isopropyl alcohol	70 percent Wintergreen ReadyInCase	Isopropyl alcohol	LIQUID	TOPICAL	20140831	20250228	OTC MONOGRAPH NOT FINAL	part333A	P & L Development, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	
49580-0277_c9f3ad41-8607-4162-80d8-bbdd56989f2b	49580-0277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent ReadyInCase	Isopropyl alcohol	LIQUID	TOPICAL	20140831		OTC MONOGRAPH NOT FINAL	part333A	P & L Development, LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
49580-0281_9ee1caf3-c876-4976-b6c6-ca7a857d5c01	49580-0281	HUMAN OTC DRUG	Pain Reliever	Childrens	Acetaminophen	SUSPENSION	ORAL	20160430	20250430	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	
49580-0282_6213ac08-ead1-4540-a764-22c3d5e994e8	49580-0282	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20160531		OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49580-0288_03899a90-3900-453e-a1e9-a2cabd2f4046	49580-0288	HUMAN OTC DRUG	Childrens Pain Relief	ReadyInCase	Acetaminophen	SUSPENSION	ORAL	20141130	20251130	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	
49580-0292_b487710a-3096-4a30-b598-d89b0baba0c7	49580-0292	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine Hydrochloride	LIQUID	ORAL	20150331		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49580-0293_1a0cb954-0db0-4a9f-82ea-3e4fb22e9d8e	49580-0293	HUMAN OTC DRUG	Childrens Dye Free Allergy		Diphenhydramine Hydrochloride	LIQUID	ORAL	20150228		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49580-0294_8ef21ba1-46df-4214-867c-625ce20bebce	49580-0294	HUMAN OTC DRUG	Mucus Relief Cough	Childrens	Dextromethorphan HBr, Guaifensin	LIQUID	ORAL	20210326		OTC MONOGRAPH DRUG	M012	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49580-0297_5a76e8eb-69b6-421e-9870-bfad8b9cd274	49580-0297	HUMAN OTC DRUG	Childrens Plus Cough and Runny Nose		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide	SUSPENSION	ORAL	20150630	20250630	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0304_3dbf04a5-0878-488b-82a8-69680f5aa7d3	49580-0304	HUMAN OTC DRUG	Pain Relief Plus Multi Symptom Cold	Childrens	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20210326		OTC MONOGRAPH DRUG	M012	P & L Development, LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49580-0312_9ddfacf1-318e-4415-a297-19fe93a72d4a	49580-0312	HUMAN OTC DRUG	Cold and Allergy	Childrens	Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20160531	20250531	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0314_a046a400-7a7d-495a-b3f8-58907fa2274a	49580-0314	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	LIQUID	ORAL	20160831		OTC MONOGRAPH DRUG	M010	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49580-0322_69a29813-8f72-42aa-a2bb-8a10d49568b6	49580-0322	HUMAN OTC DRUG	Pain Relief	Infants	Acetaminophen	SUSPENSION	ORAL	20160430	20250430	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	
49580-0324_2f9d25a0-c8a9-48e1-a790-60ea1e03512d	49580-0324	HUMAN OTC DRUG	Pain Relief	Infants	Acetaminophen	SUSPENSION	ORAL	20160430	20250430	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	
49580-0326_c4ae02eb-bc40-4e7b-bf6a-0387acc778ec	49580-0326	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20150131	20240701	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49580-0329_67da2434-ef1c-483d-9f4e-701d0055e10d	49580-0329	HUMAN OTC DRUG	Magnesium Citrate	Lemon ReadyInCase	Magnesium citrate	LIQUID	ORAL	20140630	20240630	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
49580-0334_aa265d47-f1cd-4b90-92d2-e6ae03085626	49580-0334	HUMAN OTC DRUG	Mineral oil		Mineral oil	OIL	ORAL	20140831		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	MINERAL OIL	100	mg/100mL			N	20241231
49580-0335_1d7366ba-a1ea-4e5b-8b96-c339e09be9e1	49580-0335	HUMAN OTC DRUG	Mucus Relief	Cold and Sinus Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150228	20241231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0342_23ccbfbb-41a7-493a-a2a1-caebb6c0ed78	49580-0342	HUMAN OTC DRUG	Night time cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20150228	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	500; 15; 6.25	mg/15mL; mg/15mL; mg/15mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0343_6bccb45f-0717-49e8-a8de-b92543b21c51	49580-0343	HUMAN OTC DRUG	Night Time Cold and Flu	ReadyInCase	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20141031	20241031	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0345_b40ddc2e-2388-4b41-bd53-13b6fd7f99d4	49580-0345	HUMAN OTC DRUG	Nighttime Cough	all night cough relief	Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20140731	20241231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0346_51c0f15b-dad9-43fd-9a62-2e329da3ad47	49580-0346	HUMAN OTC DRUG	Nighttime Cold and Flu	ReadyInCase	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20141130		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49580-0372_453929ea-441c-431b-b9bf-a53229490c40	49580-0372	HUMAN OTC DRUG	Stomach Relief	Regular Strength ReadyInCase	Bismuth subsalicylate	LIQUID	ORAL	20140930	20240930	OTC MONOGRAPH FINAL	part335	P & L Development, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
49580-0376_8463cc08-e15c-4d37-91fe-f3a20b444e19	49580-0376	HUMAN OTC DRUG	Sore Throat	ReadyInCase	Phenol	SPRAY	ORAL	20141130	20251130	OTC MONOGRAPH NOT FINAL	part356	P & L Development, LLC	PHENOL	1.4	g/100mL			N	
49580-0378_6254de61-36f7-4839-9100-cf3d61ba962f	49580-0378	HUMAN OTC DRUG	DayTime Cold and Cough	Childrens	Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20160331	20240331	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	5; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0379_f4d797cd-2bcd-41e6-b683-93d70e31da64	49580-0379	HUMAN OTC DRUG	Childrens Triacting Nighttime	Cold and Cough ReadyInCase	Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20141130		OTC MONOGRAPH DRUG	M012	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49580-0382_46820c73-44d1-4a32-a367-0d1dda349a52	49580-0382	HUMAN OTC DRUG	Tussin CF	Multi Symptom Cold Adult	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20150430	20250430	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0385_23dd8bd0-55d7-4eb5-aa20-183507838eff	49580-0385	HUMAN OTC DRUG	Tussin DM Cough and Chest Congestion	Adult	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20150331		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49580-0389_ac1e90c0-e034-4efc-a266-ef83d955d8c7	49580-0389	HUMAN OTC DRUG	Tussin	adult mucus and chest congestion	Guaifenesin	LIQUID	ORAL	20150228	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
49580-0390_aa004a11-b561-476c-a826-c2b212033009	49580-0390	HUMAN OTC DRUG	Witch Hazel	ReadyInCase	Witch hazel	LIQUID	TOPICAL	20140831		OTC MONOGRAPH DRUG	M016	P & L Development, LLC	WITCH HAZEL	86	g/100mL			N	20241231
49580-0394_ceab3e3f-4b3b-4502-a225-0d7f6314fbbf	49580-0394	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20171231		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49580-0415_b37f666f-5bf3-42ba-8821-43bbb71cb80a	49580-0415	HUMAN OTC DRUG	Severe Cold and Flu Relief	Daytime	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20210326	20250531	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0416_e06dfa9b-d4fa-41e7-8173-61d295e50b38	49580-0416	HUMAN OTC DRUG	Severe cold and flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine HCI	LIQUID	ORAL	20150831		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49580-0466_16c3ee15-100c-4350-9b2b-f0e3f086c63f	49580-0466	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150630		OTC MONOGRAPH DRUG	M012	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49580-0467_2212bd77-3149-4161-9832-d735995ede66	49580-0467	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20171231	20241231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0499_fc40e0fd-6661-4db4-8a58-42c38265781d	49580-0499	HUMAN OTC DRUG	Night Time Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171231	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0501_c93ef126-bb2b-4211-a9de-8518e2328803	49580-0501	HUMAN OTC DRUG	Severe Cold and Cough Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20210326		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49580-0502_c67d580a-2991-4415-95a4-99faf2837389	49580-0502	HUMAN OTC DRUG	Nighttime Severe Cold and Cough		Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20210430		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49580-0515_90edca1e-5b90-43a0-973e-f07a3062e4fa	49580-0515	HUMAN OTC DRUG	Cold Max	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine HCI	LIQUID	ORAL	20161031	20241031	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0567_b6cafd14-39f8-48c7-8c70-254d740988b5	49580-0567	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Phenylephrine HCI DoxylamineSucinate	KIT		20180131	20250228	OTC MONOGRAPH FINAL	part341	P & L Development, LLC						N	
49580-0621_3518ee23-6bba-4490-b45f-aa5baf886e52	49580-0621	HUMAN OTC DRUG	Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20180131		OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49580-0623_229e608b-906c-4d1e-928f-c01c516dee9e	49580-0623	HUMAN OTC DRUG	Infants Pain Relief		Acetaminophen	SUSPENSION	ORAL	20180131	20250228	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	
49580-0624_c7d620e7-9599-45ea-9918-31eefd6053b5	49580-0624	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20190930		OTC MONOGRAPH FINAL	part335	P & L Development, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
49580-0682_52338ace-31c6-4f8f-a28a-17951b1e1da8	49580-0682	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20180131	20250131	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	
49580-0685_9571c730-6b2c-414c-8882-16189b58fd2d	49580-0685	HUMAN OTC DRUG	Dye Free Pain Reliever	Childrens	Acetaminophen	SUSPENSION	ORAL	20180228		OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
49580-0724_a51d6704-8543-43f0-b8f2-e0b7e5820576	49580-0724	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191030		OTC MONOGRAPH FINAL	part335	P & L Development, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
49580-0736_5f16fa80-3829-4006-8f3f-f5cf7ecc8169	49580-0736	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20210326		OTC MONOGRAPH FINAL	part335	P & L Development, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
49580-0737_6d013921-964d-41a9-85fd-2522264e5769	49580-0737	HUMAN OTC DRUG	Stomach Relief	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20190930		OTC MONOGRAPH DRUG	M008	P & L Development, LLC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
49580-0808_94eb109f-054b-402a-be9d-6fd01d3dbad4	49580-0808	HUMAN OTC DRUG	Mucus Relief Nighttime Cold Flu	Maximum StrengthCold Flu and Sore Throat	Acetaminophen, Diphenhydramine HCL,Phenylephrine HCL	LIQUID	ORAL	20190501	20241231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
49580-0813_42a3905b-6a4c-4483-9eaf-05ecd1a6d8e7	49580-0813	HUMAN OTC DRUG	Daytime Nighttime Severe Cold and Flu Relief		Acetaminophen Dextromethorphan HBr Guaifenesin Phenylephrine HCI DoxylamineSucinate	KIT		20210326	20250328	OTC MONOGRAPH FINAL	part341	P & L Development, LLC						N	
49580-0817_b9888235-d2be-4e53-a188-8aca74e18e6e	49580-0817	HUMAN OTC DRUG	Tussin Cough DM	Sugar Free	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20180831	20250831	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0842_493f8492-13be-46df-834d-66a10c49bf88	49580-0842	HUMAN OTC DRUG	Stomach Relief	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20190228		OTC MONOGRAPH FINAL	part335	P & L Development, LLC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
49580-0843_5358c7f0-940b-4432-901d-b9250d61bd01	49580-0843	HUMAN OTC DRUG	Night time cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171231	20250731	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0844_ffeea8cf-078b-4ae3-b4e8-29beac0d25fd	49580-0844	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171231	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
49580-0872_58b7975c-9554-4d11-b9ff-f04ae342e967	49580-0872	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20180630	20250630	OTC MONOGRAPH FINAL	part335	P & L Development, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
49580-3278_5a915cb3-5df8-4967-9290-b1dc797ec257	49580-3278	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	LIQUID	ORAL	20191129		OTC MONOGRAPH DRUG	M013	P & L Development, LLC	ACETAMINOPHEN	500	mg/15mL			N	20241231
49580-4160_4cfe80e6-eea3-4a0d-ae61-031d2ebd149d	49580-4160	HUMAN OTC DRUG	Severe cold and flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine HCI	LIQUID	ORAL	20210326	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
49591-051_0942120a-b57e-0ac3-e063-6394a90ae611	49591-051	PLASMA DERIVATIVE	HepaGam B		HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231201		BLA	BLA125035	Kamada Ltd.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	312	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
49591-052_0942120a-b57e-0ac3-e063-6394a90ae611	49591-052	PLASMA DERIVATIVE	HepaGam B		HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231201		BLA	BLA125035	Kamada Ltd.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	312	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
49591-300_8258515a-421c-4424-97f7-7ef4eaf306d8	49591-300	PLASMA DERIVATIVE	WinRho SDF		HUMAN RHO(D) IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230801		BLA	BLA103649	Kamada Ltd.	HUMAN RHO(D) IMMUNE GLOBULIN	15000	[iU]/13mL	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
49591-310_8258515a-421c-4424-97f7-7ef4eaf306d8	49591-310	PLASMA DERIVATIVE	WinRho SDF		HUMAN RHO(D) IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230801		BLA	BLA103649	Kamada Ltd.	HUMAN RHO(D) IMMUNE GLOBULIN	5000	[iU]/4.4mL	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
49591-330_8258515a-421c-4424-97f7-7ef4eaf306d8	49591-330	PLASMA DERIVATIVE	WinRho SDF		HUMAN RHO(D) IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230801		BLA	BLA103649	Kamada Ltd.	HUMAN RHO(D) IMMUNE GLOBULIN	1500	[iU]/1.3mL	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
49591-350_8258515a-421c-4424-97f7-7ef4eaf306d8	49591-350	PLASMA DERIVATIVE	WinRho SDF		HUMAN RHO(D) IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230801		BLA	BLA103649	Kamada Ltd.	HUMAN RHO(D) IMMUNE GLOBULIN	2500	[iU]/2.2mL	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
49591-532_eaa03089-26d4-4945-b075-634cbf56dad2	49591-532	PLASMA DERIVATIVE	Cytogam		HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN	LIQUID	INTRAVENOUS	20230601		BLA	BLA103189	Kamada Ltd.	HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN	2500	mg/50mL	Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
49609-001_a52a159d-f3e3-3f7a-e053-2995a90a038f	49609-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose	F18	Fludeoxyglucose F18	INJECTION	INTRAVENOUS	20111208		ANDA	ANDA203665	SOFIE Co. dba SOFIE	FLUDEOXYGLUCOSE F-18	500	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
49609-002_a5133702-87ed-40f9-e053-2995a90ad385	49609-002	HUMAN PRESCRIPTION DRUG	Sodium Fluoride	F 18	SODIUM FLUORIDE F-18	INJECTION	INTRAVENOUS	20111208		ANDA	ANDA203544	SOFIE Co. dba SOFIE	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
49609-003_a5292896-d774-b0c8-e053-2a95a90a98bc	49609-003	HUMAN PRESCRIPTION DRUG	Ammonia	N 13	AMMONIA N-13	INJECTION	INTRAVENOUS	20110804		ANDA	ANDA203543	SOFIE Co. dba SOFIE	AMMONIA N-13	260	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
49609-101_e7fe8d56-a338-4420-b6ae-c68652343aa8	49609-101	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F-18	INJECTION	INTRAVENOUS	20111208		ANDA	ANDA203591	SOFIE Co.	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
49609-102_44793a2a-9eb4-45f5-832e-bc0fb60156c7	49609-102	HUMAN PRESCRIPTION DRUG	Sodium Fluoride F 18		SODIUM FLUORIDE F-18	INJECTION	INTRAVENOUS	20111208		ANDA	ANDA203592	SOFIE Co.	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
49609-201_1e90547c-5db8-479a-a76a-ef7888025f1a	49609-201	HUMAN PRESCRIPTION DRUG	Ammonia N 13		Ammonia N-13	INJECTION	INTRAVENOUS	20130131		ANDA	ANDA204667	SOFIE Co.	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
49631-178_ece66f36-d132-71f4-e053-2995a90a9cd2	49631-178	HUMAN OTC DRUG	OHTAS ISAN ANTACID		calcium carbonate, sodium bicarbonate	POWDER	ORAL	20001016		OTC MONOGRAPH FINAL	part331	OHTA'S ISAN CO.,LTD.	CALCIUM CARBONATE; SODIUM BICARBONATE	1; 1	g/g; g/g	Alkalinizing Activity [MoA]		N	20241231
49631-178_ece67c0d-3dd8-c117-e053-2995a90a6051	49631-178	HUMAN OTC DRUG	OHTAS ISAN ANTACID		calcium carbonate, sodium bicarbonate	POWDER	ORAL	20170701		OTC MONOGRAPH FINAL	part331	OHTA'S ISAN CO.,LTD.	CALCIUM CARBONATE; SODIUM BICARBONATE	1; 1	g/g; g/g	Alkalinizing Activity [MoA]		N	20241231
49638-101_0dfc3e38-e3a5-4f4e-e063-6394a90abb6f	49638-101	HUMAN OTC DRUG	Aspica (Aspirin)		Aspirin	TABLET, DELAYED RELEASE	ORAL	20200916		OTC MONOGRAPH DRUG	M013	America Medic & Science, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20251231
49638-102_0a21d620-da86-2bb5-e063-6294a90ae8f8	49638-102	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20210629		OTC MONOGRAPH DRUG	M013	America Medic & Science, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49644-001_0761ed22-cf14-8558-e063-6294a90ab2ac	49644-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19700101		NDA	NDA206023	Terry Supply Company Inc	OXYGEN	997	mL/L			N	20241231
49653-002_0802f2ef-d5b0-d9ac-e063-6294a90ab0a1	49653-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19800321		NDA	NDA205766	Superior Welding Supply Co	NITROGEN	990	mL/L			N	20241231
49653-003_0802ee08-d62f-ad56-e063-6294a90a7ad9	49653-003	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19800321		NDA	NDA205767	Superior Welding Supply Co	OXYGEN	990	mL/L			N	20241231
49681-010_d7443c9e-4449-47f1-9195-b9a371ef7434	49681-010	HUMAN OTC DRUG	Lusti Therapeutic Ice Analgesic Rub		menthol, camphor	GEL	TOPICAL	20100324		OTC MONOGRAPH NOT FINAL	part348	New Life Products, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	.031; .015	g/g; g/g			N	20241231
49681-012_7bc49e21-7a82-43cc-a7e3-bc96dc9e900f	49681-012	HUMAN OTC DRUG	Lusti Profesional Vaporizing Rub		Camphor,Eucalyptus Oil, Menthol	OINTMENT	TOPICAL	20100804		OTC MONOGRAPH FINAL	part341	New Life Products, Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	.048; .012; .026	g/g; g/g; g/g			N	20241231
49681-014_52ba7863-fabb-4e00-a3cc-779522dea7f2	49681-014	HUMAN OTC DRUG	new life Rubbing Isopropyl Alcohol 70% First Aid and Antiseptic		Isopropyl alcohol	LIQUID	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part333A	New Life Products, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
49681-015_851f6403-2e5b-401e-bbfc-dee03fa1a802	49681-015	HUMAN OTC DRUG	New Life Antibacterial HandSoap		Benzalkonium Chloride	LIQUID	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part333A	New Life Products, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
49681-016_dcc4ad81-322a-430c-8f49-ff694f576cb6	49681-016	HUMAN OTC DRUG	New Life 3% Hydrogen Peroxide FIRST AID ANTISEPTIC		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20210205		OTC MONOGRAPH NOT FINAL	part333A	New Life Products, Inc.	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
49681-100_913a42bd-6431-4ac5-8158-bb29b06c2e36	49681-100	HUMAN OTC DRUG	new life Moisturizing Hand Sanitizer		Ethanol	GEL	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333A	New Life Products, Inc.	ALCOHOL	70	mL/100mL			N	20241231
49681-200_d2e6b9ee-8f65-4632-aad8-25d0cdb45349	49681-200	HUMAN OTC DRUG	New Life Advanced Formula Topical Hand sanitizer		Alcohol	SPRAY	TOPICAL	20200521		OTC MONOGRAPH NOT FINAL	part333A	New Life Products, Inc.	ALCOHOL	80	mL/100mL			N	20241231
49681-400_4f00c0ed-885d-418e-aef8-ed000d1d6f5c	49681-400	HUMAN OTC DRUG	LUSTI Skin Softening hand sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	20200525		OTC MONOGRAPH NOT FINAL	part333A	New Life Products, Inc.	ALCOHOL	65	mL/100mL			N	20241231
49687-0016_0d11ab8e-d438-c7ef-e063-6294a90ae0a3	49687-0016	HUMAN OTC DRUG	Refill 2		BENZALKONIUM CHLORIDE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	KIT		20160810		OTC MONOGRAPH DRUG	part333	CMC Group, Inc.						N	20241231
49687-0017_0d11be77-159d-4bdd-e063-6394a90a244c	49687-0017	HUMAN OTC DRUG	Refill 3		BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20160810		OTC MONOGRAPH DRUG	M003	CMC Group Inc.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49687-0018_0d11b1c8-6c61-15aa-e063-6294a90a8c16	49687-0018	HUMAN OTC DRUG	Refill 4		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20160810		OTC MONOGRAPH DRUG	M003	CMC Group Inc.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
49687-0019_0d115cd7-9b33-bfa0-e063-6294a90ac7b0	49687-0019	HUMAN OTC DRUG	Refill 6		ALCOHOL, WATER	KIT		20160810		OTC MONOGRAPH DRUG	part333	CMC Group, Inc.						N	20241231
49687-0020_0d11ab8e-d3ed-c7ef-e063-6294a90ae0a3	49687-0020	HUMAN OTC DRUG	Standard ANSI First Aid		WATER, BENZALKONIUM CHLORIDE, ISOPROPYL ALCOHOL, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE HYDROCHLORIDE	KIT		20160810		OTC MONOGRAPH DRUG	part333	CMC Group, Inc.						N	20241231
49687-0021_0d6baf70-cf7f-9655-e063-6394a90a4f64	49687-0021	HUMAN OTC DRUG	Large ANSI First Aid Kit		WATER, BENZALKONIUM CHLORIDE, ISOPROPYL ALCOHOL, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE HYDROCHLORIDE	KIT	OPHTHALMIC	20160809		OTC MONOGRAPH DRUG	part333	CMC Group, Inc.						N	20241231
49687-0029_0d118256-90f0-28ef-e063-6394a90a21e8	49687-0029	HUMAN OTC DRUG	Refill Bundle 7 Large Office		BENZALKONIUM CHLORIDE	KIT		20180213		OTC MONOGRAPH DRUG	M017	CMC Group, Inc.						N	20241231
49696-622_0b50233d-0fd0-efc0-e063-6294a90ac442	49696-622	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19550101		NDA	NDA205849	Oxygen Service Company, Inc	OXYGEN	99	L/100L			N	20241231
49696-632_0b50233d-0fd0-efc0-e063-6294a90ac442	49696-632	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19550101		NDA	NDA205849	Oxygen Service Company, Inc	OXYGEN	99	L/100L			N	20241231
49698-001_0b27ac6d-eef9-4981-e063-6294a90a62e3	49698-001	HUMAN OTC DRUG	ASEPSO ANTISEPTIC ORIGINAL		CHLOROXYLENOL	SOAP	TOPICAL	20230203		OTC MONOGRAPH DRUG	505G(a)(3)	CODAA Switzerland AG	CHLOROXYLENOL	2.5	mg/g			N	20241231
49698-006_08bf2eb5-b416-0ce8-e063-6294a90af3a0	49698-006	HUMAN OTC DRUG	Asepso Sport Antiseptic		CHLOROXYLENOL	SOAP	TOPICAL	20230811		OTC MONOGRAPH DRUG	505G(a)(3)	CODAA SWITZERLAND AG	CHLOROXYLENOL	2.5	mg/g			N	20241231
49698-007_08bf3569-ac16-563d-e063-6394a90a6286	49698-007	HUMAN OTC DRUG	Asepso Aloe Scented Antiseptic		CHLOROXYLENOL	SOAP	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	CODAA Switzerland AG	CHLOROXYLENOL	2.5	mg/g			N	20241231
49698-008_08bf2eb5-b424-0ce8-e063-6294a90af3a0	49698-008	HUMAN OTC DRUG	Asepso Fresh Scented Antiseptic		CHLOROXYLENOL	SOAP	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	CODAA SWITZERLAND AG	CHLOROXYLENOL	2.5	mg/g			N	20241231
49698-009_08bf1e7b-823e-ed12-e063-6294a90a676f	49698-009	HUMAN OTC DRUG	Asepso Herbal Scented Antiseptic		CHLOROXYLENOL	SOAP	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	CODAA SWITZERLAND AG	CHLOROXYLENOL	2.5	mg/g			N	20241231
49698-010_08bf32be-a1db-0c37-e063-6294a90a5c9b	49698-010	HUMAN OTC DRUG	Asepso Lemon Scented Antiseptic		CHLOROXYLENOL	SOAP	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	CODAA SWITZERLAND AG	CHLOROXYLENOL	2.5	mg/g			N	20241231
49702-202_9c13ddca-9cd4-4460-a16a-68da944ab01d	49702-202	HUMAN PRESCRIPTION DRUG	COMBIVIR		lamivudine and zidovudine	TABLET, FILM COATED	ORAL	20101019		NDA	NDA020857	ViiV Healthcare Company	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-203_f91606a6-2657-4320-bbab-aee338efcfd7	49702-203	HUMAN PRESCRIPTION DRUG	EPIVIR		lamivudine	TABLET, FILM COATED	ORAL	20101004		NDA	NDA020564	ViiV Healthcare Company	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-204_f91606a6-2657-4320-bbab-aee338efcfd7	49702-204	HUMAN PRESCRIPTION DRUG	EPIVIR		lamivudine	TABLET, FILM COATED	ORAL	20101004		NDA	NDA020564	ViiV Healthcare Company	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-205_f91606a6-2657-4320-bbab-aee338efcfd7	49702-205	HUMAN PRESCRIPTION DRUG	EPIVIR		lamivudine	SOLUTION	ORAL	20101004		NDA	NDA020596	ViiV Healthcare Company	LAMIVUDINE	10	mg/mL	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-206_bc2d88e8-6717-4e15-af7a-370c260e82bc	49702-206	HUMAN PRESCRIPTION DRUG	EPZICOM		abacavir sulfate and lamivudine	TABLET, FILM COATED	ORAL	20101012		NDA	NDA021652	ViiV Healthcare Company	ABACAVIR SULFATE; LAMIVUDINE	600; 300	mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-207_93fd2788-9ab5-4d86-b9e0-88a10e5de332	49702-207	HUMAN PRESCRIPTION DRUG	LEXIVA		fosamprenavir calcium	TABLET, FILM COATED	ORAL	20101004		NDA	NDA021548	ViiV Healthcare Company	FOSAMPRENAVIR CALCIUM	700	mg/1	Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inducers [MoA], Protease Inhibitor [EPC]		N	20241231
49702-208_93fd2788-9ab5-4d86-b9e0-88a10e5de332	49702-208	HUMAN PRESCRIPTION DRUG	LEXIVA		fosamprenavir calcium	SUSPENSION	ORAL	20101004		NDA	NDA022116	ViiV Healthcare Company	FOSAMPRENAVIR CALCIUM	50	mg/mL	Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inducers [MoA], Protease Inhibitor [EPC]		N	20241231
49702-211_095c792a-11f5-4da3-b742-211876d3bc9d	49702-211	HUMAN PRESCRIPTION DRUG	RETROVIR		zidovudine	CAPSULE	ORAL	20101028		NDA	NDA019655	ViiV Healthcare Company	ZIDOVUDINE	100	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-212_095c792a-11f5-4da3-b742-211876d3bc9d	49702-212	HUMAN PRESCRIPTION DRUG	RETROVIR		zidovudine	SOLUTION	ORAL	20101028		NDA	NDA019910	ViiV Healthcare Company	ZIDOVUDINE	10	mg/mL	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-213_095c792a-11f5-4da3-b742-211876d3bc9d	49702-213	HUMAN PRESCRIPTION DRUG	RETROVIR		zidovudine	INJECTION, SOLUTION	INTRAVENOUS	20101104		NDA	NDA019951	ViiV Healthcare Company	ZIDOVUDINE	10	mg/mL	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-217_82d4603e-fbba-4bf5-8946-b279d775dd46	49702-217	HUMAN PRESCRIPTION DRUG	TRIZIVIR		abacavir sulfate, lamivudine, and zidovudine	TABLET, FILM COATED	ORAL	20101102		NDA	NDA021205	ViiV Healthcare Company	ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE	300; 150; 300	mg/1; mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-221_777ff172-36ec-4673-af53-7779f953898d	49702-221	HUMAN PRESCRIPTION DRUG	ZIAGEN		abacavir sulfate	TABLET, FILM COATED	ORAL	19981229		NDA	NDA020977	ViiV Healthcare Company	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-222_777ff172-36ec-4673-af53-7779f953898d	49702-222	HUMAN PRESCRIPTION DRUG	ZIAGEN		abacavir sulfate	SOLUTION	ORAL	19990128		NDA	NDA020978	ViiV Healthcare Company	ABACAVIR SULFATE	20	mg/mL	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
49702-223_9165dbbc-c0cb-40b2-b7b6-5bfa02bb7979	49702-223	HUMAN PRESCRIPTION DRUG	SELZENTRY		maraviroc	TABLET, FILM COATED	ORAL	20110516		NDA	NDA022128	ViiV Healthcare Company	MARAVIROC	150	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
49702-224_9165dbbc-c0cb-40b2-b7b6-5bfa02bb7979	49702-224	HUMAN PRESCRIPTION DRUG	SELZENTRY		maraviroc	TABLET, FILM COATED	ORAL	20110516		NDA	NDA022128	ViiV Healthcare Company	MARAVIROC	300	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
49702-226_a7af7500-2f34-45cc-bcb9-0fbf4655880a	49702-226	HUMAN PRESCRIPTION DRUG	Tivicay		dolutegravir sodium	TABLET, FILM COATED	ORAL	20160609		NDA	NDA204790	ViiV Healthcare Company	DOLUTEGRAVIR SODIUM	10	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
49702-227_a7af7500-2f34-45cc-bcb9-0fbf4655880a	49702-227	HUMAN PRESCRIPTION DRUG	Tivicay		dolutegravir sodium	TABLET, FILM COATED	ORAL	20160609		NDA	NDA204790	ViiV Healthcare Company	DOLUTEGRAVIR SODIUM	25	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
49702-228_a7af7500-2f34-45cc-bcb9-0fbf4655880a	49702-228	HUMAN PRESCRIPTION DRUG	Tivicay		dolutegravir sodium	TABLET, FILM COATED	ORAL	20130813		NDA	NDA204790	ViiV Healthcare Company	DOLUTEGRAVIR SODIUM	50	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
49702-231_c6caf251-b34f-4846-a477-576354b96d15	49702-231	HUMAN PRESCRIPTION DRUG	Triumeq		abacavir sulfate, dolutegravir sodium, lamivudine	TABLET, FILM COATED	ORAL	20140822		NDA	NDA205551	ViiV Healthcare Company	ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE	600; 50; 300	mg/1; mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
49702-233_9165dbbc-c0cb-40b2-b7b6-5bfa02bb7979	49702-233	HUMAN PRESCRIPTION DRUG	SELZENTRY		maraviroc	TABLET, FILM COATED	ORAL	20161104		NDA	NDA022128	ViiV Healthcare Company	MARAVIROC	25	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
49702-235_9165dbbc-c0cb-40b2-b7b6-5bfa02bb7979	49702-235	HUMAN PRESCRIPTION DRUG	SELZENTRY		maraviroc	TABLET, FILM COATED	ORAL	20161104		NDA	NDA022128	ViiV Healthcare Company	MARAVIROC	75	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
49702-237_9165dbbc-c0cb-40b2-b7b6-5bfa02bb7979	49702-237	HUMAN PRESCRIPTION DRUG	SELZENTRY		maraviroc	SOLUTION	ORAL	20161104	20241031	NDA	NDA208984	ViiV Healthcare Company	MARAVIROC	20	mg/mL	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	
49702-240_5abcc565-e413-4613-a958-8539df1cfa10	49702-240	HUMAN PRESCRIPTION DRUG	Cabenuva		cabotegravir and rilpivirine	KIT		20210121		NDA	NDA212888	ViiV Healthcare Company						N	20241231
49702-242_4c047819-54a8-4773-b377-0053f987f6bf	49702-242	HUMAN PRESCRIPTION DRUG	Juluca		dolutegravir sodium and rilpivirine hydrochloride	TABLET, FILM COATED	ORAL	20171121		NDA	NDA210192	ViiV Healthcare Company	DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE	50; 25	mg/1; mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
49702-246_c29f6087-381e-440e-ab90-b71e3b560f58	49702-246	HUMAN PRESCRIPTION DRUG	Dovato		dolutegravir sodium and lamivudine	TABLET, FILM COATED	ORAL	20190408		NDA	NDA211994	ViiV Healthcare Company	DOLUTEGRAVIR SODIUM; LAMIVUDINE	50; 300	mg/1; mg/1	HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
49702-248_9713d608-de29-46dd-a6c1-77b26d8be928	49702-248	HUMAN PRESCRIPTION DRUG	Vocabria		cabotegravir sodium	TABLET, FILM COATED	ORAL	20210121		NDA	NDA212887	ViiV Healthcare Company	CABOTEGRAVIR SODIUM	30	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
49702-250_ba7411e4-dc14-4225-9ed0-2931a229fd61	49702-250	HUMAN PRESCRIPTION DRUG	Rukobia		fostemsavir tromethamine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200702		NDA	NDA212950	ViiV Healthcare Company	FOSTEMSAVIR TROMETHAMINE	600	mg/1			N	20241231
49702-253_5abcc565-e413-4613-a958-8539df1cfa10	49702-253	HUMAN PRESCRIPTION DRUG	Cabenuva		cabotegravir and rilpivirine	KIT		20210121		NDA	NDA212888	ViiV Healthcare Company						N	20241231
49702-255_a7af7500-2f34-45cc-bcb9-0fbf4655880a	49702-255	HUMAN PRESCRIPTION DRUG	Tivicay PD		dolutegravir sodium	TABLET, FOR SUSPENSION	ORAL	20200612		NDA	NDA213983	ViiV Healthcare Company	DOLUTEGRAVIR SODIUM	5	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
49702-258_c6caf251-b34f-4846-a477-576354b96d15	49702-258	HUMAN PRESCRIPTION DRUG	Triumeq PD		abacavir sulfate, dolutegravir sodium, lamivudine	KIT		20220330		NDA	NDA215413	ViiV Healthcare Company						N	20241231
49702-260_9165dbbc-c0cb-40b2-b7b6-5bfa02bb7979	49702-260	HUMAN PRESCRIPTION DRUG	SELZENTRY		maraviroc	KIT		20201030		NDA	NDA208984	ViiV Healthcare Company						N	20241231
49702-264_e92b42ae-c037-4393-8547-c37c614a22b5	49702-264	HUMAN PRESCRIPTION DRUG	Apretude		Cabotegravir	KIT		20211220		NDA	NDA215499	ViiV Healthcare Company						N	20241231
49708-145_bd3f73f5-9f24-4362-a9e1-12838c768827	49708-145	HUMAN PRESCRIPTION DRUG	Bactrim		sulfamethoxazole and Trimethoprim	TABLET	ORAL	20041101		NDA	NDA017377	Sun Pharmaceutical Industries, Inc	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
49708-146_bd3f73f5-9f24-4362-a9e1-12838c768827	49708-146	HUMAN PRESCRIPTION DRUG	Bactrim DS		sulfamethoxazole and Trimethoprim	TABLET	ORAL	20041101		NDA	NDA017377	Sun Pharmaceutical Industries, Inc	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
49708-153_ec714122-b9cd-45c8-b39a-dea83b1eb2aa	49708-153	HUMAN PRESCRIPTION DRUG	Qualaquin		Quinine Sulfate	CAPSULE	ORAL	20050812		NDA	NDA021799	Sun Pharmaceutical Industries, Inc.	QUININE SULFATE	324	mg/1	Antimalarial [EPC]		N	20241231
49708-754_9c90e2ce-302f-4b3c-b7f8-1ab0e14b9c47	49708-754	HUMAN PRESCRIPTION DRUG	BROMSITE	0.075%	bromfenac	SOLUTION/ DROPS	OPHTHALMIC	20160501		NDA	NDA206911	Sun Pharmaceutical Industries, Inc.	BROMFENAC SODIUM	.76	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49726-038_082b7d7b-aebe-0831-e063-6294a90af159	49726-038	HUMAN OTC DRUG	Anxietin		Aconitum Napellus, Alfalfa, Argentum Nitricum, Aurum Metallicum, Avena Sativa, Baryta Carbonica, Calcarea Phosphorica, Chamomilla, Gelsemium Sempervirens, Glonoinum, Humulus Lupulus, Ignatia Amara, Kali Phosphoricum, Muriaticum Acidum, Natrum Phosphoricum, Passiflora Incarnata, Phosphorus, Staphysagria, Stramonium	TABLET	ORAL	20180416		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ACONITUM NAPELLUS; ALFALFA; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIBASIC POTASSIUM PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HOPS; HYDROCHLORIC ACID; MATRICARIA CHAMOMILLA; NITROGLYCERIN; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; SILVER NITRATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS IGNATII SEED; TRIBASIC CALCIUM PHOSPHATE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
49726-039_082b8df5-a74e-3641-e063-6294a90a7201	49726-039	HUMAN OTC DRUG	MoodBrite		Anacardium Orientale, Avena Sativa, Aurum Metallicum, Calcarea Carbonica, Carpinus Betulus, Flos, Cimicifuga Racemosa, Cinchona Officinalis, Hypericum Perforatum, Ignatia Amara, Kali Bromatum, Larix Decidua, Flos, Natrum Carbonicum, Natrum Sulphuricum, Phosphoricum Acidum, Phosphorus, Pulsatilla (Vulgaris), Sepia, Sinapis Arvensis, Flos, Tabacum	TABLET	ORAL	20180416		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ANEMONE PULSATILLA; AVENA SATIVA FLOWERING TOP; BLACK COHOSH; CARPINUS BETULUS FLOWERING TOP; CINCHONA OFFICINALIS BARK; GOLD; HYPERICUM PERFORATUM; LARIX DECIDUA FLOWERING TOP; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; POTASSIUM BROMIDE; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CARBONATE; SODIUM SULFATE; STRYCHNOS IGNATII SEED; TOBACCO LEAF	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
49726-040_082b8f9f-aca5-50b3-e063-6394a90adb1f	49726-040	HUMAN OTC DRUG	Respitrol		Ammonium Carbonicum, Antimonium Tartaricum, Bromium, Carbo Vegetabilis, Chlorinum, Kali Carbonicum, Lobelia Inflata, Stannum Metallicum, Sulphuricum Acidum	TABLET	ORAL	20180615		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ACTIVATED CHARCOAL; AMMONIUM CARBONATE; ANTIMONY POTASSIUM TARTRATE; BROMINE; CHLORINE; LOBELIA INFLATA; POTASSIUM CARBONATE; SULFURIC ACID; TIN	10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
49726-041_082aeec1-2640-1a72-e063-6394a90aaeed	49726-041	HUMAN OTC DRUG	Synaptol		Aconitum Ferox, Adrenalinum, Aesculus Hippocastanum, Flos, Apis Mellifica, Argentum Nitricum, Avena Sativa, Baptisia Tinctoria, Cochlearia Armoracia, Phosphorus, Scleranthus Annuus, Flos, Scutellaria Lateriflora, Sumbul, Viola Odorata	TABLET, ORALLY DISINTEGRATING	ORAL	20171211		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ACONITUM FEROX ROOT; AESCULUS HIPPOCASTANUM FLOWER; APIS MELLIFERA; AVENA SATIVA FLOWERING TOP; BAPTISIA TINCTORIA ROOT; EPINEPHRINE; FERULA SUMBUL ROOT; HORSERADISH; PHOSPHORUS; SCLERANTHUS ANNUUS FLOWERING TOP; SCUTELLARIA LATERIFLORA; SILVER NITRATE; VIOLA ODORATA	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
49726-042_082b80bc-b9f9-5082-e063-6394a90a9a3b	49726-042	HUMAN OTC DRUG	Compulsin		Calcarea Carbonica, Coffea Cruda, Iodium, Mancinella, Physostigma Venenosum, Silicea, Ulmus Procera, Flos	TABLET	ORAL	20181015		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ARABICA COFFEE BEAN; HIPPOMANE MANCINELLA FRUITING LEAFY TWIG; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYSOSTIGMA VENENOSUM SEED; SILICON DIOXIDE; ULMUS MINOR FLOWERING TWIG	10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
49726-043_082b7d7b-aebb-0831-e063-6294a90af159	49726-043	HUMAN OTC DRUG	Activive		Alfalfa, Ambra Grisea, Anacardium Orientale, Argentum Nitricum, Aurum Metallicum, Avena Sativa, Caladium Seguinum, Calcarea Carbonica, Cocculus Indicus, Gelsemium Sempervirens, Ignatia Amara, Kali Phosphoricum, Lycopodium Clavatum, Natrum Muriaticum, Nux Moschata, Phosphoricum Acidum, Phosphorus, Selenium Metallicum, Sepia, Silicea, Sulphur	TABLET	ORAL	20181019		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ALFALFA; AMBERGRIS; ANAMIRTA COCCULUS SEED; AVENA SATIVA FLOWERING TOP; DIBASIC POTASSIUM PHOSPHATE; DIEFFENBACHIA SEGUINE; GELSEMIUM SEMPERVIRENS ROOT; GOLD; LYCOPODIUM CLAVATUM SPORE; NUTMEG; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; SULFUR	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
49726-044_082b739c-570f-059e-e063-6294a90a51d1	49726-044	HUMAN OTC DRUG	Neuroveen		Aconitum Napellus, Agaricus Muscarius, Baryta Muriatica, Calendula Officinalis, Carbo Vegetabilis, Carduus Marianus, Chamomilla, Dulcamara, Glonoinum, Hamamelis Virginiana, Lycopersicum Esculentum, Magnesia Phosphorica, Phosphorus, Rhus Tox, Secale Cornutum	TABLET	ORAL	20181015		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ACONITUM NAPELLUS; ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; BARIUM CHLORIDE DIHYDRATE; CALENDULA OFFICINALIS FLOWERING TOP; CLAVICEPS PURPUREA SCLEROTIUM; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; NITROGLYCERIN; PHOSPHORUS; SILYBUM MARIANUM SEED; SOLANUM DULCAMARA TOP; TOMATO; TOXICODENDRON PUBESCENS LEAF	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
49726-045_082b739c-5711-059e-e063-6294a90a51d1	49726-045	HUMAN OTC DRUG	Rhumatol		Actaea Spicata, Aesculus Hippocastanum, Arnica Montana, Bellis Perennis, Bryonia (Alba), Calcarea Carbonica, Calcarea Fluorica, Causticum, Cimicifuga Racemosa, Formicum Acidum, Ledum Palustre, Lithium Carbonicum, Magnesia Phosphorica, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhododendron Chrysanthum, Rhus Tox, Ruta Graveolens, Salicylicum Acidum, Sepia, Zincum Metallicumk	TABLET	ORAL	20190723		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ACTAEA SPICATA ROOT; ANEMONE PRATENSIS; ARNICA MONTANA; BELLIS PERENNIS; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CAUSTICUM; FORMIC ACID; HORSE CHESTNUT; HYPERICUM PERFORATUM; LITHIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SALICYLIC ACID; SEPIA OFFICINALIS JUICE; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49726-046_082b739c-5710-059e-e063-6294a90a51d1	49726-046	HUMAN OTC DRUG	Painazol		Actaea Spicata, Aesculus Hippocastanum, Arnica Montana, Bellis Perennis, Bryonia (Alba), Calcarea Carbonica, Calcarea Fluorica, Causticum, Cimicifuga Racemosa, Formicum Acidum, Hypericum Perforatum, Ledum Palustre, Lithium Carbonicum, Magnesia Phosphorica, Phosphorus, Phytolacca Decandra, Pulsatilla (Pratensis), Rhododendron Chrysanthum, Rhus Tox, Ruta Graveolens, Salicylicum Acidum, Sepia, Sulphur, Zincum Metallicum	TABLET	ORAL	20190528		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ACTAEA SPICATA ROOT; ANEMONE PRATENSIS; ARNICA MONTANA; BELLIS PERENNIS; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CAUSTICUM; FORMIC ACID; HORSE CHESTNUT; HYPERICUM PERFORATUM; LITHIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SALICYLIC ACID; SEPIA OFFICINALIS JUICE; SULFUR; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49726-047_082b7707-e61c-4bf2-e063-6394a90a2ff9	49726-047	HUMAN OTC DRUG	Restulex		Bufo Rana, Causticum, Chamomilla, Crotalus Horridus, Digitalis Purpurea, Lachesis Mutus, Lilium Tigrinum, Pulsatilla (Pratensis) Rhus Tox, Sulphur, Tarentula Hispana, Viscum Album, Zincum Metallicum.	TABLET	ORAL	20191010		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ANEMONE PRATENSIS; BUFO BUFO CUTANEOUS GLAND; CAUSTICUM; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOSA TARANTULA; MATRICARIA CHAMOMILLA; SULFUR; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUIT; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
49726-048_082ac313-1fb1-3b87-e063-6294a90adf92	49726-048	HUMAN OTC DRUG	Synaptol Lactose Free		Aconitum Ferox, Adrenalinum, Aesculus Hippocastanum, Flos, Apis Mellifica, Argentum Nitricum, Avena Sativa, Baptisia Tinctoria, Cochlearia Armoracia, Phosphorus, Scleranthus Annuus, Flos, Scutellaria Lateriflora, Sumbul, Viola Odorata	TABLET, ORALLY DISINTEGRATING	ORAL	20220927		UNAPPROVED HOMEOPATHIC		HelloLife, Inc.	ACONITUM FEROX ROOT; AESCULUS HIPPOCASTANUM FLOWER; APIS MELLIFERA; AVENA SATIVA FLOWERING TOP; BAPTISIA TINCTORIA ROOT; EPINEPHRINE; FERULA SUMBUL ROOT; HORSERADISH; PHOSPHORUS; SCLERANTHUS ANNUUS FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; VIOLA ODORATA WHOLE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
49738-024_fe28932e-7f94-4ce9-be58-6f05f8890943	49738-024	HUMAN OTC DRUG	Extra Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160601		OTC MONOGRAPH NOT FINAL	part343	Kmart Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
49738-036_9f859b63-de2a-4e74-94cc-985c93838bea	49738-036	HUMAN OTC DRUG	sever daytime cold and flu and sever nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20170712		OTC MONOGRAPH FINAL	part341	Kmart Corporation						N	20241231
49738-037_d453bfc3-b880-4018-abb1-c891b10fd888	49738-037	HUMAN OTC DRUG	daytime cold and flu and nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20170712		OTC MONOGRAPH FINAL	part341	Kmart Corporation						N	20241231
49738-686_6c556dbe-66fd-907c-e053-2991aa0a475d	49738-686	HUMAN OTC DRUG	LORATADINE		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20170131		ANDA	ANDA206214	SMART SENSE (KMART)	LORATADINE	10	mg/1			N	20241231
49758-000_0bc809db-5be2-d962-e063-6394a90a6dca	49758-000	HUMAN OTC DRUG	Dermabon Multi Symptom Psoriasis Control		COAL TAR	SOAP	TOPICAL	20220701		OTC MONOGRAPH DRUG	M032	Dermabon de Chihuahua, S.A. de C.V.	COAL TAR	21.3	mg/g			N	20241231
49758-100_0bc824f9-7b4e-09c1-e063-6294a90ae0f2	49758-100	HUMAN OTC DRUG	Dermabon Psoriasis and Dandruff		COAL TAR	SOAP	TOPICAL	20091001		OTC MONOGRAPH DRUG	M032	Dermabon de Chihuahua, S.A. de C.V.	COAL TAR	2.13	g/100g			N	20241231
49766-2858_0c8f22fa-65e6-2c97-e063-6294a90ae68c	49766-2858	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091006		UNAPPROVED MEDICAL GAS		Max's Breathe Easy Gases & Supplies, Inc.	OXYGEN	99	L/100L			N	20241231
49770-0001_0d961ca9-d341-31b0-e063-6394a90af6e6	49770-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091001		UNAPPROVED MEDICAL GAS		Alpha Oxy-Med	OXYGEN	99	L/100L			N	20241231
49771-002_18c102cd-975a-4e96-9041-69b61cb1cb10	49771-002	HUMAN PRESCRIPTION DRUG	Mitosol		mitomycin	KIT		20120208		NDA	NDA022572	Mobius Therapeutics LLC						N	20241231
49781-064_caa1c3b2-633c-44c2-8c6c-363e6df16912	49781-064	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20140531		ANDA	ANDA074164	Cardinal Health (Leader) 49781	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
49781-097_c6c75bb4-3a9d-4562-bb5c-773e0b71fece	49781-097	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20140920		OTC MONOGRAPH FINAL	part343	CARDINAL HEALTH	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49781-148_19aeac92-7c9b-42eb-ab94-81a7cf3275c6	49781-148	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20160229	20250228	OTC MONOGRAPH DRUG	M007	Cardinal Health (Leader) 49781	SENNOSIDES	8.6	mg/1			N	
49798-001_08025a83-212d-c949-e063-6394a90a52bc	49798-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19560101		NDA	NDA205767	James Oxygen and Supply Company	OXYGEN	992	mL/L			N	20241231
49799-001_09076756-c066-3b18-e063-6294a90a555a	49799-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091001		UNAPPROVED MEDICAL GAS		Medical Equipment and Supplies of America, LLC	OXYGEN	99	L/100L			N	20241231
49817-2038_09af864d-390d-3881-e063-6394a90a3efb	49817-2038	HUMAN OTC DRUG	LESSENTIEL NATURAL GLOW FOUNDATION 16H WEAR WITH SUNSCREEN BROAD SPECTRUM SPF 20	04N MOYEN/MEDIUM	TITANIUM DIOXIDE	EMULSION	TOPICAL	20190309		OTC MONOGRAPH DRUG	M020	Guerlain	TITANIUM DIOXIDE	17.6	mg/mL			N	20241231
49817-2040_09afb7ba-9def-7b82-e063-6294a90a9be6	49817-2040	HUMAN OTC DRUG	LESSENTIEL NATURAL GLOW FOUNDATION 16H WEAR WITH SUNSCREEN BROAD SPECTRUM SPF 20	05N MIEL/HONEY	TITANIUM DIOXIDE	EMULSION	TOPICAL	20190309		OTC MONOGRAPH DRUG	M020	Guerlain	TITANIUM DIOXIDE	17.6	mg/mL			N	20241231
49817-2063_09a9fa1d-f33c-3a3f-e063-6294a90a31bf	49817-2063	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0.5C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2064_09a9fa1d-f33d-3a3f-e063-6294a90a31bf	49817-2064	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2065_09a9e336-2b56-2d05-e063-6294a90a4c7b	49817-2065	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2066_09a9fdf9-60a7-36d2-e063-6294a90a5226	49817-2066	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 1.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2067_09aa1a62-3365-4e4b-e063-6294a90a77e4	49817-2067	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 1C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2068_09a9fdf9-60ac-36d2-e063-6294a90a5226	49817-2068	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 1N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2069_09aa1e48-454b-491b-e063-6394a90ab19a	49817-2069	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 2N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2070_09aa2bb7-4c10-5fc0-e063-6394a90a91a3	49817-2070	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 2W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2071_09aa1e48-454c-491b-e063-6394a90ab19a	49817-2071	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 3.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2072_09aa276a-88f7-508d-e063-6294a90a7e0c	49817-2072	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 3N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2073_09aa38ef-1b45-52ab-e063-6294a90ac12a	49817-2073	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 3W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2074_09aa2bb7-4c11-5fc0-e063-6394a90a91a3	49817-2074	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 4N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2075_09aa3fa0-6e3d-1c5d-e063-6294a90a64b3	49817-2075	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 4W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2076_09aa1e48-4559-491b-e063-6394a90ab19a	49817-2076	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2077_09aa1e48-455a-491b-e063-6394a90ab19a	49817-2077	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 6N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2078_09aa1e48-455b-491b-e063-6394a90ab19a	49817-2078	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 7N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2079_09aa46d5-b8e9-5e76-e063-6394a90a25ce	49817-2079	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 8N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49817-2080_09afc875-1d5a-8325-e063-6294a90a5515	49817-2080	HUMAN OTC DRUG	PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Guerlain	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
49823-100_4f2f2afc-ed2e-4997-a48f-fe9d8102685b	49823-100	HUMAN OTC DRUG	ZuraGard Blue		isopropyl alcohol	SOLUTION	TOPICAL	20230227		NDA	NDA210872	Zurex Pharma, Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
49823-200_3d73184b-9a71-4b45-8b60-975315f468f3	49823-200	HUMAN OTC DRUG	ZuraGard Clear		isopropyl alcohol	SOLUTION	TOPICAL	20230227		NDA	NDA210872	Zurex Pharma, Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
49825-131_870c7bde-d419-40e7-8a36-b5c5d8faffd8	49825-131	HUMAN OTC DRUG	Spotless Cleanser	Bioelements	Salicylic Acid	CREAM	TOPICAL	20130617		OTC MONOGRAPH FINAL	part333D	Bioelements, Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
49852-301_61c20cf5-536d-be22-e053-2a91aa0abbf7	49852-301	HUMAN OTC DRUG	anti-bacterial Hand Cleanser		Ethyl Alcohol	LIQUID	TOPICAL	20140901		OTC MONOGRAPH NOT FINAL	part333A	Tri-Coastal Design Company Inc.	ALCOHOL	62	g/100mL			N	20241231
49873-018_09d87d9c-fe4d-fd02-e063-6394a90a56bd	49873-018	HUMAN OTC DRUG	Satohap		dl-camphor, l-menthol, methyl salicylate	PATCH	TOPICAL	19891108		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	5; 4; 8	mg/1; mg/1; mg/1			N	20241231
49873-019_b7be42a2-20f2-14f9-e053-2a95a90a033a	49873-019	HUMAN OTC DRUG	KEEPAN A		benzalkonium chloride, lidocaine hydrochloride	SPRAY	TOPICAL	19810715		OTC MONOGRAPH NOT FINAL	part333A	Sato Pharmaceutical Co., Ltd.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.1; 1	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49873-020_0bde6cb8-4ea3-da1f-e063-6294a90a0fd4	49873-020	HUMAN OTC DRUG	Dorama-Neo		water	LIQUID	OPHTHALMIC	19831108		OTC MONOGRAPH DRUG	M018	Sato Pharmaceutical Co., Ltd.	WATER	98.4	mL/100mL			N	20241231
49873-044_0b401747-48ee-3b1d-e063-6394a90aeebd	49873-044	HUMAN OTC DRUG	Sato Clear		NAPHAZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	19890531		OTC MONOGRAPH DRUG	M018	Sato Pharmaceutical Co., Ltd.	NAPHAZOLINE HYDROCHLORIDE	12	mg/100mL			N	20241231
49873-045_0bb8901e-89d2-b026-e063-6294a90ae77a	49873-045	HUMAN OTC DRUG	INON		aluminum hydroxide, magnesium carbonate, sodium bicarbonate	GRANULE	ORAL	19890531		OTC MONOGRAPH DRUG	M001	Sato Pharmaceutical Co., Ltd.	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE; SODIUM BICARBONATE	400; 400; 700	mg/1.92g; mg/1.92g; mg/1.92g	Alkalinizing Activity [MoA]		N	20241231
49873-050_0b7d0c0b-2732-36f6-e063-6294a90a7c17	49873-050	HUMAN OTC DRUG	Hi Vetic		tolnaftate	SOLUTION	TOPICAL	19900814		OTC MONOGRAPH DRUG	M005	Sato Pharmaceutical Co., Ltd.	TOLNAFTATE	1	g/100mL			N	20241231
49873-056_0bde5831-2b16-2948-e063-6394a90ad473	49873-056	HUMAN OTC DRUG	Hi Vetic		tolnaftate	OINTMENT	TOPICAL	19961025		OTC MONOGRAPH DRUG	M005	Sato Pharmaceutical Co., Ltd.	TOLNAFTATE	1	g/100g			N	20241231
49873-057_0bde79a3-26b2-e0d2-e063-6294a90ac663	49873-057	HUMAN OTC DRUG	Nazal		Naphazoline hydrochloride	LIQUID	NASAL	19900611		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	NAPHAZOLINE HYDROCHLORIDE	50	mg/100mL			N	20241231
49873-060_09c2dbb9-bc76-b54b-e063-6294a90a9c25	49873-060	HUMAN OTC DRUG	Satogesic		dl-camphor, l-menthol, methyl salicylate	PATCH	TOPICAL	19901203		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	5; 4; 8	mg/1; mg/1; mg/1			N	20241231
49873-065_0b7d6dc4-82df-04b0-e063-6394a90af9ec	49873-065	HUMAN OTC DRUG	Satohap		methyl salicylate, dl-camphor, l-menthol	LOTION	TOPICAL	19910205		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	5; 4; 10	g/100mL; g/100mL; g/100mL			N	20241231
49873-068_0b3fe183-c97d-44d8-e063-6294a90a67cd	49873-068	HUMAN OTC DRUG	Satohap		methyl salicylate, dl-camphor, l-menthol	SPRAY	TOPICAL	20061103		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	5; 4; 10	g/100mL; g/100mL; g/100mL			N	20241231
49873-078_0bb872a7-eb87-b3c0-e063-6394a90a6af0	49873-078	HUMAN OTC DRUG	Satos Corn and Callus Remover		salicylic acid	LIQUID	TOPICAL	19870919		OTC MONOGRAPH DRUG	M030	Sato Pharmaceutical Co., Ltd.	SALICYLIC ACID	12	g/100mL			N	20241231
49873-082_0bde8c09-5f6d-5c07-e063-6394a90ab48c	49873-082	HUMAN OTC DRUG	Ringl		acetaminophen	TABLET	ORAL	19960509		OTC MONOGRAPH DRUG	M013	Sato Pharmaceutical Co., Ltd.	ACETAMINOPHEN	325	mg/1			N	20241231
49873-108_0bde8137-27d4-5db4-e063-6394a90a5520	49873-108	HUMAN OTC DRUG	Stona for Children		acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide	SYRUP	ORAL	20010103		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/15mL; mg/15mL; mg/15mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49873-109_0bde79c5-e52f-ea0b-e063-6294a90a0ab9	49873-109	HUMAN OTC DRUG	Stonarhini		Chlorpheniramine maleate, phenylephrine	TABLET	ORAL	20011116		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49873-113_0bb87850-ad34-ce89-e063-6294a90a421d	49873-113	HUMAN OTC DRUG	Stona-S		acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride	CAPSULE	ORAL	20040927		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	162.5; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49873-114_0b3faa58-6fca-f550-e063-6394a90ad361	49873-114	HUMAN OTC DRUG	Stona		acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride	TABLET	ORAL	20040929		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	162.5; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49873-301_0b3fbae8-f6b3-d405-e063-6394a90adecd	49873-301	HUMAN OTC DRUG	Stona		dextromethorphan hydrobromide	LOZENGE	ORAL	19951119		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	DEXTROMETHORPHAN HYDROBROMIDE	10	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49873-302_09fb9b1c-b0c7-95a9-e063-6394a90a51db	49873-302	HUMAN OTC DRUG	Stona Cough		dextromethorphan hydrobromide, guaifenesin	SYRUP	ORAL	20010103		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
49873-306_0bb8901e-89d4-b026-e063-6294a90ae77a	49873-306	HUMAN OTC DRUG	Stona Cough		dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET	ORAL	20041124		OTC MONOGRAPH DRUG	M012	Sato Pharmaceutical Co., Ltd.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	15; 100; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
49873-401_0bb98362-08a0-f332-e063-6394a90ad51f	49873-401	HUMAN OTC DRUG	MINICA-S		glycerin	ENEMA	RECTAL	19940501		OTC MONOGRAPH DRUG	M007	Sato Pharmaceutical Co., Ltd.	GLYCERIN	80	mL/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
49873-402_09d87d9c-fe4c-fd02-e063-6394a90a56bd	49873-402	HUMAN OTC DRUG	Inon Ace		magnesium aluminosilicates, magnesium hydroxide, simethicone	TABLET	ORAL	19951101		OTC MONOGRAPH DRUG	M001	Sato Pharmaceutical Co., Ltd.	DIMETHICONE; MAGNESIUM HYDROXIDE; SILODRATE	20; 60; 200	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49873-403_0bde7bd2-8a69-57b4-e063-6394a90a00d2	49873-403	HUMAN OTC DRUG	Inon Ace		magnesium aluminosilicate, magnesium hydroxide	SOLUTION	ORAL	20000520		OTC MONOGRAPH DRUG	M001	Sato Pharmaceutical Co., Ltd.	MAGNESIUM HYDROXIDE; SILODRATE	250; 900	mg/30mL; mg/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
49873-404_0b54b2d1-83e7-3a18-e063-6394a90a5b58	49873-404	HUMAN OTC DRUG	Sankaijo		docusate sodium, sennosides	TABLET	ORAL	20021220		OTC MONOGRAPH DRUG	M007	Sato Pharmaceutical Co., Ltd.	DOCUSATE SODIUM; SENNOSIDES	8.33; 1.36	mg/1; mg/1			N	20241231
49873-501_0bb98362-089f-f332-e063-6394a90ad51f	49873-501	HUMAN OTC DRUG	Optic Splash		naphazoline hydrochloride, glycerin	SOLUTION/ DROPS	OPHTHALMIC	20080122		OTC MONOGRAPH DRUG	M018	Sato Pharmaceutical, Co., Ltd.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	200; 20	mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
49873-503_094a6186-10c5-ed17-e063-6394a90a601a	49873-503	HUMAN OTC DRUG	Dorama Dry Aid Eye Drops		povidone, propylene glycol	SOLUTION	OPHTHALMIC	20220113		OTC MONOGRAPH DRUG	M018	Sato Pharmaceutical Co., Ltd.	POVIDONE; PROPYLENE GLYCOL	.68; .3	g/100mL; g/100mL			N	20241231
49873-608_09d8a40d-02a1-c265-e063-6294a90a8a0b	49873-608	HUMAN OTC DRUG	Satogesic Hot		capsaicin	PATCH	TOPICAL	20061122		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	CAPSAICIN	.25	mg/1			N	20241231
49873-617_094a93d5-d88d-1d3f-e063-6294a90a3b3b	49873-617	HUMAN OTC DRUG	Satohap Lidocaine 4% Pain Relieving Pad		Lidocaine	PATCH	TOPICAL	20201101	20240630	OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
49873-618_0995a554-ad4f-6aa9-e063-6294a90a60c6	49873-618	HUMAN OTC DRUG	Satohap Lidocaine Hydrochloride 4 Percent Pain Relieving		Lidocaine Hydrochloride	LOTION	TOPICAL	20181119		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49873-619_f1177519-a692-7e16-e053-2995a90a5bdc	49873-619	HUMAN OTC DRUG	Satohap Lidocaine 4% Menthol 1% Pain Relieving Cream		Lidocaine, Menthol	CREAM	TOPICAL	20181114		OTC MONOGRAPH NOT FINAL	part348	Sato Pharmaceutical Co., Ltd.	LEVOMENTHOL; LIDOCAINE	1; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49873-620_09956557-edf5-48db-e063-6294a90a7dc8	49873-620	HUMAN OTC DRUG	Satohap Cool Type		Camphor, Menthol, Methyl Salicylate	LOTION	TOPICAL	20190110		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	5; 6; 10	g/100mL; g/100mL; g/100mL			N	20241231
49873-621_0949e5cb-b9e5-cee1-e063-6394a90a5377	49873-621	HUMAN OTC DRUG	Satohap Cool and Hot Pads		Camphor, Capsaicin, Menthol	PATCH	TOPICAL	20201218		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); CAPSAICIN; LEVOMENTHOL	3.1; .04; 6	g/100mL; g/100mL; g/100mL			N	20241231
49873-703_0b404611-4b3b-500a-e063-6394a90a62b3	49873-703	HUMAN OTC DRUG	Poli-A		hydrocortisone acetate	OINTMENT	TOPICAL	19950319		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49873-704_0b7d17ee-250b-f137-e063-6394a90a3f14	49873-704	HUMAN OTC DRUG	Tact Cool	Jelly	diphenhydramine hydrochloride, levomenthol	GEL	TOPICAL	19971002		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Co., Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE; LEVOMENTHOL	2; 1	g/100g; g/100g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49873-705_0bb93753-9288-eb0b-e063-6394a90a950b	49873-705	HUMAN OTC DRUG	TACT		diphenhydramine hydrochloride, menthol	CREAM	TOPICAL	19970909		OTC MONOGRAPH DRUG	M017	Sato Pharmaceutical Inc., Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE; LEVOMENTHOL	2; 1	g/100g; g/100g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49873-802_0b7d81d6-f5ac-a151-e063-6294a90a8322	49873-802	HUMAN OTC DRUG	Airmit Ace		dimenhydrinate	TABLET	ORAL	20050311		OTC MONOGRAPH DRUG	M009	Sato Pharmaceutical Co., Ltd.	DIMENHYDRINATE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
49873-805_0949e5cb-b9e4-cee1-e063-6394a90a5377	49873-805	HUMAN OTC DRUG	ZenTrip Motion Sickness		Meclizine Hydrochloride	TABLET	ORAL	20210501		OTC MONOGRAPH DRUG	M009	Sato Pharmaceutical Co., LTD	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
49884-006_96751f5e-4163-4fd2-9dfa-d80a6ea7c4da	49884-006	HUMAN PRESCRIPTION DRUG	Sodium Phenylbutyrate		Sodium Phenylbutyrate	POWDER	ORAL	20160831		ANDA	ANDA203918	Par Pharmaceutical, Inc.	SODIUM PHENYLBUTYRATE	.94	g/g	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
49884-007_988287a8-0070-4d4c-80b8-be03be9e254c	49884-007	HUMAN PRESCRIPTION DRUG	Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg		Aspirin and Extended - Release Dipyridamole	CAPSULE	ORAL	20170130		ANDA	ANDA207944	Par Pharmaceutical, Inc.	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
49884-009_04743afb-4e94-449d-93de-e51b78a63b06	49884-009	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	19830210		ANDA	ANDA087946	Par Pharmaceutical, Inc.	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49884-020_04743afb-4e94-449d-93de-e51b78a63b06	49884-020	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	19791213		ANDA	ANDA086923	Par Pharmaceutical, Inc.	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49884-021_04743afb-4e94-449d-93de-e51b78a63b06	49884-021	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	19791222		ANDA	ANDA086925	Par Pharmaceutical, Inc.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49884-022_04743afb-4e94-449d-93de-e51b78a63b06	49884-022	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	19811215		ANDA	ANDA087537	Par Pharmaceutical, Inc.	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49884-032_dbe61ac0-e4b2-47e4-aa72-048e86a0b984	49884-032	HUMAN PRESCRIPTION DRUG	TRANYLCYPROMINE SULFATE		tranylcypromine sulfate	TABLET, FILM COATED	ORAL	20060630	20241130	ANDA	ANDA040640	Par Pharmaceutical, Inc.	TRANYLCYPROMINE SULFATE	10	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	
49884-038_18957b76-0baa-495e-8917-03b6fc16d065	49884-038	HUMAN PRESCRIPTION DRUG	Phenoxybenzamine Hydrochloride		Phenoxybenzamine Hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA204522	Par Pharmaceutical, Inc.	PHENOXYBENZAMINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
49884-042_f5b7a432-2cf8-47ed-b6c3-c2dfc1dcdc6e	49884-042	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	SOLUTION	ORAL	20220104		ANDA	ANDA204438	Par Pharmaceutical, Inc.	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
49884-048_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-048	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-049_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-049	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-054_a8db1d0c-01bd-4245-bccd-028d0b75a085	49884-054	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021	20240131	ANDA	ANDA088292	Par Pharmaceutical, Inc.	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	
49884-055_a8db1d0c-01bd-4245-bccd-028d0b75a085	49884-055	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021	20240831	ANDA	ANDA088262	Par Pharmaceutical, Inc.	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
49884-056_a8db1d0c-01bd-4245-bccd-028d0b75a085	49884-056	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021	20240131	ANDA	ANDA088276	Par Pharmaceutical, Inc.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
49884-060_8e8769ab-bd38-47df-b878-b0c5f48b209e	49884-060	HUMAN PRESCRIPTION DRUG	Trientine Hydrochloride		Trientine Hydrochloride	CAPSULE	ORAL	20190927		ANDA	ANDA210096	Par Pharmaceutical, Inc.	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
49884-065_9e2e8ffc-bad8-4027-8c30-198f06f4a47b	49884-065	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Par Pharmaceutical, Inc.	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
49884-066_9e2e8ffc-bad8-4027-8c30-198f06f4a47b	49884-066	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Par Pharmaceutical, Inc.	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
49884-090_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-090	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-110_80d3cefb-e83e-4dbd-ba6e-2eac42ccc73f	49884-110	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20090109		ANDA	ANDA078088	Par Pharmaceutical, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-111_80d3cefb-e83e-4dbd-ba6e-2eac42ccc73f	49884-111	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20090109		ANDA	ANDA078088	Par Pharmaceutical, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-113_b87c7717-5019-43fe-9a18-d2d7ae07cc91	49884-113	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110103		ANDA	ANDA078540	Par Pharmaceutical, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
49884-117_9ac0733e-46da-41c5-a6b2-f78626d8e39f	49884-117	HUMAN PRESCRIPTION DRUG	Amiloride Hydrochloride		Amiloride Hydrochloride	TABLET	ORAL	19860122		ANDA	ANDA070346	Par Pharmaceutical, Inc.	AMILORIDE HYDROCHLORIDE ANHYDROUS	5	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
49884-119_131a5a57-ee0b-4ee9-9c61-9be3dcdcbb25	49884-119	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20191210		ANDA	ANDA207934	Par Pharmaceutical, Inc.	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-122_c2fd5bf2-ce6b-48a7-a782-17dd1df2d326	49884-122	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Par Pharmaceutical, Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
49884-123_c2fd5bf2-ce6b-48a7-a782-17dd1df2d326	49884-123	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Par Pharmaceutical, Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
49884-124_c2fd5bf2-ce6b-48a7-a782-17dd1df2d326	49884-124	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Par Pharmaceutical, Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
49884-125_131a5a57-ee0b-4ee9-9c61-9be3dcdcbb25	49884-125	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20191210		ANDA	ANDA207934	Par Pharmaceutical, Inc.	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-127_131a5a57-ee0b-4ee9-9c61-9be3dcdcbb25	49884-127	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20191210		ANDA	ANDA207934	Par Pharmaceutical, Inc.	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-128_131a5a57-ee0b-4ee9-9c61-9be3dcdcbb25	49884-128	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20221129		ANDA	ANDA207934	Par Pharmaceutical, Inc.	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-146_b3147aa9-c01c-4e14-acd8-87591e490bf5	49884-146	HUMAN PRESCRIPTION DRUG	Penicillamine		penicillamine	CAPSULE	ORAL	20200108		ANDA	ANDA211231	Par Pharmaceutical, Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
49884-147_730d33b8-b89c-4e6e-868f-15b54f0a1196	49884-147	HUMAN PRESCRIPTION DRUG	Dexlansoprazole		Dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20230610		ANDA	ANDA202294	Par Pharmaceutical, Inc.	DEXLANSOPRAZOLE	30	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49884-148_730d33b8-b89c-4e6e-868f-15b54f0a1196	49884-148	HUMAN PRESCRIPTION DRUG	Dexlansoprazole		Dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221122		ANDA	ANDA202294	Par Pharmaceutical, Inc.	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49884-151_ae026767-f65e-4c73-98c7-16eadbe42000	49884-151	HUMAN PRESCRIPTION DRUG	Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride		Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride	CAPSULE	ORAL	20230307		ANDA	ANDA205770	Par Pharmaceutical, Inc.	BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE	140; 125; 125	mg/1; mg/1; mg/1	Bismuth [CS], Bismuth [EPC], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
49884-155_e969d8d8-4da8-44e0-b866-13bdfac92829	49884-155	HUMAN PRESCRIPTION DRUG	Varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20210921		ANDA	ANDA201785	Par Pharmaceutical, Inc.	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
49884-156_e969d8d8-4da8-44e0-b866-13bdfac92829	49884-156	HUMAN PRESCRIPTION DRUG	Varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20210921		ANDA	ANDA201785	Par Pharmaceutical, Inc.	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
49884-158_9a6bc6cc-b9da-4fe1-9ee1-c9a393bb5dec	49884-158	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20220331		ANDA	ANDA205775	Par Pharmaceutical, Inc.	EVEROLIMUS	.25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-159_9a6bc6cc-b9da-4fe1-9ee1-c9a393bb5dec	49884-159	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20220331		ANDA	ANDA205775	Par Pharmaceutical, Inc.	EVEROLIMUS	.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-160_9a6bc6cc-b9da-4fe1-9ee1-c9a393bb5dec	49884-160	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20220331		ANDA	ANDA205775	Par Pharmaceutical, Inc.	EVEROLIMUS	.75	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-161_01b710fc-1c96-4e2b-95fe-af53c5966b90	49884-161	HUMAN PRESCRIPTION DRUG	CALCITONIN SALMON		CALCITONIN SALMON	SPRAY, METERED	NASAL	20090608		ANDA	ANDA076979	Par Pharmaceutical, Inc.	CALCITONIN SALMON	200	[iU]/.09mL	Calcitonin [CS], Calcitonin [EPC]		N	20241231
49884-170_dd2684d3-57f2-462f-903e-3ba58832e4f3	49884-170	HUMAN PRESCRIPTION DRUG	Sodium Phenylbutyrate		Sodium Phenylbutyrate Tablets, 500 mg	TABLET	ORAL	20160429		ANDA	ANDA204395	Par Pharmaceutical, Inc.	SODIUM PHENYLBUTYRATE	500	mg/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
49884-171_aa8338ac-c3e5-4433-995b-c13be82c4d11	49884-171	HUMAN PRESCRIPTION DRUG	Colchicine		colchicine	TABLET, FILM COATED	ORAL	20220927		ANDA	ANDA203976	Par Pharmaceutical, Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
49884-186_14ca12b0-76b6-4b0a-a25d-362090e3d320	49884-186	HUMAN PRESCRIPTION DRUG	Doxylamine Succinate and Pyridoxine Hydrochloride		Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg	TABLET, DELAYED RELEASE	ORAL	20191219		ANDA	ANDA208518	Par Pharmaceutical, Inc.	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
49884-210_b87c7717-5019-43fe-9a18-d2d7ae07cc91	49884-210	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110103		ANDA	ANDA078540	Par Pharmaceutical, Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
49884-211_b87c7717-5019-43fe-9a18-d2d7ae07cc91	49884-211	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110103		ANDA	ANDA078540	Par Pharmaceutical, Inc.	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
49884-212_ace2c7bc-036a-4db7-90ff-5fbc0e58bc87	49884-212	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20090601		ANDA	ANDA077494	Par Pharmaceutical, Inc.	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-213_80d3cefb-e83e-4dbd-ba6e-2eac42ccc73f	49884-213	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20090109		ANDA	ANDA078088	Par Pharmaceutical, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-214_80d3cefb-e83e-4dbd-ba6e-2eac42ccc73f	49884-214	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET, ORALLY DISINTEGRATING	ORAL	20090109		ANDA	ANDA078088	Par Pharmaceutical, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-222_f30ff9a6-1558-4374-9332-aa694b2d5ec1	49884-222	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	19871109		ANDA	ANDA071422	Par Pharmaceutical, Inc.	DOXEPIN HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
49884-231_b56650e6-fb8c-47c9-99d6-b39f3c343e3c	49884-231	HUMAN PRESCRIPTION DRUG	PRAZIQUANTEL		PRAZIQUANTEL	TABLET, FILM COATED	ORAL	20171127		ANDA	ANDA208820	Par Pharmaceutical, Inc.	PRAZIQUANTEL	600	mg/1	Anthelmintic [EPC]		N	20241231
49884-239_681c75ef-b582-4746-a00c-cc22aaa845fc	49884-239	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE	ORAL	20160701	20250731	ANDA	ANDA205724	Par Pharmaceutical, Inc.	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	
49884-248_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-248	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-250_c6d7dd70-2d36-4b4a-8d10-18a55db9634a	49884-250	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		olanzapine and fuoxetine	CAPSULE	ORAL	20121126		ANDA	ANDA077742	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 6	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49884-251_c6d7dd70-2d36-4b4a-8d10-18a55db9634a	49884-251	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		olanzapine and fuoxetine	CAPSULE	ORAL	20121126		ANDA	ANDA077742	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 6	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49884-252_c6d7dd70-2d36-4b4a-8d10-18a55db9634a	49884-252	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		olanzapine and fuoxetine	CAPSULE	ORAL	20121126		ANDA	ANDA077742	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 12	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49884-253_c6d7dd70-2d36-4b4a-8d10-18a55db9634a	49884-253	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		olanzapine and fuoxetine	CAPSULE	ORAL	20121126		ANDA	ANDA077742	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 12	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49884-256_e2bb3d10-4f0e-4571-971a-42c30f6e63f8	49884-256	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071826	Par Pharmaceutical, Inc.	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
49884-257_e2bb3d10-4f0e-4571-971a-42c30f6e63f8	49884-257	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071839	Par Pharmaceutical, Inc.	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
49884-269_82d1592e-d939-4539-9421-bdf321f1ffff	49884-269	HUMAN PRESCRIPTION DRUG	Omeprazole/Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	POWDER, FOR SUSPENSION	ORAL	20160718	20241130	ANDA	ANDA079182	Par Pharmaceutical, Inc.	OMEPRAZOLE; SODIUM BICARBONATE	40; 1680	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
49884-270_e1f10425-6544-4ed5-b76f-53bc21326d7a	49884-270	HUMAN PRESCRIPTION DRUG	Nascobal		cyanocobalamin	SPRAY	NASAL	20090813		NDA	NDA021642	Par Pharmaceutical, Inc.	CYANOCOBALAMIN	500	ug/1	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
49884-277_c6d7dd70-2d36-4b4a-8d10-18a55db9634a	49884-277	HUMAN PRESCRIPTION DRUG	Olanzapine and Fluoxetine		olanzapine and fuoxetine	CAPSULE	ORAL	20121126		ANDA	ANDA077742	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 3	mg/1; mg/1	Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49884-283_9a6bc6cc-b9da-4fe1-9ee1-c9a393bb5dec	49884-283	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20220126		ANDA	ANDA205775	Par Pharmaceutical, Inc.	EVEROLIMUS	1	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
49884-289_8707d220-fcf6-4b48-ae5f-1fdb44addcb7	49884-289	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	19880808	20240831	ANDA	ANDA072422	Par Pharmaceutical, Inc.	MEGESTROL ACETATE	20	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	
49884-290_8707d220-fcf6-4b48-ae5f-1fdb44addcb7	49884-290	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	19880808	20241231	ANDA	ANDA072423	Par Pharmaceutical, Inc.	MEGESTROL ACETATE	40	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	
49884-301_44c3143a-50c5-4951-83cb-9a0a1bcc0802	49884-301	HUMAN PRESCRIPTION DRUG	Oxandrolone		oxandrolone	TABLET	ORAL	20070820	20251031	ANDA	ANDA077827	Par Pharmaceutical, Inc.	OXANDROLONE	2.5	mg/1		CIII	N	
49884-302_44c3143a-50c5-4951-83cb-9a0a1bcc0802	49884-302	HUMAN PRESCRIPTION DRUG	Oxandrolone		oxandrolone	TABLET	ORAL	20070820	20251031	ANDA	ANDA077827	Par Pharmaceutical, Inc.	OXANDROLONE	10	mg/1		CIII	N	
49884-305_da765403-ebf9-4189-894d-61678ab69965	49884-305	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20110601	20240228	ANDA	ANDA065055	Par Pharmaceutical, Inc.	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
49884-306_7e84e520-6ec2-482e-8634-eee47a90e41b	49884-306	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20050805		ANDA	ANDA077171	Par Pharmaceutical, Inc.	CLONAZEPAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-307_7e84e520-6ec2-482e-8634-eee47a90e41b	49884-307	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20050805		ANDA	ANDA077171	Par Pharmaceutical, Inc.	CLONAZEPAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-308_7e84e520-6ec2-482e-8634-eee47a90e41b	49884-308	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20050805		ANDA	ANDA077171	Par Pharmaceutical, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-309_7e84e520-6ec2-482e-8634-eee47a90e41b	49884-309	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20050805		ANDA	ANDA077171	Par Pharmaceutical, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-310_7e84e520-6ec2-482e-8634-eee47a90e41b	49884-310	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20050805		ANDA	ANDA077171	Par Pharmaceutical, Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
49884-311_ace2c7bc-036a-4db7-90ff-5fbc0e58bc87	49884-311	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20090601		ANDA	ANDA077494	Par Pharmaceutical, Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-315_ace2c7bc-036a-4db7-90ff-5fbc0e58bc87	49884-315	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20091026		ANDA	ANDA077494	Par Pharmaceutical, Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-320_c4415910-1493-4b5d-9723-94ae2f6c2622	49884-320	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA078109	Par Pharmaceutical, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-321_c4415910-1493-4b5d-9723-94ae2f6c2622	49884-321	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA078109	Par Pharmaceutical, Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-322_c4415910-1493-4b5d-9723-94ae2f6c2622	49884-322	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA078109	Par Pharmaceutical, Inc.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-323_c4415910-1493-4b5d-9723-94ae2f6c2622	49884-323	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA078109	Par Pharmaceutical, Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-333_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-333	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-335_6aa2aef7-fc27-47af-b5be-8661fcc2cce1	49884-335	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49884-336_6aa2aef7-fc27-47af-b5be-8661fcc2cce1	49884-336	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
49884-339_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-339	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-347_e7e07fa7-9faa-4893-a15b-576ebc02c30f	49884-347	HUMAN PRESCRIPTION DRUG	Pimozide		Pimozide	TABLET	ORAL	20150928		ANDA	ANDA204521	Par Pharmaceutical, Inc.	PIMOZIDE	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
49884-348_e7e07fa7-9faa-4893-a15b-576ebc02c30f	49884-348	HUMAN PRESCRIPTION DRUG	Pimozide		Pimozide	TABLET	ORAL	20150928		ANDA	ANDA204521	Par Pharmaceutical, Inc.	PIMOZIDE	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
49884-358_7b07262f-73dc-494c-9b06-0f9e4c907f1c	49884-358	HUMAN PRESCRIPTION DRUG	VIGABATRIN		vigabatrin	POWDER, FOR SOLUTION	ORAL	20170427		ANDA	ANDA208218	Par Pharmaceutical, Inc.	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
49884-362_2decf1b9-9567-4351-8352-6e376ee86a84	49884-362	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Par Pharmaceutical, Inc.	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
49884-363_2decf1b9-9567-4351-8352-6e376ee86a84	49884-363	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Par Pharmaceutical, Inc.	DANTROLENE SODIUM	50	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
49884-364_2decf1b9-9567-4351-8352-6e376ee86a84	49884-364	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Par Pharmaceutical, Inc.	DANTROLENE SODIUM	100	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
49884-401_ace2c7bc-036a-4db7-90ff-5fbc0e58bc87	49884-401	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20090601		ANDA	ANDA077494	Par Pharmaceutical, Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-402_ace2c7bc-036a-4db7-90ff-5fbc0e58bc87	49884-402	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20090601		ANDA	ANDA077494	Par Pharmaceutical, Inc.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-403_ace2c7bc-036a-4db7-90ff-5fbc0e58bc87	49884-403	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20090610		ANDA	ANDA077494	Par Pharmaceutical, Inc.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
49884-412_9e42522b-dca3-45f6-b935-c8961a3b1549	49884-412	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Par Pharmaceutical, Inc.	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
49884-413_9e42522b-dca3-45f6-b935-c8961a3b1549	49884-413	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Par Pharmaceutical, Inc.	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
49884-418_18413cc4-22d5-48ff-9e62-3b5909f9c22c	49884-418	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20150902		ANDA	ANDA076744	Par Pharmaceutical, Inc.	TESTOSTERONE	25	mg/2.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
49884-424_c54a494b-ffd9-4502-81bb-96b3e0de7415	49884-424	HUMAN PRESCRIPTION DRUG	ALISKIREN		ALISKIREN	TABLET, FILM COATED	ORAL	20190325		ANDA	ANDA206665	Par Pharmaceutical, Inc.	ALISKIREN HEMIFUMARATE	150	mg/1	Renin Inhibitor [EPC], Renin Inhibitors [MoA]		N	20241231
49884-425_c54a494b-ffd9-4502-81bb-96b3e0de7415	49884-425	HUMAN PRESCRIPTION DRUG	ALISKIREN		ALISKIREN	TABLET, FILM COATED	ORAL	20190325		ANDA	ANDA206665	Par Pharmaceutical, Inc.	ALISKIREN HEMIFUMARATE	300	mg/1	Renin Inhibitor [EPC], Renin Inhibitors [MoA]		N	20241231
49884-465_3d67eb62-ade4-4be6-b85d-8e5fd933f55f	49884-465	HUMAN PRESCRIPTION DRUG	Cholestyramine		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077204	Par Pharmaceutical, Inc.	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
49884-466_3d67eb62-ade4-4be6-b85d-8e5fd933f55f	49884-466	HUMAN PRESCRIPTION DRUG	Cholestyramine		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077203	Par Pharmaceutical, Inc.	CHOLESTYRAMINE	4	g/5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
49884-468_4853ecff-dd5d-4cec-92c8-a0e1a5af145b	49884-468	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA209419	Par Pharmaceutical, Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
49884-484_c6e06263-240f-4ae3-9a7a-ba09275f4d0e	49884-484	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151216		ANDA	ANDA204158	Par Pharmaceutical, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-485_c6e06263-240f-4ae3-9a7a-ba09275f4d0e	49884-485	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151216		ANDA	ANDA204158	Par Pharmaceutical, Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-486_c6e06263-240f-4ae3-9a7a-ba09275f4d0e	49884-486	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151216		ANDA	ANDA204158	Par Pharmaceutical, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-487_c6e06263-240f-4ae3-9a7a-ba09275f4d0e	49884-487	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151216		ANDA	ANDA204158	Par Pharmaceutical, Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-510_18413cc4-22d5-48ff-9e62-3b5909f9c22c	49884-510	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20150902		ANDA	ANDA076744	Par Pharmaceutical, Inc.	TESTOSTERONE	50	mg/5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
49884-511_6b95ec55-8686-495a-b24c-4e4409a5c2e8	49884-511	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline	TABLET	ORAL	20030416		ANDA	ANDA065131	Par Pharmaceutical, Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
49884-512_6b95ec55-8686-495a-b24c-4e4409a5c2e8	49884-512	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline	TABLET	ORAL	20030416		ANDA	ANDA065131	Par Pharmaceutical, Inc.	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
49884-513_6b95ec55-8686-495a-b24c-4e4409a5c2e8	49884-513	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline	TABLET	ORAL	20030416		ANDA	ANDA065131	Par Pharmaceutical, Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
49884-539_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-539	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-546_8b31cc06-5281-497a-a94c-6ce2ec72d1d0	49884-546	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Par Pharmaceutical, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
49884-549_8599c60a-49fc-47f3-b49c-2b089f79b202	49884-549	HUMAN PRESCRIPTION DRUG	Zafirlukast		zafirlukast	TABLET, COATED	ORAL	20101119	20240430	NDA	NDA020547	Par Pharmaceutical, Inc.	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	
49884-554_8599c60a-49fc-47f3-b49c-2b089f79b202	49884-554	HUMAN PRESCRIPTION DRUG	Zafirlukast		zafirlukast	TABLET, COATED	ORAL	20101119	20240930	NDA	NDA020547	Par Pharmaceutical, Inc.	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	
49884-556_def9251e-0782-4815-b04d-0572bad753c4	49884-556	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	20211221		ANDA	ANDA211290	Par Pharmaceutical, Inc.	ISOSORBIDE DINITRATE	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
49884-561_3c26caa3-84f9-442d-b752-9dda35d0bacb	49884-561	HUMAN PRESCRIPTION DRUG	Lamotrigine Extended Release		lamotrigine extended release	TABLET	ORAL	20130118		ANDA	ANDA201791	Par Pharmaceutical, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-562_3c26caa3-84f9-442d-b752-9dda35d0bacb	49884-562	HUMAN PRESCRIPTION DRUG	Lamotrigine Extended Release		lamotrigine extended release	TABLET	ORAL	20130118		ANDA	ANDA201791	Par Pharmaceutical, Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-563_3c26caa3-84f9-442d-b752-9dda35d0bacb	49884-563	HUMAN PRESCRIPTION DRUG	Lamotrigine Extended Release		lamotrigine extended release	TABLET	ORAL	20130118		ANDA	ANDA201791	Par Pharmaceutical, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-564_3c26caa3-84f9-442d-b752-9dda35d0bacb	49884-564	HUMAN PRESCRIPTION DRUG	Lamotrigine Extended Release		lamotrigine extended release	TABLET	ORAL	20130118		ANDA	ANDA201791	Par Pharmaceutical, Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-589_1562c939-2d4d-452f-add4-2e24a29464cd	49884-589	HUMAN PRESCRIPTION DRUG	Accolate		zafirlukast	TABLET, COATED	ORAL	20151101	20240430	NDA	NDA020547	Par Pharmaceutical, Inc.	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	
49884-604_3c26caa3-84f9-442d-b752-9dda35d0bacb	49884-604	HUMAN PRESCRIPTION DRUG	Lamotrigine Extended Release		lamotrigine extended release	TABLET	ORAL	20130118		ANDA	ANDA201791	Par Pharmaceutical, Inc.	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-605_3c26caa3-84f9-442d-b752-9dda35d0bacb	49884-605	HUMAN PRESCRIPTION DRUG	Lamotrigine Extended Release		lamotrigine extended release	TABLET	ORAL	20130118		ANDA	ANDA201791	Par Pharmaceutical, Inc.	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
49884-640_c6608bc7-3b0c-4760-a7a1-bcc5c200685d	49884-640	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20000329	20241031	ANDA	ANDA040350	Par Pharmaceutical, Inc.	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
49884-641_c6608bc7-3b0c-4760-a7a1-bcc5c200685d	49884-641	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20000329	20241031	ANDA	ANDA040350	Par Pharmaceutical, Inc.	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
49884-658_17510ed6-8915-41ab-9f20-8572368f2235	49884-658	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Par Pharmaceutical Inc.	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
49884-659_17510ed6-8915-41ab-9f20-8572368f2235	49884-659	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Par Pharmaceutical Inc.	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
49884-660_17510ed6-8915-41ab-9f20-8572368f2235	49884-660	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Par Pharmaceutical Inc.	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
49884-661_17510ed6-8915-41ab-9f20-8572368f2235	49884-661	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Par Pharmaceutical Inc.	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
49884-701_2193987a-7dda-4699-9943-f1bec4d53c5d	49884-701	HUMAN PRESCRIPTION DRUG	Clomiphene Citrate		Clomiphene Citrate	TABLET	ORAL	19990830	20250228	ANDA	ANDA075528	Par Pharmaceutical, Inc.	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	
49884-720_825359dd-2aa0-4a8c-a74b-09ebd0bd6f99	49884-720	HUMAN PRESCRIPTION DRUG	sapropterin dihydrochloride		sapropterin dihydrochloride	TABLET	ORAL	20201001		ANDA	ANDA207200	Par Pharmaceutical, Inc.	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
49884-724_17d453c5-447c-42db-bee7-ca9946141ab0	49884-724	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	19990224		ANDA	ANDA075340	Par Pharmaceutical, Inc.	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
49884-726_da765403-ebf9-4189-894d-61678ab69965	49884-726	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20001201	20241130	ANDA	ANDA065055	Par Pharmaceutical, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
49884-727_da765403-ebf9-4189-894d-61678ab69965	49884-727	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20001201	20241231	ANDA	ANDA065055	Par Pharmaceutical, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
49884-768_4601487a-5d64-4b0c-9f69-19b25f46702b	49884-768	HUMAN PRESCRIPTION DRUG	Tolvaptan		Tolvaptan	TABLET	ORAL	20220310		ANDA	ANDA206119	Par Pharmaceutical, Inc.	TOLVAPTAN	15	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
49884-770_4601487a-5d64-4b0c-9f69-19b25f46702b	49884-770	HUMAN PRESCRIPTION DRUG	Tolvaptan		Tolvaptan	TABLET	ORAL	20220310		ANDA	ANDA206119	Par Pharmaceutical, Inc.	TOLVAPTAN	30	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
49884-786_1c38f5c7-7252-4368-8da9-f6d64cfaf23b	49884-786	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Par Pharmaceutical, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
49884-787_1c38f5c7-7252-4368-8da9-f6d64cfaf23b	49884-787	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Par Pharmaceutical, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
49884-788_1c38f5c7-7252-4368-8da9-f6d64cfaf23b	49884-788	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Par Pharmaceutical, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
49884-789_1c38f5c7-7252-4368-8da9-f6d64cfaf23b	49884-789	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Par Pharmaceutical, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
49884-790_1c38f5c7-7252-4368-8da9-f6d64cfaf23b	49884-790	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Par Pharmaceutical, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
49884-814_490c2177-89a0-4a42-9f98-0405fe1c7610	49884-814	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20181029		ANDA	ANDA207169	Par Pharmaceutical, Inc.	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
49884-849_490c2177-89a0-4a42-9f98-0405fe1c7610	49884-849	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20181029		ANDA	ANDA207169	Par Pharmaceutical, Inc.	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
49884-873_2f14ecc9-72be-414d-b80a-1ac055e9c91a	49884-873	HUMAN PRESCRIPTION DRUG	SAPROPTERIN DIHYDROCHLORIDE		SAPROPTERIN DIHYDROCHLORIDE	POWDER, FOR SOLUTION	ORAL	20201001		ANDA	ANDA210027	Par Pharmaceutical, Inc.	SAPROPTERIN DIHYDROCHLORIDE	500	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
49884-874_490c2177-89a0-4a42-9f98-0405fe1c7610	49884-874	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20181029		ANDA	ANDA207169	Par Pharmaceutical, Inc.	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
49884-880_c6e06263-240f-4ae3-9a7a-ba09275f4d0e	49884-880	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	KIT		20151127		ANDA	ANDA204158	Par Pharmaceutical, Inc.						N	20241231
49884-881_c6e06263-240f-4ae3-9a7a-ba09275f4d0e	49884-881	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	KIT		20151127		ANDA	ANDA204158	Par Pharmaceutical, Inc.						N	20241231
49884-882_c6e06263-240f-4ae3-9a7a-ba09275f4d0e	49884-882	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	KIT		20151127		ANDA	ANDA204158	Par Pharmaceutical, Inc.						N	20241231
49884-898_5f90507a-be73-426f-858c-289367d24ac1	49884-898	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate sublingual		Zolpidem tartrate sublingual	TABLET	SUBLINGUAL	20170911		ANDA	ANDA204229	Par Pharmaceutical, Inc.	ZOLPIDEM TARTRATE	1.75	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
49884-899_5f90507a-be73-426f-858c-289367d24ac1	49884-899	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate sublingual		Zolpidem tartrate sublingual	TABLET	SUBLINGUAL	20170911		ANDA	ANDA204229	Par Pharmaceutical, Inc.	ZOLPIDEM TARTRATE	3.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
49884-902_3dc9bb13-c8c5-467c-be6b-937db2e656f6	49884-902	HUMAN PRESCRIPTION DRUG	Mafenide acetate		Mafenide acetate	POWDER, FOR SOLUTION	TOPICAL	20130212	20250531	ANDA	ANDA201511	Par Pharmaceutical, Inc.	MAFENIDE ACETATE	50	g/1	Methylated Sulfonamide Antibacterial [EPC], Methylated Sulfonamides [EXT]		N	
49884-903_e8df627f-e5f9-4368-80a4-b0fdde64f134	49884-903	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET	SUBLINGUAL	20161104		ANDA	ANDA201509	Par Pharmaceutical, Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
49884-904_e8df627f-e5f9-4368-80a4-b0fdde64f134	49884-904	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET	SUBLINGUAL	20161104		ANDA	ANDA201509	Par Pharmaceutical, Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
49884-905_1493218d-84f4-440a-bd32-b7bbe95f9322	49884-905	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	POWDER, FOR SOLUTION	ORAL	20230103		ANDA	ANDA202964	Par Pharmaceutical, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49884-907_ec56e3fd-9c8b-4999-a9fe-3f28d1a10ecc	49884-907	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20010725		ANDA	ANDA075671	Par Pharmaceutical, Inc.	MEGESTROL ACETATE	40	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
49884-936_7bce10dd-f886-4d8e-8695-6f2bb28582ae	49884-936	HUMAN PRESCRIPTION DRUG	QUESTRAN		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077204	Par Pharmaceutical, Inc.	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
49884-937_7bce10dd-f886-4d8e-8695-6f2bb28582ae	49884-937	HUMAN PRESCRIPTION DRUG	QUESTRAN		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20030724		ANDA	ANDA077203	Par Pharmaceutical, Inc.	CHOLESTYRAMINE	4	g/5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
49884-944_e969d8d8-4da8-44e0-b866-13bdfac92829	49884-944	HUMAN PRESCRIPTION DRUG	Varenicline		varenicline tartrate	KIT		20210921		ANDA	ANDA201785	Par Pharmaceutical, Inc.						N	20241231
49884-948_5bae447c-36f9-4832-83a5-20e30fb63248	49884-948	HUMAN PRESCRIPTION DRUG	SAPROPTERIN DIHYDROCHLORIDE		SAPROPTERIN DIHYDROCHLORIDE	POWDER, FOR SOLUTION	ORAL	20201001		ANDA	ANDA207207	Par Pharmaceutical, Inc.	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
49884-984_20d37769-1721-4531-88cf-e29082373c71	49884-984	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, COATED	ORAL	20090908	20240930	ANDA	ANDA077463	Par Pharmaceutical, Inc.	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	
49892-0002_7a4b323a-285f-4f52-bf37-3bd89827eba7	49892-0002	HUMAN OTC DRUG	Musco MXT		Aralia quinquefolia, Epiphegus virginiana, Jacaranda caroba, Lacticum acidum, Hydrocotyle asiatica, Hydrocyanicum acidum,	LIQUID	ORAL	20130627		UNAPPROVED HOMEOPATHIC		Sandco International, Inc	CENTELLA ASIATICA; EPIFAGUS VIRGINIANA; HYDROGEN CYANIDE; JACARANDA CAROBA FLOWER; LACTIC ACID, DL-; PANAX QUINQUEFOLIUS WHOLE	100; 15; 100; 15; 15; 15	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
49908-117_06bca8a1-a18f-a42f-e063-6394a90af0b1	49908-117	HUMAN PRESCRIPTION DRUG	Adapalene Topical Solution		Adapalene Topical Solution	SOLUTION	TOPICAL	20211213		ANDA	ANDA203981	CALL INC (d.b.a Rochester Pharmaceuticals)	ADAPALENE	1	mg/mL	Retinoid [EPC], Retinoids [CS]		N	20241231
49908-118_06bcd5e3-0f9c-d65a-e063-6394a90a8413	49908-118	HUMAN PRESCRIPTION DRUG	Adapalene		Adapalene	SWAB	TOPICAL	20190204		ANDA	ANDA204593	CALL INC. (dba Rochester Pharmaceuticals)	ADAPALENE	1	mg/mL	Retinoid [EPC], Retinoids [CS]		N	20241231
49911-884_09c29a75-1493-1335-e063-6394a90a7f27	49911-884	HUMAN OTC DRUG	Plum Smooth Plumb Numb Gelee		Lidocaine	GEL	TOPICAL	20120329		OTC MONOGRAPH DRUG	M017	Universal Companies, Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49938-101_aef3166f-2850-4709-a00f-4c8e784d8022	49938-101	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20080815	20250831	ANDA	ANDA086842	Jacobus Pharmaceutical Company, Inc.	DAPSONE	100	mg/1	Sulfone [EPC], Sulfones [CS]		N	
49938-102_aef3166f-2850-4709-a00f-4c8e784d8022	49938-102	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20080815	20250228	ANDA	ANDA086841	Jacobus Pharmaceutical Company, Inc.	DAPSONE	25	mg/1	Sulfone [EPC], Sulfones [CS]		N	
49944-001_543d2048-954b-4fd7-acab-e70109b58e5c	49944-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19830101		UNAPPROVED MEDICAL GAS		I.D.M. Medical Supply Company Inc.	OXYGEN	99	L/100L			N	20241231
49944-010_543d2048-954b-4fd7-acab-e70109b58e5c	49944-010	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19830101		UNAPPROVED MEDICAL GAS		I.D.M. Medical Supply Company Inc.	OXYGEN	99	L/100L			N	20241231
49947-001_65ab552f-94b6-43b2-b77a-d541729fbe40	49947-001	HUMAN OTC DRUG	Hush Anesthetic		Lidocaine	SPRAY	TOPICAL	20121201		OTC MONOGRAPH DRUG	M017	HUSH Anesthetic	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49947-002_962f580f-c65d-457c-b228-aa700d91fad5	49947-002	HUMAN OTC DRUG	Hush Anesthetic		Lidocaine	GEL	TOPICAL	20121201		OTC MONOGRAPH DRUG	M017	HUSH Anesthetic	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49947-003_339f1eaf-18d6-4c6f-b48d-420e092f7ee3	49947-003	HUMAN OTC DRUG	Hush Anesthetic		Lidocaine, Benzalkonium Chloride	SOAP	TOPICAL	20140401		OTC MONOGRAPH NOT FINAL	part348	HUSH Anesthetic	BENZALKONIUM CHLORIDE; LIDOCAINE	1.3; 40	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
49953-0725_0d984c6c-1708-e0f6-e063-6294a90a5cef	49953-0725	HUMAN OTC DRUG	Povidon Iodine Prep Pads		Povidone-Iodine	SWAB	TOPICAL	20230210		OTC MONOGRAPH DRUG	M003	Dalian Rongbang Medical Healthy Devices Co., Ltd.	POVIDONE-IODINE	10	mg/mL			N	20241231
49953-0925_0d96b498-b242-3448-e063-6394a90ad2aa	49953-0925	HUMAN OTC DRUG	Lemon Glycerin Swabsticks		Glycerin	SWAB	ORAL	20230224		OTC MONOGRAPH DRUG	M022	Dalian Rongbang Medical Healthy Devices Co., Ltd.	GLYCERIN	7.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
49953-1801_0d988131-7ac9-159f-e063-6294a90a709d	49953-1801	HUMAN OTC DRUG	Alcohol Swabstick - Antiseptic		Isopropyl Alcohol	SWAB	TOPICAL	20200527		OTC MONOGRAPH DRUG	M003	Dalian Rongbang Medical Healthy Devices Co., Ltd.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
49953-1895_0d987cb6-83c6-10d6-e063-6294a90ae40c	49953-1895	HUMAN OTC DRUG	RONGBANG BZK Cleansing Swabstick		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20220318		OTC MONOGRAPH DRUG	M003	Dalian Rongbang Medical Healthy Devices Co., Ltd.	BENZALKONIUM CHLORIDE	.133	mg/100g			N	20241231
49953-2801_0d988db9-6d5e-f78e-e063-6394a90afaa4	49953-2801	HUMAN OTC DRUG	Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20100702		OTC MONOGRAPH DRUG	M003	Dalian Rongbang Medical Healthy Devices Co., Ltd.	ISOPROPYL ALCOHOL	7	mL/10mL			N	20241231
49953-2803_0d9884d8-991f-0ce7-e063-6294a90a5b66	49953-2803	HUMAN OTC DRUG	Rongbang BZK Cleansing Pad		Benzalkonium	SWAB	TOPICAL	20220318		OTC MONOGRAPH DRUG	M003	Dalian Rongbang Medical Healthy Devices Co., Ltd.	BENZALKONIUM CHLORIDE	.133	mg/100g			N	20241231
49967-003_0a19a27a-23ef-4072-8e73-d262d50ea95d	49967-003	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 60 Melt In Sunscreen Milk Broad Spectrum SPF 60 Face and Body		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20130601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 107.2; 32.1; 60; 38.6	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-007_7df9995e-46d4-4308-8316-e55016fbc550	49967-007	HUMAN OTC DRUG	Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen		Octinoxate	LOTION	TOPICAL	20100101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	75	mg/mL			N	20241231
49967-008_6a341ffe-efb5-4617-8a96-d97c791699cd	49967-008	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 60 Ultra Light Sunscreen Broad Spectrum SPF 60 Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	SPRAY	TOPICAL	20140101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	26.8; 96; 28.8; 53.8; 34.6	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
49967-009_85bcc58e-e4f7-48a9-9d4d-51449f87c88c	49967-009	HUMAN OTC DRUG	LOreal Paris Infallible Up to 24 H Fresh Wear Foundation Broad Spectrum SPF 25 Sunscreen		Octinoxate and Titanium Dioxide	LIQUID	TOPICAL	20181001		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	67; 36	mg/mL; mg/mL			N	20241231
49967-011_d164a87e-eedf-4a15-a347-eea950f79968	49967-011	HUMAN OTC DRUG	LOreal Paris Revitalift Derm Intensives Invisible UV Fluid Broad Spectrum SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	GEL	TOPICAL	20220930		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-013_6f431b15-7dea-4ee1-bf73-d9b2ea5a8af5	49967-013	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Sunscreen Broad Spectrum SPF 50 Face		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20170824		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	2.744; 2.632	g/56g; g/56g			N	20251231
49967-014_ba81290e-6316-4cda-9b20-ac2c7b8ca112	49967-014	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Sunscreen Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20171101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	.8; .63	g/13.32g; g/13.32g			N	20241231
49967-015_9e408aae-0e5e-476f-aefe-3b813f3934b7	49967-015	HUMAN OTC DRUG	CeraVe AM Facial Moisturizing Broad Spectrum SPF 30 Sunscreen		Homosalate, Meradimate, Octinoxate, Zinc Oxide, and Octocrylene	LOTION	TOPICAL	20170803		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products, Inc.	HOMOSALATE; MERADIMATE; OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 50; 20; 63	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-016_bcb39b0f-6392-4487-b5d0-f2d8d29b5243	49967-016	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Sunscreen Body Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20170915		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	TITANIUM DIOXIDE; ZINC OXIDE	4.165; 3.995	g/85g; g/85g			N	20251231
49967-017_b0482516-fafc-4b0f-aea1-1e20a276d1f1	49967-017	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios SX Daily Moisturizing Sunscreen Broad Spectrum SPF 15		Avobenzone, Ecamsule and Octocrylene	CREAM	TOPICAL	20140729	20241123	NDA	NDA021502	L'Oreal USA Products Inc	AVOBENZONE; ECAMSULE; OCTOCRYLENE	20; 20; 100	mg/g; mg/g; mg/g			N	
49967-020_e0583865-b915-43f9-a3ba-77d75b4a0783	49967-020	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 50 Tinted Mineral Face Broad Spectrum SPF 50 Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	110	mg/mL			N	20241231
49967-023_4f240059-6dd5-422b-8ffa-04c6019f4162	49967-023	HUMAN OTC DRUG	La Roche Posay Laboratorie Dermatologique Effaclar Medicated Cleanser		Salicylic Acid	GEL	TOPICAL	20140801		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-024_a54b7589-0951-4fad-ba26-958b89672de5	49967-024	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Effaclar Clarifying		Salicylic Acid	SOLUTION	TOPICAL	20140801		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	5	mg/mL			N	20251231
49967-026_6ec7f0cb-c691-426f-afa2-dd8bb9814f5c	49967-026	HUMAN OTC DRUG	IT Cosmetics Bye Bye Breakout Concentrated Derma Serum Acne Treatment		Salicylic Acid	LOTION	TOPICAL	20220401		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-035_0058a96f-0cce-4af4-98b9-c4686e6d1984	49967-035	HUMAN OTC DRUG	Garnier Clean Blackhead Eliminating Scrub		Salicylic Acid	GEL	TOPICAL	20140101		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20251231
49967-036_cbf4738a-5c24-45b8-90f4-9f250d2b9965	49967-036	HUMAN OTC DRUG	LOreal Paris Age Perfect Cell Renewal Day Moisturizer Broad Spectrum SPF 25 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
49967-038_752b3e38-a6f2-471f-a3a0-046b473a1b6d	49967-038	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 60 Face and Body Cooling Water Broad Spectrum SPF 60 Sunscreen Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 107.2; 32.1; 60; 38.6	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-043_6a9b680d-ea91-44fd-94fd-bee18621aca2	49967-043	HUMAN OTC DRUG	LOreal Paris Infallible ProGlow Broad Spectrum SPF 15 Sunscreen		Octinoxate	LIQUID	TOPICAL	20160226		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	32	mg/mL			N	20241231
49967-047_d746b613-5513-42fa-b219-c562f9fbc503	49967-047	HUMAN OTC DRUG	Kiehls Since 1851 Activated Sun Protector Broad Spectrum SPF 50 Sunscreen Water Resistant 80 MInutes		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20150215		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 107.2; 32.1; 60; 38.6	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-048_f3aa7529-2588-4923-a8a3-6734a54b1029	49967-048	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Clear Skin Face Oil Free Dry Touch Broad Spectrum SPF 60 Sunscreen Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-049_d19dedda-b6cb-4bf9-aa01-688a1776af5c	49967-049	HUMAN OTC DRUG	AcneFree Oil Free Hydrating Moisturizer UV 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20210209		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-050_ee667814-d4d3-4886-a7a7-bfaf6c03df0a	49967-050	HUMAN OTC DRUG	SkinCeuticals Physical Eye UV Defense Sunscreen		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20140418	20260727	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	90; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
49967-051_c01a122f-7b2e-4caa-9d8c-5d1c30970225	49967-051	HUMAN OTC DRUG	Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Cleanser		Salicylic Acid	GEL	TOPICAL	20220101		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-052_b9b99a11-9e06-4989-ba07-41535740a9fc	49967-052	HUMAN OTC DRUG	Matrix Biolage ScalpSync Antidandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20140501		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
49967-053_a35abbbe-0dfd-4a24-8fb6-98b2367cfcff	49967-053	HUMAN OTC DRUG	Kiehls Dermatologist Solutions Better Screen UV Serum Broad Spectrum SPF 50 Plus Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-054_a60e9207-9520-4608-9851-c35b357dde80	49967-054	HUMAN OTC DRUG	Vichy Laboratoires Capital Soleil 50 Daily AntiAging Face Sunscreen Broad Spectrum SPF 50 Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-055_45a48eff-a48d-4f90-b586-2d6d9ecbd90e	49967-055	HUMAN OTC DRUG	Kiehls Since 1851 Dermatologist Solutions Truly Targeted Acne Clearing Solution		Salicylic Acid	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-056_3a837d92-b6d2-4454-ab86-cadfd1bec74a	49967-056	HUMAN OTC DRUG	LOreal Paris Ever Pure Dandruff Scalp Care and Detox		Pyrithione Zinc	SHAMPOO	TOPICAL	20200701		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
49967-057_244d3124-90d7-4d12-949b-17c4cc80cf16	49967-057	HUMAN OTC DRUG	Kiehls Since 1851 Dermatologist Solutions Expertly Clear Acne Treating and Preventing		Salicylic Acid	LOTION	TOPICAL	20230601		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	12	mg/mL			N	20241231
49967-062_d9e5cee5-0121-4edd-8d74-6c2b1e2bf050	49967-062	HUMAN OTC DRUG	Thayers Since 1847 Natural Remedies Double Action Acne Serum		Salicylic Acid	SOLUTION	TOPICAL	20230930		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-064_24f9c9fa-e0ad-419e-ba8b-e347e480ce08	49967-064	HUMAN OTC DRUG	Yves Saint Laurent Le Teint Touche Eclat Illuminating Foundation Broad Spectrum SPF 19 Sunscreen		Octinoxate	LOTION	TOPICAL	20120601	20240129	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	70	mg/mL			N	
49967-068_2b72a13a-b70e-4947-8705-c64d4d0d47f8	49967-068	HUMAN OTC DRUG	SkinCeuticals Silymarin CF Acne Treatment		Salicylic Acid	SOLUTION	TOPICAL	20201231		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	5	mg/mL			N	20241231
49967-076_8a40d789-adf2-4537-ad81-601c92aaa169	49967-076	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Effaclar Duo Acne Treatment		Benzoyl peroxide	LOTION	TOPICAL	20120701		OTC MONOGRAPH DRUG	M006	L'OREAL USA, INC.	BENZOYL PEROXIDE	55	mg/mL			N	20241231
49967-077_8aa3392a-bb65-475b-8bca-4da38eacd4e5	49967-077	HUMAN OTC DRUG	SkinCeuticals Physical Fusion UV Defense Broad Spectrum SPF 50 Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20110101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	60; 50	mg/mL; mg/mL			N	20241231
49967-082_866a359f-7cf9-4942-8858-8dc414ccc18c	49967-082	HUMAN OTC DRUG	LOreal Paris Revitalift Triple Power Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20121201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-086_11ba862d-f363-485f-9c66-dd1ba1ec5bbc	49967-086	HUMAN OTC DRUG	Kiehls Since 1851 Blue Herbal Acne Cleanser Treatment with Frankincense and Ginger Root		Salicylic Acid	LOTION	TOPICAL	20160426		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	15	mg/mL			N	20241231
49967-091_5e3f83d1-03e6-4aff-b18c-5286ee1da034	49967-091	HUMAN OTC DRUG	La Roche Posay New 50 Body and Face SPF 50 Mineral Anthelios Gentle 100 percent mineral UV filters Soft finish with Cell Ox Shield		Titanium dioxide and zinc oxide	LOTION	TOPICAL	20181215		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 150	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20251231
49967-095_360ef510-bc5d-4ad0-ad74-1b482451898c	49967-095	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 50 Daily Antiaging Primer with Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20120405		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-097_a78bb756-7d20-4d24-ba6f-500fbcd135a9	49967-097	HUMAN OTC DRUG	SkinCeuticals Blemish Plus Age Defense Acne Treatment		Salicylic Acid	LOTION	TOPICAL	20050801		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	15	mg/mL			N	20241231
49967-099_a53bdd11-49ff-4178-a9da-290ed588308e	49967-099	HUMAN OTC DRUG	Kiehls Since 1851 Ultra Facial Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20151101		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-100_6f7926ae-2187-4d56-9528-dc3611265aed	49967-100	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Sunscreen Broad Spectrum SPF 30 Face		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180104		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	37; 35	mg/g; mg/g			N	20251231
49967-103_f9d2a328-c72e-4146-8d04-a199a1a3ed6b	49967-103	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Broad Spectrum SPF 100 Body and Face Melt In Milk Sunscreen Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20200601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 10	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-108_fdc43cb3-3b00-4682-b30a-19df3a9dc5c7	49967-108	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Anti Itch		Hydrocortisone	CREAM	TOPICAL	20171114		OTC MONOGRAPH DRUG	M017	L'Oreal USA Products Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49967-112_aa22dae5-3bdf-45c9-af8d-b66ea86d5697	49967-112	HUMAN OTC DRUG	Garnier SkinActive Clearly Brighter AntiSun Damage Daily Moisturizer Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homoslate, Octisalate and Octocrylene	LOTION	TOPICAL	20160101		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-113_96ad9e71-c0b9-4917-8f2b-816290e881b0	49967-113	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Mela B3 UV Daily Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20231015		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-126_4a222f05-8c59-4f1d-b10b-497925401248	49967-126	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Hydraphase UV Intense Moisturizer Broad Spectrum SPF 20 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20120901		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 47; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-132_655e8b71-dc35-40f8-abbd-0c58029258a4	49967-132	HUMAN OTC DRUG	Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 26 Sunscreen		Octinoxate	LIQUID	TOPICAL	20191030	20251205	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	75	mg/mL			N	
49967-136_8ae29e29-8c30-4951-a450-3999f8e90794	49967-136	HUMAN OTC DRUG	Kerastase Paris K Symbiose Scalp Renewal Micro Exfoliating Scrub Antidandruff Treatment		Salicylic Acid	SHAMPOO	TOPICAL	20221201		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc.	SALICYLIC ACID	19	mg/mL			N	20241231
49967-137_2d5e9c53-a423-4502-a461-0fce452b5828	49967-137	HUMAN OTC DRUG	Lancome Paris Absolue Hand Premium Bx Broad Spectrum SPF 15 Sunscreen Absolute Anti Age Spot Unifying And Replenishing Treatment		Avobenzone, Octisalate and Octocrylene	LOTION	TOPICAL	20040101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	20; 50; 100	mg/g; mg/g; mg/g			N	20241231
49967-138_420dad6a-2891-4381-bd0f-1c886fdae112	49967-138	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Acne Control Cleanser		Salicylic Acid	GEL	TOPICAL	20210811		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-142_e2714e35-1f14-45cf-969c-91b8c4ca000a	49967-142	HUMAN OTC DRUG	Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen Broad Spectrum SPF 50 Plus Primer and Moisturizer		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-148_6ad26d0f-8efe-4cb9-bb6d-2b21ea645506	49967-148	HUMAN OTC DRUG	LOreal Paris AntiSagging Plus Even Tone Collagen Expert Moisturizer Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20211209		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
49967-150_f7fdf5ef-62b7-4263-b962-2f8a392da34c	49967-150	HUMAN OTC DRUG	CERAVE DEVELOPED WITH DERMATOLOGISTS HYDRATING SUNSCREEN SPF 30 FACE LIGHTWEIGHT, NON-GREASY FEEL 3 ESSENTIAL CERAMIDES NIACINAMIDE MINERAL SUNSCREEN		Titanium dioxide and zinc oxide	LOTION	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	60; 50	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49967-172_dc3ff666-19b7-4146-8eed-e28b7689274d	49967-172	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Acne Control Acne Treatment		Salicylic Acid	GEL	TOPICAL	20210518		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-180_b51c3144-3b5e-4e93-91d6-3682f52fff2e	49967-180	HUMAN OTC DRUG	Valentino Very Valentino Light Lasting Perfecting Foundation Broad Spectrum SPF 26 Sunscreen		Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20210201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	67; 18	mg/mL; mg/mL			N	20241231
49967-181_9f823e15-2caa-444c-ab9b-509c5cd3ecf9	49967-181	HUMAN OTC DRUG	Kiehls Super Fluid Daily UV Defense SPF 50 plus Anti-Pollution Lightweight Formula for All Skin Types		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	CREAM	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 107; 32; 60; 39	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-190_a33f8c5d-80b5-4e21-b45b-2b0bc86a7854	49967-190	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Baby Moisturizing		dimethicone	LOTION	TOPICAL	20170817	20240506	OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc	DIMETHICONE	10	mg/mL	Skin Barrier Activity [PE]		N	
49967-194_e9e88152-8bde-40f2-a809-23db8208373e	49967-194	HUMAN OTC DRUG	Lancome Paris Visionnaire Broad Spectrum SPF 20 Sunscreen Advanced Multi Correcting All Skin Types		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20170501		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
49967-196_cc4d39ba-60d8-4a85-96f7-faadfc3b1ab3	49967-196	HUMAN OTC DRUG	Maybelline New York Master Prime By Face Studio Primer Broad Spectrum SPF 30 Sunscreen		Octinoxate	LOTION	TOPICAL	20140731		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	OCTINOXATE	75	mg/mL			N	20241231
49967-201_b672a5a2-ecf6-4da6-a535-4295f1085cd3	49967-201	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Healing Lip Balm Broad Spectrum SPF 30 Sunscreen		Avobenzone, Dimethicone, Homosalate, Octisalate and Octocrylene	STICK	TOPICAL	20170831		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; DIMETHICONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 10; 100; 50; 100	mg/g; mg/g; mg/g; mg/g; mg/g	Skin Barrier Activity [PE]		N	20251231
49967-203_ff588e86-0a43-4b6f-a916-5018e807d227	49967-203	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Tinted Mineral Light Fluid Sunscreen Broad Spectrum SPF 40 Deep		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20231215		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	170; 80	mg/mL; mg/mL			N	20241231
49967-207_76e44da7-0a36-46d5-8f80-779f009d7a4d	49967-207	HUMAN OTC DRUG	LOreal Paris Youth Code Dark Spot Corrector Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
49967-210_de458c44-6b00-481b-a1ab-c9c00ae07d96	49967-210	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Tinted Mineral Light Fluid Sunscreen Broad Spectrum SPF 40 Medium		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20231215		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	170; 80	mg/mL; mg/mL			N	20241231
49967-217_c1aa1157-8a8d-440a-bb91-9247b677c1a7	49967-217	HUMAN OTC DRUG	NYX Professional Makeup Bare With Me Daily Moisturizing Primer with Cannabis Sativa Seed Oil SPF 30		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part352	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-230_fb44a812-c218-45ff-b558-3db22610be6d	49967-230	HUMAN OTC DRUG	Vichy Laboratoires Normaderm BHA Exfoliating Serum Acne Treatment		Salicylic acid	LOTION	TOPICAL	20221212		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	10	mg/mL			N	20241231
49967-231_75e57f53-884d-4fb2-adaf-4272095e912f	49967-231	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Hydrating Mineral Sunscreen Broad Spectrum SPF 30 Face Sheer Tint Sunscreen		Titanium dioxide and zinc oxide	LOTION	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	55; 100	mg/mL; mg/mL			N	20241231
49967-232_b3c215c7-23e6-4a5d-9ed4-3554ceb61f28	49967-232	HUMAN OTC DRUG	Vichy Laboratoires Normaderm Daily Gentle Cleanser		Salicylic Acid	CREAM	TOPICAL	20120601		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	5	mg/mL			N	20251231
49967-238_597aa34c-3347-469f-b337-d2fc006c095a	49967-238	HUMAN OTC DRUG	CeraVe Acne Foaming Cleanser		benzoyl peroxide	CREAM	TOPICAL	20211201		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	BENZOYL PEROXIDE	40	mg/mL			N	20241231
49967-240_422f2a8b-66b5-41a8-b753-021be8298b62	49967-240	HUMAN OTC DRUG	Lancome Paris Renergie HPN 300 Peptide Broad Spectrum SPF 25 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
49967-246_1ff1baaa-cb21-42fe-8582-5053e330c025	49967-246	HUMAN OTC DRUG	Garnier SkinActive Ultra Lift AntiWrinkle Firming Daily Moisturizer Broad Spectrum SPF 15 Sunscreen		Avobenzone, Octisalate and Octocrylene	LOTION	TOPICAL	20160101	20240427	OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 30	mg/mL; mg/mL; mg/mL			N	
49967-248_62b57fdc-7124-4238-ba13-213a9d2bf830	49967-248	HUMAN OTC DRUG	Lancome UV Expert Aquagel Defense 50 Broad Spectrum SPF 50 with Antioxidant Vitamin E		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	CREAM	TOPICAL	20180115	20240422	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 107; 32; 60; 39	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
49967-250_f39bd922-6a77-4d4e-a5de-ab18d9e5af27	49967-250	HUMAN OTC DRUG	Lancome Paris Absolue Premium Bx Broad Spectrum SPF 15 Sunscreen Absolute Replenishing		Avobenzone, Octisalate and Octocrylene	LOTION	TOPICAL	20100201	20240226	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 30; 80	mg/mL; mg/mL; mg/mL			N	
49967-260_1ab8b290-ae1f-4492-b461-17994fb834f1	49967-260	HUMAN OTC DRUG	Garnier green labs Pore Perfecting CannaB Serum Broad Spectrum SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE and OCTOCRYLENE	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 72	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-269_08b86a9d-5f5d-4b14-ac6b-a2fd433577e9	49967-269	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra Makeup Broad Spectrum SPF 21		Octinoxate and Titanium Dioxide	STICK	TOPICAL	20151201	20251003	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	20; 19	mg/g; mg/g			N	
49967-270_786ef3d2-a89f-42ce-a9c0-282048db4dfc	49967-270	HUMAN OTC DRUG	Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 30 Sunscreen Luminous Matte Foundation		Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20220725		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	67; 11	mg/mL; mg/mL			N	20241231
49967-287_60e84489-9b1d-4c99-8f14-c7d7d8ff9ddb	49967-287	HUMAN OTC DRUG	LOREAL PARIS REVITALIFT ANTI WRINKLE FIRMING MOISTURIZER SPF 25		avobenzone, octisalate and octocrylene	LOTION	TOPICAL	20171002		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/mL; mg/mL; mg/mL			N	20241231
49967-290_6ab90506-1a2f-4542-ba93-b7afecefacb6	49967-290	HUMAN OTC DRUG	Garnier green labs Replumping HyaluMelon Broad Spectrum SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE and OCTOCRYLENE	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 72	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-291_fb7ef028-f19e-4ab5-b517-e94d464d391f	49967-291	HUMAN OTC DRUG	LOreal Paris Wrinkle Expert Age Defense 55 Plus Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20200521		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 72	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-302_6c013f3e-eace-44a3-9dab-9ba7a03bebfc	49967-302	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Broad Spectrum SPF 25 Sunscreen		Octinoxate and Titanium dioxide	LIQUID	TOPICAL	20221212		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	67; 51	mg/mL; mg/mL			N	20241231
49967-303_21dcbd66-0f29-452d-9bc7-954471c10974	49967-303	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Reno Broad Spectrum SPF 25 Sunscreen		Octinoxate and Titanium dioxide	LIQUID	TOPICAL	20221212		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	67; 115	mg/mL; mg/mL			N	20241231
49967-307_82bf925d-f4a8-400b-a2f8-68f6e9ba94be	49967-307	HUMAN OTC DRUG	Vichy Laboratoires Normaderm Phytoaction Daily Deep Cleansing		Salicylic Acid	GEL	TOPICAL	20200415		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	5	mg/mL			N	20241231
49967-312_4d92696f-4dcc-4d77-bed0-fdbc7db60733	49967-312	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios UV Hydra Daily Invisible Broad Spectrum SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-313_30f2292c-4e33-4174-8399-c1ce7ded4334	49967-313	HUMAN OTC DRUG	Garnier green labs Brightening Serum PineaC Broad Spectrum SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE and OCTOCRYLENE	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 72	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-330_517ac85c-3841-452c-8567-c35a8da5b004	49967-330	HUMAN OTC DRUG	Dermablend Professional Smooth Camo Medium Coverage Foundation Broad Spectrum SPF 25 Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20140101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	68	mg/mL			N	20241231
49967-335_30fa3be3-a12a-4fb9-b70c-280cba1734c8	49967-335	HUMAN OTC DRUG	Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 27 Sunscreen		Octinoxate and Titanium Dioxide	LIQUID	TOPICAL	20191030		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	75; 32	mg/mL; mg/mL			N	20241231
49967-344_4d91a869-eb33-42e0-8d20-4061ad0a3347	49967-344	HUMAN OTC DRUG	Urban Decay Naked Skin One and Done Hybrid Complexion Perfector Broad Spectrum SPF 20		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; ZINC OXIDE	75; 34	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20251231
49967-354_ad1c20be-a838-45e9-9667-40a06e3b6f6a	49967-354	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20190918		ANDA	ANDA091314	LOreal USA Products Inc	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
49967-355_a2e6de63-3afd-48ed-a639-a3d981f354a2	49967-355	HUMAN OTC DRUG	La Roche Posay Face Body Anthelios SPF 60 Melt In Milk Fast absorbing, velvety finish for all skin types with Cell-OC Shield XL		Avobenzone, homosalate, octisalate and octocrylene	LOTION	TOPICAL	20181215		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-362_73b21876-a8d0-49e2-b997-6dccf016bbfd	49967-362	HUMAN OTC DRUG	Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 20 Sunscreen		Octinoxate	LOTION	TOPICAL	20170601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	30	mg/mL			N	20241231
49967-363_9c4e9f67-b916-4ce7-9e73-75702b871d3b	49967-363	HUMAN OTC DRUG	Kerastase Paris K Symbiose Serum Nuit Antipelliculaire Intensif Antidandruff Treatment		Salicylic Acid	LIQUID	TOPICAL	20221201		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc.	SALICYLIC ACID	18	mg/mL			N	20241231
49967-370_c39f170f-2fb9-4fcf-90a6-66f210729cc5	49967-370	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios AOX Daily Antioxidant Serum Broad Spectrum SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	26.8; 96; 28.8; 53.8; 34.6	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-374_489ddddd-5b3e-47af-ad63-224c94a23fc4	49967-374	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Dermo Kids Gentle Face and Body Broad Spectrum SPF 60 Sunscreen Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20161101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-380_b77686f5-353a-4636-9836-087c98bda457	49967-380	HUMAN OTC DRUG	Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen		Ensulizole	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	ENSULIZOLE	27	mg/mL			N	20241231
49967-388_c907da1b-e54c-473f-a300-eefe0365f7d3	49967-388	HUMAN OTC DRUG	Mizani Scalp Care Antidandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20080601		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
49967-389_007e125f-8b6b-4791-8250-70064d9385b3	49967-389	HUMAN OTC DRUG	Mizani Scalp Care Conditioner Antidandruff Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20080601		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
49967-392_be2582cd-fb64-42ff-bc23-f9e2753e48bc	49967-392	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 30 Cooling Water Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20140201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	22.4; 80; 24; 44.8; 28.8	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-394_15a1837f-664f-4ad3-b69b-dbe212b09a9c	49967-394	HUMAN OTC DRUG	Loreal Paris Age Perfect Rosy Tone SPF 30 Renew and revive healthy tone Visibly younger-looking skin		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 27; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-401_b83b2ec2-709c-4938-8f78-54711e31f9f1	49967-401	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Baby Sunscreen Broad Spectrum SPF 45		titanium dioxide and zinc oxide	LOTION	TOPICAL	20171025		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74; 114	mg/g; mg/g			N	20251231
49967-402_e8bc575a-3c48-4b77-976d-e8ba006dccd8	49967-402	HUMAN OTC DRUG	La Roche Posay Effaclar Medicated Cleanser		Salicylic Acid	GEL	TOPICAL	20220801		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20251231
49967-409_9c24442b-9868-4269-b783-419171eda036	49967-409	HUMAN OTC DRUG	Kiehls Since 1851 Dermatologist Solutions SuperFluid UV Mineral Defense Broad Spectrum SPF 50 Plus Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20151201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	150	mg/mL			N	20241231
49967-410_fce707d4-51c3-486f-82fa-eb80d11498f6	49967-410	HUMAN OTC DRUG	Kiehls Since 1851 Super Multi Corrective Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20150701		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-425_8eb2a4f4-bf70-47b5-a115-0ad044147a04	49967-425	HUMAN OTC DRUG	LOreal Paris True Match Naturale gentle mineral makeup Broad Spectrum SPF 19		Titanium Dioxide	POWDER	TOPICAL	20060701	20260430	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	100	mg/g			N	
49967-427_6e6884b7-eb18-4050-bfde-bbec89a845c3	49967-427	HUMAN OTC DRUG	Maybelline New York Dream Nude Airfoam Air Infused Makeup Sunscreen Broad Spectrum SPF 16		Octinoxate, Octisalate and Octocrylene	AEROSOL, FOAM	TOPICAL	20111001		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; OCTISALATE; OCTOCRYLENE	71.2; 23.8; 9.5	mg/g; mg/g; mg/g			N	20251231
49967-431_2b9f3cfc-931f-4c9e-b9bd-d2e6a93fd88c	49967-431	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Sport Anthelios Activewear Broad Spectrum SPF 60 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20171017		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-439_9f7072f1-83aa-4eb2-9e93-7566b056e83b	49967-439	HUMAN OTC DRUG	Lancome Paris Absolue Bx Makeup Broad Spectrum SPF 18 Sunscreen Absolute Replenishing Radiant Makeup Normal to Dry Skin		Octinoxate	LIQUID	TOPICAL	20170101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	70	mg/mL			N	20241231
49967-443_c2133e0c-dd0c-4fe3-9714-963de57ff0ce	49967-443	HUMAN OTC DRUG	Maybelline New York Fit Me Matte Plus Poreless Mattifying Poreless Primer Broad Spectrum SPF 20 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	LIQUID	TOPICAL	20220701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-451_7a7a08f3-417b-4bcf-8bec-2e45b0fa5bd6	49967-451	HUMAN OTC DRUG	Dermablend Professional CC Continuous Correction Full Coverage Makeup Broad Spectrum SPF 50 Plus Sunscreen		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20210820		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 49; 40	mg/mL; mg/mL; mg/mL			N	20241231
49967-456_04c897b6-d939-452e-b19d-719955e1b522	49967-456	HUMAN OTC DRUG	Lancome Paris Bienfait MultiVital Broad Spectrum SPF 30 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20060701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
49967-460_62c3812a-687f-4a06-aca0-2ea6908e7445	49967-460	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios HA Mineral Broad Spectrum SPF 30 Daily Moisturizing Sunscreen		Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20201201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	55; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20251231
49967-468_1b3a169a-8852-47b4-b647-1c00715ebbe0	49967-468	HUMAN OTC DRUG	SkinCeuticals Clarifying Exfoliating Cleanser		Salicylic Acid	CREAM	TOPICAL	20170127		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-472_f7d15171-ddc7-47a2-a743-afa219aa8142	49967-472	HUMAN OTC DRUG	SkinCeuticals Physical UV Defense Broad Spectrum SPF 30 Sunscreen		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20120101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 40	mg/mL; mg/mL			N	20241231
49967-475_2e47483a-9d18-4693-beee-9e6767754021	49967-475	HUMAN OTC DRUG	LOreal Paris True Match Lumi Healthy Luminous Makeup Broad Spectrum SPF 20		Octinoxate	LIQUID	TOPICAL	20120701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	70	mg/mL			N	20241231
49967-479_5613ccdf-a5d4-48b6-b073-6a9e15a18943	49967-479	HUMAN OTC DRUG	Ralph Lauren	Romance Antiperspirant Deodorant	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20120701	20251205	OTC MONOGRAPH DRUG	M019	L'Oreal USA Products Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	1.2	g/75g			N	
49967-489_ba1a3de6-6343-48d2-973e-83598d78c17c	49967-489	HUMAN OTC DRUG	Maybelline New York Baby Lips Dr Rescue Medicated Balm		Menthol	LIPSTICK	TOPICAL	20131001		OTC MONOGRAPH DRUG	M017	L'Oreal USA Products Inc	MENTHOL	5	mg/g			N	20241231
49967-500_1c801d2d-efb6-497e-9c2d-9394436ec934	49967-500	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Healing		Petrolatum	OINTMENT	TOPICAL	20170920		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc.	PETROLATUM	46.5	g/100g			N	20241231
49967-501_b502e50d-8ffe-44e5-8041-5c1d61cddd03	49967-501	HUMAN OTC DRUG	Kiehls Since 1851 Broad Spectrum SPF 30 Sunscreen Powerful Wrinkle Reducing		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20121201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 27; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-502_801a726b-77b7-4658-b15d-d95648ac4085	49967-502	HUMAN OTC DRUG	Lancome Paris High Resolution Refill 3X Triple Action Renewal Anti Wrinkle Broad Spectrum SPF 15 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20130801		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 30	mg/g; mg/g; mg/g			N	20241231
49967-504_677aba74-cc81-4fb3-b169-d4a49b1236c7	49967-504	HUMAN OTC DRUG	LOreal Paris Skin Expert Revitalift Bright Reveal Brightening Day Moisturizer Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20160601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-512_61f5c62e-a06b-4e06-868a-db8df7fcb16b	49967-512	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Itch Relief Moisturizing		pramoxine hydrochloride	CREAM	TOPICAL	20170918		OTC MONOGRAPH DRUG	M017	L'Oreal USA Products Inc	PRAMOXINE HYDROCHLORIDE	10	mg/g			N	20241231
49967-517_5593ba06-edf8-43dd-a017-672befb85092	49967-517	HUMAN OTC DRUG	CeraVe Developed with Dermotologists Ultra Light Moisturizing Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20180122		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 27	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-518_f2a18a23-64b1-4c3e-8208-33d4ca369aaf	49967-518	HUMAN OTC DRUG	Maybelline Dream Urban Cover Full Coverage Protective Make-Up SPF 50 Antioxidant-Enriched Pollution Protection		Homosalate, Octisalate and Octocrylene	EMULSION	TOPICAL	20190601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20251231
49967-523_9dddfe11-e9de-4aa6-b745-1d582893e323	49967-523	HUMAN OTC DRUG	Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Toner		Salicylic Acid	LIQUID	TOPICAL	20210420		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-525_f1c47f56-d5f5-4eed-8e62-a2aaa579cd02	49967-525	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 50 Mineral Daily Tone Correcting Primer Broad Spectrum SPF 50 Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20160101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	250	mg/mL			N	20251231
49967-527_f7bd47b0-d8ad-4abe-92ea-734a7ffcc2f8	49967-527	HUMAN OTC DRUG	Kiehls Since 1851 Blue Herbal Acne Spot Treatment		Salicylic Acid	LOTION	TOPICAL	20160831	20250207	OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	
49967-529_a56bbaaa-5b60-4a4b-953b-99d0abfda1c8	49967-529	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Effaclar Pore Refining Acne Treatment		Salicylic acid	LIQUID	TOPICAL	20220501		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	15	mg/mL			N	20241231
49967-530_a7bbc774-db8f-4565-bf4a-461fa885a573	49967-530	HUMAN OTC DRUG	Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Balm		Salicylic Acid	GEL	TOPICAL	20220101		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-546_6b13b60b-ad0d-462c-bff2-e9e50f150a40	49967-546	HUMAN OTC DRUG	Vichy Laboratoires Capital Soleil 60 Daily AntiAging Face and Body Sunscreen Broad Spectrum SPF 60 Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-584_139d7e7e-7b13-40aa-9ca8-d993093c2a65	49967-584	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Toleriane Double Repair Moisturizer UV Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20161221		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-586_7c83dea0-3331-4ad0-9a9d-036e7fa22ab2	49967-586	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 Skin Protectant		Glycerin	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc	GLYCERIN	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
49967-591_b42708ac-ccbb-4494-aeec-8a8acea67ca4	49967-591	HUMAN OTC DRUG	Effaclar		Adapalene	GEL	TOPICAL	20190823		ANDA	ANDA091314	LOreal USA Products Inc	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
49967-595_ac912e44-b2c4-494d-9271-420c2c82b07d	49967-595	HUMAN OTC DRUG	Kiehls Since 1851 Activated Sun Protector For Face and Body Broad Spectrum SPF 50 Sunscreen		Titanium dioxide	LOTION	TOPICAL	20130601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	110	mg/mL			N	20241231
49967-601_28d3d367-df35-42a4-8f22-cd4b221e8d9a	49967-601	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Psoriasis Cleanser		Salicylic Acid	LOTION	TOPICAL	20170818		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-603_d878b502-3836-4ab9-a216-3c0759b7ab11	49967-603	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Kids Gentle Broad Spectrum SPF 50 Sunscreen for Face and Body Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 130; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-604_5bdc623c-835c-4514-8147-9928f35cecbd	49967-604	HUMAN OTC DRUG	CeraVe Acne Foaming CreamWash		benzoyl peroxide	CREAM	TOPICAL	20231201		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	BENZOYL PEROXIDE	100	mg/mL			N	20251231
49967-606_e1476124-7048-4d72-a739-927a5ca14316	49967-606	HUMAN OTC DRUG	Vichy Laboratoires Normaderm Phytoaction Acne Control Daily Moisturizer		Salicylic Acid	GEL	TOPICAL	20200901		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-608_438c24d3-fa73-4205-897e-bac00b0cd09c	49967-608	HUMAN OTC DRUG	Kiehls Since 1851 Facial Fuel Daily Energizing Moisture Treatment for Men Broad Spectrum SPF 20 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20180329		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 88; 49; 59	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-614_a307fa5c-999d-4493-bffa-58ffd60c3e98	49967-614	HUMAN OTC DRUG	Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen Broad Spectrum SPF 50 Plus Primer and Moisturizer with Antioxidant Vitamin E		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221222		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-618_ed72f45f-ed6f-446a-b244-38308c03662f	49967-618	HUMAN OTC DRUG	Kiehls Since 1851 Blue Herbal Acne Cleanser Treatment		Salicylic Acid	LOTION	TOPICAL	20170301		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	15	mg/mL			N	20241231
49967-621_fc1b324e-cdc1-420c-a2c2-750e09fc0dd5	49967-621	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Lipikar Eczema Soothing Relief		Oatmeal	CREAM	TOPICAL	20171121		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
49967-622_a06ea46a-a99c-4327-a77c-471b7eeec352	49967-622	HUMAN OTC DRUG	Urban Decay Urban Defense Complexion Primer Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 46	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-633_b71e6bdf-265f-4314-afee-eae0a683b48d	49967-633	HUMAN OTC DRUG	Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Lift and Firming Face and Neck All Skin Types		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20161227		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
49967-639_9b92a444-cab4-4c29-a0cc-2e052079380f	49967-639	HUMAN OTC DRUG	Kiehls Since 1851 Body Fuel Antiperspirant and Deodorant		Aluminum chlorohydrate	LOTION	TOPICAL	20180328		OTC MONOGRAPH DRUG	M019	L'Oreal USA Products Inc	ALUMINUM CHLOROHYDRATE	120	mg/mL			N	20241231
49967-643_55a3d469-bd74-4cc8-9d39-746f0839444b	49967-643	HUMAN OTC DRUG	Kiehls Since 1851 Butterstick Lip Treatment Broad Spectrum SPF 25 Sunscreen		Avobenzone, Octinoxate and Octocrylene	LIPSTICK	TOPICAL	20161101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	30; 60; 60	mg/g; mg/g; mg/g			N	20251231
49967-644_70d06bba-ab80-45d6-8169-c0775f6b71da	49967-644	HUMAN OTC DRUG	Garnier Ultra Lift Anti Wrinkle Firming Moisturizer		Avobenzone, Octisalate and Octocrylene	LOTION	TOPICAL	20110701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 30	mg/mL; mg/mL; mg/mL			N	20251231
49967-648_1f025bc8-9065-4b47-92f0-04b498707531	49967-648	HUMAN OTC DRUG	Vichy Laboratoires Normaderm SOS Acne Rescue Spot Corrector		Sulfur	LOTION	TOPICAL	20201201		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SULFUR	100	mg/mL			N	20241231
49967-650_469e72ca-e993-4577-a804-0d5496fc9d95	49967-650	HUMAN OTC DRUG	Vichy Laboratoires Capital Soleil 60 Mineral Sunscreen Broad Spectrum SPF 60 Water Resistant 80 Minutes Sheer Tint Ultra Lightweight		Titanium Dioxide	LOTION	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	TITANIUM DIOXIDE	148	mg/mL			N	20241231
49967-660_4073c989-143e-4555-8d55-0c78aef6e7b1	49967-660	HUMAN OTC DRUG	Vichy Laboratoires Normaderm Acne Control Daily Moisturizer		Salicylic Acid	GEL	TOPICAL	20230601		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-664_9c45edf4-3f07-46da-92a9-8c7f83b9013c	49967-664	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Pigmentclar Daily Dark Spot Correcting Moisturizer Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20140801		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-676_d95f7f52-7be4-44c2-8d44-a6d5b57cd9b9	49967-676	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra Care and Glow Skincare Foundation Broad Spectrum SPF 27 Sunscreen		Ensulizole	LIQUID	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	ENSULIZOLE	36	mg/mL			N	20241231
49967-684_540bd0a1-088c-4a87-9c16-0425b09bb478	49967-684	HUMAN OTC DRUG	Vichy Laboratories LiftActiv Peptide-C SPF 30 Phyto Peptides Vitamin C		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20191227		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-701_3b2a62c6-409e-429b-a82d-a85e69dab480	49967-701	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Psoriasis Moisturizing		Salicylic Acid	CREAM	TOPICAL	20170830		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/g			N	20241231
49967-705_3afd648b-9e39-467c-8662-32201dd30d2f	49967-705	HUMAN OTC DRUG	Thayers Since 1847 Natural Remedies Blemish Clearing Witch Hazel Aloe Vera Formula Pads		Salicylic Acid	LIQUID	TOPICAL	20210420		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-712_121b734a-53f8-45a5-9a7a-4057d49340d0	49967-712	HUMAN OTC DRUG	Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 20 Sunscreen Luminous Matte Foundation		Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20220725		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	67; 11	mg/mL; mg/mL			N	20241231
49967-726_39dcf072-6eae-406a-a2d9-6d684db4fbce	49967-726	HUMAN OTC DRUG	Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20191028		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
49967-736_1b4c3cbd-d0f6-4972-b209-9dfcde3cb4f4	49967-736	HUMAN OTC DRUG	Lancome Paris Skin Feels Good Broad Spectrum SPF 23 Sunscreen Hydrating Skin Tint Healthy Glow		Octinoxate	LIQUID	TOPICAL	20171101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	30	mg/mL			N	20241231
49967-744_4b40ba80-782a-4973-bc54-46f4000fcf87	49967-744	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Cicaplast Balm B5 Soothing Therapeutic Multipurpose		Dimethicone	CREAM	TOPICAL	20210315		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc	DIMETHICONE	10	mg/mL	Skin Barrier Activity [PE]		N	20241231
49967-754_8af8c9b8-d5ee-461c-8686-834125c20931	49967-754	HUMAN OTC DRUG	Lancome Paris Bienfait UV 50 Plus Broad Spectrum SPF 50 Plus Water Resistant 80 Minutes Super Fluid Facial Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20100801		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-767_d20a0ca4-a16a-4e37-b59e-db8f02985012	49967-767	HUMAN OTC DRUG	LOreal Paris Skin Paradise Water Infused Tinted Moisturizer Broad Spectrum SPF 19 Sunscreen		Ensulizole	LIQUID	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	ENSULIZOLE	35	mg/mL			N	20251231
49967-768_d3fab022-9243-4945-a227-6f20598307d6	49967-768	HUMAN OTC DRUG	Lancome Paris Renergie Lift MultiAction Ultra Firming and Dark Spot Correcting Moisturizer Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20170901		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-770_9b356597-64b5-4650-b228-fa4e540561df	49967-770	HUMAN OTC DRUG	SkinCeuticals Sheer Physical UV Defense Broad Spectrum SPF 50 Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20100101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	60; 50	mg/mL; mg/mL			N	20241231
49967-779_89d011c5-8916-43c5-a990-b6d167fd1d29	49967-779	HUMAN OTC DRUG	Garnier Skin Renew Miracle Skin Perfector BB		Octinoxate and Titanium Dioxide	CREAM	TOPICAL	20110801		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	40; 21	mg/mL; mg/mL			N	20251231
49967-783_c49bcdca-6e53-43d4-abbb-610c6600d947	49967-783	HUMAN OTC DRUG	SkinCeuticals Advanced Scar Control Skin Protectant		Allantoin	GEL	TOPICAL	20210601		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc	ALLANTOIN	5	mg/mL			N	20241231
49967-795_099d44dc-eff9-47d9-b252-e9f633f0016b	49967-795	HUMAN OTC DRUG	Redken 5th Avenue NYC Scalp Relief Dandruff Control		Pyrithione Zinc	SHAMPOO	TOPICAL	20060817		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
49967-797_e96dab17-d26d-4fb5-9e40-b88d0bdcbf7a	49967-797	HUMAN OTC DRUG	Kiehls Since 1851 Ultra Facial Moisturizer Broad Spectrum SPF 30 Sunscreen For All Skin Types		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20130301		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-805_75a356a0-6e8e-4374-b498-5e2e42e2391a	49967-805	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Baby Moisturizing		Dimethicone	CREAM	TOPICAL	20170915	20240319	OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc.	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	
49967-812_e9283670-dea2-471f-8bc1-7c7c58713c5a	49967-812	HUMAN OTC DRUG	Kiehls Since 1851 Dermatologist Solutions Super Fluid Daily UV Defense Broad Spectrum SPF 50 plus Sunscreen Antipollution Lightweight Formula		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-822_3e8f64c5-8323-41d6-8856-24d0564bf20b	49967-822	HUMAN OTC DRUG	Baxter of California Oil Free Moisturizer Broad Spectrum SPF 15 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20171201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 20; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-832_daf3508e-fbc2-4ff6-bad6-84cf73b3db27	49967-832	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Hydrating Sheer Sunscreen Broad Spectrum SPF 30 Face and Body Water Resistant 80 Minutes Hybrid Formula		Homosalate, Octisalate, Octocrylene, and Zinc Oxide	LOTION	TOPICAL	20221010		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	60; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-840_4b9a02e9-8357-4df6-83b2-d62857041ae4	49967-840	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Acne Control Cleanser Oil Absorbing Technology		Salicylic Acid	GEL	TOPICAL	20230331		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-855_698a290d-1d48-4b9d-8bd8-657935352c4a	49967-855	HUMAN OTC DRUG	LOreal Paris True Match Super Blendable Foundation Broad Spectrum SPF 17 Sunscreen		Titanium Dioxide	LIQUID	TOPICAL	20170616		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	28	mg/mL			N	20251231
49967-861_4a2bf4ae-ad9d-4312-ac31-b7331f1a13ba	49967-861	HUMAN OTC DRUG	SkinCeuticals Daily Brightening UV Defense Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20210401		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 72	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-864_8d4c3de2-c5b3-4383-991b-d37ba01af66b	49967-864	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 60 Melt In Sunscreen Milk Face and Body Broad Spectrum SPF 60 Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20140101	20250915	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 107.2; 32.1; 60; 38.6	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
49967-869_c44d3a93-b17d-4fc8-b972-87e75cd1d3e8	49967-869	HUMAN OTC DRUG	Vichy Laboratoires Aqualia Thermal UV Defense Moisturizer Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20190527		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-870_9c069b2b-de21-4002-9c09-6aca6da2a161	49967-870	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Baby Healing		Petrolatum	OINTMENT	TOPICAL	20171114		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc.	PETROLATUM	46.5	g/100g			N	20241231
49967-871_a13c81ec-9ee6-4eb8-8827-e6ad7c9f3f71	49967-871	HUMAN OTC DRUG	Kerastase Paris Symbiose Antidandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20221212		OTC MONOGRAPH DRUG	M032	L'Oreal USA Products Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
49967-875_ee0f43e2-ca94-44d7-a4ff-cc1e71929f4b	49967-875	HUMAN OTC DRUG	Kiehls Since 1851 Dermatologist Solutions Breakout Control Acne Treatment Facial		Salicylic Acid	LOTION	TOPICAL	20161101		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	15	mg/mL			N	20241231
49967-878_ee2067b1-d559-4fd8-bf69-7698f0b2a6bc	49967-878	HUMAN OTC DRUG	Lancome Paris Bienfait MultiVital Eye Broad Spectrum SPF 30 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20200525		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
49967-882_dc743499-66e9-46fc-a10e-4958b258afed	49967-882	HUMAN OTC DRUG	Kiehls Since 1851 Superbly Efficient Antiperspirant and Deodorant		Aluminum chlorohydrate	CREAM	TOPICAL	20100601		OTC MONOGRAPH DRUG	M019	L'Oreal USA Products Inc	ALUMINUM CHLOROHYDRATE	128	mg/mL			N	20241231
49967-886_119c7c2f-b62d-47d0-990e-09c92abad217	49967-886	HUMAN OTC DRUG	IT COSMETICS HELLO SUNSHINE INVISIBLE HYDRATING SERUM BROAD SPECTRUM SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-888_b9e30a73-81e4-4f8c-bb56-970babc4893b	49967-888	HUMAN OTC DRUG	SkinCeuticals Light Moisture UV Defense Broad Spectrum SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20180301	20250922	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	
49967-893_c47e1b79-29cf-46b4-bed5-a4f1782a4321	49967-893	HUMAN OTC DRUG	LOreal Paris Visible lift Serum Absolute Advanced Age Reversing Makeup Broad Spectrum SPF 17		Octinoxate and Titanium Dioxide	LIQUID	TOPICAL	20100701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	10; 67	mg/mL; mg/mL			N	20241231
49967-895_1cb9aca2-b493-4ee2-85c9-0001329654fc	49967-895	HUMAN OTC DRUG	Kiehls Since 1851 Dermatologist Solutions Breakout Control Targeted Acne Spot Treatment		Sulfur	LOTION	TOPICAL	20161101		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SULFUR	100	mg/mL			N	20241231
49967-899_2af1e670-d87a-423c-a0dc-9aac07b4166a	49967-899	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique	Anthelios 50 Tinted Mineral Sunscreen	Titanium Dioxide	LOTION	TOPICAL	20120601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE	110	mg/mL			N	20241231
49967-900_246b0293-ab86-44b4-b615-fef215ef0ce7	49967-900	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Skin Renewing Broad Spectrum SPF 30 Day		octinoxate and zinc oxide	CREAM	TOPICAL	20170828		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	OCTINOXATE; ZINC OXIDE	75; 105	mg/g; mg/g			N	20241231
49967-901_b001f8c2-72fd-4a1b-b226-3c8ebebf9cf0	49967-901	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Sunscreen Body Broad Spectrum SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180104		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	TITANIUM DIOXIDE; ZINC OXIDE	36.7; 35	mg/g; mg/g			N	20251231
49967-906_8dd11291-42fb-4c43-99d3-f4219bf5aa03	49967-906	HUMAN OTC DRUG	Dermablend Professional Leg and Body Makeup Broad Spectrum SPF 25 Sunscreen		Octisalate and Octocrylene	LOTION	TOPICAL	20170101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTISALATE; OCTOCRYLENE	32; 60	mg/mL; mg/mL			N	20241231
49967-907_93f2cacd-67af-4ad8-9e0a-4de8330f808f	49967-907	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique	Anthelios 50 Mineral Ultra Light Sunscreen	Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20110701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	60; 50	mg/mL; mg/mL			N	20241231
49967-910_637ff496-97a6-4e1d-b73f-76cf42b70acc	49967-910	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios UV Correct Broad Spectrum SPF 70 Daily Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20210715		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 130; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-911_ceb212c8-24df-4a59-8099-452bc92872af	49967-911	HUMAN OTC DRUG	Cerave Developed with Dermatologists Hydrating Sunscreen SPF 50 Body Lightweight, non-greasy feel 3 essential ceramides Mineral Sunscreen		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part352	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	90; 70	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49967-913_65f38de3-1580-4e1b-a09e-61c1bc0a76de	49967-913	HUMAN OTC DRUG	LOreal Paris Revitalift Miracle Blur Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	CREAM	TOPICAL	20121201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-925_26ac7b9e-562d-48c3-a4dc-838a751e975e	49967-925	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Therapeutic Hand		Dimethicone	CREAM	TOPICAL	20171212		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc	DIMETHICONE	10	mg/g	Skin Barrier Activity [PE]		N	20241231
49967-929_ac43b966-89e1-4185-af4a-ed77020a4de5	49967-929	HUMAN OTC DRUG	SkinCeuticals Physical Matte UV Defense Broad Spectrum SPF 50 Sunscreen		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20150301		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	90; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49967-930_5eb13f44-b81e-4af7-aefc-2efe68535be3	49967-930	HUMAN OTC DRUG	Giorgio Armani Maestro Summer Broad Spectrum SPF 15 Sunscreen		Octinoxate	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	30	mg/mL			N	20241231
49967-934_7def9fd5-3fb5-4b54-b05e-e3342d39a5c1	49967-934	HUMAN OTC DRUG	LOreal Paris Age Perfect Cell Renewal Day Moisturizer Broad Spectrum SPF 15 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20140701	20240419	OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 50	mg/g; mg/g; mg/g; mg/g			N	
49967-941_3f329262-e959-460f-a0df-d1ff49ac58ef	49967-941	HUMAN OTC DRUG	Kiehls Since 1851 Ultra Facial Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20150701		OTC MONOGRAPH DRUG	M020	LOreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-942_4282c54c-44e8-4451-a1a5-a406e9d6b250	49967-942	HUMAN OTC DRUG	Loreal Paris Age Perfect Radiant Serum foundation SPF 50		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20191001		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
49967-943_bff86cfd-6442-41e7-ab6c-405518ef4275	49967-943	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Tinted Mineral Light Fluid Sunscreen Broad Spectrum SPF 40 Medium Deep		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20231215		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	170; 80	mg/mL; mg/mL			N	20241231
49967-944_8f399b7e-9558-46e4-a393-990aafb0d934	49967-944	HUMAN OTC DRUG	LOreal Paris Men Expert Vita Lift Daily Moisturizer Sunscreen Broad Spectrum SPF 15		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20131219		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 20; 50; 55	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-951_1d5a8f73-1ef1-4f50-b7ae-f7182e4e5778	49967-951	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Eczema Relief Creamy		Oatmeal	OIL	TOPICAL	20201201		OTC MONOGRAPH DRUG	M016	L'Oreal USA Products Inc	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
49967-952_5be14dac-571c-478c-8c3f-464b544977cb	49967-952	HUMAN OTC DRUG	Lancome Paris Absolue Premium Bx Replenishing and Rejuvenating Day		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20100601		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	20; 50; 80	mg/g; mg/g; mg/g			N	20241231
49967-956_e67b7a18-911c-49fc-b21f-e5aef40a46f4	49967-956	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra 24H Makeup Broad Spectrum SPF 15 Sunscreen		Octinoxate	LIQUID	TOPICAL	20160701		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	30	mg/mL			N	20241231
49967-957_785ed11e-b817-4983-9fe3-78361c47d914	49967-957	HUMAN OTC DRUG	Maybelline Dream Pure BB Beauty Balm		Salicylic Acid	LOTION	TOPICAL	20140601		OTC MONOGRAPH DRUG	M006	L'Oreal USA Products Inc	SALICYLIC ACID	20	mg/mL			N	20241231
49967-959_537d1f29-e636-45c8-b507-6b49753465a8	49967-959	HUMAN OTC DRUG	Cerave Developed with Dermatologists Hydrating Sunscreen SPF 50 Face Lightweight, non-greasy feel 3 essential ceramides niacinamide Mineral		Titanium dioxide and zinc oxide	LOTION	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	90; 70	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49967-969_8ec56f5f-3741-475d-9c6d-8b68224b56bb	49967-969	HUMAN OTC DRUG	Maybelline New York Fit Me Foundation Dewy Plus Smooth SPF 18 Sunscreen		Octinoxate	LOTION	TOPICAL	20100901		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE	70	mg/mL			N	20241231
49967-970_bfa588fc-1ec8-4d3d-a2cc-cc5e2b1ae277	49967-970	HUMAN OTC DRUG	CeraVe Developed with Dermatologists Itch Relief Moisturizing		pramoxine hydrochloride	LOTION	TOPICAL	20170817		OTC MONOGRAPH DRUG	M017	L'Oreal USA Products Inc	PRAMOXINE HYDROCHLORIDE	1	mg/mL			N	20241231
49967-971_cac3e9bc-baae-4979-b643-23992b3a0748	49967-971	HUMAN OTC DRUG	Kiehls Since 1851 Activated Sun Protector Broad Spectrum SPF 30 Sunscreen Water Resistant 80 MInutes		Avobenzone, Homosalate, Octisalate, Octocrylene and Oxybenzone	LOTION	TOPICAL	20150215		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	22.4; 80; 24; 44.8; 28.8	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-972_d126f14c-ddf8-466c-8a0a-2f386880c451	49967-972	HUMAN OTC DRUG	Garnier Skin Renew Miracle Skin Perfector Combination to Oily Skin BB Broad Spectrum SPF 20 Sunscreen		Octinoxate and Titanium dioxide	CREAM	TOPICAL	20130101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	OCTINOXATE; TITANIUM DIOXIDE	30; 47	mg/mL; mg/mL			N	20251231
49967-976_9aacbd06-ea9e-4e7b-821e-c93800396aeb	49967-976	HUMAN OTC DRUG	Giorgio Armani Power Fabric Plus Weightless Matte Foundation Broad Spectrum SPF 25 Sunscreen		Octinoxate	LOTION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc.	OCTINOXATE	68	mg/mL			N	20241231
49967-990_a1b9fa29-bb5a-4bce-ba9f-1eb93881df6d	49967-990	HUMAN OTC DRUG	NYX Professional Makeup Blurscreen Primer Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 73; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
49967-994_5d281644-19de-4e1f-9086-0ffe8ed80d07	49967-994	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 60 Breakout Free Oil Free Face Dry Touch Broad Spectrum SPF 60 Sunscreen Water Resistant 80 Minutes		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	L'Oreal USA Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
49967-997_8e86ac73-ca71-461d-be92-211850273f5f	49967-997	HUMAN OTC DRUG	Cerave Developed with Dermatologists Hydrating Sunscreen SPF 30 Body Lightweight, non-greasy feel 3 essential ceramides Mineral Sunscreen		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part352	L'Oreal USA Products Inc	TITANIUM DIOXIDE; ZINC OXIDE	60; 50	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
49973-011_974312f7-a247-449d-978a-831de0f9bc83	49973-011	HUMAN OTC DRUG	Azo Urinary Tract Defense	Antibacterial Protection	Methenamine, Sodium salicylate	TABLET	ORAL	20151106		UNAPPROVED DRUG OTHER		i-Health, Inc.	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
49973-247_09a4f602-bd7a-718b-e063-6294a90aca9e	49973-247	HUMAN OTC DRUG	AZO Urinary Pain Relief	Maximum Strength	Phenazopyridine Hydrochloride	TABLET	ORAL	20180702		UNAPPROVED DRUG OTHER		i-Health, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
49973-301_9ff96c23-b19f-4664-abb3-359fb901d19b	49973-301	HUMAN OTC DRUG	AZO		Urinary Pain Relief	TABLET	ORAL	20120524		UNAPPROVED DRUG OTHER		i-Health, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
49973-667_d10299a1-ae3b-d408-e053-2a95a90acda3	49973-667	HUMAN OTC DRUG	AZO	Yeast Plus	Candida Albicans, Wood Creosote, Sodium Chloride, and Sulfur	TABLET	ORAL	20140101		UNAPPROVED HOMEOPATHIC		i-Health, Inc.	CANDIDA ALBICANS; SODIUM CHLORIDE; SULFUR; WOOD CREOSOTE	30; 12; 12; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
49991-001_0c7a2932-b2a2-b0f3-e063-6394a90a62c8	49991-001	HUMAN OTC DRUG	Rich Girl	Hand	Avobenzone, Octinoxate, and Octisalate	CREAM	TOPICAL	20120515		OTC MONOGRAPH DRUG	M020	SPECIALITY COSMETICS POLI	AVOBENZONE; OCTINOXATE; OCTISALATE	2; 7.5; 5	g/100g; g/100g; g/100g			N	20241231
49999-018_c6a370fa-db9c-49d6-a462-9e75ff9d408d	49999-018	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20111129		ANDA	ANDA071321	Quality Care Products LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
49999-026_f2dc64fe-6c56-4bfc-a7af-447cce174394	49999-026	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20110706		ANDA	ANDA040419	Quality Care Products LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
49999-046_aa4b0e12-1ddb-415a-9f13-571b33a3a472	49999-046	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	20110207		ANDA	ANDA040284	Lake Erie Medical DBA Quality Care Products LLC	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
49999-057_8d051ff2-bb22-458c-bee2-b9ab86af240c	49999-057	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	Quality Care Products LLC	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
49999-060_08b1fe98-5546-4b58-ad0a-c8ce2b2c746b	49999-060	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		ACETAMINOPHEN AND CODEINE PHOSPHATE	TABLET	ORAL	20110914		ANDA	ANDA040419	Quality Care Products, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
49999-126_de19b999-4b92-4a2a-998f-3fadb2ff7fa5	49999-126	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20120416		ANDA	ANDA062676	Quality Care Products, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
49999-150_2552e5b6-aaaf-438a-90e6-55db6882f5cd	49999-150	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20120320		ANDA	ANDA086414	Lake Erie Medical DBA Quality Care Products LLC	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49999-153_07a627dc-9d36-4531-ab2c-f5a04a4373ee	49999-153	HUMAN PRESCRIPTION DRUG	Methylprednisolone		methylprednisolone	TABLET	ORAL	20120209		NDA	NDA011153	Quality Care Products, LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
49999-265_1a489ec8-1f01-4c45-b223-a09b109bb54c	49999-265	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20101013		ANDA	ANDA075576	Quality Care Products, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
49999-291_c3374a59-c4e2-4b70-aad8-703ea045be50	49999-291	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Quality Care Products LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
49999-347_7854dd01-ae37-4959-a463-1a5bd69d83a1	49999-347	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	TABLET	ORAL	20101123		ANDA	ANDA076286	Quality Care Products LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
49999-629_5aaa1f2b-0706-4466-a889-91ee5096cbe1	49999-629	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Quality Care Products LLC	MIRTAZAPINE	15	mg/1			N	20241231
49999-644_066e7447-a3a6-8006-e063-6394a90a561e	49999-644	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20091030		ANDA	ANDA065123	Quality Care Products LLC	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
49999-848_abc05e8c-34b6-4292-9d4c-27442e47d52e	49999-848	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20120319		NDA	NDA022207	Quality Care Products LLC	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
49999-852_8476d41d-5cd8-4f4e-bdaf-b1e620d1e4c9	49999-852	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20100610		ANDA	ANDA087463	Quality Care products LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
49999-869_9cc78c29-e88b-4381-b695-40c76e462f01	49999-869	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100917		ANDA	ANDA077927	Quality Care Products LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
49999-899_5dd3dec4-949d-449d-8c3e-174ee6fb77dc	49999-899	HUMAN PRESCRIPTION DRUG	Oxycodone Hydchloride		Oxycodone Hydchloride	TABLET	ORAL	20111220		ANDA	ANDA091393	Quality Care Products LLC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
49999-924_3a4f6c35-b2a2-4ce6-9243-19c6212ae5a4	49999-924	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20060927		ANDA	ANDA077912	Quality Care Products LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50017-020_091ff4b4-5a0b-de8c-e063-6394a90aa2a0	50017-020	HUMAN OTC DRUG	Foot Saver		Antiperspirant	GEL	TOPICAL	20220405		OTC MONOGRAPH DRUG	M019	Neat Feat Products Limited	ALUMINUM CHLOROHYDRATE	13.5	g/60mL			N	20241231
50017-022_091ffc22-026c-dc27-e063-6394a90ae8ca	50017-022	HUMAN OTC DRUG	Neat 3B Bodysaver		skin protectant	CREAM	TOPICAL	20230101		OTC MONOGRAPH DRUG	M016	Neat Feat Products Limited	ZINC ACETATE	.15	g/75g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50017-024_091fb5b6-e32b-e74e-e063-6294a90a959e	50017-024	HUMAN OTC DRUG	Face Saver Gel		Antiperspirant	GEL	TOPICAL	20220404		OTC MONOGRAPH DRUG	M019	Neat Feat Products Limited	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	8.75	g/50g			N	20241231
50017-024_091fe109-9063-bd9c-e063-6394a90a5c1b	50017-024	HUMAN OTC DRUG	Face Saver Gel		Antiperspirant	GEL	TOPICAL	20211201		OTC MONOGRAPH DRUG	M019	Neat Feat Products Limited	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	8.75	g/50g			N	20241231
50017-028_091ff924-44c9-b9b3-e063-6394a90a060e	50017-028	HUMAN OTC DRUG	Neat 3B Senior B		Zinc acetate	CREAM	TOPICAL	20230102		OTC MONOGRAPH DRUG	M016	Neat Feat Products Limited	ZINC ACETATE	2	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50017-029_091ffc22-026d-dc27-e063-6394a90ae8ca	50017-029	HUMAN OTC DRUG	Hand Saver		ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	LOTION	TOPICAL	20230101		OTC MONOGRAPH DRUG	M016	Neat Feat Products Limited	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	14.39	g/100mL			N	20241231
50017-032_f4d451a5-2b14-0b84-e053-2995a90af788	50017-032	HUMAN OTC DRUG	Willow Wart		Salix alba, Thuja occidentalis	CREAM	TOPICAL	20230102		UNAPPROVED HOMEOPATHIC		Neat Feat Products Limited	SALIX ALBA BARK; THUJA OCCIDENTALIS LEAF	.5; .2	g/10g; g/10g			N	20241231
50017-033_f4d43ef5-a833-b505-e053-2995a90ace93	50017-033	HUMAN OTC DRUG	Natural Pain Relief Foot Cream		camphor	CREAM	TOPICAL	20220119		UNAPPROVED HOMEOPATHIC		Neat Feat Products Limited	CAMPHOR (NATURAL)	1.5	g/50g			N	20241231
50021-007_318a18b8-327f-49ff-b339-57eab73a5620	50021-007	HUMAN OTC DRUG	Foam Hand Sanitizer		Alcohol 70%	AEROSOL, FOAM	TOPICAL	20200407		OTC MONOGRAPH NOT FINAL	part333A	Empack Spraytech Inc.	ALCOHOL	70	mL/100mL			N	20241231
50021-008_2c4e6146-26c8-4bce-a711-db76332caa8a	50021-008	HUMAN OTC DRUG	Extra Stength Hand Sanitizer	Zytec Germ Buster	Alcohol 80%w/w	AEROSOL, SPRAY	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333E	Empack Spraytech Inc.	ALCOHOL	80	g/100g			N	20241231
50021-009_f390f62a-562b-472b-ab46-be24c4bd2c99	50021-009	HUMAN OTC DRUG	Hand Sanitizer	Zytec Germ Buster	Alcohol 70%v/v	GEL	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333E	Empack Spraytech Inc.	ALCOHOL	70	mL/100mL			N	20241231
50021-011_8d42fc82-1882-4ac1-8849-0c2ddf13fd26	50021-011	HUMAN OTC DRUG	Hand Sanitizer	Zytec Germ Buster	Alcohol 70%v/v Aerosol Gel	AEROSOL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333E	Empack Spraytech Inc.	ALCOHOL	70	mL/100mL			N	20241231
50021-014_cbe3d04a-207c-5412-e053-2995a90a18b6	50021-014	HUMAN OTC DRUG	Zytec Hand Sanitizer Wipes	80% w/w Alcohol	ALCOHOL	CLOTH	TOPICAL	20200727		OTC MONOGRAPH NOT FINAL	part333A	Empack Spraytech Inc.	ALCOHOL	80	g/100g			N	20241231
50021-017_cbe404fb-8553-eee4-e053-2995a90a068d	50021-017	HUMAN OTC DRUG	Sanitizer Wipes 70% Ethyl Alcohol		ALCOHOL	CLOTH	TOPICAL	20210914		OTC MONOGRAPH NOT FINAL	part333A	Empack Spraytech Inc.	ALCOHOL	70	mL/100mL			N	20241231
50021-020_c4299b0c-94ab-4d29-b7f8-70381966c41c	50021-020	HUMAN OTC DRUG	Foaming Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20201111		OTC MONOGRAPH NOT FINAL	part333A	Empack Spraytech Inc.	ALCOHOL	70	mL/100mL			N	20241231
50021-600_c707ba44-51db-7d45-e053-2a95a90a9c02	50021-600	HUMAN OTC DRUG	SPF 40		ZINC OXIDE	LOTION	TOPICAL	20210715		OTC MONOGRAPH NOT FINAL	part352	Empack Spraytech Inc	ZINC OXIDE	20.5	g/100g			N	20241231
50063-001_07ef001a-c64c-5639-e063-6294a90ab4d3	50063-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070101		NDA	NDA205767	Andy-Oxy Co., Inc.	OXYGEN	995	mL/L			N	20241231
50063-002_07ef1774-c53b-7fa1-e063-6294a90a20c6	50063-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20130101		NDA	NDA205766	Andy-Oxy Co., Inc.	NITROGEN	992	mL/L			N	20241231
50063-004_07eef4a6-48c5-0c04-e063-6394a90abb0a	50063-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20070101		NDA	NDA205767	Andy-Oxy Co., Inc.	OXYGEN	210	mL/L			N	20241231
50066-001_1cccdc0f-9ede-4ab3-b984-c552720dfe0b	50066-001	HUMAN OTC DRUG	Nikzon	Hemorrhoidal	PHENYLEPHRINE HYDROCHLORIDE and PRAMOXINE HYDROCHLORIDE	CREAM	TOPICAL	20131201		OTC MONOGRAPH FINAL	part346	Genoma Lab USA Inc	PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	2.5; 10	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-021_8153c706-d1be-6c42-e053-2991aa0afda4	50066-021	HUMAN OTC DRUG	Advanced Anti-Wrinkle Therapy	Cicatricure	Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%	CREAM	TOPICAL	20190121		OTC MONOGRAPH NOT FINAL	part352	Genomma Lab	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 7.5; 5; 2.7; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
50066-052_a8c78145-5e16-4938-a36a-44b33f629636	50066-052	HUMAN OTC DRUG	Asepxia Acne Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20150306		OTC MONOGRAPH FINAL	part333D	Genomma Lab USA Inc.	BENZOYL PEROXIDE	100	mg/g			N	20241231
50066-054_a6fd5981-d25d-4710-943e-9ec93fe1f8a2	50066-054	HUMAN OTC DRUG	Medicasp	Anti-dandruff	Coal Tar	SHAMPOO	TOPICAL	20130916		OTC MONOGRAPH FINAL	part358H	Genomma Lab USA Inc.	COAL TAR	5	mg/mL			N	20241231
50066-056_afbcca7e-083e-4e72-b568-47e7e624dd63	50066-056	HUMAN OTC DRUG	Dragon Pain Numbing	Topical Analgesic	LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20170907		OTC MONOGRAPH NOT FINAL	part348	Genomma Lab USA Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50066-070_a475c37d-081e-4e6d-a058-7f81ad8c1fdc	50066-070	HUMAN OTC DRUG	Lagicam	antifungal	Miconazole Nitrate	CREAM	VAGINAL	20050302		ANDA	ANDA076773	Genomma Lab USA, Inc.	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50066-080_0d8b5661-85f5-f565-e063-6294a90a9071	50066-080	HUMAN OTC DRUG	Silka	Antifungal	Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Genomma Lab USA, Inc.	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
50066-083_e90b344a-8558-4061-9fbe-2f89b219b97b	50066-083	HUMAN OTC DRUG	Silka Antifungal		Tolnaftate	LIQUID	TOPICAL	20220322		OTC MONOGRAPH FINAL	part333C	Genomma Lab USA	TOLNAFTATE	10	mg/mL			N	20241231
50066-111_1691123d-162c-416f-a8ed-1cb779f9a1c3	50066-111	HUMAN OTC DRUG	Silka	Ringworm	Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH FINAL	part333C	Genomma Lab USA, Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50066-119_827d7500-26c6-3110-e053-2991aa0a31dd	50066-119	HUMAN OTC DRUG	Scar Cream SPF 30		Avobenzone, Octocrylene, Oxybenzone	CREAM	TOPICAL	20190222		OTC MONOGRAPH NOT FINAL	part352	Genomma Lab	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	3; 10; 6	g/100g; g/100g; g/100g			N	20241231
50066-202_0d122377-d2cc-a2ce-e063-6394a90a1198	50066-202	HUMAN OTC DRUG	TRIPLE ANTIBIOTIC PLUS PAIN RELIEF		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20231221		OTC MONOGRAPH DRUG	M004	GENOMMA LAB USA, INC.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50066-208_39848469-9f54-4303-a5ea-2c711368b88c	50066-208	HUMAN OTC DRUG	Silka	Jock Itch	Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Genomma Lab USA, Inc.	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
50066-224_db8af2b6-a822-2919-e053-2995a90a8729	50066-224	HUMAN OTC DRUG	Dragon Pain Relief		lidocaine	PATCH	TOPICAL	20190118		OTC MONOGRAPH NOT FINAL	part348	Genomma Lab USA, Inc.	LIDOCAINE	40	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50066-301_a1ec3ce6-ac2f-4acc-bcb3-81594f58d6e9	50066-301	HUMAN OTC DRUG	Tukol Honey Children Cough and Congestion		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SYRUP	ORAL	20200209		OTC MONOGRAPH DRUG	M012	Genomma Lab USA	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	2; 20; 1	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-302_4db74b10-e944-4de2-8bdb-0bbb0e2bc6f2	50066-302	HUMAN OTC DRUG	Tukol Honey Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	SYRUP	ORAL	20200209		OTC MONOGRAPH DRUG	M012	Genomma Lab USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	21.667; .667; .333	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-303_a5aab8e8-7e9e-4c94-a702-1acf7ac3ac3b	50066-303	HUMAN OTC DRUG	Tukol Honey Nighttime Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	SYRUP	ORAL	20200209		OTC MONOGRAPH DRUG	M012	Genomma Lab USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	21.667; 1; .4167	mg/mL; mg/mL; mg/mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
50066-304_9b0c036b-c277-4b21-a62d-fcd16aed3961	50066-304	HUMAN OTC DRUG	Tukol Honey Daytime and Nighttime Value Pack		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Doxylamine Succinate	KIT		20230130		OTC MONOGRAPH DRUG	M012	Genomma Lab USA						N	20251231
50066-305_6cfd6ddd-7bd8-47d7-8ac0-c300e542c0a0	50066-305	HUMAN OTC DRUG	Tukol Max Action Sinus Liquid		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	SYRUP	ORAL	20210730		OTC MONOGRAPH FINAL	part341	Genomma Lab USA	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	32.5; 20; .5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-306_dbef3e9b-9f04-488b-943a-0e759b38781d	50066-306	HUMAN OTC DRUG	Tukol Max Action Sinus Caplets		Acetaminophen, Guaifenesin and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20220320		OTC MONOGRAPH FINAL	part341	Genomma Lab USA	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-307_61319534-9c6b-45eb-bb07-f495f97ae3d7	50066-307	HUMAN OTC DRUG	Tukol Max Action		oxymetazoline hydrochloride	LIQUID	TOPICAL	20210722		OTC MONOGRAPH FINAL	part341	Genomma Lab USA	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
50066-308_455117c6-cff9-4472-9106-29ff20a930a7	50066-308	HUMAN OTC DRUG	Tukol Children Cough and Congestion		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SYRUP	ORAL	20220601		OTC MONOGRAPH DRUG	M012	Genomma Lab USA	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-311_2de4de60-b5c8-4933-9dab-e47321b8f799	50066-311	HUMAN OTC DRUG	Tukol Night Time Cold and Flu Relief Softgels		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20230110		OTC MONOGRAPH FINAL	part341	Genomma Lab USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50066-312_48a5b668-3fd1-463b-8390-3ee2265639e8	50066-312	HUMAN OTC DRUG	Tukol Day Time Cold and Flu Relief Softgels		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20230110		OTC MONOGRAPH FINAL	part341	Genomma Lab USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-315_fef7772a-6a6b-407d-b080-ad8e4b542433	50066-315	HUMAN OTC DRUG	Tukol Childrens Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE	SYRUP	ORAL	20230117		OTC MONOGRAPH FINAL	part341	Genomma Lab USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	32.5; 1; 20; .5	mg/mL; mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-396_d5a01d33-2431-447c-83d2-081ee63663a1	50066-396	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl 10 mg	TABLET	ORAL	20171222		ANDA	ANDA209274	Genomma Labs USA, Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50066-411_45415c6f-3939-47fd-85c9-705fe1c36734	50066-411	HUMAN OTC DRUG	Dragon Pain Numbing Roll-On		Lidocaine hydrochloride	LIQUID	TOPICAL	20210724		OTC MONOGRAPH NOT FINAL	part348	Genomma Lab USA	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50066-412_010331fb-8731-4ec9-ab95-9110e69886e5	50066-412	HUMAN OTC DRUG	Dragon Pain Relief		MENTHOL, UNSPECIFIED FORM, CAMPHOR, (-)-, and methyl salicylate	CREAM	TOPICAL	20210813		OTC MONOGRAPH NOT FINAL	part348	Genomma Lab USA	CAMPHOR, (-)-; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
50066-454_e07fef46-68da-769c-e053-2a95a90aa065	50066-454	HUMAN OTC DRUG	XRay DOL		Camphor, Menthol, and Methyl Salicylate	CREAM	TOPICAL	20220602		OTC MONOGRAPH NOT FINAL	part348	Genomma Lab USA, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	40; 100	mg/g; mg/g			N	20241231
50066-455_8ea7771c-79de-4e73-ae5f-9c1fc632cdec	50066-455	HUMAN OTC DRUG	X Ray Pain Reliever		acetaminophen, aspirin, and caffeine	TABLET	ORAL	20231222		OTC MONOGRAPH DRUG	M013	Genomma Lab USA	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50066-456_b420f319-e207-49a6-bcc4-d7f71523416e	50066-456	HUMAN OTC DRUG	XRay Pain Relief		MENTHOL, (plus)-, CAMPHOR, (-)-, and METHYL SALICYLATE	CREAM	TOPICAL	20231226		OTC MONOGRAPH DRUG	M017	Genomma Lab USA	CAMPHOR, (-)-; MENTHOL, (+)-; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
50066-504_d97ef49f-3c56-4996-8075-a7a5ac28aced	50066-504	HUMAN OTC DRUG	Tukol Multi Symptom Cold		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20120515		OTC MONOGRAPH FINAL	part341	Genomma Lab USA, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-510_8aec02c7-8886-46a4-b342-ae33b74868b4	50066-510	HUMAN OTC DRUG	Tukol Cough and Congestion		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SYRUP	ORAL	20200607		OTC MONOGRAPH DRUG	M012	Genomma Lab USA	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	2; 20; 1	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-516_32895253-c152-48ff-8847-85106ea594c8	50066-516	HUMAN OTC DRUG	Tukol MAX ACTION Cold, Sore Throat and Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PHENYLEPHRINE HCL	LIQUID	ORAL	20161216		OTC MONOGRAPH DRUG	M012	Genomma Lab USA, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-517_4fea3e13-da6b-4b0c-b878-2ea35ba699ca	50066-517	HUMAN OTC DRUG	Tukol MAX ACTION Severe Congestion and Cough		DEXTROMETHORPHAN HBr, GUAIFENESIN, PHENYLEPHRINE HCL	LIQUID	ORAL	20161216		OTC MONOGRAPH DRUG	M012	Genomma Lab USA, Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-519_4aa9c4b3-12e4-4e80-9765-be13234ba585	50066-519	HUMAN OTC DRUG	Childrens Tukol Multi-Symptom Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20160504		OTC MONOGRAPH DRUG	M012	Genomma Lab USA, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-525_abbc3017-0f3f-4c00-aa6f-c5786b17b423	50066-525	HUMAN OTC DRUG	Childrens Tukol Acetaminophen Fever Reducer Pain Reducer		ACETAMINOPHEN	LIQUID	ORAL	20160503		OTC MONOGRAPH NOT FINAL	part343	Genomma Lab USA, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50066-533_58c626be-30c0-4482-ac84-3bac155aa308	50066-533	HUMAN OTC DRUG	Tukol X-Pecto Miel	Multi Symptom Cold	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20130915		OTC MONOGRAPH FINAL	part341	Genomma Lab USA, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-534_dbec04d7-0570-4707-981a-ab1e5d3733bb	50066-534	HUMAN OTC DRUG	Tukol Cough And Cold Honey Flavor		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SYRUP	ORAL	20190920		OTC MONOGRAPH DRUG	M012	Genomma Lab USA	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	2; 20; 1	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50066-536_158e568c-c1da-4e77-a6a4-34062f86f1fc	50066-536	HUMAN OTC DRUG	Tukol A		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20140609		OTC MONOGRAPH FINAL	part341	Genomma Lab USA, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50066-610_93a60710-8cc3-479e-a7c0-f23a870b527c	50066-610	HUMAN OTC DRUG	Bufferin Regular Strength Pain Relief		aspirin	TABLET, COATED	ORAL	20210517		OTC MONOGRAPH NOT FINAL	part343	Genomma Lab USA	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50066-611_cfa16bd1-d98a-4b2e-a801-3556dc817203	50066-611	HUMAN OTC DRUG	Ellipse Hand Sanitizer	Caribbean Scent	alcohol	LIQUID	TOPICAL	20210722		OTC MONOGRAPH NOT FINAL	part333E	Genomma Lab USA	ALCOHOL	70	mL/100mL			N	20241231
50066-612_f6674f6e-3836-40f8-8520-a9cc90864b32	50066-612	HUMAN OTC DRUG	Ellipse Hand Sanitizer	Coconut Scent	ALCOHOL	LIQUID	TOPICAL	20210722		OTC MONOGRAPH NOT FINAL	part333E	Genomma Lab USA	ALCOHOL	70	mL/100mL			N	20241231
50066-613_7d6c663a-61f8-477a-9cad-1218f9bab36b	50066-613	HUMAN OTC DRUG	Ellipse Hand Sanitizer	Fruit Scent	alcohol	LIQUID	TOPICAL	20210722		OTC MONOGRAPH NOT FINAL	part333E	Genomma Lab USA	ALCOHOL	70	mL/100mL			N	20241231
50066-614_a142d8b8-4d63-4e84-b117-b7c62089e65d	50066-614	HUMAN OTC DRUG	Bufferin Lidocaine Pain Numbing		Lidocaine hydrochloride	CREAM	TOPICAL	20230818		OTC MONOGRAPH NOT FINAL	part348	Genomma Lab USA	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50066-615_0825bfb3-ca67-4179-89f1-104d2b8e475a	50066-615	HUMAN OTC DRUG	Bufferin Pain Relief		MENTHOL, CAMPHOR, and METHYL SALICYLATE	CREAM	TOPICAL	20230818		OTC MONOGRAPH NOT FINAL	part348	Genomma Lab USA	CAMPHOR, (-)-; MENTHOL, (+)-; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
50066-621_0df9c856-1afe-7cca-e063-6294a90af916	50066-621	HUMAN OTC DRUG	Dragon with Arnical Pain Relief		Menthol	GEL	TOPICAL	20201123		OTC MONOGRAPH DRUG	M017	Genomma Lab USA Inc.	MENTHOL	4	g/100g			N	20251231
50066-704_f75345e4-c0e3-4782-a59e-b367a589cd6b	50066-704	HUMAN OTC DRUG	Cicatricure Brightening Face With SPF		Avobenzone, Homosalate, Octinoxate, Octisalate, and Oxybenzone	CREAM	TOPICAL	20191007		OTC MONOGRAPH NOT FINAL	part352	Genomma Lab USA	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	10; 45; 75; 45; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50066-801_09891759-b170-6a81-e063-6394a90a2f89	50066-801	HUMAN OTC DRUG	Asepxia Charcoal Acne Bar		Salicylic Acid	SOAP	TOPICAL	20200319		OTC MONOGRAPH DRUG	M006	Genomma Lab USA	SALICYLIC ACID	2	g/100g			N	20241231
50066-802_0988fd2f-8331-5795-e063-6394a90a871a	50066-802	HUMAN OTC DRUG	Asepxia Neutral Acne Bar		SALICYLIC ACID	SOAP	TOPICAL	20200319		OTC MONOGRAPH DRUG	M006	Genomma Lab USA	SALICYLIC ACID	2	g/100g			N	20241231
50066-803_09891759-b190-6a81-e063-6394a90a2f89	50066-803	HUMAN OTC DRUG	Asepxia Oil-Free Acne Bar		Salicylic Acid	SOAP	TOPICAL	20200319		OTC MONOGRAPH DRUG	M006	Genomma Lab USA	SALICYLIC ACID	2	g/100g			N	20241231
50066-804_09891e17-9dda-70a4-e063-6394a90a6cfd	50066-804	HUMAN OTC DRUG	Asepxia Scrub Acne Bar		Salicylic Acid	SOAP	TOPICAL	20200319		OTC MONOGRAPH DRUG	M006	Genomma Lab USA	SALICYLIC ACID	2	g/100g			N	20241231
50066-805_09891759-b1a0-6a81-e063-6394a90a2f89	50066-805	HUMAN OTC DRUG	Asepxia Softening Acne Bar		Salicylic Acid	SOAP	TOPICAL	20200319		OTC MONOGRAPH DRUG	M006	Genomma Lab USA	SALICYLIC ACID	2	g/100g			N	20241231
50066-913_0c6c9b0d-57e5-89db-e063-6294a90ac1fe	50066-913	HUMAN OTC DRUG	Tukol Max Action		Oxymetazoline HCL	SPRAY	NASAL	20210506		OTC MONOGRAPH DRUG	M012	GENOMMA LAB USA, INC.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
50072-010_2cb13a6f-ca22-4756-9ad2-ed6a621baf0f	50072-010	HUMAN PRESCRIPTION DRUG	TPOXX		tecovirimat monohydrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220531		NDA	NDA214518	SIGA Technologies, Inc.	TECOVIRIMAT	10	mg/mL	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]		N	20241231
50072-200_2cb13a6f-ca22-4756-9ad2-ed6a621baf0f	50072-200	HUMAN PRESCRIPTION DRUG	TPOXX		tecovirimat monohydrate	CAPSULE	ORAL	20180831		NDA	NDA208627	SIGA Technologies, Inc.	TECOVIRIMAT MONOHYDRATE	200	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]		N	20241231
50090-0001_17e2ae81-6a33-4b51-bee2-2e0609a9aeb6	50090-0001	HUMAN OTC DRUG	acetaminophen	for children	Acetaminophen	SUPPOSITORY	RECTAL	20101214		ANDA	ANDA070607	A-S Medication Solutions	ACETAMINOPHEN	120	mg/1			N	20241231
50090-0005_e523eda4-dcfc-4975-b5b4-9967e682235a	50090-0005	HUMAN OTC DRUG	TYLENOL Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	19840819		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	500	mg/1			N	20241231
50090-0023_95fabd91-10a0-46fe-b784-e9deac66a858	50090-0023	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19860710		ANDA	ANDA062677	A-S Medication Solutions	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-0044_6a994450-b322-439b-af5b-9306b71fe57d	50090-0044	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091116		ANDA	ANDA078253	A-S Medication Solutions	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-0049_0c16a1e3-9b5e-4ad4-96ce-43c0c7b8eaea	50090-0049	HUMAN OTC DRUG	ALLERGY		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-0050_ec4a66b7-da07-4c23-ae76-64e5112e27d8	50090-0050	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	A-S Medication Solutions	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0051_22981df4-2369-44b6-be7f-c73314f8eb05	50090-0051	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	A-S Medication Solutions	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0052_ec4a66b7-da07-4c23-ae76-64e5112e27d8	50090-0052	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	A-S Medication Solutions	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0053_22981df4-2369-44b6-be7f-c73314f8eb05	50090-0053	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	A-S Medication Solutions	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0054_789a37ae-7f9f-4d48-a15d-2c67be33b80b	50090-0054	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	A-S Medication Solutions	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0086_b9443d21-f437-4125-809b-800e2e2370ca	50090-0086	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20030701		NDA AUTHORIZED GENERIC	NDA007073	A-S Medication Solutions	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
50090-0088_4d16df2a-73a7-4298-ae1a-4d89b3a98390	50090-0088	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	A-S Medication Solutions	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0089_4cc4785b-147a-4051-853f-7ec73869601f	50090-0089	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	A-S Medication Solutions	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0116_cdbdaa58-9ba6-4b9a-919f-3475204d0e7b	50090-0116	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	A-S Medication Solutions	DICLOXACILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0120_13ef5b9d-dc03-4d36-9219-861ff7acffd8	50090-0120	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride	ER	Diethylpropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111024		ANDA	ANDA091680	A-S Medication Solutions	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-0126_ce307182-fb3a-46b7-8c0f-a55803cf809a	50090-0126	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	A-S Medication Solutions	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-0127_b28ba232-0abd-480c-afef-0df9de113c9b	50090-0127	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	A-S Medication Solutions	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-0132_f422f5a9-22c0-44e4-8645-7280afca8e15	50090-0132	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	A-S Medication Solutions	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
50090-0136_cf9f980d-eb9a-41ea-b7f1-bbe03a408037	50090-0136	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	A-S Medication Solutions	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-0137_8dd89ed8-bf50-48a6-a37a-ca872ae6ae06	50090-0137	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	A-S Medication Solutions	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50090-0139_8dd89ed8-bf50-48a6-a37a-ca872ae6ae06	50090-0139	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	A-S Medication Solutions	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50090-0140_d0ddd119-7138-4cc2-9f6f-490673b4517b	50090-0140	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-0141_02e53562-f72d-4fec-a44c-d289f7e84f3e	50090-0141	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-0142_d0ddd119-7138-4cc2-9f6f-490673b4517b	50090-0142	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-0146_189b970a-697f-4865-aa02-fc87c4708d9d	50090-0146	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	A-S Medication Solutions	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-0148_189b970a-697f-4865-aa02-fc87c4708d9d	50090-0148	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	A-S Medication Solutions	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-0149_189b970a-697f-4865-aa02-fc87c4708d9d	50090-0149	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	A-S Medication Solutions	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-0160_17983e29-569b-467b-a51b-3d42d549fd7c	50090-0160	HUMAN OTC DRUG	Tolnaftate		TOLNAFTATE	CREAM	TOPICAL	20100211		OTC MONOGRAPH FINAL	part333C	A-S Medication Solutions	TOLNAFTATE	10	mg/g			N	20241231
50090-0162_b7f33b2c-0462-410f-83d2-0015578ccbf6	50090-0162	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	.1	mg/.1g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0163_14204358-8fca-48e1-b5db-1875b0b3dc6c	50090-0163	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	19780214		ANDA	ANDA085691	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0166_edd592cc-1cf8-4799-be2e-7b1c1c4870a3	50090-0166	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-0167_05eab97e-4004-4628-bd80-39f4f94dc7fd	50090-0167	HUMAN PRESCRIPTION DRUG	Premarin		estrogens, conjugated	TABLET, FILM COATED	ORAL	20060101		NDA	NDA004782	A-S Medication Solutions	ESTROGENS, CONJUGATED	.625	mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS]		N	20241231
50090-0169_2569dfa3-93f9-471d-8552-21470403f4bb	50090-0169	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	A-S Medication Solutions	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-0182_ee4f028e-e722-49fc-80f5-d633001546d2	50090-0182	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-0183_d88438f4-83d1-4211-8e3e-52c18a7649ef	50090-0183	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-0184_40019d38-a21f-4fdd-a54c-57278a50e8a8	50090-0184	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-0185_34600138-4c39-4860-bfa1-900640f544c7	50090-0185	HUMAN OTC DRUG	Naphcon A		naphazoline hydrochloride and pheniramine maleate	SOLUTION/ DROPS	OPHTHALMIC	19940608		NDA	NDA020226	A-S Medication Solutions	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.25; 3	mg/mL; mg/mL			N	20241231
50090-0186_bbd2d9f6-7d69-46d6-920d-265715b8d218	50090-0186	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	A-S Medication Solutions	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-0189_19a9b044-3beb-43b8-a62f-2bdc81ec80e2	50090-0189	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		A-S Medication Solutions	THYROID, PORCINE	30	mg/1			N	20241231
50090-0190_0c09c8df-05da-47bb-8ed4-97ea0e8eb0c4	50090-0190	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		A-S Medication Solutions	THYROID, PORCINE	60	mg/1			N	20241231
50090-0195_e42b3b7c-28bb-45fa-8c0d-8f5639035094	50090-0195	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071307	A-S Medication Solutions	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
50090-0201_82c2f069-34ee-4c08-89af-e5a486252002	50090-0201	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	A-S Medication Solutions	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-0211_a2aa5163-b658-43bb-8fb5-30b860b065af	50090-0211	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-0212_600ef6a3-993b-4319-ba37-f6bad44f53fe	50090-0212	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-0213_f8b8b14c-3039-4ba0-8df7-0a50fd016b2d	50090-0213	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-0214_7a8b31d4-cd7a-44bb-b07d-5974a493ad36	50090-0214	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-0215_dfad598f-40b2-435a-8936-ea535d515aca	50090-0215	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		ACETAMINOPHEN and CODEINE PHOSPHATE	SOLUTION	ORAL	19810821		ANDA	ANDA087508	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	120; 12	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
50090-0219_34fade7e-b1ad-4c3b-a290-4819d4223595	50090-0219	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA062703	A-S Medication Solutions	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-0220_e03740aa-5184-42e1-a66f-5cd1c297493f	50090-0220	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA062703	A-S Medication Solutions	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-0224_e3c7309f-dcce-49ab-8f94-1c9d169f1616	50090-0224	HUMAN OTC DRUG	DELSYM		Dextromethorphan	SUSPENSION, EXTENDED RELEASE	ORAL	20100504		NDA	NDA018658	A-S Medication Solutions	DEXTROMETHORPHAN	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-0230_c49d23c9-9da7-46d4-872a-607b71a2c700	50090-0230	HUMAN PRESCRIPTION DRUG	SILVADENE		silver sulfadiazine	CREAM	TOPICAL	19731126		NDA	NDA017381	A-S Medication Solutions	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50090-0234_046da506-c4c6-4587-a62c-193a9838083c	50090-0234	HUMAN OTC DRUG	Triple Antibiotic		Polymyxin B Sulfate, Bacitracin Zinc and Neomycin Sulfate	OINTMENT	TOPICAL	19950111		OTC MONOGRAPH FINAL	part333B	A-S Medication Solutions	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-0235_c1154a13-9cda-44bf-b6ac-90973990a6f9	50090-0235	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	19840626		NDA	NDA019137	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0236_7ec59c42-94e8-4831-8cc1-83d0a703f90b	50090-0236	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	OINTMENT	TOPICAL	19840904		NDA	NDA019141	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0242_912a7f08-5a05-4f4d-81ed-3d5fd7b245d9	50090-0242	HUMAN PRESCRIPTION DRUG	SELENIUM SULFIDE		SELENIUM SULFIDE	LOTION	TOPICAL	20060925		ANDA	ANDA089996	A-S Medication Solutions	SELENIUM SULFIDE	2.5	mg/100mL			N	20241231
50090-0244_cfaee2d1-b067-4408-b893-3563f4ee87b3	50090-0244	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	A-S Medication Solutions	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0246_e04fb501-e4f0-4e70-8e1d-50ffe50bdaa7	50090-0246	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		sulfacetamide sodium	SOLUTION/ DROPS	OPHTHALMIC	19941228		ANDA	ANDA040066	A-S Medication Solutions	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50090-0247_60de81f3-f08d-46b5-a771-b84312e42721	50090-0247	HUMAN PRESCRIPTION DRUG	NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN		neomycin sulfate, polymyxin b sulfate and gramicidin	SOLUTION/ DROPS	OPHTHALMIC	19960131		ANDA	ANDA064047	A-S Medication Solutions	GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	.025; 1.75; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-0248_eb4cd716-2f64-4512-9910-b9ed6075297c	50090-0248	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19960718		ANDA	ANDA064030	A-S Medication Solutions	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
50090-0255_5eac176c-21f1-4138-ad5e-ec939f4d2937	50090-0255	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19950710		ANDA	ANDA040014	A-S Medication Solutions	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50090-0256_3841db38-7783-4537-9e04-964983a434ec	50090-0256	HUMAN PRESCRIPTION DRUG	KENALOG-40		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20090601		NDA	NDA014901	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0258_dda0a7d6-a4f2-46df-a45a-3573a8bb96c9	50090-0258	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050712		ANDA	ANDA088299	A-S Medication Solutions	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50090-0261_d88c50ba-fe16-4d39-8c61-42549f200d67	50090-0261	HUMAN PRESCRIPTION DRUG	TUBERSOL		Tuberculin Purified Protein Derivative	INJECTION, SOLUTION	INTRADERMAL	19560815		BLA	BLA103941	A-S Medication Solutions	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	5	[iU]/.1mL	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
50090-0265_3a0fa650-e762-4342-94b1-7ac2715994cf	50090-0265	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050615		ANDA	ANDA088327	A-S Medication Solutions	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50090-0267_e83d6c01-8981-4c00-b9c5-f289883dfb7c	50090-0267	HUMAN OTC DRUG	Pharbetol	Regular strength	Acetaminophen	TABLET	ORAL	20070109		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	325	mg/1			N	20241231
50090-0271_6570e7e8-b248-4375-b452-2f683d9f488b	50090-0271	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	A-S Medication Solutions	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0285_bbd2d9f6-7d69-46d6-920d-265715b8d218	50090-0285	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	A-S Medication Solutions	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-0288_df63853d-05e7-4ba7-9f26-0904a37a3008	50090-0288	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0293_31329d06-d79d-45c3-b354-62a09266147c	50090-0293	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	CREAM	TOPICAL	19780309		ANDA	ANDA085692	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0295_0e119f28-b473-4083-859e-fb153fa9c43b	50090-0295	HUMAN PRESCRIPTION DRUG	KENALOG-10		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL	20090601		NDA	NDA012041	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0301_6dc3c73f-3211-4d15-a599-5453a9e9d27a	50090-0301	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0302_a42f2126-77ed-4ea6-9101-be695746be9f	50090-0302	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0303_c732d6a4-c538-4004-a4c5-ba6de1b114db	50090-0303	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0304_4044c5e7-5f77-439d-acf3-0b47ac81c0c6	50090-0304	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0315_961bd335-5552-432f-a0fc-457aac9276f1	50090-0315	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	A-S Medication Solutions	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-0318_4ff50c2f-1a9c-4eff-b863-83e73ccf479a	50090-0318	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	19900930		ANDA	ANDA071655	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-0327_cea24273-8f72-4e34-a942-0d967378b7df	50090-0327	HUMAN PRESCRIPTION DRUG	DIETHYLPROPION HYDROCHLORIDE		DIETHYLPROPION HYDROCHLORIDE	TABLET	ORAL	20101227		ANDA	ANDA201212	A-S Medication Solutions	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-0332_b9ee14ff-f4be-419f-813e-736811a08240	50090-0332	HUMAN PRESCRIPTION DRUG	Nitrostat		nitroglycerin	TABLET	SUBLINGUAL	20000501		NDA	NDA021134	A-S Medication Solutions	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50090-0350_31e0af9b-f791-435f-9752-4cfc3100b4ab	50090-0350	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	A-S Medication Solutions	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0351_f6e20611-2227-4f72-a062-b75f8472e3b9	50090-0351	HUMAN PRESCRIPTION DRUG	acetic acid		Acetic Acid	SOLUTION	AURICULAR (OTIC)	20100122		NDA	NDA012179	A-S Medication Solutions	ACETIC ACID	20.65	mg/mL			N	20241231
50090-0353_87a75165-353b-4c21-b82d-4ccbd893f881	50090-0353	HUMAN OTC DRUG	HUMULIN R		Insulin human	INJECTION, SOLUTION	PARENTERAL	19830627		BLA	BLA018780	A-S Medication Solutions	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
50090-0355_7a9cc1fb-e926-4cfb-8d0f-c8c0f5228f0b	50090-0355	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	A-S Medication Solutions	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-0362_6bcc04e2-1c17-41c8-952f-28f9047d0b1c	50090-0362	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20060512		ANDA	ANDA087385	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0370_b2c77168-5698-4cfe-9d57-96bb0bead3c3	50090-0370	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080937	A-S Medication Solutions	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
50090-0372_c1a7fbff-398f-48e5-9acd-d8124a393047	50090-0372	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-0374_250c944e-fb84-42b2-8eec-7abd1bdf4274	50090-0374	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214	20260531	ANDA	ANDA086183	A-S Medication Solutions	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
50090-0384_f2d2633f-b727-4869-89bf-c7d277618321	50090-0384	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19961003		ANDA	ANDA074649	A-S Medication Solutions	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-0395_eb425736-6e6f-467d-8b3d-3325e3026459	50090-0395	HUMAN OTC DRUG	Pharbetol		Acetaminophen	TABLET	ORAL	20060110		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	500	mg/1			N	20241231
50090-0403_6ffa1a5f-1a62-4017-999c-8ef13fa4f0c7	50090-0403	HUMAN OTC DRUG	Novolin	70/30	Human Insulin	INJECTION, SUSPENSION	SUBCUTANEOUS	19910625		BLA	BLA019991	A-S Medication Solutions	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
50090-0404_a0cc68fb-42ca-4ef3-8e6e-a75952096a13	50090-0404	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	A-S Medication Solutions	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0405_413c430e-e6d3-4580-9cd6-89729a3c097a	50090-0405	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0406_4f4678e7-a727-4583-ae59-f2d4b5370143	50090-0406	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	A-S Medication Solutions	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0407_56178a4a-2449-45f8-8c51-217cc407d077	50090-0407	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0408_e53f99c0-dc68-4b12-8c7d-f8db30196351	50090-0408	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	19900930		ANDA	ANDA060456	A-S Medication Solutions	PENICILLIN V POTASSIUM	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0409_acce0bbf-684d-4c34-9d79-ce1514bfd2ab	50090-0409	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	19900930		ANDA	ANDA060456	A-S Medication Solutions	PENICILLIN V POTASSIUM	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0410_d884706c-dc7e-492b-a2c8-dc74b374a3b7	50090-0410	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080936	A-S Medication Solutions	ISONIAZID	100	mg/1	Antimycobacterial [EPC]		N	20241231
50090-0416_715a96d5-bbbb-4847-971e-df096220b90d	50090-0416	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
50090-0431_3f81be58-ea09-48b4-b893-5537bdce5ed4	50090-0431	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19960828		ANDA	ANDA064065	A-S Medication Solutions	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-0433_7dfcddea-2672-4186-90eb-7d3fd1afbdf5	50090-0433	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone	SOLUTION/ DROPS	AURICULAR (OTIC)	19951229		ANDA	ANDA064053	A-S Medication Solutions	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-0436_e5ab23c8-5692-49d6-b169-06b132318cf6	50090-0436	HUMAN PRESCRIPTION DRUG	DEPO-MEDROL		methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	19590528		NDA	NDA011757	A-S Medication Solutions	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0439_ec4cf6be-a115-43e6-a1ec-47322f186964	50090-0439	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0448_5924c968-aec3-4b88-8797-012c68c529a6	50090-0448	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	A-S Medication Solutions	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50090-0451_8f575dc2-2ccc-45b6-8503-52633e216235	50090-0451	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951222		ANDA	ANDA074185	A-S Medication Solutions	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-0455_a08bc12c-3ee6-46a7-a6a0-ef6eeaa9a347	50090-0455	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, CHEWABLE	ORAL	19930101		ANDA	ANDA064013	A-S Medication Solutions	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0460_2dac4561-c329-49b8-b5bd-ae6886f5d0e3	50090-0460	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA073192	A-S Medication Solutions	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50090-0481_b0a17e68-06d8-46fa-bafd-e7d3f8dada9e	50090-0481	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0482_e7c3e345-517f-45ea-ae8b-2e7257e626d3	50090-0482	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0483_ed4d53b8-0487-4bb8-9cfe-ab75d1a2574d	50090-0483	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0485_eefcf1ea-ec6a-460b-b585-6bbef83869e6	50090-0485	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20110815		ANDA	ANDA070929	A-S Medication Solutions	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
50090-0486_11a8c451-46f5-484d-9978-fca7b3c2bd82	50090-0486	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	19960131		ANDA	ANDA064096	A-S Medication Solutions	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
50090-0489_e20b690e-04fa-4a89-84b5-bd31d072da7b	50090-0489	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	A-S Medication Solutions	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-0490_6ad2c0ad-f735-4653-8936-afebd526c08d	50090-0490	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	2.5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-0491_04a20e29-58fa-4851-9892-13c687eec681	50090-0491	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961203		ANDA	ANDA040159	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-0495_d7312022-17ca-4251-a684-6045f7841266	50090-0495	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	A-S Medication Solutions	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-0497_e6ad0021-ed16-4a23-8c6b-a71fd50214a1	50090-0497	HUMAN OTC DRUG	Novolin	R	Human Insulin	INJECTION, SOLUTION	SUBCUTANEOUS	19910625		BLA	BLA019938	A-S Medication Solutions	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
50090-0498_f506090a-eafe-4b3a-ad78-132918b17646	50090-0498	HUMAN OTC DRUG	Novolin	N	Human Insulin	INJECTION, SUSPENSION	SUBCUTANEOUS	19910701		BLA	BLA019959	A-S Medication Solutions	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
50090-0500_4dc83aa9-6e82-437c-b3a3-f99c80693cca	50090-0500	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20040202		ANDA	ANDA074151	A-S Medication Solutions	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-0502_a5a65119-d0af-4dc7-86f2-42945e22771d	50090-0502	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	A-S Medication Solutions	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-0503_f2bbffd6-6939-4747-9f06-98fb673a8628	50090-0503	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	A-S Medication Solutions	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
50090-0505_41670409-b2d4-4a72-a478-bcd5714f83bf	50090-0505	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	A-S Medication Solutions	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-0507_416f21ed-8268-4979-9b91-62d1303b3540	50090-0507	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	A-S Medication Solutions	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-0513_11f19f1c-770b-4f2c-ad26-df56013babce	50090-0513	HUMAN PRESCRIPTION DRUG	Amiloride Hydrochloride and Hydrochlorothiazide		Amiloride Hydrochloride and Hydrochlorothiazide	TABLET	ORAL	19891201		ANDA	ANDA071111	A-S Medication Solutions	AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	5; 50	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-0516_77a4fe31-c09b-477a-b404-c63a4388cd6b	50090-0516	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20111205		ANDA	ANDA077839	A-S Medication Solutions	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-0517_6c4fd265-28fc-49fb-aa62-22ae999796c2	50090-0517	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	19980115		ANDA	ANDA074543	A-S Medication Solutions	ALBUTEROL SULFATE	5	mg/mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-0520_bf16a57b-59a9-4ea4-a1d0-f0ba60372799	50090-0520	HUMAN PRESCRIPTION DRUG	Pyrazinamide		Pyrazinamide	TABLET	ORAL	19950401		ANDA	ANDA081319	A-S Medication Solutions	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
50090-0523_95cb1966-8d65-454a-a17a-81cd51b9b67c	50090-0523	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	19970605		ANDA	ANDA074821	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-0525_17f8da0b-f726-41e9-bd06-237ae59432b4	50090-0525	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20100608		ANDA	ANDA091348	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-0527_29e99485-d86b-4930-90ad-9fe769042e9f	50090-0527	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20060613		ANDA	ANDA085027	A-S Medication Solutions	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0530_b29cb3b6-4913-49b3-82a2-590b1792703a	50090-0530	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA202432	A-S Medication Solutions	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
50090-0536_715a96d5-bbbb-4847-971e-df096220b90d	50090-0536	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
50090-0537_be3cceaf-638d-4c05-9d6a-03ca1452ad67	50090-0537	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	A-S Medication Solutions	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-0541_5b6da725-8670-4128-a073-09f94a412c3d	50090-0541	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20101231		ANDA	ANDA090066	A-S Medication Solutions	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50090-0542_8aaea517-79e3-453c-800b-ec9132299e12	50090-0542	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	A-S Medication Solutions	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0543_02eb3aca-0433-4c56-818d-cd8501244b84	50090-0543	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Delayed Release		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	A-S Medication Solutions	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0544_5b6da725-8670-4128-a073-09f94a412c3d	50090-0544	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	A-S Medication Solutions	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50090-0545_8aaea517-79e3-453c-800b-ec9132299e12	50090-0545	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	A-S Medication Solutions	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0549_36af3c6c-0322-48c8-8261-e6689cf37c88	50090-0549	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	19960708		ANDA	ANDA074249	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0553_646925a5-98cc-40af-82e0-bdb3cbc412fe	50090-0553	HUMAN OTC DRUG	Pepto-Bismol		Bismuth subsalicylate	TABLET	ORAL	20040630		OTC MONOGRAPH FINAL	M008	A-S Medication Solutions	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
50090-0556_bb10a1fa-af32-451c-9108-d2e13300ebca	50090-0556	HUMAN PRESCRIPTION DRUG	DEPO-MEDROL		methylprednisolone acetate	INJECTION, SUSPENSION	INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	19590528		NDA	NDA011757	A-S Medication Solutions	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0558_a1d1faf0-2909-4110-ab20-3d704bb7ae3f	50090-0558	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20120326		ANDA	ANDA074466	A-S Medication Solutions	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-0559_54821cc4-1238-4ab7-926f-4e6a185d55e5	50090-0559	HUMAN PRESCRIPTION DRUG	Prednisolone Acetate		Prednisolone Acetate	SUSPENSION/ DROPS	OPHTHALMIC	19941215		NDA AUTHORIZED GENERIC	NDA017469	A-S Medication Solutions	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0569_704bbbf7-8b57-4cb3-830c-def5e334618d	50090-0569	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19940511		ANDA	ANDA064048	A-S Medication Solutions	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
50090-0570_f492ef4f-fc1b-4ba1-b9fd-d77267615063	50090-0570	HUMAN PRESCRIPTION DRUG	Neomycin Polymyxin B Sulfates and Dexamethasone		Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19950913		ANDA	ANDA064135	A-S Medication Solutions	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-0580_1a525110-c69a-41c0-8c4c-b051ea5638ad	50090-0580	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	A-S Medication Solutions	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-0582_92b2897c-3bae-4cd0-98c5-7f1c9dd9cf00	50090-0582	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	19961111		ANDA	ANDA070848	A-S Medication Solutions	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20251231
50090-0597_032adf25-3ca5-47b6-8a6d-8219643ff9a3	50090-0597	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20061024		ANDA	ANDA076510	A-S Medication Solutions	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50090-0607_6246b7ce-c464-4d18-ba99-a5c5deb3aa88	50090-0607	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	A-S Medication Solutions	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50090-0614_838b5967-fc83-4f85-add6-04c09d5a6371	50090-0614	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	19951204		ANDA	ANDA072641	A-S Medication Solutions	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-0622_e93c78e4-524e-46cc-b985-b614b6f60ca0	50090-0622	HUMAN OTC DRUG	Aprodine		Pseudoephedrine HCl and Triprolidine HCl	TABLET, FILM COATED	ORAL	19930109		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	60; 2.5	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-0632_cc109b1e-29b6-46ae-9fba-0157bf2eb137	50090-0632	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19920201		ANDA	ANDA063181	A-S Medication Solutions	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-0638_584c7c38-4c8d-4e07-ba5a-54ec6e2ddd51	50090-0638	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	A-S Medication Solutions	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-0644_d18da4d7-1d2a-4c0c-b78e-2028e5fcebdd	50090-0644	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	A-S Medication Solutions	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-0645_bdb77ecd-40f4-4f9f-bb5e-ecf65fa99824	50090-0645	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	A-S Medication Solutions	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-0651_0bd4165c-feb6-4dcc-83c2-98b76944fe6e	50090-0651	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CREAM	TOPICAL	19980420		NDA AUTHORIZED GENERIC	NDA020404	A-S Medication Solutions	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
50090-0655_a8075d8b-e48a-4fb3-ad5e-6b8e6ce0247e	50090-0655	HUMAN PRESCRIPTION DRUG	Prednisolone		Prednisolone	SOLUTION	ORAL	20030227		ANDA	ANDA040401	A-S Medication Solutions	PREDNISOLONE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0657_524a4d8f-ffeb-4d60-a0d5-049bd0e4b1af	50090-0657	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	A-S Medication Solutions	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-0662_3fbdd641-8e16-4397-a8ca-f28dfee0737d	50090-0662	HUMAN PRESCRIPTION DRUG	Tamiflu		oseltamivir phosphate	CAPSULE	ORAL	19991027		NDA	NDA021087	A-S Medication Solutions	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
50090-0668_d9ea4c05-9c27-4c4b-9a9e-b9b8da27d226	50090-0668	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20110201		ANDA	ANDA075693	A-S Medication Solutions	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-0678_9e66067a-8d48-4dbb-84fe-270dbe57291e	50090-0678	HUMAN PRESCRIPTION DRUG	Clomiphene Citrate		Clomiphene Citrate	TABLET	ORAL	19990830	20250228	ANDA	ANDA075528	A-S Medication Solutions	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	
50090-0685_d4d91910-46d3-43d1-b15a-f3b511ff3b45	50090-0685	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140411		ANDA	ANDA074661	A-S Medication Solutions	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0689_429e3b5a-8e18-4c0e-92fa-90d73dfe5718	50090-0689	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	A-S Medication Solutions	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-0692_429e3b5a-8e18-4c0e-92fa-90d73dfe5718	50090-0692	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	A-S Medication Solutions	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-0701_a2cdbd24-ee8f-4fa2-abe2-cde2276ec1dc	50090-0701	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	A-S Medication Solutions	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-0704_a2cdbd24-ee8f-4fa2-abe2-cde2276ec1dc	50090-0704	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	A-S Medication Solutions	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-0706_a2cdbd24-ee8f-4fa2-abe2-cde2276ec1dc	50090-0706	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	A-S Medication Solutions	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-0709_71f7ed5b-d3db-4a92-bed1-99ab7eb834ab	50090-0709	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0713_71f7ed5b-d3db-4a92-bed1-99ab7eb834ab	50090-0713	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	A-S Medication Solutions	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0714_156fa79e-91a6-460c-8f93-af5115b9588a	50090-0714	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	A-S Medication Solutions	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0715_70793921-ba8d-4714-badb-23d2d5ff0443	50090-0715	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	A-S Medication Solutions	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
50090-0717_ba132d79-5bb4-4a20-8dee-c8dfe60fc46f	50090-0717	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	A-S Medication Solutions	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50090-0720_bf765d18-843e-4af4-aab8-e3e1a31c4831	50090-0720	HUMAN PRESCRIPTION DRUG	ketoconazole		ketoconazole	CREAM	TOPICAL	20040428		ANDA	ANDA076294	A-S Medication Solutions	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-0722_4fcdac5a-c817-4d51-bb73-5f74f3d0e47c	50090-0722	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20100601		ANDA	ANDA077789	A-S Medication Solutions	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
50090-0724_6fabafe0-f106-445b-b006-53036988e684	50090-0724	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20100315		ANDA	ANDA090510	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-0734_a2cdbd24-ee8f-4fa2-abe2-cde2276ec1dc	50090-0734	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	A-S Medication Solutions	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-0741_c81292e5-a450-429d-8909-cf6f039d9430	50090-0741	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20031216		ANDA	ANDA076002	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0745_68820d52-f4c7-47ee-b7e3-9535abe19d6b	50090-0745	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-0749_68820d52-f4c7-47ee-b7e3-9535abe19d6b	50090-0749	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-0757_80023785-4b99-48c1-b757-c391056fe6fc	50090-0757	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	A-S Medication Solutions	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-0759_22dadb0e-d97e-4b45-bce7-42b51e56e85d	50090-0759	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	A-S Medication Solutions	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-0761_a40c2a22-d68c-4fe4-981b-d0d007daab3e	50090-0761	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	A-S Medication Solutions	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-0762_22dadb0e-d97e-4b45-bce7-42b51e56e85d	50090-0762	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	A-S Medication Solutions	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-0763_65758992-af8d-49b8-ab43-72da8dc65f06	50090-0763	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	A-S Medication Solutions	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50090-0771_4b4ed91f-e949-47f4-a955-a4fba0eba68b	50090-0771	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020129		ANDA	ANDA075967	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-0806_8f996356-53a6-4775-851a-6f7fc2520a1f	50090-0806	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
50090-0807_1596ed37-49d2-4c3e-8de2-4e287b780af1	50090-0807	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
50090-0808_db593b7b-054e-42ab-ad39-af63bc79b9a7	50090-0808	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	A-S Medication Solutions	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-0811_36296745-8c75-415d-8e44-3abfc4c8d6f8	50090-0811	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	A-S Medication Solutions	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-0815_2d63e08c-12db-4c8d-9184-2ef5314971ed	50090-0815	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20110620		OTC MONOGRAPH FINAL	part333B	A-S Medication Solutions	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
50090-0818_f8c21bf6-1651-45af-ae1b-2a2ee595a122	50090-0818	HUMAN OTC DRUG	Mucinex		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120703		NDA	NDA021282	A-S Medication Solutions	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
50090-0819_8d05f6d9-8a59-4d65-8aa7-0c6c110852e2	50090-0819	HUMAN PRESCRIPTION DRUG	KENALOG-40		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20090601		NDA	NDA014901	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0822_0486c03e-39bd-4328-90c3-b84929648749	50090-0822	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-0831_2f73ac78-20fa-4682-93b2-ae4826b31ce0	50090-0831	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20071201		ANDA	ANDA065191	A-S Medication Solutions	AMOXICILLIN; CLAVULANIC ACID	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-0832_2f73ac78-20fa-4682-93b2-ae4826b31ce0	50090-0832	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20071201		ANDA	ANDA065191	A-S Medication Solutions	AMOXICILLIN; CLAVULANIC ACID	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-0836_36ec4fdd-4e89-4f3f-bf3b-1d76db3ec25e	50090-0836	HUMAN OTC DRUG	Loratadine	antihistamine	Loratadine	TABLET	ORAL	20081015		ANDA	ANDA076301	A-S Medication Solutions	LORATADINE	10	mg/1			N	20241231
50090-0840_36296745-8c75-415d-8e44-3abfc4c8d6f8	50090-0840	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	A-S Medication Solutions	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-0841_540496ec-9b2e-469f-8618-0f7ffb9b5118	50090-0841	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20040116		ANDA	ANDA076533	A-S Medication Solutions	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-0843_f835a7ac-ce93-43e1-ae10-7fd6e2cf24e6	50090-0843	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20100118		ANDA	ANDA040736	A-S Medication Solutions	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
50090-0845_499fe3c3-12f2-4be7-8dc1-921733a594b1	50090-0845	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20110620		OTC MONOGRAPH FINAL	part333B	A-S Medication Solutions	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
50090-0850_e642a442-75ed-40b9-be44-02f72c24c8a6	50090-0850	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	A-S Medication Solutions	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-0858_332528b5-9d49-4c64-9f7b-d3a27d47e9f1	50090-0858	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	A-S Medication Solutions	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-0862_02a630df-cc23-4463-82c4-5e58ac8fec4c	50090-0862	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200301		ANDA	ANDA078866	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-0865_dcdaafda-874e-40b4-8e0f-346570538c61	50090-0865	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-0866_144d42fc-7cc2-4ae4-b050-53d6dfff0b4b	50090-0866	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-0876_36965dca-e4e9-465f-a209-bb5f76739989	50090-0876	HUMAN PRESCRIPTION DRUG	Lantus		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20090923		BLA	BLA021081	A-S Medication Solutions	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-0878_237e3d41-c0d2-424c-8d47-9ebd833b99fe	50090-0878	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		diphenhydramine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19721127		ANDA	ANDA080817	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-0879_5cb280fa-c45d-4dbb-8e1d-c2271db20a77	50090-0879	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR	19730919		ANDA	ANDA083312	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-0887_0797d374-f582-4573-8a17-8d55185be64d	50090-0887	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	A-S Medication Solutions	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-0888_82c4b6d3-45dd-4964-95d6-a41f73146c07	50090-0888	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	A-S Medication Solutions	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-0892_bb7b12c6-0ad6-4184-87e9-3f4d8b09f5b0	50090-0892	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-0896_32e6631b-c3d2-43c7-8a34-c8eecacf9812	50090-0896	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	A-S Medication Solutions	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-0910_4d50d516-43f9-4206-b287-014b8868a9a2	50090-0910	HUMAN PRESCRIPTION DRUG	FLOVENT	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20070129		NDA	NDA021433	A-S Medication Solutions	FLUTICASONE PROPIONATE	110	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0916_eb43795c-6b16-47e3-8ac5-a74b0d382810	50090-0916	HUMAN PRESCRIPTION DRUG	FLOVENT	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20070406		NDA	NDA021433	A-S Medication Solutions	FLUTICASONE PROPIONATE	44	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0917_36d90915-c768-4dc2-ba7f-6f8fe8764e08	50090-0917	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	CREAM	VAGINAL	20050119		ANDA	ANDA076043	A-S Medication Solutions	TERCONAZOLE	4	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-0927_00ba1494-ad88-49d5-bb9f-ce0ab6193853	50090-0927	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	A-S Medication Solutions	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-0928_77950887-4a8e-4582-bc9c-f23984b05ec8	50090-0928	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20071201		ANDA	ANDA065191	A-S Medication Solutions	AMOXICILLIN; CLAVULANIC ACID	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20251231
50090-0934_a17632f6-f73b-4e4d-aa36-535d86388153	50090-0934	HUMAN PRESCRIPTION DRUG	FLOVENT	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20070125		NDA	NDA021433	A-S Medication Solutions	FLUTICASONE PROPIONATE	220	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0942_847f0f03-9379-4371-b7df-ca070982527e	50090-0942	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20110815		ANDA	ANDA070929	A-S Medication Solutions	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20251231
50090-0944_1a0fb5d6-05a6-4438-88f6-6c1c1cf64e26	50090-0944	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	A-S Medication Solutions	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-0947_8a82cebf-6e85-488d-a0fb-16bec04cddda	50090-0947	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	A-S Medication Solutions	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-0949_bf9abed3-bc5b-4606-831d-1ae78cdea91d	50090-0949	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	A-S Medication Solutions	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-0967_c72979ee-21bf-4363-974b-ee51898aeba7	50090-0967	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	A-S Medication Solutions	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-0968_c55b417f-4588-43a6-b925-dcba58c555c1	50090-0968	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20070919		ANDA	ANDA077538	A-S Medication Solutions	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-0975_e0a2b342-26bb-4c86-b9c4-20fc5160c98f	50090-0975	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	A-S Medication Solutions	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-0985_3255a2ac-5549-4a85-b93c-1789b22989fe	50090-0985	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	A-S Medication Solutions	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-0989_9a579859-c6cb-4ba3-8b1f-3279c0a861c8	50090-0989	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-0994_84ec0223-d179-4a48-a92e-310157d07411	50090-0994	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	FOR SUSPENSION	ORAL	20070904		ANDA	ANDA065283	A-S Medication Solutions	CLARITHROMYCIN	250	mg/5mL	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20251231
50090-0999_569e35de-4418-45cd-92a3-9056364661f9	50090-0999	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	A-S Medication Solutions	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-1000_b5270a84-b817-4e33-98d3-fa753f4bed9c	50090-1000	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	A-S Medication Solutions	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50090-1001_409a6177-4e3d-44d7-a329-f21b8dea9b1d	50090-1001	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	A-S Medication Solutions	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50090-1006_8c26254a-c103-49d1-a1e4-8f256ef48805	50090-1006	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	A-S Medication Solutions	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-1016_78cd2843-8c8f-43a1-b511-ba65823588ae	50090-1016	HUMAN PRESCRIPTION DRUG	BICILLIN L-A		penicillin G benzathine	INJECTION, SUSPENSION	INTRAMUSCULAR	19520627		NDA	NDA050141	A-S Medication Solutions	PENICILLIN G BENZATHINE	1200000	[iU]/2mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1023_f50c5945-d434-462a-a5ee-b50d7f3b7ed6	50090-1023	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	A-S Medication Solutions	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20251231
50090-1024_b0bead8c-94be-4b06-ab4e-3c532973dc50	50090-1024	HUMAN PRESCRIPTION DRUG	BENZPHETAMINE HYDROCHLORIDE		benzphetamine hydrochloride	TABLET	ORAL	20100721		ANDA	ANDA090968	A-S Medication Solutions	BENZPHETAMINE HYDROCHLORIDE	50	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20251231
50090-1025_de849af9-7842-4e71-a57c-e9897f370beb	50090-1025	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20041221		ANDA	ANDA076679	A-S Medication Solutions	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1033_6f0e6a47-f6d2-4863-85f9-4ed6129cde24	50090-1033	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20060530		ANDA	ANDA065264	A-S Medication Solutions	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-1034_f3bc33aa-4606-4855-9103-c21e7a86447a	50090-1034	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20060530		ANDA	ANDA065264	A-S Medication Solutions	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-1036_6df1759a-dd73-4844-b003-898e0f9b6b01	50090-1036	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-1039_d6dee8d2-3456-4aa4-a14d-86d82bb615a1	50090-1039	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-1042_aa9fc6df-5e9e-46cd-8600-e60b5f4a1dfe	50090-1042	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-1044_57e5f9b5-17f5-4bf8-b131-20615ef5191a	50090-1044	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	A-S Medication Solutions	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-1045_e986389d-aee4-4a86-b3f2-8e247ff4a890	50090-1045	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	A-S Medication Solutions	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-1048_1d9dab8d-1e3b-4c35-847d-57dbaa8c2ead	50090-1048	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20101227		ANDA	ANDA077714	A-S Medication Solutions	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
50090-1057_cb486714-7ca9-48fd-8c4a-1bd84cc81b3a	50090-1057	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	A-S Medication Solutions	MIRTAZAPINE	30	mg/1			N	20241231
50090-1062_709fda35-452f-4d3e-8762-ded551d61585	50090-1062	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	A-S Medication Solutions	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1067_c09b189e-e6be-4676-a830-daed56ee3734	50090-1067	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	A-S Medication Solutions	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1069_22e058a4-be20-4da2-90ee-c71c3732419f	50090-1069	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	A-S Medication Solutions	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1075_c288940f-d1e3-46d1-bc83-e5b615ea3314	50090-1075	HUMAN OTC DRUG	Mucinex D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021585	A-S Medication Solutions	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-1076_e18c5a01-14a1-4e19-9ddf-9174135243dd	50090-1076	HUMAN OTC DRUG	MUCINEX D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021585	A-S Medication Solutions	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20251231
50090-1077_e247189e-668b-409a-84b9-d71ef0bdca11	50090-1077	HUMAN OTC DRUG	Mucinex DM		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021620	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-1078_2900ed82-7081-46d1-8345-4613952651a9	50090-1078	HUMAN OTC DRUG	Mucinex DM		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021620	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
50090-1085_fa8200b3-64ad-4ba4-a708-7a9b564d2ac8	50090-1085	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, FILM COATED	ORAL	20071012		NDA	NDA022145	A-S Medication Solutions	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
50090-1086_6fba8389-62b9-4724-85c4-c1af920a065a	50090-1086	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	A-S Medication Solutions	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1087_35dd5753-887e-4412-a179-f81afa0ff241	50090-1087	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070312		ANDA	ANDA040707	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-1088_c3a24745-3395-4100-9e37-2fa995299b30	50090-1088	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130418		ANDA	ANDA202556	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-1109_f8f47421-2135-4410-a6b2-bc141cb5c6d5	50090-1109	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-1118_1ef1c2d7-0def-4225-b538-df69e7d32c46	50090-1118	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	A-S Medication Solutions	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-1127_b297635e-5bdc-484d-9e94-2db7f45e25d9	50090-1127	HUMAN PRESCRIPTION DRUG	Bystolic		nebivolol hydrochloride	TABLET	ORAL	20080122		NDA	NDA021742	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1129_3b5ac054-cad8-4dd1-bd9e-cfb8c3a18053	50090-1129	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	A-S Medication Solutions	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
50090-1130_3b5ac054-cad8-4dd1-bd9e-cfb8c3a18053	50090-1130	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	A-S Medication Solutions	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
50090-1135_3ae18ae8-7fe7-4f51-86d5-25d847181f3f	50090-1135	HUMAN PRESCRIPTION DRUG	Tobramycin and Dexamethasone		Tobramycin and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20090102		NDA AUTHORIZED GENERIC	NDA050592	A-S Medication Solutions	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1148_3b78d45f-a26a-4abd-a8d0-505dc7970f9f	50090-1148	HUMAN OTC DRUG	Nicotine		Nicotine	PATCH	TRANSDERMAL	19971020		ANDA	ANDA074612	A-S Medication Solutions	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
50090-1150_f3c02405-f0db-47fe-b943-fa20fdc1f432	50090-1150	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090611		ANDA	ANDA079094	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-1152_6a2cc472-3f64-4548-beb7-56ee0e2d260a	50090-1152	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20140331		ANDA	ANDA077007	A-S Medication Solutions	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
50090-1154_16c993b9-9897-4914-b124-8107e05bfc38	50090-1154	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20140331		ANDA	ANDA077007	A-S Medication Solutions	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
50090-1157_d88068a6-f7be-4ba4-b11b-46877bc62791	50090-1157	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	A-S Medication Solutions	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-1159_e7251670-2b28-4035-b5aa-6421ff7c6337	50090-1159	HUMAN PRESCRIPTION DRUG	VENTOLIN	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20060609		NDA	NDA020983	A-S Medication Solutions	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-1161_ac884400-a248-47d8-8d20-b03f35e6a325	50090-1161	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1187_1bf04358-8372-41a8-b4cc-2cce4a8edef4	50090-1187	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	CREAM	TOPICAL	20060913		ANDA	ANDA076793	A-S Medication Solutions	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50090-1196_f235c1c5-0e31-43a4-abec-f622945d799e	50090-1196	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	CREAM	VAGINAL	20040406		ANDA	ANDA075953	A-S Medication Solutions	TERCONAZOLE	8	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-1200_f41f7918-cd8c-46cb-830e-720067258093	50090-1200	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	A-S Medication Solutions	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-1201_b5faf670-f22b-4d1a-bb78-31b59d136d2f	50090-1201	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	A-S Medication Solutions	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-1202_225a6fee-cfa5-4c5d-89f3-e62515ee536c	50090-1202	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION/ DROPS	OPHTHALMIC	19990629		ANDA	ANDA075282	A-S Medication Solutions	CROMOLYN SODIUM	40	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
50090-1219_24e3d307-f471-4130-a9e5-25d1db7c47ee	50090-1219	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20030304		ANDA	ANDA076194	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-1223_7cb4161b-8aeb-4f22-b725-1dede2af21d6	50090-1223	VACCINE	ENGERIX-B		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR	20070328		BLA	BLA103239	A-S Medication Solutions	HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN	20	ug/mL			N	20241231
50090-1234_0f9c52c4-60a5-4054-885c-74e5eabc250a	50090-1234	HUMAN OTC DRUG	Allegra Allergy		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20110303		NDA	NDA020872	A-S Medication Solutions	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-1241_7acadd2a-73a7-420b-9825-6691b1d60464	50090-1241	HUMAN PRESCRIPTION DRUG	BESIVANCE		Besifloxacin	SUSPENSION	OPHTHALMIC	20090528		NDA	NDA022308	A-S Medication Solutions	BESIFLOXACIN	6	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-1245_fb05bfe4-e8d9-4abb-afe1-d651eaa4eefd	50090-1245	HUMAN PRESCRIPTION DRUG	FLOVENT	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20070508		NDA	NDA020833	A-S Medication Solutions	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50090-1247_f85e4822-30d3-4c00-b9a5-153b0d626cc6	50090-1247	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20081028		ANDA	ANDA077847	A-S Medication Solutions	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50090-1270_934ccaf1-1fb5-403c-ac58-bff7311fc767	50090-1270	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA073449	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-1275_1188a9a5-4663-44a7-9df4-e3283177e641	50090-1275	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200918		ANDA	ANDA076635	A-S Medication Solutions	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-1276_2ce47f4e-af88-48ad-a29f-788f5f9ddbe2	50090-1276	HUMAN PRESCRIPTION DRUG	Levemir		insulin detemir	INJECTION, SOLUTION	SUBCUTANEOUS	20060327		BLA	BLA021536	A-S Medication Solutions	INSULIN DETEMIR	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
50090-1277_569e35de-4418-45cd-92a3-9056364661f9	50090-1277	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	A-S Medication Solutions	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-1278_d0db1c47-4dfe-443e-a514-09f727fb0b9f	50090-1278	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	A-S Medication Solutions	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
50090-1279_a95d35f0-4d3d-4691-8d23-f30134dbcc87	50090-1279	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	A-S Medication Solutions	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-1284_6fdd10d2-4cb2-4631-bc45-744660ae5bb1	50090-1284	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	A-S Medication Solutions	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-1290_ac884400-a248-47d8-8d20-b03f35e6a325	50090-1290	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1291_ac884400-a248-47d8-8d20-b03f35e6a325	50090-1291	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1292_2eb26b61-5e59-4b41-a416-76f89820a6bb	50090-1292	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	A-S Medication Solutions	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-1297_2f135d28-5f45-4b33-9618-ffa94f83f530	50090-1297	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	A-S Medication Solutions	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-1298_bb7b12c6-0ad6-4184-87e9-3f4d8b09f5b0	50090-1298	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-1299_2b35de26-dca3-4508-b0c4-f9bdea0e41da	50090-1299	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	A-S Medication Solutions	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
50090-1301_b68d05a1-12ae-473f-b9cb-ca80cac9e2af	50090-1301	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076274	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-1302_76bab431-cefa-40bb-87f0-e31b36ec40a6	50090-1302	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		Atovaquone and Proguanil Hydrochloride	TABLET, FILM COATED	ORAL	20110915		ANDA	ANDA091211	A-S Medication Solutions	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
50090-1307_b297635e-5bdc-484d-9e94-2db7f45e25d9	50090-1307	HUMAN PRESCRIPTION DRUG	Bystolic		nebivolol hydrochloride	TABLET	ORAL	20080122		NDA	NDA021742	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1308_2eb26b61-5e59-4b41-a416-76f89820a6bb	50090-1308	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	A-S Medication Solutions	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-1323_2f36a3de-52f3-4393-b14b-b9daf9921657	50090-1323	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	A-S Medication Solutions	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-1328_7417fe8c-e956-4a9c-bdde-fa1198fb9a3f	50090-1328	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20151030		ANDA	ANDA074802	A-S Medication Solutions	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-1330_7cb28ad9-c0e7-42a6-9ce0-82ab6d0b6aa5	50090-1330	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	A-S Medication Solutions	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50090-1333_4d7a6654-3a75-4102-9043-257ec39da440	50090-1333	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	A-S Medication Solutions	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-1336_d703ef2b-e51b-4d20-990b-3dd4161629a0	50090-1336	HUMAN PRESCRIPTION DRUG	APLISOL		Tuberculin Purified Protein Derivative	INJECTION	INTRADERMAL	20080425		BLA	BLA103782	A-S Medication Solutions	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	5	[iU]/.1mL	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
50090-1340_343e9af3-cc85-4467-b51e-fcc00daf2759	50090-1340	HUMAN OTC DRUG	Mucinex		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120703		NDA	NDA021282	A-S Medication Solutions	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
50090-1346_409f8ab4-d6c1-4669-bd2f-6114ec19b83e	50090-1346	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20080701		ANDA	ANDA076407	A-S Medication Solutions	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-1347_8ad02473-82e5-42cf-8406-53ef7d6934f8	50090-1347	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	A-S Medication Solutions	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1353_cc2cf0bb-c715-4daa-a92d-4a480853826a	50090-1353	HUMAN OTC DRUG	NEW TEROCIN		Methyl Salicylate, Capsaicin, and Menthol	LOTION	TOPICAL	20130313		OTC MONOGRAPH NOT FINAL	part348	A-S Medication Solutions	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.025; 10; 25	g/100mL; g/100mL; g/100mL			N	20241231
50090-1359_718be130-4a60-4c03-97a5-9ff8f3cb85fd	50090-1359	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20140502		NDA AUTHORIZED GENERIC	NDA020612	A-S Medication Solutions	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50090-1375_9cc66c61-8205-4266-8a0b-a338ae0a8855	50090-1375	HUMAN PRESCRIPTION DRUG	Humalog		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19960614		BLA	BLA020563	A-S Medication Solutions	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
50090-1377_56362763-26c8-4a4e-b9e1-bbb3524d692c	50090-1377	VACCINE	BOOSTRIX		Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed	SUSPENSION	INTRAMUSCULAR	20090724		BLA	BLA125106	A-S Medication Solutions	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	8; 2.5; 8; 5; 2.5	ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
50090-1382_8c869de0-8e0f-4cca-8a04-0e8ee3e81449	50090-1382	HUMAN PRESCRIPTION DRUG	IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20121015		ANDA	ANDA202496	A-S Medication Solutions	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-1389_70763749-28df-4297-b1e4-2ec47594a6cc	50090-1389	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	A-S Medication Solutions	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-1398_577365d4-f4cb-4431-9b05-a3d90efb7856	50090-1398	HUMAN PRESCRIPTION DRUG	Lantus Solostar		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20090923		BLA	BLA021081	A-S Medication Solutions	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-1400_7e6c0fea-b780-4749-98cc-f6b1e4e970b5	50090-1400	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110805		ANDA	ANDA090700	A-S Medication Solutions	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-1403_a0b19dbf-5007-434e-b8f2-1c29a4d566e3	50090-1403	HUMAN PRESCRIPTION DRUG	SYMBICORT		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20070529		NDA	NDA021929	A-S Medication Solutions	BUDESONIDE; FORMOTEROL FUMARATE	160; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-1418_aa9fc6df-5e9e-46cd-8600-e60b5f4a1dfe	50090-1418	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-1430_7cd77e25-b18b-4248-9bb5-d4c72a103d13	50090-1430	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20120629		ANDA	ANDA091264	A-S Medication Solutions	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-1432_e986389d-aee4-4a86-b3f2-8e247ff4a890	50090-1432	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	A-S Medication Solutions	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-1437_d211ec24-e468-4c43-9a61-76c514c384cc	50090-1437	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	A-S Medication Solutions	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20251231
50090-1444_e5808e0f-eeb2-4e01-9665-74af2e2626f5	50090-1444	HUMAN OTC DRUG	NASACORT ALLERGY 24HR		Triamcinolone Acetonide	SPRAY, METERED	NASAL	20140203		NDA	NDA020468	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1445_075af379-8346-488f-a2a3-bf24628d68bd	50090-1445	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	19971126		ANDA	ANDA040039	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1454_06ab4a12-31b8-435c-9988-f2e1ca56003c	50090-1454	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20101124		ANDA	ANDA077421	A-S Medication Solutions	LORATADINE	5	mg/5mL			N	20241231
50090-1460_ce518215-aca4-400b-ae88-b9872c9ab3d3	50090-1460	HUMAN OTC DRUG	Nexium 24HR		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20140527		NDA	NDA204655	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-1463_898850ee-661b-43bb-b0ef-4971b77843ce	50090-1463	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA090149	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-1467_ab2faae8-3e28-451b-b901-a9b24fe0e104	50090-1467	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20081119		ANDA	ANDA077519	A-S Medication Solutions	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1470_29a6d276-ba80-4bdf-9f0e-c976d7369b33	50090-1470	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101227		ANDA	ANDA091544	A-S Medication Solutions	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20251231
50090-1475_2ce47f4e-af88-48ad-a29f-788f5f9ddbe2	50090-1475	HUMAN PRESCRIPTION DRUG	Levemir		insulin detemir	INJECTION, SOLUTION	SUBCUTANEOUS	20131031		BLA	BLA021536	A-S Medication Solutions	INSULIN DETEMIR	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
50090-1477_b488afff-f378-4be0-bad7-9fea7bf40586	50090-1477	HUMAN PRESCRIPTION DRUG	ALYACEN 1/35		norethindrone and ethinyl estradiol	KIT		20120119		ANDA	ANDA091634	A-S Medication Solutions						N	20241231
50090-1478_b289169f-a505-4268-b1f0-8b15c820f2d3	50090-1478	HUMAN PRESCRIPTION DRUG	ALYACEN 7/7/7		norethindrone and ethinyl estradiol	KIT		20120119		ANDA	ANDA091636	A-S Medication Solutions						N	20241231
50090-1484_ce955047-88f4-44de-a7b1-736baa056fb9	50090-1484	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19940729		ANDA	ANDA064067	A-S Medication Solutions	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
50090-1492_735c2da7-1761-41a2-a747-d50115a0c614	50090-1492	HUMAN OTC DRUG	Nexium 24HR		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20140527		NDA	NDA204655	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-1493_d2373083-4379-4141-8d01-d491ed232cc7	50090-1493	VACCINE	Typhim Vi		SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN	INJECTION, SOLUTION	INTRAMUSCULAR	19941128		BLA	BLA103936	A-S Medication Solutions	SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN	25	ug/.5mL	Actively Acquired Immunity [PE], Inactivated Salmonella Typhi Vaccine [EPC], Polysaccharides, Bacterial [CS], Vaccines, Inactivated [CS], Vaccines, Typhoid [CS]		N	20241231
50090-1498_ef6bb5fd-45b0-4cd7-9371-f3a91039d7d3	50090-1498	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-1501_b566cbe1-2d29-4d46-bd9c-316e363c9174	50090-1501	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	A-S Medication Solutions	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1502_23d4b1bc-00aa-4756-9bb0-74f36cbc9f6d	50090-1502	VACCINE	HAVRIX		Hepatitis A Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20070413		BLA	BLA103475	A-S Medication Solutions	HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)	1440	[iU]/mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
50090-1511_6a5b6cfa-dd7a-4f6d-a526-3ff272f33921	50090-1511	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1512_709816ad-b138-4ea6-b171-c366b1068670	50090-1512	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1513_a8079981-49b7-47e1-8860-b35fd536c3aa	50090-1513	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1514_d94697a4-3f33-49ee-add3-90803925374f	50090-1514	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1526_52853d96-d5dc-483e-b938-b9b96a8b43cf	50090-1526	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	A-S Medication Solutions	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-1533_e727fde2-3680-4542-9bb3-6ad56cdade65	50090-1533	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	A-S Medication Solutions	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-1534_92052790-ddac-4730-8590-5ed58a37c7df	50090-1534	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-1559_75e28a8b-3814-4df0-9321-f79628448308	50090-1559	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	A-S Medication Solutions	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-1564_b6f10404-69b2-47b0-970e-bf392d4a6ebd	50090-1564	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20090505		ANDA	ANDA078989	A-S Medication Solutions	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20251231
50090-1567_c6d8a7aa-c8f4-43e5-ba88-6aee886e4bb1	50090-1567	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	A-S Medication Solutions	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-1568_1bf08441-f9fe-4453-8976-3adc6e599236	50090-1568	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	A-S Medication Solutions	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-1571_825efcc5-2f3f-47ea-b72a-ea5b534ca1a8	50090-1571	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride		buprenorphine hydrochloride	TABLET	SUBLINGUAL	20100924		ANDA	ANDA090622	A-S Medication Solutions	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50090-1577_ce307182-fb3a-46b7-8c0f-a55803cf809a	50090-1577	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	A-S Medication Solutions	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-1582_f40fa36a-e143-4698-ba3c-ab1afa73d0f4	50090-1582	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20050425		ANDA	ANDA076913	A-S Medication Solutions	PREDNISOLONE SODIUM PHOSPHATE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1583_e7c3e345-517f-45ea-ae8b-2e7257e626d3	50090-1583	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	A-S Medication Solutions	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-1587_1f160121-1287-4d82-bfc5-7e64e5533bca	50090-1587	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20091030		ANDA	ANDA065123	A-S Medication Solutions	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
50090-1594_e727fde2-3680-4542-9bb3-6ad56cdade65	50090-1594	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	A-S Medication Solutions	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-1597_3f94de67-eadd-4480-b75f-81cdc3003c02	50090-1597	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	A-S Medication Solutions	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-1624_c6d8a7aa-c8f4-43e5-ba88-6aee886e4bb1	50090-1624	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	A-S Medication Solutions	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-1627_bf613d5d-bc95-4df6-9096-ac34f567ed9c	50090-1627	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	A-S Medication Solutions	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-1633_80dfa306-3c97-40f6-9d33-fc1a0171867d	50090-1633	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20080718		ANDA	ANDA076067	A-S Medication Solutions	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1645_608f8399-db16-4921-b0c8-153b81b1d568	50090-1645	VACCINE	TWINRIX		Hepatitis A and Hepatitis B (Recombinant) Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20070607		BLA	BLA103850	A-S Medication Solutions	HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED); HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN	720; 20	[iU]/mL; ug/mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
50090-1648_9f241d80-90cc-443a-bf21-80f99feff100	50090-1648	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
50090-1649_9244d2d7-3da2-46a0-a870-9d1196df1504	50090-1649	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-1658_d45a0801-3372-4024-aaae-fb500521134d	50090-1658	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	A-S Medication Solutions	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-1659_b4495c0e-5abc-4938-bb47-032e5934f161	50090-1659	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	A-S Medication Solutions	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-1660_d45a0801-3372-4024-aaae-fb500521134d	50090-1660	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	A-S Medication Solutions	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-1663_9cc66c61-8205-4266-8a0b-a338ae0a8855	50090-1663	HUMAN PRESCRIPTION DRUG	Humalog	KwikPen	Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20070906		BLA	BLA020563	A-S Medication Solutions	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
50090-1664_b01617ba-efae-44d9-b8ce-15a977d2fed5	50090-1664	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-1668_5471ed3d-e3c2-407e-b467-cc5a1c8be2fa	50090-1668	HUMAN PRESCRIPTION DRUG	TUBERSOL		Tuberculin Purified Protein Derivative	INJECTION, SOLUTION	INTRADERMAL	19560815		BLA	BLA103941	A-S Medication Solutions	TUBERCULIN PURIFIED PROTEIN DERIVATIVE	5	[iU]/.1mL	Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC], Tuberculosis Skin Test [EPC]		N	20241231
50090-1669_a8ffa7c2-a085-404a-b1c1-83d99d3af7af	50090-1669	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20071231		ANDA	ANDA076749	A-S Medication Solutions	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	3; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-1678_b01617ba-efae-44d9-b8ce-15a977d2fed5	50090-1678	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20030122		BLA	BLA020986	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-1679_d25e1d41-0ebb-4ced-b63d-edc08d2bf973	50090-1679	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20120815		ANDA	ANDA040876	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-1692_b4879225-0700-4bd7-849e-1ce6f9c995b5	50090-1692	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		A-S Medication Solutions	THYROID	90	mg/1			N	20241231
50090-1693_7be9f1ad-b434-44f4-9a60-6bac86beeacf	50090-1693	VACCINE	IPOL		POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	19901221		BLA	BLA103930	A-S Medication Solutions	POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	40; 8; 32	[D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
50090-1695_4721c870-626e-46b2-ab43-9267849952ca	50090-1695	HUMAN OTC DRUG	Tylenol Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20141101		OTC MONOGRAPH DRUG	M013	A-S Medication Solutions	ACETAMINOPHEN	500	mg/1			N	20241231
50090-1697_3b78d45f-a26a-4abd-a8d0-505dc7970f9f	50090-1697	HUMAN OTC DRUG	Nicotine		Nicotine	PATCH	TRANSDERMAL	19971020		ANDA	ANDA074612	A-S Medication Solutions	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
50090-1704_185872b9-e46e-45d4-aded-2cec16a7328a	50090-1704	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	A-S Medication Solutions	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-1710_5053f833-5678-4176-b93c-1b5622637121	50090-1710	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA065340	A-S Medication Solutions	CEFPROZIL	500	mg/1			N	20241231
50090-1718_2c94a52e-80e9-4ffc-bae8-d1eedbe10359	50090-1718	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20100528		ANDA	ANDA090121	A-S Medication Solutions	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
50090-1720_1dea7560-1ab8-496d-9796-69f12212864d	50090-1720	HUMAN OTC DRUG	Rugby Benzoyl Peroxide	Acne Medication	Benzoyl Peroxide	GEL	TOPICAL	20150120		OTC MONOGRAPH FINAL	part333D	A-S Medication Solutions	BENZOYL PEROXIDE	50	mg/mL			N	20241231
50090-1723_c5bd2c9e-5b7b-4404-bcd2-a82a46da19d8	50090-1723	HUMAN PRESCRIPTION DRUG	PREZCOBIX		DARUNAVIR ETHANOLATE and COBICISTAT	TABLET, FILM COATED	ORAL	20150131		NDA	NDA205395	A-S Medication Solutions	COBICISTAT; DARUNAVIR ETHANOLATE	150; 800	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC]		N	20251231
50090-1726_41690140-f2f1-4e02-b8b4-a74033e6c4dc	50090-1726	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071322	A-S Medication Solutions	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-1735_8f7abb2d-978d-4f26-b2be-de49d329963a	50090-1735	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077135	A-S Medication Solutions	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-1740_8d9b172d-a817-43b1-9cd9-24243b311f28	50090-1740	HUMAN PRESCRIPTION DRUG	Nystatin		nystatin	SUSPENSION	ORAL	19950415		ANDA	ANDA062512	A-S Medication Solutions	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
50090-1744_2c2b3d4c-0427-4618-8edd-435118c185bf	50090-1744	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20040514		ANDA	ANDA076622	A-S Medication Solutions	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-1745_d9f6c8a6-ea28-4d8b-83e3-2c50450afa0e	50090-1745	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-1754_29684c86-f568-48fc-9e25-ac79f4c5e23f	50090-1754	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-1758_10ca191a-a11a-455c-9bd8-064516107eba	50090-1758	VACCINE	TYPHIM VI		SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN	INJECTION, SOLUTION	INTRAMUSCULAR	19941128		BLA	BLA103936	A-S Medication Solutions	SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN	25	ug/.5mL	Actively Acquired Immunity [PE], Inactivated Salmonella Typhi Vaccine [EPC], Polysaccharides, Bacterial [CS], Vaccines, Inactivated [CS], Vaccines, Typhoid [CS]		N	20241231
50090-1778_88c54374-6fd0-4908-86f0-719a649a21f3	50090-1778	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20001020		ANDA	ANDA040409	A-S Medication Solutions	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
50090-1781_ee81560c-8542-4384-ae20-9c7ab551c957	50090-1781	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	A-S Medication Solutions	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
50090-1789_db7bc3b1-762a-4722-93af-4f313a7e2d35	50090-1789	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	A-S Medication Solutions	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-1790_fddf66a5-fccc-47b6-9166-0f1681972158	50090-1790	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	A-S Medication Solutions	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-1792_e9b68eed-e2da-4bba-b920-21b675c323f5	50090-1792	HUMAN OTC DRUG	Rugby Benzoyl Peroxide	Acne Medication	Benzoyl Peroxide	GEL	TOPICAL	20150120		OTC MONOGRAPH FINAL	part333D	A-S Medication Solutions	BENZOYL PEROXIDE	100	mg/mL			N	20241231
50090-1810_64cd4622-5ae2-4e23-b969-e2450ca3d9cf	50090-1810	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1811_5aebcb82-00e0-4c5d-964f-55df18dd088e	50090-1811	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1812_d9fd49ff-e40b-4af3-b7d9-53c652c026df	50090-1812	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1813_7c3ee85a-c634-4b3e-b089-edd3f72c0c2d	50090-1813	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1825_75c8cfe0-a727-4c6e-b176-319b6f6f30df	50090-1825	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	A-S Medication Solutions	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1826_1dd630c4-c257-44fb-9b90-68b770894e67	50090-1826	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	A-S Medication Solutions	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-1830_23ade793-ff78-4a0c-a091-d8fa6f3fac7b	50090-1830	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	A-S Medication Solutions	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-1831_8e96021c-e64e-4b03-af42-52891dc7fe39	50090-1831	VACCINE	BOOSTRIX		Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed	SUSPENSION	INTRAMUSCULAR	20090724		BLA	BLA125106	A-S Medication Solutions	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	8; 2.5; 8; 5; 2.5	ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
50090-1834_b7aace6d-e542-4a86-9e45-8c2e690daca4	50090-1834	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA071851	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-1843_49bb5de0-ea8b-4b8c-a5ea-c00dabf9f7f2	50090-1843	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	A-S Medication Solutions	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-1847_e5e205c1-c55b-47a0-ad32-7a4314434538	50090-1847	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-1848_e50a2157-5f9c-4c84-9f26-61383e406c9a	50090-1848	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20150325		ANDA	ANDA078722	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-1850_2bf9bb34-f9ac-4e93-8b27-4a87aaa1810b	50090-1850	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA090074	A-S Medication Solutions	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-1852_2dea45fb-1075-46cb-b785-492cbf9cb38f	50090-1852	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20141215		ANDA	ANDA077259	A-S Medication Solutions	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1856_894e1d7f-9c2b-4a8d-b32e-2745c7291e20	50090-1856	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	A-S Medication Solutions	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1857_96290b53-379a-4a32-a723-de8706079a61	50090-1857	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-1859_a9d19a7f-0ad9-4b43-aea8-de9ca5aace16	50090-1859	HUMAN OTC DRUG	triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20140520		OTC MONOGRAPH FINAL	part333B	A-S Medication Solutions	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-1860_209cfa40-41ef-418c-bd40-f9ca28ce555b	50090-1860	VACCINE	M-M-R II		measles, mumps, and rubella virus vaccine live	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	SUBCUTANEOUS	19710421		BLA	BLA101069	A-S Medication Solutions	MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN	1000; 12500; 1000	[TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Attenuated Measles Virus Vaccine [EPC], Live Attenuated Mumps Virus Vaccine [EPC], Live Attenuated Rubella Virus Vaccine [EPC], Measles Vaccine [CS], Mumps Vaccine [CS], Rubella Vaccine [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS], Vaccines, Attenuated [CS]		N	20241231
50090-1869_af1bf67e-b10c-4d6b-8fa3-ab80410b8c38	50090-1869	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-1876_185872b9-e46e-45d4-aded-2cec16a7328a	50090-1876	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	A-S Medication Solutions	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-1908_e02c1df7-ba15-4112-815b-eeae5ab9df2c	50090-1908	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-1909_e02c1df7-ba15-4112-815b-eeae5ab9df2c	50090-1909	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-1910_e02c1df7-ba15-4112-815b-eeae5ab9df2c	50090-1910	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-1912_502bf247-163c-4c4a-aba1-3ef18fc9d7b7	50090-1912	HUMAN PRESCRIPTION DRUG	PREDNISOLONE ACETATE		prednisolone acetate	SUSPENSION/ DROPS	OPHTHALMIC	19970819		NDA AUTHORIZED GENERIC	NDA017011	A-S Medication Solutions	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1913_41690140-f2f1-4e02-b8b4-a74033e6c4dc	50090-1913	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	A-S Medication Solutions	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-1914_2b4c5f61-608f-4726-82c7-e60a3177e85d	50090-1914	HUMAN PRESCRIPTION DRUG	Tobramycin and Dexamethasone		Tobramycin and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19991027		ANDA	ANDA064134	A-S Medication Solutions	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1920_d5bc1ab5-e4b8-42b8-a206-d0c03d0f7c8f	50090-1920	HUMAN PRESCRIPTION DRUG	Latanoprost		latanoprost	SOLUTION/ DROPS	OPHTHALMIC	20110322		ANDA	ANDA201006	A-S Medication Solutions	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
50090-1922_e3bfa231-faef-4dd0-9a21-da753853d20c	50090-1922	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	A-S Medication Solutions	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-1923_5c8706f5-f8f3-48a7-8b99-0fa722b7d178	50090-1923	HUMAN PRESCRIPTION DRUG	Proparacaine Hydrochloride		Proparacaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19950929		ANDA	ANDA040074	A-S Medication Solutions	PROPARACAINE HYDROCHLORIDE	5	mg/mL	Local Anesthesia [PE], Local Anesthetic [EPC]		N	20241231
50090-1930_a9ea8271-54f3-45f8-99d1-0f256ea57f1c	50090-1930	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	A-S Medication Solutions	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-1932_a1fdae88-a72e-482e-8eb6-8d957e9eead3	50090-1932	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20060531		ANDA	ANDA065049	A-S Medication Solutions	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
50090-1933_9e09323b-518e-43a1-ab98-3687adceb98c	50090-1933	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-1934_1d9a8521-ab67-4832-97db-6a8f1df63a86	50090-1934	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-1935_8f3e0da0-fcac-4e80-a371-b26772c01651	50090-1935	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-1936_26ea44f4-c8a0-4140-88c5-25584f012627	50090-1936	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150613		ANDA	ANDA090061	A-S Medication Solutions	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
50090-1944_d4835c16-1ffb-48ce-b3d1-02934d81e40f	50090-1944	VACCINE	PREVNAR 13		pneumococcal 13-valent conjugate vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20100312		BLA	BLA125324	A-S Medication Solutions	STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN	2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Inactivated Pneumococcal Vaccine [EPC], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Pneumococcal Vaccines [CS], Vaccines, Conjugate [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
50090-1958_c1d481ba-af9a-43d1-80ed-9db6109fe3ad	50090-1958	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	OINTMENT	OPHTHALMIC	20140508		ANDA	ANDA062447	A-S Medication Solutions	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
50090-1974_0914ee0e-d577-4fc8-9e6e-4fdeb1647c54	50090-1974	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1979_0914ee0e-d577-4fc8-9e6e-4fdeb1647c54	50090-1979	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-1985_af021b4e-9b8e-4665-be9f-ae315124d5a4	50090-1985	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	A-S Medication Solutions	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-1987_52853d96-d5dc-483e-b938-b9b96a8b43cf	50090-1987	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	A-S Medication Solutions	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-1994_ed6f88ef-9745-42e6-bcc0-48475f74949a	50090-1994	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161109		ANDA	ANDA204662	A-S Medication Solutions	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-2000_05b1ddf3-da58-4b4f-a4af-1bbeff67cd94	50090-2000	HUMAN OTC DRUG	Aller-chlor		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-2007_c2a79cdb-c1e1-4585-b8b0-e50763b310af	50090-2007	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	A-S Medication Solutions	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-2013_75433fc7-2b97-43de-b7e6-51c1116fe053	50090-2013	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	19821001		ANDA	ANDA085828	A-S Medication Solutions	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
50090-2017_6fdd10d2-4cb2-4631-bc45-744660ae5bb1	50090-2017	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	A-S Medication Solutions	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-2022_4c4bbb3f-ee8d-4a9d-83d3-400b5aa738b9	50090-2022	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	A-S Medication Solutions	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-2024_93663e29-cda9-40ad-9380-94f5cd0f1a3a	50090-2024	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	A-S Medication Solutions	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-2025_93663e29-cda9-40ad-9380-94f5cd0f1a3a	50090-2025	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	A-S Medication Solutions	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-2030_9aa83bd4-6703-4194-be6a-8956e30e5ad0	50090-2030	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	A-S Medication Solutions	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-2031_9aa83bd4-6703-4194-be6a-8956e30e5ad0	50090-2031	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	A-S Medication Solutions	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-2033_fe2f4580-2bd7-4443-beef-bfeb3fd4f02d	50090-2033	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	A-S Medication Solutions	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-2062_c4b2e759-0f3e-470e-aae5-048e92315ea2	50090-2062	VACCINE	TENIVAC		CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20101208		BLA	BLA103171	A-S Medication Solutions	CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	5; 2	[Lf]/.5mL; [Lf]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
50090-2066_2245daab-7505-416b-95d6-348def4290fb	50090-2066	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	A-S Medication Solutions	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
50090-2071_43075090-6322-4467-bfb2-acc0b0c9c786	50090-2071	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-2079_22e058a4-be20-4da2-90ee-c71c3732419f	50090-2079	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	A-S Medication Solutions	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-2080_43075090-6322-4467-bfb2-acc0b0c9c786	50090-2080	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-2081_7c442959-efc6-4ccd-9eb7-d4be75f7e915	50090-2081	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-2082_6bfb4a82-234b-430f-a3bd-f235bcbedb2f	50090-2082	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-2088_4c4bbb3f-ee8d-4a9d-83d3-400b5aa738b9	50090-2088	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	A-S Medication Solutions	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-2093_7a81ebf2-98d8-4f0f-8fcf-5040fc34ae22	50090-2093	HUMAN PRESCRIPTION DRUG	SULINDAC		sulindac	TABLET	ORAL	20090904		ANDA	ANDA072051	A-S Medication Solutions	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2097_17d299fd-e568-4f6f-989a-cbf0e47c3bf6	50090-2097	HUMAN PRESCRIPTION DRUG	Ashlyna		Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol	KIT		20150223		ANDA	ANDA203163	A-S Medication Solutions						N	20251231
50090-2101_8f7abb2d-978d-4f26-b2be-de49d329963a	50090-2101	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077135	A-S Medication Solutions	VALACYCLOVIR HYDROCHLORIDE	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-2107_32e6631b-c3d2-43c7-8a34-c8eecacf9812	50090-2107	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	A-S Medication Solutions	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-2119_2245daab-7505-416b-95d6-348def4290fb	50090-2119	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	A-S Medication Solutions	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
50090-2126_e39bafb7-205b-4ad7-9391-df7c04a88c12	50090-2126	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	GEL	VAGINAL	20150401		NDA AUTHORIZED GENERIC	NDA020208	A-S Medication Solutions	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-2127_9aee4577-c7ea-43b9-bcfc-94ac6c98608c	50090-2127	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19931129		ANDA	ANDA064052	A-S Medication Solutions	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
50090-2129_424d9747-74de-45f5-925c-16589d625fce	50090-2129	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	A-S Medication Solutions	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50090-2130_424d9747-74de-45f5-925c-16589d625fce	50090-2130	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	A-S Medication Solutions	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50090-2131_424d9747-74de-45f5-925c-16589d625fce	50090-2131	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	A-S Medication Solutions	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50090-2132_1edd4c61-9ac3-4689-b0de-c546be7fc4b1	50090-2132	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150201		ANDA	ANDA075126	A-S Medication Solutions	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2133_db7bc3b1-762a-4722-93af-4f313a7e2d35	50090-2133	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	A-S Medication Solutions	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2141_96509bd6-aebd-498d-9c35-721908ad9183	50090-2141	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	A-S Medication Solutions	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-2144_3b5ac054-cad8-4dd1-bd9e-cfb8c3a18053	50090-2144	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	A-S Medication Solutions	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
50090-2146_39dc1282-e407-4a13-bf0c-21af9463db10	50090-2146	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-2149_eb2e5dce-24e3-4590-839f-5a20582a40de	50090-2149	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-2153_a7d6436d-98f0-4b00-a7d0-039c1cfc86ac	50090-2153	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150304		ANDA	ANDA202824	A-S Medication Solutions	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-2158_1ffc79ea-7673-4879-83d7-6c5707f0e5bf	50090-2158	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	A-S Medication Solutions	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-2159_266c37a4-9e08-4c0c-be0d-6d4430a034e7	50090-2159	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	A-S Medication Solutions	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-2171_c3a24745-3395-4100-9e37-2fa995299b30	50090-2171	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-2175_2245daab-7505-416b-95d6-348def4290fb	50090-2175	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	A-S Medication Solutions	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
50090-2176_c01f2c13-05d9-4a94-93b9-4be63d66e330	50090-2176	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20130411		ANDA	ANDA202717	A-S Medication Solutions	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50090-2177_7c442959-efc6-4ccd-9eb7-d4be75f7e915	50090-2177	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-2180_4fb50561-0316-46fa-927e-4b33441de698	50090-2180	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-2182_303c229a-7c59-45ed-9423-bbd138f4f12c	50090-2182	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20020903		ANDA	ANDA070885	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2183_ce122a57-a82f-4545-9845-f1f21da5643a	50090-2183	HUMAN PRESCRIPTION DRUG	Cryselle		Norgestrel and Ethinyl Estradiol	KIT		20020724		ANDA	ANDA075840	A-S Medication Solutions						N	20241231
50090-2191_a5db2a67-56a5-4c67-a1fc-12ad662b4193	50090-2191	HUMAN PRESCRIPTION DRUG	Kelnor 1/35		Ethynodiol Diacetate and Ethinyl Estradiol	KIT		20050620		ANDA	ANDA076785	A-S Medication Solutions						N	20241231
50090-2193_cab55702-5aa0-48a9-9989-36255bffb0e4	50090-2193	HUMAN PRESCRIPTION DRUG	TOUJEO		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20150215		BLA	BLA206538	A-S Medication Solutions	INSULIN GLARGINE	300	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-2195_f4bccd57-716d-4073-b4be-c530adaa8152	50090-2195	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	A-S Medication Solutions	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-2198_39bbb167-f482-4d2d-91a9-ff48e5eea44c	50090-2198	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-2199_311f14ec-60c6-4c93-b0fc-87231f63d865	50090-2199	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-2200_7bd2f878-cad0-454c-9d81-6536a44adcc2	50090-2200	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-2201_0408c4c7-0953-464b-ae18-0afac7886087	50090-2201	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-2203_a230b350-0c45-4463-ba1c-f6564c2205b5	50090-2203	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	A-S Medication Solutions	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
50090-2207_eb2e5dce-24e3-4590-839f-5a20582a40de	50090-2207	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-2215_90efb04f-7743-424d-b72e-60f365359c84	50090-2215	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
50090-2219_d982869b-db90-43cd-a006-dd83bea95cf9	50090-2219	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-2224_c70868c0-a964-4e60-81a6-259a8da51e85	50090-2224	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	A-S Medication Solutions	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-2226_c00ed121-992c-4797-86f7-e5919f86967a	50090-2226	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-2228_db593b7b-054e-42ab-ad39-af63bc79b9a7	50090-2228	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	A-S Medication Solutions	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-2235_e51c430f-d262-4f4d-902f-14c2f5428be8	50090-2235	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	A-S Medication Solutions	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
50090-2239_eec30382-8d42-4d25-8e67-cae942268c30	50090-2239	HUMAN PRESCRIPTION DRUG	PULMICORT	FLEXHALER	Budesonide	AEROSOL, POWDER	RESPIRATORY (INHALATION)	20070319		NDA	NDA021949	A-S Medication Solutions	BUDESONIDE	180	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2244_f7d6fd17-e215-4ab5-af3d-68c4d450ac40	50090-2244	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	19940930		ANDA	ANDA040037	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2251_84350b63-7774-4468-8569-d017580c7d9d	50090-2251	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-2259_ace1fda8-3de9-4d8c-b822-bf01cfe08ad2	50090-2259	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20120406		ANDA	ANDA200538	A-S Medication Solutions						N	20241231
50090-2260_eb2e5dce-24e3-4590-839f-5a20582a40de	50090-2260	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-2272_31118343-ba79-4d4e-824f-cae7acd03695	50090-2272	HUMAN PRESCRIPTION DRUG	NOVOLOG MIX 70/30		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20020911		BLA	BLA021172	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-2273_31118343-ba79-4d4e-824f-cae7acd03695	50090-2273	HUMAN PRESCRIPTION DRUG	NOVOLOG MIX 70/30		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20011101		BLA	BLA021172	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-2301_dcf2635b-7b1b-4b9c-99dd-4dfee872636e	50090-2301	HUMAN OTC DRUG	Mucinex	Maximum Strength	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021282	A-S Medication Solutions	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
50090-2313_e3bfa231-faef-4dd0-9a21-da753853d20c	50090-2313	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	A-S Medication Solutions	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2322_386b9902-f04a-4d44-b5f8-3924ddb4a738	50090-2322	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	A-S Medication Solutions	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
50090-2326_35d39593-d126-41a7-aff7-dbc770e3b519	50090-2326	HUMAN PRESCRIPTION DRUG	Tri-Lo-Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20151230		ANDA	ANDA076784	A-S Medication Solutions						N	20241231
50090-2330_8b1be0db-50aa-4175-8f50-d1da06420b20	50090-2330	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		azelastine hydrochloride	SPRAY, METERED	NASAL	20100301		ANDA	ANDA077954	A-S Medication Solutions	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-2333_9e237e49-681f-4d01-8117-5144831ca99e	50090-2333	HUMAN PRESCRIPTION DRUG	GENTAMICIN SULFATE		gentamicin sulfate	SOLUTION/ DROPS	OPHTHALMIC	19980105		ANDA	ANDA062452	A-S Medication Solutions	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
50090-2338_e8b4d5ba-e056-4842-8a2c-c50116f7f0e2	50090-2338	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	A-S Medication Solutions	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-2339_ee78c869-e4a3-41bc-b182-397e4d69368a	50090-2339	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	A-S Medication Solutions	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-2343_8838975c-69a6-481a-9c2b-7139e3c79ced	50090-2343	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	A-S Medication Solutions	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-2371_75e28a8b-3814-4df0-9321-f79628448308	50090-2371	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	A-S Medication Solutions	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-2373_0c45335f-9414-4fd6-8ce6-836c25d6ccc9	50090-2373	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20081117		ANDA	ANDA071196	A-S Medication Solutions	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50090-2374_0c45335f-9414-4fd6-8ce6-836c25d6ccc9	50090-2374	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20081117		ANDA	ANDA071196	A-S Medication Solutions	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50090-2380_e23e23cc-0b6c-46ff-ac29-7d0e25443967	50090-2380	HUMAN OTC DRUG	MUCINEX		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120703		NDA	NDA021282	A-S Medication Solutions	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
50090-2396_7d89a2d9-fb46-4c69-814a-132ce3ceb8dd	50090-2396	HUMAN PRESCRIPTION DRUG	Mefloquine Hydrochloride		Mefloquine Hydrochloride	TABLET	ORAL	20040106		ANDA	ANDA076392	A-S Medication Solutions	MEFLOQUINE HYDROCHLORIDE	250	mg/1	Antimalarial [EPC]		N	20241231
50090-2398_1710b2c7-cef8-409d-85bb-ec640c6c1bd2	50090-2398	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19970214		ANDA	ANDA064120	A-S Medication Solutions	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-2408_5839cd0a-2686-4b5c-9cf3-7992978d5146	50090-2408	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-2419_8b396833-249f-43f4-8431-10eb80477109	50090-2419	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	19900930		ANDA	ANDA072488	A-S Medication Solutions	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2422_caf3eabb-89bd-469a-9d00-3fd3a18fb5db	50090-2422	HUMAN PRESCRIPTION DRUG	NARCAN		Naloxone Hydrochloride	SPRAY	NASAL	20170124		NDA	NDA208411	A-S Medication Solutions	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
50090-2430_e1520ecd-d599-4934-b5d6-18076df2ebb6	50090-2430	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091013		ANDA	ANDA090685	A-S Medication Solutions	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50090-2431_b5b27590-7bf8-49d8-b29d-d83ee63e5c27	50090-2431	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	A-S Medication Solutions	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-2433_db50ad56-333b-4cda-9ddb-8938baa12ca8	50090-2433	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA203311	A-S Medication Solutions	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-2435_db50ad56-333b-4cda-9ddb-8938baa12ca8	50090-2435	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA203311	A-S Medication Solutions	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-2445_ea4a4cc3-d11c-46d6-aa97-d65eef8406dd	50090-2445	HUMAN PRESCRIPTION DRUG	XIFAXAN		rifaximin	TABLET	ORAL	20040725		NDA	NDA021361	A-S Medication Solutions	RIFAXIMIN	200	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
50090-2449_9e71913b-8414-4275-85f7-74f04fd77336	50090-2449	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50090-2451_9e71913b-8414-4275-85f7-74f04fd77336	50090-2451	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50090-2452_011ee451-7668-4ce5-8e87-f9b82c9991b8	50090-2452	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160401		ANDA	ANDA080706	A-S Medication Solutions	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2453_765f4299-1de2-4ded-94a1-09977d0588cb	50090-2453	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	A-S Medication Solutions	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
50090-2455_0e5fd205-7eb6-4eae-a839-5d1873c36e0d	50090-2455	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	A-S Medication Solutions	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50090-2479_44d27e8f-4c47-4316-83d9-53cce5fe4f1e	50090-2479	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-2488_4886a92e-66c5-4c98-97c0-6deecebdec4e	50090-2488	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION	INTRAVENOUS	20000810		ANDA	ANDA088912	A-S Medication Solutions	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
50090-2491_0219309e-061a-49d3-b66d-29e4833f92a8	50090-2491	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	POWDER, FOR SUSPENSION	ORAL	19951019		NDA AUTHORIZED GENERIC	NDA050710	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-2492_34219b90-1bb2-4ef9-aa28-5f597a0ec16d	50090-2492	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	A-S Medication Solutions	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-2493_a9d1e4c2-17a7-45e4-bc2e-50eaf01ce305	50090-2493	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	A-S Medication Solutions	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50090-2494_303f40da-f422-4fd8-a27e-d79f792dfa3a	50090-2494	HUMAN PRESCRIPTION DRUG	drospirenone and ethinyl estradiol		drospirenone and ethinyl estradiol	KIT		20160325		ANDA	ANDA204848	A-S Medication Solutions						N	20251231
50090-2497_32d8434e-550e-4ba9-a709-eb10fe9a596f	50090-2497	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	INJECTION	SUBCUTANEOUS	20130916		ANDA	ANDA200183	A-S Medication Solutions	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
50090-2505_9d2a8723-9b52-4445-b3bc-82282791e1f4	50090-2505	HUMAN PRESCRIPTION DRUG	Levonest		levonorgestrel and ethinyl estradiol	KIT		20101229		ANDA	ANDA090719	A-S Medication Solutions						N	20241231
50090-2524_bf613d5d-bc95-4df6-9096-ac34f567ed9c	50090-2524	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	A-S Medication Solutions	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-2536_a1c0c926-2674-48d9-901d-cecac877c4aa	50090-2536	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-2539_3966c380-8524-4984-aac1-22fd35a650d1	50090-2539	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	A-S Medication Solutions	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-2548_8f8eca09-7c4f-4415-8ad5-ba834812fa2f	50090-2548	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2549_ecdc36b7-da4b-4d39-a9e0-6d8b24cc549b	50090-2549	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2553_8a144c28-5949-431a-8b23-a80f93d2a312	50090-2553	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-2556_34219b90-1bb2-4ef9-aa28-5f597a0ec16d	50090-2556	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	A-S Medication Solutions	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-2558_39aea0f8-fc6c-444d-9733-b2b8f2a1075a	50090-2558	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	A-S Medication Solutions	MIRTAZAPINE	30	mg/1			N	20241231
50090-2560_39461f80-61a1-40fa-948d-d69d2e3f7499	50090-2560	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	A-S Medication Solutions	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-2565_f8f47421-2135-4410-a6b2-bc141cb5c6d5	50090-2565	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-2581_bf613d5d-bc95-4df6-9096-ac34f567ed9c	50090-2581	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	A-S Medication Solutions	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-2584_6908cbb5-cb3c-4b36-8384-4a3557b3325c	50090-2584	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-2589_bb495483-17c8-4003-a4bc-afc174c597e0	50090-2589	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-2597_b8ced329-02b5-4476-8c8f-c6345940d18c	50090-2597	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2598_82d94d76-0f6f-43b3-9cd5-334af0089701	50090-2598	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20131121		ANDA	ANDA202925	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-2603_d6d5083b-19d9-45b5-9373-f7c2489faaf0	50090-2603	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20110617		ANDA	ANDA200494	A-S Medication Solutions						N	20241231
50090-2613_a4c40614-c561-45c1-8b65-eba2f899e86a	50090-2613	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	A-S Medication Solutions	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-2622_603581a7-a2f3-46f6-baa4-72c404e18e1f	50090-2622	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	A-S Medication Solutions	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-2623_75e28a8b-3814-4df0-9321-f79628448308	50090-2623	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	A-S Medication Solutions	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-2625_a25e35c8-3b67-4ed8-917c-39eb84da9805	50090-2625	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2626_94fd2d24-6cec-4e4f-93f0-d95b1cf427c8	50090-2626	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2627_e98cddca-492e-4316-b7cf-82ab7bfe0e6d	50090-2627	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20150202		ANDA	ANDA203034	A-S Medication Solutions	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
50090-2629_8f8eca09-7c4f-4415-8ad5-ba834812fa2f	50090-2629	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2632_d9f6c8a6-ea28-4d8b-83e3-2c50450afa0e	50090-2632	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-2645_a4c40614-c561-45c1-8b65-eba2f899e86a	50090-2645	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	A-S Medication Solutions	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-2648_5bb9f4e0-9621-44db-9940-3f1767ff66e4	50090-2648	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-2651_0e1604f6-ee09-4da9-8f51-b5944128f53c	50090-2651	HUMAN OTC DRUG	Guaiatussin AC		guaifenesin and codeine phosphate	LIQUID	ORAL	20100908		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
50090-2654_a4c40614-c561-45c1-8b65-eba2f899e86a	50090-2654	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	A-S Medication Solutions	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-2706_c3a24745-3395-4100-9e37-2fa995299b30	50090-2706	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-2719_ea6d412a-1b6c-4291-b13b-38ba666d8bb6	50090-2719	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	A-S Medication Solutions	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-2720_2bdcf8ea-4e05-4907-ba40-5cdcc5f63d91	50090-2720	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
50090-2724_f0830cfe-e2a4-4e4a-b982-ed454a3e5cc6	50090-2724	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-2725_f0830cfe-e2a4-4e4a-b982-ed454a3e5cc6	50090-2725	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	A-S Medication Solutions	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-2727_1f53083c-4100-418e-90ed-1b66334bca1c	50090-2727	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-2744_83ac2048-5983-4882-86a1-017bb3f1301b	50090-2744	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-2746_7863f9b2-8ebb-4be8-ab4f-ca64ee4ededa	50090-2746	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	SOLUTION	OPHTHALMIC	20091105		ANDA	ANDA076583	A-S Medication Solutions	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2747_31d4f090-6a3b-400b-9fe0-cc55a9fa93d5	50090-2747	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20060517		ANDA	ANDA040500	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-2749_f2afff2a-054f-4884-b4a8-5987ca0ff555	50090-2749	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20151019		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-2763_31080483-96fd-4c38-9600-86107728e85c	50090-2763	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20060921		ANDA	ANDA062225	A-S Medication Solutions	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
50090-2769_9ab1602f-aa57-417f-9f97-b011571302e3	50090-2769	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	A-S Medication Solutions	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-2786_e2c69319-5495-44fa-9543-ad59c29a7ea0	50090-2786	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085161	A-S Medication Solutions	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2800_39aea0f8-fc6c-444d-9733-b2b8f2a1075a	50090-2800	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	A-S Medication Solutions	MIRTAZAPINE	15	mg/1			N	20241231
50090-2803_75b69f30-d553-4559-8466-33637f54d254	50090-2803	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	A-S Medication Solutions	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2818_5bb9f4e0-9621-44db-9940-3f1767ff66e4	50090-2818	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-2819_2b67f04a-e831-43d9-aa73-2aa05178bd6d	50090-2819	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19980325		ANDA	ANDA074909	A-S Medication Solutions	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-2830_e8b4d5ba-e056-4842-8a2c-c50116f7f0e2	50090-2830	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	A-S Medication Solutions	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-2839_e62a3aa0-5461-415f-8695-35ed4244fb8c	50090-2839	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	A-S Medication Solutions	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-2840_8a144c28-5949-431a-8b23-a80f93d2a312	50090-2840	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-2853_09a7fb42-d3e0-45bd-8ec5-2424d9091ebd	50090-2853	HUMAN PRESCRIPTION DRUG	Victoza		liraglutide	INJECTION	SUBCUTANEOUS	20100125		NDA	NDA022341	A-S Medication Solutions	LIRAGLUTIDE	6	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-2854_80810afb-73ae-43f7-ba30-694293ba052f	50090-2854	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20060921		ANDA	ANDA062225	A-S Medication Solutions	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
50090-2880_bf68dbd8-5e03-4285-a539-ea9e97305531	50090-2880	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20060222		ANDA	ANDA076504	A-S Medication Solutions	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2885_3e8dbfbc-1931-4f74-bda7-66473002f639	50090-2885	HUMAN OTC DRUG	Dextromethorphan HBr, Guaifenesin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19940920		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-2896_2b67f04a-e831-43d9-aa73-2aa05178bd6d	50090-2896	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	A-S Medication Solutions	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-2899_15459945-8db4-4455-86ca-59d6b75bcd83	50090-2899	HUMAN PRESCRIPTION DRUG	Tricor		Fenofibrate	TABLET	ORAL	20160205		NDA	NDA021656	A-S Medication Solutions	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-2900_09bdc878-bfae-420b-9eae-18dd0160999f	50090-2900	HUMAN OTC DRUG	Ketotifen Fumarate		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20071001		ANDA	ANDA077958	A-S Medication Solutions	KETOTIFEN FUMARATE	.35	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
50090-2910_e98cddca-492e-4316-b7cf-82ab7bfe0e6d	50090-2910	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20150202		ANDA	ANDA203034	A-S Medication Solutions	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
50090-2918_8fb333d4-21ac-4598-9e18-2a46d718569c	50090-2918	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	TABLET	ORAL	19970706		ANDA	ANDA074871	A-S Medication Solutions	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
50090-2921_8f81d6e4-25f7-480e-b38f-3956927c46fd	50090-2921	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20150527		ANDA	ANDA204093	A-S Medication Solutions	MONTELUKAST	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50090-2925_024ad216-7433-4c9d-938b-1a8a63316f26	50090-2925	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim	SOLUTION	OPHTHALMIC	19980416		ANDA	ANDA064211	A-S Medication Solutions	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-2936_a4c40614-c561-45c1-8b65-eba2f899e86a	50090-2936	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	A-S Medication Solutions	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-2940_e6e1747e-9db5-43c4-a704-b1243de9eb2d	50090-2940	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20071212		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50090-2968_ee580d3f-a570-4529-b4e5-ca9914795f09	50090-2968	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20151228		ANDA	ANDA075882	A-S Medication Solutions	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
50090-2974_f8f47421-2135-4410-a6b2-bc141cb5c6d5	50090-2974	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-2977_8f99a421-7303-41b5-bde9-f9beb408fcf8	50090-2977	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril	TABLET	ORAL	20160616		ANDA	ANDA077222	A-S Medication Solutions	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-2980_db61f577-1818-4643-8712-23db5c162ae6	50090-2980	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil HCl		atovaquone and proguanil hydrochloride	TABLET, FILM COATED	ORAL	20120727		NDA AUTHORIZED GENERIC	NDA021078	A-S Medication Solutions	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
50090-2987_789a37ae-7f9f-4d48-a15d-2c67be33b80b	50090-2987	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	A-S Medication Solutions	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-2989_db593b7b-054e-42ab-ad39-af63bc79b9a7	50090-2989	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	A-S Medication Solutions	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-2991_82e9d94e-9962-40a4-9483-c01296c99b42	50090-2991	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20060823		ANDA	ANDA077447	A-S Medication Solutions	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-2996_8f8eca09-7c4f-4415-8ad5-ba834812fa2f	50090-2996	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3002_e6cfba3f-de99-4188-b44f-2536550385ab	50090-3002	HUMAN PRESCRIPTION DRUG	Delzicol		mesalamine	CAPSULE, DELAYED RELEASE	ORAL	20160516		NDA	NDA204412	A-S Medication Solutions	MESALAMINE	400	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
50090-3036_8b4c85f7-6376-4dfc-81a0-03c69e281b9c	50090-3036	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3039_ec896841-e46f-45ff-b7ed-62be9313ec7e	50090-3039	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140808		NDA	NDA205029	A-S Medication Solutions	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50090-3041_02e26ecf-88fe-427d-aa14-1b502fcf83fd	50090-3041	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3042_60e1fb73-b90c-4330-9e8c-50fe459789d6	50090-3042	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION/ DROPS	OPHTHALMIC	19980429		ANDA	ANDA074706	A-S Medication Solutions	CROMOLYN SODIUM	40	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
50090-3044_ab982e34-ea14-4d76-a38a-9a4b069292d1	50090-3044	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20160714		ANDA	ANDA204598	A-S Medication Solutions	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-3047_e0e8fce3-e180-41f3-a018-db449d713038	50090-3047	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20050113		ANDA	ANDA065089	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-3050_8903d199-5cc0-4a10-bb0f-6997b9c5fbeb	50090-3050	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-3055_035b5a82-4fae-4796-b7c0-375f553cb08d	50090-3055	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3059_d6963443-bb9b-4d69-ae7f-f1983d974659	50090-3059	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	A-S Medication Solutions	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-3064_db3edf57-ff6a-4b49-b5bc-da9616ffcc86	50090-3064	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-3094_b565ea03-40c3-4f17-a552-e43b33a04d3f	50090-3094	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	A-S Medication Solutions	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3104_3852b7d5-678e-4759-b1df-55709b156ddd	50090-3104	HUMAN PRESCRIPTION DRUG	Atropine		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20140718		NDA	NDA206289	A-S Medication Solutions	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-3108_1ae49448-622c-4c5f-a7b8-8bcf1e607256	50090-3108	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	A-S Medication Solutions	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-3110_96509bd6-aebd-498d-9c35-721908ad9183	50090-3110	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20151019		ANDA	ANDA040616	A-S Medication Solutions	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-3119_51fb4c07-4b18-4c51-a18a-9d130eb93778	50090-3119	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20150804		ANDA	ANDA204418	A-S Medication Solutions	FOLIC ACID	1	mg/1			N	20241231
50090-3126_501bc643-8f6d-4568-9bbb-301310be5533	50090-3126	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	A-S Medication Solutions	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
50090-3136_dda3a2fc-dfc4-44ff-976a-3c6f56d67155	50090-3136	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-3137_644d65e9-39ac-4920-8d50-bb71fa506120	50090-3137	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	A-S Medication Solutions	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3143_0c402f22-6f9a-414c-89af-c95849686b2a	50090-3143	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20141205		ANDA	ANDA075536	A-S Medication Solutions	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-3147_8b425df7-6944-4d82-9a81-9e362d4717ac	50090-3147	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA076938	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-3148_628d179c-a31b-4886-9f57-cb2c3fb32efd	50090-3148	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20160407		ANDA	ANDA040903	A-S Medication Solutions	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-3149_bea260ba-b995-494d-85f3-908de8c996e4	50090-3149	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin	CREAM	TOPICAL	20060811		ANDA	ANDA076369	A-S Medication Solutions	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
50090-3165_1bdd8a12-a3a3-48a1-b9d3-e65f0870c2af	50090-3165	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20150610		ANDA	ANDA204309	A-S Medication Solutions	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3172_74028f83-5661-4e3d-bdc7-d4b93b0c1deb	50090-3172	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20150714		ANDA	ANDA202112	A-S Medication Solutions	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-3175_f0d97714-8a8c-488e-9a27-4ffbcaf1f5c7	50090-3175	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170417		ANDA	ANDA077321	A-S Medication Solutions	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-3178_f74fee7b-ae98-4fbb-84fb-23cd573e3936	50090-3178	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	A-S Medication Solutions	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-3179_1d2e6c27-daa1-4c0a-bee5-5304960ea55a	50090-3179	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20160823		ANDA	ANDA203824	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-3180_734ac489-9314-4d58-9f5a-07ef2bcbb75e	50090-3180	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-3185_f74fee7b-ae98-4fbb-84fb-23cd573e3936	50090-3185	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	A-S Medication Solutions	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-3189_74028f83-5661-4e3d-bdc7-d4b93b0c1deb	50090-3189	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20150714		ANDA	ANDA202112	A-S Medication Solutions	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-3190_d2e44337-0c58-4876-ac90-ce557504a714	50090-3190	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20170517		ANDA	ANDA206904	A-S Medication Solutions	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-3199_0e469bdd-2787-4583-af53-18ddfff7a079	50090-3199	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-3200_32e6631b-c3d2-43c7-8a34-c8eecacf9812	50090-3200	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	A-S Medication Solutions	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3202_0e469bdd-2787-4583-af53-18ddfff7a079	50090-3202	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-3203_f61fd075-cfd8-468b-814a-2dd2dbb7d02d	50090-3203	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-3205_1d86eeb6-c882-4587-9f88-613b69b41ac1	50090-3205	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-3208_bb7b12c6-0ad6-4184-87e9-3f4d8b09f5b0	50090-3208	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-3214_c9ea95e8-0e2e-4277-a241-9ee961b9021b	50090-3214	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	A-S Medication Solutions	LEVOFLOXACIN	750	mg/1			N	20241231
50090-3228_3afd9a04-7a55-47ae-a26f-b852f7aeba2c	50090-3228	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040627	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-3229_1dd7980a-34ab-4260-a04c-75dcbfe59cb9	50090-3229	HUMAN PRESCRIPTION DRUG	Nortrel	28 Day	Norethindrone and Ethinyl Estradiol	KIT		20010606		ANDA	ANDA072695	A-S Medication Solutions						N	20241231
50090-3237_294c23aa-b4fc-4f3f-a7a7-930268788cb1	50090-3237	HUMAN PRESCRIPTION DRUG	Junel	Fe 28 Day	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20030918		ANDA	ANDA076081	A-S Medication Solutions						N	20241231
50090-3239_12ba3680-6bb1-430b-a940-7c6d123bfe0c	50090-3239	HUMAN PRESCRIPTION DRUG	Tri Femynor		norgestimate and ethinyl estradiol	KIT		20161028		ANDA	ANDA203870	A-S Medication Solutions						N	20241231
50090-3243_dc982346-3ae3-4393-9376-2d6be991aa92	50090-3243	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	A-S Medication Solutions	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-3250_0c61c8ca-1f35-4ffa-b0a1-888b08f47f5f	50090-3250	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20140910		ANDA	ANDA204314	A-S Medication Solutions	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-3252_695a1fc0-cecd-469d-a890-eba36974454d	50090-3252	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50090-3258_5a7c5bc2-f9f6-4852-8d67-a17c08a074e4	50090-3258	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	A-S Medication Solutions	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-3266_7b387019-eccb-49b0-aa12-fbbc32044421	50090-3266	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160829		ANDA	ANDA208191	A-S Medication Solutions	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50090-3271_79d874d9-4637-4a44-80fd-f650d2d6e446	50090-3271	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	113; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20251231
50090-3272_79d874d9-4637-4a44-80fd-f650d2d6e446	50090-3272	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	55; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20251231
50090-3274_74cb9c89-7aa7-46cf-a1c0-7f89a9e049f7	50090-3274	HUMAN PRESCRIPTION DRUG	Bacitracin Zinc and Polymyxin B Sulfate		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	OPHTHALMIC	20080425		ANDA	ANDA064046	A-S Medication Solutions	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-3275_319adcd0-954c-4227-8873-4922a8d0f74c	50090-3275	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123	20251130	ANDA	ANDA075657	A-S Medication Solutions	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	
50090-3277_741e6b32-cab6-49b0-8290-cfe8e72a31eb	50090-3277	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20161027		ANDA	ANDA071500	A-S Medication Solutions	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3280_0e5fd205-7eb6-4eae-a839-5d1873c36e0d	50090-3280	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	A-S Medication Solutions	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50090-3288_963fdd93-04a5-4f04-ae86-c96b5c4b9880	50090-3288	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	SHAMPOO, SUSPENSION	TOPICAL	20050411		ANDA	ANDA076942	A-S Medication Solutions	KETOCONAZOLE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-3291_695a1fc0-cecd-469d-a890-eba36974454d	50090-3291	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50090-3294_96b4d9b3-4cad-47cf-8283-ed5b4831e4dc	50090-3294	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170228		ANDA	ANDA208871	A-S Medication Solutions	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
50090-3300_cc7b9e2c-5fb9-4c57-a7c8-ea40ab873ce7	50090-3300	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151201		ANDA	ANDA206781	A-S Medication Solutions	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3307_43a8ced1-f39c-472b-ae6e-2dce4c9f9400	50090-3307	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	A-S Medication Solutions	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-3311_c9ea95e8-0e2e-4277-a241-9ee961b9021b	50090-3311	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	A-S Medication Solutions	LEVOFLOXACIN	500	mg/1			N	20241231
50090-3313_86d8be07-a281-47d7-bd0b-800077680c0e	50090-3313	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	A-S Medication Solutions	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-3314_8a7e2d18-2ad0-47d3-8da4-cf1272ebdc8b	50090-3314	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	A-S Medication Solutions	LEVOFLOXACIN	500	mg/1			N	20241231
50090-3316_49ad4cc4-ab83-4966-b18b-20b43b9120e8	50090-3316	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20160902		ANDA	ANDA206116	A-S Medication Solutions	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3326_bca5ff42-1262-4604-9013-eb2d5fabbce7	50090-3326	HUMAN PRESCRIPTION DRUG	Bystolic		nebivolol hydrochloride	TABLET	ORAL	20080122		NDA	NDA021742	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-3327_29c61536-aa42-4c6c-9a40-62b9a73f4195	50090-3327	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	CREAM	VAGINAL	20180102		ANDA	ANDA086069	A-S Medication Solutions	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-3328_a8b541ee-bc08-4525-978e-9e4d775cf04e	50090-3328	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	19921029		NDA AUTHORIZED GENERIC	NDA020246	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-3330_fafe7a3a-dc6d-4201-9fb7-fcdcb2f48a92	50090-3330	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	A-S Medication Solutions	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3333_0babcebb-b621-4183-84a3-50efcbf48542	50090-3333	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	A-S Medication Solutions	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-3335_644d65e9-39ac-4920-8d50-bb71fa506120	50090-3335	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	A-S Medication Solutions	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3336_1d9d01b9-7007-45ff-94e3-068c0c56891f	50090-3336	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	A-S Medication Solutions	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3338_d6ae2011-4fa6-4fbf-8b50-ae2f2e1e0742	50090-3338	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	A-S Medication Solutions	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-3339_d6ae2011-4fa6-4fbf-8b50-ae2f2e1e0742	50090-3339	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	A-S Medication Solutions	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-3340_3b8a02a3-c046-48b2-bd47-870398e33088	50090-3340	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	A-S Medication Solutions	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-3341_94522512-01d1-4a57-8a5a-92416efaeccc	50090-3341	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	A-S Medication Solutions	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50090-3342_0babcebb-b621-4183-84a3-50efcbf48542	50090-3342	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	A-S Medication Solutions	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-3343_90fa90cf-19f1-412f-b950-c360dae8c3e9	50090-3343	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20120625		ANDA	ANDA203269	A-S Medication Solutions	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
50090-3344_3b8a02a3-c046-48b2-bd47-870398e33088	50090-3344	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	A-S Medication Solutions	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-3352_67f582f1-d8dd-4b0b-a3e2-cb12a1cef155	50090-3352	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20111031		ANDA	ANDA200629	A-S Medication Solutions	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3354_fafe7a3a-dc6d-4201-9fb7-fcdcb2f48a92	50090-3354	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3357_6fe5e250-1c45-40e2-860e-a8a265e4b378	50090-3357	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-3358_3802e6c5-c6f6-4ed5-80c9-97e5b0a38a5d	50090-3358	HUMAN OTC DRUG	sunmark	antifungal	Tolnaftate	CREAM	TOPICAL	20060217		OTC MONOGRAPH DRUG	M005	A-S Medication Solutions	TOLNAFTATE	10	mg/g			N	20241231
50090-3359_4a6b0e09-3f06-4d54-8ea6-ce8e130f37d8	50090-3359	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	A-S Medication Solutions	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-3361_1d9d01b9-7007-45ff-94e3-068c0c56891f	50090-3361	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3367_033fe1d0-2816-463f-9bcb-82028b13ecd2	50090-3367	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	A-S Medication Solutions	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
50090-3372_6f4fbb1a-709b-4f96-86de-4ff86fbb30c2	50090-3372	VACCINE	Shingrix		Zoster Vaccine Recombinant, Adjuvanted	KIT		20171020		BLA	BLA125614	A-S Medication Solutions						N	20251231
50090-3378_fc9fb737-93aa-4d2e-a840-ec662f356429	50090-3378	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	A-S Medication Solutions	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-3387_79d874d9-4637-4a44-80fd-f650d2d6e446	50090-3387	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	232; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20251231
50090-3389_73d9c4af-0979-4663-878f-6ef708230760	50090-3389	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	A-S Medication Solutions	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3396_9874e3fa-d6d6-4816-bae1-439d2305d447	50090-3396	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20080314		ANDA	ANDA078296	A-S Medication Solutions	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-3403_908adc3a-3c4d-4905-906a-386b2eb708aa	50090-3403	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20171101		ANDA	ANDA078232	A-S Medication Solutions	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-3408_4244c61f-25e5-407f-a00f-a4025a63cfa1	50090-3408	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	19990207		ANDA	ANDA074937	A-S Medication Solutions	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3411_e72bd74a-f05c-4bd5-b387-270f5ab7babf	50090-3411	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20041116		ANDA	ANDA074056	A-S Medication Solutions	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-3418_5cf90d9a-8b6f-4017-bfe1-9efab1fe7285	50090-3418	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate Sodium	TABLET	ORAL	20171110		ANDA	ANDA201749	A-S Medication Solutions	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
50090-3419_e7726b43-b70e-4338-a61b-0a7bc6204c7d	50090-3419	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	19930901		ANDA	ANDA074260	A-S Medication Solutions	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50090-3427_6c865d88-2648-407e-a586-c8ff53bffa36	50090-3427	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-3456_62ee8c9f-0989-4809-a88d-da61223075b0	50090-3456	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170707		ANDA	ANDA086727	A-S Medication Solutions	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
50090-3461_73d9c4af-0979-4663-878f-6ef708230760	50090-3461	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	A-S Medication Solutions	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3465_62c6b2ef-2f78-46ea-9d67-e4f5366ce0fa	50090-3465	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	CAPSULE	ORAL	20141001		NDA	NDA204820	A-S Medication Solutions	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20241231
50090-3471_51e76f8d-24bc-4ae8-abc7-9f3af7889146	50090-3471	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170427		ANDA	ANDA207662	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-3472_8fcb44ee-057f-4d16-b31e-3fc29a51a4c2	50090-3472	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-3474_d0f6fe09-3801-43d3-9883-5b9d453f4dbe	50090-3474	HUMAN PRESCRIPTION DRUG	Letrozole		letrozole	TABLET, FILM COATED	ORAL	20110602		ANDA	ANDA090934	A-S Medication Solutions	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
50090-3475_8ae3bcab-a60f-4ecb-a1ca-f02f2e095512	50090-3475	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20170320		ANDA	ANDA079141	A-S Medication Solutions	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-3481_de360b4e-6a91-4439-9f4d-475de2d8f08b	50090-3481	HUMAN PRESCRIPTION DRUG	FARXIGA		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20080114		NDA	NDA202293	A-S Medication Solutions	DAPAGLIFLOZIN PROPANEDIOL	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-3482_de360b4e-6a91-4439-9f4d-475de2d8f08b	50090-3482	HUMAN PRESCRIPTION DRUG	FARXIGA		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20080114		NDA	NDA202293	A-S Medication Solutions	DAPAGLIFLOZIN PROPANEDIOL	5	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-3483_5e0d492a-0ed5-4901-9721-2024bd697996	50090-3483	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918		BLA	BLA125469	A-S Medication Solutions	DULAGLUTIDE	1.5	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-3484_5e0d492a-0ed5-4901-9721-2024bd697996	50090-3484	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918		BLA	BLA125469	A-S Medication Solutions	DULAGLUTIDE	.75	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-3485_aa4db151-b18e-4d94-8437-ed605618a668	50090-3485	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-3487_7dd35ea2-5d7c-4ada-bae7-24eb9f4e444a	50090-3487	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170427		ANDA	ANDA207662	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-3489_b94a5f1f-f634-43a3-bde5-228592424d9f	50090-3489	HUMAN PRESCRIPTION DRUG	Olopatadine		Olopatadine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20171205		ANDA	ANDA204723	A-S Medication Solutions	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
50090-3491_ee96b54f-5204-4b1b-8e9c-593f56045b66	50090-3491	HUMAN PRESCRIPTION DRUG	Tresiba		insulin degludec	INJECTION, SOLUTION	SUBCUTANEOUS	20150925		BLA	BLA203314	A-S Medication Solutions	INSULIN DEGLUDEC	200	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-3493_ca89a4b3-38cb-4686-af4d-3d6255a05868	50090-3493	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		SILDENAFIL	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA091448	A-S Medication Solutions	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-3514_b9938900-5c41-413d-a608-91f9e8fbc253	50090-3514	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	A-S Medication Solutions	ESZOPICLONE	3	mg/1		CIV	N	20241231
50090-3519_fb8fdada-fd37-41b7-85d4-b5ba5943ab18	50090-3519	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20150303		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
50090-3520_1c401983-2f63-435a-b20a-355bc458294f	50090-3520	HUMAN PRESCRIPTION DRUG	PHENAZOPYRIDINE HYDROCHLORIDE		Phenazopyridine Hydrochloride	TABLET	ORAL	20150305		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
50090-3527_7c7617c5-0136-4470-ae12-92e0a578c883	50090-3527	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-3529_0f73de1e-8ff2-4d97-a4ad-1c2ab3eee437	50090-3529	HUMAN PRESCRIPTION DRUG	Sensipar		cinacalcet hydrochloride	TABLET, COATED	ORAL	20040404		NDA	NDA021688	A-S Medication Solutions	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
50090-3537_88e8acb5-251c-442e-bd88-ea7cd0416c6e	50090-3537	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20111101		ANDA	ANDA200292	A-S Medication Solutions	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
50090-3539_2ae866bf-5318-4746-b4b7-39d643421ada	50090-3539	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20060905		ANDA	ANDA040684	A-S Medication Solutions	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3541_650a3801-b9fc-4a09-8f40-bc9f4b0ed20e	50090-3541	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19820907		ANDA	ANDA087702	A-S Medication Solutions	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3550_1ce42d67-b197-4102-bb6a-3642f321a1bd	50090-3550	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20131121		NDA AUTHORIZED GENERIC	NDA021528	A-S Medication Solutions	KETOROLAC TROMETHAMINE	4	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3560_b73504e3-ce90-4950-b967-577af188c835	50090-3560	HUMAN OTC DRUG	Rugby Nicotine Polacrilex Gum, Mint Flavor		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20040729		ANDA	ANDA076569	A-S Medication Solutions	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
50090-3561_22806441-7f80-4cf3-ae8d-a567726f65eb	50090-3561	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205391	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-3564_f4f09800-e299-40ce-8637-9180a886de99	50090-3564	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-3568_3f758075-7120-495a-9e3b-6370828dc758	50090-3568	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	OPHTHALMIC	20080214		ANDA	ANDA078031	A-S Medication Solutions	DICLOFENAC SODIUM	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3574_7bf13f6f-3ff8-4099-b5e1-e3670a0224dc	50090-3574	HUMAN PRESCRIPTION DRUG	Cimetidine		cimetidine	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074246	A-S Medication Solutions	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-3575_5d6b250e-38e6-4b77-aecf-a2b2f4481970	50090-3575	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	A-S Medication Solutions	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
50090-3576_12a650a1-6e5b-46ea-949d-5f065981b9d9	50090-3576	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-3579_06a7b34e-1ed9-4089-9367-5b21a80fe26a	50090-3579	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-3580_2a6fcf96-70a4-49a2-bb9e-7b0d4916c4f6	50090-3580	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	A-S Medication Solutions	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-3583_7606c767-4ce5-4ea2-b51c-d9c483e916fa	50090-3583	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-3625_b2423f2e-1f2c-4230-b986-27af11215b63	50090-3625	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20110701		NDA	NDA022406	A-S Medication Solutions	RIVAROXABAN	10	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50090-3645_12285983-0127-4a9f-9fcd-ee4b97115f09	50090-3645	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	CREAM	VAGINAL	20180305		ANDA	ANDA209767	A-S Medication Solutions	ESTRADIOL HEMIHYDRATE	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-3646_0e5535f7-b97c-4e7a-96c5-58105c1c4519	50090-3646	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170811		ANDA	ANDA207405	A-S Medication Solutions	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-3650_9c714cf9-521c-4449-bde6-5b53c0f6d228	50090-3650	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	A-S Medication Solutions	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-3655_14633294-48cb-4eda-a575-b802c3288f2f	50090-3655	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, COATED	ORAL	20170424		ANDA	ANDA206763	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-3656_183c07c0-6f7c-4a81-982a-461dd8f29384	50090-3656	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, COATED	ORAL	20170424		ANDA	ANDA206763	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-3657_ec0339aa-f360-45c5-82f8-3f60df9c2cf7	50090-3657	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20171223		ANDA	ANDA209234	A-S Medication Solutions	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
50090-3670_ec03cd72-1671-4b35-8100-8000cc5d4531	50090-3670	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	A-S Medication Solutions	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-3701_c3147fdf-8496-4034-828b-c3e5a7e90534	50090-3701	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205391	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-3723_98df0f63-08f3-4f01-9616-cfdba185eef7	50090-3723	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070507		ANDA	ANDA065259	A-S Medication Solutions	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-3737_55a5cef6-4d4a-4566-a1b9-3fdd0a2170bd	50090-3737	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-3747_81a3f77c-3d85-408a-a642-afc7cee5c1a8	50090-3747	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	A-S Medication Solutions	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-3763_9a652dd9-bb1e-4107-8eb2-247655c4d1f5	50090-3763	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	A-S Medication Solutions	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-3765_c35a8d19-f378-4226-ad70-cecc4417eab7	50090-3765	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	A-S Medication Solutions	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-3772_2407cb7e-5263-4035-86ae-555137ede1e2	50090-3772	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20150401		ANDA	ANDA061966	A-S Medication Solutions	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
50090-3774_265fa546-2ba7-4fa5-b0b8-a0b0afa06cfc	50090-3774	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	A-S Medication Solutions	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-3775_2aeb2028-e7d6-42bc-b353-4e74d2cf2c3b	50090-3775	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	A-S Medication Solutions	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-3787_09dcac95-f9c6-400c-868a-13af47956764	50090-3787	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20090102		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-3791_9261107c-c555-451d-a69b-27eab70d7a65	50090-3791	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-3794_079f24a1-863c-4dfa-8437-d2b4345af1f5	50090-3794	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	19830324		NDA	NDA018642	A-S Medication Solutions	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3802_99f67921-e073-4d90-b635-c4912914e9f2	50090-3802	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20150910		ANDA	ANDA089795	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-3808_5a1c04b5-d2cd-4689-b6c2-1e14315c157c	50090-3808	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-3809_e226e0f6-37f7-4967-b524-e69835eeee6c	50090-3809	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	A-S Medication Solutions	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50090-3838_5276461b-448c-41b2-8b66-04ba24bc12da	50090-3838	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203702	A-S Medication Solutions	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-3847_1b211fc6-59b2-4f55-a3e8-8a65afad4067	50090-3847	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-3852_ee3193b9-9650-4cd6-bb66-b1e43c8461ed	50090-3852	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-3853_a92ddab8-48fa-41c4-9f58-f0c0e03c2472	50090-3853	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	A-S Medication Solutions	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-3854_c03bad4d-94da-464f-9b25-0c5bea2294be	50090-3854	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA202304	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50090-3856_4430ac5d-9d27-4a4e-a635-e2ee8a1d5e8e	50090-3856	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-3867_8543326a-9aee-4c5e-a64c-9eedee222e55	50090-3867	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20090102		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-3871_0328016f-e9e9-405b-8950-4ddbd55e826e	50090-3871	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-3876_bfe48364-bb47-4e5d-bab2-fff9aa693eac	50090-3876	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	A-S Medication Solutions	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-3878_3e53970f-c97a-4d92-870b-feb3be6365f3	50090-3878	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	A-S Medication Solutions	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
50090-3879_93494b74-7a4e-4f02-be79-fbf57b21fb56	50090-3879	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	A-S Medication Solutions	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
50090-3881_74e75de5-3ce4-4a56-aa58-6eb4a12561b4	50090-3881	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	A-S Medication Solutions	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-3887_7466641c-6c35-483d-a0ad-d8fc03a2b303	50090-3887	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, COATED	ORAL	20160505		ANDA	ANDA205118	A-S Medication Solutions	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
50090-3888_5f992a67-0f93-4457-8bcf-2b045c20a31d	50090-3888	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	A-S Medication Solutions	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-3889_1d2d424f-dd0c-416b-9078-0a574a3d4dab	50090-3889	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	A-S Medication Solutions	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3906_e446b60f-6ce4-43a3-8ea0-fb7fe0fc5abb	50090-3906	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20181231		ANDA	ANDA209274	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-3907_73b9dc8b-7f1d-48a5-835b-c759284c15d9	50090-3907	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20090826		ANDA	ANDA065442	A-S Medication Solutions	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-3914_f55cfddc-6387-470a-b5ef-788496656fdf	50090-3914	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	A-S Medication Solutions	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50090-3915_fb05558b-f51c-4ac5-95b3-133bf9eb2360	50090-3915	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	A-S Medication Solutions	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3926_fa9ddc42-d1f2-449f-8d6e-cc123705c330	50090-3926	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	A-S Medication Solutions	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-3927_6ef48ae1-a82d-4628-a451-e27bffde5a15	50090-3927	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	A-S Medication Solutions	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-3941_167adab9-ab48-4ff5-9cde-cda6a463f07f	50090-3941	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	A-S Medication Solutions	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-3946_a30f8036-6f66-4ddd-9dfe-8b754d979099	50090-3946	HUMAN PRESCRIPTION DRUG	Flurbiprofen Sodium		Flurbiprofen Sodium	SOLUTION/ DROPS	OPHTHALMIC	20180331		ANDA	ANDA074447	A-S Medication Solutions	FLURBIPROFEN SODIUM	.3	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3963_27a7c2de-e720-4698-b5c1-979a9a9dcb03	50090-3963	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	A-S Medication Solutions	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3974_a9574834-3e3e-446d-a32d-3fb19d874a75	50090-3974	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	A-S Medication Solutions	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-3975_435e054f-b898-4718-90d6-cfa9f98077f9	50090-3975	HUMAN PRESCRIPTION DRUG	Desloratadine		Desloratadine	TABLET	ORAL	20150612		ANDA	ANDA078355	A-S Medication Solutions	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-3983_241d351f-51a3-4247-9e31-0b64c7c135f2	50090-3983	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	A-S Medication Solutions	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-3988_09647efc-0142-477e-a79b-dbbbb943dbb2	50090-3988	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	CAPSULE, EXTENDED RELEASE	ORAL	20180701		NDA	NDA018074	A-S Medication Solutions	PHENDIMETRAZINE TARTRATE	105	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
50090-4009_a9aa4235-620a-4834-b781-53d3e3e176d5	50090-4009	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20100607		ANDA	ANDA075522	A-S Medication Solutions	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50090-4013_a2bf5a20-39fd-48c0-80fc-97b63b0ed658	50090-4013	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20180720		ANDA	ANDA071881	A-S Medication Solutions	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-4020_3d852536-e024-4155-837c-4609c4e6f68e	50090-4020	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20180816		ANDA	ANDA209903	A-S Medication Solutions	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4049_1b5f8619-c60e-4e63-857b-3cb582b64276	50090-4049	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081126		ANDA	ANDA077715	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-4053_993edef1-0024-46b9-8c2d-6a249e1ee051	50090-4053	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	A-S Medication Solutions	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4058_8994ec4f-eff7-4d5e-98b3-a7d92381abe3	50090-4058	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET	ORAL	20170502		ANDA	ANDA205348	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-4068_0d876768-7216-4d1a-b54a-704989ec10bb	50090-4068	HUMAN PRESCRIPTION DRUG	LANTUS SOLOSTAR		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20090923		BLA	BLA021081	A-S Medication Solutions	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-4070_eb3a6d4d-e015-4e4c-bc05-2766731c7e70	50090-4070	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20160819		ANDA	ANDA204097	A-S Medication Solutions	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-4074_269edf4f-e03e-43f8-91d8-401bf707b360	50090-4074	HUMAN PRESCRIPTION DRUG	NovoLog Mix 70/30		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20011101		BLA	BLA021172	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-4083_57f75281-31cb-43e2-b7ec-701ede870fe7	50090-4083	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20091224		ANDA	ANDA040866	A-S Medication Solutions	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-4084_d8082759-1a42-485b-9dbc-7a3d5751a5ee	50090-4084	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-4086_f449ce68-aa96-490a-a8dc-ab14470895d9	50090-4086	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-4087_2fc4cf91-3b1e-4ea3-a43c-1bdb5be27ef8	50090-4087	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-4100_91c01889-5fe6-4843-8773-58f76f1ace0f	50090-4100	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET	ORAL	20170502		ANDA	ANDA205348	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-4117_1018a246-77e1-446e-b436-30feac311856	50090-4117	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20130219		ANDA	ANDA088617	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
50090-4129_ab18686c-599d-47b2-863a-1f9c6c0c42f9	50090-4129	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20181123		ANDA	ANDA210602	A-S Medication Solutions	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4137_c18966b4-588d-4da9-abc4-34e16ca3e9c9	50090-4137	HUMAN PRESCRIPTION DRUG	albuterol sulfate HFA		albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20190115		NDA AUTHORIZED GENERIC	NDA020983	A-S Medication Solutions	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-4138_9fa64f4d-30ba-4eff-b464-a1eeb21afbbb	50090-4138	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate	HFA	Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20190116		NDA AUTHORIZED GENERIC	NDA021457	A-S Medication Solutions	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-4147_5f5f27e7-447e-4531-b34a-0aa575f6f910	50090-4147	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20071221		ANDA	ANDA040530	A-S Medication Solutions	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
50090-4158_adf82f3c-0a13-4913-a4e3-3fbdd8d95a62	50090-4158	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20071003		ANDA	ANDA077127	A-S Medication Solutions	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-4164_035a2f96-916b-460a-9e9a-3309ee342d92	50090-4164	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	A-S Medication Solutions	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-4171_ae022426-348b-48ea-bc87-d2dc993bb431	50090-4171	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	A-S Medication Solutions	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-4172_9c9c3f13-4e0f-4f4a-8065-6bd89a25ff96	50090-4172	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000228		ANDA	ANDA075492	A-S Medication Solutions	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4177_49a2c875-471e-4f82-90bd-b6997234d4e6	50090-4177	HUMAN PRESCRIPTION DRUG	TOUJEO Max		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20150215		BLA	BLA206538	A-S Medication Solutions	INSULIN GLARGINE	300	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-4182_b4d23538-4d7c-43e9-baca-5bc3aa40974d	50090-4182	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
50090-4188_18da07a0-8914-4e1a-9196-1ac023659e3d	50090-4188	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20180221		ANDA	ANDA208347	A-S Medication Solutions	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
50090-4190_43826dc7-395b-4848-ae8d-fba8000a0f9e	50090-4190	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20200811		ANDA	ANDA207444	A-S Medication Solutions	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
50090-4201_a2945c2b-1237-4b87-a4a2-907b60d44589	50090-4201	HUMAN OTC DRUG	DEBROX		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20120801		OTC MONOGRAPH DRUG	M014	A-S Medication Solutions	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
50090-4202_8008c364-ca23-40e0-a7bf-f739518cf7d2	50090-4202	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	A-S Medication Solutions	ESZOPICLONE	2	mg/1		CIV	N	20241231
50090-4206_e6c9596d-5162-46bf-8e61-a8ab610b06e4	50090-4206	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20060425		ANDA	ANDA076056	A-S Medication Solutions	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-4211_6aa32532-3b08-401c-848c-651a33e4a3ad	50090-4211	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	100; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-4213_d6660e3e-132d-4a17-b8c8-03f0d4f7c2f2	50090-4213	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-4214_edadad9b-f6c8-42bb-b185-95743bb64e54	50090-4214	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	500; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-4217_4cd295b8-8c19-472e-bc67-514825b170df	50090-4217	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20181101		ANDA	ANDA077568	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-4220_0646e90f-950b-4c44-9931-97ff770e7a48	50090-4220	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20181101		ANDA	ANDA077568	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-4234_5e84b295-e18e-46e2-8e98-359a6c245ca9	50090-4234	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20001204		ANDA	ANDA075269	A-S Medication Solutions	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-4236_d1a130e7-3cee-40cf-a4c6-cb3893304987	50090-4236	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-4237_9173cb03-4741-42e1-b8a2-1ffc81b1199f	50090-4237	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-4244_d509e16e-acca-4826-a729-7c1286e356e3	50090-4244	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-4248_fa0b0258-3ff1-4481-a289-2599b2e3fd76	50090-4248	HUMAN PRESCRIPTION DRUG	Spiriva	HandiHaler	TIOTROPIUM BROMIDE	CAPSULE	ORAL; RESPIRATORY (INHALATION)	20051011		NDA	NDA021395	A-S Medication Solutions	TIOTROPIUM BROMIDE MONOHYDRATE	18	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-4251_b619ce1b-1335-4b4e-8111-78ee548d2cca	50090-4251	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20171128		ANDA	ANDA077235	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-4253_e87f82f3-1696-44a8-b4db-19ff92931350	50090-4253	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	A-S Medication Solutions	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-4256_9f453c63-7855-47c4-9ac8-adb3cbe1bb26	50090-4256	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010918		ANDA	ANDA065047	A-S Medication Solutions	CEFAZOLIN SODIUM	330	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-4259_34425db4-6600-452f-bcd7-c1291037c6e6	50090-4259	HUMAN OTC DRUG	GERI-LANTA ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20000101		OTC MONOGRAPH FINAL	part331	A-S Medication Solutions	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50090-4267_c115219c-8a17-490e-8705-bbce300ff40f	50090-4267	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20160819		ANDA	ANDA204097	A-S Medication Solutions	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-4273_bdcf07a8-fcdd-4147-9dcb-d759069ad674	50090-4273	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20181023		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	325	mg/1			N	20241231
50090-4275_3322c13f-9acb-47f4-bb4f-67b2846149aa	50090-4275	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	20111128		ANDA	ANDA091249	A-S Medication Solutions	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
50090-4283_459addb2-aeb2-4219-a993-2f1b061bd950	50090-4283	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	A-S Medication Solutions	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50090-4284_7632a756-11d5-4314-ad8c-fa26da0f1c4e	50090-4284	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-4288_bd83eecf-d2d2-4119-b7c6-4ecc45ca61c0	50090-4288	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine hydrochloride	SOLUTION	ORAL	20080724		ANDA	ANDA078398	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-4297_bd56ad34-1291-46d0-81f2-41e67516529c	50090-4297	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20170512	20251231	ANDA	ANDA206928	A-S Medication Solutions	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
50090-4307_1842b01e-9694-4a09-a9ec-ec14e68a9739	50090-4307	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161220		ANDA	ANDA207138	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-4308_9e748e9f-26c9-41a8-97bf-328c94ff361a	50090-4308	HUMAN OTC DRUG	oxymetazoline hcl		oxymetazoline hydrochloride	SPRAY	NASAL	20051205		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
50090-4316_622390e9-db90-4eb8-a82e-0e60b0f9d000	50090-4316	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190220		ANDA	ANDA076301	A-S Medication Solutions	LORATADINE	10	mg/1			N	20241231
50090-4345_7e1ef9b9-048c-4240-bcca-d3bd60cf5ced	50090-4345	HUMAN OTC DRUG	SudoGest Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19910910		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-4347_173dbdb4-8609-421a-9e10-4f847d5c3296	50090-4347	HUMAN PRESCRIPTION DRUG	Tretinoin		tretinoin	CREAM	TOPICAL	20190122		ANDA	ANDA211645	A-S Medication Solutions	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
50090-4348_af5af087-b392-4b99-925a-ad8e920d6db9	50090-4348	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	A-S Medication Solutions	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50090-4356_54de6aa4-851d-4611-be14-cc689050352f	50090-4356	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	VAGINAL	19970113		ANDA	ANDA074444	A-S Medication Solutions	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-4360_1a553ca6-934c-4b67-bbd7-139648964266	50090-4360	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070925	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-4363_5a91b076-cfd6-49b3-9beb-808c2f109b26	50090-4363	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130305		ANDA	ANDA202389	A-S Medication Solutions	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-4364_8f7706b7-8c1b-4c13-bb18-3ec25c98425f	50090-4364	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	A-S Medication Solutions	CANAGLIFLOZIN	300	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-4365_de5f3b6e-a50f-4027-9c98-4be60fa21ce2	50090-4365	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	A-S Medication Solutions	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
50090-4371_fbeda9a5-2af1-4be2-97dc-faf28548c4c7	50090-4371	HUMAN PRESCRIPTION DRUG	Colesevelam HCL		Colesevelam HCL	TABLET, FILM COATED	ORAL	20181006		ANDA	ANDA209038	A-S Medication Solutions	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
50090-4382_04858aee-3233-413a-8dfa-0c64c1a0f1b9	50090-4382	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	A-S Medication Solutions	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
50090-4384_3d4cc600-beb6-4409-b15e-2014a2d94363	50090-4384	HUMAN PRESCRIPTION DRUG	Jardiance		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	A-S Medication Solutions	EMPAGLIFLOZIN	25	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-4385_3fb9cb90-f3cd-4240-bfea-d522f88a329b	50090-4385	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	A-S Medication Solutions	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-4408_272961ee-ad60-4609-b263-d343abf3d07c	50090-4408	HUMAN PRESCRIPTION DRUG	Polocaine		MEPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20090720		ANDA	ANDA089410	A-S Medication Solutions	MEPIVACAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
50090-4409_f9c4b7f4-0b85-405f-a6dc-a59256ce2dbe	50090-4409	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	A-S Medication Solutions	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-4425_be52a1f6-504e-4d3b-8bca-e025dbe37f79	50090-4425	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	A-S Medication Solutions	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-4434_c170cfda-22dc-4baf-a870-1bfee47a0e2c	50090-4434	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA200022	A-S Medication Solutions	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
50090-4435_93fbc018-11ee-444d-ac62-56f49ddc04ee	50090-4435	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin and Polymyxin B Sulfates and Dexamethasone	OINTMENT	OPHTHALMIC	19960221		NDA AUTHORIZED GENERIC	NDA050065	A-S Medication Solutions	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-4445_caf91f11-e05d-4ece-82c6-5ce5fe3f24b0	50090-4445	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20190501		ANDA	ANDA207057	A-S Medication Solutions	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-4452_64b0bbfe-8e57-45c9-886c-44c2c2b15ca3	50090-4452	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-4453_19340230-9333-4d07-aa1b-708485519db2	50090-4453	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-4458_57c5f28a-3308-4eb6-ae6d-9e911f1f6989	50090-4458	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-4473_272e5227-d512-49c1-9424-4ce3328be727	50090-4473	HUMAN PRESCRIPTION DRUG	Finacea		azelaic acid	GEL	TOPICAL	20021224		NDA	NDA021470	A-S Medication Solutions	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
50090-4480_85764b9f-0558-46d5-babf-dc8ad2666306	50090-4480	HUMAN PRESCRIPTION DRUG	Pradaxa		dabigatran etexilate mesylate	CAPSULE	ORAL	20170728		NDA	NDA022512	A-S Medication Solutions	DABIGATRAN ETEXILATE MESYLATE	150	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
50090-4487_ee59ffab-989c-40dd-a419-1a7fd42cce6e	50090-4487	HUMAN PRESCRIPTION DRUG	Humira		Adalimumab	KIT		20060623		BLA	BLA125057	A-S Medication Solutions						N	20241231
50090-4489_e12a9c3b-b892-4a23-ae69-ab402839cc85	50090-4489	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	A-S Medication Solutions	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-4492_1415572d-8ed7-4dc7-9506-764952ce7438	50090-4492	HUMAN PRESCRIPTION DRUG	JARDIANCE		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	A-S Medication Solutions	EMPAGLIFLOZIN	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-4500_5907ee0c-c7d5-4e1c-9c12-8390ccb34c42	50090-4500	HUMAN PRESCRIPTION DRUG	NOVOLOG		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20030122		BLA	BLA020986	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-4502_2134ba7b-59af-4e20-8b3d-4539e69c7733	50090-4502	HUMAN PRESCRIPTION DRUG	ADVAIR DISKUS		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20010205		NDA	NDA021077	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-4503_a934a344-0ee2-420c-980c-ae69581875fe	50090-4503	HUMAN PRESCRIPTION DRUG	Victoza		liraglutide	INJECTION	SUBCUTANEOUS	20100125		NDA	NDA022341	A-S Medication Solutions	LIRAGLUTIDE	6	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-4504_1d2908e9-01ac-46d0-a2c3-624422766572	50090-4504	HUMAN PRESCRIPTION DRUG	ADVAIR HFA		fluticasone propionate and salmeterol xinafoate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20080929		NDA	NDA021254	A-S Medication Solutions	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	115; 21	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-4511_8726ae64-54c7-4b0b-b8ea-50776938809b	50090-4511	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20171120		ANDA	ANDA209734	A-S Medication Solutions	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
50090-4516_fa2017d9-4efb-4c39-a29a-c990a43aa247	50090-4516	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20160513		ANDA	ANDA207183	A-S Medication Solutions	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
50090-4527_1d8965cf-632c-4153-8b19-dd99c37aca59	50090-4527	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-4533_bb3e168c-8a92-4763-bce4-bd3e05769e5f	50090-4533	HUMAN PRESCRIPTION DRUG	Lincomycin		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20150705		ANDA	ANDA201746	A-S Medication Solutions	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
50090-4534_f8502d68-530a-4e10-880c-5a1ea20aa875	50090-4534	HUMAN PRESCRIPTION DRUG	HYLENEX Recombinant		Hyaluronidase (Human Recombinant)	INJECTION, SOLUTION	SUBCUTANEOUS	20051202		BLA	BLA021859	A-S Medication Solutions	HYALURONIDASE (HUMAN RECOMBINANT)	150	[USP'U]/mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
50090-4539_b68f46d2-4a29-444a-a77f-775338252162	50090-4539	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-4540_88cf678e-342c-4abf-bf36-db067b915e70	50090-4540	HUMAN PRESCRIPTION DRUG	Geodon		ziprasidone mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20031223		NDA	NDA020919	A-S Medication Solutions	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
50090-4543_04793e78-0032-4331-84a2-ed3a160b88bd	50090-4543	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR	20161215		NDA AUTHORIZED GENERIC	NDA019430	A-S Medication Solutions	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50090-4546_42fc7934-b5dc-45ee-a305-94a73e5d6c0e	50090-4546	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET	ORAL	20190826		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	PSEUDOEPHEDRINE HYDROCHLORIDE	60	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-4552_c37b3393-7db2-43fe-a335-d83126b92a0e	50090-4552	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19710303		ANDA	ANDA061395	A-S Medication Solutions	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-4553_260e57f4-a6ce-449b-a0dd-b7122249db7f	50090-4553	HUMAN PRESCRIPTION DRUG	Bentyl		Dicyclomine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	19520813		NDA	NDA008370	A-S Medication Solutions	DICYCLOMINE HYDROCHLORIDE	20	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-4556_6a88491b-44ff-4a17-aea2-34e8f92600c1	50090-4556	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-4560_a9f8e184-e02b-47dc-b961-ef0265d5bc26	50090-4560	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	A-S Medication Solutions	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-4572_dad8591e-064e-4f1c-83d3-05c8491f1bf9	50090-4572	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	A-S Medication Solutions	LEVOFLOXACIN	500	mg/1			N	20241231
50090-4573_851d38ee-eb11-4039-85af-17e8d910207f	50090-4573	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20250731	ANDA	ANDA200839	A-S Medication Solutions	LEVOFLOXACIN	500	mg/1			N	
50090-4575_aa5114bb-9acc-4fe5-9bc5-b9205435122f	50090-4575	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	A-S Medication Solutions	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-4577_0953f374-0524-4d5c-b79e-2a256098233a	50090-4577	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	A-S Medication Solutions	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50090-4579_c3c2c5f0-6ce2-4fb5-88a5-5505a53861d8	50090-4579	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	A-S Medication Solutions	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-4582_b77b1f0e-f256-4aaf-8126-70a24ed32fd4	50090-4582	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	A-S Medication Solutions	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-4586_e38cebea-a00c-48eb-8f48-ea30fae08c40	50090-4586	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-4601_9965dc42-8ed7-4c39-a0e2-37e88f753c3e	50090-4601	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-4604_a7707a1f-8b4e-4ed7-9b8f-42ba1f9c0d34	50090-4604	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA205707	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-4605_6fbb8f2d-cd42-4fea-9173-7c22341ff2c9	50090-4605	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-4608_c3c1637d-7777-4709-8707-aa28fb86db9f	50090-4608	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-4610_affcdf90-0c7d-437d-98f1-3d3e940b7664	50090-4610	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-4613_ee451747-800b-4401-9573-6d260fc5e13d	50090-4613	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20190710		ANDA	ANDA211125	A-S Medication Solutions	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
50090-4614_c8633256-3c25-4c9b-93b6-b56ba07a984c	50090-4614	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	A-S Medication Solutions	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-4622_0b6395a6-ef66-4f4f-a62b-97f36da0014c	50090-4622	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171222		ANDA	ANDA209335	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-4625_fa56bbc0-f03a-4694-b3bb-694358a96620	50090-4625	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-4626_ff0c0a9d-346d-4962-81af-0a53c4871332	50090-4626	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50090-4629_fc95a1d0-5bd4-4ca8-b4cb-980f790a4700	50090-4629	HUMAN OTC DRUG	Sudafed Sinus Congestion 12 Hour		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190617		ANDA	ANDA075153	A-S Medication Solutions	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-4632_ef67ba26-cfad-4a52-81b2-c2ae62512b34	50090-4632	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	A-S Medication Solutions	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-4635_8b4020ad-7ea2-4fa4-82e3-4fc437a7bdeb	50090-4635	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170115		ANDA	ANDA204216	A-S Medication Solutions	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4636_ebd0c9a2-10b1-47f6-9df7-88cd812321ec	50090-4636	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4637_ef2e4f28-f2c3-4382-93fc-3e087439a0c1	50090-4637	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4638_d2e46eff-5ef3-4315-a690-ed09438c0258	50090-4638	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4641_4d9ee6aa-5191-4a23-b9c0-38f575b96171	50090-4641	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	A-S Medication Solutions	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50090-4645_45b92a07-d380-46cd-8857-b50eb93e4d49	50090-4645	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	A-S Medication Solutions	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-4648_295ddf45-0173-4916-9641-ebd5fa248ac9	50090-4648	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, COATED	ORAL	20170106		ANDA	ANDA207750	A-S Medication Solutions	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
50090-4651_5e478d12-c656-456d-8248-58cb7a1d7f73	50090-4651	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	A-S Medication Solutions	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-4652_d9444760-ce28-4655-b50c-5c1e8acdca7b	50090-4652	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	A-S Medication Solutions	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-4659_dff39b8e-b753-490c-8f7b-84bcbf9b2297	50090-4659	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20180517		ANDA	ANDA210577	A-S Medication Solutions	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20251231
50090-4660_646cb491-dc6a-462f-a6a2-a6e44ab519ab	50090-4660	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209908	A-S Medication Solutions	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-4661_dc91f2f3-c5e8-4c78-aec4-ad45e327bfa4	50090-4661	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	A-S Medication Solutions	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-4662_c893a910-0828-45fd-a7ea-36008abdd636	50090-4662	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	A-S Medication Solutions	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-4663_f44c58b5-8f4e-4b44-9043-5cb508c3e340	50090-4663	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	A-S Medication Solutions	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-4665_c3820142-dbcf-4683-a447-95b406e0cf8b	50090-4665	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	A-S Medication Solutions	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-4667_e6efda54-5838-409d-b26a-a5b77ed7495f	50090-4667	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-4668_8d81d19a-763e-435e-a0bf-1646e5da0f9f	50090-4668	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-4670_a8ac7afb-fb86-4fef-ae20-3b71c3b2044b	50090-4670	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-4671_937b724c-1feb-4eab-b827-bcf673d529dc	50090-4671	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	A-S Medication Solutions	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-4678_e584e687-4aeb-4401-b299-d2887e405b6d	50090-4678	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	A-S Medication Solutions	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-4679_e8295a64-0c00-4e25-87ab-bd19e17a4cde	50090-4679	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	CREAM	TOPICAL	20190226		ANDA	ANDA208885	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-4680_38ac25fc-2057-49f3-aa92-5e81e0416bcb	50090-4680	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	CREAM	TOPICAL	20190226		ANDA	ANDA208885	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-4682_7eaa261c-f1ea-4690-bbe6-80df38ed13e8	50090-4682	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20181206		ANDA	ANDA211659	A-S Medication Solutions	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50090-4684_149ffbd4-ac16-4667-bda7-142cbb272614	50090-4684	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	A-S Medication Solutions	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50090-4688_8aad0269-bf0a-4062-be12-5d81fb8f182c	50090-4688	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-4691_5ea3d671-78e4-4253-983a-9edb24095cf4	50090-4691	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	A-S Medication Solutions	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-4692_3ae0bb5b-bc8c-4d70-a93f-b872e304a4c0	50090-4692	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20080804		ANDA	ANDA076768	A-S Medication Solutions	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
50090-4696_476aeedd-2b8a-4f58-b694-34a56ea5b176	50090-4696	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	19830324		NDA	NDA018642	A-S Medication Solutions	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-4697_2bae8977-9b78-48c9-a22a-9ea0c4c5075c	50090-4697	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20170105		ANDA	ANDA204304	A-S Medication Solutions	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
50090-4698_f6aee86f-75fe-4c9f-9b1d-235897f34c23	50090-4698	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20170330		ANDA	ANDA207378	A-S Medication Solutions	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-4700_fd1fcc97-fc81-4396-a789-b92409cbf4a7	50090-4700	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-4705_af8de9d0-94fe-4798-a844-132a669e7540	50090-4705	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20150527		ANDA	ANDA204093	A-S Medication Solutions	MONTELUKAST	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50090-4706_55326e28-a303-42c3-9aab-f8789f63c948	50090-4706	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20060511		OTC MONOGRAPH FINAL	part333B	A-S Medication Solutions	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
50090-4708_d72bcf3e-a925-48a3-8530-8ffc9b4505f2	50090-4708	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160811		ANDA	ANDA204343	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-4712_24d7366d-895c-4a1d-a24d-7cd7abad42c0	50090-4712	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	A-S Medication Solutions	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-4720_d99f8860-fef1-403a-b2dc-7a6ad5ffd934	50090-4720	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-4722_7c6c1f46-1eba-4c95-a7d7-0d8b266a5445	50090-4722	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-4725_03cbfcf9-e993-4e1c-8112-3ce52d61e102	50090-4725	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	A-S Medication Solutions	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-4727_42511a1a-a6e1-4c32-bad5-4d5c377b4b31	50090-4727	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-4729_cb464343-5110-4c5a-bf92-90da4183afe3	50090-4729	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-4730_e0bc8d44-d41d-42d0-a174-a1b61df7ee0f	50090-4730	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-4733_b0212334-f216-4f97-8e33-4d841901eff1	50090-4733	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20181029		ANDA	ANDA074224	A-S Medication Solutions	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-4734_f2a581e4-a434-4f0b-9731-e755058c69a0	50090-4734	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20160118		ANDA	ANDA203002	A-S Medication Solutions	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-4736_1a1cb60d-2d45-4090-8bea-053fb320f8f1	50090-4736	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	A-S Medication Solutions	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-4737_2fbf7f59-b842-4e55-ab0f-472ea95bdc04	50090-4737	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	A-S Medication Solutions	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-4738_38e3cdf9-3f2c-42a7-9102-d35bf2d1d482	50090-4738	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079172	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-4741_c01c6ad7-a304-4190-9d9e-cdef0dc8c6f5	50090-4741	HUMAN OTC DRUG	CHILDRENS ALLERGY RELIEF		cetirizine hydrochloride	SOLUTION	ORAL	20190313		ANDA	ANDA210622	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-4743_43b5f629-a4c7-49dd-a75b-47911757e578	50090-4743	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		fosinopril sodium	TABLET	ORAL	20171001		ANDA	ANDA205670	A-S Medication Solutions	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-4747_9078b14e-d33c-4166-b3ea-a3f571bdfb15	50090-4747	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170614		ANDA	ANDA090693	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-4749_0fd464d3-7083-49cc-8c8f-112992448396	50090-4749	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170614		ANDA	ANDA090693	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-4750_f90a7e25-88b3-4d4f-9930-964418e6cf8c	50090-4750	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-4751_e50376c6-3db4-429f-bf11-982f49d5e4df	50090-4751	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	A-S Medication Solutions	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-4752_48ae8c14-7705-41db-8988-e83cec10cd0c	50090-4752	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	A-S Medication Solutions	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4761_fbf09ce6-f4e0-4395-ae52-fe8adda80461	50090-4761	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20060804		ANDA	ANDA087385	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-4772_e7badab0-81cc-4fc1-b8a7-6d133dba2514	50090-4772	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171224		ANDA	ANDA209222	A-S Medication Solutions	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-4781_7bb7b81f-241e-471c-92bd-daf69035980a	50090-4781	HUMAN PRESCRIPTION DRUG	Moxifloxacin ophthalmic solution		Moxifloxacin ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20190213		ANDA	ANDA209469	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-4788_02d2f842-554b-41f2-94d4-1acedb18c49c	50090-4788	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	A-S Medication Solutions	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-4789_2bbd635f-76fa-4feb-9d3d-f84505d0e381	50090-4789	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	A-S Medication Solutions	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-4794_a9437daf-a970-4965-9f90-1c9c85ca030b	50090-4794	HUMAN PRESCRIPTION DRUG	DESLORATADINE		DESLORATADINE	TABLET, FILM COATED	ORAL	20130225		ANDA	ANDA078352	A-S Medication Solutions	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-4795_7bb9235c-a715-4113-b8b0-3f91d1fd3f2a	50090-4795	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	A-S Medication Solutions	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-4797_6b65f0fd-af09-475b-a591-0efeb50891f7	50090-4797	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	A-S Medication Solutions	LEVOFLOXACIN	250	mg/1			N	20241231
50090-4799_8c8e8110-3fed-487f-8b62-7edd332aa328	50090-4799	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-4800_81e0c81e-c8d4-444f-9c04-21a7b9ce6485	50090-4800	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	A-S Medication Solutions	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-4801_92fdef74-c140-434b-af9f-af66440fef9d	50090-4801	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-4803_964359dc-018a-469d-a2e6-cf5191a4b2ec	50090-4803	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	A-S Medication Solutions	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
50090-4805_8e5a48d7-5b55-4f07-a79b-ccbd8717523c	50090-4805	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-4806_bac154f6-997c-49b9-8f45-514a611ddfcf	50090-4806	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204082	A-S Medication Solutions	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-4809_7e6e7433-4913-4766-a56c-f57241481f52	50090-4809	HUMAN PRESCRIPTION DRUG	metronidazole vaginal		metronidazole	GEL	VAGINAL	20190708		ANDA	ANDA211786	A-S Medication Solutions	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-4812_539f36e4-e67b-4d3f-98a4-cf307f22e42a	50090-4812	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-4813_e1b3146d-77bf-4996-a727-95c4170ebe9c	50090-4813	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-4821_54fc6302-fb6b-43b2-abdd-2c65b5ac96bf	50090-4821	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20180726		ANDA	ANDA077565	A-S Medication Solutions	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-4825_5b34b705-a4c5-4d65-85f0-a95631617521	50090-4825	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	A-S Medication Solutions	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50090-4833_1705f4d2-1551-4046-98d4-344d036956bd	50090-4833	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	A-S Medication Solutions	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-4839_2c08cf3b-88f4-4e63-aefc-12797a030a07	50090-4839	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-4847_c06c073c-f5f8-41ad-b8e4-7697e3f97fbe	50090-4847	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20251231
50090-4848_5aaa9a82-c3b8-4ccb-83c4-2ab9cc779d3b	50090-4848	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20251231
50090-4850_16c0bd23-76c4-4294-a819-1ec8b218ca31	50090-4850	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20251231
50090-4853_4858b2b3-fa81-4906-b002-5bb1d3bb100b	50090-4853	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-4859_b003bb0d-7cb0-4ace-b778-d80eb75a1406	50090-4859	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
50090-4861_531a923b-1d54-48ac-a6cd-642e775a97c8	50090-4861	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	A-S Medication Solutions	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-4862_f86be7e8-4667-4fdb-b6c1-0be2231a965d	50090-4862	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20040326		ANDA	ANDA075022	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
50090-4865_dbd9089f-143d-4c41-b4db-2d849ca254d9	50090-4865	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-4867_0b7e0899-5b3e-4303-8529-85cf9f61f072	50090-4867	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	19900101		ANDA	ANDA062421	A-S Medication Solutions	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-4872_9a48b360-6b64-4b43-bf31-306ffa7867dc	50090-4872	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-4874_57dd6b69-1298-4154-9af6-6ea4d0896618	50090-4874	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430	20240601	ANDA	ANDA211604	A-S Medication Solutions	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
50090-4875_0abaa126-6e31-4eaf-8707-42fb12a68b7e	50090-4875	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-4882_20057f70-1994-43ac-b9f9-0dc7d27a6d6b	50090-4882	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride Ophthalmic		Dorzolamide Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20191111		ANDA	ANDA204778	A-S Medication Solutions	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
50090-4885_e2330f85-4aec-4c03-9c0e-400137136c01	50090-4885	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	A-S Medication Solutions	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-4887_98a41ba5-37b2-46cd-bca8-fa85c77fef09	50090-4887	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	A-S Medication Solutions	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-4891_fd7d0d68-c8fb-4f4b-88c4-8b3ad8e81e4e	50090-4891	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-4892_fb10b50e-587a-4b10-8ec9-4f74da93e41c	50090-4892	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-4893_764f585e-7e35-4fc5-8b3a-fac25ba5b4ea	50090-4893	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	A-S Medication Solutions	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-4897_d3a82d65-b841-41db-80a8-f1b6d575f2f2	50090-4897	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	A-S Medication Solutions	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-4898_1c3f227e-bba0-41ca-972e-0b53c72a7d2d	50090-4898	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	A-S Medication Solutions	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-4901_7ead0f66-be03-46e5-be9b-f7c29aa54293	50090-4901	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	A-S Medication Solutions	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-4902_d7749269-230c-4df9-b1b8-85cb0a87adcd	50090-4902	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	A-S Medication Solutions	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-4903_802c29a4-2bca-4d78-8502-1384b41d1dea	50090-4903	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20140303		ANDA	ANDA203245	A-S Medication Solutions	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-4904_b581fdeb-42e3-4e21-a6f0-f12b8a927d75	50090-4904	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-4906_0ec71c7e-f1e8-47a8-bdc2-e9ccefccf6f2	50090-4906	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170811		ANDA	ANDA207405	A-S Medication Solutions	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-4910_7e6b1fd5-9466-4976-9b49-0dc6855cad57	50090-4910	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	A-S Medication Solutions	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-4914_5f9e39e2-c753-46d1-b391-d348188f8def	50090-4914	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	A-S Medication Solutions	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-4915_3493064d-a7c5-4513-ac9a-d8ac5028ad24	50090-4915	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130319		ANDA	ANDA202389	A-S Medication Solutions	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-4918_da6a8768-a019-4406-9069-286c51b55e4c	50090-4918	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20131121		ANDA	ANDA202925	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-4920_7556a189-563d-4717-b792-c90860e904db	50090-4920	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20140501		ANDA	ANDA091244	A-S Medication Solutions	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
50090-4925_4242e317-1764-436a-aff6-338a58f1b0a2	50090-4925	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20120118		ANDA	ANDA091205	A-S Medication Solutions	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
50090-4927_7286b27f-eb5f-4f5f-ab30-a8604f1d59f4	50090-4927	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	A-S Medication Solutions	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-4935_14702c7a-4a84-4cec-a0dc-0b70c13939d7	50090-4935	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160526		ANDA	ANDA203711	A-S Medication Solutions	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-4951_90e231e5-02bb-42a9-80fd-94d74032fdc2	50090-4951	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-4952_fd1ae123-f269-4fb2-bdbe-ddc3ccd14d5a	50090-4952	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20161210		ANDA	ANDA090912	A-S Medication Solutions	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
50090-4955_89df7a68-ff4e-4269-89bf-a2aa0bd3afb6	50090-4955	HUMAN PRESCRIPTION DRUG	Insulin Aspart		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-4956_2ad9b7ed-f298-4b30-8e08-07ca601c7b66	50090-4956	HUMAN PRESCRIPTION DRUG	Insulin Aspart		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20030122		BLA	BLA020986	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-4958_599e7fa2-f396-46e2-a54c-769982306105	50090-4958	VACCINE	GARDASIL 9		Human Papillomavirus 9-valent Vaccine, Recombinant	INJECTION, SUSPENSION	INTRAMUSCULAR	20141210		BLA	BLA125508	A-S Medication Solutions	HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN	40; 60; 40; 20; 20; 20; 20; 20; 30	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
50090-4959_e7306eaf-dfee-4768-9ede-fcc751dc336e	50090-4959	HUMAN PRESCRIPTION DRUG	.Insulin Aspart Protamine and Insulin Aspart		insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20020911		BLA	BLA021172	A-S Medication Solutions	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-4961_064cb3ff-90ce-4d8a-9e3f-2bc05e16174e	50090-4961	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	19970528	20250630	ANDA	ANDA064150	A-S Medication Solutions	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	
50090-4967_3cff43fc-e525-4e94-802f-af15a169fe1a	50090-4967	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		Chloroquine Phosphate	TABLET	ORAL	20110701		ANDA	ANDA091621	A-S Medication Solutions	CHLOROQUINE PHOSPHATE	250	mg/1	Antimalarial [EPC]		N	20241231
50090-4968_307aec37-9f24-4b15-84e0-c679d4d26643	50090-4968	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170907		ANDA	ANDA202765	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-4969_39ef94b2-c7cc-45c6-8f62-720e4928a659	50090-4969	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170907		ANDA	ANDA202765	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-4981_0674a65a-16c5-4d26-a099-7c5f4cc61d14	50090-4981	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	A-S Medication Solutions	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-4985_a474c11e-1e87-45ad-b546-ddaab7e02700	50090-4985	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20140409	20250101	ANDA	ANDA078326	A-S Medication Solutions	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
50090-4993_808ab347-bf54-43b5-90fd-dde7b150bd87	50090-4993	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20101006		ANDA	ANDA078245	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5004_6690b368-c4f2-4f50-924c-515e86a275fd	50090-5004	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20180827		ANDA	ANDA040616	A-S Medication Solutions	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-5005_c87674c2-937e-4a5c-b654-3427a8c0eeb5	50090-5005	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	A-S Medication Solutions	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5006_611b863a-9ecd-4c45-b7f5-6f04fabbeadc	50090-5006	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	A-S Medication Solutions	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5008_71058c3d-80fe-471d-a6b6-f3fa9215dfa6	50090-5008	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	A-S Medication Solutions	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5013_32c52dc4-ef09-4c6c-8c8a-1416be139cd4	50090-5013	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200121		ANDA	ANDA204216	A-S Medication Solutions	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5019_dee90bc1-978f-425b-b3f3-64730b66faf8	50090-5019	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5021_80e6cea4-db42-4816-8ba7-7a19e73dd811	50090-5021	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20040101		ANDA	ANDA075010	A-S Medication Solutions	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5029_4a627123-1563-4586-9cde-6588413cbb60	50090-5029	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	A-S Medication Solutions	CANAGLIFLOZIN	300	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-5031_9e31678c-6489-4377-a1b8-8bd6fb54b709	50090-5031	HUMAN PRESCRIPTION DRUG	QVAR REDIHALER		Beclomethasone Dipropionate HFA	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180215		NDA	NDA207921	A-S Medication Solutions	BECLOMETHASONE DIPROPIONATE	40	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5032_778908c5-aa3d-496b-b530-9a5da5eebc6c	50090-5032	HUMAN PRESCRIPTION DRUG	QVAR REDIHALER		Beclomethasone Dipropionate HFA	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180215		NDA	NDA207921	A-S Medication Solutions	BECLOMETHASONE DIPROPIONATE	80	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5033_5c389685-450c-46e4-92e6-1f28db88ba15	50090-5033	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	A-S Medication Solutions	CANAGLIFLOZIN	100	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-5034_f8148180-4b45-4670-a46c-94171161f367	50090-5034	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	A-S Medication Solutions	CANAGLIFLOZIN	100	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-5036_32458c95-4cff-4b30-bc62-0f0b2203a584	50090-5036	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	A-S Medication Solutions	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50090-5038_fac862e7-2429-4567-9ecb-96a0a50d5d4f	50090-5038	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	A-S Medication Solutions	PREGABALIN	75	mg/1		CV	N	20241231
50090-5039_ecc320e0-b8a2-46f9-b605-c1bc426ca941	50090-5039	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA077342	A-S Medication Solutions	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5040_84034fbb-9056-414d-8cc6-3170b49407ea	50090-5040	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	A-S Medication Solutions	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-5052_e8f2087f-35bb-495d-9ad0-3511a5819e25	50090-5052	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-5053_f010f88a-c1cd-4d9f-aa82-90fd21b17dba	50090-5053	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5057_0037a701-3f3e-4c6e-9338-58655ac1d770	50090-5057	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5058_f106ecd1-625d-4c2c-893d-8345e28c69e3	50090-5058	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	A-S Medication Solutions	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-5059_1ae0dd3b-94e2-4d58-87b0-c6df923aa27e	50090-5059	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	A-S Medication Solutions	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5060_659c59e5-8fd8-43b8-b1c3-191f55647031	50090-5060	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5062_aa17b885-ad31-423d-9443-9f166358d303	50090-5062	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20180801		ANDA	ANDA075389	A-S Medication Solutions	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-5063_cf6940d8-d272-4b18-bb25-8db6d6c0b3ea	50090-5063	HUMAN PRESCRIPTION DRUG	Priftin		rifapentine	TABLET, FILM COATED	ORAL	20170208		NDA	NDA021024	A-S Medication Solutions	RIFAPENTINE	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20251231
50090-5064_390f1a96-5a87-435a-be78-6784a81c6f1b	50090-5064	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20151015		NDA AUTHORIZED GENERIC	NDA018225	A-S Medication Solutions	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-5067_6f5558d3-6fd0-482c-9667-c974a1edef44	50090-5067	HUMAN OTC DRUG	Allergy Relief	Non drowsy	Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	A-S Medication Solutions	LORATADINE	10	mg/1			N	20241231
50090-5068_dc3de4bb-530b-49c4-bbd0-371d090894e4	50090-5068	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20151015		NDA AUTHORIZED GENERIC	NDA018225	A-S Medication Solutions	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-5070_6158ab72-3f75-44d3-a255-c66e3ef664b6	50090-5070	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5071_3d23ee1a-85f5-4d68-b719-f0c2aaad3f38	50090-5071	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	A-S Medication Solutions	PREGABALIN	75	mg/1		CV	N	20241231
50090-5072_f9c3f72b-3671-419d-8fcd-61a97b585616	50090-5072	HUMAN PRESCRIPTION DRUG	tranexamic acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20190930		ANDA	ANDA212676	A-S Medication Solutions	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
50090-5078_78dc9536-4f6d-4f5b-b136-27424af8b2b2	50090-5078	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	A-S Medication Solutions	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-5079_1b65247a-38ac-495b-8210-76d381467251	50090-5079	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180619		ANDA	ANDA210034	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5089_b2732992-8f73-4220-8f4b-44886065a3b2	50090-5089	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070924	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-5095_923ed88d-06b5-4c66-a0bd-3e3e63e1dc7e	50090-5095	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	A-S Medication Solutions	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
50090-5096_e4a5c68b-f117-463d-b0d9-1ac42e55e377	50090-5096	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	A-S Medication Solutions	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
50090-5101_16481e35-1454-4c33-abaf-51601eb92526	50090-5101	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE (SR)		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160817		ANDA	ANDA206122	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-5105_522b5083-fc64-4e3b-ae9f-c183dd498b54	50090-5105	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070974	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-5106_dfc9c35e-a5ea-4152-9513-31f8526950b1	50090-5106	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
50090-5107_90281ba7-4281-479d-ae12-41b5714dd5f2	50090-5107	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
50090-5110_e06f16b5-efd2-4139-9422-3beb9f732173	50090-5110	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	A-S Medication Solutions	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50090-5111_e309fae6-2171-4713-842a-75de122be6bc	50090-5111	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	A-S Medication Solutions	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5113_0be498b0-382f-4df5-bced-75535404b02b	50090-5113	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20101006		ANDA	ANDA078245	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5120_2a8f2e4b-c3d2-45cf-9e79-58200e801223	50090-5120	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	A-S Medication Solutions	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-5134_006cdc3e-9071-44fa-8394-707f05018c9b	50090-5134	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190917		ANDA	ANDA078279	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5140_39890843-4a7a-4034-b44d-226594d8e9e1	50090-5140	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET	ORAL	20090710		ANDA	ANDA078939	A-S Medication Solutions	ETHAMBUTOL HYDROCHLORIDE	100	mg/1	Antimycobacterial [EPC]		N	20241231
50090-5160_9f5574a1-bd50-4db0-8a05-8d3968825ca0	50090-5160	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	A-S Medication Solutions	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5163_20f19446-7921-4fe9-9a11-47d3da2f5123	50090-5163	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-5165_e28b726f-8c6d-487d-a251-8ee3ba497f5a	50090-5165	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20070226		ANDA	ANDA077690	A-S Medication Solutions	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-5168_3a34303c-a810-438f-a187-61682538a379	50090-5168	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20150429		ANDA	ANDA203154	A-S Medication Solutions	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-5170_2c4ec383-f107-49fe-932b-61fe837c5e95	50090-5170	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20160722		ANDA	ANDA077534	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5172_9724fbe8-3224-43eb-93c0-6c75fae24b8b	50090-5172	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20160722		ANDA	ANDA077534	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5175_012d17ee-3ee6-4fac-968f-ddaf0ce20b41	50090-5175	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20160722		ANDA	ANDA077534	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5176_dcd732a9-3d12-4237-8384-255d6141bef2	50090-5176	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-5178_f007cd3b-388e-491e-a22d-ed124c2cba12	50090-5178	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150603		ANDA	ANDA204197	A-S Medication Solutions	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5180_ee55f98b-3781-4ac3-ad33-4e265b551603	50090-5180	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190120		ANDA	ANDA207394	A-S Medication Solutions	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5181_353113a4-5fb8-4fd3-98ad-7e5cdc4201c4	50090-5181	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5182_4feb6a62-6f91-4973-9f2d-401889c3ebbe	50090-5182	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5183_0df9e4cb-feba-4837-920d-63850fdbb695	50090-5183	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20200213		ANDA	ANDA213412	A-S Medication Solutions	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-5184_a6479237-7f52-49d4-8dac-c6bb9ff3fa58	50090-5184	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5186_2b833f22-4bcc-447b-bdd1-82f0a34b2b87	50090-5186	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20190301		ANDA	ANDA076513	A-S Medication Solutions	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-5187_0f676701-853c-43ae-b9a5-9c343eebd825	50090-5187	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209539	A-S Medication Solutions	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5188_b2cd4d52-3c05-4110-bbf3-28a2d7495226	50090-5188	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5189_68b52be2-fca7-4329-89f2-bac216c405a1	50090-5189	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5190_f984757e-b327-4f5e-8f07-6eefcffac404	50090-5190	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	A-S Medication Solutions	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5191_b4e28e8f-ba4c-4da2-aa39-4d20365fa101	50090-5191	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	A-S Medication Solutions	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5192_5b2ec706-d7b6-4c25-a7b6-a8db54e0fa29	50090-5192	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	A-S Medication Solutions	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5194_5a63a288-896f-4b3d-a5c9-e3f4f52a17f5	50090-5194	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20150429		ANDA	ANDA203154	A-S Medication Solutions	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-5198_8736b303-c038-4d93-8222-c1a969ca6506	50090-5198	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-5200_c8de5281-4542-4ecc-9e52-572166af7ee8	50090-5200	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-5201_ef9f93cb-969e-49ab-b0c4-1350cbe77ca8	50090-5201	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	A-S Medication Solutions	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
50090-5202_7e45c96b-5e87-4c5b-889f-a983ebe904f7	50090-5202	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	A-S Medication Solutions	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5205_808ec5d4-a0f8-4374-8a6d-e8e6b4d5bf85	50090-5205	HUMAN PRESCRIPTION DRUG	TRIHEXYPHENIDYL HYDROCHLORIDE		TRIHEXYPHENIDYL HYDROCHLORIDE	TABLET	ORAL	20190128		ANDA	ANDA040254	A-S Medication Solutions	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
50090-5207_90e85226-4409-4e7c-802d-ff740ba2d096	50090-5207	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5208_fbe1f34a-0e2f-4219-bcc5-219500067f85	50090-5208	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5209_bd6a1f94-f3b6-497b-b2fd-fe5ca4929ba9	50090-5209	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20190301		ANDA	ANDA076513	A-S Medication Solutions	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-5216_e7f8546d-8041-42b1-88e2-8764ac85277c	50090-5216	HUMAN PRESCRIPTION DRUG	NP Thyroid 60		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20101111		UNAPPROVED DRUG OTHER		A-S Medication Solutions	LEVOTHYROXINE; LIOTHYRONINE	38; 9	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
50090-5217_57ca594e-466b-447b-bb69-0ad3fe4179bc	50090-5217	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20200130		ANDA	ANDA211556	A-S Medication Solutions	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
50090-5218_b80aed44-291f-4708-8f9e-6ccf9d761a33	50090-5218	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	A-S Medication Solutions	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50090-5220_dde568f1-a47b-4b05-a949-c697a165d53a	50090-5220	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20140501		ANDA	ANDA076601	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-5223_13ecfb12-dda6-4a91-ae3c-0338cbcfde6b	50090-5223	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180920		ANDA	ANDA072096	A-S Medication Solutions	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5229_4ec8f393-895e-498e-90e3-5c5d1c62dab2	50090-5229	HUMAN PRESCRIPTION DRUG	NP Thyroid 90		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20110203		UNAPPROVED DRUG OTHER		A-S Medication Solutions	LEVOTHYROXINE; LIOTHYRONINE	57; 13.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
50090-5231_3e61fa7b-6cfd-4b41-ae50-dc2e87be7f38	50090-5231	HUMAN PRESCRIPTION DRUG	Albuterol sulfate		Albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200825		ANDA	ANDA209954	A-S Medication Solutions	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-5232_46350bab-a6b1-4157-8c60-caeeb52af68a	50090-5232	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM, AUGMENTED	TOPICAL	20031209		ANDA	ANDA076543	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5235_893aeefd-b757-4d8c-8f17-711a114c0d9b	50090-5235	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	A-S Medication Solutions	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5236_eba51b78-3ceb-4350-9d17-cdd7b188e420	50090-5236	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	A-S Medication Solutions	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5238_eb33b285-f377-43a9-b1ff-86ba14af6d68	50090-5238	HUMAN PRESCRIPTION DRUG	Naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA078486	A-S Medication Solutions	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5241_b1201ae7-275a-49a3-bdfd-36576c4469da	50090-5241	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	A-S Medication Solutions	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-5244_915f0176-56ba-4a38-8c9e-bedca88a0bc8	50090-5244	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20180720		ANDA	ANDA210138	A-S Medication Solutions	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-5245_608fe58b-865a-4ce5-95c9-2c0e3f651667	50090-5245	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA210497	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-5246_12f3c39f-6fe7-4678-a6fd-614dd5592182	50090-5246	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-5249_a6f721ac-db8e-4c8e-9046-f04cbd12d218	50090-5249	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-5253_caca7395-7eaa-4d05-bd4b-fb92e997f480	50090-5253	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	A-S Medication Solutions	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-5254_867ba9e7-dd6a-4e43-88f0-a2fcb8ece9ec	50090-5254	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20190819		ANDA	ANDA090589	A-S Medication Solutions	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50090-5256_612d60d3-c470-4533-a6ef-719c4f2905ca	50090-5256	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5257_4cb6d80c-2943-4322-86c9-f59a1c0058e2	50090-5257	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	A-S Medication Solutions	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
50090-5258_7141a479-c02e-4160-99e0-2dfbbd4b237a	50090-5258	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	A-S Medication Solutions	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
50090-5261_01c5a0e6-1d41-4b4d-9413-d72d1d1834f6	50090-5261	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	A-S Medication Solutions	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-5262_9d5a5a4c-f85f-416b-a80e-5e0d650af3b8	50090-5262	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	A-S Medication Solutions	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-5264_12213fea-8255-4f65-8590-2d31c8197ac4	50090-5264	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		clobetasol propionate	SOLUTION	TOPICAL	20191002		ANDA	ANDA211494	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5265_feb1a21d-ab6a-4015-99c2-e55a098a10f3	50090-5265	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20190208		ANDA	ANDA075581	A-S Medication Solutions	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
50090-5267_6f299ecc-ca16-4b08-82b0-9b83bc0ad93f	50090-5267	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150708		ANDA	ANDA202821	A-S Medication Solutions	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
50090-5273_bac0c4d3-f01c-4ade-a739-51480e272328	50090-5273	HUMAN OTC DRUG	Ear Drops	Major	Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20191010		OTC MONOGRAPH DRUG	M014	A-S Medication Solutions	CARBAMIDE PEROXIDE	6.5	g/100mL			N	20251231
50090-5274_ac2b33e3-45e5-4061-a50f-5615a310d9a0	50090-5274	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20181128		ANDA	ANDA204003	A-S Medication Solutions	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-5275_a43702c9-509c-4e6a-bc57-6361d6863ebb	50090-5275	HUMAN PRESCRIPTION DRUG	PREDNISOLONE ACETATE		prednisolone acetate	SUSPENSION/ DROPS	OPHTHALMIC	19970819		NDA AUTHORIZED GENERIC	NDA017011	A-S Medication Solutions	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5282_81455578-b702-45f6-b99c-22968f4a4f38	50090-5282	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20050825		ANDA	ANDA065136	A-S Medication Solutions	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-5284_cd9aaa14-e9ae-4307-b837-be45f047b65d	50090-5284	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20121018		ANDA	ANDA075269	A-S Medication Solutions	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5285_63948b5c-a27b-48cb-939b-3b82cf59e59a	50090-5285	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20051018		ANDA	ANDA065144	A-S Medication Solutions	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-5286_d192df4c-a408-4b8f-9cb4-8c7221091678	50090-5286	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	A-S Medication Solutions	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-5287_270e52df-d16b-4a96-b751-ff580c2f00c4	50090-5287	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20170925		NDA AUTHORIZED GENERIC	NDA018333	A-S Medication Solutions	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
50090-5288_3847be6e-8942-4a1f-8a91-78c75aa1698c	50090-5288	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		DIMETHYL FUMARATE	CAPSULE, DELAYED RELEASE	ORAL	20200924		ANDA	ANDA210500	A-S Medication Solutions	DIMETHYL FUMARATE	240	mg/1			N	20241231
50090-5293_66c3bb56-0642-4ebb-b9ac-7ac6b91843f2	50090-5293	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	A-S Medication Solutions	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-5294_077cd5d9-bda2-4de5-a882-7de9948db5b8	50090-5294	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	A-S Medication Solutions	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5297_7a2ede87-19fc-48d6-b54e-43ad660187ab	50090-5297	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-5299_06f4b6eb-beb0-48ae-a320-de15f5740fd7	50090-5299	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	A-S Medication Solutions	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-5306_1609f2d2-6893-42a4-ae4f-02c867fd5ee8	50090-5306	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150708		ANDA	ANDA202821	A-S Medication Solutions	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
50090-5309_62aaae85-fee2-4706-884b-c898d3dff6cf	50090-5309	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	A-S Medication Solutions	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-5310_f2224058-b05d-4719-ad1e-85194a6f2e3d	50090-5310	HUMAN OTC DRUG	GAVILAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA091077	A-S Medication Solutions	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50090-5312_5d70869d-59cb-4cbe-80a1-0b4106c4eab0	50090-5312	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	A-S Medication Solutions	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5313_7179bb36-c5cd-4c47-9f5c-f8a19f41ced0	50090-5313	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180912		OTC MONOGRAPH DRUG	M013	A-S Medication Solutions	ACETAMINOPHEN	500	mg/1			N	20241231
50090-5315_7b3059b0-402b-4cea-88c4-5e7e787a34e7	50090-5315	HUMAN PRESCRIPTION DRUG	Nystatin		NYSTATIN	SUSPENSION	ORAL	20200717		ANDA	ANDA203621	A-S Medication Solutions	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
50090-5325_f68bfe89-9f78-498b-828d-4ea58c4af9bf	50090-5325	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	A-S Medication Solutions	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5327_107dcbf9-9c02-41fe-859d-e9b418b62d3c	50090-5327	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20161215		ANDA	ANDA208709	A-S Medication Solutions	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-5328_6e2b5ad2-48ed-4517-a301-a16403e61a9a	50090-5328	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	A-S Medication Solutions	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5329_0c824968-0f36-43d5-bbd2-343cb06c6658	50090-5329	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20120424		ANDA	ANDA077027	A-S Medication Solutions	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
50090-5330_05b466ea-5127-473e-b037-95e9ca9662b3	50090-5330	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076274	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-5331_b6e97cd0-a8d8-422b-9a71-b90b80ce8879	50090-5331	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20190501		ANDA	ANDA207057	A-S Medication Solutions	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-5333_21d6b8fe-8c6e-4584-a091-d5ccd1984865	50090-5333	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5334_c799e3b4-7b1b-440e-ad0a-02eee6a2d8df	50090-5334	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-5335_dbf5cc65-196b-4d7c-a311-d30c7d9fef63	50090-5335	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181219		ANDA	ANDA210921	A-S Medication Solutions	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-5339_d7eaf085-c1ae-43ef-bb69-16a195c423b5	50090-5339	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	A-S Medication Solutions	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5340_296c27bd-561c-4f3f-a0d2-298de63e60aa	50090-5340	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	A-S Medication Solutions	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5342_1c5881e8-a567-4945-800b-49b0e4441f28	50090-5342	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051103		ANDA	ANDA075293	A-S Medication Solutions	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-5344_197add28-495a-4ea8-bb12-6600bf97151e	50090-5344	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	A-S Medication Solutions	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5345_48d61518-d6f5-4b1e-8d5f-88cdd766a17d	50090-5345	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5346_0e7db024-f779-41ca-9fcc-a0b707320279	50090-5346	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	A-S Medication Solutions	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-5347_03b137fc-9288-4d55-9193-081dc2165533	50090-5347	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
50090-5349_0d975b5a-2168-45c5-8c36-d28210d84161	50090-5349	HUMAN PRESCRIPTION DRUG	Scopolamine		scopolamine	PATCH	TRANSDERMAL	20190619		ANDA	ANDA203753	A-S Medication Solutions	SCOPOLAMINE	1	mg/3d	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-5350_81b6c0c2-d012-4c85-bbfa-efaedc2e7236	50090-5350	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180912		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	500	mg/1			N	20241231
50090-5353_2d660e74-e22d-4493-9e7b-51c8031c3c69	50090-5353	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-5356_fefcec1f-2d32-4111-a1a7-1d66bb197f93	50090-5356	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH NOT FINAL	part334	A-S Medication Solutions	DOCUSATE SODIUM	250	mg/1			N	20241231
50090-5357_2ea4f94f-bc85-40e5-b2f2-f56c0419e602	50090-5357	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA078466	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5359_6c4751ed-4ae4-453d-accc-25b7f42e7c18	50090-5359	HUMAN OTC DRUG	MECLIZINE		Meclizine HCl 25mg	TABLET, CHEWABLE	ORAL	20180201		OTC MONOGRAPH FINAL	part336	A-S Medication Solutions	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50090-5361_7becc541-9068-4c11-9211-e000b9e57ee6	50090-5361	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	A-S Medication Solutions	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5362_d02afee2-a290-430d-9d5b-5dce49cbb0ab	50090-5362	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20150601		ANDA	ANDA040428	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-5363_dddab767-63d0-47dd-8415-48ae08d2e41d	50090-5363	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191121		ANDA	ANDA213136	A-S Medication Solutions	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5366_eafd3275-4da4-4bc7-95d5-f2d218013280	50090-5366	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207398	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-5367_dbfea09e-c8a0-4e2e-a7f3-d97a54b631be	50090-5367	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	A-S Medication Solutions	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5371_413ee906-4d92-46f1-af67-e568524fc124	50090-5371	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-5373_bd76931e-a844-4564-972a-c442eb051e8f	50090-5373	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-5376_f21ab02c-45c8-4933-8ab6-e676d3062dda	50090-5376	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207398	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-5378_3eab803f-6666-43bc-a22b-bbade6c881e3	50090-5378	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	A-S Medication Solutions	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5379_c099abfc-1d80-4996-a1b5-9f7ccb7e9414	50090-5379	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	A-S Medication Solutions	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5380_3fb9d286-cf7e-449d-9d37-900849628384	50090-5380	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	A-S Medication Solutions	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-5386_e12e92fc-1d46-43f0-85b4-1d2c99bea8c3	50090-5386	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA078671	A-S Medication Solutions	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5389_6ca33aba-8342-4742-aba5-5ee226315b1f	50090-5389	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA078466	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5391_386fe9e8-2c9c-4bec-9ce1-8a333e147806	50090-5391	HUMAN PRESCRIPTION DRUG	Insulin Lispro		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200212		BLA	BLA020563	A-S Medication Solutions	INSULIN LISPRO	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
50090-5392_c30d818c-ddc1-42d0-b9a1-2573a63bd149	50090-5392	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5396_060b6bdc-9ddc-4a8f-9c90-d686707bc9ce	50090-5396	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-5397_d54849ef-363f-43c5-ab89-c491f90fea0d	50090-5397	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-5400_cef0183c-6e38-4b99-99d0-f6909372c942	50090-5400	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20171110		ANDA	ANDA205823	A-S Medication Solutions	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-5402_52f045ae-6fbf-43f4-8b3e-d22352c2ab22	50090-5402	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20200903		ANDA	ANDA209281	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5403_93bc58a9-9cb9-4441-8912-53053f8abb0b	50090-5403	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20130411		ANDA	ANDA202717	A-S Medication Solutions	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50090-5404_fe4794ce-2a04-4105-92e2-dfc0238ff3b8	50090-5404	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100205		ANDA	ANDA078466	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5405_c479da67-ccd3-4cae-96c2-0d99d4a527ab	50090-5405	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
50090-5408_88f2c342-e51b-432e-8aae-1fdae187ab44	50090-5408	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	A-S Medication Solutions	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5409_351ba2ac-be0c-4273-bc32-fa70e90b883d	50090-5409	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-5415_13483d93-57aa-42a6-86ea-ad308c07321a	50090-5415	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	A-S Medication Solutions	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5416_cf96b92b-c090-4758-ad6c-71e5ecff6f33	50090-5416	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	A-S Medication Solutions	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-5418_ed4ae8a2-fd12-46c1-989d-5ef6e9238d88	50090-5418	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	A-S Medication Solutions	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5420_dc071d00-269d-4a32-b4e6-485c55ab6cb3	50090-5420	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	A-S Medication Solutions	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-5422_cb78d0c3-de38-40ed-a74b-8391b860e1cb	50090-5422	HUMAN PRESCRIPTION DRUG	Ella		ulipristal acetate	TABLET	ORAL	20200511		NDA	NDA022474	A-S Medication Solutions	ULIPRISTAL ACETATE	30	mg/1	Progesterone Agonist/Antagonist [EPC], Selective Progesterone Receptor Modulators [MoA]		N	20241231
50090-5427_f9296928-e194-489f-ab20-3094e0166996	50090-5427	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170808		ANDA	ANDA207633	A-S Medication Solutions	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
50090-5428_3c1f9da4-af81-4f04-b9e7-984f85d86ef7	50090-5428	HUMAN PRESCRIPTION DRUG	Ketorolac tromethamine		Ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190318		ANDA	ANDA204216	A-S Medication Solutions	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5429_3fa7e5ea-da92-4b30-bd78-d92f4d2498de	50090-5429	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	A-S Medication Solutions	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-5437_2d2cd04a-bf33-4f47-8b69-0baf82595ea0	50090-5437	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	A-S Medication Solutions	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5439_6622d992-22bf-4f50-a446-d20eb3fce66d	50090-5439	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	A-S Medication Solutions	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-5440_2f23e738-86d1-4c87-8dc4-325073723e92	50090-5440	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	A-S Medication Solutions	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
50090-5444_c6ec3078-15e0-4dc1-bd36-8a18ca0e8dd2	50090-5444	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50090-5445_d10a3d44-64b6-4a02-abeb-eb22523bd62c	50090-5445	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5446_181be8d2-bfe0-4c22-9929-7546550253eb	50090-5446	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5450_9ee7f46e-a2e2-4486-aa9e-4482ae3b0df2	50090-5450	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20201001		ANDA	ANDA208847	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5452_3094b051-dd72-4fa0-94e6-15d57d6db553	50090-5452	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	A-S Medication Solutions	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-5457_822ce3ed-46da-46e9-9e18-36140d2e99af	50090-5457	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	19901101		ANDA	ANDA081099	A-S Medication Solutions	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
50090-5459_ab301ba1-4650-4fe2-9b37-424c0f2fed4b	50090-5459	HUMAN OTC DRUG	ACETAMINOPHEN 325 MG		ACETAMINOPHEN	TABLET	ORAL	20151101		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	325	mg/1			N	20241231
50090-5466_f4cacaa2-218f-48ae-9035-c07e9423889b	50090-5466	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	A-S Medication Solutions	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-5467_68b8dd5a-c40a-4004-97c3-c989f85bba82	50090-5467	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20200903		BLA	BLA125469	A-S Medication Solutions	DULAGLUTIDE	3	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-5468_9b84c57f-716c-4263-a62a-67538fa97859	50090-5468	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	A-S Medication Solutions	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5469_fe46b7c7-cb54-4f6f-a158-43916e5013d1	50090-5469	HUMAN OTC DRUG	Tylenol Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20190819		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	500	mg/1			N	20241231
50090-5470_4612dfd1-b484-47e5-aa1e-84271a9fd5aa	50090-5470	HUMAN OTC DRUG	RUGBY HYDROCORTISONE WITH ALOE		HYDROCORTISONE	CREAM	TOPICAL	20200114		OTC MONOGRAPH NOT FINAL	part348	A-S Medication Solutions	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5473_c0926bd7-00ab-4b1f-a043-36091e98dfb8	50090-5473	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	A-S Medication Solutions	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-5474_4a157d6c-8de8-462f-ac20-b4c09e3295d0	50090-5474	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	A-S Medication Solutions	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
50090-5480_e956cb01-a44e-4855-9359-ce5787862311	50090-5480	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20171101		ANDA	ANDA078232	A-S Medication Solutions	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5481_9eb85519-96b5-4fad-bf7d-66d890d8ca06	50090-5481	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20171101		ANDA	ANDA078232	A-S Medication Solutions	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5483_c3dcb7c8-32ef-4f12-9144-c73dcdc4a49a	50090-5483	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-5488_a8f2dbc1-faf8-4507-9865-9d3e47fa079c	50090-5488	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	OINTMENT	TOPICAL	20180501		ANDA	ANDA208933	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50090-5490_e2ac7144-b263-43d2-9086-8729534abab7	50090-5490	HUMAN PRESCRIPTION DRUG	Telmisartan		telmisartan	TABLET	ORAL	20140707		ANDA	ANDA202397	A-S Medication Solutions	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5491_28b91c2a-e33a-4b09-8636-4c53ea6f1358	50090-5491	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20170117		ANDA	ANDA206553	A-S Medication Solutions	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
50090-5492_6ec2fad4-f0a6-4039-980d-0075f5174d90	50090-5492	HUMAN PRESCRIPTION DRUG	Telmisartan		telmisartan	TABLET	ORAL	20140707		ANDA	ANDA202397	A-S Medication Solutions	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5493_20378fa4-7c7f-4c6b-b931-68273e5e1f9f	50090-5493	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-5494_2e8f6ea5-8ff3-4e7c-8985-c4cc8cab1571	50090-5494	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	A-S Medication Solutions	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-5496_657da15c-a1f9-4bbe-b9f7-da1c4c5b5e8d	50090-5496	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20201030		OTC MONOGRAPH FINAL	M009	A-S Medication Solutions	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50090-5501_e23ee382-482a-477b-9ba1-b979f48b8bfd	50090-5501	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	A-S Medication Solutions	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5502_7511c56d-21ea-4bad-89b9-62329c2e3d75	50090-5502	HUMAN PRESCRIPTION DRUG	JANUMET		SITAGLIPTIN and METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20070330		NDA	NDA022044	A-S Medication Solutions	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	1000; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5503_5ecef164-e711-462e-8b65-5ecba25393c4	50090-5503	HUMAN PRESCRIPTION DRUG	JANUMET		SITAGLIPTIN and METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20070330		NDA	NDA022044	A-S Medication Solutions	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	1000; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5504_daeedefc-b17c-4c81-8677-dc75b1eb8af2	50090-5504	HUMAN PRESCRIPTION DRUG	JANUMET	XR	sitagliptin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120202		NDA	NDA202270	A-S Medication Solutions	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	1000; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5506_92ab2db9-d41b-42d1-b0e5-4fae3f5947f1	50090-5506	HUMAN OTC DRUG	Sunmark Loratadine		Loratadine	TABLET	ORAL	20070621		ANDA	ANDA076301	A-S Medication Solutions	LORATADINE	10	mg/1			N	20241231
50090-5508_25287712-888d-4b0d-b4c1-374d1d6f8322	50090-5508	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	A-S Medication Solutions	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-5509_0dff81a9-0da7-4470-a013-b245bb5ec3fa	50090-5509	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	A-S Medication Solutions	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-5510_7d4124eb-c5be-4a8b-90ea-0d02e1d841bc	50090-5510	HUMAN OTC DRUG	Cetirizine		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA078336	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-5517_a79dbbc6-143b-4dd8-ab1a-8d640f077afd	50090-5517	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5524_ce62f6bc-9164-4c34-b56a-77b679202add	50090-5524	HUMAN OTC DRUG	Docusate Sodium		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20081028		OTC MONOGRAPH NOT FINAL	part334	A-S Medication Solutions	DOCUSATE SODIUM	100	mg/1			N	20241231
50090-5532_cc259140-817e-45b6-ace5-e8f26d8fe0a3	50090-5532	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20181206		ANDA	ANDA076301	A-S Medication Solutions	LORATADINE	10	mg/1			N	20241231
50090-5535_05d405aa-cfa9-4bd7-a096-708c3841a788	50090-5535	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20121213		OTC MONOGRAPH NOT FINAL	part343	A-S Medication Solutions	ACETAMINOPHEN	500	mg/1			N	20241231
50090-5540_da663ac4-d9e8-4233-acdf-4bd9aefc4552	50090-5540	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170710		ANDA	ANDA202824	A-S Medication Solutions	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-5543_9a43c172-e359-48f7-813d-1ba3c70a522e	50090-5543	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	A-S Medication Solutions	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-5547_1325f170-4498-4996-ba8f-617f081b318e	50090-5547	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5550_3ca434ad-c551-4bea-8f50-625640c8970c	50090-5550	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	A-S Medication Solutions	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5552_c072b85e-77e4-4f8b-949d-5c5bdad260dc	50090-5552	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180531		ANDA	ANDA209735	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5553_812e0fac-58df-4590-bbe6-ff3f39d21753	50090-5553	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	A-S Medication Solutions	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-5554_80f5476f-667c-4b46-9aaf-be2531f61c5e	50090-5554	HUMAN OTC DRUG	Pseudoephedrine hydrochloride		Pseudoephedrine hydrochloride	TABLET, FILM COATED	ORAL	20060428		ANDA	ANDA077442	A-S Medication Solutions	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-5560_00a12f6d-3284-42ef-886c-8d5260e868b3	50090-5560	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	A-S Medication Solutions	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50090-5562_f60a5f13-501f-48b6-b13e-62160b4f343f	50090-5562	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20170324		ANDA	ANDA203572	A-S Medication Solutions	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-5570_ac33434a-791b-4d7e-8360-d2d168c81fe7	50090-5570	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5571_854be77b-2a59-4141-a411-7931a2a63304	50090-5571	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	19901130		ANDA	ANDA073193	A-S Medication Solutions	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5573_8ca0749d-9855-48cd-bbcc-f28a24fd9513	50090-5573	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20191001		ANDA	ANDA040657	A-S Medication Solutions	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
50090-5574_b2747bb4-79a6-4e24-aa7c-79fe610523e1	50090-5574	HUMAN PRESCRIPTION DRUG	Alogliptin		Alogliptin	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022271	A-S Medication Solutions	ALOGLIPTIN BENZOATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5577_95d53217-3aba-4693-97b1-99e6bc56d048	50090-5577	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20201224		ANDA	ANDA078895	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-5580_c9593ce5-e926-4719-820f-62a6ad0745c1	50090-5580	HUMAN PRESCRIPTION DRUG	Vienva TM		Levonorgestrel and Ethinyl Estradiol	KIT		20180315		ANDA	ANDA201088	A-S Medication Solutions						N	20241231
50090-5582_b4d55479-9a8f-42ac-a0c8-4239073cda7c	50090-5582	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride		Pioglitazone Hydrochloride	TABLET	ORAL	20201028		ANDA	ANDA076798	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-5585_cfeddd56-d91c-42ee-91d2-98e5cf752e55	50090-5585	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	A-S Medication Solutions	SITAGLIPTIN PHOSPHATE	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5586_cd891e71-c2f7-4f1b-a871-0cf669450877	50090-5586	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	A-S Medication Solutions	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
50090-5587_d26a15bd-6af9-4915-b2e0-e3d953907c75	50090-5587	HUMAN PRESCRIPTION DRUG	Ivermectin		Ivermectin	TABLET	ORAL	20141115		ANDA	ANDA204154	A-S Medication Solutions	IVERMECTIN	3	mg/1	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
50090-5588_9d257684-b767-4d5a-b29f-7f5b4bc109d7	50090-5588	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	A-S Medication Solutions	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50090-5589_0fedba61-4fe5-4901-8ba2-b7bc9a84c426	50090-5589	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	A-S Medication Solutions	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
50090-5592_a756536d-01bf-4487-b796-a22d49eff381	50090-5592	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	A-S Medication Solutions	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
50090-5593_6d9375d0-5143-4f12-bb42-4eb7bbed70ea	50090-5593	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20171120		ANDA	ANDA209734	A-S Medication Solutions	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
50090-5596_34c5029f-951f-44f6-86a4-0ab593c59827	50090-5596	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	A-S Medication Solutions	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
50090-5606_ff825a2d-2bc7-41b8-807f-484d8b84fa2b	50090-5606	HUMAN OTC DRUG	Phenylephrine HCl	Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200409		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50090-5607_5832c1ef-9d62-42ca-a90f-dc6748fb17cf	50090-5607	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	20210629		OTC MONOGRAPH DRUG	M005	A-S Medication Solutions	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-5609_dd320e54-f40e-4419-9ed4-2b4e485a56f2	50090-5609	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200201		ANDA	ANDA204216	A-S Medication Solutions	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5610_1806c991-1ce1-4bbd-be83-23bc48deaf7f	50090-5610	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20210527		ANDA	ANDA075090	A-S Medication Solutions	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-5611_977cb584-edcb-49b9-9ab5-65074888bf94	50090-5611	HUMAN PRESCRIPTION DRUG	NUVARING		etonogestrel and ethinyl estradiol	INSERT, EXTENDED RELEASE	VAGINAL	20210601		NDA	NDA021187	A-S Medication Solutions	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-5613_ad614edb-7707-4477-b804-0216f8dbc8cb	50090-5613	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	A-S Medication Solutions	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
50090-5614_97b4a6a7-d4fa-499e-aad4-0ed13cf8e4e8	50090-5614	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161114		ANDA	ANDA202557	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
50090-5615_32a348b0-eed2-48cf-b609-cc7e7ea19e08	50090-5615	HUMAN OTC DRUG	pseudoephedrine hydrochloride		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20081017		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-5616_c37e4cd3-22d5-432a-899b-eee6da953de8	50090-5616	HUMAN PRESCRIPTION DRUG	JANUMET		SITAGLIPTIN and METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20070330		NDA	NDA022044	A-S Medication Solutions	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	500; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5617_6c9ca2af-b4ef-454d-ba56-d0c0205ef886	50090-5617	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	TABLET	ORAL	20161027		ANDA	ANDA205530	A-S Medication Solutions	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
50090-5618_1f6a6065-70b8-491b-bdad-991476ec49e7	50090-5618	HUMAN PRESCRIPTION DRUG	JANUMET		SITAGLIPTIN and METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20070330		NDA	NDA022044	A-S Medication Solutions	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	500; 50	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5619_a0b48c1c-1896-49da-8f5c-17538f25413c	50090-5619	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20210706		NDA AUTHORIZED GENERIC	NDA020246	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-5621_aae24572-c3f8-4e8e-9f06-521a7937ab2e	50090-5621	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-5625_22aab262-5705-4bdf-b195-78a8cb601669	50090-5625	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide	SYRUP	ORAL	20150206		ANDA	ANDA205292	A-S Medication Solutions	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-5626_195bfb91-3e55-4461-897a-453e5963bcd9	50090-5626	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20171101		ANDA	ANDA078232	A-S Medication Solutions	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-5632_fd41bf4c-0472-45aa-8818-668133509236	50090-5632	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5633_c8f2f27d-0476-44d9-8a46-da01eccf390a	50090-5633	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924	20240831	ANDA	ANDA204991	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
50090-5634_25b440e3-4eff-4c68-bd46-78d143e3ae55	50090-5634	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5636_06ee643f-7f87-489c-996b-6d40504485f7	50090-5636	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5638_0d540a4e-27a4-4acc-b51c-5e6f9873dded	50090-5638	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20191209		ANDA	ANDA202240	A-S Medication Solutions	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5639_17bff0c8-bf96-4a95-99ef-5d57f09fdb19	50090-5639	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5641_2c9c96a8-5561-4fd3-9b71-8b14032a2fc7	50090-5641	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	A-S Medication Solutions	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5643_4a932f66-fffd-4432-b47e-c3d1f5ad55db	50090-5643	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20210520		ANDA	ANDA214129	A-S Medication Solutions	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-5645_46005fda-f4b3-47c8-b75d-0ba71b69c673	50090-5645	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5651_e870fa8d-9127-439a-ad50-fa0a5a4ee0d0	50090-5651	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-5654_53a4673a-6fd9-4913-910a-1e97190315fe	50090-5654	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-5659_9b06bc10-3015-48ca-b249-9e12c0629752	50090-5659	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-5661_345cee99-1518-414f-a723-2fef5b2c29fb	50090-5661	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-5663_57b255bf-2908-470b-a3d3-0bb6e452900d	50090-5663	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	A-S Medication Solutions	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-5664_d306b804-186b-44c1-bb43-23d43c773ec5	50090-5664	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	A-S Medication Solutions	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-5665_6c61b940-b66a-47ff-9b6a-48ff5f397aac	50090-5665	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200511		ANDA	ANDA212861	A-S Medication Solutions	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-5666_b626e5ea-7a48-4525-b9a3-d7c0739639dd	50090-5666	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	A-S Medication Solutions	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-5667_91dfef68-de28-4ebe-8b8a-f18965a77c85	50090-5667	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	OROPHARYNGEAL	20070227	20240531	ANDA	ANDA040708	A-S Medication Solutions	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
50090-5672_f347fd75-39a6-447e-a279-e720171cb687	50090-5672	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20070919		ANDA	ANDA078164	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5673_7c078258-37ca-41c0-bd92-c037b3030c5a	50090-5673	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	A-S Medication Solutions	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-5674_d80e0a1c-83db-44b9-94b6-5e2e83c630d5	50090-5674	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	20210629		OTC MONOGRAPH DRUG	M005	A-S Medication Solutions	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-5676_6b30a823-54cc-4409-8a68-b1c6e06c5402	50090-5676	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5677_65261f50-86a3-4e92-a5e3-40653817a55b	50090-5677	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	A-S Medication Solutions	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
50090-5678_408d896f-b277-4704-af46-2ae66544d1bc	50090-5678	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5679_d3f5652b-4149-4b50-a9e3-c38972af2800	50090-5679	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-5680_1975a56c-cdd2-4c69-8d86-f728862ab56c	50090-5680	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-5682_2ce53b00-a0cf-456d-9d9a-ed9c91780c31	50090-5682	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-5686_87102d10-a37e-4842-898a-f907f05b80d5	50090-5686	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181113		ANDA	ANDA210918	A-S Medication Solutions	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50090-5687_2e7fc983-d9f5-48ed-befc-fa6d90b32d52	50090-5687	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-5688_9a6ee7b9-8c85-4e90-beaa-60d38a8b67c8	50090-5688	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-5691_92d7f3e6-cbfc-49e1-937f-1968c988c21d	50090-5691	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	A-S Medication Solutions	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-5693_e06435c7-1faf-4915-ad61-8b431cf3a53c	50090-5693	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20160415		ANDA	ANDA201722	A-S Medication Solutions	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
50090-5694_6d546370-640f-4edf-b281-2a8e3f828774	50090-5694	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 20/12.5	TABLET	ORAL	20170424	20240531	ANDA	ANDA206515	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
50090-5695_d4295aab-774d-454c-9e85-6686c2e5dbcd	50090-5695	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	A-S Medication Solutions	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-5702_01334b9e-b775-42e5-b6af-264ff2c882fc	50090-5702	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	A-S Medication Solutions	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-5703_bec46141-46f9-4545-ae9b-0f9f351f004f	50090-5703	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20120910		ANDA	ANDA078169	A-S Medication Solutions	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5708_3f276fdf-1952-4676-8192-1637e98eabc8	50090-5708	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5709_df7c7de7-f8e3-4351-898d-008666993296	50090-5709	HUMAN PRESCRIPTION DRUG	rifampin		rifampin	CAPSULE	ORAL	20140108		ANDA	ANDA090034	A-S Medication Solutions	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
50090-5710_c71bfca7-0a94-45eb-b0d6-4a1d01c44232	50090-5710	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20130513		ANDA	ANDA090867	A-S Medication Solutions	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-5711_0cbd4000-e54c-4cae-945b-d503c8e00131	50090-5711	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5712_1e9ca337-e55e-4e55-8dc0-d75d1f8aed37	50090-5712	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5713_20e118d9-a0e9-4dbe-895e-36eede2b91a2	50090-5713	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5716_96bb0a7a-9a5e-4232-aa2d-f52196784f71	50090-5716	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-5720_b27cac11-6bb2-4e64-922e-899f20ec0dc0	50090-5720	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5721_50a31894-f470-4e51-80de-3929bab7ef5d	50090-5721	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5722_13c14b03-cabb-4476-ab7b-c1eda358d44c	50090-5722	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5723_6bcb7236-a6fe-449b-a3bb-8c7dbe77e2b8	50090-5723	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5726_112bce25-6467-4f51-9d28-a021de6f847e	50090-5726	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	A-S Medication Solutions	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
50090-5727_9d0bedaa-8707-4659-b79d-f34989c2d26c	50090-5727	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20201029		ANDA	ANDA213957	A-S Medication Solutions	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50090-5728_154a8e7e-94cf-413f-9a2b-5f07b7bfa61c	50090-5728	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20201029		ANDA	ANDA213957	A-S Medication Solutions	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50090-5730_0bfa08c7-2c74-4436-aa35-8cd37a21bd75	50090-5730	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	A-S Medication Solutions	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-5733_96b4f61f-0809-491a-8047-218634477cf8	50090-5733	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	A-S Medication Solutions	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5738_25bc96b5-0c59-49cd-9d2c-d56db5915479	50090-5738	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071031		ANDA	ANDA078512	A-S Medication Solutions	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5740_734f0596-fbf2-4d22-befc-930579c98dc5	50090-5740	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20200421		ANDA	ANDA207798	A-S Medication Solutions	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-5741_2a2cb20e-d82d-4dab-8a26-4be38e8d02a2	50090-5741	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071031		ANDA	ANDA078512	A-S Medication Solutions	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5744_3fb53b3c-379a-41f1-9f31-3861f25e251e	50090-5744	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-5745_50612acf-dd02-4959-9fde-24c86839c8c1	50090-5745	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5746_24b52da3-823c-4fd6-a2ad-c97f8e5a0503	50090-5746	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5747_c67cfd3e-5e80-4e92-8046-ca9c13946bf2	50090-5747	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20191125		ANDA	ANDA210761	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-5750_df1bc99a-e8e9-4624-8725-c110daca9dca	50090-5750	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	A-S Medication Solutions	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-5751_cc4b973d-fa29-4cc9-b79d-f7624d9ac64f	50090-5751	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	A-S Medication Solutions	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-5752_e3d90d5c-a9a3-45b9-b2ea-f2d0d521e87a	50090-5752	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5756_05a464b8-f745-42cf-ba4b-afae5c77f1bd	50090-5756	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5761_26df2438-2d17-4683-b43d-68e6605495b3	50090-5761	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5762_f2c65de2-1a9d-4807-b9e0-2b6c5cbcb48d	50090-5762	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
50090-5764_d02789c9-d0d8-4d32-8b97-be24c2b26e44	50090-5764	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	A-S Medication Solutions	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-5766_144da1fc-bf68-44fc-a6ad-9f1d00d6838f	50090-5766	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20200901		ANDA	ANDA213446	A-S Medication Solutions	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-5767_1d8e84e8-f07d-40dd-8710-2c044ec48533	50090-5767	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	A-S Medication Solutions	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-5768_0c35725f-8a21-4dfd-a01e-2e9cab78cbeb	50090-5768	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-5769_ffc8c24f-c08f-4d75-9632-f083487d3ee9	50090-5769	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	19970520		ANDA	ANDA074747	A-S Medication Solutions	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5770_b234305b-f0b3-4140-a717-60e24f2f0699	50090-5770	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5771_75f25202-82d2-4f63-a2d2-4dc6d703db79	50090-5771	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5772_2e951b86-f856-487a-a446-7f36550a221a	50090-5772	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5773_68eb5483-1564-409b-b6e8-e658728b425c	50090-5773	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170614		ANDA	ANDA202824	A-S Medication Solutions	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-5775_28ef47f3-802f-4c13-8824-2cd5a43ae82a	50090-5775	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5776_e847f32b-6c85-4e8d-8733-3b0b850016eb	50090-5776	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	A-S Medication Solutions	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-5777_53a03a68-4cd2-4dff-ae48-d1882cd67705	50090-5777	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5778_65db89ab-c4c6-41b7-8f0d-e838cae7ef1f	50090-5778	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SOLUTION	TOPICAL	20171104		ANDA	ANDA209361	A-S Medication Solutions	CLOBETASOL PROPIONATE	.4625	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5779_583d05a5-b7e7-4b29-97b0-2d861f80fd55	50090-5779	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20200301		ANDA	ANDA209846	A-S Medication Solutions	CLINDAMYCIN PHOSPHATE	11.9	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-5781_2376e05a-017f-4445-ab6a-74bcf15852c7	50090-5781	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20121016		ANDA	ANDA202928	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-5786_9bc57b80-e93c-4655-a056-644e483a263a	50090-5786	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20070124		ANDA	ANDA077785	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-5787_97b26ff9-6392-4ba3-be9e-f71bbd2921a6	50090-5787	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	A-S Medication Solutions	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50090-5788_378c923f-8430-46d7-b5ab-3a8ec007f347	50090-5788	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160105		ANDA	ANDA078103	A-S Medication Solutions	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5789_92080c7d-41b5-4a3e-a6c6-39158e4843ad	50090-5789	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA211825	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
50090-5790_4f43532a-3a7b-44d7-8df1-64e14dcd0f99	50090-5790	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA211825	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
50090-5792_bf13270d-ae3f-417e-aaf3-3ba92b255be8	50090-5792	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-5793_5159b894-0a65-44d9-b28c-724268f779da	50090-5793	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	A-S Medication Solutions	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5794_77b17b3f-b660-422e-9037-50ce2c5c5f2c	50090-5794	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	A-S Medication Solutions	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5796_78a1916f-fe3e-47c5-85f2-77a9a1ea9920	50090-5796	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20180601		ANDA	ANDA200884	A-S Medication Solutions	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-5797_3425e3b2-645a-478f-adcf-5f9cc93a2e0c	50090-5797	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
50090-5799_5bb41a86-8975-42d4-a657-94bf7910916b	50090-5799	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20190225		ANDA	ANDA207420	A-S Medication Solutions	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
50090-5801_f1a0f370-c447-4acb-9b93-9f4302400c5d	50090-5801	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20180904		ANDA	ANDA208360	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5803_22086354-7198-47db-b951-67d267d92f1d	50090-5803	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	A-S Medication Solutions	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
50090-5804_1f6ac937-6707-4d59-846e-532afcfd45d1	50090-5804	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	A-S Medication Solutions	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
50090-5806_50844523-1657-40e7-ba83-320b4b91bc6c	50090-5806	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	A-S Medication Solutions	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-5808_7501d63d-0c6f-4910-8094-394403ee0ce9	50090-5808	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210120		ANDA	ANDA214603	A-S Medication Solutions	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
50090-5809_f22b7db7-372b-4cb8-a08f-7637e0fa46e0	50090-5809	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20071228		ANDA	ANDA077987	A-S Medication Solutions	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5810_3b41da76-67b3-4921-ae37-d0be4c8ada4c	50090-5810	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	A-S Medication Solutions	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
50090-5811_af5bca73-a913-4d8f-954d-a6ed48e02d5c	50090-5811	HUMAN PRESCRIPTION DRUG	cefdinir		cefdinir	POWDER, FOR SUSPENSION	ORAL	20210220		ANDA	ANDA210534	A-S Medication Solutions	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-5812_980e0124-8839-4ef7-81c1-a352e3300d83	50090-5812	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, FILM COATED	ORAL	20200724		ANDA	ANDA212434	A-S Medication Solutions	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
50090-5814_96102e8c-8b9e-445e-a364-5d1e36f15780	50090-5814	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA209727	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5816_9b7af65f-ad6c-46a4-b80d-f39ea6d80341	50090-5816	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA209727	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5818_4a0aea0e-7d7f-4a3c-82d1-cca96ef6bd6f	50090-5818	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	A-S Medication Solutions	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5819_928aea26-2b55-4e1c-9a7d-9aeddfdb32a5	50090-5819	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	A-S Medication Solutions	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5821_9ee8a62d-7b41-41d3-9405-87c162cc664f	50090-5821	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-5822_c61eb6a1-adbb-4482-a434-b1394e655d0f	50090-5822	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161214		ANDA	ANDA207138	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-5824_563642a0-1c34-4e03-8248-9f179e24197d	50090-5824	HUMAN PRESCRIPTION DRUG	WEGOVY		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20210605		NDA	NDA215256	A-S Medication Solutions	SEMAGLUTIDE	.25	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-5825_a0de85a6-bbaa-4de7-96a3-cd6756b17f1e	50090-5825	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19840507		ANDA	ANDA062396	A-S Medication Solutions	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-5826_82bcf84a-7f49-423c-a1ec-17befb33993d	50090-5826	HUMAN PRESCRIPTION DRUG	FOSFOMYCIN TROMETHAMINE		Granules for Oral	POWDER	ORAL	20201006		ANDA	ANDA212548	A-S Medication Solutions	FOSFOMYCIN TROMETHAMINE	3	g/1			N	20241231
50090-5827_bf34956d-5b78-4375-aabe-ece922d4a7ef	50090-5827	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	A-S Medication Solutions	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50090-5830_0f97dbd6-3f6a-4063-80ec-03188660d083	50090-5830	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20120910		ANDA	ANDA078169	A-S Medication Solutions	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5832_fdbbca96-290b-4c82-b8ca-3f27106a5921	50090-5832	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20151013		ANDA	ANDA202840	A-S Medication Solutions	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
50090-5833_cded3df3-e9b0-4b92-9b33-a07da00b2c0b	50090-5833	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA076938	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-5834_2f4ab4e8-63aa-4382-90e7-7657b52c69f9	50090-5834	HUMAN PRESCRIPTION DRUG	Cabergoline		Cabergoline	TABLET	ORAL	20180809		ANDA	ANDA204735	A-S Medication Solutions	CABERGOLINE	.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
50090-5837_b01fbcb4-85b5-4a89-8a38-992bbec68ea5	50090-5837	HUMAN PRESCRIPTION DRUG	Benzphetamine Hydrochloride		Benzphetamine Hydrochloride	TABLET, FILM COATED	ORAL	20151216		ANDA	ANDA090346	A-S Medication Solutions	BENZPHETAMINE HYDROCHLORIDE	50	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
50090-5838_14207d3e-465e-4bb1-a8cc-c1e0f3ecd134	50090-5838	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201014		ANDA	ANDA212378	A-S Medication Solutions	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50090-5842_73156e35-eb53-4edf-b1db-ba2cdfa98467	50090-5842	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	A-S Medication Solutions	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-5844_ee82d665-455c-44b3-b7eb-ab0d836bc71f	50090-5844	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol Capsules,	CAPSULE	ORAL	20181210		ANDA	ANDA204276	A-S Medication Solutions	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
50090-5845_b497547b-3c93-4ea2-bc0e-5f0b1397b831	50090-5845	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20200624		ANDA	ANDA207767	A-S Medication Solutions	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
50090-5846_251e8089-c206-4019-99e6-58e8c89a735f	50090-5846	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	A-S Medication Solutions	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5847_bb4ba87d-4ad8-49c5-92a5-19fa82a4a081	50090-5847	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	A-S Medication Solutions	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5848_685df89d-5407-446a-ba5c-b4b6b1a8a47f	50090-5848	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5849_d478e960-e600-4467-a348-a30a4df6efa4	50090-5849	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA212678	A-S Medication Solutions	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
50090-5850_f10b029f-722e-4c7e-93ea-c21e8c05c0f3	50090-5850	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	A-S Medication Solutions	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50090-5852_6c3497d1-3e60-400f-bfef-0f72f87bb130	50090-5852	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	A-S Medication Solutions	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-5853_4ed19ca8-e239-41ce-afc3-4211caa41781	50090-5853	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	A-S Medication Solutions	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-5854_56e24dcd-78ac-4641-a391-94fe2a418a59	50090-5854	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20200701		ANDA	ANDA204019	A-S Medication Solutions	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-5855_30f0a112-e03f-4d8a-b7ec-1cbef4c5304b	50090-5855	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	A-S Medication Solutions	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50090-5859_ad7668d4-9529-4431-b8ff-3bb7d4e9866e	50090-5859	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	TABLET	ORAL	20180701		ANDA	ANDA085588	A-S Medication Solutions	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
50090-5861_35b99a59-ac61-447a-a16b-08ecbb7b1ad3	50090-5861	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	A-S Medication Solutions	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5862_c7f8d15e-5ae7-431d-ae43-1ad93910b3ec	50090-5862	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20150217		ANDA	ANDA076363	A-S Medication Solutions	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
50090-5863_fa954a9d-1523-4cfe-8a58-d6988cec87fb	50090-5863	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, COATED	ORAL	20060329		ANDA	ANDA065255	A-S Medication Solutions	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-5868_8ed73a37-390b-4cc9-a0b4-093637038100	50090-5868	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-5870_4c349c25-c277-4c0f-9ca4-f5296b652eff	50090-5870	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	A-S Medication Solutions	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-5873_73002a86-03ec-4b44-867e-c2e0ce94081f	50090-5873	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-5880_2de6f218-298e-430b-a240-78708ba1c39d	50090-5880	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, COATED	ORAL	20060329		ANDA	ANDA065255	A-S Medication Solutions	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-5884_5a3aca3c-b447-40dd-b79e-3b506791860d	50090-5884	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	A-S Medication Solutions	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-5888_74307089-9918-401b-a9e1-1ec6b4d56889	50090-5888	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin 5% w/w	CREAM	TOPICAL	20190408		ANDA	ANDA211303	A-S Medication Solutions	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
50090-5890_708bf3c0-c834-43cc-9fab-d22a0615ffc9	50090-5890	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-5891_a46f23f7-942a-41ff-a7c5-612352fa1348	50090-5891	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-5893_b6546725-2742-4aef-a3cf-0c53aeaea638	50090-5893	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20201219		ANDA	ANDA075229	A-S Medication Solutions	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-5894_eb4bb24a-1b71-4fe2-8d11-353ccf45c9cd	50090-5894	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20190520		ANDA	ANDA210043	A-S Medication Solutions	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5895_dc7664a2-5396-4a66-abce-7a832f5bfdec	50090-5895	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5901_1633f8fa-2915-48eb-bf22-90ce27228fbf	50090-5901	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190220		ANDA	ANDA212977	A-S Medication Solutions	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
50090-5904_27f3263a-5105-4ead-b90e-87ca5019f1b1	50090-5904	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
50090-5906_c4b0520b-1ae4-4da8-90de-e93016c34a76	50090-5906	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	A-S Medication Solutions	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-5907_997d15e2-6cf2-41a3-85d7-1b8c4d7e0458	50090-5907	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	A-S Medication Solutions	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-5908_fefa320d-95d8-414e-ad54-40c9f6d2c55d	50090-5908	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride Nasal	INHALANT	NASAL	20211220		NDA AUTHORIZED GENERIC	NDA208411	A-S Medication Solutions	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
50090-5915_6c7a94ae-865c-4ea6-8f80-3a1bd0872fbd	50090-5915	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5918_ab870a00-d776-4e40-b217-de1214258bab	50090-5918	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20210504		ANDA	ANDA214549	A-S Medication Solutions	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
50090-5921_01fedf0c-e08f-42b1-ba36-da9de3ebcdaf	50090-5921	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5923_5d5bd08b-8e58-4975-84dd-94a8663e1cbf	50090-5923	HUMAN PRESCRIPTION DRUG	Pregnyl		CHORIOGONADOTROPIN ALFA	KIT		19761020		BLA	BLA017692	A-S Medication Solutions						N	20241231
50090-5924_9f497755-dd55-441c-adf0-9648d98a91f1	50090-5924	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	INTRAVENOUS	20210217		ANDA	ANDA212461	A-S Medication Solutions	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-5925_66ef6644-216f-4f03-af6e-d3ca132cf7cc	50090-5925	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20211021		NDA AUTHORIZED GENERIC	NDA020246	A-S Medication Solutions	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-5926_99e7c450-2c83-487e-a326-76c1653723b8	50090-5926	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA200022	A-S Medication Solutions	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
50090-5928_c19fa1eb-b981-4cd7-beaa-1a3a68ddbecf	50090-5928	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20181026		ANDA	ANDA211285	A-S Medication Solutions	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
50090-5931_8e5b820b-07d1-4a48-af8f-4e9d732dc829	50090-5931	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19930831		ANDA	ANDA072640	A-S Medication Solutions	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-5932_27e10537-d417-4b91-83ce-144f1d2b946a	50090-5932	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-5937_e0de23e7-d197-4941-9791-043b87142dd4	50090-5937	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5939_12f97332-350e-4c0b-acf6-7cd63354b912	50090-5939	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA078295	A-S Medication Solutions	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
50090-5940_66bf0163-74cb-46b2-9189-8b26ef6d84b1	50090-5940	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-5942_01f5a844-b38f-43ca-ad85-e0806cc94aba	50090-5942	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-5944_275745bb-b010-45d6-9541-78d365e2dd46	50090-5944	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220101		NDA AUTHORIZED GENERIC	NDA022287	A-S Medication Solutions	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-5945_edd61e45-c897-408e-a4b1-01ac130a10fb	50090-5945	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA040904	A-S Medication Solutions	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
50090-5948_58f1ff5e-21cc-46d9-a453-c9f749ce7a3e	50090-5948	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20151019		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50090-5949_a5c23c93-1c61-4768-b7f2-1e430cd21a8d	50090-5949	HUMAN PRESCRIPTION DRUG	Ozempic		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20200930		NDA	NDA209637	A-S Medication Solutions	SEMAGLUTIDE	1.34	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-5952_ce0c8e83-63cd-49d4-b1c9-368b490a59f6	50090-5952	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20201030		OTC MONOGRAPH DRUG	M009	A-S Medication Solutions	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50090-5953_2cf88e0f-be0e-4fc6-ace8-b33f54bfaf8e	50090-5953	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	A-S Medication Solutions	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
50090-5955_804b147d-eef7-4eab-87d4-4703c5c34b26	50090-5955	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	A-S Medication Solutions	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
50090-5958_29660190-d05a-4aef-bbd4-d216b9c419be	50090-5958	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate USP, 1%	GEL	TOPICAL	20200113		ANDA	ANDA212438	A-S Medication Solutions	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
50090-5959_74985d3b-59fe-491b-bf40-962faa0274ab	50090-5959	HUMAN PRESCRIPTION DRUG	Etonogestrel/Ethinyl Estradiol		etonogestrel and ethinyl estradiol	INSERT, EXTENDED RELEASE	VAGINAL	20210601		NDA AUTHORIZED GENERIC	NDA021187	A-S Medication Solutions	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-5960_f2351ecd-0078-41ba-bd32-769fd8977ede	50090-5960	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5962_321701b0-f525-4704-ad7f-87c8bf8d01de	50090-5962	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5963_ca2464e2-e2b2-4d11-a546-123ed1e4ccdb	50090-5963	HUMAN PRESCRIPTION DRUG	Pyrazinamide		Pyrazinamide	TABLET	ORAL	20210511		ANDA	ANDA080157	A-S Medication Solutions	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
50090-5967_1c84eb20-fec8-4d59-a3df-013359c16572	50090-5967	HUMAN OTC DRUG	FLONASE SENSIMIST	ALLERGY RELIEF	fluticasone furoate	SPRAY, METERED	NASAL	20170201		NDA	NDA022051	A-S Medication Solutions	FLUTICASONE FUROATE	27.5	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5968_08f74948-1549-4dd3-b93f-be28dbd3e097	50090-5968	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		ipratropium bromide	SPRAY, METERED	NASAL	20200526		ANDA	ANDA076155	A-S Medication Solutions	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-5969_755bfbb2-176d-4a95-81b6-d947637f82ac	50090-5969	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210507		ANDA	ANDA214092	A-S Medication Solutions	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50090-5970_252921c9-9d25-414b-9dc9-40585f49ba83	50090-5970	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	A-S Medication Solutions	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-5971_38107038-38f9-4d48-a0a3-c4e4203e9103	50090-5971	HUMAN OTC DRUG	Rugby Regular Strength Acetaminophen		Acetaminophen	TABLET	ORAL	20210311		OTC MONOGRAPH DRUG	M013	A-S Medication Solutions	ACETAMINOPHEN	325	mg/1			N	20241231
50090-5978_ed3f7b10-a3ca-45b2-94ae-ba22560450f0	50090-5978	HUMAN OTC DRUG	Plan B One-Step		levonorgestrel	TABLET	ORAL	20180510		NDA	NDA021998	A-S Medication Solutions	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
50090-5979_b7f86f9d-4521-4b49-90d3-0c4d273f9f8a	50090-5979	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate Cream USP, 0.05%	Clobetasol Propionate Cream USP, 0.05%	Clobetasol Propionate USP, 0.05%	CREAM	TOPICAL	20201001		ANDA	ANDA212982	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5980_53545079-9e5b-4dc5-b5ca-189bf245d22a	50090-5980	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20061110		ANDA	ANDA087385	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-5983_b4e6db7c-73f8-453b-82f7-d865e23dda83	50090-5983	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	A-S Medication Solutions	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-5984_c7796a9c-a68a-48ff-a049-c7c1d685d18c	50090-5984	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	A-S Medication Solutions	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50090-5985_67e8d1ee-ea2c-48ad-911f-696692652d2e	50090-5985	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120921		ANDA	ANDA078020	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-5986_6a48ed2b-8479-4e06-8048-e48453bf80d7	50090-5986	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-5988_32bc2aa5-854d-4d66-a8d1-bcb5a6dded74	50090-5988	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20110809		NDA AUTHORIZED GENERIC	NDA021519	A-S Medication Solutions	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-5992_6c9b6520-ed77-4663-b29d-36b70840f429	50090-5992	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET, FILM COATED	ORAL	20210329		ANDA	ANDA213652	A-S Medication Solutions	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
50090-5993_58968f11-76a2-4e8d-8414-dc636614dedb	50090-5993	HUMAN PRESCRIPTION DRUG	alogliptin and metformin hydrochloride		alogliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA203414	A-S Medication Solutions	ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE	12.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-5996_19ea574c-7ae8-4577-9189-c095bbc131e2	50090-5996	HUMAN OTC DRUG	Rugby Lubricating Drops		Polyvinyl Alcohol	SOLUTION/ DROPS	OPHTHALMIC	20210419		OTC MONOGRAPH DRUG	M018	A-S Medication Solutions	POLYVINYL ALCOHOL	14	mg/mL			N	20241231
50090-5998_7173ecf1-644e-4c21-bbdd-f58d2ddfe0a2	50090-5998	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	A-S Medication Solutions	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50090-5999_fa0045a1-b3ca-45cb-b8db-b8696c505268	50090-5999	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20020930		ANDA	ANDA089682	A-S Medication Solutions	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6014_a790037d-79fe-46b6-8337-9800d4106259	50090-6014	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19730112		ANDA	ANDA083177	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6020_6922714f-5cc7-4329-b07a-4c148c83a7b9	50090-6020	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20181105		ANDA	ANDA209692	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-6023_77d085a4-81b9-4807-8b43-3b10780c2e77	50090-6023	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	A-S Medication Solutions	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6027_ce321bb5-3271-4e30-beef-bdd6d94fc1f9	50090-6027	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20201001		ANDA	ANDA208847	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6028_ffcfa748-953b-4d6f-aea9-bff55e7a2bac	50090-6028	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20090127		ANDA	ANDA078947	A-S Medication Solutions	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50090-6030_4de38b83-6511-4845-8a07-3207a4077fab	50090-6030	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220126		ANDA	ANDA215995	A-S Medication Solutions	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
50090-6033_ad2fad43-82bf-4c15-877e-8f53fedaf514	50090-6033	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	A-S Medication Solutions	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
50090-6034_e6179e6c-4fd5-4340-a555-4b93a506e206	50090-6034	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6035_78ac1148-3977-4e81-a57f-d09c59a41267	50090-6035	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20151228		ANDA	ANDA075882	A-S Medication Solutions	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
50090-6041_71ed5df1-1bf7-43ed-8564-50a121f30c19	50090-6041	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	A-S Medication Solutions	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-6042_9b3bfda0-2a6a-4547-b96d-b1d5f2b9817b	50090-6042	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	A-S Medication Solutions	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-6043_cad2cea9-68bf-4e4e-afc6-60bd21846b6c	50090-6043	HUMAN PRESCRIPTION DRUG	CIPRO	HC	ciprofloxacin hydrochloride and hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19990315		NDA	NDA020805	A-S Medication Solutions	CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE	2; 10	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-6044_fe57f46d-1a31-45d4-bdc4-941406d5cf02	50090-6044	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	A-S Medication Solutions	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6046_9cb63b5f-73e6-404b-8d38-438f82bbdecd	50090-6046	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole Cream, 2%	CREAM	TOPICAL	20210527		ANDA	ANDA212443	A-S Medication Solutions	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-6049_483885a7-a6fa-46a4-83f8-e4e3750a551e	50090-6049	HUMAN PRESCRIPTION DRUG	GONAL-F RFF		follitropin alfa	KIT	SUBCUTANEOUS	20040325		BLA	BLA021765	A-S Medication Solutions						N	20241231
50090-6050_a3e71133-dd0d-47a9-9743-395af7a85a8c	50090-6050	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	A-S Medication Solutions	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-6051_52d28c75-c5a5-4389-abff-8a243ba26d99	50090-6051	HUMAN PRESCRIPTION DRUG	OZEMPIC		semaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20220425		NDA	NDA209637	A-S Medication Solutions	SEMAGLUTIDE	2.68	mg/mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-6052_8ac2ae66-bcdc-417a-a8c5-7070d7acadb2	50090-6052	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		lithium carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120702		ANDA	ANDA202288	A-S Medication Solutions	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
50090-6053_e8f7bfa5-09f3-4017-9ce8-7661d66c49ad	50090-6053	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	A-S Medication Solutions	FLUTICASONE PROPIONATE	44	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50090-6054_6a5806cd-a79c-44aa-9ed5-2c8831606df0	50090-6054	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6055_a154ac1e-437e-491a-a88b-722cae030520	50090-6055	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	A-S Medication Solutions	FLUTICASONE PROPIONATE	220	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50090-6056_eed9bf82-62ca-478b-b20b-12a0449249db	50090-6056	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065387	A-S Medication Solutions	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6058_e8c10de7-0d8a-4590-9d51-7efa90af348c	50090-6058	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	A-S Medication Solutions	FLUTICASONE PROPIONATE	110	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6059_2396443d-2104-4663-8b5b-38c7dea1aefb	50090-6059	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	LIQUID	ORAL	20210505		OTC MONOGRAPH DRUG	M013	A-S Medication Solutions	ACETAMINOPHEN	160	mg/5mL			N	20241231
50090-6061_68766ef1-e037-4981-b1de-92d3208f54ae	50090-6061	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6062_6244f5f5-8e03-4fa0-a2a9-0b8f2f25fb47	50090-6062	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6063_6cd1204f-119f-4913-8065-f458f2c4598f	50090-6063	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20170215		ANDA	ANDA206251	A-S Medication Solutions	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-6064_11f98b1a-3393-4484-970b-3437c958a5e4	50090-6064	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6069_9fe63a1b-7944-4b27-bd49-288fcb59eccd	50090-6069	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20021218		ANDA	ANDA075638	A-S Medication Solutions	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-6070_8b26d241-1749-4db2-b0b0-bdb87699451f	50090-6070	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	A-S Medication Solutions	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
50090-6072_4cc34840-c7ce-4363-860c-841ab292153f	50090-6072	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	GEL	TOPICAL	20210310		ANDA	ANDA214251	A-S Medication Solutions	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-6073_79615d20-0231-4d1a-a3f5-7037b5d7a4be	50090-6073	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20220415		ANDA	ANDA075109	A-S Medication Solutions	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-6074_a280129e-2be4-4467-8306-dafe1ee1784e	50090-6074	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	A-S Medication Solutions	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50090-6075_9e3ec7b2-b6c9-40ec-b02b-4685dbc49b1f	50090-6075	HUMAN OTC DRUG	FLONASE SENSIMIST	ALLERGY RELIEF	fluticasone furoate	SPRAY, METERED	NASAL	20170201		NDA	NDA022051	A-S Medication Solutions	FLUTICASONE FUROATE	27.5	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6076_3beeda9c-62fa-4175-8b05-2dc51dd1d137	50090-6076	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	A-S Medication Solutions	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6077_353b5b45-a6e0-4b8d-a5be-92231fdba0f8	50090-6077	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	A-S Medication Solutions	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6079_ceba1bb2-f850-4744-963e-92c4fa47edd2	50090-6079	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180604		ANDA	ANDA205868	A-S Medication Solutions	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6080_29e12cfb-6ab8-4146-899f-e0639a8790e0	50090-6080	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	A-S Medication Solutions	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-6081_107069a9-db7c-4635-93f8-3d56fdf0399c	50090-6081	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6083_25ac42c3-2e8b-41e2-a312-fa4fac9300cb	50090-6083	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	A-S Medication Solutions	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6084_c779ca7e-3be9-4369-9eaf-beb9f90402e8	50090-6084	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	A-S Medication Solutions	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6086_c725a66c-391d-46de-8448-8a8dd1cabbd2	50090-6086	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20211114		ANDA	ANDA090515	A-S Medication Solutions	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6087_b9b3c2af-d7cc-4a81-96da-4f6a74945a5a	50090-6087	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6089_8bcc18fa-467b-428e-8675-c777298cae7d	50090-6089	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6090_933f21d7-e0b6-431d-999f-ae8a0f7561cd	50090-6090	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6094_bb097f51-4333-4c3a-bc5d-47471ae66240	50090-6094	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6097_fcc7f722-81b9-4aad-b7f2-74c46fd8fbfe	50090-6097	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201106		ANDA	ANDA205541	A-S Medication Solutions	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50090-6099_041c817b-a338-4062-bfa6-28dcd6a9ab9f	50090-6099	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	A-S Medication Solutions	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
50090-6100_cdb0af11-c5f5-45e0-bacd-5a13591bb5e5	50090-6100	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6101_874b3aad-9187-4840-a214-5ff656a672a1	50090-6101	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6103_9b194f6f-695d-4ded-a059-bcd257cb59f2	50090-6103	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6104_4673b970-f253-4518-b358-9434a8738eea	50090-6104	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6105_26d0c6dd-8cd0-44c5-87e6-e9a5b48d6e63	50090-6105	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6108_eeb0e0ae-31b8-4954-ac31-de5c082b18eb	50090-6108	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	A-S Medication Solutions	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50090-6109_b1ddd118-1dcd-475c-986b-20a2c1536eaf	50090-6109	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	A-S Medication Solutions	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50090-6111_b8297dfc-5dcc-42d0-9519-0a754bb86b2e	50090-6111	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20120913		ANDA	ANDA200221	A-S Medication Solutions	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50090-6115_cdaf6ec0-1799-488d-8a08-7477c0cc8359	50090-6115	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6116_7bb1a056-3e6b-4d00-a955-2279eb026c01	50090-6116	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6118_bd3775e7-84ba-438e-bf8e-16c64f670edb	50090-6118	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6120_1fb9e6f1-a9ad-4138-ae2e-09f0258bf929	50090-6120	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	CAPSULE	ORAL	20170407		ANDA	ANDA205566	A-S Medication Solutions	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-6122_e56ff683-47fb-45ce-b279-8642c248a6ee	50090-6122	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	A-S Medication Solutions	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6123_841b40e2-3a2f-41a8-9b1b-08995834d759	50090-6123	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	A-S Medication Solutions	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6126_06e4d0c5-a04c-42e0-aa03-3b072e679761	50090-6126	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20200213		ANDA	ANDA213412	A-S Medication Solutions	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-6127_9238a61e-9948-407d-9dd3-7ad5c703ae15	50090-6127	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6128_32505dfe-8d29-4a03-8f8a-2a7712fb1b7a	50090-6128	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20211101		ANDA	ANDA209495	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6129_65894e51-4a95-421d-96e2-68483b3af453	50090-6129	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20170720		ANDA	ANDA208938	A-S Medication Solutions	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
50090-6130_87e8ae53-7a25-46af-991c-eae474b6aeae	50090-6130	HUMAN PRESCRIPTION DRUG	Fosfomycin Tromethamine		Fosfomycin Tromethamine	GRANULE, FOR SOLUTION	ORAL	20211022		ANDA	ANDA214554	A-S Medication Solutions	FOSFOMYCIN TROMETHAMINE	3	g/1			N	20241231
50090-6133_72e80edd-b0d6-4b10-9b79-ffd12490a591	50090-6133	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA062269	A-S Medication Solutions	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-6134_342f09d4-0649-4561-84d8-f667832ca920	50090-6134	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA062269	A-S Medication Solutions	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-6137_92e67be7-3a5b-428b-bcc6-437875cd7f2c	50090-6137	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	A-S Medication Solutions	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6138_4529df9b-a34b-44ed-a1d1-03928d85db5e	50090-6138	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	A-S Medication Solutions	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6139_e3621fee-ac5a-43dc-8bd1-611dc879bc6a	50090-6139	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	A-S Medication Solutions	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6140_958c57a2-7fec-478f-9028-677a213ba0cd	50090-6140	HUMAN OTC DRUG	Docusate Sodium		DOCUSATE SODIUM	CAPSULE	ORAL	20200228		OTC MONOGRAPH DRUG	M007	A-S Medication Solutions	DOCUSATE SODIUM	100	mg/1			N	20241231
50090-6142_53e92009-965c-4487-9143-6ca9159893d6	50090-6142	HUMAN PRESCRIPTION DRUG	KETOCONAZOLE		ketoconazole	TABLET	ORAL	20200410		ANDA	ANDA075912	A-S Medication Solutions	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50090-6143_a726ffd7-e7bd-4005-8b8a-b4d9bb58b67f	50090-6143	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6144_3378441e-e572-45a8-89d5-861d2e6cb11d	50090-6144	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20210311		ANDA	ANDA202682	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6146_cf7b51a3-cb9a-446d-9077-408334571887	50090-6146	HUMAN PRESCRIPTION DRUG	Diltiazem hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181031		ANDA	ANDA203023	A-S Medication Solutions	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-6147_1604ba71-7e8b-4596-8dd0-5488981cc96c	50090-6147	HUMAN OTC DRUG	CR-371059 Tolnaftate 1%		CR-371059 Tolnaftate 1%	CREAM	TOPICAL	20210301		OTC MONOGRAPH DRUG	M004	A-S Medication Solutions	TOLNAFTATE	1	g/100g			N	20241231
50090-6149_737de259-9c42-469a-a3de-e8fb55c061eb	50090-6149	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20181206		ANDA	ANDA211659	A-S Medication Solutions	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50090-6150_fddc382b-a898-4692-a851-81f1a6d084a5	50090-6150	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	A-S Medication Solutions	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
50090-6151_71e9abd0-5602-4bf1-a5b5-957e676c9541	50090-6151	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220430		ANDA	ANDA080399	A-S Medication Solutions	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6152_89b21b01-2d7b-4312-911e-75aca88ecdb3	50090-6152	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220430		ANDA	ANDA080399	A-S Medication Solutions	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6153_ceef939d-fab3-4224-84aa-4e584205d53b	50090-6153	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6154_153e5ed0-ab33-4c88-8aab-3024f8be4e54	50090-6154	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180824		ANDA	ANDA203203	A-S Medication Solutions	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6156_b0f13e3e-01fe-442b-9df7-02851585e731	50090-6156	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20200925		ANDA	ANDA087068	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6157_06b5df0b-d602-4e3b-b2aa-43df95f41196	50090-6157	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20200925		ANDA	ANDA087059	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6158_79cdf6e4-06d9-409c-b8cb-aec5bbf2eddb	50090-6158	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20200925		ANDA	ANDA087059	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6161_b4058364-4be6-4f6e-8b58-a93564d029e0	50090-6161	HUMAN PRESCRIPTION DRUG	NORETHINDRONE		NORETHINDRONE	TABLET	ORAL	20201111		ANDA	ANDA091325	A-S Medication Solutions	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-6162_4db7a7ca-5316-475a-aea8-3d70c7daf510	50090-6162	HUMAN PRESCRIPTION DRUG	Naratriptan		Naratriptan	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA091441	A-S Medication Solutions	NARATRIPTAN HYDROCHLORIDE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
50090-6163_93f6f565-a9ba-4bac-9227-b27a57b0204e	50090-6163	HUMAN OTC DRUG	children allergy relief dye free cherry		Diphenhydramine HCl	SOLUTION	ORAL	20220422		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6164_18c4408b-5d97-4f06-99fe-c7e8df68bf33	50090-6164	HUMAN OTC DRUG	Allergy relief		Loratadine	TABLET	ORAL	20200201		ANDA	ANDA075209	A-S Medication Solutions	LORATADINE	10	mg/1			N	20241231
50090-6167_48f59c0e-8a09-48ab-86fa-2f73bcdc7388	50090-6167	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	A-S Medication Solutions	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6168_8e880b1c-13c6-48b8-bfcb-321e88360265	50090-6168	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6171_07cacf06-d973-4928-b449-e3b8d1eee34a	50090-6171	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070507		ANDA	ANDA065259	A-S Medication Solutions	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-6177_88a25d54-f913-4a43-9f04-9ab1979ff633	50090-6177	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, COATED	ORAL	20171230		ANDA	ANDA211324	A-S Medication Solutions	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
50090-6178_34c1f3df-2dd5-4834-8643-9f772971c23f	50090-6178	HUMAN PRESCRIPTION DRUG	Insulin Glargine Solostar		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20220502		BLA	BLA021081	A-S Medication Solutions	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-6179_252c626f-1abb-4bd4-880b-504beb9ae6c7	50090-6179	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-6180_f80a021d-0cae-4b0e-b3e0-95c32fa4f0df	50090-6180	VACCINE	MENQUADFI		NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN	INJECTION, SOLUTION	INTRAMUSCULAR	20200423		BLA	BLA125701	A-S Medication Solutions	NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN	10; 10; 10; 10	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
50090-6181_0dc2b405-d013-4e99-9a6d-9da394043d20	50090-6181	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin Sulfate, Polymyxin B Sulfate, and Dexamethasone	OINTMENT	OPHTHALMIC	19940725		ANDA	ANDA064063	A-S Medication Solutions	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-6182_7a969bb0-94fb-4060-bc4b-b281165448e5	50090-6182	HUMAN PRESCRIPTION DRUG	STEGLATRO		ertugliflozin	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209803	A-S Medication Solutions	ERTUGLIFLOZIN PIDOLATE	5	mg/1			N	20251231
50090-6183_631e4fb0-7c3b-4985-b7ee-3bd1b02ba541	50090-6183	HUMAN PRESCRIPTION DRUG	STEGLATRO		ertugliflozin	TABLET, FILM COATED	ORAL	20171219		NDA	NDA209803	A-S Medication Solutions	ERTUGLIFLOZIN PIDOLATE	15	mg/1			N	20251231
50090-6184_643c3afa-c4d7-4ec7-9882-36027621e488	50090-6184	HUMAN PRESCRIPTION DRUG	Insulin Glargine		insulin glargine	INJECTION, SOLUTION	SUBCUTANEOUS	20220502		BLA	BLA021081	A-S Medication Solutions	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-6185_cdbcf2e8-5b71-46ac-8eef-b56f735e0d9b	50090-6185	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20180801		ANDA	ANDA078466	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6186_56b27405-1d43-4552-b892-bbdc45175c4c	50090-6186	HUMAN PRESCRIPTION DRUG	Lidocaine Viscous		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19850426		ANDA	ANDA088802	A-S Medication Solutions	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50090-6188_93b18226-2169-4140-9639-9e10d3acfeea	50090-6188	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
50090-6189_293a0007-ee4b-46b0-a69e-2ff3622ddcf3	50090-6189	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	A-S Medication Solutions	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6190_b3ee72ba-9e34-480e-8f1b-072de2b0b3e3	50090-6190	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	A-S Medication Solutions	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6191_a0472cdd-02b5-4155-a720-c4d90960ad62	50090-6191	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	A-S Medication Solutions	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
50090-6193_ee346fc9-8b1a-4db4-830c-b1cdf30ec29f	50090-6193	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6195_45fe659b-3e06-4fa7-87e5-d542fbd63c5c	50090-6195	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	A-S Medication Solutions	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50090-6196_f05d8f95-7681-41dd-91aa-d859ee049970	50090-6196	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20211005		ANDA	ANDA203379	A-S Medication Solutions	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
50090-6199_ace59398-ff81-4474-9740-05c8594b28ac	50090-6199	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20191101		ANDA	ANDA212798	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-6201_20794cff-f30e-4c3a-b0d9-8996b0def874	50090-6201	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	A-S Medication Solutions	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6203_c36f2d7a-8b1f-4f86-8987-b807fcd6700b	50090-6203	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	A-S Medication Solutions	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6204_ead79d53-af01-4c53-963c-17481f020984	50090-6204	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6205_e31eb3c5-7af6-42dc-9e1b-db0c42367073	50090-6205	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-6210_e98a3ea5-8cfb-4866-ad6e-fab47a05c705	50090-6210	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET	ORAL	20130419		ANDA	ANDA203145	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6211_11751d38-03ee-4903-ade0-ac0929c479e2	50090-6211	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20160722		ANDA	ANDA206379	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6212_003107f8-e20d-4c62-8cde-090bc2736d0c	50090-6212	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20220110		ANDA	ANDA207774	A-S Medication Solutions	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-6213_80d686fb-c0ee-4bbc-b633-c476ddaa834b	50090-6213	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20211101		ANDA	ANDA209495	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6214_03154b4a-530a-49e3-a98d-dba2ce126083	50090-6214	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6216_d8344fa6-6e74-4a25-a1fd-116487d02cb9	50090-6216	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20220622		ANDA	ANDA091179	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-6219_53f4477e-13d8-402e-aa02-8a1e9addd00a	50090-6219	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	A-S Medication Solutions	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6221_7e889f34-f928-4d81-b154-f741f3e85897	50090-6221	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	A-S Medication Solutions	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6222_2cb8142e-02a7-4914-baaa-9f943a11fccc	50090-6222	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-6224_4f3236a5-113f-43fa-8408-fea21658d7fa	50090-6224	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	A-S Medication Solutions	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6225_f4c9ce07-2b24-40b7-a886-468be5fe1e17	50090-6225	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	A-S Medication Solutions	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6226_c0981152-20d0-449e-a639-28342c965a36	50090-6226	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		azithromycin	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	A-S Medication Solutions	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-6227_07b1378e-0d27-4326-a9ee-422d52aba518	50090-6227	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20200701		ANDA	ANDA204019	A-S Medication Solutions	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-6228_302f4727-c3d2-4b7f-a734-eefc0007973d	50090-6228	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-6229_069271e9-e8a9-4ed7-84c5-1760d539760e	50090-6229	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR	20190102		ANDA	ANDA209255	A-S Medication Solutions	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
50090-6232_be7848ca-7784-4a81-88ed-0b34cd723621	50090-6232	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20151031		ANDA	ANDA206083	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6235_067bfd2e-9345-4d59-be4f-5d814c70bc57	50090-6235	HUMAN PRESCRIPTION DRUG	PIRMELLA 7/7/7		NORETHINDRONE AND ETHINYL ESTRADIOL	KIT		20190816	20240228	ANDA	ANDA201510	A-S Medication Solutions						N	
50090-6236_bd11a09b-abbd-40ac-974e-359abcacc8d1	50090-6236	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	A-S Medication Solutions	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6237_b5d06d6e-3e84-4879-a8ee-18a131e9adb0	50090-6237	HUMAN PRESCRIPTION DRUG	PIFELTRO		doravirine	TABLET, FILM COATED	ORAL	20180720		NDA	NDA210806	A-S Medication Solutions	DORAVIRINE	100	mg/1	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
50090-6238_bb3c4af3-6c65-404e-821e-e9984e2b5878	50090-6238	HUMAN PRESCRIPTION DRUG	SELZENTRY		maraviroc	TABLET, FILM COATED	ORAL	20110516		NDA	NDA022128	A-S Medication Solutions	MARAVIROC	150	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
50090-6239_b04f590a-7686-4b43-8eea-a7e94893d784	50090-6239	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	A-S Medication Solutions	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
50090-6240_2f53c228-6ead-4535-9deb-ca70caa2d347	50090-6240	HUMAN OTC DRUG	GOOD SENSE		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050422		ANDA	ANDA078326	A-S Medication Solutions	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
50090-6241_b7c2e7c4-17b7-4795-bbee-c2a265299a14	50090-6241	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191121		ANDA	ANDA213136	A-S Medication Solutions	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6244_39f19064-5e8d-4b96-b4de-7a18fc265310	50090-6244	HUMAN PRESCRIPTION DRUG	JANUMET XR		sitagliptin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120202		NDA	NDA202270	A-S Medication Solutions	METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE	1000; 100	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
50090-6247_b735d0b4-cc3e-4e5a-910a-6f7c4a0e08d8	50090-6247	HUMAN PRESCRIPTION DRUG	Biktarvy		bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20180207		NDA	NDA210251	A-S Medication Solutions	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	50; 200; 25	mg/1; mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
50090-6248_e8f6efeb-45b5-4864-b4b0-880246031cb8	50090-6248	HUMAN PRESCRIPTION DRUG	Moxifloxacin Ophthalmic		Moxifloxacin Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200824		ANDA	ANDA208778	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-6253_0f155f8c-be6c-4c9b-ac08-c655972c5ab6	50090-6253	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210120		ANDA	ANDA214422	A-S Medication Solutions	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-6254_68d542a1-d983-491f-8cac-1f32631b523a	50090-6254	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6259_c4a4f7bd-ccd2-4edd-aa0d-b4f8db38f840	50090-6259	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	A-S Medication Solutions	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6260_7a9d7038-e5a4-49c5-a6cd-9ab2b572b556	50090-6260	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210429		ANDA	ANDA213854	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6265_d9b0fc73-c74a-412f-b27d-b9a00b3f6261	50090-6265	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20220415		ANDA	ANDA210616	A-S Medication Solutions	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6266_b7678af0-7092-4103-a9d3-5f76bd03b96b	50090-6266	HUMAN PRESCRIPTION DRUG	Terconazole		terconazole	CREAM	VAGINAL	20050218		ANDA	ANDA076712	A-S Medication Solutions	TERCONAZOLE	4	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-6267_d90d6b7a-b321-4277-baf4-9fede17b1b3f	50090-6267	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-6268_82b1d205-8f81-4755-b34d-931352fa834b	50090-6268	HUMAN PRESCRIPTION DRUG	PIFELTRO		doravirine	TABLET, FILM COATED	ORAL	20180720		NDA	NDA210806	A-S Medication Solutions	DORAVIRINE	100	mg/1	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
50090-6279_c9096700-6262-4adb-8a9b-e6f421dddd84	50090-6279	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20110401		OTC MONOGRAPH DRUG	M004	A-S Medication Solutions	ISOPROPYL ALCOHOL	.7	mL/1			N	20241231
50090-6280_e3ddf397-4b8f-40cf-adbc-d1f056fc27a6	50090-6280	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET	ORAL	20200512		ANDA	ANDA213342	A-S Medication Solutions	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
50090-6281_3a25f4d3-d463-497b-b914-861ffefd3141	50090-6281	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
50090-6289_dde485ed-08f8-40ca-9cb3-109af1fe615a	50090-6289	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6291_66ab513c-2884-42c1-8fca-1e3054d9a64f	50090-6291	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	A-S Medication Solutions	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
50090-6293_5a328ef9-4391-4827-abfb-980764b4e997	50090-6293	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6294_70d932ff-815e-49f1-9fed-4fd89bbe31cb	50090-6294	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	A-S Medication Solutions	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-6296_5bf7a87e-9897-498b-9797-9d2c8413e86d	50090-6296	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		azithromycin	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	A-S Medication Solutions	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-6298_7485799b-1173-4f4e-8ab1-9218c63b1557	50090-6298	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20180417		ANDA	ANDA209013	A-S Medication Solutions	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-6299_8878f816-8262-4172-b007-ce8e7ac089bb	50090-6299	HUMAN PRESCRIPTION DRUG	Terconazole	Vaginal Cream 0.8%	terconazole	CREAM	VAGINAL	20050201		NDA	NDA021735	A-S Medication Solutions	TERCONAZOLE	8	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-6301_a374bf84-105a-4f9d-8303-2b27df2e7bff	50090-6301	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6302_2ce74f64-9eef-4d4b-9b9c-6ef82be7820b	50090-6302	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079172	A-S Medication Solutions	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6303_6dfd8c04-630f-4cd7-a5a7-8e4c9154d22c	50090-6303	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210601		ANDA	ANDA077321	A-S Medication Solutions	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-6304_c3a19faf-7718-4b8c-b497-2e975a785ba8	50090-6304	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	A-S Medication Solutions	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6306_d55189a3-ae04-4c99-aa42-dfc22f8e7d23	50090-6306	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	A-S Medication Solutions	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6308_ec738c22-9dd0-489d-af8b-1103d67d78eb	50090-6308	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	A-S Medication Solutions	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6309_c1350837-ef0e-4ecf-9aa9-09f2b197901a	50090-6309	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20171001		ANDA	ANDA210554	A-S Medication Solutions	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6310_44a52833-81d0-4b4a-8f7b-e863b94af466	50090-6310	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20210510		ANDA	ANDA214698	A-S Medication Solutions	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
50090-6311_69bff0c2-9269-4a13-b6b7-d0cefd065c50	50090-6311	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191121		ANDA	ANDA213136	A-S Medication Solutions	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6313_59fdd1f6-53cb-4f29-bb76-dbe6a03d8753	50090-6313	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-6315_bfb9c17e-ff6d-4d1e-a654-353a936cc832	50090-6315	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-6319_56a23f52-e69d-4ba9-9118-0d53863eb2f6	50090-6319	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6321_e3a7463f-a3ed-41bc-a0a5-d24fe7715529	50090-6321	HUMAN PRESCRIPTION DRUG	NYLIA 7/7/7		Norethindrone and Ethinyl Estradiol	KIT		20161021		ANDA	ANDA207054	A-S Medication Solutions						N	20241231
50090-6322_f6d891ed-a372-4f20-b4d3-a77f3af53d71	50090-6322	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	A-S Medication Solutions	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6323_946fef91-d1e0-4fca-9343-8dba847fdcc8	50090-6323	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	A-S Medication Solutions	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6324_cfb8e0a8-1fd9-4883-bf99-f79e44e3ea4f	50090-6324	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		amoxicillin and clavulanate potassium	TABLET, COATED	ORAL	20221121		NDA AUTHORIZED GENERIC	NDA050720	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-6327_dd1cf8de-0389-4e98-be80-dc164a6dbcff	50090-6327	HUMAN PRESCRIPTION DRUG	Budesonide and Formoterol Fumarate Dihydrate		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20200103		NDA AUTHORIZED GENERIC	NDA021929	A-S Medication Solutions	BUDESONIDE; FORMOTEROL FUMARATE	160; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-6328_d786e289-37d8-4cb3-9bf0-967fbd5ebc2b	50090-6328	HUMAN PRESCRIPTION DRUG	Diltiazem hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181031		ANDA	ANDA203023	A-S Medication Solutions	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50090-6329_06dd8f2d-65a9-4fff-a2cf-0ca69540c1af	50090-6329	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	A-S Medication Solutions	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
50090-6331_da3e0c05-8fc7-4fd7-a2d1-183a9413da18	50090-6331	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20200205		UNAPPROVED DRUG OTHER		A-S Medication Solutions	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6333_3ca3764d-95f2-4bce-8089-2044f78319b4	50090-6333	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	A-S Medication Solutions	ATORVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6335_d3a10247-e6a9-4247-b1cc-87092d2b6033	50090-6335	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	A-S Medication Solutions	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-6336_bf72b106-e8dc-4f1b-bc67-aa6c6f89ed9a	50090-6336	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension		neomycin and polymyxin B sulfates and hydrocortisone otic	SUSPENSION	AURICULAR (OTIC)	20190315		NDA AUTHORIZED GENERIC	NDA060613	A-S Medication Solutions	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50090-6337_2dec0190-221d-478b-877e-34c3b0bf806b	50090-6337	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	A-S Medication Solutions	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-6341_c04e9df0-32ec-4603-bb2d-249844721467	50090-6341	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	A-S Medication Solutions	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
50090-6342_00a96556-045b-4814-b82d-9513aaa7faa0	50090-6342	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	A-S Medication Solutions	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50090-6345_2b846551-7dac-40bf-bbed-29b20f760767	50090-6345	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	A-S Medication Solutions	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6346_e1bd7518-5c59-4b98-8867-1dc3e953e4f9	50090-6346	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	A-S Medication Solutions	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6347_cfddbd29-f63f-476d-a919-4f10dd485a9b	50090-6347	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	A-S Medication Solutions	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6348_a4548b54-9d64-45e5-a257-817ffcb85c25	50090-6348	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	A-S Medication Solutions	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6349_7c8102b0-05b0-4105-bfc3-1a2a5b49d32b	50090-6349	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6351_b119946b-9623-4942-b497-f03a4c765c37	50090-6351	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6353_4f970241-2f46-4d59-9c1d-bb44b8e954db	50090-6353	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211215		ANDA	ANDA075932	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6354_cdd2b33e-6de5-4a72-86cd-29489be1edc3	50090-6354	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211215		ANDA	ANDA075932	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6355_83295f14-96e9-4204-a99e-3a9dbd99a167	50090-6355	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	A-S Medication Solutions	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6356_384e84cb-15d5-4c73-8554-ab2136ca8e59	50090-6356	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070131		ANDA	ANDA065282	A-S Medication Solutions	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-6357_820f6616-7ce5-4adf-8515-21efd5b02997	50090-6357	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20170701		ANDA	ANDA202867	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-6358_1e426c73-8145-47fe-9470-39c853f54446	50090-6358	HUMAN OTC DRUG	Biofreeze Roll-On		MENTHOL	GEL	TOPICAL	20130117		OTC MONOGRAPH DRUG	M017	A-S Medication Solutions	MENTHOL	40	mg/mL			N	20241231
50090-6359_b6d01e6e-b27d-4ceb-97bb-09106c4e4f2a	50090-6359	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	A-S Medication Solutions	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-6360_207e973c-61a9-4274-bb05-9040a5e1c23e	50090-6360	HUMAN OTC DRUG	Biofreeze Professional Colorless Roll-On		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20160603		OTC MONOGRAPH NOT FINAL	part348	A-S Medication Solutions	MENTHOL	50	mg/mL			N	20241231
50090-6361_9c68dfd2-3a33-4d4a-9149-76cfcfd8602e	50090-6361	HUMAN OTC DRUG	Biofreeze Colorless		MENTHOL	GEL	TOPICAL	20120103		OTC MONOGRAPH NOT FINAL	part348	A-S Medication Solutions	MENTHOL	40	mg/mL			N	20241231
50090-6363_a99286af-6fb9-4df5-a6bc-7007fc1b0554	50090-6363	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	A-S Medication Solutions	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-6367_04c9cf60-c39a-46d4-926b-e5c87a0be5d9	50090-6367	HUMAN OTC DRUG	Biofreeze Professional		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20160603		OTC MONOGRAPH NOT FINAL	part348	A-S Medication Solutions	MENTHOL	50	mg/mL			N	20241231
50090-6368_2a384568-81db-40de-9ac2-7721b04a193c	50090-6368	HUMAN PRESCRIPTION DRUG	BRIMONIDINE TARTRATE		BRIMONIDINE TARTRATE	SOLUTION/ DROPS	OPHTHALMIC	20190311		ANDA	ANDA208992	A-S Medication Solutions	BRIMONIDINE TARTRATE	2	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50090-6369_8c34e7c3-20ac-4d2a-ba80-c61adf0cd232	50090-6369	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	A-S Medication Solutions	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6371_7edab3e7-24d6-43a0-af67-eeee8c5ca549	50090-6371	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20090714		ANDA	ANDA090037	A-S Medication Solutions	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6372_e25b6732-85b6-41a7-bda4-551c91e95407	50090-6372	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20191101		ANDA	ANDA040702	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6373_bab952dc-89ba-47f2-b853-2c978b45e24c	50090-6373	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20101109		ANDA	ANDA075693	A-S Medication Solutions	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50090-6374_1529b388-2aad-440d-8b01-a40291c834ba	50090-6374	HUMAN PRESCRIPTION DRUG	Kurvelo		levonorgestrel and ethinyl estradiol	KIT		20210207		ANDA	ANDA091408	A-S Medication Solutions						N	20241231
50090-6376_3853db37-cbaa-4c70-b92b-99d67fdf01f9	50090-6376	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220524		ANDA	ANDA208412	A-S Medication Solutions	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6377_9c6c8e7b-61bd-437b-ba6e-cb394ad19d16	50090-6377	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20210401		ANDA	ANDA203653	A-S Medication Solutions	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-6378_85c20e4c-b99b-48b2-af60-ea28455ebfa8	50090-6378	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA090025	A-S Medication Solutions	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6379_024c0025-c427-4f09-87d9-07b6a92e43a8	50090-6379	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6380_9817a8a2-182e-49dc-8c56-e21656eae510	50090-6380	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	A-S Medication Solutions	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6381_63491821-5b94-4a6a-bf52-6a7ba556cabc	50090-6381	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	POWDER, FOR SUSPENSION	ORAL	20040813		ANDA	ANDA065098	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-6382_8a86d443-43f0-42c6-bc75-57c750d6bae6	50090-6382	HUMAN PRESCRIPTION DRUG	Budesonide and Formoterol Fumarate Dihydrate		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20200103		NDA AUTHORIZED GENERIC	NDA021929	A-S Medication Solutions	BUDESONIDE; FORMOTEROL FUMARATE	80; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-6383_adc8730d-7b7a-4e5c-a3a1-6466ea45f0be	50090-6383	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150514		NDA	NDA020076	A-S Medication Solutions	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
50090-6384_4b68934b-8241-4c45-be79-c49d755094f3	50090-6384	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-6386_51b8cbf9-19e5-41d9-bff5-c8a7aaae5eab	50090-6386	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-6387_b44a3fb8-d84e-4b78-8854-aa618a1a8461	50090-6387	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070409		ANDA	ANDA040597	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-6389_797f8859-cfed-4898-9ff0-d50971e0c7a3	50090-6389	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6391_9736dfc4-160a-4df2-8524-4419fea3403b	50090-6391	HUMAN PRESCRIPTION DRUG	LEVEMIR		insulin detemir	INJECTION, SOLUTION	SUBCUTANEOUS	20131031		BLA	BLA021536	A-S Medication Solutions	INSULIN DETEMIR	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
50090-6393_5f502b0f-4c1f-455e-b460-3e76ebe91b12	50090-6393	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-6394_ec154992-07c0-4760-b39f-b7eb04abe8ac	50090-6394	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	A-S Medication Solutions	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6395_195779c6-f42d-4de0-84a4-e024d70f3e60	50090-6395	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121022		ANDA	ANDA088619	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6400_0f1a6f0c-50ec-4e4b-a804-5385a2fd2e40	50090-6400	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20150827		ANDA	ANDA206528	A-S Medication Solutions	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
50090-6401_5fce52b9-3a75-438b-b7d1-01d94682ed07	50090-6401	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20140806		ANDA	ANDA075536	A-S Medication Solutions	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-6402_a705554b-69d1-48ef-bcba-d07910793a9d	50090-6402	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	OINTMENT	TOPICAL	20200618		ANDA	ANDA209701	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6403_35286385-ad2f-49e6-be05-bf9bfc8165db	50090-6403	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	A-S Medication Solutions	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-6405_aff43a8a-086e-4fe8-b896-8815a00a7243	50090-6405	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6406_71665148-8d2e-4c55-b9e1-d44516b10f0e	50090-6406	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6408_02a97c35-9b10-4959-939d-2082af155165	50090-6408	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	A-S Medication Solutions	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6409_01de2787-3128-4024-ba09-d1fb000955b5	50090-6409	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	A-S Medication Solutions	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-6411_90e13ed1-553b-456f-9433-9cd449c4cd69	50090-6411	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131		BLA	BLA761024	A-S Medication Solutions	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
50090-6412_f4fbafda-1f75-45ab-90cc-2ab67a9ae973	50090-6412	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20220818		ANDA	ANDA202467	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-6413_8aceead9-abbd-445e-9f5e-89b80484a77b	50090-6413	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET	ORAL	20211104		ANDA	ANDA215562	A-S Medication Solutions	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6414_23c59a01-2db9-474a-b262-eed752dc8470	50090-6414	HUMAN PRESCRIPTION DRUG	Levemir		insulin detemir	INJECTION, SOLUTION	SUBCUTANEOUS	20131031		BLA	BLA021536	A-S Medication Solutions	INSULIN DETEMIR	100	[iU]/mL	Insulin Analog [EPC], Insulin [Chemical/Ingredient]		N	20241231
50090-6415_91f7fd75-daf4-4966-8bcb-459ebe412a36	50090-6415	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	A-S Medication Solutions	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6417_1e4f7dd7-60f2-433d-9971-96b9576a4666	50090-6417	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	A-S Medication Solutions	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-6418_db7d6cf0-2227-4560-b9e7-16da4845c354	50090-6418	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-6420_b7cc5cf2-8419-4fb4-88ab-f0a2c31ab91f	50090-6420	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6421_5f539932-98a6-400f-994e-08eb8b974a19	50090-6421	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50090-6422_0c7d9f83-3bf0-47ae-8384-3c453a03b922	50090-6422	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6424_a919bef3-9760-4205-bd77-2b85bd986a1d	50090-6424	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6426_8ad6c696-f867-4923-8c89-fc0a7b51e9fd	50090-6426	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	A-S Medication Solutions	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6427_4d059bb7-1477-4265-a716-83f850a3ab1c	50090-6427	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20180801		ANDA	ANDA078466	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6428_d1e915c3-0135-4080-a421-23c147c583af	50090-6428	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131		BLA	BLA761024	A-S Medication Solutions	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
50090-6431_20e7b205-90c4-4ac8-bc30-a55f38a1030d	50090-6431	HUMAN PRESCRIPTION DRUG	promethazine hydrochloride		promethazine hydrochloride	SYRUP	ORAL	20120608		ANDA	ANDA091675	A-S Medication Solutions	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50090-6432_aba7ca7e-edbd-4b42-8491-4b0f6361bab8	50090-6432	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	A-S Medication Solutions	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6433_1ea5e334-7ffd-411e-867c-51b1449814f8	50090-6433	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6435_d4ba8b1e-0739-474c-9ae2-f38d55a405e3	50090-6435	HUMAN OTC DRUG	Codeine-Guaifenesin		Codeine Phosphate and Guaifenesin	SOLUTION	ORAL	20200715		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
50090-6436_9242208e-0015-49f6-8246-c958618e818f	50090-6436	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210000	A-S Medication Solutions	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50090-6437_6af69041-a80f-45e8-8f0a-eb9c5a58d723	50090-6437	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	A-S Medication Solutions	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-6438_6bf72f5b-ee22-47bb-a052-2bf67dde23a9	50090-6438	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208049	A-S Medication Solutions	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-6439_68a9b7e3-8bf4-4e52-a853-9b30b906e314	50090-6439	HUMAN PRESCRIPTION DRUG	REZVOGLAR KWIKPEN		Insulin glargine-aglr	INJECTION, SOLUTION	SUBCUTANEOUS	20211217		BLA	BLA761215	A-S Medication Solutions	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
50090-6440_ca11c467-1901-4879-9e30-90c916fe56af	50090-6440	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6441_c8101104-2fae-4e29-80cc-87ac0e70a66e	50090-6441	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6442_98f81a45-8127-40d8-98a9-a250e0054d9c	50090-6442	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
50090-6444_76438a5c-b49b-427b-a022-0fc86beb3375	50090-6444	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6445_77c698ed-fa40-46d8-8ea2-b75ab8f1bfad	50090-6445	HUMAN PRESCRIPTION DRUG	cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20170906		ANDA	ANDA065234	A-S Medication Solutions	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
50090-6446_6fd1d19f-3d72-4c29-b97b-d5a11dbeeb0b	50090-6446	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230126		ANDA	ANDA201962	A-S Medication Solutions	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
50090-6447_6cc32177-9e49-494f-b049-d115c0840056	50090-6447	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230126		ANDA	ANDA201962	A-S Medication Solutions	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
50090-6448_d30564b1-14c8-4a83-9925-b81a743d8485	50090-6448	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	A-S Medication Solutions	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6450_28ce2593-26c7-4148-aaf5-bbcfb5be1a7a	50090-6450	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	A-S Medication Solutions	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6451_696a119e-a84a-47ba-97cf-39cd5ea5dcd3	50090-6451	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	A-S Medication Solutions	APIXABAN	2.5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50090-6452_46a68ec5-d52b-46dd-920f-38eff4165301	50090-6452	HUMAN PRESCRIPTION DRUG	JARDIANCE		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	A-S Medication Solutions	EMPAGLIFLOZIN	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-6453_ef6fe0e3-e633-4ae0-a41e-550140116e5a	50090-6453	HUMAN PRESCRIPTION DRUG	TRULICITY		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918		BLA	BLA125469	A-S Medication Solutions	DULAGLUTIDE	.75	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-6454_d32cc824-92b9-4b7e-969f-181b7f5d815d	50090-6454	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	A-S Medication Solutions	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50090-6455_5bc337f8-3db2-4a06-b8e0-aec636d86f15	50090-6455	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	A-S Medication Solutions	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
50090-6456_f4f19825-5cc9-42b4-a099-011c8e070ece	50090-6456	HUMAN PRESCRIPTION DRUG	TRULICITY		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918		BLA	BLA125469	A-S Medication Solutions	DULAGLUTIDE	1.5	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-6457_e9b4a4d9-03dd-4591-9af5-2af49d56717d	50090-6457	HUMAN PRESCRIPTION DRUG	JARDIANCE		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	A-S Medication Solutions	EMPAGLIFLOZIN	25	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50090-6458_467273e5-b0b7-4e7a-b80f-9850b347f0d6	50090-6458	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	A-S Medication Solutions	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6459_a6bec4e9-7e8c-42b5-861b-4bf87b934118	50090-6459	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	A-S Medication Solutions	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6465_d770d745-f094-4920-8691-07b8b2f7f2e3	50090-6465	HUMAN OTC DRUG	diphenhydramine hcl and zinc acetate		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20051205		OTC MONOGRAPH NOT FINAL	part348	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6466_80e64698-e15f-4a2b-a9c9-b5a8b001892b	50090-6466	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6467_17cc096b-1c05-43c4-a4e7-68f633ca212a	50090-6467	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide		promethazine hydrochloride and dextromethorphan hydrobromide	SYRUP	ORAL	19850104		ANDA	ANDA088864	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-6468_634b3f9d-99d9-4b4b-8ac9-5223157b8782	50090-6468	HUMAN OTC DRUG	Dove	Original Clean 24h Invisible Solid Antiperspirant Deodorant	Aluminum Chlorohydrate	STICK	TOPICAL	20161107		OTC MONOGRAPH FINAL	part350	A-S Medication Solutions	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
50090-6469_81e9c251-9b9b-4b23-9843-9cbe7100e7d9	50090-6469	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	A-S Medication Solutions	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6470_742b5cd6-8462-4df8-8195-915a55c35464	50090-6470	HUMAN OTC DRUG	Dove Men plus Care		Clean Comfort 72H Antiperspirant	STICK	TOPICAL	20220622		OTC MONOGRAPH FINAL	part350	A-S Medication Solutions	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
50090-6471_c9dae524-0feb-4ff7-beba-8d28fde03cae	50090-6471	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20201020		ANDA	ANDA214219	A-S Medication Solutions	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50090-6472_9b869ed6-cd2a-48b5-84b1-c5e0e1f29a89	50090-6472	HUMAN OTC DRUG	Ketotifen Fumarate		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20200918		NDA AUTHORIZED GENERIC	NDA021996	A-S Medication Solutions	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
50090-6473_37185adb-a514-4564-b1df-bd67ef804e24	50090-6473	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	A-S Medication Solutions	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6474_18a904e4-7b0d-4680-afcf-49260382d113	50090-6474	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20010529		ANDA	ANDA075673	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6475_38b7ab14-7d4b-4320-9ac1-aff51707e31a	50090-6475	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	A-S Medication Solutions	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
50090-6476_d0d1ae77-fcb3-481f-906f-37c2f822b587	50090-6476	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190731		OTC MONOGRAPH FINAL	part341	A-S Medication Solutions	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50090-6477_f056f9db-c6c2-4b34-9cd6-936ef94be2d6	50090-6477	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	A-S Medication Solutions	PREGABALIN	75	mg/1		CV	N	20241231
50090-6478_e4a9e83b-5cbd-4c4e-9fd5-2b02607e6e75	50090-6478	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190807		NDA AUTHORIZED GENERIC	NDA020186	A-S Medication Solutions	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6479_8b4f3dc2-8a87-4c0d-915a-e4fdf16c5691	50090-6479	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6480_d92ff747-f590-40a8-9736-91219d1628fa	50090-6480	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6481_e195f138-51b4-48a7-9d05-df6629574610	50090-6481	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6482_8cb18584-2709-445a-bea2-f077bc3c6296	50090-6482	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6483_d88e8647-924c-4492-a503-a8b0e0beef70	50090-6483	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6484_e27245da-15ff-4057-881a-9be2b2c654ad	50090-6484	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6485_03d46bbe-d8d9-46b5-990f-b3384a312f1d	50090-6485	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6486_5b4eb68e-20ee-4d51-b5d8-5750babb5572	50090-6486	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	A-S Medication Solutions	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6487_d3898bac-3832-407f-8ce5-40c39c8b924a	50090-6487	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	A-S Medication Solutions	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6488_f6eb4df4-393d-4ecb-ba1a-6b4e5fa493bb	50090-6488	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	A-S Medication Solutions	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6489_6f5fd6cb-d8ee-40d0-ac1d-dd6c657b42a2	50090-6489	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	A-S Medication Solutions	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6490_cdd905f1-e3c6-46b0-9ef0-38d431c4610d	50090-6490	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20150806		ANDA	ANDA075496	A-S Medication Solutions	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-6491_139efb34-7bd4-46a7-9aeb-20e7b973d7a2	50090-6491	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20140306		ANDA	ANDA204997	A-S Medication Solutions	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
50090-6492_8f6a9480-989d-4f54-a0f9-344d4fca1b8a	50090-6492	HUMAN PRESCRIPTION DRUG	MYCOPHENOLIC ACID		MYCOPHENOLIC ACID	TABLET, DELAYED RELEASE	ORAL	20210924		ANDA	ANDA208315	A-S Medication Solutions	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
50090-6493_22450f1d-9d74-467c-96a8-a8a3d6a59e68	50090-6493	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	A-S Medication Solutions	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-6494_13d82bf9-d3a6-40c1-8abb-d223553d4083	50090-6494	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA212114	A-S Medication Solutions	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
50090-6495_33cc42c7-6468-4d25-bd44-f28ba03ea6cd	50090-6495	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20041020		ANDA	ANDA076346	A-S Medication Solutions	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6496_de04fd88-d95a-4048-bad1-3e4c671519a2	50090-6496	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	A-S Medication Solutions	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6499_3da26732-4dd8-43bb-80f2-129d54ef84ae	50090-6499	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20040601		ANDA	ANDA076346	A-S Medication Solutions	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6500_1e05a219-f2bb-482b-baa3-2d8ab1be6d6d	50090-6500	HUMAN PRESCRIPTION DRUG	CLOMID		Clomiphene Citrate	TABLET	ORAL	20220909		ANDA	ANDA075528	A-S Medication Solutions	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
50090-6501_7271996d-a89b-4aa1-9741-5d461b2e67e1	50090-6501	HUMAN PRESCRIPTION DRUG	LOKELMA		sodium zirconium cyclosilicate	POWDER, FOR SUSPENSION	ORAL	20180904		NDA	NDA207078	A-S Medication Solutions	SODIUM ZIRCONIUM CYCLOSILICATE	10	g/10g			N	20241231
50090-6502_f69e7a3d-5f83-4022-939a-7e373d0b0cdb	50090-6502	HUMAN PRESCRIPTION DRUG	LOKELMA		sodium zirconium cyclosilicate	POWDER, FOR SUSPENSION	ORAL	20180904		NDA	NDA207078	A-S Medication Solutions	SODIUM ZIRCONIUM CYCLOSILICATE	5	g/5g			N	20241231
50090-6503_f1b51c26-982d-48e6-a040-0ce5b41da22d	50090-6503	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	A-S Medication Solutions	PREGABALIN	100	mg/1		CV	N	20241231
50090-6504_797c1411-c5f6-4480-ab2a-1b98fd96173a	50090-6504	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	A-S Medication Solutions	PREGABALIN	200	mg/1		CV	N	20241231
50090-6505_0890b677-17fa-4b42-a3b1-f23563cea713	50090-6505	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6506_318deb0c-d033-4439-bf62-0bacfd6c2d86	50090-6506	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	A-S Medication Solutions	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6508_97a69557-7605-4036-bc6c-e2adce490e8a	50090-6508	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6510_88243632-5385-40a9-9e80-77ba3a7c7b72	50090-6510	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6511_eaa2a0b4-ad2e-4838-8f6d-a4990bb48d21	50090-6511	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6512_1f10d97d-94f3-4f0a-8332-df2d5fb95b0d	50090-6512	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079022	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6513_cbd6dff8-95f7-43ab-b37d-56c5cbea18e5	50090-6513	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6514_f84a485f-17d9-4fae-90aa-8a4b72fe7d1d	50090-6514	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221201		ANDA	ANDA202666	A-S Medication Solutions	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6515_7f55725b-8310-4f03-9565-1204d0835c02	50090-6515	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20180731		ANDA	ANDA209313	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
50090-6516_2a41ab5a-57c0-46de-ba6e-dd10544d0da1	50090-6516	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20180731		ANDA	ANDA209313	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6517_faf432c6-6a38-451f-acf3-fd88ca30c98e	50090-6517	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6519_9c392f80-c595-42e9-a077-3a3c97aaf326	50090-6519	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6521_c3aa4a14-b719-46a0-83da-8d01b6f43a43	50090-6521	HUMAN PRESCRIPTION DRUG	PEG-3350 and Electrolytes		Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20090701		NDA AUTHORIZED GENERIC	NDA019011	A-S Medication Solutions	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/4L; g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50090-6522_85293571-5d32-4ed0-82a8-79b71addbdc8	50090-6522	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6524_0062ce5a-f58e-4b0c-8ffd-f85fe52ed3e0	50090-6524	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6526_e0955e12-a216-4763-a88b-5593578aa9c4	50090-6526	HUMAN OTC DRUG	hydrocortisone		hydrocortisone	OINTMENT	TOPICAL	20110818		OTC MONOGRAPH DRUG	M017	A-S Medication Solutions	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6527_18f86640-ad2f-4850-97c6-014869742c62	50090-6527	HUMAN PRESCRIPTION DRUG	Acetic Acid		Acetic Acid	SOLUTION	AURICULAR (OTIC)	20200605		ANDA	ANDA040607	A-S Medication Solutions	ACETIC ACID	20.65	mg/mL			N	20241231
50090-6529_442f3eaf-3419-4ffb-a1f5-1fa15389b221	50090-6529	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA065063	A-S Medication Solutions	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
50090-6532_779c0a84-2471-4eb3-90d3-ebbc272a0292	50090-6532	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19800107		ANDA	ANDA083177	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6533_0c1dc96d-57b5-496b-b45f-3bbdfc187905	50090-6533	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20220421		ANDA	ANDA209535	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6534_f74e9265-530d-46d3-9c77-1b7679cdeaee	50090-6534	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	A-S Medication Solutions	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6536_687184dc-0622-4b41-96c3-dbe2b4766b55	50090-6536	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20120115		ANDA	ANDA040734	A-S Medication Solutions	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
50090-6537_4eed4247-3f99-405e-ae88-9528536766bd	50090-6537	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20200921		ANDA	ANDA209281	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6538_b6221e59-ed88-4d25-a948-0f90c16f8dcf	50090-6538	HUMAN OTC DRUG	Cetirizine hydrochloride		Cetirizine hydrochloride	TABLET, COATED	ORAL	20220113		ANDA	ANDA209274	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6539_2a4d6425-5ec3-4566-a91c-6ff6df20772c	50090-6539	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	A-S Medication Solutions	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6541_c32d570b-2e8d-4381-b1e9-631108125f5c	50090-6541	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	SOLUTION	ORAL	20190827		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
50090-6542_3ce3e1c4-7d33-4a69-bc66-6f98334732c2	50090-6542	HUMAN OTC DRUG	Tusnel	EX	Guaifenesin	LIQUID	ORAL	20190501		OTC MONOGRAPH DRUG	M012	A-S Medication Solutions	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
50090-6546_5f27c1fb-4c7a-45ad-aef6-53f58dcf4a11	50090-6546	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH DRUG	M005	A-S Medication Solutions	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50090-6547_4ac4f000-7be7-414e-bf2e-b55516fe26b3	50090-6547	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20220421		ANDA	ANDA209535	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6549_86b06691-64db-44e1-95d9-bede805160a4	50090-6549	HUMAN OTC DRUG	Mucinex DM	Maximum Strength	Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021620	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-6550_69000021-3626-48ba-bb9a-db5fa48d0c4b	50090-6550	HUMAN PRESCRIPTION DRUG	Glucagon		Glucagon	KIT		20210210		ANDA	ANDA208086	A-S Medication Solutions						N	20241231
50090-6552_a420ce0d-e458-46ca-aa9c-aaba680e455b	50090-6552	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	A-S Medication Solutions	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
50090-6554_7ef4dabc-2d8d-47f5-8b32-cf9f2f2f12d1	50090-6554	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
50090-6559_0a11ad92-6d6e-4405-b4d0-6fd380d21143	50090-6559	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
50090-6560_9e4a9dac-8e00-4b2d-b3a1-2c9826e32e66	50090-6560	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	19970917		ANDA	ANDA074880	A-S Medication Solutions	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
50090-6561_7db2d685-8704-4f12-a2c3-23d22d22acd8	50090-6561	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	OINTMENT	TOPICAL	20170731		ANDA	ANDA205510	A-S Medication Solutions	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-6562_e64b9f30-a539-4549-9406-2fad867900f9	50090-6562	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SOLUTION	TOPICAL	20191104		ANDA	ANDA078172	A-S Medication Solutions	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
50090-6563_bb476cca-37c9-423e-be57-4d4866e05b2f	50090-6563	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	A-S Medication Solutions	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-6565_4686ca34-20ab-40c8-89ca-c291d85b595d	50090-6565	HUMAN OTC DRUG	Novolin	N	Human Insulin	INJECTION, SUSPENSION	SUBCUTANEOUS	20190906		BLA	BLA019959	A-S Medication Solutions	INSULIN HUMAN	100	[iU]/mL	Insulin [CS], Insulin [EPC]		N	20241231
50090-6566_a6e02619-a4ee-4603-ad7a-c60187412f1a	50090-6566	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20220421		ANDA	ANDA209535	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6567_bb5a5854-43f0-4719-bd50-ef4eb77d81b2	50090-6567	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20220809		ANDA	ANDA202928	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-6568_1e105bdd-7eb5-435a-807c-9b648be49b6d	50090-6568	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20220809		ANDA	ANDA202928	A-S Medication Solutions	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50090-6569_647c5f92-a379-4176-8fd9-64e95702a20d	50090-6569	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190502		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6571_acaa63ae-a7bc-4997-9bfb-6292ff7bed52	50090-6571	HUMAN PRESCRIPTION DRUG	TRULICITY		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20200903		BLA	BLA125469	A-S Medication Solutions	DULAGLUTIDE	3	mg/.5mL	GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]		N	20241231
50090-6572_fa110538-d0e0-46b6-8bce-f9cd55e1bbfc	50090-6572	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190502		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6573_ea2c5002-3a61-4858-b900-cc55390fab77	50090-6573	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6574_d58637fe-31d4-41e1-a52c-6c5075b461da	50090-6574	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6576_fd80d2ec-af38-4ce5-9f6f-534fd2b22195	50090-6576	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20021101		ANDA	ANDA076187	A-S Medication Solutions	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6577_793fd500-f266-42b4-9d5d-604d3a77cd2a	50090-6577	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201221		ANDA	ANDA210071	A-S Medication Solutions	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6578_dc671a06-2de9-4fda-84a4-d576ff7fe2b2	50090-6578	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230620		ANDA	ANDA210401	A-S Medication Solutions	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-6580_ab32c8a5-8f9b-40e1-bc25-c69aaf237aca	50090-6580	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210930		ANDA	ANDA214092	A-S Medication Solutions	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50090-6581_2505ce8d-2867-49e4-a2bb-2ca1188af4d4	50090-6581	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20230214		ANDA	ANDA209553	A-S Medication Solutions	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-6582_19efa6cd-f01e-4ff5-ab4d-bfa5a18c7246	50090-6582	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	A-S Medication Solutions	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-6585_146ea904-9204-4638-bcd3-b42aebee0845	50090-6585	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral		Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral	SOLUTION	ORAL	20201005		ANDA	ANDA040649	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-6586_c2ed30a9-91ae-4f05-b8ec-a22eeb0b1494	50090-6586	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20210501		ANDA	ANDA211922	A-S Medication Solutions	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6587_261e2c03-7495-4a76-aebe-8e7c795cb8e5	50090-6587	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	LOTION	TOPICAL	20040528		ANDA	ANDA076216	A-S Medication Solutions	AMMONIUM LACTATE	120	mg/g	Acidifying Activity [MoA]		N	20241231
50090-6588_82287cb4-5de6-4470-ae7d-fa65e8b30c3a	50090-6588	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20160912		ANDA	ANDA076363	A-S Medication Solutions	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
50090-6589_8805f391-a4c9-4399-ab71-9198128e27a3	50090-6589	HUMAN PRESCRIPTION DRUG	LIDOCAINE AND PRILOCAINE		Lidocaine and Prilocaine	CREAM	TOPICAL	20221220		ANDA	ANDA212482	A-S Medication Solutions	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
50090-6590_04b2e591-e608-4aa2-b5d9-d88b8f316f10	50090-6590	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20210501		ANDA	ANDA211922	A-S Medication Solutions	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6591_f6e37a9c-c563-4ebc-ae92-52ca1b882422	50090-6591	HUMAN OTC DRUG	BP Wash		BENZOYL PEROXIDE	EMULSION	TOPICAL	20110815		OTC MONOGRAPH DRUG	M006	A-S Medication Solutions	BENZOYL PEROXIDE	25	mg/g			N	20241231
50090-6592_58dec914-4f3e-430d-a167-b2f67ae96080	50090-6592	HUMAN PRESCRIPTION DRUG	Clindamycin Phoaphate Topical USP, 1%		Clindamycin Phosphate Topical USP, 1%	SOLUTION	TOPICAL	20190304		ANDA	ANDA209914	A-S Medication Solutions	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-6593_86b55132-aaea-4c58-b2c9-d2f8fd750089	50090-6593	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin phosphate	SOLUTION	TOPICAL	20040331		ANDA	ANDA065184	A-S Medication Solutions	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
50090-6594_982ac673-efaa-4d21-b6d8-0cabbd5b45d7	50090-6594	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6595_ca8d1b61-e076-4094-9b53-37827b50db74	50090-6595	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA202632	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-6596_537f4ea0-a35c-4826-ba5f-336c9e274000	50090-6596	HUMAN PRESCRIPTION DRUG	Cabergoline		Cabergoline	TABLET	ORAL	20220615		ANDA	ANDA076310	A-S Medication Solutions	CABERGOLINE	.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
50090-6599_59739442-2975-4203-997f-cf65cd63672b	50090-6599	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6600_49b3e189-6f4f-4443-a50a-e837db477c14	50090-6600	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	A-S Medication Solutions	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6601_cf80dfb5-e639-430d-a3d7-9fa27e9935a6	50090-6601	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	20200423		ANDA	ANDA089424	A-S Medication Solutions	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6602_9ec2c200-b196-4a91-8c99-194580254632	50090-6602	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6603_30db7ddc-f345-457d-a04f-1258502e147e	50090-6603	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	A-S Medication Solutions	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50090-6604_fb640000-de53-4d9b-a36d-aaa0eb4ed88e	50090-6604	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6606_63e7c4d9-eb3e-47da-8807-234bd7df2977	50090-6606	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170427		ANDA	ANDA207662	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6607_68360104-6b80-4b68-9c54-b4a9b5b701ce	50090-6607	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19950830		ANDA	ANDA074388	A-S Medication Solutions	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6608_29ea9739-73f0-4dc5-9392-8088957cb30c	50090-6608	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA088468	A-S Medication Solutions	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50090-6609_20c49868-6dc2-4951-8729-16b51689c387	50090-6609	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA202632	A-S Medication Solutions	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
50090-6610_21bc062b-158b-42ba-9cc2-a092768c6013	50090-6610	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6611_5300c470-b015-4d5d-9da1-27ea95451bba	50090-6611	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	A-S Medication Solutions	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6612_de84a146-ebc3-4f6b-8efa-2317bd27f595	50090-6612	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	A-S Medication Solutions	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6613_fadbb379-3123-4f9b-8bf7-cb554a934dba	50090-6613	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6614_6c97aa4d-6512-49fd-a25d-600b6f033610	50090-6614	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6616_bc78fafb-1968-41f2-aede-d8c286e959eb	50090-6616	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6619_6866c32d-8ecf-41b3-846f-d0cb9f820a26	50090-6619	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200323		ANDA	ANDA080352	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6621_ba761d3b-668e-4b97-87c8-d971cb80419c	50090-6621	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200323		ANDA	ANDA080352	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6623_239dda37-8a86-41b6-bb36-7c888542cc75	50090-6623	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200323		ANDA	ANDA080352	A-S Medication Solutions	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6624_48b45350-d5c4-4266-aed3-8dce028edde9	50090-6624	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6626_3aa1348c-dc6e-4500-abdc-9170862a52c5	50090-6626	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6628_6b419ab6-a986-456b-9787-b5d31566f62b	50090-6628	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6629_f47b1db7-369b-45fb-95c4-3befab5661d5	50090-6629	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20191001		ANDA	ANDA040657	A-S Medication Solutions	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
50090-6630_06dee602-ec02-455e-a13f-136803d646a7	50090-6630	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20210201		ANDA	ANDA209838	A-S Medication Solutions	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
50090-6631_c9e05973-b0ce-4a55-8597-d7cdeeeb7796	50090-6631	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20210201		ANDA	ANDA209838	A-S Medication Solutions	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
50090-6632_29f0e71a-8c15-458a-9573-d645afd585e0	50090-6632	HUMAN PRESCRIPTION DRUG	Olmesartan medoxomil		Olmesartan medoxomil	TABLET	ORAL	20170425		ANDA	ANDA204814	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6633_606e4657-7d61-4f7b-bbb5-93e05d1f70ff	50090-6633	HUMAN PRESCRIPTION DRUG	Olmesartan medoxomil		Olmesartan medoxomil	TABLET	ORAL	20170425		ANDA	ANDA204814	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6634_a61f5411-6d6f-4c6d-8921-a763b16486c6	50090-6634	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6635_95866e15-d194-4771-8617-2dcf94808d1d	50090-6635	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161109		ANDA	ANDA204662	A-S Medication Solutions	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-6636_5b57f84a-92e5-4973-a2aa-6deaeb1ddbb3	50090-6636	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6637_59eb00d5-25cc-4f23-bd33-820d9be3f568	50090-6637	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	A-S Medication Solutions	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6638_d35177bc-fd2a-4498-9e0b-4207b8320329	50090-6638	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20180201		ANDA	ANDA209025	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
50090-6639_45b128e4-06ab-4a55-a6c5-e547fa950100	50090-6639	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA209688	A-S Medication Solutions	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-6640_02101932-08ca-4069-a6b2-b182eea53269	50090-6640	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA209688	A-S Medication Solutions	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-6642_f7d4f744-9479-4688-b177-86801fed3245	50090-6642	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	A-S Medication Solutions	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6645_21d79bf8-cbcc-40cb-a900-8ff6bacde82e	50090-6645	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6646_915fd3d6-40bc-4329-a22a-efe57be44e74	50090-6646	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	A-S Medication Solutions	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6649_27dc580f-4a4b-4aa5-9e37-42a67059d9fd	50090-6649	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
50090-6655_55f40911-dfa2-4c85-8faa-a0d9ec530be1	50090-6655	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6657_f8934174-e679-418a-a77c-9d3c57f15ce4	50090-6657	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
50090-6659_ef93bd62-a353-485a-aeff-7868363aad86	50090-6659	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6661_59d7eefa-412f-492c-994f-4f943cc87472	50090-6661	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA216557	A-S Medication Solutions	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50090-6662_d0731e07-c932-4805-a1da-a7dc351b8a44	50090-6662	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207465	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6663_04111092-3d87-4031-8d3b-5dc682021aa3	50090-6663	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207465	A-S Medication Solutions	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6664_442cd179-b378-40cc-b7c6-5dbfe2b26401	50090-6664	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20220222		ANDA	ANDA211013	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-6666_e4ad6bc9-90ba-4e65-b323-14ecebff9912	50090-6666	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6667_e17033ee-753c-47e7-8fc9-ad0414976874	50090-6667	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6671_1b4d02e1-bb9d-4149-9d21-07651e091e56	50090-6671	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	A-S Medication Solutions	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6672_35d0725a-46e5-48f1-8245-e9cf9f3208fc	50090-6672	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	A-S Medication Solutions	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6673_b7f19e5f-fd9a-4c1c-a57e-b705fd5f53df	50090-6673	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160927		ANDA	ANDA206121	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-6674_a30a4a66-dc54-4eeb-9c79-2364faad423b	50090-6674	HUMAN OTC DRUG	NICOTINE		nicotine polacrilex	GUM, CHEWING	ORAL	20230814		ANDA	ANDA206393	A-S Medication Solutions	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20251231
50090-6675_8a23799c-bf42-492a-8a60-4c89747b72d2	50090-6675	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	A-S Medication Solutions	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6676_25886091-9371-4930-af33-b2f476138a03	50090-6676	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	A-S Medication Solutions	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6677_7ba12e10-aa1f-4051-b58d-072bfabd8344	50090-6677	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	A-S Medication Solutions	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6679_e09b4277-1fe3-4b52-8f10-375a5b634c0d	50090-6679	HUMAN OTC DRUG	Cetirizine hydrochloride		Cetirizine hydrochloride	TABLET, COATED	ORAL	20220113		ANDA	ANDA209274	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6680_3e3fff34-2c75-49d6-bf71-11aadf68f22a	50090-6680	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	A-S Medication Solutions	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6682_16bc3eba-ab01-40b7-9509-58ace017c5bf	50090-6682	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	A-S Medication Solutions	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50090-6686_b64984f8-2631-42dc-b397-acedcd8c25b8	50090-6686	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170525		ANDA	ANDA203281	A-S Medication Solutions	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6689_70999306-c59c-4757-a0d2-c2da07a35e09	50090-6689	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20190912		ANDA	ANDA212254	A-S Medication Solutions	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-6690_cb403d9e-1fb4-49e0-959d-d053428be516	50090-6690	HUMAN PRESCRIPTION DRUG	Cilostazol		cilostazol	TABLET	ORAL	20180101		ANDA	ANDA077208	A-S Medication Solutions	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
50090-6692_f734f6f0-ad9b-4f13-9a96-b3fc83b51251	50090-6692	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		OMEGA-3-ACID ETHYL ESTERS	CAPSULE, LIQUID FILLED	ORAL	20200702		ANDA	ANDA210093	A-S Medication Solutions	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
50090-6695_ecf3645f-5aa1-4f88-85fd-75087f87d7e9	50090-6695	HUMAN OTC DRUG	good sense nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230823		ANDA	ANDA206393	A-S Medication Solutions	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20251231
50090-6696_d5e47232-406b-4e43-8ae8-4ad3ec8351d6	50090-6696	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220603		ANDA	ANDA078490	A-S Medication Solutions	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6697_f7d7f932-eb34-4671-bf77-b873c4a05cc1	50090-6697	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220603		ANDA	ANDA078490	A-S Medication Solutions	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
50090-6699_e2197187-9fdd-4174-83cd-5fbcce11c29f	50090-6699	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	A-S Medication Solutions	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50090-6700_b3f682d7-b270-4daf-8789-313ee9aa65d3	50090-6700	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	A-S Medication Solutions	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
50090-6701_158dc5a6-fde3-499e-848b-53ed53b09a0b	50090-6701	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190220		ANDA	ANDA076301	A-S Medication Solutions	LORATADINE	10	mg/1			N	20251231
50090-6702_57eb3004-f630-4418-a421-c235024c74b3	50090-6702	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6703_e24128ef-66b6-4337-8a71-c473370eb999	50090-6703	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	A-S Medication Solutions	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6704_c43bbba6-5049-486a-9d8a-92e72d2937f9	50090-6704	HUMAN PRESCRIPTION DRUG	HADLIMA		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	A-S Medication Solutions	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
50090-6705_f29c7432-aeb1-4eea-b6b1-05572b973220	50090-6705	HUMAN PRESCRIPTION DRUG	HADLIMA		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	A-S Medication Solutions	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
50090-6706_0b7601d5-a393-47fb-a71a-cfbe1ec2b153	50090-6706	HUMAN PRESCRIPTION DRUG	HADLIMA		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	A-S Medication Solutions	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
50090-6707_3510ed8d-5c11-4f96-bddd-33ec5e87ea5e	50090-6707	HUMAN PRESCRIPTION DRUG	HADLIMA		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	A-S Medication Solutions	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
50090-6708_ac21eb5e-87be-45e3-8232-d63dd436b27b	50090-6708	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220208		ANDA	ANDA214982	A-S Medication Solutions	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
50090-6710_9415145a-f0c8-452d-8c56-750a184df984	50090-6710	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	SPRAY	NASAL	20220621		ANDA	ANDA211951	A-S Medication Solutions	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
50090-6711_c8e9e4a3-65ea-411c-b712-51f6c0e8f555	50090-6711	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20180612		ANDA	ANDA091174	A-S Medication Solutions	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
50090-6712_3e169e78-d7e0-47c1-aa4e-00090b8f34e5	50090-6712	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	A-S Medication Solutions	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-6713_26ba1718-9a11-4c8f-b16f-88106755915c	50090-6713	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20141126		ANDA	ANDA203818	A-S Medication Solutions	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6714_39775c40-a0bd-4981-be4e-0ea1cfa7c321	50090-6714	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	A-S Medication Solutions	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6716_819f72fd-026c-4bb8-a3ea-9f8d1d1b71d0	50090-6716	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220701		ANDA	ANDA204467	A-S Medication Solutions	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-6717_f49ce92e-ea3a-48c1-8976-d69926410ff9	50090-6717	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20181228		ANDA	ANDA211256	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6718_09540522-e165-403f-ad22-f3ed9a730df4	50090-6718	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	A-S Medication Solutions	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6719_bcc74523-5105-45d3-ab70-df7c4ee972aa	50090-6719	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
50090-6720_6c19a1df-221e-479c-bee0-f3c8cdabd210	50090-6720	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA078490	A-S Medication Solutions	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6721_f712bc85-889c-4771-97b0-8ddfa57c6c87	50090-6721	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA078490	A-S Medication Solutions	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
50090-6722_d2a350ae-b90f-4e13-99d3-89045f494e82	50090-6722	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		DIMETHYL FUMARATE	CAPSULE, DELAYED RELEASE	ORAL	20200924		ANDA	ANDA210500	A-S Medication Solutions	DIMETHYL FUMARATE	240	mg/1			N	20241231
50090-6723_a994a3c2-1b53-43ba-bd93-122d80045931	50090-6723	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	A-S Medication Solutions	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50090-6724_92d71db9-ce85-4382-87ac-0a68334f64ee	50090-6724	HUMAN PRESCRIPTION DRUG	DESLORATADINE		DESLORATADINE	TABLET, FILM COATED	ORAL	20130225		ANDA	ANDA078352	A-S Medication Solutions	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6727_37980782-0d52-478b-8005-c5c8cf99af38	50090-6727	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20220118		ANDA	ANDA074260	A-S Medication Solutions	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50090-6728_4eb04657-7513-49e7-975a-1aeef5a4ea19	50090-6728	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	A-S Medication Solutions	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6731_172ed6de-fef8-49ca-8073-1418fcf874b5	50090-6731	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	A-S Medication Solutions	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6732_ba60e56a-0354-4189-a42e-827eccacfe71	50090-6732	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220330		ANDA	ANDA216067	A-S Medication Solutions	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6733_5e346534-1159-4c79-9422-1e288b127c62	50090-6733	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	A-S Medication Solutions	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-6734_49f60bd9-4ffc-4423-8cc8-9b20b16a5ca9	50090-6734	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	A-S Medication Solutions	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6735_d880104d-7b71-4954-8017-7c65165fd9d0	50090-6735	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	A-S Medication Solutions	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6736_33ee2725-84e2-49fa-a0b4-ac4fcd1ec16f	50090-6736	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20180904		ANDA	ANDA208360	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6738_374ef7df-cab6-4f9d-8a97-18eba0244416	50090-6738	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210105		ANDA	ANDA210014	A-S Medication Solutions	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6739_523e2e08-af46-4003-8112-80de28f3bd86	50090-6739	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA210704	A-S Medication Solutions	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6740_ecfa4fb9-19d4-4058-9025-419f51022b70	50090-6740	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		A-S Medication Solutions	THYROID	90	mg/1			N	20241231
50090-6741_bee54e03-a973-47f7-b726-5d7f6d3bf61e	50090-6741	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210818		ANDA	ANDA211953	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6742_9a604f8d-7642-40bb-b002-97783bb35972	50090-6742	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	A-S Medication Solutions	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6743_058fd401-51fc-44b4-97c8-41e57c928a72	50090-6743	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211215		ANDA	ANDA075932	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6744_a9a07ac6-dab4-4696-af68-f575264495a6	50090-6744	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20210602		ANDA	ANDA070886	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-6746_83177dee-9da4-409b-a28d-56390f9c0d6b	50090-6746	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA206928	A-S Medication Solutions	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6747_e13e894c-350c-4165-91e8-28a721aedce1	50090-6747	HUMAN OTC DRUG	ROBAFEN DM		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220107		OTC MONOGRAPH DRUG	M102	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-6748_ba2e342b-17e2-4dc6-ba23-c7aa41db8090	50090-6748	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20141101		ANDA	ANDA077066	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-6750_c6fe422a-a542-426b-a939-7542ccbd557b	50090-6750	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20220222		ANDA	ANDA211013	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-6751_7a9ab5f3-e4e0-4443-970a-00353257821d	50090-6751	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	A-S Medication Solutions	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-6752_9baccf96-a124-4a00-ba5d-ede963595b92	50090-6752	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6753_d0143d34-a44c-46ae-abe5-04e8bdeaf6a3	50090-6753	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6754_23f2a9a3-d16f-435c-babf-3875275732e0	50090-6754	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6755_b5571a11-c9ac-481d-a723-b715c6cf9311	50090-6755	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide		Promethazine Hydrochloride and Dextromethorphan Hydrobromide	SOLUTION	ORAL	20140131		ANDA	ANDA091687	A-S Medication Solutions	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50090-6756_4ccf302b-0c01-4e14-81a5-2904b7116e78	50090-6756	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210615		ANDA	ANDA076286	A-S Medication Solutions	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-6757_79fb9e47-ef5b-41ac-935f-cc87a3e5d525	50090-6757	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210615		ANDA	ANDA076286	A-S Medication Solutions	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-6758_c493cba9-1dd0-464e-a094-7c339d2ceb89	50090-6758	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20170926		ANDA	ANDA207446	A-S Medication Solutions	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6759_e33c88be-6934-4fdf-afd7-90ffdc727474	50090-6759	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20170926		ANDA	ANDA207446	A-S Medication Solutions	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6760_f6c20c19-2574-4239-8567-dce1c45017fa	50090-6760	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20150804		ANDA	ANDA204418	A-S Medication Solutions	FOLIC ACID	1	mg/1			N	20241231
50090-6762_53b6d99c-7bf8-47b0-8b45-73033abaea2b	50090-6762	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6764_aa5adc70-84cd-49ad-bc90-cd47f00a552d	50090-6764	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	A-S Medication Solutions	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6765_307a539f-739a-4909-b41e-3fe98624cb53	50090-6765	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA206928	A-S Medication Solutions	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6767_db03e3bc-412a-4336-a97c-dbcdb4bbc1bc	50090-6767	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220330		ANDA	ANDA216067	A-S Medication Solutions	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6768_fe1e72df-f70a-4e79-8ebf-10f3a9983961	50090-6768	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium Tablets	TABLET, FILM COATED	ORAL	20220512		ANDA	ANDA215750	A-S Medication Solutions	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6769_634cd926-12b0-4a21-8648-85b5e672478c	50090-6769	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20141101		ANDA	ANDA077066	A-S Medication Solutions	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
50090-6770_2d7c6212-c292-4857-8baa-d2bb485b6fa9	50090-6770	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	A-S Medication Solutions	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6771_2946f34c-545a-4b8d-9041-46cf0d4bd851	50090-6771	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	A-S Medication Solutions	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
50090-6772_60003d11-73e2-4ed7-ab91-24b7285bbfde	50090-6772	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221102		ANDA	ANDA214456	A-S Medication Solutions	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6774_bf2e3b2f-4973-4e8a-9131-779dc6e8fbd9	50090-6774	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210818		ANDA	ANDA211953	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6775_99a2c894-a27c-4b4a-b8fc-5335029ebf28	50090-6775	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6777_f89a7b80-e780-4f43-b04d-fcb2be135df4	50090-6777	HUMAN PRESCRIPTION DRUG	Labetalol hydrochloride		Labetalol hydrochloride	TABLET, FILM COATED	ORAL	19980803		ANDA	ANDA075133	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50090-6778_5482004c-a140-496c-bc1d-ec9cb91926c7	50090-6778	HUMAN PRESCRIPTION DRUG	Labetalol hydrochloride		Labetalol hydrochloride	TABLET, FILM COATED	ORAL	19980803		ANDA	ANDA075133	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6779_07a0d84c-a28a-4947-8d05-7eb78ef04617	50090-6779	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	A-S Medication Solutions	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6780_dc42df0e-e2c4-48a7-9748-c5216e081716	50090-6780	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide	Oil	Fluocinolone Acetonide	OIL	TOPICAL	20160718		ANDA	ANDA090982	A-S Medication Solutions	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6781_8f47c9bd-e5c7-4050-9c1b-65337f698f67	50090-6781	HUMAN OTC DRUG	CHILDRENS ZYRTEC		Cetirizine hydrochloride	TABLET, CHEWABLE	ORAL	20210621		NDA	NDA021621	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6782_0c0d4259-230e-46dd-b857-928cfc6808fd	50090-6782	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20160120		ANDA	ANDA206969	A-S Medication Solutions	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.02; 1	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50090-6783_d2e08f97-6672-40dd-a3c5-80532cea29fb	50090-6783	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20220801		ANDA	ANDA065055	A-S Medication Solutions	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
50090-6785_67bdf216-8da7-4400-a7fc-669c15f507f4	50090-6785	HUMAN PRESCRIPTION DRUG	Labetalol hydrochloride		Labetalol hydrochloride	TABLET, FILM COATED	ORAL	19980803		ANDA	ANDA075133	A-S Medication Solutions	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6787_df2bb243-63e3-4bfa-9c0e-f56afbd03d39	50090-6787	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	OINTMENT, AUGMENTED	TOPICAL	20200319		ANDA	ANDA209106	A-S Medication Solutions	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6789_7eaa3d74-224c-44f8-8e63-68ea83fb136c	50090-6789	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170614		ANDA	ANDA090693	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6790_d2e7957e-90bc-4da1-b8a9-5b72c4c04c78	50090-6790	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215767	A-S Medication Solutions	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-6791_5bbe7b52-0450-46bc-b1bc-5566958b65de	50090-6791	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	A-S Medication Solutions	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
50090-6793_bba8a2a0-1ffa-44a5-9027-6599c3131ad3	50090-6793	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	A-S Medication Solutions	PREGABALIN	75	mg/1		CV	N	20241231
50090-6794_911ade83-6dc1-4ef6-9f78-813bfdeba334	50090-6794	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20221207		ANDA	ANDA215886	A-S Medication Solutions	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-6795_d1f9565e-dfeb-41af-9677-39108ad5bd2e	50090-6795	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20221207		ANDA	ANDA215886	A-S Medication Solutions	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50090-6796_ce8a32cf-d41e-4ffa-a5b0-61b6f78d49cb	50090-6796	HUMAN PRESCRIPTION DRUG	PULMICORT FLEXHALER		Budesonide	AEROSOL, POWDER	RESPIRATORY (INHALATION)	20070319		NDA	NDA021949	A-S Medication Solutions	BUDESONIDE	180	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6797_0cd22668-25bf-44b7-8bc2-2cea6d5ad4c5	50090-6797	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		A-S Medication Solutions	THYROID	30	mg/1			N	20241231
50090-6798_4ce3190c-27b9-48ad-a292-57a9c32dfd04	50090-6798	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA216557	A-S Medication Solutions	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50090-6799_93b69487-3cc7-4b1c-b3a5-2b6f574f8160	50090-6799	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203659	A-S Medication Solutions	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6800_bb009145-e086-4bd0-8cb9-ba89201f967b	50090-6800	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, coated	TABLET	ORAL	20180618		ANDA	ANDA209912	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6801_0443bbc6-fc76-419f-8258-aa9b7e8fb47c	50090-6801	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, coated	TABLET	ORAL	20180618		ANDA	ANDA209912	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6802_bef7bd92-1e16-40d7-8158-1ef956cd843f	50090-6802	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210515		ANDA	ANDA213827	A-S Medication Solutions	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-6803_0f6d5078-9b67-4051-963c-03cc7c64d296	50090-6803	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	A-S Medication Solutions	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6804_fd01ce26-b71e-4e3c-ad60-9fb30ab9ede9	50090-6804	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20210617		ANDA	ANDA204882	A-S Medication Solutions	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-6805_9f323da8-63bb-42d1-b4a2-1698bd7ad8d7	50090-6805	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6807_17061d2b-0252-48ad-8d4a-126d74148e45	50090-6807	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221102		ANDA	ANDA214456	A-S Medication Solutions	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6808_01a4a136-ecab-4c98-a853-c5750e70605b	50090-6808	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	A-S Medication Solutions	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6809_72451ee8-dd6f-452f-9d4c-6015d3852139	50090-6809	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	A-S Medication Solutions	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6810_bfb0adc5-3172-4225-a5c3-5999a14d5052	50090-6810	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20091201		ANDA	ANDA075442	A-S Medication Solutions	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
50090-6811_86e83fe6-f6f1-4a7a-a9c6-351e6d43c73a	50090-6811	HUMAN PRESCRIPTION DRUG	Estradiol Vaginal		estradiol	CREAM	VAGINAL	20211001		ANDA	ANDA212313	A-S Medication Solutions	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-6812_7b4d9265-7e3c-470e-ab01-5c61aa4ef141	50090-6812	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	A-S Medication Solutions	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50090-6813_132e1b7b-c63c-43d3-ac31-8ca034f1210f	50090-6813	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA211091	A-S Medication Solutions	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
50090-6814_bde553cf-5b4f-4bf1-a882-0cda0196a1f6	50090-6814	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate ophthalmic		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20200615		ANDA	ANDA204777	A-S Medication Solutions	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	22.3; 6.8	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6818_ce9e2178-8bd1-4b51-aeb3-659df644370c	50090-6818	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20170919		ANDA	ANDA206391	A-S Medication Solutions	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50090-6819_78bfc853-d28c-4548-8c2b-20d23d394edc	50090-6819	HUMAN PRESCRIPTION DRUG	Tretinoin		tretinoin	CREAM	TOPICAL	20190125		ANDA	ANDA211644	A-S Medication Solutions	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
50090-6820_a222a9a2-0e79-4a6a-8f41-9d5a7d8f36ae	50090-6820	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		naltrexone hydrochloride	TABLET, FILM COATED	ORAL	20020322		ANDA	ANDA076264	A-S Medication Solutions	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
50090-6823_a453edbe-7fe8-47dd-993d-ea6653b2542d	50090-6823	HUMAN OTC DRUG	RUGBY FLUTICASONE PROPIONATE NASAL		Fluticasone propionate	SPRAY, METERED	NASAL	20181218		ANDA	ANDA207957	A-S Medication Solutions	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6824_b61a225d-8311-4f02-be79-7b8204ef08a8	50090-6824	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6825_cd31bf4e-a841-4775-94ce-1c7d18ed2b39	50090-6825	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6826_0f07c41d-fb2d-4f24-95ec-228c49c79c34	50090-6826	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	A-S Medication Solutions	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6827_dd86d9bb-3c72-4518-9967-8703c66edc6a	50090-6827	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	A-S Medication Solutions	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6828_45c79027-c21d-4afe-b4e7-fb2bcfe8d196	50090-6828	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	A-S Medication Solutions	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6829_6b75ad6d-97c1-4eb4-9256-bdbc4341346a	50090-6829	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	A-S Medication Solutions	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-6830_bcea941c-d404-4e4d-9ea9-028efb0355d7	50090-6830	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	A-S Medication Solutions	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6831_cd1c7708-518d-4d1e-9d4b-177454d2c393	50090-6831	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	A-S Medication Solutions	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6832_ce426361-1b33-495b-9253-386873883c85	50090-6832	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	A-S Medication Solutions	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6833_f4142002-eef9-4d84-87b7-0b1b16ea2d1f	50090-6833	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA075215	A-S Medication Solutions	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6834_86bf1670-811f-4877-8a2d-c2fcb613e277	50090-6834	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220907		ANDA	ANDA214654	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6835_68ce0e5b-ffc2-4bff-8be7-1dee6b37ea83	50090-6835	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210412		ANDA	ANDA205229	A-S Medication Solutions	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
50090-6836_f90198a3-6e81-4be0-b0ae-f9c982151afa	50090-6836	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		olmesartan medoxomil and hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA207804	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6837_d69c04d7-e19a-466e-9192-0f8f3e83dc06	50090-6837	HUMAN OTC DRUG	SUNMARK CHILDRENS LORATADINE SRP SF GRAPE		Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	A-S Medication Solutions	LORATADINE	5	mg/5mL			N	20241231
50090-6838_83c61bca-33bc-48a4-86d5-4e48736369f9	50090-6838	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6839_c6535e8a-c308-4e3e-aae0-21ac6417c674	50090-6839	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6840_a3635ae1-8162-43fb-8f06-c1af4d55fbe4	50090-6840	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160927		ANDA	ANDA206121	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-6841_2b08e46d-b066-4072-8e4c-8875d98c08b3	50090-6841	HUMAN PRESCRIPTION DRUG	LAGEVRIO		molnupiravir	CAPSULE	ORAL	20211223		EMERGENCY USE AUTHORIZATION		A-S Medication Solutions	MOLNUPIRAVIR	200	mg/1			N	20241231
50090-6842_6746cd5d-9b2e-4618-85a6-7a03aa4e18e2	50090-6842	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	A-S Medication Solutions	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50090-6844_9c518aae-83a4-4291-9f1d-4c43f4addfe3	50090-6844	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	A-S Medication Solutions	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-6845_71dc16e6-bd50-4aca-83ee-b63eb5a87a8c	50090-6845	HUMAN OTC DRUG	Childrens Zyrtec		Cetirizine hydrochloride	TABLET, CHEWABLE	ORAL	20210621		NDA	NDA021621	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	2.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6846_3e57b69e-a9bd-4480-9466-aabbc6208e32	50090-6846	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6847_f96b01dc-b8d2-40b8-827d-65361368c7b1	50090-6847	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	A-S Medication Solutions	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50090-6848_4edee9b0-23a0-4e64-a8c1-3dd89d5674cd	50090-6848	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA203499	A-S Medication Solutions	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6849_6fd6db61-c772-4909-a782-2f7dcd296c89	50090-6849	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA203499	A-S Medication Solutions	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6850_d02a9c18-0659-4b98-803b-fab2ae420bd1	50090-6850	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070409		ANDA	ANDA040597	A-S Medication Solutions	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
50090-6851_64eae69a-c01a-49c4-93d1-333b26983809	50090-6851	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	A-S Medication Solutions	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50090-6852_9586a5f8-3644-4a45-bb30-f36e87f71154	50090-6852	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	A-S Medication Solutions	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6853_98e0133b-f0b3-4f58-b5f2-b7c89f3fc4d0	50090-6853	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	A-S Medication Solutions	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6854_fbff2867-8cad-4460-8b6f-f78d3414f967	50090-6854	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	A-S Medication Solutions	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6855_c2771ccc-574b-4f1e-a409-e545741538d6	50090-6855	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	A-S Medication Solutions	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6856_4ba732d7-a3ed-42a6-9ca0-265282f82672	50090-6856	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6857_8a9baef0-b398-4b75-ad99-5c8fedb1d808	50090-6857	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6858_55c63ccd-b644-450b-8612-9283ceb91479	50090-6858	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6859_43872c33-0180-4bff-8762-6f864dd66ce8	50090-6859	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50090-6860_6f1de8da-d73c-40f3-ab41-6d50efb25076	50090-6860	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	A-S Medication Solutions	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
50090-6861_59123af8-143d-4928-bc97-7fc1e43de518	50090-6861	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6862_d417e7b3-391a-4155-90a6-fdf114e630f7	50090-6862	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6863_da9f6f45-acd7-4a27-a847-436610344cf0	50090-6863	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6864_f19f2e5e-bf03-4331-bdaa-b1ec11ecb967	50090-6864	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	A-S Medication Solutions	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50090-6865_4a1e0698-9622-42e6-8424-44561da74854	50090-6865	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	A-S Medication Solutions	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6866_154aa33e-c68a-4dbe-84d7-c785eefad7ee	50090-6866	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	19981120		ANDA	ANDA074726	A-S Medication Solutions	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-6867_6a6563cf-3112-4560-ab33-63ac5b41783e	50090-6867	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	19981120		ANDA	ANDA074726	A-S Medication Solutions	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50090-6868_c472fde4-c4d2-4ae7-978a-469fbc5ebe2e	50090-6868	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20101020		ANDA	ANDA074584	A-S Medication Solutions	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50090-6869_624a0565-ee42-4f30-a23e-825ae6ae6709	50090-6869	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20101020		ANDA	ANDA074584	A-S Medication Solutions	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50090-6871_92b81e37-08f6-495e-a662-63e72240d5b2	50090-6871	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6872_5b1b69e6-3c4d-49d1-8b65-67a9b9250dfb	50090-6872	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6873_eaf58d24-cc64-4f48-9c2f-73be817132fd	50090-6873	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20220818		ANDA	ANDA202467	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-6874_3b1dc082-75a6-412f-8d58-e79677e4a9c2	50090-6874	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20220818		ANDA	ANDA202467	A-S Medication Solutions	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
50090-6875_f97d1b05-f2f0-4800-a9bb-ee346be06754	50090-6875	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	A-S Medication Solutions	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6876_58bb8d11-ab83-4d36-9483-23a85decb5bd	50090-6876	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	A-S Medication Solutions	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6877_878a6b3f-e4fb-4cb0-af57-81a77819dc13	50090-6877	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	A-S Medication Solutions	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50090-6879_877b4b2e-f9ab-4c7b-a517-cc28ad911214	50090-6879	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6880_d26978c4-d9df-4565-84b1-403db716d72e	50090-6880	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6881_cff35fea-1bb7-4c05-bd6d-d665b8427d42	50090-6881	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20150806		ANDA	ANDA075459	A-S Medication Solutions	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50090-6882_ccd50b76-fca5-4c9b-9cab-13e47faea4a2	50090-6882	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220701		ANDA	ANDA204467	A-S Medication Solutions	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-6884_25169406-e7c1-42dd-85c0-93af09fe2e65	50090-6884	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6885_03a8e408-df4c-4311-b8de-ad19b9203a5e	50090-6885	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6886_0af3d84f-b323-43c2-9736-c94b0018e054	50090-6886	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	A-S Medication Solutions	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6887_2fb92517-ad93-4385-aadc-33ce1b770a25	50090-6887	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20170601		ANDA	ANDA204237	A-S Medication Solutions	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6888_bf0ee06f-ffce-4ac6-9680-2425f8f7a887	50090-6888	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200325		ANDA	ANDA211732	A-S Medication Solutions	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6889_de1c7a8e-2458-4abf-827b-6fe0955ca898	50090-6889	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6890_9e208210-c925-4495-98fa-a826d0042e87	50090-6890	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA216436	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6891_9cff2a4a-e533-4954-a932-dc727b56a21f	50090-6891	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA216436	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6893_69bca497-ed13-4dc1-be94-da12432c0701	50090-6893	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6894_04cc654a-6812-4c80-95d5-b0e22574bfcb	50090-6894	HUMAN PRESCRIPTION DRUG	Desvenlafaxine Succinate		Desvenlafaxine Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204172	A-S Medication Solutions	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6895_6b76cb8b-affc-40aa-9318-351edab023a9	50090-6895	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	A-S Medication Solutions	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50090-6896_0b64f645-6a4f-453e-931f-f4f0cae3c669	50090-6896	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111123		ANDA	ANDA200834	A-S Medication Solutions	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6897_8c40f650-b61d-47e9-9053-e6653541d516	50090-6897	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	A-S Medication Solutions	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6898_36e7610c-5f4a-49bd-a45e-492757aea7ba	50090-6898	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20060425		ANDA	ANDA076056	A-S Medication Solutions	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6899_6305eb2c-9868-4672-8df2-2ac727f8c5d9	50090-6899	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6900_376d45c5-39db-45a8-83f3-d5a3ef654786	50090-6900	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	A-S Medication Solutions	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50090-6901_1ce9fb0c-6acd-4205-8747-528c5339ba19	50090-6901	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-6902_751ea5bd-2266-48aa-8f5f-184a96aad57a	50090-6902	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
50090-6908_b8981ce7-0475-490c-9035-71717a62124c	50090-6908	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	A-S Medication Solutions	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6909_4c77ea5b-6330-4599-9076-450300b66ab2	50090-6909	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	A-S Medication Solutions	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
50090-6910_8b4415ac-83c5-4fe2-81f3-8b5ce73041ed	50090-6910	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	A-S Medication Solutions	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6912_c21cc25c-04b1-4ffd-a87c-077073b72fb4	50090-6912	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	A-S Medication Solutions	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
50090-6913_f0729765-9ea7-4acf-813b-f4de1fa5b717	50090-6913	HUMAN PRESCRIPTION DRUG	Gemfibrozil		gemfibrozil	TABLET	ORAL	20101220		ANDA	ANDA079072	A-S Medication Solutions	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
50090-6916_a8804aa3-e649-4e2e-8beb-0ac4f1363e26	50090-6916	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	A-S Medication Solutions	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-6917_a32cf691-ce37-45e1-98a6-0d7707777b2d	50090-6917	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	A-S Medication Solutions	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6918_09b3c027-4957-4f0b-82e9-1cb50b76c87c	50090-6918	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	A-S Medication Solutions	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50090-6919_3e73e8c8-7289-4a44-bb47-9d10ef270a1a	50090-6919	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6921_7a12f84b-4320-4742-8e11-3e0b27e5139d	50090-6921	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6922_0c27f8bb-da35-435e-8342-8e75a1083324	50090-6922	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	A-S Medication Solutions	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6924_85fe1b65-b417-453f-a975-ea67541780cc	50090-6924	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	A-S Medication Solutions	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6925_f30de206-e7b1-4631-bc41-5588df1bd047	50090-6925	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-6927_4e8ca436-5c2b-447f-8f9b-4aeae9e16da6	50090-6927	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	A-S Medication Solutions	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50090-6928_2e78718f-1253-4cc9-b518-e56f51524a51	50090-6928	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190701		OTC MONOGRAPH DRUG	M013	A-S Medication Solutions	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50090-6929_76f448ba-9f76-4340-bf8d-4747b2d72e31	50090-6929	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190701		OTC MONOGRAPH DRUG	M013	A-S Medication Solutions	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50090-6931_697cc789-b0dc-48af-a4aa-4d3cc253cd1d	50090-6931	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070312		ANDA	ANDA040707	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50090-6932_f6e6fdaf-9f94-46b1-a51a-6991db39336c	50090-6932	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	A-S Medication Solutions	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50090-6935_2bf10cc9-8492-45c1-8e7c-5e75e1c8d283	50090-6935	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20041116		ANDA	ANDA074056	A-S Medication Solutions	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6936_58b66c16-af1f-4149-bb4c-25ef0f6a29ab	50090-6936	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20030701		NDA AUTHORIZED GENERIC	NDA007073	A-S Medication Solutions	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
50090-6937_f1e4d5a1-fc65-47ce-b6bd-47b1c793dccf	50090-6937	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	A-S Medication Solutions	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50090-6938_2d81e9fd-c78c-42e1-94fe-1c357d72d969	50090-6938	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	A-S Medication Solutions	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50090-6939_cd560cd9-4e1d-4641-8c3b-d994ed0dcafc	50090-6939	HUMAN PRESCRIPTION DRUG	Gemfibrozil		gemfibrozil	TABLET	ORAL	20101220		ANDA	ANDA079072	A-S Medication Solutions	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
50090-6940_43288fb7-d4bd-46ae-8569-c12efbd47987	50090-6940	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	A-S Medication Solutions	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20251231
50090-6941_8055a69e-066e-4952-af52-d0f2da3c8930	50090-6941	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	A-S Medication Solutions	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20251231
50090-6942_26aae9d8-f5a6-4084-80d0-abdad784d198	50090-6942	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	A-S Medication Solutions	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
50090-6943_85769778-437b-4822-a079-e02753ce91f6	50090-6943	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190917		ANDA	ANDA078279	A-S Medication Solutions	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50090-6945_3426ba1a-0b97-4f7d-83e0-5e06f9de85cc	50090-6945	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209908	A-S Medication Solutions	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50090-6946_3e21edf1-194e-4cbc-ab25-db966aac733a	50090-6946	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20201224		ANDA	ANDA078895	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50090-6947_d88b94eb-00d5-4a10-988a-801d53865116	50090-6947	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	A-S Medication Solutions	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50090-6949_bf633580-bc4e-438b-b7df-a22eadf916b5	50090-6949	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	A-S Medication Solutions	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6950_2b80be53-9255-421a-8146-cdd4fd684857	50090-6950	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	A-S Medication Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
50090-6951_18e336dd-0ee5-46a7-9dd1-fba87421e207	50090-6951	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231019		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20251231
50090-6952_5c688f8a-bd7f-41d6-ae5b-d8c59dc3d0e8	50090-6952	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231019		UNAPPROVED DRUG OTHER		A-S Medication Solutions	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
50090-6957_a0bf64f6-8bfe-4382-b170-8fc6c6924f07	50090-6957	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20191121		ANDA	ANDA207813	A-S Medication Solutions	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-6958_1f2e4a5c-d94d-4544-82d6-333d0c56ab0b	50090-6958	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20191121		ANDA	ANDA207813	A-S Medication Solutions	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-6959_599774f5-f0b2-4f17-b477-aed96228496a	50090-6959	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA203699	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50090-6960_cfb62efc-36c9-4a0d-8179-2b1d347694a9	50090-6960	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA203699	A-S Medication Solutions	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50090-6962_424a5d03-d760-4ae3-9974-3bdb487d835d	50090-6962	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230430		ANDA	ANDA210015	A-S Medication Solutions	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50090-6963_7a0088db-1e25-49db-9a22-c99cd6adfd8f	50090-6963	HUMAN OTC DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	SPRAY	NASAL	20230730		ANDA	ANDA211951	A-S Medication Solutions	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
50090-6965_72dc2e57-df1a-4d62-a8a2-cde96890bc2c	50090-6965	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20190218		ANDA	ANDA204097	A-S Medication Solutions	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6966_152bdcf5-866b-47c5-a491-c6595c2bc4ff	50090-6966	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171115		ANDA	ANDA209823	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-6967_a88c7b98-1c1f-4512-85a7-bf2b5d835220	50090-6967	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171115		ANDA	ANDA209823	A-S Medication Solutions	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50090-6968_988b043b-b190-4b7b-a99a-397e21efa62d	50090-6968	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220701		ANDA	ANDA204467	A-S Medication Solutions	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
50090-6970_ef01482a-e886-4594-9ae7-86fe08c43c5b	50090-6970	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	A-S Medication Solutions	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6971_925f0625-454c-4646-81ca-b9b07c67a576	50090-6971	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	A-S Medication Solutions	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
50090-6972_08a08e21-404b-4d25-8672-c4a6ae59b662	50090-6972	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20210820		ANDA	ANDA215184	A-S Medication Solutions	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50090-6973_de8ee364-daeb-4826-a135-e06db47424f5	50090-6973	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20220622		ANDA	ANDA076509	A-S Medication Solutions	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
50090-6974_ceae8452-995f-4005-b8a5-b482b47ca580	50090-6974	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20220622		ANDA	ANDA076509	A-S Medication Solutions	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50090-6975_ccc582b9-6286-40df-aff3-7edceff70e63	50090-6975	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	A-S Medication Solutions	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6976_f12f62ad-8cb9-4d5d-a385-49ac8b0a5a80	50090-6976	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	A-S Medication Solutions	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-6978_f5825e58-429e-4a79-b0c3-2b66edd4b04e	50090-6978	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20181123		ANDA	ANDA209828	A-S Medication Solutions	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50090-6979_20e6ad84-17d4-4fb3-aaa1-ee040f102f5b	50090-6979	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20120629		ANDA	ANDA091264	A-S Medication Solutions	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50090-6980_289f2b49-7dea-4a1f-91d4-13741e1d7b4b	50090-6980	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	A-S Medication Solutions	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50090-6981_7f8de798-b2b5-420c-a7ff-54353f6cc53e	50090-6981	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	A-S Medication Solutions	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6982_13fa49f7-a8d8-480e-a20e-4cdfb723c183	50090-6982	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6984_caabca8e-5ea9-4d1d-8a88-08437e0d1b7e	50090-6984	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	A-S Medication Solutions	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
50090-6985_e806b5bf-3256-474d-85fb-f1afb415824e	50090-6985	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	A-S Medication Solutions	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
50090-6986_f0ec020d-32d3-49cc-a35c-4ae91771a8ea	50090-6986	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	A-S Medication Solutions	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
50090-6987_d1636606-b787-40e9-9066-0e3452c9f4d2	50090-6987	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-6988_46f6397e-cc46-44f8-88d1-0004e657304d	50090-6988	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
50090-6989_67a6e94b-c408-4877-9d86-628c571eb54c	50090-6989	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	A-S Medication Solutions	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50090-6994_d74dadc8-3861-4ff7-92d2-69e983a732e0	50090-6994	HUMAN PRESCRIPTION DRUG	COLESEVELAM HYDROCHLORIDE		COLESEVELAM HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220801		NDA	NDA021176	A-S Medication Solutions	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
50090-6995_a14b8135-6187-46a0-b956-af2fb764229d	50090-6995	HUMAN PRESCRIPTION DRUG	COLESEVELAM HYDROCHLORIDE		COLESEVELAM HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220801		NDA	NDA021176	A-S Medication Solutions	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
50090-6996_d1e08a73-ecab-4e76-a661-aa41a0747662	50090-6996	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	A-S Medication Solutions	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50090-6998_aaba6108-647a-4d19-9976-611298bfcb11	50090-6998	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200130		ANDA	ANDA210986	A-S Medication Solutions	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50090-6999_13ec0bb9-d5aa-4e86-91e2-3be896570a4d	50090-6999	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	A-S Medication Solutions	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50090-7000_e572b532-c04e-470b-94d3-ec04b32835e6	50090-7000	HUMAN PRESCRIPTION DRUG	Atropine		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20211126		ANDA	ANDA215624	A-S Medication Solutions	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
50090-7001_e412cffb-19ca-49a1-8562-564d7f1fe1b8	50090-7001	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA075215	A-S Medication Solutions	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50090-7002_01198707-f4d8-47fd-b8d2-59a01d62278b	50090-7002	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA075215	A-S Medication Solutions	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50090-7004_9334e5d4-6132-409c-a9d0-d77cf18b4d87	50090-7004	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50090-7005_1dd8e099-9ec4-429b-8235-407443dccbb8	50090-7005	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	A-S Medication Solutions	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50090-7007_2807f1f8-832c-41f3-b727-50d0e086f471	50090-7007	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	A-S Medication Solutions	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
50090-7008_d7937760-72c6-46bb-862b-db3d6b5357c1	50090-7008	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	A-S Medication Solutions	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20251231
50090-7009_426f0c38-49b6-47b5-b26f-eadb71a801e0	50090-7009	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20201224		ANDA	ANDA078895	A-S Medication Solutions	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
50090-7013_005f4187-1334-401a-abc1-82eaa5177df5	50090-7013	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	A-S Medication Solutions	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
50090-7017_cd6a411a-4612-4fc7-aca5-53dac08c30af	50090-7017	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	A-S Medication Solutions	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20251231
50090-7022_676bbf3b-2b1e-40b2-98c0-a2333e84aef9	50090-7022	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	A-S Medication Solutions	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
50090-7026_e00adae5-ea19-46aa-8314-97ecec0f12a2	50090-7026	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20151019		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50090-7027_86b01cce-7cd7-4aae-9391-9744d05338de	50090-7027	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20151019		ANDA	ANDA090836	A-S Medication Solutions	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50096-505_04c66585-1221-4c3f-e063-6294a90a57a7	50096-505	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9.8% and Sulfur 4.8%		SULFACETAMIDE SODIUM, SULFUR	LOTION	TOPICAL	20050901	20240131	UNAPPROVED DRUG OTHER		Rosemar Labs, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	
50102-211_48f3a64f-278d-4d51-9dbd-da7e1436d06f	50102-211	HUMAN OTC DRUG	EContra One-Step		Levonorgestrel	TABLET	ORAL	20180208		ANDA	ANDA206867	Afaxys Pharma, LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
50102-220_fcc43b16-32b2-46c3-878e-e9c44915d421	50102-220	HUMAN PRESCRIPTION DRUG	Aubra EQ		Levonorgestrel and Ethinyl Estradiol	KIT		20161114		ANDA	ANDA206886	Afaxys Pharma, LLC						N	20241231
50102-224_700bfd50-4ae7-448d-97dd-d212b5fbff38	50102-224	HUMAN PRESCRIPTION DRUG	TARINA 24 FE		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170615		ANDA	ANDA207504	Afaxys Pharma, LLC						N	20241231
50102-228_4daddb44-fa57-496e-9c83-67cb3ceeafb7	50102-228	HUMAN PRESCRIPTION DRUG	Tarina Fe 1/20 EQ		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170616		ANDA	ANDA207505	Afaxys Pharma, LLC						N	20241231
50102-230_3a68cd51-a4da-410f-b1b2-c9b647786f81	50102-230	HUMAN PRESCRIPTION DRUG	Chateal EQ		Levonorgestrel and Ethinyl Estradiol	KIT		20160923		ANDA	ANDA206866	Afaxys Pharma, LLC						N	20241231
50102-231_bb0e872b-05ee-4e30-bc1f-808f2c533e5d	50102-231	HUMAN PRESCRIPTION DRUG	Tri-VyLibra Lo		Norgestimate and Ethinyl Estradiol	KIT		20161104		ANDA	ANDA205762	Afaxys Pharma, LLC						N	20241231
50102-233_ac6853f1-cf7c-4d0e-ae9f-680ca20c38f7	50102-233	HUMAN PRESCRIPTION DRUG	Tri-VyLibra		Norgestimate and Ethinyl Estradiol	KIT		20160706		ANDA	ANDA205441	Afaxys Pharma, LLC						N	20241231
50102-235_f5f15a23-5bd1-4aa9-8f3d-c899fad37bcf	50102-235	HUMAN PRESCRIPTION DRUG	VyLibra		norgestimate and ethinyl estradiol	KIT		20160707		ANDA	ANDA205449	Afaxys Pharma, LLC						N	20241231
50102-240_8b910c13-9204-4bcf-a3f8-ff35d7581459	50102-240	HUMAN PRESCRIPTION DRUG	Jasmiel		Drospirenone and Ethinyl Estradiol	KIT		20180227		ANDA	ANDA209632	Afaxys Pharma, LLC						N	20241231
50102-254_98f6e7dc-706c-43fd-a1b1-ff09709fab8a	50102-254	HUMAN PRESCRIPTION DRUG	Cyred EQ		Desogestrel and Ethinyl Estradiol	KIT		20170517		ANDA	ANDA207081	Afaxys Pharma, LLC						N	20241231
50102-300_ffb8f5fe-9e1a-4ca9-adc9-181093af01b9	50102-300	HUMAN PRESCRIPTION DRUG	Lyleq		NORETHINDRONE	TABLET	ORAL	20160923		ANDA	ANDA207304	Afaxys Pharma, LLC	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50102-400_4906a1e0-c3aa-48e3-8915-00f2e607185a	50102-400	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		lidocaine hydrochloride	INJECTION	INFILTRATION; PERINEURAL	20220629		ANDA	ANDA215132	Afaxys Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50111-327_faf6c313-03e6-4bf8-ac9f-65642ae10097	50111-327	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA088467	Teva Pharmaceuticals USA, Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50111-328_faf6c313-03e6-4bf8-ac9f-65642ae10097	50111-328	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA088468	Teva Pharmaceuticals USA, Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50111-333_7cd1fdc3-7f1e-491f-8886-74ea96f67181	50111-333	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	19900930		ANDA	ANDA070027	Teva Pharmaceuticals USA, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50111-334_7cd1fdc3-7f1e-491f-8886-74ea96f67181	50111-334	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	19900930		ANDA	ANDA070033	Teva Pharmaceuticals USA, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50111-397_faf6c313-03e6-4bf8-ac9f-65642ae10097	50111-397	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA089098	Teva Pharmaceuticals USA, Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50111-398_faf6c313-03e6-4bf8-ac9f-65642ae10097	50111-398	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA089097	Teva Pharmaceuticals USA, Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50111-450_597b1197-ccf6-4e9a-819c-34a582f8100a	50111-450	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200311		ANDA	ANDA071525	Teva Pharmaceuticals USA, Inc.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50111-456_e7c01ece-edf5-473e-8c00-1ba7663179cc	50111-456	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	19900930		ANDA	ANDA071655	Teva Pharmaceuticals USA, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50111-560_597b1197-ccf6-4e9a-819c-34a582f8100a	50111-560	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA071523	Teva Pharmaceuticals USA, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50111-561_597b1197-ccf6-4e9a-819c-34a582f8100a	50111-561	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201008		ANDA	ANDA071524	Teva Pharmaceuticals USA, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
50111-647_1299e4a3-2b8e-4e1d-aa6d-9d8e05e527b4	50111-647	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50111-648_1299e4a3-2b8e-4e1d-aa6d-9d8e05e527b4	50111-648	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	Teva Pharmaceuticals USA, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50111-787_5c38757a-364c-4d42-96e5-948946921b00	50111-787	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065225	Teva Pharmaceuticals USA, Inc.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50111-788_5c38757a-364c-4d42-96e5-948946921b00	50111-788	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065223	Teva Pharmaceuticals USA, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50111-789_9b156676-34a9-491c-b0e5-382e49e98129	50111-789	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051201		ANDA	ANDA065218	Teva Pharmaceuticals USA, Inc.	AZITHROMYCIN MONOHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
50111-915_dbbff712-90f2-48ed-9a93-e156715af9f0	50111-915	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20040601		ANDA	ANDA076346	Teva Pharmaceuticals USA, Inc.	TORSEMIDE	5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50111-916_dbbff712-90f2-48ed-9a93-e156715af9f0	50111-916	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20040601		ANDA	ANDA076346	Teva Pharmaceuticals USA, Inc.	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50111-917_dbbff712-90f2-48ed-9a93-e156715af9f0	50111-917	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20040601		ANDA	ANDA076346	Teva Pharmaceuticals USA, Inc.	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50111-918_dbbff712-90f2-48ed-9a93-e156715af9f0	50111-918	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20041020		ANDA	ANDA076346	Teva Pharmaceuticals USA, Inc.	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50114-7004_11e7b387-3044-4f7f-b3e7-2938cae3d0b2	50114-7004	HUMAN PRESCRIPTION DRUG	Traumeel		ARNICA MONTANA ROOT, ATROPA BELLADONNA, CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA RECUTITA, ACHILLEA MILLEFOLIUM, CALCIUM SULFIDE, COMFREY ROOT, ACONITUM NAPELLUS, BELLIS PERENNIS, MERCURIUS SOLUBILIS, HYPERICUM PERFORATUM, ECHINACEA, UNSPECIFIED, ECHINACEA PURPUREA and HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	INJECTION	INTRA-ARTICULAR; INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20070509	20241231	UNAPPROVED HOMEOPATHIC		Medinatura	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	3; 2; 2; 2; 2; 6; 2; 6; 2; 2; 1; 2; 3; 6	[hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL			N	
50114-7015_cb45601b-173d-4390-bbd2-09476195dca3	50114-7015	HUMAN PRESCRIPTION DRUG	Engystol		CYNANCHUM VINCETOXICUM ROOT and SULFUR	INJECTION	INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20140531	20250228	UNAPPROVED HOMEOPATHIC		MediNatura	CYNANCHUM VINCETOXICUM ROOT; SULFUR	6; 4	[hp_X]/1.1mL; [hp_X]/1.1mL			N	
50114-7030_481ac8c7-8ec2-40e1-b29a-e846a24ad4a2	50114-7030	HUMAN PRESCRIPTION DRUG	Zeel		ARNICA MONTANA ROOT, TOXICODENDRON PUBESCENS LEAF, SOLANUM DULCAMARA TOP, COMFREY ROOT, SULFUR, SANGUINARIA CANADENSIS ROOT, SUS SCROFA CARTILAGE, SUS SCROFA EMBRYO, SUS SCROFA UMBILICAL CORD, SUS SCROFA PLACENTA, .ALPHA.-LIPOIC ACID, COENZYME A, NADIDE and SODIUM DIETHYL OXALACETATE	INJECTION	INTRA-ARTICULAR; INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20140731	20241231	UNAPPROVED HOMEOPATHIC		MediNatura	.ALPHA.-LIPOIC ACID; ARNICA MONTANA ROOT; COENZYME A; COMFREY ROOT; NADIDE; SANGUINARIA CANADENSIS ROOT; SODIUM DIETHYL OXALACETATE; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	8; 4; 8; 6; 8; 4; 8; 3; 6; 6; 6; 6; 6; 2	[hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL; [hp_X]/2mL			N	
50114-8200_e98cb3c3-b037-4a55-8a13-17c162de99cc	50114-8200	HUMAN PRESCRIPTION DRUG	Lymphomyosot X		ARANEUS DIADEMATUS, TRIBASIC CALCIUM PHOSPHATE, EQUISETUM HYEMALE, FERROUS IODIDE,FUMARIA OFFICINALIS FLOWERING TOP, GENTIANA LUTEA ROOT, GERANIUM ROBERTIANUM, MYOSOTIS ARVENSIS, NASTURTIUM OFFICINALE, SODIUM SULFATE, PINUS SYLVESTRIS LEAFY TWIG,SMILAX REGELII ROOT, SCROPHULARIA NODOSA, TEUCRIUM SCORODONIA FLOWERING TOP, THYROID, UNSPECIFIED andVERONICA OFFICINALIS FLOWERING TOP	INJECTION	INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20140731	20240831	UNAPPROVED HOMEOPATHIC		MediNatura	ARANEUS DIADEMATUS; EQUISETUM HYEMALE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; THYROID, UNSPECIFIED; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	6; 12; 3; 4; 5; 4; 3; 4; 4; 3; 6; 4; 3; 12; 12; 3	[hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
50114-9001_9429158c-c8cc-48c2-9ef8-d1e444c31787	50114-9001	HUMAN PRESCRIPTION DRUG	WellMind Vertigo		SEMECARPUS ANACARDIUM JUICE, ANAMIRTA COCCULUS SEED, CONIUM MACULATUM FLOWERING TOP, KEROSENE, and SELENIUM	TABLET	ORAL	20150101	20240831	UNAPPROVED HOMEOPATHIC		MediNatura Inc.	ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; PETROLEUM ALKYLATE; SELENIUM; SEMECARPUS ANACARDIUM JUICE	4; 3; 8; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
50114-9002_1cee4bf7-c20f-41d0-bbfb-16391966e9af	50114-9002	HUMAN PRESCRIPTION DRUG	BHI Uri-Control RX		APIS MELLIFERA, SILVER NITRATE, ATROPA BELLADONNA, LYTTA VESICATORIA, CAUSTICUM, EQUISETUM HYEMALE, PETROSELINUM CRISPUM, PULSATILLA VULGARIS, SMILAX REGELII ROOT, and TURPENTINE OIL	TABLET	ORAL	20150101	20260331	UNAPPROVED HOMEOPATHIC		MediNatura Inc	APIS MELLIFERA; ATROPA BELLADONNA; CAUSTICUM; EQUISETUM HYEMALE; LYTTA VESICATORIA; PETROSELINUM CRISPUM; PULSATILLA VULGARIS; SILVER NITRATE; SMILAX ORNATA ROOT; TURPENTINE OIL	6; 4; 8; 6; 6; 8; 6; 6; 6; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
50130-316_082e2a81-7df0-6d4a-e063-6294a90a5f7f	50130-316	HUMAN OTC DRUG	BIO-ICE		MENTHOL, CAMPHOR	GEL	TOPICAL	20130101		OTC MONOGRAPH DRUG	M017	Electrostim Medical Services Inc. d/b/a EMSI	CAMPHOR (SYNTHETIC); MENTHOL	.48; 5.4	g/100mL; g/100mL			N	20241231
50153-110_092d15ec-a5a7-32d9-e063-6394a90a844e	50153-110	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19950921		UNAPPROVED MEDICAL GAS		Island Equipment Company	OXYGEN	99	L/100L			N	20241231
50157-001_ca7b4e4b-7819-862b-e053-2a95a90ad906	50157-001	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-003_c32b3e32-a47d-13b7-e053-2a95a90a48c6	50157-003	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-004_c32b409e-10ee-206d-e053-2995a90a4a46	50157-004	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-006_ca7bb2d7-a4f1-f07c-e053-2a95a90a0f20	50157-006	HUMAN OTC DRUG	Antibacterial	2X Ultra cleansing	Benzalkonium Chloride	LIQUID	TOPICAL	20210821		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-012_f5b0c848-b0d6-04a9-e053-2a95a90af944	50157-012	HUMAN OTC DRUG	Acne Wash	Kissable	Salicylic Acid	GEL	TOPICAL	20230227		OTC MONOGRAPH FINAL	part333D	BRANDS INTERNATIONAL	SALICYLIC ACID	2	mg/100mL			N	20241231
50157-013_f5b114f5-374b-eaba-e053-2a95a90a932e	50157-013	HUMAN OTC DRUG	Deep Pore Charcoal Acne scrub		Salicylic Acid	LIQUID	TOPICAL	20230222		OTC MONOGRAPH FINAL	part358H	Brands International Corporation	SALICYLIC ACID	1	g/100mL			N	20241231
50157-016_ca7b4f22-7472-d16f-e053-2a95a90a95cc	50157-016	HUMAN OTC DRUG	Antibacterial	2X	Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-050_d1fa9035-1201-d5a7-e053-2995a90aa4a7	50157-050	HUMAN OTC DRUG	Hand Sanitizer Alcohol Free	NYC HEALTH HOSPITALS	Benzalkonium Chloride	SOLUTION	TOPICAL	20211129		OTC MONOGRAPH NOT FINAL	part333E	Brands International Corp	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
50157-100_a79783e1-ab17-6211-e053-2995a90aa66d	50157-100	HUMAN OTC DRUG	Visibly Clean Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20141115		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	62	mL/100mL			N	20241231
50157-120_ad2a3d07-d439-4b7c-e053-2995a90a3b94	50157-120	HUMAN OTC DRUG	Hello Bello		Ethyl Alcohol	LIQUID	TOPICAL	20200818		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corp	ALCOHOL	75	mL/1000mL			N	20241231
50157-125_021dabae-fd63-b5a6-e063-6294a90ac2aa	50157-125	HUMAN OTC DRUG	PYRITHIONE ZINC		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20220816		OTC MONOGRAPH FINAL	M032	BRANDS INTERNATIONAL	PYRITHIONE ZINC	.3	g/100mL			N	20241231
50157-225_d3db2f57-0e2a-169a-e053-2995a90a0551	50157-225	HUMAN OTC DRUG	Hello Bello Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20211223		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	ALCOHOL	75	mL/100mL			N	20241231
50157-264_c01c93b1-dbcb-40e6-e053-2a95a90ad262	50157-264	HUMAN OTC DRUG	Everwipe Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20210416		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-333_f6f431fa-b2c1-d108-e053-6394a90ae95a	50157-333	HUMAN OTC DRUG	ZINC OXIDE		ZINC OXIDE	OINTMENT	TOPICAL	20230315		OTC MONOGRAPH FINAL	part347	BRANDS INTERNATIONAL	ZINC OXIDE	20	g/100g			N	20241231
50157-335_a37ccb83-3990-1187-e053-2a95a90ae1be	50157-335	HUMAN OTC DRUG	Visibly Clean Hand Sanitizer		alcohol	GEL	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	.7	mL/mL			N	20241231
50157-336_a2dbcdce-733f-38c6-e053-2995a90af340	50157-336	HUMAN OTC DRUG	Visibly Clean Hand Sanitizer		alcohol	GEL	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	.65	mL/mL			N	20241231
50157-338_a4af1018-a4ca-1227-e053-2995a90a3b3e	50157-338	HUMAN OTC DRUG	Purple Frog Hand Sanitizer		Ethylalcohol	GEL	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	.7	mL/mL			N	20241231
50157-340_bc18e19c-2f9c-3e5b-e053-2995a90a61ae	50157-340	HUMAN OTC DRUG	NYC Health Hospitals	Hand Sanitizer	Ethyl Alcohol	GEL	TOPICAL	20210224		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	.75	mL/mL			N	20241231
50157-423_bd11c4db-176a-2979-e053-2a95a90aaee6	50157-423	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20210305		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-424_bd11ce19-2465-40b7-e053-2995a90ad425	50157-424	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20210305		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-425_bd119a59-3d2f-3e8c-e053-2995a90a54e0	50157-425	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20210305		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-451_e80e06f6-e44a-7b34-e053-2a95a90afc3f	50157-451	HUMAN OTC DRUG	Antibacterial	Lavender	Benzalkonium Chloride	LIQUID	TOPICAL	20220906		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-452_e819ab31-412e-5bed-e053-2a95a90a307d	50157-452	HUMAN OTC DRUG	Antibacterial	Lemon Sage	Benzalkonium Chloride	LIQUID	TOPICAL	20220906		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-454_e819e61a-459a-cea6-e053-2a95a90a437c	50157-454	HUMAN OTC DRUG	Antibacterial	Orange Clementine	Benzalkonium Chloride	LIQUID	TOPICAL	20220906		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-477_e91ff69e-84b8-ead0-e053-2995a90a752d	50157-477	HUMAN OTC DRUG	Zinc Oxide 40%		Diaper Rash Skin	CREAM	TOPICAL	20220920		OTC MONOGRAPH FINAL	M016	BRANDS INTERNATIONAL	ZINC OXIDE	40	g/100mL			N	20241231
50157-501_a1c539d2-b36d-91a3-e053-2a95a90a6892	50157-501	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200304		OTC MONOGRAPH NOT FINAL	part333A	Brands International	ALCOHOL	62	mL/100mL			N	20241231
50157-501_efa6911e-270d-68ed-e053-2a95a90ab9ea	50157-501	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200304		OTC MONOGRAPH NOT FINAL	part333A	Brands International	ALCOHOL	62	mL/100mL			N	20241231
50157-503_a5c69c86-e43f-358a-e053-2a95a90a0950	50157-503	HUMAN OTC DRUG	Germs Be Gone Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	.8	mL/mL			N	20241231
50157-504_a7aefeca-b4a1-63ae-e053-2995a90a23d3	50157-504	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20200319		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	65	mL/100mL			N	20241231
50157-506_ab0ee67f-8743-2803-e053-2995a90a47d6	50157-506	HUMAN OTC DRUG	Germs be gone hand Sanitizer		Alcohol	GEL	TOPICAL	20200319		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	75	mL/100mL			N	20241231
50157-507_bf6d63b6-cf0b-e04a-e053-2a95a90a9f8b	50157-507	HUMAN OTC DRUG	Germs be gone hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200722		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	75	mL/100mL			N	20241231
50157-508_af4bb6ee-7847-4d11-e053-2995a90a0520	50157-508	HUMAN OTC DRUG	Antibacterial	Vanilla and Shea Butter	Benzalkonium Chloride	LIQUID	TOPICAL	20200910		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-509_af873fa4-b5c0-1872-e053-2995a90a70e0	50157-509	HUMAN OTC DRUG	Antibacterial Moisturizing	Aloe and Vitamin E	Benzalkonium Chloride	LIQUID	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-511_b0000e40-a63a-9263-e053-2a95a90a2f5f	50157-511	HUMAN OTC DRUG	Moonlite Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-512_b45889ab-7a49-becd-e053-2a95a90a60c7	50157-512	HUMAN OTC DRUG	Germs Be Gone Antiseptic wipes		Benzalkonium chloride	CLOTH	TOPICAL	20200921		OTC MONOGRAPH NOT FINAL	part333A	Brands International corporation	BENZALKONIUM CHLORIDE	.13	1/1001			N	20241231
50157-513_b5952802-c2f8-3f21-e053-2a95a90a8b51	50157-513	HUMAN OTC DRUG	Germs be gone hand Sanitizer		Alcohol	GEL	TOPICAL	20201203		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	75	mL/100mL			N	20241231
50157-514_b9e49521-08da-1907-e053-2995a90ad321	50157-514	HUMAN OTC DRUG	Antibacterial Moisturizing	Cherry BlossomAloe and Vitamin E	Benzalkonium Chloride	LIQUID	TOPICAL	20210126		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-515_b9e49af0-a6fe-1ac7-e053-2995a90a5411	50157-515	HUMAN OTC DRUG	Antibacterial Moisturizing	Rosemary Mint Aloe and Vitamin E	Benzalkonium Chloride	LIQUID	TOPICAL	20210126		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-516_b9e40c73-c2f6-faaa-e053-2a95a90a5c47	50157-516	HUMAN OTC DRUG	Antibacterial	Coconut Water Aloe and Vitamin E	Benzalkonium Chloride	LIQUID	TOPICAL	20210126		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-517_b9e49521-08e9-1907-e053-2995a90ad321	50157-517	HUMAN OTC DRUG	Antibacterial Moisturizing	Lavender Vanilla Aloe and Vitamin E	Benzalkonium Chloride	LIQUID	TOPICAL	20210126		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50157-518_bd49c4a8-4ed1-477c-e053-2995a90a98a8	50157-518	HUMAN OTC DRUG	Everwipe hand Sanitizer		Alcohol	GEL	TOPICAL	20210311		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	70	mL/100mL			N	20241231
50157-520_bf6da312-7585-2242-e053-2995a90a35a7	50157-520	HUMAN OTC DRUG	Germs be gone hand Sanitizer		Alcohol	LIQUID	TOPICAL	20201203		OTC MONOGRAPH NOT FINAL	part333E	Brands International	ALCOHOL	75	mL/100mL			N	20241231
50157-521_c98909b5-a144-9c1a-e053-2995a90a5e7d	50157-521	HUMAN OTC DRUG	Germs Be Gone Antiseptic wipes	Unscented	Benzalkonium chloride	CLOTH	TOPICAL	20210811		OTC MONOGRAPH NOT FINAL	part333A	Brands International corporation	BENZALKONIUM CHLORIDE	.13	1/1001			N	20241231
50157-522_c98944f8-94b8-d260-e053-2995a90a5ed7	50157-522	HUMAN OTC DRUG	Germs Be Gone Antiseptic wipes	Scented	Benzalkonium chloride	CLOTH	TOPICAL	20210811		OTC MONOGRAPH NOT FINAL	part333A	Brands International corporation	BENZALKONIUM CHLORIDE	.13	1/1001			N	20241231
50157-523_c98984c9-b666-0305-e053-2a95a90a68cc	50157-523	HUMAN OTC DRUG	Germs Be Gone Antibacterial	Non Scented	Antiseptic Hand Cream	CREAM	TOPICAL	20210814		OTC MONOGRAPH NOT FINAL	part333A	BRANDS INTERNATIONAL CORPORATION	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
50157-524_c99088df-b1a9-0d93-e053-2995a90af4a5	50157-524	HUMAN OTC DRUG	Germs Be Gone Antibacterial	Scented	Antiseptic Hand Cream	CREAM	TOPICAL	20210814		OTC MONOGRAPH NOT FINAL	part333A	BRANDS INTERNATIONAL CORPORATION	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
50157-526_c991074f-9d95-6592-e053-2a95a90a8c08	50157-526	HUMAN OTC DRUG	Germs be gone Sanitizer	Scented	Hand Sanitizer	SOLUTION	TOPICAL	20210814		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
50157-530_e72b0ad0-3315-7538-e053-2995a90aecba	50157-530	HUMAN OTC DRUG	Germs Be Gone Antiseptic wipes		Ethyl Alcohol	CLOTH	TOPICAL	20200921		OTC MONOGRAPH NOT FINAL	part333A	Brands International corporation	ALCOHOL	75	g/100mL			N	20241231
50157-569_a2b682b9-f389-45c0-e053-2995a90abab5	50157-569	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200304		OTC MONOGRAPH NOT FINAL	part333A	Brands International	ALCOHOL	62	mL/100mL			N	20241231
50157-601_ed76c513-2329-40ec-e053-2995a90a020d	50157-601	HUMAN OTC DRUG	Antibacterial	Spring Rain	Benzalkonium Chloride	LIQUID	TOPICAL	20220906		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-602_f692d818-1620-126c-e053-2995a90ad54d	50157-602	HUMAN OTC DRUG	Antibacterial	Green Apple	Benzalkonium Chloride	LIQUID	TOPICAL	20221114		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-603_ed769147-dfbe-3ebc-e053-2995a90a9ead	50157-603	HUMAN OTC DRUG	Antibacterial	Spring Rain	Benzalkonium Chloride	LIQUID	TOPICAL	20221114		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-604_ed76e19b-1042-515b-e053-2995a90a2420	50157-604	HUMAN OTC DRUG	Antibacterial	Spring Rain	Benzalkonium Chloride	LIQUID	TOPICAL	20221114		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-605_ed77114d-a0c5-d37c-e053-2a95a90a283e	50157-605	HUMAN OTC DRUG	Antibacterial	Spring Rain	Benzalkonium Chloride	LIQUID	TOPICAL	20221114		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-606_ed777946-e742-08e3-e053-2995a90aa88d	50157-606	HUMAN OTC DRUG	Antibacterial	Spring Rain	Benzalkonium Chloride	LIQUID	TOPICAL	20221114		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-607_ed77b201-10df-363d-e053-2995a90a9975	50157-607	HUMAN OTC DRUG	Antibacterial	Spring Rain	Benzalkonium Chloride	LIQUID	TOPICAL	20221114		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-608_ed77f3fa-3089-1e4e-e053-2a95a90a6b80	50157-608	HUMAN OTC DRUG	Antibacterial	Spring Rain	Benzalkonium Chloride	LIQUID	TOPICAL	20221114		OTC MONOGRAPH NOT FINAL	part333A	Brands International Corporation	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
50157-609_f54ec753-75f9-ad28-e053-2a95a90af282	50157-609	HUMAN OTC DRUG	Deep cleansing foaming acne scrub		Salicylic Acid	LIQUID	TOPICAL	20230222		OTC MONOGRAPH FINAL	part358H	Brands International Corporation	SALICYLIC ACID	2	g/mL			N	20241231
50157-610_f54f9c1f-9852-25a5-e053-2995a90a444f	50157-610	HUMAN OTC DRUG	Diabetics Foot Cream	4 oz	Dimethicone, Petrolatum	LOTION	TOPICAL	20230222		OTC MONOGRAPH FINAL	part347	BRANDS INTERNATIONAL	DIMETHICONE; PETROLATUM	1; 30	g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
50157-612_f550d1b7-7198-919a-e053-2a95a90a95b2	50157-612	HUMAN OTC DRUG	Oatmeal Daily Moisturizing 8oz.		Dimethicone	LOTION	TOPICAL	20230222		OTC MONOGRAPH FINAL	part347	BRANDS INTERNATIONAL	DIMETHICONE	3	g/227g	Skin Barrier Activity [PE]		N	20241231
50164-0003_c3ea0e7d-d5f0-47e2-b8ca-f934aa37a903	50164-0003	HUMAN OTC DRUG	Trauma Free		Symphytum Officinale, Bellis Perennis, Hypericum Perforatum, Magnesia Phosphorica, Ruta Graveolens, Arnica Montana	LIQUID	ORAL	20160624		UNAPPROVED HOMEOPATHIC		Sago Natural Products	ARNICA MONTANA; BELLIS PERENNIS; COMFREY ROOT; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; RUTA GRAVEOLENS FLOWERING TOP	200; 12; 6; 12; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50164-0004_6b7e4683-5d6e-42f3-be8d-369df0e3561c	50164-0004	HUMAN OTC DRUG	Trauma Free		Symphytum Officinale, Bellis Perennis, Hypericum Perforatum, Magnesia Phosphorica, Ruta Graveolens, Arnica Montana	LIQUID	ORAL	20160624		UNAPPROVED HOMEOPATHIC		Sago Natural Products	ARNICA MONTANA; BELLIS PERENNIS; COMFREY ROOT; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; RUTA GRAVEOLENS FLOWERING TOP	200; 12; 6; 12; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50181-0001_3b360f48-fcee-4a73-a81b-845592866e93	50181-0001	HUMAN OTC DRUG	MBM 11 Thyroid Adrenal		Iodium, Phytolacca Decandra, Adrenalinum, Adrenocorticotrophin, Thyroidinum, Belladonna, Phosphorus, Calcarea Carbonica, Natrum Muriaticum, Nux Moschata, Stramonium, Argentum Nitricum	LIQUID	ORAL	20120803		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	ATROPA BELLADONNA; CORTICOTROPIN; DATURA STRAMONIUM; EPINEPHRINE; IODINE; NUTMEG; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; SILVER NITRATE; SODIUM CHLORIDE; SUS SCROFA THYROID	34; 5; 89; 3; 3; 89; 89; 55; 3; 233; 89; 5	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50181-0011_60fc34b5-2af2-47d9-b86d-5c9e406ffb1b	50181-0011	HUMAN OTC DRUG	MBM 10 Stomach		Condurango, Stomach (Suis), Nux Vomica, Aurum Metallicum, Antimonium Crudum, Hyoscyamus Niger, Sulphur	LIQUID	ORAL	20130913		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	ANTIMONY TRISULFIDE; GOLD; HYOSCYAMUS NIGER; MARSDENIA CONDURANGO BARK; STRYCHNOS NUX-VOMICA SEED; SULFUR; SUS SCROFA STOMACH	233; 144; 233; 3; 89; 233; 5	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
50181-0012_2caecce2-766b-49a1-9428-23735496df49	50181-0012	HUMAN OTC DRUG	4 Kidney		Solidago Virgaurea, Berberis Vulgaris, Aconitum Napellus, Argentum Nitricum, Arnica Montana, Nitricum Acidum	LIQUID	ORAL	20121012		UNAPPROVED HOMEOPATHIC		The Wellness Center	ACONITUM NAPELLUS; ARNICA MONTANA; BERBERIS VULGARIS ROOT BARK; NITRIC ACID; SILVER NITRATE; SOLIDAGO VIRGAUREA FLOWERING TOP	1; 1; 30; 1; 1; 3	[hp_M]/mL; [hp_M]/mL; [hp_C]/mL; [hp_M]/mL; [hp_M]/mL; [hp_X]/mL			N	20241231
50181-0013_9cb2784c-5ab2-49fb-bed5-c18871c6270d	50181-0013	HUMAN OTC DRUG	2 Gallbladder		Fel Tauri, Chionanthus Virginica, Arsenicum Album, Nux Vomica, Platinum Metallicum	LIQUID	ORAL	20121024		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	ARSENIC TRIOXIDE; BOS TAURUS BILE; CHIONANTHUS VIRGINICUS BARK; PLATINUM; STRYCHNOS NUX-VOMICA SEED	1; 3; 34; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_M]/mL; [hp_M]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
50181-0024_19e6569c-1a3f-464f-9f2b-0e305475670f	50181-0024	HUMAN OTC DRUG	MBM 8 Small Intestine		Condurango, Intestine (Suis), Phytolacca Decandra, Aconitum Napellus, Aurum Metallicum, Sulphur, Hydrastis Canadensis, Mercurius Solubilis, Graphites, Pulsatilla	LIQUID	ORAL	20130405		UNAPPROVED HOMEOPATHIC		The Wellness Center	ACONITUM NAPELLUS; GOLD; GOLDENSEAL; GRAPHITE; MARSDENIA CONDURANGO BARK; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; PORK INTESTINE; PULSATILLA VULGARIS; SULFUR	55; 55; 89; 233; 3; 144; 3; 3; 233; 55	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50181-0026_7e36db6b-9038-459d-b658-a1c4e35b55e4	50181-0026	HUMAN OTC DRUG	6 Liver		Chelidonium Majus, Cholesterinum, Arsenicum Album, Belladonna, Lycopodium Clavatum, Tarentula Hispana	LIQUID	ORAL	20130809		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; CHELIDONIUM MAJUS; CHOLESTEROL; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA	1; 1; 3; 30; 1; 10	[hp_M]/mL; [hp_M]/mL; [hp_X]/mL; [hp_C]/mL; [hp_M]/mL; [hp_M]/mL			N	20241231
50181-0036_d54b0607-ad30-4e12-be42-4b4697643988	50181-0036	HUMAN OTC DRUG	Candida Ease		Borax, Thuja Occidentalis, Arsenicum Album, Kreosotum, Sulphur, Candida Parapsilosis, Candida Albicans, Aspergillus Niger, Mucor Racemosus, Candida Krusei, Candida Pseudotropicalis, Candida Tropicalis	LIQUID	ORAL	20160809		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	ARSENIC TRIOXIDE; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS WHOLE; KLUYVEROMYCES MARXIANUS; MUCOR RACEMOSUS; SODIUM BORATE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	6; 12; 15; 12; 34; 14; 32; 12; 3; 6; 3; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
50181-0037_85a14a12-a1d1-4830-bde9-98eaf743ce1a	50181-0037	HUMAN OTC DRUG	1 Bladder		Berberis Vulgaris, Thuja Occidentalis, Apis Mellifica, Pulsatilla, Staphysagria, Baryta Carbonica, Bryonia, Hepar Sulphuris Calcareum	LIQUID	ORAL	20140103		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	APIS MELLIFERA; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM SULFIDE; DELPHINIUM STAPHISAGRIA SEED; PULSATILLA VULGARIS; THUJA OCCIDENTALIS LEAF	200; 1; 3; 1; 1; 200; 200; 30	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
50181-0040_b3abae0c-0576-4cc5-b6cf-9c854e8efd60	50181-0040	HUMAN OTC DRUG	BIOTOX STD	2	Chelidonium Majus, Phytolacca Decandra, Herpes Zoster Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Sulphur	LIQUID	ORAL	20150113		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	CHELIDONIUM MAJUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; PHYTOLACCA AMERICANA ROOT; SULFUR	3; 30; 30; 12; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
50181-0041_4f2d0d1d-4fc4-4701-b0fb-9d557dd7f90b	50181-0041	HUMAN OTC DRUG	Neurobalance Pro		Adrenocorticotrophin, GABA, Glutamic Acid, Norepinephrine, Acetylcholine Chloride, Adrenalinum, L-Dopa, Serotonin (Hydrochloride), Thyroidinum (Suis), Anacardium Orientale, Baryta Carbonica, Calcarea Carbonica, Stramonium	LIQUID	ORAL	20151002		UNAPPROVED HOMEOPATHIC		The Wellness Center for Reseach and Education, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; BARIUM CARBONATE; CORTICOTROPIN; DATURA STRAMONIUM; EPINEPHRINE; GLUTAMIC ACID; LEVODOPA; NOREPINEPHRINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEMECARPUS ANACARDIUM JUICE; SEROTONIN HYDROCHLORIDE; THYROID, PORCINE	6; 6; 6; 6; 30; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50181-0043_05b13696-c2ab-4590-b884-dd2341617548	50181-0043	HUMAN OTC DRUG	Radiation		Chelidonium Majus, Fucus Vesiculosus, Hypericum Perforatum, Sulphur, Cesium Chloride, Glandula Suprarenalis Suis, Thyroidinum (Suis), Strontium Carbonicum, Cadmium Iodatum, Cadmium Sulphuricum, X-Ray, Radium Bromatum, Uranium Nitricum, Electricitas, Plutonium Nitricum	LIQUID	ORAL	20140513		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); CADMIUM IODIDE; CADMIUM SULFATE; CESIUM CHLORIDE; CHELIDONIUM MAJUS; FUCUS VESICULOSUS; HYPERICUM PERFORATUM; LACTOSE; PLUTONIUM; RADIUM BROMIDE; STRONTIUM CARBONATE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYROID; URANYL NITRATE HEXAHYDRATE	8; 8; 8; 6; 3; 3; 6; 30; 30; 15; 8; 6; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
50181-0050_955ff28e-59b1-44f5-8caa-bf806ab8943e	50181-0050	HUMAN OTC DRUG	9 Spleen Pancreas		CEANOTHUS AMERICANUS, SENNA (CASSIA ANGUSTIFOLIA), CHIONANTHUS VIRGINICA, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, SEPIA	LIQUID	ORAL	20141215		UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	ARSENIC TRIOXIDE; CEANOTHUS AMERICANUS LEAF; CHIONANTHUS VIRGINICUS BARK; LYCOPODIUM CLAVATUM SPORE; SENNA LEAF; SEPIA OFFICINALIS JUICE	1; 3; 30; 1; 3; 1	[hp_M]/mL; [hp_X]/mL; [hp_C]/mL; [hp_M]/mL; [hp_X]/mL; [hp_M]/mL			N	20241231
50181-0057_24ce3717-7660-4140-b48a-29587e097278	50181-0057	HUMAN OTC DRUG	BioTox P		Pertussinum	LIQUID	ORAL	20180227		UNAPPROVED HOMEOPATHIC		The Wellness Center For Research and Education	HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED	15	[hp_C]/mL			N	20241231
50181-0059_41964e1b-bfe5-41a7-a0c7-55607148d506	50181-0059	HUMAN OTC DRUG	BioTox DIP		Aconitum Napellus, Arsenicum Album, Kali Bichromicum, Kali Muriaticum, Kali Phosphoricum, Lachesis Mutus, Lycopodium Clavatum, Mercurius Cyanatus, Phytolacca Decandra, Rhus Tox	LIQUID	ORAL	20180316		UNAPPROVED HOMEOPATHIC		The Wellness Center For Research and Education	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; DIBASIC POTASSIUM PHOSPHATE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURIC CYANIDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50181-0079_a567973b-2ee6-4f64-89ec-dd0bcacf64f7	50181-0079	HUMAN PRESCRIPTION DRUG	HAIR STIM		Pediculus Capitis, Thyroidinum (Suis), Baryta Carbonica, Borax, Calcarea Carbonica, Cinchona Officinalis, Glandula Suprarenalis Suis, Hydrofluoricum Acidum, Mercurius Solubilis, Mezereum, Natrum Muriaticum, Phosphorus, Pulsatilla (Pratensis), Sepia, Silicea, Sulphur, Thuja Occidentalis, Vinca Minor	LIQUID	ORAL	20211102	20261102	UNAPPROVED HOMEOPATHIC		The Wellness Center for Research and Education, Inc.	BARIUM CARBONATE; CINCHONA OFFICINALIS BARK; DAPHNE MEZEREUM BARK; HYDROFLUORIC ACID; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PEDICULUS HUMANUS VAR. CAPITIS; PHOSPHORUS; PULSATILLA PRATENSIS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM BORATE; SODIUM CHLORIDE; SULFUR; SUS SCROFA ADRENAL GLAND; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, PORCINE; VINCA MINOR	30; 30; 30; 30; 30; 30; 5; 30; 30; 30; 30; 30; 30; 30; 30; 30; 4; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
50184-1005_f305ee7e-86d1-7600-e053-2a95a90a231c	50184-1005	HUMAN OTC DRUG	clear days ahead	oil-free salicylic acid acne treatment cleanser	Salicylic Acid	LIQUID	TOPICAL	20120411		OTC MONOGRAPH FINAL	part333D	Philosophy Inc.	SALICYLIC ACID	2.4	g/240mL			N	20241231
50184-1010_f3060611-fa0e-4b0b-e053-2a95a90a470a	50184-1010	HUMAN OTC DRUG	clear days ahead	oil-free salicylic acid acne treatment and moisturizer	Salicylic Acid	CREAM	TOPICAL	20120401		OTC MONOGRAPH FINAL	part333D	Philosophy Inc.	SALICYLIC ACID	.6	g/60mL			N	20241231
50184-1011_f355b368-0777-552c-e053-2a95a90a7486	50184-1011	HUMAN OTC DRUG	renewed hope in a jar spf 30		Avobenzone, Octinoxate, Octocrylene	CREAM	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part352	Philosophy, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	2.7; 6.99; 2	g/100mL; g/100mL; g/100mL			N	20241231
50184-1012_f355ce23-b4e0-25bd-e053-2a95a90abb7d	50184-1012	HUMAN OTC DRUG	ultimate miracle worker eye spf 15		Avobenzone, Homosalate, Octinoxate, Octocrylene	CREAM	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part352	Philosophy, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	2.7; 2; 5; 2.16	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
50184-1013_f3060611-fa1e-4b0b-e053-2a95a90a470a	50184-1013	HUMAN OTC DRUG	ultimate miracle worker multi-rejuvenating spf 30		Avobenzone, Octinoxate, Octocrylene	CREAM	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part352	Philosophy, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	2.7; 6.99; 2	g/100mL; g/100mL; g/100mL			N	20241231
50184-1015_f305d8f7-f8f8-026b-e053-2a95a90a69c1	50184-1015	HUMAN OTC DRUG	clear days ahead	overnight repair salicylic acid acne treatment pads	Salicylic Acid	CLOTH	TOPICAL	20120401		OTC MONOGRAPH FINAL	part333D	Philosophy Inc.	SALICYLIC ACID	283.5	mg/56.7g			N	20241231
50184-1020_f305e91b-f07a-2d34-e053-2a95a90a6f90	50184-1020	HUMAN OTC DRUG	clear days ahead	fast-acting salicylic acid acne spot treatment	Salicylic Acid	GEL	TOPICAL	20120401		OTC MONOGRAPH FINAL	part333D	Philosophy	SALICYLIC ACID	.3	g/15mL			N	20241231
50184-1033_f305b745-229d-4655-e053-2a95a90a9639	50184-1033	HUMAN OTC DRUG	hope in a jar	a to z cream broad spectrum spf 20 sunscreen	Titanium Dioxide, zinc oxide	CREAM	TOPICAL	20130501		OTC MONOGRAPH NOT FINAL	part352	Philosophy	TITANIUM DIOXIDE; ZINC OXIDE	3.35; 5.49	g/30mL; g/30mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50184-1060_f305a3f7-2b94-dd79-e053-2995a90a2bfd	50184-1060	HUMAN OTC DRUG	purity made simple		Salicylic Acid	CREAM	TOPICAL	20180401		OTC MONOGRAPH FINAL	part333D	Philosophy, Inc.	SALICYLIC ACID	.5	ug/mL			N	20241231
50184-1062_f305c001-ee61-bef5-e053-2a95a90aafcd	50184-1062	HUMAN OTC DRUG	miracle worker anti-aging foundation spf 30		Octinoxate, Octisalate, Oxybenzone, Titanium Dioxide	LIQUID	TOPICAL	20190319		OTC MONOGRAPH NOT FINAL	part352	Philosophy, Inc.	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	7.5; 5; 3.5; .49	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
50201-0421_f0306b64-e6f7-476c-e053-2a95a90a2576	50201-0421	HUMAN OTC DRUG	Bromo Seltzer		ASPIRIN, SODIUM BICARBONATE, CITRIC ACID	TABLET, EFFERVESCENT	ORAL	20120716		OTC MONOGRAPH FINAL	part343	Tower Laboratories Ltd	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50201-4212_f0466c5c-f3f7-e95e-e053-2a95a90ace9d	50201-4212	HUMAN OTC DRUG	Top Value Effervescent Pain Relief		Apirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20061201		OTC MONOGRAPH FINAL	part343	Tower Laboratories Ltd	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50201-4213_f0465d32-30b7-0ac9-e053-2995a90a26b9	50201-4213	HUMAN OTC DRUG	Top Value Effervescent Pain Relief		Aspirin, Citric Acid, Sodium Bicarobonate	TABLET, EFFERVESCENT	ORAL	20061201		OTC MONOGRAPH FINAL	part343	Tower Laboratories Ltd	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50201-4216_ef6c032d-7806-d552-e053-2a95a90a84dc	50201-4216	HUMAN OTC DRUG	Good Sense Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20130211	20241231	OTC MONOGRAPH FINAL	part343	Tower Laboratories Ltd.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
50201-7682_c1bd1648-940b-1df0-e053-2995a90ab996	50201-7682	HUMAN OTC DRUG	Top Value Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20100701		OTC MONOGRAPH FINAL	part341	Tower Laboratories Ltd	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50201-8736_ef6bfb28-6d94-79a4-e053-2a95a90a131d	50201-8736	HUMAN OTC DRUG	Good Sense Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20130219	20241231	OTC MONOGRAPH FINAL	part341	Tower Laboratories Ltd.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
50201-8752_c6f23b0b-4653-01f2-e053-2a95a90ace7c	50201-8752	HUMAN OTC DRUG	Top Value Effervescent Cold Relief - Orange		Aspirin, Chlorpheniramine maleate, Phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20210416		OTC MONOGRAPH FINAL	part341	Tower Laboratories Ltd.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50222-203_f859e9b6-d4c5-472e-b165-24a05897dd79	50222-203	HUMAN PRESCRIPTION DRUG	Protopic		Tacrolimus	OINTMENT	TOPICAL	20001208	20241231	NDA	NDA050777	LEO Pharma Inc	TACROLIMUS	.3	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	
50222-211_f859e9b6-d4c5-472e-b165-24a05897dd79	50222-211	HUMAN PRESCRIPTION DRUG	Protopic		Tacrolimus	OINTMENT	TOPICAL	20001208	20241231	NDA	NDA050777	LEO Pharma Inc	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	
50222-227_47443f37-b9e3-4b46-9434-5042ec558572	50222-227	HUMAN PRESCRIPTION DRUG	Taclonex		calcipotriene and betamethasone dipropionate	OINTMENT	TOPICAL	20080601		NDA	NDA021852	LEO Pharma Inc.	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
50222-302_0b771976-2050-4eef-bc39-3c853c7c0ac2	50222-302	HUMAN PRESCRIPTION DRUG	ENSTILAR		calcipotriene and betamethasone dipropionate	AEROSOL, FOAM	TOPICAL	20151016		NDA	NDA207589	LEO Pharma Inc.	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
50222-303_f51a0452-513f-488f-b0f9-b723cf96bdf7	50222-303	HUMAN PRESCRIPTION DRUG	FINACEA FOAM		azelaic acid	AEROSOL, FOAM	TOPICAL	20181001		NDA	NDA207071	LEO Pharma Inc.	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
50222-346_5b709bae-6a5c-4a83-8bb1-83c8069d8086	50222-346	HUMAN PRESCRIPTION DRUG	Adbry		tralokinumab-ldrm	INJECTION, SOLUTION	SUBCUTANEOUS	20220102		BLA	BLA761180	LEO Pharma Inc.	TRALOKINUMAB	150	mg/mL	Interleukin-13 Antagonist [EPC], Interleukin-13 Antagonists [MoA]		N	20241231
50222-501_5d56e57e-6b91-4916-96d8-6dca1af7487d	50222-501	HUMAN PRESCRIPTION DRUG	TACLONEX		calcipotriene and betamethasone dipropionate	SUSPENSION	TOPICAL	20080601		NDA	NDA022185	LEO Pharma Inc.	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
50222-505_be4ce27a-2c6d-4d04-880f-d18cf79b685e	50222-505	HUMAN PRESCRIPTION DRUG	Finacea		azelaic acid	GEL	TOPICAL	20021224		NDA	NDA021470	LEO Pharma Inc.	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
50227-1001_d655aa42-ce08-9318-e053-2995a90ac7ad	50227-1001	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1002_d655aa42-ce15-9318-e053-2995a90ac7ad	50227-1002	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1003_d655aae9-4757-6fbc-e053-2995a90a9ba3	50227-1003	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1004_d655aae9-4764-6fbc-e053-2995a90a9ba3	50227-1004	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1005_d655aa42-ce21-9318-e053-2995a90ac7ad	50227-1005	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1007_d655aa42-ce2c-9318-e053-2995a90ac7ad	50227-1007	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1009_d655b0d2-0f9b-de6b-e053-2995a90a43f7	50227-1009	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1010_d655b0d2-0fa8-de6b-e053-2995a90a43f7	50227-1010	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1011_d655b0d2-0fb4-de6b-e053-2995a90a43f7	50227-1011	HUMAN OTC DRUG	Patterson Dental Topical Anesthetic		Benzocaine	GEL	DENTAL	20150201		OTC MONOGRAPH NOT FINAL	part356	Patterson Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50227-1020_04de22f0-f167-4e07-b25e-5e6b9bb3146f	50227-1020	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111107		ANDA	ANDA088389	Patterson Dental	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.02; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50227-1030_0fd162ef-0f6d-414a-9d74-fe6a955b024d	50227-1030	HUMAN PRESCRIPTION DRUG	LIDOCAINE		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111107		ANDA	ANDA088390	Patterson Dental	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50227-1040_ab5278a3-01c4-41d7-a93d-0458501fe609	50227-1040	HUMAN PRESCRIPTION DRUG	ARTICAINE		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20141222		NDA AUTHORIZED GENERIC	NDA020971	Patterson Dental	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .01	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50227-1050_da6ddd6a-585b-4d9a-b2da-0d75e83f3630	50227-1050	HUMAN PRESCRIPTION DRUG	ARTICAINE		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20141222		NDA AUTHORIZED GENERIC	NDA020971	Patterson Dental	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
50227-1080_51d3babf-6d58-40fa-b50b-ee800bfa72ef	50227-1080	HUMAN PRESCRIPTION DRUG	Mepivacaine		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20110101		ANDA	ANDA088387	Patterson Dental Supply, Inc.	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
50228-105_f1d709ff-59a3-841a-e053-2a95a90a9c29	50228-105	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	ScieGen Pharmaceuticals Inc	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50228-106_f1d709ff-59a3-841a-e053-2a95a90a9c29	50228-106	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	ScieGen Pharmaceuticals Inc	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50228-107_f1d709ff-59a3-841a-e053-2a95a90a9c29	50228-107	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	ScieGen Pharmaceuticals Inc	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50228-109_f1b2306e-24ae-607d-e053-2a95a90aa908	50228-109	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	ScieGen Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
50228-111_5c6f4c6a-cc43-4f4d-bc16-688310c98c72	50228-111	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20140723		ANDA	ANDA203018	ScieGen Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50228-112_5c6f4c6a-cc43-4f4d-bc16-688310c98c72	50228-112	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20140205		ANDA	ANDA203018	ScieGen Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50228-113_09ac572d-ab78-a0dd-e063-6294a90a33fd	50228-113	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	ScieGen Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-114_09ac572d-ab78-a0dd-e063-6294a90a33fd	50228-114	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	ScieGen Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-115_09ac572d-ab78-a0dd-e063-6294a90a33fd	50228-115	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	ScieGen Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-116_09845f21-f02e-34b2-e063-6394a90a7677	50228-116	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA206381	ScieGen Pharmaceuticals, Inc.	ROSUVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-117_09845f21-f02e-34b2-e063-6394a90a7677	50228-117	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA206381	ScieGen Pharmaceuticals, Inc.	ROSUVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-118_09845f21-f02e-34b2-e063-6394a90a7677	50228-118	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA206381	ScieGen Pharmaceuticals, Inc.	ROSUVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-119_09845f21-f02e-34b2-e063-6394a90a7677	50228-119	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA206381	ScieGen Pharmaceuticals, Inc.	ROSUVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-121_0789c766-42ac-6467-e063-6294a90a2c6a	50228-121	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20150915		ANDA	ANDA204165	ScieGen Pharmaceuticals Inc	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50228-124_0789c766-42ac-6467-e063-6294a90a2c6a	50228-124	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20150915		ANDA	ANDA204165	ScieGen Pharmaceuticals Inc	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
50228-126_f1b43155-549f-a159-e053-2a95a90a958e	50228-126	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141029		ANDA	ANDA203855	ScieGen Pharmaceuticals Inc	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50228-127_f1b43155-549f-a159-e053-2a95a90a958e	50228-127	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141029		ANDA	ANDA203855	ScieGen Pharmaceuticals Inc	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50228-128_f1b43155-549f-a159-e053-2a95a90a958e	50228-128	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141029		ANDA	ANDA203855	ScieGen Pharmaceuticals Inc	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50228-129_f1b43155-549f-a159-e053-2a95a90a958e	50228-129	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141029		ANDA	ANDA203855	ScieGen Pharmaceuticals Inc	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50228-130_f1b43155-549f-a159-e053-2a95a90a958e	50228-130	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141029		ANDA	ANDA203855	ScieGen Pharmaceuticals Inc	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50228-131_f1b43155-549f-a159-e053-2a95a90a958e	50228-131	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141029		ANDA	ANDA203855	ScieGen Pharmaceuticals Inc	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50228-132_f1da8d58-f8d8-3616-e053-2995a90a27ea	50228-132	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20211027		ANDA	ANDA204038	ScieGen Pharmaceuticals, INC.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-133_f1da8d58-f8d8-3616-e053-2995a90a27ea	50228-133	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20211027		ANDA	ANDA204038	ScieGen Pharmaceuticals, INC.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-134_f1da8d58-f8d8-3616-e053-2995a90a27ea	50228-134	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20211027		ANDA	ANDA204038	ScieGen Pharmaceuticals, INC.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-135_f1da8d58-f8d8-3616-e053-2995a90a27ea	50228-135	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20211027		ANDA	ANDA204038	ScieGen Pharmaceuticals, INC.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-136_621f40f1-d72b-49cb-a6d6-9886b7cd40fb	50228-136	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20140909		ANDA	ANDA203646	ScieGen Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50228-139_97b9d05c-4429-476c-afa6-7758716d805a	50228-139	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20141029		ANDA	ANDA203907	ScieGen Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
50228-140_97b9d05c-4429-476c-afa6-7758716d805a	50228-140	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20141029		ANDA	ANDA203907	ScieGen Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
50228-144_dc26e8f7-ea50-ef28-e053-2995a90a7ea1	50228-144	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	ScieGen Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50228-145_dc26e8f7-ea50-ef28-e053-2995a90a7ea1	50228-145	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	ScieGen Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50228-146_b3367687-43bf-5df1-e053-2a95a90a4e14	50228-146	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	ScieGen Pharmaceuticals Inc	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50228-156_ec97e42f-2649-6fb3-e053-2a95a90a2a40	50228-156	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	ScieGen Pharmaceuticals, Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-157_ec97e42f-2649-6fb3-e053-2a95a90a2a40	50228-157	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	ScieGen Pharmaceuticals, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-158_ec97e42f-2649-6fb3-e053-2a95a90a2a40	50228-158	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	ScieGen Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-159_ec97e42f-2649-6fb3-e053-2a95a90a2a40	50228-159	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	ScieGen Pharmaceuticals, Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-160_ba124fb5-fa8b-be15-e053-2a95a90ab560	50228-160	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20151207		ANDA	ANDA204774	ScieGen Pharmaceuticals, Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-161_ba124fb5-fa8b-be15-e053-2a95a90ab560	50228-161	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20151207		ANDA	ANDA204774	ScieGen Pharmaceuticals, Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-162_ba124fb5-fa8b-be15-e053-2a95a90ab560	50228-162	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20151207		ANDA	ANDA204774	ScieGen Pharmaceuticals, Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-174_0e365624-304c-4884-e063-6294a90ad54f	50228-174	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	ScieGen Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50228-175_0e365624-304c-4884-e063-6294a90ad54f	50228-175	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	ScieGen Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50228-176_0e365624-304c-4884-e063-6294a90ad54f	50228-176	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	ScieGen Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50228-177_09ad7ac4-43dc-139b-e063-6394a90a727c	50228-177	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	ScieGen Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-178_09ad7ac4-43dc-139b-e063-6394a90a727c	50228-178	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	ScieGen Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-179_09ad3cab-a2fc-d992-e063-6394a90af9c5	50228-179	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	ScieGen Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-180_09ad3cab-a2fc-d992-e063-6394a90af9c5	50228-180	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	ScieGen Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-181_09ad3cab-a2fc-d992-e063-6394a90af9c5	50228-181	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	ScieGen Pharmaceuticals, Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-182_bcb83203-049e-1ddd-e053-2a95a90ae336	50228-182	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	ScieGen Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50228-183_bcb83203-049e-1ddd-e053-2a95a90ae336	50228-183	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	ScieGen Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50228-184_bcb83203-049e-1ddd-e053-2a95a90ae336	50228-184	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	ScieGen Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50228-185_bcb83203-049e-1ddd-e053-2a95a90ae336	50228-185	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	ScieGen Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50228-189_097ebce2-21e9-f5f0-e063-6294a90af3b1	50228-189	HUMAN PRESCRIPTION DRUG	Levetiracetam	Extended-Release	levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA205130	ScieGen Pharmaceuticals, Inc	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-190_097ebce2-21e9-f5f0-e063-6294a90af3b1	50228-190	HUMAN PRESCRIPTION DRUG	Levetiracetam	Extended-Release	levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA205130	ScieGen Pharmaceuticals, Inc	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-192_4a44f83b-a9a5-4b48-be19-19890154629b	50228-192	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205237	ScieGen Pharmaceuticals Inc	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
50228-193_4a44f83b-a9a5-4b48-be19-19890154629b	50228-193	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205237	ScieGen Pharmaceuticals Inc	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
50228-194_4a44f83b-a9a5-4b48-be19-19890154629b	50228-194	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205237	ScieGen Pharmaceuticals Inc	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
50228-195_4a44f83b-a9a5-4b48-be19-19890154629b	50228-195	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205237	ScieGen Pharmaceuticals Inc	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
50228-201_60d30a0f-a76f-4aa8-b4fc-0dd1f6e44675	50228-201	HUMAN OTC DRUG	fexofenadine hcl		fexofenadine hcl	TABLET, FILM COATED	ORAL	20141226		ANDA	ANDA204507	ScieGen Pharmaceuticals, Inc.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50228-202_60d30a0f-a76f-4aa8-b4fc-0dd1f6e44675	50228-202	HUMAN OTC DRUG	fexofenadine hcl		fexofenadine hcl	TABLET, FILM COATED	ORAL	20141226		ANDA	ANDA204507	ScieGen Pharmaceuticals, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50228-306_f1da5bd3-72c2-15ff-e053-2995a90a89db	50228-306	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, FILM COATED	ORAL	20161012		ANDA	ANDA206384	ScieGen Pharmaceuticals Inc	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
50228-319_ec9440ec-0301-59bb-e053-2a95a90afe94	50228-319	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151130		ANDA	ANDA206382	ScieGen Pharmaceuticals, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50228-320_ec9440ec-0301-59bb-e053-2a95a90afe94	50228-320	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151130		ANDA	ANDA206382	ScieGen Pharmaceuticals, Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50228-321_ec9440ec-0301-59bb-e053-2a95a90afe94	50228-321	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151130		ANDA	ANDA206382	ScieGen Pharmaceuticals, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50228-322_ec9440ec-0301-59bb-e053-2a95a90afe94	50228-322	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, ORALLY DISINTEGRATING	ORAL	20151130		ANDA	ANDA206382	ScieGen Pharmaceuticals, Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
50228-323_c6a2f8f8-5cab-2753-e053-2995a90acf4c	50228-323	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170831		ANDA	ANDA207466	ScieGen Pharmaceuticals, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
50228-324_8fbc9a67-ee90-4b5d-b9be-a037bef430de	50228-324	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-325_8fbc9a67-ee90-4b5d-b9be-a037bef430de	50228-325	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-326_8fbc9a67-ee90-4b5d-b9be-a037bef430de	50228-326	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-327_8fbc9a67-ee90-4b5d-b9be-a037bef430de	50228-327	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-328_8fbc9a67-ee90-4b5d-b9be-a037bef430de	50228-328	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-329_8fbc9a67-ee90-4b5d-b9be-a037bef430de	50228-329	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160929		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-330_09d7163b-7e76-1473-e063-6294a90a81a1	50228-330	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole orally disintegrating	TABLET	ORAL	20180418		ANDA	ANDA207240	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-331_09d7163b-7e76-1473-e063-6294a90a81a1	50228-331	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole orally disintegrating	TABLET	ORAL	20180418		ANDA	ANDA207240	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-333_02ae977c-f584-4433-e063-6394a90a1290	50228-333	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20230728		ANDA	ANDA213329	ScieGen Pharmaceuticals Inc	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
50228-334_2bf47ff1-3045-4953-abca-bfac55d5253d	50228-334	HUMAN PRESCRIPTION DRUG	Ethacrynic Acid		Ethacrynic Acid	TABLET	ORAL	20190827		ANDA	ANDA211232	ScieGen Pharmaceuticals Inc	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50228-338_d9b7b0d0-71db-578b-e053-2a95a90a8514	50228-338	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(SR)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190501		ANDA	ANDA206122	ScieGen Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
50228-339_b866b8df-72d9-2de9-e053-2995a90a3d70	50228-339	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	ScieGen Pharmaceuticals, Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-340_b866b8df-72d9-2de9-e053-2995a90a3d70	50228-340	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	ScieGen Pharmaceuticals, Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-341_b866b8df-72d9-2de9-e053-2995a90a3d70	50228-341	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	ScieGen Pharmaceuticals, Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50228-350_09ad7ac4-4414-139b-e063-6394a90a727c	50228-350	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	25	mg/1		CV	N	20241231
50228-351_09ad7ac4-4414-139b-e063-6394a90a727c	50228-351	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	50	mg/1		CV	N	20241231
50228-352_09ad7ac4-4414-139b-e063-6394a90a727c	50228-352	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	75	mg/1		CV	N	20241231
50228-353_09ad7ac4-4414-139b-e063-6394a90a727c	50228-353	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	100	mg/1		CV	N	20241231
50228-354_09ad7ac4-4414-139b-e063-6394a90a727c	50228-354	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	150	mg/1		CV	N	20241231
50228-355_09ad7ac4-4414-139b-e063-6394a90a727c	50228-355	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	200	mg/1		CV	N	20241231
50228-356_09ad7ac4-4414-139b-e063-6394a90a727c	50228-356	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	225	mg/1		CV	N	20241231
50228-357_09ad7ac4-4414-139b-e063-6394a90a727c	50228-357	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ScieGen Pharmaceuticals, Inc	PREGABALIN	300	mg/1		CV	N	20241231
50228-363_0980fd8e-c1e1-5473-e063-6294a90aaf5e	50228-363	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE	ORAL	20161206		ANDA	ANDA207476	ScieGen Pharmaceuticals, Inc.	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50228-364_0980fd8e-c1e1-5473-e063-6294a90aaf5e	50228-364	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE	ORAL	20161206		ANDA	ANDA207476	ScieGen Pharmaceuticals, Inc.	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50228-365_c335e4df-bdcb-4369-b032-ab5df4f04498	50228-365	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20181203		ANDA	ANDA209010	ScieGen Pharmaceuticals, Inc	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50228-366_c335e4df-bdcb-4369-b032-ab5df4f04498	50228-366	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20181203		ANDA	ANDA209010	ScieGen Pharmaceuticals, Inc	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50228-367_c335e4df-bdcb-4369-b032-ab5df4f04498	50228-367	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20181203		ANDA	ANDA209010	ScieGen Pharmaceuticals, Inc	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50228-368_c335e4df-bdcb-4369-b032-ab5df4f04498	50228-368	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20181203		ANDA	ANDA209010	ScieGen Pharmaceuticals, Inc	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50228-379_bb3c776e-8a43-cb5e-e053-2995a90a4f83	50228-379	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20201023		ANDA	ANDA210673	ScieGen Pharmaceuticals Inc	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
50228-380_ba224507-6ca4-f9f9-e053-2a95a90ae5c1	50228-380	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ScieGen Pharmaceuticals, Inc	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-381_ba224507-6ca4-f9f9-e053-2a95a90ae5c1	50228-381	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ScieGen Pharmaceuticals, Inc	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-382_ba224507-6ca4-f9f9-e053-2a95a90ae5c1	50228-382	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ScieGen Pharmaceuticals, Inc	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-383_ba224507-6ca4-f9f9-e053-2a95a90ae5c1	50228-383	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ScieGen Pharmaceuticals, Inc	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-384_ba224507-6ca4-f9f9-e053-2a95a90ae5c1	50228-384	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ScieGen Pharmaceuticals, Inc	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-420_08a26093-1715-5580-e063-6294a90a4ff6	50228-420	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20190320		ANDA	ANDA210935	ScieGen Pharmaceuticals, Inc	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-421_08a26093-1715-5580-e063-6294a90a4ff6	50228-421	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20190320		ANDA	ANDA210935	ScieGen Pharmaceuticals, Inc	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-422_09841251-bf59-ddda-e063-6294a90af97e	50228-422	HUMAN PRESCRIPTION DRUG	Fluoxetine		FLUOXETINE HYDROCHLORIDE	TABLET	ORAL	20190110		ANDA	ANDA211282	ScieGen Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-423_2572d72e-cdfa-477f-b17b-893f548ef99c	50228-423	HUMAN PRESCRIPTION DRUG	RANOLAZINE		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190604		ANDA	ANDA211829	ScieGen Pharmaceuticals, Inc	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50228-424_2572d72e-cdfa-477f-b17b-893f548ef99c	50228-424	HUMAN PRESCRIPTION DRUG	RANOLAZINE		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190604		ANDA	ANDA211829	ScieGen Pharmaceuticals, Inc	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50228-427_b9432117-2521-7360-e053-2a95a90acd2a	50228-427	HUMAN PRESCRIPTION DRUG	SOLIFENACIN SUCCINATE		SOLIFENACIN SUCCINATE	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA211657	ScieGen Pharmaceuticals, Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50228-428_b9432117-2521-7360-e053-2a95a90acd2a	50228-428	HUMAN PRESCRIPTION DRUG	SOLIFENACIN SUCCINATE		SOLIFENACIN SUCCINATE	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA211657	ScieGen Pharmaceuticals, Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50228-429_bbb2d8e3-70b5-78f2-e053-2995a90a285e	50228-429	HUMAN PRESCRIPTION DRUG	Droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214017	ScieGen Pharmaceuticals Inc	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
50228-430_bbb2d8e3-70b5-78f2-e053-2995a90a285e	50228-430	HUMAN PRESCRIPTION DRUG	Droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214017	ScieGen Pharmaceuticals Inc	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
50228-431_bbb2d8e3-70b5-78f2-e053-2995a90a285e	50228-431	HUMAN PRESCRIPTION DRUG	Droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214017	ScieGen Pharmaceuticals Inc	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
50228-432_c89bb727-cb27-9cb4-e053-2a95a90af35b	50228-432	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	ScieGen Pharmaceuticals, Inc.	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-433_c89bb727-cb27-9cb4-e053-2a95a90af35b	50228-433	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	ScieGen Pharmaceuticals, Inc.	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-434_09aa47d4-240e-5682-e063-6294a90a29fe	50228-434	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	ScieGen Pharmaceuticals, Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-435_09aa47d4-240e-5682-e063-6294a90a29fe	50228-435	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	ScieGen Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-436_09aa47d4-240e-5682-e063-6294a90a29fe	50228-436	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	ScieGen Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-437_082e1e1e-b056-f989-e063-6394a90a8045	50228-437	HUMAN PRESCRIPTION DRUG	Naproxen and esomeprazole magnesium		Naproxen and esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20231011		ANDA	ANDA217738	ScieGen Pharmaceuticals, Inc	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 375	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50228-438_082e1e1e-b056-f989-e063-6394a90a8045	50228-438	HUMAN PRESCRIPTION DRUG	Naproxen and esomeprazole magnesium		Naproxen and esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20231011		ANDA	ANDA217738	ScieGen Pharmaceuticals, Inc	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 500	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50228-441_09c07f37-fe44-f211-e063-6394a90aae02	50228-441	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	CAPSULE	ORAL	20220801		ANDA	ANDA212077	ScieGen Pharmaceuticals, Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
50228-442_09af4fec-e2cf-2c8d-e063-6294a90af999	50228-442	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET	ORAL	20220801		ANDA	ANDA212078	ScieGen Pharmaceuticals, Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
50228-443_09af4fec-e2cf-2c8d-e063-6294a90af999	50228-443	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET	ORAL	20220801		ANDA	ANDA212078	ScieGen Pharmaceuticals, Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
50228-445_2cd1dc49-0219-4df8-8865-96ac77e77334	50228-445	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Extended-Release Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210416		ANDA	ANDA213334	ScieGen Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50228-446_2cd1dc49-0219-4df8-8865-96ac77e77334	50228-446	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Extended-Release Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210416		ANDA	ANDA213334	ScieGen Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50228-451_09acadb7-c0a4-d753-e063-6294a90af9a9	50228-451	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	ScieGen Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-452_09acadb7-c0a4-d753-e063-6294a90af9a9	50228-452	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	ScieGen Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-453_09acadb7-c0a4-d753-e063-6294a90af9a9	50228-453	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	ScieGen Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-454_09acadb7-c0a4-d753-e063-6294a90af9a9	50228-454	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	ScieGen Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
50228-457_f1b1f43e-9775-0570-e053-2995a90ae404	50228-457	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210507		ANDA	ANDA214092	ScieGen Pharmaceuticals Inc	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50228-458_f1b1f43e-9775-0570-e053-2995a90ae404	50228-458	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210507		ANDA	ANDA214092	ScieGen Pharmaceuticals Inc	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50228-459_f1b1f43e-9775-0570-e053-2995a90ae404	50228-459	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210507		ANDA	ANDA214092	ScieGen Pharmaceuticals Inc	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50228-460_cea3f5f1-014d-0c1d-e053-2995a90a7f01	50228-460	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20211005		ANDA	ANDA214091	ScieGen Pharmaceuticals Inc	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50228-461_cea3f5f1-014d-0c1d-e053-2995a90a7f01	50228-461	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20211005		ANDA	ANDA214091	ScieGen Pharmaceuticals Inc	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
50228-462_e90bfe09-9adb-03c0-e053-2a95a90a061e	50228-462	HUMAN PRESCRIPTION DRUG	Pregabalin Extended Release		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220914		ANDA	ANDA215675	ScieGen Pharmaceuticals, INC.	PREGABALIN	82.5	mg/1		CV	N	20241231
50228-463_e90bfe09-9adb-03c0-e053-2a95a90a061e	50228-463	HUMAN PRESCRIPTION DRUG	Pregabalin Extended Release		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220914		ANDA	ANDA215675	ScieGen Pharmaceuticals, INC.	PREGABALIN	165	mg/1		CV	N	20241231
50228-464_e90bfe09-9adb-03c0-e053-2a95a90a061e	50228-464	HUMAN PRESCRIPTION DRUG	Pregabalin Extended Release		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220914		ANDA	ANDA215675	ScieGen Pharmaceuticals, INC.	PREGABALIN	330	mg/1		CV	N	20241231
50228-465_d711b3e1-58e0-2a00-e053-2995a90a5ef8	50228-465	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	ScieGen Pharmaceuticals Inc	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-466_d711b3e1-58e0-2a00-e053-2995a90a5ef8	50228-466	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	ScieGen Pharmaceuticals Inc	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50228-467_09a95635-597e-d608-e063-6294a90a203f	50228-467	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230508		ANDA	ANDA076442	ScieGen Pharmaceuticals Inc	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-468_09a95635-597e-d608-e063-6294a90a203f	50228-468	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230508		ANDA	ANDA076442	ScieGen Pharmaceuticals Inc	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-469_09a95635-597e-d608-e063-6294a90a203f	50228-469	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230508		ANDA	ANDA076442	ScieGen Pharmaceuticals Inc	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50228-470_097fcff2-ea61-0878-e063-6394a90aa0fd	50228-470	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220527		ANDA	ANDA215069	ScieGen Pharmaceuticals, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-471_097fcff2-ea61-0878-e063-6394a90aa0fd	50228-471	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220527		ANDA	ANDA215069	ScieGen Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-472_097fcff2-ea61-0878-e063-6394a90aa0fd	50228-472	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20210611		ANDA	ANDA215069	ScieGen Pharmaceuticals, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-473_097fcff2-ea61-0878-e063-6394a90aa0fd	50228-473	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20210611		ANDA	ANDA215069	ScieGen Pharmaceuticals, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50228-474_1a9a8e17-2320-4a91-b75f-5868866db2c4	50228-474	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20200430		ANDA	ANDA207466	ScieGen Pharmaceuticals, Inc.	METAXALONE	400	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
50228-475_f52587a6-f60d-515d-e053-2995a90aadb8	50228-475	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200225		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-476_f52587a6-f60d-515d-e053-2995a90aadb8	50228-476	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200225		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-477_f52587a6-f60d-515d-e053-2995a90aadb8	50228-477	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200225		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-478_f52587a6-f60d-515d-e053-2995a90aadb8	50228-478	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200224		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-479_f52587a6-f60d-515d-e053-2995a90aadb8	50228-479	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200225		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-480_f52587a6-f60d-515d-e053-2995a90aadb8	50228-480	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200225		ANDA	ANDA206383	ScieGen Pharmaceuticals Inc	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50228-481_f2f77139-2bfc-e538-e053-2a95a90a1e07	50228-481	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA216521	ScieGen Pharmaceuticals, Inc	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-482_f2f77139-2bfc-e538-e053-2a95a90a1e07	50228-482	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA216521	ScieGen Pharmaceuticals, Inc	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-483_f2f77139-2bfc-e538-e053-2a95a90a1e07	50228-483	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA216521	ScieGen Pharmaceuticals, Inc	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-484_f2f77139-2bfc-e538-e053-2a95a90a1e07	50228-484	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA216521	ScieGen Pharmaceuticals, Inc	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-495_f969ed11-d077-1416-e053-6294a90a44c2	50228-495	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230406		ANDA	ANDA216327	ScieGen Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-496_f969ed11-d077-1416-e053-6294a90a44c2	50228-496	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230406		ANDA	ANDA216327	ScieGen Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-497_f969ed11-d077-1416-e053-6294a90a44c2	50228-497	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230406		ANDA	ANDA216327	ScieGen Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-498_f969ed11-d077-1416-e053-6294a90a44c2	50228-498	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230406		ANDA	ANDA216327	ScieGen Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-499_f969ed11-d077-1416-e053-6294a90a44c2	50228-499	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230406		ANDA	ANDA216327	ScieGen Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-500_f969ed11-d077-1416-e053-6294a90a44c2	50228-500	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230406		ANDA	ANDA216327	ScieGen Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
50228-502_08a71033-79d3-fdbe-e063-6394a90a9e31	50228-502	HUMAN PRESCRIPTION DRUG	Clotrimazole Topical Solution USP, 1%		Clotrimazole Topical Solution USP, 1%	SOLUTION	TOPICAL	20231016		ANDA	ANDA216569	ScieGen Pharmaceuticals, Inc	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50228-503_dabc66fe-9cb1-3e39-e053-2995a90ab45f	50228-503	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Extended-Release Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220222		ANDA	ANDA214629	ScieGen Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50228-504_dabc66fe-9cb1-3e39-e053-2995a90ab45f	50228-504	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Extended-Release Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220222		ANDA	ANDA214629	ScieGen Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50231-211_0dff4b29-9947-84ae-e063-6394a90aab97	50231-211	HUMAN OTC DRUG	MEDISTIK DUAL		MENTHOL, METHYL SALICYLATE, EUCALUPTUS	STICK	TOPICAL	20110415		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	EUCALYPTUS GLOBULUS LEAF; MENTHOL; METHYL SALICYLATE	1; 15; 30	g/100g; g/100g; g/100g			N	20251231
50231-221_0dffa563-6da0-8949-e063-6394a90ae41b	50231-221	HUMAN OTC DRUG	MEDISTIK PROFESSIONAL DUAL ACTION		MENTHOL, METHYL SALICYLATE, EUCALUPTUS	STICK	TOPICAL	20110415		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	EUCALYPTUS GLOBULUS LEAF; MENTHOL; METHYL SALICYLATE	1; 15; 30	g/100g; g/100g; g/100g			N	20251231
50231-311_0dff2f23-e604-7da0-e063-6394a90a42b4	50231-311	HUMAN OTC DRUG	Medistik	analgesic	Menthol and Methyl Salicylate	STICK	TOPICAL	20110415		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	MENTHOL; METHYL SALICYLATE	15; 30	g/100g; g/100g			N	20251231
50231-411_0dff9f29-358b-afd6-e063-6294a90a9598	50231-411	HUMAN OTC DRUG	MEDISTIK ICE		Menthol, Camphor	SOLUTION	TOPICAL	20160217		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	CAMPHOR OIL; MENTHOL	4; 10	g/100mL; g/100mL			N	20251231
50231-421_0dff67d9-48e5-e993-e063-6294a90a94d0	50231-421	HUMAN OTC DRUG	MEDISTIK PROFESSIONAL ICE THERAPY		MENTHOL, CAMPHOR	GEL	TOPICAL	20160217		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	CAMPHOR OIL; MENTHOL	4; 10	g/100mL; g/100mL			N	20251231
50231-422_0dff67d9-48ef-e993-e063-6294a90a94d0	50231-422	HUMAN OTC DRUG	MEDISTIK PROFESSIONAL ICE THERAPY		MENTHOL, CAMPHOR	SOLUTION	TOPICAL	20160217		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	CAMPHOR OIL; MENTHOL	4; 10	g/100mL; g/100mL			N	20251231
50231-511_0dff6720-b3e2-84ac-e063-6394a90a72e1	50231-511	HUMAN OTC DRUG	MEDISTIK DUAL HOT AND COLD		Methyl Salicylate, Menthol	SPRAY	TOPICAL	20160219		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	MENTHOL; METHYL SALICYLATE	10; 12	g/100mL; g/100mL			N	20251231
50231-521_0dff9f29-353e-afd6-e063-6294a90a9598	50231-521	HUMAN OTC DRUG	MEDISTIK PROFESSIONAL DUAL ACTION		Methyl Salicylate, Menthol	SPRAY	TOPICAL	20160219		OTC MONOGRAPH DRUG	M017	Natureteq Inc.	MENTHOL; METHYL SALICYLATE	10; 12	g/100mL; g/100mL			N	20251231
50241-014_475c5f6f-4943-4448-b95b-f42d7b513924	50241-014	HUMAN OTC DRUG	MG DermaClean		N/A	LIQUID	TOPICAL	20190125		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
50241-223_b8fc079e-65a1-4161-8d0a-56af0e5396bc	50241-223	HUMAN OTC DRUG	MG FoamSan 70		Ethyl Alcohol	LIQUID	TOPICAL	20200821		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	ALCOHOL	.7	L/L			N	20241231
50241-224_abcade84-7869-48de-aa06-7cb1123e473b	50241-224	HUMAN OTC DRUG	Hand Sanitizer Solution 101		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180414		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20241231
50241-259_65aa0907-eea6-4098-85cc-df3a95f1f654	50241-259	HUMAN OTC DRUG	MG DermaSan		N/A	LIQUID	TOPICAL	20181001		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
50241-302_60aa3036-9463-4c83-9525-32d79485c3e5	50241-302	HUMAN OTC DRUG	MG DermaWash		Benzalkonium Chloride	LIQUID	TOPICAL	20180924		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20241231
50241-317_1dc7268b-c64d-43b9-8166-0f47d9b243e9	50241-317	HUMAN OTC DRUG	Antibacterial Liquid Hand		Benzalkonium Chloride	LIQUID	TOPICAL	20180415		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20241231
50241-326_52165ca4-12bb-4b83-84f3-8ade387d1885	50241-326	HUMAN OTC DRUG	MG DermaGel 62		Ethyl Alcohol	LIQUID	TOPICAL	20200327		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	ALCOHOL	.62	L/L			N	20241231
50241-330_6fbfef30-af1e-47cc-a713-2991eb089b0e	50241-330	HUMAN OTC DRUG	MG DermaSan 72		Isopropyl Alcohol	GEL	TOPICAL	20200330		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	ISOPROPYL ALCOHOL	.72	L/L			N	20241231
50241-339_009bc8f3-d98d-464d-8c53-4f8cdacc2ad9	50241-339	HUMAN OTC DRUG	MG DermaFoam		Benzalkonium Chloride	LIQUID	TOPICAL	20180925		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20241231
50241-522_4f04746f-1322-4581-8867-b1a02448e984	50241-522	HUMAN OTC DRUG	MG FoamSan		Benzalkonium Chloride	LIQUID	TOPICAL	20200526		UNAPPROVED DRUG OTHER		Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
50242-007_290af574-997a-4b47-a018-e90bd1223d49	50242-007	HUMAN PRESCRIPTION DRUG	Enspryng		Satralizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20200814		BLA	BLA761149	Genentech Inc.	SATRALIZUMAB	120	mg/mL			N	20241231
50242-040_bee4bec5-70c9-491e-a22d-576ba9de4dfe	50242-040	HUMAN PRESCRIPTION DRUG	XOLAIR		omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20030620		BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150	mg/1.2mL	Anti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]		N	20241231
50242-041_7595e1d4-9e6f-4887-b051-efd6c7b0e058	50242-041	HUMAN PRESCRIPTION DRUG	Cathflo Activase		Alteplase	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010904		BLA	BLA103172	Genentech, Inc.	ALTEPLASE	2.2	mg/2mL			N	20241231
50242-044_d156776e-911a-4db0-945b-9d952f4ece42	50242-044	HUMAN PRESCRIPTION DRUG	Activase		Alteplase	KIT		19871113		BLA	BLA103172	Genentech, Inc.						N	20241231
50242-051_2e957336-f4e0-4272-bf24-611f1c20f8e3	50242-051	HUMAN PRESCRIPTION DRUG	Rituxan		rituximab	INJECTION, SOLUTION	INTRAVENOUS	19971126		BLA	BLA103705	Genentech, Inc.	RITUXIMAB	10	mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
50242-053_2e957336-f4e0-4272-bf24-611f1c20f8e3	50242-053	HUMAN PRESCRIPTION DRUG	Rituxan		rituximab	INJECTION, SOLUTION	INTRAVENOUS	19971126		BLA	BLA103705	Genentech, Inc.	RITUXIMAB	10	mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
50242-060_3580958a-7a01-45c0-8d9c-87d9a3963158	50242-060	HUMAN PRESCRIPTION DRUG	Avastin		bevacizumab	INJECTION, SOLUTION	INTRAVENOUS	20040226		BLA	BLA125085	Genentech, Inc.	BEVACIZUMAB	100	mg/4mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
50242-061_3580958a-7a01-45c0-8d9c-87d9a3963158	50242-061	HUMAN PRESCRIPTION DRUG	Avastin		bevacizumab	INJECTION, SOLUTION	INTRAVENOUS	20040226		BLA	BLA125085	Genentech, Inc.	BEVACIZUMAB	400	mg/16mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
50242-062_5c1bf1f1-3ef7-4411-9305-b4f4080b769a	50242-062	HUMAN PRESCRIPTION DRUG	TARCEVA		erlotinib hydrochloride	TABLET	ORAL	20050430		NDA	NDA021743	Genentech, Inc.	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
50242-063_5c1bf1f1-3ef7-4411-9305-b4f4080b769a	50242-063	HUMAN PRESCRIPTION DRUG	TARCEVA		erlotinib hydrochloride	TABLET	ORAL	20050430		NDA	NDA021743	Genentech, Inc.	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
50242-064_5c1bf1f1-3ef7-4411-9305-b4f4080b769a	50242-064	HUMAN PRESCRIPTION DRUG	TARCEVA		erlotinib hydrochloride	TABLET	ORAL	20050430		NDA	NDA021743	Genentech, Inc.	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
50242-070_46ab013a-7f43-41f7-8ee8-fc77437561ee	50242-070	HUMAN PRESCRIPTION DRUG	Gazyva		obinutuzumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20131101		BLA	BLA125486	Genentech, Inc.	OBINUTUZUMAB	1000	mg/40mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
50242-074_4c3b5898-d8f8-4dea-b77a-8a88d0419327	50242-074	HUMAN PRESCRIPTION DRUG	Nutropin AQ NuSpin 10		somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	19951229		BLA	BLA020522	Genentech, Inc.	SOMATROPIN	10	mg/2mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
50242-075_4c3b5898-d8f8-4dea-b77a-8a88d0419327	50242-075	HUMAN PRESCRIPTION DRUG	Nutropin AQ NuSpin 5		somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	19951229		BLA	BLA020522	Genentech, Inc.	SOMATROPIN	5	mg/2mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
50242-076_4c3b5898-d8f8-4dea-b77a-8a88d0419327	50242-076	HUMAN PRESCRIPTION DRUG	Nutropin AQ NuSpin 20		somatropin	INJECTION, SOLUTION	SUBCUTANEOUS	19951229		BLA	BLA020522	Genentech, Inc.	SOMATROPIN	20	mg/2mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
50242-077_e1b28acf-9e32-4bdf-b2bc-5e7b27d98268	50242-077	HUMAN PRESCRIPTION DRUG	Herceptin Hylecta		Trastuzumab and hyaluronidase-oysk	INJECTION, SOLUTION	SUBCUTANEOUS	20190228		BLA	BLA761106	Genentech, Inc.	HYALURONIDASE (HUMAN RECOMBINANT); TRASTUZUMAB	10000; 600	U/5mL; mg/5mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS], HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
50242-078_38c9bd01-2138-4960-98fe-d5ac801f9ae8	50242-078	HUMAN PRESCRIPTION DRUG	Susvimo		Ranibizumab	INJECTION, SOLUTION	INTRAVITREAL	20211022		BLA	BLA761197	Genentech, Inc.	RANIBIZUMAB	100	mg/mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
50242-080_bff71896-6094-485b-a864-50c1ff847faa	50242-080	HUMAN PRESCRIPTION DRUG	LUCENTIS		RANIBIZUMAB	INJECTION, SOLUTION	INTRAVITREAL	20060630		BLA	BLA125156	Genentech, Inc.	RANIBIZUMAB	10	mg/mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
50242-082_bff71896-6094-485b-a864-50c1ff847faa	50242-082	HUMAN PRESCRIPTION DRUG	LUCENTIS		RANIBIZUMAB	INJECTION, SOLUTION	INTRAVITREAL	20120810		BLA	BLA125156	Genentech, Inc.	RANIBIZUMAB	6	mg/mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
50242-085_d156776e-911a-4db0-945b-9d952f4ece42	50242-085	HUMAN PRESCRIPTION DRUG	Activase		Alteplase	KIT		19871113		BLA	BLA103172	Genentech, Inc.						N	20241231
50242-087_e40e1696-14c3-4366-a516-f36d0d9004b1	50242-087	HUMAN PRESCRIPTION DRUG	KADCYLA		ADO-TRASTUZUMAB EMTANSINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20130222		BLA	BLA125427	Genentech, Inc.	TRASTUZUMAB EMTANSINE	20	mg/mL			N	20241231
50242-088_e40e1696-14c3-4366-a516-f36d0d9004b1	50242-088	HUMAN PRESCRIPTION DRUG	KADCYLA		ADO-TRASTUZUMAB EMTANSINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20130222		BLA	BLA125427	Genentech, Inc.	TRASTUZUMAB EMTANSINE	20	mg/mL			N	20241231
50242-090_12c533cf-cb4e-4c17-986c-100fcd1056eb	50242-090	HUMAN PRESCRIPTION DRUG	ZELBORAF		Vemurafenib	TABLET, FILM COATED	ORAL	20110817		NDA	NDA202429	Genentech, Inc.	VEMURAFENIB	240	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA]		N	20241231
50242-091_6432013b-2489-45d3-b6f6-658e05818d76	50242-091	HUMAN PRESCRIPTION DRUG	Rozlytrek		ENTRECTINIB	CAPSULE	ORAL	20190815		NDA	NDA212725	Genentech, Inc.	ENTRECTINIB	100	mg/1			N	20241231
50242-094_6432013b-2489-45d3-b6f6-658e05818d76	50242-094	HUMAN PRESCRIPTION DRUG	Rozlytrek		ENTRECTINIB	CAPSULE	ORAL	20190815		NDA	NDA212725	Genentech, Inc.	ENTRECTINIB	200	mg/1			N	20241231
50242-096_6815251d-7f8d-4b04-8fc5-b1ec85a617ca	50242-096	HUMAN PRESCRIPTION DRUG	VABYSMO		Faricimab	INJECTION, SOLUTION	INTRAVITREAL	20220128		BLA	BLA761235	Genentech, Inc.	FARICIMAB	6	mg/.05mL			N	20241231
50242-100_8d882c6d-d753-48d6-80a6-2cbe5a2eb96f	50242-100	HUMAN PRESCRIPTION DRUG	Pulmozyme		dornase alfa	SOLUTION	RESPIRATORY (INHALATION)	19931230		BLA	BLA103532	Genentech, Inc.	DORNASE ALFA	1	mg/mL	Decreased Respiratory Secretion Viscosity [PE], Deoxyribonuclease I [CS], Recombinant Human Deoxyribonuclease 1 [EPC], Recombinant Proteins [CS]		N	20241231
50242-103_82ec8149-4e6f-407d-8751-784dae4c75c0	50242-103	HUMAN PRESCRIPTION DRUG	POLIVY		polatuzumab vedotin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190610		BLA	BLA761121	Genentech, Inc.	POLATUZUMAB VEDOTIN	30	mg/1.88mL			N	20241231
50242-105_82ec8149-4e6f-407d-8751-784dae4c75c0	50242-105	HUMAN PRESCRIPTION DRUG	POLIVY		polatuzumab vedotin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190610		BLA	BLA761121	Genentech, Inc.	POLATUZUMAB VEDOTIN	140	mg/7.52mL			N	20241231
50242-108_c37582b9-6667-47fe-90ca-7f9ff3c87ba9	50242-108	HUMAN PRESCRIPTION DRUG	Rituxan Hycela		rituximab and hyaluronidase	INJECTION, SOLUTION	SUBCUTANEOUS	20170622		BLA	BLA761064	Genentech, Inc.	HYALURONIDASE (HUMAN RECOMBINANT); RITUXIMAB	2000; 120	U/mL; mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC], Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
50242-109_c37582b9-6667-47fe-90ca-7f9ff3c87ba9	50242-109	HUMAN PRESCRIPTION DRUG	Rituxan Hycela		rituximab and hyaluronidase	INJECTION, SOLUTION	SUBCUTANEOUS	20170622		BLA	BLA761064	Genentech, Inc.	HYALURONIDASE (HUMAN RECOMBINANT); RITUXIMAB	2000; 120	U/mL; mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC], Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
50242-120_b1dff2e2-a09b-4ebd-bd7a-93906a4b1b0f	50242-120	HUMAN PRESCRIPTION DRUG	TNKase		tenecteplase	KIT		20181107		BLA	BLA103909	Genentech, Inc.						N	20241231
50242-121_6b98edca-c605-4883-9f0e-1fe47ea3890e	50242-121	HUMAN PRESCRIPTION DRUG	ESBRIET		PIRFENIDONE	CAPSULE	ORAL	20141015		NDA	NDA022535	Genentech, Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
50242-122_6b98edca-c605-4883-9f0e-1fe47ea3890e	50242-122	HUMAN PRESCRIPTION DRUG	ESBRIET		PIRFENIDONE	TABLET, COATED	ORAL	20170111		NDA	NDA208780	Genentech, Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
50242-123_6b98edca-c605-4883-9f0e-1fe47ea3890e	50242-123	HUMAN PRESCRIPTION DRUG	ESBRIET		PIRFENIDONE	TABLET, COATED	ORAL	20170111		NDA	NDA208780	Genentech, Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
50242-125_d916e332-2cd0-42fe-84fd-e116cdd69f82	50242-125	HUMAN PRESCRIPTION DRUG	Columvi		Glofitamab	SOLUTION, CONCENTRATE	INTRAVENOUS	20230615		BLA	BLA761309	Genentech, Inc.	GLOFITAMAB	2.5	mg/2.5mL			N	20241231
50242-127_d916e332-2cd0-42fe-84fd-e116cdd69f82	50242-127	HUMAN PRESCRIPTION DRUG	Columvi		Glofitamab	CONCENTRATE	INTRAVENOUS	20230615		BLA	BLA761309	Genentech, Inc.	GLOFITAMAB	10	mg/10mL			N	20241231
50242-130_987ae747-5cad-4d92-9df6-3978807dbdec	50242-130	HUMAN PRESCRIPTION DRUG	ALECENSA		ALECTINIB HYDROCHLORIDE	CAPSULE	ORAL	20151211		NDA	NDA208434	Genentech, Inc.	ALECTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
50242-132_5a465e06-40e4-48d0-9e25-8e0c9b6bee94	50242-132	HUMAN PRESCRIPTION DRUG	Herceptin		Trastuzumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170210		BLA	BLA103792	Genentech, Inc.	TRASTUZUMAB	150	mg/7.4mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
50242-135_dcb66364-6d57-4088-b445-5043bd97116c	50242-135	HUMAN PRESCRIPTION DRUG	ACTEMRA		tocilizumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20100108		BLA	BLA125276	Genentech, Inc.	TOCILIZUMAB	80	mg/4mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
50242-136_dcb66364-6d57-4088-b445-5043bd97116c	50242-136	HUMAN PRESCRIPTION DRUG	ACTEMRA		tocilizumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20100108		BLA	BLA125276	Genentech, Inc.	TOCILIZUMAB	200	mg/10mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
50242-137_dcb66364-6d57-4088-b445-5043bd97116c	50242-137	HUMAN PRESCRIPTION DRUG	ACTEMRA		tocilizumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20100108		BLA	BLA125276	Genentech, Inc.	TOCILIZUMAB	400	mg/20mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
50242-138_dcb66364-6d57-4088-b445-5043bd97116c	50242-138	HUMAN PRESCRIPTION DRUG	Actemra		tocilizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20131021		BLA	BLA125472	Genentech, Inc.	TOCILIZUMAB	162	mg/.9mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
50242-140_e0e041f9-94d4-4ec0-8aa5-f6b06e5b6320	50242-140	HUMAN PRESCRIPTION DRUG	ERIVEDGE		vismodegib	CAPSULE	ORAL	20120130		NDA	NDA203388	Genentech, Inc.	VISMODEGIB	150	mg/1	Hedgehog Pathway Inhibitor [EPC], Smoothened Receptor Antagonists [MoA]		N	20241231
50242-142_3c8d2a27-5057-4c5a-b9fc-c6d67afdd2f7	50242-142	HUMAN PRESCRIPTION DRUG	Lunsumio		Mosunetuzumab	CONCENTRATE	INTRAVENOUS	20221222		BLA	BLA761263	Genentech, Inc.	MOSUNETUZUMAB	30	mg/30mL			N	20241231
50242-143_dcb66364-6d57-4088-b445-5043bd97116c	50242-143	HUMAN PRESCRIPTION DRUG	Actemra ACTPen		tocilizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20181119		BLA	BLA125472	Genentech, Inc.	TOCILIZUMAB	162	mg/.9mL	Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]		N	20241231
50242-145_7ad83ddc-5af2-4a0c-ac86-97fcb10ea8a6	50242-145	HUMAN PRESCRIPTION DRUG	PERJETA		Pertuzumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20120608		BLA	BLA125409	Genentech, Inc.	PERTUZUMAB	30	mg/mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
50242-150_b0d874a0-ba3b-42b5-93f6-bbb732b7ba45	50242-150	HUMAN PRESCRIPTION DRUG	OCREVUS		ocrelizumab	INJECTION	INTRAVENOUS	20170328		BLA	BLA761053	Genentech, Inc.	OCRELIZUMAB	300	mg/10mL	Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
50242-159_3c8d2a27-5057-4c5a-b9fc-c6d67afdd2f7	50242-159	HUMAN PRESCRIPTION DRUG	Lunsumio		Mosunetuzumab	CONCENTRATE	INTRAVENOUS	20221222		BLA	BLA761263	Genentech, Inc.	MOSUNETUZUMAB	1	mg/mL			N	20241231
50242-175_3720e6dd-9987-4d04-b0dc-7cff2273ae0c	50242-175	HUMAN PRESCRIPTION DRUG	EVRYSDI		Risdiplam	POWDER, FOR SOLUTION	ORAL	20200807		NDA	NDA213535	Genentech Inc.	RISDIPLAM	.75	mg/mL	Increased Protein Synthesis [PE], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Survival of Motor Neuron 2 Splicing Modifier [EPC], Survival of Motor Neuron 2 Splicing Modifiers [MoA]		N	20241231
50242-210_115d2334-1943-4e4e-bd30-eab20521e7e5	50242-210	HUMAN PRESCRIPTION DRUG	Gavreto		Pralsetinib	CAPSULE	ORAL	20210701		NDA	NDA213721	Genentech, Inc.	PRALSETINIB	100	mg/1	Kinase Inhibitor [EPC], Rearranged during Transfection (RET) Inhibitors [MoA]		N	20241231
50242-214_bee4bec5-70c9-491e-a22d-576ba9de4dfe	50242-214	HUMAN PRESCRIPTION DRUG	Xolair PFS		omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20180928		BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	75	mg/.5mL	Anti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]		N	20241231
50242-215_bee4bec5-70c9-491e-a22d-576ba9de4dfe	50242-215	HUMAN PRESCRIPTION DRUG	Xolair PFS		omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20180928		BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150	mg/mL	Anti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]		N	20241231
50242-227_bee4bec5-70c9-491e-a22d-576ba9de4dfe	50242-227	HUMAN PRESCRIPTION DRUG	Xolair		omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818		BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	300	mg/2mL	Anti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]		N	20241231
50242-245_04be6beb-fee6-42cb-8b8d-ee7ac8da3262	50242-245	HUMAN PRESCRIPTION DRUG	Phesgo		pertuzumab, trastuzumab, and hyaluronidase-zzxf	INJECTION, SOLUTION	SUBCUTANEOUS	20200629		BLA	BLA761170	Genentech, Inc.	HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB	30000; 1200; 600	U/15mL; mg/15mL; mg/15mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS], HER2/Neu/cerbB2 Antagonists [MoA], HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC], HER2/neu Receptor Antagonist [EPC]		N	20241231
50242-260_04be6beb-fee6-42cb-8b8d-ee7ac8da3262	50242-260	HUMAN PRESCRIPTION DRUG	Phesgo		pertuzumab, trastuzumab, and hyaluronidase-zzxf	INJECTION, SOLUTION	SUBCUTANEOUS	20200629		BLA	BLA761170	Genentech, Inc.	HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB	20000; 600; 600	U/10mL; mg/10mL; mg/10mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS], HER2/Neu/cerbB2 Antagonists [MoA], HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC], HER2/neu Receptor Antagonist [EPC]		N	20241231
50242-583_1148daf7-47c1-4ef3-8162-41f8b37201ab	50242-583	HUMAN PRESCRIPTION DRUG	Xofluza		BALOXAVIR MARBOXIL	GRANULE, FOR SOLUTION	ORAL	20181024		NDA	NDA214410	Genentech, Inc.	BALOXAVIR MARBOXIL	40	mg/20mL	Chelating Activity [MoA], Polymerase Acidic Endonuclease Inhibitor [EPC], Polymerase Acidic Endonuclease Inhibitors [MoA]		N	20241231
50242-623_6432013b-2489-45d3-b6f6-658e05818d76	50242-623	HUMAN PRESCRIPTION DRUG	Rozlytrek		ENTRECTINIB	PELLET	ORAL	20231020		NDA	NDA218550	Genentech, Inc.	ENTRECTINIB	50	mg/mg			N	20241231
50242-717_1728ab50-4d7c-4342-9587-5f734576f70b	50242-717	HUMAN PRESCRIPTION DRUG	Cotellic		COBIMETINIB	TABLET, FILM COATED	ORAL	20151110		NDA	NDA206192	Genentech, Inc.	COBIMETINIB FUMARATE	20	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
50242-860_1148daf7-47c1-4ef3-8162-41f8b37201ab	50242-860	HUMAN PRESCRIPTION DRUG	Xofluza		BALOXAVIR MARBOXIL	TABLET, FILM COATED	ORAL	20181024		NDA	NDA210854	Genentech, Inc.	BALOXAVIR MARBOXIL	40	mg/1	Chelating Activity [MoA], Polymerase Acidic Endonuclease Inhibitor [EPC], Polymerase Acidic Endonuclease Inhibitors [MoA]		N	20241231
50242-877_1148daf7-47c1-4ef3-8162-41f8b37201ab	50242-877	HUMAN PRESCRIPTION DRUG	Xofluza		BALOXAVIR MARBOXIL	TABLET, FILM COATED	ORAL	20181024		NDA	NDA210854	Genentech, Inc.	BALOXAVIR MARBOXIL	80	mg/1	Chelating Activity [MoA], Polymerase Acidic Endonuclease Inhibitor [EPC], Polymerase Acidic Endonuclease Inhibitors [MoA]		N	20241231
50242-917_8d7d4e8e-c532-448d-bd98-39af4e0fb3e0	50242-917	HUMAN PRESCRIPTION DRUG	TECENTRIQ		atezolizumab	INJECTION, SOLUTION	INTRAVENOUS	20160518		BLA	BLA761034	Genentech, Inc.	ATEZOLIZUMAB	1200	mg/20mL	Antibodies [CS], Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
50242-918_8d7d4e8e-c532-448d-bd98-39af4e0fb3e0	50242-918	HUMAN PRESCRIPTION DRUG	TECENTRIQ		atezolizumab	INJECTION, SOLUTION	INTRAVENOUS	20190308		BLA	BLA761034	Genentech, Inc.	ATEZOLIZUMAB	840	mg/14mL	Antibodies [CS], Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
50242-920_bbf98231-9308-4099-9808-a170a48fdfb3	50242-920	HUMAN PRESCRIPTION DRUG	Hemlibra		emicizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20171116		BLA	BLA761083	Genentech, Inc.	EMICIZUMAB	30	mg/mL			N	20241231
50242-921_bbf98231-9308-4099-9808-a170a48fdfb3	50242-921	HUMAN PRESCRIPTION DRUG	Hemlibra		emicizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20171116		BLA	BLA761083	Genentech, Inc.	EMICIZUMAB	60	mg/.4mL			N	20241231
50242-922_bbf98231-9308-4099-9808-a170a48fdfb3	50242-922	HUMAN PRESCRIPTION DRUG	Hemlibra		emicizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20171116		BLA	BLA761083	Genentech, Inc.	EMICIZUMAB	105	mg/.7mL			N	20241231
50242-923_bbf98231-9308-4099-9808-a170a48fdfb3	50242-923	HUMAN PRESCRIPTION DRUG	Hemlibra		emicizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20171116		BLA	BLA761083	Genentech, Inc.	EMICIZUMAB	150	mg/mL			N	20241231
50242-930_bbf98231-9308-4099-9808-a170a48fdfb3	50242-930	HUMAN PRESCRIPTION DRUG	Hemlibra		emicizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230316		BLA	BLA761083	Genentech, Inc.	EMICIZUMAB	300	mg/2mL			N	20241231
50254-457_8855e412-c1a4-40c1-969a-e9a2c80c7a55	50254-457	HUMAN OTC DRUG	Clean Hands Instant Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200107		OTC MONOGRAPH NOT FINAL	part333E	Beaver Research Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50254-585_1d1d2abf-54f0-42f6-86e9-41d231ffc564	50254-585	HUMAN OTC DRUG	High Five Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200107		OTC MONOGRAPH NOT FINAL	part333E	Beaver Research Company	ALCOHOL	.62	mL/mL			N	20241231
50254-693_bd48b6e1-d93d-5616-e053-2995a90aca39	50254-693	HUMAN OTC DRUG	Slap Happy		Slap Happy	LIQUID	TOPICAL	20200102		OTC MONOGRAPH NOT FINAL	part333A	Beaver Research Company	ALCOHOL	67	mL/100mL			N	20241231
50261-104_b33c36b2-f0a2-4525-a841-75c3ba011961	50261-104	HUMAN PRESCRIPTION DRUG	IMVEXXY		estradiol	INSERT	VAGINAL	20180705		NDA	NDA208564	Mayne Pharma LLC	ESTRADIOL	4	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50261-110_b33c36b2-f0a2-4525-a841-75c3ba011961	50261-110	HUMAN PRESCRIPTION DRUG	IMVEXXY		estradiol	INSERT	VAGINAL	20180703		NDA	NDA208564	Mayne Pharma LLC	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50261-211_306280d6-5026-479c-bf5b-287fbcd855ec	50261-211	HUMAN PRESCRIPTION DRUG	Bijuva		estradiol and progesterone	CAPSULE	ORAL	20190403		NDA	NDA210132	Mayne Pharma LLC	ESTRADIOL; PROGESTERONE	1; 100	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone [CS], Progesterone [EPC]		N	20241231
50261-251_306280d6-5026-479c-bf5b-287fbcd855ec	50261-251	HUMAN PRESCRIPTION DRUG	Bijuva		estradiol and progesterone	CAPSULE	ORAL	20230331		NDA	NDA210132	Mayne Pharma LLC	ESTRADIOL; PROGESTERONE	.5; 100	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone [CS], Progesterone [EPC]		N	20241231
50261-313_17feae6d-baa1-4f2c-8989-c5400c2a1a88	50261-313	HUMAN PRESCRIPTION DRUG	ANNOVERA		segesterone acetate and ethinyl estradiol	RING	VAGINAL	20190812		NDA	NDA209627	TherapeuticsMD, Inc.	ETHINYL ESTRADIOL; SEGESTERONE ACETATE	17.4; 103	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50268-037_fd771acd-9f9e-5733-e053-6394a90aee99	50268-037	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230606		ANDA	ANDA214548	AvPAK	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50268-038_fd771acd-9f9e-5733-e053-6394a90aee99	50268-038	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230606		ANDA	ANDA214548	AvPAK	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50268-039_fd771acd-9f9e-5733-e053-6394a90aee99	50268-039	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230606		ANDA	ANDA214548	AvPAK	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50268-040_fd771acd-9f9e-5733-e053-6394a90aee99	50268-040	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230606		ANDA	ANDA214548	AvPAK	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50268-041_f5c60367-77d7-03a6-e053-2a95a90ab98f	50268-041	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230228		ANDA	ANDA214548	AvPAK	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50268-049_df222f46-8586-6f96-e053-2995a90aaac6	50268-049	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET	ORAL	20200410		ANDA	ANDA091560	AvPAK	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
50268-050_0e84d3db-f7e4-c625-e063-6394a90a8e03	50268-050	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20100916		ANDA	ANDA075047	AvPAK	ACEBUTOLOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50268-052_0e84d3db-f7e5-c625-e063-6394a90a8e03	50268-052	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160307		ANDA	ANDA076200	AvPAK	ACETAMINOPHEN	650	mg/1			N	20251231
50268-054_0e84d0e5-6d2f-b85a-e063-6394a90a5f99	50268-054	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20200707		ANDA	ANDA209734	AvPAK	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20251231
50268-057_0e84d0e5-6d30-b85a-e063-6394a90a5f99	50268-057	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20200213		ANDA	ANDA078983	AvPAK	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50268-058_0e84d0e5-6d30-b85a-e063-6394a90a5f99	50268-058	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20200213		ANDA	ANDA078983	AvPAK	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50268-061_07ef3ccc-8d52-c59d-e063-6394a90a411e	50268-061	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20110316		ANDA	ANDA075382	AvPAK	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50268-062_07ef3ccc-8d52-c59d-e063-6394a90a411e	50268-062	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20140718		ANDA	ANDA075382	AvPAK	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50268-069_d5cbebf4-afde-508e-e053-2995a90a5ada	50268-069	HUMAN PRESCRIPTION DRUG	Amantadine HCl		AMANTADINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20140328		ANDA	ANDA078720	AvPAK	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
50268-074_0e2239db-f066-b016-e063-6294a90a41d7	50268-074	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20201211		ANDA	ANDA208250	AvPAK	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
50268-075_0e84d97f-dee7-c648-e063-6394a90a7df5	50268-075	HUMAN PRESCRIPTION DRUG	ANASTROZOLE		ANASTROZOLE	TABLET	ORAL	20191011		ANDA	ANDA079220	AvPAK	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20251231
50268-076_0e2239db-f066-b016-e063-6294a90a41d7	50268-076	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20201211		ANDA	ANDA208249	AvPAK	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
50268-086_d5cbb80c-c326-ac08-e053-2995a90a264d	50268-086	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20200507		ANDA	ANDA210692	AvPAK	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20251231
50268-087_0e84c670-45a7-5e67-e063-6294a90a9e5b	50268-087	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160428		ANDA	ANDA205064	AvPAK	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-088_0e84c670-45a7-5e67-e063-6294a90a9e5b	50268-088	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160428		ANDA	ANDA205064	AvPAK	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-089_0e84c670-45a7-5e67-e063-6294a90a9e5b	50268-089	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160428		ANDA	ANDA205064	AvPAK	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-090_0e84c670-45a7-5e67-e063-6294a90a9e5b	50268-090	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160428		ANDA	ANDA205064	AvPAK	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-091_0e84c670-45a7-5e67-e063-6294a90a9e5b	50268-091	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160428		ANDA	ANDA205064	AvPAK	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-092_0e84c670-45a7-5e67-e063-6294a90a9e5b	50268-092	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160428		ANDA	ANDA205064	AvPAK	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-097_f37cbf5f-0fd3-8811-e053-2a95a90a3377	50268-097	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20190911		ANDA	ANDA075389	AvPAK	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50268-105_07ef2d53-1a6b-7d4c-e063-6294a90a8da6	50268-105	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210511		ANDA	ANDA211659	AvPAK	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50268-106_07ef4659-da07-a2dc-e063-6294a90a42e0	50268-106	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210302		ANDA	ANDA211659	AvPAK	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50268-107_07ef4659-da07-a2dc-e063-6294a90a42e0	50268-107	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210302		ANDA	ANDA211659	AvPAK	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
50268-109_facb79f4-17f7-2163-e053-6394a90ad136	50268-109	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20140428		ANDA	ANDA076820	AvPAK	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50268-110_facb79f4-17f7-2163-e053-6394a90ad136	50268-110	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20140428		ANDA	ANDA076820	AvPAK	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50268-111_facb79f4-17f7-2163-e053-6394a90ad136	50268-111	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20140428		ANDA	ANDA076820	AvPAK	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50268-112_facb79f4-17f7-2163-e053-6394a90ad136	50268-112	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20140428		ANDA	ANDA076820	AvPAK	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
50268-127_0e85a1ff-1540-187e-e063-6394a90a3b1e	50268-127	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20220110		ANDA	ANDA077910	AvPAK	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
50268-130_07ef3ccc-8d55-c59d-e063-6394a90a411e	50268-130	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20190423		ANDA	ANDA209724	AvPAK	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50268-131_07ef3ccc-8d55-c59d-e063-6394a90a411e	50268-131	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20190423		ANDA	ANDA209724	AvPAK	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50268-132_07ef3ccc-8d55-c59d-e063-6394a90a411e	50268-132	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20190423		ANDA	ANDA209724	AvPAK	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50268-135_0e85a5c9-76a6-f621-e063-6394a90a8782	50268-135	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20201021		ANDA	ANDA078888	AvPAK	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20251231
50268-140_0e85c22f-4437-16b4-e063-6394a90a8600	50268-140	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181121	20241031	ANDA	ANDA077284	AvPAK	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
50268-141_0e85c22f-4437-16b4-e063-6394a90a8600	50268-141	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161014	20250131	ANDA	ANDA077284	AvPAK	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
50268-142_0e85aee7-1b9d-f05c-e063-6294a90af404	50268-142	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20170802		ANDA	ANDA076143	AvPAK	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50268-143_0e85aee7-1b9d-f05c-e063-6294a90af404	50268-143	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20170802		ANDA	ANDA076143	AvPAK	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
50268-144_08a4c6c5-aad2-e056-e063-6394a90aa103	50268-144	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl and Naloxone HCl		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20161208		ANDA	ANDA203136	AvPAK	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50268-145_08a4c6c5-aad2-e056-e063-6394a90aa103	50268-145	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl and Naloxone HCl		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20161208		ANDA	ANDA203136	AvPAK	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50268-151_0e85a5c9-76a7-f621-e063-6394a90a8782	50268-151	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20140915		ANDA	ANDA090836	AvPAK	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50268-152_0e85a5c9-76a7-f621-e063-6394a90a8782	50268-152	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20140915		ANDA	ANDA090836	AvPAK	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
50268-153_0e85c211-0dfd-56aa-e063-6394a90a3063	50268-153	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET	ORAL	20220224		ANDA	ANDA208368	AvPAK	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20251231
50268-162_0e85a5c9-76a9-f621-e063-6394a90a8782	50268-162	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200214		ANDA	ANDA209755	AvPAK	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
50268-163_0e85a5c9-76a9-f621-e063-6394a90a8782	50268-163	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200214		ANDA	ANDA209755	AvPAK	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
50268-164_0e85a5c9-76a9-f621-e063-6394a90a8782	50268-164	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200214		ANDA	ANDA209755	AvPAK	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
50268-165_0e85a5c9-76a9-f621-e063-6394a90a8782	50268-165	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200214		ANDA	ANDA209755	AvPAK	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
50268-166_0e85a5c9-76a9-f621-e063-6394a90a8782	50268-166	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200214		ANDA	ANDA209755	AvPAK	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
50268-167_df21e622-654c-2eab-e053-2995a90a5f1c	50268-167	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20191112		ANDA	ANDA210742	AvPAK	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50268-168_de5b2d20-dbdf-3fd3-e053-2995a90a0de4	50268-168	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20191017		ANDA	ANDA204519	AvPAK	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50268-169_de5b2d20-dbdf-3fd3-e053-2995a90a0de4	50268-169	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20191017		ANDA	ANDA204519	AvPAK	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50268-170_0e85dcfa-d9ef-5fbb-e063-6394a90aeae6	50268-170	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20211019		ANDA	ANDA078986	AvPAK	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
50268-171_0e85dcfa-d9ef-5fbb-e063-6394a90aeae6	50268-171	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20211019		ANDA	ANDA078986	AvPAK	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
50268-172_0e85dcfa-d9ef-5fbb-e063-6394a90aeae6	50268-172	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20211019		ANDA	ANDA078986	AvPAK	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
50268-173_f26608ec-7330-3a20-e053-2a95a90ad426	50268-173	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230116		ANDA	ANDA077856	AvPAK	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50268-174_f26608ec-7330-3a20-e053-2a95a90ad426	50268-174	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230116		ANDA	ANDA077856	AvPAK	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50268-175_f26608ec-7330-3a20-e053-2a95a90ad426	50268-175	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230116		ANDA	ANDA077856	AvPAK	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50268-176_0e85fc4a-96b7-b715-e063-6294a90a22e6	50268-176	HUMAN PRESCRIPTION DRUG	cilostazol		cilostazol	TABLET	ORAL	20161018		ANDA	ANDA077030	AvPAK	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20251231
50268-177_0e85fc4a-96b7-b715-e063-6294a90a22e6	50268-177	HUMAN PRESCRIPTION DRUG	cilostazol		cilostazol	TABLET	ORAL	20161018		ANDA	ANDA077030	AvPAK	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20251231
50268-178_0e85fb58-7ccc-8ae3-e063-6294a90a2553	50268-178	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20161010		ANDA	ANDA065489	AvPAK	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20251231
50268-179_0e85fb58-7ccc-8ae3-e063-6294a90a2553	50268-179	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20161010		ANDA	ANDA065489	AvPAK	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20251231
50268-182_fe0712a4-b475-3f35-e053-6294a90a2ce3	50268-182	HUMAN PRESCRIPTION DRUG	Sodium Citrate and Citric Acid		SODIUM CITRATE and CITRIC ACID MONOHYDRATE	SOLUTION	ORAL	20230613		UNAPPROVED DRUG OTHER		AvPAK	ANHYDROUS CITRIC ACID; SODIUM CITRATE	334; 500	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
50268-183_fe0712a4-b475-3f35-e053-6294a90a2ce3	50268-183	HUMAN PRESCRIPTION DRUG	Sodium Citrate and Citric Acid		SODIUM CITRATE and CITRIC ACID MONOHYDRATE	SOLUTION	ORAL	20230613		UNAPPROVED DRUG OTHER		AvPAK	ANHYDROUS CITRIC ACID; SODIUM CITRATE	334; 500	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
50268-184_0e85fc4a-96b8-b715-e063-6294a90a22e6	50268-184	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20191011		ANDA	ANDA204165	AvPAK	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20251231
50268-187_0e85fc4a-96b9-b715-e063-6294a90a22e6	50268-187	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20210915		ANDA	ANDA204711	AvPAK	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20251231
50268-189_0e85fd80-0968-6f07-e063-6394a90a0555	50268-189	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20210322		ANDA	ANDA207555	AvPAK	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20251231
50268-190_d5cef227-edd1-613b-e053-2995a90a787c	50268-190	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140610		ANDA	ANDA090478	AvPAK	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50268-191_e530fd1e-06fe-0432-e053-2995a90adf5f	50268-191	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA090478	AvPAK	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50268-192_fcec031f-6d5e-1e99-e053-6294a90aa9a8	50268-192	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20230530		ANDA	ANDA078895	AvPAK	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50268-193_fcec031f-6d5e-1e99-e053-6294a90aa9a8	50268-193	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20230530		ANDA	ANDA078895	AvPAK	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50268-194_fcec031f-6d5e-1e99-e053-6294a90aa9a8	50268-194	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20230530		ANDA	ANDA078895	AvPAK	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50268-217_0e86077e-b1ee-4811-e063-6394a90a51d2	50268-217	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		Dantrolene Sodium	CAPSULE	ORAL	20210309		ANDA	ANDA076856	AvPAK	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20251231
50268-222_de9ab9b3-809a-adb9-e053-2a95a90a2703	50268-222	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20220509		ANDA	ANDA075580	AvPAK	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-223_de9ab9b3-809a-adb9-e053-2a95a90a2703	50268-223	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20220509		ANDA	ANDA075580	AvPAK	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-224_de9ab9b3-809a-adb9-e053-2a95a90a2703	50268-224	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20220509		ANDA	ANDA075580	AvPAK	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-225_de9ab9b3-809a-adb9-e053-2a95a90a2703	50268-225	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20220509		ANDA	ANDA075580	AvPAK	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-258_0e86077e-b1ef-4811-e063-6394a90a51d2	50268-258	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	CAPSULE, COATED PELLETS	ORAL	20160714		ANDA	ANDA078919	AvPAK	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
50268-259_0e852f9b-ed2b-bc08-e063-6394a90a28db	50268-259	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20220916		ANDA	ANDA203730	AvPAK	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
50268-260_0e852f9b-ed2b-bc08-e063-6394a90a28db	50268-260	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20220916		ANDA	ANDA203730	AvPAK	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
50268-266_09060222-ce98-8e02-e063-6294a90af117	50268-266	HUMAN OTC DRUG	Docusate Calcium 240 mg sodium free		Docusate Calcium	CAPSULE, LIQUID FILLED	ORAL	20170517		OTC MONOGRAPH DRUG	M007	AvPAK	DOCUSATE CALCIUM	240	mg/1			N	20241231
50268-268_09060222-ce99-8e02-e063-6294a90af117	50268-268	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20170517		OTC MONOGRAPH DRUG	M007	AvPAK	DOCUSATE SODIUM	250	mg/1			N	20241231
50268-277_0e88a4e4-c31b-7594-e063-6294a90a25ff	50268-277	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20140604		ANDA	ANDA062676	AvPAK	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50268-278_0e88a4e4-c31b-7594-e063-6294a90a25ff	50268-278	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20140604		ANDA	ANDA062676	AvPAK	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50268-279_0e88a4e4-c31b-7594-e063-6294a90a25ff	50268-279	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20140604		ANDA	ANDA062677	AvPAK	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50268-280_0e88a4e4-c31d-7594-e063-6294a90a25ff	50268-280	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20200515		ANDA	ANDA205115	AvPAK	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50268-281_0e88a4e4-c31d-7594-e063-6294a90a25ff	50268-281	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20200515		ANDA	ANDA205115	AvPAK	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
50268-295_df222f46-8587-6f96-e053-2995a90aaac6	50268-295	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET, FILM COATED	ORAL	20161205		ANDA	ANDA203437	AvPAK	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
50268-297_0e88b79b-c698-3c90-e063-6394a90a294f	50268-297	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20200407		ANDA	ANDA090455	AvPAK	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20251231
50268-298_0e88a969-d676-75b3-e063-6294a90a50d8	50268-298	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170702		ANDA	ANDA208803	AvPAK	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20251231
50268-299_dfdca61d-8825-6230-e053-2995a90a209d	50268-299	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA075718	AvPAK	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50268-303_0e88b79b-c69a-3c90-e063-6394a90a294f	50268-303	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20141006		ANDA	ANDA075805	AvPAK	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
50268-304_0e88b79b-c69a-3c90-e063-6394a90a294f	50268-304	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20141006		ANDA	ANDA075805	AvPAK	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
50268-312_f1ec714b-5ed5-53fd-e053-2a95a90a0508	50268-312	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20150813		ANDA	ANDA076509	AvPAK	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50268-313_f1ec714b-5ed5-53fd-e053-2a95a90a0508	50268-313	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20150813		ANDA	ANDA076509	AvPAK	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
50268-314_df222f46-8588-6f96-e053-2995a90aaac6	50268-314	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20190123		ANDA	ANDA090061	AvPAK	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
50268-320_0e88bd1e-9413-9239-e063-6294a90a846e	50268-320	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150212		ANDA	ANDA075442	AvPAK	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20251231
50268-321_0e88bd1e-9413-9239-e063-6294a90a846e	50268-321	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150212		ANDA	ANDA075442	AvPAK	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20251231
50268-325_faa47fb0-9293-71a9-e053-6394a90ace70	50268-325	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20230501		ANDA	ANDA207057	AvPAK	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50268-326_026a7219-78bb-48c7-e063-6394a90ad736	50268-326	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20230808		ANDA	ANDA207057	AvPAK	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50268-330_0e88ac32-02f5-37a2-e063-6394a90a118f	50268-330	HUMAN PRESCRIPTION DRUG	FLUDROCORTISONE ACETATE		FLUDROCORTISONE ACETATE	TABLET	ORAL	20110801		ANDA	ANDA040431	AvPAK	FLUDROCORTISONE ACETATE	.1	mg/1			N	20251231
50268-331_0e88b79b-c69b-3c90-e063-6394a90a294f	50268-331	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20210412		ANDA	ANDA204652	AvPAK	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20251231
50268-332_0e88b79b-c69b-3c90-e063-6394a90a294f	50268-332	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20210412		ANDA	ANDA204652	AvPAK	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20251231
50268-337_0e88bd1e-941a-9239-e063-6294a90a846e	50268-337	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20160909		ANDA	ANDA077731	AvPAK	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
50268-338_0e88bd1e-941b-9239-e063-6294a90a846e	50268-338	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20220922		ANDA	ANDA090856	AvPAK	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
50268-339_0e88bd1e-941a-9239-e063-6294a90a846e	50268-339	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20160909		ANDA	ANDA077731	AvPAK	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
50268-350_d5dd5fa0-952b-e079-e053-2995a90a73c6	50268-350	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20140710		ANDA	ANDA077836	AvPAK	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
50268-358_df224039-d4b6-032d-e053-2a95a90ab6ec	50268-358	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20191002		ANDA	ANDA077091	AvPAK	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50268-359_df224039-d4b6-032d-e053-2a95a90ab6ec	50268-359	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20191002		ANDA	ANDA077091	AvPAK	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50268-360_df224039-d4b6-032d-e053-2a95a90ab6ec	50268-360	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20191002		ANDA	ANDA077091	AvPAK	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
50268-361_0e88c0f2-16c2-3684-e063-6394a90a12d0	50268-361	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20200710		ANDA	ANDA075795	AvPAK	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
50268-362_0e88c0f2-16c2-3684-e063-6394a90a12d0	50268-362	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20200710		ANDA	ANDA075795	AvPAK	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
50268-363_df2243cd-68f0-71d6-e053-2995a90ac9ba	50268-363	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20210311		ANDA	ANDA202675	AvPAK	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50268-366_e3277017-1d59-7105-e053-2995a90a9255	50268-366	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220706		ANDA	ANDA214534	AvPAK	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50268-367_e3277017-1d59-7105-e053-2995a90a9255	50268-367	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220706		ANDA	ANDA214534	AvPAK	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50268-368_e3277017-1d59-7105-e053-2995a90a9255	50268-368	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220706		ANDA	ANDA214534	AvPAK	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50268-369_ded754e2-c88e-1fd6-e053-2995a90a809e	50268-369	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220406		ANDA	ANDA214534	AvPAK	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50268-374_0e88c9e2-8db7-917c-e063-6294a90a6ec9	50268-374	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20170607		ANDA	ANDA075109	AvPAK	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
50268-398_0e88c9e2-8db8-917c-e063-6294a90a6ec9	50268-398	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20210414		ANDA	ANDA040156	AvPAK	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
50268-399_0e88c9e2-8db8-917c-e063-6294a90a6ec9	50268-399	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20210414		ANDA	ANDA040156	AvPAK	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
50268-400_0e88c9e2-8db9-917c-e063-6294a90a6ec9	50268-400	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20161028		ANDA	ANDA040746	AvPAK	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
50268-401_0e88bd1e-941c-9239-e063-6294a90a846e	50268-401	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20140915		ANDA	ANDA040736	AvPAK	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
50268-402_0e88bd1e-941c-9239-e063-6294a90a846e	50268-402	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20140915		ANDA	ANDA040736	AvPAK	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
50268-404_ef564517-7c8e-2485-e053-2995a90a185a	50268-404	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20221208		ANDA	ANDA203561	AvPAK	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
50268-405_f3959288-e6ad-c8f3-e053-2a95a90a888d	50268-405	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20230131		ANDA	ANDA040646	AvPAK	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50268-406_f3959288-e6ad-c8f3-e053-2a95a90a888d	50268-406	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20230131		ANDA	ANDA040646	AvPAK	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50268-407_f3959288-e6ad-c8f3-e053-2a95a90a888d	50268-407	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20230131		ANDA	ANDA040646	AvPAK	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50268-411_0e8897fb-39da-08df-e063-6394a90a3981	50268-411	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20170117		UNAPPROVED DRUG OTHER		AvPAK	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
50268-412_0e88cfe8-c75b-99cc-e063-6294a90a7959	50268-412	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20200515		ANDA	ANDA210441	AvPAK	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20251231
50268-430_de5ae64a-e92b-1414-e053-2995a90aea21	50268-430	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20150519		ANDA	ANDA091240	AvPAK	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50268-431_de5ae64a-e92b-1414-e053-2995a90aea21	50268-431	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20150520		ANDA	ANDA091240	AvPAK	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50268-440_026bef1a-3fd5-426b-e063-6294a90abe96	50268-440	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20230808		ANDA	ANDA202910	AvPAK	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50268-441_026bef1a-3fd5-426b-e063-6294a90abe96	50268-441	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20230808		ANDA	ANDA202910	AvPAK	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50268-442_026bef1a-3fd5-426b-e063-6294a90abe96	50268-442	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20230808		ANDA	ANDA202910	AvPAK	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50268-447_0e88d132-f617-b2c4-e063-6294a90ad1aa	50268-447	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	20160913		ANDA	ANDA086923	AvPAK	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
50268-448_0e88d132-f617-b2c4-e063-6294a90ad1aa	50268-448	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	20170606		ANDA	ANDA086925	AvPAK	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
50268-449_0e88d132-f617-b2c4-e063-6294a90ad1aa	50268-449	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	20160913		ANDA	ANDA087537	AvPAK	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
50268-450_0e88cfe8-c75f-99cc-e063-6294a90a7959	50268-450	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE	ORAL	20180323		ANDA	ANDA205080	AvPAK	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
50268-470_d5ddc7ca-fcb2-c72c-e053-2a95a90a54e7	50268-470	HUMAN PRESCRIPTION DRUG	Levetiracetam	Levetiracetam	Levetiracetam	SOLUTION	ORAL	20191014		ANDA	ANDA203052	AvPAK	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50268-476_0e88cfe8-c762-99cc-e063-6294a90a7959	50268-476	HUMAN PRESCRIPTION DRUG	LETROZOLE		LETROZOLE	TABLET	ORAL	20191002		ANDA	ANDA200161	AvPAK	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20251231
50268-477_0e88cfe8-c763-99cc-e063-6294a90a7959	50268-477	HUMAN PRESCRIPTION DRUG	LEFLUNOMIDE		LEFLUNOMIDE	TABLET	ORAL	20200917		ANDA	ANDA077090	AvPAK	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20251231
50268-478_0e88cfe8-c763-99cc-e063-6294a90a7959	50268-478	HUMAN PRESCRIPTION DRUG	LEFLUNOMIDE		LEFLUNOMIDE	TABLET	ORAL	20200917		ANDA	ANDA077090	AvPAK	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20251231
50268-482_f8992796-6155-777d-e053-6394a90afaaf	50268-482	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20230405		ANDA	ANDA215579	AvPAK	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50268-489_0e88cfe8-c764-99cc-e063-6294a90a7959	50268-489	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190528		ANDA	ANDA208314	AvPAK	LORATADINE	10	mg/1			N	20251231
50268-504_0e88c9e2-8dbe-917c-e063-6294a90a6ec9	50268-504	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200529		ANDA	ANDA078243	AvPAK	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
50268-505_0e88c9e2-8dbe-917c-e063-6294a90a6ec9	50268-505	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200529		ANDA	ANDA078243	AvPAK	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
50268-506_0e88c9e2-8dbe-917c-e063-6294a90a6ec9	50268-506	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200529		ANDA	ANDA078243	AvPAK	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
50268-520_0e88d132-f618-b2c4-e063-6294a90ad1aa	50268-520	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20210323		ANDA	ANDA090200	AvPAK	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
50268-521_0e88d132-f618-b2c4-e063-6294a90ad1aa	50268-521	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20210323		ANDA	ANDA090200	AvPAK	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
50268-522_08a00809-169f-83f1-e063-6294a90ae667	50268-522	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine	TABLET	ORAL	20130808		ANDA	ANDA201451	AvPAK	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50268-523_08a00809-169f-83f1-e063-6294a90ae667	50268-523	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20130808		ANDA	ANDA201451	AvPAK	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50268-525_0e88c9e2-8dbf-917c-e063-6294a90a6ec9	50268-525	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20121009		ANDA	ANDA077918	AvPAK	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50268-526_0e88c9e2-8dbf-917c-e063-6294a90a6ec9	50268-526	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20121009		ANDA	ANDA077918	AvPAK	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50268-527_0e88ac32-02f6-37a2-e063-6394a90a118f	50268-527	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20210526		ANDA	ANDA210040	AvPAK	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
50268-528_0e88c9e2-8dc0-917c-e063-6294a90a6ec9	50268-528	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20200710		ANDA	ANDA207416	AvPAK	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
50268-529_0e88c9e2-8dc0-917c-e063-6294a90a6ec9	50268-529	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20200213		ANDA	ANDA207416	AvPAK	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
50268-530_d5de17a3-b150-06fa-e053-2995a90ae4e5	50268-530	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20150313		ANDA	ANDA203399	AvPAK	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
50268-534_de5b2643-fb04-3d31-e053-2a95a90a28c4	50268-534	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20191030		ANDA	ANDA079067	AvPAK	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50268-535_de5b2643-fb04-3d31-e053-2a95a90a28c4	50268-535	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20191030		ANDA	ANDA079067	AvPAK	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
50268-540_de5aea76-b625-16ea-e053-2a95a90abb6d	50268-540	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA090617	AvPAK	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50268-541_de5aea76-b625-16ea-e053-2a95a90abb6d	50268-541	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA090617	AvPAK	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50268-542_de5aea76-b625-16ea-e053-2a95a90abb6d	50268-542	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA078889	AvPAK	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50268-543_de5aea76-b625-16ea-e053-2a95a90abb6d	50268-543	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA078889	AvPAK	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50268-545_0e88fdee-dba0-56cd-e063-6394a90a47c6	50268-545	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210422		ANDA	ANDA211009	AvPAK	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
50268-546_0e88fdee-dba0-56cd-e063-6394a90a47c6	50268-546	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210422		ANDA	ANDA211009	AvPAK	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
50268-547_0e88fdee-dba0-56cd-e063-6394a90a47c6	50268-547	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210422		ANDA	ANDA211009	AvPAK	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
50268-548_0e88fdee-dba0-56cd-e063-6394a90a47c6	50268-548	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210422		ANDA	ANDA211009	AvPAK	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
50268-550_0e77340b-3417-fe13-e063-6294a90a0301	50268-550	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220308		ANDA	ANDA078321	AvPAK	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
50268-551_0e772402-6cfe-8c75-e063-6294a90a5c45	50268-551	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220502		ANDA	ANDA078321	AvPAK	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
50268-553_e7618900-9bd6-3899-e053-2995a90a127e	50268-553	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20220811		ANDA	ANDA209587	AvPAK	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
50268-556_0e77455b-8a05-91de-e063-6394a90ad7b0	50268-556	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20220208		ANDA	ANDA202843	AvPAK	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20251231
50268-557_fbbe5b83-2c0c-5147-e053-6294a90ab97b	50268-557	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	CAPSULE	ORAL	20230515		ANDA	ANDA200197	AvPAK	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
50268-558_fbbe5b83-2c0c-5147-e053-6294a90ab97b	50268-558	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA091249	AvPAK	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
50268-561_0e773c6a-0177-fae5-e063-6294a90af595	50268-561	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190826		ANDA	ANDA077746	AvPAK	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
50268-562_0e773c6a-0177-fae5-e063-6294a90af595	50268-562	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190826		ANDA	ANDA077746	AvPAK	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
50268-563_0e773c6a-0177-fae5-e063-6294a90af595	50268-563	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190826		ANDA	ANDA077746	AvPAK	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
50268-568_0e773c6a-0175-fae5-e063-6294a90af595	50268-568	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20190611		ANDA	ANDA065170	AvPAK	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20251231
50268-570_e07bf55c-f24c-0893-e053-2995a90a8da3	50268-570	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20160801		ANDA	ANDA202566	AvPAK	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
50268-571_e07bf55c-f24c-0893-e053-2995a90a8da3	50268-571	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20160801		ANDA	ANDA202566	AvPAK	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
50268-573_eeb57e23-4655-a6f0-e053-2995a90a3c75	50268-573	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20141112		ANDA	ANDA200405	AvPAK	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50268-574_eeb57e23-4655-a6f0-e053-2995a90a3c75	50268-574	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20141112		ANDA	ANDA200405	AvPAK	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
50268-576_df227112-ca44-427d-e053-2a95a90affb2	50268-576	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA202632	AvPAK	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50268-577_f26593da-bfc9-ee50-e053-2a95a90a997d	50268-577	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20230116		ANDA	ANDA214242	AvPAK	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
50268-584_0e7729de-104e-e578-e063-6394a90a7de6	50268-584	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20170914		ANDA	ANDA203578	AvPAK	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20251231
50268-585_ed85abd7-ef86-7ac6-e053-2995a90a042b	50268-585	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20210128		ANDA	ANDA078281	AvPAK	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50268-592_d5de9e49-4cd1-35b6-e053-2995a90ae1d0	50268-592	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20121016		ANDA	ANDA078432	AvPAK	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50268-594_0e774462-8189-9c5d-e063-6294a90affac	50268-594	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20150211		ANDA	ANDA075927	AvPAK	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50268-595_0e774462-8189-9c5d-e063-6294a90affac	50268-595	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20150211		ANDA	ANDA075927	AvPAK	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
50268-597_d5dea0ce-95fe-5f94-e053-2995a90a11fd	50268-597	HUMAN PRESCRIPTION DRUG	Nifedipine	ER	Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110211		ANDA	ANDA077127	AvPAK	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50268-598_d5dea0ce-95fe-5f94-e053-2995a90a11fd	50268-598	HUMAN PRESCRIPTION DRUG	Nifedipine	ER	Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110211		ANDA	ANDA077127	AvPAK	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50268-599_d5dea0ce-95fe-5f94-e053-2995a90a11fd	50268-599	HUMAN PRESCRIPTION DRUG	Nifedipine	ER	Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110211		ANDA	ANDA077410	AvPAK	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50268-603_0e773c6a-0171-fae5-e063-6294a90af595	50268-603	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170314		ANDA	ANDA075520	AvPAK	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
50268-604_0e773c6a-0171-fae5-e063-6294a90af595	50268-604	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170314		ANDA	ANDA075520	AvPAK	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
50268-605_0e773c6a-0171-fae5-e063-6294a90af595	50268-605	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170314		ANDA	ANDA075520	AvPAK	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
50268-615_0993d95e-90b9-4903-e063-6294a90aae4f	50268-615	HUMAN PRESCRIPTION DRUG	OLANZAPINE		OLANZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20140423		ANDA	ANDA091415	AvPAK	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50268-621_df227112-ca46-427d-e053-2a95a90affb2	50268-621	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA078539	AvPAK	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50268-622_df227112-ca46-427d-e053-2a95a90affb2	50268-622	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA078539	AvPAK	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50268-623_0e77340b-340f-fe13-e063-6294a90a0301	50268-623	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20171208		ANDA	ANDA073671	AvPAK	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20251231
50268-624_0e77340b-340f-fe13-e063-6294a90a0301	50268-624	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20171208		ANDA	ANDA073652	AvPAK	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20251231
50268-625_0e77340b-340d-fe13-e063-6294a90a0301	50268-625	HUMAN PRESCRIPTION DRUG	Nitrofurantoin	(monohydrate/macrocrystals)	Nitrofurantoin monohydrate/macrocrystals	CAPSULE	ORAL	20180815		ANDA	ANDA207372	AvPAK	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20251231
50268-627_d5defdd9-516b-c23b-e053-2a95a90ac472	50268-627	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20120525		ANDA	ANDA078503	AvPAK	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50268-628_d5defdd9-516b-c23b-e053-2a95a90ac472	50268-628	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20120525		ANDA	ANDA078503	AvPAK	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50268-629_d5defdd9-516b-c23b-e053-2a95a90ac472	50268-629	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20120525		ANDA	ANDA078503	AvPAK	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
50268-630_df227112-ca47-427d-e053-2a95a90affb2	50268-630	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20160526		ANDA	ANDA201504	AvPAK	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50268-631_df227112-ca47-427d-e053-2a95a90affb2	50268-631	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20160526		ANDA	ANDA201504	AvPAK	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50268-632_df227112-ca47-427d-e053-2a95a90affb2	50268-632	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20160526		ANDA	ANDA201504	AvPAK	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50268-633_df227112-ca47-427d-e053-2a95a90affb2	50268-633	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20160526		ANDA	ANDA201504	AvPAK	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50268-634_df227112-ca47-427d-e053-2a95a90affb2	50268-634	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20160526		ANDA	ANDA201504	AvPAK	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50268-635_df227112-ca47-427d-e053-2a95a90affb2	50268-635	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20160526		ANDA	ANDA201504	AvPAK	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50268-639_e87e3ca9-921b-3ed6-e053-2995a90a889f	50268-639	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20150219		ANDA	ANDA078281	AvPAK	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50268-640_de5ab3cb-15fa-518d-e053-2a95a90a4931	50268-640	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20160311		ANDA	ANDA078406	AvPAK	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50268-642_de5ab3cb-15fa-518d-e053-2a95a90a4931	50268-642	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20160311		ANDA	ANDA078406	AvPAK	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50268-643_de5ab3cb-15fa-518d-e053-2a95a90a4931	50268-643	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20160311		ANDA	ANDA078406	AvPAK	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
50268-644_0e76e634-d945-70ac-e063-6294a90a6ad3	50268-644	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180709		ANDA	ANDA040777	AvPAK	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
50268-645_0e76e634-d945-70ac-e063-6294a90a6ad3	50268-645	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180709		ANDA	ANDA040778	AvPAK	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
50268-646_0e76e634-d945-70ac-e063-6294a90a6ad3	50268-646	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180709		ANDA	ANDA040778	AvPAK	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
50268-647_05cfabb7-5cc6-8905-e063-6394a90aeeb5	50268-647	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	SOLUTION	ORAL	20230920		ANDA	ANDA091483	AvPAK	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
50268-649_f8acf91d-57f3-3c4f-e053-6294a90acc21	50268-649	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	SUSPENSION	ORAL	20230405		ANDA	ANDA202961	AvPAK	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50268-652_ed85abd7-ef87-7ac6-e053-2995a90a042b	50268-652	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20210107		ANDA	ANDA077220	AvPAK	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
50268-656_f77e81c3-f542-e79c-e053-6394a90adb91	50268-656	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20230322		ANDA	ANDA075576	AvPAK	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50268-657_f77efca3-eac3-ec61-e053-6294a90aa325	50268-657	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20230322		ANDA	ANDA078490	AvPAK	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50268-662_039b7484-9cae-0d40-e063-6294a90a422c	50268-662	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20230823		ANDA	ANDA071972	AvPAK	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50268-663_039b7484-9cae-0d40-e063-6294a90a422c	50268-663	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20230823		ANDA	ANDA071972	AvPAK	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50268-664_039b7484-9cae-0d40-e063-6294a90a422c	50268-664	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20230823		ANDA	ANDA071972	AvPAK	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50268-665_0e76f50e-255d-d499-e063-6394a90aa92e	50268-665	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA076341	AvPAK	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50268-666_0e76f50e-255d-d499-e063-6394a90aa92e	50268-666	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA076341	AvPAK	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50268-667_0e76f50e-255d-d499-e063-6394a90aa92e	50268-667	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA076341	AvPAK	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50268-668_0e76f50e-255d-d499-e063-6394a90aa92e	50268-668	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA076341	AvPAK	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50268-671_0e76f50e-255a-d499-e063-6394a90aa92e	50268-671	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20160128		ANDA	ANDA202128	AvPAK	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
50268-674_f32df7c0-33ec-e6d6-e053-2a95a90a2e8d	50268-674	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20230126		ANDA	ANDA210041	AvPAK	POTASSIUM CHLORIDE	1.5	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50268-675_f32df7c0-33ec-e6d6-e053-2a95a90a2e8d	50268-675	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20230126		ANDA	ANDA210041	AvPAK	POTASSIUM CHLORIDE	3	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
50268-676_0e76f0d9-0ac4-e097-e063-6394a90adba2	50268-676	HUMAN PRESCRIPTION DRUG	omega-3-acid ethyl esters		omega-3-acid ethyl esters	CAPSULE	ORAL	20210308		ANDA	ANDA203893	AvPAK	OMEGA-3-ACID ETHYL ESTERS	900	mg/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20251231
50268-679_fd8d9cc6-c715-68bb-e053-6294a90a4cb2	50268-679	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230607		ANDA	ANDA215939	AvPAK	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50268-680_fd8d9cc6-c715-68bb-e053-6294a90a4cb2	50268-680	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230607		ANDA	ANDA215939	AvPAK	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50268-681_fd8d9cc6-c715-68bb-e053-6294a90a4cb2	50268-681	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230607		ANDA	ANDA215939	AvPAK	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50268-683_de95df83-a497-1900-e053-2995a90abf24	50268-683	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20220509		ANDA	ANDA212500	AvPAK	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50268-684_d5dfaf0e-ec7c-7a1a-e053-2995a90a633d	50268-684	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine Maleate	TABLET	ORAL	20190416		ANDA	ANDA040268	AvPAK	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50268-685_d5dfaf0e-ec7c-7a1a-e053-2995a90a633d	50268-685	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	20190416		ANDA	ANDA040268	AvPAK	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
50268-686_0e76db01-1826-6a4e-e063-6294a90a6e32	50268-686	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20110519		ANDA	ANDA040866	AvPAK	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
50268-687_0e76db01-1826-6a4e-e063-6294a90a6e32	50268-687	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20110519		ANDA	ANDA040866	AvPAK	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
50268-694_d5dfb02c-43db-2099-e053-2995a90a8afb	50268-694	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20180627		ANDA	ANDA208206	AvPAK	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20251231
50268-708_de5aeea5-b994-604d-e053-2a95a90a2b51	50268-708	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20210106		ANDA	ANDA091693	AvPAK	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
50268-709_0e7604d4-417d-6453-e063-6394a90a515e	50268-709	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20181214		ANDA	ANDA207616	AvPAK	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50268-710_0e7604d4-417d-6453-e063-6394a90a515e	50268-710	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20181214		ANDA	ANDA207616	AvPAK	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50268-711_0e7604d4-417d-6453-e063-6394a90a515e	50268-711	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20181214		ANDA	ANDA207616	AvPAK	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
50268-717_0e760af4-a7f1-7bbd-e063-6294a90af053	50268-717	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20150529		ANDA	ANDA202025	AvPAK	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
50268-718_0e760de3-3cc7-51f3-e063-6394a90ac009	50268-718	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20180423		ANDA	ANDA201578	AvPAK	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
50268-720_0e760fa3-6452-643b-e063-6394a90a9c7f	50268-720	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20190114		ANDA	ANDA207288	AvPAK	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20251231
50268-722_e9235698-6dc3-71fa-e053-2995a90af41b	50268-722	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220920		ANDA	ANDA209953	AvPAK	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50268-723_e9235698-6dc3-71fa-e053-2995a90af41b	50268-723	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220920		ANDA	ANDA209953	AvPAK	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50268-724_ed871978-2196-4f8e-e053-2a95a90a9270	50268-724	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA076140	AvPAK	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
50268-725_ed871978-2196-4f8e-e053-2a95a90a9270	50268-725	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA076140	AvPAK	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
50268-728_d5dfb02c-43e0-2099-e053-2995a90a8afb	50268-728	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20140923		ANDA	ANDA090624	AvPAK	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20251231
50268-732_0e762160-5dc1-7c4c-e063-6294a90a68fd	50268-732	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate Oral	SUSPENSION	ORAL	20200817		ANDA	ANDA209356	AvPAK	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20251231
50268-733_0e76247c-ec88-6abd-e063-6394a90a99d5	50268-733	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Gel		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20220509		UNAPPROVED DRUG OTHER		AvPAK	SODIUM FLUORIDE	5	mg/g			N	20251231
50268-738_df22addc-06e7-9804-e053-2a95a90a6c3f	50268-738	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200226		ANDA	ANDA210069	AvPAK	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50268-739_df22addc-06e7-9804-e053-2a95a90a6c3f	50268-739	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200318		ANDA	ANDA210069	AvPAK	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
50268-740_0e76286e-b432-865a-e063-6294a90ac761	50268-740	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20180117		ANDA	ANDA207405	AvPAK	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
50268-741_e699a31a-25fd-554b-e053-2a95a90a843a	50268-741	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20220819		ANDA	ANDA078110	AvPAK	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50268-742_e699a31a-25fd-554b-e053-2a95a90a843a	50268-742	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20220819		ANDA	ANDA078110	AvPAK	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50268-743_e699a31a-25fd-554b-e053-2a95a90a843a	50268-743	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20220819		ANDA	ANDA078110	AvPAK	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50268-744_e699a31a-25fd-554b-e053-2a95a90a843a	50268-744	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20220819		ANDA	ANDA078110	AvPAK	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50268-745_0e76247c-ec8a-6abd-e063-6394a90a99d5	50268-745	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate Oral	SUSPENSION	ORAL	20220831		ANDA	ANDA209356	AvPAK	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20251231
50268-746_0878ee58-3b55-40ef-e063-6294a90a5521	50268-746	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20231024		ANDA	ANDA203311	AvPAK	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50268-747_0878ee58-3b55-40ef-e063-6294a90a5521	50268-747	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20231024		ANDA	ANDA203311	AvPAK	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50268-748_0878ee58-3b55-40ef-e063-6294a90a5521	50268-748	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20231024		ANDA	ANDA203311	AvPAK	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50268-749_0878ee58-3b55-40ef-e063-6294a90a5521	50268-749	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20231024		ANDA	ANDA203311	AvPAK	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
50268-754_df22b298-4e70-c529-e053-2995a90a65f8	50268-754	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20141007		ANDA	ANDA079234	AvPAK	TORSEMIDE	5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50268-755_df22b298-4e70-c529-e053-2995a90a65f8	50268-755	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20141007		ANDA	ANDA079234	AvPAK	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50268-756_df22b298-4e70-c529-e053-2995a90a65f8	50268-756	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20141007		ANDA	ANDA079234	AvPAK	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50268-757_df22b298-4e70-c529-e053-2995a90a65f8	50268-757	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20141007		ANDA	ANDA079234	AvPAK	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
50268-758_0e762d44-1c09-90c4-e063-6294a90a4676	50268-758	HUMAN PRESCRIPTION DRUG	TENOFOVIR DISOPROXIL FUMARATE		tenofovir disoproxil fumarate	TABLET	ORAL	20200330		ANDA	ANDA090742	AvPAK	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20251231
50268-759_0e762ac7-26ba-854a-e063-6294a90a78e0	50268-759	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20170824		ANDA	ANDA076286	AvPAK	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
50268-760_0e762ac7-26ba-854a-e063-6294a90a78e0	50268-760	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20170824		ANDA	ANDA076286	AvPAK	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
50268-761_0e762779-4eda-82eb-e063-6294a90a0299	50268-761	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170323		ANDA	ANDA203691	AvPAK	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20251231
50268-762_0e762779-4eda-82eb-e063-6294a90a0299	50268-762	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170323		ANDA	ANDA203691	AvPAK	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20251231
50268-764_de5b2643-fb01-3d31-e053-2a95a90a28c4	50268-764	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200213		ANDA	ANDA075317	AvPAK	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-765_de5b2643-fb01-3d31-e053-2a95a90a28c4	50268-765	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200213		ANDA	ANDA075317	AvPAK	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-766_de5b2643-fb01-3d31-e053-2a95a90a28c4	50268-766	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200213		ANDA	ANDA075317	AvPAK	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-767_de5b2643-fb01-3d31-e053-2a95a90a28c4	50268-767	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200213		ANDA	ANDA075317	AvPAK	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
50268-772_0e7601e7-a14f-644a-e063-6394a90a5f80	50268-772	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET	ORAL	20220916		NDA AUTHORIZED GENERIC	NDA022430	AvPAK	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20251231
50268-774_0e762779-4edd-82eb-e063-6294a90a0299	50268-774	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET	ORAL	20150114		ANDA	ANDA090485	AvPAK	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
50268-776_0e76286e-b434-865a-e063-6294a90ac761	50268-776	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200221		ANDA	ANDA205253	AvPAK	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20251231
50268-779_089108d1-3f5b-5835-e063-6394a90a4195	50268-779	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20231019		ANDA	ANDA071456	AvPAK	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50268-780_089108d1-3f5b-5835-e063-6394a90a4195	50268-780	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20231019		ANDA	ANDA071457	AvPAK	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50268-787_0e764061-e7a8-6701-e063-6394a90a489f	50268-787	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET, FILM COATED	ORAL	20160727		ANDA	ANDA205166	AvPAK	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20251231
50268-788_de5ad748-6512-dce9-e053-2995a90a76ec	50268-788	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20140922		ANDA	ANDA090682	AvPAK	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50268-789_de5ad748-6512-dce9-e053-2995a90a76ec	50268-789	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20140922		ANDA	ANDA090682	AvPAK	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
50268-797_0e768c1f-3c98-c128-e063-6294a90a4463	50268-797	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20210219		ANDA	ANDA211301	AvPAK	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20251231
50268-803_e698e5c7-f4a6-2beb-e053-2995a90a256b	50268-803	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, COATED	ORAL	20220819		ANDA	ANDA206654	AvPAK	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50268-811_0e768c1f-3c9a-c128-e063-6294a90a4463	50268-811	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20210512		ANDA	ANDA077561	AvPAK	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-812_0e768c1f-3c9a-c128-e063-6294a90a4463	50268-812	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20210512		ANDA	ANDA077561	AvPAK	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-813_0e768c1f-3c9a-c128-e063-6294a90a4463	50268-813	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20210512		ANDA	ANDA077561	AvPAK	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-814_0e768c1f-3c9a-c128-e063-6294a90a4463	50268-814	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20210512		ANDA	ANDA077561	AvPAK	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20251231
50268-816_d5e0cf6a-8e99-6810-e053-2995a90a656c	50268-816	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20140702		ANDA	ANDA077869	AvPAK	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
50268-817_0e7688ae-79e3-7d4d-e063-6394a90a36a7	50268-817	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210427		ANDA	ANDA203332	AvPAK	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
50268-818_0e7688ae-79e3-7d4d-e063-6394a90a36a7	50268-818	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210427		ANDA	ANDA203332	AvPAK	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
50268-819_0e7688ae-79e3-7d4d-e063-6394a90a36a7	50268-819	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210427		ANDA	ANDA203332	AvPAK	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
50268-872_f5783d51-4c1d-e6ac-e053-2995a90a3525	50268-872	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20220713		UNAPPROVED DRUG OTHER		AvPAK	UREA	40	g/100g			N	20241231
50269-000_fc853a47-eb01-7942-e053-6394a90af228	50269-000	HUMAN OTC DRUG	MOTRIN IB		IBUPROFEN	TABLET, FILM COATED	ORAL	20181210		ANDA	ANDA077349	JC World Bell Wholesale Co., Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50269-005_09735fbf-7797-ca3f-e063-6294a90a9f94	50269-005	HUMAN OTC DRUG	Bayer Genuine Aspirin		ASPIRIN	TABLET	ORAL	20191030		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50269-006_09735fbf-77a9-ca3f-e063-6294a90a9f94	50269-006	HUMAN OTC DRUG	Bayer Genuine Aspirin		ASPIRIN	TABLET	ORAL	20191030		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50269-007_09735b2f-2b04-ca91-e063-6294a90a210a	50269-007	HUMAN OTC DRUG	Midol Complete		ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE	TABLET	ORAL	20191030		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50269-008_097353b6-41f6-cea1-e063-6294a90aea19	50269-008	HUMAN OTC DRUG	Tylenol Extra Strength		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20191115		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50269-009_09735b2f-2b17-ca91-e063-6294a90a210a	50269-009	HUMAN OTC DRUG	MIDOL COMPLETE		ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE	TABLET	ORAL	20191120		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50269-014_dc783f6a-05e5-1b8f-e053-2995a90a2f05	50269-014	HUMAN OTC DRUG	Zyrtec 1s Blister		CETIRIZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190120		NDA	NDA019835	JC World Bell Wholesale Co., Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50269-016_0cf37e5a-d9db-7b3f-e063-6394a90a60d1	50269-016	HUMAN OTC DRUG	Pepcid Complete		FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE	TABLET, CHEWABLE	ORAL	20200901		NDA	NDA020958	JC World Bell Wholesale Co., Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50269-017_097362c3-b18e-404b-e063-6394a90a1361	50269-017	HUMAN OTC DRUG	Afrin Original Nasal		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20201001		OTC MONOGRAPH DRUG	M012	JC World Bell Wholesale Co., Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
50269-019_dc78fa60-232b-fc15-e053-2995a90a706a	50269-019	HUMAN OTC DRUG	Zyrtec 2s Blister		CETIRIZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190120		NDA	NDA019835	JC World Bell Wholesale Co., Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50269-152_08b77458-da9b-a6b1-e063-6394a90a3fcb	50269-152	HUMAN OTC DRUG	ALKA SELTZER PLUS 2S BLISTER PACK		ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE	TABLET, EFFERVESCENT	ORAL	20191030	20240320	OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
50269-155_e60e66b0-5f87-4879-e053-2995a90a8c5a	50269-155	HUMAN OTC DRUG	Zantac 360 1 per blister 6 blisters		FAMOTIDINE	TABLET, FILM COATED	ORAL	20211001		ANDA	ANDA206531	JC World Bell Wholesale Co., Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50269-156_e6496ffd-fe5a-8b04-e053-2a95a90a8ced	50269-156	HUMAN OTC DRUG	Zantac 360 2 per blister 6 blisters		FAMOTIDINE	TABLET, FILM COATED	ORAL	20211001		ANDA	ANDA206531	JC World Bell Wholesale Co., Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50269-157_ff599824-85d9-0ed5-e053-6294a90a1c87	50269-157	HUMAN OTC DRUG	Advil		IBUPROFEN	TABLET, COATED	TOPICAL	19840518		NDA	NDA018989	JC World Bell Wholesale Co., Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50269-226_09738b82-8e10-7e4c-e063-6294a90a4dd0	50269-226	HUMAN OTC DRUG	Benadryl Ultra Tab		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180816		OTC MONOGRAPH DRUG	M012	JC World Bell Wholesale Co., Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50269-307_097362c3-b19f-404b-e063-6394a90a1361	50269-307	HUMAN OTC DRUG	Alka Seltzer Originial 1s Blister Pack		ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20191030		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50269-402_097353b6-4218-cea1-e063-6294a90aea19	50269-402	HUMAN OTC DRUG	Tylenol Cold Plus Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180920		OTC MONOGRAPH DRUG	M012	JC World Bell Wholesale Co., Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50269-449_09734a55-eff5-3b22-e063-6394a90ad2d2	50269-449	HUMAN OTC DRUG	Tylenol Extra Strength		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20180920		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50269-507_09735b2f-2b2a-ca91-e063-6294a90a210a	50269-507	HUMAN OTC DRUG	Tylenol Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180920		OTC MONOGRAPH DRUG	M012	JC World Bell Wholesale Co., Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50269-608_09af5277-5a19-3c72-e063-6294a90a704d	50269-608	HUMAN OTC DRUG	Tylenol PM		ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180816		OTC MONOGRAPH DRUG	M013	JC World Bell Wholesale Co., Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50289-3250_f1e9a470-0dbf-4ff3-e053-2a95a90acd77	50289-3250	HUMAN OTC DRUG	AER	Pre-moistened Witch Hazel Pad	Witch Hazel	SOLUTION	RECTAL; TOPICAL	20180628		OTC MONOGRAPH FINAL	M015	Birchwood Laboratories LLC	WITCH HAZEL	500	mg/mL			N	20241231
50289-9250_f1e99045-dfe8-8de0-e053-2a95a90a9add	50289-9250	HUMAN OTC DRUG	B-SURE Traveler Towelette		B-SURE Traveler	SOLUTION	RECTAL; TOPICAL	20200120		OTC MONOGRAPH FINAL	M015	Birchwood Laboratories LLC	WITCH HAZEL	.5	g/g			N	20241231
50322-003_0801e096-6b72-deaa-e063-6294a90acfe7	50322-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20090101		NDA	NDA205866	C & C Oxygen Company	NITROGEN	990	mL/L			N	20241231
50322-005_0801cd99-a4af-262a-e063-6394a90ae99a	50322-005	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091210		NDA	NDA205865	C&C Oxygen Company	OXYGEN	990	mL/L			N	20241231
50332-0043_7c34c98f-e15e-4c7b-bd17-ab51f167672f	50332-0043	HUMAN OTC DRUG	WOUND WIPES		benzalkonium chloride	SWAB	TOPICAL	19740101		OTC MONOGRAPH NOT FINAL	part333A	HART Health	BENZALKONIUM CHLORIDE	.0013	g/g			N	20241231
50332-0047_eb67274e-2749-4311-99b5-fbd249c82c26	50332-0047	HUMAN OTC DRUG	PVP Iodine		Povidone-Iodine	SWAB	TOPICAL	19740401		OTC MONOGRAPH NOT FINAL	part333A	HART Health	POVIDONE-IODINE	.1	g/g			N	20241231
50332-0103_59312948-c3b0-4ea5-b84c-57fa694d4464	50332-0103	HUMAN OTC DRUG	CETAFEN		ACETAMINOPHEN	TABLET	ORAL	19860604		OTC MONOGRAPH NOT FINAL	part343	HART Health	ACETAMINOPHEN	325	mg/1			N	20241231
50332-0126_e0d2dc86-581f-4401-987b-cb8fbe7c6caf	50332-0126	HUMAN OTC DRUG	Sudo-Tab PE		phenylephrine hcl	TABLET	ORAL	20051003		OTC MONOGRAPH FINAL	part341	HART Health	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50332-0130_7c3b7649-6dc8-475b-b3a4-fec092ce6fe6	50332-0130	HUMAN OTC DRUG	PROPRINAL		Ibuprofen Capsules 200 mg	CAPSULE, LIQUID FILLED	ORAL	20170111		ANDA	ANDA079205	HART Health	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50332-0140_03734058-7c87-4154-b207-6e30b2b608db	50332-0140	HUMAN OTC DRUG	BACKPRIN		Magnesium Salicylate Tetrahydrate	TABLET, FILM COATED	ORAL	20230109		OTC MONOGRAPH NOT FINAL	part343	HART Health	MAGNESIUM SALICYLATE	580	mg/1			N	20241231
50332-0141_306e7e60-b982-4cac-9ce8-139debfc9b89	50332-0141	HUMAN OTC DRUG	CETAFEN COUGH and COLD		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl , Guaifenesin, ,	TABLET, FILM COATED	ORAL	20230109		OTC MONOGRAPH FINAL	part341	HART Health	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50332-0143_e50f419b-86aa-4038-b8c1-a0034b3ff560	50332-0143	HUMAN OTC DRUG	EXAPRIN-AC		Aspirin,Caffeine	TABLET, FILM COATED	ORAL	20230109		OTC MONOGRAPH NOT FINAL	part343	HART Health	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50332-0145_63551507-9181-47bb-97fb-d3e50e9ad15b	50332-0145	HUMAN OTC DRUG	FEM-PRIN		Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20230109		OTC MONOGRAPH NOT FINAL	part343	HART Health	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
50332-0146_91fce2fe-e6e3-4ad5-b95e-fc622624e8d5	50332-0146	HUMAN OTC DRUG	THORACOL		Honey Lemon Cough Drops	LOZENGE	ORAL	20230109		OTC MONOGRAPH FINAL	part341	HART Health	MENTHOL	9	mg/1			N	20241231
50332-0147_520b9a82-6d31-46f8-85c0-0725655784ee	50332-0147	HUMAN OTC DRUG	THERASTAT, CHERRY		Cherry Cough Drops	LOZENGE	ORAL	20230109		OTC MONOGRAPH FINAL	part341	HART Health	MENTHOL	7	mg/1			N	20241231
50332-0148_803373ec-fd73-4b58-9068-7df3237b2c30	50332-0148	HUMAN OTC DRUG	CETAFEN		ACETAMINOPHEN	TABLET	ORAL	19860604		OTC MONOGRAPH NOT FINAL	part343	HART Health	ACETAMINOPHEN	325	mg/1			N	20241231
50332-0149_df467d13-9a76-4a87-b33a-1d4c9427ce7b	50332-0149	HUMAN OTC DRUG	CETAFEN EXTRA		acetaminophen	TABLET	ORAL	19900105		OTC MONOGRAPH NOT FINAL	part343	HART Health	ACETAMINOPHEN	500	mg/1			N	20241231
50332-0151_9e682eac-717d-4bb2-910e-6ed1a5605fca	50332-0151	HUMAN OTC DRUG	NUTRALOX		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	19870120		OTC MONOGRAPH FINAL	part331	HART Health	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
50332-0201_1dd8d3d9-ac44-4420-b573-47712c6effdf	50332-0201	HUMAN OTC DRUG	Eye Clean		Eye Wash	LIQUID	OPHTHALMIC	19000101		OTC MONOGRAPH FINAL	part349	HART Health	WATER	98.3	mL/100mL			N	20241231
50382-015_ee82ed37-f0ed-5b67-e053-2a95a90ab91c	50382-015	HUMAN OTC DRUG	Muscle Rub		MENTHOL, UNSPECIFIED FORM and Methyl Salicylate	CREAM	TOPICAL	20120601		OTC MONOGRAPH NOT FINAL	part348	Galentic Pharma (India) Private Limited	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 150	mg/g; mg/g			N	20241231
50382-016_ee83231b-d346-b82c-e053-2a95a90a490a	50382-016	HUMAN OTC DRUG	Muscle and Joint		Menthol, Unspecified Form	GEL	TOPICAL	20120601		OTC MONOGRAPH NOT FINAL	part348	Galentic Pharma (India) Private Limited	MENTHOL, UNSPECIFIED FORM	25	mg/g			N	20241231
50382-020_ee857dfc-abc7-2bf8-e053-2a95a90acc96	50382-020	HUMAN OTC DRUG	Burn		Lidocaine Hydrochloride	GEL	TOPICAL	20170907		OTC MONOGRAPH NOT FINAL	part348	Galentic Pharma (India) Private Limited	LIDOCAINE HYDROCHLORIDE	20	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50382-022_f3a2f68b-6f5e-9180-e053-2a95a90abdfe	50382-022	HUMAN OTC DRUG	Burn		Lidocaine Hydrochloride and Benzalkonium Chloride	CREAM	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part348	Galentic Pharma (India) Private Limited	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50383-241_a9bd3532-5fcb-4811-95f6-d811eae8cd29	50383-241	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20120228		ANDA	ANDA090601	Akorn	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50383-261_7265e092-2ed5-4b1a-83e8-e3bd2cfb10f4	50383-261	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20190201		NDA	NDA202667	Akorn	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50383-287_91c3b011-d7c5-4638-9062-f2b39cc3cddf	50383-287	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20160107	20250331	ANDA	ANDA204431	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	
50383-294_91c3b011-d7c5-4638-9062-f2b39cc3cddf	50383-294	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		buprenorphine hydrochloride and naloxone hydrochloride	TABLET	SUBLINGUAL	20160107	20250331	ANDA	ANDA204431	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	
50383-356_0196a8e5-bda8-4b6c-9f59-dc5fa2e16e0d	50383-356	HUMAN PRESCRIPTION DRUG	Lactulose		Lactulose	SOLUTION	ORAL	19950703		ANDA	ANDA074076	Akorn	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50383-357_0196a8e5-bda8-4b6c-9f59-dc5fa2e16e0d	50383-357	HUMAN PRESCRIPTION DRUG	Lactulose		Lactulose	SOLUTION	ORAL	19950703		ANDA	ANDA074076	Akorn	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50383-363_c672230f-307a-47c6-885d-4e9bea28b308	50383-363	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19950710		ANDA	ANDA040014	Akorn	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50383-705_9ddced20-77c8-4183-b223-4d0389bef41a	50383-705	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	CONCENTRATE	ORAL	20120130		ANDA	ANDA200169	Akorn	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50383-775_c672230f-307a-47c6-885d-4e9bea28b308	50383-775	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19950710		ANDA	ANDA040014	Akorn	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50383-779_0196a8e5-bda8-4b6c-9f59-dc5fa2e16e0d	50383-779	HUMAN PRESCRIPTION DRUG	Lactulose		Lactulose	SOLUTION	ORAL	19950703		ANDA	ANDA074076	Akorn	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50383-804_6994efab-2353-4868-bcde-c3ee3a2b1e8e	50383-804	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Codeine Phosphate		Promethazine Hydrochloride and Codeine Phosphate	SOLUTION	ORAL	19970826		ANDA	ANDA040151	Akorn	CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE	10; 6.25	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]	CV	N	20241231
50383-805_9d5b76d0-633e-44f1-b1e1-63efab89626d	50383-805	HUMAN PRESCRIPTION DRUG	promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate		promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate	SOLUTION	ORAL	20150616		ANDA	ANDA040674	Akorn	CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE	10; 5; 6.25	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]	CV	N	20241231
50383-912_390eb078-fcae-43b1-bcef-14d452cea368	50383-912	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION	TOPICAL	20180926		ANDA	ANDA203051	Akorn	BIMATOPROST	3	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
50383-913_f448e568-540e-4027-be47-e7a5aa1051d3	50383-913	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SOLUTION	ORAL	20160316		ANDA	ANDA201995	Akorn	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50383-924_dcc1b802-6d4f-4208-bd8c-241103757c6c	50383-924	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride		buprenorphine hydrochloride	TABLET	SUBLINGUAL	20100924	20250331	ANDA	ANDA090622	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	
50383-930_dcc1b802-6d4f-4208-bd8c-241103757c6c	50383-930	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride		buprenorphine hydrochloride	TABLET	SUBLINGUAL	20100924	20250331	ANDA	ANDA090622	Akorn Operating Company LLC (dba Akorn)	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	
50383-943_6f46b6ea-b467-46c0-b3e3-1fb14e8cafd1	50383-943	HUMAN PRESCRIPTION DRUG	Olopatadine Hydrochloride		Olopatadine Hydrochloride Nasal	SPRAY, METERED	NASAL	20200929		ANDA	ANDA213757	Akorn	OLOPATADINE HYDROCHLORIDE	665	ug/1	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
50390-001_08370288-7313-b684-e063-6294a90ad541	50390-001	HUMAN OTC DRUG	Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Light/Medium		ENSULIZOLE,OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	ENSULIZOLE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	20; 55; 5; 8.8; 98	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-002_08377e5c-ec80-b444-e063-6394a90ab72a	50390-002	HUMAN OTC DRUG	Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Medium		ENSULIZOLE,OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	ENSULIZOLE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	20; 55; 5; 8.8; 98	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-003_08379ef8-26f0-2bfd-e063-6394a90afb76	50390-003	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation SPF 15 Broad Spectrum Sunscreen		TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-004_0837939a-f051-8ac1-e063-6294a90aa342	50390-004	HUMAN OTC DRUG	Artistry Beauty Balm Perfecting Primer SPF 35 Broad Spectrum Sunscreen		ENSULIZOLE, OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20150505		OTC MONOGRAPH DRUG	M020	Amway Corp	ENSULIZOLE; OCTINOXATE; ZINC OXIDE	20; 50; 54.9	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-010_08375f9c-9f50-5f4a-e063-6294a90a128f	50390-010	HUMAN OTC DRUG	Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Sunscreen Deep		ENSULIZOLE, OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	ENSULIZOLE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	20; 55; 5; 84; 98	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-011_0837488b-c5e4-34c6-e063-6294a90aca13	50390-011	HUMAN OTC DRUG	Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Med/Deep		ENSULIZOLE, OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	ENSULIZOLE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	20; 55; 5; 84; 98	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-014_08381ab0-71c0-4fdd-e063-6394a90ab0cc	50390-014	HUMAN OTC DRUG	Artistry Hydro-V Sheer Weightless Foundation SPF 15 Broad Spectrum Sunscreen		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-108_0daad476-bd32-bd5d-e063-6394a90ac74a	50390-108	HUMAN OTC DRUG	ARTISTRY IDEAL RADIANCE UV Protect SPF 50 PLUS Broad Spectrum Sunscreen		OCTINOXATE, OCTISALATE, ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20130911		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	68; 45; 24.9; 126.6	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
50390-111_083830bb-0805-7b2c-e063-6394a90abfbe	50390-111	HUMAN OTC DRUG	ARTISTRY YOUTH XTEND Lifting Smoothing Foundation Broad Spectrum SPF 20 Sunscreen		OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-200_08383916-d50e-c45c-e063-6394a90a9247	50390-200	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Brule	L4W1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-201_08381c17-1961-7795-e063-6394a90adc81	50390-201	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Buff	L1W1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-202_08384958-7e3f-b793-e063-6294a90ae17d	50390-202	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Chablis	L1C1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-203_08384958-7e4e-b793-e063-6294a90ae17d	50390-203	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Chiffon	L2C1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-204_08384958-7e5d-b793-e063-6294a90ae17d	50390-204	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Cream	L1W2	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-205_08471877-6554-4d69-e063-6294a90a411c	50390-205	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Golden	L4N1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-206_08386388-013b-be49-e063-6294a90af2b1	50390-206	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Mink	L6W1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-207_08386ab6-b62f-065c-e063-6294a90ae4be	50390-207	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Ochre	L2N1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-208_08473d25-2569-0439-e063-6294a90ae294	50390-208	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Soleil	L3W1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-209_08474c0d-0149-3039-e063-6294a90a3f4f	50390-209	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Tawny	L3N1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-210_08478903-c72a-ff2f-e063-6394a90afd14	50390-210	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Walnut	L6N1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-211_08475d9f-992f-d267-e063-6394a90a9ed2	50390-211	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Cappuccino	L5W1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-212_08476cdd-0535-88bf-e063-6294a90ae80d	50390-212	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Caramel	L5N1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-213_0847655a-c069-2531-e063-6394a90aebc6	50390-213	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Natural	L2N2	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-214_084773d8-3806-03d7-e063-6294a90a5602	50390-214	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Plush	L3C1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-215_0847655a-c078-2531-e063-6394a90aebc6	50390-215	HUMAN OTC DRUG	Artistry Exact Fit Longwearing Foundation Shade Sand	L2W1	TITANIUM DIOXIDE	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Amway Corp	TITANIUM DIOXIDE	40.25	mg/mL			N	20241231
50390-216_084773d8-3815-03d7-e063-6294a90a5602	50390-216	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Shade Buff	L1W1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-217_084790b6-c35e-06db-e063-6294a90aae0f	50390-217	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Shade Caramel	L5N1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-218_08476cdd-0544-88bf-e063-6294a90ae80d	50390-218	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Shade Chablis	L1C1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-219_0847abcf-c452-e8d1-e063-6394a90a0433	50390-219	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Shade Chiffon	L2C1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-220_0847be1e-bac5-e5fc-e063-6394a90a8a26	50390-220	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Shade Golden	L4N1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-221_08476cdd-0553-88bf-e063-6294a90ae80d	50390-221	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Shade Ochre	L2N1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-222_0847abcf-c461-e8d1-e063-6394a90a0433	50390-222	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Sand	L2W1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-223_0847d1c1-ec5b-2599-e063-6394a90a109d	50390-223	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Shade Soleil	L3W1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-224_0847d369-49c4-6807-e063-6294a90afc84	50390-224	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Tawny	L3N1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-225_0847d369-49d3-6807-e063-6294a90afc84	50390-225	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Walnut	L6N1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-226_0847d1c1-ec4c-2599-e063-6394a90a109d	50390-226	HUMAN OTC DRUG	Artistry Hydra V Sheer Weightless Foundation Plush	L3C1	OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20170923		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; ZINC OXIDE	40; 27.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50390-227_0847d369-49e2-6807-e063-6294a90afc84	50390-227	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Buff	L1W1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-228_085adac8-08b0-87c4-e063-6294a90ac2c2	50390-228	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Chablis	L1C1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-229_085adac8-08e1-87c4-e063-6294a90ac2c2	50390-229	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Cream	L1W2	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-230_085adac8-08d1-87c4-e063-6294a90ac2c2	50390-230	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Mink	L6W1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-231_085b50a9-68bd-d6e6-e063-6394a90a09be	50390-231	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Ochre	L2N1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-232_085b6df0-ddea-06ff-e063-6294a90abe0e	50390-232	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Sand	L2W1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-233_085ba286-d7e3-3b8f-e063-6394a90a39f7	50390-233	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Soleil	L3W1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-234_085b790a-0f48-e63b-e063-6394a90a0bbf	50390-234	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Tawny	L3N1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-235_085ba045-3c85-fb30-e063-6394a90a3491	50390-235	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Walnut	L6N1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-236_085b82b0-431c-ec55-e063-6294a90a8c37	50390-236	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Brule	L4W1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-237_085b8b5c-5045-362b-e063-6394a90a12b3	50390-237	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Cappuccino	L5W1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-238_085bb064-0a17-cb0d-e063-6294a90a16a1	50390-238	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Caramel	L5N1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-239_085b50a9-68d7-d6e6-e063-6394a90a09be	50390-239	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Chiffon	L2C1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-240_085bbc1a-02f3-ea11-e063-6394a90a3391	50390-240	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Golden	L4N1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-241_085bb064-0a26-cb0d-e063-6294a90a16a1	50390-241	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Natural	L2N2	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50390-242_085bc532-b23a-8f18-e063-6394a90a03ae	50390-242	HUMAN OTC DRUG	Artistry Youth Xtend Lifting Smoothing Foundation Shade Plush	L3C1	OCTINOXATE, OXYBENZONE	CREAM	TOPICAL	20130506		OTC MONOGRAPH DRUG	M020	Amway Corp	OCTINOXATE; OXYBENZONE	75; 5	mg/mL; mg/mL			N	20241231
50402-100_66171a45-4f8f-44f7-b8b0-03bec093d838	50402-100	HUMAN PRESCRIPTION DRUG	IDkit HP ONE		citric acid anhydrous and 13C urea	SOLUTION	ORAL	20091228		NDA	NDA021314	Meridian Bioscience Israel Ltd	CITRIC ACID MONOHYDRATE; UREA C-13	4; 75	g/1; mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Carbon Radioisotopes [CS], Decreased Coagulation Factor Activity [PE], Helicobacter pylori Diagnostic [EPC], Radioactive Tracers [CS], Urea [CS]		N	20241231
50405-016_d178c48d-e53a-496c-9d70-5ced4894f952	50405-016	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	SPRAY	TOPICAL	20200910		OTC MONOGRAPH NOT FINAL	part333A	SOHM Inc	ISOPROPYL ALCOHOL	67	mL/100mL			N	20241231
50405-300_f38a03a2-39ba-44ec-9f1d-b63e5f11ce58	50405-300	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA079042	SOHM, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50405-301_f38a03a2-39ba-44ec-9f1d-b63e5f11ce58	50405-301	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA079042	SOHM, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50405-302_f38a03a2-39ba-44ec-9f1d-b63e5f11ce58	50405-302	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA079042	SOHM, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50405-303_f38a03a2-39ba-44ec-9f1d-b63e5f11ce58	50405-303	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA079042	SOHM, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50405-800_d639c140-a4bf-41cd-8ca3-45ee38a2c0b5	50405-800	HUMAN PRESCRIPTION DRUG	Hydroquinone 4%		Hydroquinone	CREAM	TOPICAL	20230605		UNAPPROVED DRUG OTHER		SOHM, Inc.	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
50405-850_33c53704-fdee-4209-ac08-24ab0e8ebfd5	50405-850	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10 % and Sulfur 5 % Cleanser		Sodium Sulfacetamide and Sulfur	LIQUID	TOPICAL	20230430		UNAPPROVED DRUG OTHER		SOHM, Inc	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50405-851_67acba09-6267-4139-ad2b-e6b7849752a9	50405-851	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10 % and Sulfur 2 % Cleanser		Sodium Sulfacetamide and Sulfur	LOTION	TOPICAL	20230503		UNAPPROVED DRUG OTHER		SOHM, Inc	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50405-852_03870d74-89a9-4f1d-8852-f3aa9c71daf4	50405-852	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9.8 % and Sulfur 4.8 % Cleanser		Sodium Sulfacetamide and Sulfur	LOTION	TOPICAL	20230503		UNAPPROVED DRUG OTHER		SOHM, Inc	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
50419-171_e41b7882-eaee-4c0d-8117-2203fe3cd73f	50419-171	HUMAN PRESCRIPTION DRUG	Stivarga		regorafenib	TABLET, FILM COATED	ORAL	20120927		NDA	NDA203085	Bayer HealthCare Pharmaceuticals Inc.	REGORAFENIB	40	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A9 Inhibitors [MoA]		N	20241231
50419-208_72b1b15b-ef39-4039-a0b3-596d12182db2	50419-208	HUMAN PRESCRIPTION DRUG	Xofigo		Radium Ra 223 dichloride	INJECTION	INTRAVENOUS	20130520		NDA	NDA203971	Bayer HealthCare Pharmaceuticals Inc.	RADIUM RA-223 DICHLORIDE	30	uCi/mL	Radioactive alpha-Particle Emitting Therapeutic Agent [EPC], alpha-Particle Emitting Activity [MoA]		N	20241231
50419-250_b98e0281-74d7-4e33-addb-87b59226b31e	50419-250	HUMAN PRESCRIPTION DRUG	Adempas		riociguat	TABLET, FILM COATED	ORAL	20131008		NDA	NDA204819	Bayer HealthCare Pharmaceuticals Inc.	RIOCIGUAT	.5	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
50419-251_b98e0281-74d7-4e33-addb-87b59226b31e	50419-251	HUMAN PRESCRIPTION DRUG	Adempas		riociguat	TABLET, FILM COATED	ORAL	20131008		NDA	NDA204819	Bayer HealthCare Pharmaceuticals Inc.	RIOCIGUAT	1	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
50419-252_b98e0281-74d7-4e33-addb-87b59226b31e	50419-252	HUMAN PRESCRIPTION DRUG	Adempas		riociguat	TABLET, FILM COATED	ORAL	20131008		NDA	NDA204819	Bayer HealthCare Pharmaceuticals Inc.	RIOCIGUAT	1.5	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
50419-253_b98e0281-74d7-4e33-addb-87b59226b31e	50419-253	HUMAN PRESCRIPTION DRUG	Adempas		riociguat	TABLET, FILM COATED	ORAL	20131008		NDA	NDA204819	Bayer HealthCare Pharmaceuticals Inc.	RIOCIGUAT	2	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
50419-254_b98e0281-74d7-4e33-addb-87b59226b31e	50419-254	HUMAN PRESCRIPTION DRUG	Adempas		riociguat	TABLET, FILM COATED	ORAL	20131008		NDA	NDA204819	Bayer HealthCare Pharmaceuticals Inc.	RIOCIGUAT	2.5	mg/1	Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]		N	20241231
50419-320_8e6b4ee4-6dc0-49c0-959e-3cfc0cb4e800	50419-320	HUMAN PRESCRIPTION DRUG	EOVIST		Gadoxetate Disodium	INJECTION, SOLUTION	INTRAVENOUS	20080703		NDA	NDA022090	Bayer HealthCare Pharmaceuticals Inc.	GADOXETATE DISODIUM	181.43	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
50419-325_ae710aa9-4b20-449a-9860-3c2f7c18fe23	50419-325	HUMAN PRESCRIPTION DRUG	Gadavist		gadobutrol	INJECTION	INTRAVENOUS	20110314		NDA	NDA201277	Bayer HealthCare Pharmaceuticals Inc.	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
50419-325_afc7ff32-c70b-43d5-8826-7c6d2bbc163d	50419-325	HUMAN PRESCRIPTION DRUG	Gadavist		gadobutrol	INJECTION	INTRAVENOUS	20110314		NDA	NDA201277	Bayer HealthCare Pharmaceuticals Inc.	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
50419-325_d3c2beb0-18cd-499c-9122-11e83f0d658a	50419-325	HUMAN PRESCRIPTION DRUG	Gadavist		gadobutrol	INJECTION	INTRAVENOUS	20110314		NDA	NDA201277	Bayer HealthCare Pharmaceuticals Inc.	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
50419-344_dc7d3ecf-fbd3-4a06-878b-88e5b36441fc	50419-344	HUMAN PRESCRIPTION DRUG	Ultravist		iopromide	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20091230		NDA	NDA020220	Bayer HealthCare Pharmaceuticals Inc.	IOPROMIDE	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
50419-346_dc7d3ecf-fbd3-4a06-878b-88e5b36441fc	50419-346	HUMAN PRESCRIPTION DRUG	Ultravist		iopromide	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20091230		NDA	NDA020220	Bayer HealthCare Pharmaceuticals Inc.	IOPROMIDE	370	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
50419-347_dc7d3ecf-fbd3-4a06-878b-88e5b36441fc	50419-347	HUMAN PRESCRIPTION DRUG	Ultravist		iopromide	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20220608		NDA	NDA020220	Bayer HealthCare Pharmaceuticals Inc.	IOPROMIDE	300	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
50419-348_dc7d3ecf-fbd3-4a06-878b-88e5b36441fc	50419-348	HUMAN PRESCRIPTION DRUG	Ultravist		iopromide	INJECTION	INTRA-ARTERIAL; INTRAVENOUS	20220608		NDA	NDA020220	Bayer HealthCare Pharmaceuticals Inc.	IOPROMIDE	370	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
50419-385_209c53a5-83dd-4eae-9f6f-66130657f8e7	50419-385	HUMAN PRESCRIPTION DRUG	ALIQOPA		copanlisib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170914		NDA	NDA209936	Bayer HealthCare Pharmaceuticals Inc.	COPANLISIB	15	mg/mL	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
50419-390_3e340753-c526-4748-9e8a-d99e3511d7ef	50419-390	HUMAN PRESCRIPTION DRUG	VITRAKVI		LAROTRECTINIB	CAPSULE	ORAL	20190726		NDA	NDA210861	Bayer HealthCare Pharmaceuticals Inc.	LAROTRECTINIB	25	mg/1	Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]		N	20241231
50419-391_3e340753-c526-4748-9e8a-d99e3511d7ef	50419-391	HUMAN PRESCRIPTION DRUG	VITRAKVI		LAROTRECTINIB	CAPSULE	ORAL	20190726		NDA	NDA210861	Bayer HealthCare Pharmaceuticals Inc.	LAROTRECTINIB	100	mg/1	Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]		N	20241231
50419-392_3e340753-c526-4748-9e8a-d99e3511d7ef	50419-392	HUMAN PRESCRIPTION DRUG	VITRAKVI		LAROTRECTINIB	SOLUTION, CONCENTRATE	OROPHARYNGEAL	20190726		NDA	NDA211710	Bayer HealthCare Pharmaceuticals Inc.	LAROTRECTINIB	20	mg/mL	Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]		N	20241231
50419-393_3e340753-c526-4748-9e8a-d99e3511d7ef	50419-393	HUMAN PRESCRIPTION DRUG	VITRAKVI		LAROTRECTINIB	SOLUTION, CONCENTRATE	OROPHARYNGEAL	20221206		NDA	NDA211710	Bayer HealthCare Pharmaceuticals Inc.	LAROTRECTINIB	20	mg/mL	Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]		N	20241231
50419-395_78565601-df32-45a6-9d08-ac84738c8963	50419-395	HUMAN PRESCRIPTION DRUG	NUBEQA		darolutamide	TABLET, FILM COATED	ORAL	20190731		NDA	NDA212099	Bayer HealthCare Pharmaceuticals Inc.	DAROLUTAMIDE	300	mg/1			N	20241231
50419-402_0940c8a8-b5cd-4ba6-9fc8-ca4f55ae3973	50419-402	HUMAN PRESCRIPTION DRUG	Yasmin		drospirenone and ethinyl estradiol	KIT		20010511		NDA	NDA021098	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50419-403_4908c96d-9aaa-467f-93aa-332dbb3bc715	50419-403	HUMAN PRESCRIPTION DRUG	Safyral		Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium	KIT		20120213		NDA	NDA022574	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50419-405_bd3baa73-1d24-49e2-9120-fa7c82f3af90	50419-405	HUMAN PRESCRIPTION DRUG	Yaz		Drospirenone and ethinyl estradiol	KIT		20060316		NDA	NDA021676	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50419-407_17511575-fbd6-4764-9759-bf51305903ae	50419-407	HUMAN PRESCRIPTION DRUG	Beyaz		Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium	KIT		20101007		NDA	NDA022532	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50419-409_9829fdd3-fb12-4039-8c6e-de634fe5b6db	50419-409	HUMAN PRESCRIPTION DRUG	Natazia		estradiol valerate and estradiol valerate/dienogest	KIT		20100506		NDA	NDA022252	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50419-422_157ce370-1ff2-4a01-88bf-a1117aeb8c19	50419-422	HUMAN PRESCRIPTION DRUG	Skyla		Levonorgestrel	INTRAUTERINE DEVICE	INTRAUTERINE	20130111		NDA	NDA203159	Bayer HealthCare Pharmaceuticals Inc.	LEVONORGESTREL	13.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
50419-423_c252476c-7dc8-4ef5-a7c7-380b8016ca27	50419-423	HUMAN PRESCRIPTION DRUG	Mirena		Levonorgestrel	INTRAUTERINE DEVICE	INTRAUTERINE	20091001		NDA	NDA021225	Bayer HealthCare Pharmaceuticals Inc.	LEVONORGESTREL	52	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
50419-424_610ebea6-16a0-4ba5-b621-ac47e3baf07c	50419-424	HUMAN PRESCRIPTION DRUG	Kyleena		Levonorgestrel	INTRAUTERINE DEVICE	INTRAUTERINE	20160919		NDA	NDA208224	Bayer HealthCare Pharmaceuticals Inc.	LEVONORGESTREL	19.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
50419-451_7809d35a-3b56-4234-9c63-1666d40bf09d	50419-451	HUMAN PRESCRIPTION DRUG	Climara		Estradiol	PATCH	TRANSDERMAL	19941222		NDA	NDA020375	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50419-452_7809d35a-3b56-4234-9c63-1666d40bf09d	50419-452	HUMAN PRESCRIPTION DRUG	Climara		Estradiol	PATCH	TRANSDERMAL	19941222		NDA	NDA020375	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50419-453_7809d35a-3b56-4234-9c63-1666d40bf09d	50419-453	HUMAN PRESCRIPTION DRUG	Climara		Estradiol	PATCH	TRANSDERMAL	19980323		NDA	NDA020375	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50419-454_7809d35a-3b56-4234-9c63-1666d40bf09d	50419-454	HUMAN PRESCRIPTION DRUG	Climara		Estradiol	PATCH	TRANSDERMAL	19990305		NDA	NDA020375	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50419-455_546794ef-9847-480e-a12a-e14f0c9575de	50419-455	HUMAN PRESCRIPTION DRUG	Menostar		estradiol	PATCH	TRANSDERMAL	20040608		NDA	NDA020375	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL	14	ug/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50419-456_7809d35a-3b56-4234-9c63-1666d40bf09d	50419-456	HUMAN PRESCRIPTION DRUG	Climara		Estradiol	PATCH	TRANSDERMAL	20030527		NDA	NDA020375	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50419-459_7809d35a-3b56-4234-9c63-1666d40bf09d	50419-459	HUMAN PRESCRIPTION DRUG	Climara		Estradiol	PATCH	TRANSDERMAL	20080103		NDA	NDA020375	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL	.06	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
50419-482_23b483a9-7331-4d98-be0a-9ce4d37b671f	50419-482	HUMAN PRESCRIPTION DRUG	Angeliq		drospirenone and estradiol	TABLET, FILM COATED	ORAL	20120229		NDA	NDA021355	Bayer HealthCare Pharmaceuticals Inc.	DROSPIRENONE; ESTRADIOL	.25; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50419-483_23b483a9-7331-4d98-be0a-9ce4d37b671f	50419-483	HUMAN PRESCRIPTION DRUG	Angeliq		drospirenone and estradiol	TABLET, FILM COATED	ORAL	20051128		NDA	NDA021355	Bayer HealthCare Pharmaceuticals Inc.	DROSPIRENONE; ESTRADIOL	.5; 1	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50419-488_57a88370-996d-4c12-bd30-c934b65b9c9d	50419-488	HUMAN PRESCRIPTION DRUG	Nexavar		sorafenib	TABLET, FILM COATED	ORAL	20051220		NDA	NDA021923	Bayer HealthCare Pharmaceuticals Inc.	SORAFENIB	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
50419-489_57a88370-996d-4c12-bd30-c934b65b9c9d	50419-489	HUMAN PRESCRIPTION DRUG	Nexavar		sorafenib	TABLET, FILM COATED	ORAL	20231002		NDA	NDA021923	Bayer HealthCare Pharmaceuticals Inc.	SORAFENIB	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
50419-491_f9c315d5-835d-4499-b4da-83dbd3dc696a	50419-491	HUMAN PRESCRIPTION DRUG	Climara Pro		Estradiol and Levonorgestrel	PATCH	TRANSDERMAL	20031121		NDA	NDA021258	Bayer HealthCare Pharmaceuticals Inc.	ESTRADIOL; LEVONORGESTREL	.045; .015	mg/d; mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
50419-524_8028db70-d490-4d61-94ad-0220b25df27a	50419-524	HUMAN PRESCRIPTION DRUG	Betaseron		interferon beta-1b	KIT		20090709		BLA	BLA103471	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50419-540_a02ada67-06d1-47f8-bdc9-8b8e692ff6b4	50419-540	HUMAN PRESCRIPTION DRUG	Kerendia		finerenone	TABLET, FILM COATED	ORAL	20210709		NDA	NDA215341	Bayer Healthcare Pharmaceuticals Inc.	FINERENONE	10	mg/1	Mineralocorticoid Receptor Antagonists [MoA], Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]		N	20241231
50419-541_a02ada67-06d1-47f8-bdc9-8b8e692ff6b4	50419-541	HUMAN PRESCRIPTION DRUG	Kerendia		finerenone	TABLET, FILM COATED	ORAL	20210709		NDA	NDA215341	Bayer Healthcare Pharmaceuticals Inc.	FINERENONE	20	mg/1	Mineralocorticoid Receptor Antagonists [MoA], Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]		N	20241231
50419-747_6a15349c-a747-4413-b00a-4eaa99087545	50419-747	HUMAN PRESCRIPTION DRUG	Biltricide		praziquantel	TABLET, FILM COATED	ORAL	20110421		NDA	NDA018714	Bayer HealthCare Pharmaceuticals Inc.	PRAZIQUANTEL	600	mg/1	Anthelmintic [EPC]		N	20251231
50419-750_379d893b-36ba-4d44-bb35-2eddbc49dfd3	50419-750	HUMAN PRESCRIPTION DRUG	LAMPIT		nifurtimox	TABLET, FILM COATED	ORAL	20201001		NDA	NDA213464	Bayer Healthcare Pharmaceuticals INC.	NIFURTIMOX	30	mg/1			N	20241231
50419-751_379d893b-36ba-4d44-bb35-2eddbc49dfd3	50419-751	HUMAN PRESCRIPTION DRUG	LAMPIT		nifurtimox	TABLET, FILM COATED	ORAL	20201001		NDA	NDA213464	Bayer Healthcare Pharmaceuticals INC.	NIFURTIMOX	120	mg/1			N	20241231
50419-754_d4987631-55b6-49e8-9281-3fa55a7c13b3	50419-754	HUMAN PRESCRIPTION DRUG	Cipro		ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	19871022		NDA	NDA019537	Bayer HealthCare Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50419-758_d4987631-55b6-49e8-9281-3fa55a7c13b3	50419-758	HUMAN PRESCRIPTION DRUG	Cipro		ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	19871022		NDA	NDA019537	Bayer HealthCare Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
50419-773_d4987631-55b6-49e8-9281-3fa55a7c13b3	50419-773	HUMAN PRESCRIPTION DRUG	Cipro		ciprofloxacin	KIT		19970926		NDA	NDA020780	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50419-777_d4987631-55b6-49e8-9281-3fa55a7c13b3	50419-777	HUMAN PRESCRIPTION DRUG	Cipro		ciprofloxacin	KIT		19970926		NDA	NDA020780	Bayer HealthCare Pharmaceuticals Inc.						N	20241231
50425-010_09315b3f-7408-3611-e063-6394a90aee4a	50425-010	HUMAN OTC DRUG	Scrub Care Povidone Iodine Cleansing Scrub		povidone iodine	SOLUTION	TOPICAL	20010101	20240229	OTC MONOGRAPH DRUG	505G(a)(3)	CareFusion 213 LLC	POVIDONE-IODINE	7.5	mg/mL			N	
50425-011_093126dc-cd2f-166a-e063-6394a90a1ea2	50425-011	HUMAN OTC DRUG	Scrub Care Povidone Iodine Topical Paint		povidone iodine	SOLUTION	TOPICAL	20010101	20240229	OTC MONOGRAPH DRUG	505G(a)(3)	CareFusion 213 LLC	POVIDONE-IODINE	10	mg/mL			N	
50428-0031_0865bc64-11f1-1b4c-e063-6294a90aa073	50428-0031	HUMAN OTC DRUG	Safety 1st Social Safety Pack		ALCOHOL	KIT		20200701		OTC MONOGRAPH DRUG	505G(a)(3)	Dorel Juvenile Inc.						N	20241231
50428-0033_086580f8-62f2-c786-e063-6294a90a2cc3	50428-0033	HUMAN OTC DRUG	Safety 1st Oh Sh t Kit		ALCOHOL	KIT		20200701		OTC MONOGRAPH DRUG	505G(a)(3)	Dorel Juvenile Inc.						N	20241231
50435-200_f68ed878-971b-4e0e-e053-2995a90a9ccc	50435-200	HUMAN OTC DRUG	Royal Alcohol Cleansing		ISOPROPYL ALCOHOL	PATCH	TOPICAL	20171111		OTC MONOGRAPH NOT FINAL	part333A	Filo America	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
50436-0015_26a41379-2c7c-4f7a-b953-2157aee9625b	50436-0015	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	Unit Dose Services	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50436-0250_dbfd6ac5-be2c-4a60-96da-4fa5bbd15f88	50436-0250	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20120815		ANDA	ANDA040876	Unit Dose Services	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50436-0323_2940ae96-4d64-4431-a535-8bf0ee258f4d	50436-0323	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	UNIT DOSE SERVICES	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50436-0356_4c28faab-0b44-42e8-b1a4-5db1eda9b41f	50436-0356	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20160428		ANDA	ANDA206298	UNIT DOSE SERVICES.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50436-0357_0017bd4c-60d3-4841-83ad-d0529662c355	50436-0357	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20160519		ANDA	ANDA206493	UNIT DOSE SERVICES.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50436-0401_972ebdd6-5d3d-4921-a63a-eb6d024210d6	50436-0401	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA090478	UNIT DOSE SERVICES	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50436-0402_0871a160-f827-45f1-9ae0-9b89235bb136	50436-0402	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	UNIT DOSE SERVICES	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50436-0474_ee1e8867-90c3-4ad2-a8ec-abde77bab2c5	50436-0474	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	OINTMENT	TOPICAL	20190101		ANDA	ANDA210958	UNIT DOSE SERVICES	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50436-0474_f5424994-50b4-4e8f-9a06-c824b410ef54	50436-0474	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	OINTMENT	TOPICAL	20190101		ANDA	ANDA210958	Unit Dose Services	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50436-2500_02d8963e-027f-4c0e-8a81-22f6faf9c4cc	50436-2500	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20120815		ANDA	ANDA040876	UNIT DOSE SERVICES	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50436-3175_fab557c5-1f06-464c-86e3-cd3485ce149b	50436-3175	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	UNIT DOSE SERVICES	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50436-3339_f4fd1d7b-f2b8-4ed6-adef-6cc07b0c3cf8	50436-3339	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230116		ANDA	ANDA203818	UNIT DOSE SERVICES	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50436-3340_d12f9758-c0ff-4163-bb2f-a9254477b3e2	50436-3340	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20160902		ANDA	ANDA206116	UNIT DOSE SERVICES	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50436-6190_cd7ba0d2-f57b-4310-8f4e-eb168f580f89	50436-6190	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	Unit Dose Services	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50436-6746_b7ba58fe-56bc-4f72-adee-7e9f8667c592	50436-6746	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	UNIT DOSE SERVICES.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50436-6746_d83ae73b-8fa9-406f-890b-6b767975d80d	50436-6746	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	UNIT DOSE SERVICES	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50436-9029_8f4a58ff-f1d9-40b2-ba95-a5df87ecaaee	50436-9029	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	Unit Dose Services	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
50436-9805_ec14f35b-29dd-4c21-916a-88e366e7a7d1	50436-9805	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	UNIT DOSE SERVICES	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
50438-001_08c11030-7bab-55ae-e063-6394a90a1437	50438-001	HUMAN OTC DRUG	ROYAL Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL	20141029		OTC MONOGRAPH DRUG	M007	Filo America	MAGNESIUM SULFATE, UNSPECIFIED FORM	1	kg/kg	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50458-028_088b53cb-a931-d9a7-e063-6294a90afb43	50458-028	HUMAN PRESCRIPTION DRUG	Spravato		Esketamine Hydrochloride	SOLUTION	NASAL	20190305		NDA	NDA211243	Janssen Pharmaceuticals Inc.	ESKETAMINE HYDROCHLORIDE	28	mg/.2mL		CIII	N	20241231
50458-098_ed2029cb-3288-c2f0-e053-2a95a90a8023	50458-098	HUMAN PRESCRIPTION DRUG	ELMIRON		PENTOSAN POLYSULFATE SODIUM	CAPSULE, GELATIN COATED	ORAL	19960926		NDA	NDA020193	Janssen Pharmaceuticals, Inc.	PENTOSAN POLYSULFATE SODIUM	100	mg/1	Glycosaminoglycan [EPC], Glycosaminoglycans [CS]		N	20241231
50458-140_004c990c-b658-432f-e063-6394a90aa93d	50458-140	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN	100	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-141_004c990c-b658-432f-e063-6394a90aa93d	50458-141	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN	300	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-253_f911a4fb-4b5c-ba34-e053-6394a90a202a	50458-253	HUMAN PRESCRIPTION DRUG	Haldol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	19860114		NDA	NDA018701	Janssen Pharmaceuticals, Inc.	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
50458-254_f911a4fb-4b5c-ba34-e053-6394a90a202a	50458-254	HUMAN PRESCRIPTION DRUG	Haldol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	19860114		NDA	NDA018701	Janssen Pharmaceuticals, Inc.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
50458-290_091c35a0-b034-20e9-e063-6294a90a99f5	50458-290	HUMAN PRESCRIPTION DRUG	SPORANOX		ITRACONAZOLE	CAPSULE	ORAL	19920911		NDA	NDA020083	Janssen Pharmaceuticals, Inc.	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50458-295_091ec6b1-4ff4-6281-e063-6394a90a33b1	50458-295	HUMAN PRESCRIPTION DRUG	SPORANOX		itraconazole	SOLUTION	ORAL	19970221		NDA	NDA020657	Janssen Pharmaceuticals, Inc.	ITRACONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50458-300_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-300	HUMAN PRESCRIPTION DRUG	RISPERDAL		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Janssen Pharmaceuticals, Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-302_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-302	HUMAN PRESCRIPTION DRUG	RISPERDAL		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Janssen Pharmaceuticals, Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-305_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-305	HUMAN PRESCRIPTION DRUG	RISPERDAL		risperidone	SOLUTION	ORAL	19960610		NDA	NDA020588	Janssen Pharmaceuticals, Inc.	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
50458-306_0a342d67-f908-9269-e063-6294a90ace24	50458-306	HUMAN PRESCRIPTION DRUG	RISPERDAL CONSTA		risperidone	KIT		20031029		NDA	NDA021346	Janssen Pharmaceuticals, Inc.						N	20241231
50458-307_0a342d67-f908-9269-e063-6294a90ace24	50458-307	HUMAN PRESCRIPTION DRUG	RISPERDAL CONSTA		risperidone	KIT		20031029		NDA	NDA021346	Janssen Pharmaceuticals, Inc.						N	20241231
50458-308_0a342d67-f908-9269-e063-6294a90ace24	50458-308	HUMAN PRESCRIPTION DRUG	RISPERDAL CONSTA		risperidone	KIT		20031029		NDA	NDA021346	Janssen Pharmaceuticals, Inc.						N	20241231
50458-309_0a342d67-f908-9269-e063-6294a90ace24	50458-309	HUMAN PRESCRIPTION DRUG	RISPERDAL CONSTA		risperidone	KIT		20031029		NDA	NDA021346	Janssen Pharmaceuticals, Inc.						N	20241231
50458-315_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-315	HUMAN PRESCRIPTION DRUG	RISPERDAL M-TAB		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20030402		NDA	NDA021444	Janssen Pharmaceuticals, Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-320_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-320	HUMAN PRESCRIPTION DRUG	RISPERDAL		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Janssen Pharmaceuticals, Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-325_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-325	HUMAN PRESCRIPTION DRUG	RISPERDAL M-TAB		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20030402		NDA	NDA021444	Janssen Pharmaceuticals, Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-330_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-330	HUMAN PRESCRIPTION DRUG	RISPERDAL		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Janssen Pharmaceuticals, Inc.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-335_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-335	HUMAN PRESCRIPTION DRUG	RISPERDAL M-TAB		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20030402		NDA	NDA021444	Janssen Pharmaceuticals, Inc.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-350_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-350	HUMAN PRESCRIPTION DRUG	RISPERDAL		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Janssen Pharmaceuticals, Inc.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-355_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-355	HUMAN PRESCRIPTION DRUG	RISPERDAL M-TAB		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20030402		NDA	NDA021444	Janssen Pharmaceuticals, Inc.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-395_e6469796-0068-4ff7-8b27-2ac1b2a2f6a9	50458-395	HUMAN PRESCRIPTION DRUG	RISPERDAL M-TAB		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20030402		NDA	NDA021444	Janssen Pharmaceuticals, Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-540_004d0398-3384-8623-e063-6394a90aaae7	50458-540	HUMAN PRESCRIPTION DRUG	INVOKAMET		canagliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20140808		NDA	NDA204353	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	50; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-541_004d0398-3384-8623-e063-6394a90aaae7	50458-541	HUMAN PRESCRIPTION DRUG	INVOKAMET		canagliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20140808		NDA	NDA204353	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	50; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-542_004d0398-3384-8623-e063-6394a90aaae7	50458-542	HUMAN PRESCRIPTION DRUG	INVOKAMET		canagliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20140808		NDA	NDA204353	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	150; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-543_004d0398-3384-8623-e063-6394a90aaae7	50458-543	HUMAN PRESCRIPTION DRUG	INVOKAMET		canagliflozin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20140808		NDA	NDA204353	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	150; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-550_039a5dde-bc31-0348-e063-6294a90ad5b3	50458-550	HUMAN PRESCRIPTION DRUG	INVEGA		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20061219		NDA	NDA021999	Janssen Pharmaceuticals, Inc.	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-551_039a5dde-bc31-0348-e063-6294a90ad5b3	50458-551	HUMAN PRESCRIPTION DRUG	INVEGA		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20061219		NDA	NDA021999	Janssen Pharmaceuticals, Inc.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-552_039a5dde-bc31-0348-e063-6294a90ad5b3	50458-552	HUMAN PRESCRIPTION DRUG	INVEGA		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20061219		NDA	NDA021999	Janssen Pharmaceuticals, Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-554_039a5dde-bc31-0348-e063-6294a90ad5b3	50458-554	HUMAN PRESCRIPTION DRUG	INVEGA		paliperidone	TABLET, EXTENDED RELEASE	ORAL	20090910		NDA	NDA021999	Janssen Pharmaceuticals, Inc.	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50458-560_d3689608-b6a3-11ec-9f5e-dd27aa5d3342	50458-560	HUMAN PRESCRIPTION DRUG	INVEGA SUSTENNA		paliperidone palmitate	INJECTION	INTRAMUSCULAR	20090731		NDA	NDA022264	Janssen Pharmaceuticals, Inc.	PALIPERIDONE PALMITATE	39	mg/.25mL	Atypical Antipsychotic [EPC]		N	20241231
50458-561_d3689608-b6a3-11ec-9f5e-dd27aa5d3342	50458-561	HUMAN PRESCRIPTION DRUG	INVEGA SUSTENNA		paliperidone palmitate	INJECTION	INTRAMUSCULAR	20090731		NDA	NDA022264	Janssen Pharmaceuticals, Inc.	PALIPERIDONE PALMITATE	78	mg/.5mL	Atypical Antipsychotic [EPC]		N	20241231
50458-562_d3689608-b6a3-11ec-9f5e-dd27aa5d3342	50458-562	HUMAN PRESCRIPTION DRUG	INVEGA SUSTENNA		paliperidone palmitate	INJECTION	INTRAMUSCULAR	20090731		NDA	NDA022264	Janssen Pharmaceuticals, Inc.	PALIPERIDONE PALMITATE	117	mg/.75mL	Atypical Antipsychotic [EPC]		N	20241231
50458-563_d3689608-b6a3-11ec-9f5e-dd27aa5d3342	50458-563	HUMAN PRESCRIPTION DRUG	INVEGA SUSTENNA		paliperidone palmitate	INJECTION	INTRAMUSCULAR	20090731		NDA	NDA022264	Janssen Pharmaceuticals, Inc.	PALIPERIDONE PALMITATE	156	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
50458-564_d3689608-b6a3-11ec-9f5e-dd27aa5d3342	50458-564	HUMAN PRESCRIPTION DRUG	INVEGA SUSTENNA		paliperidone palmitate	INJECTION	INTRAMUSCULAR	20090731		NDA	NDA022264	Janssen Pharmaceuticals, Inc.	PALIPERIDONE PALMITATE	234	mg/1.5mL	Atypical Antipsychotic [EPC]		N	20241231
50458-575_0aaf0811-077b-1625-e063-6394a90a9177	50458-575	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	GRANULE, FOR SUSPENSION	ORAL	20211201		NDA	NDA215859	Janssen Pharmaceuticals, Inc.	RIVAROXABAN	155	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50458-577_0aaf0811-077b-1625-e063-6394a90a9177	50458-577	HUMAN PRESCRIPTION DRUG	XARELTO		rivaroxaban	TABLET, FILM COATED	ORAL	20181009		NDA	NDA022406	Janssen Pharmaceuticals, Inc.	RIVAROXABAN	2.5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50458-578_0aaf0811-077b-1625-e063-6394a90a9177	50458-578	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20111104		NDA	NDA022406	Janssen Pharmaceuticals, Inc.	RIVAROXABAN	15	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50458-579_0aaf0811-077b-1625-e063-6394a90a9177	50458-579	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20111105		NDA	NDA022406	Janssen Pharmaceuticals, Inc.	RIVAROXABAN	20	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50458-580_0aaf0811-077b-1625-e063-6394a90a9177	50458-580	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20110701		NDA	NDA022406	Janssen Pharmaceuticals, Inc.	RIVAROXABAN	10	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
50458-584_0aaf0811-077b-1625-e063-6394a90a9177	50458-584	HUMAN PRESCRIPTION DRUG	XARELTO		Rivaroxaban	KIT		20140916		NDA	NDA022406	Janssen Pharmaceuticals, Inc.						N	20241231
50458-585_08b98ac0-d816-ef9b-e063-6394a90a2192	50458-585	HUMAN PRESCRIPTION DRUG	CONCERTA		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20000801		NDA	NDA021121	Janssen Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
50458-586_08b98ac0-d816-ef9b-e063-6394a90a2192	50458-586	HUMAN PRESCRIPTION DRUG	CONCERTA		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20000801		NDA	NDA021121	Janssen Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
50458-587_08b98ac0-d816-ef9b-e063-6394a90a2192	50458-587	HUMAN PRESCRIPTION DRUG	CONCERTA		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20000801		NDA	NDA021121	Janssen Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
50458-588_08b98ac0-d816-ef9b-e063-6394a90a2192	50458-588	HUMAN PRESCRIPTION DRUG	CONCERTA		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20000801		NDA	NDA021121	Janssen Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
50458-596_d3ef1b19-aa0a-48d5-a392-a0c67ae0ec7b	50458-596	HUMAN PRESCRIPTION DRUG	Risperidone		risperidone	SOLUTION	ORAL	19960610		NDA	NDA020588	Janssen Pharmaceutical, Inc.	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
50458-606_ecee2692-8107-11eb-93d4-6ef4fb2ca371	50458-606	HUMAN PRESCRIPTION DRUG	INVEGA TRINZA		paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20150519		NDA	NDA207946	Janssen Pharmaceuticals, Inc	PALIPERIDONE PALMITATE	273	mg/.88mL	Atypical Antipsychotic [EPC]		N	20241231
50458-607_ecee2692-8107-11eb-93d4-6ef4fb2ca371	50458-607	HUMAN PRESCRIPTION DRUG	INVEGA TRINZA		paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20150519		NDA	NDA207946	Janssen Pharmaceuticals, Inc	PALIPERIDONE PALMITATE	410	mg/1.32mL	Atypical Antipsychotic [EPC]		N	20241231
50458-608_ecee2692-8107-11eb-93d4-6ef4fb2ca371	50458-608	HUMAN PRESCRIPTION DRUG	INVEGA TRINZA		paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20150519		NDA	NDA207946	Janssen Pharmaceuticals, Inc	PALIPERIDONE PALMITATE	546	mg/1.75mL	Atypical Antipsychotic [EPC]		N	20241231
50458-609_ecee2692-8107-11eb-93d4-6ef4fb2ca371	50458-609	HUMAN PRESCRIPTION DRUG	INVEGA TRINZA		paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20150519		NDA	NDA207946	Janssen Pharmaceuticals, Inc	PALIPERIDONE PALMITATE	819	mg/2.63mL	Atypical Antipsychotic [EPC]		N	20241231
50458-611_db3433a4-72bb-4f9a-8b6b-54f9ab7ca43a	50458-611	HUMAN PRESCRIPTION DRUG	INVEGA HAFYERA		paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20210830		NDA	NDA207946	Janssen Pharmaceuticals, Inc	PALIPERIDONE PALMITATE	1092	mg/3.5mL	Atypical Antipsychotic [EPC]		N	20241231
50458-612_db3433a4-72bb-4f9a-8b6b-54f9ab7ca43a	50458-612	HUMAN PRESCRIPTION DRUG	INVEGA HAFYERA		paliperidone palmitate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20210830		NDA	NDA207946	Janssen Pharmaceuticals, Inc	PALIPERIDONE PALMITATE	1560	mg/5mL	Atypical Antipsychotic [EPC]		N	20241231
50458-639_fb80f4b4-14e7-484c-e053-6294a90af892	50458-639	HUMAN PRESCRIPTION DRUG	Topamax		topiramate	TABLET, COATED	ORAL	19970101		NDA	NDA020505	Janssen Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50458-640_fb80f4b4-14e7-484c-e053-6294a90af892	50458-640	HUMAN PRESCRIPTION DRUG	Topamax		topiramate	TABLET, COATED	ORAL	19970101		NDA	NDA020505	Janssen Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50458-641_fb80f4b4-14e7-484c-e053-6294a90af892	50458-641	HUMAN PRESCRIPTION DRUG	Topamax		topiramate	TABLET, COATED	ORAL	19970101		NDA	NDA020505	Janssen Pharmaceuticals, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50458-642_fb80f4b4-14e7-484c-e053-6294a90af892	50458-642	HUMAN PRESCRIPTION DRUG	Topamax		topiramate	TABLET, COATED	ORAL	19970101		NDA	NDA020505	Janssen Pharmaceuticals, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50458-645_fb80f4b4-14e7-484c-e053-6294a90af892	50458-645	HUMAN PRESCRIPTION DRUG	Topamax		topiramate	CAPSULE, COATED PELLETS	ORAL	19981101		NDA	NDA020844	Janssen Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50458-647_fb80f4b4-14e7-484c-e053-6294a90af892	50458-647	HUMAN PRESCRIPTION DRUG	Topamax		topiramate	CAPSULE, COATED PELLETS	ORAL	19981101		NDA	NDA020844	Janssen Pharmaceuticals, Inc.	TOPIRAMATE	15	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50458-675_5757cf97-389e-4199-8b53-d32a18e55800	50458-675	HUMAN PRESCRIPTION DRUG	VERMOX		mebendazole	TABLET, CHEWABLE	ORAL	20161020		NDA	NDA208398	Janssen Pharmaceuticals, Inc.	MEBENDAZOLE	500	mg/1	Anthelmintic [EPC]		N	20241231
50458-707_031492a4-9020-b9ed-e063-6394a90a84b4	50458-707	HUMAN PRESCRIPTION DRUG	PONVORY		Ponesimod	KIT		20210318		NDA	NDA213498	Janssen Pharmaceuticals, Inc						N	20241231
50458-720_031492a4-9020-b9ed-e063-6394a90a84b4	50458-720	HUMAN PRESCRIPTION DRUG	PONVORY		Ponesimod	TABLET, FILM COATED	ORAL	20210318		NDA	NDA213498	Janssen Pharmaceuticals, Inc	PONESIMOD	20	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
50458-940_004d0398-3384-8623-e063-6394a90aaae7	50458-940	HUMAN PRESCRIPTION DRUG	INVOKAMET XR		canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160920		NDA	NDA205879	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	50; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-941_004d0398-3384-8623-e063-6394a90aaae7	50458-941	HUMAN PRESCRIPTION DRUG	INVOKAMET XR		canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160920		NDA	NDA205879	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	50; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-942_004d0398-3384-8623-e063-6394a90aaae7	50458-942	HUMAN PRESCRIPTION DRUG	INVOKAMET XR		canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160920		NDA	NDA205879	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	150; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50458-943_004d0398-3384-8623-e063-6394a90aaae7	50458-943	HUMAN PRESCRIPTION DRUG	INVOKAMET XR		canagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160920		NDA	NDA205879	Janssen Pharmaceuticals, Inc.	CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE	150; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
50474-001_2a0189a4-01b0-474a-87c0-d46f882c51a1	50474-001	HUMAN PRESCRIPTION DRUG	Keppra		levetiracetam	SOLUTION	ORAL	20031020		NDA	NDA021505	UCB, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-002_dc15eb44-a23b-4e7d-b74d-92e278b3f4b2	50474-002	HUMAN PRESCRIPTION DRUG	Keppra		levetiracetam	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20060823		NDA	NDA021872	UCB, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-370_c6efa4e8-aa1f-4436-b0a7-2ccffb971275	50474-370	HUMAN PRESCRIPTION DRUG	Briviact		brivaracetam	TABLET, FILM COATED	ORAL	20160512		NDA	NDA205836	UCB, Inc.	BRIVARACETAM	10	mg/1	Epoxide Hydrolase Inhibitors [MoA]	CV	N	20241231
50474-470_c6efa4e8-aa1f-4436-b0a7-2ccffb971275	50474-470	HUMAN PRESCRIPTION DRUG	Briviact		brivaracetam	TABLET, FILM COATED	ORAL	20160512		NDA	NDA205836	UCB, Inc.	BRIVARACETAM	25	mg/1	Epoxide Hydrolase Inhibitors [MoA]	CV	N	20241231
50474-500_5776d86f-c632-429f-ac0b-88ade1a3930c	50474-500	HUMAN PRESCRIPTION DRUG	Nayzilam		midazolam	SPRAY	NASAL	20190517		NDA	NDA211321	UCB, Inc.	MIDAZOLAM	5	mg/.1mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50474-570_c6efa4e8-aa1f-4436-b0a7-2ccffb971275	50474-570	HUMAN PRESCRIPTION DRUG	Briviact		brivaracetam	TABLET, FILM COATED	ORAL	20160512		NDA	NDA205836	UCB, Inc.	BRIVARACETAM	50	mg/1	Epoxide Hydrolase Inhibitors [MoA]	CV	N	20241231
50474-594_2a0189a4-01b0-474a-87c0-d46f882c51a1	50474-594	HUMAN PRESCRIPTION DRUG	Keppra		levetiracetam	TABLET, FILM COATED	ORAL	20000424		NDA	NDA021035	UCB, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-595_2a0189a4-01b0-474a-87c0-d46f882c51a1	50474-595	HUMAN PRESCRIPTION DRUG	Keppra		levetiracetam	TABLET, FILM COATED	ORAL	20000424		NDA	NDA021035	UCB, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-596_2a0189a4-01b0-474a-87c0-d46f882c51a1	50474-596	HUMAN PRESCRIPTION DRUG	Keppra		levetiracetam	TABLET, FILM COATED	ORAL	20000424		NDA	NDA021035	UCB, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-597_2a0189a4-01b0-474a-87c0-d46f882c51a1	50474-597	HUMAN PRESCRIPTION DRUG	Keppra		levetiracetam	TABLET, FILM COATED	ORAL	20000424		NDA	NDA021035	UCB, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-598_755d518d-ea88-4344-b13e-2ca55e1d99e9	50474-598	HUMAN PRESCRIPTION DRUG	Keppra	XR	levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080924		NDA	NDA022285	UCB, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-599_755d518d-ea88-4344-b13e-2ca55e1d99e9	50474-599	HUMAN PRESCRIPTION DRUG	Keppra	XR	levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090401		NDA	NDA022285	UCB, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
50474-670_c6efa4e8-aa1f-4436-b0a7-2ccffb971275	50474-670	HUMAN PRESCRIPTION DRUG	Briviact		brivaracetam	TABLET, FILM COATED	ORAL	20160512		NDA	NDA205836	UCB, Inc.	BRIVARACETAM	75	mg/1	Epoxide Hydrolase Inhibitors [MoA]	CV	N	20241231
50474-700_f161a8e2-b6e2-27d7-e053-2995a90aa01c	50474-700	HUMAN PRESCRIPTION DRUG	Cimzia		certolizumab pegol	KIT		20080420		BLA	BLA125160	UCB, Inc.						N	20241231
50474-710_f161a8e2-b6e2-27d7-e053-2995a90aa01c	50474-710	HUMAN PRESCRIPTION DRUG	Cimzia		certolizumab pegol	INJECTION, SOLUTION	SUBCUTANEOUS	20090514		BLA	BLA125160	UCB, Inc.	CERTOLIZUMAB PEGOL	200	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
50474-770_c6efa4e8-aa1f-4436-b0a7-2ccffb971275	50474-770	HUMAN PRESCRIPTION DRUG	Briviact		brivaracetam	TABLET, FILM COATED	ORAL	20160512		NDA	NDA205836	UCB, Inc.	BRIVARACETAM	100	mg/1	Epoxide Hydrolase Inhibitors [MoA]	CV	N	20241231
50474-780_c202fa01-c0e8-4876-9043-0645b78c82e4	50474-780	HUMAN PRESCRIPTION DRUG	Bimzelx		bimekizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20231017		BLA	BLA761151	UCB, Inc.	BIMEKIZUMAB	160	mg/mL			N	20241231
50474-781_c202fa01-c0e8-4876-9043-0645b78c82e4	50474-781	HUMAN PRESCRIPTION DRUG	Bimzelx		bimekizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20231017		BLA	BLA761151	UCB, Inc.	BIMEKIZUMAB	160	mg/mL			N	20241231
50474-801_e3051cb1-69ca-43e9-ade3-d2f2e52c49b3	50474-801	HUMAN PRESCRIPTION DRUG	Neupro		rotigotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20120402		NDA	NDA021829	UCB, Inc.	ROTIGOTINE	1	mg/24h			N	20241231
50474-802_e3051cb1-69ca-43e9-ade3-d2f2e52c49b3	50474-802	HUMAN PRESCRIPTION DRUG	Neupro		rotigotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20120402		NDA	NDA021829	UCB, Inc.	ROTIGOTINE	2	mg/24h			N	20241231
50474-803_e3051cb1-69ca-43e9-ade3-d2f2e52c49b3	50474-803	HUMAN PRESCRIPTION DRUG	Neupro		rotigotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20120402		NDA	NDA021829	UCB, Inc.	ROTIGOTINE	3	mg/24h			N	20241231
50474-804_e3051cb1-69ca-43e9-ade3-d2f2e52c49b3	50474-804	HUMAN PRESCRIPTION DRUG	Neupro		rotigotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20120402		NDA	NDA021829	UCB, Inc.	ROTIGOTINE	4	mg/24h			N	20241231
50474-805_e3051cb1-69ca-43e9-ade3-d2f2e52c49b3	50474-805	HUMAN PRESCRIPTION DRUG	Neupro		rotigotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20120402		NDA	NDA021829	UCB, Inc.	ROTIGOTINE	6	mg/24h			N	20241231
50474-806_e3051cb1-69ca-43e9-ade3-d2f2e52c49b3	50474-806	HUMAN PRESCRIPTION DRUG	Neupro		rotigotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20120402		NDA	NDA021829	UCB, Inc.	ROTIGOTINE	8	mg/24h			N	20241231
50474-808_e3051cb1-69ca-43e9-ade3-d2f2e52c49b3	50474-808	HUMAN PRESCRIPTION DRUG	Neupro		rotigotine	KIT		20120402		NDA	NDA021829	UCB, Inc.						N	20241231
50474-870_c6efa4e8-aa1f-4436-b0a7-2ccffb971275	50474-870	HUMAN PRESCRIPTION DRUG	Briviact		brivaracetam	SOLUTION	ORAL	20160512		NDA	NDA205838	UCB, Inc.	BRIVARACETAM	10	mg/mL	Epoxide Hydrolase Inhibitors [MoA]	CV	N	20241231
50474-970_c6efa4e8-aa1f-4436-b0a7-2ccffb971275	50474-970	HUMAN PRESCRIPTION DRUG	Briviact		brivaracetam	INJECTION, SUSPENSION	INTRAVENOUS	20160512		NDA	NDA205837	UCB, Inc.	BRIVARACETAM	50	mg/5mL	Epoxide Hydrolase Inhibitors [MoA]	CV	N	20241231
50474-980_7e1ada52-3db4-4e6b-9ec2-1c61cef0bd29	50474-980	HUMAN PRESCRIPTION DRUG	RYSTIGGO		ROZANOLIXIZUMAB	INJECTION, SOLUTION	SUBCUTANEOUS	20230626		BLA	BLA761286	UCB, Inc.	ROZANOLIXIZUMAB	140	mg/mL			N	20241231
50474-990_7126c28c-eece-4e9d-b46f-9e203195e759	50474-990	HUMAN PRESCRIPTION DRUG	ZILBRYSQ		zilucoplan	INJECTION, SOLUTION	SUBCUTANEOUS	20240103		NDA	NDA216834	UCB, Inc.	ZILUCOPLAN	40	mg/mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
50474-991_7126c28c-eece-4e9d-b46f-9e203195e759	50474-991	HUMAN PRESCRIPTION DRUG	ZILBRYSQ		zilucoplan	INJECTION, SOLUTION	SUBCUTANEOUS	20240103		NDA	NDA216834	UCB, Inc.	ZILUCOPLAN	40	mg/mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
50474-992_7126c28c-eece-4e9d-b46f-9e203195e759	50474-992	HUMAN PRESCRIPTION DRUG	ZILBRYSQ		zilucoplan	INJECTION, SOLUTION	SUBCUTANEOUS	20240103		NDA	NDA216834	UCB, Inc.	ZILUCOPLAN	40	mg/mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
50481-3201_0e0c62d9-cfb8-4f18-e063-6394a90a8150	50481-3201	HUMAN OTC DRUG	Tussy Antiperspirant and Deodorant Original Fresh Spice		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20100127		OTC MONOGRAPH DRUG	M019	KCM Brands LLC	ALUMINUM CHLOROHYDRATE	190	mg/mL			N	20251231
50481-3300_0e0c62d9-cfb9-4f18-e063-6394a90a8150	50481-3300	HUMAN OTC DRUG	Tussy Antiperspirant and Deodorant Invisible Original Fresh Spice		ALUMINUM CHLOROHYDRATE	STICK	TOPICAL	20100127		OTC MONOGRAPH DRUG	M019	KCM Brands LLC	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20251231
50484-010_155959d1-0367-4fb6-8877-29099d08801c	50484-010	HUMAN PRESCRIPTION DRUG	COLLAGENASE SANTYL		COLLAGENASE SANTYL	OINTMENT	TOPICAL	20061018		BLA	BLA101995	SMITH & NEPHEW, INC	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	250	[arb'U]/g	Collagen-specific Enzyme [EPC], Collagenases [Chemical/Ingredient]		N	20241231
50484-810_0c3fee4a-499b-49ec-e063-6394a90ac276	50484-810	HUMAN PRESCRIPTION DRUG	REGRANEX		becaplermin	GEL	TOPICAL	20111101		BLA	BLA103691	Smith & Nephew, Inc.	BECAPLERMIN	100	ug/g	Human Platelet-derived Growth Factor [EPC], Platelet-Derived Growth Factor [CS]		N	20241231
50486-468_d17aea84-0bb2-8ff1-e053-2a95a90adf21	50486-468	HUMAN OTC DRUG	Zilactin	Early Relief Cold Sore	benzyl alcohol	GEL	TOPICAL	20050630		OTC MONOGRAPH NOT FINAL	part356	Blairex Laboratories, Inc.	BENZYL ALCOHOL	.1	g/g	Pediculicide [EPC]		N	20241231
50486-550_d17abbc0-8870-6c82-e053-2995a90a5940	50486-550	HUMAN OTC DRUG	Zilactin-B		benzocaine	GEL	TOPICAL	20050629		OTC MONOGRAPH NOT FINAL	part356	Blairex Laboratories, Inc.	BENZOCAINE	.1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50486-616_d17a5ee8-52bc-3d1d-e053-2995a90aa804	50486-616	HUMAN OTC DRUG	Sleepinal		diphenhydramine hydrochloride	CAPSULE	ORAL	19991001		OTC MONOGRAPH FINAL	part338	Blairex Laboratories, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50488-0901_b2618d56-dcea-489a-949d-3d16d63d504d	50488-0901	HUMAN OTC DRUG	Laxacin		Docusate sodium and sennosides	TABLET	ORAL	20181015		OTC MONOGRAPH NOT FINAL	part334	Alexso, Inc.	DOCUSATE SODIUM; SENNOSIDES A AND B	50; 8.6	mg/1; mg/1			N	20241231
50488-1001_51cdd48c-49c7-4673-9fc7-e4f4aaf04050	50488-1001	HUMAN OTC DRUG	Terocin		Lidocaine, Menthol	PATCH	TOPICAL	20130501		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	600; 600	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50488-1015_de688d51-edff-4eec-98c1-0ee168638ae5	50488-1015	HUMAN OTC DRUG	Methyl Salicylate		Methyl Salicylate	CREAM	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	METHYL SALICYLATE	250	mg/g			N	20241231
50488-1025_e1749c42-dfe9-4ef0-92e8-a6b41a056fe7	50488-1025	HUMAN OTC DRUG	Capsaicin		Capsaicin	CREAM	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	CAPSAICIN	.025	g/100g			N	20241231
50488-1060_44d9a34c-0121-4976-ac6e-73b0029bc8a5	50488-1060	HUMAN OTC DRUG	Capsaicin 0.1 Percent		Capsaicin	CREAM	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	CAPSAICIN	.1	g/100g			N	20241231
50488-1075_a385c645-bfa1-427c-bb81-31ca56326cfa	50488-1075	HUMAN OTC DRUG	Capsaicin 0.075 Percent		Capsaicin	CREAM	TOPICAL	20211208		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	CAPSAICIN	.075	g/100g			N	20241231
50488-1129_d99af9ae-4312-4518-b8ac-469efc619075	50488-1129	HUMAN OTC DRUG	New Terocin		Methyl Salicylate, Capsaicin, and Menthol	LOTION	TOPICAL	20130313		OTC MONOGRAPH NOT FINAL	part348	Alexso Inc.	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.025; 10; 25	g/100mL; g/100mL; g/100mL			N	20241231
50488-2004_30906cba-8a98-465d-b1d4-ac14cfbfe5fd	50488-2004	HUMAN OTC DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	LIDOCAINE	4	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50488-2010_b40f677d-3b13-4e6d-8800-b7ba6443c67a	50488-2010	HUMAN OTC DRUG	Methyl Salicylate		Methyl Salicylate	PATCH	TOPICAL	20210211		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	METHYL SALICYLATE	10	g/100g			N	20241231
50488-2025_ab722340-47c2-6d64-e053-2995a90a14f7	50488-2025	HUMAN OTC DRUG	Capsaicin		Capsaicin	PATCH	TOPICAL	20200108		OTC MONOGRAPH NOT FINAL	part348	Alexso, Inc	CAPSAICIN	.025	g/100g			N	20241231
50488-4125_0fd04f20-1efc-4fb5-ab7a-8d930dd989e4	50488-4125	HUMAN OTC DRUG	Diphenhydramine HCl 12.5mg Antihistamine		Diphenhydramine Hydrochloride	BAR, CHEWABLE	ORAL	20210208		OTC MONOGRAPH FINAL	part341	Alexso, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50488-6040_0f2285bb-e726-497d-a690-b3ac543f98e7	50488-6040	HUMAN OTC DRUG	Methyl Salicylate 40 Percent		Methyl Salicylate	CREAM	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	Alexso, Inc	METHYL SALICYLATE	400	mg/g			N	20241231
50493-0001_06d2bc94-42ef-6e34-e063-6394a90a87ab	50493-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100118		UNAPPROVED MEDICAL GAS		Service Drug	OXYGEN	99	L/100L			N	20241231
50505-001_a8c8a910-a510-4403-bffe-292152835165	50505-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19640101		NDA	NDA205849	James Supplies, L.L.c	OXYGEN	99	L/100L			N	20241231
50522-221_9c344eb8-2a2a-4266-8a3e-5243eb5a2fe3	50522-221	HUMAN OTC DRUG	Sani		ALCOHOL	GEL	TOPICAL	20120524		OTC MONOGRAPH NOT FINAL	part333E	AIS Specialty Products, Inc.	ALCOHOL	.7	mL/mL			N	20241231
50552-002_0bbcf4ed-16b1-7573-e063-6294a90afcd8	50552-002	HUMAN OTC DRUG	Anti-Bacterial Wipes		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20100203		OTC MONOGRAPH DRUG	M005	Tongling Jieya Biological Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.155	g/100g			N	20241231
50554-002_0760bb5f-85a7-c294-e063-6394a90aa71d	50554-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20140101		NDA	NDA205850	DuPuy Oxygen & Supply Company, Inc.	NITROGEN	990	mL/L			N	20241231
50554-005_0760c404-9d3c-a7cc-e063-6294a90a6c7e	50554-005	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19540101		NDA	NDA206009	DuPuy Oxygen & Supply Company, Inc.	NITROUS OXIDE	990	mL/L			N	20241231
50554-007_0760c404-9d3b-a7cc-e063-6294a90a6c7e	50554-007	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20140113		NDA	NDA205826	DuPuy Oxygen & Supply Company, Inc.	AIR	1000	mL/L			N	20241231
50554-100_0760a31d-934c-56a0-e063-6294a90acb70	50554-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140101		NDA	NDA205849	DuPuy Oxygen & Supply Company, Inc.	OXYGEN	990	mL/L			N	20241231
50563-471_fd20ec6b-113d-577d-e053-6294a90a27d3	50563-471	HUMAN OTC DRUG	eco harbor HAND SANITIZING MIST EUCALYPTUS MINT		Ethyl Alcohol	SPRAY	TOPICAL	20230602		OTC MONOGRAPH NOT FINAL	part333A	ENCHANTE ACCESSORIES INC.	ALCOHOL	75	mL/100mL			N	20241231
50563-472_fd212517-25eb-0717-e053-6394a90a75cf	50563-472	HUMAN OTC DRUG	eco harbor HAND SANITIZING MIST VANILLA BEAN		Ethyl Alcohol	SPRAY	TOPICAL	20230602		OTC MONOGRAPH NOT FINAL	part333A	ENCHANTE ACCESSORIES INC.	ALCOHOL	75	mL/100mL			N	20241231
50563-473_fd21168d-ff2d-a217-e053-6294a90ad8bb	50563-473	HUMAN OTC DRUG	eco harbor HAND SANITIZING MIST FRENCH LAVENDER		Ethyl Alcohol	SPRAY	TOPICAL	20230602		OTC MONOGRAPH NOT FINAL	part333A	ENCHANTE ACCESSORIES INC.	ALCOHOL	75	mL/100mL			N	20241231
50563-474_fd212517-25f8-0717-e053-6394a90a75cf	50563-474	HUMAN OTC DRUG	eco harbor HAND SANITIZING MIST ORANGE CITRUS		Ethyl Alcohol	SPRAY	TOPICAL	20230602		OTC MONOGRAPH NOT FINAL	part333A	ENCHANTE ACCESSORIES INC.	ALCOHOL	75	mL/100mL			N	20241231
50573-0011_c5fa2a4c-84c8-33e6-e053-2a95a90adc8a	50573-0011	HUMAN OTC DRUG	Crema Cero Zinc Oxide Skin Protectant Diaper Rash Baby Original Formula		ZINC OXIDE	OINTMENT	TOPICAL	20210430	20240430	OTC MONOGRAPH FINAL	part347	Laboratorios Cero S.A	ZINC OXIDE	49	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
50580-100_f75309c0-017f-bf2e-e053-6294a90af564	50580-100	HUMAN OTC DRUG	Infants Motrin		Ibuprofen	SUSPENSION/ DROPS	ORAL	20040601		NDA	NDA020603	Johnson & Johnson Consumer Inc.	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-120_f754e34d-7094-b460-e053-6294a90a7013	50580-120	HUMAN OTC DRUG	Motrin IB Migraine		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210118		ANDA	ANDA078682	Johnson & Johnson Consumer Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-134_f7555a4a-ab6c-65bc-e053-6394a90a483f	50580-134	HUMAN OTC DRUG	Imodium	A-D	Loperamide Hydrochloride	SOLUTION	ORAL	20040701		NDA	NDA019487	Johnson & Johnson Consumer Inc.	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50580-170_0a191907-544e-3745-e063-6294a90a8e5c	50580-170	HUMAN OTC DRUG	Childrens TYLENOL		Acetaminophen	SUSPENSION	ORAL	20170116		OTC MONOGRAPH DRUG	M013	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-177_f76a892e-197a-025c-e053-6394a90a7501	50580-177	HUMAN OTC DRUG	TYLENOL For Children Plus Adults		Acetaminophen	SUSPENSION	ORAL	20210701		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-184_078198c3-e1e2-165f-e063-6394a90ac512	50580-184	HUMAN OTC DRUG	Childrens Motrin		Ibuprofen	SUSPENSION	ORAL	20010901		NDA	NDA020516	Johnson & Johnson Consumer Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-194_f779ddd1-61e2-3aa8-e053-6294a90a9e40	50580-194	HUMAN OTC DRUG	Childrens TYLENOL	COLD PLUS COUGH PLUS SORE THROAT	Acetaminophen and Dextromethorphan Hydrobromide	SUSPENSION	ORAL	20170626		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	160; 5	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50580-198_f7667336-91a5-828b-e053-6394a90a4a67	50580-198	HUMAN OTC DRUG	Motrin	Infants	Ibuprofen	SUSPENSION/ DROPS	ORAL	20010901		NDA	NDA020603	Johnson & Johnson Consumer Inc.	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-208_f7901979-4f6e-84c6-e053-6394a90adfc1	50580-208	HUMAN OTC DRUG	Motrin Dual Action With Tylenol		Acetaminophen and Ibuprofen	TABLET, FILM COATED	ORAL	20230320		ANDA	ANDA214836	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-209_f75599a0-c465-c0df-e053-6394a90ae28e	50580-209	HUMAN OTC DRUG	TYLENOL Extra Strength		Acetaminophen	POWDER	ORAL	20200615		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/.95g			N	20241231
50580-226_0bfb564c-02cf-2a07-e063-6394a90a35f2	50580-226	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20080901		OTC MONOGRAPH DRUG	M012	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-228_fbdfb028-f11f-d968-e053-6294a90adcb4	50580-228	HUMAN OTC DRUG	Benadryl Allergy Liqui-Gels		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20090301		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-230_f760c3b4-7796-8007-e053-6394a90aa14d	50580-230	HUMAN OTC DRUG	Motrin IB		Ibuprofen	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA077349	Johnson & Johnson Consumer Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-231_f77a6745-23c2-6df4-e053-6294a90aaf23	50580-231	HUMAN OTC DRUG	TYLENOL Cold Plus Flu Severe and TYLENOL COLD MAX CoPack		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE	KIT		20180820		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-232_f76133af-be7c-87d9-e053-6394a90aa996	50580-232	HUMAN OTC DRUG	Childrens Benadryl Chewables		diphenhydramine hydrochloride	TABLET, CHEWABLE	ORAL	20160711		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-239_f76704a3-23aa-9918-e053-6294a90a7b7c	50580-239	HUMAN OTC DRUG	SUDAFED PE SINUS CONGESTION		diphenhydramine hydrochloride and phenylephrine hydrochloride	KIT		20190617		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-240_f761c8ad-3d2f-3195-e053-6394a90a9ad6	50580-240	HUMAN OTC DRUG	Sudafed Sinus Congestion 24 Hour		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190617	20250930	NDA	NDA020021	Johnson & Johnson Consumer Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	240	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
50580-241_f77aaffd-821d-2d17-e053-6294a90a1e1a	50580-241	HUMAN OTC DRUG	Tylenol Cold plus Flu Severe and Tylenol Cold Max		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20161003		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-242_f762149f-6da6-b362-e053-6394a90a96f2	50580-242	HUMAN OTC DRUG	Sudafed Sinus Congestion 12 Hour		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190617		ANDA	ANDA075153	Johnson & Johnson Consumer Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50580-243_f81d924e-10ec-0e9d-e053-6294a90a2ddf	50580-243	HUMAN OTC DRUG	Extra Strength TYLENOL Severe Cough Plus Sore Throat Night		Acetaminophen, Dextromethorphan Hydrobromide and Doxylamine Succinate.	LIQUID	ORAL	20230619		OTC MONOGRAPH FINAL	M012:Part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	1000; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50580-245_f77b153f-1c93-065c-e053-6294a90a5961	50580-245	HUMAN OTC DRUG	Childrens TYLENOL	COLD plus COUGH plus RUNNY NOSE	Acetaminophen, Chlorpheniramine Maleate, and Dextromethorphan Hydrobromide	SUSPENSION	ORAL	20170626		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50580-299_f78afdf2-53f2-8b15-e053-6294a90a13f7	50580-299	HUMAN OTC DRUG	Childrens TYLENOL	COLD Plus FLU	Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	SUSPENSION	ORAL	20170626		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-309_f7906fd6-8ad5-2167-e053-6394a90aa3f2	50580-309	HUMAN OTC DRUG	Tylenol 8HR		acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160118		NDA	NDA019872	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
50580-317_f790e51d-fdcf-33a4-e053-6294a90a23ea	50580-317	HUMAN OTC DRUG	Imodium	A-D	Loperamide hydrochloride	TABLET, FILM COATED	ORAL	20150713		ANDA	ANDA075232	Johnson & Johnson Consumer Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50580-325_f79327c6-40e0-5190-e053-6394a90aacba	50580-325	HUMAN OTC DRUG	Infants TYLENOL		Acetaminophen	SUSPENSION	ORAL	20170925		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-338_0be99b2a-2229-1342-e063-6394a90a4017	50580-338	HUMAN OTC DRUG	IMODIUM	Multi-Symptom Relief	loperamide hydrochloride and dimethicone	TABLET	ORAL	20080701		NDA	NDA021140	Johnson & Johnson Consumer Inc.	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
50580-341_f795dd02-291d-d691-e053-6294a90a88e0	50580-341	HUMAN OTC DRUG	Childrens Benadryl Allergy Plus Congestion		Diphenhydramine hydrochloride and Phenylephrine hydrochloride	SOLUTION	ORAL	20140930		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	12.5; 5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-344_f79285b3-b4c6-162e-e053-6294a90aab30	50580-344	HUMAN OTC DRUG	Extra Strength TYLENOL Cold Plus Flu Multi-Action	Day	acetaminophen, Pseudoephedrine hydrochloride, and Dextromethorphan Hydrobromide	TABLET, FILM COATED	ORAL	20210621		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	500; 15; 30	mg/1; mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50580-363_f794eeda-b8c2-90ac-e053-6394a90a7360	50580-363	HUMAN OTC DRUG	SUDAFED Sinus Congestion		Pseudoephedrine Hydrochloride	TABLET, FILM COATED	ORAL	20210731		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50580-367_f7931fc1-2c38-7837-e053-6294a90abeb2	50580-367	HUMAN OTC DRUG	Imodium A-D		Loperamide Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160711		NDA	NDA021855	Johnson & Johnson Consumer Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50580-369_f88392ed-5eea-6319-e053-6394a90aa612	50580-369	HUMAN OTC DRUG	Tylenol Cold plus Flu plus Cough	Night	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20190617		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-370_f79eb306-433a-d012-e053-6394a90a77c0	50580-370	HUMAN OTC DRUG	Benadryl		diphenhydramine hydrochloride	KIT		20170612		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-374_f79ed0c1-b484-f111-e053-6394a90ac7ca	50580-374	HUMAN OTC DRUG	Extra Strength TYLENOL Cold plus Flu Multi-Action	Day/Night	acetaminophen, pseudoephedrine hydrochloride, dextromethorphan hydrobromide, and chlorpheniramine maleate	KIT		20210621		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-378_f7a2fc54-072f-1a19-e053-6394a90a3d55	50580-378	HUMAN OTC DRUG	Tylenol Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20141101		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-402_f7a354e1-47ba-8441-e053-6294a90acf26	50580-402	HUMAN OTC DRUG	TYLENOL Cold Plus Flu	Severe	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20110901		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-403_f7de0f5a-0b5d-2210-e053-6394a90aa856	50580-403	HUMAN OTC DRUG	TYLENOL COLD PLUS FLU SEVERE		Acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	SOLUTION	ORAL	20100705		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-409_fbf85f43-1d5e-f9a8-e053-6394a90a3c8b	50580-409	HUMAN OTC DRUG	Motrin IB		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20150126		ANDA	ANDA078682	Johnson & Johnson Consumer Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-412_f7b60e83-8e0b-08e0-e053-6394a90a0815	50580-412	HUMAN OTC DRUG	TYLENOL	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	20160919		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-414_03b6a52f-95f0-b000-e063-6294a90ae0b8	50580-414	HUMAN OTC DRUG	TYLENOL COLD PLUS FLU SEVERE DAY/NIGHT		acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	KIT		20160718		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-415_f7b6b09b-2792-e268-e053-6294a90a0c0e	50580-415	HUMAN OTC DRUG	Benadryl Allergy Plus Congestion		Diphenhydramine Hydrochloride and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20170619		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	25; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-424_f74f86e0-d834-ff52-e053-6294a90ac9e6	50580-424	HUMAN OTC DRUG	Childrens TYLENOL		ACETAMINOPHEN	SUSPENSION	ORAL	20170116		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-433_f767de46-17ff-3529-e053-6394a90a4789	50580-433	HUMAN OTC DRUG	Infants TYLENOL		Acetaminophen	SUSPENSION	ORAL	20170807		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-434_f78d1bbf-afcb-4126-e053-6294a90af7ec	50580-434	HUMAN OTC DRUG	Sudafed Sinus 12 Hour Pressure plus Pain		Naproxen sodium and Pseudoephedrine Hydrochloride	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20190617		ANDA	ANDA076518	Johnson & Johnson Consumer Inc.	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
50580-435_f78e77df-2002-4bca-e053-6294a90a4e87	50580-435	HUMAN OTC DRUG	Sudafed PE Sinus Pressure Plus Pain		Acetaminophen and Phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20190617		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-436_f767ddcc-8ce8-1940-e053-6294a90aedec	50580-436	HUMAN OTC DRUG	Sudafed PE Head Congestion Plus Pain		Ibuprofen and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20190617		ANDA	ANDA203200	Johnson & Johnson Consumer Inc.	IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	200; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-437_f767fdef-ab0e-f2e1-e053-6294a90aaac7	50580-437	HUMAN OTC DRUG	Sudafed PE Sinus Congestion		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20190617		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-447_f76846ba-d2da-2a39-e053-6294a90ab3f0	50580-447	HUMAN OTC DRUG	SUDAFED PE Head Congestion Plus Mucus		acetaminophen, guaifenesin, and phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20190617		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-449_f790eb5a-22f6-25b5-e053-6294a90acc13	50580-449	HUMAN OTC DRUG	TYLENOL Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	19840819		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-450_f76846ba-d2db-2a39-e053-6294a90ab3f0	50580-450	HUMAN OTC DRUG	SUDAFED PE Head Congestion Plus Flu Severe		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20190617		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-451_f78c169f-c141-068a-e053-6294a90af2c6	50580-451	HUMAN OTC DRUG	TYLENOL	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	19940819		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-456_f7687494-c056-8127-e053-6294a90af6b1	50580-456	HUMAN OTC DRUG	Childrens TYLENOL	COLD Plus FLU	Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	SUSPENSION	ORAL	20170626		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-457_f78ea394-269b-ec1b-e053-6294a90a473c	50580-457	HUMAN OTC DRUG	TYLENOL Extra Strength		acetaminophen	TABLET, FILM COATED	ORAL	20200710		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-458_f780a8ee-c96d-03b3-e053-6394a90ae96e	50580-458	HUMAN OTC DRUG	TYLENOL	Regular Strength	acetaminophen	TABLET, FILM COATED	ORAL	20200717		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
50580-460_f78143d5-424a-1f13-e053-6294a90acf85	50580-460	HUMAN OTC DRUG	Childrens Tylenol		acetaminophen	KIT		20180507		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.						N	20241231
50580-487_f78f0c42-67e8-0f7f-e053-6294a90a58d8	50580-487	HUMAN OTC DRUG	Tylenol	Regular Strength	Acetaminophen	CAPSULE, LIQUID FILLED	ORAL	20160105		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
50580-488_f78204b2-f3c3-a536-e053-6294a90ac35e	50580-488	HUMAN OTC DRUG	TYLENOL	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20170116		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-489_f78f490c-5d85-025a-e053-6394a90a6a1a	50580-489	HUMAN OTC DRUG	TYLENOL Cold plus Flu plus Cough	Day	Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20180716		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-490_f787821a-500d-70f3-e053-6394a90a6de8	50580-490	HUMAN OTC DRUG	TYLENOL Extra Strength		Acetaminophen	TABLET, COATED	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-495_f787cb57-c90b-0524-e053-6294a90a99ff	50580-495	HUMAN OTC DRUG	TYLENOL	Regular Strength	Acetaminophen	TABLET	ORAL	20191201		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
50580-496_f7926850-6ed9-231d-e053-6294a90a01ca	50580-496	HUMAN OTC DRUG	TYLENOL	Regular Strength	Acetaminophen	TABLET	ORAL	19990201		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
50580-507_030b1ad6-1508-b4c7-e063-6394a90a344a	50580-507	HUMAN OTC DRUG	Tylenol Sinus Severe		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20150515		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-509_f79d66fd-2a20-dc4c-e053-6394a90ab688	50580-509	HUMAN OTC DRUG	Childrens TYLENOL		Acetaminophen	SUSPENSION	ORAL	20170116		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-511_f79e03df-d703-e23b-e053-6294a90a02ab	50580-511	HUMAN OTC DRUG	TYLENOL Cold Plus Mucus Severe		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine hydrochloride	SOLUTION	ORAL	20150622		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-515_0e1afc73-2bcb-12f9-e063-6294a90a1573	50580-515	HUMAN OTC DRUG	TYLENOL Cold Max	Day	acetaminophen, dextromethorphan hydrobromide, and phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20150715	20250131	OTC MONOGRAPH DRUG	M012	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
50580-521_f7a030e5-3a59-07cd-e053-6294a90ac2d6	50580-521	HUMAN OTC DRUG	Childrens TYLENOL		Acetaminophen	TABLET, CHEWABLE	ORAL	20170227		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/1			N	20241231
50580-522_f7a27eec-6ba9-952d-e053-6294a90a99da	50580-522	HUMAN OTC DRUG	Childrens Tylenol		Acetaminophen	TABLET, CHEWABLE	ORAL	20170227		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/1			N	20241231
50580-526_f7a261aa-2424-f96f-e053-6394a90aa47f	50580-526	HUMAN OTC DRUG	Tylenol Cold Plus Flu Severe Day and Tylenol Cold Plus Flu Plus Cough Night 2-pack		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and guaifenesin, phenylephrine hydrochloride	KIT		20191028		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-529_f79eb306-4339-d012-e053-6394a90a77c0	50580-529	HUMAN OTC DRUG	Tylenol Cold Plus Flu Severe Day and Tylenol Cold Plus Flu Plus Cough Night 3-Pack		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and guaifenesin, phenylephrine hydrochloride	KIT		20190805		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.						N	20241231
50580-533_f7dc274f-0171-3cba-e053-6294a90ae4a2	50580-533	HUMAN OTC DRUG	Benadryl Allergy EXTRA STRENGTH		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20220705		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-534_f7bccdbb-082a-0eec-e053-6294a90af019	50580-534	HUMAN OTC DRUG	Childrens Benadryl ALLERGY		Diphenhydramine hydrochloride	SOLUTION	ORAL	20080701		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-535_f7bd0010-e4b1-85a8-e053-6294a90ab6f6	50580-535	HUMAN OTC DRUG	Childrens Benadryl DYE-FREE ALLERGY		Diphenhydramine hydrochloride	SOLUTION	ORAL	20080701		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-536_f7e44ee2-aeef-b4e3-e053-6294a90a9a53	50580-536	HUMAN OTC DRUG	Childrens Sudafed	Nasal Decongestant	Pseudoephedrine hydrochloride	SOLUTION	ORAL	20081001		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	15	mg/5mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50580-547_f7c317f2-75f3-b92e-e053-6394a90a1ab1	50580-547	HUMAN OTC DRUG	SUDAFED PE Pressure Plus Pain		acetaminophen and phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20120701		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-555_f7c35c08-a527-1e77-e053-6294a90a0a09	50580-555	HUMAN OTC DRUG	Childrens TYLENOL		Acetaminophen	POWDER	ORAL	20190715		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/1			N	20241231
50580-563_f7db3163-4f91-c5db-e053-6394a90a5b70	50580-563	HUMAN OTC DRUG	Motrin	PM	Ibuprofen and Diphenhydramine Citrate	TABLET, COATED	ORAL	20100111		ANDA	ANDA079113	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-566_f7c3aaa5-0375-ebf0-e053-6294a90ae261	50580-566	HUMAN OTC DRUG	Tylenol	Cold Plus Head Congestion Severe	Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20130715		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-574_fea77162-f269-a1af-e053-6394a90ab491	50580-574	HUMAN OTC DRUG	MOTRIN ARTHRITIS PAIN		Diclofenac sodium	GEL	TOPICAL	20220620		ANDA	ANDA211253	Johnson & Johnson Consumer Inc.	DICLOFENAC SODIUM	9.3	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-576_037ec598-cba7-dbb6-e063-6394a90ac42c	50580-576	HUMAN OTC DRUG	TYLENOL 8 HR MUSCLE ACHES AND PAIN		acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231001		ANDA	ANDA211544	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
50580-579_f7e4c0ff-9c51-9114-e053-6294a90a0c8e	50580-579	HUMAN OTC DRUG	Childrens TYLENOL		Acetaminophen	SUSPENSION	ORAL	20170116		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-590_ff16d4d6-393d-b55b-e053-6394a90afdea	50580-590	HUMAN OTC DRUG	TYLENOL	Extra Strength	acetaminophen	TABLET, FILM COATED	ORAL	20180716		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-598_f7535956-d2ac-f058-e053-6394a90a4a45	50580-598	HUMAN OTC DRUG	TYLENOL SINUS PLUS HEADACHE	DAY	Acetaminophen and Phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20150715		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-599_f753e39c-133a-acab-e053-6294a90ac24b	50580-599	HUMAN OTC DRUG	Infants TYLENOL		acetaminophen	SUSPENSION	ORAL	20170626		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-600_f755ca12-fb71-b153-e053-6294a90aebea	50580-600	HUMAN OTC DRUG	TYLENOL	Regular Strength	Acetaminophen	TABLET, FILM COATED	ORAL	20170531		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
50580-601_f755ca12-fb73-b153-e053-6294a90aebea	50580-601	HUMAN OTC DRUG	Childrens MOTRIN		Ibuprofen	SUSPENSION	ORAL	19950901		NDA	NDA020516	Johnson & Johnson Consumer Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-603_f7561065-3a8e-4d2e-e053-6294a90a4a06	50580-603	HUMAN OTC DRUG	Childrens Motrin		Ibuprofen	SUSPENSION	ORAL	20160125		NDA	NDA020516	Johnson & Johnson Consumer Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-604_f75623b5-1a33-1b2f-e053-6294a90a0674	50580-604	HUMAN OTC DRUG	Childrens Motrin		Ibuprofen	SUSPENSION	ORAL	20160125		NDA	NDA020516	Johnson & Johnson Consumer Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-608_f7569d66-9b31-9918-e053-6394a90a8302	50580-608	HUMAN OTC DRUG	Tylenol PM	Extra Strength	acetaminophen and diphenhydramine hydrochloride	TABLET, FILM COATED	ORAL	20160711		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-612_f756a509-def7-c593-e053-6294a90a0262	50580-612	HUMAN OTC DRUG	Childrens TYLENOL		Acetaminophen	SUSPENSION	ORAL	20160801		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-614_f7569d66-9b34-9918-e053-6394a90a8302	50580-614	HUMAN OTC DRUG	Childrens TYLENOL		ACETAMINOPHEN	SUSPENSION	ORAL	20160801		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50580-646_f767c9fd-adef-3d1e-e053-6294a90afae8	50580-646	HUMAN OTC DRUG	RHINOCORT Allergy		budesonide	SPRAY, METERED	NASAL	20160114		NDA	NDA020746	Johnson & Johnson Consumer Inc.	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50580-692_f765a1d8-0aaf-7f0c-e053-6294a90a1b7b	50580-692	HUMAN OTC DRUG	TYLENOL	Extra Strength	acetaminophen	TABLET, FILM COATED	ORAL	20180806		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50580-719_f767c9fd-adf0-3d1e-e053-6294a90afae8	50580-719	HUMAN OTC DRUG	ZYRTEC-D		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230228		NDA	NDA021150	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
50580-721_f767c9fd-adf1-3d1e-e053-6294a90afae8	50580-721	HUMAN OTC DRUG	Childrens Zyrtec Allergy		Cetirizine Hydrochloride	SYRUP	ORAL	20090120		NDA	NDA022155	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-726_fc0b46fb-3d22-5c34-e053-6394a90a292c	50580-726	HUMAN OTC DRUG	Zyrtec Allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080101		NDA	NDA019835	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-728_f767ddcc-8ce5-1940-e053-6294a90aedec	50580-728	HUMAN OTC DRUG	ZYRTEC-D	Allergy Plus Congestion	Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080101		NDA	NDA021150	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
50580-730_f767ddcc-8ce6-1940-e053-6294a90aedec	50580-730	HUMAN OTC DRUG	Childrens Zyrtec		Cetirizine Hydrochloride	SYRUP	ORAL	20090601		NDA	NDA022155	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-752_f767ddcc-8ce7-1940-e053-6294a90aedec	50580-752	HUMAN OTC DRUG	Zyrtec Allergy		cetirizine hydrochloride	KIT		20200615		NDA	NDA019835	Johnson & Johnson Consumer Inc.						N	20241231
50580-753_f767ddcc-8ce9-1940-e053-6294a90aedec	50580-753	HUMAN OTC DRUG	Zyrtec		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20220620		NDA	NDA021621	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-778_fc716386-ac2f-afde-e053-6394a90a2f57	50580-778	HUMAN OTC DRUG	Zyrtec Allergy		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20140120		NDA	NDA022578	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-779_f79f797b-7f37-041f-e053-6394a90a7c2f	50580-779	HUMAN OTC DRUG	ZYRTEC		Cetirizine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20100208		NDA	NDA022429	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-782_fbf85f43-1d5f-f9a8-e053-6394a90a3c8b	50580-782	HUMAN OTC DRUG	Childrens Zyrtec Allergy		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20140120		NDA	NDA022578	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-783_f79f902f-03d2-7558-e053-6394a90a3a43	50580-783	HUMAN OTC DRUG	Tylenol 8 HR Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20150713		NDA	NDA019872	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
50580-784_f79f9b66-79c1-a473-e053-6294a90a9e4c	50580-784	HUMAN OTC DRUG	Childrens Sudafed PE	NASAL DECONGESTANT	Phenylephrine hydrochloride	SOLUTION	ORAL	20081001		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	PHENYLEPHRINE HYDROCHLORIDE	2.5	mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-785_f79f9b66-79d2-a473-e053-6294a90a9e4c	50580-785	HUMAN OTC DRUG	Childrens SUDAFED PE Cold plus Cough		Dextromethorphan hydrobromide and Phenylephrine hydrochloride	SOLUTION	ORAL	20081001		OTC MONOGRAPH FINAL	part341	Johnson & Johnson Consumer Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	5; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50580-790_f7b5e3b5-fc58-e72f-e053-6294a90aa1e4	50580-790	HUMAN OTC DRUG	Childrens Zyrtec		Cetirizine hydrochloride	TABLET, CHEWABLE	ORAL	20210621		NDA	NDA021621	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	2.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-791_0e939452-59b2-27fc-e063-6394a90a780c	50580-791	HUMAN OTC DRUG	Childrens Zyrtec		Cetirizine hydrochloride	TABLET, CHEWABLE	ORAL	20210621		NDA	NDA021621	Johnson & Johnson Consumer Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
50580-833_f7b5e3b5-fc5a-e72f-e053-6294a90aa1e4	50580-833	HUMAN OTC DRUG	TYLENOL PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	SOLUTION	ORAL	20180625		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-843_f7b5e5e1-df5f-ea45-e053-6294a90a3d6f	50580-843	HUMAN OTC DRUG	Simply Sleep		diphenhydramine hydrochloride	TABLET, FILM COATED	ORAL	20040201		OTC MONOGRAPH FINAL	part338	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50580-932_f7b5e3b5-fc6f-e72f-e053-6294a90aa1e4	50580-932	HUMAN OTC DRUG	Childrens Motrin		Ibuprofen	TABLET, CHEWABLE	ORAL	20190617		ANDA	ANDA076359	Johnson & Johnson Consumer Inc.	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-933_f7b5f153-10b2-159e-e053-6294a90a432c	50580-933	HUMAN OTC DRUG	Childrens Motrin		Ibuprofen	TABLET, CHEWABLE	ORAL	20190617		ANDA	ANDA076359	Johnson & Johnson Consumer Inc.	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50580-937_f7b5f153-10b3-159e-e053-6294a90a432c	50580-937	HUMAN OTC DRUG	Tylenol Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20190819		OTC MONOGRAPH NOT FINAL	part343	Johnson & Johnson Consumer Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50594-002_a93dda73-9760-425d-88b9-22285fe45820	50594-002	HUMAN OTC DRUG	sound body acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20150521		ANDA	ANDA077351	Big Lots Stores, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
50594-005_3d193b6e-ef1d-4d48-961b-e1db68807994	50594-005	HUMAN OTC DRUG	sound body ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150421		ANDA	ANDA077349	Big Lots Stores, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50594-006_d88b7985-ef04-4f75-8132-acdcaee16d24	50594-006	HUMAN OTC DRUG	sound body all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20150428		ANDA	ANDA078336	Big Lots Stores, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50594-008_b9dfeb2a-cba4-4bff-a1dd-9c37589ec5ec	50594-008	HUMAN OTC DRUG	sound body nighttime sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20150421		OTC MONOGRAPH FINAL	part338	Big Lots Stores, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50594-010_d2bfbaa2-b7f1-4a07-8143-15c611c4dd83	50594-010	HUMAN OTC DRUG	Sound Body Allergy Relief		Loratadine	TABLET	ORAL	20150612		ANDA	ANDA076301	Big Lots Stores, Inc.	LORATADINE	10	mg/1			N	20241231
50594-011_feaa1f7e-eb69-47c4-9db8-56a2f0850579	50594-011	HUMAN OTC DRUG	Sound Body Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150817		NDA	NDA022032	Big Lots Stores, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50594-012_c356b11a-f87d-4615-93fa-60edee88be07	50594-012	HUMAN OTC DRUG	Sound Body Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20160119		OTC MONOGRAPH NOT FINAL	part343	Big Lots Stores, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50594-013_a295a7d5-aac8-4e82-91eb-bc67881b9541	50594-013	HUMAN OTC DRUG	Sound Body Childrens Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20160112		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50594-014_8af06f97-a644-487d-961a-4d2345fa03fd	50594-014	HUMAN OTC DRUG	Sound Body Cold and Flu Relief	DayTime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20151015		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50594-015_68f167cb-15f1-4b75-97b5-3c2e0da664f8	50594-015	HUMAN OTC DRUG	Sound Body Milk of Magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20160324		OTC MONOGRAPH NOT FINAL	part334	Big Lots Stores, Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50594-016_effaace9-a0ab-4cf8-9e88-5cd6a5ae1d24	50594-016	HUMAN OTC DRUG	Sound Body Cold and Flu Relief		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20160503		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50594-017_67814c0b-c95f-44b0-81c8-31215405f82b	50594-017	HUMAN OTC DRUG	Sound Body Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20160503		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
50594-018_45fc679b-fde2-47e2-8d4e-0fcac50e9546	50594-018	HUMAN OTC DRUG	Sound Body Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20160503		ANDA	ANDA074937	Big Lots Stores, Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50594-019_18ddeefc-104f-491d-9c64-8c3c73428cb0	50594-019	HUMAN OTC DRUG	Sound Body Pain Reliever		Acetaminophen	TABLET	ORAL	20160919		OTC MONOGRAPH NOT FINAL	part343	Big Lots Stores, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50594-020_9e3fac68-dc49-4875-8cda-2d2425e9c7e4	50594-020	HUMAN OTC DRUG	Sound Body Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160919		ANDA	ANDA072096	Big Lots Stores, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50594-021_56288bfc-6908-416f-9c3d-763e539c7da6	50594-021	HUMAN OTC DRUG	Sound Body Tussin DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20160919		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50594-024_48730f79-9c81-4a00-8e43-61b579a76982	50594-024	HUMAN OTC DRUG	Sound Body Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20170420		ANDA	ANDA074661	Big Lots Stores, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50594-027_403448bb-71fc-4bff-b2c5-d6ef397da823	50594-027	HUMAN OTC DRUG	sound body cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20170330		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50594-028_02ea9bae-b683-475b-92b4-c667eaf02380	50594-028	HUMAN OTC DRUG	sound body calcium antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180615		OTC MONOGRAPH FINAL	part331	Big Lots Stores, Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
50594-029_cc58c934-98c6-46ae-8c79-64c66f4e68ad	50594-029	HUMAN OTC DRUG	sound body esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20180326		ANDA	ANDA207193	Big Lots Stores, Inc.	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50594-038_0e883a0f-ef17-109e-e063-6294a90aa908	50594-038	HUMAN OTC DRUG	Menthol cough drops		Menthol	LOZENGE	ORAL	20171117		OTC MONOGRAPH DRUG	M012	Big Lots	MENTHOL	5.4	mg/1			N	20251231
50594-040_0e8880b0-2630-3302-e063-6394a90a24c0	50594-040	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20171117		OTC MONOGRAPH DRUG	M012	Big Lots	MENTHOL	7.5	mg/1			N	20251231
50594-041_968e4820-8d9d-4665-a9de-ea2da805380d	50594-041	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20150429		OTC MONOGRAPH FINAL	part333D	Big Lots	SALICYLIC ACID	19.8	mg/g			N	20241231
50594-042_0e888e0b-e027-7b68-e063-6294a90aaead	50594-042	HUMAN OTC DRUG	Sugar Free Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20171204		OTC MONOGRAPH DRUG	M012	Big Lots	MENTHOL	7.6	mg/1			N	20251231
50594-045_8bf6e142-d032-4fa0-888b-b88d170791b0	50594-045	HUMAN OTC DRUG	sound body pain relief		Acetaminophen	TABLET	ORAL	20220613		OTC MONOGRAPH NOT FINAL	part343	Big Lots Stores, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50594-069_1fa33081-bca1-4c5e-a026-87d240d38b3f	50594-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20180816		OTC MONOGRAPH FINAL	part347	Big Lots	PETROLATUM	1	g/g			N	20241231
50594-072_6b375573-291f-4402-9b18-234213fcd8b8	50594-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20150430		OTC MONOGRAPH NOT FINAL	part356	Big Lots	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50594-075_c5da9102-9644-98d1-e053-2a95a90a6278	50594-075	HUMAN OTC DRUG	Big Lots Soundbody Sheer Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20190829		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50594-104_114d6a36-024b-47ee-90ee-e657e1aa7467	50594-104	HUMAN OTC DRUG	sound body tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220722		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50594-140_a804db4b-0673-49ff-ad4c-034559da2c75	50594-140	HUMAN OTC DRUG	sound body naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20200507		ANDA	ANDA074661	Big Lots Stores, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50594-148_c5e8fcc9-db4c-9ee7-e053-2a95a90ac940	50594-148	HUMAN OTC DRUG	Big Lots Soundbody Sun Defense Screen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20141003		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 45; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50594-149_c8aede4f-3d85-63d1-e053-2a95a90afb1a	50594-149	HUMAN OTC DRUG	Big Lots Soundbody SPF 30 Sport Sunscreen		Avobenzone, Homosalate, Octocrylene,	AEROSOL, SPRAY	TOPICAL	20210121		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/g; mg/g; mg/g			N	20241231
50594-150_c8c1c525-7fb0-f7f5-e053-2995a90ae959	50594-150	HUMAN OTC DRUG	BIG LOTS SOUNDBODY SPF 50 SPORT SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
50594-151_db3ad7b9-0d91-0b1d-e053-2995a90a1f1e	50594-151	HUMAN OTC DRUG	Big Lots Soundbody SPF 70 Sun Defense		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20191114		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	300; 1500; 500; 400; 600	mg/10g; mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
50594-152_e4b6fe4e-4539-e8a2-e053-2995a90a4bc2	50594-152	HUMAN OTC DRUG	BIG LOTS SOUNDBODY KIDS SUNSCREEN SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210121		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
50594-153_9d8f0fa8-0394-4868-a5e4-9b61d89f8cf0	50594-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20150429		OTC MONOGRAPH FINAL	part358H	Big Lots	PYRITHIONE ZINC	10	mg/mL			N	20241231
50594-154_e717ec77-8bec-645a-e053-2a95a90ac11b	50594-154	HUMAN OTC DRUG	Big Lots Soundbody SPF 70 Sport Sunscreen		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20210121		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
50594-155_f0dd499f-1724-8232-e053-2995a90a71bd	50594-155	HUMAN OTC DRUG	Big Lots Soundbody SPF 50 Ultra Sport Sunscreen		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20191016		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
50594-156_f0e82a9f-17ad-b1c5-e053-2995a90ae07a	50594-156	HUMAN OTC DRUG	Big Lots Soundbody SPF 30 Ultra Sport Sunscreen		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20190919		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
50594-157_f1168323-ea2a-c121-e053-2995a90aa566	50594-157	HUMAN OTC DRUG	Big Lots Soundbody SPF 50 Ultra Shield Sunscreen		Avobenzone Homosalate Octisalate Octocrylene	LOTION	TOPICAL	20191016		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50594-158_f40db355-80ef-6c94-e053-2a95a90a3acd	50594-158	HUMAN OTC DRUG	Big Lots Soundbody SPF 50 Baby Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201207		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50594-159_f4231b1b-a1ab-6698-e053-2a95a90a6426	50594-159	HUMAN OTC DRUG	Big Lots Soundbody SPF 50 Ultra Shield Sunscreen		Avobenzone Homosalate Octisalate Octocrylene	SPRAY	TOPICAL	20191114		OTC MONOGRAPH NOT FINAL	part352	BIG LOTS STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
50594-166_60dcf0ac-999d-4914-a778-311b73df3a26	50594-166	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	BIG LOTS	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50594-200_21e61ca8-78ae-4630-b142-ecae42c2e3af	50594-200	HUMAN OTC DRUG	sound body daytime cold and flu relief nighttime cold and flu relief		Acetaminophen, dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20210708		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.						N	20241231
50594-229_5f727d37-5522-4272-9054-ffc52b3473a4	50594-229	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20160223		OTC MONOGRAPH FINAL	part333D	Big Lots	BENZOYL PEROXIDE	100	mg/g			N	20241231
50594-247_4752b963-7c17-46ff-bcb0-5f5ba49eaef5	50594-247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20090105		OTC MONOGRAPH FINAL	part347	BIG LOTS	PETROLATUM	410	mg/g			N	20241231
50594-306_571a6b73-5c03-4921-87da-74b06ee056fe	50594-306	HUMAN OTC DRUG	sound body clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20200311		ANDA	ANDA090685	Big Lots Stores, Inc.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50594-319_a17cd263-8a91-401c-a5fd-45e4dceaaad0	50594-319	HUMAN OTC DRUG	sound body allergy relief		Fluticasone propionate	SPRAY, METERED	NASAL	20180326		ANDA	ANDA207957	Big Lots Stores, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50594-335_fc7d3aa7-110c-455f-b16a-389ebe79a20d	50594-335	HUMAN OTC DRUG	sound body cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20150304		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50594-374_743194c4-cc2f-4064-89c5-5867d5afce48	50594-374	HUMAN OTC DRUG	sound body migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20200730		ANDA	ANDA075794	Big Lots Stores, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50594-395_d0516ed9-eb5f-4e15-a8b6-b0b8a5b001e6	50594-395	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20210430		OTC MONOGRAPH NOT FINAL	part334	Big Lots	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50594-428_78a98fe3-724f-42bc-a9be-4a520fa7383d	50594-428	HUMAN OTC DRUG	sound body gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190328		OTC MONOGRAPH FINAL	part332	Big Lots Stores, Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
50594-441_e5616c38-2fc0-4e20-8ae2-a5487b9ecf31	50594-441	HUMAN OTC DRUG	sound body nighttime sleep aid		Doxylamine succinate	TABLET	ORAL	20190424		ANDA	ANDA040167	Big Lots Stores, Inc.	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50594-459_beabe14f-b105-4d77-b1ff-2cf681c8326c	50594-459	HUMAN OTC DRUG	sound body cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20150304		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50594-504_90469578-13e1-4c78-8d02-424573d6cc11	50594-504	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20210430		ANDA	ANDA204507	Big Lots	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50594-602_93c50731-5b9a-4600-b5ff-d0c085c1020d	50594-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20150721		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution, Inc	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50594-619_21d33794-02a8-4e95-8436-437b325abf95	50594-619	HUMAN OTC DRUG	Daily Moisturizing		Daily Moistruizing	LOTION	TOPICAL	20150429		OTC MONOGRAPH FINAL	part347	Big Lots	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
50594-664_d5f9cf02-2c35-467b-9a0f-a73c36ca87a6	50594-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20150430		OTC MONOGRAPH NOT FINAL	part356	Big Lots	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50594-719_ac1d1f26-193f-481e-86d6-121c99df3c09	50594-719	HUMAN OTC DRUG	sound body nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20190320		OTC MONOGRAPH FINAL	part341	Big Lots Stores, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
50594-801_660bb090-3384-430c-a397-f5b34b245635	50594-801	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20210820		ANDA	ANDA204507	Big Lots	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50594-804_a3f1b383-2619-4ec7-afbc-ec8f382b23b9	50594-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20160329		OTC MONOGRAPH NOT FINAL	part333A	Big Lots	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
50594-810_792bb9b3-845f-445b-8728-8d5adb014b0e	50594-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20150909		OTC MONOGRAPH NOT FINAL	part333A	Big Lots	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
50594-812_5095a123-415e-4c3f-86f8-e056ced60f41	50594-812	HUMAN OTC DRUG	sound body mucus dm		dextromethorphan Hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207602	Big Lots Stores, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50594-821_422d4b0c-d450-4536-8c47-b4c51e0a8eca	50594-821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20150115		OTC MONOGRAPH FINAL	part333D	Big Lots	SALICYLIC ACID	21	mg/mL			N	20241231
50594-822_04a9e4a9-16a9-4e12-b168-4abebdf96790	50594-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20150430		OTC MONOGRAPH FINAL	part346	Big Lots	WITCH HAZEL	979	mg/mL			N	20241231
50594-843_a9d24291-49c4-48bd-b0df-cda61f0a8030	50594-843	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210430		ANDA	ANDA206568	Big Lots	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50594-855_6789e947-86dd-4041-875b-14a70fc9dd50	50594-855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20170910		OTC MONOGRAPH NOT FINAL	part356	Big Lots	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50594-863_786249c6-85d4-430e-b2ac-1583ff73fd7e	50594-863	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCL	TABLET, COATED	ORAL	20210820		OTC MONOGRAPH FINAL	part341	Big Lots	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50594-864_597b9aeb-650f-480c-9dbc-2744e242aef5	50594-864	HUMAN OTC DRUG	50% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	20141008		OTC MONOGRAPH NOT FINAL	part333A	Big Lots	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
50594-871_f56ef865-32d4-49da-bd0a-690ae7859216	50594-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20141008		OTC MONOGRAPH NOT FINAL	part333A	Sound Body	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
50594-875_e51defd9-0020-4ef2-ad6a-e1481e0247c6	50594-875	HUMAN OTC DRUG	Astringent		Salicylic Acid	LIQUID	TOPICAL	20160315		OTC MONOGRAPH FINAL	part333D	Big Lots	SALICYLIC ACID	5	mg/mL			N	20241231
50594-877_0bb3124d-74b5-1948-e063-6294a90ae0cb	50594-877	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEVER		ACETAMINOPHEN	TABLET	ORAL	20210819		OTC MONOGRAPH DRUG	M013	BIG LOTS STORES, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
50594-878_0bb72449-6365-b526-e063-6294a90a4b27	50594-878	HUMAN OTC DRUG	EXTRA STRENGHT HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20210819		OTC MONOGRAPH DRUG	M013	BIG LOTS STORES, INC.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50594-971_d0813947-2189-4cf9-959c-c51c1750cd04	50594-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20170919		OTC MONOGRAPH DRUG	M021	Big Lots	SODIUM FLUORIDE	.02	mg/mL			N	20241231
50594-995_6356a192-3c74-4024-a042-7f3298012885	50594-995	HUMAN OTC DRUG	Daily Facial Moisturizer		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20170225		OTC MONOGRAPH FINAL	part352	BIG LOTS	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/mL; mg/mL; mg/mL			N	20241231
50632-001_852e6c10-2932-4263-a658-8011aec61dfc	50632-001	VACCINE	JYNNEOS		Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen	INJECTION, SUSPENSION	SUBCUTANEOUS	20210317		BLA	BLA125678	Bavarian Nordic A/S	VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN	50000000	1/.5mL			N	20241231
50632-010_1f797b93-5be1-4f6e-8e01-bda00bdca051	50632-010	VACCINE	RabAvert		Rabies Vaccine	KIT		19971111		BLA	BLA103334	Bavarian Nordic A/S						N	20241231
50633-110_ead6b85f-cb43-49cf-8024-95be6aec87d1	50633-110	PLASMA DERIVATIVE	CroFab		ovine crotalidae venoms immune fab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20000210		BLA	BLA103788	BTG International Inc.	AGKISTRODON PISCIVORUS IMMUNE FAB ANTIVENIN (OVINE); CROTALUS ADAMANTEUS IMMUNE FAB ANTIVENIN (OVINE); CROTALUS ATROX IMMUNE FAB ANTIVENIN (OVINE); CROTALUS SCUTULATUS IMMUNE FAB ANTIVENIN (OVINE)	1; 1; 1; 1	g/1; g/1; g/1; g/1	Antivenin [EPC], Antivenin [EPC], Antivenin [EPC], Antivenin [EPC], Antivenins [Chemical/Ingredient], Antivenins [Chemical/Ingredient], Antivenins [Chemical/Ingredient], Antivenins [Chemical/Ingredient], Passively Acquired Immunity [PE], Passively Acquired Immunity [PE], Passively Acquired Immunity [PE], Passively Acquired Immunity [PE], Venom Neutralization [MoA], Venom Neutralization [MoA], Venom Neutralization [MoA], Venom Neutralization [MoA]		N	20241231
50633-120_264eda52-fe4a-4fad-9a07-c3b94872bf24	50633-120	PLASMA DERIVATIVE	DigiFab		ovine digoxin immune fab	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20010831		BLA	BLA103910	BTG International Inc.	OVINE DIGOXIN IMMUNE FAB	40	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
50633-210_d9ab768d-1c30-4c2a-b013-91f61bc11aa0	50633-210	HUMAN PRESCRIPTION DRUG	Voraxaze		glucarpidase	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120401		BLA	BLA125327	BTG International Inc.	GLUCARPIDASE	1000	[USP'U]/1	Carboxypeptidase [EPC], Carboxypeptidases [CS]		N	20241231
50633-310_9955075c-c059-4b63-b387-e98ef13e60dc	50633-310	HUMAN PRESCRIPTION DRUG	Cyanokit		Hydroxocobalamin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211215		NDA	NDA022041	BTG INTERNATIONAL INC.	HYDROXOCOBALAMIN	5	g/250mL	Antidote [EPC]		N	20241231
50633-320_0f593953-f5b0-40cf-87e7-fadbd1b43d97	50633-320	HUMAN PRESCRIPTION DRUG	Calcium Edetate de Sodium		EDETATE CALCIUM DISODIUM ANHYDROUS	SOLUTION	INTRAVENOUS	20221021		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BTG International Inc	EDETATE CALCIUM DISODIUM ANHYDROUS	50	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
50633-910_ae74f926-f0a4-4dd6-9dfb-79fd8454cac2	50633-910	HUMAN OTC DRUG	ThyroSafe		Potassium Iodide	TABLET	ORAL	20020930		ANDA	ANDA076350	BTG International Inc.	POTASSIUM IODIDE	65	mg/1			N	20241231
50663-395_f5483598-9d8d-1d4e-e053-2a95a90a9054	50663-395	HUMAN OTC DRUG	ZOTOS PROFESSIONAL Nutri for Women 2% Minoxidil Topical Solution		MINOXIDIL	SOLUTION	TOPICAL	20230306		ANDA	ANDA078176	HENKEL US OPERATIONS CORPORATION	MINOXIDIL	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
50685-001_fc871659-ce2b-1be6-e053-6294a90aa5e4	50685-001	HUMAN OTC DRUG	Good Care Povidone Iodine		POVIDONE-IODINE	SWAB	TOPICAL	20101001	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	POVIDONE-IODINE	100	mg/mL			N	
50685-002_fc8734cc-7f79-07ff-e053-6394a90a0aa3	50685-002	HUMAN OTC DRUG	Good Care Isopropyl Alcohol		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20101001	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	
50685-004_fc8753e5-9ebf-349b-e053-6394a90acd38	50685-004	HUMAN OTC DRUG	Good Care Surgical Brush With Nail Cleaner		POVIDONE-IODINE	SPONGE	TOPICAL	20101001	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	POVIDONE-IODINE	10	mg/mL			N	
50685-005_fc878b71-6c7e-53ac-e053-6294a90aba93	50685-005	HUMAN OTC DRUG	Good Care Surgical Brush With Nail Cleaner		POVIDONE-IODINE	SPONGE	TOPICAL	20101001	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	POVIDONE-IODINE	7.5	mg/mL			N	
50685-006_fc8792f6-1997-d6e3-e053-6394a90a2ccb	50685-006	HUMAN OTC DRUG	Good Care Alcohol Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20110323	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	ISOPROPYL ALCOHOL	70	g/100g			N	
50685-007_fc875d4d-ec38-3497-e053-6394a90a88c9	50685-007	HUMAN OTC DRUG	Good Care Povidone Iodine Pad		POVIDONE-IODINE	SWAB	TOPICAL	20110323	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	POVIDONE-IODINE	10	mg/mL			N	
50685-008_fc8797f1-908a-accb-e053-6294a90a1649	50685-008	HUMAN OTC DRUG	Good Care Sterile Scrub Brush with PCMX		CHLOROXYLENOL	SOLUTION	TOPICAL	20130213	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	CHLOROXYLENOL	33	mg/mL			N	
50685-009_fc8792f6-199a-d6e3-e053-6394a90a2ccb	50685-009	HUMAN OTC DRUG	Good Care Povidone Iodine Swabsticks		POVIDONE-IODINE	SWAB	TOPICAL	20130213	20260430	OTC MONOGRAPH NOT FINAL	part333E	Dalian Goodwood Medical Care Ltd.	POVIDONE-IODINE	10	g/100g			N	
50685-010_fc87a4b2-f17a-acc9-e053-6294a90a170a	50685-010	HUMAN OTC DRUG	BZK		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20150319	20260430	OTC MONOGRAPH NOT FINAL	part333A	Dalian Goodwood Medical Care Ltd.	BENZALKONIUM CHLORIDE	1	mg/g			N	
50699-1072_2b8e5dc6-75e7-4df0-aa21-198038b95137	50699-1072	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205865	Atlas Welding Supply Co Inc	OXYGEN	99	L/100L			N	20241231
50699-1977_1f655db8-abb4-41c3-81f2-6cabb749070d	50699-1977	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205866	Atlas Welding Supply Co Inc	NITROGEN	99	L/100L			N	20241231
50718-0035_db32e987-fff4-4e09-b00a-a42b3a0b869e	50718-0035	HUMAN OTC DRUG	CONTROL Dandruff- Free Beard Wash		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20221201		OTC MONOGRAPH DRUG	M032	Kamedis Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
50742-112_3f0bf907-bf81-4c4c-829c-4ecf623be276	50742-112	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20180919		ANDA	ANDA204963	Ingenus Pharmaceuticals, LLC	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50742-113_3f0bf907-bf81-4c4c-829c-4ecf623be276	50742-113	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20180919		ANDA	ANDA204963	Ingenus Pharmaceuticals, LLC	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50742-114_3f0bf907-bf81-4c4c-829c-4ecf623be276	50742-114	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20180919		ANDA	ANDA204963	Ingenus Pharmaceuticals, LLC	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50742-115_3f0bf907-bf81-4c4c-829c-4ecf623be276	50742-115	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20180919		ANDA	ANDA204963	Ingenus Pharmaceuticals, LLC	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50742-116_3f0bf907-bf81-4c4c-829c-4ecf623be276	50742-116	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20180919		ANDA	ANDA204963	Ingenus Pharmaceuticals, LLC	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50742-117_3f0bf907-bf81-4c4c-829c-4ecf623be276	50742-117	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		desipramine hydrochloride	TABLET	ORAL	20180919		ANDA	ANDA204963	Ingenus Pharmaceuticals, LLC	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
50742-118_8acb1cc1-9a85-44d5-b570-65baddf92c4d	50742-118	HUMAN PRESCRIPTION DRUG	Cabergoline		Cabergoline	TABLET	ORAL	20180809		ANDA	ANDA204735	Ingenus Pharmaceuticals, LLC	CABERGOLINE	.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
50742-142_7fd02d91-96c5-46b0-a6d1-ebaef663f54c	50742-142	HUMAN PRESCRIPTION DRUG	METHENAMINE HIPPURATE		methenamine hippurate	TABLET	ORAL	20201218		ANDA	ANDA210068	Ingenus Pharmaceuticals, LLC	METHENAMINE HIPPURATE	1	g/1			N	20241231
50742-151_3269eba8-7c07-4caf-b2c6-22471da75fc2	50742-151	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20190311		ANDA	ANDA211368	Ingenus Pharmaceuticals, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
50742-175_1548dff4-f987-4dbe-87ec-f4e9d1d60366	50742-175	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181113		ANDA	ANDA210918	Ingenus Pharmaceuticals, LLC	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-176_1548dff4-f987-4dbe-87ec-f4e9d1d60366	50742-176	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181113		ANDA	ANDA210918	Ingenus Pharmaceuticals, LLC	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-177_1548dff4-f987-4dbe-87ec-f4e9d1d60366	50742-177	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181113		ANDA	ANDA210918	Ingenus Pharmaceuticals, LLC	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-181_b5ceabc2-75ea-43d9-8911-1cb7df7589e9	50742-181	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20200730		ANDA	ANDA211132	Ingenus Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	5	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
50742-182_b5ceabc2-75ea-43d9-8911-1cb7df7589e9	50742-182	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20200730		ANDA	ANDA211132	Ingenus Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	10	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
50742-183_b5ceabc2-75ea-43d9-8911-1cb7df7589e9	50742-183	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20200730		ANDA	ANDA211132	Ingenus Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	15	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
50742-184_b5ceabc2-75ea-43d9-8911-1cb7df7589e9	50742-184	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20200730		ANDA	ANDA211132	Ingenus Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	25	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
50742-190_64a5bdd2-1281-4dd4-9f64-f3e0fae1421b	50742-190	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20150923		ANDA	ANDA205087	Ingenus Pharmaceuticals LLC	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
50742-191_aa39ce08-d1dc-463c-95b7-fbd85048767a	50742-191	HUMAN PRESCRIPTION DRUG	PRIMAQUINE PHOSPHATE		PRIMAQUINE PHOSPHATE	TABLET, FILM COATED	ORAL	20180123		ANDA	ANDA206043	Ingenus Pharmaceuticals, LLC	PRIMAQUINE PHOSPHATE	15	mg/1	Antimalarial [EPC]		N	20241231
50742-193_b0eeccbf-775d-4ff7-805c-cc176f965198	50742-193	HUMAN PRESCRIPTION DRUG	TOLCAPONE		tolcapone	TABLET	ORAL	20180821		ANDA	ANDA208937	Ingenus Pharmaceuticals, LLC	TOLCAPONE	100	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
50742-224_fe05ad15-db11-4d9e-9fb8-721cec4633d9	50742-224	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		tizanidine hydrochloride	CAPSULE	ORAL	20190320		ANDA	ANDA210267	Ingenus Pharmaceuticals, LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50742-225_fe05ad15-db11-4d9e-9fb8-721cec4633d9	50742-225	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		tizanidine hydrochloride	CAPSULE	ORAL	20190320		ANDA	ANDA210267	Ingenus Pharmaceuticals, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50742-226_fe05ad15-db11-4d9e-9fb8-721cec4633d9	50742-226	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		tizanidine hydrochloride	CAPSULE	ORAL	20190320		ANDA	ANDA210267	Ingenus Pharmaceuticals, LLC	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50742-233_34358d5e-82d4-490b-95ba-e93c19cbf6e5	50742-233	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20170731		ANDA	ANDA203434	Ingenus Pharmaceuticals, LLC	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
50742-238_6679e75a-da5e-4e6f-ae28-f145a9543306	50742-238	HUMAN PRESCRIPTION DRUG	QUININE SULFATE		QUININE SULFATE	CAPSULE	ORAL	20171211		ANDA	ANDA204372	Ingenus Pharmaceuticals, LLC	QUININE SULFATE	324	mg/1	Antimalarial [EPC]		N	20241231
50742-239_3b641000-11ad-43fb-be6f-2be03b5b1cd8	50742-239	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		Mexiletine hydrochloride	CAPSULE	ORAL	20210126		ANDA	ANDA214352	Ingenus Pharmaceuticals, LLC	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
50742-240_3b641000-11ad-43fb-be6f-2be03b5b1cd8	50742-240	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		Mexiletine hydrochloride	CAPSULE	ORAL	20210126		ANDA	ANDA214352	Ingenus Pharmaceuticals, LLC	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
50742-241_3b641000-11ad-43fb-be6f-2be03b5b1cd8	50742-241	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		Mexiletine hydrochloride	CAPSULE	ORAL	20210126		ANDA	ANDA214352	Ingenus Pharmaceuticals, LLC	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
50742-246_62228a4b-3e48-471c-9e51-37bf1f44cb7b	50742-246	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate and hydralazine hydrochloride		Isosorbide dinitrate and hydralazine hydrochloride	TABLET	ORAL	20220212		ANDA	ANDA215586	Ingenus Pharmaceuticals, LLC	HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE	37.5; 20	mg/1; mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC], Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-247_68a03cb8-23e0-4326-8a73-2838c11029a8	50742-247	HUMAN PRESCRIPTION DRUG	Clonidine		clonidine	TABLET, EXTENDED RELEASE	ORAL	20190305		ANDA	ANDA209675	Ingenus Pharmaceuticals, LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
50742-248_6c087cf6-74bb-4427-b816-94058d003414	50742-248	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Ingenus Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50742-249_6c087cf6-74bb-4427-b816-94058d003414	50742-249	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Ingenus Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50742-250_6c087cf6-74bb-4427-b816-94058d003414	50742-250	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Ingenus Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50742-251_6c087cf6-74bb-4427-b816-94058d003414	50742-251	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Ingenus Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50742-252_6c087cf6-74bb-4427-b816-94058d003414	50742-252	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Ingenus Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
50742-257_7037d97b-63ec-48c8-993b-11b979690e58	50742-257	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230801		ANDA	ANDA216404	Ingenus Pharmaceuticals, LLC	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50742-258_7037d97b-63ec-48c8-993b-11b979690e58	50742-258	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230801		ANDA	ANDA216404	Ingenus Pharmaceuticals, LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50742-259_7037d97b-63ec-48c8-993b-11b979690e58	50742-259	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230801		ANDA	ANDA216404	Ingenus Pharmaceuticals, LLC	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
50742-260_fd63b0e3-28c6-4bc5-a395-f907f8111348	50742-260	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Ingenus Pharmaceuticals, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50742-261_fd63b0e3-28c6-4bc5-a395-f907f8111348	50742-261	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Ingenus Pharmaceuticals, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50742-262_fd63b0e3-28c6-4bc5-a395-f907f8111348	50742-262	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Ingenus Pharmaceuticals, LLC	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50742-263_c840af64-8fdd-4486-bdfd-6acadd70af5b	50742-263	HUMAN PRESCRIPTION DRUG	Probenecid and Colchicine		Probenecid and Colchicine	TABLET	ORAL	20190516		ANDA	ANDA040618	Ingenus Pharmaceuticals, LLC	COLCHICINE; PROBENECID	.5; 500	mg/1; mg/1	Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
50742-267_ec08066e-8299-493e-b502-e56db778b15e	50742-267	HUMAN PRESCRIPTION DRUG	Norethindrone acetate		norethindrone acetate	TABLET	ORAL	20190829		ANDA	ANDA206490	Ingenus Pharmaceuticals, LLC	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50742-278_63a4ed8c-769f-45e0-b7b5-26329b355a70	50742-278	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	TABLET, FILM COATED	ORAL	20220926		ANDA	ANDA216275	Ingenus Pharmaceuticals, LLC	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50742-279_1fc17b56-f6d9-4729-be80-53ce0f2e44d0	50742-279	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	20211011		ANDA	ANDA215585	Ingenus Pharmaceuticals, LLC	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50742-283_c42c48e3-419f-4d2e-8ad1-519d1ae9c6ea	50742-283	HUMAN PRESCRIPTION DRUG	Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride		Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride	CAPSULE	ORAL	20230704		ANDA	ANDA217511	Ingenus Pharmaceuticals, LLC	BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE	140; 125; 125	mg/1; mg/1; mg/1	Bismuth [CS], Bismuth [EPC], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
50742-287_a6586769-4fb8-41df-bfd6-0971090ab79b	50742-287	HUMAN PRESCRIPTION DRUG	Timolol Maleate		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20220915		ANDA	ANDA216533	Ingenus Pharmaceuticals, LLC	TIMOLOL MALEATE	3.4	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50742-288_a6586769-4fb8-41df-bfd6-0971090ab79b	50742-288	HUMAN PRESCRIPTION DRUG	Timolol Maleate		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20220915		ANDA	ANDA216533	Ingenus Pharmaceuticals, LLC	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50742-299_e6dff149-d47e-4c5d-b5a1-b7d14583bc54	50742-299	HUMAN PRESCRIPTION DRUG	FROVATRIPTAN		frovatriptan succinate	TABLET, FILM COATED	ORAL	20220722		ANDA	ANDA213891	Ingenus Pharmaceuticals, LLC	FROVATRIPTAN SUCCINATE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
50742-310_35c3308c-dd1f-4eed-955b-5f8ad4732a0b	50742-310	HUMAN PRESCRIPTION DRUG	Mafenide Acetate		Mafenide Acetate	POWDER, FOR SOLUTION	TOPICAL	20181022	20250331	ANDA	ANDA206716	Ingenus Pharmaceuticals, LLC	MAFENIDE ACETATE	50	g/1	Methylated Sulfonamide Antibacterial [EPC], Methylated Sulfonamides [EXT]		N	
50742-317_8bc14da4-d68d-4556-a7e9-d361325da913	50742-317	HUMAN PRESCRIPTION DRUG	Flunisolide		Flunisolide	SOLUTION	NASAL	20220623		ANDA	ANDA207802	Ingenus Pharmaceuticals, LLC	FLUNISOLIDE	.25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50742-323_d2b2581d-16f3-468d-b0aa-657747142287	50742-323	HUMAN PRESCRIPTION DRUG	Dorzolamide hydrochloride and timolol maleate		Dorzolamide hydrochloride and timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20230502		ANDA	ANDA217260	Ingenus Pharmaceuticals, LLC	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50742-331_ae741024-87c1-4820-9b74-95cc91eca827	50742-331	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50742-332_ae741024-87c1-4820-9b74-95cc91eca827	50742-332	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50742-333_ae741024-87c1-4820-9b74-95cc91eca827	50742-333	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50742-334_ae741024-87c1-4820-9b74-95cc91eca827	50742-334	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50742-335_ae741024-87c1-4820-9b74-95cc91eca827	50742-335	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50742-336_ae741024-87c1-4820-9b74-95cc91eca827	50742-336	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	3.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50742-337_ae741024-87c1-4820-9b74-95cc91eca827	50742-337	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA213444	Ingenus Pharmaceuticals, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
50742-340_e370870e-837c-4405-82a4-95f5c8824217	50742-340	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220524		ANDA	ANDA204890	Ingenus Pharmaceuticals, LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
50742-341_e370870e-837c-4405-82a4-95f5c8824217	50742-341	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220524		ANDA	ANDA204890	Ingenus Pharmaceuticals, LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
50742-349_c6151f4b-35b7-4098-aa40-271c4386c5cd	50742-349	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20230124		ANDA	ANDA215616	Ingenus Pharmaceuticals LLC	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50742-350_c6151f4b-35b7-4098-aa40-271c4386c5cd	50742-350	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20230124		ANDA	ANDA215616	Ingenus Pharmaceuticals LLC	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50742-351_c6151f4b-35b7-4098-aa40-271c4386c5cd	50742-351	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20230124		ANDA	ANDA215616	Ingenus Pharmaceuticals LLC	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
50742-352_c95d20e3-06e8-4f36-ae61-f0796a38acdf	50742-352	HUMAN OTC DRUG	Her Style		levonorgestrel	TABLET	ORAL	20221130		ANDA	ANDA207976	Ingenus Pharmaceuticals, LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
50742-364_036c6990-7539-f75f-e063-6294a90a7cd2	50742-364	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		buprenorphine and naloxone	FILM	BUCCAL; SUBLINGUAL	20230829		ANDA	ANDA212756	INGENUS PHARMACEUTICALS, LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50742-365_036c6990-7539-f75f-e063-6294a90a7cd2	50742-365	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		buprenorphine and naloxone	FILM	BUCCAL; SUBLINGUAL	20230829		ANDA	ANDA212756	INGENUS PHARMACEUTICALS, LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	12; 3	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50742-366_932e3701-75ae-438f-bb6a-2c2662c73ee5	50742-366	HUMAN PRESCRIPTION DRUG	Gefitinib		Gefitinib	TABLET, COATED	ORAL	20230427		ANDA	ANDA211591	Ingenus Pharmaceuticals, LLC	GEFITINIB	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
50742-372_077f75c7-fa20-9098-e063-6294a90a6700	50742-372	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20231101		ANDA	ANDA210272	INGENUS PHARMACEUTICALS, LLC	BUPRENORPHINE	5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50742-373_077f75c7-fa20-9098-e063-6294a90a6700	50742-373	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20231101		ANDA	ANDA210272	INGENUS PHARMACEUTICALS, LLC	BUPRENORPHINE	7.5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50742-374_077f75c7-fa20-9098-e063-6294a90a6700	50742-374	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20231101		ANDA	ANDA210272	INGENUS PHARMACEUTICALS, LLC	BUPRENORPHINE	10	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50742-375_077f75c7-fa20-9098-e063-6294a90a6700	50742-375	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20231101		ANDA	ANDA210272	INGENUS PHARMACEUTICALS, LLC	BUPRENORPHINE	15	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50742-376_077f75c7-fa20-9098-e063-6294a90a6700	50742-376	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20231101		ANDA	ANDA210272	INGENUS PHARMACEUTICALS, LLC	BUPRENORPHINE	20	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
50742-401_096d9fbd-b19c-4ade-a601-1ddad80c0218	50742-401	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20170605		ANDA	ANDA206935	Ingenus Pharmaceuticals, LLC	IRINOTECAN HYDROCHLORIDE	40	mg/2mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
50742-402_096d9fbd-b19c-4ade-a601-1ddad80c0218	50742-402	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20170605		ANDA	ANDA206935	Ingenus Pharmaceuticals, LLC	IRINOTECAN HYDROCHLORIDE	100	mg/5mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
50742-405_91b1d13f-6401-496f-a2e5-76e84775efd0	50742-405	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20181029		ANDA	ANDA207562	Ingenus Pharmaceuticals, LLC	OXALIPLATIN	50	mg/10mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
50742-406_91b1d13f-6401-496f-a2e5-76e84775efd0	50742-406	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20181029		ANDA	ANDA207562	Ingenus Pharmaceuticals, LLC	OXALIPLATIN	100	mg/20mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
50742-430_c71b018e-22c6-4c0f-a8e8-6e320822e092	50742-430	HUMAN PRESCRIPTION DRUG	DECITABINE		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190925		ANDA	ANDA210984	Ingenus Pharmaceuticals, LLC	DECITABINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
50742-431_831c6991-9cc6-48cf-8414-f254746507d8	50742-431	HUMAN PRESCRIPTION DRUG	DOCETAXEL		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20170907		ANDA	ANDA207563	Ingenus Pharmaceuticals, LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
50742-438_2142b5a6-e96e-4cf0-a066-7d33b8801608	50742-438	HUMAN PRESCRIPTION DRUG	ARSENIC TRIOXIDE		arsenic trioxide	INJECTION	INTRAVENOUS	20181115		ANDA	ANDA209315	Ingenus Pharmaceuticals, LLC	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
50742-447_69fafb3c-1c18-4d34-83b2-3ab9ddaa6769	50742-447	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20230701		ANDA	ANDA208487	Ingenus Pharmaceuticals, LLC	CARBOPLATIN	450	mg/45mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
50742-448_69fafb3c-1c18-4d34-83b2-3ab9ddaa6769	50742-448	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20230701		ANDA	ANDA208487	Ingenus Pharmaceuticals, LLC	CARBOPLATIN	600	mg/60mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
50742-463_831c6991-9cc6-48cf-8414-f254746507d8	50742-463	HUMAN PRESCRIPTION DRUG	DOCETAXEL		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20170907		ANDA	ANDA207563	Ingenus Pharmaceuticals, LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
50742-484_4ae077c0-fea9-40d8-9c07-0c5f8dcd69b8	50742-484	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220501		ANDA	ANDA210824	Ingenus Pharmaceuticals, LLC	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
50742-496_fbfd32c8-27e6-4f09-a09c-5fce401b87c1	50742-496	HUMAN PRESCRIPTION DRUG	GEMCITABINE		gemcitabine	INJECTION, SOLUTION	INTRAVENOUS	20230701		ANDA	ANDA210383	Ingenus Pharmaceuticals, LLC	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
50742-497_fbfd32c8-27e6-4f09-a09c-5fce401b87c1	50742-497	HUMAN PRESCRIPTION DRUG	GEMCITABINE		gemcitabine	INJECTION, SOLUTION	INTRAVENOUS	20230701		ANDA	ANDA210383	Ingenus Pharmaceuticals, LLC	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
50742-498_fbfd32c8-27e6-4f09-a09c-5fce401b87c1	50742-498	HUMAN PRESCRIPTION DRUG	GEMCITABINE		gemcitabine	INJECTION, SOLUTION	INTRAVENOUS	20230701		ANDA	ANDA210383	Ingenus Pharmaceuticals, LLC	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
50742-505_03b17f54-a7bc-4b9a-a3db-6510f1ded8e5	50742-505	HUMAN PRESCRIPTION DRUG	Scopolamine		Scopolamine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20201124		ANDA	ANDA212342	Ingenus Pharmaceuticals, LLC	SCOPOLAMINE	1.5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
50742-513_fcec90fc-83c9-15e2-e053-6394a90ab2d5	50742-513	HUMAN PRESCRIPTION DRUG	NITRO-DUR		nitroglycerin	PATCH	TRANSDERMAL	20171206		NDA	NDA020145	Ingenus Pharmaceuticals, LLC	NITROGLYCERIN	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-514_fcec90fc-83c9-15e2-e053-6394a90ab2d5	50742-514	HUMAN PRESCRIPTION DRUG	NITRO-DUR		nitroglycerin	PATCH	TRANSDERMAL	20171206		NDA	NDA020145	Ingenus Pharmaceuticals, LLC	NITROGLYCERIN	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-515_fcec90fc-83c9-15e2-e053-6394a90ab2d5	50742-515	HUMAN PRESCRIPTION DRUG	NITRO-DUR		nitroglycerin	PATCH	TRANSDERMAL	20171206		NDA	NDA020145	Ingenus Pharmaceuticals, LLC	NITROGLYCERIN	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-516_fcec90fc-83c9-15e2-e053-6394a90ab2d5	50742-516	HUMAN PRESCRIPTION DRUG	NITRO-DUR		nitroglycerin	PATCH	TRANSDERMAL	20171206		NDA	NDA020145	Ingenus Pharmaceuticals, LLC	NITROGLYCERIN	80	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-517_fcec90fc-83c9-15e2-e053-6394a90ab2d5	50742-517	HUMAN PRESCRIPTION DRUG	NITRO-DUR		nitroglycerin	PATCH	TRANSDERMAL	20171206		NDA	NDA020145	Ingenus Pharmaceuticals, LLC	NITROGLYCERIN	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-518_fcec90fc-83c9-15e2-e053-6394a90ab2d5	50742-518	HUMAN PRESCRIPTION DRUG	NITRO-DUR		nitroglycerin	PATCH	TRANSDERMAL	20171206		NDA	NDA020145	Ingenus Pharmaceuticals, LLC	NITROGLYCERIN	160	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
50742-519_da2e589c-8946-4193-8543-6d26c05fc48a	50742-519	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20200730		NDA	NDA212501	Ingenus Pharmaceuticals, LLC	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
50742-520_da2e589c-8946-4193-8543-6d26c05fc48a	50742-520	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20200730		NDA	NDA212501	Ingenus Pharmaceuticals, LLC	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
50742-521_da2e589c-8946-4193-8543-6d26c05fc48a	50742-521	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20211119		NDA	NDA212501	Ingenus Pharmaceuticals, LLC	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
50742-615_d2c80a25-d81c-4d5a-b70d-96343aaf059c	50742-615	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Ingenus Pharmaceuticals, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50742-616_d2c80a25-d81c-4d5a-b70d-96343aaf059c	50742-616	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Ingenus Pharmaceuticals, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50742-617_d2c80a25-d81c-4d5a-b70d-96343aaf059c	50742-617	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Ingenus Pharmaceuticals, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50742-618_d2c80a25-d81c-4d5a-b70d-96343aaf059c	50742-618	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Ingenus Pharmaceuticals, LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50742-620_173c0a1a-2bf2-4d03-a308-9b8689723558	50742-620	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20170215		ANDA	ANDA202987	Ingenus Pharmaceuticals, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50742-621_173c0a1a-2bf2-4d03-a308-9b8689723558	50742-621	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20170215		ANDA	ANDA202987	Ingenus Pharmaceuticals, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50742-622_173c0a1a-2bf2-4d03-a308-9b8689723558	50742-622	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20170215		ANDA	ANDA202987	Ingenus Pharmaceuticals, LLC	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
50742-623_723a8db6-baa2-47f7-a352-0ed4c25a184e	50742-623	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET	ORAL	20170201		ANDA	ANDA206974	Ingenus Pharmaceuticals, LLC	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
50742-624_723a8db6-baa2-47f7-a352-0ed4c25a184e	50742-624	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET	ORAL	20170201		ANDA	ANDA206974	Ingenus Pharmaceuticals, LLC	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
50742-633_3e4910d8-ca8d-481b-ac89-c22b47cb66db	50742-633	HUMAN PRESCRIPTION DRUG	Metformin		metformin	TABLET, EXTENDED RELEASE	ORAL	20181210		ANDA	ANDA209674	Ingenus Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50742-634_3e4910d8-ca8d-481b-ac89-c22b47cb66db	50742-634	HUMAN PRESCRIPTION DRUG	Metformin		metformin	TABLET, EXTENDED RELEASE	ORAL	20181210		ANDA	ANDA209674	Ingenus Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
50742-635_c60d254b-4705-446f-9fdd-72188c23e861	50742-635	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Ingenus Pharmaceuticals, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50742-636_c60d254b-4705-446f-9fdd-72188c23e861	50742-636	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Ingenus Pharmaceuticals, LLC	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50742-637_c60d254b-4705-446f-9fdd-72188c23e861	50742-637	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Ingenus Pharmaceuticals, LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50742-638_c60d254b-4705-446f-9fdd-72188c23e861	50742-638	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Ingenus Pharmaceuticals, LLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50742-639_c60d254b-4705-446f-9fdd-72188c23e861	50742-639	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170831		ANDA	ANDA208947	Ingenus Pharmaceuticals, LLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
50742-645_22a3bdbc-8edf-45a5-ad5c-4a0c3f73f255	50742-645	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20201020		ANDA	ANDA214219	Ingenus Pharmaceuticals, LLC	TRIAZOLAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50742-646_22a3bdbc-8edf-45a5-ad5c-4a0c3f73f255	50742-646	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20201020		ANDA	ANDA214219	Ingenus Pharmaceuticals, LLC	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
50742-656_c32266ed-621f-41e1-8902-5118f97ce7c7	50742-656	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20190521		ANDA	ANDA040823	Ingenus Pharmaceuticals, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
50742-657_bb15ca3a-56be-430a-a34b-3c04b5c08aba	50742-657	HUMAN PRESCRIPTION DRUG	Estradiol and Norethindrone Acetate		Estradiol and Norethindrone Acetate	TABLET	ORAL	20190403		ANDA	ANDA210612	Ingenus Pharmaceuticals, LLC	ESTRADIOL; NORETHINDRONE ACETATE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50742-658_bb15ca3a-56be-430a-a34b-3c04b5c08aba	50742-658	HUMAN PRESCRIPTION DRUG	Estradiol and Norethindrone Acetate		Estradiol and Norethindrone Acetate	TABLET	ORAL	20190403		ANDA	ANDA210612	Ingenus Pharmaceuticals, LLC	ESTRADIOL; NORETHINDRONE ACETATE	.5; .1	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
50742-659_fba74f4e-0961-4509-b1a9-0925c15d49e4	50742-659	HUMAN PRESCRIPTION DRUG	Dolishale		Levonorgestrel and Ethinyl Estradiol	TABLET	ORAL	20210103		ANDA	ANDA091692	Ingenus Pharmaceuticals, LLC	ETHINYL ESTRADIOL; LEVONORGESTREL	20; 90	ug/1; ug/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
50742-665_5e9a2654-23e8-43de-a8fa-d981d7f13e40	50742-665	HUMAN PRESCRIPTION DRUG	Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide		Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide	ELIXIR	ORAL	20210801		UNAPPROVED DRUG OTHER		Ingenus Pharmaceuticals, LLC	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
50742-666_5e9a2654-23e8-43de-a8fa-d981d7f13e40	50742-666	HUMAN PRESCRIPTION DRUG	Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide		Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide	ELIXIR	ORAL	20210801		UNAPPROVED DRUG OTHER		Ingenus Pharmaceuticals, LLC	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
50742-667_3796f3d7-7e45-4a49-aaa2-7363c197b2f2	50742-667	HUMAN PRESCRIPTION DRUG	Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide		Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide	TABLET	ORAL	20210801		UNAPPROVED DRUG OTHER		Ingenus Pharmaceuticals, LLC	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/1; mg/1; mg/1; mg/1	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
50771-001_fc073e2e-4b2a-3a3d-e053-6294a90a5037	50771-001	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET	ORAL	20160906		ANDA	ANDA202036	Yaopharma Co., Ltd.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50771-002_fc073e2e-4b2a-3a3d-e053-6294a90a5037	50771-002	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET	ORAL	20160906		ANDA	ANDA202036	Yaopharma Co., Ltd.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50771-003_fc073e2e-4b2a-3a3d-e053-6294a90a5037	50771-003	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET	ORAL	20160906		ANDA	ANDA202036	Yaopharma Co., Ltd.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50771-004_fc073e2e-4b2a-3a3d-e053-6294a90a5037	50771-004	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET	ORAL	20160906		ANDA	ANDA202036	Yaopharma Co., Ltd.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50771-005_fc073e2e-4b2a-3a3d-e053-6294a90a5037	50771-005	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET	ORAL	20160906		ANDA	ANDA202036	Yaopharma Co., Ltd.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
50804-004_501adc64-2a1a-486a-ad44-4afc65903bb8	50804-004	HUMAN OTC DRUG	GOOD SENSE READY TO USE	LAXATIVE	sodium phosphate, dibasic, unspecified form and sodium phosphate, monobasic, unspecified form	ENEMA	RECTAL	20181204		OTC MONOGRAPH NOT FINAL	part334	Good Sense	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/133mL; g/133mL			N	20241231
50804-006_e8b846bc-7203-21ef-e053-2995a90a2e55	50804-006	HUMAN OTC DRUG	Pressure plus Pain PE plus Mucus		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160530	20241231	OTC MONOGRAPH FINAL	part341	GoodSense	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
50804-007_07a0123e-6f38-fce0-e063-6394a90ac640	50804-007	HUMAN OTC DRUG	GoodSense Alcohol Swabs		Isopropyl Alcohol	SWAB	TOPICAL	20191104		OTC MONOGRAPH DRUG	M003	Geiss, Destin and Dunn	ISOPROPYL ALCOHOL	.07	mL/mL			N	20241231
50804-009_06d1220f-5694-7a34-e063-6394a90ac314	50804-009	HUMAN OTC DRUG	Good Sense SF Cherry Cough Drops		Menthol	LOZENGE	ORAL	20210716		OTC MONOGRAPH FINAL	part341	Geiss, Destin, Dunn	MENTHOL	5.8	mg/1			N	20241231
50804-012_087c9e16-031d-c240-e063-6394a90ac8c3	50804-012	HUMAN OTC DRUG	GoodSense Antacid Fruit Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210708		OTC MONOGRAPH DRUG	M001	Geiss, Destin, Dunn	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
50804-013_ffe9bbc5-e625-fc16-e053-6294a90a625d	50804-013	HUMAN OTC DRUG	GoodSense Menthol Cough Drops		Menthol	LOZENGE	ORAL	20210709		OTC MONOGRAPH FINAL	part341	Geiss, Destin, Dunn	MENTHOL	5.4	mg/1			N	20241231
50804-014_ffea157b-75c6-1ab6-e053-6394a90a727f	50804-014	HUMAN OTC DRUG	Good Sense Cherry Cough Drops		Menthol	LOZENGE	ORAL	20210715		OTC MONOGRAPH FINAL	part341	Geiss, Destin, Dunn	MENTHOL	5.8	mg/1			N	20241231
50804-020_12cd7255-5fcd-4c6d-9981-0e67f99dda40	50804-020	HUMAN OTC DRUG	Good Sense Lubricant Eye Drops		Polyethylene glycol 400, propylene glycol	LIQUID	OPHTHALMIC	20190517		OTC MONOGRAPH FINAL	part349	Good Sense	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
50804-021_ffea2ec3-317d-06e1-e053-6394a90a6b73	50804-021	HUMAN OTC DRUG	Good Sense Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20210715		OTC MONOGRAPH FINAL	part341	Geiss, Destin, Dunn	MENTHOL	7.5	mg/1			N	20241231
50804-022_087cb717-e554-ca05-e063-6294a90aae05	50804-022	HUMAN OTC DRUG	GoodSense Cherry Cough Drops		Menthol	LOZENGE	ORAL	20210715		OTC MONOGRAPH DRUG	M012	Geiss, Destin, Dunn	MENTHOL	5.8	mg/1			N	20241231
50804-023_087cb717-e555-ca05-e063-6294a90aae05	50804-023	HUMAN OTC DRUG	Good Sense Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20210716		OTC MONOGRAPH DRUG	M012	Geiss, Destin, Dunn	MENTHOL	7.5	mg/1			N	20241231
50804-025_ffea1b29-1c03-603a-e053-6294a90a1e9c	50804-025	HUMAN OTC DRUG	Good Sense Cherry Benzocaine Lozenges		Benzocaine	LOZENGE	ORAL	20210716		OTC MONOGRAPH NOT FINAL	part356	Geiss, Destin, Dunn	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50804-027_ffeaa4ce-e348-446d-e053-6394a90a2925	50804-027	HUMAN OTC DRUG	Good Sense Antacid Soft Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210716		OTC MONOGRAPH FINAL	part331	Geiss, Destin Dunn	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
50804-028_06d18d29-b23e-c60d-e063-6294a90a1486	50804-028	HUMAN OTC DRUG	Good Sense SF Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20220610		OTC MONOGRAPH FINAL	part341	Geiss, Destin, Dunn	MENTHOL	7.6	mg/1			N	20241231
50804-047_eea13e12-6c7d-3416-e053-2995a90a696b	50804-047	HUMAN OTC DRUG	Good Sense	Medicated	WITCH HAZEL	CLOTH	TOPICAL	20151216		OTC MONOGRAPH FINAL	part346	Geiss, Destin & Dunn, Inc	WITCH HAZEL	500	mg/1			N	20241231
50804-060_6088d277-ce31-4f6e-8e99-28915218cba8	50804-060	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20150831	20250425	OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
50804-072_27323458-1f5d-4c4f-ba47-bc5ad11ef92f	50804-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL	MOUTHWASH	ORAL	20090815		OTC MONOGRAPH NOT FINAL	part348	Perrigo Direct, INC.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50804-076_19775c31-e4d6-4e77-958c-02d9cae34fb9	50804-076	HUMAN OTC DRUG	GoodSense	Antibiotic plus Pain Relief	Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	CREAM	TOPICAL	20120321		OTC MONOGRAPH FINAL	part333B	Geiss, Destin & Dunn, Inc.	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50804-077_a79b94e0-009a-4561-abd6-7d378e022dd9	50804-077	HUMAN OTC DRUG	GOOD SENSE ULTRA STRENGTH MUSCLE RUB		CAMPHOR, (-)-, MENTHOL, UNSPECIFIED FORM, and METHYL SALICYLATE	CREAM	TOPICAL	20181219		OTC MONOGRAPH NOT FINAL	part348	GOOD SENSE	CAMPHOR, (-)-; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
50804-078_17a7f29b-8d88-493b-b54a-ce45403df0f0	50804-078	HUMAN OTC DRUG	MEDICATED CHEST RUB		camphor (synthetic), eucalyptus oil, and menthol, unspecified form	OINTMENT	TOPICAL	20210211		OTC MONOGRAPH FINAL	part341	GOODSENSE	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	.048; .012; .026	g/g; g/g; g/g			N	20241231
50804-079_96cb14c1-544f-48cc-bb1b-b014fbc7d36d	50804-079	HUMAN OTC DRUG	Diaper Rash		Zinc Oxide	PASTE	TOPICAL	20200529		OTC MONOGRAPH FINAL	part347	GOODSENSE	ZINC OXIDE	400	mg/g			N	20241231
50804-083_f1d85298-b4ba-23fd-e053-2995a90afa7b	50804-083	HUMAN OTC DRUG	GoodSense SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part352	Geiss, Destin, & Dunn, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
50804-088_51d752c5-0390-4a5f-872f-70a32bbff593	50804-088	HUMAN OTC DRUG	Iodine		Iodine	LIQUID	TOPICAL	20081108		OTC MONOGRAPH NOT FINAL	part333A	Perrigo Direct, Inc.	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
50804-091_62aec081-56f9-4408-8313-a7b383e26209	50804-091	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	20200602		OTC MONOGRAPH DRUG	M012	Geiss, Destin & Dunn Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50804-110_0d2968de-d654-21f7-e063-6294a90a6bf7	50804-110	HUMAN OTC DRUG	Good Sense Artificial Tears		polyvinyl alcohol, povidone	SOLUTION	OPHTHALMIC	20200102		OTC MONOGRAPH DRUG	M018	Geiss, Destin & Dunn, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
50804-112_53de9018-fbe4-425a-85f6-ebf08d108730	50804-112	HUMAN OTC DRUG	GoodSense Regular Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20231207		OTC MONOGRAPH DRUG	part331	GoodSense	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
50804-113_8376486b-f031-4438-aace-9c1d46bd26da	50804-113	HUMAN OTC DRUG	Goodsense Regular Strength Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180808		OTC MONOGRAPH FINAL	part331	GoodSense	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
50804-121_0d2968de-d655-21f7-e063-6294a90a6bf7	50804-121	HUMAN OTC DRUG	GoodSense Eye Drops Irritation Relief		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20200102		OTC MONOGRAPH DRUG	M018	Geiss, Destin & Dunn, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
50804-122_d0c00c58-7797-4577-8a23-feecc3e40c82	50804-122	HUMAN OTC DRUG	GS Stomach Relief		Bismuth subsalicylate 525 mg	LIQUID	ORAL	20181030		OTC MONOGRAPH FINAL	part335	Good Sense (Geiss, Destin & Dunn, Inc.)	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
50804-123_ee294d15-56ce-4bce-e053-2995a90a6111	50804-123	HUMAN OTC DRUG	Sinus and Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH FINAL	part341	GOODSENSE	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-124_f204d934-e90f-49e2-e053-2995a90a2383	50804-124	HUMAN OTC DRUG	Good Sense Hot and Cold Medicated Patch		MENTHOL	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	GOOD SENSE	MENTHOL	5	g/100g			N	20241231
50804-125_f204b6f6-942e-4261-e053-2995a90a963a	50804-125	HUMAN OTC DRUG	Good Sense Hot and Cold Medicated Patch Small		MENTHOL	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	GOOD SENSE	MENTHOL	5	g/100g			N	20241231
50804-126_dfee9135-b092-6d82-e053-2995a90a181a	50804-126	HUMAN OTC DRUG	Goodsense Extra Strength Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20181226		OTC MONOGRAPH NOT FINAL	part348	Geiss, Destin and Dunn, Inc.	MENTHOL	50	mg/1			N	20241231
50804-127_27889481-d636-4c3d-b740-03c3cf066a0e	50804-127	HUMAN OTC DRUG	Goodsense Extra Strength Antacid Assorted Fruit		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180808		OTC MONOGRAPH FINAL	part331	GoodSense	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
50804-128_ef5819f5-89b6-e139-e053-2a95a90a57c7	50804-128	HUMAN OTC DRUG	Allergy Multi Symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	GOODSENSE	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-129_2fcdeb06-17de-49d8-97bb-8d31e1c0c61f	50804-129	HUMAN OTC DRUG	GoodSense Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180830		OTC MONOGRAPH FINAL	part331	GoodSense	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
50804-130_0d299e20-a041-3080-e063-6294a90ad709	50804-130	HUMAN OTC DRUG	GoodSense Eye Drops Advanced Relief Moisturizer		dextran, polyethylene glycol 400, povidone, tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200102		OTC MONOGRAPH DRUG	M018	Geiss, Derstin & Dunn, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
50804-137_f1d856f8-842b-33b7-e053-2995a90af575	50804-137	HUMAN OTC DRUG	GoodSense SPF 30 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 6%	LOTION	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part352	Geiss, Destin, & Dunn, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
50804-141_0d295927-09cb-5b68-e063-6394a90a965f	50804-141	HUMAN OTC DRUG	GoodSense Eye Drops Original Formula		tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200103		OTC MONOGRAPH DRUG	M018	Geiss, Destin & Dunn, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
50804-143_dde17432-ab7f-4bfd-a9eb-edd42c68f3fe	50804-143	HUMAN OTC DRUG	GOODSENSE ATHLETES FOOT		Clotrimazole	CREAM	TOPICAL	20201012		OTC MONOGRAPH FINAL	part333C	GOODSENSE	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
50804-150_0d298a45-a59c-1ecc-e063-6294a90a6db4	50804-150	HUMAN OTC DRUG	GoodSense Redness Relief Plus		gllycerin, naphazoline hydrochloride	SOLUTION	OPHTHALMIC	20200102		OTC MONOGRAPH DRUG	M018	Geiss, Destin & Dunn, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
50804-153_d050bab2-0e68-49a4-bcfa-518ff7668bba	50804-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20090518		OTC MONOGRAPH FINAL	part358H	Geiss, Destin + Dunn, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
50804-156_a004c0ab-dbd7-427a-aaa2-eecf446bda69	50804-156	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20170531		OTC MONOGRAPH DRUG	M022	Good Sense (Geiss, Destin & Dunn, Inc.)	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
50804-157_f09ea7f2-4b3c-4abd-b66d-bc1b048b8013	50804-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20230512		OTC MONOGRAPH DRUG	M013	Geiss, Destin & Dunn Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50804-160_0d297793-9715-6382-e063-6394a90a7d3e	50804-160	HUMAN OTC DRUG	GoodSense Ultra Lubricant Eye Drops		polyethylene glycol 400, propylene glycol	SOLUTION	OPHTHALMIC	20200103		OTC MONOGRAPH DRUG	M018	Geiss, Destin & Dunn, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
50804-164_a0402b1a-a20f-40db-b647-0014e239a7f9	50804-164	HUMAN OTC DRUG	citroma		Magesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Perrigo Direct, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-166_27ebba6d-41a9-4fb7-adbc-ef4b99a9e30f	50804-166	HUMAN OTC DRUG	citroma		Magesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Perrigo Direct, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-171_cbcc2e13-b925-4555-88ab-eec9d5b05d5e	50804-171	HUMAN OTC DRUG	GOODSENSE Ultra Strength Antacid Assorted Fruit		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180808		OTC MONOGRAPH FINAL	part331	GoodSense	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
50804-173_e557ba60-ccca-a218-e053-2995a90af997	50804-173	HUMAN OTC DRUG	Head Congestion Mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220803		OTC MONOGRAPH FINAL	part341	GOODSENSE	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-174_e8b84b46-f031-34cb-e053-2995a90aab2d	50804-174	HUMAN OTC DRUG	Pressure Plus Pain PE Plus Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141201	20240630	OTC MONOGRAPH FINAL	part341	GoodSense	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
50804-175_492deace-7ea1-4fe3-a4c7-b2c6f195d68c	50804-175	HUMAN OTC DRUG	Goodsense Ultra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180815		OTC MONOGRAPH FINAL	part331	Good Sense (Geiss, Destin & Dunn, Inc.)	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
50804-176_8719d2a9-7634-4c24-a5c6-cb0dc97c7e70	50804-176	HUMAN OTC DRUG	GOODSENSE Ultra Strength Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180808		OTC MONOGRAPH FINAL	part331	GoodSense	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
50804-190_d8b6d34f-daaf-4f9c-8f08-e5e75e8c6c63	50804-190	HUMAN OTC DRUG	Bisacodyl Laxative	Enteric Coated	Bisacodyl	TABLET, COATED	ORAL	20100716	20250131	OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
50804-191_dfdced39-6938-4f2d-e053-2a95a90a6f2e	50804-191	HUMAN OTC DRUG	Goodsense Oral Pain Relief		Benzocaine	GEL	TOPICAL	20140509		OTC MONOGRAPH FINAL	part333B	Geiss, Destin and Dunn, Inc.	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50804-198_893b3614-9cfa-4855-896a-76c0504a9899	50804-198	HUMAN OTC DRUG	Motion Sickness		Dimenhydrinate	TABLET	ORAL	20200407		OTC MONOGRAPH DRUG	M009	Geiss, Destin & Dunn Inc.	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50804-199_a9c1e858-f79b-4f42-b971-5d23201de116	50804-199	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20130423		ANDA	ANDA078682	Good Sense (Geiss, Destin & Dunn, Inc.)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50804-211_eea13e12-6c6f-3416-e053-2995a90a696b	50804-211	HUMAN OTC DRUG	GOODSENSE Maximum Strength Medicated		WITCH HAZEL	CLOTH	TOPICAL	20170727		OTC MONOGRAPH FINAL	part346	GEISS, DESTIN & DUNN, INC	WITCH HAZEL	50	g/100g			N	20241231
50804-220_ee2958ea-a296-48bd-e053-2995a90a5740	50804-220	HUMAN OTC DRUG	sinus pressure and pain pe		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	GOODSENSE	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-221_f1d8661e-1958-71f4-e053-2995a90a2fc1	50804-221	HUMAN OTC DRUG	GoodSense SPF 30 Sunscreen		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20191021		OTC MONOGRAPH NOT FINAL	part352	Geiss, Destin, & Dunn, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
50804-236_8e28fa59-e975-4e09-8000-9fdb445ad5f0	50804-236	HUMAN OTC DRUG	Nighttime sleep aid	Maximum Strength	DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20140201	20250201	OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
50804-253_0bf1bed2-016b-0e32-e063-6294a90a025c	50804-253	HUMAN OTC DRUG	GoodSense Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	Perrigo Direct, Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
50804-255_0c03564e-d9da-d148-e063-6394a90a7d7f	50804-255	HUMAN OTC DRUG	GoodSense Complete Lice Treatment Kit		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20231001		OTC MONOGRAPH DRUG	M031	Perrigo Direct, LLC						N	20241231
50804-262_e4047cc0-193f-4492-8947-8bcb330320bc	50804-262	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	20200701		OTC MONOGRAPH DRUG	M011	Geiss, Destin & Dunn Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50804-274_e557a9dd-0176-67f8-e053-2995a90ae7d0	50804-274	HUMAN OTC DRUG	Head Congestion Flu Severe PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220803		OTC MONOGRAPH FINAL	part341	GOODSENSE	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-275_2296774a-1166-4ccc-81cc-77137980832a	50804-275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20160831		OTC MONOGRAPH DRUG	M003	Good Sense (Geiss, Destin & Dunn, Inc.)	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
50804-277_8509cd9d-3790-47af-b307-9913aae37d25	50804-277	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine Maleate	TABLET	ORAL	20211130		OTC MONOGRAPH DRUG	M012	Good Sense	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50804-281_7c8dde0d-9d86-481e-8140-6d1605276013	50804-281	HUMAN OTC DRUG	Vapor Inhaler	levmetamfetamine nasal decongestant, Good Sense	Levmetamfetamine	INHALANT	NASAL	20210308		OTC MONOGRAPH FINAL	part341	Geiss, Destin & Dunn, Inc.	LEVMETAMFETAMINE	50	mg/1			N	20241231
50804-299_efeaf847-a760-471b-9858-c2c24910941f	50804-299	HUMAN OTC DRUG	Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	19930920		OTC MONOGRAPH NOT FINAL	part356	Perrigo Direct, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
50804-311_a413e6dd-27e3-46de-bd31-15183943c28c	50804-311	HUMAN OTC DRUG	Everyday Clean		Pyrithione Zinc	SHAMPOO	TOPICAL	20090609		OTC MONOGRAPH DRUG	M032	Perrigo Direct, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
50804-316_3f972a81-2984-49f6-b3a5-488944034142	50804-316	HUMAN OTC DRUG	Severe Cold and Cough Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20160731	20250731	OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
50804-318_4f5024af-308a-4f12-a604-0ef2ebf98664	50804-318	HUMAN OTC DRUG	Antiseptic		Eucayptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19900915		OTC MONOGRAPH NOT FINAL	part356	Perrigo Direct, Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50804-327_95a7c062-6954-473e-b1c7-9156b4df9cf6	50804-327	HUMAN OTC DRUG	Bisacodyl Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20210429		OTC MONOGRAPH DRUG	505G(a)(3)	Geiss, Destin & Dunn Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-328_96261d5f-2be5-4146-a86f-b5c144b0562e	50804-328	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen 500 mg	TABLET	ORAL	20141217		OTC MONOGRAPH DRUG	M013	Good Sense	ACETAMINOPHEN	500	mg/1			N	20241231
50804-337_a59d4d8d-bd78-4a60-a765-7ff0b223db0f	50804-337	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20160930		OTC MONOGRAPH DRUG	M012	Good Sense (Geiss, Destin & Dunn, Inc.)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-364_ea87326d-90c7-4e8b-84d5-84e11dc8429c	50804-364	HUMAN OTC DRUG	Goodsense Fiber		Methylcellulose	TABLET	ORAL	20151201		OTC MONOGRAPH NOT FINAL	part334	GoodSense	METHYLCELLULOSE (4000 CPS)	500	mg/1			N	20241231
50804-371_cb111f90-011d-408b-a47e-afe230f649ac	50804-371	HUMAN OTC DRUG	Mucus Relief	Immediate Release	Guaifenesin 400mg	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M012	Good Sense	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
50804-376_c5ce7d1e-69df-4f6e-b803-334a0187e868	50804-376	HUMAN OTC DRUG	Sore Throat		Phenol	SPRAY	ORAL	20140930		OTC MONOGRAPH DRUG	M022	Good Sense (Geiss, Destin & Dunn, Inc.)	PHENOL	1.5	g/100mL			N	20241231
50804-377_43b40d7c-4efe-4c71-bd20-a4ad71dec2e7	50804-377	HUMAN OTC DRUG	Sore Throat		Phenol	SPRAY	ORAL	20140930		OTC MONOGRAPH DRUG	M022	Good Sense (Geiss, Destin & Dunn, Inc.)	PHENOL	1.5	g/100mL			N	20241231
50804-390_623f0e8c-05d6-4156-97ce-8482b4b27a1c	50804-390	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20160930	20250930	OTC MONOGRAPH FINAL	part347	Good Sense (Geiss, Destin & Dunn, Inc.)	WITCH HAZEL	842	mg/mL			N	
50804-395_f28c080b-866a-4951-870f-6158b4e6b93d	50804-395	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20171231		OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-403_1d08eeb2-9d37-4aed-a242-5627c60b24ed	50804-403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	LIQUID	TOPICAL	20140728		OTC MONOGRAPH NOT FINAL	part333A	Geiss, Destin & Dunn, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50804-421_f03090cf-5a86-ca73-e053-2a95a90abc61	50804-421	HUMAN OTC DRUG	Good Sense Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20211115		OTC MONOGRAPH FINAL	part343	Good Sense	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50804-432_54b3c3cc-9664-417d-8ffe-391708e4c58a	50804-432	HUMAN OTC DRUG	Mucus Relief DM	Immediate Release	Mucus Relief DM	TABLET	ORAL	20220518		OTC MONOGRAPH DRUG	M012	Good Sense	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50804-468_54ddfe02-4885-42d0-8f53-3456375824ae	50804-468	HUMAN OTC DRUG	Daytime		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20150831	20250131	OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
50804-503_c4e00dff-e88b-49f2-8c68-93dc7adefd21	50804-503	HUMAN OTC DRUG	Cold and Flu	Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200609		OTC MONOGRAPH DRUG	M012	Geiss, Destin & Dunn Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
50804-520_d485c65c-12df-4453-aae7-f51e58f58256	50804-520	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20100715		NDA	NDA021855	Good Sense (Geiss, Destin & Dunn, Inc.)	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50804-525_0862d8e2-d144-4468-b02f-45334b3165ce	50804-525	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160831	20250131	OTC MONOGRAPH NOT FINAL	part343	Good Sense (Geiss, Destin & Dunn, Inc.)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
50804-551_ee294d15-56b0-4bce-e053-2995a90a6111	50804-551	HUMAN OTC DRUG	Cold Multi-Symptom Daytime and Nighttime		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	KIT		20111231		OTC MONOGRAPH FINAL	part341	GoodSense						N	20241231
50804-590_fb7fa9b0-4460-aab0-e053-6394a90ae10e	50804-590	HUMAN OTC DRUG	Cough Drops		Sugar Free Honey Lemon	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	Perrigo Direct Inc.	MENTHOL	7.6	mg/1			N	20241231
50804-591_fb80995a-1686-9b87-e053-6394a90a7f73	50804-591	HUMAN OTC DRUG	Cough Drops		Simply Cherry Cough Drops	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	Perrigo Direct, Inc.	MENTHOL	5.8	mg/1			N	20241231
50804-592_fb806d74-97ad-330f-e053-6294a90ade9b	50804-592	HUMAN OTC DRUG	Cough Drops		Simply Menthol Cough Drops	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	Perrigo Direct, Inc.	MENTHOL	5.4	mg/1			N	20241231
50804-593_fb8985dd-23c5-d404-e053-6294a90a9a2f	50804-593	HUMAN OTC DRUG	Cough Drops		Simply Honey Lemon	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	Perrigo Direct Inc.	MENTHOL	7.5	mg/1			N	20241231
50804-594_0696b10c-972a-9dcf-e063-6294a90a1034	50804-594	HUMAN OTC DRUG	Cough Drops		Simply Sugar Free Honey Lemon	PASTILLE	ORAL	20230930		OTC MONOGRAPH FINAL	part341	Perrigo Direct Inc.	MENTHOL	7.6	mg/1			N	20241231
50804-619_0993d17e-73ca-48fd-e063-6294a90abc13	50804-619	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID AND GASRELIEF		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M001	GOODSENSE	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-629_09945404-e4d0-6269-e063-6294a90a5b8d	50804-629	HUMAN OTC DRUG	ANTACID AND GASRELIEF		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M001	GOODSENSE	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-631_fc4faf21-1ae8-4e87-9ed2-f41c91e8d691	50804-631	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20190131	20250131	OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	SENNOSIDES	8.6	mg/1			N	
50804-638_099439f3-879b-7747-e063-6394a90a3706	50804-638	HUMAN OTC DRUG	ANTACID AND GASRELIEF		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20200701		OTC MONOGRAPH DRUG	M001	GOODSENSE	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-639_0994a3e9-6cf6-8cfc-e063-6394a90a380e	50804-639	HUMAN OTC DRUG	ADVANCED ANTACID MINT		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M001	GOODSENSE	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-647_09946aec-3543-acc9-e063-6394a90aa5fa	50804-647	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M007	GOOD SENSE	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-648_09945971-85f7-82aa-e063-6294a90aaf5b	50804-648	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M007	GOODSENSE	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-649_09943bb2-176b-774b-e063-6394a90a01ba	50804-649	HUMAN OTC DRUG	MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	SUSPENSION	ORAL	20200701		OTC MONOGRAPH DRUG	M007	GOODSENSE	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50804-664_cc391ee3-a7d3-43e4-b6e4-c0f94ca7745a	50804-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19921001		OTC MONOGRAPH NOT FINAL	part356	Perrigo Direct Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
50804-672_ee29473d-92b6-d23a-e053-2a95a90a1343	50804-672	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20130630		OTC MONOGRAPH FINAL	part341	GoodSense	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-700_0d383700-e25a-881f-e063-6294a90a347c	50804-700	HUMAN OTC DRUG	Good Sense Lubricating Plus Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20230719		OTC MONOGRAPH DRUG	M018	GoodSense	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
50804-701_ad7336f7-902b-4151-a1f4-c128b8c0423c	50804-701	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20230203		OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	DOCUSATE SODIUM	100	mg/1			N	20241231
50804-735_52b207d1-d709-4a47-a077-d3be9c05419b	50804-735	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20181231	20241227	OTC MONOGRAPH FINAL	part338	Good Sense (Geiss, Destin & Dunn, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
50804-742_c80455e2-717d-4fbd-8dc7-e12d26cbbe7f	50804-742	HUMAN OTC DRUG	Daytime Cold Flu		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20190131	20241227	OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
50804-748_f28eee59-d9b0-0cd8-e053-2995a90af245	50804-748	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20150810		OTC MONOGRAPH FINAL	part358B	Geiss Destin & Dunn Inc.	SALICYLIC ACID	.17	g/9mL			N	20241231
50804-749_f3941a3e-1017-7afc-e053-2995a90a7b5d	50804-749	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover	LIQUID	TOPICAL	20150810		OTC MONOGRAPH FINAL	part358B	Geiss, Destin & Dunn, Inc.	SALICYLIC ACID	.17	g/9.8mL			N	20241231
50804-750_8da6210c-ee17-4ecd-bbd9-f91daabf2380	50804-750	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180630	20250630	ANDA	ANDA206999	Good Sense (Geiss, Destin & Dunn, Inc.)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
50804-755_f28ef69d-3980-38a3-e053-2995a90a6950	50804-755	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20210709		OTC MONOGRAPH NOT FINAL	part333A	Geiss Destin & Dunn Inc.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
50804-804_05592ff5-0783-4a2d-abf1-edd532f06b9f	50804-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20110422		OTC MONOGRAPH NOT FINAL	part333A	Perrigo Direct, Inc	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
50804-805_ee293ea9-2264-13c9-e053-2995a90aaa07	50804-805	HUMAN OTC DRUG	Cold and Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160530		OTC MONOGRAPH FINAL	part341	GoodSense	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-810_7aa546d4-ab35-464c-9eea-b2b7ba0dda5a	50804-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20100408		OTC MONOGRAPH NOT FINAL	part333A	Perrigo Direct, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
50804-815_19c5ab46-23c2-4cc7-b1ad-9a63f018b7c2	50804-815	HUMAN OTC DRUG	Laxative pills	Maximum Strength	Sennosides	TABLET	ORAL	20190131	20250131	OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	SENNOSIDES	25	mg/1			N	
50804-822_00c219b4-8752-414c-9f93-00f393ba5748	50804-822	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20110422		OTC MONOGRAPH FINAL	part346	Perrigo Direct, Inc.	WITCH HAZEL	979	mg/mL			N	20241231
50804-825_e7901a04-c964-fe5e-e053-2a95a90a8ddb	50804-825	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20170801		OTC MONOGRAPH FINAL	part341	GoodSense	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50804-826_e7901a04-c98e-fe5e-e053-2a95a90a8ddb	50804-826	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20170801		OTC MONOGRAPH NOT FINAL	part343	GoodSense	ACETAMINOPHEN	500	mg/1			N	20241231
50804-829_29e2eacb-35a1-45de-bffb-e6a3d196d698	50804-829	HUMAN OTC DRUG	Stimulant Laxative Plus	Stool Softener	Docusate sodium, Sennosides	TABLET	ORAL	20181231	20251231	OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
50804-831_d7997cc3-c797-45b7-ab0a-9f9259132f92	50804-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	19940805		OTC MONOGRAPH NOT FINAL	part334	Perrigo Direct, Inc.	MINERAL OIL	999	mg/mL			N	20241231
50804-838_db8af2b6-a825-2919-e053-2995a90a8729	50804-838	HUMAN OTC DRUG	GoodSense Pain Relief		Lidocaine	PATCH	TOPICAL	20190221		OTC MONOGRAPH NOT FINAL	part348	Geiss, Destin & Dunn, Inc	LIDOCAINE	40	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50804-840_ee293ea9-2251-13c9-e053-2995a90aaa07	50804-840	HUMAN OTC DRUG	Allergy Relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20181201		ANDA	ANDA206214	GOODSENSE	LORATADINE	10	mg/1			N	20241231
50804-845_5ee13c70-d0b3-40dd-9238-12768e7b762c	50804-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20110422		OTC MONOGRAPH FINAL	part344	Perrigo Direct, Inc.	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
50804-855_ba74cf69-6b9b-4683-84a4-ff3c9cfa15d6	50804-855	HUMAN OTC DRUG	Stool Softener Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20200630		OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
50804-857_21b74f4e-8117-4d1c-90f3-e80d766d97dd	50804-857	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20200228		OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
50804-858_b3476368-48db-4fda-ba7d-afe11ec7c480	50804-858	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin	TABLET	ORAL	20200630		OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50804-860_5c3e6620-5ac4-45a5-9316-0cb336b4be3e	50804-860	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20210430		OTC MONOGRAPH FINAL	part338	Good Sense (Geiss, Destin & Dunn, Inc.)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50804-862_098ab208-0beb-4869-8d20-0dae9686cd13	50804-862	HUMAN OTC DRUG	Docusate Sodium		DOCUSATE SODIUM	CAPSULE	ORAL	20210528		OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	DOCUSATE SODIUM	100	mg/1			N	20241231
50804-864_14df19b7-e9c9-480e-a5f8-43236220f679	50804-864	HUMAN OTC DRUG	50% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	20100521		OTC MONOGRAPH NOT FINAL	part333A	Perrigo Direct, Inc.	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
50804-871_19329e8a-da94-4d25-9d8e-e0fe3de9b9b2	50804-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19920615		OTC MONOGRAPH NOT FINAL	part333A	Perrigo Direct, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
50804-873_d125b2b1-0409-ca68-e053-2a95a90a8fbb	50804-873	HUMAN OTC DRUG	Good Sense Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20211115		OTC MONOGRAPH FINAL	part341	Good Sense	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-876_1cbcd45b-3afb-4ebf-87bf-ecf7c3c79559	50804-876	HUMAN OTC DRUG	Rubbing		Ethyl Alcohol	LIQUID	TOPICAL	20090518		OTC MONOGRAPH NOT FINAL	part333A	Perrigo Direct, Inc.	ALCOHOL	70	mL/100mL			N	20241231
50804-878_68f4d98d-1def-42cd-a2b5-f30f694e695b	50804-878	HUMAN OTC DRUG	Stool Softener Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20200630	20241227	OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
50804-880_cfbbdda9-fd06-09fc-e053-2995a90ae8c2	50804-880	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20190101		OTC MONOGRAPH NOT FINAL	part343	GOODSENSE	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50804-882_ab674a1a-950f-441e-856c-7f8ba244f6d4	50804-882	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20210917		OTC MONOGRAPH NOT FINAL	part334	Good Sense (Geiss, Destin & Dunn, Inc.)	SENNOSIDES	8.6	mg/1			N	20241231
50804-898_59044c86-bfcd-4fe6-9659-efc8724793b9	50804-898	HUMAN OTC DRUG	Daytime Cold Flu	Non Drowsy	Acetaminophen Dextromethorphen HBr Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH FINAL	part341	Good Sense (Geiss, Destin & Dunn, Inc.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50804-955_f1d8692b-defd-d55f-e053-2a95a90ae615	50804-955	HUMAN OTC DRUG	Good Sense Burn Relief Aloe		Lidocaine HCl	GEL	TOPICAL	20201204		OTC MONOGRAPH NOT FINAL	part348	Geiss, Destin & Dunn, Inc	LIDOCAINE HYDROCHLORIDE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50804-990_229b7e97-208b-40f9-9dfd-649e8ccb67ef	50804-990	HUMAN OTC DRUG	Menstrual Relief		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20200324		OTC MONOGRAPH DRUG	M013	Geiss, Destin & Dunn Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50809-001_08b3db2d-0417-fb0e-e063-6294a90a60f4	50809-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100517		UNAPPROVED MEDICAL GAS		Abilene Oxygen Inc.	OXYGEN	99	L/100L			N	20241231
50814-002_0889331f-b20f-4b93-e063-6294a90a64c7	50814-002	HUMAN OTC DRUG	Antiseptic Towelette		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20160322		OTC MONOGRAPH DRUG	M003	GFA Production (Xiamen) Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
50814-008_0888df53-3684-acfe-e063-6394a90a3d70	50814-008	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20160701		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
50814-016_83716894-42d6-8de2-e053-2a91aa0a0fe6	50814-016	HUMAN OTC DRUG	Refill 2		BENZALKONIUM CHLORIDE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	KIT		20160810		OTC MONOGRAPH FINAL	part333B	GFA Production (Xiamen) Co., Ltd.						N	20241231
50814-020_83716894-42f0-8de2-e053-2a91aa0a0fe6	50814-020	HUMAN OTC DRUG	Standard ANSI First Aid		WATER, BENZALKONIUM CHLORIDE, ISOPROPYL ALCOHOL, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE HYDROCHLORIDE	KIT	TOPICAL	20160810		OTC MONOGRAPH FINAL	part333B	GFA Production (Xiamen) Co., Ltd.						N	20241231
50814-021_08893c35-7d0c-4b5e-e063-6294a90afe9e	50814-021	HUMAN OTC DRUG	Large ANSI First Aid Kit		WATER, BENZALKONIUM CHLORIDE, ISOPROPYL ALCOHOL, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE HYDROCHLORIDE	KIT		20160809		OTC MONOGRAPH DRUG	M004	GFA Production (Xiamen) Co., Ltd.						N	20241231
50814-030_090d28f8-6d9a-cbaf-e063-6394a90a65a9	50814-030	HUMAN OTC DRUG	FAK Care4 Bus and School Yellow ORM D		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, ISOPROPYL ALCOHOL, BENZOCAINE, ALCOHOL	KIT		20180208		OTC MONOGRAPH DRUG	M004	GFA Production (Xiamen) Co., Ltd.						N	20241231
50814-031_789960be-2b27-f292-e053-2991aa0a13a2	50814-031	HUMAN OTC DRUG	FAK Large Office First Aid kit		BENZALKONIUM CHLORIDE	KIT		20180208		OTC MONOGRAPH FINAL	part349B	GFA Production (Xiamen) Co., Ltd.						N	20241231
50814-038_0888f7db-5b58-d846-e063-6394a90ac05b	50814-038	HUMAN OTC DRUG	INSECT STING RELIEF		BENZOCAINE	SWAB	TOPICAL	20180629		OTC MONOGRAPH DRUG	M017	GFA Production (Xiamen) Co., Ltd.	ALCOHOL; BENZOCAINE	60; 6	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50814-039_0888df53-36a1-acfe-e063-6394a90a3d70	50814-039	HUMAN OTC DRUG	Alcohol Cleansing		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20160322		OTC MONOGRAPH DRUG	M003	GFA Production (Xiamen) Co., Ltd.	ISOPROPYL ALCOHOL	700	mg/g			N	20241231
50814-040_0c868857-d595-9413-e063-6294a90a0bab	50814-040	HUMAN OTC DRUG	Insect Sting Relief		BENZOCAINE, ALCOHOL	CLOTH	TOPICAL	20181111		OTC MONOGRAPH DRUG	M003	GFA Production (Xiamen) Co., Ltd.	ALCOHOL; BENZOCAINE	600; 60	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50814-041_0888f7db-5b64-d846-e063-6394a90ac05b	50814-041	HUMAN OTC DRUG	INSECT STING RELIEF		BENZOCAINE, ALCOHOL	SWAB	TOPICAL	20180629		OTC MONOGRAPH DRUG	M017	GFA Production (Xiamen) Co., Ltd.	ALCOHOL; BENZOCAINE	600; 60	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50814-042_08891611-d70b-1df6-e063-6294a90ae3c2	50814-042	HUMAN OTC DRUG	FAK Care4 Bus and School Yellow ORM D		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, ISOPROPYL ALCOHOL, BENZOCAINE, ALCOHOL	KIT		20180208		OTC MONOGRAPH DRUG	M004	GFA Production (Xiamen) Co., Ltd.						N	20241231
50814-050_0888c674-1e46-805b-e063-6394a90a61d0	50814-050	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200301		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	.62	mL/mL			N	20241231
50814-051_0888e83d-82b5-05e3-e063-6294a90a08f0	50814-051	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200301		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	.7	mL/mL			N	20241231
50814-055_08894305-0542-54a2-e063-6394a90aa560	50814-055	HUMAN OTC DRUG	Genuine First Aid Alcohol Cleansing Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
50814-056_0888c3af-5d84-80be-e063-6394a90aca09	50814-056	HUMAN OTC DRUG	Genuine First Aid Antiseptic Hand Sanitizer Ethyl Alcohol		ALCOHOL	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	.62	mL/mL			N	20241231
50814-057_088948bf-835b-61b6-e063-6294a90a6f0d	50814-057	HUMAN OTC DRUG	Genuine First Aid Antiseptic Towelette		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50814-058_0888da32-6074-7c47-e063-6394a90a01e8	50814-058	HUMAN OTC DRUG	Genuine First Aid First Aid Antibiotic Bacitracin Zinc		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	M004	GFA Production (Xiamen) Co., Ltd.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50814-059_0888df53-3692-acfe-e063-6394a90a3d70	50814-059	HUMAN OTC DRUG	Genuine First Aid First Aid Antiseptic Pain Relieving Cream		BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50814-060_08890566-7160-c8cf-e063-6294a90a399f	50814-060	HUMAN OTC DRUG	Genuine First Aid Hand Sanitizer Ethyl Alcohol		ALCOHOL	GEL	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	.7	mL/mL			N	20241231
50814-061_0888c674-1e55-805b-e063-6394a90a61d0	50814-061	HUMAN OTC DRUG	Genuine First Aid Hand Sanitizer with Cap Ethyl Alcohol		ALCOHOL	GEL	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	.7	mL/mL			N	20241231
50814-062_0888e83d-82c3-05e3-e063-6294a90a08f0	50814-062	HUMAN OTC DRUG	Genuine First Aid Hand Sanitizer with Pump Ethyl Alcohol		ALCOHOL	GEL	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	.7	mL/mL			N	20241231
50814-063_0888f7db-5b49-d846-e063-6394a90ac05b	50814-063	HUMAN OTC DRUG	Genuine First Aid Hand Sanitizer Ethyl Alcohol		ALCOHOL	GEL	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production (Xiamen) Co., Ltd.	ALCOHOL	.7	mL/mL			N	20241231
50814-065_08891f6f-328a-2c93-e063-6394a90a281e	50814-065	HUMAN OTC DRUG	Genuine First Aid Insect Sting Relief Pad 1 ct		BENZOCAINE, ALCOHOL	SWAB	TOPICAL	20200101		OTC MONOGRAPH DRUG	M017	GFA Production (Xiamen) Co., Ltd.	ALCOHOL; BENZOCAINE	600; 60	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50814-077_0aaeaa08-d664-cb12-e063-6394a90a9163	50814-077	HUMAN OTC DRUG	Genuine First Aid Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M004	GFA Production(Xiamen) Co.,Ltd	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	U/g; mg/g; U/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
50814-078_0aaee809-d252-6119-e063-6294a90aee7a	50814-078	HUMAN OTC DRUG	Genuine First Aid Hand Sanitizer		ALCOHOL	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	ok505G(a)(3)	GFA Production(Xiamen) Co.,Ltd	ALCOHOL	62	mL/100mL			N	20241231
50814-079_0aaeb2ed-5380-5f43-e063-6294a90aeaa2	50814-079	HUMAN OTC DRUG	Genuine First Aid Pain Relieving Cream		BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M003	GFA Production (Xiamen) Co., Ltd.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
50814-080_0c632723-8800-2cee-e063-6394a90a9f4a	50814-080	HUMAN OTC DRUG	Genuine First Aid Alcohol Cleansing Pad		BENZOCAINE, ALCOHOL	CLOTH	TOPICAL	20230111		OTC MONOGRAPH DRUG	M017	GFA Production (Xiamen) Co., Ltd.	ALCOHOL; BENZOCAINE	600; 60	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
50814-081_0c622b05-d98c-ecd4-e063-6294a90ab6a2	50814-081	HUMAN OTC DRUG	Genuine First Aid Antiseptic Towelette		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20230111		OTC MONOGRAPH DRUG	M003	GFA Production (Xiamen) Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
50814-082_0c664957-81d0-76db-e063-6394a90aa0c9	50814-082	HUMAN OTC DRUG	Genuine First Aid Alcohol Cleansing Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20230111		OTC MONOGRAPH DRUG	505G(a)(3)	GFA Production(Xiamen) Co.,Ltd	ISOPROPYL ALCOHOL	70	mL/100g			N	20241231
50816-025_3bad7908-7b15-4746-a95e-2c2761ded189	50816-025	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20200831		NDA AUTHORIZED GENERIC	NDA019962	New American Therapeutics	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50816-050_3bad7908-7b15-4746-a95e-2c2761ded189	50816-050	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20200831		NDA AUTHORIZED GENERIC	NDA019962	New American Therapeutics	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50816-100_3bad7908-7b15-4746-a95e-2c2761ded189	50816-100	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20200831		NDA AUTHORIZED GENERIC	NDA019962	New American Therapeutics	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50816-200_3bad7908-7b15-4746-a95e-2c2761ded189	50816-200	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	New American Therapeutics	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
50844-004_ab260fd3-3089-4399-afc2-e85ca012bd83	50844-004	HUMAN OTC DRUG	Severe Congestion and Cough Relief	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20170301		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-005_f6575465-fb5e-4890-bd1c-74d6096dd226	50844-005	HUMAN OTC DRUG	Cold, Flu and Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20170301		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-014_1cd9acb3-5c08-4f1f-ad9f-b1a940169169	50844-014	HUMAN OTC DRUG	Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	SOLUTION	ORAL	20190110		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50844-018_57a2d62c-4be2-4976-969d-bfe191c34cd1	50844-018	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20181231		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-043_fb52d1d3-1827-4c78-8ec4-c127afb7c93d	50844-043	HUMAN OTC DRUG	Nighttime Cough DM		Dextromethorphan HBr, Doxylamine Succinate	SOLUTION	ORAL	20210716		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50844-073_818c6fae-270a-4ef7-8e1f-f3147af4fa0b	50844-073	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, FILM COATED	ORAL	20220705		OTC MONOGRAPH DRUG	505G(a)(3)	L.N.K. International, Inc.	SENNOSIDES	25	mg/1			N	20241231
50844-079_8f3a176c-d8a2-4e0b-892a-60b425bf8b89	50844-079	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20230201		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
50844-102_86fbfe4d-97e5-4f8d-86a2-b005a9d9cd35	50844-102	HUMAN OTC DRUG	Nighttime sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20200304		OTC MONOGRAPH DRUG	M010	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-104_69bf78be-9044-4fc8-ab9f-420501be81df	50844-104	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET	ORAL	20230525		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
50844-112_7fa8fe6b-e139-446f-b036-4dedbd419a19	50844-112	HUMAN OTC DRUG	Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50844-120_5495ce05-2d90-479b-b153-46caae688bb7	50844-120	HUMAN OTC DRUG	Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20220428		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-157_70f20aae-190f-4698-a68f-cc50895d0eff	50844-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50844-175_53939480-208f-4958-8d82-971a89384222	50844-175	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50844-199_cffd1cc0-89d1-4288-8fbe-5196e27f7a29	50844-199	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	L.N.K. International, Inc.	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-200_1eb0118e-e83c-4feb-8628-7f7a0831ec1e	50844-200	HUMAN OTC DRUG	Nighttime sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20160912		OTC MONOGRAPH DRUG	M010	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-218_9253d612-46b8-44e6-8a1b-b34722799bc0	50844-218	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	19900912		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50844-219_79f8f2b2-5dc3-41c2-921d-b847481e3398	50844-219	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	20200116		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50844-226_2cec881a-df52-458a-87c9-49c142d15d13	50844-226	HUMAN OTC DRUG	Alert	Alertness Aid	Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	L.N.K. International, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50844-229_7c043926-b0f0-41c5-b6bd-3072a20a215a	50844-229	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20220218		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-235_9f771d40-365d-4b1a-9dcb-f167ffd036ee	50844-235	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19940515		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-244_511d4d67-18ea-4375-908e-fb89f45022e2	50844-244	HUMAN OTC DRUG	Sinus Congestion		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220218		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-250_2ce5dda1-5f1c-4966-a7ac-7cd3cdd9b7ff	50844-250	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20190720		OTC MONOGRAPH DRUG	M010	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-251_d8deed81-1675-45c9-9da7-5d4b3ecc4184	50844-251	HUMAN OTC DRUG	Cold and Flu Daytime Relief		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20190720		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-252_392f6042-a41e-4932-9c72-38751a40d0d0	50844-252	HUMAN OTC DRUG	Cold and Flu Nighttime Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20190714		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50844-254_89efc8e3-cee0-454f-a03a-892ecf36e9c5	50844-254	HUMAN OTC DRUG	Coated Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20190715		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50844-255_f810ed8b-f6cb-4252-a36a-1aee4003a41f	50844-255	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20190723		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50844-256_d11a7f8f-7e4e-46ff-b485-e34e9aa17843	50844-256	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20190730		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-257_5c372314-d6f4-4e94-9727-be7695f167ac	50844-257	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20190722		ANDA	ANDA075010	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-258_c28e0a93-83a2-4b44-9027-8634a9367765	50844-258	HUMAN OTC DRUG	Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20190715		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50844-259_725898d1-05ee-4324-96b1-23bd7525a2c6	50844-259	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20190715		ANDA	ANDA076497	L.N.K. International, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
50844-260_4fc73ce4-3203-4560-a9a3-4f296d7c93d8	50844-260	HUMAN OTC DRUG	Nighttime Sleep Aid		Doxylamine succinate	TABLET	ORAL	20190723		ANDA	ANDA040564	L.N.K. International, Inc.	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50844-261_dc9e496e-cb8c-44f1-9fe0-beceaed8d9be	50844-261	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190806		ANDA	ANDA204872	L.N.K. International, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-263_ff40a863-2175-48aa-acf3-898ce1232396	50844-263	HUMAN OTC DRUG	Nasal Decongestant		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20190805	20240616	OTC MONOGRAPH FINAL	part341	L.N.K. International, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
50844-269_8c182eed-797b-4535-b278-5d2599e123fe	50844-269	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20191118		ANDA	ANDA079174	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-270_1a374fff-1ae1-4ec6-93c0-5de80e40c42a	50844-270	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20191114		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50844-271_687c338b-3f0d-496a-bc25-dc56f09b150a	50844-271	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190912		ANDA	ANDA079096	L.N.K. International, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-291_fc931971-3bcb-46b4-b6f9-4bd163154f1a	50844-291	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-292_cdf0b8db-fccf-4f46-aaf6-69e85228ff70	50844-292	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-327_c56d1f82-86a4-4d75-bac8-5d6b54396bef	50844-327	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	L.N.K. International, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50844-329_4fcfd14b-5561-4de7-9faa-0589c56e06ed	50844-329	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-344_e1257837-2a1f-4f4e-938d-2723d18e0219	50844-344	HUMAN OTC DRUG	Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210310		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50844-348_390b8cc9-4a51-4d1e-8e59-9e4d6594994c	50844-348	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20030102		OTC MONOGRAPH DRUG	505G(a)(3)	L.N.K. International, Inc.	SENNOSIDES	25	mg/1			N	20241231
50844-352_36672eda-1abe-4cd2-b7d5-339469c89875	50844-352	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-353_95a3ee26-906d-441a-9f29-13146183288c	50844-353	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-375_f25c2f8e-a8b8-4906-b9cb-d2de12b41118	50844-375	HUMAN OTC DRUG	Anti-diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	L.N.K. International, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50844-386_483d9fca-a996-424a-b236-2005e3c3bd35	50844-386	HUMAN OTC DRUG	Nighttime Sleep Aid		Doxylamine succinate	TABLET	ORAL	20020411		ANDA	ANDA040564	L.N.K. International, Inc.	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
50844-390_ff83b563-58c0-4779-a6c8-5919904902ed	50844-390	HUMAN OTC DRUG	Menstrual Complete	Maximum Strength	Acetaminophen, Caffeine and Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50844-392_4b0278d5-0331-48e9-8dbf-f4b9b1366d5e	50844-392	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-393_78f2c94a-f1dc-46df-ae19-73c492a1678c	50844-393	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-399_03cb5512-5a89-42df-b893-5667fdcd0a12	50844-399	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20230719		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50844-400_fa7ac292-5400-484c-8c95-9893947b6390	50844-400	HUMAN OTC DRUG	Severe Congestion and Cough Relief		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20210315		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-403_d88a00d5-c2c3-402f-a914-3e4cddd08e6a	50844-403	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20020624		OTC MONOGRAPH DRUG	M009	L.N.K. International, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
50844-413_eeba3ba3-67f8-4ee9-abde-8bd52558ea9a	50844-413	HUMAN OTC DRUG	Back and Body	Extra Strength	Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20040412		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50844-417_2d6a2a90-b5a5-4848-a139-3b2780e7fda2	50844-417	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20170201		ANDA	ANDA204872	L.N.K. International, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-438_27705e1b-2a79-4a24-80ce-70d51612afa0	50844-438	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-443_3fa49efb-4e0f-4d65-ac73-2a669022cf45	50844-443	HUMAN OTC DRUG	Sinus Congestion PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20201201		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-467_d11ec4b9-e567-43e7-8519-644894c24e07	50844-467	HUMAN OTC DRUG	Sinus and Headache	Daytime	Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-471_648f3cd7-751c-4ce3-9c1e-f9646b0dcf4c	50844-471	HUMAN OTC DRUG	Naproxen Headache Pain		Naproxen Sodium	TABLET, FILM COATED	ORAL	20200916		ANDA	ANDA204872	L.N.K. International, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-493_3d9d599b-4893-4e8c-bc02-c80c7742386a	50844-493	HUMAN OTC DRUG	Sinus Congestion		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210714		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-519_21f2c8ba-4f1c-4db4-924d-86019b888f23	50844-519	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50844-529_008fb3fd-ca2e-4aa7-8da9-38bc45f6d543	50844-529	HUMAN OTC DRUG	Cold Relief	Multi-Symptom	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	KIT		20050721		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.						N	20241231
50844-547_f441b7af-9f41-4f01-9a2a-eb15a3fc91b0	50844-547	HUMAN OTC DRUG	Cold and Flu	Severe, Day, Night	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr. Guaifenesin, Phenylephrine HCl	KIT		20210715		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.						N	20241231
50844-563_3e471422-814d-4924-a664-489b10c8eed8	50844-563	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50844-572_63b3e2dd-d00c-4c01-980a-b394272157d0	50844-572	HUMAN OTC DRUG	Sinus Severe		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210315		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-600_820bbd67-1208-4247-b4a7-9531ef909f49	50844-600	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50844-604_2d6a2a90-b5a5-4848-a139-3b2780e7fda2	50844-604	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20170201		ANDA	ANDA204872	L.N.K. International, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-633_b476ced2-7f9c-410e-8a8e-7ecd7d4e52be	50844-633	HUMAN OTC DRUG	Mucus Relief DM Cough		Dextromethorphan HBr and Guaifenesin	TABLET, FILM COATED	ORAL	20230807		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50844-640_293ad1e0-cf82-46dc-b853-99395d528fb8	50844-640	HUMAN OTC DRUG	Cold and Flu	Daytime Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220216		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-664_a51b1b11-f190-4fc0-96c1-9b4015525a49	50844-664	HUMAN OTC DRUG	Sinus Congestion and Pain Relief	Non-Drowsy	Acetaminophen and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-675_7f75bdf7-9a11-4f6a-aef4-6fe45ea6f2ea	50844-675	HUMAN OTC DRUG	Aspi-Cor		Aspirin	TABLET, DELAYED RELEASE	ORAL	20150203		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
50844-677_0b8a265f-39e6-48d7-872b-29991aea2697	50844-677	HUMAN OTC DRUG	Cold and Flu Nighttime Severe		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220207		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50844-679_c128ea4b-7da2-43b1-a3c3-769ff3d6cdb2	50844-679	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength	Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
50844-689_1b066995-6ee7-4509-b435-3475247a0138	50844-689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50844-697_bb65e18d-d883-43db-83d7-7121a4b1d793	50844-697	HUMAN OTC DRUG	WOMENS LAXATIVE		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20210726		OTC MONOGRAPH DRUG	505G(a)(3)	L.N.K. International, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50844-714_54664102-f678-4b4f-8fc6-da692e8e82a8	50844-714	HUMAN OTC DRUG	Naproxen Back and Muscle Pain		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190201		ANDA	ANDA204872	L.N.K. International, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-729_cbe42ff0-3a0d-4a3a-831d-ec2b804e79ff	50844-729	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210414	20240328	OTC MONOGRAPH FINAL	part341	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
50844-735_69412f60-274d-4805-a9a6-e103a34b097e	50844-735	HUMAN OTC DRUG	Loperamide HCl		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	L.N.K. International, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50844-753_8c154532-7d3f-4e20-a527-9b99f864249b	50844-753	HUMAN OTC DRUG	Anti Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	L.N.K. International, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
50844-754_1f46dd46-ae56-4403-bf46-006f90c73bc2	50844-754	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200408		ANDA	ANDA078682	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-773_4c58a22d-cde5-44a4-a49d-ae53a8c6aebd	50844-773	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, FILM COATED	ORAL	20220618		OTC MONOGRAPH DRUG	505G(a)(3)	L.N.K. International, Inc.	SENNOSIDES	25	mg/1			N	20241231
50844-795_17004341-e96d-4ef2-9b75-0d1af5307b3b	50844-795	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210506	20240120	OTC MONOGRAPH FINAL	part332	L.N.K. International, Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
50844-921_5ef008c1-ff9f-4b34-b21c-989fe451ebe1	50844-921	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50844-930_64e2a1fd-829b-445a-9382-b274936e6db0	50844-930	HUMAN OTC DRUG	Menstrual Complete	Maximum Strength	Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
50844-932_6e1f7a1b-4887-42b4-a32d-3afcbff940b1	50844-932	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	L.N.K. International, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-948_9d883e86-7585-42fe-9924-fd3654859c19	50844-948	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20030102		OTC MONOGRAPH DRUG	505G(a)(3)	L.N.K. International, Inc.	SENNOSIDES	25	mg/1			N	20241231
50844-951_ec7507ed-0a6b-4198-ab3b-413fb3cc44bb	50844-951	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
50844-956_25918b66-7ac6-4399-b956-17b617792e11	50844-956	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	L.N.K. International, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
50844-993_0ea35e02-5df6-4b57-95ec-471c468512a4	50844-993	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	L.N.K. International, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
50845-0035_4a6605ba-99fe-4ae3-8e9c-6c51a3136678	50845-0035	HUMAN OTC DRUG	Vital Female Sexual Energy		Agnus Castus, Arnica Montana, Caulophyllum Thalictroides, Cinchona Officinalis, Damiana, Hypophysis Suis, L-Arginine, Lactuca Virosa, Onosmodium Virginianum, Oophorinum Suis, Phosphoricum Acidum, Sepia, Thuja Occidentalis	SPRAY	ORAL	20100810		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ARGININE; ARNICA MONTANA; CAULOPHYLLUM THALICTROIDES ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; LACTUCA VIROSA; ONOSMODIUM VIRGINIANUM WHOLE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG	6; 3; 6; 3; 3; 3; 30; 200; 30; 30; 12; 30; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
50845-0043_1b926eb1-560f-4c97-bfd9-d5633789b802	50845-0043	HUMAN OTC DRUG	Anger		Aconitum napellus, Asafoetida, Chamomilla, Crocus sativus, Hyoscyamus niger, Ignatia amara, Sumbul, Valeriana officinalis	SPRAY	ORAL	20100825	20240321	UNAPPROVED HOMEOPATHIC		Liddell Laboratories	ACONITUM NAPELLUS; ASAFETIDA; FERULA SUMBUL ROOT; HYOSCYAMUS NIGER; MATRICARIA RECUTITA; SAFFRON; STRYCHNOS IGNATII SEED; VALERIAN	200; 4; 3; 200; 3; 3; 4; 3	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
50845-0044_13fb8511-b007-44c0-b84f-4916b64a938b	50845-0044	HUMAN OTC DRUG	Back Pain and Sciatica		Aconitum Napellus, Arnica Montana, Belladonna, Cimicifuga Racemosa, Euphorbium Officinarum, Gelsemium Sempervirens, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox	SPRAY	ORAL	20110105		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BLACK COHOSH; EUPHORBIA RESINIFERA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYTOLACCA AMERICANA ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RANUNCULUS BULBOSUS; TOXICODENDRON PUBESCENS LEAF	200; 200; 6; 6; 6; 6; 200; 10; 3; 30; 30; 200	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50845-0047_6e9f6de3-a9e1-4358-9b37-89014a64e8ea	50845-0047	HUMAN OTC DRUG	Anxiety plus Tension		Agnus castus, Avena sativa, Cinchona officinalis, Humulus lupulus, Hyoscyamus niger, Ignatia amara, Passiflora incarnata, Valeriana officinalis	SPRAY	ORAL	20100811		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	AVENA SATIVA FLOWERING TOP; CHASTE TREE; CINCHONA OFFICINALIS BARK; HOPS; HYOSCYAMUS NIGER; PASSIFLORA INCARNATA TOP; STRYCHNOS IGNATII SEED; VALERIAN	1; 6; 6; 2; 200; 3; 200; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
50845-0053_1fc2ae43-0e61-43c7-9692-162fcb0727a5	50845-0053	HUMAN OTC DRUG	Overwhelmed		Antimonium Crudum, Arsenicum Album, Baryta Carbonica, Calcarea Phosphorica, Calcarea Silicata, Cicuta Virosa, Conium Maculatum	SPRAY	ORAL	20100811	20251019	UNAPPROVED HOMEOPATHIC		Liddell Laboratories	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; CALCIUM SILICATE; CICUTA VIROSA ROOT; CONIUM MACULATUM FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE	30; 30; 12; 12; 30; 30; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
50845-0057_a6728022-ecd6-4d4b-8bba-bef34da25d2c	50845-0057	HUMAN OTC DRUG	Wart Free		Antimonium crudum, Baptisia tinctoria, Causticum, Nitricum acidum, Thuja occidentalis,	SPRAY	ORAL	20110331		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ANTIMONY TRISULFIDE; BAPTISIA TINCTORIA ROOT; CAUSTICUM; NITRIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	30; 3; 200; 200; 200	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
50845-0100_f3158bbf-7ff6-47be-8efe-6d3c9a4fa891	50845-0100	HUMAN OTC DRUG	Morning Sickness		Symphoricarpus racemosus,	SPRAY	ORAL	20110524	20240225	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	SYMPHORICARPOS ALBUS FRUIT	30	[hp_C]/mL			N	
50845-0108_54f9955d-1e43-4ea3-bcf4-8a26f0647cc9	50845-0108	HUMAN OTC DRUG	Insomnia		Aquilegia vulgaris, Avena sativa, Chamomilla, Coffea cruda, Cypripedium pubescens, Humulus lupulus, Hypericum perforatum, Kali phosphoricum, Melatonin, Melissa officinalis, Natrum muriaticum, Passiflora incarnata, Valeriana officinalis	SPRAY	ORAL	20121204	20240410	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	AQUILEGIA VULGARIS; ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; CHAMOMILLA; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; HOPS; HYPERICUM PERFORATUM; MELATONIN; MELISSA OFFICINALIS; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; VALERIAN	2; 6; 2; 2; 3; 3; 3; 6; 3; 2; 12; 30; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
50845-0124_692c3aff-84c4-4f61-9c6b-2469d892f727	50845-0124	HUMAN OTC DRUG	Appetite Increase		Alfalfa, Avena sativa, Oleum morrhuae	SPRAY	ORAL	20110328	20240226	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ALFALFA; AVENA SATIVA FLOWERING TOP; COD LIVER OIL	1; 1; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
50845-0135_dc7663f0-b12e-43ef-8c0c-e0453768a584	50845-0135	HUMAN OTC DRUG	Insect Bites		Anthracinum, Apis Mellifica, Arnica Montana, Calendula Officinalis, Conium Maculatum, Echinacea (Angustifolia), Euphorbia Pilulifera, Grindelia, Histaminum Hydrochloricum, Hypericum perforatum, Lachesis Mutus, Latrodectus Mactans, Ledum Palustre, Pyrogenium, Tarentula Cubensis	LIQUID	ORAL	20140707	20251110	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	APIS MELLIFERA; ARNICA MONTANA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; CALENDULA OFFICINALIS FLOWERING TOP; CITHARACANTHUS SPINICRUS; CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; EUPHORBIA HIRTA FLOWERING TOP; GRINDELIA HIRSUTULA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; RANCID BEEF	3; 200; 200; 3; 10; 200; 3; 4; 6; 12; 6; 200; 30; 6; 30	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
50845-0162_39d2f54b-2ec3-4bf5-8374-10523b32200e	50845-0162	HUMAN OTC DRUG	POSTPARTUM BLUES		Aconitum Napellus, Ambra Grisea, Hypericum Perforatum, Ignatia Amara, Nux Vomica, Spigelia Anthelmia	SPRAY	ORAL	20150113	20240218	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ACONITUM NAPELLUS; AMBERGRIS; HYPERICUM PERFORATUM; SPIGELIA ANTHELMIA; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED	30; 30; 3; 6; 30; 200	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
50845-0177_9e8a8231-a1b9-4a37-b0da-659560261a33	50845-0177	HUMAN OTC DRUG	Bedwetting		Belladonna, Cantharis, Causticum, Cina, Equisetum hyemale, Ingatia amara, Physalis alkekengi, Sepia, Uranium nitricum, Verbascum thapsus,	LIQUID	ORAL	20121115	20240214	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ATROPA BELLADONNA; CAUSTICUM; EQUISETUM HYEMALE; LYTTA VESICATORIA; PHYSALIS ALKEKENGI FRUIT; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; URANYL NITRATE HEXAHYDRATE; VERBASCUM THAPSUS	6; 200; 200; 3; 200; 3; 200; 200; 12; 3	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	
50845-0183_19d0f3d1-fcbc-48b9-80b1-dd6831cc7573	50845-0183	HUMAN OTC DRUG	Injuries		Anthracinum, Arnica montana, Bellis perennis, Calendula officinalis, Echinacea (Angustifolia), Hamamelis virginiana, Hypericum perforatum, Pyrogenium	SPRAY	ORAL	20120418	20241127	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ARNICA MONTANA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; RANCID BEEF	3; 30; 3; 3; 3; 3; 3; 200	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	
50845-0221_b7e3b481-06f2-4921-bf6e-8e97e78977ea	50845-0221	HUMAN OTC DRUG	Vital Skin Hair Nails		L-Alanine, L-Arginine, L-Carnitine, Cysteinum, L-Glutamine, L-Histidine, L-Isoleucine, L-Leucine, L-Lysine, L-Methionine, L-Ornithine, L-Proline, L-Serine, L-Tryptophan, L-Tyrosine, L-Valine, Apis Mellifica, Biotin, Epidermis Suis, Galium Aparine, Hamamelis Virginiana, Hepar Suis, HGH, Hypophysis Suis, Natrum Muriaticum, Pantothenic Acid, Phosphoricum Acidum, Riboflavinum, Thuja Occidentalis	SPRAY	ORAL	20160427	20260402	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ALANINE; APIS MELLIFERA; ARGININE; BIOTIN; CYSTEINE; GALIUM APARINE; GLUTAMINE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HISTIDINE; ISOLEUCINE; LEUCINE; LEVOCARNITINE; LYSINE; METHIONINE; ORNITHINE; PANTOTHENIC ACID; PHOSPHORIC ACID; PORK LIVER; PROLINE; RIBOFLAVIN; SERINE; SODIUM CHLORIDE; SOMATROPIN; SUS SCROFA PITUITARY GLAND; SUS SCROFA SKIN; THUJA OCCIDENTALIS LEAFY TWIG; TRYPTOPHAN; TYROSINE; VALINE	8; 200; 8; 10; 8; 5; 8; 3; 8; 8; 8; 8; 8; 8; 8; 6; 3; 6; 8; 6; 8; 200; 60; 30; 9; 200; 8; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [kp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Bee Venoms [CS], Carnitine Analog [EPC], Carnitine [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Human Growth Hormone [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC], Recombinant Human Growth Hormone [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	
50845-0226_6b79b1e9-13b6-4748-a4fc-70b1755ded84	50845-0226	HUMAN OTC DRUG	Hemorrhoid Relief		Aesculus Hippocastanum, Arnica Montana, Calcarea Fluorica, Carduus Marianus, Collinsonia Canadensis, Hamamelis Virginiana, Muriaticum Acidum, Ratanhia	SPRAY	ORAL	20151130	20250129	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	AESCULUS HIPPOCASTANUM FLOWER; ARNICA MONTANA; CALCIUM FLUORIDE; COLLINSONIA CANADENSIS ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYDROCHLORIC ACID; KRAMERIA LAPPACEA ROOT; MILK THISTLE	1; 3; 9; 3; 3; 6; 3; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
50845-0238_5d7067c9-e01c-4210-b2af-395ef8305070	50845-0238	HUMAN OTC DRUG	Vaccines		Arnica Montana, Mercurius Corrosivus, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens	LIQUID	ORAL	20180306	20250212	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ARNICA MONTANA; MERCURIC CHLORIDE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAF; URTICA URENS	3; 200; 200; 200; 3	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL			N	
50845-0241_e1f1eea2-2c34-4661-b359-038d70bd3ad8	50845-0241	HUMAN OTC DRUG	Pain		Aconitum Napellus, Arnica Montana, Arsenicum Album, Bellis Perennis, Cartilago Suis, Causticum, Chamomilla, Coffea Cruda, Euphorbium Officinarum, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Passiflora Incarnata, Pyrogenium, Ranunculus Bulbosus, Symphytum Officinale	LIQUID	ORAL	20181015	20240220	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ACONITUM NAPELLUS; ARABICA COFFEE BEAN; ARNICA MONTANA; ARSENIC TRIOXIDE; BELLIS PERENNIS; CAUSTICUM; COMFREY ROOT; EUPHORBIA RESINIFERA RESIN; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA TOP; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RANCID BEEF; RANUNCULUS BULBOSUS; SUS SCROFA CARTILAGE	200; 200; 3; 200; 3; 200; 6; 6; 200; 12; 3; 1; 3; 200; 6; 6	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
50845-0250_67d05c71-dbcd-4141-ba1d-eec23beafd2e	50845-0250	HUMAN OTC DRUG	Chemicals		Carduus Marianus, Hepar Suis, Lung Suis, Nux Vomica, Pancreas Suis, Phosphorus, Serum Anguillae, Terebinthina, X-Ray, Zingiber Officinale	SPRAY	ORAL	20190325		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); ANGUILLA ROSTRATA BLOOD SERUM; GINGER; PHOSPHORUS; PORK LIVER; SILYBUM MARIANUM SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LUNG; SUS SCROFA PANCREAS; TURPENTINE OIL	200; 30; 6; 200; 6; 3; 200; 6; 6; 6	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
50845-0251_df521eee-ede6-4a79-96de-ce9b70d4be45	50845-0251	HUMAN OTC DRUG	Snore Defense		Antimonium tartaricum, Carbo vegetabilis, Grindelia (Robusta), Lung suis, Mucosa nasalis suis, Nux vomica, Quebracho, Sticta pulmonaria, Teucrium marum	SPRAY	ORAL	20190402	20240402	UNAPPROVED HOMEOPATHIC		Liddell Laboratories	ACTIVATED CHARCOAL; ANTIMONY POTASSIUM TARTRATE; ASPIDOSPERMA QUEBRACHO-BLANCO BARK; GRINDELIA HIRSUTULA FLOWERING TOP; LOBARIA PULMONARIA; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; TEUCRIUM MARUM	12; 200; 3; 200; 200; 12; 6; 6; 3	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
50845-0253_a9bf700b-7627-4df6-8a49-84355f350b59	50845-0253	HUMAN OTC DRUG	Stomach Distress		Bismuthum Subnitricum, Calcarea Sulphurica, Carbo Animalis, Carbo Vegetabilis, Cinchona Officinalis, Hydrastis Canadensis, Nux Vomica, Ornithogalum Umbellatum, Pyrogenium, Silicea,	SPRAY	ORAL	20190412		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ACTIVATED CHARCOAL; BISMUTH SUBNITRATE; CALCIUM SULFATE ANHYDROUS; CARBO ANIMALIS; CINCHONA OFFICINALIS BARK; GOLDENSEAL; ORNITHOGALUM UMBELLATUM WHOLE; RANCID BEEF; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	12; 200; 200; 12; 200; 12; 12; 200; 12; 200	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
50845-0254_c31eec3e-2616-40e9-9437-c5e81f5be1e6	50845-0254	HUMAN OTC DRUG	Sinus Congestion Headache		Antimonium Tartaricum, Asafoetida, Baptisia Tinctoria, Echinacea (Angustifolia), Eupatorium Perfoliatum, Euphorbia Pilulifera, Hepar Sulphuris Calcareum, Hydrastis Canadensis, Iodium, Kali Bichromicum, Lachesis Mutus, Magnesia Carbonica, Mucosa Nasalis Suis, Pulsatilla (Vulgaris), Pyrogenium, Silicea, Teucrium Marum	SPRAY	ORAL	20190424	20240630	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ASAFETIDA; BAPTISIA TINCTORIA ROOT; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHORBIA HIRTA FLOWERING TOP; GOLDENSEAL; IODINE; LACHESIS MUTA VENOM; MAGNESIUM CARBONATE; POTASSIUM DICHROMATE; RANCID BEEF; SILICON DIOXIDE; SUS SCROFA NASAL MUCOSA; TEUCRIUM MARUM	30; 6; 30; 3; 30; 3; 6; 3; 30; 200; 200; 10; 30; 200; 30; 12; 3	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	
50845-0255_4c079d79-7d78-4773-97c8-23af6f47ecdb	50845-0255	HUMAN OTC DRUG	Motion Sickness		Carbolicum acidum, Cocculus indicus, Hepar suis, Lobelia Inflata, Nux vomica, Phosphoricum acidum, Sepia	SPRAY	ORAL	20190524	20240730	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ANAMIRTA COCCULUS SEED; LOBELIA INFLATA; PHENOL; PHOSPHORIC ACID; PORK LIVER; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED	200; 6; 6; 200; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
50845-0258_5d7b1729-05fd-413b-8999-635af6b91950	50845-0258	HUMAN OTC DRUG	Incontinence		Belladonna, Cantharis, Causticum, Cina, Equisetum hyemale, Ignatia amara, Physalis alkekengi, Sepia, Pulsatilla (pratensis), Verbascum thapsus	SPRAY	ORAL	20200309	20241028	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ATROPA BELLADONNA; CAUSTICUM; EQUISETUM HYEMALE; LYTTA VESICATORIA; PHYSALIS ALKEKENGI FRUIT; PULSATILLA PRATENSIS WHOLE; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; VERBASCUM THAPSUS	6; 200; 200; 3; 200; 6; 12; 200; 200; 6	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL			N	
50845-0259_d4199224-1f3c-4cdd-bf46-00b87a39baf6	50845-0259	HUMAN OTC DRUG	Ear Discomfort		Aconitum Napellus, Anthracinum, Arnica Montana, Baptisia Tinctoria, Belladonna, Capsicum Annuum, Chamomilla, Chenopodium Anthelminticum, Euphorbium Officinarum, Lachesis Mutus, Magnesia Phosphorica, Plantago Major, Pulsatilla (Pratensis), Verbascum Thapsus	LIQUID	ORAL	20200309	20250102	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PRATENSIS; ARNICA MONTANA; ATROPA BELLADONNA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; CAPSICUM; DYSPHANIA AMBROSIOIDES WHOLE; EUPHORBIA RESINIFERA RESIN; LACHESIS MUTA VENOM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; PLANTAGO MAJOR; VERBASCUM THAPSUS	200; 30; 200; 200; 200; 3; 6; 15; 6; 200; 10; 3; 3; 6	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	
50845-0264_f235e5ed-43be-4517-bb8e-5f062932c5c3	50845-0264	HUMAN OTC DRUG	Snore Defense		Antimonium tartaricum, Carbo vegetabilis, Grindelia (Robusta), Lung suis, Mucosa nasalis suis, Nux vomica, Sambucus nigra, Sticta pulmonaria, Teucrium marum	SPRAY	ORAL	20200310	20241217	UNAPPROVED HOMEOPATHIC		Liddell Laboratories	ACTIVATED CHARCOAL; ANTIMONY POTASSIUM TARTRATE; GRINDELIA HIRSUTULA FLOWERING TOP; LOBARIA PULMONARIA; SAMBUCUS NIGRA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; TEUCRIUM MARUM	12; 200; 200; 200; 3; 12; 6; 6; 3	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
50845-0265_98ae5431-1b62-4394-a9b9-cb8c45f674f2	50845-0265	HUMAN OTC DRUG	Pain		Aconitum Napellus, Arnica Montana, Bellis Perennis, Bryonia (Alba), Cartilago Suis, Causticum, Chamomilla, Coffea Cruda, Euphorbium Officinarum, Gnaphalium Polycephalum, Hypericum Perforatum, Magnesia Phosphorica, Passiflora Incarnata, Pyrogenium, Ranunculus Bulbosus, Symphytum Officinale	SPRAY	ORAL	20200326		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ACONITUM NAPELLUS WHOLE; ARABICA COFFEE BEAN; ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BRYONIA ALBA ROOT; CAUSTICUM; COMFREY ROOT; EUPHORBIA RESINIFERA RESIN; HYPERICUM PERFORATUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RANCID BEEF; RANUNCULUS BULBOSUS WHOLE; SUS SCROFA CARTILAGE	200; 200; 3; 3; 12; 200; 6; 6; 200; 12; 3; 1; 3; 200; 6; 6	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
50845-0266_87f447b1-2229-491d-a61e-631d4b03a7c6	50845-0266	HUMAN OTC DRUG	Candida Yeast		Baptisia Tinctoria, Borax, Candida Albicans, Candida Parapsilosis, Cinchona Officinalis, Echinacea (Angustifolia), Nitricum Acidum, Pulsatilla (Pratensis), Pyrogenium, Sepia, Sulphuricum Acidum, Thuja Occidentalis	SPRAY	ORAL	20200318	20250326	UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ANEMONE PRATENSIS; BAPTISIA TINCTORIA ROOT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CINCHONA OFFICINALIS BARK; ECHINACEA ANGUSTIFOLIA WHOLE; NITRIC ACID; RANCID BEEF; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SULFURIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	30; 3; 12; 8; 30; 3; 30; 200; 30; 30; 30; 30	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	
50845-0269_cdb4274e-5d6d-441c-a283-e8252e696d3d	50845-0269	HUMAN OTC DRUG	Anger		Aconitum napellus, Asafoetida, Chamomilla, Crocus sativus, Hyoscyamus niger, Ignatia amara, Staphysagria, Valeriana officinalis	SPRAY	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Liddell Laboratories	ACONITUM NAPELLUS WHOLE; DELPHINIUM STAPHISAGRIA SEED; FERULA ASSA-FOETIDA RESIN; HYOSCYAMUS NIGER; MATRICARIA CHAMOMILLA WHOLE; SAFFRON; STRYCHNOS IGNATII SEED; VALERIAN	200; 200; 4; 200; 3; 3; 4; 3	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
50845-0272_b5a38025-d7f8-4589-9c07-553bdca09e1f	50845-0272	HUMAN OTC DRUG	Insomnia		Aquilegia Vulgaris, Avena Sativa, Chamomilla, Coffea Cruda, Cypripedium Pubescens, Humulus Lupulus, Hypericum Perforatum, Kali Phosphoricum, Melatonin, Melissa Officinalis, Natrum Muriaticum, Passiflora Incarnata, Valeriana Officinalis	SPRAY	ORAL	20201223		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	AQUILEGIA VULGARIS; ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DIBASIC POTASSIUM PHOSPHATE; HOPS; HYPERICUM PERFORATUM WHOLE; MATRICARIA CHAMOMILLA WHOLE; MELATONIN; MELISSA OFFICINALIS WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; SODIUM CHLORIDE; VALERIAN	2; 6; 2; 8; 12; 3; 6; 2; 6; 3; 2; 30; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
50845-0274_6a28ccf7-80a2-4db1-a1aa-ec417335b8ae	50845-0274	HUMAN OTC DRUG	Fem Flora Defense		Baptisia Tinctoria, Borax, Candida Albicans, Candida Parapsilosis, Cinchona Officinalis, Echinacea (Angustifolia), Nitricum Acidum, Pulsatilla (Pratensis), Pyrogenium, Sepia, Sulphuricum Acidum, Thuja Occidentalis	SPRAY	ORAL	20210422		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	BAPTISIA TINCTORIA ROOT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CINCHONA OFFICINALIS BARK; ECHINACEA ANGUSTIFOLIA WHOLE; NITRIC ACID; PULSATILLA PRATENSIS WHOLE; RANCID BEEF; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SULFURIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	3; 12; 8; 30; 3; 30; 30; 200; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
50845-0278_0a4df381-9054-406f-9134-1946a08e9fa2	50845-0278	HUMAN OTC DRUG	Vital Skin Hair Nails		L-Alanine, L-Arginine, L-Carnitine, Cysteinum, L-Glutamine, L-Histidine, L-Isoleucine, L-Leucine, L-Lysine, L-Methionine, L-Ornithine, L-Proline, L-Serine, L-Tryptophan, L-Tyrosine, L-Valine, Apis Mellifica, Biotin, Epidermis Suis, Galium Aparine, Hamamelis Virginiana, Hepar Suis, HGH, Hypophysis Suis, Natrum Muriaticum, Pantothenic Acid, Phosphoricum Acidum, Riboflavinum, Thuja Occidentalis	SPRAY	ORAL	20210726		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	ALANINE; APIS MELLIFERA; ARGININE; BIOTIN; CYSTEINE; GALIUM APARINE WHOLE; GLUTAMINE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HISTIDINE; ISOLEUCINE; LEUCINE; LEVOCARNITINE; LYSINE; METHIONINE; ORNITHINE; PANTOTHENIC ACID; PHOSPHORIC ACID; PORK LIVER; PROLINE; RIBOFLAVIN; SERINE; SODIUM CHLORIDE; SOMATROPIN; SUS SCROFA PITUITARY GLAND; SUS SCROFA SKIN; THUJA OCCIDENTALIS LEAFY TWIG; TRYPTOPHAN; TYROSINE; VALINE	10; 200; 10; 10; 10; 5; 10; 3; 10; 10; 10; 10; 10; 10; 10; 6; 3; 6; 10; 6; 10; 200; 60; 30; 9; 200; 10; 10; 10	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Bee Venoms [CS], Carnitine Analog [EPC], Carnitine [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Human Growth Hormone [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC], Recombinant Human Growth Hormone [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
50845-0280_8da03e77-3ea7-4d94-9fde-60587116bd04	50845-0280	HUMAN OTC DRUG	Derma Pain		Calendula Officinalis, Croton Tiglium, Natrum Muriaticum, Plantago Major, Rhus Tox, Sarsaparilla (Smilax Regelii)	SPRAY	TOPICAL	20220629		UNAPPROVED HOMEOPATHIC		Liddell Laboratories, Inc.	CALENDULA OFFICINALIS FLOWERING TOP; CROTON TIGLIUM SEED; PLANTAGO MAJOR WHOLE; SMILAX ORNATA ROOT; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	12; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
50862-1310_0b60f175-717a-4764-aed8-aa5dcbead4dc	50862-1310	HUMAN OTC DRUG	Ally Hand Sanitizer Wipes		Alcohol	CLOTH	TOPICAL	20220405		OTC MONOGRAPH DRUG	M003	Guy & O'Neill, Inc.	ALCOHOL	70	mL/1001			N	20251231
50865-017_03a8c5b9-b040-8b10-e063-6294a90ac578	50865-017	HUMAN OTC DRUG	E2 SANITIZING HAND		E2 SANITIZING HAND	SOAP	TOPICAL	20150915		OTC MONOGRAPH NOT FINAL	part333A	KUTOL PRODUCTS COMPANY	BENZALKONIUM CHLORIDE	.003	mg/mL			N	20241231
50865-025_03376605-1ca8-91b4-e063-6394a90aa98d	50865-025	HUMAN OTC DRUG	Soft and Silky Antiseptic		Antiseptic Lotion Soap	SOLUTION	TOPICAL	20131104		OTC MONOGRAPH NOT FINAL	part333A	Kutol Products Company, Inc.	CHLOROXYLENOL	3.82	g/100mL			N	20241231
50865-056_03a904f5-0643-f1e2-e063-6294a90af80e	50865-056	HUMAN OTC DRUG	Santi-Gel Instant Hand Sanitizer		Santi-Gel Instant Hand Sanitizer	SOLUTION	TOPICAL	20130522		OTC MONOGRAPH NOT FINAL	part333A	Kutol Products Company, Inc.	ALCOHOL	62.5	mL/100mL			N	20241231
50865-060_03fbd386-91bd-0b9a-e063-6394a90ac400	50865-060	HUMAN OTC DRUG	Golden Medicated		Medicated Lotion Soap	SOLUTION	TOPICAL	20140311		OTC MONOGRAPH NOT FINAL	part333A	Kutol Products Company	CHLOROXYLENOL	.3	g/100mL			N	20241231
50865-213_03379280-d49d-081d-e063-6394a90a9c6e	50865-213	HUMAN OTC DRUG	Foaming Advanced Antibacterial Hand		benzalkonium chloride	SOAP	TOPICAL	20151001		OTC MONOGRAPH NOT FINAL	part333A	Kutol Products Company	BENZALKONIUM CHLORIDE	.003	mg/mL			N	20241231
50865-683_03376605-1ccd-91b4-e063-6394a90aa98d	50865-683	HUMAN OTC DRUG	Foaming Sanitizing Hand		benzalkonium chloride	SOAP	TOPICAL	20151001		OTC MONOGRAPH NOT FINAL	part333E	Kutol Products Company	BENZALKONIUM CHLORIDE	.003	mg/mL			N	20241231
50865-688_0337689b-c5e6-d881-e063-6394a90aaec9	50865-688	HUMAN OTC DRUG	eZFoam Foaming Alcohol Hand Sanitizer		Foaming Hand Sanitizer	SOLUTION	TOPICAL	20130627		OTC MONOGRAPH NOT FINAL	part333A	Kutol Products Company	ALCOHOL	62	mL/100mL			N	20241231
50865-710_0337689b-c5e9-d881-e063-6394a90aaec9	50865-710	HUMAN OTC DRUG	Foaming Sanitizing Hand		alcohol	SOAP	TOPICAL	20151001		OTC MONOGRAPH NOT FINAL	part333E	Kutol Products Company	ALCOHOL	.072	mg/mL			N	20241231
50881-005_7ad0702b-6815-4b62-a2f3-5c9bd6dbc5dc	50881-005	HUMAN PRESCRIPTION DRUG	JAKAFI		ruxolitinib	TABLET	ORAL	20111116		NDA	NDA202192	Incyte Corporation	RUXOLITINIB	5	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
50881-006_7a7df4a8-e6a7-40c8-9f30-b714033de087	50881-006	HUMAN PRESCRIPTION DRUG	ZYNYZ		retifanlimab-dlwr	INJECTION	INTRAVENOUS	20230322		BLA	BLA761334	Incyte Corporation	RETIFANLIMAB	25	mg/mL	Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]		N	20241231
50881-007_412d91a7-8bf3-43b4-8231-6f47edc60f9a	50881-007	HUMAN PRESCRIPTION DRUG	OPZELURA		ruxolitinib	CREAM	TOPICAL	20210921		NDA	NDA215309	Incyte Corporation	RUXOLITINIB PHOSPHATE	15	mg/g	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
50881-010_7ad0702b-6815-4b62-a2f3-5c9bd6dbc5dc	50881-010	HUMAN PRESCRIPTION DRUG	JAKAFI		ruxolitinib	TABLET	ORAL	20111116		NDA	NDA202192	Incyte Corporation	RUXOLITINIB	10	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
50881-015_7ad0702b-6815-4b62-a2f3-5c9bd6dbc5dc	50881-015	HUMAN PRESCRIPTION DRUG	JAKAFI		ruxolitinib	TABLET	ORAL	20111116		NDA	NDA202192	Incyte Corporation	RUXOLITINIB	15	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
50881-020_7ad0702b-6815-4b62-a2f3-5c9bd6dbc5dc	50881-020	HUMAN PRESCRIPTION DRUG	JAKAFI		ruxolitinib	TABLET	ORAL	20111116		NDA	NDA202192	Incyte Corporation	RUXOLITINIB	20	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
50881-025_7ad0702b-6815-4b62-a2f3-5c9bd6dbc5dc	50881-025	HUMAN PRESCRIPTION DRUG	JAKAFI		ruxolitinib	TABLET	ORAL	20111116		NDA	NDA202192	Incyte Corporation	RUXOLITINIB	25	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
50881-026_c6db56e1-8d15-47a3-a247-94583b0f69a3	50881-026	HUMAN PRESCRIPTION DRUG	PEMAZYRE		pemigatinib	TABLET	ORAL	20200417		NDA	NDA213736	Incyte Corporation	PEMIGATINIB	4.5	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50881-027_c6db56e1-8d15-47a3-a247-94583b0f69a3	50881-027	HUMAN PRESCRIPTION DRUG	PEMAZYRE		pemigatinib	TABLET	ORAL	20200417		NDA	NDA213736	Incyte Corporation	PEMIGATINIB	9	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50881-028_c6db56e1-8d15-47a3-a247-94583b0f69a3	50881-028	HUMAN PRESCRIPTION DRUG	PEMAZYRE		pemigatinib	TABLET	ORAL	20200417		NDA	NDA213736	Incyte Corporation	PEMIGATINIB	13.5	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
50914-7720_1f46b3df-897f-4a96-9feb-9e5c9dd2864f	50914-7720	HUMAN PRESCRIPTION DRUG	Volumex		Iodinated I-131 Albumin	INJECTION, SOLUTION	INTRAVENOUS	19930801		BLA	BLA017837	Iso-Tex Diagnostics, Inc.	HUMAN SERUM ALBUMIN I-131	.025	mCi/mL	Radiopharmaceutical Activity [MoA]		N	20241231
50914-7729_03a98b4c-213b-4537-8d3a-aaa9f9f1cc9b	50914-7729	HUMAN PRESCRIPTION DRUG	Glofil-125		Sodium Iothalamate I-125 injection	INJECTION, SOLUTION	INTRAVENOUS	19830501		NDA	NDA017279	Iso-Tex Diagnostics, Inc.	IOTHALAMATE SODIUM I-125	.275	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
50914-7731_a0a63fb3-6957-4446-8bf0-67c91325f753	50914-7731	HUMAN PRESCRIPTION DRUG	Megatope		Iodinated I-131 Albumin	INJECTION, SOLUTION	INTRAVENOUS	19960521		BLA	BLA017837	Iso-Tex Diagnostics, Inc.	HUMAN SERUM ALBUMIN I-131	1	mCi/mL	Radiopharmaceutical Activity [MoA]		N	20241231
50914-7732_00ad6e0d-58de-41b1-93d1-7ba11ae0bba5	50914-7732	HUMAN PRESCRIPTION DRUG	Jeanatope		Iodinated I-125 Albumin	INJECTION, SOLUTION	INTRAVENOUS	19900601		BLA	BLA017836	Iso-Tex Diagnostics, Inc.	HUMAN SERUM ALBUMIN I-125	.01	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
50914-7733_cfd145b7-bf08-49a8-9995-a08d166f8e54	50914-7733	HUMAN PRESCRIPTION DRUG	Jeanatope		Iodinated I-125 Albumin	INJECTION, SOLUTION	INTRAVENOUS	20220309		BLA	BLA017836	Iso-Tex Diagnostics, Inc.	HUMAN SERUM ALBUMIN I-125	1000	uCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
50967-126_f28edbaa-6e1e-d477-e053-2995a90ab60d	50967-126	HUMAN PRESCRIPTION DRUG	IROSPAN 24/6		IRON, FOLIC ACID, VITAMIN/MINERAL SUPPLEMENT	KIT		20110415		UNAPPROVED DRUG OTHER		WOMENS CHOICE PHARMACEUTICALS LLC						N	20241231
50967-219_f28ee215-1dc9-0062-e053-2995a90a6c14	50967-219	HUMAN PRESCRIPTION DRUG	NESTABS	Prenatal Multi-vitamin/Mineral Supplement	Multi-vitamin/Mineral Supplement with Sodium Ascorbate, Cholecalciferol, di-alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine HCL, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (II) bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, and Choline Bitartrate	TABLET, FILM COATED	ORAL	20110201		UNAPPROVED DRUG OTHER		WOMENS CHOICE PHARMACEUTICALS LLC	.ALPHA.-TOCOPHEROL ACETATE, D-; CALCIUM CARBONATE; CALCIUM FORMATE; CHOLECALCIFEROL; CHOLINE BITARTRATE; CYANOCOBALAMIN; FERROUS BISGLYCINATE; FOLIC ACID; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; ZINC OXIDE	30; 45; 155; 450; 55; 10; 32; 1; 20; 100; 50; 3; 120; 3; 10	[iU]/1; mg/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
50967-317_f28eb4a7-f30f-9dcb-e053-2a95a90af706	50967-317	HUMAN PRESCRIPTION DRUG	NESTABS DHA	Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA	Sodium Ascorbate, Cholecalciferol, di-alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine HCL, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (II) bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, with doconexent and icosapent	KIT		20110201		UNAPPROVED DRUG OTHER		WOMENS CHOICE PHARMACEUTICALS LLC						N	20241231
50967-357_f28dff05-e53b-9a19-e053-2a95a90a6b1f	50967-357	HUMAN PRESCRIPTION DRUG	PROCORT		1.85% hydrocortisone acetate - 1.15% pramoxine hci cream	CREAM	TOPICAL	20110630		UNAPPROVED DRUG OTHER		Womens Choice Pharmaceuticals LLC	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	18.5; 11.5	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
50970-001_0b527abd-28ca-db35-e063-6394a90a8453	50970-001	HUMAN OTC DRUG	e-HCG	Fat Release System	arginine, acetylcarnitine, l-, ornithine and human chorionic gonadotropin	LIQUID	ORAL	20100819		UNAPPROVED HOMEOPATHIC		AnuMed International LLC	ACETYLCARNITINE; ARGININE; HUMAN CHORIONIC GONADOTROPIN; ORNITHINE	30; 30; 60; 30	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
50970-002_0b528b3e-5cd1-e56c-e063-6394a90a3e7d	50970-002	HUMAN OTC DRUG	e-HGH		hGH somatropin	LIQUID	ORAL	20110501		UNAPPROVED HOMEOPATHIC		AnuMed International LLC	SOMATROPIN	6	[hp_C]/200mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
50970-003_0b5290dd-a314-1581-e063-6294a90ab0c6	50970-003	HUMAN OTC DRUG	IGF-1 Endurance Plus		insulin-like growth factor-1 (IGF-1)	LIQUID	ORAL	20110501		UNAPPROVED HOMEOPATHIC		AnuMed International LLC	MECASERMIN	30	[hp_C]/30mL			N	20241231
50980-207_2e833f78-5ede-4e76-a1c7-6523cd419411	50980-207	HUMAN OTC DRUG	Ben E. Keith FIHS		Benzalkonium Chloride	SOLUTION	TOPICAL	20160531		OTC MONOGRAPH NOT FINAL	part333E	Ben E. Keith Foods	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
50991-132_fda90ac0-7479-4cd6-e053-6294a90abbf0	50991-132	HUMAN OTC DRUG	Polytussin DM		Dextromethorphan HBr, Phenylephrine HCl, Pyrilamine Maleate	SYRUP	ORAL	20230608		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE	7.5; 5; 12.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-136_fc5401e2-ed66-72e7-e053-6294a90a81f3	50991-136	HUMAN OTC DRUG	Endal		Triprolidine HCl, Dextromethorphan HBr	LIQUID	ORAL	20230522		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	10; 1.25	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
50991-212_0850712c-557a-e7d3-e063-6394a90aefcd	50991-212	HUMAN OTC DRUG	Poly-Vent IR		Guaifenesin and Pseudoephedrine HCl	TABLET	ORAL	20130611		OTC MONOGRAPH DRUG	M012	Poly Pharmaceuticals, Inc.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	380; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
50991-214_f4c8866f-be6e-304b-e053-2995a90aca55	50991-214	HUMAN OTC DRUG	Poly-Vent DM		Dextromethorphan HBr, Guaifenesin and Pseudoephedrine HCl	TABLET	ORAL	20130617		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	20; 380; 60	mg/1; mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50991-220_f4c8925c-ac50-43b1-e053-2995a90a916c	50991-220	HUMAN OTC DRUG	Poly-Hist DM		Dextromethorphan Hydrobromide, Phenylephrine HCl and Thonzylamine HCl	LIQUID	ORAL	20130622		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE	10; 5; 25	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-444_fdaa062d-110f-798d-e053-6394a90a755c	50991-444	HUMAN OTC DRUG	ALAHIST DM		Dextromethorphan HBr, Pheniramine Maleate, Phenylephrine HCl	LIQUID	ORAL	20230608		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	10; 12.5; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-535_f4c84047-fd3f-ea66-e053-2a95a90ae9aa	50991-535	HUMAN OTC DRUG	Duraflu		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PSEUDOEPHEDRINE HCl	TABLET	ORAL	20151001		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	325; 20; 200; 60	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
50991-626_f4c8866f-be6d-304b-e053-2995a90aca55	50991-626	HUMAN OTC DRUG	Poly Hist Forte		Doxylamine Succinate and Phenylephrine Hydrochloride	TABLET	ORAL	20190601		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	10.5; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-723_efbb79b0-5f44-7ada-e053-2995a90ae470	50991-723	HUMAN OTC DRUG	Poly-Tussin AC		Brompheniramine Maleate, Codeine Phosphate, Phenylephrine Hydrochloride	LIQUID	ORAL	20140602		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], alpha-1 Adrenergic Agonist [EPC]	CV	N	20241231
50991-736_efbbcabc-f615-8aba-e053-2995a90a249a	50991-736	HUMAN OTC DRUG	Deconex IR		Guaifenesin and Phenylephrine HCl	TABLET	ORAL	20160808		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	385; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-740_f17bdf02-2295-daaf-e053-2995a90add07	50991-740	HUMAN OTC DRUG	DECONEX	DMX	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	TABLET	ORAL	20190601		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	17.5; 400; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-776_ef311398-9775-2727-e053-2995a90a749d	50991-776	HUMAN OTC DRUG	Alahist D		Pheniramine Maleate, Phenylephrine HCl	TABLET	ORAL	20200401		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	17.5; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-783_f4bfa866-34a6-377a-e053-2a95a90a2ae6	50991-783	HUMAN OTC DRUG	ALA-HIST IR		Dexbrompheniramine Maleate	TABLET	ORAL	20110822		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXBROMPHENIRAMINE MALEATE	2	mg/1			N	20241231
50991-788_f4bf7f15-6579-71c4-e053-2a95a90aeb27	50991-788	HUMAN OTC DRUG	Alahist PE		Dexbrompheniramine Maleate, Phenylephrine Hydrochloride	TABLET	ORAL	20200824		OTC MONOGRAPH FINAL	part341	Poly Pharmaceuticals, Inc.	DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 7.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
50991-999_db8eb46a-aea5-3cf0-e053-2a95a90a59f2	50991-999	HUMAN PRESCRIPTION DRUG	Norgesic Forte		Orphenadrine Citrate, Aspirin and Caffeine	TABLET, MULTILAYER	ORAL	20190401		ANDA	ANDA075141	Poly Pharmaceuticals, Inc.	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770; 60; 50	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Muscle Relaxant [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
50996-001_a5080730-c424-4757-9f15-1d26be70a0eb	50996-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20100602		NDA	NDA205840	Smith's Drugs fo Forest City, Inc. dba Smith Drugs	OXYGEN	99	L/100L			N	20241231
51009-149_49c5386e-4101-4375-a369-3d2aa48427b5	51009-149	HUMAN OTC DRUG	Simply White	Sweet Mint	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20100312	20251230	OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	.0024	g/g			N	
51009-202_2c188d9a-ae86-48eb-8dcb-18aca8f20bde	51009-202	HUMAN OTC DRUG	Tom Whole Care Peppermint	fights cavities whitening fresh breath helps fight tartar	Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20140606		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
51009-203_4c8f86d3-419b-4465-872e-af7c99dc8d79	51009-203	HUMAN OTC DRUG	Toms Whole Care Spearmint	fights cavities whitening fresh breath helps fight tartar	Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20140606		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
51009-205_39836806-e9ee-491d-a493-d99223f68a05	51009-205	HUMAN OTC DRUG	Toms Wicked Fresh Cool Peppermint	fresh breath / cavity protection	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20130808		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
51009-206_8c7be1e0-b431-41c0-842a-e00bdcf081c3	51009-206	HUMAN OTC DRUG	Toms Wicked Fresh Spearmint Ice	fresh breath / cavity protection	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20140606		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
51009-218_a293b163-41ec-4bec-a923-f54de9c5e2c0	51009-218	HUMAN OTC DRUG	Toms Luminous White Fluoride Clean Mint	cavity protection / whitening	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20151201		OTC MONOGRAPH DRUG	M021	Tom's of Maine, Inc.	SODIUM FLUORIDE	.00243	g/g			N	20241231
51009-219_4bc5a89f-d961-45fb-bb3b-c3d09fe20ae2	51009-219	HUMAN OTC DRUG	Toms Whole Care Cinnamon Clove	FIGHTS CAVITIES WHITENING FRESH BREATH HELPS FIGHT TARTAR	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20160712		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
51009-238_ad655c58-f689-42bd-95b1-974980ba633b	51009-238	HUMAN OTC DRUG	Natural Fluoride Fresh Mint	cavity protection whitening fresh breath	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20120901		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	.00243	g/g			N	20241231
51009-248_63a0c641-c741-47d2-9c57-8c5ecaf2b3b3	51009-248	HUMAN OTC DRUG	Simply White	Clean Mint	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20110829		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	.00243	g/g			N	20241231
51009-837_65501f6e-06b7-44a3-ab5a-b663d740afb7	51009-837	HUMAN OTC DRUG	Toms Whole Care Mouthwash Fresh Mint		Sodium Fluoride	RINSE	DENTAL	20171208		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	1	mg/10mL			N	20241231
51009-840_2384ce1c-33a5-41fd-aa4f-4fe617bdea33	51009-840	HUMAN OTC DRUG	Toms Childrens Anticavity Mouthwash Silly Strawberry		sodium fluoride	RINSE	DENTAL	20181218		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	2	mg/10mL			N	20241231
51009-841_3650d35e-b5b0-4b8f-abfa-992fc6416dfa	51009-841	HUMAN OTC DRUG	Toms of Maine Coconut Lavender Antiperspriant / Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20190401		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-842_b0c34442-b8f2-4765-9516-2f97ea95e097	51009-842	HUMAN OTC DRUG	Toms of Maine for Men Mountain Spring Antiperspirant / Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20190401		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-843_87e9868d-16af-42ad-87cf-59819a91974a	51009-843	HUMAN OTC DRUG	Toms of Maine Natural Powder Antiperspirant / Deodorant		aluminum chlorohydrate	STICK	TOPICAL	20190401		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-844_b31813a5-83c1-4f63-8343-9eb5971bd319	51009-844	HUMAN OTC DRUG	Toms of Maine for Men North Woods Antiperspriant Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20190401		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-845_b551413a-4516-4a67-bffc-788cf10583ef	51009-845	HUMAN OTC DRUG	Toms of Maine Coconut Lavender Antiperspirant / Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20210320		OTC MONOGRAPH FINAL	part350	Tom's of Maine, Inc.	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-846_0ff14a79-1581-4e6d-97f4-63a07f38688e	51009-846	HUMAN OTC DRUG	Toms of Maine Natural Powder Antiperspirant / Deodorant		aluminum chlorohydrate	STICK	TOPICAL	20210601		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-847_1c850c2a-5501-404d-b29e-75e935cfa87e	51009-847	HUMAN OTC DRUG	Toms of Maine for Men North Woods Antiperspirant Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20210306		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-848_a229602f-f414-40c6-990c-2577692b6046	51009-848	HUMAN OTC DRUG	Toms of Maine for Men Mountain Spring Antiperspirant Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20210601		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-849_baea3a8d-c32a-423d-b0fd-ec056fe9ecb7	51009-849	HUMAN OTC DRUG	Toms of Maine for Men Charcoal Antiperspirant / Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20200814		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-850_a81e4827-0e60-49b0-942a-8c4e480c91e2	51009-850	HUMAN OTC DRUG	Toms of Maine for Women Charcoal Antiperspirant / Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20200814		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-851_ef0b6af9-ea47-4fa9-88ff-0e590466fa69	51009-851	HUMAN OTC DRUG	Toms of Maine for Men Charcoal Antiperspirant / Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20210601		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-852_0733deee-0ced-414d-8abe-f8012d8a3958	51009-852	HUMAN OTC DRUG	Toms of Maine for Women Charcoal Antiperspirant / Deodorant		Aluminum chlorohydrate	STICK	TOPICAL	20210701		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-853_c3021936-0124-4470-ba21-d87a8b4b6076	51009-853	HUMAN OTC DRUG	Toms of Maine Vanilla Antiperspirant / Deodorant		aluminum chlorohydrate	STICK	TOPICAL	20211101		OTC MONOGRAPH FINAL	part350	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-854_0868e8c1-86d1-4f1d-8edd-0bc73b9bd870	51009-854	HUMAN OTC DRUG	Toms Kids Watermelon Wiggle		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20231201		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	20241231
51009-855_ef3f167a-f497-4e05-ba7f-51da95c7d9ff	51009-855	HUMAN OTC DRUG	Toms of Maine for Men North Woods Antiperspriant Deodorant - Free Talc wo Olea		Aluminum chlorohydrate	STICK	TOPICAL	20231013		OTC MONOGRAPH DRUG	M019	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-856_ff970949-a922-4ab7-a024-0297a5e5c48d	51009-856	HUMAN OTC DRUG	Toms of Maine Toms of Maine Cucumber Aloe AP wo Olea		Aluminum chlorohydrate	STICK	TOPICAL	20231013		OTC MONOGRAPH DRUG	M019	Tom's of Maine	ALUMINUM CHLOROHYDRATE	220	mg/g			N	20241231
51009-900_a6329472-22d4-4d85-9a3f-021a5486bd8e	51009-900	HUMAN OTC DRUG	Peppermint Charcoal Anticavity PCFT6	gently whitens teeth / fights cavities / safe for enamel / safe for everyday use	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20181218		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	.0024	g/g			N	20241231
51009-902_07002c00-58b2-4209-871b-51458716224f	51009-902	HUMAN OTC DRUG	Toms Whole Care Wintermint - WWT4		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20181119		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
51009-910_5774a5b9-5f2a-4121-bb71-a1800da988b1	51009-910	HUMAN OTC DRUG	Silly Strawberry Anticavity - BFT51 MRT		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20100815		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	.0014	g/g			N	20241231
51009-911_54413508-1e8b-4d1c-89f3-89d7d42e418a	51009-911	HUMAN OTC DRUG	Outrageous Orange Anticavity - OFT51 MRT		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191115		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	.0014	g/g			N	20241231
51009-912_fe655349-3311-4e24-a15d-4a2451617c98	51009-912	HUMAN OTC DRUG	Wicked Cool Anticavity - LMFT51 MRT		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20191115		OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	.0014	g/g			N	20241231
51009-914_74b83a26-a66a-4696-a6ec-ee5cb91fc80d	51009-914	HUMAN OTC DRUG	Luminous White with Activated Charcoal CWLT		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20201111	20240726	OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	.0015	g/1			N	
51009-916_c152bbb7-13b6-4f0a-9f99-1f0356b57e87	51009-916	HUMAN OTC DRUG	BLUE Save the Animals		Sodium Monofluorophosphate	CREAM	DENTAL	20210630	20251230	OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	
51009-917_3d730563-d1cb-40bd-8dab-bd4ba9041846	51009-917	HUMAN OTC DRUG	Watermelon Save the Animals		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20211130	20251230	OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	
51009-918_c6155179-c3ab-4bdf-a50b-4970a736737b	51009-918	HUMAN OTC DRUG	Toms Teeth and Gum Health		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20211130	20251230	OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM FLUORIDE	1.1	mg/g			N	
51009-919_9217aa29-0673-4b6a-9867-ad93f64b97eb	51009-919	HUMAN OTC DRUG	Toms Fresh and Bright		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20211130	20251230	OTC MONOGRAPH FINAL	part355	Tom's of Maine, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	
51012-001_55b8602d-c647-478b-955d-df971e4f5aba	51012-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20090101		NDA	NDA205849	Gilmore Liquid Air Co.	OXYGEN	99	L/100L			N	20241231
51012-002_fdb2780d-e2f7-4117-8284-ef82552a48ef	51012-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20090101		NDA	NDA205850	Gilmore Liquid Air Co.	NITROGEN	99	L/100L			N	20241231
51012-003_4ede3d21-1f34-4604-9927-4a113253f293	51012-003	HUMAN PRESCRIPTION DRUG	AIR		AIR	GAS	RESPIRATORY (INHALATION)	20090101		NDA	NDA205909	Gilmore Liquid Air Co.	AIR	20.5	L/100L			N	20241231
51013-103_b23cc43f-3c8b-496a-b6d4-eb260344372d	51013-103	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20161012		ANDA	ANDA206568	PuraCap Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-104_a428dca7-f2fc-4eb3-98f3-79ee598d74f3	51013-104	HUMAN OTC DRUG	Nighttime Sleep-Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20150526		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-108_46932ce6-af48-4b2e-8d2a-34e5d28edcca	51013-108	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20140512		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-109_b08f246d-4f61-4120-95c9-adf40596ed5f	51013-109	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160713		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-110_6a7ee5f2-2e5b-45c7-8daf-9bdb64a1d56d	51013-110	HUMAN OTC DRUG	Maximum Strength Nighttime Cold/Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCI	CAPSULE, LIQUID FILLED	ORAL	20160221		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-111_d5285de6-d5e0-4571-a0e8-4864c5396984	51013-111	HUMAN OTC DRUG	STOOL SOFTENER DOCUSATE SODIUM 50 MG		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20140822		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	50	mg/1			N	20241231
51013-115_7b6027bd-a8f8-4872-8dff-2695745f819b	51013-115	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160715		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-117_e548cdb6-fe2d-495b-bb5d-2773b7e41c3c	51013-117	HUMAN OTC DRUG	CVS Daytime COLD and FLU RELIEF and Nighttime COLD and FLU RELIEF		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20160630		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-118_1547fd30-16a3-41e8-8796-8e9133a69180	51013-118	HUMAN OTC DRUG	DAY Cold and Flu Plus and NIGHTTIME Cold and Flu Plus		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20160728		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-120_99b712f8-e65c-4d2d-92f2-be989dfb4179	51013-120	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20161002		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
51013-122_64b62ed6-6837-4210-918f-aec526859078	51013-122	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20160630		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
51013-122_c4d21f2c-548f-44fe-b015-723210781f0f	51013-122	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20160601		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
51013-123_0feaf992-2a4c-44f1-81a1-62558ef12c83	51013-123	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20170717		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-124_4a9623f8-f8d8-418a-a24c-390cd6701e69	51013-124	HUMAN OTC DRUG	DayTime and NiteTime		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20160627		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-125_3b1172b1-f576-44b3-a812-ca44d93c6e1c	51013-125	HUMAN OTC DRUG	Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20160701		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-127_934906a6-004b-406c-b560-35672343a86a	51013-127	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160111		OTC MONOGRAPH FINAL	part332	PURACAP PHARMACEUTICAL LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-128_a724fd8d-dccb-4339-b58b-74464ee7ec07	51013-128	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160712		OTC MONOGRAPH NOT FINAL	part343	PuraCap Pharmaceutical LLC	ACETAMINOPHEN	500	mg/1			N	20241231
51013-129_75d266c7-980d-4844-86bf-3b4cba0a0f26	51013-129	HUMAN OTC DRUG	Night Time Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160505		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-130_9477b290-b29b-4816-b969-ac3ba7b1f6fa	51013-130	HUMAN OTC DRUG	DAYTIME COLD and FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160630		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-131_b795770b-08a7-4ff9-a86a-1854d2ef7e27	51013-131	HUMAN OTC DRUG	NIGHTTIME COLD and FLU		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20160630		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-132_db03b7a1-354b-4ee0-aafa-e0149c1903dc	51013-132	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160726		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-134_c2de4336-f1db-48a6-9e6a-86eff8d87ea4	51013-134	HUMAN OTC DRUG	DayTime Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160426		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-135_04894e70-c333-40c7-9a53-45b308eb61c7	51013-135	HUMAN OTC DRUG	Nite Time Cold and Flu		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate, Dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20171219		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-137_9a223804-f229-442b-85a9-7f0f8fd74ba1	51013-137	HUMAN OTC DRUG	NAPROXEN SODIUM		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180320		ANDA	ANDA208363	PuraCap Pharmaceutical LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-138_3ce37a95-20f8-44a0-abc9-e2e57ab68907	51013-138	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160720		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-141_6db76171-5d8a-4ee7-b69c-0b5fdea039c9	51013-141	HUMAN OTC DRUG	DDM Day time and Nite time cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20160620		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-142_35a23f15-fbe1-41b2-8395-41505ebf6578	51013-142	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160601		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-142_f7d355dc-d3b1-4db6-8e3b-1d8c390ed84c	51013-142	HUMAN OTC DRUG	Nighttime SLEEP AID		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160630		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-143_5542af43-0b79-47f6-a6c8-ab727e431017	51013-143	HUMAN OTC DRUG	DAY TIME COLD and FLU FORMULA		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160714		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-144_be59b33e-95a6-4d13-b366-02130e4e5c5b	51013-144	HUMAN OTC DRUG	DYE-FREE ALLERGY		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160627		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-147_369e85d7-18ae-454f-babf-f39d05662339	51013-147	HUMAN OTC DRUG	NIGHTTIME COLD and FLU		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20160713		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-154_06c16b74-55eb-4851-ad8a-772ecc936ba3	51013-154	HUMAN OTC DRUG	Nighttime Severe Cold and Flu Relief		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate, Dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20160727		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-155_5a6cafc6-e67c-432b-a423-7a1891b8e756	51013-155	HUMAN OTC DRUG	DayTime Severe Cold and Flu Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160726		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-156_7df87a67-d625-4535-995b-a807adfe3cc8	51013-156	HUMAN OTC DRUG	NiteTime Sinus Relief		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20160726		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 6.25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-157_729898ef-3f81-4541-9065-4381f09af447	51013-157	HUMAN OTC DRUG	DayTime Sinus		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160726		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-158_b07a93aa-e569-4767-8476-0b8f0382bdc6	51013-158	HUMAN OTC DRUG	DAY TIME and NIGHT TIME COLD and FLU FORMULA		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20160720		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-159_04418089-7aa2-4061-b7b4-356495587b82	51013-159	HUMAN OTC DRUG	Daytime Sinus and Congestion		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160726		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-160_b2a2cd7a-09cf-4070-ba10-2b6a42db2312	51013-160	HUMAN OTC DRUG	Nighttime Sinus and Congestion Relief		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20160727		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 6.25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-161_3b65c9ad-fea1-4923-b8e4-2789a129c8d3	51013-161	HUMAN OTC DRUG	Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20160706		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-162_9b5e32ca-5188-4b10-b83d-6f6d09cb808f	51013-162	HUMAN OTC DRUG	NIGHT TIME COLD and FLU FORMULA		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate, Dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20160714		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-163_20de9285-72b8-4007-9f13-7d5ea986c6ed	51013-163	HUMAN OTC DRUG	Daytime SEVERE COLD and FLU		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160720		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-164_fce99ead-ad54-44b2-aa7c-b1681b521da6	51013-164	HUMAN OTC DRUG	Nighttime SEVERE COLD and FLU		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate, Dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20160720		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-166_c30cf25a-f77a-4e43-a143-9676cb5a3707	51013-166	HUMAN OTC DRUG	Tussin DM Cough and Chest Congestion		dextromethorphan hydrobromide, guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20160720		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-167_7f89ab5c-3ba1-44b0-b8b4-b4c5780d1834	51013-167	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160726		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-168_bebcc7b6-ea00-4e54-a720-d491d1063e52	51013-168	HUMAN OTC DRUG	DG Day Time Cold and Flu Formula and Night Time Cold and Flu Formula		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20160615		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-169_a8ca2b56-c759-44fa-8ae8-ece68b279c80	51013-169	HUMAN OTC DRUG	Severe Sinus Congestion Allergy and Cough Formula		Acetaminophen, Dextromethorphan hydrobromide , Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160629		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-170_63ce0194-6f37-4ce7-a32a-fe6bbc94ac7c	51013-170	HUMAN OTC DRUG	Maximum Strength Congestion and Headache		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160610		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-171_45d99b00-e0cf-4d32-96f6-1e751c43d745	51013-171	HUMAN OTC DRUG	Maximum Strength Night Time Cold and Flu Relief		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160610		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-172_ac5ea99e-f61c-4e77-af52-28c527448b03	51013-172	HUMAN OTC DRUG	Extra Strength Pain Reliever		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160608		OTC MONOGRAPH NOT FINAL	part343	PuraCap Pharmaceutical LLC	ACETAMINOPHEN	500	mg/1			N	20241231
51013-173_cf769f7b-fe36-4cc3-9fbc-2f2dacd46641	51013-173	HUMAN OTC DRUG	Regular Strength Pain Reliever		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160623		OTC MONOGRAPH NOT FINAL	part343	PuraCap Pharmaceutical LLC	ACETAMINOPHEN	325	mg/1			N	20241231
51013-174_3d4cbe65-946e-40e2-af4c-8b196a6e7209	51013-174	HUMAN OTC DRUG	Daytime Severe Cold and Flu Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160613		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-175_77205d33-ad7d-4ea7-a87b-caecd4811046	51013-175	HUMAN OTC DRUG	Night Time Severe Cold and Flu Relief		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate, Dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20160609		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-177_a5821bd5-3ff8-49e5-be1f-421440c586aa	51013-177	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160728		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-178_de0b6b37-023e-4bbc-b140-543c386e621f	51013-178	HUMAN OTC DRUG	Tussin DM Cough and Chest Congestion		dextromethorphan hydrobromide, guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20160727		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-179_518b94dd-2b8b-4c42-ba6b-3ed2ddd3d196	51013-179	HUMAN OTC DRUG	MAXIMUM STRENGTH Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160712		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-181_dc48a41e-2ea8-4e30-b1a9-b7b64f8082bf	51013-181	HUMAN OTC DRUG	Nighttime SLEEP AID		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160627		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-182_2c245b01-c141-4c63-8bc9-0762bee7a04e	51013-182	HUMAN OTC DRUG	Extra Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160701		OTC MONOGRAPH NOT FINAL	part343	PuraCap Pharmaceutical LLC	ACETAMINOPHEN	500	mg/1			N	20241231
51013-183_0e8f5228-efd1-479a-ac7f-d0c24b469bd4	51013-183	HUMAN OTC DRUG	Daytime Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20161012		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-183_89a4afe2-c581-4ae7-8b8c-9089c9c292e1	51013-183	HUMAN OTC DRUG	Daytime Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160715		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-184_469853fb-a180-43cd-a8ec-b3ec963c1089	51013-184	HUMAN OTC DRUG	Nitetime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20161012		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-184_8755f743-2ac8-487c-b3e2-e08a31967ba6	51013-184	HUMAN OTC DRUG	Nitetime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20160718		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-185_0f017013-cd97-4a9f-8a8e-e7e4e9c15b34	51013-185	HUMAN OTC DRUG	Day Time Sinus Relief		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160714		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-186_5e2b9d63-1ea7-4630-b6a3-16374061a6d4	51013-186	HUMAN OTC DRUG	Night Time Sinus Relief		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20160715		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 6.25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-187_d2a89b6e-c4c3-4dc8-abea-8b5dd81f9cb2	51013-187	HUMAN OTC DRUG	DAY TIME Cold Flu Medicine		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20170717		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-188_9d0b575b-fbc7-4d50-8d88-e282ec5c9eb3	51013-188	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20170717		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-189_502b3ea9-76ea-481f-8a82-2bd413528958	51013-189	HUMAN OTC DRUG	DAY TIME Cold Flu Medicine		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20161006		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-190_7d15e759-a3d5-49d4-b8a2-b8b588392a6f	51013-190	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20180529		ANDA	ANDA209909	PuraCap Pharmaceutical LLC	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
51013-191_f44379ae-1108-41fe-b638-3a8eaf21708a	51013-191	HUMAN OTC DRUG	COLD FLU and SORE THROAT RELIEF		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170714		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-192_a7603755-5144-4543-8d67-28233217cee0	51013-192	HUMAN OTC DRUG	Severe sinus Congestion Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170714		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-193_aa27a97d-5150-4c3c-bea4-ea9e887f0430	51013-193	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170714		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-194_9331c907-b0e9-447e-b550-dc574a552578	51013-194	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170714		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
51013-195_bda2a8d1-e220-4c0e-96ef-a3f443077423	51013-195	HUMAN OTC DRUG	COLD FLU and SORE THROAT RELIEF		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170717		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-196_272fd171-4304-4f8b-ba5c-43143be22ce8	51013-196	HUMAN OTC DRUG	Daytime and Nighttime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20170712		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-197_4f724590-9b55-4d4b-b7e1-e2534af8e665	51013-197	HUMAN OTC DRUG	cold, flu and sore throat		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170712		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-198_fb6f97b5-cd90-4c50-a444-2c835e763961	51013-198	HUMAN OTC DRUG	Severe sinus Congestion Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170712		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-199_4b4743e7-23a3-4468-91b2-ea658b78683a	51013-199	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20170714		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-319_127ceac7-923c-47f4-a768-47f7e46b2e97	51013-319	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20171109		ANDA	ANDA079174	PuraCap Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-320_1b2f1b11-905c-4c77-b609-ffae53749092	51013-320	HUMAN OTC DRUG	Extra Strength Acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20171109		OTC MONOGRAPH NOT FINAL	part343	PuraCap Pharmaceutical LLC	ACETAMINOPHEN	500	mg/1			N	20241231
51013-321_841fb60d-9e76-4a46-8905-7de3f25b6788	51013-321	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20171128		OTC MONOGRAPH FINAL	part335	PuraCap Pharmaceutical LLC	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
51013-322_116d1b6a-03af-4b3c-a81a-e1a598bf4f6b	51013-322	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, CHEWABLE	ORAL	20171128		OTC MONOGRAPH FINAL	part336	PuraCap Pharmaceutical LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
51013-323_5f8ca325-03d7-4046-ad97-44e43e970a91	51013-323	HUMAN OTC DRUG	Extra Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20171213		OTC MONOGRAPH FINAL	part331	PuraCap Pharmaceutical LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
51013-400_800b0a64-caf8-4543-acd3-93e72a2b8b0d	51013-400	HUMAN OTC DRUG	Nite Time Cold and Flu		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate, Dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20170717		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-401_c659a680-6a7c-4c4f-97ca-2cbcad0b2a60	51013-401	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170712		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
51013-402_0ad2c7fe-b9a5-43de-9226-a6bc10fb4aaf	51013-402	HUMAN OTC DRUG	Regular Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20170714		OTC MONOGRAPH NOT FINAL	part343	PuraCap Pharmaceutical LLC	ACETAMINOPHEN	325	mg/1			N	20241231
51013-405_147c7748-c76b-441b-9a6f-48e91eaa78e2	51013-405	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170714		ANDA	ANDA206568	PuraCap Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-406_3680ac72-3552-419c-accb-22eba60b4ae9	51013-406	HUMAN OTC DRUG	Chest Congestion and Cough HBP		Dextromethorphan hydrobromide, Guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20170406		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51013-408_232cc5b3-4645-439d-afce-19f8fb96c151	51013-408	HUMAN OTC DRUG	Daytime Congestion Pressure and Pain		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170406		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-409_e4aecbfa-f053-41be-9c26-28351920d797	51013-409	HUMAN OTC DRUG	Mucinex Fast-Max SEVERE COLD		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170523		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-410_4b67e45b-f17d-480a-a4ca-32fefb966dff	51013-410	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170714		ANDA	ANDA206568	PuraCap Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-415_2f83d323-28e8-432f-ac93-771775aaf3dc	51013-415	HUMAN OTC DRUG	COLD FLU and SORE THROAT RELIEF		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170829		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-416_73a82f8d-19a7-49e3-bdbf-a2d6743d9407	51013-416	HUMAN OTC DRUG	Day Severe Cold and Night Cold and Flu	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20170829		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-417_e23985f6-c3ba-4f15-9d87-7971d161d605	51013-417	HUMAN OTC DRUG	Severe sinus Congestion Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170829		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51013-419_384f678d-8ee5-4fc6-8db2-fe956a1ceab0	51013-419	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170925		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-420_f04b1e27-f5b6-42e4-a36c-7a229d24db20	51013-420	HUMAN OTC DRUG	MAXIMUM STRENGTH Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170925		OTC MONOGRAPH FINAL	part338	PuraCap Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51013-421_1f723c4e-6023-4e9a-b1c8-868983ebc837	51013-421	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170829		ANDA	ANDA206568	PuraCap Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-422_c5872fd7-c1a6-49ab-b245-0cd83d546c85	51013-422	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20171101		ANDA	ANDA206568	PuraCap Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-423_6732619f-c0e5-44be-98eb-224eea9d9ecf	51013-423	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20171122		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-424_8fe6ff6c-015b-4dd2-973d-d4f622b5f34f	51013-424	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20171122		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-426_f7eacd3f-b26a-4e73-b282-67d44e45a956	51013-426	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180212		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
51013-427_c07f704a-ccac-47dc-8b17-8d0c5ae137f0	51013-427	HUMAN OTC DRUG	Day and Night Severe Sinus Congestion and Cough	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20180208		OTC MONOGRAPH FINAL	part341	PuraCap Pharmaceutical LLC						N	20241231
51013-428_1f1348b4-3823-4c78-bb8b-8eb0df1b9b9f	51013-428	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180208		OTC MONOGRAPH FINAL	part332	PuraCap Pharmaceutical LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-429_2b20a5a6-2db3-4cb9-98b0-28b22ef4a573	51013-429	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180213		ANDA	ANDA206568	PURACAP PHARMACEUTICAL LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51013-430_51dd27fd-405d-4ca7-a14a-ed7cdae8da59	51013-430	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180327		OTC MONOGRAPH FINAL	part332	PURACAP PHARMACEUTICAL LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-431_b441cd93-a301-43bb-9b13-636ff247eb3d	51013-431	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180327		OTC MONOGRAPH FINAL	part332	PURACAP PHARMACEUTICAL LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-433_20af4b8f-d450-409d-83b0-e9c78d5f504a	51013-433	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180329		OTC MONOGRAPH NOT FINAL	part334	PURACAP PHARMACEUTICAL LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
51013-436_ff8454b2-d33b-4b93-bbaf-c2dd1dbad183	51013-436	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180327		OTC MONOGRAPH FINAL	part332	PURACAP PHARMACEUTICAL LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-439_9b4d1bff-55f1-4f86-a9dd-bcc7ad39e763	51013-439	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190325		OTC MONOGRAPH FINAL	part332	PURACAP PHARMACEUTICAL LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
51013-814_58eeb318-031b-4872-985d-cd7e0f379716	51013-814	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210507		OTC MONOGRAPH NOT FINAL	part334	PuraCap Pharmaceutical LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
51027-0007_f105a369-1361-1126-e053-2995a90aeba6	51027-0007	HUMAN OTC DRUG	KINKAN		ammonia, camphor (natural), menthol	LINIMENT	TOPICAL	20000426		OTC MONOGRAPH NOT FINAL	part348	KINKANDO CO., LTD .	AMMONIA; CAMPHOR (NATURAL); MENTHOL	1.1; 1.55; 3	g/50mL; g/50mL; g/50mL			N	20241231
51027-0330_f105bb7f-3ec9-0d70-e053-2a95a90a9188	51027-0330	HUMAN OTC DRUG	KINKAN COOL		diphenhydramine hydrochloride, menthol	LINIMENT	TOPICAL	20000426		OTC MONOGRAPH NOT FINAL	part348	KINKANDO CO., LTD .	DIPHENHYDRAMINE HYDROCHLORIDE; MENTHOL	1; .5	g/50mL; g/50mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51028-002_079d0588-ec93-8ad2-e063-6394a90a075e	51028-002	HUMAN OTC DRUG	Chamosyn		Barrier Cream	OINTMENT	TOPICAL	20150115		UNAPPROVED DRUG OTHER		Links Medical Products	MENTHOL; ZINC OXIDE	1; 200	mg/g; mg/g			N	20241231
51028-003_079d0588-ec93-8ad2-e063-6394a90a075e	51028-003	HUMAN OTC DRUG	Chamosyn	Paraben Free	Barrier Cream	OINTMENT	TOPICAL	20160101		UNAPPROVED DRUG OTHER		Links Medical Products	MENTHOL; ZINC OXIDE	4.5; 200	mg/g; mg/g			N	20241231
51042-001_f916f0af-19ee-47e0-bf05-864155c12918	51042-001	HUMAN OTC DRUG	FIRST MARK ULTRA FOAMING ANTIBACTERIAL		Benzalkonium Chloride	SOLUTION	TOPICAL	20150812		OTC MONOGRAPH NOT FINAL	part333E	Performance Food Group	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
51042-002_44f10772-3b18-4a68-856e-f9c8b407db3e	51042-002	HUMAN OTC DRUG	FIRST MARK ULTRA HAND SANITIZER		Alcohol	LIQUID	TOPICAL	20210521		OTC MONOGRAPH NOT FINAL	part333E	Performance Food Group	ALCOHOL	60	mL/100mL			N	20241231
51042-692_3962f0ba-7e4f-445b-b6ac-b24c6a2f9932	51042-692	HUMAN OTC DRUG	First Mark	Foaming Hand Cleaner	Benzethonium Chloride	LIQUID	TOPICAL	20100623		OTC MONOGRAPH NOT FINAL	part333E	Performance Food Group	BENZETHONIUM CHLORIDE	.2	mg/100mL			N	20241231
51048-005_bd92b199-1ad6-4de9-9dc3-4a349668658d	51048-005	HUMAN OTC DRUG	DOP Isopropyl Rubbing Alcohol 70%		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20000101		OTC MONOGRAPH NOT FINAL	part333A	Omega & Delta Co., Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51048-027_7faa2ccc-9b55-43e7-8104-8b0599917d45	51048-027	HUMAN OTC DRUG	DOP Hand Sanitizer		Alcohol	GEL	TOPICAL	20090309		OTC MONOGRAPH NOT FINAL	part333A	Omega & Delta Co	ALCOHOL	65	mL/100mL			N	20241231
51048-040_e1fcedbd-1fd7-46bd-a13f-7f0817598c4a	51048-040	HUMAN OTC DRUG	DOP Hydrogen Peroxide 3%		Hydrogen Peroxide	LIQUID	TOPICAL	20000101		OTC MONOGRAPH NOT FINAL	part333A	Omega & Delta Co. Inc.	HYDROGEN PEROXIDE	3	g/100mL			N	20241231
51048-201_b6093016-1da2-4026-bf2e-da1adec89e11	51048-201	HUMAN OTC DRUG	Odorono	Antiperspirant and Deodorant Roll-on Original	Aluminum Chlorohydrate	LIQUID	TOPICAL	20060508		OTC MONOGRAPH FINAL	part350	Omega & Delta Co	ALUMINUM CHLOROHYDRATE	20	g/100mL			N	20241231
51048-202_2c80c6dc-485c-4847-b5b8-a39d9ab74563	51048-202	HUMAN OTC DRUG	Odorono	Antiperspirant and Deodorant Roll-on Powder	Aluminum Chlorohydrate	LIQUID	TOPICAL	20060508		OTC MONOGRAPH FINAL	part350	Omega & Delta Co	ALUMINUM CHLOROHYDRATE	20	g/100mL			N	20241231
51051-002_07ef0415-61c3-516d-e063-6294a90ac87a	51051-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20160215		NDA	NDA205766	Atlas Welding Supply Company, Inc.	NITROGEN	990	mL/L			N	20241231
51051-003_07ef001a-c65d-5639-e063-6294a90ab4d3	51051-003	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20160215		NDA	NDA205767	Atlas Welding Supply Company, Inc.	OXYGEN	990	mL/L			N	20241231
51060-040_f16592f4-6e3a-40ee-95ff-86d07586d7c8	51060-040	HUMAN OTC DRUG	Amazonian Clay BB Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen	Ivory	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-041_f16592f4-6e3a-40ee-95ff-86d07586d7c8	51060-041	HUMAN OTC DRUG	Amazonian Clay BB Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen	Light	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-042_f16592f4-6e3a-40ee-95ff-86d07586d7c8	51060-042	HUMAN OTC DRUG	Amazonian Clay BB Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen	Light-Medium	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-043_f16592f4-6e3a-40ee-95ff-86d07586d7c8	51060-043	HUMAN OTC DRUG	Amazonian Clay BB Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen	Medium	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-044_f16592f4-6e3a-40ee-95ff-86d07586d7c8	51060-044	HUMAN OTC DRUG	Amazonian Clay BB Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen	Medium-Tan	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-045_f16592f4-6e3a-40ee-95ff-86d07586d7c8	51060-045	HUMAN OTC DRUG	Amazonian Clay BB Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen	Tan	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-046_f16592f4-6e3a-40ee-95ff-86d07586d7c8	51060-046	HUMAN OTC DRUG	Amazonian Clay BB Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen	Tan-Deep	Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-114_af5b36c6-d8f9-4054-86aa-3ee8cf7c7c25	51060-114	HUMAN OTC DRUG	Tarteguard 20 Tinted Moisturizer	light	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20170401		OTC MONOGRAPH FINAL	part352	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-115_af5b36c6-d8f9-4054-86aa-3ee8cf7c7c25	51060-115	HUMAN OTC DRUG	Tarteguard 20 Tinted Moisturizer	light-medium	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20170401		OTC MONOGRAPH FINAL	part352	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-116_af5b36c6-d8f9-4054-86aa-3ee8cf7c7c25	51060-116	HUMAN OTC DRUG	Tarteguard 20 Tinted Moisturizer	medium	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20170401		OTC MONOGRAPH FINAL	part352	Tarte, Inc	TITANIUM DIOXIDE; ZINC OXIDE	50; 50	mg/mL; mg/mL			N	20241231
51060-197_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-197	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	8B porcelain beige	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-198_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-198	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	13N fair neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-199_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-199	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	14S fair sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-200_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-200	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	16B fair-light beige	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-201_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-201	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	16S fair-light sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-202_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-202	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	16N fair-light neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-203_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-203	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	22S light sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-204_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-204	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	22N light neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-205_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-205	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	22B light beige	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-206_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-206	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	24G light golden	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-207_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-207	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	27S light-medium sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-208_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-208	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	27N light-medium neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-209_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-209	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	29H light-medium honey	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-210_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-210	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	34S medium sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-211_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-211	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	34N medium neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-212_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-212	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	35G medium golden	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-213_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-213	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	36H medium-tan honey	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-214_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-214	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	36N medium-tan neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-215_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-215	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	38S medium-tan sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-216_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-216	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	42N tan neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-217_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-217	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	44H tan honey	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-218_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-218	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	44S tan sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-219_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-219	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	48S tan-deep sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-220_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-220	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	49H tan-deep honey	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-221_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-221	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	50S deep sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-222_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-222	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	52N deep neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-223_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-223	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	54H deep honey	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-224_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-224	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	58S rich sand	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-225_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-225	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	59N rich neutral	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-226_858d0f56-fc5a-4ac4-99b2-88d750537f50	51060-226	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	60H mahogany	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-236_ad48dc96-794e-4075-aeb1-f21bf2b5f2d9	51060-236	HUMAN OTC DRUG	SEA set and protect mineral sunscreen Broad Spectrum SPF 30	translucent	Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20200305		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	86; 100	mg/mL; mg/mL			N	20241231
51060-237_ad48dc96-794e-4075-aeb1-f21bf2b5f2d9	51060-237	HUMAN OTC DRUG	SEA set and protect mineral sunscreen Broad Spectrum SPF 30	translucent deep	Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20200305		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	86; 100	mg/mL; mg/mL			N	20241231
51060-243_9233328c-e728-450c-b00b-599abab04352	51060-243	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	fair	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-244_9233328c-e728-450c-b00b-599abab04352	51060-244	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	light	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-245_9233328c-e728-450c-b00b-599abab04352	51060-245	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	medium	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-246_9233328c-e728-450c-b00b-599abab04352	51060-246	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	medium-tan	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-247_9233328c-e728-450c-b00b-599abab04352	51060-247	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	tan	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-248_9233328c-e728-450c-b00b-599abab04352	51060-248	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	tan deep	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-249_9233328c-e728-450c-b00b-599abab04352	51060-249	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	deep	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-250_9233328c-e728-450c-b00b-599abab04352	51060-250	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	rich	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-251_9233328c-e728-450c-b00b-599abab04352	51060-251	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	mahogany	titanium dioxide and zinc oxide	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-287_ff5bd785-d7c5-45ca-9f17-0e2a6f4ab644	51060-287	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	13N fair neutral	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-288_ff5bd785-d7c5-45ca-9f17-0e2a6f4ab644	51060-288	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	22N light neutral	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-289_ff5bd785-d7c5-45ca-9f17-0e2a6f4ab644	51060-289	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	27N light-medium neutral	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-290_ff5bd785-d7c5-45ca-9f17-0e2a6f4ab644	51060-290	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	34N medium neutral	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-291_ff5bd785-d7c5-45ca-9f17-0e2a6f4ab644	51060-291	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	44S tan sand	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-292_ff5bd785-d7c5-45ca-9f17-0e2a6f4ab644	51060-292	HUMAN OTC DRUG	foundcealer multi-tasking foundation Broad Spectrum SPF 20 Sunscreen	52N deep neutral	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20190321		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	74.7; 47.5	mg/mL; mg/mL			N	20241231
51060-311_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-311	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	fair	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-312_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-312	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	light	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-313_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-313	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	light-medium	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-314_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-314	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	medium	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-315_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-315	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	tan	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-316_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-316	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	tan-deep	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-317_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-317	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	deep	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-318_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-318	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	rich	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-319_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-319	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	mahogany	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-320_ee3e9160-448d-4e4f-83f4-71f78c9eb69b	51060-320	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	light	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-321_ee3e9160-448d-4e4f-83f4-71f78c9eb69b	51060-321	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	medium	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-322_ee3e9160-448d-4e4f-83f4-71f78c9eb69b	51060-322	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	tan	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-323_ee3e9160-448d-4e4f-83f4-71f78c9eb69b	51060-323	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	deep	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20190513		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-324_a6ea200c-3a48-4804-a5e2-b7c3caaa2927	51060-324	HUMAN OTC DRUG	BB Tinted Treatment 12-Hour Primer Broad Spectrum SPF 30 Sunscreen	fair	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-325_a6ea200c-3a48-4804-a5e2-b7c3caaa2927	51060-325	HUMAN OTC DRUG	BB Tinted Treatment 12-Hour Primer Broad Spectrum SPF 30 Sunscreen	light	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-326_a6ea200c-3a48-4804-a5e2-b7c3caaa2927	51060-326	HUMAN OTC DRUG	BB Tinted Treatment 12-Hour Primer Broad Spectrum SPF 30 Sunscreen	medium	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-327_a6ea200c-3a48-4804-a5e2-b7c3caaa2927	51060-327	HUMAN OTC DRUG	BB Tinted Treatment 12-Hour Primer Broad Spectrum SPF 30 Sunscreen	tan	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-328_a6ea200c-3a48-4804-a5e2-b7c3caaa2927	51060-328	HUMAN OTC DRUG	BB Tinted Treatment 12-Hour Primer Broad Spectrum SPF 30 Sunscreen	deep	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-329_a6ea200c-3a48-4804-a5e2-b7c3caaa2927	51060-329	HUMAN OTC DRUG	BB Tinted Treatment 12-Hour Primer Broad Spectrum SPF 30 Sunscreen	rich	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-331_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-331	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	12N fair neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-332_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-332	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	16N fair-light neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-333_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-333	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	16B fair-light beige	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-334_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-334	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	20B light beige	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-335_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-335	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	22N light neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-336_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-336	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	27S light-medium sand	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-337_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-337	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	29N light-medium neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-338_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-338	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	32S medium sand	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-339_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-339	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	35N medium neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-340_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-340	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	36S medium-tan sand	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-341_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-341	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	37N medium-tan neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-342_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-342	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	42H tan honey	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-343_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-343	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	44N tan neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-344_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-344	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	47S tan-deep sand	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-345_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-345	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	47H tan-deep honey	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-346_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-346	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	53N deep neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-347_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-347	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	53H deep honey	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-349_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-349	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	58N rich neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-350_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-350	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	60N mahogany neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-351_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-351	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	61N espresso neutral	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-352_1f1f0737-6818-4dfd-988b-a8407ebaffec	51060-352	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	16N fair-light neutral	Titanium Dioxide	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-353_1f1f0737-6818-4dfd-988b-a8407ebaffec	51060-353	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	22N light neutral	Titanium Dioxide	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-354_1f1f0737-6818-4dfd-988b-a8407ebaffec	51060-354	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	35N medium neutral	Titanium Dioxide	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-355_1f1f0737-6818-4dfd-988b-a8407ebaffec	51060-355	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	44N tan neutral	Titanium Dioxide	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-356_1f1f0737-6818-4dfd-988b-a8407ebaffec	51060-356	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	53N deep neutral	Titanium Dioxide	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-357_1f1f0737-6818-4dfd-988b-a8407ebaffec	51060-357	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	58N rich neutral	Titanium Dioxide	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-358_ab575868-0ef2-490c-b5cb-2290f15dfbee	51060-358	HUMAN OTC DRUG	double duty beauty shape tape cloud coverage Broad Spectrum SPF 15 Sunscreen	57S rich sand	TITANIUM DIOXIDE	LIQUID	TOPICAL	20211126		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE	99	mg/mL			N	20241231
51060-359_9233328c-e728-450c-b00b-599abab04352	51060-359	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	light-medium	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-360_9233328c-e728-450c-b00b-599abab04352	51060-360	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	deep-sand	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-361_9233328c-e728-450c-b00b-599abab04352	51060-361	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	rich honey	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-362_9233328c-e728-450c-b00b-599abab04352	51060-362	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	mahogany honey	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-363_9233328c-e728-450c-b00b-599abab04352	51060-363	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	espresso	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-364_9233328c-e728-450c-b00b-599abab04352	51060-364	HUMAN OTC DRUG	BB tinted treatment primer Broad Spectrum SPF 30 Sunscreen	fair-light	TITANIUM DIOXIDE AND ZINC OXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part352	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-365_9c9e3d35-6030-4782-8840-616d418e3246	51060-365	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	light	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-366_9c9e3d35-6030-4782-8840-616d418e3246	51060-366	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	medium	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-367_9c9e3d35-6030-4782-8840-616d418e3246	51060-367	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	medium-tan	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-368_9c9e3d35-6030-4782-8840-616d418e3246	51060-368	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	tan	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-369_9c9e3d35-6030-4782-8840-616d418e3246	51060-369	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	tan deep	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-370_9c9e3d35-6030-4782-8840-616d418e3246	51060-370	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	deep	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-371_9c9e3d35-6030-4782-8840-616d418e3246	51060-371	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	rich	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-372_9c9e3d35-6030-4782-8840-616d418e3246	51060-372	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	mahogany	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-373_9c9e3d35-6030-4782-8840-616d418e3246	51060-373	HUMAN OTC DRUG	BB blur tinted moisturizer Broad Spectrum SPF 30	fair	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-374_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-374	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	fair-light	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20231230		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51060-375_05ab6269-05a1-485d-8ae1-a00dd2761506	51060-375	HUMAN OTC DRUG	sugar rush skin treat poreless tinted moisturizer Broad Spectrum SPF 20 Sunscreen	medium-tan	Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20231230		OTC MONOGRAPH DRUG	M020	Tarte, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 35	mg/mL; mg/mL			N	20241231
51072-088_6dae5e5c-bddc-446d-abce-b4fd8b2e74c5	51072-088	HUMAN OTC DRUG	Pyrantel Pamoate		Pyrantel Pamoate	SUSPENSION	ORAL	20151121		OTC MONOGRAPH DRUG	M024	Jefferson Labs	PYRANTEL PAMOATE	50	mg/mL			N	20241231
51079-023_d347ec32-b7e2-1638-e053-2995a90abefd	51079-023	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	20050415		ANDA	ANDA076698	Mylan Institutional Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51079-024_d347ec32-b7e2-1638-e053-2995a90abefd	51079-024	HUMAN PRESCRIPTION DRUG	Metolazone		metolazone	TABLET	ORAL	20050201		ANDA	ANDA076698	Mylan Institutional Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51079-028_0d8150a0-e00b-9912-e063-6394a90ac370	51079-028	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20101101		ANDA	ANDA090596	Mylan Institutional Inc.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
51079-051_e16f0cce-daca-7b6a-e053-2995a90a2e06	51079-051	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20110223		ANDA	ANDA090970	Mylan Institutional Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51079-058_d3bf6636-6135-42c1-e053-2a95a90a2801	51079-058	HUMAN PRESCRIPTION DRUG	Chlorthalidone		chlorthalidone	TABLET	ORAL	19980612		ANDA	ANDA086831	Mylan Institutional Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51079-072_f83913bb-1644-224f-e053-6294a90a7e09	51079-072	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19970206	20240731	NDA	NDA018487	Mylan Institutional Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	
51079-073_f83913bb-1644-224f-e053-6294a90a7e09	51079-073	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19970206	20240831	NDA	NDA018487	Mylan Institutional Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	
51079-074_f83922ff-cbe0-4b94-e053-6294a90a8162	51079-074	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20071226		ANDA	ANDA089097	Mylan Institutional Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51079-075_f83922ff-cbe0-4b94-e053-6294a90a8162	51079-075	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20071226		ANDA	ANDA088467	Mylan Institutional Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51079-076_f83922ff-cbe0-4b94-e053-6294a90a8162	51079-076	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20071226		ANDA	ANDA088468	Mylan Institutional Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51079-083_0d7fd7c2-c5bc-db30-e063-6394a90ad625	51079-083	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19940609		ANDA	ANDA080937	Mylan Institutional Inc.	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
51079-086_d3d2e685-11f1-d78b-e053-2995a90ab286	51079-086	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030801		ANDA	ANDA076122	Mylan Institutional Inc.	MIRTAZAPINE	15	mg/1			N	20241231
51079-087_d3d2e685-11f1-d78b-e053-2995a90ab286	51079-087	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030801		ANDA	ANDA076122	Mylan Institutional Inc.	MIRTAZAPINE	30	mg/1			N	20241231
51079-088_d3d2e685-11f1-d78b-e053-2995a90ab286	51079-088	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030801		ANDA	ANDA076122	Mylan Institutional Inc.	MIRTAZAPINE	45	mg/1			N	20241231
51079-093_d3d75834-1d95-3bbb-e053-2995a90aa0ef	51079-093	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	20110307		ANDA	ANDA078518	Mylan Institutional Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51079-103_0d8127a3-05dd-c361-e063-6294a90ab0bc	51079-103	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	19961223		ANDA	ANDA040424	Mylan Institutional Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51079-121_e2afd617-0323-4407-e053-2a95a90aead3	51079-121	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20091201		ANDA	ANDA090763	Mylan Institutional Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51079-141_0e9df2a7-01de-d71b-e063-6394a90a7dfe	51079-141	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20220601		ANDA	ANDA084769	Mylan Institutional Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
51079-142_d347e35e-b57d-5caa-e053-2995a90aba4b	51079-142	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		lithium carbonate	TABLET, EXTENDED RELEASE	ORAL	20120420		ANDA	ANDA202219	Mylan Institutional Inc.	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20241231
51079-164_d3d75570-e826-c783-e053-2a95a90a88f8	51079-164	HUMAN PRESCRIPTION DRUG	Voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20110808		ANDA	ANDA090547	Mylan Institutional Inc.	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51079-165_d3d75570-e826-c783-e053-2a95a90a88f8	51079-165	HUMAN PRESCRIPTION DRUG	Voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20110808		ANDA	ANDA090547	Mylan Institutional Inc.	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51079-169_d39bece3-aa9c-7991-e053-2a95a90a87d0	51079-169	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190513		ANDA	ANDA202033	Mylan Institutional Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-170_d39bece3-aa9c-7991-e053-2a95a90a87d0	51079-170	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190513		ANDA	ANDA202033	Mylan Institutional Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-171_d39bece3-aa9c-7991-e053-2a95a90a87d0	51079-171	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190516		ANDA	ANDA202033	Mylan Institutional Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-180_d347e324-2fc2-8e90-e053-2995a90a1766	51079-180	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		lithium carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120810		ANDA	ANDA202288	Mylan Institutional Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
51079-204_e16f04c1-6e58-d6c0-e053-2995a90affaa	51079-204	HUMAN PRESCRIPTION DRUG	Abacavir Sulfate		abacavir sulfate	TABLET, FILM COATED	ORAL	20120801		ANDA	ANDA091294	Mylan Institutional Inc.	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
51079-205_0d8128c5-9ac9-c706-e063-6294a90a1aa0	51079-205	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	19970429		ANDA	ANDA018659	Mylan Institutional Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51079-206_0d8128c5-9ac9-c706-e063-6294a90a1aa0	51079-206	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	19970429		ANDA	ANDA018659	Mylan Institutional Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51079-208_d35e8d0b-cf2b-be9b-e053-2995a90ab051	51079-208	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20140130		ANDA	ANDA091226	Mylan Institutional Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51079-209_d35e8d0b-cf2b-be9b-e053-2995a90ab051	51079-209	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20140129		ANDA	ANDA091226	Mylan Institutional Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51079-210_d35e8d0b-cf2b-be9b-e053-2995a90ab051	51079-210	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20140129		ANDA	ANDA091226	Mylan Institutional Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51079-211_d35e8d0b-cf2b-be9b-e053-2995a90ab051	51079-211	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20140123		ANDA	ANDA091226	Mylan Institutional Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51079-246_f914b6be-0b7d-d7da-e053-6294a90abcf9	51079-246	HUMAN OTC DRUG	Loratadine		loratadine	TABLET	ORAL	20130430	20240831	ANDA	ANDA076154	Mylan Institutional Inc.	LORATADINE	10	mg/1			N	
51079-255_d347f791-e22a-c2b3-e053-2a95a90aaa15	51079-255	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040920		ANDA	ANDA076704	Mylan Institutional Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-284_f4348843-5a3f-4e2b-e053-2a95a90acd61	51079-284	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19971031		ANDA	ANDA070325	Mylan Institutional Inc.	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51079-285_f4348843-5a3f-4e2b-e053-2a95a90acd61	51079-285	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19971104		ANDA	ANDA070325	Mylan Institutional Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51079-286_f4348843-5a3f-4e2b-e053-2a95a90acd61	51079-286	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19971031		ANDA	ANDA070325	Mylan Institutional Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51079-288_0eaeb920-5452-13c4-e063-6394a90a2291	51079-288	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET, ORALLY DISINTEGRATING	ORAL	20160926		ANDA	ANDA201824	Mylan Institutional Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20251231
51079-306_08a2221c-381a-8f50-e063-6294a90a36f1	51079-306	HUMAN OTC DRUG	Polyethylene Glycol (3350)		polyethylene glycol (3350)	POWDER, FOR SOLUTION	ORAL	20091012		ANDA	ANDA078915	Mylan Institutional Inc.	POLYETHYLENE GLYCOL 3500	17	g/17g			N	20241231
51079-374_0e9df2a7-01de-d71b-e063-6394a90a7dfe	51079-374	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20220526		ANDA	ANDA084768	Mylan Institutional Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
51079-375_0e9df2a7-01de-d71b-e063-6394a90a7dfe	51079-375	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20220526		ANDA	ANDA083116	Mylan Institutional Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
51079-379_f87020cf-6b8d-7aeb-e053-6394a90a238e	51079-379	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	TABLET, FILM COATED	ORAL	20090601	20240731	ANDA	ANDA065521	Mylan Institutional Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	
51079-431_d347ec32-b81f-1638-e053-2995a90abefd	51079-431	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20090803		ANDA	ANDA070278	Mylan Institutional Inc.	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
51079-436_0d8120a6-a1da-c732-e063-6294a90a52aa	51079-436	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19980612		ANDA	ANDA070791	Mylan Institutional Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51079-437_0d8120a6-a1da-c732-e063-6294a90a52aa	51079-437	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19980508		ANDA	ANDA070791	Mylan Institutional Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51079-438_0d8120a6-a1da-c732-e063-6294a90a52aa	51079-438	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19980528		ANDA	ANDA070791	Mylan Institutional Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51079-440_d3d75570-e7ce-c783-e053-2a95a90a88f8	51079-440	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20070205		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51079-441_d3d75570-e7ce-c783-e053-2a95a90a88f8	51079-441	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20070205		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51079-442_d3d75570-e7ce-c783-e053-2a95a90a88f8	51079-442	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20070205		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51079-443_d3d75570-e7ce-c783-e053-2a95a90a88f8	51079-443	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20070205		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51079-444_d3d75570-e7ce-c783-e053-2a95a90a88f8	51079-444	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20070226		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51079-445_d3d75570-e7ce-c783-e053-2a95a90a88f8	51079-445	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20070226		ANDA	ANDA076187	Mylan Institutional Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51079-453_0d814e5b-1a9a-f029-e063-6294a90abad3	51079-453	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20060911		ANDA	ANDA076577	Mylan Institutional Inc.	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51079-458_e16f1c73-e781-b6d0-e053-2a95a90a2084	51079-458	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20060522		ANDA	ANDA076056	Mylan Institutional Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51079-527_f83913bb-1644-224f-e053-6294a90a7e09	51079-527	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19970206	20240831	ANDA	ANDA070082	Mylan Institutional Inc.	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	
51079-550_d4eb8a9f-0218-a52d-e053-2995a90a97af	51079-550	HUMAN PRESCRIPTION DRUG	Acyclovir		acyclovir	OINTMENT	TOPICAL	20131127		ANDA	ANDA202459	Mylan Institutional Inc.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51079-565_d34804f5-bd27-3c6e-e053-2a95a90a770c	51079-565	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19980429		ANDA	ANDA088004	Mylan Institutional Inc.	THIORIDAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-566_d34804f5-bd27-3c6e-e053-2a95a90a770c	51079-566	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19950612		ANDA	ANDA088004	Mylan Institutional Inc.	THIORIDAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-567_d34804f5-bd27-3c6e-e053-2a95a90a770c	51079-567	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19980506		ANDA	ANDA088004	Mylan Institutional Inc.	THIORIDAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-572_d348007e-2c56-c2aa-e053-2a95a90af0e7	51079-572	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19980304		ANDA	ANDA040209	Mylan Institutional Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-573_d348007e-2c56-c2aa-e053-2a95a90af0e7	51079-573	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19980304		ANDA	ANDA040209	Mylan Institutional Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-574_d348007e-2c56-c2aa-e053-2a95a90af0e7	51079-574	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19970829		ANDA	ANDA040209	Mylan Institutional Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-575_d348007e-2c56-c2aa-e053-2a95a90af0e7	51079-575	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	19980304		ANDA	ANDA040209	Mylan Institutional Inc.	TRIFLUOPERAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-580_d34804f5-bd27-3c6e-e053-2a95a90a770c	51079-580	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		thioridazine hydrochloride	TABLET, FILM COATED	ORAL	19980622		ANDA	ANDA088004	Mylan Institutional Inc.	THIORIDAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51079-597_df2722c0-f75d-2bb6-e053-2a95a90ad3e5	51079-597	HUMAN OTC DRUG	Cetirizine Hydrochloride		cetirizine hydrochloride	TABLET, FILM COATED	ORAL	20120330		ANDA	ANDA076677	Mylan Institutional Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51079-599_e2b07377-5515-3eed-e053-2a95a90af870	51079-599	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20130610		ANDA	ANDA202856	Mylan Institutional Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51079-608_e2b07377-5515-3eed-e053-2a95a90af870	51079-608	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20130610		ANDA	ANDA202856	Mylan Institutional Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51079-630_f87033e6-7d12-7914-e053-6294a90a621c	51079-630	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19981005	20240630	ANDA	ANDA072575	Mylan Institutional Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
51079-631_f87033e6-7d12-7914-e053-6294a90a621c	51079-631	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19981006	20240630	ANDA	ANDA072575	Mylan Institutional Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
51079-632_f87033e6-7d12-7914-e053-6294a90a621c	51079-632	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19981006	20240831	ANDA	ANDA072575	Mylan Institutional Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
51079-651_0d8120a6-a1da-c732-e063-6294a90a52aa	51079-651	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19980602		ANDA	ANDA070791	Mylan Institutional Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51079-670_0eadf4bc-0baf-8c76-e063-6394a90adad6	51079-670	HUMAN PRESCRIPTION DRUG	Methotrexate		methotrexate	TABLET	ORAL	19950713		ANDA	ANDA081235	Mylan Institutional Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
51079-684_0d8112f7-281d-b313-e063-6294a90ad2d0	51079-684	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19970724		ANDA	ANDA073457	Mylan Institutional Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-685_0d8112f7-281d-b313-e063-6294a90ad2d0	51079-685	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19970723		ANDA	ANDA073457	Mylan Institutional Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-690_f8395587-939e-e16e-e053-6294a90a738f	51079-690	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	19970310	20240331	ANDA	ANDA072741	Mylan Institutional Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	
51079-721_f87020cf-6b8d-7aeb-e053-6394a90a238e	51079-721	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	CAPSULE	ORAL	20090601	20240831	ANDA	ANDA065520	Mylan Institutional Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	
51079-733_d347ec32-b81f-1638-e053-2995a90abefd	51079-733	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20040201		ANDA	ANDA070278	Mylan Institutional Inc.	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
51079-734_d347ec32-b81f-1638-e053-2995a90abefd	51079-734	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20040201		ANDA	ANDA070278	Mylan Institutional Inc.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
51079-735_d347ec32-b81f-1638-e053-2995a90abefd	51079-735	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20040215		ANDA	ANDA070278	Mylan Institutional Inc.	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
51079-736_d347ec32-b81f-1638-e053-2995a90abefd	51079-736	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20040215		ANDA	ANDA070278	Mylan Institutional Inc.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
51079-749_0d8128c5-9b37-c706-e063-6294a90a1aa0	51079-749	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	20100706		ANDA	ANDA075417	Mylan Institutional Inc.	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51079-753_d450278c-8b87-4614-e053-2a95a90ab358	51079-753	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20130924		ANDA	ANDA070848	Mylan Institutional Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
51079-759_0d8112f7-281d-b313-e063-6294a90ad2d0	51079-759	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19990616		ANDA	ANDA073457	Mylan Institutional Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-766_0d814089-4d66-bc8a-e063-6294a90ab3b5	51079-766	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090203		ANDA	ANDA077567	Mylan Institutional Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51079-767_0d814089-4d66-bc8a-e063-6294a90ab3b5	51079-767	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090203		ANDA	ANDA077567	Mylan Institutional Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51079-771_d3af12b4-8e76-2323-e053-2a95a90ac0e5	51079-771	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070914		ANDA	ANDA077316	Mylan Institutional Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51079-782_e16f1c73-e781-b6d0-e053-2a95a90a2084	51079-782	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20071003		ANDA	ANDA076056	Mylan Institutional Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51079-801_d347f791-e22a-c2b3-e053-2a95a90aaa15	51079-801	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	19940503		ANDA	ANDA076704	Mylan Institutional Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51079-817_0d8150a0-e00b-9912-e063-6394a90ac370	51079-817	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20101115		ANDA	ANDA090596	Mylan Institutional Inc.	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
51079-818_0d8150a0-e00b-9912-e063-6394a90ac370	51079-818	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20101101		ANDA	ANDA090596	Mylan Institutional Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
51079-821_d3d76bba-67d4-9694-e053-2995a90a9557	51079-821	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20081104		ANDA	ANDA076919	Mylan Institutional Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51079-886_d44f4ed5-5f3b-4848-e053-2a95a90ab3a9	51079-886	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20131230		ANDA	ANDA072801	Mylan Institutional Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
51079-888_d44f4ed5-5f3b-4848-e053-2a95a90ab3a9	51079-888	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20140102		ANDA	ANDA070184	Mylan Institutional Inc.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
51079-917_0d8118d0-578c-7043-e063-6394a90ac76d	51079-917	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991001		ANDA	ANDA075138	Mylan Institutional Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51079-921_0d8128c5-9b37-c706-e063-6294a90a1aa0	51079-921	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	19991115		ANDA	ANDA075417	Mylan Institutional Inc.	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51079-922_0d8128c5-9b37-c706-e063-6294a90a1aa0	51079-922	HUMAN PRESCRIPTION DRUG	Clozapine		clozapine	TABLET	ORAL	19991115		ANDA	ANDA075417	Mylan Institutional Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51079-923_0e0d2dec-f824-807f-e063-6394a90ad142	51079-923	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		carbidopa and levodopa	TABLET, EXTENDED RELEASE	ORAL	19991201		ANDA	ANDA075091	Mylan Institutional Inc.	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20251231
51079-924_f838a986-bd2f-16bd-e053-6294a90a0395	51079-924	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991215		ANDA	ANDA074910	Mylan Institutional Inc.	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51079-925_f838a986-bd2f-16bd-e053-6294a90a0395	51079-925	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991215		ANDA	ANDA074910	Mylan Institutional Inc.	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51079-926_f838a986-bd2f-16bd-e053-6294a90a0395	51079-926	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991215		ANDA	ANDA074910	Mylan Institutional Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51079-930_d3af12b4-8e76-2323-e053-2a95a90ac0e5	51079-930	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070914		ANDA	ANDA077316	Mylan Institutional Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51079-931_d3af12b4-8e76-2323-e053-2a95a90ac0e5	51079-931	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070914		ANDA	ANDA077316	Mylan Institutional Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51079-932_d3af12b4-8e76-2323-e053-2a95a90ac0e5	51079-932	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20070914		ANDA	ANDA077316	Mylan Institutional Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51079-960_0d8128c5-9ae0-c706-e063-6294a90a1aa0	51079-960	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20010415		ANDA	ANDA076008	Mylan Institutional Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
51079-978_0e0d2dec-f824-807f-e063-6394a90ad142	51079-978	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		carbidopa and levodopa	TABLET, EXTENDED RELEASE	ORAL	20020201		ANDA	ANDA075091	Mylan Institutional Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20251231
51079-979_0d8127a3-05dd-c361-e063-6294a90ab0bc	51079-979	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20020220		ANDA	ANDA040424	Mylan Institutional Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51079-980_0d8127a3-05dd-c361-e063-6294a90ab0bc	51079-980	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20020220		ANDA	ANDA040424	Mylan Institutional Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51079-985_0d8128c5-9ae0-c706-e063-6294a90a1aa0	51079-985	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20020325		ANDA	ANDA076008	Mylan Institutional Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
51079-986_0d8128c5-9ae0-c706-e063-6294a90a1aa0	51079-986	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20020325		ANDA	ANDA076008	Mylan Institutional Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
51079-994_0d8128c5-9ae0-c706-e063-6294a90a1aa0	51079-994	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20021201		ANDA	ANDA076008	Mylan Institutional Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
51097-001_0e8c19d4-bfd2-7c60-e063-6394a90a70e9	51097-001	HUMAN PRESCRIPTION DRUG	Adasuve		loxapine	AEROSOL, POWDER	RESPIRATORY (INHALATION)	20220531		NDA	NDA022549	Alexza Pharmaceuticals, Inc.	LOXAPINE	10	mg/1			N	20251231
51105-001_6f19251c-cfc2-4e89-9063-e573b859e653	51105-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19760101		NDA	NDA205767	Wilson Products Compressed Gas Co.	OXYGEN	990	mL/L			N	20241231
51105-002_6874ee23-c915-4cc0-bd91-7a6170bec310	51105-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20220427		NDA	NDA205766	Wilson Products Compressed Gas Co.	NITROGEN	990	mL/L			N	20241231
51142-001_4e53fc6b-4774-4224-8759-eadd150ff959	51142-001	HUMAN OTC DRUG	Care Science Essential First Aid		ethyl alcohol, isopropyl alcohol, bacitracin zinc, neomycin sulfate, polymyxin-B sulfate	KIT		20210311		OTC MONOGRAPH NOT FINAL	part333E	ASO LLC						N	20241231
51142-444_ed207c20-a982-8dfa-e053-2a95a90abde7	51142-444	HUMAN OTC DRUG	Alcohol Prep Pad		Alcohol Prep Pad	LIQUID	TOPICAL	20180924		OTC MONOGRAPH NOT FINAL	part333E	ASO LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51142-445_f2a41151-a806-566c-e053-2995a90af877	51142-445	HUMAN OTC DRUG	Alcohol Prep Pad		Alcohol Prep Pad	SWAB	TOPICAL	20180924		OTC MONOGRAPH NOT FINAL	part333A	ASO LLC	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
51142-595_0a342930-143d-3e10-e063-6394a90aeb8e	51142-595	HUMAN OTC DRUG	Compound W		Salicylic acid gel	GEL	TOPICAL	20201201		OTC MONOGRAPH DRUG	M028	ASO LLC	SALICYLIC ACID	170	mg/g			N	20241231
51142-652_eff7293a-fb6f-0c0a-e053-2995a90a69fd	51142-652	HUMAN OTC DRUG	Antibacterial Lidocaine Wound Gel		benzalkonium chloride, lidocaine hydrochloride	GEL	TOPICAL	20191028		OTC MONOGRAPH NOT FINAL	part333A	ASO LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 2	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51144-001_20eeafc9-ef3a-48e9-a26d-d3c1d0369250	51144-001	HUMAN PRESCRIPTION DRUG	TUKYSA		tucatinib	TABLET	ORAL	20200417		NDA	NDA213411	SEAGEN INC.	TUCATINIB	50	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]		N	20241231
51144-002_20eeafc9-ef3a-48e9-a26d-d3c1d0369250	51144-002	HUMAN PRESCRIPTION DRUG	TUKYSA		tucatinib	TABLET	ORAL	20200417		NDA	NDA213411	SEAGEN INC.	TUCATINIB	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]		N	20241231
51144-003_4a0c58f5-5ec7-4ff5-9edd-498b9c7cfbb9	51144-003	HUMAN PRESCRIPTION DRUG	TIVDAK		tisotumab vedotin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210920		BLA	BLA761208	Seagen Inc.	TISOTUMAB VEDOTIN	40	mg/4mL			N	20241231
51144-020_3a9b3c3a-d327-4954-8a03-0dd7bbf080aa	51144-020	HUMAN PRESCRIPTION DRUG	PADCEV	EJFV	ENFORTUMAB VEDOTIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191218		BLA	BLA761137	SEAGEN INC.	ENFORTUMAB VEDOTIN	20	mg/2mL			N	20241231
51144-030_3a9b3c3a-d327-4954-8a03-0dd7bbf080aa	51144-030	HUMAN PRESCRIPTION DRUG	PADCEV	EJFV	ENFORTUMAB VEDOTIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191218		BLA	BLA761137	SEAGEN INC.	ENFORTUMAB VEDOTIN	30	mg/3mL			N	20241231
51144-050_06e66dfb-7f66-4fd2-930f-876324ce1ac5	51144-050	HUMAN PRESCRIPTION DRUG	ADCETRIS		brentuximab vedotin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110825		BLA	BLA125388	SEAGEN INC.	BRENTUXIMAB VEDOTIN	50	mg/10.5mL	CD30-directed Antibody Interactions [MoA], CD30-directed Immunoconjugate [EPC], Immunoconjugates [CS], Microtubule Inhibition [PE]		N	20241231
51150-142_57734aab-d1de-4b99-8f5f-20a0e136d266	51150-142	HUMAN OTC DRUG	Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen Broad Spectrum SPF 50 Plus Primer and Moisturizer		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51150-180_4c903614-4d51-4e7c-92c8-77e4caa8d780	51150-180	HUMAN OTC DRUG	Valentino Very Valentino Light Lasting Perfecting Foundation Broad Spectrum SPF 26 Sunscreen		Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20210201		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE; TITANIUM DIOXIDE	67; 18	mg/mL; mg/mL			N	20241231
51150-240_2b1261ae-e2a0-4602-8705-92a1ec21ab7e	51150-240	HUMAN OTC DRUG	Lancome Paris Renergie HPN 300 Peptide Broad Spectrum SPF 25 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
51150-270_ad29ce0e-173e-44dd-83d4-a9f5e242be69	51150-270	HUMAN OTC DRUG	Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 30 Sunscreen Luminous Matte Foundation		Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20220725		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE; TITANIUM DIOXIDE	67; 11	mg/mL; mg/mL			N	20241231
51150-302_b7f081a0-1033-42ae-930c-93b3e39589b4	51150-302	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Broad Spectrum SPF 25 Sunscreen		Octinoxate and Titanium dioxide	LIQUID	TOPICAL	20221212		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE; TITANIUM DIOXIDE	67; 51	mg/mL; mg/mL			N	20241231
51150-303_62b4b1a0-29b1-4717-a6bc-c9610eb6d3e1	51150-303	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Reno Broad Spectrum SPF 25 Sunscreen		Octinoxate and Titanium dioxide	LIQUID	TOPICAL	20221212		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE; TITANIUM DIOXIDE	67; 115	mg/mL; mg/mL			N	20241231
51150-335_7771a467-be6b-4d43-a28a-ffb582b55335	51150-335	HUMAN OTC DRUG	Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 27 Sunscreen		Octinoxate and Titanium Dioxide	LIQUID	TOPICAL	20191030		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE; TITANIUM DIOXIDE	75; 32	mg/mL; mg/mL			N	20241231
51150-363_504aada4-70a0-463d-930f-4a5edd4a8408	51150-363	HUMAN OTC DRUG	Yves Saint Laurent All Hours Foundation Flawless Coverage Broad Spectrum SPF 20 Sunscreen		Octinoxate	LOTION	TOPICAL	20170601		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE	30	mg/mL			N	20251231
51150-380_e04f6a9e-a55e-482a-b0df-5fe013288910	51150-380	HUMAN OTC DRUG	Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen		Ensulizole	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	ENSULIZOLE	27	mg/mL			N	20241231
51150-457_3b312153-6b66-46d3-b0bc-cbd38fe1f510	51150-457	HUMAN OTC DRUG	Lancome Paris Bienfait MultiVital 24 HR Moisturization Broad Spectrum SPF 30 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20060701		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
51150-614_2fb00072-6565-4ec8-824a-f503e5dbbb0e	51150-614	HUMAN OTC DRUG	Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen Broad Spectrum SPF 50 Plus Primer and Moisturizer with Antioxidant Vitamin E		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221222		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51150-634_c19ae4c0-ba94-4842-93ff-407c6616069d	51150-634	HUMAN OTC DRUG	Lancome Paris Renergie Lift MultiAction Sunscreen Broad Spectrum SPF 15 Lift Firming Face Neck For All Skin Types		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20161227		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
51150-676_7248d30a-15bb-46ab-89f1-6de2c9e0a63a	51150-676	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra Care and Glow Skincare Foundation Broad Spectrum SPF 27 Sunscreen		Ensulizole	LIQUID	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	ENSULIZOLE	36	mg/mL			N	20241231
51150-712_b963b27d-9394-4870-8207-d1a3efb3a0fd	51150-712	HUMAN OTC DRUG	Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 20 Sunscreen Luminous Matte Foundation		Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20220725		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE; TITANIUM DIOXIDE	67; 11	mg/mL; mg/mL			N	20241231
51150-726_de4f8296-3011-432b-90b7-7628b502b2cc	51150-726	HUMAN OTC DRUG	Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20191028		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 70	mg/g; mg/g; mg/g			N	20241231
51150-736_21c70aa6-7c00-4471-96b3-2aae64da2fa4	51150-736	HUMAN OTC DRUG	Lancome Paris Skin Feels Good Broad Spectrum SPF 23 Sunscreen Hydrating Skin Tint Healthy Glow		Octinoxate	LIQUID	TOPICAL	20171101		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE	30	mg/mL			N	20241231
51150-931_5f09426a-66b5-428b-a131-5434434a2ee1	51150-931	HUMAN OTC DRUG	Giorgio Armani Maestro LiquidSummer Broad Spectrum SPF 15 Sunscreen		Octinoxate	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE	30	mg/mL			N	20241231
51150-953_c4fb4255-92a7-4008-82ee-92727e216e98	51150-953	HUMAN OTC DRUG	Lancome Paris Absolue Premium Bx Replenishing Rejuvenating Broad Spectrum SPF 15 Day		Avobenzone, Octisalate and Octocrylene	CREAM	TOPICAL	20100601		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	AVOBENZONE; OCTISALATE; OCTOCRYLENE	20; 50; 80	mg/g; mg/g; mg/g			N	20241231
51150-955_1625ae22-db7c-4f58-9da0-02c0e67053b3	51150-955	HUMAN OTC DRUG	Lancome Paris Teint Idole Ultra 24H Makeup All Skin Types Broad Spectrum SPF 15 Sunscreen		Octinoxate	LIQUID	TOPICAL	20160701		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE	30	mg/mL			N	20251231
51150-976_df537d03-8478-4294-8a7e-56b3556726cc	51150-976	HUMAN OTC DRUG	Giorgio Armani Power Fabric Plus Weightless Matte Foundation Broad Spectrum SPF 25 Sunscreen		Octinoxate	LOTION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	SICOS ET CIE	OCTINOXATE	68	mg/mL			N	20241231
51151-000_0973a822-e694-feb3-e063-6294a90ab132	51151-000	HUMAN OTC DRUG	CIDACIN Antifungal Treatment		TOLNAFTATE	SOLUTION	TOPICAL	20120607		OTC MONOGRAPH DRUG	M005	Pedicis Research LLC	TOLNAFTATE	1	g/100mL			N	20241231
51151-391_0973b73d-5dd0-0986-e063-6294a90a5917	51151-391	HUMAN OTC DRUG	HEMPCIN Advanced Topical Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20230213		OTC MONOGRAPH DRUG	M017	Pedicis Research, LLC	MENTHOL	50	mg/g			N	20241231
51167-106_15c7c553-95fc-4bc3-9596-31f1e4158a74	51167-106	HUMAN PRESCRIPTION DRUG	Trikafta		Elexacaftor, Tezacaftor, and Ivacaftor	KIT		20210608		NDA	NDA212273	Vertex Pharmaceuticals Incorporated						N	20241231
51167-113_bc1a7f6d-0292-4ddc-8887-0a7e4af95058	51167-113	HUMAN PRESCRIPTION DRUG	SYMDEKO		Tezacaftor and Ivacaftor	KIT		20190621		NDA	NDA210491	Vertex Pharmaceuticals Incorporated						N	20241231
51167-122_13ae2223-41a9-429f-bb21-a683ab7eed37	51167-122	HUMAN PRESCRIPTION DRUG	ORKAMBI		lumacaftor and ivacaftor	GRANULE	ORAL	20220902		NDA	NDA211358	Vertex Pharmaceuticals Incorporated	IVACAFTOR; LUMACAFTOR	94; 75	mg/1; mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-200_fe19efba-2c80-41a6-a55a-0e6e07c665a7	51167-200	HUMAN PRESCRIPTION DRUG	Kalydeco		ivacaftor	TABLET, FILM COATED	ORAL	20120131		NDA	NDA203188	Vertex Pharmaceuticals Incorporated	IVACAFTOR	150	mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-290_f704729e-2fe9-4545-8971-5218abceeef0	51167-290	CELLULAR THERAPY	CASGEVY		exagamglogene autotemcel	INJECTION, SUSPENSION	INTRAVENOUS	20231208		BLA	BLA125787	Vertex Pharmaceuticals Incorporated	EXAGAMGLOGENE AUTOTEMCEL	13000000	1/mL			N	20241231
51167-300_fe19efba-2c80-41a6-a55a-0e6e07c665a7	51167-300	HUMAN PRESCRIPTION DRUG	Kalydeco		ivacaftor	GRANULE	ORAL	20150323		NDA	NDA207925	Vertex Pharmaceuticals Incorporated	IVACAFTOR	50	mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-331_15c7c553-95fc-4bc3-9596-31f1e4158a74	51167-331	HUMAN PRESCRIPTION DRUG	Trikafta		Elexacaftor, Tezacaftor, and Ivacaftor	KIT		20191021		NDA	NDA212273	Vertex Pharmaceuticals Incorporated						N	20241231
51167-400_fe19efba-2c80-41a6-a55a-0e6e07c665a7	51167-400	HUMAN PRESCRIPTION DRUG	Kalydeco		ivacaftor	GRANULE	ORAL	20150323		NDA	NDA207925	Vertex Pharmaceuticals Incorporated	IVACAFTOR	75	mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-445_15c7c553-95fc-4bc3-9596-31f1e4158a74	51167-445	HUMAN PRESCRIPTION DRUG	Trikafta		Elexacaftor, Tezacaftor, and Ivacaftor	KIT		20230426		NDA	NDA217660	Vertex Pharmaceuticals Incorporated						N	20241231
51167-446_15c7c553-95fc-4bc3-9596-31f1e4158a74	51167-446	HUMAN PRESCRIPTION DRUG	Trikafta		Elexacaftor, Tezacaftor, and Ivacaftor	KIT		20230426		NDA	NDA217660	Vertex Pharmaceuticals Incorporated						N	20241231
51167-500_13ae2223-41a9-429f-bb21-a683ab7eed37	51167-500	HUMAN PRESCRIPTION DRUG	ORKAMBI		lumacaftor and ivacaftor	GRANULE	ORAL	20180807		NDA	NDA211358	Vertex Pharmaceuticals Incorporated	IVACAFTOR; LUMACAFTOR	188; 150	mg/1; mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-600_fe19efba-2c80-41a6-a55a-0e6e07c665a7	51167-600	HUMAN PRESCRIPTION DRUG	Kalydeco		ivacaftor	GRANULE	ORAL	20190429		NDA	NDA207925	Vertex Pharmaceuticals Incorporated	IVACAFTOR	25	mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-661_bc1a7f6d-0292-4ddc-8887-0a7e4af95058	51167-661	HUMAN PRESCRIPTION DRUG	SYMDEKO		Tezacaftor and Ivacaftor	KIT		20180212		NDA	NDA210491	Vertex Pharmaceuticals Incorporated						N	20241231
51167-700_13ae2223-41a9-429f-bb21-a683ab7eed37	51167-700	HUMAN PRESCRIPTION DRUG	ORKAMBI		lumacaftor and ivacaftor	TABLET, FILM COATED	ORAL	20160928		NDA	NDA206038	Vertex Pharmaceuticals Incorporated	IVACAFTOR; LUMACAFTOR	125; 100	mg/1; mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-770_fe19efba-2c80-41a6-a55a-0e6e07c665a7	51167-770	HUMAN PRESCRIPTION DRUG	Kalydeco		ivacaftor	GRANULE	ORAL	20230503		NDA	NDA207925	Vertex Pharmaceuticals Incorporated	IVACAFTOR	13.4	mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-785_fe19efba-2c80-41a6-a55a-0e6e07c665a7	51167-785	HUMAN PRESCRIPTION DRUG	Kalydeco		ivacaftor	GRANULE	ORAL	20230503		NDA	NDA207925	Vertex Pharmaceuticals Incorporated	IVACAFTOR	5.8	mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-809_13ae2223-41a9-429f-bb21-a683ab7eed37	51167-809	HUMAN PRESCRIPTION DRUG	ORKAMBI		lumacaftor and ivacaftor	TABLET, FILM COATED	ORAL	20150702		NDA	NDA206038	Vertex Pharmaceuticals Incorporated	IVACAFTOR; LUMACAFTOR	125; 200	mg/1; mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51167-900_13ae2223-41a9-429f-bb21-a683ab7eed37	51167-900	HUMAN PRESCRIPTION DRUG	ORKAMBI		lumacaftor and ivacaftor	GRANULE	ORAL	20180807		NDA	NDA211358	Vertex Pharmaceuticals Incorporated	IVACAFTOR; LUMACAFTOR	125; 100	mg/1; mg/1	Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51191-3015_b0368e3c-741f-4b9d-bd29-4fdc17d6a51a	51191-3015	HUMAN OTC DRUG	SPF 50 UVA/UVB		ENSULIZOLE, OXYBENZONE, AVOBENZONE, OCTOCRYLENE	CREAM	TOPICAL	20130415		OTC MONOGRAPH NOT FINAL	part352	MULTALER ET CIE S.A.S.	AVOBENZONE; ENSULIZOLE; OCTOCRYLENE; OXYBENZONE	3; 3; 8; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
51206-201_ef1abc86-26ba-48a2-b40f-a2f4a5291545	51206-201	HUMAN OTC DRUG	UltraCare	Oral Anesthetic Bubble Gum	Benzocaine	GEL	DENTAL	19860601	20240831	OTC MONOGRAPH NOT FINAL	part356	Ultradent Products, Inc.	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
51206-202_19052b2e-209d-4151-a35c-2ee002fb4fdb	51206-202	HUMAN OTC DRUG	UltraCare	Oral Anesthetic Walterberry	Benzocaine	GEL	DENTAL	19930601	20241231	OTC MONOGRAPH NOT FINAL	part356	Ultradent Products, Inc.	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
51206-302_0eeb825c-4021-469e-bb64-b6fb3126090a	51206-302	HUMAN OTC DRUG	Opalescence Whitening		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	19940701		OTC MONOGRAPH FINAL	part355	Ultradent Products, Inc	SODIUM FLUORIDE	1.1	mg/g			N	20241231
51206-308_e2ae1bba-6fcc-40cd-a0b7-482115391568	51206-308	HUMAN OTC DRUG	Opalescence Sensitivity Relief Whitening		Potassium Nitrate and Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20151130		OTC MONOGRAPH NOT FINAL	part356	Ultradent Products, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
51206-311_86eb110a-1fe4-4a39-b227-ed6594089b1d	51206-311	HUMAN OTC DRUG	Opal by Opalescence Sensitivity		Potassium Nitrate and Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20231119		OTC MONOGRAPH DRUG	M022	Ultradent Products, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.1	mg/g; mg/g			N	20241231
51206-312_1a82543f-9648-467e-948e-b0a8350209f2	51206-312	HUMAN OTC DRUG	Opal by Opalescence Original		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20231119		OTC MONOGRAPH DRUG	M021	Ultradent Products, Inc.	SODIUM FLUORIDE	1.1	mg/g			N	20241231
51206-401_97a027ea-85de-41af-b02d-8f50907cf455	51206-401	HUMAN PRESCRIPTION DRUG	Flor-Opal Sustained-Release Fluoride		Sodium Fluoride	GEL	DENTAL	19900531	20240131	UNAPPROVED DRUG OTHER		Ultradent Products, Inc	SODIUM FLUORIDE	5	mg/mL			N	
51224-001_8c55a83f-07f4-4f96-8b85-b1df90c8e116	51224-001	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20150810		ANDA	ANDA202765	TAGI Pharma, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
51224-007_a20e99db-1594-46d8-99ef-ff16420e4574	51224-007	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	TAGI Pharma, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51224-009_1d7eca32-37c5-4810-93d8-d918e4a2eedb	51224-009	HUMAN PRESCRIPTION DRUG	Cholestyramine Light		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20201112		ANDA	ANDA209599	TAGI Pharma, Inc.	CHOLESTYRAMINE	4	g/4.8g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
51224-010_8c55a83f-07f4-4f96-8b85-b1df90c8e116	51224-010	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170907		ANDA	ANDA202765	TAGI Pharma, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
51224-011_cbbff3c3-886a-43c1-9b91-983cbfd673fd	51224-011	HUMAN PRESCRIPTION DRUG	Cholestyramine		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20210310		ANDA	ANDA209597	TAGI Pharma, Inc.	CHOLESTYRAMINE	4	g/8.3g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
51224-012_f70b960c-7d8d-4b87-8b5a-57cbcda74af0	51224-012	HUMAN PRESCRIPTION DRUG	Phentolamine Mesylate		Phentolamine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170715		ANDA	ANDA207686	TAGI Pharma, Inc.	PHENTOLAMINE MESYLATE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51224-013_483a2f8c-8a16-4255-a68b-23ab6b46eb4a	51224-013	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20181130		ANDA	ANDA209781	TAGI Pharma, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51224-018_98c8ff40-9e00-4793-ba69-5e36ced32984	51224-018	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20220805		ANDA	ANDA212878	TAGI Pharma, Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51224-019_adc504e8-dd72-401d-aa44-57dde50b499c	51224-019	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20200101	20240402	ANDA	ANDA075477	TAGI Pharma, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
51224-020_62d835b1-e8f8-439a-bfb1-d42a18c431bc	51224-020	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	TAGI Pharma, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51224-021_be5b794d-ef38-46a2-b07e-cede35622bcc	51224-021	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20190501		ANDA	ANDA207057	TAGI Pharma, Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51224-022_466e8d2b-4732-4a47-8f26-f8dad6a6a6c8	51224-022	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	TAGI Pharma, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
51224-024_666abc7f-c475-45cc-b288-28a3f7da887d	51224-024	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20220101		ANDA	ANDA215615	TAGI Pharma, Inc.	METHAZOLAMIDE	25	mg/1			N	20241231
51224-101_cbd7dd0e-9945-46c1-8770-b97cfa910384	51224-101	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	TAGI Pharma, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
51224-107_a20e99db-1594-46d8-99ef-ff16420e4574	51224-107	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	TAGI Pharma, Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51224-118_98c8ff40-9e00-4793-ba69-5e36ced32984	51224-118	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20220805		ANDA	ANDA212875	TAGI Pharma, Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51224-119_adc504e8-dd72-401d-aa44-57dde50b499c	51224-119	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20200101	20240402	ANDA	ANDA075477	TAGI Pharma, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
51224-120_62d835b1-e8f8-439a-bfb1-d42a18c431bc	51224-120	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	TAGI Pharma, Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51224-121_be5b794d-ef38-46a2-b07e-cede35622bcc	51224-121	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20190501		ANDA	ANDA207057	TAGI Pharma, Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51224-122_f10d425b-2182-4316-baa6-2778c5e67a3d	51224-122	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	TAGI Pharma, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
51224-124_666abc7f-c475-45cc-b288-28a3f7da887d	51224-124	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20220101		ANDA	ANDA215615	TAGI Pharma, Inc.	METHAZOLAMIDE	50	mg/1			N	20241231
51224-151_ddcc7cdd-5ea2-41a6-beb1-fdb9a73b5963	51224-151	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20110415	20240430	ANDA	ANDA075517	TAGI Pharma, Inc.	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	
51224-162_4056d8c0-ca3f-4f8c-9fee-af9727a65267	51224-162	HUMAN OTC DRUG	Astringent		Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate	POWDER, FOR SOLUTION	TOPICAL	20120601	20240930	OTC MONOGRAPH NOT FINAL	part347	TAGI Pharma Inc.	ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE	1347; 952	mg/2299mg; mg/2299mg	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
51224-202_6bb9aac7-67f6-4338-bb57-2608fa4a1467	51224-202	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	TAGI Pharma, Inc	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
51224-203_6bb9aac7-67f6-4338-bb57-2608fa4a1467	51224-203	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	TAGI Pharma, Inc	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
51224-206_c82a0ed4-3236-4166-90a8-f5e43e6dd883	51224-206	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20130923		ANDA	ANDA075274	TAGI Pharma Inc.	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51224-220_62d835b1-e8f8-439a-bfb1-d42a18c431bc	51224-220	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	TAGI Pharma, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51224-222_568a062a-f21b-4c4b-b5ce-db21cc443231	51224-222	HUMAN PRESCRIPTION DRUG	Azithromycin dihydrate		Azithromycin dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA207566	TAGI Pharma, Inc.	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
51224-425_1747e6bf-81c5-44f2-859e-bbe9a6c6b42f	51224-425	HUMAN PRESCRIPTION DRUG	TETRABENAZINE		TETRABENAZINE	TABLET	ORAL	20170201	20251231	ANDA	ANDA207682	TAGI Pharma, Inc.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	
51224-426_1747e6bf-81c5-44f2-859e-bbe9a6c6b42f	51224-426	HUMAN PRESCRIPTION DRUG	TETRABENAZINE		TETRABENAZINE	TABLET	ORAL	20170201	20250731	ANDA	ANDA207682	TAGI Pharma, Inc.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	
51239-1909_0670d211-3374-ddbd-e063-6394a90aee29	51239-1909	HUMAN OTC DRUG	SCRUBS Hand Sanitizer Wipe		Hand Sanitizer Wipe	CLOTH	CUTANEOUS	20161001	20250329	OTC MONOGRAPH NOT FINAL	part333E	ITW Pro Brands	BENZALKONIUM CHLORIDE	.00097	g/mL			N	
51239-2909_0680a19d-764f-e7b3-e063-6394a90a9f65	51239-2909	HUMAN OTC DRUG	SCRUBS Hand Sanitizer Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20230913		OTC MONOGRAPH NOT FINAL	part333E	ITW Pro Brands	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
51239-2921_f1e99045-dfe9-8de0-e053-2a95a90a9add	51239-2921	HUMAN OTC DRUG	Scrubs Sunscreen		Sunscreen	LOTION	TOPICAL	20170501	20241201	OTC MONOGRAPH FINAL	part352	ITW Pro Brands	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	.01; .05; .075; .05; .06	g/g; g/g; g/g; g/g; g/g			N	
51239-3921_06d645e3-1ac3-1031-e063-6394a90a0514	51239-3921	HUMAN OTC DRUG	Scrubs Sunscren		Sunscreen	LOTION	TOPICAL	20211201	20250506	OTC MONOGRAPH DRUG	M020	ITW Pro Brands	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .075; .05; .05	g/g; g/g; g/g; g/g			N	
51248-150_00cdc16c-ae98-4ae0-ac6a-9e13e6417471	51248-150	HUMAN PRESCRIPTION DRUG	VESIcare		solifenacin succinate	TABLET, FILM COATED	ORAL	20050105		NDA	NDA021518	Astellas Pharma US, Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51248-151_00cdc16c-ae98-4ae0-ac6a-9e13e6417471	51248-151	HUMAN PRESCRIPTION DRUG	VESIcare		solifenacin succinate	TABLET, FILM COATED	ORAL	20050105		NDA	NDA021518	Astellas Pharma US, Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51248-250_1b2e74b9-d2ab-4394-ac49-32208aae8751	51248-250	HUMAN PRESCRIPTION DRUG	VESIcare	LS	solifenacin succinate	SUSPENSION	ORAL	20200526		NDA	NDA209529	Astellas Pharma US, Inc.	SOLIFENACIN SUCCINATE	1	mg/mL	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51267-890_ab1b082f-fd25-43f7-b7ea-13a34aa05cc2	51267-890	HUMAN PRESCRIPTION DRUG	Contrave	Extended-Release	naltrexone hydrochloride and bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141022		NDA	NDA200063	Nalpropion Pharmaceuticals LLC	BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE	90; 8	mg/1; mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51285-040_5bf77f2f-a676-4eee-927d-e0a7fad342a0	51285-040	HUMAN PRESCRIPTION DRUG	Ziac		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19931026	20250630	NDA	NDA020186	Teva Women's Health LLC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	
51285-047_5bf77f2f-a676-4eee-927d-e0a7fad342a0	51285-047	HUMAN PRESCRIPTION DRUG	Ziac		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19931026	20250531	NDA	NDA020186	Teva Women's Health LLC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	
51285-050_5bf77f2f-a676-4eee-927d-e0a7fad342a0	51285-050	HUMAN PRESCRIPTION DRUG	Ziac		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19931026	20250531	NDA	NDA020186	Teva Women's Health LLC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	
51285-063_babcd12b-2a18-4add-8d57-aac76ed27c19	51285-063	HUMAN PRESCRIPTION DRUG	Prefest		Estradiol/Norgestimate	KIT		20060530	20240731	ANDA	ANDA076812	Teva Women's Health LLC						N	
51285-087_f21e7a12-0337-4227-9a12-50e4176cdb9b	51285-087	HUMAN PRESCRIPTION DRUG	Seasonique		Levonorgestrel / Ethinyl Estradiol and Ethinyl Estradiol	KIT		20060710	20240630	NDA	NDA021840	Teva Women's Health LLC						N	
51285-092_54118a4e-8a7e-4101-a428-8f887b22b983	51285-092	HUMAN PRESCRIPTION DRUG	LoSeasonique		Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol	KIT		20090323	20240430	NDA	NDA022262	Teva Women's Health LLC						N	
51285-120_7223888f-ae5f-477c-af77-9b0bf7683a27	51285-120	HUMAN PRESCRIPTION DRUG	Mircette		Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol	KIT		20140915	20240930	ANDA	ANDA075863	Teva Women's Health LLC						N	
51285-125_ac1ba264-f0d0-4aea-b392-66924639042b	51285-125	HUMAN PRESCRIPTION DRUG	Loestrin	Fe 28 Day	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20150226		ANDA	ANDA076081	Teva Women's Health LLC						N	20241231
51285-127_ac1ba264-f0d0-4aea-b392-66924639042b	51285-127	HUMAN PRESCRIPTION DRUG	Loestrin	21 Day	Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20150226		ANDA	ANDA076381	Teva Women's Health LLC	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	30; 1.5	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
51285-128_ac1ba264-f0d0-4aea-b392-66924639042b	51285-128	HUMAN PRESCRIPTION DRUG	Loestrin	Fe 28 Day	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20150226		ANDA	ANDA076064	Teva Women's Health LLC						N	20241231
51285-131_ac1ba264-f0d0-4aea-b392-66924639042b	51285-131	HUMAN PRESCRIPTION DRUG	Loestrin	21 Day	Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20150226		ANDA	ANDA076380	Teva Women's Health LLC	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	20; 1	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
51285-138_07bf8d78-4199-484b-8298-060f84fc1b02	51285-138	VACCINE	Adenovirus Type 4 and Type 7 Vaccine, Live		Adenovirus Type 4 and Type 7 Vaccine, Live	KIT		20110916		BLA	BLA125296	Teva Women's Health, Inc.						N	20241231
51285-204_b81fa2bd-2b54-4c5b-aafd-e9c9c2048fa1	51285-204	HUMAN PRESCRIPTION DRUG	ParaGard T 380A		Copper	INTRAUTERINE DEVICE	INTRAUTERINE	20040101	20240430	NDA	NDA018680	Teva Women's Health LLC	COPPER	313.4	mg/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	
51285-366_6743bd6d-9c6b-4f43-b444-8faa4b5d5221	51285-366	HUMAN PRESCRIPTION DRUG	Trexall		Methotrexate	TABLET, FILM COATED	ORAL	20010503		ANDA	ANDA040385	Teva Women's Health, Inc.	METHOTREXATE SODIUM	5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
51285-367_6743bd6d-9c6b-4f43-b444-8faa4b5d5221	51285-367	HUMAN PRESCRIPTION DRUG	Trexall		Methotrexate	TABLET, FILM COATED	ORAL	20010503		ANDA	ANDA040385	Teva Women's Health, Inc.	METHOTREXATE SODIUM	7.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
51285-368_6743bd6d-9c6b-4f43-b444-8faa4b5d5221	51285-368	HUMAN PRESCRIPTION DRUG	Trexall		Methotrexate	TABLET, FILM COATED	ORAL	20010503		ANDA	ANDA040385	Teva Women's Health, Inc.	METHOTREXATE SODIUM	10	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
51285-369_6743bd6d-9c6b-4f43-b444-8faa4b5d5221	51285-369	HUMAN PRESCRIPTION DRUG	Trexall		Methotrexate	TABLET, FILM COATED	ORAL	20010503		ANDA	ANDA040385	Teva Women's Health, Inc.	METHOTREXATE SODIUM	15	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
51285-424_8cfac7d2-c6b7-4211-93b6-46441b1ba0e9	51285-424	HUMAN PRESCRIPTION DRUG	Aygestin		Norethindrone Acetate	TABLET	ORAL	20030612	20240831	ANDA	ANDA075951	Teva Women's Health LLC	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	
51285-431_a42f77e9-8127-4f46-9d99-e5dddb3bfefd	51285-431	HUMAN PRESCRIPTION DRUG	QUARTETTE		Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol	KIT		20130725	20250131	NDA	NDA204061	Teva Women's Health LLC						N	
51293-611_f780f27a-7ccc-7dd5-e053-6394a90a2163	51293-611	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		ECI Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
51293-612_f780f27a-7ccc-7dd5-e053-6394a90a2163	51293-612	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		ECI Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
51293-625_f178d4f9-0669-f121-e053-2a95a90a5d9d	51293-625	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		ECI Pharmaceuticals, LLC	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
51293-626_f178d4f9-0669-f121-e053-2a95a90a5d9d	51293-626	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		ECI Pharmaceuticals, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
51293-627_f178d4f9-0669-f121-e053-2a95a90a5d9d	51293-627	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		ECI Pharmaceuticals, LLC	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
51293-628_f178d4f9-0669-f121-e053-2a95a90a5d9d	51293-628	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		ECI Pharmaceuticals, LLC	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
51293-839_f7809ac8-f645-88a4-e053-6294a90ae67d	51293-839	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210201		ANDA	ANDA210420	ECI Pharmaceuticals, LLC	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51293-840_f7809ac8-f645-88a4-e053-6294a90ae67d	51293-840	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210201		ANDA	ANDA210420	ECI Pharmaceuticals, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51293-841_f7809ac8-f645-88a4-e053-6294a90ae67d	51293-841	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210201		ANDA	ANDA210420	ECI Pharmaceuticals, LLC	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51293-842_f7809ac8-f645-88a4-e053-6294a90ae67d	51293-842	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210201		ANDA	ANDA210420	ECI Pharmaceuticals, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51316-000_f0cb08c3-6d5d-5660-e053-2995a90aeeaa	51316-000	HUMAN OTC DRUG	CVS Health Sport SPF 50 Face		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181113		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 130; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-003_6bdac83d-e4e6-452c-a136-cb5d44e21346	51316-003	HUMAN OTC DRUG	CVS	Tropical Fruit	Antacid	TABLET, CHEWABLE	ORAL	20210805		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-006_95d4b993-1566-6792-c67d-4fb0ef478989	51316-006	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221001		ANDA	ANDA202194	CVS Pharmacy, Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51316-007_46975e97-aa0a-4ae8-88e5-13d6fe3443de	51316-007	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221117		ANDA	ANDA209116	CVS Pharmacy, Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51316-008_2fa9e8d1-3b73-07eb-85b0-6214d6111439	51316-008	HUMAN OTC DRUG	Guaifenesin 600 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215932	CVS Pharmacy	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
51316-009_60b6b5aa-5005-db80-feb2-39c187ae0e0c	51316-009	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBR		Guaifenesin and Dextromethorphan HBR	TABLET, EXTENDED RELEASE	ORAL	20230815		ANDA	ANDA217340	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-010_f0d608d9-1c0a-b65c-e053-2a95a90aad33	51316-010	HUMAN OTC DRUG	CVS Health SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181205		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 150; 50; 15	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-011_f7079790-bce9-4ea6-837b-9f11d0202405	51316-011	HUMAN OTC DRUG	CVS PHARMACY	Extra Strength Gas Relief	Simethicone Antigas	TABLET, CHEWABLE	ORAL	20210805		OTC MONOGRAPH FINAL	part332	CVS	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51316-012_5a104d37-c640-4bb9-9daa-b271ca63789b	51316-012	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20220204		ANDA	ANDA208077	CVS PHARMACY, INC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51316-013_f074a64d-dc02-1a37-e053-2995a90adc49	51316-013	HUMAN OTC DRUG	Sugar Free Cough Drops		Honey Lemon	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
51316-014_f038b51e-2b8b-2249-e053-2a95a90ae5c1	51316-014	HUMAN OTC DRUG	Sugar Free Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
51316-015_877059ac-0b47-f032-1c34-50666ca5cc51	51316-015	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220603		ANDA	ANDA215434	CVS Health Corp	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51316-016_f0750cec-a3c7-6f1c-e053-2995a90a8870	51316-016	HUMAN OTC DRUG	Cough Drops		Honey Lemon	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
51316-017_f0dd2d02-2055-7e82-e053-2995a90a4e6c	51316-017	HUMAN OTC DRUG	CVS Health Sport SPF 50		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20181026		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
51316-018_da4ec187-1660-6380-0293-4d72ec188589	51316-018	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCl		Fexofenadine HCl and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20221130		ANDA	ANDA079043	CVS Pharmacy, Inc	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51316-019_f0e8c734-4dd1-2eeb-e053-2a95a90ad505	51316-019	HUMAN OTC DRUG	CVS Health SPORT SPF 30		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20161108		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
51316-020_f0ec5f47-2f9d-0558-e053-2a95a90aa7ca	51316-020	HUMAN OTC DRUG	CVS Health SPF 100 Clear		Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20191120		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 20; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
51316-021_0399d6cc-ae96-4f64-adc0-b09668d9582c	51316-021	HUMAN OTC DRUG	Extra Strength		Antacid Tablets	TABLET, CHEWABLE	ORAL	20210802		OTC MONOGRAPH FINAL	part331	CVS PHARMACY	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-022_f0f196ab-c27e-d23b-e053-2a95a90a23cc	51316-022	HUMAN OTC DRUG	CVS Health Sunburn Relief Cooling Lidocaine 0.5 Pain-Relieving		Lidocaine HCl	GEL	TOPICAL	20181005		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51316-023_f0f276d0-a431-0cac-e053-2a95a90ad4c8	51316-023	HUMAN OTC DRUG	CVS Health	Sport SPF 15 Clear	Avobenzone, Homosalate, Octisalate	AEROSOL, SPRAY	TOPICAL	20181128		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE	20; 100; 50	mg/g; mg/g; mg/g			N	20241231
51316-024_f116504f-5d6e-299d-e053-2995a90a7c26	51316-024	HUMAN OTC DRUG	CVS Health SPF 50 Ultra Protection		Avobenzone Homosalate Octisalate Octocrylene	LOTION	TOPICAL	20190103		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-025_f12ba764-afeb-3f81-e053-2a95a90a1291	51316-025	HUMAN OTC DRUG	CVS Health SPF 30 Ultra Protection		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20181120		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-026_f13f7704-ff2f-74aa-e053-2a95a90a1cf6	51316-026	HUMAN OTC DRUG	CVS HEALTH SPORT SPF 50 CLEAR SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20191024		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
51316-027_f31dd4a5-9bac-1f11-e053-2a95a90a3739	51316-027	HUMAN OTC DRUG	CVS Health Sport SPF 70 Clear		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20190619		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
51316-028_f32dc488-6686-5a77-e053-2995a90a544b	51316-028	HUMAN OTC DRUG	CVS Health SPF 30 Ultra Sheer		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170207		OTC MONOGRAPH FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 80; 50; 40; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-029_f32ec4f7-f919-0a7a-e053-2995a90a0a11	51316-029	HUMAN OTC DRUG	CVS Health SPF 30 Ultra Sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181031		OTC MONOGRAPH FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-030_f40e39c9-eb8c-e547-e053-2995a90a8ca0	51316-030	HUMAN OTC DRUG	CVS Health Sport SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181205		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-031_9196c48f-a255-4b9d-880f-65ffa0ce9423	51316-031	HUMAN OTC DRUG	CVS Ultra Strength		Antacid Tablets	TABLET, CHEWABLE	ORAL	20210806		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-032_f4102512-dd45-e3d0-e053-2a95a90aead5	51316-032	HUMAN OTC DRUG	CVS Health SPF 70 Age Defense Face		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20190129		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-033_f4147978-2cd5-345a-e053-2995a90a67ed	51316-033	HUMAN OTC DRUG	CVS Health SPF 30 Breakout Free Face		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190121		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 60; 40; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-034_f4147978-2cd4-345a-e053-2995a90a67ed	51316-034	HUMAN OTC DRUG	CVS Health SPF 30 Beach Guard		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181205		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27; 80; 50; 35	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-035_f41e0df4-7ca3-5f29-e053-2a95a90a01e8	51316-035	HUMAN OTC DRUG	CVS Health SPF 30 Clear		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190521		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
51316-036_f42402ff-0d71-9231-e053-2995a90aa46d	51316-036	HUMAN OTC DRUG	CVS Health SPF 50 Clear		Avobenzone Homosalate Octisalate Octocrylene	SPRAY	TOPICAL	20191015		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
51316-037_f799addf-f453-4f97-e053-6394a90ad0ed	51316-037	HUMAN OTC DRUG	CVS Health Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211110		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27; 90; 45; 65	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-038_f7a768b6-8559-34af-e053-6294a90ac7e8	51316-038	HUMAN OTC DRUG	CVS Health 60 Plus Sensitive Skin Sun		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20181102		OTC MONOGRAPH FINAL	M020	CVS Pharmacy	TITANIUM DIOXIDE; ZINC OXIDE	49; 47	mg/mL; mg/mL			N	20241231
51316-039_f7a835d2-a8ac-184e-e053-6394a90a3e4e	51316-039	HUMAN OTC DRUG	CVS Health Oil Free Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate	STICK	TOPICAL	20181031		OTC MONOGRAPH FINAL	M020	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE	20; 150; 50	mg/g; mg/g; mg/g			N	20241231
51316-040_f7a8c3f8-9259-21fb-e053-6394a90a42a2	51316-040	HUMAN OTC DRUG	CVS Health SPF 100 Ultra Sheer		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20190115		OTC MONOGRAPH FINAL	M020	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
51316-041_fa44327b-5a27-5ec0-e053-6294a90aaea3	51316-041	HUMAN OTC DRUG	CVS HEALTH KIDS AND BABY 50 MINERAL-BASED		OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20181213		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	OCTISALATE; ZINC OXIDE	50; 145	mg/mL; mg/mL			N	20241231
51316-042_f9c89b92-cea4-f1d8-e053-6294a90acd7a	51316-042	HUMAN OTC DRUG	CVS Health AM Moisturizing Facial Broad Spectrum SPF 30 Sunscreen		HOMOSALATE, OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20180418		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	HOMOSALATE; OCTOCRYLENE; ZINC OXIDE	150; 20; 63	mg/mL; mg/mL; mg/mL			N	20241231
51316-043_fa19e9d3-6ab9-cbd6-e053-6294a90aae9b	51316-043	HUMAN OTC DRUG	CVS Health 50 Clear Zinc Broad Spectrum SPF 50 Sunscreen		OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20181003		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	OCTOCRYLENE; ZINC OXIDE	40; 50	mg/mL; mg/mL			N	20241231
51316-044_ef50a27b-87a1-4f3f-bfad-f9845822e3a6	51316-044	HUMAN OTC DRUG	Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate	OINTMENT	TOPICAL	20220225		OTC MONOGRAPH FINAL	part333B	CVS PHARMACY, INC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[iU]/g; [iU]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
51316-045_fa2b2abc-d521-ad70-e053-6394a90acf1f	51316-045	HUMAN OTC DRUG	CVS Health 50 Hydrating Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20191209		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	TITANIUM DIOXIDE; ZINC OXIDE	90; 70	mg/mL; mg/mL			N	20241231
51316-046_fa2c69df-c088-c31d-e053-6394a90a194c	51316-046	HUMAN OTC DRUG	CVS Health 50 Hydrating Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20191209		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	TITANIUM DIOXIDE; ZINC OXIDE	90; 70	mg/mL; mg/mL			N	20241231
51316-047_fa40220d-b611-c67f-e053-6394a90ab377	51316-047	HUMAN OTC DRUG	CVS Health Concealing Acne Treatment Maximum Strength Adult Acne Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20190517		OTC MONOGRAPH FINAL	M006	CVS PHARMACY	BENZOYL PEROXIDE	100	mg/g			N	20241231
51316-048_fa4086c8-c4e7-316f-e053-6394a90a82f8	51316-048	HUMAN OTC DRUG	CVS Health Quick Action Spot Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20190517		OTC MONOGRAPH FINAL	M006	CVS PHARMACY	BENZOYL PEROXIDE	100	mg/g			N	20241231
51316-049_fa413b02-e4cd-bf6f-e053-6394a90a950b	51316-049	HUMAN OTC DRUG	CVS Beauty 360 7-in-1 Complete Daily Moisturizer Anti-Aging Formula with Broad Spectrum SPF 15 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20180613		OTC MONOGRAPH FINAL	M020	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 40; 45; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-050_06c22d8b-bff9-5d9e-e063-6394a90ad387	51316-050	HUMAN OTC DRUG	CVS Mixed Berry Antacid HBG 54ct		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220920		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
51316-051_06c22d8b-bffa-5d9e-e063-6394a90ad387	51316-051	HUMAN OTC DRUG	CVS Mixed Berry Antacid HBG 28ct		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220922		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
51316-052_f6f45d9c-f9fd-225b-e053-6394a90a30e1	51316-052	HUMAN OTC DRUG	CVS Wild Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230315		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
51316-053_f6f5dc9a-b574-70c1-e053-6394a90acdb0	51316-053	HUMAN OTC DRUG	CVS Wild Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230315		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
51316-054_fbe6cdc7-74d8-8149-e053-6394a90a45ec	51316-054	HUMAN OTC DRUG	CVS Health Sport 30 Clear		Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20211110		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 60; 60	mg/g; mg/g; mg/g			N	20241231
51316-055_fc4adabf-24e9-ee42-e053-6394a90a3ff0	51316-055	HUMAN OTC DRUG	CVS Health 45 Ultra Sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190904		OTC MONOGRAPH FINAL	M020	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 23.5	mg/g; mg/g; mg/g; mg/g			N	20241231
51316-056_fc4b2635-2808-267f-e053-6294a90a5e22	51316-056	HUMAN OTC DRUG	CVS Health Sport 70		AVOBENZONE. HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220927		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-057_fc4bd2d2-94f3-0e05-e053-6294a90a6b8b	51316-057	HUMAN OTC DRUG	CVS Health Sport 70 Clear		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20221005		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
51316-058_08a5607b-4e84-72e4-e063-6394a90a7ec3	51316-058	HUMAN OTC DRUG	CVS HEALTH LIVE BETTER BODY MINERAL SUNSCREEN BROAD SPECTRUM SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20200121		OTC MONOGRAPH DRUG	M020	CVS PHARMACY	TITANIUM DIOXIDE; ZINC OXIDE	30; 150	mg/mL; mg/mL			N	20241231
51316-059_0a248127-003c-f491-e063-6394a90af837	51316-059	HUMAN OTC DRUG	CVS Health Sport 100 Clear		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20221005		OTC MONOGRAPH DRUG	M020	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
51316-061_a3b8b93d-6725-4c5c-8b80-dcc27e408501	51316-061	HUMAN OTC DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20210109		ANDA	ANDA210593	CVS Pharamacy, Inc	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51316-064_a72576f6-0c54-40b4-abb2-72290c4883ac	51316-064	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20210903		ANDA	ANDA213105	CVS PHARMACY, INC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-071_c84bf7a4-0567-4d1c-bcaa-976de2a31ff4	51316-071	HUMAN OTC DRUG	GUAIFENESIN		guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20221007		ANDA	ANDA209254	CVS	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
51316-073_caca313b-ee0a-421c-8a96-505799f6fb9c	51316-073	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20210930		ANDA	ANDA208077	CVS PHARMACY, INC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51316-074_55bb1507-7560-4198-85fc-efa66ff16105	51316-074	HUMAN OTC DRUG	Allergy Relief		fluticasone propionate	SPRAY, METERED	NASAL	20221231		ANDA	ANDA208024	CVS PHARMACY, INC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51316-078_09c397dd-c759-634f-e063-6394a90a52e7	51316-078	HUMAN OTC DRUG	CVS Health Hydrogen Peroxide Wipes		HYDROGEN PEROXIDE	CLOTH	TOPICAL	20190401		OTC MONOGRAPH DRUG	M003	CVS PHARMACY, INC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
51316-079_c5942acd-db6e-47ab-b2f1-440f06d320e2	51316-079	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20230718		OTC MONOGRAPH DRUG	M013	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	ACETAMINOPHEN	160	mg/5mL			N	20241231
51316-101_0bded185-6bf4-3dd2-e063-6294a90a95e2	51316-101	HUMAN OTC DRUG	Daytime Severe Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, Guaifenesin, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20221110		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-102_bb3288f4-16b7-475f-b6f5-608104a7a8fc	51316-102	HUMAN OTC DRUG	CVS PHARMACY,INC.	Assorted Berry	Antacid Tablets	TABLET, CHEWABLE	ORAL	20210723		OTC MONOGRAPH FINAL	part331	CVS PHARMACY,INC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-103_9442339a-47aa-4835-8fdf-b7b833635495	51316-103	HUMAN OTC DRUG	CVS PHARMACY	Assorted Fruit Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210802		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	1000	mg/1			N	20241231
51316-106_0bf0899b-c17e-05cf-e063-6294a90a3cfe	51316-106	HUMAN OTC DRUG	Non Drowsy Severe Daytime and Nighttime Cold and Flu Relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride, guaifenesin	KIT		20221110		OTC MONOGRAPH DRUG	M012	CVS Pharmacy						N	20241231
51316-107_eb499b51-5182-44b2-8c86-b04c31dbd0dd	51316-107	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20221230		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY, INC	DOCUSATE SODIUM	100	mg/1			N	20241231
51316-110_f965da6f-621c-46de-b8b7-697715a4b84d	51316-110	HUMAN OTC DRUG	CVS PHARMACY	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20210805		OTC MONOGRAPH DRUG	M002	CVS	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51316-111_327bb72d-3998-4436-99e2-61d7ff4135b6	51316-111	HUMAN OTC DRUG	CVS PHARMACY	Gas relief	Simethicone	TABLET, CHEWABLE	ORAL	20210806		OTC MONOGRAPH FINAL	part332	CVS	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
51316-112_0b7736df-c7df-7d00-e063-6294a90aa57e	51316-112	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, FILM COATED	ORAL	20230323		OTC MONOGRAPH DRUG	M007	CVS Pharmacy, Inc	SENNOSIDES	8.6	mg/1			N	20241231
51316-114_520f15a0-3749-4f4d-804e-0286e5f450f6	51316-114	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20231031		ANDA	ANDA090962	CVS PHARMACY, INC	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20251231
51316-115_3035c656-a126-4e6a-acba-8f1221d67b8e	51316-115	HUMAN OTC DRUG	Extra Strength Smooth		Antacid Tablets	TABLET, CHEWABLE	ORAL	20210806		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-122_e066f5bd-5f34-4e04-beec-3c7d6db49381	51316-122	HUMAN OTC DRUG	CVS Fiber Therapy		Methylcellulose	TABLET	ORAL	20230914		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
51316-123_1c89403f-e8e6-4d68-8469-e12185c9bbf5	51316-123	HUMAN OTC DRUG	Cold and Flu	Daytime Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20230728		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED						N	20241231
51316-124_010a5cae-7f6b-4f13-916b-a91225282bf9	51316-124	HUMAN OTC DRUG	CVS Stomach Relief		Bismuth subsalicylate	TABLET	ORAL	20210806		OTC MONOGRAPH FINAL	part335	CVS	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
51316-128_f2f2009f-34ce-2b49-e053-2a95a90a1722	51316-128	HUMAN OTC DRUG	CVS	Enamel Guard	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
51316-129_0d297793-9716-6382-e063-6394a90a7d3e	51316-129	HUMAN OTC DRUG	CVS Advanced Eye Drops		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
51316-131_0c0239c7-91a6-0fef-e063-6294a90aa2b8	51316-131	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET	ORAL	20231001		ANDA	ANDA216592	CVS	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51316-132_0c0239c7-91a4-0fef-e063-6294a90aa2b8	51316-132	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET	ORAL	20231006		ANDA	ANDA216592	CVS	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51316-140_dbb1519b-fd0c-46eb-bec6-ccb72faf53b8	51316-140	HUMAN OTC DRUG	CVS Original Nasal Mist		Oxymetazoline HCL	SPRAY	NASAL	20220430		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
51316-141_fa2d07aa-abac-b533-e053-6294a90a6c7c	51316-141	HUMAN OTC DRUG	Pramoxine Itch relief		Pramoxine HCl 1%	CREAM	TOPICAL	20230425		OTC MONOGRAPH NOT FINAL	part348	CVS	PRAMOXINE HYDROCHLORIDE	1	g/100g			N	20241231
51316-142_09079688-4a34-fb60-e063-6394a90ae488	51316-142	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20211101		OTC MONOGRAPH DRUG	M001	CVS PHARMACY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51316-143_07d7e59b-e5a9-a487-e063-6294a90a4559	51316-143	HUMAN OTC DRUG	CVS muscle relief		Magnesium Sulfate Heptahydrate	SPRAY	TOPICAL	20231016		UNAPPROVED HOMEOPATHIC		CVS Health	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/210mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51316-144_07da1e53-9830-4f91-e063-6394a90ae88e	51316-144	HUMAN OTC DRUG	CVS Itch relief moisturizing		Pramoxine HCl 1%	LOTION	TOPICAL	20231017		OTC MONOGRAPH DRUG	M017	CVS Health	PRAMOXINE HYDROCHLORIDE	1	g/100mL			N	20241231
51316-152_472e2422-75b6-41b8-8527-7e50b0947ab5	51316-152	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20231231		OTC MONOGRAPH DRUG	M002	CVS PHARMACY, INC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
51316-156_3eabf9a5-c05a-479b-9b66-ff90ff586578	51316-156	HUMAN OTC DRUG	CVS DayTime and NightTime Value Pack	Cold and Flu	Acetaminophen, Phenylephrine Hydrochloride, and Doxylamine Succinate	KIT		20230310		OTC MONOGRAPH DRUG	M012	CVS PHARMACY						N	20241231
51316-179_d6b5ab52-c0c1-46ce-b835-a3b47a50de4a	51316-179	HUMAN OTC DRUG	nighttime severe		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230628		OTC MONOGRAPH FINAL	part341	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-200_f28ea684-ffd6-4c46-e053-2995a90abade	51316-200	HUMAN OTC DRUG	CVS Health	Medicated Chest Rub	camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20210701		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	47; 12; 26	mg/g; mg/g; mg/g			N	20241231
51316-201_d1e8db4e-4fb8-4482-a52c-078fe1c46258	51316-201	HUMAN OTC DRUG	CVS PHARMACY,INC.	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20210723		OTC MONOGRAPH FINAL	part331	CVS PHARMACY,INC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-212_545f3e4c-dc71-4296-84ea-13d70d58873b	51316-212	HUMAN OTC DRUG	Minoxidil	(For Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20220819		ANDA	ANDA209074	CVS Pharmacy	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51316-213_f2117b0d-d23a-4eb4-af7b-1eb69cf9f3df	51316-213	HUMAN OTC DRUG	Minoxidil	(For Women)	Minoxidil	AEROSOL, FOAM	TOPICAL	20220805		ANDA	ANDA209074	CVS Pharmacy	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51316-216_0dd7dc9e-2c9d-5279-e063-6394a90ae799	51316-216	HUMAN OTC DRUG	CVS LEG CRAMPS		cinchona officinalis bark, aconitum napellus, pseudognaphalium obtusifolium, ledum palustre twig, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, and viscum album fruiting top	TABLET, SOLUBLE	ORAL	20220125		UNAPPROVED HOMEOPATHIC		CVS HEALTH	ACONITUM NAPELLUS; CINCHONA OFFICINALIS BARK; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP	6; 3; 6; 6; 3; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51316-225_0883340e-4a35-6eb2-e063-6294a90aabe0	51316-225	HUMAN OTC DRUG	HEMORRHOIDAL WITH LIDOCAINE		GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE, WHITE PETROLATUM	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M016	CVS PHARMACY, INC	GLYCERIN; LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE; WHITE PETROLATUM	144; 50; 2.5; 150	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-226_0883ae94-84a7-74b2-e063-6294a90a418e	51316-226	HUMAN OTC DRUG	MAXIMUM STRENGTH HEMORRHOIDAL RELIEF		LIDOCAINE	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M017	CVS PHARMACY, INC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51316-227_08836a49-23fb-f3be-e063-6294a90a8cdd	51316-227	HUMAN OTC DRUG	HYDROCORTISONE		HYDROCORTISONE	CREAM	TOPICAL	20221015		OTC MONOGRAPH DRUG	M017	CVS PHARMACY, INC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51316-228_08848262-9c73-800d-e063-6294a90a217e	51316-228	HUMAN OTC DRUG	HEMORRHOIDAL		MINERAL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE	OINTMENT	TOPICAL	20220615		OTC MONOGRAPH DRUG	M015	CVS PHARMACY, INC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-229_08848262-9c86-800d-e063-6294a90a217e	51316-229	HUMAN OTC DRUG	MAXIMUM STRENGTH HEMORRHOIDAL RELIEF with Finger Cots		LIDOCAINE	CREAM	TOPICAL	20220708		OTC MONOGRAPH DRUG	M015	CVS PHARMACY, INC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51316-230_088427be-7677-723f-e063-6394a90a644f	51316-230	HUMAN OTC DRUG	HYDROCORTISONE		HYDROCORTISONE	CREAM	TOPICAL	20220830		OTC MONOGRAPH DRUG	M017	CVS PHARMACY, INC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51316-260_e6160679-13e9-47ca-9664-2f347e46d1a9	51316-260	HUMAN OTC DRUG	Childrens Allergy		Fexofenadine HCl	SUSPENSION	ORAL	20231015		ANDA	ANDA203330	CVS PHARMACY, INC	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-265_fb711520-65de-35d7-e053-6294a90a0ef8	51316-265	HUMAN OTC DRUG	CVS Roll-On		Capsaisin 0.1%	GEL	TOPICAL	20221222		OTC MONOGRAPH NOT FINAL	part348	CVS	CAPSAICIN	.1	g/100g			N	20241231
51316-268_3cd7293b-329d-41d1-b4b2-64148e0a4b18	51316-268	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20221130		OTC MONOGRAPH NOT FINAL	part356	CVS PHARMACY, INC	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
51316-275_a90cd0d3-b527-4f29-9453-f9ad8b57ca20	51316-275	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20221130		OTC MONOGRAPH NOT FINAL	part333A	CVS PHARMACY, INC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51316-277_d22682a3-8607-4abb-9add-c48ad0697815	51316-277	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20221130		OTC MONOGRAPH NOT FINAL	part333A	CVS PHARMACY, INC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
51316-282_4ff67518-c6be-4c1d-8554-84cef376db07	51316-282	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20230215		OTC MONOGRAPH NOT FINAL	part343	CVS PHARMACY, INC	ACETAMINOPHEN	160	mg/5mL			N	20241231
51316-300_af5a655f-5c22-470d-8867-cdc167eea330	51316-300	HUMAN OTC DRUG	CVS	Naturals	calcium carbonate	TABLET, CHEWABLE	ORAL	20211101		OTC MONOGRAPH FINAL	part331	CVS PHARMACY	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-301_e8de4ae1-c3a0-426d-afba-477a835cb089	51316-301	HUMAN OTC DRUG	CVS PHARMACY	Assorted Berry Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210802		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-304_b0990702-5a7a-4f60-9400-0f3b20621c3e	51316-304	HUMAN OTC DRUG	Tussin DM	Daytime	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20230418		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-323_da6b5a86-7cfd-4cc8-a619-20eb9da935b3	51316-323	HUMAN OTC DRUG	severe tussin cf		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230324		OTC MONOGRAPH FINAL	part341	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-324_e1d638d5-40fd-432f-bd07-47a113e4bf72	51316-324	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20230215		OTC MONOGRAPH NOT FINAL	part343	CVS PHARMACY, INC	ACETAMINOPHEN	160	mg/5mL			N	20241231
51316-343_bf20774b-d7a3-4c7e-aed6-3c6e881ff092	51316-343	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20230315		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-344_e3cf2958-f6f0-41f7-817e-295ab6d1f095	51316-344	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20230315		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-347_f5b609e1-e63c-2e3b-e053-2995a90a76b9	51316-347	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20230202		OTC MONOGRAPH FINAL	M010	CVS Pharmacy, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-395_3133bd55-63d3-4c8f-b755-60e228124998	51316-395	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY, INC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51316-404_68e96007-980a-4380-b461-e104db29e4b8	51316-404	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, CHEWABLE	ORAL	20231227		OTC MONOGRAPH DRUG	M009	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
51316-405_88f0daa0-e3f8-40e5-8d33-287728475131	51316-405	HUMAN OTC DRUG	CVS	Extra Strength Smooth	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210816		OTC MONOGRAPH FINAL	part331	CVS PHARMACY	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51316-417_388d817f-2249-4906-b752-195107bcb085	51316-417	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20211104	20240127	ANDA	ANDA204872	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
51316-423_4c11c074-502e-49e4-8e1d-b62cb4dbb3f4	51316-423	HUMAN OTC DRUG	Ivermectin		Ivermectin	LOTION	TOPICAL	20200506		ANDA	ANDA210720	CVS Pharmacy	IVERMECTIN	5	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
51316-430_34c79d3f-7b78-41ad-8243-279f0227f8fd	51316-430	HUMAN OTC DRUG	Tussin DM	Nighttime	Dextromethorphan HBr, Doxylamine Succinate	SOLUTION	ORAL	20230414		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-434_e2fc0e74-a6f9-4723-b50d-3657b0c5152e	51316-434	HUMAN OTC DRUG	Tussin DM	Daytime Nighttime	Dextromethorphan HBr, Doxylamine Succinate, Guaifenesin	KIT	ORAL	20230418		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED						N	20241231
51316-463_438d35be-37b0-4244-9053-82aa9873f93c	51316-463	HUMAN OTC DRUG	Severe Congestion, Cough, Cold and Flu Relief	Maximum Strength, Nighttime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, Triprolidine HCl	KIT		20220527		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED						N	20241231
51316-466_91008f3e-c476-4b77-9931-46d834a89dc7	51316-466	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20230301		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-485_14ef6cb8-a82e-46ff-9d45-bcbfc9cef346	51316-485	HUMAN OTC DRUG	Allergy Plus Congestion Relief		Diphenhydramine HCl, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220809		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	25; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-491_f55fd755-8551-3eae-e053-2995a90abb16	51316-491	HUMAN OTC DRUG	Salicylic Acid		Clear Medicated Corn removers	PATCH	TOPICAL	20220222		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/121			N	20241231
51316-499_879fc3b3-06d8-4b1c-b0aa-56ed8d6fba89	51316-499	HUMAN OTC DRUG	Night Time Cough		Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20230315		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-502_0df0c81c-4662-38d8-e063-6394a90ad8f6	51316-502	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20211231		ANDA	ANDA212795	CVS PHARMACY, INC	LORATADINE	5	mg/1			N	20251231
51316-503_0df114fa-ae43-e77d-e063-6294a90a8c36	51316-503	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210808		ANDA	ANDA213294	CVS PHARMACY, INC	LORATADINE	10	mg/1			N	20251231
51316-539_932a3d40-9b52-4e91-bc61-6fd506f2d9e6	51316-539	HUMAN OTC DRUG	Theraflu Relief Max Strength	Daytime	Acetaminophen, Dextromethorphan HBr	POWDER, FOR SOLUTION	ORAL	20230417		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	1000; 30	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-546_e5d7dbd1-baa9-4b8b-aa61-1a836bffa107	51316-546	HUMAN OTC DRUG	Sinus PE Head Congestion and Flu Severe		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210925		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-549_4b567234-1da9-4e10-a427-877eea2be1c1	51316-549	HUMAN OTC DRUG	Theraflu Relief Max Strength	Nighttime	Acetaminophen, Chlorpheniramine Maleate and Dextromethophan HBr	POWDER, FOR SOLUTION	ORAL	20230417		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	1000; 4; 30	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-557_09d673a5-11c1-4e5b-e063-6294a90a135e	51316-557	HUMAN OTC DRUG	CVS Healthy Isopropyl Rubbing Alcohol Pads 70		ISOPROPYL ALCOHOL	PATCH	TOPICAL	20210815		OTC MONOGRAPH DRUG	M003	CVS Health	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51316-559_5151127a-4d09-413a-a08b-f76fb77e1188	51316-559	HUMAN OTC DRUG	Multi Symptom Flu Relief Max Strength	Daytime Nighttime Combo Pack	Acetaminophen, Dextromethorphan HBr, and Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	KIT		20230421		OTC MONOGRAPH FINAL	part341	CVS PHARMACY						N	20241231
51316-597_1dfbc52e-bdec-4caf-b7f0-2bc7848d8d5a	51316-597	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20231130		OTC MONOGRAPH DRUG	M016	CVS PHARMACY, INC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
51316-600_d3ea6cd4-1d2a-4f2e-a03c-fcbc092b7e97	51316-600	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan Hydrobromide		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20220419		ANDA	ANDA214781	CVS PHARMACY, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-613_867a4ab1-0f93-4fbb-87e2-1d6772c66cf6	51316-613	HUMAN OTC DRUG	daytime severe		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230628		OTC MONOGRAPH FINAL	part341	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-614_bb68e2d6-2b57-4e36-ae7c-0a3fbb301214	51316-614	HUMAN OTC DRUG	Severe Cold, Cold and Flu	Maximum Strength, Daytime, Nightime	Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20220816	20250222	OTC MONOGRAPH FINAL	part341	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED						N	
51316-615_0d29b49a-71d5-b6b9-e063-6294a90a9247	51316-615	HUMAN OTC DRUG	CVS Hydration Eye Drops		Polyetylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20230119		OTC MONOGRAPH DRUG	M018	CVS	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
51316-617_75c9df9e-0d98-44ec-be43-be97334877a4	51316-617	HUMAN OTC DRUG	Daytime Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20230213		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-618_6face7de-e5b2-4009-9fb7-1390c2efac0f	51316-618	HUMAN OTC DRUG	CVS DT and NT Combo Pack	Cold and Flu	Acetaminophen, Phenylephrine Hydrochloride, and Doxylamine Succinate	KIT		20230320		OTC MONOGRAPH DRUG	M012	CVS PHARMACY						N	20241231
51316-625_5de17f1f-0f1a-4636-ba79-07878c919502	51316-625	HUMAN OTC DRUG	CVS Diaper Rash		Zinc Oxide and Dimethicone	OINTMENT	TOPICAL	20230101		OTC MONOGRAPH FINAL	part347	CVS Health	DIMETHICONE; ZINC OXIDE	10; 100	mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
51316-630_b218c9d1-0ce7-4a57-ad7c-619a9fcfad37	51316-630	HUMAN OTC DRUG	CVS Severe Multi-Symptom Cough Cold Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20230109		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-631_4bb3cfde-739d-4119-ab23-2f6d7581d52f	51316-631	HUMAN OTC DRUG	CVS Severe Cough, Flu Plus Sore Throat	Honey	acetaminophen, dextromethorphan hbr	SOLUTION	ORAL	20230217		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-641_32971052-755a-4995-ac42-5ccd04a85390	51316-641	HUMAN OTC DRUG	CVS NightTime Cold		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and phenylephrine hydrochloride	SOLUTION	ORAL	20230109		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-645_b98b0800-9a13-413a-b576-2b7b15b58288	51316-645	HUMAN OTC DRUG	CHILDRENS DIMETAPP COLD AND COUGH		brompheniramine maleate, dextromethorphan HBr, phenylephrine HCl	LIQUID	ORAL	20230220		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-647_98cda028-2ec6-4740-9d6e-50181740cf8b	51316-647	HUMAN OTC DRUG	Daytime, Nighttime Severe Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20221103		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED						N	20241231
51316-670_f05f6e73-2dd5-3f16-e053-2a95a90a8c65	51316-670	HUMAN OTC DRUG	CVS Health SPF 100 Ultra Protection		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20190513		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51316-692_ccf2690b-e082-4aeb-9186-ba4d3789f627	51316-692	HUMAN OTC DRUG	CVS Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20230213		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-695_27173c5f-34b6-49d7-915d-f8f4a1798154	51316-695	HUMAN OTC DRUG	CVS Childrens Pain plus Fever Relief		Acetaminophen	SUSPENSION	ORAL	20230220		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	160	mg/5mL			N	20241231
51316-701_0ca30be9-3c21-96d0-e063-6394a90ae002	51316-701	HUMAN OTC DRUG	Allergy Relief DIPHENHYDRAMINE HCl, 25 mg Antihistamine		Diphenhydramine HCl	BAR, CHEWABLE	ORAL	20230421		OTC MONOGRAPH DRUG	M012	CVS Pharmacy, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-702_fa1c2e2a-1947-10f7-e053-6394a90abc07	51316-702	HUMAN OTC DRUG	Gas Relief SIMETHICONE 250 mg Anti-gas		SIMETHICONE	TABLET, CHEWABLE	ORAL	20220308		OTC MONOGRAPH FINAL	part332	CVS Pharmacy, Inc.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
51316-703_e7d1a38d-4404-d327-e053-2995a90ae0b5	51316-703	HUMAN OTC DRUG	Handsoap		Benzalkonium Chloride	SOAP	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part333E	CVS Pharmacy	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
51316-704_e78ad7c1-23ac-6fec-e053-2995a90a16c0	51316-704	HUMAN OTC DRUG	CVS Pharmacy		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20220815		OTC MONOGRAPH NOT FINAL	part333E	CVS Pharmacy Inc	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
51316-705_e582bdcf-0d8c-39f1-e053-2995a90a01f2	51316-705	HUMAN OTC DRUG	Handsoap		Benzalkonium chloride	SOAP	TOPICAL	20220804		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy Inc.	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
51316-706_e584a181-1227-5dda-e053-2a95a90ab645	51316-706	HUMAN OTC DRUG	Handsoap		Benzalkonium Chloride	SOAP	TOPICAL	20220804		OTC MONOGRAPH NOT FINAL	part333A	CVS PHARMACY, INC	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
51316-707_bd25513b-39cc-49d4-a526-445d18ce9cc0	51316-707	HUMAN OTC DRUG	CVS Stomach Relief	Ultra Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20221010		OTC MONOGRAPH DRUG	M008	CVS PHARMACY	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
51316-710_c39d21a0-340d-4394-a2cc-177a9bfd5d00	51316-710	HUMAN OTC DRUG	CVS dye-free childrens allergy		Diphenhydramine hydrochloride	SYRUP	ORAL	20220722		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-714_05fdd8ba-7a96-46a5-81cb-a5ff2e582cd9	51316-714	HUMAN OTC DRUG	Headache Pain		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220418	20240127	ANDA	ANDA204872	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
51316-715_4934e413-da63-4ddb-b3e0-3ab86841dc86	51316-715	HUMAN OTC DRUG	Esomeprazole		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20220902		ANDA	ANDA212866	CVS	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51316-716_ed069e4c-79b9-bbb9-e053-2a95a90a3b18	51316-716	HUMAN OTC DRUG	Perineal Cooling Liners		WITCH HAZEL	SWAB	TOPICAL	20221030		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	WITCH HAZEL	500	mg/g			N	20241231
51316-717_faeb6b2d-ab24-6237-e053-6394a90a0d76	51316-717	HUMAN OTC DRUG	CVS Lubricant Eye Nighttime		mineral oil and white petrolatum	OINTMENT	OPHTHALMIC	20230504		OTC MONOGRAPH FINAL	part349	CVS	MINERAL OIL; PETROLATUM	30; 940	mg/g; mg/g			N	20241231
51316-722_f70ef0c3-0386-4fde-8764-d9e94ce64515	51316-722	HUMAN OTC DRUG	All Day Moisture		Homosalate, Zinc Oxide	LOTION	TOPICAL	20221221		OTC MONOGRAPH FINAL	part352	CVS Pharmacy	HOMOSALATE; ZINC OXIDE	50; 30	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
51316-727_a1f9136c-ca0a-4549-bcca-6ce648defca1	51316-727	HUMAN OTC DRUG	CVS Daytime Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, GUAIFENESIN PHENYLEPHRINE HCL	LIQUID	ORAL	20230109		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-733_d18e8414-311e-49dc-a459-817445af3d76	51316-733	HUMAN OTC DRUG	CVS Childrens Nighttime Multi Symptom Cold		Acetaminophen , Diphenhydramine Hydrochloride,Phenylephrine Hydrochloride	LIQUID	ORAL	20230220		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51316-738_b26fdf6a-d46b-4b0c-a26a-e44eb9e0e14e	51316-738	HUMAN OTC DRUG	Multi-Symptom Flu HBP		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20220624		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-740_d7bace4f-a779-40dc-83bb-bc041530641e	51316-740	HUMAN OTC DRUG	CVS	Maximum Strength	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20230217		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-743_b915b04d-3bd6-4f5e-a54a-922a51bc9a1f	51316-743	HUMAN OTC DRUG	CVS Adult Mucus	chest congestion	Guaifenesin	SYRUP	ORAL	20230217		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
51316-744_7c5f2774-4706-453f-bd7a-856097447f87	51316-744	HUMAN OTC DRUG	CVS ADULT COUGH PLUS CHEST CONGESTION DM		dextromethorphan hydrobromide and guaifenesin	SOLUTION	ORAL	20230213		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-745_46170baf-9b80-45ca-9d64-4a14910e6b2f	51316-745	HUMAN OTC DRUG	CVS childrens Cough and Cold		chlorpheniramine maleate, dextrometrorphan HBr	LIQUID	ORAL	20230217		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-749_f6e8f66d-45a3-4b23-a37e-552e972db3f8	51316-749	HUMAN OTC DRUG	CVS SUGAR FREE ADULT COUGH PLUS CHEST CONGESTION DM		dextromethorphan hydrobromide and guaifenesin	SOLUTION	ORAL	20230710		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-752_35068774-088e-4c29-b556-18546aa99ae3	51316-752	HUMAN OTC DRUG	CVS Nighttime Childrens	Cold and Cough Multi-Symptom Relief	Chlorpheniramine maleate and Dextromethorphan Hydrobromide	SOLUTION	ORAL	20230220		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/15mL; mg/15mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-763_52bca09e-9c76-4e31-b5de-13b5db970657	51316-763	HUMAN OTC DRUG	DOCOSANOL		DOCOSANOL	CREAM	TOPICAL	20230106		ANDA	ANDA215839	CVS Pharmacy, Inc.	DOCOSANOL	100	mg/g			N	20241231
51316-764_0ce294c6-6b0f-36d1-e063-6294a90a5f26	51316-764	HUMAN OTC DRUG	Cetirizine		Cetiirizine	TABLET	ORAL	20231016		ANDA	ANDA209274	CVS PHARMACY, INC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-768_0d6f0139-80a5-6345-e063-6294a90a6381	51316-768	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20240101		ANDA	ANDA211075	CVS	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-775_decc55ee-983b-400a-9589-0fd40697047f	51316-775	HUMAN OTC DRUG	CVS Adult Cough plus Chest Congestion DM Max	with Honey	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20230217		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-778_f21a60e6-028a-495c-a9d5-a1b83e669853	51316-778	HUMAN OTC DRUG	Long Acting Cough Softgels		Dextromethorphan Hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20210728		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-779_0af304a2-fe2f-432c-bcbf-3dc3b13787f1	51316-779	HUMAN OTC DRUG	Nighttime Sleep-Aid Softgel		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210723		OTC MONOGRAPH FINAL	part338	CVS PHARMACY, INC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-781_8a2a56b5-615d-4f4f-bef3-3f622965a639	51316-781	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20230324		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
51316-800_b33866c5-5af3-48ce-a5c1-5ce36a4a3836	51316-800	HUMAN OTC DRUG	FEXOFENADINE HYDROCHLORIDE		FEXOFENADINE HYDROCHLORIDE	TABLET	ORAL	20220920		ANDA	ANDA091567	CVS PHARMACY, INC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-801_93404a1d-ff78-4a5f-bf59-7323d78be195	51316-801	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20230130		ANDA	ANDA211075	CVS PHARMACY, INC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-806_97e3c84a-37d3-4048-9b14-54327c75054a	51316-806	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20230131		ANDA	ANDA209274	CVS PHARMACY, INC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-813_1eb56a94-33ee-4c91-8177-6803b35ad29a	51316-813	HUMAN OTC DRUG	Maximum Strength Gas Relief Softgel		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20221101		OTC MONOGRAPH FINAL	part332	CVS PHARMACY, INC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
51316-817_f1eea795-d9ef-49e9-a385-58883a3c913b	51316-817	HUMAN OTC DRUG	Back and Muscle Pain		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220418		ANDA	ANDA204872	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51316-835_f4468840-e17d-6888-e053-2995a90a04a0	51316-835	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20221116		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-837_0d299e20-a042-3080-e063-6294a90ad709	51316-837	HUMAN OTC DRUG	CVS Maximum Redness Relief		Glycerin, Naphazoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20230324		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
51316-848_fcd03968-2a03-3793-e053-6394a90a6e2f	51316-848	HUMAN OTC DRUG	Sugar Free Cough Drops		Honey Lemon	PASTILLE	ORAL	20230529		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	7.6	mg/1			N	20241231
51316-849_468e4df7-d77b-496a-aa7b-ef6d867d6cb5	51316-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201220		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	ALCOHOL	62	mg/mL			N	20241231
51316-850_fcd163f1-3967-1ee6-e053-6394a90a5766	51316-850	HUMAN OTC DRUG	Natural Herb Cough Drops		Menthol Herb	PASTILLE	ORAL	20230529		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	4.8	mg/1			N	20241231
51316-851_fcd0747b-9214-d45c-e053-6294a90a9598	51316-851	HUMAN OTC DRUG	Sugar Free Cough Drops		Menthol	PASTILLE	ORAL	20230529		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
51316-852_fce6a88b-9329-b9f1-e053-6294a90aa80b	51316-852	HUMAN OTC DRUG	Lemon Mint Herb Throat Drops		Sugar Free Lemon Mint Herb	PASTILLE	ORAL	20230529		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	1.1	mg/1			N	20241231
51316-880_fb7fa9b0-4432-aab0-e053-6394a90ae10e	51316-880	HUMAN OTC DRUG	Magnesium Citrate		CVS Magnesium Citrate Oral Solution - Lemon	LIQUID	ORAL	20230512		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51316-881_fb80d364-71a3-8b31-e053-6394a90a3795	51316-881	HUMAN OTC DRUG	Magnesium Citrate		CVS Magnesium Citrate Oral Solution - Grape	LIQUID	ORAL	20230512		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51316-882_fb80ffce-a7b7-7f19-e053-6294a90a5c6b	51316-882	HUMAN OTC DRUG	Magnesium Citrate		CVS Magnesium Citrate Oral Solution - Cherry	LIQUID	ORAL	20230512		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51316-885_f0335578-035d-49b4-e053-2a95a90ad65e	51316-885	HUMAN OTC DRUG	CVS Pain Relieving		Camphor 5.5% Menthol 16%	LOTION	TOPICAL	20221219		OTC MONOGRAPH NOT FINAL	part348	CVS	CAMPHOR (SYNTHETIC); MENTHOL	16; 5.5	mg/g; mg/g			N	20241231
51316-898_e9314c92-dbd3-7674-e053-2995a90af8b6	51316-898	HUMAN OTC DRUG	Maximum Strength Antifungal Liquid		Tolnaftate	LIQUID	TOPICAL	20220921		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	TOLNAFTATE	.3	g/30mL			N	20241231
51316-899_e82c9f84-4ae9-7989-e053-2a95a90a0c37	51316-899	HUMAN OTC DRUG	CVS cold and Hot		Menthol 16%	SPRAY	TOPICAL	20220908		OTC MONOGRAPH NOT FINAL	part348	CVS	MENTHOL	16	g/100g			N	20241231
51316-915_6c06b535-15b5-4fd0-b466-987aab6603ed	51316-915	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20230131		ANDA	ANDA075209	CVS PHARMACY, INC	LORATADINE	10	mg/1			N	20241231
51316-963_2323a56a-8ec7-403a-ac0b-dfdddc3edfcb	51316-963	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20231023		OTC MONOGRAPH DRUG	M012	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51316-970_a47d8036-88c3-4b04-b257-90e65d2ce922	51316-970	HUMAN OTC DRUG	MAXIMUM STRENGTH Mucus D		guaifenesin and pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220810		ANDA	ANDA212542	CVS Pharmacy	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
51316-973_2f27d0e7-573a-4e55-8ed3-d60f2711e393	51316-973	HUMAN OTC DRUG	Childrens Pain and Fever		Childrens Pain and Fever	SUSPENSION	ORAL	20230605		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
51316-975_b5bd866d-a710-44c4-864f-695bb5fb78f7	51316-975	HUMAN OTC DRUG	Childrens Pain and Fever		Childrens Pain and Fever	SUSPENSION	ORAL	20230605		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
51316-990_e8ba4d6e-08d1-1b32-e053-2a95a90aaecc	51316-990	HUMAN OTC DRUG	Arthritis Cream		Trolamine Salicylate 10%	CREAM	TOPICAL	20220915		OTC MONOGRAPH NOT FINAL	part348	CVS	TROLAMINE SALICYLATE	10	g/100g			N	20241231
51316-991_0a33fa8a-8af1-30ed-e063-6394a90a1808	51316-991	HUMAN OTC DRUG	CVS Mini Enema		docusate sodium w/benzocaine	LIQUID	RECTAL	20210820		OTC MONOGRAPH DRUG	M007	CVS HEALTH	BENZOCAINE; DOCUSATE SODIUM	20; 283	mg/5mL; mg/5mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
51316-993_85bd100e-7bbc-4ab0-9f19-e119a28f16d3	51316-993	HUMAN OTC DRUG	Guaifenesin D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210506		ANDA	ANDA212542	CVS Pharmacy, Inc.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
51316-994_e7a3e6de-a674-aca3-e053-2a95a90ac2ca	51316-994	HUMAN OTC DRUG	CVS Muscle Rub		Menthol 10%, Methyl Salicylate 15%	CREAM	TOPICAL	20220831		OTC MONOGRAPH NOT FINAL	part348	CVS Health	MENTHOL; METHYL SALICYLATE	100; 150	mg/g; mg/g			N	20241231
51316-995_09057261-3be5-31ca-e063-6394a90a18cc	51316-995	HUMAN OTC DRUG	CVS Arnica Cream		Arnica Montana	CREAM	TOPICAL	20220328		UNAPPROVED HOMEOPATHIC		CVS Health	ARNICA MONTANA	1	[hp_X]/g			N	20241231
51316-996_e891e41b-5a5e-1a0f-e053-2a95a90a34fa	51316-996	HUMAN OTC DRUG	CVS Pain Relief		Menthol 10.5%	SPRAY	TOPICAL	20220913		OTC MONOGRAPH NOT FINAL	part348	CVS	MENTHOL	10.5	g/100g			N	20241231
51316-997_e9c2924b-e204-f6b9-e053-2995a90a2f09	51316-997	HUMAN OTC DRUG	CVS Pain Relief		Menthol 4%	GEL	TOPICAL	20200929		OTC MONOGRAPH NOT FINAL	part348	CVS	MENTHOL	4	g/100g			N	20241231
51316-998_9594fa99-4f6a-4647-8585-4769b75cd779	51316-998	HUMAN OTC DRUG	Allergy Relief Dye-Free Softgel		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210720		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51316-999_e78ebd5b-1341-0931-e053-2995a90acb30	51316-999	HUMAN OTC DRUG	CVS Hot and Cold Balm		Menthol 7.6% Methyl Salicylate 29%	CREAM	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part348	CVS	MENTHOL; METHYL SALICYLATE	7.6; 29	g/99.2g; g/99.2g			N	20241231
51319-072_7f888802-8d39-42c6-9579-7540fa8c8560	51319-072	HUMAN PRESCRIPTION DRUG	Oxygen	Compressed U.S.P	Oxygen	GAS	RESPIRATORY (INHALATION)	20150301		UNAPPROVED MEDICAL GAS		Apria Healthcare LLC	OXYGEN	.995	mL/L			N	20241231
51319-073_7f888802-8d39-42c6-9579-7540fa8c8560	51319-073	HUMAN PRESCRIPTION DRUG	Oxygen	Refrigerated Liquid U.S.P	Oxygen	GAS	RESPIRATORY (INHALATION)	20150301		UNAPPROVED MEDICAL GAS		Apria Healthcare LLC	OXYGEN	.995	mL/L			N	20241231
51326-038_fbbae9e0-f0bf-4031-bc40-0b99bbe1e62d	51326-038	HUMAN OTC DRUG	Gly-Sal 5-2 Pads		Salicylic Acid	CLOTH	TOPICAL	19900227		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	SALICYLIC ACID	.02	g/1			N	20241231
51326-039_39700b88-6308-4682-b1b2-107140d92913	51326-039	HUMAN OTC DRUG	Gly-Sal 10-2 Pads		Salicylic Acid	CLOTH	TOPICAL	20000728		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	SALICYLIC ACID	.02	g/1			N	20241231
51326-057_2d23e013-8f53-46cb-b9fe-26c7c3711903	51326-057	HUMAN OTC DRUG	Dr. Dennis Gross Alpha Beta On the Spot Eliminator		Salicylic Acid	GEL	TOPICAL	20231117		OTC MONOGRAPH DRUG	M006	Topiderm, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
51326-102_f36547fe-d116-479a-8d81-561a6694a25e	51326-102	HUMAN OTC DRUG	Replenix Lip Therapy	homosalate	homosalate	LIPSTICK	TOPICAL	20220102		OTC MONOGRAPH NOT FINAL	part352	Topiderm, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	30; 150; 75; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
51326-108_5ddca73e-dfd3-446f-a0d2-3daadc9abddb	51326-108	HUMAN OTC DRUG	Aloe Cort		Hydrocortisone	CREAM	TOPICAL	19900227		OTC MONOGRAPH DRUG	M017	Topiderm, Inc.	HYDROCORTISONE	.57	g/57g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51326-111_e1454e6d-6296-4323-bc20-49cd6cb753be	51326-111	HUMAN OTC DRUG	REPLENIX ACNE Solution BENZOYL PEROXIDE WASH		Benzoyl Peroxide	LIQUID	TOPICAL	20171101		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
51326-112_76eb998f-5b37-4224-94f7-d47979f58542	51326-112	HUMAN OTC DRUG	REPLENIX ACNE SOLUTIONS WASH		Benzoyl Peroxide	LIQUID	TOPICAL	20171101		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
51326-113_bc8e280f-d928-46b7-acd6-ec852f1a4efd	51326-113	HUMAN OTC DRUG	REPLENIX ACNE 10% WASH PARABEN FREE WITH ALOE		Benzoyl Peroxide	LIQUID	TOPICAL	20171101		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
51326-121_0455d937-704b-47e1-8ca5-2925ab973f8c	51326-121	HUMAN OTC DRUG	Topix Mineral Brightening and Correcting Eye Make-up	SPF 50	ZINC OXIDE and TITANIUM DIOXIDE	LOTION	TOPICAL	20210124		OTC MONOGRAPH FINAL	part352	Topiderm, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	64; 65	mg/mL; mg/mL			N	20241231
51326-122_216dcd58-29c1-4a01-8b66-8f55154918af	51326-122	HUMAN OTC DRUG	Essential Moisturizing Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210109		OTC MONOGRAPH FINAL	part352	Topiderm, Inc.	OCTINOXATE; ZINC OXIDE	75; 148	mg/g; mg/g			N	20241231
51326-123_6cd9a5d4-5d1b-4573-a9c7-7587efcad593	51326-123	HUMAN OTC DRUG	Tinted Mineral Sunscreen	SPF 50	ZINC OXIDE and TITANIUM DIOXIDE	LOTION	TOPICAL	20201110		OTC MONOGRAPH FINAL	part352	Topiderm, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	75; 110	mg/g; mg/g			N	20241231
51326-125_13426b29-07f0-45ab-bed0-4af45356f094	51326-125	HUMAN OTC DRUG	Mineral Sunscreen	SPF 50	Zinc Oxide Titanium Dioxide	POWDER	TOPICAL	20201014		OTC MONOGRAPH FINAL	part352	Topiderm, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	225; 240	mg/g; mg/g			N	20241231
51326-130_b67367ac-6c9d-424b-9196-27c1c95fe112	51326-130	HUMAN OTC DRUG	Topix Mineral Mattifying Tinted Sunscreen	SPF 30	Zinc Oxide	CREAM	TOPICAL	20230221		OTC MONOGRAPH FINAL	part352	Topiderm, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	32; 162	mg/g; mg/g			N	20241231
51326-137_f4ba7fdd-7b54-4bac-991c-0d91181a6f20	51326-137	HUMAN OTC DRUG	Topix Mineral Mattifying Tinted Sunscreen	SPF 50	Zinc oxide	LOTION	TOPICAL	20221115		OTC MONOGRAPH DRUG	M020	Topiderm, Inc.	ZINC OXIDE	205	mg/g			N	20241231
51326-160_86526a3a-3bf7-446b-b419-feb41461a979	51326-160	HUMAN OTC DRUG	Mens Minoxidil	Hair Growth System	Minoxidil	SOLUTION	TOPICAL	20210323		ANDA	ANDA076239	Topiderm, Inc.	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51326-161_b2a7381d-b3ed-4db7-b7eb-06a3894ae34b	51326-161	HUMAN OTC DRUG	Womens Minoxidil	Hair Growth System	Minoxidil	LIQUID	TOPICAL	20210326		ANDA	ANDA078176	Topiderm, Inc.	MINOXIDIL	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51326-165_d2337eb6-9792-4775-864d-1fdc9a9d1181	51326-165	HUMAN OTC DRUG	Mens Minoxidil Hair Regrowth		MINOXIDIL	KIT		20230616		ANDA	ANDA076239	Topiderm, Inc						N	20241231
51326-166_761a2c4f-c949-4eca-b136-d251279ed3a1	51326-166	HUMAN OTC DRUG	Womens Minoxidil Hair Regrowth		MINOXIDIL	KIT		20230616		ANDA	ANDA078176	Topiderm, Inc						N	20241231
51326-179_c756672e-daa1-4ed1-8834-17c73b23f670	51326-179	HUMAN OTC DRUG	Dr. Gross AB Acne Daily Breakout		salicylic acid	LIQUID	TOPICAL	20231110		OTC MONOGRAPH DRUG	M006	Topiderm, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
51326-201_e95cd431-e6df-4047-bd6f-0204b0ddf146	51326-201	HUMAN OTC DRUG	Replenix Tinted Sunscreen	SPF 50	Zinc Oxide and Octinoxate	LOTION	TOPICAL	20220422		OTC MONOGRAPH FINAL	part352	Topiderm, Inc.	OCTINOXATE; ZINC OXIDE	75; 145	mg/g; mg/g			N	20241231
51326-203_34c76824-3047-41a6-805a-a17e63e0c019	51326-203	HUMAN OTC DRUG	Zolidyne		Pyrithione Zinc	SHAMPOO	TOPICAL	19930122		OTC MONOGRAPH DRUG	M032	Topiderm, Inc.	PYRITHIONE ZINC	20	mg/mL			N	20241231
51326-245_9069ee6d-cf2d-4462-a049-eb79d381d858	51326-245	HUMAN OTC DRUG	Mineral Repair SPF 45		zinc oxide	LOTION	TOPICAL	20220507		OTC MONOGRAPH DRUG	M020	Topiderm, Inc.	ZINC OXIDE	150	mg/g			N	20241231
51326-370_208bc456-0191-46b5-88e0-ee357e71f0fa	51326-370	HUMAN OTC DRUG	Topix Mineral Mattifying Tinted Sunscreeninted	SPF 50	Zinc Oxide	LOTION	TOPICAL	20230320		OTC MONOGRAPH DRUG	M020	Topiderm, Inc.	ZINC OXIDE	205	mg/g			N	20241231
51326-411_3f4c6873-4988-477e-b77e-0d4d981eb76d	51326-411	HUMAN OTC DRUG	Replenix Acne		Benzoyl Peroxide	GEL	TOPICAL	19930122		OTC MONOGRAPH DRUG	M006	Topiderm, Inc	BENZOYL PEROXIDE	50	mg/g			N	20241231
51326-412_d2182fb1-b7ad-47d2-9855-0cde7465add5	51326-412	HUMAN OTC DRUG	Replenix Acne		Benzoyl Peroxide	GEL	TOPICAL	19930122		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	BENZOYL PEROXIDE	100	mg/g			N	20241231
51326-829_1e23a07e-f101-477a-98ab-51df88e50464	51326-829	HUMAN OTC DRUG	Antioxidant Sunscreen SPF 40		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20000728		OTC MONOGRAPH DRUG	M020	Topiderm, Inc.	OCTINOXATE; ZINC OXIDE	75; 70	mg/mL; mg/mL			N	20241231
51326-870_facf2f71-8433-436b-9d4d-85ef301c7699	51326-870	HUMAN OTC DRUG	Derma-e Eczema Relief		Oatmeal	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M016	Topiderm, Inc	OATMEAL	.01	g/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
51326-884_08943c30-5564-45c7-8a9f-0eb705b2a3ae	51326-884	HUMAN OTC DRUG	Resurfix Plus		Petrolatum	OINTMENT	TOPICAL	20000101		OTC MONOGRAPH DRUG	M016	Topiderm, Inc.	PETROLATUM	86	mg/g			N	20241231
51326-900_2af17da6-253d-4958-92ce-2dc70987b669	51326-900	HUMAN OTC DRUG	Sanix Alcohol Hand Rub		Alcohol	LIQUID	TOPICAL	20200317		OTC MONOGRAPH DRUG	M003	Topiderm, Inc	ALCOHOL	.62	mL/mL			N	20241231
51326-923_45299656-b734-4edb-a780-e99a5a333043	51326-923	HUMAN OTC DRUG	Gly-Sal 2-2 Pads		Salicylic Acid	CLOTH	TOPICAL	20191216		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	SALICYLIC ACID	20	mg/1			N	20241231
51326-929_ef33baaf-fbab-483d-9c2a-fbce487ce9be	51326-929	HUMAN OTC DRUG	Replenix Acne Gly-Sal 2-2 Foaming Cleanser		Salicylic Acid	LIQUID	TOPICAL	20160315		OTC MONOGRAPH DRUG	M006	Topiderm, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
51346-532_2615a4c1-4d98-4794-a918-0260d130bc0a	51346-532	HUMAN OTC DRUG	CALIFORNIA ALOE FRESH POW DERY SUN		HOMOSALATE, OCTOCRYLENE, ETHYLHEXYL SALICYLATE, BUTYL METHOXYDIBENZOYLMETHANE	STICK	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part352	NATURE REPUBLIC CO., LTD.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.6; 1.89; .94; 1.89	g/21g; g/21g; g/21g; g/21g			N	20241231
51352-126_08acd38f-9907-4e04-e063-6294a90ad491	51352-126	HUMAN OTC DRUG	EACH		Myrrh tincture	PASTE, DENTIFRICE	DENTAL	20231030		OTC MONOGRAPH DRUG	M022	Dongwha Pharm. Co., Ltd.	MYRRH	6.2	mg/g			N	20241231
51352-189_0be75f4b-0006-4115-e063-6394a90a8929	51352-189	HUMAN OTC DRUG	PANCOLD A		Acetaminophen, Guaifenesin, Pentoxyverine citrate, Phenylpehrine Hydcrochloride, Chlorpheniramine Maleate, Caffeine Anhydrous	LIQUID	ORAL	20230701		OTC MONOGRAPH DRUG	M012	DONGWHA PHARM. CO. LTD.	ACETAMINOPHEN; CAFFEINE; CHLORPHENIRAMINE MALEATE; GUAIFENESIN; PENTOXYVERINE CITRATE; PHENYLEPHRINE HYDROCHLORIDE	300; 30; 2.5; 80; 15; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Increased Respiratory Secretions [PE], Methylxanthine [EPC], Xanthines [CS], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51367-001_15de8ff9-5d90-4722-91c1-bb6c42b11582	51367-001	HUMAN OTC DRUG	Yat Tip Xiao		Salicylic Acid	PLASTER	TOPICAL	19770101		OTC MONOGRAPH FINAL	part358F	Internationa Nature Nutraceuticals, Inc	SALICYLIC ACID	156	mg/1			N	20241231
51367-007_5c67d239-219a-4188-9469-df0d0eff9ed3	51367-007	HUMAN OTC DRUG	Yu Long You Pain Relieving		Camphor, Menthol, Methyl Salicylate	LOTION	TOPICAL	20030701		OTC MONOGRAPH NOT FINAL	part348	International Nature Nutraceuticals	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	3.97; 1.78; 7.04	g/1; g/1; g/1			N	20241231
51367-009_4d7a00c7-6bfe-4f03-bab7-2d8671c42862	51367-009	HUMAN OTC DRUG	Glycerin Liquid Laxative Enema(Kaisalilu)		Glycerin	LIQUID	RECTAL	19920705		OTC MONOGRAPH NOT FINAL	part334	International Nature Nutraceuticals	GLYCERIN	12.5	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
51367-020_e6363226-3b02-4c5b-85cd-26076facd17b	51367-020	HUMAN OTC DRUG	Refined Gou Pi Pain Relieving Plaster		Methyl Salicylate, Camphor, Menthol	PLASTER	TOPICAL	19790516		OTC MONOGRAPH NOT FINAL	part348	International Nature Nutraceuticals	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	116; 116; 120.8	mg/1; mg/1; mg/1			N	20241231
51367-021_082911fa-76c0-4121-8487-2466ca194304	51367-021	HUMAN OTC DRUG	Shang Shi Zhi Tong Pain Relieving Plaster		Methyl Salicylate, Camphor, Menthol	PLASTER	TOPICAL	19760816		OTC MONOGRAPH NOT FINAL	part348	International Nature Nutraceuticals	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	116; 116; 120.8	mg/1; mg/1; mg/1			N	20241231
51367-022_6c46aa16-7dfc-43c9-a1e1-ac124e68287e	51367-022	HUMAN OTC DRUG	Zhuang Gu Feng Shi Pain Relieving Plaster		Methyl Salicylate, Camphor, Menthol	PLASTER	TOPICAL	19770716		OTC MONOGRAPH NOT FINAL	part348	International Nature Nutraceuticals	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	116; 116; 118.8	mg/1; mg/1; mg/1			N	20241231
51367-031_5cefa0ef-01d2-47e9-8be5-d6a267fe78dd	51367-031	HUMAN OTC DRUG	Wok Lok Pain Relieving Oil		Camphor, Menthol, Methyl Salicylate	OIL	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	International Nature Nutraceuticals Inc.	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	1.2; 5.6; 18.32	mg/1; mg/1; mg/1			N	20241231
51367-032_d99da891-dba1-4707-98a6-9ff855655e8f	51367-032	HUMAN OTC DRUG	Medicated Balm Arthritis Pain Relieving Cream		Camphor, Menthol	CREAM	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	International Nature Nutraceuticals Inc.	CAMPHOR (NATURAL); MENTHOL	6.75; 12	g/1; g/1			N	20241231
51367-034_6daf23fc-efb5-4cab-b4fc-9d53ded33eab	51367-034	HUMAN OTC DRUG	Shexiang Zhuanggugao		Methyl Salicylate and Camphor (Synthetic) and Menthol	PLASTER	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part348	International Nature Nutraceuticals	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	21.78; 18.67; 29	mg/1; mg/1; mg/1			N	20241231
51367-035_0352596e-e996-4fa6-99b0-86904ea76710	51367-035	HUMAN OTC DRUG	Pi Yuan Chin		Naphazoline Hydrochloride	SOLUTION/ DROPS	NASAL	20220715		OTC MONOGRAPH DRUG	M	International Nature Nutraceuticals	NAPHAZOLINE HYDROCHLORIDE	1	mg/1			N	20241231
51376-127_088e9dab-a2f3-f690-e063-6294a90a65ac	51376-127	HUMAN OTC DRUG	CALCIUM CARBONATE		calcium carbonate	TABLET, CHEWABLE	ORAL	20150401		OTC MONOGRAPH DRUG	M001	Blessings International	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51376-130_07eed601-b5e7-f430-e063-6294a90ab1b3	51376-130	HUMAN OTC DRUG	Childrens Chewable Acetaminophen		Acetaminophen	TABLET, CHEWABLE	ORAL	20221101		OTC MONOGRAPH DRUG	M013	BLESSINGS INTERNATIONAL	ACETAMINOPHEN	80	mg/1			N	20241231
51386-291_f6557780-36b2-ac14-e053-2a95a90a2447	51386-291	HUMAN OTC DRUG	BEAUTY SHIELD BROAD SPECTRUM SUNSCREEN (Napoleon Perdis)		Zinc Oxide	LOTION	TOPICAL	20210325		OTC MONOGRAPH NOT FINAL	part352	Napoleon PerdisCosmetic Pty Ltd	ZINC OXIDE	132	mg/mL			N	20241231
51393-4006_5fe8669e-d1f1-42a9-8fb1-fb2efc4a6ae0	51393-4006	HUMAN OTC DRUG	ROSACEA		THUJA OCCIDENTALIS LEAFY TWIG	SOLUTION/ DROPS	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Forces of Nature	THUJA OCCIDENTALIS LEAFY TWIG	8	[hp_X]/1000mL			N	20241231
51393-4009_0a578a2e-7c67-4ca5-ba81-25ddcec03623	51393-4009	HUMAN OTC DRUG	Muscle Pain	Pain Management	Arnica Montana, Horse Chestnut, Hypericum Perforatum, Ruta Graveolens Flowering Top, and Thuja Occidentalis Leafy Twig	SOLUTION/ DROPS	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARNICA MONTANA WHOLE; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	30; 6; 12; 30; 6	[hp_C]/1000mL; [hp_C]/1000mL; [hp_C]/1000mL; [hp_C]/1000mL; [hp_X]/1000mL			N	20241231
51393-4013_216068ca-1edd-4050-8963-363761bd498d	51393-4013	HUMAN OTC DRUG	Skin Tags		Thuja Occidentalis Leafy Twig and Calendula Officinalis Whole	SOLUTION/ DROPS	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS WHOLE; THUJA OCCIDENTALIS LEAFY TWIG	6; 6	[hp_X]/100mL; [hp_X]/100mL			N	20241231
51393-4014_a3fa52f8-b478-4c2d-b4f7-57ea5eb87a26	51393-4014	HUMAN OTC DRUG	Sleep Well	Control	Avena Sativa Flowering Top, Arabica Coffee Bean, Lavandula Angustifolia Subsp. Angustifolia Flower, Macropiper Methysticum Root, and Valerian	SOLUTION/ DROPS	TOPICAL	20180901		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWER; MACROPIPER METHYSTICUM ROOT; VALERIAN	30; 30; 12; 30; 12	[hp_C]/100mL; [hp_X]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
51393-4015_f06d8f87-2b2d-48a3-a810-5c1ad7e5ed80	51393-4015	HUMAN OTC DRUG	Back Pain	Pain Management	Arnica Montana, HORSE CHESTNUT, Hypericum Perforatum, RUTA GRAVEOLENS WHOLE, and SODIUM CHLORIDE	SOLUTION/ DROPS	TOPICAL	20191101		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARNICA MONTANA WHOLE; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; RUTA GRAVEOLENS WHOLE; SODIUM CHLORIDE	30; 6; 12; 30; 30	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL			N	20241231
51393-4016_25e3ca67-32a1-4145-9cc7-71ca5b131cb9	51393-4016	HUMAN OTC DRUG	Anti-Itch	Extra Strength	CALENDULA OFFICINALIS Flowering TOP, HYPERICUM PERFORATUM WHOLE, and SODIUM CHLORIDE	SOLUTION/ DROPS	TOPICAL	20200901		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS FLOWERING TOP; HYPERICUM PERFORATUM WHOLE; SODIUM CHLORIDE	8; 8; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
51393-5000_f46de410-ac13-42b6-abf1-75db440a5ab2	51393-5000	HUMAN OTC DRUG	Cold and Flu	Maximum Strength	european elderberry, berberis vulgaris root, solidago canadensis flowering top, achillea millefolium flowering top, holy basil leaf, garlic, ginger, and fenugreek seed	SOLUTION/ DROPS	SUBLINGUAL	20190201		UNAPPROVED HOMEOPATHIC		Forces of Nature	ACHILLEA MILLEFOLIUM FLOWERING TOP; BERBERIS VULGARIS ROOT; EUROPEAN ELDERBERRY; FENUGREEK SEED; GARLIC; GINGER; HOLY BASIL LEAF; SOLIDAGO CANADENSIS FLOWERING TOP	8; 34; 89; 89; 89; 89; 89; 21	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS]		N	20241231
51393-5001_e3cd4f1f-3364-4066-83b6-e82207565d72	51393-5001	HUMAN OTC DRUG	Allergy	Maximum Strength	Urtica Dioica, Althaea Officinalis Root, Inula Helenium Root, Angelica Archangelica Root, Pine Needle Oil (Pinus Sylvestris), Sodium Chloride, and Silicon Dioxide	SOLUTION/ DROPS	SUBLINGUAL	20190201		UNAPPROVED HOMEOPATHIC		Forces of Nature	ALTHAEA OFFICINALIS ROOT; ANGELICA ARCHANGELICA ROOT; INULA HELENIUM ROOT; PINE NEEDLE OIL (PINUS SYLVESTRIS); SILICON DIOXIDE; SODIUM CHLORIDE; URTICA DIOICA WHOLE	34; 89; 55; 89; 89; 55; 8	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL			N	20241231
51393-5002_b15405fe-57d4-4915-9868-7994adfed2d3	51393-5002	HUMAN OTC DRUG	Sinus	Maximum Strength	HOLY BASIL LEAF, BERBERIS VULGARIS ROOT, GARLIC, THUJA OCCIDENTALIS LEAF, ECHINACEA ANGUSTIFOLIA ROOT, and SILICON DIOXIDE	SOLUTION/ DROPS	SUBLINGUAL	20190201		UNAPPROVED HOMEOPATHIC		Forces of Nature	BERBERIS VULGARIS ROOT; ECHINACEA ANGUSTIFOLIA ROOT; GARLIC; HOLY BASIL LEAF; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAF	34; 55; 89; 89; 55; 89	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
51393-5003_d820fddd-ecff-4766-981d-b2a0e1a59543	51393-5003	HUMAN OTC DRUG	More Focus		Taraxacum Officinale Root, Verbena Hastata Top, Lactuca Virosa Leaf, Chamomile Flower Oil, Arabica Coffee Bean, and Scutellaria Lateriflora Whole	SOLUTION/ DROPS	SUBLINGUAL	20200601		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARABICA COFFEE BEAN; CHAMOMILE FLOWER OIL; LACTUCA VIROSA LEAF; SCUTELLARIA LATERIFLORA WHOLE; TARAXACUM OFFICINALE ROOT; VERBENA HASTATA TOP	30; 30; 12; 12; 6; 12	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
51393-5005_4c78dcd5-e369-4a3e-8ef3-e7d5d9428c75	51393-5005	HUMAN OTC DRUG	Heartburn		Garlic, Berberis Vulgaris Root, Calendula Officinalis Flowering Top, Iris Versicolor Root, Ginger, and Valerian	SOLUTION/ DROPS	SUBLINGUAL	20201001		UNAPPROVED HOMEOPATHIC		Forces of Nature	BERBERIS VULGARIS ROOT; CALENDULA OFFICINALIS FLOWERING TOP; GARLIC; GINGER; IRIS VERSICOLOR ROOT; VALERIAN	6; 6; 89; 89; 12; 12	[hp_X]/100mL; [hp_X]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS]		N	20241231
51393-5006_4507a3bf-2f07-4bde-9e28-399e121f9162	51393-5006	HUMAN OTC DRUG	Calm Mood		Garlic, Avena Sativa Flowering Top, Angelica Archangelica Root, Arabica Coffee Bean, Holy Basil Leaf, Passiflora Edulis Flower, Scutellaria Lateriflora Whole, Verbena Hastata Top, and Macropiper Methysticum Root	SOLUTION/ DROPS	SUBLINGUAL	20210101		UNAPPROVED HOMEOPATHIC		Forces of Nature	ANGELICA ARCHANGELICA ROOT; ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; GARLIC; HOLY BASIL LEAF; MACROPIPER METHYSTICUM ROOT; PASSIFLORA EDULIS FLOWER; SCUTELLARIA LATERIFLORA WHOLE; VERBENA HASTATA TOP	89; 30; 30; 89; 89; 30; 30; 12; 6	[hp_C]/100mL; [hp_C]/100mL; [hp_X]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
51393-5008_4663fa5e-c044-44c8-ac19-2a179c8371f3	51393-5008	HUMAN OTC DRUG	Allergy Kids		Urtica Dioica Leaf, Inula Helenium Root, Angelica Archangelica Root, Pine Needle Oil (Pinus Sylvestris), Sodium Chloride, and Althaea Officinalis Root	SOLUTION/ DROPS	SUBLINGUAL	20221101		UNAPPROVED HOMEOPATHIC		Forces of Nature	ALTHAEA OFFICINALIS ROOT; ANGELICA ARCHANGELICA ROOT; INULA HELENIUM ROOT; PINE NEEDLE OIL (PINUS SYLVESTRIS); SODIUM CHLORIDE; URTICA DIOICA LEAF	8; 8; 8; 12; 12; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
51393-5009_03692ebc-55c1-4cc3-b2b5-48e72274b852	51393-5009	HUMAN OTC DRUG	Calm Mood Kids		avena sativa top, angelica archangelica root, holy basil leaf, passiflora edulis flower, scutellaria lateriflora whole, verbena hastata top, and macropiper methysticum root	SOLUTION/ DROPS	SUBLINGUAL	20221101		UNAPPROVED HOMEOPATHIC		Forces of Nature	ANGELICA ARCHANGELICA ROOT; AVENA SATIVA TOP; HOLY BASIL LEAF; MACROPIPER METHYSTICUM ROOT; PASSIFLORA EDULIS FLOWER; SCUTELLARIA LATERIFLORA WHOLE; VERBENA HASTATA TOP	12; 6; 12; 12; 12; 12; 12	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
51393-5010_230212b8-0598-4a05-b417-1aa820c26b3e	51393-5010	HUMAN OTC DRUG	Sleep Kids		Avena Sativa Top, Lavandula Angustifolia Subsp. Pyrenaica Whole, Macropiper Methysticum Root, and Valerian	SOLUTION/ DROPS	TOPICAL	20221101		UNAPPROVED HOMEOPATHIC		Forces of Nature	AVENA SATIVA TOP; LAVANDULA ANGUSTIFOLIA SUBSP. PYRENAICA WHOLE; MACROPIPER METHYSTICUM ROOT; VALERIAN	12; 12; 12; 12	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
51393-5011_13f6e8c0-b3c0-4a2d-ac7a-d25f5e379fa2	51393-5011	HUMAN OTC DRUG	Eczema Kids		Centella Asiatica Whole, Sodium Chloride, Iris Versicolor Root, Arctium Lappa Root, Ruta Graveolens Whole, and Taraxacum Officinale Root	SOLUTION/ DROPS	TOPICAL	20221101		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARCTIUM LAPPA ROOT; CENTELLA ASIATICA WHOLE; IRIS VERSICOLOR ROOT; RUTA GRAVEOLENS WHOLE; SODIUM CHLORIDE; TARAXACUM OFFICINALE ROOT	12; 12; 12; 12; 6; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
51393-5012_a7061c75-0049-4a89-a5cf-5fbf944da2b4	51393-5012	HUMAN OTC DRUG	Cold and Flu Kids		european elderberry, berberis vulgaris root, solidago canadensis flowering top, achillea millefolium flowering top, garlic, and ginger	SOLUTION/ DROPS	SUBLINGUAL	20230101		UNAPPROVED HOMEOPATHIC		Forces of Nature	ACHILLEA MILLEFOLIUM FLOWERING TOP; BERBERIS VULGARIS ROOT; EUROPEAN ELDERBERRY; GARLIC; GINGER; SOLIDAGO CANADENSIS FLOWERING TOP	8; 10; 10; 8; 8; 10	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS]		N	20241231
51393-5622_88fec24c-caaa-4fd1-85ce-e03723b93d4d	51393-5622	HUMAN OTC DRUG	Eczema Control		Centella Asiatica, Iris Versicolor Root, Arctium Lappa Root, Sodium Chloride, Ruta Graveolens Flowering Top, Silicon Dioxide, Taraxacum Officinale, and Thuja Occidentalis Root	SOLUTION/ DROPS	TOPICAL	20111201		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARCTIUM LAPPA ROOT; CENTELLA ASIATICA WHOLE; IRIS VERSICOLOR ROOT; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; SODIUM CHLORIDE; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS ROOT	12; 12; 12; 12; 6; 12; 6; 8	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_C]/100mL; [hp_X]/100mL			N	20241231
51393-6112_2e5b06a9-e9cd-4aae-84fe-8bb3593af410	51393-6112	HUMAN OTC DRUG	Acne/Pimple Control		Calendula Officinalis Flowering Top and Silicon Dioxide	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE	6; 6	[hp_X]/1000mL; [hp_X]/1000mL			N	20241231
51393-6334_ec42f66c-d1cd-4cc2-820b-a7bc1a9c3565	51393-6334	HUMAN OTC DRUG	Fissure Control		Calendula Officinalis Flowering Top And Hamamelis Virginiana Root Bark/Stem Bark	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS FLOWERING TOP; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	6; 6	[hp_X]/1000mL; [hp_X]/1000mL			N	20241231
51393-6447_4fbcedf7-671a-423f-8d76-a5abab2b36cf	51393-6447	HUMAN OTC DRUG	Hemorrhoid Control	Extra Strength	Hamamelis Virginiana Root Bark/Stem Bark and Horse Chestnut	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT	8; 8	[hp_X]/1000mL; [hp_X]/1000mL			N	20241231
51393-6657_faf8037a-a309-43fd-98c1-024d408fae9c	51393-6657	HUMAN OTC DRUG	H-Balm Control	Extra Strength	calendula officinalis flowering top, echinacea, sodium chloride, and thuja occidentalis leafy twig	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA, UNSPECIFIED; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG	10; 10; 10; 10	[hp_X]/1000mL; [hp_X]/1000mL; [hp_X]/1000mL; [hp_X]/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51393-6988_5d7084b8-a67a-4eb8-8696-a703d12bf69a	51393-6988	HUMAN OTC DRUG	Nail Fungus Control		Calendula Officinalis Flowering Top and Silicon Dioxide	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE	6; 6	[hp_X]/1000mL; [hp_X]/1000mL			N	20241231
51393-6989_6ef9a881-e2bd-44d6-91cc-e822c2df882b	51393-6989	HUMAN OTC DRUG	Nail Fungus Control	Extra Strength	Calendula Officinalis Flowering Top, Silicon Dioxide, and Hypericum Perforatum	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS FLOWERING TOP; HYPERICUM PERFORATUM WHOLE; SILICON DIOXIDE	8; 8; 8	[hp_X]/1000mL; [hp_X]/1000mL; [hp_X]/1000mL			N	20241231
51393-7112_da32a471-cb5e-47a8-a6d7-85a89339ca1b	51393-7112	HUMAN OTC DRUG	Scar Control		Calendula Officinalis Flowering Top, Allylthiourea, and Silicon Dioxide	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	ALLYLTHIOUREA; CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE	8; 6; 6	[hp_C]/1000mL; [hp_X]/1000mL; [hp_X]/1000mL			N	20241231
51393-7434_f1cbc1ba-2c4c-4587-91f1-71ec75315307	51393-7434	HUMAN OTC DRUG	Wart Control	Extra Strength	Calendula Officinalis Flowering Top, Phytolacca Americana Root, And Thuja Occidentalis Leafy Twig	SOLUTION/ DROPS	TOPICAL	20110406		UNAPPROVED HOMEOPATHIC		Forces of Nature	CALENDULA OFFICINALIS FLOWERING TOP; PHYTOLACCA AMERICANA ROOT; THUJA OCCIDENTALIS LEAFY TWIG	8; 8; 8	[hp_X]/1000mL; [hp_X]/1000mL; [hp_X]/1000mL			N	20241231
51393-7566_13530212-4239-41b2-8612-81c89bdceb3a	51393-7566	HUMAN OTC DRUG	Nerve Pain		Arabica Coffee Bean, Silicon Dioxide, and Hypericum Perforatum	SOLUTION/ DROPS	TOPICAL	20130101		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARABICA COFFEE BEAN; HYPERICUM PERFORATUM WHOLE; SILICON DIOXIDE	30; 30; 30	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
51393-7577_6234b777-4c9b-454b-ad55-062b783ca407	51393-7577	HUMAN OTC DRUG	Headache	Pain Management	Iris Versicolor Root, Lavandula Angustifolia Flowering Top, and Silicon Dioxide	SOLUTION/ DROPS	TOPICAL	20111201		UNAPPROVED HOMEOPATHIC		Forces of Nature	IRIS VERSICOLOR ROOT; LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWERING TOP; SILICON DIOXIDE	30; 12; 30	[hp_C]/1000mL; [hp_X]/1000mL; [hp_C]/1000mL			N	20241231
51393-7588_0e50403b-de8a-4788-af58-5b123cf7df96	51393-7588	HUMAN OTC DRUG	Migraine	Pain Management	Iris Versicolor Root and Sodium Chloride	SOLUTION/ DROPS	TOPICAL	20111201		UNAPPROVED HOMEOPATHIC		Forces of Nature	IRIS VERSICOLOR ROOT; SODIUM CHLORIDE	30; 30	[hp_X]/100mL; [hp_C]/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51393-7591_8525de08-c893-4d87-8dac-6faa9de90a8b	51393-7591	HUMAN OTC DRUG	Joint Pain	Pain Management	Aesculus Hippocastanum Whole and Ruta Graveolens Whole	SOLUTION/ DROPS	TOPICAL	20170115		UNAPPROVED HOMEOPATHIC		Forces of Nature	AESCULUS HIPPOCASTANUM WHOLE; RUTA GRAVEOLENS WHOLE	30; 30	[hp_C]/1000mL; [hp_C]/1000mL			N	20241231
51393-7611_e27306a0-a53b-4fbc-a880-5da2208d435c	51393-7611	HUMAN OTC DRUG	Athletes Foot/Jock Itch	Control	Centella Asiatica, Silicon Dioxide, and Thuja Occidentalis Root	SOLUTION/ DROPS	TOPICAL	20111201		UNAPPROVED HOMEOPATHIC		Forces of Nature	CENTELLA ASIATICA WHOLE; SILICON DIOXIDE; THUJA OCCIDENTALIS ROOT	30; 8; 30	[hp_C]/1000mL; [hp_X]/1000mL; [hp_C]/1000mL			N	20241231
51393-7633_da89eabf-c021-4712-ab76-95256af2b323	51393-7633	HUMAN OTC DRUG	Psoriasis Control		Centella Asiatica, Sodium Chloride, and Silicon Dioxide	SOLUTION/ DROPS	TOPICAL	20111201		UNAPPROVED HOMEOPATHIC		Forces of Nature	CENTELLA ASIATICA; SILICON DIOXIDE; SODIUM CHLORIDE	12; 8; 30	[hp_C]/1000mL; [hp_X]/1000mL; [hp_X]/1000mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51393-7656_b970bec0-dd61-4377-abd0-2b878916c957	51393-7656	HUMAN OTC DRUG	Gout	Pain Management	Arnica Montana, Urtica Urens, Silicon Dioxide, and Thuja Occidentalis Leaf	SOLUTION/ DROPS	TOPICAL	20170215		UNAPPROVED HOMEOPATHIC		Forces of Nature	ARNICA MONTANA WHOLE; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAF; URTICA URENS WHOLE	30; 8; 12; 30	[hp_C]/1000mL; [hp_X]/1000mL; [hp_X]/1000mL; [hp_C]/1000mL			N	20241231
51393-8111_ad7bf964-4769-41dc-b4c3-3d73db3cebe7	51393-8111	HUMAN OTC DRUG	Varicose Veins	Control	Horse Chestnut, MILK THISTLE, and Hamamelis Virginiana Root Bark/Stem Bark	SOLUTION/ DROPS	TOPICAL	20111201		UNAPPROVED HOMEOPATHIC		Forces of Nature	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; MILK THISTLE	30; 30; 12	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL			N	20241231
51400-001_08029ab0-4ac0-5dcb-e063-6394a90a48d2	51400-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19760101		NDA	NDA205767	MID-SOUTH WELDING SUPPLY, INC.	OXYGEN	99	L/100L			N	20241231
51407-011_03881eee-d7cc-b0f0-e063-6394a90a5639	51407-011	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA077744	Golden State Medical Supply, Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51407-012_03881eee-d7cc-b0f0-e063-6394a90a5639	51407-012	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA077744	Golden State Medical Supply, Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51407-013_03881eee-d7cc-b0f0-e063-6394a90a5639	51407-013	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA077744	Golden State Medical Supply, Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51407-015_f0d6bb63-87f3-b5b9-e053-2995a90af03d	51407-015	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20040423		ANDA	ANDA076550	Golden State Medical Supply, Inc.	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-016_f0d6bb63-87f3-b5b9-e053-2995a90af03d	51407-016	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20040423		ANDA	ANDA076550	Golden State Medical Supply, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-017_f0d6bb63-87f3-b5b9-e053-2995a90af03d	51407-017	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20040423		ANDA	ANDA076550	Golden State Medical Supply, Inc.	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-018_0517c34f-9efe-2fe1-e063-6294a90a51d3	51407-018	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20021028		ANDA	ANDA075882	Golden State Medical Supply, Inc.	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-019_0517c34f-9efe-2fe1-e063-6294a90a51d3	51407-019	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20021028		ANDA	ANDA075882	Golden State Medical Supply, Inc.	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-020_0517c34f-9efe-2fe1-e063-6294a90a51d3	51407-020	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20021028		ANDA	ANDA075882	Golden State Medical Supply, Inc.	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-024_c173ad0f-5294-c759-e053-2a95a90aa791	51407-024	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	19960429		ANDA	ANDA074299	Golden State Medical Supply, Inc.	INDAPAMIDE	1.25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51407-025_c173ad0f-5294-c759-e053-2a95a90aa791	51407-025	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	19950727		ANDA	ANDA074299	Golden State Medical Supply, Inc.	INDAPAMIDE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51407-026_0c7bd093-08f8-af90-e063-6294a90ab4dd	51407-026	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	19930630		ANDA	ANDA040001	Golden State Medical Supply, Inc.	METHAZOLAMIDE	25	mg/1			N	20241231
51407-027_0c7bd093-08f8-af90-e063-6294a90ab4dd	51407-027	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	19930630		ANDA	ANDA040001	Golden State Medical Supply, Inc.	METHAZOLAMIDE	50	mg/1			N	20241231
51407-032_0be04d56-bd9e-2c5d-e063-6294a90a4bd5	51407-032	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076274	Golden State Medical Supply, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
51407-039_079bfd7b-b3bb-24f2-e063-6394a90a7d09	51407-039	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078384	Golden State Medical Supply, Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-040_079bfd7b-b3bb-24f2-e063-6394a90a7d09	51407-040	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078384	Golden State Medical Supply, Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-041_079bfd7b-b3bb-24f2-e063-6394a90a7d09	51407-041	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078384	Golden State Medical Supply, Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-042_079bfd7b-b3bb-24f2-e063-6394a90a7d09	51407-042	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078384	Golden State Medical Supply, Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-047_0befd4f8-b5dd-2139-e063-6394a90a7d54	51407-047	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Golden State Medical Supply, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51407-048_0befd4f8-b5dd-2139-e063-6394a90a7d54	51407-048	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Golden State Medical Supply, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51407-049_0befd4f8-b5dd-2139-e063-6394a90a7d54	51407-049	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Golden State Medical Supply, Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51407-050_bf01ec26-6f1e-2f06-e053-2995a90a8ac9	51407-050	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171025		ANDA	ANDA090132	Golden State Medical Supply, Inc.	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-051_bf01ec26-6f1e-2f06-e053-2995a90a8ac9	51407-051	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171025		ANDA	ANDA090132	Golden State Medical Supply, Inc.	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-052_bf01ec26-6f1e-2f06-e053-2995a90a8ac9	51407-052	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171025		ANDA	ANDA090132	Golden State Medical Supply, Inc.	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-053_bf01ec26-6f1e-2f06-e053-2995a90a8ac9	51407-053	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171025		ANDA	ANDA090132	Golden State Medical Supply, Inc.	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51407-059_e64f5555-8bce-683b-e053-2995a90adeae	51407-059	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171226		ANDA	ANDA203832	Golden State Medical Supply, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51407-066_02fb5ce8-27d8-2d13-e063-6294a90ab4ef	51407-066	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090120	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-067_02fb5ce8-27d8-2d13-e063-6294a90ab4ef	51407-067	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-068_02fb5ce8-27d8-2d13-e063-6294a90ab4ef	51407-068	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-069_02fb5ce8-27d8-2d13-e063-6294a90ab4ef	51407-069	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-070_02fb5ce8-27d8-2d13-e063-6294a90ab4ef	51407-070	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-071_02fb5ce8-27d8-2d13-e063-6294a90ab4ef	51407-071	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-073_f657f971-f59f-5436-e053-2a95a90a9d6c	51407-073	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA208947	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-074_f657f971-f59f-5436-e053-2a95a90a9d6c	51407-074	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA208947	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-075_f657f971-f59f-5436-e053-2a95a90a9d6c	51407-075	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA208947	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-076_f657f971-f59f-5436-e053-2a95a90a9d6c	51407-076	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA208947	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-077_f657f971-f59f-5436-e053-2a95a90a9d6c	51407-077	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA208947	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-078_0bf363df-cc87-38f4-e063-6394a90a9328	51407-078	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Golden State Medical Supply, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-079_0bf363df-cc87-38f4-e063-6394a90a9328	51407-079	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Golden State Medical Supply, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-080_0bf363df-cc87-38f4-e063-6394a90a9328	51407-080	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Golden State Medical Supply, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-081_0bf363df-cc87-38f4-e063-6394a90a9328	51407-081	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Golden State Medical Supply, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-082_090b6221-94d7-7512-e063-6294a90a33f2	51407-082	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20200205		ANDA	ANDA210425	Golden State Medical Supply, Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
51407-083_fb311367-1561-ad33-e053-6394a90a23eb	51407-083	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20220518		ANDA	ANDA210568	Golden State Medical Supply, Inc.	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
51407-084_fb311367-1561-ad33-e053-6394a90a23eb	51407-084	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20220518		ANDA	ANDA210568	Golden State Medical Supply, Inc.	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
51407-086_0d81b0dc-c86c-21bc-e063-6294a90a420a	51407-086	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20150917		ANDA	ANDA203807	Golden State Medical Supply, Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-087_05e2a633-c9b7-0198-e063-6394a90a22bf	51407-087	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA204800	Golden State Medical Supply, Inc.	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-088_05e2a633-c9b7-0198-e063-6394a90a22bf	51407-088	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA204800	Golden State Medical Supply, Inc.	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-089_05e2a633-c9b7-0198-e063-6394a90a22bf	51407-089	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA204800	Golden State Medical Supply, Inc.	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-090_f9a10d2e-7a48-3b52-e053-6294a90a4f49	51407-090	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20020903		ANDA	ANDA075753	Golden State Medical Supply, Inc.	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51407-091_f9a10d2e-7a48-3b52-e053-6294a90a4f49	51407-091	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20020409		ANDA	ANDA075753	Golden State Medical Supply, Inc.	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51407-092_f9a10d2e-7a48-3b52-e053-6294a90a4f49	51407-092	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20020409		ANDA	ANDA075753	Golden State Medical Supply, Inc.	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51407-093_f9a1bb88-e463-b19b-e053-6394a90a8cc6	51407-093	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20050513		ANDA	ANDA076433	Golden State Medical Supply, Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51407-094_f9a1bb88-e463-b19b-e053-6394a90a8cc6	51407-094	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20050513		ANDA	ANDA076433	Golden State Medical Supply, Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51407-095_038909c9-2c5e-d40b-e063-6294a90a1ec6	51407-095	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20160714		ANDA	ANDA200483	Golden State Medical Supply, Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51407-096_038909c9-2c5e-d40b-e063-6294a90a1ec6	51407-096	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20160714		ANDA	ANDA200483	Golden State Medical Supply, Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51407-099_064b250e-4b43-3cd6-e063-6294a90a64db	51407-099	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171023		ANDA	ANDA209823	Golden State Medical Supply, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51407-100_0cd2290d-89df-d7b5-e063-6294a90a4585	51407-100	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20170530		ANDA	ANDA078983	Golden State Medical Supply, Inc.	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-101_0cd2290d-89df-d7b5-e063-6294a90a4585	51407-101	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20170530		ANDA	ANDA078983	Golden State Medical Supply, Inc.	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-102_0cd2290d-89df-d7b5-e063-6294a90a4585	51407-102	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20170530		ANDA	ANDA078983	Golden State Medical Supply, Inc.	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-103_0cd2290d-89df-d7b5-e063-6294a90a4585	51407-103	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20170530		ANDA	ANDA078983	Golden State Medical Supply, Inc.	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-104_0cd2290d-89df-d7b5-e063-6294a90a4585	51407-104	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20170530		ANDA	ANDA078983	Golden State Medical Supply, Inc.	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-105_0cd2290d-89df-d7b5-e063-6294a90a4585	51407-105	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20170530		ANDA	ANDA078983	Golden State Medical Supply, Inc.	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-106_0cd2290d-89df-d7b5-e063-6294a90a4585	51407-106	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20170530		ANDA	ANDA078983	Golden State Medical Supply, Inc.	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-107_0ce00714-8fcb-4e8e-e063-6394a90a2833	51407-107	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20070131		ANDA	ANDA076588	Golden State Medical Supply, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51407-108_0ce00714-8fcb-4e8e-e063-6394a90a2833	51407-108	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20070131		ANDA	ANDA076588	Golden State Medical Supply, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51407-109_05e52376-eb97-c676-e063-6294a90aaecc	51407-109	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040116		ANDA	ANDA076704	Golden State Medical Supply, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-110_05e52376-eb97-c676-e063-6294a90aaecc	51407-110	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040116		ANDA	ANDA076704	Golden State Medical Supply, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-111_05e52376-eb97-c676-e063-6294a90aaecc	51407-111	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040116		ANDA	ANDA076704	Golden State Medical Supply, Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-112_fd791a05-52e8-8a25-e053-6294a90a4021	51407-112	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		EMTRICITABINE and TENOFOVIR Disoproxil Fumarate	TABLET	ORAL	20210113		ANDA	ANDA091055	Golden State Medical Supply, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
51407-113_0ab0b554-ec38-0140-e063-6394a90a525e	51407-113	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	Golden State Medical Supply, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51407-114_0ab0b554-ec38-0140-e063-6394a90a525e	51407-114	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	19831110		NDA	NDA018823	Golden State Medical Supply, Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51407-121_e28610fd-7976-d7fb-e053-2995a90af654	51407-121	HUMAN PRESCRIPTION DRUG	Methotrexate		methotrexate	TABLET	ORAL	19920515		ANDA	ANDA081235	Golden State Medical Supply, Inc.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
51407-128_0e760af4-a7f2-7bbd-e063-6294a90af053	51407-128	HUMAN PRESCRIPTION DRUG	BUDESONIDE (ENTERIC COATED)		Budesonide	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20160408		ANDA	ANDA206623	Golden State Medical Supply, Inc.	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
51407-129_07d8bc58-9f31-8e11-e063-6294a90a2a2c	51407-129	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Golden State Medical Supply, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-130_07d8bc58-9f31-8e11-e063-6294a90a2a2c	51407-130	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Golden State Medical Supply, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-133_efbbeda7-6bf9-13ca-e053-2995a90a4177	51407-133	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20150902		ANDA	ANDA203503	Golden State Medical Supply, Inc.	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-145_04272f63-185d-b77e-e063-6394a90a08a1	51407-145	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	19990430		ANDA	ANDA075382	Golden State Medical Supply, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51407-146_04272f63-185d-b77e-e063-6394a90a08a1	51407-146	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	19990430		ANDA	ANDA075382	Golden State Medical Supply, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51407-147_f680d79f-116a-5461-e053-2995a90aa3fe	51407-147	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19871029		ANDA	ANDA086067	Golden State Medical Supply, Inc.	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51407-148_f680d79f-116a-5461-e053-2995a90aa3fe	51407-148	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19871029		ANDA	ANDA086066	Golden State Medical Supply, Inc.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51407-149_f680d79f-116a-5461-e053-2995a90aa3fe	51407-149	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19871102		ANDA	ANDA088088	Golden State Medical Supply, Inc.	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51407-153_05e59443-f508-42c5-e063-6294a90acf6f	51407-153	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207408	Golden State Medical Supply, Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-154_05e59443-f508-42c5-e063-6294a90acf6f	51407-154	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207408	Golden State Medical Supply, Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-155_05e59443-f508-42c5-e063-6294a90acf6f	51407-155	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207408	Golden State Medical Supply, Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-156_05e59443-f508-42c5-e063-6294a90acf6f	51407-156	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207408	Golden State Medical Supply, Inc.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-157_e0e30917-059e-3d1b-e053-2995a90a058a	51407-157	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161021		ANDA	ANDA206574	Golden State Medical Supply, Inc.	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
51407-165_f836322d-3e2e-362f-e053-6394a90a9074	51407-165	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076126	Golden State Medical Supply, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
51407-169_079ae211-51e7-6892-e063-6394a90a2aca	51407-169	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20130524		ANDA	ANDA091174	Golden State Medical Supply Inc.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
51407-170_079ae211-51e7-6892-e063-6394a90a2aca	51407-170	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20130524		ANDA	ANDA091174	Golden State Medical Supply Inc.	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
51407-174_02f87db7-067d-54fa-e063-6394a90a93ba	51407-174	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181031	20240430	ANDA	ANDA208960	Golden State Medical Supply, Inc.	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
51407-182_026cab3b-094a-7716-e063-6294a90aa8bc	51407-182	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	19990607		ANDA	ANDA075252	Golden State Medical Supply, Inc.	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
51407-184_05e69b7c-9261-b022-e063-6294a90af7dd	51407-184	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA090678	Golden State Medical Supply, Inc.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-190_0c7b8b84-3a6b-7cb1-e063-6294a90a42a4	51407-190	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA200909	Golden State Medical Supply	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-191_0c7b8b84-3a6b-7cb1-e063-6294a90a42a4	51407-191	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA200909	Golden State Medical Supply	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-192_0c7b8b84-3a6b-7cb1-e063-6294a90a42a4	51407-192	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA200909	Golden State Medical Supply	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-193_0c7b8b84-3a6b-7cb1-e063-6294a90a42a4	51407-193	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA200909	Golden State Medical Supply	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-197_bba586cb-59aa-66f4-e053-2a95a90a933c	51407-197	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Golden State Medical Supply, Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51407-198_bba586cb-59aa-66f4-e053-2a95a90a933c	51407-198	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Golden State Medical Supply, Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51407-199_bba586cb-59aa-66f4-e053-2a95a90a933c	51407-199	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Golden State Medical Supply, Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51407-203_07d8d712-5b41-913c-e063-6394a90a6a60	51407-203	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825	20240331	ANDA	ANDA202330	Golden State Medical Supply, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	
51407-204_e808ab5d-61f3-fa10-e053-2995a90a9b11	51407-204	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20170907		ANDA	ANDA200884	Golden State Medical Supply, Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51407-205_e808ab5d-61f3-fa10-e053-2995a90a9b11	51407-205	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20170907		ANDA	ANDA200884	Golden State Medical Supply, Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51407-206_0d8236b2-5561-79de-e063-6294a90a9bb3	51407-206	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171103		ANDA	ANDA210081	Golden State Medical Supply, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-207_0d8236b2-5561-79de-e063-6294a90a9bb3	51407-207	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171103		ANDA	ANDA210081	Golden State Medical Supply, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51407-208_0ce032f4-e572-59e0-e063-6394a90a60bf	51407-208	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181105		ANDA	ANDA210918	Golden State Medical Supply, Inc.	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51407-209_0ce032f4-e572-59e0-e063-6394a90a60bf	51407-209	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181105		ANDA	ANDA210918	Golden State Medical Supply, Inc.	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51407-210_0ce032f4-e572-59e0-e063-6394a90a60bf	51407-210	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181105		ANDA	ANDA210918	Golden State Medical Supply, Inc.	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51407-215_e4a5f571-7663-fafa-e053-2a95a90a72b0	51407-215	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19961003		ANDA	ANDA074649	Golden State Medical Supply Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51407-235_ddd3bc33-ff27-9ac8-e053-2995a90a6825	51407-235	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Golden State Medical Supply, Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-236_ddd3bc33-ff27-9ac8-e053-2995a90a6825	51407-236	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Golden State Medical Supply, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-237_ddd3bc33-ff27-9ac8-e053-2995a90a6825	51407-237	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Golden State Medical Supply, Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-238_ddd3bc33-ff27-9ac8-e053-2995a90a6825	51407-238	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Golden State Medical Supply, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-239_ddd3bc33-ff27-9ac8-e053-2995a90a6825	51407-239	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20110408		ANDA	ANDA070213	Golden State Medical Supply, Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-246_063109c6-0a0f-c575-e063-6294a90a57a2	51407-246	HUMAN PRESCRIPTION DRUG	Dalfampridine		Dalfampridine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180711		ANDA	ANDA206863	Golden State Medical Supply, Inc.	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
51407-250_063096f3-0fe7-99ab-e063-6294a90ab7cf	51407-250	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Golden State Medical Supply, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-251_0dad5b9f-61cf-8e15-e063-6394a90ac078	51407-251	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Golden State Medical Supply	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-252_0dad5b9f-61cf-8e15-e063-6394a90ac078	51407-252	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Golden State Medical Supply	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-253_0dad5b9f-61cf-8e15-e063-6394a90ac078	51407-253	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Golden State Medical Supply	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51407-256_07d99454-004d-d684-e063-6294a90afa51	51407-256	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20021101		ANDA	ANDA075410	Golden State Medical Supply, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-258_06c3176d-e6ff-4231-e063-6394a90a694b	51407-258	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET	ORAL	20190514		ANDA	ANDA211117	Golden State Medical Supply	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
51407-261_0d82ec9b-3d72-1741-e063-6394a90a95c5	51407-261	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Golden State Medical Supply, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-262_0d82ec9b-3d72-1741-e063-6394a90a95c5	51407-262	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Golden State Medical Supply, Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-263_0d82ec9b-3d72-1741-e063-6394a90a95c5	51407-263	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Golden State Medical Supply, Inc.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-264_0d82ec9b-3d72-1741-e063-6394a90a95c5	51407-264	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Golden State Medical Supply, Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-265_064994eb-5baf-6ec2-e063-6394a90a0e78	51407-265	HUMAN PRESCRIPTION DRUG	TRIHEXYPHENIDYL HYDROCHLORIDE		TRIHEXYPHENIDYL HYDROCHLORIDE	TABLET	ORAL	19981224		ANDA	ANDA040254	Golden State Medical Supply Inc.	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
51407-266_064994eb-5baf-6ec2-e063-6394a90a0e78	51407-266	HUMAN PRESCRIPTION DRUG	TRIHEXYPHENIDYL HYDROCHLORIDE		TRIHEXYPHENIDYL HYDROCHLORIDE	TABLET	ORAL	19981224		ANDA	ANDA040254	Golden State Medical Supply Inc.	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
51407-267_e286d363-06af-753f-e053-2a95a90a4faf	51407-267	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20170616		ANDA	ANDA203899	Golden State Medical Supply, Inc.	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
51407-268_e286d363-06af-753f-e053-2a95a90a4faf	51407-268	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20170616		ANDA	ANDA203899	Golden State Medical Supply, Inc.	NIACIN	1000	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
51407-269_0659dbe7-b0d4-4718-e063-6294a90afa46	51407-269	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		imatinib	TABLET, FILM COATED	ORAL	20170621		ANDA	ANDA204644	Golden State Medical Supply, Inc.	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
51407-270_0659dbe7-b0d4-4718-e063-6294a90afa46	51407-270	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		imatinib	TABLET, FILM COATED	ORAL	20170621		ANDA	ANDA204644	Golden State Medical Supply, Inc.	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
51407-272_eedf0a25-2e92-3b2a-e053-2a95a90a68fb	51407-272	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20150923		ANDA	ANDA205087	Golden State Medical Supply	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
51407-273_bcbcf138-b279-9936-e053-2a95a90a5ae9	51407-273	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	19920430		ANDA	ANDA073552	Golden State Medical Supply, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-274_0d83527d-d3f5-38ce-e063-6394a90ab5b6	51407-274	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	TABLET, DELAYED RELEASE	ORAL	20190125		ANDA	ANDA211858	Golden State Medical Supply, Inc.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
51407-275_03ae297e-2215-264c-e063-6294a90a8e39	51407-275	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Golden State Medical Supply, Inc.	THIOTHIXENE	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
51407-276_03ae297e-2215-264c-e063-6294a90a8e39	51407-276	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Golden State Medical Supply, Inc.	THIOTHIXENE	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
51407-277_03ae297e-2215-264c-e063-6294a90a8e39	51407-277	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Golden State Medical Supply, Inc.	THIOTHIXENE	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
51407-278_03ae297e-2215-264c-e063-6294a90a8e39	51407-278	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Golden State Medical Supply, Inc.	THIOTHIXENE	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
51407-279_98e41a1d-747a-7d3e-e053-2995a90afd47	51407-279	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20021218		ANDA	ANDA075638	Golden State Medical Supply, Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51407-286_0d83734c-04e9-476d-e063-6394a90ab746	51407-286	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19980505		ANDA	ANDA071251	Golden State Medical Supply, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-287_f873dc20-c7d4-5e4f-e053-6394a90a04f2	51407-287	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20201210		ANDA	ANDA212977	Golden State Medical Supply, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-288_ad2ab0c4-188d-f025-e053-2a95a90a2816	51407-288	HUMAN PRESCRIPTION DRUG	Quinidine Gluconate		Quinidine Gluconate	TABLET, EXTENDED RELEASE	ORAL	19870211		ANDA	ANDA089338	Golden State Medical Supply	QUINIDINE GLUCONATE	324	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
51407-293_0d83a581-2032-534b-e063-6294a90ae5a0	51407-293	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20191015		ANDA	ANDA205414	Golden State Medical Supply, Inc.	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51407-294_0d83a581-2032-534b-e063-6294a90ae5a0	51407-294	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20191015		ANDA	ANDA205414	Golden State Medical Supply, Inc.	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51407-298_090b9182-2e6d-d2f9-e063-6394a90a6f77	51407-298	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Golden State Medical Supply, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51407-299_02f8f5fa-ed92-c5be-e063-6294a90a5484	51407-299	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-300_02f8f5fa-ed92-c5be-e063-6294a90a5484	51407-300	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-301_02f8f5fa-ed92-c5be-e063-6294a90a5484	51407-301	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-302_02f8f5fa-ed92-c5be-e063-6294a90a5484	51407-302	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-303_07d99454-004d-d684-e063-6294a90afa51	51407-303	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090123		ANDA	ANDA075410	Golden State Medical Supply, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-315_07d9743b-924e-0c19-e063-6294a90acda8	51407-315	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	19980430	20240430	ANDA	ANDA074947	Golden State Medical Supply	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
51407-316_07d9743b-924e-0c19-e063-6294a90acda8	51407-316	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	19980430	20240430	ANDA	ANDA074947	Golden State Medical Supply	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
51407-317_07d9743b-924e-0c19-e063-6294a90acda8	51407-317	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	19980430	20240430	ANDA	ANDA074947	Golden State Medical Supply	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	
51407-318_d43cda90-2ddf-d377-e053-2995a90aa7b0	51407-318	HUMAN PRESCRIPTION DRUG	Theophylline	(Anhydrous)	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20060421		ANDA	ANDA040560	Golden State Medical Supply, Inc.	THEOPHYLLINE ANHYDROUS	400	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
51407-319_d43cda90-2ddf-d377-e053-2995a90aa7b0	51407-319	HUMAN PRESCRIPTION DRUG	Theophylline	(Anhydrous)	Theophylline	TABLET, EXTENDED RELEASE	ORAL	20060421		ANDA	ANDA040560	Golden State Medical Supply, Inc.	THEOPHYLLINE ANHYDROUS	600	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
51407-320_0d840a90-73b6-7118-e063-6394a90a6c98	51407-320	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20141029		ANDA	ANDA203104	Golden State Medical Supply, Inc.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51407-321_f9dff08a-ed95-86de-e053-6394a90a1043	51407-321	HUMAN PRESCRIPTION DRUG	Moxifloxacin		moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20170630		ANDA	ANDA090080	Golden State Medical Supply, Inc.	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
51407-322_02e9b46e-3e19-0efe-e063-6394a90ae050	51407-322	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	20010314	20240229	ANDA	ANDA065028	Golden State Medical Supply, Inc.	RIFAMPIN	150	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	
51407-324_e7b55557-0210-f358-e053-2995a90af86d	51407-324	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20160725		ANDA	ANDA203203	Golden State Medical Supply, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-330_02ae31f3-6a70-bf0f-e063-6394a90a17cc	51407-330	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20170510		ANDA	ANDA040702	Golden State Medical Supply, Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-331_02ae31f3-6a70-bf0f-e063-6394a90a17cc	51407-331	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20070316		ANDA	ANDA040702	Golden State Medical Supply, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-332_02ae31f3-6a70-bf0f-e063-6394a90a17cc	51407-332	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20070316		ANDA	ANDA040702	Golden State Medical Supply, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-333_f6cc658e-da1d-5b4c-e053-6294a90a8532	51407-333	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20100607		ANDA	ANDA065496	Golden State Medical Supply, Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
51407-334_f6cc658e-da1d-5b4c-e053-6294a90a8532	51407-334	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20100607		ANDA	ANDA065496	Golden State Medical Supply, Inc.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
51407-336_e548ce3a-a8e7-094f-e053-2995a90a0837	51407-336	HUMAN PRESCRIPTION DRUG	Colesevelam hydrochloride		Colesevelam hydrochloride	TABLET	ORAL	20200715		ANDA	ANDA209946	Golden State Medical Supply, Inc.	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
51407-342_e0e3bc89-4fd9-1670-e053-2a95a90a869b	51407-342	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Golden State Medical Supply, Inc.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-343_e0e3bc89-4fd9-1670-e053-2a95a90a869b	51407-343	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Golden State Medical Supply, Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-344_e0e3bc89-4fd9-1670-e053-2a95a90a869b	51407-344	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Golden State Medical Supply, Inc.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-345_e0e3bc89-4fd9-1670-e053-2a95a90a869b	51407-345	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Golden State Medical Supply, Inc.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-346_e0e3bc89-4fd9-1670-e053-2a95a90a869b	51407-346	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Golden State Medical Supply, Inc.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-347_e0e3bc89-4fd9-1670-e053-2a95a90a869b	51407-347	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Golden State Medical Supply, Inc.	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-350_efbd131f-7237-237c-e053-2995a90a0c83	51407-350	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030619		ANDA	ANDA076122	Golden State Medical Supply, Inc.	MIRTAZAPINE	15	mg/1			N	20241231
51407-351_efbd131f-7237-237c-e053-2995a90a0c83	51407-351	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030619		ANDA	ANDA076122	Golden State Medical Supply, Inc.	MIRTAZAPINE	30	mg/1			N	20241231
51407-352_efbd131f-7237-237c-e053-2995a90a0c83	51407-352	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030619		ANDA	ANDA076122	Golden State Medical Supply, Inc.	MIRTAZAPINE	45	mg/1			N	20241231
51407-355_0ab31a16-7a19-8cd8-e063-6394a90a03f9	51407-355	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820422		ANDA	ANDA087800	Golden State Medical Supply, Inc.	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-356_0ab31a16-7a19-8cd8-e063-6394a90a03f9	51407-356	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820422		ANDA	ANDA087801	Golden State Medical Supply, Inc.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-357_0ab31a16-7a19-8cd8-e063-6394a90a03f9	51407-357	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820101		ANDA	ANDA080352	Golden State Medical Supply, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-358_0ab31a16-7a19-8cd8-e063-6394a90a03f9	51407-358	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820101		ANDA	ANDA084122	Golden State Medical Supply, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-359_0ab31a16-7a19-8cd8-e063-6394a90a03f9	51407-359	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820101		ANDA	ANDA087342	Golden State Medical Supply, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-360_0ab31a16-7a19-8cd8-e063-6394a90a03f9	51407-360	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820101	20240430	ANDA	ANDA084283	Golden State Medical Supply, Inc.	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
51407-361_0517894a-1418-12fe-e063-6394a90ad41f	51407-361	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19820101		ANDA	ANDA084612	Golden State Medical Supply, Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-362_0d9921c1-ead4-6cc5-e063-6294a90a7d81	51407-362	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20050301		ANDA	ANDA076943	Golden State Medical Supply, Inc.	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51407-365_026cef5c-3321-d52d-e063-6294a90a6df6	51407-365	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	19970228	20250228	ANDA	ANDA040204	Golden State Medical Supply, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
51407-366_c8975701-4160-1019-e053-2995a90a18d8	51407-366	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200917		ANDA	ANDA208851	Golden State Medical Supply, Inc.	BUDESONIDE	9	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-367_0816f132-ccd6-f3e6-e063-6394a90a88c3	51407-367	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	TABLET	ORAL	19891205		ANDA	ANDA072637	Golden State Medical Supply	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
51407-368_0816f132-ccd6-f3e6-e063-6394a90a88c3	51407-368	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	TABLET	ORAL	19891205		ANDA	ANDA072637	Golden State Medical Supply	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
51407-369_03897071-314d-af0f-e063-6394a90a9a14	51407-369	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20011114		ANDA	ANDA075682	Golden State Medical Supply, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51407-370_03897071-314d-af0f-e063-6394a90a9a14	51407-370	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20011114		ANDA	ANDA075682	Golden State Medical Supply, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51407-371_03897071-314d-af0f-e063-6394a90a9a14	51407-371	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20011114		ANDA	ANDA075682	Golden State Medical Supply, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51407-372_f6ce8bea-8908-caf4-e053-6294a90a93dc	51407-372	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	19860716		ANDA	ANDA070772	Golden State Medical Supply, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
51407-373_0b53957e-ac09-8c89-e063-6394a90af3ad	51407-373	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010202		ANDA	ANDA065061	Golden State Medical Supply, Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
51407-374_0631402a-9b24-501b-e063-6394a90a7064	51407-374	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Golden State Medical Supply, Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-376_d9e44b15-dc38-f778-e053-2995a90a4ba1	51407-376	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	19860716		ANDA	ANDA070772	Golden State Medical Supply, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
51407-379_f7ad1139-6367-5cce-e053-6394a90a5730	51407-379	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	19960516		ANDA	ANDA074450	Golden State Medical Supply, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-380_f7ad1139-6367-5cce-e053-6394a90a5730	51407-380	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	19960516		ANDA	ANDA074450	Golden State Medical Supply, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-381_f7ad1139-6367-5cce-e053-6394a90a5730	51407-381	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	19960516		ANDA	ANDA074450	Golden State Medical Supply, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
51407-382_f6ced867-6a0c-5c5f-e053-6394a90a2735	51407-382	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	TABLET	ORAL	20180312		ANDA	ANDA204869	Golden State Medical Supply, Inc.	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
51407-383_0e9a65f8-f5b1-c203-e063-6394a90aff37	51407-383	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	19820101		ANDA	ANDA086724	Golden State Medical Supply, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
51407-384_06d236c0-a53b-c9f7-e063-6294a90a5ac9	51407-384	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20090320		ANDA	ANDA090097	Golden State Medical Supply, Inc.	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
51407-385_06d236c0-a53b-c9f7-e063-6294a90a5ac9	51407-385	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20090320		ANDA	ANDA090097	Golden State Medical Supply, Inc.	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
51407-387_f1d8c7f1-90d0-94e8-e053-2a95a90af57f	51407-387	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20001201	20241130	ANDA	ANDA065055	Golden State Medical Supply, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
51407-388_0712935b-edf7-9614-e063-6294a90a9906	51407-388	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA207849	Golden State Medical Supply, Inc.	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51407-389_0712935b-edf7-9614-e063-6294a90a9906	51407-389	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA207849	Golden State Medical Supply, Inc.	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51407-390_0712935b-edf7-9614-e063-6294a90a9906	51407-390	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA207849	Golden State Medical Supply, Inc.	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51407-403_051dc4e1-e2ee-828e-e063-6394a90a3555	51407-403	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Golden State Medical Supply, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-404_051dc4e1-e2ee-828e-e063-6394a90a3555	51407-404	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Golden State Medical Supply, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-405_051dc4e1-e2ee-828e-e063-6394a90a3555	51407-405	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Golden State Medical Supply, Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-406_051dc4e1-e2ee-828e-e063-6394a90a3555	51407-406	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Golden State Medical Supply, Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-413_f9b7337c-2e39-9458-e053-6394a90ae19e	51407-413	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Golden State Medical Supply, Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
51407-414_f9b7337c-2e39-9458-e053-6394a90ae19e	51407-414	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170217		ANDA	ANDA202330	Golden State Medical Supply, Inc.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
51407-415_f9b7337c-2e39-9458-e053-6394a90ae19e	51407-415	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Golden State Medical Supply, Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
51407-416_f9b7337c-2e39-9458-e053-6394a90ae19e	51407-416	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Golden State Medical Supply, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
51407-417_f9b7337c-2e39-9458-e053-6394a90ae19e	51407-417	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Golden State Medical Supply, Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
51407-424_0389b02e-8aa7-7c29-e063-6394a90af8be	51407-424	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-425_0389b02e-8aa7-7c29-e063-6394a90af8be	51407-425	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-426_0389b02e-8aa7-7c29-e063-6394a90af8be	51407-426	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-427_0389b02e-8aa7-7c29-e063-6394a90af8be	51407-427	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Golden State Medical Supply, Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-428_07a0ee89-63db-4b25-e063-6394a90aea2f	51407-428	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA076710	Golden State Medical Supply, Inc.	LEVOFLOXACIN	250	mg/1			N	20241231
51407-429_07a0ee89-63db-4b25-e063-6394a90aea2f	51407-429	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA076710	Golden State Medical Supply, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
51407-430_07a0ee89-63db-4b25-e063-6394a90aea2f	51407-430	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA076710	Golden State Medical Supply, Inc.	LEVOFLOXACIN	750	mg/1			N	20241231
51407-431_f6f78f0b-5533-35ed-e053-6394a90a3250	51407-431	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210330		ANDA	ANDA213827	Golden State Medical Supply, Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51407-432_f6f78f0b-5533-35ed-e053-6394a90a3250	51407-432	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210330		ANDA	ANDA213827	Golden State Medical Supply, Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51407-433_f6f78f0b-5533-35ed-e053-6394a90a3250	51407-433	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210330		ANDA	ANDA213827	Golden State Medical Supply, Inc.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51407-434_efd2cbad-e123-c9e2-e053-2a95a90a5b2f	51407-434	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Golden State Medical Supply, Inc.	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-435_efd2cbad-e123-c9e2-e053-2a95a90a5b2f	51407-435	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Golden State Medical Supply, Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-436_efd2cbad-e123-c9e2-e053-2a95a90a5b2f	51407-436	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Golden State Medical Supply, Inc.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-437_efd2cbad-e123-c9e2-e053-2a95a90a5b2f	51407-437	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Golden State Medical Supply, Inc.	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-438_efd2cbad-e123-c9e2-e053-2a95a90a5b2f	51407-438	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20210122		ANDA	ANDA212996	Golden State Medical Supply, Inc.	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-439_0e762d44-1c07-90c4-e063-6294a90a4676	51407-439	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20030220		ANDA	ANDA075797	Golden State Medical Supply, Inc.	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20251231
51407-440_0e762d44-1c07-90c4-e063-6294a90a4676	51407-440	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20030220		ANDA	ANDA075797	Golden State Medical Supply, Inc.	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20251231
51407-441_f6f8baac-cde4-d1d7-e053-6294a90a1988	51407-441	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20201014		ANDA	ANDA210382	Golden State Medical Supply, Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
51407-442_f6f8baac-cde4-d1d7-e053-6294a90a1988	51407-442	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20201014		ANDA	ANDA210382	Golden State Medical Supply, Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
51407-443_0b5375dc-7251-6d3e-e063-6394a90a472f	51407-443	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	20040318		ANDA	ANDA076561	Golden State Medical Supply, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51407-444_efd33283-585b-de28-e053-2a95a90a9272	51407-444	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20170712		ANDA	ANDA205927	Golden State Medical Supply, Inc.	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
51407-445_efd33283-585b-de28-e053-2a95a90a9272	51407-445	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20170712		ANDA	ANDA205927	Golden State Medical Supply, Inc.	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
51407-449_090bceb1-3052-f6af-e063-6394a90a7219	51407-449	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140806		ANDA	ANDA203546	Golden State Medical Supply, Inc.	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
51407-450_090bceb1-3052-f6af-e063-6394a90a7219	51407-450	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140806		ANDA	ANDA203546	Golden State Medical Supply, Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
51407-451_090bceb1-3052-f6af-e063-6394a90a7219	51407-451	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140806		ANDA	ANDA203546	Golden State Medical Supply, Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
51407-452_09198209-ed1a-8196-e063-6294a90a3268	51407-452	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SUSPENSION	ORAL	20210420		ANDA	ANDA215043	Golden State Medical Supply, Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51407-453_0ce0b798-94f8-7d3a-e063-6394a90a2d39	51407-453	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Golden State Medical Supply, Inc.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-454_0ce0b798-94f8-7d3a-e063-6394a90a2d39	51407-454	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Golden State Medical Supply, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-455_0ce0b798-94f8-7d3a-e063-6394a90a2d39	51407-455	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Golden State Medical Supply, Inc.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-456_0ce0b798-94f8-7d3a-e063-6394a90a2d39	51407-456	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Golden State Medical Supply, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-457_0ce0b798-94f8-7d3a-e063-6394a90a2d39	51407-457	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Golden State Medical Supply, Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-458_0b532d93-1614-917e-e063-6294a90a0c4c	51407-458	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210107		ANDA	ANDA214534	Golden State Medical Supply, Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-459_0b532d93-1614-917e-e063-6294a90a0c4c	51407-459	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210107		ANDA	ANDA214534	Golden State Medical Supply, Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-460_0b532d93-1614-917e-e063-6294a90a0c4c	51407-460	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210107		ANDA	ANDA214534	Golden State Medical Supply, Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-461_0b532d93-1614-917e-e063-6294a90a0c4c	51407-461	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210107		ANDA	ANDA214534	Golden State Medical Supply, Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-462_08923f8b-3f5e-83af-e063-6394a90a0971	51407-462	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20040211		ANDA	ANDA076118	Golden State Medical Supply, Inc.	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51407-463_08923f8b-3f5e-83af-e063-6394a90a0971	51407-463	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20040211		ANDA	ANDA076118	Golden State Medical Supply, Inc.	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51407-464_08923f8b-3f5e-83af-e063-6394a90a0971	51407-464	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20040211		ANDA	ANDA076118	Golden State Medical Supply, Inc.	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51407-465_08923f8b-3f5e-83af-e063-6394a90a0971	51407-465	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20040211		ANDA	ANDA076118	Golden State Medical Supply, Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51407-467_efd372d9-9ba4-1ef4-e053-2a95a90a6560	51407-467	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	19820101		ANDA	ANDA086988	Golden State Medical Supply, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51407-468_efd372d9-9ba4-1ef4-e053-2a95a90a6560	51407-468	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	19820101		ANDA	ANDA086988	Golden State Medical Supply, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51407-471_c8467b5f-9d93-1468-e053-2995a90acdf9	51407-471	HUMAN PRESCRIPTION DRUG	SOLIFENACIN SUCCINATE		SOLIFENACIN SUCCINATE	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA211657	Golden State Medical Supply, Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51407-472_c8467b5f-9d93-1468-e053-2995a90acdf9	51407-472	HUMAN PRESCRIPTION DRUG	SOLIFENACIN SUCCINATE		SOLIFENACIN SUCCINATE	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA211657	Golden State Medical Supply, Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51407-473_0d9a924a-78ea-c97a-e063-6394a90a4b49	51407-473	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA205231	Golden State Medical Supply, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-474_0d9a924a-78ea-c97a-e063-6394a90a4b49	51407-474	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA205231	Golden State Medical Supply, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-475_0d9a924a-78ea-c97a-e063-6394a90a4b49	51407-475	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA205231	Golden State Medical Supply, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-476_0d9a924a-78ea-c97a-e063-6394a90a4b49	51407-476	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA205231	Golden State Medical Supply, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51407-477_0e76ea05-c3d6-8465-e063-6294a90a747f	51407-477	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200618		ANDA	ANDA212928	Golden State Medical Supply, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20251231
51407-478_0e76ea05-c3d6-8465-e063-6294a90a747f	51407-478	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200618		ANDA	ANDA212928	Golden State Medical Supply, Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20251231
51407-479_0e76ea05-c3d6-8465-e063-6294a90a747f	51407-479	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200618		ANDA	ANDA212928	Golden State Medical Supply, Inc.	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20251231
51407-480_0dadd0c9-e842-b0ac-e063-6294a90ab103	51407-480	HUMAN PRESCRIPTION DRUG	Tetrabenazine		tetrabenazine	TABLET	ORAL	20200317		ANDA	ANDA206093	Golden State Medical Supply, Inc.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
51407-481_0dadd0c9-e842-b0ac-e063-6294a90ab103	51407-481	HUMAN PRESCRIPTION DRUG	Tetrabenazine		tetrabenazine	TABLET	ORAL	20200317		ANDA	ANDA206093	Golden State Medical Supply, Inc.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
51407-483_03adf6fa-9a63-6169-e063-6294a90a905d	51407-483	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20150416		ANDA	ANDA203659	Golden State Medical Supply, Inc.	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-484_03adf6fa-9a63-6169-e063-6294a90a905d	51407-484	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20150416		ANDA	ANDA203659	Golden State Medical Supply, Inc.	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-485_03adf6fa-9a63-6169-e063-6294a90a905d	51407-485	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20150416		ANDA	ANDA203659	Golden State Medical Supply, Inc.	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-486_03adf6fa-9a63-6169-e063-6294a90a905d	51407-486	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20150416		ANDA	ANDA203659	Golden State Medical Supply, Inc.	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-524_0e8b7b39-ea48-e560-e063-6294a90ab5bd	51407-524	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960910		ANDA	ANDA074569	Golden State Medical Supply, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
51407-527_0389b02e-8acb-7c29-e063-6394a90af8be	51407-527	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181121		ANDA	ANDA210992	Golden State Medical Supply, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-528_0389b02e-8acb-7c29-e063-6394a90af8be	51407-528	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181121		ANDA	ANDA210992	Golden State Medical Supply, Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-548_b5e90203-a411-9dad-e053-2995a90a13bf	51407-548	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191211		ANDA	ANDA212037	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-549_b5e90203-a411-9dad-e053-2995a90a13bf	51407-549	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191211		ANDA	ANDA212037	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-550_b5e90203-a411-9dad-e053-2995a90a13bf	51407-550	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191211		ANDA	ANDA212037	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-551_b5e90203-a411-9dad-e053-2995a90a13bf	51407-551	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191211		ANDA	ANDA212037	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-552_b5e90203-a411-9dad-e053-2995a90a13bf	51407-552	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191211		ANDA	ANDA212037	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-553_b5e90203-a411-9dad-e053-2995a90a13bf	51407-553	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191211		ANDA	ANDA212037	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-556_f707fd82-6f8c-d43a-e053-6394a90a1012	51407-556	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	TABLET	ORAL	20081201		ANDA	ANDA040864	Golden State Medical Supply, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
51407-557_0cf87661-ee5a-e1d5-e063-6294a90ae270	51407-557	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-558_0cf87661-ee5a-e1d5-e063-6294a90ae270	51407-558	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-559_0cf87661-ee5a-e1d5-e063-6294a90ae270	51407-559	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-560_0cf87661-ee5a-e1d5-e063-6294a90ae270	51407-560	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-561_0cf87661-ee5a-e1d5-e063-6294a90ae270	51407-561	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-562_0cf87661-ee5a-e1d5-e063-6294a90ae270	51407-562	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20211126		ANDA	ANDA214403	Golden State Medical Supply, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
51407-600_09be2bf1-9fd8-0baa-e063-6394a90a8360	51407-600	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Golden State Medical Supply, Inc.	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51407-601_09be2bf1-9fd8-0baa-e063-6394a90a8360	51407-601	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Golden State Medical Supply, Inc.	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51407-602_09be2bf1-9fd8-0baa-e063-6394a90a8360	51407-602	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Golden State Medical Supply, Inc.	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51407-603_09be2bf1-9fd8-0baa-e063-6394a90a8360	51407-603	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	Golden State Medical Supply, Inc.	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51407-605_fb34afb2-c92f-f68e-e053-6394a90accca	51407-605	HUMAN PRESCRIPTION DRUG	calcipotriene		calcipotriene	CREAM	TOPICAL	20150609		ANDA	ANDA205772	Golden State Medical Supply, Inc.	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
51407-606_f1d7dfa5-c532-2170-e053-2a95a90a8607	51407-606	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	OINTMENT	TOPICAL	20100324		ANDA	ANDA090633	Golden State Medical Supply, Inc.	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
51407-610_f7582032-efbf-5f5b-e053-6394a90a994e	51407-610	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20061207		ANDA	ANDA077918	Golden State Medical Supply, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51407-611_f7582032-efbf-5f5b-e053-6394a90a994e	51407-611	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20061207		ANDA	ANDA077918	Golden State Medical Supply, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51407-612_06315aa0-db39-611d-e063-6294a90ae563	51407-612	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Golden State Medical Supply, Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-613_06315aa0-db39-611d-e063-6294a90ae563	51407-613	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Golden State Medical Supply, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-614_d5ce6370-2392-2cf0-e053-2a95a90a0adf	51407-614	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20180620		ANDA	ANDA209603	Golden State Medical Supply, Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-615_d5ce6370-2392-2cf0-e053-2a95a90a0adf	51407-615	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20180620		ANDA	ANDA209603	Golden State Medical Supply, Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-616_d5ce6370-2392-2cf0-e053-2a95a90a0adf	51407-616	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20180620		ANDA	ANDA209603	Golden State Medical Supply, Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-620_f758c3d6-9dd5-9071-e053-6294a90a479e	51407-620	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950831		ANDA	ANDA074497	Golden State Medical Supply, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51407-621_f758c3d6-9dd5-9071-e053-6294a90a479e	51407-621	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950831		ANDA	ANDA074497	Golden State Medical Supply, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51407-622_f758e684-bb7a-97ff-e053-6394a90adf5a	51407-622	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20160825		ANDA	ANDA202987	Golden State Medical Supply, Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-623_f758e684-bb7a-97ff-e053-6394a90adf5a	51407-623	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20160825		ANDA	ANDA202987	Golden State Medical Supply, Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-624_f758e684-bb7a-97ff-e053-6394a90adf5a	51407-624	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20160825		ANDA	ANDA202987	Golden State Medical Supply, Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-629_038a4de7-852c-d8e4-e063-6394a90a22e7	51407-629	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	19820101	20241031	ANDA	ANDA084657	Golden State Medical Supply, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
51407-637_e4e4819f-f4da-b074-e053-2a95a90abb10	51407-637	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20010524		ANDA	ANDA084903	Golden State Medical Supply, Inc.	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51407-638_e4e4819f-f4da-b074-e053-2a95a90abb10	51407-638	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	19781201		ANDA	ANDA084903	Golden State Medical Supply, Inc.	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51407-639_f9b7bf39-7f1b-8723-e053-6394a90a7416	51407-639	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20130916		ANDA	ANDA091649	Golden State Medical Supply, Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51407-640_f9b7bf39-7f1b-8723-e053-6394a90a7416	51407-640	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20130916		ANDA	ANDA091649	Golden State Medical Supply, Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51407-641_02e6f701-eff9-cc17-e063-6394a90af4ba	51407-641	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20201210		ANDA	ANDA212977	Golden State Medical Supply, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-642_f7596882-ab57-6972-e053-6394a90aa13c	51407-642	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20210330		ANDA	ANDA212918	Golden State Medical Supply, Inc.	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
51407-645_df37d337-9963-0c31-e053-2a95a90a3258	51407-645	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET	ORAL	20211029		ANDA	ANDA215563	Golden State Medical Supply, Inc.	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-646_df37d337-9963-0c31-e053-2a95a90a3258	51407-646	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET	ORAL	20211029		ANDA	ANDA215563	Golden State Medical Supply, Inc.	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-656_e920b343-f519-7487-e053-2995a90a719a	51407-656	HUMAN PRESCRIPTION DRUG	Nateglinide		nateglinide	TABLET	ORAL	20090909		ANDA	ANDA077463	Golden State Medical Supply, Inc.	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
51407-657_e920b343-f519-7487-e053-2995a90a719a	51407-657	HUMAN PRESCRIPTION DRUG	Nateglinide		nateglinide	TABLET	ORAL	20090909		ANDA	ANDA077463	Golden State Medical Supply, Inc.	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
51407-661_e5e64d6b-f1d4-34bc-e053-2995a90a5032	51407-661	HUMAN PRESCRIPTION DRUG	Fesoterodine fumarate		Fesoterodine fumarate	TABLET, EXTENDED RELEASE	ORAL	20190813		ANDA	ANDA204975	Golden State Medical Supply, Inc.	FESOTERODINE FUMARATE	4	mg/1			N	20241231
51407-662_e5e64d6b-f1d4-34bc-e053-2995a90a5032	51407-662	HUMAN PRESCRIPTION DRUG	Fesoterodine fumarate		Fesoterodine fumarate	TABLET, EXTENDED RELEASE	ORAL	20190813		ANDA	ANDA204975	Golden State Medical Supply, Inc.	FESOTERODINE FUMARATE	8	mg/1			N	20241231
51407-663_0d98aa94-45c1-d95d-e063-6394a90aa2c4	51407-663	HUMAN OTC DRUG	Olopatadine hydrochloride		Olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20151207		ANDA	ANDA078350	Golden State Medical Supply, Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
51407-664_f27b41f1-f5b8-1c1c-e053-2a95a90a3518	51407-664	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Golden State Medical Supply, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-665_0bf42c32-5895-293c-e063-6294a90a3722	51407-665	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate		hydrocortisone acetate	SUPPOSITORY	RECTAL	20131112		UNAPPROVED DRUG OTHER		Golden State Medical Supply, Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-666_f7ad39d0-66e2-1c41-e053-6294a90adcbc	51407-666	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	19951018		ANDA	ANDA074007	Golden State Medical Supply, Inc.	ACEBUTOLOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-667_f7ad39d0-66e2-1c41-e053-6294a90adcbc	51407-667	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	19951018		ANDA	ANDA074007	Golden State Medical Supply, Inc.	ACEBUTOLOL HYDROCHLORIDE	400	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51407-668_e9ecbadb-c517-6fe5-e053-2a95a90a7577	51407-668	HUMAN PRESCRIPTION DRUG	AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE		amlodipine besylate valsartan hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA201087	Golden State Medical Supply, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-669_e9ecbadb-c517-6fe5-e053-2a95a90a7577	51407-669	HUMAN PRESCRIPTION DRUG	AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE		amlodipine besylate valsartan hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA201087	Golden State Medical Supply, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-670_e9ecbadb-c517-6fe5-e053-2a95a90a7577	51407-670	HUMAN PRESCRIPTION DRUG	AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE		amlodipine besylate valsartan hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA201087	Golden State Medical Supply, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-671_e9ecbadb-c517-6fe5-e053-2a95a90a7577	51407-671	HUMAN PRESCRIPTION DRUG	AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE		amlodipine besylate valsartan hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA201087	Golden State Medical Supply, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-672_e9ecbadb-c517-6fe5-e053-2a95a90a7577	51407-672	HUMAN PRESCRIPTION DRUG	AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE		amlodipine besylate valsartan hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150601		ANDA	ANDA201087	Golden State Medical Supply, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 320	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51407-676_e8838f98-fd20-f53a-e053-2995a90a1d62	51407-676	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		posaconazole	TABLET, DELAYED RELEASE	ORAL	20220510		ANDA	ANDA212226	Golden State Medical Supply, Inc.	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51407-677_ec6d398b-7af7-2a42-e053-2a95a90ae2b1	51407-677	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20220323		ANDA	ANDA215788	Golden State Medical Supply, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51407-678_ff0d77e8-b115-1a32-e053-6294a90a9fcc	51407-678	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20001201		ANDA	ANDA065055	Golden State Medical Supply, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51407-679_07607aeb-30aa-3707-e063-6294a90ae5c6	51407-679	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203062	Golden State Medical Supply, Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51407-680_07607aeb-30aa-3707-e063-6294a90ae5c6	51407-680	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203062	Golden State Medical Supply, Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51407-681_075f61e8-aa39-6b98-e063-6294a90acf3c	51407-681	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Golden State Medical Supply, Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51407-682_075f61e8-aa39-6b98-e063-6294a90acf3c	51407-682	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Golden State Medical Supply, Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51407-683_f9b8c0d5-a8aa-3d6e-e053-6294a90a4d4c	51407-683	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Golden State Medical Supply, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51407-684_f9b8c0d5-a8aa-3d6e-e053-6294a90a4d4c	51407-684	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Golden State Medical Supply, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51407-691_02fa5d85-63f1-054d-e063-6394a90a0fa7	51407-691	HUMAN PRESCRIPTION DRUG	vilazodone		vilazodone hydrochloride	TABLET	ORAL	20210121	20240229	NDA AUTHORIZED GENERIC	NDA022567	Golden State Medical Supply, Inc.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	
51407-692_02fa5d85-63f1-054d-e063-6394a90a0fa7	51407-692	HUMAN PRESCRIPTION DRUG	Vilazodone		vilazodone hydrochloride	TABLET	ORAL	20210121	20240531	NDA AUTHORIZED GENERIC	NDA022567	Golden State Medical Supply, Inc.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	
51407-693_02fa5d85-63f1-054d-e063-6394a90a0fa7	51407-693	HUMAN PRESCRIPTION DRUG	Vilazodone		vilazodone hydrochloride	TABLET	ORAL	20210121	20240731	NDA AUTHORIZED GENERIC	NDA022567	Golden State Medical Supply, Inc.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	
51407-694_09bfd925-7cff-133e-e063-6294a90a9b81	51407-694	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200406		ANDA	ANDA205232	GOLDEN STATE MEDICAL SUPPLY, INC.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-695_09bfd925-7cff-133e-e063-6294a90a9b81	51407-695	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200406		ANDA	ANDA205232	GOLDEN STATE MEDICAL SUPPLY, INC.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-696_09bfd925-7cff-133e-e063-6294a90a9b81	51407-696	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200406		ANDA	ANDA205232	GOLDEN STATE MEDICAL SUPPLY, INC.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-697_09bfd925-7cff-133e-e063-6294a90a9b81	51407-697	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200406		ANDA	ANDA205232	GOLDEN STATE MEDICAL SUPPLY, INC.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51407-721_026fb651-99eb-d7f7-e063-6394a90aed25	51407-721	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204921	Golden State Medical Supply, Inc.	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51407-722_026fb651-99eb-d7f7-e063-6394a90aed25	51407-722	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204921	Golden State Medical Supply, Inc.	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51407-723_026fb651-99eb-d7f7-e063-6394a90aed25	51407-723	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204921	Golden State Medical Supply, Inc.	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51407-724_026fb651-99eb-d7f7-e063-6394a90aed25	51407-724	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA204921	Golden State Medical Supply, Inc.	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51407-731_0d848feb-35e3-bf95-e063-6294a90a3353	51407-731	HUMAN PRESCRIPTION DRUG	Travoprost		travoprost	SOLUTION	OPHTHALMIC	20150710		ANDA	ANDA203431	Golden State Medical Supply, Inc.	TRAVOPROST	.04	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
51407-732_026fe333-0e9b-5720-e063-6394a90af94d	51407-732	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	19980330		ANDA	ANDA074823	Golden State Medical Supply, Inc.	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51407-733_026fe333-0e9b-5720-e063-6394a90af94d	51407-733	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	19980330		ANDA	ANDA074823	Golden State Medical Supply, Inc.	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51407-734_026fe333-0e9b-5720-e063-6394a90af94d	51407-734	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	19980330		ANDA	ANDA074823	Golden State Medical Supply, Inc.	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51407-735_026fe333-0e9b-5720-e063-6394a90af94d	51407-735	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	19980330		ANDA	ANDA074823	Golden State Medical Supply, Inc.	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51407-737_04178cdb-34f0-7d01-e063-6294a90a3bb3	51407-737	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		clobetasol propionate	SOLUTION	TOPICAL	20191002		ANDA	ANDA211494	Golden State Medical Supply, Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-738_f756ebc3-07b1-1291-e053-6394a90a313c	51407-738	HUMAN PRESCRIPTION DRUG	Trimethoprim		Trimethoprim	TABLET	ORAL	20221028		ANDA	ANDA216393	Golden State Medical Supply, Inc.	TRIMETHOPRIM	100	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51407-739_0d996701-2fad-2021-e063-6394a90a87db	51407-739	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20190819		ANDA	ANDA204562	Golden State Medical Supply, Inc.	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51407-740_0d996701-2fad-2021-e063-6394a90a87db	51407-740	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20190819		ANDA	ANDA204562	Golden State Medical Supply, Inc.	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51407-741_f7573809-771b-04c9-e053-6294a90ab193	51407-741	HUMAN PRESCRIPTION DRUG	Zileuton		zileuton	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212670	Golden State Medical Supply, Inc.	ZILEUTON	600	mg/1	5-Lipoxygenase Inhibitor [EPC], 5-Lipoxygenase Inhibitors [MoA], Decreased Leukotriene Production [PE]		N	20241231
51407-744_f82022a7-f7c6-fe9a-e053-6394a90ae7f8	51407-744	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20080429		NDA AUTHORIZED GENERIC	NDA021908	Golden State Medical Supply, Inc.	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
51407-745_f82022a7-f7c6-fe9a-e053-6394a90ae7f8	51407-745	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20060131		NDA AUTHORIZED GENERIC	NDA021908	Golden State Medical Supply, Inc.	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
51407-746_0e787c25-ca2d-514e-e063-6394a90a4cf5	51407-746	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220916		ANDA	ANDA202666	Golden State Medical Supply, Inc.	DEXLANSOPRAZOLE	30	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
51407-747_0e787c25-ca2d-514e-e063-6394a90a4cf5	51407-747	HUMAN PRESCRIPTION DRUG	Dexlansoprazole	delayed release	dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220916		ANDA	ANDA202666	Golden State Medical Supply, Inc.	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
51407-748_091fdfe2-76a8-c48e-e063-6394a90ad4fc	51407-748	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20200730		NDA	NDA212501	Golden State Medical Supply, Inc.	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
51407-749_091fdfe2-76a8-c48e-e063-6394a90ad4fc	51407-749	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20200730		NDA	NDA212501	Golden State Medical Supply, Inc.	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
51407-750_091fdfe2-76a8-c48e-e063-6394a90ad4fc	51407-750	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20211119		NDA	NDA212501	Golden State Medical Supply, Inc.	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
51407-754_0631dc59-4622-8f2d-e063-6294a90a1a7b	51407-754	HUMAN PRESCRIPTION DRUG	URSODIOL		ursodiol	CAPSULE	ORAL	20210122		ANDA	ANDA210344	Golden State Medical Supply, Inc.	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
51407-755_fa5a08db-c41c-5503-e053-6294a90a2a5a	51407-755	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA201962	Golden State Medical Supply, Inc.	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
51407-756_fa5a08db-c41c-5503-e053-6294a90a2a5a	51407-756	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA201962	Golden State Medical Supply, Inc.	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
51407-757_fa2eb9e8-060c-1de4-e053-6294a90ad01d	51407-757	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Golden State Medical Supply, Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-758_fa2eb9e8-060c-1de4-e053-6294a90ad01d	51407-758	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Golden State Medical Supply, Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-759_fa2eb9e8-060c-1de4-e053-6294a90ad01d	51407-759	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Golden State Medical Supply, Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-760_0ce4684a-4736-e669-e063-6394a90a58c1	51407-760	HUMAN PRESCRIPTION DRUG	sorafenib		sorafenib	TABLET, FILM COATED	ORAL	20221109		ANDA	ANDA209050	Golden State Medical Supply, Inc.	SORAFENIB	200	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
51407-765_fe08a2df-651b-bac7-e053-6294a90aaf20	51407-765	HUMAN PRESCRIPTION DRUG	Droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214017	Golden State Medical Supply, Inc.	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
51407-766_fe08a2df-651b-bac7-e053-6294a90aaf20	51407-766	HUMAN PRESCRIPTION DRUG	Droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214017	Golden State Medical Supply, Inc.	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
51407-767_fe08a2df-651b-bac7-e053-6294a90aaf20	51407-767	HUMAN PRESCRIPTION DRUG	Droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214017	Golden State Medical Supply, Inc.	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
51407-771_091a3056-e8ad-cd99-e063-6294a90a9083	51407-771	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20130328		ANDA	ANDA090011	Golden State Medical Supply, Inc.	AMLODIPINE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-772_091a3056-e8ad-cd99-e063-6294a90a9083	51407-772	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20130328		ANDA	ANDA090011	Golden State Medical Supply, Inc.	AMLODIPINE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-773_091a3056-e8ad-cd99-e063-6294a90a9083	51407-773	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20130328		ANDA	ANDA090011	Golden State Medical Supply, Inc.	AMLODIPINE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-774_091a3056-e8ad-cd99-e063-6294a90a9083	51407-774	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20130328		ANDA	ANDA090011	Golden State Medical Supply, Inc.	AMLODIPINE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51407-783_014152a7-2595-6a86-e063-6394a90a6a17	51407-783	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	19970228		ANDA	ANDA040204	Golden State Medical Supply, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51407-784_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-784	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-785_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-785	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-786_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-786	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-787_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-787	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-788_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-788	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-789_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-789	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-790_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-790	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-791_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-791	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-792_f75c281e-d7f8-3f6c-e053-6394a90a33a1	51407-792	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Golden State Medical Supply, Inc.	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51407-793_0942b76a-e1aa-e109-e063-6294a90a0f75	51407-793	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Golden State Medical Supply, Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-794_0942b76a-e1aa-e109-e063-6294a90a0f75	51407-794	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Golden State Medical Supply, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-795_0942b76a-e1aa-e109-e063-6294a90a0f75	51407-795	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Golden State Medical Supply, Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-796_0942b76a-e1aa-e109-e063-6294a90a0f75	51407-796	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Golden State Medical Supply, Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-797_0942b76a-e1aa-e109-e063-6294a90a0f75	51407-797	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Golden State Medical Supply, Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-798_0942b76a-e1aa-e109-e063-6294a90a0f75	51407-798	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Golden State Medical Supply, Inc.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-799_04cd6a7e-c606-7287-e063-6294a90abae6	51407-799	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181116		ANDA	ANDA209635	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-800_04cd6a7e-c606-7287-e063-6294a90abae6	51407-800	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-801_04cd6a7e-c606-7287-e063-6294a90abae6	51407-801	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-802_04cd6a7e-c606-7287-e063-6294a90abae6	51407-802	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-803_04cd6a7e-c606-7287-e063-6294a90abae6	51407-803	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Golden State Medical Supply, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-811_0828dd9c-8064-a99e-e063-6394a90ad915	51407-811	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	TABLET	ORAL	20230403		ANDA	ANDA214823	Golden State Medical Supply, Inc.	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-812_0828dd9c-8064-a99e-e063-6394a90ad915	51407-812	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	TABLET	ORAL	20230403		ANDA	ANDA214823	Golden State Medical Supply, Inc.	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51407-816_020bcc33-8883-713f-e063-6394a90a130d	51407-816	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Golden State Medical Supply, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51407-817_00627df4-ed37-e8f6-e063-6394a90af66a	51407-817	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Golden State Medical Supply, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-818_00627df4-ed37-e8f6-e063-6394a90af66a	51407-818	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Golden State Medical Supply, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-819_00627df4-ed37-e8f6-e063-6394a90af66a	51407-819	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Golden State Medical Supply, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51407-820_0ce49cc9-d7e9-f5f0-e063-6394a90abb29	51407-820	HUMAN PRESCRIPTION DRUG	Balsalazide Disodium		Balsalazide Disodium	CAPSULE	ORAL	20071228		ANDA	ANDA077806	Golden State Medical Supply, Inc.	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
51407-821_0e873d10-2aa0-7cfd-e063-6294a90a8d9e	51407-821	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20230601		ANDA	ANDA216782	Golden State Medical Supply, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
51407-824_07f29685-f1eb-8222-e063-6294a90a2680	51407-824	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180703		ANDA	ANDA205457	Golden State Medical Supply, Inc.	BUDESONIDE	9	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51407-825_0e876342-48a3-c5b6-e063-6394a90ab56a	51407-825	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	TOPICAL	19850403		ANDA	ANDA088803	Golden State Medical Supply, Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
51407-826_074ed3e5-7fe9-a81b-e063-6394a90afa79	51407-826	HUMAN PRESCRIPTION DRUG	Brenzavvy		Bexagliflozin	TABLET	ORAL	20230120		NDA	NDA214373	Golden State Medical Supply, Inc.	BEXAGLIFLOZIN	20	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
51407-827_0bef10ed-e48f-95ae-e063-6294a90a86eb	51407-827	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	19990319		NDA AUTHORIZED GENERIC	NDA020612	Golden State Medical Supply, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51407-828_074fb8a1-3ea1-0d6b-e063-6394a90aaf60	51407-828	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Golden State Medical Supply, Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51407-829_074f85b2-57bf-4455-e063-6294a90a0cbc	51407-829	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110718		ANDA	ANDA079013	Golden State Medical Supply, Inc.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51407-832_08b71fe4-c1ca-d186-e063-6294a90aed92	51407-832	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20190904		ANDA	ANDA208058	Golden State Medical Supply, Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-833_08b71fe4-c1ca-d186-e063-6294a90aed92	51407-833	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20190904		ANDA	ANDA208058	Golden State Medical Supply, Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51407-834_08673a85-a7d7-048c-e063-6294a90a1500	51407-834	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab	KIT		20230702		BLA	BLA761154	Golden State Medical Supply, Inc.						N	20241231
51407-835_08673a85-a7d7-048c-e063-6294a90a1500	51407-835	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab	KIT		20230702		BLA	BLA761154	Golden State Medical Supply, Inc.						N	20241231
51407-852_0d99abde-eaf8-8cc0-e063-6394a90a0836	51407-852	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20170816		ANDA	ANDA206261	Golden State Medical Supply, Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51407-853_0c05574c-f9b9-5d92-e063-6394a90a9d00	51407-853	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN		ERYTHROMYCIN	TABLET, DELAYED RELEASE	ORAL	20210726		ANDA	ANDA211975	Golden State Medical Supply, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
51407-854_0c05574c-f9b9-5d92-e063-6394a90a9d00	51407-854	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN		ERYTHROMYCIN	TABLET, DELAYED RELEASE	ORAL	20210726		ANDA	ANDA211975	Golden State Medical Supply, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
51407-855_0c05d68c-0f9e-50d9-e063-6294a90a1b4c	51407-855	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, COATED	ORAL	20200706		ANDA	ANDA212015	Golden State Medical Supply, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
51407-856_0c05d68c-0f9e-50d9-e063-6294a90a1b4c	51407-856	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, COATED	ORAL	20200706		ANDA	ANDA212015	Golden State Medical Supply, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
51414-101_f0031230-c4ce-612f-e053-2995a90a360e	51414-101	HUMAN OTC DRUG	aloe vera gel		ALOE VERA LEAF	GEL	TOPICAL	20140508		OTC MONOGRAPH NOT FINAL	part356	Yuyao Jessie Commodity Co.,Ltd.	ALOE VERA LEAF	5	g/100g			N	20241231
51414-103_f0033086-4ab3-b3e3-e053-2995a90ad171	51414-103	HUMAN OTC DRUG	antibacterial hand sanitizer		Benzalkonium Chloride	SPRAY	TOPICAL	20140227		OTC MONOGRAPH NOT FINAL	part333E	Yuyao Jessie Commodity Co.,Ltd.	BENZALKONIUM CHLORIDE	.4	g/100g			N	20241231
51414-104_f0032431-b082-39a9-e053-2995a90aa061	51414-104	HUMAN OTC DRUG	SPF30 sunscreen		Octinoxate,oxybenzone,OCTISALATE	SPRAY	TOPICAL	20120912		OTC MONOGRAPH NOT FINAL	part352	Yuyao Jessie Commodity Co.,Ltd.	OCTINOXATE; OCTISALATE; OXYBENZONE	7.5; 4; 4	g/100g; g/100g; g/100g			N	20241231
51414-105_f0036d99-1936-1b61-e053-2995a90aaff8	51414-105	HUMAN OTC DRUG	Mouthwash		Cetylpyridinium chloride	RINSE	DENTAL	20160110		OTC MONOGRAPH NOT FINAL	part356	Yuyao Jessie Commodity Co.,Ltd.	CETYLPYRIDINIUM CHLORIDE	.07	g/100g			N	20241231
51414-106_f0033086-4ab1-b3e3-e053-2995a90ad171	51414-106	HUMAN OTC DRUG	Insect Bite Relief		Hydrocortisone	SPRAY	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part348	Yuyao Jessie Commodity Co.,Ltd.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51414-107_f0033086-4ab2-b3e3-e053-2995a90ad171	51414-107	HUMAN OTC DRUG	1% Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20151201		OTC MONOGRAPH NOT FINAL	part348	Yuyao Jessie Commodity Co.,Ltd.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51414-300_e2ca51a4-c1a3-2294-e053-2995a90a23e6	51414-300	HUMAN OTC DRUG	LIP BALM		Avobenzone Octinoxate	OINTMENT	TOPICAL	20100919		OTC MONOGRAPH FINAL	part352	Yuyao Jessie Commodity Co., Ltd.	AVOBENZONE; OCTINOXATE	1.5; 6	g/100g; g/100g			N	20241231
51414-400_f0036d99-1937-1b61-e053-2995a90aaff8	51414-400	HUMAN OTC DRUG	antibacterial wet wipes		Benzalkonium Chloride	SWAB	TOPICAL	20120508		OTC MONOGRAPH NOT FINAL	part333A	Yuyao Jessie Commodity Co.,Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
51414-905_da8b7c91-74fb-3c9b-e053-2995a90ac715	51414-905	HUMAN OTC DRUG	SUNSCREEN		Octinoxate,ZINC OXIDE,OCTISALATE	STICK	TOPICAL	20140508		OTC MONOGRAPH NOT FINAL	part352	Yuyao Jessie Commodity Co.,Ltd.	OCTINOXATE; OCTISALATE; ZINC OXIDE	3; 3; 1	g/100g; g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
51414-906_da8b491b-bc8b-a5b1-e053-2a95a90acfad	51414-906	HUMAN OTC DRUG	Sunscreen		Octinoxate,oxybenzone,OCTISALATE,Titanium dioxide	LOTION	TOPICAL	20120912		OTC MONOGRAPH NOT FINAL	part352	Yuyao Jessie Commodity Co.,Ltd.	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	7; 4; 3; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
51414-907_da8b1d01-44f0-f1ef-e053-2995a90aa943	51414-907	HUMAN OTC DRUG	Sunscreen		Octocrylene ,Homosalate,Avobenzone,Octisalate	LOTION	TOPICAL	20120912		OTC MONOGRAPH NOT FINAL	part352	Yuyao Jessie Commodity Co.,Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
51414-908_da8b0f52-4c04-756f-e053-2995a90ab217	51414-908	HUMAN OTC DRUG	SPF15 LIP BALM		Avobenzone Octinoxate	OINTMENT	TOPICAL	20190104		OTC MONOGRAPH FINAL	part352	Yuyao Jessie Commodity Co.,Ltd.	OCTINOXATE; OCTISALATE; OXYBENZONE	7.5; 2; 3	g/100g; g/100g; g/100g			N	20241231
51414-909_da8b0f52-4c03-756f-e053-2995a90ab217	51414-909	HUMAN OTC DRUG	Pain Relieving Burn Gel		Burn Gel	GEL	TOPICAL	20190101		OTC MONOGRAPH FINAL	part346	Yuyao Jessie Commodity Co.,Ltd.	LIDOCAINE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51414-910_da8b04ef-9499-f29e-e053-2995a90a8405	51414-910	HUMAN OTC DRUG	SPF15 LIP BALM		Octocrylene,Octyl Salicylate	OINTMENT	TOPICAL	20200518		OTC MONOGRAPH FINAL	part352	Yuyao Jessie Commodity Co.,Ltd.	OCTISALATE; OCTOCRYLENE	4; 8	g/100g; g/100g			N	20241231
51414-912_da8ab831-a0ba-526b-e053-2a95a90a18ce	51414-912	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20201010		OTC MONOGRAPH NOT FINAL	part333A	Yuyao Jessie Commodity Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
51414-915_f57df9cc-5a3b-fc4c-e053-2995a90a08c3	51414-915	HUMAN OTC DRUG	antibacterial hand sanitizer		Alcohol	GEL	TOPICAL	20230225		OTC MONOGRAPH NOT FINAL	part333A	Yuyao Jessie Commodity Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
51414-916_f6a12ce8-2173-f26b-e053-6294a90a5bf9	51414-916	HUMAN OTC DRUG	antibacterial hand sanitizer		Alcohol	SPRAY	TOPICAL	20230225		OTC MONOGRAPH NOT FINAL	part333A	Yuyao Jessie Commodity Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
51417-0002_09c346bb-a6a3-5785-e063-6394a90a5709	51417-0002	HUMAN OTC DRUG	Clean Screen Mineral SPF30 Mattifying Face Sunscreen Broad Spectrum		ZINC OXIDE	CREAM	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	REN Ltd	ZINC OXIDE	220	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
51417-0003_0b58f5d5-37ca-da6e-e063-6394a90a804c	51417-0003	HUMAN OTC DRUG	REN Clean Favourites		ZINC OXIDE	KIT		20190901		OTC MONOGRAPH DRUG	M020	REN Ltd						N	20241231
51417-0005_09c36f46-85c7-57be-e063-6394a90a7f26	51417-0005	HUMAN OTC DRUG	Clearcalm Non-Drying Acne Treatment		SALICYLIC ACID	GEL	TOPICAL	20190601		OTC MONOGRAPH DRUG	M006	Ren Ltd.	SALICYLIC ACID	5	mg/mL			N	20241231
51452-036_0973ce0d-48e1-5977-e063-6394a90ad88e	51452-036	HUMAN OTC DRUG	Point Relief Cold Spot Pain Relieving		MENTHOL	GEL	TOPICAL	20190401		OTC MONOGRAPH DRUG	M017	Fabrication Enterprises	MENTHOL	120	mg/g			N	20241231
51452-037_0973b73d-5dde-0986-e063-6294a90a5917	51452-037	HUMAN OTC DRUG	Point Relief cold Spot Pain Relieving roll-on		MENTHOL	LIQUID	TOPICAL	20190401		OTC MONOGRAPH DRUG	M017	Fabrication Enterprises	MENTHOL	140	mg/mL			N	20241231
51452-912_f204f9db-04d2-5c3a-e053-2995a90a7eb3	51452-912	HUMAN OTC DRUG	Point Relief LidoSpot with Menthol		Lidocaine, Menthol	PATCH	TOPICAL	20180701		OTC MONOGRAPH NOT FINAL	part348	Fabrication Enterprises	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51457-000_09d7052e-ec73-ef60-e063-6294a90af214	51457-000	HUMAN OTC DRUG	Alo Therapeutic Massage		MENTHOL, HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20120607		OTC MONOGRAPH DRUG	M017	Theraplex Solutions	HISTAMINE DIHYDROCHLORIDE; MENTHOL	.1; 3	g/100g; g/100g			N	20241231
51457-001_09d72589-13fd-349f-e063-6294a90a4d95	51457-001	HUMAN OTC DRUG	ALO THERAPEUTIC MASSAGE PAIN RELIEVING		MENTHOL, HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20130320		OTC MONOGRAPH DRUG	M017	Theraplex Solutions	HISTAMINE DIHYDROCHLORIDE; MENTHOL	.1; 3	g/100g; g/100g			N	20241231
51467-005_db1a6f3b-9211-41b9-bcd4-c546d28d1f02	51467-005	HUMAN OTC DRUG	COLTALIN		Acetaminophen, Chlorpheniramine maleate, Phenylephrine hydrochloride	TABLET	ORAL	20040301		OTC MONOGRAPH FINAL	part341	FORTUNE PHARMACAL COMPANY LIMITED	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51467-006_058a8bec-3971-47b2-b62b-e041bfb41b9c	51467-006	HUMAN OTC DRUG	CHILDRENS COLTALIN		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE	TABLET, CHEWABLE	ORAL	20040301		OTC MONOGRAPH FINAL	part341	FORTUNE PHARMACAL COMPANY LIMITED	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	80; .5; 1.25	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51467-007_555ea231-0265-47e7-b038-438b715df76b	51467-007	HUMAN OTC DRUG	COLTALIN-DM		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20040301		OTC MONOGRAPH FINAL	part341	FORTUNE PHARMACAL COMPANY LIMITED	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51467-008_fd95787b-2091-4143-885d-ebe68055f9a5	51467-008	HUMAN OTC DRUG	COLTALIN-ND		ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20040301		OTC MONOGRAPH FINAL	part341	FORTUNE PHARMACAL COMPANY LIMITED	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51467-009_598d6bd5-7cea-4f3e-bd40-2d7cbc2f49d5	51467-009	HUMAN OTC DRUG	EXCAUGH		Guaifenesin	TABLET	ORAL	20160426		OTC MONOGRAPH FINAL	part341	FORTUNE PHARMACAL COMPANY, LIMITED	GUAIFENESIN	100	mg/1			N	20241231
51467-010_f1a3a75a-b454-4cdd-b982-96fae5372386	51467-010	HUMAN OTC DRUG	Extra Fast Coltalin		Acetaminophen, Chlorpheniramine maleate, Phenylephrine hydrochloride	TABLET	ORAL	20170404		OTC MONOGRAPH FINAL	part341	FORTUNE PHARMACAL COMPANY LIMITED	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51467-100_2a111c73-7bca-4f5c-9caf-196d2db754b2	51467-100	HUMAN OTC DRUG	MAGSIL ANTACID (LEMON MINT)		Aluminum Hydroxide Dried Gel, Magnesium Hydroxide, and Simethicone	TABLET, CHEWABLE	ORAL	20170920		OTC MONOGRAPH FINAL	part331	FORTUNE PHARMACAL COMPANY LIMITED	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 21; 200	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51467-101_b44d3b25-671a-4a8d-87a5-62cd4b71b2a6	51467-101	HUMAN OTC DRUG	SPRINSOL		Chlorpheniramine maleate	TABLET	ORAL	20170922		OTC MONOGRAPH FINAL	part341	FORTUNE PHARMACAL COMPANY LIMITED	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51475-001_082d19fb-1811-4e7d-e063-6294a90a388f	51475-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070522		UNAPPROVED MEDICAL GAS		Baird Respiratory Therapy, Inc.	OXYGEN	99	L/100L			N	20241231
51486-002_076103a1-a40d-4bd1-e063-6394a90aab28	51486-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20100101		NDA	NDA205866	ILMO Products Company	NITROGEN	990	mL/L			N	20241231
51486-005_0761299a-e915-7665-e063-6394a90a6003	51486-005	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20120501		NDA	NDA205852	ILMO Products Company	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
51486-007_07610e87-e109-c8e2-e063-6294a90a4b39	51486-007	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20120501		NDA	NDA206009	ILMO Products Company	NITROUS OXIDE	990	mL/L			N	20241231
51486-018_07612f65-6233-5254-e063-6294a90ae02f	51486-018	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20090101		NDA	NDA205865	ILMO Products Company	OXYGEN	210	mL/L			N	20241231
51486-020_0761147f-1336-606e-e063-6394a90abd5d	51486-020	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	20190902		NDA	NDA213990	ILMO Products Company	HELIUM	990	mL/L			N	20241231
51486-720_07db7c07-1db8-9494-e063-6294a90a0c53	51486-720	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205865	ILMO Products Company	OXYGEN	990	mL/L			N	20241231
51511-596_de5c73a8-a549-36e7-e053-2a95a90a357f	51511-596	HUMAN OTC DRUG	Salicylic Acid Wart Remover		Salicylic Acid	STRIP	TOPICAL	20090201		OTC MONOGRAPH FINAL	part358H	ASO Pharmaceutical Co. Ltd.	SALICYLIC ACID	40	mg/1			N	20241231
51514-0332_f23abcad-41ef-193e-e053-2a95a90a0ffd	51514-0332	HUMAN OTC DRUG	Josie Maran Argan Daily Moisturizer SPF47		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20140109		OTC MONOGRAPH DRUG	M020	Autumn Harp, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	5.1; 6.4	mg/100mL; mg/100mL			N	20241231
51514-0337_f2162166-3d54-392f-e053-2a95a90a8fc1	51514-0337	HUMAN OTC DRUG	Josie Maran Argan Daily Moisturizer SPF47 Protect and Perfect		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20140124		OTC MONOGRAPH DRUG	M020	Autumn Harp, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	5.9; 9.4	mg/100mL; mg/100mL			N	20251231
51514-0342_f23ad3c1-5d73-6c65-e053-2a95a90a0d1f	51514-0342	HUMAN OTC DRUG	Vitamin E SPF15 Lip Balm		Avobenzone, Octisalate, Octocrylene	STICK	TOPICAL	20130313		OTC MONOGRAPH DRUG	M020	Autumn Harp, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2; 5; 3	g/100g; g/100g; g/100g			N	20241231
51514-0356_f2143810-412a-0f93-e053-2a95a90a053a	51514-0356	HUMAN OTC DRUG	Benefit Weightless Moisture Face Moisturizer Broad Spectrum SPF 15 Sunscreen		Octocrylene, Homosalate, Avobenzone	LOTION	TOPICAL	20200301		OTC MONOGRAPH DRUG	M020	Autumn Harp, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.5; 3; 4	mg/100mg; mg/100mg; mg/100mg			N	20241231
51514-0357_f1efbede-120a-4d12-e053-2995a90a0d82	51514-0357	HUMAN OTC DRUG	Tinted Lip Balm SPF30 Wild Peony		SPF30 Lip Balm	STICK	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Autumn Harp	ZINC OXIDE	19	g/100g			N	20241231
51514-0358_f1efc0bf-e09c-4b70-e053-2995a90a53dd	51514-0358	HUMAN OTC DRUG	Tinted Lip Balm SPF30 Sienna Rose		SPF30 Lip Balm	STICK	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Autumn Harp	ZINC OXIDE	19	g/100g			N	20241231
51514-0360_f5744a48-2b3a-4949-e053-2a95a90ab15d	51514-0360	HUMAN OTC DRUG	Bath and Body Works SPF20 Coconut Lip Balm		SPF20 Lip Balm	STICK	TOPICAL	20220201		OTC MONOGRAPH DRUG	M020	Autumn Harp	AVOBENZONE; HOMOSALATE; OCTISALATE	2.5; 10; 5	mg/100mg; mg/100mg; mg/100mg			N	20241231
51514-0361_fd6807e1-c8c1-b361-e053-6294a90aea0c	51514-0361	HUMAN OTC DRUG	Sheer Tint Mineral Sunscreen Broad Spectrum SPF 50 - Light/Medium Shade		SPF 50 Sunscreen Broad Spectrum - Light/Medium Shade	LOTION	TOPICAL	20230715		OTC MONOGRAPH DRUG	M020	Autumn Harp	TITANIUM DIOXIDE; ZINC OXIDE	2.37; 13.35	g/100g; g/100g			N	20241231
51514-0362_fd6807e1-c8c1-b361-e053-6294a90aea0c	51514-0362	HUMAN OTC DRUG	Sheer Tint Mineral Sunscreen Broad Spectrum SPF 50 - Medium/Deep Shade		SPF 50 Sunscreen Broad Spectrum - Medium/Deep Shade	LOTION	TOPICAL	20230715		OTC MONOGRAPH DRUG	M020	Autumn Harp	TITANIUM DIOXIDE; ZINC OXIDE	2.37; 13.35	g/100g; g/100g			N	20241231
51514-0363_01df9746-991c-4363-e063-6294a90aaac6	51514-0363	HUMAN OTC DRUG	Barrier Balm		Barrier Balm	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M016	Autumn Harp, Inc.	DIMETHICONE 20; PETROLATUM	13; 41.9	g/100g; g/100g			N	20241231
51514-0364_f2619092-3e80-5105-e053-2a95a90a3f5a	51514-0364	HUMAN OTC DRUG	Prime Time Daily Protecting Primer SPF 30		SPF 30 Prime Time Primer	LOTION	TOPICAL	20230102		OTC MONOGRAPH DRUG	M020	Autumn Harp Inc.	TITANIUM DIOXIDE; ZINC OXIDE	3.13; 10.49	g/100g; g/100g			N	20251231
51525-0112_ba8fed77-5c19-474f-8daf-79ff7157b60e	51525-0112	HUMAN PRESCRIPTION DRUG	Hyoscyamine		hyoscyamine sulfate	TABLET	ORAL	20160401		UNAPPROVED DRUG OTHER		Wallace Pharmaceuticals Inc.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
51525-0113_7bf0f72a-6712-4609-bf8f-ae5a9b0de739	51525-0113	HUMAN PRESCRIPTION DRUG	Hyoscyamine	SL	hyoscyamine sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20160415	20240131	UNAPPROVED DRUG OTHER		Wallace Pharmaceuticals Inc.	HYOSCYAMINE SULFATE	.125	mg/1			N	
51525-0115_a627db34-75b8-4fda-8a8e-9450924eacec	51525-0115	HUMAN PRESCRIPTION DRUG	Hyoscyamine	ER	hyoscyamine sulfate	TABLET, EXTENDED RELEASE	ORAL	20160501		UNAPPROVED DRUG OTHER		Wallace Pharmaceuticals Inc.	HYOSCYAMINE SULFATE	.375	mg/1			N	20241231
51525-0430_525ae813-9695-47a8-8f75-9a3abadd3b50	51525-0430	HUMAN PRESCRIPTION DRUG	Felbamate		felbamate	TABLET	ORAL	20111111		NDA AUTHORIZED GENERIC	NDA020189	Wallace Pharmaceuticals Inc.	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51525-0431_525ae813-9695-47a8-8f75-9a3abadd3b50	51525-0431	HUMAN PRESCRIPTION DRUG	Felbamate		felbamate	TABLET	ORAL	20111111		NDA AUTHORIZED GENERIC	NDA020189	Wallace Pharmaceuticals Inc.	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51525-0442_525ae813-9695-47a8-8f75-9a3abadd3b50	51525-0442	HUMAN PRESCRIPTION DRUG	Felbamate		felbamate	SUSPENSION	ORAL	20111123		NDA AUTHORIZED GENERIC	NDA020189	Wallace Pharmaceuticals Inc.	FELBAMATE	600	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51525-0470_1cc1763b-778f-46c1-9379-aac3fbb7a61b	51525-0470	HUMAN PRESCRIPTION DRUG	cromolyn sodium		cromolyn sodium	SOLUTION	ORAL	20151021		NDA AUTHORIZED GENERIC	NDA020479	Wallace Pharmaceuticals Inc.	CROMOLYN SODIUM	20	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
51525-5901_405a8c9e-40b7-4179-9f0e-c55460a60a54	51525-5901	HUMAN PRESCRIPTION DRUG	Carisoprodol		carisoprodol	TABLET	ORAL	20100701		NDA AUTHORIZED GENERIC	NDA011792	Wallace Pharmaceuticals Inc.	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
51531-0288_eac42a75-e947-5a23-e053-2995a90a17a9	51531-0288	HUMAN OTC DRUG	MKMen Advanced Facial Hydrator Sunscreen SPF 30		avobenzone, homosalate, octisalate, octocrylene, oxybenzone	LOTION	TOPICAL	20130516		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 5; 5; 2; 4	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
51531-0549_013e5cbb-6188-fa59-e063-6294a90aab21	51531-0549	HUMAN OTC DRUG	Mary Kay TimeWise Repair Volu-Firm Day Cream Broad Spectrum SPF 30		avobenzone, homosalate, octisalate, octocrylene, oxybenzone	CREAM	TOPICAL	20190516		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 9; 4.5; 4; 4.5	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
51531-0850_eab4a7a6-b3f2-0e2f-e053-2a95a90a4bdf	51531-0850	HUMAN OTC DRUG	Mary Kay Foundation Primer		avobenzone, homosalate, octisalate, octocrylene	GEL	TOPICAL	20120301		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.5; 9; 5; 3	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
51531-1349_013e39e5-b0d2-e359-e063-6294a90a0ef2	51531-1349	HUMAN OTC DRUG	Clear Proof Clarifying Cleansing Gel	Acne Medication	Salicylic Acid	GEL	TOPICAL	20130815		OTC MONOGRAPH FINAL	M006	Mary Kay Inc.	SALICYLIC ACID	2	g/100g			N	20241231
51531-1606_ef413b00-5c40-5d89-e053-2995a90ab575	51531-1606	HUMAN OTC DRUG	Mary Kay TimeWise Repair Volu-Firm Sampler Set		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	KIT		20190816		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.						N	20241231
51531-1614_ef413ee0-029c-2afd-e053-2a95a90a9db0	51531-1614	HUMAN OTC DRUG	Mary Kay TimeWise Repair Volu-Firm The Go Set		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	KIT		20190816		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.						N	20241231
51531-2822_013ef0a1-6f80-8e8b-e063-6294a90aa3a1	51531-2822	HUMAN OTC DRUG	Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Very Light		homosalate, octinoxate, oxybenzone	CREAM	TOPICAL	20140216		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	HOMOSALATE; OCTINOXATE; OXYBENZONE	5; 6.5; 1.2	g/100mL; g/100mL; g/100mL			N	20241231
51531-2823_013ebe71-4de6-b13d-e063-6394a90a974e	51531-2823	HUMAN OTC DRUG	Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Light to Medium		homosalate, octinoxate, oxybenzone	CREAM	TOPICAL	20140216		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	HOMOSALATE; OCTINOXATE; OXYBENZONE	5; 6.5; 1.2	g/100mL; g/100mL; g/100mL			N	20241231
51531-2824_013ec91b-a242-fd47-e063-6294a90ad9af	51531-2824	HUMAN OTC DRUG	Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Medium to Deep		homosalate, octinoxate, oxybenzone	CREAM	TOPICAL	20140216		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	HOMOSALATE; OCTINOXATE; OXYBENZONE	5; 6.5; 1.2	g/100mL; g/100mL; g/100mL			N	20241231
51531-2825_013eb954-ae59-dc57-e063-6394a90a5a8e	51531-2825	HUMAN OTC DRUG	Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Deep		homosalate, octinoxate, oxybenzone	CREAM	TOPICAL	20140216		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	HOMOSALATE; OCTINOXATE; OXYBENZONE	5; 6.5; 1.2	g/100mL; g/100mL; g/100mL			N	20241231
51531-5604_0e8814e5-056a-eef6-e063-6394a90a23cd	51531-5604	HUMAN OTC DRUG	Mary Kay TimeWise Miracle Set 3D Sampler (Normal to Dry Skin)		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	KIT		20180516	20250219	OTC MONOGRAPH DRUG	M020	Mary Kay Inc.						N	
51531-5607_0e892178-162e-bfab-e063-6294a90a6b48	51531-5607	HUMAN OTC DRUG	Mary Kay TimeWise Miracle Set 3D Sampler (Combo to Oily Skin)		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	KIT		20180516	20250214	OTC MONOGRAPH DRUG	M020	Mary Kay Inc.						N	
51531-6620_013e9c84-8e25-d486-e063-6294a90a4c92	51531-6620	HUMAN OTC DRUG	Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Very Deep		homosalate, octinoxate, oxybenzone	CREAM	TOPICAL	20160216		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	HOMOSALATE; OCTINOXATE; OXYBENZONE	5; 6.5; 1.2	g/100mL; g/100mL; g/100mL			N	20241231
51531-6743_e95a84ea-0cd2-27a8-e053-2995a90ae78c	51531-6743	HUMAN OTC DRUG	Clear Proof Blemish Control Toner	Acne Medication	Salicylic Acid	LIQUID	TOPICAL	20130815		OTC MONOGRAPH FINAL	M006	Mary Kay Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
51531-7385_066e8cee-5a1c-d31f-e063-6394a90a7687	51531-7385	HUMAN OTC DRUG	Mary Kay TimeWise Daytime Defender Sunscreen Broad Spectrum SPF 30		Avobenzone/Octisalate/Octocrylene	LOTION	TOPICAL	20230720		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 4.5; 9	g/100g; g/100g; g/100g			N	20241231
51531-8434_ef402b0e-809f-530f-e053-2995a90acd2a	51531-8434	HUMAN OTC DRUG	Mary Kay TimeWise Repair Volu-Firm Set		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	KIT		20190816		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.						N	20241231
51531-8735_b6c2b979-2941-1569-e053-2995a90a532c	51531-8735	HUMAN OTC DRUG	Mary Kay Satin Hands Shea Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333A	Mary Kay Inc.	ALCOHOL	75	mL/100mL			N	20241231
51531-8968_e95be11f-3b8f-722d-e053-2a95a90a4fb3	51531-8968	HUMAN OTC DRUG	Clear Proof Acne System The Go Set		Benzoyl Peroxide and Salicylic Acid	KIT		20130815		OTC MONOGRAPH FINAL	M006	Mary Kay Inc.						N	20241231
51531-8977_e95b95bb-416f-7502-e053-2a95a90aeb24	51531-8977	HUMAN OTC DRUG	Clear Proof Acne System		Benzoyl Peroxide and Salicylic Acid	KIT		20130815		OTC MONOGRAPH FINAL	M006	Mary Kay Inc.						N	20241231
51531-9004_013f0a11-2a60-bf9f-e063-6294a90a2b19	51531-9004	HUMAN OTC DRUG	Mary Kay TimeWise Age Minimize 3D Day Cream SPF 30 Broad Spectrum Sunscreen (Normal to Dry Skin)		avobenzone, homosalate, octisalate, octocrylene, oxybenzone	CREAM	TOPICAL	20180516		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 9; 4.5; 3; 4.5	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
51531-9005_013f12a8-05ef-73e7-e063-6294a90a4f5b	51531-9005	HUMAN OTC DRUG	Mary Kay TimeWise Age Minimize 3D Day Cream SPF 30 Broad Spectrum Sunscreen (Combo to Oily Skin)		avobenzone, homosalate, octisalate, octocrylene, oxybenzone	CREAM	TOPICAL	20180516		OTC MONOGRAPH FINAL	M020	Mary Kay Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 9; 4.5; 3; 4.5	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
51531-9020_0e75e818-8de4-59e4-e063-6394a90a6704	51531-9020	HUMAN OTC DRUG	Mary Kay TimeWise Miracle Set 3D The Go Set (Combo to Oily Skin)		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	KIT		20180516	20260731	OTC MONOGRAPH DRUG	M020	Mary Kay Inc.						N	
51531-9021_0d97538a-cfce-76a2-e063-6394a90af0c0	51531-9021	HUMAN OTC DRUG	Mary Kay TimeWise Miracle Set 3D The Go Set (Normal to Dry Skin)		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	KIT		20180516	20251107	OTC MONOGRAPH DRUG	M020	Mary Kay Inc.						N	
51531-9071_e959da7c-3755-681e-e053-2a95a90abcd3	51531-9071	HUMAN OTC DRUG	Clear Proof Acne Treatment	Acne Medication	Benzoyl Peroxide	GEL	TOPICAL	20120615		OTC MONOGRAPH FINAL	M006	Mary Kay Inc.	BENZOYL PEROXIDE	5	g/100g			N	20241231
51532-3806_20d65482-3be7-4f8a-b18c-c5d9f4ac34c7	51532-3806	HUMAN OTC DRUG	Afassco Burn Gel		LIDOCAINE	GEL	TOPICAL	20190825		OTC MONOGRAPH FINAL	part346	Afassco Inc.	LIDOCAINE	70	mg/3.5g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51532-4605_95fe9fe5-ec60-44b8-b9e8-2500dd28e024	51532-4605	HUMAN OTC DRUG	Afassco Triple Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20181207		OTC MONOGRAPH FINAL	part333B	Afassco Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
51532-4608_92af3a7d-2f36-4eff-81c0-3a9ed607527c	51532-4608	HUMAN OTC DRUG	AFASSCO 1% Hydrocortisone		HYDROCORTISONE	OINTMENT	TOPICAL	20181207		OTC MONOGRAPH NOT FINAL	part348	Afassco Inc.	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51532-5300_f5940692-ef5c-492d-9d0b-c8c477eebb50	51532-5300	HUMAN OTC DRUG	Antiseptic		benzalkonium chloride, benzocaine	SPRAY	TOPICAL	20120709		OTC MONOGRAPH NOT FINAL	part333A	Afassco Inc.	BENZALKONIUM CHLORIDE; BENZOCAINE	1; 50	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
51628-0030_092c06e0-65b1-cea9-e063-6394a90a9d93	51628-0030	HUMAN OTC DRUG	American Red Cross 70 Isopropyl Alcohol		ISOPROPYL ALCOHOL	AEROSOL, SPRAY	TOPICAL	20231101		OTC MONOGRAPH DRUG	M003	My Imports Usa, LLC	ISOPROPYL ALCOHOL	70	mL/100g			N	20241231
51628-0031_092d62e1-199a-60e2-e063-6394a90a7eb3	51628-0031	HUMAN OTC DRUG	American Red Cross 70 Isopropyl Alcohol with Continuous Nitrogen Gas		ISOPROPYL ALCOHOL	AEROSOL, SPRAY	TOPICAL	20231101		OTC MONOGRAPH DRUG	M003	My Imports Usa, LLC	ISOPROPYL ALCOHOL	70	mL/100g			N	20241231
51628-0032_092f94af-937e-26d4-e063-6394a90a386c	51628-0032	HUMAN OTC DRUG	American Red Cross 91 Isopropyl Alcohol with Continuous Nitrogen Gas		ISOPROPYL ALCOHOL	AEROSOL, SPRAY	TOPICAL	20231101		OTC MONOGRAPH DRUG	M003	My Imports Usa, LLC	ISOPROPYL ALCOHOL	91	mL/100g			N	20241231
51628-0033_0d0b3755-9f0b-026d-e063-6294a90ac96c	51628-0033	HUMAN OTC DRUG	Xtra Antibacterial Hand Juicy Orange		CHLOROXYLENOL	GEL	TOPICAL	20231201		OTC MONOGRAPH DRUG	505G(a)(3)	MY IMPORTS USA, LLC	CHLOROXYLENOL	3	mg/mL			N	20241231
51628-1015_ac93f426-94af-59f3-e053-2995a90abcb5	51628-1015	HUMAN OTC DRUG	AMORAY 70% ISOPROPYL RUBBING ALCOHOL		Isopropyl Alcohol	LIQUID	TOPICAL	20200811		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORT USA INC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51628-1016_ac93f7ba-8576-0747-e053-2a95a90a752b	51628-1016	HUMAN OTC DRUG	AMORAY 70% ISOPROPYL RUBBING ALCOHOL WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200811		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORT USA INC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51628-4232_d8c1f5ef-4caa-ba16-e053-2995a90adb50	51628-4232	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 50%		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
51628-4233_d85bbf0b-edfb-4e21-e053-2a95a90ab0ed	51628-4233	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 50% WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	My Imports USA, LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
51628-4234_ddb57bf2-c0ae-ae2b-e053-2995a90acaa0	51628-4234	HUMAN OTC DRUG	AMERICAN REDCROSS 70% ISOPROPYL RUBBING ALCOHOL		Isopropyl Alcohol	LIQUID	TOPICAL	20200811		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS USA LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51628-4235_ddb57bf2-c0a0-ae2b-e053-2995a90acaa0	51628-4235	HUMAN OTC DRUG	AMERICAN REDCROSS 70% ISOPROPYL RUBBING ALCOHOL WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200811		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS USA LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
51628-4236_de481072-a6db-6784-e053-2995a90ad5ab	51628-4236	HUMAN OTC DRUG	91% Isopropyl Rubbing Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20210114		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS USA LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
51628-4237_ddafe1eb-9553-cd21-e053-2995a90ad402	51628-4237	HUMAN OTC DRUG	AMERICAN REDCROSS 91% ISOPROPYL RUBBING ALCOHOL WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200811		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS USA LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
51628-4238_de46f796-db9c-68c5-e053-2a95a90a871d	51628-4238	HUMAN OTC DRUG	American Red Cross 3 Hydrogen Peroxide		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20210110		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS USA LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
51628-4239_de47a879-9cd1-5fbb-e053-2a95a90a1fba	51628-4239	HUMAN OTC DRUG	American Red Cross 50% Isopropyl Rubbing Alcohol		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20220310		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS USA LLC	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
51628-4240_de7a9b21-b04b-5686-e053-2995a90a2d42	51628-4240	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 50% WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20220505		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORTS USA, LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
51628-4433_f72dfac5-4b9a-8a58-e053-6294a90ada4c	51628-4433	HUMAN OTC DRUG	American Red Cross 70% Ethyl Alcohol Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20230313		OTC MONOGRAPH NOT FINAL	part333A	MY IMPORT USA LLC	ALCOHOL	70	mL/100mL			N	20241231
51655-006_f29ef945-b32d-48a7-e053-2a95a90a4bf4	51655-006	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20220711		ANDA	ANDA075479	Northwind Pharmaceuticals, LLC	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-007_f29f378b-4628-49b0-e053-2995a90a29d1	51655-007	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20220805		UNAPPROVED DRUG OTHER		Northwind Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
51655-008_f29f4e6c-8dc4-d573-e053-2995a90acb11	51655-008	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20220808		ANDA	ANDA078152	Northwind Pharmaceuticals, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-009_f5b689a2-7be8-08bc-e053-2995a90a68ce	51655-009	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20140507		ANDA	ANDA076509	Northwind Pharmaceuticals	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51655-015_fe0673e0-aef8-4916-e053-6294a90a0085	51655-015	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150225		ANDA	ANDA075022	Northwind Pharmaceuticals, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
51655-016_f29f8ae1-4827-d8eb-e053-2a95a90a691a	51655-016	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20220808		ANDA	ANDA078539	Northwind Pharmaceuticals, LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-020_f29ff436-5eff-1376-e053-2995a90a769a	51655-020	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20220811		ANDA	ANDA074185	Northwind Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51655-029_f30401c1-9620-44dd-e053-2a95a90a69d6	51655-029	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20150209		ANDA	ANDA077614	Northwind Pharmaceuticals, LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51655-030_f2a06c6f-a8c1-55af-e053-2995a90ac93e	51655-030	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20220323		ANDA	ANDA077614	Northwind Pharmaceuticals	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51655-031_f3041fac-ff84-6f53-e053-2a95a90ac026	51655-031	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20150209		ANDA	ANDA070848	Northwind Pharmaceuticals, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
51655-033_0817a373-ed83-f7fb-e063-6294a90a2259	51655-033	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20200929		ANDA	ANDA078251	Northwind Pharmaceuticals, LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51655-034_f2a0407c-2e06-60eb-e053-2a95a90abc99	51655-034	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20220809		ANDA	ANDA077614	Northwind Pharmaceuticals, LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51655-042_ff9730da-776d-1902-e053-6394a90a015d	51655-042	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220909		ANDA	ANDA091625	Northwind Pharmaceuticals, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-043_f7e4a4d2-989b-41a8-e053-6294a90aa6be	51655-043	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20210324		ANDA	ANDA078216	Northwind Pharmaceuticals	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-048_f2a0ac76-9d92-eaad-e053-2a95a90a4d67	51655-048	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200520		ANDA	ANDA091625	Northwind Pharmaceuticals	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-058_f7f7d359-8bde-a596-e053-6294a90a79c0	51655-058	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20220711		ANDA	ANDA075479	Northwind Pharmaceuticals, LLC	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-059_f874eded-171f-9e86-e053-6294a90a49f9	51655-059	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20230303		ANDA	ANDA207446	Northwind Pharmaceuticals, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-060_f5f0036c-a710-be96-e053-2995a90a9fdb	51655-060	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20220907		ANDA	ANDA207446	Northwind Pharmaceuticals, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-062_fe0673e0-aef9-4916-e053-6294a90a0085	51655-062	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220927		ANDA	ANDA208898	Northwind Pharmaceuticals, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-063_f2a13ac8-88b0-1530-e053-2a95a90a8bb1	51655-063	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20220927		ANDA	ANDA206693	Northwind Pharmaceuticals, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-065_e324a3ad-44da-5e73-e053-2a95a90ab3ff	51655-065	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20160623		ANDA	ANDA076118	Northwind Pharmaceuticals	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-066_e325b646-779b-c626-e053-2995a90a053b	51655-066	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20160304		ANDA	ANDA076118	Northwind Pharmaceuticals	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-068_05429a4a-5b0c-536c-e063-6294a90ad7dc	51655-068	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220928		ANDA	ANDA209727	Northwind Pharmaceuticals, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-070_f2a18ecb-07dc-e54d-e053-2995a90a8745	51655-070	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20220928		ANDA	ANDA076056	Northwind Pharmaceuticals, LLC	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-073_f3045b65-c9d0-f423-e053-2995a90ad9e4	51655-073	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20141112		ANDA	ANDA076056	Northwind Pharmaceuticals, LLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-075_f2a1af50-a052-3e55-e053-2a95a90a9184	51655-075	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20220927		ANDA	ANDA202038	Northwind Pharmaceuticals, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51655-076_f7f8194e-539b-a25b-e053-6294a90a8b50	51655-076	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20201020		ANDA	ANDA204279	Northwind Pharmaceuticals, LLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-077_fc4c5b2e-aa0b-40f5-e053-6294a90a016d	51655-077	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20221005		ANDA	ANDA206145	Northwind Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51655-080_054299e7-5013-39bb-e063-6294a90a33be	51655-080	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20201210		ANDA	ANDA204279	Northwind Pharmaceuticals, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-081_f2a4aa87-7994-a064-e053-2995a90aaf63	51655-081	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20221004		ANDA	ANDA075465	Northwind Pharmaceuticals, LLC	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-082_f67d5b96-c354-0f47-e053-2a95a90af1a2	51655-082	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230306		ANDA	ANDA071450	Northwind Pharmaceuticals, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51655-084_f67da2bb-5624-1f9c-e053-2995a90a0340	51655-084	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230306		ANDA	ANDA213999	Northwind Pharmaceuticals, LLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51655-085_f3047e8a-4977-1135-e053-2995a90a2870	51655-085	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20140601		ANDA	ANDA091179	Northwind Pharmaceuticals, LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51655-086_ff0e4e97-8f03-bd36-e053-6394a90a47ae	51655-086	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA076558	Northwind Pharmaceuticals, LLC	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
51655-087_f2a530bd-6a87-251d-e053-2995a90adac4	51655-087	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221004		ANDA	ANDA079060	Northwind Pharmaceuticals, LLC	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-088_f6dd070c-8cf9-c8ab-e053-6294a90ac060	51655-088	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230306		ANDA	ANDA087059	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-098_f9887fb5-ffd9-a466-e053-6294a90a6fa7	51655-098	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220906		ANDA	ANDA090693	Northwind Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51655-102_e326b6fb-d31f-33f3-e053-2a95a90a2518	51655-102	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20140825		ANDA	ANDA075511	Northwind Pharmaceuticals	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51655-104_0864ecf0-4b11-715e-e063-6294a90a1778	51655-104	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20220909		ANDA	ANDA078512	Northwind Pharmaceuticals, LLC	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
51655-106_0cce6a38-f9f1-5382-e063-6294a90a5672	51655-106	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20141230		ANDA	ANDA075795	Northwind Pharmaceuticals, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-107_0d81ec65-060d-47aa-e063-6294a90ae256	51655-107	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20140724		ANDA	ANDA040659	Northwind Pharmaceuticals, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20251231
51655-109_f2b354b4-2a9a-6c41-e053-2a95a90a7891	51655-109	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20220819		ANDA	ANDA202824	Northwind Pharmaceuticals, LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-110_f2b377b9-fdae-77d8-e053-2a95a90a193d	51655-110	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20220907		ANDA	ANDA075479	Northwind Pharmaceuticals, LLC	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-113_0de5b56f-e1bb-9787-e063-6394a90a3559	51655-113	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA078034	Northwind Pharmaceuticals, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
51655-115_f2b39343-cf61-faf8-e053-2a95a90ae84f	51655-115	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20221005		ANDA	ANDA211347	Northwind Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51655-116_f2b3b385-658e-5918-e053-2a95a90afcba	51655-116	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20220711		ANDA	ANDA078032	Northwind Pharmaceuticals, LLC	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-118_063163ca-25d9-6156-e063-6294a90a949f	51655-118	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20140601		ANDA	ANDA076639	Northwind Pharmaceuticals, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
51655-119_f2b3d15f-d73d-9dd1-e053-2a95a90a6bb0	51655-119	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20220816		ANDA	ANDA204279	Northwind Pharmaceuticals, LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-120_f2b3e5d4-8ae1-acfc-e053-2a95a90a4b30	51655-120	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20141229		ANDA	ANDA078181	Northwind Pharmaceuticals, LLC	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-121_f304d8da-3d24-7ca8-e053-2a95a90ab772	51655-121	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200903		ANDA	ANDA202446	Northwind Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51655-128_f6dcc3b4-5ee8-3d09-e053-6294a90ae8f6	51655-128	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20230306		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-130_f6dc8084-d6b6-9a22-e053-6394a90a6afc	51655-130	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20230227		ANDA	ANDA209013	Northwind Pharmaceuticals, LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-137_f2b42895-ae23-2d2b-e053-2995a90a899a	51655-137	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20221004		ANDA	ANDA077534	Northwind Pharmaceuticals, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-140_f6ca1097-1c76-c682-e053-6294a90a2bd6	51655-140	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20230203		ANDA	ANDA083426	Northwind Pharmaceuticals, LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51655-143_f2b3fb48-b40a-8d80-e053-2995a90a6beb	51655-143	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20170814		ANDA	ANDA077836	Northwind Pharmaceuticals, LLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
51655-144_088d0db2-371c-d404-e063-6394a90a360f	51655-144	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200527		ANDA	ANDA077626	Northwind Pharmaceuticals, LLC	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-146_f2b43815-22dd-6569-e053-2a95a90a370d	51655-146	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20220711		ANDA	ANDA077321	Northwind Pharmaceuticals, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-147_f6ca7416-ee7b-5019-e053-6294a90adf9d	51655-147	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA090432	Northwind Pharmaceuticals, LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-148_f2b4593b-1114-9ed0-e053-2a95a90af705	51655-148	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20221004		ANDA	ANDA091264	Northwind Pharmaceuticals, LLC	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51655-149_d9ba6c65-22be-10c4-e053-2995a90ada2e	51655-149	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20210507		ANDA	ANDA202389	Northwind Pharmaceuticals	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-152_0027a6cc-35eb-4b64-e063-6394a90ac29a	51655-152	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20230331		ANDA	ANDA075964	Northwind Pharmaceuticals, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
51655-153_fe069fd7-a79d-ad66-e053-6394a90ae747	51655-153	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20230417		ANDA	ANDA205936	Northwind Pharmaceuticals, LLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51655-156_00345cef-ce33-d2a4-e063-6394a90a2482	51655-156	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20141106		ANDA	ANDA065271	Northwind Pharmaceuticals, LLC	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
51655-166_fceb8c35-2390-34e2-e053-6294a90a7458	51655-166	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20141113		ANDA	ANDA075419	Northwind Pharmaceuticals, LLC	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-170_088e176e-a37b-f757-e063-6394a90a202b	51655-170	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20140715		ANDA	ANDA074754	Northwind Pharmaceuticals, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-171_f2b46c1a-bf96-1622-e053-2a95a90a91f0	51655-171	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20220721		ANDA	ANDA207466	Northwind Pharmaceuticals, LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-172_fa14cb76-74f4-e6a0-e053-6394a90a69c0	51655-172	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20230419		ANDA	ANDA202025	Northwind Pharmaceuticals, LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-173_0826b2e9-7777-ee31-e063-6294a90a3c4a	51655-173	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20200617		ANDA	ANDA077206	Northwind Pharmaceuticals, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-175_f2b4716c-411b-62cd-e053-2a95a90a6f4b	51655-175	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20221007		ANDA	ANDA201451	Northwind Pharmaceuticals, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
51655-176_f2b4948d-d325-4b84-e053-2a95a90a7d12	51655-176	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20200929		ANDA	ANDA075185	NORTHWIND PHARMACEUTICALS	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-177_03fe74ac-e319-b981-e063-6294a90a290b	51655-177	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20221005		ANDA	ANDA077929	Northwind Pharmaceuticals, LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
51655-180_df634576-182f-6a83-e053-2a95a90ac6e4	51655-180	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20200604		ANDA	ANDA075795	NORTHWIND PHARMACEUTICALS	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-188_f7f97bfe-1f42-0bdd-e053-6294a90a3599	51655-188	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20230323		ANDA	ANDA090624	Northwind Pharmaceuticals, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
51655-193_f2b4b132-54a6-c875-e053-2a95a90af443	51655-193	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221005		ANDA	ANDA204161	Northwind Pharmaceuticals, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-194_f6cac2f0-b486-cfde-e053-6294a90ae2f3	51655-194	HUMAN OTC DRUG	Cetirizine		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20221018		ANDA	ANDA078336	Northwind Pharmaceuticals, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51655-195_f2b4eb37-c7ca-8544-e053-2995a90ac505	51655-195	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20221116		ANDA	ANDA209312	Northwind Pharmaceuticals, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-196_faf6c072-b399-4e40-e053-6294a90aa651	51655-196	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20220720		ANDA	ANDA090469	Northwind Pharmaceuticals, LLC	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-197_faf6c0c5-e5f5-4de5-e053-6294a90abd1a	51655-197	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230425		ANDA	ANDA040581	Northwind Pharmaceuticals, LLC	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-201_fa154843-fb36-ed08-e053-6394a90acb47	51655-201	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20230419		ANDA	ANDA077183	Northwind Pharmaceuticals, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-202_f7f9f6a5-7b0d-1109-e053-6294a90aeaf2	51655-202	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20230315		ANDA	ANDA078212	Northwind Pharmaceuticals, LLC	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-203_088e7aa4-1911-f725-e063-6294a90add32	51655-203	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20200901		ANDA	ANDA204106	Northwind Pharmaceuticals, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-205_f9890734-561c-f11b-e053-6294a90a6f8b	51655-205	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20230108		ANDA	ANDA209312	Northwind Pharmaceuticals, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-206_f9891c0c-2dec-3dd4-e053-6294a90a2664	51655-206	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20230407		ANDA	ANDA209013	Northwind Pharmaceuticals, LLC	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-207_d9babfa4-b486-318b-e053-2a95a90aa3d5	51655-207	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20210728		ANDA	ANDA075657	Northwind Pharmaceuticals	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-208_054299e7-501d-39bb-e063-6294a90a33be	51655-208	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20210430		ANDA	ANDA040362	Northwind Pharmaceuticals, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-209_f2b54952-7f98-4d62-e053-2995a90a3ea9	51655-209	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20221021		ANDA	ANDA077534	Northwind Pharmaceuticals, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-213_faf73dbb-98bc-26a9-e053-6394a90aab3a	51655-213	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20221020		ANDA	ANDA202239	Northwind Pharmaceuticals, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-216_00b25729-f148-64ef-e063-6394a90a7eb9	51655-216	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20230317		ANDA	ANDA077859	Northwind Pharmaceuticals, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
51655-217_f2b591db-cc78-0acc-e053-2995a90aaef9	51655-217	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20200519		ANDA	ANDA073449	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-219_d9bb7ff1-8dbd-d191-e053-2995a90a13db	51655-219	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20210608		ANDA	ANDA085082	Northwind Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51655-223_f2b5d628-fe1a-b1cd-e053-2a95a90ab215	51655-223	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20221025		ANDA	ANDA090555	Northwind Pharmaceuticals, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51655-226_f2b671c9-9875-2668-e053-2a95a90a1b46	51655-226	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221025		NDA	NDA019123	Northwind Pharmaceuticals, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51655-227_ff96d682-da18-e576-e053-6294a90a8c7f	51655-227	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230215		ANDA	ANDA040197	Northwind Pharmaceuticals, LLC	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
51655-228_f80b0b95-f4dc-2d6c-e053-6294a90acf92	51655-228	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20220819		ANDA	ANDA071972	Northwind Pharmaceuticals, LLC	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-229_f80b2f93-5267-4e62-e053-6294a90a2376	51655-229	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230215		ANDA	ANDA040197	Northwind Pharmaceuticals, LLC	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
51655-230_f2b695d5-6134-43b5-e053-2a95a90a3450	51655-230	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20221027		ANDA	ANDA075229	Northwind Pharmaceuticals, LLC	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-231_f2b6bfa1-536a-90a3-e053-2995a90a6b70	51655-231	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine HCl	TABLET	ORAL	20221116		ANDA	ANDA204507	Northwind Pharmaceuticals, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51655-232_f2b6c8e3-e4f5-51e2-e053-2a95a90a25aa	51655-232	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210324		ANDA	ANDA077321	Northwind Pharmaceuticals	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-233_f2b6d647-9c4b-ed9a-e053-2a95a90a644a	51655-233	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220817		ANDA	ANDA075511	Northwind Pharmaceuticals, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51655-234_f2b6fbe6-c743-1d8d-e053-2995a90a8705	51655-234	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20220816		ANDA	ANDA208709	Northwind Pharmaceuticals, LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51655-235_f2b70cc7-7659-a5b2-e053-2a95a90a8e48	51655-235	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20221229		ANDA	ANDA079170	Northwind Pharmaceuticals, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-236_dabf8bc0-5de7-edce-e053-2995a90a73c9	51655-236	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20210510		ANDA	ANDA202389	Northwind Pharmaceuticals	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-237_f7e4a2a2-52d1-3932-e053-6294a90a6cc1	51655-237	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20210423		ANDA	ANDA208706	Northwind Pharmaceuticals	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51655-239_f80b4223-221d-f2d8-e053-6394a90ac87e	51655-239	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA213854	Northwind Pharmaceuticals, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-240_0de5b56f-e1bc-9787-e063-6394a90a3559	51655-240	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20221006		ANDA	ANDA070184	Northwind Pharmaceuticals, LLC	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20251231
51655-242_f6cb79a5-8123-d4df-e053-6294a90a2b80	51655-242	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230306		ANDA	ANDA085161	Northwind Pharmaceuticals, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-243_f2b748ca-2a39-0ac1-e053-2a95a90a1fb9	51655-243	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20221116		ANDA	ANDA078020	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-244_f2b77f2f-333f-f3e3-e053-2a95a90a1fa7	51655-244	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, FILM COATED	ORAL	20221027		ANDA	ANDA090866	Northwind Pharmaceuticals, LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-252_faf78e99-3a3f-7802-e053-6394a90a80a2	51655-252	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20230425		ANDA	ANDA088487	Northwind Pharmaceuticals, LLC	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-253_088f73fd-a224-ea44-e063-6294a90acb49	51655-253	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20201104		ANDA	ANDA204590	Northwind Pharmaceuticals, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-256_f80b8d6b-0993-8252-e053-6394a90a8fc6	51655-256	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20230322		ANDA	ANDA079172	Northwind Pharmaceuticals, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-257_f6cbc747-b23b-3f6d-e053-6294a90a9f71	51655-257	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20210217		ANDA	ANDA085223	Northwind Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51655-265_f7e48dbc-c8f2-9641-e053-6394a90aca1b	51655-265	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20200608		ANDA	ANDA077206	Northwind Pharmaceuticals	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-272_f80bf3c7-7d9c-9d79-e053-6294a90a7fdc	51655-272	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20200504		ANDA	ANDA085182	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-274_f9a1d0bc-4628-ca80-e053-6394a90a35f2	51655-274	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20200520		ANDA	ANDA204597	Northwind Pharmaceuticals	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-275_d9f2ae7d-6c41-6429-e053-2a95a90ab8dc	51655-275	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA090796	Northwind Pharmaceuticals	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-277_f2b79e87-8ddd-2013-e053-2995a90a0d8b	51655-277	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20220908		ANDA	ANDA078032	Northwind Pharmaceuticals, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-280_f2b7e27b-60cc-4864-e053-2995a90abbf5	51655-280	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20221026		ANDA	ANDA075185	Northwind Pharmaceuticals, LLC	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-281_e07d2b74-ae2c-cfeb-e053-2a95a90ae783	51655-281	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20220511		ANDA	ANDA200981	Northwind Pharmaceuticals	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-284_f2b81f5c-76b8-62c2-e053-2a95a90aba3d	51655-284	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20200513		ANDA	ANDA078032	Northwind Pharmaceuticals	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-291_f9894bf4-b0e8-c1e1-e053-6294a90a4b3a	51655-291	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20221027		ANDA	ANDA078925	Northwind Pharmaceuticals, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-296_f2b88a07-10f8-5b2a-e053-2a95a90a7aa0	51655-296	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20221116		ANDA	ANDA091604	Northwind Pharmaceuticals, LLC	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-300_0d821215-b567-d5be-e063-6394a90a56b2	51655-300	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20141022		ANDA	ANDA203834	Northwind Pharmaceuticals, LLC	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
51655-302_f2b8adcb-4d63-daa1-e053-2995a90ae4c4	51655-302	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20200519		ANDA	ANDA070221	Northwind Pharmaceuticals, LLC	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-305_0a204958-c413-05dd-e063-6394a90a4b31	51655-305	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20200520		ANDA	ANDA086242	Northwind Pharmaceuticals, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51655-307_f2b8e9d9-1275-22ca-e053-2a95a90a6f1a	51655-307	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20221117		ANDA	ANDA076899	Northwind Pharmaceuticals, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
51655-309_f80c5f1e-6a37-4b76-e053-6394a90a681d	51655-309	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20230322		ANDA	ANDA079172	Northwind Pharmaceuticals, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-310_f2b92056-ca3e-c5c6-e053-2995a90a9973	51655-310	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20221128		ANDA	ANDA076796	Northwind Pharmaceuticals, LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51655-311_f2b94137-205c-1c77-e053-2a95a90afc15	51655-311	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20220714		ANDA	ANDA077912	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-312_f9a09daa-48e6-6b0b-e053-6294a90a1458	51655-312	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20200521		ANDA	ANDA075805	Northwind Pharmaceuticals	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51655-314_f9a1db51-e22f-e7a3-e053-6394a90aec09	51655-314	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20200521		ANDA	ANDA204597	Northwind Pharmaceuticals	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-315_f2f058ed-19b1-a2ea-e053-2a95a90ad2b6	51655-315	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20221123		ANDA	ANDA071881	Northwind Pharmaceuticals, LLC	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51655-317_f2f080c9-d9fa-6e3a-e053-2a95a90aba97	51655-317	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20221128		ANDA	ANDA065442	Northwind Pharmaceuticals, LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
51655-322_faf7cfa1-cd95-d983-e053-6394a90a701d	51655-322	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20230425		ANDA	ANDA209603	Northwind Pharmaceuticals, LLC	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-323_fb0764e5-d66e-fe80-e053-6394a90ae782	51655-323	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20230502		ANDA	ANDA090555	Northwind Pharmaceuticals, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51655-325_fc4c90e0-473f-5ed4-e053-6394a90a55e8	51655-325	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230519		ANDA	ANDA090515	Northwind Pharmaceuticals, LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51655-327_f822dab7-f5e0-4217-e053-6294a90ad1ab	51655-327	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20221128		ANDA	ANDA076710	Northwind Pharmaceuticals, LLC	LEVOFLOXACIN	750	mg/1			N	20241231
51655-329_f2f1205b-c446-0fe2-e053-2995a90a8a13	51655-329	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20201120		ANDA	ANDA091276	Northwind Pharmaceuticals, LLC	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-330_f2f12ad6-e1de-14b2-e053-2a95a90a0217	51655-330	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	20220826		ANDA	ANDA040268	Northwind Pharmaceuticals, LLC	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51655-331_f8233591-725e-78af-e053-6294a90a0d60	51655-331	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	TABLET	ORAL	20230328		ANDA	ANDA205530	Northwind Pharmaceuticals, LLC	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
51655-332_dabfa9e9-b162-aed5-e053-2995a90aaf0a	51655-332	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20210610		ANDA	ANDA078932	Northwind Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51655-334_f8236ed1-39b9-688b-e053-6294a90a0e0a	51655-334	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230324		ANDA	ANDA213999	Northwind Pharmaceuticals, LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51655-335_f9b14262-82c0-716e-e053-6394a90a0326	51655-335	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20200521		ANDA	ANDA076164	Northwind Pharmaceuticals	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-337_0ccf5ed7-0391-e3d5-e063-6294a90ad9db	51655-337	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200526		ANDA	ANDA204720	Northwind Pharmaceuticals, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-339_08905d18-2703-c04f-e063-6394a90a3f7c	51655-339	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20200527		ANDA	ANDA078895	Northwind Pharmaceuticals, LLC	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-340_089fd7d6-e583-daec-e063-6294a90ab9b6	51655-340	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20200527		UNAPPROVED DRUG OTHER		Northwind Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
51655-341_f9a09812-dc0b-1d0d-e053-6294a90ac65f	51655-341	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20200528		ANDA	ANDA075657	Northwind Pharmaceuticals	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-343_f6ddb6c0-d0b5-2297-e053-6294a90a83c9	51655-343	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20230228		ANDA	ANDA076056	Northwind Pharmaceuticals, LLC	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-344_f2f16b87-3b7b-57cf-e053-2995a90ae90c	51655-344	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20200527		ANDA	ANDA203512	Northwind Pharmaceuticals	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51655-345_08a03e6e-1eb3-0312-e063-6294a90aa4f7	51655-345	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20200528		ANDA	ANDA077397	Northwind Pharmaceuticals, LLC	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-346_f2f1778d-3143-5436-e053-2a95a90a85d1	51655-346	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200527		ANDA	ANDA077626	Northwind Pharmaceuticals	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-347_0ccbcb1e-813f-9a20-e063-6294a90ae516	51655-347	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200528		ANDA	ANDA077626	Northwind Pharmaceuticals, LLC	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-349_f2f1a2df-3005-349f-e053-2a95a90a1c4d	51655-349	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20221130		ANDA	ANDA208412	Northwind Pharmaceuticals, LLC	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-350_f2f1edc7-e199-3da3-e053-2995a90a4a99	51655-350	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20221129		ANDA	ANDA091605	Northwind Pharmaceuticals, LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51655-353_f30528af-3eb9-a9c4-e053-2995a90ae69d	51655-353	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20150225		ANDA	ANDA070974	Northwind Pharmaceuticals, LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-354_0cf7e3f4-ca4d-5498-e063-6294a90ad3a8	51655-354	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20200527		ANDA	ANDA075010	Northwind Pharmaceuticals, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-355_f7e23f6d-f0f8-35c2-e053-6294a90a75b6	51655-355	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20200528		ANDA	ANDA080352	Northwind Pharmaceuticals	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-357_f2f21c02-a2b9-689c-e053-2a95a90a2166	51655-357	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200528		ANDA	ANDA202304	Northwind Pharmaceuticals	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51655-359_fbd40479-c40a-f0c3-e053-6294a90a2913	51655-359	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230509		ANDA	ANDA211575	Northwind Pharmaceuticals, LLC	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-360_08a2221c-3818-8f50-e063-6294a90a36f1	51655-360	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20200528		ANDA	ANDA078110	Northwind Pharmaceuticals, LLC	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
51655-361_0ccf3451-3f8b-ca70-e063-6294a90af61a	51655-361	HUMAN PRESCRIPTION DRUG	Glipizide	XL	glipizide	TABLET, EXTENDED RELEASE	ORAL	20200528		NDA AUTHORIZED GENERIC	NDA020329	Northwind Pharmaceuticals, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-363_08655aca-122b-8f65-e063-6394a90a9416	51655-363	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200528		ANDA	ANDA075927	Northwind Pharmaceuticals, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
51655-364_08a46139-bc75-0acc-e063-6394a90ae6d0	51655-364	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20200528		ANDA	ANDA077714	Northwind Pharmaceuticals, LLC	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
51655-365_0827123f-5f40-4230-e063-6394a90ab08a	51655-365	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20200529		ANDA	ANDA079163	Northwind Pharmaceuticals, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51655-366_f2f2232c-2de9-267c-e053-2995a90af2f6	51655-366	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20221130		ANDA	ANDA071523	Northwind Pharmaceuticals, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
51655-368_f9a1c27a-ac10-fa8e-e053-6294a90a45fa	51655-368	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200604		ANDA	ANDA078321	Northwind Pharmaceuticals	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51655-383_f2f2d6da-eb41-4290-e053-2a95a90a6ca0	51655-383	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20220907		ANDA	ANDA078181	Northwind Pharmaceuticals, LLC	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-385_f9896cb6-0eef-e944-e053-6294a90a7c71	51655-385	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200521		ANDA	ANDA091625	Northwind Pharmaceuticals	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-386_f8358bf6-3b64-4fd9-e053-6294a90a3d11	51655-386	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20230328		ANDA	ANDA210614	Northwind Pharmaceuticals, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-387_f8353a61-951c-6af7-e053-6294a90afdaa	51655-387	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230328		ANDA	ANDA078103	Northwind Pharmaceuticals, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-388_fc4cd6f4-e01c-ad2d-e053-6294a90aebd6	51655-388	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20230519		ANDA	ANDA078212	Northwind Pharmaceuticals, LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51655-389_f835fe9a-d4c7-b3ef-e053-6294a90a9837	51655-389	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230329		ANDA	ANDA078020	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-390_d9bbacb3-63b5-2922-e053-2a95a90a6085	51655-390	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20220128		ANDA	ANDA206975	Northwind Pharmaceuticals	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
51655-396_08a49589-0c4f-2988-e063-6394a90a6fcb	51655-396	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20200707		ANDA	ANDA078671	Northwind Pharmaceuticals, LLC	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-397_d9c9fd0e-7801-8068-e053-2995a90a5bb9	51655-397	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20200708		ANDA	ANDA077614	Northwind Pharmaceuticals	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51655-398_dffe5ced-a9b0-f2f1-e053-2a95a90ab3c3	51655-398	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20200715		UNAPPROVED DRUG OTHER		Northwind Pharmaceuticals	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
51655-399_f3053195-b857-cf9e-e053-2995a90aea9a	51655-399	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20200427		ANDA	ANDA076180	Northwind Pharmaceuticals	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-403_f9896587-1c49-ef33-e053-6294a90ad903	51655-403	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20230413		ANDA	ANDA215307	Northwind Pharmaceuticals, LLC	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
51655-406_f2f30c5f-483b-35df-e053-2995a90a1b0c	51655-406	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20220906		ANDA	ANDA091604	Northwind Pharmaceuticals, LLC	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-407_f2f3564a-d43b-6c36-e053-2a95a90ae878	51655-407	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20221027		ANDA	ANDA210614	Northwind Pharmaceuticals, LLC	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-410_f7e274b5-0663-b549-e053-6294a90ab743	51655-410	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20140428		ANDA	ANDA085162	Northwind Pharmaceuticals, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-411_f7e4a874-49e9-b881-e053-6394a90a7670	51655-411	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20200313		ANDA	ANDA076164	Northwind Pharmaceuticals	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-412_f3055919-aff5-72e7-e053-2995a90ace4d	51655-412	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20140729		ANDA	ANDA077912	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-414_f30598f5-b9fe-a9b1-e053-2995a90a0828	51655-414	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20140825		ANDA	ANDA076194	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-415_f305c001-ee5a-bef5-e053-2a95a90aafcd	51655-415	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20171207		ANDA	ANDA078539	Northwind Pharmaceuticals, LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-416_d9f434eb-c480-3eff-e053-2a95a90a0149	51655-416	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20210804		ANDA	ANDA040362	Northwind Pharmaceuticals	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-418_08b30971-cbab-b346-e063-6294a90aad5d	51655-418	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	50 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200715		ANDA	ANDA090382	Northwind Pharmaceuticals, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-422_fe06b671-bc57-7b89-e053-6294a90a3115	51655-422	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20221229		ANDA	ANDA040907	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-423_08b35c69-6891-66d2-e063-6294a90a1c69	51655-423	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20200817		ANDA	ANDA208834	Northwind Pharmaceuticals, LLC	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-424_f2f3e2ab-6dbb-dc2f-e053-2a95a90a3b93	51655-424	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20220922		UNAPPROVED DRUG OTHER		Northwind Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
51655-426_f7e2e2a9-45c5-ce40-e053-6294a90afd35	51655-426	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20200827		ANDA	ANDA070322	Northwind Pharmaceuticals	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-427_df7480fb-aed2-3c5a-e053-2995a90acca2	51655-427	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200901		ANDA	ANDA208170	Northwind Pharmaceuticals	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-429_f8364779-afe9-abd8-e053-6294a90a3f44	51655-429	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20200902		ANDA	ANDA078235	Northwind Pharmaceuticals, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51655-432_f2f42c98-4119-5f70-e053-2a95a90add02	51655-432	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200909		ANDA	ANDA079057	Northwind Pharmaceuticals, LLC	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-433_f2f45df3-0bc1-0d31-e053-2a95a90a7005	51655-433	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20200917		ANDA	ANDA200884	Northwind Pharmaceuticals, LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51655-435_e327bd32-a13c-3a0b-e053-2995a90a78ae	51655-435	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20200916		ANDA	ANDA077731	Northwind Pharmaceuticals	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51655-436_dac023cf-237c-3c0e-e053-2a95a90a41f9	51655-436	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20200921		ANDA	ANDA204776	Northwind Pharmaceuticals	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-437_dac04016-7b20-11af-e053-2995a90afc2b	51655-437	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20200928		ANDA	ANDA204776	Northwind Pharmaceuticals	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-441_ff9730da-7770-1902-e053-6394a90a015d	51655-441	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20221130		ANDA	ANDA205245	Northwind Pharmaceuticals, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
51655-443_f2f5a8df-2c3d-12a5-e053-2a95a90a9076	51655-443	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20200930		ANDA	ANDA201807	Northwind Pharmaceuticals, LLC	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-445_df603ee5-4ae8-ddc0-e053-2995a90aa557	51655-445	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA070925	Northwind Pharmaceuticals	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-446_d9ca2484-7294-7db6-e053-2995a90a0f13	51655-446	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20201002		ANDA	ANDA078420	Northwind Pharmaceuticals	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-448_f2f5edbb-c490-4492-e053-2995a90a589c	51655-448	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20201013		ANDA	ANDA078034	Northwind Pharmaceuticals, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-449_08b42b33-f3fb-c3f7-e063-6294a90a43a0	51655-449	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20201020		ANDA	ANDA202389	Northwind Pharmaceuticals, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-450_fe828c61-d125-5c57-e053-6294a90a670c	51655-450	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20230614		ANDA	ANDA076140	Northwind Pharmaceuticals, LLC	SOTALOL HYDROCHLORIDE	240	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
51655-451_f3036329-04be-bbc3-e053-2995a90ab86b	51655-451	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20221206		ANDA	ANDA070923	Northwind Pharmaceuticals, LLC	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-452_f3035f40-3f57-7d0c-e053-2a95a90a003f	51655-452	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220926		ANDA	ANDA203270	Northwind Pharmaceuticals, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51655-453_f7e31fee-2e20-a2ac-e053-6294a90a8c63	51655-453	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20201020		NDA	NDA021210	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-456_f305f1f6-9349-6703-e053-2995a90a39d6	51655-456	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20201023		ANDA	ANDA202696	Northwind Pharmaceuticals, LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-457_ff97b682-ab9c-e891-e053-6294a90ac865	51655-457	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20230504		ANDA	ANDA074140	Northwind Pharmaceuticals, LLC	NAPROXEN SODIUM	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-459_f989d7df-be02-438f-e053-6294a90a6005	51655-459	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230329		ANDA	ANDA078103	Northwind Pharmaceuticals, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-461_f306cc84-2306-375e-e053-2995a90a9048	51655-461	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20201029		ANDA	ANDA210371	Northwind Pharmaceuticals, LLC	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
51655-462_d9cb038e-9cfa-6600-e053-2995a90a3cb9	51655-462	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20220223		ANDA	ANDA040712	Northwind Pharmaceuticals	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51655-463_f30810e1-3a59-0c90-e053-2a95a90ad7a3	51655-463	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201029		ANDA	ANDA210921	Northwind Pharmaceuticals, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51655-464_08b8f2d5-711e-758a-e063-6394a90a75e8	51655-464	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20201027		ANDA	ANDA209288	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-465_f3084cb6-67b6-6f10-e053-2a95a90a0d3d	51655-465	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20201027		ANDA	ANDA209288	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-467_f308798d-7df1-420a-e053-2995a90a76b6	51655-467	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20201029		ANDA	ANDA088619	Northwind Pharmaceuticals, LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-468_f3089ee6-190e-4749-e053-2a95a90a15d8	51655-468	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20201106		ANDA	ANDA202659	Northwind Pharmaceuticals, LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-469_fb07e8c7-e62b-1ee2-e053-6394a90ad000	51655-469	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20221130		ANDA	ANDA078296	Northwind Pharmaceuticals, LLC	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-473_f309302f-d6e7-997e-e053-2995a90a14e5	51655-473	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201106		ANDA	ANDA209167	Northwind Pharmaceuticals, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-474_dac06b73-4572-2e8b-e053-2995a90a751e	51655-474	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20201113		ANDA	ANDA090796	Northwind Pharmaceuticals	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-475_f3095546-7f73-2665-e053-2995a90aff07	51655-475	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20201118		NDA AUTHORIZED GENERIC	NDA018333	Northwind Pharmaceuticals, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
51655-476_f3097091-4bec-6e74-e053-2995a90a87db	51655-476	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20201130		ANDA	ANDA075580	Northwind Pharmaceuticals, LLC	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-477_f3097d62-ba5b-ef2f-e053-2995a90a59e2	51655-477	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20221202		ANDA	ANDA210742	Northwind Pharmaceuticals, LLC	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51655-478_fd65fe4d-c56f-8a5f-e053-6394a90a461d	51655-478	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20230105		ANDA	ANDA062396	Northwind Pharmaceuticals, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51655-479_f7e35853-4b4a-2298-e053-6294a90a058a	51655-479	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20201119		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-481_f3173c0d-2b63-7c7b-e053-2995a90ada05	51655-481	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20201119		NDA	NDA018823	Northwind Pharmaceuticals, LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51655-482_f317816b-ba03-4733-e053-2995a90a49b6	51655-482	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20201119		ANDA	ANDA211682	Northwind Pharmaceuticals, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51655-483_d9cb3417-e8cc-13f8-e053-2a95a90a294b	51655-483	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20201123		ANDA	ANDA209713	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-484_f317a5a4-f04a-467e-e053-2995a90a1529	51655-484	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20201123		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-485_dac07d8f-6b74-20ab-e053-2a95a90af3ba	51655-485	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20201123		ANDA	ANDA209713	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-486_dac0c8f1-e3d0-11e6-e053-2a95a90adbcb	51655-486	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20201123		ANDA	ANDA076180	Northwind Pharmaceuticals	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-487_f317fe1e-d7c5-fb8b-e053-2a95a90a5445	51655-487	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201125		ANDA	ANDA209167	Northwind Pharmaceuticals, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-489_f3184d76-b990-3190-e053-2995a90a0240	51655-489	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20201210		ANDA	ANDA077091	Northwind Pharmaceuticals, LLC	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-490_f6debb60-d886-230b-e053-6394a90ad73a	51655-490	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20230105		ANDA	ANDA208921	Northwind Pharmaceuticals, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
51655-491_f3187048-969f-30e6-e053-2a95a90a8fc8	51655-491	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	20201210		ANDA	ANDA073457	Northwind Pharmaceuticals, LLC	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-492_d9cb9251-7b32-72a0-e053-2a95a90a4315	51655-492	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20210107		ANDA	ANDA090937	Northwind Pharmaceuticals	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-493_dad4d691-382a-bf8f-e053-2995a90a2fe5	51655-493	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20210113		ANDA	ANDA084122	Northwind Pharmaceuticals	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-502_f9248f53-0218-d2a5-e053-6294a90a6380	51655-502	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20150306		ANDA	ANDA202556	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-506_0903b222-1a43-64aa-e063-6294a90abba0	51655-506	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20200521		ANDA	ANDA202556	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-507_dae330da-d2d8-5daa-e053-2a95a90a8ef3	51655-507	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20210113		ANDA	ANDA075520	Northwind Pharmaceuticals	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51655-510_d9cbb486-28b6-eb5e-e053-2a95a90afaea	51655-510	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20220221		ANDA	ANDA201407	Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-511_f318a6d5-6b1b-f16e-e053-2a95a90a3d95	51655-511	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20221220		ANDA	ANDA202557	Northwind Pharmaceuticals, LLC	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
51655-512_d9f50844-f12f-653e-e053-2a95a90acad1	51655-512	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCl 200mg		Phenazopyridine Hydrochloride	TABLET	ORAL	20210114		UNAPPROVED DRUG OTHER		Northwind Pharmaceuticals	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
51655-513_f7e31fee-2e20-a2ac-e053-6294a90a8c63	51655-513	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210120		NDA	NDA021210	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-514_f98a14c8-8cbb-96ef-e053-6294a90a4db9	51655-514	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20220714		ANDA	ANDA077739	Northwind Pharmaceuticals, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-515_f3190696-0529-75a5-e053-2995a90ab92c	51655-515	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20220817		ANDA	ANDA202556	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-519_f3193018-09cc-f09a-e053-2995a90a5441	51655-519	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221219		ANDA	ANDA204161	Northwind Pharmaceuticals, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-520_0de63d56-ef74-996b-e063-6294a90a7354	51655-520	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	20231227		ANDA	ANDA040159	Northwind Pharmaceuticals, LLC	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20251231
51655-522_e3afa83d-c79d-848a-e053-2a95a90ac922	51655-522	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20220629		ANDA	ANDA090510	Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-523_f3198e1b-6345-ad96-e053-2995a90a4aaf	51655-523	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20220906		ANDA	ANDA203154	Northwind Pharmaceuticals, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51655-526_f319cbce-f814-202d-e053-2995a90a9732	51655-526	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20220706		ANDA	ANDA210742	Northwind Pharmaceuticals, LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51655-527_f86e5357-543e-f9ec-e053-6294a90a49b3	51655-527	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20220916		ANDA	ANDA077739	Northwind Pharmaceuticals, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-528_f7e35853-4b4a-2298-e053-6294a90a058a	51655-528	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210120		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-532_f31a1ad8-c537-f4c5-e053-2995a90ae2cb	51655-532	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20221221		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-533_f31aef65-1277-742a-e053-2a95a90ad06a	51655-533	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20221228		ANDA	ANDA078512	Northwind Pharmaceuticals, LLC	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-534_d9cbda32-ace5-107f-e053-2995a90a1681	51655-534	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20220302		ANDA	ANDA077739	Northwind Pharmaceuticals, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-537_f31b5d54-7537-4290-e053-2a95a90ac235	51655-537	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20221228		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-539_dae3c6bf-e205-0629-e053-2995a90a9f0c	51655-539	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20210114		ANDA	ANDA208170	Northwind Pharmaceuticals	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-541_03ae4cf6-e09a-27cf-e063-6294a90ab664	51655-541	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20230519		ANDA	ANDA208412	Northwind Pharmaceuticals, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
51655-544_f31ba99a-79a3-16f6-e053-2995a90a9277	51655-544	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20221227		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-545_0039e564-0762-619b-e063-6394a90a886c	51655-545	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20220830		ANDA	ANDA211487	Northwind Pharmaceuticals, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
51655-553_da31596e-0373-e121-e053-2995a90a13bf	51655-553	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20210120		ANDA	ANDA206530	Northwind Pharmaceuticals	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51655-554_ca5a121f-a04e-6a91-e053-2a95a90ac31a	51655-554	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA200884	Northwind Pharmaceuticals, LLC	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51655-556_f31bfc3a-d4a2-555c-e053-2a95a90a03f7	51655-556	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20220811		ANDA	ANDA090564	Northwind Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51655-557_f7e31fee-2e20-a2ac-e053-6294a90a8c63	51655-557	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210122		NDA	NDA021210	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-558_f6dfaf57-d161-5775-e053-6394a90ad3e9	51655-558	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20210125		ANDA	ANDA078296	Northwind Pharmaceuticals, LLC	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-559_0de6a6d0-a10f-e114-e063-6394a90a34dd	51655-559	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20231011		ANDA	ANDA201991	Northwind Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
51655-564_dae403cd-b6fd-7c50-e053-2995a90a95e3	51655-564	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20210125		ANDA	ANDA203646	Northwind Pharmaceuticals	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51655-565_dae4124a-4f0d-acac-e053-2995a90a8c82	51655-565	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20210125		ANDA	ANDA077091	Northwind Pharmaceuticals, LLC	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-566_dae7b1c1-7ff2-883c-e053-2a95a90a1a2b	51655-566	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20210127		ANDA	ANDA090564	Northwind Pharmaceuticals	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51655-568_dae7c63d-eef1-58d0-e053-2a95a90a667e	51655-568	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20210128		ANDA	ANDA074726	Northwind Pharmaceuticals, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51655-569_f99e2e7c-fc0b-1744-e053-6394a90a4b2c	51655-569	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210202		ANDA	ANDA207206	Northwind Pharmaceuticals, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-570_dae7e933-abb9-469d-e053-2a95a90a5030	51655-570	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20210205		ANDA	ANDA078895	Northwind Pharmaceuticals	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-571_f31d08ee-f64b-2b42-e053-2995a90a4029	51655-571	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20220714		ANDA	ANDA077929	Northwind Pharmaceuticals, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-574_f31d5599-0df2-19f0-e053-2a95a90a3c5c	51655-574	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20200916		ANDA	ANDA090200	Northwind Pharmaceuticals, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-575_df63611f-90e5-6bbe-e053-2a95a90a2aad	51655-575	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20200824		ANDA	ANDA090200	Northwind Pharmaceuticals	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-576_f31b9bb5-3def-2308-e053-2a95a90a9629	51655-576	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20221227		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-577_f31dd3b3-d123-1cdb-e053-2a95a90adda4	51655-577	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20140402		ANDA	ANDA077927	Northwind Pharmaceuticals, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-578_f86e1afc-1873-a265-e053-6294a90a8305	51655-578	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20230329		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-579_f32b4a01-edeb-fc85-e053-2995a90ac175	51655-579	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20221228		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-582_f32b8809-80ea-18f2-e053-2995a90a5428	51655-582	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20221230		ANDA	ANDA071251	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-583_f86efbc1-baa0-1c6e-e053-6394a90a967f	51655-583	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20230330		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-586_f32b932c-5d98-600e-e053-2a95a90a71bd	51655-586	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20230103		ANDA	ANDA078925	Northwind Pharmaceuticals, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-589_ff973a1e-3f63-91c2-e053-6294a90af5c4	51655-589	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA088618	Northwind Pharmaceuticals	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-592_fb0809c2-7cc0-691a-e053-6294a90a1f2f	51655-592	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20230103		ANDA	ANDA208170	Northwind Pharmaceuticals, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-593_f32c1aa0-d9f7-9802-e053-2995a90a3223	51655-593	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20230103		ANDA	ANDA210614	Northwind Pharmaceuticals, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-594_db0e9c21-dc26-629a-e053-2a95a90a5ac3	51655-594	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20210203		ANDA	ANDA077987	Northwind Pharmaceuticals	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-596_db0f177b-8953-df51-e053-2995a90aa240	51655-596	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20210401		ANDA	ANDA091276	Northwind Pharmaceuticals	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-597_df73f151-49cc-e206-e053-2995a90a44e9	51655-597	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210203		ANDA	ANDA207206	Northwind Pharmaceuticals, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-598_db0f5668-89ad-3fda-e053-2a95a90a3d06	51655-598	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20210212		ANDA	ANDA078155	Northwind Pharmaceuticals	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-602_db0f91ac-4331-f481-e053-2a95a90a884f	51655-602	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20210219		ANDA	ANDA208774	Northwind Pharmaceuticals	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-603_da31fb95-ea05-1fd9-e053-2995a90ad99b	51655-603	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210219		ANDA	ANDA076286	Northwind Pharmaceuticals	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-604_db10c67c-19e5-5f1d-e053-2a95a90a0020	51655-604	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20210218		ANDA	ANDA076187	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-605_d9cc124d-63cd-e507-e053-2a95a90ad505	51655-605	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20210401		ANDA	ANDA077031	Northwind Pharmaceuticals	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-606_f99e436f-9b34-3b9c-e053-6394a90ade52	51655-606	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200528		ANDA	ANDA076343	Northwind Pharmaceuticals, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51655-608_f32c38bb-ba51-e11e-e053-2995a90a759e	51655-608	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20150202		ANDA	ANDA077627	Northwind Pharmaceuticals, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51655-613_f32c95ae-0787-d0c5-e053-2a95a90a66c1	51655-613	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20221115		ANDA	ANDA090548	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-614_f32cbebc-6482-665d-e053-2995a90af315	51655-614	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20150825		ANDA	ANDA091624	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-615_df73f151-49cc-e206-e053-2995a90a44e9	51655-615	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210219		ANDA	ANDA207206	Northwind Pharmaceuticals, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-616_f32ce694-3ac9-82df-e053-2a95a90a6d09	51655-616	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20220720		ANDA	ANDA203561	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-617_06318bef-290b-08ac-e063-6294a90a8ee0	51655-617	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20220906		ANDA	ANDA078212	Northwind Pharmaceuticals, LLC	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
51655-620_f32d32d4-7e24-4d3e-e053-2a95a90ad432	51655-620	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20230103		ANDA	ANDA040616	Northwind Pharmaceuticals, LLC	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51655-621_f32d755e-4983-ee40-e053-2995a90a4ebe	51655-621	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20200706		ANDA	ANDA091416	Northwind Pharmaceuticals, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-629_f86f57ce-c4bc-2169-e053-6294a90a387b	51655-629	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20230103		ANDA	ANDA040616	Northwind Pharmaceuticals, LLC.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51655-630_f32e5b0f-1fdb-9b33-e053-2995a90a8103	51655-630	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20140407		ANDA	ANDA071251	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-631_0a207940-02df-1b15-e063-6394a90aa6d7	51655-631	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20200518		ANDA	ANDA071851	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-632_e3b000ab-f49f-99bb-e053-2a95a90af98d	51655-632	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220602		ANDA	ANDA202446	Northwind Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51655-633_fd666f5d-c4b8-f12f-e053-6394a90ac851	51655-633	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20230105		ANDA	ANDA090682	Northwind Pharmaceuticals, LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51655-636_fe82bd54-a12c-a85f-e053-6394a90a44c6	51655-636	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20230120		ANDA	ANDA205936	Northwind Pharmaceuticals, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51655-639_db111406-3112-3d8f-e053-2995a90ad46b	51655-639	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210128		ANDA	ANDA202446	Northwind Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51655-643_f32f2299-4acc-1b5f-e053-2995a90a5279	51655-643	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA078155	Northwind Pharmaceuticals, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-649_ff0edf52-9806-63ff-e053-6394a90a46ae	51655-649	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210401		ANDA	ANDA077095	Northwind Pharmaceuticals	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51655-655_db11808a-b19b-f07d-e053-2995a90a63e0	51655-655	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210226		ANDA	ANDA203145	Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-657_db47898c-1c6c-6bd6-e053-2995a90a1881	51655-657	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210401		ANDA	ANDA212517	Northwind Pharmaceuticals	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-658_d9cc801e-2aad-40ab-e053-2995a90a4539	51655-658	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20210126		ANDA	ANDA205253	Northwind Pharmaceuticals	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
51655-659_db479d71-c5ce-cfa4-e053-2995a90af500	51655-659	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20210323		ANDA	ANDA090937	Northwind Pharmaceuticals	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-662_f330690b-b0d4-3609-e053-2995a90a4245	51655-662	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200603		ANDA	ANDA071524	Northwind Pharmaceuticals, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
51655-663_db47cbdd-a481-02b6-e053-2a95a90af672	51655-663	HUMAN OTC DRUG	Good Sense anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20210402		ANDA	ANDA075232	Northwind Pharmaceuticals	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
51655-664_0865b3af-a350-433b-e063-6294a90a9683	51655-664	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20150216		ANDA	ANDA078216	Northwind Pharmaceuticals, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-665_f330b7a0-bbe1-0f00-e053-2a95a90a37b8	51655-665	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20220809		ANDA	ANDA209823	Northwind Pharmaceuticals, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51655-666_fb07c805-3c40-06d6-e053-6394a90a1ead	51655-666	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20230108		ANDA	ANDA076710	Northwind Pharmaceuticals, LLC	LEVOFLOXACIN	500	mg/1			N	20241231
51655-667_0865b3af-a350-433b-e063-6294a90a9683	51655-667	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20210112		ANDA	ANDA078216	Northwind Pharmaceuticals, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-668_fbd4f6a6-435f-d802-e053-6394a90a6b74	51655-668	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20230403		ANDA	ANDA065136	Northwind Pharmaceuticals, LLC	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
51655-674_f331763c-ba8e-69b1-e053-2a95a90a07f8	51655-674	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20230108		ANDA	ANDA040702	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-679_fd668eff-581b-259d-e053-6394a90a1a1e	51655-679	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230215		ANDA	ANDA203834	Northwind Pharmaceuticals, LLC	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51655-680_d9ccb408-3b80-e207-e053-2995a90a0cfb	51655-680	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20220302		ANDA	ANDA077031	Northwind Pharmaceuticals	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-686_db47ddae-c575-427f-e053-2a95a90aae48	51655-686	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20210401		ANDA	ANDA075991	Northwind Pharmaceuticals	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-687_f7e31fee-2e20-a2ac-e053-6294a90a8c63	51655-687	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210330		NDA	NDA021210	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-694_f7e31fee-2e20-a2ac-e053-6294a90a8c63	51655-694	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210401		NDA	NDA021210	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-695_db47e55b-d403-ac9e-e053-2a95a90a94c0	51655-695	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20210323		ANDA	ANDA203536	Northwind Pharmaceuticals	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-696_f7e31fee-2e20-a2ac-e053-6294a90a8c63	51655-696	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210401		NDA	NDA021210	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-697_db481bcd-d1c8-a7b2-e053-2995a90a2f2c	51655-697	HUMAN PRESCRIPTION DRUG	Cimetidine		cimetidine	TABLET, FILM COATED	ORAL	20210401		ANDA	ANDA074246	Northwind Pharmaceuticals	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51655-698_db4d850e-81b9-4dcd-e053-2995a90aec76	51655-698	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210401		ANDA	ANDA203145	Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-699_db4da763-1404-63e9-e053-2a95a90a5f0c	51655-699	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20210402		ANDA	ANDA077851	Northwind Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-701_f7e47fd0-041e-82e0-e053-6394a90a8806	51655-701	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20210419		ANDA	ANDA087342	Northwind Pharmaceuticals, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-703_fe8319e3-d980-12a4-e053-6294a90aa8cc	51655-703	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20230403		ANDA	ANDA090682	Northwind Pharmaceuticals, LLC	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51655-705_f7e31fee-2e20-a2ac-e053-6294a90a8c63	51655-705	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210430		NDA	NDA021210	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-706_db4db609-8063-883c-e053-2a95a90aea8a	51655-706	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA210733	Northwind Pharmaceuticals	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51655-707_db4dd9d6-5181-c4ce-e053-2995a90ae9f2	51655-707	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210507	20240131	ANDA	ANDA077321	Northwind Pharmaceuticals	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
51655-708_db5b9f9a-e9af-6480-e053-2995a90af4bd	51655-708	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210521		ANDA	ANDA076341	Northwind Pharmaceuticals	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-709_db5bd99e-8047-4d1a-e053-2995a90ab9f7	51655-709	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20210507		ANDA	ANDA077443	Northwind Pharmaceuticals	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-710_f6f5c82a-3753-52bb-e053-6394a90aa3bb	51655-710	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20230203		ANDA	ANDA207402	Northwind Pharmaceuticals, LLC	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
51655-711_f3319edc-acf6-874f-e053-2a95a90aa160	51655-711	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20230120		ANDA	ANDA204234	Northwind Pharmaceuticals, LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51655-713_db5d9e6c-6565-b0f7-e053-2995a90a77f2	51655-713	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA078384	Northwind Pharmaceuticals	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51655-714_db5de856-c80a-2add-e053-2a95a90a9b13	51655-714	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20210526		NDA	NDA021116	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-717_db5f1693-ca65-7a97-e053-2995a90acbff	51655-717	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20210526		ANDA	ANDA078932	Northwind Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51655-719_db5f7ee5-9bda-1819-e053-2a95a90a91df	51655-719	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20210614		ANDA	ANDA090170	Northwind Pharmaceuticals	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51655-721_db5fba3f-d3fc-0628-e053-2a95a90a6a9f	51655-721	HUMAN PRESCRIPTION DRUG	Sildenafil		sildinafil	TABLET, FILM COATED	ORAL	20210608		ANDA	ANDA201150	Northwind Pharmaceuticals	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-722_db895ded-327c-1635-e053-2995a90a5b55	51655-722	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20210617		ANDA	ANDA074821	Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-723_f7e490e9-6c03-8d70-e053-6294a90aafda	51655-723	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20210609		NDA	NDA021116	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-725_db898bc1-a73a-e62e-e053-2995a90a3d81	51655-725	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20210611		ANDA	ANDA201507	Northwind Pharmaceuticals	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-726_f7e47cc4-3a3f-eb2d-e053-6294a90a8f67	51655-726	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20210610		ANDA	ANDA084122	Northwind Pharmaceuticals, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-727_db89c497-bc35-adce-e053-2a95a90a7560	51655-727	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20210611		NDA	NDA021116	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-728_db981e28-468c-fb1b-e053-2a95a90a3da9	51655-728	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210616		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-729_db98aaba-5926-f81b-e053-2a95a90a4879	51655-729	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20210616		ANDA	ANDA076180	Northwind Pharmaceuticals, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-730_db9907a7-2caf-39e0-e053-2a95a90ad617	51655-730	HUMAN PRESCRIPTION DRUG	Ergocalciferol Capsules,		Ergocalciferol Capsules,	CAPSULE	ORAL	20210616		ANDA	ANDA204276	Northwind Pharmaceuticals	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
51655-731_d9cd9685-aea0-d2c0-e053-2995a90a3eb8	51655-731	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20150105		ANDA	ANDA077927	Northwind Pharmaceuticals	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-733_da343939-990e-3322-e053-2995a90a0621	51655-733	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20210707		ANDA	ANDA078420	Northwind Pharmaceuticals	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-734_db990ce1-b194-4a81-e053-2a95a90a627b	51655-734	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20210617		ANDA	ANDA206173	Northwind Pharmaceuticals	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51655-735_da345513-12e5-48a6-e053-2a95a90adf02	51655-735	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA208834	Northwind Pharmaceuticals	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-736_d9cdc803-649d-f43c-e053-2995a90a2c64	51655-736	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	20210617		ANDA	ANDA073457	Northwind Pharmaceuticals	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-737_da562e58-878e-b376-e053-2995a90a41f5	51655-737	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20210719		ANDA	ANDA077690	Northwind Pharmaceuticals	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-738_da565efa-2acd-32d9-e053-2995a90a4c49	51655-738	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20210709		ANDA	ANDA203126	Northwind Pharmaceuticals	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-739_db9983ed-6efe-096f-e053-2a95a90a5e63	51655-739	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210628		ANDA	ANDA212399	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-740_f331dc6c-32cf-05f1-e053-2a95a90a56bb	51655-740	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20220923		ANDA	ANDA076416	Northwind Pharmaceuticals, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-742_da5708e0-d93b-611b-e053-2995a90a0879	51655-742	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210809		ANDA	ANDA212399	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-743_d9ce6e61-ce30-7755-e053-2995a90a943d	51655-743	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210629		ANDA	ANDA212517	Northwind Pharmaceuticals	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-744_da6b1dc9-36b2-7db4-e053-2a95a90a9703	51655-744	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20210709		ANDA	ANDA202882	Northwind Pharmaceuticals	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51655-746_f3321dc5-0fb8-0d12-e053-2a95a90a9694	51655-746	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20221230		ANDA	ANDA078235	Northwind Pharmaceuticals, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51655-747_da6b77a5-2094-b7f7-e053-2995a90ab10d	51655-747	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20210715		ANDA	ANDA209288	Northwind Pharmaceuticals	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-750_da6b9b19-2ea2-9a39-e053-2995a90ad730	51655-750	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20210712		ANDA	ANDA078619	Northwind Pharmaceuticals	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-753_f6f61a0e-3eef-c5bd-e053-6394a90ab281	51655-753	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20230124		ANDA	ANDA063011	Northwind Pharmaceuticals, LLC	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51655-754_0de6a6d0-a110-e114-e063-6394a90a34dd	51655-754	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210715		ANDA	ANDA206948	Northwind Pharmaceuticals	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20251231
51655-755_0a72bc4f-ee0b-f927-e063-6394a90a437d	51655-755	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20230403		ANDA	ANDA076820	Northwind Pharmaceuticals, LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
51655-756_da6bfffb-7b05-b522-e053-2a95a90a4736	51655-756	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20210719		ANDA	ANDA201619	Northwind Pharmaceuticals	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-757_da6c1de1-4bae-27ff-e053-2995a90acc5e	51655-757	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA072096	Northwind Pharmaceuticals	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-759_da6c3f54-e2b2-22d2-e053-2995a90a27c1	51655-759	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA090796	Northwind Pharmaceuticals	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-762_da6ce982-995e-5bed-e053-2a95a90a674f	51655-762	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210716		ANDA	ANDA206948	Northwind Pharmaceuticals	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
51655-763_da6fce58-0efa-f3b1-e053-2995a90a1bec	51655-763	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20210716		ANDA	ANDA087801	Northwind Pharmaceuticals	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-764_da704abd-4e61-f32e-e053-2a95a90a2830	51655-764	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20210719		UNAPPROVED DRUG OTHER		Northwind Pharmaceuticals	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
51655-765_da7f948f-803a-5f0d-e053-2a95a90ad0f0	51655-765	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20210730		ANDA	ANDA080292	Northwind Pharmaceuticals	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-766_da7feb56-5f59-7487-e053-2995a90a119e	51655-766	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20210727		ANDA	ANDA202389	Northwind Pharmaceuticals	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-767_da8042b5-708d-1da3-e053-2a95a90aa0bd	51655-767	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210802		ANDA	ANDA070322	Northwind Pharmaceuticals	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-774_f3402462-5d87-b4c9-e053-2a95a90aaab0	51655-774	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20220829		ANDA	ANDA090455	Northwind Pharmaceuticals, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
51655-776_da807eb3-349f-61b9-e053-2995a90a0e21	51655-776	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20210407		ANDA	ANDA040749	Northwind Pharmaceuticals	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
51655-780_da80fef1-9442-36ff-e053-2995a90adec5	51655-780	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20210802		ANDA	ANDA202987	Northwind Pharmaceuticals	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-782_da814e62-9fc7-87c9-e053-2a95a90a7cd1	51655-782	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20210804		ANDA	ANDA071587	Northwind Pharmaceuticals	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51655-783_da8280de-18c0-40c0-e053-2a95a90a1eb3	51655-783	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210812		ANDA	ANDA212399	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-790_da829e69-1c14-d5bf-e053-2a95a90a9048	51655-790	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20211104		ANDA	ANDA207222	Northwind Pharmaceuticals	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51655-791_d9ced981-d790-6600-e053-2995a90ace3b	51655-791	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220118		ANDA	ANDA090083	Northwind Pharmaceuticals	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-792_d9cefc55-7644-ce9b-e053-2a95a90aff12	51655-792	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20220120		ANDA	ANDA204770	Northwind Pharmaceuticals	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-793_d9ddfd2a-1962-90f9-e053-2a95a90a7f9b	51655-793	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20220120		ANDA	ANDA204883	Northwind Pharmaceuticals	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-794_d9de0817-cac2-4ee5-e053-2a95a90a5fa7	51655-794	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL	TABLET, FILM COATED	ORAL	20220120		ANDA	ANDA091448	Northwind Pharmaceuticals	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-795_d9de3627-9aa3-65c8-e053-2995a90ab5ec	51655-795	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220119		ANDA	ANDA090083	Northwind Pharmaceuticals	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-796_0ccb85a5-4b91-b30a-e063-6294a90a781b	51655-796	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20220218		ANDA	ANDA202330	Northwind Pharmaceuticals	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
51655-797_082791c9-6ae3-1451-e063-6294a90a6195	51655-797	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20220221		ANDA	ANDA202038	Northwind Pharmaceuticals, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51655-798_0ccbaf07-3b90-cd37-e063-6394a90a537a	51655-798	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220218		ANDA	ANDA075269	Northwind Pharmaceuticals	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-801_f70875ab-2430-4876-e053-6294a90a8092	51655-801	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA078343	Northwind Pharmaceuticals, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51655-809_f708b983-1314-b571-e053-6294a90ad39a	51655-809	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20201130		ANDA	ANDA090469	Northwind Pharmaceuticals, LLC	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-810_ffd8120d-fc3d-58f7-e053-6394a90a2430	51655-810	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20150930		ANDA	ANDA074223	Northwind Pharmaceuticals, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-813_db99c77a-0b02-9da6-e053-2a95a90a5199	51655-813	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20210610		ANDA	ANDA078539	Northwind Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-818_03fe93b8-667d-49ac-e063-6294a90a1657	51655-818	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20230131		ANDA	ANDA208170	Northwind Pharmaceuticals, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-820_da82b6af-3e64-5b9f-e053-2a95a90a8b31	51655-820	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20210707		ANDA	ANDA203814	Northwind Pharmaceuticals	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51655-828_0ccbbadf-2aaf-c4ea-e063-6394a90ac963	51655-828	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220221		ANDA	ANDA203835	Northwind Pharmaceuticals	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-831_f7091c54-0985-7f6e-e053-6394a90afb4d	51655-831	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230203		ANDA	ANDA083177	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51655-832_f755e514-d6b9-fae0-e053-6394a90a4380	51655-832	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20220223		ANDA	ANDA202433	Northwind Pharmaceuticals	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-834_f755ffef-66fc-1de5-e053-6294a90ab746	51655-834	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA203311	Northwind Pharmaceuticals, LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-841_f7568102-35e9-94e8-e053-6394a90afa83	51655-841	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230206		ANDA	ANDA077691	Northwind Pharmaceuticals, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-842_f99da162-f201-1c19-e053-6294a90acffb	51655-842	HUMAN OTC DRUG	Cetirizine Hydrochloride Tablets,10 mg		Cetirizine Hydrochloride	TABLET	ORAL	20230207		ANDA	ANDA078933	Northwind Pharmaceuticals, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51655-845_f75765ce-262d-e832-e053-6394a90a6066	51655-845	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate TAB		hyoscyamine sulfate	TABLET	ORAL	20230206		UNAPPROVED DRUG OTHER		Northwind Pharmaceuticals, LLC	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
51655-846_f86fabd0-26f2-c327-e053-6394a90a5ee1	51655-846	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20230330		NDA AUTHORIZED GENERIC	NDA021342	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-847_fb0873f4-2a04-1cf5-e053-6394a90ae944	51655-847	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20230410		ANDA	ANDA087479	Northwind Pharmaceuticals, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
51655-848_ffd80f45-e997-6e24-e053-6294a90a3b02	51655-848	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20230206		ANDA	ANDA078235	Northwind Pharmaceuticals, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51655-849_f757c500-0f16-a830-e053-6394a90a859c	51655-849	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230203		ANDA	ANDA200834	Northwind Pharmaceuticals, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51655-853_075f47ee-88ce-102b-e063-6394a90acbf8	51655-853	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20221007		ANDA	ANDA206145	Northwind Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
51655-854_f7584431-11ab-8213-e053-6294a90a1585	51655-854	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20230207		ANDA	ANDA204097	Northwind Pharmaceuticals, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51655-855_f7587226-3024-de46-e053-6294a90aad08	51655-855	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20230206		ANDA	ANDA078947	Northwind Pharmaceuticals, LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51655-856_f7590970-c54e-24e9-e053-6294a90ac400	51655-856	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20230213		ANDA	ANDA213864	Northwind Pharmaceuticals, LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
51655-860_fb0873f4-2a05-1cf5-e053-6394a90ae944	51655-860	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20230209		ANDA	ANDA040275	Northwind Pharmaceuticals, LLC	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
51655-861_ff97ce75-f6c8-7d64-e053-6294a90a91c3	51655-861	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20230215		ANDA	ANDA205936	Northwind Pharmaceuticals, LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51655-864_0542b81c-6592-4f91-e063-6294a90a246e	51655-864	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20230213		ANDA	ANDA071972	Northwind Pharmaceuticals, LLC	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-869_0de6a6d0-a111-e114-e063-6394a90a34dd	51655-869	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20230825		ANDA	ANDA077073	Northwind Pharmaceuticals, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
51655-873_f99e0b4c-e758-4ccd-e053-6294a90ab722	51655-873	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20230410		ANDA	ANDA078296	Northwind Pharmaceuticals, LLC	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-881_f76ba89d-3182-0479-e053-6294a90a33da	51655-881	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20220707		ANDA	ANDA090548	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-884_0ccbc25d-a39b-cc31-e063-6294a90aac6e	51655-884	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20220302		ANDA	ANDA200981	Northwind Pharmaceuticals	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-888_fa161c77-f15c-eb42-e053-6294a90a5e11	51655-888	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230418		ANDA	ANDA213854	Northwind Pharmaceuticals, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-889_f76bec18-e22f-6d9c-e053-6394a90a01cb	51655-889	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20230215		ANDA	ANDA077253	Northwind Pharmaceuticals, LLC	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51655-893_f76c23d5-26b7-cfb2-e053-6294a90aea42	51655-893	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220823		ANDA	ANDA075757	Northwind Pharmaceuticals, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51655-898_00c38fe8-d757-adf8-e063-6294a90a6aa8	51655-898	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20150811		ANDA	ANDA201013	Northwind Pharmaceuticals, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
51655-904_fb0892da-3db8-3202-e053-6394a90ab605	51655-904	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20230427		ANDA	ANDA091604	Northwind Pharmaceuticals, LLC	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-910_00b10a79-f4dd-4866-e063-6394a90a9b6a	51655-910	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20230614		ANDA	ANDA211610	Northwind Pharmaceuticals, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
51655-913_f76c3907-b263-3a38-e053-6294a90a4bbd	51655-913	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20210122		ANDA	ANDA090469	Northwind Pharmaceuticals	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-914_fe831731-7353-e6a2-e053-6294a90adb3d	51655-914	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20230615		ANDA	ANDA205096	Northwind Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
51655-915_ff0e0009-8baf-e0eb-e053-6294a90afa82	51655-915	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20230626		ANDA	ANDA075614	Northwind Pharmaceuticals, LLC	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-918_0ccbcb1e-813e-9a20-e063-6294a90ae516	51655-918	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220302		ANDA	ANDA090083	Northwind Pharmaceuticals	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
51655-919_fa16cb4e-d70b-d07f-e053-6294a90a9512	51655-919	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230420		ANDA	ANDA213854	Northwind Pharmaceuticals, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-920_f76c6280-1141-9ad8-e053-6294a90aa16a	51655-920	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20140311		ANDA	ANDA090548	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-921_f8720c95-a856-711d-e053-6394a90a42fe	51655-921	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20200707		ANDA	ANDA091624	Northwind Pharmaceuticals	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-922_0ccd2ec8-bc18-9709-e063-6294a90a3a9d	51655-922	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20220318		ANDA	ANDA210918	Northwind Pharmaceuticals, LLC	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51655-923_0828a3cc-5d8a-16ef-e063-6294a90a47d2	51655-923	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20220304		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-924_0829c35e-caee-c8bf-e063-6294a90abf05	51655-924	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20220304		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-928_f76d03b8-f8d7-59b8-e053-6394a90a3a3f	51655-928	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20220706		ANDA	ANDA078512	Northwind Pharmaceuticals, LLC	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-933_fbd4ee27-40e0-f228-e053-6294a90a4293	51655-933	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20220720		ANDA	ANDA078539	Northwind Pharmaceuticals, LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51655-934_f76d782a-59ff-2093-e053-6394a90a8668	51655-934	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220916		ANDA	ANDA204161	Northwind Pharmaceuticals, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51655-935_f76db66c-5624-9465-e053-6394a90a65ce	51655-935	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20220726		ANDA	ANDA088832	Northwind Pharmaceuticals, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-937_f77e87d5-8fb7-f658-e053-6294a90a9fe4	51655-937	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220727		ANDA	ANDA208898	Northwind Pharmaceuticals, LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-938_f77ee72c-c1ca-c1d5-e053-6294a90a52b0	51655-938	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20220727		ANDA	ANDA077534	Northwind Pharmaceuticals, LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-939_f77f4869-4be5-a8a7-e053-6394a90a760b	51655-939	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20220804		ANDA	ANDA084283	Northwind Pharmaceuticals, LLC	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-940_da82bf64-916d-5313-e053-2995a90a0b45	51655-940	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20210715		ANDA	ANDA040230	Northwind Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51655-942_f780290f-fbe3-103d-e053-6394a90a2f9e	51655-942	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20200521		ANDA	ANDA077870	Northwind Pharmaceuticals, LLC	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-943_082a2acf-f3d5-70d1-e063-6394a90a2809	51655-943	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20220330		ANDA	ANDA078384	Northwind Pharmaceuticals, LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
51655-945_f780a066-a92e-f388-e053-6394a90a3b76	51655-945	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220413		ANDA	ANDA204467	Northwind Pharmaceuticals	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51655-946_082ae54d-5079-8613-e063-6294a90ac112	51655-946	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20220323		ANDA	ANDA207687	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-947_f780bb91-483b-d1a6-e053-6294a90ab74b	51655-947	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20230221		ANDA	ANDA076710	Northwind Pharmaceuticals, LLC	LEVOFLOXACIN	250	mg/1			N	20241231
51655-948_04b3301f-e051-ed5d-e063-6294a90a819c	51655-948	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230220		NDA	NDA016620	Northwind Pharmaceuticals, LLC	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
51655-957_f9a09f20-d261-6d21-e053-6294a90a02bb	51655-957	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED	ORAL	20200601		ANDA	ANDA070994	Northwind Pharmaceuticals	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51655-959_f78158e1-0d25-1728-e053-6394a90a3b90	51655-959	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230131		ANDA	ANDA090700	Northwind Pharmaceuticals, LLC	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51655-961_082bcaa2-ef3a-bbbc-e063-6294a90a3ceb	51655-961	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20220323		ANDA	ANDA207222	Northwind Pharmaceuticals, LLC	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51655-962_0ccbbbba-658c-cd84-e063-6394a90a6b50	51655-962	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20220415		ANDA	ANDA070924	Northwind Pharmaceuticals	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51655-963_0ccbc25d-a396-cc31-e063-6294a90aac6e	51655-963	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20220504		ANDA	ANDA091240	Northwind Pharmaceuticals	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51655-964_0cf84463-3b80-fcdf-e063-6394a90a1967	51655-964	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20140617		ANDA	ANDA065061	Northwind Pharmaceuticals, LLC	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
51655-964_ff97ce75-f6cc-7d64-e053-6294a90a91c3	51655-964	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20230313		ANDA	ANDA065061	Northwind Pharmaceuticals, LLC	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
51655-965_ff97b682-aba1-e891-e053-6294a90ac865	51655-965	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20230627		ANDA	ANDA204313	Northwind Pharmaceuticals, LLC	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51655-966_ff9af4f1-67fa-93c1-e053-6294a90a4eaa	51655-966	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230627		ANDA	ANDA204720	Northwind Pharmaceuticals, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-967_ffbca7dc-f568-29a8-e053-6294a90af2b2	51655-967	HUMAN PRESCRIPTION DRUG	Alfuzosin hydrochloride		Alfuzosin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230629		ANDA	ANDA203192	Northwind Pharmaceuticals, LLC	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
51655-968_0ccba2fd-17bd-c673-e063-6394a90a7b05	51655-968	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220408		ANDA	ANDA071450	Northwind Pharmaceuticals	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
51655-969_f7e4b806-4a67-8dc7-e053-6294a90ac9c2	51655-969	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230228		ANDA	ANDA213999	Northwind Pharmaceuticals, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51655-972_03702662-832a-71b8-e063-6294a90a0a82	51655-972	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220922		ANDA	ANDA208412	Northwind Pharmaceuticals, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-973_f7e55ad0-0a17-10e6-e053-6394a90a3698	51655-973	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20220504		ANDA	ANDA090478	Northwind Pharmaceuticals	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51655-974_f99e2e7c-fc0c-1744-e053-6394a90a4b2c	51655-974	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20230228		ANDA	ANDA205245	Northwind Pharmaceuticals, LLC	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
51655-975_f7e60d2e-31a5-9d5e-e053-6394a90a0aa3	51655-975	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20230228		ANDA	ANDA091604	Northwind Pharmaceuticals, LLC	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-976_0867e4e2-2b5b-5e81-e063-6394a90adef3	51655-976	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20220413		ANDA	ANDA076341	Northwind Pharmaceuticals, LLC	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-981_087879b0-2c8e-f93f-e063-6294a90a8fe7	51655-981	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220420		ANDA	ANDA078619	Northwind Pharmaceuticals, LLC	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51655-982_f870dd4a-92a1-3a41-e053-6394a90a781c	51655-982	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20220504		ANDA	ANDA206928	Northwind Pharmaceuticals	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-983_f870d3e4-ee98-39db-e053-6394a90a38eb	51655-983	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20220504		ANDA	ANDA206928	Northwind Pharmaceuticals	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
51655-984_08792bef-95f6-5c25-e063-6394a90a774b	51655-984	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20220519		ANDA	ANDA206173	Northwind Pharmaceuticals, LLC	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51655-985_087acc9c-6315-e0ac-e063-6294a90ab257	51655-985	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20220504		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-986_0ccbaf07-3b92-cd37-e063-6394a90a537a	51655-986	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20220518		ANDA	ANDA071524	Northwind Pharmaceuticals	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
51655-987_087b453b-a688-77d1-e063-6394a90a68c8	51655-987	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220518		ANDA	ANDA206465	Northwind Pharmaceuticals, LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-988_0ccbaf07-3b91-cd37-e063-6394a90a537a	51655-988	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20220518		ANDA	ANDA213385	Northwind Pharmaceuticals	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51655-989_087c1f4d-a5db-5b0e-e063-6294a90a2db7	51655-989	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20220519		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-990_e3b031e9-5ab4-8c27-e053-2a95a90a0d08	51655-990	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220527		ANDA	ANDA203126	Northwind Pharmaceuticals	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51655-992_e3b09507-c11a-f18e-e053-2995a90a311a	51655-992	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20220603		ANDA	ANDA214129	Northwind Pharmaceuticals	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
51655-993_f86fe457-a1b5-e54d-e053-6294a90a9bc7	51655-993	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20230329		ANDA	ANDA040616	Northwind Pharmaceuticals, LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51655-994_e3b1478b-7c35-7a54-e053-2995a90ac643	51655-994	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20220627		ANDA	ANDA077321	Northwind Pharmaceuticals	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-995_e3b28bf9-b06b-c1ca-e053-2995a90ae910	51655-995	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20220624		ANDA	ANDA077321	Northwind Pharmaceuticals	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51655-996_e3d924b5-0787-46d3-e053-2995a90a027b	51655-996	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220627		ANDA	ANDA208898	Northwind Pharmaceuticals	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
51655-997_e3d94989-376f-4ffd-e053-2a95a90ad213	51655-997	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20220624		ANDA	ANDA209713	Northwind Pharmaceuticals	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
51655-998_fe070e2e-3e75-fb84-e053-6294a90afd88	51655-998	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20230227		ANDA	ANDA065095	Northwind Pharmaceuticals, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51655-999_fe071f65-e18b-8c64-e053-6394a90a61f8	51655-999	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230227		ANDA	ANDA077321	Northwind Pharmaceuticals, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
51660-027_df9b1217-4941-448a-9225-7c0684c141ff	51660-027	HUMAN OTC DRUG	Esomeprazole		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200814		ANDA	ANDA212866	Ohm Laboratories Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51660-029_ddcb30f2-969a-44af-a647-78d44ddcd37f	51660-029	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20190601		ANDA	ANDA207891	OHM LABORATORIES INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51660-037_5c658417-d5df-493c-a5c8-982decd7f2e1	51660-037	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA090818	Ohm Laboratories Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-057_efb49ad2-ac54-4918-9c5a-7228a6dfa21c	51660-057	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20210401		ANDA	ANDA212542	Ohm Laboratories, Inc.	GUAIFENESIN; PSEUDOEPHEDRINE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-058_efb49ad2-ac54-4918-9c5a-7228a6dfa21c	51660-058	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20210401		ANDA	ANDA212542	Ohm Laboratories, Inc.	GUAIFENESIN; PSEUDOEPHEDRINE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-061_0ae27ef3-b66f-469b-a0de-6cdd0a3a3a3f	51660-061	HUMAN OTC DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20180721		ANDA	ANDA210593	Ohm Laboratories Inc.	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
51660-066_1ae46a4b-8176-44fc-bc57-ed9e62c02746	51660-066	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, CHEWABLE	ORAL	20220721		ANDA	ANDA090142	OHM LABORATORIES INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51660-069_86ddd92a-920c-40b8-b0bd-29bfb3b38bfc	51660-069	HUMAN OTC DRUG	Loperamide HCl and Simethicone		Loperamide HCl and Simethicone	TABLET	ORAL	20220113		ANDA	ANDA077500	Ohm Laboratories Inc.	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
51660-106_39374c29-01cf-43ea-a597-c07f18a91b94	51660-106	HUMAN OTC DRUG	DYE-FREE CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20200901		ANDA	ANDA210088	Ohm Laboratories Inc.	LORATADINE	5	mg/1			N	20241231
51660-110_82aa6314-52a5-47ba-92c4-2340de30423c	51660-110	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20210701		ANDA	ANDA214781	OHM LABORATORIES INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51660-112_0ea6f0fd-9b11-1347-e063-6394a90a6b12	51660-112	HUMAN OTC DRUG	Dye-Free Childrens Loratadine		LORATADINE	TABLET, CHEWABLE	ORAL	20200819		ANDA	ANDA210088	Ohm Laboratories Inc.	LORATADINE	5	mg/1			N	20251231
51660-123_0ea718d4-6b42-b9ee-e063-6294a90a8111	51660-123	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Ohm Laboratories Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
51660-140_0ea6cbb4-10cd-fecf-e063-6394a90a513b	51660-140	HUMAN PRESCRIPTION DRUG	VALSARTAN		VALSARTAN	TABLET, FILM COATED	ORAL	20140707		ANDA	ANDA077492	Ohm Laboratories Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
51660-141_0ea6cbb4-10cd-fecf-e063-6394a90a513b	51660-141	HUMAN PRESCRIPTION DRUG	VALSARTAN		VALSARTAN	TABLET, FILM COATED	ORAL	20140707		ANDA	ANDA077492	Ohm Laboratories Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
51660-142_0ea6cbb4-10cd-fecf-e063-6394a90a513b	51660-142	HUMAN PRESCRIPTION DRUG	VALSARTAN		VALSARTAN	TABLET, FILM COATED	ORAL	20140707		ANDA	ANDA077492	Ohm Laboratories Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
51660-143_0ea6cbb4-10cd-fecf-e063-6394a90a513b	51660-143	HUMAN PRESCRIPTION DRUG	VALSARTAN		VALSARTAN	TABLET, FILM COATED	ORAL	20140707		ANDA	ANDA077492	Ohm Laboratories Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
51660-200_0a47e228-67b9-984b-e063-6394a90a652c	51660-200	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA207311	Ohm Laboratories Inc.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
51660-204_11bd16c8-f5e0-4dac-9667-f4ed02c6aee5	51660-204	HUMAN OTC DRUG	Pseudoephedrine hydrochloride		Pseudoephedrine hydrochloride	TABLET, FILM COATED	ORAL	20060428		ANDA	ANDA077442	Ohm Laboratories Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-301_eb963e6d-d883-41dd-96ed-5284d105a8f4	51660-301	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20210701		ANDA	ANDA214781	OHM LABORATORIES INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
51660-333_1dcbcf53-1ec5-4cd7-af8d-b4eec5d3d0b9	51660-333	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Ohm Laboratories Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
51660-423_cd566d12-38cf-4ae5-961e-427c64660c5d	51660-423	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine hydrochloride		ibuprofen and pseudoephedrine hydrochloride	TABLET, SUGAR COATED	ORAL	20011013		ANDA	ANDA074567	Ohm Laboratories Inc.	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-490_a2971a78-3eb0-4249-b2ec-040b5adf1b21	51660-490	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, SUGAR COATED	ORAL	20011013		ANDA	ANDA074567	Ohm Laboratories Inc.	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-491_37f65a08-f442-43ba-9691-556b6863aeb3	51660-491	HUMAN OTC DRUG	Loratadine and Pseudoephedrine		loratadine and pseudoephedrine	TABLET, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Ohm Laboratories Inc.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-492_060dbf55-8c1c-4c02-98e2-83cd6c0bd3fc	51660-492	HUMAN OTC DRUG	Pseudoephedrine hydrochloride		pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	Ohm Laboratories Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-493_f197efd7-d871-49e6-9984-51628bab7e8d	51660-493	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine hydrochloride		ibuprofen and pseudoephedrine hydrochloride	TABLET, SUGAR COATED	ORAL	20011013		ANDA	ANDA074567	Ohm Laboratories Inc.	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-526_ab379305-5823-49e9-89ca-641c1d37a6f3	51660-526	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20171101		ANDA	ANDA076134	OHM LABORATORIES INC.	LORATADINE	10	mg/1			N	20241231
51660-527_7b87d8ea-1102-4642-8a39-b2504dbda716	51660-527	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20070831		ANDA	ANDA077153	Ohm Laboratories Inc.	LORATADINE	10	mg/1			N	20241231
51660-566_3f025732-d30a-4d58-8c34-bc79e1f33a21	51660-566	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220401		ANDA	ANDA209254	Ohm Laboratories, Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
51660-567_3f025732-d30a-4d58-8c34-bc79e1f33a21	51660-567	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220401		ANDA	ANDA209254	Ohm Laboratories, Inc.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
51660-723_c82a6cf9-b461-411a-8ded-b33917bbdd51	51660-723	HUMAN OTC DRUG	Levonorgestrel		Levonorgestrel	TABLET	ORAL	20171101		ANDA	ANDA202635	Ohm Laboratories Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
51660-724_a0aa350d-1d73-4951-9b48-2b35a1ae55c3	51660-724	HUMAN OTC DRUG	Loratadine and Pseudoephedrine		loratadine and pseudoephedrine	TABLET, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Ohm Laboratories Inc.	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-753_48a60b3d-d011-4d0f-84dc-414c713c76ba	51660-753	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20180601		ANDA	ANDA210088	Ohm Laboratories Inc.	LORATADINE	5	mg/1			N	20241231
51660-754_0ea6e88f-9c46-1fe5-e063-6394a90ae867	51660-754	HUMAN OTC DRUG	Childrens Loratadine		LORATADINE	TABLET, CHEWABLE	ORAL	20180630		ANDA	ANDA210088	Ohm Laboratories Inc.	LORATADINE	5	mg/1			N	20251231
51660-939_2a87ee90-da59-4e35-9cda-27759ba080d4	51660-939	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	Ohm Laboratories Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51660-940_abfd39a3-e6e1-443e-b867-2571c1e03ca3	51660-940	HUMAN OTC DRUG	Allergy relief-D		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170502		ANDA	ANDA090922	Ohm Laboratories Inc.	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
51660-998_091c0633-b5d5-462a-8aa0-36ae245dbbbc	51660-998	HUMAN OTC DRUG	FEXOFENADINE HYDROCHLORIDE		FEXOFENADINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220429		ANDA	ANDA091567	OHM LABORATORIES INC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51660-999_e2f82980-16e0-47ef-9721-429e9b6205f1	51660-999	HUMAN OTC DRUG	Levonorgestrel		Levonorgestrel	TABLET	ORAL	20171101		ANDA	ANDA202635	Ohm Laboratories Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
51662-1200_9ef30198-d1e0-3fa8-e053-2995a90ae895	51662-1200	HUMAN PRESCRIPTION DRUG	ACTIVATED CHARCOAL		ACTIVATED CHARCOAL	SUSPENSION	ORAL	20181222		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	ACTIVATED CHARCOAL	208	mg/mL			N	20241231
51662-1201_075fc2cd-3b45-c167-e063-6294a90a76a2	51662-1201	HUMAN PRESCRIPTION DRUG	Adenosine Injection, 6mg/2mL (3mg/mL) Vial		Adenosine Injection, 6mg/2mL (3mg/mL) Vial	INJECTION, SOLUTION	INTRAVENOUS	20180714		ANDA	ANDA078076	HF Acquisition Co. LLC, DBA Health First	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
51662-1204_0e739cf0-6ac6-03b2-e063-6294a90a6548	51662-1204	HUMAN PRESCRIPTION DRUG	AMINOPHYLLINE		AMINOPHYLLINE	INJECTION, SOLUTION	INTRAVENOUS	20180913		ANDA	ANDA087242	HF Acquisition Co LLC, DBA HealthFirst	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20251231
51662-1205_082cbb74-8e0d-3f6b-e063-6394a90a6444	51662-1205	HUMAN PRESCRIPTION DRUG	AMIODARONE HYDROCHLORIDE		AMIODARONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180919		ANDA	ANDA077234	HF Acquisition Co LLC, DBA HealthFirst	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1207_ed26eb52-8a4a-17c2-e053-2a95a90ab7d9	51662-1207	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20180822		UNAPPROVED DRUG OTHER		HF Acquisition Co. LLC, DBA Health First	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1208_ed27cf17-ecf5-abf0-e053-2995a90a8f2d	51662-1208	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20180820		UNAPPROVED DRUG OTHER		HF Acquisition Co., LLC, DBA Health First	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1209_efa49433-1cfd-6f94-e053-2a95a90a0047	51662-1209	HUMAN PRESCRIPTION DRUG	CALCIUM CHLORIDE		CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS; INTRAVENTRICULAR	20180913		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
51662-1211_9ef9f290-2f30-3b88-e053-2a95a90a98dc	51662-1211	HUMAN PRESCRIPTION DRUG	5% DEXTROSE		5% DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20181018		NDA	NDA016367	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
51662-1213_ef6a78fb-553f-a83e-e053-2995a90a6164	51662-1213	HUMAN PRESCRIPTION DRUG	25% Dextrose Infant		25% Dextrose Infant	INJECTION, SOLUTION	INTRAVENOUS	20180819		NDA	NDA019445	HF Acquisition Co. LLC, DBA Health First	DEXTROSE MONOHYDRATE	250	mg/mL			N	20241231
51662-1214_9f932738-bc2e-0cac-e053-2a95a90aa47e	51662-1214	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20181006		NDA	NDA016367	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
51662-1215_ef6a86f1-40b3-ea77-e053-2a95a90a4f74	51662-1215	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20180913		NDA	NDA019445	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
51662-1216_a97b46df-2ba3-ad80-e053-2995a90ac2e5	51662-1216	HUMAN PRESCRIPTION DRUG	50% DEXTROSE		50% DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20180919		NDA	NDA019445	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
51662-1217_ba9e5740-c00b-1c7c-e053-2995a90afe34	51662-1217	HUMAN PRESCRIPTION DRUG	DIGOXIN		DIGOXIN	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180913		ANDA	ANDA083391	HF Acquisition Co LLC, DBA HealthFirst	DIGOXIN	.25	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
51662-1219_082ca650-156d-0847-e063-6394a90a7d79	51662-1219	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180816		ANDA	ANDA080817	HF Acquisition Co. LLC, DBA Health First	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51662-1220_ed270ace-8971-384a-e053-2995a90a7d1b	51662-1220	HUMAN PRESCRIPTION DRUG	DOPAMINE HCI		DOPAMINE HCI	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180823		NDA	NDA018132	HF Acquisition Co. LLC, DBA Health First	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1221_ba994a2d-ea6f-7d72-e053-2a95a90ab16e	51662-1221	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION, SOLUTION	ENDOTRACHEAL; INTRACARDIAC; INTRAVENOUS	20180917		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1222_ef6a8b2a-010d-10dd-e053-2a95a90a1555	51662-1222	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	SUBCUTANEOUS	20180914		NDA AUTHORIZED GENERIC	NDA020800	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.15	mg/.15mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1223_ef6a8b2a-010d-10dd-e053-2a95a90a1555	51662-1223	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	SUBCUTANEOUS	20180914		NDA AUTHORIZED GENERIC	NDA020800	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1224_ef6a8b2a-010e-10dd-e053-2a95a90a1555	51662-1224	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRAMUSCULAR	20180915		NDA	NDA019430	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1225_ef6a8b2a-010e-10dd-e053-2a95a90a1555	51662-1225	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRAMUSCULAR	20180915		NDA	NDA019430	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1226_dd449031-797d-e899-e053-2a95a90a0f4d	51662-1226	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180914		NDA	NDA018667	HF Acquisition Co LLC, DBA HealthFirst	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51662-1227_bd95eef1-b754-d72f-e053-2a95a90a8cc4	51662-1227	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180914		NDA	NDA018667	HF Acquisition Co LLC, DBA HealthFirst	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51662-1228_9f03d200-e490-fed3-e053-2a95a90a698a	51662-1228	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		LABETALOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180914		ANDA	ANDA075240	HF Acquisition Co LLC, DBA HealthFirst	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1229_9f03e438-5854-ed7b-e053-2995a90abec3	51662-1229	HUMAN PRESCRIPTION DRUG	LACTATED RINGERS AND DEXTROSE		SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM CHLORIDE, DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20181006		NDA	NDA017608	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 5; 30; 600; 310	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51662-1230_da6a6ce1-d108-86a7-e053-2a95a90aa8bc	51662-1230	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	INTRAVENOUS	20180825		ANDA	ANDA083158	HF Acquisition Co. LLC, DBA Health First	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1231_f7a82dc9-7fc3-dac0-e053-6294a90aa53d	51662-1231	HUMAN PRESCRIPTION DRUG	2% LIDOCAINE HCI		2% LIDOCAINE HCI	INJECTION, SOLUTION	INTRAVENOUS	20180825		ANDA	ANDA083158	HF Acquisition Co. LLC, DBA Health First	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1232_fa2aebcd-3cd7-5128-e053-6294a90ac612	51662-1232	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20180917		ANDA	ANDA089644	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 10	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1233_b8b7671f-1504-3b0a-e053-2995a90a3f0b	51662-1233	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20190628		ANDA	ANDA040078	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1235_e146645a-8afc-7326-e053-2a95a90ac5ce	51662-1235	HUMAN PRESCRIPTION DRUG	50% MAGNESIUM SULFATE		50% MAGNESIUM SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180825		ANDA	ANDA075151	HF Acquisition Co. LLC, DBA Health First	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51662-1238_ef6a784b-3d10-da51-e053-2a95a90ad05d	51662-1238	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180903		ANDA	ANDA070172	HF Acquisition Co. LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1239_ba9ec212-8f96-d2fe-e053-2995a90a4b42	51662-1239	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION	PARENTERAL	20180903		ANDA	ANDA072076	HF Acquisition Co. LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1240_07627f49-62b7-7d91-e063-6294a90a796d	51662-1240	HUMAN PRESCRIPTION DRUG	NARCAN NALOXONE HCI		NARCAN NALOXONE HCI	SPRAY	NASAL	20181015		NDA	NDA208411	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1242_086af8a0-3845-a687-e063-6294a90a7060	51662-1242	HUMAN PRESCRIPTION DRUG	NALOXONE HCI		NALOXONE HCI	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180818		ANDA	ANDA070256	HF Acquisition Co. LLC, DBA Health First	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1244_ef6a97a7-d1f3-2b32-e053-2995a90aaa24	51662-1244	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	SPRAY	ORAL	20180818		NDA	NDA018705	HF Acquisition Co. LLC, DBA Health First	NITROGLYCERIN	400	ug/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1245_05f45bd5-e309-93d9-e063-6294a90a92e6	51662-1245	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180923		ANDA	ANDA077541	HF Acquisition Co LLC, DBA HealthFirst	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51662-1246_ef6a97a7-d1f5-2b32-e053-2995a90aaa24	51662-1246	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20181119		ANDA	ANDA090469	HF Acquisition Co LLC, DBA HealthFirst	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51662-1247_ba9ec36f-2e7f-7529-e053-2a95a90a5bde	51662-1247	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HCI		PROMETHAZINE HCI	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180826		ANDA	ANDA083312	HF Acquisition Co. LLC, DBA HealthFirst	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51662-1248_f1c527cb-04ab-37c8-e053-2a95a90a045a	51662-1248	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HCI		PROMETHAZINE HCI	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180826		ANDA	ANDA083312	HF Acquisition Co. LLC, DBA HealthFirst	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51662-1249_086a3e12-f2cc-85f4-e063-6294a90a8c58	51662-1249	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HCI		PHENYLEPHRINE HCI	INJECTION	INTRAVENOUS	20180916		NDA	NDA203826	HF Acquisition Co LLC, DBA HealthFirst	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51662-1250_ef6a784b-3d13-da51-e053-2a95a90ad05d	51662-1250	HUMAN PRESCRIPTION DRUG	PHENYTOIN SODIUM		PHENYTOIN SODIUM	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180919		ANDA	ANDA084307	HF Acquisition Co LLC, DBA HealthFirst	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51662-1251_da641d25-ec13-41b1-e053-2995a90a9c5a	51662-1251	HUMAN PRESCRIPTION DRUG	PHENYTOIN SODIUM		PHENYTOIN SODIUM	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180916		ANDA	ANDA084307	HF Acquisition Co LLC, DBA HealthFirst	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51662-1253_ed270559-31e9-122b-e053-2a95a90aedc5	51662-1253	HUMAN PRESCRIPTION DRUG	FLUMAZENIL		FLUMAZENIL	INJECTION, SOLUTION	INTRAVENOUS	20180826		ANDA	ANDA078527	HF Acquisition Co. LLC, DBA Health First	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
51662-1254_e76dd025-7dda-6c73-e053-2995a90a6fff	51662-1254	HUMAN PRESCRIPTION DRUG	FLUMAZENIL		FLUMAZENIL	INJECTION, SOLUTION	INTRAVENOUS	20180901		ANDA	ANDA078527	HF Acquisition Co. LLC, DBA HealthFirst	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
51662-1255_ef6a86f1-40b4-ea77-e053-2a95a90a4f74	51662-1255	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20180917		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51662-1256_c17591ff-889c-5863-e053-2a95a90a4d53	51662-1256	HUMAN PRESCRIPTION DRUG	8.4% SODIUM BICARBONATE		8.4% SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20180901		UNAPPROVED DRUG OTHER		HF Acquisition Co. LLC, DBA HealthFirst	SODIUM BICARBONATE	84	mg/mL			N	20241231
51662-1257_ef6a86f1-40b5-ea77-e053-2a95a90a4f74	51662-1257	HUMAN PRESCRIPTION DRUG	BACTERIOSTATIC SODIUM CHLORIDE		BACTERIOSTATIC SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180917		NDA	NDA018800	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	9	mg/mL			N	20241231
51662-1258_9f1d52ba-9229-7ba9-e053-2995a90aad85	51662-1258	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181006		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1259_ef6c06e5-62e3-dd42-e053-2a95a90aad16	51662-1259	HUMAN PRESCRIPTION DRUG	BACTERIOSTATIC SODIUM CHLORIDE		BACTERIOSTATIC SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180919		NDA	NDA018800	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	9	mg/mL			N	20241231
51662-1260_9f1d664b-0437-293a-e053-2a95a90a6f7e	51662-1260	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181016		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1261_ed22b170-d455-4a37-e053-2995a90ac0be	51662-1261	HUMAN PRESCRIPTION DRUG	SOLU-CORTEF		SOLU-CORTEF	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180903		NDA	NDA009866	HF Acquisition Co. LLC, DBA HealthFirst	HYDROCORTISONE SODIUM SUCCINATE	100	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1262_ef6c032d-7810-d552-e053-2a95a90a84dc	51662-1262	HUMAN PRESCRIPTION DRUG	SOLU-CORTEF		SOLU-CORTEF	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180903		NDA	NDA009866	HF Acquisition Co. LLC, DBA HealthFirst	HYDROCORTISONE SODIUM SUCCINATE	250	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1263_086a9f2c-038b-e6cd-e063-6394a90a7373	51662-1263	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		SOLU-MEDROL	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180902		NDA	NDA011856	HF Acquisition Co. LLC, DBA HealthFirst	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1264_0869e794-6af2-034c-e063-6294a90a0c98	51662-1264	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		SOLU-MEDROL	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180902		NDA	NDA011856	HF Acquisition Co. LLC, DBA HealthFirst	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1265_9f1ee89b-abd0-49cf-e053-2995a90a873c	51662-1265	HUMAN PRESCRIPTION DRUG	STERILE WATER		STERILE WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180917		NDA	NDA018801	HF Acquisition Co LLC, DBA HealthFirst	WATER	1	mL/mL			N	20241231
51662-1266_9f1f2bf0-fda1-af5c-e053-2a95a90a24c0	51662-1266	HUMAN PRESCRIPTION DRUG	STERILE WATER		STERILE WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180902		NDA	NDA018801	HF Acquisition Co. LLC, DBA HealthFirst	WATER	1	mL/mL			N	20241231
51662-1267_0e75d235-5054-514b-e063-6394a90a6e8e	51662-1267	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180922		NDA	NDA020983	HF Acquisition Co LLC, DBA HealthFirst	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
51662-1269_b8b5924a-5529-1a4d-e053-2995a90a92c7	51662-1269	HUMAN PRESCRIPTION DRUG	VERAPAMIL HCI		VERAPAMIL HCI	INJECTION, SOLUTION	INTRAVENOUS	20180917		ANDA	ANDA070737	HF Acquisition Co LLC, DBA HealthFirst	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1270_ef6c0627-6859-7864-e053-2a95a90a2919	51662-1270	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180901		ANDA	ANDA075136	HF Acquisition Co. LLC, DBA HealthFirst	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1274_0dfa3df0-db89-be14-e063-6294a90a6a9d	51662-1274	HUMAN OTC DRUG	MEDIQUE APAP EXTRA STRENGTH acetaminophen tablet, film coated		MEDIQUE APAP EXTRA STRENGTH acetaminophen tablet, film coated	TABLET, FILM COATED	ORAL	20240102		OTC MONOGRAPH DRUG	505G(a)(3)	HF Acquisition Co LLC, DBA HealthFirst	ACETAMINOPHEN	500	mg/1			N	20251231
51662-1282_9f1f7d08-14cf-c279-e053-2995a90a6667	51662-1282	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20180919		ANDA	ANDA208191	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1282_ef6c1e17-5332-ac5f-e053-2995a90a83e4	51662-1282	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20210511		ANDA	ANDA208191	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1288_075fcd53-2b81-79c3-e063-6394a90a2c6a	51662-1288	HUMAN PRESCRIPTION DRUG	METOCLOPRAMIDE		METOCLOPRAMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180922		ANDA	ANDA073118	HF Acquisition Co LLC, DBA HealthFirst	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
51662-1289_076219c3-500c-def9-e063-6294a90a0468	51662-1289	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	ENDOTRACHEAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180923		NDA	NDA021146	HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1290_0813a29f-7653-2fc3-e063-6294a90a607d	51662-1290	HUMAN PRESCRIPTION DRUG	ADRENALIN (EPINEPHRINE)		ADRENALIN (EPINEPHRINE)	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20180921		NDA	NDA204200	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1291_e92162db-ea21-43f5-e053-2995a90ad4f8	51662-1291	HUMAN PRESCRIPTION DRUG	DOPAMINE HCI		DOPAMINE HCI	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180919		NDA	NDA018132	HF Acquisition Co LLC, DBA HealthFirst	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1292_ae80d94a-79ae-65d8-e053-2a95a90a5dac	51662-1292	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20180919		ANDA	ANDA074802	HF Acquisition Co LLC, DBA HealthFirst	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51662-1293_ef6c0627-685d-7864-e053-2a95a90a2919	51662-1293	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20181126		ANDA	ANDA077908	HF Acquisition Co LLC, DBA HealthFirst	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1295_ae80d94a-79ae-65d8-e053-2a95a90a5dac	51662-1295	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20180919		ANDA	ANDA074802	HF Acquisition Co LLC, DBA HealthFirst	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51662-1297_ba98fcd9-f73c-5fd3-e053-2995a90ae50d	51662-1297	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20190721		ANDA	ANDA084282	HF Acquisition Co LLC, DBA HealthFirst	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1300_9f03e438-5854-ed7b-e053-2995a90abec3	51662-1300	HUMAN PRESCRIPTION DRUG	LACTATED RINGERS		SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181006		NDA	NDA017641	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51662-1301_9f1fa99b-962b-073c-e053-2a95a90af2a4	51662-1301	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	IRRIGANT	IRRIGATION	20181018		NDA	NDA017514	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1302_efe725f1-35b2-3764-e053-2a95a90acb3c	51662-1302	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI AND DEXTROSE		LIDOCAINE HCI AND DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20190409		NDA	NDA018461	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	4	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1306_9f932738-bc2e-0cac-e053-2a95a90aa47e	51662-1306	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20181006		NDA	NDA016367	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
51662-1307_ef6c1e17-5335-ac5f-e053-2995a90a83e4	51662-1307	HUMAN PRESCRIPTION DRUG	ADRENALIN(R)		ADRENALIN(R)	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20180919		NDA	NDA204640	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1308_9f211ea1-1f0e-a9eb-e053-2995a90af9a9	51662-1308	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181018		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1310_f1de60da-96e7-74a6-e053-2995a90ab5f4	51662-1310	HUMAN PRESCRIPTION DRUG	INFANT 4.2% SODIUM BICARBONATE		INFANT 4.2% SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20181021		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	42	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51662-1311_ae808675-c055-7f6c-e053-2995a90a5b49	51662-1311	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20181006		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1312_ef6be610-0974-3a89-e053-2995a90a08bf	51662-1312	HUMAN PRESCRIPTION DRUG	CALCIUM GLUCONATE		CALCIUM GLUCONATE	INJECTION, SOLUTION	INTRAVENOUS	20181018		NDA	NDA208418	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
51662-1314_cfc4383a-4c3c-69a0-e053-2a95a90a268a	51662-1314	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION	INTRAVENOUS	20181117		NDA	NDA204485	HF Acquisition Co LLC, DBA HealthFirst	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
51662-1315_ba9ee8b4-ee9c-3d1b-e053-2995a90a11de	51662-1315	HUMAN PRESCRIPTION DRUG	LEVOPHED(R) NOREPINEPHRINE BITARTRATE		LEVOPHED(R) NOREPINEPHRINE BITARTRATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20181018		NDA	NDA007513	HF Acquisition Co LLC, DBA HealthFirst	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1316_e87f7a00-c8d7-7de0-e053-2a95a90a973c	51662-1316	HUMAN PRESCRIPTION DRUG	DOPAMINE HYDROCHLORIDE		DOPAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181019		NDA	NDA018826	HF Acquisition Co LLC, DBA HealthFirst	DOPAMINE HYDROCHLORIDE	1.6	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1317_ef6d1d51-1649-8884-e053-2a95a90a35e8	51662-1317	HUMAN PRESCRIPTION DRUG	6% HETASTARCH IN 0.9% SODIUM CHLORIDE		6% HETASTARCH IN 0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181126		ANDA	BA740193	HF Acquisition Co LLC, DBA HealthFirst	HETASTARCH	6	g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC], Starch [CS]		N	20241231
51662-1318_9f23308a-6c72-23df-e053-2995a90aefe8	51662-1318	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181126		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1320_07622550-07dd-f3b7-e063-6294a90ab38f	51662-1320	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION, SOLUTION	INTRAMUSCULAR	20180921		NDA	NDA201739	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1321_07622550-07dd-f3b7-e063-6294a90ab38f	51662-1321	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION, SOLUTION	INTRAMUSCULAR	20180921		NDA	NDA201739	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.15	mg/.15mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1322_ef6d3c4d-479f-d8e1-e053-2a95a90a1802	51662-1322	HUMAN PRESCRIPTION DRUG	ESMOLOL HYDROCHLORIDE		ESMOLOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181019		ANDA	ANDA076474	HF Acquisition Co LLC, DBA HealthFirst	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1323_ef6d3da2-6bf2-fbc7-e053-2a95a90a74cd	51662-1323	HUMAN PRESCRIPTION DRUG	GLUCAG0N		glucagon kit	KIT	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20181020		NDA	NDA020298	HF Acquisition Co LLC, DBA HealthFirst						N	20241231
51662-1325_ef6d3da2-6bf3-fbc7-e053-2a95a90a74cd	51662-1325	HUMAN PRESCRIPTION DRUG	EPHEDRINE SULFATE		EPHEDRINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20181021		NDA	NDA208943	HF Acquisition Co LLC, DBA HealthFirst	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1326_082b1c18-137d-002e-e063-6294a90ab3a9	51662-1326	HUMAN PRESCRIPTION DRUG	2% LIDOCAINE HCI		2% LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20181022		ANDA	ANDA088327	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1329_9f235abe-84cc-4c07-e053-2995a90aac0b	51662-1329	HUMAN PRESCRIPTION DRUG	STERILE WATER		STERILE WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20181008		NDA	NDA018801	HF Acquisition Co LLC, DBA HealthFirst	WATER	1	mL/mL			N	20241231
51662-1330_ef6d3da2-6bf5-fbc7-e053-2a95a90a74cd	51662-1330	HUMAN PRESCRIPTION DRUG	DOBUTAMINE		DOBUTAMINE	INJECTION, SOLUTION	INTRAVENOUS	20190407		NDA	NDA020201	HF Acquisition Co LLC, DBA HealthFirst	DOBUTAMINE HYDROCHLORIDE	200	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1331_9f2bdb4a-40dc-82db-e053-2995a90a7991	51662-1331	HUMAN PRESCRIPTION DRUG	RINGERS		SODIUM LACTATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20181021		NDA	NDA017641	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51662-1332_ef6d3bae-5390-440c-e053-2995a90a3a9f	51662-1332	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN IN DEXTROSE		NITROGLYCERIN, DEXTROSE	INJECTION	INTRAVENOUS	20181126		NDA	NDA019970	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	20	mg/100mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1333_9f2bf1d8-b0f3-fd8b-e053-2995a90aa3f1	51662-1333	HUMAN PRESCRIPTION DRUG	INTRALIPID		INTRALIPID	EMULSION	INTRAVENOUS	20181221		NDA	NDA018449	HF Acquisition Co LLC, DBA HealthFirst	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
51662-1334_e8809442-47d1-74d4-e053-2a95a90a4ff4	51662-1334	HUMAN PRESCRIPTION DRUG	PROCAINAMIDE HCI		PROCAINAMIDE HCI	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190210		ANDA	ANDA089069	HF Acquisition Co LLC, DBA HealthFirst	PROCAINAMIDE HYDROCHLORIDE	100	mg/mL	Antiarrhythmic [EPC]		N	20241231
51662-1335_f2a0ac76-9d93-eaad-e053-2a95a90a4d67	51662-1335	HUMAN PRESCRIPTION DRUG	DILTIAZEM HCI		DILTIAZEM HCI	INJECTION	INTRAVENOUS	20181221		ANDA	ANDA078538	HF Acquisition Co LLC, DBA HealthFirst	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51662-1336_082af01e-d219-1a22-e063-6394a90ae6b3	51662-1336	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181126		NDA	NDA018667	HF Acquisition Co LLC, DBA HealthFirst	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51662-1337_e1462e12-994e-a709-e053-2a95a90a9ded	51662-1337	HUMAN PRESCRIPTION DRUG	DOBUTAMINE		DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20181126		ANDA	ANDA074086	HF Acquisition Co LLC, DBA HealthFirst	DOBUTAMINE HYDROCHLORIDE	12.5	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1338_ea041758-28b2-4a63-e053-2a95a90a6343	51662-1338	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	INJECTION	INTRAVENOUS	20181222		ANDA	ANDA077760	HF Acquisition Co LLC, DBA HealthFirst	PROPRANOLOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1339_ef6d3da2-6bf8-fbc7-e053-2a95a90a74cd	51662-1339	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20181221		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1340_ef6d3da2-6bf9-fbc7-e053-2a95a90a74cd	51662-1340	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	OINTMENT	TOPICAL	20181222		ANDA	ANDA087355	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	20	mg/g	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1341_ba9e9615-df07-45a4-e053-2a95a90a0dd8	51662-1341	HUMAN PRESCRIPTION DRUG	AMINOPHYLLINE		AMINOPHYLLINE	INJECTION, SOLUTION	INTRAVENOUS	20190210		ANDA	ANDA087242	HF Acquisition Co LLC, DBA HealthFirst	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
51662-1342_9f2c4a73-8e22-2302-e053-2a95a90a78b2	51662-1342	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20181222		NDA	NDA018803	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1343_0e23d654-d8b7-af1c-e063-6294a90a6f14	51662-1343	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20181222		ANDA	ANDA087702	HF Acquisition Co LLC, DBA HealthFirst	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
51662-1345_ef6d5098-ac66-42c7-e053-2995a90aa48f	51662-1345	HUMAN PRESCRIPTION DRUG	ADENOSINE		ADENOSINE	INJECTION, SOLUTION	INTRAVENOUS	20181130		ANDA	ANDA203883	HF Acquisition Co LLC, DBA HealthFirst	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
51662-1346_ef6d3bae-5393-440c-e053-2995a90a3a9f	51662-1346	HUMAN PRESCRIPTION DRUG	CLONIDINE HCI		CLONIDINE HCI	INJECTION, SOLUTION	INTRAVENOUS	20181223		ANDA	ANDA200300	HF Acquisition Co LLC, DBA HealthFirst	CLONIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51662-1347_ef7bd5a0-02a5-7b66-e053-2995a90a8ffa	51662-1347	HUMAN PRESCRIPTION DRUG	CALCIUM GLUCONATE		CALCIUM GLUCONATE	INJECTION, SOLUTION	INTRAVENOUS	20181221		NDA	NDA208418	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
51662-1348_ef7bd6e6-d62c-7e93-e053-2a95a90aef83	51662-1348	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181126		ANDA	ANDA040466	HF Acquisition Co LLC, DBA HealthFirst	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51662-1351_ef7bda2f-c978-0108-e053-2995a90acb4e	51662-1351	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	SPRAY	ORAL	20181127		NDA	NDA018705	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	400	ug/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1352_e76df41f-037f-e4e1-e053-2995a90a5ed8	51662-1352	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		MAGNESIUM SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20181221		NDA	NDA020309	HF Acquisition Co LLC, DBA HealthFirst	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51662-1353_9f6bb8f9-02a0-0602-e053-2a95a90a3006	51662-1353	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		SUCCINYLCHOLINE CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190206		NDA	NDA008845	HF Acquisition Co LLC, DBA HealthFirst	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
51662-1354_bc7f0844-d97b-1b39-e053-2995a90a1fb9	51662-1354	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20190208		ANDA	ANDA078519	HF Acquisition Co LLC, DBA HealthFirst	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
51662-1355_bc7f145c-81b3-f8e7-e053-2a95a90add55	51662-1355	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20190210		ANDA	ANDA078519	HF Acquisition Co LLC, DBA HealthFirst	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
51662-1358_ef7bd6e6-d62d-7e93-e053-2a95a90aef83	51662-1358	HUMAN PRESCRIPTION DRUG	AMIODARONE HYDROCHLORIDE		AMIODARONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190706		ANDA	ANDA076217	HF Acquisition Co LLC, DBA HealthFirst	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1359_9f2ef5ec-018e-a56c-e053-2a95a90ae68b	51662-1359	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20190718		NDA	NDA018803	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1363_ef7bd6e6-d62f-7e93-e053-2a95a90aef83	51662-1363	HUMAN PRESCRIPTION DRUG	AMIODARONE HCI		AMIODARONE HCI	INJECTION, SOLUTION	INTRAVENOUS	20191208		ANDA	ANDA075761	HF Acquisition Co LLC, DBA HealthFirst	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1364_f1c5a9b4-7657-3041-e053-2995a90a851c	51662-1364	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	INTRAVENOUS	20191208		NDA	NDA017584	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1365_ef7bd5a0-02a7-7b66-e053-2995a90a8ffa	51662-1365	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL TARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20191208		ANDA	ANDA091045	HF Acquisition Co LLC, DBA HealthFirst	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1366_ef7bd6e6-d630-7e93-e053-2a95a90aef83	51662-1366	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191208		ANDA	ANDA076972	HF Acquisition Co LLC, DBA HealthFirst	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51662-1367_ef7bd5a0-02a8-7b66-e053-2995a90a8ffa	51662-1367	HUMAN PRESCRIPTION DRUG	METOCLOPRAMIDE		METOCLOPRAMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191014		ANDA	ANDA091392	HF Acquisition Co LLC, DBA HealthFirst	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/2mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
51662-1370_ef7bd5a0-02a9-7b66-e053-2995a90a8ffa	51662-1370	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191013		ANDA	ANDA084916	HF Acquisition Co LLC, DBA HealthFirst	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1371_ef7bd5a0-02aa-7b66-e053-2995a90a8ffa	51662-1371	HUMAN PRESCRIPTION DRUG	ESMOLOL HYDROCHLORIDE		ESMOLOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20191208		ANDA	ANDA076573	HF Acquisition Co LLC, DBA HealthFirst	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1372_ef7bd6e6-d631-7e93-e053-2a95a90aef83	51662-1372	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		MAGNESIUM SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191014		NDA	NDA019316	HF Acquisition Co LLC, DBA HealthFirst	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51662-1373_ef7bd6e6-d632-7e93-e053-2a95a90aef83	51662-1373	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		MAGNESIUM SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20191209		ANDA	ANDA206485	HF Acquisition Co LLC, DBA HealthFirst	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51662-1374_bc7f2c44-5f02-3331-e053-2995a90ae365	51662-1374	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191111		ANDA	ANDA040466	HF Acquisition Co LLC, DBA HealthFirst	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51662-1375_e9fd11b6-5cbd-ba83-e053-2a95a90a42af	51662-1375	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	INJECTION, SOLUTION	INTRAVENOUS	20191209		ANDA	ANDA075813	HF Acquisition Co LLC, DBA HealthFirst	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
51662-1376_c9161f60-594f-783c-e053-2995a90a15f4	51662-1376	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191209		ANDA	ANDA040388	HF Acquisition Co LLC, DBA HealthFirst	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51662-1377_a62e2a6a-6236-7580-e053-2a95a90aa2b0	51662-1377	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200521		ANDA	ANDA076974	HF Acquisition Co LLC, DBA HealthFirst	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51662-1378_9f2f9a5b-96e5-285d-e053-2a95a90a0a86	51662-1378	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION	PARENTERAL	20191015		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1379_f44ba3bb-ab4c-3cfb-e053-2995a90a045f	51662-1379	HUMAN PRESCRIPTION DRUG	CALCIUM CHLORIDE		CALCIUM CHLORIDE	INJECTION	INTRAVENOUS; INTRAVENTRICULAR	20191209		ANDA	ANDA203477	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
51662-1380_ef7bd5a0-02ac-7b66-e053-2995a90a8ffa	51662-1380	HUMAN PRESCRIPTION DRUG	DEXTROSE		DEXTROSE	INJECTION	PARENTERAL	20191029		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	500	mg/mL			N	20241231
51662-1381_ba8c02aa-7f62-6cf3-e053-2a95a90aa71e	51662-1381	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRACARDIAC; INTRAVENOUS	20210204		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1381_e651aebd-f61a-c3a6-e053-2995a90aea01	51662-1381	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRACARDIAC; INTRAVENOUS	20220815		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1382_fdb27c86-e330-771c-e053-6294a90a928d	51662-1382	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION	INTRAVENOUS	20191029		ANDA	ANDA083173	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1383_097e7e9a-77f3-a5d0-e063-6294a90a6926	51662-1383	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION	INTRAVENOUS	20200518		ANDA	ANDA203449	HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51662-1384_e3bd7e8a-9930-2eb9-e053-2a95a90a44c2	51662-1384	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191018		ANDA	ANDA080407	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1385_9f303df3-dfc6-0ea3-e053-2995a90a20f0	51662-1385	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191015		ANDA	ANDA070257	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1386_9f303e48-037c-6a48-e053-2a95a90a7cf1	51662-1386	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	INJECTION, SOLUTION	INTRAVENOUS	20191007		ANDA	ANDA072034	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	5	mg/mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1387_9f303e48-038d-6a48-e053-2a95a90a7cf1	51662-1387	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20191016		ANDA	ANDA080205	HF Acquisition Co LLC, DBA HealthFirst	POTASSIUM CHLORIDE	149	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51662-1388_9f305c82-dff2-5d77-e053-2995a90af693	51662-1388	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191007		ANDA	ANDA040730	HF Acquisition Co LLC, DBA HealthFirst	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51662-1389_f2a0d052-6a12-7c1f-e053-2995a90add40	51662-1389	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	JELLY	TOPICAL	20191018		ANDA	ANDA086283	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1390_ed27a836-95ca-a8a9-e053-2a95a90a6f0d	51662-1390	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		MAGNESIUM SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191007		NDA	NDA019316	HF Acquisition Co LLC, DBA HealthFirst	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51662-1391_a083f381-1615-304f-e053-2a95a90a27eb	51662-1391	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191008		ANDA	ANDA040572	HF Acquisition Co LLC, DBA HealthFirst	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1392_fa1acf3e-1366-8460-e053-6394a90a5d88	51662-1392	HUMAN PRESCRIPTION DRUG	PROCAINAMIDE HCI		PROCAINAMIDE HCI	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191016		ANDA	ANDA089070	HF Acquisition Co LLC, DBA HealthFirst	PROCAINAMIDE HYDROCHLORIDE	500	mg/mL	Antiarrhythmic [EPC]		N	20241231
51662-1393_9f30e8a9-73b2-8ca1-e053-2a95a90a0577	51662-1393	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN LINGUAL		NITROGLYCERIN LINGUAL	SPRAY	ORAL	20191009		ANDA	ANDA091496	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	400	ug/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1394_ba9e6a14-a147-92d2-e053-2a95a90ad481	51662-1394	HUMAN PRESCRIPTION DRUG	CYANOCOBALAMIN		CYANOCOBALAMIN	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20191018		ANDA	ANDA080515	HF Acquisition Co LLC, DBA HealthFirst	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
51662-1395_082ce9e5-e5c8-f78c-e063-6294a90a2bce	51662-1395	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI AND EPINEPHRINE		LIDOCAINE HCI AND EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191021		ANDA	ANDA089644	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 10	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1396_e5307e6d-53c1-ff68-e053-2a95a90abc20	51662-1396	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HYDROCHLORIDE		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	PERINEURAL	20191016		ANDA	ANDA070597	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1397_b9d4ad2a-07eb-0a86-e053-2a95a90a868b	51662-1397	HUMAN PRESCRIPTION DRUG	SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE)		SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE)	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191008		ANDA	ANDA070967	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1398_ba9e3388-7bcd-fb3a-e053-2995a90a1152	51662-1398	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20191017		ANDA	ANDA070737	HF Acquisition Co LLC, DBA HealthFirst	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1399_b9d51661-7f1b-9c7b-e053-2995a90a3c5a	51662-1399	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCI AND EPINEPHRINE		BUPIVACAINE HCI AND EPINEPHRINE	INJECTION, SOLUTION	PERINEURAL	20191209		ANDA	ANDA070968	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1400_9f30c710-81d1-1b52-e053-2a95a90a91b7	51662-1400	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20191019		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	42	mg/mL			N	20241231
51662-1401_da6f5ea1-361a-c53f-e053-2995a90a058a	51662-1401	HUMAN PRESCRIPTION DRUG	CHLOROPROCAINE HCI		CHLOROPROCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191013		NDA	NDA009435	HF Acquisition Co LLC, DBA HealthFirst	CHLOROPROCAINE HYDROCHLORIDE	20	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
51662-1402_da4567bf-0370-9c01-e053-2a95a90a377d	51662-1402	HUMAN PRESCRIPTION DRUG	DOXY 100(TM) DOXYCYCLINE		DOXY 100(TM) DOXYCYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191007		ANDA	ANDA062475	HF Acquisition Co LLC, DBA HealthFirst	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51662-1403_f1c7a605-e3c6-f7bb-e053-2a95a90ae595	51662-1403	HUMAN PRESCRIPTION DRUG	POLOCAINE(R) -MPF (MEPIVACAINE HCI)		POLOCAINE(R) -MPF (MEPIVACAINE HCI)	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20191210		ANDA	ANDA089406	HF Acquisition Co LLC, DBA HealthFirst	MEPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1404_9f31d2c6-c6a1-72d6-e053-2995a90a9795	51662-1404	HUMAN PRESCRIPTION DRUG	DOXAPRAM HYDROCHLORIDE		DOXAPRAM HYDROCHLORIDE	INJECTION	INTRAVENOUS	20191019		NDA	NDA014879	HF Acquisition Co LLC, DBA HealthFirst	DOXAPRAM HYDROCHLORIDE	20	mg/mL	Increased Medullary Respiratory Drive [PE], Respiratory Stimulant [EPC]		N	20241231
51662-1405_da6fd3dc-1acd-1cb1-e053-2a95a90a08cd	51662-1405	HUMAN PRESCRIPTION DRUG	XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)		XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20191111		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 10	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1406_9f31e587-ed76-31bf-e053-2995a90afbb8	51662-1406	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HCI		CHLORPROMAZINE HCI	INJECTION	INTRAMUSCULAR	20191021		ANDA	ANDA083329	HF Acquisition Co LLC, DBA HealthFirst	CHLORPROMAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51662-1407_ea03c55f-478f-157b-e053-2995a90a4cd1	51662-1407	HUMAN PRESCRIPTION DRUG	(CHLOROPROCAINE HCI		(CHLOROPROCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191013		NDA	NDA009435	HF Acquisition Co LLC, DBA HealthFirst	CHLOROPROCAINE HYDROCHLORIDE	10	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
51662-1408_f1c8de65-1803-b092-e053-2a95a90ad501	51662-1408	HUMAN PRESCRIPTION DRUG	CHLOROPROCAINE HCI		CHLOROPROCAINE HCI	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20191029		NDA	NDA009435	HF Acquisition Co LLC, DBA HealthFirst	CHLOROPROCAINE HYDROCHLORIDE	20	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
51662-1409_ed231b04-3495-3140-e053-2a95a90af2ee	51662-1409	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191111		NDA	NDA017029	HF Acquisition Co LLC, DBA HealthFirst	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
51662-1410_ef903461-8439-77a0-e053-2a95a90a6c2d	51662-1410	HUMAN PRESCRIPTION DRUG	PYRIDOXINE HCI		PYRIDOXINE HCI	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191008		ANDA	ANDA080618	HF Acquisition Co LLC, DBA HealthFirst	PYRIDOXINE HYDROCHLORIDE	100	mg/mL	Analogs/Derivatives [Chemical/Ingredient], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
51662-1411_05f96eeb-8067-5960-e063-6294a90a54fc	51662-1411	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20191111		NDA	NDA018916	HF Acquisition Co LLC, DBA HealthFirst	HEPARIN SODIUM	10000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
51662-1412_da6410d8-4563-3b1c-e053-2995a90afdc9	51662-1412	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE		LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20191014		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1413_9f33d1ba-0e05-0cbd-e053-2a95a90af992	51662-1413	HUMAN PRESCRIPTION DRUG	5% DEXTROSE		5% DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20191014		NDA	NDA016367	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
51662-1414_fe44bc49-aac2-f93c-e053-6294a90a461d	51662-1414	HUMAN PRESCRIPTION DRUG	PROTAMINE SULFATE		PROTAMINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20191013		ANDA	ANDA089454	HF Acquisition Co LLC, DBA HealthFirst	PROTAMINE SULFATE	10	mg/mL	Heparin Binding Activity [MoA], Heparin Reversal Agent [EPC], Reversed Anticoagulation Activity [PE]		N	20241231
51662-1415_9f33e3f2-3fd3-4fa0-e053-2a95a90aba01	51662-1415	HUMAN PRESCRIPTION DRUG	CHROMIUM CHROMIC CHLORIDE		CHROMIUM CHROMIC CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20191018		NDA	NDA018961	HF Acquisition Co LLC, DBA HealthFirst	CHROMIC CHLORIDE	4	ug/mL			N	20241231
51662-1416_f1dbd962-5c4f-1a6e-e053-2a95a90a0553	51662-1416	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191018		ANDA	ANDA088325	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1418_9f3402f0-5808-1ffc-e053-2995a90a1eb9	51662-1418	HUMAN PRESCRIPTION DRUG	NALBUPHINE HCI		NALBUPHINE HCI	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191029		ANDA	ANDA070918	HF Acquisition Co LLC, DBA HealthFirst	NALBUPHINE HYDROCHLORIDE	20	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
51662-1419_f1dca39b-3f65-114c-e053-2995a90a2d20	51662-1419	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191018		ANDA	ANDA089644	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 10	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1420_9f340f34-927a-5c1f-e053-2995a90a0b00	51662-1420	HUMAN PRESCRIPTION DRUG	NALBUPHINE HCI		NALBUPHINE HCI	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191029		ANDA	ANDA070915	HF Acquisition Co LLC, DBA HealthFirst	NALBUPHINE HYDROCHLORIDE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
51662-1421_9f341fda-4a12-d124-e053-2a95a90a424e	51662-1421	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20191018		ANDA	ANDA080205	HF Acquisition Co LLC, DBA HealthFirst	POTASSIUM CHLORIDE	149	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51662-1422_f2a02050-d11e-3983-e053-2a95a90a41d8	51662-1422	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20191210		ANDA	ANDA084625	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1423_9f340921-03ed-9a1c-e053-2995a90aa4a2	51662-1423	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN LINGUAL		NITROGLYCERIN LINGUAL	SPRAY	ORAL	20191009		ANDA	ANDA091496	HF Acquisition Co LLC, DBA HealthFirst	NITROGLYCERIN	400	ug/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
51662-1424_9f34d89a-4c89-2e76-e053-2995a90aac7d	51662-1424	HUMAN PRESCRIPTION DRUG	OFIRMEV (ACETAMINOPHEN)		OFIRMEV (ACETAMINOPHEN)	INJECTION, SOLUTION	INTRAVENOUS	20191221		NDA	NDA022450	HF Acquisition Co LLC, DBA HealthFirst	ACETAMINOPHEN	10	mg/mL			N	20241231
51662-1425_9f350776-c56a-6191-e053-2995a90aceba	51662-1425	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191221		ANDA	ANDA208973	HF Acquisition Co LLC, DBA HealthFirst	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51662-1426_9f34afb4-c009-0cbe-e053-2a95a90a91f7	51662-1426	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20200110		ANDA	ANDA207634	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1427_9f34afb4-c01b-0cbe-e053-2a95a90a91f7	51662-1427	HUMAN PRESCRIPTION DRUG	ESMOLOL HYDROCHLORIDE		ESMOLOL HYDROCHLORIDE	INJECTION	INTRAVENOUS	20191221		NDA	NDA019386	HF Acquisition Co LLC, DBA HealthFirst	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1428_a14a6a4d-232c-634f-e053-2a95a90a2323	51662-1428	HUMAN PRESCRIPTION DRUG	NICARDIPINE HYDROCHLORIDE		NICARDIPINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200320		NDA	NDA019734	HF Acquisition Co LLC, DBA HealthFirst	NICARDIPINE HYDROCHLORIDE	.1	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51662-1429_9f34d552-eda1-2b15-e053-2995a90a55c7	51662-1429	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE ACETATE		METHYLPREDNISOLONE ACETATE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20191221		ANDA	ANDA040557	HF Acquisition Co LLC, DBA HealthFirst	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1430_ef905718-1e91-c54c-e053-2a95a90a6465	51662-1430	HUMAN PRESCRIPTION DRUG	TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)		TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE)	INJECTION	INTRAMUSCULAR	20200110		NDA	NDA017530	HF Acquisition Co LLC, DBA HealthFirst	TRIMETHOBENZAMIDE HYDROCHLORIDE	100	mg/mL	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
51662-1431_9f350776-c56a-6191-e053-2995a90aceba	51662-1431	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191221		ANDA	ANDA208973	HF Acquisition Co LLC, DBA HealthFirst	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51662-1432_9f34beae-ebbe-2ba3-e053-2995a90affaf	51662-1432	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20191221		ANDA	ANDA206781	HF Acquisition Co LLC, DBA HealthFirst	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1434_9f3518fc-a386-67bb-e053-2a95a90a024a	51662-1434	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200110		ANDA	ANDA203198	HF Acquisition Co LLC, DBA HealthFirst	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
51662-1435_9f34a683-69ae-5f70-e053-2995a90a5c01	51662-1435	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200110		ANDA	ANDA207496	HF Acquisition Co LLC, DBA HealthFirst	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51662-1436_9f34beae-ebca-2ba3-e053-2995a90affaf	51662-1436	HUMAN PRESCRIPTION DRUG	BUFFERED PENICILLIN G POTASSIUM		BUFFERED PENICILLIN G POTASSIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200129		ANDA	ANDA065079	HF Acquisition Co LLC, DBA HealthFirst	PENICILLIN G POTASSIUM	5000000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
51662-1438_f2a02050-d11e-3983-e053-2a95a90a41d8	51662-1438	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl		LIDOCAINE HCl	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20191221		ANDA	ANDA084625	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1439_f1deeef3-92c7-a88e-e053-2a95a90a74a3	51662-1439	HUMAN PRESCRIPTION DRUG	PHYSOSTIGMINE SALICYLATE		PHYSOSTIGMINE SALICYLATE	INJECTION	INTRAVENOUS	20191222		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	PHYSOSTIGMINE SALICYLATE	1	mg/mL			N	20241231
51662-1440_9f36b94b-37b1-ecc1-e053-2995a90a86c2	51662-1440	HUMAN PRESCRIPTION DRUG	CYANOCOBALAMIN		CYANOCOBALAMIN	INJECTION, SOLUTION	INTRAMUSCULAR	20200129		ANDA	ANDA080737	HF Acquisition Co LLC, DBA HealthFirst	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
51662-1441_9f36b94b-379f-ecc1-e053-2995a90a86c2	51662-1441	HUMAN PRESCRIPTION DRUG	IRON DEXTRAN		IRON DEXTRAN	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191222		NDA	NDA017441	HF Acquisition Co LLC, DBA HealthFirst	IRON DEXTRAN	50	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51662-1442_9f36a623-9c17-c5b8-e053-2a95a90ae224	51662-1442	HUMAN PRESCRIPTION DRUG	VERAPAMIL HCI		VERAPAMIL HCI	INJECTION	INTRAVENOUS	20191222		NDA	NDA018925	HF Acquisition Co LLC, DBA HealthFirst	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1444_e87ff37b-dbeb-cd9d-e053-2995a90ab734	51662-1444	HUMAN PRESCRIPTION DRUG	ESMOLOL HYDROCHLORIDE		ESMOLOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20191222		ANDA	ANDA205520	HF Acquisition Co LLC, DBA HealthFirst	ESMOLOL HYDROCHLORIDE	100	mg/10mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1447_9f36abf9-c5a2-8143-e053-2995a90a5098	51662-1447	HUMAN PRESCRIPTION DRUG	DIPYRIDAMOLE		DIPYRIDAMOLE	INJECTION	INTRAVENOUS	20200110		ANDA	ANDA074521	HF Acquisition Co LLC, DBA HealthFirst	DIPYRIDAMOLE	5	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
51662-1448_ef7c1a32-f72b-3c5a-e053-2995a90abd43	51662-1448	HUMAN PRESCRIPTION DRUG	LEXISCAN(R) (REGADENOSON)		LEXISCAN(R) (REGADENOSON)	INJECTION, SOLUTION	INTRAVENOUS	20191210		NDA	NDA022161	HF Acquisition Co LLC, DBA HealthFirst	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
51662-1449_9f36ebb9-a22b-48b9-e053-2a95a90ab121	51662-1449	HUMAN PRESCRIPTION DRUG	BUMETANIDE		BUMETANIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200111		ANDA	ANDA079196	HF Acquisition Co LLC, DBA HealthFirst	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51662-1450_0c9264f7-1871-f6db-e063-6294a90a3f09	51662-1450	HUMAN PRESCRIPTION DRUG	ADENOSINE		ADENOSINE	INJECTION, SOLUTION	INTRAVENOUS	20191211		ANDA	ANDA077133	HF Acquisition Co LLC, DBA HealthFirst	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
51662-1451_9f36e116-ddb2-5d2d-e053-2a95a90a53f3	51662-1451	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		MAGNESIUM SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191211		NDA	NDA019316	HF Acquisition Co LLC, DBA HealthFirst	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51662-1452_097e92b8-ee77-02b6-e063-6294a90ace9a	51662-1452	HUMAN PRESCRIPTION DRUG	CALCIUM CHLORIDE		CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200710		NDA	NDA021117	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51662-1453_ef7c1a32-f72c-3c5a-e053-2995a90abd43	51662-1453	HUMAN PRESCRIPTION DRUG	DEXTROSE MONOHYDRATE		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20200111		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
51662-1455_9f42e2ee-41b5-a215-e053-2995a90a01a4	51662-1455	HUMAN PRESCRIPTION DRUG	AMIDATE(TM) ETOMIDATE		AMIDATE(TM) ETOMIDATE	INJECTION, SOLUTION	INTRAVENOUS	20191212		NDA	NDA018227	HF Acquisition Co LLC, DBA HealthFirst	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1456_b107e2b0-091e-b326-e053-2a95a90aa253	51662-1456	HUMAN PRESCRIPTION DRUG	BUPIVICAINE HYDROCHLORIDE		BUPIVICAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20191212		ANDA	ANDA070583	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1457_ef8fb8f1-b70c-18c8-e053-2a95a90a2384	51662-1457	HUMAN PRESCRIPTION DRUG	DILTIAZEM HCI		DILTIAZEM HCI	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191215		ANDA	ANDA075853	HF Acquisition Co LLC, DBA HealthFirst	DILTIAZEM HYDROCHLORIDE	100	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51662-1458_9f4303c0-4968-edf1-e053-2995a90ab806	51662-1458	HUMAN PRESCRIPTION DRUG	DOPAMINE HCI IN 5% DEXTROSE		DOPAMINE HCI IN 5% DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20191212		NDA	NDA018826	HF Acquisition Co LLC, DBA HealthFirst	DOPAMINE HYDROCHLORIDE	1.6	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1459_0762982e-561c-4595-e063-6394a90a58b3	51662-1459	HUMAN PRESCRIPTION DRUG	AMIDATE(TM) ETOMIDATE		AMIDATE(TM) ETOMIDATE	INJECTION, SOLUTION	INTRAVENOUS	20200331		NDA	NDA018227	HF Acquisition Co LLC, DBA HealthFirst	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1460_9f431f0d-dbe3-434b-e053-2a95a90a63ca	51662-1460	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191222		ANDA	ANDA088100	HF Acquisition Co LLC, DBA HealthFirst	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
51662-1461_9f433db1-0396-3448-e053-2a95a90a4d8a	51662-1461	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	INTRAVENOUS	20191215		ANDA	ANDA040302	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1463_9f42d7fd-d0da-41b5-e053-2a95a90ad5c7	51662-1463	HUMAN PRESCRIPTION DRUG	7.5% SODIUM BICARBONATE		7.5% SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20200129		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	75	mg/mL			N	20241231
51662-1464_9f4348ad-bd1d-1a07-e053-2995a90a85f0	51662-1464	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191212		NDA	NDA018803	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	9	mg/mL			N	20241231
51662-1465_9f435afe-c983-52e3-e053-2995a90a55e9	51662-1465	HUMAN PRESCRIPTION DRUG	1% LIDOCAINE HCI		1% LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191213		ANDA	ANDA088299	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1466_c91637f6-1e58-6498-e053-2a95a90ad635	51662-1466	HUMAN PRESCRIPTION DRUG	1% LIDOCAINE HCI		1% LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191213		ANDA	ANDA088299	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1467_9f435afe-c983-52e3-e053-2995a90a55e9	51662-1467	HUMAN PRESCRIPTION DRUG	2% LIDOCAINE HCI		2% LIDOCAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20191213		ANDA	ANDA088327	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1468_ef8ffb00-a24a-347d-e053-2995a90a34f4	51662-1468	HUMAN PRESCRIPTION DRUG	MANNITOL		MANNITOL	INJECTION, SOLUTION	INTRAVENOUS	20191213		NDA	NDA016269	HF Acquisition Co LLC, DBA HealthFirst	MANNITOL	12.5	g/50mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
51662-1469_9f42d7fd-d0c0-41b5-e053-2a95a90ad5c7	51662-1469	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191214		ANDA	ANDA077548	HF Acquisition Co LLC, DBA HealthFirst	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51662-1470_9f435afe-c99b-52e3-e053-2995a90a55e9	51662-1470	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20191214		ANDA	ANDA077908	HF Acquisition Co LLC, DBA HealthFirst	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1471_9f437ae6-878b-660b-e053-2995a90a5ff7	51662-1471	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20191215		ANDA	ANDA077908	HF Acquisition Co LLC, DBA HealthFirst	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1472_9f42d7fd-d0da-41b5-e053-2a95a90ad5c7	51662-1472	HUMAN PRESCRIPTION DRUG	PEDIATRIC 8.4% SODIUM BICARBONATE		PEDIATRIC 8.4% SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAMUSCULAR	20200129		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	84	mg/mL			N	20241231
51662-1473_9f44a882-1b9b-9af9-e053-2995a90aa062	51662-1473	HUMAN PRESCRIPTION DRUG	BACTERIOSTATIC WATER		BACTERIOSTATIC WATER	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191214		NDA	NDA018802	HF Acquisition Co LLC, DBA HealthFirst	WATER	1	mL/mL			N	20241231
51662-1474_9f450e2c-e0ad-377f-e053-2a95a90af33b	51662-1474	HUMAN PRESCRIPTION DRUG	STERILE WATER		STERILE WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191214		NDA	NDA018801	HF Acquisition Co LLC, DBA HealthFirst	WATER	1	mL/mL			N	20241231
51662-1475_9f44bf20-73cc-a2bc-e053-2995a90a27dc	51662-1475	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191215		ANDA	ANDA075164	HF Acquisition Co LLC, DBA HealthFirst	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
51662-1476_c71b0ae2-d021-7123-e053-2995a90ab01c	51662-1476	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION, SOLUTION	INTRAMUSCULAR	20191201		NDA	NDA201739	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.1	mg/.1mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1477_9f44bf20-73df-a2bc-e053-2995a90a27dc	51662-1477	HUMAN PRESCRIPTION DRUG	ENALAPRILAT		ENALAPRILAT	INJECTION	INTRAVENOUS	20200201		ANDA	ANDA078687	HF Acquisition Co LLC, DBA HealthFirst	ENALAPRILAT	1.25	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51662-1478_0623a299-0fdf-3cd7-e063-6294a90a35dd	51662-1478	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL TARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20191214		ANDA	ANDA078085	HF Acquisition Co LLC, DBA HealthFirst	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1480_9f449192-1707-4843-e053-2995a90a9a67	51662-1480	HUMAN PRESCRIPTION DRUG	NEXTERONE (AMIODARONE HCI)		NEXTERONE (AMIODARONE HCI)	INJECTION, SOLUTION	INTRAVENOUS	20200129		NDA	NDA022325	HF Acquisition Co LLC, DBA HealthFirst	AMIODARONE HYDROCHLORIDE	1.5	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1481_9f449192-1707-4843-e053-2995a90a9a67	51662-1481	HUMAN PRESCRIPTION DRUG	NEXTERONE (AMIODARONE HCI)		NEXTERONE (AMIODARONE HCI)	INJECTION, SOLUTION	INTRAVENOUS	20200129		NDA	NDA022325	HF Acquisition Co LLC, DBA HealthFirst	AMIODARONE HYDROCHLORIDE	1.8	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1482_9f450e2c-e098-377f-e053-2a95a90af33b	51662-1482	HUMAN PRESCRIPTION DRUG	NICARDIPINE HYDROCHLORIDE		NICARDIPINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20200201		NDA	NDA022276	HF Acquisition Co LLC, DBA HealthFirst	NICARDIPINE HYDROCHLORIDE	25	mg/10mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
51662-1483_9f44d6c2-6f0e-9bae-e053-2995a90a279e	51662-1483	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT		SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191214		NDA	NDA011856	HF Acquisition Co LLC, DBA HealthFirst	METHYLPREDNISOLONE SODIUM SUCCINATE	500	mg/4mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1484_9f44b29c-edb2-9bb4-e053-2995a90acf54	51662-1484	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200111		ANDA	ANDA090963	HF Acquisition Co LLC, DBA HealthFirst	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51662-1485_9f44d6c2-6f21-9bae-e053-2995a90a279e	51662-1485	HUMAN PRESCRIPTION DRUG	ETOMIDATE		ETOMIDATE	INJECTION	INTRAVENOUS	20200111		ANDA	ANDA202354	HF Acquisition Co LLC, DBA HealthFirst	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1486_a07195bc-7443-32b4-e053-2995a90a0151	51662-1486	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200309		ANDA	ANDA090571	HF Acquisition Co LLC, DBA HealthFirst	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
51662-1487_c9161f60-5951-783c-e053-2995a90a15f4	51662-1487	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200111		ANDA	ANDA090963	HF Acquisition Co LLC, DBA HealthFirst	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51662-1488_9f4486dd-7633-902d-e053-2a95a90a5479	51662-1488	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20200111		ANDA	ANDA204216	HF Acquisition Co LLC, DBA HealthFirst	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51662-1489_f1f298fa-0a95-a4f4-e053-2a95a90ac621	51662-1489	HUMAN PRESCRIPTION DRUG	DOPAMINE HYDROCHLORIDE		DOPAMINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210807		ANDA	ANDA207707	HF Acquisition Co LLC, DBA HealthFirst	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1490_c6c8539b-0daa-2d97-e053-2a95a90a3aa8	51662-1490	HUMAN PRESCRIPTION DRUG	DOPAMINE HYDROCHLORIDE		DOPAMINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210710		ANDA	ANDA207707	HF Acquisition Co LLC, DBA HealthFirst	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1493_9f454a28-ebef-2ce0-e053-2995a90a298c	51662-1493	HUMAN PRESCRIPTION DRUG	DEXTROSE MONOHYDRATE		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20200111		NDA	NDA016367	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	5	g/100mL			N	20241231
51662-1495_9f4536f0-d9de-3b36-e053-2a95a90ab8f1	51662-1495	HUMAN PRESCRIPTION DRUG	EVZIO(R) NALOXONE HCl		EVZIO(R) NALOXONE HCl	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20200111		NDA	NDA209862	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	2	mg/.4mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1497_9f454a28-ebff-2ce0-e053-2995a90a298c	51662-1497	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20200218		ANDA	ANDA202981	HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	42	mg/mL			N	20241231
51662-1498_a0845f53-edae-e28f-e053-2995a90a31cf	51662-1498	HUMAN PRESCRIPTION DRUG	GLUCAGON		GLUCAGON	KIT	INTRAMUSCULAR; INTRAVENOUS	20200310		NDA	NDA201849	HF Acquisition Co LLC, DBA HealthFirst						N	20241231
51662-1499_9f4536f0-d9cd-3b36-e053-2a95a90ab8f1	51662-1499	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	SOLUTION	RESPIRATORY (INHALATION)	20200129		ANDA	ANDA074880	HF Acquisition Co LLC, DBA HealthFirst	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
51662-1503_0762dcd2-6199-d505-e063-6294a90a2f2d	51662-1503	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl AND EPINEPHRINE		LIDOCAINE HCl AND EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20200311		ANDA	ANDA089646	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1504_097ef1e4-1c04-3059-e063-6294a90ad9fb	51662-1504	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl AND EPINEPHRINE		LIDOCAINE HCl AND EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20200311		ANDA	ANDA089646	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1505_097efe41-b22e-2dca-e063-6294a90ac3c3	51662-1505	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI AND EPINEPHRINE		LIDOCAINE HCI AND EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20200311		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1506_097f4ad6-37a8-500f-e063-6294a90aa55d	51662-1506	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI AND EPINEPHRINE		LIDOCAINE HCI AND EPINEPHRINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20200311		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1507_a035fca6-f253-75c3-e053-2a95a90a785f	51662-1507	HUMAN PRESCRIPTION DRUG	Epinephrine Convenience Kit		Epinephrine	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20200208		NDA	NDA204200	HF Acquisition Co LLC, DBA HealthFirst						N	20241231
51662-1508_c915aae5-c4e8-16cd-e053-2995a90a8b43	51662-1508	HUMAN PRESCRIPTION DRUG	GENTAMICIN		GENTAMICIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210510		ANDA	ANDA062366	HF Acquisition Co LLC, DBA HealthFirst	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
51662-1509_c4c658a0-93f1-6639-e053-2a95a90abffa	51662-1509	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210614		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1511_b98519b2-197f-5a71-e053-2995a90ab79a	51662-1511	HUMAN PRESCRIPTION DRUG	ADENOSINE		ADENOSINE	INJECTION	INTRAVENOUS	20210121		ANDA	ANDA077283	HF Acquisition Co LLC, DBA HealthFirst	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
51662-1513_ef7c1f9d-3076-5fc6-e053-2a95a90aafec	51662-1513	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200818		ANDA	ANDA203760	HF Acquisition Co LLC, DBA HealthFirst	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
51662-1514_b2a9ec04-4f1b-2767-e053-2995a90a7bc2	51662-1514	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20200331		ANDA	ANDA090469	HF Acquisition Co LLC, DBA HealthFirst	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51662-1516_a14ca7d9-de31-a303-e053-2a95a90a5304	51662-1516	HUMAN PRESCRIPTION DRUG	LACTATED RINGERS		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200320		NDA	NDA017641	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51662-1517_a2b8220f-e33b-51c3-e053-2995a90a0734	51662-1517	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200407		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1518_a2bba76a-08cf-6902-e053-2995a90ab9c9	51662-1518	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200407		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1520_a62b71db-8ba3-6f6b-e053-2a95a90a29d1	51662-1520	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200521		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1521_a62cf623-9b8b-37e0-e053-2995a90add5b	51662-1521	HUMAN PRESCRIPTION DRUG	LACTATED RINGERS AND DEXTROSE		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20200521		NDA	NDA017608	HF Acquisition Co LLC, DBA HealthFirst	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 5; 30; 600; 310	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51662-1522_ac0fd44a-3f3a-8d7e-e053-2995a90afeec	51662-1522	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200804		NDA	NDA016366	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	900	mg/100mL			N	20241231
51662-1523_ed22eab5-2438-d732-e053-2995a90a4ea0	51662-1523	HUMAN PRESCRIPTION DRUG	THIAMINE HCl		THIAMINE HCl	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210614		ANDA	ANDA080556	HF Acquisition Co LLC, DBA HealthFirst	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
51662-1524_beb6d1cf-98dc-d0a5-e053-2995a90ace90	51662-1524	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		Haloperidol Lactate	INJECTION, SOLUTION	INTRAMUSCULAR	20210329		ANDA	ANDA075689	HF Acquisition Co LLC, DBA HealthFirst	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
51662-1525_b972f6e4-4fa0-4c68-e053-2995a90ae11b	51662-1525	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		SUCCINYLCHOLINE CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210121		ANDA	ANDA210698	HF Acquisition Co LLC, DBA HealthFirst	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
51662-1526_c171f1d0-6de2-5730-e053-2995a90ac5de	51662-1526	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		SUCCINYLCHOLINE CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210503		ANDA	ANDA212638	HF Acquisition Co LLC, DBA HealthFirst	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
51662-1527_05fa67da-2012-fdac-e063-6294a90a1c8c	51662-1527	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION	INTRAVENOUS	20210425		ANDA	ANDA212461	HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1528_e37c871a-be8b-3101-e053-2995a90a6d56	51662-1528	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		NOREPINEPHRINE BITARTRATE	INJECTION	INTRAVENOUS	20210808		ANDA	ANDA203662	HF Acquisition Co LLC, DBA HealthFirst	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51662-1529_dec63a6d-67ff-9c7a-e053-2995a90a200c	51662-1529	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210715		ANDA	ANDA213209	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1531_c12156e6-96f5-23ea-e053-2995a90a4102	51662-1531	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION, SOLUTION	INTRAVENOUS	20210425		NDA	NDA209359	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1532_c54b7f45-69f6-bc1b-e053-2995a90a666f	51662-1532	HUMAN PRESCRIPTION DRUG	TRANEXAMIC ACID		TRANEXAMIC ACID	INJECTION, SOLUTION	INTRAVENOUS	20210620		ANDA	ANDA205035	HF Acquisition Co LLC, DBA HealthFirst	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
51662-1533_c915cb71-f04b-2377-e053-2995a90a5d92	51662-1533	HUMAN PRESCRIPTION DRUG	FLUORESCEIN		FLUORESCEIN	INJECTION	INTRAVENOUS	20210510		NDA	NDA022186	HF Acquisition Co LLC, DBA HealthFirst	FLUORESCEIN SODIUM	100	mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
51662-1534_c915cb71-f04c-2377-e053-2995a90a5d92	51662-1534	HUMAN PRESCRIPTION DRUG	POLOCAINE (MEPIVACAINE HCl)		POLOCAINE (MEPIVACAINE HCl)	INJECTION, SOLUTION	INFILTRATION	20210511		ANDA	ANDA089407	HF Acquisition Co LLC, DBA HealthFirst	MEPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1535_c915a68d-8e33-19a3-e053-2995a90a5313	51662-1535	HUMAN PRESCRIPTION DRUG	POLOCAINE (MEPIVACAINE HCl)		POLOCAINE (MEPIVACAINE HCl)	INJECTION, SOLUTION	INFILTRATION	20210510		ANDA	ANDA089410	HF Acquisition Co LLC, DBA HealthFirst	MEPIVACAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1536_c915ef02-f367-ee57-e053-2995a90a1588	51662-1536	HUMAN PRESCRIPTION DRUG	VITAMIN K1 - PHYTONADIONE		VITAMIN K1 - PHYTONADIONE	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210510		ANDA	ANDA087955	HF Acquisition Co LLC, DBA HealthFirst	PHYTONADIONE	10	mg/mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
51662-1537_cfc3a2b5-b057-0bef-e053-2995a90a7353	51662-1537	HUMAN PRESCRIPTION DRUG	VITAMIN K1 PHYTONADIONE		VITAMIN K1, PHYTONADIONE	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20211101		ANDA	ANDA087954	HF Acquisition Co LLC, DBA HealthFirst	PHYTONADIONE	2	mg/mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
51662-1538_f1de16f6-1bc1-4841-e053-2a95a90afaf2	51662-1538	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl		LIDOCAINE HCl	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20210503		ANDA	ANDA088329	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1539_cdb2c4b4-a20b-3f8f-e053-2a95a90aaf72	51662-1539	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, FILM COATED	ORAL	20211006		ANDA	ANDA076183	HF Acquisition Co LLC, DBA HealthFirst	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51662-1540_05f8c392-5fde-dd62-e063-6294a90aa177	51662-1540	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN		ACETAMINOPHEN	INJECTION, SOLUTION	INTRAVENOUS	20220409		ANDA	ANDA210969	HF Acquisition Co LLC, DBA HealthFirst	ACETAMINOPHEN	10	mg/mL			N	20241231
51662-1541_0c91fa8f-dc40-e004-e063-6294a90a6c3e	51662-1541	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220520		ANDA	ANDA210967	HF Acquisition Co LLC, DBA HealthFirst	DEXAMETHASONE SODIUM PHOSPHATE	100	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51662-1542_dc43b289-4f33-1c1e-e053-2995a90a3a23	51662-1542	HUMAN PRESCRIPTION DRUG	ETOMIDATE		ETOMIDATE	INJECTION, SOLUTION	INTRAVENOUS	20220409		ANDA	ANDA206126	HF Acquisition Co LLC, DBA HealthFirst	ETOMIDATE	40	mg/20mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1543_e37cda02-963d-92cf-e053-2a95a90aad95	51662-1543	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI		LIDOCAINE HCI	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20210807		ANDA	ANDA203082	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1544_dd43eb7b-f0e4-3be7-e053-2995a90ae672	51662-1544	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210808		ANDA	ANDA212455	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1545_dc444a4b-16eb-568d-e053-2995a90a53a7	51662-1545	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20220409		ANDA	ANDA206206	HF Acquisition Co LLC, DBA HealthFirst	ROCURONIUM BROMIDE	100	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
51662-1546_c76d45aa-9ee3-aa65-e053-2995a90a4702	51662-1546	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20210718		ANDA	ANDA206206	HF Acquisition Co LLC, DBA HealthFirst	ROCURONIUM BROMIDE	50	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
51662-1547_e51c763e-281a-341f-e053-2995a90a0565	51662-1547	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220731		ANDA	ANDA206670	HF Acquisition Co LLC, DBA HealthFirst	VECURONIUM BROMIDE	10	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
51662-1548_df7a677c-e654-5f4b-e053-2995a90a06b3	51662-1548	HUMAN PRESCRIPTION DRUG	VERAPAMIL HCI		VERAPAMIL HCI	INJECTION, SOLUTION	INTRAVENOUS	20220520		ANDA	ANDA212965	HF Acquisition Co LLC, DBA HealthFirst	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1549_df79ee3a-f0ee-1cc7-e053-2995a90af97f	51662-1549	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220520		ANDA	ANDA212965	HF Acquisition Co LLC, DBA HealthFirst	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51662-1550_e3cada58-aa1c-8792-e053-2a95a90a388f	51662-1550	HUMAN PRESCRIPTION DRUG	XYLOCAINE-MPF WITH EPI		XYLOCAINE-MPF WITH EPI	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20210628		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1551_c4bf5905-add8-1cb0-e053-2995a90a7334	51662-1551	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		LIDOCAINE HYDROCHLORIDE	JELLY	TOPICAL	20210614		ANDA	ANDA086283	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1552_c4c0df51-cc38-323d-e053-2995a90a154a	51662-1552	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		LIDOCAINE HYDROCHLORIDE	JELLY	TOPICAL	20210614		ANDA	ANDA086283	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1553_e842b45e-1606-197e-e053-2a95a90a9ba4	51662-1553	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl		LIDOCAINE HCl	SOLUTION	TOPICAL	20210614		ANDA	ANDA086364	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1554_c4c3be3a-ea29-864f-e053-2a95a90a701a	51662-1554	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210614		ANDA	ANDA090963	HF Acquisition Co LLC, DBA HealthFirst	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51662-1555_c3f1db01-58c0-2226-e053-2a95a90a8b33	51662-1555	HUMAN PRESCRIPTION DRUG	HYALURONIDASE		HYALURONIDASE	INJECTION, SOLUTION	SUBCUTANEOUS	20210604		BLA	BLA021859	HF Acquisition Co LLC, DBA HealthFirst	HYALURONIDASE (HUMAN RECOMBINANT)	150	[USP'U]/mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
51662-1556_c4c48277-eb9f-6150-e053-2a95a90ab21d	51662-1556	HUMAN PRESCRIPTION DRUG	METHYLERGONOVINE MALEATE		METHYLERGONOVINE MALEATE	INJECTION	INTRAVENOUS	20210614		ANDA	ANDA040889	HF Acquisition Co LLC, DBA HealthFirst	METHYLERGONOVINE MALEATE	.2	mg/mL	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
51662-1557_c4be8467-7b7f-551d-e053-2995a90a3045	51662-1557	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20210614		ANDA	ANDA209933	HF Acquisition Co LLC, DBA HealthFirst	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51662-1558_e181c18d-32a9-587e-e053-2995a90acc5b	51662-1558	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE EDISYLATE		PROCHLORPERAZINE EDISYLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220615		ANDA	ANDA089903	HF Acquisition Co LLC, DBA HealthFirst	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51662-1559_c77ef2f7-a847-5e05-e053-2995a90aaae0	51662-1559	HUMAN PRESCRIPTION DRUG	DICYCLOMINE HYDROCHLORIDE		DICYCLOMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR	20210719		ANDA	ANDA210257	HF Acquisition Co LLC, DBA HealthFirst	DICYCLOMINE HYDROCHLORIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51662-1560_e880b8d7-61c1-41cc-e053-2995a90aaaeb	51662-1560	HUMAN PRESCRIPTION DRUG	AMPICILLIN		AMPICILLIN	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220731		ANDA	ANDA065499	HF Acquisition Co LLC, DBA HealthFirst	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
51662-1562_c76f4b3b-9f94-349f-e053-2995a90a2d57	51662-1562	HUMAN PRESCRIPTION DRUG	SODIUM TETRADECYL SULFATE		SODIUM TETRADECYL SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20210718		ANDA	ANDA040541	HF Acquisition Co LLC, DBA HealthFirst	TETRADECYL HYDROGEN SULFATE (ESTER)	10	mg/mL			N	20241231
51662-1563_c59db022-bda9-1732-e053-2a95a90a24f8	51662-1563	HUMAN PRESCRIPTION DRUG	(SOTRADECOL) SODIUM TETRADECYL SULFATE		(SOTRADECOL) SODIUM TETRADECYL SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20210625		ANDA	ANDA040541	HF Acquisition Co LLC, DBA HealthFirst	TETRADECYL HYDROGEN SULFATE (ESTER)	30	mg/mL			N	20241231
51662-1564_c75971f8-9641-a6e8-e053-2995a90af654	51662-1564	HUMAN PRESCRIPTION DRUG	ZIPRASIDONE MESYLATE		ZIPRASIDONE MESYLATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20210717		ANDA	ANDA211908	HF Acquisition Co LLC, DBA HealthFirst	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda	51662-1565	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCI AND DEXTROSE		LIDOCAINE HCI AND DEXTROSE	INJECTION, SOLUTION	INTRAVENOUS	20210717		NDA	NDA019830	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	5; .8	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1566_c6cfbe58-1ec0-28dd-e053-2a95a90a193a	51662-1566	HUMAN PRESCRIPTION DRUG	DOBUTAMINE HYDROCHLORIDE		DOBUTAMINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210710		NDA	NDA020255	HF Acquisition Co LLC, DBA HealthFirst	DOBUTAMINE HYDROCHLORIDE	100	mg/100mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1567_c6cf2223-4a94-0b28-e053-2a95a90ade53	51662-1567	HUMAN PRESCRIPTION DRUG	COSYNTROPIN		COSYNTROPIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210710		ANDA	ANDA202147	HF Acquisition Co LLC, DBA HealthFirst	COSYNTROPIN	.25	mg/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
51662-1568_c59cb54c-bee6-96d6-e053-2995a90a767c	51662-1568	HUMAN PRESCRIPTION DRUG	VENOFER (IRON SUCROSE)		VENOFER (IRON SUCROSE)	INJECTION, SOLUTION	INTRAVENOUS	20210625		NDA	NDA021135	HF Acquisition Co LLC, DBA HealthFirst	IRON SUCROSE	20	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
51662-1572_e1473983-75b7-5788-e053-2a95a90a6b08	51662-1572	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210628		NDA	NDA018902	HF Acquisition Co LLC, DBA HealthFirst	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51662-1573_e51eddda-0034-2c92-e053-2a95a90a544a	51662-1573	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20220218		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51662-1574_e880ca9f-0828-2529-e053-2995a90a5625	51662-1574	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210628		NDA	NDA018902	HF Acquisition Co LLC, DBA HealthFirst	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51662-1575_c5d9b063-e3ff-ec2f-e053-2995a90ab3f2	51662-1575	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210628		NDA	NDA018902	HF Acquisition Co LLC, DBA HealthFirst	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51662-1576_e37d6b33-794f-aefa-e053-2a95a90a1d06	51662-1576	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210630		ANDA	ANDA210665	HF Acquisition Co LLC, DBA HealthFirst	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51662-1577_c755e41b-acbb-7234-e053-2995a90aff0f	51662-1577	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210717		ANDA	ANDA207310	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51662-1578_c72b193e-0688-e002-e053-2995a90a7182	51662-1578	HUMAN PRESCRIPTION DRUG	HEPARIN SODIUM IN SODIUM CHLORIDE		HEPARIN SODIUM IN SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210715		NDA	NDA017029	HF Acquisition Co LLC, DBA HealthFirst	HEPARIN SODIUM	10000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
51662-1579_c5da455f-3214-ab11-e053-2995a90a54ee	51662-1579	HUMAN PRESCRIPTION DRUG	FLUMAZENIL		FLUMAZENIL	INJECTION, SOLUTION	INTRAVENOUS	20210628		ANDA	ANDA076955	HF Acquisition Co LLC, DBA HealthFirst	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
51662-1581_e37e1599-db89-2fcd-e053-2995a90a00e5	51662-1581	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCI		BUPIVACAINE HCI	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220710		ANDA	ANDA207183	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1584_0c9147ad-592b-3f96-e063-6394a90aa516	51662-1584	HUMAN PRESCRIPTION DRUG	Dextrose monohydrate		Dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20220211		ANDA	ANDA203451	HF Acquisition Co LLC, DBA HealthFirst	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
51662-1586_e65e03c1-9a67-b30b-e053-2995a90aeb73	51662-1586	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220816		ANDA	ANDA213279	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1587_0bcbd676-6405-19a2-e063-6394a90ace9b	51662-1587	HUMAN PRESCRIPTION DRUG	XYLOCAIN (LIDOCAINE HCl )		XYLOCAINE (LIDOCAINE HCl )	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220615		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1588_e3a84fa0-25d4-9660-e053-2a95a90ac967	51662-1588	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCl		BUPIVACAINE HCl	INJECTION, SOLUTION	PERINEURAL	20220711		NDA	NDA018304	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1592_e3a84fa0-25d4-9660-e053-2a95a90ac967	51662-1592	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCl		BUPIVACAINE HCl	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220713		NDA	NDA018304	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1593_e39435a3-1f6a-78c5-e053-2995a90a7fc3	51662-1593	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl		LIDOCAINE HCl	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220711		ANDA	ANDA080408	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1594_e46ebc7f-584f-e2b7-e053-2995a90ad17b	51662-1594	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20220722		ANDA	ANDA075784	HF Acquisition Co LLC, DBA HealthFirst	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51662-1595_e8b91ddf-7223-57b9-e053-2995a90a0d8e	51662-1595	HUMAN PRESCRIPTION DRUG	AMPICILLIN		AMPICILLIN	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220818		ANDA	ANDA062719	HF Acquisition Co LLC, DBA HealthFirst	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
51662-1596_e8bc96bc-7877-4906-e053-2a95a90ae6ba	51662-1596	HUMAN PRESCRIPTION DRUG	LIDOCAINE HCl		LIDOCAINE HCl	INJECTION, SOLUTION	RETROBULBAR; TOPICAL; TRANSTRACHEAL	20220915		ANDA	ANDA088295	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1597_e9fbe619-2aff-f1d7-e053-2a95a90aab29	51662-1597	HUMAN PRESCRIPTION DRUG	GENTAMICIN SULFATE		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20221001		ANDA	ANDA062420	HF Acquisition Co LLC, DBA HealthFirst	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
51662-1600_e52fe254-8873-35ce-e053-2a95a90a339e	51662-1600	HUMAN PRESCRIPTION DRUG	0.5% LIDOCAINE HCl		0.5% LIDOCAINE HCl	INJECTION, SOLUTION	INFILTRATION; INTRAVENOUS	20220801		ANDA	ANDA088328	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1601_f2a06703-8682-4031-e053-2a95a90a7428	51662-1601	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220829		ANDA	ANDA090963	HF Acquisition Co LLC, DBA HealthFirst	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51662-1602_ea035948-1a97-5d6e-e053-2995a90a3e7b	51662-1602	HUMAN PRESCRIPTION DRUG	LABETALOL HCl		LABETALOL HCl	INJECTION	INTRAVENOUS	20220829		ANDA	ANDA075303	HF Acquisition Co LLC, DBA HealthFirst	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51662-1604_e8b987c8-b5cc-74cd-e053-2a95a90a5a93	51662-1604	HUMAN PRESCRIPTION DRUG	XYLOCAINE- MPF (LIDOCAINE HCl )		LIDOCAINE HCl	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20220915		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51662-1606_e5307e6d-53c1-ff68-e053-2a95a90abc20	51662-1606	HUMAN PRESCRIPTION DRUG	0.25% BUPIVACAINE HCl		0.25% BUPIVACAINE HCl	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20220801		ANDA	ANDA070590	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1607_e6666508-8193-10f8-e053-2995a90a530f	51662-1607	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION	INTRAVENOUS	20220816		NDA	NDA204485	HF Acquisition Co LLC, DBA HealthFirst	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
51662-1609_e5247ed5-6171-c13f-e053-2a95a90a4101	51662-1609	HUMAN PRESCRIPTION DRUG	0.9% SODIUM CHLORIDE		0.9% SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220731		ANDA	ANDA207956	HF Acquisition Co LLC, DBA HealthFirst	SODIUM CHLORIDE	9	g/1000mL			N	20241231
51662-1611_e5ebf7aa-fbe6-45b1-e053-2a95a90a5cbf	51662-1611	HUMAN PRESCRIPTION DRUG	GRAFCO SILVER NITRATE (75% SILVER NITRATE, 25% POTASSIUM NITRATE)		GRAFCO SILVER NITRATE (75% SILVER NITRATE, 25% POTASSIUM NITRATE)	STICK	TOPICAL	20220810		UNAPPROVED DRUG OTHER		HF Acquisition Co LLC, DBA HealthFirst	POTASSIUM NITRATE; SILVER NITRATE	12.74; 38.21	mg/1; mg/1			N	20241231
51662-1619_ed229b93-a192-259f-e053-2a95a90ae632	51662-1619	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION	ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20221001		ANDA	ANDA213561	HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1620_f8fcda15-8ba7-e66a-e053-6294a90a385c	51662-1620	HUMAN PRESCRIPTION DRUG	NALOXONE HCl		NALOXONE HCl	SPRAY	NASAL	20230410		ANDA	ANDA211951	HF Acquisition Co LLC, DBA HealthFirst	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
51662-1623_f5f03364-e71d-9bcd-e053-2995a90a8ada	51662-1623	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION	INTRAVENOUS	20230302		ANDA	ANDA214314	HF Acquisition Co LLC, DBA HealthFirst	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
51662-1626_06beb2c9-31b1-e46c-e063-6394a90a66d0	51662-1626	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20230713		ANDA	ANDA216120	HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1627_0bedba78-0ec1-79f2-e063-6294a90a7d9e	51662-1627	HUMAN PRESCRIPTION DRUG	Atropine sulfate		Atropine sulfate	INJECTION, SOLUTION	INTRAVENOUS	20230714		ANDA	ANDA216120	HF Acquisition Co LLC, DBA HealthFirst	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
51662-1629_f9c82678-5f4e-fded-e053-6394a90ac16d	51662-1629	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRAVENOUS	20230420		NDA	NDA211363	HF Acquisition Co LLC, DBA HealthFirst	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51662-1630_05bcd89f-38fb-a9c9-e063-6294a90a2c71	51662-1630	HUMAN PRESCRIPTION DRUG	PROCAINAMIDE HYDROCHLORIDE		PROCAINAMIDE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230623		ANDA	ANDA088636	HF Acquisition Co LLC, DBA HealthFirst	PROCAINAMIDE HYDROCHLORIDE	100	mg/mL	Antiarrhythmic [EPC]		N	20241231
51662-1631_fa6eb0f8-7c42-2e17-e053-6294a90ac8ca	51662-1631	HUMAN PRESCRIPTION DRUG	ADENOSINE		ADENOSINE	INJECTION	INTRAVENOUS	20230428		ANDA	ANDA078686	HF Acquisition Co LLC, DBA HealthFirst	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
51662-1632_ff0edf52-980f-63ff-e053-6394a90a46ae	51662-1632	HUMAN PRESCRIPTION DRUG	ADENOSINE		ADENOSINE	INJECTION, SOLUTION	INTRAVENOUS	20230623		ANDA	ANDA077133	HF Acquisition Co LLC, DBA HealthFirst	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
51662-1634_0635683b-880b-0cd4-e063-6394a90ab73e	51662-1634	HUMAN PRESCRIPTION DRUG	ETOMIDATE injection, solution		ETOMIDATE injection, solution	INJECTION, SOLUTION	INTRAVENOUS	20230925		ANDA	ANDA206126	HF Acquisition Co LLC, DBA HealthFirst	ETOMIDATE	20	mg/10mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
51662-1635_06446e9a-0e86-0623-e063-6294a90ac403	51662-1635	HUMAN PRESCRIPTION DRUG	THIAMINE HYDROCHLORIDE injection, solution		THIAMINE HYDROCHLORIDE injection, solution	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230926		ANDA	ANDA080571	HF Acquisition Co LLC, DBA HealthFirst	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
51662-1638_06c15208-c601-7173-e063-6394a90a2f94	51662-1638	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HYDROCHLORIDE injection, solution		BUPIVACAINE HYDROCHLORIDE injection, solution	INJECTION, SOLUTION	PERINEURAL	20160513		ANDA	ANDA207183	HF Acquisition Co LLC, DBA HealthFirst	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
51662-1640_074abb29-72da-b09f-e063-6294a90af0a9	51662-1640	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20230717		ANDA	ANDA205656	HF Acquisition Co LLC, DBA HealthFirst	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
51662-1645_0c6c5678-e988-b822-e063-6394a90ac88b	51662-1645	HUMAN PRESCRIPTION DRUG	XYLOCAINE		XYLOCAINE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	HF Acquisition Co LLC, DBA HealthFirst	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51672-1253_2b0274c4-7f1e-479c-a172-f1bd22c22797	51672-1253	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	19840626		NDA	NDA019117	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1254_2b0274c4-7f1e-479c-a172-f1bd22c22797	51672-1254	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	19890119		ANDA	ANDA072494	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1258_150f75cd-12c1-4bd9-8648-98ecf4537fb0	51672-1258	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	19960708		ANDA	ANDA074249	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1259_150f75cd-12c1-4bd9-8648-98ecf4537fb0	51672-1259	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	OINTMENT	TOPICAL	19960712		ANDA	ANDA074248	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1260_c36fc08c-8853-421c-9b84-96a67c04ea34	51672-1260	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	19960729		ANDA	ANDA074580	Taro Pharmaceuticals U.S.A., Inc.	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-1261_8febf251-2b84-4473-90ee-943b8b4380e3	51672-1261	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	GEL	TOPICAL	19980714		ANDA	ANDA074904	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1262_7751daa3-9f47-4c47-8235-2978e6ff30ef	51672-1262	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	OINTMENT	TOPICAL	19960607		ANDA	ANDA074286	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1263_4c8622ba-6683-49f1-95de-896e7ddd1a33	51672-1263	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	19871222		ANDA	ANDA062364	Taro Pharmaceuticals U.S.A., Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
51672-1264_2b0274c4-7f1e-479c-a172-f1bd22c22797	51672-1264	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	19990630		ANDA	ANDA075008	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1267_96478729-ff65-4daa-ab2a-8cd7e82ae534	51672-1267	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	PASTE	DENTAL	19861001		ANDA	ANDA070730	Taro Pharmaceuticals U.S.A., Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1269_26f72658-a9d0-44a4-ae37-b9df4cebd0e6	51672-1269	HUMAN PRESCRIPTION DRUG	BETAMETHASONE VALERATE		Betamethasone Valerate	CREAM	TOPICAL	19880106		ANDA	ANDA072041	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1270_8febf251-2b84-4473-90ee-943b8b4380e3	51672-1270	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	19901130		ANDA	ANDA073193	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1271_8febf251-2b84-4473-90ee-943b8b4380e3	51672-1271	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	19901130		ANDA	ANDA073210	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1272_4c8622ba-6683-49f1-95de-896e7ddd1a33	51672-1272	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	19930329		ANDA	ANDA063305	Taro Pharmaceuticals U.S.A., Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
51672-1273_05671e28-d9c2-4bab-9f0b-243efde67f16	51672-1273	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	19961231		ANDA	ANDA074799	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1274_060f74ef-0884-413b-92a7-28d06f6a578f	51672-1274	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	19920430		ANDA	ANDA073552	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1275_e3356d10-c970-4e82-be44-6e36d4414f5a	51672-1275	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19930831		ANDA	ANDA072640	Taro Pharmaceuticals U.S.A., Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-1279_2b0274c4-7f1e-479c-a172-f1bd22c22797	51672-1279	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	GEL	TOPICAL	19970729		ANDA	ANDA074935	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1280_3b4311a5-a164-4923-a138-dc6cf681be5a	51672-1280	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	19920630		ANDA	ANDA073548	Taro Pharmaceuticals U.S.A., Inc.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1281_3b4311a5-a164-4923-a138-dc6cf681be5a	51672-1281	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	OINTMENT	TOPICAL	19940803		ANDA	ANDA074254	Taro Pharmaceuticals U.S.A., Inc.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1282_81e9bdd6-e1b8-4364-a548-68d598784dee	51672-1282	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	19971126		ANDA	ANDA040039	Taro Pharmaceuticals U.S.A., Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1284_0eff3f9b-a7a4-4a98-9ba4-c4f1cd3d35c9	51672-1284	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	19940930		ANDA	ANDA040037	Taro Pharmaceuticals U.S.A., Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1289_d045b29c-a41d-4c90-8872-5a49ac877a92	51672-1289	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	19930128		ANDA	ANDA064022	Taro Pharmaceuticals U.S.A., Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
51672-1290_b47e0e0f-1047-44e0-b9ed-1a1a3e25e442	51672-1290	HUMAN PRESCRIPTION DRUG	Hydrocortisone Valerate		Hydrocortisone Valerate	CREAM	TOPICAL	19980825		ANDA	ANDA075042	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1292_b47e0e0f-1047-44e0-b9ed-1a1a3e25e442	51672-1292	HUMAN PRESCRIPTION DRUG	Hydrocortisone Valerate		Hydrocortisone Valerate	OINTMENT	TOPICAL	19980825		ANDA	ANDA075043	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1293_6460cb47-a350-4f71-aa53-0c0b08281025	51672-1293	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	SOLUTION	TOPICAL	19981116		ANDA	ANDA075224	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1294_150f75cd-12c1-4bd9-8648-98ecf4537fb0	51672-1294	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	GEL	TOPICAL	19990528		ANDA	ANDA075279	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1295_41024311-eec1-4ac6-81c3-e72aea75fc0f	51672-1295	HUMAN PRESCRIPTION DRUG	Diflorasone Diacetate		Diflorasone Diacetate	OINTMENT	TOPICAL	19990514		ANDA	ANDA075331	Taro Pharmaceuticals U.S.A., Inc.	DIFLORASONE DIACETATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1297_7952b861-44ab-4141-9117-fb17f8f44d65	51672-1297	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20000517		ANDA	ANDA075633	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1298_146e8ac5-b879-4b84-9e3f-f3b1748965dd	51672-1298	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20021218		ANDA	ANDA075638	Taro Pharmaceuticals U.S.A., Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51672-1300_0eb9ae45-97c0-e392-e063-6394a90a344e	51672-1300	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	LOTION	TOPICAL	20040528		ANDA	ANDA076216	Taro Pharmaceuticals U.S.A., Inc.	AMMONIUM LACTATE	120	mg/g	Acidifying Activity [MoA]		N	20251231
51672-1301_40cef773-5c0f-4ab9-82be-4baa650a9da2	51672-1301	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	CREAM	TOPICAL	20030410		ANDA	ANDA075883	Taro Pharmaceuticals U.S.A., Inc.	AMMONIUM LACTATE	120	mg/g	Acidifying Activity [MoA]		N	20241231
51672-1302_dc4ec072-d969-4af8-b9e6-a36a8a301112	51672-1302	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	CREAM	VAGINAL	20040406		ANDA	ANDA075953	Taro Pharmaceuticals U.S.A., Inc.	TERCONAZOLE	8	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-1303_43c14366-9dfd-4849-a2b0-c53223056c4d	51672-1303	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20021126		ANDA	ANDA076005	Taro Pharmaceuticals U.S.A., Inc.	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-1304_ca40b931-9a3c-4163-b8ad-47353b581864	51672-1304	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	CREAM	VAGINAL	20050119		ANDA	ANDA076043	Taro Pharmaceuticals U.S.A., Inc.	TERCONAZOLE	4	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-1305_68181662-60f5-4ec3-a6ce-a632a7e813e4	51672-1305	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	SOLUTION	TOPICAL	20060315		ANDA	ANDA076788	Taro Pharmaceuticals U.S.A., Inc.	MOMETASONE FUROATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1306_c32f560b-8291-4c70-b5aa-c24a226836a7	51672-1306	HUMAN PRESCRIPTION DRUG	Alclometasone dipropionate		Alclometasone dipropionate	CREAM	TOPICAL	20050915		ANDA	ANDA076587	Taro Pharmaceuticals U.S.A., Inc.	ALCLOMETASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1308_1003cd3d-c3d2-433b-82a1-03844326188d	51672-1308	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	LOTION	TOPICAL	20040728		ANDA	ANDA076493	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/mL; mg/mL	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1309_7e8170ad-6fa0-42b2-b5cc-fc56fb46ca0b	51672-1309	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	GEL	TOPICAL	20031202		ANDA	ANDA076508	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1310_facdc991-1981-4ca6-b10e-1f2cb5c3535e	51672-1310	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM, AUGMENTED	TOPICAL	20031209		ANDA	ANDA076543	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1311_90d94502-76d6-4b74-86f8-0ddc7aa44d63	51672-1311	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20041203		ANDA	ANDA076624	Taro Pharmaceuticals U.S.A., Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1312_49195b56-51d2-4404-96b3-c77a06a295c8	51672-1312	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20050923		ANDA	ANDA065170	Taro Pharmaceuticals U.S.A., Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
51672-1315_519a0520-c8d2-43b6-a45b-98c6e118eb1e	51672-1315	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20041221		ANDA	ANDA076679	Taro Pharmaceuticals U.S.A., Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1316_4f474a39-2f6e-4ade-818d-f626a04f51e2	51672-1316	HUMAN PRESCRIPTION DRUG	Alclometasone Dipropionate		Alclometasone dipropionate	OINTMENT	TOPICAL	20040729		ANDA	ANDA076730	Taro Pharmaceuticals U.S.A., Inc.	ALCLOMETASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1317_c6803523-be80-4491-b882-4a94513be731	51672-1317	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	OINTMENT, AUGMENTED	TOPICAL	20041012		ANDA	ANDA076753	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1318_64754c9c-d639-4976-8628-139562ff1c20	51672-1318	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		ciclopirox olamine	CREAM	TOPICAL	20050412		ANDA	ANDA076790	Taro Pharmaceuticals U.S.A., Inc.	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
51672-1321_bf6fd425-06da-4684-80ff-d75bc6f0947c	51672-1321	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	CREAM	TOPICAL	20050804		ANDA	ANDA077227	Taro Pharmaceuticals U.S.A., Inc.	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1322_9e50ab82-0f41-4034-bce0-747380a3d735	51672-1322	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	OINTMENT	TOPICAL	20041216		ANDA	ANDA076994	Taro Pharmaceuticals U.S.A., Inc.	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1323_25819de3-29fb-421e-ba38-0f933499c4ca	51672-1323	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SUSPENSION	TOPICAL	20050810		ANDA	ANDA077092	Taro Pharmaceuticals U.S.A., Inc.	CICLOPIROX OLAMINE	7.7	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
51672-1330_5c1feee6-4277-4071-9ee8-31ffbdbb8faf	51672-1330	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	SUPPOSITORY	VAGINAL	20070309		ANDA	ANDA077553	Taro Pharmaceuticals U.S.A., Inc.	TERCONAZOLE	80	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-1335_062b2f1d-cd7d-4aea-a8af-be1fee65ebfc	51672-1335	HUMAN PRESCRIPTION DRUG	Oralone		Triamcinolone Acetonide	PASTE	DENTAL	19861001		ANDA	ANDA070730	Taro Pharmaceuticals U.S.A., Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1340_d352f08e-d78e-4c1f-a624-7cd782209c60	51672-1340	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	LOTION, AUGMENTED	TOPICAL	20070521		ANDA	ANDA077477	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1347_0a87fa8b-5aa5-41d1-bea2-f73726faea8b	51672-1347	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SHAMPOO	TOPICAL	20210325		ANDA	ANDA214867	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1348_aa5df9db-13f0-4170-a0d5-2ec8db37c373	51672-1348	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	SOLUTION	ORAL	20120503		ANDA	ANDA079121	Taro Pharmaceuticals U.S.A., Inc.	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51672-1350_e341f74b-6d36-4f26-8af9-1f4b9c3d3efd	51672-1350	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	LOTION	TOPICAL	20120702		ANDA	ANDA200302	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1351_366c6876-0556-47cf-bd1f-b60e4391d144	51672-1351	HUMAN PRESCRIPTION DRUG	Ciclopirox		ciclopirox	SHAMPOO	TOPICAL	20110223		ANDA	ANDA090269	Taro Pharmaceuticals U.S.A., Inc.	CICLOPIROX	10	mg/.96mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
51672-1352_1b5da4d5-cba3-43c9-9254-419ffc90691e	51672-1352	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	OINTMENT	TOPICAL	19850117		NDA	NDA018594	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1353_0c2ce328-14a5-4c5d-9873-334f51d7c175	51672-1353	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20140714		ANDA	ANDA200734	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1356_49928caf-c898-43cc-95ee-e6f4b2060e2c	51672-1356	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	OIL	TOPICAL	20160519		ANDA	ANDA202368	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINOLONE ACETONIDE	.11	mg/118.28mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1357_286d0980-2b85-4bf4-8332-548da0ddad4b	51672-1357	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	OIL	TOPICAL	20160519		ANDA	ANDA209336	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINOLONE ACETONIDE	.11	mg/118.28mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1358_13008703-e555-4697-8d92-951d60351451	51672-1358	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20141126		ANDA	ANDA203818	Taro Pharmaceuticals U.S.A., Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-1359_528cc84f-ae30-4b07-b4ff-9ff044f76522	51672-1359	HUMAN PRESCRIPTION DRUG	Oxiconazole Nitrate		Oxiconazole Nitrate	CREAM	TOPICAL	20160307		ANDA	ANDA205076	Taro Pharmaceuticals U.S.A., Inc.	OXICONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-1360_318fdb7d-10d9-49cf-bbd1-0a7480b962d9	51672-1360	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	TOPICAL	20161221		ANDA	ANDA205469	Taro Pharmaceuticals U.S.A., Inc.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
51672-1362_067fb7e0-1f18-4e14-8f10-8eca25f5fde4	51672-1362	HUMAN PRESCRIPTION DRUG	Naftifine Hydrochloride		Naftifine Hydrochloride	CREAM	TOPICAL	20160908		ANDA	ANDA205975	Taro Pharmaceuticals U.S.A., Inc.	NAFTIFINE HYDROCHLORIDE	10	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
51672-1363_bee6bcb3-bcd8-4e63-99f6-820aa20150c8	51672-1363	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20160428		ANDA	ANDA206298	Taro Pharmaceuticals U.S.A., Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-1364_125f6e42-b3a2-41be-911d-39acb86c19d8	51672-1364	HUMAN PRESCRIPTION DRUG	ADAPALENE and BENZOYL PEROXIDE		ADAPALENE and BENZOYL PEROXIDE	GEL	TOPICAL	20180124		ANDA	ANDA206959	Taro Pharmaceuticals U.S.A., Inc.	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1365_da8607e3-0065-4646-a45d-a18b044bde21	51672-1365	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		fluocinolone acetonide	SOLUTION	TOPICAL	20150327		ANDA	ANDA089124	Taro Pharmaceuticals U.S.A., Inc.	FLUOCINOLONE ACETONIDE	.1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1366_db958941-32f2-47ba-8b8f-a9fcf6560edb	51672-1366	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20171215		ANDA	ANDA206218	Taro Pharmaceuticals U.S.A., Inc.	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
51672-1367_31e7b626-56fd-4d25-ac69-df91c2603f7c	51672-1367	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20190819		ANDA	ANDA206575	Taro Pharmaceuticals U.S.A., Inc.	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	25; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
51672-1368_c87c4720-553b-44bb-a8de-892ea40183c2	51672-1368	HUMAN PRESCRIPTION DRUG	Naftifine Hydrochloride		Naftifine Hydrochloride	CREAM	TOPICAL	20160106		ANDA	ANDA206901	Taro Pharmaceuticals U.S.A., Inc.	NAFTIFINE HYDROCHLORIDE	20	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
51672-1369_a529e577-2335-4fda-83eb-43cf41d456b3	51672-1369	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230531		ANDA	ANDA208098	Taro Pharmaceuticals U.S.A., Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-1370_2e376ae7-c2e9-44bc-b724-9358d2a28be6	51672-1370	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin Calcium	CREAM	TOPICAL	20200427		ANDA	ANDA207116	Taro Pharmaceuticals U.S.A., Inc.	MUPIROCIN CALCIUM	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
51672-1371_47d64a81-91ca-40e9-83f2-8312f063577e	51672-1371	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SPRAY	TOPICAL	20180326		ANDA	ANDA208842	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.05	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1373_c47b0254-ae17-4e0e-a094-99104d1c7c7a	51672-1373	HUMAN PRESCRIPTION DRUG	Tazarotene		Tazarotene	CREAM	TOPICAL	20170403		ANDA	ANDA208258	Taro Pharmaceuticals U.S.A., Inc.	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1374_e8ef4870-6351-4567-adb4-b8a8778183ad	51672-1374	HUMAN PRESCRIPTION DRUG	Tazarotene		Tazarotene	CREAM	TOPICAL	20170403		ANDA	ANDA208258	Taro Pharmaceuticals U.S.A., Inc.	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1376_9ffda8a6-78db-4240-a35f-5f63b0526d16	51672-1376	HUMAN PRESCRIPTION DRUG	Naftifine Hydrochloride		Naftifine Hydrochloride	GEL	TOPICAL	20230401		ANDA	ANDA208201	Taro Pharmaceuticals U.S.A., Inc.	NAFTIFINE HYDROCHLORIDE	20	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
51672-1377_ab2a35c8-f4cd-41a7-966d-9e168009ed64	51672-1377	HUMAN PRESCRIPTION DRUG	Adapalene		Adapalene	GEL	TOPICAL	20160623		ANDA	ANDA208322	Taro Pharmaceuticals U.S.A., Inc.	ADAPALENE	3	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1381_608c6bb5-2c37-406b-a9b6-f79bc30367c1	51672-1381	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin and Benzoyl Peroxide Gel	KIT		20180525		ANDA	ANDA208776	Taro Pharmaceuticals U.S.A., Inc.						N	20241231
51672-1381_7fd6345a-1c24-4b89-b4c8-3652f9790b6a	51672-1381	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin and Benzoyl Peroxide Gel	KIT		20200121		ANDA	ANDA208776	Taro Pharmaceuticals U.S.A., Inc.						N	20241231
51672-1381_920db728-ae2e-4fdf-a9f7-4762abd81295	51672-1381	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin and Benzoyl Peroxide Gel	KIT		20200121		ANDA	ANDA208776	Taro Pharmaceuticals U.S.A., Inc.						N	20241231
51672-1381_f0d6e414-82dc-489a-85a2-939f3c7aa46b	51672-1381	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin and Benzoyl Peroxide Gel	KIT		20180525		ANDA	ANDA208776	Taro Pharmaceuticals U.S.A., Inc.						N	20241231
51672-1384_8b95551a-4272-47ed-b3b6-7155df5e43eb	51672-1384	HUMAN PRESCRIPTION DRUG	Adapalene and Benzoyl Peroxide		ADAPALENE and BENZOYL PEROXIDE	GEL	TOPICAL	20181017		ANDA	ANDA209148	Taro Pharmaceuticals U.S.A., Inc.	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1385_3c25eb48-a189-41d5-8c93-8940ddafcea6	51672-1385	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170623		ANDA	ANDA209204	Taro Pharmaceuticals U.S.A., Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-1386_3bf60a1f-44db-449f-be34-7e6147138c2b	51672-1386	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20161027		ANDA	ANDA071500	Taro Pharmaceuticals U.S.A., inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1387_376bd0ae-c2d6-4807-a79b-ec3f62cca6de	51672-1387	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20171016		ANDA	ANDA209506	Taro Pharmaceuticals U.S.A., Inc.	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
51672-1388_11bff382-bdba-42f9-9fe7-21d95c085c3b	51672-1388	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20190626		ANDA	ANDA210191	Taro Pharmaceuticals U.S.A., Inc.	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
51672-1389_f88be93e-6bb0-41d0-9628-68488a211e78	51672-1389	HUMAN PRESCRIPTION DRUG	Azelaic Acid		Azelaic Acid	GEL	TOPICAL	20190823		ANDA	ANDA210549	Taro Pharmaceuticals U.S.A., Inc.	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
51672-1390_bd35d866-131a-4018-9e03-66d751eb43cc	51672-1390	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	SPRAY	TOPICAL	20200617		ANDA	ANDA211722	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1394_181b3b98-3ee1-404c-b1a8-c721f6ada207	51672-1394	HUMAN PRESCRIPTION DRUG	Tretinoin		tretinoin	CREAM	TOPICAL	20190125		ANDA	ANDA211644	Taro Pharmaceuticals U.S.A., Inc.	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1395_bd6801aa-246d-4788-8275-3d5c93b6f076	51672-1395	HUMAN PRESCRIPTION DRUG	Tretinoin		tretinoin	CREAM	TOPICAL	20190122		ANDA	ANDA211645	Taro Pharmaceuticals U.S.A., Inc.	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1396_3d883b5c-0a4e-4b18-a0ec-a02fae1d12d3	51672-1396	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	SPRAY	TOPICAL	20130411		NDA AUTHORIZED GENERIC	NDA204141	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	2.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-1397_34940f27-ae26-41f3-9544-bd9d500fa85c	51672-1397	HUMAN PRESCRIPTION DRUG	TAVABOROLE		TAVABOROLE	SOLUTION	TOPICAL	20210507		ANDA	ANDA212215	Taro Pharmaceuticals U.S.A., Inc.	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
51672-1399_5cd26676-6ca1-4c22-ace6-a97407e6bda0	51672-1399	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	GEL	TOPICAL	20201110		ANDA	ANDA214052	Taro Pharmaceuticals U.S.A., Inc.	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
51672-1400_d96b455b-dd02-4c7f-99b9-64723738fd05	51672-1400	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	LOTION	TOPICAL	20210628		ANDA	ANDA214526	Taro Pharmaceuticals U.S.A., Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
51672-1402_68ae0c48-7f7c-43c6-a767-676e32be34dc	51672-1402	HUMAN PRESCRIPTION DRUG	Calcipotriene and Betamethasone Dipropionate		Calcipotriene and Betamethasone Dipropionate	SUSPENSION	TOPICAL	20200902		ANDA	ANDA213269	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	50; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
51672-1403_cd255027-9e43-41a2-b161-8110796e7f5a	51672-1403	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20180605		ANDA	ANDA208683	Taro Pharmaceuticals U.S.A., Inc.	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
51672-1405_40827951-dbc4-4a28-a662-9e08d2cb0dcd	51672-1405	HUMAN PRESCRIPTION DRUG	Oxymetazoline Hydrochloride		Oxymetazoline Hydrochloride	CREAM	TOPICAL	20211004		ANDA	ANDA213584	Taro Pharmaceuticals U.S.A., Inc.	OXYMETAZOLINE HYDROCHLORIDE	10	mg/g	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
51672-1406_6cb00624-2c0b-47e9-9d6d-38bbf7292c4f	51672-1406	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231026		ANDA	ANDA214454	Taro Pharmaceuticals U.S.A., Inc.	DOCOSANOL	100	mg/g			N	20241231
51672-1407_1f80ccf0-020f-41de-b77a-e2d88a835d45	51672-1407	HUMAN PRESCRIPTION DRUG	Tretinoin		tretinoin	CREAM	TOPICAL	20230105		ANDA	ANDA215713	Taro Pharmaceuticals U.S.A., Inc.	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-1411_0c05574c-f9a4-5d92-e063-6394a90a9d00	51672-1411	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	TOPICAL	20231208		ANDA	ANDA218182	Taro Pharmaceuticals U.S.A., Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51672-2001_46fd39ef-5b7b-4c97-979f-c86cdf04b162	51672-2001	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	19911001		OTC MONOGRAPH FINAL	part333C	Taro Pharmaceuticals U.S.A., Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-2002_d4a89df0-e355-4cc6-a035-9bd3cafa4345	51672-2002	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH FINAL	part333C	Taro Pharmaceuticals U.S.A., Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-2003_42aa6f14-d38f-410a-9f23-811e08fea629	51672-2003	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	19951204		ANDA	ANDA072641	Taro Pharmaceuticals U.S.A., Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-2010_505e6403-5098-46b1-bd93-0f0c64784ec0	51672-2010	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20010913		OTC MONOGRAPH NOT FINAL	part348	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE	.5	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-2013_546a3631-8018-4433-a1fa-922626494ef8	51672-2013	HUMAN OTC DRUG	Hydrocortisone	with Aloe	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Taro Phamaceuticals U.S.A., Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-2016_34f19b6e-8d34-4f3c-80ec-34d81ee6e044	51672-2016	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	19951214		OTC MONOGRAPH FINAL	part333B	Taro Pharmaceuticals U.S.A., Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
51672-2018_d97e0037-cd87-4bb2-8f28-aa384b685cd6	51672-2018	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-2020_15beaada-5700-46cd-97bc-9da26393c181	51672-2020	HUMAN OTC DRUG	Tolnaftate Antifungal		Tolnaftate	CREAM	TOPICAL	19950101		OTC MONOGRAPH FINAL	part333C	Taro Pharmaceuticals U.S.A., Inc.	TOLNAFTATE	1	g/100g			N	20241231
51672-2027_4468ef01-b79c-4d45-8fa5-72650f732236	51672-2027	HUMAN OTC DRUG	Triple Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20120331		OTC MONOGRAPH FINAL	part333B	Taro Pharmaceuticals U.S.A., Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
51672-2030_b6e8883a-066f-44a5-ab4e-fe507bbf861d	51672-2030	HUMAN OTC DRUG	Oxymetazoline Hydrochloride	12-Hour	Oxymetazoline Hydrochloride	SPRAY	NASAL	20060225		OTC MONOGRAPH FINAL	part341	Taro Pharmaceuticals U.S.A., Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
51672-2035_f71c79c6-c274-4175-801e-5fa6e11086dd	51672-2035	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	VAGINAL	19970113		ANDA	ANDA074444	Taro Pharmaceuticals U.S.A., Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-2037_b45ed188-20d9-4de5-8f52-0f57cfe2bf11	51672-2037	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	19960501		OTC MONOGRAPH FINAL	part333C	Taro Pharmaceuticals U.S.A., Inc.	CLOTRIMAZOLE	1	g/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-2044_0e4c5189-613d-ebe6-e063-6294a90a58a7	51672-2044	HUMAN OTC DRUG	Double Antibiotic		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	TOPICAL	19901205		OTC MONOGRAPH DRUG	M004	Taro Pharmaceuticals U.S.A., Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
51672-2062_708f18d8-30c5-40df-8972-28a3703753fc	51672-2062	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20000412		NDA	NDA021143	Taro Pharmaceuticals U.S.A., Inc.	CLOTRIMAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-2063_9b5c4508-91ad-428d-8704-64aa27579344	51672-2063	HUMAN OTC DRUG	Hydrocortisone	Plus 12 Moisturizers	Hydrocortisone	CREAM	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-2069_fadbd97a-7096-4c78-b019-a03ab2ca2925	51672-2069	HUMAN OTC DRUG	Hydrocortisone Acetate	Antipruritic (Anti-Itch)	Hydrocortisone Acetate	CREAM	TOPICAL	20010601		OTC MONOGRAPH NOT FINAL	part348	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-2070_1d1ac9e4-4789-45c0-9a99-d23a6d0a8c5e	51672-2070	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	VAGINAL	20050302		ANDA	ANDA076773	Taro Pharmaceuticals U.S.A., Inc.	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51672-2073_f19e5d03-5c87-46a1-bba0-25c67ab75662	51672-2073	HUMAN OTC DRUG	Childrens Loratadine		Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	Taro Pharmaceuticals U.S.A., Inc.	LORATADINE	5	mg/5mL			N	20241231
51672-2075_5a5a8e07-1943-46c6-9c73-4a3a666f868d	51672-2075	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20060511		OTC MONOGRAPH FINAL	part333B	Taro Pharmaceuticals U.S.A., Inc.	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
51672-2080_5dd8baac-4c68-4c27-8b98-544a8949a4b0	51672-2080	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Taro Pharmaceuticals U.S.A., Inc.	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
51672-2085_d8ae719e-320f-43b3-ba1c-61cfd42d164b	51672-2085	HUMAN OTC DRUG	Childrens Loratadine		Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	Taro Pharmaceuticals U.S.A., Inc.	LORATADINE	5	mg/5mL			N	20241231
51672-2089_adbdffa5-1b80-416d-b193-330ef3ce63be	51672-2089	HUMAN OTC DRUG	Diphenhydramine Hydrochloride and Zinc Acetate		Diphenhydramine Hydrochloride and Zinc Acetate	CREAM	TOPICAL	20050920		OTC MONOGRAPH NOT FINAL	part348	Taro Pharmaceuticals U.S.A., Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51672-2092_a032a1a9-e0ce-4176-8479-75263c601d65	51672-2092	HUMAN OTC DRUG	Childrens Loratadine		Loratadine	SOLUTION	ORAL	20100227		ANDA	ANDA076805	Taro Pharmaceuticals U.S.A., Inc.	LORATADINE	5	mg/5mL			N	20241231
51672-2100_2c67420b-73a6-4382-bc58-fc031ac3e6af	51672-2100	HUMAN OTC DRUG	Athletes Foot		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	Taro Pharmaceuticals U.S.A., inc.	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
51672-2101_a0159f92-c609-486b-a727-bc4d431ed8eb	51672-2101	HUMAN OTC DRUG	Jock Itch		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	Taro Pharmaceuticals U.S.A., inc.	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
51672-2102_590a6b63-2797-4ea3-a0c1-f69f68c4fae3	51672-2102	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride	Sugar Free Grape	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Taro Pharmaceuticals U.S.A., Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51672-2106_37a18ea9-4178-4252-b094-aac4318d929b	51672-2106	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	Taro Pharmaceuticals U.S.A., Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51672-2108_31f7a7ea-9574-4641-a4ab-55f2c1f1d3e4	51672-2108	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20161208		ANDA	ANDA201865	Taro Pharmaceuticals U.S.A., Inc.	LORATADINE	5	mg/5mL			N	20241231
51672-2114_3ab328f8-6389-44fd-bb84-8b28709dbc30	51672-2114	HUMAN OTC DRUG	Feverall	Infants	Acetaminophen	SUPPOSITORY	RECTAL	20131212		NDA	NDA018337	Taro Pharmaceuticals U.S.A. Inc.	ACETAMINOPHEN	80	mg/1			N	20241231
51672-2115_f78b5761-ee3c-4a98-b152-cd0d2b08faa9	51672-2115	HUMAN OTC DRUG	Feverall	Childrens	Acetaminophen	SUPPOSITORY	RECTAL	20131212		NDA	NDA018337	Taro Pharmaceuticals U.S.A. Inc.	ACETAMINOPHEN	120	mg/1			N	20241231
51672-2116_fbd0c378-6d46-4f6f-b473-610dd4d20bb1	51672-2116	HUMAN OTC DRUG	Feverall	Jr. Strength	Acetaminophen	SUPPOSITORY	RECTAL	20131212		NDA	NDA018337	Taro Pharmaceuticals U.S.A. Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
51672-2117_c107ee4d-6fd8-4cd8-9f80-5d140801eaba	51672-2117	HUMAN OTC DRUG	Feverall	Adults	Acetaminophen	SUPPOSITORY	RECTAL	20131212		NDA	NDA018337	Taro Pharmaceuticals U.S.A. Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
51672-2120_0d5c5ca2-8559-44b0-9319-3547eae6006d	51672-2120	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Taro Pharmaceuticals U.S.A., Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
51672-2128_cb843afe-5943-40a4-93d5-1adbf0f1bb01	51672-2128	HUMAN OTC DRUG	Minoxidil	5% (For Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20190102		ANDA	ANDA209074	Taro Pharmaceuticals U.S.A., Inc.	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51672-2129_8368f44e-aac8-497e-9398-be2505eec439	51672-2129	HUMAN OTC DRUG	Minoxidil	For Women	Minoxidil	AEROSOL, FOAM	TOPICAL	20190422		ANDA	ANDA209074	Taro Pharmaceuticals U.S.A., Inc.	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
51672-2130_0bcaf969-6210-6f7e-e063-6294a90a25c4	51672-2130	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170627		ANDA	ANDA209207	Taro Pharmaceuticals U.S.A., Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-2131_7f289479-6ec5-49c3-b724-851e90c68264	51672-2131	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Taro Pharmaceuticals U.S.A., Inc.	LORATADINE	5	mg/5mL			N	20241231
51672-2144_0e17af82-18cd-8503-e063-6394a90a4e5a	51672-2144	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20220721		ANDA	ANDA209207	Taro Pharmaceuticals U.S.A., Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
51672-2146_e23924a0-8d29-45b6-bd5b-6b73594e557e	51672-2146	HUMAN OTC DRUG	IBUPROFEN	Infants	IBUPROFEN	SUSPENSION/ DROPS	ORAL	20230808		ANDA	ANDA217261	Taro Pharmaceuticals U.S.A., Inc.	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-2150_d5207322-641a-4812-b8b0-1213b041d4a1	51672-2150	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20220114		ANDA	ANDA215940	Taro Pharmaceuticals U.S.A., Inc.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51672-3003_0cd38d29-d174-8246-e063-6394a90a2e67	51672-3003	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20050428		ANDA	ANDA088799	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-3004_0cd38d29-d174-8246-e063-6394a90a2e67	51672-3004	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20050428		ANDA	ANDA086155	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-3007_2f73f2cf-0dc9-4a26-a5b5-9218141245e1	51672-3007	HUMAN PRESCRIPTION DRUG	Hydrocortisone and Acetic Acid		Hydrocortisone and Acetic Acid	SOLUTION	AURICULAR (OTIC)	20050428		ANDA	ANDA088759	Taro Pharmaceuticals U.S.A., Inc.	ACETIC ACID; HYDROCORTISONE	20.8; 10.4	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-3008_943ddae6-29fe-49e4-81a1-94496772d0fc	51672-3008	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	19810817		ANDA	ANDA086724	Taro Pharmaceuticals U.S.A., Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51672-3009_367518ef-8e24-4823-8b29-78002f88aee7	51672-3009	HUMAN PRESCRIPTION DRUG	U-Cort		Hydrocortisone Acetate	CREAM	TOPICAL	19880613		ANDA	ANDA089472	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-3020_f77cea78-e687-4255-91f2-52056ffaa316	51672-3020	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20130325		ANDA	ANDA086724	Taro Pharmaceuticals U.S.A., Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51672-4001_7ff22c22-51b5-4ce3-93ee-8959359fab3c	51672-4001	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Taro Pharmaceuticals U.S.A., Inc.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4002_7ff22c22-51b5-4ce3-93ee-8959359fab3c	51672-4002	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Taro Pharmaceuticals U.S.A., Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4003_7ff22c22-51b5-4ce3-93ee-8959359fab3c	51672-4003	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Taro Pharmaceuticals U.S.A., Inc.	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4004_7ff22c22-51b5-4ce3-93ee-8959359fab3c	51672-4004	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Taro Pharmaceuticals U.S.A., Inc.	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4005_17ac5b3c-e41f-459b-8da8-7e9a725dbb5b	51672-4005	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19961003		ANDA	ANDA074649	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4011_06e0ecf4-00ed-4a0f-8853-f35d7d435883	51672-4011	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Taro Pharmaceuticals U.S.A., Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4012_06e0ecf4-00ed-4a0f-8853-f35d7d435883	51672-4012	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Taro Pharmaceuticals U.S.A., Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4013_06e0ecf4-00ed-4a0f-8853-f35d7d435883	51672-4013	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	19961231		ANDA	ANDA074694	Taro Pharmaceuticals U.S.A., Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4016_e9fb945d-c1f0-4323-bb72-d796a3d6453f	51672-4016	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	19980430		ANDA	ANDA075078	Taro Pharmaceuticals U.S.A., Inc.	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-4017_e9fb945d-c1f0-4323-bb72-d796a3d6453f	51672-4017	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	19980430		ANDA	ANDA075078	Taro Pharmaceuticals U.S.A., Inc.	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-4018_e9fb945d-c1f0-4323-bb72-d796a3d6453f	51672-4018	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	19980311		ANDA	ANDA075074	Taro Pharmaceuticals U.S.A., Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-4022_e379abc1-3c52-4a1f-a53f-628f6454e22c	51672-4022	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	19970528		ANDA	ANDA040195	Taro Pharmaceuticals U.S.A., Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
51672-4023_e379abc1-3c52-4a1f-a53f-628f6454e22c	51672-4023	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	19970528		ANDA	ANDA040195	Taro Pharmaceuticals U.S.A., Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
51672-4025_74e1d323-cd6f-41c3-9b5c-0f40e7acf27c	51672-4025	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20010330		ANDA	ANDA075424	Taro Pharmaceuticals U.S.A., Inc.	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51672-4026_da3f4801-92d7-4031-b690-e6d559c383cb	51672-4026	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	TABLET	ORAL	19990615		ANDA	ANDA075319	Taro Pharmaceuticals U.S.A., Inc.	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51672-4027_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4027	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4028_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4028	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4029_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4029	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4030_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4030	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4031_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4031	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4032_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4032	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4033_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4033	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4034_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4034	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4035_0d0458de-a9a7-a32b-e063-6394a90ae0c7	51672-4035	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Taro Pharmaceuticals U.S.A., Inc.	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
51672-4036_e9fb945d-c1f0-4323-bb72-d796a3d6453f	51672-4036	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20000425		ANDA	ANDA075074	Taro Pharmaceuticals U.S.A., Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-4037_e64450c0-8dde-4920-9bf9-c714e09e1566	51672-4037	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51672-4038_e64450c0-8dde-4920-9bf9-c714e09e1566	51672-4038	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51672-4039_e64450c0-8dde-4920-9bf9-c714e09e1566	51672-4039	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123	20251130	ANDA	ANDA075657	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	
51672-4040_e64450c0-8dde-4920-9bf9-c714e09e1566	51672-4040	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51672-4041_17ac5b3c-e41f-459b-8da8-7e9a725dbb5b	51672-4041	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	20001024		ANDA	ANDA075687	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4042_a22613cd-20d8-4b29-8520-d66368b47ea0	51672-4042	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20000427		ANDA	ANDA075731	Taro Pharmaceuticals U.S.A., Inc.	CLORAZEPATE DIPOTASSIUM	3.75	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51672-4043_a22613cd-20d8-4b29-8520-d66368b47ea0	51672-4043	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20000427		ANDA	ANDA075731	Taro Pharmaceuticals U.S.A., Inc.	CLORAZEPATE DIPOTASSIUM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51672-4044_a22613cd-20d8-4b29-8520-d66368b47ea0	51672-4044	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20000427		ANDA	ANDA075731	Taro Pharmaceuticals U.S.A., Inc.	CLORAZEPATE DIPOTASSIUM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51672-4045_0c080ad7-430c-4a34-e063-6294a90aa534	51672-4045	HUMAN PRESCRIPTION DRUG	Enalapril Maleate and Hydrochlorothiazide		Enalapril Maleate and Hydrochlorothiazide	TABLET	ORAL	20010918		ANDA	ANDA075788	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE	5; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51672-4046_0c080ad7-430c-4a34-e063-6294a90aa534	51672-4046	HUMAN PRESCRIPTION DRUG	Enalapril Maleate and Hydrochlorothiazide		Enalapril Maleate and Hydrochlorothiazide	TABLET	ORAL	20010918	20250101	ANDA	ANDA075788	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE	10; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
51672-4047_17ac5b3c-e41f-459b-8da8-7e9a725dbb5b	51672-4047	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	SUSPENSION	ORAL	20040920		ANDA	ANDA076729	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	100	mg/5mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4048_694c21f7-c6be-4419-96ce-6c2e84178288	51672-4048	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20010529		ANDA	ANDA075673	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4051_213bd46b-ab03-40e1-8361-65b406cebc5b	51672-4051	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Taro Pharmaceuticals U.S.A., Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-4052_213bd46b-ab03-40e1-8361-65b406cebc5b	51672-4052	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Taro Pharmaceuticals U.S.A., Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-4053_213bd46b-ab03-40e1-8361-65b406cebc5b	51672-4053	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Taro Pharmaceuticals U.S.A., Inc.	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51672-4055_74e1d323-cd6f-41c3-9b5c-0f40e7acf27c	51672-4055	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20010330		ANDA	ANDA075424	Taro Pharmaceuticals U.S.A., Inc.	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51672-4056_74e1d323-cd6f-41c3-9b5c-0f40e7acf27c	51672-4056	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20031202		ANDA	ANDA076362	Taro Pharmaceuticals U.S.A., Inc.	AMIODARONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51672-4057_74e1d323-cd6f-41c3-9b5c-0f40e7acf27c	51672-4057	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20021129		ANDA	ANDA076362	Taro Pharmaceuticals U.S.A., Inc.	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51672-4060_0e7f65fb-5a8e-087b-e063-6294a90a9b38	51672-4060	HUMAN PRESCRIPTION DRUG	Amcinonide		Amcinonide	OINTMENT	TOPICAL	20030319		ANDA	ANDA076367	Taro Pharmaceuticals U.S.A., Inc.	AMCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
51672-4061_26e4c766-6315-4c55-9814-181258a45ad5	51672-4061	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		Hydrocortisone Butyrate	SOLUTION	TOPICAL	20040114		ANDA	ANDA076364	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE BUTYRATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4062_3225bf24-833e-4d6a-bfe8-08df4fecb218	51672-4062	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	SOLUTION	TOPICAL	20031105		ANDA	ANDA076526	Taro Pharmaceuticals U.S.A., Inc.	FLUOROURACIL	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51672-4063_3225bf24-833e-4d6a-bfe8-08df4fecb218	51672-4063	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	SOLUTION	TOPICAL	20031105		ANDA	ANDA076526	Taro Pharmaceuticals U.S.A., Inc.	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51672-4064_8d540365-1548-467f-9701-a84829a7d086	51672-4064	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20040729		ANDA	ANDA076507	Taro Pharmaceuticals U.S.A., Inc.	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51672-4065_8d540365-1548-467f-9701-a84829a7d086	51672-4065	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20040729		ANDA	ANDA076507	Taro Pharmaceuticals U.S.A., Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51672-4066_8d540365-1548-467f-9701-a84829a7d086	51672-4066	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20040729		ANDA	ANDA076507	Taro Pharmaceuticals U.S.A., Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51672-4067_8d540365-1548-467f-9701-a84829a7d086	51672-4067	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20040729		ANDA	ANDA076507	Taro Pharmaceuticals U.S.A., Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
51672-4069_e9176357-1e57-4c5e-8382-29166348f050	51672-4069	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20040408		ANDA	ANDA040521	Taro Pharmaceuticals U.S.A., Inc.	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4070_f0145be4-c079-4a65-8f5d-2cf8d078313f	51672-4070	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20140501		ANDA	ANDA076601	Taro Pharmaceuticals U.S.A., Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51672-4074_26e4c766-6315-4c55-9814-181258a45ad5	51672-4074	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		Hydrocortisone Butyrate	CREAM	TOPICAL	20050804		ANDA	ANDA076654	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE BUTYRATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4079_c5e77dd5-c1ab-4967-8000-48077b8e06f1	51672-4079	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	LOTION	TOPICAL	20141031		ANDA	ANDA202161	Taro Pharmaceuticals U.S.A., Inc.	DESONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4081_4a44d53f-dbf0-4667-9911-4761be05aa07	51672-4081	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin phosphate	SOLUTION	TOPICAL	20040331		ANDA	ANDA065184	Taro Pharmaceuticals U.S.A., Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
51672-4083_26e4c766-6315-4c55-9814-181258a45ad5	51672-4083	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		Hydrocortisone Butyrate	OINTMENT	TOPICAL	20041227		ANDA	ANDA076842	Taro Pharmaceuticals U.S.A., Inc.	HYDROCORTISONE BUTYRATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4091_e10032ef-6d48-44cb-9b7f-9a338f35ca51	51672-4091	HUMAN PRESCRIPTION DRUG	Ondansetron		ondansetron hydrochloride	SOLUTION	ORAL	20071130		ANDA	ANDA077009	Taro Pharmaceuticals U.S.A., Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51672-4095_ec64eb18-f4ff-438e-bb6e-a089f963847b	51672-4095	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	OINTMENT	TOPICAL	20050614		ANDA	ANDA077145	Taro Pharmaceuticals U.S.A., Inc.	FLUTICASONE PROPIONATE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4105_802f2425-e2a0-483a-8378-6c579e7738a2	51672-4105	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET	ORAL	20071115		ANDA	ANDA077801	Taro Pharmaceuticals U.S.A., Inc.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4106_802f2425-e2a0-483a-8378-6c579e7738a2	51672-4106	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET	ORAL	20071115		ANDA	ANDA077801	Taro Pharmaceuticals U.S.A., Inc.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4107_802f2425-e2a0-483a-8378-6c579e7738a2	51672-4107	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET	ORAL	20071115		ANDA	ANDA077801	Taro Pharmaceuticals U.S.A., Inc.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4108_288442cd-0f6b-49e1-9acc-d8f613f54810	51672-4108	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20110328		ANDA	ANDA077729	Taro Pharmaceuticals U.S.A., Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51672-4109_288442cd-0f6b-49e1-9acc-d8f613f54810	51672-4109	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20110328		ANDA	ANDA077729	Taro Pharmaceuticals U.S.A., Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51672-4110_288442cd-0f6b-49e1-9acc-d8f613f54810	51672-4110	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20110328		ANDA	ANDA077729	Taro Pharmaceuticals U.S.A., Inc.	ONDANSETRON HYDROCHLORIDE	24	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51672-4111_02da2736-14c6-4e3d-9936-05da2b25dfd6	51672-4111	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20060905		ANDA	ANDA040684	Taro Pharmaceuticals U.S.A., Inc.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4116_d5b90aeb-7cd5-48b8-97a5-8d6f3307e2a3	51672-4116	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	GEL	TOPICAL	20060718		ANDA	ANDA077819	Taro Pharmaceuticals U.S.A., Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
51672-4117_58f62443-03ba-4b31-bad8-efe3330a66f2	51672-4117	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	19880229		ANDA	ANDA062876	Taro Pharmaceuticals U.S.A., Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
51672-4118_c2f0194f-61d5-4977-9451-5c13af691310	51672-4118	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	CREAM	TOPICAL	20100305		ANDA	ANDA090368	Taro Pharmaceuticals U.S.A., Inc.	FLUOROURACIL	50	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51672-4123_17ac5b3c-e41f-459b-8da8-7e9a725dbb5b	51672-4123	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20090331		ANDA	ANDA078115	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4124_17ac5b3c-e41f-459b-8da8-7e9a725dbb5b	51672-4124	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20090331		ANDA	ANDA078115	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4125_17ac5b3c-e41f-459b-8da8-7e9a725dbb5b	51672-4125	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20090331		ANDA	ANDA078115	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4130_d589a030-fb7b-4957-b543-8dafba6104ba	51672-4130	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078525	Taro Pharmaceuticals U.S.A., Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51672-4131_d589a030-fb7b-4957-b543-8dafba6104ba	51672-4131	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078525	Taro Pharmaceuticals U.S.A., Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51672-4132_d589a030-fb7b-4957-b543-8dafba6104ba	51672-4132	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078525	Taro Pharmaceuticals U.S.A., Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51672-4133_d589a030-fb7b-4957-b543-8dafba6104ba	51672-4133	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078525	Taro Pharmaceuticals U.S.A., Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51672-4136_559a39a2-ec8e-443b-9df0-4c909633981c	51672-4136	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20090210		ANDA	ANDA078774	Taro Pharmaceuticals U.S.A., Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4137_559a39a2-ec8e-443b-9df0-4c909633981c	51672-4137	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20100201		ANDA	ANDA078960	Taro Pharmaceuticals U.S.A., Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4141_559a39a2-ec8e-443b-9df0-4c909633981c	51672-4141	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20100201		ANDA	ANDA078960	Taro Pharmaceuticals U.S.A., Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4142_559a39a2-ec8e-443b-9df0-4c909633981c	51672-4142	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20100201		ANDA	ANDA078960	Taro Pharmaceuticals U.S.A., Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4143_559a39a2-ec8e-443b-9df0-4c909633981c	51672-4143	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20100201		ANDA	ANDA078960	Taro Pharmaceuticals U.S.A., Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4145_cd5069f0-4bdf-46cf-8278-cc821732f5c8	51672-4145	HUMAN PRESCRIPTION DRUG	Imiquimod		Imiquimod	CREAM	TOPICAL	20110415		ANDA	ANDA200173	Taro Pharmaceuticals U.S.A., Inc.	IMIQUIMOD	50	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
51672-4146_1aa91dac-0e01-46c6-bc45-93b08e84574c	51672-4146	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	TABLET, CHEWABLE	ORAL	20140417		ANDA	ANDA200565	Taro Pharmaceuticals U.S.A., Inc	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4147_3ca1984e-69f7-4fc5-9184-3843d737e518	51672-4147	HUMAN PRESCRIPTION DRUG	Meprobamate		Meprobamate	TABLET	ORAL	20110523		ANDA	ANDA200998	Taro Pharmaceuticals U.S.A., Inc.	MEPROBAMATE	200	mg/1		CIV	N	20241231
51672-4148_3ca1984e-69f7-4fc5-9184-3843d737e518	51672-4148	HUMAN PRESCRIPTION DRUG	Meprobamate		Meprobamate	TABLET	ORAL	20110523		ANDA	ANDA200998	Taro Pharmaceuticals U.S.A., Inc.	MEPROBAMATE	400	mg/1		CIV	N	20241231
51672-4149_2708f550-3bdc-4550-99ed-f98db2a24475	51672-4149	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20130621		ANDA	ANDA201106	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4150_2708f550-3bdc-4550-99ed-f98db2a24475	51672-4150	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20130621		ANDA	ANDA201106	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4151_2708f550-3bdc-4550-99ed-f98db2a24475	51672-4151	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20130621		ANDA	ANDA201106	Taro Pharmaceuticals U.S.A., Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
51672-4154_40e08498-616d-46d1-9987-0ad5580915b8	51672-4154	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	OINTMENT	TOPICAL	20100324		ANDA	ANDA090633	Taro Pharmaceuticals U.S.A., Inc.	CALCIPOTRIENE	.05	mg/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
51672-4161_2e256952-b11b-490a-9773-6f523a5b286a	51672-4161	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine dihydrochloride	SOLUTION	ORAL	20130726		ANDA	ANDA202673	Taro Pharmaceuticals U.S.A., inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51672-4164_6f4c6a7f-eee9-45b2-b0ed-64377aab9d49	51672-4164	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20170314		ANDA	ANDA204651	Taro Pharmaceuticals U.S.A., Inc.	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
51672-4165_a492ebb0-0f7b-4bdd-9146-b8dc74025f38	51672-4165	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	SYRUP	ORAL	20170227		ANDA	ANDA205112	Taro Pharmaceuticals U.S.A., Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
51672-4166_0b06ddbb-6100-464f-9266-ace704fe8a40	51672-4166	HUMAN PRESCRIPTION DRUG	Clocortolone Pivalate		Clocortolone Pivalate	CREAM	TOPICAL	20200421		ANDA	ANDA206370	Taro Pharmaceuticals U.S.A., inc.	CLOCORTOLONE PIVALATE	.001	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4172_ff558824-b008-4b94-8aa5-d7818bc27a4f	51672-4172	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	SUSPENSION	ORAL	20170616		ANDA	ANDA206314	Taro Pharmaceuticals U.S.A., Inc.	FELBAMATE	600	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4174_416a748b-c388-4f4d-b69e-52830aa70ad2	51672-4174	HUMAN PRESCRIPTION DRUG	Imiquimod		Imiquimod	CREAM	TOPICAL	20210126		ANDA	ANDA205971	Taro Pharmaceuticals U.S.A., Inc.	IMIQUIMOD	37.5	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
51672-4178_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4178	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.	ILOPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51672-4179_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4179	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.	ILOPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51672-4180_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4180	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.	ILOPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51672-4181_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4181	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.	ILOPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51672-4182_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4182	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.	ILOPERIDONE	8	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51672-4183_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4183	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.	ILOPERIDONE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51672-4184_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4184	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	TABLET	ORAL	20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.	ILOPERIDONE	12	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51672-4185_0c6d8e37-6982-22d4-e063-6294a90a4f6b	51672-4185	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20170420		ANDA	ANDA207093	Taro Pharmaceuticals U.S.A., inc.	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4186_0c6d8e37-6982-22d4-e063-6294a90a4f6b	51672-4186	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20170420		ANDA	ANDA207093	Taro Pharmaceuticals U.S.A., inc.	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51672-4188_987e98dd-68eb-4374-8169-9cae7b81a0a3	51672-4188	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	AEROSOL, FOAM	TOPICAL	20170524		ANDA	ANDA208204	Taro Pharmaceuticals U.S.A., Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4193_5ef7bae9-8c73-465f-bc4f-8fa184538eb5	51672-4193	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	AEROSOL, FOAM	TOPICAL	20181004		ANDA	ANDA208779	Taro Pharmaceuticals U.S.A., Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-4194_357bd300-1ff2-4c79-8310-21c1da2fd8d8	51672-4194	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	AEROSOL, FOAM	TOPICAL	20221001		ANDA	ANDA210004	Taro Pharmaceuticals U.S.A., Inc.	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
51672-4196_5687c33f-3ebd-4e19-91b8-e067066e13dd	51672-4196	HUMAN PRESCRIPTION DRUG	Deferiprone		Deferiprone	TABLET	ORAL	20190208		ANDA	ANDA208800	Taro Pharmaceuticals U.S.A., Inc.	DEFERIPRONE	500	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
51672-4197_e93b86ed-7d01-4de9-b670-2955005676f3	51672-4197	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20190301		ANDA	ANDA209430	Taro Pharmaceuticals U.S.A., Inc.	DAPSONE	25	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
51672-4198_e93b86ed-7d01-4de9-b670-2955005676f3	51672-4198	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20190301		ANDA	ANDA209430	Taro Pharmaceuticals U.S.A., Inc.	DAPSONE	100	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
51672-4200_30b09990-10ca-4452-920b-c1d1dc830120	51672-4200	HUMAN PRESCRIPTION DRUG	Azithromycin		AZITHROMYCIN MONOHYDRATE	SUSPENSION	ORAL	20191211		ANDA	ANDA211521	Taro Pharmaceuticals U.S.A., Inc.	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
51672-4202_9e675959-c479-406e-a6f7-dd330f166f6b	51672-4202	HUMAN PRESCRIPTION DRUG	Clobazam		clobazam	TABLET	ORAL	20181022		ANDA	ANDA209440	Taro Pharmaceuticals U.S.A., Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
51672-4203_9e675959-c479-406e-a6f7-dd330f166f6b	51672-4203	HUMAN PRESCRIPTION DRUG	Clobazam		clobazam	TABLET	ORAL	20181022		ANDA	ANDA209440	Taro Pharmaceuticals U.S.A., Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
51672-4210_42e2146c-a750-4c71-b6be-b1101c662454	51672-4210	HUMAN PRESCRIPTION DRUG	Clobazam		clobazam	SUSPENSION	ORAL	20190416		ANDA	ANDA210978	Taro Pharmaceuticals U.S.A., Inc.	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
51672-4213_6787555e-8a11-481c-b05c-179b0aedcf5c	51672-4213	HUMAN PRESCRIPTION DRUG	Iloperidone		Iloperidone	KIT		20190722		ANDA	ANDA207098	Taro Pharmaceuticals U.S.A., Inc.						N	20241231
51672-4215_a0569c03-e6a4-4bc0-8c9d-f2f84f24cf2a	51672-4215	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20190409		ANDA	ANDA204651	Taro Pharmaceuticals U.S.A., Inc.	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
51672-4217_f71ace15-9ee2-4547-88fa-f787496b7dc5	51672-4217	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	Taro Pharmaceuticals U.S.A., Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4218_f71ace15-9ee2-4547-88fa-f787496b7dc5	51672-4218	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	Taro Pharmaceuticals U.S.A., Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4219_f71ace15-9ee2-4547-88fa-f787496b7dc5	51672-4219	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	Taro Pharmaceuticals U.S.A., Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4220_f71ace15-9ee2-4547-88fa-f787496b7dc5	51672-4220	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	Taro Pharmaceuticals U.S.A., Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4221_f71ace15-9ee2-4547-88fa-f787496b7dc5	51672-4221	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	Taro Pharmaceuticals U.S.A., Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51672-4223_9ce1d13b-484c-42c0-8a83-f63a373448e5	51672-4223	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20230724		ANDA	ANDA213458	Taro Pharmaceuticals U.S.A., Inc.	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51672-4224_9ce1d13b-484c-42c0-8a83-f63a373448e5	51672-4224	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20230724		ANDA	ANDA213458	Taro Pharmaceuticals U.S.A., Inc.	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51672-4225_9ce1d13b-484c-42c0-8a83-f63a373448e5	51672-4225	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20230724		ANDA	ANDA213458	Taro Pharmaceuticals U.S.A., Inc.	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
51672-4226_6dc14104-d18b-4950-908c-8425eefa8154	51672-4226	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	SOLUTION	ORAL	20230515		ANDA	ANDA214458	Taro Pharmaceuticals U.S.A., Inc.	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
51672-4227_76691cd5-431e-4b53-9abd-136c278ab612	51672-4227	HUMAN PRESCRIPTION DRUG	Clobazam		clobazam	SUSPENSION	ORAL	20210630		ANDA	ANDA210978	Taro Pharmaceuticals U.S.A., Inc.	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
51672-4230_b9664cbb-1e38-4caa-8780-6f0ae6ed0712	51672-4230	HUMAN OTC DRUG	Ivermectin		Ivermectin	LOTION	TOPICAL	20200506		ANDA	ANDA210720	Taro Pharmaceuticals U.S.A., Inc.	IVERMECTIN	5	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
51672-4231_0c559e83-7235-2de2-e063-6394a90a3701	51672-4231	HUMAN PRESCRIPTION DRUG	Sildenafil		SILDENAFIL CITRATE	POWDER, FOR SUSPENSION	ORAL	20211116		ANDA	ANDA215522	Taro Pharmaceuticals U.S.A. Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
51672-4234_26b34456-8d94-4cd1-8c92-beb213a9cd0a	51672-4234	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220414		ANDA	ANDA215674	Taro Pharmaceuticals U.S.A. Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51672-4235_26b34456-8d94-4cd1-8c92-beb213a9cd0a	51672-4235	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220414		ANDA	ANDA215674	Taro Pharmaceuticals U.S.A. Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51672-4236_26b34456-8d94-4cd1-8c92-beb213a9cd0a	51672-4236	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220414		ANDA	ANDA215674	Taro Pharmaceuticals U.S.A. Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51672-4241_0c080ad7-430c-4a34-e063-6294a90aa534	51672-4241	HUMAN PRESCRIPTION DRUG	Enalapril Maleate and Hydrochlorothiazide		Enalapril Maleate and Hydrochlorothiazide	TABLET	ORAL	20231120		ANDA	ANDA075788	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE	10; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
51672-4245_e64450c0-8dde-4920-9bf9-c714e09e1566	51672-4245	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Taro Pharmaceuticals U.S.A., Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
51672-5202_49cfa6c5-ce19-435b-aede-8597d8152eb5	51672-5202	HUMAN PRESCRIPTION DRUG	Topicort		Desoximetasone	GEL	TOPICAL	19980714		ANDA	ANDA074904	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5203_f42ec0f5-b9db-4cc1-b466-4ff4869d8a8f	51672-5203	HUMAN PRESCRIPTION DRUG	Topicort		Desoximetasone	OINTMENT	TOPICAL	19921215		ANDA	ANDA074286	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5204_49cfa6c5-ce19-435b-aede-8597d8152eb5	51672-5204	HUMAN PRESCRIPTION DRUG	Topicort		Desoximetasone	CREAM	TOPICAL	19901130		ANDA	ANDA073193	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5205_49cfa6c5-ce19-435b-aede-8597d8152eb5	51672-5205	HUMAN PRESCRIPTION DRUG	Topicort		Desoximetasone	CREAM	TOPICAL	19901130		ANDA	ANDA073210	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5263_225eb636-250c-4c3b-b321-89ee75bfadd9	51672-5263	HUMAN PRESCRIPTION DRUG	Topicort		Desoximetasone	OINTMENT	TOPICAL	19850117		NDA	NDA018594	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5278_5d928da9-5181-4a23-a067-27b596d7136a	51672-5278	HUMAN PRESCRIPTION DRUG	Calcitrene		Calcipotriene	OINTMENT	TOPICAL	20100324		ANDA	ANDA090633	Taro Pharmaceuticals U.S.A., Inc.	CALCIPOTRIENE	.05	mg/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
51672-5281_6242f3d2-d7c2-49be-ba00-fe14ba49d7c4	51672-5281	HUMAN PRESCRIPTION DRUG	Topicort		Desoximetasone	SPRAY	TOPICAL	20130411		NDA	NDA204141	Taro Pharmaceuticals U.S.A., Inc.	DESOXIMETASONE	2.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5292_9cea1bb9-ec9a-4d12-aec1-c6e83e01baaa	51672-5292	HUMAN PRESCRIPTION DRUG	psorcon		Diflorasone Diacetate	CREAM	TOPICAL	20140801		ANDA	ANDA075508	Taro Pharmaceuticals U.S.A., Inc.	DIFLORASONE DIACETATE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5293_f0a63cc5-d38b-45b2-8810-f9edcbbde2ce	51672-5293	HUMAN PRESCRIPTION DRUG	Ovide		Malathion	LOTION	TOPICAL	20140131		ANDA	ANDA091559	Taro Pharmaceuticals U.S.A., Inc.	MALATHION	.0005	g/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51672-5294_404b8baf-6c2d-4d41-ab1c-a1f9f3012626	51672-5294	HUMAN PRESCRIPTION DRUG	Malathion		Malathion	LOTION	TOPICAL	20140131		ANDA	ANDA091559	Taro Pharmaceuticals U.S.A., Inc.	MALATHION	.0005	g/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51672-5296_03f5c25b-a1d6-496d-8231-4100c5bcdbe4	51672-5296	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20150601		ANDA	ANDA040428	Taro Pharmaceuticals U.S.A., Inc.	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51672-5297_03f5c25b-a1d6-496d-8231-4100c5bcdbe4	51672-5297	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20150601		ANDA	ANDA040428	Taro Pharmaceuticals U.S.A., Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
51672-5301_35858be1-8e9a-453e-97c5-b03b80f22015	51672-5301	HUMAN PRESCRIPTION DRUG	Flurandrenolide		Flurandrenolide	CREAM	TOPICAL	20160425		NDA	NDA012806	Taro Pharmaceuticals U.S.A., Inc.	FLURANDRENOLIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51672-5302_750328ca-20f2-44db-8f03-54eb82582b8d	51672-5302	HUMAN PRESCRIPTION DRUG	Ciclopirox		ciclopirox	SOLUTION	TOPICAL	20160404		ANDA	ANDA078233	Taro Pharmaceuticals U.S.A., Inc.	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
51672-5305_0e6c04f1-804f-4d51-bdfd-bc21a0caeeb6	51672-5305	HUMAN PRESCRIPTION DRUG	PLIAGLIS		Lidocaine and Tetracaine	CREAM	TOPICAL	20181211		NDA	NDA021717	Taro Pharmaceuticals U.S.A., Inc.	LIDOCAINE; TETRACAINE	70; 70	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
51672-5306_45117075-989b-44a8-9a25-33e33ce7c8b9	51672-5306	HUMAN PRESCRIPTION DRUG	FLUOXETINE HYDROCHLORIDE		FLUOXETINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190215		ANDA	ANDA211477	Taro Pharmaceuticals U.S.A., Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
51672-5309_4ed772e7-cb33-4364-ae61-287095cdffe9	51672-5309	HUMAN OTC DRUG	beeRX Cold Sore Treatment		Glycerin	GEL	TOPICAL	20230601		OTC MONOGRAPH FINAL	part347	Taro Pharmaceuticals U.S.A., Inc.	GLYCERIN	.2	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
51672-5316_0e8fd624-fbe2-c134-e063-6294a90a01e2	51672-5316	HUMAN PRESCRIPTION DRUG	Glycopyrrolate Oral Solution		Glycopyrrolate Oral Solution	LIQUID	ORAL	20220705		ANDA	ANDA212467	Taro Pharmaceuticals U.S.A. Inc.	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
51672-5318_b3f54a92-14fb-438e-8c48-b33706e5d719	51672-5318	HUMAN OTC DRUG	Bebe Bottoms		Zinc Oxide	SPRAY	TOPICAL	20231201		OTC MONOGRAPH DRUG	M016	TARO PHARMACEUTICALS U.S.A., INC.	ZINC OXIDE	100	mg/mL			N	20241231
51672-5319_f61f2ea0-dab0-4ef3-b249-4e56fd579553	51672-5319	HUMAN OTC DRUG	FeverAll		ACETAMINOPHEN	SUSPENSION	ORAL	20230601		OTC MONOGRAPH NOT FINAL	part343	TARO PHARMACEUTICALS U.S.A., INC.	ACETAMINOPHEN	160	mg/5mL			N	20241231
51672-5320_4bb36f77-531b-4fdc-815e-2383839569be	51672-5320	HUMAN OTC DRUG	FeverAll		Acetaminophen	SUSPENSION	ORAL	20230601		OTC MONOGRAPH NOT FINAL	part343	TARO PHARMACEUTICALS U.S.A., INC.	ACETAMINOPHEN	160	mg/5mL			N	20241231
51706-900_dabbac64-0108-738f-e053-2a95a90a9dd6	51706-900	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200527		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	75	mL/100mL			N	20241231
51706-901_dabbac64-0107-738f-e053-2a95a90a9dd6	51706-901	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200527		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	75	mL/100mL			N	20241231
51706-902_dabbac64-0103-738f-e053-2a95a90a9dd6	51706-902	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200527		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-903_dabb9e08-1152-52f4-e053-2a95a90a3290	51706-903	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200527		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-904_dabbccd0-d72a-365d-e053-2a95a90ac849	51706-904	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200527		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-909_dabc262f-d31e-020a-e053-2995a90ac4f9	51706-909	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	75	mL/100mL			N	20241231
51706-911_dab8f517-b06c-da02-e053-2995a90a6ec8	51706-911	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-940_dab6d3a1-d350-4aa0-e053-2995a90ad2fc	51706-940	HUMAN OTC DRUG	Foaming Hand Sanitizer		Benzalkonium chloride	LIQUID	TOPICAL	20200820		OTC MONOGRAPH NOT FINAL	part333A	Landy International	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
51706-941_dab6ba4e-bd1c-2476-e053-2a95a90ad329	51706-941	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200825		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	65	mL/100mL			N	20241231
51706-942_dab6d3a1-d34f-4aa0-e053-2995a90ad2fc	51706-942	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200825		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	65	mL/100mL			N	20241231
51706-943_dab6e90a-1a90-7a90-e053-2995a90a1c53	51706-943	HUMAN OTC DRUG	WeClean Hand Sanitizer Cinnamon Stick Scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-944_dab70be7-5849-292a-e053-2a95a90a759e	51706-944	HUMAN OTC DRUG	WeClean Hand Sanitizer Sugar Cookie Scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-945_dab71cf4-1658-5021-e053-2a95a90acd02	51706-945	HUMAN OTC DRUG	WeClean Hand Sanitizer Winter Berry Scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-946_dab70be7-584a-292a-e053-2a95a90a759e	51706-946	HUMAN OTC DRUG	WeClean Hand Sanitizer Cranberry Spice Scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-947_dab72b5c-21d9-dbdc-e053-2a95a90af904	51706-947	HUMAN OTC DRUG	WeClean Hand Sanitizer Sugar Plum Scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-948_dab70be7-584c-292a-e053-2a95a90a759e	51706-948	HUMAN OTC DRUG	WeClean Hand Sanitizer Starry night citrus spice scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-949_dab72b5c-21da-dbdc-e053-2a95a90af904	51706-949	HUMAN OTC DRUG	WeClean Hand Sanitizer Peppermint Bliss Scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-950_dab66192-3e83-2c4a-e053-2995a90af5ac	51706-950	HUMAN OTC DRUG	WeClean Hand Sanitizer Mistletoe Scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-951_dab66eb0-01f7-04ac-e053-2995a90a29bd	51706-951	HUMAN OTC DRUG	WeClean Hand Sanitizer winter wonderland scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-952_dab66192-3e82-2c4a-e053-2995a90af5ac	51706-952	HUMAN OTC DRUG	WeClean Hand Sanitizer Gingerbread cookie scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-953_dab657d3-63cd-4477-e053-2995a90a28c3	51706-953	HUMAN OTC DRUG	WeClean Hand Sanitizer winter wonderland scent		Ethyl Alcohol	GEL	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-954_dab5c2ee-9b01-5658-e053-2a95a90afeb8	51706-954	HUMAN OTC DRUG	Crazy Cleanz Hand Sanitizer Eucalyptus Scented		Benzalkonium chloride	LIQUID	TOPICAL	20200915		OTC MONOGRAPH NOT FINAL	part333A	Landy International	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
51706-959_dab5bee4-4f44-5fdb-e053-2a95a90ac316	51706-959	HUMAN OTC DRUG	Crazy Cleanz Hand Sanitizer Frosted Strawberry Scented		Ethyl Alcohol	GEL	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-960_dab56fbf-2a12-da91-e053-2a95a90ac40f	51706-960	HUMAN OTC DRUG	Crazy Cleanz Hand Sanitizer Vanilla Swirl Scented		Ethyl Alcohol	GEL	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-961_dab517e6-8c00-1c0c-e053-2a95a90a5299	51706-961	HUMAN OTC DRUG	Crazy Cleanz Hand Sanitizer Berry Swirl Scented		Ethyl Alcohol	GEL	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333A	Landy International	ALCOHOL	62	mL/100mL			N	20241231
51706-965_0e0653c0-8286-19e3-e063-6394a90a87c9	51706-965	HUMAN OTC DRUG	HAND SANITIZER SWEET PEACH CITRUS		ALCOHOL	GEL	TOPICAL	20211015		OTC MONOGRAPH DRUG	505G(a)(3)	Landy International	ALCOHOL	70	mL/100mL			N	20251231
51706-966_0e0666e0-558d-fa24-e063-6294a90a6154	51706-966	HUMAN OTC DRUG	SANITIZING HAND SWEET PEACH CITRUS		ALCOHOL	LIQUID	TOPICAL	20211015		OTC MONOGRAPH DRUG	505G(a)(3)	Landy International	ALCOHOL	70	mL/100mL			N	20251231
51754-0102_5f09a6b3-abb1-4d80-9ed9-88a343ea472b	51754-0102	HUMAN PRESCRIPTION DRUG	Zinc Chloride		Zinc Chloride	INJECTION	INTRAVENOUS	20210827		ANDA	ANDA212007	Exela Pharma Sciences,LLC	ZINC CHLORIDE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
51754-0103_18dc9e1c-b9db-4160-96f7-8c4391bcf8c9	51754-0103	HUMAN PRESCRIPTION DRUG	CUPRIC CHLORIDE		cupric chloride	INJECTION, SOLUTION	INTRAVENOUS	20230201		ANDA	ANDA212071	Exela Pharma Sciences, LLC	CUPRIC CHLORIDE	.4	mg/mL			N	20241231
51754-0104_1ec6f467-e66b-406a-ba60-bd4c5ce8fbaf	51754-0104	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine Injection	INJECTION	INTRAVENOUS	20210716		ANDA	ANDA204797	Exela Pharma Sciences, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
51754-0105_5cc9bfdb-0160-4a8c-a85f-d1fe0f95c8c3	51754-0105	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine Solution	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20231113		ANDA	ANDA205643	Exela Pharma Sciences, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
51754-0108_0ae0a575-08e1-43a3-9b6c-8c5f165db35f	51754-0108	HUMAN PRESCRIPTION DRUG	TRANEXAMIC ACID IN SODIUM CHLORIDE		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20190601		NDA	NDA212020	Exela Pharma Sciences, LLC	TRANEXAMIC ACID	10	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
51754-0203_d053ac54-7922-4e79-a5a2-62eb3c2c3f4d	51754-0203	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20160422		NDA	NDA018925	EXELA PHARMA SCIENCES, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51754-0204_f1a97533-a1b0-4b0e-b4c2-76d5bee9b4e2	51754-0204	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20170201		NDA	NDA018925	EXELA PHARMA SCIENCES, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51754-0205_d053ac54-7922-4e79-a5a2-62eb3c2c3f4d	51754-0205	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20180611		NDA	NDA018925	EXELA PHARMA SCIENCES, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51754-0500_0408e50a-e029-40d6-9ccf-2399edbcddf9	51754-0500	HUMAN PRESCRIPTION DRUG	caffeine citrate		caffeine citrate	INJECTION	INTRAVENOUS	20150330		ANDA	ANDA077233	Exela Pharma Sciences, LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
51754-0501_6717d816-ee3c-4633-ba00-98e539734243	51754-0501	HUMAN PRESCRIPTION DRUG	caffeine citrate		CAFFEINE CITRATE	SOLUTION	ORAL	20060921		ANDA	ANDA077304	Exela Pharma Sciences, LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
51754-0502_d93dd760-6b92-4b1b-9fd6-960c3c25f3ce	51754-0502	HUMAN PRESCRIPTION DRUG	caffeine citrate		CAFFEINE CITRATE	INJECTION	INTRAVENOUS	20060921		ANDA	ANDA077233	Exela Pharma Sciences, LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
51754-0503_74eacede-e465-482b-979f-773b4d531764	51754-0503	HUMAN PRESCRIPTION DRUG	caffeine citrate		CAFFEINE CITRATE	SOLUTION	ORAL	20060921		ANDA	ANDA077304	Exela Pharma Sciences, LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
51754-1000_f227d408-1656-435e-bfc7-9ad7423706a3	51754-1000	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140223		ANDA	ANDA206039	Exela Pharma Sciences, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
51754-1006_ed0040fb-c481-4477-8712-00fa6350cd70	51754-1006	HUMAN PRESCRIPTION DRUG	NIPRIDE RTU		Sodium Nitroprusside	INJECTION, SOLUTION	INTRAVENOUS	20170320		NDA	NDA209387	EXELA PHARMA SCIENCES, LLC	SODIUM NITROPRUSSIDE	.5	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
51754-1007_3f3dc2d1-9383-4c95-b97a-3e25c588d8a4	51754-1007	HUMAN PRESCRIPTION DRUG	ELCYS		Cysteine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20190528		NDA	NDA210660	Exela Pharma Sciences, LLC	CYSTEINE HYDROCHLORIDE	10	mg/mL			N	20241231
51754-1008_9a52ae2f-1cea-4ad5-a074-66bbf06578d3	51754-1008	HUMAN PRESCRIPTION DRUG	ELCYS		Cysteine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20231212		NDA	NDA210660	Exela Pharma Sciences, LLC	CYSTEINE HYDROCHLORIDE	50	mg/mL			N	20241231
51754-1029_ed0040fb-c481-4477-8712-00fa6350cd70	51754-1029	HUMAN PRESCRIPTION DRUG	NIPRIDE RTU		Sodium Nitroprusside	INJECTION, SOLUTION	INTRAVENOUS	20180720		NDA	NDA209387	EXELA PHARMA SCIENCES, LLC	SODIUM NITROPRUSSIDE	.2	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
51754-1210_f203ef67-80a5-1ef2-e053-2995a90a961c	51754-1210	HUMAN PRESCRIPTION DRUG	Bloxiverz		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20130724		NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51754-1220_f203ef67-80a5-1ef2-e053-2995a90a961c	51754-1220	HUMAN PRESCRIPTION DRUG	Bloxiverz		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20130724		NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51754-1240_2d69cd60-50c4-4ec3-926e-4d4756ad2c94	51754-1240	HUMAN PRESCRIPTION DRUG	Bloxiverz		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210303		NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51754-1240_761d8917-27da-4a0c-9acc-98688cbc1d46	51754-1240	HUMAN PRESCRIPTION DRUG	Bloxiverz		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210303		NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51754-2001_9ed8665b-91b9-4a6d-a7cc-177040e35e35	51754-2001	HUMAN PRESCRIPTION DRUG	Potassium Acetate		POTASSIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160107		ANDA	ANDA206203	Exela Pharma Sciences, LLC	POTASSIUM ACETATE	3.93	g/20mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51754-2004_2b86b9e8-48ba-4a72-b705-48c2751016e6	51754-2004	HUMAN PRESCRIPTION DRUG	Potassium Acetate		Potassium Acetate	INJECTION	INTRAVENOUS	20230801		ANDA	ANDA206203	Exela Pharma Sciences, LLC	POTASSIUM ACETATE	200	meq/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51754-2005_2b86b9e8-48ba-4a72-b705-48c2751016e6	51754-2005	HUMAN PRESCRIPTION DRUG	Potassium Acetate		Potassium Acetate	INJECTION	INTRAVENOUS	20230801		ANDA	ANDA212692	Exela Pharma Sciences, LLC	POTASSIUM ACETATE	100	meq/50mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51754-2130_5aa322a4-0b10-4f41-ba56-508fc2b25229	51754-2130	HUMAN PRESCRIPTION DRUG	MIDAZOLAM HYDROCHLORIDE		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20221201		NDA	NDA215868	Exela Pharma Sciences, LLC	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51754-2131_5aa322a4-0b10-4f41-ba56-508fc2b25229	51754-2131	HUMAN PRESCRIPTION DRUG	MIDAZOLAM HYDROCHLORIDE		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20221201		NDA	NDA215868	Exela Pharma Sciences, LLC	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51754-2150_e8e80dc7-fa22-4dff-95d6-299a579fd0a3	51754-2150	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAVENOUS	20230501		NDA	NDA215870	Exela Pharma Sciences, LLC	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51754-2160_e8e80dc7-fa22-4dff-95d6-299a579fd0a3	51754-2160	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAVENOUS	20230501		NDA	NDA215870	Exela Pharma Sciences, LLC	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51754-2500_238a983f-81bb-4033-b6ca-5fee7d6d291c	51754-2500	HUMAN PRESCRIPTION DRUG	GANCICLOVIR		GANCICLOVIR	INJECTION, SOLUTION	INTRAVENOUS	20170228		NDA	NDA209347	EXELA PHARMA SCIENCES, LLC	GANCICLOVIR	2	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
51754-3000_8380def7-7f6c-48f1-84ba-935077479130	51754-3000	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20211130		NDA	NDA215252	Exela Pharma Sciences,LLC	DILTIAZEM HYDROCHLORIDE	1	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51754-3500_8380def7-7f6c-48f1-84ba-935077479130	51754-3500	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20211130		NDA	NDA215252	Exela Pharma Sciences,LLC	DILTIAZEM HYDROCHLORIDE	1	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51754-4000_e457de4e-3de8-4cb9-9c1b-5e0ff5630f5b	51754-4000	HUMAN PRESCRIPTION DRUG	Vazculep		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210326		NDA	NDA204300	Exela Phrama Sciences, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51754-4010_e457de4e-3de8-4cb9-9c1b-5e0ff5630f5b	51754-4010	HUMAN PRESCRIPTION DRUG	Vazculep		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210326		NDA	NDA204300	Exela Phrama Sciences, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51754-4020_e457de4e-3de8-4cb9-9c1b-5e0ff5630f5b	51754-4020	HUMAN PRESCRIPTION DRUG	Vazculep		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210326		NDA	NDA204300	Exela Phrama Sciences, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51754-4200_5a627a89-7997-4af5-a1d0-2cedbe1bc868	51754-4200	HUMAN PRESCRIPTION DRUG	Akovaz		ephedrine sulfate	INJECTION	INTRAVENOUS	20210415		NDA	NDA208289	Exela Pharma Sciences, LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51754-4250_5a627a89-7997-4af5-a1d0-2cedbe1bc868	51754-4250	HUMAN PRESCRIPTION DRUG	Akovaz		ephedrine sulfate	INJECTION	INTRAVENOUS	20210510		NDA	NDA208289	Exela Pharma Sciences, LLC	EPHEDRINE SULFATE	5	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
51754-5001_4da0ba66-756d-4b4d-8018-81ca16578ef1	51754-5001	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA211091	Exela Pharma Sciences, LLC	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51754-5002_4da0ba66-756d-4b4d-8018-81ca16578ef1	51754-5002	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20200901		ANDA	ANDA211091	Exela Pharma Sciences, LLC	SODIUM BICARBONATE	75	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51754-5011_4da0ba66-756d-4b4d-8018-81ca16578ef1	51754-5011	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20200901		ANDA	ANDA211091	Exela Pharma Sciences, LLC	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51754-5012_4da0ba66-756d-4b4d-8018-81ca16578ef1	51754-5012	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20180927		ANDA	ANDA211091	Exela Pharma Sciences, LLC	SODIUM BICARBONATE	42	mg/mL	Alkalinizing Activity [MoA]		N	20241231
51754-5060_622efc66-cdc6-4560-8fc6-d66aeda93421	51754-5060	HUMAN PRESCRIPTION DRUG	Betamethasone Sodium Phosphate and Betamethasone Acetate		Betamethasone Sodium Phosphate and Betamethasone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20210601		NDA AUTHORIZED GENERIC	NDA014602	Exela Pharma Sciences, LLC	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
51754-6000_2ae8439a-1a05-4d94-95d5-67614cbb8be3	51754-6000	HUMAN PRESCRIPTION DRUG	GLYRX-PF		glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180801		NDA	NDA210997	Exela Pharma Sciences, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51754-6001_2ae8439a-1a05-4d94-95d5-67614cbb8be3	51754-6001	HUMAN PRESCRIPTION DRUG	GLYRX-PF		glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180801		NDA	NDA210997	Exela Pharma Sciences, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51754-6013_2ae8439a-1a05-4d94-95d5-67614cbb8be3	51754-6013	HUMAN PRESCRIPTION DRUG	GLYRX-PF		glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200601		NDA	NDA210997	Exela Pharma Sciences, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51754-6015_2ae8439a-1a05-4d94-95d5-67614cbb8be3	51754-6015	HUMAN PRESCRIPTION DRUG	GLYRX-PF		glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200601		NDA	NDA210997	Exela Pharma Sciences, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51754-7000_e69b3024-f4bd-456e-8c74-2f9bc33739c9	51754-7000	HUMAN PRESCRIPTION DRUG	Erythromycin Lactobionate		ERYTHROMYCIN LACTOBIONATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210315		ANDA	ANDA211086	Exela Pharma Sciences, LLC	ERYTHROMYCIN LACTOBIONATE	500	mg/10mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
51759-202_0ca1b7ee-c1d4-40cc-b545-34d9acf767ad	51759-202	HUMAN PRESCRIPTION DRUG	AJOVY		fremanezumab-vfrm	INJECTION	SUBCUTANEOUS	20200329		BLA	BLA761089	Teva Pharmaceuticals USA, Inc.	FREMANEZUMAB	225	mg/1.5mL			N	20241231
51759-204_0ca1b7ee-c1d4-40cc-b545-34d9acf767ad	51759-204	HUMAN PRESCRIPTION DRUG	AJOVY		fremanezumab-vfrm	INJECTION	SUBCUTANEOUS	20180915		BLA	BLA761089	Teva Pharmaceuticals USA, Inc.	FREMANEZUMAB	225	mg/1.5mL			N	20241231
51759-305_a0b81ec6-78d0-4be1-8cad-135a94cf403c	51759-305	HUMAN PRESCRIPTION DRUG	UZEDY		risperidone	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230501		NDA	NDA213586	Teva Pharmaceuticals USA, Inc.	RISPERIDONE	50	mg/.14mL	Atypical Antipsychotic [EPC]		N	20241231
51759-410_a0b81ec6-78d0-4be1-8cad-135a94cf403c	51759-410	HUMAN PRESCRIPTION DRUG	UZEDY		risperidone	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230501		NDA	NDA213586	Teva Pharmaceuticals USA, Inc.	RISPERIDONE	75	mg/.21mL	Atypical Antipsychotic [EPC]		N	20241231
51759-520_a0b81ec6-78d0-4be1-8cad-135a94cf403c	51759-520	HUMAN PRESCRIPTION DRUG	UZEDY		risperidone	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230501		NDA	NDA213586	Teva Pharmaceuticals USA, Inc.	RISPERIDONE	100	mg/.28mL	Atypical Antipsychotic [EPC]		N	20241231
51759-630_a0b81ec6-78d0-4be1-8cad-135a94cf403c	51759-630	HUMAN PRESCRIPTION DRUG	UZEDY		risperidone	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230501		NDA	NDA213586	Teva Pharmaceuticals USA, Inc.	RISPERIDONE	125	mg/.35mL	Atypical Antipsychotic [EPC]		N	20241231
51759-740_a0b81ec6-78d0-4be1-8cad-135a94cf403c	51759-740	HUMAN PRESCRIPTION DRUG	UZEDY		risperidone	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230501		NDA	NDA213586	Teva Pharmaceuticals USA, Inc.	RISPERIDONE	150	mg/.42mL	Atypical Antipsychotic [EPC]		N	20241231
51759-850_a0b81ec6-78d0-4be1-8cad-135a94cf403c	51759-850	HUMAN PRESCRIPTION DRUG	UZEDY		risperidone	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230501		NDA	NDA213586	Teva Pharmaceuticals USA, Inc.	RISPERIDONE	200	mg/.56mL	Atypical Antipsychotic [EPC]		N	20241231
51759-960_a0b81ec6-78d0-4be1-8cad-135a94cf403c	51759-960	HUMAN PRESCRIPTION DRUG	UZEDY		risperidone	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230501		NDA	NDA213586	Teva Pharmaceuticals USA, Inc.	RISPERIDONE	250	mg/.7mL	Atypical Antipsychotic [EPC]		N	20241231
51785-900_e43f5c69-97fd-7ce8-e053-2a95a90af93c	51785-900	HUMAN OTC DRUG	Herbalife SKIN Protective Moisturizer Broad Spectrum SPF 30 Mineral Sunscreen		Zinc Oxide	CREAM	TOPICAL	20220501		OTC MONOGRAPH FINAL	part352	Herbalife International of America Inc.	ZINC OXIDE	17.5	g/100mL			N	20241231
51785-922_e43f30d1-a100-5a14-e053-2a95a90a1935	51785-922	HUMAN OTC DRUG	Herbalife Herbal Aloe Face and Body Mineral Sunscreen Broad Spectrum SPF 30		Zinc Oxide	CREAM	TOPICAL	20220501		OTC MONOGRAPH FINAL	part352	Herbalife International of America, Inc.	ZINC OXIDE	19.24	g/100mL			N	20241231
51791-001_cfe22223-1c43-419d-a847-412d853f1fcd	51791-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19820101		NDA	NDA205889	Eastern Welding Supply, Inc.	OXYGEN	99	L/100L			N	20241231
51801-001_de8efd5c-a055-462d-a104-5bca4773fe0c	51801-001	HUMAN PRESCRIPTION DRUG	Effer-K	Orange	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	977.5	mg/1			N	20241231
51801-003_f63dc6e5-6c40-4731-be57-73860ea7a403	51801-003	HUMAN PRESCRIPTION DRUG	GloStrips		Fluorescein Sodium	STRIP	OPHTHALMIC	20130730		UNAPPROVED DRUG OTHER		Nomax Inc.	FLUORESCEIN SODIUM	.6	mg/1	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
51801-004_77d8ad19-ba34-4cd0-9e87-acb2cb9d96b9	51801-004	HUMAN PRESCRIPTION DRUG	GloStrips		Rose Bengal Sodium	STRIP	OPHTHALMIC	20130820		UNAPPROVED DRUG OTHER		Nomax Inc.	ROSE BENGAL SODIUM	1.3	mg/1			N	20241231
51801-005_de8efd5c-a055-462d-a104-5bca4773fe0c	51801-005	HUMAN PRESCRIPTION DRUG	Effer-K	Lemon Citrus	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	977.5	mg/1			N	20241231
51801-006_de8efd5c-a055-462d-a104-5bca4773fe0c	51801-006	HUMAN PRESCRIPTION DRUG	Effer-K	Cherry Berry	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	977.5	mg/1			N	20241231
51801-007_de8efd5c-a055-462d-a104-5bca4773fe0c	51801-007	HUMAN PRESCRIPTION DRUG	Effer-K	Unflavored	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	977.5	mg/1			N	20241231
51801-008_7490418c-b489-4b90-bc3d-33ed71231e2d	51801-008	HUMAN PRESCRIPTION DRUG	Dry Eye Test		Fluorescein Sodium	STRIP	OPHTHALMIC	20131205		UNAPPROVED DRUG OTHER		Nomax Inc.	FLUORESCEIN SODIUM	.12	mg/1	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
51801-009_be8f6626-961d-48c3-ba7f-a2fae87c4cb6	51801-009	HUMAN PRESCRIPTION DRUG	GloStrips		Fluorescein Sodium	STRIP	OPHTHALMIC	20130730		UNAPPROVED DRUG OTHER		Nomax Inc.	FLUORESCEIN SODIUM	1	mg/1	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
51801-011_ba1639f4-e624-41da-a8d7-e97676b900d7	51801-011	HUMAN PRESCRIPTION DRUG	Effer-K	20 mEq Unflavored	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	782	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51801-012_ba1639f4-e624-41da-a8d7-e97676b900d7	51801-012	HUMAN PRESCRIPTION DRUG	Effer-K	20 mEq Orange Cream	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	782	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51801-013_ba1639f4-e624-41da-a8d7-e97676b900d7	51801-013	HUMAN PRESCRIPTION DRUG	Effer-K	10 mEq Unflavored	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	391	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51801-014_ba1639f4-e624-41da-a8d7-e97676b900d7	51801-014	HUMAN PRESCRIPTION DRUG	Effer-K	10 mEq Cherry Vanilla	POTASSIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20130130		UNAPPROVED DRUG OTHER		Nomax Inc.	POTASSIUM BICARBONATE	391	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
51801-366_0a984938-98b5-b96f-e063-6394a90aaa0b	51801-366	HUMAN OTC DRUG	Amcon Labs Hand Sanitizer Instant Foam Sanitizer with Alcohol		Alcohol	SOLUTION	TOPICAL	20230804		OTC MONOGRAPH DRUG	505G(a)(3)	Nomax, Inc.	ALCOHOL	620	mL/L			N	20241231
51801-437_0a985160-e7c4-ee16-e063-6294a90ae08a	51801-437	HUMAN OTC DRUG	Amcon Labs Hand Sanitizer Fragrance Free Gel Sanitizer		Alcohol	GEL	TOPICAL	20230804		OTC MONOGRAPH DRUG	505G(a)(3)	Nomax, Inc.	ALCOHOL	600	mL/L			N	20241231
51801-779_0a983685-8893-b7ec-e063-6394a90a97d9	51801-779	HUMAN OTC DRUG	Amcon Labs Hand Sanitizer Light Cleansing		Alcohol	SPRAY	TOPICAL	20230804		OTC MONOGRAPH DRUG	505G(a)(3)	Nomax, Inc.	ALCOHOL	600	mL/L			N	20241231
51803-001_030da5c8-77cc-9f64-e063-6294a90acfad	51803-001	HUMAN OTC DRUG	IOSAT		Potassium Iodide	TABLET	ORAL	19821014		NDA	NDA018664	Anbex Inc.	POTASSIUM IODIDE	130	mg/1			N	20241231
51803-002_030d9de7-e804-4818-e063-6294a90af468	51803-002	HUMAN OTC DRUG	IOSAT		Potassium Iodide	TABLET	ORAL	20130501		NDA	NDA018664	Anbex Inc.	POTASSIUM IODIDE	65	mg/1			N	20241231
51811-100_dae79bca-bb74-af47-e053-2a95a90ae587	51811-100	HUMAN OTC DRUG	Antimicrobial Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20120521		OTC MONOGRAPH NOT FINAL	part333E	HPC Ventures, LLC	ALCOHOL	665	mL/L			N	20241231
51817-170_df501797-3c7e-5ae2-e053-2995a90a99e8	51817-170	HUMAN PRESCRIPTION DRUG	Busulfan		busulfan	INJECTION	INTRAVENOUS	20170519		ANDA	ANDA207050	Pharmascience Inc.	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
51817-171_f05916fd-4785-f545-e053-2995a90aa901	51817-171	HUMAN PRESCRIPTION DRUG	Ganciclovir		ganciclovir sodium	INJECTION, SOLUTION	INTRAVENOUS	20180424		ANDA	ANDA207645	Pharmascience Inc.	GANCICLOVIR SODIUM	500	mg/10mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
51817-586_de0c8157-9e0e-4964-e053-2995a90a1259	51817-586	HUMAN PRESCRIPTION DRUG	Bortezomib		bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502		ANDA	ANDA208392	Pharmascience Inc.	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
51822-021_0c863e4e-1b19-6315-e063-6294a90a9034	51822-021	HUMAN OTC DRUG	Petrocort Antipruritic Lip 21		HYDROCORTISONE	LIPSTICK	TOPICAL	20171226		OTC MONOGRAPH DRUG	M017	Clinical Formula LLC	HYDROCORTISONE	.005	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51824-001_8dc7072a-ccc6-4e98-80a7-d3bd806075ea	51824-001	HUMAN OTC DRUG	CAREALL Tolnaftate		Tolnaftate	CREAM	TOPICAL	20120601		OTC MONOGRAPH DRUG	M005	New World Imports, Inc	TOLNAFTATE	10	mg/g			N	20241231
51824-003_05bf6e36-e8e3-4c6a-9d9a-068993b7c73c	51824-003	HUMAN OTC DRUG	CAREALL Bacitracin		Bacitracin Zinc	CREAM	TOPICAL	20120601		OTC MONOGRAPH DRUG	M004	New World Imports, Inc	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
51824-007_833a4fe8-39ad-4d73-a183-62715f006689	51824-007	HUMAN OTC DRUG	CAREALL Muscle Rub	Ultra Strength	Menthol, Methyl Salicylate	CREAM	TOPICAL	20120601		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	MENTHOL; METHYL SALICYLATE	100; 150	mg/g; mg/g			N	20241231
51824-014_6a2bbc2a-4f1b-43d0-9d3d-d8ee803486d5	51824-014	HUMAN OTC DRUG	CAREALL Musle and Joint		Menthol	GEL	TOPICAL	20120601		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	MENTHOL	25	mg/g			N	20241231
51824-020_09915173-0a95-e447-e063-6294a90aa3d5	51824-020	HUMAN OTC DRUG	Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20120612		OTC MONOGRAPH DRUG	505G(a)(3)	New World Imports, Inc.	ALCOHOL	.7	mL/mL			N	20241231
51824-021_09920569-69b8-5ed1-e063-6294a90a028e	51824-021	HUMAN OTC DRUG	Freshscent Anti-Perspirant Deodorant		ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20120614		OTC MONOGRAPH DRUG	M019	New World Imports, Inc.	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
51824-022_09924bb2-c9a5-d0bb-e063-6394a90aed50	51824-022	HUMAN OTC DRUG	Freshscent Anti-Perspirant Deodorant		ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20120614		OTC MONOGRAPH DRUG	M019	New World Imports, Inc.	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
51824-023_09914704-ecef-dfdb-e063-6294a90ae4c3	51824-023	HUMAN OTC DRUG	Freshscent Anti-Perspirant Deodorant		ALUMINUM CHLOROHYDRATE	SPRAY	TOPICAL	20120614		OTC MONOGRAPH DRUG	M019	New World Imports, Inc.	ALUMINUM CHLOROHYDRATE	13	g/100mL			N	20241231
51824-029_0cb19ddc-af50-4b4b-8875-26a9c48c32f8	51824-029	HUMAN OTC DRUG	Freshmint Premium Anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20130101		OTC MONOGRAPH DRUG	M021	New World Imports, Inc	SODIUM FLUORIDE	2.43	mg/g			N	20241231
51824-032_53e9f1ca-e066-4fe5-ba43-715abd56e8fb	51824-032	HUMAN OTC DRUG	CAREALL Zinc Oxide		Zinc Oxide	OINTMENT	TOPICAL	20130404		OTC MONOGRAPH DRUG	M016	New World Imports Inc	ZINC OXIDE	.2	g/g			N	20241231
51824-033_2bc4880c-b3ab-4dab-9abf-00e011dbe737	51824-033	HUMAN OTC DRUG	CAREALL Vitamin A and D		Lanolin and Petrolatum	OINTMENT	TOPICAL	20120501	20260101	OTC MONOGRAPH DRUG	M016	New World Imports, Inc	LANOLIN; PETROLATUM	.01; .97	g/g; g/g			N	
51824-034_ead0e4a7-cd3f-428a-b013-51c46064a229	51824-034	HUMAN OTC DRUG	Freshmint Premium Anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20130404		OTC MONOGRAPH DRUG	M021	New World Imports, Inc	SODIUM FLUORIDE	2.43	mg/g			N	20241231
51824-039_fb94518f-ca48-4b68-88f7-964125491e95	51824-039	HUMAN OTC DRUG	CAREALL Eyedrops Original		Tetrahydrozoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20140601		OTC MONOGRAPH DRUG	M018	New World Imports, Inc	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
51824-041_c32b8b7d-a3a5-41f3-b71c-c1e2bf7ccdef	51824-041	HUMAN OTC DRUG	CAREALL Petroleum		PETROLATUM	JELLY	TOPICAL	20140601		OTC MONOGRAPH DRUG	M016	New World Imports, Inc	PETROLATUM	1	g/g			N	20241231
51824-045_8d968ced-6702-4a2a-9a84-52d86b4bc174	51824-045	HUMAN OTC DRUG	CareAll Medicated Chest Rub		Camphor, Menthol, Eucalyptus	OINTMENT	TOPICAL	20140709		OTC MONOGRAPH DRUG	M012	New World Imports, Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
51824-046_da399095-72a7-4c45-b006-4043fab8012e	51824-046	HUMAN OTC DRUG	Freshmint Premium Anticavity Gel		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20150101		OTC MONOGRAPH DRUG	M021	New World Imports, Inc	SODIUM FLUORIDE	2.43	mg/g			N	20241231
51824-049_0999c1ea-7659-4028-897b-228a447eb169	51824-049	HUMAN OTC DRUG	CareALL Non Aspirin	Extra Strength	Acetaminophen	TABLET	ORAL	20150917		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
51824-050_4940ef00-688b-4e66-a75d-bc13d37369eb	51824-050	HUMAN OTC DRUG	CAREALL Hydrocortisone	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20160311		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	HYDROCORTISONE ACETATE	1	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51824-052_fa69af19-a36d-4de2-9586-b7c257ae552f	51824-052	HUMAN OTC DRUG	CareALL Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20160315		OTC MONOGRAPH DRUG	M004	New World Imports, Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
51824-053_21bad52b-0c0c-4cb3-8788-3bd148284a69	51824-053	HUMAN OTC DRUG	Freshmint Sensitive		Potassium Nitrate and Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20100916		OTC MONOGRAPH DRUG	m021	New World Imports, Inc	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.4	mg/g; mg/g			N	20241231
51824-056_62aeb97c-6967-4e5a-94ae-1b12f5de0199	51824-056	HUMAN OTC DRUG	CAREALL Diphenhydramine		Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20160428	20261201	OTC MONOGRAPH DRUG	M012	New World Imports, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
51824-057_91fa8291-db07-44be-afbf-c69f08f00426	51824-057	HUMAN OTC DRUG	CAREALL Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20160329		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
51824-058_561a5c64-9b2e-4f3d-968f-d0b9d7125b98	51824-058	HUMAN OTC DRUG	CAREALL Sennosides		Sennosides	TABLET	ORAL	20160418		OTC MONOGRAPH DRUG	M007	New World Imports, Inc	SENNOSIDES A AND B	8.6	mg/1			N	20251231
51824-060_e2ed9cbc-d8aa-429a-88ff-921c37a84c2d	51824-060	HUMAN OTC DRUG	CareALL Acetaminophen	Extra Strength	Acetaminophen	TABLET	ORAL	20160415		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
51824-061_fda1c00e-2083-49f6-9714-77e9fc93e712	51824-061	HUMAN OTC DRUG	CareALL Acetaminophen		Acetaminophen	TABLET	ORAL	20160415		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN	325	mg/1			N	20241231
51824-063_2b6cd8d8-0c91-486e-9741-be84e67a7f12	51824-063	HUMAN OTC DRUG	CAREALL Clotrimazole		Clotrimazole	CREAM	TOPICAL	20160321		OTC MONOGRAPH DRUG	M005	New World Imports, Inc	CLOTRIMAZOLE	10	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51824-064_a3b32304-93eb-4861-adda-42cf4e2f3bce	51824-064	HUMAN OTC DRUG	CAREALL Ibuprofen		Ibuprofen	TABLET	ORAL	20170811		ANDA	ANDA079174	New World Imports	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51824-067_c017f729-d8ef-4882-9391-a8137e686ce6	51824-067	HUMAN OTC DRUG	Freshmint Anticavity Fluoride		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20100916		OTC MONOGRAPH DRUG	M021	New World Imports, Inc	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
51824-068_d6b0dfe0-5a8a-4647-bfcb-2dc507b9f65d	51824-068	HUMAN OTC DRUG	Freshmint Anticavity Fluoride		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20100917		OTC MONOGRAPH DRUG	M021	New World Imports, Inc	SODIUM FLUORIDE	2.2	mg/g			N	20241231
51824-069_8b8fb595-7289-4e3d-82b5-352a3fa28f80	51824-069	HUMAN OTC DRUG	CAREALL Non-Aspirin PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET	ORAL	20181130		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51824-072_5eeae4dc-b15f-4f3b-b88e-c4c2371179ab	51824-072	HUMAN OTC DRUG	CAREALL Naproxen		Naproxen Sodium	TABLET	ORAL	20190116		ANDA	ANDA079096	New World Imports, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51824-074_e39e2d7f-8cd0-4d9d-a401-5db982a485cd	51824-074	HUMAN OTC DRUG	CareALL Triple Antibiotic plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCl	OINTMENT	TOPICAL	20190902		OTC MONOGRAPH DRUG	M004	New World Imports, Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
51824-075_49dda466-3496-49ec-a374-6182b5353b52	51824-075	HUMAN OTC DRUG	CAREALL Loratadine		Loratadine	TABLET	ORAL	20200302		ANDA	ANDA210722	New World Imports	LORATADINE	10	mg/1			N	20241231
51824-076_152a6864-7d31-46c6-895d-a5134cbc1af5	51824-076	HUMAN OTC DRUG	CAREALL Cetirizine HCl		Cetirizine	TABLET	ORAL	20200302		ANDA	ANDA209274	New World Imports	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51824-077_1661f7e6-98ad-4ce3-b856-874d08116ec5	51824-077	HUMAN OTC DRUG	CAREALL Aspirin		Aspirin	TABLET, COATED	ORAL	20200601		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
51824-078_43eb74b9-a618-4048-9568-456e3a5ebf66	51824-078	HUMAN OTC DRUG	CAREALL Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	20201201		OTC MONOGRAPH DRUG	M005	New World Imports, Inc	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51824-079_19439af4-c73a-4c2d-aa46-c16cf0a34d69	51824-079	HUMAN OTC DRUG	CAREALL Hemorrhoidal		mineral oil, petrolatum, phenylephrine hcl	OINTMENT	TOPICAL	20200101		OTC MONOGRAPH DRUG	M015	New World Imports, Inc	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
51824-082_55a101d1-c284-46a6-b070-8136561d2abe	51824-082	HUMAN OTC DRUG	CareALL Creamy Petroleum Jelly		Petrolatum	CREAM	TOPICAL	20210201		OTC MONOGRAPH DRUG	M016	New World Imports, Inc	PETROLATUM	30	g/100g			N	20241231
51824-083_51bf80bc-4a49-4422-b7f6-29b3f118eab0	51824-083	HUMAN OTC DRUG	CareALL Creamy Cocoa Butter Petroleum Jelly		Petrolatum	CREAM	TOPICAL	20210201		OTC MONOGRAPH DRUG	M016	New World Imports, Inc	PETROLATUM	30	g/100g			N	20241231
51824-084_ea926cd0-0392-403c-93da-18bffd4b5046	51824-084	HUMAN OTC DRUG	CareAll Vaporizing Chest Rub		Camphor, Menthol, Eucalyptus	OINTMENT	TOPICAL	20210201	20250930	OTC MONOGRAPH DRUG	M012	New World Imports, Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.047; .012; .0125	g/g; g/g; g/g			N	
51824-085_c74c7235-c4a0-49e1-99e8-a9a4d20b6689	51824-085	HUMAN OTC DRUG	CareALL Acetaminophen		Acetaminophen	TABLET	ORAL	20210318		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN	325	mg/1			N	20241231
51824-086_968b1ad3-11a0-4a70-9457-d67bf33dc350	51824-086	HUMAN OTC DRUG	CareALL Acetaminophen	Extra Strength	Acetaminophen	TABLET	ORAL	20210318		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
51824-087_afd81f85-6eea-4282-8298-a745fb2c9292	51824-087	HUMAN OTC DRUG	CareALL Non Aspirin	Extra Strength	Acetaminophen	TABLET	ORAL	20210318		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
51824-093_d24fd08c-0fd6-4d43-ad4e-863172b4ad96	51824-093	HUMAN OTC DRUG	CAREALL Clotrimazole		Clotrimazole	CREAM	TOPICAL	20220701		OTC MONOGRAPH DRUG	M005	New World Imports, Inc	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
51824-094_25b33cab-460d-4dc4-b480-2567978ad0dc	51824-094	HUMAN OTC DRUG	CareALL Arthritis and Muscle		Capsaicin	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	CAPSAICIN	.025	g/g			N	20241231
51824-095_8d3ae0af-7579-44d7-af3f-11e75b6587ec	51824-095	HUMAN OTC DRUG	CAREALL Vitamin A and D		Petrolatum	OINTMENT	TOPICAL	20230519		OTC MONOGRAPH DRUG	M016	New World Imports, Inc	PETROLATUM	.97	g/g			N	20241231
51824-096_94921388-0319-43bc-86d7-231ca0c14df7	51824-096	HUMAN OTC DRUG	CareALL First Aid Burn Cream		Benzalkonium Chloride, Lidocaine HCl	CREAM	TOPICAL	20240102		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.005; .0013	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51824-097_c1bf9857-8467-4e90-920e-c0748386ed55	51824-097	HUMAN OTC DRUG	CAREALL Hydrocortisone	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51824-098_089fac68-12b4-4998-b44b-858016f68d2e	51824-098	HUMAN OTC DRUG	CAREALL Hydrocortisone	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51824-099_2ea8c02b-0e94-43c2-be5a-97980122f028	51824-099	HUMAN OTC DRUG	CareALL Acetaminophen	Extra Strength	Acetaminophen	TABLET	ORAL	20231128		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
51824-102_1c52b496-e4b7-4f0b-a3e1-a494041f7466	51824-102	HUMAN OTC DRUG	CAREALL Allergy Relief		Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20231206		OTC MONOGRAPH DRUG	M012	New World Imports, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51824-103_48c2ea86-afb9-4962-b71d-4afa6fc41186	51824-103	HUMAN OTC DRUG	CAREALL Allergy Relief		Loratadine	TABLET	ORAL	20231207		ANDA	ANDA210722	New World Imports	LORATADINE	10	mg/1			N	20241231
51824-104_6b00a045-9dc7-46a4-bcd8-e235850fe288	51824-104	HUMAN OTC DRUG	CAREALL Allergy Relief		Cetirizine HCl	TABLET	ORAL	20231207		ANDA	ANDA209274	New World Imports	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51824-105_4e8ae88e-f4a4-4b92-a838-e36a5cc2aee8	51824-105	HUMAN OTC DRUG	CAREALL Muscle Rub	Ultra Strength	Menthol, Methyl Salicylate	CREAM	TOPICAL	20231212		OTC MONOGRAPH DRUG	M017	New World Imports, Inc	LEVOMENTHOL; METHYL SALICYLATE	100; 150	mg/g; mg/g			N	20241231
51824-107_f3eaca32-ddfb-4825-8b92-b3f171a494d3	51824-107	HUMAN OTC DRUG	CAREALL Pain Relief PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET	ORAL	20240110		OTC MONOGRAPH DRUG	M013	New World Imports, Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
51861-050_0814f567-cdaa-8d8e-e063-6294a90af37e	51861-050	HUMAN OTC DRUG	Protective Day		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTOCRYLENE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	USANA Health Sciences, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	3; 10; 7.5; 2	g/100g; g/100g; g/100g; g/100g			N	20241231
51861-060_0814f4b9-3a70-e425-e063-6394a90ad662	51861-060	HUMAN OTC DRUG	Protective Day		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTOCRYLENE	LOTION	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	USANA Health Sciences, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	30; 100; 75; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
51861-080_08151a03-10b8-08ea-e063-6394a90a6eeb	51861-080	HUMAN OTC DRUG	Usana Celavive Daily Mineral Protective Cream Moisturizer with Sunscreen SPF 30		ZINC OXIDE	CREAM	TOPICAL	20210409		OTC MONOGRAPH DRUG	M020	USANA Health Sciences, Inc.	ZINC OXIDE	182	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
51862-016_912a2e7c-3615-4dff-b8b8-27eed882ab3f	51862-016	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20160601		ANDA	ANDA073556	Mayne Pharma Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51862-028_82a2b0fd-c90b-445c-b8fa-719cdbe7c61d	51862-028	HUMAN PRESCRIPTION DRUG	Lutera		levonorgestrel and ethinyl estradiol	KIT		20160803		ANDA	ANDA076625	Mayne Pharma Inc.						N	20241231
51862-047_3c0c7e77-ed9d-46a7-8052-501e6e565fe9	51862-047	HUMAN PRESCRIPTION DRUG	Amethia		ETHINYL ESTRADIOL and LEVONORGESTREL	KIT		20161012		ANDA	ANDA078834	Mayne Pharma Inc						N	20241231
51862-073_fc2d4f1d-8898-4fa8-858e-59d60daca9e0	51862-073	HUMAN PRESCRIPTION DRUG	Estazolam		Estazolam	TABLET	ORAL	20201018		ANDA	ANDA074921	Mayne Pharma	ESTAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51862-074_fc2d4f1d-8898-4fa8-858e-59d60daca9e0	51862-074	HUMAN PRESCRIPTION DRUG	Estazolam		Estazolam	TABLET	ORAL	20201018		ANDA	ANDA074921	Mayne Pharma	ESTAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51862-095_ffd27bfc-4d28-74b5-e053-6394a90a24e1	51862-095	HUMAN PRESCRIPTION DRUG	DISOPYRAMIDE PHOSPHATE		DISOPYRAMIDE PHOSPHATE	CAPSULE	ORAL	20220401		ANDA	ANDA070173	Mayne Pharma Commercial LLC	DISOPYRAMIDE PHOSPHATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
51862-096_ffd27bfc-4d28-74b5-e053-6394a90a24e1	51862-096	HUMAN PRESCRIPTION DRUG	DISOPYRAMIDE PHOSPHATE		DISOPYRAMIDE PHOSPHATE	CAPSULE	ORAL	20220401		ANDA	ANDA070173	Mayne Pharma Commercial LLC	DISOPYRAMIDE PHOSPHATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
51862-097_49a4d83a-9976-49f2-b40b-dc18b9117ae1	51862-097	HUMAN PRESCRIPTION DRUG	Levora		levonorgestrel and ethinyl estradiol	KIT		20160803		ANDA	ANDA073594	Mayne Pharma Inc.						N	20241231
51862-179_0e852f57-a919-aaad-e063-6294a90a7a2c	51862-179	HUMAN PRESCRIPTION DRUG	butalbital, acetaminophen and caffeine		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20120416		ANDA	ANDA089007	Mayne Pharma	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20251231
51862-180_920da7e2-796f-41c2-a6dc-f01a90537d90	51862-180	HUMAN OTC DRUG	Pramoxine hydrochloride		Pramoxine hydrochloride	AEROSOL, FOAM	TOPICAL	20111031		OTC MONOGRAPH FINAL	part346	Mayne Pharma	PRAMOXINE HYDROCHLORIDE	10	mg/g			N	20241231
51862-185_ffd2a1bb-d072-8af8-e053-6394a90a48ed	51862-185	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161101		ANDA	ANDA205386	Mayne Pharma Commercial LLC	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-186_ffd2a1bb-d072-8af8-e053-6394a90a48ed	51862-186	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161101		ANDA	ANDA205386	Mayne Pharma Commercial LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-187_ffd2a1bb-d072-8af8-e053-6394a90a48ed	51862-187	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161101		ANDA	ANDA205386	Mayne Pharma Commercial LLC	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-188_ffd2a1bb-d072-8af8-e053-6394a90a48ed	51862-188	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161101		ANDA	ANDA205386	Mayne Pharma Commercial LLC	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-240_ffd2f3f5-c77b-0028-e053-6394a90aaf17	51862-240	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20180102		ANDA	ANDA075389	Mayne Pharma Commercial LLC	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51862-241_ffd2f3f5-c77b-0028-e053-6394a90aaf17	51862-241	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20180416		ANDA	ANDA075389	Mayne Pharma Commercial LLC	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51862-242_ffd2f3f5-c77b-0028-e053-6394a90aaf17	51862-242	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20180102		ANDA	ANDA075389	Mayne Pharma Commercial LLC	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51862-258_cb3d0738-1ec9-47a9-9167-8a4eb905ddab	51862-258	HUMAN PRESCRIPTION DRUG	Nextstellis		drospirenone and estetrol	KIT		20210416		NDA	NDA214154	Mayne Pharma						N	20241231
51862-290_bbcdfc0d-2b7c-4d9d-83cd-83ffbdc67786	51862-290	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	20200403		ANDA	ANDA212384	Mayne Pharma Inc.	TRIAMCINOLONE ACETONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51862-295_710a9f84-28e4-4387-9164-1d0dd21c03bc	51862-295	HUMAN PRESCRIPTION DRUG	FABIOR		tazarotene	AEROSOL, FOAM	TOPICAL	20170310		NDA	NDA202428	Mayne Pharma	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
51862-320_ffd2dc9a-ec81-812b-e053-6294a90ab6b7	51862-320	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20180101		ANDA	ANDA090097	Mayne Pharma Commercial LLC	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
51862-321_ffd2dc9a-ec81-812b-e053-6294a90ab6b7	51862-321	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20180101		ANDA	ANDA090097	Mayne Pharma Commercial LLC	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
51862-322_ffd2dc9a-ec81-812b-e053-6294a90ab6b7	51862-322	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20180101		ANDA	ANDA090097	Mayne Pharma Commercial LLC	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
51862-328_c086281e-4210-40e9-bbf4-13f1de63cc34	51862-328	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride Extended-Release		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230130		ANDA	ANDA215775	Mayne Pharma	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51862-329_c086281e-4210-40e9-bbf4-13f1de63cc34	51862-329	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride Extended-Release		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230130		ANDA	ANDA215775	Mayne Pharma	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51862-330_c086281e-4210-40e9-bbf4-13f1de63cc34	51862-330	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride Extended-Release		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230130		ANDA	ANDA215775	Mayne Pharma	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
51862-339_ffd326e9-a80a-275a-e053-6394a90a213a	51862-339	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		chlorzoxazone	TABLET	ORAL	20200731		ANDA	ANDA211849	Mayne Pharma Commercial LLC	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
51862-345_a76fac17-7734-4eb7-a5c5-b0410a18cb90	51862-345	HUMAN PRESCRIPTION DRUG	dextroamphetamine sulfate		dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20160805	20240229	ANDA	ANDA203901	Mayne Pharma Inc.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
51862-346_a76fac17-7734-4eb7-a5c5-b0410a18cb90	51862-346	HUMAN PRESCRIPTION DRUG	dextroamphetamine sulfate		dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20160805	20240229	ANDA	ANDA203901	Mayne Pharma Inc.	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
51862-362_d05a8a27-b7f9-40cc-a36a-97209fc998b1	51862-362	HUMAN PRESCRIPTION DRUG	FLUOROURACIL		FLUOROURACIL	CREAM	TOPICAL	20191203		ANDA	ANDA077524	Mayne Pharma Inc.	FLUOROURACIL	50	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
51862-376_0ab6061c-756f-48e6-ac67-cc6c15a5a752	51862-376	HUMAN PRESCRIPTION DRUG	SORILUX		calcipotriene	AEROSOL, FOAM	TOPICAL	20170411		NDA	NDA022563	Mayne Pharma	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
51862-453_d876b634-0405-4ace-b85d-27191bb0b1fc	51862-453	HUMAN PRESCRIPTION DRUG	Clonidine		CLONIDINE	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160803		ANDA	ANDA079090	Mayne Pharma Inc.	CLONIDINE	.1	mg/24h	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51862-454_d876b634-0405-4ace-b85d-27191bb0b1fc	51862-454	HUMAN PRESCRIPTION DRUG	Clonidine		CLONIDINE	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160803		ANDA	ANDA079090	Mayne Pharma Inc.	CLONIDINE	.2	mg/24h	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51862-455_d876b634-0405-4ace-b85d-27191bb0b1fc	51862-455	HUMAN PRESCRIPTION DRUG	Clonidine		CLONIDINE	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160803		ANDA	ANDA079090	Mayne Pharma Inc.	CLONIDINE	.3	mg/24h	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
51862-458_2401a70a-8308-4b1b-b1c8-05b91ec230a2	51862-458	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20160718		ANDA	ANDA065044	Mayne Pharma Inc.	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51862-460_2401a70a-8308-4b1b-b1c8-05b91ec230a2	51862-460	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20160718		ANDA	ANDA065044	Mayne Pharma Inc.	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51862-462_ffc3f14b-73c4-97c7-e053-6294a90aa622	51862-462	HUMAN PRESCRIPTION DRUG	Tolsura		Itraconazole	CAPSULE, GELATIN COATED	ORAL	20181211		NDA	NDA208901	Mayne Pharma Commercial LLC	ITRACONAZOLE	65	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
51862-471_89e0c754-110c-443b-9a0e-454993b21992	51862-471	HUMAN PRESCRIPTION DRUG	Leena		Norethindrone and Ethinyl Estradiol	KIT		20160803		NDA AUTHORIZED GENERIC	NDA018977	Mayne Pharma Inc.						N	20241231
51862-486_f26c56ff-9afc-47cc-a94a-974bf8f5039f	51862-486	HUMAN PRESCRIPTION DRUG	Trimethoprim		Trimethoprim	TABLET	ORAL	20160718		NDA	NDA018679	Mayne Pharma	TRIMETHOPRIM	100	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
51862-510_aac48fc3-0be0-4880-a512-b1331f1bc889	51862-510	HUMAN PRESCRIPTION DRUG	Trivora		Levonorgestrel and Ethinyl Estradiol	KIT		20160803		ANDA	ANDA074538	Mayne Pharma Inc.						N	20241231
51862-514_9d1ee9ee-0e36-4055-9b6e-2445bc713cab	51862-514	HUMAN PRESCRIPTION DRUG	Desogestrel and Ethinyl Estradiol		Desogestrel and Ethinyl Estradiol	KIT		20201004		ANDA	ANDA091234	Mayne Pharma Inc.						N	20241231
51862-540_ea23805b-70aa-2efd-e053-2995a90a43af	51862-540	HUMAN PRESCRIPTION DRUG	butalbital, acetaminophen and caffeine		butalbital, acetaminophen and caffeine	TABLET	ORAL	20150828	20250331	ANDA	ANDA089175	Mayne Pharma	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	
51862-544_0e8544ff-f3e3-f505-e063-6394a90a81d5	51862-544	HUMAN PRESCRIPTION DRUG	butalbital and acetaminophen		butalbital and acetaminophen	CAPSULE	ORAL	20180730		ANDA	ANDA207313	Mayne Pharma	ACETAMINOPHEN; BUTALBITAL	300; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20251231
51862-545_ae9f13aa-78c2-4c78-8fd5-a0e4d22b2798	51862-545	HUMAN PRESCRIPTION DRUG	SRONYX		Levonorgestrel and Ethinyl Estradiol	KIT		20160803		ANDA	ANDA077681	Mayne Pharma Inc.						N	20241231
51862-557_fcef6d47-ec45-d10e-e053-6294a90a3416	51862-557	HUMAN PRESCRIPTION DRUG	Doryx		doxycycline hyclate	TABLET, DELAYED RELEASE	ORAL	20150526	20240131	NDA	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
51862-558_fcef6d47-ec45-d10e-e053-6294a90a3416	51862-558	HUMAN PRESCRIPTION DRUG	Doryx		doxycycline hyclate	TABLET, DELAYED RELEASE	ORAL	20150413	20250430	NDA	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	200	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
51862-559_aacc1875-287e-408b-82f6-ade24f5d899d	51862-559	HUMAN PRESCRIPTION DRUG	DORYX MPC		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20160701	20240630	NDA	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	120	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
51862-560_aacc1875-287e-408b-82f6-ade24f5d899d	51862-560	HUMAN PRESCRIPTION DRUG	DORYX MPC		doxycycline hyclate	TABLET, DELAYED RELEASE	ORAL	20230102		NDA	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	60	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51862-564_0a443e47-7789-4141-b056-2f1c83601eee	51862-564	HUMAN PRESCRIPTION DRUG	Low-Ogestrel		Norgestrel and Ethinyl Estradiol	KIT		20160803		ANDA	ANDA075288	Mayne Pharma Inc.						N	20241231
51862-571_ea09463b-6f16-4086-9290-9721fa93d666	51862-571	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20201002		NDA AUTHORIZED GENERIC	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	80	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51862-580_d9a1678d-e215-4bed-a484-317d658fbe11	51862-580	HUMAN PRESCRIPTION DRUG	BUDESONIDE (ENTERIC COATED)		Budesonide	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20191031		ANDA	ANDA206623	Mayne Pharma Inc.	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51862-604_5953ed83-ca12-4336-989f-599dde7209c4	51862-604	HUMAN PRESCRIPTION DRUG	LEXETTE		Halobetasol propionate	AEROSOL, FOAM	TOPICAL	20190423		NDA	NDA210566	Mayne Pharma	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51862-606_f7af4186-fdc8-41b9-898a-f18ab831eb04	51862-606	HUMAN PRESCRIPTION DRUG	Halobetasol propionate		Halobetasol propionate	AEROSOL, FOAM	TOPICAL	20190204		NDA	NDA210566	Mayne Pharma	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
51862-609_f29266ce-c1e4-42e2-b546-8e29f6c3690e	51862-609	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride (LA)		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190501		ANDA	ANDA200886	Mayne Pharma	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
51862-610_f29266ce-c1e4-42e2-b546-8e29f6c3690e	51862-610	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride (LA)		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181206		ANDA	ANDA078458	Mayne Pharma	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
51862-611_f29266ce-c1e4-42e2-b546-8e29f6c3690e	51862-611	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride (LA)		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181206		ANDA	ANDA078458	Mayne Pharma	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
51862-612_f29266ce-c1e4-42e2-b546-8e29f6c3690e	51862-612	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride (LA)		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181206		ANDA	ANDA078458	Mayne Pharma	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
51862-614_f29266ce-c1e4-42e2-b546-8e29f6c3690e	51862-614	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride (LA)		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181206		ANDA	ANDA078458	Mayne Pharma	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
51862-615_ffc42b7e-44f5-ea5f-e053-6394a90a05c7	51862-615	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20220114		ANDA	ANDA207270	Mayne Pharma Commercial LLC	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-617_ffc42b7e-44f5-ea5f-e053-6394a90a05c7	51862-617	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20220114		ANDA	ANDA207270	Mayne Pharma Commercial LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-634_fae09d4d-1120-e15d-e053-6294a90abb56	51862-634	HUMAN PRESCRIPTION DRUG	Fentanyl Buccal		Fentanyl Citrate	TABLET	BUCCAL; SUBLINGUAL	20190614		NDA AUTHORIZED GENERIC	NDA021947	Mayne Pharma	FENTANYL CITRATE	100	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-635_fae09d4d-1120-e15d-e053-6294a90abb56	51862-635	HUMAN PRESCRIPTION DRUG	Fentanyl Buccal		Fentanyl Citrate	TABLET	BUCCAL; SUBLINGUAL	20190614		NDA AUTHORIZED GENERIC	NDA021947	Mayne Pharma	FENTANYL CITRATE	200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-636_fae09d4d-1120-e15d-e053-6294a90abb56	51862-636	HUMAN PRESCRIPTION DRUG	Fentanyl Buccal		Fentanyl Citrate	TABLET	BUCCAL; SUBLINGUAL	20190614		NDA AUTHORIZED GENERIC	NDA021947	Mayne Pharma	FENTANYL CITRATE	400	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-637_fae09d4d-1120-e15d-e053-6294a90abb56	51862-637	HUMAN PRESCRIPTION DRUG	Fentanyl Buccal		Fentanyl Citrate	TABLET	BUCCAL; SUBLINGUAL	20190614		NDA AUTHORIZED GENERIC	NDA021947	Mayne Pharma	FENTANYL CITRATE	600	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-638_fae09d4d-1120-e15d-e053-6294a90abb56	51862-638	HUMAN PRESCRIPTION DRUG	Fentanyl Buccal		Fentanyl Citrate	TABLET	BUCCAL; SUBLINGUAL	20190614		NDA AUTHORIZED GENERIC	NDA021947	Mayne Pharma	FENTANYL CITRATE	800	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
51862-642_48d4944a-8050-439e-b003-a21a2cd3d555	51862-642	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20210827		ANDA	ANDA075797	Mayne Pharma Commercial LLC	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
51862-643_48d4944a-8050-439e-b003-a21a2cd3d555	51862-643	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20210827		ANDA	ANDA075797	Mayne Pharma Commercial LLC	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
51862-645_0048909e-ca81-45c9-9f5c-c5891f9bc85e	51862-645	HUMAN PRESCRIPTION DRUG	Nymyo		norgestimate and ethinyl estradiol	KIT		20201011		ANDA	ANDA090523	Mayne Pharma Inc.						N	20241231
51862-646_0b6d819d-063f-41a6-a62b-ffb2a62e5dce	51862-646	HUMAN PRESCRIPTION DRUG	Tri-Nymyo		Norgestimate and Ethinyl Estradiol	KIT		20201024		ANDA	ANDA090524	Mayne Pharma Inc.						N	20241231
51862-648_ae88cfe9-5fe5-4192-b174-91aa060cc3a3	51862-648	HUMAN PRESCRIPTION DRUG	Microgestin 24 Fe		Norethindrone acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20201012		ANDA	ANDA202994	Mayne Pharma Inc.						N	20241231
51862-682_5bcbc281-342c-4b05-8409-53a08b1fc9f6	51862-682	HUMAN PRESCRIPTION DRUG	SOLTAMOX		TAMOXIFEN CITRATE	LIQUID	ORAL	20210618		NDA	NDA021807	Mayne Pharma	TAMOXIFEN CITRATE	20	mg/10mL	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
51862-690_003abd8e-d4b8-fc69-e063-6394a90a381f	51862-690	HUMAN PRESCRIPTION DRUG	tavaborole		tavaborole	SOLUTION	TOPICAL	20210201		ANDA	ANDA211297	Mayne Pharma Commercial LLC	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
51862-695_ffd2c936-9b9d-b7a3-e053-6394a90af6a3	51862-695	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20170614		ANDA	ANDA208765	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51862-696_ffd2c936-9b9d-b7a3-e053-6394a90af6a3	51862-696	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20170614		ANDA	ANDA208765	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
51862-709_ea09463b-6f16-4086-9290-9721fa93d666	51862-709	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20160526	20240731	NDA AUTHORIZED GENERIC	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
51862-855_ffd2c936-9bf2-b7a3-e053-6394a90af6a3	51862-855	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20180716		ANDA	ANDA073618	Mayne Pharma Commercial LLC	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
51862-856_ffd2c936-9bf2-b7a3-e053-6394a90af6a3	51862-856	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20180716		ANDA	ANDA073589	Mayne Pharma Commercial LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
51862-858_ffd2c936-9bf2-b7a3-e053-6394a90af6a3	51862-858	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20180716		ANDA	ANDA073607	Mayne Pharma Commercial LLC	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
51862-866_7fe013d6-bb93-41df-8110-33d210eeab1f	51862-866	HUMAN PRESCRIPTION DRUG	Microgestin Fe 1/20		Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20201012		ANDA	ANDA091454	Mayne Pharma Inc.						N	20241231
51862-868_365a6126-d5f6-4456-a7ef-2b3872e28f3a	51862-868	HUMAN PRESCRIPTION DRUG	Microgestin 1/20		Norethindrone Acetate/Ethinyl Estradiol	KIT		20201012		ANDA	ANDA202995	Mayne Pharma Inc.						N	20241231
51862-870_f313633b-a2bf-40c0-8570-fe118c0030c5	51862-870	HUMAN PRESCRIPTION DRUG	Microgestin Fe 1.5/30		Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20201012		ANDA	ANDA091453	Mayne Pharma Inc.						N	20241231
51862-872_beac0871-2e87-4a33-9852-96d66b35b492	51862-872	HUMAN PRESCRIPTION DRUG	Microgestin 1.5/30		Norethindrone Acetate/Ethinyl Estradiol	KIT		20201011		ANDA	ANDA202996	Mayne Pharma Inc.						N	20241231
51862-884_022c6de4-4589-4d4c-8ac4-977c7e3ef568	51862-884	HUMAN PRESCRIPTION DRUG	CAMILA		NORETHINDRONE	TABLET	ORAL	20180615		ANDA	ANDA076177	Mayne Pharma Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
51862-886_b5af3007-e701-4b30-b732-5283b864211f	51862-886	HUMAN PRESCRIPTION DRUG	ERRIN		NORETHINDRONE	TABLET	ORAL	20180418		ANDA	ANDA076225	Mayne Pharma Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
51862-890_555bb0ac-47f9-4c8e-99e0-1c0e4b283b9a	51862-890	HUMAN PRESCRIPTION DRUG	Azurette		desogestrel/ethinyl estradiol and ethinyl estradiol	KIT		20201003		ANDA	ANDA091247	Mayne Pharma Inc.						N	20241231
51862-892_5e36c153-ca1f-4bc1-87fd-5840a4aa5de8	51862-892	HUMAN PRESCRIPTION DRUG	Necon		norethindrone and ethinyl estradiol	KIT	ORAL	20201012		ANDA	ANDA091204	Mayne Pharma Inc.						N	20241231
51862-894_543b7167-e2e3-4730-a2d5-71b61d785cfd	51862-894	HUMAN PRESCRIPTION DRUG	Zovia 1/35		Ethynodiol Diacetate and Ethinyl Estradiol Tablets	KIT		20201016		ANDA	ANDA209548	Mayne Pharma Inc.						N	20241231
51862-896_7e6e6059-38b5-4a26-8bf3-f88ad246b83c	51862-896	HUMAN PRESCRIPTION DRUG	Tilia Fe		NdAc and EE Tablets and Ferrous Fumarate Tablets	KIT		20201015		ANDA	ANDA202962	Mayne Pharma Inc.						N	20241231
51862-900_ffd22a25-a759-c4ed-e053-6394a90a3b3a	51862-900	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20201005		ANDA	ANDA203807	Mayne Pharma Commercial LLC	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51862-901_ffd22a25-a759-c4ed-e053-6394a90a3b3a	51862-901	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20201005		ANDA	ANDA203807	Mayne Pharma Commercial LLC	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51862-902_ffd22a25-a759-c4ed-e053-6394a90a3b3a	51862-902	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20201005		ANDA	ANDA203807	Mayne Pharma Commercial LLC	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51862-903_ffd22a25-a759-c4ed-e053-6394a90a3b3a	51862-903	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20201005		ANDA	ANDA203807	Mayne Pharma Commercial LLC	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51862-941_ffd2d4dc-22a4-dd11-e053-6294a90a8ca4	51862-941	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071134	Mayne Pharma Commercial LLC	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51862-942_ffd2d4dc-22a4-dd11-e053-6294a90a8ca4	51862-942	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071135	Mayne Pharma Commercial LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51862-943_ffd2d4dc-22a4-dd11-e053-6294a90a8ca4	51862-943	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071136	Mayne Pharma Commercial LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
51862-945_a7804223-4fad-40cf-96c1-c3ee2cbd1fd1	51862-945	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Mayne Pharma Inc.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51862-946_a7804223-4fad-40cf-96c1-c3ee2cbd1fd1	51862-946	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Mayne Pharma Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51862-947_a7804223-4fad-40cf-96c1-c3ee2cbd1fd1	51862-947	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Mayne Pharma Inc.	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51862-948_a7804223-4fad-40cf-96c1-c3ee2cbd1fd1	51862-948	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Mayne Pharma Inc.	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51870-001_09924f88-259d-8607-e063-6294a90af6ac	51870-001	HUMAN OTC DRUG	Roll On Anti-Perspirant Deodorant		ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20120626		OTC MONOGRAPH DRUG	M019	Keefe Group	ALUMINUM CHLOROHYDRATE	14	g/100mL			N	20241231
51870-003_08285b20-46f4-6dde-e063-6394a90a582a	51870-003	HUMAN OTC DRUG	Next1 Anti-bacterial Deodorant Sport		Benzalkonium Chloride	SOAP	TOPICAL	20170615		OTC MONOGRAPH DRUG	505G(a)(3)	Keefe Group	BENZALKONIUM CHLORIDE	.1	g/100g			N	20251231
51870-004_0c6e84a9-3c44-558a-e063-6394a90a4faf	51870-004	HUMAN OTC DRUG	Next 1 Anti-bacterial Deodorant		Benzalkonium Chloride	SOAP	TOPICAL	20170615		OTC MONOGRAPH DRUG	505G(a)(3)	Keefe Group	BENZALKONIUM CHLORIDE	.1	g/100g			N	20251231
51870-007_0c6e78a3-3a52-8e62-e063-6294a90a902b	51870-007	HUMAN OTC DRUG	Elementz		Pyrithione Zinc	SHAMPOO	TOPICAL	20190610		OTC MONOGRAPH DRUG	505G(a)(3)	Keefe Group	PYRITHIONE ZINC	1	g/100mL			N	20251231
51879-122_06c46c8c-793b-c44e-e063-6394a90a1d29	51879-122	HUMAN OTC DRUG	Licefreee		Sodium chloride	KIT	TOPICAL	20160713		UNAPPROVED HOMEOPATHIC		Tec Laboratories, Inc.						N	20241231
51879-164_ffc38ad5-d415-4e68-e053-6294a90aa840	51879-164	HUMAN OTC DRUG	Tecnu Rash Relief		Grindelia Robusta, Calendula officinalis	SPRAY	TOPICAL	20230712		UNAPPROVED HOMEOPATHIC		Tec Laboratories Inc.	CALENDULA OFFICINALIS FLOWER; GRINDELIA HIRSUTULA FLOWERING TOP	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
51879-180_06c47ba9-1b38-8349-e063-6294a90a7d86	51879-180	HUMAN OTC DRUG	Licefreee		Head Lice Treatment	SPRAY	TOPICAL	20090501		UNAPPROVED HOMEOPATHIC		Tec Laboratories, Inc.	SODIUM CHLORIDE	1	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51879-191_06c46c8c-793a-c44e-e063-6394a90a1d29	51879-191	HUMAN OTC DRUG	Licefreee Everyday		Sodium Chloride	SHAMPOO	TOPICAL	20160713		UNAPPROVED HOMEOPATHIC		Tec Laboratories,Inc.	SODIUM CHLORIDE	1	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
51879-211_06c47318-c41a-e56e-e063-6394a90a086f	51879-211	HUMAN OTC DRUG	NuNature First Aid Gel		Lidocaine HCI/Benzethonium Chloride	GEL	TOPICAL	20220811		OTC MONOGRAPH NOT FINAL	part348	Tec Laboratories Inc	BENZETHONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	2; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
51879-260_06c4cc42-a216-3949-e063-6394a90a665e	51879-260	HUMAN OTC DRUG	Licefreee AfterLice		Pramoxine HCI	SPRAY	TOPICAL	20231016		OTC MONOGRAPH DRUG	M017	Tec Laboratories Inc.	PRAMOXINE HYDROCHLORIDE	10	mg/g			N	20241231
51879-300_06c44878-9041-3892-e063-6294a90a0cdb	51879-300	HUMAN OTC DRUG	Licefreee Ultimate Family Kit		Head Lice Treatment	KIT	TOPICAL	20220209		UNAPPROVED HOMEOPATHIC		Tec Laboratories, Inc.						N	20241231
51879-400_f047af5d-45d9-11ae-e053-2a95a90a2a22	51879-400	HUMAN OTC DRUG	Tecnu Ivy Complete Kit		Ivy Treatment	KIT	TOPICAL	20230116		OTC MONOGRAPH NOT FINAL	part348	Tec Laboratories Inc.						N	20241231
51879-802_06c46c8c-7936-c44e-e063-6394a90a1d29	51879-802	HUMAN OTC DRUG	Tecnu Calagel		Diphenhydramine Hydrochloride	GEL	TOPICAL	20190620		OTC MONOGRAPH DRUG	M017	Tec Laboratories Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	20	mg/g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
51885-9487_52ba408a-5552-4842-9070-22e268055e29	51885-9487	HUMAN OTC DRUG	Traumeel		ACONITUM NAPELLUS, ARNICA MONTANA ROOT, ATROPA BELLADONNA, BELLIS PERENNIS, CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA RECUTITA, ECHINACEA, UNSPECIFIED, ECHINACEA PURPUREA, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, CALCIUM SULFIDE, HYPERICUM PERFORATUM, MERCURIUS SOLUBILIS, ACHILLEA MILLEFOLIUM and COMFREY ROOT	OINTMENT	TOPICAL	20210920		UNAPPROVED HOMEOPATHIC		Biologische Heilmittel Heel	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	1; 1; 3; 1; 1; 6; 1; 4; 1; 1; 1; 6; 1; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
51885-9489_49ef1c5d-a07b-4bc0-9de1-dc40d8477d8f	51885-9489	HUMAN OTC DRUG	Zeel		ALPHA LIPOIC ACID, ARNICA MONTANA WHOLE,SUS SCROFA CARTILAGE, COENZYME A,SOLANUM DULCAMARA TOP,SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD, NADIDE, SODIUM DIETHYL OXALACETATE,SUS SCROFA PLACENTA,TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SILICON DIOXIDE,SULFUR,CORIANDER	OINTMENT	TOPICAL	20210922		UNAPPROVED HOMEOPATHIC		Biologische Heilmittel Heel	ALPHA LIPOIC ACID; ARNICA MONTANA WHOLE; COENZYME A; CORIANDER; NADIDE; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SODIUM DIETHYL OXALACETATE; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	6; 2; 6; 8; 6; 2; 6; 6; 2; 6; 2; 2; 2; 2; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
51887-001_0761944c-ed9a-0ca3-e063-6394a90acad9	51887-001	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19930101		NDA	NDA205766	Maine Oxy-Acetylene Supply Company	NITROGEN	99	L/100L			N	20241231
51887-200_07617a70-ccd2-b9ef-e063-6394a90aad8c	51887-200	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Oxygen		Carbon Dioxide Oxygen	GAS	RESPIRATORY (INHALATION)	20040202		NDA	NDA205764	Maine Oxy-Acetylene Supply Company	CARBON DIOXIDE	200	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
51887-302_07617a70-ccd1-b9ef-e063-6394a90aad8c	51887-302	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Nitrogen		Carbon Dioxide Nitrogen	GAS	RESPIRATORY (INHALATION)	20040202		NDA	NDA205764	Maine Oxy-Acetylene Supply Company	CARBON DIOXIDE	200	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
51887-402_07617bf4-1bf5-c8a7-e063-6294a90a485b	51887-402	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Air		Carbon Dioxide Air	GAS	RESPIRATORY (INHALATION)	20040202		NDA	NDA205764	Maine Oxy-Acetylene Supply Company	CARBON DIOXIDE	200	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
51887-502_07616c45-3af6-92ae-e063-6294a90a9c51	51887-502	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20040202		NDA	NDA205767	Maine Oxy-Acetylene Supply Company	OXYGEN	200	mL/L			N	20241231
51887-720_0761944c-ed9b-0ca3-e063-6394a90acad9	51887-720	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19890101		NDA	NDA205767	Maine Oxy-Acetylene Supply Company	OXYGEN	990	mL/L			N	20241231
51956-0001_8ce6f8ae-c5f5-4731-8efb-9a8c3d52942f	51956-0001	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190306		ANDA	ANDA206318	Zydus Lifesciences Limited	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51956-0002_8ce6f8ae-c5f5-4731-8efb-9a8c3d52942f	51956-0002	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190306		ANDA	ANDA206318	Zydus Lifesciences Limited	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51956-0003_8ce6f8ae-c5f5-4731-8efb-9a8c3d52942f	51956-0003	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190306		ANDA	ANDA206318	Zydus Lifesciences Limited	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51960-001_e7ad349d-f315-4a13-a679-7f666580f7fa	51960-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19980101		NDA	NDA205767	Kent Welding Supply	OXYGEN	99	L/100L			N	20241231
51987-0002_4632800b-a1d7-464f-bee3-d3d9ebbdb54d	51987-0002	HUMAN OTC DRUG	Hydrate	II	Coffea Tosta, Avena Sativa, Equisetum Hyemale, Hypericum Perforatum, Ginkgo Biloba, Germanium Sesquioxide, Silicea	LIQUID	ORAL	20130822		UNAPPROVED HOMEOPATHIC		Maplewood Company	AVENA SATIVA FLOWERING TOP; COFFEA ARABICA SEED, ROASTED; EQUISETUM HYEMALE; GERMANIUM SESQUIOXIDE; GINKGO; HYPERICUM PERFORATUM; SILICON DIOXIDE	3; 2; 3; 8; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
51990-033_fc547fcf-8176-6336-e053-6294a90aa668	51990-033	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230410		ANDA	ANDA212564	Yabao Pharmaceutical Co., Ltd. Beijing	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51990-034_fc547fcf-8176-6336-e053-6294a90aa668	51990-034	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230410		ANDA	ANDA212564	Yabao Pharmaceutical Co., Ltd. Beijing	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51990-035_fc547fcf-8176-6336-e053-6294a90aa668	51990-035	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230410		ANDA	ANDA212564	Yabao Pharmaceutical Co., Ltd. Beijing	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
51991-005_fa1cc230-4895-4603-8f87-47e45e64f683	51991-005	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET, FILM COATED	ORAL	20191219		ANDA	ANDA211031	Breckenridge Pharmaceutical, Inc.	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
51991-006_16c3e5ec-6bf4-4426-9f87-3279beca98a2	51991-006	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20181128		ANDA	ANDA204003	Breckenridge Pharmaceutical, Inc	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51991-073_8e76b92b-cd02-4f03-a660-42b518c56e56	51991-073	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20040701		ANDA	ANDA076560	Breckenridge Pharmaceutical, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
51991-074_c1f2cb14-e9d1-49e8-a078-cde046472048	51991-074	HUMAN PRESCRIPTION DRUG	Ascomp with Codeine		Butalbital, Aspirin, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20090501		ANDA	ANDA075231	Breckenridge Pharmaceutical, Inc.	ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	20241231
51991-144_fb3ccbf0-3e5f-4c36-8131-39ab78a408ba	51991-144	HUMAN PRESCRIPTION DRUG	METHYLERGONOVINE MALEATE		Methylergonovine Maleate	INJECTION	INTRAVENOUS	20161107		ANDA	ANDA040889	Breckenridge Pharmaceutical, Inc.	METHYLERGONOVINE MALEATE	.2	mg/mL	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
51991-191_8c49301b-6633-47c3-aa16-2c99df7fa2c6	51991-191	HUMAN PRESCRIPTION DRUG	Methscopolamine Bromide		methscopolamine bromide	TABLET	ORAL	20120521		ANDA	ANDA040642	Breckenridge Pharmaceutical, Inc.	METHSCOPOLAMINE BROMIDE	2.5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51991-192_8c49301b-6633-47c3-aa16-2c99df7fa2c6	51991-192	HUMAN PRESCRIPTION DRUG	Methscopolamine Bromide		methscopolamine bromide	TABLET	ORAL	20120521		ANDA	ANDA040642	Breckenridge Pharmaceutical, Inc.	METHSCOPOLAMINE BROMIDE	5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
51991-292_d5951704-7378-4f09-a291-30c58f75507b	51991-292	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Breckenridge Pharmaceutical, Inc.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51991-293_d5951704-7378-4f09-a291-30c58f75507b	51991-293	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Breckenridge Pharmaceutical, Inc.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51991-294_d5951704-7378-4f09-a291-30c58f75507b	51991-294	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Breckenridge Pharmaceutical, Inc.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
51991-311_16c3e5ec-6bf4-4426-9f87-3279beca98a2	51991-311	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	Breckenridge Pharmaceutical, Inc	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51991-312_16c3e5ec-6bf4-4426-9f87-3279beca98a2	51991-312	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	Breckenridge Pharmaceutical, Inc	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51991-333_e95a03c6-f423-7177-e053-2a95a90a0add	51991-333	HUMAN PRESCRIPTION DRUG	Carbinoxamine Maleate		carbinoxamine maleate	TABLET	ORAL	20121210	20250609	ANDA	ANDA040442	Breckenridge Pharmaceutical, Inc.	CARBINOXAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
51991-334_e95a03c6-f423-7177-e053-2a95a90a0add	51991-334	HUMAN PRESCRIPTION DRUG	Carbinoxamine Maleate		carbinoxamine maleate	SYRUP	ORAL	20121210	20250315	ANDA	ANDA040458	Breckenridge Pharmaceutical, Inc.	CARBINOXAMINE MALEATE	4	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
51991-348_510045c3-e917-4556-9744-324daa97d9ba	51991-348	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204921	Breckenridge Pharmaceutical, Inc.	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51991-349_510045c3-e917-4556-9744-324daa97d9ba	51991-349	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204921	Breckenridge Pharmaceutical, Inc.	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51991-350_510045c3-e917-4556-9744-324daa97d9ba	51991-350	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204921	Breckenridge Pharmaceutical, Inc.	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51991-351_510045c3-e917-4556-9744-324daa97d9ba	51991-351	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204921	Breckenridge Pharmaceutical, Inc.	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
51991-354_d48d54bc-d3a2-47bb-8959-65f6837d1c33	51991-354	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231	20240731	ANDA	ANDA200482	Breckenridge Pharmaceutical, Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	
51991-355_d48d54bc-d3a2-47bb-8959-65f6837d1c33	51991-355	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231	20240731	ANDA	ANDA200482	Breckenridge Pharmaceutical, Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	
51991-358_c4e02ae2-2be7-4c34-8f36-a7c5001d20fe	51991-358	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20210308		ANDA	ANDA205960	Breckenridge Pharmaceutical, Inc.	ASENAPINE MALEATE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51991-359_c4e02ae2-2be7-4c34-8f36-a7c5001d20fe	51991-359	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20210308		ANDA	ANDA205960	Breckenridge Pharmaceutical, Inc.	ASENAPINE MALEATE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51991-360_c4e02ae2-2be7-4c34-8f36-a7c5001d20fe	51991-360	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20201210		ANDA	ANDA205960	Breckenridge Pharmaceutical, Inc.	ASENAPINE MALEATE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51991-361_c4e02ae2-2be7-4c34-8f36-a7c5001d20fe	51991-361	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20201210		ANDA	ANDA205960	Breckenridge Pharmaceutical, Inc.	ASENAPINE MALEATE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51991-362_24ffdbe7-4f42-4277-942a-9edd765df282	51991-362	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN Benzoate		RIZATRIPTAN Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203478	Breckenridge Pharmaceutical, Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51991-363_24ffdbe7-4f42-4277-942a-9edd765df282	51991-363	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN Benzoate		RIZATRIPTAN Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203478	Breckenridge Pharmaceutical, Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
51991-379_36e34f3e-8f18-4a48-9380-da4029f706a9	51991-379	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus tablets	TABLET	ORAL	20210521		ANDA	ANDA205432	Breckenridge Pharmaceutical, Inc.	EVEROLIMUS	.25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
51991-380_36e34f3e-8f18-4a48-9380-da4029f706a9	51991-380	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus tablets	TABLET	ORAL	20210521		ANDA	ANDA205432	Breckenridge Pharmaceutical, Inc.	EVEROLIMUS	.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
51991-381_36e34f3e-8f18-4a48-9380-da4029f706a9	51991-381	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus tablets	TABLET	ORAL	20210521		ANDA	ANDA205432	Breckenridge Pharmaceutical, Inc.	EVEROLIMUS	.75	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
51991-474_5d019d6f-2bf4-49f4-b539-0bcfd418c42f	51991-474	HUMAN PRESCRIPTION DRUG	Estradiol / Norethindrone Acetate		Estradiol and Norethindrone Acetate	TABLET, FILM COATED	ORAL	20080417		ANDA	ANDA078324	Breckenridge Pharmaceutical, Inc.	ESTRADIOL; NORETHINDRONE ACETATE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
51991-526_768f926a-f86e-44c4-8070-0db89c907b9b	51991-526	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20101227		ANDA	ANDA077714	Breckenridge Pharmaceutical, Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
51991-611_56084dea-5acb-40e4-8056-1226f930476c	51991-611	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	SOLUTION	ORAL	20171101	20240331	ANDA	ANDA201466	Breckenridge Pharmaceutical, Inc.	METHYLPHENIDATE HYDROCHLORIDE	1	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
51991-612_56084dea-5acb-40e4-8056-1226f930476c	51991-612	HUMAN PRESCRIPTION DRUG	methylphenidate hydrochloride		methylphenidate hydrochloride	SOLUTION	ORAL	20171101	20240331	ANDA	ANDA201466	Breckenridge Pharmaceutical, Inc.	METHYLPHENIDATE HYDROCHLORIDE	2	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
51991-620_05b980b8-3c82-49dd-b289-0b1b1d1d7273	51991-620	HUMAN PRESCRIPTION DRUG	ANASTROZOLE		ANASTROZOLE	TABLET	ORAL	20100628		ANDA	ANDA079220	Breckenridge Pharmaceutical, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
51991-623_5d019d6f-2bf4-49f4-b539-0bcfd418c42f	51991-623	HUMAN PRESCRIPTION DRUG	Estradiol / Norethindrone Acetate		Estradiol and Norethindrone Acetate	TABLET, FILM COATED	ORAL	20110609		ANDA	ANDA078324	Breckenridge Pharmaceutical, Inc.	ESTRADIOL; NORETHINDRONE ACETATE	.5; .1	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
51991-651_9e6c00bc-2eaf-4cd8-be6b-3a5506acfa6b	51991-651	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	SOLUTION	ORAL	20131119	20241231	ANDA	ANDA079120	Breckenridge Pharmaceutical, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
51991-704_bfd71421-c03d-4025-a044-b20a7dc588a8	51991-704	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	Breckenridge Pharmaceutical, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
51991-705_bfd71421-c03d-4025-a044-b20a7dc588a8	51991-705	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	Breckenridge Pharmaceutical, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
51991-706_bfd71421-c03d-4025-a044-b20a7dc588a8	51991-706	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	Breckenridge Pharmaceutical, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
51991-707_bfd71421-c03d-4025-a044-b20a7dc588a8	51991-707	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	Breckenridge Pharmaceutical, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
51991-735_7fbd17c9-2fa3-43ff-8402-0ce96fc2b954	51991-735	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	TABLET	ORAL	20090622		ANDA	ANDA078969	Breckenridge Pharmaceutical, Inc.	GRANISETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
51991-746_1e4862a4-536c-425b-a5f3-b0ee300c7177	51991-746	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Breckenridge Pharmaceutical, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51991-747_1e4862a4-536c-425b-a5f3-b0ee300c7177	51991-747	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Breckenridge Pharmaceutical, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51991-748_1e4862a4-536c-425b-a5f3-b0ee300c7177	51991-748	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Breckenridge Pharmaceutical, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51991-750_1e4862a4-536c-425b-a5f3-b0ee300c7177	51991-750	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20180521		ANDA	ANDA203088	Breckenridge Pharmaceutical, Inc.	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
51991-759_188dd3de-be94-4f0e-8186-d63c3cb5623f	51991-759	HUMAN PRESCRIPTION DRUG	LETROZOLE		LETROZOLE	TABLET	ORAL	20110604		ANDA	ANDA200161	Breckenridge Pharmaceutical, Inc.	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
51991-793_e5ca7373-56f1-47e5-a7f9-28359ee55ee4	51991-793	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613	20241231	ANDA	ANDA091689	Breckenridge Pharmaceutical, Inc	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	
51991-794_e5ca7373-56f1-47e5-a7f9-28359ee55ee4	51991-794	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613	20241231	ANDA	ANDA091689	Breckenridge Pharmaceutical, Inc	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	
51991-795_e5ca7373-56f1-47e5-a7f9-28359ee55ee4	51991-795	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613	20241231	ANDA	ANDA091689	Breckenridge Pharmaceutical, Inc	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	
51991-796_e5ca7373-56f1-47e5-a7f9-28359ee55ee4	51991-796	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20120613	20241231	ANDA	ANDA091689	Breckenridge Pharmaceutical, Inc	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	
51991-797_1ba11f6a-c960-4e56-9f71-fdc972d990db	51991-797	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20170623	20240131	ANDA	ANDA207234	Breckenridge Pharmaceutical, Inc.	AZACITIDINE	100	mg/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	
51991-814_00b0d20e-8d18-4336-a966-6add80268c8d	51991-814	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SPRAY, METERED	NASAL	20150729	20241231	ANDA	ANDA090176	Breckenridge Pharmaceutical, Inc.	AZELASTINE HYDROCHLORIDE	137	ug/.137mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
51991-817_6e8ddc7b-58d9-453f-956c-270735cdbfb7	51991-817	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Breckenridge Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51991-818_6e8ddc7b-58d9-453f-956c-270735cdbfb7	51991-818	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Breckenridge Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51991-819_6e8ddc7b-58d9-453f-956c-270735cdbfb7	51991-819	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Breckenridge Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51991-820_6e8ddc7b-58d9-453f-956c-270735cdbfb7	51991-820	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Breckenridge Pharmaceutical, Inc.	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
51991-821_9e4d9035-1795-402b-8a0e-3b7b5be122ae	51991-821	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210305		ANDA	ANDA205426	Breckenridge Pharmaceutical, Inc.	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
51991-822_9e4d9035-1795-402b-8a0e-3b7b5be122ae	51991-822	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210305		ANDA	ANDA205426	Breckenridge Pharmaceutical, Inc.	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
51991-823_9e4d9035-1795-402b-8a0e-3b7b5be122ae	51991-823	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210305		ANDA	ANDA205426	Breckenridge Pharmaceutical, Inc.	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
51991-824_9e4d9035-1795-402b-8a0e-3b7b5be122ae	51991-824	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210305		ANDA	ANDA205426	Breckenridge Pharmaceutical, Inc.	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
51991-836_6917c9f5-a785-4ba2-86a2-dfbc6852d839	51991-836	HUMAN PRESCRIPTION DRUG	Epinastine Hydrochloride		Epinastine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20131105	20240930	ANDA	ANDA090870	Breckenridge Pharmaceutical, Inc.	EPINASTINE HYDROCHLORIDE	.5	mg/mL	Adrenergic Agonists [MoA], Adrenergic Receptor Agonist [EPC], Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	
51991-837_f5f83019-f264-4675-a36b-72090e28b9a1	51991-837	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20131203	20241130	ANDA	ANDA078488	Breckenridge Pharmaceutical, Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
51991-838_bafb4a6b-b611-47d0-9e58-ccbd9f2676da	51991-838	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20131021	20240131	ANDA	ANDA040644	Breckenridge Pharmaceutical, Inc.	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	
51991-877_86248dca-e59b-4bac-b324-f7199bcd62f3	51991-877	HUMAN PRESCRIPTION DRUG	EPLERENONE		EPLERENONE	TABLET, FILM COATED	ORAL	20180918		ANDA	ANDA208283	Breckenridge Pharmaceutical, Inc.	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51991-878_86248dca-e59b-4bac-b324-f7199bcd62f3	51991-878	HUMAN PRESCRIPTION DRUG	EPLERENONE		EPLERENONE	TABLET, FILM COATED	ORAL	20180918		ANDA	ANDA208283	Breckenridge Pharmaceutical, Inc.	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
51991-881_ba9bf514-b9b6-49be-873d-3df4a2d0721a	51991-881	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET	ORAL	20230312		ANDA	ANDA209583	Breckenridge Pharmaceutical, Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
51991-882_ba9bf514-b9b6-49be-873d-3df4a2d0721a	51991-882	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET	ORAL	20230312		ANDA	ANDA209583	Breckenridge Pharmaceutical, Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
51991-890_956a5cec-07cb-4600-91fa-b4e3366bcd1b	51991-890	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20191105	20250731	ANDA	ANDA208488	Breckenridge Pharmaceutical, Inc.	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	
51991-891_956a5cec-07cb-4600-91fa-b4e3366bcd1b	51991-891	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20191105	20250731	ANDA	ANDA208488	Breckenridge Pharmaceutical, Inc.	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	
51991-892_956a5cec-07cb-4600-91fa-b4e3366bcd1b	51991-892	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20191105	20250731	ANDA	ANDA208488	Breckenridge Pharmaceutical, Inc.	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	
51991-895_b91cc0f3-f252-48f8-8623-41ad9ee59af4	51991-895	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20180316	20250131	ANDA	ANDA208721	Breckenridge Pharmaceutical, Inc.	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	
51991-896_b91cc0f3-f252-48f8-8623-41ad9ee59af4	51991-896	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20180316	20250131	ANDA	ANDA208721	Breckenridge Pharmaceutical, Inc.	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	
51991-897_ecb4d89a-867d-4162-92fc-ba6520da18b3	51991-897	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Breckenridge Pharmaceutical, Inc.	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51991-898_ecb4d89a-867d-4162-92fc-ba6520da18b3	51991-898	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Breckenridge Pharmaceutical, Inc.	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51991-899_ecb4d89a-867d-4162-92fc-ba6520da18b3	51991-899	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Breckenridge Pharmaceutical, Inc.	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
51991-900_407e4632-c0fe-47c3-9de7-e4d5d7aae2d8	51991-900	HUMAN PRESCRIPTION DRUG	clobazam		CLOBAZAM	TABLET	ORAL	20181022	20250731	ANDA	ANDA209308	Breckenridge Pharmaceutical, Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	
51991-901_407e4632-c0fe-47c3-9de7-e4d5d7aae2d8	51991-901	HUMAN PRESCRIPTION DRUG	clobazam		CLOBAZAM	TABLET	ORAL	20181022	20250731	ANDA	ANDA209308	Breckenridge Pharmaceutical, Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	
51991-906_49aa5945-fd91-41ed-a8fc-3f33276d1d57	51991-906	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20190118		ANDA	ANDA210662	Breckenridge Pharmaceutical, Inc.	TETRACYCLINE HYDROCHLORIDE	250	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
51991-907_49aa5945-fd91-41ed-a8fc-3f33276d1d57	51991-907	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20190118		ANDA	ANDA210662	Breckenridge Pharmaceutical, Inc.	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
51991-928_c4e02ae2-2be7-4c34-8f36-a7c5001d20fe	51991-928	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20201210		ANDA	ANDA205960	Breckenridge Pharmaceutical, Inc.	ASENAPINE MALEATE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
51991-942_5dd7eda3-b825-46f4-8d40-6960486696d2	51991-942	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20161205	20240831	ANDA	ANDA207321	Breckenridge Pharmaceutical, Inc.	DEXRAZOXANE HYDROCHLORIDE	500	mg/50mL	Cytoprotective Agent [EPC]		N	
51991-943_a6819fae-6e10-4be8-bfcc-3242e2cf6ad7	51991-943	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET	ORAL	20170502	20250731	ANDA	ANDA205348	Breckenridge Pharmaceutical, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	
51991-944_8f10c709-f611-484b-ade5-c79585b5d23c	51991-944	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20170405		ANDA	ANDA208127	Breckenridge Pharmaceutical, Inc.	TRIMIPRAMINE MALEATE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51991-945_8f10c709-f611-484b-ade5-c79585b5d23c	51991-945	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20170405		ANDA	ANDA208127	Breckenridge Pharmaceutical, Inc.	TRIMIPRAMINE MALEATE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51991-946_8f10c709-f611-484b-ade5-c79585b5d23c	51991-946	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20170405		ANDA	ANDA208127	Breckenridge Pharmaceutical, Inc.	TRIMIPRAMINE MALEATE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
51991-958_407e4632-c0fe-47c3-9de7-e4d5d7aae2d8	51991-958	HUMAN PRESCRIPTION DRUG	clobazam		CLOBAZAM	TABLET	ORAL	20211019	20250731	ANDA	ANDA209308	Breckenridge Pharmaceutical, Inc.	CLOBAZAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	
51991-961_5f8f9f53-2c72-4a5c-9e50-894154140bcc	51991-961	HUMAN OTC DRUG	Polyethylene Glycol 3350		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190327	20240930	ANDA	ANDA090812	Breeckenridge Pharmaceutical, Inc.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
51991-962_5f8f9f53-2c72-4a5c-9e50-894154140bcc	51991-962	HUMAN OTC DRUG	Polyethylene Glycol 3350		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190327	20240930	ANDA	ANDA090812	Breeckenridge Pharmaceutical, Inc.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
51991-974_2fb3c38a-b580-4ac0-be75-7053a41920a0	51991-974	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20211112		ANDA	ANDA215409	Breckenridge Pharmaceutical, Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
51991-981_1e807e86-f6f0-47bf-b992-bb7cc05836be	51991-981	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20201217	20260430	ANDA	ANDA213592	Breckenridge Pharmaceutical, Inc.	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	
51991-982_1e807e86-f6f0-47bf-b992-bb7cc05836be	51991-982	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20201217	20260430	ANDA	ANDA213592	Breckenridge Pharmaceutical, Inc.	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	
51991-983_e4e3973a-b9b8-4fef-93b4-361413f4dddf	51991-983	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		Norepinephrine Bitartrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210701		ANDA	ANDA214455	Breckenridge Pharmaceutical, Inc.	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
51996-001_076185ab-0614-ce35-e063-6394a90a8ad4	51996-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19760101		NDA	NDA205840	Mississippi Welders Supply Company, Inc.	OXYGEN	990	mL/L			N	20241231
51996-003_0761b2dd-1b78-2aa8-e063-6394a90a7784	51996-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20100301		NDA	NDA205839	Mississippi Welders Supply Company, Inc.	NITROGEN	990	mL/L			N	20241231
52000-001_6dffaf6a-8fa0-4606-a9d9-39929810082f	52000-001	HUMAN OTC DRUG	Allure Isopropyl Rubbing Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20120629		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-002_d4cdc195-ab98-4cc3-93dc-b65db55ff9cd	52000-002	HUMAN OTC DRUG	Allure Isopropyl Rubbing Alcohol With Wintergreen		Isopropyl Alcohol	LIQUID	TOPICAL	20120630		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-005_eca06bfc-2c54-2ce0-e053-2995a90a79a9	52000-005	HUMAN OTC DRUG	UNIVERSAL PURE PETROLEUM		White Petroleum	JELLY	TOPICAL	20130206		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	PETROLATUM	1	g/g			N	20241231
52000-007_92f05de8-dacc-420d-a874-4139d8d4f441	52000-007	HUMAN OTC DRUG	UNIVERSAL PURE PETROLEUM COCOA BUTTER SCENTED		White Petroleum	JELLY	TOPICAL	20130206		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	PETROLATUM	1	g/g			N	20241231
52000-008_ee0c18d1-ab71-8efe-e053-2a95a90ad9b8	52000-008	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 50%		Isopropyl Alcohol	LIQUID	TOPICAL	20120313		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-009_ee0c1c4d-5b9c-b931-e053-2995a90a7934	52000-009	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 50% With Wintergreen		Isopropyl Alcohol	LIQUID	TOPICAL	20120315		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-010_ee0c2158-1b70-0af3-e053-2a95a90a0843	52000-010	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70%		Isopropyl Alcohol	LIQUID	TOPICAL	20120315		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52000-011_ee0c2c65-c596-f449-e053-2995a90aaf2f	52000-011	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70% With Wintergreen		Isopropyl Alcohol	LIQUID	TOPICAL	20120315		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52000-012_ee0c344b-bac1-0f81-e053-2a95a90a9c7b	52000-012	HUMAN OTC DRUG	Vaporizing Chest Rub		Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20130315		OTC MONOGRAPH FINAL	part341	Universal Distribution Center LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
52000-013_d882e2a1-eb18-30f1-e053-2a95a90aebdf	52000-013	HUMAN OTC DRUG	Ice Cold Analgesic Gel		Menthol and Camphor	GEL	TOPICAL	20130315		OTC MONOGRAPH FINAL	part341	Universal Distribution Center LLC	CAMPHOR (SYNTHETIC); MENTHOL	.5; 1	g/100g; g/100g			N	20241231
52000-019_d882e909-0266-2490-e053-2995a90a9487	52000-019	HUMAN OTC DRUG	Triple Antibiotic First Aid		Bacitracin Zinc, Neomycin and Polymyxin B Sulfate	OINTMENT	TOPICAL	20150415		OTC MONOGRAPH FINAL	part333B	Universal Distribution Center LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
52000-020_d882ec1c-a98e-693d-e053-2995a90a282d	52000-020	HUMAN OTC DRUG	Muscle Rub		Menthol	GEL	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	MENTHOL	.025	g/g			N	20241231
52000-021_d886d8a2-f71a-6a38-e053-2a95a90a70b3	52000-021	HUMAN OTC DRUG	Anti-Fungal		Miconazole Nitrate	CREAM	TOPICAL	20150415		OTC MONOGRAPH FINAL	part333C	Universal Distribution Center LLC	MICONAZOLE NITRATE	.02	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52000-022_b6087eab-5f3b-e87e-e053-2995a90abb47	52000-022	HUMAN OTC DRUG	Hydrocortisone Anti-Itch		Hydrocortisone	CREAM	TOPICAL	20201209		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52000-023_d886cfd3-5e21-6470-e053-2a95a90ac246	52000-023	HUMAN OTC DRUG	Anti-Itch		Diphenhydramine Hydrochloride and Zinc Acetate	CREAM	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	.02; .001	g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
52000-026_d886d8a2-f727-6a38-e053-2a95a90a70b3	52000-026	HUMAN OTC DRUG	Vitamin A and D		Vitamin A and D	CREAM	TOPICAL	20160804		OTC MONOGRAPH NOT FINAL	part347	Universal Distribution Center LLC	VITAMIN A; VITAMIN D	181.8; 1200	[iU]/g; [iU]/g	Vitamin A [CS], Vitamin A [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
52000-027_d886ff5e-6be4-039a-e053-2995a90a5835	52000-027	HUMAN OTC DRUG	First Aid		Lidocaine HCL and Phenol	CREAM	TOPICAL	20160804		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	LIDOCAINE HYDROCHLORIDE; PHENOL	.005; .005	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
52000-028_d8870c0f-85ea-e5d9-e053-2a95a90a4489	52000-028	HUMAN OTC DRUG	Hemorrhoid Anesthetic		Mineral Oil, Petrolatum, Phenylephrine HCL	OINTMENT	TOPICAL	20160805		OTC MONOGRAPH FINAL	part346	Universal Distribution Center LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	.14; .749; .0025	g/g; g/g; g/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52000-030_bd776b08-984d-4132-b7f0-87807d84fd0e	52000-030	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 99%		Isopropyl Alcohol	LIQUID	TOPICAL	20161104		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
52000-032_789309a4-4793-40a7-b0ab-a73cbf148c59	52000-032	HUMAN OTC DRUG	Cold and Hot Medicated Patch		menthol	PATCH	TOPICAL	20170621		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	MENTHOL, UNSPECIFIED FORM	205.5	mg/1			N	20241231
52000-033_cecb11b7-4f0c-4930-bcc7-8b0ec6027e39	52000-033	HUMAN OTC DRUG	Cold and Hot Medicated Large		menthol	PATCH	TOPICAL	20170621		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	MENTHOL, UNSPECIFIED FORM	428.5	mg/1			N	20241231
52000-038_5f86e792-3255-4ee6-e053-2991aa0a54a0	52000-038	HUMAN OTC DRUG	Medicated Body		Menthol and Zinc Oxide	POWDER	TOPICAL	20171204		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	MENTHOL; ZINC OXIDE	1.5; 10	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52000-039_d8874472-8be1-38bc-e053-2995a90aaf3f	52000-039	HUMAN OTC DRUG	Vaporizing Chest Rub		Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20180514		OTC MONOGRAPH FINAL	part341	Universal Distribution Center LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
52000-040_81ddb992-34a9-1e1b-e053-2a91aa0a8159	52000-040	HUMAN OTC DRUG	Capsaicin Heat		capsaicin	PATCH	TOPICAL	20190307		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	CAPSAICIN	.025	g/100g			N	20241231
52000-041_eae591d5-1e82-466c-bb0e-305666b297b4	52000-041	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	PEACH DREAM	benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Universal Distribution Center LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52000-042_159d3e01-139b-4f32-80a9-166b1eeda6a5	52000-042	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	LAVENDER BOUQUET	benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Universal Distribution Center LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52000-043_fef57971-173d-41db-957c-84842d8deafb	52000-043	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	TROPICAL BEACH	benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Universal Distribution Center LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52000-044_cd639bab-3616-48b0-b63d-d7771d7156d4	52000-044	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	BERRY MEDLEY	benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Universal Distribution Center LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52000-045_0718e1be-e778-00f3-e063-6394a90a114e	52000-045	HUMAN OTC DRUG	U ICE COLD		menthol	OINTMENT	TOPICAL	20180801		OTC MONOGRAPH DRUG	M017	UNIVERSAL DISTRIBUTION CENTER LLC	CAMPHOR, (-)-; MENTHOL	.5; 1	g/100g; g/100g			N	20241231
52000-046_6ae89141-c5d9-48f7-80bf-d2e7a4bb6a9e	52000-046	HUMAN OTC DRUG	Pain Relief Hot Patch		menthol and capsaicin	PATCH	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	CAPSAICIN; MENTHOL, UNSPECIFIED FORM	.83; 30	mg/g; mg/g			N	20241231
52000-047_f6bc676c-aab1-41fd-b009-8f5cc5f2e274	52000-047	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	BLUEBERRIES	benzalkonium chloride	LIQUID	TOPICAL	20200325		OTC MONOGRAPH NOT FINAL	part333E	Universal Distribution Center LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52000-048_007f7da7-972b-4307-a739-1119ba622c9c	52000-048	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	CUCUMBER and TEA TREE	benzalkonium chloride	LIQUID	TOPICAL	20200325		OTC MONOGRAPH NOT FINAL	part333E	Universal Distribution Center LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52000-049_a60d8d84-4ca9-3cf3-e053-2995a90ad358	52000-049	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 99%		Isopropyl Alcohol	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
52000-050_a60d91e2-595e-406a-e053-2995a90af77e	52000-050	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 50%		Isopropyl Alcohol	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-051_a60d8f71-ab33-ab0c-e053-2995a90a6bae	52000-051	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 50% with Wintergreen		Isopropyl Alcohol	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-052_a60d8f71-ab25-ab0c-e053-2995a90a6bae	52000-052	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70%		Isopropyl Alcohol	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52000-053_a60d582d-84d0-d035-e053-2a95a90ad665	52000-053	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70% with Wintergreen		Isopropyl Alcohol	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52000-056_d8874472-8bef-38bc-e053-2995a90aaf3f	52000-056	HUMAN OTC DRUG	Triple Antibiotic First Aid Antibiotic		Bacitracin Zinc, Neomycin and Polymyxin B Sulfate	OINTMENT	TOPICAL	20201209		OTC MONOGRAPH FINAL	part333B	Universal Distribution Center LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
52000-057_d88746b0-448e-bb6b-e053-2a95a90ac2aa	52000-057	HUMAN OTC DRUG	Hemorrhoid Anesthetic		Mineral Oil, Petrolatum, Phenylephrine HCL	OINTMENT	TOPICAL	20201209		OTC MONOGRAPH FINAL	part346	Universal Distribution Center LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	.14; .749; .0025	g/g; g/g; g/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52000-059_d8875597-f746-270a-e053-2a95a90a59fc	52000-059	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20201209		OTC MONOGRAPH FINAL	part333B	Universal Distribution Center LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
52000-060_d8875597-f754-270a-e053-2a95a90a59fc	52000-060	HUMAN OTC DRUG	Oral Pain Relief		Benzocaine and Benzalkonium Chloride	GEL	TOPICAL	20201209		OTC MONOGRAPH NOT FINAL	part356	Universal Distribution Center LLC	BENZALKONIUM CHLORIDE; BENZOCAINE	.01; .2	g/g; g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52000-061_b60871ac-cbda-e21e-e053-2995a90ad8ca	52000-061	HUMAN OTC DRUG	Anti-Fungal		Miconazole Nitrate	CREAM	TOPICAL	20201209		OTC MONOGRAPH FINAL	part333C	Universal Distribution Center LLC	MICONAZOLE NITRATE	.02	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52000-071_d8875597-f762-270a-e053-2a95a90a59fc	52000-071	HUMAN OTC DRUG	Extra Strength	Itch Stopping	Itch Stopping Cream	CREAM	TOPICAL	20210121		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Centre LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
52000-072_d88776d4-0b5d-7ac3-e053-2a95a90ad422	52000-072	HUMAN OTC DRUG	Muscle Rub Pain Reliever Gel		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20210124		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Centre LLC	MENTHOL, UNSPECIFIED FORM	25	mg/g			N	20241231
52000-073_d8877f9a-fdf0-e708-e053-2a95a90a315d	52000-073	HUMAN OTC DRUG	Diaper Rash skin protectant		Lanolin and Petrolatum	OINTMENT	TOPICAL	20210125		OTC MONOGRAPH FINAL	part347	Universal Distribution Centre LLC	LANOLIN; PETROLATUM	136.4; 469.9	mg/g; mg/g			N	20241231
52000-101_e7711f73-4588-4f11-adca-837a66453de6	52000-101	HUMAN OTC DRUG	UNIVERSAL BABY FRESH SCENT PETROLEUM		White Petroleum	JELLY	TOPICAL	20191101		OTC MONOGRAPH DRUG	M016	Universal Distribution Center LLC	PETROLATUM	99.9	g/100g			N	20241231
52000-102_951a86ca-ad48-4680-83f2-ad939990051c	52000-102	HUMAN OTC DRUG	UNIVERSAL COCOA BUTTER SCENT PETROLEUM		White Petroleum	JELLY	TOPICAL	20191101		OTC MONOGRAPH DRUG	M016	Universal Distribution Center LLC	PETROLATUM	99.9	g/100g			N	20241231
52000-103_ede3ad25-1465-43f2-81d8-a8dc9225c9b8	52000-103	HUMAN OTC DRUG	UNIVERSAL LAVENDER SCENT PETROLEUM		White Petroleum	JELLY	TOPICAL	20191101		OTC MONOGRAPH DRUG	M016	Universal Distribution Center LLC	PETROLATUM	99.9	g/100g			N	20241231
52000-104_e464a1a6-ac35-4949-abdb-40c19970a1fc	52000-104	HUMAN OTC DRUG	UNIVERSAL ORIGINAL PETROLEUM		White Petroleum	JELLY	TOPICAL	20191101		OTC MONOGRAPH DRUG	M016	Universal Distribution Center LLC	PETROLATUM	99.9	g/100g			N	20241231
52000-105_58b2217d-5ab4-4db5-8b59-cac4a647b414	52000-105	HUMAN OTC DRUG	Universal Ice Cold Analgesic		Menthol	GEL	TOPICAL	20200125		OTC MONOGRAPH DRUG	M017	Universal Distribution Center LLC	MENTHOL, UNSPECIFIED FORM	1.25	g/100g			N	20241231
52000-106_b89ff727-4759-4299-ae51-29faad8a69dd	52000-106	HUMAN OTC DRUG	Universal Ice Cold Analgesic		Menthol	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	M017	Universal Distribution Center LLC	MENTHOL, UNSPECIFIED FORM	1.25	g/100mL			N	20241231
52000-107_69e7d7f5-a88f-4067-b25e-0b7ab646044f	52000-107	HUMAN OTC DRUG	ANTI CAVITY FLUORIDE		Sodium Monofluorophosphate	PASTE	DENTAL	20200515		OTC MONOGRAPH DRUG	M021	Universal Distribution Center LLC	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
52000-108_ede5654c-864e-44c6-904b-ca2ac4532096	52000-108	HUMAN OTC DRUG	ADVANCED WHITENING ANTI CAVITY FLUORIDE		Sodium Monofluorophosphate	PASTE	DENTAL	20200518		OTC MONOGRAPH DRUG	M021	Universal Distribution Center LLC	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
52000-109_1199f2f8-98e4-4b76-9be9-3b921495a3c3	52000-109	HUMAN OTC DRUG	UNIVERSAL SENSITIVE ANTI-CAVITY FLUORIDE		potassium nitrate and sodium fluoride	PASTE	DENTAL	20200520		OTC MONOGRAPH DRUG	M022	Universal Distribution Center LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .15	g/100g; g/100g			N	20241231
52000-110_d0808a4c-4c1f-4bd1-a8b0-bf13a29bd1d4	52000-110	HUMAN OTC DRUG	UNIVERSAL CHARCOAL WITH ALOE VERA ANTI-CAVITY FLUORIDE		Sodium fluoride	PASTE	DENTAL	20200525		OTC MONOGRAPH DRUG	M021	Universal Distribution Center LLC	SODIUM FLUORIDE	.15	g/100g			N	20241231
52000-111_42b18d2a-c986-42a0-9f88-9ee8e8b1290b	52000-111	HUMAN OTC DRUG	UNIVERSAL ANTI-CAVITY FLUORIDE		Sodium Monofluorophosphate	PASTE	DENTAL	20200530		OTC MONOGRAPH DRUG	M021	Universal Distribution Center LLC	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
52000-112_e3086345-3da8-4262-9854-15ab1e031e58	52000-112	HUMAN OTC DRUG	UNIVERSAL ADVANCED WHITENING ANTI-CAVITY FLUORIDE		Sodium Monofluorophosphate	PASTE	DENTAL	20200530		OTC MONOGRAPH DRUG	M021	Universal Distribution Center LLC	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
52000-113_b404496d-fd70-4d79-b4fb-1cb0e73fe292	52000-113	HUMAN OTC DRUG	Universal Vaporizing Chest Rub		Menthol and Camphor and Eucalyptus	OINTMENT	TOPICAL	20200616		OTC MONOGRAPH DRUG	M012	Universal Distribution Center LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	4.7; 1; 1.25	g/100g; g/100g; g/100g			N	20241231
52000-118_ec67a1ee-ad72-54f2-e053-2995a90a7690	52000-118	HUMAN OTC DRUG	UNIVERSAL BABY FRESH SCENT PETROLEUM		White Petroleum	JELLY	TOPICAL	20191101		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	PETROLATUM	99.9	g/100g			N	20241231
52000-119_ec687ea2-40cf-0cad-e053-2a95a90a2180	52000-119	HUMAN OTC DRUG	UNIVERSAL COCOA BUTTER SCENT PETROLEUM		White Petroleum	JELLY	TOPICAL	20191101		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	PETROLATUM	99.9	g/100g			N	20241231
52000-123_151e9449-04a3-4730-8da5-b8776b85c7d9	52000-123	HUMAN OTC DRUG	PETROLEUM jelly		Petrolatum	CREAM	TOPICAL	20150727		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	PETROLATUM	30	g/100mL			N	20241231
52000-124_711797b1-da21-4626-9bcc-3d9127ca3cbd	52000-124	HUMAN OTC DRUG	COCOA BUTTER PETROLEUM jelly		Petrolatum	CREAM	TOPICAL	20150727		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	PETROLATUM	30	g/100mL			N	20241231
52000-131_0744fb42-e0cf-8730-e063-6294a90aadd8	52000-131	HUMAN OTC DRUG	HAND SANITIZER 1.85OZ		ALCOHOL	GEL	TOPICAL	20180101		OTC MONOGRAPH DRUG	M003	UNIVERSAL DISTRIBUTION CENTER LLC	ALCOHOL	62	mL/100mL			N	20241231
52000-132_07599127-3179-6281-e063-6294a90a71af	52000-132	HUMAN OTC DRUG	2PK HAND SANITIZER CLASSIC		ALCOHOL	GEL	TOPICAL	20180101		OTC MONOGRAPH DRUG	M003	UNIVERSAL DISTRIBUTION CENTER LLC	ALCOHOL	62	mL/100mL			N	20241231
52000-133_0754b6b1-3a61-a95a-e063-6394a90a9229	52000-133	HUMAN OTC DRUG	2PK HAND SANITIZER ALOE VERA		ALCOHOL	GEL	TOPICAL	20180101		OTC MONOGRAPH DRUG	M003	UNIVERSAL DISTRIBUTION CENTER LLC	ALCOHOL	62	mL/100mL			N	20241231
52000-150_066b57f8-30b0-1b77-e063-6294a90a0998	52000-150	HUMAN OTC DRUG	UNIVERSAL LAVENDER SCENT PETROLEUM		White Petroleum	JELLY	TOPICAL	20191101		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	PETROLATUM	99.9	g/100g			N	20241231
52000-201_a8a8145d-fb88-1040-e053-2a95a90a6983	52000-201	HUMAN OTC DRUG	U INSTANT HAND SANITIZER CLASSIC 2OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ALCOHOL	62	mL/100mL			N	20241231
52000-202_a8b72947-05a7-4179-e053-2995a90a3e36	52000-202	HUMAN OTC DRUG	U INSTANT HAND SANITIZER CLASSIC 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ALCOHOL	62	mL/100mL			N	20241231
52000-203_a8b7eb00-86a5-368b-e053-2995a90ae7af	52000-203	HUMAN OTC DRUG	U INSTANT HAND SANITIZER LAVENDER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ALCOHOL	62	mL/100mL			N	20241231
52000-204_a8b87709-420e-73bb-e053-2a95a90a3e3c	52000-204	HUMAN OTC DRUG	U INSTANT HAND SANITIZER CLASSIC 16OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ALCOHOL	62	mL/100mL			N	20241231
52000-205_af5318fe-fe0c-5242-e053-2a95a90acf28	52000-205	HUMAN OTC DRUG	U INSTANT HAND SANITIZER CLASSIC 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ALCOHOL	70	mL/100mL			N	20241231
52000-301_4c3b70ef-0279-42fe-9006-d66630e7b9e3	52000-301	HUMAN OTC DRUG	Universal ARTHRITIS and SPORT		Methyl Salicylate, Capsicum	LIQUID	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Universal Distribution Center LLC	CAPSICUM; METHYL SALICYLATE	.0012; .61	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
52000-302_77f22dbb-9790-4bae-ba31-085d44aad064	52000-302	HUMAN OTC DRUG	Universal ARTHRITIS and SPORT		Methyl Salicylate, Capsicum	LIQUID	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Universal Distribution Center LLC	CAPSICUM; METHYL SALICYLATE	.0012; .61	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
52000-303_afbaef4e-3992-446b-b2a5-87fea7abd9c6	52000-303	HUMAN OTC DRUG	Universal ARTHRITIS and SPORT		Methyl Salicylate, Capsicum	LIQUID	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Universal Distribution Center LLC	CAPSICUM; METHYL SALICYLATE	.0012; .61	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
52000-406_fd789b4b-9932-442f-8080-1bfdb2eeda03	52000-406	HUMAN OTC DRUG	Universal Rubbing Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
52000-407_c91fb4af-dc71-470c-80bf-0edf871e8c96	52000-407	HUMAN OTC DRUG	Universal PAIN RELIEF		Lidocaine	PATCH	TOPICAL	20230630		OTC MONOGRAPH NOT FINAL	part348	Universal Distribution Center LLC	LIDOCAINE	.04	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
52000-410_0c781f79-4059-4216-8c77-d057a20a88df	52000-410	HUMAN OTC DRUG	Universal 50% Rubbing Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-411_effba046-9b6a-455b-b044-bbb6b9f9424c	52000-411	HUMAN OTC DRUG	Universal 70% Rubbing Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52000-412_395f7122-55f3-434d-89cf-633f473000ab	52000-412	HUMAN OTC DRUG	Universal 50% Rubbing Alcohol with Wintergreen and Glycerin		Isopropyl alcohol	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52000-413_6b035a1b-74ca-47f5-b4c5-ae00a72ece8d	52000-413	HUMAN OTC DRUG	Universal 70% Rubbing Alcohol with Wintergreen and Glycerin		Isopropyl alcohol	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part333A	Universal Distribution Center LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52000-414_185481dd-ffd6-49f8-8419-3b7c7451e3d2	52000-414	HUMAN OTC DRUG	Universal WITCH HAZEL		witch hazel	SOLUTION	TOPICAL	20230701		OTC MONOGRAPH FINAL	part347	Universal Distribution Center LLC	WITCH HAZEL	3	g/100mL			N	20241231
52003-011_784bab05-94ba-438c-aeff-0ee14a8a8cf4	52003-011	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205817	Messer Canada Inc.	OXYGEN	995	mL/L			N	20241231
52003-016_310cc776-1706-4986-8b43-9bac97979518	52003-016	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19600101		UNAPPROVED MEDICAL GAS		Messer Canada Inc.	NITROGEN	995	mL/L			N	20241231
52015-080_196bc622-60fc-4d2a-8d8f-93aa8d0db246	52015-080	HUMAN PRESCRIPTION DRUG	Dificid		fidaxomicin	TABLET, FILM COATED	ORAL	20110527		NDA	NDA201699	Merck Sharp & Dohme LLC	FIDAXOMICIN	200	mg/1	Macrolide Antibacterial [EPC], Macrolides [CS]		N	20241231
52015-700_196bc622-60fc-4d2a-8d8f-93aa8d0db246	52015-700	HUMAN PRESCRIPTION DRUG	DIFICID		FIDAXOMICIN	GRANULE, FOR SUSPENSION	ORAL	20200218		NDA	NDA213138	Merck Sharp & Dohme LLC	FIDAXOMICIN	200	mg/5mL	Macrolide Antibacterial [EPC], Macrolides [CS]		N	20241231
52031-0876_5e55a447-9145-4c57-9965-fd2bc8945871	52031-0876	HUMAN OTC DRUG	Dettol First Aid Antiseptic		chloroxylenol	LIQUID	CUTANEOUS	20220901		OTC MONOGRAPH DRUG	M003	Reckitt Benckiser (UK) Ltd.	CHLOROXYLENOL	4.8	g/15mL			N	20241231
52053-0001_7f04a1a2-cf94-4664-9815-463e121204d2	52053-0001	HUMAN OTC DRUG	Sambucol Cold and Flu Relief		Bryonia, Gelsemium Sempervirens, Sabucus Nigra, Sulphur, Zincum Gluconicum	TABLET, ORALLY DISINTEGRATING	ORAL	20130326		UNAPPROVED HOMEOPATHIC		PharmaCare US, Inc.	BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SULFUR; ZINC GLUCONATE	6; 6; 3; 12; 2	[hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52053-0004_4965b936-5b69-4de6-a5c5-b127c922423a	52053-0004	HUMAN OTC DRUG	Sambucol Cold and Flu Relief		Bryonia, Gelsemium Sempervirens, Sabucus Nigra, Sulphur, Zincum Gluconicum	TABLET	ORAL	20211004		UNAPPROVED HOMEOPATHIC		PharmaCare US, Inc.	BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SULFUR; ZINC GLUCONATE	6; 6; 3; 12; 2	[hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg; [hp_X]/mg	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52063-709_09d72888-7c83-700d-e063-6394a90a701b	52063-709	HUMAN OTC DRUG	ACNE FORTE Acne Treatment Cream		BENZOYL PEROXIDE	CREAM	TOPICAL	20220110		OTC MONOGRAPH DRUG	M006	GSCM Ventures Inc. DBA Revitol	BENZOYL PEROXIDE	50	mg/mL			N	20241231
52083-055_e9d05532-a0d0-48e8-bd95-c6275bfbe8a5	52083-055	HUMAN OTC DRUG	Supress DX Pediatric Drops		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SYRUP	ORAL	20110329		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-056_6b4b229d-56e9-4920-9549-f60f50667f27	52083-056	HUMAN OTC DRUG	SUPRESS-PE	Pediatric	Guiafenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20140114		OTC MONOGRAPH FINAL	part341	Kramer Novis	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	50; 2.5	mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-057_f3752319-1292-4d33-8d94-37b5a295b265	52083-057	HUMAN OTC DRUG	SUPRESS A		Dexbromopheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	SYRUP	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	1; 10; 5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-058_584d5e8d-618d-4451-9c23-897f64b3e34c	52083-058	HUMAN OTC DRUG	Supress DM		dextromethorphan hydrobromide, guaifenesin	SYRUP	ORAL	20131002		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 50	mg/mL; mg/mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
52083-231_40bc9e45-285b-479b-b160-8cee2cf8ba40	52083-231	HUMAN OTC DRUG	Tussi Pres		guaifenesin, phenylephrine hydrochloride, dextromethorphan hydrobromide	SYRUP	ORAL	20110328		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-232_55722edd-8e94-4cb1-914d-5545ee17cb79	52083-232	HUMAN OTC DRUG	TUSSI PRES PEDIATRIC		GUAIFENESIN, PHENYLEPHRINE HCL,DEXTROMETHORPHAN HYDROBROMIDE	SYRUP	ORAL	20110324		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 75; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-237_be1c412d-21bb-4a19-b682-50d00fd3dccf	52083-237	HUMAN OTC DRUG	Tussi Pres B		dextromethorphan hydrobromide, brompheniramine maleate, phenylephrine hydrochloride	SYRUP	ORAL	20110329		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 20; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-239_1043a161-b529-4a8a-99ca-61d57419b7ec	52083-239	HUMAN OTC DRUG	TUSICOF		dextromethorphan, guaifenesin, and phenylephrine	SYRUP	ORAL	20100817		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-242_72c48d04-90db-4af0-bc88-3b28f949a04b	52083-242	HUMAN OTC DRUG	Myco Nail A Antifungal Solution		Undecylenic acid	LIQUID	TOPICAL	20140114		OTC MONOGRAPH FINAL	part333C	Kramer Novis	UNDECYLENIC ACID	250	mg/mL			N	20241231
52083-400_0ce3d63e-43c0-43d9-a1ff-cb48da835eee	52083-400	HUMAN OTC DRUG	ZYNCOF		Dextromethorphan HBr and Guaifenesin	SYRUP	ORAL	20110601		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
52083-600_0aeed24e-ca81-4f3e-b98c-31857395fd4b	52083-600	HUMAN OTC DRUG	G-ZYNCOF		Dextromethorphan HBr and Guaifenesin	SYRUP	ORAL	20121203		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
52083-622_84c38749-284a-42f4-8a7b-9daf89a96c85	52083-622	HUMAN OTC DRUG	Tusslin		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SYRUP	ORAL	20140701		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	28; 388; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-623_a5539e41-632f-4d48-8a49-1d93e5c531be	52083-623	HUMAN OTC DRUG	Tusslin	Pediatric	Dextromethorphan Hbr, Guiafenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20140127		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	7.5; 88; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-630_39b9140f-3d5f-47e8-87db-3985a66681c8	52083-630	HUMAN OTC DRUG	PECGEN DMX		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20150401		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 187	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
52083-632_9e934ca0-f4c9-4e86-9e8d-088fd79f305c	52083-632	HUMAN OTC DRUG	Presgen		guaifenesin, phenylephrine hydrochloride, dextromethorphan hydrobromide	SYRUP	ORAL	20110328		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-637_8d67304c-5718-4e3f-be6b-b5d920f442b2	52083-637	HUMAN OTC DRUG	Presgen B		dextromethorphan hydrobromide, brompheniramine maleate, phenylephrine hydrochloride	SYRUP	ORAL	20110329		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 20; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-639_3e6452b2-a583-47e7-a0e8-cc70045a7383	52083-639	HUMAN OTC DRUG	G-TUSICOF		dextromethorphan, guaifenesin, and phenylephrine	SYRUP	ORAL	20120924		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-641_e780b307-299b-45ea-9b56-01faee3cdec0	52083-641	HUMAN OTC DRUG	Desgen	Pediatric	Dextromethorphan Hbr, Guiafenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20140127		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-646_57de1640-53c1-427d-9b5d-1088cf309a76	52083-646	HUMAN OTC DRUG	DESGEN DM		Dextromethorphan HBr ,Guaifenesin ,Phenylephrine HCl	SOLUTION	ORAL	20141018		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-648_f5bc8478-e93d-4d5b-b744-5b0c49843d35	52083-648	HUMAN OTC DRUG	DESGEN DM Tabs		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE	TABLET	ORAL	20150826		OTC MONOGRAPH DRUG	M012	KRAMER NOVIS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	10; 200; 30	mg/1; mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
52083-650_5d0747f8-3088-4716-896c-f71383c284c2	52083-650	HUMAN OTC DRUG	GENCONTUSS		CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20150608		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-653_045188e8-2c41-476a-b86f-75cf57bc2101	52083-653	HUMAN OTC DRUG	PRESGEN PEDIATRIC		GUAIFENESIN, PHENYLEPHRINE HCL,DEXTROMETHORPHAN HYDROBROMIDE	SYRUP	ORAL	20110324		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 75; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-655_a7a9c734-51f2-4396-bad0-0da368adcd75	52083-655	HUMAN OTC DRUG	G-Supress DX		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SYRUP	ORAL	20110329		OTC MONOGRAPH FINAL	part341	KRAMER NOVIS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-660_13682546-cf2e-493d-a0fa-12777b7849fa	52083-660	HUMAN OTC DRUG	Sorbugen		dextromethorphan hydrobromide, glycerol guaiacolate	SYRUP	ORAL	20141008		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	15; 150	mg/7.5mL; mg/7.5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
52083-678_7d8d222b-b7a2-4165-b432-d400969ec490	52083-678	HUMAN OTC DRUG	G-TRON	PED	Dextromethorphan Hbr, Guiafenesin, Phenylephrine HCl	SOLUTION	ORAL	20140127		OTC MONOGRAPH FINAL	part341	Kramer Novis	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	15; 350; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52083-680_260104be-70ab-461e-b8e4-11371407fbbc	52083-680	HUMAN OTC DRUG	DERMOGEN		ZINC OXIDE	CREAM	TOPICAL	20160404		OTC MONOGRAPH FINAL	part347	KRAMER NOVIS	ZINC OXIDE	15.25	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52083-714_9f4c663e-aa3c-4190-83c7-61ec6f0a4eb7	52083-714	HUMAN OTC DRUG	Gumsol		Benzocaine, Zinc Chloride	SPRAY	ORAL	20140228		OTC MONOGRAPH NOT FINAL	part356	Kramer Novis	BENZOCAINE; ZINC CHLORIDE	1.5; .03	g/30mL; g/30mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52085-001_088dd0d2-a0d9-9cf0-e063-6294a90ad07b	52085-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20070401		NDA	NDA205849	ANALGESIC SERVICES, INC.	OXYGEN	99	L/100L			N	20241231
52085-002_088dd0d2-a0d8-9cf0-e063-6294a90ad07b	52085-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20131201		NDA	NDA205850	ANALGESIC SERVICES, INC.	NITROGEN	99	L/100L			N	20241231
52086-011_f791c94b-7fbb-3857-e053-6294a90ac6be	52086-011	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19830908		NDA	NDA205889	Helget Gas Products	OXYGEN	999	mL/L			N	20241231
52086-012_f791db00-775d-00da-e053-6294a90adaf7	52086-012	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19830908		NDA	NDA205891	Helget Gas Products	NITROGEN	990	mL/L			N	20241231
52086-015_ee00206d-b8c5-49e4-e053-2995a90a8e3b	52086-015	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19830908		NDA	NDA206014	Helget Gas Products	NITROUS OXIDE	995	mL/L			N	20241231
52156-200_d825258a-20c3-5a23-e053-2a95a90a555a	52156-200	HUMAN PRESCRIPTION DRUG	Compressed Oxygen		Compressed Oxygen	GAS	RESPIRATORY (INHALATION)	20100422		NDA	NDA205840	Tri-Med Medical Supplies, Inc	OXYGEN	1	L/L			N	20241231
52166-001_0825519a-ed86-f448-e063-6294a90a733c	52166-001	HUMAN OTC DRUG	Argentyn 23		Argentum Metallicaum	GEL	TOPICAL	20090101		UNAPPROVED HOMEOPATHIC		Natural Immunogenics Corp.	SILVER	30	[hp_X]/mL			N	20241231
52166-002_082548c9-735b-cff8-e063-6294a90a26f6	52166-002	HUMAN OTC DRUG	Sovereign Silver		Argentum Metallicum	GEL	TOPICAL	20090101		UNAPPROVED HOMEOPATHIC		Natural Immunogenics Corp.	SILVER	30	[hp_X]/mL			N	20241231
52166-014_08255bc1-f139-0dd8-e063-6294a90a904a	52166-014	HUMAN OTC DRUG	Sovereign Silver Skin Care		Argentum Metallicum	GEL	TOPICAL	20220106		UNAPPROVED HOMEOPATHIC		Natural Immunogenics Corp.	SILVER	30	[hp_X]/mL			N	20241231
52166-015_0825519a-ed92-f448-e063-6294a90a733c	52166-015	HUMAN OTC DRUG	Sovereign Silver		Argentum Metallicum	GEL	TOPICAL	20221220		UNAPPROVED HOMEOPATHIC		Natural Immunogenics Corp.	SILVER	30	[hp_X]/mL			N	20241231
52166-016_05e1cf85-6b19-57fe-e063-6294a90a55fc	52166-016	HUMAN OTC DRUG	Sovereign Silver Foaming Facial Cleanser		Salicylic Acid/Acne treatment Gel	GEL	TOPICAL	20230724		OTC MONOGRAPH FINAL	part333D	Natural Immunogenics Corporation	SALICYLIC ACID	1	g/59mL			N	20241231
52166-017_05e1c415-3131-5d82-e063-6294a90aafb7	52166-017	HUMAN OTC DRUG	Sovereign Silver Acne Spot Treatment Medicated Serum		Salicylic Acid	LIQUID	TOPICAL	20230724		OTC MONOGRAPH FINAL	part333D	Natural Immunogenics Corporation	SALICYLIC ACID	2	g/29mL			N	20241231
52183-102_558fe182-2401-4314-9e6f-ca6e644bb112	52183-102	HUMAN OTC DRUG	Ludens Watermelon Throat Drops		Pectin	LOZENGE	ORAL	20091029		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	1.7	mg/1			N	20241231
52183-199_0bc4526a-5d34-bb8a-e063-6394a90abfeb	52183-199	HUMAN OTC DRUG	NasalCrom		cromolyn sodium	SPRAY, METERED	NASAL	20091029		ANDA	ANDA075702	Prestige Brands Holdings, Inc.	CROMOLYN SODIUM	5.2	mg/1	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
52183-202_558fe182-2401-4314-9e6f-ca6e644bb112	52183-202	HUMAN OTC DRUG	Ludens Watermelon Throat Drops		Pectin	LOZENGE	ORAL	20091029		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-204_558fe182-2401-4314-9e6f-ca6e644bb112	52183-204	HUMAN OTC DRUG	Ludens Green Apple Throat Drops		Pectin	LOZENGE	ORAL	20150801		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-209_558fe182-2401-4314-9e6f-ca6e644bb112	52183-209	HUMAN OTC DRUG	Ludens Strawberry Banana Throat Drops		Pectin	LOZENGE	ORAL	20150701		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-212_220c0e48-cfca-4a78-83da-5b75432ceed6	52183-212	HUMAN OTC DRUG	Ludens	Honey and Berry	pectin	LOZENGE	ORAL	20170701		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-217_973b7e0f-910d-440d-aadc-3e4f5b795c11	52183-217	HUMAN OTC DRUG	Ludens Assorted Flavors		pectin	LOZENGE	ORAL	20170613		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-220_ee98e940-2bad-4bf7-a431-19ec0d4e71c3	52183-220	HUMAN OTC DRUG	Ludens Honey Lemon		pectin	LOZENGE	ORAL	20180201		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-223_e042ef55-48d2-43c6-91d1-55becd1f9f7c	52183-223	HUMAN OTC DRUG	TAGAMET		cimetidine	TABLET	ORAL	20230201		NDA	NDA020238	Prestige Brands Holdings, Inc.	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
52183-227_ee53bd6a-ffb8-4a8a-bf69-eab87daa0a03	52183-227	HUMAN OTC DRUG	Ludens	Dual Relief	pectin and menthol	LOZENGE	ORAL	20180615		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	MENTHOL; PECTIN	2.5; 2.8	mg/1; mg/1			N	20241231
52183-229_558fe182-2401-4314-9e6f-ca6e644bb112	52183-229	HUMAN OTC DRUG	Ludens Wild Cherry Throat Drops		Pectin	LOZENGE	ORAL	20091029		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-239_4a0e60eb-f121-41b2-8a50-0a4638850efc	52183-239	HUMAN OTC DRUG	Ludens Wild Honey Throat Drops		Pectin	LOZENGE	ORAL	20100708		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-249_96bdef6f-54dc-4cf2-a89f-85f2e53fc057	52183-249	HUMAN OTC DRUG	LUDENS SUGAR FREE WILD CHERRY THROAT		Pectin	LOZENGE	ORAL	20100712		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-255_bdd552bf-5b1d-411b-8155-1efa4d420fbd	52183-255	HUMAN OTC DRUG	Ludens Honey Licorice Throat Drops		Menthol	LOZENGE	ORAL	20091029		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	MENTHOL	1.6	mg/1			N	20241231
52183-259_bdd552bf-5b1d-411b-8155-1efa4d420fbd	52183-259	HUMAN OTC DRUG	Ludens Honey Licorice Throat Drops		Menthol	LOZENGE	ORAL	20091029		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	MENTHOL	1	mg/1			N	20241231
52183-289_558fe182-2401-4314-9e6f-ca6e644bb112	52183-289	HUMAN OTC DRUG	Ludens Berry Assortment Throat Drops		Pectin	LOZENGE	ORAL	20091029		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	2.8	mg/1			N	20241231
52183-299_558fe182-2401-4314-9e6f-ca6e644bb112	52183-299	HUMAN OTC DRUG	Ludens Wild Cherry Throat Drops		Pectin	LOZENGE	ORAL	20091029		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PECTIN	1.7	mg/1			N	20241231
52187-522_60a1c32b-70e4-332b-e053-2a91aa0a3fd8	52187-522	HUMAN PRESCRIPTION DRUG	Salicylic Acid		salicylic acid	SOLUTION	TOPICAL	20150601		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SALICYLIC ACID	285	mg/mL			N	20241231
52187-525_5c60df47-58d0-5226-e053-2a91aa0a1646	52187-525	HUMAN PRESCRIPTION DRUG	XALIX		SALICYLIC ACID	SOLUTION	TOPICAL	20171025		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SALICYLIC ACID	280	mg/g			N	20241231
52187-526_5df4c5b6-3ad3-7f2c-e053-2991aa0a021b	52187-526	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	LIQUID	TOPICAL	20171114		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SALICYLIC ACID	260	mg/mL			N	20241231
52187-527_9a9e8c76-5207-1522-e053-2a95a90a0491	52187-527	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	LIQUID	TOPICAL	20171114		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SALICYLIC ACID	275	mg/mL			N	20241231
52187-530_b7123c28-8647-1526-e053-2a95a90a6ec3	52187-530	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		sodium sulfacetamide, sulfur	LIQUID	TOPICAL	20190130		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	90; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-531_a6185774-2622-4f52-e053-2995a90a42c0	52187-531	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		SODIUM SULFACETAMIDE, SULFUR	SUSPENSION	TOPICAL	20200520		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	80; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-532_b715ced9-99a6-5331-e053-2995a90aaacd	52187-532	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE, IODOQUINOL		hydrocortisone, iodoquinol	CREAM	TOPICAL	20181016		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	HYDROCORTISONE; IODOQUINOL	10; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52187-536_ba0fc821-1fc3-20f9-e053-2a95a90ad977	52187-536	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		SODIUM SULFACETAMIDE, SULFUR	RINSE	TOPICAL	20210129		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-545_bba39920-8fc7-3632-e053-2a95a90aa41c	52187-545	HUMAN PRESCRIPTION DRUG	IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES		IODOQUINOL, HYDROCORTISONE ACETATE, ALOE POLYSACCHARIDES	GEL	TOPICAL	20210218		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	ALOE VERA LEAF POLYSACCHARIDES; HYDROCORTISONE ACETATE; IODOQUINOL	10; 20; 10	mg/g; mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52187-546_db857027-0176-e452-e053-2995a90a4df5	52187-546	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20220331		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-547_d916e437-366b-c00d-e053-2995a90ace0c	52187-547	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM, SULFUR		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20220228		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-548_db841a96-42cc-6ff6-e053-2995a90a7cca	52187-548	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM, SULFUR		SULFACETAMIDE SODIUM, SULFUR	LOTION	TOPICAL	20220331		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-549_db83b517-90d6-44f2-e053-2995a90a2cf3	52187-549	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20220331		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	UREA	470	mg/g			N	20241231
52187-550_d916958d-97c3-c4ec-e053-2a95a90a77d8	52187-550	HUMAN PRESCRIPTION DRUG	SELENIUM SULFIDE		SELENIUM SULFIDE	SHAMPOO	TOPICAL	20220228		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SELENIUM SULFIDE	23	mg/mL			N	20241231
52187-551_d917055f-0049-08b9-e053-2995a90aa246	52187-551	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate, Iodoquinol		Hydrocortisone Acetate, Iodoquinol	CREAM	TOPICAL	20220228		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	HYDROCORTISONE ACETATE; IODOQUINOL	19; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52187-552_efa5f665-5784-f079-e053-2a95a90a89ad	52187-552	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM, SULFUR		SULFACETAMIDE SODIUM, SULFUR	CLOTH	TOPICAL	20210607		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-553_d7fc8def-53f9-56c1-e053-2995a90a2434	52187-553	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM		SULFACETAMIDE SODIUM	SHAMPOO	TOPICAL	20211006		UNAPPROVED DRUG OTHER		KMM Pharmaceuticals, LLC	SULFACETAMIDE SODIUM	98	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
52187-555_d7acf745-e17f-009d-e053-2a95a90ab32e	52187-555	HUMAN PRESCRIPTION DRUG	ERGOTAMINE TARTRATE, CAFFEINE		ERGOTAMINE TARTRATE, CAFFEINE	TABLET	ORAL	20220210		ANDA	ANDA040590	KMM Pharmaceuticals, LLC	CAFFEINE; ERGOTAMINE TARTRATE	100; 1	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Ergotamine Derivative [EPC], Ergotamines [CS], Methylxanthine [EPC], Xanthines [CS]		N	20241231
52187-556_df7434aa-d4bf-63a1-e053-2a95a90a2751	52187-556	HUMAN PRESCRIPTION DRUG	DESONIDE		DESONIDE	GEL	TOPICAL	20220228		ANDA	ANDA202470	KMM Pharmaceuticals, LLC	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52191-350_04c665ff-b933-6629-e063-6294a90a1205	52191-350	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		SELENIUM SULFIDE	SHAMPOO	TOPICAL	20180412	20240531	UNAPPROVED DRUG OTHER		Bowyn Labs, LLC	SELENIUM SULFIDE	23	mg/mL			N	
52191-352_04c66b94-4c2b-bba0-e063-6394a90a8e0d	52191-352	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate, Iodoquinol		Hydrocortisone Acetate, Iodoquinol	CREAM	TOPICAL	20110729	20240229	UNAPPROVED DRUG OTHER		Bowyn Labs, LLC	HYDROCORTISONE ACETATE; IODOQUINOL	19; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
52220-080_b639e8a1-bd2d-4e63-8ec0-351de9558c70	52220-080	HUMAN OTC DRUG	ARRAY Anitbacterial Foam Handwash		Chloroxylenol	LIQUID	TOPICAL	20061130		OTC MONOGRAPH NOT FINAL	part333E	Gordon Food Service, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
52220-400_ae919f35-aa9c-4603-96b5-2e61018a068b	52220-400	HUMAN OTC DRUG	ARRAY Plum Scent Antibacterial Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Gordon Food Service, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
52220-701_09d2b9cf-12ca-f826-e063-6294a90a7fe5	52220-701	HUMAN OTC DRUG	Array Antiseptic Handwash		PCMX	SOAP	TOPICAL	20221027		OTC MONOGRAPH DRUG	505G(a)(3)	Gordon Food Service, Inc.	CHLOROXYLENOL	1	g/L			N	20241231
52241-100_0c0d4eac-3530-250d-e063-6294a90aad14	52241-100	HUMAN OTC DRUG	Katinko Pain And Itch Relieving		CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE	OINTMENT	TOPICAL	20100524		OTC MONOGRAPH DRUG	M017	Greenstone Pharmaceutical Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	11; 7.6; 13	g/100g; g/100g; g/100g			N	20241231
52241-301_0c0ca95f-4185-c869-e063-6294a90af71b	52241-301	HUMAN OTC DRUG	Katinko External Analgesic Oil		CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE	OIL	TOPICAL	20230601		OTC MONOGRAPH DRUG	M017	Greenstone Pharmaceutical Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	50; 160; 300	mg/mL; mg/mL; mg/mL			N	20241231
52242-001_06e5e953-a4f2-6c6f-e063-6294a90a8597	52242-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091006		UNAPPROVED MEDICAL GAS		Doyle's Medical Supply LLC	OXYGEN	99	L/100L			N	20241231
52244-010_a4d5f2fd-266b-4469-bf99-c51d572b1fdb	52244-010	HUMAN PRESCRIPTION DRUG	Edex		alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	20120415		NDA	NDA020649	Endo Pharmaceuticals Inc.	ALPROSTADIL	10	ug/mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
52244-020_a4d5f2fd-266b-4469-bf99-c51d572b1fdb	52244-020	HUMAN PRESCRIPTION DRUG	Edex		alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	20120115		NDA	NDA020649	Endo Pharmaceuticals Inc.	ALPROSTADIL	20	ug/mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
52244-040_a4d5f2fd-266b-4469-bf99-c51d572b1fdb	52244-040	HUMAN PRESCRIPTION DRUG	Edex		alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	20120315		NDA	NDA020649	Endo Pharmaceuticals Inc.	ALPROSTADIL	40	ug/mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
52244-100_3d3b5bb2-53fa-44bc-b3ce-321158492d00	52244-100	HUMAN PRESCRIPTION DRUG	Theo-24		theophylline anhydrous	CAPSULE, EXTENDED RELEASE	ORAL	20140825		ANDA	ANDA087942	Endo Pharmaceuticals, Inc.	THEOPHYLLINE ANHYDROUS	100	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
52244-200_3d3b5bb2-53fa-44bc-b3ce-321158492d00	52244-200	HUMAN PRESCRIPTION DRUG	Theo-24		theophylline anhydrous	CAPSULE, EXTENDED RELEASE	ORAL	20140825		ANDA	ANDA087943	Endo Pharmaceuticals, Inc.	THEOPHYLLINE ANHYDROUS	200	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
52244-300_3d3b5bb2-53fa-44bc-b3ce-321158492d00	52244-300	HUMAN PRESCRIPTION DRUG	Theo-24		theophylline anhydrous	CAPSULE, EXTENDED RELEASE	ORAL	20140825		ANDA	ANDA087944	Endo Pharmaceuticals, Inc.	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
52244-400_3d3b5bb2-53fa-44bc-b3ce-321158492d00	52244-400	HUMAN PRESCRIPTION DRUG	Theo-24		theophylline anhydrous	CAPSULE, EXTENDED RELEASE	ORAL	20140825		ANDA	ANDA081034	Endo Pharmaceuticals, Inc.	THEOPHYLLINE ANHYDROUS	400	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
52246-929_e37c79d5-e9c4-4ee5-870a-b44000f03748	52246-929	HUMAN PRESCRIPTION DRUG	Natroba		spinosad	SUSPENSION	TOPICAL	20110125		NDA	NDA022408	ParaPRO LLC	SPINOSAD	9	mg/mL	Pediculicide [EPC]		N	20241231
52257-1370_013faf78-fd39-4e8a-bc66-cb8d2a6d0913	52257-1370	HUMAN OTC DRUG	ATOMY PROPOLIS TOOTHPAS TE 200G		Sodium Monofluorophosphate, Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20191125		OTC MONOGRAPH FINAL	part355	ATOMY CO., LTD.	SODIUM FLUORIDE; SODIUM MONOFLUOROPHOSPHATE	.2; .32	g/200g; g/200g			N	20241231
52257-1380_02002922-7cd8-4e5d-adb3-d60241e7dc18	52257-1380	HUMAN OTC DRUG	ATOMY PROPOLIS TOOTHPAS TE 50G		Sodium Monofluorophosphate, Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20191201		OTC MONOGRAPH FINAL	part355	ATOMY CO., LTD.	SODIUM FLUORIDE; SODIUM MONOFLUOROPHOSPHATE	.05; .08	g/50g; g/50g			N	20241231
52257-1390_0f70d01a-59d3-4c5a-8ae5-ea9404d51568	52257-1390	HUMAN OTC DRUG	ATOMY SUN		HOMOSALATE, OCTOCRYLENE, ETHYLHEXYL SALICYLATE, BUTYL METHOXYDIBENZOYLMETHANE	STICK	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part352	ATOMY CO., LTD.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.4; 2.02; .67; 1.35	g/15g; g/15g; g/15g; g/15g			N	20241231
52257-1400_2aa8a5ec-dcfd-4c91-be0e-4b01ff425e6e	52257-1400	HUMAN OTC DRUG	ATOMY DERMA CALMING SUN		Titanium Dioxide	STICK	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part352	ATOMY CO., LTD.	TITANIUM DIOXIDE	1.41	g/16g			N	20241231
52257-1430_1bc0aad3-9bf1-437d-ab31-a07a189929da	52257-1430	HUMAN OTC DRUG	ATOMY BB SUNSCREEN		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	ATOMY CO., LTD.	TITANIUM DIOXIDE; ZINC OXIDE	8.22; 5.76	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52261-0000_66ae38d4-613b-424b-a0af-247dbf70d85d	52261-0000	HUMAN OTC DRUG	Cosco Hand Saniitizer 80%		Alcohol	GEL	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ALCOHOL	80	L/100L			N	20241231
52261-0001_7df8b22d-31cb-4832-87e5-468017dd422d	52261-0001	HUMAN OTC DRUG	Cosco Hand Sanitizer 75%		Alcohol	GEL	TOPICAL	20200429		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ISOPROPYL ALCOHOL	75	L/100L			N	20241231
52261-0500_af7d3c7f-8c60-405d-9d52-6c040ac81e3a	52261-0500	HUMAN OTC DRUG	BerbereX Wound Cleanser		Benzethonium Chloride	LIQUID	TOPICAL	20150517		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ALLANTOIN; BENZETHONIUM CHLORIDE	5; 1	g/1000mL; g/1000mL			N	20241231
52261-0601_11d3d1e9-f1f6-4876-bfb0-8b8acfaf723f	52261-0601	HUMAN OTC DRUG	Berberex Wound Gel		Benzethonium Chloride, Allantoin	GEL	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ALLANTOIN; BENZETHONIUM CHLORIDE	.005; .0012	kg/kg; kg/kg			N	20241231
52261-0602_690c76d2-9577-4b2b-a933-464c42a5bb2b	52261-0602	HUMAN OTC DRUG	FloraSeptic Wound Gel		Benzethonium Chloride, Allantoin	GEL	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ALLANTOIN; BENZETHONIUM CHLORIDE	.005; .0012	kg/kg; kg/kg			N	20241231
52261-0800_669e7de9-8e87-4e2b-a775-b50bee4032bc	52261-0800	HUMAN OTC DRUG	Facet Daily Moisturizer SPF 35		Avobenzone, Octocrylene, Octisalate, Octinoxate	LOTION	TOPICAL	20220901		OTC MONOGRAPH FINAL	part352	Cosco International, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.03; .075; .05; .095	kg/kg; kg/kg; kg/kg; kg/kg			N	20241231
52261-0900_d06c1ac8-faa5-49a1-a0c0-72ed7c27826a	52261-0900	HUMAN OTC DRUG	Pete and Pedro		Coal Tar Solution and Menthol Shampoo	LOTION/SHAMPOO	TOPICAL	20190124		OTC MONOGRAPH FINAL	part358H	Cosco International, Inc.	COAL TAR; MENTHOL	.001836; .00153	kg/kg; kg/kg			N	20241231
52261-0901_eba9276a-5684-4490-9ffb-7ed947287523	52261-0901	HUMAN OTC DRUG	Pete and Pedro Sanitize		Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ALCOHOL	70	L/100L			N	20241231
52261-0902_5a60f3ed-6dcd-4c6f-8995-76d2f6154136	52261-0902	HUMAN OTC DRUG	Pete and Pedro Sanitize		Isopropyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ISOPROPYL ALCOHOL	70	L/100L			N	20241231
52261-1400_e37fff37-4d90-4fd9-af7c-48bbabf0cfa6	52261-1400	HUMAN OTC DRUG	Flakes Cedar Mint Anti Dandruff		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20221201		OTC MONOGRAPH FINAL	part358H	Cosco International, Inc.	PYRITHIONE ZINC	.02	kg/kg			N	20241231
52261-3800_55e27d57-de31-42c4-bfd9-ffe0e476a5fb	52261-3800	HUMAN OTC DRUG	Healthy Skin Cleanser		Salicylic Acid Cleanser	LIQUID	TOPICAL	20190125		OTC MONOGRAPH FINAL	part333D	Cosco International, Inc.	SALICYLIC ACID	.02	kg/kg			N	20241231
52261-4700_e26cef07-713c-4ee8-89dd-13de661c70ed	52261-4700	HUMAN OTC DRUG	Carpe Antiperspirant for Feet		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20170925		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15048	kg/kg			N	20241231
52261-4701_ad0e5761-2c55-4b95-ab77-a8190833377b	52261-4701	HUMAN OTC DRUG	Carpe Antiperspirant for Hands		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20170925		OTC MONOGRAPH DRUG	M350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15048	kg/kg			N	20251231
52261-4702_516bbbca-3ca8-44d5-bc4d-399f734ffdcd	52261-4702	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Cucumber Splash Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220401		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4703_f7712106-d90d-490f-bdf3-c109cc5897a5	52261-4703	HUMAN OTC DRUG	Carpe Antiperspirant for Underarms		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20180827		OTC MONOGRAPH DRUG	M350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15048	kg/kg			N	20251231
52261-4707_c9a2b2c9-b03b-4322-bc77-4f81f4b543a5	52261-4707	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Cypress Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20210901		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4708_44a8ac62-ace8-4f08-b494-ab6971d82d78	52261-4708	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Fresh Vanilla Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20210901		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4710_7bce5a38-0795-40ba-a7eb-58a49f7f5cd7	52261-4710	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Peony Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220301		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4711_0a527c2f-e7aa-4536-b1a8-6c9bbf9c6417	52261-4711	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Fresh Powder Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20211201		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4712_147a6f51-0330-4c36-b897-39b18cb7ab87	52261-4712	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Mountain Breeze Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220401		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4713_606fb28c-24c8-446d-9288-7af90b1c4e3d	52261-4713	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Fragrance Free		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220401		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4714_79d3946a-b6cf-4524-91ef-388044f5ce40	52261-4714	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Rose Water Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220601		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4716_d04f2be1-9e20-4f05-a92d-f356b783a41d	52261-4716	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Vanilla Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220427		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4717_ab7f0ac1-f810-413a-b3c1-d2031ed69671	52261-4717	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Sandalwood Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220427		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4718_4bf2dfbe-2c39-4e32-800b-05c1e56af41e	52261-4718	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Cucumber Splash Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4719_6989c1b4-d907-4f2c-bfd6-33956ae2f45f	52261-4719	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Fresh Powder Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4720_f1b538cd-4999-4ed3-b849-efb0583c7f5b	52261-4720	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Rose Water Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4721_d94b0c1a-954e-4bb3-a4d1-5437b3c422ec	52261-4721	HUMAN OTC DRUG	Carpe Antiperspirant Underarm		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20230801		OTC MONOGRAPH DRUG	M350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4722_bf7bab71-db6c-490c-95b2-885b83d0cba5	52261-4722	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Mountain Breeze Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4723_d1665fc6-64c9-46c0-856d-b8db69f042db	52261-4723	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Apple Spice Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4724_a38dbe33-6041-4550-a887-ac0ae91b76a4	52261-4724	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Christmas Tree Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4725_340ac387-e3fb-4847-bf56-602deb06ba88	52261-4725	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Peppermint Bark Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4726_75265b7e-8d3a-4599-820b-99ab7d4426a2	52261-4726	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Warm Vanilla Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4727_816d42aa-0522-4935-a5ea-7b5e52fbd36d	52261-4727	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Lavender Citrus Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH DRUG	M350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4728_871a7d84-fc67-4300-aec8-fe3cf035758e	52261-4728	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Warm Gingerbread Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20220502		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4729_e700c686-9e7c-4e4e-87cf-78f81c4a8c74	52261-4729	HUMAN OTC DRUG	Carpe Antiperspirant Hand White Jasmine Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20230301		OTC MONOGRAPH DRUG	M350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4730_8062d4d6-9621-4524-b61e-dbb45bc3b68f	52261-4730	HUMAN OTC DRUG	Carpe Antiperspirant Hand Rose Water Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20230401		OTC MONOGRAPH DRUG	M350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4731_b2d72fcb-a7ac-4041-8516-89d190a7cc0b	52261-4731	HUMAN OTC DRUG	Carpe Antiperspirant Hand Warm Vanilla Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20230401		OTC MONOGRAPH DRUG	M350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4732_d10b3bf5-1412-4aad-ae41-3ee26816885f	52261-4732	HUMAN OTC DRUG	Carpe Antiperspirant Underarm Coconut Vanilla Scent		Aluminum Sesquichlorohydrate	LOTION	TOPICAL	20230120		OTC MONOGRAPH FINAL	part350	Cosco International, Inc.	ALUMINUM SESQUICHLOROHYDRATE	.15	kg/kg			N	20241231
52261-4900_e67a890c-373e-43a7-8750-3ab5345ce963	52261-4900	HUMAN OTC DRUG	ASYSTEM Daily Defense Moisturizer SPF30		Homosalate	LOTION	TOPICAL	20190730		OTC MONOGRAPH FINAL	part352	Cosco International, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .08; .05; .055	kg/kg; kg/kg; kg/kg; kg/kg			N	20241231
52261-4902_6e95a6c7-5365-48a3-9af2-243ab24b62f5	52261-4902	HUMAN OTC DRUG	ASYSTEM Radical Relief Gel Roll-On		Menthol, Methyl Salicylate	GEL	TOPICAL	20230703		OTC MONOGRAPH NOT FINAL	part348	Cosco International, Inc.	MENTHOL; METHYL SALICYLATE	.1; .15	kg/kg; kg/kg			N	20241231
52261-5800_0c4206d2-bb4d-4adc-9546-67081c2f47f9	52261-5800	HUMAN OTC DRUG	Botanimedix OnychoRX Antifungal Nail Gel		Undecylenic Acid	GEL	TOPICAL	20200101		OTC MONOGRAPH FINAL	part333C	Cosco International, Inc.	UNDECYLENIC ACID	.2508	kg/kg			N	20241231
52261-5801_cbb76405-cf2a-49cc-aa80-1495a316afd7	52261-5801	HUMAN OTC DRUG	Botanimedix TineaRX Antifungal Drying Emulsion		Clotrimazole	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part333C	Cosco International, Inc.	CLOTRIMAZOLE	.01	kg/kg	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52261-6300_72c3c6d3-3074-4b28-bc09-f9564b0a4358	52261-6300	HUMAN OTC DRUG	OARS AND ALPS MUSCLE RECOVERY BALM		Menthol, Methyl Salicylate	CREAM	TOPICAL	20220214		OTC MONOGRAPH NOT FINAL	part348	Cosco International, Inc	MENTHOL; METHYL SALICYLATE	.05; .1	kg/kg; kg/kg			N	20241231
52261-7400_e416fd8a-dc7e-4b31-beec-9ca17b48afbf	52261-7400	HUMAN OTC DRUG	Safelite AutoGlass Touch Point Sanitization Wipes		Benzalkonium Chloride	SWAB	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	BENZALKONIUM CHLORIDE	.13	1/1			N	20241231
52261-7700_58b397f7-c773-44c3-82f8-8b5f79730be4	52261-7700	HUMAN OTC DRUG	Get Mr Skincare Daily Protection SPF30 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20201001		OTC MONOGRAPH FINAL	part352	Cosco International, Inc.	ZINC OXIDE	.1875	kg/kg	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52261-8100_3d0b1bd1-e123-4020-8997-be5ab0485906	52261-8100	HUMAN OTC DRUG	Dr. Scholls Instant Cool Athletes Foot Wipes		Tolnaftate	SWAB	TOPICAL	20220127		OTC MONOGRAPH FINAL	part333C	Cosco International, Inc.	TOLNAFTATE	10	g/1000g			N	20241231
52261-8700_5e3516bc-221b-43d7-8ba4-f6a206d7e76d	52261-8700	HUMAN OTC DRUG	Lululemon Selfcare No Nasties Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part333A	Cosco International, Inc.	ALCOHOL	70	L/100L			N	20241231
52268-012_ad292d54-e63b-e6ad-e053-2a95a90a261d	52268-012	HUMAN PRESCRIPTION DRUG	SUPREP Bowel Prep		sodium sulfate, potassium sulfate, magnesium sulfate	SOLUTION, CONCENTRATE	ORAL	20100805		NDA	NDA022372	Braintree Laboratories, Inc.	MAGNESIUM SULFATE, UNSPECIFIED FORM; POTASSIUM SULFATE; SODIUM SULFATE	1.6; 3.13; 17.5	g/mL; g/mL; g/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
52268-100_c3649858-77b7-2295-e053-2995a90a048f	52268-100	HUMAN PRESCRIPTION DRUG	GoLYTELY		Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride	POWDER, FOR SOLUTION	ORAL	19840713		NDA	NDA019011	Braintree Laboratories, Inc.	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/4L; g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
52268-112_ad292d54-e63b-e6ad-e053-2a95a90a261d	52268-112	HUMAN PRESCRIPTION DRUG	SUPREP Bowel Prep		sodium sulfate, potassium sulfate, magnesium sulfate	SOLUTION, CONCENTRATE	ORAL	20100805		NDA	NDA022372	Braintree Laboratories, Inc.	MAGNESIUM SULFATE, UNSPECIFIED FORM; POTASSIUM SULFATE; SODIUM SULFATE	1.2; 2.35; 13.13	g/133.1mL; g/133.1mL; g/133.1mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
52268-201_093f5259-d407-4295-e063-6294a90abb17	52268-201	HUMAN PRESCRIPTION DRUG	SUTAB		sodium sulfate, magnesium sulfate, and potassium chloride	TABLET	ORAL	20201110		NDA	NDA213135	Braintree Laboratories, Inc.	MAGNESIUM SULFATE ANHYDROUS; POTASSIUM CHLORIDE; SODIUM SULFATE	2.7; 2.25; 17.75	g/1; g/1; g/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
52268-302_e190c47f-b1d3-4624-e053-2a95a90a2eba	52268-302	HUMAN PRESCRIPTION DRUG	NuLYTELY		polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride	POWDER, FOR SOLUTION	ORAL	19910422	20240831	NDA	NDA019797	Braintree Laboratories, Inc.	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	420; 1.48; 5.72; 11.2	g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
52268-550_ff5c09e0-dd90-12a1-e053-6294a90ab8a9	52268-550	HUMAN PRESCRIPTION DRUG	SUFLAVE		polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution	KIT		20230615		NDA	NDA215344	Braintree Laboratories, Inc.						N	20241231
52272-001_0eb1b81a-019d-0556-e063-6394a90acd8d	52272-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19830827		NDA	NDA205849	Albright Welding Supply Co., Inc.	OXYGEN	990	mL/L			N	20251231
52276-312_9f614389-7029-4d7c-97cf-5b5af6694589	52276-312	HUMAN PRESCRIPTION DRUG	Carbaglu		Carglumic Acid	TABLET, FOR SUSPENSION	ORAL	20100318		NDA	NDA022562	Recordati Rare Diseases	CARGLUMIC ACID	200	mg/1	Carbamoyl Phosphate Synthetase 1 Activator [EPC], Carbamoyl Phosphate Synthetase 1 Activators [MoA]		N	20241231
52276-400_1f286147-1f5c-4f83-984e-af1298b8712c	52276-400	HUMAN PRESCRIPTION DRUG	Cystadane		betaine	POWDER, FOR SOLUTION	ORAL	19961025		NDA	NDA020576	Recordati Rare Diseases	BETAINE	1	g/g	Methylating Activity [MoA], Methylating Agent [EPC]		N	20241231
52279-001_08048b9f-ec61-cc7e-e063-6394a90a957a	52279-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20021001		NDA	NDA205767	Wesco Gas & Welding Supply, Inc.	OXYGEN	992	mL/L			N	20241231
52279-002_08048b9f-ec60-cc7e-e063-6394a90a957a	52279-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20021001		NDA	NDA205713	Wesco Gas & Welding Supply, Inc.	NITROGEN	990	mL/L			N	20241231
52301-303_efbd615a-660a-549b-e053-2a95a90acac8	52301-303	HUMAN OTC DRUG	Formula 303		Valerian Root, Passiflora, Magnesium Carbonate	TABLET	ORAL	19900919		UNAPPROVED HOMEOPATHIC		Dee Cee Laboratories	MAGNESIUM CARBONATE; PASSIFLORA INCARNATA FLOWER; VALERIAN	1; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
52305-225_0c43cba0-df30-c340-e063-6394a90a778e	52305-225	HUMAN OTC DRUG	United Airlines Clean Plus Clorox		Ethyl Alcohol	LIQUID	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Freshorize LLC	ALCOHOL	62	mL/100mL			N	20241231
52305-601_0c43c36d-43ab-d627-e063-6294a90a8872	52305-601	HUMAN OTC DRUG	United Airlines		Benzalkonium Chloride	LIQUID	TOPICAL	20200629		OTC MONOGRAPH DRUG	505G(a)(3)	Freshorize Ltd	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52305-602_0c56b705-1280-24eb-e063-6294a90ae900	52305-602	HUMAN OTC DRUG	Alaska Airlines		Benzalkonium Chloride	LIQUID	TOPICAL	20200629		OTC MONOGRAPH DRUG	505G(a)(3)	Freshorize Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
52305-802_0c43b516-7609-c826-e063-6294a90ae4e3	52305-802	HUMAN OTC DRUG	Wasted		Benzalkonium Chloride	LIQUID	TOPICAL	20231218		OTC MONOGRAPH DRUG	505G(a)(3)	Freshorize Ltd	BENZALKONIUM CHLORIDE; HYDROGENATED CASTOR OIL	.13; .75	g/100mL; g/100mL			N	20241231
52311-656_fc742d10-f881-7eda-e053-6294a90adbb3	52311-656	HUMAN OTC DRUG	NENA Hand Sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	20200422	20240505	OTC MONOGRAPH NOT FINAL	part333E	Ironwood Clay Company, Inc.	ALCOHOL	72	mL/100mL			N	
52311-676_0322da2e-85a2-2bd7-e063-6294a90abb04	52311-676	HUMAN OTC DRUG	NENA Mineral Sunscreen SPF 30		Zinc Oxide,Titanium Dioxide	CREAM	TOPICAL	20231001		OTC MONOGRAPH FINAL	part352	Ironwood Clay Company, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2.3; 22	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52316-720_0c00b4f6-ff1f-df94-e063-6394a90a96da	52316-720	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20170801		OTC MONOGRAPH DRUG	M007	DSC Laboratories Inc.	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
52316-723_0c0014a8-3f27-2459-e063-6294a90a8647	52316-723	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20120815		OTC MONOGRAPH DRUG	M007	DSC Laboratories Inc.	GLYCERIN	2.1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
52316-724_0c0071e9-7f06-dfdb-e063-6394a90af616	52316-724	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20120815		OTC MONOGRAPH DRUG	M007	DSC Laboratories Inc.	GLYCERIN	1.2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
52316-725_0c00a453-546f-acfb-e063-6294a90a9dd3	52316-725	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20200417		OTC MONOGRAPH DRUG	M007	DSC Laboratories Inc.	GLYCERIN	2.1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
52358-0001_05e353aa-b693-bfbf-e063-6294a90a44fd	52358-0001	HUMAN OTC DRUG	Baby Butz		Zinc Oxide	CREAM	TOPICAL	20130715		OTC MONOGRAPH DRUG	M016	Olen Skin Care Corporation	ZINC OXIDE	17.1	g/57g			N	20241231
52358-0002_05e31db2-ee50-f735-e063-6394a90ae6f0	52358-0002	HUMAN OTC DRUG	SUPRADERM		white petrolatum, lanolin	CREAM	TOPICAL	20141017		OTC MONOGRAPH DRUG	M016	Olen Skin Care Corporation	LANOLIN; PETROLATUM	.15; .3	g/g; g/g			N	20241231
52358-0003_05e32199-f4a3-035e-e063-6394a90a5ee1	52358-0003	HUMAN OTC DRUG	Sunblocz Baby and Kids		Zinc oxide	CREAM	TOPICAL	20160621		OTC MONOGRAPH DRUG	M020	Olen Cosmetics Corporation	ZINC OXIDE	28.9	g/118mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52358-0004_05e37cd7-f0c0-3bde-e063-6294a90a2acf	52358-0004	HUMAN OTC DRUG	Sunblocz		Zinc oxide	CREAM	TOPICAL	20160621		OTC MONOGRAPH DRUG	M020	Olen Cosmetics Corporation	ZINC OXIDE	43.4	g/177mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52374-001_0d787187-bbf3-49c2-9ef0-9064cd6722f6	52374-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19901119		UNAPPROVED MEDICAL GAS		Messer Gas Puerto Rico, Inc	OXYGEN	99	L/100L			N	20241231
52374-002_7500523a-d11a-4284-948b-3746ce6736b1	52374-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19901127		UNAPPROVED MEDICAL GAS		Messer Gas Puerto Rico, Inc	NITROGEN	99	L/100L			N	20241231
52374-003_79e237e2-f41d-4753-a108-4e77f470afa0	52374-003	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Compressed		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19650101		UNAPPROVED MEDICAL GAS		MESSER GAS PUERTO RICO, INC	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
52374-006_e5822450-4557-40e6-bdb9-dce9aa4ab839	52374-006	HUMAN PRESCRIPTION DRUG	Air, Compressed		Nitrogen, Oxygen	GAS	RESPIRATORY (INHALATION)	19891108		NDA	NDA211270	Messer Gas Puerto Rico Inc	OXYGEN	21	L/100L			N	20241231
52374-011_945457bd-296a-477a-a1c0-e66258a580c2	52374-011	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205818	Messer Gas Puerto Rico, Inc	OXYGEN	995	mL/L			N	20241231
52374-016_000e63c6-7540-4fac-9abb-9e11e50a7141	52374-016	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205816	Messer Gas Puerto Rico, Inc	NITROGEN	995	mL/L			N	20241231
52374-101_fd29183d-7fb5-4db4-aab3-81e85e48cea3	52374-101	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19860616		UNAPPROVED MEDICAL GAS		Messer Gas Puerto Rico, Inc	OXYGEN	99	L/100L			N	20241231
52374-102_3982e020-4330-44b1-8795-efd9af4b301f	52374-102	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19860801		UNAPPROVED MEDICAL GAS		Messer Gas Puerto Rico, Inc	NITROGEN	99	L/100L			N	20241231
52374-103_b8e41cf5-2404-49c2-bb38-ef554d36bd1f	52374-103	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19650101		NDA	NDA205815	MESSER GAS PUERTO RICO, INC	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
52380-0001_efe371ad-a36a-29ac-e053-2a95a90a95f9	52380-0001	HUMAN OTC DRUG	Aplicare Povidone-Iodine		POVIDONE-IODINE	SOLUTION	TOPICAL	19840301	20250531	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	
52380-0011_0801932c-8862-35d8-e063-6294a90a67c1	52380-0011	HUMAN OTC DRUG	Aplicare Povidone-Iodine		POVIDONE-IODINE	SOLUTION	TOPICAL	20170531	20260930	OTC MONOGRAPH DRUG	M003	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	
52380-0013_080237a1-7924-ce26-e063-6294a90a9df4	52380-0013	HUMAN OTC DRUG	Aplicare Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	19831201	20260630	OTC MONOGRAPH DRUG	M003	Aplicare Products, LLC	HYDROGEN PEROXIDE	3	mL/100mL			N	
52380-0024_efe34b32-3be4-cf93-e053-2a95a90ab385	52380-0024	HUMAN OTC DRUG	Aplicare Povidone-Iodine Scrub		Povidone-iodine Scrub	SOLUTION	TOPICAL	19920701	20250331	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	
52380-0038_efe32216-7705-52b4-e053-2a95a90a5ac1	52380-0038	HUMAN OTC DRUG	Aplicare Povidone Iodine Swabstick		Povidone Iodine	SOLUTION	TOPICAL	20030601	20240831	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	
52380-0101_efe342f9-9a5c-b9b4-e053-2a95a90a3e00	52380-0101	HUMAN OTC DRUG	Aplicare Povidone-Iodine Paint		Povidone-Iodine	SOLUTION	TOPICAL	19920301	20250731	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	
52380-0126_f4d355cb-89b4-3f40-e053-2a95a90a907e	52380-0126	HUMAN OTC DRUG	Aplicare Povidone-Iodine		Povidone-Iodine	OINTMENT	TOPICAL	20170531	20251231	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/g			N	
52380-0540_efe327ce-23aa-60a6-e053-2a95a90abf12	52380-0540	HUMAN OTC DRUG	Aplicare Antiseptic Hand Rinse		Ethanol	GEL	TOPICAL	20060801	20250731	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	ALCOHOL	.62	mL/mL			N	
52380-1905_0e762160-5dc0-7c4c-e063-6294a90a68fd	52380-1905	HUMAN OTC DRUG	Aplicare Povidone-Iodine		Povidone-Iodine	SOLUTION	TOPICAL	19980901		OTC MONOGRAPH DRUG	505G(a)(3)	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	20251231
52380-2801_0e7601e7-a14e-644a-e063-6394a90a5f80	52380-2801	HUMAN OTC DRUG	Aplicare Povidone-Iodine		Povidone-Iodine	SOLUTION	TOPICAL	19980101		OTC MONOGRAPH DRUG	505G(a)(3)	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	20251231
52380-2802_0e7631de-0d29-6ec3-e063-6394a90ab5d2	52380-2802	HUMAN OTC DRUG	Aplicare Povidone-iodine Scrub		Povidone-iodine	SOLUTION	TOPICAL	19980101		OTC MONOGRAPH DRUG	505G(a)(3)	Aplicare Products, LLC	POVIDONE-IODINE	7.5	mg/mL			N	20251231
52380-3101_f0303c78-e339-4713-e053-2a95a90a733b	52380-3101	HUMAN OTC DRUG	Aplicare Povidone-iodine Triples		Povidone-iodine	SOLUTION	TOPICAL	19980301	20250331	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	
52380-3105_ff499f58-956b-395e-e053-6294a90a7c0d	52380-3105	HUMAN OTC DRUG	Aplicare		isopropyl alcohol	SWAB	TOPICAL	20201001	20260228	OTC MONOGRAPH NOT FINAL	part333E	Aplicare Products, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	
52380-4801_0e762bd1-b6a0-6a45-e063-6394a90a6e3c	52380-4801	HUMAN OTC DRUG	Aplicare Povidone-Iodine		Povidone-Iodine	SOLUTION	TOPICAL	19980101		OTC MONOGRAPH DRUG	505G(a)(3)	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	20251231
52380-4802_0e762bd1-b69e-6a45-e063-6394a90a6e3c	52380-4802	HUMAN OTC DRUG	Aplicare Povidone-iodine Scrub		Povidone-iodine	SOLUTION	TOPICAL	19980101		OTC MONOGRAPH DRUG	505G(a)(3)	Aplicare Products, LLC	POVIDONE-IODINE	7.5	mg/mL			N	20251231
52380-5101_01f27a63-15f8-cee4-e063-6394a90afa3b	52380-5101	HUMAN OTC DRUG	Aplicare Povidone-iodine Triples		Povidone-iodine	SOLUTION	TOPICAL	20170531	20251130	OTC MONOGRAPH NOT FINAL	part333A	Aplicare Products, LLC	POVIDONE-IODINE	10	mg/mL			N	
52389-153_0b4d36c5-f959-77c0-e063-6294a90a1609	52389-153	HUMAN OTC DRUG	BackAid	Max	acetaminophen, pamabrom	TABLET, FILM COATED	ORAL	19920201		OTC MONOGRAPH DRUG	M013	Alva-Amco Pharmacal Companies, Inc.	ACETAMINOPHEN; PAMABROM	500; 25	mg/1; mg/1			N	20241231
52389-155_0b4d743f-316f-999e-e063-6294a90a9402	52389-155	HUMAN OTC DRUG	Diurex	Ultra	Caffeine	TABLET, FILM COATED	ORAL	20050901		OTC MONOGRAPH DRUG	M027	Alva-Amco Pharmacal Companies, Inc.	CAFFEINE	100	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
52389-166_0b4d44ce-1e39-8112-e063-6394a90adf0e	52389-166	HUMAN OTC DRUG	Psoriasin Gel		Coal Tar Topical Gel	GEL	TOPICAL	19960218		OTC MONOGRAPH DRUG	M032	Alva-Amco Pharmacal Companies, Inc.	COAL TAR	12.5	mg/g			N	20241231
52389-173_0b4c9cc5-1d22-3e82-e063-6394a90ab054	52389-173	HUMAN OTC DRUG	Prosacea		Sulphur	GEL	TOPICAL	20060206		UNAPPROVED HOMEOPATHIC		Alva-Amco Pharmacal Companies, Inc.	SULFUR	1	[hp_X]/g			N	20241231
52389-226_0b4ce11d-c0af-0ca7-e063-6294a90acf8c	52389-226	HUMAN OTC DRUG	Fungicure	Anti-Fungal Wash	Sepia	SOAP	TOPICAL	20160307		UNAPPROVED HOMEOPATHIC		Alva-Amco Pharmacal Companies, Inc.	SEPIA OFFICINALIS JUICE	12	[hp_X]/mL			N	20241231
52389-237_0b500fd2-3ed5-ed5a-e063-6294a90a92da	52389-237	HUMAN OTC DRUG	Arthriten	Inflammatory Pain Formula	acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20120723		OTC MONOGRAPH DRUG	M013	Alva-Amco Pharmacal Companies, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
52389-241_0b4d3ef3-c486-a14b-e063-6294a90abadf	52389-241	HUMAN OTC DRUG	Uricalm	Maximum Strength	Phenazopyridine Hydochloride	TABLET, FILM COATED	ORAL	20080429		UNAPPROVED DRUG OTHER		Alva-Amco Pharmacal Companies, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
52389-242_0b4dd7a5-8fb1-f72a-e063-6394a90a88d3	52389-242	HUMAN OTC DRUG	Nauzene		Sodium Citrate	TABLET, CHEWABLE	ORAL	20000708		OTC MONOGRAPH DRUG	M001	Alva-Amco Pharmacal Companies, Inc.	TRISODIUM CITRATE DIHYDRATE	230	mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
52389-249_0b4d8159-e944-7cd4-e063-6394a90a49bc	52389-249	HUMAN OTC DRUG	Diurex	Max	Pamabrom	TABLET, FILM COATED	ORAL	19951220		OTC MONOGRAPH DRUG	M027	Alva-Amco Pharmacal Companies, Inc.	PAMABROM	50	mg/1			N	20241231
52389-298_0b4dada4-49e0-0a1a-e063-6294a90a1bca	52389-298	HUMAN OTC DRUG	Fungicure Anti-Fungal Liquid		Tolnaftate	LIQUID	TOPICAL	20201013		OTC MONOGRAPH DRUG	M005	Alva-Amco Pharmacal Companies, Inc.	TOLNAFTATE	8.65	mg/mL			N	20241231
52389-306_0b4c9520-a065-e718-e063-6294a90a14fd	52389-306	HUMAN OTC DRUG	Diurex	Water Pills	Caffeine, magnesium salicylate	TABLET, COATED	ORAL	20050515		OTC MONOGRAPH DRUG	M027	Alva-Amco Pharmacal Companies, Inc.	CAFFEINE; MAGNESIUM SALICYLATE	50; 162.5	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
52389-325_0b782198-58e6-5343-e063-6294a90a3713	52389-325	HUMAN OTC DRUG	Diurex		Pamabrom	CAPSULE	ORAL	20050401		OTC MONOGRAPH DRUG	M027	Alva-Amco Pharmacal Companies, Inc.	PAMABROM	50	mg/1			N	20241231
52389-337_0b4d5a48-99f7-b88e-e063-6394a90ab5ee	52389-337	HUMAN OTC DRUG	Arthriten	Max	acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20170824		OTC MONOGRAPH DRUG	M013	Alva-Amco Pharmacal Companies, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
52389-406_0b4d2a4d-d9f8-90e4-e063-6394a90aebf6	52389-406	HUMAN OTC DRUG	Diurex Water Pills	XPL	Caffeine	TABLET, FILM COATED	ORAL	20160817		OTC MONOGRAPH DRUG	M027	Alva-Amco Pharmacal Companies, Inc.	CAFFEINE	100	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
52389-600_0b4d3ef3-c482-a14b-e063-6294a90abadf	52389-600	HUMAN OTC DRUG	Fungicure	Intensive	Clotrimazole	LIQUID	TOPICAL	20080605		OTC MONOGRAPH DRUG	M005	Alva-Amco Pharmacal Companies, Inc.	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52389-621_0680717b-ed11-8ff5-e063-6394a90a65a5	52389-621	HUMAN OTC DRUG	Nauzene Homeopathic		Lactic acid, wild hops	LIQUID	ORAL	20140408	20260531	UNAPPROVED HOMEOPATHIC		Alva-Amco Pharmacal Companies, Inc.	BRYONIA ALBA ROOT; LACTIC ACID	3; 3	[hp_X]/15mL; [hp_X]/15mL	Acidifying Activity [MoA]		N	
52389-647_0b7825eb-a352-5197-e063-6294a90a9ffe	52389-647	HUMAN OTC DRUG	Fungicure Manicure Pedicure Liquid Gel		Clotrimazole	GEL	TOPICAL	20160705		OTC MONOGRAPH DRUG	M005	Alva-Amco Pharmacal Companies, Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52389-656_0b4d12ea-a2a4-e71c-e063-6294a90ad894	52389-656	HUMAN OTC DRUG	Diurex	Ultimate	Caffeine	TABLET, FILM COATED	ORAL	20151031		OTC MONOGRAPH DRUG	M027	Alva-Amco Pharmacal Companies, Inc.	CAFFEINE	100	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
52389-666_0b4cc7b6-dca4-579c-e063-6394a90a308b	52389-666	HUMAN OTC DRUG	Fungicure	AF Wash	Sepia	SOAP	TOPICAL	20180301		UNAPPROVED HOMEOPATHIC		Alva-Amco Pharmacal Companies, Inc.	SEPIA OFFICINALIS JUICE	12	[hp_X]/mL			N	20241231
52389-670_0b4d44ce-1e3a-8112-e063-6394a90adf0e	52389-670	HUMAN OTC DRUG	Psoriasin In-Shower	Treatment	Coal Tar	LOTION/SHAMPOO	TOPICAL	20210303		OTC MONOGRAPH DRUG	M032	Alva-Amco Pharmacal Companies, LLC	COAL TAR	20	mg/g			N	20241231
52389-733_0b4d847a-fcd7-df31-e063-6294a90a0c5e	52389-733	HUMAN OTC DRUG	Fungicure Liquid Gel		Clotrimazole	GEL	TOPICAL	20151231		OTC MONOGRAPH DRUG	M005	Alva-Amco Pharmacal Companies, Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52389-752_0b4c97b2-a86a-3787-e063-6394a90a2c93	52389-752	HUMAN OTC DRUG	Psoriasin	Deep Moisturizing	Coal Tar	OINTMENT	TOPICAL	20190621		OTC MONOGRAPH DRUG	M032	Alva-Amco Pharmacal Companies, Inc.	COAL TAR	20	mg/g			N	20241231
52410-1010_0d6f6a5b-4b89-b1e6-e063-6294a90ac7ba	52410-1010	HUMAN OTC DRUG	Novita Pure Petrolatum Jelly		Petrolatum	JELLY	TOPICAL	20161015		OTC MONOGRAPH DRUG	M016	Shield Line LLC	PETROLATUM	100	g/100g			N	20241231
52410-1011_0d6f557f-12d4-dfbb-e063-6394a90a0414	52410-1011	HUMAN OTC DRUG	Novita Petrolatum with Cocoa Butter		Petrolatum	JELLY	TOPICAL	20161012		OTC MONOGRAPH DRUG	M016	Shield line LLC	PETROLATUM	99.9	g/100g			N	20241231
52410-1020_0d6ff81c-2502-2099-e063-6394a90ace34	52410-1020	HUMAN OTC DRUG	Novita Petrolatum Jelly Pink		Petrolatum	JELLY	TOPICAL	20161011		OTC MONOGRAPH DRUG	M016	Shield Line LLC	PETROLATUM	99.9	g/100g			N	20241231
52410-1021_0d6f557f-12d8-dfbb-e063-6394a90a0414	52410-1021	HUMAN OTC DRUG	Novita Baby Petrolatum Jelly		Petrolatum	JELLY	TOPICAL	20161011		OTC MONOGRAPH DRUG	M016	Shield Line LLC	PETROLATUM	99.9	g/100g			N	20241231
52410-1030_0d702fb8-16c4-1891-e063-6394a90a686d	52410-1030	HUMAN OTC DRUG	Aloe Vera Petrolatum Jelly		Petrolatum	JELLY	TOPICAL	20230612		OTC MONOGRAPH DRUG	M016	Shield Line LLC	PETROLATUM	99.35	g/100g			N	20241231
52410-3020_f2163826-6274-703d-e053-2a95a90a63f3	52410-3020	HUMAN OTC DRUG	Medpride		White Petrolatum	OINTMENT	TOPICAL	20130923		OTC MONOGRAPH FINAL	part347	Shield Line LLC	PETROLATUM	100	g/100g			N	20241231
52410-3024_091a2a46-7a7f-ec89-e063-6394a90a4995	52410-3024	HUMAN OTC DRUG	Clotrimazole 1%	Athletes Foot	Clotrimazole	CREAM	TOPICAL	20200304		OTC MONOGRAPH DRUG	M005	Shield Line LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52410-3025_0384f946-af18-1c4f-e063-6394a90a2d96	52410-3025	HUMAN OTC DRUG	Medpride	First Aid	Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate	OINTMENT	TOPICAL	20130517		OTC MONOGRAPH FINAL	part333B	Shield Line LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
52410-3040_091a53f5-293e-e980-e063-6294a90a7063	52410-3040	HUMAN OTC DRUG	Medpride		Zinc Oxide	OINTMENT	TOPICAL	20130523		OTC MONOGRAPH DRUG	M016	Shield Line LLC	ZINC OXIDE	20	g/100g			N	20241231
52410-3045_091a3387-1d4b-f9e7-e063-6394a90adb14	52410-3045	HUMAN OTC DRUG	MedPride	Vitamin A and D	White Petrolatum	OINTMENT	TOPICAL	20130523		OTC MONOGRAPH DRUG	M016	Shield Line LLC	PETROLATUM	76	g/100g			N	20241231
52410-3050_091a53f5-2937-e980-e063-6294a90a7063	52410-3050	HUMAN OTC DRUG	MedPride		Hydrocortisone	CREAM	TOPICAL	20130523		OTC MONOGRAPH DRUG	M017	Shield Line LLC	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52410-4031_01cd6b00-e61a-f9d2-e063-6294a90a172a	52410-4031	HUMAN OTC DRUG	MedPride Medicated Body Powder	Powder	MENTHOL, ZINC OXIDE	POWDER	TOPICAL	20211005		OTC MONOGRAPH NOT FINAL	part348	Shield Line LLC	MENTHOL; ZINC OXIDE	.15; 1	g/100g; g/100g			N	20241231
52410-4091_e6ffd6ea-ef1b-0144-e053-2995a90ac155	52410-4091	HUMAN OTC DRUG	MedPride 91% Rubbing Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20190408		OTC MONOGRAPH NOT FINAL	part333A	Shield Line LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
52410-4096_e6efc2d5-eed0-434f-e053-2a95a90a3c30	52410-4096	HUMAN OTC DRUG	MedPRIDE		Isopropyl Alcohol	LIQUID	TOPICAL	20150201		OTC MONOGRAPH NOT FINAL	part333A	Shield Line LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52410-4105_04b4a39b-e447-8ea2-e063-6294a90a1c43	52410-4105	HUMAN OTC DRUG	MedPride	Alcohol Wipes	Isopropyl Alcohol	CLOTH	TOPICAL	20130527		OTC MONOGRAPH NOT FINAL	part333A	Shield Line LLC	ALCOHOL	.75	g/1			N	20241231
52410-4114_f901c56b-d6a5-a800-e053-6394a90ad2cd	52410-4114	HUMAN OTC DRUG	MedPride Prep Solution	Topical Antiseptic Microbicide	POVIDONE-IODINE	SOLUTION	TOPICAL	20190513		OTC MONOGRAPH NOT FINAL	part333E	Shield Line LLC	POVIDONE-IODINE	100	mg/mL			N	20241231
52410-4115_0a201302-8866-d8d1-e063-6394a90ae26e	52410-4115	HUMAN OTC DRUG	MedPride	PrepPads	Povidone Iodine	SOLUTION	TOPICAL	20181020		OTC MONOGRAPH DRUG	M003	Shield Line LLC	POVIDONE-IODINE	.1	g/1			N	20241231
52410-4116_fdf8f48a-a241-2509-e053-6294a90a433c	52410-4116	HUMAN OTC DRUG	MedPride Povidone Iodine Scrub Solution	Skin Cleanser	POVIDONE-IODINE	SOLUTION	TOPICAL	20190514		OTC MONOGRAPH NOT FINAL	part333E	Shield Line LLC	POVIDONE-IODINE	75	mg/mL			N	20241231
52410-8020_091a2ecd-c046-cf89-e063-6294a90a00ce	52410-8020	HUMAN OTC DRUG	AmeriDerm	PeriShield	ZINC OXIDE	OINTMENT	TOPICAL	20150101		OTC MONOGRAPH DRUG	M016	Shield Line LLC	ZINC OXIDE	3.8	g/100g			N	20241231
52412-100_bf433db9-4fdc-4f84-8d34-3c85ec1465bf	52412-100	HUMAN OTC DRUG	Dormin		Diphenhydramine Hydrochloride	CAPSULE	ORAL	19920101		OTC MONOGRAPH FINAL	part338	Randob Labs,Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
52412-175_fbf8a6f2-531c-5047-e053-6294a90aaa01	52412-175	HUMAN OTC DRUG	ERO Ear Wax Removal Kit		Carbamide Peroxide 6.5%	LIQUID	TOPICAL	20210416		OTC MONOGRAPH FINAL	M014	Randob Labs	CARBAMIDE PEROXIDE	6.5	g/100mL			N	20241231
52412-200_0dae32b1-8bb5-dcf2-e063-6294a90a3637	52412-200	HUMAN OTC DRUG	Sting-Kill		Benzocaine and Menthol	SOLUTION	TOPICAL	19650101		OTC MONOGRAPH DRUG	M017	RANDOB LABS, LTD. DBA CROSSINGWELL CONSUMER HEALTH	BENZOCAINE; MENTHOL	200; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52412-285_f886f501-1199-1e7e-e053-6394a90a20b8	52412-285	HUMAN OTC DRUG	Balmex Diaper Rash		Zinc Oxide 11.3%	CREAM	TOPICAL	20210419		OTC MONOGRAPH FINAL	M016	Randob Labs, LTD	ZINC OXIDE	11.3	g/100g			N	20241231
52412-300_a2ae5bf8-117b-4c44-bb0c-4f1b6dbaf25a	52412-300	HUMAN OTC DRUG	Fire Out		Benzocaine and Menthol	SOLUTION	TOPICAL	20160215		OTC MONOGRAPH NOT FINAL	part348	Randob Ltd.	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	200; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52412-350_d3e63adc-f6ed-4b0e-a677-059bf0be567c	52412-350	HUMAN OTC DRUG	Chiggerex		Benzocaine	CREAM	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part348	Randob Labs,Ltd.	BENZOCAINE	.1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52412-400_18af2fdd-d234-4675-afc6-e0bdd19cdbbd	52412-400	HUMAN OTC DRUG	Balmex Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20150427		OTC MONOGRAPH FINAL	part347	Randob Labs,Ltd.	ZINC OXIDE	.113	g/g			N	20241231
52412-450_8460153a-29a3-4b1e-8e15-c1be1176e97c	52412-450	HUMAN OTC DRUG	BALMEX MULTI-PURPOSE		Petrolatum	OINTMENT	TOPICAL	20150427		OTC MONOGRAPH FINAL	part347	Randob Labs,Ltd.	PETROLATUM	511	mg/g			N	20241231
52412-500_3b905d74-d3d4-4b83-8c32-3a3ead9d23cc	52412-500	HUMAN OTC DRUG	BALMEX ADULT CARE RASH		Zinc Oxide	CREAM	TOPICAL	20150427		OTC MONOGRAPH FINAL	part347	Randob Labs,Ltd.	ZINC OXIDE	.113	g/g			N	20241231
52412-600_0ce5bdec-f500-73d9-e063-6294a90a6a87	52412-600	HUMAN OTC DRUG	Earwax Removal Drops		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20200703		OTC MONOGRAPH DRUG	M014	Randob Labs, Ltd.	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
52412-775_0412afd6-c575-44ec-b40b-a1da2bffb5e2	52412-775	HUMAN OTC DRUG	ZINC-OXYDE PLUS		Zinc Oxide and Ferric Oxide Red	CREAM	TOPICAL	20220330		OTC MONOGRAPH FINAL	part347	Randob Labs,Ltd. DBA Crossingwell Consumer Health	FERRIC OXIDE RED; ZINC OXIDE	.02; .206	g/g; g/g			N	20241231
52412-901_9bcb7e0c-ae59-41d8-b755-d6991fd0a690	52412-901	HUMAN OTC DRUG	Pediacare Childrens Grape		Acetaminophen	SUSPENSION	ORAL	20230103		OTC MONOGRAPH NOT FINAL	part343	RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH	ACETAMINOPHEN	160	mg/5mL			N	20241231
52412-906_007e4eee-3603-46fc-b7fd-978f06805d06	52412-906	HUMAN OTC DRUG	Pediacare Childrens Acetaminophen Grape		Acetaminophen	SUSPENSION	ORAL	20230103		OTC MONOGRAPH NOT FINAL	part343	RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH	ACETAMINOPHEN	160	mg/5mL			N	20241231
52412-910_3cd2cd8d-d5cd-4eaf-9e60-980a7f62a3b8	52412-910	HUMAN OTC DRUG	Pediacare Childrens Ibuprofen Berry		IBUPROFEN	SUSPENSION	ORAL	20230103		ANDA	ANDA210602	RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52412-911_50d6bf9d-ae37-4af3-bfeb-cc0abf8cb094	52412-911	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20230715		ANDA	ANDA209179	Randob Labs., Ltd.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52412-912_e069060f-fbb2-4c7a-b872-00b3ab86d01b	52412-912	HUMAN OTC DRUG	Fast Acting	Pedia Crae	ACETAMINOPHEN	SUSPENSION	ORAL	20230526		OTC MONOGRAPH NOT FINAL	part343	Randob Labs., Ltd.	ACETAMINOPHEN	160	mg/5mL			N	20241231
52412-920_9a2fbb26-f9f6-4eea-bbc2-a37a586ecb69	52412-920	HUMAN OTC DRUG	Pediacare Childrens Cough and Cold Grape		BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	SYRUP	ORAL	20230103		OTC MONOGRAPH FINAL	part341	RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52412-992_caf8e909-90c3-4c17-aebd-6430d23ef53f	52412-992	HUMAN OTC DRUG	Pediacare Childrens Cough and Congestion Grape		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	SYRUP	ORAL	20230103		OTC MONOGRAPH FINAL	part341	RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
52427-272_6d3b144d-6f51-f276-548b-c44c0154924c	52427-272	HUMAN PRESCRIPTION DRUG	Naprelan		Naproxen Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140117		NDA	NDA020353	ALMATICA PHARMA INC.	NAPROXEN SODIUM	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52427-273_6d3b144d-6f51-f276-548b-c44c0154924c	52427-273	HUMAN PRESCRIPTION DRUG	Naprelan		Naproxen Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140117		NDA	NDA020353	ALMATICA PHARMA INC.	NAPROXEN SODIUM	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52427-274_6d3b144d-6f51-f276-548b-c44c0154924c	52427-274	HUMAN PRESCRIPTION DRUG	Naprelan		Naproxen Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140117		NDA	NDA020353	ALMATICA PHARMA INC.	NAPROXEN SODIUM	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52427-285_9f875682-a45c-def8-adee-59297393a5ac	52427-285	HUMAN PRESCRIPTION DRUG	Macrobid		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110531		NDA	NDA020064	Almatica Pharma LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
52427-286_f96e496b-3557-f5ff-83ef-a3805d766ea6	52427-286	HUMAN PRESCRIPTION DRUG	Macrodantin		Nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Almatica Pharma LLC	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
52427-287_f96e496b-3557-f5ff-83ef-a3805d766ea6	52427-287	HUMAN PRESCRIPTION DRUG	Macrodantin		Nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Almatica Pharma LLC	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
52427-288_f96e496b-3557-f5ff-83ef-a3805d766ea6	52427-288	HUMAN PRESCRIPTION DRUG	Macrodantin		Nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Almatica Pharma LLC	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
52427-382_f0c3e816-8357-cc71-fa60-5fe4e71c5a57	52427-382	HUMAN PRESCRIPTION DRUG	TENORETIC		Atenolol and Chlorthalidone	TABLET	ORAL	20150421		NDA	NDA018760	Almatica Pharma LLC	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
52427-383_f0c3e816-8357-cc71-fa60-5fe4e71c5a57	52427-383	HUMAN PRESCRIPTION DRUG	TENORETIC		Atenolol and Chlorthalidone	TABLET	ORAL	20150421		NDA	NDA018760	Almatica Pharma LLC	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
52427-429_80751505-9468-f8bc-7fe2-2ee38a78473d	52427-429	HUMAN PRESCRIPTION DRUG	TENORMIN		Atenolol	TABLET	ORAL	20150415		NDA	NDA018240	Almatica Pharma LLC	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52427-430_80751505-9468-f8bc-7fe2-2ee38a78473d	52427-430	HUMAN PRESCRIPTION DRUG	TENORMIN		Atenolol	TABLET	ORAL	20150415		NDA	NDA018240	Almatica Pharma LLC	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52427-431_80751505-9468-f8bc-7fe2-2ee38a78473d	52427-431	HUMAN PRESCRIPTION DRUG	TENORMIN		Atenolol	TABLET	ORAL	20150415		NDA	NDA018240	Almatica Pharma LLC	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52427-435_08d4f62f-fa28-6afc-d4bf-311386d4ad35	52427-435	HUMAN PRESCRIPTION DRUG	Zestoretic		lisinopril and hydrochlorothiazide	TABLET	ORAL	20150415		NDA	NDA019888	Almatica Pharma Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
52427-436_08d4f62f-fa28-6afc-d4bf-311386d4ad35	52427-436	HUMAN PRESCRIPTION DRUG	Zestoretic		lisinopril and hydrochlorothiazide	TABLET	ORAL	20150415		NDA	NDA019888	Almatica Pharma Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
52427-437_08d4f62f-fa28-6afc-d4bf-311386d4ad35	52427-437	HUMAN PRESCRIPTION DRUG	Zestoretic		lisinopril and hydrochlorothiazide	TABLET	ORAL	20150415		NDA	NDA019888	Almatica Pharma Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
52427-438_1de3a979-aea3-4676-bb01-7f8a4de140f2	52427-438	HUMAN PRESCRIPTION DRUG	Zestril		Lisinopril	TABLET	ORAL	20150407		NDA	NDA019777	Almatica Pharma LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
52427-439_1de3a979-aea3-4676-bb01-7f8a4de140f2	52427-439	HUMAN PRESCRIPTION DRUG	Zestril		Lisinopril	TABLET	ORAL	20150407		NDA	NDA019777	Almatica Pharma LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
52427-440_1de3a979-aea3-4676-bb01-7f8a4de140f2	52427-440	HUMAN PRESCRIPTION DRUG	Zestril		Lisinopril	TABLET	ORAL	20150407		NDA	NDA019777	Almatica Pharma LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
52427-441_1de3a979-aea3-4676-bb01-7f8a4de140f2	52427-441	HUMAN PRESCRIPTION DRUG	Zestril		Lisinopril	TABLET	ORAL	20150407		NDA	NDA019777	Almatica Pharma LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
52427-442_1de3a979-aea3-4676-bb01-7f8a4de140f2	52427-442	HUMAN PRESCRIPTION DRUG	Zestril		Lisinopril	TABLET	ORAL	20150407		NDA	NDA019777	Almatica Pharma LLC	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
52427-443_1de3a979-aea3-4676-bb01-7f8a4de140f2	52427-443	HUMAN PRESCRIPTION DRUG	Zestril		Lisinopril	TABLET	ORAL	20150407		NDA	NDA019777	Almatica Pharma LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
52427-575_c32284bb-ebd9-86a7-d213-0386fbbc565a	52427-575	HUMAN PRESCRIPTION DRUG	Forfivo	XL	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		NDA	NDA022497	Almatica Pharma Inc.	BUPROPION HYDROCHLORIDE	450	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
52427-576_d82d2525-f0ab-b5aa-ae31-3b35d1587c6e	52427-576	HUMAN PRESCRIPTION DRUG	Fluoxetine HCl		Fluoxetine HCl	TABLET, FILM COATED	ORAL	20170901		NDA	NDA202133	Almatica Pharma Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
52427-632_7795ca2e-89b3-9096-28bf-9d4f544a5f22	52427-632	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220630		NDA	NDA215429	Almatica Pharma LLC	VENLAFAXINE BESYLATE MONOHYDRATE	112.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
52427-658_f57da925-46cd-fc83-7cd1-f6f508849740	52427-658	HUMAN PRESCRIPTION DRUG	LOREEV XR		lorazepam	CAPSULE, EXTENDED RELEASE	ORAL	20210831		NDA	NDA214826	Almatica Pharma LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
52427-661_f57da925-46cd-fc83-7cd1-f6f508849740	52427-661	HUMAN PRESCRIPTION DRUG	LOREEV XR		lorazepam	CAPSULE, EXTENDED RELEASE	ORAL	20220301		NDA	NDA214826	Almatica Pharma LLC	LORAZEPAM	1.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
52427-663_f57da925-46cd-fc83-7cd1-f6f508849740	52427-663	HUMAN PRESCRIPTION DRUG	LOREEV XR		lorazepam	CAPSULE, EXTENDED RELEASE	ORAL	20210831		NDA	NDA214826	Almatica Pharma LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
52427-664_90d1fd01-81aa-b50c-ca0d-3742c73cc9e7	52427-664	HUMAN PRESCRIPTION DRUG	sertraline HCl		sertraline hydrochloride	CAPSULE	ORAL	20211004		NDA	NDA215133	Almatica Pharma LLC	SERTRALINE HYDROCHLORIDE	150	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
52427-667_f57da925-46cd-fc83-7cd1-f6f508849740	52427-667	HUMAN PRESCRIPTION DRUG	LOREEV XR		lorazepam	CAPSULE, EXTENDED RELEASE	ORAL	20210831		NDA	NDA214826	Almatica Pharma LLC	LORAZEPAM	3	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
52427-672_90d1fd01-81aa-b50c-ca0d-3742c73cc9e7	52427-672	HUMAN PRESCRIPTION DRUG	sertraline HCl		sertraline hydrochloride	CAPSULE	ORAL	20211004		NDA	NDA215133	Almatica Pharma LLC	SERTRALINE HYDROCHLORIDE	200	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
52427-691_c5090df0-eaa2-e110-fa83-3f773dc232a4	52427-691	HUMAN PRESCRIPTION DRUG	citalopram		citalopram	CAPSULE	ORAL	20220131		NDA	NDA215428	Almatica Pharma LLC	CITALOPRAM HYDROBROMIDE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
52427-775_115cca5b-24af-8014-9bb3-2bb04401e3e1	52427-775	HUMAN PRESCRIPTION DRUG	zolpidem tartrate		zolpidem tartrate	CAPSULE	ORAL	20230509		NDA	NDA215721	Almatica Pharma LLC	ZOLPIDEM TARTRATE	7.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
52427-800_08339349-877e-5342-c14a-6ebb83f3f063	52427-800	HUMAN PRESCRIPTION DRUG	Comtan		entacapone	TABLET, FILM COATED	ORAL	20201005		NDA	NDA020796	Almatica Pharma LLC	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
52427-803_7881acf0-5f3c-861a-ca44-b82bd0323dd7	52427-803	HUMAN PRESCRIPTION DRUG	Gralise		gabapentin	TABLET, FILM COATED	ORAL	20201001		NDA	NDA022544	Almatica Pharma LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
52427-804_7881acf0-5f3c-861a-ca44-b82bd0323dd7	52427-804	HUMAN PRESCRIPTION DRUG	Gralise		gabapentin	TABLET, FILM COATED	ORAL	20230420		NDA	NDA022544	Almatica Pharma LLC	GABAPENTIN	450	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
52427-805_3fb120cb-9592-2622-1136-949cddf4edca	52427-805	HUMAN PRESCRIPTION DRUG	Stalevo		carbidopa, levodopa, and entacapone	TABLET, FILM COATED	ORAL	20201005		NDA	NDA021485	Almatica Pharma LLC	CARBIDOPA; ENTACAPONE; LEVODOPA	12.5; 200; 50	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
52427-806_7881acf0-5f3c-861a-ca44-b82bd0323dd7	52427-806	HUMAN PRESCRIPTION DRUG	Gralise		gabapentin	TABLET, FILM COATED	ORAL	20201001		NDA	NDA022544	Almatica Pharma LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
52427-809_3fb120cb-9592-2622-1136-949cddf4edca	52427-809	HUMAN PRESCRIPTION DRUG	Stalevo		carbidopa, levodopa, and entacapone	TABLET, FILM COATED	ORAL	20201005		NDA	NDA021485	Almatica Pharma LLC	CARBIDOPA; ENTACAPONE; LEVODOPA	18.75; 200; 75	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
52427-815_7881acf0-5f3c-861a-ca44-b82bd0323dd7	52427-815	HUMAN PRESCRIPTION DRUG	Gralise		gabapentin	KIT		20201001	20240801	NDA	NDA022544	Almatica Pharma LLC						N	
52427-816_3fb120cb-9592-2622-1136-949cddf4edca	52427-816	HUMAN PRESCRIPTION DRUG	Stalevo		carbidopa, levodopa, and entacapone	TABLET, FILM COATED	ORAL	20201005		NDA	NDA021485	Almatica Pharma LLC	CARBIDOPA; ENTACAPONE; LEVODOPA	25; 200; 100	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
52427-827_3fb120cb-9592-2622-1136-949cddf4edca	52427-827	HUMAN PRESCRIPTION DRUG	Stalevo		carbidopa, levodopa, and entacapone	TABLET, FILM COATED	ORAL	20201005		NDA	NDA021485	Almatica Pharma LLC	CARBIDOPA; ENTACAPONE; LEVODOPA	31.25; 200; 125	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
52427-834_3fb120cb-9592-2622-1136-949cddf4edca	52427-834	HUMAN PRESCRIPTION DRUG	Stalevo		carbidopa, levodopa, and entacapone	TABLET, FILM COATED	ORAL	20201005		NDA	NDA021485	Almatica Pharma LLC	CARBIDOPA; ENTACAPONE; LEVODOPA	37.5; 200; 150	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
52427-842_3fb120cb-9592-2622-1136-949cddf4edca	52427-842	HUMAN PRESCRIPTION DRUG	Stalevo		carbidopa, levodopa, and entacapone	TABLET, FILM COATED	ORAL	20201005		NDA	NDA021485	Almatica Pharma LLC	CARBIDOPA; ENTACAPONE; LEVODOPA	50; 200; 200	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
52427-850_7881acf0-5f3c-861a-ca44-b82bd0323dd7	52427-850	HUMAN PRESCRIPTION DRUG	Gralise		gabapentin	TABLET, FILM COATED	ORAL	20230420		NDA	NDA022544	Almatica Pharma LLC	GABAPENTIN	750	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
52427-890_7881acf0-5f3c-861a-ca44-b82bd0323dd7	52427-890	HUMAN PRESCRIPTION DRUG	Gralise		gabapentin	TABLET, FILM COATED	ORAL	20230420		NDA	NDA022544	Almatica Pharma LLC	GABAPENTIN	900	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
52438-011_5be92c40-9330-4331-83d1-bfd0539b79ee	52438-011	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205767	Messer LLC	OXYGEN	995	mL/L			N	20241231
52438-014_d39a2982-fef7-4fbd-bb0a-c4ef89794891	52438-014	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Refrigerated		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19650101		NDA	NDA205764	Messer LLC	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
52438-016_bfe47957-790d-429e-8f4d-24ef2be93e60	52438-016	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205766	Messer LLC	NITROGEN	995	mL/L			N	20241231
52454-001_ff3b8c57-c65e-7c3f-e053-6394a90a937e	52454-001	HUMAN OTC DRUG	Fonow		Bacitracin, Neomycin, Polymyxin B, Lidocaine HCL	OINTMENT	TOPICAL	20180101		OTC MONOGRAPH FINAL	part333B	Zhejiang Fonow Medicine Co., Ltd.	BACITRACIN; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	500; 40; 3.5; 5000	[iU]/g; mg/g; mg/g; [iU]/g	Amide Local Anesthetic [EPC], Amides [CS], Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Antiarrhythmic [EPC], Decreased Cell Wall Synthesis & Repair [PE], Local Anesthesia [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
52456-022_09c77795-2e5f-22c2-e063-6294a90afc96	52456-022	HUMAN OTC DRUG	Rodial Broad Spectrum SPF 50 Drops Anti-Blue Light and Pollution		OCTOCRYLENE, OCTINOXATE, OXYBENZONE, OCTISALATE, AVOBENZONE	LOTION	TOPICAL	20210720		OTC MONOGRAPH DRUG	M020	Rodial Ltd.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 75; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
52456-025_0e892178-1620-bfab-e063-6294a90a6b48	52456-025	HUMAN OTC DRUG	Dragons Blood SPF15		OCTINOXATE, HOMOSALATE, OXYBENZONE	CREAM	TOPICAL	20230401		OTC MONOGRAPH DRUG	M020	Rodial	HOMOSALATE; OCTINOXATE; OXYBENZONE	30; 60; 30	mg/mL; mg/mL; mg/mL			N	20251231
52481-2481_ad236b36-ffdc-4059-80fe-63b48e9968da	52481-2481	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19770101		UNAPPROVED MEDICAL GAS		Genesis Respiratory Services	OXYGEN	99.9	L/100L			N	20241231
52486-051_f690d3b5-496b-fc58-e053-2a95a90aa2c9	52486-051	HUMAN OTC DRUG	isopropyl alcohol swab		PARA-AID STERILE ALCOHOL PREP PADS	SWAB	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	Mcure Health Solutions Inc.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
52486-610_f783f111-3a6b-0c11-e053-6294a90af789	52486-610	HUMAN OTC DRUG	BZK Antiseptic Towelette		benzalkonium chloride	CLOTH	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	MCURE HEALTH SOLUTIONS INC.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
52489-001_0a9272c2-5368-0ea9-e063-6394a90aa09b	52489-001	HUMAN OTC DRUG	Sweet Carefor Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Imperial Palace Commodity(shenzhen)CO.,LTD	ALCOHOL	75	mL/100mL			N	20241231
52489-002_0a925aef-f544-06e5-e063-6394a90af326	52489-002	HUMAN OTC DRUG	Antibacterial Wipes		Benzalkonium chloride	CLOTH	TOPICAL	20200527		OTC MONOGRAPH DRUG	505G(a)(3)	Imperial Palace Commodity (shenzhen) Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52489-003_0a9272c2-5369-0ea9-e063-6394a90aa09b	52489-003	HUMAN OTC DRUG	Antibacterial LotionTissue		Benzalkonium chloride	CLOTH	TOPICAL	20210129		OTC MONOGRAPH DRUG	505G(a)(3)	Imperial Palace Commodity (shenzhen) Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52494-100_6c0bc222-9b01-4eb6-90e8-cdcac1e06e78	52494-100	HUMAN OTC DRUG	Method Men Face with Zinc Oxide Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210110		OTC MONOGRAPH NOT FINAL	part352	Method Products Inc.	ZINC OXIDE	6	g/100mL			N	20241231
52503-1322_d06cb8b2-b26e-95ad-e053-2995a90aa3b0	52503-1322	HUMAN OTC DRUG	PASSIFLORA PLEX		Passiflora incarnata, Ignatia amara, Jalapa, Coffea cruda, Magnesium metalicum, Palladium metallicum, Tellurium metallicum, Phosphoricum acidum	LIQUID	SUBLINGUAL	20150209		UNAPPROVED DRUG OTHER		SanUp	ARABICA COFFEE BEAN; IPOMOEA PURGA ROOT; MAGNESIUM; PALLADIUM; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORIC ACID; STRYCHNOS IGNATII SEED; TELLURIUM	10; 8; 10; 10; 3; 14; 8; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
52524-0000_09ab1e3b-6d33-f7ca-e063-6294a90a0b7d	52524-0000	HUMAN OTC DRUG	Extra Strength Taminol Acetaminophen		ACETAMINOPHEN	TABLET	ORAL	20231218		OTC MONOGRAPH DRUG	M013	VIVA PHARMACEUTICAL INC	ACETAMINOPHEN	500	mg/1			N	20241231
52536-006_13386839-9eb4-4956-a788-d94a7b63cb77	52536-006	HUMAN PRESCRIPTION DRUG	isosorbide dinitrate and hydralazine hydrochloride		hydralazine hydrochloride and isosorbide dinitrate	TABLET, FILM COATED	ORAL	20220415		NDA AUTHORIZED GENERIC	NDA020727	Wilshire Pharmaceuticals	HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE	37.5; 20	mg/1; mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC], Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
52536-057_4f799c39-3aea-40d8-9d9e-bc89643953e2	52536-057	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20180329		ANDA	ANDA200166	Wilshire Pharmaceuticals	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
52536-059_4f799c39-3aea-40d8-9d9e-bc89643953e2	52536-059	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20180329		ANDA	ANDA200166	Wilshire Pharmaceuticals	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
52536-103_f9275e3a-b44f-4839-989c-ee88d44eef46	52536-103	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20180315		ANDA	ANDA061621	Wilshire Pharmaceuticals	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-104_69c31e9c-689f-4332-949c-c67eec27f018	52536-104	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride for Oral Solution		vancomycin hydrochloride	KIT		20230331		NDA AUTHORIZED GENERIC	NDA208910	Wilshire Pharmaceuticals, Inc.						N	20241231
52536-105_f9275e3a-b44f-4839-989c-ee88d44eef46	52536-105	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20180315		ANDA	ANDA061621	Wilshire Pharmaceuticals	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-106_69c31e9c-689f-4332-949c-c67eec27f018	52536-106	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride for Oral Solution		vancomycin hydrochloride	KIT		20230331		NDA AUTHORIZED GENERIC	NDA208910	Wilshire Pharmaceuticals, Inc.						N	20241231
52536-107_69c31e9c-689f-4332-949c-c67eec27f018	52536-107	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride for Oral Solution		vancomycin hydrochloride	KIT		20230331		NDA AUTHORIZED GENERIC	NDA208910	Wilshire Pharmaceuticals, Inc.						N	20241231
52536-108_69c31e9c-689f-4332-949c-c67eec27f018	52536-108	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride for Oral Solution		vancomycin hydrochloride	KIT		20230331		NDA AUTHORIZED GENERIC	NDA208910	Wilshire Pharmaceuticals, Inc.						N	20241231
52536-129_c00045b2-67b8-4f8a-a1de-f76137acfc3d	52536-129	HUMAN PRESCRIPTION DRUG	Meclizine hydrochloride		Meclizine hydrochloride	TABLET	ORAL	20190415		ANDA	ANDA205136	Wilshire Pharmaceuticals Inc	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
52536-130_240e9111-2531-403a-bbd3-161d87185b1e	52536-130	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN ETHYLSUCCINATE		Erythromycin Ethylsuccinate	SUSPENSION	ORAL	20190325		NDA	NDA050207	Wilshire Pharmaceuticals	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-132_240e9111-2531-403a-bbd3-161d87185b1e	52536-132	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN ETHYLSUCCINATE		Erythromycin Ethylsuccinate	SUSPENSION	ORAL	20200824		NDA	NDA050207	Wilshire Pharmaceuticals	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-133_c00045b2-67b8-4f8a-a1de-f76137acfc3d	52536-133	HUMAN PRESCRIPTION DRUG	Meclizine hydrochloride		Meclizine hydrochloride	TABLET	ORAL	20190415		ANDA	ANDA205136	Wilshire Pharmaceuticals Inc	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
52536-134_98a85646-cc9b-429f-9b46-4a3ce1b5c129	52536-134	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20160928		NDA	NDA050207	Wilshire Pharmaceuticals Inc.	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-136_98a85646-cc9b-429f-9b46-4a3ce1b5c129	52536-136	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20160928		NDA	NDA050207	Wilshire Pharmaceuticals Inc.	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-137_c00045b2-67b8-4f8a-a1de-f76137acfc3d	52536-137	HUMAN PRESCRIPTION DRUG	Meclizine hydrochloride		Meclizine hydrochloride	TABLET	ORAL	20190415		ANDA	ANDA205136	Wilshire Pharmaceuticals Inc	MECLIZINE HYDROCHLORIDE	50	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
52536-162_a59a035c-0de4-4857-8c9e-6a206d34e85f	52536-162	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20180206		ANDA	ANDA205973	Wilshire Pharmaceuticals, Inc.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
52536-164_a59a035c-0de4-4857-8c9e-6a206d34e85f	52536-164	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20180206		ANDA	ANDA205973	Wilshire Pharmaceuticals, Inc.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
52536-168_a59a035c-0de4-4857-8c9e-6a206d34e85f	52536-168	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20180206		ANDA	ANDA205973	Wilshire Pharmaceuticals, Inc.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
52536-170_a59a035c-0de4-4857-8c9e-6a206d34e85f	52536-170	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20180206		ANDA	ANDA205973	Wilshire Pharmaceuticals, Inc.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
52536-180_51e95182-425a-4775-adfd-7ab014fb31b8	52536-180	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20190722		ANDA	ANDA062298	Wilshire Pharmaceuticals	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-183_51e95182-425a-4775-adfd-7ab014fb31b8	52536-183	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20190722		ANDA	ANDA062298	Wilshire Pharmaceuticals	ERYTHROMYCIN	333	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-186_51e95182-425a-4775-adfd-7ab014fb31b8	52536-186	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20190722		ANDA	ANDA062298	Wilshire Pharmaceuticals	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
52536-500_93b2aed7-a87a-4a21-82fd-81858fba2d3c	52536-500	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20120716		ANDA	ANDA090533	Wilshire Pharmaceuticals, Inc.	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
52536-510_93b2aed7-a87a-4a21-82fd-81858fba2d3c	52536-510	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20120720		ANDA	ANDA090533	Wilshire Pharmaceuticals, Inc.	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
52536-515_93b2aed7-a87a-4a21-82fd-81858fba2d3c	52536-515	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20210806		ANDA	ANDA090533	Wilshire Pharmaceuticals, Inc.	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
52536-520_93b2aed7-a87a-4a21-82fd-81858fba2d3c	52536-520	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20210806		ANDA	ANDA090533	Wilshire Pharmaceuticals, Inc.	DEXTROAMPHETAMINE SULFATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
52536-530_93b2aed7-a87a-4a21-82fd-81858fba2d3c	52536-530	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20210806		ANDA	ANDA090533	Wilshire Pharmaceuticals, Inc.	DEXTROAMPHETAMINE SULFATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
52536-600_4585aafe-0af8-4786-a419-6a7e76671ca2	52536-600	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	SUSPENSION	ORAL	20230401		NDA AUTHORIZED GENERIC	NDA215602	Wilshire Pharmaceuticals, Inc.	BACLOFEN	5	mg/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
52536-625_2023970d-d229-449a-8e5a-282d4073c846	52536-625	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		testosterone cypionate	INJECTION	INTRAMUSCULAR	20190531		ANDA	ANDA206368	Wilshire Pharmaceuticals	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
52536-682_cb54b880-5c9c-4f70-9580-f19bad2d2238	52536-682	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20170215		ANDA	ANDA205126	Wilshire Pharmaceuticals, Inc.	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
52536-688_cb54b880-5c9c-4f70-9580-f19bad2d2238	52536-688	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20170215		ANDA	ANDA205126	Wilshire Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
52544-064_a3a41d01-59e7-4ac1-a3f4-8a934d4a71a4	52544-064	HUMAN PRESCRIPTION DRUG	Layolis Fe		norethindrone, ethinyl estradiol, and ferrous fumarate	KIT	ORAL	20111223		NDA AUTHORIZED GENERIC	NDA022573	Actavis Pharma, Inc.						N	20241231
52544-080_120dced9-0659-4b61-bec7-d4ac87499a5b	52544-080	HUMAN PRESCRIPTION DRUG	Fioricet		Butalbital, Acetaminophen, and Caffeine	CAPSULE	ORAL	20130729		ANDA	ANDA040885	Actavis Pharma, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
52544-082_a5f64dd1-2aea-41fb-8d5a-eda9fac7aa5d	52544-082	HUMAN PRESCRIPTION DRUG	Fioricet with Codeine		Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate	CAPSULE	ORAL	20130729		ANDA	ANDA076560	Actavis Pharma, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	300; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
52544-295_ed1b659f-b9be-4ce6-8751-8e5e26a8f195	52544-295	HUMAN PRESCRIPTION DRUG	Amethyst		Levonorgestrel and Ethinyl Estradiol	TABLET	ORAL	20110613	20240731	ANDA	ANDA079218	Actavis Pharma, Inc.	ETHINYL ESTRADIOL; LEVONORGESTREL	20; 90	ug/1; ug/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	
52544-629_d98a1fdf-3727-41aa-9974-9a7680441740	52544-629	HUMAN PRESCRIPTION DRUG	Nora BE		Norethindrone	TABLET	ORAL	20050512	20260630	NDA AUTHORIZED GENERIC	NDA017060	Actavis Pharma, Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	
52544-691_69b750fd-ab07-4051-891d-d091e5edbbc2	52544-691	HUMAN PRESCRIPTION DRUG	Matzim LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110328		ANDA	ANDA077686	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
52544-692_69b750fd-ab07-4051-891d-d091e5edbbc2	52544-692	HUMAN PRESCRIPTION DRUG	Matzim LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110328		ANDA	ANDA077686	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
52544-693_69b750fd-ab07-4051-891d-d091e5edbbc2	52544-693	HUMAN PRESCRIPTION DRUG	Matzim LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110328		ANDA	ANDA077686	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
52544-694_69b750fd-ab07-4051-891d-d091e5edbbc2	52544-694	HUMAN PRESCRIPTION DRUG	Matzim LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110328		ANDA	ANDA077686	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
52544-695_69b750fd-ab07-4051-891d-d091e5edbbc2	52544-695	HUMAN PRESCRIPTION DRUG	Matzim LA		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110328		ANDA	ANDA077686	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
52554-9050_0d99237c-0b57-0af6-e063-6394a90aba14	52554-9050	HUMAN OTC DRUG	Cell Fusion C Laser Sunscreen Broad Spectrum SPF 50		Homosalate, Octisalate, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20231228		OTC MONOGRAPH DRUG	M020	CMS LAB Inc.	HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	7.5; 4.5; 2.2; 12.7	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
52568-001_66fc9802-91c6-4cc7-a3aa-2de8ed27df49	52568-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205889	Crumpton Welding Supply & Equipment, Inc.	OXYGEN	99	L/100L			N	20241231
52568-002_21093dc2-701d-4f0a-b396-d0cdc957720b	52568-002	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA209989	Crumpton Welding Supply & Equipment, Inc.	NITROUS OXIDE	99	L/100L			N	20241231
52568-006_a074e1e5-6c06-4aa3-bb6d-903927b3fcb5	52568-006	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205891	Crumpton Welding Supply & Equipment, Inc.	NITROGEN	99	L/100L			N	20241231
52568-007_2e61425c-f7fa-47f5-8fd0-ba2ea9a7ecd6	52568-007	HUMAN PRESCRIPTION DRUG	AIR COMPRESSED		AIR COMPRESSED	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205889	Crumpton Welding Supply & Equipment, Inc.	OXYGEN	20	L/100L			N	20241231
52584-026_1fd6a517-f601-4d28-be4f-b3b2f08403ec	52584-026	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20111005	20240331	ANDA	ANDA078076	General Injectables & Vaccines, Inc	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	
52584-030_c4a983d0-f641-4195-996b-5d3e5bd4f93f	52584-030	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	20120612	20240229	ANDA	ANDA086283	General Injectables & Vaccines, Inc	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
52584-034_1b815c1a-b0df-46ac-bcee-345b6abb970d	52584-034	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	20120530	20240229	ANDA	ANDA086283	General Injectables & Vaccines, Inc	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
52584-035_5b6c3a57-86e4-4265-b929-d73ab679e3f8	52584-035	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		lidocaine hydrochloride	JELLY	TOPICAL	20120828	20240131	ANDA	ANDA086283	General Injectables & Vaccines, Inc	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
52584-037_705c4709-580e-4f02-8a74-bc9aa0641fe2	52584-037	HUMAN PRESCRIPTION DRUG	KETALAR		ketamine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20121017	20250228	NDA	NDA016812	General Injectables & Vaccines, Inc	KETAMINE HYDROCHLORIDE	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	
52584-047_4d4aba77-9fee-4fd9-9f8d-7dc40160122d	52584-047	HUMAN PRESCRIPTION DRUG	Solu-Medrol		Methylprednisolone Sodium Succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100401	20240831	NDA	NDA011856	General Injectables & Vaccines, Inc	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
52584-059_6b7741e7-bbb2-4d29-bd74-f2f4d93f058a	52584-059	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180305	20241031	ANDA	ANDA075243	General Injectables and Vaccines, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
52584-064_a6f0e0ef-c943-4a05-be31-8fa81d394162	52584-064	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150916	20240331	NDA	NDA019316	General Injectables and Vaccines, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
52584-078_362f4f7d-94de-488a-bd55-339812f1f107	52584-078	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180703	20240430	ANDA	ANDA083312	General Injectables and Vaccines, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	
52584-079_5ea85bf9-54d3-4aae-b85a-8668e52e170e	52584-079	HUMAN PRESCRIPTION DRUG	STERILE WATER		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180703	20241001	NDA	NDA018801	General Injectables and Vaccines, Inc.	WATER	1	mL/mL			N	
52584-086_dc1d131d-b3e7-4759-b61b-fd18765201d4	52584-086	HUMAN PRESCRIPTION DRUG	INFED		iron dextran	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190121	20250131	NDA	NDA017441	General Injectables & Vaccines, Inc.	IRON DEXTRAN	50	mg/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
52584-087_3104e1a1-525e-4f0b-b406-39c633f5b795	52584-087	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190506	20240331	ANDA	ANDA203661	General Injectables & Vaccines, Inc.	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
52584-089_83fa1c4e-a268-491b-a035-2305c17d7213	52584-089	HUMAN PRESCRIPTION DRUG	Flumazenil		flumazenil	INJECTION	INTRAVENOUS	20190524	20240131	ANDA	ANDA076755	General Injectables and Vaccines, Inc.	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	
52584-095_14a92400-b26b-4707-9e26-6e028671bc09	52584-095	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		lidocaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20191111	20241130	ANDA	ANDA203082	General Injectables & Vaccines, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
52584-096_0f0d471b-7a06-4c7e-a740-bf531a3655af	52584-096	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		sodium bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20191111	20240201	ANDA	ANDA202981	General Injectables & Vaccines, Inc.	SODIUM BICARBONATE	42	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	
52584-099_74676d86-cf55-4ab1-86a6-10b37991face	52584-099	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		sodium bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20210902	20240229	UNAPPROVED DRUG OTHER		General Injectables and Vaccines, Inc.	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	
52584-109_27c4834c-bf0d-49f2-97bd-73d3a7fc5550	52584-109	HUMAN PRESCRIPTION DRUG	SODIUM CHLORIDE		sodium chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210728	20240331	ANDA	ANDA212248	General Injectables and Vaccines, Inc.	SODIUM CHLORIDE	4	meq/mL			N	
52584-115_40e3b8e6-5893-4f70-963f-9728122307cd	52584-115	HUMAN PRESCRIPTION DRUG	Brevibloc		Brevibloc	INJECTION	INTRAVENOUS	20100701	20240131	NDA	NDA019386	General Injectables & Vaccines	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
52584-119_ebeddafa-8f42-4323-8e0e-3b55a1fb7d68	52584-119	HUMAN PRESCRIPTION DRUG	Tigan		Trimethobenzamide Hydrochloride	INJECTION	INTRAMUSCULAR	20100801	20240930	NDA	NDA017530	General Injectables & Vaccines, Inc	TRIMETHOBENZAMIDE HYDROCHLORIDE	100	mg/mL	Antiemetic [EPC], Emesis Suppression [PE]		N	
52584-120_ca0a8154-7e84-4bbe-9de9-2cd45acc145b	52584-120	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210317	20240331	ANDA	ANDA207633	General Injectables and Vaccines, INC.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	
52584-159_41c6894d-f8e8-4242-96a5-819d4f322155	52584-159	HUMAN PRESCRIPTION DRUG	Adrenalin		epineprine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20190813	20240131	NDA	NDA204200	General Injectables and Vaccines, Inc.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
52584-160_3dbb9b88-8e63-4bd3-818e-0b2751337283	52584-160	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100701	20240201	ANDA	ANDA070590	General Injectables & Vaccines, Inc	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	
52584-182_16bfc51e-2183-488e-ae91-91cedf58d563	52584-182	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		Lidocaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100301	20240401	ANDA	ANDA089646	General Injectables & Vaccines	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
52584-186_b95cb3c1-cee0-41a6-b9ac-7103570f9739	52584-186	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION	INTRAVENOUS	20190703	20240331	ANDA	ANDA088912	General Injectables and Vaccines, Inc.	SODIUM CHLORIDE	9	mg/mL			N	
52584-277_3b9d1eb6-c435-4471-a1d8-c4fb08e43643	52584-277	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride Anhydrous	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100901	20240301	ANDA	ANDA088327	General Injectables & Vaccines, Inc	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
52584-286_d5f721d9-8d51-44c9-b61a-fc20807b9f3d	52584-286	HUMAN PRESCRIPTION DRUG	NAROPIN		ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20140311	20250930	NDA	NDA020533	General Injectables & Vaccines, Inc	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	
52584-360_247dc1e8-daa7-40ac-a7ec-335b62cf6d86	52584-360	HUMAN PRESCRIPTION DRUG	Calcium Gluconate		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20180212	20240331	NDA	NDA208418	General Injectables and Vaccines, Inc.	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
52584-369_246eb8ce-8d10-4065-b0ad-8ed87733d592	52584-369	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	INJECTION	PARENTERAL	20140507	20240131	ANDA	ANDA072076	General Injectables & Vaccines, Inc.	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	
52584-376_04fb8ca4-1465-4ba1-92f9-22db184f6f64	52584-376	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100701	20240331	ANDA	ANDA080817	General Injectables & Vaccines, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
52584-397_5988b250-29e5-4477-a4c9-a57a4031af8a	52584-397	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR	20180702	20240731	ANDA	ANDA083329	General Injectables and Vaccines, Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	
52584-399_fc109528-7ffa-4a6b-99c6-72bcd196d8a8	52584-399	HUMAN PRESCRIPTION DRUG	CYANOCOBALAMIN		CYANOCOBALAMIN	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20180720	20240331	ANDA	ANDA204829	General Injectables and Vaccines, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	
52584-410_39654037-4e1f-4e3a-96b2-fc71adedcecf	52584-410	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20100701	20241130	ANDA	ANDA083391	General Injectables and Vaccines, Inc	DIGOXIN	.25	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	
52584-420_dc18cfc4-1721-496b-b769-310b384075af	52584-420	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140526	20240131	ANDA	ANDA040802	General Injectables and Vaccines, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
52584-465_3bea6afe-dc78-4db1-9a10-5d454c5ac335	52584-465	HUMAN PRESCRIPTION DRUG	Sensorcaine		Bupivacaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20111017	20260131	NDA	NDA018304	General Injectables & Vaccines, Inc	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	
52584-466_737ce3c3-f280-4120-9ed6-d22f85891bea	52584-466	HUMAN PRESCRIPTION DRUG	Sensorcaine MPF		bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20111026	20240131	ANDA	ANDA070553	General Injectables & Vaccines, Inc	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	
52584-467_a1f2d772-af08-4745-ae2a-4ba1a966f822	52584-467	HUMAN PRESCRIPTION DRUG	Sensorcaine		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20111018	20260131	NDA	NDA018304	General Injectables & Vaccines, Inc	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	
52584-485_65258d73-c6f1-472f-be9a-2df8789e9e93	52584-485	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20110926	20260228	NDA	NDA006488	General Injectables and Vaccines, inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
52584-486_905cfe2e-c4ce-47b7-a091-1ec3fcfff13b	52584-486	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine HCl	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20111109	20260131	NDA	NDA006488	General Injectables & Vaccines, Inc	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
52584-489_35eab8bc-aff5-4119-8291-cebc47733de5	52584-489	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride and epinephrine	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20110927	20240331	NDA	NDA006488	General Injectables & Vaccines, Inc	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
52584-495_6e36766a-ff5b-4135-9e9d-c01c3962c1d0	52584-495	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100801	20240630	ANDA	ANDA083312	General Injectables & Vaccines, Inc	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	
52584-496_347b809e-521a-48d9-ae5f-53d8173cd159	52584-496	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	20100801	20240531	ANDA	ANDA083312	General Injectables & Vaccines, Inc	PROMETHAZINE HYDROCHLORIDE	50	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	
52584-517_5316141c-f8d0-419a-aaa9-67244dfc5f7c	52584-517	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20100701	20240301	NDA	NDA019445	General Injectables & Vaccines, Inc	DEXTROSE MONOHYDRATE	25	g/50mL			N	
52584-641_a7f8ad5a-504c-4e9d-9e1f-c690052fa6ee	52584-641	HUMAN PRESCRIPTION DRUG	Suprane		Desflurane	LIQUID	RESPIRATORY (INHALATION)	20120425	20250131	NDA	NDA020118	General Injectables & Vaccines, Inc	DESFLURANE	240	mL/240mL	General Anesthesia [PE], General Anesthetic [EPC]		N	
52584-642_512e413b-44a6-4d26-bec7-5ddeb563f1fd	52584-642	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170113	20240229	NDA	NDA019316	General Injectables and Vaccines, Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
52584-648_f8b43fa2-8812-4988-adba-5f62c4be7613	52584-648	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20100701	20240301	NDA	NDA019445	General Injectables & Vaccines, Inc	DEXTROSE MONOHYDRATE	25	g/50mL			N	
52584-665_0ba29411-e95d-4bee-aee1-e3a135d6aa33	52584-665	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	INJECTION, SOLUTION	SUBCUTANEOUS	20111116	20240331	ANDA	ANDA076887	General Injectables & Vaccines, Inc	TERBUTALINE SULFATE	1	mg/mL			N	
52584-681_d459c583-43d2-42e3-9138-4409f9e4f5bf	52584-681	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180702	20240131	ANDA	ANDA090963	General Injectables and Vaccines, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
52584-749_81498f25-2a5a-45b1-9b3e-770305064cb1	52584-749	HUMAN PRESCRIPTION DRUG	MIDAZOLAM		midazoalm	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201112	20241231	ANDA	ANDA090850	General Injectables and Vaccines, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
52584-754_32b9244c-5dce-4eb0-a80d-d644d161bf84	52584-754	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100801	20240201	ANDA	ANDA075151	General Injectables & Vaccines, Inc	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
52584-811_09913c85-4cc5-4b95-8dbf-5f3f4fd0a28f	52584-811	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	INJECTION, SOLUTION	INTRAVENOUS	20180702	20240401	NDA	NDA018890	General Injectables and Vaccines, Inc.	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	
52584-887_f0c7a2af-39be-4b38-b267-c17d615c15c8	52584-887	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20100301	20250401	NDA	NDA018801	General Injectables & Vaccines, Inc	WATER	1	mL/mL			N	
52584-888_d6fbd61f-6143-4e65-9fc9-19bb06f700c5	52584-888	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20100801	20240301	NDA	NDA018803	General Injectables & Vaccines, Inc	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	
52584-923_7b9d68f9-622d-4422-92a4-c100fc49ebbe	52584-923	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191230	20241130	ANDA	ANDA065047	General Injectables & Vaccines, Inc.	CEFAZOLIN SODIUM	225	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
52584-924_c8f69e4a-5deb-4349-89d7-85a10a5c0ba0	52584-924	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201119	20250131	ANDA	ANDA065047	General Injectables and Vaccines, Inc.	CEFAZOLIN SODIUM	330	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
52584-928_1f6bc9bf-defc-45a6-9098-778ebf6379b9	52584-928	HUMAN PRESCRIPTION DRUG	Calcium Chloride		Calcium Choride	INJECTION, SOLUTION	INTRAVENOUS; INTRAVENTRICULAR	20100301	20240201	UNAPPROVED DRUG OTHER		General Injectables & Vaccines, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
52584-978_37100309-f0a5-4948-a019-88c2b1ef9f6f	52584-978	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	INJECTION	PARENTERAL	20131206	20240229	ANDA	ANDA072076	General Injectables & Vaccines, Inc	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	
52605-041_83e3e459-c254-45e3-a5ac-2e717e08c348	52605-041	HUMAN PRESCRIPTION DRUG	amlodipine besylate		amlodipine besylate	TABLET	ORAL	20160711		ANDA	ANDA207821	POLYGEN PHARMACEUTICALS INC.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
52605-042_83e3e459-c254-45e3-a5ac-2e717e08c348	52605-042	HUMAN PRESCRIPTION DRUG	amlodipine besylate		amlodipine besylate	TABLET	ORAL	20160711		ANDA	ANDA207821	POLYGEN PHARMACEUTICALS INC.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
52605-043_83e3e459-c254-45e3-a5ac-2e717e08c348	52605-043	HUMAN PRESCRIPTION DRUG	amlodipine besylate		amlodipine besylate	TABLET	ORAL	20160711		ANDA	ANDA207821	POLYGEN PHARMACEUTICALS INC.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
52605-067_46abf1bc-3aaf-4d26-8f2b-b0340e9b32e4	52605-067	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA211045	POLYGEN PHARMACEUTICALS INC.	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
52605-068_46abf1bc-3aaf-4d26-8f2b-b0340e9b32e4	52605-068	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA211045	POLYGEN PHARMACEUTICALS INC.	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
52605-071_4fe4f372-10c2-42ca-bc69-d78a489672b2	52605-071	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA210587	POLYGEN PHARMACEUTICALS INC.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
52605-072_4fe4f372-10c2-42ca-bc69-d78a489672b2	52605-072	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA210587	POLYGEN PHARMACEUTICALS INC.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
52605-082_9e3256b5-2032-4615-967d-449d49b09921	52605-082	HUMAN PRESCRIPTION DRUG	clopidogrel		clopidogrel	TABLET	ORAL	20210301		ANDA	ANDA213351	POLYGEN PHARMACEUTICALS INC.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
52605-083_9e3256b5-2032-4615-967d-449d49b09921	52605-083	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20210301		ANDA	ANDA213351	POLYGEN PHARMACEUTICALS INC.	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
52642-012_06e76e24-a425-5ffd-e063-6294a90a4911	52642-012	HUMAN OTC DRUG	Cherry Cough Drop		Menthol	LOZENGE	ORAL	20150427		OTC MONOGRAPH FINAL	part341	BestCo Inc.	MENTHOL	5.8	mg/1			N	20241231
52642-013_06e76ca9-ea3f-5e57-e063-6294a90a89e9	52642-013	HUMAN OTC DRUG	Honey Lemon Cough Drop		Menthol	LOZENGE	ORAL	20150427		OTC MONOGRAPH FINAL	part341	BestCo Inc.	MENTHOL	7.5	mg/1			N	20241231
52642-020_06e77370-10c7-6354-e063-6294a90ad20f	52642-020	HUMAN OTC DRUG	Strawberry Cough Drops		Menthol	LOZENGE	ORAL	20110701		OTC MONOGRAPH FINAL	part341	BestCo Inc.	MENTHOL	2.7	mg/1			N	20241231
52642-034_09835179-3dae-8640-e063-6294a90ae84e	52642-034	HUMAN OTC DRUG	Antacid Flavor Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170726		OTC MONOGRAPH DRUG	M001	BestCo Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
52642-035_09833ece-14f6-8193-e063-6294a90a1714	52642-035	HUMAN OTC DRUG	Sound Health Heartburn and Gas Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20191227		OTC MONOGRAPH DRUG	M001	BestCo Inc.	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
52642-036_06e77370-10c8-6354-e063-6294a90ad20f	52642-036	HUMAN OTC DRUG	Cherry Sore Throat Lozenges		Benzocaine	LOZENGE	ORAL	20180815		OTC MONOGRAPH NOT FINAL	part356	Bestco Inc.	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52642-037_09835062-ec0c-8834-e063-6294a90a9d34	52642-037	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	LOZENGE	ORAL	20180823		OTC MONOGRAPH DRUG	M012	Bestco Inc.	MENTHOL	5.4	mg/1			N	20241231
52642-038_0983621a-e708-bac5-e063-6394a90a490a	52642-038	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20180823		OTC MONOGRAPH DRUG	M012	Bestco Inc.	MENTHOL	7.5	mg/1			N	20241231
52642-042_06e761d0-9ee9-3e5a-e063-6394a90ab72c	52642-042	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	LOZENGE	ORAL	20181010		OTC MONOGRAPH FINAL	part341	Bestco Inc.	MENTHOL	5.4	mg/1			N	20241231
52642-043_06e761d0-9eea-3e5a-e063-6394a90ab72c	52642-043	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20181010		OTC MONOGRAPH FINAL	part341	Bestco Inc.	MENTHOL	5.8	mg/1			N	20241231
52642-043_06e76e24-a423-5ffd-e063-6294a90a4911	52642-043	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20181011		OTC MONOGRAPH FINAL	part341	Bestco Inc.	MENTHOL	5.8	mg/1			N	20241231
52642-044_06e761d0-9eec-3e5a-e063-6394a90ab72c	52642-044	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20181011		OTC MONOGRAPH FINAL	part341	Bestco Inc.	MENTHOL	7.5	mg/1			N	20241231
52642-044_06e77370-10c6-6354-e063-6294a90ad20f	52642-044	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20181011		OTC MONOGRAPH FINAL	part341	Bestco Inc.	MENTHOL	7.5	mg/1			N	20241231
52642-045_06e761d0-9eed-3e5a-e063-6394a90ab72c	52642-045	HUMAN OTC DRUG	Sugar Free Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20181011		OTC MONOGRAPH FINAL	part341	Bestco Inc.	MENTHOL	7.6	mg/1			N	20241231
52642-046_06e77d10-8fe5-736f-e063-6294a90a2c29	52642-046	HUMAN OTC DRUG	Sugar Free Cherry Cough Drops		Menthol	LOZENGE	ORAL	20181016		OTC MONOGRAPH FINAL	part341	Bestco Inc.	MENTHOL	5.8	mg/1			N	20241231
52642-050_09826c91-3f5e-5dc3-e063-6394a90ae212	52642-050	HUMAN OTC DRUG	BestHealth Herbal Cough Drops		Menthol	LOZENGE	ORAL	20210331		OTC MONOGRAPH DRUG	M012	Bestco LLC	MENTHOL	4.8	mg/1			N	20241231
52642-055_06e79465-1126-6806-e063-6394a90a2113	52642-055	HUMAN OTC DRUG	Best Health Menthol Cough Drops		Menthol	LOZENGE	ORAL	20220427		OTC MONOGRAPH FINAL	part341	Bestco LLC	MENTHOL	5.4	mg/1			N	20241231
52642-057_09831227-b67f-63f4-e063-6294a90a7b35	52642-057	HUMAN OTC DRUG	Best Health Berry Soothers Throat Drops		Pectin	LOZENGE	ORAL	20220428		OTC MONOGRAPH DRUG	M012	Bestco LLC	PECTIN	7	mg/1			N	20241231
52651-001_84484184-24c7-43f4-aa4b-92719850355b	52651-001	HUMAN OTC DRUG	TN Dickinsons Witch Hazel Astringent		Witch Hazel	LIQUID	TOPICAL	19891202		OTC MONOGRAPH FINAL	part347	Dickinson Brands Inc.	WITCH HAZEL	86	g/100mL			N	20241231
52651-003_5ad45306-3937-4d2b-af2f-91bc0d7ab50e	52651-003	HUMAN OTC DRUG	TN Dickinsons Witch Hazel Hemorrhoidal Pads		witch hazel	CLOTH	TOPICAL	19941201		OTC MONOGRAPH FINAL	part346	Dickinson Brands Inc.	WITCH HAZEL	1.2	g/1			N	20241231
52652-1950_7c3e975b-bac5-46bd-bc74-13ccd89c4cf3	52652-1950	HUMAN PRESCRIPTION DRUG	THYQUIDITY		Levothyroxine Sodium	SOLUTION	ORAL	20230405		NDA	NDA214047	Azurity Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
52652-2001_3b7dce90-1119-49cf-80bf-38e07e4d8dc4	52652-2001	HUMAN PRESCRIPTION DRUG	Xatmep		Methotrexate	SOLUTION	ORAL	20170501		NDA	NDA208400	Azurity Pharmaceuticals, Inc.	METHOTREXATE	2.5	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
52652-3001_39d16ba9-53e0-4052-8a27-61e75de1528a	52652-3001	HUMAN PRESCRIPTION DRUG	Qbrelis		lisinopril	SOLUTION	ORAL	20160829		NDA	NDA208401	Azurity Pharmaceuticals, Inc.	LISINOPRIL	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
52652-4001_d22f35fc-e834-47cd-a987-c1e92729e1d6	52652-4001	HUMAN PRESCRIPTION DRUG	Epaned		enalapril maleate	SOLUTION	ORAL	20161003		NDA	NDA208686	Azurity Pharmaceuticals, Inc.	ENALAPRIL MALEATE	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
52652-5001_78965c75-1ba7-48f0-bc14-029d5bb34f88	52652-5001	HUMAN PRESCRIPTION DRUG	Katerzia		Amlodipine	SUSPENSION	ORAL	20190815		NDA	NDA211340	Azurity Pharmaceuticals, Inc.	AMLODIPINE BENZOATE	1	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
52652-6001_a62deacf-f040-458c-83ca-0e7d39473c11	52652-6001	HUMAN PRESCRIPTION DRUG	FLEQSUVY		baclofen	SUSPENSION	ORAL	20220207		NDA	NDA215602	Azurity Pharmaceuticals, Inc.	BACLOFEN	5	mg/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
52652-8001_df27963d-6762-4aee-9d48-f5d33ae5ff66	52652-8001	HUMAN PRESCRIPTION DRUG	ZONISADE		ZONISAMIDE	SUSPENSION	ORAL	20220715		NDA	NDA214273	Azurity Phramaceuticals, Inc.	ZONISAMIDE	100	mg/5mL	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
52652-9001_7e182a3b-8858-4f7e-9f34-b92cd3a435fb	52652-9001	HUMAN PRESCRIPTION DRUG	Eprontia		Topiramate	SOLUTION	ORAL	20211206		NDA	NDA214679	Azurity Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/mL	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
52654-0001_4a7d8678-91fc-4a07-84b8-e613d23ac512	52654-0001	HUMAN OTC DRUG	MP		Achyrocline Satureioides, Arctostaphylos Uva Ursi Leaf, Cassia Occidentalis, Mirabilis Jalapa, Petiveria Alliacea, Physalis Angulata, Schinus Molle	LIQUID	ORAL	20160518	20240408	UNAPPROVED HOMEOPATHIC		Chi Research, Inc.	ACHYROCLINE SATUREIOIDES; ARCTOSTAPHYLOS UVA-URSI LEAF; MIRABILIS JALAPA FLOWERING TOP; PETIVERIA ALLIACEA WHOLE; PHYSALIS ANGULATA; SCHINUS MOLLE BARK; SENNA OCCIDENTALIS	32; 32; 32; 32; 32; 32; 32	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
52654-0003_05096613-11bb-460f-95ca-cc4e79e980c8	52654-0003	HUMAN OTC DRUG	SP		Brosimum Acutifolium, Himatanthus Sucuuba, Mansoa Alliacea, Minquartia Guianensis, Phyllanthus Niruri, Piper Aduncum	LIQUID	ORAL	20160518	20240415	UNAPPROVED HOMEOPATHIC		Chi Research, Inc.	BROSIMUM ACUTIFOLIUM BARK; HIMATANTHUS LANCIFOLIUS BARK; MANSOA ALLIACEA BARK; MANSOA ALLIACEA LEAF; MINQUARTIA GUIANENSIS BARK; PHYLLANTHUS NIRURI WHOLE; PIPER ADUNCUM LEAF	32; 32; 32; 32; 32; 32; 32	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
52654-0007_2d6c2f7b-a06a-4591-a5f7-211354417e94	52654-0007	HUMAN OTC DRUG	MP		Berberis Vulgaris, Isatis Tinctoria, Morinda Citrifolia, Petiveria Tetrandra, Schinus Molle, Thymolum, Uva-Ursi	LIQUID	ORAL	20200303		UNAPPROVED HOMEOPATHIC		Chi Research, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; ISATIS TINCTORIA WHOLE; NONI FRUIT JUICE; PETIVERIA ALLIACEA ROOT; SCHINUS MOLLE FRUITING TOP; THYMOL	32; 32; 32; 32; 32; 32; 32	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
52667-006_4e77a097-eb23-4d14-e054-00144ff88e88	52667-006	HUMAN OTC DRUG	100% Pure Yerba Mate MIst	SPF 30	Zinc Oxide	AEROSOL, SPRAY	TOPICAL	20170501		OTC MONOGRAPH NOT FINAL	part352	Purity Cosmetics	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52670-550_0bb18820-85d4-821f-e063-6394a90a0291	52670-550	HUMAN PRESCRIPTION DRUG	Sodium Fluoride F 18		sodium fluoride F 18	INJECTION	INTRAVENOUS	20130628		ANDA	ANDA203605	Mayo Clinic	SODIUM FLUORIDE F-18	91.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
52670-551_0bb18b12-7009-cbec-e063-6294a90a7673	52670-551	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F-18	INJECTION	INTRAVENOUS	20130805		ANDA	ANDA203612	Mayo Clinic	FLUDEOXYGLUCOSE F-18	240	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
52670-552_0bb195c8-3a3a-8d5f-e063-6394a90afbce	52670-552	HUMAN PRESCRIPTION DRUG	Ammonia N 13		ammonia n-13	INJECTION, SOLUTION	INTRAVENOUS	20130225		ANDA	ANDA203321	Mayo Clinic	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
52670-556_0ea00a60-85e1-a813-e063-6294a90a9f33	52670-556	HUMAN PRESCRIPTION DRUG	Choline C 11		Choline C-11	INJECTION	INTRAVENOUS	20120912		NDA	NDA203155	Mayo Clinic	CHOLINE C-11	33.1	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20251231
52674-544_fda21d98-37d1-416d-ae7d-90cc6348c449	52674-544	HUMAN OTC DRUG	Gold and Sudsy		CHLOROXYLENOL	SOAP	TOPICAL	20151012		OTC MONOGRAPH NOT FINAL	part333E	Cosgrove Enterprises, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
52682-206_c4718b91-3d55-4894-a6c4-20c3838e74a9	52682-206	HUMAN OTC DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	TABLET	ORAL	20110124	20250401	OTC MONOGRAPH FINAL	part331	Ingenus Pharmaceuticals NJ, LLC	SODIUM BICARBONATE	650	mg/1	Alkalinizing Activity [MoA]		N	
52685-433_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-433	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	I00	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-434_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-434	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	I20	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-435_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-435	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	I40	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-436_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-436	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	I60	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-437_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-437	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	B20	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-438_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-438	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	B40	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-439_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-439	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	B60	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-440_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-440	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	O20	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-441_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-441	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	O40	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-442_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-442	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	O60	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52685-443_7cf345f1-ad2e-e873-e053-2991aa0aa106	52685-443	HUMAN OTC DRUG	SHISEIDO THE MAKEUP PERFECT SMOOTHING COMPACT FOUNDATION (Refill)	O80	Octinoxate and Titanium dioxide	POWDER	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO CO., LTD.	OCTINOXATE; TITANIUM DIOXIDE	140; 250	mg/10g; mg/10g			N	20241231
52686-255_8c79fbd8-4010-45ef-b385-a961f145f7a7	52686-255	HUMAN OTC DRUG	SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL FOUNDATION (REFILL)	O60	OCTINOXATE and TITANIUM DIOXIDE	PASTE	TOPICAL	20110301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICA INC.	OCTINOXATE; TITANIUM DIOXIDE	.39; .66	g/10g; g/10g			N	20241231
52686-335_d60b9657-e1ec-42a6-8706-7e7370d01402	52686-335	HUMAN OTC DRUG	SHISEIDO SUN PROTECTION EYE		OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE	CREAM	TOPICAL	20121201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICA INC.	OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	479; 495; 1749	mg/16.5g; mg/16.5g; mg/16.5g			N	20241231
52695-001_08021bfc-d1e4-90a4-e063-6294a90a7759	52695-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19540101		NDA	NDA205865	Humphries, Inc.	OXYGEN	995	mL/L			N	20241231
52695-003_08022a72-71b9-c48a-e063-6394a90a7c52	52695-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20180101		NDA	NDA205866	Humphries, Inc.	NITROGEN	990	mL/L			N	20241231
52698-001_080297ff-a3e4-398b-e063-6394a90a2f28	52698-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205849	Bill Munn Supply, Inc.	OXYGEN	99	L/100L			N	20241231
52698-003_0802bcb4-fca5-2397-e063-6294a90a2862	52698-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205850	Bill Munn Supply, Inc.	NITROGEN	990	mL/L			N	20241231
52709-1501_6b4f4eeb-efb8-4f1f-ad69-9aa00744aa6c	52709-1501	STANDARDIZED ALLERGENIC	GRASTEK		Timothy Grass Pollen Allergen Extract	TABLET	SUBLINGUAL	20140411		BLA	BLA125473	ALK-Abello A S	PHLEUM PRATENSE POLLEN	2800	[BAU]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
52709-1601_521ab801-bd3d-48a9-b210-07ef7f87a989	52709-1601	STANDARDIZED ALLERGENIC	RAGWITEK		AMBROSIA ARTEMISIIFOLIA POLLEN	TABLET	SUBLINGUAL	20140417		BLA	BLA125478	ALK-Abello A S	AMBROSIA ARTEMISIIFOLIA POLLEN	12	[Amb'a'1'U]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
52709-1701_1e822337-6296-4aa4-94b2-479fd3d9f217	52709-1701	STANDARDIZED ALLERGENIC	Odactra		DERMATOPHAGOIDES PTERONYSSINUS and DERMATOPHAGOIDES FARINAE	TABLET	SUBLINGUAL	20180101		BLA	BLA125592	ALK-Abello A S	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	6; 6	[arb'U]/1; [arb'U]/1	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
52747-155_f55f0e5d-a5a6-4bd4-ba3a-839dcf34eeac	52747-155	HUMAN OTC DRUG	V-Bella		BORIC ACID	SUPPOSITORY	VAGINAL	20200801		UNAPPROVED HOMEOPATHIC		U.S. PHARMACEUTICAL CORPORATION	BORIC ACID	3	[hp_X]/1			N	20241231
52747-255_108fa2fe-f7a1-4c68-927e-70ef523e81d0	52747-255	HUMAN OTC DRUG	HYLAFEM	BORICUM ACIDUM 3X	Boricum Acidum	SUPPOSITORY	VAGINAL	20191209		UNAPPROVED HOMEOPATHIC		U.S. PHARMACEUTICAL CORPORATION	BORIC ACID	3	[hp_X]/1			N	20241231
52747-475_078bb582-0cfe-3dea-e063-6394a90a8604	52747-475	HUMAN OTC DRUG	Norel AD		acetaminophen, chlorpheniramine maleate, and phenylephrine HCl	TABLET, MULTILAYER	ORAL	20120427		OTC MONOGRAPH DRUG	M012	U.S. PHARMACEUTICAL CORPORATION	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
52747-620_b46f9a07-eb1a-4870-88d3-ad9a2364fdc1	52747-620	HUMAN PRESCRIPTION DRUG	Concept OB		Vitamin Mineral Supplement	CAPSULE	ORAL	20090101		UNAPPROVED DRUG OTHER		U.S. Pharmaceutical Corporation	ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; IRON; MAGNESIUM SULFATE, UNSPECIFIED FORM; MANGANESE SULFATE; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC SULFATE, UNSPECIFIED FORM	210; 300; 7; 800; 10; 42.5; 1; 42.5; 6.9; 1.3; 20; 25; 5; 5; 18.2	mg/1; ug/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
52747-621_aaee698d-9522-49c9-afd3-d0c5d52e3ccd	52747-621	HUMAN PRESCRIPTION DRUG	Concept DHA		Vitamin- Mineral Omega-3 Supplement	CAPSULE, LIQUID FILLED	ORAL	20090624		UNAPPROVED DRUG OTHER		U.S. Pharmaceutical Corporation	ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; IRON; MAGNESIUM SULFATE, UNSPECIFIED FORM; NIACIN; OMEGA-3-ACID ETHYL ESTERS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC SULFATE, UNSPECIFIED FORM	25; 300; 5; 2; 12.5; 17.5; 1; 17.5; 5; 1.8; 200; 25; 3; 2; 10	mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Fatty Acids, Omega-3 [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Omega-3 Fatty Acid [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
52747-711_7aa8c3c6-7a91-4217-9e48-e1dfcf938060	52747-711	HUMAN PRESCRIPTION DRUG	Integra F		Ferrous Fumarate and Polysacchride Iron Complex and Folic Acid	CAPSULE	ORAL	20090427		UNAPPROVED DRUG OTHER		U.S. Pharmaceutical Corporation	ASCORBIC ACID; FERROUS ASPARTO GLYCINATE; FERROUS FUMARATE; FOLIC ACID; NIACIN	40; 62.5; 62.5; 1; 3	mg/1; mg/1; mg/1; mg/1; mg/1	Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin C [EPC]		N	20241231
52747-712_e63cf4c9-15bb-4acf-9b50-c525374267de	52747-712	HUMAN PRESCRIPTION DRUG	Integra Plus		Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement	CAPSULE	ORAL	20090427		UNAPPROVED DRUG OTHER		U.S. Pharmaceutical Corporation	ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; FERROUS ASPARTO GLYCINATE; FERROUS FUMARATE; FOLIC ACID; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE	210; 300; 5; 62.5; 62.5; 1; 20; 25; 5; 5	mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
52768-001_8b8dbff0-19ba-4967-893e-6451685dc851	52768-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F-18		FLUDEOXYGLUCOSE F-18	INJECTION, SOLUTION	INTRAVENOUS	20101010		ANDA	ANDA204546	Precision Nuclear, LLC	FLUDEOXYGLUCOSE F-18	500	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
52768-100_83a25b5d-25e8-408d-89b0-a8eee42663cb	52768-100	HUMAN PRESCRIPTION DRUG	AMMONIA N-13		AMMONIA N-13	INJECTION, SOLUTION	INTRAVENOUS	20101010		ANDA	ANDA204547	Precision Nuclear LLC	AMMONIA N-13	260	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
52768-125_1cf15f21-e57a-402e-a297-286d43275a24	52768-125	HUMAN PRESCRIPTION DRUG	Sodium Fluoride	F 18	SODIUM FLUORIDE F-18	INJECTION	INTRAVENOUS	20110101		ANDA	ANDA204542	Precision Nuclear LLC	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
52784-010_f5beff3c-2981-21e4-e053-2995a90acbf5	52784-010	HUMAN OTC DRUG	ARTEMISIA ARGYI LEAF		Arm Slim Sticker	PATCH	CUTANEOUS	20230322		UNAPPROVED HOMEOPATHIC		ZHENGZHOU GIANT BIOCHEMISTRY GROUP CO.,LTD	ARTEMISIA ARGYI LEAF	16	g/100g			N	20241231
52784-020_0bbb46ec-3020-17bb-e063-6294a90af97f	52784-020	HUMAN OTC DRUG	Magnet molding honey pastes		Ginger Oil 10%	PATCH	TOPICAL	20231205		UNAPPROVED HOMEOPATHIC		ZHENGZHOU GIANT BIOCHEMISTRY GROUP CO.,LTD	GINGER OIL	10	g/100g			N	20241231
52784-021_0cc44ebb-f70f-fa09-e063-6394a90a3fc9	52784-021	HUMAN OTC DRUG	Tiger Pain		Chuanxiong, Clove, Myrrh	PATCH	TOPICAL	20231218		UNAPPROVED DRUG OTHER		ZHENGZHOU GIANT BIOCHEMISTRY GROUP CO.,LTD	CLOVE; LIGUSTICUM SINENSE SUBSP. CHUANXIONG ROOT; MYRRH	.12; .73; .28	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
52784-022_0cd9629f-694b-1c5e-e063-6294a90ab388	52784-022	HUMAN OTC DRUG	Knee Joint Patch		PANAX NOTOGINSENG ROOT	PATCH	TOPICAL	20231218		UNAPPROVED DRUG OTHER		ZHENGZHOU GIANT BIOCHEMISTRY GROUP CO.,LTD	PANAX NOTOGINSENG ROOT	11	g/100g			N	20241231
52793-700_6d506120-be53-45ed-a5bb-ce3c73f97003	52793-700	HUMAN PRESCRIPTION DRUG	Ahealon		arnica montana, calendula officinalis flowering top, echinacea angustifolia, st. johns wort, silver, sulfur, allylthiourea and urtica urens	SPRAY	TOPICAL	20120409		UNAPPROVED HOMEOPATHIC		PRINCETON BIOTECHNOLOGY CORPORATION	ALLYLTHIOUREA; ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; SILVER; ST. JOHN'S WORT; SULFUR; URTICA URENS	30; 30; 30; 30; 30; 30; 30; 30	[kp_C]/60mL; [kp_C]/60mL; [kp_C]/60mL; [kp_C]/60mL; [kp_C]/60mL; [kp_C]/60mL; [kp_C]/60mL; [kp_C]/60mL			N	20241231
52810-102_0eb2cdb8-428b-509e-e063-6394a90a9f57	52810-102	HUMAN OTC DRUG	ACNE FREE		ECHINACEA ANGUSTIFOLIA, CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER, MAHONIA AQUIFOLIUM FRUITING TOP	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; MAHONIA AQUIFOLIUM FRUITING TOP; SAMBUCUS NIGRA FLOWER	1; 1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-103_0eb2c0fe-dc54-4b76-e063-6394a90a5e76	52810-103	HUMAN OTC DRUG	EXTRA DRAWING ACNE RELIEF		MAHONIA AQUIFOLIUM, CALENDULA OFFICINALIS, ECHINACEA ANGUSTIFOLIA, SAMBUCUS NIGRA, THUJA OCCIDENTALIS	SALVE	TOPICAL	20160613		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; MAHONIA AQUIFOLIUM FRUITING TOP; SAMBUCUS NIGRA FLOWER; THUJA OCCIDENTALIS LEAF	1; 1; 1; 1; 1	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20251231
52810-206_0eb2ac3a-9d05-6156-e063-6294a90a9ada	52810-206	HUMAN OTC DRUG	SKIN TAG RELIEF		CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER, ECHINACEA ANGUSTIFOLIA, THUJA OCCIDENTALIS	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER; THUJA OCCIDENTALIS LEAF	1; 1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-207_0eb2ec0f-969d-9a70-e063-6294a90abd56	52810-207	HUMAN OTC DRUG	BED SORE AND WOUND		ARNICA MONTANA, ECHINACEA, CALENDULA OFFICINALIS, SAMBUSCUS NIGRA	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWER; ECHINACEA PURPUREA; SAMBUCUS NIGRA FLOWER	2; 2; 2; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-212_0eb2ebd0-b45f-54b2-e063-6394a90a5bc8	52810-212	HUMAN OTC DRUG	FIRST AID		SAMBUCUS NIGRA FLOWER, CALENDULA OFFICINALIS FLOWER, ECHINACEA ANGUSTIFOLIA	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER	1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-213_0eb2eaa2-f957-5876-e063-6394a90ac52d	52810-213	HUMAN OTC DRUG	ORIGINAL HEALING		SAMBUCUS NIGRA FLOWER, CALENDULA OFFICINALIS FLOWER, ECHINACEA ANGUSTIFOLIA	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER	1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-214_0eb2c553-cad9-7045-e063-6294a90ab7bd	52810-214	HUMAN OTC DRUG	BABY ACNE		CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER, THUJA OCCIDENTALIS	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; SAMBUCUS NIGRA FLOWER; THUJA OCCIDENTALIS LEAF	1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-216_0eb2acb8-5c64-5ed8-e063-6294a90ac802	52810-216	HUMAN OTC DRUG	BABY DIAPER RASH		CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; SAMBUCUS NIGRA FLOWER	1; 1	[hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-218_0eb2e9eb-7b92-57f5-e063-6394a90aa795	52810-218	HUMAN OTC DRUG	RASH RELIEF		ARNICA MONTANA, CALENDULA OFFICINALIS, SAMBUCUS NIGRA	SALVE	TOPICAL	20150504		UNAPPROVED HOMEOPATHIC		PUREMEDY	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWER; SAMBUCUS NIGRA FLOWER	1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-219_0eb2e8d0-0969-79d6-e063-6294a90ab274	52810-219	HUMAN OTC DRUG	ALL NATURAL WOUND AND BURN		CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER, ECHINACEA ANGUSTIFOLIA	SPRAY	TOPICAL	20160909		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER	1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-402_0eb2c7be-2f9b-4f00-e063-6394a90ab150	52810-402	HUMAN OTC DRUG	SHINGLES RELIEF		CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER, ECHINACEA ANGUSTIFOLIA, THUJA OCCIDENTALIS, ARNICA MONTANA	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER; THUJA OCCIDENTALIS LEAF	1; 1; 1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-411_0eb2c04a-c9e6-6734-e063-6294a90a642e	52810-411	HUMAN OTC DRUG	ECZEMA AND PSORIASIS FREE		SAMBUCUS NIGRA FLOWER, CALENDULA OFFICINALIS FLOWER, ECHINACEA ANGUSTIFOLIA, BERBERIS VULGARIS WHOLE	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	BERBERIS VULGARIS WHOLE; CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER	1; 1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-501_0eb2cdb8-428a-509e-e063-6394a90a9f57	52810-501	HUMAN OTC DRUG	FUNGUS FREE		PINUS SYLVESTRIS, SAMBUCUS NIGRA FLOWER, CALENDULA OFFICINALIS FLOWER, THUJA OCCIDENTALIS LEAFY TWIG	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; PINE NEEDLE OIL (PINUS SYLVESTRIS); SAMBUCUS NIGRA FLOWER; THUJA OCCIDENTALIS LEAFY TWIG	2; 1; 2; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-511_0eb2b9ae-107d-4732-e063-6394a90a4587	52810-511	HUMAN OTC DRUG	FUNGUS FREE		SAMBUCUS NIGRA FLOWER, CALENDULA OFFICINALIS FLOWER, THUJA OCCIDENTALIS LEAFY TWIG, ECHINACEA ANGUSTIFOLIA	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER; THUJA OCCIDENTALIS LEAFY TWIG	1; 1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-702_0eb2c0fe-dc50-4b76-e063-6394a90a5e76	52810-702	HUMAN OTC DRUG	POISON OAK AND IVY RELIEF		CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER, ECHINACEA ANGUSTIFOLIA, ARNICA MONTANA	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER	1; 1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-703_0eb2c89f-e04c-4fb8-e063-6394a90a656f	52810-703	HUMAN OTC DRUG	SORE MUSCLE AND JOINT PAIN RELIEF		ARNICA MONTANA AND HYPERICUM PERFORATUM	CREAM	TOPICAL	20131017		UNAPPROVED HOMEOPATHIC		PUREMEDY	ARNICA MONTANA; HYPERICUM PERFORATUM	1; 1	[hp_X]/100mL; [hp_X]/100mL			N	20251231
52810-802_0eb2f914-e454-9929-e063-6294a90a1cb1	52810-802	HUMAN OTC DRUG	HEMORRHOID RELIEF		CALENDULA OFFICINALIS FLOWER, SAMBUCUS NIGRA FLOWER, ECHINACEA ANGUSTIFOLIA, THUJA OCCIDENTALIS	SALVE	TOPICAL	20121018		UNAPPROVED HOMEOPATHIC		PUREMEDY	CALENDULA OFFICINALIS FLOWER; ECHINACEA ANGUSTIFOLIA; SAMBUCUS NIGRA FLOWER; THUJA OCCIDENTALIS LEAF	1; 1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
52817-117_f6667426-b68b-1ac7-e053-2a95a90a905b	52817-117	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20220628		ANDA	ANDA214896	TruPharma LLC.	PRIMIDONE	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
52817-180_632878aa-1e5b-4e4b-8a15-5bb9968812b5	52817-180	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070925	TruPharma, LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
52817-181_632878aa-1e5b-4e4b-8a15-5bb9968812b5	52817-181	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070924	TruPharma, LLC	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
52817-182_632878aa-1e5b-4e4b-8a15-5bb9968812b5	52817-182	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070923	TruPharma, LLC	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
52817-195_bb37b29d-c827-d710-e053-2995a90acf1d	52817-195	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20200901		ANDA	ANDA208708	TRUPHARMA LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
52817-196_bb37b29d-c827-d710-e053-2995a90acf1d	52817-196	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20200224		ANDA	ANDA208708	TRUPHARMA LLC	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
52817-200_1df8bd81-54fe-44ea-98aa-5f13592dd8bd	52817-200	HUMAN PRESCRIPTION DRUG	ACETAZOLAMIDE		ACETAZOLAMIDE	TABLET	ORAL	20210419		ANDA	ANDA211372	TRUPHARMA, LLC	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
52817-201_1df8bd81-54fe-44ea-98aa-5f13592dd8bd	52817-201	HUMAN PRESCRIPTION DRUG	ACETAZOLAMIDE		ACETAZOLAMIDE	TABLET	ORAL	20210419		ANDA	ANDA211372	TRUPHARMA, LLC	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
52817-210_c67264ab-9491-4aee-a28a-c97e1497915b	52817-210	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20170117		ANDA	ANDA206553	TRUPHARMA, LLC	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
52817-230_2ea41124-ef4c-4ad1-957f-71c1266ee95f	52817-230	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20201012		ANDA	ANDA212053	TruPharma, LLC	CHLORZOXAZONE	375	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
52817-231_2ea41124-ef4c-4ad1-957f-71c1266ee95f	52817-231	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20201012		ANDA	ANDA212053	TruPharma, LLC	CHLORZOXAZONE	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
52817-235_06ea67d8-b615-776b-e063-6294a90a3185	52817-235	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA212650	TruPharma, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
52817-260_edabf40d-d160-c14b-e053-2995a90af00d	52817-260	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		oxybutynin chloride	TABLET	ORAL	20190101		ANDA	ANDA210125	TruPharma LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
52817-270_5a87a01a-efe7-4740-96d1-c62a1b2d927a	52817-270	HUMAN PRESCRIPTION DRUG	Bisoprolol		Bisoprolol fumarate	TABLET, FILM COATED	ORAL	20190620		ANDA	ANDA075474	TruPharma, LLC	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52817-271_5a87a01a-efe7-4740-96d1-c62a1b2d927a	52817-271	HUMAN PRESCRIPTION DRUG	Bisoprolol		Bisoprolol fumarate	TABLET, FILM COATED	ORAL	20190620		ANDA	ANDA075474	TruPharma, LLC	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52817-280_edabf702-d221-78ba-e053-2995a90ae7bf	52817-280	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	20200901		ANDA	ANDA210653	TruPharma LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
52817-281_edabf702-d221-78ba-e053-2995a90ae7bf	52817-281	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	20200901		ANDA	ANDA210653	TruPharma LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
52817-282_edabf702-d221-78ba-e053-2995a90ae7bf	52817-282	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		clomipramine hydrochloride	CAPSULE	ORAL	20200901		ANDA	ANDA210653	TruPharma LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
52817-290_cf9c178e-b82c-4620-9711-35c96ec1fc9e	52817-290	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE	ORAL	20210601		ANDA	ANDA071026	TruPharma, LLC	OXAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
52817-291_cf9c178e-b82c-4620-9711-35c96ec1fc9e	52817-291	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE	ORAL	20210601		ANDA	ANDA071026	TruPharma, LLC	OXAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
52817-292_cf9c178e-b82c-4620-9711-35c96ec1fc9e	52817-292	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE	ORAL	20210601		ANDA	ANDA071026	TruPharma, LLC	OXAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
52817-295_a8abd38f-2334-34e3-e053-2a95a90acb7d	52817-295	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20160801		ANDA	ANDA204883	TruPharma LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
52817-319_b8da4a75-4c34-1d06-e053-2a95a90a7886	52817-319	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	TruPharma LLC	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
52817-320_b8da4a75-4c34-1d06-e053-2a95a90a7886	52817-320	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	TruPharma LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
52817-321_b8da4a75-4c34-1d06-e053-2a95a90a7886	52817-321	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	TruPharma LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
52817-323_b8d7c553-3894-7d6d-e053-2a95a90ae868	52817-323	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190819		ANDA	ANDA212543	TruPharma, LLC	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
52817-324_b8d7c553-3894-7d6d-e053-2a95a90ae868	52817-324	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190819		ANDA	ANDA212543	TruPharma, LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
52817-325_b8d7c553-3894-7d6d-e053-2a95a90ae868	52817-325	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190819		ANDA	ANDA212543	TruPharma, LLC	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
52817-330_b8c3dbd2-89f7-215b-e053-2995a90a7f74	52817-330	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	TruPharma LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
52817-331_b8c3dbd2-89f7-215b-e053-2995a90a7f74	52817-331	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	TruPharma LLC	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
52817-332_b8c3dbd2-89f7-215b-e053-2995a90a7f74	52817-332	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	TruPharma LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
52817-340_9baf3129-a0f9-1c46-e053-2995a90a8f40	52817-340	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20180701		ANDA	ANDA204882	TruPharma LLC	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
52817-341_9baf3129-a0f9-1c46-e053-2995a90a8f40	52817-341	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20180701		ANDA	ANDA204882	TruPharma LLC	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
52817-342_9baf3129-a0f9-1c46-e053-2995a90a8f40	52817-342	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20180701		ANDA	ANDA204882	TruPharma LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
52817-345_f0d4825a-95dd-48f8-e053-2a95a90aeeb0	52817-345	HUMAN PRESCRIPTION DRUG	buPROpion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220126		ANDA	ANDA211200	TruPharma LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
52817-346_f0d4825a-95dd-48f8-e053-2a95a90aeeb0	52817-346	HUMAN PRESCRIPTION DRUG	buPROpion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220127		ANDA	ANDA211200	TruPharma LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
52817-358_be1b1011-ee45-331c-e053-2995a90ae2fd	52817-358	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	TruPharma LLC	METOPROLOL TARTRATE	37.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52817-359_be1b1011-ee45-331c-e053-2995a90ae2fd	52817-359	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	TruPharma LLC	METOPROLOL TARTRATE	75	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52817-360_be1b1011-ee45-331c-e053-2995a90ae2fd	52817-360	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	TruPharma LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52817-361_be1b1011-ee45-331c-e053-2995a90ae2fd	52817-361	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	TruPharma LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52817-362_be1b1011-ee45-331c-e053-2995a90ae2fd	52817-362	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	TruPharma LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
52817-364_7710473d-d215-4a09-882a-33d68090c291	52817-364	HUMAN PRESCRIPTION DRUG	Triamterene		Triamterene Capsules	CAPSULE	ORAL	20181212		ANDA	ANDA211581	TRUPHARMA LLC	TRIAMTERENE	50	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
52817-365_7710473d-d215-4a09-882a-33d68090c291	52817-365	HUMAN PRESCRIPTION DRUG	Triamterene		Triamterene Capsules	CAPSULE	ORAL	20181212		ANDA	ANDA211581	TRUPHARMA LLC	TRIAMTERENE	100	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
52817-367_84c1caf5-1280-45e0-9c5e-40eac4f25f9d	52817-367	HUMAN PRESCRIPTION DRUG	Ethacrynic acid		Ethacrynic acid	TABLET	ORAL	20190912		ANDA	ANDA211809	TRUPHARMA LLC	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
52817-375_0eb6d1fe-949a-312a-e063-6294a90ae10c	52817-375	HUMAN PRESCRIPTION DRUG	Clonidine		Clonidine	TABLET, EXTENDED RELEASE	ORAL	20240111		NDA AUTHORIZED GENERIC	NDA022500	TruPharma, LLC	CLONIDINE	.17	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
52817-380_0177ebbe-5e72-1fb4-e063-6294a90ab32b	52817-380	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	20230727		ANDA	ANDA216908	TruPharma LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52817-381_0177ebbe-5e72-1fb4-e063-6294a90ab32b	52817-381	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	20230727		ANDA	ANDA216908	TruPharma LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52817-385_076b74ec-ead5-781c-e063-6394a90ab362	52817-385	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20231003		ANDA	ANDA214874	TruPharma LLC	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
52817-390_f8d2095e-d709-7b97-e053-6294a90af7d6	52817-390	HUMAN PRESCRIPTION DRUG	Carbidopa-levodopa		carbidopa and levodopa	TABLET	ORAL	20220921		ANDA	ANDA216505	TruPharma, LLC	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
52817-391_f8d2095e-d709-7b97-e053-6294a90af7d6	52817-391	HUMAN PRESCRIPTION DRUG	Carbidopa-levodopa		carbidopa and levodopa	TABLET	ORAL	20220921		ANDA	ANDA216505	TruPharma, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
52817-392_f8d2095e-d709-7b97-e053-6294a90af7d6	52817-392	HUMAN PRESCRIPTION DRUG	Carbidopa-levodopa		carbidopa and levodopa	TABLET	ORAL	20220921		ANDA	ANDA216505	TruPharma, LLC	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
52817-601_5de4b775-55bc-433a-9635-0ba2be74d918	52817-601	HUMAN PRESCRIPTION DRUG	VERSACLOZ		Clozapine	SUSPENSION	ORAL	20180615		NDA	NDA203479	TruPharma LLC	CLOZAPINE	50	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
52817-610_939a1e39-7b92-4e3d-ae81-2be9c4415834	52817-610	HUMAN PRESCRIPTION DRUG	Clonidine Transdermal System USP, 0.1 mg/day		clonidine transdermal system	PATCH	TRANSDERMAL	20230630		NDA	NDA018891	TruPharma, LLC	CLONIDINE	.1	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
52817-611_939a1e39-7b92-4e3d-ae81-2be9c4415834	52817-611	HUMAN PRESCRIPTION DRUG	Clonidine Transdermal System USP, 0.2 mg/day		clonidine transdermal system	PATCH	TRANSDERMAL	20230630		NDA	NDA018891	TruPharma, LLC	CLONIDINE	.2	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
52817-612_939a1e39-7b92-4e3d-ae81-2be9c4415834	52817-612	HUMAN PRESCRIPTION DRUG	Clonidine Transdermal System USP, 0.3 mg/day		clonidine transdermal system	PATCH	TRANSDERMAL	20230630		NDA	NDA018891	TruPharma, LLC	CLONIDINE	.3	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
52817-615_f7fd27bd-cd40-704c-e053-6394a90a6a6f	52817-615	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		tramadol hydrochloride	SOLUTION	ORAL	20200911		NDA AUTHORIZED GENERIC	NDA214044	TruPharma, LLC	TRAMADOL HYDROCHLORIDE	5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
52817-620_0806a6f9-b626-f98e-e063-6294a90a84bb	52817-620	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	SOLUTION	ORAL	20231012		NDA AUTHORIZED GENERIC	NDA208193	TRUPHARMA, LLC	BACLOFEN	10	mg/5mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
52817-720_2fbd7414-f94f-4e18-8d0e-3ae69a5449f7	52817-720	HUMAN PRESCRIPTION DRUG	apomorphine hydrocloride		APOMORPHINE HYDROCHLORIDE	INJECTION	SUBCUTANEOUS	20220224		ANDA	ANDA212025	TruPharma, LLC	APOMORPHINE HYDROCHLORIDE	30	mg/3mL	Dopamine Agonists [MoA], Dopaminergic Agonist [EPC]		N	20241231
52817-800_ed514fee-9f8f-4262-86c5-d632dca0d9b8	52817-800	HUMAN PRESCRIPTION DRUG	Clotrimazole Topical Solution USP, 1%		Clotrimazole Topical Solution USP, 1%	SOLUTION	TOPICAL	20190725		ANDA	ANDA212281	TruPharma LLC	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
52817-811_4c97b22b-26df-4051-96a6-2d47241e6639	52817-811	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	CREAM	TOPICAL	20220210		ANDA	ANDA040671	TruPharma, LLC	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52817-815_edabc3ff-6801-0067-e053-2a95a90ac024	52817-815	HUMAN PRESCRIPTION DRUG	Aminocaproic acid		Aminocaproic Acid	SOLUTION	ORAL	20200925		ANDA	ANDA212494	TruPharma LLC	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
52817-816_35cb918d-e8af-4bf0-9881-bc0550a4aaff	52817-816	HUMAN PRESCRIPTION DRUG	Acetic Acid		Acetic Acid	SOLUTION	AURICULAR (OTIC)	20200605		ANDA	ANDA040607	TruPharma, LLC	ACETIC ACID	20.65	mg/mL			N	20241231
52817-817_efb6720c-0d97-4f7f-9323-743ff91e86f0	52817-817	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate pramoxine HCl		Hydrocortisone Acetate, Pramoxine HCl	CREAM	TOPICAL	20201119		UNAPPROVED DRUG OTHER		TRUPHARMA, LLC	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52817-820_e711470b-ad0e-495d-94ae-04c283dfd493	52817-820	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride Oral Solution		Metformin Hydrochloride	SOLUTION	ORAL	20220125		ANDA	ANDA211309	TRUPHARMA, LLC	METFORMIN HYDROCHLORIDE	500	mg/5mL	Biguanide [EPC], Biguanides [CS]		N	20241231
52817-821_e711470b-ad0e-495d-94ae-04c283dfd493	52817-821	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride Oral Solution		Metformin Hydrochloride	SOLUTION	ORAL	20220125		ANDA	ANDA211309	TRUPHARMA, LLC	METFORMIN HYDROCHLORIDE	500	mg/5mL	Biguanide [EPC], Biguanides [CS]		N	20241231
52817-822_e711470b-ad0e-495d-94ae-04c283dfd493	52817-822	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride Oral Solution		Metformin Hydrochloride	SOLUTION	ORAL	20220125		ANDA	ANDA211309	TRUPHARMA, LLC	METFORMIN HYDROCHLORIDE	500	mg/5mL	Biguanide [EPC], Biguanides [CS]		N	20241231
52817-824_c87cc890-4383-4287-a7ff-bfc2962796e0	52817-824	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate USP, 0.05%		Betamethasone Dipropionate USP, 0.05%	OINTMENT	TOPICAL	20220218		ANDA	ANDA215186	TruPharma LLC	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52817-830_282b6b99-4a63-47a6-b1c3-8561af8fd606	52817-830	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine	SOLUTION	ORAL	20220209		ANDA	ANDA212533	TRUPHARMA, LLC	LEVOCARNITINE	1	g/10mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
52854-326_06c058c2-3600-7f60-e063-6394a90a068e	52854-326	HUMAN OTC DRUG	Expedition BackCountry SPF 30		octocrylene, octisalate, and avobenzone	SPRAY	TOPICAL	20201207		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100mL; g/100mL; g/100mL			N	20241231
52854-403_06c07069-717b-4827-e063-6294a90ab035	52854-403	HUMAN OTC DRUG	Land Shark SPF 40		zinc oxide and titanium dioxide	LOTION	TOPICAL	20211025		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	4.2; 13	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52854-513_06bf9131-1f28-a82b-e063-6394a90adef0	52854-513	HUMAN OTC DRUG	Reef Kids SPF 30 Oxybenzone Free		octocrylene, octisalate, and avobenzone	LOTION	TOPICAL	20170501		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100mL; g/100mL; g/100mL			N	20241231
52854-515_06bf768f-6c0e-a4d9-e063-6394a90ad050	52854-515	HUMAN OTC DRUG	Reef Babies SPF 50 Oxybenzone Free		octocrylene, octisalate, and avobenzone	LOTION	TOPICAL	20170501		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
52854-538_06c02c09-e4d2-3b29-e063-6394a90af7ac	52854-538	HUMAN OTC DRUG	Reef Kids SPF 30 Oxybenzone Free		octocrylene, octisalate, and avobenzone	SPRAY	TOPICAL	20201207		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100mL; g/100mL; g/100mL			N	20241231
52854-558_06c0570f-e0fd-0904-e063-6394a90a66b3	52854-558	HUMAN OTC DRUG	Reef Babies SPF 50 Oxybenzone Free		octocrylene, octisalate, and avobenzone	SPRAY	TOPICAL	20201207		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
52854-600_06bf31c1-979c-81df-e063-6294a90a3947	52854-600	HUMAN OTC DRUG	Hand Sanitizer		SDA 40B Alcohol 200 Proof	LIQUID	TOPICAL	20090328		OTC MONOGRAPH DRUG	M003	Tropical Seas, Inc.	ALCOHOL	64.325	g/100mL			N	20241231
52854-615_06c062b6-e037-5e3e-e063-6394a90aba0b	52854-615	HUMAN OTC DRUG	Land Shark Zinky SPF 36 Azure Blue		zinc oxide	CREAM	TOPICAL	20211025		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	ZINC OXIDE	24	g/100g			N	20241231
52854-625_06c06105-7c8c-07f0-e063-6294a90a8e4d	52854-625	HUMAN OTC DRUG	Land Shark Zinky SPF 36 Pink Beach		zinc oxide	CREAM	TOPICAL	20211025		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	ZINC OXIDE	24	g/100g			N	20241231
52854-645_06c07069-717c-4827-e063-6294a90ab035	52854-645	HUMAN OTC DRUG	Land Shark Zinky SPF 36 Pacific Purple		zinc oxide	CREAM	TOPICAL	20211025		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	ZINC OXIDE	24	g/100g			N	20241231
52854-908_06bf8f3e-c273-31ae-e063-6294a90a728d	52854-908	HUMAN OTC DRUG	Land Shark SPF 8		octinoxate and oxybenzone	LOTION	TOPICAL	20200722		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	OCTINOXATE; OXYBENZONE	4.5; 1.5	g/100mL; g/100mL			N	20241231
52854-913_06c058c2-35ff-7f60-e063-6394a90a068e	52854-913	HUMAN OTC DRUG	Land Shark SPF 30		octocrylene, octisalate, and avobenzone	SPRAY	TOPICAL	20201207		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100mL; g/100mL; g/100mL			N	20241231
52854-915_06bf9df5-8d90-8780-e063-6394a90ae735	52854-915	HUMAN OTC DRUG	Land Shark SPF 15		octocrylene, octisalate, and avobenzone	LOTION	TOPICAL	20200214		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1; 2; 3	g/100mL; g/100mL; g/100mL			N	20241231
52854-916_06c04ea4-d51a-5d71-e063-6394a90ac10c	52854-916	HUMAN OTC DRUG	Land Shark SPF 15		octocrylene, octisalate, and avobenzone	SPRAY	TOPICAL	20201207		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1; 2; 3	g/100mL; g/100mL; g/100mL			N	20241231
52854-920_06bfa8b2-eedb-4795-e063-6294a90adbf1	52854-920	HUMAN OTC DRUG	Land Shark SPF 20		octocrylene, octisalate, and avobenzone	LOTION	TOPICAL	20200722		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1; 2; 3	g/100mL; g/100mL; g/100mL			N	20241231
52854-927_06bf8f3e-c277-31ae-e063-6294a90a728d	52854-927	HUMAN OTC DRUG	Land Shark SPF 30		octocrylene, octisalate, avobenzone	LIPSTICK	TOPICAL	20200803		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100g; g/100g; g/100g			N	20241231
52854-928_06bf3a8a-318b-83d3-e063-6294a90a45f1	52854-928	HUMAN OTC DRUG	Land Shark SPF 8		octinoxate and oxybenzone	OIL	TOPICAL	20200722		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	OCTINOXATE; OXYBENZONE	5; 2	g/100mL; g/100mL			N	20241231
52854-933_06e8042e-30a4-163b-e063-6294a90a74f3	52854-933	HUMAN OTC DRUG	Land Shark SPF 30		octocrylene, octisalate, and avobenzone	LOTION	TOPICAL	20200214		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100mL; g/100mL; g/100mL			N	20241231
52854-943_06c07eb6-83a1-38b9-e063-6294a90ade6b	52854-943	HUMAN OTC DRUG	Land Shark SPF 30 Clear Zinc		zinc oxide and titanium dioxide	CREAM	TOPICAL	20211018		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	3.2; 7.5	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52854-944_06c0811c-ad06-22f5-e063-6294a90a934c	52854-944	HUMAN OTC DRUG	Land Shark SPF 30 Tinted Zinc		zinc oxide and titanium dioxide	CREAM	TOPICAL	20211018		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	3.2; 7.5	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
52854-945_06bf4c31-63bd-c7c3-e063-6294a90a4471	52854-945	HUMAN OTC DRUG	Land Shark SPF 45		octocrylene, octinoxate, oxybenzone, homosalate and octisalate	LOTION	TOPICAL	20200722		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	5; 7.5; 5; 8; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
52854-950_06bf8ae7-2cf6-2e8d-e063-6294a90a13ac	52854-950	HUMAN OTC DRUG	Land Shark SPF 50		octocrylene, octisalate, and avobenzone	LOTION	TOPICAL	20200214		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
52854-951_06c062b6-e030-5e3e-e063-6394a90aba0b	52854-951	HUMAN OTC DRUG	Land Shark SPF 50		octocrylene, octisalate, and avobenzone	SPRAY	TOPICAL	20201207		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
52854-952_06c1a300-2460-c70a-e063-6394a90aad60	52854-952	HUMAN OTC DRUG	Expedition BackCountry SPF 50		octocrylene, octisalate, and avobenzone	LOTION	TOPICAL	20230810		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
52854-956_06c06105-7c79-07f0-e063-6294a90a8e4d	52854-956	HUMAN OTC DRUG	Land Shark SPF 50 Sport		octocrylene, octisalate, and avobenzone	SPRAY	TOPICAL	20201207		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
52854-976_06d446a8-2fbd-fea1-e063-6394a90a835e	52854-976	HUMAN OTC DRUG	Expedition BackCountry SPF 30		octocrylene, octisalate, avobenzone	LIPSTICK	TOPICAL	20230810		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100g; g/100g; g/100g			N	20241231
52854-981_06bfa8b2-eede-4795-e063-6294a90adbf1	52854-981	HUMAN OTC DRUG	Land Shark SPF 30		octocrylene, octisalate, avobenzone	LIPSTICK	TOPICAL	20200803		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100g; g/100g; g/100g			N	20241231
52854-982_06bf9df5-8d92-8780-e063-6394a90ae735	52854-982	HUMAN OTC DRUG	Land Shark SPF 30		octocrylene, octisalate, avobenzone	LIPSTICK	TOPICAL	20200803		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100g; g/100g; g/100g			N	20241231
52854-983_06bf9131-1f25-a82b-e063-6394a90adef0	52854-983	HUMAN OTC DRUG	Land Shark SPF 30		octocrylene, octisalate, avobenzone	LIPSTICK	TOPICAL	20200803		OTC MONOGRAPH DRUG	M020	Tropical Seas, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 3; 5	g/100g; g/100g; g/100g			N	20241231
52856-501_880650ec-dac5-4e10-be94-f4e92e4861f8	52856-501	HUMAN PRESCRIPTION DRUG	EMFLAZA		deflazacort	TABLET	ORAL	20180910		NDA	NDA208684	PTC Therapeutics, Inc.	DEFLAZACORT	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52856-502_880650ec-dac5-4e10-be94-f4e92e4861f8	52856-502	HUMAN PRESCRIPTION DRUG	EMFLAZA		deflazacort	TABLET	ORAL	20180910		NDA	NDA208684	PTC Therapeutics, Inc.	DEFLAZACORT	18	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52856-503_880650ec-dac5-4e10-be94-f4e92e4861f8	52856-503	HUMAN PRESCRIPTION DRUG	EMFLAZA		deflazacort	TABLET	ORAL	20180910		NDA	NDA208684	PTC Therapeutics, Inc.	DEFLAZACORT	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52856-504_880650ec-dac5-4e10-be94-f4e92e4861f8	52856-504	HUMAN PRESCRIPTION DRUG	EMFLAZA		deflazacort	TABLET	ORAL	20180910		NDA	NDA208684	PTC Therapeutics, Inc.	DEFLAZACORT	36	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52856-505_880650ec-dac5-4e10-be94-f4e92e4861f8	52856-505	HUMAN PRESCRIPTION DRUG	EMFLAZA		deflazacort	SUSPENSION	ORAL	20180910		NDA	NDA208685	PTC Therapeutics, Inc.	DEFLAZACORT	22.75	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
52862-010_acc04184-80a6-4b2a-e053-2a95a90aeaf1	52862-010	HUMAN OTC DRUG	Health Smart Baby		TALC	POWDER	TOPICAL	20121219		OTC MONOGRAPH NOT FINAL	part347	Home Smart Products	TALC	1	g/g			N	20241231
52862-011_ac9d47aa-8ae6-51d5-e053-2a95a90a4823	52862-011	HUMAN OTC DRUG	Health Smart Lavender Baby Petroleum		White Petroleum	JELLY	TOPICAL	20130728		OTC MONOGRAPH FINAL	part347	Home Smart Products	PETROLATUM	99.9	g/100g			N	20241231
52862-012_ac9d51f3-7fea-91b2-e053-2995a90aba49	52862-012	HUMAN OTC DRUG	Health Smart Aloe Vera Petroleum		White Petroleum	JELLY	TOPICAL	20130728		OTC MONOGRAPH FINAL	part347	Home Smart Products	PETROLATUM	99.9	g/100g			N	20241231
52862-013_d5db84e2-0a28-364c-e053-2a95a90a37cd	52862-013	HUMAN OTC DRUG	Health Smart Original Petroleum		White Petroleum	JELLY	TOPICAL	20130728		OTC MONOGRAPH FINAL	part347	Home Smart Products	PETROLATUM	100	g/100g			N	20241231
52862-014_ac9d47aa-8af9-51d5-e053-2a95a90a4823	52862-014	HUMAN OTC DRUG	Health Smart Cocoa Butter Petroleum		White Petroleum	JELLY	TOPICAL	20130728		OTC MONOGRAPH FINAL	part347	Home Smart Products	PETROLATUM	99.9	g/100g			N	20241231
52862-015_ac9d655f-6eec-c4a6-e053-2a95a90a14b6	52862-015	HUMAN OTC DRUG	Health Smart Baby Petroleum		White Petroleum	JELLY	TOPICAL	20130728		OTC MONOGRAPH FINAL	part347	Home Smart Products	PETROLATUM	99.9	g/100g			N	20241231
52862-016_d887934a-793a-54f1-e053-2a95a90af978	52862-016	HUMAN OTC DRUG	Health Smart Vaporizing Chest Rub		Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20131001		OTC MONOGRAPH NOT FINAL	part348	Home Smart Products	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
52862-020_ac9d655f-6efa-c4a6-e053-2a95a90a14b6	52862-020	HUMAN OTC DRUG	Health Smart Medicated Body		Menthol and Zinc Oxide	POWDER	TOPICAL	20140227		OTC MONOGRAPH NOT FINAL	part348	International Wholesale Inc dba Home Smart Products	MENTHOL; ZINC OXIDE	.15; 1	g/100g; g/100g			N	20241231
52862-021_ac9d954b-9cdd-d059-e053-2995a90a2ddc	52862-021	HUMAN OTC DRUG	Health Smart Medicated Foot		Menthol	POWDER	TOPICAL	20140227		OTC MONOGRAPH NOT FINAL	part348	International Wholesale Inc dba Home Smart Products	MENTHOL	1	g/100g			N	20241231
52862-022_a85dbb02-e3ea-b64c-e053-2995a90a2913	52862-022	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 50%		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	Home Smart Products	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52862-023_d5892548-6c2b-15b4-e053-2a95a90a4e3c	52862-023	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 50% WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	Home Smart Products	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
52862-024_a85dbb02-e3fd-b64c-e053-2995a90a2913	52862-024	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70%		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	Home Smart Products	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52862-025_d5892e66-6bf5-604e-e053-2a95a90a922e	52862-025	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 70% WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	Home Smart Products	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
52862-028_d1601307-a687-4423-e053-2a95a90a2b51	52862-028	HUMAN OTC DRUG	91% Isopropyl Rubbing Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20210114		OTC MONOGRAPH NOT FINAL	part333A	Home Smart Products	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
52862-029_d198ce47-532a-47fa-e053-2a95a90ab18f	52862-029	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 99% WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	Home Smart Products	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
52862-030_045d48cf-ff91-7d20-e063-6394a90a520c	52862-030	HUMAN OTC DRUG	Health Smart Medicated Body		Menthol and Zinc Oxide	POWDER	TOPICAL	20140227		OTC MONOGRAPH NOT FINAL	part348	International Wholesale Inc dba Home Smart Products	MENTHOL; ZINC OXIDE	.15; 1	g/100g; g/100g			N	20241231
52862-040_ac9ed700-e028-3110-e053-2a95a90a48ba	52862-040	HUMAN OTC DRUG	Health Smart Vaporizing Chest Rub		Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20131001		OTC MONOGRAPH NOT FINAL	part348	Home Smart Products	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
52862-041_acab55b7-2d64-c96e-e053-2995a90a2243	52862-041	HUMAN OTC DRUG	Health Smart Vaporizing Chest Rub		Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20131001		OTC MONOGRAPH NOT FINAL	part348	Home Smart Products	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
52862-131_d6ebe00c-b693-5171-e053-2a95a90a976c	52862-131	HUMAN OTC DRUG	White Rain Original Petroleum		White Petroleum	JELLY	TOPICAL	20220108		OTC MONOGRAPH FINAL	part347	INTERNATIONAL WHOLESALE INC.	PETROLATUM	100	g/100g			N	20241231
52862-133_d7068cea-fa8b-b3e5-e053-2a95a90aa56c	52862-133	HUMAN OTC DRUG	white rain Cocoa Butter Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20220108		OTC MONOGRAPH FINAL	part347	INTERNATIONAL WHOLESALE INC.	PETROLATUM	99.9	g/100g			N	20241231
52862-202_e4d9bc39-bea5-2192-e053-2995a90a0012	52862-202	HUMAN OTC DRUG	Epsom Salts		Magnesium Sulfate	GRANULE	ORAL; TOPICAL	20190709		OTC MONOGRAPH NOT FINAL	part334	International Wholesale Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	100	g/100g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
52862-203_e5f3edc2-1b7a-533a-e053-2a95a90ae9b6	52862-203	HUMAN OTC DRUG	Epsom Salts		Magnesium Sulfate	GRANULE	ORAL; TOPICAL	20190709		OTC MONOGRAPH NOT FINAL	part334	International Wholesale Inc.	MAGNESIUM SULFATE HEPTAHYDRATE	100	g/100g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
52862-500_08323f12-4b84-11ee-e063-6394a90a6f66	52862-500	HUMAN OTC DRUG	FreshMax Fluoride Regular Flavor		SODIUM MONOFLUOROPHOSPHATE	PASTE	DENTAL	20170227		OTC MONOGRAPH DRUG	M021	International Wholesale Inc	SODIUM MONOFLUOROPHOSPHATE	76	mg/g			N	20241231
52862-501_08325f65-2d2d-9ffc-e063-6294a90a3a8c	52862-501	HUMAN OTC DRUG	FreshMax Fluoride Minty Flavor		SODIUM MONOFLUOROPHOSPHATE	PASTE	DENTAL	20170227		OTC MONOGRAPH DRUG	M021	International Wholesale Inc	SODIUM MONOFLUOROPHOSPHATE	76	mg/g			N	20241231
52862-601_0c83ad46-57f5-9a3b-e063-6294a90adad1	52862-601	HUMAN OTC DRUG	HEALTH SMART ANTIBACTERIAL HAND ORIGINAL		CHLOROXYLENOL	LIQUID	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	CHLOROXYLENOL	3	mg/mL			N	20241231
52862-602_0c83935b-835c-7a1c-e063-6294a90a7902	52862-602	HUMAN OTC DRUG	HEALTH SMART ANTIBACTERIAL HAND LAVENDER CHAMOMILE		CHLOROXYLENOL	LIQUID	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	CHLOROXYLENOL	3	mg/mL			N	20241231
52862-603_0c83afd6-4248-38ba-e063-6394a90a0fce	52862-603	HUMAN OTC DRUG	HEALTH SMART ANTIBACTERIAL HAND SWEET PEA ORCHID		CHLOROXYLENOL	LIQUID	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	CHLOROXYLENOL	3	mg/mL			N	20241231
52862-604_0c83935b-836a-7a1c-e063-6294a90a7902	52862-604	HUMAN OTC DRUG	HEALTH SMART ANTIBACTERIAL HAND CUCUMBER MELON		CHLOROXYLENOL	LIQUID	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	CHLOROXYLENOL	3	mg/mL			N	20241231
52862-605_0c83bd92-3b33-bc7b-e063-6294a90afa19	52862-605	HUMAN OTC DRUG	HEALTH SMART ANTIBACTERIAL HAND SPRING RAIN H S		CHLOROXYLENOL	LIQUID	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	CHLOROXYLENOL	3	mg/mL			N	20241231
52862-606_0c83bd92-3b41-bc7b-e063-6294a90afa19	52862-606	HUMAN OTC DRUG	HEALTH SMART HAND SANITIZER ORIGINAL		ALCOHOL	GEL	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	ALCOHOL	.62	mL/mL			N	20241231
52862-607_0c83afd6-4256-38ba-e063-6394a90a0fce	52862-607	HUMAN OTC DRUG	HEALTH SMART HAND SANITIZER CUCUMBER MELON		ALCOHOL	GEL	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	ALCOHOL	.62	mL/mL			N	20241231
52862-608_0c83935b-8378-7a1c-e063-6294a90a7902	52862-608	HUMAN OTC DRUG	HEALTH SMART HAND SANITIZER SWEET PEA		ALCOHOL	GEL	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	ALCOHOL	.62	mL/mL			N	20241231
52862-609_0c83935b-8386-7a1c-e063-6294a90a7902	52862-609	HUMAN OTC DRUG	HEALTH SMART HAND SANITIZER LAVENDER		ALCOHOL	GEL	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	ALCOHOL	.62	mL/mL			N	20241231
52862-610_0c83cb14-c7d4-3b79-e063-6394a90a4d77	52862-610	HUMAN OTC DRUG	HEALTH SMART HAND SANITIZER PEACH		ALCOHOL	GEL	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	ALCOHOL	.62	mL/mL			N	20241231
52862-611_0c863e4e-1af5-6315-e063-6294a90a9034	52862-611	HUMAN OTC DRUG	HEALTH SMART ANTIBACTERIAL WET WIPES FOR HANDS AND FACE		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200622		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
52862-612_08659a5c-2d17-2f98-e063-6394a90a7760	52862-612	HUMAN OTC DRUG	Health Smart Hand Sanitizer ORIGINAL		ALCOHOL	GEL	TOPICAL	20200814		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale Inc	ALCOHOL	.62	mL/mL			N	20241231
52862-613_0a4d37f0-dbd5-fde6-e063-6394a90a39b0	52862-613	HUMAN OTC DRUG	Health Smart Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201001		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
52862-615_0a4d3bb3-2a76-06ab-e063-6394a90ac197	52862-615	HUMAN OTC DRUG	White Rain Foaming Antibacterial Hand Spring Water		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230101		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-616_0a4d3efe-90a1-c9cd-e063-6294a90ad090	52862-616	HUMAN OTC DRUG	White Rain Antibacterial Hand Lemon Zest		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230101		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-617_0a4d419d-798a-089f-e063-6394a90a9f44	52862-617	HUMAN OTC DRUG	White Rain Antibacterial Hand Classic Gold		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230101		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-620_0a4d471b-c3f0-0a6a-e063-6394a90ad57b	52862-620	HUMAN OTC DRUG	White Rain Antibacterial Hand MILK and HONEY		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-621_0a4d3efe-90a2-c9cd-e063-6294a90ad090	52862-621	HUMAN OTC DRUG	White Rain Antibacterial Hand SOOTHING ALOE		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-622_0a4d29df-b046-fe00-e063-6394a90a2194	52862-622	HUMAN OTC DRUG	White Rain Antibacterial Hand LAVENDER BREEZE		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-623_0a4d52aa-f85c-f3d6-e063-6394a90ae9da	52862-623	HUMAN OTC DRUG	White Rain Antibacterial Hand WHITE TEA		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-624_0a4d3265-080d-d2ed-e063-6394a90adbee	52862-624	HUMAN OTC DRUG	White Rain Antibacterial Hand SPRING WATER		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52862-625_0a4d419d-798b-089f-e063-6394a90a9f44	52862-625	HUMAN OTC DRUG	White Rain Antibacterial Hand COCONUT and GINGER		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	505G(a)(3)	International Wholesale, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
52915-010_c5cedf8c-1e41-42dd-8afc-40c8f0c0ca24	52915-010	HUMAN OTC DRUG	ECZEMA		OATMEAL	LOTION/SHAMPOO	TOPICAL	20121001		OTC MONOGRAPH FINAL	part347	ORGANIC & SUSTAINABLE BEAUTY	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
52915-030_e40a2382-118b-4621-ae33-9734483a8db9	52915-030	HUMAN OTC DRUG	SPF30 EVERYDAY/YEAR-ROUND SUNSCREEN		TITANIUM DIOXIDE	LOTION/SHAMPOO	TOPICAL	20150831		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	TITANIUM DIOXIDE	120	mg/g			N	20241231
52915-040_ad6615ea-4604-41be-8059-83bb623099d0	52915-040	HUMAN OTC DRUG	SPF30 SUMMER BLEND SUNSCREEN		TITANIUM DIOXIDE	LOTION/SHAMPOO	TOPICAL	20100401		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	TITANIUM DIOXIDE	120	mg/g			N	20241231
52915-050_916fe983-7ba6-452f-afcc-12552377f740	52915-050	HUMAN OTC DRUG	SPF30 SUPER SENSITIVE SUNSCREEN		TITANIUM DIOXIDE	LOTION/SHAMPOO	TOPICAL	20150831		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	TITANIUM DIOXIDE	120	mg/g			N	20241231
52915-060_4da2b6ad-3de2-4b9f-9d49-657197507f7d	52915-060	HUMAN OTC DRUG	SPF30 EVERYDAY/YEAR-ROUND SUNSCREEN		TITANIUM DIOXIDE	STICK	TOPICAL	20110401		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	TITANIUM DIOXIDE	170	mg/g			N	20241231
52915-066_357df162-f41a-45bd-a62e-5471a995b1c9	52915-066	HUMAN OTC DRUG	LEMON MYRTLE HAND SANITIZER		ALCOHOL	SPRAY	TOPICAL	20151030		OTC MONOGRAPH NOT FINAL	part333A	ORGANIC & SUSTAINABLE BEAUTY	ALCOHOL	62	mL/100mL			N	20241231
52915-067_82e0fcdf-5148-4e8f-8cd0-cc5ea347fa73	52915-067	HUMAN OTC DRUG	SPF30 CALENDULA SUNSCREEN		TITANIUM DIOXIDE	LOTION	TOPICAL	20121201		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	TITANIUM DIOXIDE	120	mg/g			N	20241231
52915-068_431f39f4-7a9b-4855-bef3-cf7deb2b4bf5	52915-068	HUMAN OTC DRUG	KIDS SPF30 SUPER SENSITIVE PLUS C111 SUNSCREEN		TITANIUM DIOXIDE	LOTION	TOPICAL	20140203		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	TITANIUM DIOXIDE	120	mg/g			N	20241231
52915-069_6afed5fe-19a2-4e43-ab89-57eed6097e5a	52915-069	HUMAN OTC DRUG	CALMING DIAPER RASH		ZINC OXIDE	CREAM	TOPICAL	20150831		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	ZINC OXIDE	120	mg/g			N	20241231
52915-070_bb0d4015-8966-401c-b4e7-1b204f060b4c	52915-070	HUMAN OTC DRUG	SPF30 SUPER SENSITIVE SUNSCREEN		TITANIUM DIOXIDE	STICK	TOPICAL	20110401		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	TITANIUM DIOXIDE	170	mg/g			N	20241231
52915-074_157214c5-aff9-4742-af15-f8cec119bd13	52915-074	HUMAN OTC DRUG	CALMING HAND SANITIZER		ALCOHOL	SPRAY	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part333A	ORGANIC & SUSTAINABLE BEAUTY	ALCOHOL	62	mL/100mL			N	20241231
52915-075_64a3c94d-8839-460a-ad05-d7913b6df00b	52915-075	HUMAN OTC DRUG	EUCALYPTUS EASE HAND SANITIZER		ALCOHOL	SPRAY	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part333A	ORGANIC & SUSTAINABLE BEAUTY	ALCOHOL	62	mL/100mL			N	20241231
52915-076_42f48b67-7e38-4b18-b842-56947890ebb2	52915-076	HUMAN OTC DRUG	SUPER SENSITIVE HAND SANITIZER		ALCOHOL	SPRAY	TOPICAL	20200422		OTC MONOGRAPH NOT FINAL	part333A	ORGANIC & SUSTAINABLE BEAUTY	ALCOHOL	62	mL/mL			N	20241231
52915-120_0d86dbed-a022-4bba-979e-54b15d3fe4bd	52915-120	HUMAN OTC DRUG	ECZEMA		OATMEAL	CREAM	TOPICAL	20121201		OTC MONOGRAPH FINAL	part347	ORGANIC & SUSTAINABLE BEAUTY	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
52915-140_793a4992-4bce-4ceb-abe0-16e49242471a	52915-140	HUMAN OTC DRUG	SUPER SENSITIVE DIAPER RASH		ZINC OXIDE	CREAM	TOPICAL	20150831		OTC MONOGRAPH FINAL	part352	ORGANIC & SUSTAINABLE BEAUTY	ZINC OXIDE	120	mg/g			N	20241231
52920-127_edf77c7b-6f18-bd37-e053-2a95a90aea22	52920-127	HUMAN OTC DRUG	Pure Petroleum	Aloe with Vitamin E Oil	White Petroleum	JELLY	TOPICAL	20150810		OTC MONOGRAPH FINAL	part347	Singhfam Corporation	PETROLATUM	99.9	g/100g			N	20241231
52920-133_edf72d8b-faad-6aac-e053-2995a90a1444	52920-133	HUMAN OTC DRUG	Chest Rub	Vaporizing Action	Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20150810		OTC MONOGRAPH NOT FINAL	part348	Singhfam Corporation	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
52920-135_f1e4caee-b50f-a0a6-e053-2a95a90aadce	52920-135	HUMAN OTC DRUG	ELIZABETH HEALTH STYLE CHESTRUB VAPORIZING ACTION		CAMPHOR (SYNTHETIC), LEVOMENTHOL, EUCALYPTUS	OINTMENT	TOPICAL	20230105		OTC MONOGRAPH NOT FINAL	part348	Singhfam Corporation	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; LEVOMENTHOL	5; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
52925-112_91d0a4a1-11bd-4163-9667-80ff0b1e8658	52925-112	HUMAN OTC DRUG	VCF CONTRACEPTIVE		NONOXYNOL-9	FILM, SOLUBLE	VAGINAL	19880601		OTC MONOGRAPH NOT FINAL	part333A	APOTHECUS PHARMACEUTICAL CORP.	NONOXYNOL-9	280	mg/1			N	20241231
52925-512_d167d030-407a-4694-9211-7f2b5a27659f	52925-512	HUMAN OTC DRUG	VCF CONTRACEPTIVE PRE-FILLED APPLICATORS		NONOXYNOL-9	GEL, METERED	VAGINAL	20140601		OTC MONOGRAPH NOT FINAL	part333A	APOTHECUS PHARMACEUTICAL CORP	NONOXYNOL-9	4	g/100g			N	20241231
52937-001_3cbbd4ee-5c31-4ed9-a39c-01b3529967f9	52937-001	HUMAN PRESCRIPTION DRUG	Vascepa		icosapent ethyl	CAPSULE	ORAL	20121001		NDA	NDA202057	Amarin Pharma Inc.	ICOSAPENT ETHYL	1000	mg/1			N	20241231
52937-003_3cbbd4ee-5c31-4ed9-a39c-01b3529967f9	52937-003	HUMAN PRESCRIPTION DRUG	Vascepa		icosapent ethyl	CAPSULE	ORAL	20160916		NDA	NDA202057	Amarin Pharma Inc.	ICOSAPENT ETHYL	500	mg/1			N	20241231
52937-101_3cbbd4ee-5c31-4ed9-a39c-01b3529967f9	52937-101	HUMAN PRESCRIPTION DRUG	Vascepa		icosapent ethyl	CAPSULE	ORAL	20121001		NDA	NDA202057	Amarin Pharma Inc.	ICOSAPENT ETHYL	1000	mg/1			N	20241231
52958-034_83f3e458-59ad-48aa-8ac0-241bd833391d	52958-034	HUMAN PRESCRIPTION DRUG	Bivalirudin		Bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191023		ANDA	ANDA210031	Hainan Shuangcheng Pharmaceuticals Co., Ltd.	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
52958-040_e72cda01-7019-4b27-b3f8-a857b254fd9f	52958-040	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20220421		ANDA	ANDA213081	Hainan Shuangcheng Pharmaceuticals Co., Ltd.	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
52958-402_e72cda01-7019-4b27-b3f8-a857b254fd9f	52958-402	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20210907		ANDA	ANDA213081	Hainan Shuangcheng Pharmaceuticals Co., Ltd.	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
52959-193_f0c0aebf-485d-cc35-e053-2995a90a9f1e	52959-193	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20180102		ANDA	ANDA091416	H.J. Harkins Company., Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
52982-100_f2a4af1a-0ccd-5446-e053-2995a90a231d	52982-100	HUMAN OTC DRUG	Your Logo Here Antiseptic First Aid		benzocaine and benzethonium chloride	AEROSOL, SPRAY	TOPICAL	20120101		OTC MONOGRAPH NOT FINAL	part348	Dixon Investments, Inc.	BENZETHONIUM CHLORIDE; BENZOCAINE	170; 8500	mg/85g; mg/85g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52982-101_f2a48124-0794-51c2-e053-2a95a90aa1af	52982-101	HUMAN OTC DRUG	Your Logo Here Burn First Aid		benzocaine, benzethonium chloride, and menthol	AEROSOL, SPRAY	TOPICAL	20130405		OTC MONOGRAPH NOT FINAL	part348	Dixon Investments, Inc.	BENZETHONIUM CHLORIDE; BENZOCAINE; MENTHOL	170; 8500; 281	mg/85g; mg/85g; mg/85g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52982-105_f2a4b40c-93d4-dcf2-e053-2995a90ad945	52982-105	HUMAN OTC DRUG	Your Logo Here Bandage Aid		benzethonium chloride and benzocaine	AEROSOL, SPRAY	TOPICAL	20130405		OTC MONOGRAPH NOT FINAL	part333A	Dixon Investments, Inc.	BENZETHONIUM CHLORIDE; BENZOCAINE	170; 2720	mg/85g; mg/85g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
52982-106_f2a4af1a-0ccc-5446-e053-2995a90a231d	52982-106	HUMAN OTC DRUG	Your Label Here Blood Clotting First Aid		benzethonium chloride and lidocaine	AEROSOL, SPRAY	TOPICAL	20130405		OTC MONOGRAPH NOT FINAL	part348	Dixon Investments, Inc.	BENZETHONIUM CHLORIDE; LIDOCAINE	170; 3400	mg/85g; mg/85g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
52993-001_7b9dbebd-c385-4fa4-88a1-32fd91555c20	52993-001	HUMAN OTC DRUG	Zinka Clear Zinc Oxide Sunscreen		Octinoxate, Zinc Oxide, Octisalate, Oxybenzone	LOTION	TOPICAL	20070301		OTC MONOGRAPH FINAL	part352	Zinka, Inc.	OCTINOXATE; OCTISALATE; OXYBENZONE; ZINC OXIDE	50; 30; 25; 43	mg/g; mg/g; mg/g; mg/g			N	20241231
52993-127_f1dbc20e-cd6d-7b62-e053-2a95a90ac52f	52993-127	HUMAN OTC DRUG	Zinka SPF 30 Clear Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 8%	SPRAY	TOPICAL	20210419		OTC MONOGRAPH NOT FINAL	part352	Zinka, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
53002-0050_d764f4e8-5a5b-42c1-80bd-e0f016668364	53002-0050	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	POWDER, FOR SUSPENSION	ORAL	20040813		ANDA	ANDA065098	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-0051_0299f703-6fac-4959-986f-408fbba0fadc	53002-0051	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-0060_0b88000b-3d0a-4db6-a012-b91f49670ae9	53002-0060	HUMAN PRESCRIPTION DRUG	valacyclovir hydrochloride		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	20120405		ANDA	ANDA201506	RPK Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0061_acabd586-8e36-4c30-903c-0e5e5d6d9181	53002-0061	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	RPK Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0082_a52d5ae4-7d93-4390-8d44-c16ab71f38ee	53002-0082	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	RPK Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0083_c7c01967-27fa-42cb-9243-7d263778edfe	53002-0083	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20180504		ANDA	ANDA210401	RPK Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0084_c88af239-56bd-4943-802f-93d2975ae7ac	53002-0084	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	RPK Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0085_bd8bb258-9142-4eda-aaad-1289e41d9caa	53002-0085	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	RPK Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0100_a343596c-7866-4d76-a148-6d02a48f88b1	53002-0100	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20050113		ANDA	ANDA065089	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-0101_25f7e867-d239-4d06-9097-24bfbc551159	53002-0101	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine		Acetaminophen and Codeine	TABLET	ORAL	20080529		ANDA	ANDA040779	RPK Pharmaceuticals, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
53002-0102_66ac0fb6-0143-437a-abdb-e36e96a23c21	53002-0102	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	RPK Pharmaceuticals, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
53002-0130_3e188a75-be71-47c8-baf1-7e184ff8c84c	53002-0130	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	RPK Pharmaceuticals, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-0131_931a703d-94de-4368-83c8-cd0ff30fe46a	53002-0131	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	RPK Pharmaceuticals, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-0140_8d26f91b-2e2b-43eb-a8ab-7bc6cedd2210	53002-0140	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION/ DROPS	OPHTHALMIC	19990629		ANDA	ANDA075282	RPK Pharmaceuticals, Inc.	CROMOLYN SODIUM	40	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
53002-0151_da8d9af9-4dd9-4caa-b235-fe6632656fae	53002-0151	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	20170303		ANDA	ANDA208590	RPK Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-0170_03c775f4-21bb-48f2-be56-6678d6e09dc9	53002-0170	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	RPK Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-0171_a492ed81-8cb4-44c0-8f88-30d33ba69105	53002-0171	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	RPK Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-0270_8cc0dbba-3057-4a11-b591-a50ea6ecd423	53002-0270	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	RPK Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0271_fdc34522-21a2-426f-9f04-1ffd8a4f0c4b	53002-0271	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	RPK Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0272_23aaab05-bef8-478b-a065-4ef2689d105a	53002-0272	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	RPK Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0340_070669d5-de3b-4709-957c-1247ce84ec22	53002-0340	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	RPK Pharmaceuticals, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53002-0341_41ed9ec9-6595-4ee3-8548-b777e3739bd1	53002-0341	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	RPK Pharmaceuticals, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
53002-0411_fe115abb-06cc-4729-baee-39e91e4befb1	53002-0411	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	RPK Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
53002-0412_66d75b80-bb1a-47f2-8ea6-aebd291d829a	53002-0412	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040749	RPK Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
53002-0413_4a34c0fc-541b-44ca-8d1a-3c5fc495aca3	53002-0413	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	RPK Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
53002-0473_70b4be8c-3520-4f58-8574-f3211faaf502	53002-0473	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207398	RPK Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-0474_fd56aaa2-c6ec-4631-adfb-b1146a2297ba	53002-0474	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	RPK Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-0510_bd37bce9-8df8-4d58-8f70-3dc1ed9179de	53002-0510	HUMAN PRESCRIPTION DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20151207		ANDA	ANDA206306	RPK Pharmaceuticals, Inc.	OLOPATADINE HYDROCHLORIDE	1.11	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
53002-0520_963a0082-465f-4ec8-aa06-82ea82eb441c	53002-0520	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	RPK Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-0521_7025749c-d12f-4469-8432-aade34f0e14d	53002-0521	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA090478	RPK Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-0523_efd2ef8a-b380-4499-91ed-77f97000a473	53002-0523	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	RPK Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-0524_12ece8c9-4eb4-48ae-bf92-1564990c8718	53002-0524	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	RPK Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-0550_21a87efa-dba9-43d0-b8df-0e35a0b0ffc0	53002-0550	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	RPK Pharmaceuticals, Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
53002-0570_6b61ac58-07f0-4c13-bd1c-15ce029b6270	53002-0570	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20070727		ANDA	ANDA077851	RPK Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0571_008474e2-169a-4522-8df4-c7c0e9f28ba1	53002-0571	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	RPK Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0572_07fce9e1-5acb-456e-9b85-4a528c1fe76f	53002-0572	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	RPK Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0580_e7133572-1b94-4cea-8050-83a694935141	53002-0580	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	RPK Pharmaceuticals, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0582_7c030256-38c9-43a9-b903-81f11361ac55	53002-0582	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	RPK Pharmaceuticals, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0590_2308d68e-9595-48ca-acbe-c5c1b0b817c1	53002-0590	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	RPK Pharmaceuticals, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0591_7494d054-cedf-484c-a5cc-05f699f018ef	53002-0591	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	RPK Pharmaceuticals, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0600_ea499045-f2a6-462b-8e51-8605af499e1e	53002-0600	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	RPK Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0601_db2cc2fc-e398-4627-bb58-802ab322334b	53002-0601	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	RPK Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-0610_d927e6af-c8ed-4fdd-8563-2bb77f4aa97f	53002-0610	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	RPK Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-0612_1468aa90-0616-4d95-bc70-f2a06685188e	53002-0612	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA080356	RPK Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-0620_2b9b0feb-4de7-4ff2-9070-6e8ccc2d47d5	53002-0620	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	RPK Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
53002-0622_1e064952-90e5-40c6-8a74-f0ebbc3be4e3	53002-0622	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	RPK Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
53002-0640_07873151-03d7-4426-bc48-57537620b2b4	53002-0640	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202438	RPK Pharmaceuticals, Inc.	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-0673_d937921d-11a0-4ba2-aa44-aef5dd995401	53002-0673	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	RPK Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53002-0674_cc19b9dc-97e1-4e75-99a6-1d49942daca9	53002-0674	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	RPK Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53002-1004_59f5ae12-f36f-455d-a329-4d9057b42fc6	53002-1004	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19950222		ANDA	ANDA074056	RPK Pharmaceuticals, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1005_b30c84b9-639b-4d4e-8fd4-f4842aca41fa	53002-1005	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	RPK Pharmaceuticals, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1016_7c0522b2-5aed-43ba-a593-3e7bdd618845	53002-1016	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	RPK Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1017_929b6de9-6f02-4cd0-bcbd-6d2d61c9fd4f	53002-1017	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	RPK Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
53002-1026_b30c84b9-639b-4d4e-8fd4-f4842aca41fa	53002-1026	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	RPK Pharmaceuticals, Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1068_563ede18-dec2-4b4b-ae86-ade1d4efda3d	53002-1068	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20161013		ANDA	ANDA077836	RPK Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
53002-1074_6cf801b4-b359-44ce-b9a2-ac2c492a818d	53002-1074	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED	ORAL	19861001		ANDA	ANDA070994	RPK Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-1105_888f7eda-9f6e-4eb4-b60f-6a90b1fc9045	53002-1105	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA071524	RPK Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53002-1108_59f5ae12-f36f-455d-a329-4d9057b42fc6	53002-1108	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20041116		ANDA	ANDA074056	RPK Pharmaceuticals, Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1111_80d32fba-b440-495a-944d-55489efed881	53002-1111	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20110718		ANDA	ANDA074550	RPK Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
53002-1119_6c1b7967-8991-4b94-ab95-140681c34a2b	53002-1119	HUMAN PRESCRIPTION DRUG	NP Thyroid 30		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20110114		UNAPPROVED DRUG OTHER		RPK Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	19; 4.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
53002-1123_8a839083-5a0b-4d0c-b967-80c8526ab213	53002-1123	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	RPK Pharmaceuticals, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
53002-1129_ff572f24-9420-4ac1-8ccf-e5db94e435d4	53002-1129	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090917		ANDA	ANDA078906	RPK Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-1132_888f7eda-9f6e-4eb4-b60f-6a90b1fc9045	53002-1132	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA071523	RPK Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53002-1138_59f5ae12-f36f-455d-a329-4d9057b42fc6	53002-1138	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19950217		ANDA	ANDA074056	RPK Pharmaceuticals, Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1176_e5e1b3b3-dad6-49d6-b7e3-d04726857102	53002-1176	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	TABLET, FILM COATED	ORAL	19980811		ANDA	ANDA075219	RPK Pharmaceuticals, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-1178_8a839083-5a0b-4d0c-b967-80c8526ab213	53002-1178	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	RPK Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
53002-1188_0731ad42-89e2-4120-8177-a4bed25b6d65	53002-1188	HUMAN PRESCRIPTION DRUG	Cryselle		Norgestrel and Ethinyl Estradiol	KIT		20020724		ANDA	ANDA075840	RPK Pharmaceuticals, Inc.						N	20241231
53002-1192_06ae8dc4-5b05-4bcf-b298-c892bbadfbff	53002-1192	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1202_64eee541-dbcb-448c-aafb-bc0dc7c3467f	53002-1202	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950405		ANDA	ANDA074132	RPK Pharmaceuticals, Inc.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
53002-1205_ff572f24-9420-4ac1-8ccf-e5db94e435d4	53002-1205	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110805		ANDA	ANDA090700	RPK Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-1215_06ae8dc4-5b05-4bcf-b298-c892bbadfbff	53002-1215	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1225_8a839083-5a0b-4d0c-b967-80c8526ab213	53002-1225	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	RPK Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
53002-1233_89a6bdae-3d0f-41b2-808b-4a9686ab62bd	53002-1233	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	RPK Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
53002-1246_5efb6a53-ecd9-4f30-b115-a25050f351f4	53002-1246	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20111209		ANDA	ANDA201407	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1248_02fbcffc-2c7c-42a6-a0ad-a31a0df0033d	53002-1248	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	RPK Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
53002-1249_59d898db-8e37-4a02-8def-3e296271250f	53002-1249	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1250_4d89b974-4b75-4833-84b8-fcbcfe816a43	53002-1250	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	RPK Pharmaceuticals, Inc.	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
53002-1252_f789510c-5cb6-47b4-9ab4-20a7d2bc944c	53002-1252	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA073449	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1270_2c8c65d0-8f32-4ca2-9632-216948261cf3	53002-1270	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	RPK Pharmaceuticals, Inc.	MIRTAZAPINE	30	mg/1			N	20241231
53002-1279_8c078b64-0a6e-45c0-9053-9172da11a7db	53002-1279	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		azelastine hydrochloride	SPRAY, METERED	NASAL	20100301		ANDA	ANDA077954	RPK Pharmaceuticals, Inc.	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53002-1292_51c9f718-3736-4985-9729-0510e6a222a6	53002-1292	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	RPK Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
53002-1305_7c0522b2-5aed-43ba-a593-3e7bdd618845	53002-1305	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	RPK Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1306_39281c03-3d7c-499d-bc00-4bacc96c09a4	53002-1306	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960918		ANDA	ANDA074569	RPK Pharmaceuticals, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53002-1308_cbce3720-fb76-414b-a7b8-6125d85bf97c	53002-1308	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20020701		ANDA	ANDA076194	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1320_59900837-7961-4866-b678-5af4d6fc6c7a	53002-1320	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		CIPROFLOXACIN HYDROCHLORIDE	SOLUTION/ DROPS	TOPICAL	20080320		ANDA	ANDA077689	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	3.5	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-1335_44f92004-25d6-4758-a16d-e2b1060c44d4	53002-1335	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-1338_62397cb6-9faf-4461-8c12-89899d645a22	53002-1338	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	RPK Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-1345_56618038-a7f8-47f1-8f8e-d2a58c7fca48	53002-1345	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	RPK Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
53002-1350_fccd14cb-70f1-4916-8ff6-bce97c5955f2	53002-1350	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	RPK Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
53002-1351_59d898db-8e37-4a02-8def-3e296271250f	53002-1351	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1352_59d898db-8e37-4a02-8def-3e296271250f	53002-1352	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1359_3cbfb31c-3e52-40b5-8aef-2ea42f73a242	53002-1359	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	RPK Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1360_3cbfb31c-3e52-40b5-8aef-2ea42f73a242	53002-1360	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	RPK Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1361_f29e4638-bbde-440e-b821-88d1657bf5f1	53002-1361	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	RPK Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-1365_f29e4638-bbde-440e-b821-88d1657bf5f1	53002-1365	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	RPK Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-1366_f29e4638-bbde-440e-b821-88d1657bf5f1	53002-1366	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	RPK Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-1369_c976f8cf-b453-44bc-908e-37a907d116de	53002-1369	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065378	RPK Pharmaceuticals, Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-1385_684947b5-38c4-4e68-81f6-3de935f4d19b	53002-1385	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20080314		ANDA	ANDA078296	RPK Pharmaceuticals, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-1387_35bee7ef-be76-4a28-b077-9fdef77eb7b3	53002-1387	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-1401_33ca102e-49cd-42e5-a359-a5e983b09fff	53002-1401	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	RPK Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	220	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-1418_71d41eae-5857-4fa1-bdbd-fb4c192ff6e2	53002-1418	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	RPK Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53002-1419_064ada7a-3ba9-4bef-9b4e-9c22a313ed50	53002-1419	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	RPK Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53002-1424_e6d336e8-f391-4ad3-a42d-8c095035b819	53002-1424	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020301		ANDA	ANDA075022	RPK Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
53002-1425_718b1086-bf8e-4b96-8794-e5e0fc641003	53002-1425	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20040326		ANDA	ANDA075022	RPK Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
53002-1431_af54109e-e811-4671-87de-2e4ff180da8f	53002-1431	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130305		ANDA	ANDA202389	RPK Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1434_f9fa251f-3165-4ae2-b46b-0abd0980d0c7	53002-1434	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	RPK Pharmaceuticals, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
53002-1437_e973fec0-fdba-41eb-a143-0f50cdbe65ef	53002-1437	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	RPK Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53002-1439_44f92004-25d6-4758-a16d-e2b1060c44d4	53002-1439	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-1440_44f92004-25d6-4758-a16d-e2b1060c44d4	53002-1440	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-1441_74394d8e-a7e2-472f-bde2-c4d74898a064	53002-1441	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20130411		ANDA	ANDA202717	RPK Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
53002-1463_8a839083-5a0b-4d0c-b967-80c8526ab213	53002-1463	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	RPK Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
53002-1467_80bc8d9c-e6a1-492d-b732-09d899efdb1b	53002-1467	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110805		ANDA	ANDA090700	RPK Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-1472_a0538d80-a2e4-4f24-a614-2fc3bd47aa24	53002-1472	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160629		ANDA	ANDA090705	RPK Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-1474_7b3f6aec-2353-4dcb-bff5-b2b743b2465d	53002-1474	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	RPK Pharmaceuticals, Inc.	MIRTAZAPINE	15	mg/1			N	20241231
53002-1494_b7aa41c1-dd45-49ec-b046-c44493c2faa0	53002-1494	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	RPK Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-1495_8903df93-fdb3-495e-9733-26e382e85a6d	53002-1495	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081126		ANDA	ANDA077715	RPK Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
53002-1500_e0291175-3c5d-4e27-8e89-88d3c0c7b983	53002-1500	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	RPK Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
53002-1501_a01d0d87-d355-4028-bcb5-fd8892248388	53002-1501	HUMAN PRESCRIPTION DRUG	PHENYTOIN SODIUM		PHENYTOIN SODIUM	CAPSULE, EXTENDED RELEASE	ORAL	20061212		ANDA	ANDA040621	RPK Pharmaceuticals, Inc.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-1503_d94bb8d9-d1d1-4e37-acbd-356d718e2879	53002-1503	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	RPK Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-1505_c46a6a41-3994-4f96-8faf-97d18b5f7d63	53002-1505	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	RPK Pharmaceuticals, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
53002-1507_06ae8dc4-5b05-4bcf-b298-c892bbadfbff	53002-1507	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1512_5b0fef88-b009-4121-a8cc-bb50ac40f13c	53002-1512	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		Lamotrigine	TABLET	ORAL	20101101		ANDA	ANDA077783	RPK Pharmaceuticals, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
53002-1513_5b0fef88-b009-4121-a8cc-bb50ac40f13c	53002-1513	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		Lamotrigine	TABLET	ORAL	20101101		ANDA	ANDA077783	RPK Pharmaceuticals, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
53002-1516_3ef419af-7f9a-46a5-9a0d-6c7966a9d37c	53002-1516	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	RPK Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
53002-1521_121c828a-e698-4176-a8c5-6b8eb5a150d5	53002-1521	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20010730		ANDA	ANDA074943	RPK Pharmaceuticals, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
53002-1526_2fee3967-6e6b-422d-9518-86c9f794fd57	53002-1526	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	RPK Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-1527_7caf92e9-37da-43dd-bcae-5b12a226a275	53002-1527	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	RPK Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-1528_7caf92e9-37da-43dd-bcae-5b12a226a275	53002-1528	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	RPK Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-1529_a1ce16ac-9b5e-4932-b0f6-50fc24531578	53002-1529	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	RPK Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
53002-1538_bfbdaee4-29be-4118-8315-a291a2c0e867	53002-1538	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	RPK Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-1539_ef873f79-d411-4862-8323-9281a467d8d6	53002-1539	HUMAN PRESCRIPTION DRUG	SRONYX		Levonorgestrel and Ethinyl Estradiol	KIT		20160803		ANDA	ANDA077681	RPK Pharmaceuticals, Inc.						N	20241231
53002-1547_765e59b2-fd6e-4b7a-bdae-6023eb15c08f	53002-1547	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	RPK Pharmaceuticals, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-1552_1e84157b-c3dc-479c-9552-aa57d9d28548	53002-1552	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200226		ANDA	ANDA203760	RPK Pharmaceuticals, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
53002-1554_b6d100bc-342f-4dd4-9440-2ab0a78a3cac	53002-1554	HUMAN PRESCRIPTION DRUG	Albuterol sulfate		Albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200825		ANDA	ANDA209954	RPK Pharmaceuticals, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
53002-1556_33b7aca0-3942-43da-a00f-ebb6468de0f5	53002-1556	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	RPK Pharmaceuticals, Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1557_10b29f1f-8d13-4bdb-a359-c51f64159bef	53002-1557	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20210315		NDA AUTHORIZED GENERIC	NDA020503	RPK Pharmaceuticals, Inc.	ALBUTEROL SULFATE	108	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
53002-1561_b7aa41c1-dd45-49ec-b046-c44493c2faa0	53002-1561	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	RPK Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-1562_7f3deaf1-c342-4f55-8555-d091112da6b9	53002-1562	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	RPK Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-1565_12ae72b5-54e0-494b-a6f3-58c8d2190821	53002-1565	HUMAN PRESCRIPTION DRUG	Levora		levonorgestrel and ethinyl estradiol	KIT		20160803		ANDA	ANDA073594	RPK Pharmaceuticals, Inc.						N	20241231
53002-1566_7d1db548-0325-418a-8a88-a947c373bad3	53002-1566	HUMAN PRESCRIPTION DRUG	Trivora		Levonorgestrel and Ethinyl Estradiol	KIT		20160803		ANDA	ANDA074538	RPK Pharmaceuticals, Inc.						N	20241231
53002-1568_4a398dbd-6d78-4a71-8f3a-41aa8494d2ba	53002-1568	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	RPK Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	100; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
53002-1569_7caf92e9-37da-43dd-bcae-5b12a226a275	53002-1569	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	RPK Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-1570_71c6d4fe-5ef8-4b69-935b-ca3398cde54b	53002-1570	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA075522	RPK Pharmaceuticals, Inc.	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
53002-1572_33b7aca0-3942-43da-a00f-ebb6468de0f5	53002-1572	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	RPK Pharmaceuticals, Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1573_33b7aca0-3942-43da-a00f-ebb6468de0f5	53002-1573	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	RPK Pharmaceuticals, Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1574_33b7aca0-3942-43da-a00f-ebb6468de0f5	53002-1574	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	RPK Pharmaceuticals, Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1577_c16f4a7a-f2c6-42c3-9a70-10b1dbc800e9	53002-1577	HUMAN PRESCRIPTION DRUG	OCELLA		drospirenone and ethinyl estradiol	KIT		20010611		NDA AUTHORIZED GENERIC	NDA021098	RPK Pharmaceuticals, Inc.						N	20241231
53002-1579_42dfeb78-bce9-43b2-9d5c-d71f03e11653	53002-1579	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	RPK Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1592_192efd6b-b95b-49d1-acda-1eaddc78d224	53002-1592	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	RPK Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-1593_192efd6b-b95b-49d1-acda-1eaddc78d224	53002-1593	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	RPK Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-1596_9d53fee6-9edf-49c6-ac88-70fc5791e339	53002-1596	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20090101		ANDA	ANDA079088	RPK Pharmaceuticals, Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
53002-1601_6be7239f-d59f-49cf-bcf3-7830b14e6ad7	53002-1601	HUMAN PRESCRIPTION DRUG	Azurette		desogestrel/ethinyl estradiol and ethinyl estradiol	KIT		20201003		ANDA	ANDA091247	RPK Pharmaceuticals, Inc.						N	20241231
53002-1604_42ee1ff7-4404-42b5-be60-8766c7df262b	53002-1604	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20080317		ANDA	ANDA076128	RPK Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
53002-1612_83fe60ff-511e-4c42-ac72-5b4cc002b300	53002-1612	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	RPK Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-1623_124cc589-0fff-45f1-9ef7-70917b58e149	53002-1623	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20170517		ANDA	ANDA206904	RPK Pharmaceuticals, Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
53002-1631_03c45581-895a-40f6-8693-104f689bbd1a	53002-1631	HUMAN PRESCRIPTION DRUG	Reclipsen	28 Day	Desogestrel and Ethinyl Estradiol	KIT		20170101		ANDA	ANDA075256	RPK Pharmaceuticals, Inc.						N	20241231
53002-1633_abfd9505-5ecb-4066-b461-36096e50ebae	53002-1633	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	SOLUTION	ORAL	20110127		ANDA	ANDA091342	RPK Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53002-1637_7aca6454-9f9f-48ba-9a8a-9e2a8f09419c	53002-1637	HUMAN PRESCRIPTION DRUG	Low-Ogestrel		Norgestrel and Ethinyl Estradiol	KIT		20160803		ANDA	ANDA075288	RPK Pharmaceuticals, Inc.						N	20241231
53002-1638_167c22f2-f172-4595-b850-1e523c8afa82	53002-1638	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-1643_167c22f2-f172-4595-b850-1e523c8afa82	53002-1643	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-1653_ce65bbdc-1485-4ade-93b8-a362278f4f04	53002-1653	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA090513	RPK Pharmaceuticals, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
53002-1655_41a55e79-35c2-48f2-9549-8e69e0f5b16c	53002-1655	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20180221		ANDA	ANDA208347	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-1663_eec67425-e83e-4ff3-8722-e852f5a219b6	53002-1663	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	RPK Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
53002-1671_c102cada-b711-4ea6-bde3-89c9afce8ce0	53002-1671	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	RPK Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1672_f555197a-4e8d-46ba-9d5e-ac93cdda72ae	53002-1672	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	RPK Pharmaceuticals, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
53002-1674_985da4af-6850-4c9c-9e46-db38d6402697	53002-1674	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1686_8843daf4-719e-4ecf-b3fa-fd9eef8df018	53002-1686	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, FILM COATED	ORAL	20071012		NDA	NDA022145	RPK Pharmaceuticals, Inc.	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
53002-1688_feff0609-4c4f-4399-a046-f07e4469822c	53002-1688	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	RPK Pharmaceuticals, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53002-1700_91c26d75-ee3e-4ee6-9cae-abfc89ad71ac	53002-1700	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	RPK Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53002-1702_5c8fc187-9253-444d-9e31-b93ea4521fb1	53002-1702	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070312		ANDA	ANDA040707	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1704_ceb68353-890f-4124-aecd-912c79430081	53002-1704	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20060531		ANDA	ANDA065049	RPK Pharmaceuticals, Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
53002-1707_5a1108bb-6bfb-4fdc-bbd9-1f6dbcf80bb5	53002-1707	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	RPK Pharmaceuticals, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53002-1710_35bee7ef-be76-4a28-b077-9fdef77eb7b3	53002-1710	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-1712_a0a3ba9e-ebb6-4b3d-99da-a420eff6bced	53002-1712	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	RPK Pharmaceuticals, Inc.	MIRTAZAPINE	45	mg/1			N	20241231
53002-1713_0c82f867-6b3f-4cd8-913f-0f4f74683d17	53002-1713	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20160722		ANDA	ANDA204339	RPK Pharmaceuticals, Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-1716_24939e89-dacf-42cc-84a7-2d334166bbeb	53002-1716	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20040923		ANDA	ANDA065162	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-1718_8b10a036-c487-4ec7-a7bf-460bce7d2bd7	53002-1718	HUMAN PRESCRIPTION DRUG	Priftin		rifapentine	TABLET, FILM COATED	ORAL	20170208		NDA	NDA021024	RPK Pharmaceuticals, Inc.	RIFAPENTINE	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
53002-1719_6a4d64ad-561c-4f3f-b078-822c9606e875	53002-1719	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20130531		ANDA	ANDA078380	RPK Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
53002-1725_cae7e7c3-3121-4132-ab99-c5a121bb7d94	53002-1725	HUMAN PRESCRIPTION DRUG	Balziva		Norethindrone and Ethinyl Estradiol	KIT		20061016		ANDA	ANDA076238	RPK Pharmaceuticals, Inc.						N	20241231
53002-1726_4d89b974-4b75-4833-84b8-fcbcfe816a43	53002-1726	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	RPK Pharmaceuticals, Inc.	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
53002-1727_4d89b974-4b75-4833-84b8-fcbcfe816a43	53002-1727	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	RPK Pharmaceuticals, Inc.	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
53002-1728_4d89b974-4b75-4833-84b8-fcbcfe816a43	53002-1728	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	RPK Pharmaceuticals, Inc.	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
53002-1732_78b27999-f484-4a81-9482-5bf9a2db0814	53002-1732	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20120406		ANDA	ANDA200538	RPK Pharmaceuticals, Inc.						N	20241231
53002-1733_0213c02e-c54e-4b04-80ab-30ae6cc92b85	53002-1733	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20110617		ANDA	ANDA200494	RPK Pharmaceuticals, Inc.						N	20241231
53002-1734_99e3c46d-70b6-4d56-9a88-59bbfa55ca2f	53002-1734	HUMAN PRESCRIPTION DRUG	ALYACEN 7/7/7		norethindrone and ethinyl estradiol	KIT		20120119		ANDA	ANDA091636	RPK Pharmaceuticals, Inc.						N	20241231
53002-1735_2a10afa2-592d-4782-b76b-6772c6cd49b5	53002-1735	HUMAN PRESCRIPTION DRUG	drospirenone and ethinyl estradiol		drospirenone and ethinyl estradiol	KIT		20150817		ANDA	ANDA204296	RPK Pharmaceuticals, Inc.						N	20241231
53002-1750_1eb8f3fc-6583-4f71-8c6c-ad4c57bddeec	53002-1750	HUMAN PRESCRIPTION DRUG	ProAir RespiClick		Albuterol Sulfate	POWDER, METERED	RESPIRATORY (INHALATION)	20150423		NDA	NDA205636	RPK Pharmaceuticals, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
53002-1775_785afee6-400e-418d-9bf2-c4fe0559e462	53002-1775	HUMAN PRESCRIPTION DRUG	Velivet	Triphasic Regimen	Desogestrel and Ethinyl Estradiol	KIT		20040301		ANDA	ANDA076455	RPK Pharmaceuticals, Inc.						N	20241231
53002-1776_07cd1b8f-b955-458d-9fa2-fb63cae91755	53002-1776	HUMAN PRESCRIPTION DRUG	Tri-VyLibra		Norgestimate and Ethinyl Estradiol	KIT		20160706		ANDA	ANDA205441	RPK Pharmaceuticals, Inc.						N	20241231
53002-1777_655a4984-144b-4ded-855e-6c6e915da4d9	53002-1777	HUMAN PRESCRIPTION DRUG	VyLibra		norgestimate and ethinyl estradiol	KIT		20160707		ANDA	ANDA205449	RPK Pharmaceuticals, Inc.						N	20241231
53002-1778_ad6c07ed-bf76-4dce-a9cf-a5f7fb8ad483	53002-1778	HUMAN PRESCRIPTION DRUG	Tri-VyLibra Lo		Norgestimate and Ethinyl Estradiol	KIT		20161104		ANDA	ANDA205762	RPK Pharmaceuticals, Inc.						N	20241231
53002-1779_ab3d2832-f359-450b-9326-f205ad59062f	53002-1779	HUMAN PRESCRIPTION DRUG	Jolessa		Levonorgestrel / Ethinyl Estradiol	KIT		20031013		NDA AUTHORIZED GENERIC	NDA021544	RPK Pharmaceuticals, Inc.						N	20241231
53002-1780_8589cde4-cd71-476f-9bf5-9169fba087ab	53002-1780	HUMAN PRESCRIPTION DRUG	ALYACEN 1/35		norethindrone and ethinyl estradiol	KIT		20120119		ANDA	ANDA091634	RPK Pharmaceuticals, Inc.						N	20241231
53002-1782_3e44e381-a076-4a17-93a5-91f0049ddca4	53002-1782	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	2.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1783_865b9d1d-2643-4ac7-b0e9-cd180e8c3fc4	53002-1783	HUMAN PRESCRIPTION DRUG	Jasmiel		Drospirenone and Ethinyl Estradiol	KIT		20180227		ANDA	ANDA209632	RPK Pharmaceuticals, Inc.						N	20241231
53002-1784_c85612fe-405d-44a9-9790-f8fcfd134ef4	53002-1784	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1785_5e11bdda-3f21-4ad7-8739-9ad3a732489f	53002-1785	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1787_ad481bbd-7f51-4e09-8d95-6992a4094e6a	53002-1787	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1788_47cbefac-62de-49dd-aad7-491c513d5ba8	53002-1788	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-1789_78ac38c1-db95-496a-bb57-66ee0c7e970b	53002-1789	HUMAN PRESCRIPTION DRUG	TARINA 24 FE		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170615		ANDA	ANDA207504	RPK Pharmaceuticals, Inc.						N	20241231
53002-1792_0e1770d8-4a56-4b80-b080-bb3bce72b71f	53002-1792	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000228		ANDA	ANDA075492	RPK Pharmaceuticals, Inc.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-1793_d15c3fd7-8e69-4ac1-ad6d-172c8b5e7bde	53002-1793	HUMAN PRESCRIPTION DRUG	Lyleq		NORETHINDRONE	TABLET	ORAL	20160923		ANDA	ANDA207304	RPK Pharmaceuticals, Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
53002-1794_e4269715-5ec9-4a3d-bf85-f793b15d2efe	53002-1794	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	RPK Pharmaceuticals, Inc.	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-1796_0d848e82-5e4e-4777-b59d-41c81b26cc29	53002-1796	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET	ORAL	20190807		ANDA	ANDA211653	RPK Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-1798_94b803e1-8329-44ea-a04d-f49cb54ae3fe	53002-1798	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100419		ANDA	ANDA077183	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1799_ed8e4503-48a6-4bee-85d1-3b68722f0b3a	53002-1799	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100419		ANDA	ANDA077183	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1801_02a93ebf-2fae-4893-9662-9d45104f1fad	53002-1801	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204065	RPK Pharmaceuticals, Inc.	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-1802_97ea7ade-a21c-480b-82b6-fc743b8bae2c	53002-1802	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA090149	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1803_7c9e2287-133d-4e60-8d2f-5df1ee69da23	53002-1803	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		azelastine hydrochloride	SOLUTION/ DROPS	INTRAOCULAR	20130321		ANDA	ANDA202305	RPK Pharmaceuticals, Inc.	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53002-1804_988262b1-cea5-4079-a6bc-7373ba429600	53002-1804	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-1805_0397b4e7-4482-4fbc-aa2b-329599ec0df7	53002-1805	HUMAN PRESCRIPTION DRUG	Nystop		Nystatin	POWDER	TOPICAL	19960816		ANDA	ANDA064118	RPK Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
53002-1806_2c711384-f0a3-4ad1-aa60-ba595a2621c2	53002-1806	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	RPK Pharmaceuticals, Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53002-1807_b78c683a-b41e-440c-97c2-af68dc50dd97	53002-1807	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20141222		NDA AUTHORIZED GENERIC	NDA020538	RPK Pharmaceuticals, Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
53002-1808_e1a37040-d992-401e-806a-d517d69e5da5	53002-1808	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20141222		NDA AUTHORIZED GENERIC	NDA020538	RPK Pharmaceuticals, Inc.	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
53002-1810_3fa1b0d4-ded9-42b9-9b62-06fb76c86f4e	53002-1810	HUMAN PRESCRIPTION DRUG	Tivicay		dolutegravir sodium	TABLET, FILM COATED	ORAL	20130813		NDA	NDA204790	RPK Pharmaceuticals, Inc.	DOLUTEGRAVIR SODIUM	50	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
53002-1812_13838df2-0f9a-405b-a948-b86dfa1b5541	53002-1812	HUMAN PRESCRIPTION DRUG	Hailey Fe 1.5/30		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20180605		ANDA	ANDA209031	RPK Pharmaceuticals, Inc.						N	20241231
53002-1813_3830acee-e964-46d9-93a7-5fe4ea766fbd	53002-1813	HUMAN PRESCRIPTION DRUG	Volnea		Desogestrel and Ethinyl Estradiol	KIT		20171201		ANDA	ANDA202689	RPK Pharmaceuticals, Inc.						N	20241231
53002-2004_987ca21d-9138-4e3b-90ec-98b61ea29d28	53002-2004	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	RPK Pharmaceuticals, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-2008_70bccc79-0b85-44ac-86ca-774cc5b35edd	53002-2008	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	RPK Pharmaceuticals, Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
53002-2010_42ee5300-97cd-46fa-a780-5da23c0b5000	53002-2010	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	RPK Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2020_42ee5300-97cd-46fa-a780-5da23c0b5000	53002-2020	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	RPK Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2034_0dedf211-9329-490f-bb48-1130d9e6b2a6	53002-2034	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20181127		ANDA	ANDA210733	RPK Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
53002-2068_dc37c2b4-e7c1-4005-9618-f46fd3fac45a	53002-2068	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	RPK Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
53002-2080_62f97e42-281b-441c-beac-18f2f9712754	53002-2080	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	RPK Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2090_c976f8cf-b453-44bc-908e-37a907d116de	53002-2090	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065387	RPK Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2091_16a98955-e2c7-4971-b2ba-77e531caebc3	53002-2091	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	RPK Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2100_33edf978-4ff3-4502-814b-bb9eafb5183b	53002-2100	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	RPK Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
53002-2111_95a826b2-f2ce-44c9-b88c-3e93765356f2	53002-2111	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	RPK Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
53002-2123_ee9d3c7a-affd-4814-90dc-f371aebfcd53	53002-2123	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	RPK Pharmaceuticals, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
53002-2130_a5aa28f3-30bb-4c19-9b87-f818d1f013a9	53002-2130	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	19900930		ANDA	ANDA060456	RPK Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2132_e830df6f-5218-4781-87ab-6303bfa5c513	53002-2132	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	RPK Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53002-2138_28bf5d7e-afee-4c73-93bf-f4e6af05df04	53002-2138	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	RPK Pharmaceuticals, Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-2160_62f97e42-281b-441c-beac-18f2f9712754	53002-2160	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	RPK Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2178_9b7df070-bbbc-403f-9585-a607cdbbf923	53002-2178	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	RPK Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
53002-2180_5f8ce57a-89db-4fde-834c-6b62fab0ad29	53002-2180	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	RPK Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2181_32f74fac-4c20-4e67-833b-2ced493e015c	53002-2181	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	RPK Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2182_ac767c8b-f9ad-4594-8e6b-63db369dfc42	53002-2182	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	RPK Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2199_467c3e18-cc41-4835-b8c1-709e65dce5b9	53002-2199	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	RPK Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53002-2210_b230162a-613f-4a78-879b-9083f7b686b4	53002-2210	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	RPK Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53002-2225_71da7924-d575-4ff7-b222-bdf4a44f653f	53002-2225	HUMAN PRESCRIPTION DRUG	azithromycin		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	19990212		NDA AUTHORIZED GENERIC	NDA050693	RPK Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	1	g/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-2231_850360ea-a486-47f4-9d93-c5e6699e2ccc	53002-2231	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		azithromycin	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	RPK Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-2251_7cf080a5-999a-43f4-9035-21699da0e07b	53002-2251	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	RPK Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
53002-2252_759ec7ed-4bff-4ec4-9482-57fd581a4086	53002-2252	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-2260_5f8ce57a-89db-4fde-834c-6b62fab0ad29	53002-2260	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	RPK Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2261_5dbfab31-b608-4496-85ae-c5239edea26f	53002-2261	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	RPK Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2290_5eb773b2-b238-4c4c-82bb-d51be058731d	53002-2290	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	RPK Pharmaceuticals, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2294_3905d3ea-f785-4b2e-86e7-8c46b5e5f8b0	53002-2294	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	RPK Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	44	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-2305_f67e6af1-0f30-455d-afe0-4e86f0c793f7	53002-2305	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	RPK Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-2308_4b74a63c-abdd-4906-883e-0eb567b245c9	53002-2308	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-2310_dc7cb7b8-a681-4fa8-8601-2454bff572d9	53002-2310	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	RPK Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	110	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-2321_d6da6ed6-4099-4bfa-888e-4afdd4835601	53002-2321	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	RPK Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
53002-2322_69ab3f1c-84df-4478-9593-31713005bedc	53002-2322	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	RPK Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
53002-2335_86084b26-cf7e-41bc-b0b8-fa0ae846b2b2	53002-2335	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-2338_c3b06e35-3218-44e6-8f1c-e0a18395acda	53002-2338	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	RPK Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-2350_776cd516-2a42-4b8e-b0f3-29777c858095	53002-2350	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	RPK Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
53002-2352_4f623b7a-c230-480b-921d-f2a872fca934	53002-2352	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-2359_42dfeb78-bce9-43b2-9d5c-d71f03e11653	53002-2359	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	RPK Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-2360_dfc88893-963e-409f-af26-2f5cf008e7eb	53002-2360	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	RPK Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-2361_07d5aae7-1682-4068-9a43-fc9a0193b857	53002-2361	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111123		ANDA	ANDA200834	RPK Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-2365_dc0859ba-c727-457c-b56c-17f956117390	53002-2365	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	RPK Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-2366_0c851fea-3353-4832-b5a1-931a502ccce2	53002-2366	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	RPK Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
53002-2369_8d066562-a567-4cfe-9713-ab4f7d5ce119	53002-2369	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20030226		ANDA	ANDA065119	RPK Pharmaceuticals, Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-2385_07d0cfd0-efed-464c-86c2-bcd8752c8189	53002-2385	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	RPK Pharmaceuticals, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-2390_b984a323-40f2-4cc6-b666-b8d92816ae3e	53002-2390	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065101	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-2391_9c72ac19-f7b9-41d4-bac8-0168f8c73f7a	53002-2391	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021127		ANDA	ANDA065117	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-2392_aa710ecc-aad6-4675-a058-a591257527e8	53002-2392	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA205707	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-2419_0e362c0a-4d14-4321-818b-6a68ac429a3b	53002-2419	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	RPK Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53002-2421_abf1d68c-4e55-4296-8a5a-e7dc6e095ee1	53002-2421	HUMAN PRESCRIPTION DRUG	Nystatin		nystatin	SUSPENSION	ORAL	19950415		ANDA	ANDA062512	RPK Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
53002-2423_09f996b5-1240-44ae-913f-9b82bcd45657	53002-2423	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	RPK Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-2436_45b836da-636b-40e7-8c0e-de7af90ca672	53002-2436	HUMAN PRESCRIPTION DRUG	QVAR REDIHALER		Beclomethasone Dipropionate HFA	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180215		NDA	NDA207921	RPK Pharmaceuticals, Inc.	BECLOMETHASONE DIPROPIONATE	40	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-2438_66f3d24c-ad32-455c-bd93-462677bda3e6	53002-2438	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	RPK Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-2440_fc7af74c-3e90-480c-ae01-c35426c1254a	53002-2440	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-2445_96c9d20e-afc0-4c82-9485-64db83a78972	53002-2445	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	RPK Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
53002-2450_260889bf-c562-43c5-80fb-3cfb31771999	53002-2450	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20060320		ANDA	ANDA075677	RPK Pharmaceuticals, Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-2452_17fefa3c-8646-44dc-a889-5f69a755e846	53002-2452	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20190823		ANDA	ANDA204313	RPK Pharmaceuticals, Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-2470_ca2dafaa-1ebc-41cb-a803-869c75cf6c12	53002-2470	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	RPK Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
53002-2471_282eb907-1e6c-48ea-a3b6-2e7fe9b1bcff	53002-2471	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	RPK Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
53002-2478_be6c6ade-7d58-4162-94f5-3b5dac87ba8e	53002-2478	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	19900930		ANDA	ANDA070033	RPK Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
53002-2505_7224deb8-4aeb-4d4a-99a1-725c850de7f1	53002-2505	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	RPK Pharmaceuticals, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
53002-2507_04ae09c2-3842-4cbc-baa5-7b6c48d4c1ab	53002-2507	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-2508_8260cb49-d827-4c7d-83d7-890d425204b1	53002-2508	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150217		ANDA	ANDA077285	RPK Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
53002-2509_482a45cc-8840-482f-aaeb-f0bfafa87689	53002-2509	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	RPK Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
53002-2512_f5adca48-7424-4d34-98e3-36fa181badab	53002-2512	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	RPK Pharmaceuticals, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
53002-2513_2e58de22-88df-4d13-a2a6-34a92d368b85	53002-2513	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	RPK Pharmaceuticals, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
53002-2516_1bb2e1e4-ffa8-459a-bac0-ff17f21791a0	53002-2516	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	RPK Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
53002-2526_b47c3871-49b1-4f20-897e-a844d346a95b	53002-2526	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20060530		ANDA	ANDA065264	RPK Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2527_0d80bfd7-73f0-4b5b-acc1-5d2588248974	53002-2527	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	RPK Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-2528_0d80bfd7-73f0-4b5b-acc1-5d2588248974	53002-2528	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	RPK Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-2529_ca6ae428-73b2-476b-943d-cab2cabf539a	53002-2529	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	RPK Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
53002-2535_b6caa52f-ff5c-4ff0-b4e8-92a3cd7374a1	53002-2535	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	RPK Pharmaceuticals, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-2537_91799143-7166-4699-919a-bfeb803be666	53002-2537	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	RPK Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-2540_32f74fac-4c20-4e67-833b-2ced493e015c	53002-2540	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA062703	RPK Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2562_192efd6b-b95b-49d1-acda-1eaddc78d224	53002-2562	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	RPK Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-2569_0d80bfd7-73f0-4b5b-acc1-5d2588248974	53002-2569	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	RPK Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-2584_681ee5e8-60f2-4029-9669-c662f19cfc62	53002-2584	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20190115		NDA AUTHORIZED GENERIC	NDA020983	RPK Pharmaceuticals, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
53002-2592_7f3deaf1-c342-4f55-8555-d091112da6b9	53002-2592	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	RPK Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-2593_7f3deaf1-c342-4f55-8555-d091112da6b9	53002-2593	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	RPK Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-2604_8dff1b96-b107-486b-9a66-da2a54e03da8	53002-2604	HUMAN PRESCRIPTION DRUG	Ofloxacin Otic		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20040514		ANDA	ANDA076527	RPK Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
53002-2612_e3e35f97-6cb5-4b1c-a345-b9e941d53280	53002-2612	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200203		ANDA	ANDA204161	RPK Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-2616_ced3a7e4-691a-41c6-9f4a-191069262bc2	53002-2616	HUMAN PRESCRIPTION DRUG	Microgestin Fe 1/20		Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20201012		ANDA	ANDA091454	RPK Pharmaceuticals, Inc.						N	20241231
53002-2623_fa822b5f-229e-49bd-a237-5a33d568557d	53002-2623	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20210520		ANDA	ANDA214129	RPK Pharmaceuticals, Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
53002-2624_167c22f2-f172-4595-b850-1e523c8afa82	53002-2624	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20110601		ANDA	ANDA091497	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-2626_e07ae258-eb3e-4ac9-aeff-95c643780b22	53002-2626	HUMAN PRESCRIPTION DRUG	Moxifloxacin ophthalmic solution		Moxifloxacin ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20190213		ANDA	ANDA209469	RPK Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2630_28822df7-626a-43a0-8648-7ca0cc7b5c0a	53002-2630	HUMAN PRESCRIPTION DRUG	Ella		ulipristal acetate	TABLET	ORAL	20200511		NDA	NDA022474	RPK Pharmaceuticals, Inc.	ULIPRISTAL ACETATE	30	mg/1	Progesterone Agonist/Antagonist [EPC], Selective Progesterone Receptor Modulators [MoA]		N	20241231
53002-2638_d35b6ba7-f886-4d7b-86fd-90a8ca4695a3	53002-2638	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-2640_b3c480f6-8271-4f43-9d09-669bfa524b7a	53002-2640	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2641_f748fb7b-5eb5-4d25-bc09-d542b7f62106	53002-2641	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20061101		ANDA	ANDA076794	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2642_68633ef1-13db-4584-ade5-910b89074810	53002-2642	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
53002-2644_7f12fdd6-faba-410b-b03b-0f555a18ba82	53002-2644	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2645_760f6035-f123-49b7-9c2d-e2e1e762fc5d	53002-2645	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2654_5cd44f48-511e-428e-bb69-3c0acaa53fe7	53002-2654	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	RPK Pharmaceuticals, Inc.	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2666_8414c769-98d1-4d0a-9140-b787ccae9b73	53002-2666	HUMAN PRESCRIPTION DRUG	Budesonide and Formoterol Fumarate Dihydrate		Budesonide and Formoterol Fumarate Dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20200103		NDA AUTHORIZED GENERIC	NDA021929	RPK Pharmaceuticals, Inc.	BUDESONIDE; FORMOTEROL FUMARATE	80; 4.5	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
53002-2670_a874c2f2-efbd-4274-86ba-3ca3635ee5b6	53002-2670	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	RPK Pharmaceuticals, Inc.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2683_499ede15-e47e-4e92-be0d-7f246b3231f7	53002-2683	HUMAN PRESCRIPTION DRUG	Chateal EQ		Levonorgestrel and Ethinyl Estradiol	KIT		20160923		ANDA	ANDA206866	RPK Pharmaceuticals, Inc.						N	20241231
53002-2688_b8282582-7c7c-40a4-a520-2f223bfc97ef	53002-2688	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090123		ANDA	ANDA075410	RPK Pharmaceuticals, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53002-2692_795f5d73-7841-471a-ba07-bad6a6965ceb	53002-2692	HUMAN PRESCRIPTION DRUG	Aubra EQ		Levonorgestrel and Ethinyl Estradiol	KIT		20161114		ANDA	ANDA206886	RPK Pharmaceuticals, Inc.						N	20241231
53002-2707_6c2fcf9b-1008-4657-a319-2c2beaf0108f	53002-2707	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	RPK Pharmaceuticals, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53002-2711_4e2e9175-444e-46df-af2b-1d240a6447c1	53002-2711	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA062269	RPK Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53002-2712_53f007a0-2126-4e6e-876a-941dd7dad3ca	53002-2712	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	RPK Pharmaceuticals, Inc.	MIRTAZAPINE	45	mg/1			N	20241231
53002-2713_542c68d2-cfbd-4963-9645-853e66756b01	53002-2713	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20191009		ANDA	ANDA211343	RPK Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53002-2719_90ddbeb1-19e8-42d1-a112-41a3b4ec5041	53002-2719	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103		ANDA	ANDA203814	RPK Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
53002-2722_b0583db2-8222-4183-8cf4-36402bc07188	53002-2722	HUMAN PRESCRIPTION DRUG	Cyred EQ		Desogestrel and Ethinyl Estradiol	KIT		20170517		ANDA	ANDA207081	RPK Pharmaceuticals, Inc.						N	20241231
53002-2723_4100bdb1-4db9-4d6c-88cf-f606c0f97a39	53002-2723	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA076938	RPK Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2750_cacd3d38-f49f-4ebb-a864-b0aa1e72dcef	53002-2750	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	RPK Pharmaceuticals, Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
53002-2755_e084af2b-d2de-447b-988c-a8849b7337da	53002-2755	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20150204		ANDA	ANDA077210	RPK Pharmaceuticals, Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
53002-2756_6ce34a96-f40f-488c-bf3c-8afaeffd748f	53002-2756	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20150204		ANDA	ANDA077210	RPK Pharmaceuticals, Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
53002-2757_05a4dd51-a108-4c65-80bb-203ec8928660	53002-2757	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20150522		ANDA	ANDA077210	RPK Pharmaceuticals, Inc.	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
53002-2760_f17c23b4-9ac2-41d8-a987-55d12d4a0812	53002-2760	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	RPK Pharmaceuticals, Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
53002-2781_1e05b683-991a-464e-86fc-768855bdcce3	53002-2781	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191023		ANDA	ANDA204161	RPK Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-2785_c862365f-ed11-45b9-b4d7-400fb31081a1	53002-2785	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET	ORAL	20130419		ANDA	ANDA203145	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-2786_757abac3-3eee-4c2c-91bb-25664cbe6c6c	53002-2786	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-2787_8d14d2af-495d-43af-9af7-0c7bb875638e	53002-2787	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-2788_89dfdc2b-c619-48ae-bc77-e08b3dc2fd39	53002-2788	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-2790_b3c480f6-8271-4f43-9d09-669bfa524b7a	53002-2790	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2791_51cb4223-f94f-43ab-9988-4fa2d6d71329	53002-2791	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
53002-2792_7690bcc1-ed94-43f7-944d-58acf490ae9e	53002-2792	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2793_0bdbcf6c-68d9-4791-a068-a378f90992c4	53002-2793	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2794_3d4b09e2-d551-423a-bb8e-ca11176885fb	53002-2794	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-2806_104a395a-ee06-4a39-ad06-1372dbdd7a6c	53002-2806	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	RPK Pharmaceuticals, Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53002-2880_c347ed0d-1489-4aff-b394-b9105a04f3b9	53002-2880	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19920201		ANDA	ANDA063181	RPK Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53002-2920_e001f0f5-3043-49a2-932d-b4a092a54657	53002-2920	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080937	RPK Pharmaceuticals, Inc.	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
53002-3010_56907f19-170a-4526-b03a-4277492b698d	53002-3010	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	RPK Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3011_e02a2964-1671-4427-84ac-80adf6c0e05c	53002-3011	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	RPK Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3040_43776533-94f8-461e-a218-0bfe3d8e04ec	53002-3040	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	RPK Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-3041_544b6a7b-9b53-42e4-ad9d-9de77edf5700	53002-3041	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	RPK Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-3042_1d59a49e-2cc1-4e38-a2d8-b19805755771	53002-3042	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	RPK Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-3050_653e7210-9581-471e-82d4-a18a33bfd3f3	53002-3050	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	RPK Pharmaceuticals, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3051_e0069b35-6718-48a2-924c-75499ad857e2	53002-3051	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	RPK Pharmaceuticals, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3068_ef930a14-0f0d-4afd-b5aa-5e67893cdd5c	53002-3068	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	RPK Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
53002-3080_55521469-0607-444d-891b-974bc3e4fb4a	53002-3080	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA090478	RPK Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-3081_ac7dc723-e0cb-44f4-b4e5-2527aa63cde3	53002-3081	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	RPK Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-3090_85cd49b5-8617-4d28-8ac8-9936c390769d	53002-3090	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	RPK Pharmaceuticals, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3091_4e7d0248-223c-4cf6-8aed-6fadee0cdb65	53002-3091	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	RPK Pharmaceuticals, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3100_1385f165-d41a-4ece-9193-7d0285602381	53002-3100	HUMAN PRESCRIPTION DRUG	naproxen		naproxen	TABLET	ORAL	20160705		ANDA	ANDA091305	RPK Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3101_83e00829-cc71-4541-8550-8ce55cfa4117	53002-3101	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	RPK Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3102_010bccdc-9379-4ecc-993c-5427bb4133ef	53002-3102	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	RPK Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3110_5f9ba4a4-8999-4f1d-82a4-7a90b06fc6c8	53002-3110	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	RPK Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3111_2c66cbf6-01b9-4744-88d8-9f570c9c19a8	53002-3111	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	RPK Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3112_1385f165-d41a-4ece-9193-7d0285602381	53002-3112	HUMAN PRESCRIPTION DRUG	naproxen		naproxen	TABLET	ORAL	20160705		ANDA	ANDA091305	RPK Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3113_7d315e30-6404-44db-94a2-38ed0d152827	53002-3113	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	RPK Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3120_3c0c5795-858a-47f8-b526-14cd830e49d7	53002-3120	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	RPK Pharmaceuticals, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3121_90b8e8c2-0000-48b4-9aab-abb6822b4068	53002-3121	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040194	RPK Pharmaceuticals, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3122_ee3fb5d4-fbf1-479f-9bc2-4362f66747b2	53002-3122	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	RPK Pharmaceuticals, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3132_00c6f169-31c3-49a6-b4b3-5b00ef0e7c94	53002-3132	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA071523	RPK Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53002-3150_409afe77-0691-4a5d-9d30-60d2ff5a534d	53002-3150	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCl 200mg		Phenazopyridine Hydrochloride	TABLET	ORAL	20141231		UNAPPROVED DRUG OTHER		RPK Pharmaceuticals, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
53002-3151_b0526ba3-c6b4-4ac8-8384-dea7ac0a6789	53002-3151	HUMAN PRESCRIPTION DRUG	PHENAZOPYRIDINE HYDROCHLORIDE		Phenazopyridine Hydrochloride	TABLET	ORAL	20150305		UNAPPROVED DRUG OTHER		RPK Pharmaceuticals, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
53002-3152_7a6d2c0d-94ee-451c-9f6d-68c3689b392b	53002-3152	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		RPK Pharmaceuticals, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
53002-3192_9b1b7204-6add-4cc6-a66e-753c6f62eb68	53002-3192	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-3199_f4b4c736-a965-4536-ac53-e58f5bdf5559	53002-3199	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	RPK Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53002-3215_94b0b1fc-4080-45d2-9456-a0724709b0b2	53002-3215	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-3224_74922948-e205-4085-bfa5-1ffbe5f2b9f1	53002-3224	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	RPK Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-3225_1261fe36-75b8-4b96-ab20-393f5cf3bfc0	53002-3225	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	RPK Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
53002-3240_1385f165-d41a-4ece-9193-7d0285602381	53002-3240	HUMAN PRESCRIPTION DRUG	naproxen		naproxen	TABLET	ORAL	20160705		ANDA	ANDA091305	RPK Pharmaceuticals, Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3241_984d2f71-6047-4826-905f-7545f33a3711	53002-3241	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	RPK Pharmaceuticals, Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3250_85cd49b5-8617-4d28-8ac8-9936c390769d	53002-3250	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	RPK Pharmaceuticals, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3252_bea8a9d3-d98a-4d4e-8f1b-1bbfd47bd1d7	53002-3252	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085161	RPK Pharmaceuticals, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3280_b6b2beae-297e-446e-99db-03ffff418942	53002-3280	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20031124		ANDA	ANDA074151	RPK Pharmaceuticals, Inc.	CIMETIDINE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53002-3290_55aa57ee-2d14-4a59-aa7b-93e5fd10d549	53002-3290	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	RPK Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
53002-3291_f65d035f-c78d-4d23-9350-b1cfa2deabc5	53002-3291	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	RPK Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
53002-3335_8b42e8a8-f969-413c-a89c-8dd022c5543f	53002-3335	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-3340_7a585112-df9d-44a3-88c8-7849a9ae9716	53002-3340	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	RPK Pharmaceuticals, Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53002-3351_286895ac-9aea-48f7-9337-d365e60f8285	53002-3351	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	RPK Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53002-3369_9c2e28bb-75c9-4429-905e-d5d4cf6cd400	53002-3369	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	RPK Pharmaceuticals, Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-3370_d2e2499b-e5bc-49dc-a460-0e0e9def9349	53002-3370	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	RPK Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3372_69d85120-99fd-4d8e-a211-5f1b65a2cca7	53002-3372	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	RPK Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3387_8acbbca4-a0f5-4fa5-b96f-a91da222fb8d	53002-3387	HUMAN PRESCRIPTION DRUG	oseltamavir phosphate		oseltamavir phosphate	CAPSULE	ORAL	20170921		ANDA	ANDA207211	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-3391_c445459a-aac6-4215-aab7-75d28486dedd	53002-3391	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	RPK Pharmaceuticals, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
53002-3392_a7444dea-53c5-48d6-ad58-d2103096de6f	53002-3392	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	RPK Pharmaceuticals, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
53002-3400_586dd6f0-2137-4725-994e-14b89f675296	53002-3400	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170707		ANDA	ANDA086727	RPK Pharmaceuticals, Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
53002-3401_71fd5b2d-290f-47b4-9e4a-54404e27b3c9	53002-3401	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	RPK Pharmaceuticals, Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
53002-3410_69ebabb8-cecc-49c4-b9b9-f0581eb68bc6	53002-3410	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		ACETAMINOPHEN and CODEINE PHOSPHATE	SOLUTION	ORAL	19810821		ANDA	ANDA087508	RPK Pharmaceuticals, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	120; 12	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
53002-3423_76b56960-9799-42ac-879f-25b805352730	53002-3423	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	RPK Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-3431_e8bd2670-4e9b-4be9-b8ce-657d9cf7e368	53002-3431	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	OROPHARYNGEAL	20070227		ANDA	ANDA040708	RPK Pharmaceuticals, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53002-3432_265db5e1-fa10-4c88-8313-0594e5440c5d	53002-3432	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		lidocaine hydrochloride	SOLUTION	TOPICAL	19821118		ANDA	ANDA087872	RPK Pharmaceuticals, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53002-3439_8e2014f4-0c63-47e4-afe7-60e1edb4aa42	53002-3439	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-3440_1a01c1d4-c1b4-466e-8cff-922acb8352e2	53002-3440	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	20170501		UNAPPROVED DRUG OTHER		RPK Pharmaceuticals, Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3450_55aa57ee-2d14-4a59-aa7b-93e5fd10d549	53002-3450	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19860730		ANDA	ANDA085223	RPK Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
53002-3451_980dab0c-720b-4849-b0da-ba952c171eb6	53002-3451	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	RPK Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
53002-3477_45b836da-636b-40e7-8c0e-de7af90ca672	53002-3477	HUMAN PRESCRIPTION DRUG	QVAR REDIHALER		Beclomethasone Dipropionate HFA	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180215		NDA	NDA207921	RPK Pharmaceuticals, Inc.	BECLOMETHASONE DIPROPIONATE	80	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3500_e06b0224-0f2c-4f10-b386-577033a9fec7	53002-3500	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	RPK Pharmaceuticals, Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3501_db478b68-8439-4ca6-9aac-bf723cf23375	53002-3501	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	RPK Pharmaceuticals, Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3510_303aaed9-ff59-4ded-9224-cdbb50c1fae1	53002-3510	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	RPK Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
53002-3520_3ce0659e-435d-47aa-8b8e-0baca4775ab7	53002-3520	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA080356	RPK Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-3562_ac34049a-f89d-4c7c-a47e-b00154e95dcf	53002-3562	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20200304		ANDA	ANDA078284	RPK Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-3567_2794af57-6906-4702-b74f-a3e98cbf0fa4	53002-3567	HUMAN PRESCRIPTION DRUG	Microgestin Fe 1.5/30		Norethindrone Acetate/Ethinyl Estradiol and Ferrous Fumarate	KIT		20201012		ANDA	ANDA091453	RPK Pharmaceuticals, Inc.						N	20241231
53002-3570_e07e5e30-8774-4f40-b085-b3e873ba7d4b	53002-3570	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	RPK Pharmaceuticals, Inc.	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
53002-3590_cd0f8819-dae5-4046-8efb-60124b7d34c1	53002-3590	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	RPK Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-3591_43776533-94f8-461e-a218-0bfe3d8e04ec	53002-3591	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	RPK Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-3600_d91d9313-0476-4cbc-bca3-32be7f1835fc	53002-3600	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070176	RPK Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-3601_137add8e-d3db-4c4d-adc7-eec57211c2d4	53002-3601	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070176	RPK Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-3626_40ccee9b-c954-4f7c-b349-3370acf21c94	53002-3626	HUMAN PRESCRIPTION DRUG	Moxifloxacin		moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20170701		ANDA	ANDA090080	RPK Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-3638_d688b217-2ec0-472c-9a1d-95b27cda0d61	53002-3638	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-3643_eb71854c-4192-4bda-99bd-d77f24cb2913	53002-3643	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-3671_bb1be512-5427-4cb1-ba0f-c8a228ef8e27	53002-3671	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	RPK Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-3688_0dcdba97-db92-4b69-9119-ce3fc633b77c	53002-3688	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078490	RPK Pharmaceuticals, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53002-3710_d22271a0-7474-4941-ad2b-2eac633aa672	53002-3710	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20180209		ANDA	ANDA208348	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-3711_657d7b31-9828-491b-b6a9-694059a47130	53002-3711	HUMAN PRESCRIPTION DRUG	Tarina Fe 1/20 EQ		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170616		ANDA	ANDA207505	RPK Pharmaceuticals, Inc.						N	20241231
53002-3713_c0c84f7d-a535-4b49-ab86-b372c18abfbb	53002-3713	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20120625		ANDA	ANDA203269	RPK Pharmaceuticals, Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
53002-3716_05875558-1549-47f4-99d8-b694dc7a018a	53002-3716	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-3719_9f8c7f79-89c6-46a0-8900-9345d9875fb3	53002-3719	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	RPK Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
53002-3750_508d0a0d-ef37-4c65-8538-033f5bf09712	53002-3750	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20170731		ANDA	ANDA209047	RPK Pharmaceuticals, Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
53002-3952_204b18e7-8297-4436-b073-d74435c47922	53002-3952	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	RPK Pharmaceuticals, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53002-3980_56907f19-170a-4526-b03a-4277492b698d	53002-3980	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	RPK Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-3981_66fd620c-5d48-4f17-a94c-c74a7871db3a	53002-3981	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	RPK Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-4021_e91858f4-0c92-451b-8824-032a87d79d1d	53002-4021	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	RPK Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53002-4105_0a824675-ed1f-4af2-a1fc-7a31003ded4e	53002-4105	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	RPK Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53002-4108_c689a7bc-40a4-44ca-ba3b-707b0423a998	53002-4108	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	RPK Pharmaceuticals, Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-4111_e430daa0-57d2-4723-8bbc-a8fa1f5a8265	53002-4111	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	RPK Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
53002-4140_89d05296-91ba-415f-bb04-b0566230f6e0	53002-4140	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	RPK Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53002-4141_f745123d-5d8f-4397-be97-c63f2c607220	53002-4141	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070974	RPK Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53002-4170_a9881f36-fcef-4187-9dee-2aa7a5c3f1bf	53002-4170	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	RPK Pharmaceuticals, Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
53002-4181_d03cd719-652a-4085-b368-9460257390d6	53002-4181	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	RPK Pharmaceuticals, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53002-4192_5ea9ed36-bc91-44f3-b590-d01bc3d94d04	53002-4192	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-4215_dfc0f5e1-2242-41bc-ad38-a36c424b4043	53002-4215	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	RPK Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-4228_8e868fbf-090a-4676-a45e-94246f344607	53002-4228	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	RPK Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-4262_4b99239e-0abb-4e42-b144-abd0a36192b0	53002-4262	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral		Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral	SOLUTION	ORAL	20201005		ANDA	ANDA040649	RPK Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53002-4300_3c484f1c-eb5f-4486-b7cf-cfebf6823b1e	53002-4300	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	RPK Pharmaceuticals, Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
53002-4320_d9652da2-cb36-42fc-ae51-746079c1e6a6	53002-4320	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20101115		ANDA	ANDA076003	RPK Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
53002-4322_542bfe25-db5f-4d96-9a79-ab70acd5072f	53002-4322	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	RPK Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
53002-4369_511ae844-9127-4c80-af8a-1e5b05e1168c	53002-4369	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	RPK Pharmaceuticals, Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
53002-4411_1a7a209b-fd69-4ca7-b731-265e90a25c66	53002-4411	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	RPK Pharmaceuticals, Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
53002-4422_52bd2d6d-dce5-45d6-903a-c85b68b4dd0a	53002-4422	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	RPK Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
53002-4423_c033a0fd-b143-4ec0-9387-d442b7e7ce95	53002-4423	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	RPK Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-4441_fdafd27a-c8dc-4755-a742-419bd8a7cb7a	53002-4441	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA202468	RPK Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
53002-4460_80d32fba-b440-495a-944d-55489efed881	53002-4460	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20110718		ANDA	ANDA074550	RPK Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
53002-4461_2c388ca6-3a7b-44e1-ac3a-7a77866d3b2d	53002-4461	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	RPK Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
53002-4462_95a826b2-f2ce-44c9-b88c-3e93765356f2	53002-4462	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	RPK Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
53002-4495_0f62a36a-9d83-4d08-9a31-e393be1e61d8	53002-4495	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	RPK Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
53002-4501_a472ecd0-5e15-482a-bc98-9e8ae90b502f	53002-4501	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20170724		ANDA	ANDA040684	RPK Pharmaceuticals, Inc.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-4508_da2cfb4c-921a-4488-a3ee-feb57976297c	53002-4508	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA210497	RPK Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
53002-4560_d91d9313-0476-4cbc-bca3-32be7f1835fc	53002-4560	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070175	RPK Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-4624_325c784b-8a71-42d0-8efa-9081c34bd5c4	53002-4624	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-4642_1fb9f1ec-711f-47f5-8138-1d762e6c8255	53002-4642	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200130		ANDA	ANDA210986	RPK Pharmaceuticals, Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-4643_a471dbaf-4f28-4b28-8e15-2152e72508fd	53002-4643	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-4710_d20d698c-cf89-4f40-854b-e6beeae37bd9	53002-4710	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-4719_0f2a998c-586b-4f6e-ab8d-ec132094bb71	53002-4719	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20180504		ANDA	ANDA210394	RPK Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
53002-4720_44fc48f6-970d-45e4-adb1-102956aae9ff	53002-4720	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	RPK Pharmaceuticals, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53002-4721_b1617424-c714-4279-a981-b8337e8189ef	53002-4721	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	RPK Pharmaceuticals, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53002-4722_104a395a-ee06-4a39-ad06-1372dbdd7a6c	53002-4722	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	RPK Pharmaceuticals, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53002-4730_2817bd5b-7849-4756-9de5-04ba813ab056	53002-4730	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA202096	RPK Pharmaceuticals, Inc.	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
53002-4820_f11acd64-aaca-44cc-9fb8-04673c7772b9	53002-4820	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	RPK Pharmaceuticals, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
53002-4821_b9a9d796-5e07-455c-84d9-e103052dea08	53002-4821	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20090406		NDA	NDA018877	RPK Pharmaceuticals, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
53002-4910_1f8e9b6b-9c6d-418f-bfa9-79ccad3b71f9	53002-4910	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	RPK Pharmaceuticals, Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
53002-4930_9807b6b8-b9a9-4e50-b974-35e4e653a036	53002-4930	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	19961111		ANDA	ANDA070848	RPK Pharmaceuticals, Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
53002-4940_89d05296-91ba-415f-bb04-b0566230f6e0	53002-4940	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	RPK Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53002-4941_53152cf9-7b85-4e81-b16f-8a568af7da59	53002-4941	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070975	RPK Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53002-4950_d91d9313-0476-4cbc-bca3-32be7f1835fc	53002-4950	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070177	RPK Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-4951_24c50dc2-a140-47d6-8363-36a1e8fed0f8	53002-4951	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070177	RPK Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53002-4970_757c1b28-40aa-4559-91dd-fb9392464ecd	53002-4970	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-4972_d8d17974-bd7b-4ddd-b4a5-808b041e39e4	53002-4972	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19730112		ANDA	ANDA083177	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53002-5016_12c703a1-93a6-4e38-bb31-2ac8b959f506	53002-5016	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	RPK Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-5020_51c9f718-3736-4985-9729-0510e6a222a6	53002-5020	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	RPK Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
53002-5105_7a8a7b6e-c5b3-445d-8aa9-70105de53cb5	53002-5105	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201008		ANDA	ANDA071524	RPK Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53002-5110_46af24c9-95fc-4cff-8b2e-823acb38a1f1	53002-5110	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20100601		ANDA	ANDA077789	RPK Pharmaceuticals, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
53002-5198_db32414b-2aa7-4e69-975f-5a9df9b981e9	53002-5198	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	RPK Pharmaceuticals, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
53002-5228_701e185b-b2eb-4b1d-a4da-26440f174382	53002-5228	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	RPK Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-5279_16aa47c1-f35c-4fc8-99b3-d7b03b9c57ac	53002-5279	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SPRAY, METERED	NASAL	20200508		ANDA	ANDA212289	RPK Pharmaceuticals, Inc.	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53002-5291_6afec26d-6288-41c0-a88a-bb2d3bf1e80e	53002-5291	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	RPK Pharmaceuticals, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53002-5324_c9999820-168e-4eb6-bbc7-bca06b422671	53002-5324	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20190301		ANDA	ANDA076513	RPK Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
53002-5330_413964d2-6000-41e6-bf91-fb720224636d	53002-5330	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20111031		ANDA	ANDA200629	RPK Pharmaceuticals, Inc.	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-5360_26b00c5b-0f64-4b1d-93aa-991167e13bb8	53002-5360	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	RPK Pharmaceuticals, Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-5370_26b00c5b-0f64-4b1d-93aa-991167e13bb8	53002-5370	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	RPK Pharmaceuticals, Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-5387_42e50056-05a9-46a5-9537-e0ec3354f42f	53002-5387	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-5430_ce37adfa-f4e3-4dfe-b9ca-212219aa4dff	53002-5430	HUMAN PRESCRIPTION DRUG	ORPHENADRINE CITRATE		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	RPK Pharmaceuticals, Inc.	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-5441_152331a2-33d4-4cf3-9703-9bc6e74401b4	53002-5441	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, FILM COATED	ORAL	20160101		ANDA	ANDA204290	RPK Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
53002-5453_4577c976-2964-484a-8fca-d1f3c00c779a	53002-5453	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20160201		ANDA	ANDA078032	RPK Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53002-5472_d1c2dfc6-6f4f-4825-a2c9-f506015d1f48	53002-5472	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	RPK Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-5604_d86ca525-2be2-48a1-87ca-7d5432acc2a1	53002-5604	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxaxin	SOLUTION/ DROPS	AURICULAR (OTIC)	20080317		ANDA	ANDA076616	RPK Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
53002-5624_f1103a7f-b8b2-459d-b055-1ccf7c10be90	53002-5624	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-5643_69a879c3-11f1-44ae-8374-a114b1d2eb7e	53002-5643	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-5700_8e34e087-dc5c-44d2-adf3-d016fdd7ddbd	53002-5700	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	RPK Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-5701_cdc2a48b-6376-4ef5-9c2f-da6c3edc8384	53002-5701	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	RPK Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-5760_5b48518b-ad34-4a3e-b98d-07b02ccc9670	53002-5760	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	RPK Pharmaceuticals, Inc.	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53002-5800_e7f76b12-88b7-4790-b04c-afb9421dfbab	53002-5800	HUMAN PRESCRIPTION DRUG	NP Thyroid 90		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20110203		UNAPPROVED DRUG OTHER		RPK Pharmaceuticals, Inc.	LEVOTHYROXINE; LIOTHYRONINE	57; 13.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
53002-5890_aadded46-c21d-46f0-b3b4-a76d29e4d25b	53002-5890	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040627	RPK Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
53002-5891_b7958cf1-4a58-4125-b695-a3fad773ebbb	53002-5891	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	RPK Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
53002-5892_e7b483a8-6b06-4e27-a3cb-4e1ef5de3137	53002-5892	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	RPK Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
53002-5893_1ccf4e39-8e1c-4246-86a4-ca11c1d3053a	53002-5893	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20161210		ANDA	ANDA091133	RPK Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
53002-6050_32595e7a-48f2-43a6-8b96-49c928c93559	53002-6050	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	RPK Pharmaceuticals, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
53002-6062_004033a5-d119-43a3-a957-85fc890fbf92	53002-6062	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA040659	RPK Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
53002-6221_79e4bc57-0559-433c-8c10-ee258d96aa3b	53002-6221	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065223	RPK Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-6290_6afec26d-6288-41c0-a88a-bb2d3bf1e80e	53002-6290	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	RPK Pharmaceuticals, Inc.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53002-6387_c62e7ede-1ba2-4235-bd1b-5e53febfae37	53002-6387	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	RPK Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
53002-6423_6c125ce5-3188-4f43-b35b-6f31639cbad7	53002-6423	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	RPK Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53002-6431_8e9be3b8-2a4f-481e-90ff-4e678694d8a2	53002-6431	HUMAN PRESCRIPTION DRUG	rifampin		rifampin	CAPSULE	ORAL	20140108		ANDA	ANDA090034	RPK Pharmaceuticals, Inc.	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
53002-6440_630cda95-79bd-4292-99f7-29ed274b0b3c	53002-6440	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	RPK Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
53002-6441_d43cde42-711a-4c6f-b899-7307d8abdb83	53002-6441	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	RPK Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
53002-6604_175bc8ef-bd41-42df-ab5d-ec69f3381d8e	53002-6604	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin otic	SOLUTION	AURICULAR (OTIC)	20220715		ANDA	ANDA216130	RPK Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
53002-6624_4f821487-e66e-43ed-9cfe-c6b38128bfc2	53002-6624	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-6643_cc9b89b5-fcdb-48bf-baaf-8251d86c93d7	53002-6643	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-6670_eaeb5cf2-b4a9-4bc5-96a6-38618d6f375f	53002-6670	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	RPK Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53002-6960_93020a57-ab93-469c-99f7-4dfe721dcd4a	53002-6960	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	RPK Pharmaceuticals, Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-6990_82138460-c1b7-41ab-8af1-b4abb9b3b6aa	53002-6990	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	RPK Pharmaceuticals, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-7040_b8cef6a2-c972-40e6-bf63-0d07c8cb401d	53002-7040	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	RPK Pharmaceuticals, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
53002-7041_cf324897-ba31-4542-80fa-c4f726aa6272	53002-7041	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	RPK Pharmaceuticals, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
53002-7042_ddfb32a2-8972-49f0-b235-6ae11ef8a717	53002-7042	HUMAN PRESCRIPTION DRUG	Nitrofurantoin	(monohydrate/macrocrystals)	Nitrofurantoin monohydrate/macrocrystals	CAPSULE	ORAL	20170525		ANDA	ANDA207372	RPK Pharmaceuticals, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
53002-7221_29ae6fcb-9dd2-4b04-b68c-8cd45b2defe1	53002-7221	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	RPK Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
53002-7240_e3cdedbd-3969-44e9-b36e-f848ea2c8969	53002-7240	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	CREAM	VAGINAL	20040406		ANDA	ANDA075953	RPK Pharmaceuticals, Inc.	TERCONAZOLE	8	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53002-7340_858ea991-32c6-47c2-8a55-a2cddca2b91d	53002-7340	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	VAGINAL	20061031	20241130	ANDA	ANDA077264	RPK Pharmaceuticals, Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	
53002-7341_6654da01-f78d-4eea-8f60-818007286e03	53002-7341	HUMAN PRESCRIPTION DRUG	Vandazole		Metronidazole	GEL	VAGINAL	20051004		NDA	NDA021806	RPK Pharmaceuticals, Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
53002-7561_84670ddb-948a-4260-992c-67e2be13bf48	53002-7561	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20151204		ANDA	ANDA203584	RPK Pharmaceuticals, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-7562_57e86b51-9d2d-47f2-b58d-dca66c20ccbe	53002-7562	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20050825		ANDA	ANDA065136	RPK Pharmaceuticals, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-7624_d41f8add-db3e-4bed-a345-5d470f37be47	53002-7624	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	RPK Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53002-7691_03f87bb0-e8ea-4056-9fbb-38af5e24c120	53002-7691	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20070919		ANDA	ANDA077538	RPK Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-7693_c4660c8d-59fd-4228-bbca-b3a3545f6715	53002-7693	HUMAN PRESCRIPTION DRUG	FLUTICASONE		fluticasone propionate	SPRAY, METERED	NASAL	20120109		ANDA	ANDA078492	RPK Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-7780_f6996d93-ed57-4772-ae55-933ae1977f48	53002-7780	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	SOLUTION	OPHTHALMIC	20091105		ANDA	ANDA076583	RPK Pharmaceuticals, Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53002-7830_acabd586-8e36-4c30-903c-0e5e5d6d9181	53002-7830	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	RPK Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
53002-7880_5d20964f-37b7-4490-b9b7-eb6d64c662c1	53002-7880	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY, METERED	NASAL	20030331		ANDA	ANDA076103	RPK Pharmaceuticals, Inc.	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
53002-7890_b984a323-40f2-4cc6-b666-b8d92816ae3e	53002-7890	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065096	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-7891_9c72ac19-f7b9-41d4-bac8-0168f8c73f7a	53002-7891	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021121		ANDA	ANDA065093	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-7892_d8371e2a-48bd-4368-ba88-204c926e858c	53002-7892	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-7895_ff9e0e11-ec6d-40de-9415-6ef74182c19b	53002-7895	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		amoxicillin and clavulanate potassium	TABLET, COATED	ORAL	20221121		NDA AUTHORIZED GENERIC	NDA050720	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-7898_43434ccb-a337-4079-aeb5-a4584cf53abf	53002-7898	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021121		ANDA	ANDA065093	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-7899_20647854-f9a4-4d14-a99d-b84c71d3e945	53002-7899	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA204755	RPK Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
53002-8101_d2bb8e19-80f5-4286-ba13-7ea2a6c3e090	53002-8101	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	CREAM	TOPICAL	20170615		ANDA	ANDA075264	RPK Pharmaceuticals, Inc.	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
53002-8130_417eb166-3b17-484b-9a7c-1d4da1c8a413	53002-8130	HUMAN PRESCRIPTION DRUG	Terconazole		Terconazole	CREAM	VAGINAL	20050119		ANDA	ANDA076043	RPK Pharmaceuticals, Inc.	TERCONAZOLE	4	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53002-8150_9960a400-22b2-4637-bd84-ecf5c55aeee5	53002-8150	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20021218		ANDA	ANDA075638	RPK Pharmaceuticals, Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-8151_d7bbf9a7-52d5-455a-add8-3bff2dbdb07d	53002-8151	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20190208		ANDA	ANDA075581	RPK Pharmaceuticals, Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
53002-8220_54930429-c917-40a2-ad74-449b34b5bd70	53002-8220	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20060915		ANDA	ANDA062472	RPK Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
53002-8260_82778eda-b750-4d86-886c-ae3e06e1e259	53002-8260	HUMAN PRESCRIPTION DRUG	SELENIUM SULFIDE		SELENIUM SULFIDE	LOTION	TOPICAL	20060925		ANDA	ANDA089996	RPK Pharmaceuticals, Inc.	SELENIUM SULFIDE	2.5	mg/100mL			N	20241231
53002-8280_29825ecd-d077-4288-9f86-731582c03160	53002-8280	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20060928		ANDA	ANDA076592	RPK Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-8281_1a4fcc8a-71ee-4ffd-b044-4dfa4c5aeb0d	53002-8281	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM, AUGMENTED	TOPICAL	20031209		ANDA	ANDA076543	RPK Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-8320_b234f258-6452-4fdc-82a1-0b2ef955c3e4	53002-8320	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20080528		ANDA	ANDA078541	RPK Pharmaceuticals, Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-8321_401dc847-735d-4d83-ab20-28a28abd429e	53002-8321	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20041221		ANDA	ANDA076679	RPK Pharmaceuticals, Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-8350_d13c5618-cd91-45b4-8c37-9763a01e772d	53002-8350	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	19750416		ANDA	ANDA080692	RPK Pharmaceuticals, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-8370_3ed0ec90-0034-44ed-afd4-5db293b2ebe9	53002-8370	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20130917		ANDA	ANDA064050	RPK Pharmaceuticals, Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
53002-8371_37655ff1-ab83-4ad8-9fd1-e9da45f7d8cc	53002-8371	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20200615		ANDA	ANDA208767	RPK Pharmaceuticals, Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
53002-8400_61fb2882-7041-4208-b0e5-dfd63cb055f8	53002-8400	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	19960729		ANDA	ANDA074580	RPK Pharmaceuticals, Inc.	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53002-8410_a990b8ce-d771-42ef-869d-1610e2f2b7aa	53002-8410	HUMAN PRESCRIPTION DRUG	Atrovent	HFA	ipratropium bromide	AEROSOL, METERED	RESPIRATORY (INHALATION)	20050501		NDA	NDA021527	RPK Pharmaceuticals, Inc.	IPRATROPIUM BROMIDE	17	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
53002-8450_d0c7dc15-5ed5-4df1-a633-127154aeab3f	53002-8450	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	OINTMENT	TOPICAL	19851219		ANDA	ANDA070069	RPK Pharmaceuticals, Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-8620_2cb396d3-7c30-4a9e-b4bc-d8809e477aa9	53002-8620	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19970214		ANDA	ANDA064120	RPK Pharmaceuticals, Inc.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-8621_48c7b55a-f6df-465a-ad76-d5cdfbd2a982	53002-8621	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim	SOLUTION	OPHTHALMIC	19980416		ANDA	ANDA064211	RPK Pharmaceuticals, Inc.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-8690_787f739c-0d8e-4104-a568-41ae49199319	53002-8690	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium and Prednisolone Sodium Phosphate		Sulfacetamide Sodium and Prednisolone Sodium Phosphate	SOLUTION/ DROPS	OPHTHALMIC	19951229		ANDA	ANDA074449	RPK Pharmaceuticals, Inc.	PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM	2.3; 100	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
53002-8780_d3ec84ef-c783-4caa-926d-67dcad3826ce	53002-8780	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	19930528		ANDA	ANDA081203	RPK Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9000_cbd325d1-a944-4cc7-9876-992e46d7f942	53002-9000	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19960828		ANDA	ANDA064065	RPK Pharmaceuticals, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9001_e1a1a973-7615-41f2-8d3b-e27e96f01769	53002-9001	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SUSPENSION	AURICULAR (OTIC)	20030317		ANDA	ANDA062488	RPK Pharmaceuticals, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9010_033c98a5-6039-4572-8b10-5395767baa5c	53002-9010	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		sulfacetamide sodium	SOLUTION/ DROPS	OPHTHALMIC	19941228		ANDA	ANDA040066	RPK Pharmaceuticals, Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
53002-9050_2d56d031-ba88-44e6-a210-25065351cb2b	53002-9050	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19940729		ANDA	ANDA064067	RPK Pharmaceuticals, Inc.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
53002-9060_a515b888-7bf0-4793-a3b0-d445d471a96e	53002-9060	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SOLUTION	AURICULAR (OTIC)	20030318		ANDA	ANDA062423	RPK Pharmaceuticals, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [iU]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9061_b30d5479-7065-43c5-82b5-69f032d95f7f	53002-9061	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone	SOLUTION/ DROPS	AURICULAR (OTIC)	19951229		ANDA	ANDA064053	RPK Pharmaceuticals, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9090_0bbb8a0f-4cf3-41f1-804c-acd2c48fdae6	53002-9090	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	RPK Pharmaceuticals, Inc.	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
53002-9091_113a89bb-a005-45ea-a4f1-165a85ea49ce	53002-9091	HUMAN PRESCRIPTION DRUG	SSD		Silver Sulfadiazine	CREAM	TOPICAL	20110504		NDA	NDA018578	RPK Pharmaceuticals, Inc.	SILVER SULFADIAZINE	10	g/1000g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
53002-9120_b81d3193-8b58-409b-9015-a951ff21c3c7	53002-9120	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20150910		ANDA	ANDA089796	RPK Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9200_014bb3f5-8f14-4f5f-bf81-75f34a984ef5	53002-9200	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20161001		ANDA	ANDA073085	RPK Pharmaceuticals, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9201_35a16129-99ad-43e4-bfff-9e3e6cccb794	53002-9201	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	19900930		ANDA	ANDA072488	RPK Pharmaceuticals, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9202_28c867b0-31db-487d-8df1-cf5dad9c044a	53002-9202	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20161027		ANDA	ANDA071500	RPK Pharmaceuticals, Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9210_4b61f422-c8cf-43e0-9191-bdb6a2862917	53002-9210	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	CREAM	TOPICAL	19830831		NDA	NDA018861	RPK Pharmaceuticals, Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9211_91c09b62-ba40-4b4a-876a-ecb09c0d970b	53002-9211	HUMAN PRESCRIPTION DRUG	BETAMETHASONE VALERATE		Betamethasone Valerate	CREAM	TOPICAL	19880106		ANDA	ANDA072041	RPK Pharmaceuticals, Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9230_dd3d86ab-6074-4041-801f-15b972d443b4	53002-9230	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19931129		ANDA	ANDA064052	RPK Pharmaceuticals, Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
53002-9232_25261e27-cd46-4698-b808-ae825838976c	53002-9232	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19950109		ANDA	ANDA062535	RPK Pharmaceuticals, Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
53002-9270_91270dd4-8c99-4ba6-86ce-681c329bf7c8	53002-9270	HUMAN PRESCRIPTION DRUG	polycin		bacitracin zinc and polymyxin b sulfates	OINTMENT	OPHTHALMIC	20141112		ANDA	ANDA065022	RPK Pharmaceuticals, Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9271_244b7362-edd7-45fe-874a-41bcf15b4cda	53002-9271	HUMAN PRESCRIPTION DRUG	Bacitracin Zinc and Polymyxin B Sulfate		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	OPHTHALMIC	20080425		ANDA	ANDA064046	RPK Pharmaceuticals, Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9280_bba2eee9-9b82-414a-978f-94881bf42970	53002-9280	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20160331		ANDA	ANDA205082	RPK Pharmaceuticals, Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9292_08b4b0d2-356a-4604-aafa-926aa46bc675	53002-9292	HUMAN PRESCRIPTION DRUG	GENTAMICIN SULFATE		gentamicin sulfate	SOLUTION/ DROPS	OPHTHALMIC	19980105		ANDA	ANDA062452	RPK Pharmaceuticals, Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
53002-9293_cea68708-1f54-4ee8-8133-75f8f91600cd	53002-9293	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19940511		ANDA	ANDA064048	RPK Pharmaceuticals, Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
53002-9320_35bf4873-998a-4122-8061-23bd893ead7d	53002-9320	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	RPK Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
53002-9331_893f6f39-cca2-4a64-a848-856426720857	53002-9331	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20150414		ANDA	ANDA089798	RPK Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9333_1e08d996-223e-43ba-a7f3-925a3106661e	53002-9333	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	RPK Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9334_5eddf58e-e6e7-4133-bc48-a5d10f26d194	53002-9334	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	CREAM	TOPICAL	20170417		ANDA	ANDA208848	RPK Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9360_2796e6ed-32e2-4456-9db2-7bb519d1f456	53002-9360	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	19871222		ANDA	ANDA062364	RPK Pharmaceuticals, Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
53002-9361_b92ff935-123e-48f0-9d83-c23df7b72a33	53002-9361	HUMAN PRESCRIPTION DRUG	NYSTATIN AND TRIAMCINOLONE ACETONIDE		nystatin, triamcinolone acetonide	CREAM	TOPICAL	20171127		ANDA	ANDA208479	RPK Pharmaceuticals, Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
53002-9380_0129b8db-22a6-4e1a-a120-23c89bcbdba6	53002-9380	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20060921		ANDA	ANDA062225	RPK Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
53002-9450_0f7a5e78-e00f-4eef-a948-d91c8169351a	53002-9450	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		ciclopirox olamine	CREAM	TOPICAL	20050412		ANDA	ANDA076790	RPK Pharmaceuticals, Inc.	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
53002-9510_067dbef1-4f49-4e71-a19f-11887f4e9e53	53002-9510	HUMAN PRESCRIPTION DRUG	Neomycin Polymyxin B Sulfates and Dexamethasone		Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19950913		ANDA	ANDA064135	RPK Pharmaceuticals, Inc.	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9511_a74ccb43-6d81-489a-807c-9e396b9a1276	53002-9511	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		neomycin sulfate, polymyxin b sulfate and dexamethasone	SUSPENSION	OPHTHALMIC	19960221		ANDA	ANDA062341	RPK Pharmaceuticals, Inc.	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53002-9570_40ff6ece-7e10-440f-b5f6-e41a0982b50d	53002-9570	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin	CREAM	TOPICAL	20060811		ANDA	ANDA076369	RPK Pharmaceuticals, Inc.	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
53002-9571_5a4020c5-e60f-4856-bfa4-c35dd4bbac36	53002-9571	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin 5% w/w	CREAM	TOPICAL	20190408		ANDA	ANDA211303	RPK Pharmaceuticals, Inc.	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
53002-9660_bb74b13c-82fc-4a28-b675-68adb7c9cd18	53002-9660	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20020930		ANDA	ANDA089682	RPK Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9661_82cfbca0-dc6f-49d6-9244-e1e0f7f2dfb2	53002-9661	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	RPK Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9662_788dda19-a4dd-49a8-88ed-833a0a965bac	53002-9662	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	RPK Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9742_d9f93f67-9761-431b-8012-720e3becfa2e	53002-9742	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20010529		ANDA	ANDA075673	RPK Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9743_f9b29f0b-58c7-4d31-a99d-311c9d7ad1b4	53002-9743	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20010605		ANDA	ANDA075502	RPK Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9770_1831ff41-a301-491e-9692-7f2ceac350e1	53002-9770	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	RPK Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53002-9850_fd42ba30-2600-4bbe-bb00-3684ba916006	53002-9850	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20110608		ANDA	ANDA090480	RPK Pharmaceuticals, Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
53002-9851_d3d32a78-6926-4904-a004-b1e9b01b94f2	53002-9851	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20050923		ANDA	ANDA065170	RPK Pharmaceuticals, Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
53002-9853_8d3c133a-e784-446b-b822-e59c590e4db3	53002-9853	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20091030		ANDA	ANDA065123	RPK Pharmaceuticals, Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
53002-9970_cebfdefc-bd50-4ab6-b11c-53f566ec3e61	53002-9970	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	OINTMENT	TOPICAL	19960712		ANDA	ANDA074248	RPK Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53020-265_c9a92c4b-a806-481f-9809-8acd50f41363	53020-265	HUMAN PRESCRIPTION DRUG	DAPIPRAZOLE		DAPIPRAZOLE	KIT		20190731		ANDA	ANDA204902	Baradaina, LLC						N	20251231
53041-021_eae72b44-5c9d-4bd8-8aec-ba70651928d0	53041-021	HUMAN OTC DRUG	Guardian Pink Bismuth		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20211008		OTC MONOGRAPH FINAL	part335	Guardian Drug Company	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
53041-022_fe632563-c3de-4214-b41d-4e7a1fbfcf59	53041-022	HUMAN OTC DRUG	Guardian Pink-Bismuth Cherry		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20231204		OTC MONOGRAPH DRUG	part335	Guardian Drug Company	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
53041-098_281729d2-7257-4ea1-8c6a-ec4e9ff8b6fa	53041-098	HUMAN OTC DRUG	Guardian Regular Strength Alkums		Calcium carbonate	TABLET, CHEWABLE	ORAL	20211005		OTC MONOGRAPH DRUG	part331	Guardian Drug Company	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
53041-127_fcf55cab-3592-40ec-9cb1-ac6ce76a089f	53041-127	HUMAN OTC DRUG	Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20120202		OTC MONOGRAPH FINAL	part331	Guardian Drug Company	CALCIUM CARBONATE	750	1/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
53041-130_df7c4a87-1090-4327-b7de-b40f9a4f891f	53041-130	HUMAN OTC DRUG	Guardian Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20220502		OTC MONOGRAPH FINAL	part331	Guardian Drug Company	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
53041-147_801a86ba-7c6d-4b44-aed1-e33a4375832d	53041-147	HUMAN OTC DRUG	Fiber Caps		Calcium polycarbophil	TABLET, FILM COATED	ORAL	20100715		OTC MONOGRAPH NOT FINAL	part334	Guardian Drug Company	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
53041-159_d1d3c5f1-4a39-4b32-91e6-0f23b81659f6	53041-159	HUMAN OTC DRUG	Senna-Lax		Sennosides	TABLET	ORAL	20020202		OTC MONOGRAPH NOT FINAL	part334	Guardian Drug Company	SENNOSIDES	8.6	mg/1			N	20241231
53041-184_1abd8d4a-c91f-4ead-8cfb-4237c16d723f	53041-184	HUMAN OTC DRUG	Guardian Extra Strength Assorted Berry Antacid	Extra strength Assorted Berry Antacid	Calcium carbonate	TABLET, CHEWABLE	ORAL	20231205		OTC MONOGRAPH DRUG	part331	Guardian Drug Company	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
53041-190_5940554a-6e73-4475-bcdd-6f1addc5fd49	53041-190	HUMAN OTC DRUG	Mucus Relief 600 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200624		ANDA	ANDA209215	Guardian Drug Company	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
53041-191_5940554a-6e73-4475-bcdd-6f1addc5fd49	53041-191	HUMAN OTC DRUG	Mucus Relief Maximum Strength 1200 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200624		ANDA	ANDA209215	Guardian Drug Company	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
53041-233_8186c3e8-1ae5-459d-8771-ad2d1ae95387	53041-233	HUMAN OTC DRUG	Guaifenesin Extended-Release 600 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA209215	Guardian Drug Company	GUAIFENESIN	600	mg/1			N	20241231
53041-234_8186c3e8-1ae5-459d-8771-ad2d1ae95387	53041-234	HUMAN OTC DRUG	Guaifenesin Extended-Release 1200 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA209215	Guardian Drug Company	GUAIFENESIN	1200	mg/1			N	20241231
53041-263_289e6064-8eb8-4b56-bc9e-ee82ad83674f	53041-263	HUMAN OTC DRUG	Loperamide Hydrochloride, Simethicone		Loperamide Hydrochloride, Simethicone	TABLET	ORAL	20210601		ANDA	ANDA214541	Guardian Drug Company	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
53041-527_8a8e017d-a00d-4ab4-8e16-3b472922e5e4	53041-527	HUMAN OTC DRUG	Pink-Bismuth		Bismuth Subsalicylate	LIQUID	ORAL	20080530		OTC MONOGRAPH FINAL	part335	Guardian Drug Company	BISMUTH SUBSALICYLATE	262	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
53041-572_e690a788-b856-44b3-afff-bb950d1eb117	53041-572	HUMAN OTC DRUG	Childrens Ibuprofen bubblegum		Ibuprofen	SUSPENSION/ DROPS	ORAL	20211013		ANDA	ANDA210149	Guardian Drug Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53041-577_868dd5cb-520e-4a7c-98fe-e2bf4c7af7ad	53041-577	HUMAN OTC DRUG	Childrens Metapp Daytime		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20120606		OTC MONOGRAPH FINAL	part341	Guardian Drug Company	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53041-615_6aa29e63-96d6-4636-92b9-60963fc06477	53041-615	HUMAN OTC DRUG	Childrens Tussnex Multi-symptom cold		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20121201		OTC MONOGRAPH FINAL	part341	Guardian Drug Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53041-616_f0043922-e35a-4797-ae85-d39f80ff6218	53041-616	HUMAN OTC DRUG	Tussnex FM Cold and Sinus		Acteaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20121201		OTC MONOGRAPH FINAL	part341	Guardian Drug Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53041-617_2d85a0db-2a04-48d5-ad40-e4cb65aa7e67	53041-617	HUMAN OTC DRUG	Tussnex FM Severe cough and congestion		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20121201		OTC MONOGRAPH FINAL	part341	Guardian Drug Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53041-618_111aa6dd-ced2-4a31-b8f5-9d971ea920c6	53041-618	HUMAN OTC DRUG	Tussnex FM Cold, Flu and Sore Throat		Acteaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20121201		OTC MONOGRAPH FINAL	part341	Guardian Drug Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53041-622_c08115c4-4dde-4728-bc87-c65bf576b520	53041-622	HUMAN OTC DRUG	Childrens Tussnex		Acteaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20120505		OTC MONOGRAPH FINAL	part341	Guardian Drug Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53041-628_5f24ed36-1675-43dd-9192-470eb8a85ec7	53041-628	HUMAN OTC DRUG	Maximum strength Tussnex FM DM Max		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20120501		OTC MONOGRAPH FINAL	part341	Guardian Drug Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53041-632_e690a788-b856-44b3-afff-bb950d1eb117	53041-632	HUMAN OTC DRUG	Childrens Ibuprofen fruit		Ibuprofen	SUSPENSION/ DROPS	ORAL	20211013		ANDA	ANDA210149	Guardian Drug Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53041-634_510c1692-f23a-497b-8738-4b29e7c549e8	53041-634	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20180821		ANDA	ANDA210149	Guardian Drug Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53041-637_d0465832-f323-4ecd-a285-33a8c15eb799	53041-637	HUMAN OTC DRUG	Concentrated ibuprofen infants		Ibuprofen	SUSPENSION/ DROPS	ORAL	20181003		ANDA	ANDA210755	Guardian Drug Company	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53041-638_e690a788-b856-44b3-afff-bb950d1eb117	53041-638	HUMAN OTC DRUG	Childrens Ibuprofen blue raspberry		Ibuprofen	SUSPENSION/ DROPS	ORAL	20211013		ANDA	ANDA210149	Guardian Drug Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53041-639_e690a788-b856-44b3-afff-bb950d1eb117	53041-639	HUMAN OTC DRUG	Childrens Ibuprofen grape		Ibuprofen	SUSPENSION/ DROPS	ORAL	20211013		ANDA	ANDA210149	Guardian Drug Company	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53041-663_27536955-37df-4dcc-ad75-2b364fe95460	53041-663	HUMAN PRESCRIPTION DRUG	Omeprazole, Sodium bicarbonate		Omeprazole, Sodium bicarbonate	CAPSULE	ORAL	20200507		ANDA	ANDA212587	Guardian Drug Company	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53041-664_27536955-37df-4dcc-ad75-2b364fe95460	53041-664	HUMAN PRESCRIPTION DRUG	Omeprazole, Sodium bicarbonate		Omeprazole, Sodium bicarbonate	CAPSULE	ORAL	20200507		ANDA	ANDA212587	Guardian Drug Company	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53041-666_d599747a-3eb5-4ea6-a63c-024393fc8fa7	53041-666	HUMAN OTC DRUG	Esomeprazole Magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230324		ANDA	ANDA216149	Guardian Drug Company	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53041-680_859606e1-12d2-4eff-b6f3-4fa59c4da89b	53041-680	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20210709		ANDA	ANDA214892	Guardian Drug Company	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
53041-681_859606e1-12d2-4eff-b6f3-4fa59c4da89b	53041-681	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20210709		ANDA	ANDA214892	Guardian Drug Company	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
53041-688_9cfdb214-1075-4449-9a01-f04cf5d0edfe	53041-688	HUMAN PRESCRIPTION DRUG	Diatrizoate Meglumine and Diatrizoate Sodium		Diatrizoate Meglumine and Diatrizoate Sodium	SOLUTION	ORAL; RECTAL	20191218		ANDA	ANDA214201	Guardian Drug Company	DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM	660; 100	mg/mL; mg/mL	Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA]		N	20241231
53041-690_9cfdb214-1075-4449-9a01-f04cf5d0edfe	53041-690	HUMAN PRESCRIPTION DRUG	Diatrizoate Meglumine and Diatrizoate Sodium		Diatrizoate Meglumine and Diatrizoate Sodium	SOLUTION	ORAL; RECTAL	20191218		ANDA	ANDA214201	Guardian Drug Company	DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM	660; 100	mg/mL; mg/mL	Radiographic Contrast Agent [EPC], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA], X-Ray Contrast Activity [MoA]		N	20241231
53045-130_a4ea50c9-6f31-4469-ae90-5c9061df93b6	53045-130	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170717		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-131_84a16a98-7dad-42dc-902a-7ef2e74558a7	53045-131	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170719		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-132_586ae194-44b8-43ac-87b8-0668f4645827	53045-132	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170719		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-133_63fecd9c-19fc-40bc-89e0-32c0cd5ddcf7	53045-133	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170719		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-134_2e2b1369-5601-4c48-b807-6b2e8c866b4e	53045-134	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170720		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-135_4284221e-bcf8-4840-9bfc-18c8bf0716f6	53045-135	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-136_0685f576-cf74-4d77-8eb7-ff0cecf21576	53045-136	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-137_27cf7a78-f2ec-4b63-aa94-503d9613cc73	53045-137	HUMAN OTC DRUG	Ioline		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-138_8e01b193-fdc4-4ea8-94a9-7f2b30fe806b	53045-138	HUMAN OTC DRUG	Iolite		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-140_33eb6c31-6bd2-4c7c-b7e3-01088def8fc7	53045-140	HUMAN OTC DRUG	Avant		Benzocaine	GEL	DENTAL	20210122		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-141_c3ed7803-9104-44e1-a2e8-0283fc888364	53045-141	HUMAN OTC DRUG	Avant		Benzocaine	GEL	DENTAL	20210122		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-142_aa00b745-814b-4004-bbac-010e3202508b	53045-142	HUMAN OTC DRUG	Avant		Benzocaine	GEL	DENTAL	20210122		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-144_f9e372b3-489f-4a17-a75f-d159f32c212e	53045-144	HUMAN OTC DRUG	Avant		Benzocaine	GEL	DENTAL	20210122		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-145_eca4cd0b-82ab-48f8-8bfc-9fc9e1f9339d	53045-145	HUMAN OTC DRUG	Avant		Benzocaine	GEL	DENTAL	20210122		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-146_be19f6c2-b5dd-4a3b-8670-34e133c9a0f8	53045-146	HUMAN OTC DRUG	Avant		Benzocaine	GEL	DENTAL	20210122		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-147_060fda3c-b1f4-41b0-bb18-d276f9975924	53045-147	HUMAN OTC DRUG	Avant		Benzocaine	GEL	DENTAL	20210122		OTC MONOGRAPH DRUG	M022	Dharma Research, Inc.	BENZOCAINE	6.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53045-200_e3e37317-62bd-4365-8bac-cf99db614201	53045-200	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	10.241	g/490g			N	20241231
53045-201_205e68a0-f45e-4339-9eea-512e216e05ae	53045-201	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	10.241	g/490g			N	20241231
53045-202_82c5c7de-3c8d-4d31-9d98-32b196abe517	53045-202	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	6.027	g/490g			N	20241231
53045-203_90fe60c1-b7dc-4162-9f56-25675460f2b3	53045-203	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	6.027	g/490g			N	20241231
53045-204_e5021a36-15ba-4b0c-986c-ad0bf444e813	53045-204	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	6.027	g/490g			N	20241231
53045-205_dd3dc685-7167-463c-8752-aa9f2ac2dad3	53045-205	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL; TOPICAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	SODIUM FLUORIDE	6.027	g/490g			N	20241231
53045-206_373417c2-b73d-4928-978a-ffa2b4b38746	53045-206	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	6.027	g/490g			N	20241231
53045-207_32945372-5fd3-4a22-8c70-f3abed417d58	53045-207	HUMAN PRESCRIPTION DRUG	Ionite APF		Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	6.027	g/490g			N	20241231
53045-235_5d289e00-80ff-4403-8fdf-780b2d932efb	53045-235	HUMAN PRESCRIPTION DRUG	Ionite APF	Neutral	Sodium Fluoride	GEL	DENTAL; ORAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	4.41	g/490g			N	20241231
53045-237_aed31a6c-2771-41cf-a35a-785e4a776366	53045-237	HUMAN PRESCRIPTION DRUG	Ionite APF	Neutral	Sodium Fluoride	GEL	DENTAL; ORAL; TOPICAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	4.41	g/490g			N	20241231
53045-250_86b603bc-a794-4814-9216-366a80d7642b	53045-250	HUMAN PRESCRIPTION DRUG	Ionite APF	Foam	Sodium Fluoride	AEROSOL, FOAM	DENTAL; ORAL; TOPICAL	20130422		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	SODIUM FLUORIDE	1.5498	g/126g			N	20241231
53045-251_5afd6058-8b76-4081-82df-10a4f49614f0	53045-251	HUMAN PRESCRIPTION DRUG	Ionite APF	Foam	Sodium Fluoride	AEROSOL, FOAM	DENTAL; ORAL; TOPICAL	20130422		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	1.5498	g/126g			N	20241231
53045-252_2d39144b-2d4c-47bf-8f4a-e40e0da8d24f	53045-252	HUMAN PRESCRIPTION DRUG	Ionite APF	Foam	Sodium Fluoride	AEROSOL, FOAM	DENTAL; ORAL; TOPICAL	20130422		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	1.5498	g/126g			N	20241231
53045-253_f0e20d54-cd8d-42f2-bfda-dbf162f62f18	53045-253	HUMAN PRESCRIPTION DRUG	Ionite APF	Foam	Sodium Fluoride	AEROSOL, FOAM	DENTAL; ORAL; TOPICAL	20130422		UNAPPROVED DRUG OTHER		Dharma Research, inc.	SODIUM FLUORIDE	1.5498	g/126g			N	20241231
53045-265_ff676d2f-3188-4d27-b6a4-83e164154381	53045-265	HUMAN PRESCRIPTION DRUG	Ionite R		Sodium Fluoride	LIQUID	DENTAL; ORAL	20131103		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	SODIUM FLUORIDE	38	g/L			N	20241231
53045-266_87ff143d-62ff-4b12-8800-ca730c2dce0a	53045-266	HUMAN PRESCRIPTION DRUG	Ionite R		Sodium Fluoride	LIQUID	DENTAL; ORAL	20131103		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	SODIUM FLUORIDE	38	g/L			N	20241231
53045-267_a3205319-0c52-4547-bc90-7d078f805894	53045-267	HUMAN PRESCRIPTION DRUG	Avant		Sodium Fluoride	LIQUID	DENTAL	20210122		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	SODIUM FLUORIDE	2	g/L			N	20241231
53045-268_78538c89-5afb-4316-a86a-1e5237d543e9	53045-268	HUMAN PRESCRIPTION DRUG	Avant		Sodium Fluoride	LIQUID	DENTAL	20210122		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	SODIUM FLUORIDE	2	g/L			N	20241231
53045-270_9c407eb7-c06d-4059-83e1-a20abff762e6	53045-270	HUMAN OTC DRUG	Ionite H		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20150802		OTC MONOGRAPH DRUG	M021	Dharma Research, Inc.	STANNOUS FLUORIDE	.4	mg/100g			N	20241231
53045-271_91060eb1-2d2e-4100-912f-05e7b46c9ae3	53045-271	HUMAN OTC DRUG	Ionite H		Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20150802		OTC MONOGRAPH DRUG	M021	Dharma Research, Inc.	STANNOUS FLUORIDE	.4	mg/100g			N	20241231
53045-275_48ad63b9-3911-40fe-8bd2-bcace77e5713	53045-275	HUMAN OTC DRUG	Ionite H		Stannous Fluoride	MOUTHWASH	DENTAL	20150803		OTC MONOGRAPH DRUG	M021	Dharma Research, Inc.	STANNOUS FLUORIDE	.63	mg/100mL			N	20241231
53045-276_3e4113aa-0884-4a00-9492-47ce6242f3bc	53045-276	HUMAN OTC DRUG	Ionite H		Stannous Fluoride	MOUTHWASH	DENTAL	20150803		OTC MONOGRAPH DRUG	M021	Dharma Research, Inc.	STANNOUS FLUORIDE	.63	mg/100mL			N	20241231
53045-280_0b21c890-82f5-4e90-8aa1-1e06d631760e	53045-280	HUMAN PRESCRIPTION DRUG	Ionite H		Sodium Fluoride, Potassium Nitrate	GEL, DENTIFRICE	DENTAL	20150802		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; 1.1	mg/100g; mg/100g			N	20241231
53045-281_ab938727-9383-48ce-a7a6-ed39d7d3ef15	53045-281	HUMAN PRESCRIPTION DRUG	Ionite H		Sodium Fluoride, Potassium Nitrate	GEL, DENTIFRICE	DENTAL	20150802		UNAPPROVED DRUG OTHER		Dharma Research, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; 1.1	mg/100g; mg/100g			N	20241231
53045-300_6b95574e-24cf-4cb9-a23a-284c2981fa33	53045-300	HUMAN PRESCRIPTION DRUG	Frenna AC		Aluminum Chloride	SOLUTION	DENTAL; ORAL; TOPICAL	20130101		UNAPPROVED DRUG OTHER		Dharma Research, inc.	ALUMINUM CHLORIDE	8.75	g/35g			N	20241231
53097-568_628f9609-6583-49be-be77-b64cfbc46fd7	53097-568	HUMAN PRESCRIPTION DRUG	Marinol		Dronabinol	CAPSULE	ORAL	20170510		NDA	NDA018651	ThePharmaNetwork, LLC	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
53097-569_628f9609-6583-49be-be77-b64cfbc46fd7	53097-569	HUMAN PRESCRIPTION DRUG	Marinol		Dronabinol	CAPSULE	ORAL	20170510		NDA	NDA018651	ThePharmaNetwork, LLC	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
53097-570_628f9609-6583-49be-be77-b64cfbc46fd7	53097-570	HUMAN PRESCRIPTION DRUG	Marinol		Dronabinol	CAPSULE	ORAL	20170510		NDA	NDA018651	ThePharmaNetwork, LLC	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
53097-571_5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48	53097-571	HUMAN PRESCRIPTION DRUG	MARINOL		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	ThePharmaNetwork, LLC	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
53097-572_5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48	53097-572	HUMAN PRESCRIPTION DRUG	MARINOL		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	ThePharmaNetwork, LLC	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
53097-573_5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48	53097-573	HUMAN PRESCRIPTION DRUG	MARINOL		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	ThePharmaNetwork, LLC	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
53117-046_affef754-2097-48fc-975b-63a35c991da7	53117-046	HUMAN OTC DRUG	Pep Tum		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20141223		OTC MONOGRAPH DRUG	M008	First Aid Direct	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
53117-248_1588de6a-189b-456d-9569-00332627fa50	53117-248	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET, COATED	ORAL	20050503		ANDA	ANDA076497	First Aid Direct	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
53117-414_2951457f-e466-43c5-a39e-274c36098613	53117-414	HUMAN OTC DRUG	Allergy Relief		Loratadine 10mg	TABLET	ORAL	20201111		ANDA	ANDA210722	First Aid Direct	LORATADINE	10	mg/1			N	20241231
53118-002_eea139e1-95b9-dd04-e053-2995a90a1965	53118-002	HUMAN OTC DRUG	Sanitex Antibacterial Hand Wipes	Fresh Scent	Benzalkonium Chloride	SWAB	TOPICAL	20150617		OTC MONOGRAPH NOT FINAL	part333A	Precare Corp	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
53125-265_af74c5b8-8857-41b2-807c-4b5a761e0e8f	53125-265	HUMAN OTC DRUG	Germ Stuff		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20171221		OTC MONOGRAPH NOT FINAL	part333E	North Woods	BENZALKONIUM CHLORIDE	25	mg/mL			N	20241231
53125-700_861e2386-96d0-8b8e-e053-2991aa0ac57a	53125-700	HUMAN OTC DRUG	North Woods Derma Foam Hand Sanitizer		Benzalkonium Chloride	SOAP	TOPICAL	20151001		OTC MONOGRAPH NOT FINAL	part333A	Superior Chemical Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
53125-700_ad51a4f8-6757-1ce3-e053-2995a90a0dec	53125-700	HUMAN OTC DRUG	North Woods Derma Foam Hand Sanitizer		Benzalkonium Chloride	SOAP	TOPICAL	20151001		OTC MONOGRAPH NOT FINAL	part333A	Superior Chemical Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
53125-708_f4374364-b80a-dc7e-e053-2995a90af560	53125-708	HUMAN OTC DRUG	North Woods Supreme Antiseptic Hand Cleanser		Chloroxylenol	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333E	Superior Chemical Corporation	CHLOROXYLENOL	3.75	mg/mL			N	20241231
53125-709_ab987adb-b4df-8798-e053-2995a90a3de2	53125-709	HUMAN OTC DRUG	DermaFoam Premium Antibacterial		Benzalkonium Chloride	SOAP	TOPICAL	20170719		OTC MONOGRAPH NOT FINAL	part333E	Superior Chemical	BENZALKONIUM CHLORIDE	.13	mg/mL			N	20241231
53125-717_85908601-0c5a-395f-e053-2a91aa0a8d0f	53125-717	HUMAN OTC DRUG	North Woods Derma Foam E-2		Benzalkonium Chloride	SOAP	TOPICAL	20160915		OTC MONOGRAPH NOT FINAL	part333A	Superior Chemical Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
53125-800_ad516aa8-98b2-014a-e053-2a95a90aaa4b	53125-800	HUMAN OTC DRUG	Excel Hand Sanitizer		Alcohol	SOAP	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	Superior Chemical Corporation	ALCOHOL	.7	mL/mL			N	20241231
53125-801_ad516489-eb32-2267-e053-2995a90af33b	53125-801	HUMAN OTC DRUG	North Woods Derma Gel Clear		Alcohol	GEL	TOPICAL	20190801		OTC MONOGRAPH NOT FINAL	part333E	Superior Chemical Corporation	ALCOHOL	.7	mL/mL			N	20241231
53125-802_f279624b-b4fe-f422-e053-2995a90a8728	53125-802	HUMAN OTC DRUG	North Woods D-Germ		Alcohol	GEL	TOPICAL	20210413	20240114	OTC MONOGRAPH NOT FINAL	part333E	Superior Chemical Corporation	ALCOHOL	70	mL/100mL			N	
53125-817_ab982f91-4aa3-0dba-e053-2995a90a4ab8	53125-817	HUMAN OTC DRUG	North Woods Derma Foam E-2		Benzalkonium Chloride	SOAP	TOPICAL	20160915		OTC MONOGRAPH NOT FINAL	part333A	Superior Chemical Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
53145-304_1c74114b-e1fb-48a6-ac7d-2a8c4ed84ad1	53145-304	HUMAN OTC DRUG	Polvos de Sulpha	First Aid Antibiotic	Bacitracin Zinc, Polymyxin B Sulfate	POWDER	TOPICAL	20061211		OTC MONOGRAPH DRUG	M004	Menper Distributors Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53152-0001_ae9bc9a0-0c46-fd9a-e053-2995a90a1664	53152-0001	HUMAN OTC DRUG	Pure Vitac Instant Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200904		OTC MONOGRAPH NOT FINAL	part333E	AOSS Medical Supply, Inc.	ALCOHOL	62	mL/100mL			N	20241231
53152-0004_ae9cfb55-28f1-dd6c-e053-2995a90a8271	53152-0004	HUMAN OTC DRUG	Pure Vitac Instant Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200904		OTC MONOGRAPH NOT FINAL	part333E	AOSS Medical Supply, Inc.	ALCOHOL	62	mL/100mL			N	20241231
53152-0008_ae9d5681-d11e-419d-e053-2a95a90a4d62	53152-0008	HUMAN OTC DRUG	Pure Vitac Instant Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200904		OTC MONOGRAPH NOT FINAL	part333E	AOSS Medical Supply, Inc.	ALCOHOL	62	mL/100mL			N	20241231
53157-106_9b2d582f-29e4-4bb3-e053-2995a90a710c	53157-106	HUMAN PRESCRIPTION DRUG	Leukotrap WB System - AS3		CP2D/AS-3 Anticoagulant and Additive System	SOLUTION	INTRAVENOUS	20151007		NDA	BN820915	Haemonetics Corporation	ADENINE; DEXTROSE	.033; 1.21	g/110mL; g/110mL			N	20241231
53157-123_9b2e21ce-f828-67bb-e053-2995a90adf56	53157-123	HUMAN PRESCRIPTION DRUG	Leukotrap - CP2D Solution		Anticoagulant Citrate Phosphate Double Dextrose	SOLUTION	INTRAVENOUS	19831109		NDA	BN820915	Haemonetics Corporation	DEXTROSE	3.57	g/70mL			N	20241231
53157-124_9b2e21ce-f828-67bb-e053-2995a90adf56	53157-124	HUMAN PRESCRIPTION DRUG	Leukotrap - AS-3 Solution		Additive Solution - 3	SOLUTION	INTRAVENOUS	19831109		NDA	BN820915	Haemonetics Corporation	ADENINE; DEXTROSE	.033; 1.21	g/110mL; g/110mL			N	20241231
53157-126_9b2d582f-29e4-4bb3-e053-2995a90a710c	53157-126	HUMAN PRESCRIPTION DRUG	Leukotrap WB System - CP2D		CP2D/AS-3 Anticoagulant and Additive System	SOLUTION	INTRAVENOUS	20151007		NDA	BN820915	Haemonetics Corporation	DEXTROSE	3.57	g/70mL			N	20241231
53157-130_9b2da1c1-c942-6c25-e053-2995a90a5fe7	53157-130	HUMAN PRESCRIPTION DRUG	CPDA-1 Blood Collection System		Blood Collection System	SOLUTION	INTRAVENOUS	19801106		NDA	BN800077	Haemonetics Corporation	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.019; .229; 2.23; 1.84; .155	g/70mL; g/70mL; g/70mL; g/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53157-136_9b2d582f-29f4-4bb3-e053-2995a90a710c	53157-136	HUMAN PRESCRIPTION DRUG	Leukotrap WB System		CPDA-1 Blood Bag Collection System	SOLUTION	INTRAVENOUS	19801106		NDA	BN800077	Haemonetics Corporation	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.019; .229; 2.23; 1.84; .155	g/70mL; g/70mL; g/70mL; g/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53157-136_9b2d6596-8ea5-7714-e053-2995a90a620f	53157-136	HUMAN PRESCRIPTION DRUG	Leukotrap WB System		CPDA-1 Blood Bag Collection System	SOLUTION	INTRAVENOUS	19801106		NDA	BN800077	Haemonetics Corporation	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.019; .229; 2.23; 1.84; .155	g/70mL; g/70mL; g/70mL; g/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53157-136_9b2d8341-2e3d-d59e-e053-2995a90a8f86	53157-136	HUMAN PRESCRIPTION DRUG	Leukotrap WB System		CPDA-1 Blood Bag Collection System	SOLUTION	INTRAVENOUS	19801106		NDA	BN800077	Haemonetics Corporation	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.019; .229; 2.23; 1.84; .155	g/70mL; g/70mL; g/70mL; g/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53157-262_d67faebb-c273-36f0-e053-2a95a90a7ae8	53157-262	HUMAN PRESCRIPTION DRUG	Leukotrap WB System		Leukotrap WB System	KIT	INTRAVENOUS	19830922		NDA	BN820915	Haemonetics Corporation						N	20241231
53157-455_e154f8b7-89a1-dfbb-e053-2995a90a300a	53157-455	HUMAN PRESCRIPTION DRUG	Leukotrap - CP2D		ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE	SOLUTION	INTRAVENOUS	20191009		NDA	BN820915	Haemonetics Corporation	DEXTROSE, UNSPECIFIED FORM	4.64	g/100mL			N	20241231
53157-460_e15674bf-142c-653c-e053-2995a90a726a	53157-460	HUMAN PRESCRIPTION DRUG	Leukotrap - AS-3		AS-3	SOLUTION	INTRAVENOUS	20191009		NDA	BN820915	Haemonetics Corporation	ADENINE; DEXTROSE, UNSPECIFIED FORM	.03; 1	g/100mL; g/100mL			N	20241231
53157-462_e156e252-b167-54c7-e053-2a95a90a8e95	53157-462	HUMAN PRESCRIPTION DRUG	AS-3		AS-3	SOLUTION	INTRAVENOUS	20191009		NDA	BN820915	Haemonetics Corporation	ADENINE; DEXTROSE, UNSPECIFIED FORM	.03; 1	g/100mL; g/100mL			N	20241231
53157-730_017ddc37-03eb-b30b-e063-6294a90a519e	53157-730	HUMAN PRESCRIPTION DRUG	CPDA-1 Blood Collection System		Blood Collection System	SOLUTION	INTRAVENOUS	19801106		NDA	BN800077	Haemonetics Corporation	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.017; .206; 2.01; 1.66; .14	g/63mL; g/63mL; g/63mL; g/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53157-736_00da2513-06fc-7790-e063-6294a90a4d54	53157-736	HUMAN PRESCRIPTION DRUG	Leukotrap WB System		CPDA-1 Blood Bag Collection System	SOLUTION	INTRAVENOUS	19801106		NDA	BN800077	Haemonetics Corporation	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.017; .206; 2.01; 1.66; .14	g/63mL; g/63mL; g/63mL; g/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53157-736_9b2bb14c-0d61-6074-e053-2995a90a2b7a	53157-736	HUMAN PRESCRIPTION DRUG	Leukotrap WB System		CPDA-1 Blood Bag Collection System	SOLUTION	INTRAVENOUS	19801106		NDA	BN800077	Haemonetics Corporation	ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.017; .206; 2.01; 1.66; .14	g/63mL; g/63mL; g/63mL; g/63mL; g/63mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53157-791_a72d2782-96cd-2a9d-e053-2995a90afc08	53157-791	HUMAN PRESCRIPTION DRUG	Pall Sterile Cord Blood Collection Unit		Sterile Cord Blood Collection Unit	SOLUTION	INTRAVENOUS	20110316		NDA	BN800222	Haemonetics Corporation	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.114; .893; .921; .0078	g/35mL; g/35mL; g/35mL; g/35mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53163-101_b6f67433-60ea-463d-944a-da069148fa64	53163-101	HUMAN OTC DRUG	Altipres-B		BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20121101		OTC MONOGRAPH FINAL	part341	Alternative Pharmacal Corporation	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 20; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53163-103_afe0e032-1d25-467b-a9a2-6653d9c815f1	53163-103	HUMAN OTC DRUG	Altipres	Pediatric	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20130501		OTC MONOGRAPH FINAL	part341	Alternative Pharmacal Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 75; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53163-104_0d59b203-586c-4754-a638-c3a5e8025d7e	53163-104	HUMAN OTC DRUG	Altipres		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20130501		OTC MONOGRAPH FINAL	part341	Alternative Pharmacal Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53163-106_f2f48593-234d-400f-b3f5-eaf31f98ba5f	53163-106	HUMAN OTC DRUG	Igualtuss		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20140301		OTC MONOGRAPH FINAL	part341	Alternative Pharmacal Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	28; 388; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53163-108_20ae625d-ca76-40d2-8cfd-dced5f7058a3	53163-108	HUMAN OTC DRUG	Altidesp		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20150301		OTC MONOGRAPH FINAL	part341	Alternative Pharmacal Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 50; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53163-113_b4509f15-c100-4010-ac0f-63b145214671	53163-113	HUMAN OTC DRUG	Altituss		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20150301		OTC MONOGRAPH FINAL	part341	Alternative Pharmacal Corporation	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	15; 150	mg/7.5mL; mg/7.5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53175-001_097e2efb-9a04-c6e6-e063-6294a90a6d7d	53175-001	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20120910		OTC MONOGRAPH DRUG	M003	Dyad Medical Sourcing, LLC	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
53175-002_97a0df8f-aa89-4320-a1d8-beff362836a9	53175-002	HUMAN OTC DRUG	HCS Roll-On Antiperspirant		Aluminum Chlorohydrate	LIQUID	TOPICAL	20141101	20240720	OTC MONOGRAPH FINAL	part350	Dyad Medical Sourcing, LLC	ALUMINUM CHLOROHYDRATE	78	mg/mL			N	
53175-810_89b772e6-04ba-4810-9309-fab4a99ab9fb	53175-810	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part333A	Dyad Medical Sourcing, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53185-002_7b83f711-862f-40fb-b2d5-bc403163310a	53185-002	HUMAN OTC DRUG	Clear Choice Extra Strength Pain Reliever		ACETAMINOPHEN	TABLET	ORAL	20120913		OTC MONOGRAPH DRUG	M013	Athlete's Needs, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
53185-005_d26ac076-dfbe-4235-8c66-d767d67d4904	53185-005	HUMAN OTC DRUG	Clear Choice Regular Strength Pain Reliever		ACETAMINOPHEN	TABLET	ORAL	20130603		OTC MONOGRAPH DRUG	M013	Athlete's Needs, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
53185-249_c0cda176-d438-4854-86a9-9d1ac00124a3	53185-249	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19930804		OTC MONOGRAPH DRUG	M013	Athlete's Needs Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53185-277_3bbe161c-4342-40b5-82b6-5270ef0e31d3	53185-277	HUMAN OTC DRUG	Chlorpheniramine maleate 4mg		Chlorpheniramine maleate 4mg	TABLET, COATED	ORAL	20141215		OTC MONOGRAPH DRUG	M012	Athlete's Needs, Inc.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53185-362_15a4708b-ad90-4051-9b5d-976f70658931	53185-362	HUMAN OTC DRUG	Naproxen Sodium 220mg		Naproxen Sodium 220mg	TABLET, COATED	ORAL	20141223		ANDA	ANDA090545	Athlete's Needs, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53185-381_9d68e8bc-54bb-438f-a0fb-2df0c9ef2dd3	53185-381	HUMAN OTC DRUG	Ibuprofen 200mg		Ibuprofen 200mg	TABLET, COATED	ORAL	20161007		ANDA	ANDA202312	Athlete's Needs, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53185-394_aa5989d3-2bbf-448d-b90f-ec90849011c1	53185-394	HUMAN OTC DRUG	Naproxen Sodium 220mg		Naproxen Sodium 220mg	TABLET, COATED	ORAL	20141223		ANDA	ANDA090545	Athlete's Needs, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53185-604_1156da96-fa04-4788-ad06-c6dbed0a6fca	53185-604	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220311		ANDA	ANDA204872	Athlete's Needs Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53187-199_792a9fc5-8095-4301-993a-65441e7e9a3e	53187-199	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20130325	20240126	ANDA	ANDA078682	LIVE BETTER (The Great Atlantic & Pacific Tea Company)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
53205-001_b06700b0-e401-4454-be84-ec64eb8a929b	53205-001	HUMAN OTC DRUG	D-COL Personal Hygiene Convenience kit		Pyrithione Zinc and Chloroxylenol	KIT		20180530		OTC MONOGRAPH FINAL	part358H	D-COL Inc						N	20241231
53208-000_0c5b6a69-0a54-0f46-e063-6294a90a4fca	53208-000	HUMAN OTC DRUG	ISA KNOX 365 BB SUNSCREEN Broad Spectrum SPF 40, PA		TITANIUM DIOXIDE	CREAM	TOPICAL	20130313		OTC MONOGRAPH DRUG	M020	LG Household and Healthcare, Inc.	TITANIUM DIOXIDE	121.6	mg/g			N	20241231
53208-001_0c83afd6-4237-38ba-e063-6394a90a0fce	53208-001	HUMAN OTC DRUG	O HUI Sun Science Ideal Cover Sunscreen Broad Spectrum		TITANIUM DIOXIDE	CREAM	TOPICAL	20130313		OTC MONOGRAPH DRUG	M020	LG Household and Healthcare, Inc.	TITANIUM DIOXIDE	121.6	mg/g			N	20241231
53208-002_0c83935b-8350-7a1c-e063-6294a90a7902	53208-002	HUMAN OTC DRUG	ISA KNOX 365 SUNSCREEN BROAD SPECTRUM SPF 50 Plus		HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE	CREAM	TOPICAL	20141028		OTC MONOGRAPH DRUG	M020	LG Household and Healthcare, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53208-052_d309ec50-72bb-9e8e-e053-2995a90ac040	53208-052	HUMAN OTC DRUG	THEFACESHOP Cushion CC SPF 50 Apricot Beige	Oil-Free	Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
53208-053_d30a1aed-8079-ca92-e053-2995a90ac324	53208-053	HUMAN OTC DRUG	THEFACESHOP Cushion CC SPF 50 Natural Beige	Oil-Free	Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
53208-062_d309eebc-44f5-bce6-e053-2995a90a3bd2	53208-062	HUMAN OTC DRUG	THEFACESHOP Cushion CC Total Cover SPF 50 Apricot Beige		Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
53208-063_d30a9236-07eb-f4a9-e053-2a95a90a5726	53208-063	HUMAN OTC DRUG	THEFACESHOP Cushion CC Total Cover SPF 50 Natural Beige		Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
53208-195_d30a9fee-b173-62f0-e053-2a95a90aac1e	53208-195	HUMAN OTC DRUG	THEFACESHOP Natural Sun Oil-Free Sunscreen Broad Spectrum SPF 50		Ensulizole, Octinoxate, Octisalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	1.75; 3.5; 2.25; 2.285; 5.825	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-196_d30ab8ff-da62-5131-e053-2a95a90a4b00	53208-196	HUMAN OTC DRUG	THEFACESHOP Natural Sun Long Lasting Sunscreen Broad Spectrum SPF 50		Ensulizole, Octinoxate, Octisalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	1.75; 3.5; 2.25; 2.285; 5.825	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-201_d6e827e7-5f3b-fd0a-e053-2a95a90a2a35	53208-201	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-202_d6e8310b-257a-1ef5-e053-2a95a90ad507	53208-202	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE ACTIVE FACE AND BODY PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-203_01679517-f9fd-6673-e063-6394a90abed4	53208-203	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230714		OTC MONOGRAPH FINAL	M020	LG H&H Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-210_d6e822a6-a07e-c3c6-e053-2995a90aedec	53208-210	HUMAN OTC DRUG	ISA KNOX LXNEW PLATINUM SCULPTING DAY BROAD SPECTRUM SPF 30 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 7; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-211_f1166cb4-b472-7043-e053-2a95a90a7fa7	53208-211	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY MINERAL FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH FINAL	M020	LG H&H Co., Ltd.	ZINC OXIDE	15.52	g/50mL			N	20241231
53208-212_016731e2-06b4-9287-e063-6394a90a9c54	53208-212	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY MINERAL FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		ZINC OXIDE	CREAM	TOPICAL	20230714		OTC MONOGRAPH FINAL	M020	LG H&H Co., Ltd.	ZINC OXIDE	15.52	g/50mL			N	20241231
53208-301_0a6463d7-a347-cd64-e063-6394a90aba9f	53208-301	HUMAN OTC DRUG	Dominas Dark Spot UV Defense Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	LG H&H Co.,Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-561_05b17ebf-54b4-809e-e063-6394a90aac68	53208-561	HUMAN OTC DRUG	EUTHYMOL Extraordinary Pink Whitening		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	LG H&H CO., LTD.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
53208-562_0a8b650c-5eca-987c-e063-6394a90abba7	53208-562	HUMAN OTC DRUG	EUTHYMOL Extraordinary Pink Whitening		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20231023		OTC MONOGRAPH DRUG	M021	LG H&H CO., LTD.	SODIUM FLUORIDE	1.6	mg/g			N	20241231
53208-571_05b2273a-59f8-1a25-e063-6394a90a888f	53208-571	HUMAN OTC DRUG	POP Hint Of Mint		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	LG H&H CO., LTD.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
53208-572_0abae81f-3e1e-57b6-e063-6294a90a3e3f	53208-572	HUMAN OTC DRUG	POP Feeling Peachy		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20231117		OTC MONOGRAPH DRUG	M021	LG H&H CO., LTD.	SODIUM FLUORIDE	1.4	mg/g			N	20241231
53208-581_05b276a1-3776-104d-e063-6294a90a7537	53208-581	HUMAN OTC DRUG	POP Gel Pumpin Strawberry		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	LG H&H CO., LTD.	SODIUM FLUORIDE	1.3	mg/g			N	20241231
53208-582_05b25083-12f6-7a85-e063-6394a90a492e	53208-582	HUMAN OTC DRUG	POP Gel Whatzzup Watermelon		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230918		OTC MONOGRAPH FINAL	part355	LG H&H CO., LTD.	SODIUM FLUORIDE	1.3	mg/g			N	20241231
53208-600_d2f9c540-2009-2ced-e053-2995a90a9634	53208-600	HUMAN OTC DRUG	OHUI Ultimate Cover CC Cushion Compact 01 Light Beige		Titanium Dioxide	POWDER	TOPICAL	20160125		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
53208-601_d3074789-ce92-6abb-e053-2995a90acaae	53208-601	HUMAN OTC DRUG	OHUI Ultimate Cover CC Cushion Compact 02 Natural Beige		Titanium Dioxide	POWDER	TOPICAL	20160125		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
53208-650_f8377a86-3d77-e2af-e053-6294a90a0b6c	53208-650	HUMAN OTC DRUG	O HUI DAY SHIELD PERFECT SUN BLACK BROAD SPECTRUM SPF 50 SUNSCREEN		Octisalate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230331		OTC MONOGRAPH FINAL	M020	LG H&H Co., Ltd.	OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	2.5; 4; 1.53; 8.73	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-710_0289089e-c02b-6c32-e063-6294a90a13aa	53208-710	HUMAN OTC DRUG	belif The true cream aqua bomb sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20230808		OTC MONOGRAPH FINAL	M020	LG H&H Co.,Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-710_d6809b0d-1539-4197-e053-2a95a90a37d7	53208-710	HUMAN OTC DRUG	belif The true cream aqua bomb sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20220126		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53208-800_d308036f-0f49-3deb-e053-2a95a90a9f53	53208-800	HUMAN OTC DRUG	Babience KIDS Sunscreen pinkfong BABY SHARK SPF 50		Ensulizole, Octinoxate, Octisalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part352	LG HOUSEHOLD & HEALTH CARE LTD	ENSULIZOLE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	1.75; 3.5; 2.25; 2.285; 5.825	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
53225-1020_07db7c07-1dcd-9494-e063-6294a90a0c53	53225-1020	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20220708		UNAPPROVED DRUG OTHER		Terrain Pharmaceuticals	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53225-1022_0c79cb67-2f8f-46b2-e063-6294a90aa1f2	53225-1022	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20140101		OTC MONOGRAPH DRUG	M017	Terrain Pharmaceuticals	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53225-1023_0c7b2d82-6720-584f-e063-6394a90ad606	53225-1023	HUMAN OTC DRUG	LidoPro Patch		Lidocaine, Menthol, and Methyl Salicylate	PATCH	TOPICAL	20141202		OTC MONOGRAPH DRUG	M017	Terrain Pharmaceuticals	LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	4; 5; 4	mg/100mg; mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53225-1025_0c7b5d33-1289-7b90-e063-6294a90a553a	53225-1025	HUMAN PRESCRIPTION DRUG	LIDOTHOL		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20150616		UNAPPROVED DRUG OTHER		Terrain Pharmaceuticals	LIDOCAINE; MENTHOL	4.5; 5	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53225-1026_0c7b8746-bf71-6ddf-e063-6394a90a7586	53225-1026	HUMAN PRESCRIPTION DRUG	Lidothol		LIDOCAINE HCl, MENTHOL	GEL	TOPICAL	20190401		UNAPPROVED DRUG OTHER		Terrain Pharmaceuticals	LIDOCAINE HYDROCHLORIDE; MENTHOL	4.5; 5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53225-1030_0c7b9350-4d6d-710d-e063-6394a90a1111	53225-1030	HUMAN OTC DRUG	VIVA Patch		Camphor, Lidocaine, and Methyl Salicylate	PATCH	TOPICAL	20160831		OTC MONOGRAPH DRUG	M017	Terrain Pharmaceuticals	CAMPHOR (NATURAL); LIDOCAINE; METHYL SALICYLATE	2; 2.5; 4	mg/100mg; mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53225-1070_0c798050-d1b1-1ff8-e063-6294a90a416f	53225-1070	HUMAN PRESCRIPTION DRUG	Diclona Gel		Lidocaine 4.5%, Diclofenac 1%	GEL	TOPICAL	20220502		UNAPPROVED DRUG OTHER		Terrain Pharmaceuticals	DICLOFENAC SODIUM; LIDOCAINE	.01; .045	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Antiarrhythmic [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53225-1076_f821869d-f5de-0fa9-e053-6394a90a8e1a	53225-1076	HUMAN PRESCRIPTION DRUG	Diclona Patch		Lidocaine 4.5%, Diclofenac 1.25%	PATCH	TOPICAL	20220331		UNAPPROVED DRUG OTHER		Terrain Pharmaceuticals	DICLOFENAC SODIUM; LIDOCAINE HYDROCHLORIDE	.0125; .045	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Antiarrhythmic [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53238-001_eaf8ae5d-9bd9-62ce-e053-2995a90a0e0b	53238-001	HUMAN OTC DRUG	PERIOSCIENCES White Care AO Pro		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20120913		OTC MONOGRAPH FINAL	part355	PERIOSCIENCES LLC	SODIUM FLUORIDE	.24	mg/100mL			N	20241231
53238-002_eaf8ae5d-9bda-62ce-e053-2995a90a0e0b	53238-002	HUMAN OTC DRUG	PERIOSCIENCES SENSITIVE AO Pro		POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20130527		OTC MONOGRAPH NOT FINAL	part356	PERIOSCIENCES LLC	POTASSIUM NITRATE; SODIUM MONOFLUOROPHOSPHATE	50; 1.3	mg/mL; mg/mL			N	20241231
53238-003_eaf8bfcf-7f2e-dee1-e053-2a95a90abe21	53238-003	HUMAN OTC DRUG	PERIOSCIENCES HYDRATING AO Pro		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20130527		OTC MONOGRAPH FINAL	part355	PERIOSCIENCES LLC	SODIUM MONOFLUOROPHOSPHATE	1.3	mg/mL			N	20241231
53247-113_3af5c1af-8a15-429d-9d5c-30f5eb3a1a49	53247-113	HUMAN OTC DRUG	Bob Barker Antibacterial unwrapped body		BENZETHONIUM CHLORIDE	SOAP	CUTANEOUS	20170601		OTC MONOGRAPH DRUG	M003	Bob Barker Company Inc.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20241231
53247-114_af431665-b390-49fb-bd89-71bb9434c5cc	53247-114	HUMAN OTC DRUG	Bob Barker Antibacterial wrapped body		BENZETHONIUM CHLORIDE	SOAP	CUTANEOUS	20170601		OTC MONOGRAPH DRUG	M003	Bob Barker Company Inc.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20241231
53247-117_ce6da6d3-a0eb-4f9a-b3c8-b26702af1e5c	53247-117	HUMAN OTC DRUG	Bob Barker Antibacterial wrapped body		BENZETHONIUM CHLORIDE	SOAP	CUTANEOUS	20170601		OTC MONOGRAPH DRUG	M003	Bob Barker Company Inc.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20241231
53247-118_b8465e03-be09-487a-9ca8-36b6fdc0dc7b	53247-118	HUMAN OTC DRUG	Bob Barker Antibacterial un-wrapped body		BENZETHONIUM CHLORIDE	SOAP	CUTANEOUS	20170601		OTC MONOGRAPH DRUG	M003	Bob Barker Company Inc.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20241231
53247-121_4a368d7f-3f84-47ca-8bbe-fdeee6efa3b4	53247-121	HUMAN OTC DRUG	CinnaFresh		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20080101		OTC MONOGRAPH DRUG	M021	Bob Barker Company Inc.	SODIUM FLUORIDE	2.2	mg/g			N	20241231
53247-122_e3362f0b-0a6b-4b7a-898e-b9dd3f92ae69	53247-122	HUMAN OTC DRUG	Maximum Security		Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20080101		OTC MONOGRAPH DRUG	M021	Bob Barker Company Inc.	SODIUM FLUORIDE	2.2	mg/g			N	20241231
53247-123_4916bff5-91eb-4485-ae42-6176834e29da	53247-123	HUMAN OTC DRUG	Nature Mint Anticavity		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20080101		OTC MONOGRAPH DRUG	M021	Bob Barker Company Inc.	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
53247-124_c2cefa3d-3888-455e-a8cc-71103946671a	53247-124	HUMAN OTC DRUG	LiceOut		piperonyl butoxide and pyrethrum extract	SHAMPOO	TOPICAL	20220102		OTC MONOGRAPH DRUG	M031	Bob Barker Company Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	3; .3	g/100mL; g/100mL			N	20241231
53247-750_08b5d943-9b59-4cf5-e063-6294a90a56d0	53247-750	HUMAN OTC DRUG	Anti-Perspirant Deodorant		ALUMINUM CHLOROHYDRATE	SPRAY	TOPICAL	20170622		OTC MONOGRAPH DRUG	M019	Bob Barker Company	ALUMINUM CHLOROHYDRATE	13	g/100mL			N	20241231
53329-003_027df3f1-638a-8b75-e063-6394a90ae96a	53329-003	HUMAN OTC DRUG	Spectrum Hand Sanitizer		ethyl alcohol	GEL	TOPICAL	20180706		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	ALCOHOL	85	mL/100mL			N	20241231
53329-009_e66110f2-a841-19d6-e053-2995a90a39a1	53329-009	HUMAN OTC DRUG	Spectrum		Ethyl alcohol	GEL	TOPICAL	20160815		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ALCOHOL	70	g/100mL			N	20241231
53329-010_097fbc5e-1d38-8b3b-e063-6294a90a0f29	53329-010	HUMAN OTC DRUG	Antiperspirant		aluminum chlorohydrate	SPRAY	TOPICAL	20100601		OTC MONOGRAPH DRUG	M019	Medline Industries, LP	ALUMINUM CHLOROHYDRATE	13	g/100mL			N	20241231
53329-013_e94a72e9-6878-1802-e053-2a95a90a60dd	53329-013	HUMAN OTC DRUG	Pure and Gentle		mineral oil	ENEMA	RECTAL	20140409		OTC MONOGRAPH NOT FINAL	part334	Medline Industries, LP	MINERAL OIL	100	g/100mL			N	20241231
53329-014_e997512b-6226-3d7b-e053-2995a90aea90	53329-014	HUMAN OTC DRUG	Pure and Gentle Laxative		sodium phosphate	ENEMA	RECTAL	20140409		OTC MONOGRAPH NOT FINAL	part334	Medline Industries, LP	SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC	7; 19	g/118mL; g/118mL			N	20241231
53329-020_e9979154-e13c-12a4-e053-2995a90a8160	53329-020	HUMAN OTC DRUG	Chewable Aspirin Adult low dose		aspirin	TABLET, CHEWABLE	ORAL	20180417		OTC MONOGRAPH NOT FINAL	part343	Medline Industries, LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53329-021_03712fa7-67e2-4c84-e063-6394a90a990a	53329-021	HUMAN OTC DRUG	Hydraguard-D		Dimethicone	CREAM	TOPICAL	20191126		OTC MONOGRAPH FINAL	part347	Medline Industries, LP	DIMETHICONE	12.5	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-030_07d66fb2-f4d2-479c-e063-6394a90a5e91	53329-030	HUMAN OTC DRUG	DuoCare Clinical Oral Rinse		Cetylpyridinium Chloride	MOUTHWASH	DENTAL	20181101		OTC MONOGRAPH DRUG	M022	Medline Industries, LP	CETYLPYRIDINIUM CHLORIDE	1	mg/mL			N	20241231
53329-031_e9983d64-bd98-5954-e053-2995a90ad5f2	53329-031	HUMAN OTC DRUG	Curad Maximum Strength Triple Antibiotic		bacitracin, neomycin, polymyxin B, pramoxine hydrochloride	OINTMENT	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333B	Medline Industries, LP	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53329-032_0b64db1c-7022-77c8-e063-6394a90a2af2	53329-032	HUMAN OTC DRUG	62% Ethyl Alcohol Antiseptic Nasal		ethyl alcohol	SWAB	TOPICAL	20190910		OTC MONOGRAPH DRUG	505G(a)(3)	Medline Industries, LP	ALCOHOL	62	mL/100mL			N	20241231
53329-033_e9ab1c23-5f93-d015-e053-2a95a90a6400	53329-033	HUMAN OTC DRUG	Medline		cetirizine hcl	TABLET	ORAL	20200501		ANDA	ANDA209274	Medline Industries, LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53329-042_03716e15-741e-c696-e063-6394a90a356d	53329-042	HUMAN OTC DRUG	Soothe and Cool Free Medseptic	Skin Protectant	Lanolin	OINTMENT	TOPICAL	20070101		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	LANOLIN	500	mg/g			N	20241231
53329-059_efcdffb5-a81d-20ab-e053-2a95a90af898	53329-059	HUMAN OTC DRUG	Aloetouch Protect	Fragrance Free	Dimethicone	CLOTH	TOPICAL	20120801		OTC MONOGRAPH FINAL	part347	Medline Industries, LP	DIMETHICONE	3.2	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-060_fd281195-7b2a-b0cd-e053-6394a90aa8a5	53329-060	HUMAN OTC DRUG	Readybath TPC	Total Perineal Care	Dimethicone	CLOTH	TOPICAL	20070101		OTC MONOGRAPH FINAL	M016	Medline Industries, Inc.	DIMETHICONE	.544	g/1	Skin Barrier Activity [PE]		N	20241231
53329-067_efceb3a5-8762-fb96-e053-2995a90a1c8f	53329-067	HUMAN OTC DRUG	Soothe and Cool		White Petrolatum	OINTMENT	TOPICAL	20070101		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	935	mg/g			N	20241231
53329-068_026dae55-aa87-c4f5-e063-6294a90ad7e5	53329-068	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20180101		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	1	g/g			N	20241231
53329-069_efceb428-e7b4-6399-e053-2a95a90ab01d	53329-069	HUMAN OTC DRUG	Roll On Anti Perspirant	Alcohol Free	Aluminum Chlorohydrate	SOLUTION	TOPICAL	20070101		OTC MONOGRAPH FINAL	part350	Medline Industries, LP	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
53329-071_026dc53f-3b0c-a372-e063-6394a90ac408	53329-071	HUMAN OTC DRUG	Soothe and Cool Moisture Barrier		Petrolatum	OINTMENT	TOPICAL	20060301		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	98.3	g/100g			N	20241231
53329-072_e9b0c006-8e8d-c5e5-e053-2995a90adb16	53329-072	HUMAN OTC DRUG	Soothe and Cool Free Moisture Barrier		Petrolatum	OINTMENT	TOPICAL	20070101		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	92.8	g/100g			N	20241231
53329-073_e9ac358e-c9bf-7091-e053-2a95a90a4609	53329-073	HUMAN OTC DRUG	MicroKlenz Antimicrobial		Benzethonium Chloride	LIQUID	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZETHONIUM CHLORIDE	.1	mg/100mL			N	20241231
53329-074_e9c051ed-06c4-1422-e053-2995a90a87e7	53329-074	HUMAN OTC DRUG	Remedy Barrier Cream Cloths	Fragrance Free	Dimethicone	CLOTH	TOPICAL	20160831		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE	3.6	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-075_e9c09dca-f258-4149-e053-2995a90a1a07	53329-075	HUMAN OTC DRUG	Readyflush Protect Wipes	Fragrance Free	Dimethicone	CLOTH	TOPICAL	20120801		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE	3.2	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-078_e9c051ed-06c4-1422-e053-2995a90a87e7	53329-078	HUMAN OTC DRUG	Remedy Barrier Cream Cloths		Dimethicone	CLOTH	TOPICAL	20131219		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE	3.6	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-080_0322128b-e1f9-6f53-e063-6394a90afc29	53329-080	HUMAN OTC DRUG	Soothe And Cool Treat		Miconazole Nitrate	CREAM	TOPICAL	20070101		OTC MONOGRAPH FINAL	M005	Medline Industries, LP	MICONAZOLE NITRATE	20	mg/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53329-083_ea750db7-ddd8-8264-e053-2a95a90a4586	53329-083	HUMAN OTC DRUG	SparkleFresh	Flouride Toothpaste	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20070101		OTC MONOGRAPH FINAL	part355	Medline Industries, LP	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
53329-086_da305d7c-8182-78e2-e053-2995a90a011d	53329-086	HUMAN OTC DRUG	Medline Peroxi Fresh	Mouthwash	Hydrogen Peroxide	MOUTHWASH	DENTAL	20070101		OTC MONOGRAPH NOT FINAL	part356	Medline Industries, LP	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
53329-087_026f7ed1-bcd5-9ba9-e063-6394a90ab713	53329-087	HUMAN OTC DRUG	Triple Antibiotic		bacitracin zinc, neomycin sulfate, polymyxin B sulfate	OINTMENT	TOPICAL	20180101		OTC MONOGRAPH FINAL	part333B	Medline Industries, LP	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53329-089_026de3dd-f4df-1ddf-e063-6294a90a613e	53329-089	HUMAN OTC DRUG	First Aid Antibiotic		bacitracin zinc	OINTMENT	TOPICAL	20100301		OTC MONOGRAPH FINAL	part333B	Medline Industries, LP	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
53329-090_fe41a7bb-f45d-411f-e053-6394a90afd7e	53329-090	HUMAN OTC DRUG	Vitamin A and D		Skin Protectant	OINTMENT	TOPICAL	20100301	20241231	OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	935	mg/g			N	
53329-091_026de641-b235-cecc-e063-6394a90ad072	53329-091	HUMAN OTC DRUG	Anti-itch		hydrocortisone	CREAM	TOPICAL	20100301		OTC MONOGRAPH NOT FINAL	part348	Medline Industries, LP	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53329-092_026dec9e-b559-67a1-e063-6294a90ad50e	53329-092	HUMAN OTC DRUG	Petroleum-Free Lip Balm		Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20100401		OTC MONOGRAPH FINAL	M020	Medline Industries, LP	OCTINOXATE; OXYBENZONE	2; 4.5	g/100g; g/100g			N	20241231
53329-094_032211ad-1f6c-64a1-e063-6294a90a0954	53329-094	HUMAN OTC DRUG	RadiaBlock		Oxybenzone, Octinoxate	LIPSTICK	TOPICAL	20130301	20250430	OTC MONOGRAPH NOT FINAL	part352	Medline Industries, LP	OCTINOXATE; OXYBENZONE	75; 30	mg/g; mg/g			N	
53329-097_065cd9e2-0242-661c-e063-6294a90a4c6f	53329-097	HUMAN OTC DRUG	Remedy Essentials		White Petrolatum,Zinc Oxide	PASTE	TOPICAL	20161114		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM; ZINC OXIDE	75; 20	g/100g; g/100g			N	20241231
53329-103_fe41b8cb-2114-19f7-e053-6294a90a5325	53329-103	HUMAN OTC DRUG	Curad Cream Skin Protectant		petrolatum, zinc oxide	CREAM	TOPICAL	20190101	20240731	OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM; ZINC OXIDE	75; 20	g/100g; g/100g			N	
53329-105_fad08107-5625-2028-e053-6294a90a1b22	53329-105	HUMAN OTC DRUG	Medline Remedy Phytoplex Calazime		menthol, zinc oxide, petrolatum	PASTE	TOPICAL	20180709		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	MENTHOL; PETROLATUM; ZINC OXIDE	44; 53; 20.6	g/100g; g/100g; g/100g			N	20241231
53329-132_0b6534d0-8c9a-bd9a-e063-6294a90a030e	53329-132	HUMAN OTC DRUG	62% Ethyl Alcohol Antiseptic Nasal		ethyl alcohol	SWAB	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Medline Industries, LP	ALCOHOL	62	mL/100mL			N	20241231
53329-133_0b653332-6ea1-bb94-e063-6294a90a24c3	53329-133	HUMAN OTC DRUG	Medline		ethyl alcohol	SWAB	TOPICAL	20220101	20250131	OTC MONOGRAPH DRUG	505G(a)(3)	Medline Industries, LP	ALCOHOL	62	mL/100mL			N	
53329-136_fd142766-b917-c285-e053-6394a90a9600	53329-136	HUMAN OTC DRUG	Phytoplex Clear Aid		White Petrolatum,Zinc Oxide	PASTE	TOPICAL	20170701		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM; ZINC OXIDE	71.5; 1	g/100g; g/100g			N	20241231
53329-137_facff7f9-60b6-5ca7-e053-6394a90a6ef0	53329-137	HUMAN OTC DRUG	Z-Guard		White Petrolatum,Zinc Oxide	PASTE	TOPICAL	20160106		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM; ZINC OXIDE	57; 17	g/100g; g/100g			N	20241231
53329-140_0879103e-9d55-710a-e063-6294a90a8281	53329-140	HUMAN OTC DRUG	Remedy Skin Repair		Dimethicone	CREAM	TOPICAL	20100301		OTC MONOGRAPH DRUG	M016	Medline Industries, LP	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-144_087d66ff-1a8d-dcb2-e063-6294a90a2f8c	53329-144	HUMAN OTC DRUG	Medline		white petrolatum, zinc oxide	PASTE	TOPICAL	20230901		OTC MONOGRAPH DRUG	M016	Medline Industries, LP	WHITE PETROLATUM; ZINC OXIDE	57; 17	g/100g; g/100g			N	20241231
53329-146_03110b38-0c57-17d6-e063-6394a90a7d86	53329-146	HUMAN OTC DRUG	Medline		white petrolatum	OINTMENT	TOPICAL	20230301		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	WHITE PETROLATUM	983	mg/g			N	20241231
53329-147_0d997d1d-8664-201f-e063-6394a90a285e	53329-147	HUMAN OTC DRUG	Medline		miconazole nitrate	CREAM	TOPICAL	20230801		OTC MONOGRAPH DRUG	M005	Medline Industries, LP	MICONAZOLE NITRATE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53329-150_00766a7b-797f-dd15-e063-6394a90af9ac	53329-150	HUMAN OTC DRUG	Medline		white petrolatum	JELLY	TOPICAL	20230401		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	WHITE PETROLATUM	1	g/g			N	20241231
53329-152_e9b1a475-b6ae-035e-e053-2a95a90aa421	53329-152	HUMAN OTC DRUG	Medline Remedy Phytoplex Skin Repair		Dimethicone	CREAM	TOPICAL	20180212		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE	5	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-153_0da8bbce-586a-3f71-e063-6294a90aedda	53329-153	HUMAN OTC DRUG	Medline		white petrolatum, zinc oxide	PASTE	TOPICAL	20230501		OTC MONOGRAPH DRUG	M016	Medline Industries, LP	WHITE PETROLATUM; ZINC OXIDE	490; 150	mg/g; mg/g			N	20241231
53329-154_0d94fd18-a121-e171-e063-6394a90ae9c0	53329-154	HUMAN OTC DRUG	Medline		dimethicone	CREAM	TOPICAL	20230901		OTC MONOGRAPH DRUG	M016	Medline Industries, LP	DIMETHICONE	15	mg/mL	Skin Barrier Activity [PE]		N	20241231
53329-155_0d96588d-c64e-e7e8-e063-6294a90a5c57	53329-155	HUMAN OTC DRUG	Medline		dimethicone	CREAM	TOPICAL	20230801		OTC MONOGRAPH DRUG	M016	Medline Industries, LP	DIMETHICONE	15	mg/mL	Skin Barrier Activity [PE]		N	20241231
53329-156_006539c9-1983-d6de-e063-6294a90a1a5a	53329-156	HUMAN OTC DRUG	Medline		menthol, white petrolatum, zinc oxide	PASTE	TOPICAL	20230401		OTC MONOGRAPH FINAL	M015	Medline Industries, LP	MENTHOL; PETROLATUM; ZINC OXIDE	4.4; 530; 206	mg/g; mg/g; mg/g			N	20241231
53329-157_03220277-a922-0908-e063-6394a90afc4a	53329-157	HUMAN OTC DRUG	Remedy Nutrashield		Dimethicone	LOTION	TOPICAL	20050601		OTC MONOGRAPH FINAL	part347	Medline Industries, LP	DIMETHICONE	1	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-159_0077ae65-91a6-6ab9-e063-6394a90ad899	53329-159	HUMAN OTC DRUG	Medline		dimethicone	CREAM	TOPICAL	20230401		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE	125	mg/mL	Skin Barrier Activity [PE]		N	20241231
53329-160_ebe1d517-1b41-7d56-e053-2995a90adcfe	53329-160	HUMAN OTC DRUG	Remedy Cleansing Body		dimethicone	LOTION	TOPICAL	20080801	20240121	OTC MONOGRAPH FINAL	part347	Medline Industries, LP	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	
53329-161_ebe22ef9-7535-5e78-e053-2a95a90a0d3b	53329-161	HUMAN OTC DRUG	Remedy Skin Repair		dimethicone	CREAM	TOPICAL	20080801	20240511	OTC MONOGRAPH FINAL	part347	Medline Industries, LP	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	
53329-162_ebe29642-7bcd-2879-e053-2a95a90a961c	53329-162	HUMAN OTC DRUG	Remedy Antifungal	With Olivamine	Miconazole Nitrate	CREAM	TOPICAL	20070101	20240726	OTC MONOGRAPH FINAL	part333C	Medline Industries, LP	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	
53329-165_026e0b60-5505-4a2f-e063-6394a90a1cc9	53329-165	HUMAN OTC DRUG	REMEDY Calazime Skin Protectant		calamine, menthol, white petrolatum, zinc oxide	PASTE	TOPICAL	20120323		OTC MONOGRAPH FINAL	part347	Medline Industries, LP	FERRIC OXIDE RED; MENTHOL; PETROLATUM; ZINC OXIDE	.5; .2; 69; 19.5	g/100g; g/100g; g/100g; g/100g			N	20241231
53329-169_efcfbc69-31f3-445f-e053-2a95a90ab1da	53329-169	HUMAN OTC DRUG	Remedy Antifungal		Miconazole Nitrate	POWDER	TOPICAL	20121119		OTC MONOGRAPH FINAL	M005	Medline Industries, LP	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53329-171_efcfbf86-bddd-1bba-e053-2a95a90ad29a	53329-171	HUMAN OTC DRUG	Remedy with Phytoplex		Miconazole Nitrate	OINTMENT	TOPICAL	20160411		OTC MONOGRAPH FINAL	M005	Medline Industries, LP	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53329-176_fd8bd12e-a526-e524-e053-6394a90a523d	53329-176	HUMAN OTC DRUG	Medline		zinc oxide, petrolatum	CREAM	TOPICAL	20230401		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM; ZINC OXIDE	78; 20	g/100g; g/100g			N	20241231
53329-177_027e814e-059e-6fbe-e063-6294a90a1e02	53329-177	HUMAN OTC DRUG	Cleanse		Benzalkonium Chloride 0.13%	SOLUTION	TOPICAL	20160819		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
53329-180_da3130f3-a315-b8a3-e053-2995a90a8084	53329-180	HUMAN OTC DRUG	ReadyBath Luxe		Benzalkonium Chloride	CLOTH	TOPICAL	20160501		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
53329-181_da312c06-b6ed-8161-e053-2995a90a48f2	53329-181	HUMAN OTC DRUG	ReadyBath Luxe		Benzalkonium Chloride	CLOTH	TOPICAL	20160501		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
53329-182_e9d3b3ee-9d36-12e0-e053-2a95a90abffe	53329-182	HUMAN OTC DRUG	ReadyBath Select		Benzalkonium Chloride	CLOTH	TOPICAL	20160501		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
53329-183_e9d3a4f3-fe6e-80ab-e053-2995a90a9f50	53329-183	HUMAN OTC DRUG	ReadyBath Select		Benzalkonium Chloride	CLOTH	TOPICAL	20160501		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
53329-184_027e77f8-c20b-fad9-e063-6394a90aa714	53329-184	HUMAN OTC DRUG	Cleanse		Benzalkonium Chloride	SOLUTION	TOPICAL	20160926		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
53329-186_fd8b5698-78fb-77a7-e053-6294a90ae1bc	53329-186	HUMAN OTC DRUG	Medline		petrolatum	OINTMENT	TOPICAL	20230401		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	WHITE PETROLATUM	934	mg/g			N	20241231
53329-188_065d36a8-cd4b-6198-e063-6394a90a98bd	53329-188	HUMAN OTC DRUG	Medline		white petrolatum	OINTMENT	TOPICAL	20230801		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	WHITE PETROLATUM	93.4	g/100g			N	20241231
53329-191_017eb760-49ef-5ff6-e063-6294a90a6268	53329-191	HUMAN OTC DRUG	Medline		nicotine	PATCH	TRANSDERMAL	20220630		ANDA	ANDA074611	Medline Industries, LP	NICOTINE	14	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
53329-192_017eb760-49ef-5ff6-e063-6294a90a6268	53329-192	HUMAN OTC DRUG	Medline		nicotine	PATCH	TRANSDERMAL	20220630		ANDA	ANDA074612	Medline Industries, LP	NICOTINE	21	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
53329-193_017eb760-49ef-5ff6-e063-6294a90a6268	53329-193	HUMAN OTC DRUG	Medline		nicotine	PATCH	TRANSDERMAL	20220630		ANDA	ANDA074645	Medline Industries, LP	NICOTINE	7	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
53329-202_027e77f8-c20a-fad9-e063-6394a90aa714	53329-202	HUMAN OTC DRUG	Hand Sanitizer		ethyl alcohol	GEL	TOPICAL	20150406		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	ALCOHOL	70	mL/100mL			N	20241231
53329-203_097fbb10-5a27-0677-e063-6394a90aad86	53329-203	HUMAN OTC DRUG	Epi-Clenz Pure Instant Hand Antiseptic		ethyl alcohol	GEL	TOPICAL	20120402		OTC MONOGRAPH DRUG	505G(a)(3)	Medline Industries, LP	ALCOHOL	70	mL/100mL			N	20241231
53329-209_0280893c-8a9c-8aeb-e063-6294a90af72a	53329-209	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20160527		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ALCOHOL	.879	mg/mL			N	20241231
53329-214_027df98e-8a9c-0254-e063-6294a90a350f	53329-214	HUMAN OTC DRUG	Spectrum 62% Hand Sanitizer		ethyl alcohol	GEL	TOPICAL	20180409		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ALCOHOL	62	mL/100mL			N	20241231
53329-220_efcfdf7f-c320-b0d2-e053-2a95a90a2cce	53329-220	HUMAN OTC DRUG	Medline		zinc oxide	STICK	TOPICAL	20210901		OTC MONOGRAPH FINAL	M020	Medline Industries, LP	ZINC OXIDE	20	g/100g			N	20241231
53329-244_f06f2769-7f19-51c5-e053-2a95a90ac824	53329-244	HUMAN OTC DRUG	ReadyPrep CHG		Chlorhexidine gluconate 2%	CLOTH	TOPICAL	20190114		NDA	NDA207964	Medline Industries, LP	CHLORHEXIDINE GLUCONATE	500	mg/1	Decreased Cell Wall Integrity [PE]		N	20241231
53329-301_03121072-c99c-d603-e063-6294a90a5ada	53329-301	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20100805		ANDA	ANDA077789	Medline Industries, LP	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
53329-302_efcfa488-6020-fcbd-e053-2995a90ad540	53329-302	HUMAN OTC DRUG	Remedy Skin Protectant		White Petrolatum	PASTE	TOPICAL	20131106		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	59	g/100g			N	20241231
53329-303_00791f0e-45dc-5b86-e063-6294a90af9cd	53329-303	HUMAN OTC DRUG	Soothe and Cool Moisture Guard		White Petrolatum	PASTE	TOPICAL	20131106	20250531	OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	59	g/100g			N	
53329-410_e9b24e47-ff1b-95e8-e053-2a95a90a3dac	53329-410	HUMAN OTC DRUG	MediPlast		salicylic acid	PLASTER	TOPICAL	20080801		OTC MONOGRAPH FINAL	part358F	Medline Industries, LP	SALICYLIC ACID	40	g/100g			N	20241231
53329-497_0b64e78c-78e9-96c0-e063-6394a90a939b	53329-497	HUMAN OTC DRUG	Medline Nasal Antiseptic Swabs		Povidone Iodine swabstick	SOLUTION	TOPICAL	20180115		OTC MONOGRAPH DRUG	505G(a)(3)	Medline Industries, LP	POVIDONE-IODINE	10	mg/mL			N	20241231
53329-641_ec06209c-15a3-8c07-e053-2a95a90a2dbe	53329-641	HUMAN OTC DRUG	Medline Acetaminophen		Acetaminophen	TABLET	ORAL	20131226	20240131	OTC MONOGRAPH NOT FINAL	part343	Medline Industries, LP	ACETAMINOPHEN	500	mg/1			N	
53329-643_efd0f6f1-820e-32e8-e053-2a95a90a0e66	53329-643	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Medline Industries, LP	ACETAMINOPHEN	650	mg/1			N	20241231
53329-652_efd12ec8-8f3d-c1e3-e053-2995a90a685a	53329-652	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	Medline Industries, LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53329-664_efd178a7-b311-31c3-e053-2a95a90a22c1	53329-664	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Medline Industries, LP	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
53329-674_02818b70-7259-29dc-e063-6294a90a746f	53329-674	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20170929		ANDA	ANDA079174	Medline industries, LP	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53329-688_e9d34869-ede4-2a14-e053-2995a90a61fd	53329-688	HUMAN OTC DRUG	Naproxen Sodium 220mg		Naproxen Sodium	TABLET	ORAL	20180801		ANDA	ANDA090545	Medline Industries, LP	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53329-769_0321b1a1-cfeb-1611-e063-6294a90ad76d	53329-769	HUMAN OTC DRUG	Sensi-Care		dimethicon, zinc oxide	CREAM	TOPICAL	20200930		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE; ZINC OXIDE	5; 5	g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
53329-770_026e26dd-452c-0d38-e063-6394a90a3d5c	53329-770	HUMAN OTC DRUG	Sensi-Care		petrolatum, dimethicone	CREAM	TOPICAL	20200930		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE; PETROLATUM	1; 30	g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
53329-771_efdff7d9-0155-f285-e053-2a95a90a20d4	53329-771	HUMAN OTC DRUG	Sensi-Care		petrolatum, zinc oxide	CREAM	TOPICAL	20200930		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM; ZINC OXIDE	49; 15	g/100g; g/100g			N	20241231
53329-772_e90cb960-fa44-2822-e053-2a95a90a3ad0	53329-772	HUMAN OTC DRUG	Aloe Vesta		petrolatum	SPRAY	TOPICAL	20210901	20240304	OTC MONOGRAPH FINAL	part347	Medline Industries, LP	PETROLATUM	36	g/100g			N	
53329-773_03c3925a-c812-6731-e063-6294a90a5939	53329-773	HUMAN OTC DRUG	Aloe Vesta		Petrolatum	OINTMENT	TOPICAL	20200930	20250831	OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	43	g/100g			N	
53329-774_026e2703-66c2-950a-e063-6294a90acfe5	53329-774	HUMAN OTC DRUG	Aloe Vesta		miconazole nitrate	OINTMENT	TOPICAL	20200930		OTC MONOGRAPH FINAL	M005	Medline Industries, LP	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53329-775_032195e0-a729-60f4-e063-6394a90a1337	53329-775	HUMAN OTC DRUG	Aloe Vesta		dimethicone	LOTION	TOPICAL	20210701	20250531	OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	
53329-797_efe00842-c7d4-172e-e053-2995a90a634e	53329-797	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	SOLUTION	TOPICAL	20150806		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
53329-798_efe01a92-7ab6-63cf-e053-2a95a90a2a6a	53329-798	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20150630		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-800_efe00f98-4874-48d4-e053-2a95a90ad0ba	53329-800	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20090216		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-805_03ae0172-1373-a757-e063-6394a90a263a	53329-805	HUMAN OTC DRUG	Medline Alcohol Prep	Sterile, Medium	Isopropyl Alcohol	SWAB	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-807_e9be1c58-ac95-2a3b-e053-2a95a90aca37	53329-807	HUMAN OTC DRUG	Medline Alcohol Swabstick	Triples	Isopropyl Alcohol	SWAB	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-811_03ade119-6c40-a742-e063-6394a90a8ce2	53329-811	HUMAN OTC DRUG	Medline Alcohol Prep	Sterile, Large	Isopropyl Alcohol	SWAB	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-812_067050a7-bc97-f1cb-e063-6394a90a2817	53329-812	HUMAN OTC DRUG	Medline Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-826_efe0376e-80c3-52a5-e053-2a95a90aefc7	53329-826	HUMAN OTC DRUG	Curad Alcohol	Sterile, Thick	Isopropyl Alcohol	SWAB	TOPICAL	20120515		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-827_03709a76-9f5b-a2cd-e063-6294a90a80de	53329-827	HUMAN OTC DRUG	Curad Alcohol Prep Pads	Medium	Isopropyl Alcohol	SWAB	TOPICAL	20121219		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-828_e9be945a-7c0a-3253-e053-2995a90abab4	53329-828	HUMAN OTC DRUG	Curad		isopropyl alcohol	SWAB	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53329-840_eb5183f6-ea81-8f41-e053-2995a90aa2b7	53329-840	HUMAN OTC DRUG	Spectrum Hand Sanitizer Wipes		ethyl alcohol	CLOTH	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	ALCOHOL	70	mL/100mL			N	20241231
53329-842_d66fd925-e3d8-7725-e053-2a95a90a4a70	53329-842	HUMAN OTC DRUG	Medline		ethyl alcohol	CLOTH	TOPICAL	20200731		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	ALCOHOL	80	mL/100mL			N	20241231
53329-918_e4bb242e-4ddc-632d-e053-2995a90ad20c	53329-918	HUMAN OTC DRUG	Medline		benzalkonium chloride, lidocain hydrochloride	SPRAY	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53329-919_e4bb1616-5bab-b414-e053-2995a90ae42c	53329-919	HUMAN OTC DRUG	Medline		benzalkonium chloride, lidocain hydrochloride	SPRAY	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53329-923_d788596d-d943-7a48-e053-2a95a90a0f1b	53329-923	HUMAN OTC DRUG	Scrub-In Surgical Scrub Brush/Sponge		Chloroxylenol	SOLUTION	TOPICAL	20120901		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	CHLOROXYLENOL	3.3	mg/100mL			N	20241231
53329-938_da31f307-36ba-3dff-e053-2995a90a083a	53329-938	HUMAN OTC DRUG	Povidone-Iodine		Povidone-Iodine	SOLUTION	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	POVIDONE-IODINE	.75	g/100mL			N	20241231
53329-939_da32c1e9-d73e-25ea-e053-2a95a90a4825	53329-939	HUMAN OTC DRUG	Povidone-Iodine	Topical Antiseptic	Povidone-Iodine	SOLUTION	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	POVIDONE-IODINE	10	mg/mL			N	20241231
53329-941_037029f2-6c2a-697e-e063-6294a90a8d6f	53329-941	HUMAN OTC DRUG	Povidone-Iodine	Prep Pads Medium	Povidone-Iodine	CLOTH	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	POVIDONE-IODINE	10	mg/mL			N	20241231
53329-943_efe05a36-f8ba-254f-e053-2995a90a0102	53329-943	HUMAN OTC DRUG	Povidone-Iodine		Povidone-Iodine	SOLUTION	TOPICAL	20161104		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	POVIDONE-IODINE	10	mg/mL			N	20241231
53329-944_efe0670e-8a15-41f2-e053-2a95a90a3216	53329-944	HUMAN OTC DRUG	Povidone-Iodine		Povidone-Iodine	SOLUTION	TOPICAL	20161104		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	POVIDONE-IODINE	7.5	mg/mL			N	20241231
53329-945_e9be7955-d868-b332-e053-2995a90ac18f	53329-945	HUMAN OTC DRUG	Povidone-Iodine	Swabsticks Singles	Povidone-Iodine	SWAB	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	POVIDONE-IODINE	10	mg/mL			N	20241231
53329-946_e9be7955-d868-b332-e053-2995a90ac18f	53329-946	HUMAN OTC DRUG	Povidone-Iodine	Swabsticks Triples	Povidone-Iodine	SWAB	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333E	Medline Industries, LP	POVIDONE-IODINE	10	mg/mL			N	20241231
53329-980_efe071b2-0f27-7423-e053-2995a90ab685	53329-980	HUMAN OTC DRUG	Hydrogen peroxide		Hydrogen peroxide	SOLUTION	ORAL; TOPICAL	20150811		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
53329-981_efe07cd9-7390-d557-e053-2995a90a17a1	53329-981	HUMAN OTC DRUG	Hydrogen Peroxide	First Aid Antiseptic	Hydrogen Peroxide	LIQUID	TOPICAL	20070101		OTC MONOGRAPH NOT FINAL	part333A	Medline Industries, LP	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
53329-984_039c2aad-a89a-a936-e063-6394a90ac53e	53329-984	HUMAN OTC DRUG	ActivICE		menthol	GEL	TOPICAL	20190304		OTC MONOGRAPH NOT FINAL	part348	Medline Industries, LP	MENTHOL	80	mg/mL			N	20241231
53329-985_e9d3271f-0be4-5d04-e053-2995a90aaf84	53329-985	HUMAN OTC DRUG	Aspirin Adult low dose		acetylsalicyclic acid	TABLET, DELAYED RELEASE	ORAL	20180625		OTC MONOGRAPH NOT FINAL	part343	Medline Industries, LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53329-986_e9d34869-ede3-2a14-e053-2995a90a61fd	53329-986	HUMAN OTC DRUG	Senna Natural Vegetable		sennosides	TABLET, COATED	ORAL	20190101		OTC MONOGRAPH NOT FINAL	part334	Medline Industries, LP	SENNOSIDES A AND B	8.6	mg/1			N	20241231
53329-988_efe0b1c4-5719-e951-e053-2995a90a7883	53329-988	HUMAN OTC DRUG	Extra Pain Relief Acetaminophen, Aspirin (NSAID) and Caffeine		acetaminophen, salicyclic acid, caffeine	TABLET, FILM COATED	ORAL	20180604		OTC MONOGRAPH NOT FINAL	part343	Medline Industries, LP	ACETAMINOPHEN; CAFFEINE; SALICYLIC ACID	250; 65; 250	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
53329-989_efe0b013-dbb1-85b9-e053-2995a90ad08e	53329-989	HUMAN OTC DRUG	Senna S		sennosides and docusate sodium	TABLET, COATED	ORAL	20180522		OTC MONOGRAPH NOT FINAL	part334	Medline Industries, LP	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
53329-991_efe0c151-541d-04ae-e053-2995a90a026a	53329-991	HUMAN OTC DRUG	ActivICE		menthol	SPRAY	TOPICAL	20190304		OTC MONOGRAPH NOT FINAL	part348	Medline Industries, LP	MENTHOL	80	g/1000g			N	20241231
53329-992_03adad6a-32b1-fb1e-e063-6394a90a7f2c	53329-992	HUMAN OTC DRUG	ActivICE		menthol	LIQUID	TOPICAL	20190304		OTC MONOGRAPH NOT FINAL	part348	Medline Industries, LP	MENTHOL	80	g/1000g			N	20241231
53329-993_efe1a0f9-ed14-54d7-e053-2a95a90afb80	53329-993	HUMAN OTC DRUG	Soothe and Cool Protect		Petrolatum	JELLY	TOPICAL	20190401		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	PETROLATUM	1	g/g			N	20241231
53329-994_d7c0e496-2d1b-4aab-e053-2a95a90ad294	53329-994	HUMAN OTC DRUG	foaming hand wash		chlorhexidine gluconate	LIQUID	TOPICAL	20200101		NDA	NDA019422	Medline Industries, LP	CHLORHEXIDINE GLUCONATE	20	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
53329-995_efe1a76d-ef6c-37f6-e053-2995a90a9538	53329-995	HUMAN OTC DRUG	Medline Remedy Phytoplex Skin Repair		Dimeticone	CREAM	TOPICAL	20191101		OTC MONOGRAPH FINAL	M016	Medline Industries, LP	DIMETHICONE	5	g/100mL	Skin Barrier Activity [PE]		N	20241231
53329-996_037657d1-8d93-d960-e063-6394a90ae5ea	53329-996	HUMAN OTC DRUG	ActivICE		menthol	SPRAY	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part348	Medline Industries, LP	MENTHOL	100	mg/mL			N	20241231
53329-998_08ad6da5-252b-78b1-e063-6294a90a9446	53329-998	HUMAN OTC DRUG	SPECTRUM HAND SANITIZER WIPES		Alcohol Wipes	CLOTH	TOPICAL	20210430		OTC MONOGRAPH DRUG	505G(a)(3)	Medline Industries, Inc.	ALCOHOL	70	mL/100mL			N	20241231
53341-080_0e1be542-e11b-4e87-b5cd-72243692a206	53341-080	HUMAN OTC DRUG	Southern Soft Luxury Foam Antibacterial Hand Wash		Chloroxylenol	LIQUID	TOPICAL	20070115		OTC MONOGRAPH NOT FINAL	part333E	CCP Industries	CHLOROXYLENOL	.003	mg/mL			N	20241231
53345-002_29f65c6a-412f-4549-bd7f-280262f69c76	53345-002	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20130415		OTC MONOGRAPH FINAL	part338	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53345-003_4b6d6cc9-7122-4c32-9803-536063699a26	53345-003	HUMAN OTC DRUG	Gas Relief Ultra Strength		Simethicone 180 mg	CAPSULE, LIQUID FILLED	ORAL	20130415		OTC MONOGRAPH FINAL	part332	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DIMETHICONE 410	180	mg/1			N	20241231
53345-004_a6b60701-ca63-4574-9b9a-9010c1adb442	53345-004	HUMAN OTC DRUG	DayTime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20130615		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-005_c66478dc-6b14-4b47-9d27-d18b799adbac	53345-005	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20130415		OTC MONOGRAPH FINAL	part338	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53345-006_f45e2b27-396b-45be-8f85-fe7a173fe15d	53345-006	HUMAN OTC DRUG	Nighttime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20130415		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53345-007_5fa60c3e-ff31-4a8f-8249-84a4aa9ce50c	53345-007	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20130915		OTC MONOGRAPH FINAL	part336	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53345-008_73492597-8881-402e-8358-8cfae45f719f	53345-008	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20130415		OTC MONOGRAPH NOT FINAL	part334	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DOCUSATE SODIUM	100	mg/1			N	20241231
53345-009_4dd36c12-b51b-4d08-8107-e16fbcb72e45	53345-009	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20130415		OTC MONOGRAPH FINAL	part332	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
53345-010_35ebb4f8-1bc9-422b-80d0-e22ccaf9ee72	53345-010	HUMAN OTC DRUG	ACETAMINOPHEN (RED)		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160404		OTC MONOGRAPH NOT FINAL	part343	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	ACETAMINOPHEN	325	mg/1			N	20241231
53345-010_c29edf43-69e6-4893-affc-737d2ff28929	53345-010	HUMAN OTC DRUG	ACETAMINOPHEN (RED)		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20130415		OTC MONOGRAPH NOT FINAL	part343	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN	325	mg/1			N	20241231
53345-011_85aaafd0-4196-40d7-9c03-9c8131e23a5e	53345-011	HUMAN OTC DRUG	Dextromethorphan HBr 15 mg		Dextromethorphan HBr	CAPSULE, LIQUID FILLED	ORAL	20140130		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53345-012_ee071cdd-9ac5-4b50-be3a-7e0b81c474b8	53345-012	HUMAN OTC DRUG	DayTime Sinus Relief		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20130615		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-013_d6ca2932-a474-433c-b829-53298fa3ce5c	53345-013	HUMAN OTC DRUG	NightTime Sinus Relief		Acetaminophen, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20130615		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 6.25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-014_3cd90bef-d64d-4fb5-97db-2cd0a72c9098	53345-014	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20161006		ANDA	ANDA206568	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53345-014_c0a95440-b423-48ee-ac93-4e7dd2093064	53345-014	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170713		ANDA	ANDA206568	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53345-015_091b5a04-68e3-46be-a523-e55ecb972b88	53345-015	HUMAN OTC DRUG	DOCUSATE SODIUM 50 MG		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20131112		OTC MONOGRAPH NOT FINAL	part334	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DOCUSATE SODIUM	50	mg/1			N	20241231
53345-018_d4701ff2-fb16-4473-97a3-a25a6a29f4b6	53345-018	HUMAN OTC DRUG	DOCUSATE SODIUM 100mg Two-Tone		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20131223		OTC MONOGRAPH NOT FINAL	part334	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DOCUSATE SODIUM	100	mg/1			N	20241231
53345-019_7e915bad-424f-9f41-e053-2a91aa0a1e47	53345-019	HUMAN OTC DRUG	Pain Relief Extra Strength		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20140106		OTC MONOGRAPH NOT FINAL	part343	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN	500	mg/1			N	20241231
53345-020_610de5b3-af0e-4aa1-a625-0edc6a0da81f	53345-020	HUMAN OTC DRUG	Night Cold Flu Cough and Allergy		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20130529		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-021_3ca25eb5-c23b-4cea-982c-8d5dcadf0b7d	53345-021	HUMAN OTC DRUG	Daytime Severe Cold and Flu		acetaminophen, dextromethorphan hydrobromide, Guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20140711		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-022_c65cd3cf-31da-4a4e-9ea1-dc574059f429	53345-022	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20140813		OTC MONOGRAPH FINAL	part338	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53345-023_1f15df70-e6d0-4268-935a-2a33e92b4ebc	53345-023	HUMAN OTC DRUG	DOCUSATE SODIUM 100mg Two-Tone		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20140811		OTC MONOGRAPH NOT FINAL	part334	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DOCUSATE SODIUM	100	mg/1			N	20241231
53345-023_a9ff7e3d-b5ff-420b-a69b-eaea297d90b0	53345-023	HUMAN OTC DRUG	DOCUSATE SODIUM 100mg Two-Tone		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20150410		OTC MONOGRAPH NOT FINAL	part334	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	DOCUSATE SODIUM	100	mg/1			N	20241231
53345-025_89a3aa43-4f4c-4e9d-b7a3-a944365abde5	53345-025	HUMAN OTC DRUG	DayTime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20140811		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-026_046e6ccf-3de4-4834-ad75-44380a0d7aa4	53345-026	HUMAN OTC DRUG	Nighttime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20140811		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53345-027_94118d40-32cd-4887-8d04-e3be3c992d60	53345-027	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20141014		OTC MONOGRAPH FINAL	part338	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53345-028_fb266478-35ac-45b3-af4d-3461c7e5f26f	53345-028	HUMAN OTC DRUG	Dextromethorphan HBr 15 mg		Dextromethorphan HBr	CAPSULE, LIQUID FILLED	ORAL	20141210		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53345-029_c12b6ec6-d391-4d21-9a02-405c5781cb1d	53345-029	HUMAN OTC DRUG	DOCUSATE SODIUM 100mg		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20150128		OTC MONOGRAPH NOT FINAL	part334	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	DOCUSATE SODIUM	100	mg/1			N	20241231
53345-030_c3ac7eba-d28a-4dec-aeba-25f4a976d48a	53345-030	HUMAN OTC DRUG	DayTime Sinus		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20150226		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-031_e624ba71-5ccf-4f08-8769-675effd06b90	53345-031	HUMAN OTC DRUG	NightTime Sinus		Acetaminophen, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20150226		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 6.25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-032_999447e3-9752-4e34-aa84-dcd17b07d2fd	53345-032	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160630		OTC MONOGRAPH FINAL	part332	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
53345-032_ae4b0597-e7ce-4855-8deb-93a486c05d42	53345-032	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20150128		OTC MONOGRAPH FINAL	part332	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
53345-033_a43c7cdb-030b-4c6c-b22b-6d3f27f57a5b	53345-033	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20150128		OTC MONOGRAPH FINAL	part332	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
53345-034_babbd9ac-7577-45c6-970b-b3bd776c4a72	53345-034	HUMAN OTC DRUG	Maximum Strength-Cough and Chest Congestion DM		Maximum Strength-Cough and Chest Congestion DM	CAPSULE, LIQUID FILLED	ORAL	20150630		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53345-035_3293bcc2-ab75-4979-9981-31a8db304a02	53345-035	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20160210		OTC MONOGRAPH NOT FINAL	part334	Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd	DOCUSATE SODIUM	250	mg/1			N	20241231
53345-036_e0366d3d-cb59-448b-97ba-f1cc207138a0	53345-036	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160725		OTC MONOGRAPH FINAL	part332	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
53345-037_b5d3028b-d3d8-40b8-b013-9a7e99c3eaef	53345-037	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20180425		ANDA	ANDA209909	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
53345-039_8748389d-27ff-47b5-bbe9-03592e2d7d45	53345-039	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170713		ANDA	ANDA206568	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53345-039_f71f6afe-6939-43f7-9167-69362b2a337f	53345-039	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170323		ANDA	ANDA206568	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53345-042_1b92fe6c-7407-40e0-bcb2-27a62f4399a9	53345-042	HUMAN OTC DRUG	NAPROXEN SODIUM		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180320		ANDA	ANDA208363	Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53345-045_c629ac3f-6f0d-4738-b9d7-ecd88561570e	53345-045	HUMAN OTC DRUG	Cough and Cold plus		Acetaminophen, Phenylephrine HCl, Chlorpheniramine Maleate, Dextromethorphan HBr	CAPSULE, LIQUID FILLED	ORAL	20170324		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-050_9524bc23-2aa5-4d58-8193-a972c52f1e04	53345-050	HUMAN OTC DRUG	Ibuprofen mini		Ibuprofen mini	CAPSULE, LIQUID FILLED	ORAL	20181120		ANDA	ANDA206568	Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53345-052_74104416-024e-4812-853f-3b3005d75b9f	53345-052	HUMAN OTC DRUG	ASP Daytime PE		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53345-053_c5db1b54-9e03-4e6c-aa71-8ca1e5a1e548	53345-053	HUMAN OTC DRUG	ASP Nighttime Max		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	Humanwell PuraCap Pharmaceutical (Wuhan), Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53405-0007_9abadf45-277b-4e5f-b731-7876ea04f44b	53405-0007	HUMAN OTC DRUG	E.O.L.		Rosa Canina, Flos, Stillingia Sylvatica, Zincum Gluconicum, Thiaminum Hydrochloricum, Fragaria Vesca, Nicotinamidum, Rheum (Officinale), Serotonin (Hydrochloride), 5-Hydroxytryptophan, Betainum Muriaticum, Biotin, Cholinum, Cysteinum, DL-Methionine, L-Alanine, L-Cystine, L-Glutamic Acid, L-Glutamine, L-Lysine, L-Methionine, L-Serine, Oxytocin Acetate, Para-Aminobenzoic Acid, Potassium Gluconate, Thymus (Suis), Thyroidinum (Suis), Ubidecarenonum, Vitamin D3, Dopamine Hydrochloride, Lithium Bromatum, Squalene	SPRAY	ORAL	20170822	20240719	UNAPPROVED HOMEOPATHIC		InLight Creation, LLC.	AESCULUS HIPPOCASTANUM FLOWER; ALANINE; ALPINE STRAWBERRY; AMINOBENZOIC ACID; BETAINE HYDROCHLORIDE; BIOTIN; BORRELIA BURGDORFERI; BROMELAINS; CANDIDA ALBICANS; CHOLECALCIFEROL; CHOLINE HYDROXIDE; COCONUT OIL; COPPER; CRANBERRY; CYSTEINE; CYSTINE; DOPAMINE HYDROCHLORIDE; GLUTAMIC ACID; GLUTAMINE; HIPPEASTRUM PUNICEUM WHOLE; ILEX AQUIFOLIUM FLOWERING TOP; LEMON JUICE; LITHIUM BROMIDE; LYSINE; MALUS DOMESTICA FLOWER; METHIONINE; NIACINAMIDE; OXITRIPTAN; OXYTOCIN ACETATE; PHENYLALANINE; POTASSIUM GLUCONATE; PUMPKIN SEED; RACEMETHIONINE; RHEUM OFFICINALE ROOT; ROSA CANINA FLOWER; SELENIUM; SELENIUM DIOXIDE; SERINE; SEROTONIN HYDROCHLORIDE; SQUALENE; STILLINGIA SYLVATICA ROOT; SUS SCROFA THYMUS; SUS SCROFA THYROID; THIAMINE HYDROCHLORIDE; UBIDECARENONE; ZINC GLUCONATE	30; 6; 5; 6; 6; 6; 12; 6; 12; 6; 6; 12; 8; 7; 6; 6; 7; 6; 6; 3; 30; 18; 7; 6; 30; 6; 5; 5; 6; 8; 6; 17; 6; 5; 3; 8; 8; 6; 5; 7; 3; 6; 6; 4; 6; 3	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Uterine Smooth Muscle Contraction or Tone [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylating Activity [MoA], Methylating Agent [EPC], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxytocic [EPC], Oxytocin [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vitamin B Complex Member [EPC], Vitamin B Complex [CS], Vitamin D [CS], Vitamin D [EPC]		N	
53405-0008_b180554c-b474-4e4d-a2c8-c1e088bea205	53405-0008	HUMAN OTC DRUG	E.O.L.		Stillingia Sylvatica, Zincum Gluconicum, Thiaminum Hydrochloricum, Fragaria Vesca, Nicotinamidum, Rheum (Palmatum), Serotonin (Hydrochloride), 5-Hydroxytryptophan, Betainum Muriaticum, Biotin, Cholinum, Cysteinum, DL-Methionine, L-Alanine, L-Cystine, L-Glutamic Acid, L-Glutamine, L-Lysine, L-Methionine, L-Serine, Para-Aminobenzoic Acid, Potassium Gluconate, Thymus (Suis), Thyroidinum (Suis), Ubidecarenonum, Vitamin D3, Dopamine Hydrochloride, Lithium Bromatum, Squalene, Vaccinium Macrocarpon, Oxytocin,	SPRAY	ORAL	20211206		UNAPPROVED HOMEOPATHIC		InLight Creation, LLC.	AESCULUS HIPPOCASTANUM FLOWER; ALANINE; AMINOBENZOIC ACID; BETAINE HYDROCHLORIDE; BIOTIN; BORRELIA BURGDORFERI; BROMELAINS; CANDIDA ALBICANS; CHOLECALCIFEROL; CHOLINE HYDROXIDE; COCONUT OIL; COPPER; CRANBERRY; CYSTEINE; CYSTINE; DOPAMINE HYDROCHLORIDE; FRAGARIA VESCA FRUIT; GLUTAMIC ACID; GLUTAMINE; HIPPEASTRUM PUNICEUM WHOLE; ILEX AQUIFOLIUM FLOWERING TOP; LEMON JUICE; LITHIUM BROMIDE; LYSINE; MALUS DOMESTICA FLOWER; METHIONINE; NIACINAMIDE; OXITRIPTAN; OXYTOCIN; PHENYLALANINE; POTASSIUM GLUCONATE; PUMPKIN SEED; RACEMETHIONINE; RHEUM PALMATUM ROOT; SELENIUM; SELENIUM DIOXIDE; SERINE; SEROTONIN HYDROCHLORIDE; SQUALENE; STILLINGIA SYLVATICA ROOT; SUS SCROFA THYMUS; SUS SCROFA THYROID; THIAMINE HYDROCHLORIDE; UBIDECARENONE; ZINC GLUCONATE	30; 6; 6; 6; 6; 12; 6; 12; 6; 6; 12; 8; 7; 6; 6; 7; 5; 6; 6; 9; 30; 18; 7; 6; 30; 6; 5; 6; 16; 8; 6; 17; 6; 5; 8; 8; 6; 5; 7; 3; 6; 6; 4; 6; 3	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Uterine Smooth Muscle Contraction or Tone [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylating Activity [MoA], Methylating Agent [EPC], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxytocic [EPC], Oxytocin [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vitamin B Complex Member [EPC], Vitamin B Complex [CS], Vitamin D [CS], Vitamin D [EPC]		N	20241231
53425-001_08025ff2-44b0-2581-e063-6294a90a2884	53425-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100719		NDA	NDA205712	IWS Gas and Supply of Texas, LTD	OXYGEN	995	mL/L			N	20241231
53425-002_080237a1-7937-ce26-e063-6294a90a9df4	53425-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20111101		NDA	NDA205713	IWS Gas and Supply of Texas, LTD	NITROGEN	995	mL/L			N	20241231
53436-084_2be9a0fe-27cd-453c-98c3-162c98f66784	53436-084	HUMAN PRESCRIPTION DRUG	VELTASSA		patiromer	POWDER, FOR SUSPENSION	ORAL	20151023		NDA	NDA205739	Vifor Pharma, Inc.	PATIROMER	8.4	g/1	Potassium Binder [EPC], Potassium Ion Binding Activity [MoA]		N	20241231
53436-168_2be9a0fe-27cd-453c-98c3-162c98f66784	53436-168	HUMAN PRESCRIPTION DRUG	VELTASSA		patiromer	POWDER, FOR SUSPENSION	ORAL	20151023		NDA	NDA205739	Vifor Pharma, Inc.	PATIROMER	16.8	g/1	Potassium Binder [EPC], Potassium Ion Binding Activity [MoA]		N	20241231
53436-252_2be9a0fe-27cd-453c-98c3-162c98f66784	53436-252	HUMAN PRESCRIPTION DRUG	VELTASSA		patiromer	POWDER, FOR SUSPENSION	ORAL	20151023		NDA	NDA205739	Vifor Pharma, Inc.	PATIROMER	25.2	g/1	Potassium Binder [EPC], Potassium Ion Binding Activity [MoA]		N	20241231
53440-001_076223c6-2959-bcec-e063-6394a90ac1d8	53440-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205767	Westair Gases & Equipment, Inc.	OXYGEN	995	mL/L			N	20241231
53440-002_0761fb5a-1cc5-a6a1-e063-6294a90a29af	53440-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205766	Westair Gases & Equipment, Inc.	NITROGEN	995	mL/L			N	20241231
53440-003_07622070-c3ad-bfdf-e063-6394a90aeb37	53440-003	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA206009	Westair Gases & Equipment, Inc.	NITROUS OXIDE	995	mL/L			N	20241231
53440-004_076219c3-509e-def9-e063-6294a90a0468	53440-004	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205764	Westair Gases & Equipment, Inc.	CARBON DIOXIDE	995	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
53440-007_076223c6-2958-bcec-e063-6394a90ac1d8	53440-007	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205767	Westair Gases & Equipment, Inc.	OXYGEN	995	mL/L			N	20241231
53440-008_07623035-0498-e150-e063-6294a90ac131	53440-008	HUMAN PRESCRIPTION DRUG	Carbogen		Carbogen	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205767	Westair Gases & Equipment, Inc.	OXYGEN	950	mL/L			N	20241231
53451-0101_5b1d346e-2db1-4c2a-baf5-a4598642a4e7	53451-0101	HUMAN PRESCRIPTION DRUG	Horizant		gabapentin enacarbil	TABLET, EXTENDED RELEASE	ORAL	20130501		NDA	NDA022399	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	GABAPENTIN ENACARBIL	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53451-0103_5b1d346e-2db1-4c2a-baf5-a4598642a4e7	53451-0103	HUMAN PRESCRIPTION DRUG	Horizant		gabapentin enacarbil	TABLET, EXTENDED RELEASE	ORAL	20130501		NDA	NDA022399	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	GABAPENTIN ENACARBIL	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53452-001_0760a1e9-57f8-33c6-e063-6294a90afbb6	53452-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19630101		NDA	NDA205767	Dale Oxygen And Acetylene Service, Inc	OXYGEN	990	mL/L			N	20241231
53452-002_076095da-ac6d-4d65-e063-6294a90a1ecf	53452-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19630101		NDA	NDA205766	Dale Oxygen And Acetylene Service, Inc	NITROGEN	990	mL/L			N	20241231
53452-003_07607aeb-30df-3707-e063-6294a90ae5c6	53452-003	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19630101		NDA	NDA205767	Dale Oxygen And Acetylene Service, Inc	OXYGEN	210	mL/L			N	20241231
53462-075_dc8c9b6d-4de0-18e0-e053-2a95a90a7353	53462-075	HUMAN OTC DRUG	Perox-A-Mint Solution		HYDROGEN PEROXIDE	MOUTHWASH	BUCCAL	19980521		OTC MONOGRAPH NOT FINAL	part356	Sage Products, LLC	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
53462-175_d8a01fea-681a-2a16-e053-2a95a90ad13f	53462-175	HUMAN OTC DRUG	Antiseptic Oral Rinse		CETYLPYRIDINIUM CHLORIDE	MOUTHWASH	BUCCAL	20000621		OTC MONOGRAPH NOT FINAL	part356	Sage Products LLC	CETYLPYRIDINIUM CHLORIDE	.5	mg/mL			N	20241231
53462-275_fc5ee360-8f42-6373-e053-6394a90a3644	53462-275	HUMAN OTC DRUG	Antiplaque solution		CETYLPYRIDINIUM CHLORIDE	MOUTHWASH	BUCCAL	20090109		OTC MONOGRAPH NOT FINAL	part356	Sage Products LLC	CETYLPYRIDINIUM CHLORIDE	.5	mg/mL			N	20241231
53462-375_dc90967c-d1f6-6c05-e053-2995a90ac7e5	53462-375	HUMAN OTC DRUG	Corinz		Cetylpyridinium Chloride	RINSE	ORAL	20150120		OTC MONOGRAPH NOT FINAL	part356	Sage Products, LLC	CETYLPYRIDINIUM CHLORIDE	.5	mg/mL			N	20241231
53462-705_fc776e67-dde2-4d38-e053-6294a90a6ea8	53462-705	HUMAN OTC DRUG	CHLORHEXIDINE GLUCONATE		CHLORHEXIDINE GLUCONATE	CLOTH	TOPICAL	20060201		NDA	NDA021669	Sage Products LLC	CHLORHEXIDINE GLUCONATE	500	mg/1	Decreased Cell Wall Integrity [PE]		N	20241231
53462-915_0bdba093-da8e-673e-e063-6394a90a2cbf	53462-915	HUMAN OTC DRUG	Comfort Shield Barrier		dimethicone	CLOTH	TOPICAL	19900101		OTC MONOGRAPH DRUG	M016	Sage Products LLC	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
53462-916_02fc0730-987c-a6a5-e063-6394a90a8eb4	53462-916	HUMAN OTC DRUG	RestoreZ		Zinc Oxide	CLOTH	TOPICAL	20230810		OTC MONOGRAPH FINAL	part347	Sage Products LLC	ZINC OXIDE	150	mg/g			N	20241231
53489-118_0bc66ce8-33fd-5416-e063-6394a90acc50	53489-118	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19860710		ANDA	ANDA062676	Sun Pharmaceutical Industries, Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53489-119_0bc66ce8-33fd-5416-e063-6394a90acc50	53489-119	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19860710		ANDA	ANDA062676	Sun Pharmaceutical Industries, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53489-120_0bc66ce8-33fd-5416-e063-6394a90acc50	53489-120	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19860710		ANDA	ANDA062677	Sun Pharmaceutical Industries, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53489-141_47cec250-341a-4694-a232-93106833a75e	53489-141	HUMAN PRESCRIPTION DRUG	Quinidine Gluconate		Quinidine Gluconate	TABLET, EXTENDED RELEASE	ORAL	19870210		ANDA	ANDA089338	Sun Pharmaceutical Industries, Inc.	QUINIDINE GLUCONATE	324	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
53489-143_3dbb5369-c3a5-47b8-91e4-5715b22aa7d9	53489-143	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Sun Pharmaceutical Industries, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53489-144_ca98fb3f-e314-4fe4-9ffc-d37aa4e9f19a	53489-144	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		Spironolactone and Hydrochlorothiazide	TABLET	ORAL	19870702		ANDA	ANDA089534	Sun Pharmaceutical Industries, Inc.	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53489-145_1fe0bf04-8e44-4c19-8ef4-9481ad24a78d	53489-145	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	19860825		ANDA	ANDA071017	Sun Pharmaceutical Industries, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
53489-146_1fe0bf04-8e44-4c19-8ef4-9481ad24a78d	53489-146	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	19860825		ANDA	ANDA071017	Sun Pharmaceutical Industries, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
53489-148_2c96c6f9-3008-48ba-86ea-e9b83502da67	53489-148	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		Thioridazine Hydrochloride	TABLET, FILM COATED	ORAL	19881007		ANDA	ANDA089953	Sun Pharmaceutical Industries, Inc.	THIORIDAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53489-149_2c96c6f9-3008-48ba-86ea-e9b83502da67	53489-149	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		Thioridazine Hydrochloride	TABLET, FILM COATED	ORAL	19881007		ANDA	ANDA089953	Sun Pharmaceutical Industries, Inc.	THIORIDAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53489-150_2c96c6f9-3008-48ba-86ea-e9b83502da67	53489-150	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		Thioridazine Hydrochloride	TABLET, FILM COATED	ORAL	19881007		ANDA	ANDA089953	Sun Pharmaceutical Industries, Inc.	THIORIDAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53489-156_a9f599ca-45eb-48d3-a7d7-73a05d9934c6	53489-156	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	Sun Pharmaceutical Industries, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
53489-157_a9f599ca-45eb-48d3-a7d7-73a05d9934c6	53489-157	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	Sun Pharmaceutical Industries, Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
53489-176_32bc49e5-840e-4965-8e64-4b1945f9963c	53489-176	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	TABLET	ORAL	19891205		ANDA	ANDA072637	Sun Pharmaceutical Industries, Inc.	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
53489-177_32bc49e5-840e-4965-8e64-4b1945f9963c	53489-177	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	TABLET	ORAL	19891205		ANDA	ANDA072637	Sun Pharmaceutical Industries, Inc.	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
53489-281_273c1270-5303-44f5-be30-0c779d88fea1	53489-281	HUMAN PRESCRIPTION DRUG	Ergoloid Mesylates		Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-ergocryptine mesylate, and Dihydro-.beta.-ergocryptine mesylate	TABLET	ORAL	19911031		ANDA	ANDA081113	Sun Pharmaceutical Industries, Inc.	DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE; DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE; DIHYDROERGOCORNINE MESYLATE; DIHYDROERGOCRISTINE MESYLATE	.222; .111; .333; .333	mg/1; mg/1; mg/1; mg/1			N	20241231
53489-328_3dbb5369-c3a5-47b8-91e4-5715b22aa7d9	53489-328	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Sun Pharmaceutical Industries, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53489-329_3dbb5369-c3a5-47b8-91e4-5715b22aa7d9	53489-329	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Sun Pharmaceutical Industries, Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53489-368_6b871b9b-1cce-44db-a487-93cd6a6bb9cb	53489-368	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041102		ANDA	ANDA075896	Sun Pharmaceutical Industries, Inc.	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53489-369_6b871b9b-1cce-44db-a487-93cd6a6bb9cb	53489-369	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041102		ANDA	ANDA075896	Sun Pharmaceutical Industries, Inc.	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53489-370_6b871b9b-1cce-44db-a487-93cd6a6bb9cb	53489-370	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041102		ANDA	ANDA075896	Sun Pharmaceutical Industries, Inc.	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
53489-376_90cbbf48-e36f-46f5-8b58-c61b16b0aa86	53489-376	HUMAN PRESCRIPTION DRUG	Trimethobenzamide Hydrochloride		Trimethobenzamide Hydrochloride	CAPSULE	ORAL	20030828		ANDA	ANDA076570	Sun Pharmaceutical Industries, Inc.	TRIMETHOBENZAMIDE HYDROCHLORIDE	300	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
53489-386_013dfdcc-0138-4f9d-a058-90b7ad1befb0	53489-386	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	19951214		ANDA	ANDA072709	Sun Pharmaceutical Industries, Inc.	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
53489-387_013dfdcc-0138-4f9d-a058-90b7ad1befb0	53489-387	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	19951214		ANDA	ANDA072709	Sun Pharmaceutical Industries, Inc.	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
53489-400_2628bf08-c7f5-4aef-8e14-bf987eca87ea	53489-400	HUMAN PRESCRIPTION DRUG	Nystatin		nystatin	TABLET, FILM COATED	ORAL	19881222		ANDA	ANDA062838	Sun Pharmaceutical Industries, Inc.	NYSTATIN	500000	[USP'U]/1	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
53489-478_3567b400-08be-4012-89c0-e9f57fc8873e	53489-478	HUMAN PRESCRIPTION DRUG	SULINDAC		sulindac	TABLET	ORAL	20090904		ANDA	ANDA072050	Sun Pharmaceutical Industries, Inc.	SULINDAC	150	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53489-479_3567b400-08be-4012-89c0-e9f57fc8873e	53489-479	HUMAN PRESCRIPTION DRUG	SULINDAC		sulindac	TABLET	ORAL	20090904		ANDA	ANDA072051	Sun Pharmaceutical Industries, Inc.	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53489-500_2c96c6f9-3008-48ba-86ea-e9b83502da67	53489-500	HUMAN PRESCRIPTION DRUG	Thioridazine Hydrochloride		Thioridazine Hydrochloride	TABLET, FILM COATED	ORAL	19881007		ANDA	ANDA089953	Sun Pharmaceutical Industries, Inc.	THIORIDAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53489-510_a4387b4a-d4d2-48b6-bd6d-e22b69547263	53489-510	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	19930324		ANDA	ANDA073137	Sun Pharmaceutical Industries, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53489-511_a4387b4a-d4d2-48b6-bd6d-e22b69547263	53489-511	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	19930324		ANDA	ANDA073137	Sun Pharmaceutical Industries, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53489-517_a4387b4a-d4d2-48b6-bd6d-e22b69547263	53489-517	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	19930324		ANDA	ANDA073137	Sun Pharmaceutical Industries, Inc.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
53489-551_90501597-9f9b-483d-a46b-7e60c7b45cad	53489-551	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		propafenone hydrochloride	TABLET, FILM COATED	ORAL	20011129		ANDA	ANDA075998	Sun Pharmaceutical Industries, Inc.	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
53489-552_90501597-9f9b-483d-a46b-7e60c7b45cad	53489-552	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		propafenone hydrochloride	TABLET, FILM COATED	ORAL	20011129		ANDA	ANDA075998	Sun Pharmaceutical Industries, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
53489-553_90501597-9f9b-483d-a46b-7e60c7b45cad	53489-553	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		propafenone hydrochloride	TABLET, FILM COATED	ORAL	20011129		ANDA	ANDA075998	Sun Pharmaceutical Industries, Inc.	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	20241231
53489-647_6308da5c-cc47-4112-9829-70d0bda27930	53489-647	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20050513		ANDA	ANDA065134	Sun Pharmaceutical Industries, Inc.	DOXYCYCLINE HYCLATE	20	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
53489-648_4eeff7a1-a4af-41ac-98cf-2790d40c91df	53489-648	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20090909		ANDA	ANDA078581	Sun Pharmaceutical Industries, Inc.	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53489-649_4eeff7a1-a4af-41ac-98cf-2790d40c91df	53489-649	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20061026		ANDA	ANDA071175	Sun Pharmaceutical Industries, Inc.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53489-650_4eeff7a1-a4af-41ac-98cf-2790d40c91df	53489-650	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20061026		ANDA	ANDA071175	Sun Pharmaceutical Industries, Inc.	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53489-651_4eeff7a1-a4af-41ac-98cf-2790d40c91df	53489-651	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20061026		ANDA	ANDA071175	Sun Pharmaceutical Industries, Inc.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
53489-676_67c4f745-b359-436e-8fe5-fa21c86647a8	53489-676	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	Sun Pharmaceutical Industries, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
53489-700_d18ebeb2-8589-423b-8c0d-4b6a11b64443	53489-700	HUMAN PRESCRIPTION DRUG	Quinine Sulfate		Quinine Sulfate	CAPSULE	ORAL	20120723		NDA AUTHORIZED GENERIC	NDA021799	Sun Pharmaceutical Industries, Inc.	QUININE SULFATE	324	mg/1	Antimalarial [EPC]		N	20241231
53499-0159_b9617644-aa20-4c73-8146-a40c490746d7	53499-0159	HUMAN OTC DRUG	Umcka Cold Flu Berry Chewable		Pelargonium sidoides, Aconitum Napellus, Bryonia, Eucalyptus Globulus, Eupatorium Perfoliatum, Gelsemium Sempervirens, Ipecacuanha, Phosphorus	TABLET, CHEWABLE	ORAL	20170821	20250531	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-0165_e3d37ded-b7a9-4880-a75e-7ffaea4eeabf	53499-0165	HUMAN OTC DRUG	Umcka ColdCare Childrens Cherry		Pelargonium sidoides	SYRUP	ORAL	20090901	20250430	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/120mL			N	
53499-0193_f542d6c4-d43d-4010-a319-7c86e4b2d518	53499-0193	HUMAN OTC DRUG	Cough and Bronchial with Zinc		ANTIMONY PENTASULFIDE, BRYONIA ALBA ROOT, DROSERA ROTUNDIFOLIA, EUCALYPTUS GLOBULUS LEAF, IPECAC, SPONGIA OFFICINALIS SKELETON, ROASTED, ZINC GLUCONATE	SYRUP	ORAL	20040701	20240430	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	ANTIMONY PENTASULFIDE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA FLOWERING TOP; EUCALYPTUS GLOBULUS LEAF; IPECAC; SPONGIA OFFICINALIS SKELETON, ROASTED; ZINC GLUCONATE	8; 3; 4; 3; 4; 3; 1	[hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
53499-0232_f65ce459-d292-4ec0-b122-2a559c861a86	53499-0232	HUMAN OTC DRUG	Air Power		GUAIFENESIN	TABLET	ORAL	20210614		OTC MONOGRAPH DRUG	M012	Schwabe North America, Inc	GUAIFENESIN	200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
53499-0293_617b6b27-4ed0-44a4-bf70-62e15d17e1ce	53499-0293	HUMAN OTC DRUG	Cough and Bronchial		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN	SYRUP	ORAL	20040701	20241031	UNAPPROVED HOMEOPATHIC		Schwabe North America	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 3; 6; 3; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_C]/118mL; [hp_X]/118mL; [hp_C]/118mL			N	
53499-0390_ecf0674b-97d7-4d0a-8e3d-141e7d551096	53499-0390	HUMAN OTC DRUG	Florasone		CARDIOSPERMUM HALICACABUM FLOWERING TOP	CREAM	TOPICAL	20060101		UNAPPROVED HOMEOPATHIC		Schwabe North America	CARDIOSPERMUM HALICACABUM FLOWERING TOP	1	[hp_X]/28g			N	20241231
53499-0693_237bb0cc-daae-49bd-9fad-7efdad327234	53499-0693	HUMAN OTC DRUG	Nightime Cough and Bronchial		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN, MEDICAGO SATIVA LEAF, OAT, ARABICA COFFEE BEAN	SYRUP	ORAL	20040701	20250131	UNAPPROVED HOMEOPATHIC		Schwabe North America	ACONITUM NAPELLUS; ARABICA COFFEE BEAN; BRYONIA ALBA ROOT; CALCIUM SULFIDE; MEDICAGO SATIVA LEAF; OAT; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 6; 3; 6; 1; 1; 3; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_C]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_C]/118mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
53499-0803_ab061d98-13f7-415c-984b-51ad134137db	53499-0803	HUMAN OTC DRUG	Sambucus Flu Relief		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS, SAMBUCUS NIGRA FLOWERING TOP	SYRUP	ORAL	20231130		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP	4; 4; 2; 6; 4; 3; 6; 3	[hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL			N	20241231
53499-1060_7feac152-de98-4873-880f-68ec18e5a763	53499-1060	HUMAN OTC DRUG	Umcka ColdCare	Day Plus Night	Umcka ColdCare Day Plus Night	KIT		20151209		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.						N	20241231
53499-1159_ff9d5040-5769-4c7d-9936-c2ed4fbf1b91	53499-1159	HUMAN OTC DRUG	Cold Flu Relief Berry Chewable		Pelargonium sidoides, Aconitum Napellus, Bryonia, Eucalyptus Globulus, Eupatorium Perfoliatum, Gelsemium Sempervirens, Ipecacuanha, Phosphorus	TABLET, CHEWABLE	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
53499-1165_2ed80047-2edf-4df7-ae4c-540562539f3b	53499-1165	HUMAN OTC DRUG	Cold Relief Syrup Kids Cherry		Pelargonium sidoides	SYRUP	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/120mL			N	20241231
53499-1166_6aca38e2-bc65-47d3-9e7d-cd5c30d795a5	53499-1166	HUMAN OTC DRUG	Umcka FastActives Cherry		Pelargonium sidoides	POWDER	ORAL	20180703		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/700mg			N	20241231
53499-1293_fe33f99d-e463-4c41-8a2e-7ecd45372bb0	53499-1293	HUMAN OTC DRUG	Cough and Bronchial		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN	SYRUP	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Schwabe North America	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 3; 6; 3; 6	[hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL; [hp_X]/120mL; [hp_C]/120mL			N	20241231
53499-1391_99987865-e648-4746-ab77-ff24708d2a8e	53499-1391	HUMAN OTC DRUG	ALPHA SH		SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS	TABLET	SUBLINGUAL	20110818	20270131	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	GOLDENSEAL; POTASSIUM CHLORIDE; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE	6; 3; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
53499-1693_aea5fbda-1590-41ee-8f7d-ab074e462d18	53499-1693	HUMAN OTC DRUG	Nightime Cough and Bronchial		ACONITUM NAPELLUS, BRYONIA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN, MEDICAGO SATIVA LEAF, OAT, ARABICA COFFEE BEAN	SYRUP	ORAL	20230303		UNAPPROVED HOMEOPATHIC		Schwabe North America	ACONITUM NAPELLUS; ARABICA COFFEE BEAN; BRYONIA ALBA ROOT; CALCIUM SULFIDE; MEDICAGO SATIVA LEAF; OAT; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 6; 3; 6; 1; 1; 3; 6	[hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
53499-1845_2953f824-0236-4268-b672-b6e74e0ac1c5	53499-1845	HUMAN OTC DRUG	Umcka Elderberry		Umcka Elderberry	SYRUP	ORAL	20221109		UNAPPROVED HOMEOPATHIC		Schwabe North America	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP	4; 4; 2; 6; 4; 3; 1; 6; 3	[hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL			N	20241231
53499-1990_6e00db9c-3465-492c-a0ae-5b2731ccf623	53499-1990	HUMAN OTC DRUG	PSORIAFLORA		MAHONIA AQUIFOLIUM ROOT BARK	CREAM	TOPICAL	20060101		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	MAHONIA AQUIFOLIUM ROOT BARK	2	[hp_X]/28g			N	20241231
53499-1991_4269b0c6-eaaf-4034-b9e3-931f7c92edf1	53499-1991	HUMAN OTC DRUG	TOXICODENDRON PUBESCENS LEAF		TOXICODENDRON PUBESCENS LEAF	LIQUID	ORAL	20211117	20240430	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	TOXICODENDRON PUBESCENS LEAF	4	[hp_X]/29mL			N	
53499-2137_1d79a925-232e-4d88-bd1e-0f07712def68	53499-2137	HUMAN OTC DRUG	Umcka ColdCare Starter Kit		Umcka ColdCare Starter Kit	KIT		20171009		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.						N	20241231
53499-2347_6ac94e79-e9f3-4072-be63-842ea20171e1	53499-2347	HUMAN OTC DRUG	Umcka Cold Flu Berry Chewable		Pelargonium sidoides, Aconitum Napellus, Bryonia, Eucalyptus Globulus, Eupatorium Perfoliatum, Gelsemium Sempervirens, Ipecacuanha, Phosphorus	TABLET, CHEWABLE	ORAL	20180827	20241231	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-2351_e056c260-1de7-4344-8344-439665882683	53499-2351	HUMAN OTC DRUG	Umcka Coldcare Cherry		Pelargonium sidoides	TABLET, CHEWABLE	ORAL	20180827	20250430	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/1			N	
53499-2391_7b67343b-d693-4cbd-964e-4d673a401a3e	53499-2391	HUMAN OTC DRUG	Migraide		CYCLAMEN PURPURASCENS TUBER, BLACK COHOSH, IRIS VERSICOLOR WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, SANGUINARIA CANADENSIS ROOT	TABLET	SUBLINGUAL	20150702	20251231	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	BLACK COHOSH; CYCLAMEN PURPURASCENS TUBER; GELSEMIUM SEMPERVIRENS WHOLE; IRIS VERSICOLOR WHOLE; SANGUINARIA CANADENSIS ROOT	3; 3; 3; 2; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-2798_60c73474-ba7b-4c3e-8da7-88d4bbe0e4b3	53499-2798	HUMAN OTC DRUG	SCIATIC AIDE		ARSENIC TRIOXIDE, CHAMOMILE, CITRULLUS COLOCYNTHIS FRUIT PULP, SULFUR	TABLET	SUBLINGUAL	20110818	20270630	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	ARSENIC TRIOXIDE; CHAMOMILE; CITRULLUS COLOCYNTHIS FRUIT PULP; SULFUR	12; 3; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-2991_191d754b-951c-44a5-a918-08e1dbe8978f	53499-2991	HUMAN OTC DRUG	TOXICODENDRON PUBESCENS LEAF		TOXICODENDRON PUBESCENS LEAF	LIQUID	ORAL	20230302		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	TOXICODENDRON PUBESCENS LEAF	4	[hp_X]/30mL			N	20241231
53499-3194_559b5307-54fa-40af-9af1-a8c7a4f10056	53499-3194	HUMAN OTC DRUG	Umcka Allergy and Sinus		PELARGONIUM SIDOIDES ROOT, HYDRASTIS CANADENSIS WHOLE, POTASSIUM CHLORIDE, SANGUINARIA CANADENSIS ROOT, PULSATILLA VULGARIS, SILICON DIOXIDE	TABLET, CHEWABLE	ORAL	20180601		UNAPPROVED HOMEOPATHIC		Schwabe North American, Inc.	HYDRASTIS CANADENSIS WHOLE; PELARGONIUM SIDOIDES ROOT; POTASSIUM CHLORIDE; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE	6; 1; 3; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
53499-3351_71e3891f-25d5-47af-9c87-4144eeff1f8f	53499-3351	HUMAN OTC DRUG	Cold Relief Kids Cherry		Pelargonium sidoides	TABLET, CHEWABLE	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/1			N	20241231
53499-3391_bc629508-09ed-4ceb-b954-9dbc2c2d07ab	53499-3391	HUMAN OTC DRUG	Migraide		CYCLAMEN PURPURASCENS TUBER, BLACK COHOSH, IRIS VERSICOLOR WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, SANGUINARIA CANADENSIS ROOT	TABLET	SUBLINGUAL	20211109	20270131	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	BLACK COHOSH; CYCLAMEN PURPURASCENS TUBER; GELSEMIUM SEMPERVIRENS WHOLE; IRIS VERSICOLOR WHOLE; SANGUINARIA CANADENSIS ROOT	3; 3; 3; 4; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-3533_a1540a26-52e7-4f53-896a-10858c0102b2	53499-3533	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	TABLET	SUBLINGUAL	20060101	20251031	UNAPPROVED HOMEOPATHIC		Schwabe North America	ARNICA MONTANA	6	[hp_X]/1			N	
53499-3571_626305bd-4ae7-4180-a6b5-baf5db47c1e5	53499-3571	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	TABLET	SUBLINGUAL	20060101	20270331	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ARNICA MONTANA	30	[hp_C]/1			N	
53499-3572_68443f27-ae8b-4cea-824f-3803cb386feb	53499-3572	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	TABLET	SUBLINGUAL	20060101	20251230	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ARNICA MONTANA	30	[hp_X]/1			N	
53499-3590_6d1cbd34-3766-4351-8567-db3113d6f168	53499-3590	HUMAN OTC DRUG	Allergiemittel		CARDIOSPERMUM HALICACABUM FLOWERING TOP, GALPHIMIA GLAUCA FLOWERING TOP, LUFFA OPERCULATA FRUIT	TABLET	SUBLINGUAL	20200428		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT	3; 3; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
53499-4463_85240464-3d8a-4d99-b5bd-d5b9b0f009a1	53499-4463	HUMAN OTC DRUG	Cold Relief Alcohol Free Cherry Syrup		Pelargonium sidoides	SYRUP	ORAL	20230522		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/120mL			N	20241231
53499-5090_5f98d2ef-264b-4585-a708-4d4e514f92e6	53499-5090	HUMAN OTC DRUG	Arniflora		ARNICA MONTANA	GEL	TOPICAL	20110101		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	ARNICA MONTANA	1	[hp_X]/28g			N	20241231
53499-5144_9ec958c6-3a00-4708-ac47-68037c988d91	53499-5144	HUMAN OTC DRUG	Umcka Coldcare Cherry		Pelargonium sidoides	TABLET, CHEWABLE	ORAL	20110824	20250630	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/1			N	
53499-5146_fff06c40-1e11-4ae8-b322-8b0e9bb0d6bc	53499-5146	HUMAN OTC DRUG	Umcka Coldcare Lemon		Pelargonium sidoides	POWDER	ORAL	20090701		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/5g			N	20241231
53499-5190_b668a8ea-7d81-4d83-b3e4-ca4f5d2352e7	53499-5190	HUMAN OTC DRUG	Califlora		Calendula officinalis	GEL	TOPICAL	20060101	20250331	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/78g			N	
53499-5270_7986bc89-e052-4291-b770-dcc75feda17a	53499-5270	HUMAN OTC DRUG	Umcka Original ColdCare		Pelargonium sidoides	LIQUID	ORAL	20090202		UNAPPROVED HOMEOPATHIC		Schwabe North America	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/30mL			N	20241231
53499-5271_9c79085a-0109-45c2-9160-5a8a93bf8091	53499-5271	HUMAN OTC DRUG	Umcka ColdCare Alcohol-Free		Pelargonium sidoides	LIQUID	ORAL	20090202		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/30mL			N	20241231
53499-5272_ca028c50-ded5-4fbf-9c58-feb3adbdbceb	53499-5272	HUMAN OTC DRUG	Umcka Menthol		Pelargonium sidoides	SYRUP	ORAL	20060101		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/120mL			N	20241231
53499-5273_32136169-9523-4341-b997-bf4ea39b19f1	53499-5273	HUMAN OTC DRUG	Umcka ColdCare Alcohol Free Cherry		Pelargonium sidoides	SYRUP	ORAL	20060101	20250831	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/240mL			N	
53499-5492_27e3c199-5e6c-48f4-ba5a-eb5cf059d5eb	53499-5492	HUMAN OTC DRUG	Sports For Trauma		Bellis Perennis, Hypericum Perfomatum,Toxicodendron Pubscens Leaf, Ruta Graveolens Flowering Top	GEL	TOPICAL	20040701	20240131	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	BELLIS PERENNIS; HYPERICUM PERFORATUM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	1; 2; 1; 3	[hp_X]/71g; [hp_X]/71g; [hp_X]/71g; [hp_X]/71g			N	
53499-5794_443d4150-f7b0-471e-a8a5-d138e3fd5848	53499-5794	HUMAN OTC DRUG	Umcka ColdCare Sugar Free Grape		Pelargonium sidoides	SYRUP	ORAL	20060901		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/120mL			N	20241231
53499-5864_2d5fed29-eb7d-42d2-a1e6-2d8847e39fe9	53499-5864	HUMAN OTC DRUG	Umcka Cough	ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM SULFIDE, SPONGIA OFFICINALIS SKELETON, ROASTED , TIN, PELARGONIUM SIDOIDES ROOT	UMCKA COUGH	SYRUP	ORAL	20121001		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; PELARGONIUM SIDOIDES ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 3; 6; 1; 3; 6	[hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL			N	20241231
53499-6144_a271255a-1171-4290-a2ad-d2244c979838	53499-6144	HUMAN OTC DRUG	Cold Relief Cherry		Pelargonium sidoides	TABLET, CHEWABLE	ORAL	20230905		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/1			N	20241231
53499-6270_05428708-5162-47c5-90b5-fc12805e2789	53499-6270	HUMAN OTC DRUG	Umcka Original ColdCare		Pelargonium sidoides	LIQUID	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Schwabe North America	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/30mL			N	20241231
53499-6271_e89fbee4-8d24-4616-80fa-9f77f9654e21	53499-6271	HUMAN OTC DRUG	Umcka ColdCare Alcohol-Free		Pelargonium sidoides	LIQUID	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/59mL			N	20241231
53499-6273_0c4fd62c-54d6-4480-aaa9-4e4d80452ab8	53499-6273	HUMAN OTC DRUG	Cold Relief Syrup Cherry		Pelargonium sidoides	SYRUP	ORAL	20230825		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/240mL			N	20241231
53499-6390_49fdd21b-5f59-4e5f-a2e3-ca966d4ea3a8	53499-6390	HUMAN OTC DRUG	Ssssting Stop		Echinacea Angustifolia, Ledum Palustre Twig, Urtica Dioica	GEL	TOPICAL	20040701		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ECHINACEA ANGUSTIFOLIA; LEDUM PALUSTRE TWIG; URTICA DIOICA	1; 2; 1	[hp_X]/78g; [hp_X]/78g; [hp_X]/78g			N	20241231
53499-6492_da5a13e2-e3d2-4aaa-afeb-e66396ee7ca8	53499-6492	HUMAN OTC DRUG	Sports For Trauma		Bellis Perennis, Hypericum Perfomatum,Toxicodendron Pubscens Leaf, Ruta Graveolens Flowering Top	GEL	TOPICAL	20210903		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	BELLIS PERENNIS; HYPERICUM PERFORATUM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	1; 2; 1; 4	[hp_X]/70g; [hp_X]/70g; [hp_X]/70g; [hp_X]/70g			N	20241231
53499-7290_772c0bef-899f-4b6e-84cf-aa4279044bdd	53499-7290	HUMAN OTC DRUG	Triflora		Urtica doicia, Rhus Toxicodendron, Ledum Palustre	GEL	TOPICAL	20211001		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	LEDUM PALUSTRE TWIG; TOXICODENDRON PUBESCENS LEAF; URTICA DIOICA	2; 4; 1	[hp_X]/77g; [hp_X]/77g; [hp_X]/77g			N	20241231
53499-8393_3922f494-e1e9-4a08-96a2-89440ac163ae	53499-8393	HUMAN OTC DRUG	Childrens Cough and Bronchial		ANTIMONY PENTASULFIDE, BRYONIA ALBA ROOT, DROSERA ROTUNDIFOLIA, EUCALYPTUS GLOBULUS LEAF, IPECAC, ILLICIUM ANISATUM WHOLE	SYRUP	ORAL	20170418	20240331	UNAPPROVED DRUG OTHER		Schwabe North America, Inc	ANTIMONY PENTASULFIDE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA FLOWERING TOP; EUCALYPTUS GLOBULUS LEAF; ILLICIUM ANISATUM WHOLE; IPECAC	6; 3; 4; 3; 3; 4	[hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL			N	
53499-9098_bc3fdfb9-d463-41f6-9aba-ee19e7f91a23	53499-9098	HUMAN OTC DRUG	CHILDRENS ALPHA COLD FLU		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS	TABLET	SUBLINGUAL	20170701	20250131	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS	7; 7; 7; 7; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-9148_88f0b5b3-2eee-48b1-99aa-f53435c1b601	53499-9148	HUMAN OTC DRUG	Umcka Cold Flu Berry		ACONITUM NAPELLUS, BRYONIA ALBA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, GELSEMIUM SEMPERVIRENS, IPECACUANHA, PELARGONIUM SIDOIDES, PHOSPHORUS	SYRUP	ORAL	20170101		UNAPPROVED HOMEOPATHIC		Schwabe North America	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL			N	20241231
53499-9161_a1ec8de7-3335-4059-98a5-0432d3c884b2	53499-9161	HUMAN OTC DRUG	Umcka Cold Flu Orange		Pelargonium sidoides, Aconitum napellus, Bryonia, Eucalyptus globulus, Eupatorium perfoliatum, Gelsemium sempervirens, Ipecacuanha, Phosphorus	TABLET, CHEWABLE	ORAL	20170908		UNAPPROVED HOMEOPATHIC		Schwabe North Amertica, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
53499-9339_0f543c7a-ab9b-47f9-beeb-dde04e362379	53499-9339	HUMAN OTC DRUG	Alpha CF		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS,	TABLET	SUBLINGUAL	20170401	20270331	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS	4; 4; 2; 6; 4; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-9349_a2fda298-0d93-4c52-95b7-22d789b87fc0	53499-9349	HUMAN OTC DRUG	Umcka FastActives Berry		Pelargonium sidoides, Aconitum Napellus, Bryonia, Eucalyptus Globulus, Eupatorium Perfoliatum, Gelsemium Sempervirens, Ipecacuanha, Phosphorus	POWDER	ORAL	20170414		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/912mg; [hp_X]/912mg; [hp_X]/912mg; [hp_X]/912mg; [hp_X]/912mg; [hp_X]/912mg; [hp_X]/912mg; [hp_X]/912mg			N	20241231
53499-9490_72b5f627-4426-4fe0-9ebe-caec26fce1f9	53499-9490	HUMAN OTC DRUG	ALPHA CF		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS	TABLET	SUBLINGUAL	20180713	20250930	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS	4; 4; 2; 6; 4; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-9498_cacfe331-1c06-4471-8121-580d03a528a9	53499-9498	HUMAN OTC DRUG	Bronchial and Breathing Aide		ACONITUM NAPELLUS, CALCIUM SULFIDE, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN	TABLET	SUBLINGUAL	20170401	20270331	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	ACONITUM NAPELLUS; CALCIUM SULFIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 12; 3; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-9590_9fbfba4a-99d0-4a0f-99ba-09aa05b2a135	53499-9590	HUMAN OTC DRUG	Allergiemittel		CARDIOSPERMUM HALICACABUM FLOWERING TOP, GALPHIMIA GLAUCA FLOWERING TOP, LUFFA OPERCULATA FRUIT	TABLET	SUBLINGUAL	20170401	20250130	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT	3; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-9598_8aee1c8e-4a86-444e-a771-0d410d914a66	53499-9598	HUMAN OTC DRUG	SMOKE FREE		DIEFFENBACHIA SEGUINE, DAPHNE ODORA BARK, GRAPHITES, VALERIAN	TABLET	SUBLINGUAL	20170601	20251230	UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	DAPHNE ODORA BARK; DIEFFENBACHIA SEGUINE; GRAPHITE; VALERIAN	12; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
53499-9803_52e21257-27af-4de4-abe5-8ccadceead1a	53499-9803	HUMAN OTC DRUG	Sambucus Flucare		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS, SAMBUCUS NIGRA FLOWERING TOP	SYRUP	ORAL	20171003		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP	4; 4; 2; 6; 4; 3; 6; 3	[hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL			N	20241231
53499-9845_19fe253f-a909-4496-89f5-90738064e3f0	53499-9845	HUMAN OTC DRUG	Umcka Elderberry		Umcka Elderberry	SYRUP	ORAL	20170515	20241031	UNAPPROVED HOMEOPATHIC		Schwabe North America	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS; SAMBUCUS NIGRA FLOWERING TOP	4; 4; 2; 6; 4; 3; 4; 6; 3	[hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL			N	
53511-001_0a5d9eb5-f4b0-0233-e063-6294a90ae617	53511-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19730101		NDA	NDA205889	Volunteer Welding Supply Inc	OXYGEN	99	L/100L			N	20241231
53511-003_0a5d9d28-ad25-000c-e063-6294a90a69a0	53511-003	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19730101		NDA	NDA209989	Volunteer Welding Supply Inc	NITROUS OXIDE	99	L/100L			N	20241231
53511-004_0a5d70e6-0313-7f76-e063-6394a90a72ed	53511-004	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19730101		NDA	NDA205891	Volunteer Welding Supply Inc	NITROGEN	99	L/100L			N	20241231
53590-100_44ccfab5-962b-4be9-81f2-6d10a6701299	53590-100	HUMAN OTC DRUG	MOZI-Q		Ledum Palustre Twig, Urtica Urens, Simaba Cedron Seed, Delphinium Staphisagria Seed, Grindelia Hirsutula Flowering Top	TABLET, CHEWABLE	ORAL	20121015		UNAPPROVED HOMEOPATHIC		Xerion Dispensary Ltd.	DELPHINIUM STAPHISAGRIA SEED; GRINDELIA HIRSUTULA FLOWERING TOP; LEDUM PALUSTRE TWIG; SIMABA CEDRON SEED; URTICA URENS	4; 6; 3; 4; 6	[hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1			N	20241231
53590-102_60a907d7-e715-4f75-832c-5017ad36fa71	53590-102	HUMAN OTC DRUG	MOZI-Qfor kids and infa	for kids and infants	Ledum Palustre Twig, Urtica Urens, Simaba Cedron Seed, Delphinium Staphisagria Seed, Grindelia Hirsutula Flowering Top	LIQUID	ORAL	20140201		UNAPPROVED HOMEOPATHIC		Xerion Dispensary Ltd.	DELPHINIUM STAPHISAGRIA SEED; GRINDELIA HIRSUTULA FLOWERING TOP; LEDUM PALUSTRE TWIG; SIMABA CEDRON SEED; URTICA URENS	4; 6; 3; 4; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
53590-104_65b26bf9-ccc0-44db-96e4-511975f9c8d4	53590-104	HUMAN OTC DRUG	MOZI-Q		Ledum Palustre Twig, Urtica Urens, Simaba Cedron Seed, Delphinium Staphisagria Seed, Grindelia Hirsutula Flowering Top	LOTION	TOPICAL	20140201		UNAPPROVED HOMEOPATHIC		Xerion Dispensary Ltd.	DELPHINIUM STAPHISAGRIA SEED; GRINDELIA HIRSUTULA FLOWERING TOP; LEDUM PALUSTRE TWIG; SIMABA CEDRON SEED; URTICA URENS	4; 6; 3; 4; 6	[hp_X]/50g; [hp_C]/50g; [hp_X]/50g; [hp_C]/50g; [hp_X]/50g			N	20241231
53603-1047_46367843-c371-0288-e054-00144ff88e88	53603-1047	HUMAN OTC DRUG	instant hand sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20170116		OTC MONOGRAPH NOT FINAL	part333E	BB17, LLC	ALCOHOL	62	mL/100mL			N	20241231
53603-1048_4636e39d-3257-1529-e054-00144ff88e88	53603-1048	HUMAN OTC DRUG	instant hand sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20170116		OTC MONOGRAPH NOT FINAL	part333E	BB17, LLC	ALCOHOL	62	mL/100mL			N	20241231
53603-1049_464b7a83-0be4-6d33-e054-00144ff88e88	53603-1049	HUMAN OTC DRUG	instant hand sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20170116		OTC MONOGRAPH NOT FINAL	part333E	BB17, LLC	ALCOHOL	62	mL/100mL			N	20241231
53622-001_f1f20a2e-6a8b-4e0f-916f-aa28067cbfcd	53622-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19820101		NDA	NDA205865	Regional Home Care, Inc.	OXYGEN	99	L/100L			N	20241231
53634-128_f3d39df9-1619-7014-e053-2995a90af7bb	53634-128	HUMAN OTC DRUG	spf 30 mineral Sunscreen		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221215		OTC MONOGRAPH FINAL	M020	Malin and Goetz Inc	TITANIUM DIOXIDE; ZINC OXIDE	3.71; 2.71	g/100mL; g/100mL			N	20241231
53634-129_fe1b3122-b6e3-46fa-e053-6394a90afd59	53634-129	HUMAN OTC DRUG	spf 30 Lip Balm		Titanium Dioxide	STICK	TOPICAL	20230501		OTC MONOGRAPH FINAL	M020	Malin and Goetz Inc	TITANIUM DIOXIDE	3.3	g/100mL			N	20241231
53645-1001_fb70a36a-ab4b-7165-e053-6294a90a7a88	53645-1001	HUMAN OTC DRUG	Arnica		Arnica montana	GLOBULE	ORAL	20130902		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ARNICA MONTANA	30	[hp_X]/23g			N	20241231
53645-1002_fe1938ba-73ed-a906-e053-6394a90a1338	53645-1002	HUMAN OTC DRUG	Arnica		Arnica montana	GLOBULE	ORAL	20130902		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ARNICA MONTANA	6	[hp_X]/23g			N	20241231
53645-1010_faa51e8c-03eb-c0cc-e053-6394a90a04c6	53645-1010	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	TIN	6	[hp_X]/23g			N	20241231
53645-1012_fed12937-c844-4751-e053-6294a90a16a6	53645-1012	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	GLOBULE	ORAL	20230623		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	TIN	30	[hp_X]/23g			N	20241231
53645-1021_9a4f919f-bbd7-c014-e053-2995a90a547e	53645-1021	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	GOLD	30	[hp_X]/23g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53645-1022_fe193935-9635-8fa9-e053-6294a90a6697	53645-1022	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	GOLD	6	[hp_X]/23g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53645-1031_9a430af1-9690-2d51-e053-2a95a90a7f34	53645-1031	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILVER	30	[hp_X]/23g			N	20241231
53645-1032_f0320037-f867-baeb-e053-2995a90a9646	53645-1032	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	GLOBULE	ORAL	20130627		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILVER	6	[hp_X]/23g			N	20241231
53645-1041_9c9f4448-d8d8-9258-e053-2a95a90a532f	53645-1041	HUMAN OTC DRUG	Glandula Suprarenalis (Adrenal)		Glandula Suprarenalis (Adrenal)	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BOS TAURUS ADRENAL GLAND	6	[hp_X]/23g			N	20241231
53645-1050_9c9e61ed-e8a4-e2bf-e053-2995a90a4e1f	53645-1050	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	CREAM	TOPICAL	20130227		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	COPPER	6	[hp_X]/50mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
53645-1060_9c9ed6ec-6d1a-12ed-e053-2995a90a3a3a	53645-1060	HUMAN OTC DRUG	Stannum Metallicum		Stannum Metallicum	CREAM	TOPICAL	20130312		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	TIN	6	[hp_X]/50mL			N	20241231
53645-1070_9c9e95f2-af0e-0f04-e053-2995a90a48f7	53645-1070	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	CREAM	TOPICAL	20130312		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILVER	6	[hp_X]/50mL			N	20241231
53645-1080_9c9ed8d1-9a9c-e2d6-e053-2995a90a93ce	53645-1080	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	CREAM	TOPICAL	20130312		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	IRON	6	[hp_X]/50mL			N	20241231
53645-1090_b911198d-280d-698d-e053-2a95a90ade20	53645-1090	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	GLOBULE	ORAL	20131007		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LYCOPODIUM CLAVATUM SPORE	6	[hp_X]/23g			N	20241231
53645-1091_b910ae6d-6a0f-c284-e053-2a95a90ac161	53645-1091	HUMAN OTC DRUG	Lycopodium Clavatum		Lycopodium Clavatum	GLOBULE	ORAL	20131007		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LYCOPODIUM CLAVATUM SPORE	30	[hp_X]/23g			N	20241231
53645-1100_b910dc80-c299-f43b-e053-2995a90a2e10	53645-1100	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	COPPER	6	[hp_X]/23g	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
53645-1101_faa49f9c-9fd7-921d-e053-6394a90ac068	53645-1101	HUMAN OTC DRUG	Cuprum Metallicum		Cuprum Metallicum	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	COPPER	30	[hp_X]/23g	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
53645-1110_b9ab9e7d-f583-5ab7-e053-2995a90aab8d	53645-1110	HUMAN OTC DRUG	Belladonna		Belladonna	GLOBULE	ORAL	20130607		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ATROPA BELLADONNA	30	[hp_X]/23g			N	20241231
53645-1111_b9abc176-da72-3c26-e053-2a95a90a0b41	53645-1111	HUMAN OTC DRUG	Belladonna		Belladonna	GLOBULE	ORAL	20130607		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ATROPA BELLADONNA	6	[hp_X]/23g			N	20241231
53645-1120_b9abfd65-bb0d-2c09-e053-2995a90abc94	53645-1120	HUMAN OTC DRUG	Antimonium Crudum		Antimonium Crudum	GLOBULE	ORAL	20130902		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ANTIMONY TRISULFIDE	6	[hp_X]/23g			N	20241231
53645-1140_b9abfde3-022c-67ab-e053-2995a90a8dd1	53645-1140	HUMAN OTC DRUG	Apis Mell.		Apis Mell.	GLOBULE	ORAL	20130620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	APIS MELLIFERA VENOM	6	[hp_X]/23g			N	20241231
53645-1141_b9abfd65-bb0e-2c09-e053-2995a90abc94	53645-1141	HUMAN OTC DRUG	Apis Mell.		Apis Mell.	GLOBULE	ORAL	20130620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	APIS MELLIFERA VENOM	30	[hp_X]/23g			N	20241231
53645-1150_b9ac7488-7cdf-53a5-e053-2995a90a7cb0	53645-1150	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SODIUM CHLORIDE	30	[hp_X]/23g			N	20241231
53645-1160_b9ac4f13-9389-d2a6-e053-2a95a90a19ee	53645-1160	HUMAN OTC DRUG	Silicea		Silicea	GLOBULE	ORAL	20130621		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILICON DIOXIDE	6	[hp_X]/23g			N	20241231
53645-1161_b9ac77dc-c990-7910-e053-2995a90aa169	53645-1161	HUMAN OTC DRUG	Silicea		Silicea	GLOBULE	ORAL	20130621		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILICON DIOXIDE	30	[hp_X]/23g			N	20241231
53645-1162_fd293c82-301f-6455-e053-6394a90a714c	53645-1162	HUMAN OTC DRUG	Silicea 6X		Silicea 6X	CREAM	TOPICAL	20230602		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILICON DIOXIDE	6	[hp_X]/50mL			N	20241231
53645-1170_faa4d343-4b68-a977-e053-6394a90a5744	53645-1170	HUMAN OTC DRUG	Phosphorus		Phosphorus	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	PHOSPHORUS	30	[hp_X]/23g			N	20241231
53645-1171_faa4d67c-b95c-f5e8-e053-6294a90a9fb1	53645-1171	HUMAN OTC DRUG	Phosphorus		Phosphorus	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	PHOSPHORUS	6	[hp_X]/23g			N	20241231
53645-1180_ba25c0de-7d70-c1c4-e053-2a95a90a90fa	53645-1180	HUMAN OTC DRUG	Mercurius Vivus		Mercurius Vivus	GLOBULE	ORAL	20130620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	MERCURY	30	[hp_X]/23g			N	20241231
53645-1190_ba25c348-bf40-cd75-e053-2995a90ac151	53645-1190	HUMAN OTC DRUG	Calc Carb		Calc Carb	GLOBULE	ORAL	20130905		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_X]/23g			N	20241231
53645-1200_fd274e3c-95fe-173d-e053-6394a90a6b2e	53645-1200	HUMAN OTC DRUG	Sulfur		Sulfur	GLOBULE	ORAL	20230602		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SULFUR	7	[hp_X]/23g			N	20241231
53645-1202_fe91f114-3640-59a5-e053-6294a90a7514	53645-1202	HUMAN OTC DRUG	Sulfur		Sulfur	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SULFUR	30	[hp_X]/23g			N	20241231
53645-1211_faa4e5ab-e0d5-75c3-e053-6394a90a744a	53645-1211	HUMAN OTC DRUG	Hepar Sulf		Hepar Sulf	GLOBULE	ORAL	20171120		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CALCIUM SULFIDE	6	[hp_X]/23g			N	20241231
53645-1212_fe91d607-5e25-48e4-e053-6294a90ac522	53645-1212	HUMAN OTC DRUG	Hepar Sulf		Hepar Sulf	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CALCIUM SULFIDE	30	[hp_X]/23g			N	20241231
53645-1220_b99bad22-372f-22f5-e053-2995a90a70f0	53645-1220	HUMAN OTC DRUG	Thuja		Thuja	GLOBULE	ORAL	20130621		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/23g			N	20241231
53645-1230_b99a05e4-920f-74e6-e053-2995a90a47d1	53645-1230	HUMAN OTC DRUG	Thyroidinum		Thyroidinum	GLOBULE	ORAL	20130621		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	THYROID, BOVINE	6	[hp_X]/23g			N	20241231
53645-1240_ba25c348-bf43-cd75-e053-2995a90ac151	53645-1240	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	GLOBULE	ORAL	20130902		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BERBERIS VULGARIS FRUIT	6	[hp_X]/23g			N	20241231
53645-1250_ba25c0de-7d72-c1c4-e053-2a95a90a90fa	53645-1250	HUMAN OTC DRUG	Plumbum Mel.		Plumbum Mel.	GLOBULE	ORAL	20130621		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LEAD	30	[hp_X]/23g			N	20241231
53645-1270_ba25c0de-7d73-c1c4-e053-2a95a90a90fa	53645-1270	HUMAN OTC DRUG	Leonurus Cardiaca		Leonurus Cardiaca	GLOBULE	ORAL	20130620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LEONURUS CARDIACA	6	[hp_X]/23g			N	20241231
53645-1280_ba25c348-bf44-cd75-e053-2995a90ac151	53645-1280	HUMAN OTC DRUG	Lobelia Inflata		Lobelia Inflata	GLOBULE	ORAL	20130621		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LOBELIA INFLATA	6	[hp_X]/23g			N	20241231
53645-1290_faa4bfea-4b39-e530-e053-6294a90a5e5f	53645-1290	HUMAN OTC DRUG	Formicum Acidum		Formicum Acidum	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	FORMIC ACID	6	[hp_X]/23g			N	20241231
53645-1320_ba25c348-bf46-cd75-e053-2995a90ac151	53645-1320	HUMAN OTC DRUG	Chamomilla		Chamomilla	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	MATRICARIA RECUTITA	30	[hp_X]/23g			N	20241231
53645-1321_ba25ed16-eaa7-6d71-e053-2995a90abff5	53645-1321	HUMAN OTC DRUG	Chamomilla		Chamomilla	GLOBULE	ORAL	20131007		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	MATRICARIA RECUTITA	7	[hp_X]/23g			N	20241231
53645-1330_faa55070-cf51-e2e2-e053-6394a90a1b36	53645-1330	HUMAN OTC DRUG	Millefolium		Millefolium	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ACHILLEA MILLEFOLIUM	30	[hp_X]/23g			N	20241231
53645-1331_fe7cf073-5311-c8ae-e053-6294a90a1f7a	53645-1331	HUMAN OTC DRUG	Millefolium		Millefolium	GLOBULE	ORAL	20230619		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ACHILLEA MILLEFOLIUM	6	[hp_X]/23g			N	20241231
53645-1340_ba25ed16-eaa8-6d71-e053-2995a90abff5	53645-1340	HUMAN OTC DRUG	Argentum Quartz		Argentum Quartz	GLOBULE	ORAL	20130620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILICON DIOXIDE; SILVER	6; 6	[hp_X]/23g; [hp_X]/23g			N	20241231
53645-1350_ba25f18b-c861-29ba-e053-2995a90a407b	53645-1350	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ARSENIC	30	[hp_X]/23g			N	20241231
53645-1360_faa48e9c-a346-c745-e053-6294a90a9b21	53645-1360	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ARSENIC TRIOXIDE	30	[hp_X]/23g			N	20241231
53645-1370_faa457d4-24ed-637a-e053-6394a90a680c	53645-1370	HUMAN OTC DRUG	Aesculus		Aesculus	GLOBULE	ORAL	20171229		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	AESCULUS HIPPOCASTANUM WHOLE	50	[hp_X]/23g			N	20241231
53645-1380_ba25f18b-c863-29ba-e053-2995a90a407b	53645-1380	HUMAN OTC DRUG	Alumina		Alumina	GLOBULE	ORAL	20130902		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ALUMINUM OXIDE	30	[hp_X]/23g			N	20241231
53645-1410_fd65d24a-d9d9-f326-e053-6294a90acf13	53645-1410	HUMAN OTC DRUG	Avena Sativa 30X		Avena Sativa 30X	GLOBULE	ORAL	20230526		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	AVENA SATIVA FLOWERING TOP	30	[hp_X]/23g			N	20241231
53645-1430_faa4af8f-b8f4-98a8-e053-6394a90ac9f7	53645-1430	HUMAN OTC DRUG	Cichorium Intybus		Cichorium Intybus	GLOBULE	ORAL	20171209		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CICHORIUM INTYBUS (CHICORY) ROOT OLIGOSACCHARIDES	30	[hp_X]/23g			N	20241231
53645-1450_faa4abcc-5074-d8dc-e053-6294a90aadcf	53645-1450	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	COFFEA ARABICA FRUIT	30	[hp_X]/23g			N	20241231
53645-1451_faa4af8f-b8f3-98a8-e053-6394a90ac9f7	53645-1451	HUMAN OTC DRUG	Coffea Tosta		Coffea Tosta	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	COFFEA ARABICA FRUIT	6	[hp_X]/23g			N	20241231
53645-1460_fe1966d8-3278-dc78-e053-6294a90a98b3	53645-1460	HUMAN OTC DRUG	Colchicum Autumnale		Colchicum Autumnale	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	COLCHICUM AUTUMNALE BULB	6	[hp_X]/23g			N	20241231
53645-1470_ba2658a8-9fb8-b21d-e053-2a95a90af27e	53645-1470	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	GLOBULE	ORAL	20130628		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	IRON	6	[hp_X]/23g			N	20241231
53645-1471_faa4d67c-b958-f5e8-e053-6294a90a9fb1	53645-1471	HUMAN OTC DRUG	Ferrum Metallicum		Ferrum Metallicum	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	IRON	30	[hp_X]/23g			N	20241231
53645-1480_ba2658a8-9fb9-b21d-e053-2a95a90af27e	53645-1480	HUMAN OTC DRUG	Ferrum Phos		Ferrum Phos	GLOBULE	ORAL	20131007		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	FERROSOFERRIC PHOSPHATE	6	[hp_X]/23g			N	20241231
53645-1500_faa4af8f-b8fa-98a8-e053-6394a90ac9f7	53645-1500	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscyamus Niger	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	HYOSCYAMUS NIGER	30	[hp_X]/23g			N	20241231
53645-1501_faa4d67c-b95a-f5e8-e053-6294a90a9fb1	53645-1501	HUMAN OTC DRUG	Hyoscyamus Niger		Hyoscymus Niger	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	HYOSCYAMUS NIGER	6	[hp_X]/23g			N	20241231
53645-1530_fe1aaead-8e29-e1d4-e053-6394a90a96f4	53645-1530	HUMAN OTC DRUG	Lachesis Mutus		Lachesis Mutus	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LACHESIS MUTA VENOM	30	[hp_X]/23g			N	20241231
53645-1541_faa4eec2-abfb-b221-e053-6394a90a3d74	53645-1541	HUMAN OTC DRUG	Ledum Palustre		Ledum Palustre	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	RHODODENDRON TOMENTOSUM LEAFY TWIG	6	[hp_X]/23g			N	20241231
53645-1550_faa4eec2-abfd-b221-e053-6394a90a3d74	53645-1550	HUMAN OTC DRUG	Prunus Spinosa		Prunus Spinosa	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	PRUNUS SPINOSA FLOWER BUD	6	[hp_X]/23g			N	20241231
53645-1561_faa5271f-c098-cf0f-e053-6394a90a8c14	53645-1561	HUMAN OTC DRUG	Sepia		Sepia	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SEPIA OFFICINALIS JUICE	6	[hp_X]/23g			N	20241231
53645-1562_fe91e020-165b-0b7a-e053-6394a90a800b	53645-1562	HUMAN OTC DRUG	Sepia		Sepia	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SEPIA OFFICINALIS JUICE	30	[hp_X]/23g			N	20241231
53645-1580_ba266d94-2871-e454-e053-2a95a90af059	53645-1580	HUMAN OTC DRUG	Histaminum Hydrochloricum		Histaminum Hydrochloricum	GLOBULE	ORAL	20131007		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	HISTAMINE DIHYDROCHLORIDE	30	[hp_X]/23g			N	20241231
53645-1590_faa51e8c-03ea-c0cc-e053-6394a90a04c6	53645-1590	HUMAN OTC DRUG	Teucrium Scorodonia		Teucrium Scorodonia	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	TEUCRIUM SCORODONIA FLOWERING TOP	6	[hp_X]/23g			N	20241231
53645-1600_faa4d343-4b66-a977-e053-6394a90a5744	53645-1600	HUMAN OTC DRUG	Juglans Regia		Juglans Regia	GLOBULE	ORAL	20171120		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	JUGLANS REGIA SHELL	30	[hp_X]/23g			N	20241231
53645-1610_faa46dc2-a26d-6100-e053-6394a90aa966	53645-1610	HUMAN OTC DRUG	Aconitum		Aconitum	GLOBULE	ORAL	20171124		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ACONITUM NAPELLUS ROOT	30	[hp_X]/23g			N	20241231
53645-1631_fe91dac8-d543-9b91-e053-6394a90a2fc2	53645-1631	HUMAN OTC DRUG	Tormentilla		Tormentilla	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	POTENTILLA ERECTA ROOT	30	[hp_X]/23g			N	20241231
53645-1640_ba2658a8-9fc1-b21d-e053-2a95a90af27e	53645-1640	HUMAN OTC DRUG	Argentum Nitricum 6x		Argentum Nitricum 6x	GLOBULE	ORAL	20131125		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILVER NITRATE	6	[hp_X]/23g			N	20241231
53645-1641_faa4a428-c529-9252-e053-6394a90a7a17	53645-1641	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SILVER NITRATE	29	[hp_X]/23g			N	20241231
53645-1650_faa4abcc-506c-d8dc-e053-6294a90aadcf	53645-1650	HUMAN OTC DRUG	Bee Pollen		Bee Pollen	GLOBULE	ORAL	20171209		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BEE POLLEN	30	[hp_X]/23g			N	20241231
53645-1660_faa4abcc-507b-d8dc-e053-6294a90aadcf	53645-1660	HUMAN OTC DRUG	Cantharis		Cantharis	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LYTTA VESICATORIA	30	[hp_X]/23g			N	20241231
53645-1670_faa4bfea-4b7c-e530-e053-6294a90a5e5f	53645-1670	HUMAN OTC DRUG	Graphitis		Graphitis	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	GRAPHITE	30	[hp_X]/23g			N	20241231
53645-1680_faa4d343-4b62-a977-e053-6394a90a5744	53645-1680	HUMAN OTC DRUG	Magnesia Phos		Magnesia Phos	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_X]/23g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53645-1691_fe921a82-80c7-f0fd-e053-6394a90af4af	53645-1691	HUMAN OTC DRUG	Levisticum Officinalis		Levisticum Officinalis	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	LEVISTICUM OFFICINALE ROOT	6	[hp_X]/23g			N	20241231
53645-1700_ba268015-4fa0-d2ae-e053-2a95a90af606	53645-1700	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	GLOBULE	ORAL	20131007		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CALCIUM FLUORIDE	6	[hp_X]/23g			N	20241231
53645-1720_faa489eb-70f2-7a13-e053-6394a90a2a7c	53645-1720	HUMAN OTC DRUG	Allium Cepa		Allium Cepa	GLOBULE	ORAL	20171230		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ALLIUM CEPA WHOLE	8	[hp_X]/23g			N	20241231
53645-1721_faa48e9c-a345-c745-e053-6294a90a9b21	53645-1721	HUMAN OTC DRUG	Allium Cepa		Allium Cepa	GLOBULE	ORAL	20171230		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ALLIUM CEPA WHOLE	30	[hp_X]/23g			N	20241231
53645-1730_fe1bda28-5a29-7e9d-e053-6394a90a4b9f	53645-1730	HUMAN OTC DRUG	Strophanthus Kombe		Strophanthus Kombe	GLOBULE	ORAL	20230614		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	STROPHANTHUS KOMBE SEED	6	[hp_X]/23g			N	20241231
53645-1750_ba267a25-834a-4189-e053-2a95a90a9654	53645-1750	HUMAN OTC DRUG	Ferrum Carbonicum		Ferrum Carbonicum	GLOBULE	ORAL	20131007		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	FERROUS CARBONATE	6	[hp_X]/23g			N	20241231
53645-1770_faa48e9c-a348-c745-e053-6294a90a9b21	53645-1770	HUMAN OTC DRUG	Bryophyllum		Bryophyllum	GLOBULE	ORAL	20171209		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	KALANCHOE PINNATA LEAF	6	[hp_X]/23g			N	20241231
53645-1780_ba267a25-834c-4189-e053-2a95a90a9654	53645-1780	HUMAN OTC DRUG	Calc Phos		Calc Phos	GLOBULE	ORAL	20130906		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	TRIBASIC CALCIUM PHOSPHATE	30	[hp_X]/23g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
53645-1790_faa4abcc-5072-d8dc-e053-6294a90aadcf	53645-1790	HUMAN OTC DRUG	Calcarea Sulfurica		Calcarea Sulfurica	GLOBULE	ORAL	20171120		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CALCIUM SULFATE ANHYDROUS	6	[hp_X]/23g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
53645-1800_faa4abcc-506f-d8dc-e053-6294a90aadcf	53645-1800	HUMAN OTC DRUG	Camphora		Camphora	GLOBULE	ORAL	20171124		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CINNAMOMUM CAMPHORA LEAF	6	[hp_X]/23g			N	20241231
53645-1801_faa48e9c-a34d-c745-e053-6294a90a9b21	53645-1801	HUMAN OTC DRUG	Camphora		Camphora	GLOBULE	ORAL	20171124		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CINNAMOMUM CAMPHORA LEAF	30	[hp_X]/23g			N	20241231
53645-1810_faa4bfea-4b34-e530-e053-6294a90a5e5f	53645-1810	HUMAN OTC DRUG	Carbo Betulae		Carbo Betulae	GLOBULE	ORAL	20171124		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BETULA PENDULA BARK	6	[hp_X]/23g			N	20241231
53645-1811_faa4bfea-4b30-e530-e053-6294a90a5e5f	53645-1811	HUMAN OTC DRUG	Carbo Betulae		Carbo Betulae	GLOBULE	ORAL	20171124		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BETULA PENDULA BARK	30	[hp_X]/23g			N	20241231
53645-1830_faa4d343-4b5f-a977-e053-6394a90a5744	53645-1830	HUMAN OTC DRUG	Gelsemium		Gelsemium	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_X]/23g			N	20241231
53645-1831_fe921a82-8082-f0fd-e053-6394a90af4af	53645-1831	HUMAN OTC DRUG	Gelsemium		Gelsemium	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	GELSEMIUM SEMPERVIRENS ROOT	6	[hp_X]/23g			N	20241231
53645-1860_fe1c6a92-066a-6fd0-e053-6294a90af2fc	53645-1860	HUMAN OTC DRUG	Stibium Cream		Stibium Cream	CREAM	TOPICAL	20230614		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ANTIMONY	6	[hp_X]/50mL			N	20241231
53645-1871_fe916773-3d0b-6242-e053-6394a90ab4d7	53645-1871	HUMAN OTC DRUG	Nux Vomica		Nux Vomica	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	STRYCHNOS NUX-VOMICA SEED	30	[hp_X]/23g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
53645-1880_faa48e9c-a349-c745-e053-6294a90a9b21	53645-1880	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	GLOBULE	ORAL	20171209		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BRYONIA ALBA ROOT	6	[hp_X]/23g			N	20241231
53645-1890_faa4abcc-507f-d8dc-e053-6294a90aadcf	53645-1890	HUMAN OTC DRUG	Cinchona Officinalis		Cinchona Officinalis	GLOBULE	ORAL	20171209		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CINCHONA OFFICINALIS BARK	6	[hp_X]/23g			N	20241231
53645-1900_fd65d803-92f2-1c46-e053-6394a90ace16	53645-1900	HUMAN OTC DRUG	Celestite 6X		Celestite 6X	GLOBULE	ORAL	20230526		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	STRONTIUM SULFATE	6	[hp_X]/23g			N	20241231
53645-1910_faa4e5ab-e0d2-75c3-e053-6394a90a744a	53645-1910	HUMAN OTC DRUG	Ferrum Muriaticum		Ferrum Muriaticum	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	FERRIC CHLORIDE HEXAHYDRATE	6	[hp_X]/23g	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
53645-1920_faa4af8f-b896-98a8-e053-6394a90ac9f7	53645-1920	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	GLOBULE	ORAL	20171209		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BAPTISIA TINCTORIA	6	[hp_X]/23g			N	20241231
53645-1931_fe91543e-a799-6399-e053-6394a90af5e5	53645-1931	HUMAN OTC DRUG	Aesculus		Aesculus	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	AESCULUS HIPPOCASTANUM WHOLE	8	[hp_X]/23g			N	20241231
53645-1950_fd277f13-f1e8-033d-e053-6294a90a0250	53645-1950	HUMAN OTC DRUG	Oxalis Montana 6X		Oxalis Montana 6X	GLOBULE	ORAL	20230602		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	OXALIS ACETOSELLA WHOLE	6	[hp_X]/23g			N	20241231
53645-1960_faa473aa-e69f-69a2-e053-6394a90a7988	53645-1960	HUMAN OTC DRUG	Abrotanum		Abrotanum	GLOBULE	ORAL	20171229		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ARTEMISIA ABROTANUM WHOLE	6	[hp_X]/23g			N	20241231
53645-1980_fe1b3122-b69c-46fa-e053-6394a90afd59	53645-1980	HUMAN OTC DRUG	Pulsatilla		Pulsatilla	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	PULSATILLA VULGARIS	6	[hp_X]/23g			N	20241231
53645-1981_fe1ac6f8-f676-bc15-e053-6294a90aeab2	53645-1981	HUMAN OTC DRUG	Pulsatilla		Pulsatilla	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	PULSATILLA VULGARIS	30	[hp_X]/23g			N	20241231
53645-1990_faa4bfea-4b37-e530-e053-6294a90a5e5f	53645-1990	HUMAN OTC DRUG	Conium Maculatum		Conium Maculatum	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CONIUM MACULATUM LEAF	30	[hp_X]/23g			N	20241231
53645-2000_faa4c72c-5b7c-a3c1-e053-6394a90a9be1	53645-2000	HUMAN OTC DRUG	Drosera		Drosera	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	DROSERA INTERMEDIA	6	[hp_X]/23g			N	20241231
53645-2001_fe921a82-8032-f0fd-e053-6394a90af4af	53645-2001	HUMAN OTC DRUG	Drosera		Drosera	LIQUID	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	DROSERA INTERMEDIA	6	[hp_X]/55mL			N	20241231
53645-2030_fd288e0a-bf10-d7e9-e053-6294a90ac081	53645-2030	HUMAN OTC DRUG	Aurum Metallicum 6X		Aurum Metallicum 6X	CREAM	TOPICAL	20230602		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	GOLD	6	[hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
53645-2040_003a229c-b00b-e9f3-e063-6294a90aa5ed	53645-2040	HUMAN OTC DRUG	Stramonium		Stramonium	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	DATURA STRAMONIUM	30	[hp_X]/23g			N	20241231
53645-2051_fe17fb5b-9f4f-d9ed-e053-6394a90a0ec5	53645-2051	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvensis	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ANAGALLIS ARVENSIS	30	[hp_X]/23g			N	20241231
53645-2080_faa4d67c-b959-f5e8-e053-6294a90a9fb1	53645-2080	HUMAN OTC DRUG	Helleborus Niger		Helleborus Niger	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	HELLEBORUS NIGER ROOT	29	[hp_X]/23g			N	20241231
53645-2090_faa5116c-4818-21fc-e053-6294a90aa810	53645-2090	HUMAN OTC DRUG	Viscum Album		Viscum Album	GLOBULE	ORAL	20140203		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM FRUITING TOP	25	[hp_X]/23g			N	20241231
53645-2100_faa51e8c-03ec-c0cc-e053-6394a90a04c6	53645-2100	HUMAN OTC DRUG	Ferrum Arsenicosum		Ferrum Arsenicosum	GLOBULE	ORAL	20181216		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	FERROUS ARSENATE	30	[hp_C]/23g			N	20241231
53645-2101_fe9290c2-2899-0015-e053-6394a90a86e1	53645-2101	HUMAN OTC DRUG	Ferrum Arsenicosum		Ferrum Arsenicosum	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	FERROUS ARSENATE	15	[hp_C]/23g			N	20241231
53645-2110_faa4c72c-5b7d-a3c1-e053-6394a90a9be1	53645-2110	HUMAN OTC DRUG	Natrum Muriaticum		Natrium Muriaticum	GLOBULE	ORAL	20181216		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	SODIUM CHLORIDE	15	[hp_C]/23g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
53645-2120_faa5271f-c099-cf0f-e053-6394a90a8c14	53645-2120	HUMAN OTC DRUG	Iodium		Iodium	GLOBULE	ORAL	20181216		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	IODINE	30	[hp_C]/23g			N	20241231
53645-2121_fe92637a-c88c-f9dd-e053-6294a90a7fa3	53645-2121	HUMAN OTC DRUG	Iodium		Iodium	GLOBULE	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	IODINE	15	[hp_C]/23g			N	20241231
53645-2140_faa4fc9a-7edf-be5f-e053-6394a90ab943	53645-2140	HUMAN OTC DRUG	Strophanthus		Strophanthus	GLOBULE	ORAL	20181216		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	STROPHANTHUS GRATUS SEED; STROPHANTHUS KOMBE SEED	4; 4	[hp_X]/23g; [hp_X]/23g			N	20241231
53645-2141_fe91d607-5e26-48e4-e053-6294a90ac522	53645-2141	HUMAN OTC DRUG	Strophanthus		Strophanthus	LIQUID	ORAL	20230620		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	STROPHANTHUS GRATUS SEED; STROPHANTHUS KOMBE SEED	4; 4	[hp_X]/55mL; [hp_X]/55mL			N	20241231
53645-2160_fbfe01e8-ae59-09ed-e053-6394a90abb9d	53645-2160	HUMAN OTC DRUG	Viscum Salix RK 30X		Viscum Salix RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2170_fbfb4a5e-fbde-947a-e053-6294a90a1606	53645-2170	HUMAN OTC DRUG	Viscum Acacia RK 30X		Viscum Acacia RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2180_fbfdeb3c-8bfc-6e43-e053-6394a90a2960	53645-2180	HUMAN OTC DRUG	Viscum Quercus RK 30X		Viscum Quercus RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2190_fbfda05e-2e21-1cc2-e053-6394a90a88bd	53645-2190	HUMAN OTC DRUG	Viscum Populus RK 30X		Viscum Populus RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2200_fbfbf9fb-31fb-ef43-e053-6294a90a4c88	53645-2200	HUMAN OTC DRUG	Viscum Carpinus RK 30X		Viscum Carpinus RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2210_fbfc505a-b797-9375-e053-6394a90ac641	53645-2210	HUMAN OTC DRUG	Viscum Mali RK 30X		Viscum Mali RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2220_fbfdcdff-95f1-ea3d-e053-6394a90a8ad3	53645-2220	HUMAN OTC DRUG	Viscum Pyrus RK 30X		Viscum Pyrus RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2230_fbbe1f23-12c8-f07c-e053-6294a90a3226	53645-2230	HUMAN OTC DRUG	Viscum Abietes RK 30X		Viscum Abietes RK 30X	LIQUID	ORAL	20230515		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM SUBSP. ABIETIS WHOLE	30	[hp_X]/20mL			N	20241231
53645-2240_056793ef-b2b3-1254-e063-6394a90abcf3	53645-2240	HUMAN OTC DRUG	Malus Radix 6X		Malus Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	MALUS DOMESTICA ROOT	6	[hp_X]/30mL			N	20241231
53645-2250_05519041-c819-db46-e063-6394a90acd25	53645-2250	HUMAN OTC DRUG	Betula Radix 6X		Betula Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	BETULA PAPYRIFERA WHOLE	6	[hp_X]/30mL			N	20241231
53645-2260_0567990e-636b-af14-e063-6294a90a726f	53645-2260	HUMAN OTC DRUG	Robinia Radix 6X		Robinia Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ROBINIA PSEUDOACACIA WHOLE	6	[hp_X]/30mL			N	20241231
53645-2270_056793ef-b2b7-1254-e063-6394a90abcf3	53645-2270	HUMAN OTC DRUG	Ulmus Radix 6X		Ulmus Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ULMUS PARVIFOLIA WHOLE	6	[hp_X]/30mL			N	20241231
53645-2280_056793ef-b2a3-1254-e063-6394a90abcf3	53645-2280	HUMAN OTC DRUG	Acer Radix 6X		Acer Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	ACER RUBRUM WHOLE	6	[hp_X]/30mL			N	20241231
53645-2290_0566c99c-b0d2-eda4-e063-6294a90ae2f8	53645-2290	HUMAN OTC DRUG	Quercus Radix 6X		Quercus Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	QUERCUS ALBA WHOLE	6	[hp_X]/30mL			N	20241231
53645-2300_043e1eb8-e21c-b1a0-e063-6394a90ab5f5	53645-2300	HUMAN OTC DRUG	Viscum Tilia RK 30X		Viscum Tilia RK 30X	LIQUID	ORAL	20230831		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2310_043e2d78-423c-3fa8-e063-6394a90ac882	53645-2310	HUMAN OTC DRUG	Viscum Acer RK 30X		Viscum Acer RK 30X	LIQUID	ORAL	20230831		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53645-2320_056781af-c078-7821-e063-6294a90a57ee	53645-2320	HUMAN OTC DRUG	Cerasus Radix 6X		Cerasus Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	PRUNUS AVIUM WHOLE	6	[hp_X]/30mL			N	20241231
53645-2330_0567a880-5289-22e4-e063-6394a90a27f3	53645-2330	HUMAN OTC DRUG	Carpinus Radix 6X		Carpinus Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	CARPINUS CAROLINIANA WHOLE	6	[hp_X]/30mL			N	20241231
53645-2340_0567a8ac-f9ac-294d-e063-6394a90a0ef1	53645-2340	HUMAN OTC DRUG	Populus Radix 6X		Populus Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	POPULUS DELTOIDES SUBSP. DELTOIDES WHOLE; POPULUS NIGRA WHOLE	6; 6	[hp_X]/30mL; [hp_X]/30mL			N	20241231
53645-2350_05caa87d-36e3-7ec7-e063-6294a90a71f4	53645-2350	HUMAN OTC DRUG	Fraxinus Radix 6X		Fraxinus Radix 6X	LIQUID	ORAL	20230914		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	FRAXINUS AMERICANA WHOLE	6	[hp_X]/30mL			N	20241231
53645-2360_06578611-1f4c-6fd0-e063-6294a90a8df3	53645-2360	HUMAN OTC DRUG	Viscum Robinia RK 30X		Viscum Robinia RK 30X	LIQUID	ORAL	20230927		UNAPPROVED HOMEOPATHIC		True Botanica, LLC	VISCUM ALBUM WHOLE	30	[hp_X]/20mL			N	20241231
53675-140_09862169-501d-f8eb-e063-6294a90a6f2d	53675-140	HUMAN OTC DRUG	Aruba Aloe Lip Sunscreen and Moisturizer		OXYBENZONE, PADIMATE	LIPSTICK	TOPICAL	20110601		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	OXYBENZONE; PADIMATE O	3; 8	g/100g; g/100g			N	20241231
53675-150_0a2106c1-eb81-4885-e063-6394a90a778e	53675-150	HUMAN OTC DRUG	Aruba Aloe Very Water Resistant Sunscreen		HOMOSALATE, OCTINOXATE, PADIMATE O , OXYBENZONE	LOTION	TOPICAL	20110605		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm, NV	HOMOSALATE; OCTINOXATE; OXYBENZONE; PADIMATE O	80; 70; 30; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53675-152_09862684-d7b1-e2a3-e063-6294a90a8d59	53675-152	HUMAN OTC DRUG	Aruba Aloe Very Water Resistant Sunscreen For Kids	SPF 30	HOMOSALATE, OCTINOXATE, PADIMATE O , OXYBENZONE	LOTION	TOPICAL	20110605		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm, NV	HOMOSALATE; OCTINOXATE; OXYBENZONE; PADIMATE O	80; 70; 30; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53675-154_0a214dca-b7d0-9a59-e063-6294a90a0b62	53675-154	HUMAN OTC DRUG	Aruba Aloe Very Water Resistant Sunscreen - For Faces	SPF 30	HOMOSALATE, OCTINOXATE, PADIMATE O, OXYBENZONE	LOTION	TOPICAL	20110706		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	HOMOSALATE; OCTINOXATE; OXYBENZONE; PADIMATE O	80; 70; 30; 42	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53675-155_0986172c-ce1e-2106-e063-6394a90ab452	53675-155	HUMAN OTC DRUG	Aruba Aloe Very Water Resistant Sunscreen	SPF 15	OCTINOXATE, OXYBENZONE	LOTION	TOPICAL	20110708		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm, NV	OCTINOXATE; OXYBENZONE	75; 45	mg/mL; mg/mL			N	20241231
53675-157_0a21d8e0-059f-e088-e063-6394a90a2d1d	53675-157	HUMAN OTC DRUG	Aruba Aloe Very Water Resistant Sunscreen	SPF 8	OCTINOXATE, OXYBENZONE	LOTION	TOPICAL	20110708		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm, NV	OCTINOXATE; OXYBENZONE	70; 20	mg/mL; mg/mL			N	20241231
53675-158_098627cf-f8b1-2a19-e063-6394a90ab53f	53675-158	HUMAN OTC DRUG	Aruba Aloe Very Water Resistant Sunscreen	SPF 50	OCTOCRYLENE, OCTINOXATE, OXYBENZONE, HOMOSALATE, OCTYL SALICYLATE, AVOBENZONE	LOTION	TOPICAL	20130226		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 75; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53675-160_09862c49-6c44-2d7c-e063-6394a90ac5b3	53675-160	HUMAN OTC DRUG	Island Remedy All-day Revitalizing Moisturizer with SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20160524		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	57.8; 37.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-161_098633f1-4876-2e09-e063-6394a90a3db4	53675-161	HUMAN OTC DRUG	Antiperspirant Deodorant Extra Dry Men		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20170601		OTC MONOGRAPH DRUG	M019	Aruba Aloe Balm NV	ALUMINUM CHLOROHYDRATE	250	mg/mL			N	20241231
53675-162_09863729-8dee-35a9-e063-6394a90a9a57	53675-162	HUMAN OTC DRUG	Antiperspirant Deodorant Extra Dry Women		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20170601		OTC MONOGRAPH DRUG	M019	Aruba Aloe Balm NV	ALUMINUM CHLOROHYDRATE	250	mg/mL			N	20241231
53675-163_098633f1-4883-2e09-e063-6394a90a3db4	53675-163	HUMAN OTC DRUG	Antiperspirant Deodorant Fresh Women		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20170601		OTC MONOGRAPH DRUG	M019	Aruba Aloe Balm NV	ALUMINUM CHLOROHYDRATE	160	mg/mL			N	20241231
53675-164_0986172c-ce2d-2106-e063-6394a90ab452	53675-164	HUMAN OTC DRUG	Alcoholada Pain Relieving		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20170610		OTC MONOGRAPH DRUG	M017	Aruba Aloe Balm NV	LIDOCAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53675-165_098633f1-4890-2e09-e063-6394a90a3db4	53675-165	HUMAN OTC DRUG	Sunscreen SPF 50 Plus Broad Spectrum UVA UVB protection		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20170610		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 75; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53675-170_09af6337-0cd8-4cb7-e063-6294a90a0e4a	53675-170	HUMAN OTC DRUG	Broad Spectrum SPF 30 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171025		OTC MONOGRAPH DRUG	M017	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	80; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-171_09863729-8dfb-35a9-e063-6394a90a9a57	53675-171	HUMAN OTC DRUG	Broad Spectrum Water Resistant SPF 50 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171025		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-172_09af6337-0ce8-4cb7-e063-6294a90a0e4a	53675-172	HUMAN OTC DRUG	Broad Spectrum Water Resistant SPF 50 Mineral Sunscreen Babies		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171025		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-173_0986480e-77c8-0bbe-e063-6294a90a1908	53675-173	HUMAN OTC DRUG	Alcoholada Gel Pain Relieving Pain		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20171025		OTC MONOGRAPH DRUG	M017	Aruba Aloe Balm NV	LIDOCAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53675-174_09863729-8e0a-35a9-e063-6394a90a9a57	53675-174	HUMAN OTC DRUG	Broad Spectrum Water Resistant SPF 30 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171025		OTC MONOGRAPH DRUG	M017	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	80; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-175_0986172c-ce3c-2106-e063-6394a90ab452	53675-175	HUMAN OTC DRUG	Broad Spectrum Water Resistant SPF 50 Mineral Sunscreen Faces		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171025		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-176_09af864d-38dd-3881-e063-6394a90a3efb	53675-176	HUMAN OTC DRUG	Broad Spectrum SPF 50 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171025		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-180_09862169-5034-f8eb-e063-6294a90a6f2d	53675-180	HUMAN OTC DRUG	Broad Spectrum SPF 30 Water Resistant (80 Minutes)		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-183_098653c2-89ea-2a12-e063-6394a90a817e	53675-183	HUMAN OTC DRUG	Broad Spectrum SPF 30 Water Resistant Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-184_0986172c-ce4b-2106-e063-6394a90ab452	53675-184	HUMAN OTC DRUG	Mineral Sunscreen Lip Balm SPF 15		TITANIUM DIOXIDE, ZINC OXIDE	LIPSTICK	TOPICAL	20190105		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	ZINC OXIDE	80	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-185_09862861-908d-3158-e063-6394a90aa0d5	53675-185	HUMAN OTC DRUG	Hand Sanitizer 80 Alcohol		ALCOHOL	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Aruba Aloe Balm NV	ALCOHOL	.8	mL/mL			N	20241231
53675-186_09862c49-6c50-2d7c-e063-6394a90ac5b3	53675-186	HUMAN OTC DRUG	Aruba Aloe Sport Line Broad Spectrum SPF 50 Anti Chafing		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200515		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-187_0986480e-77d7-0bbe-e063-6294a90a1908	53675-187	HUMAN OTC DRUG	Aruba Aloe Sport Line Lip Balm Broad Spectrum SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	STICK	TOPICAL	20200515		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	50; 80	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-188_09863729-8e19-35a9-e063-6394a90a9a57	53675-188	HUMAN OTC DRUG	Broad Spectrum SPF 30 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200615		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	80; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-189_098627cf-f8e3-2a19-e063-6394a90ab53f	53675-189	HUMAN OTC DRUG	Broad Spectrum SPF 50 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200615		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-190_09862861-909c-3158-e063-6394a90aa0d5	53675-190	HUMAN OTC DRUG	Broad Spectrum SPF 50 Faces Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200615		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-191_09866e0b-7358-2316-e063-6294a90a5009	53675-191	HUMAN OTC DRUG	Broad Spectrum SPF 50 Babies Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200615		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-192_09862861-90ab-3158-e063-6394a90aa0d5	53675-192	HUMAN OTC DRUG	Aruba Aloe Hand Sanitizer 80% Alcohol		ALCOHOL	GEL	TOPICAL	20200915		OTC MONOGRAPH DRUG	505G(a)(3)	Aruba Aloe Balm NV	ALCOHOL	.8	mL/mL			N	20241231
53675-193_098627cf-f8f3-2a19-e063-6394a90ab53f	53675-193	HUMAN OTC DRUG	Aruba Aloe Hand Sanitizer 80% Alcohol		ALCOHOL	SPRAY	TOPICAL	20200915		OTC MONOGRAPH DRUG	505G(a)(3)	Aruba Aloe Balm NV	ALCOHOL	.8	mL/mL			N	20241231
53675-194_09862861-90ba-3158-e063-6394a90aa0d5	53675-194	HUMAN OTC DRUG	Aruba Aloe SPF 50 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220120		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-195_098627cf-f904-2a19-e063-6394a90ab53f	53675-195	HUMAN OTC DRUG	Aruba Aloe SPF 50 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220120		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-196_09867cbe-b035-4e80-e063-6394a90aca95	53675-196	HUMAN OTC DRUG	Aruba Aloe SPF 50 Mineral Sunscreen FACES		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220120		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-197_09863729-8e2a-35a9-e063-6394a90a9a57	53675-197	HUMAN OTC DRUG	Aruba Aloe SPF 50 Mineral Sunscreen BABIES		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220120		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	100; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-198_09867544-1f6a-4689-e063-6394a90ad041	53675-198	HUMAN OTC DRUG	Aruba Aloe SPF 30 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220120		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	80; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-199_098684cc-4962-2d65-e063-6394a90a5f6c	53675-199	HUMAN OTC DRUG	Aruba Aloe SPF 30 Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220120		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	TITANIUM DIOXIDE; ZINC OXIDE	80; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-200_0986848b-11e8-5305-e063-6394a90a5281	53675-200	HUMAN OTC DRUG	Antiperspirant Deodorant Extra Dry Men		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20220224		OTC MONOGRAPH DRUG	M019	Aruba Aloe Balm NV	ALUMINUM CHLOROHYDRATE	250	mg/mL			N	20241231
53675-201_098688fd-eb04-29d6-e063-6294a90ade41	53675-201	HUMAN OTC DRUG	Antiperspirant Deodorant Extra Dry Women		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20220224		OTC MONOGRAPH DRUG	M019	Aruba Aloe Balm NV	ALUMINUM CHLOROHYDRATE	250	mg/mL			N	20241231
53675-202_09866b9c-aa24-45eb-e063-6394a90a4903	53675-202	HUMAN OTC DRUG	Antiperspirant Deodorant Powder Fresh Women		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20220224		OTC MONOGRAPH DRUG	M019	Aruba Aloe Balm NV	ALUMINUM CHLOROHYDRATE	160	mg/mL			N	20241231
53675-203_098688fd-eb12-29d6-e063-6294a90ade41	53675-203	HUMAN OTC DRUG	Sport Broad Spectrum SPF50 Water Resistant 80 minutes Mineral Sunscreen UVA UVB Protection Stick		ZINC OXIDE	STICK	TOPICAL	20220308		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-204_09867544-1f7a-4689-e063-6394a90ad041	53675-204	HUMAN OTC DRUG	Sport Deodorant Extra Antiperspirant		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20220308		OTC MONOGRAPH DRUG	M019	Aruba Aloe Balm NV	ALUMINUM CHLOROHYDRATE	250	mg/mL			N	20241231
53675-205_09869240-b6d2-4c64-e063-6394a90a2cbe	53675-205	HUMAN OTC DRUG	Broad Spectrum SPF50 Water Resistant (80 minutes) Mineral Sunscreen UVA UVB Protection Stick for Kids		ZINC OXIDE	STICK	TOPICAL	20220308		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53675-206_0ac01bf8-0f76-121a-e063-6294a90a970d	53675-206	HUMAN OTC DRUG	Broad Spectrum SPF15 Very Water Resistant (80 Minutes) Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	CREAM	TOPICAL	20230602		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 73.4; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53675-207_0ac055c2-6afa-8d76-e063-6294a90ab966	53675-207	HUMAN OTC DRUG	Broad Spectrum SPF30 Very Water Resistant (80 Minutes) Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	CREAM	TOPICAL	20230602		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 73.4; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53675-208_0eae7a1b-f5ac-eb4a-e063-6394a90af2c5	53675-208	HUMAN OTC DRUG	Aruba Aloe broad spectrum SPF 15 Lip sunscreen and Moisturizer		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	Aruba Aloe Balm NV	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 73.4; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20251231
53683-0001_079c1b89-f01b-3640-e063-6394a90aae0d	53683-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091016		UNAPPROVED MEDICAL GAS		MEDOX Corporation	OXYGEN	99	L/100L			N	20241231
53727-121_0c5bffd9-f247-8bee-e063-6294a90ac249	53727-121	HUMAN OTC DRUG	Mineral Sunscreen Broad Spectrum SPF30		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230301		OTC MONOGRAPH DRUG	M020	COSMECCA KOREA CO., LTD	TITANIUM DIOXIDE; ZINC OXIDE	34.4; 48.8	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53729-0002_e1fab9b0-3c7c-8625-e053-2a95a90a5a76	53729-0002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19870901		NDA	NDA205827	BUCKEYE WELDING SUPPLY COMPANY, INC.	OXYGEN	992	mL/L			N	20241231
53730-001_64436c80-261c-4952-a19b-9b8ab5476419	53730-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19840101		NDA	NDA205889	Clovis Equipment & Supply Company	OXYGEN	99	L/100L			N	20241231
53746-019_4c0cc309-a167-412b-90af-d88b28d5ea0e	53746-019	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20170517		ANDA	ANDA205619	Amneal Pharmaceuticals of New York LLC	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53746-020_4c0cc309-a167-412b-90af-d88b28d5ea0e	53746-020	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20170517		ANDA	ANDA205619	Amneal Pharmaceuticals of New York LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53746-021_4c0cc309-a167-412b-90af-d88b28d5ea0e	53746-021	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20170517		ANDA	ANDA205619	Amneal Pharmaceuticals of New York LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
53746-077_c2c9cf77-504d-4d7c-8899-c3cb6f76c545	53746-077	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20100922		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals of New York LLC	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	.625; 1.25	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
53746-078_c2c9cf77-504d-4d7c-8899-c3cb6f76c545	53746-078	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20100922		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals of New York LLC	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	1.25; 2.5	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
53746-101_10e5f9be-7920-4775-801b-e1c32b996410	53746-101	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Amneal Pharmaceuticals of New York LLC	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
53746-102_10e5f9be-7920-4775-801b-e1c32b996410	53746-102	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Amneal Pharmaceuticals of New York LLC	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
53746-103_10e5f9be-7920-4775-801b-e1c32b996410	53746-103	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Amneal Pharmaceuticals of New York LLC	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
53746-109_a1f160ce-a6c6-441b-a9f0-03f50bb5349e	53746-109	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20100118		ANDA	ANDA040736	Amneal Pharmaceuticals of New York LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
53746-110_1244f022-428b-46ed-b0b3-dced183310db	53746-110	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20100218		ANDA	ANDA040746	Amneal Pharmaceuticals of New York LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
53746-116_6605b229-ede5-4ebf-b749-dde315916268	53746-116	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Ibuprofen		Hydrocodone Bitartrate and Ibuprofen	TABLET	ORAL	20100218		ANDA	ANDA076642	Amneal Pharmaceuticals of New York LLC	HYDROCODONE BITARTRATE; IBUPROFEN	2.5; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
53746-117_6605b229-ede5-4ebf-b749-dde315916268	53746-117	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Ibuprofen		Hydrocodone Bitartrate and Ibuprofen	TABLET	ORAL	20100218		ANDA	ANDA076642	Amneal Pharmaceuticals of New York LLC	HYDROCODONE BITARTRATE; IBUPROFEN	10; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
53746-131_56a6bf62-e671-4670-9ca6-7f3814c77a41	53746-131	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20090105		ANDA	ANDA071334	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-132_334e2dc4-9b6a-47c1-aee2-c52e32d86c98	53746-132	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20090105		ANDA	ANDA071335	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-137_f4c2fa2d-a18b-4c05-82c8-ac04f654df3b	53746-137	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20090105		ANDA	ANDA071935	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-140_e2b9bf54-0449-4f9b-86e8-e3b292387dd5	53746-140	HUMAN OTC DRUG	Ibuprofen	Pain Releiver/ Fever Reducer	Ibuprofen	TABLET	ORAL	20091216		ANDA	ANDA071333	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-142_ef67c08a-fc4f-4e6c-a58f-8ed743b2b6aa	53746-142	HUMAN OTC DRUG	Ibuprofen	(NSAID) Pain Releiver/ Fever Reducer	Ibuprofen	TABLET	ORAL	20091216		ANDA	ANDA072199	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-143_e2b9bf54-0449-4f9b-86e8-e3b292387dd5	53746-143	HUMAN OTC DRUG	Ibuprofen	Pain Releiver/ Fever Reducer	Ibuprofen	TABLET	ORAL	20091216		ANDA	ANDA071333	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-144_ef67c08a-fc4f-4e6c-a58f-8ed743b2b6aa	53746-144	HUMAN OTC DRUG	Ibuprofen	(NSAID) Pain Releiver/ Fever Reducer	Ibuprofen	TABLET	ORAL	20091216		ANDA	ANDA072199	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-145_6605b229-ede5-4ebf-b749-dde315916268	53746-145	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Ibuprofen		Hydrocodone Bitartrate and Ibuprofen	TABLET	ORAL	20100218		ANDA	ANDA076642	Amneal Pharmaceuticals of New York LLC	HYDROCODONE BITARTRATE; IBUPROFEN	7.5; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
53746-146_6605b229-ede5-4ebf-b749-dde315916268	53746-146	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Ibuprofen		Hydrocodone Bitartrate and Ibuprofen	TABLET	ORAL	20100218		ANDA	ANDA076642	Amneal Pharmaceuticals of New York LLC	HYDROCODONE BITARTRATE; IBUPROFEN	5; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
53746-169_cf08de43-a887-40f3-a074-57ecc8d3093a	53746-169	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine	TABLET, FILM COATED	ORAL	20150430		ANDA	ANDA090041	Amneal Pharmaceuticals of New York LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
53746-173_cf08de43-a887-40f3-a074-57ecc8d3093a	53746-173	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine	TABLET, FILM COATED	ORAL	20150430		ANDA	ANDA090041	Amneal Pharmaceuticals of New York LLC	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
53746-188_a107976d-f1e2-4d47-b1e0-5b961c1c8d2d	53746-188	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Amneal Pharmaceuticals of New York LLC	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-189_a107976d-f1e2-4d47-b1e0-5b961c1c8d2d	53746-189	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Amneal Pharmaceuticals of New York LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-190_a107976d-f1e2-4d47-b1e0-5b961c1c8d2d	53746-190	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Amneal Pharmaceuticals of New York LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-191_9cc39ab5-450a-4e0b-948d-fdebd66c0f6f	53746-191	HUMAN OTC DRUG	Naproxen Sodium (NSAID)	Fever Reducer/ Pain Reliever	Naproxen Sodium	TABLET	ORAL	20091125		ANDA	ANDA079096	Amneal Pharmaceuticals of New York LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-192_9cc39ab5-450a-4e0b-948d-fdebd66c0f6f	53746-192	HUMAN OTC DRUG	Naproxen Sodium (NSAID)	Fever Reducer/ Pain Reliever	Naproxen Sodium	TABLET	ORAL	20091125		ANDA	ANDA079096	Amneal Pharmaceuticals of New York LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-193_823ef251-7e4a-48c7-8bb1-9b73b8c6f420	53746-193	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20070426		ANDA	ANDA078432	Amneal Pharmaceuticals of New York LLC	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-194_823ef251-7e4a-48c7-8bb1-9b73b8c6f420	53746-194	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20070426		ANDA	ANDA078432	Amneal Pharmaceuticals of New York LLC	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-218_b54ea950-c304-4247-8492-b0db96fca81f	53746-218	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	Amneal Pharmaceuticals of New York LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
53746-219_b54ea950-c304-4247-8492-b0db96fca81f	53746-219	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	Amneal Pharmaceuticals of New York LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
53746-220_b54ea950-c304-4247-8492-b0db96fca81f	53746-220	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	Amneal Pharmaceuticals of New York LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
53746-226_1df433e4-8372-4d77-81a0-50e718f5f822	53746-226	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	INSERT	VAGINAL	20150607		ANDA	ANDA205256	Amneal Pharmaceuticals of New York LLC	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
53746-248_acd7e4c4-f9c9-4dae-b42e-e25622de9921	53746-248	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride		Alosetron Hydrochloride	TABLET, FILM COATED	ORAL	20230906		ANDA	ANDA206647	Amneal Pharmaceuticals of New York LLC	ALOSETRON HYDROCHLORIDE	.5	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53746-249_acd7e4c4-f9c9-4dae-b42e-e25622de9921	53746-249	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride		Alosetron Hydrochloride	TABLET, FILM COATED	ORAL	20230906		ANDA	ANDA206647	Amneal Pharmaceuticals of New York LLC	ALOSETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
53746-253_8625e9c6-6542-43d2-a657-34161884a7d0	53746-253	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20091216		ANDA	ANDA077824	Amneal Pharmaceuticals of New York LLC	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53746-254_8625e9c6-6542-43d2-a657-34161884a7d0	53746-254	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20091216		ANDA	ANDA077824	Amneal Pharmaceuticals of New York LLC	RANITIDINE HYDROCHLORIDE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53746-271_051f48dd-067b-4b1f-a737-938fae54a006	53746-271	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100225		ANDA	ANDA076899	Amneal Pharmaceuticals of New York LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
53746-272_051f48dd-067b-4b1f-a737-938fae54a006	53746-272	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	Amneal Pharmaceuticals of New York LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
53746-291_77cf7b02-2f68-41ff-be0d-8ad569613822	53746-291	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160925		ANDA	ANDA204415	Amneal Pharmaceuticals of New York LLC	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53746-292_77cf7b02-2f68-41ff-be0d-8ad569613822	53746-292	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160925		ANDA	ANDA204415	Amneal Pharmaceuticals of New York LLC	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53746-293_77cf7b02-2f68-41ff-be0d-8ad569613822	53746-293	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160925		ANDA	ANDA204415	Amneal Pharmaceuticals of New York LLC	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53746-361_298543d1-a6a0-4a7d-82ae-bcecc0f737fc	53746-361	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20220307		ANDA	ANDA040625	Amneal Pharmaceuticals of New York LLC	FOLIC ACID	1	mg/1			N	20241231
53746-441_8d286aaf-5d6c-4d69-8e97-1f3f8f027027	53746-441	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220422		ANDA	ANDA201451	Amneal Pharmaceuticals of New York LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
53746-442_8d286aaf-5d6c-4d69-8e97-1f3f8f027027	53746-442	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220422		ANDA	ANDA201451	Amneal Pharmaceuticals of New York LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
53746-458_0a178197-17b9-4e74-a85b-abd0ba469966	53746-458	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20130430		ANDA	ANDA079233	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-460_0a178197-17b9-4e74-a85b-abd0ba469966	53746-460	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20130430		ANDA	ANDA079233	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-462_0a178197-17b9-4e74-a85b-abd0ba469966	53746-462	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20130430		ANDA	ANDA079233	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-464_13cf50be-6a31-45d1-a314-98d23e4ee7ec	53746-464	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-465_13cf50be-6a31-45d1-a314-98d23e4ee7ec	53746-465	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-466_13cf50be-6a31-45d1-a314-98d23e4ee7ec	53746-466	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Amneal Pharmaceuticals of New York LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53746-511_7de11f5c-2350-4278-88dd-a7623e0f4cd0	53746-511	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53746-514_7de11f5c-2350-4278-88dd-a7623e0f4cd0	53746-514	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53746-515_7de11f5c-2350-4278-88dd-a7623e0f4cd0	53746-515	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
53746-521_eb9e03f5-1fa6-4b8a-9066-dc8bcbe9f476	53746-521	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20220622		ANDA	ANDA091179	Amneal Pharmaceuticals of New York LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53746-522_eb9e03f5-1fa6-4b8a-9066-dc8bcbe9f476	53746-522	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20220622		ANDA	ANDA091179	Amneal Pharmaceuticals of New York LLC	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53746-540_b0e32570-da9f-4fa8-a0a2-0334fce7ff7a	53746-540	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20100218		ANDA	ANDA078218	Amneal Pharmaceuticals of New York LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53746-541_b0e32570-da9f-4fa8-a0a2-0334fce7ff7a	53746-541	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20100218		ANDA	ANDA078218	Amneal Pharmaceuticals of New York LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
53746-542_1ea3fb2d-0e9d-41d9-8d24-e8d4327e62c6	53746-542	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20130222		ANDA	ANDA202128	Amneal Pharmaceuticals of New York LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
53746-544_ac6a300f-94ee-4b1c-9aaf-bce9b2c7781c	53746-544	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20091224		ANDA	ANDA040866	Amneal Pharmaceuticals of New York LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53746-545_ac6a300f-94ee-4b1c-9aaf-bce9b2c7781c	53746-545	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20091224		ANDA	ANDA040866	Amneal Pharmaceuticals of New York LLC	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53746-553_b3ba9f93-52d6-4287-9e28-92059e0bf18b	53746-553	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20130531		ANDA	ANDA203399	Amneal Pharmaceuticals of New York LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
53746-554_bd37276e-8e9f-48ec-9565-a83a5a4f9aea	53746-554	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline	TABLET	ORAL	20220525		ANDA	ANDA065425	Amneal Pharmaceuticals of New York LLC	DEMECLOCYCLINE HYDROCHLORIDE	150	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
53746-555_bd37276e-8e9f-48ec-9565-a83a5a4f9aea	53746-555	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline	TABLET	ORAL	20220525		ANDA	ANDA065425	Amneal Pharmaceuticals of New York LLC	DEMECLOCYCLINE HYDROCHLORIDE	300	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
53746-571_cca0bc22-27f5-4146-a6e2-af25b814d7df	53746-571	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20220415		ANDA	ANDA040855	Amneal Pharmaceuticals of New York LLC	BETHANECHOL CHLORIDE	5	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
53746-572_cca0bc22-27f5-4146-a6e2-af25b814d7df	53746-572	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20220415		ANDA	ANDA040855	Amneal Pharmaceuticals of New York LLC	BETHANECHOL CHLORIDE	10	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
53746-573_cca0bc22-27f5-4146-a6e2-af25b814d7df	53746-573	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20220415		ANDA	ANDA040855	Amneal Pharmaceuticals of New York LLC	BETHANECHOL CHLORIDE	25	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
53746-574_cca0bc22-27f5-4146-a6e2-af25b814d7df	53746-574	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20220415		ANDA	ANDA040855	Amneal Pharmaceuticals of New York LLC	BETHANECHOL CHLORIDE	50	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
53746-590_4daaf871-3ef0-4dea-b140-e67573ea5e9b	53746-590	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20141008		ANDA	ANDA201658	Amneal Pharmaceuticals of New York LLC	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
53746-617_56d377a8-e63b-458d-b30b-56160ce8de8e	53746-617	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET	ORAL	20091217		ANDA	ANDA090485	Amneal Pharmaceuticals of New York LLC	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
53746-641_fe4cd965-0740-40bc-a301-26e337c8406e	53746-641	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20091201		ANDA	ANDA075442	Amneal Pharmaceuticals of New York LLC	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
53746-642_fe4cd965-0740-40bc-a301-26e337c8406e	53746-642	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20091201		ANDA	ANDA075442	Amneal Pharmaceuticals of New York LLC	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
53746-643_fe4cd965-0740-40bc-a301-26e337c8406e	53746-643	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20091201		ANDA	ANDA075442	Amneal Pharmaceuticals of New York LLC	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
53746-669_90f5d871-9db1-4ca1-93c5-781932fb41d7	53746-669	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20091201		ANDA	ANDA075047	Amneal Pharmaceuticals of New York LLC	ACEBUTOLOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53746-670_90f5d871-9db1-4ca1-93c5-781932fb41d7	53746-670	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20091201		ANDA	ANDA075047	Amneal Pharmaceuticals of New York LLC	ACEBUTOLOL HYDROCHLORIDE	400	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
53746-711_bd665bca-22a6-4ebe-8a61-f47ce397e7f3	53746-711	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20220415		ANDA	ANDA075109	Amneal Pharmaceuticals of New York LLC	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53746-713_bd665bca-22a6-4ebe-8a61-f47ce397e7f3	53746-713	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20220415		ANDA	ANDA075109	Amneal Pharmaceuticals of New York LLC	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
53746-734_a979682b-bb8c-4ba1-8373-3170967a2125	53746-734	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20220810		ANDA	ANDA201680	Amneal Pharmaceuticals of New York LLC	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53746-735_a979682b-bb8c-4ba1-8373-3170967a2125	53746-735	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20220810		ANDA	ANDA201680	Amneal Pharmaceuticals of New York LLC	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
53746-745_eb9e03f5-1fa6-4b8a-9066-dc8bcbe9f476	53746-745	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20220622		ANDA	ANDA091179	Amneal Pharmaceuticals of New York LLC	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
53746-751_a5681c1e-2eeb-4cc4-981e-799ecf823405	53746-751	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA076820	Amneal Pharmaceuticals of New York LLC	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
53746-752_a5681c1e-2eeb-4cc4-981e-799ecf823405	53746-752	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA076820	Amneal Pharmaceuticals of New York LLC	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
53746-753_a5681c1e-2eeb-4cc4-981e-799ecf823405	53746-753	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA076820	Amneal Pharmaceuticals of New York LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
53746-754_a5681c1e-2eeb-4cc4-981e-799ecf823405	53746-754	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20220926		ANDA	ANDA076820	Amneal Pharmaceuticals of New York LLC	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
53746-837_c858d258-1dad-4407-be52-947e2f9b2dc7	53746-837	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20230801		ANDA	ANDA204011	Amneal Pharmaceuticals of New York LLC	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53746-838_c858d258-1dad-4407-be52-947e2f9b2dc7	53746-838	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20230801		ANDA	ANDA204011	Amneal Pharmaceuticals of New York LLC	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53746-839_c858d258-1dad-4407-be52-947e2f9b2dc7	53746-839	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20230801		ANDA	ANDA204011	Amneal Pharmaceuticals of New York LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53746-840_c858d258-1dad-4407-be52-947e2f9b2dc7	53746-840	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20221010		ANDA	ANDA204011	Amneal Pharmaceuticals of New York LLC	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
53746-845_1ed15f09-2051-401f-a320-5f04b85ac8e2	53746-845	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals of New York LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53746-846_1ed15f09-2051-401f-a320-5f04b85ac8e2	53746-846	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals of New York LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53746-847_1ed15f09-2051-401f-a320-5f04b85ac8e2	53746-847	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals of New York LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53746-848_1ed15f09-2051-401f-a320-5f04b85ac8e2	53746-848	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals of New York LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53746-849_1ed15f09-2051-401f-a320-5f04b85ac8e2	53746-849	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals of New York LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
53746-923_5c54cea8-fde5-41f4-a94b-03b910685b3d	53746-923	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230517		ANDA	ANDA204857	Amneal Pharmaceuticals of New York LLC	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
53746-924_5c54cea8-fde5-41f4-a94b-03b910685b3d	53746-924	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230517		ANDA	ANDA204857	Amneal Pharmaceuticals of New York LLC	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
53746-925_5c54cea8-fde5-41f4-a94b-03b910685b3d	53746-925	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230517		ANDA	ANDA204857	Amneal Pharmaceuticals of New York LLC	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
53746-926_5c54cea8-fde5-41f4-a94b-03b910685b3d	53746-926	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230517		ANDA	ANDA204857	Amneal Pharmaceuticals of New York LLC	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
53755-100_0be8bf72-ed3d-549e-e063-6294a90a64fe	53755-100	HUMAN OTC DRUG	SERIOUS SKINCARE SERIOUS-C3 PLASMA TM BIO TECHNOLOGY C VITAMIN C ESTER PROTECTIVE DAYTIME BROAD SPECTRUM MOISTURIZER SPF 30		AVOBENZONE, OCTOCRYLENE, OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20211201		OTC MONOGRAPH DRUG	M020	Flageoli Limited	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 75; 50; 27; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53755-101_0c5b602d-b968-ffad-e063-6294a90a4eee	53755-101	HUMAN OTC DRUG	SERIOUS SKINCARE SERIOUS C3 PLASMA BIO TECHNOLOGY C VITAMIN C ESTER PROTECTIVE DAYTIME BROAD SPECTRUM MOISTURIZER SPF 30		AVOBENZONE, OCTOCRYLENE, OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	Flageoli Limited	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 75; 50; 27; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53755-110_0c5b904e-58b0-3a41-e063-6294a90a5d88	53755-110	HUMAN OTC DRUG	Serious Skincare Continuously Clear Acne Medication For Problematic skin Dry Lo Pro All- Over Treatment		SALICYLIC ACID	LOTION	TOPICAL	20180601		OTC MONOGRAPH DRUG	M006	Flageoli Limited	SALICYLIC ACID	10	mg/mL			N	20241231
53755-392_0973bc65-d2d5-0fef-e063-6294a90a1290	53755-392	HUMAN OTC DRUG	SERIOUS SKINCARE Continuously Clear Clearz It		BENZOYL PEROXIDE	CREAM	TOPICAL	20230227		OTC MONOGRAPH DRUG	M006	Flageoli Limited	BENZOYL PEROXIDE	50	mg/mL			N	20241231
53777-001_0761d577-ec35-6627-e063-6394a90a40f0	53777-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19791101		NDA	NDA205865	Thompson Brothers Supplies Inc	OXYGEN	990	mL/L			N	20241231
53799-241_ccfe0de7-b1eb-4fee-8aa3-65470fa5e2c9	53799-241	HUMAN OTC DRUG	Nasal Allergy Relief		cardiospermum halicacabum flowering top, galphimia glauca flowering top, luffa operculata fruit and schoenocaulon officinale seed	SPRAY	NASAL	20210426		UNAPPROVED HOMEOPATHIC		Similasan AG	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
53799-245_57bf80df-3d41-45bc-9e70-febf2f6e157a	53799-245	HUMAN OTC DRUG	Kids Nasal Allergy Relief		cardiospermum halicacabum flowering top, galphimia glauca flowering top, luffa operculata fruit and schoenocaulon officinale seed	SPRAY	NASAL	20210423		UNAPPROVED HOMEOPATHIC		Similasan AG	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
53799-266_89087072-198c-4897-8ca0-eb1f5fa00715	53799-266	HUMAN OTC DRUG	Kids Cold and Mucus Relief Plus Echinacea		atropa belladonna, drosera rotundifolia flowering top, echinacea pallida, prunus laurocerasus leaf, rumex crispus root, linum catharticum, verbascum thapsus and zinc	SYRUP	ORAL	20160201		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; DROSERA ROTUNDIFOLIA FLOWERING TOP; ECHINACEA PALLIDA; LINUM CATHARTICUM; PRUNUS LAUROCERASUS LEAF; RUMEX CRISPUS ROOT; VERBASCUM THAPSUS; ZINC	6; 4; 6; 6; 4; 4; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
53799-275_ff025d2a-57e4-41b9-b720-80ccb5e9dfc1	53799-275	HUMAN OTC DRUG	Ear Ringing Remedy		ALLYLTHIOUREA, ARNICA MONTANA FLOWER, CALCIUM SULFIDE, ERIODICTYON CALIFORNICUM LEAF, LACHESIS MUTA VENOM, LYCOPODIUM CLAVATUM SPORE, QUININE SULFATE, SILICA DIMETHYL SILYLATE	SOLUTION	AURICULAR (OTIC)	20210309		UNAPPROVED HOMEOPATHIC		Similasan AG	ALLYLTHIOUREA; ARNICA MONTANA FLOWER; CALCIUM SULFIDE; ERIODICTYON CALIFORNICUM LEAF; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; QUININE SULFATE; SILICA DIMETHYL SILYLATE	15; 15; 12; 12; 15; 12; 12; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL	Antimalarial [EPC]		N	20241231
53799-277_05097b5f-5334-465d-89b1-53c1dd6f0ef0	53799-277	HUMAN OTC DRUG	Earache Relief		Chamomilla and Mercurius Solubilis and Sulphur	SOLUTION	AURICULAR (OTIC)	20130702		UNAPPROVED HOMEOPATHIC		Similasan AG	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-278_340c26fe-613c-435b-89e7-d3a3d09c7e9e	53799-278	HUMAN OTC DRUG	Swimmers Ear Relief Ear Drops		ANEMONE PULSATILLA, GRAPHITE and SULFUR	LIQUID	AURICULAR (OTIC)	20201215		UNAPPROVED HOMEOPATHIC		Similasan AG	ANEMONE PULSATILLA; GRAPHITE; SULFUR	12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
53799-279_17164dc7-5682-4275-9b5a-a3c00cbac91b	53799-279	HUMAN OTC DRUG	Kids Earache Relief		Matricaria recutita, Mercurius Solubilis, Anemone patens and Sulphur	SOLUTION	AURICULAR (OTIC)	20180720		UNAPPROVED HOMEOPATHIC		Similasan AG	MATRICARIA CHAMOMILLA; MERCURIUS SOLUBILIS; PULSATILLA PATENS WHOLE; SULFUR	10; 15; 12; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-300_0e1c06e0-df5f-4a0c-894c-70f1517dc891	53799-300	HUMAN OTC DRUG	Dry Eye Relief		Atropa Belladonna and Euphrasia Stricta and Mercuric Chloride	SOLUTION/ DROPS	OPHTHALMIC	20201002		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/.4mL; [hp_X]/.4mL; [hp_X]/.4mL			N	20241231
53799-301_b2baf22b-43da-4c6a-a1c2-a147e0730cfd	53799-301	HUMAN OTC DRUG	Allergy Eye Relief		apis mellifera, euphrasia stricta, schoenocaulon officinale seed	SOLUTION/ DROPS	OPHTHALMIC	20150413		UNAPPROVED HOMEOPATHIC		Similasan AG	APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
53799-302_0064fc96-86a7-4154-8ff1-d1744c015300	53799-302	HUMAN OTC DRUG	Allergy Eye Relief		apis mellifera, euphrasia stricta and schoenocaulon officinale seed	SOLUTION/ DROPS	OPHTHALMIC	20200928		UNAPPROVED HOMEOPATHIC		Similasan AG	APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
53799-304_76316dee-cf92-4387-bbfd-98c1e1e6463d	53799-304	HUMAN OTC DRUG	Computer Eye Relief		Conium maculatum and Natrium muriaticum and Ruta graveolens and Senega officinalis	SOLUTION/ DROPS	OPHTHALMIC	20130702		UNAPPROVED HOMEOPATHIC		Similasan AG	CONIUM MACULATUM FLOWERING TOP; POLYGALA SENEGA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE	6; 6; 6; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
53799-305_249ba992-b0e3-4edc-b16a-a50a689b29fe	53799-305	HUMAN OTC DRUG	Stye Eye Relief		conium maculatum flowering top, graphite and sulfur	SOLUTION/ DROPS	OPHTHALMIC	20050102		UNAPPROVED HOMEOPATHIC		Similasan AG	CONIUM MACULATUM FLOWERING TOP; GRAPHITE; SULFUR	6; 12; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-360_c005cbfd-1f01-4250-86b2-6a87100049f2	53799-360	HUMAN OTC DRUG	Aging Eye Relief		jacobaea maritima, sodium chloride and ruta graveolens flowering top	SOLUTION/ DROPS	OPHTHALMIC	20140401		UNAPPROVED HOMEOPATHIC		Similasan AG	JACOBAEA MARITIMA; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE	6; 6; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-364_0d3bcaff-c07c-45bd-bfc9-108a1bf97d3c	53799-364	HUMAN OTC DRUG	Allergy Eye Relief		apis mellifera, euphrasia stricta, schoenocaulon officinale seed	SOLUTION/ DROPS	OPHTHALMIC	20150413		UNAPPROVED HOMEOPATHIC		Similasan AG	APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
53799-365_7ecf2ebc-817d-4d47-8578-a24a427bb973	53799-365	HUMAN OTC DRUG	Pink Eye Relief		Belladonna, Euphrasia officinalis, Hepar sulphuris	SOLUTION/ DROPS	OPHTHALMIC	20170201		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA	6; 12; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-368_2f17982f-cc1c-41b3-a821-b35c46e7c6ef	53799-368	HUMAN OTC DRUG	Kids Pink Eye Relief		ATROPA BELLADONNA, CALCIUM SULFIDE, EUPHRASIA STRICTA and PLATYCLADUS ORIENTALIS LEAF	LIQUID	OPHTHALMIC	20181115		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA; PLATYCLADUS ORIENTALIS LEAF	6; 12; 6; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-373_1dab3ccb-847f-449a-8046-6973239b1704	53799-373	HUMAN OTC DRUG	Complete Eye Relief		atropa belladonna, euphrasia stricta and mercuric chloride	SOLUTION/ DROPS	OPHTHALMIC	20190215		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-375_85063ea9-a792-4b98-8fd6-e6932f0053ab	53799-375	HUMAN OTC DRUG	Dry Eye Relief		atropa belladonna, euphrasia stricta and mercuric chloride	SOLUTION/ DROPS	OPHTHALMIC	20190215		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-376_a83108d4-24e4-490f-8f88-e30e854f7b57	53799-376	HUMAN OTC DRUG	Dry Eye Relief Trial Size 15x		Belladonna, Euphrasia officinalis, Mercurius sublimatus,	SOLUTION/ DROPS	OPHTHALMIC	20210708		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-377_00975ca5-68a4-48bc-86b3-fe5aef463a32	53799-377	HUMAN OTC DRUG	Pink Eye Nighttime		Belladonna, Euphrasia officinalis, Hepar sulphuris	GEL	OPHTHALMIC	20201109		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA	6; 12; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-400_c60421df-3235-4884-ac65-4ff6a64faf2b	53799-400	HUMAN OTC DRUG	Walgreens Allergy Eye		apis mellifera, euphrasia stricta and schoenocaulon officinale seed	SOLUTION/ DROPS	OPHTHALMIC	20180601		UNAPPROVED HOMEOPATHIC		Similasan AG	APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
53799-401_d1412036-e8c6-4e59-9395-4b182fec0031	53799-401	HUMAN OTC DRUG	Waldo Hydration Drops		conium maculatum flowering top, polygala senega root, ruta graveolens flowering top and sodium chloride	LIQUID	OPHTHALMIC	20200929		UNAPPROVED HOMEOPATHIC		Similasan AG	CONIUM MACULATUM FLOWERING TOP; POLYGALA SENEGA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE	6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
53799-402_bd49222f-e7d3-43b6-b238-a4fbb0084a4a	53799-402	HUMAN OTC DRUG	Pink Eye		ATROPA BELLADONNA, EUPHRASIA STRICTA, CALCIUM SULFIDE	SOLUTION/ DROPS	OPHTHALMIC	20190215		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA	6; 12; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-403_b8d4f292-5f4c-40fc-b744-d1fda13e2c4f	53799-403	HUMAN OTC DRUG	Pink Eye Remedy		ATROPA BELLADONNA, CALCIUM SULFIDE, EUPHRASIA STRICTA	SOLUTION/ DROPS	OPHTHALMIC	20071201		UNAPPROVED HOMEOPATHIC		Similasan AG	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA	6; 12; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-404_72c052b6-a99c-462e-bdf3-73cdc6b0c44f	53799-404	HUMAN OTC DRUG	Walgreens Stye Eye Relief		GRAPHITE, SULFUR, CONIUM MACULATUM	SOLUTION/ DROPS	OPHTHALMIC	20190601		UNAPPROVED HOMEOPATHIC		Similasan AG	CONIUM MACULATUM FLOWERING TOP; GRAPHITE; SULFUR	6; 12; 12	[hp_C]/10mL; [hp_C]/10mL; [hp_C]/10mL			N	20241231
53799-405_89edf769-8377-4ab3-bd37-5f12a07ac7ee	53799-405	HUMAN OTC DRUG	Earache Drops		Chamomilla, Mercurius Solubilis and Sulphur	SOLUTION/ DROPS	AURICULAR (OTIC)	20210916		UNAPPROVED HOMEOPATHIC		Similasan AG	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-406_fba5174b-c137-4448-a71d-c45e00f9deb2	53799-406	HUMAN OTC DRUG	Earache Relief		Chamomilla and Mercurius Solubilis and Sulphur	SOLUTION	AURICULAR (OTIC)	20230403		UNAPPROVED HOMEOPATHIC		Similasan AG	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
53799-500_1f82aafc-a51d-43f3-b456-a2e022c75fa2	53799-500	HUMAN OTC DRUG	Kids Allergy Eye Relief		Apis and Euphrasia and Pulsatilla and Sabadilla	SOLUTION/ DROPS	OPHTHALMIC	20200928		UNAPPROVED HOMEOPATHIC		Similasan AG	APIS MELLIFERA; EUPHRASIA STRICTA; PULSATILLA VULGARIS; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
53809-201_ead5f038-87c6-4935-87e7-60e0f26658ec	53809-201	HUMAN OTC DRUG	DOMETUSS-DM		GUAIFENESIN, DEXTROMETHORPHAN HBr	LIQUID	ORAL	20160121		OTC MONOGRAPH FINAL	part341	Domel Laboratories	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 200	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53809-202_6db8a77f-ba8d-419c-8999-6ca93ab9a919	53809-202	HUMAN OTC DRUG	DOMETUSS		chlorpheniramine maleate, dextromethorphan hydrobromide, and phenylephrine hydrochloride	SYRUP	ORAL	20150801		OTC MONOGRAPH FINAL	part341	Domel Laboratories	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 20; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53809-203_c16cfa01-24f0-46ba-982b-d308f48ae669	53809-203	HUMAN OTC DRUG	DOMETUSS-DMX		GUAIFENESIN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20160121		OTC MONOGRAPH FINAL	part341	Domel Laboratories	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	30; 200; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53809-206_0a1b6678-feef-4381-ad56-c5023e5c7f79	53809-206	HUMAN OTC DRUG	DOMETUSS-DA		CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20160121		OTC MONOGRAPH FINAL	part341	Domel Laboratories	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	1; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53809-240_a0119974-f4dc-4a21-8934-6a4b74f578e3	53809-240	HUMAN OTC DRUG	DOMETUSS-NR		DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20160121		OTC MONOGRAPH FINAL	part341	Domel Laboratories	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53809-250_dc4a9eb6-1eb6-46ed-b51d-ef80ec05e694	53809-250	HUMAN OTC DRUG	DOMETUSS-G		GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20191111		OTC MONOGRAPH FINAL	part341	DOMEL	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53835-001_0d1bf27a-4c74-56c6-e063-6394a90a04e3	53835-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091030		UNAPPROVED MEDICAL GAS		Heckman Healthcare Service & Supplies Inc.	OXYGEN	99	L/100L			N	20241231
53854-123_0bf2ddb2-5d5e-1839-e063-6294a90ad075	53854-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Friendship Home Health Inc.	OXYGEN	99	L/100L			N	20241231
53863-002_f925809f-5497-97f3-e053-6294a90a94b4	53863-002	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333A	Exelencia Importers, Corp.	ALCOHOL	70	mL/100mL			N	20241231
53863-003_f925809f-5496-97f3-e053-6294a90a94b4	53863-003	HUMAN OTC DRUG	Silk Line Silk Day Cream SPF 15		Octinoxate, Octocrylene, Octisalate	CREAM	TOPICAL	20201026		OTC MONOGRAPH FINAL	part352	Exelencia Importers, Corp.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	7.5; 2; 7	g/100mL; g/100mL; g/100mL			N	20241231
53863-125_f9257df8-c7c4-984e-e053-6294a90ab51e	53863-125	HUMAN OTC DRUG	Exel Clarifying Line	SPF 50	Octinoxate, Octocrylene, Oxybenzone, Tatanium Dioxide	CREAM	TOPICAL	20150514		OTC MONOGRAPH FINAL	part352	Exelencia importers	OCTINOXATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	7.5; 8; 3; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
53877-001_05957b63-ef61-4c95-b683-7bb697ae2a89	53877-001	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)		Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)	SOLUTION	INTRAVENOUS	20120522		NDA	BN820528	Terumo Corporation	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.275; 2.99; 31.9; 2.22; 26.3	g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53877-001_c4dc38da-cec1-48d4-9d6e-7169bf486248	53877-001	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)		Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)	SOLUTION	INTRAVENOUS	20091214		NDA	BN820528	Terumo Corporation	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.275; 2.99; 31.9; 2.22; 26.3	g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53877-001_ddc359d4-cffe-4f5c-8265-7e3893086d97	53877-001	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)		Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)	SOLUTION	INTRAVENOUS	20091210		NDA	BN820528	Terumo Corporation	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.275; 2.99; 31.9; 2.22; 26.3	g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53877-001_fcf4b978-3a77-440f-b93a-e92dc9d4dce5	53877-001	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)		Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)	SOLUTION	INTRAVENOUS	20091118		NDA	BN820528	Terumo Corporation	ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	.275; 2.99; 31.9; 2.22; 26.3	g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53877-005_4a524a51-df6c-4cc7-8695-72e302a92474	53877-005	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100113		NDA	BN880217	Terumo Corporation						N	20241231
53877-005_77409641-424b-4d6d-8505-ac2fe4b5891d	53877-005	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20091215		NDA	BN880217	Terumo Corporation						N	20241231
53877-006_f19da384-0dda-4154-a2bc-5c0ca286ca27	53877-006	HUMAN PRESCRIPTION DRUG	IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100226		NDA	BN880217	Terumo Corporation						N	20241231
53877-007_f3094788-ddc7-4466-bc23-75841d3e0224	53877-007	HUMAN PRESCRIPTION DRUG	IMUFLEX WB-SP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) and OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) and AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20101215		NDA	BN880217	Terumo Corporation						N	20241231
53877-008_223f098a-ed15-410d-921e-c075c1330bd5	53877-008	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100505		NDA	BN880217	Terumo Corporation						N	20241231
53877-008_b01e998e-cd44-4e1f-87d9-4fa529e9338c	53877-008	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100505		NDA	BN880217	Terumo Corporation						N	20241231
53877-008_d0070ffb-d720-465b-b1e8-08e28559e5f4	53877-008	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100505		NDA	BN880217	Terumo Corporation						N	20241231
53877-008_d3569763-88f4-4bcd-b712-6217be0987d6	53877-008	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100505		NDA	BN880217	Terumo Corporation						N	20241231
53877-009_89f94557-3a16-4a36-9766-4d03d9defd79	53877-009	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System with Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100505		NDA	BN880217	Terumo Corporation						N	20241231
53877-009_a862126d-62f0-483a-acaa-00c2927f1a9d	53877-009	HUMAN PRESCRIPTION DRUG	TERUFLEX Blood Bag System with Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative		Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative	KIT	INTRAVENOUS	20100505		NDA	BN880217	Terumo Corporation						N	20241231
53877-010_dcde5c97-a5cb-43fb-b890-296a0a67b22f	53877-010	HUMAN PRESCRIPTION DRUG	imuflex wb-sp blood bag system with integral whole blood leukocyte reduction filter (saving platelets) with diversion blood sampling arm		Anticoagulant Citrate Phosphate Dextrose (CPD)	SOLUTION	INTRAVENOUS	20190211		NDA	BN880217	Terumo Corporation	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM; TRISODIUM CITRATE DIHYDRATE	209; 1.79; 156; 1.84	mg/70mL; g/70mL; mg/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
53897-000_0c83cb14-c7c3-3b79-e063-6394a90a4d77	53897-000	HUMAN OTC DRUG	Clinical Strength MiracleDry Antiperspirant Deodorant AM		ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	LIQUID	TOPICAL	20121015		OTC MONOGRAPH DRUG	M019	Highland Consumer Products	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	18	mg/mL			N	20241231
53897-001_0c5b6a69-0a65-0f46-e063-6294a90a4fca	53897-001	HUMAN OTC DRUG	Clinical Strength MiracleDry Antiperspirant Deodorant PM		ALUMINUM CHLORIDE	LIQUID	TOPICAL	20121015		OTC MONOGRAPH DRUG	M019	Highland Consumer Products	ALUMINUM CHLORIDE	12	mg/mL			N	20241231
53942-001_c6a41cd9-2073-6c85-e053-2995a90a3e00	53942-001	HUMAN OTC DRUG	SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20150128		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
53942-002_e3de3a3a-55c4-94a1-e053-2a95a90a9827	53942-002	HUMAN OTC DRUG	SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20120225		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
53942-003_621d9b46-bb50-4a62-b8e2-90072e4dccac	53942-003	HUMAN OTC DRUG	SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20160315		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53942-004_0c089f1e-59cc-4f78-826c-2fcb209b6e93	53942-004	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20130508		OTC MONOGRAPH FINAL	part355	Demoulas Super Markets, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
53942-005_9561f768-1264-40dd-b8c5-ca4d571580d2	53942-005	HUMAN OTC DRUG	SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20120309		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	10; 100; 50; 8; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53942-006_e3de44b9-bea6-33b7-e053-2a95a90a1a76	53942-006	HUMAN OTC DRUG	MARKET BASKET KIDS SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20120225		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
53942-007_e7182e12-6bf6-2581-e053-2a95a90afa31	53942-007	HUMAN OTC DRUG	Market Basket Continuous Sunscreen General Protection SPF 70		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
53942-008_f0dde904-ef53-f68d-e053-2995a90a7bb4	53942-008	HUMAN OTC DRUG	Market Basket Moisturizing Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
53942-009_f0e8fcdf-7679-11e1-e053-2995a90af244	53942-009	HUMAN OTC DRUG	Market Basket Moisturizing Sunscreen Broad Spectrum SPF 30		Avobenzone Homosalate Octocrylene	LOTION	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
53942-010_f4238118-f82b-19da-e053-2a95a90aa5f0	53942-010	HUMAN OTC DRUG	Market Basket Continuous Sunscreen SPF 50		Avobenzone Homosalate Octisalate Octocrylene	SPRAY	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	DEMOULAS SUPER MARKETS, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
53942-069_a79c9c5b-4f22-41bf-a223-1409433c1f50	53942-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	19890915		OTC MONOGRAPH FINAL	part347	Demoulas Supermarkets	PETROLATUM	1	g/g			N	20241231
53942-072_e8a77b74-238d-4cce-ad4a-f38c6788f778	53942-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL, Menthol, Methyl salicylate, thymol	MOUTHWASH	ORAL	20070330		OTC MONOGRAPH NOT FINAL	part348	Demoulas Super Markets	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53942-093_082a1e40-f3fa-9bcc-e063-6294a90a684b	53942-093	HUMAN OTC DRUG	Market Basket Menthol Cough Drops		Menthol	LOZENGE	ORAL	20210329		OTC MONOGRAPH DRUG	M012	DeMoulas	MENTHOL	5.4	mg/1			N	20241231
53942-094_082a261e-efc7-9323-e063-6294a90a3764	53942-094	HUMAN OTC DRUG	Market Basket Cherry Cough Drops		Menthol	LOZENGE	ORAL	20210331		OTC MONOGRAPH DRUG	M012	53942	MENTHOL	5.8	mg/1			N	20241231
53942-095_082a1cb5-808e-4b2e-e063-6394a90a62d8	53942-095	HUMAN OTC DRUG	Market Basket Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20210331		OTC MONOGRAPH DRUG	M012	DeMoulas	MENTHOL	7.5	mg/1			N	20241231
53942-119_0dabfb68-a823-5398-e063-6294a90aab91	53942-119	HUMAN OTC DRUG	Childrens Ibuprofen Oral Suspension		IBUPROFEN	SUSPENSION	ORAL	20190816		ANDA	ANDA210602	DEMOULAS SUPERMARKETS INC.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53942-153_9675eb5e-93ca-4404-87b7-06473ded54b8	53942-153	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH DRUG	M032	Demoulas Super Markets, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
53942-163_b219eab9-b352-42eb-8023-2a238c33067e	53942-163	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20060513		OTC MONOGRAPH FINAL	part355	Demoulas Super Markets, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
53942-203_ea23a104-e734-9a62-e053-2a95a90a9cb2	53942-203	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20221001		ANDA	ANDA213420	Demoulas Super Markets, Inc	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
53942-204_ea23a5a6-3f0f-41bb-e053-2a95a90a1f5c	53942-204	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20221001		ANDA	ANDA213420	Demoulas Super Markets, Inc	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
53942-213_e25764ff-e2ba-49f5-bf9f-dfc9d805b5fd	53942-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20210825		OTC MONOGRAPH FINAL	part355	DEMOULAS SUPER MARKETS, INC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
53942-253_7f344285-842c-4416-90aa-e97048ffa380	53942-253	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20180501		OTC MONOGRAPH DRUG	M032	DEMOULAS SUPER MARKETS, INC	PYRITHIONE ZINC	10	mg/mL			N	20241231
53942-281_dc792e81-bce9-4e5d-ac5e-c74a4b389f1c	53942-281	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20090130		OTC MONOGRAPH DRUG	M032	Demoulas Super Markets, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
53942-299_59c70e62-2b60-4484-8ba8-a76b80da6309	53942-299	HUMAN OTC DRUG	Antispetic		Cetylpyridinium chloride	LIQUID	ORAL	20120221		OTC MONOGRAPH NOT FINAL	part356	Demoulas Super Markets	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
53942-311_39cd2a52-1931-4558-aa41-6ccc542c1bbc	53942-311	HUMAN OTC DRUG	Dandruff		PYRITHIONE ZINC	LOTION/SHAMPOO	TOPICAL	20090130		OTC MONOGRAPH DRUG	M032	Demoulas Super Markets, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
53942-318_74d9ea11-f3f3-439b-8cd3-3ea5863011e8	53942-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19900715		OTC MONOGRAPH NOT FINAL	part356	Demoulas Super Markets	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53942-370_49f9bb23-b402-4826-ae1e-1ca629f85c16	53942-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20151122		OTC MONOGRAPH NOT FINAL	part333A	Demoulas Super Markets, Inc	ALCOHOL	70	mL/100mL			N	20241231
53942-403_9c526cb3-c7ad-46f4-a344-a8653bf1c651	53942-403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	LIQUID	TOPICAL	20140828		OTC MONOGRAPH NOT FINAL	part333A	Demoulas Super Markets, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
53942-421_e15439c7-0e3d-7752-e053-2995a90a1a40	53942-421	HUMAN OTC DRUG	Market Basket Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20211022		OTC MONOGRAPH FINAL	part343	Demoulas Super Markets, Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53942-435_1b994030-0efc-4138-a17c-aabbd22cecc8	53942-435	HUMAN OTC DRUG	Glowing White		Sodium fluoride	MOUTHWASH	ORAL	20150729		OTC MONOGRAPH FINAL	part355	Demoulas Super Markets, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
53942-439_11422eea-928b-4af3-a07d-49f5ea81c5dc	53942-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20150624		OTC MONOGRAPH NOT FINAL	part333A	Demoulas Super Markets, Inc	ALCOHOL	70	mL/100mL			N	20241231
53942-466_d3f196c7-a61a-4fd5-86fe-7b282ab51897	53942-466	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20140601		OTC MONOGRAPH NOT FINAL	part333A	Demoulas Super Markets, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
53942-501_0dac168e-499b-525a-e063-6294a90a089a	53942-501	HUMAN OTC DRUG	NIGHT-TIME	MULTI-SYMPTOM COLD/FLU Original	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20121001		OTC MONOGRAPH DRUG	M013	DeMoulas Market Basket	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53942-502_c10720f3-54c8-43ad-b28a-941b3c557773	53942-502	HUMAN OTC DRUG	NIGHT-TIME	MULTI-SYMPTOM COLD/FLU Cherry	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20121001		OTC MONOGRAPH DRUG	M013	DeMoulas Market Basket	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53942-503_a8caafe0-3e94-4d99-9737-48765c546c17	53942-503	HUMAN OTC DRUG	Tussin DM	Cough and Chest Congestion	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	LIQUID	ORAL	20121001		OTC MONOGRAPH DRUG	M012	DeMoulas Market Basket	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53942-504_dd517595-1514-4f3e-8d62-81c3ad57270c	53942-504	HUMAN OTC DRUG	Tussin CF Multi-Symptom Cold		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20120920		OTC MONOGRAPH DRUG	M012	DeMoulas Market Basket	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53942-505_d2d346ad-05dc-4c5a-9cb0-559434b62f97	53942-505	HUMAN OTC DRUG	Childrens Allergy		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20120911		OTC MONOGRAPH DRUG	M009	DeMoulas Market Basket	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53942-506_ed7f1c85-7869-46c8-9f8f-3ba637f81b6e	53942-506	HUMAN OTC DRUG	DAY-TIME	Cold and Flu	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20120912		OTC MONOGRAPH DRUG	M013	DeMoulas Market Basket	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53942-515_b2c93822-291f-4839-a6fd-9b515a8965a9	53942-515	HUMAN OTC DRUG	Cold and Sinus	Maxium Strength	ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20130919		OTC MONOGRAPH DRUG	M012	DeMoulas Market Basket	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53942-516_b505e146-c5c6-4f36-8cbb-cb08c0940bcc	53942-516	HUMAN OTC DRUG	Cold, Flu and Sore Throat	Maxium Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20130919		OTC MONOGRAPH DRUG	M012	DeMoulas Market Basket	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53942-519_f129426c-0ac6-4791-8ee6-8745b8cb0965	53942-519	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20100901		OTC MONOGRAPH FINAL	part347	Demoulas Supermarkets, Inc	PETROLATUM	1000	mg/100g			N	20241231
53942-522_1e87d9fb-3c88-4c4e-8a3e-1c8b9458d6fa	53942-522	HUMAN OTC DRUG	Nighttime Sleep-Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20130919		OTC MONOGRAPH DRUG	M010	DeMoulas Market Basket	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53942-557_67d9d4ea-ca8d-4405-8437-578ca53ce0e9	53942-557	HUMAN OTC DRUG	Stomach Relief	Regular Strength	BISMUTH SUBSALICYLATE	SUSPENSION	ORAL	20181001		OTC MONOGRAPH DRUG	M008	Demoulas Super Markets Inc	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
53942-558_9c832971-fd38-4183-acd5-d520aae9c8f6	53942-558	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	BISMUTH SUBSALICYLATE	SUSPENSION	ORAL	20181001		OTC MONOGRAPH DRUG	M008	Demoulas Super Markets Inc	BISMUTH SUBSALICYLATE	1050	mg/30mL			N	20241231
53942-581_0e0e6d27-4f1c-44ed-8404-867c50f3ca58	53942-581	HUMAN OTC DRUG	Sodium fluoride		Sodium fluoride	MOUTHWASH	ORAL	20230605		OTC MONOGRAPH FINAL	part355	Demoulas Super Markets, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
53942-664_48be2952-162d-423b-a2fd-54186a853d74	53942-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19980315		OTC MONOGRAPH NOT FINAL	part356	Demoulas Super Markets, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53942-810_b1132720-1cb8-4fd2-b543-f74805fa060e	53942-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20031124		OTC MONOGRAPH NOT FINAL	part333A	DEMOULAS SUPER MARKETS, INC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53942-855_3018ba37-b809-4387-be42-10c75ea0f117	53942-855	HUMAN OTC DRUG	Eucalyptol, menthol, methyl salicylate, thymol		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20230605		OTC MONOGRAPH NOT FINAL	part356	Demoulas Super Markets, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53942-871_bd5236c5-774f-44c8-9a60-8c7527481411	53942-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Demoulas Super Markets, Inc	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
53942-971_9c168522-e9c6-4415-8b1b-a128f3699b95	53942-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20220404		OTC MONOGRAPH FINAL	part355	Demoulas	SODIUM FLUORIDE	.02	mg/mL			N	20241231
53943-002_f27a6799-e2f0-ee8d-e053-2a95a90aead1	53943-002	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171219		OTC MONOGRAPH FINAL	part358F	Discount Drug Mart	SALICYLIC ACID	40	mg/91			N	20241231
53943-003_f27a61cd-c616-ee8b-e053-2a95a90aec26	53943-003	HUMAN OTC DRUG	Lidocaine		Burn Relief	AEROSOL, SPRAY	TOPICAL	20171219		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53943-004_f27a6bf7-8935-7125-e053-2995a90ab4a3	53943-004	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20171219		OTC MONOGRAPH FINAL	part358F	Discount Drug Mart	SALICYLIC ACID	40	mg/41			N	20241231
53943-006_f19f09ad-d892-e3b5-6dff-4de270ec4194	53943-006	HUMAN OTC DRUG	Allergy Relief		Fluticasone Propionate	SPRAY, METERED	NASAL	20170703		ANDA	ANDA208150	Discount Drug Mart	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53943-007_f27a6799-e2ef-ee8d-e053-2a95a90aead1	53943-007	HUMAN OTC DRUG	Tolnafate		Foot Odor Control Spray	AEROSOL, POWDER	TOPICAL	20171219		OTC MONOGRAPH FINAL	part333C	Discount Drug Mart	TOLNAFTATE	1.3	g/113g			N	20241231
53943-009_f27974d4-460d-09d2-e053-2995a90a4ea4	53943-009	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20171219		OTC MONOGRAPH FINAL	part358B	Discount Drug Mart	SALICYLIC ACID	.17	mg/9mL			N	20241231
53943-016_0029ee94-3c34-42fb-982f-9baefdfe0b3b	53943-016	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	DISCOUNT DRUG MART	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53943-022_43048059-bf4e-48bf-b7bc-c7925349c630	53943-022	HUMAN OTC DRUG	Discount Drug Mart Vitamin E Hand Sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	20180209		OTC MONOGRAPH NOT FINAL	part333E	Discount Drug Mart	ALCOHOL	650	mg/mL			N	20241231
53943-029_082a581a-c7e2-e614-e063-6394a90a87da	53943-029	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20181008		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	MENTHOL	7.5	mg/1			N	20241231
53943-030_f27a6f8a-512a-7cf9-e053-2995a90a762d	53943-030	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief	SPRAY	TOPICAL	20130325		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-032_0d29bc02-e799-6633-e063-6394a90a2226	53943-032	HUMAN OTC DRUG	Discount Drug Mart Eye Drops Dry Eye Relief		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20230328		OTC MONOGRAPH DRUG	M018	Discount Drug Mart	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
53943-034_04dc4061-2994-aaad-e063-6294a90a4bc3	53943-034	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET, FILM COATED	ORAL	20230908		ANDA	ANDA216999	DISCOUNT DRUG MART, INC.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-035_b4d985d2-310e-413f-afa4-042c85e20099	53943-035	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	DISCOUNT DRUG MART	LORATADINE	10	mg/1			N	20241231
53943-062_0d29c98c-6cda-41ca-e063-6294a90a4587	53943-062	HUMAN OTC DRUG	Discount Drug Mart Eye Drops A.C.		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20230322		OTC MONOGRAPH DRUG	M018	Discount Drug Mart	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53943-070_08b6c9f1-a863-af96-e063-6294a90a94ff	53943-070	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20171102		OTC MONOGRAPH DRUG	M003	Discount Drug Mart	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53943-072_2c0dac13-c32b-489a-8bd7-db0b29b8491c	53943-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20211001		OTC MONOGRAPH NOT FINAL	part356	Discount Drug Mart	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53943-080_af0e5d46-a79e-55e8-e053-2995a90a8d10	53943-080	HUMAN OTC DRUG	LOW DOSE ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20111216		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53943-081_d20282b1-46c7-230e-e053-2a95a90ac0af	53943-081	HUMAN OTC DRUG	Enteric Coated Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20100118		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53943-090_94e2d20f-f41a-661c-e053-2995a90a8ba4	53943-090	HUMAN OTC DRUG	Allergy		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20071130		OTC MONOGRAPH FINAL	part341	Discount Drug Mart	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-091_08b6e47b-c31a-359f-e063-6294a90a062b	53943-091	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20171107		OTC MONOGRAPH DRUG	M003	Discount Drug Mart	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
53943-092_d2061013-cbbf-b03d-e053-2995a90aa57c	53943-092	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20080818		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	500	mg/1			N	20241231
53943-098_0ce5d04b-a561-4fe0-e063-6394a90a634b	53943-098	HUMAN OTC DRUG	DDM Ear Drops for Swimmers		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20080101		OTC MONOGRAPH DRUG	M014	Discount Drug Mart	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
53943-099_08b6c73d-16d8-03c3-e063-6294a90acc2c	53943-099	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20171024		OTC MONOGRAPH DRUG	M003	Discount Drug Mart	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
53943-100_92f4f2cc-b650-ccd7-7046-56974cf4fb70	53943-100	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20210101		ANDA	ANDA077367	Discount Drug Mart, Inc	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53943-101_92f4f2cc-b650-ccd7-7046-56974cf4fb70	53943-101	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20210101		ANDA	ANDA077367	Discount Drug Mart, Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
53943-102_06574e56-1398-a3af-e063-6394a90a4867	53943-102	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Menthol	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	MENTHOL	5.4	mg/1			N	20241231
53943-103_ea23950f-2502-70a3-e053-2a95a90a7641	53943-103	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET	ORAL	20221001		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	500	mg/1			N	20241231
53943-104_ea23a104-e71f-9a62-e053-2a95a90a9cb2	53943-104	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20221001		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	500	mg/1			N	20241231
53943-105_0ce5da4d-7ae7-57f3-e063-6394a90a2761	53943-105	HUMAN OTC DRUG	DDM Instant Antiseptic Pain Relief		Camphor 10.8% and Phenol 4.7%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Discount Drug Mart	CAMPHOR (NATURAL); PHENOL	108; 47	mg/mL; mg/mL			N	20241231
53943-107_ce8bf384-8e7e-4ddd-92bf-22adaa0bcf65	53943-107	HUMAN OTC DRUG	Multi Symptom	Antacid	Calcium carbonate ,Magnesium hydroxide,Simethicone	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH FINAL	part331	DISCOUNT DRUG MART	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	675; 60; 135	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-108_dcf029f0-3f56-4da5-b4e8-c5b8ba4ad0fe	53943-108	HUMAN OTC DRUG	Extra Strength Antacid	Freshmint	Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH FINAL	part331	DISCOUNT DRUG MART	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	675; 135	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-111_af0e20e2-d5fa-48cc-e053-2995a90a36e2	53943-111	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200301		ANDA	ANDA202312	DISCOUNT DRUG MART	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-112_af0e5d46-a788-55e8-e053-2995a90a8d10	53943-112	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200301		ANDA	ANDA202312	DISCOUNT DRUG MART	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-113_d202719b-791c-21d0-e053-2995a90a7a10	53943-113	HUMAN OTC DRUG	Allergy		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20071130		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-116_f1107c48-3f24-841d-e053-2995a90a6e68	53943-116	HUMAN OTC DRUG	Allergy Relief		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20210820		ANDA	ANDA202538	DISCOUNT DRUG MART, INC.	LORATADINE	10	mg/1			N	20241231
53943-119_548f3a20-1725-4384-907b-2b15e45f96e7	53943-119	HUMAN OTC DRUG	Childrens Ibuprofen Oral Suspension		IBUPROFEN	SUSPENSION	ORAL	20190816		ANDA	ANDA210602	Discount Drug Mart	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-120_f27a61cd-c618-ee8b-e053-2a95a90aec26	53943-120	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20180212		OTC MONOGRAPH FINAL	part333C	Discount Drug Mart	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53943-123_0ea718d4-6b56-b9ee-e063-6294a90a8111	53943-123	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Discount Drug Mart	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
53943-128_d202855d-3e0a-0a45-e053-2995a90a76d6	53943-128	HUMAN OTC DRUG	Nyt Time Sleep Caps		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20070627		OTC MONOGRAPH FINAL	part338	DISCOUNT DRUG MART	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-131_d20273fd-f7d2-3c31-e053-2a95a90a3868	53943-131	HUMAN OTC DRUG	Suphedrine PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20111206		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-138_e557c9bb-9aed-5ae1-e053-2995a90a7bdd	53943-138	HUMAN OTC DRUG	COLD MAX		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20091113		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-144_d202719b-7905-21d0-e053-2995a90a7a10	53943-144	HUMAN OTC DRUG	Naproxen		NAPROXEN SODIUM	TABLET, COATED	ORAL	20141028		ANDA	ANDA079096	DISCOUNT DRUG MART	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-145_d202719b-78f1-21d0-e053-2995a90a7a10	53943-145	HUMAN OTC DRUG	Naproxen		NAPROXEN SODIUM	TABLET, COATED	ORAL	20141028		ANDA	ANDA079096	DISCOUNT DRUG MART	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-146_d2027052-bb8e-ed80-e053-2a95a90ab83d	53943-146	HUMAN OTC DRUG	Adult Low Strength Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20100625		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53943-150_0668ddcc-0215-8e97-e063-6294a90a4f32	53943-150	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Honey Lemon	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	MENTHOL	7.5	mg/1			N	20241231
53943-152_ccc271cc-6ab3-f753-e053-2995a90a1161	53943-152	HUMAN OTC DRUG	Adult Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20210924		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53943-153_7dca933c-c9f5-488c-b97d-c7f12d888dde	53943-153	HUMAN OTC DRUG	Drug Mart Vegetable Laxative plus Stool Softener		Docusate sodium, Sennosides	TABLET	ORAL	20210720		OTC MONOGRAPH NOT FINAL	part334	Discount Drug Mart, Inc	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
53943-154_28346bcc-cc94-4241-935d-ccc05996d54f	53943-154	HUMAN OTC DRUG	Drug Mart Stool Softener plus Stimulant Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20210720		OTC MONOGRAPH NOT FINAL	part334	Discount Drug Mart, Inc	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
53943-157_8952522c-a742-4b17-bf59-445e3c11c7b3	53943-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20191022		OTC MONOGRAPH DRUG	M013	Discount Drug Mart	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53943-163_af0e39ce-4e0f-51a6-e053-2995a90a5944	53943-163	HUMAN OTC DRUG	COLD and FLU SEVERE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120119		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-166_42972f90-8e5b-4d65-835d-65c4fdd855b0	53943-166	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Discount Drug Mart	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-167_d202511f-8419-becc-e053-2995a90ac82f	53943-167	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20131111		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-170_ea2394e5-4dae-0d72-e053-2a95a90a1b25	53943-170	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20140516		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	500	mg/1			N	20241231
53943-174_e8b85dec-2695-4557-e053-2a95a90a4173	53943-174	HUMAN OTC DRUG	Pressure Pain and Cold Suphedrine PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140516	20240630	OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
53943-175_af0e28d7-0531-2c4d-e053-2995a90ad38e	53943-175	HUMAN OTC DRUG	COLD PLUS HEAD CONGESTION SEVERE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140516		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-176_f0fe6e6e-b412-dd9f-e053-2a95a90a5ec8	53943-176	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20181101		NDA	NDA021855	DISCOUNT DRUG MART, INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
53943-178_e5d2cae9-bf93-287b-e053-2995a90a7d40	53943-178	HUMAN OTC DRUG	Daytime Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140818		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-179_da537372-a936-4ef8-e053-2a95a90a7827	53943-179	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20181101		NDA	NDA021920	DISCOUNT DRUG MART, INC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-186_efced42c-c838-41b1-e053-2995a90aba0d	53943-186	HUMAN OTC DRUG	COLD AND FLU SEVERE		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20190501		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART						N	20241231
53943-191_d20273fd-f7e3-3c31-e053-2a95a90a3868	53943-191	HUMAN OTC DRUG	Rest Simply		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20100127		OTC MONOGRAPH FINAL	part338	DISCOUNT DRUG MART	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-193_c6f315a9-9341-db6c-e053-2a95a90a1b2f	53943-193	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20210706		ANDA	ANDA210722	DISCOUNT DRUG MART	LORATADINE	10	mg/1			N	20241231
53943-194_af0d3f87-af0b-23a5-e053-2995a90a338a	53943-194	HUMAN OTC DRUG	ALLERGY RELIEF		Cetirizine hydrochloride	TABLET, COATED	ORAL	20190117		ANDA	ANDA209274	DISCOUNT DRUG MART	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-197_efce7526-1a58-086d-e053-2995a90a3a4e	53943-197	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210201		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-198_efce7526-1a59-086d-e053-2995a90a3a4e	53943-198	HUMAN OTC DRUG	Mucus Relief Cold and Flu All in One		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210201		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-199_efb6c954-1414-b191-e053-2995a90af41a	53943-199	HUMAN OTC DRUG	Mucus Relief Sinus Pressure Pain and Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210201		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-200_af0d5b42-1ee0-6da4-e053-2a95a90a59df	53943-200	HUMAN OTC DRUG	Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200101		ANDA	ANDA211544	DISCOUNT DRUG MART	ACETAMINOPHEN	650	mg/1			N	20241231
53943-201_ea2394e5-4d99-0d72-e053-2a95a90a1b25	53943-201	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET	ORAL	20100105		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	325	mg/1			N	20241231
53943-202_0668498c-d936-82e2-e063-6294a90a8bcf	53943-202	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Cherry	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	MENTHOL	5.8	mg/1			N	20241231
53943-203_d2028e23-24b1-954f-e053-2a95a90a04de	53943-203	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET	ORAL	20140224		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	500	mg/1			N	20241231
53943-204_0ca9df6b-df27-4658-8c9d-751ceb61d820	53943-204	HUMAN OTC DRUG	Pseudoephedrine hydrochloride		Pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180302		ANDA	ANDA077442	DISCOUNT DRUG MART	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
53943-205_ccc274d9-98cf-3305-e053-2a95a90ad2a4	53943-205	HUMAN OTC DRUG	Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20210924		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53943-207_0ce5eb71-362b-4afa-e063-6394a90af577	53943-207	HUMAN OTC DRUG	DDM Decolorized Iodine		Ethyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Discount Drug Mart	ALCOHOL	.45	mL/mL			N	20241231
53943-212_f0d57297-0136-77c3-e053-2995a90a2292	53943-212	HUMAN OTC DRUG	IBUPROFEN		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190601		ANDA	ANDA078682	DISCOUNT DRUG MART, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-213_0ce5d2b3-ddbb-a886-e063-6294a90a1902	53943-213	HUMAN OTC DRUG	DDM Iodine Tincture Mild		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	19790101		OTC MONOGRAPH DRUG	M003	Discount Drug Mart	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
53943-214_f0d4e472-4a8c-6734-e053-2a95a90afffa	53943-214	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200721		ANDA	ANDA078682	DISCOUNT DRUG MART, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-219_f0ff6c1c-a2cf-11d1-e053-2a95a90adb24	53943-219	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20190802		NDA	NDA022429	DISCOUNT DRUG MART, INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-220_efb6ce7d-305f-160b-e053-2995a90a76fb	53943-220	HUMAN OTC DRUG	Sinus Pressure plus Pain PE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200901		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-228_af0e20e2-d5cd-48cc-e053-2995a90a36e2	53943-228	HUMAN OTC DRUG	ALLERGY MULTISYMPTOM		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20080909		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-239_e557ccba-53e4-81e4-e053-2a95a90aea9b	53943-239	HUMAN OTC DRUG	Cold Max Nighttime		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220803		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-250_2690d9b1-b70a-4185-8447-14f9acac9646	53943-250	HUMAN OTC DRUG	DOCUSATE SODIUM 100mg Two-Tone		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20191223		OTC MONOGRAPH NOT FINAL	part334	Discount Drug Mart, Inc	DOCUSATE SODIUM	100	mg/1			N	20241231
53943-253_0bf26f12-29f1-a471-e063-6294a90a4972	53943-253	HUMAN OTC DRUG	Discount Drug Mart Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101028		OTC MONOGRAPH DRUG	M031	Discount Drug Mart	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
53943-255_0c56c205-ac34-571d-e063-6294a90aacbd	53943-255	HUMAN OTC DRUG	Discount Lice Treatment		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20101028		OTC MONOGRAPH DRUG	M031	Discount drug mart						N	20241231
53943-256_87231460-8b29-b995-e053-2a91aa0a6c43	53943-256	HUMAN OTC DRUG	Discount Drug Mart Value Vapor Steam		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20111102		OTC MONOGRAPH FINAL	part341	Drug Mart	CAMPHOR (SYNTHETIC)	.623	g/10mL			N	20241231
53943-258_99fbc349-1974-36d2-e053-2995a90a10a6	53943-258	HUMAN OTC DRUG	Discount Drug Mart Extra Strength Itch Stopping		Diphenhydramine hydrochloride and Zinc acetate	CREAM	TOPICAL	20140317		OTC MONOGRAPH DRUG	M017	Discount Drug Mart	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-261_8748d13d-8634-6ab1-e053-2995a90a2580	53943-261	HUMAN OTC DRUG	Discount Drug Mart Regular Strength Itch Stopping		Diphenhydramine hydrochloride, Zinc acetate	CREAM	TOPICAL	20140317		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-262_0c42841c-9a73-1902-e063-6394a90ac45c	53943-262	HUMAN OTC DRUG	Discount Drug Mart Anti-Itch		Camphor, Menthol	LOTION	TOPICAL	20160414		OTC MONOGRAPH DRUG	M017	Discount Drug Mart	CAMPHOR (SYNTHETIC); MENTHOL	.5; .5	g/100g; g/100g			N	20241231
53943-265_0c530ae4-9788-7809-e063-6394a90a143d	53943-265	HUMAN OTC DRUG	Freds Medicated anti itch		Pramoxine hydrochloride, menthol	CREAM	TOPICAL	20140413		OTC MONOGRAPH DRUG	M017	Discount Drug Mart	MENTHOL; PRAMOXINE HYDROCHLORIDE	1; 1	g/100g; g/100g			N	20241231
53943-269_853ea48c-de95-ad1e-e053-2a91aa0a2401	53943-269	HUMAN OTC DRUG	Discount Drug Mart Anti-itch		HYDROCORTISONE	CREAM	TOPICAL	20130210		OTC MONOGRAPH NOT FINAL	part348	DISCOUNT DRUG MART, INC.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53943-274_ee297c6b-99d3-d5c6-e053-2a95a90a019d	53943-274	HUMAN OTC DRUG	Head Congestion plus Flu Severe PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220801		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-291_9e75a7e5-a864-4b30-ae3e-61995af7e6fd	53943-291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Discount Drug Mart	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-292_f3d77de6-2922-487c-a395-4e096a5b37a6	53943-292	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Discount Drug Mart	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
53943-298_ea238c06-3d40-3dbb-e053-2995a90aabc3	53943-298	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20070319		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	500	mg/1			N	20241231
53943-304_ee2a84bc-6416-75e8-e053-2a95a90a88a2	53943-304	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20100105		OTC MONOGRAPH NOT FINAL	part343	DISCOUNT DRUG MART	ACETAMINOPHEN	500	mg/1			N	20241231
53943-319_d20607bf-3387-3ef2-e053-2a95a90a4be5	53943-319	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20091113		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-320_d2027052-bba2-ed80-e053-2a95a90ab83d	53943-320	HUMAN OTC DRUG	Stay Awake		CAFFEINE	TABLET	ORAL	20120119		OTC MONOGRAPH FINAL	part340	DISCOUNT DRUG MART	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
53943-323_efb6d83e-c90e-4e5a-e053-2a95a90a0651	53943-323	HUMAN OTC DRUG	SINUS AND HEADACHE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200901		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-325_0ce5eb71-362c-4afa-e063-6394a90af577	53943-325	HUMAN OTC DRUG	DDM Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Discount Drug Mart	POVIDONE-IODINE	100	mg/mL			N	20241231
53943-336_2a74f567-08de-421f-8e79-f98d8746f4ca	53943-336	HUMAN OTC DRUG	Discount Drugmart Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20100104		UNAPPROVED DRUG OTHER		Discount Drug Mart, Inc	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
53943-370_11d02eb4-fcd6-422a-b861-978b09f19262	53943-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20120921		OTC MONOGRAPH NOT FINAL	part333A	Drug Mart	ALCOHOL	70	mL/100mL			N	20241231
53943-375_b26355a5-6830-44bc-9e8b-b06c1bb45849	53943-375	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20191213		ANDA	ANDA076497	Discount Drug Mart	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
53943-390_29c11208-42c0-4a3c-a5bb-72d0f90b05e1	53943-390	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20200107		OTC MONOGRAPH DRUG	M013	Discount Drug Mart	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
53943-392_d202451e-1f9e-8680-e053-2995a90ad35d	53943-392	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210901		ANDA	ANDA211075	DISCOUNT DRUG MART	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-400_0ce5be01-e0bc-7245-e063-6294a90acccf	53943-400	HUMAN OTC DRUG	DDM Calaclear		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Discount Drug Mart	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53943-413_0cf31b40-816c-d055-e063-6294a90af5d0	53943-413	HUMAN OTC DRUG	DDM Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	Discount Drug Mart	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53943-420_0cf32b24-4cf7-d1d4-e063-6294a90a1638	53943-420	HUMAN OTC DRUG	DDM Calagesic		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Discount Drug Mart	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
53943-421_f0306e96-1348-3b5d-e053-2995a90a8d66	53943-421	HUMAN OTC DRUG	Drug Mart Effervescent Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20150128		OTC MONOGRAPH FINAL	part343	Discount Drug Mart, Inc	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
53943-422_0d29cc74-465a-735b-e063-6394a90a22de	53943-422	HUMAN OTC DRUG	Discount Drug Mart Eye Drops Advanced Relief		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	Discount Drug Mart, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
53943-439_9337829d-19e0-4930-8d51-5a89e6dd9a7e	53943-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20120921		OTC MONOGRAPH NOT FINAL	part333A	Discount Drug Mart, Inc	ALCOHOL	700	mg/mL			N	20241231
53943-449_7e59532a-5779-47b2-9351-979fe96805af	53943-449	HUMAN OTC DRUG	Childrens Chewable Acetaminophen		Acetaminophen	TABLET, CHEWABLE	ORAL	20200113		OTC MONOGRAPH DRUG	M013	Discount Drug Mart	ACETAMINOPHEN	160	mg/1			N	20241231
53943-467_0cf331fe-33c0-3343-e063-6394a90a1120	53943-467	HUMAN OTC DRUG	DDM Camphor Spirit		Camphor 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Discount Drug Mart	CAMPHOR (NATURAL)	100	mg/mL			N	20241231
53943-501_8cf9dce0-ad03-42b2-a1fb-9984b4d261d5	53943-501	HUMAN OTC DRUG	Original Night-Time	MULTI-SYMPTOM COLD/FLU RELIEF	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20141021		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53943-502_23497684-17b7-47f0-a28c-b3eba54d1eb7	53943-502	HUMAN OTC DRUG	Night-Time	Multi-Symptom Cold/Flu Relief	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20141119		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53943-503_7b27f0da-c411-408e-86a1-a35bda14869d	53943-503	HUMAN OTC DRUG	Tussin DM		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	LIQUID	ORAL	20141119		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53943-504_acbc2537-6aae-449f-94f6-d3ca1dbc01d3	53943-504	HUMAN OTC DRUG	Tussin CF		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20141119		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-505_be851893-fde0-401b-97ad-8fe5c7f7e98d	53943-505	HUMAN OTC DRUG	CHILDRENS ALLERGY		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20150112		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-506_cb584130-7529-413b-846a-676dd7a60a16	53943-506	HUMAN OTC DRUG	Day-Time COLD/FLU RELIEF		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HCL	LIQUID	ORAL	20141025		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-507_1de2201c-edfc-4583-82ef-d2c5917753e9	53943-507	HUMAN OTC DRUG	Tussin		GUAIFENESIN	LIQUID	ORAL	20141119		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
53943-508_c099c649-a70f-4862-8002-7d5f53b784e2	53943-508	HUMAN OTC DRUG	Night-Time	COUGH RELIEF	DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20141027		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53943-509_0667192c-cf4c-236e-e063-6294a90a57e8	53943-509	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Vitamin C Sugar-Free	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	MENTHOL	2.7	mg/1			N	20241231
53943-511_84e6e026-db45-4a01-9ae8-2794a9daa73e	53943-511	HUMAN OTC DRUG	Childrens Chest Congestion Relief Grape		GUAIFENESIN	LIQUID	ORAL	20150204		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
53943-512_5b5266a3-3ff0-450b-8427-b59b1007e3c7	53943-512	HUMAN OTC DRUG	Childrens Cough Mucus Relief		DEXTROMETHORPHANN Hbr, GUAIFENESIN	LIQUID	ORAL	20160804		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53943-514_ee15211c-48ae-2dd7-e053-2995a90a888c	53943-514	HUMAN OTC DRUG	Mouthwash		Eucalyptol, Menthol, Methyl Salicylate, Thymol	LIQUID	ORAL	20211101		OTC MONOGRAPH NOT FINAL	part356	DISCOUNT DRUG MART	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53943-515_0cf32b24-4cfa-d1d4-e063-6294a90a1638	53943-515	HUMAN OTC DRUG	DDM Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Discount Drug Mart	CASTOR OIL	1	mg/mL			N	20241231
53943-519_872bfe3f-1312-d304-a3c7-43843459d93a	53943-519	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20200120		ANDA	ANDA078343	Discount Drug Mart, Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-520_0e0fa94d-9c8d-5be8-9ba3-197e4e350c95	53943-520	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20161118		ANDA	ANDA078878	Discount Drug Mart, Inc	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53943-522_25864798-ac18-4235-b646-a07f984f5d17	53943-522	HUMAN OTC DRUG	NIGHT TIME SLEEP-AID		DIPHENHYDRAMINE HCL	LIQUID	ORAL	20131210		OTC MONOGRAPH DRUG	M010	Discount Drug Mart	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-526_3628558a-d459-4781-bca0-fe3f44f1444f	53943-526	HUMAN OTC DRUG	Childrens Pain and Fever		ACETAMINOPHEN	LIQUID	ORAL	20160804		OTC MONOGRAPH DRUG	M013	Discount Drug Mart	ACETAMINOPHEN	160	mg/5mL			N	20241231
53943-527_b0831e91-928e-e761-476e-13aec08037be	53943-527	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200301		ANDA	ANDA207673	Discount Drug Mart, Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
53943-555_08b6f9a7-d2ed-4dd3-e063-6394a90a8da9	53943-555	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20200114		OTC MONOGRAPH DRUG	505G(a)(3)	Discount Drug Mart	WITCH HAZEL	86	mg/100mL			N	20241231
53943-556_e8746598-7c5f-b59e-e053-2995a90acc41	53943-556	HUMAN OTC DRUG	DISCOUNT DRUG MART	Original Flavor Mouthwash	EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL	LIQUID	ORAL	20220912		OTC MONOGRAPH NOT FINAL	part356	DISCOUNT DRUG MART	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53943-602_190d2dfe-b842-4333-bc50-09d114bc613e	53943-602	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20021202		OTC MONOGRAPH NOT FINAL	part334	Discount Drug Mart	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-603_d0c03b0b-7731-4c8e-88a6-d93717551b79	53943-603	HUMAN OTC DRUG	Night Time Multi-Symptom Cold and Flu Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20231108		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53943-604_b97ccef9-653a-435d-b7f6-5bffae92ca9a	53943-604	HUMAN OTC DRUG	Day Time Multi-Symptom Cold and Flu Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20231108		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-652_722c96af-3a0e-4850-a63b-0ed954f0b51e	53943-652	HUMAN OTC DRUG	Discount Drug Mart		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230417		NDA	NDA022015	DISCOUNT DRUG MART	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-676_f4e47f47-ef08-425c-ad05-ff4625f3a65e	53943-676	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20191220		OTC MONOGRAPH DRUG	505G(a)(3)	Discount Drug Mart	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-689_182c15f8-b3da-4e8b-930c-20fc8d146b94	53943-689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20191016		OTC MONOGRAPH DRUG	M012	Discount Drug Mart	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
53943-708_0952533b-ff49-4952-ac01-45ebc736bb2c	53943-708	HUMAN OTC DRUG	Discount Drug Mart nausea control	Cherry Flavor	dextrose(glucose),Levulose(fructose),Phosphoric acid	SOLUTION	ORAL	20190328		UNAPPROVED DRUG OTHER		DISCOUNT DRUG MART	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
53943-715_6c36d364-18ec-41fc-9104-5757352b8ffa	53943-715	HUMAN OTC DRUG	Discount Drug Mart	Original Nasal	oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
53943-716_292046c8-55c0-4025-aa13-48a3139652a3	53943-716	HUMAN OTC DRUG	Discount Drug Mart	Maximum Strength Nasal	Oxymetazoline hydrochloride	SPRAY	NASAL	20190522		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
53943-718_93de3b26-b98e-4158-b859-f51319ce510d	53943-718	HUMAN OTC DRUG	Discount Drug Mart	Severe Congestion Nasal	Oxymetazoline hydrochloride	SPRAY	NASAL	20190522		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
53943-720_4dd151ad-31e8-443d-b6ac-49ba726ad895	53943-720	HUMAN OTC DRUG	Discount drug mart	Extra Moisturizing	oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
53943-726_4260b563-1d3f-4fb7-a6ef-e9140f4e6508	53943-726	HUMAN OTC DRUG	Discount Drug Mart	Severe Nasal	Oxymetazoline Hydrochloride	SPRAY	NASAL	20190521		OTC MONOGRAPH FINAL	part341	DISCOUNT DRUG MART	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
53943-742_2f8e63c3-6606-4663-b74e-e6c58bcd4505	53943-742	HUMAN OTC DRUG	Polyethylene glycol 3350		Polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190821		ANDA	ANDA090812	Discount Drug Mart	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-756_cad16940-d24c-4bf6-9f99-cae68b8d8f18	53943-756	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20211004		OTC MONOGRAPH NOT FINAL	part356	Discount Drug Mart	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
53943-804_d4156395-5b92-4af1-8f04-ac939c490320	53943-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20101130		OTC MONOGRAPH NOT FINAL	part333A	Discount Drug Mart	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
53943-805_14d06f67-8b46-4e3a-b049-fe3b6b042b60	53943-805	HUMAN OTC DRUG	Discount Drugmart Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20150213		OTC MONOGRAPH NOT FINAL	part334	Discount Drug Mart, Inc	BISACODYL	10	mg/2000mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
53943-821_849c3ab3-2b3c-4de5-a9de-8d801f39c82c	53943-821	HUMAN OTC DRUG	Discount Drugmart Allergy Relief		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210804		OTC MONOGRAPH FINAL	part341	Discount Drug Mart, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-822_64214cba-1b9e-4cb6-af60-9f382e1d4b79	53943-822	HUMAN OTC DRUG	Discount Drugmart Nighttime Sleep-Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210915		OTC MONOGRAPH FINAL	part338	Discount Drug Mart, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
53943-823_52e065e0-9f34-4461-8f8f-79bda390e887	53943-823	HUMAN OTC DRUG	Discount Drugmart Gas Relief	Extra Strength Softgels	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210915		OTC MONOGRAPH FINAL	part332	Discount Drug Mart, Inc	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
53943-826_0c7fdbaa-6427-7749-e063-6294a90a7a36	53943-826	HUMAN OTC DRUG	less drowsy motion sickness relief		Meclizine Hydrochloride	TABLET	ORAL	20141201		OTC MONOGRAPH DRUG	M009	Discount Drug Mart	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
53943-835_0c86980d-ee66-96f8-e063-6294a90a42a6	53943-835	HUMAN OTC DRUG	DISCOUNT drug mart FOOD FAIR earwax removal kit		CARBAMIDE PEROXIDE	SOLUTION	TOPICAL	20141127		OTC MONOGRAPH DRUG	M014	Discount Drug Mart	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
53943-836_0bfa64cf-77d0-dd0a-e063-6394a90a824d	53943-836	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	TABLET, CHEWABLE	ORAL	20170913		OTC MONOGRAPH DRUG	M013	DISCOUNT DRUG MART	ACETAMINOPHEN	160	mg/1			N	20241231
53943-837_0bfa9474-9d86-a1e1-e063-6294a90a18ab	53943-837	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	TABLET, CHEWABLE	ORAL	20170913		OTC MONOGRAPH DRUG	M013	DISCOUNT DRUG MART	ACETAMINOPHEN	160	mg/1			N	20241231
53943-838_0c86980d-ee78-96f8-e063-6294a90a42a6	53943-838	HUMAN OTC DRUG	Discount Drug Mart Earwax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20140601		OTC MONOGRAPH DRUG	M014	Discount Drug Mart	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
53943-846_bdcdcd45-78ba-91ae-e053-2995a90a0777	53943-846	HUMAN OTC DRUG	Discount Drug Mart Ear Relief Ear Drops		MATRICARIA CHAMOMILLA WHOLE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20140701		UNAPPROVED HOMEOPATHIC		Discount Drug Mart	MATRICARIA CHAMOMILLA WHOLE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
53943-871_2f07cf85-535c-42ac-8981-821aa43c745d	53943-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20100720		OTC MONOGRAPH NOT FINAL	part333A	Discount Drug Mart	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
53943-873_7ced0e53-3494-c6a7-e053-2991aa0a80cd	53943-873	HUMAN OTC DRUG	Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20150130		OTC MONOGRAPH FINAL	part341	Discount Drug Mart	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
53943-904_f2050298-8bf8-2d70-e053-2a95a90a4fb8	53943-904	HUMAN OTC DRUG	2-Count HEAT PATCHES		CAPSAICIN	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart, Inc	CAPSAICIN	.025	g/100g			N	20241231
53943-907_f2050298-8c0a-2d70-e053-2a95a90a4fb8	53943-907	HUMAN OTC DRUG	Medicated Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart, Inc	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
53943-910_becbcc41-d09c-47d5-a771-6231ad5c769d	53943-910	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20090514		OTC MONOGRAPH NOT FINAL	part333A	Discount Drug Mart	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
53943-911_f204ced9-4613-0544-e053-2a95a90ac1f3	53943-911	HUMAN OTC DRUG	DISCOUNT DRUG MART PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart, Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
53943-975_4ee4c604-4a18-4955-8b5e-b2eeff1cb7f8	53943-975	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20171101		ANDA	ANDA076134	DISCOUNT DRUG MART	LORATADINE	10	mg/1			N	20241231
53943-983_f4ee88a8-bf3a-454f-e053-2a95a90ae2a1	53943-983	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20151109		OTC MONOGRAPH FINAL	part333B	Discount Drug Mart, Inc.	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
53943-984_f4ee89f0-25d5-6ffc-e053-2995a90a857b	53943-984	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20151030		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53943-985_f4ee8b96-fc2f-3a66-e053-2a95a90a0a60	53943-985	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20151030		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53943-986_f4ee8b96-fc30-3a66-e053-2a95a90a0a60	53943-986	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20120130		OTC MONOGRAPH NOT FINAL	part348	Discount Drug Mart, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
53943-987_f4ee8b96-fc31-3a66-e053-2a95a90a0a60	53943-987	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B	OINTMENT	TOPICAL	20120801		OTC MONOGRAPH FINAL	part333B	Discount Drug Mart, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53943-988_f4eebdf9-034f-6acf-e053-2a95a90a7740	53943-988	HUMAN OTC DRUG	Triple Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20151030		OTC MONOGRAPH FINAL	part333B	Discount Drug Mart, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
53943-990_f4ee870c-a1dd-1d42-e053-2a95a90ada2d	53943-990	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20151109		OTC MONOGRAPH FINAL	part333C	Discount Drug Mart, Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
53943-995_f4ee8b96-fc32-3a66-e053-2a95a90a0a60	53943-995	HUMAN OTC DRUG	Vaporizing Chest Rub		Camphor, Eucalyptus Oil, Menthol	GEL	TOPICAL	20151104		OTC MONOGRAPH FINAL	part341	Discount Drug Mart Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 2.6; 1.2	g/100g; g/100g; g/100g			N	20241231
53950-6010_09a874aa-9bd5-322a-e063-6294a90a4944	53950-6010	HUMAN OTC DRUG	BODYOGRAPHYPRO ANTI-BACTERIAL SANITIZING		ETHYL ALCOHOL	SPRAY	TOPICAL	20200815		OTC MONOGRAPH DRUG	M014	Robanda International, Inc.	ALCOHOL	60	mL/100mL			N	20241231
53950-7007_09bd97d2-f8b1-cafa-e063-6294a90ac980	53950-7007	HUMAN OTC DRUG	Robanda Anti-Aging Hand		Avobenzone, Octinoxate, Octisalate, Oxybenzone	LOTION	TOPICAL	20121102		UNAPPROVED DRUG OTHER		Robanda International, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	1; 7.5; 5; 6	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
53952-001_0c4396cf-6598-9fd5-e063-6394a90a27b2	53952-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190130		UNAPPROVED MEDICAL GAS		Cole Care, Inc.	OXYGEN	99	L/100L			N	20241231
53991-001_08025ff2-44b5-2581-e063-6294a90a2884	53991-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20121024		NDA	NDA205767	Southern Gas and Supply of Mississippi, Inc.	OXYGEN	995	mL/L			N	20241231
53991-002_08025ff2-44b4-2581-e063-6294a90a2884	53991-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20200101		NDA	NDA205766	SOUTHERN GAS AND SUPPLY, INC.	NITROGEN	995	mL/L			N	20241231
54031-020_0a2095ac-5703-39ba-e063-6294a90aa1c9	54031-020	HUMAN OTC DRUG	Max Mineral		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210215		OTC MONOGRAPH DRUG	M020	Peter Thomas Roth Labs, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.9276575; 9.271756	g/48.19g; g/48.19g			N	20241231
54031-069_0a20cdf1-4008-331f-e063-6394a90a04dc	54031-069	HUMAN OTC DRUG	GOODBYE ACNE Complete treatment gel		Salicylic Acid	GEL	TOPICAL	20210615		OTC MONOGRAPH DRUG	M006	Peter Thomas Roth, LLC	SALICYLIC ACID	.9638	g/48.19g			N	20241231
54057-082_e9c68e7d-e281-4181-89fa-3ec9183131f0	54057-082	HUMAN OTC DRUG	AFFEX Antimicrobial Foaming Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20130815		OTC MONOGRAPH NOT FINAL	part333E	Afflink, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
54057-400_3714ed61-ba5c-4816-ad69-f2fc81886af9	54057-400	HUMAN OTC DRUG	AFFEX Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Afflink, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
54057-401_8256dbbd-3af0-40c5-9241-66b4330dd39e	54057-401	HUMAN OTC DRUG	CLASSIC TOUCH Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	AFFLAB, Affiliated Laboratories, a Division of AFFLINK	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
54092-063_40de069d-9fb0-4ad2-946d-babdbe02bf18	54092-063	HUMAN PRESCRIPTION DRUG	Agrylin		anagrelide hydrochloride	CAPSULE	ORAL	19970314		NDA	NDA020333	Takeda Pharmaceuticals America, Inc.	ANAGRELIDE HYDROCHLORIDE ANHYDROUS	.5	mg/1	Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]		N	20241231
54092-100_9c2c0dbc-e265-4814-aaa2-fd606b32af1f	54092-100	HUMAN PRESCRIPTION DRUG	Mesalamine		MESALAMINE	TABLET, DELAYED RELEASE	ORAL	20170829		NDA AUTHORIZED GENERIC	NDA022000	Takeda Pharmaceuticals America, Inc.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
54092-171_910f1db8-24b2-4406-9b6e-0b5dad5003c2	54092-171	HUMAN PRESCRIPTION DRUG	Carbatrol		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	19991222		NDA	NDA020712	Takeda Pharmaceuticals America, Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
54092-172_910f1db8-24b2-4406-9b6e-0b5dad5003c2	54092-172	HUMAN PRESCRIPTION DRUG	Carbatrol		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	19970930		NDA	NDA020712	Takeda Pharmaceuticals America, Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
54092-173_910f1db8-24b2-4406-9b6e-0b5dad5003c2	54092-173	HUMAN PRESCRIPTION DRUG	Carbatrol		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	19970930		NDA	NDA020712	Takeda Pharmaceuticals America, Inc.	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
54092-189_40a2c7d6-1e5d-40bb-a2a6-efe2888f856b	54092-189	HUMAN PRESCRIPTION DRUG	Pentasa		mesalamine	CAPSULE	ORAL	19930510		NDA	NDA020049	Takeda Pharmaceuticals America, Inc.	MESALAMINE	250	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
54092-191_40a2c7d6-1e5d-40bb-a2a6-efe2888f856b	54092-191	HUMAN PRESCRIPTION DRUG	Pentasa		mesalamine	CAPSULE	ORAL	20040708		NDA	NDA020049	Takeda Pharmaceuticals America, Inc.	MESALAMINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
54092-252_5624059d-27f2-44d4-a8dc-3eeba15446c8	54092-252	HUMAN PRESCRIPTION DRUG	Fosrenol		lanthanum carbonate	TABLET, CHEWABLE	ORAL	20041026		NDA	NDA021468	Takeda Pharmaceuticals America, Inc.	LANTHANUM CARBONATE	500	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
54092-253_5624059d-27f2-44d4-a8dc-3eeba15446c8	54092-253	HUMAN PRESCRIPTION DRUG	Fosrenol		lanthanum carbonate	TABLET, CHEWABLE	ORAL	20051123		NDA	NDA021468	Takeda Pharmaceuticals America, Inc.	LANTHANUM CARBONATE	750	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
54092-254_5624059d-27f2-44d4-a8dc-3eeba15446c8	54092-254	HUMAN PRESCRIPTION DRUG	Fosrenol		lanthanum carbonate	TABLET, CHEWABLE	ORAL	20051123		NDA	NDA021468	Takeda Pharmaceuticals America, Inc.	LANTHANUM CARBONATE	1000	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
54092-256_5624059d-27f2-44d4-a8dc-3eeba15446c8	54092-256	HUMAN PRESCRIPTION DRUG	Fosrenol		lanthanum carbonate	POWDER	ORAL	20140924		NDA	NDA204734	Takeda Pharmaceuticals America, Inc.	LANTHANUM CARBONATE	750	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
54092-257_5624059d-27f2-44d4-a8dc-3eeba15446c8	54092-257	HUMAN PRESCRIPTION DRUG	Fosrenol		lanthanum carbonate	POWDER	ORAL	20140924		NDA	NDA204734	Takeda Pharmaceuticals America, Inc.	LANTHANUM CARBONATE	1000	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
54092-381_34670d75-3bba-4318-af18-a214820d3db0	54092-381	HUMAN PRESCRIPTION DRUG	Adderall	XR	Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20020522		NDA	NDA021303	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-383_34670d75-3bba-4318-af18-a214820d3db0	54092-383	HUMAN PRESCRIPTION DRUG	Adderall	XR	Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20011011		NDA	NDA021303	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-385_34670d75-3bba-4318-af18-a214820d3db0	54092-385	HUMAN PRESCRIPTION DRUG	Adderall	XR	Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20020522		NDA	NDA021303	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-387_34670d75-3bba-4318-af18-a214820d3db0	54092-387	HUMAN PRESCRIPTION DRUG	Adderall	XR	Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20011011		NDA	NDA021303	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-389_34670d75-3bba-4318-af18-a214820d3db0	54092-389	HUMAN PRESCRIPTION DRUG	Adderall	XR	Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20020522		NDA	NDA021303	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-391_34670d75-3bba-4318-af18-a214820d3db0	54092-391	HUMAN PRESCRIPTION DRUG	Adderall	XR	Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate	CAPSULE, EXTENDED RELEASE	ORAL	20011011		NDA	NDA021303	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-468_10bb4f26-7831-4814-81c6-1d6e4f08bb86	54092-468	HUMAN PRESCRIPTION DRUG	MYDAYIS		DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20170620		NDA	NDA022063	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-471_10bb4f26-7831-4814-81c6-1d6e4f08bb86	54092-471	HUMAN PRESCRIPTION DRUG	MYDAYIS		DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20170620		NDA	NDA022063	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-474_10bb4f26-7831-4814-81c6-1d6e4f08bb86	54092-474	HUMAN PRESCRIPTION DRUG	MYDAYIS		DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20170620		NDA	NDA022063	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	9.375; 9.375; 9.375; 9.375	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-476_466df3d0-83f7-4082-b08a-1674b8e6a9e5	54092-476	HUMAN PRESCRIPTION DRUG	Lialda		mesalamine	TABLET, DELAYED RELEASE	ORAL	20070116		NDA	NDA022000	Takeda Pharmaceuticals America, Inc.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
54092-477_10bb4f26-7831-4814-81c6-1d6e4f08bb86	54092-477	HUMAN PRESCRIPTION DRUG	MYDAYIS		DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20170620		NDA	NDA022063	Takeda Pharmaceuticals America, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	12.5; 12.5; 12.5; 12.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
54092-513_1eef54c1-5c87-44f1-bab6-42f72d4fe0be	54092-513	HUMAN PRESCRIPTION DRUG	Intuniv		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20090902		NDA	NDA022037	Takeda Pharmaceuticals America, Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
54092-515_1eef54c1-5c87-44f1-bab6-42f72d4fe0be	54092-515	HUMAN PRESCRIPTION DRUG	Intuniv		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20090902		NDA	NDA022037	Takeda Pharmaceuticals America, Inc.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
54092-517_1eef54c1-5c87-44f1-bab6-42f72d4fe0be	54092-517	HUMAN PRESCRIPTION DRUG	Intuniv		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20090902		NDA	NDA022037	Takeda Pharmaceuticals America, Inc.	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
54092-519_1eef54c1-5c87-44f1-bab6-42f72d4fe0be	54092-519	HUMAN PRESCRIPTION DRUG	Intuniv		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20090902		NDA	NDA022037	Takeda Pharmaceuticals America, Inc.	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
54092-546_84219f75-9a6d-4e43-833c-9149193cf079	54092-546	HUMAN PRESCRIPTION DRUG	MOTEGRITY		PRUCALOPRIDE	TABLET, FILM COATED	ORAL	20181214		NDA	NDA210166	Takeda Pharmaceuticals America, Inc.	PRUCALOPRIDE SUCCINATE	1	mg/1	Serotonin 4 Receptor Agonists [MoA], Serotonin-4 Receptor Agonist [EPC]		N	20241231
54092-547_84219f75-9a6d-4e43-833c-9149193cf079	54092-547	HUMAN PRESCRIPTION DRUG	MOTEGRITY		PRUCALOPRIDE	TABLET, FILM COATED	ORAL	20181214		NDA	NDA210166	Takeda Pharmaceuticals America, Inc.	PRUCALOPRIDE SUCCINATE	2	mg/1	Serotonin 4 Receptor Agonists [MoA], Serotonin-4 Receptor Agonist [EPC]		N	20241231
54092-700_22b76b84-ac55-42f6-ad5a-de64f6f890db	54092-700	HUMAN PRESCRIPTION DRUG	ELAPRASE		idursulfase	SOLUTION, CONCENTRATE	INTRAVENOUS	20060724		BLA	BLA125151	Takeda Pharmaceuticals America, Inc.	IDURSULFASE	6	mg/3mL	Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
54092-701_4e83f128-888a-4dd7-9708-72af5fd05058	54092-701	HUMAN PRESCRIPTION DRUG	VPRIV		velaglucerase alfa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100226		BLA	BLA022575	Takeda Pharmaceuticals America, Inc.	VELAGLUCERASE ALFA	2.5	mg/mL	Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]		N	20241231
54092-702_59a20124-1c8d-4f0e-9932-1c574cdc6f45	54092-702	HUMAN PRESCRIPTION DRUG	Firazyr		icatibant acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20110825		NDA	NDA022150	Takeda Pharmaceuticals America, Inc.	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
54108-0420_0a314b3d-6a32-4381-a756-8fe402859a30	54108-0420	HUMAN OTC DRUG	Sun Defense Mineral Sunscreen SPF 30 Face		Zinc Oxide	CREAM	TOPICAL	20160101		OTC MONOGRAPH DRUG	M020	derma e	ZINC OXIDE	200	mg/g			N	20241231
54108-1485_54cde561-0789-4ed3-825f-40d638a71001	54108-1485	HUMAN OTC DRUG	Derma E Mineral sunscreen	Mineral	ZINC OXIDE	POWDER	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	derma e	TITANIUM DIOXIDE; ZINC OXIDE	172.9; 200	mg/g; mg/g			N	20241231
54108-3700_768e2280-d505-4446-9090-f14c8e6fa84f	54108-3700	HUMAN OTC DRUG	Acne Deep Pore Cleansing Wash		SALICYLIC ACID	GEL	TOPICAL	20150101		OTC MONOGRAPH DRUG	M006	derma e	SALICYLIC ACID	20	mg/mL			N	20241231
54108-3710_5b55c529-32f0-49d7-9e2b-65a060993180	54108-3710	HUMAN OTC DRUG	Derma E Acne Clarifying Mask		Sulfur	CREAM	TOPICAL	20221214		OTC MONOGRAPH FINAL	part333D	derma e	SULFUR	100	mg/g			N	20241231
54108-3750_1a5725d8-9f67-45d8-a126-73116f794ec5	54108-3750	HUMAN OTC DRUG	Deep Pore Acne Scrub		SALICYLIC ACID	PASTE	TOPICAL	20150101		OTC MONOGRAPH DRUG	M006	derma e	SALICYLIC ACID	20	mg/g			N	20241231
54111-112_844e66fe-296b-445d-a44c-7e52e1409db8	54111-112	HUMAN OTC DRUG	BRODA Acne		SALICYLIC ACID	GEL	TOPICAL	20131029		OTC MONOGRAPH DRUG	M006	Bentley Laboratories, LLC	SALICYLIC ACID	.4	g/20g			N	20241231
54111-119_56f8f14b-283e-4f93-a1b7-58f999b98a87	54111-119	HUMAN OTC DRUG	RODAN and FIELDS ENHANCEMENTS	LIGHT	TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20120815		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.384; .196	g/4g; g/4g			N	20241231
54111-120_56f8f14b-283e-4f93-a1b7-58f999b98a87	54111-120	HUMAN OTC DRUG	RODAN and FIELDS ENHANCEMENTS	MEDIUM	TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20120905		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.384; .196	g/4g; g/4g			N	20241231
54111-121_56f8f14b-283e-4f93-a1b7-58f999b98a87	54111-121	HUMAN OTC DRUG	RODAN and FIELDS ENHANCEMENTS	BRONZE	TITANIUM DIOXIDE, ZINC OXIDE	POWDER	TOPICAL	20130419		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.384; .196	g/4g; g/4g			N	20241231
54111-122_f2f0d967-ed98-4413-be5a-808313757c54	54111-122	HUMAN OTC DRUG	RODAN and FIELDS UNBLEMISH		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20100305		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.21; 1.425	g/30mL; g/30mL			N	20241231
54111-139_e059bf8d-3cd6-455c-967d-a73e20444979	54111-139	HUMAN OTC DRUG	Brandless Lip Balm Coconut Broad Spectrum	15%	Zinc Oxide	LOTION	TOPICAL	20180501		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	.6375	g/4.25g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-143_1d1f3d4a-c17a-42b2-af85-54167ab7921f	54111-143	HUMAN OTC DRUG	COOLA CLASSIC FACE SUNSCREEN White Tea Broad Spectrum	SPF 50	AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE	LOTION	TOPICAL	20191107		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.75; 5; 2; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
54111-145_5368324e-9b83-48dc-8ab3-88146d9423f8	54111-145	HUMAN OTC DRUG	COOLA Classic Body Sunscreen Fragrance-Free	SPF 50	AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE	LOTION	TOPICAL	20191106		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.75; 5; 2; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
54111-146_7d0440d0-91bd-4c66-86d7-5e4722d1951a	54111-146	HUMAN OTC DRUG	COOLA Classic Body Sunscreen Pina Colada	SPF 30	AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE	LOTION	TOPICAL	20191106		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.75; 2.5; 1.5; 3.75	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
54111-148_aae99fc7-d6b1-44fc-a2d8-0004df757b85	54111-148	HUMAN OTC DRUG	COOLA Refreshing Water Mist SPF 18		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20200730		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 10; 5; 5.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
54111-154_d93b809e-b41b-43c4-a682-c2dc9cc64d61	54111-154	HUMAN OTC DRUG	Intensive Daily Repair Body Butter		Colloidal Oatmeal	CREAM	TOPICAL	20210611		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	OATMEAL	8	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54111-159_d3c22d8a-a5b6-4413-af98-b8682d3306d5	54111-159	HUMAN OTC DRUG	Nudestix Daily Mineral Veil SPF 30	Tint Free - Cool	ZINC OXIDE 15%	LOTION	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-160_da8723c1-1d02-47a9-82ad-0ea4527c721c	54111-160	HUMAN OTC DRUG	Nudestix Daily Mineral Veil SPF 30	Tint - Warm	ZINC OXIDE 15%	LOTION	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-161_8dc23a58-5730-46e6-ad92-5cde0e4874f2	54111-161	HUMAN OTC DRUG	Nudestix Daily Mineral Veil SPF 30	Tint - Hot	ZINC OXIDE 15%	LOTION	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-162_59eaa506-abec-41ba-8706-6d1095a4bb3f	54111-162	HUMAN OTC DRUG	Intensive Daily Repair Body Butter		Colloidal Oatmeal	CREAM	TOPICAL	20220221		OTC MONOGRAPH DRUG	M016	Bentley Laboratories, LLC	OATMEAL	8	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54111-163_af580721-c7e8-4f90-8e7f-07d7516e33b6	54111-163	HUMAN OTC DRUG	JOSIE MARAN MOISTURE REPAIR FACIAL BARRIER		Colloidal Oatmeal 1%	CREAM	TOPICAL	20220309		OTC MONOGRAPH DRUG	M016	Bentley Laboratories, LLC	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54111-164_86f4bab2-88a5-4974-892f-2e4ee0e7e073	54111-164	HUMAN OTC DRUG	JOSIE MARAN OTC ECZEMA BODY BUTTER -Vanilla and Chamomile		COLLOIDAL OATMEAL 0.8%	CREAM	TOPICAL	20220708		OTC MONOGRAPH DRUG	M016	Bentley Laboratories, LLC	OATMEAL	8	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54111-165_67ec5c30-fe18-4945-84fb-c80b32539dae	54111-165	HUMAN OTC DRUG	JOSIE MARAN Intensive Daily Repair Body Butter -Vanilla and Shea		COLLOIDAL OATMEAL 0.8%	CREAM	TOPICAL	20220708		OTC MONOGRAPH DRUG	M016	Bentley Laboratories, LLC	OATMEAL	8	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54111-166_f7259e33-67bb-4899-a8de-c211a4b6c626	54111-166	HUMAN OTC DRUG	NUDESCREEN LIP PRIMER SPF 30 - NATURAL TINT		ZINC OXIDE	LIPSTICK	TOPICAL	20230212		OTC MONOGRAPH NOT FINAL	part352	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-167_5eeaaeb6-38b1-4f69-b200-efbca0e7ab89	54111-167	HUMAN OTC DRUG	NUDESCREEN DAILY MINERAL VEIL SPF 30 - TINT NUDE		ZINC OXIDE	LOTION	TOPICAL	20230212		OTC MONOGRAPH FINAL	part347	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-168_f4026a95-4584-42b2-a010-c5d18df8fc94	54111-168	HUMAN OTC DRUG	NUDESCREEN DAILY MINERAL VEIL SPF 30 - TINT TAN		ZINC OXIDE	LOTION	TOPICAL	20230212		OTC MONOGRAPH FINAL	part347	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-169_c6b77f4c-9c2d-43d5-be06-aa57e43672f4	54111-169	HUMAN OTC DRUG	MOISTURIZING DANDRUFF	1% Pyrithione Zinc	Pyrithione Zinc	SHAMPOO	TOPICAL	20230301		OTC MONOGRAPH FINAL	part358H	Bentley Laboratories, LLC	PYRITHIONE ZINC	1	g/100mL			N	20241231
54111-170_96935492-5482-469b-9b40-ce2dd835bf64	54111-170	HUMAN OTC DRUG	Acne Control Superclean Body Wash	AHA BHA Formula	SALICYLIC ACID	GEL	TOPICAL	20230301		OTC MONOGRAPH FINAL	part333D	Bentley Laboratories, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
54111-171_5a52ba9d-10a8-42f9-999e-bf7088339f05	54111-171	HUMAN OTC DRUG	Salicylic Acid Cleanser		Exfoliating and Clarifying Face Wash	GEL	TOPICAL	20230701		OTC MONOGRAPH FINAL	part333D	Bentley Laboratories, LLC	SALICYLIC ACID	5	mg/mL			N	20241231
54111-172_87ccef52-a9a7-4067-a0b5-32dbf6d1ea08	54111-172	HUMAN OTC DRUG	Moisturizing Morning Cream SPF 15		Octocrylene and Octisalate Cream	CREAM	TOPICAL	20230718		OTC MONOGRAPH FINAL	part352	Bentley Laboratories, LLC	OCTISALATE; OCTOCRYLENE	2; 5	g/100mL; g/100mL			N	20241231
54111-173_d6421f8d-9022-4d5c-92c9-22389775c935	54111-173	HUMAN OTC DRUG	Tone Control Morning Cream SPF 15		Octocrylene and Octisalate Cream	CREAM	TOPICAL	20230718		OTC MONOGRAPH FINAL	part352	Bentley Laboratories, LLC	OCTISALATE; OCTOCRYLENE	2; 5	g/100mL; g/100mL			N	20241231
54111-174_f2312c7b-13f8-4622-9c6e-a3104113a830	54111-174	HUMAN OTC DRUG	NUDESCREEN BLUSH TINT SPF 30- SUNSET ROSE		ZINC OXIDE SUNSCREEN	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-175_a71d7999-7375-4269-a041-9fc95a18014c	54111-175	HUMAN OTC DRUG	NUDESCREEN BLUSH TINT SPF 30 - SUNNY SWEET CHEEKS		ZINC OXIDE SUNSCREEN	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-176_5a358b05-a2ab-4ca6-bd01-5f39c4a6149f	54111-176	HUMAN OTC DRUG	NUDESCREEN BLUSH TINT SPF 30 - PINK SUNRISE		ZINC OXIDE SUNSCREEN	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-177_f17a257b-43e6-4bbf-b07c-c9427f6ef368	54111-177	HUMAN OTC DRUG	NUDESCREEN BLUSH TINT SPF 30 - SUNKISSED		ZINC OXIDE SUNSCREEN	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-178_ab709d00-775a-4ed5-8a3f-106618dc7728	54111-178	HUMAN OTC DRUG	NUDESCREEN BLUSH TINT SPF 30 - STRAWBERRY SUNBURST		ZINC OXIDE SUNSCREEN	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54111-179_429102ec-2e2f-41d6-8866-70bdaa563d8e	54111-179	HUMAN OTC DRUG	NUDESCREEN BLUSH TINT SPF 30 - PEACHES N SOL		ZINC OXIDE SUNSCREEN	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Bentley Laboratories, LLC	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54123-114_d5b5854f-79b3-4442-a0de-93b93f656286	54123-114	HUMAN PRESCRIPTION DRUG	Zubsolv		buprenorphine hydrochloride and naloxone hydrochloride	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20141211		NDA	NDA204242	Orexo US, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	11.4; 2.9	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
54123-907_d5b5854f-79b3-4442-a0de-93b93f656286	54123-907	HUMAN PRESCRIPTION DRUG	Zubsolv		buprenorphine hydrochloride and naloxone hydrochloride	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20130704		NDA	NDA204242	Orexo US, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	.7; .18	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
54123-914_d5b5854f-79b3-4442-a0de-93b93f656286	54123-914	HUMAN PRESCRIPTION DRUG	Zubsolv		buprenorphine hydrochloride and naloxone hydrochloride	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20130704		NDA	NDA204242	Orexo US, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	1.4; .36	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
54123-929_d5b5854f-79b3-4442-a0de-93b93f656286	54123-929	HUMAN PRESCRIPTION DRUG	Zubsolv		buprenorphine hydrochloride and naloxone hydrochloride	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20130704		NDA	NDA204242	Orexo US, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	2.9; .71	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
54123-957_d5b5854f-79b3-4442-a0de-93b93f656286	54123-957	HUMAN PRESCRIPTION DRUG	Zubsolv		buprenorphine hydrochloride and naloxone hydrochloride	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20130704		NDA	NDA204242	Orexo US, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	5.7; 1.4	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
54123-986_d5b5854f-79b3-4442-a0de-93b93f656286	54123-986	HUMAN PRESCRIPTION DRUG	Zubsolv		buprenorphine hydrochloride and naloxone hydrochloride	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20141211		NDA	NDA204242	Orexo US, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE	8.6; 2.1	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
54131-001_edc67db0-8c17-416e-b645-51639cf53f61	54131-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19630101		UNAPPROVED MEDICAL GAS		Del Rio Welders Equipment, Inc.	OXYGEN	99	L/100L			N	20241231
54136-118_0d06d93b-dffd-faec-e063-6294a90ac985	54136-118	HUMAN OTC DRUG	Incredibly Clear Acne Spot		Salicylic Acid	GEL	TOPICAL	20200514		OTC MONOGRAPH DRUG	M006	Better Planet Brands LLC	SALICYLIC ACID	2	g/100g			N	20241231
54136-153_0d06a661-4513-65aa-e063-6394a90a7606	54136-153	HUMAN OTC DRUG	Radically Rejuvenating Day Cream		Zinc Oxide	CREAM	TOPICAL	20200409		OTC MONOGRAPH DRUG	M020	Better Planet Brands LLC	ZINC OXIDE	15.5	g/100g			N	20241231
54136-322_0d06c4df-a0ac-6467-e063-6394a90a5538	54136-322	HUMAN OTC DRUG	Calming Itch and Irritation		Colloidal Oatmeal	LOTION	TOPICAL	20200511		OTC MONOGRAPH DRUG	M016	Better Planet Brands LLC	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54136-681_0d06b3ae-860e-e66b-e063-6294a90a86a8	54136-681	HUMAN OTC DRUG	Everyday Eczema Unscented		Colloidal Oatmeal	LOTION	TOPICAL	20200511		OTC MONOGRAPH DRUG	M016	Better Planet Brands LLC	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54136-946_0d0683d4-3a1e-c83c-e063-6294a90a2b6c	54136-946	HUMAN OTC DRUG	Seriously Soothing Face Cream		Zinc Oxide	CREAM	TOPICAL	20200422		OTC MONOGRAPH DRUG	M020	Better Planet Brands LLC	ZINC OXIDE	15.5	g/100g			N	20241231
54146-0001_a78d4bb4-b188-426e-ac73-e1aa95480fa4	54146-0001	HUMAN OTC DRUG	Flu-Cold		Echinacea, Arsenicum Album, Baptisia Tinctoria, Eupatorium Perfoliatum, Gelsemium Sempervirens, Lycopodium Clavatum, Phosphorus, Pyrogenium, Rhus Toxicodendron	LIQUID	ORAL	20130430		UNAPPROVED HOMEOPATHIC		Natural Wonders	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	12; 12; 3; 12; 12; 12; 12; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54155-052_c9c41ea7-32e8-4371-b8d6-9e031821c33c	54155-052	HUMAN OTC DRUG	PO SUM ON MEDICATED		MENTHOL	OIL	TOPICAL	20040510		OTC MONOGRAPH NOT FINAL	part348	PO SUM ON MEDICINE FACTORY LIMITED	MENTHOL	15	g/100mL			N	20241231
54155-053_1920807c-c5db-4268-8610-714a539bc788	54155-053	HUMAN OTC DRUG	PO SUM ON HEALING BALM		MENTHOL	OINTMENT	TOPICAL	20170525		OTC MONOGRAPH NOT FINAL	part348	PO SUM ON MEDICINE FACTORY LIMITED	MENTHOL	13	g/100g			N	20241231
54162-940_cc723205-04c3-410f-8fa1-93900afb9142	54162-940	HUMAN OTC DRUG	Geritrex Aspirin		Aspirin	TABLET, COATED	ORAL	20181011		OTC MONOGRAPH NOT FINAL	part343	Geritrex LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
54162-941_f6080edf-c278-4721-8335-4c299adf0c9e	54162-941	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20181015		ANDA	ANDA075010	Geritrex LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
54181-006_0e6c69cc-8dd8-f309-e063-6294a90a4299	54181-006	HUMAN OTC DRUG	Hydra Finish SPF 15		HOMOSALATE, OCTINOXATE	CREAM	TOPICAL	20160722		OTC MONOGRAPH DRUG	M020	Guinot	HOMOSALATE; OCTINOXATE	40; 60	mg/mL; mg/mL			N	20251231
54181-009_0814f3c4-26ed-6b31-e063-6294a90a4877	54181-009	HUMAN OTC DRUG	HYDRA BEAUTE SPF 15		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	Guinot	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	28.5; 50; 70; 30; 90	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
54181-015_081503c4-1d87-9655-e063-6294a90a183a	54181-015	HUMAN OTC DRUG	Pur Confort SPF 15		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20180501		OTC MONOGRAPH DRUG	M020	Guinot	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	28.5; 50; 70; 30; 90	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
54202-001_bc599473-7051-4838-bdaf-92e3563a3ef8	54202-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19850101		UNAPPROVED MEDICAL GAS		All Saints Home Medical	OXYGEN	99	L/100L			N	20241231
54218-500_e854d955-03b3-4ae5-a8d9-6400805d1036	54218-500	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19700101		NDA	NDA205767	United States Welding, Inc.	OXYGEN	99	L/100L			N	20241231
54218-600_73e6dca2-d04e-44ad-a71c-34737b91bee3	54218-600	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19700101		NDA	NDA205766	United States Welding, Inc.	NITROGEN	99	L/100L			N	20241231
54218-800_58d416df-7e19-4667-88b9-9256f782c6e7	54218-800	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19700101		NDA	NDA205704	United States Welding, Inc.	NITROUS OXIDE	99	kg/100kg			N	20241231
54225-013_fc90f315-03c4-6358-e053-6394a90a3b2d	54225-013	HUMAN OTC DRUG	INSTANT HAND SANITIZER		Alcohol	GEL	EXTRACORPOREAL	20230526		OTC MONOGRAPH NOT FINAL	part333E	YIWU SLOGGI COSMETICS CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
54230-356_097fcff2-ea99-0878-e063-6394a90aa0fd	54230-356	HUMAN OTC DRUG	Celadrin	Joint and Muscle Pain Relieving	Menthol	CREAM	TOPICAL	20121001		OTC MONOGRAPH DRUG	M017	Factors Group of Nutritional Products	MENTHOL	12.5	mg/g			N	20241231
54237-001_f6835f5c-7748-27c4-e053-2a95a90acd47	54237-001	HUMAN OTC DRUG	Instant Hand Sanitizer		Hand Sanitizer	LIQUID	EXTRACORPOREAL	20200325		OTC MONOGRAPH NOT FINAL	part333E	Guangzhou Daieme Cosmetic Co,.Ltd	ALCOHOL	42	mL/60mL			N	20241231
54237-020_f6746abb-583e-d7ef-e053-2995a90a24b3	54237-020	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	EXTRACORPOREAL	20200831		OTC MONOGRAPH NOT FINAL	part333E	Guangzhou Daieme Cosmetic Co,.Ltd	ALCOHOL	1417.5	mL/1890mL			N	20241231
54244-001_0801d255-e0ba-9e59-e063-6394a90ad9a4	54244-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19740905		NDA	NDA205865	CONROE WELDING SUPPLY, INC.	OXYGEN	995	mL/L			N	20241231
54257-089_08bf70ec-89e8-36e5-e063-6294a90a6772	54257-089	HUMAN OTC DRUG	Senna S		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M007	Magno-Humphries, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
54257-170_0e12b912-5db1-bb3e-e063-6394a90aa446	54257-170	HUMAN OTC DRUG	Allergy Relief		FEXOFENADINE HYDROCHLORIDE	TABLET	ORAL	20210325		ANDA	ANDA204507	Magno-Humphries, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
54257-180_7353dcda-daf1-4b00-992b-d4855477f666	54257-180	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Magno-Humphries, Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
54257-270_cf6d242a-ce61-23b7-e053-2a95a90a856c	54257-270	HUMAN OTC DRUG	Allergy Relief		CETIRIZINE HYDROCHLORIDE	TABLET	ORAL	20200124		ANDA	ANDA209274	Magno-Humphries, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54257-274_08bf7b4e-4f73-7538-e063-6394a90a6627	54257-274	HUMAN OTC DRUG	ENTERIC COATED ASPIRIN		ASPIRIN	TABLET	ORAL	20200116		OTC MONOGRAPH DRUG	M013	Magno-Humphries, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
54257-277_08bf6b23-2a76-3732-e063-6294a90a2305	54257-277	HUMAN OTC DRUG	Mucosa DM		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	TABLET	ORAL	20170404		OTC MONOGRAPH DRUG	M012	Magno-Humphries, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
54257-278_08bf29ff-1c79-1547-e063-6294a90ac7ee	54257-278	HUMAN OTC DRUG	Pain Reliever PM		ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M013	Magno-Humphries, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54257-379_08bf29ff-1c8c-1547-e063-6294a90ac7ee	54257-379	HUMAN OTC DRUG	Fiber Laxative		CALCIUM POLYCARBOPHIL	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M007	Magno-Humphries, Inc.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
54257-473_08bf6b23-2a85-3732-e063-6294a90a2305	54257-473	HUMAN OTC DRUG	Pain Reliever		ACETAMINOPHEN	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M013	Magno-Humphries, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
54257-479_0e12b04e-2bdf-0a8b-e063-6294a90a3d47	54257-479	HUMAN OTC DRUG	FIBER LAXATIVE		CALCIUM POLYCARBOPHIL	TABLET	ORAL	20220725		OTC MONOGRAPH DRUG	M007	Magno-Humphries, Inc.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20251231
54257-573_cf6e6c2c-3775-f475-e053-2995a90a2754	54257-573	HUMAN OTC DRUG	Acetaminophen Extended-Release		ACETAMINOPHEN	TABLET	ORAL	20200124		ANDA	ANDA211544	Magno-Humphries, Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
54257-679_08bf6b23-2aa8-3732-e063-6294a90a2305	54257-679	HUMAN OTC DRUG	Sennosides Natural Laxative		SENNOSIDES	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M007	Magno-Humphries, Inc.	SENNOSIDES	8.6	mg/1			N	20241231
54257-720_08bf78b4-64d4-cd41-e063-6294a90a96db	54257-720	HUMAN OTC DRUG	Acetaminophen Regular Strength		ACETAMINOPHEN	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M013	Magno-Humphries, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
54257-776_08bf8c82-76e6-440e-e063-6294a90af3d3	54257-776	HUMAN OTC DRUG	Mucosa Guifenesin		GUAIFENESIN	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M012	Magno-Humphries, Inc.	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
54257-802_86008c15-a2ce-4c0b-8323-5a0caa7f2570	54257-802	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Magno-Humphries, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
54257-858_08bf8c82-76d4-440e-e063-6294a90af3d3	54257-858	HUMAN OTC DRUG	Extraprin		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20200124		OTC MONOGRAPH DRUG	M013	Magno-Humphries, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
54257-902_08bf67ab-e837-2223-e063-6294a90a0878	54257-902	HUMAN OTC DRUG	Stool Softener Docusate Sodium		DOCUSATE SODIUM	CAPSULE, GELATIN COATED	ORAL	20170404		OTC MONOGRAPH DRUG	M007	Magno-Humphries, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
54257-902_08bf70ec-89c9-36e5-e063-6294a90a6772	54257-902	HUMAN OTC DRUG	Stool Softener Docusate Sodium		DOCUSATE SODIUM	CAPSULE, GELATIN COATED	ORAL	20200124		OTC MONOGRAPH DRUG	M007	Magno-Humphries, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
54260-001_070fd6a3-2716-19c6-e063-6394a90ad1dc	54260-001	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA206009	Nitrous Oxide	NITROUS OXIDE	990	mL/L			N	20241231
54273-006_85731b59-73da-4aae-adf7-40cff79c4fb3	54273-006	HUMAN OTC DRUG	ZIMS MAX FREEZE	PRO FORMULA	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20180701		OTC MONOGRAPH DRUG	M017	KOBAYASHI Healthcare International, Inc.	MENTHOL, UNSPECIFIED FORM	70	mg/g			N	20241231
54273-007_3674680c-30ec-49e4-99b2-9319199ff6a5	54273-007	HUMAN OTC DRUG	ZIMS MAX FREEZE	PRO FORMULA	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20180801		OTC MONOGRAPH DRUG	M017	KOBAYASHI Healthcare International, Inc.	MENTHOL, UNSPECIFIED FORM	70	mg/g			N	20241231
54273-008_7603d7df-335d-432b-b747-6a955119973b	54273-008	HUMAN OTC DRUG	ZIMS MAX FREEZE	PRO FORMULA	MENTHOL	SPRAY	TOPICAL	20180924		OTC MONOGRAPH DRUG	M017	KOBAYASHI Healthcare International, Inc.	MENTHOL, UNSPECIFIED FORM	160	mg/g			N	20241231
54273-009_171be518-73bb-4425-9565-1545166d3f51	54273-009	HUMAN OTC DRUG	ZIMS MAX FREEZE	PRO FORMULA	MENTHOL, UNSPECIFIED FORM	LIQUID	TOPICAL	20180820		OTC MONOGRAPH DRUG	M017	KOBAYASHI Healthcare International, Inc.	MENTHOL, UNSPECIFIED FORM	160	mg/mL			N	20241231
54273-010_46c8e781-48f0-4e4a-aa16-54bae3ecd0e3	54273-010	HUMAN OTC DRUG	ZIMS MAX FREEZE		LIDOCAINE HYDROCHLORIDE and MENTHOL,	PATCH	TOPICAL	20220201		OTC MONOGRAPH DRUG	M017	KOBAYASHI Healthcare International, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	760; 190	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54273-011_223b6899-de24-47f9-842b-588689ab1a41	54273-011	HUMAN OTC DRUG	ZIMS MAX FREEZE	LEG CRAMP	Menthol	LIQUID	TOPICAL	20220901		OTC MONOGRAPH DRUG	M017	KOBAYASHI Healthcare International, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	31; 50; 115	mg/mL; mg/mL; mg/mL			N	20241231
54273-012_8ee2a905-cc9f-4d1b-a9b4-5a5757a7af2b	54273-012	HUMAN OTC DRUG	ZIMS MAX FREEZE		LIDOCAINE HYDROCHLORIDE and MENTHOL,	PATCH	TOPICAL	20230510		OTC MONOGRAPH DRUG	M017	KOBAYASHI Healthcare International, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	760; 190	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54288-100_06f95c23-c908-982b-e063-6394a90a353f	54288-100	HUMAN PRESCRIPTION DRUG	ZOLEDRONIC ACID		ZOLEDRONIC ACID	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180402		ANDA	ANDA207341	BPI Labs, LLC	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
54288-103_06fd451b-ef8a-137f-e063-6394a90a8a2c	54288-103	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140808		NDA	NDA205029	BPI Labs, LLC	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
54288-105_06f9542c-d232-880d-e063-6394a90aab39	54288-105	HUMAN PRESCRIPTION DRUG	Dehydrated Alcohol		Alcohol	INJECTION, SOLUTION	PERCUTANEOUS	20181024		NDA	NDA207987	BPI Labs, LLC	ALCOHOL	1	mL/mL			N	20241231
54288-109_06f96225-77ba-97d9-e063-6394a90ace31	54288-109	HUMAN PRESCRIPTION DRUG	Melphalan hydrochloride		Melphalan Hydrochloride	KIT		20210702		ANDA	ANDA209197	BPI Labs LLC						N	20241231
54288-111_06f9676f-94db-ab74-e063-6394a90ae690	54288-111	HUMAN PRESCRIPTION DRUG	HYOSCYAMINE SULFATE		HYOSCYAMINE SULFATE	INJECTION, SOLUTION	SUBCUTANEOUS	20191018		UNAPPROVED DRUG OTHER		BPI Labs LLC	HYOSCYAMINE SULFATE	.5	mg/mL			N	20241231
54288-117_06fd4e9f-bc72-0d5f-e063-6294a90ad352	54288-117	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRAVENOUS	20230524		NDA	NDA205029	BPI Labs, LLC	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
54288-120_06f96225-77b8-97d9-e063-6394a90ace31	54288-120	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220316		NDA	NDA205029	BPI Labs, LLC	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
54288-124_cc365998-ad67-495e-b7d3-e669de3f6bdf	54288-124	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20231115		ANDA	ANDA216977	BPI Labs LLC	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
54288-125_06f96225-77bc-97d9-e063-6394a90ace31	54288-125	HUMAN PRESCRIPTION DRUG	Potassium Chloride for Oral Solution		Potassium Chloride for Oral Solution	POWDER, FOR SOLUTION	ORAL	20191021		ANDA	ANDA212183	BPI Labs LLC	POTASSIUM CHLORIDE	1.5	g/1.58g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54288-127_06f94cf4-782c-0797-e063-6394a90a32c4	54288-127	HUMAN PRESCRIPTION DRUG	Tetracaine HCL		Tetracaine HCL	INJECTION	SUBARACHNOID	20200626		UNAPPROVED DRUG OTHER		BPI LABS LLC	TETRACAINE HYDROCHLORIDE	10	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
54288-135_06f9676f-94da-ab74-e063-6394a90ae690	54288-135	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20200408		ANDA	ANDA206651	BPI LABS LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
54288-136_06fd57fc-7f79-28bd-e063-6394a90a17c5	54288-136	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220107		UNAPPROVED DRUG OTHER		BPI Labs LLC	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
54288-137_06fd57fc-7f79-28bd-e063-6394a90a17c5	54288-137	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220107		UNAPPROVED DRUG OTHER		BPI Labs LLC	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
54288-140_06f9676f-94dc-ab74-e063-6394a90ae690	54288-140	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20200713		ANDA	ANDA205600	BPI LABS LLC	LEVOFLOXACIN	15	mg/mL			N	20241231
54288-141_ca3316cb-789b-480b-addf-d8ea19cfe4f2	54288-141	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230308		ANDA	ANDA214283	BPI Labs LLC	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
54288-142_aff11037-bc62-4580-93b2-7ec748fbbef2	54288-142	HUMAN PRESCRIPTION DRUG	PAPAVERINE HYDROCHLORIDE		Papaverine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	20210710		UNAPPROVED DRUG OTHER		BPI Labs LLC	PAPAVERINE HYDROCHLORIDE	30	mg/mL			N	20241231
54288-147_06f909bd-1a91-b916-e063-6394a90a1a54	54288-147	HUMAN PRESCRIPTION DRUG	Methylene Blue		Methylene Blue	INJECTION	INTRAVENOUS	20211223		UNAPPROVED DRUG OTHER		BPI LABS LLC	METHYLENE BLUE	10	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
54288-151_06f95c23-c906-982b-e063-6394a90a353f	54288-151	HUMAN PRESCRIPTION DRUG	Aminocaproic acid		Aminocaproic acid	SOLUTION	ORAL	20220516		ANDA	ANDA213825	BPI LABS LLC	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
54288-155_06fd4219-e95c-1384-e063-6394a90ab67a	54288-155	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRACARDIAC; INTRAVENOUS	20230417		UNAPPROVED DRUG OTHER		BPI LABS LLC	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
54288-159_06fd70ae-8e36-90b7-e063-6294a90a0622	54288-159	HUMAN PRESCRIPTION DRUG	Methylene Blue		Methylene Blue	INJECTION	INTRAVENOUS	20230515		UNAPPROVED DRUG OTHER		BPI LABS LLC	METHYLENE BLUE	10	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
54288-160_06fd8290-5294-92b6-e063-6294a90a63b1	54288-160	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20230704		ANDA	ANDA216156	BPI Labs LLC	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54288-161_06fd8290-5294-92b6-e063-6294a90a63b1	54288-161	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20230704		ANDA	ANDA216156	BPI Labs LLC	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54288-163_08f19c5b-9ece-fff7-e063-6294a90ae692	54288-163	HUMAN PRESCRIPTION DRUG	Phenobarbital Oral Solution		Phenobarbital Oral	SOLUTION	ORAL	20231027		UNAPPROVED DRUG OTHER		BPI Labs LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
54288-164_e71af906-3280-4cbc-a81b-56f7838b9df9	54288-164	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20230731		ANDA	ANDA207324	BPI Labs LLC	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
54288-165_e71af906-3280-4cbc-a81b-56f7838b9df9	54288-165	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20230731		ANDA	ANDA207324	BPI Labs LLC	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
54288-166_e71af906-3280-4cbc-a81b-56f7838b9df9	54288-166	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20230731		ANDA	ANDA207324	BPI Labs LLC	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
54288-167_e71af906-3280-4cbc-a81b-56f7838b9df9	54288-167	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20230731		ANDA	ANDA207324	BPI Labs LLC	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
54288-600_07499f03-92b9-a295-e063-6294a90ace68	54288-600	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		EPINEPHRINE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20230116		NDA	NDA205029	BPI Labs, LLC	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
54295-302_f7816277-b8ad-1726-e053-6394a90a3af1	54295-302	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	CREAM	TOPICAL	20121210		UNAPPROVED DRUG OTHER		Trinity Pharmaceuticals, LLC	SALICYLIC ACID	60	mg/g			N	20241231
54295-303_f7816e8e-23d9-7375-e053-6294a90a78c6	54295-303	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	LOTION	TOPICAL	20121210		UNAPPROVED DRUG OTHER		Trinity Pharmaceuticals, LLC	SALICYLIC ACID	60	mg/g			N	20241231
54295-304_f7816e8e-23ed-7375-e053-6294a90a78c6	54295-304	HUMAN PRESCRIPTION DRUG	Salicylic Acid		salicylic acid	SOLUTION	TOPICAL	20131116		UNAPPROVED DRUG OTHER		Trinity Pharmaceuticals, LLC	SALICYLIC ACID	275	mg/mL			N	20241231
54295-308_f781ada8-f8ff-b233-e053-6394a90a87ff	54295-308	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20140901		UNAPPROVED DRUG OTHER		Trinity Pharmaceuticals, LLC	UREA	40	g/100g			N	20241231
54295-311_f7817c34-5292-7623-e053-6394a90a6b97	54295-311	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20131202		UNAPPROVED DRUG OTHER		Trinity Pharmaceuticals, LLC	UREA	39	g/100g			N	20241231
54295-312_f7819295-3e4c-bee8-e053-6294a90a4430	54295-312	HUMAN PRESCRIPTION DRUG	UREA		UREA	LOTION	TOPICAL	20140919		UNAPPROVED DRUG OTHER		Trinity Pharmaceuticals, LLC	UREA	40	g/100g			N	20241231
54296-0001_05e90b98-059a-cf6b-e063-6394a90a8477	54296-0001	HUMAN OTC DRUG	CIPHERKEYshampoo		black soybean extracts	SHAMPOO	TOPICAL	20230914		UNAPPROVED DRUG OTHER		Jeuncell Co.,Ltd	SOYBEAN OIL	3	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
54296-0002_05ec53fb-93fc-fcbf-e063-6294a90aaa00	54296-0002	HUMAN OTC DRUG	CIPHERKEY HAIR TONIC		black soybean extracts	LIQUID	TOPICAL	20230921		UNAPPROVED DRUG OTHER		Jeuncell Co.,Ltd	SOYBEAN OIL	8	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
54296-0003_05ec8358-926e-d82a-e063-6294a90a4f1c	54296-0003	HUMAN OTC DRUG	CIPHERKEY IT SKIN		Morus Alba Leaf Extract	LIQUID	TOPICAL	20230921		UNAPPROVED DRUG OTHER		Jeuncell Co.,Ltd	MORUS ALBA LEAF	6	g/100mL			N	20241231
54296-0004_05ebd071-3383-a537-e063-6294a90ab59a	54296-0004	HUMAN OTC DRUG	JANGBALZZANG BIOTINshampoo		black soybean extracts	SHAMPOO	TOPICAL	20230921		UNAPPROVED DRUG OTHER		Jeuncell Co.,Ltd	SOYBEAN OIL	4	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
54296-0005_05ec49a2-b34c-7f77-e063-6294a90a04bd	54296-0005	HUMAN OTC DRUG	JANGBALZZANG HAIR TONIC		black soybean extracts	LIQUID	TOPICAL	20230921		UNAPPROVED DRUG OTHER		Jeuncell Co.,Ltd	SOYBEAN OIL	6	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
54305-010_8c248964-cfbd-46e9-af17-8e3da561b4d6	54305-010	HUMAN OTC DRUG	ORGANIC PEPPERMINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	20191202		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	1.9	mg/1			N	20241231
54305-102_77e09e49-1c1d-49e1-8675-3a02a8c96f4b	54305-102	HUMAN OTC DRUG	SUGAR FREE LEMON MINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	1.1	mg/1			N	20241231
54305-108_e983ec0e-a304-4f5a-99b0-1ccbade2dddd	54305-108	HUMAN OTC DRUG	NATURAL HONEY HERB COUGH SUPPRESSANT THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	2	mg/1			N	20241231
54305-153_8cf282d2-2f47-4f81-9778-a4e2e889b36f	54305-153	HUMAN OTC DRUG	COOL RELIEF ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20180601		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	15.3	mg/1			N	20241231
54305-156_539f5fb5-e478-4254-89e8-6d1223a3ccaf	54305-156	HUMAN OTC DRUG	COOL RELIEF LEMON FROST ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20190401		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	16	mg/1			N	20241231
54305-175_adb28f96-9619-4e51-ac75-73abc70084ab	54305-175	HUMAN OTC DRUG	THE ORIGINAL NATURAL HERB COUGH DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	4.8	mg/1			N	20241231
54305-185_93d7a787-6b15-4c70-91c0-1592f89b3ec1	54305-185	HUMAN OTC DRUG	MOUNTAIN HERB SUGAR FREE WITH STEVIA COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20150901		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	4.8	mg/1			N	20241231
54305-201_b942ea18-8d81-4b5e-b676-5f946ab5fbf5	54305-201	HUMAN OTC DRUG	RICOLA MAX THROAT CARE SWISS CHERRY		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	8.3	mg/1			N	20241231
54305-202_42543e18-4c42-4caf-b62c-c83071bd2c8b	54305-202	HUMAN OTC DRUG	RICOLA MAX THROAT CARE COOL PEPPERMINT		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	8.3	mg/1			N	20241231
54305-203_3cec026f-5338-4d71-babc-acceb3be5a16	54305-203	HUMAN OTC DRUG	RICOLA MAX THROAT CARE HONEY LEMON		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	8.3	mg/1			N	20241231
54305-206_111738f2-6463-4802-bccd-cc3dbb4a47d8	54305-206	HUMAN OTC DRUG	RICOLA MAX NASAL CARE COOL MENTHOL		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	15.3	mg/1			N	20241231
54305-301_15890ced-90c4-4f3c-bc11-853a07982776	54305-301	HUMAN OTC DRUG	Throat Balm Caramel Pectin		Pectin	LOZENGE	ORAL	20221101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	PECTIN	3.8	mg/1			N	20241231
54305-313_ef8143b0-e1aa-4d08-af29-d30fe9e58f62	54305-313	HUMAN OTC DRUG	DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20110403		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	8.3	mg/1			N	20241231
54305-323_88e06588-7b94-45df-936b-c77149fd3b11	54305-323	HUMAN OTC DRUG	DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20110403		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	8.3	mg/1			N	20241231
54305-331_4ac1b08c-ac20-4dd6-b855-31e375de1782	54305-331	HUMAN OTC DRUG	DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20110403		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	8.5	mg/1			N	20241231
54305-436_cbfac894-f4a7-49f6-9180-503ea3893b02	54305-436	HUMAN OTC DRUG	BERRY MEDLEY THROAT DROPS		MENTHOL	LOZENGE	ORAL	20210517		OTC MONOGRAPH DRUG	M022	Ricola Ag	MENTHOL	1.7	mg/1			N	20241231
54305-467_7ad04492-3ae0-42a8-8bd2-1238697cddd4	54305-467	HUMAN OTC DRUG	Natural Honey Lemon with Echinacea Cough Suppressant Throat Drops		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	3.5	mg/1			N	20241231
54305-489_4ad64aff-8860-49a4-8eaa-7b473e42c3ae	54305-489	HUMAN OTC DRUG	NATURAL LEMON MINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	1.5	mg/1			N	20241231
54305-507_62b41d9c-227d-493b-b0d2-a3869f1e4b46	54305-507	HUMAN OTC DRUG	Natural Cherry Honey Herb Throat Drops		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	1.8	mg/1			N	20241231
54305-513_0c2e4356-449e-4e9a-85ce-5ac4e9ef7d83	54305-513	HUMAN OTC DRUG	COOL RELIEF ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20200201		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	13.2	mg/1			N	20241231
54305-517_af8c3230-0a9e-483b-a07d-e80c343b643a	54305-517	HUMAN OTC DRUG	Natural Cherry Honey Herb Throat Drops		MENTHOL	LOZENGE	ORAL	20220101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	2.1	mg/1			N	20241231
54305-518_f19c4da9-e507-412d-9448-7861bfb2da4f	54305-518	HUMAN OTC DRUG	Cherry Throat Drops		MENTHOL	LOZENGE	ORAL	20230401		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	1.3	mg/1			N	20241231
54305-617_a884d04e-fd77-4e86-8250-38ec58ae1a87	54305-617	HUMAN OTC DRUG	EXTRA STRENGTH WITH NATURAL MENTHOL GLACIER MINT COUGH SUPPRESSANT		MENTHOL	LOZENGE	ORAL	20130527		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	8.3	mg/1			N	20241231
54305-676_778d1824-9a83-4d52-b670-4a79a1981592	54305-676	HUMAN OTC DRUG	NATURAL LEMON MINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	1.6	mg/1			N	20241231
54305-802_ab3ca15b-fbc7-40be-8f2c-b6341d63aa02	54305-802	HUMAN OTC DRUG	SUGAR FREE ORIGINAL SWISS HERB COUGH SUPPRESSANT THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420412		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	4.8	mg/1			N	20241231
54305-840_5812b137-b316-470c-ac3d-995f1f734aaf	54305-840	HUMAN OTC DRUG	SUGAR FREE GREEN TEA WITH ECHINACEA COUGH SUPPRESSANT THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	4.1	mg/1			N	20241231
54305-909_7be78a75-2adc-47b4-bbcd-0ca0497d6d3c	54305-909	HUMAN OTC DRUG	Natural Cherry Honey Herb Throat Drops		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	2	mg/1			N	20241231
54305-910_72281fbd-d850-4b79-bf53-8d3bdd5d156f	54305-910	HUMAN OTC DRUG	Cherry Throat Drops		MENTHOL	LOZENGE	ORAL	20230401		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	1.4	mg/1			N	20241231
54305-923_b8352119-5a8c-4567-bc8e-c0bf20cb6904	54305-923	HUMAN OTC DRUG	THE ORIGINAL NATURAL HERB COUGH DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola Ag	MENTHOL	5.3	mg/1			N	20241231
54305-933_5ff3763f-b3c7-4981-a86d-6e850d5bb882	54305-933	HUMAN OTC DRUG	Original Herb Cough Drops		MENTHOL	LOZENGE	ORAL	20220101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	5.5	mg/1			N	20241231
54305-976_19dfa82e-8429-4a73-a797-dffac8452e5b	54305-976	HUMAN OTC DRUG	SUGAR FREE SWISS CHERRY HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola Ag	MENTHOL	2.2	mg/1			N	20241231
54312-019_08c13282-54b1-52a8-e063-6394a90a5c1d	54312-019	HUMAN OTC DRUG	VITACILINA NEOMYCIN SULFATE FIRST AID ANTIBIOTIC		NEOMYCIN SULFATE	OINTMENT	TOPICAL	20160730		OTC MONOGRAPH DRUG	M004	Compania Internacional de Comercio, S.A.P.I de C.V.	NEOMYCIN SULFATE	3.5	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
54312-125_08c11d0d-600e-5641-e063-6394a90a1134	54312-125	HUMAN OTC DRUG	Derman Antifungal		ZINC UNDECYLENATE	CREAM	TOPICAL	20130812		OTC MONOGRAPH DRUG	M005	Compania Internacional de Comercio, S.A.P.I de C.V.	UNDECYLENIC ACID; ZINC UNDECYLENATE	5; 18	g/100g; g/100g			N	20241231
54312-325_08c13282-54a5-52a8-e063-6394a90a5c1d	54312-325	HUMAN OTC DRUG	DERMAN ANTIFUNGAL		UNDECYLENIC ACID	SPRAY	TOPICAL	20131021		OTC MONOGRAPH DRUG	M005	Compania Internacional de Comercio, S.A.P.I de C.V.	UNDECYLENIC ACID	100	mg/mL			N	20241231
54312-525_08c115b6-8e8c-149b-e063-6294a90a51fb	54312-525	HUMAN OTC DRUG	VITACILINA Bebe Diaper Rash		ALLANTOIN, ZINC OXIDE	OINTMENT	TOPICAL	20130930		OTC MONOGRAPH DRUG	M016	Compania Internacional de Comercio, S.A.P.I de C.V.	ALLANTOIN; ZINC OXIDE	10; 250	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54312-825_08c1157e-e2d4-2809-e063-6394a90acf48	54312-825	HUMAN OTC DRUG	Rocainol TOPICAL ANALGESIC		METHYL SALICYLATE, MENTHOL	OINTMENT	TOPICAL	20130930		OTC MONOGRAPH DRUG	M017	Compania Internacional de Comercio, S.A.P.I de C.V.	MENTHOL; METHYL SALICYLATE	8; 16	g/100g; g/100g			N	20241231
54312-925_08c12b68-e06d-3c2e-e063-6294a90a9998	54312-925	HUMAN OTC DRUG	DERMAN ANTIFUNGAL		ZINC UNDECYLENATE, UNDECYLENIC ACID	POWDER	TOPICAL	20130930		OTC MONOGRAPH DRUG	M005	Compania Internacional de Comercio, S.A.P.I. de C.V.	UNDECYLENIC ACID; ZINC UNDECYLENATE	2; 20	g/100g; g/100g			N	20241231
54316-123_3c908560-43d6-4204-bd8f-8111cdefc2a9	54316-123	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205767	Youngstown Oxygen & Welding Supply, Inc.	OXYGEN	.995	L/L			N	20241231
54323-103_081242ad-b00b-e723-e063-6394a90a50e1	54323-103	HUMAN OTC DRUG	Flanders Healing		White Petrolatum	OINTMENT	TOPICAL	20201204		OTC MONOGRAPH DRUG	M016	Flanders Inc	PETROLATUM	40	g/100g			N	20241231
54323-215_0811ee13-b4eb-f61d-e063-6394a90a04ea	54323-215	HUMAN OTC DRUG	Flanders Buttocks		White petrolatum, zinc oxide	OINTMENT	TOPICAL	19861016		OTC MONOGRAPH DRUG	M016	Flanders Inc	PETROLATUM; ZINC OXIDE	66.2; 13.4	g/100g; g/100g			N	20241231
54340-017_f9a355a9-aa5e-7b17-e053-6394a90a573c	54340-017	HUMAN OTC DRUG	Dial refresh and renew Antibacterial	Mountain Fresh	Benzalkonium Chloride	SOAP	TOPICAL	20221122		OTC MONOGRAPH NOT FINAL	part333E	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-020_efd567c3-d75d-cf05-e053-2995a90af691	54340-020	HUMAN OTC DRUG	Dial Antibacterial	with Vitamins	Benzalkonium Chloride	SOAP	TOPICAL	20221122		OTC MONOGRAPH NOT FINAL	part333E	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-141_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-141	HUMAN OTC DRUG	Dial Complete LHS Lavender and Jasmine		Liquid Hand Soap Lavender and Jasmine	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-142_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-142	HUMAN OTC DRUG	Dial Complete Spring Water		Antibacterial Hand Wash Spring Water	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-143_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-143	HUMAN OTC DRUG	Dial Complete Gold		Antibacterial Hand Wash Gold	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-144_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-144	HUMAN OTC DRUG	Dial Complete LHS Sweet Watermelon		Liquid Hand Soap Sweet Watermelon	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-145_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-145	HUMAN OTC DRUG	Dial Complete White Tea		Antibacterial Hand Wash White Tea	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-146_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-146	HUMAN OTC DRUG	Dial Complete Aloe		Antibacterial Hand Wash Aloe	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-147_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-147	HUMAN OTC DRUG	Dial Complete LHS Lemon and Sage		Liquid Hand Soap Lemon and Sage	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-148_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-148	HUMAN OTC DRUG	Dial Complete LHS Pomegranate and Tangerine		Liquid Hand Soap Pomegranate and Tangerine	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-149_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-149	HUMAN OTC DRUG	Dial Complete Spring Water FHW		Dial Complete Spring Water FHW	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-150_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-150	HUMAN OTC DRUG	Dial Complete Fresh Pear FHW		Dial Complete Fresh Pear FHW	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-151_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-151	HUMAN OTC DRUG	Dial Complete FHW Fresh Lavendar		Dial Complete FHW Fresh Lavendar	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-152_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-152	HUMAN OTC DRUG	Dial Complete FHW Soothing White Tea		Dial Complete FHW Soothing White Tea	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-153_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-153	HUMAN OTC DRUG	Dial Complete FHW Coconut Water		Dial Complete FHW Coconut Water	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-154_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-154	HUMAN OTC DRUG	Dial Complete FHW Silk and Seaberry		Dial Complete FHW Silk and Seaberry	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-155_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-155	HUMAN OTC DRUG	Dial Complete FHW Power Berries		Dial Complete FHW Power Berries	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-156_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-156	HUMAN OTC DRUG	Dial Complete FHW Citrus Sunburst		Dial Complete FHW Citrus Sunburst	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-157_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-157	HUMAN OTC DRUG	Dial Complete 2in1 FHW Manuka Honey		Dial Complete 2in1 FHW Manuka Honey	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-158_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-158	HUMAN OTC DRUG	Dial Complete 2in1 FHW Rose Oil		Dial Complete 2in1 FHW Rose Oil	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-159_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-159	HUMAN OTC DRUG	Dial Complete 2in1 FHW Pearl Essence		Dial Complete 2in1 FHW Pearl Essence	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-160_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-160	HUMAN OTC DRUG	Dial Complete 2in1 FHW Mint and Shea		Dial Complete 2in1 FHW Mint and Shea	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-161_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-161	HUMAN OTC DRUG	Dial Complete CG FHW Aloe		Dial Complete CG FHW Aloe	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-162_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-162	HUMAN OTC DRUG	Dial Complete CG FHW Grapefruit		Dial Complete CG FHW Grapefruit	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-163_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-163	HUMAN OTC DRUG	Dial Complete CG FHW Fragrance Free		Dial Complete CG FHW Fragrance Free	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-164_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-164	HUMAN OTC DRUG	Dial Complete LHS Clean and Gentle		Liquid Hand Soap Waterlilly	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-165_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-165	HUMAN OTC DRUG	Dial Complete LHS Clean and Gentle		Liquid Hand Soap Clean and Gentle	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-166_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-166	HUMAN OTC DRUG	Dial Complete BW Men		Dial Complete BW Men	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-167_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-167	HUMAN OTC DRUG	Dial Complete BW Apple Blossom		Dial Complete BW Apple Blossom	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-168_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-168	HUMAN OTC DRUG	Dial Complete Limited Edition FHW Fireside Crackle		Dial Complete Limited Edition FHW Fireside Crackle	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-169_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-169	HUMAN OTC DRUG	Dial Complete Limited Edition FHW Ice Crystals		Dial Complete Limited Edition FHW Ice Crystals	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-170_0b2821b9-b9c9-2cf6-e063-6394a90a8c98	54340-170	HUMAN OTC DRUG	Dial Complete Limited Edition FHW Midnight Toast		Dial Complete Limited Edition FHW Midnight Toast	SOLUTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-172_0c5747d6-2efe-abf9-e063-6394a90ad03a	54340-172	HUMAN OTC DRUG	Dial Antibacterial Gel Hand Sanitizer		Dial Antibacterial Gel Hand Sanitizer	GEL	TOPICAL	20220621		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	ALCOHOL	.62	g/100mL			N	20241231
54340-173_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-173	HUMAN OTC DRUG	Dial Antibacterial Defense Gold		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-174_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-174	HUMAN OTC DRUG	Dial Antibacterial and Sensitive Fragrance Free		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-175_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-175	HUMAN OTC DRUG	Dial Antibacterial Defense Lavender and Jasmine		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-176_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-176	HUMAN OTC DRUG	Dial Antibacterial Defense White Tea		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-177_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-177	HUMAN OTC DRUG	Dial Antibacterial Defense Pomegranate and Tangerine		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-181_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-181	HUMAN OTC DRUG	Dial Antibacterial Defense Lemon and Sage		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-182_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-182	HUMAN OTC DRUG	Dial Antibacterial and Sensitive Aloe		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-183_0c53cf6c-7f69-98aa-e063-6394a90a149d	54340-183	HUMAN OTC DRUG	Dial Antibacterial Defense Spring Water		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-184_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-184	HUMAN OTC DRUG	Dial Foaming Antibacterial Defense Coconut Water		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-185_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-185	HUMAN OTC DRUG	Dial Foaming Antibacterial Defense Fresh Pear		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-186_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-186	HUMAN OTC DRUG	Dial Foaming Antibacterial Defense Soothing White Tea		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-188_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-188	HUMAN OTC DRUG	Dial Foaming Antibacterial Defense Citrus Sunburst		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-189_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-189	HUMAN OTC DRUG	Dial Foaming Antibacterial Defense Fresh Lavender		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-190_0a338a2e-f91b-2a17-e063-6294a90acad1	54340-190	HUMAN OTC DRUG	Dial Advanced Clean Antibacterial Body Wash Apple Blossom		Benzalkonium Chloride	SOLUTION	TOPICAL	20220501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-191_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-191	HUMAN OTC DRUG	Dial Foaming Antibacterial Defense Power Berries		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-193_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-193	HUMAN OTC DRUG	Dial Foaming Antibacterial Sensitive Aloe		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-194_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-194	HUMAN OTC DRUG	Dial Foaming Antibacterial Sensitive Fragrance Free		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-195_0bdab40d-ee89-1ebf-e063-6394a90aafcd	54340-195	HUMAN OTC DRUG	Dial Foaming Antibacterial Defense Spring Water		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54340-260_f7f5eda3-fc22-ffff-e053-6394a90a5265	54340-260	HUMAN OTC DRUG	Dial refresh and renew	Antibacterial white	Benzalkonium Chloride	SOAP	TOPICAL	20230102		OTC MONOGRAPH NOT FINAL	part333E	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-262_f7f6d5ad-929c-26ef-e053-6294a90a9ce1	54340-262	HUMAN OTC DRUG	Dial advanced clean	Antibacterial gold	Benzalkonium Chloride	SOAP	TOPICAL	20230102		OTC MONOGRAPH NOT FINAL	part333E	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-265_082856c9-a019-3b54-e063-6394a90af3c3	54340-265	HUMAN OTC DRUG	Dial Complete	White Antibacterial	Benzalkonium Chloride	SOAP	TOPICAL	20210722	20241228	OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	
54340-266_0a24c2c8-8154-9bf8-e063-6294a90a066e	54340-266	HUMAN OTC DRUG	Dial Antibacterial Calm and Soothe		Benzalkonium Chloride	SOAP	TOPICAL	20220907		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-269_0dfa4948-6ba4-bc88-e063-6294a90a87b6	54340-269	HUMAN OTC DRUG	Dial Complete	Gold Antibacterial	Benzalkonium Chloride	SOAP	TOPICAL	20220310	20241228	OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	
54340-270_0a246eae-0a38-80a8-e063-6294a90a4c39	54340-270	HUMAN OTC DRUG	Dial Complete Antibacterial Bar	Spring Water	Benzalkonium chloride	SOAP	TOPICAL	20210308		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-272_0a20069f-55c6-e3b7-e063-6394a90a7d6d	54340-272	HUMAN OTC DRUG	Dial Antibacterial Bar		Dial Gold Antibacterial Bar Soap	SOAP	TOPICAL	20170301		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-272_f4362d2e-d309-1b17-e053-2a95a90aadb9	54340-272	HUMAN OTC DRUG	Dial Antibacterial Bar		Dial Gold Antibacterial Bar Soap	SOAP	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part333E	Henkel Corporation	BENZALKONIUM CHLORIDE	.113	g/113g			N	20241231
54340-274_0a24d60a-7ed4-1d1b-e063-6394a90a60a0	54340-274	HUMAN OTC DRUG	Dial Antibacterial Bar		Dial Mountain Fresh Antibacterial Bar Soap	SOAP	TOPICAL	20170701		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-278_09d2bc09-6d92-bcf9-e063-6294a90af0a2	54340-278	HUMAN OTC DRUG	Dial Antibacterial Bar		Dial White Antibacterial Bar Soap	SOAP	TOPICAL	20170701		OTC MONOGRAPH DRUG	505G(a)(3)	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54340-282_f0fbed65-66e8-1966-e053-2995a90ab989	54340-282	HUMAN OTC DRUG	Dial Antibacterial Bar		Dial Vitamins Antibacterial Soap	SOAP	TOPICAL	20171002	20251231	OTC MONOGRAPH NOT FINAL	part333E	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	
54340-300_f8390075-4f13-ee0f-e053-6294a90a808b	54340-300	HUMAN OTC DRUG	Dial refresh and renew Antibacterial Bar	Spring Water	Benzalkonium chloride	SOAP	TOPICAL	20230102		OTC MONOGRAPH NOT FINAL	part333E	Henkel Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
54348-049_ea80f872-77da-6cc7-e053-2995a90af155	54348-049	HUMAN PRESCRIPTION DRUG	Lorazepam		LORAZEPAM	TABLET	ORAL	20190711		ANDA	ANDA078203	PharmPak, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
54348-114_ea92a656-4fd4-df01-e053-2a95a90a9de3	54348-114	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE		PROCHLORPERAZINE	TABLET	ORAL	20190712		ANDA	ANDA040268	PharmPak, Inc.	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
54348-117_ea92baba-9184-5d68-e053-2a95a90a5e8f	54348-117	HUMAN PRESCRIPTION DRUG	Promethazine		PROMETHAZINE	TABLET	ORAL	20190711		ANDA	ANDA040712	PharmPak, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
54348-148_ea92d79f-b58c-2ad8-e053-2a95a90acafb	54348-148	HUMAN PRESCRIPTION DRUG	Misoprostol		MISOPROSTOL	TABLET	ORAL	20190710		ANDA	ANDA091667	PharmPak, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
54348-340_eb00ddbc-db02-8bba-e053-2a95a90af70c	54348-340	HUMAN PRESCRIPTION DRUG	Spironolactone		SPIRONOLACTONE	TABLET	ORAL	20190709		ANDA	ANDA091426	PharmPak, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
54348-506_ea92f170-7889-dd0d-e053-2a95a90a80f0	54348-506	HUMAN PRESCRIPTION DRUG	Prednisone		PREDNISONE	TABLET	ORAL	20190712		ANDA	ANDA080356	PharmPak, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54348-624_ea935f93-6c2c-2e8a-e053-2995a90a2ce0	54348-624	HUMAN PRESCRIPTION DRUG	Acyclovir		ACYCLOVIR	TABLET	ORAL	20190709		ANDA	ANDA203834	PharmPak, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
54348-625_ea935f93-6c2d-2e8a-e053-2995a90a2ce0	54348-625	HUMAN PRESCRIPTION DRUG	Sulfamethox-TMP DS		SULFAMETHOXAZOLE, TRIMETHOPRIM	TABLET	ORAL	20190711		ANDA	ANDA076899	PharmPak, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
54348-627_ea937906-dba1-207f-e053-2a95a90a111e	54348-627	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	PharmPak, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
54348-662_ea938405-8d24-fa08-e053-2995a90af8dc	54348-662	HUMAN PRESCRIPTION DRUG	ciprofloxacin		CIPROFLOXACIN	TABLET	ORAL	20190710		ANDA	ANDA076639	PharmPak, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
54348-663_ea938ef9-a316-2003-e053-2a95a90aa829	54348-663	HUMAN PRESCRIPTION DRUG	ciprofloxacin		CIPROFLOXACIN	TABLET	ORAL	20190710		ANDA	ANDA076639	PharmPak, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
54348-701_ea93984c-32f9-71e9-e053-2995a90a84d2	54348-701	HUMAN PRESCRIPTION DRUG	Estradiol		ESTRADIOL	TABLET	ORAL	20190709		ANDA	ANDA040197	PharmPak, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
54348-702_ea93984c-32fa-71e9-e053-2995a90a84d2	54348-702	HUMAN PRESCRIPTION DRUG	Estradiol		ESTRADIOL	TABLET	ORAL	20190709		ANDA	ANDA040197	PharmPak, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
54348-740_ea93abaf-cd17-a842-e053-2995a90a8fb3	54348-740	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET, FILM COATED	ORAL	20190710		ANDA	ANDA203458	PharmPak, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
54348-745_eaa5779b-424d-01ba-e053-2a95a90ae500	54348-745	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET, FILM COATED	ORAL	20190712		ANDA	ANDA203458	PharmPak, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
54348-805_eaa58b56-e846-aab7-e053-2995a90a49c2	54348-805	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone		MEDROXYPROGESTERONE	TABLET	ORAL	20190712		ANDA	ANDA040159	PharmPak, Inc.	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
54348-819_eaa5779b-4250-01ba-e053-2a95a90ae500	54348-819	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON	TABLET, FILM COATED	ORAL	20190710		ANDA	ANDA078539	PharmPak, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
54348-821_eaa58b56-e847-aab7-e053-2995a90a49c2	54348-821	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20190808		ANDA	ANDA078539	Pharmpak, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
54348-825_eaa5b55d-10af-aab9-e053-2995a90a05d7	54348-825	HUMAN PRESCRIPTION DRUG	Ibuprofen		IBUPROFEN	TABLET, FILM COATED	ORAL	20190711		ANDA	ANDA091625	PharmPak, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
54348-830_eaa5b55d-10b0-aab9-e053-2995a90a05d7	54348-830	HUMAN PRESCRIPTION DRUG	Ibuprofen		IBUPROFEN	TABLET, FILM COATED	ORAL	20190711		ANDA	ANDA091625	PharmPak, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
54348-835_eaa5cc60-19cc-a3f1-e053-2995a90a968f	54348-835	HUMAN PRESCRIPTION DRUG	Ibuprofen		IBUPROFEN	TABLET, FILM COATED	ORAL	20190711		ANDA	ANDA091625	PharmPak, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
54348-849_eaa5e1eb-d68d-a3f7-e053-2995a90aa735	54348-849	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Mono		NITROFURANTOIN MONOHYDRATE	CAPSULE	ORAL	20190710		NDA	NDA020064	PharmPak, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
54348-857_eb018961-75d1-2d69-e053-2995a90a38be	54348-857	HUMAN PRESCRIPTION DRUG	Azithromycin		AZITHROMYCIN MONOHYDRATE	TABLET, FILM COATED	ORAL	20190710		ANDA	ANDA065225	PharmPak, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
54348-989_eaa6022b-bb02-9383-e053-2995a90abe88	54348-989	HUMAN PRESCRIPTION DRUG	Prochlorperazine		PROCHLORPERAZINE	TABLET	ORAL	20190711		ANDA	ANDA040268	PharmPak, Inc.	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
54365-014_0a4ce387-972b-d780-e063-6394a90ad203	54365-014	HUMAN OTC DRUG	PurPrep		povidone iodine and isopropyl alcohol	SPONGE	TOPICAL	20200409		OTC MONOGRAPH DRUG	505G(a)(3)	CareFusion 213 LLC	ISOPROPYL ALCOHOL; POVIDONE-IODINE	725; 8.3	mg/mL; mg/mL			N	20241231
54365-400_07131644-0197-8510-e063-6294a90acd0f	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		Chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20021007		NDA	NDA021555	CareFusion 213 LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a1f4673-3e14-976b-e063-6394a90a5eed	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20190524		NDA	NDA020832	CareFusion 213, LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a1f531e-55e5-7573-e063-6294a90aaa48	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20190524		NDA	NDA020832	CareFusion 213, LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a1f7394-bd4f-b627-e063-6394a90a0a90	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20000714		NDA	NDA020832	CareFusion 213 LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a207445-d6c7-1add-e063-6394a90ae9ba	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20000714		NDA	NDA020832	CareFusion 213 LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a215248-f2c9-8e1a-e063-6294a90a8ff3	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20140723		NDA	NDA020832	CareFusion 213 LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a218eb6-b1fc-fa33-e063-6294a90a57d4	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20020426		NDA	NDA020832	CareFusion 213 LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a2431d5-75cd-386d-e063-6294a90a5be9	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20000714		NDA	NDA020832	CareFusion 213 LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a610752-d9de-1c07-e063-6394a90a45ab	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20190524		NDA	NDA020832	CareFusion 213, LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a9d4e36-305c-2120-e063-6294a90a01bd	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20190524		NDA	NDA020832	CareFusion 213, LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54365-400_0a9d6f57-965a-e06d-e063-6294a90a7f1b	54365-400	HUMAN OTC DRUG	ChloraPrep One-Step		chlorhexidine gluconate and isopropyl alcohol	SOLUTION	TOPICAL	20190524		NDA	NDA020832	CareFusion 213, LLC	CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL	20; .7	mg/mL; mL/mL	Decreased Cell Wall Integrity [PE]		N	20241231
54384-1072_f2cce2c9-d53f-41df-8015-f3af8212d345	54384-1072	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19720101		UNAPPROVED MEDICAL GAS		American Oxygen Company, Inc	OXYGEN	99	L/100L			N	20241231
54384-1073_f2cce2c9-d53f-41df-8015-f3af8212d345	54384-1073	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19720101		UNAPPROVED MEDICAL GAS		American Oxygen Company, Inc	OXYGEN	99	L/100L			N	20241231
54436-010_465ff14c-acdd-4ca2-81e3-7f07cc2fb2e4	54436-010	HUMAN PRESCRIPTION DRUG	Otrexup		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011		NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	10	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
54436-012_465ff14c-acdd-4ca2-81e3-7f07cc2fb2e4	54436-012	HUMAN PRESCRIPTION DRUG	Otrexup		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011		NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	12.5	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
54436-015_465ff14c-acdd-4ca2-81e3-7f07cc2fb2e4	54436-015	HUMAN PRESCRIPTION DRUG	Otrexup		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011		NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	15	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
54436-017_465ff14c-acdd-4ca2-81e3-7f07cc2fb2e4	54436-017	HUMAN PRESCRIPTION DRUG	Otrexup		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011		NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	17.5	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
54436-020_465ff14c-acdd-4ca2-81e3-7f07cc2fb2e4	54436-020	HUMAN PRESCRIPTION DRUG	Otrexup		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011		NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	20	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
54436-022_465ff14c-acdd-4ca2-81e3-7f07cc2fb2e4	54436-022	HUMAN PRESCRIPTION DRUG	Otrexup		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011		NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	22.5	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
54436-025_465ff14c-acdd-4ca2-81e3-7f07cc2fb2e4	54436-025	HUMAN PRESCRIPTION DRUG	Otrexup		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20131011		NDA	NDA204824	Antares Pharma, Inc.	METHOTREXATE	25	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
54436-112_25f914d5-0744-43fd-a6f2-32156697e646	54436-112	HUMAN PRESCRIPTION DRUG	Tlando		testosterone undecanoate	CAPSULE, LIQUID FILLED	ORAL	20220415		NDA	NDA208088	Antares Pharma, Inc.	TESTOSTERONE UNDECANOATE	112.5	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
54436-200_cb6917b9-70b7-45be-9f4e-b1c55938bf9b	54436-200	HUMAN PRESCRIPTION DRUG	XYOSTED		testosterone enanthate	INJECTION	SUBCUTANEOUS	20181115		NDA	NDA209863	Antares Pharma, Inc.	TESTOSTERONE ENANTHATE	100	mg/.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
54436-250_cb6917b9-70b7-45be-9f4e-b1c55938bf9b	54436-250	HUMAN PRESCRIPTION DRUG	XYOSTED		testosterone enanthate	INJECTION	SUBCUTANEOUS	20181115		NDA	NDA209863	Antares Pharma, Inc.	TESTOSTERONE ENANTHATE	50	mg/.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
54436-275_cb6917b9-70b7-45be-9f4e-b1c55938bf9b	54436-275	HUMAN PRESCRIPTION DRUG	XYOSTED		testosterone enanthate	INJECTION	SUBCUTANEOUS	20181115		NDA	NDA209863	Antares Pharma, Inc.	TESTOSTERONE ENANTHATE	75	mg/.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
54436-325_bba94cdc-188c-45ff-9423-b2c971bcc13c	54436-325	HUMAN PRESCRIPTION DRUG	NOCDURNA		DESMOPRESSIN ACETATE	TABLET	SUBLINGUAL	20210806	20250531	NDA	NDA022517	Antares Pharma, Inc.	DESMOPRESSIN ACETATE	27.7	ug/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
54436-350_bba94cdc-188c-45ff-9423-b2c971bcc13c	54436-350	HUMAN PRESCRIPTION DRUG	NOCDURNA		DESMOPRESSIN ACETATE	TABLET	SUBLINGUAL	20210806	20250531	NDA	NDA022517	Antares Pharma, Inc.	DESMOPRESSIN ACETATE	55.3	ug/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
54451-001_08019f8f-c239-1e79-e063-6394a90ae7fa	54451-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205767	Baker's Gas & Welding Supplies Inc.	OXYGEN	999	mL/L			N	20241231
54451-005_0801c70e-96fb-0140-e063-6294a90a61eb	54451-005	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA205766	Baker's Gas & Welding Supplies Inc.	NITROGEN	990	mL/L			N	20241231
54458-889_e4ec3325-3ee2-4c6a-af8a-1da984969c06	54458-889	HUMAN PRESCRIPTION DRUG	CITALOPRAM		CITALOPRAM	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA077038	International Laboratories, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
54458-980_e4ec3325-3ee2-4c6a-af8a-1da984969c06	54458-980	HUMAN PRESCRIPTION DRUG	CITALOPRAM		CITALOPRAM	TABLET, FILM COATED	ORAL	20080625		ANDA	ANDA077038	International Laboratories, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
54458-981_e4ec3325-3ee2-4c6a-af8a-1da984969c06	54458-981	HUMAN PRESCRIPTION DRUG	CITALOPRAM		CITALOPRAM	TABLET, FILM COATED	ORAL	20080625		ANDA	ANDA077038	International Laboratories, LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
54473-096_f205b04d-16d4-02ba-e053-2a95a90a0108	54473-096	HUMAN OTC DRUG	Dermatin	Antifungal	Clotrimazole	CREAM	TOPICAL	20120101		OTC MONOGRAPH FINAL	part333C	Melaleuca, Inc.	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
54473-117_fc4cde7e-b2d4-6d80-e053-6394a90a51fd	54473-117	HUMAN OTC DRUG	DermaCort	Anti-itch	Hydrocortisone	CREAM	TOPICAL	20000802		OTC MONOGRAPH NOT FINAL	part348	Melaleuca, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54473-132_f2053d5d-50ee-f9b2-e053-2a95a90a6d14	54473-132	HUMAN OTC DRUG	CounterAct	Cough Drops Honey Lemon	Menthol	LOZENGE	ORAL	20080520		OTC MONOGRAPH FINAL	part341	Melaleuca, Inc.	MENTHOL	7	mg/1			N	20241231
54473-151_f17969dc-70f0-7b32-e053-2a95a90a792e	54473-151	HUMAN OTC DRUG	Alloy	Antiperspirant and Deodorant	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20070501		OTC MONOGRAPH FINAL	part350	Melaleuca, Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.39	g/64g			N	20241231
54473-163_f2077821-678a-72bc-e053-2a95a90afe26	54473-163	HUMAN OTC DRUG	Sun Shades	Sport Sport Plus	Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20090501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	4.7106; 23.553; 7.851; 15.702	g/177mL; g/177mL; g/177mL; g/177mL			N	20241231
54473-166_0338b445-8b01-bdf2-e063-6394a90a925d	54473-166	HUMAN OTC DRUG	CounterAct	Allergy	Loratadine	TABLET	ORAL	20230819		ANDA	ANDA075209	Melaleuca, Inc.	LORATADINE	10	mg/1			N	20241231
54473-218_f3460524-3a17-183a-e053-2995a90a603d	54473-218	HUMAN OTC DRUG	Sun Shades Mineral Plus Sunscreen	with Zinc Oxide	OCTISALATE 5%, OCTOCRYlENE 3%, ZINC OXIDE 10.5%	LOTION	TOPICAL	20121227		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	9.225; 5.535; 18.45	g/177mL; g/177mL; g/177mL			N	20241231
54473-219_f20776f8-e287-778b-e053-2995a90a56b9	54473-219	HUMAN OTC DRUG	Sun Shades Lip Balm	Vanilla Bean	Avobenzone 2.5%, Octinoxate 6%, Oxybenzone 3%	STICK	TOPICAL	20130201		OTC MONOGRAPH FINAL	part352	Melaleuca Inc.	AVOBENZONE; OCTINOXATE; OXYBENZONE	.1175; .282; .141	g/4.25g; g/4.25g; g/4.25g			N	20241231
54473-220_f2077821-6789-72bc-e053-2a95a90afe26	54473-220	HUMAN OTC DRUG	Sun Shades Lip Balm	Mountain Mint	Avobenzone 2.5%, Octinoxate 6%, Oxybenzone 3%	STICK	TOPICAL	20130201		OTC MONOGRAPH FINAL	part352	Melaleuca Inc.	AVOBENZONE; OCTINOXATE; OXYBENZONE	.1175; .282; .141	g/4.25g; g/4.25g; g/4.25g			N	20241231
54473-221_f1870e06-260c-97e4-e053-2995a90af541	54473-221	HUMAN OTC DRUG	Clarity Clear Skin Essentials	Deep-Cleaning Astringent	SALICYLIC ACID	LIQUID	TOPICAL	20120913		OTC MONOGRAPH FINAL	part333D	Melaleuca, Inc.	SALICYLIC ACID	.623	g/130mL			N	20241231
54473-222_f18bae4a-11a5-7319-e053-2995a90ad1e8	54473-222	HUMAN OTC DRUG	Clarity Clear Skin Essentials	Foaming Cleanser	SALICYLIC ACID	LIQUID	TOPICAL	20120913		OTC MONOGRAPH FINAL	part333D	Melaleuca, Inc.	SALICYLIC ACID	.691	g/133mL			N	20241231
54473-223_f39606be-19c9-58d1-e053-2a95a90a908f	54473-223	HUMAN OTC DRUG	Sun Shades Lip Balm	Cranberry Tangerine	Avobenzone 2.5%, Octinoxate 6%, Oxybenzone 3%	STICK	TOPICAL	20230131		OTC MONOGRAPH FINAL	part352	Melaleuca Inc.	AVOBENZONE; OCTINOXATE; OXYBENZONE	.1175; .282; .141	g/4.25g; g/4.25g; g/4.25g			N	20241231
54473-224_f178d444-f5ee-1aa8-e053-2a95a90ab840	54473-224	HUMAN OTC DRUG	Affinia	Facial Moisturizer	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20120801		OTC MONOGRAPH FINAL	part352	Melaleuca, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.1888; 7.296; 3.648; 6.08	g/120mL; g/120mL; g/120mL; g/120mL			N	20241231
54473-225_f1870405-9e24-5b4b-e053-2a95a90a37ea	54473-225	HUMAN OTC DRUG	Clarity Clear Skin Essentials	Acne Spot Treatment	SALICYLIC ACID	CREAM	TOPICAL	20120913		OTC MONOGRAPH FINAL	part333D	Melaleuca Inc.	SALICYLIC ACID	.156	g/8.9mL			N	20241231
54473-226_f207602e-1b23-36bf-e053-2995a90a724a	54473-226	HUMAN OTC DRUG	Sun Shades Lip Balm	Pina Colada	Avobenzone 2.5%, Octinoxate 6%, Oxybenzone 3%	STICK	TOPICAL	20130201		OTC MONOGRAPH FINAL	part352	Melaleuca Inc.	AVOBENZONE; OCTINOXATE; OXYBENZONE	.1175; .282; .141	g/4.25g; g/4.25g; g/4.25g			N	20241231
54473-241_cb05b9c6-c1b9-b210-e053-2a95a90afaea	54473-241	HUMAN OTC DRUG	Sheer Confidence Antiperspirant Deodorant	Moonlit Orchid	Aluminum zirconium tetrachlorohydrex gly (19% Anhydrous)	STICK	TOPICAL	20130501		OTC MONOGRAPH FINAL	part350	Melaleuca Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/57g			N	20241231
54473-243_cb059e51-792c-3223-e053-2a95a90a3a94	54473-243	HUMAN OTC DRUG	Sheer Confidence Antiperspirant Deodorant	Perfect Powder	Aluminum zirconium tetrachlorohydrex gly (19% Anhydrous)	STICK	TOPICAL	20130501		OTC MONOGRAPH FINAL	part350	Melaleuca Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/57g			N	20241231
54473-272_f179635b-647d-5a01-e053-2a95a90aa756	54473-272	HUMAN OTC DRUG	Alloy	Antiperspirant and Deodorant	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	STICK	TOPICAL	20170101		OTC MONOGRAPH FINAL	part350	Melaleuca, Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.39	g/64g			N	20241231
54473-278_cb059e51-792b-3223-e053-2a95a90a3a94	54473-278	HUMAN OTC DRUG	Sheer Confidence Antiperspirant Deodorant	Caribbean Sunset	Aluminum zirconium tetrachlorohydrex gly (19% Anhydrous)	STICK	TOPICAL	20130501		OTC MONOGRAPH FINAL	part350	Melaleuca Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	10.83	g/57g			N	20241231
54473-279_f2074d04-f1ea-4141-e053-2a95a90a2d60	54473-279	HUMAN OTC DRUG	Sei Bella CC Brightening Creme	Fair	Octinoxate 7.5%, Titanium Dioxide 5%, Zinc Oxide 1%	LOTION	TOPICAL	20170501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.475; 1.65; .3267	g/33mL; g/33mL; g/33mL			N	20241231
54473-280_f2075073-be4f-17a4-e053-2995a90a0176	54473-280	HUMAN OTC DRUG	Sei Bella CC Brightening Creme	Light	Octinoxate 7.5%, Titanium Dioxide 5%, Zinc Oxide 1%	LOTION	TOPICAL	20170501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.475; 1.65; .3267	g/33mL; g/33mL; g/33mL			N	20241231
54473-281_f2074d04-f1e9-4141-e053-2a95a90a2d60	54473-281	HUMAN OTC DRUG	Sei Bella CC Brightening Creme	Medium	Octinoxate 7.5%, Titanium Dioxide 5%, Zinc Oxide 1%	LOTION	TOPICAL	20170501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.475; 1.65; .3267	g/33mL; g/33mL; g/33mL			N	20241231
54473-282_f2075073-be4e-17a4-e053-2995a90a0176	54473-282	HUMAN OTC DRUG	Sei Bella CC Brightening Creme	Medium Tan	Octinoxate 7.5%, Titanium Dioxide 5%, Zinc Oxide 1%	LOTION	TOPICAL	20170501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	2.475; 1.65; .3267	g/33mL; g/33mL; g/33mL			N	20241231
54473-283_68e20c57-7b31-4e96-e053-2991aa0aab3e	54473-283	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Light to Medium 160 N	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-284_68e2dfaa-d174-e6a9-e053-2a91aa0a4663	54473-284	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Light to Medium 200 N	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-285_68e2e541-c584-0f12-e053-2991aa0a4ab2	54473-285	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Medium 300 W	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-286_68e2e541-c597-0f12-e053-2991aa0a4ab2	54473-286	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Medium 320 C	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-287_68e30211-90c8-0419-e053-2a91aa0ac9cb	54473-287	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Medium 440 N	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-288_68e30255-5651-3b4a-e053-2991aa0ab3f7	54473-288	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Medium to Deep 450 W	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-289_68e30255-5653-3b4a-e053-2991aa0ab3f7	54473-289	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Medium to Deep 500 W	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-290_68e31a82-0cd1-5a1a-e053-2991aa0a33f8	54473-290	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Deep 550 N	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-291_f2077821-678c-72bc-e053-2a95a90afe26	54473-291	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc and Neomycin and Polymyxin B sulfate	OINTMENT	TOPICAL	19950701		OTC MONOGRAPH FINAL	part333B	Melaleuca, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	500; 3.5; 10000	U/g; mg/g; U/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
54473-294_f38399eb-d483-44aa-e053-2a95a90ab96e	54473-294	HUMAN OTC DRUG	BreathAway	Mouth Rinse Fresh Mint	Cetylpyridinium Chloride	MOUTHWASH	TOPICAL	20110502		OTC MONOGRAPH NOT FINAL	part356	Melaleuca, Inc.	CETYLPYRIDINIUM CHLORIDE	.3394	g/473mL			N	20241231
54473-295_f18713f1-6380-059e-e053-2995a90ac3e4	54473-295	HUMAN OTC DRUG	Clarity Clear Skin Essentials	Acne treatment	SALICYLIC ACID	CREAM	TOPICAL	20120913		OTC MONOGRAPH FINAL	part333D	Melaleuca Inc.	SALICYLIC ACID	.28	g/14g			N	20241231
54473-296_f205510b-90fb-770f-e053-2995a90a7fb0	54473-296	HUMAN OTC DRUG	Clear Defense		Ethyl alcohol	GEL	TOPICAL	20100409		OTC MONOGRAPH NOT FINAL	part333A	Melaleuca, Inc.	ALCOHOL	150.97	g/266mL			N	20241231
54473-297_f2056b6c-e97c-fd86-e053-2995a90afd0f	54473-297	HUMAN OTC DRUG	CounterAct	Cough Drops Orchard Cherry	Menthol	LOZENGE	ORAL	20080520		OTC MONOGRAPH FINAL	part341	Melaleuca, Inc.	MENTHOL	7	mg/1			N	20241231
54473-300_6624be86-c9a9-53b8-e053-2a91aa0a87ef	54473-300	HUMAN OTC DRUG	koala pals	berrylicious	Sodium Fluoride	PASTE, DENTIFRICE	TOPICAL	20100401		OTC MONOGRAPH FINAL	part355	Melaleuca, Inc.	SODIUM FLUORIDE	.2592	g/108g			N	20241231
54473-301_68933f55-0cd8-0074-e053-2991aa0adfb7	54473-301	HUMAN OTC DRUG	Whitening	Tooth Polish	Sodium Fluoride	PASTE	TOPICAL	20100401		OTC MONOGRAPH FINAL	part355	Melaleuca, Inc.	SODIUM FLUORIDE	.26244	g/108g			N	20241231
54473-302_68933f55-0cd9-0074-e053-2991aa0adfb7	54473-302	HUMAN OTC DRUG	Sensitive	Tooth Polish	Potassium Nitrate and Sodium Fluoride	PASTE, DENTIFRICE	TOPICAL	20120103		OTC MONOGRAPH NOT FINAL	part356	Melaleuca, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5.4; .26244	g/108g; g/108g			N	20241231
54473-304_7fbf2b51-9097-0a1f-e053-2991aa0a6aa1	54473-304	HUMAN OTC DRUG	CounterAct	PM	Acetaminophen and Diphenhydramine	TABLET	ORAL	20160502		OTC MONOGRAPH NOT FINAL	part343	Melaleuca, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54473-305_f215c9d6-3319-67c8-e053-2995a90afbc3	54473-305	HUMAN OTC DRUG	CounterAct	Pain	Acetaminophen	TABLET, FILM COATED	ORAL	20160502		OTC MONOGRAPH NOT FINAL	part343	Melaleuca, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
54473-306_01935f28-eb3c-d489-e063-6394a90afb16	54473-306	HUMAN OTC DRUG	CounterAct	IB	Ibuprofen	TABLET, COATED	ORAL	20230814		ANDA	ANDA072096	Melaleuca, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
54473-307_dc7e0acf-0ab8-b142-e053-2a95a90aab55	54473-307	HUMAN OTC DRUG	Affinia Antiperspirant Deodorant	Sweet Cream and Willow	Aluminum zirconium tetrachlorohydrex gly	STICK	TOPICAL	20220412		OTC MONOGRAPH FINAL	part350	Melaleuca Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	16	g/57g			N	20241231
54473-308_f2057d6a-e22d-4d60-e053-2a95a90a3c42	54473-308	HUMAN OTC DRUG	CounterAct	IB	Ibuprofen	TABLET, COATED	ORAL	20190815		ANDA	ANDA091239	Melaleuca, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
54473-309_f2074d04-f1ec-4141-e053-2a95a90a2d60	54473-309	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Sheer to Light 20 N	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-310_f2075073-be55-17a4-e053-2995a90a0176	54473-310	HUMAN OTC DRUG	Sei Bella Tinted BB Moisturizing Creme	Sheer to Light 140 N	Titanium Dioxide 5% and Zinc Oxide 5%	LOTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.5; 1.5	g/30mL; g/30mL			N	20241231
54473-311_f2054cd2-8395-7f92-e053-2995a90a9acc	54473-311	HUMAN OTC DRUG	Clear Defense		Ethyl alcohol	GEL	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333A	Melaleuca, Inc.	ALCOHOL	150.97	g/266mL			N	20241231
54473-312_f206019b-7675-260e-e053-2a95a90aba69	54473-312	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	120 W	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-313_f205fdef-d1c9-c5c1-e053-2995a90aba92	54473-313	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	220 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-314_f2060681-87e8-4d58-e053-2a95a90af8b7	54473-314	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	180 C	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-315_f2060681-87e6-4d58-e053-2a95a90af8b7	54473-315	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	40 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-316_f2060d07-638b-57c5-e053-2995a90a480c	54473-316	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	280 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-317_f2060d07-638a-57c5-e053-2995a90a480c	54473-317	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	100 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-318_f2060d07-638c-57c5-e053-2995a90a480c	54473-318	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	60 C	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-319_f2060d07-638d-57c5-e053-2995a90a480c	54473-319	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	380 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-320_f2060d07-6391-57c5-e053-2995a90a480c	54473-320	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	490 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-321_f20602ca-ed06-6fdd-e053-2995a90a494c	54473-321	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	80 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-322_f20602ca-ed07-6fdd-e053-2995a90a494c	54473-322	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	340 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-323_f20602ca-ed08-6fdd-e053-2995a90a494c	54473-323	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	460 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-324_f2060d07-6395-57c5-e053-2995a90a480c	54473-324	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	240 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-325_f206019b-767a-260e-e053-2a95a90aba69	54473-325	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	325 C	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-326_f2060d07-6399-57c5-e053-2995a90a480c	54473-326	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	400 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-327_f2060d07-639d-57c5-e053-2995a90a480c	54473-327	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	540 W	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-328_f206019b-767d-260e-e053-2a95a90aba69	54473-328	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	560 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-329_f2060d07-639e-57c5-e053-2995a90a480c	54473-329	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	480 C	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-330_f2060d07-639f-57c5-e053-2995a90a480c	54473-330	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	620 C	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-331_f206019b-767f-260e-e053-2a95a90aba69	54473-331	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	640 W	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-332_f2060d07-63a0-57c5-e053-2995a90a480c	54473-332	HUMAN OTC DRUG	Sei Bella Flawless Liquid Foundation	600 N	Octinoxate 6% Octisalate 5% Titanium Dioxide 2%	LOTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Melaleuca Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.8; 1.5; .6	g/30mL; g/30mL; g/30mL			N	20241231
54473-333_f205b04d-16da-02ba-e053-2a95a90a0108	54473-333	HUMAN OTC DRUG	Koala Kubs Diaper Rash Cream		Diaper Rash Cream	CREAM	TOPICAL	20210709		OTC MONOGRAPH FINAL	part347	Melaleuca, Inc.	ZINC OXIDE	150	mg/88mL			N	20241231
54473-334_f383eeef-f80a-8ea4-e053-2995a90a514c	54473-334	HUMAN OTC DRUG	Ultra Pain-A-Trate	Pain-Relieving Cream	Camphor and Menthol and Methyl Salicylate	CREAM	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part348	Melaleuca, Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.4; 8.5; 25.5	g/85g; g/85g; g/85g			N	20241231
54473-335_f205b4ae-b264-34d9-e053-2a95a90a7f19	54473-335	HUMAN OTC DRUG	Original Pain-A-Trate	Pain-Relieving Cream	Camphor and Menthol and Methyl Salicylate	CREAM	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part348	Melaleuca, Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	32.5; 15; 150	mg/g; mg/g; mg/g			N	20241231
54473-336_f205b4ae-b262-34d9-e053-2a95a90a7f19	54473-336	HUMAN OTC DRUG	HemAway		Lidocaine	CREAM	TOPICAL	20200804		OTC MONOGRAPH FINAL	part346	Melaleuca, Inc.	LIDOCAINE	1.5	g/30g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54473-338_f1792d29-1b1d-68e0-e053-2a95a90a8a57	54473-338	HUMAN OTC DRUG	Affinia Antiperspirant Deodorant	Vanilla Musk and Jasmine	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20220412		OTC MONOGRAPH FINAL	part350	Melaleuca, Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	16	g/57g			N	20241231
54473-339_dd1b7c36-bbb9-7836-e053-2995a90ae446	54473-339	HUMAN OTC DRUG	Alloy Antiperspirant and Deodorant		Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20220420		OTC MONOGRAPH FINAL	part350	Melaleuca, Inc	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	10.24	g/64g			N	20241231
54482-020_0a973add-5420-1131-e063-6294a90a8e8d	54482-020	HUMAN PRESCRIPTION DRUG	CYSTARAN		cysteamine hydrochloride	SOLUTION	OPHTHALMIC	20121230		NDA	NDA200740	Leadiant Biosciences, Inc.	CYSTEAMINE HYDROCHLORIDE	6.5	mg/mL	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
54482-054_0a97e646-03a9-9614-e063-6294a90a4ab9	54482-054	HUMAN PRESCRIPTION DRUG	Matulane		procarbazine hydrochloride	CAPSULE	ORAL	19851227		NDA	NDA016785	Leadiant Biosciences, Inc.	PROCARBAZINE HYDROCHLORIDE	50	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
54482-144_2c9d6e54-df46-4aab-9f82-cf0cb6343a98	54482-144	HUMAN PRESCRIPTION DRUG	CARNITOR		levocarnitine	TABLET	ORAL	19851227		NDA	NDA018948	Leadiant Biosciences, Inc.	LEVOCARNITINE	330	mg/1	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
54482-145_0aabbf57-bdac-c8de-e063-6294a90a63ed	54482-145	HUMAN PRESCRIPTION DRUG	Carnitor		levocarnitine	SOLUTION	ORAL	19860410		NDA	NDA019257	Leadiant Biosciences, Inc.	LEVOCARNITINE	1	g/10mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
54482-147_0a9cb8a2-c17d-9bd3-e063-6294a90ac0e0	54482-147	HUMAN PRESCRIPTION DRUG	Carnitor		levocarnitine	INJECTION, SOLUTION	INTRAVENOUS	19921216		NDA	NDA020182	Leadiant Biosciences, Inc.	LEVOCARNITINE	1	g/5mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
54482-148_0aabed26-1b36-955b-e063-6294a90aa3cf	54482-148	HUMAN PRESCRIPTION DRUG	Carnitor SF		levocarnitine	SOLUTION	ORAL	19860410		NDA	NDA019257	Leadiant Biosciences, Inc.	LEVOCARNITINE	1	g/10mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
54528-001_0bb077ee-7c3a-c5a2-e063-6294a90a2c1a	54528-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141031		UNAPPROVED MEDICAL GAS		Commonwealth Home Health Care, Inc.	OXYGEN	995	mL/L			N	20241231
54532-0024_5d3766e3-586c-4cf0-89c1-fc7c0c1138b5	54532-0024	HUMAN OTC DRUG	Hevert Trauma Roll-On		Arnica Montana Root, Bellis Perennis, Calendula Officinalis Flowering Top, Hamamelis Virginiana Root Bark/Stem Bark, Hypericum Perforatum, Achillea Millefolium Flowering Top, Ruta Graveolens Flowering Top, and Comfrey Root	GEL	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Hevert Arzneimittel GmbH & Co KG	ACHILLEA MILLEFOLIUM FLOWERING TOP; ARNICA MONTANA ROOT; BELLIS PERENNIS WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP	1; 3; 1; 1; 6; 1; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54532-0030_89f59a46-dacb-42cd-b9ad-f8107cc92128	54532-0030	HUMAN OTC DRUG	HEVERT DETOX		Arsenic Trioxide, Clematis Recta Flowering top, Conium Maculatum Flowering Top, Lachesis Muta Venom, Mercuric Iodide, Phytolacca Americana Root, Toxicodendron Pubescens shoot, Scrophularia Nodosa leaf with stem, Sulfur, Milk Thistle, Chelidonium majus root, Taraxacum officinale, Nitric Acid, Apis Mellifera, Atropa Belladonna, Lytta Vesicatoria, Juniper Berry, Solidago Virgaurea Flowering Top, Eichhornia Crassipes Whole, Okoubaka aubrevillei bark, QUASSIA AMARA WOOD, and TARAXACUM OFFICINALE	KIT		20160915		UNAPPROVED HOMEOPATHIC		Hevert Arzneimittel GmbH & Co KG						N	20241231
54532-0031_5fd4ef4b-cf67-4828-8492-266a585109a6	54532-0031	HUMAN OTC DRUG	Hevert Detox Intestinum		Eichhornia Crassipes Whole, OKOUBAKA AUBREVILLEI BARK, QUASSIA AMARA WOOD, and TARAXACUM OFFICINALE	LIQUID	ORAL	20160615		UNAPPROVED HOMEOPATHIC		Hevert Arzneimittel GmbH & Co KG	EICHHORNIA CRASSIPES WHOLE; OKOUBAKA AUBREVILLEI BARK; QUASSIA AMARA WOOD; TARAXACUM OFFICINALE	1; 2; 1; 1	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
54532-0032_01fabd3b-07af-43df-9faf-5476d53a30a9	54532-0032	HUMAN OTC DRUG	Hevert Detox Kidney		Nitric Acid, Apis Mellifera, Atropa Belladonna, Lytta Vesicatoria, Juniper Berry, and Solidago Virgaurea Flowering Top	LIQUID	ORAL	20160615		UNAPPROVED HOMEOPATHIC		Hevert Arzneimittel GmbH & Co KG	APIS MELLIFERA; ATROPA BELLADONNA; JUNIPER BERRY; LYTTA VESICATORIA; NITRIC ACID; SOLIDAGO VIRGAUREA FLOWERING TOP	3; 6; 3; 4; 6; 1	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
54532-0033_0462749a-eefc-4d64-805f-43237e07448f	54532-0033	HUMAN OTC DRUG	Hevert Detox Liver		Milk Thistle, Chelidonium Majus Root, and Taraxacum officinale	LIQUID	ORAL	20160615		UNAPPROVED HOMEOPATHIC		Hevert Arzneimittel GmbH & Co KG	CHELIDONIUM MAJUS ROOT; MILK THISTLE; TARAXACUM OFFICINALE	3; 1; 3	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
54532-0034_b071dd55-090c-4989-ba4c-869c5f0f6a0b	54532-0034	HUMAN OTC DRUG	Hevert Detox Lymph		Arsenic Trioxide, Clematis Recta Flowering top, Conium Maculatum Flowering Top, Lachesis Muta Venom, Mercuric Iodide, Phytolacca Americana Root, Toxicodendron Pubescens shoot, Scrophularia Nodosa leaf with stem, and Sulfur	LIQUID	ORAL	20160615		UNAPPROVED HOMEOPATHIC		Hevert Arzneimittel GmbH & Co KG	ARSENIC TRIOXIDE; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; LACHESIS MUTA VENOM; MERCURIC IODIDE; PHYTOLACCA AMERICANA ROOT; SCROPHULARIA NODOSA LEAF WITH STEM; SULFUR; TOXICODENDRON PUBESCENS SHOOT	6; 4; 6; 8; 8; 4; 3; 4; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
54532-0035_13a942b6-8fa3-4c0d-a482-33d5a7da2fa7	54532-0035	HUMAN OTC DRUG	Hevert Contrallergia		APIS MELLIFERA, GALPHIMIA GLAUCA WHOLE, POTASSIUM DICHROMATE, TEUCRIUM MARUM TOP, and VERBASCUM DENSIFLORUM Flowering TOP	TABLET	ORAL	20191201	20241231	UNAPPROVED HOMEOPATHIC		Hevert Arzneimittel GmbH & Co KG	APIS MELLIFERA; GALPHIMIA GLAUCA WHOLE; POTASSIUM DICHROMATE; TEUCRIUM MARUM TOP; VERBASCUM DENSIFLORUM FLOWERING TOP	4; 4; 6; 4; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
54622-015_aa38adf0-48e2-4ce1-abf8-64de5ebe5681	54622-015	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	SOLUTION	TOPICAL	20170703		OTC MONOGRAPH NOT FINAL	part333A	Georgia Pacific Consumer Products	ALCOHOL	.67	mL/mL			N	20241231
54622-120_0c8ddafd-aadf-13e7-e063-6394a90ad7cd	54622-120	HUMAN OTC DRUG	EnMotion Foam Hand Sanitizer		Ethyl alcohol	LIQUID	TOPICAL	20180125		OTC MONOGRAPH DRUG	505G(a)(3)	Georgia-Pacific Consumer Products LP	ALCOHOL	70	mL/100mL			N	20241231
54622-121_0c8d9899-4f38-ebc8-e063-6294a90a3b73	54622-121	HUMAN OTC DRUG	enMotion Foam	High Frequency Use	Ethyl Alcohol	SOLUTION	TOPICAL	20210610		OTC MONOGRAPH DRUG	505G(a)(3)	Georgia-Pacific Consumer Products LP	ALCOHOL	.7	mL/mL			N	20241231
54622-122_0c8dce8f-6198-0915-e063-6394a90af924	54622-122	HUMAN OTC DRUG	Pacific Blue Ultra Foaming	Fragrance Free	Ethyl Alcohol	SOLUTION	TOPICAL	20210611		OTC MONOGRAPH DRUG	505G(a)(3)	Georgia-Pacific Consumer Products LP	ALCOHOL	70	mg/mL			N	20241231
54622-129_0c8d91f6-fefc-0447-e063-6394a90a738b	54622-129	HUMAN OTC DRUG	SafeHaven Personal Gel Hand Sanitizer		Ethyl Alcohol	SOLUTION	TOPICAL	20210519		OTC MONOGRAPH DRUG	505G(a)(3)	Georgia-Pacific Consumer Products LP	ALCOHOL	.719	mL/mL			N	20241231
54622-146_4b75f279-6749-43a4-9a4e-ad4c27eea461	54622-146	HUMAN OTC DRUG	enMotion Foam		Benzalkonium chloride	SOLUTION	TOPICAL	20160602		OTC MONOGRAPH NOT FINAL	part333A	Georgia Pacific Consumer Products	BENZALKONIUM CHLORIDE	.998	g/mL			N	20241231
54622-148_923f09f2-b310-442d-a8fe-6d5993a17b53	54622-148	HUMAN OTC DRUG	Hand Sanitizer		Benzalkonium Chloride 0.1%w/w	LIQUID	TOPICAL	20171201		OTC MONOGRAPH NOT FINAL	part333A	Georgia Pacific Consumer Products	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
54622-308_9b01b466-fb98-f255-e053-2995a90ac92d	54622-308	HUMAN OTC DRUG	Pacific Blue Select Gel Hand Sanitizer Fragrance and Dye Free		Ethyl alcohol	LIQUID	TOPICAL	20171011		OTC MONOGRAPH NOT FINAL	part333E	Georgia-Pacific Consumer Products	ALCOHOL	67	mL/100mL			N	20241231
54622-309_9b01b466-fbbd-f255-e053-2995a90ac92d	54622-309	HUMAN OTC DRUG	Pacific Blue Basic Gel Hand Sanitizer with Moisturizers		Ethyl alcohol	LIQUID	TOPICAL	20180111		OTC MONOGRAPH NOT FINAL	part333E	Georgia-Pacific Consumer Products	ALCOHOL	67	mL/100mL			N	20241231
54622-312_c846e3f7-c9b3-1a72-e053-2a95a90ac963	54622-312	HUMAN OTC DRUG	GP enMotion Antimicrobial Foam		Benzalkonium chloride	SOLUTION	TOPICAL	20210729		OTC MONOGRAPH NOT FINAL	part333E	Georgia-Pacific Consumer Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54622-313_c8d09207-d153-5abc-e053-2a95a90aaf92	54622-313	HUMAN OTC DRUG	GP PBU Antimicrobial Foam		Benzalkonium Chloride	SOLUTION	TOPICAL	20210805		OTC MONOGRAPH NOT FINAL	part333E	Georgia Pacific Consumer Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54622-314_03afa75a-5ac9-3921-e063-6294a90aa77a	54622-314	HUMAN OTC DRUG	enMotion Antimicrobial Foam with Moisturizers Fragrance Free		Benzalkonium Chloride	SOLUTION	TOPICAL	20230609		OTC MONOGRAPH NOT FINAL	part333E	Georgia-Pacific Consumer Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54622-315_fe0c15e7-f4bf-9a28-e053-6394a90a52ba	54622-315	HUMAN OTC DRUG	enMotion Antimicrobial Foam with Moisturizers Tranquil Aloe		Benzalkonium Chloride	SOLUTION	TOPICAL	20230613		OTC MONOGRAPH NOT FINAL	part333E	Georgia-Pacific Consumer Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54622-316_03afabb8-940c-803e-e063-6394a90a41aa	54622-316	HUMAN OTC DRUG	Pacific Blue ultra Antimicrobial Foam Fragrance Free		Benzalkonium Chloride	SOLUTION	TOPICAL	20230614		OTC MONOGRAPH NOT FINAL	part333E	Georgia-Pacific Consumer Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54622-317_fe16fd9d-7507-743a-e053-6394a90a52a8	54622-317	HUMAN OTC DRUG	Pacific Blue ultra Antimicrobial Foam Pacific Citrus		Benzalkonium Chloride	SOLUTION	TOPICAL	20230614		OTC MONOGRAPH NOT FINAL	part333E	Georgia-Pacific Consumer Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
54622-486_0c8da2bf-be2f-e749-e063-6294a90a87d4	54622-486	HUMAN OTC DRUG	enMotion Foam	High Frequency Use	Ethyl Alcohol	SOLUTION	TOPICAL	20160602		OTC MONOGRAPH DRUG	505G(a)(3)	Georgia Pacific Consumer Products	ALCOHOL	.7	mL/mL			N	20241231
54622-572_d4f88f36-b2ad-45ca-ba4a-d5fb628985f7	54622-572	HUMAN OTC DRUG	Pacific Blue Ultra		Benzalkonium Chloride	SOAP	TOPICAL	20160525		OTC MONOGRAPH NOT FINAL	part333A	Georgia Pacific Consumer Products	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
54622-700_44b3a593-df38-4853-934b-814a12fa4ee8	54622-700	HUMAN OTC DRUG	enMotion Antimicrobial	with Moisturizers, Tranquil Aloe	Benzalkonium chloride	SOAP	TOPICAL	20160602		OTC MONOGRAPH NOT FINAL	part333A	Georgia Pacific Consumer Products	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
54622-701_0c8d7246-6a31-f3fb-e063-6394a90aae51	54622-701	HUMAN OTC DRUG	Pacific Blue Ultra Foaming	Fragrance Free	Ethyl Alcohol	SOLUTION	TOPICAL	20160602		OTC MONOGRAPH DRUG	505G(a)(3)	Georgia-Pacific Consumer Products LP	ALCOHOL	70	mg/mL			N	20241231
54622-703_756600f2-ff05-4727-b4c5-c82fc1eb0480	54622-703	HUMAN OTC DRUG	enMotion Antimicrobial	with Moisturizers, Fragrance Free	Benzalkonium chloride	SOAP	TOPICAL	20160602		OTC MONOGRAPH NOT FINAL	part333A	Georgia Pacific Consumer Products	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
54622-708_0c8d93d6-36d7-ea52-e063-6294a90ad2a2	54622-708	HUMAN OTC DRUG	enMotion Foam	with Moisturizers fragrance free	Ethyl Alcohol	SOLUTION	TOPICAL	20160602		OTC MONOGRAPH DRUG	505G(a)(3)	Georgia-Pacific Consumer Products LP	ALCOHOL	70	mg/mL			N	20241231
54622-712_fd8fdb96-f160-4b86-b5fa-026f00693a3c	54622-712	HUMAN OTC DRUG	Pacific Blue Ultra Antimicrobial	Pacific Citrus	Benzalkonium chloride	SOAP	TOPICAL	20160525		OTC MONOGRAPH NOT FINAL	part333A	Georgia Pacific Consumer Products	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
54629-600_6786b7c4-5d1c-458a-ae03-819d4726dbba	54629-600	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000501		OTC MONOGRAPH NOT FINAL	part334	National Vitamin Company	DOCUSATE SODIUM	100	mg/1			N	20241231
54629-601_8194c8a5-d1e9-428d-ab41-a782ffde2b70	54629-601	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000501		OTC MONOGRAPH NOT FINAL	part334	National Vitamin Company	DOCUSATE SODIUM	250	mg/1			N	20241231
54629-640_f06f12d6-1c98-4027-87c7-1140a7740490	54629-640	HUMAN OTC DRUG	Docusate Calcium 240 mg sodium free		Docusate Calcium	CAPSULE, LIQUID FILLED	ORAL	20160201		OTC MONOGRAPH NOT FINAL	part334	National Vitamin Company	DOCUSATE CALCIUM	240	mg/1			N	20241231
54633-014_60ba6f8a-861c-d4f6-e053-2991aa0a4a71	54633-014	HUMAN OTC DRUG	Gentian Violet 2%		gentian violet 2%	SOLUTION	TOPICAL	20141014		OTC MONOGRAPH NOT FINAL	part333A	The Podiatree Company	GENTIAN VIOLET	2	g/100mL			N	20241231
54633-017_60cb962b-0e2d-105a-e053-2a91aa0a040e	54633-017	HUMAN OTC DRUG	Fortinia OF		clotrimazole 1%	SOLUTION	TOPICAL	20170705		OTC MONOGRAPH FINAL	part333C	The Podiatree Company	CLOTRIMAZOLE	1	g/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
54633-018_68a4ed34-f491-67a6-e053-2a91aa0a0428	54633-018	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	20180330		OTC MONOGRAPH FINAL	part333C	The Podiatree Company	CLOTRIMAZOLE	1	g/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
54633-018_79234400-0767-792c-e053-2a91aa0a6e6d	54633-018	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	20181026		OTC MONOGRAPH FINAL	part333C	The Podiatree Company	CLOTRIMAZOLE	1	g/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
54633-115_f1ed2a28-1ebc-bbb3-e053-2a95a90ae6c5	54633-115	HUMAN OTC DRUG	Veraciti		salicylic acid	GEL	TOPICAL	20151001		OTC MONOGRAPH FINAL	part358B	The Podiatree Company	SALICYLIC ACID	17	g/100g			N	20241231
54633-214_60dcd391-7bf3-9ec2-e053-2991aa0a4a17	54633-214	HUMAN OTC DRUG	Fortinia		clotrimazole 1%	SOLUTION	TOPICAL	20141001		OTC MONOGRAPH FINAL	part333C	The Podiatree Company	CLOTRIMAZOLE	1	g/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
54633-216_60c88eb7-22ff-4881-e053-2a91aa0a70ce	54633-216	HUMAN OTC DRUG	Fortinia ID		phenol	LIQUID	TOPICAL	20170103		OTC MONOGRAPH NOT FINAL	part333A	The Podiatree Company	PHENOL	1.5	g/100mL			N	20241231
54633-314_60ba7ee8-7134-c6bb-e053-2a91aa0ac466	54633-314	HUMAN OTC DRUG	Fortinia		Clotrimazole	CREAM	TOPICAL	20150202		OTC MONOGRAPH FINAL	part333C	The Podiatree Company	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
54633-413_60b91648-c805-7468-e053-2991aa0a6c1e	54633-413	HUMAN OTC DRUG	Aarica		Aluminum Chloride	LIQUID	TOPICAL	20140506		OTC MONOGRAPH FINAL	part350	The Podiatree Company	ALUMINUM CHLORIDE	15	g/100mL			N	20241231
54633-414_625ba6c8-a04b-12c9-e053-2991aa0aad86	54633-414	HUMAN OTC DRUG	K2 Cold Therapy		Menthol	LIQUID	TOPICAL	20140506		OTC MONOGRAPH NOT FINAL	part348	The Podiatree Co	MENTHOL	10	g/100mL			N	20241231
54633-612_60de23d0-6e76-3b97-e053-2a91aa0aea5e	54633-612	HUMAN OTC DRUG	Castellani Paint 1.5%		phenol	LIQUID	TOPICAL	20130701		OTC MONOGRAPH NOT FINAL	part333A	The Podiatree Company	PHENOL	15	mg/mL			N	20241231
54633-712_60dcc23a-940e-15aa-e053-2a91aa0a549f	54633-712	HUMAN OTC DRUG	Castellani Paint 1.5%		phenol	LIQUID	TOPICAL	20130701		OTC MONOGRAPH NOT FINAL	part333A	The Podiatree Company	PHENOL	15	mg/mL			N	20241231
54633-913_60b9aa2d-ae5b-567b-e053-2a91aa0a1e29	54633-913	HUMAN OTC DRUG	Tolnaftate		Antifungal Powder Spray	AEROSOL, POWDER	TOPICAL	20130701		OTC MONOGRAPH FINAL	part333C	The Podiatree Company	TOLNAFTATE	1	g/100g			N	20241231
54638-0003_2ac74866-2180-4655-8dd3-9f23e1eaed3d	54638-0003	HUMAN OTC DRUG	Rehydrate		Avena Sativa, Equisetum Hyemale, Hypericum Perforatum, Ulmus Fulva, Glycyrrhiza Glabra, Silicea, Pueraria Lobata, Carlsbad Aqua, Adenosinum Triphosphoricum Dinatrum, Germanium Sesquioxide, Hydrogen, Oxygen, Wiesbaden	LIQUID	ORAL	20150212		UNAPPROVED HOMEOPATHIC		ParaDocs All Natural, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; AVENA SATIVA FLOWERING TOP; EQUISETUM HYEMALE; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; HYDROGEN; HYPERICUM PERFORATUM; OXYGEN; PUERARIA MONTANA VAR. LOBATA ROOT; SILICON DIOXIDE; ULMUS RUBRA BARK; WATER	30; 3; 4; 30; 12; 30; 6; 30; 8; 12; 6; 12	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54638-0004_6aebf3a4-cc32-47ec-8d67-dbdf401fb313	54638-0004	HUMAN OTC DRUG	Rehydrate Jr.		Avena Sativa, Equisetum Hyemale, Hypericum Perforatum, Ulmus Fulva, Glycyrrhiza Glabra, Glycyrrhiza Glabra, Pueraria Lobata, Aqua Sulis, Carlsbad Aqua, Adenosinum Triphosphoricum Dinatrum, Germanium Sesquioxide, Hydrogen, Oxygenium, Wiesbaden	LIQUID	ORAL	20200311		UNAPPROVED HOMEOPATHIC		ParaDocs All Natural, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; AVENA SATIVA FLOWERING TOP; EQUISETUM HYEMALE; GERMANIUM SESQUIOXIDE; GLYCYRRHIZA GLABRA; HYDROGEN; HYPERICUM PERFORATUM; OXYGEN; PUERARIA MONTANA VAR. LOBATA ROOT; ULMUS RUBRA BARK; WATER	30; 3; 4; 30; 12; 30; 6; 30; 12; 6; 12	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54643-5646_6d824510-160c-4812-9ffe-fd17f48bb7d5	54643-5646	HUMAN PRESCRIPTION DRUG	PEDIATRIC INFUVITE MULTIPLE VITAMINS FOR INFUSION		ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin 5-phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20010221		NDA	NDA021265	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	7; 80; 20; 400; 1; 5; 140; 17; .2; 1; 1.4; 1.2; 2300	[iU]/5mL; mg/5mL; ug/5mL; [iU]/5mL; ug/5mL; mg/5mL; ug/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; [iU]/5mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-5647_cc7fa252-25c2-47d6-9da8-726b290c87c0	54643-5647	HUMAN PRESCRIPTION DRUG	Pediatric Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	KIT		20040129		NDA	NDA021646	Sandoz Inc						N	20241231
54643-5649_b4ff008f-b27e-4274-9f74-ba27aed1eeef	54643-5649	HUMAN PRESCRIPTION DRUG	Infuvite Adult Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20050518		NDA	NDA021163	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	10; 200; 60; 200; 5; 15; 600; 40; 150; 6; 3.6; 6; 3300	[iU]/10mL; mg/10mL; ug/10mL; [iU]/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; mg/10mL; mg/10mL; [iU]/10mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-5650_b4ff008f-b27e-4274-9f74-ba27aed1eeef	54643-5650	HUMAN PRESCRIPTION DRUG	Infuvite Adult Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20030616		NDA	NDA021559	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	10; 200; 60; 200; 5; 15; 600; 40; 150; 6; 3.6; 6; 3300	[iU]/10mL; mg/10mL; ug/10mL; [iU]/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; mg/10mL; mg/10mL; [iU]/10mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-7862_30a702f6-2b9e-4a34-a3fc-fb3522896cd8	54643-7862	HUMAN PRESCRIPTION DRUG	Adult Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20050518		NDA	NDA021163	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	10; 200; 60; 200; 5; 15; 600; 40; 150; 6; 3.6; 6; 3300	[iU]/10mL; mg/10mL; ug/10mL; [iU]/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; mg/10mL; mg/10mL; [iU]/10mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-7874_30a702f6-2b9e-4a34-a3fc-fb3522896cd8	54643-7874	HUMAN PRESCRIPTION DRUG	Adult Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20030616		NDA	NDA021559	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	10; 200; 60; 200; 5; 15; 600; 40; 150; 6; 3.6; 6; 3300	[iU]/10mL; mg/10mL; ug/10mL; [iU]/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; mg/10mL; mg/10mL; [iU]/10mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-7886_a2d6735d-ba42-4c15-9dc9-90e18f15e443	54643-7886	HUMAN PRESCRIPTION DRUG	Pediatric Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20010221		NDA	NDA021265	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	7; 80; 20; 400; 1; 5; 140; 17; .2; 1; 1.4; 1.2; 2300	[iU]/5mL; mg/5mL; ug/5mL; [iU]/5mL; ug/5mL; mg/5mL; ug/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; [iU]/5mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-7898_a2d6735d-ba42-4c15-9dc9-90e18f15e443	54643-7898	HUMAN PRESCRIPTION DRUG	Pediatric Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	KIT		20040129		NDA	NDA021646	Sandoz Inc						N	20241231
54643-9007_10174266-1bd1-44a5-a1be-41d0be88d949	54643-9007	HUMAN PRESCRIPTION DRUG	Adult Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20050518		NDA	NDA021163	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	10; 200; 60; 200; 5; 15; 600; 40; 150; 6; 3.6; 6; 3300	[iU]/10mL; mg/10mL; ug/10mL; [iU]/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; mg/10mL; mg/10mL; [iU]/10mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-9015_10174266-1bd1-44a5-a1be-41d0be88d949	54643-9015	HUMAN PRESCRIPTION DRUG	Adult Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20030616		NDA	NDA021559	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	10; 200; 60; 200; 5; 15; 600; 40; 150; 6; 3.6; 6; 3300	[iU]/10mL; mg/10mL; ug/10mL; [iU]/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; ug/10mL; mg/10mL; mg/10mL; mg/10mL; [iU]/10mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-9023_4a121d03-e32c-4a67-8641-fc0fc7aafe13	54643-9023	HUMAN PRESCRIPTION DRUG	Pediatric Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	INJECTION, SOLUTION	INTRAVENOUS	20161223		NDA	NDA021265	Sandoz Inc	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	7; 80; 20; 400; 1; 5; 140; 17; .2; 1; 1.4; 1.2; 2300	[iU]/5mL; mg/5mL; ug/5mL; [iU]/5mL; ug/5mL; mg/5mL; ug/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; [iU]/5mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
54643-9031_4a121d03-e32c-4a67-8641-fc0fc7aafe13	54643-9031	HUMAN PRESCRIPTION DRUG	Pediatric Infuvite Multiple Vitamins		Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 phosphate sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-tocopherol acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin	KIT		20161223		NDA	NDA021646	Sandoz Inc						N	20241231
54679-0001_aff0ee3a-6c3a-4550-81b3-d075dead7685	54679-0001	HUMAN OTC DRUG	Antimicrobial 652		CHLOROXYLENOL	LOTION	TOPICAL	19940101		OTC MONOGRAPH DRUG	M003	Montgomery County Chapter Nysarc, Inc dba Liberty Enterprises	CHLOROXYLENOL	3.6	mg/800mL			N	20241231
54702-501_f18b8a5a-9bfe-329c-e053-2995a90af8f3	54702-501	HUMAN PRESCRIPTION DRUG	ORALTAG		Iohexol	FOR SOLUTION	ORAL	20160701		NDA	NDA205383	Interpharma Praha, a.s.	IOHEXOL	4.5	g/1	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
54706-0001_06d697c5-5eba-80d3-e063-6294a90a22f9	54706-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100204		UNAPPROVED MEDICAL GAS		Garrett County Memorial Hospital	OXYGEN	99	L/100L			N	20241231
54723-009_f8a9c393-0fe2-8c0d-e053-6394a90ae5d8	54723-009	HUMAN OTC DRUG	Inderma MD		Benzocaine	CREAM	TOPICAL	20230331		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	BENZOCAINE	20	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54723-010_f8aa19bd-dcd4-da67-e053-6394a90a2646	54723-010	HUMAN OTC DRUG	Inderma MD		Lidocaine	CREAM	TOPICAL	20230331		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-011_f8aa1d81-bd28-9dfc-e053-6294a90a150e	54723-011	HUMAN OTC DRUG	Inderma MD		Tetracaine	CREAM	TOPICAL	20230331		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	TETRACAINE	2	g/100mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
54723-012_0323dadf-d27e-ccbe-e063-6294a90a1f9c	54723-012	HUMAN OTC DRUG	PENICHILLIN		Benzocaine	CREAM	TOPICAL	20230331		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	BENZOCAINE	20	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54723-013_0323fd1e-d879-6ac0-e063-6294a90a39d4	54723-013	HUMAN OTC DRUG	PENICHILLIN		Lidocaine	CREAM	TOPICAL	20230331		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-014_03241bf4-2d87-9933-e063-6394a90a435a	54723-014	HUMAN OTC DRUG	PENICHILLIN		Tetracaine	CREAM	TOPICAL	20230331		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	TETRACAINE	2	g/100mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
54723-015_066fb3b6-7f1d-94e0-e063-6294a90a5e97	54723-015	HUMAN OTC DRUG	Painless Tattoo 1		Benzocaine	CREAM	TOPICAL	20230926		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	BENZOCAINE	20	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54723-016_066fd660-f08b-e0a4-e063-6394a90a443f	54723-016	HUMAN OTC DRUG	Painless Tattoo 2		Lidocaine	CREAM	TOPICAL	20230926		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-017_066fb3b6-7f28-94e0-e063-6294a90a5e97	54723-017	HUMAN OTC DRUG	Painless Tattoo 3		Tetracaine	CREAM	TOPICAL	20230926		OTC MONOGRAPH NOT FINAL	part348	Sambria Pharmaceuticals, LLC	TETRACAINE	2	g/100mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
54723-175_0b78e757-351a-9b38-e063-6394a90a145a	54723-175	HUMAN OTC DRUG	NeuroMed 7 Topical Pain Relief		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20130815		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals, LLC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-200_0904f675-97c8-f3a2-e063-6394a90aa127	54723-200	HUMAN OTC DRUG	Lidocaine		LIDOCAINE	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals Inc.	LIDOCAINE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-300_09407301-5f55-bc9d-e063-6294a90a0966	54723-300	HUMAN OTC DRUG	NeuroMed Topical Anesthetic	7	LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20150820		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-300_0940833d-4e81-6ec6-e063-6394a90a4c15	54723-300	HUMAN OTC DRUG	NeuroMed Topical Anesthetic	7	LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-310_094099ac-19f7-7d6b-e063-6394a90a936b	54723-310	HUMAN OTC DRUG	NeuroMed Topical Analgesic	LA	Tetracaine HCL	CREAM	TOPICAL	20160201		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals, Inc.	TETRACAINE HYDROCHLORIDE	20	mg/1000mg	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
54723-722_09409bed-56a7-7d3d-e063-6394a90a7af0	54723-722	HUMAN OTC DRUG	NeuroMed	FA	Benzocaine	CREAM	TOPICAL	20160201		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals, Inc.	BENZOCAINE	20	mg/100mg	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54723-722_09409e9e-d9b1-d451-e063-6294a90a7614	54723-722	HUMAN OTC DRUG	NeuroMed	FA	Benzocaine	CREAM	TOPICAL	20170821		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals, Inc.	BENZOCAINE	20	mg/100mg	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54723-997_094099ac-1a05-7d6b-e063-6394a90a936b	54723-997	HUMAN OTC DRUG	Comfortox Tetracaine		Tetracaine HCL	CREAM	TOPICAL	20160914		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals, Inc.	TETRACAINE HYDROCHLORIDE	20	mg/1000mg	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
54723-998_09409e9e-d9be-d451-e063-6294a90a7614	54723-998	HUMAN OTC DRUG	Comfortox Lidocaine		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20160914		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals	LIDOCAINE HYDROCHLORIDE	40	mg/1000mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54723-999_0940a694-3682-847d-e063-6394a90a3f35	54723-999	HUMAN OTC DRUG	Comfortox Benzocaine		Benzocaine	CREAM	TOPICAL	20160907		OTC MONOGRAPH DRUG	M017	Sambria Pharmaceuticals, Inc.	BENZOCAINE	20	mg/100mg	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54738-020_5cc6cec2-9f03-6cf9-e053-2991aa0ada77	54738-020	HUMAN OTC DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	TABLET	ORAL	20150501		OTC MONOGRAPH FINAL	part331	Richmond Pharmaceuticals, Inc.	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54738-025_5cc4c45d-5b77-0912-e053-2991aa0a10a5	54738-025	HUMAN OTC DRUG	Meclizine HCL		Meclizine HCl 25mg Chewable Tablets	TABLET, CHEWABLE	ORAL	20150501		OTC MONOGRAPH FINAL	part336	Richmond Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
54738-030_5cc88da4-0292-200b-e053-2a91aa0ab317	54738-030	HUMAN OTC DRUG	ANTACID		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20150501		OTC MONOGRAPH FINAL	part331	Richmond Pharmaceuticals, Inc.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
54738-035_5cec472c-8a20-32e5-e053-2991aa0a3222	54738-035	HUMAN OTC DRUG	Sodium Bicarbonate Antacid		Sodium Bicarbonate	TABLET	ORAL	20150601		OTC MONOGRAPH FINAL	part331	Richmond Pharmaceuticals, Inc.	SODIUM BICARBONATE	325	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54738-040_5cc3aaa6-e19e-a116-e053-2991aa0a1422	54738-040	HUMAN OTC DRUG	APAP		Acetaminophen	TABLET	ORAL	20150401		OTC MONOGRAPH NOT FINAL	part343	Richmond Pharmaceuticals, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
54738-092_5cc5fab2-77b5-05c5-e053-2991aa0a272d	54738-092	HUMAN OTC DRUG	Chewable Acetaminophen	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20150401		OTC MONOGRAPH NOT FINAL	part343	Richmond Pharmaceuticals, Inc.	ACETAMINOPHEN	80	mg/1			N	20241231
54738-102_5cc53a8f-4daa-7cff-e053-2991aa0a383b	54738-102	HUMAN OTC DRUG	Pepto Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20150601		OTC MONOGRAPH FINAL	part335	Richmond Pharmaceuticals, Inc	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
54738-103_5cc3ebfe-ce74-423d-e053-2a91aa0a4616	54738-103	HUMAN OTC DRUG	Anti Allergy		Chlorpheniramine Maleate	TABLET	ORAL	20150501		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals, Inc.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54738-111_5cc3bf1b-4678-6a53-e053-2a91aa0abfa6	54738-111	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20150501		OTC MONOGRAPH FINAL	part343	Richmond Pharmaceuticals, Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
54738-115_9a63ba0a-0e06-744b-e053-2a95a90a9344	54738-115	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20000215		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54738-115_9a63d162-4e53-4f35-e053-2a95a90a4492	54738-115	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20150501		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54738-116_5cc3bf1b-466c-6a53-e053-2a91aa0abfa6	54738-116	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20150501		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54738-116_9a63ba0a-0e06-744b-e053-2a95a90a9344	54738-116	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20000215		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54738-128_5cc44dca-00c9-b589-e053-2a91aa0a0521	54738-128	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20150401		OTC MONOGRAPH FINAL	part343	Richmond Pharmaceuticals, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
54738-518_5cc86981-732a-038f-e053-2991aa0a19d4	54738-518	HUMAN OTC DRUG	Simethicone		Simethicone	TABLET, CHEWABLE	ORAL	20110301		OTC MONOGRAPH FINAL	part332	Richmond Pharmaceuticals, Inc.	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
54738-540_5cc3aaa6-e1aa-a116-e053-2991aa0a1422	54738-540	HUMAN OTC DRUG	APAP		Acetaminophen	TABLET	ORAL	20150401		OTC MONOGRAPH NOT FINAL	part343	Richmond Pharmaceuticals, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
54738-541_5cc3ebfe-ce68-423d-e053-2a91aa0a4616	54738-541	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20150601		OTC MONOGRAPH FINAL	part343	Richmond Pharmaceuticals, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
54738-548_5cc3aaa6-e192-a116-e053-2991aa0a1422	54738-548	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20150501		OTC MONOGRAPH NOT FINAL	part343	Richmond Pharmaceuticals, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
54738-559_5cec1103-cec1-0e47-e053-2991aa0a32c5	54738-559	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20150401		OTC MONOGRAPH FINAL	part343	Richmond Pharmaceuticals, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
54738-901_09624157-b39f-4a90-9651-17eeac2ce39c	54738-901	HUMAN PRESCRIPTION DRUG	Quinidine Gluconate		Quinidine Gluconate	TABLET, EXTENDED RELEASE	ORAL	19870210		ANDA	ANDA089338	Richmond Pharmaceuticals, Inc.	QUINIDINE GLUCONATE	324	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
54738-963_9a63ba0a-0ded-744b-e053-2a95a90a9344	54738-963	HUMAN OTC DRUG	FERROUS SULFATE		FERROUS SULFATE	TABLET	ORAL	20150601		UNAPPROVED DRUG OTHER		Richmond Pharmaceuticals, Inc.	FERROUS SULFATE	325	mg/1			N	20241231
54738-963_9a63ba0a-0df9-744b-e053-2a95a90a9344	54738-963	HUMAN OTC DRUG	Ferrous Sulfate		Ferrous Sulfate	TABLET	ORAL	20081105		UNAPPROVED DRUG OTHER		Richmond Pharmaceuticals Inc.	FERROUS SULFATE	325	mg/1			N	20241231
54738-973_9119b7f0-3e7b-7be7-e053-2995a90a4634	54738-973	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20160201		OTC MONOGRAPH FINAL	part331	Richmond Pharmaceuticals, Inc.	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54738-974_90e05619-e46e-59d1-e053-2995a90ae8ae	54738-974	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20160201		OTC MONOGRAPH FINAL	part331	Richmond Pharmaceuticals, Inc.	MAGNESIUM OXIDE	420	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54738-980_73570295-8ab7-1c19-e053-2991aa0a6b82	54738-980	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 200 mg	TABLET	ORAL	20160301		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals, Inc.	GUAIFENESIN	200	mg/1			N	20241231
54738-981_5cc3bf1b-4684-6a53-e053-2a91aa0abfa6	54738-981	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 400 mg	TABLET	ORAL	20160301		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals, Inc.	GUAIFENESIN	400	mg/1			N	20241231
54738-985_5cc409a8-23e1-738f-e053-2a91aa0ac0d5	54738-985	HUMAN OTC DRUG	Mucus Relief Cough and Congestion DM		Guaifenesin and Dextromethorphan HBr	TABLET	ORAL	20160401		OTC MONOGRAPH FINAL	part341	Richmond Pharmaceuticals, Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
54748-101_664ff7b4-5b62-4bc1-a229-7f58509cf524	54748-101	HUMAN OTC DRUG	EO HAND SANITIZER	Lavender	alcohol	SPRAY	TOPICAL	20130115		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-102_217dade1-0848-4b38-9906-2034bdbcfb7e	54748-102	HUMAN OTC DRUG	EO HAND SANITIZER	Peppermint	alcohol	SPRAY	TOPICAL	20130115		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-103_83c9cbf8-9b76-4091-894a-eb8337b88fef	54748-103	HUMAN OTC DRUG	EO HAND SANITIZER	Sweet Orange	alcohol	SPRAY	TOPICAL	20130115		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-201_a597e3af-cb5f-45d8-a63a-76f24f651240	54748-201	HUMAN OTC DRUG	EO HAND SANITIZER	Lavender	alcohol	GEL	TOPICAL	20130115		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-203_ec64506a-2256-46ee-b9c6-c30ebedb7821	54748-203	HUMAN OTC DRUG	EO HAND SANITIZER	Unscented	alcohol	GEL	TOPICAL	20130115		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-301_9c9632c9-7a78-424f-bcd1-89447f100268	54748-301	HUMAN OTC DRUG	everyone Hand Sanitizer	Coconut Lemon	alcohol	SPRAY	TOPICAL	20130607		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-302_79382027-64c3-4927-962b-0e9a4905e784	54748-302	HUMAN OTC DRUG	everyone Hand Sanitizer	Peppermint Citrus	alcohol	SPRAY	TOPICAL	20130607		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-303_2ff55f1c-97f5-47f1-9074-6cf7eee21c86	54748-303	HUMAN OTC DRUG	Everyone Hand Sanitizer Lavender Aloe		alcohol	SPRAY	TOPICAL	20170215		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-304_37d8e72f-e2ce-4317-89e5-6960315cb72e	54748-304	HUMAN OTC DRUG	Everyone Hand Sanitizer	ruby grapefruit	Alcohol	SPRAY	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-305_c8a5b9a7-6d36-4aab-b304-0178a126e706	54748-305	HUMAN OTC DRUG	EVERYONE HAND SANITIZER		Alcohol	SPRAY	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-401_265ef0be-28e4-4f8c-bc39-d1d6542347f5	54748-401	HUMAN OTC DRUG	everyone Hand Sanitizer	Coconut Lemon	alcohol	GEL	TOPICAL	20130607		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-402_87d223dd-c73b-4003-b695-f84ffe48873e	54748-402	HUMAN OTC DRUG	everyone Hand Sanitizer	Peppermint Citrus	alcohol	GEL	TOPICAL	20130607		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-403_ebb68b0e-e63f-41dc-acef-c77e4f8a0a7f	54748-403	HUMAN OTC DRUG	Everyone Hand Sanitizer Lavender Aloe		ALCOHOL	GEL	TOPICAL	20170215		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-501_6944d7d0-c44e-44a5-ab14-e3a70ce4ae51	54748-501	HUMAN OTC DRUG	everyone hand SANITIZER	Coconut Lemon	alcohol	CLOTH	TOPICAL	20150515		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-502_31992604-c770-4364-8be0-50a6f5054898	54748-502	HUMAN OTC DRUG	EO Hand Sanitizer Wipes Lavender		Alcohol	CLOTH	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-502_47b9788f-1e04-48b5-9619-6e2badfac50c	54748-502	HUMAN OTC DRUG	EO Hand Sanitizer Wipes Lavender		Alcohol	CLOTH	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-504_c0fa7cfe-1619-4440-9746-52b3329d1cb7	54748-504	HUMAN OTC DRUG	Everyone hand sanitizer wipes		Alcohol	CLOTH	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-505_a7355c3e-76dc-4ecb-917e-e9f95ff79742	54748-505	HUMAN OTC DRUG	EVERYONE HAND SANITIZER WIPES	Lavender Aloe	ALCOHOL	CLOTH	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	.62	mL/mL			N	20241231
54748-506_bd39ec22-30b9-4e63-9094-4bd5d46ff2b2	54748-506	HUMAN OTC DRUG	Everyone Hand Sanitizer	Coconut Lemon	Alcohol	CLOTH	TOPICAL	20200728		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-601_7d442503-85d9-4925-bb44-20a8a2874309	54748-601	HUMAN OTC DRUG	everyone hand sanitizer	coconut lemon	Ethyl Alcohol	SPRAY	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-602_3988239e-7410-4c33-baa8-79c434f276bc	54748-602	HUMAN OTC DRUG	everyone hand sanitizer	lavender aloe	Ethyl Alcohol	SPRAY	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-603_47c2ac1e-fb3c-418a-8fc9-e12224a9edbb	54748-603	HUMAN OTC DRUG	everyone hand sanitizer	peppermint citrus	Ethyl Alcohol	SPRAY	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-604_a7290afd-e582-4df5-86a6-7b33ba8a994f	54748-604	HUMAN OTC DRUG	everyone hand sanitizer	ruby grapefruit	Ethyl Alcohol	SPRAY	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-701_6adbe842-a65e-4d83-9414-06ed84fe3e79	54748-701	HUMAN OTC DRUG	everyone hand sanitizer wipes	coconut lemon	Ethyl Alcohol	CLOTH	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-702_0817ff8f-5130-4741-ae77-38755c5da1b7	54748-702	HUMAN OTC DRUG	everyone hand sanitizer wipes	lavender aloe	Ethyl Alcohol	CLOTH	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54748-703_d93fdc16-c46d-4409-93fc-2dd26064e0b6	54748-703	HUMAN OTC DRUG	everyone hand sanitizer wipes	ruby grapefruit	Ethyl Alcohol	CLOTH	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	EO Products, LLC	ALCOHOL	62	mL/100mL			N	20241231
54766-093_7cfc87e7-a349-eed3-e053-2991aa0afd6a	54766-093	HUMAN PRESCRIPTION DRUG	RIDAURA		auranofin	CAPSULE	ORAL	20161215		NDA	NDA018689	Sebela Pharmaceuticals Inc.	AURANOFIN	3	mg/1			N	20241231
54766-200_7cfe62d8-961c-5023-e053-2a91aa0a3575	54766-200	HUMAN PRESCRIPTION DRUG	Motofen		difenoxin and atropine sulfate	TABLET	ORAL	20170411		NDA	NDA017744	Sebela Pharmaceuticals Inc.	ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE	.025; 1	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
54766-201_04b2262f-adec-c53b-e063-6294a90a3610	54766-201	HUMAN PRESCRIPTION DRUG	PEXEVA		paroxetine mesylate	TABLET, FILM COATED	ORAL	20170602	20240531	NDA	NDA021299	Sebela Pharmaceuticals Inc.	PAROXETINE MESYLATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
54766-202_04b2262f-adec-c53b-e063-6294a90a3610	54766-202	HUMAN PRESCRIPTION DRUG	PEXEVA		paroxetine mesylate	TABLET, FILM COATED	ORAL	20170602	20240531	NDA	NDA021299	Sebela Pharmaceuticals Inc.	PAROXETINE MESYLATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
54766-203_04b2262f-adec-c53b-e063-6294a90a3610	54766-203	HUMAN PRESCRIPTION DRUG	PEXEVA		paroxetine mesylate	TABLET, FILM COATED	ORAL	20170602	20240531	NDA	NDA021299	Sebela Pharmaceuticals Inc.	PAROXETINE MESYLATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
54766-204_04b2262f-adec-c53b-e063-6294a90a3610	54766-204	HUMAN PRESCRIPTION DRUG	PEXEVA		paroxetine mesylate	TABLET, FILM COATED	ORAL	20170602	20240531	NDA	NDA021299	Sebela Pharmaceuticals Inc.	PAROXETINE MESYLATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
54766-590_84897784-a8ea-4408-e053-2991aa0a9b9d	54766-590	HUMAN PRESCRIPTION DRUG	IMURAN		azathioprine	TABLET	ORAL	20171201		NDA	NDA016324	Sebela Pharmaceuticals Inc.	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
54766-716_6061fb5a-a9e6-1630-e053-2991aa0ac4d8	54766-716	HUMAN PRESCRIPTION DRUG	Pramosone Cream		hydrocortisone acetate and pramoxine hydrochloride	CREAM	TOPICAL	20150804		ANDA	ANDA085368	Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	10; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-726_0bd81067-6752-4959-e063-6394a90acd00	54766-726	HUMAN PRESCRIPTION DRUG	Pramosone		hydrocortisone acetate and pramoxine hydrochloride	LOTION	TOPICAL	20141016		ANDA	ANDA085979	Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	25; 10	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-729_7d51ca9c-cb17-fbf6-e053-2a91aa0a0348	54766-729	HUMAN PRESCRIPTION DRUG	Pramosone		hydrocortisone acetate and pramoxine hydrochloride	LOTION	TOPICAL	20150702		ANDA	ANDA085980	Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	10; 10	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-760_60636fa0-18a3-3875-e053-2a91aa0acb11	54766-760	HUMAN PRESCRIPTION DRUG	Pramosone		hydrocortisone acetate and pramoxine hydrochloride	CREAM	TOPICAL	20150414		UNAPPROVED DRUG OTHER		Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	25; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-763_6063a847-17e1-7fa2-e053-2a91aa0abccc	54766-763	HUMAN PRESCRIPTION DRUG	pramosone		hydrocortisone acetate and pramoxine hydrochloride	OINTMENT	TOPICAL	20150805		UNAPPROVED DRUG OTHER		Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	10; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-770_7d8a5d94-b15d-89f8-e053-2a91aa0a104b	54766-770	HUMAN PRESCRIPTION DRUG	Naftin		NAFTIFINE HYDROCHLORIDE	GEL	TOPICAL	20180122		NDA	NDA019356	Sebela Pharmaceuticals Inc.	NAFTIFINE HYDROCHLORIDE	10	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
54766-772_0c509c9b-c156-802c-e063-6394a90a5b3b	54766-772	HUMAN PRESCRIPTION DRUG	Naftin		Naftifine Hydrochloride	GEL	TOPICAL	20180301		NDA	NDA204286	Sebela Pharmaceuticals Inc.	NAFTIFINE HYDROCHLORIDE	2	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
54766-777_6063ad02-65bd-4b2e-e053-2991aa0af3d4	54766-777	HUMAN PRESCRIPTION DRUG	Pramosone		hydrocortisone acetate and pramoxine hydrochloride	OINTMENT	TOPICAL	20150805		UNAPPROVED DRUG OTHER		Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	25; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-778_6061fb5a-a9cb-1630-e053-2991aa0ac4d8	54766-778	HUMAN PRESCRIPTION DRUG	Analpram HC		hydrocortisone acetate and pramoxine hydrochloride	CREAM	TOPICAL	20150805		ANDA	ANDA085368	Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	10; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-799_f0489ac1-832c-565a-e053-2995a90a9944	54766-799	HUMAN PRESCRIPTION DRUG	Analpram HC		hydrocortisone acetate and pramoxine hydrochloride	CREAM	TOPICAL	20150807		UNAPPROVED DRUG OTHER		Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	25; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-829_60626863-b3aa-b92b-e053-2991aa0a8f69	54766-829	HUMAN PRESCRIPTION DRUG	Analpram HC		hydrocortisone acetate and pramoxine hydrochloride	LOTION	TOPICAL	20150805		ANDA	ANDA085979	Sebela Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	25; 10	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
54766-894_87fd4e30-01d6-6ab3-e053-2995a90a522f	54766-894	HUMAN PRESCRIPTION DRUG	LOTRONEX		alosetron hydrochloride	TABLET	ORAL	20160711		NDA	NDA021107	Sebela Pharmaceuticals Inc.	ALOSETRON HYDROCHLORIDE	.5	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
54766-895_87fd4e30-01d6-6ab3-e053-2995a90a522f	54766-895	HUMAN PRESCRIPTION DRUG	LOTRONEX		alosetron hydrochloride	TABLET	ORAL	20160711		NDA	NDA021107	Sebela Pharmaceuticals Inc.	ALOSETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
54767-001_0803197c-090d-4f85-e063-6394a90a2fd6	54767-001	HUMAN PRESCRIPTION DRUG	oxygen		oxygen	GAS	RESPIRATORY (INHALATION)	20100914		NDA	NDA205767	Shaw Oxygen Company Inc	OXYGEN	995	mL/L			N	20241231
54776-004_080308f6-2f72-4f66-e063-6394a90a7b9d	54776-004	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Oxygen Mixture		Carbon Dioxide Oxygen Mixture	GAS	RESPIRATORY (INHALATION)	20130101		NDA	NDA205889	Spec Connection International Inc	OXYGEN	800	mL/L			N	20241231
54776-005_080308f6-2f71-4f66-e063-6394a90a7b9d	54776-005	HUMAN PRESCRIPTION DRUG	Hyperbaric Chamber Mix		Hyperbaric Chamber Mix	GAS	RESPIRATORY (INHALATION)	20130101		NDA	NDA205889	Spec Connection International Inc	OXYGEN	500	mL/L			N	20241231
54776-006_0803231b-7fa6-6f86-e063-6394a90a9808	54776-006	HUMAN PRESCRIPTION DRUG	Heliox		Heliox	GAS	RESPIRATORY (INHALATION)	20130101		NDA	NDA205889	Spec Connection International Inc	OXYGEN	300	mL/L			N	20241231
54799-893_247669c4-e928-462f-ad7d-fd7fc5e2011e	54799-893	HUMAN OTC DRUG	retaine PM		Mineral Oil, White petrolatum	OINTMENT	OPHTHALMIC	20130902		OTC MONOGRAPH FINAL	part347	OCuSOFT, Inc.	MINERAL OIL; PETROLATUM	200; 800	mg/g; mg/g			N	20241231
54799-917_b44f24fa-6384-4fd3-9070-f3f195260f9d	54799-917	HUMAN OTC DRUG	retaine MGD		Mineral Oil	EMULSION	OPHTHALMIC	20120105		OTC MONOGRAPH FINAL	part349	OCuSOFT, Inc.	LIGHT MINERAL OIL; MINERAL OIL	2; 2	mg/.4mL; mg/.4mL			N	20241231
54828-001_eb884bdb-3ff8-4765-8ee8-550a583c4bac	54828-001	HUMAN PRESCRIPTION DRUG	Neuraceq		florbetaben F 18	INJECTION, SOLUTION	INTRAVENOUS	20140320		NDA	NDA204677	Life Molecular Imaging, Ltd	FLORBETABEN F-18	135	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
54832-0001_06e61bc0-971f-e15d-e063-6394a90a7784	54832-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091202		UNAPPROVED MEDICAL GAS		West Plains Health Service, Inc. dba Ozarks Healthcare Medical Equipment	OXYGEN	99	L/100L			N	20241231
54838-116_bb16b285-0ad1-41e8-b59b-3de9ca3936fc	54838-116	HUMAN OTC DRUG	Silace		Docusate sodium	LIQUID	ORAL	19901005	20241130	OTC MONOGRAPH NOT FINAL	part334	Lannett Company, Inc.	DOCUSATE SODIUM	10	mg/mL			N	
54838-117_0c91f982-f8fd-450c-86eb-3f49f4ef11d5	54838-117	HUMAN OTC DRUG	Siltussin SA		Guaifenesin	LIQUID	ORAL	19981005	20241231	OTC MONOGRAPH FINAL	part341	Lannett Company, Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
54838-133_77e74ca8-1539-444b-b810-3115b3a8a154	54838-133	HUMAN OTC DRUG	Siltussin DM DAS Cough Formula		Guaifenesin and Dextromethorphan Hydrobromide	LIQUID	ORAL	19950905	20240331	OTC MONOGRAPH FINAL	part341	Lannett Company, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
54838-135_cb6d2fa4-3d1a-4c5d-96f7-bf562c7c833b	54838-135	HUMAN OTC DRUG	Siladryl Allergy Medicine		diphenhydramine hydrochloride	LIQUID	ORAL	19970101	20241130	OTC MONOGRAPH FINAL	part341	Lannett Company, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
54838-144_00a8f2c9-f087-456e-b9e6-c07eb71b8f86	54838-144	HUMAN OTC DRUG	Childrens Silapap		Acetaminophen	LIQUID	ORAL	19940905	20240531	OTC MONOGRAPH NOT FINAL	part343	Lannett Company, Inc.	ACETAMINOPHEN	160	mg/5mL			N	
54838-501_42ff1015-affa-4206-8f5d-a5c76d9c726f	54838-501	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	SOLUTION	ORAL	19930928		ANDA	ANDA073364	Lannett Company, Inc.	HALOPERIDOL LACTATE	2	mg/mL	Typical Antipsychotic [EPC]		N	20241231
54838-502_4e7be61a-5c07-4cdc-b250-c73447c9a8b3	54838-502	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	SOLUTION	ORAL	20130821		ANDA	ANDA201674	Lannett Company, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/5mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
54838-506_73dce3ff-12d9-4030-9de5-b3bba4eb5c7b	54838-506	HUMAN PRESCRIPTION DRUG	Hyosyne		Hyoscyamine Sulfate	SOLUTION/ DROPS	ORAL	19971001		UNAPPROVED DRUG OTHER		Lannett Company, Inc.	HYOSCYAMINE SULFATE	.125	mg/mL			N	20241231
54838-510_b453f744-aeaa-43a9-bde7-07ff10764265	54838-510	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	SYRUP	ORAL	19960329		ANDA	ANDA074520	Lannett Company, Inc.	OXYBUTYNIN CHLORIDE	5	mg/5mL	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
54838-511_dbc5c8d2-fc1e-4a2d-b63e-fa3c947662f8	54838-511	HUMAN PRESCRIPTION DRUG	Hyosyne		Hyoscyamine Sulfate	ELIXIR	ORAL	19971101		UNAPPROVED DRUG OTHER		Lannett Company, Inc.	HYOSCYAMINE SULFATE	.125	mg/5mL			N	20241231
54838-512_5cc9ca2c-8c32-48d5-aae3-933b75636a78	54838-512	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	SOLUTION	ORAL	19981229		ANDA	ANDA074721	Lannett Company, Inc.	DOXEPIN HYDROCHLORIDE	10	mg/mL	Tricyclic Antidepressant [EPC]		N	20241231
54838-523_bda5665d-4bcd-4426-9397-e438485d0d29	54838-523	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	LIQUID	ORAL	20090827		ANDA	ANDA077849	Lannett Company, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
54838-550_7de0da70-e977-4b4c-8998-d0392e62651a	54838-550	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine Hydrochloride	SOLUTION	ORAL	20101210		ANDA	ANDA091288	Lannett Company, Inc.	RANITIDINE HYDROCHLORIDE	15	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
54838-551_a81d3f6e-18ae-4e0f-b613-21135676e9cf	54838-551	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	SOLUTION	ORAL	20130612	20240531	ANDA	ANDA090477	Lannett Company, Inc.	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
54838-554_f1983bc7-0a23-48f5-b64f-fc3f3032cc69	54838-554	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20101124		ANDA	ANDA077421	Lannett Company, Inc.	LORATADINE	5	mg/5mL			N	20241231
54838-555_a9b814b9-978c-4791-a9d4-4458e99b5b9f	54838-555	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	SOLUTION	ORAL	20110127	20241130	ANDA	ANDA091342	Lannett Company, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
54838-556_a2b8caa4-4d41-424e-9e92-f8fb4c86c11b	54838-556	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	SOLUTION	ORAL	20110413	20240229	ANDA	ANDA091156	Lannett Company, Inc.	THEOPHYLLINE ANHYDROUS	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	
54838-558_f1983bc7-0a23-48f5-b64f-fc3f3032cc69	54838-558	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20101124		ANDA	ANDA077421	Lannett Company, Inc.	LORATADINE	5	mg/5mL			N	20241231
54838-563_a34c4769-eafb-4130-94e4-5490b336994b	54838-563	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	SOLUTION	ORAL	20150130		ANDA	ANDA202386	Lannett Company, Inc.	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
54838-566_372c0e32-3f27-43be-b646-824212a97615	54838-566	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	SOLUTION	ORAL	20141031	20241130	ANDA	ANDA203564	Lannett Company, Inc.	LAMIVUDINE	10	mg/mL	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	
54838-570_780d948c-9244-4f08-ba78-fdcbe962ce35	54838-570	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	SOLUTION	ORAL	20150817		ANDA	ANDA204171	Lannett Company, Inc.	ARIPIPRAZOLE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
54859-001_8d50fa10-d47c-47ac-86d9-8a89e6308c9d	54859-001	HUMAN OTC DRUG	Dologesic	NF	Acetaminophen, Dexbrompheniramine Maleate	TABLET	ORAL	20160401		OTC MONOGRAPH NOT FINAL	part343	Llorens Pharmaceutical International Division	ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE	500; 1	mg/1; mg/1			N	20241231
54859-010_83ec16e9-3cd3-4d2e-8abe-494a28c65cb9	54859-010	HUMAN OTC DRUG	Dologesic	DF	Acetaminophen, Dexbrompheniramine Maleate	TABLET	ORAL	20160401		OTC MONOGRAPH NOT FINAL	part343	Llorens Pharmaceutical International Division	ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE	500; 1	mg/1; mg/1			N	20241231
54859-011_822df434-72cd-496b-b046-44c459642806	54859-011	HUMAN OTC DRUG	Limpia Pecho		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
54859-120_bdc7538b-60af-4dce-b072-ad2a91cb7716	54859-120	HUMAN OTC DRUG	Dermagesic		Pramoxine HCl, Zinc Oxide, Calamine	LIQUID	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part347	Llorens Pharmaceuticals International Division	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.4; 1; .4	mg/100mL; mg/100mL; mg/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54859-202_3bc1d84a-63d6-4bde-b953-2e76539339fe	54859-202	HUMAN OTC DRUG	Dermagesic		Pramoxine HCl, Zinc Oxide, Calamine	CREAM	TOPICAL	20160401		OTC MONOGRAPH NOT FINAL	part347	Llorens Pharmaceutical International Division	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	4; 10; 4	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54859-415_5b954343-ea6b-45dd-88c1-27a51aa007c0	54859-415	HUMAN OTC DRUG	Amino Rip Muscle Pain Relief		Lidocaine HCl	LIQUID	TOPICAL	20191001		OTC MONOGRAPH FINAL	part348	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	LIDOCAINE	4	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54859-502_5d562cdd-a7fd-493b-b0dd-caf34e61d591	54859-502	HUMAN OTC DRUG	Tusnel		Dextromethorphan, Guiafenesin, Pseudoephedrine HCl	LIQUID	ORAL	20060101		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	15; 200; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
54859-503_e68250f2-c90d-4555-8d98-55b5906df24b	54859-503	HUMAN OTC DRUG	Orasep		Benzocaine, Menthol, Cetylpyridinium Chloride	LIQUID	TOPICAL	20100401		OTC MONOGRAPH NOT FINAL	part356	Llorens Pharmaceutical International Division	BENZOCAINE; CETYLPYRIDINIUM CHLORIDE; MENTHOL	2; .1; .5	mg/100mL; mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54859-504_4176f4cc-cc29-4715-90fc-3c6d739f339d	54859-504	HUMAN OTC DRUG	Orasep		Benzocaine, Menthol, Cetylpyridinium Chloride	LIQUID	TOPICAL	20100401		OTC MONOGRAPH NOT FINAL	part356	Llorens Pharmaceutical International Division	BENZOCAINE; CETYLPYRIDINIUM CHLORIDE; MENTHOL	2; .1; .5	mg/100mL; mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
54859-505_7bb71b9d-9085-4df4-addb-2f61e1dd658a	54859-505	HUMAN OTC DRUG	Tusnel Diabetic		Dextromethorphan, Guaifenesin	LIQUID	ORAL	20031201		OTC MONOGRAPH FINAL	part341	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
54859-506_a6d82b30-2a69-4ab0-ac2a-9f1014fe3df2	54859-506	HUMAN OTC DRUG	Tusnel	SF	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
54859-507_ca45fcf4-a645-4c75-a30b-ca9435a5b5ce	54859-507	HUMAN OTC DRUG	Tusnel	EX	Guaifenesin	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division, Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
54859-508_bce65e4f-a4b1-4b28-b6f9-ac1f614dec82	54859-508	HUMAN OTC DRUG	Triponel		Dextromethorphan HBr, Phenylephrine HCl, Triprolidine HCl	LIQUID	ORAL	20190801		OTC MONOGRAPH FINAL	part341	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	15; 5; 1.25	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
54859-509_fe037eac-4d73-4463-be15-c5637b87b015	54859-509	HUMAN OTC DRUG	Tusnel Cough Suppressant Expectorant		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
54859-513_4eddf947-9d0c-4e2c-968c-a948f7694681	54859-513	HUMAN OTC DRUG	Dologesic Roll-On		Lidocaine Hcl	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Llorens Pharmaceutical International Division, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
54859-514_ed564072-8e90-470b-9db6-a706403c4b70	54859-514	HUMAN OTC DRUG	Triponel		Dextromethorphan HBr, Pseufoephedrine HCl, Triprolidine HCl	LIQUID	ORAL	20180501		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	15; 30; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
54859-517_96a211dd-6812-48f8-8fef-ddfa47995cfd	54859-517	HUMAN OTC DRUG	Tusnel	DM	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
54859-520_3ba8cde8-85c8-4c33-a66c-aacc26fb6146	54859-520	HUMAN OTC DRUG	Tusnel	C	Codeine Phosphate, Guiafenesin, Pseudoephedrine HCl	LIQUID	ORAL	19950101		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division	CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	10; 100; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], alpha-Adrenergic Agonist [EPC]	CV	N	20241231
54859-544_c018e718-f343-42eb-a069-a51a55c5b0cb	54859-544	HUMAN OTC DRUG	Tusnel	Pediatric	Dextromethorphan, Guiafenesin, Pseudoephedrine HCl	LIQUID	ORAL	20060101		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 50; 15	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
54859-603_a3f45673-555c-46e7-9afe-7e6276f1b327	54859-603	HUMAN OTC DRUG	Tusnel DM	Pediatric	Dextromethorphan, Guiafenesin, Pseudoephedrine HCl	SOLUTION/ DROPS	ORAL	19930101		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	2.5; 25; 7.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
54859-604_08481494-3a4d-4c21-963a-9d603f1abdff	54859-604	HUMAN OTC DRUG	Tusnel Pediatric	DM	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 75; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
54859-605_47dff372-3f9d-48bc-86a3-5d0ee6b3d68e	54859-605	HUMAN OTC DRUG	Tusnel Pediatric Drops		Guaifenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20190801		OTC MONOGRAPH FINAL	part341	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	25; 1.25	mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
54859-606_e0fc03c4-634f-4ba2-a194-9a350d7b2937	54859-606	HUMAN OTC DRUG	Tusnel-DM Pediatric		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION/ DROPS	ORAL	20190801		OTC MONOGRAPH FINAL	part341	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	2.5; 25; 1.25	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
54859-702_21a5aaa5-eb19-425d-b026-47efa1c04bdc	54859-702	HUMAN OTC DRUG	Conex		Dexbrompheniramine Maleate, Pseudoephedrine HCl	TABLET	ORAL	20071101		OTC MONOGRAPH FINAL	part341	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
54859-801_732630f4-d829-4cab-8834-74ce18a6f145	54859-801	HUMAN OTC DRUG	Tusnel		Dextromethorphan HBr, Guaifenesin, Pseudoephedrine HCl	TABLET	ORAL	20070701		OTC MONOGRAPH FINAL	part341	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	30; 400; 60	mg/1; mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
54859-802_0b13510e-96ea-481c-9013-ff68716ac472	54859-802	HUMAN OTC DRUG	Conex		Dexbrompheniramine Maleate, Pseudoephedrine	LIQUID	ORAL	20071101		OTC MONOGRAPH FINAL	part341	Llorens Pharmaceutical International Division	DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	1; 30	mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
54859-808_33f62b61-9780-454e-98c1-5d3188ecbdee	54859-808	HUMAN OTC DRUG	Senna Syrup		Sennosides	LIQUID	ORAL	20190501		OTC MONOGRAPH NOT FINAL	part334	Llorens Pharmaceutical International Division, Inc.	SENNOSIDES	8.8	mg/5mL			N	20241231
54859-809_bc82b2f0-d6ab-41ab-8e64-2f7c4a955ba4	54859-809	HUMAN OTC DRUG	Liquid Acetaminophen		Acetaminophen	LIQUID	ORAL	20191001		OTC MONOGRAPH NOT FINAL	part343	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	ACETAMINOPHEN	160	mg/5mL			N	20241231
54859-811_1e39ad91-f2ba-401c-83f1-543deb7ca715	54859-811	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	LIQUID	ORAL	20191001		OTC MONOGRAPH FINAL	part341	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
54859-813_0a7003c3-ab45-4797-8b98-44dba7314f33	54859-813	HUMAN OTC DRUG	Docusate Sodium Liquid		Docusate Sodium	LIQUID	ORAL	20211201		OTC MONOGRAPH NOT FINAL	part334	LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION	DOCUSATE SODIUM	50	mg/5mL			N	20241231
54860-215_3b16ecae-7670-4083-8fdc-ba92e97efe36	54860-215	HUMAN OTC DRUG	Smart Care HAND SANITIZER		Ethyl Alcohol	GEL	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Science Co., ltd.	ALCOHOL	62	mL/100mL			N	20241231
54860-350_0dc1a9c9-822b-4917-8440-a54370804555	54860-350	HUMAN OTC DRUG	Smart Care Marvel Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20200820		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Science Co., ltd.	ALCOHOL	62	mL/100mL			N	20241231
54860-404_fb2aa29f-39e0-6d44-e053-6394a90a934c	54860-404	HUMAN OTC DRUG	Beautifier Life 75% Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20230507		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Science Co.,Ltd.	ALCOHOL	75	mL/100mL			N	20241231
54860-405_fb5427b6-7fb6-854c-e053-6294a90a1ebd	54860-405	HUMAN OTC DRUG	Hand sanitizer 29ml	01	alcohol	GEL	TOPICAL	20230511		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	65	mL/100mL			N	20241231
54860-406_fb67806a-3e2e-c5fe-e053-6394a90a5099	54860-406	HUMAN OTC DRUG	Smart care Marvel Hand Sanitizer 1oz	01	alcohol	LIQUID	TOPICAL	20230511		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
54860-407_fb79c551-080f-fd6e-e053-6294a90a076a	54860-407	HUMAN OTC DRUG	Smart Care Advance Hand Sanitizer 16.9oz	01	alcohol	GEL	TOPICAL	20230512		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	70	mL/100mL			N	20241231
54860-408_fb7a9faf-28b9-29d4-e053-6294a90a08c2	54860-408	HUMAN OTC DRUG	Smart Care hand Sanitizer 2oz	01	alcohol	LIQUID	TOPICAL	20230512		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
54860-409_fb7badb0-acad-1420-e053-6394a90aeef1	54860-409	HUMAN OTC DRUG	Smart Care Hand Sanitizer 8oz	01	alcohol	LIQUID	TOPICAL	20230512		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Science Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
54860-410_fb7c11bb-c05d-c703-e053-6394a90ae757	54860-410	HUMAN OTC DRUG	Smart Care Hand Sanitizer 33.8oz	01	alcohol	LIQUID	TOPICAL	20230512		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Science Co.,Ltd	ALCOHOL	62	mL/100mL			N	20241231
54860-411_fb7badb0-acac-1420-e053-6394a90aeef1	54860-411	HUMAN OTC DRUG	Smart Care Hand Sanitizer 16.9oz	01	alcohol	LIQUID	TOPICAL	20230515		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Science Co.,Ltd	ALCOHOL	62	mL/100mL			N	20241231
54860-412_fc532a97-0831-7b11-e053-6294a90a98a8	54860-412	HUMAN OTC DRUG	Hand sanitizer 29ml	01	alcohol	LIQUID	TOPICAL	20230523		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	65	mL/100mL			N	20241231
54860-413_fc546a9f-63a7-39a3-e053-6294a90afc69	54860-413	HUMAN OTC DRUG	Hand sanitizer 29ml	01	alcohol	LIQUID	TOPICAL	20230523		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	65	mL/100mL			N	20241231
54860-414_fc547fcf-8174-6336-e053-6294a90aa668	54860-414	HUMAN OTC DRUG	Hand sanitizer 29ml	01	alcohol	LIQUID	TOPICAL	20230523		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	65	mL/100mL			N	20241231
54860-415_037b4ad8-0ba1-7ae2-e063-6294a90a5887	54860-415	HUMAN OTC DRUG	Hand sanitizer 29ml	01	alcohol	LIQUID	TOPICAL	20230822		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Lantern Scicence Co.,Ltd.	ALCOHOL	65	mL/100mL			N	20241231
54860-416_07f8f075-b31a-bcc0-e063-6394a90af7f2	54860-416	HUMAN OTC DRUG	LANTERN SUNSCREEN SPF50	01	LANTERN	PASTE	TOPICAL	20231018		OTC MONOGRAPH DRUG	M020	Shenzhen Lantern Scicence Co.,Ltd.	AVOBENZONE; OCTINOXATE; TITANIUM DIOXIDE	3; 8.5; 3	g/100g; g/100g; g/100g			N	20241231
54860-417_080c8f40-3c21-3cae-e063-6394a90a6ac6	54860-417	HUMAN OTC DRUG	SUN SCREENLOTION SPF30	01	Octinoxate,Avobenzone,Oxybenzone,Titanium dioxide	LOTION	TOPICAL	20231019		OTC MONOGRAPH DRUG	M020	Shenzhen Lantern Scicence Co.,Ltd.	AVOBENZONE; OCTINOXATE; OXYBENZONE	3; 8.5; 3	g/100mL; g/100mL; g/100mL			N	20241231
54879-001_edabba4c-716e-e913-e053-2a95a90a6282	54879-001	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET, FILM COATED	ORAL	20061215		NDA AUTHORIZED GENERIC	NDA016320	STI Pharma LLC	ETHAMBUTOL HYDROCHLORIDE	100	mg/1	Antimycobacterial [EPC]		N	20241231
54879-002_edabba4c-716e-e913-e053-2a95a90a6282	54879-002	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET, FILM COATED	ORAL	20061215		NDA AUTHORIZED GENERIC	NDA016320	STI Pharma LLC	ETHAMBUTOL HYDROCHLORIDE	400	mg/1	Antimycobacterial [EPC]		N	20241231
54879-037_edaba8b6-1dda-4a6b-e053-2a95a90ac51f	54879-037	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201103		ANDA	ANDA214308	STI Pharma LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
54897-701_90d3065d-9432-4fde-83a8-b434526b1801	54897-701	HUMAN OTC DRUG	Salivea		Fluoride Toothpaste	PASTE, DENTIFRICE	DENTAL	20180219		OTC MONOGRAPH FINAL	part355	Laclede, Inc.	SODIUM MONOFLUOROPHOSPHATE	1.4	mg/g			N	20241231
54932-501_f67efa31-1709-42b3-ae74-4638dbbb1a1a	54932-501	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	LIQUID	ORAL	20190329		UNAPPROVED DRUG OTHER		BioRamo, LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
54973-0604_efe279ac-c5ad-ab0e-e053-2a95a90a33a9	54973-0604	HUMAN OTC DRUG	ARNICA MONTANA		arnica montana	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARNICA MONTANA	6	[hp_X]/1			N	20241231
54973-0605_f030c209-0abc-272e-e053-2995a90a63cf	54973-0605	HUMAN OTC DRUG	ARSENICUM ALBUM		arsenic trioxide	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARSENIC TRIOXIDE	6	[hp_X]/1			N	20241231
54973-0615_f032a3b2-3d34-d2a0-e053-2995a90aa861	54973-0615	HUMAN OTC DRUG	HYPERICUM PERF		hypericum perforatum	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	HYPERICUM PERFORATUM	6	[hp_X]/1			N	20241231
54973-1068_eeb2667a-b85a-894a-e053-2995a90a96db	54973-1068	HUMAN OTC DRUG	Bioplasma		calcium fluoride, tribasic calcium phosphate, calcium sulfate anhydrous, ferrosoferric phosphate, potassium chloride, potassium phosphate, dibasic, potassium sulfate, magnesium phosphate, dibasic trihydrate, sodium chloride, sodium phosphate, dibasic, heptahydrate, sodium sulfate, and silicon dioxide	TABLET, SOLUBLE	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	6; 3; 3; 3; 3; 3; 3; 6; 6; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-1069_eea48655-aa7d-c74f-e053-2a95a90aa56f	54973-1069	HUMAN OTC DRUG	BIOCHEMIC PHOSPHATE		tribasic calcium phosphate, ferrosoferric phosphate, potassium phosphate, dibasic, magnesium phosphate, dibasic trihydrate, and sodium phosphate, dibasic, heptahydrate	TABLET	ORAL	19790919		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TRIBASIC CALCIUM PHOSPHATE	3; 3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-1120_ef43098f-998a-7001-e053-2995a90aa820	54973-1120	HUMAN OTC DRUG	CALMS NERVE TENSION SLEEPLESSNESS		passiflora incarnata flower, avena sativa leaf, hops, and chamomile	TABLET	ORAL	19800101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	AVENA SATIVA LEAF; CHAMOMILE; HOPS; PASSIFLORA INCARNATA FLOWER	1; 2; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
54973-1129_efb8723f-0a31-7da0-e053-2995a90a3638	54973-1129	HUMAN OTC DRUG	NERVE TONIC STRESS RELIEF		calcium phosphate, iron, potassium phosphate, unspecified form, magnesium phosphate, dibasic trihydrate, and sodium phosphate	TABLET	ORAL	19700101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM PHOSPHATE; IRON; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM PHOSPHATE, UNSPECIFIED FORM; SODIUM PHOSPHATE	3; 3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-2033_ef415a03-ceec-1783-e053-2995a90a9da8	54973-2033	HUMAN OTC DRUG	CALC FLUOR		calcium fluoride	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM FLUORIDE	6	[hp_X]/1			N	20241231
54973-2043_ef4134e5-99a9-4f8b-e053-2a95a90ac88f	54973-2043	HUMAN OTC DRUG	CALC PHOS		CALCIUM PHOSPHATE	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM PHOSPHATE	6	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
54973-2049_ef42dcb3-c833-7393-e053-2995a90ae27e	54973-2049	HUMAN OTC DRUG	CALCIUM SULPHATE		CALCIUM SULFATE	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM SULFATE	6	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
54973-2903_f030b556-709d-5859-e053-2a95a90a9be5	54973-2903	HUMAN OTC DRUG	APIS MELLIFICA		apis mellifera	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	APIS MELLIFERA	30	[hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
54973-2904_f030bfd2-4131-3a7a-e053-2a95a90a46c2	54973-2904	HUMAN OTC DRUG	ARNICA MONTANA		arnica montana	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARNICA MONTANA	30	[hp_X]/1			N	20241231
54973-2906_efe29ae2-f5b7-48f8-e053-2a95a90af9e7	54973-2906	HUMAN OTC DRUG	BELLADONNA		atropa belladonna root	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ATROPA BELLADONNA ROOT	30	[hp_X]/1			N	20241231
54973-2911_f030df86-ed45-2b16-e053-2a95a90aa949	54973-2911	HUMAN OTC DRUG	CHAMOMILLA		matricaria chamomilla flowering top oil	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	MATRICARIA CHAMOMILLA FLOWERING TOP OIL	30	[hp_X]/1			N	20241231
54973-2913_f03293bc-f5bf-5e83-e053-2995a90afb9a	54973-2913	HUMAN OTC DRUG	GELSEMIUM SEMP		gelsemium sempervirens root	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_X]/1			N	20241231
54973-2916_f032a3b2-3d48-d2a0-e053-2995a90aa861	54973-2916	HUMAN OTC DRUG	IGNATIA AMARA		strychnos ignatii seed	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	STRYCHNOS IGNATII SEED	30	[hp_X]/1			N	20241231
54973-2921_f049fc1f-176e-6437-e053-2a95a90a3f71	54973-2921	HUMAN OTC DRUG	NUX VOMICA		strychnos nux-vomica seed	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	STRYCHNOS NUX-VOMICA SEED	30	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54973-2923_eff981fd-5439-7c34-e053-2a95a90a3e8e	54973-2923	HUMAN OTC DRUG	PULSATILLA NIG		pulsatilla vulgaris	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	PULSATILLA VULGARIS	30	[hp_X]/1			N	20241231
54973-2924_f031cc09-246b-5958-e053-2a95a90a1311	54973-2924	HUMAN OTC DRUG	RHUS TOX		toxicodendron radicans leaf	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	TOXICODENDRON RADICANS LEAF	30	[hp_X]/1			N	20241231
54973-2925_f031f307-9f45-61d1-e053-2a95a90a2114	54973-2925	HUMAN OTC DRUG	RUTA GRAV		ruta graveolens flowering top	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	RUTA GRAVEOLENS FLOWERING TOP	30	[hp_X]/1			N	20241231
54973-2926_f0322950-80be-20d6-e053-2995a90ac14a	54973-2926	HUMAN OTC DRUG	SPONGIA TOSTA		spongia officinalis skeleton, roasted	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_X]/1			N	20241231
54973-2932_f0318c3f-3d09-2c34-e053-2995a90a7924	54973-2932	HUMAN OTC DRUG	PHOSPHORUS		phosphorus	TABLET	ORAL	19550101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	PHOSPHORUS	30	[hp_X]/1			N	20241231
54973-2956_07dd227b-ece8-e692-e063-6394a90acb62	54973-2956	HUMAN OTC DRUG	LEG CRAMPS		cinchona officinalis bark, aconitum napellus, pseudognaphalium obtusifolium, ledum palustre twig, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, and viscum album fruiting top	TABLET, SOLUBLE	ORAL	19951204		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	ACONITUM NAPELLUS; CINCHONA OFFICINALIS BARK; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP	6; 3; 6; 6; 3; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3010_ef432e0a-980a-88a6-e053-2995a90aeb3c	54973-3010	HUMAN OTC DRUG	COLD		Aconitum Napellus, Allium Cepa, Gelsemium Semp., Zincum Gluconicum	TABLET	ORAL	19970217		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; GELSEMIUM SEMPERVIRENS ROOT; ONION; ZINC GLUCONATE	6; 6; 6; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
54973-3012_ec987b66-eecb-8f90-e053-2995a90afe23	54973-3012	HUMAN OTC DRUG	Seasonal Allergy Relief		onion, sodium chloride, histamine dihydrochloride, cucumber, galphimia glauca flowering top, and strychnos nux-vomica seed	TABLET, SOLUBLE	ORAL	20020529		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CUCUMBER; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; ONION; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
54973-3014_efb8303b-5fe8-560a-e053-2995a90a6a5d	54973-3014	HUMAN OTC DRUG	NERVE TONIC		calcium phosphate, iron, potassium phosphate, unspecified form, magnesium phosphate, dibasic trihydrate, and sodium phosphate	TABLET	ORAL	19700101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM PHOSPHATE, UNSPECIFIED FORM; IRON; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM PHOSPHATE, UNSPECIFIED FORM; SODIUM PHOSPHATE	3; 3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3075_01cfaa3e-5e1a-18fa-e063-6394a90a084e	54973-3075	HUMAN OTC DRUG	Cold and Cough 4 Kids		ONION, CALCIUM SULFIDE, SODIUM CHLORIDE, PHOSPHORUS, PULSATILLA VULGARIS, SULFUR, and GOLDENSEAL	LIQUID	ORAL	20080801		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 12; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
54973-3084_fa1a4689-911f-afd1-e053-6294a90a44ca	54973-3084	HUMAN OTC DRUG	ARNICA		arnica montana	TABLET, SOLUBLE	ORAL	20081217		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARNICA MONTANA	30	[hp_X]/1			N	20241231
54973-3085_efb7ce0e-1be5-b164-e053-2a95a90afecf	54973-3085	HUMAN OTC DRUG	MUSCLE THERAPY WITH ARNICA		arnica montana, bellis perennis, hypericum perforatum, ledum palustre twig, and ruta graveolens flowering top	GEL	TOPICAL	20090115		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARNICA MONTANA; BELLIS PERENNIS; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; RUTA GRAVEOLENS FLOWERING TOP	2; 3; 3; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
54973-3093_05cafe75-b3dd-e990-e063-6294a90a3ca9	54973-3093	HUMAN OTC DRUG	Leg Cramps PM		oyster shell calcium carbonate, crude, causticum, matricaria recutita, cinchona officinalis bark, copper, lycopodium clavatum spore, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, silicon dioxide, and sulfur	TABLET, SOLUBLE	ORAL	20100101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CAUSTICUM; CINCHONA OFFICINALIS BARK; COPPER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; SULFUR; TOXICODENDRON PUBESCENS LEAF	12; 3; 12; 12; 6; 6; 12; 12; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3108_f0312ed9-d660-0c99-e053-2995a90a30fe	54973-3108	HUMAN OTC DRUG	MAGNESIA PHOS		magnesium phosphate, dibasic trihydrate	TABLET	ORAL	19600101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3114_ec71c58d-a5f0-d6a5-e053-2995a90a2ab2	54973-3114	HUMAN OTC DRUG	LEG CRAMPS		cinchona officinalis bark, aconitum napellus, pseudognaphalium obtusifolium, ledum palustre twig, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, and viscum album fruiting top	TABLET, SOLUBLE	ORAL	19951204		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; CINCHONA OFFICINALIS BARK; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP	6; 3; 6; 6; 3; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3154_efa3be17-4614-b709-e053-2a95a90a6dcf	54973-3154	HUMAN OTC DRUG	COUGH BABY		ipecac, bryonia alba root, spongia officinalis skeleton, roasted, phosphorus, causticum, drosera rotundifolia, and rumex crispus root	SYRUP	ORAL	20121017		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	BRYONIA ALBA ROOT; CAUSTICUM; DROSERA ROTUNDIFOLIA; IPECAC; PHOSPHORUS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 6; 6; 6; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-3158_0761fb5a-1cbf-a6a1-e063-6294a90a29af	54973-3158	HUMAN OTC DRUG	Tiny Cold		eupatorium perfoliatum flowering top, euphrasia stricta, gelsemium sempervirens root, and potassium iodide	TABLET, SOLUBLE	ORAL	20111228		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; POTASSIUM IODIDE	6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3160_efce3b89-2e8f-20c8-e053-2a95a90af89b	54973-3160	HUMAN OTC DRUG	SNIFFLES N SNEEZES 4 KIDS		aconitum napellus root, onion, gelsemium sempervirens root, and zinc gluconate	TABLET	ORAL	20130610		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS ROOT; GELSEMIUM SEMPERVIRENS ROOT; ONION; ZINC GLUCONATE	6; 6; 6; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
54973-3162_ece4a6c3-1411-60cb-e053-2a95a90af80f	54973-3162	HUMAN OTC DRUG	Restful Legs		arsenic trioxide, lycopodium clavatum spore, pulsatilla vulgaris, toxicodendron pubescens leaf, sulfur, and zinc	TABLET, SOLUBLE	ORAL	20060717		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARSENIC TRIOXIDE; LYCOPODIUM CLAVATUM SPORE; PULSATILLA VULGARIS; SULFUR; TOXICODENDRON PUBESCENS LEAF; ZINC	12; 6; 6; 6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3172_efa40953-abb8-885e-e053-2a95a90a6482	54973-3172	HUMAN OTC DRUG	EARACHE DROPS		belladonna leaf, calcium carbonate, chamomile, lycopodium clavatum spore, anemone patens, and sulfur	LIQUID	AURICULAR (OTIC)	20040617		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PATENS WHOLE; BELLADONNA LEAF; CALCIUM CARBONATE; CHAMOMILE; LYCOPODIUM CLAVATUM SPORE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
54973-3174_ee8ce15d-4b99-6dde-e053-2a95a90a45c6	54973-3174	HUMAN OTC DRUG	Baby Gas Drops		silver nitrate, ferula sumbul root, activated charcoal, chamomile, cinchona officinalis bark, citrullus colocynthis fruit, lycopodium clavatum spore, nutmeg, and sepia officinalis juice	LIQUID	ORAL	20140115		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACTIVATED CHARCOAL; CHAMOMILE; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT; FERULA SUMBUL ROOT; LYCOPODIUM CLAVATUM SPORE; NUTMEG; SEPIA OFFICINALIS JUICE; SILVER NITRATE	12; 6; 6; 6; 6; 30; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54973-3179_edfe5da0-ee7f-30c2-e053-2995a90ae175	54973-3179	HUMAN OTC DRUG	4 Kids Complete Cold and Mucus		bryonia alba root, euphrasia stricta, calcium sulfide, sodium chloride, phosphorus, anemone pulsatilla, rumex crispus root, and silicon dioxide	LIQUID	ORAL	20140701		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; EUPHRASIA STRICTA; PHOSPHORUS; RUMEX CRISPUS ROOT; SILICON DIOXIDE; SODIUM CHLORIDE	6; 6; 12; 6; 30; 6; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-3180_eea4461d-3cbb-a410-e053-2995a90a5558	54973-3180	HUMAN OTC DRUG	Baby Nighttime Tiny Cold		chamomile, eupatorium perfoliatum flowering top, euphrasia stricta, gelsemium sempervirens root, and potassium iodide	LIQUID	ORAL	20140701		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CHAMOMILE; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; POTASSIUM IODIDE	6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-3183_efa3f603-afa3-4668-e053-2a95a90ac5d2	54973-3183	HUMAN OTC DRUG	Defend Cold and Mucus		BRYONIA ALBA ROOT, EUPHRASIA STRICTA, CALCIUM SULFIDE, SODIUM CHLORIDE, PHOSPHORUS, ANEMONE PATENS, RUMEX CRISPUS ROOT, and SILICON DIOXIDE	LIQUID	ORAL	20140701		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	BRYONIA ALBA ROOT; CALCIUM SULFIDE; EUPHRASIA STRICTA; PHOSPHORUS; PULSATILLA PATENS WHOLE; RUMEX CRISPUS ROOT; SILICON DIOXIDE; SODIUM CHLORIDE	6; 12; 6; 30; 6; 6; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-3187_efa3f8c6-e263-6bc1-e053-2a95a90ae1bd	54973-3187	HUMAN OTC DRUG	DEFEND Sinus		OYSTER SHELL CALCIUM CARBONATE, CRUDE, GOLDENSEAL, POTASSIUM DICHROMATE, and PULSATILLA VULGARIS	TABLET, SOLUBLE	ORAL	20140701		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	GOLDENSEAL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS	6; 3; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3196_efce4dc3-032f-a57c-e053-2a95a90a9838	54973-3196	HUMAN OTC DRUG	Tummy Ache 4Kids		silver nitrate, asafetida, activated charcoal, matricaria recutita, cinchona officinalis bark, citrullus colocynthis fruit pulp, lycopodium clavatum spore, nutmeg, and pulsatilla vulgaris	TABLET	ORAL	20141020		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACTIVATED CHARCOAL; ASAFETIDA; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; NUTMEG; PULSATILLA VULGARIS; SILVER NITRATE	12; 6; 6; 6; 30; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54973-3202_ec859b05-8a27-44e7-e053-2995a90a3d14	54973-3202	HUMAN OTC DRUG	Leg Cramps		ACONITUM NAPELLUS, ARNICA MONTANA, LEDUM PALUSTRE TWIG, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF, and VISCUM ALBUM FRUITING TOP	OINTMENT	TOPICAL	20150512		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP	3; 3; 3; 10; 6; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3203_efb7ec4e-0a49-2aae-e053-2a95a90aebf2	54973-3203	HUMAN OTC DRUG	Muscle Therapy with Arnica Pain Relief Gel		Arnica Montana,Bellis Perennis,Hypericum Perforatum,Ruta GraveolensFlowering Top and Rhododendron Tomentosum Leafy Twig	GEL	TOPICAL	20180827		UNAPPROVED HOMEOPATHIC		Hylands Inc.	ARNICA MONTANA; BELLIS PERENNIS; HYPERICUM PERFORATUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP	1; 2; 2; 2; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
54973-3206_efce1ee2-5859-4587-e053-2995a90a3bba	54973-3206	HUMAN OTC DRUG	Sleep		HYOSCYAMUS NIGER, STRYCHNOS IGNATII SEED, and POTASSIUM PHOSPHATE, DIBASIC	TABLET	ORAL	20141105		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	HYOSCYAMUS NIGER; POTASSIUM PHOSPHATE, DIBASIC; STRYCHNOS IGNATII SEED	6; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3243_05a94f86-713b-305d-e063-6294a90af5c5	54973-3243	HUMAN OTC DRUG	4 KIDS COLD N COUGH GRAPE FLAVOR		onion, calcium sulfide, goldenseal, sodium chloride, phosphorus, anemone pulsatilla, and sulfur	LIQUID	ORAL	20160210		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 12; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
54973-3257_ef42f70d-e49a-eadd-e053-2995a90ab730	54973-3257	HUMAN OTC DRUG	CALMS FORTE		avena sativa flowering top, tribasic calcium phosphate, matricaria recutita, ferrosoferric phosphate, hops, potassium phosphate, dibasic, magnesium phosphate, dibasic trihydrate, sodium phosphate, dibasic, heptahydrate, and passiflora incarnata flower	TABLET	ORAL	20160429		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	AVENA SATIVA FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HOPS; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWER; POTASSIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TRIBASIC CALCIUM PHOSPHATE	4; 3; 4; 3; 4; 4; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3274_ef42fef9-4849-0874-e053-2a95a90a4e80	54973-3274	HUMAN OTC DRUG	CALMS FORTE		avena sativa flowering top, tribasic calcium phosphate, matricaria recutita, ferrosoferric phosphate, hops, potassium phosphate, dibasic, magnesium phosphate, dibasic trihydrate, sodium phosphate, dibasic, heptahydrate, and passiflora incarnata flower	TABLET	ORAL	20160429		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	AVENA SATIVA FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HOPS; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWER; POTASSIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TRIBASIC CALCIUM PHOSPHATE	4; 3; 4; 3; 4; 4; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3284_0384ed1c-8da1-f57c-e063-6394a90ad016	54973-3284	HUMAN OTC DRUG	BABY MUCUS PLUS COLD RELIEF		bryonia alba root, euphrasia stricta, calcium sulfide, sodium chloride, phosphorus, anemone pulsatilla, rumex crispus root, and silicon dioxide	LIQUID	ORAL	20160513		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; EUPHRASIA STRICTA; PHOSPHORUS; RUMEX CRISPUS ROOT; SILICON DIOXIDE; SODIUM CHLORIDE	6; 6; 12; 6; 30; 6; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-3307_ee8fb0c2-2a21-f92f-e053-2a95a90a8d16	54973-3307	HUMAN OTC DRUG	Baby Tiny Cold Daytime and Nighttime		eupatorium perfoliatum flowering top, euphrasia stricta, gelsemium sempervirens root, potassium iodide, and matricaria recutita	KIT		20170111		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3315_091af092-cfbc-3c0d-e063-6294a90a228e	54973-3315	HUMAN OTC DRUG	Baby Oral Pain Relief		oyster shell calcium carbonate, crude, tribasic calcium phosphate, arabica coffee bean, arnica montana, ferrum phosphoricum and matricaria chamomilla	TABLET	ORAL	20170817		UNAPPROVED HOMEOPATHIC		Hyland' Inc.	ARABICA COFFEE BEAN; ARNICA MONTANA; FERRUM PHOSPHORICUM; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; TRIBASIC CALCIUM PHOSPHATE	6; 30; 12; 12; 12; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54973-3316_ee17f29f-b5c9-5b63-e053-2a95a90ac63b	54973-3316	HUMAN OTC DRUG	4 Kids Oral Pain Relief		Oyster Shell Calcium Carbonate, Crude, Arabica Coffee Bean, Arnica Montana, Tribasic Calcium Phosphate, Ferrum Phosphoricum and Matricaria Chamomilla	TABLET	ORAL	20170818		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARABICA COFFEE BEAN; ARNICA MONTANA; FERRUM PHOSPHORICUM; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; TRIBASIC CALCIUM PHOSPHATE	6; 30; 12; 12; 12; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54973-3324_f278d60f-551e-08c2-e053-2a95a90ac358	54973-3324	HUMAN OTC DRUG	Baby Nighttime Oral Pain Relief		Arnica Montana, Tribasic Calcium Phosphate, Matricaria Chamomilla, Silicon Dioxide, Magnesium Phosphate, Dibasic Trihydrate, Ferrosoferric Phosphate, Arabica Coffee Bean and Oyster Shell Calcium Carbonate, Crude	TABLET	ORAL	20170817		UNAPPROVED HOMEOPATHIC		Hyland' Inc.	ARABICA COFFEE BEAN; ARNICA MONTANA; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE	6; 30; 12; 12; 12; 12; 12; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3325_ee180cdd-90b8-b803-e053-2a95a90aec8c	54973-3325	HUMAN OTC DRUG	4 Kids Oral Pain Relief Nighttime		arnica montana,tribasic calcium phosphate,silicon dioxide,matricaria chamomilla,ferrum phosphoricum,arabica coffee bean,magnesium phosphate, dibasic trihydrate and oyster shell calcium carbonate, crude	TABLET	ORAL	20170818		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARABICA COFFEE BEAN; ARNICA MONTANA; FERRUM PHOSPHORICUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE	6; 30; 12; 12; 12; 12; 12; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3331_ece9634b-2aa1-52fd-e053-2995a90aef51	54973-3331	HUMAN OTC DRUG	Calm		TRIBASIC CALCIUM PHOSPHATE,FERROSOFERRIC PHOSPHATE,DIBASIC POTASSIUM PHOSPHATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE and MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	TABLET	ORAL	20171204		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TRIBASIC CALCIUM PHOSPHATE	3; 3; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3332_efbe13e2-aa1c-0a4d-e053-2995a90a9242	54973-3332	HUMAN OTC DRUG	Rest		SILVER NITRATE,CAUSTICUM,MATRICARIA CHAMOMILLA,ANAMIRTA COCCULUS SEED,SODIUM CHLORIDE,PHOSPHORUS and VALERIAN	TABLET	ORAL	20171130		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANAMIRTA COCCULUS SEED; CAUSTICUM; MATRICARIA CHAMOMILLA; PHOSPHORUS; SILVER NITRATE; SODIUM CHLORIDE; VALERIAN	12; 6; 3; 12; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-3333_ee8c77fe-b88a-4168-e053-2a95a90a7cd0	54973-3333	HUMAN OTC DRUG	Awaken		DAPHNE MEZEREUM BARK,SULFUR,DELPHINIUM STAPHISAGRIA SEED,SEPIA OFFICINALIS JUICE,SODIUM CHLORIDE,PHOSPHORIC ACID,DIBASIC POTASSIUM PHOSPHATE and THUJA OCCIDENTALIS LEAFY TWIG	TABLET	ORAL	20171201		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	DAPHNE MEZEREUM BARK; DELPHINIUM STAPHISAGRIA SEED; DIBASIC POTASSIUM PHOSPHATE; PHOSPHORIC ACID; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	12; 30; 6; 6; 30; 6; 12; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54973-3347_ef432678-afb8-22df-e053-2a95a90a4d65	54973-3347	HUMAN OTC DRUG	Chamomilla		MATRICARIA CHAMOMILLA	TABLET	ORAL	20180202		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	MATRICARIA CHAMOMILLA	6	[hp_X]/1			N	20241231
54973-3349_efa8ec56-54c2-559e-e053-2995a90a17e1	54973-3349	HUMAN OTC DRUG	Menopause Plus Mood		sulfur, causticum, zinc, atropa belladonna, caulophyllum thalictroides root, lachesis muta venom, black cohosh, anemone pulsatilla, sepia officinalis juice, and viola tricolor	TABLET	SUBLINGUAL	20180601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; ATROPA BELLADONNA; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; CAUSTICUM; LACHESIS MUTA VENOM; SEPIA OFFICINALIS JUICE; SULFUR; VIOLA TRICOLOR; ZINC	12; 12; 12; 12; 12; 30; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3350_efa9e568-f60b-6a86-e053-2995a90a83ab	54973-3350	HUMAN OTC DRUG	Menopause Plus Mood		ATROPA BELLADONNA, CAULOPHYLLUM THALICTROIDES ROOT, CAUSTICUM- BLACK COHOSH, LACHESIS MUTA VENOM, ANEMONE PULSATILLA, SEPIA OFFICINALIS JUICE, SULFUR, VIOLA TRICOLOR and ZINC	KIT	SUBLINGUAL	20180601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3352_ec81ef8b-44d0-ee0a-e053-2a95a90a90bf	54973-3352	HUMAN OTC DRUG	Restful Legs PM		ANEMONE PATENS,MATRICARIA CHAMOMILLA,SULFUR,ZINC,TOXICODENDRON PUBESCENS LEAF,ARSENIC TRIOXIDE,ARABICA COFFEE BEAN,LYCOPODIUM CLAVATUM SPORE	TABLET	ORAL	20180314		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PULSATILLA PATENS WHOLE; SULFUR; TOXICODENDRON PUBESCENS LEAF; ZINC	3; 12; 6; 3; 6; 6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54973-3354_efa6c162-cf28-93f3-e053-2a95a90a4e62	54973-3354	HUMAN OTC DRUG	Menopause Plus Energy		CAULOPHYLLUM THALICTROIDES ROOT,DIBASIC POTASSIUM PHOSPHATE,PHOSPHORIC ACID,ANEMONE PULSATILLA,ATROPA BELLADONNA,BLACK COHOSH,LACHESIS MUTA VENOM,SULFUR and SEPIA OFFICINALIS JUICE	KIT	ORAL	20180601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3356_efb79f0c-cc1f-d1bf-e053-2995a90a66d6	54973-3356	HUMAN OTC DRUG	Menopause Plus Sleep		ATROPA BELLADONNA, CAULOPHYLLUM THALICTROIDES ROOT, BLACK COHOSH, NITROGLYCERIN, STRYCHNOS IGNATII SEED, ANEMONE PULSATILLA, SEPIA OFFICINALIS JUICE, SULFUR and LACHESIS MUTA VENOM	KIT	SUBLINGUAL	20180601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3358_efa78986-38f2-f817-e053-2995a90a2ad7	54973-3358	HUMAN OTC DRUG	Menopause Plus Moisture		ATROPA BELLADONNA, BERBERIS VULGARIS ROOT BARK, CAULOPHYLLUM THALICTROIDES ROOT, BLACK COHOSH, GRAPHITE, LACHESIS MUTA VENOM, ANEMONE PULSATILLA, SEPIA OFFICINALIS JUICE, DELPHINIUM STAPHISAGRIA SEED and SULFUR	KIT	SUBLINGUAL	20180601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3361_efa6d50d-e523-93f1-e053-2a95a90aff67	54973-3361	HUMAN OTC DRUG	Menopause Plus Bladder		LYTTA VESICATORIA,CAULOPHYLLUM THALICTROIDES ROOT,EQUISETUM HYEMALE,ANEMONE PULSATILLA,RHUS AROMATICA ROOT BARK,ATROPA BELLADONNA,SULFUR,SEPIA OFFICINALIS JUICE,BLACK COHOSH and LACHESIS MUTA VENOM	TABLET	SUBLINGUAL	20180601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; ATROPA BELLADONNA; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; EQUISETUM HYEMALE; LACHESIS MUTA VENOM; LYTTA VESICATORIA; RHUS AROMATICA ROOT BARK; SEPIA OFFICINALIS JUICE; SULFUR	12; 12; 12; 12; 6; 30; 6; 6; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3371_f98bd339-1709-6f48-e053-6394a90ad617	54973-3371	HUMAN OTC DRUG	Baby Nighttime Mucus Plus Cold Relief		CALCIUM SULFIDE,PHOSPHORUS,SULFUR,RUMEX CRISPUS ROOT,SODIUM CHLORIDE,ARABICA COFFEE BEAN,ANEMONE PULSATILLA,SILICON DIOXIDE, GOLDENSEAL,ONION,BRYONIA ALBA ROOT,EUPHRASIA STRICTA and MATRICARIA CHAMOMILLA	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; BRYONIA ALBA ROOT; CALCIUM SULFIDE; EUPHRASIA STRICTA; GOLDENSEAL; MATRICARIA CHAMOMILLA; ONION; PHOSPHORUS; RUMEX CRISPUS ROOT; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR	6; 3; 6; 12; 6; 6; 3; 6; 30; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
54973-3372_edfdffd2-0080-6d36-e053-2a95a90aa818	54973-3372	HUMAN OTC DRUG	4 Kids Cold and Mucus Nighttime		EUPHRASIA STRICTA,SILICON DIOXIDE, RUMEX CRISPUS ROOT, ANEMONE PULSATILLA, GOLDENSEAL, SODIUM CHLORIDE, PHOSPHORUS, ONION, BRYONIA ALBA ROOT, MATRICARIA CHAMOMILLA, ARABICA COFFEE BEAN, CALCIUM SULFIDE and SULFUR	LIQUID	ORAL	20180627		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; BRYONIA ALBA ROOT; CALCIUM SULFIDE; EUPHRASIA STRICTA; GOLDENSEAL; MATRICARIA CHAMOMILLA; ONION; PHOSPHORUS; RUMEX CRISPUS ROOT; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR	6; 3; 6; 12; 6; 6; 3; 6; 30; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
54973-3374_0397de56-d497-5ac4-e063-6294a90accb2	54973-3374	HUMAN OTC DRUG	BABY MUCUS PLUS COLD RELIEF DAYTIME AND NIGHTTIME		calcium sulfide,phosphorus,sulfur,rumex crispus root,sodium chloride,arabica coffee bean,anemone pulsatilla,silicon dioxide, goldenseal,onion,bryonia alba root,euphrasia stricta and matricaria chamomilla	KIT		20181101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3375_0672749b-be66-5162-e063-6294a90ab231	54973-3375	HUMAN OTC DRUG	4 Kids Cold and Cough Nighttime		ONION, CALCIUM SULFIDE, SODIUM CHLORIDE, ANEMONE PULSATILLA, ARABICA COFFEE BEAN, MATRICARIA CHAMOMILLA, SULFUR, PHOSPHORUS and GOLDENSEAL	LIQUID	ORAL	20180701		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; CALCIUM SULFIDE; GOLDENSEAL; MATRICARIA CHAMOMILLA; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 6; 12; 6; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
54973-3377_feb923fe-6d36-e75a-e053-6294a90a24c7	54973-3377	HUMAN OTC DRUG	4 Kids Cold and Cough Nighttime Natural Grape Flavor		onion,anemone pulsatilla, phosphorus, goldenseal, calcium sulfide, sodium chloride, sulfur, matricaria chamomilla and arabica coffee bean	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; CALCIUM SULFIDE; GOLDENSEAL; MATRICARIA CHAMOMILLA; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 6; 12; 6; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
54973-3378_065c36c9-14e6-306a-e063-6394a90af8ff	54973-3378	HUMAN OTC DRUG	4 Kids Cold and Cough Daytime and Nighttime		onion, calcium sulfide, sodium chloride, anemone pulsatilla, arabica coffee bean, matricaria chamomilla, sulfur, phosphorus and goldenseal	KIT		20180608		UNAPPROVED HOMEOPATHIC		Hylands Inc.						N	20241231
54973-3379_edc482c1-3301-dc20-e053-2995a90ae882	54973-3379	HUMAN OTC DRUG	4 Kids Cold and Cough Day and Night Grape Flavor		onion,anemone pulsatilla, phosphorus, goldenseal, calcium sulfide, sodium chloride, sulfur, matricaria chamomilla and arabica coffee bean	KIT	ORAL	20181201		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3381_ee135b47-823d-6d00-e053-2995a90a80d2	54973-3381	HUMAN OTC DRUG	4 Kids Cold and Mucus		euphrasia stricta,silicon dioxide, rumex crispus root, anemone pulsatilla, goldenseal, sodium chloride, phosphorus, onion, bryonia alba root, matricaria chamomilla, arabica coffee bean, calcium sulfide and sulfur	KIT		20180801		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-3382_ee16dcc8-ed04-59bd-e053-2995a90a1957	54973-3382	HUMAN OTC DRUG	4 Kids Complete Allergy Daytime		Sodium Chloride, Aconitum Napellus, Luffa Operculata Fruit, Euphrasia Stricta,Galphimia Glauca Flowering Top, Histamine Dihydrochloride,Onion,Anemone Pulsatilla and Schoennocaulon Officinale Seed	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; ONION; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE	6; 6; 6; 12; 12; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
54973-3383_ee17d291-2a46-3ba7-e053-2a95a90a4ffb	54973-3383	HUMAN OTC DRUG	4 Kids Leg Pain Relief		Tribasic Calcium Phosphate, Arnica Montana, Oyster Shell Calcium Carbonate, Crude, Copper, Eupatorium Perfoliatum Flowering Top, Magnesium Phosphate, Dibasic Trihydrate, Phosphorus, Guaiacum Officinale Resin and Phosphoric Acid	TABLET	ORAL	20181101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARNICA MONTANA; COPPER; EUPATORIUM PERFOLIATUM FLOWERING TOP; GUAIACUM OFFICINALE RESIN; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; TRIBASIC CALCIUM PHOSPHATE	30; 12; 30; 12; 12; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-3392_ee179f50-a7e0-8a0f-e053-2a95a90a876e	54973-3392	HUMAN OTC DRUG	4 Kids Earache Relief		ATROPA BELLADONNA,OYSTER SHELL CALCIUM CARBONATE, CRUDE,LYCOPODIUM CLAVATUM SPORE,ANEMONE PULSATILLA,SULFUR and MATRICARIA CHAMOMILLA	LIQUID	AURICULAR (OTIC)	20190301		UNAPPROVED HOMEOPATHIC		Hylands	ANEMONE PULSATILLA; ATROPA BELLADONNA; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
54973-3393_ee178924-32b4-b5f4-e053-2995a90a6a07	54973-3393	HUMAN OTC DRUG	4 Kids Earache Relief		MATRICARIA CHAMOMILLA,FERRIC PHOSPHATE,SULFUR,OYSTER SHELL CALCIUM CARBONATE, CRUDE,LYCOPODIUM CLAVATUM SPORE and ANEMONE PULSATILLA	TABLET	ORAL	20181201		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; FERROSOFERRIC PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
54973-3397_eb95bb71-9607-1885-e053-2995a90a9eda	54973-3397	HUMAN OTC DRUG	FLEXMORE		Atropa Belladonna, Bryonia Alba Root, Colchicum Autumnale Bulb, Guaiacum Officinale Resin, Kalmia Latifolia Leaf, Rhododendron Tomentosum Leafy Twig, Ruta Graveolens Flowering Top, Tribasic Calcium Phosphate, Comfrey Root and Toxicodendron Pubescens Leaf	TABLET	ORAL	20190601		UNAPPROVED HOMEOPATHIC		Hyland's	ATROPA BELLADONNA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; GUAIACUM OFFICINALE RESIN; KALMIA LATIFOLIA LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	30; 30; 12; 30; 12; 12; 30; 12; 30; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3400_edc4c1e6-863c-524f-e053-2995a90a7c8e	54973-3400	HUMAN OTC DRUG	4 Kids Cold and Cough Daytime		onion, calcium sulfide, sodium chloride, phosphorus, pulsatilla vulgaris, sulfur, and goldenseal	LIQUID	ORAL	20080801		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; SODIUM CHLORIDE; SULFUR	6; 12; 6; 6; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
54973-3401_efa4f263-df82-446e-e053-2a95a90a5194	54973-3401	HUMAN OTC DRUG	Flexmore PM		BRYONIA ALBA ROOT,ERROSOFERRIC PHOSPHATE,RHODODENDRON TOMENTOSUM LEAFY TWIG,COLCHICUM AUTUMNALE BULB,ANEMONE PULSATILLA,POTASSIUM PHOSPHATE, DIBASIC,KALMIA LATIFOLIA LEAF,COMFREY ROOT,TOXICODENDRON PUBESCENS LEAF and ATROPA BELLADONNA	TABLET	ORAL	20190601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; ATROPA BELLADONNA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; KALMIA LATIFOLIA LEAF; POTASSIUM PHOSPHATE, DIBASIC; RHODODENDRON TOMENTOSUM LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 30; 30; 12; 30; 30; 12; 9; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54973-3402_efce5d5a-9201-7f01-e053-2a95a90a0bb1	54973-3402	HUMAN OTC DRUG	Young Adult Serene		Gelsemium Sempervirens Root, Arsenic Trioxide, Aconitum Napellus, Sulfur, Potassium Phosphate, Dibasic, Phosphorus, Silver Nitrate, Strychnos Ignatii Seed and Anamirta Cocculus Seed	TABLET	ORAL	20190601		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; ANAMIRTA COCCULUS SEED; ARSENIC TRIOXIDE; GELSEMIUM SEMPERVIRENS ROOT; PHOSPHORUS; POTASSIUM PHOSPHATE, DIBASIC; SILVER NITRATE; STRYCHNOS IGNATII SEED; SULFUR	30; 30; 30; 30; 30; 12; 30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54973-3406_f63d54e1-a3c1-a20b-e053-2a95a90ac76d	54973-3406	HUMAN OTC DRUG	4 Kids Stuffy Nose and Sinus		PULSATILLA PRATENSIS WHOLE,OYSTER SHELL CALCIUM CARBONATE, CRUDE,GOLDENSEAL and POTASSIUM DICHROMATE	TABLET	ORAL	20200127		UNAPPROVED HOMEOPATHIC		Hylands Inc.	GOLDENSEAL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; PULSATILLA PRATENSIS WHOLE	6; 3; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-3431_f030e9fc-1ece-b915-e053-2a95a90a5356	54973-3431	HUMAN OTC DRUG	FERRUM PHOSPHATE		sodium phosphate	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM PHOSPHATE	6	[hp_X]/1			N	20241231
54973-4003_efb8a045-db95-0207-e053-2a95a90a7fb2	54973-4003	HUMAN OTC DRUG	Poison Ivy and Poison Oak Relief		CROTON TIGLIUM SEED,TOXICODENDRON PUBESCENS LEAF and XEROPHYLLUM ASPHODELOIDES	TABLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CROTON TIGLIUM SEED; TOXICODENDRON PUBESCENS LEAF; XEROPHYLLUM ASPHODELOIDES	9; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-4005_efb8c15d-1175-1db9-e053-2995a90a8fac	54973-4005	HUMAN OTC DRUG	Quitters Relief Headache		ACONITUM NAPELLUS,ATROPA BELLADONNA,DELPHINIUM STAPHISAGRIA SEED,IRIS VERSICOLOR ROOT and STRYCHNOS NUX-VOMICA SEED	TABLET	ORAL	20201215		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; DELPHINIUM STAPHISAGRIA SEED; IRIS VERSICOLOR ROOT; STRYCHNOS NUX-VOMICA SEED	6; 6; 12; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54973-4007_efb8d829-5553-70d4-e053-2995a90ac925	54973-4007	HUMAN OTC DRUG	Quitters Relief Irritability		Aconitum Napellus Whole, Anamirta Cocculus Seed, Arsenic Trioxide, Delphinium Staphisagria Seed, Dibasic Potassium Phosphate, Gelsemium Sempervirens Root, Phosphorus, Silver Nitrate and Sulfur	TABLET	ORAL	20201215		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS WHOLE; ANAMIRTA COCCULUS SEED; ARSENIC TRIOXIDE; DELPHINIUM STAPHISAGRIA SEED; DIBASIC POTASSIUM PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; PHOSPHORUS; SILVER NITRATE; STRYCHNOS IGNATII SEED; SULFUR	30; 30; 30; 12; 12; 30; 30; 30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-4008_efa50f1b-2f79-510f-e053-2a95a90ad548	54973-4008	HUMAN OTC DRUG	Headache Relief		Atropa Belladonna, Gelsemium Sempervirens Root, Ipecac and Iris Versicolor Root	TABLET	ORAL	20200403		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ATROPA BELLADONNA; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; IRIS VERSICOLOR ROOT	12; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-4009_fb360897-c464-de3b-e053-6294a90a6e36	54973-4009	HUMAN OTC DRUG	Pain Relief		DIBASIC POTASSIUM PHOSPHATE,HYPERICUM PERFORATUM,TOXICODENDRON PUBESCENS LEAF,BRYONIA ALBA ROOT and MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	TABLET	ORAL	20200403		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	BRYONIA ALBA ROOT; DIBASIC POTASSIUM PHOSPHATE; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-4010_efa4626c-d312-051c-e053-2995a90a27a6	54973-4010	HUMAN OTC DRUG	Fever Reducer		Aconitum Napellus, Gelsemium Sempervirens Root, Atropa Belladonna and Bryonia Alba Root	TABLET	ORAL	20200330		UNAPPROVED HOMEOPATHIC		Hylands Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT	6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-4011_fb5962be-5af1-206f-e053-6294a90aa8b0	54973-4011	HUMAN OTC DRUG	Backache Relief		Aconitum Napellus, Bryonia Alba Root, Magnesium Phosphate, Dibasic Trihydrate, Bellis Perennis, Toxicodendron Pubescens Leaf and Arnica Montana	TABLET	ORAL	20200330		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-4015_0e78cb95-f917-de0a-e063-6294a90a523f	54973-4015	HUMAN OTC DRUG	4 KIDS PAIN RELIEF		Anemone Pulsatilla, Toxicodendron Pubescens Leaf, Gelsemium Sempervirens Root, Phosphorus, Eupatorium Perfoliatum Flowering Top, Bryonia Alba Root, Arnica Montana and Aconitum Napellus	LIQUID	ORAL	20200127		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARNICA MONTANA; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	30; 9; 30; 30; 30; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
54973-4018_ee2667b3-dc43-06c6-e053-2a95a90ab62f	54973-4018	HUMAN OTC DRUG	4 KIDS PAIN RELIEF GRAPE		Aconitum Napellus, Toxicodendron Pubescens Leaf, Anemone Pulsatilla, Gelsemium Sempervirens Root, Arnica Montana, Eupatorium Perfoliatum Flowering Top, Bryonia Alba Root and Phosphorus	LIQUID	ORAL	20200127		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARNICA MONTANA; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	30; 9; 30; 30; 30; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-4020_ee26e726-dfc2-3809-e053-2a95a90a59a3	54973-4020	HUMAN OTC DRUG	4 Kids Sore Throat Grape		Spongia Officinalis Skeleton, Roasted, Aconitum Napellus, Phosphorus, Calcium Sulfide and Ferrosoferric Phosphate	LIQUID	ORAL	20200214		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ACONITUM NAPELLUS; CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; PHOSPHORUS; SPONGIA OFFICINALIS SKELETON, ROASTED	15; 12; 12; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-4030_efb7ae5d-9017-5a5c-e053-2a95a90a36a1	54973-4030	HUMAN OTC DRUG	Migraine Relief		Gelsemium Sempervirens Root, Strychnos Nux-Vomica Seed, Iris Versicolor Root, Sanguinaria Canadensis Root, Atropa Belladonna and Nitroglycerin	TABLET	ORAL	20200330		UNAPPROVED HOMEOPATHIC		Hyland's Inc	ATROPA BELLADONNA; GELSEMIUM SEMPERVIRENS ROOT; IRIS VERSICOLOR ROOT; NITROGLYCERIN; SANGUINARIA CANADENSIS ROOT; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 12; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
54973-4056_066fcfa7-9652-d619-e063-6394a90a5726	54973-4056	HUMAN OTC DRUG	Cough and Mucus Grape Flavor		ANTIMONY POTASSIUM TARTRATE,BRYONIA ALBA ROOT,FERROSOFERRIC PHOSPHATE,CALCIUM SULFIDE,IPECAC,PHOSPHORUS,ANEMONE PULSATILLA,RUMEX CRISPUS ROOT	LIQUID	ORAL	20220301		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; IPECAC; PHOSPHORUS; RUMEX CRISPUS ROOT	12; 15; 15; 12; 12; 12; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-4057_0648086d-3017-059e-e063-6294a90af536	54973-4057	HUMAN OTC DRUG	Kids Cough and Mucus Nighttime Grape Flavor		RUMEX CRISPUS ROOT, ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, MATRICARIA CHAMOMILLA WHOLE, PULSATILLA VULGARIS, CALCIUM SULFIDE, IPECAC, GOLDENSEAL, PHOSPHORUS, FERROSOFERRIC PHOSPHATE	LIQUID	ORAL	20220301		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; IPECAC; MATRICARIA CHAMOMILLA WHOLE; PHOSPHORUS; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT	15; 15; 12; 12; 15; 12; 6; 15; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-4059_045322b1-3b5b-bff9-e063-6294a90a503c	54973-4059	HUMAN OTC DRUG	Kids Cough and Mucus Day and Night Grape		RUMEX CRISPUS ROOT, ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA ROOT, MATRICARIA CHAMOMILLA WHOLE, PULSATILLA VULGARIS, CALCIUM SULFIDE, IPECAC, GOLDENSEAL, PHOSPHORUS, FERROSOFERRIC PHOSPHATE	KIT		20220301		UNAPPROVED HOMEOPATHIC		Hyland's Inc.						N	20241231
54973-4069_efb8b02c-8f56-2c66-e053-2995a90ab748	54973-4069	HUMAN OTC DRUG	PRID		Ichthammol, Calcium Sulfide, Calendula Officinalis Flowering Top, Arnica Montana, Echinacea Angustifolia, Silicon Dioxide, Sulfur	SALVE	TOPICAL	20220301		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	ARNICA MONTANA; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; ICHTHAMMOL; SILICON DIOXIDE; SULFUR	3; 12; 3; 3; 2; 12; 12	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
54973-4071_f03549c0-fcca-fa78-e053-2995a90a186f	54973-4071	HUMAN OTC DRUG	Bioplasma		Sodium Phosphate, Dibasic, Heptahydrate, Calcium Sulfate Anhydrous, Ferrosoferric Phosphate, Potassium Phosphate, Dibasic, Potassium Sulfate, Magnesium Phosphate, Dibasic Trihydrate, Sodium Chloride, Sodium Sulfate, Silicon Dioxide, Potassium Chloride, Calcium Fluoride, Tribasic Calcium Phosphate	TABLET	ORAL	20211119		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	6; 3; 3; 3; 3; 3; 3; 6; 6; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-4072_eeb4dc05-f925-1cff-e053-2a95a90a1294	54973-4072	HUMAN OTC DRUG	CALC FLUOR		CALCIUM FLUORIDE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM FLUORIDE	6	[hp_X]/1			N	20241231
54973-4073_ef417863-1eaa-1780-e053-2995a90adfcc	54973-4073	HUMAN OTC DRUG	Calc Phos		TRIBASIC CALCIUM PHOSPHATE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	TRIBASIC CALCIUM PHOSPHATE	6	[hp_X]/1			N	20241231
54973-4075_efa416e9-7351-10a3-e053-2995a90aa4b9	54973-4075	HUMAN OTC DRUG	Ferrum Phos		FERROSOFERRIC PHOSPHATE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	FERROSOFERRIC PHOSPHATE	6	[hp_X]/1			N	20241231
54973-4077_efa53214-b2a7-cfd0-e053-2a95a90abbdf	54973-4077	HUMAN OTC DRUG	Kali Phos		DIBASIC POTASSIUM PHOSPHATE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hylands Inc.	DIBASIC POTASSIUM PHOSPHATE	6	[hp_X]/1			N	20241231
54973-4079_efa5965e-bac6-395e-e053-2995a90af6c4	54973-4079	HUMAN OTC DRUG	Mag Phos		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-4080_efb80254-f357-271d-e053-2995a90a7163	54973-4080	HUMAN OTC DRUG	Nat Mur		SODIUM CHLORIDE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-4081_efb82213-3991-510a-e053-2a95a90a5166	54973-4081	HUMAN OTC DRUG	Nat Phos		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-4083_efcdac0e-3ad9-d79a-e053-2995a90a128d	54973-4083	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	TABLET	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SILICON DIOXIDE	6	[hp_X]/1			N	20241231
54973-4086_eea4eee4-6482-b59c-e053-2995a90a0dd4	54973-4086	HUMAN OTC DRUG	Bioplasma		SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	6; 3; 3; 3; 3; 3; 3; 6; 6; 3; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-4087_0e12b912-5dae-bb3e-e063-6394a90aa446	54973-4087	HUMAN OTC DRUG	CALC FLUOR 6X		CALCIUM FLUORIDE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM FLUORIDE	6	[hp_X]/1			N	20251231
54973-4088_edb1aeca-c483-81b0-e053-2a95a90a6575	54973-4088	HUMAN OTC DRUG	CALC PHOS 6X		TRIBASIC CALCIUM PHOSPHATE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	TRIBASIC CALCIUM PHOSPHATE	6	[hp_X]/1			N	20241231
54973-4089_ef419380-c0c2-71b6-e053-2a95a90a9e66	54973-4089	HUMAN OTC DRUG	CALC SULPH 6X		CALCIUM SULFATE ANHYDROUS	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	CALCIUM SULFATE ANHYDROUS	6	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
54973-4090_efa42167-cf82-e1f3-e053-2a95a90aa956	54973-4090	HUMAN OTC DRUG	Ferrum Phos 6X		FERROSOFERRIC PHOSPHATE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	FERROSOFERRIC PHOSPHATE	6	[hp_X]/1			N	20241231
54973-4091_efa52659-26a3-bf4c-e053-2995a90a388a	54973-4091	HUMAN OTC DRUG	KALI MUR 6X		POTASSIUM CHLORIDE	TABLET, SOLUBLE	ORAL	20211201		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	POTASSIUM CHLORIDE	6	[hp_X]/1			N	20241231
54973-4092_efa4e3ce-61ae-3485-e053-2995a90acb29	54973-4092	HUMAN OTC DRUG	Kali Phos 6X		POTASSIUM PHOSPHATE, DIBASIC	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	POTASSIUM PHOSPHATE, DIBASIC	6	[hp_X]/1			N	20241231
54973-4093_efa56728-e7de-1100-e053-2a95a90a1c24	54973-4093	HUMAN OTC DRUG	Kali Sulph 6X		POTASSIUM SULFATE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	POTASSIUM SULFATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54973-4094_efa5a092-9f22-64e8-e053-2995a90a0939	54973-4094	HUMAN OTC DRUG	Mag Phos 6X		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-4095_efb7e246-e750-ddc4-e053-2a95a90ae029	54973-4095	HUMAN OTC DRUG	Nat Mur 6X		SODIUM CHLORIDE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-4096_efb83b34-d5f4-abdc-e053-2995a90af19c	54973-4096	HUMAN OTC DRUG	Nat Phos 6X		SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-4097_efb83f14-db64-ac97-e053-2995a90a85fa	54973-4097	HUMAN OTC DRUG	NAT SULPH 6X		SODIUM SULFATE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM SULFATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-4098_efcdc6ad-833d-47b5-e053-2995a90a67fe	54973-4098	HUMAN OTC DRUG	Silicea 6X		SILICON DIOXIDE	TABLET, SOLUBLE	ORAL	20211206		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SILICON DIOXIDE	6	[hp_X]/1			N	20241231
54973-4101_7fcc81e3-24f1-472c-bd4f-35a17f566572	54973-4101	HUMAN OTC DRUG	Hylands Naturals Diaper Rash Cream		ZINC OXIDE	CREAM	TOPICAL	20221205		OTC MONOGRAPH FINAL	part347	Hylands	ZINC OXIDE	10	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
54973-4109_025c1c1d-6558-a548-e063-6394a90ad5b0	54973-4109	HUMAN OTC DRUG	Kids Cold and Cough Daytime		CALCIUM SULFIDE,GOLDENSEAL,ONION,PHOSPHORUS,PULSATILLA VULGARIS, SODIUM CHLORIDE	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; PULSATILLA VULGARIS; SODIUM CHLORIDE; SULFUR	12; 6; 6; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
54973-4110_e65f14cb-5a8f-0ad5-e053-2a95a90a6f5d	54973-4110	HUMAN OTC DRUG	Kids Cold and Cough Daytime Grape Flavor		Onion, Calcium Sulfide, Golden Seal, Sodium Chloride, Phosphorus, Pulsatilla Vulgaris Whole, Sulfur	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	CALCIUM SULFIDE; GOLDENSEAL; ONION; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; SODIUM CHLORIDE; SULFUR	12; 6; 6; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
54973-4111_e676dbb7-2130-47e3-e053-2995a90af4e1	54973-4111	HUMAN OTC DRUG	Kids Cold and Cough Nighttime Grape Flavor		Onion, Chamomile, Arabica Coffee Bean, Calcium Sulfide, Golden Seal, Sodium Chloride, Phosphorus, Pulsatilla Vulgaris Top, Sulfur	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	ARABICA COFFEE BEAN; CALCIUM SULFIDE; CHAMOMILE; GOLDENSEAL; ONION; PHOSPHORUS; PULSATILLA VULGARIS TOP; SODIUM CHLORIDE; SULFUR	6; 12; 6; 6; 6; 12; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
54973-4112_05f92b70-2d18-1bcf-e063-6294a90aba07	54973-4112	HUMAN OTC DRUG	Kids Cold and Cough Combo Pack		Onion, Chamomile, Arabica Coffee Bean, Calcium Sulfide, Golden Seal, Sodium Chloride, Phosphorus, Pulsatilla Vulgaris Top, Sulfur	KIT	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.						N	20241231
54973-4113_ff356114-817f-8b23-e053-6294a90a66d8	54973-4113	HUMAN OTC DRUG	Kids Cough and Mucus Daytime Grape Flavor		BRYONIA ALBA ROOT,CALCIUM SULFIDE,PULSATILLA VULGARIS WHOLE,FERROSOFERRIC PHOSPHATE,PHOSPHORUS,ANTIMONY POTASSIUM TARTRATE,IPECAC,RUMEX CRISPUS ROOT	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; IPECAC; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; RUMEX CRISPUS ROOT	15; 15; 12; 12; 12; 15; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-4114_ff356114-816d-8b23-e053-6294a90a66d8	54973-4114	HUMAN OTC DRUG	Kids Cough and Mucus Nighttime Grape		ANTIMONY POTASSIUM TARTRATE,BRYONIA ALBA ROOT,CALCIUM SULFIDE,CHAMOMILE,FERROSOFERRIC PHOSPHATE,GOLDENSEAL,IPECAC,PHOSPHORUS,PULSATILLA VULGARIS,RUMEX CRISPUS ROOT	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHAMOMILE; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; IPECAC; PHOSPHORUS; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT	15; 15; 12; 6; 12; 15; 12; 15; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
54973-4115_e7157883-6b24-b61c-e053-2995a90afdc2	54973-4115	HUMAN OTC DRUG	Kids Stuffy Nose and Sinus		OYSTER SHELL CALCIUM CARBONATE, CRUDE, GOLDENSEAL, POTASSIUM DICHROMATE, PULSATILLA PRATENSIS WHOLE	TABLET	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	GOLDENSEAL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; PULSATILLA PRATENSIS WHOLE	6; 3; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
54973-4123_af8a21b3-8d3c-4133-b5ea-9017e83a6b35	54973-4123	HUMAN OTC DRUG	Hylands Naturals Vanilla Sunscreen Lip Balm SPF 15		Broad Spectrum SPF 15 Vanilla Lip Balm	STICK	TOPICAL	20221018		OTC MONOGRAPH DRUG	M020	Hylands	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	20; 65; 50; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
54973-4124_017ed754-9fe9-2cb5-e063-6294a90ab2f6	54973-4124	HUMAN OTC DRUG	Hylands Naturals Earache Drops		belladonna leaf,calcium carbonate,chamomile,lycopodium clavatum spore,anemone patens whole,sulfur	LIQUID	AURICULAR (OTIC)	20230727		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	BELLADONNA LEAF; CALCIUM CARBONATE; CHAMOMILE; LYCOPODIUM CLAVATUM SPORE; PULSATILLA PATENS WHOLE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
54973-5224_f032ca21-e3ef-78b6-e053-2a95a90af8c4	54973-5224	HUMAN OTC DRUG	KALI MURIATICUM		potassium chloride	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	POTASSIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
54973-5228_f032850d-4fae-2cc2-e053-2a95a90a4c96	54973-5228	HUMAN OTC DRUG	KALI PHOS		potassium phosphate, unspecified form	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	POTASSIUM PHOSPHATE, UNSPECIFIED FORM	6	[hp_X]/1			N	20241231
54973-5230_f0330ffb-503d-2671-e053-2995a90a8218	54973-5230	HUMAN OTC DRUG	KALI SULPH		potassium sulfate	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	POTASSIUM SULFATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-6020_f0312815-fc55-1ff3-e053-2995a90ac4c4	54973-6020	HUMAN OTC DRUG	MAGNESIA PHOS		magnesium phosphate, dibasic trihydrate	TABLET	ORAL	19600101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
54973-6433_f03159cf-dfd9-fdf2-e053-2a95a90a5837	54973-6433	HUMAN OTC DRUG	NATRUM MURIATICUM		sodium chloride	TABLET	ORAL	19600101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM CHLORIDE	6	[hp_X]/1			N	20241231
54973-6436_f0314b46-2a29-a3ec-e053-2995a90af4f2	54973-6436	HUMAN OTC DRUG	NAT. PHOS.		sodium phosphate, dibasic, anhydrous	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	6	[hp_X]/1			N	20241231
54973-6440_f03141f6-9def-7d57-e053-2995a90a16ae	54973-6440	HUMAN OTC DRUG	NAT SULPH		sodium sulfate anhydrous	TABLET	ORAL	19400101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SODIUM SULFATE ANHYDROUS	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
54973-7516_ee8d0910-e9ad-0692-e053-2a95a90a6d8c	54973-7516	HUMAN OTC DRUG	BABY INFANT EARACHE DROPS		belladonna leaf, calcium carbonate, chamomile, lycopodium clavatum spore, anemone patens, and sulfur	LIQUID	AURICULAR (OTIC)	20040316		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	BELLADONNA LEAF; CALCIUM CARBONATE; CHAMOMILE; LYCOPODIUM CLAVATUM SPORE; PULSATILLA PATENS WHOLE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
54973-8081_f03254bf-1190-17ba-e053-2a95a90a13bb	54973-8081	HUMAN OTC DRUG	SILICEA		silicon dioxide	TABLET	ORAL	19600101		UNAPPROVED HOMEOPATHIC		Hyland's Inc.	SILICON DIOXIDE	6	[hp_X]/1			N	20241231
54973-9147_e831b8e5-6f76-bb61-e053-2a95a90a4cc6	54973-9147	HUMAN OTC DRUG	Motion Sickness		strychnos nux-vomica seed, tobacco leaf, kerosene, and anamirta cocculus seed	TABLET, SOLUBLE	ORAL	19941201		UNAPPROVED HOMEOPATHIC		Hyland's Consumer Health Inc.	ANAMIRTA COCCULUS SEED; KEROSENE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	30; 12; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
54997-410_ec6eacdb-6119-cc0b-e053-2995a90a4a02	54997-410	HUMAN OTC DRUG	aKwa Daystar Shade	SPF 40	Homosalate, Zinc Oxide, Octisalate	LOTION	TOPICAL	20200602		OTC MONOGRAPH FINAL	M020	4-Life Reasearch USA, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	10; 4.5; 9.425	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
55028-015_0745338f-5b57-9c1f-e063-6294a90aa741	55028-015	HUMAN OTC DRUG	Wash-free hand sanitizer		Wash-free hand sanitizer	GEL	TOPICAL	20200330		OTC MONOGRAPH DRUG	M016	Zhongshan Dermey Commodity Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
55037-113_0bc88fc0-ce9a-13b4-e063-6394a90a61c1	55037-113	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	Matheson Tri-Gas, Inc.	OXYGEN	992	mL/L			N	20241231
55037-201_0bc86eaf-898f-1397-e063-6394a90adf87	55037-201	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205891	Matheson Tri-Gas, Inc.	NITROGEN	992	mL/L			N	20241231
55037-301_0a4a90f7-b326-ef0f-e063-6394a90a8ba0	55037-301	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA209989	Matheson Tri-Gas, Inc.	NITROUS OXIDE	992	mL/L			N	20241231
55037-302_0a4a4b43-c239-3a20-e063-6294a90a739a	55037-302	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205890	Matheson Tri-Gas, Inc.	AIR	1000	mL/L			N	20241231
55037-401_0a4a5d34-76d7-e0c9-e063-6394a90a78b8	55037-401	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205846	Matheson Tri-Gas, Inc.	CARBON DIOXIDE	992	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
55037-501_0a4a9410-ccd0-efc2-e063-6394a90a76ab	55037-501	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205843	Matheson Tri-Gas, Inc.	HELIUM	992	mL/L			N	20241231
55037-800_0a4a971d-6fce-6cfb-e063-6294a90a678b	55037-800	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 10/90		Oxygen/Nitrogen 10/90	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	100	mL/L			N	20241231
55037-810_0a4a971d-6fcf-6cfb-e063-6294a90a678b	55037-810	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 12/88		Oxygen/Nitrogen 12/88	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	120	mL/L			N	20241231
55037-820_0a4a94aa-6dcf-6d1a-e063-6294a90afbff	55037-820	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 15/85		Oxygen/Nitrogen 15/85	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	150	mL/L			N	20241231
55037-830_0a4a90f7-b328-ef0f-e063-6394a90a8ba0	55037-830	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 21/79		Oxygen/Nitrogen 21/79	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	210	mL/L			N	20241231
55037-840_0a4a90f7-b327-ef0f-e063-6394a90a8ba0	55037-840	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 25/75		Oxygen/Nitrogen 25/75	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	250	mL/L			N	20241231
55037-850_0a4a95ed-fd16-edd2-e063-6394a90a59e4	55037-850	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 26/74		Oxygen/Nitrogen 26/74	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	260	mL/L			N	20241231
55037-860_0a4a9410-cce2-efc2-e063-6394a90a76ab	55037-860	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 30/70		Oxygen/Nitrogen 30/70	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	300	mL/L			N	20241231
55037-870_0a4a9aed-5eec-f648-e063-6394a90a1d76	55037-870	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 38/62		Oxygen/Nitrogen 38/62	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	380	mL/L			N	20241231
55037-880_0a4a9aed-5eed-f648-e063-6394a90a1d76	55037-880	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 40/60		Oxygen/Nitrogen 40/60	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	400	mL/L			N	20241231
55037-890_0a4a9410-cce5-efc2-e063-6394a90a76ab	55037-890	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 5/95		Oxygen/Nitrogen 5/95	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	50	mL/L			N	20241231
55037-900_0a4a9410-cce3-efc2-e063-6394a90a76ab	55037-900	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 50/50		Oxygen/Nitrogen 50/50	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	500	mL/L			N	20241231
55037-910_0a4a94e7-030f-df2c-e063-6394a90aff1a	55037-910	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 52/48		Oxygen/Nitrogen 52/48	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	520	mL/L			N	20241231
55037-920_0a4a95ed-fd17-edd2-e063-6394a90a59e4	55037-920	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 75/25		Oxygen/Nitrogen 75/25	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	750	mL/L			N	20241231
55037-930_0a4a94aa-6dd0-6d1a-e063-6294a90afbff	55037-930	HUMAN PRESCRIPTION DRUG	Oxygen/Nitrogen 9.7/90.3		Oxygen/Nitrogen 9.7/90.3	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205889	MATHESON TRI-GAS, INC.	OXYGEN	97	mL/L			N	20241231
55038-001_0c6c8b42-9eb7-7c64-e063-6294a90a5c41	55038-001	HUMAN OTC DRUG	POMADA DRAGON PAIN RELIEVING		CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20120731		OTC MONOGRAPH DRUG	M017	TELEVISA CONSUMER PRODUCTS USA	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
55050-0011_0760ed09-ebb4-de21-e063-6294a90ad52c	55050-0011	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19580101		NDA	NDA205849	Holston Gases, Inc.	OXYGEN	99	L/100L			N	20241231
55050-0016_076103a1-a40c-4bd1-e063-6394a90aab28	55050-0016	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19580101		NDA	NDA205850	Holston Gases, Inc	NITROGEN	99	L/100L			N	20241231
55050-0018_07610a71-ea85-611b-e063-6394a90accbf	55050-0018	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19580101		NDA	NDA206009	Holston Gases, Inc	NITROUS OXIDE	99	kg/100kg			N	20241231
55111-112_b7966736-4865-d3ad-d218-886c8a286492	55111-112	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA076938	Dr. Reddy's Laboratories Limited	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
55111-113_64b3063f-c4bd-46a9-7b1f-f41cf403a8f7	55111-113	HUMAN PRESCRIPTION DRUG	ZENATANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20150309		ANDA	ANDA202099	Dr. Reddy's Laboratories Limited	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
55111-118_0e165efa-c6cc-c254-e143-a757293c26b3	55111-118	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20060930		ANDA	ANDA077367	Dr.Reddys Laboratories Limited	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-119_b30502a9-c0c8-909c-ec34-956a5e058223	55111-119	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075718	Dr.Reddy's Laboratories Limited	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-120_b30502a9-c0c8-909c-ec34-956a5e058223	55111-120	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075718	Dr.Reddy's Laboratories Limited	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-121_36e09eff-3948-2638-b633-d5ec2bc03d2a	55111-121	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20120717		ANDA	ANDA091650	Dr. Reddy's Laboratories Limited	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-122_36e09eff-3948-2638-b633-d5ec2bc03d2a	55111-122	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20120717		ANDA	ANDA091650	Dr. Reddy's Laboratories Limited	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-123_36e09eff-3948-2638-b633-d5ec2bc03d2a	55111-123	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20120717		ANDA	ANDA091650	Dr. Reddy's Laboratories Limited	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-124_3ec2bef7-b820-857f-1c70-e57c2d2c6dbf	55111-124	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20120717		ANDA	ANDA202357	Dr. Reddy's Laboratories Limited	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-126_50f8ebb9-e137-8f40-cf4e-e20cde841c83	55111-126	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	Dr. Reddy's Laboratories Limited	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
55111-127_50f8ebb9-e137-8f40-cf4e-e20cde841c83	55111-127	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	Dr. Reddy's Laboratories Limited	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
55111-128_50f8ebb9-e137-8f40-cf4e-e20cde841c83	55111-128	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	Dr. Reddy's Laboratories Limited	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
55111-129_9741e6f4-a2dc-7543-1138-da97eafe11bd	55111-129	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	CAPSULE	ORAL	20010112		ANDA	ANDA075742	Dr. Reddy's Laboratories Limited	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-130_9741e6f4-a2dc-7543-1138-da97eafe11bd	55111-130	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	CAPSULE	ORAL	20010401		ANDA	ANDA075742	Dr. Reddy's Laboratories Limited	RANITIDINE HYDROCHLORIDE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-131_654a9ddb-f441-a17a-f8ae-633148d041c8	55111-131	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20000301		ANDA	ANDA075294	Dr. Reddy's Laboratories Limited	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-133_8b3e7cd9-3a3d-7b47-d751-09ab6cee3d1b	55111-133	HUMAN PRESCRIPTION DRUG	Enalapril maleate and hydrochlorothiazide		Enalapril maleate and hydrochlorothiazide	TABLET	ORAL	20011015		ANDA	ANDA075909	Dr. Reddy's Laboratories Limited	ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE	5; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
55111-134_8b3e7cd9-3a3d-7b47-d751-09ab6cee3d1b	55111-134	HUMAN PRESCRIPTION DRUG	Enalapril maleate and hydrochlorothiazide		Enalapril maleate and hydrochlorothiazide	TABLET	ORAL	20011015		ANDA	ANDA075909	Dr. Reddy's Laboratories Limited	ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE	10; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
55111-135_64b3063f-c4bd-46a9-7b1f-f41cf403a8f7	55111-135	HUMAN PRESCRIPTION DRUG	ZENATANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20130326		ANDA	ANDA202099	Dr. Reddy's Laboratories Limited	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
55111-136_64b3063f-c4bd-46a9-7b1f-f41cf403a8f7	55111-136	HUMAN PRESCRIPTION DRUG	ZENATANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20130326		ANDA	ANDA202099	Dr. Reddy's Laboratories Limited	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
55111-137_64b3063f-c4bd-46a9-7b1f-f41cf403a8f7	55111-137	HUMAN PRESCRIPTION DRUG	ZENATANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20130326		ANDA	ANDA202099	Dr. Reddy's Laboratories Limited	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
55111-143_c90be993-a036-8483-01a3-b6e2f04475c1	55111-143	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140620		ANDA	ANDA076658	Dr. Reddy's Laboratories Limited	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55111-144_c90be993-a036-8483-01a3-b6e2f04475c1	55111-144	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140620		ANDA	ANDA076658	Dr. Reddy's Laboratories Limited	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55111-145_c90be993-a036-8483-01a3-b6e2f04475c1	55111-145	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140620		ANDA	ANDA076658	Dr. Reddy's Laboratories Limited	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55111-146_c90be993-a036-8483-01a3-b6e2f04475c1	55111-146	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140620		ANDA	ANDA076658	Dr. Reddy's Laboratories Limited	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55111-150_ec5088cd-9e68-ba14-e274-7e3935c87f17	55111-150	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20160930		ANDA	ANDA076006	Dr.Reddy's Laboratories Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55111-153_c70e1611-6d98-55f5-7b07-5af617562f48	55111-153	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	Dr. Reddy's Laboratories Limited	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55111-154_c70e1611-6d98-55f5-7b07-5af617562f48	55111-154	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	Dr. Reddy's Laboratories Limited	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55111-155_9064dccd-0ae4-688a-3216-6ced5e514340	55111-155	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	Dr. Reddy's Laboratories Limited	ONDANSETRON HYDROCHLORIDE	16	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55111-156_c70e1611-6d98-55f5-7b07-5af617562f48	55111-156	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	Dr. Reddy's Laboratories Limited	ONDANSETRON HYDROCHLORIDE	24	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55111-157_15530d1c-4ef2-6e63-c251-e7c33f42a915	55111-157	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	Dr. Reddy's Laboratories Limited	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-158_15530d1c-4ef2-6e63-c251-e7c33f42a915	55111-158	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	Dr. Reddy's Laboratories Limited	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-159_15530d1c-4ef2-6e63-c251-e7c33f42a915	55111-159	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	Dr. Reddy's Laboratories Limited	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-163_ba26436d-7009-476f-23b0-45676a0e7805	55111-163	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076255	Dr. Reddy's Laboratories Ltd.	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-167_0705cef5-9059-6024-6b05-11d19e1defa4	55111-167	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076133	Dr. Reddy's Laboratories Ltd.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-168_0705cef5-9059-6024-6b05-11d19e1defa4	55111-168	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076133	Dr. Reddy's Laboratories Ltd.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-169_032c7109-eeca-170e-54d0-cfb44f135f07	55111-169	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077380	Dr.Reddy's Laboratories Limited	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-170_6a4ecca8-c7eb-fd8a-a3a7-a2f213ced322	55111-170	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET, FILM COATED	ORAL	20010131		ANDA	ANDA075855	Dr. Reddy's Laboratories Limited	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55111-171_c9c6e0dd-0d0c-cea7-76ef-5b8897aa0ef7	55111-171	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20130102		ANDA	ANDA076436	Dr. Reddy's Laboratories Limited	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
55111-172_3e2181d6-f6be-c77e-e3f3-63e26fc35897	55111-172	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET	ORAL	20070228		ANDA	ANDA076437	Dr. Reddy's Laboratories Limited	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
55111-179_d3850e2b-1b17-3f80-72ff-dac1541d9c08	55111-179	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	Dr. Reddy's Laboratories Limited	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55111-180_d3850e2b-1b17-3f80-72ff-dac1541d9c08	55111-180	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	Dr. Reddy's Laboratories Limited	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55111-181_2de4ebba-b125-4355-35f5-69b92e56634b	55111-181	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA076920	Dr. Reddy's Laboratories Limited	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55111-182_2de4ebba-b125-4355-35f5-69b92e56634b	55111-182	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA076920	Dr. Reddy's Laboratories Limited	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55111-183_2de4ebba-b125-4355-35f5-69b92e56634b	55111-183	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA076920	Dr. Reddy's Laboratories Limited	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55111-186_032c7109-eeca-170e-54d0-cfb44f135f07	55111-186	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077380	Dr.Reddy's Laboratories Limited	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-188_032c7109-eeca-170e-54d0-cfb44f135f07	55111-188	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077380	Dr.Reddy's Laboratories Limited	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-189_032c7109-eeca-170e-54d0-cfb44f135f07	55111-189	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077380	Dr.Reddy's Laboratories Limited	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-190_032c7109-eeca-170e-54d0-cfb44f135f07	55111-190	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077380	Dr.Reddy's Laboratories Limited	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-196_322bd1c6-46c5-d774-a38e-1104cc203fce	55111-196	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076273	Dr.Reddy's Laboratories Limited	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
55111-197_84334c5d-1663-972c-5d96-03eb1be16f64	55111-197	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20070816		ANDA	ANDA078425	Dr. Reddy's Laboratories Limited	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-198_84334c5d-1663-972c-5d96-03eb1be16f64	55111-198	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077752	Dr. Reddy's Laboratories Limited	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-199_84334c5d-1663-972c-5d96-03eb1be16f64	55111-199	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077752	Dr. Reddy's Laboratories Limited	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-200_84334c5d-1663-972c-5d96-03eb1be16f64	55111-200	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077752	Dr. Reddy's Laboratories Limited	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-220_eea9c1cd-22a3-911a-935e-08f22d71839e	55111-220	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090129		ANDA	ANDA076708	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-221_eea9c1cd-22a3-911a-935e-08f22d71839e	55111-221	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090129		ANDA	ANDA076708	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-222_eea9c1cd-22a3-911a-935e-08f22d71839e	55111-222	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090129		ANDA	ANDA076708	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-223_eea9c1cd-22a3-911a-935e-08f22d71839e	55111-223	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090129		ANDA	ANDA076708	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-225_2cd813df-d72b-9337-d6ae-139b729a5e75	55111-225	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090129		ANDA	ANDA076701	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-226_2cd813df-d72b-9337-d6ae-139b729a5e75	55111-226	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090129		ANDA	ANDA076701	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-229_5f4e21ff-4bcc-df0d-a629-ba190d95edc0	55111-229	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20091231		ANDA	ANDA076714	Dr.Reddy's Laboratories Limited	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-230_5f4e21ff-4bcc-df0d-a629-ba190d95edc0	55111-230	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20091231		ANDA	ANDA076714	Dr.Reddy's Laboratories Limited	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-231_5f4e21ff-4bcc-df0d-a629-ba190d95edc0	55111-231	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20091231		ANDA	ANDA076714	Dr.Reddy's Laboratories Limited	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-248_1b3acece-e7d3-2b1f-db18-77e04f6d7918	55111-248	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078904	Dr. Reddy's Laboratories Limited	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55111-249_032c7109-eeca-170e-54d0-cfb44f135f07	55111-249	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077380	Dr.Reddy's Laboratories Limited	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-250_2f91e1fb-bc6c-d37e-f6ef-b49fe92ded97	55111-250	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA076390	Dr.Reddys Laboratories Limited	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
55111-252_31305b0b-ee75-85e9-081c-73d15c0a7b83	55111-252	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA076649	Dr. Reddy's Laboratories Limited	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55111-253_31305b0b-ee75-85e9-081c-73d15c0a7b83	55111-253	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA076649	Dr. Reddy's Laboratories Limited	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55111-254_31305b0b-ee75-85e9-081c-73d15c0a7b83	55111-254	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA076649	Dr. Reddy's Laboratories Limited	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55111-255_31305b0b-ee75-85e9-081c-73d15c0a7b83	55111-255	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA076649	Dr. Reddy's Laboratories Limited	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55111-256_f66ffaf8-843a-63aa-9b00-489e63230098	55111-256	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	Dr. Reddy's Laboratories Limited	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-257_f66ffaf8-843a-63aa-9b00-489e63230098	55111-257	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	Dr. Reddy's Laboratories Limited	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-258_f66ffaf8-843a-63aa-9b00-489e63230098	55111-258	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	Dr. Reddy's Laboratories Limited	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-259_f66ffaf8-843a-63aa-9b00-489e63230098	55111-259	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	Dr. Reddy's Laboratories Limited	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-262_5519f229-020c-9ab4-e716-8788fa90ae3e	55111-262	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA076534	Dr.Reddy's Laboratories Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-263_5519f229-020c-9ab4-e716-8788fa90ae3e	55111-263	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA076534	Dr.Reddy's Laboratories Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-264_5519f229-020c-9ab4-e716-8788fa90ae3e	55111-264	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA076534	Dr.Reddy's Laboratories Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-265_5519f229-020c-9ab4-e716-8788fa90ae3e	55111-265	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA076534	Dr.Reddy's Laboratories Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-268_84334c5d-1663-972c-5d96-03eb1be16f64	55111-268	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077752	Dr. Reddy's Laboratories Limited	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-272_95636324-4ed9-c8b5-94bc-8c5009144f5d	55111-272	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, COATED	ORAL	19980729		ANDA	ANDA075168	Dr.Reddy's Laboratories Limited	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55111-273_95636324-4ed9-c8b5-94bc-8c5009144f5d	55111-273	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, COATED	ORAL	19980729		ANDA	ANDA075168	Dr.Reddy's Laboratories Limited	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55111-274_5f4e21ff-4bcc-df0d-a629-ba190d95edc0	55111-274	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20091231		ANDA	ANDA076714	Dr.Reddy's Laboratories Limited	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55111-279_21c4cfb3-e421-d5ab-922a-7714e7118330	55111-279	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA076710	Dr. Reddy's Laboratories Limited	LEVOFLOXACIN	250	mg/1			N	20241231
55111-280_21c4cfb3-e421-d5ab-922a-7714e7118330	55111-280	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA076710	Dr. Reddy's Laboratories Limited	LEVOFLOXACIN	500	mg/1			N	20241231
55111-281_21c4cfb3-e421-d5ab-922a-7714e7118330	55111-281	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA076710	Dr. Reddy's Laboratories Limited	LEVOFLOXACIN	750	mg/1			N	20241231
55111-282_acb3404e-c2a4-f21f-5f5b-f0ceab355395	55111-282	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20110224		ANDA	ANDA090392	Dr.Reddy's laboratories Ltd.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-284_6de5eed9-dc8d-d6ad-adb9-ca9dba06053c	55111-284	HUMAN PRESCRIPTION DRUG	Fluoxetine hydrochloride		Fluoxetine Hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20100324		ANDA	ANDA078572	Dr.Reddy's Laboratories Limited	FLUOXETINE HYDROCHLORIDE	90	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55111-289_331f44b3-1c83-c214-7d48-e5d44fc8bd2a	55111-289	HUMAN PRESCRIPTION DRUG	Naproxen and esomeprazole magnesium		Naproxen and esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20200218		ANDA	ANDA204206	Dr. Reddy's Laboratories Limited	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 375	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-291_8c734b50-3369-df0f-8a18-5bd1bdf51093	55111-291	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Dr. Reddy's Laboratories Limited	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55111-292_8c734b50-3369-df0f-8a18-5bd1bdf51093	55111-292	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Dr. Reddy's Laboratories Limited	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55111-293_8c734b50-3369-df0f-8a18-5bd1bdf51093	55111-293	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Dr. Reddy's Laboratories Limited	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55111-302_56b6362a-e95e-2a8c-9937-75975e064659	55111-302	HUMAN PRESCRIPTION DRUG	Donepezil hydrochloride		Donepezil hydrochloride	TABLET, FILM COATED	ORAL	20130726		ANDA	ANDA202723	Dr. Reddys Laboratories Limited	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55111-310_254e5866-1ba8-8d97-bc03-19916119ff87	55111-310	HUMAN PRESCRIPTION DRUG	Nizatidine		Nizatidine	CAPSULE	ORAL	20050915		ANDA	ANDA077314	Dr Reddy's Laboratories Limited	NIZATIDINE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-311_254e5866-1ba8-8d97-bc03-19916119ff87	55111-311	HUMAN PRESCRIPTION DRUG	Nizatidine		Nizatidine	CAPSULE	ORAL	20050915		ANDA	ANDA077314	Dr Reddy's Laboratories Limited	NIZATIDINE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-320_e3d50334-9896-b2f9-a481-8383eb84b16a	55111-320	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	Dr. Reddy's Laboratories Limited	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55111-321_e3d50334-9896-b2f9-a481-8383eb84b16a	55111-321	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	Dr. Reddy's Laboratories Limited	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55111-322_e3d50334-9896-b2f9-a481-8383eb84b16a	55111-322	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	Dr. Reddy's Laboratories Limited	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55111-328_1f405b49-b32b-876e-3ef0-ea4f8b9473c5	55111-328	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET	ORAL	20090909		ANDA	ANDA077461	Dr. Reddy's Laboratories Limited	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
55111-329_1f405b49-b32b-876e-3ef0-ea4f8b9473c5	55111-329	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET	ORAL	20090909		ANDA	ANDA077461	Dr. Reddy's Laboratories Limited	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
55111-332_5c22ca2e-52db-fb09-be54-ddf8c4e428c8	55111-332	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA077619	Dr.Reddy's Laboratories Limited	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-333_5c22ca2e-52db-fb09-be54-ddf8c4e428c8	55111-333	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA077619	Dr.Reddy's Laboratories Limited	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-338_6fafdf6a-6153-9a62-1774-755f2bcf0cc2	55111-338	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100419		ANDA	ANDA077183	Dr.Reddy's Laboratories Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	2.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55111-339_6fafdf6a-6153-9a62-1774-755f2bcf0cc2	55111-339	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100419		ANDA	ANDA077183	Dr.Reddy's Laboratories Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55111-340_6fafdf6a-6153-9a62-1774-755f2bcf0cc2	55111-340	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100419		ANDA	ANDA077183	Dr.Reddy's Laboratories Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55111-341_6fafdf6a-6153-9a62-1774-755f2bcf0cc2	55111-341	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100419		ANDA	ANDA077183	Dr.Reddy's Laboratories Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55111-342_77a66875-7c9c-8c98-9ddf-99f2bfaac6ef	55111-342	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077038	Dr. Reddy's Laboratories Limited	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55111-343_77a66875-7c9c-8c98-9ddf-99f2bfaac6ef	55111-343	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077038	Dr. Reddy's Laboratories Limited	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55111-344_77a66875-7c9c-8c98-9ddf-99f2bfaac6ef	55111-344	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077038	Dr. Reddy's Laboratories Limited	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55111-349_e12ef2fc-f146-a40f-d71c-96a144518d82	55111-349	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20140407		ANDA	ANDA090859	Dr. Reddy's Laboratories Limited	FENOFIBRATE	43	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
55111-351_36bfe6fc-ad7e-a44a-b24c-7b2bdc8d2067	55111-351	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080115		ANDA	ANDA078343	Dr.Reddy's Laboratories Limited	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-352_b6b13871-d413-7582-bd37-090b800d61f0	55111-352	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20110901		ANDA	ANDA077130	Dr. Reddy's Laboratories Limited	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55111-353_b6b13871-d413-7582-bd37-090b800d61f0	55111-353	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20110901		ANDA	ANDA077130	Dr. Reddy's Laboratories Limited	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55111-354_b6b13871-d413-7582-bd37-090b800d61f0	55111-354	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20110901		ANDA	ANDA077130	Dr. Reddy's Laboratories Limited	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55111-355_b6b13871-d413-7582-bd37-090b800d61f0	55111-355	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20110901		ANDA	ANDA077130	Dr. Reddy's Laboratories Limited	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55111-356_8a7a65fb-c395-3033-4671-cc44ab69c941	55111-356	HUMAN PRESCRIPTION DRUG	Donepezil hydrochloride		Donepezil hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA201001	Dr. Reddys Laboratories Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55111-357_8a7a65fb-c395-3033-4671-cc44ab69c941	55111-357	HUMAN PRESCRIPTION DRUG	Donepezil hydrochloride		Donepezil hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA201001	Dr. Reddys Laboratories Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55111-360_81e0cf6d-918d-eee8-74ac-51f11c039fe6	55111-360	HUMAN PRESCRIPTION DRUG	Desloratadine		Desloratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20130111		ANDA	ANDA078367	Dr. Reddy's Laboratories Limited	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-363_29866a93-821e-a52f-1562-e244abe3324c	55111-363	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicrabonate		Omeprazole and Sodium Bicrabonate	CAPSULE	ORAL	20160715		ANDA	ANDA204068	Dr.Reddy's Laboratories Limited	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-364_29866a93-821e-a52f-1562-e244abe3324c	55111-364	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicrabonate		Omeprazole and Sodium Bicrabonate	CAPSULE	ORAL	20160715		ANDA	ANDA204068	Dr.Reddy's Laboratories Limited	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-395_e12ef2fc-f146-a40f-d71c-96a144518d82	55111-395	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20140407		ANDA	ANDA090859	Dr. Reddy's Laboratories Limited	FENOFIBRATE	130	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
55111-396_0e165efa-c6cc-c254-e143-a757293c26b3	55111-396	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20060930		ANDA	ANDA077367	Dr.Reddys Laboratories Limited	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-397_41f88be5-fb44-24af-30db-543aacb1a040	55111-397	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20100301		ANDA	ANDA078878	Dr. Reddy's Laboratories Limited	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-398_c8eb1d41-1fd2-7c06-486c-e6abf08faa6d	55111-398	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	Dr.Reddy's Laboratories Ltd.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-399_c8eb1d41-1fd2-7c06-486c-e6abf08faa6d	55111-399	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	Dr.Reddy's Laboratories Ltd.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-404_8459fe61-6721-7cfb-31a4-b05105bc73b8	55111-404	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET, COATED	ORAL	20091202		ANDA	ANDA078192	Dr. Reddy's Laboratories Limited	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55111-419_72b59dc4-8b58-66c0-9262-5ebaab9f6589	55111-419	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20180906		ANDA	ANDA202383	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-428_72b59dc4-8b58-66c0-9262-5ebaab9f6589	55111-428	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20130620		ANDA	ANDA202383	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-447_525f547d-5d98-ecff-8eb4-13ceb0407e4d	55111-447	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20141118		ANDA	ANDA076667	Dr. Reddy's Laboratories Limited	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
55111-453_a0b75dbc-2382-70bc-7bd9-c6ef3ee4ed3e	55111-453	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA078421	Dr.Reddy's Laboratories Ltd.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-454_a0b75dbc-2382-70bc-7bd9-c6ef3ee4ed3e	55111-454	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA078421	Dr.Reddy's Laboratories Ltd.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-455_a0b75dbc-2382-70bc-7bd9-c6ef3ee4ed3e	55111-455	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA078421	Dr.Reddy's Laboratories Ltd.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-466_e5d8bb5b-0f76-143c-3ce5-930ad24c6a5f	55111-466	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Dr. Reddy's Laboratories Limited	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55111-467_e5d8bb5b-0f76-143c-3ce5-930ad24c6a5f	55111-467	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Dr. Reddy's Laboratories Limited	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55111-468_610f213a-a956-71d0-8777-9de4096a607c	55111-468	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Dr. Reddy's Laboratories Limited	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55111-469_610f213a-a956-71d0-8777-9de4096a607c	55111-469	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Dr. Reddy's Laboratories Limited	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55111-476_6f5c36d3-3f99-803c-5be6-66b2e1058946	55111-476	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20081003		ANDA	ANDA040862	Dr. Reddy's Laboratories Limited	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55111-477_6f5c36d3-3f99-803c-5be6-66b2e1058946	55111-477	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20081003		ANDA	ANDA040862	Dr. Reddy's Laboratories Limited	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55111-496_3ed652e7-8f96-5524-8224-b621ea858c03	55111-496	HUMAN PRESCRIPTION DRUG	capecitabine		capecitabine	TABLET	ORAL	20201210		ANDA	ANDA204345	Dr. Reddy's Laboratories Limited	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55111-497_3ed652e7-8f96-5524-8224-b621ea858c03	55111-497	HUMAN PRESCRIPTION DRUG	capecitabine		capecitabine	TABLET	ORAL	20201210		ANDA	ANDA204345	Dr. Reddy's Laboratories Limited	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55111-519_d266ad8b-af60-8e42-149b-e881323543a5	55111-519	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Dr. Reddy's Laboratories Limited	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55111-520_d266ad8b-af60-8e42-149b-e881323543a5	55111-520	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Dr. Reddy's Laboratories Limited	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55111-521_d266ad8b-af60-8e42-149b-e881323543a5	55111-521	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Dr. Reddy's Laboratories Limited	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55111-522_d266ad8b-af60-8e42-149b-e881323543a5	55111-522	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Dr. Reddy's Laboratories Limited	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55111-525_a0c94acc-3eb7-d790-64b1-0bc8804689de	55111-525	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100514		ANDA	ANDA090509	Dr. Reddy's Laboratories Limited	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
55111-526_a0c94acc-3eb7-d790-64b1-0bc8804689de	55111-526	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100514		ANDA	ANDA090509	Dr. Reddy's Laboratories Limited	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
55111-527_a0c94acc-3eb7-d790-64b1-0bc8804689de	55111-527	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100514		ANDA	ANDA090509	Dr. Reddy's Laboratories Limited	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
55111-528_d266ad8b-af60-8e42-149b-e881323543a5	55111-528	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Dr. Reddy's Laboratories Limited	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55111-529_be502229-0e61-8481-dda9-794c93637dd7	55111-529	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078755	Dr.Reddy's Laboratories Limited	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-530_be502229-0e61-8481-dda9-794c93637dd7	55111-530	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078755	Dr.Reddy's Laboratories Limited	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-531_be502229-0e61-8481-dda9-794c93637dd7	55111-531	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078755	Dr.Reddy's Laboratories Limited	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-532_d543bb66-5ca6-8d08-ebc8-04c9a7c227a8	55111-532	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	CAPSULE	ORAL	20090123		ANDA	ANDA078979	Dr. Reddy's Laboratories Ltd	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-533_207065d8-03a2-be25-7888-873d0850f88b	55111-533	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20130811		ANDA	ANDA090161	Dr. Reddy's Laboratories Ltd	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-534_1dedd754-13c5-0f14-3273-d6ee87b487c3	55111-534	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20130811		ANDA	ANDA090070	Dr. Reddy's Laboratories Ltd	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-545_20a19933-a7c1-3739-c472-272204375d1e	55111-545	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	TABLET	ORAL	20080616		ANDA	ANDA078301	Dr. Reddy's Laboratories Limited	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-546_20a19933-a7c1-3739-c472-272204375d1e	55111-546	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	TABLET	ORAL	20080616		ANDA	ANDA078301	Dr. Reddy's Laboratories Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-547_20a19933-a7c1-3739-c472-272204375d1e	55111-547	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	TABLET	ORAL	20080616		ANDA	ANDA078301	Dr. Reddy's Laboratories Limited	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-548_20a19933-a7c1-3739-c472-272204375d1e	55111-548	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	TABLET	ORAL	20080616		ANDA	ANDA078301	Dr. Reddy's Laboratories Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-549_20a19933-a7c1-3739-c472-272204375d1e	55111-549	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride		Venlafaxine hydrochloride	TABLET	ORAL	20080616		ANDA	ANDA078301	Dr. Reddy's Laboratories Limited	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55111-551_81e0cf6d-918d-eee8-74ac-51f11c039fe6	55111-551	HUMAN PRESCRIPTION DRUG	Desloratadine		Desloratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20130111		ANDA	ANDA078367	Dr. Reddy's Laboratories Limited	DESLORATADINE	2.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-556_f01d4f6c-c0db-9761-301c-ee198615fe61	55111-556	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20130711		ANDA	ANDA203131	Dr.Reddy's Laboratories Limited	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55111-557_29216032-68a5-566a-5eaf-ffc9cb597e9a	55111-557	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20110824		ANDA	ANDA079043	Dr.Reddy's Laboratories Limited	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
55111-563_d266ad8b-af60-8e42-149b-e881323543a5	55111-563	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Dr. Reddy's Laboratories Limited	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55111-564_d266ad8b-af60-8e42-149b-e881323543a5	55111-564	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Dr. Reddy's Laboratories Limited	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55111-565_d2953b94-9244-2c86-ac0c-7610dd1e7963	55111-565	HUMAN OTC DRUG	Ibuprofen and Diphenhydramine Citrate		Ibuprofen and Diphenhydramine Citrate	TABLET	ORAL	20100131		ANDA	ANDA090619	Dr. Reddy's Laboratories Limited	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55111-575_efe1ec99-d9d7-58b9-0468-92a9e38a49f2	55111-575	HUMAN PRESCRIPTION DRUG	Ibandronate sodium		Ibandronate sodium	TABLET	ORAL	20120621		ANDA	ANDA078997	Dr. Reddy's Laboratories Limited	IBANDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
55111-586_2b57e667-c854-2ed1-32f9-b06c6fea1930	55111-586	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA090149	Dr.Reddy's Laboratories Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55111-587_2b57e667-c854-2ed1-32f9-b06c6fea1930	55111-587	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA090149	Dr.Reddy's Laboratories Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55111-593_8bc013e8-5324-099d-e603-d78012b126bd	55111-593	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120806		ANDA	ANDA201581	Dr.Reddy's Laboratories Limited	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
55111-594_8bc013e8-5324-099d-e603-d78012b126bd	55111-594	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120806		ANDA	ANDA201581	Dr.Reddy's Laboratories Limited	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
55111-596_0e1f7098-170b-68e7-eeeb-23fe6e51094c	55111-596	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150711		ANDA	ANDA090048	Dr. Reddys Laboratories Limited	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
55111-597_0e1f7098-170b-68e7-eeeb-23fe6e51094c	55111-597	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150711		ANDA	ANDA090048	Dr. Reddys Laboratories Limited	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
55111-606_032c7109-eeca-170e-54d0-cfb44f135f07	55111-606	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077380	Dr.Reddy's Laboratories Limited	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55111-611_53ac3a17-be8c-bc52-d592-b2285ee88b20	55111-611	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150814		ANDA	ANDA203354	Dr. Reddy's Laboratories Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
55111-612_53ac3a17-be8c-bc52-d592-b2285ee88b20	55111-612	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150814		ANDA	ANDA203354	Dr. Reddy's Laboratories Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
55111-613_53ac3a17-be8c-bc52-d592-b2285ee88b20	55111-613	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150814		ANDA	ANDA203354	Dr. Reddy's Laboratories Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
55111-614_53ac3a17-be8c-bc52-d592-b2285ee88b20	55111-614	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150814		ANDA	ANDA203354	Dr. Reddy's Laboratories Limited	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
55111-615_53ac3a17-be8c-bc52-d592-b2285ee88b20	55111-615	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150814		ANDA	ANDA203354	Dr. Reddy's Laboratories Limited	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
55111-617_80330f6a-9926-fb31-a9d2-791babc4da96	55111-617	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, COATED	ORAL	20140415		ANDA	ANDA091024	Dr. Reddy's Laboratories Limited	ESZOPICLONE	3	mg/1		CIV	N	20241231
55111-619_80330f6a-9926-fb31-a9d2-791babc4da96	55111-619	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, COATED	ORAL	20140415		ANDA	ANDA091024	Dr. Reddy's Laboratories Limited	ESZOPICLONE	2	mg/1		CIV	N	20241231
55111-625_b5fb9efb-3369-e1f9-384c-bd22e8ecad92	55111-625	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET, FILM COATED	ORAL	20101118		ANDA	ANDA090372	Dr. Reddys Laboratories Limited	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
55111-626_b5fb9efb-3369-e1f9-384c-bd22e8ecad92	55111-626	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET, FILM COATED	ORAL	20101118		ANDA	ANDA090372	Dr. Reddys Laboratories Limited	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
55111-629_80330f6a-9926-fb31-a9d2-791babc4da96	55111-629	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, COATED	ORAL	20140415		ANDA	ANDA091024	Dr. Reddy's Laboratories Limited	ESZOPICLONE	1	mg/1		CIV	N	20241231
55111-637_ce7fa22b-68f0-23fb-6ee0-121a41f01ca7	55111-637	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20080123		ANDA	ANDA065436	Dr. Reddy's Laboratories Limited	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55111-638_ce7fa22b-68f0-23fb-6ee0-121a41f01ca7	55111-638	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20080123		ANDA	ANDA065436	Dr. Reddy's Laboratories Limited	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55111-639_ce7fa22b-68f0-23fb-6ee0-121a41f01ca7	55111-639	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20080123		ANDA	ANDA065436	Dr. Reddy's Laboratories Limited	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55111-643_84f5fee1-0654-d13a-f25d-ee4ec06188c6	55111-643	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078490	Dr. Reddy's Laboratories Limited	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-644_84f5fee1-0654-d13a-f25d-ee4ec06188c6	55111-644	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078490	Dr. Reddy's Laboratories Limited	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-645_84f5fee1-0654-d13a-f25d-ee4ec06188c6	55111-645	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078490	Dr. Reddy's Laboratories Limited	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-646_ec1b249b-2d77-55d9-0520-23884a961cf0	55111-646	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole	TABLET, FILM COATED	ORAL	20110603		ANDA	ANDA091191	Dr. Reddy's Laboratories Limited	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
55111-648_51baf5c0-1517-06f6-3102-47df40906299	55111-648	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20080714		ANDA	ANDA040847	Dr. Reddy's Laboratories Limited	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55111-649_51baf5c0-1517-06f6-3102-47df40906299	55111-649	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20080714		ANDA	ANDA040847	Dr. Reddy's Laboratories Limited	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55111-650_f086bb19-b70f-dbe3-e053-2995a90ab118	55111-650	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170831		ANDA	ANDA207466	Dr. Reddys Laboratories Limited	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
55111-652_3ee9d7ec-6aac-b8d0-de5c-d65e97bb8fb6	55111-652	HUMAN PRESCRIPTION DRUG	Bivalirudin		Bivalirudin	INJECTION	INTRACAVERNOUS	20170531		ANDA	ANDA201577	Dr. Reddy's Laboratories Limited	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
55111-653_22cfda31-1ea6-c8d4-f5a5-fc386f1acad4	55111-653	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20141027		ANDA	ANDA201578	Dr. Reddy's Laboratories Limited	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
55111-654_22cfda31-1ea6-c8d4-f5a5-fc386f1acad4	55111-654	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20141027		ANDA	ANDA201578	Dr. Reddy's Laboratories Limited	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
55111-659_78d63517-2d1a-fc70-4ffb-3ebbfa065218	55111-659	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120606		ANDA	ANDA201576	Dr. Reddys Laboratories Limited	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
55111-661_78d63517-2d1a-fc70-4ffb-3ebbfa065218	55111-661	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120606		ANDA	ANDA201576	Dr. Reddys Laboratories Limited	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
55111-662_78d63517-2d1a-fc70-4ffb-3ebbfa065218	55111-662	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120606		ANDA	ANDA201576	Dr. Reddys Laboratories Limited	ROPINIROLE HYDROCHLORIDE	8	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
55111-663_9cdba353-c828-7ee6-0fed-9eb342df7ffc	55111-663	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20140625		ANDA	ANDA091412	Dr. Reddy's Laboratories Limited	PARICALCITOL	1	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
55111-664_9cdba353-c828-7ee6-0fed-9eb342df7ffc	55111-664	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20140625		ANDA	ANDA091412	Dr. Reddy's Laboratories Limited	PARICALCITOL	2	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
55111-665_9cdba353-c828-7ee6-0fed-9eb342df7ffc	55111-665	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20140625		ANDA	ANDA091412	Dr. Reddy's Laboratories Limited	PARICALCITOL	4	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
55111-671_65582039-3d2c-1c40-53d3-5b0c5d720323	55111-671	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA091023	Dr.Reddy's Laboratories Limited	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
55111-678_2a3f9c6b-885b-843d-9cc8-3eb67395fbda	55111-678	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20110714		ANDA	ANDA091316	Dr. Reddy's Laboratories Limited	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55111-679_2a3f9c6b-885b-843d-9cc8-3eb67395fbda	55111-679	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20110714		ANDA	ANDA091316	Dr. Reddy's Laboratories Limited	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55111-680_2a3f9c6b-885b-843d-9cc8-3eb67395fbda	55111-680	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20110714		ANDA	ANDA091316	Dr. Reddy's Laboratories Limited	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55111-681_2a3f9c6b-885b-843d-9cc8-3eb67395fbda	55111-681	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		Fondaparinux Sodium	INJECTION	SUBCUTANEOUS	20110714		ANDA	ANDA091316	Dr. Reddy's Laboratories Limited	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55111-682_c102040d-6d3a-1ca8-f426-ce99be7d7902	55111-682	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Dr. Reddy's Laboratories Limited	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55111-683_c102040d-6d3a-1ca8-f426-ce99be7d7902	55111-683	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Dr. Reddy's Laboratories Limited	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55111-684_c102040d-6d3a-1ca8-f426-ce99be7d7902	55111-684	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Dr. Reddy's Laboratories Limited	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55111-685_4c67e83c-b344-e96f-690c-5c020972fb34	55111-685	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20130304		ANDA	ANDA091186	Dr. Reddy's Laboratories Limited	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
55111-686_f87af163-c123-ad86-b98f-c0e06ab2b1e8	55111-686	HUMAN PRESCRIPTION DRUG	gemcitabine		gemcitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110725		ANDA	ANDA091365	Dr. Reddy's Laboratories Limited	GEMCITABINE HYDROCHLORIDE	200	mg/5mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55111-687_f87af163-c123-ad86-b98f-c0e06ab2b1e8	55111-687	HUMAN PRESCRIPTION DRUG	gemcitabine		gemcitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110725		ANDA	ANDA091365	Dr. Reddy's Laboratories Limited	GEMCITABINE HYDROCHLORIDE	1	g/25mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55111-688_e6186e67-db84-ea0b-9bd0-e33feb37082b	55111-688	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20130403		ANDA	ANDA091363	Dr.Reddy's Laboratories Ltd	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
55111-693_4d3769ab-6051-d797-32f0-049d110a2ea9	55111-693	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20140224		ANDA	ANDA090495	Dr. Reddy's Laboratories Limited	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55111-694_7b1217ad-b626-0b2b-88d8-ae44fa91dbbd	55111-694	HUMAN PRESCRIPTION DRUG	Palonosetron		Palonosetron	INJECTION, SOLUTION	INTRAVENOUS	20180323		ANDA	ANDA201533	Dr.Reddy's Laboratories Limited	PALONOSETRON HYDROCHLORIDE	.05	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55111-699_36bfe6fc-ad7e-a44a-b24c-7b2bdc8d2067	55111-699	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080115		ANDA	ANDA078343	Dr.Reddy's Laboratories Limited	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-701_331f44b3-1c83-c214-7d48-e5d44fc8bd2a	55111-701	HUMAN PRESCRIPTION DRUG	Naproxen and esomeprazole magnesium		Naproxen and esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20200218		ANDA	ANDA204206	Dr. Reddy's Laboratories Limited	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 500	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-717_72b59dc4-8b58-66c0-9262-5ebaab9f6589	55111-717	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20130620		ANDA	ANDA202383	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-718_72b59dc4-8b58-66c0-9262-5ebaab9f6589	55111-718	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20130620		ANDA	ANDA202383	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-719_72b59dc4-8b58-66c0-9262-5ebaab9f6589	55111-719	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20130620		ANDA	ANDA202383	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-720_72b59dc4-8b58-66c0-9262-5ebaab9f6589	55111-720	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20130620		ANDA	ANDA202383	Dr.Reddy's Laboratories Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55111-725_8bc013e8-5324-099d-e603-d78012b126bd	55111-725	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, COATED	ORAL	20120806		ANDA	ANDA201582	Dr.Reddy's Laboratories Limited	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
55111-727_78d63517-2d1a-fc70-4ffb-3ebbfa065218	55111-727	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120606		ANDA	ANDA201576	Dr. Reddys Laboratories Limited	ROPINIROLE HYDROCHLORIDE	6	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
55111-728_78d63517-2d1a-fc70-4ffb-3ebbfa065218	55111-728	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120606		ANDA	ANDA201576	Dr. Reddys Laboratories Limited	ROPINIROLE HYDROCHLORIDE	12	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
55111-729_0837a638-aa97-b433-6fa4-cd4adf3bc82c	55111-729	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091001		ANDA	ANDA071586	Dr. Reddy's Laboratories Limited	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55111-730_0837a638-aa97-b433-6fa4-cd4adf3bc82c	55111-730	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091001		ANDA	ANDA071587	Dr. Reddy's Laboratories Limited	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55111-731_48e7d0aa-d6a3-6f6d-cea1-68cb64bc45c1	55111-731	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180330		ANDA	ANDA201618	Dr. Reddy's Laboratories Limited	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55111-732_48e7d0aa-d6a3-6f6d-cea1-68cb64bc45c1	55111-732	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180119		ANDA	ANDA201618	Dr. Reddy's Laboratories Limited	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55111-733_48e7d0aa-d6a3-6f6d-cea1-68cb64bc45c1	55111-733	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180119		ANDA	ANDA201618	Dr. Reddy's Laboratories Limited	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55111-734_48e7d0aa-d6a3-6f6d-cea1-68cb64bc45c1	55111-734	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20180119		ANDA	ANDA201618	Dr. Reddy's Laboratories Limited	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55111-739_6065013b-122b-95f2-fe85-e34d8eaf89d2	55111-739	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190819		ANDA	ANDA202194	Dr. Reddy's Laboratories Limited	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55111-762_01a187d9-f0b8-d068-0be0-98654e8de135	55111-762	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA203511	Dr. Reddy's Laboratories Limited	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
55111-763_1d9ac31e-956b-897f-2d41-da76d70dd40c	55111-763	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	GRANULE	ORAL	20120920		ANDA	ANDA202906	Dr.Reddy's Laboratories Limited	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
55111-782_e637b622-72de-e0be-d4e8-c2fac4efc8da	55111-782	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20110103		ANDA	ANDA076502	Dr. Reddy's Laboratories Limited	FEXOFENADINE HYDROCHLORIDE	30	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-783_e637b622-72de-e0be-d4e8-c2fac4efc8da	55111-783	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20110103		ANDA	ANDA076502	Dr. Reddy's Laboratories Limited	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-784_e637b622-72de-e0be-d4e8-c2fac4efc8da	55111-784	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20110103		ANDA	ANDA076502	Dr. Reddy's Laboratories Limited	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55111-789_fac5ad1b-6b4b-0c5b-f504-26eb1b4b1089	55111-789	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20170929		ANDA	ANDA206094	DR. REDDY'S LABORATORIES LIMITED	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55111-796_25711455-9482-c211-793c-6d09539f1c09	55111-796	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20201125		ANDA	ANDA205374	DR REDDY'S LABORATORIES LIMITED	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55111-797_25711455-9482-c211-793c-6d09539f1c09	55111-797	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20201125		ANDA	ANDA205374	DR REDDY'S LABORATORIES LIMITED	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55111-798_029cd2ef-2247-abda-d74e-4b589a7dae62	55111-798	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCL		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20171229		ANDA	ANDA208369	Dr. Reddys Laboratories Limited	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
55111-799_029cd2ef-2247-abda-d74e-4b589a7dae62	55111-799	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCL		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20171229		ANDA	ANDA208369	Dr. Reddys Laboratories Limited	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
55118-530_e449f0c9-0298-4420-8b41-6229b72ef0da	55118-530	HUMAN OTC DRUG	Kleenex Ultra Moisturizing Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark Corporation	ALCOHOL	70	mL/100mL			N	20241231
55118-531_d2bf8c39-22f8-4b53-a4ed-299d89e0365f	55118-531	HUMAN OTC DRUG	Kleenex Reveal Moisturizing Foam Hand Sanitizer		alcohol	SOLUTION	TOPICAL	20180515		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark	ALCOHOL	70	mL/100mL			N	20241231
55118-546_32a4ad5e-18bf-43c0-a938-f0afb3e3b5c5	55118-546	HUMAN OTC DRUG	Scott Moisturizing Foam Hand Sanitizer		alcohol	SOLUTION	TOPICAL	20180416		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark	ALCOHOL	62	mL/100mL			N	20241231
55118-664_412df657-a914-4c6a-a4ee-bab3c937f57a	55118-664	HUMAN OTC DRUG	SCOTT FOAM HAND SANITIZER		Benzalkonium Chloride	SOLUTION	TOPICAL	20181116		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
55118-701_67829125-8817-4922-8af8-6fb912c11697	55118-701	HUMAN OTC DRUG	KLEENEX Foam Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark	BENZALKONIUM CHLORIDE	1.3	mg/1000mL			N	20241231
55118-704_49cbe22b-09e4-42cc-acd1-e04b97e11301	55118-704	HUMAN OTC DRUG	KLEENEX INSTANT HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20210830		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark Corporation	ALCOHOL	68	mL/100mL			N	20241231
55118-800_ed35383c-6d5b-4928-b605-479a092599b5	55118-800	HUMAN OTC DRUG	SCOTT Antimicrobial Foam Skin Cleanser		Benzalkonium Chloride	SOLUTION	TOPICAL	20181116		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark	BENZALKONIUM CHLORIDE	1	mg/1000mL			N	20241231
55118-900_dcd9b725-8b77-4b1b-9f0b-904417ac48bc	55118-900	HUMAN OTC DRUG	SCOTT Antiseptic Foam Skin Cleanser		Chloroxylenol	SOLUTION	TOPICAL	20181116		OTC MONOGRAPH NOT FINAL	part333E	Kimberly-Clark	CHLOROXYLENOL	17.5	g/L			N	20241231
55127-001_4e768ea0-cfaf-49dc-99d8-976bc28cc234	55127-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20141201		NDA	NDA205840	Thumb Welding Supplies Inc	OXYGEN	99	L/100L			N	20241231
55128-111_16ca5aa3-3cfc-4162-9a22-cd48250f4c5c	55128-111	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19820101		UNAPPROVED MEDICAL GAS		Terre Haute Home Health Care Products dba Anderson's Medical Products	OXYGEN	99	L/100L			N	20241231
55135-132_74b74300-bd0b-47c4-9591-b5a5e494f0ce	55135-132	HUMAN PRESCRIPTION DRUG	TRODELVY		SACITUZUMAB GOVITECAN	POWDER, FOR SOLUTION	INTRAVENOUS	20200422		BLA	BLA761115	Gilead Sciences	SACITUZUMAB GOVITECAN	180	mg/1			N	20241231
55147-001_080297ff-a3e1-398b-e063-6394a90a2f28	55147-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19950101		NDA	NDA205767	Minneapolis Oxygen Company	OXYGEN	990	mL/L			N	20241231
55147-002_0802bcb4-fca1-2397-e063-6294a90a2862	55147-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19950101		NDA	NDA205766	Minneapolis Oxygen Company	NITROGEN	990	mL/L			N	20241231
55147-004_08028cba-3e50-c188-e063-6294a90a6c7a	55147-004	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	19950101		NDA	NDA205767	Minneapolis Oxygen Company	OXYGEN	210	mL/L			N	20241231
55150-111_5af50c4d-f5ae-4a8c-832b-07dd7b3794d5	55150-111	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120201		ANDA	ANDA065499	Eugia US LLC	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-112_5af50c4d-f5ae-4a8c-832b-07dd7b3794d5	55150-112	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120201		ANDA	ANDA065499	Eugia US LLC	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-113_5af50c4d-f5ae-4a8c-832b-07dd7b3794d5	55150-113	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120201		ANDA	ANDA065499	Eugia US LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-114_5af50c4d-f5ae-4a8c-832b-07dd7b3794d5	55150-114	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120201		ANDA	ANDA065499	Eugia US LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-115_6e79da27-bd31-44d0-a77f-d07f3f43d8aa	55150-115	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120201		ANDA	ANDA065493	Eugia US LLC	AMPICILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-116_16fdfdb9-9e26-48d0-8838-570d30c8e897	55150-116	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120210		ANDA	ANDA090349	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-116_7c6af46b-5730-405f-afd3-06345c59dc32	55150-116	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120210		ANDA	ANDA090349	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-117_16fdfdb9-9e26-48d0-8838-570d30c8e897	55150-117	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120210		ANDA	ANDA090349	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-117_7c6af46b-5730-405f-afd3-06345c59dc32	55150-117	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120210		ANDA	ANDA090349	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-118_23bd8a79-8dcd-4351-9797-5b94b1ddf35c	55150-118	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120210		ANDA	ANDA090339	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-118_437a26f4-776b-4f74-99b2-09ad79831b0c	55150-118	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120210		ANDA	ANDA090339	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-119_477757a4-9621-4c37-b129-0324196fc68c	55150-119	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120123		ANDA	ANDA065498	Eugia US LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-120_477757a4-9621-4c37-b129-0324196fc68c	55150-120	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120123		ANDA	ANDA065498	Eugia US LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-121_477757a4-9621-4c37-b129-0324196fc68c	55150-121	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120123		ANDA	ANDA065498	Eugia US LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-122_fae2b755-1cd4-457b-81ad-54552fd7b296	55150-122	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20121226		ANDA	ANDA091613	Eugia US LLC	NAFCILLIN SODIUM	1	g/4mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-123_d905fe2c-b3b6-450b-b27c-cb0c7159bf8f	55150-123	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20121226		ANDA	ANDA091613	Eugia US LLC	NAFCILLIN SODIUM	2	g/8mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-123_fae2b755-1cd4-457b-81ad-54552fd7b296	55150-123	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20121226		ANDA	ANDA091613	Eugia US LLC	NAFCILLIN SODIUM	2	g/8mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-124_75a0071e-380b-40c6-86ad-78eaae0e4922	55150-124	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20121226		ANDA	ANDA091614	Eugia US LLC	NAFCILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-124_94a8ca5c-8dd5-4a13-8b8c-9e5718fd7ff6	55150-124	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20121226		ANDA	ANDA091614	Eugia US LLC	NAFCILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-125_89f57944-8219-4526-a15f-0b8f01547453	55150-125	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20121221		ANDA	ANDA202600	AuroMedics Pharma LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55150-126_89f57944-8219-4526-a15f-0b8f01547453	55150-126	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20121221		ANDA	ANDA202599	AuroMedics Pharma LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55150-127_c46c59f4-6728-464b-a25c-00cf4b515fe1	55150-127	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130118		ANDA	ANDA201539	Eugia US LLC	OXACILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-128_c46c59f4-6728-464b-a25c-00cf4b515fe1	55150-128	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130118		ANDA	ANDA201539	Eugia US LLC	OXACILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-129_8483535d-845a-4c9b-9c6a-36841e5b1747	55150-129	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin Sodium	POWDER, FOR SOLUTION	INTRAVENOUS	20130118		ANDA	ANDA201538	Eugia US LLC	OXACILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55150-154_410e306b-e8b9-4ff5-b703-a3005eec272f	55150-154	HUMAN PRESCRIPTION DRUG	Acyclovir Sodium		Acyclovir Sodium	INJECTION, SOLUTION	INTRAVENOUS	20131011		ANDA	ANDA203701	Eugia US LLC	ACYCLOVIR SODIUM	500	mg/10mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55150-154_ce906c2c-05e6-4356-995a-d2c95fd11787	55150-154	HUMAN PRESCRIPTION DRUG	Acyclovir Sodium		Acyclovir Sodium	INJECTION, SOLUTION	INTRAVENOUS	20131011		ANDA	ANDA203701	AuroMedics Pharma LLC	ACYCLOVIR SODIUM	500	mg/10mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55150-155_410e306b-e8b9-4ff5-b703-a3005eec272f	55150-155	HUMAN PRESCRIPTION DRUG	Acyclovir Sodium		Acyclovir Sodium	INJECTION, SOLUTION	INTRAVENOUS	20131011		ANDA	ANDA203701	Eugia US LLC	ACYCLOVIR SODIUM	1000	mg/20mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55150-155_ce906c2c-05e6-4356-995a-d2c95fd11787	55150-155	HUMAN PRESCRIPTION DRUG	Acyclovir Sodium		Acyclovir Sodium	INJECTION, SOLUTION	INTRAVENOUS	20131011		ANDA	ANDA203701	AuroMedics Pharma LLC	ACYCLOVIR SODIUM	1000	mg/20mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55150-156_b302d53d-76af-480c-a710-a60552ae4b40	55150-156	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20130124		ANDA	ANDA202328	AuroMedics Pharma LLC	LEVOFLOXACIN	500	mg/20mL			N	20241231
55150-157_b302d53d-76af-480c-a710-a60552ae4b40	55150-157	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20130124		ANDA	ANDA202328	AuroMedics Pharma LLC	LEVOFLOXACIN	750	mg/30mL			N	20241231
55150-158_66106835-8639-42fb-a26d-80348a253a89	55150-158	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203040	AuroMedics Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-159_66106835-8639-42fb-a26d-80348a253a89	55150-159	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203040	AuroMedics Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-160_66106835-8639-42fb-a26d-80348a253a89	55150-160	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203040	AuroMedics Pharma LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-161_1d827eb4-623d-4ffa-b95e-43de66de07a2	55150-161	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-162_1d827eb4-623d-4ffa-b95e-43de66de07a2	55150-162	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-163_1d827eb4-623d-4ffa-b95e-43de66de07a2	55150-163	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-164_1d827eb4-623d-4ffa-b95e-43de66de07a2	55150-164	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-165_1d827eb4-623d-4ffa-b95e-43de66de07a2	55150-165	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-166_c6f23ad9-ca87-47a3-8d85-dfc334e5a91b	55150-166	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil Citrate	INJECTION, SOLUTION	INTRAVENOUS	20150401		ANDA	ANDA203988	Eugia US LLC	SILDENAFIL CITRATE	10	mg/12.5mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
55150-167_5b78d923-3422-452e-a334-462926dfa187	55150-167	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20131105		ANDA	ANDA203895	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-168_5b78d923-3422-452e-a334-462926dfa187	55150-168	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20131105		ANDA	ANDA203895	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-169_5b78d923-3422-452e-a334-462926dfa187	55150-169	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL	20131105		ANDA	ANDA203895	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-170_5b78d923-3422-452e-a334-462926dfa187	55150-170	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL	20131105		ANDA	ANDA203895	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-171_5b78d923-3422-452e-a334-462926dfa187	55150-171	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20131105		ANDA	ANDA203895	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-172_5b78d923-3422-452e-a334-462926dfa187	55150-172	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20131105		ANDA	ANDA203895	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-173_63816cf3-251a-44d1-9994-c30f73537473	55150-173	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	INJECTION, SOLUTION	SUBCUTANEOUS	20130423		ANDA	ANDA202758	AuroMedics Pharma LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55150-173_788fbdee-80fc-418c-93d9-214e6761fb82	55150-173	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	INJECTION, SOLUTION	SUBCUTANEOUS	20130423		ANDA	ANDA202758	Eugia US LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55150-174_6760771b-9c61-458d-9778-81a3da96cb9f	55150-174	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150619		ANDA	ANDA203294	Eugia US LLC	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
55150-175_9f1ec15d-50a3-4bbd-8096-12312044ecda	55150-175	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20160706		ANDA	ANDA204238	AuroMedics Pharma LLC	GRANISETRON HYDROCHLORIDE	1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55150-176_9f1ec15d-50a3-4bbd-8096-12312044ecda	55150-176	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20160706		ANDA	ANDA204238	AuroMedics Pharma LLC	GRANISETRON HYDROCHLORIDE	4	mg/4mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55150-177_f93cb0f9-36fe-4d5b-8fb3-8d341d17ac77	55150-177	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION, SOLUTION	INTRAVENOUS	20160201		ANDA	ANDA204312	AuroMedics Pharma LLC	LEVETIRACETAM	500	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55150-178_7c6af46b-5730-405f-afd3-06345c59dc32	55150-178	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120913		ANDA	ANDA090340	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-179_7c6af46b-5730-405f-afd3-06345c59dc32	55150-179	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120913		ANDA	ANDA090340	Eugia US LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-180_c2e4f552-4ed1-4c8c-b865-39596b79b1ad	55150-180	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20171025		ANDA	ANDA204550	AuroMedics Pharma LLC	AMIODARONE HYDROCHLORIDE	150	mg/3mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55150-181_c2e4f552-4ed1-4c8c-b865-39596b79b1ad	55150-181	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20171025		ANDA	ANDA204550	AuroMedics Pharma LLC	AMIODARONE HYDROCHLORIDE	450	mg/9mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55150-182_c2e4f552-4ed1-4c8c-b865-39596b79b1ad	55150-182	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20171025		ANDA	ANDA204550	AuroMedics Pharma LLC	AMIODARONE HYDROCHLORIDE	900	mg/18mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55150-183_9f5d3050-9cdf-404f-ac0f-72399178959f	55150-183	HUMAN PRESCRIPTION DRUG	NICARDIPINE HYDROCHLORIDE		NICARDIPINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210408		ANDA	ANDA211121	AuroMedics Pharma LLC	NICARDIPINE HYDROCHLORIDE	25	mg/10mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55150-183_c5ead57c-6f9e-41f5-b9cc-04c4c3abbcc9	55150-183	HUMAN PRESCRIPTION DRUG	NICARDIPINE HYDROCHLORIDE		NICARDIPINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210408		ANDA	ANDA211121	AuroMedics Pharma LLC	NICARDIPINE HYDROCHLORIDE	25	mg/10mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55150-185_efe8602a-8335-402c-a394-1218d00b2dca	55150-185	HUMAN PRESCRIPTION DRUG	Esomeprazole Sodium		Esomeprazole Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160810		ANDA	ANDA204657	Eugia US LLC	ESOMEPRAZOLE SODIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55150-186_11d5832f-0449-426f-b25a-157963153b2f	55150-186	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		Palonosetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20181106		ANDA	ANDA204702	Eugia US LLC	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55150-187_ee71139f-c092-456e-92bc-431a306e58b4	55150-187	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		Caffeine Citrate	INJECTION, SOLUTION	INTRAVENOUS	20150922		ANDA	ANDA205013	AuroMedics Pharma LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
55150-188_0c59bf92-f331-44d7-b8ab-5b4b7adca98b	55150-188	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20160114		ANDA	ANDA205035	AuroMedics Pharma LLC	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
55150-191_1f7e14bc-bafe-4ecb-8679-5d23900f9c05	55150-191	HUMAN PRESCRIPTION DRUG	Ibandronate Sodium		Ibandronate Sodium	INJECTION, SOLUTION	INTRAVENOUS	20150819		ANDA	ANDA205332	AuroMedics Pharma LLC	IBANDRONATE SODIUM	3	mg/3mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
55150-192_3329ba34-b3ed-4517-8055-38c522dcf0b0	55150-192	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20171102		ANDA	ANDA205331	Eugia US LLC	ADENOSINE	60	mg/20mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
55150-193_3329ba34-b3ed-4517-8055-38c522dcf0b0	55150-193	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20171102		ANDA	ANDA205331	Eugia US LLC	ADENOSINE	90	mg/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
55150-194_82113867-6dc3-4e8c-bd4c-37915ffbf665	55150-194	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20150723		ANDA	ANDA205520	Eugia US LLC	ESMOLOL HYDROCHLORIDE	100	mg/10mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55150-195_5c702449-8911-42f1-8057-139cef400fb8	55150-195	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20160915		ANDA	ANDA205612	Eugia US LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-196_5c702449-8911-42f1-8057-139cef400fb8	55150-196	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20160915		ANDA	ANDA205612	Eugia US LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-197_5c702449-8911-42f1-8057-139cef400fb8	55150-197	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20160915		ANDA	ANDA205612	Eugia US LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-198_5c702449-8911-42f1-8057-139cef400fb8	55150-198	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20160915		ANDA	ANDA205612	Eugia US LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-199_5c702449-8911-42f1-8057-139cef400fb8	55150-199	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; PERINEURAL	20160915		ANDA	ANDA205612	Eugia US LLC	ROPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-200_5c702449-8911-42f1-8057-139cef400fb8	55150-200	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL	20160915		ANDA	ANDA205612	Eugia US LLC	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-201_5c702449-8911-42f1-8057-139cef400fb8	55150-201	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL	20160915		ANDA	ANDA205612	Eugia US LLC	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-202_9d6b31b0-246c-48af-b258-e95be24cc2b1	55150-202	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160330		ANDA	ANDA205675	Eugia US LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55150-203_575e0edf-ce63-47ca-9ece-fcaafebc4f2e	55150-203	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160331		ANDA	ANDA205780	Eugia US LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
55150-204_575e0edf-ce63-47ca-9ece-fcaafebc4f2e	55150-204	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160331		ANDA	ANDA205780	Eugia US LLC	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
55150-205_8c5bada9-6107-4f48-a477-10effdacd5e9	55150-205	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160329		ANDA	ANDA205779	Eugia US LLC	VANCOMYCIN HYDROCHLORIDE	5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
55150-206_8c5bada9-6107-4f48-a477-10effdacd5e9	55150-206	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160329		ANDA	ANDA205779	Eugia US LLC	VANCOMYCIN HYDROCHLORIDE	10	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
55150-207_51488d0e-d063-466f-8591-ae2fa7cc88bc	55150-207	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170327		ANDA	ANDA205835	Eugia US LLC	MEROPENEM	500	mg/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
55150-208_51488d0e-d063-466f-8591-ae2fa7cc88bc	55150-208	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170327		ANDA	ANDA205835	Eugia US LLC	MEROPENEM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
55150-209_cc0d3661-5f2e-43fb-a2ae-7d3f89c7e58c	55150-209	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		Dexmedetomidine	INJECTION, SOLUTION	INTRAVENOUS	20160317		ANDA	ANDA205867	Eugia US LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
55150-210_5441509c-8a3f-452c-a812-61374fb1423b	55150-210	HUMAN PRESCRIPTION DRUG	BIVALIRUDIN		BIVALIRUDIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180727		ANDA	ANDA205962	Eugia US LLC	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
55150-212_1f725197-7518-45a6-a0ad-110e651f14f2	55150-212	HUMAN PRESCRIPTION DRUG	PARICALCITOL		PARICALCITOL	INJECTION	INTRAVENOUS	20181009		ANDA	ANDA205982	Eugia US LLC	PARICALCITOL	2	ug/mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
55150-213_1f725197-7518-45a6-a0ad-110e651f14f2	55150-213	HUMAN PRESCRIPTION DRUG	PARICALCITOL		PARICALCITOL	INJECTION	INTRAVENOUS	20181009		ANDA	ANDA205982	Eugia US LLC	PARICALCITOL	5	ug/mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
55150-214_1f725197-7518-45a6-a0ad-110e651f14f2	55150-214	HUMAN PRESCRIPTION DRUG	PARICALCITOL		PARICALCITOL	INJECTION	INTRAVENOUS	20181009		ANDA	ANDA205982	Eugia US LLC	PARICALCITOL	10	ug/2mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
55150-215_1f725197-7518-45a6-a0ad-110e651f14f2	55150-215	HUMAN PRESCRIPTION DRUG	PARICALCITOL		PARICALCITOL	INJECTION	INTRAVENOUS	20181009		ANDA	ANDA205982	Eugia US LLC	PARICALCITOL	10	ug/2mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
55150-216_379b43a8-f4ba-4a29-a478-23dbb33fbefa	55150-216	HUMAN PRESCRIPTION DRUG	Atracurium Besylate		Atracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20150408		ANDA	ANDA206010	AuroMedics Pharma LLC	ATRACURIUM BESYLATE	50	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-217_12db80ae-2d05-4941-8c95-8ff454a31d80	55150-217	HUMAN PRESCRIPTION DRUG	Atracurium Besylate		Atracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20150408		ANDA	ANDA206011	AuroMedics Pharma LLC	ATRACURIUM BESYLATE	100	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-218_944b269c-d810-411d-9ed4-8edd9d0ac1b7	55150-218	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION	INTRAVENOUS	20151208		ANDA	ANDA206127	Eugia US LLC	EPTIFIBATIDE	75	mg/100mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20251231
55150-219_944b269c-d810-411d-9ed4-8edd9d0ac1b7	55150-219	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION	INTRAVENOUS	20151208		ANDA	ANDA206127	Eugia US LLC	EPTIFIBATIDE	20	mg/10mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20251231
55150-220_944b269c-d810-411d-9ed4-8edd9d0ac1b7	55150-220	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION	INTRAVENOUS	20151208		ANDA	ANDA206127	Eugia US LLC	EPTIFIBATIDE	200	mg/100mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20251231
55150-221_278b160e-cdc4-451e-9405-cb001f443680	55150-221	HUMAN PRESCRIPTION DRUG	ETOMIDATE		ETOMIDATE	INJECTION, SOLUTION	INTRAVENOUS	20170224		ANDA	ANDA206126	Eugia US LLC	ETOMIDATE	20	mg/10mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
55150-222_278b160e-cdc4-451e-9405-cb001f443680	55150-222	HUMAN PRESCRIPTION DRUG	ETOMIDATE		ETOMIDATE	INJECTION, SOLUTION	INTRAVENOUS	20170224		ANDA	ANDA206126	Eugia US LLC	ETOMIDATE	40	mg/20mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
55150-223_980dbd07-e6d0-4d8a-8cbe-37c36c9e94c5	55150-223	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160527		ANDA	ANDA206128	Eugia US LLC	METHOCARBAMOL	1000	mg/10mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55150-225_256e0877-720b-40a2-be71-d503e8b860ab	55150-225	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION, SOLUTION	INTRAVENOUS	20170412		ANDA	ANDA206206	Eugia US LLC	ROCURONIUM BROMIDE	50	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-226_256e0877-720b-40a2-be71-d503e8b860ab	55150-226	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION, SOLUTION	INTRAVENOUS	20170412		ANDA	ANDA206206	Eugia US LLC	ROCURONIUM BROMIDE	100	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-228_84923263-9a37-44db-8456-98f46c84306f	55150-228	HUMAN PRESCRIPTION DRUG	Tigecycline		Tigecycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190611		ANDA	ANDA206335	AuroMedics Pharma LLC	TIGECYCLINE	50	mg/1	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
55150-230_bf1892c1-2d91-462a-aef1-09adcd01b59c	55150-230	HUMAN PRESCRIPTION DRUG	FONDAPARINUX SODIUM		FONDAPARINUX SODIUM	INJECTION, SOLUTION	SUBCUTANEOUS	20171226		ANDA	ANDA206918	AuroMedics Pharma LLC	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55150-231_bf1892c1-2d91-462a-aef1-09adcd01b59c	55150-231	HUMAN PRESCRIPTION DRUG	FONDAPARINUX SODIUM		FONDAPARINUX SODIUM	INJECTION, SOLUTION	SUBCUTANEOUS	20171226		ANDA	ANDA206918	AuroMedics Pharma LLC	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55150-232_bf1892c1-2d91-462a-aef1-09adcd01b59c	55150-232	HUMAN PRESCRIPTION DRUG	FONDAPARINUX SODIUM		FONDAPARINUX SODIUM	INJECTION, SOLUTION	SUBCUTANEOUS	20171226		ANDA	ANDA206918	AuroMedics Pharma LLC	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55150-233_bf1892c1-2d91-462a-aef1-09adcd01b59c	55150-233	HUMAN PRESCRIPTION DRUG	FONDAPARINUX SODIUM		FONDAPARINUX SODIUM	INJECTION, SOLUTION	SUBCUTANEOUS	20171226		ANDA	ANDA206918	AuroMedics Pharma LLC	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55150-234_ba953500-6973-4b5c-a055-d5ef9d78ca28	55150-234	HUMAN PRESCRIPTION DRUG	Polymyxin B		Polymyxin B	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	20160404		ANDA	ANDA206589	Eugia US LLC	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55150-235_16094b20-98e3-45d1-b463-d013d454e65a	55150-235	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181220		ANDA	ANDA206670	Eugia US LLC	VECURONIUM BROMIDE	10	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-235_26368338-338e-4438-8fc7-366e8e6f9bbb	55150-235	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181220		ANDA	ANDA206670	Eugia US LLC	VECURONIUM BROMIDE	10	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-236_16094b20-98e3-45d1-b463-d013d454e65a	55150-236	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181220		ANDA	ANDA206670	Eugia US LLC	VECURONIUM BROMIDE	20	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-236_26368338-338e-4438-8fc7-366e8e6f9bbb	55150-236	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181220		ANDA	ANDA206670	Eugia US LLC	VECURONIUM BROMIDE	20	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-237_e8f1290b-1f61-41ba-a542-a5fe17ef8553	55150-237	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151201		ANDA	ANDA206781	Eugia US LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-238_e8f1290b-1f61-41ba-a542-a5fe17ef8553	55150-238	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151201		ANDA	ANDA206781	Eugia US LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-239_e8f1290b-1f61-41ba-a542-a5fe17ef8553	55150-239	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151201		ANDA	ANDA206781	Eugia US LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-240_1ae5b904-e265-412e-8d11-a38c68d707a5	55150-240	HUMAN PRESCRIPTION DRUG	Isosulfan Blue		Isosulfan Blue	INJECTION, SOLUTION	SUBCUTANEOUS	20160202		ANDA	ANDA206831	AuroMedics Pharma LLC	ISOSULFAN BLUE	50	mg/5mL			N	20241231
55150-240_98b2ad0a-5f57-4157-b6b8-8e6cb5ccf4ae	55150-240	HUMAN PRESCRIPTION DRUG	Isosulfan Blue		Isosulfan Blue	INJECTION, SOLUTION	SUBCUTANEOUS	20160202		ANDA	ANDA206831	AuroMedics Pharma LLC	ISOSULFAN BLUE	50	mg/5mL			N	20241231
55150-241_22fd3221-0cbe-4fc2-b4ca-e93faa99b8c0	55150-241	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION, SOLUTION	INTRAVENOUS	20181127		NDA	NDA209552	Eugia US LLC	ARGATROBAN	50	mg/50mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
55150-242_c2679be6-de5a-4116-921f-abb5fd91039f	55150-242	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	INJECTION, SOLUTION	INTRAVENOUS	20160804		ANDA	ANDA206917	Eugia US LLC	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
55150-243_2216c654-d598-4cfd-bfd0-84a77ca2fe8c	55150-243	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin in 5% Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20160210		ANDA	ANDA206919	AuroMedics Pharma LLC	LEVOFLOXACIN	250	mg/50mL			N	20241231
55150-244_2216c654-d598-4cfd-bfd0-84a77ca2fe8c	55150-244	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin in 5% Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20160210		ANDA	ANDA206919	AuroMedics Pharma LLC	LEVOFLOXACIN	500	mg/100mL			N	20241231
55150-245_2216c654-d598-4cfd-bfd0-84a77ca2fe8c	55150-245	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin in 5% Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20160210		ANDA	ANDA206919	AuroMedics Pharma LLC	LEVOFLOXACIN	750	mg/150mL			N	20241231
55150-246_c2b8749d-192a-44e6-8389-04352ab9c3eb	55150-246	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam in sodium chloride	INJECTION, SOLUTION	INTRAVENOUS	20170104		ANDA	ANDA207160	Eugia US LLC	LEVETIRACETAM	500	mg/100mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55150-247_c2b8749d-192a-44e6-8389-04352ab9c3eb	55150-247	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam in sodium chloride	INJECTION, SOLUTION	INTRAVENOUS	20170104		ANDA	ANDA207160	Eugia US LLC	LEVETIRACETAM	1000	mg/100mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55150-248_c2b8749d-192a-44e6-8389-04352ab9c3eb	55150-248	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam in sodium chloride	INJECTION, SOLUTION	INTRAVENOUS	20170104		ANDA	ANDA207160	Eugia US LLC	LEVETIRACETAM	1500	mg/100mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55150-249_5b78d923-3422-452e-a334-462926dfa187	55150-249	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20160513		ANDA	ANDA207183	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-250_5b78d923-3422-452e-a334-462926dfa187	55150-250	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20160513		ANDA	ANDA207183	Eugia US LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55150-251_683b3d7b-b194-49a5-85cc-d5a4b544b258	55150-251	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-252_683b3d7b-b194-49a5-85cc-d5a4b544b258	55150-252	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-253_683b3d7b-b194-49a5-85cc-d5a4b544b258	55150-253	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-254_683b3d7b-b194-49a5-85cc-d5a4b544b258	55150-254	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-255_683b3d7b-b194-49a5-85cc-d5a4b544b258	55150-255	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-256_683b3d7b-b194-49a5-85cc-d5a4b544b258	55150-256	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Eugia US LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55150-259_ccd128d5-3c14-4d66-b989-25fd875360a4	55150-259	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20160229		ANDA	ANDA207358	Eugia US LLC	ACETYLCYSTEINE	6	g/30mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
55150-262_3788596f-603d-47b4-bd9e-7a944c5d07d8	55150-262	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151215		ANDA	ANDA207667	AuroMedics Pharma LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-263_3788596f-603d-47b4-bd9e-7a944c5d07d8	55150-263	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151215		ANDA	ANDA207667	AuroMedics Pharma LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-264_3788596f-603d-47b4-bd9e-7a944c5d07d8	55150-264	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151215		ANDA	ANDA207667	AuroMedics Pharma LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	500	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-265_3788596f-603d-47b4-bd9e-7a944c5d07d8	55150-265	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone Sodium Succinate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151215		ANDA	ANDA207667	AuroMedics Pharma LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	2	g/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-266_c85e7c96-b74d-41ee-a07a-c3bc44ca4fc8	55150-266	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160926		ANDA	ANDA207751	AuroMedics Pharma LLC	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
55150-267_5252b3d9-df12-4b15-b4b3-7aa52cbc1d9c	55150-267	HUMAN PRESCRIPTION DRUG	FLUPHENAZINE DECANOATE		FLUPHENAZINE DECANOATE	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20171017		ANDA	ANDA207739	Eugia US LLC	FLUPHENAZINE DECANOATE	125	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55150-270_555e9fb0-74b8-4f52-8142-24f611c3d1b8	55150-270	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20210825		NDA	NDA210735	AuroMedics Pharma LLC	CYCLOPHOSPHAMIDE	500	mg/2.5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
55150-270_7b2418f8-8581-4f47-8861-b9dee79fa6bb	55150-270	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20231120		NDA	NDA210735	Eugia US LLC	CYCLOPHOSPHAMIDE	500	mg/2.5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20251231
55150-271_555e9fb0-74b8-4f52-8142-24f611c3d1b8	55150-271	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20210825		NDA	NDA210735	AuroMedics Pharma LLC	CYCLOPHOSPHAMIDE	1	g/5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
55150-271_7b2418f8-8581-4f47-8861-b9dee79fa6bb	55150-271	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20231120		NDA	NDA210735	Eugia US LLC	CYCLOPHOSPHAMIDE	1	g/5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20251231
55150-272_7b2418f8-8581-4f47-8861-b9dee79fa6bb	55150-272	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION	INTRAVENOUS	20231120		NDA	NDA210735	Eugia US LLC	CYCLOPHOSPHAMIDE	2	g/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20251231
55150-273_4985bf3c-abe5-4bbb-9dcc-6de387d36d6b	55150-273	HUMAN PRESCRIPTION DRUG	Thiamine Hydrochloride		Thiamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220420		ANDA	ANDA208703	AuroMedics Pharma LLC	THIAMINE HYDROCHLORIDE	200	mg/2mL			N	20241231
55150-276_f901e2b2-f143-4237-8e95-0d134585490b	55150-276	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20231020		ANDA	ANDA211817	Eugia US LLC	TESTOSTERONE CYPIONATE	1000	mg/10mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
55150-277_f901e2b2-f143-4237-8e95-0d134585490b	55150-277	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20231020		ANDA	ANDA211817	Eugia US LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
55150-278_f901e2b2-f143-4237-8e95-0d134585490b	55150-278	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20231020		ANDA	ANDA211817	Eugia US LLC	TESTOSTERONE CYPIONATE	2000	mg/10mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
55150-282_a28ffcd6-2f2d-4a14-aa19-d31450e03a67	55150-282	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180625		ANDA	ANDA209133	Eugia US LLC	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
55150-282_f59ba76a-bae0-445d-a895-e4dec82f3766	55150-282	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180625		ANDA	ANDA209133	Eugia US LLC	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
55150-283_7da711ff-37df-49be-a42a-11148573499a	55150-283	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20171208		ANDA	ANDA209125	Eugia US LLC	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
55150-284_17bd5e7a-d7ad-4a4f-aba1-51fb73fb502b	55150-284	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20201027		ANDA	ANDA209665	Eugia US LLC	CISATRACURIUM BESYLATE	10	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-286_17bd5e7a-d7ad-4a4f-aba1-51fb73fb502b	55150-286	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20200508		ANDA	ANDA209144	Eugia US LLC	CISATRACURIUM BESYLATE	20	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
55150-287_1c966c02-f3de-40dd-83ec-1bc2a3de2c7f	55150-287	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate in 5% Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20200903		ANDA	ANDA209666	Eugia US LLC	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
55150-288_1c966c02-f3de-40dd-83ec-1bc2a3de2c7f	55150-288	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate in 5% Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20200903		ANDA	ANDA209666	Eugia US LLC	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
55150-292_eea49fec-ee88-4ac2-bc4f-5ff7a7b1bbda	55150-292	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181128		ANDA	ANDA210244	AuroMedics Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55150-293_eea49fec-ee88-4ac2-bc4f-5ff7a7b1bbda	55150-293	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181128		ANDA	ANDA210244	AuroMedics Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55150-294_eea49fec-ee88-4ac2-bc4f-5ff7a7b1bbda	55150-294	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181128		ANDA	ANDA210244	AuroMedics Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55150-295_eea49fec-ee88-4ac2-bc4f-5ff7a7b1bbda	55150-295	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181128		ANDA	ANDA210244	AuroMedics Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55150-296_cc0d3661-5f2e-43fb-a2ae-7d3f89c7e58c	55150-296	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20201207		ANDA	ANDA210321	Eugia US LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
55150-297_cc0d3661-5f2e-43fb-a2ae-7d3f89c7e58c	55150-297	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20201207		ANDA	ANDA210321	Eugia US LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
55150-299_8d16627d-e2ed-468f-b3e7-4c53d3371724	55150-299	HUMAN PRESCRIPTION DRUG	FOSAPREPITANT DIMEGLUMINE		FOSAPREPITANT DIMEGLUMINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210112		ANDA	ANDA210625	Eugia US LLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
55150-300_eb69ad14-eb6e-450c-a9db-4afc4283db5a	55150-300	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210107		ANDA	ANDA210696	AuroMedics Pharma LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55150-301_83623537-573d-40fc-8a40-e6beabf72c8c	55150-301	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20201113		ANDA	ANDA210697	Eugia US LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55150-302_83623537-573d-40fc-8a40-e6beabf72c8c	55150-302	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20201113		ANDA	ANDA210697	Eugia US LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55150-304_6cea7d09-202b-45f7-a0d4-7c9f42d3fad1	55150-304	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200605		ANDA	ANDA210966	Eugia US LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-305_a3d81504-0718-4e8a-999b-2017f5a4b914	55150-305	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190607		ANDA	ANDA210967	Eugia US LLC	DEXAMETHASONE SODIUM PHOSPHATE	100	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-306_44ca9ab1-7336-4914-b059-79559747ac39	55150-306	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	INJECTION, SOLUTION	INTRAMUSCULAR	20181206		ANDA	ANDA210965	Eugia US LLC	PROGESTERONE	50	mg/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
55150-307_ddbd820d-6245-44a7-b539-3c6813ffa58a	55150-307	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20201021		ANDA	ANDA210969	Eugia US LLC	ACETAMINOPHEN	10	mg/mL			N	20241231
55150-308_bf04f518-1842-4b07-8c54-95a725f88837	55150-308	HUMAN PRESCRIPTION DRUG	OLANZAPINE		OLANZAPINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20201022		ANDA	ANDA210968	Eugia US LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55150-311_b8f27635-ad16-41d2-a667-eaf51437947a	55150-311	HUMAN PRESCRIPTION DRUG	Hydroxyprogesterone Caproate		Hydroxyprogesterone Caproate	INJECTION	INTRAMUSCULAR	20190509		ANDA	ANDA211142	AuroMedics Pharma LLC	HYDROXYPROGESTERONE CAPROATE	1250	mg/5mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
55150-313_a0cbcdb5-f657-49f7-8f86-cc5959d69db0	55150-313	HUMAN PRESCRIPTION DRUG	Methylprednisolone Acetate		Methylprednisolone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20230413		ANDA	ANDA211930	Eugia US LLC	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-314_a0cbcdb5-f657-49f7-8f86-cc5959d69db0	55150-314	HUMAN PRESCRIPTION DRUG	Methylprednisolone Acetate		Methylprednisolone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20230413		ANDA	ANDA211930	Eugia US LLC	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-315_1b3f3c63-0500-4c0a-8ac2-3d525ccf4537	55150-315	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		succinylcholine chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231016		ANDA	ANDA217808	Eugia US LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
55150-316_60214a42-889a-48c7-b8fa-1ec064a9695e	55150-316	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210209		ANDA	ANDA211864	AuroMedics Pharma LLC	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
55150-317_60214a42-889a-48c7-b8fa-1ec064a9695e	55150-317	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210209		ANDA	ANDA211864	AuroMedics Pharma LLC	ISOPROTERENOL HYDROCHLORIDE	1	mg/5mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
55150-318_2964c0f8-7fa2-438d-bc34-173e06ad3be9	55150-318	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR	20200707		ANDA	ANDA211816	Eugia US LLC	CHLORPROMAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55150-319_2964c0f8-7fa2-438d-bc34-173e06ad3be9	55150-319	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR	20200707		ANDA	ANDA211816	Eugia US LLC	CHLORPROMAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55150-320_41e11afb-5fa4-4212-889d-1092dbd0702a	55150-320	HUMAN PRESCRIPTION DRUG	SODIUM NITROPRUSSIDE		SODIUM NITROPRUSSIDE	INJECTION	INTRAVENOUS	20201210		ANDA	ANDA211934	AuroMedics Pharma LLC	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
55150-321_171272c7-d76e-4352-81bc-fcb40386d7d0	55150-321	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230202		ANDA	ANDA212162	Eugia US LLC	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55150-322_115c774a-520c-4a73-90b3-f7dc0dc38036	55150-322	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190503		ANDA	ANDA212174	AuroMedics Pharma LLC	FUROSEMIDE	20	mg/2mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55150-323_115c774a-520c-4a73-90b3-f7dc0dc38036	55150-323	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190503		ANDA	ANDA212174	AuroMedics Pharma LLC	FUROSEMIDE	40	mg/4mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55150-324_115c774a-520c-4a73-90b3-f7dc0dc38036	55150-324	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190503		ANDA	ANDA212174	AuroMedics Pharma LLC	FUROSEMIDE	100	mg/10mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55150-326_18adf4af-63ed-41e6-ab59-87085ce3e5fb	55150-326	HUMAN PRESCRIPTION DRUG	CLOFARABINE		CLOFARABINE	INJECTION	INTRAVENOUS	20221003		ANDA	ANDA212457	Eugia US LLC	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55150-327_7c489f03-5a4f-45a8-8d54-1324c02207d3	55150-327	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191015		ANDA	ANDA212455	Eugia US LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
55150-328_858b305f-4438-4399-8b8c-b40c6312c0de	55150-328	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191104		ANDA	ANDA212456	Eugia US LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
55150-329_c9f7d676-5c95-4cc3-b5fb-bc3e8d545847	55150-329	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20220822		ANDA	ANDA212824	Eugia US LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
55150-330_f7e90e69-fe05-4699-8d2e-a888e11fe1da	55150-330	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20220831		ANDA	ANDA212844	Eugia US LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
55150-331_414e3206-0454-4cf2-847f-4d035b49b532	55150-331	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20170921		ANDA	ANDA205529	Eugia US LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
55150-332_414e3206-0454-4cf2-847f-4d035b49b532	55150-332	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20170921		ANDA	ANDA205529	Eugia US LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
55150-333_cfbace29-2dee-41d7-9025-8cc963adbc79	55150-333	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20160929		ANDA	ANDA205487	Eugia US LLC	CARBOPLATIN	50	mg/5mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
55150-334_cfbace29-2dee-41d7-9025-8cc963adbc79	55150-334	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20160929		ANDA	ANDA205487	Eugia US LLC	CARBOPLATIN	150	mg/15mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
55150-335_cfbace29-2dee-41d7-9025-8cc963adbc79	55150-335	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20160929		ANDA	ANDA205487	Eugia US LLC	CARBOPLATIN	450	mg/45mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
55150-337_9ee55070-7613-47ec-b52c-d2650fb3ae8b	55150-337	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		BORTEZOMIB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502		ANDA	ANDA212825	Eugia US LLC	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
55150-339_f4bc4992-0f90-42aa-827c-fa90158dd522	55150-339	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201020		ANDA	ANDA212939	Eugia US LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55150-340_f4bc4992-0f90-42aa-827c-fa90158dd522	55150-340	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201020		ANDA	ANDA212939	Eugia US LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55150-341_f4bc4992-0f90-42aa-827c-fa90158dd522	55150-341	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20201020		ANDA	ANDA212939	Eugia US LLC	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55150-342_efd433ac-b10b-48e4-bda2-4d0395062d34	55150-342	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200706		ANDA	ANDA212965	Eugia US LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55150-343_efd433ac-b10b-48e4-bda2-4d0395062d34	55150-343	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200706		ANDA	ANDA212965	Eugia US LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55150-344_2106b93b-565c-43f9-9432-c5787c3aab5e	55150-344	HUMAN PRESCRIPTION DRUG	DAPTOMYCIN		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210902		ANDA	ANDA213171	Eugia US LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
55150-345_c752f856-09d0-43ad-8563-3850ea11996d	55150-345	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210114		ANDA	ANDA213279	Eugia US LLC	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
55150-348_c5729883-88d7-40fe-8fe4-fe39204ccb30	55150-348	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20231102		ANDA	ANDA213244	Eugia US LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55150-349_c5729883-88d7-40fe-8fe4-fe39204ccb30	55150-349	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20231102		ANDA	ANDA213244	Eugia US LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55150-351_56d5047e-3f99-4100-af4f-388870986ced	55150-351	HUMAN PRESCRIPTION DRUG	Icatibant		Icatibant	INJECTION, SOLUTION	SUBCUTANEOUS	20230814		ANDA	ANDA213521	Eugia US LLC	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
55150-352_4b122664-72ee-402e-a2b3-806c236f486c	55150-352	HUMAN PRESCRIPTION DRUG	IRINOTECAN HYDROCHLORIDE		IRINOTECAN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200211		ANDA	ANDA213278	Eugia US LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
55150-353_4b122664-72ee-402e-a2b3-806c236f486c	55150-353	HUMAN PRESCRIPTION DRUG	IRINOTECAN HYDROCHLORIDE		IRINOTECAN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200211		ANDA	ANDA213278	Eugia US LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
55150-354_4b122664-72ee-402e-a2b3-806c236f486c	55150-354	HUMAN PRESCRIPTION DRUG	IRINOTECAN HYDROCHLORIDE		IRINOTECAN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200211		ANDA	ANDA213278	Eugia US LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
55150-355_4b122664-72ee-402e-a2b3-806c236f486c	55150-355	HUMAN PRESCRIPTION DRUG	IRINOTECAN HYDROCHLORIDE		IRINOTECAN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220411		ANDA	ANDA213278	Eugia US LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
55150-356_bd79333b-3bf1-4f64-85a4-ccee347b7f79	55150-356	HUMAN PRESCRIPTION DRUG	Plerixafor		Plerixafor	SOLUTION	SUBCUTANEOUS	20230724		ANDA	ANDA213672	Eugia US LLC	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
55150-357_3376536b-043d-478a-b129-7ce11ec94e3e	55150-357	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20220124		ANDA	ANDA213717	AuroMedics Pharma LLC	DOXERCALCIFEROL	2	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
55150-358_3376536b-043d-478a-b129-7ce11ec94e3e	55150-358	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20220124		ANDA	ANDA213717	AuroMedics Pharma LLC	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
55150-359_3376536b-043d-478a-b129-7ce11ec94e3e	55150-359	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20220124		ANDA	ANDA213717	AuroMedics Pharma LLC	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
55150-360_24358d03-d06d-4946-8ebd-a62bc15d33c0	55150-360	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220714		ANDA	ANDA213873	AuroMedics Pharma LLC	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55150-364_a0566c8d-7cb0-4ee7-8599-f2e8dc8992c7	55150-364	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR	20201208		ANDA	ANDA213874	AuroMedics Pharma LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
55150-365_6f24975c-5191-4fc2-a8da-e57358f8e154	55150-365	HUMAN PRESCRIPTION DRUG	Amphotericin B		Amphotericin B	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221117		ANDA	ANDA214010	Eugia US LLC	AMPHOTERICIN B	50	mg/12.5mL	Lipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
55150-366_2a999752-f350-4eff-97e7-e7106dfa85b5	55150-366	HUMAN PRESCRIPTION DRUG	ARSENIC TRIOXIDE		ARSENIC TRIOXIDE	INJECTION, SOLUTION	INTRAVENOUS	20211015		ANDA	ANDA214011	AuroMedics Pharma LLC	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
55150-370_85e3dc1e-98ae-4c4c-8af9-237375475e08	55150-370	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION	INTRAVENOUS	20220815		ANDA	ANDA214314	Eugia US LLC	VASOPRESSIN	20	[USP'U]/mL			N	20241231
55150-370_bb178f2e-887f-4d63-a579-883295e7ef93	55150-370	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION	INTRAVENOUS	20220815		ANDA	ANDA214314	Eugia US LLC	VASOPRESSIN	20	[USP'U]/mL			N	20241231
55150-373_f4afb298-f2e7-45b4-8c14-fb31db883179	55150-373	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20210614		ANDA	ANDA214579	AuroMedics Pharma LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55150-376_2c794637-f383-49c6-9f3d-6bcc25e79e66	55150-376	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210920		ANDA	ANDA214569	Eugia US LLC	DECITABINE	50	mg/26mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55150-378_1263799c-13dc-488b-b158-b834736a4e66	55150-378	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20210625		ANDA	ANDA214575	AuroMedics Pharma LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
55150-379_1263799c-13dc-488b-b158-b834736a4e66	55150-379	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20210625		ANDA	ANDA214575	AuroMedics Pharma LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
55150-380_1263799c-13dc-488b-b158-b834736a4e66	55150-380	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20210625		ANDA	ANDA214575	AuroMedics Pharma LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
55150-381_d9465d8d-67cb-4650-8c84-a9293d45ac92	55150-381	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA214632	Eugia US LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
55150-382_d9465d8d-67cb-4650-8c84-a9293d45ac92	55150-382	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA214632	Eugia US LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
55150-383_d9465d8d-67cb-4650-8c84-a9293d45ac92	55150-383	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA214632	Eugia US LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	1000	mg/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
55150-384_d9abdda5-80e3-407c-b636-9cc5fc438098	55150-384	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR; SOFT TISSUE	20220705		ANDA	ANDA212400	AuroMedics Pharma LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-385_d9abdda5-80e3-407c-b636-9cc5fc438098	55150-385	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR; SOFT TISSUE	20220705		ANDA	ANDA212400	AuroMedics Pharma LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55150-386_cfbace29-2dee-41d7-9025-8cc963adbc79	55150-386	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20200803		ANDA	ANDA205487	Eugia US LLC	CARBOPLATIN	600	mg/60mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
55150-388_2e88e379-b712-4dec-97a2-c90ef3638372	55150-388	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		POSACONAZOLE	INJECTION	INTRAVENOUS	20231226		ANDA	ANDA214842	Eugia US LLC	POSACONAZOLE	18	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55150-391_4357b1f0-fcc2-448a-9580-13b55ba470de	55150-391	HUMAN PRESCRIPTION DRUG	BENDAMUSTINE HYDROCHLORIDE		BENDAMUSTINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230605		ANDA	ANDA214739	Eugia US LLC	BENDAMUSTINE HYDROCHLORIDE	25	mg/5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
55150-392_4357b1f0-fcc2-448a-9580-13b55ba470de	55150-392	HUMAN PRESCRIPTION DRUG	BENDAMUSTINE HYDROCHLORIDE		BENDAMUSTINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230605		ANDA	ANDA214739	Eugia US LLC	BENDAMUSTINE HYDROCHLORIDE	100	mg/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
55150-393_23509cbb-fa31-4369-98d1-2ce454828db9	55150-393	HUMAN PRESCRIPTION DRUG	AZACITIDINE		AZACITIDINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230103		ANDA	ANDA215066	Eugia US LLC	AZACITIDINE	100	mg/4mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
55150-394_558b7451-9561-440f-bfee-38f1d5528299	55150-394	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAVENOUS	20230630		ANDA	ANDA215169	Eugia US LLC	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
55150-400_334b418c-b6d9-4bde-a046-70a5dd73076f	55150-400	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230213		ANDA	ANDA215147	Eugia US LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55150-401_f8c608b3-50b8-4d5d-9e8a-e92c0d2e3cdc	55150-401	HUMAN PRESCRIPTION DRUG	Gentamicin		Gentamicin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20240108		ANDA	ANDA215236	Eugia US LLC	GENTAMICIN SULFATE	10	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
55150-402_60ca1487-392d-4721-aa45-3de38722896c	55150-402	HUMAN PRESCRIPTION DRUG	Gentamicin		Gentamicin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20240108		ANDA	ANDA215237	Eugia US LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
55150-403_60ca1487-392d-4721-aa45-3de38722896c	55150-403	HUMAN PRESCRIPTION DRUG	Gentamicin		Gentamicin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20240108		ANDA	ANDA215237	Eugia US LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
55150-420_b6fe7379-bb70-414a-9f92-bba99036ff05	55150-420	HUMAN PRESCRIPTION DRUG	esmolol hydrochloride		esmolol hydrochloride in sodium chloride	INJECTION	INTRAVENOUS	20220321		ANDA	ANDA216244	Eugia US LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55150-421_b6fe7379-bb70-414a-9f92-bba99036ff05	55150-421	HUMAN PRESCRIPTION DRUG	esmolol hydrochloride		esmolol hydrochloride in sodium chloride	INJECTION	INTRAVENOUS	20220321		ANDA	ANDA216244	Eugia US LLC	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55150-425_3c5a9f21-bd94-4058-9222-0480d91e755a	55150-425	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230329		ANDA	ANDA216552	Eugia US LLC	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
55150-426_3c5a9f21-bd94-4058-9222-0480d91e755a	55150-426	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230329		ANDA	ANDA216552	Eugia US LLC	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
55150-427_3c5a9f21-bd94-4058-9222-0480d91e755a	55150-427	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230329		ANDA	ANDA216552	Eugia US LLC	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
55150-429_1751523a-e22e-4faf-bdb1-c850afe2fd36	55150-429	HUMAN PRESCRIPTION DRUG	Tirofiban		Tirofiban	INJECTION, SOLUTION	INTRAVENOUS	20230501		ANDA	ANDA216379	Eugia US LLC	TIROFIBAN HYDROCHLORIDE	5	mg/100mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
55150-430_1751523a-e22e-4faf-bdb1-c850afe2fd36	55150-430	HUMAN PRESCRIPTION DRUG	Tirofiban		Tirofiban	INJECTION, SOLUTION	INTRAVENOUS	20230501		ANDA	ANDA216379	Eugia US LLC	TIROFIBAN HYDROCHLORIDE	12.5	mg/250mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
55150-431_ea070887-e81e-4998-87ae-86f52718d003	55150-431	HUMAN PRESCRIPTION DRUG	DACTINOMYCIN		DACTINOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210315		ANDA	ANDA203385	Eugia US LLC	DACTINOMYCIN	.5	mg/mL	Actinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]		N	20241231
55150-434_cb72203a-0b09-42d5-bf51-7f479feb3adb	55150-434	HUMAN PRESCRIPTION DRUG	DEXRAZOXANE		DEXRAZOXANE	KIT		20160512		ANDA	ANDA200752	AuroMedics Pharma LLC						N	20241231
55150-434_d46a20d7-9c50-4e05-b491-61e7ac3088a7	55150-434	HUMAN PRESCRIPTION DRUG	DEXRAZOXANE		DEXRAZOXANE	KIT		20160512		ANDA	ANDA200752	Eugia US LLC						N	20241231
55150-437_d46a20d7-9c50-4e05-b491-61e7ac3088a7	55150-437	HUMAN PRESCRIPTION DRUG	DEXRAZOXANE		DEXRAZOXANE	KIT		20160512		ANDA	ANDA200752	Eugia US LLC						N	20241231
55150-438_f8e2e509-789f-46af-9e08-765619eaf3ba	55150-438	HUMAN PRESCRIPTION DRUG	KETAMINE HYDROCHLORIDE		KETAMINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210315		ANDA	ANDA076092	AuroMedics Pharma LLC	KETAMINE HYDROCHLORIDE	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
55150-439_f8e2e509-789f-46af-9e08-765619eaf3ba	55150-439	HUMAN PRESCRIPTION DRUG	KETAMINE HYDROCHLORIDE		KETAMINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210315		ANDA	ANDA076092	AuroMedics Pharma LLC	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
55150-440_f8e2e509-789f-46af-9e08-765619eaf3ba	55150-440	HUMAN PRESCRIPTION DRUG	KETAMINE HYDROCHLORIDE		KETAMINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210315		ANDA	ANDA076092	AuroMedics Pharma LLC	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
55150-443_c82d9c48-e9fd-489b-a9f3-7a28f42d0a1e	55150-443	HUMAN PRESCRIPTION DRUG	regadenoson		regadenoson	INJECTION	INTRAVENOUS	20221026		ANDA	ANDA216437	Eugia US LLC	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
55150-450_f5a010cf-5954-4e6d-acfa-fb414efdf471	55150-450	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231030		ANDA	ANDA216732	Eugia US LLC	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
55150-451_f5a010cf-5954-4e6d-acfa-fb414efdf471	55150-451	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231030		ANDA	ANDA216732	Eugia US LLC	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
55150-452_f5a010cf-5954-4e6d-acfa-fb414efdf471	55150-452	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231030		ANDA	ANDA216732	Eugia US LLC	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
55150-459_a4c3b724-8c36-4d18-86b1-5ecee40cfbf4	55150-459	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		CARBOPROST TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20230525		ANDA	ANDA216939	Eugia US LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
55150-470_c37c251f-92e9-40f0-8b0c-00d42875d776	55150-470	HUMAN PRESCRIPTION DRUG	TOBRAMYCIN		TOBRAMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230621		ANDA	ANDA217519	Eugia US LLC	TOBRAMYCIN SULFATE	1.2	g/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
55150-471_9aa42538-c84e-4886-8d3d-a7dfded5120f	55150-471	HUMAN PRESCRIPTION DRUG	Vancomycin hydrochloride		Vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230804		ANDA	ANDA217401	Eugia US LLC	VANCOMYCIN HYDROCHLORIDE	1.25	g/25mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
55150-472_9aa42538-c84e-4886-8d3d-a7dfded5120f	55150-472	HUMAN PRESCRIPTION DRUG	Vancomycin hydrochloride		Vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230804		ANDA	ANDA217401	Eugia US LLC	VANCOMYCIN HYDROCHLORIDE	1.5	g/30mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
55150-473_80f4bdb8-131e-4485-b7a2-accd596d4cde	55150-473	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231012		ANDA	ANDA217409	Eugia US LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/250mL; g/250mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-474_80f4bdb8-131e-4485-b7a2-accd596d4cde	55150-474	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231012		ANDA	ANDA217409	Eugia US LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	12; 1.5	g/100mL; g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55150-478_b6e5202f-3892-4dae-9364-4395d99014d3	55150-478	HUMAN PRESCRIPTION DRUG	LEUPROLIDE ACETATE		LEUPROLIDE ACETATE	KIT		20220606		ANDA	ANDA212963	Eugia US LLC						N	20241231
55150-928_5da55538-2602-4704-a9da-603c9f7ff7dc	55150-928	HUMAN PRESCRIPTION DRUG	DACTINOMYCIN		DACTINOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210315		ANDA	ANDA203385	AuroMedics Pharma LLC	DACTINOMYCIN	.5	mg/mL	Actinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]		N	20241231
55151-123_82a1acde-bda0-4091-9872-eb5bae976bae	55151-123	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20110101		UNAPPROVED MEDICAL GAS		E-Z Oxygen LLC, dba AO2	OXYGEN	99	L/100L			N	20241231
55154-0120_c6bde6b7-d4a7-4155-b158-1760e4649753	55154-0120	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110727		ANDA	ANDA074802	Cardinal Health 107, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-0124_cdf86398-ce7b-425e-b1db-4f4b032a57ea	55154-0124	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE ANHYDROUS	INJECTION, SOLUTION	INFILTRATION	20100330		ANDA	ANDA088299	Cardinal Health 107, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55154-0126_e0cbabde-aee5-48cc-864f-86f2bcffc10b	55154-0126	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20110908		NDA	NDA018803	Cardinal Health 107, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
55154-0127_a59b50d5-e39c-426b-b1c2-fbce60cff0f6	55154-0127	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20110915		NDA	NDA018801	Cardinal Health 107, LLC	WATER	1	mL/mL			N	20241231
55154-0132_db20c49e-fd0c-4ae8-af26-fe0d6b4983aa	55154-0132	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride and Epinephrine		lidocaine hydrochloride anhydrous and epinephrine	INJECTION, SOLUTION	INFILTRATION	20100405		ANDA	ANDA089644	Cardinal Health 107, LLC	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	10; 10	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55154-0253_b868ac0f-549b-4e58-aee3-dace665ed68c	55154-0253	HUMAN PRESCRIPTION DRUG	Prevacid		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20020830		NDA	NDA021428	Cardinal Health 107, LLC	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-0256_d1858181-7949-43f3-82e4-5583451bef3e	55154-0256	HUMAN PRESCRIPTION DRUG	Trintellix		vortioxetine	TABLET, FILM COATED	ORAL	20131002		NDA	NDA204447	Cardinal Health 107, LLC	VORTIOXETINE HYDROBROMIDE	10	mg/1			N	20241231
55154-0257_d1858181-7949-43f3-82e4-5583451bef3e	55154-0257	HUMAN PRESCRIPTION DRUG	Trintellix		vortioxetine	TABLET, FILM COATED	ORAL	20131002		NDA	NDA204447	Cardinal Health 107, LLC	VORTIOXETINE HYDROBROMIDE	20	mg/1			N	20241231
55154-0410_b3054328-9fd6-4abb-bc33-a27d4d358d55	55154-0410	HUMAN PRESCRIPTION DRUG	Tradjenta		linagliptin	TABLET, FILM COATED	ORAL	20110509		NDA	NDA201280	Cardinal Health 107, LLC	LINAGLIPTIN	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
55154-0411_f0f16ffd-a85d-4ffd-a759-b0ffcfa0e9c3	55154-0411	HUMAN PRESCRIPTION DRUG	Jardiance		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	Cardinal Health 107, LLC	EMPAGLIFLOZIN	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
55154-0412_f0f16ffd-a85d-4ffd-a759-b0ffcfa0e9c3	55154-0412	HUMAN PRESCRIPTION DRUG	Jardiance		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	Cardinal Health 107, LLC	EMPAGLIFLOZIN	25	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
55154-0450_af9449dc-87aa-43d2-96c4-db47a8fb785b	55154-0450	HUMAN PRESCRIPTION DRUG	Metoclopramide hydrochloride		Metoclopramide hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19931210		ANDA	ANDA073135	Cardinal Health 107, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
55154-0612_ffe84b7b-1dac-4000-9169-7c6e4c98528e	55154-0612	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	Cardinal Health 107, LLC	APIXABAN	2.5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55154-0613_ffe84b7b-1dac-4000-9169-7c6e4c98528e	55154-0613	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	Cardinal Health 107, LLC	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55154-0661_02f81a9d-0650-4813-8b5f-96573efeddf8	55154-0661	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	CAPSULE	ORAL	20090102		OTC MONOGRAPH DRUG	M017	Cardinal Health 107, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55154-0669_d0cfec92-1f44-4c28-a333-4b259918ea2f	55154-0669	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20110603		ANDA	ANDA075139	Cardinal Health 107, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-0683_3a561e67-75b5-4bc1-9c25-dd1812a9ce64	55154-0683	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	CAPSULE	ORAL	20110603	20250731	OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55154-0741_4340a970-62b3-4b0b-bc94-01d943a41eeb	55154-0741	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090610		ANDA	ANDA075682	Cardinal Health 107, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-1341_1c737dbb-c86a-47ec-b433-a59d46ff121f	55154-1341	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20070216		ANDA	ANDA076001	Cardinal Health 107, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-1342_4340a970-62b3-4b0b-bc94-01d943a41eeb	55154-1342	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090610		ANDA	ANDA075682	Cardinal Health 107, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-1380_4340a970-62b3-4b0b-bc94-01d943a41eeb	55154-1380	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090610		ANDA	ANDA075682	Cardinal Health 107, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-1396_4df9bfa8-251b-4dcd-9203-797a366e9058	55154-1396	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20100920		ANDA	ANDA077272	Cardinal Health 107, LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-1398_d27c5b74-1b92-4494-840d-bbf4f03fe568	55154-1398	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Cardinal Health 107, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
55154-1422_aae845b9-675d-470d-94db-cbf2f4ddcba5	55154-1422	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20110701		NDA	NDA022406	Cardinal Health 107, LLC	RIVAROXABAN	10	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55154-1423_aae845b9-675d-470d-94db-cbf2f4ddcba5	55154-1423	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20111105		NDA	NDA202439	Cardinal Health 107, LLC	RIVAROXABAN	20	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55154-1424_aae845b9-675d-470d-94db-cbf2f4ddcba5	55154-1424	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20111104		NDA	NDA202439	Cardinal Health 107, LLC	RIVAROXABAN	15	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
55154-1425_10016e4f-3a2a-4e7b-9cc0-5ec5d378f484	55154-1425	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	Cardinal Health 107, LLC	CANAGLIFLOZIN	100	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
55154-1426_10016e4f-3a2a-4e7b-9cc0-5ec5d378f484	55154-1426	HUMAN PRESCRIPTION DRUG	INVOKANA		canagliflozin	TABLET, FILM COATED	ORAL	20130329		NDA	NDA204042	Cardinal Health 107, LLC	CANAGLIFLOZIN	300	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
55154-1495_03517b55-cc47-4d19-a430-a2a192053b0f	55154-1495	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20110601		ANDA	ANDA091426	Cardinal Health 107, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
55154-1555_bf9124d3-6d81-46b7-aee1-b48940a960e1	55154-1555	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200103		ANDA	ANDA204216	Cardinal Health 107, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-1556_bf9124d3-6d81-46b7-aee1-b48940a960e1	55154-1556	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200103		ANDA	ANDA204216	Cardinal Health 107, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-1557_00d2bff1-6f3d-4425-9d09-a3d6dd4f1f71	55154-1557	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	INJECTION, SOLUTION	INTRAVENOUS	20200331		ANDA	ANDA204205	Cardinal Health 107, LLC	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-1577_e40755b8-63db-4756-a38f-938af271c834	55154-1577	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20040413		ANDA	ANDA074937	Cardinal Health 107, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-1578_0b2d8c88-351d-4f89-b113-96389498b376	55154-1578	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20051215		ANDA	ANDA062512	Cardinal Health 107, LLC	NYSTATIN	500000	[USP'U]/5mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
55154-1980_7cfdeeec-1613-4c07-a976-29c2cefc53e6	55154-1980	HUMAN PRESCRIPTION DRUG	DASH Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	LIQUID	ORAL	20180425		ANDA	ANDA074291	Cardinal Health 107, LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20251231
55154-1981_d4b4c6cc-b9e7-4848-b10b-121d05255c26	55154-1981	HUMAN PRESCRIPTION DRUG	DASH Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	LIQUID	ORAL	20180425		ANDA	ANDA074291	Cardinal Health 107, LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20251231
55154-2064_919592d4-651c-467f-ad78-6fab14f86b9e	55154-2064	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20091221	20240229	ANDA	ANDA040625	Cardinal Health 107, LLC	FOLIC ACID	1	mg/1			N	
55154-2065_9963ec18-aa0b-4e98-9cbf-11e7d00b960a	55154-2065	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090922		ANDA	ANDA077633	Cardinal Health 107, LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
55154-2074_20dd875f-99dd-4831-825e-a883c852aa28	55154-2074	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080805		ANDA	ANDA040657	Cardinal Health 107, LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
55154-2082_76c05e84-b54b-4a61-8f62-fe944599c17f	55154-2082	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20080318		ANDA	ANDA086242	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55154-2083_76c05e84-b54b-4a61-8f62-fe944599c17f	55154-2083	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20080318		ANDA	ANDA086242	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55154-2089_dc4aa115-3efb-4761-a780-2bbb039792a1	55154-2089	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101012		ANDA	ANDA078243	Cardinal Health 107, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55154-2126_8369d630-3837-48bb-a10e-83c9035c26fb	55154-2126	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20100618		ANDA	ANDA077739	Cardinal Health 107, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-2127_9d594778-c31d-4604-903b-b965ab7f0a77	55154-2127	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20150210		ANDA	ANDA087479	Cardinal Health 107, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55154-2128_aede363d-2272-4ffb-a9ff-edbeb8f32455	55154-2128	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180123		ANDA	ANDA077321	Cardinal Health 107, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55154-2129_94399b34-50e2-4e0b-83c7-69d3b0a99480	55154-2129	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20200325		ANDA	ANDA090200	Cardinal Health 107, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55154-2130_94399b34-50e2-4e0b-83c7-69d3b0a99480	55154-2130	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20200325		ANDA	ANDA090200	Cardinal Health 107, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55154-2132_6ec88f64-66a2-4ca9-9913-c192fc33f88b	55154-2132	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20230116		ANDA	ANDA077839	Cardinal Health 107, LLC	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
55154-2133_18eb6536-3ec4-41b1-aeb8-df82ace1b28e	55154-2133	HUMAN PRESCRIPTION DRUG	IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20181215		ANDA	ANDA202496	Cardinal Health 107, LLC	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
55154-2134_51350fab-a919-4d97-9d0c-d9dc7286244c	55154-2134	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20181226		ANDA	ANDA075693	Cardinal Health 107, LLC	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55154-2137_6dd867fe-597e-4915-8baf-98a605bf9324	55154-2137	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20220525		ANDA	ANDA040625	Cardinal Health 107, LLC	FOLIC ACID	1	mg/1			N	20241231
55154-2138_95229a3d-0de2-4c7b-a107-3c2ed057bf51	55154-2138	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA215939	Cardinal Health 107, LLC	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-2139_95229a3d-0de2-4c7b-a107-3c2ed057bf51	55154-2139	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA215939	Cardinal Health 107, LLC	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-2326_cdc4f6a1-1352-4b05-a4ed-f6a3112736a8	55154-2326	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Cardinal Health 107, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55154-2327_cdc4f6a1-1352-4b05-a4ed-f6a3112736a8	55154-2327	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Cardinal Health 107, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55154-2328_53e25ac5-37b6-4baa-b530-7e60d474eea2	55154-2328	HUMAN OTC DRUG	Polyethylene glycol 3350		Polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190630		ANDA	ANDA203928	Cardinal Health 107, LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55154-2329_c39c0f1a-923f-4763-b032-e892602ccfb8	55154-2329	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	Cardinal Health 107, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55154-2330_21b7a469-b3a6-49fb-bf01-20d197da28f0	55154-2330	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Cardinal Health 107, LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
55154-2331_21b7a469-b3a6-49fb-bf01-20d197da28f0	55154-2331	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Cardinal Health 107, LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
55154-2332_7f9cadaa-0446-4a66-886d-e4781c4bffa4	55154-2332	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Cardinal Health 107, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-2333_cdc4f6a1-1352-4b05-a4ed-f6a3112736a8	55154-2333	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Cardinal Health 107, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55154-2334_dbe83731-4880-47db-819a-876423cc43e3	55154-2334	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20171215		ANDA	ANDA086989	Cardinal Health 107, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55154-2335_dbe83731-4880-47db-819a-876423cc43e3	55154-2335	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130115		ANDA	ANDA086988	Cardinal Health 107, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55154-2336_c60941ec-05b4-4210-b748-a3dd517a350d	55154-2336	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Cardinal Health 107, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-2337_6ffb7c82-f780-4527-a7c3-e7d0f7b3b91e	55154-2337	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	Cardinal Health 107, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55154-2338_abbe8786-4096-4043-af75-04d85a9e6951	55154-2338	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20180208		ANDA	ANDA210117	Cardinal Health 107, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55154-2339_c31f9604-745a-44eb-88de-35b543e48637	55154-2339	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Cardinal Health 107, LLC	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-2341_e4bb9432-412e-424a-85e2-0d632c2c69a9	55154-2341	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Cardinal Health 107, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55154-2342_e4bb9432-412e-424a-85e2-0d632c2c69a9	55154-2342	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Cardinal Health 107, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55154-2344_076ebe2e-d2b3-424c-8201-d2d671b36250	55154-2344	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55154-2345_283af6d2-8ea2-4225-b2e7-a2057dbdb793	55154-2345	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20150601		ANDA	ANDA203730	Cardinal Health 107, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-2347_85505615-a19c-4f20-89d4-7595bee6d0a0	55154-2347	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, FILM COATED	ORAL	20230717		OTC MONOGRAPH DRUG	M007	Cardinal Health 107, LLC	SENNOSIDES	8.6	mg/1			N	20241231
55154-2353_92830d08-7df6-4283-882b-befb7d3e7ed3	55154-2353	HUMAN PRESCRIPTION DRUG	Metoclopramide		METOCLOPRAMIDE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20090922		ANDA	ANDA073118	Cardinal Health 107, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
55154-2364_8d58a79e-98fe-45a6-9f29-1d0f1d36cfb1	55154-2364	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100713		NDA AUTHORIZED GENERIC	NDA018667	Cardinal Health 107, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-2365_eed23602-6441-4579-9b5e-94ea8a9f749c	55154-2365	HUMAN PRESCRIPTION DRUG	Furosemide		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050228		NDA	NDA018667	Cardinal Health 107, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-2380_ebf3a7a1-af77-4710-a858-07b8755290ad	55154-2380	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20091207		ANDA	ANDA089522	Cardinal Health 107, LLC	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-2392_26b1cd0d-67d1-4113-a8b1-f9d856d57984	55154-2392	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19830815		ANDA	ANDA062420	Cardinal Health 107, LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
55154-2576_6ebfa391-4179-4309-89b8-e3f91c02481e	55154-2576	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200720		ANDA	ANDA070974	Cardinal Health 107, LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55154-2577_6ebfa391-4179-4309-89b8-e3f91c02481e	55154-2577	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200720		ANDA	ANDA070975	Cardinal Health 107, LLC	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55154-2578_1c8f04f2-fcf2-4b6d-90e4-d1118b37dd10	55154-2578	HUMAN OTC DRUG	Sennosides and Docusate Sodium		Sennosides and Docusate Sodium	TABLET	ORAL	20210803		OTC MONOGRAPH DRUG	M007	Cardinal Health 107, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
55154-2579_72cf23b2-0f13-480c-9af7-d8f19ee29a8d	55154-2579	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20230201		ANDA	ANDA090778	Cardinal Health 107, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55154-2627_bdb9e7cf-bfbb-48b4-a8be-9038820d8279	55154-2627	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230801		ANDA	ANDA205231	Cardinal Health 107, LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55154-2628_cdd5dfb7-4efb-4235-8023-5ce145c09038	55154-2628	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230809		ANDA	ANDA075718	Cardinal Health 107, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55154-2665_4dd18261-ea64-45d7-8ee8-84cc998c265e	55154-2665	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	CUTANEOUS	20130915		ANDA	ANDA200675	Cardinal Health 107, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55154-2666_1ad4ae86-8cdf-46c5-a98d-5d1333ab204e	55154-2666	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20150401		NDA	NDA021487	Cardinal Health 107, LLC	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
55154-2667_1ad4ae86-8cdf-46c5-a98d-5d1333ab204e	55154-2667	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20150401		NDA	NDA021487	Cardinal Health 107, LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
55154-2827_35b7ff7e-f1a8-46ff-88b8-75bab51f319d	55154-2827	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20100706		ANDA	ANDA090808	Cardinal Health 107, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-2861_9c630ddb-625f-4b9e-9856-04921117e474	55154-2861	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Cardinal Health 107, LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55154-2876_a8f5b2c5-c27a-4b30-a37f-de612677c9b8	55154-2876	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA077541	Cardinal Health 107, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55154-2877_45d37088-a426-4ba6-af8c-9af9932e3448	55154-2877	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA077541	Cardinal Health 107, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55154-3189_7f7ee0e1-3b7d-444d-854b-bb6168fc68f0	55154-3189	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20101129		ANDA	ANDA040302	Cardinal Health 107, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55154-3329_9f849f46-7a01-4fdb-9f08-0948b234c7fd	55154-3329	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20091102		ANDA	ANDA078216	Cardinal Health 107, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-3349_9f849f46-7a01-4fdb-9f08-0948b234c7fd	55154-3349	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20091102		ANDA	ANDA078216	Cardinal Health 107, LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-3356_ab70f3dc-708e-4455-99ff-a2b9fe2d71a3	55154-3356	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20120913		ANDA	ANDA200243	Cardinal Health 107, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
55154-3357_6fcf643e-c36a-4c6c-9f5e-f67f50256372	55154-3357	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Cardinal Health 107, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-3358_0c344e57-4fe1-41ee-b817-3c2aeaecbd98	55154-3358	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20170929		ANDA	ANDA206094	Cardinal Health 107, LLC	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55154-3359_7618b5c8-3966-43d4-96ac-192f97500969	55154-3359	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Cardinal Health 107, LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-3361_6225ea9f-55c3-4f1c-823d-00e9f059b0f8	55154-3361	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Cardinal Health 107, LLC	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-3363_0481c94e-0ca5-40b5-a586-932bda69ff0c	55154-3363	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Cardinal Health 107, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-3364_eb9ed01b-2a0c-4e22-b437-059bf7f290ac	55154-3364	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Cardinal Health 107, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
55154-3365_88e19ad1-ba4a-426f-81aa-1a6adf60bcaa	55154-3365	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20010330		ANDA	ANDA075424	Cardinal Health 107, LLC	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55154-3366_6fcf643e-c36a-4c6c-9f5e-f67f50256372	55154-3366	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Cardinal Health 107, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-3367_b90b3630-c0b9-481a-9396-53f46cfcc833	55154-3367	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Cardinal Health 107, LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-3368_198cecd9-b1fc-4c44-891f-43ed3433492c	55154-3368	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Cardinal Health 107, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
55154-3369_736ce3ba-6b8f-412f-8960-465c3b01b559	55154-3369	HUMAN OTC DRUG	Docusate Sodium - Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210904		OTC MONOGRAPH DRUG	M007	Cardinal Health 107, LLC	DOCUSATE SODIUM	100	mg/1			N	20251231
55154-3370_ae7faf40-515a-4442-9d12-0be5222939cd	55154-3370	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220707		ANDA	ANDA211347	Cardinal Health 107, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55154-3371_0d66d983-fafb-4134-b5d9-605281d6342c	55154-3371	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Cardinal Health 107, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55154-3372_b46f231a-65d3-400d-ae6b-3216830807a2	55154-3372	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Cardinal Health 107, LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
55154-3376_7b851e33-8f27-42ef-9057-a0adc4192adf	55154-3376	HUMAN PRESCRIPTION DRUG	Clopidogrel Bisulfate		Clopidogrel Bisulfate	TABLET	ORAL	20120517		ANDA	ANDA090844	Cardinal Health 107, LLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
55154-3400_f65ac7e6-27c0-4908-a91c-889a14dcec86	55154-3400	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20150625		ANDA	ANDA076658	Cardinal Health 107, LLC	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55154-3540_79e3e801-5863-449e-a4f4-a36a498e72ef	55154-3540	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-3541_79e3e801-5863-449e-a4f4-a36a498e72ef	55154-3541	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-3542_79e3e801-5863-449e-a4f4-a36a498e72ef	55154-3542	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-3543_79e3e801-5863-449e-a4f4-a36a498e72ef	55154-3543	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-3544_79e3e801-5863-449e-a4f4-a36a498e72ef	55154-3544	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20100723		ANDA	ANDA077857	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-3552_01a27cc8-b87d-43d2-96d3-230bbdcf3c9f	55154-3552	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	CAPSULE	ORAL	20090123		ANDA	ANDA078979	Cardinal Health 107, LLC	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-3554_45132fa1-6697-41ae-8ab1-ab40161e215b	55154-3554	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	19990224		ANDA	ANDA075340	Cardinal Health 107, LLC	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
55154-3556_96db5dee-7c01-4f96-8b1e-1fcd2103d0fe	55154-3556	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Cardinal Health 107, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
55154-3558_ad60d958-198a-4c19-9b7b-b9d741eebc7d	55154-3558	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-3559_ad60d958-198a-4c19-9b7b-b9d741eebc7d	55154-3559	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190502		ANDA	ANDA209713	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-3560_ad60d958-198a-4c19-9b7b-b9d741eebc7d	55154-3560	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-3561_ad60d958-198a-4c19-9b7b-b9d741eebc7d	55154-3561	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-3562_ad60d958-198a-4c19-9b7b-b9d741eebc7d	55154-3562	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-3563_ad60d958-198a-4c19-9b7b-b9d741eebc7d	55154-3563	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-3564_568b8880-7997-4786-8c57-28816ce52655	55154-3564	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Cardinal Health 107, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-3565_b0bb417a-7b43-4ecc-ad80-b56b273b1679	55154-3565	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Cardinal Health 107, LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55154-3566_1391a9f6-1e70-4271-aa37-907aa0f0a49c	55154-3566	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Cardinal Health 107, LLC	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
55154-3567_e5fe2ece-40a1-49eb-818f-62ff3c3bb199	55154-3567	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20180501		ANDA	ANDA210441	Cardinal Health 107, LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
55154-3568_0706f9e0-7d73-430a-af90-7d1706046eb8	55154-3568	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Cardinal Health 107, LLC	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-3569_fd8a815e-88b7-4bef-9e32-6dbc735711a3	55154-3569	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Cardinal Health 107, LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-3570_fd8a815e-88b7-4bef-9e32-6dbc735711a3	55154-3570	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Cardinal Health 107, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-3571_f2eafcbb-77ab-461e-aa09-9cc4123eb3bd	55154-3571	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	TABLET, FILM COATED	ORAL	20101106		ANDA	ANDA090456	Cardinal Health 107, LLC	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
55154-3572_b8d257be-b055-4e46-ba28-1bfd8db0906f	55154-3572	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	Cardinal Health 107, LLC	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-3573_8c180fa7-bfd3-4b4f-bea6-e6b056302ccc	55154-3573	HUMAN PRESCRIPTION DRUG	Major Oral Rinse		0.12% Chlorhexidine Gluconate	RINSE	ORAL	20201120		ANDA	ANDA077789	Cardinal Health 107, LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
55154-3574_ed988aff-cdad-4d40-8400-8acf0bd90c67	55154-3574	HUMAN PRESCRIPTION DRUG	Major Oral Rinse		0.12% Chlorhexidine Gluconate	RINSE	ORAL	20201120		ANDA	ANDA077789	Cardinal Health 107, LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20251231
55154-3680_412b85f3-e55b-49ae-9d50-5b7f39b0c55f	55154-3680	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	Cardinal Health 107, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55154-3939_d14ab7c6-d54f-47a3-aa33-d5e3b1e3614f	55154-3939	HUMAN PRESCRIPTION DRUG	Solu-Medrol		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Cardinal Health 107, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-3940_c60ea5ad-80e4-4238-b34e-101e63f15a06	55154-3940	HUMAN PRESCRIPTION DRUG	Solu-Medrol		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Cardinal Health 107, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-3941_c60ea5ad-80e4-4238-b34e-101e63f15a06	55154-3941	HUMAN PRESCRIPTION DRUG	Solu-Medrol		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Cardinal Health 107, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-3942_9b0ea726-b1a6-4178-b044-2cd65bd46c15	55154-3942	HUMAN PRESCRIPTION DRUG	Solu-Cortef		hydrocortisone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19550427		NDA	NDA009866	Cardinal Health 107, LLC	HYDROCORTISONE SODIUM SUCCINATE	100	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-3944_a6fece32-13ef-417a-98f7-56fd3f19dee9	55154-3944	HUMAN PRESCRIPTION DRUG	Solu-Medrol		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Cardinal Health 107, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4028_a50db670-0fda-4f68-b5ee-dbe3ae69bc4a	55154-4028	HUMAN PRESCRIPTION DRUG	Lovenox		enoxaparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19930329		NDA	NDA020164	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-4056_145a0ea5-09df-443f-99ee-8afc58f9d8cf	55154-4056	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20100510		ANDA	ANDA064142	Cardinal Health 107, LLC	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
55154-4061_1289a520-d714-4ac2-a0dd-6fafe31569a0	55154-4061	HUMAN OTC DRUG	Milk of Magnesia		Magnesium Hydroxide	SUSPENSION	ORAL	20180419		OTC MONOGRAPH DRUG	M001	Cardinal Health 107, LLC	MAGNESIUM HYDROXIDE	400	mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55154-4080_e389ac91-5341-41e6-b172-26302bf290ab	55154-4080	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201223		ANDA	ANDA212297	Cardinal Health 107, LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
55154-4151_7da79708-ee20-40c7-9ee4-0851d99416d5	55154-4151	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150720		ANDA	ANDA090048	Cardinal Health 107, LLC	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
55154-4152_ec4d2256-0340-4166-90ee-c264eef3ac82	55154-4152	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Cardinal Health 107, LLC	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55154-4153_f7abc2ff-21bc-48b5-9989-c5ac84f5c9cd	55154-4153	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180930		ANDA	ANDA207342	Cardinal Health 107, LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55154-4154_c60941ec-05b4-4210-b748-a3dd517a350d	55154-4154	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Cardinal Health 107, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-4156_6209ae19-7ea0-437d-8e5d-12e37917ed13	55154-4156	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20220512		ANDA	ANDA210971	Cardinal Health 107, LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55154-4157_c98ecf77-ae9a-438b-9bad-ffbed25d95bc	55154-4157	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Cardinal Health 107, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55154-4161_6225ea9f-55c3-4f1c-823d-00e9f059b0f8	55154-4161	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Cardinal Health 107, LLC	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-4162_25a19b30-b07a-4531-b65b-8b3b305bdd2e	55154-4162	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070217	Cardinal Health 107, LLC	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4163_98a24cc0-0058-4baa-9c97-7117694194cc	55154-4163	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Cardinal Health 107, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-4165_6229247e-ee15-466e-a8ac-adcd646b738d	55154-4165	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-4166_1272aada-9a5b-4397-bb65-9398927aa325	55154-4166	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20141031		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-4167_b9537a29-ba3a-4c74-bf4f-baf4843ad197	55154-4167	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20180829		ANDA	ANDA211067	Cardinal Health 107, LLC	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55154-4168_450c3e32-6d91-4508-b064-49b293e86cec	55154-4168	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20140813		ANDA	ANDA090687	Cardinal Health 107, LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
55154-4169_a23b6070-eb4b-48e3-b563-8232206a6be4	55154-4169	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20080226		ANDA	ANDA077728	Cardinal Health 107, LLC	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
55154-4170_c31f9604-745a-44eb-88de-35b543e48637	55154-4170	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Cardinal Health 107, LLC	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4171_b90b3630-c0b9-481a-9396-53f46cfcc833	55154-4171	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Cardinal Health 107, LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-4172_46cb7e3f-c739-433d-9dbe-427c2d95bef1	55154-4172	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Cardinal Health 107, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
55154-4173_7590186a-83f1-4192-941c-3d4ad4793cec	55154-4173	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20220118		ANDA	ANDA074260	Cardinal Health 107, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
55154-4174_cb8ce75a-2578-43cc-b847-4acedbdf1091	55154-4174	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Cardinal Health 107, LLC	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
55154-4183_8eccf8a8-083c-436a-a79d-4f4154e6f895	55154-4183	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20120326		ANDA	ANDA204147	Cardinal Health 107, LLC	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55154-4225_91f29067-0390-4662-9729-20e55701e58d	55154-4225	HUMAN PRESCRIPTION DRUG	Protonix	I.V.	pantoprazole sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20010501		NDA	NDA020988	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-4232_2fd2b436-0be8-4f80-8554-2f663bc8af80	55154-4232	HUMAN PRESCRIPTION DRUG	Protonix	Delayed-Release	pantoprazole sodium	GRANULE, DELAYED RELEASE	ORAL	20080229		NDA	NDA022020	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-4236_ff7791a7-d763-491e-832d-e37e5a06632a	55154-4236	HUMAN PRESCRIPTION DRUG	Protonix	I.V.	PANTOPRAZOLE SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20010501		NDA	NDA020988	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-4305_65b3f57c-6880-4fc6-a050-8a04bf961dab	55154-4305	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Cardinal Health 107, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
55154-4306_624469a1-ded9-453a-973e-c5a2f0602bb0	55154-4306	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20220307		ANDA	ANDA040625	Cardinal Health 107, LLC	FOLIC ACID	1	mg/1			N	20241231
55154-4307_c5ac2265-393a-4fbe-b974-1dd0b9243ec8	55154-4307	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20121106		ANDA	ANDA091479	Cardinal Health 107, LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
55154-4308_c03676d4-14b7-4551-8d9e-de26ec60da0b	55154-4308	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Cardinal Health 107, LLC	PREGABALIN	100	mg/1		CV	N	20241231
55154-4309_ad60d958-198a-4c19-9b7b-b9d741eebc7d	55154-4309	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-4310_9b8cbfb6-cf36-4377-9d18-70832d760ebd	55154-4310	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230808		ANDA	ANDA040362	Cardinal Health 107, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4311_e25863fd-586c-4bc1-be45-65c32eb0fc22	55154-4311	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20230807		ANDA	ANDA074644	Cardinal Health 107, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4312_65b3f57c-6880-4fc6-a050-8a04bf961dab	55154-4312	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Cardinal Health 107, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
55154-4313_5d515c2a-dac9-42d8-aede-66d28a427dbc	55154-4313	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075718	Cardinal Health 107, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55154-4314_56aca0e2-8691-4701-beba-e2315524709f	55154-4314	HUMAN PRESCRIPTION DRUG	Nystatin		NYSTATIN	SUSPENSION	ORAL	20200717		ANDA	ANDA203621	Cardinal Health 107, LLC	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
55154-4315_5622f8d2-1893-441b-8011-fa90c8a63b0b	55154-4315	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20210901		ANDA	ANDA215106	Cardinal Health 107, LLC	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4316_a91defd2-486b-4995-ba4c-640525ab575d	55154-4316	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	SOLUTION	ORAL	20150604		ANDA	ANDA201157	Cardinal Health 107, LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-4317_bdb9e7cf-bfbb-48b4-a8be-9038820d8279	55154-4317	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230801		ANDA	ANDA205231	Cardinal Health 107, LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55154-4318_5ad315f2-fa09-4956-b931-f9966fb73e4e	55154-4318	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230901		ANDA	ANDA077856	Cardinal Health 107, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-4319_5ad315f2-fa09-4956-b931-f9966fb73e4e	55154-4319	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230901		ANDA	ANDA077856	Cardinal Health 107, LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-4320_4ebcb0e5-1c93-4b3f-8749-6835c56afce5	55154-4320	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20221107		ANDA	ANDA078069	Cardinal Health 107, LLC	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-4321_bdb9e7cf-bfbb-48b4-a8be-9038820d8279	55154-4321	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230801		ANDA	ANDA205231	Cardinal Health 107, LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55154-4322_111ab7c6-b0c3-4d15-9f40-6c03d3d16bc2	55154-4322	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		POSACONAZOLE	TABLET, DELAYED RELEASE	ORAL	20210203		ANDA	ANDA213454	Cardinal Health 107, LLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55154-4323_4ebcb0e5-1c93-4b3f-8749-6835c56afce5	55154-4323	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20221107		ANDA	ANDA078069	Cardinal Health 107, LLC	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-4324_ef55ca6b-cdbf-422a-b183-850cb74eb205	55154-4324	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	TABLET	ORAL	20221026		OTC MONOGRAPH DRUG	M001	Cardinal Health 107, LLC	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
55154-4332_415a1543-b8ad-417b-8fdd-fc03d5a8dd2a	55154-4332	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	19990305		ANDA	ANDA075382	Cardinal Health 107, LLC	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55154-4341_52f6e766-b88e-43fc-9c8f-e08b82e4ee8c	55154-4341	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20170517		OTC MONOGRAPH DRUG	M007	Cardinal Health 107, LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
55154-4342_b8ecbe14-7b7a-4598-9e85-02b34f21c76f	55154-4342	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	20190416		ANDA	ANDA040268	Cardinal Health 107, LLC	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55154-4343_83d5f883-6eed-434c-b838-ffb0695fea49	55154-4343	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20140428		ANDA	ANDA076820	Cardinal Health 107, LLC	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
55154-4344_83d5f883-6eed-434c-b838-ffb0695fea49	55154-4344	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20140428		ANDA	ANDA076820	Cardinal Health 107, LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
55154-4345_20c48859-bb62-4dfb-bdb3-a32b58a60dbe	55154-4345	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20190423		ANDA	ANDA209724	Cardinal Health 107, LLC	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-4346_410d5577-e50a-44f3-aaa8-fbf391a0c261	55154-4346	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20210128		ANDA	ANDA078281	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-4351_9336d2fe-7a40-4cdd-a297-da5ab626018c	55154-4351	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20010927	20240229	ANDA	ANDA075562	Cardinal Health 107, LLC	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
55154-4357_5b72e7fd-eb46-45fc-9425-a44680498103	55154-4357	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20071231	20240430	ANDA	ANDA076749	Cardinal Health 107, LLC	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	3; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	
55154-4359_c1f31cd1-8f55-4e02-8b5c-d1a2a005bc60	55154-4359	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	19970917	20240331	ANDA	ANDA074880	Cardinal Health 107, LLC	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	
55154-4375_3d166b33-97d9-4bfd-a768-49e58bf7bc1c	55154-4375	HUMAN OTC DRUG	Loratadine		loratadine	TABLET	ORAL	20130430	20300131	ANDA	ANDA076154	Cardinal Health 107, LLC	LORATADINE	10	mg/1			N	
55154-4376_0c50a4b2-8c3b-4868-9af1-9339ba655d61	55154-4376	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20101029		ANDA	ANDA076187	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-4377_0c50a4b2-8c3b-4868-9af1-9339ba655d61	55154-4377	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20070226		ANDA	ANDA076187	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-4379_4c3086cc-2cce-4331-8700-24973a8693b9	55154-4379	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20130924		ANDA	ANDA070848	Cardinal Health 107, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
55154-4382_3f89bf3f-048e-4ab3-bf48-ab444f666535	55154-4382	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20110223		ANDA	ANDA090970	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-4383_c177cc00-45b5-4e28-a244-3507ff637f5e	55154-4383	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20131230		ANDA	ANDA072801	Cardinal Health 107, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
55154-4384_5c4fca2f-7d58-487d-901e-8411a3d6f281	55154-4384	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20140123		ANDA	ANDA091226	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-4410_f1b75b17-df17-4318-9e63-4b0384a15aa0	55154-4410	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20111205		ANDA	ANDA077839	Cardinal Health 107, LLC	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
55154-4451_1c3beaf2-65ad-432e-9a38-62f486f268d3	55154-4451	HUMAN PRESCRIPTION DRUG	Metoprolol		metoprolol tartrate	INJECTION	INTRAVENOUS	20120925		ANDA	ANDA078950	Cardinal Health 107, LLC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4452_f5f482d7-9912-4196-ad53-f1045eafff2a	55154-4452	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Cardinal Health 107, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-4453_76fc29d3-f418-48fb-88ce-609a859fb474	55154-4453	HUMAN PRESCRIPTION DRUG	ONDANSETRON HYDROCHLORIDE		ONDANSETRON HYDROCHLORIDE	SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130313		ANDA	ANDA078287	Cardinal Health 107, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55154-4567_1512a62c-40f9-4c04-9a5d-393722e9aec5	55154-4567	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	Cardinal Health 107, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55154-4624_42404a6b-6b1a-4e6a-be9a-62cf93dc51d5	55154-4624	HUMAN PRESCRIPTION DRUG	VIIBRYD		vilazodone hydrochloride	TABLET	ORAL	20110429	20240430	NDA	NDA022567	Cardinal Health 107, LLC	VILAZODONE HYDROCHLORIDE	40	mg/1			N	
55154-4626_95ebe049-c48d-4664-8b4e-74c0370b4a23	55154-4626	HUMAN PRESCRIPTION DRUG	Savella		milnacipran hydrochloride	TABLET, FILM COATED	ORAL	20090417		NDA	NDA022256	Cardinal Health 107, LLC	MILNACIPRAN HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55154-4627_42404a6b-6b1a-4e6a-be9a-62cf93dc51d5	55154-4627	HUMAN PRESCRIPTION DRUG	VIIBRYD		vilazodone hydrochloride	TABLET	ORAL	20110429	20240229	NDA	NDA022567	Cardinal Health 107, LLC	VILAZODONE HYDROCHLORIDE	20	mg/1			N	
55154-4679_ffdbfa41-c992-4542-98fd-c0761db5d05f	55154-4679	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141007		ANDA	ANDA090554	Cardinal Health 107, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-4680_04f20389-8085-46dc-8aea-c9ca93a73d17	55154-4680	HUMAN OTC DRUG	Mucinex		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20160101		NDA	NDA021282	Cardinal Health 107, LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55154-4687_09dbe60d-3cfa-439b-9064-081261e56302	55154-4687	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20161205		ANDA	ANDA077397	Cardinal Health 107, LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-4690_29d3e753-7841-4aff-9f56-1b3bbad8b08e	55154-4690	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120524		ANDA	ANDA077127	Cardinal Health 107, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55154-4692_09dbe60d-3cfa-439b-9064-081261e56302	55154-4692	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20170403		ANDA	ANDA077397	Cardinal Health 107, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-4695_ffe637d2-3436-49a9-88f5-865b5a8b8935	55154-4695	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20040726		ANDA	ANDA040301	Cardinal Health 107, LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
55154-4696_c6576953-3d68-459f-8c1c-ad564845f0e8	55154-4696	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20040729		ANDA	ANDA040301	Cardinal Health 107, LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
55154-4697_ffe637d2-3436-49a9-88f5-865b5a8b8935	55154-4697	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20040726		ANDA	ANDA040301	Cardinal Health 107, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
55154-4698_4f935187-a38c-4f31-a5a4-57e6cb5a8ab6	55154-4698	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180925		ANDA	ANDA090617	Cardinal Health 107, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4699_bcd5e5fd-a8b4-4d4d-90e5-61154939a6fa	55154-4699	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20170103		ANDA	ANDA073192	Cardinal Health 107, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
55154-4733_754e18f8-6c05-4582-982a-97f83a4f6297	55154-4733	HUMAN PRESCRIPTION DRUG	Bumetanide		BUMETANIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20111116		ANDA	ANDA074332	Cardinal Health 107, LLC	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-4743_1428550b-2b7b-4893-9b41-2f436713c54d	55154-4743	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20020722		ANDA	ANDA075857	Cardinal Health 107, LLC	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-4745_7832b2e2-27d8-4161-a7af-f6530709efd5	55154-4745	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		METOPROLOL TARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20080429		ANDA	ANDA078085	Cardinal Health 107, LLC	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4747_4daf0faf-e861-46a8-90fb-b4263841106f	55154-4747	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	19991129		ANDA	ANDA075239	Cardinal Health 107, LLC	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4752_8369d630-3837-48bb-a10e-83c9035c26fb	55154-4752	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20100609		ANDA	ANDA076704	Cardinal Health 107, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4759_81bbd77a-c4bd-4cde-882b-8ef2afad8b8a	55154-4759	HUMAN PRESCRIPTION DRUG	DIVALPROEX SODIUM		DIVALPROEX SODIUM	CAPSULE, COATED PELLETS	ORAL	20090401		ANDA	ANDA078919	Cardinal Health 107, LLC	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-4782_089683be-958d-4514-bf95-40957623c28e	55154-4782	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20110502		ANDA	ANDA078103	Cardinal Health 107, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-4783_dc4aa115-3efb-4761-a780-2bbb039792a1	55154-4783	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101012		ANDA	ANDA078243	Cardinal Health 107, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55154-4790_8369d630-3837-48bb-a10e-83c9035c26fb	55154-4790	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20130723		ANDA	ANDA077739	Cardinal Health 107, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-4848_e6b347dc-7127-4c0f-ba3f-64296e0305aa	55154-4848	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180308		ANDA	ANDA208784	Cardinal Health 107, LLC	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-4849_5721bdd7-beec-4d4d-942a-0460fedc9ced	55154-4849	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20190111		ANDA	ANDA077519	Cardinal Health 107, LLC	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4901_47edc4ff-4d53-4f30-8ea9-9a57f3d43d2b	55154-4901	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	Cardinal Health 107, LLC	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4914_47edc4ff-4d53-4f30-8ea9-9a57f3d43d2b	55154-4914	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19820826		ANDA	ANDA087916	Cardinal Health 107, LLC	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4920_2a291189-3e7a-4818-96f6-7e10c0ab5636	55154-4920	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19870728		NDA	NDA017812	Cardinal Health 107, LLC	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
55154-4938_cd5fb2e0-dec1-4ccf-b34b-4d35c9752965	55154-4938	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19720421		ANDA	ANDA080352	Cardinal Health 107, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4946_cd5fb2e0-dec1-4ccf-b34b-4d35c9752965	55154-4946	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030213		ANDA	ANDA087342	Cardinal Health 107, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4949_cd5fb2e0-dec1-4ccf-b34b-4d35c9752965	55154-4949	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030213		ANDA	ANDA084122	Cardinal Health 107, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4950_cd5fb2e0-dec1-4ccf-b34b-4d35c9752965	55154-4950	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030314		ANDA	ANDA084283	Cardinal Health 107, LLC	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-4976_29e96acb-90c0-493d-b86d-55a74d3ffc27	55154-4976	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20130614		ANDA	ANDA076134	Cardinal Health 107, LLC	LORATADINE	10	mg/1			N	20241231
55154-4980_b097ee87-bf66-4faa-8065-239f2f04c59e	55154-4980	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131223		ANDA	ANDA090694	Cardinal Health 107, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55154-4981_b097ee87-bf66-4faa-8065-239f2f04c59e	55154-4981	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131223		ANDA	ANDA090694	Cardinal Health 107, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55154-5035_09c1db7d-4f68-4515-8a4d-063846c1a2d8	55154-5035	HUMAN OTC DRUG	MiraLAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20090223		NDA	NDA022015	Cardinal Health 107, LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55154-5040_214965ad-9396-47a8-9521-531b7e2b4a7e	55154-5040	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	Cardinal Health 107, LLC	SITAGLIPTIN PHOSPHATE	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
55154-5042_c5f27d29-9128-4d50-b040-c69f02ea759c	55154-5042	HUMAN PRESCRIPTION DRUG	JANUVIA		sitagliptin	TABLET, FILM COATED	ORAL	20061016		NDA	NDA021995	Cardinal Health 107, LLC	SITAGLIPTIN PHOSPHATE	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
55154-5059_e592868d-34b3-440f-acf1-955917ec8414	55154-5059	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol	TABLET	ORAL	20040215		ANDA	ANDA070278	Cardinal Health 107, LLC	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
55154-5074_119d50d5-a0b7-48ad-8e97-8d434b4f4d17	55154-5074	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	20091120		ANDA	ANDA070325	Cardinal Health 107, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-5085_be9dc9b9-7fab-43b2-8f1b-d0f6c7f88585	55154-5085	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20110513	20300131	ANDA	ANDA088468	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
55154-5102_0a611cbe-91da-480a-9524-6f13e4491559	55154-5102	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		diphenhydramine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110628		ANDA	ANDA080817	Cardinal Health 107, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55154-5106_e51121eb-4bb7-47eb-8ce6-c74fa8560f1a	55154-5106	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110628		ANDA	ANDA083391	Cardinal Health 107, LLC	DIGOXIN	.25	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
55154-5118_6eabe326-90c6-426b-ac80-67673f2e7694	55154-5118	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19820907		ANDA	ANDA087702	Cardinal Health 107, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-5130_740dcf6d-5dc4-467a-90ba-3648f0c59e97	55154-5130	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	19720322		NDA	NDA017037	Cardinal Health 107, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-5154_7afaf1cf-ff5c-4106-90c6-f23a9f67d486	55154-5154	HUMAN PRESCRIPTION DRUG	Dexilant		dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20100412	20250430	NDA	NDA022287	Cardinal Health 107, LLC	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
55154-5355_26c2af34-cb11-4ce2-9a8e-a7edc6c88606	55154-5355	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20091130		ANDA	ANDA076122	Cardinal Health 107, LLC	MIRTAZAPINE	15	mg/1			N	20241231
55154-5356_0bc82d06-7e35-4c5c-9c81-5f0b61ac6db3	55154-5356	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040920		ANDA	ANDA076704	Cardinal Health 107, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-5362_0c50a4b2-8c3b-4868-9af1-9339ba655d61	55154-5362	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20101029		ANDA	ANDA076187	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-5365_9cfa23fa-5967-41ed-84d3-5689cbc03899	55154-5365	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20120210		ANDA	ANDA076056	Cardinal Health 107, LLC	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-5370_9cfa23fa-5967-41ed-84d3-5689cbc03899	55154-5370	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20120210		ANDA	ANDA076056	Cardinal Health 107, LLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-5380_0c50a4b2-8c3b-4868-9af1-9339ba655d61	55154-5380	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20101029		ANDA	ANDA076187	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-5381_0c50a4b2-8c3b-4868-9af1-9339ba655d61	55154-5381	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20101029		ANDA	ANDA076187	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-5382_700941b9-de3e-49c7-bca2-f85663cdf223	55154-5382	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	TABLET, FILM COATED	ORAL	20111025	20300131	ANDA	ANDA065521	Cardinal Health 107, LLC	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	
55154-5395_0c50a4b2-8c3b-4868-9af1-9339ba655d61	55154-5395	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20101029		ANDA	ANDA076187	Cardinal Health 107, LLC	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55154-5397_e15a3f48-1e3d-4b36-8e16-fc5aff4c44f4	55154-5397	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20100331	20300131	ANDA	ANDA075272	Cardinal Health 107, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	
55154-5399_2e67d888-db29-4505-80ca-0ca2482b7790	55154-5399	HUMAN OTC DRUG	Cetirizine Hydrochloride		cetirizine hydrochloride	TABLET, FILM COATED	ORAL	20120330		ANDA	ANDA076677	Cardinal Health 107, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
55154-5454_528e37eb-d874-4bbb-8609-82c111155cf0	55154-5454	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20110520		ANDA	ANDA018659	Cardinal Health 107, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55154-5494_e15a3f48-1e3d-4b36-8e16-fc5aff4c44f4	55154-5494	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20100331	20300131	ANDA	ANDA075272	Cardinal Health 107, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	
55154-5512_0bc82d06-7e35-4c5c-9c81-5f0b61ac6db3	55154-5512	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	19940503		ANDA	ANDA076704	Cardinal Health 107, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-5517_5c2554ab-54a5-47de-8908-ce11c05f500c	55154-5517	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20110204	20300131	ANDA	ANDA040424	Cardinal Health 107, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	
55154-5534_528e37eb-d874-4bbb-8609-82c111155cf0	55154-5534	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20110520		ANDA	ANDA018659	Cardinal Health 107, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55154-5554_119d50d5-a0b7-48ad-8e97-8d434b4f4d17	55154-5554	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	20091120		ANDA	ANDA070325	Cardinal Health 107, LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-5623_af99d27a-1cdc-419a-a6ea-f87b5148930d	55154-5623	HUMAN PRESCRIPTION DRUG	Midodrine HCl		midodrine hydrochloride	TABLET	ORAL	20041103		ANDA	ANDA076725	Cardinal Health 107, LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
55154-5633_7255512a-f596-4e09-8f8c-7bed20447cde	55154-5633	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	Cardinal Health 107, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-5634_2bbac62a-dab3-4d2c-8fc8-dce797735537	55154-5634	HUMAN PRESCRIPTION DRUG	KLOR-CON M		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20110118		ANDA	ANDA074726	Cardinal Health 107, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55154-5675_b5e55ebc-6854-4585-bdfd-0c782ec9c112	55154-5675	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20110218		ANDA	ANDA077316	Cardinal Health 107, LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-5676_b5e55ebc-6854-4585-bdfd-0c782ec9c112	55154-5676	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20110218		ANDA	ANDA077316	Cardinal Health 107, LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-5677_b5e55ebc-6854-4585-bdfd-0c782ec9c112	55154-5677	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20110218		ANDA	ANDA077316	Cardinal Health 107, LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-5678_b5e55ebc-6854-4585-bdfd-0c782ec9c112	55154-5678	HUMAN PRESCRIPTION DRUG	Carvedilol		carvedilol	TABLET, FILM COATED	ORAL	20110218		ANDA	ANDA077316	Cardinal Health 107, LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-5689_be9dc9b9-7fab-43b2-8f1b-d0f6c7f88585	55154-5689	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20110513	20300131	ANDA	ANDA088467	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
55154-5699_c9df9007-b6ae-4a30-8480-35d5ffca5241	55154-5699	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20120829		ANDA	ANDA076919	Cardinal Health 107, LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-5730_1bfcd79e-ea3d-44c5-90d2-02304b963d70	55154-5730	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine	INHALANT	ORAL; RESPIRATORY (INHALATION)	20110506		ANDA	ANDA072489	Cardinal Health 107, LLC	ACETYLCYSTEINE	100	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
55154-5731_1bfcd79e-ea3d-44c5-90d2-02304b963d70	55154-5731	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine	INHALANT	ORAL; RESPIRATORY (INHALATION)	20110506		ANDA	ANDA072547	Cardinal Health 107, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
55154-5777_5c421a5b-b52c-4c47-bd4a-6718ebf1a519	55154-5777	HUMAN PRESCRIPTION DRUG	Sodium Citrate and Citric Acid		SODIUM CITRATE and CITRIC ACID MONOHYDRATE	SOLUTION	ORAL	19690101		UNAPPROVED DRUG OTHER		Cardinal Health 107, LLC	ANHYDROUS CITRIC ACID; SODIUM CITRATE, UNSPECIFIED FORM	334; 500	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
55154-5780_0910827a-8299-4d01-9c4f-6b97843431ed	55154-5780	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	SOLUTION	ORAL	20020901		OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
55154-5782_0aa51d1d-ab04-4c40-8aca-0ba2fb4456f4	55154-5782	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	SOLUTION	ORAL	20150604		ANDA	ANDA201157	Cardinal Health 107, LLC	LEVETIRACETAM	500	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-5783_536ca7a3-cfc6-43e1-b4fc-b3ebc64fc853	55154-5783	HUMAN OTC DRUG	GUAIFENESIN DM		GUAIFENESIN and DEXTROMETHORPHAN	SYRUP	ORAL	19920701		OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	DEXTROMETHORPHAN; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55154-5785_de048b9d-1d8d-4535-ab29-f10b1b01cb7a	55154-5785	HUMAN OTC DRUG	GUAIFENESIN DM		GUAIFENESIN and DEXTROMETHORPHAN	SYRUP	ORAL	19920701		OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	DEXTROMETHORPHAN; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55154-5787_5842dbe0-08b2-4363-82f8-9de5e854d1bf	55154-5787	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20070917		OTC MONOGRAPH DRUG	M013	Cardinal Health 107, LLC	ACETAMINOPHEN	160	mg/5mL			N	20251231
55154-5788_0517606c-5b84-499d-9037-905771179f4e	55154-5788	HUMAN PRESCRIPTION DRUG	Nystatin		NYSTATIN	SUSPENSION	ORAL	20200717		ANDA	ANDA203621	Cardinal Health 107, LLC	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
55154-5789_5a6bc1e4-24b9-4a5f-9115-8afbe98a0a1e	55154-5789	HUMAN PRESCRIPTION DRUG	Lidocaine Viscous		Lidocaine Hydrochloride	SOLUTION	ORAL	19850426		ANDA	ANDA088802	Cardinal Health 107, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55154-5790_92c8672a-c6b8-4ec8-a815-c30bdd960ac7	55154-5790	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20220315		ANDA	ANDA211884	Cardinal Health 107, LLC	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
55154-5791_795436f1-cba4-448b-8605-90dcbec3f5fc	55154-5791	HUMAN OTC DRUG	Guaifenesin and Codeine Phosphate		Guaifenesin and Codeine Phosphate	SOLUTION	ORAL	20230627		OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
55154-5882_a1ad6e33-562b-4a85-84aa-74f86dd5c97c	55154-5882	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20090610		ANDA	ANDA077002	Cardinal Health 107, LLC	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
55154-5884_1cb4a564-819e-479e-ac1d-791e8f2c5d27	55154-5884	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-5896_7d0235dc-b4e8-4f39-a877-4f547c67a9cb	55154-5896	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076255	Cardinal Health 107, LLC	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-5897_e6a13d29-bfa5-4f59-95c7-1faffb150756	55154-5897	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20131201		ANDA	ANDA076710	Cardinal Health 107, LLC	LEVOFLOXACIN	500	mg/1			N	20241231
55154-5898_e6a13d29-bfa5-4f59-95c7-1faffb150756	55154-5898	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20131201		ANDA	ANDA076710	Cardinal Health 107, LLC	LEVOFLOXACIN	750	mg/1			N	20241231
55154-5899_6225ea9f-55c3-4f1c-823d-00e9f059b0f8	55154-5899	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20131130		ANDA	ANDA079088	Cardinal Health 107, LLC	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-6262_700941b9-de3e-49c7-bca2-f85663cdf223	55154-6262	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	CAPSULE	ORAL	20111025	20300131	ANDA	ANDA065520	Cardinal Health 107, LLC	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	
55154-6628_9d847c37-47c3-41cc-9203-b2d5fb95842d	55154-6628	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20100910		ANDA	ANDA086242	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55154-6634_c2a4f55f-9f2f-4385-a38a-5d214d2fb212	55154-6634	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20130709		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-6635_c2a4f55f-9f2f-4385-a38a-5d214d2fb212	55154-6635	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20130709		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-6643_dc4aa115-3efb-4761-a780-2bbb039792a1	55154-6643	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101013		ANDA	ANDA078243	Cardinal Health 107, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
55154-6645_ee45d12f-4ada-46a6-8399-fe28502532bc	55154-6645	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		Fludrocortisone Acetate	TABLET	ORAL	20080509		ANDA	ANDA040431	Cardinal Health 107, LLC	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
55154-6646_c2a4f55f-9f2f-4385-a38a-5d214d2fb212	55154-6646	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20130709		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-6689_d953b2f5-c25b-47a1-99bc-6524c614bcc1	55154-6689	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131		ANDA	ANDA078990	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-6690_d953b2f5-c25b-47a1-99bc-6524c614bcc1	55154-6690	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240531	ANDA	ANDA078990	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
55154-6692_d953b2f5-c25b-47a1-99bc-6524c614bcc1	55154-6692	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131		ANDA	ANDA078990	Cardinal Health 107, LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
55154-6709_a9850a4d-1fb5-4ab6-af34-a302b2ad7689	55154-6709	HUMAN PRESCRIPTION DRUG	Potassium chloride extended release		Potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20151211		ANDA	ANDA205993	Cardinal Health 107, LLC	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55154-6777_39db2c9d-1bcb-4e99-96a7-ae9c6edf9480	55154-6777	HUMAN PRESCRIPTION DRUG	XIFAXAN		rifaximin	TABLET	ORAL	20100501		NDA	NDA021361	Cardinal Health 107, LLC	RIFAXIMIN	550	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
55154-6843_22c7f6dd-4cb1-4149-9a28-460f759035ff	55154-6843	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Cardinal Health 107, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55154-6875_c5a43901-8506-4aab-a72e-481f59dda523	55154-6875	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20130120		ANDA	ANDA078226	Cardinal Health 107, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55154-6881_e6ce93a0-fc29-44fd-8abe-e28bd93ed5c0	55154-6881	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076255	Cardinal Health 107, LLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-6883_79a44689-e948-4c79-af9a-94c5ebdcbbef	55154-6883	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078227	Cardinal Health 107, LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-6884_79a44689-e948-4c79-af9a-94c5ebdcbbef	55154-6884	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078227	Cardinal Health 107, LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-6885_79a44689-e948-4c79-af9a-94c5ebdcbbef	55154-6885	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078227	Cardinal Health 107, LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-6886_2a225078-cf11-4e3c-82f9-4838fc2e4cc5	55154-6886	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Cardinal Health 107, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-6889_e6ce93a0-fc29-44fd-8abe-e28bd93ed5c0	55154-6889	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA076255	Cardinal Health 107, LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-6892_c5a43901-8506-4aab-a72e-481f59dda523	55154-6892	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20130120		ANDA	ANDA078226	Cardinal Health 107, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55154-6893_9b756500-a6d1-4c42-8f55-b8fd40ceabb9	55154-6893	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20141015		ANDA	ANDA090939	Cardinal Health 107, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-6897_fe72254e-a28d-4d7e-9ec2-8d614324be96	55154-6897	HUMAN OTC DRUG	Unit Dose Bisacodyl		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	M007	Cardinal Health 107, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
55154-6931_afb62788-383c-4323-b307-167cdfe7a221	55154-6931	HUMAN PRESCRIPTION DRUG	ONGLYZA		SAXAGLIPTIN	TABLET, FILM COATED	ORAL	20141120		NDA	NDA022350	Cardinal Health 107, LLC	SAXAGLIPTIN HYDROCHLORIDE	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
55154-6932_6de09446-8a14-4c42-a60d-5c9ece90cbc4	55154-6932	HUMAN PRESCRIPTION DRUG	FARXIGA		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20080114		NDA	NDA202293	Cardinal Health 107, LLC	DAPAGLIFLOZIN PROPANEDIOL	5	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
55154-6933_6de09446-8a14-4c42-a60d-5c9ece90cbc4	55154-6933	HUMAN PRESCRIPTION DRUG	FARXIGA		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20080114		NDA	NDA202293	Cardinal Health 107, LLC	DAPAGLIFLOZIN PROPANEDIOL	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
55154-6960_c6bde6b7-d4a7-4155-b158-1760e4649753	55154-6960	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110727		ANDA	ANDA074802	Cardinal Health 107, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-6970_3aedbf45-4f80-488d-96de-b75ad26ca459	55154-6970	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20100106		ANDA	ANDA070583	Cardinal Health 107, LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
55154-6976_3f3d4ba8-15ab-4de1-9668-2f9d73f07ea9	55154-6976	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		ONDANSETRON HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA077548	Cardinal Health 107, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55154-6985_83a11c76-7c64-489f-8095-74d8fa5f8929	55154-6985	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20090831		ANDA	ANDA090571	Cardinal Health 107, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-7076_6bfd6331-2ffa-4ba6-aa18-f0ae5b1b9273	55154-7076	HUMAN PRESCRIPTION DRUG	HALOPERIDOL LACTATE		HALOPERIDOL LACTATE	INJECTION, SOLUTION	INTRAMUSCULAR	20110510		ANDA	ANDA078347	Cardinal Health 107, LLC	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
55154-7128_280ba782-da06-4f70-a4f2-2e05110b85ff	55154-7128	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20130322		ANDA	ANDA065095	Cardinal Health 107, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55154-7140_cda8dedc-e144-4f74-b64f-9870726da755	55154-7140	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		Dantrolene Sodium	CAPSULE	ORAL	20080925		ANDA	ANDA076856	Cardinal Health 107, LLC	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
55154-7142_66493c6a-04b3-4d00-a60f-b055b159c700	55154-7142	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20120601		ANDA	ANDA078235	Cardinal Health 107, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-7143_858f845c-fc1f-4c21-8bf1-81efbd0eddbd	55154-7143	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	20080812		ANDA	ANDA075340	Cardinal Health 107, LLC	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
55154-7145_ffdbfa41-c992-4542-98fd-c0761db5d05f	55154-7145	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141007		ANDA	ANDA090554	Cardinal Health 107, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55154-7146_66493c6a-04b3-4d00-a60f-b055b159c700	55154-7146	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20120601		ANDA	ANDA078235	Cardinal Health 107, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-7147_37a703ec-18bd-4e08-bbb5-278b8158a89b	55154-7147	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20120601		ANDA	ANDA040511	Cardinal Health 107, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
55154-7228_c3f59533-f177-4760-97a6-ad890a12b34a	55154-7228	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20140502		NDA AUTHORIZED GENERIC	NDA020612	Cardinal Health 107, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55154-7275_53885fdc-63f3-42a2-b7b1-84b47fda4dc4	55154-7275	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Cardinal Health 107, LLC	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-7276_1e395f70-2748-421d-b2cd-54d37e095ca3	55154-7276	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20090410		ANDA	ANDA065061	Cardinal Health 107, LLC	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
55154-7278_79a44689-e948-4c79-af9a-94c5ebdcbbef	55154-7278	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20121114		ANDA	ANDA078227	Cardinal Health 107, LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55154-7279_0069c3c2-5166-4443-b793-79c5a3b19112	55154-7279	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Cardinal Health 107, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-7280_8b5d7084-2c4e-48f0-a429-89ee562ab0ee	55154-7280	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Cardinal Health 107, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-7287_edb115a0-cb16-4adf-afed-103fc9a9957a	55154-7287	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20141001		ANDA	ANDA076533	Cardinal Health 107, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55154-7288_9b756500-a6d1-4c42-8f55-b8fd40ceabb9	55154-7288	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20141015		ANDA	ANDA090939	Cardinal Health 107, LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-7289_ef904a48-c166-456f-93c6-f70d37cc6c4c	55154-7289	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20141031		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-7291_b4563a0a-961a-4d10-8ec0-62bccce59e58	55154-7291	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20150105		ANDA	ANDA200270	Cardinal Health 107, LLC	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
55154-7292_b4563a0a-961a-4d10-8ec0-62bccce59e58	55154-7292	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20150105		ANDA	ANDA200495	Cardinal Health 107, LLC	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
55154-7293_83ca0568-3ba8-495b-b865-8b598d8ed52a	55154-7293	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20150514		ANDA	ANDA086242	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55154-7294_83ca0568-3ba8-495b-b865-8b598d8ed52a	55154-7294	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20150514		ANDA	ANDA086242	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55154-7295_83ca0568-3ba8-495b-b865-8b598d8ed52a	55154-7295	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20150514		ANDA	ANDA086242	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55154-7297_fe895375-a458-4032-8d43-96c3cc3a723a	55154-7297	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Cardinal Health 107, LLC	MIRTAZAPINE	15	mg/1			N	20241231
55154-7353_ae3163a2-d8ea-4735-bc5f-e74c83d5dcac	55154-7353	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		sodium polystyrene sulfonate	SUSPENSION	ORAL; RECTAL	19830101		ANDA	ANDA087859	Cardinal Health 107, LLC	SODIUM POLYSTYRENE SULFONATE	15	g/60mL			N	20241231
55154-7475_87c08f11-475b-45c2-84a7-639fc61a811a	55154-7475	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110921		ANDA	ANDA090963	Cardinal Health 107, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55154-7553_a1a42c0e-791d-4e4e-900c-cc36764ecc9c	55154-7553	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20090629		ANDA	ANDA040419	Cardinal Health 107, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
55154-7628_ef904a48-c166-456f-93c6-f70d37cc6c4c	55154-7628	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20141031		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-7629_9abef2a7-4c16-429d-b52f-301fbe10c7e1	55154-7629	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20070419		ANDA	ANDA075677	Cardinal Health 107, LLC	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55154-7630_1cb4a564-819e-479e-ac1d-791e8f2c5d27	55154-7630	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Cardinal Health 107, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-7633_8bb1281b-c95d-46e7-b861-4382a1c8c494	55154-7633	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141001		ANDA	ANDA090429	Cardinal Health 107, LLC	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
55154-7634_cb43620b-430b-4c3c-ac95-b530e2b3b390	55154-7634	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20150601		ANDA	ANDA090074	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-7635_c8a9ed60-7893-482a-aaca-0bf2b5a253fc	55154-7635	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20150715		ANDA	ANDA078220	Cardinal Health 107, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
55154-7637_7da79708-ee20-40c7-9ee4-0851d99416d5	55154-7637	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150720		ANDA	ANDA090048	Cardinal Health 107, LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
55154-7645_24cbfdf7-53c2-4e49-9398-07d225b77854	55154-7645	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150625		ANDA	ANDA204197	Cardinal Health 107, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-7646_24cbfdf7-53c2-4e49-9398-07d225b77854	55154-7646	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150625		ANDA	ANDA204197	Cardinal Health 107, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-7649_5b43d772-e6bf-4e0b-9e26-393cf0dd6881	55154-7649	HUMAN PRESCRIPTION DRUG	tamsulosin hydrochloride		tamsulosin hydrochloride	CAPSULE	ORAL	20150105		ANDA	ANDA078015	Cardinal Health 107, LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55154-7850_b2b11ef1-073e-47c5-a773-cd0561df4774	55154-7850	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19940729		ANDA	ANDA064067	Cardinal Health 107, LLC	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
55154-7875_f65ac7e6-27c0-4908-a91c-889a14dcec86	55154-7875	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20150625		ANDA	ANDA076658	Cardinal Health 107, LLC	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55154-7876_c8a9ed60-7893-482a-aaca-0bf2b5a253fc	55154-7876	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20150715		ANDA	ANDA077241	Cardinal Health 107, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
55154-7879_4db69d8a-6318-46d3-8617-042fb716e1ec	55154-7879	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20061226		ANDA	ANDA076183	Cardinal Health 107, LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55154-7881_7618b5c8-3966-43d4-96ac-192f97500969	55154-7881	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Cardinal Health 107, LLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-7882_a6660e2e-7e36-426d-863e-d07854f7ccc2	55154-7882	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110528		ANDA	ANDA090686	Cardinal Health 107, LLC	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55154-7883_a6660e2e-7e36-426d-863e-d07854f7ccc2	55154-7883	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110528		ANDA	ANDA090686	Cardinal Health 107, LLC	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
55154-7888_8bb1281b-c95d-46e7-b861-4382a1c8c494	55154-7888	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141001		ANDA	ANDA090429	Cardinal Health 107, LLC	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
55154-7894_7618b5c8-3966-43d4-96ac-192f97500969	55154-7894	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Cardinal Health 107, LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-7895_806cb7ac-0cc9-47ac-a433-3a24ad4ddee5	55154-7895	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20090811		ANDA	ANDA076899	Cardinal Health 107, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
55154-7897_e14a7ef9-820a-42e8-ba15-94405efa7112	55154-7897	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180912		OTC MONOGRAPH DRUG	M013	Cardinal Health 107, LLC	ACETAMINOPHEN	500	mg/1			N	20251231
55154-7899_d6be94df-f49e-4b9e-8449-9da079f758ad	55154-7899	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20181023		OTC MONOGRAPH DRUG	M013	Cardinal Health 107, LLC	ACETAMINOPHEN	325	mg/1			N	20251231
55154-7975_201c4cb7-553c-4cce-979b-9bebb29f2d43	55154-7975	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Cardinal Health 107, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-7976_201c4cb7-553c-4cce-979b-9bebb29f2d43	55154-7976	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Cardinal Health 107, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-7977_201c4cb7-553c-4cce-979b-9bebb29f2d43	55154-7977	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Cardinal Health 107, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55154-7979_64500978-cff4-4dff-af3d-39858b889dfd	55154-7979	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20091216		ANDA	ANDA040765	Cardinal Health 107, LLC	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-7981_799de820-451a-4759-88dd-be9729577356	55154-7981	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Cardinal Health 107, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55154-7985_389af6c8-387a-4ce2-9eee-4ab434c1108a	55154-7985	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Cardinal Health 107, LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55154-7987_d8094232-acb3-43c6-b56e-38020e8d8946	55154-7987	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Cardinal Health 107, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55154-7990_ada89285-f980-4a38-97a4-9f5173ff7b0d	55154-7990	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19781201		ANDA	ANDA086066	Cardinal Health 107, LLC	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
55154-7991_ada89285-f980-4a38-97a4-9f5173ff7b0d	55154-7991	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	19830426		ANDA	ANDA088088	Cardinal Health 107, LLC	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
55154-7992_0481c94e-0ca5-40b5-a586-932bda69ff0c	55154-7992	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Cardinal Health 107, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-7993_0481c94e-0ca5-40b5-a586-932bda69ff0c	55154-7993	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Cardinal Health 107, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-7994_a16ff9ba-96db-435e-ae56-c6736032b498	55154-7994	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040604	Cardinal Health 107, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55154-7995_761ce0b3-1ae1-4a95-8a66-617b76fdb81e	55154-7995	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070904		ANDA	ANDA040597	Cardinal Health 107, LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
55154-7996_41e524f5-bd05-4de3-aed7-a5c946cd12f0	55154-7996	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Cardinal Health 107, LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55154-7998_53885fdc-63f3-42a2-b7b1-84b47fda4dc4	55154-7998	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Cardinal Health 107, LLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-7999_4211aaa5-701d-45d6-841c-bd1dc9ce8190	55154-7999	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Cardinal Health 107, LLC	PAROXETINE HYDROCHLORIDE ANHYDROUS	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55154-8075_0b0ebc8f-cf87-4a59-bbaa-7cc75e98587f	55154-8075	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	Cardinal Health 107, LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
55154-8078_c39c0f1a-923f-4763-b032-e892602ccfb8	55154-8078	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	Cardinal Health 107, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55154-8079_1c4f1636-400d-4004-9f9b-0012b38ebb79	55154-8079	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20030702		ANDA	ANDA065095	Cardinal Health 107, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55154-8080_cf2dbfe7-7338-445f-b4c1-1105c13783d4	55154-8080	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20150315		ANDA	ANDA084176	Cardinal Health 107, LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55154-8081_c595ada5-212e-4b67-8d86-80dcb718ab31	55154-8081	HUMAN OTC DRUG	Cetirizine		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA078336	Cardinal Health 107, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
55154-8082_5392301c-8570-4c79-aee4-627d8c980e31	55154-8082	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20050221		ANDA	ANDA076301	Cardinal Health 107, LLC	LORATADINE	10	mg/1			N	20241231
55154-8083_b0f364cc-c8ef-4bc2-a7a7-f4062251fb61	55154-8083	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150613		ANDA	ANDA090061	Cardinal Health 107, LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
55154-8085_95c1913f-92a4-40fb-8521-6b2a0baeec02	55154-8085	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Cardinal Health 107, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
55154-8086_cb8ce75a-2578-43cc-b847-4acedbdf1091	55154-8086	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Cardinal Health 107, LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
55154-8087_95c1913f-92a4-40fb-8521-6b2a0baeec02	55154-8087	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Cardinal Health 107, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
55154-8089_f64a2b16-2e08-492a-8075-f838b93b7d70	55154-8089	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20160118		ANDA	ANDA203002	Cardinal Health 107, LLC	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55154-8090_1f9f9d6e-fbde-4577-8ad8-230236fd76c3	55154-8090	HUMAN OTC DRUG	Polyethylene glycol 3350		Polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190630		ANDA	ANDA203928	Cardinal Health 107, LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55154-8091_4b899547-a5b5-410b-a9df-b30185ac9b1b	55154-8091	HUMAN OTC DRUG	Polyethylene glycol 3350		Polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190630		ANDA	ANDA203928	Cardinal Health 107, LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55154-8092_7618b5c8-3966-43d4-96ac-192f97500969	55154-8092	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Cardinal Health 107, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55154-8093_c5a43901-8506-4aab-a72e-481f59dda523	55154-8093	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20130120		ANDA	ANDA078226	Cardinal Health 107, LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55154-8094_6826ad94-7137-4b02-9ab4-826134322284	55154-8094	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818		ANDA	ANDA065398	Cardinal Health 107, LLC	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
55154-8095_27fde482-3c69-4da2-9fe4-e312f880fbe8	55154-8095	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515		ANDA	ANDA204713	Cardinal Health 107, LLC	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
55154-8096_c39c0f1a-923f-4763-b032-e892602ccfb8	55154-8096	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Cardinal Health 107, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55154-8097_c03676d4-14b7-4551-8d9e-de26ec60da0b	55154-8097	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Cardinal Health 107, LLC	PREGABALIN	50	mg/1		CV	N	20241231
55154-8098_c03676d4-14b7-4551-8d9e-de26ec60da0b	55154-8098	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Cardinal Health 107, LLC	PREGABALIN	75	mg/1		CV	N	20241231
55154-8099_98a24cc0-0058-4baa-9c97-7117694194cc	55154-8099	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Cardinal Health 107, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-8104_4a0c1e4c-981d-4f0b-afe9-8d97b90c5220	55154-8104	HUMAN PRESCRIPTION DRUG	Multaq		Dronedarone	TABLET, FILM COATED	ORAL	20090701		NDA	NDA022425	Cardinal Health 107, LLC	DRONEDARONE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55154-8131_666d1845-5a05-4805-b706-43cdbaa3ecb0	55154-8131	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	Cardinal Health 107, LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-8136_6d89a287-af01-4431-8889-8813d5e04a8c	55154-8136	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20121122		ANDA	ANDA077691	Cardinal Health 107, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55154-8138_666d1845-5a05-4805-b706-43cdbaa3ecb0	55154-8138	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	Cardinal Health 107, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-8145_87b2d33f-e9d1-45b1-a1aa-2b7e94899048	55154-8145	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Cardinal Health 107, LLC	MIRTAZAPINE	30	mg/1			N	20241231
55154-8175_3f34aa16-dbe6-4e97-83e8-2fa344ad9465	55154-8175	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20090422		ANDA	ANDA077091	Cardinal Health 107, LLC	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55154-8176_3af2981f-e9f9-4ccd-815a-9a9f05c47f49	55154-8176	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20120716	20240430	ANDA	ANDA078539	Cardinal Health 107, LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
55154-8177_29d3e753-7841-4aff-9f56-1b3bbad8b08e	55154-8177	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120807		ANDA	ANDA077127	Cardinal Health 107, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55154-8179_9fab1983-e704-42bc-b424-f626ab780719	55154-8179	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20140311		ANDA	ANDA076140	Cardinal Health 107, LLC	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
55154-8180_f7cf6d0d-9b6f-4e04-be6b-b8d64fb68a78	55154-8180	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20171228		ANDA	ANDA076143	Cardinal Health 107, LLC	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55154-8181_a34302d9-985f-47fc-95d4-ee07b5ee310b	55154-8181	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20150331		ANDA	ANDA071745	Cardinal Health 107, LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55154-8183_fd23bbd7-00fe-48b7-8918-29db7b95e007	55154-8183	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20181004		ANDA	ANDA084285	Cardinal Health 107, LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55154-8184_4cfcbd52-66a2-4e5f-be3d-56db5759f280	55154-8184	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20190415		ANDA	ANDA203928	Cardinal Health 107, LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55154-8185_af9cb46d-da61-4ff0-93f1-657cc5fb26c5	55154-8185	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20190615		ANDA	ANDA204742	Cardinal Health 107, LLC	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55154-8186_8749a43b-7c15-48e4-bd7b-09a2e36d41a7	55154-8186	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol Capsules 0.25 mcg	CAPSULE	ORAL	20190123		ANDA	ANDA091356	Cardinal Health 107, LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
55154-8187_3bc13938-b3d4-43db-a0af-741413e5846c	55154-8187	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20141104		ANDA	ANDA078069	Cardinal Health 107, LLC	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-8188_ba191a8b-f3f5-48a1-b6da-55489852099d	55154-8188	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20170817		ANDA	ANDA207179	Cardinal Health 107, LLC	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55154-8189_05e47930-1b13-4020-8c0c-4fae05d54de1	55154-8189	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20191216		ANDA	ANDA078926	Cardinal Health 107, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-8190_81fc8b1f-0f80-4959-a3ed-b7a1d1245d1d	55154-8190	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20200220		ANDA	ANDA070772	Cardinal Health 107, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
55154-8191_b2cceada-2e74-4e97-aac1-84cecc9b1f21	55154-8191	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20091023		ANDA	ANDA075576	Cardinal Health 107, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-8192_0ccbb353-898a-4be4-a8a6-fa0e3e4302a9	55154-8192	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190716		ANDA	ANDA207743	Cardinal Health 107, LLC	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55154-8193_05e47930-1b13-4020-8c0c-4fae05d54de1	55154-8193	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20191216		ANDA	ANDA078926	Cardinal Health 107, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-8194_c66422ea-b88d-4a54-8249-b52f66ab15ec	55154-8194	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20201125		ANDA	ANDA090858	Cardinal Health 107, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-8195_c66422ea-b88d-4a54-8249-b52f66ab15ec	55154-8195	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20201125		ANDA	ANDA090858	Cardinal Health 107, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-8198_3bc13938-b3d4-43db-a0af-741413e5846c	55154-8198	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20141105		ANDA	ANDA078069	Cardinal Health 107, LLC	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55154-8225_172cee9d-1f33-4363-a716-c9db724b8c0c	55154-8225	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170615		ANDA	ANDA208973	Cardinal Health 107, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55154-8226_c98b4840-38a2-4bbc-bccc-9cfbb90961e0	55154-8226	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20180707		ANDA	ANDA211079	Cardinal Health 107, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55154-8335_9c76662f-6846-4f80-85fa-20980a465f48	55154-8335	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20051208		ANDA	ANDA077376	Cardinal Health 107, LLC	MIRTAZAPINE	15	mg/1			N	20241231
55154-8336_68ef6a53-b1c3-4fc8-b0af-7de8e97b5b39	55154-8336	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160330		ANDA	ANDA205675	Cardinal Health 107, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55154-8337_9bb6e75c-5bc3-4a55-8ac6-3473d1e4993e	55154-8337	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Cardinal Health 107, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55154-8712_eaa551c0-5c11-45b4-9f9b-3533810c065b	55154-8712	HUMAN PRESCRIPTION DRUG	Myrbetriq		mirabegron	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120628		NDA	NDA202611	Cardinal Health 107, LLC	MIRABEGRON	25	mg/1	Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]		N	20241231
55154-8713_eaa551c0-5c11-45b4-9f9b-3533810c065b	55154-8713	HUMAN PRESCRIPTION DRUG	Myrbetriq		mirabegron	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120628		NDA	NDA202611	Cardinal Health 107, LLC	MIRABEGRON	50	mg/1	Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]		N	20241231
55154-9357_b03e1c7b-0f7d-4496-b65b-573635e89e72	55154-9357	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION	INTRAVENOUS	20000810		ANDA	ANDA088912	Cardinal Health 107, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
55154-9363_f7cc373a-3db7-4341-a2a1-44d80e0f6180	55154-9363	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		diphenhydramine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20020528		ANDA	ANDA040466	Cardinal Health 107, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55154-9364_26ca4cac-ad28-4d57-95b5-a857f210e41e	55154-9364	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000907		ANDA	ANDA084916	Cardinal Health 107, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55154-9366_196fd752-9fbe-4157-be8b-d1e58482efce	55154-9366	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20010905		ANDA	ANDA075784	Cardinal Health 107, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-9368_ae956d16-c68f-4530-93a5-3cf538eb4bbe	55154-9368	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20001018		ANDA	ANDA075784	Cardinal Health 107, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-9398_3a163d54-847a-4a29-853f-c0607c10902c	55154-9398	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20001018		ANDA	ANDA075784	Cardinal Health 107, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55154-9403_2301ca53-8fb1-4bff-b9b6-4f2e37b4e02b	55154-9403	HUMAN OTC DRUG	Milk of Magnesia		Milk of Magnesia	SUSPENSION	ORAL	20110607		OTC MONOGRAPH DRUG	M001	Cardinal Health 107, LLC	MAGNESIUM HYDROXIDE	2400	mg/30mL			N	20241231
55154-9422_c585020b-7e1f-45e2-a06d-ae2fe5e1828d	55154-9422	HUMAN OTC DRUG	Mag-Al Plus XS		Magnesium Hydroxide, Aluminum Hydroxide, Simethicone	SUSPENSION	ORAL	20110607		OTC MONOGRAPH DRUG	M001	Cardinal Health 107, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	2400; 240; 2400	mg/30mL; mg/30mL; mg/30mL	Skin Barrier Activity [PE]		N	20241231
55154-9429_0dca466c-99b4-4d84-b6b0-cf29b24d21dc	55154-9429	HUMAN OTC DRUG	Mag-Al Plus		Magnesium Hydroxide, Aluminum Hydroxide, Simethicone	SUSPENSION	ORAL	20110607		OTC MONOGRAPH DRUG	M001	Cardinal Health 107, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	1200; 120; 1200	mg/30mL; mg/30mL; mg/30mL	Skin Barrier Activity [PE]		N	20241231
55154-9444_dd28d1ce-03ad-455a-9f7a-1a86dc039b4d	55154-9444	HUMAN PRESCRIPTION DRUG	AMANTADINE HYDROCHLORIDE		AMANTADINE HYDROCHLORIDE	SOLUTION	ORAL	19950717		ANDA	ANDA074509	Cardinal Health 107, LLC	AMANTADINE HYDROCHLORIDE	50	mg/5mL	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
55154-9448_4043c1e0-b672-4549-b8ef-d0dd154d1334	55154-9448	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	19660730		ANDA	ANDA074623	Cardinal Health 107, LLC	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55154-9449_1c0efebf-4e8e-48ab-96a8-987e54218040	55154-9449	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20070801		OTC MONOGRAPH DRUG	M013	Cardinal Health 107, LLC	ACETAMINOPHEN	650	mg/20.3mL			N	20251231
55154-9450_0910827a-8299-4d01-9c4f-6b97843431ed	55154-9450	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	SOLUTION	ORAL	20020901		OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
55154-9553_d8a5eeb0-0d9e-420e-9a87-6cad12da7a3e	55154-9553	HUMAN PRESCRIPTION DRUG	Haloperidol		HALOPERIDOL LACTATE	INJECTION, SOLUTION	INTRAMUSCULAR	20101215		ANDA	ANDA075689	Cardinal Health 107, LLC	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
55154-9554_5839a673-4b89-4839-8523-6774e55e61fd	55154-9554	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA040388	Cardinal Health 107, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55154-9581_79f37dcc-627f-4f56-a0b8-dfe9fcffe158	55154-9581	HUMAN PRESCRIPTION DRUG	Furosemide		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000712		NDA	NDA018902	Cardinal Health 107, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-9582_ff9e6c64-ba84-47eb-8d08-038e18e8e331	55154-9582	HUMAN PRESCRIPTION DRUG	Furosemide		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000712		NDA	NDA018902	Cardinal Health 107, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55154-9583_40648c69-55d1-4237-89d7-84db01ce1c1f	55154-9583	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191104		NDA	NDA017029	Cardinal Health 107, LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-9584_5b1e243e-89c5-448b-a192-45ef95201a44	55154-9584	HUMAN PRESCRIPTION DRUG	Oxytocin		OXYTOCIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000810		NDA	NDA018248	Cardinal Health 107, LLC	OXYTOCIN	10	[USP'U]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
55154-9585_dd9a7222-7419-4b91-95c4-902bd3024fe1	55154-9585	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200325		NDA	NDA017029	Cardinal Health 107, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
55154-9618_982eb2fb-710f-41e5-89b3-484cb137fd4f	55154-9618	HUMAN PRESCRIPTION DRUG	BRILINTA		Ticagrelor	TABLET	ORAL	20110805		NDA	NDA022433	Cardinal Health 107, LLC	TICAGRELOR	90	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
55154-9626_15bd2f54-d49b-45f7-a933-204cd5f82989	55154-9626	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19950710	20240630	ANDA	ANDA040014	Cardinal Health 107, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
55154-9627_6a8d7267-cfa3-41e9-b66c-96be237681b7	55154-9627	HUMAN OTC DRUG	Guaiatussin AC	Sugar Free	guaifenesin and codeine phosphate	LIQUID	ORAL	20100908		OTC MONOGRAPH DRUG	M012	Cardinal Health 107, LLC	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
55154-9630_d5806d9e-4be0-4605-bdae-3e5849385399	55154-9630	HUMAN OTC DRUG	Docu Liquid		Docusate Sodium	LIQUID	ORAL	19970801		OTC MONOGRAPH DRUG	M007	Cardinal Health 107, LLC	DOCUSATE SODIUM	50	mg/5mL			N	20241231
55154-9631_a02c199a-5b64-497f-a829-d40b1254eafd	55154-9631	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19950710		ANDA	ANDA040014	Cardinal Health 107, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55165-0106_a8077cfe-b8db-4a5b-a933-93832e5d2ec4	55165-0106	HUMAN OTC DRUG	Blemish serum		Salicylic acid	LOTION	TOPICAL	20140626		OTC MONOGRAPH FINAL	part333D	Juice Beauty	SALICYLIC ACID	.75	g/100mL			N	20241231
55165-0110_123fe009-2517-47e6-b480-ef21e2b90af2	55165-0110	HUMAN OTC DRUG	SPF 30 tinted mineral moisturizer Sheer		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-0111_123fe009-2517-47e6-b480-ef21e2b90af2	55165-0111	HUMAN OTC DRUG	SPF 30 tinted mineral moisturizer Sand		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-0201_5692792b-73e1-43e3-a57f-ef14f5f4e91c	55165-0201	HUMAN OTC DRUG	SPF 8 Lip Moisturizers		Zinc Oxide	KIT		20141010		OTC MONOGRAPH FINAL	part352	Juice Beauty						N	20241231
55165-0202_7306c557-b14d-47b2-b142-78ed066ea960	55165-0202	HUMAN OTC DRUG	SPF 30 Oil-Free Moisturizer		Zinc Oxide	LOTION	TOPICAL	20100515		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-0203_4b6b9b46-0c61-422d-9ca4-4aed9dffab4d	55165-0203	HUMAN OTC DRUG	GREEN APPLE HAND SANITIZER		Alcohol	GEL	TOPICAL	20200522		OTC MONOGRAPH NOT FINAL	part333A	Juice Beauty	ALCOHOL	70	mL/100mL			N	20241231
55165-0204_e1552d9d-74cc-472c-91d5-95f8438bba06	55165-0204	HUMAN OTC DRUG	SPF 30 Sport Sunscreen		Zinc Oxide	LOTION	TOPICAL	20140603		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-0301_985fd351-b912-4aa7-92b1-c0c1f30253f4	55165-0301	HUMAN OTC DRUG	PREBIOTIX SPF 45 Glow		Zinc Oxide	LOTION	TOPICAL	20230219		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	22	g/100mL			N	20241231
55165-1001_663b87a7-6211-4dbc-a73b-699d2f4f4338	55165-1001	HUMAN OTC DRUG	Stem Cellular CC Cream natural glow		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-1002_663b87a7-6211-4dbc-a73b-699d2f4f4338	55165-1002	HUMAN OTC DRUG	Stem Cellular CC Cream rosy glow		Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-1003_663b87a7-6211-4dbc-a73b-699d2f4f4338	55165-1003	HUMAN OTC DRUG	Stem Cellular CC Cream beach glow		Zinc Oxide	LOTION	TOPICAL	20200310		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-1004_663b87a7-6211-4dbc-a73b-699d2f4f4338	55165-1004	HUMAN OTC DRUG	Stem Cellular CC Cream desert glow		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-1005_663b87a7-6211-4dbc-a73b-699d2f4f4338	55165-1005	HUMAN OTC DRUG	Stem Cellular CC Cream warm glow		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-1006_663b87a7-6211-4dbc-a73b-699d2f4f4338	55165-1006	HUMAN OTC DRUG	Stem Cellular CC Cream sun-kissed glow		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55165-1007_663b87a7-6211-4dbc-a73b-699d2f4f4338	55165-1007	HUMAN OTC DRUG	Stem Cellular CC Cream deep glow		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Juice Beauty	ZINC OXIDE	20	g/100mL			N	20241231
55239-004_0a090b1d-aca6-61ab-e063-6294a90a05c3	55239-004	HUMAN OTC DRUG	Pharma C Wipes 70 Isopropyl Alcohol		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20190301	20241201	OTC MONOGRAPH DRUG	M003	Kleen Test Products Corporation	ISOPROPYL ALCOHOL	700	mg/mL			N	
55239-326_0a09699a-0fa6-7404-e063-6394a90afebc	55239-326	HUMAN OTC DRUG	Pharma C Wipes 70 Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20220201	20241201	OTC MONOGRAPH DRUG	M003	Kleen Test Products Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	
55239-327_09c385d7-2e81-f49a-e063-6294a90a77bf	55239-327	HUMAN OTC DRUG	Pharma C Wipes 70 Isopropyl Alcohol		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20220201		OTC MONOGRAPH DRUG	M003	Kleen Test Products Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
55239-358_09c37c1c-308b-6d9f-e063-6394a90a5de3	55239-358	HUMAN OTC DRUG	The Pharma C Company Medicated Foam with Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20220515		OTC MONOGRAPH DRUG	M015	Kleen Test Products Corporation	WITCH HAZEL	500	mg/mL			N	20241231
55239-359_09c3a8c5-a238-8c5e-e063-6394a90ac328	55239-359	HUMAN OTC DRUG	The Pharma-C Company Medicated Hemorrhoidal Pads		WITCH HAZEL	CLOTH	TOPICAL	20210501		OTC MONOGRAPH DRUG	M015	Kleen Test Products Corporation	WITCH HAZEL	500	mg/mL			N	20241231
55239-360_09c3a8c5-a247-8c5e-e063-6394a90ac328	55239-360	HUMAN OTC DRUG	The Pharma-C Company 3 Hydrogen Peroxide Wipes		HYDROGEN PEROXIDE	CLOTH	TOPICAL	20210501		OTC MONOGRAPH DRUG	M003	Kleen Test Products Corporation	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
55239-361_09c37c1c-309a-6d9f-e063-6394a90a5de3	55239-361	HUMAN OTC DRUG	The Pharma-C Company 70 Isopropyl Alcohol Pads		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20210201		OTC MONOGRAPH DRUG	M003	Kleen Test Products Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
55239-362_09c37526-4fef-7bf6-e063-6394a90a6788	55239-362	HUMAN OTC DRUG	The Pharma-C Company 70 Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20190301		OTC MONOGRAPH DRUG	M003	Kleen Test Products Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
55239-555_0a0aef1f-b991-0920-e063-6394a90aa146	55239-555	HUMAN OTC DRUG	Pharma C wipes Hemorrhoidal		WITCH HAZEL	CLOTH	TOPICAL	20210501	20241201	OTC MONOGRAPH DRUG	M015	Kleen Test Products Corporation	WITCH HAZEL	500	mg/mL			N	
55253-801_4f6d6bdf-8143-4d0f-9a2c-f732527f8692	55253-801	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120329		NDA AUTHORIZED GENERIC	NDA020717	CIMA LABS INC.	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
55253-802_4f6d6bdf-8143-4d0f-9a2c-f732527f8692	55253-802	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120329		NDA AUTHORIZED GENERIC	NDA020717	CIMA LABS INC.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
55264-007_f5781495-1085-424a-e053-2995a90a4686	55264-007	HUMAN OTC DRUG	Sinsin Mulpas		Camphor, Menthol, Methyl Salicylate	LIQUID	CUTANEOUS; TOPICAL; TRANSDERMAL	20140110		OTC MONOGRAPH NOT FINAL	part348	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	4.5; 4.2; 6.9	mg/mL; mg/mL; mg/mL			N	20241231
55264-012_f5b822e0-794c-1f53-e053-2995a90a77d9	55264-012	HUMAN OTC DRUG	SINSINPAP COOL		LEVOMENTHOL, THYMOL, CAMPHOR, MENTHA, EUCALYPTUS	PATCH	CUTANEOUS; TOPICAL; TRANSDERMAL	20160530		OTC MONOGRAPH NOT FINAL	part348	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; LEVOMENTHOL; PEPPERMINT OIL; THYMOL	82.4; 16.5; 49.4; 164.7; 16.5	mg/1; mg/1; mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55264-020_f566e256-8b5c-3a28-e053-2a95a90af1c4	55264-020	HUMAN OTC DRUG	Arex Sinsin Pas		Camphor, Mentha Oil, Menthol, Methyl Salicylate, Zinc Oxide	PATCH	CUTANEOUS; TOPICAL; TRANSDERMAL	20150831		OTC MONOGRAPH NOT FINAL	part348	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE; PEPPERMINT OIL; ZINC OXIDE	17.05; 45.45; 45.45; 22.73; 215.91	mg/1; mg/1; mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55264-021_f5780205-c72f-7bcf-e053-2a95a90a8ce9	55264-021	HUMAN OTC DRUG	Arex Sinsin Pas		Camphor, Mentha Oil, Menthol, Methyl Salicylate, Zinc Oxide	PATCH	CUTANEOUS; TOPICAL; TRANSDERMAL	20130726		OTC MONOGRAPH NOT FINAL	part348	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE; PEPPERMINT OIL; ZINC OXIDE	34.1; 90.9; 90.9; 45.46; 431.82	mg/1; mg/1; mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55264-101_0e3c635a-adb7-f966-e063-6294a90aedb6	55264-101	HUMAN OTC DRUG	SINSINPAS Pain Relieving Patch		DL-Camphor, L-menthol, methyl salicylate	PATCH	TOPICAL	20170501		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	5.56; 25.48; 28.1	g/459.93g; g/459.93g; g/459.93g			N	20251231
55264-102_0e3c635a-adb8-f966-e063-6294a90aedb6	55264-102	HUMAN OTC DRUG	AIR SINSINPAS-EX		L-menthol, Methyl salicylate, Dl-Camphor	SPRAY	TOPICAL	20170822		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	6; 6.4; 3.5	g/200mL; g/200mL; g/200mL			N	20251231
55264-103_0e3c6c41-6e7c-1e7c-e063-6394a90a7fcd	55264-103	HUMAN OTC DRUG	SINSINPAP HOT		Dl-Camphor, Mentha oil, Eucalyptus oil	PATCH	TOPICAL	20180213		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; PEPPERMINT OIL	82.4; 16.5; 164.7	mg/17.5g; mg/17.5g; mg/17.5g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
55264-104_0e3cb18b-0257-3807-e063-6394a90a3793	55264-104	HUMAN OTC DRUG	SINSINPAS COLD		L-Menthol	PATCH	TOPICAL	20180801		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	MENTHOL	.85	g/17g			N	20251231
55264-106_0e3c6c41-6e7f-1e7c-e063-6394a90a7fcd	55264-106	HUMAN OTC DRUG	SINSINPAS LIDOCAINE PAIN RELIEVING		Lidocaine	PATCH	CUTANEOUS; TOPICAL; TRANSDERMAL	20170525		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	LIDOCAINE	560	mg/14g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
55264-107_f5b7bc7f-1a07-5a6d-e053-2a95a90a84d6	55264-107	HUMAN OTC DRUG	SINSIN MULPAS		L-menthol, Methyl salicylate, DL-camphor, Chlorpheniramine maleate, Thymol	LIQUID	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part348	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); CHLORPHENIRAMINE MALEATE; MENTHOL; METHYL SALICYLATE	4500; 100; 4200; 6900	mg/120mL; mg/120mL; mg/120mL; mg/120mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55264-108_0e3ca520-41c7-28d6-e063-6394a90a5bba	55264-108	HUMAN OTC DRUG	SINSINPAS AREX INSTANT PAIN RELIEF (NOT FOR SALE)		Camphor, Mentha Oil, Menthol, Methyl Salicylate, Zinc Oxide	PATCH	TOPICAL	20201106		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE; PEPPERMINT OIL; ZINC OXIDE	17.05; 45.45; 45.45; 22.73; 215.91	mg/1; mg/1; mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
55264-109_0e3cb43a-d0eb-3728-e063-6394a90a619a	55264-109	HUMAN OTC DRUG	SINSINPAS AREX INSTANT PAIN RELIEF SMALL		Camphor, Menthol, Mentha Oil, Methyl Salicylate, Zinc Oxide	PATCH	CUTANEOUS; TOPICAL; TRANSDERMAL	20210629		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE; PEPPERMINT OIL; ZINC OXIDE	34.1; 90.9; 90.9; 45.46; 431.82	mg/1; mg/1; mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
55264-110_0e3cbb1d-3c32-392e-e063-6394a90ac8c7	55264-110	HUMAN OTC DRUG	SINSINPAS HOT LARGE		Capsaicin	PATCH	TOPICAL	20210629		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	CAPSAICIN	30	mg/1			N	20251231
55264-112_0e3cb18b-0253-3807-e063-6394a90a3793	55264-112	HUMAN OTC DRUG	SINSINPAS AREXLOTION		L-Menthol	LOTION	TOPICAL	20210827		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	ALPHA-TOCOPHEROL ACETATE; LEVOMENTHOL; METHYL SALICYLATE	1; 60; 200	mg/1; mg/1; mg/1			N	20251231
55264-114_0e3cb332-0192-23b2-e063-6294a90aed38	55264-114	HUMAN OTC DRUG	SINSINPAS AREXGEL		L-Menthol	PATCH	TOPICAL	20210827		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	96; 76.8; 57.6	mg/1; mg/1; mg/1			N	20251231
55264-115_0e3cbd23-3479-2cb9-e063-6294a90ae8a5	55264-115	HUMAN OTC DRUG	SINSINPAS CORN REMOVER		Salicylic Acid	PATCH	TOPICAL	20220627		OTC MONOGRAPH DRUG	M017	Sinsin Pharmaceutical Co., Ltd.	SALICYLIC ACID	25.6	mg/1001			N	20251231
55289-019_0152652e-638e-79d4-e063-6294a90ad2ba	55289-019	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19900930		ANDA	ANDA061926	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55289-020_01526f56-25e9-ec88-e063-6394a90ac7c9	55289-020	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19900930		ANDA	ANDA061926	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55289-025_05f3439a-ef17-7365-e063-6394a90aa1b1	55289-025	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20110906		ANDA	ANDA061621	PD-Rx Pharmaceuticals, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
55289-037_fe465b9a-f9e7-2a9b-e053-6394a90afed3	55289-037	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	PD-Rx Pharmaceuticals, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55289-049_05f36ca9-68e4-b536-e063-6294a90a9fb3	55289-049	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	19871101		ANDA	ANDA087499	PD-Rx Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
55289-053_01526f56-261d-ec88-e063-6394a90ac7c9	55289-053	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	PD-Rx Pharmaceuticals, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55289-057_05f37b56-c9e0-c080-e063-6394a90a34a3	55289-057	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
55289-058_05f3835b-d7c5-e4d8-e063-6394a90a33b6	55289-058	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
55289-067_f93b8feb-82f6-8158-e053-6294a90a7c2b	55289-067	HUMAN PRESCRIPTION DRUG	Chlorthalidone		chlorthalidone	TABLET	ORAL	19810226		ANDA	ANDA086831	PD-Rx Pharmaceuticals, Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
55289-075_05f33924-a704-73cf-e063-6394a90aa212	55289-075	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20110906		ANDA	ANDA061621	PD-Rx Pharmaceuticals, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
55289-090_05f3935d-5887-045c-e063-6294a90a2fd7	55289-090	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA073449	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
55289-092_05f344e7-a6e6-b5ab-e063-6294a90a7880	55289-092	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	PD-Rx Pharmaceuticals, Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55289-112_05f33924-a705-73cf-e063-6394a90aa212	55289-112	HUMAN PRESCRIPTION DRUG	Erythrocin Stearate		ERYTHROMYCIN STEARATE	TABLET, FILM COATED	ORAL	20110801		ANDA	ANDA060359	PD-Rx Pharmaceuticals, Inc.	ERYTHROMYCIN STEARATE	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
55289-119_f28d9f42-cfe1-07bc-e053-2a95a90ac707	55289-119	HUMAN PRESCRIPTION DRUG	Compro		PROCHLORPERAZINE	SUPPOSITORY	RECTAL	20000901		ANDA	ANDA040246	PD-Rx Pharmaceuticals, Inc.	PROCHLORPERAZINE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55289-133_05f3173f-ac1a-75cb-e063-6294a90a6622	55289-133	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	PD-Rx Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
55289-150_fb5d158f-fc88-6f9f-e053-6294a90a64fa	55289-150	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	PD-Rx Pharmaceuticals, Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55289-160_07ff65c7-f1d5-e1b5-e063-6294a90a2a9c	55289-160	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	PD-Rx Pharmaceuticals, Inc.	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
55289-168_05f3c9e6-4478-3507-e063-6294a90a36d5	55289-168	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077487	PD-Rx Pharmaceuticals, Inc.	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55289-182_01546da4-818f-ec29-e063-6394a90a0304	55289-182	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, CHEWABLE	ORAL	19930101		ANDA	ANDA064013	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55289-196_d92e4d7f-8be5-5cf6-e053-2995a90a1f8a	55289-196	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	PD-Rx Pharmaceuticals, Inc.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55289-201_05f3835b-d7c8-e4d8-e063-6394a90a33b6	55289-201	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA063065	PD-Rx Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55289-202_05f3935d-588a-045c-e063-6294a90a2fd7	55289-202	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19920201		ANDA	ANDA063181	PD-Rx Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55289-217_05f3dd78-1076-6359-e063-6294a90a8a8a	55289-217	HUMAN PRESCRIPTION DRUG	ERY-TAB		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20110418		ANDA	ANDA062298	PD-Rx Pharmaceuticals, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
55289-218_e9adecd3-6dba-d489-e053-2a95a90a27c0	55289-218	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20080825		ANDA	ANDA077419	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55289-233_05f37b56-c9e2-c080-e063-6394a90a34a3	55289-233	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070176	PD-Rx Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55289-261_05f3dd78-1077-6359-e063-6294a90a8a8a	55289-261	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		PD-Rx Pharmaceuticals, Inc.	SUS SCROFA THYROID	60	mg/1			N	20241231
55289-262_05f3c9e6-4479-3507-e063-6294a90a36d5	55289-262	HUMAN PRESCRIPTION DRUG	Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		PD-Rx Pharmaceuticals, Inc.	SUS SCROFA THYROID	120	mg/1			N	20241231
55289-272_fa19ef91-a111-0f76-e053-6394a90a4c5f	55289-272	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	PD-Rx Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55289-301_05f419d9-5c5f-b2b2-e063-6294a90a83f3	55289-301	HUMAN PRESCRIPTION DRUG	Glipizide	ER	Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20031119		ANDA	ANDA076467	PD-Rx Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55289-315_f89d4e7c-ad5c-8448-e053-6294a90ac039	55289-315	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA073192	PD-Rx Pharmaceuticals, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
55289-330_0763c21b-1de8-8a89-e063-6294a90abaab	55289-330	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030213		ANDA	ANDA084283	PD-Rx Pharmaceuticals, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55289-344_05f3dd78-107a-6359-e063-6294a90a8a8a	55289-344	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	19960213		ANDA	ANDA074505	PD-Rx Pharmaceuticals, Inc.	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55289-359_0155bfae-d537-94ff-e063-6394a90adec4	55289-359	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20020410		ANDA	ANDA075604	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55289-367_fbd53122-0528-9baa-e053-6294a90a5399	55289-367	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20070426		ANDA	ANDA078432	PD-Rx Pharmaceuticals, Inc.	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55289-370_05f419d9-5c60-b2b2-e063-6294a90a83f3	55289-370	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55289-382_0155d2a5-3b4f-bafc-e063-6394a90ad6c8	55289-382	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040223		ANDA	ANDA076704	PD-Rx Pharmaceuticals, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55289-393_05f421d7-ff92-881c-e063-6394a90a4e99	55289-393	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	PD-Rx Pharmaceuticals, Inc.	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
55289-469_05f429ea-9887-f330-e063-6394a90a6378	55289-469	HUMAN PRESCRIPTION DRUG	INDOMETHACIN		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20090306		ANDA	ANDA079175	PD-Rx Pharmaceuticals, Inc.	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55289-479_06bd6f4f-aa1b-4c21-e063-6394a90a856b	55289-479	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	CAPSULE	ORAL	20061011		OTC MONOGRAPH DRUG	M012	PD-Rx Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55289-488_05f419d9-5c62-b2b2-e063-6294a90a83f3	55289-488	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA071851	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
55289-492_05f5890c-5c06-a825-e063-6294a90a6d32	55289-492	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20091202		ANDA	ANDA040625	PD-Rx Pharmaceuticals, Inc.	FOLIC ACID	1	mg/1			N	20241231
55289-493_06bd4b19-f28d-2ba0-e063-6394a90a1c23	55289-493	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE	ORAL	20160301		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
55289-502_05f59f9c-bda2-9201-e063-6294a90aad6a	55289-502	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE, GELATIN COATED	ORAL	19841107		ANDA	ANDA062396	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55289-523_0155d2a5-3bb4-bafc-e063-6394a90ad6c8	55289-523	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19980325		ANDA	ANDA074909	PD-Rx Pharmaceuticals, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55289-525_05f5a35d-5dd9-bae5-e063-6294a90ad748	55289-525	HUMAN PRESCRIPTION DRUG	ERY-TAB		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20110418		ANDA	ANDA062298	PD-Rx Pharmaceuticals, Inc.	ERYTHROMYCIN	333	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
55289-536_efe1a0f9-ed1b-54d7-e053-2a95a90afb80	55289-536	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890228		ANDA	ANDA072575	PD-Rx Pharmaceuticals, Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55289-560_06bd57d2-f4c7-e66e-e063-6294a90a701e	55289-560	HUMAN OTC DRUG	Chlorpheniramine Maleate		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	PD-Rx Pharmaceuticals, Inc.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55289-563_0c54d277-2bb7-4659-e063-6294a90ad058	55289-563	HUMAN OTC DRUG	Acetaminophen	Regular Strength	Acetaminophen	TABLET	ORAL	20070109		OTC MONOGRAPH DRUG	M013	PD-Rx Pharmaceuticals, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
55289-569_074ece7e-e1a9-a65b-e063-6294a90acb06	55289-569	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	PD-Rx Pharmaceuticals, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
55289-581_05f62d61-d2e3-d8b2-e063-6294a90a6fd9	55289-581	HUMAN PRESCRIPTION DRUG	Cimetidine		cimetidine	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074246	PD-Rx Pharmaceuticals, Inc.	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55289-582_f93b8380-193d-231c-e053-6294a90a7581	55289-582	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	PD-Rx Pharmaceuticals, Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55289-589_05f660dc-2b6c-a585-e063-6394a90a57c9	55289-589	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070131		ANDA	ANDA065282	PD-Rx Pharmaceuticals, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
55289-592_05f62d61-d2e4-d8b2-e063-6294a90a6fd9	55289-592	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	PD-Rx Pharmaceuticals, Inc.	DICLOXACILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
55289-624_f89d302c-1086-e2d3-e053-6394a90a879c	55289-624	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
55289-633_f93c76dd-aebc-c97a-e053-6294a90a9a3e	55289-633	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	PD-Rx Pharmaceuticals, Inc.	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55289-649_05f6890e-0cba-a5be-e063-6394a90acfb3	55289-649	HUMAN PRESCRIPTION DRUG	MethylPREDNISolone		methylprednisolone	TABLET	ORAL	19981222		ANDA	ANDA040183	PD-Rx Pharmaceuticals, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55289-660_05f67adb-a0bc-189c-e063-6294a90a483d	55289-660	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	PD-Rx Pharmaceuticals, Inc.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55289-692_05f67adb-a0bd-189c-e063-6294a90a483d	55289-692	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	PD-Rx Pharmaceuticals, Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55289-694_05f6890e-0cbd-a5be-e063-6394a90acfb3	55289-694	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	PD-Rx Pharmaceuticals, Inc.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
55289-701_f89d29bd-47c6-8ade-e053-6394a90ab5b6	55289-701	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20120815		ANDA	ANDA040876	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
55289-704_0516f626-d27f-3a39-e063-6294a90a47be	55289-704	HUMAN PRESCRIPTION DRUG	Prevacid		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	19950510		NDA	NDA020406	PD-Rx Pharmaceuticals, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55289-720_05f6824d-77c9-6c3a-e063-6294a90ab3dc	55289-720	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	19970528		ANDA	ANDA040195	PD-Rx Pharmaceuticals, Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
55289-723_017e3df4-42ed-b272-e063-6294a90ab7ab	55289-723	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090917		ANDA	ANDA078906	PD-Rx Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55289-728_f28dadfe-ed9f-1d47-e053-2a95a90a2ad3	55289-728	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20171101		ANDA	ANDA076134	PD-Rx Pharmaceuticals, Inc.	LORATADINE	10	mg/1			N	20241231
55289-738_05f6e4ee-4ff7-d2b5-e063-6394a90af047	55289-738	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20040818	20240229	ANDA	ANDA076368	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
55289-757_fe46b4bb-6e77-2907-e053-6394a90a144e	55289-757	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	19880721		ANDA	ANDA072234	PD-Rx Pharmaceuticals, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
55289-767_02092a2f-d731-5109-e063-6294a90a94f7	55289-767	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065096	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55289-779_05f67adb-a0c1-189c-e063-6294a90a483d	55289-779	HUMAN PRESCRIPTION DRUG	Glipizide	ER	Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20031119		ANDA	ANDA076467	PD-Rx Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55289-791_f89d1677-4074-ae30-e053-6394a90a0353	55289-791	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
55289-798_05f709fb-8858-fada-e063-6394a90a4349	55289-798	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	PD-Rx Pharmaceuticals, Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55289-806_074ec180-e1cc-7a22-e063-6394a90a7c0e	55289-806	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	PD-Rx Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55289-822_05f6e4ee-4ff8-d2b5-e063-6394a90af047	55289-822	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	PD-Rx Pharmaceuticals, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
55289-824_0209347c-6506-02ad-e063-6294a90ad1ab	55289-824	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	PD-Rx Pharmaceuticals, Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55289-845_0209674a-f188-aef1-e063-6394a90a8e67	55289-845	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065101	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
55289-866_02095841-c4fc-554d-e063-6294a90aaf55	55289-866	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20030702		ANDA	ANDA065095	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55289-880_06be1d9e-7170-1b56-e063-6294a90aa3da	55289-880	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180112		OTC MONOGRAPH DRUG	M013	PD-Rx Pharmaceuticals, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
55289-881_05f77230-a091-366f-e063-6294a90a70c7	55289-881	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	PD-Rx Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55289-884_02097c4d-ed96-8f5b-e063-6294a90a8073	55289-884	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55289-903_fb5d2541-0b24-aa17-e053-6394a90ae3e6	55289-903	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750603		ANDA	ANDA084613	PD-Rx Pharmaceuticals, Inc.	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55289-923_f92a7eda-ddcc-0bf2-e053-6294a90a8af1	55289-923	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	PD-Rx Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55289-928_f89cf6b0-3ad4-8b87-e053-6394a90a14eb	55289-928	HUMAN PRESCRIPTION DRUG	PROMETHEGAN		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20020228		ANDA	ANDA040428	PD-Rx Pharmaceuticals, Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55289-930_05f87e3d-f96f-4fa9-e063-6394a90ad92d	55289-930	HUMAN PRESCRIPTION DRUG	Sulindac		Sulindac	TABLET	ORAL	19900403		ANDA	ANDA071795	PD-Rx Pharmaceuticals, Inc.	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55289-949_06be3508-7537-1685-e063-6294a90a7ff1	55289-949	HUMAN OTC DRUG	Fiber Lax		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20100901		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
55289-959_05f843af-1e83-59b9-e063-6394a90a49cc	55289-959	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401		ANDA	ANDA077662	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55289-972_020987eb-942d-18c4-e063-6294a90a2706	55289-972	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	PD-Rx Pharmaceuticals, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55289-993_05f81f14-528d-8f82-e063-6394a90ab6f6	55289-993	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	19920801		ANDA	ANDA073665	PD-Rx Pharmaceuticals, Inc.	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
55289-995_05f81f14-528c-8f82-e063-6394a90ab6f6	55289-995	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	PD-Rx Pharmaceuticals, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55292-122_8893e663-d79a-498d-9429-beb94b98a9fa	55292-122	HUMAN PRESCRIPTION DRUG	NEOPROFEN		ibuprofen lysine	SOLUTION	INTRAVENOUS	20060413		NDA	NDA021903	Recordati Rare Diseases Inc.	IBUPROFEN LYSINE	10	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55292-131_020b4f40-1cec-b6c3-e063-6294a90a0e57	55292-131	HUMAN PRESCRIPTION DRUG	Signifor		pasireotide	INJECTION	SUBCUTANEOUS	20121214		NDA	NDA200677	Recordati Rare Diseases, Inc.	PASIREOTIDE	.3	mg/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
55292-132_020b4f40-1cec-b6c3-e063-6294a90a0e57	55292-132	HUMAN PRESCRIPTION DRUG	Signifor		pasireotide	INJECTION	SUBCUTANEOUS	20121214		NDA	NDA200677	Recordati Rare Diseases, Inc.	PASIREOTIDE	.6	mg/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
55292-133_020b4f40-1cec-b6c3-e063-6294a90a0e57	55292-133	HUMAN PRESCRIPTION DRUG	Signifor		pasireotide	INJECTION	SUBCUTANEOUS	20121214		NDA	NDA200677	Recordati Rare Diseases, Inc.	PASIREOTIDE	.9	mg/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
55292-139_7f9d4693-34c2-42ea-9b93-f41bfed6eb7b	55292-139	HUMAN PRESCRIPTION DRUG	Signifor LAR		pasireotide	KIT		20141215		NDA	NDA203255	Recordati Rare Diseases, Inc.						N	20241231
55292-140_7f9d4693-34c2-42ea-9b93-f41bfed6eb7b	55292-140	HUMAN PRESCRIPTION DRUG	Signifor LAR		pasireotide	KIT		20141215		NDA	NDA203255	Recordati Rare Diseases, Inc.						N	20241231
55292-141_7f9d4693-34c2-42ea-9b93-f41bfed6eb7b	55292-141	HUMAN PRESCRIPTION DRUG	Signifor LAR		pasireotide	KIT		20141215		NDA	NDA203255	Recordati Rare Diseases, Inc.						N	20241231
55292-142_7f9d4693-34c2-42ea-9b93-f41bfed6eb7b	55292-142	HUMAN PRESCRIPTION DRUG	Signifor LAR		pasireotide	KIT		20141215		NDA	NDA203255	Recordati Rare Diseases, Inc.						N	20241231
55292-143_7f9d4693-34c2-42ea-9b93-f41bfed6eb7b	55292-143	HUMAN PRESCRIPTION DRUG	Signifor LAR		pasireotide	KIT		20141215		NDA	NDA203255	Recordati Rare Diseases, Inc.						N	20241231
55292-201_b9a905cf-3d84-41a1-9aba-95a35ef8d624	55292-201	HUMAN PRESCRIPTION DRUG	Chemet		succimer	CAPSULE	ORAL	20130821		NDA	NDA019998	Recordati Rare Diseases, Inc.	SUCCIMER	100	mg/1	Lead Chelating Activity [MoA], Lead Chelator [EPC]		N	20241231
55292-320_10dfb430-b311-4afe-9f28-e8cb47aa629a	55292-320	HUMAN PRESCRIPTION DRUG	Isturisa		Osilodrostat	TABLET, COATED	ORAL	20200331		NDA	NDA212801	Recordati Rare Diseases, Inc.	OSILODROSTAT PHOSPHATE	1	mg/1	Cortisol Synthesis Inhibitor [EPC], Cytochrome P450 11B1 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA]		N	20241231
55292-321_10dfb430-b311-4afe-9f28-e8cb47aa629a	55292-321	HUMAN PRESCRIPTION DRUG	Isturisa		Osilodrostat	TABLET, COATED	ORAL	20200331		NDA	NDA212801	Recordati Rare Diseases, Inc.	OSILODROSTAT PHOSPHATE	5	mg/1	Cortisol Synthesis Inhibitor [EPC], Cytochrome P450 11B1 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA]		N	20241231
55292-410_14790aa9-d493-4d63-b24d-caf35230caf5	55292-410	HUMAN PRESCRIPTION DRUG	CYSTADROPS		cysteamine hydrochloride	SOLUTION	OPHTHALMIC	20200819		NDA	NDA211302	RECORDATI RARE DISEASES, INC.	CYSTEAMINE HYDROCHLORIDE	3.5	mg/mL	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
55292-702_745f96fb-57fa-4e71-9a6d-ff6dc3ead0c7	55292-702	HUMAN PRESCRIPTION DRUG	Panhematin		hemin	POWDER, FOR SOLUTION	INTRAVENOUS	19830720		BLA	BLA101246	RECORDATI RARE DISEASES, INC.	HEMIN	7	mg/mL			N	20241231
55292-811_2afdf978-8e90-40e9-872f-9f8775dcd41c	55292-811	HUMAN PRESCRIPTION DRUG	Cosmegen		dactinomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19641210		NDA	NDA050682	Recordati Rare Diseases, Inc.	DACTINOMYCIN	.5	mg/mL	Actinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]		N	20241231
55301-004_ca2a3750-49c2-4d39-9f57-094a8957eebc	55301-004	HUMAN OTC DRUG	Kids Flouride Rinse		Sodium Fluoride	RINSE	ORAL	20110209		OTC MONOGRAPH FINAL	part355	Military Exchanges	SODIUM FLUORIDE	.2	mg/mL			N	20241231
55301-021_e467c306-a2ee-4976-e053-2995a90a56ed	55301-021	HUMAN OTC DRUG	EXCHANGE SELECT KIDS SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20110502		OTC MONOGRAPH NOT FINAL	part352	Army & Air Force Exchange Service	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
55301-022_e467c9c1-b615-790b-e053-2a95a90a4f57	55301-022	HUMAN OTC DRUG	EXCHANGE SELECT SPORT SUNSCREEN CONTINUOUS SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20110502		OTC MONOGRAPH NOT FINAL	part352	Army & Air Force Exchange Service	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
55301-038_5d7f7e45-7d6a-10dc-e053-2991aa0a389c	55301-038	HUMAN OTC DRUG	Sugar Free Cherry Cough Drops		Menthol	LOZENGE	ORAL	20171108		OTC MONOGRAPH FINAL	part341	Army & Air Force Exchange Service	MENTHOL	5.8	1/1			N	20241231
55301-041_e716ba8c-0149-07f2-e053-2a95a90a53df	55301-041	HUMAN OTC DRUG	Exchange Select Sport Sunscreen Continuous SPF 70		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20110502		OTC MONOGRAPH NOT FINAL	part352	Army & Air Force Exchange Service	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
55301-042_f5582854-d315-6c2b-e053-2a95a90a0ec3	55301-042	HUMAN OTC DRUG	EXCHANGE SELECT SPORT SUNSCREEN CONTINUOUS SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20130328		OTC MONOGRAPH FINAL	M020	Army & Air Force Exchange Service	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
55301-050_a8c73cd8-3559-4ebd-9695-f970e1f8f993	55301-050	HUMAN OTC DRUG	Exchange Select Ibuprofen PM		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20150828		ANDA	ANDA079113	Army & Air Force Exchange Service	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-052_d7dfeb1d-71a4-46a7-aac5-9ff526bfb85d	55301-052	HUMAN OTC DRUG	exchange select sleeptime		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20230309		OTC MONOGRAPH FINAL	part338	Army & Air Force Exchange Service	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-063_8ada7d8a-f8d1-42f1-96d3-74503c34217e	55301-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20021029		OTC MONOGRAPH FINAL	part347	For Your Military Exchange	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; mg/mL			N	20241231
55301-066_ff139eb3-14a0-4924-a4af-e01e485f85f5	55301-066	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150831		OTC MONOGRAPH FINAL	part341	AAFES/Your Military Exchanges	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-067_461012a3-9aa1-4a26-b460-b976eae00c96	55301-067	HUMAN OTC DRUG	Exchange Select triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20160226		OTC MONOGRAPH FINAL	part333B	Army & Air Force Exchange Service	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55301-069_14b0651f-aaf4-4520-a1be-c1576baa1d1f	55301-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20090106		OTC MONOGRAPH FINAL	part347	Your Military Exchange	PETROLATUM	1	g/g			N	20241231
55301-072_2f514eff-4439-41a3-89f2-1af41a998dd7	55301-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20020719		OTC MONOGRAPH NOT FINAL	part348	Military Exchanges	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55301-076_db19d938-42f8-4bb6-aa83-8c32f7b4cf9a	55301-076	HUMAN OTC DRUG	Exchange select all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20160513		ANDA	ANDA078336	Army & Air Force Exchange Service	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-102_8aead341-d9cb-4e52-981b-16f64e9c4731	55301-102	HUMAN OTC DRUG	Exchange Select Antacid	Tropical Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190306		OTC MONOGRAPH FINAL	part331	ARMY AND AIR FORCE EXCHANGE SERVICE	CALCIUM CARBONATE	750	mg/1			N	20241231
55301-107_d3fab6c6-2260-47c9-8345-38eea0253c9e	55301-107	HUMAN OTC DRUG	Exchange select		Vegetable Laxative From Senna Concentrate	TABLET	ORAL	20210209		OTC MONOGRAPH NOT FINAL	part334	ARMY AND AIR FORCE EXCHANGE SERVICE	SENNOSIDES	8.6	mg/1			N	20241231
55301-112_a295e834-2894-4100-89d5-a6776ab25570	55301-112	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	AAFES/Your Military Exchanges	DOCOSANOL	100	mg/g			N	20251231
55301-123_9a8aa326-af98-4275-a57f-c28cc9edc53f	55301-123	HUMAN OTC DRUG	Exchange Select First Aid Triple Anitbiotic Pain Relieving		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20160303		OTC MONOGRAPH FINAL	part333B	Army & Air Force Exchange Service	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55301-124_36d51c04-5a7e-4f01-b202-7d58d2e6029b	55301-124	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20190320		OTC MONOGRAPH FINAL	part335	YOUR MILITARY EXCHANGE	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
55301-130_f39516e5-a9b2-aebd-e053-2995a90a6448	55301-130	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Pen	LIQUID	TOPICAL	20171227		OTC MONOGRAPH FINAL	part333C	ARMY & AIR FORCE EXCHANGE SERVICE	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
55301-131_f27b5ee3-702b-19bd-e053-2a95a90ad25f	55301-131	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20171227		OTC MONOGRAPH FINAL	part333C	ARMY & AIR FORCE EXCHANGE SERVICE	TOLNAFTATE	1.5	g/150g			N	20241231
55301-132_f27b52ee-984a-0947-e053-2a95a90a1e53	55301-132	HUMAN OTC DRUG	Tolnaftate		Antifungal Powder Spray	AEROSOL, SPRAY	TOPICAL	20120103		OTC MONOGRAPH FINAL	part333C	ARMY & AIR FORCE EXCHANGE SERVICE	TOLNAFTATE	1.3	g/130g			N	20241231
55301-133_f27b5d02-dc70-2151-e053-2a95a90abf1d	55301-133	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20171227		OTC MONOGRAPH FINAL	part358B	ARMY & AIR FORCE EXCHANGE SERVICE	SALICYLIC ACID	.17	mg/9mL			N	20241231
55301-153_0f96177c-75f5-4c6d-8d4e-d5aa2e35293b	55301-153	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19990126		OTC MONOGRAPH FINAL	part358H	Your Military Exchanges	PYRITHIONE ZINC	10	mg/mL			N	20241231
55301-157_e15fcfb8-b7b4-4416-9139-837a4ebb92ac	55301-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55301-163_0646d198-c067-4273-b0e7-541fc64e40db	55301-163	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	MOUTHWASH	ORAL	20060129		OTC MONOGRAPH DRUG	M021	Your Military Exchanges	SODIUM FLUORIDE	.1	mg/mL			N	20241231
55301-166_a9dd018b-e473-41ff-bcf7-efeafbcf54d1	55301-166	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20210603		OTC MONOGRAPH NOT FINAL	part334	Military Exchanges	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55301-175_51153d80-47bf-4ecd-ba42-77633cfb385b	55301-175	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN	500	mg/1			N	20241231
55301-177_0d29cfd7-4e7d-770c-e063-6394a90aff3b	55301-177	HUMAN OTC DRUG	Exchange Select Eye Drops Advanced Relief Moisturizer		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200212		OTC MONOGRAPH DRUG	M018	Army and Air Force Exchange Service	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
55301-178_0d29cc74-465b-735b-e063-6394a90a22de	55301-178	HUMAN OTC DRUG	Exchange Select Artificial Tears Lubricant Eye Drops		glycerin, hypromellose, polyethylene glycol 400	SOLUTION	OPHTHALMIC	20200212		OTC MONOGRAPH DRUG	M018	Army and Air Force Exchange Service	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
55301-188_a49a243d-8a08-46e7-9732-01a891b6d4f3	55301-188	HUMAN OTC DRUG	Exchange Select Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20160304		OTC MONOGRAPH FINAL	part346	Army & Air Force Exchange Service	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-189_ed282473-a1a0-4a87-86ec-2cd27634c3aa	55301-189	HUMAN OTC DRUG	Sleep-Aid		Diphenhydramine HCl	TABLET	ORAL	19900410		OTC MONOGRAPH DRUG	M010	ARMY AND AIR FORCE EXCHANGE SERVICE	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-190_c4925811-5ad6-4876-9138-19c2747f6ac8	55301-190	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	19900315		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-199_43d2698e-287c-47d1-a3d9-a2af04faf8b9	55301-199	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170630	20241227	ANDA	ANDA078682	AAFES/Your Military Exchanges	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55301-201_59577582-5ec2-4407-8638-629ef69209e5	55301-201	HUMAN OTC DRUG	Exchange Select Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160226		OTC MONOGRAPH NOT FINAL	part348	Army & Air Force Exchange Service	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55301-202_a914b5f3-ae30-4a8d-bcb8-745c78029ea6	55301-202	HUMAN OTC DRUG	exchange select Extra Strength Antacid	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190402		OTC MONOGRAPH FINAL	part331	ARMY AND AIR FORCE EXCHANGE SERVICE	CALCIUM CARBONATE	750	mg/1			N	20241231
55301-203_a9bcb259-66ee-4580-b378-ec3817e24e76	55301-203	HUMAN OTC DRUG	exchange select Ultra Strength Antacid	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190402		OTC MONOGRAPH FINAL	part331	ARMY AND AIR FORCE EXCHANGE SERVICE	CALCIUM CARBONATE	1000	mg/1			N	20241231
55301-205_161e0238-5ecb-47fd-89b2-7e2c7e781c0a	55301-205	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20080204		OTC MONOGRAPH FINAL	part358H	Your Military Exchange	COAL TAR	25	mg/mL			N	20241231
55301-211_73d01aa2-667f-444f-80e0-e2998222a989	55301-211	HUMAN OTC DRUG	exchange select miconazole 1		Miconazole nitrate	KIT		20200729		ANDA	ANDA079114	Army & Air Force Exchange Service						N	20241231
55301-213_d2955c2c-1be3-4eb2-9bd2-2f2cbaac889a	55301-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20041224		OTC MONOGRAPH FINAL	part355	Military Exchanges	SODIUM FLUORIDE	.2	mg/mL			N	20241231
55301-220_89ae1c44-c85d-40ab-82ae-dc352541e7e0	55301-220	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	CREAM	TOPICAL	20150707		OTC MONOGRAPH NOT FINAL	part348	Your Military Exchanges	ZINC OXIDE	130	mg/g			N	20241231
55301-226_9a6d8911-e8f8-4222-9546-42bab8b6b655	55301-226	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	ARMY AND AIR FORCE EXCHANGE SERVICE	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20251231
55301-227_ab041d97-2c73-46b7-92ed-9c0e01b6913f	55301-227	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	19921214		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55301-235_45ff247b-d6db-4dea-bc6b-e7996148ebf4	55301-235	HUMAN OTC DRUG	Acetaminophen PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19940515		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-248_dd3f27d8-1eaa-4e60-8eb4-682e91635f50	55301-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20090123		OTC MONOGRAPH FINAL	part341	Military Exchanges	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
55301-278_87542443-c0f2-4981-8bb2-c2d689475d31	55301-278	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20150519		OTC MONOGRAPH NOT FINAL	part333A	Your Military Exchanges	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
55301-279_f0440bc5-4c75-4a97-91c1-35f950f7f3c3	55301-279	HUMAN OTC DRUG	Exchange Select Hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20160505		OTC MONOGRAPH FINAL	part346	Army & Air Force Exchange Service	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-281_8c5270d3-2252-4684-9293-a8e68b2a6732	55301-281	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20020606		OTC MONOGRAPH FINAL	part358H	Your Military Exchange	PYRITHIONE ZINC	10	mg/mL			N	20241231
55301-291_9683efa4-5075-4a76-8aa5-1f613567405f	55301-291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	ARMY AND AIR FORCE EXCHANGE SERVICE	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-292_67de81b6-f5e0-4e93-ba15-696a81242803	55301-292	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	ARMY AND AIR FORCE EXCHANGE SERVICE	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-299_5a840905-41dd-4418-bd0f-7e987da9dcb3	55301-299	HUMAN OTC DRUG	Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20100628		OTC MONOGRAPH NOT FINAL	part356	Your Military Exchanges	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
55301-304_c5bd07bb-8ec4-4015-9450-95f60f8f9d98	55301-304	HUMAN OTC DRUG	Exchange Select Nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20111028		OTC MONOGRAPH FINAL	part341	Army & Air Force Exchange Service	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55301-306_f269a77c-0d01-4628-a331-e321f5d9a8de	55301-306	HUMAN OTC DRUG	Exchange Select ClearLax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20151008		ANDA	ANDA090685	Army & Air Force Exchange Service	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55301-311_0fead829-b282-4fd6-a306-d27fdae09af9	55301-311	HUMAN OTC DRUG	Everyday Clean 2 in 1		pyrithione zinc	SHAMPOO	TOPICAL	20040709		OTC MONOGRAPH FINAL	part358H	Your Military Exchanges	PYRITHIONE ZINC	10	mg/10mL			N	20241231
55301-314_e10ed15f-0c36-4fbf-9ce0-8d54f1b0cf82	55301-314	HUMAN OTC DRUG	EZ Nite Sleep Aid		Diphenhydramine HCl	LIQUID	ORAL	20150831		OTC MONOGRAPH FINAL	part338	AAFES/Your Military Exchanges	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-318_ce13243a-f618-4025-bdea-043ff7b92a64	55301-318	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl salicylate, thymol	MOUTHWASH	ORAL	20020708		OTC MONOGRAPH NOT FINAL	part356	Your Military Exchanges	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55301-326_7a26ffa5-eb2b-43cc-b44d-083d36fae531	55301-326	HUMAN OTC DRUG	Tartar Control Plus		eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19991025		OTC MONOGRAPH NOT FINAL	part356	Your Military Exchanges	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55301-329_49acf733-266e-4ea4-bc6f-157a349dc6a6	55301-329	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-334_92aacb48-fc62-4bfc-9a82-e5dd6df31535	55301-334	HUMAN OTC DRUG	Headache Formula	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20080313		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55301-337_3abef780-b612-4564-a702-04b9d690f26b	55301-337	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	AAFES/Your Military Exchanges	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-344_4d0ebc08-9a3a-4558-adc7-fc6ac731a88f	55301-344	HUMAN OTC DRUG	Nite Time Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20160131		OTC MONOGRAPH FINAL	part341	AAFES/Your Military Exchanges	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55301-348_13387330-3532-493f-a19f-7b1e7be61297	55301-348	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20030102		OTC MONOGRAPH DRUG	505G(a)(3)	ARMY AND AIR FORCE EXCHANGE SERVICE	SENNOSIDES	25	mg/1			N	20241231
55301-357_404096b6-6fb7-4d6c-9964-ca49bd667b0f	55301-357	HUMAN OTC DRUG	exchange select antacid	regular strength	Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20130108		OTC MONOGRAPH FINAL	part331	Army & Air Force Exchange Service	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55301-368_2e70737d-5e7c-48ab-a1fd-9322e37b38f7	55301-368	HUMAN OTC DRUG	exchange select naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20080826		ANDA	ANDA074661	Army & Air Force Exchange Service	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-370_7f438413-4317-4d35-ae4c-cceb7a8fa101	55301-370	HUMAN OTC DRUG	Advanced		Ethyl Alcohol	GEL	TOPICAL	20120927		OTC MONOGRAPH NOT FINAL	part333A	Your Military Exchanges	ALCOHOL	70	mL/100mL			N	20241231
55301-372_995bfb9e-1a60-419e-b033-98d2fa4e100f	55301-372	HUMAN OTC DRUG	Pink Bismuth	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20150831	20250831	OTC MONOGRAPH FINAL	part335	AAFES/Your Military Exchanges	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55301-375_06acc56d-2288-494a-b188-b4f056455c41	55301-375	HUMAN OTC DRUG	Anti Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	ARMY AND AIR FORCE EXCHANGE SERVICE	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
55301-376_afd46976-1e5f-478c-868c-8afbf4e869fe	55301-376	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20181231	20241231	OTC MONOGRAPH NOT FINAL	part356	AAFES/Your Military Exchanges	PHENOL	1.4	g/100mL			N	
55301-382_cfc34a1f-f4dc-4999-9d2c-766465eaa81b	55301-382	HUMAN OTC DRUG	Tussin Multi Symptom Cold CF	Adult	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20150831		OTC MONOGRAPH FINAL	part341	AAFES/Your Military Exchanges	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-385_19733bc4-01d0-4da5-a8bd-dc0a23a8183d	55301-385	HUMAN OTC DRUG	Tussin Cough and Chest Congestion DM	Adult	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20150930		OTC MONOGRAPH FINAL	part341	AAFES/Your Military Exchanges	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55301-388_2222fdc3-82eb-443b-a013-3187d2cf4c68	55301-388	HUMAN OTC DRUG	Exchange Select Nasal		Oxymetazoline HCl	SPRAY	NASAL	20140106		OTC MONOGRAPH FINAL	part341	Army & Air Force Exchange Service	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55301-392_da911261-30b0-40b9-9ae3-b9330274baf7	55301-392	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	ARMY AND AIR FORCE EXCHANGE SERVICE	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-393_2b1ab1e6-e273-45ca-b422-0ce39fc3bc57	55301-393	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	ARMY AND AIR FORCE EXCHANGE SERVICE	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-403_e7b15517-588c-4128-ab7a-223ec6692a60	55301-403	HUMAN OTC DRUG	Motion Sickness		Meclizine HCl	TABLET	ORAL	20020624		OTC MONOGRAPH DRUG	M009	ARMY AND AIR FORCE EXCHANGE SERVICE	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
55301-412_ab7be654-8c4b-4161-b969-13da62f4db16	55301-412	HUMAN OTC DRUG	Exchange Select Cold Sore Treatment		Camphor, Menthol, Phenol, White Petrolatum	GEL	TOPICAL	20201104		OTC MONOGRAPH NOT FINAL	part333E	Army & Air Force Exchange Service	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
55301-428_37a8e983-777a-4cd3-b0df-cfc31765f6d4	55301-428	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA078699	AAFES/Your Military Exchanges	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-429_37a8e983-777a-4cd3-b0df-cfc31765f6d4	55301-429	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA078697	AAFES/Your Military Exchanges	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-434_60644235-7e36-4c62-a561-204cd2f38156	55301-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130826		OTC MONOGRAPH NOT FINAL	part356	Your Military Exchange	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55301-435_db16f94c-acd1-4dee-8884-319f7305bc3e	55301-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150601		OTC MONOGRAPH FINAL	part355	Your Military Exchanges	SODIUM FLUORIDE	.1	mg/mL			N	20241231
55301-439_1d161412-9686-4012-b74a-8b888c81107a	55301-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20130429		OTC MONOGRAPH NOT FINAL	part333A	Your Military Exchanges	ALCOHOL	616	mL/mL			N	20241231
55301-446_3c903dd6-0fc1-44fa-9cd8-85218bec5114	55301-446	HUMAN OTC DRUG	Sinus Headache and Pain	Day, Non-drowsy	Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-450_768e4b27-9bc4-471e-86fa-5e9676b212ca	55301-450	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN	160	mg/1			N	20241231
55301-455_e838e197-a743-41c3-bd0a-3bd72c48950e	55301-455	HUMAN OTC DRUG	Allergy Multi-Symptom		Acetaminophen, Chlorpheniramine Maleate and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050628		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-462_298bc242-f2ef-4499-b2e5-59743319abd7	55301-462	HUMAN OTC DRUG	Suphedrine PE Sinus plus Allergy		Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20050609		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-464_c3679cbd-3453-4611-ba94-80a0e2a5ff4f	55301-464	HUMAN OTC DRUG	Allergy and Sinus Headache		Acetaminophen, Diphenhydramine HCl and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050615		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-470_8a15ca00-cedb-412a-8cdb-1de126366afc	55301-470	HUMAN OTC DRUG	Cold	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050715		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-482_5bf32f91-39e4-43bf-b2bd-cb31c6c55613	55301-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20131227		OTC MONOGRAPH FINAL	part355	Military Exchange	SODIUM FLUORIDE	.1	mg/mL			N	20241231
55301-486_14985848-d791-42b9-ad7e-810a85bb1ee1	55301-486	HUMAN OTC DRUG	exchange select stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20230302		OTC MONOGRAPH NOT FINAL	part334	Army & Air Force Exchange Service	DOCUSATE SODIUM	100	mg/1			N	20241231
55301-503_94f6ff1c-6281-46cf-900a-02774934bac7	55301-503	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079044	AAFES/Your Military Exchanges	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-504_94f6ff1c-6281-46cf-900a-02774934bac7	55301-504	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079038	AAFES/Your Military Exchanges	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-506_9cf0a3de-896a-47d0-959f-f77fafdc5d73	55301-506	HUMAN OTC DRUG	exchange select allergy relief		Fluticasone propionate	SPRAY, METERED	NASAL	20171027		ANDA	ANDA207957	Army & Air Force Exchange Service	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55301-519_5f67c803-2efc-4ab5-a3bb-b6166bcb7864	55301-519	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN	500	mg/1			N	20241231
55301-527_3462fcd4-1095-4541-8a1c-e43bf963afce	55301-527	HUMAN OTC DRUG	Sinus Congestion and Pain	Severe	Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-533_197ff9b8-cb09-42cf-9335-652688c66f4a	55301-533	HUMAN OTC DRUG	Mucus Relief DM		Dextromethorphan HBr and Guaifenesin	TABLET, FILM COATED	ORAL	20051231		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55301-543_503af3f8-f80f-442a-bac9-d82875cee2bc	55301-543	HUMAN OTC DRUG	NiteTime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171231		OTC MONOGRAPH FINAL	part341	AAFES/Your Military Exchanges	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55301-547_24a371bf-983e-4eb8-b578-1701b052505d	55301-547	HUMAN OTC DRUG	Cold and Flu	Day and Night, Severe	Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	KIT		20230331		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE						N	20241231
55301-573_097d596b-dbf1-487e-8e50-332893b07f1e	55301-573	HUMAN OTC DRUG	Cold and Flu	Severe, Day and Nighttime	Acetaminophen,Chlorpheniramine maleate, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	KIT		20050804	20250331	OTC MONOGRAPH FINAL	part341	ARMY AND AIR FORCE EXCHANGE SERVICE						N	
55301-595_9e540edb-2cfa-4353-a704-44bb7cd7221f	55301-595	HUMAN OTC DRUG	Exchange Select antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20160304		OTC MONOGRAPH FINAL	part331	Army & Air Force Exchange Service	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
55301-600_61660aef-e69c-434b-837f-b84ad8ec79d4	55301-600	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55301-602_e0f6ae81-1a59-4601-8135-e2f32594d38c	55301-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20021218		OTC MONOGRAPH NOT FINAL	part334	Your Military Exchange	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55301-612_c1b9eeab-6dcd-4b30-93fb-da22563c95db	55301-612	HUMAN OTC DRUG	exchange select allergy relief		Loratadine	TABLET	ORAL	20080826		ANDA	ANDA076301	Army & Air Force Exchange Service	LORATADINE	10	mg/1			N	20241231
55301-617_259cddbe-07cb-4319-adae-56f4783bad50	55301-617	HUMAN OTC DRUG	exchange select nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20180905		ANDA	ANDA077007	Army & Air Force Exchange Service	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-619_2f3bbf8b-630e-4d4f-bb28-ab80eec0810a	55301-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20110406		OTC MONOGRAPH FINAL	part347	Your Military Exchanges	DIMETHICONE	1.3	kg/100mL	Skin Barrier Activity [PE]		N	20241231
55301-620_ae3336ad-cc8c-4886-a5b6-5b1e779ad4f7	55301-620	HUMAN OTC DRUG	Severe Cold and Flu Relief	Daytime/Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Guaifenesin, Phenylephrine HCl	KIT		20180831		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE						N	20241231
55301-664_45be1895-6446-4d55-adfe-bd2e8b6bb7ee	55301-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20020709		OTC MONOGRAPH NOT FINAL	part356	Your Military Exchanges	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55301-676_34a710d5-ab45-4cc7-9881-f476e9789cf7	55301-676	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	ARMY AND AIR FORCE EXCHANGE SERVICE	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55301-679_edce5a2a-04cd-4c5b-a4a0-8aa121c5618d	55301-679	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength	Acetaminophen, Pamabrom, Pyrilamine Maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
55301-680_f5d3f7cd-b299-4bde-b3d1-2919d4e362c0	55301-680	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20210423		OTC MONOGRAPH DRUG	M002	ARMY AND AIR FORCE EXCHANGE SERVICE	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
55301-689_30b214f5-b9d1-4781-9c71-3221bb8d9248	55301-689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55301-724_770c3dd3-58ed-4354-8a7e-c902251c906f	55301-724	HUMAN OTC DRUG	Pink Bismuth	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part335	AAFES/Your Military Exchanges	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55301-734_e39e82a5-f642-4643-8509-4e585b8fa566	55301-734	HUMAN OTC DRUG	exchange select nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20180814		ANDA	ANDA203690	Army & Air Force Exchange Service	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-745_111c3cfa-46f1-48ce-8b33-9546e660d783	55301-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180331		ANDA	ANDA206568	AAFES/Your Military Exchanges	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-748_e3c9abf3-abe3-4836-bc15-d9dfc41385d1	55301-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180228		ANDA	ANDA208363	AAFES/Your Military Exchanges	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55301-753_ea3589ef-6021-458c-b3e4-927c26244c44	55301-753	HUMAN OTC DRUG	Suphedrine PE Sinus Congestion	Non-Drowsy	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210115		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
55301-773_8100a7a8-7877-413f-8a10-8f07dec98897	55301-773	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, FILM COATED	ORAL	20221229		OTC MONOGRAPH DRUG	505G(a)(3)	ARMY AND AIR FORCE EXCHANGE SERVICE	SENNOSIDES	25	mg/1			N	20241231
55301-810_aad9ebad-cbf2-4154-a7bd-10f7b7af12c9	55301-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20100408		OTC MONOGRAPH NOT FINAL	part333A	Your Military Exchanges	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
55301-812_99a11bea-8cf5-4c5d-95b1-eaedccaf9e7d	55301-812	HUMAN OTC DRUG	Exchange Select Mucus DM		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180801		ANDA	ANDA207602	Army & Air Force Exchange Service	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55301-817_45b59bde-99b6-4d99-8645-4252bee2bd78	55301-817	HUMAN OTC DRUG	Adult Tussin Cough and Chest Congestion DM	Sugar Free	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20181231		OTC MONOGRAPH FINAL	part341	AAFES/Your Military Exchanges	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55301-821_e3bf1e1d-e3b8-4415-abf7-bb090e953473	55301-821	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	19900912		OTC MONOGRAPH DRUG	M013	ARMY AND AIR FORCE EXCHANGE SERVICE	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55301-822_6545afe6-0aae-4a86-8cf5-48f4c50cca07	55301-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20021029		OTC MONOGRAPH FINAL	part347	Your Military Exchanges	WITCH HAZEL	86	kg/100L			N	20241231
55301-831_6ae8f2e6-d50d-4aa0-b303-2821bc2a5811	55301-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20150605		OTC MONOGRAPH NOT FINAL	part334	Your Military Exchanges	MINERAL OIL	999	mg/mL			N	20241231
55301-845_588cc5b2-6e7f-4c9c-8852-cbf7f47fef4c	55301-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20150626		OTC MONOGRAPH FINAL	part344	Your Military Exchanges	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
55301-847_6bb61ea9-5991-4b9f-b8cb-9c8c75a26fcc	55301-847	HUMAN OTC DRUG	exchange select aller ease		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20211229		ANDA	ANDA212971	Army & Air Force Exchange Service	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55301-857_6cb9d015-8650-4ba0-94c6-85135b6ad248	55301-857	HUMAN OTC DRUG	Exchange Select Atheletes foot		Clotrimazole	CREAM	TOPICAL	20160407		OTC MONOGRAPH FINAL	part333C	Army & Air Force Exchange Service	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55301-871_a07f3e35-1d21-4441-8af5-b4d6556cbb69	55301-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20021010		OTC MONOGRAPH NOT FINAL	part333A	Army + Air Force Exchange Service	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
55301-873_268ded35-3e84-43f7-b3ff-6fafc6c39aed	55301-873	HUMAN OTC DRUG	exchange select nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20180919		ANDA	ANDA077007	Army & Air Force Exchange Service	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-875_b2f4952a-7af1-413d-8068-14b0775eca85	55301-875	HUMAN OTC DRUG	Salicylic Acid		Astringent	LIQUID	TOPICAL	20090605		OTC MONOGRAPH FINAL	part333D	Your Military Exchanges	SALICYLIC ACID	5	mg/mL			N	20241231
55301-876_90cd724b-14c3-4028-bbb0-832536a65bb2	55301-876	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20110420		OTC MONOGRAPH NOT FINAL	part333A	Your Military Exchanges	ALCOHOL	70	mL/100mL			N	20241231
55301-877_0011bd50-1429-4b4e-a478-7ec8e7f7966f	55301-877	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20210701		ANDA	ANDA208754	AAFES/Your Military Exchanges	DOCOSANOL	100	mg/g			N	20241231
55301-898_44f0b5f1-72d9-4f6a-96b0-dc37a3da35a5	55301-898	HUMAN OTC DRUG	Exchange Select Esomeprazole Magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20171204		ANDA	ANDA207193	Army & Air Force Exchange Service	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55301-902_cc17479f-1642-4f71-8049-509561be03a6	55301-902	HUMAN OTC DRUG	Suphedrine PE Sinus Pressure Plus Pain		Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20210916		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55301-907_2fc12396-80b4-4f90-96ee-e667c07e40e9	55301-907	HUMAN OTC DRUG	Medicated Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part348	ARMY AND AIR FORCE EXCHANGE SERVICE	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
55301-912_935ff97b-c0bd-46d5-85b7-956c61540874	55301-912	HUMAN OTC DRUG	MAXIMUM STRENGTH Lidocaine Plus Menthol		Lidocaine, Menthol	PATCH	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part348	ARMY AND AIR FORCE EXCHANGE SERVICE	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55301-915_fa95ce8c-782a-4aea-9fc6-44f71e96b52d	55301-915	HUMAN OTC DRUG	exchange select omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20081028		NDA	NDA022032	Army & Air Force Exchange Service	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55301-916_ac116802-351f-433e-a325-02afea38ef95	55301-916	HUMAN OTC DRUG	Exchange Select Miconazole 1		Miconazole nitrate	KIT		20160325		ANDA	ANDA079114	Army & Air Force Exchange Service						N	20241231
55301-922_c3bc25d0-4b18-4c89-af46-537519ac370c	55301-922	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20200701	20241231	ANDA	ANDA208754	AAFES/Your Military Exchanges	DOCOSANOL	100	mg/g			N	
55301-932_4f692c0a-8c75-45ed-8645-54712b4e7ebc	55301-932	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, FILM COATED	ORAL	20051222		OTC MONOGRAPH DRUG	M012	ARMY AND AIR FORCE EXCHANGE SERVICE	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55301-941_6ddfe22b-1944-4a8d-91f2-ae16b7a88e9e	55301-941	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	LIQUID	TOPICAL	20140728		OTC MONOGRAPH NOT FINAL	part333A	Your Military Exchange	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
55301-947_a4073ccf-072a-4659-a523-7ea7bb9777e4	55301-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20090514		OTC MONOGRAPH FINAL	part333D	Military Exchanges	SALICYLIC ACID	20	mg/mL			N	20241231
55301-957_e926cf6f-305a-4912-be07-a45bb7905822	55301-957	HUMAN OTC DRUG	exchange select nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20180919		ANDA	ANDA203690	Army & Air Force Exchange Service	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55301-986_5f0017b6-99c0-47ed-9118-9a37adfbe868	55301-986	HUMAN OTC DRUG	Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190401		ANDA	ANDA040564	ARMY AND AIR FORCE EXCHANGE SERVICE	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55305-115_f63dc3b8-c791-3250-e053-2995a90a597b	55305-115	HUMAN OTC DRUG	AeroWash Eyewash		Eyewash Solution	LIQUID	OPHTHALMIC	20200101		NDA	NDA022305	Aero Healthcare US LLC	WATER	.983	mL/mL			N	20241231
55305-123_f75575ec-33c1-8328-e053-6294a90a3d5b	55305-123	HUMAN OTC DRUG	Aerosoothe		Triple Antibiotic Ointment	OINTMENT	TOPICAL	20151020		OTC MONOGRAPH FINAL	part333B	Aero Healthcare US LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55305-126_faa3a4ef-3c71-06ca-e053-6394a90a512d	55305-126	HUMAN OTC DRUG	AeroTab Non-Aspirin		ACETAMINOPHEN 500MG ES	TABLET	ORAL	20171031		OTC MONOGRAPH NOT FINAL	part343	Aero Healthcare	ACETAMINOPHEN	500	mg/1			N	20241231
55305-127_f63cee1f-8c8b-19e9-e053-2a95a90a854e	55305-127	HUMAN OTC DRUG	Aerotab Pain Reliever		Pain Reliever	TABLET	ORAL	20221101		OTC MONOGRAPH NOT FINAL	part343	Aero Healthcare	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
55312-029_dc8bca48-533b-4088-b150-6ac4e5df6726	55312-029	HUMAN OTC DRUG	Epsom Salt		MAGNESIUM SULFATE	GRANULE	ORAL	19980605		OTC MONOGRAPH NOT FINAL	part334	Western Family	MAGNESIUM SULFATE HEPTAHYDRATE	100	kg/100kg	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55315-008_0a6840c1-490b-436a-ae66-f6dffbdc5ee1	55315-008	HUMAN OTC DRUG	Athletes Foot		Clotrimazole	CREAM	TOPICAL	20181115		OTC MONOGRAPH FINAL	part333C	FRED'S, INC.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55315-009_221d1f32-5433-4de7-80a2-a9d12e81dc3d	55315-009	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20180331	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55315-060_c65bec74-3bf5-45d7-b88d-67a8f0e9cac2	55315-060	HUMAN OTC DRUG	NON ASPIRIN PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20151217	20250425	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-066_5a3b2a48-a055-4495-95e6-e4dbaaff99cb	55315-066	HUMAN OTC DRUG	Cold and Flu	Daytime Relief	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150731	20240731	OTC MONOGRAPH DRUG	M012	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-069_f059d005-1a6c-4bf4-9256-adb2480bc365	55315-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20141108		OTC MONOGRAPH FINAL	part347	Fred's Inc	PETROLATUM	1	g/g			N	20241231
55315-070_a2a822cd-813e-44c8-8353-cbca15fd3566	55315-070	HUMAN OTC DRUG	Stomach Relief	Cherry	Bismuth subsalicylate	LIQUID	ORAL	20150331	20240630	OTC MONOGRAPH DRUG	M008	Freds Inc	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55315-082_31a6fc26-b658-4a7f-a46e-b579391d2bb2	55315-082	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20171231	20240630	OTC MONOGRAPH DRUG	M013	Freds Inc	ACETAMINOPHEN	160	mg/5mL			N	
55315-092_443ae22a-bc4b-46b2-8072-5a388f2bd2de	55315-092	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine Hydrochloride	LIQUID	ORAL	20150430	20240430	OTC MONOGRAPH DRUG	M012	Freds Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-102_675cedb3-83f5-4972-965b-59a4c9c0f649	55315-102	HUMAN OTC DRUG	Night Time Sinus		Acetaminophen, Doxylamine Succinate, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20121205	20240404	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 6.25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-123_0ea71b09-2bcf-8966-e063-6294a90a813e	55315-123	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Fred's Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
55315-168_e5bad7e7-9289-40d3-abca-afa22a5bfb76	55315-168	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET	ORAL	20150930	20240426	ANDA	ANDA079096	Freds Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55315-169_1e33fc07-9351-4f95-9a04-277c1761ac6a	55315-169	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET	ORAL	20150930	20240426	ANDA	ANDA079096	Freds Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55315-180_d5183572-9325-4a54-a029-a70c4081782b	55315-180	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20181115		OTC MONOGRAPH FINAL	part333B	Fred's, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55315-181_f6f6ccf6-8b2a-4bd5-81ea-55aea3958c07	55315-181	HUMAN OTC DRUG	Freds Hydrocortisone	with Aloe	Hydrocortisone	CREAM	TOPICAL	20181115		OTC MONOGRAPH NOT FINAL	part348	FRED'S, INC.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55315-182_c4fa34b2-1ca9-4333-a656-0e44d4c54108	55315-182	HUMAN OTC DRUG	Freds Hydrocortisone	Plus 12 Moisturizers	Hydrocortisone	CREAM	TOPICAL	20181115		OTC MONOGRAPH NOT FINAL	part348	FRED'S, INC.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55315-190_2ac424ec-70fb-4b24-8f8e-7f445b9a6eb7	55315-190	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, COATED	ORAL	20100708	20250131	OTC MONOGRAPH NOT FINAL	part334	Freds Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55315-192_33b18d7c-541e-4ef8-a6a8-fdb1c8a186d1	55315-192	HUMAN OTC DRUG	Triple Antibiotic	Plus Pain Relief	bacitracin zinc, neomycin sulfate, polymyxin B sulfate, and pramoxine hydrochloride	OINTMENT	TOPICAL	20120331		OTC MONOGRAPH FINAL	part333B	FRED'S, INC.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55315-236_85778a59-976c-43a0-a25a-d8b633d5f666	55315-236	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20140201	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-244_4c396dba-4f4d-4abe-b006-b2bbf09689ac	55315-244	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20150430	20240426	OTC MONOGRAPH NOT FINAL	part334	Freds Inc	DOCUSATE SODIUM	100	mg/1			N	
55315-248_871a8c91-bee1-476b-8f29-845e6a74fa08	55315-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20090123		OTC MONOGRAPH FINAL	part341	Fred's Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
55315-268_aead34d1-d761-491b-ab24-31b11997fb0c	55315-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20141231	20240630	OTC MONOGRAPH DRUG	M022	Freds Inc	HYDROGEN PEROXIDE	2.65	mL/100mL			N	
55315-271_d0458b37-2d18-41e6-bdcb-37c445bbc659	55315-271	HUMAN OTC DRUG	Isopropyl alcohol	50 percent	Isopropyl alcohol	LIQUID	TOPICAL	20141231	20240630	OTC MONOGRAPH DRUG	M003	Freds Inc	ISOPROPYL ALCOHOL	50	mL/100mL			N	
55315-272_88ef753e-e32c-4f80-af04-411cae8734ea	55315-272	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol	50 percent Wintergreen	Isopropyl alcohol	LIQUID	TOPICAL	20141231	20240630	OTC MONOGRAPH DRUG	M003	Freds Inc	ISOPROPYL ALCOHOL	50	mL/100mL			N	
55315-275_25560d4d-8f1e-46db-84b7-774735574ebb	55315-275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20141231	20240630	OTC MONOGRAPH DRUG	M003	Freds Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	
55315-277_58bee24d-83ee-457f-84ab-997af6f363e1	55315-277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20141231	20240630	OTC MONOGRAPH DRUG	M003	Freds Inc	ISOPROPYL ALCOHOL	91	mL/100mL			N	
55315-282_cab5bb69-1ed3-427e-85ac-6636fcfac941	55315-282	HUMAN OTC DRUG	Childrens Non Aspirin		Acetaminophen	SUSPENSION	ORAL	20150630	20240630	OTC MONOGRAPH DRUG	M013	Freds Inc	ACETAMINOPHEN	160	mg/5mL			N	
55315-288_3899c679-0af0-41fd-b7d3-f0e8c6ee6870	55315-288	HUMAN OTC DRUG	Childrens Pain Reliever		Acetaminophen	SUSPENSION	ORAL	20151130	20240630	OTC MONOGRAPH DRUG	M013	Freds Inc	ACETAMINOPHEN	160	mg/5mL			N	
55315-297_a22b8980-ef51-471f-bef6-fee013b9bbdf	55315-297	HUMAN OTC DRUG	Childrens Plus Cough and Runny Nose		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide	SUSPENSION	ORAL	20151217	20240331	OTC MONOGRAPH DRUG	M012	Freds Inc	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-300_922d7aae-33b4-4634-aef0-e89a34a3e6bf	55315-300	HUMAN OTC DRUG	Childrens Plus Flu		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan Hydrobromide, Phenylephrine HCI	SUSPENSION	ORAL	20150630	20240126	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-301_a3afd43d-bf5f-4044-9952-243aac1251fa	55315-301	HUMAN OTC DRUG	FREDS SALINE TWIN PACK	LAXATIVE	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20191220		OTC MONOGRAPH NOT FINAL	part334	FRED'S	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/133mL; g/133mL			N	20241231
55315-304_8ba27ccb-4e49-4a25-80e5-1992e3d2b009	55315-304	HUMAN OTC DRUG	Childrens Plus Multi Symptom Cold		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	SUSPENSION	ORAL	20150331	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-312_e5a550a4-d35a-48ed-8a9c-0122db10b4f4	55315-312	HUMAN OTC DRUG	Childrens Dibromm Cold and Allergy		Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20150731	20240731	OTC MONOGRAPH DRUG	M012	Freds Inc	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-313_f7a5e4a5-9637-417a-af12-29bcd39e7c0d	55315-313	HUMAN OTC DRUG	Childrens Dibromm Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20150630	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-314_35fb6a51-3977-4433-b23d-5dab6ad13ae2	55315-314	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	LIQUID	ORAL	20180228	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-316_196e0e67-0ce1-461d-8ec2-50efe13bba08	55315-316	HUMAN OTC DRUG	Daytime Flu Relief Therapy	Severe Cough and Cold	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20151130	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-317_c857161b-7cf9-45e8-9194-124047aca168	55315-317	HUMAN OTC DRUG	Flu Relief Therapy Severe Cough and Cold	Nighttime	Acetaminophen, Diphenhydramine Hydrochloride, Phenylephrine Hydrochloride	LIQUID	ORAL	20151130	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
55315-327_e5460311-5296-449a-81b1-5c21842b9051	55315-327	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20180731	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55315-328_73e51a4d-2c7f-4a97-8500-0a3bd5a73d6c	55315-328	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20150630	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55315-333_bb89acc6-20df-465f-aca0-424c0d4dc32f	55315-333	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20040430		ANDA	ANDA076200	Fred's Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
55315-334_2747c1d7-19c8-44b0-88b7-998a1512a9de	55315-334	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	OIL	ORAL; TOPICAL	20161031	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	MINERAL OIL	100	mg/100mL			N	
55315-337_d9c97921-b31d-45a4-bac6-b0b5e6ac2739	55315-337	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20151031	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-342_da7bfccd-641f-4a16-b55f-0292559f35c9	55315-342	HUMAN OTC DRUG	Cold and Flu	Nighttime Relief	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20150731	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-344_b0501d34-9ed8-47f6-83b2-e45757a827a7	55315-344	HUMAN OTC DRUG	Cold and Flu	Nighttime Relief	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20150731	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-345_c9b5c7bc-9404-4993-b71d-3b8648859347	55315-345	HUMAN OTC DRUG	Nighttime Cough Relief		Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20150731	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-354_17d2db07-4de0-4e02-8e2e-0082c275faab	55315-354	HUMAN OTC DRUG	CHILDRENS ALLERGY RELIEF		Cetirizine Hydrochloride	SOLUTION	ORAL	20150131		ANDA	ANDA090750	Fred's, Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55315-366_f28b745e-8b0b-05da-e053-2995a90ac9c4	55315-366	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover Liquid	LIQUID	TOPICAL	20150901		OTC MONOGRAPH FINAL	part358F	Freds Stores of Tennessee, Inc	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
55315-367_b0461fd2-1ee8-0698-5fd2-d10a803f850e	55315-367	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20151016		ANDA	ANDA078878	FREDS	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55315-370_fcf856a6-9df2-46a6-b2ad-86e57f89fe45	55315-370	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20150202		OTC MONOGRAPH NOT FINAL	part333A	Fred's, Inc	ALCOHOL	70	mL/100mL			N	20241231
55315-371_72154fee-b301-4f47-a708-b1bf77333977	55315-371	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20150331	20240412	OTC MONOGRAPH FINAL	part335	Freds Inc	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55315-372_c8b52001-3569-4453-97bd-a66ee8b67ef0	55315-372	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20150331	20240630	OTC MONOGRAPH DRUG	M008	Freds Inc	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55315-373_f28b9230-3158-8c78-e053-2995a90a7c40	55315-373	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20171219		OTC MONOGRAPH FINAL	part333C	Freds Stores of Tennessee, Inc	TOLNAFTATE	1.5	g/150g			N	20241231
55315-374_f28b8ce7-6e0f-6706-e053-2a95a90ad1fe	55315-374	HUMAN OTC DRUG	Lidocaine		Burn Relief	AEROSOL, SPRAY	TOPICAL	20171219		OTC MONOGRAPH NOT FINAL	part348	Freds Stores of Tennessee, Inc	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55315-382_301a402b-0d58-4cc1-ad9d-f7fde98679cc	55315-382	HUMAN OTC DRUG	Tussin Multi Symptom Cold CF	Adult	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20150531	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-385_60e5fd02-018b-48e1-b9f6-beecd238732e	55315-385	HUMAN OTC DRUG	Adult Tussin Cough and Chest Congestion DM		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20150630	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-390_57df7dfd-8561-4959-b4da-db0ed2c741cd	55315-390	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20141231	20240630	OTC MONOGRAPH DRUG	M016	Freds Inc	WITCH HAZEL	842	mg/mL			N	
55315-395_4afcdd71-9b6d-42d7-835a-1ed4f7694913	55315-395	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20180228	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55315-403_95147820-d3bc-41a6-8548-7b9b94e282cc	55315-403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20150123		OTC MONOGRAPH NOT FINAL	part333A	Fred's Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
55315-413_da6acc7d-6950-8bd1-e053-2a95a90a3fb0	55315-413	HUMAN OTC DRUG	Freds Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	19980325	20240331	OTC MONOGRAPH FINAL	part347	Fred's, Inc.	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
55315-435_0dbe885f-b1f6-4401-a14f-ebdd9511b515	55315-435	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Fred's, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55315-443_206b41d8-e6e4-46b0-b5b1-2f61bb18547b	55315-443	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20180331	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-468_2a005355-a3ea-4b87-9acd-5f89a77b90ef	55315-468	HUMAN OTC DRUG	Daytime cold and flu relief		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20151218	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-487_f8bbef28-8730-4d30-8862-3ad2f8550442	55315-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160331	20240630	OTC MONOGRAPH DRUG	M016	Freds Inc	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
55315-492_becc9550-2f0d-402a-9429-7485fa042594	55315-492	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20160131	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	SENNOSIDES	25	mg/1			N	
55315-499_a2747420-28f8-486d-95d8-409c3b0afe6b	55315-499	HUMAN OTC DRUG	Cough Relief	Nighttime	Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20180131	20240426	OTC MONOGRAPH FINAL	part341	Freds Inc	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-505_67989da3-c37d-46c4-ba6f-adc842770596	55315-505	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160430	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-528_30c112e9-7c17-45cc-829d-d0cceea230c4	55315-528	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20030819		ANDA	ANDA076134	Fred's Inc.	LORATADINE	10	mg/1			N	20241231
55315-578_b02bd2a0-2f2c-43b1-a212-f532704b734e	55315-578	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190228	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	DOCUSATE SODIUM	100	mg/1			N	
55315-584_6b615b4b-1aa4-4b35-a6bf-d3e33c8a233e	55315-584	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE	ORAL	20180331	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	DOCUSATE SODIUM	100	mg/1			N	
55315-690_1ff4450a-eecc-420e-ab3d-9b4abb8bd4f1	55315-690	HUMAN OTC DRUG	Allergy Relief	Antihistamine	Diphenhydramine HCl	TABLET	ORAL	20100722	20240126	OTC MONOGRAPH FINAL	part336	Freds Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-732_2cca56df-ff8c-40ae-9e3b-f877ae847a2d	55315-732	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20190228	20240630	ANDA	ANDA207342	Freds Inc	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
55315-735_fe895e8e-fc91-4bac-b7bd-0a6f7eac5437	55315-735	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20181231	20241227	OTC MONOGRAPH FINAL	part341	Freds Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-737_4c5dc483-ffb4-4a86-bdd1-dbfef0d41a26	55315-737	HUMAN OTC DRUG	Freds	Miconazole 3	Miconazole Nitrate	CREAM	VAGINAL	20050302		ANDA	ANDA076773	FRED'S, INC.	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55315-741_f3ccc195-faa6-49b0-98c8-60aa5994f7b0	55315-741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180131	20250131	ANDA	ANDA207235	Freds Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-742_8c713f05-8273-4714-b619-575cf1837afc	55315-742	HUMAN OTC DRUG	Cold and Flu	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20180831	20241227	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55315-743_a00469d4-560d-4819-bf42-202315b278fb	55315-743	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180831	20241227	OTC MONOGRAPH FINAL	part341	Freds Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-748_5dd318fa-b234-4a7c-bea9-36d5bd147f46	55315-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190228	20240630	ANDA	ANDA208363	Freds Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55315-806_b0458063-a6ce-483d-8736-3fde8cf07d5c	55315-806	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20190228	20250228	ANDA	ANDA209274	Freds Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55315-815_a97a84b3-99ed-4470-91f0-dc519360d24f	55315-815	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	VAGINAL	19970113		ANDA	ANDA074444	FRED'S, INC.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55315-817_2cbd606b-06ca-41a8-ad69-d48435019a7c	55315-817	HUMAN OTC DRUG	Adult Tussin Cough and Chest Congestion DM	Sugar Free	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20180630	20240630	OTC MONOGRAPH DRUG	M012	Freds Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55315-824_f28b80ac-1317-4313-e053-2995a90a56d3	55315-824	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20151202		OTC MONOGRAPH FINAL	part358F	Freds Stores of Tennessee, Inc	SALICYLIC ACID	.17	g/9mL			N	20241231
55315-829_14a36e9f-7351-4118-a70a-ec6bfd947731	55315-829	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20181031	20240630	OTC MONOGRAPH DRUG	M007	Freds Inc	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
55315-832_d180c5a8-52b1-440a-8561-2a12fd2c2196	55315-832	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180930	20240630	OTC MONOGRAPH DRUG	M002	Freds Inc	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
55315-844_0b585827-3d29-4fb3-ae5a-cb6e219a7f6c	55315-844	HUMAN OTC DRUG	Naproxen Sodium PM		Naproxen Sodium	TABLET	ORAL	20190228	20240630	ANDA	ANDA209726	Freds Inc	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55315-867_9640a616-7084-4a84-ac04-4cfd0360d7cc	55315-867	HUMAN OTC DRUG	Low Dose Aspirin	Enteric Safety-Coated	Aspirin	TABLET	ORAL	20190331	20250331	OTC MONOGRAPH NOT FINAL	part343	Freds Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
55315-988_5486d426-470a-0bed-e054-00144ff8d46c	55315-988	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCl		Acetaminophen Diphenhydramine HCl	CAPSULE	ORAL	20170817		OTC MONOGRAPH NOT FINAL	part343	FREDS, INC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55315-996_f98a589b-6ae8-49c7-a273-444180714fc0	55315-996	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Fred's, Inc.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55316-009_5137b9f4-0011-43a6-9e7e-6488ffe9f924	55316-009	HUMAN OTC DRUG	Daily Oatmeal		Dimethicone	LOTION	TOPICAL	20150406		OTC MONOGRAPH FINAL	part347	DZA BRANDS, LLC	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
55316-011_05b76a30-fefc-45cc-92f0-f10d24f37614	55316-011	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20150320		OTC MONOGRAPH FINAL	part358H	Delhaize	PYRITHIONE ZINC	1	g/mL			N	20241231
55316-012_caf33623-b654-4570-901d-735234e05055	55316-012	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170308		OTC MONOGRAPH FINAL	part341	DZA Brands LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55316-013_46ea1549-99e4-4eb8-922a-844768c7ab78	55316-013	HUMAN OTC DRUG	cold, flu and sore throat		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170308		OTC MONOGRAPH FINAL	part341	DZA Brands LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55316-017_c39fd5a4-653b-458c-8f5a-b9d8bc8a1a4e	55316-017	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20150320		OTC MONOGRAPH FINAL	part358H	DZA BRANDS, llc	PYRITHIONE ZINC	10	mg/mL			N	20241231
55316-063_c157b5cb-59d7-4455-9624-4f20e3ca9e20	55316-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20080205		OTC MONOGRAPH FINAL	part347	DZB Brands, LLC	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL			N	20241231
55316-153_2ddb9133-9b48-44eb-8d75-89d127763f63	55316-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH FINAL	part358H	DZA Brands, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
55316-205_4a18e503-48f8-447a-bff0-dcd0d2bdb50f	55316-205	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20080508		OTC MONOGRAPH FINAL	part358H	DZA Brands, LLC	COAL TAR	5	mg/mL			N	20241231
55316-213_0576328c-a6b7-44be-8d53-a82d4eb33464	55316-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20110107		OTC MONOGRAPH FINAL	part355	DZA Brands, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
55316-296_0b592952-f40b-4a81-9017-55f41e032433	55316-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20090602		OTC MONOGRAPH FINAL	part358H	DZA Brands, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
55316-318_fe69a482-d17a-4b4e-9195-bd134a1c2993	55316-318	HUMAN OTC DRUG	Antiseptic		EUCALYPTOL, Menthol, Methyl salicylate, thymol	RINSE	ORAL	20080205		OTC MONOGRAPH NOT FINAL	part356	DZA Brands, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55316-370_5e64976f-f9af-4ee6-8604-3ac5ec099780	55316-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20140530		OTC MONOGRAPH NOT FINAL	part333A	DZA Brands	ALCOHOL	70	mL/100mL			N	20241231
55316-403_67f02358-2999-44a0-9bab-81bfa8c4d1e4	55316-403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20150206		OTC MONOGRAPH NOT FINAL	part333A	DZA Brands, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
55316-435_1a182dfa-cdce-48bb-8c97-99a916fede6d	55316-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150811		OTC MONOGRAPH FINAL	part355	DZA Brands	SODIUM FLUORIDE	.2	mg/mL			N	20241231
55316-439_9d0afef9-6078-448e-8cb2-b445c2a7657c	55316-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140327		OTC MONOGRAPH NOT FINAL	part333A	Delhaize	ALCOHOL	700	mg/mL			N	20241231
55316-602_4aed384c-8a0b-4886-a976-ff80d5bd6744	55316-602	HUMAN OTC DRUG	epsom salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20080227		OTC MONOGRAPH NOT FINAL	part334	DZA Brands, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55316-664_8d1104c7-d3bc-4e54-a4de-e999e69f46c7	55316-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20080205		OTC MONOGRAPH NOT FINAL	part356	DZA Brands LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55316-822_bdde0ccf-dead-47c0-93aa-446a4051b2e4	55316-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20080131		OTC MONOGRAPH FINAL	part347	DZA Brands	WITCH HAZEL	86	kg/100L			N	20241231
55316-831_32e54ddf-3712-4941-9828-f4ee5cfb8c07	55316-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20071022		OTC MONOGRAPH NOT FINAL	part334	DZA Brands LLC	MINERAL OIL	999	mg/mL			N	20241231
55316-871_2e53e007-f687-408d-a1d3-ca59f0753eba	55316-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20090122		OTC MONOGRAPH NOT FINAL	part333A	DZA Brands,	HYDROGEN PEROXIDE	.3	kg/100L			N	20241231
55316-942_155570f2-39c9-4a3c-b433-d97c2a61fc6d	55316-942	HUMAN OTC DRUG	Health		Cetylpyridinium chloride	MOUTHWASH	ORAL	20150403		OTC MONOGRAPH NOT FINAL	part356	DZA Brands LLC	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
55316-947_214aa484-f4b1-4b20-a525-51bb044c6355	55316-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20101209		OTC MONOGRAPH FINAL	part333D	DZA BRANDS, LLC	SALICYLIC ACID	20.6	mg/mL			N	20241231
55316-952_237626c3-ed37-4efb-8f88-19c67870c237	55316-952	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20150206		OTC MONOGRAPH NOT FINAL	part333A	DZA Brands	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
55319-002_c8c217a6-8322-1525-e053-2a95a90af7d7	55319-002	HUMAN OTC DRUG	FAMILY DOLLAR TROPIC SUN KIDS SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191011		OTC MONOGRAPH NOT FINAL	part352	Family Dollar Services Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
55319-003_e46823ad-0cb1-a1d6-e053-2995a90aab72	55319-003	HUMAN OTC DRUG	FAMILY DOLLAR TROPIC SUN SPORT SUNSCREEN CONTINUOUS SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20191011		OTC MONOGRAPH NOT FINAL	part352	Family Dollar Services Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
55319-004_d402acad-49cf-4ac8-a232-0aef7f2b6170	55319-004	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20110802		OTC MONOGRAPH DRUG	M021	Family Dollar Services, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
55319-005_778c6613-8b00-4520-9134-4d8f67b4c87c	55319-005	HUMAN OTC DRUG	Saline Laxative		sodium phosphate	ENEMA	RECTAL	20120831		OTC MONOGRAPH NOT FINAL	part334	FAMILY DOLLAR STORES, INC.	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
55319-006_ffd80d14-6500-369e-e053-6394a90a373b	55319-006	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20130524		OTC MONOGRAPH FINAL	part341	Family Dollar	MENTHOL	5.4	mg/1			N	20241231
55319-006_ffd82cb4-5991-6d04-e053-6294a90a9fa6	55319-006	HUMAN OTC DRUG	Menthol cough drops		menthol	LOZENGE	ORAL	20130524		OTC MONOGRAPH FINAL	part341	Family Dollar	MENTHOL	5.4	mg/1			N	20241231
55319-007_ffe76d1c-902e-c0c7-e053-6394a90af7e7	55319-007	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20130524		OTC MONOGRAPH FINAL	part341	Family Dollar	MENTHOL	5.8	mg/1			N	20241231
55319-007_ffe76d1c-9031-c0c7-e053-6394a90af7e7	55319-007	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20130524		OTC MONOGRAPH FINAL	part341	Family Dollar	MENTHOL	5.8	mg/1			N	20241231
55319-008_ffe764e8-1523-3b75-e053-6294a90a0692	55319-008	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20130524		OTC MONOGRAPH FINAL	part341	Family Dollar	MENTHOL	7.5	mg/1			N	20241231
55319-008_ffe83e68-bb78-5362-e053-6394a90ad404	55319-008	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20130524		OTC MONOGRAPH FINAL	part341	Family Dollar	MENTHOL	7.5	mg/1			N	20241231
55319-018_082beea4-52c3-0ff2-e063-6294a90a7bf1	55319-018	HUMAN OTC DRUG	Antacid Anti-Gas Relief Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20180126		OTC MONOGRAPH DRUG	M001	Family Dollar	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
55319-028_e7179edb-1a40-b9a7-e053-2a95a90aa40b	55319-028	HUMAN OTC DRUG	Family Dollar Tropic Sun SPF 70 Sport Sunscreen		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20191019		OTC MONOGRAPH NOT FINAL	part352	Family Dollar Services Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
55319-029_869ffa92-3784-4897-8519-d3617c2ade6b	55319-029	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20150531	20250530	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-030_f1405ddf-6148-2c52-e053-2a95a90a4cd9	55319-030	HUMAN OTC DRUG	FAMILY DOLLAR TROPIC SUN SPF 50 SPORT SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20191011		OTC MONOGRAPH NOT FINAL	part352	Family Dollar Services Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
55319-034_f40e2819-1d3c-d238-e053-2995a90af96e	55319-034	HUMAN OTC DRUG	Family Dollar Tropic Sun SPF 50 Baby Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190927		OTC MONOGRAPH NOT FINAL	part352	Family Dollar Services Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55319-043_293f86f8-0000-4896-aec5-b42e585781c5	55319-043	HUMAN OTC DRUG	Nighttime Cough DM		Dextromethorphan HBr, Doxylamine Succinate	SOLUTION	ORAL	20190801		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-044_d21f9f45-244a-418a-85a2-6de16faff963	55319-044	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170630	20250630	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM	100	mg/1			N	
55319-046_6403a89b-ae4d-42e5-9a5c-d51613f0f42a	55319-046	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200630	20250630	ANDA	ANDA207753	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-047_37cf7337-a74e-45af-94ef-e7a6a2659cb6	55319-047	HUMAN OTC DRUG	Saline		Saline	SPRAY	NASAL	20200728		OTC MONOGRAPH DRUG	M022	FAMILY DOLLAR SERVICES INC	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
55319-048_ffe8cf75-387a-8c7a-e053-6394a90af47a	55319-048	HUMAN OTC DRUG	Family Wellness Strawberry Cough Drops		Menthol	LOZENGE	ORAL	20230412		OTC MONOGRAPH FINAL	part341	Family Dollar	MENTHOL	2.7	mg/1			N	20241231
55319-049_ffe97c77-f513-1c33-e053-6294a90aaad3	55319-049	HUMAN OTC DRUG	Family Wellness Antacid Relief Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230412		OTC MONOGRAPH FINAL	part331	Family Dollar	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55319-051_e77b6ffb-9021-4520-93c1-20cf697ff1bd	55319-051	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230817		ANDA	ANDA209339	Family Dollar Stores, LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55319-052_a2ad02ba-a2b2-4572-bc20-0ad5de7678ba	55319-052	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20230811		ANDA	ANDA211059	Family Dollar Stores, LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
55319-053_0bd0c0ce-b9a6-c10e-e063-6394a90a3c77	55319-053	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20230811		OTC MONOGRAPH DRUG	M013	Family Dollar Stores, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55319-061_f7abdad5-43ed-425b-bbe6-ec1f8f18ca1c	55319-061	HUMAN OTC DRUG	DayTime Severe Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin and Phenylephrine HCl	LIQUID	ORAL	20230705		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-063_4e6b85cf-1cc0-4560-adb0-9f73783d4f28	55319-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	19890715		OTC MONOGRAPH FINAL	part347	Family Dollar	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL			N	20241231
55319-066_e3570fd8-f180-461f-8f6b-dc5d515ddbf5	55319-066	HUMAN OTC DRUG	Daytime Cold and Flu	Multi symptom relief	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150831	20250831	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-069_dc469163-7e72-4a5b-b18f-66e6e91ecfa1	55319-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20090105		OTC MONOGRAPH FINAL	part347	Family Dollar Stores, Inc	PETROLATUM	1	g/g			N	20241231
55319-071_7709292f-9305-485c-80f2-9a794b1bc238	55319-071	HUMAN OTC DRUG	Isopropyl alcohol	50 percent	Isopropyl alcohol	LIQUID	TOPICAL	20140630	20250630	OTC MONOGRAPH NOT FINAL	part333A	Family Dollar (FAMILY WELLNESS)	ISOPROPYL ALCOHOL	50	mL/100mL			N	
55319-072_3f84d16b-0645-4864-a802-3d1419de977c	55319-072	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol	50 percent Wintergreen	Isopropyl alcohol	LIQUID	TOPICAL	20140831	20250430	OTC MONOGRAPH NOT FINAL	part333A	Family Dollar (FAMILY WELLNESS)	ISOPROPYL ALCOHOL	50	mL/100mL			N	
55319-079_b02d287a-165e-4d0f-b42d-9884a1d5833e	55319-079	HUMAN OTC DRUG	Childrens Cold and Cough	Nighttime	Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20141130	20251130	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
55319-084_b60eb603-597b-45ea-a81a-7a9dd2609f64	55319-084	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20151130	20240426	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
55319-092_b827112b-0e21-469f-936c-fcc2a206086c	55319-092	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine HCl	LIQUID	ORAL	20150228	20250228	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-101_5de54ab8-780c-4daf-9758-844aa02040bc	55319-101	HUMAN OTC DRUG	Medicated Chest Rub	Family Wellness	Camphor, Menthol, Eucalyptus Oil	CREAM	TOPICAL	20110719		OTC MONOGRAPH FINAL	part341	Family Dollar Services Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
55319-103_5d7cc3fd-df87-38a2-e053-2a91aa0a69fb	55319-103	HUMAN OTC DRUG	Vitamin A and D		Lanolin and Petrolatum	OINTMENT	TOPICAL	20171108		OTC MONOGRAPH FINAL	part347	Family Dollar Services Inc	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
55319-104_41351eab-bda3-4147-aa04-89321a32ed4b	55319-104	HUMAN OTC DRUG	Childrens All Day Allergy	Sugar Free Grape	Cetirizine Hydrochloride	SUSPENSION	ORAL	20080422		ANDA	ANDA090182	FAMILY WELLNESS	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-107_02a01a02-a61d-4137-aa7b-c0b76d19d4ef	55319-107	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20140731	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	GUAIFENESIN	400	mg/1			N	
55319-109_2e2bf6fb-6205-4c0e-a314-900c17486fdd	55319-109	HUMAN OTC DRUG	Mucus Relief	DM	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20140731	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-113_9ab2e9ff-5e29-4a37-b52f-f910337a1abd	55319-113	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Family Dollar (FAMILY WELLNESS)	DOCOSANOL	100	mg/g			N	20241231
55319-126_b3661a74-f299-48c0-96a3-e0050f8c9a40	55319-126	HUMAN OTC DRUG	Magnesium Citrate	Saline Laxative	Magnesium citrate	LIQUID	ORAL	20170630	20250630	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-136_ea710bfa-eee3-4284-9b18-2533771276e6	55319-136	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20230831		ANDA	ANDA079129	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-137_8a400cb7-c92c-48e2-af36-bbbf3609bddf	55319-137	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20230730		ANDA	ANDA079129	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-139_0c52ef8d-a012-f97b-e063-6294a90a06b3	55319-139	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET	ORAL	20231101		ANDA	ANDA216592	Family Dollar	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-144_f27b5d02-dc72-2151-e053-2a95a90abf1d	55319-144	HUMAN OTC DRUG	Miconazole nitrate		Antifungal Miconazorb AF Powder Talc Free	POWDER	TOPICAL	20191001		OTC MONOGRAPH FINAL	part333C	Family Dollar Services Inc.	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55319-150_dcf65be2-1305-44c4-beec-f4d58071b224	55319-150	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170627		ANDA	ANDA209207	FAMILY WELLNESS	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-151_538b54f7-3a1e-4d83-b571-1a6a291de307	55319-151	HUMAN OTC DRUG	Kids Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230508		OTC MONOGRAPH FINAL	part331	FAMILY DOLLAR SERVICES INC	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55319-163_9d84e7ee-eefa-405e-8f92-283931d415fc	55319-163	HUMAN OTC DRUG	Anticavity Fluoride Rinse		SODIUM FLUORIDE	MOUTHWASH	ORAL	20111214		OTC MONOGRAPH DRUG	M021	Midwood Brands, Inc	SODIUM FLUORIDE	.1	mg/mL			N	20241231
55319-164_e0c835cf-9575-452f-b5c1-cfbe0fa91aca	55319-164	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20190218		OTC MONOGRAPH NOT FINAL	part334	MIDWOOD BRANDS, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55319-168_6708cae8-44fd-4c60-9094-f347714648eb	55319-168	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20120815	20250131	ANDA	ANDA079096	Family Dollar (FAMILY WELLNESS)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-177_0c4045e9-a5d7-5d33-e063-6394a90ae1ce	55319-177	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230901		OTC MONOGRAPH DRUG	M013	FAMILY DOLLAR	ACETAMINOPHEN	500	mg/1			N	20241231
55319-180_f27b6be0-a441-5802-e053-2a95a90aeec6	55319-180	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20170630		OTC MONOGRAPH FINAL	part358F	Family Dollar Services Inc.	SALICYLIC ACID	.17	g/9mL			N	20241231
55319-182_f27ac05c-4cc3-42f8-e053-2995a90a5e7b	55319-182	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20131001		OTC MONOGRAPH FINAL	part333C	Family Dollar Services Inc.	TOLNAFTATE	1.5	g/150.2g			N	20241231
55319-184_f3947918-1401-0ad5-e053-2a95a90a4a56	55319-184	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20120401		OTC MONOGRAPH FINAL	part358F	Family Dollar Services Inc.	SALICYLIC ACID	40	mg/1			N	20241231
55319-185_0c3f368b-26a9-8247-e063-6294a90a0348	55319-185	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230901		ANDA	ANDA211544	FAMILY DOLLAR	ACETAMINOPHEN	650	mg/1			N	20241231
55319-186_8ca729b7-468f-4329-ac93-e9ce43a40db3	55319-186	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20150504	20240426	ANDA	ANDA076460	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-195_18fa2d85-1921-46e5-873d-f77b11ae2ba5	55319-195	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, COATED	ORAL	20130630	20240426	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-196_f27b5ee3-7033-19bd-e053-2a95a90ad25f	55319-196	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20180901		OTC MONOGRAPH FINAL	part333C	Family Dollar Services Inc.	TOLNAFTATE	1.3	g/130g			N	20241231
55319-199_77d5306e-601e-4590-8784-f0215961cf00	55319-199	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170630	20250630	ANDA	ANDA078682	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-204_345e1b5a-1766-458b-a3e1-43a991a3b96a	55319-204	HUMAN OTC DRUG	Severe Congestion and Cough		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20240104		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
55319-206_d55c7f7b-3b1d-4545-913e-984c4bd9654c	55319-206	HUMAN OTC DRUG	Dye Free Infants Pain and Fever		acetaminophen	SUSPENSION	ORAL	20230508		OTC MONOGRAPH NOT FINAL	part343	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN	160	mg/5mL			N	20241231
55319-208_db8b029c-c502-4df1-e053-2995a90ae72f	55319-208	HUMAN OTC DRUG	Family Wellness Cold Hot		Menthol	PATCH	TOPICAL	20191107		OTC MONOGRAPH NOT FINAL	part348	Family Dollar Services, Inc.	MENTHOL	50	mg/1			N	20241231
55319-211_7bf6a21a-80fa-47ea-8639-7d9ac2a1e9e7	55319-211	HUMAN OTC DRUG	Family Dollar Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20100104		UNAPPROVED DRUG OTHER		Family Dollar Services Inc	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
55319-252_803dfedd-bf37-4356-ac46-8bdc22c5d25d	55319-252	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20230915		ANDA	ANDA079129	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-253_0bdffebb-52e1-ba99-e063-6394a90ac071	55319-253	HUMAN OTC DRUG	Family Wellness Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	Family Dollar	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
55319-255_16490a52-fb4a-4747-b11d-55fe1ef747f3	55319-255	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20140430	20240426	ANDA	ANDA091353	Family Dollar (FAMILY WELLNESS)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-256_b77cddd8-d3d3-4d8c-8e37-7d169d89d367	55319-256	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20140430	20240426	ANDA	ANDA091353	Family Dollar (FAMILY WELLNESS)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-268_39779610-d951-418e-9b76-95a80fa57f73	55319-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20140831	20250430	OTC MONOGRAPH NOT FINAL	part356	Family Dollar (FAMILY WELLNESS)	HYDROGEN PEROXIDE	2.65	mL/100mL			N	
55319-275_8a985a77-d5a7-4704-b730-8442dd2a5f24	55319-275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20171231	20250131	OTC MONOGRAPH NOT FINAL	part333A	Family Dollar (FAMILY WELLNESS)	ISOPROPYL ALCOHOL	70	mL/100mL			N	
55319-277_bb7b135d-fdad-4f1e-856d-aae8eeb977d9	55319-277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20140630	20250630	OTC MONOGRAPH NOT FINAL	part333A	Family Dollar (FAMILY WELLNESS)	ISOPROPYL ALCOHOL	91	mL/100mL			N	
55319-282_a9424810-4f01-477a-a48b-36fc5dd31722	55319-282	HUMAN OTC DRUG	Childrens Pain Reliever		Acetaminophen	SUSPENSION	ORAL	20150930	20240930	OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN	160	mg/5mL			N	
55319-288_a8d119d0-701a-4581-82fc-818a14c9500b	55319-288	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20150228	20250228	OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN	160	mg/5mL			N	
55319-294_8d7abdd6-c8fa-45dd-81d7-05e56ca3fd6c	55319-294	HUMAN OTC DRUG	Mucus Relief Cough	Childrens	Dextromethorphan HBr, Guaifensin	LIQUID	ORAL	20160229	20250228	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-298_95e67aea-fff7-4700-ba13-565364192bfc	55319-298	HUMAN OTC DRUG	Senna		Sennosides	TABLET, FILM COATED	ORAL	20231212		OTC MONOGRAPH DRUG	505G(a)(3)	Family Dollar Services Inc	SENNOSIDES	8.6	mg/1			N	20241231
55319-299_91453fc1-09bf-4981-8bee-fdbc344496d5	55319-299	HUMAN OTC DRUG	Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20130502		OTC MONOGRAPH NOT FINAL	part356	Midwood Brands, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
55319-304_f5b9df74-3049-49af-8290-8c6859bb7632	55319-304	HUMAN OTC DRUG	Childrens Plus Multi Symptom Cold		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20141130	20241130	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-306_984cdd83-d4d2-4603-ba97-098538b9b532	55319-306	HUMAN OTC DRUG	family wellness laxative		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20110621	20240131	ANDA	ANDA090685	Family Dollar Services Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-312_ed5f4793-39d0-4dcc-8cf7-a1e58be4547d	55319-312	HUMAN OTC DRUG	Childrens Cold and Allergy Relief		Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20150630	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-313_053aba0d-e3d9-4542-a818-57b5c9c5c479	55319-313	HUMAN OTC DRUG	Childrens Cold and Cough Relief		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20151031	20251031	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-314_8ff0379a-3ad6-4438-856b-8432ac6adf19	55319-314	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	LIQUID	ORAL	20170731	20250731	OTC MONOGRAPH FINAL	part338	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-318_fa954e89-ee49-4ec0-96bd-ca2e57159916	55319-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19910122		OTC MONOGRAPH DRUG	505G(a)(3)	Family Dollar Services, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55319-325_b8c3f0e6-0e69-4878-9d67-04ccdee6b497	55319-325	HUMAN OTC DRUG	Infants Gas Relief		Simethicone	SUSPENSION	ORAL	20170228	20240426	OTC MONOGRAPH FINAL	part332	Family Dollar (FAMILY WELLNESS)	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	
55319-327_a3ce1af1-c897-4d09-a2d3-46680fd266a1	55319-327	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Family Dollar Services Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55319-336_9a8b7357-0985-44fc-9630-52cfd6a8d399	55319-336	HUMAN OTC DRUG	Mucus Relief	Cold Flu and Sore Throat Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141231	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-337_d21aa3c5-55b1-4dfa-92c6-f9b0e0e81b4c	55319-337	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141130	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-342_6df98f59-7248-4f6c-8bab-9bbd3b56a6db	55319-342	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20160229	20250228	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	500; 15; 6.25	mg/15mL; mg/15mL; mg/15mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-344_3506d7c9-14aa-4345-98f5-144044e98761	55319-344	HUMAN OTC DRUG	Night Time Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171231	20250131	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-345_f6bb9220-8c6e-49d5-8e6b-a7409cc7d066	55319-345	HUMAN OTC DRUG	Night Time Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20160331	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-346_7cbebbb3-5e33-4552-89ff-a0afe1eb4c75	55319-346	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20160331	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	500; 15; 6.25	mg/15mL; mg/15mL; mg/15mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-353_1b1e10da-b618-4467-b117-616229624a49	55319-353	HUMAN OTC DRUG	Family Wellness Sleep Aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20200715		OTC MONOGRAPH FINAL	part338	Family Dollar Services Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-366_0c52b0ce-c803-635f-e063-6394a90acd08	55319-366	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20231101		ANDA	ANDA079174	Family Dollar	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-367_9758e87d-4f75-430d-801a-65cb00d46e24	55319-367	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Family Dollar Services Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
55319-371_beaaf168-0fab-48b3-8bea-f324a4fb70fc	55319-371	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20141231	20250131	OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55319-372_87ded6ba-e817-4a8d-9be1-8273c9dfefb6	55319-372	HUMAN OTC DRUG	Stomach Relief	Original Strength	Bismuth subsalicylate	LIQUID	ORAL	20141231	20250430	OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55319-376_4a199a92-217c-4b8e-a9a6-ebf5d3d67a0c	55319-376	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140630		OTC MONOGRAPH NOT FINAL	part356	Family Dollar (FAMILY WELLNESS)	PHENOL	1.4	g/100mL			N	20241231
55319-378_b73616be-af28-470d-9592-050d1872b17f	55319-378	HUMAN OTC DRUG	Cold and Cough Day Time	Childrens	Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20150831	20250831	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	5; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-381_0633a947-b7a2-0588-e063-6294a90aa848	55319-381	HUMAN OTC DRUG	Family Wellness Hemorrhoidal		Mineral Oil, Petrolatum, and Phenylephrine HCL	OINTMENT	TOPICAL	20230918		OTC MONOGRAPH FINAL	M015	Family Dollar Services, Inc	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-382_54a1c8d3-8f62-476b-9109-7e2c60619ed8	55319-382	HUMAN OTC DRUG	Multi Symptom Cold CF	Adult	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20150331	20251231	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-385_7a8fa935-1287-4b60-b2c9-5b58f1f216e7	55319-385	HUMAN OTC DRUG	Tussin Cough and Chest Congestion DM	Adult	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20150228	20251231	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-388_fe07ad15-d59e-237d-e053-6294a90a9776	55319-388	HUMAN OTC DRUG	Family Dollar	Oral Pain Relief	Benzocaine	LIQUID	ORAL	20130801		OTC MONOGRAPH NOT FINAL	part356	Family Dollar Services Inc.	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55319-390_f330eb81-882a-4ba0-9c3b-a8f5e3f8b864	55319-390	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20140831	20251231	OTC MONOGRAPH FINAL	part347	Family Dollar (FAMILY WELLNESS)	WITCH HAZEL	842	mg/mL			N	
55319-395_ce86332d-0cc3-44a1-ba0d-9efc631a9e85	55319-395	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20171231	20241231	OTC MONOGRAPH DRUG	M007	Family Dollar (FAMILY WELLNESS)	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-402_06faa975-282e-47a6-e063-6394a90aca13	55319-402	HUMAN OTC DRUG	Medicated Wipes Hemorroidal Wipes With Witch Hazel		WITCH HAZEL	CLOTH	TOPICAL	20240101		OTC MONOGRAPH DRUG	M015	FAMILY DOLLAR STORES	WITCH HAZEL	500	mg/mL			N	20241231
55319-404_6cb0634f-db35-4731-88ed-1654969844f0	55319-404	HUMAN OTC DRUG	EZ Nite Sleep	Nighttime Sleep Aid	Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20140731	20240426	OTC MONOGRAPH FINAL	part338	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-406_29c643c1-d0b4-4fe2-8ef1-5a064227e980	55319-406	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET, FILM COATED	ORAL	20231215		ANDA	ANDA204872	Family Dollar Services Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-407_2025c032-02f2-41be-9c14-636175aefa8b	55319-407	HUMAN OTC DRUG	family wellness acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20200618		OTC MONOGRAPH NOT FINAL	part343	Family Dollar Services Inc	ACETAMINOPHEN	500	mg/1			N	20241231
55319-414_c032f607-dae8-4b1a-86f4-e67c7a42e364	55319-414	HUMAN OTC DRUG	Tussin Nighttime Cough DM	Maximum Strength	Dextromethorphan HBr, Doxylamine succinate	LIQUID	ORAL	20160731	20241025	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/10mL; mg/10mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-415_42973963-5d3f-4942-a5b4-58e493d7cd8b	55319-415	HUMAN OTC DRUG	Severe Cold and Flu Relief	Daytime	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20171231	20251031	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-416_aafc6878-afce-49f6-8519-2b7cf90fed05	55319-416	HUMAN OTC DRUG	Severe cold and flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine HCI	LIQUID	ORAL	20151231	20251231	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-419_18a8d63a-249f-43bc-bd47-85540f6b7bd1	55319-419	HUMAN OTC DRUG	family wellness lice treatment kit		piperonyl butoxide, pyrethrum extract	KIT		20180914		OTC MONOGRAPH FINAL	part358G	Family Dollar Services Inc						N	20241231
55319-425_9642ec68-9266-4fe2-9a97-d1472154d8a2	55319-425	HUMAN OTC DRUG	Stomach Relief	Cherry	Bismuth subsalicylate	LIQUID	ORAL	20150331	20251031	OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55319-426_8ad89bd8-3fca-c1dc-92b7-01c7cb5476d3	55319-426	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20211101		ANDA	ANDA077367	Family Dollar Stores, Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55319-427_8ad89bd8-3fca-c1dc-92b7-01c7cb5476d3	55319-427	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20211101		ANDA	ANDA077367	Family Dollar Stores, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55319-439_ecdddc3f-fe4f-4492-80d7-47bb31c288a7	55319-439	HUMAN OTC DRUG	Nighttime Sleep Aid		Nighttime Sleep Aid	TABLET	ORAL	20231031		ANDA	ANDA040564	Family Dollar Stores, Inc	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55319-443_6ac1ebcd-8b63-45b1-8034-9cfb351f4076	55319-443	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171231	20251231	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-447_478fc145-a67d-4c29-a0ff-4c3811e52aa0	55319-447	HUMAN OTC DRUG	Acetaminophen PM	Extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20141130	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-451_745934d0-9753-4473-9c08-e7904b1078b1	55319-451	HUMAN OTC DRUG	Nighttime Severe Cold and Cough		ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20230703		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-453_8f57b074-71c3-4140-afa8-3ee412c41d7f	55319-453	HUMAN OTC DRUG	Suphedrine PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-467_03a80700-b12d-4499-a543-4850840d5fb0	55319-467	HUMAN OTC DRUG	Family Wellness Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20200626		OTC MONOGRAPH NOT FINAL	part343	Family Dollar Services Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55319-468_f414cc41-8ffd-48f4-be4e-775c53d59931	55319-468	HUMAN OTC DRUG	Non-Drowsy Daytime Multi Symptom Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20151031	20240726	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-472_2f1d2f6b-b8a4-4200-a1ae-93998d36d29b	55319-472	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20160331	20250331	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)						N	
55319-479_4ac36cef-845b-4c3c-9788-72191737a918	55319-479	HUMAN OTC DRUG	family wellness allergy		Diphenhydramine Hydrochloride	TABLET	ORAL	20200722		OTC MONOGRAPH FINAL	part341	Family Dollar Services Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-481_9025a057-1a30-457d-879d-e66649d2631e	55319-481	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	20160630	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-482_787d7dfb-3d22-41e7-9a40-78259ba7e1b8	55319-482	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20230406		OTC MONOGRAPH DRUG	M012	Family Dollar Stores, Inc	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
55319-486_d7b66e82-e9b1-404e-8cb2-3042f3cb0d2a	55319-486	HUMAN OTC DRUG	Natural Vegetable Laxative		Sennosides	TABLET	ORAL	20151031	20240426	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	SENNOSIDES	8.6	mg/1			N	
55319-487_6cade8c6-ba85-4b09-ba05-d8a1bfa2d432	55319-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160229	20251030	OTC MONOGRAPH FINAL	part347	Family Dollar (FAMILY WELLNESS)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
55319-494_7e81b0b7-dcbf-4c44-ace7-e6cc8d21b8ce	55319-494	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET	ORAL	20160331	20240426	OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN	500	mg/1			N	
55319-496_4dbf90f4-892f-4a13-af2d-d6522a65059c	55319-496	HUMAN OTC DRUG	Sinus and Headache		Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20240102		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
55319-499_c621329f-e125-4271-ae8c-3d64de333188	55319-499	HUMAN OTC DRUG	Night Time Cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20171231	20251231	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-511_b7ce17df-f05f-417e-a204-fe258ed8c52a	55319-511	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20201127		OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55319-528_5b24dfc0-83b9-4fc5-88f9-f7daf7e4821e	55319-528	HUMAN OTC DRUG	Antacid antigas	Maximum Strength	Aluminum hydroxide, Magnesium hydroxide, Simethicone	LIQUID	ORAL	20180630	20250630	OTC MONOGRAPH FINAL	part331	Family Dollar (FAMILY WELLNESS)	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-541_14494ec3-ed21-46c2-802a-e2124e370fdd	55319-541	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	CAPSULE	ORAL	20180731	20240426	OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN	500	mg/1			N	
55319-547_a8d73098-aa20-485f-8942-2d9f56fd7887	55319-547	HUMAN OTC DRUG	Multi Symptom Severe Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	POWDER, FOR SOLUTION	ORAL	20230703		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-548_fbc1d544-5d83-431b-addc-d49717388042	55319-548	HUMAN OTC DRUG	Milk of Magnesia cherry		Magnesium Hydroxide	SUSPENSION	ORAL	20180630	20240426	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-551_47f7b38a-54c6-4700-b0e5-50da0fd572e2	55319-551	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230701		ANDA	ANDA207342	Family Dollar (FAMILY WELLNESS)	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55319-552_5b4ad927-e72a-41ef-911b-7e57811d24c2	55319-552	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230701		ANDA	ANDA206568	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-555_4c4915a3-cee5-4f65-8537-86e20bafb92d	55319-555	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230701		OTC MONOGRAPH FINAL	part347	Family Dollar (FAMILY WELLNESS)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
55319-558_0ae7435b-fd63-42dc-a729-bcef39dbdd26	55319-558	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	SUSPENSION	ORAL	20230701		OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN	160	mg/5mL			N	20241231
55319-559_6adb9317-a4e2-4153-b702-c712b35685d5	55319-559	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	SUSPENSION	ORAL	20230701		OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN	160	mg/5mL			N	20241231
55319-560_76127a93-233d-400d-82d2-1acc82cc94b3	55319-560	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20230701		OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55319-561_dd1a154d-7f7a-4eda-acd2-bb4246694fb6	55319-561	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20230701		OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM	100	mg/1			N	20241231
55319-562_6b8c69a3-5284-4658-8f24-1770da668997	55319-562	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20230701		OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-564_03a16eec-a4de-4895-b3e6-9fedadc8b5f3	55319-564	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20230701		OTC MONOGRAPH FINAL	part338	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-565_b7c13a19-d148-483d-82c5-56e0667d6db1	55319-565	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium, Sennosides	TABLET	ORAL	20230701		OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
55319-566_d827ea7d-0195-4c5f-80f2-2dfc81dd6da8	55319-566	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBR, Doxylamine succinate, Phenylephrine HCl	KIT		20230701		OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)						N	20241231
55319-567_7aeda391-7b12-41a0-bdeb-25e5716e8e88	55319-567	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part356	Family Dollar (FAMILY WELLNESS)	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
55319-568_021cd732-6441-4c63-a6fb-8a7d362840ad	55319-568	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170630	20240426	ANDA	ANDA079174	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-569_6ff97ef6-a97c-40f2-8d7c-21068be4ee98	55319-569	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part333A	Family Dollar (FAMILY WELLNESS)	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
55319-570_d91863ab-baa4-48ef-9bdc-60127aa61614	55319-570	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part333A	Family Dollar (FAMILY WELLNESS)	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
55319-571_a820926b-d7a4-48d0-ada4-467635bfe84a	55319-571	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part333A	Family Dollar (FAMILY WELLNESS)	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
55319-572_710a8c11-25f4-4704-a679-84686148ed40	55319-572	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55319-573_6e53c6f6-52cc-4fa8-b87d-f170dcd1908c	55319-573	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20230701		ANDA	ANDA074164	Family Dollar (FAMILY WELLNESS)	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55319-574_53f2a198-f89d-4d8e-92f8-f0bf7cd0fc22	55319-574	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20230831		ANDA	ANDA079129	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-578_773b6b86-d414-492f-9a02-abaacc76cf3e	55319-578	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170630	20250630	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM	100	mg/1			N	
55319-585_7ab523a4-fff3-4a86-8b09-6ed6435e5af7	55319-585	HUMAN OTC DRUG	Tartar control		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20231107		OTC MONOGRAPH DRUG	505G(a)(3)	Family Dollar Services, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55319-586_cf26553c-c1da-4a9a-8f45-4a40ef6613c1	55319-586	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20190131	20250430	OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
55319-590_c7ea108c-0ae8-4311-bbfe-432d05f91fc0	55319-590	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20171231		OTC MONOGRAPH FINAL	part347	Family Dollar (FAMILY WELLNESS)	WITCH HAZEL	842	mg/mL			N	20241231
55319-601_4995c637-faa1-477c-acd6-6d57ae08b8de	55319-601	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20191119		OTC MONOGRAPH DRUG	M013	Family Dollar Services Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20251231
55319-602_573db49e-85ce-49de-be54-c6cfe2caaedd	55319-602	HUMAN OTC DRUG	Severe Cold and Cough	Nighttime	Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20200630	20250731	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
55319-605_62272312-c609-48ff-819a-cd52bdd1b3e8	55319-605	HUMAN OTC DRUG	Mucus Relief DM Max	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20180731	20250731	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-609_0c037956-1606-1dc4-e063-6294a90aa53a	55319-609	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20230406		OTC MONOGRAPH DRUG	M012	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-610_657bc4f2-8891-4825-852e-12c4b925c393	55319-610	HUMAN OTC DRUG	DayTime Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin and Phenylephrine HCl	LIQUID	ORAL	20230703		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-612_d0ca2ac3-4cb2-465f-b11e-c6fc71e95812	55319-612	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20121218		OTC MONOGRAPH FINAL	part358H	Family Dollar Services, Inc.	PYRITHIONE ZINC	1	g/mL			N	20241231
55319-615_0c049cac-82f2-3788-e063-6394a90a1625	55319-615	HUMAN OTC DRUG	Non Drowsy DAY and NIGHT Multi-Symptom Cold and Flu Formula		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20230406		OTC MONOGRAPH DRUG	M012	Family Dollar (FAMILY WELLNESS)						N	20241231
55319-617_0c03990e-6d8a-e2f0-e063-6394a90a06f5	55319-617	HUMAN OTC DRUG	Daytime Severe Sinus Congestion and Pain		Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20230406		OTC MONOGRAPH DRUG	M012	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-618_0c03990e-6d8c-e2f0-e063-6394a90a06f5	55319-618	HUMAN OTC DRUG	Clear Stool Softener		Docusate sodium	CAPSULE	ORAL	20230406		OTC MONOGRAPH DRUG	M007	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM	50	mg/1			N	20241231
55319-625_cb4fc17f-57f6-4e2d-9939-3832d5f3f73e	55319-625	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160831	20250831	OTC MONOGRAPH NOT FINAL	part343	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
55319-628_c70efa4f-ba7f-3252-e053-2a95a90a5739	55319-628	HUMAN OTC DRUG	MAXIMUM STRENGTH COLD AND FLU		ACETAMINOPHEN,DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200824		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-634_65ef7143-a71d-400a-ae9c-6d293d22a90b	55319-634	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	OIL	ORAL; TOPICAL	20170630	20250630	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	MINERAL OIL	100	mg/100mL			N	
55319-645_5ce66097-4718-4cb5-872a-a7d4816773b8	55319-645	HUMAN OTC DRUG	CHILDRENS DIMETAPP COLD AND COUGH		brompheniramine maleate, dextromethorphan HBr, phenylephrine HCl	LIQUID	ORAL	20230508		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-661_da909a3a-d335-45a3-b272-acd9999204ac	55319-661	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20171005	20240426	ANDA	ANDA079174	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-664_784093ed-f902-4f57-bc57-63bd61fe5c90	55319-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20110111		OTC MONOGRAPH DRUG	505G(a)(3)	Family Dollar Services, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55319-666_11912e35-714b-487a-b510-76a2d7b801eb	55319-666	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20190218		OTC MONOGRAPH NOT FINAL	part334	MIDWOOD BRANDS, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55319-680_0c521000-16c9-c8b7-e063-6394a90ae9b4	55319-680	HUMAN OTC DRUG	Acetaminophen, Aspirin and Caffeine		Acetaminophen, Aspirin and Caffeine	TABLET	ORAL	20230901		ANDA	ANDA214039	FAMILY DOLLAR	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55319-681_484fb43b-8a97-4725-9ea7-aa56fb3610bc	55319-681	HUMAN OTC DRUG	Family DollarSevere Nighttime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and phenylephrine hydrochloride	SOLUTION	ORAL	20230707		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-692_ba69bb44-bd87-4dab-bae7-d20cd856fd4f	55319-692	HUMAN OTC DRUG	Family Dollar Nighttime Cold and Flu Relief	Original Flavor	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20230710		OTC MONOGRAPH DRUG	M012	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-700_928956d7-913e-4c80-be6e-2f486b4b3052	55319-700	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20171213		OTC MONOGRAPH NOT FINAL	part333E	Family Dollar Services	POVIDONE-IODINE	10	mg/mL			N	20241231
55319-701_19fc53dd-2cc9-4290-934e-488695b8b3ee	55319-701	HUMAN OTC DRUG	Severe Cold and Cough Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20200630	20250630	OTC MONOGRAPH DRUG	M012	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-702_6950b431-2fd1-4a4e-bee5-b3b83d94be98	55319-702	HUMAN OTC DRUG	Sinus Pressure and Pain		Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20240104		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
55319-704_b08f3e01-9149-475f-8aac-3da6ed9fc880	55319-704	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20171201		OTC MONOGRAPH FINAL	part352	Family Dollar Services Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55319-713_bf324779-88a2-447a-9e64-827bbfbb1cbd	55319-713	HUMAN OTC DRUG	dishwashing		chloroxylenol	LIQUID	TOPICAL	20191214		OTC MONOGRAPH NOT FINAL	part333A	Family Dollar	CHLOROXYLENOL	3.09	mg/mL			N	20241231
55319-715_427908e4-0485-46b2-a636-63122b3dd85c	55319-715	HUMAN OTC DRUG	Family Dollar		Nasal	SPRAY	NASAL	20200228		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55319-716_dcbe26fa-3bb7-4603-b468-cba2b6875823	55319-716	HUMAN OTC DRUG	NO DRIP	NASAL MIST	Oxymetazoline hydrochloride	SPRAY	NASAL	20200309		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55319-717_baa41f77-6c1d-4b0d-9ccf-c8d1f74da78b	55319-717	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET, FILM COATED	ORAL	20231213		ANDA	ANDA204872	Family Dollar Services Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-724_e6110a97-3a7c-41ee-83b4-d75ce36a0d48	55319-724	HUMAN OTC DRUG	Stomach Relief	Original Strength	Bismuth subsalicylate	LIQUID	ORAL	20191030	20251030	OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55319-727_0c65a123-6c2d-4a23-99a6-bd442bfd0041	55319-727	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Family Dollar Services, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	26.49; 132.45; 44.15; 52.98	mg/g; mg/g; mg/g; mg/g			N	20241231
55319-730_cf56ebd6-1cd9-49e2-94cc-fc8010b65f81	55319-730	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20060606		ANDA	ANDA074164	Family Dollar (FAMILY WELLNESS)	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55319-731_46f8746a-2446-406a-9027-020e1d7bdbea	55319-731	HUMAN OTC DRUG	Mucus Relief DM Max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20240105		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
55319-732_b2e58db2-9a88-4b64-854a-b5aeb49a8630	55319-732	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180711	20250731	ANDA	ANDA207342	Family Dollar (FAMILY WELLNESS)	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
55319-734_72bdf0dd-1e39-4cb3-b250-7fc02d28acf7	55319-734	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20230701		ANDA	ANDA209692	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-735_3cc6fbe6-35ba-427b-9b39-8e2e3e5af415	55319-735	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20180930	20241227	OTC MONOGRAPH FINAL	part338	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-736_5377bb39-a680-4ff6-9aad-0f603b317fe8	55319-736	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20191030	20251030	OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55319-737_e93faa75-2e7f-4da6-947e-506575d65fcd	55319-737	HUMAN OTC DRUG	Stomach Relief Ultra		Bismuth subsalicylate	LIQUID	ORAL	20191030	20251030	OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
55319-738_ef56bbb5-a4e7-404a-8663-8ff4b7699e64	55319-738	HUMAN OTC DRUG	Milk of Magnesia Mint		Magnesium Hydroxide	SUSPENSION	ORAL	20180630	20240426	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-739_75317cc6-c068-4cae-aef4-95d92ff0a686	55319-739	HUMAN OTC DRUG	family wellness pain relief		Acetaminophen	TABLET	ORAL	20200226		OTC MONOGRAPH NOT FINAL	part343	Family Dollar Services Inc	ACETAMINOPHEN	500	mg/1			N	20241231
55319-740_d84367f0-34bf-4494-a47c-26743951b38b	55319-740	HUMAN OTC DRUG	Maximum Strength Adult Cough plus Chest Congestion DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20230508		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-742_cb4f19a9-8cf3-4cf7-a4b4-284305028796	55319-742	HUMAN OTC DRUG	Daytime Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20180731	20240726	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-743_06002227-51c7-4585-869a-76fc8c871b24	55319-743	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180430	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-744_80046867-3e5b-4a40-ad5e-cd6643779cac	55319-744	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20180430	20240726	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)						N	
55319-745_4b35fac8-5d2e-49ca-8435-f941c1dc7085	55319-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131	20260131	ANDA	ANDA206568	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-748_4d5f2002-f335-4e80-99fa-2f5ca6c4aafb	55319-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401	20250730	ANDA	ANDA208363	Family Dollar (FAMILY WELLNESS)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-750_03988cac-5ecc-4a68-a5c3-746c4ac57969	55319-750	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180731	20250731	ANDA	ANDA206999	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-752_38351aeb-43be-4abe-9bff-1fb4117d2439	55319-752	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Family Dollar Services, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.9; 133.9; 51.5; 72.1; 41.2	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
55319-754_30a802eb-6250-46a1-8906-ee0d364a3c70	55319-754	HUMAN OTC DRUG	Childrens Cough and Cold		chlorpheniramine maleate, dextrometrorphan HBr	LIQUID	ORAL	20230508		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-755_d9aada3f-e7ea-4b27-9e08-1f934ee2f8f2	55319-755	HUMAN OTC DRUG	Antacid antigas	Regular Strength	Aluminum hydroxide, Magnesium hydroxide, Simethicone	LIQUID	ORAL	20180630	20250630	OTC MONOGRAPH FINAL	part331	Family Dollar (FAMILY WELLNESS)	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55319-764_9bd51dbd-61e7-42b2-a088-543d7caa9b60	55319-764	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	Family Dollar Services, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.6; 119; 45.9; 45.9; 55.08	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55319-771_4c880be8-19e4-48e5-acc8-9134c0476233	55319-771	HUMAN OTC DRUG	Nighttime Multi Symptom Cold and Flu Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20150831	20240426	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-787_f2fc02de-c0ab-4b18-a6eb-06ad0a938c3e	55319-787	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Family Dollar Services, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	26.49; 132.45; 44.15; 52.98	mg/g; mg/g; mg/g; mg/g			N	20241231
55319-788_6133dc7d-72a8-4c04-bae3-33039923be3e	55319-788	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Family Dollar Services, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27.03; 135.15; 45.05; 90.1; 54.06	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
55319-789_57e21a31-9ba6-4997-90f4-74388afb72ed	55319-789	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Family Dollar Services, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	26.07; 86.9; 43.45; 34.76; 43.45	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
55319-790_2e3a4b79-4576-4427-8bb7-b9dbfc3456e6	55319-790	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	Family Dollar Services, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	25.95; 86.5; 43.25; 17.3; 34.6	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
55319-800_f4182753-5350-4bf3-a3e5-78805f28c4ff	55319-800	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCL	TABLET	ORAL	20160731	20240426	OTC MONOGRAPH FINAL	part338	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-801_e7bd46db-0cdc-427b-b20b-b3774928f119	55319-801	HUMAN OTC DRUG	Tussin Nighttime Cough DM	Maximum Strength	Dextromethorphan HBr, Doxylamine succinate	LIQUID	ORAL	20181231	20241025	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-804_9ec5d080-44f1-c9a4-e053-2a95a90a84b0	55319-804	HUMAN OTC DRUG	Family Wellness Ear Relief Ear Drops		MATRICARIA CHAMOMILLA, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20191101		UNAPPROVED HOMEOPATHIC		Family Dollar Services Inc	MATRICARIA CHAMOMILLA; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55319-808_8baef60a-6aee-4e13-b2c8-e52aa6dffba5	55319-808	HUMAN OTC DRUG	Family Dollar Daytime and Nighttime Combo Pack	Cold and Flu	Acetaminophen, Dextromethorphan HBr, Phenylephrine Hydrochloride, and Doxylamine Succinate	KIT		20230821		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC						N	20241231
55319-810_ddb0c5b0-a4f0-4fb7-bdae-54a4a68077c4	55319-810	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20171211		OTC MONOGRAPH NOT FINAL	part333A	Midwood Brands, Inc	ISOPROPYL ALCOHOL	.7	mg/mL			N	20241231
55319-811_e8df8f1b-fee4-415b-9d64-2e4e214e7e2d	55319-811	HUMAN OTC DRUG	family wellness multi symptom severe cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20180913		OTC MONOGRAPH FINAL	part341	Family Dollar Services Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-812_1af44b6d-a747-4e70-bb80-c7359479e37f	55319-812	HUMAN OTC DRUG	Childrens Cold and Allergy Relief		Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20200626	20250626	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55319-813_ba3d93b3-dbfb-4a68-86a6-32212b8e1cc9	55319-813	HUMAN OTC DRUG	Daytime Nighttime Severe Cold and Flu		Acetaminophen Dextromethorphan HBr Guaifenesin Phenylephrine HCL DoxylamineSucinate	KIT		20190731	20250731	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)						N	
55319-815_4941b31a-2311-4ad2-9f78-50c912974faa	55319-815	HUMAN OTC DRUG	Severe Congestion and Pain		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20231213		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-816_8b5e331f-fff5-4d61-9b8f-bbf55771fab7	55319-816	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCL	CAPSULE	ORAL	20191227	20251227	OTC MONOGRAPH FINAL	part338	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-820_e7a7dd1f-c449-4422-9a21-4d29160561b1	55319-820	HUMAN OTC DRUG	Family Wellness Ultra Strength Muscle Rub		Ultra Strength Muscle Rub	CREAM	TOPICAL	20230930		OTC MONOGRAPH NOT FINAL	part348	FAMILY DOLLAR (Family Wellness)	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
55319-824_9ea9c87a-6755-4f3c-95ff-2df806d74780	55319-824	HUMAN OTC DRUG	Family Wellness Hot and Cold Pain Relief		Hot and Cold Pain Relief	CREAM	TOPICAL	20230930		OTC MONOGRAPH NOT FINAL	part348	FAMILY DOLLAR (Family Wellness)	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 300	mg/g; mg/g			N	20241231
55319-826_a3afcef4-6621-4378-8803-8227dcbfaf03	55319-826	HUMAN OTC DRUG	Family Wellness Anorectal Lidocaine		Anorectal Lidocaine	CREAM	TOPICAL	20230930		OTC MONOGRAPH FINAL	part346	FAMILY DOLLAR (Family Wellness)	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55319-827_01570fc6-f98d-485e-aef2-312a812dae86	55319-827	HUMAN OTC DRUG	Family Wellness Oxymetazoline Sinus Severe		Oxymetazoline	SPRAY	NASAL	20230930		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR (Family Wellness)	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55319-829_a88feb85-3777-4faa-bf0d-3e45f1c299dd	55319-829	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20190331	20241025	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
55319-831_254c195f-59a4-4ea1-a755-f9fd58cc80df	55319-831	HUMAN OTC DRUG	Natural Vegetable Laxative		Sennosides	TABLET	ORAL	20181231	20250425	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	SENNOSIDES	8.6	mg/1			N	
55319-835_0c7fb0f8-58fa-ded0-e063-6394a90a4baa	55319-835	HUMAN OTC DRUG	Family Wellness Earwax Removal Earwax and Bulb		CARBAMIDE PEROXIDE	KIT		20191101		OTC MONOGRAPH DRUG	M014	Family Dollar Services Inc						N	20241231
55319-842_c2fcd749-58fd-4a73-bc4f-6fc04f6b72fd	55319-842	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20190228	20251030	OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
55319-843_9812deaa-8b09-4b07-b4c9-5b4d28dff9f1	55319-843	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190331	20250331	ANDA	ANDA206568	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55319-849_a5e39549-4731-4140-a9e8-47cfaa471a35	55319-849	HUMAN OTC DRUG	Nighttime Multi Symptom Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20191129	20251130	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-850_2925d976-a411-46c4-a939-2c4680ab45d8	55319-850	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20190930	20250930	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)						N	
55319-855_4c615533-33f3-49f6-a3a6-42b1014e8fd0	55319-855	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20200630	20251231	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
55319-857_0ef54c00-4d33-467d-adc9-60dab77ea3a1	55319-857	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20191129	20251129	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
55319-858_035d5ca2-f466-4723-a869-480b2722cc3c	55319-858	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20191129	20251129	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55319-860_fb6b8fe2-a5bd-46f9-96e6-d30ee867ce5d	55319-860	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCL	CAPSULE	ORAL	20200131	20250131	OTC MONOGRAPH FINAL	part338	Family Dollar (FAMILY WELLNESS)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-863_bd091d35-bc96-4b5c-bfa3-a726c658f9a1	55319-863	HUMAN OTC DRUG	Pain Relief PM	Extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20200228	20250228	OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55319-864_820b7386-46d1-460d-b244-429c2934e27a	55319-864	HUMAN OTC DRUG	50% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	20160614		OTC MONOGRAPH NOT FINAL	part333A	Family Dollar Services, Inc	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
55319-866_f58f47d4-9f92-4724-bc73-8bf3f6aa5a8d	55319-866	HUMAN OTC DRUG	family wellness lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20121205		OTC MONOGRAPH FINAL	part358G	Family Dollar Services Inc	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
55319-871_26272718-6acd-4e1c-be19-75a5cda08db8	55319-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19890715		OTC MONOGRAPH NOT FINAL	part333A	Family Dollar	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
55319-875_0c7a709a-b28e-91b3-e063-6294a90a41c6	55319-875	HUMAN OTC DRUG	Family Wellness Effervescent Cold Relief Orange		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20110915		OTC MONOGRAPH DRUG	M012	Family Dollar Services, Inc.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-878_564a9a09-d1f0-4aad-aec6-9ea9d872c054	55319-878	HUMAN OTC DRUG	Stool Softener Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20200630	20251231	OTC MONOGRAPH NOT FINAL	part334	Family Dollar (FAMILY WELLNESS)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
55319-890_2c7a1cd1-f8ff-4209-830a-324deae42329	55319-890	HUMAN OTC DRUG	Family Wellness Chest Congestion Relief DM	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20230427		OTC MONOGRAPH FINAL	part341	Family Dollar Services Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-891_e6eed6a7-0d9d-486d-b6a5-da30c785353e	55319-891	HUMAN OTC DRUG	Family Wellness Chest Congestion Relief		Guaifenesin	TABLET	ORAL	20230427		OTC MONOGRAPH FINAL	part341	Family Dollar Services Inc	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55319-892_b9440294-42cb-485a-93aa-adac7c1ee7f8	55319-892	HUMAN OTC DRUG	Family Wellness Pain Relief Powder		Aspirin and Caffeine	POWDER	ORAL	20230427		OTC MONOGRAPH NOT FINAL	part343	Family Dollar Services Inc	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55319-893_c210f5de-3bcd-4c9f-9118-49c3baf15179	55319-893	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20231213		ANDA	ANDA075139	Family Dollar Services Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-903_8d2d0c7e-ddc0-47f6-9f84-f447c632238b	55319-903	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20231229		OTC MONOGRAPH DRUG	M009	Family Dollar Services Inc	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20251231
55319-906_0d383700-e256-881f-e063-6294a90a347c	55319-906	HUMAN OTC DRUG	Family Wellness Advanced Redness Relief Eye Drops		Polyethylene glycol 400, Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230812		OTC MONOGRAPH DRUG	M018	Family Dollar Services, Inc.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE	1; .05	g/100mL; g/100mL			N	20241231
55319-907_0d383700-e257-881f-e063-6294a90a347c	55319-907	HUMAN OTC DRUG	Family Wellness Original Redness Relief Eye Drops		Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230812		OTC MONOGRAPH DRUG	M018	Family Dollar Services, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
55319-908_0d38267e-cdfa-a2c0-e063-6394a90ab84c	55319-908	HUMAN OTC DRUG	Family Wellness Artificial Tears		Polyvinyl alcohol, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20230812		OTC MONOGRAPH DRUG	M018	Family Dollar Services, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
55319-909_0d385aa4-0523-b4c5-e063-6294a90a65f8	55319-909	HUMAN OTC DRUG	Family Wellness Maximum Redness Relief Eye Drops		Glycerin, Naphazoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230812		OTC MONOGRAPH DRUG	M018	Family Dollar Services, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
55319-912_cef63000-9df2-4312-afbd-f932d7ebc112	55319-912	HUMAN OTC DRUG	Family Dollar Daytime Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20230707		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-916_1acd0db6-b99f-a6ee-e74f-77022a0521e8	55319-916	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20120810		ANDA	ANDA078878	Family Dollar Stores, Inc.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55319-917_706ad449-ef0a-6212-7f56-8fcb3dc9e3a1	55319-917	HUMAN OTC DRUG	Allergy Relief		Fexofenadine hydrochloride	TABLET	ORAL	20120412		ANDA	ANDA076502	Family Dollar Stores, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-918_1f889c03-e2a4-4ff4-ab10-5af8c1e0ed83	55319-918	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20231213		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-922_34fefb9c-3633-49b5-9c81-ea304ce283be	55319-922	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20230515		ANDA	ANDA208754	Family Dollar (FAMILY WELLNESS)	DOCOSANOL	100	mg/g			N	20241231
55319-923_61bb8f1a-1b26-4a06-83c3-2919a362c988	55319-923	HUMAN OTC DRUG	Childrens Allergy		Fexofenadine HCl	SUSPENSION	ORAL	20230701		ANDA	ANDA203330	Family Dollar (FAMILY WELLNESS)	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-926_be57de74-4f22-4a1f-8b3a-1c53cf9dee60	55319-926	HUMAN OTC DRUG	Family Dollar	Nighttime Cold and Flu Relief	Acetaminophen, Dextromethorphan Hydrobromide and Doxylamine succinate	LIQUID	ORAL	20230710		OTC MONOGRAPH DRUG	M012	FAMILY DOLLAR SERVICES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-932_fe3df2a4-b9dd-405e-87ab-c96ec393f750	55319-932	HUMAN OTC DRUG	Allergy		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-933_ad68a507-fa69-e6ef-e053-2995a90a5cd3	55319-933	HUMAN OTC DRUG	MAXIMUM STRENGHT DAY COLD AND FLU FORMULA		ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200805		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-934_ad68bdc1-3246-2700-e053-2a95a90aa9e7	55319-934	HUMAN OTC DRUG	MAXIMUM STRENTH NIGHT COLD AND FLU FORMULA		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20200802		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-935_bc2847bd-d71b-dc69-e053-2995a90aa2c8	55319-935	HUMAN OTC DRUG	MAXIMUM STRENGTH DAY-NIGHT COLD AND FLU FORMULA		ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE HCL	KIT	ORAL	20200802		OTC MONOGRAPH FINAL	part341	FAMILY DOLLAR						N	20241231
55319-938_fe95e4c9-f5bf-4810-a88e-bd9fb112fde2	55319-938	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20230831		ANDA	ANDA075209	Family Dollar (FAMILY WELLNESS)	LORATADINE	10	mg/1			N	20241231
55319-939_65ed577d-07a6-40e5-bff5-26b9ec806f04	55319-939	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20170901		ANDA	ANDA077498	FAMILY DOLLAR SERVICES, INC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-941_17cd3f17-b071-4435-82c3-7b845247e81a	55319-941	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20151216		OTC MONOGRAPH NOT FINAL	part347	Family Dollar Services, Inc.,	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
55319-946_3fb74839-899b-4134-85c1-d33b2f2c3bde	55319-946	HUMAN OTC DRUG	kidgets infants pain reliever plus fever reducer		Acetaminophen	SUSPENSION	ORAL	20200910		OTC MONOGRAPH NOT FINAL	part343	Family Dollar Services Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
55319-948_1331ab43-f406-42b7-9ced-c1db516c8a11	55319-948	HUMAN OTC DRUG	Stomach Relief Ultra		Bismuth subsalicylate	LIQUID	ORAL	20230701		OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55319-951_4751ca14-657e-49df-98f4-9f79ec4492b7	55319-951	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	LIQUID	ORAL	20230701		OTC MONOGRAPH FINAL	part335	Family Dollar (FAMILY WELLNESS)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55319-952_598d6565-9ade-4349-8ea4-1aaae1b7b413	55319-952	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20150715		OTC MONOGRAPH FINAL	part347	Family Dollar Services INC	PETROLATUM	340	mg/g			N	20241231
55319-953_5011412d-dc6f-4fcd-92dc-3223bb1853c5	55319-953	HUMAN OTC DRUG	Sinus Congestion		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Family Dollar Services Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
55319-956_b175ed9f-d412-4c3b-a32f-ab89f813c37f	55319-956	HUMAN OTC DRUG	Antibacterial		Chloroxylenol	LIQUID	TOPICAL	20160429		OTC MONOGRAPH NOT FINAL	part333A	Family Dollar	CHLOROXYLENOL	3.09	mg/mL			N	20241231
55319-957_73c1c2a3-8224-4c78-928f-93143a8f66e5	55319-957	HUMAN OTC DRUG	Childrens Allergy		Fexofenadine HCL	SUSPENSION	ORAL	20231031		ANDA	ANDA203330	Family Dollar (FAMILY WELLNESS)	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-959_db8af2b6-a828-2919-e053-2995a90a8729	55319-959	HUMAN OTC DRUG	PAIN RELIEF LIDOCAINE		LIDOCAINE	PATCH	TOPICAL	20180907		OTC MONOGRAPH NOT FINAL	part348	FAMILY DOLLAR	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55319-960_51e42300-4111-40e1-a8ee-673e0adb43af	55319-960	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20230701		OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-962_c2822425-dd4a-436e-87aa-52a5e2f05e55	55319-962	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20230701		ANDA	ANDA209274	Family Dollar (FAMILY WELLNESS)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-965_ff16fc15-6ad7-4762-bc4f-b302472483d9	55319-965	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20230701		ANDA	ANDA211075	Family Dollar (FAMILY WELLNESS)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55319-966_6ef8a148-a064-483e-a688-8db69e054965	55319-966	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230701		ANDA	ANDA204833	Family Dollar (FAMILY WELLNESS)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55319-967_2082209b-cf6c-484f-9f38-82fc227d25c7	55319-967	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20230701		OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-968_8d7f1aa7-e52e-413b-a7c9-2a63e0ae0b82	55319-968	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20230701		OTC MONOGRAPH FINAL	part341	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55319-969_6a7b581b-863b-4c39-92f4-db33f065036f	55319-969	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20230515		ANDA	ANDA208077	Family Dollar (FAMILY WELLNESS)	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-970_a0a2bde5-641e-44f0-b9a1-b57dd0993325	55319-970	HUMAN OTC DRUG	Migraine Relief		Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20230701		ANDA	ANDA214039	Family Dollar (FAMILY WELLNESS)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55319-971_6b743b09-ea10-4f1e-9301-53333e7c11d9	55319-971	HUMAN OTC DRUG	Ibuprofen Minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230701		ANDA	ANDA206568	Family Dollar (FAMILY WELLNESS)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55319-972_799e1744-39e4-4d51-851f-ceda28cf0921	55319-972	HUMAN OTC DRUG	Antiseptic Rinse Spring Mint		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20140512		OTC MONOGRAPH DRUG	505G(a)(3)	Midwood Brands, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55319-980_03372376-eef0-943d-e063-6394a90a52ee	55319-980	HUMAN OTC DRUG	Family Wellness Clotrimazole 1 Anti Fungal Cream		CLOTRIMAZOLE	CREAM	TOPICAL	20240101		OTC MONOGRAPH FINAL	part333C	Family Dollar Stores, Inc	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55319-981_eb8f00c5-6faf-4464-b1fc-9df4f8f13f24	55319-981	HUMAN OTC DRUG	Family Wellness HEMORRHOID		Glycerin, Petrolatum, Phenylephrine HCL, Pramoxine HCL	CREAM	TOPICAL	20231002		OTC MONOGRAPH DRUG	M015	FAMILY DOLLAR (Family Wellness)	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	144; 150; 2.5; 10	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55319-982_033705bc-f609-4d0c-e063-6394a90aa183	55319-982	HUMAN OTC DRUG	Family Wellness Max Strength 1 Hydrocortisone Cream		HYDROCORTISONE	CREAM	TOPICAL	20240101		OTC MONOGRAPH NOT FINAL	part348	Family Dollar Stores, Inc	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55319-983_3c853555-c557-4b90-bc8f-277c59c65cbe	55319-983	HUMAN OTC DRUG	Family Wellness Oxymetazoline No Drip		Oxymetazoline	SPRAY	NASAL	20231002		OTC MONOGRAPH DRUG	M012	FAMILY DOLLAR (Family Wellness)	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55319-985_26795e57-311e-4145-9272-4ccbaaa04108	55319-985	HUMAN OTC DRUG	Family Wellness Oxymetazoline		Oxymetazoline	SPRAY	NASAL	20231002		OTC MONOGRAPH DRUG	M012	FAMILY DOLLAR (Family Wellness)	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55319-990_abf4cdea-1a9c-7c8e-e053-2a95a90a83a5	55319-990	HUMAN OTC DRUG	FAMILY WELLNESS ICE BLUE		MENTHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part348	FAMILY DOLLAR SERVICES INC	MENTHOL	2	g/100g			N	20241231
55319-991_03372763-6935-0286-e063-6394a90a2fca	55319-991	HUMAN OTC DRUG	Family Wellness Athletes Foot Tolnaftate 1 Cream		TOLNAFTATE	CREAM	TOPICAL	20240101		OTC MONOGRAPH FINAL	part333C	Family Dollar Stores, Inc	TOLNAFTATE	10	mg/g			N	20241231
55322-0001_079bb7e2-5528-cf0e-e063-6394a90a74c8	55322-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19850601		UNAPPROVED MEDICAL GAS		Diamond Drugs Inc. dba Diamond Medical Supply	OXYGEN	99	L/100L			N	20241231
55328-801_687d09ae-dc71-4405-bbdd-142e51180f38	55328-801	HUMAN OTC DRUG	Salonpas		Diclofenac Sodium	GEL	TOPICAL	20160321		ANDA	ANDA208077	Hisamitsu America, Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55328-900_04dcd8e1-8637-41df-a7fb-b63cc3c9bd9f	55328-900	HUMAN OTC DRUG	Salonpas DEEP Relieving		Camphor, Menthol, Methyl salicylate	GEL	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20130601		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu America, Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 10; 15	g/100g; g/100g; g/100g			N	20241231
55328-901_9f73d847-ae8a-46d3-b349-c7a671d6993d	55328-901	HUMAN OTC DRUG	Salonpas LIDOCAINE PLUS		Benzyl alcohol, Lidocaine hydrochloride	LIQUID	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20170901		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu America, Inc.	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	10; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
55328-902_839462af-c649-444a-aa29-2bf5f831b081	55328-902	HUMAN OTC DRUG	Salonpas LIDOCAINE PLUS		Benzyl alcohol, Lidocaine hydrochloride	CREAM	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20170623		OTC MONOGRAPH NOT FINAL	part348	Hisamitsu America, Inc.	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	10; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
55330-0001_4c37603e-04de-4269-b6d6-d53234b5c89c	55330-0001	HUMAN OTC DRUG	Wholistic Thyroid Balance		Fucus Vesiculosus, Thyroidinum (Suis), Spongia Tosta	LIQUID	ORAL	20130820		UNAPPROVED HOMEOPATHIC		Institute for Wholistic Rejuvenation	FUCUS VESICULOSUS; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA THYROID	3; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55346-0401_0a963bca-efc8-8a5f-e063-6394a90aeae3	55346-0401	HUMAN OTC DRUG	Home Care Fluoride		Stannous Fluoride	GEL	DENTAL; ORAL	19991231		OTC MONOGRAPH DRUG	M021	Dental Technologies, Inc.	STANNOUS FLUORIDE	.969	mg/g			N	20241231
55346-0402_0a963bca-efc7-8a5f-e063-6394a90aeae3	55346-0402	HUMAN OTC DRUG	Home Care Fluoride		Stannous Fluoride	GEL	DENTAL; ORAL	19991231		OTC MONOGRAPH DRUG	M021	Dental Technologies, Inc.	STANNOUS FLUORIDE	.969	mg/g			N	20241231
55346-0404_0a960f6c-5b86-b557-e063-6294a90ac9f4	55346-0404	HUMAN OTC DRUG	Home Care Fluoride		Stannous Fluoride	GEL	DENTAL; ORAL	19991231		OTC MONOGRAPH DRUG	M021	Dental Technologies, Inc.	STANNOUS FLUORIDE	.969	mg/g			N	20241231
55346-0408_0a960f6c-5b87-b557-e063-6294a90ac9f4	55346-0408	HUMAN OTC DRUG	Home Care Fluoride		Stannous Fluoride	GEL	DENTAL; ORAL	19991231		OTC MONOGRAPH DRUG	M021	Dental Technologies, Inc.	STANNOUS FLUORIDE	.969	mg/g			N	20241231
55346-0942_60132265-446f-7e66-e053-2991aa0a8237	55346-0942	HUMAN PRESCRIPTION DRUG	Alpha-Pro		Sodium Fluoride and Hydrofluoric Acid	GEL	DENTAL	20130401		UNAPPROVED DRUG OTHER		Dental Technologies, Inc.	HYDROFLUORIC ACID; SODIUM FLUORIDE	4.4; 7.9	mg/g; mg/g			N	20241231
55346-0943_6013b56c-c1f3-7949-e053-2991aa0a9887	55346-0943	HUMAN PRESCRIPTION DRUG	Alpha-Pro		Sodium Fluoride and Hydrofluoric Acid	GEL	DENTAL	20130401		UNAPPROVED DRUG OTHER		Dental Technologies, Inc.	HYDROFLUORIC ACID; SODIUM FLUORIDE	4.4; 7.9	mg/g; mg/g			N	20241231
55346-2901_0a96438c-7341-8bce-e063-6394a90a0ce7	55346-2901	HUMAN OTC DRUG	Alpha-Caine	Topical Anesthetic	Benzocaine	GEL	DENTAL; PERIODONTAL	19991231		OTC MONOGRAPH DRUG	M022	Dental Technologies, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55346-2902_0a96438c-7340-8bce-e063-6394a90a0ce7	55346-2902	HUMAN OTC DRUG	Alpha-Caine	Topical Anesthetic	Benzocaine	GEL	DENTAL; PERIODONTAL	19991231		OTC MONOGRAPH DRUG	M022	Dental Technologies, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55346-2903_0a966a3d-cdd8-376c-e063-6294a90a50de	55346-2903	HUMAN OTC DRUG	Alpha-Caine	Topical Anesthetic	Benzocaine	GEL	DENTAL; PERIODONTAL	19991231		OTC MONOGRAPH DRUG	M022	Dental Technologies, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55346-2904_0a966a3d-cdd9-376c-e063-6294a90a50de	55346-2904	HUMAN OTC DRUG	Alpha-Caine	Topical Anesthetic	Benzocaine	GEL	DENTAL; PERIODONTAL	19991231		OTC MONOGRAPH DRUG	M022	Dental Technologies, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55346-3302_a2cca707-103e-7265-e053-2995a90aebfc	55346-3302	HUMAN OTC DRUG	San-EZ Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333A	Dental Technologies, Inc.	ALCOHOL	70	mL/100mL			N	20241231
55346-3501_0a0d5748-6ced-0f47-e063-6294a90a154e	55346-3501	HUMAN OTC DRUG	PEROXY SHIELD MOUTH SORE		1.5% Hydrogen Peroxide	RINSE	ORAL	20200603		OTC MONOGRAPH DRUG	M022	Dental Technologies, Inc.	HYDROGEN PEROXIDE	1.5	mL/100mL			N	20241231
55404-001_0a4a4e6d-9f4d-d55b-e063-6394a90ab7eb	55404-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19640101		NDA	NDA205767	Lessors, Incorporated	OXYGEN	995	mL/L			N	20241231
55404-002_0a4a6b68-1be8-e3e0-e063-6394a90a0ffe	55404-002	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	19640101		NDA	NDA209989	Lessors, Incorporated	NITROUS OXIDE	990	mL/L			N	20241231
55443-0085_071038d9-8176-6953-e063-6394a90a8a84	55443-0085	HUMAN OTC DRUG	VioNex		Chloroxylenol	GEL	TOPICAL	19920101	20241001	OTC MONOGRAPH DRUG	M003	Metrex Research, LLC	CHLOROXYLENOL	.52	g/100mL			N	
55443-0400_07105b28-5cba-a46e-e063-6394a90a7747	55443-0400	HUMAN OTC DRUG	VIONEXUS		ALCOHOL	LIQUID	TOPICAL	20181101		OTC MONOGRAPH DRUG	M003	METREX RESEARCH, LLC	ALCOHOL	72	mL/100mL			N	20241231
55443-0600_07105e71-b823-b295-e063-6394a90a0129	55443-0600	HUMAN OTC DRUG	VioNexus		Chloroxylenol	LIQUID	TOPICAL	20191001		OTC MONOGRAPH DRUG	M003	Metrex Research, LLC	CHLOROXYLENOL	1	g/100mL			N	20241231
55465-002_076103a1-a410-4bd1-e063-6394a90aab28	55465-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19860801		NDA	NDA206024	Ivey Industries	NITROGEN	990	mL/L			N	20241231
55466-104_021d64e5-1ab6-704a-e063-6294a90ad783	55466-104	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-105_021d64e5-1ab6-704a-e063-6294a90ad783	55466-105	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-106_021d64e5-1ab6-704a-e063-6294a90ad783	55466-106	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-107_021d64e5-1ab6-704a-e063-6294a90ad783	55466-107	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-108_021d64e5-1ab6-704a-e063-6294a90ad783	55466-108	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-109_021d64e5-1ab6-704a-e063-6294a90ad783	55466-109	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-110_021d64e5-1ab6-704a-e063-6294a90ad783	55466-110	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-111_021d64e5-1ab6-704a-e063-6294a90ad783	55466-111	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-112_021d64e5-1ab6-704a-e063-6294a90ad783	55466-112	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-113_021d64e5-1ab6-704a-e063-6294a90ad783	55466-113	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-114_021d64e5-1ab6-704a-e063-6294a90ad783	55466-114	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-115_021d64e5-1ab6-704a-e063-6294a90ad783	55466-115	HUMAN PRESCRIPTION DRUG	LEVO-T		Levothyroxine Sodium	TABLET	ORAL	20151029		NDA	NDA021342	Neolpharma, Inc.	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
55466-129_06445910-ddca-2206-e063-6394a90aa519	55466-129	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate	TABLET	ORAL	20231229		ANDA	ANDA210754	Neolpharma, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
55466-130_06445910-ddca-2206-e063-6394a90aa519	55466-130	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate	TABLET	ORAL	20231229		ANDA	ANDA210754	Neolpharma, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	10; 10; 10; 10	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
55466-131_06445910-ddca-2206-e063-6394a90aa519	55466-131	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate	TABLET	ORAL	20231229		ANDA	ANDA210754	Neolpharma, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	15; 15; 15; 15	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
55466-132_06445910-ddca-2206-e063-6394a90aa519	55466-132	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate	TABLET	ORAL	20231229		ANDA	ANDA210754	Neolpharma, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	20; 20; 20; 20	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
55466-133_06445910-ddca-2206-e063-6394a90aa519	55466-133	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate	TABLET	ORAL	20231229		ANDA	ANDA210754	Neolpharma, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	30; 30; 30; 30	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
55490-029_f683a5a1-58b6-2ab9-e053-2a95a90a3952	55490-029	HUMAN OTC DRUG	75% Alcohol wipes		Wipes	CLOTH	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333A	Baijieyuan Biotechnology (Shandong) Co., Ltd.	ALCOHOL	75	mL/1001			N	20241231
55490-036_f945fc70-fdf7-eddb-e053-6294a90a7fe4	55490-036	HUMAN OTC DRUG	75% Alcohol Wipes		Wipes	CLOTH	TOPICAL	20211223		OTC MONOGRAPH NOT FINAL	part333E	Baijieyuan Biotechnology (Shandong) Co., Ltd.	ALCOHOL	75	mL/1001			N	20241231
55494-100_4cfa361c-cdad-49a1-bd52-56c6d5f4fdea	55494-100	HUMAN PRESCRIPTION DRUG	DICLEGIS		doxylamine succinate and pyridoxine hydrochloride	TABLET, DELAYED RELEASE	ORAL	20130515		NDA	NDA021876	Duchesnay USA, Inc.	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
55494-120_af3a70f8-e0ea-4863-a89b-55e3ebe481f3	55494-120	HUMAN PRESCRIPTION DRUG	BONJESTA		doxylamine succinate and pyridoxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180219		NDA	NDA209661	Duchesnay USA, Inc.	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	20; 20	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
55494-580_e85d61c1-b94b-4188-9bc6-01e0f467d5e9	55494-580	HUMAN PRESCRIPTION DRUG	Osphena		Ospemifene	TABLET, FILM COATED	ORAL	20230401		NDA	NDA203505	Duchesnay USA, Inc.	OSPEMIFENE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
55505-111_5b28bb1e-7b5b-43e5-b36e-f4d2a7db57d7	55505-111	HUMAN OTC DRUG	Safetussin	DM	Dextromethorpan Guaifenesin	LIQUID	ORAL	20101129		OTC MONOGRAPH DRUG	M012	Kramer Laboratories	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55505-173_39448ad4-bdbb-470a-8061-460e394987b1	55505-173	HUMAN OTC DRUG	Safetussin	PM	Dextromethorphan Doxylamine Succinate	LIQUID	ORAL	20170209		OTC MONOGRAPH DRUG	M012	Kramer Laboratories	DEXTROMETHORPHAN; DOXYLAMINE SUCCINATE	7.5; 3.125	mg/5mL; mg/5mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55505-177_f04a5c8d-b309-449f-a80d-0096bd0c9c71	55505-177	HUMAN OTC DRUG	Fungi Nail Toe and Foot		Tolnaftate	SOLUTION	TOPICAL	20190325		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	10	mg/mL			N	20241231
55505-185_6c1043b4-2ce6-4c95-bdee-a604a64d9449	55505-185	HUMAN OTC DRUG	Fungi Nail Toe and Foot		Tolnaftate	OINTMENT	TOPICAL	20181115		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	1	g/100g			N	20241231
55505-186_54be9971-21ac-410d-ae23-7f9fce2d4d0a	55505-186	HUMAN OTC DRUG	HC Max Hongo Cura		Tolnaftate	OINTMENT	TOPICAL	20181115		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	1	g/100g			N	20241231
55505-189_408cdd96-147e-4ad4-a71c-1eeef8a62a82	55505-189	HUMAN OTC DRUG	Safetussin	DM	Dextromethorphan Guaifenesin	LIQUID	ORAL	20150701		OTC MONOGRAPH DRUG	M012	Kramer Laboratories	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55505-192_787642a1-831e-42f4-9ac0-8cff31b910ae	55505-192	HUMAN OTC DRUG	Nizoral		Ketoconazole	SHAMPOO	TOPICAL	20190107		NDA	NDA020310	Kramer Laboratories	KETOCONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55505-193_8d1af7f8-c1ee-4a2e-995a-c8fb37d23ea1	55505-193	HUMAN OTC DRUG	Fungi Nail Anti-Fungal Pen		Tolnaftate	LIQUID	TOPICAL	20200301		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	1	g/100mL			N	20241231
55505-194_a4a31658-db6a-4927-b3d2-47d2b2658f84	55505-194	HUMAN OTC DRUG	HC MAX FOR JOCK ITCH		Tolnaftate	OINTMENT	TOPICAL	20200601		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	1	g/100g			N	20241231
55505-195_a1d0a317-bc5e-4207-b72b-3a8da0142942	55505-195	HUMAN OTC DRUG	HC Max Anti-Fungal		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20200528		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	1.5	g/150g			N	20241231
55505-196_b420c0dd-0f15-4cec-ba8f-1c65630f65fb	55505-196	HUMAN OTC DRUG	Nizoral		Ketoconazole	SHAMPOO	TOPICAL	20220616		NDA	NDA020310	Kramer Laboratories	KETOCONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
55505-197_231278e9-183d-4e35-88f7-c547a3593b89	55505-197	HUMAN OTC DRUG	Kaopectate		Bismuth subsalicylate	TABLET, COATED	ORAL	20201001		OTC MONOGRAPH DRUG	M008	Kramer Laboratories	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
55505-198_400be10d-5bc4-4c1d-aefa-8ac18efa7e30	55505-198	HUMAN OTC DRUG	Kaopectate Vanilla Flavor Anti Diarrheal		bismuth subsalicylate	LIQUID	ORAL	20201001		OTC MONOGRAPH DRUG	M008	Kramer Laboratories	BISMUTH SUBSALICYLATE	262	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55505-199_b689d63b-3d27-4660-b6b4-77645a9b158b	55505-199	HUMAN OTC DRUG	Kaopectate Peppermint Flavor Anti Diarrheal		bismuth subsalicylate	LIQUID	ORAL	20201001		OTC MONOGRAPH DRUG	M008	Kramer Laboratories	BISMUTH SUBSALICYLATE	262	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55505-200_ef507300-2940-4c94-8bf6-b6dfc513bf7f	55505-200	HUMAN OTC DRUG	Kaopectate Max Peppermint Flavor Anti Diarrheal		bismuth subsalicylate	LIQUID	ORAL	20201101		OTC MONOGRAPH DRUG	M008	Kramer Laboratories	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55505-202_515b531d-1afa-4e65-8101-e9f498aab5f4	55505-202	HUMAN OTC DRUG	Nizoral Psoriasis		Salicylic Acid	SHAMPOO	TOPICAL	20201201		OTC MONOGRAPH DRUG	M032	Kramer Laboratories	SALICYLIC ACID	3	g/100mL			N	20241231
55505-203_a5c268de-e507-4f28-a1cf-658ffda12373	55505-203	HUMAN OTC DRUG	HC Max For Athletes Foot		Tolnaftate	OINTMENT	TOPICAL	20200513		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	1	g/100g			N	20241231
55505-206_6627383a-9c25-4bc4-9427-cf08d4b6e459	55505-206	HUMAN OTC DRUG	Kaopectate		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20210201		OTC MONOGRAPH DRUG	M008	Kramer Laboratories	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
55505-217_7d52a2aa-1c9f-4d02-ae7e-77dde20c3450	55505-217	HUMAN OTC DRUG	Safetussin High Blood Pressure and diabetes	Cough, Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Guaifenesin	LIQUID	ORAL	20230417		OTC MONOGRAPH DRUG	M012	KRAMER LABORATORIES	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	650; 20; 400	mg/30mL; mg/30mL; mg/30mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55505-219_75b9e595-b00f-48e2-be5c-25b9e41660cd	55505-219	HUMAN OTC DRUG	Opti-Nail 2-in-1		Tolnaftate	LIQUID	TOPICAL	20230120		OTC MONOGRAPH DRUG	M005	Kramer Laboratories	TOLNAFTATE	1	g/100mL			N	20241231
55505-220_9fa112c9-e391-459f-a831-6d716992a18e	55505-220	HUMAN OTC DRUG	SAFETUSSIN Non Drowsy	Cough plus chest congestion	Dextromethorphan Hydrobromide, and Guaifenesin	LIQUID	ORAL	20230601		OTC MONOGRAPH DRUG	M012	KRAMER LABORATORIES	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55505-221_3c6c9b47-d0b2-499a-9cad-8e4bc9b1bdf6	55505-221	HUMAN OTC DRUG	Safetussin PM Nighttime	Cough relief	Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20230728		OTC MONOGRAPH DRUG	M012	Kramer Laboratories	DEXTROMETHORPHAN; DOXYLAMINE SUCCINATE	7.5; 3.125	mg/5mL; mg/5mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55505-222_c914c76f-814a-4a51-94aa-74eb0f5a6e23	55505-222	HUMAN OTC DRUG	Nizoral Scalp Itch Relief		HYDROCORTISONE	SHAMPOO	TOPICAL	20240101		OTC MONOGRAPH NOT FINAL	part348	Kramer Laboratories	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55505-223_5d188b11-c2b8-4b78-9118-1b8ee142df9a	55505-223	HUMAN OTC DRUG	Nizoral Eczema Relief Cream		Colloidal Oatmeal	CREAM	TOPICAL	20240101		OTC MONOGRAPH FINAL	part347	Kramer Laboratories	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55505-224_edd9955f-5ce0-4e34-b5f5-c49a1c518ee9	55505-224	HUMAN OTC DRUG	Nizoral Psoriasis Relief		Salicylic Acid	CREAM	TOPICAL	20240101		OTC MONOGRAPH FINAL	part358H	Kramer Laboratories	SALICYLIC ACID	3	g/100g			N	20241231
55505-225_d45ec9d0-f8b9-41ef-8dd9-11caf6a1b3eb	55505-225	HUMAN OTC DRUG	EXTRA STRENGTH	gas relief	SIMETHICONE	LIQUID	ORAL	20200826		OTC MONOGRAPH DRUG	M002	KRAMER LABORATORIES	DIMETHICONE	125	mg/5mL	Skin Barrier Activity [PE]		N	20241231
55513-002_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-002	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060911		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	25	ug/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-003_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-003	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060911		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	40	ug/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-004_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-004	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060911		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	60	ug/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-005_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-005	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060911		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	100	ug/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-006_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-006	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060911		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	200	ug/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-021_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-021	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060814		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	40	ug/.4mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-023_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-023	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060814		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	60	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-025_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-025	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060814		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	100	ug/.5mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-027_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-027	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060911		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	150	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-028_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-028	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060814		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	200	ug/.4mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-032_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-032	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060607		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	500	ug/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-057_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-057	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060826		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	25	ug/.42mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-073_4c1e9ef1-8a4d-4720-a101-98b86325c8df	55513-073	HUMAN PRESCRIPTION DRUG	Sensipar		cinacalcet hydrochloride	TABLET, COATED	ORAL	20040404		NDA	NDA021688	Amgen Inc	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
55513-074_4c1e9ef1-8a4d-4720-a101-98b86325c8df	55513-074	HUMAN PRESCRIPTION DRUG	Sensipar		cinacalcet hydrochloride	TABLET, COATED	ORAL	20040404		NDA	NDA021688	Amgen Inc	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
55513-075_4c1e9ef1-8a4d-4720-a101-98b86325c8df	55513-075	HUMAN PRESCRIPTION DRUG	Sensipar		cinacalcet hydrochloride	TABLET, COATED	ORAL	20040404		NDA	NDA021688	Amgen Inc	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
55513-078_c314612a-7d20-43a9-b323-6cb2c3f083ed	55513-078	HUMAN PRESCRIPTION DRUG	Imlygic		talimogene laherparepvec	INJECTION, SUSPENSION	INTRALESIONAL	20151102		BLA	BLA125518	Amgen Inc	TALIMOGENE LAHERPAREPVEC	1000000	[PFU]/mL			N	20241231
55513-079_c314612a-7d20-43a9-b323-6cb2c3f083ed	55513-079	HUMAN PRESCRIPTION DRUG	Imlygic		talimogene laherparepvec	INJECTION, SUSPENSION	INTRALESIONAL	20151102		BLA	BLA125518	Amgen Inc	TALIMOGENE LAHERPAREPVEC	100000000	[PFU]/mL			N	20241231
55513-098_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-098	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060826		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	10	ug/.4mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-100_3a6214f7-0ff4-47b1-8a6d-696228504f61	55513-100	HUMAN PRESCRIPTION DRUG	TEZSPIRE		tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217		BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210	mg/1.9mL	Thymic Stromal Lymphopoietin Blocker [EPC], Thymic Stromal Lymphopoietin Blockers [MoA]		N	20241231
55513-110_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-110	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060814		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	300	ug/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-111_5a5173e4-bb8c-4eac-adcd-98effe0a5226	55513-111	HUMAN PRESCRIPTION DRUG	ARANESP		darbepoetin alfa	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060814		BLA	BLA103951	Amgen Inc	DARBEPOETIN ALFA	300	ug/.6mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-112_3a6214f7-0ff4-47b1-8a6d-696228504f61	55513-112	HUMAN PRESCRIPTION DRUG	TEZSPIRE		tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217		BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210	mg/1.9mL	Thymic Stromal Lymphopoietin Blocker [EPC], Thymic Stromal Lymphopoietin Blockers [MoA]		N	20241231
55513-123_3a6214f7-0ff4-47b1-8a6d-696228504f61	55513-123	HUMAN PRESCRIPTION DRUG	TEZSPIRE		tezepelumab-ekko	INJECTION, SOLUTION	SUBCUTANEOUS	20211217		BLA	BLA761224	Amgen, Inc	TEZEPELUMAB	210	mg/1.9mL	Thymic Stromal Lymphopoietin Blocker [EPC], Thymic Stromal Lymphopoietin Blockers [MoA]		N	20241231
55513-126_24d7c973-9b2d-4b32-baf5-0bcde9ce4c9b	55513-126	HUMAN PRESCRIPTION DRUG	EPOGEN		epoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890630		BLA	BLA103234	Amgen Inc	EPOETIN	2000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-132_14829f5f-b04b-4479-bcfb-809fb1570ae7	55513-132	HUMAN PRESCRIPTION DRUG	Kanjinti		trastuzumab-anns	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190611		BLA	BLA761073	Amgen Inc	TRASTUZUMAB	420	mg/20mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
55513-137_3e8d8499-e557-4e75-8655-554a1a2d0b04	55513-137	HUMAN PRESCRIPTION DRUG	Otezla		apremilast	TABLET, FILM COATED	ORAL	20200226		NDA	NDA205437	Amgen Inc	APREMILAST	30	mg/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
55513-141_14829f5f-b04b-4479-bcfb-809fb1570ae7	55513-141	HUMAN PRESCRIPTION DRUG	Kanjinti		trastuzumab-anns	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191028		BLA	BLA761073	Amgen Inc	TRASTUZUMAB	150	mg/7.15mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
55513-144_24d7c973-9b2d-4b32-baf5-0bcde9ce4c9b	55513-144	HUMAN PRESCRIPTION DRUG	EPOGEN		epoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19930816		BLA	BLA103234	Amgen Inc	EPOETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-148_24d7c973-9b2d-4b32-baf5-0bcde9ce4c9b	55513-148	HUMAN PRESCRIPTION DRUG	EPOGEN		epoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19930816		BLA	BLA103234	Amgen Inc	EPOETIN	4000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-160_d3375aa6-a868-417b-ac5f-d0103e470dd6	55513-160	HUMAN PRESCRIPTION DRUG	BLINCYTO		blinatumomab	KIT		20141218		BLA	BLA125557	Amgen Inc						N	20241231
55513-164_14829f5f-b04b-4479-bcfb-809fb1570ae7	55513-164	HUMAN PRESCRIPTION DRUG	Kanjinti		trastuzumab-anns	KIT		20230201		BLA	BLA761073	Amgen Inc						N	20241231
55513-190_50374606-0a76-45df-8b19-8323cc511e87	55513-190	HUMAN PRESCRIPTION DRUG	Neulasta		pegfilgrastim	INJECTION	SUBCUTANEOUS	20020401		BLA	BLA125031	Amgen Inc	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
55513-192_50374606-0a76-45df-8b19-8323cc511e87	55513-192	HUMAN PRESCRIPTION DRUG	Neulasta		pegfilgrastim	KIT		20020401		BLA	BLA125031	Amgen Inc						N	20241231
55513-206_11156d95-bd9a-4d3c-bff3-371869ea13e8	55513-206	HUMAN PRESCRIPTION DRUG	MVASI		bevacizumab-awwb	INJECTION, SOLUTION	INTRAVENOUS	20180601		BLA	BLA761028	Amgen Inc	BEVACIZUMAB	100	mg/4mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
55513-207_11156d95-bd9a-4d3c-bff3-371869ea13e8	55513-207	HUMAN PRESCRIPTION DRUG	MVASI		bevacizumab-awwb	INJECTION, SOLUTION	INTRAVENOUS	20180601		BLA	BLA761028	Amgen Inc	BEVACIZUMAB	400	mg/16mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
55513-209_2eacc44a-29a9-49e6-a93e-63aa38725478	55513-209	HUMAN PRESCRIPTION DRUG	NEUPOGEN		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20001002		BLA	BLA103353	Amgen Inc	FILGRASTIM	480	ug/.8mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
55513-221_3e6f88f4-b351-41c3-809b-7abd712d92f8	55513-221	HUMAN PRESCRIPTION DRUG	Nplate		romiplostim	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20080825		BLA	BLA125268	Amgen Inc	ROMIPLOSTIM	250	ug/.5mL	Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA]		N	20241231
55513-222_3e6f88f4-b351-41c3-809b-7abd712d92f8	55513-222	HUMAN PRESCRIPTION DRUG	Nplate		romiplostim	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20080825		BLA	BLA125268	Amgen Inc	ROMIPLOSTIM	500	ug/mL	Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA]		N	20241231
55513-223_3e6f88f4-b351-41c3-809b-7abd712d92f8	55513-223	HUMAN PRESCRIPTION DRUG	Nplate		romiplostim	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20190802		BLA	BLA125268	Amgen Inc	ROMIPLOSTIM	125	ug/.25mL	Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA]		N	20241231
55513-224_4d103e96-5706-47e3-bdb5-757964f9e379	55513-224	HUMAN PRESCRIPTION DRUG	Riabni		rituximab-arrx	INJECTION, SOLUTION	INTRAVENOUS	20210106		BLA	BLA761140	Amgen Inc	RITUXIMAB	100	mg/10mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
55513-267_24d7c973-9b2d-4b32-baf5-0bcde9ce4c9b	55513-267	HUMAN PRESCRIPTION DRUG	EPOGEN		epoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19900430		BLA	BLA103234	Amgen Inc	EPOETIN	3000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-283_24d7c973-9b2d-4b32-baf5-0bcde9ce4c9b	55513-283	HUMAN PRESCRIPTION DRUG	EPOGEN		epoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19941205		BLA	BLA103234	Amgen Inc	EPOETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-326_4d103e96-5706-47e3-bdb5-757964f9e379	55513-326	HUMAN PRESCRIPTION DRUG	Riabni		rituximab-arrx	INJECTION, SOLUTION	INTRAVENOUS	20210106		BLA	BLA761140	Amgen Inc	RITUXIMAB	500	mg/50mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
55513-369_3e8d8499-e557-4e75-8655-554a1a2d0b04	55513-369	HUMAN PRESCRIPTION DRUG	Otezla		apremilast	KIT		20200226		NDA	NDA205437	Amgen Inc						N	20241231
55513-399_c481ca56-b445-4d59-99e8-573945962923	55513-399	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814		BLA	BLA761024	Amgen Inc	ADALIMUMAB	20	mg/.2mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-400_c481ca56-b445-4d59-99e8-573945962923	55513-400	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131		BLA	BLA761024	Amgen Inc	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-410_c481ca56-b445-4d59-99e8-573945962923	55513-410	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131		BLA	BLA761024	Amgen Inc	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-411_c481ca56-b445-4d59-99e8-573945962923	55513-411	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131		BLA	BLA761024	Amgen Inc	ADALIMUMAB	20	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-413_c481ca56-b445-4d59-99e8-573945962923	55513-413	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230406		BLA	BLA761024	Amgen Inc	ADALIMUMAB	10	mg/.2mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-478_24d7c973-9b2d-4b32-baf5-0bcde9ce4c9b	55513-478	HUMAN PRESCRIPTION DRUG	EPOGEN		epoetin alfa	SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19970303		BLA	BLA103234	Amgen Inc	EPOETIN	20000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
55513-479_c481ca56-b445-4d59-99e8-573945962923	55513-479	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814		BLA	BLA761024	Amgen Inc	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-480_c481ca56-b445-4d59-99e8-573945962923	55513-480	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814		BLA	BLA761024	Amgen Inc	ADALIMUMAB	80	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-481_c481ca56-b445-4d59-99e8-573945962923	55513-481	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814		BLA	BLA761024	Amgen Inc	ADALIMUMAB	80	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-482_c481ca56-b445-4d59-99e8-573945962923	55513-482	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814		BLA	BLA761024	Amgen Inc	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-485_3e8d8499-e557-4e75-8655-554a1a2d0b04	55513-485	HUMAN PRESCRIPTION DRUG	Otezla		apremilast	KIT		20200226		NDA	NDA205437	Amgen Inc						N	20241231
55513-488_336c6783-a078-4639-ba70-b59fdc55ce43	55513-488	HUMAN PRESCRIPTION DRUG	LUMAKRAS		sotorasib	TABLET, COATED	ORAL	20210528		NDA	NDA214665	Amgen Inc	SOTORASIB	120	mg/1			N	20241231
55513-504_336c6783-a078-4639-ba70-b59fdc55ce43	55513-504	HUMAN PRESCRIPTION DRUG	LUMAKRAS		sotorasib	TABLET, COATED	ORAL	20230202		NDA	NDA214665	Amgen Inc	SOTORASIB	320	mg/1			N	20241231
55513-530_2eacc44a-29a9-49e6-a93e-63aa38725478	55513-530	HUMAN PRESCRIPTION DRUG	NEUPOGEN		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19970519		BLA	BLA103353	Amgen Inc	FILGRASTIM	300	ug/mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
55513-546_2eacc44a-29a9-49e6-a93e-63aa38725478	55513-546	HUMAN PRESCRIPTION DRUG	NEUPOGEN		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19970407		BLA	BLA103353	Amgen Inc	FILGRASTIM	480	ug/1.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
55513-670_bf659ad2-542a-468d-b196-6b74370c6ebc	55513-670	HUMAN PRESCRIPTION DRUG	AVSOLA		infliximab-axxq	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191212		BLA	BLA761086	Amgen Inc	INFLIXIMAB	100	mg/10mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
55513-710_1cebc74b-6c5c-4fa7-9f16-59f4695e29ee	55513-710	HUMAN PRESCRIPTION DRUG	Prolia		denosumab	INJECTION	SUBCUTANEOUS	20100605		BLA	BLA125320	Amgen Inc	DENOSUMAB	60	mg/mL	RANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]		N	20241231
55513-730_dd914cae-07e4-4eb4-bed7-5f6ece674ee4	55513-730	HUMAN PRESCRIPTION DRUG	XGEVA		denosumab	INJECTION	SUBCUTANEOUS	20101118		BLA	BLA125320	Amgen Inc	DENOSUMAB	120	mg/1.7mL	RANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]		N	20241231
55513-740_e4cbc29d-7e7f-4406-8543-3f3ab4ef7b0b	55513-740	HUMAN PRESCRIPTION DRUG	PARSABIV		etelcalcetide	INJECTION, SOLUTION	INTRAVENOUS	20170403		NDA	NDA208325	Amgen Inc	ETELCALCETIDE HYDROCHLORIDE	2.5	mg/.5mL	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
55513-741_e4cbc29d-7e7f-4406-8543-3f3ab4ef7b0b	55513-741	HUMAN PRESCRIPTION DRUG	PARSABIV		etelcalcetide	INJECTION, SOLUTION	INTRAVENOUS	20170403		NDA	NDA208325	Amgen Inc	ETELCALCETIDE HYDROCHLORIDE	5	mg/mL	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
55513-742_e4cbc29d-7e7f-4406-8543-3f3ab4ef7b0b	55513-742	HUMAN PRESCRIPTION DRUG	PARSABIV		etelcalcetide	INJECTION, SOLUTION	INTRAVENOUS	20170403		NDA	NDA208325	Amgen Inc	ETELCALCETIDE HYDROCHLORIDE	10	mg/2mL	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
55513-750_ad0cad06-6727-4812-89f4-beb4f2e92a5c	55513-750	HUMAN PRESCRIPTION DRUG	REPATHA		Evolocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150831		BLA	BLA125522	Amgen Inc	EVOLOCUMAB	140	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
55513-760_ad0cad06-6727-4812-89f4-beb4f2e92a5c	55513-760	HUMAN PRESCRIPTION DRUG	REPATHA		Evolocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20150831		BLA	BLA125522	Amgen Inc	EVOLOCUMAB	140	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
55513-770_ad0cad06-6727-4812-89f4-beb4f2e92a5c	55513-770	HUMAN PRESCRIPTION DRUG	REPATHA		Evolocumab	KIT		20160801		BLA	BLA125522	Amgen Inc						N	20241231
55513-800_9f7f886a-6d34-48f7-9f13-a34e315aeafe	55513-800	HUMAN PRESCRIPTION DRUG	Corlanor		ivabradine	TABLET, FILM COATED	ORAL	20150420		NDA	NDA206143	Amgen Inc	IVABRADINE HYDROCHLORIDE	5	mg/1	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA], Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]		N	20241231
55513-810_9f7f886a-6d34-48f7-9f13-a34e315aeafe	55513-810	HUMAN PRESCRIPTION DRUG	Corlanor		ivabradine	TABLET, FILM COATED	ORAL	20150420		NDA	NDA206143	Amgen Inc	IVABRADINE HYDROCHLORIDE	7.5	mg/1	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA], Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]		N	20241231
55513-813_9f7f886a-6d34-48f7-9f13-a34e315aeafe	55513-813	HUMAN PRESCRIPTION DRUG	Corlanor		ivabradine	SOLUTION	ORAL	20190419		NDA	NDA209964	Amgen Inc	IVABRADINE HYDROCHLORIDE	5	mg/5mL	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA], Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]		N	20241231
55513-840_9e3343fd-826c-41a4-a655-c71b4a651a16	55513-840	HUMAN PRESCRIPTION DRUG	AIMOVIG		erenumab-aooe	INJECTION	SUBCUTANEOUS	20180522		BLA	BLA761077	Amgen Inc	ERENUMAB	70	mg/mL			N	20241231
55513-841_9e3343fd-826c-41a4-a655-c71b4a651a16	55513-841	HUMAN PRESCRIPTION DRUG	AIMOVIG		erenumab-aooe	INJECTION	SUBCUTANEOUS	20180522		BLA	BLA761077	Amgen Inc	ERENUMAB	70	mg/mL			N	20241231
55513-842_9e3343fd-826c-41a4-a655-c71b4a651a16	55513-842	HUMAN PRESCRIPTION DRUG	AIMOVIG		erenumab-aooe	INJECTION, SOLUTION	SUBCUTANEOUS	20190315		BLA	BLA761077	Amgen Inc	ERENUMAB	140	mg/mL			N	20241231
55513-843_9e3343fd-826c-41a4-a655-c71b4a651a16	55513-843	HUMAN PRESCRIPTION DRUG	AIMOVIG		erenumab-aooe	INJECTION, SOLUTION	SUBCUTANEOUS	20190315		BLA	BLA761077	Amgen Inc	ERENUMAB	140	mg/mL			N	20241231
55513-880_5636619f-733e-4e3b-b497-cd8e8b63999b	55513-880	HUMAN PRESCRIPTION DRUG	Evenity		romosozumab-aqqg	INJECTION, SOLUTION	SUBCUTANEOUS	20190409		BLA	BLA761062	Amgen Inc	ROMOSOZUMAB	105	mg/1.17mL			N	20241231
55513-924_2eacc44a-29a9-49e6-a93e-63aa38725478	55513-924	HUMAN PRESCRIPTION DRUG	NEUPOGEN		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20001002		BLA	BLA103353	Amgen Inc	FILGRASTIM	300	ug/.5mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
55513-954_59928d12-bde9-4433-8316-a142514ef952	55513-954	HUMAN PRESCRIPTION DRUG	Vectibix		panitumumab	SOLUTION	INTRAVENOUS	20061010		BLA	BLA125147	Amgen Inc	PANITUMUMAB	100	mg/5mL	Antibodies, Monoclonal [CS], Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]		N	20241231
55513-956_59928d12-bde9-4433-8316-a142514ef952	55513-956	HUMAN PRESCRIPTION DRUG	Vectibix		panitumumab	SOLUTION	INTRAVENOUS	20061010		BLA	BLA125147	Amgen Inc	PANITUMUMAB	400	mg/20mL	Antibodies, Monoclonal [CS], Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]		N	20241231
55528-400_fc8a2605-d815-5cf8-e053-6394a90ab9d2	55528-400	HUMAN OTC DRUG	Alpha-H Total Eclipse		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20230505		OTC MONOGRAPH FINAL	part352	Alpha-H	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
55550-102_f2b4ed5f-347d-9ee4-e053-2995a90a25f0	55550-102	HUMAN OTC DRUG	Sunscreen		Homosalate, Octinoxate, Octisalate, Oxybenzone	LOTION	TOPICAL	20230120		OTC MONOGRAPH NOT FINAL	part352	Total Resources International	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	6; 7.5; 5; 5	mg/g; mg/g; mg/g; mg/g			N	20241231
55550-220_09c52633-c563-0f8d-e063-6394a90a938f	55550-220	HUMAN OTC DRUG	Antiseptic Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200410		OTC MONOGRAPH DRUG	505G(a)(3)	Total Resources	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
55550-221_1db95571-8693-4bb2-a7f4-ce08e86593bc	55550-221	HUMAN OTC DRUG	ANTISEPTIC WIPE	01	Benzalkonium Chloride	PATCH	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part333A	Total Resources International Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
55550-222_f3d02cf2-9034-670b-e053-2a95a90a46aa	55550-222	HUMAN OTC DRUG	STERILE ALCOHOL PREP PADS	01	isopropyl alcohol	SWAB	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part333A	Total Resources International Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
55550-225_0ccdd939-2b8c-7f29-e063-6394a90a4e1e	55550-225	HUMAN OTC DRUG	ANTISEPTIC WIPE		BENZALKONIUM CHLORIDE WIPE	CLOTH	TOPICAL	20200701		OTC MONOGRAPH DRUG	505G(a)(3)	Total Resources International	BENZALKONIUM CHLORIDE	13	g/100g			N	20241231
55550-250_0d1fccd7-bfaa-3d94-e063-6294a90a6fb2	55550-250	HUMAN OTC DRUG	Hand Sanitizer Handy Helper Wipes		Alcohol	CLOTH	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Total Resources International	ALCOHOL	65	mL/100mL			N	20241231
55550-801_09c54740-0ec9-2005-e063-6394a90a59e7	55550-801	HUMAN OTC DRUG	Alcohol Prep Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20200410		OTC MONOGRAPH DRUG	505G(a)(3)	Total Resource	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
55560-0103_5e3d683f-43d9-4dfc-a5ff-5d056bec33a7	55560-0103	HUMAN OTC DRUG	1000 Roses Daily Shade Facial SPF 18		Octisalate, Octocrylene, and Avobenzone	LOTION	TOPICAL	20140301		OTC MONOGRAPH FINAL	part352	Andalou naturals	AVOBENZONE; OCTISALATE; OCTOCRYLENE	25; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
55560-0104_3a20b00d-30eb-4fd2-b71c-d2d6f82ccb1a	55560-0104	HUMAN OTC DRUG	Perfecting BB Beauty Balm Natural Tint SPF 30		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Andalou naturals	ZINC OXIDE	200	mg/mL			N	20241231
55560-0106_f93d1e1a-3917-4df5-9084-f22bd6072e0b	55560-0106	HUMAN OTC DRUG	1000 Roses CC Color Plus Correct Sheer Tan SPF 30		Zinc Oxide	LOTION	TOPICAL	20140301		OTC MONOGRAPH FINAL	part352	Andalou naturals	ZINC OXIDE	200	mg/mL			N	20241231
55560-0107_1b7aa3e8-108b-4b68-a94e-02bfee45193c	55560-0107	HUMAN OTC DRUG	DIY Booster SPF 30 Facial Serum Unscented		Octinoxate, Octisalate, Avobenzone, and Zinc Oxide	LOTION	TOPICAL	20140301		OTC MONOGRAPH FINAL	part352	Andalou naturals	AVOBENZONE; OCTINOXATE; OCTISALATE; ZINC OXIDE	30; 70; 50; 1	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55560-0108_8735d34c-fd33-4dfb-b919-306f38dd281a	55560-0108	HUMAN OTC DRUG	Vitamin C BB Beauty Balm Sheer Tint SFP 30		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Andalou naturals	ZINC OXIDE	200	mg/mL			N	20241231
55560-0109_f0ace3dc-0de9-467c-9c8c-e52278913391	55560-0109	HUMAN OTC DRUG	Argan Stem Cell BB Benefit Balm Un-Tinted SFP 30		Zinc Oxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH FINAL	part352	Andalou naturals	ZINC OXIDE	200	mg/mL			N	20241231
55560-1810_70f023d4-8621-4e87-aa6e-124f74e058df	55560-1810	HUMAN OTC DRUG	Blemish Vanishing		Salicylic Acid	GEL	TOPICAL	20110301		OTC MONOGRAPH FINAL	part333D	Andalou naturals	SALICYLIC ACID	20	mg/mL			N	20241231
55560-1812_4aaa3b6d-067b-4717-92dc-f7f51f91053a	55560-1812	HUMAN OTC DRUG	CannaCell Sun Buddy Facial SPF 30		Zinc Oxide	LOTION	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	Andalou naturals	ZINC OXIDE	200	mg/mL			N	20241231
55560-2201_479f3e2d-663b-4d54-be33-3de2fdc294e1	55560-2201	HUMAN OTC DRUG	ANDALOU NATURALS DEEP HYDRATION DAILY SHADE BLUE LIGHT DEFENSE FACIAL SPF 30		ZINC OXIDE	LOTION	TOPICAL	20220112		OTC MONOGRAPH FINAL	part352	Andalou naturals	ZINC OXIDE	157	mg/mL			N	20241231
55560-3331_6a023501-2e6d-49a2-ba7a-46cfcada2134	55560-3331	HUMAN OTC DRUG	ULTRA SHEER DAILY DEFENSE FACIAL SPF 18		Homosalate, Octisalate, and Avobenzone	LOTION	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	Andalou naturals	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 40	mg/mL; mg/mL; mg/mL			N	20241231
55560-5001_fe3d13ec-5d51-426d-9714-2921a1714ea4	55560-5001	HUMAN OTC DRUG	SPF30 SHEER TOUCH FACIAL SUNSCREEN		ZINC OXIDE	LOTION	TOPICAL	20201008		OTC MONOGRAPH FINAL	part347	Andalou naturals	ZINC OXIDE	215	mg/mL			N	20241231
55560-5002_74c169b1-abde-4b27-bca8-3dc59006cb44	55560-5002	HUMAN OTC DRUG	SPF30 SHEER TOUCH TINTED SUNSCREEN	LIGHT - MEDIUM	ZINC OXIDE	LOTION	TOPICAL	20201008		OTC MONOGRAPH FINAL	part347	Andalou naturals	ZINC OXIDE	215	mg/mL			N	20241231
55560-5003_74c169b1-abde-4b27-bca8-3dc59006cb44	55560-5003	HUMAN OTC DRUG	SPF30 SHEER TOUCH TINTED SUNSCREEN	MEDIUM - DARK	ZINC OXIDE	LOTION	TOPICAL	20201008		OTC MONOGRAPH FINAL	part347	Andalou naturals	ZINC OXIDE	215	mg/mL			N	20241231
55566-1010_46eadc24-f279-48a3-a321-bfd70591f3ac	55566-1010	HUMAN PRESCRIPTION DRUG	Fyremadel		ganirelix acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20220228		ANDA	ANDA204246	Ferring Pharmaceuticals Inc.	GANIRELIX ACETATE	250	ug/.5mL	Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]		N	20241231
55566-1050_2f8eba64-9c7c-4d88-be10-6c0db8409e25	55566-1050	HUMAN PRESCRIPTION DRUG	ADSTILADRIN		nadofaragene firadenovec-vncg	SUSPENSION	INTRAVESICAL	20230701		BLA	BLA125700	Ferring Pharmaceuticals	NADOFARAGENE FIRADENOVEC	300000000000	{VP}/mL			N	20241231
55566-1501_1df4de14-609b-4068-bdb5-5454007a6577	55566-1501	HUMAN PRESCRIPTION DRUG	Novarel		gonadotrophin, chorionic	KIT		19740115		BLA	BLA017016	Ferring Pharmaceuticals Inc.						N	20241231
55566-1502_1df4de14-609b-4068-bdb5-5454007a6577	55566-1502	HUMAN PRESCRIPTION DRUG	Novarel		gonadotrophin, chorionic	KIT		20170830		BLA	BLA017016	Ferring Pharmaceuticals Inc.						N	20241231
55566-1801_49c4d59a-f8ee-4ce3-99d9-97a2962727ff	55566-1801	HUMAN PRESCRIPTION DRUG	ZOMACTON		somatropin	KIT		20150507		BLA	BLA019774	Ferring Pharmaceuticals Inc.						N	20241231
55566-1901_49c4d59a-f8ee-4ce3-99d9-97a2962727ff	55566-1901	HUMAN PRESCRIPTION DRUG	ZOMACTON		somatropin	KIT	SUBCUTANEOUS	20150507		BLA	BLA019774	Ferring Pharmaceuticals Inc.						N	20241231
55566-2200_8837d5af-4cd2-4274-a30d-db28acc86364	55566-2200	HUMAN PRESCRIPTION DRUG	DDAVP		Desmopressin Acetate	INJECTION	INTRAVENOUS	19840501		NDA	NDA018938	Ferring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
55566-2300_8837d5af-4cd2-4274-a30d-db28acc86364	55566-2300	HUMAN PRESCRIPTION DRUG	DDAVP		Desmopressin Acetate	INJECTION	INTRAVENOUS	19840501		NDA	NDA018938	Ferring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
55566-2600_edd04b63-ab97-40cd-92d1-7f77abf0e0b8	55566-2600	HUMAN PRESCRIPTION DRUG	DDAVP		Desmopressin Acetate	TABLET	ORAL	19950906		NDA	NDA019955	Ferring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
55566-2700_edd04b63-ab97-40cd-92d1-7f77abf0e0b8	55566-2700	HUMAN PRESCRIPTION DRUG	DDAVP		Desmopressin Acetate	TABLET	ORAL	19950906		NDA	NDA019955	Ferring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
55566-2800_e99e60a2-51eb-417e-b2c4-67d5df479ea7	55566-2800	HUMAN PRESCRIPTION DRUG	CERVIDIL		DINOPROSTONE	INSERT	VAGINAL	19950330		NDA	NDA020411	Ferring Pharmaceuticals Inc.	DINOPROSTONE	10	mg/241mg	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
55566-6500_e3da255e-071c-4ec7-882f-3f3bd6d2eab6	55566-6500	HUMAN PRESCRIPTION DRUG	ENDOMETRIN		Progesterone	INSERT	VAGINAL	20070621		NDA	NDA022057	Ferring Pharmaceuticals Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
55566-6700_680250da-771a-48d2-896e-e4bda5da8915	55566-6700	HUMAN PRESCRIPTION DRUG	CLENPIQ		SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID	LIQUID	ORAL	20180629		NDA	NDA209589	Ferring Pharmaceuticals Inc.	ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE	12; 3.5; 10	g/160mL; g/160mL; mg/160mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55566-6800_7b00c0bc-920b-44a6-b7e6-730d8a8791dd	55566-6800	HUMAN PRESCRIPTION DRUG	CLENPIQ		SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID	LIQUID	ORAL	20230329		NDA	NDA209589	Ferring Pharmaceuticals Inc.	ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE	12; 3.5; 10	g/175mL; g/175mL; mg/175mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55566-7501_e16b59cb-0690-4349-b3d7-520b4a929202	55566-7501	HUMAN PRESCRIPTION DRUG	Menopur		menotropins	KIT		20041029		BLA	BLA021663	Ferring Pharmaceuticals Inc.						N	20241231
55566-8303_bd21743c-94d0-4b84-a317-57d374a348b1	55566-8303	HUMAN PRESCRIPTION DRUG	FIRMAGON		Degarelix	KIT		20090302		NDA	NDA022201	Ferring Pharmaceuticals Inc.						N	20241231
55566-8403_bd21743c-94d0-4b84-a317-57d374a348b1	55566-8403	HUMAN PRESCRIPTION DRUG	FIRMAGON		Degarelix	KIT		20090302		NDA	NDA022201	Ferring Pharmaceuticals Inc.						N	20241231
55566-9800_80beb793-bf8c-4a85-96d7-46a0d270f4c7	55566-9800	HUMAN PRESCRIPTION DRUG	Rebyota		Donor Human Stool	SUSPENSION	RECTAL	20230109		BLA	BLA125739	Ferring Pharmaceuticals Inc.	DONOR HUMAN STOOL	50000000000	[CFU]/150mL			N	20241231
55579-110_f49c61bc-9a3e-d885-e053-2995a90ad8af	55579-110	HUMAN PRESCRIPTION DRUG	Acetaminophen		ACETAMINOPHEN	INJECTION	INTRAVENOUS	20201207		ANDA	ANDA202605	Solupharm Pharmazeutische Erzeugnisse GmbH	ACETAMINOPHEN	1000	mg/100mL			N	20241231
55579-405_d92bd5a7-d41c-31d1-e053-2995a90a143a	55579-405	HUMAN PRESCRIPTION DRUG	Acetaminophen		ACETAMINOPHEN	INJECTION, SOLUTION	INTRAVENOUS	20201207		ANDA	ANDA202605	Solupharm Pharmazeutische Erzeugnisse GmbH	ACETAMINOPHEN	10	mg/mL			N	20241231
55614-210_afead1c9-dbb6-4afd-808b-2b175d0d9ca7	55614-210	HUMAN OTC DRUG	Solstice Pain Relieving		Camphor, Menthol, Methyl Salicylate	PATCH	TOPICAL	20190726		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
55614-310_85f98b84-cb10-49bb-9726-718ebf34ae87	55614-310	HUMAN OTC DRUG	Solstice Pain Relieving		Camphor, Menthol, Methyl Salicylate	PATCH	TOPICAL	20190729		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
55614-410_452cd1b1-cbd7-4d42-80cc-f0da98635503	55614-410	HUMAN OTC DRUG	Solstice Capsaicin Patch Hot		Capsaicin	PATCH	TOPICAL	20190918		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAPSAICIN	.025	g/100g			N	20241231
55614-600_ed121bd1-3069-4e31-abb0-85cd0bfda60d	55614-600	HUMAN OTC DRUG	Lung Choy Shung Pain Relief Liquid		Menthol and Camphor	LINIMENT	TOPICAL	20191125		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL	2.8; 2.8	g/100mL; g/100mL			N	20241231
55614-610_b220978d-1507-4fd5-b796-d04fcf5448ee	55614-610	HUMAN OTC DRUG	FARGELIN HEMORRHOIDAL		Calamine, Petrolatum and Phenylephrine hydrochloride	OINTMENT	RECTAL; TOPICAL	20191127		OTC MONOGRAPH FINAL	part346	MADISON ONE ACME INC	FERRIC OXIDE RED; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; ZINC OXIDE	.05; 79.25; .25; 10.3	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55614-620_baa1a0a1-12b6-4c97-bf68-9d0776890a51	55614-620	HUMAN OTC DRUG	701 DIEDA ZHENGTONG YAOGAO MEDICATED		Camphor and Menthol	PLASTER	TRANSDERMAL	20200504		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5	g/100g; g/100g			N	20241231
55614-630_6accfc36-fadd-4978-9927-55e5836a238b	55614-630	HUMAN OTC DRUG	EXTRA STRENGTH HUA TUO PAIN RELIEF		CAMPHOR AND MENTHOL	PATCH	TRANSDERMAL	20200401		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 2.6	g/100g; g/100g			N	20241231
55614-641_633780bf-979a-4fce-835e-6fe633c88f4b	55614-641	HUMAN OTC DRUG	ZANG HONG HUA PAIN RELIEVING		Camphor, Capsaicin, and Methyl salicylate	OIL	TOPICAL	20210330		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); CAPSAICIN; METHYL SALICYLATE	10; .025; 60	g/100mL; g/100mL; g/100mL			N	20241231
55614-650_45073a79-ddfc-4cb6-857b-c20831eb87b1	55614-650	HUMAN OTC DRUG	HUA TUO XIAN GAO ANTIFUNGAL		Clotrimazole	OINTMENT	TOPICAL	20200401		OTC MONOGRAPH FINAL	part333C	MADISON ONE ACME INC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55614-661_a7dd17ef-7754-4cd7-b4d7-4080a463e109	55614-661	HUMAN OTC DRUG	NECK AND LUMBAR PAIN RELIEVING BALM		CAMPHOR, MENTHOL, METHYL SALICYLATE	OINTMENT	TOPICAL	20200521		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	11; 16; 30	g/100g; g/100g; g/100g			N	20241231
55614-670_feed8e80-3d51-43a7-b449-83415a51c4d0	55614-670	HUMAN OTC DRUG	SHU JIN HUO LUO PAIN RELIEVING		CAMPHOR, MENTHOL, METHYL SALICYLATE	OIL	TOPICAL	20210323		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	10; 16; 50	g/100mL; g/100mL; g/100mL			N	20241231
55614-671_21f86e78-348d-452b-bc0c-70e54475093d	55614-671	HUMAN OTC DRUG	HUO LUO PAIN RELIEVING		CAMPHOR, MENTHOL, METHYL SALICYLATE	OIL	TOPICAL	20201218		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	10; 16; 50	g/100mL; g/100mL; g/100mL			N	20241231
55614-680_0a539dc0-3deb-4d98-bbdf-ad82e26df973	55614-680	HUMAN OTC DRUG	JOSEPHS LION PAIN RELIEVING		Camphor, Menthol, Methyl Salicylate	OIL	TOPICAL	20200604		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	5; 8; 10	g/100mL; g/100mL; g/100mL			N	20241231
55614-690_699029bd-ae17-4853-b7ae-311e50dea95e	55614-690	HUMAN OTC DRUG	QIAN LI ZHUI FENG PAIN RELIEVING		Camphor, Menthol, and Methyl Salicylate	OIL	TOPICAL	20201027		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	10; 15; 48	g/100mL; g/100mL; g/100mL			N	20241231
55614-700_d7728dc2-7a6c-4b4e-8182-c31a1d3c6826	55614-700	HUMAN OTC DRUG	WU YANG BRAND PAIN RELIEVING MEDICATED		MENTHOL AND CAMPHOR	PLASTER	TRANSDERMAL	20200831		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL	3; 5	g/100g; g/100g			N	20241231
55614-711_ae0440f7-23fa-4642-81db-e3cee5ea4759	55614-711	HUMAN OTC DRUG	HEI GUI PAIN RELIEVING		Camphor and Methyl Salicylate	OIL	TOPICAL	20210330		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); METHYL SALICYLATE	5; 50	g/100mL; g/100mL			N	20241231
55614-730_8e07806b-b2ad-467c-9723-1f9b4abd3f03	55614-730	HUMAN OTC DRUG	E MEI SHAN MEDICATED		CAMPHOR AND MENTHOL	PLASTER	TRANSDERMAL	20210216		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL	31; 26	mg/1; mg/1			N	20241231
55614-740_5f6f385a-c9d8-44a3-b575-16caefbfafe5	55614-740	HUMAN OTC DRUG	YULAM DIE DA WAN HUA PAIN RELIEVING		Menthol and Camphor	OIL	TOPICAL	20221102		OTC MONOGRAPH NOT FINAL	part348	MADISON ONE ACME INC	CAMPHOR (SYNTHETIC); MENTHOL	4; 3	g/100mL; g/100mL			N	20241231
55621-001_08849eb4-ae6b-8151-e063-6394a90a5a7e	55621-001	HUMAN OTC DRUG	Thera	Plus	Hydrocortisone	CREAM	TOPICAL	20130301		OTC MONOGRAPH DRUG	M017	Zhejiang Jingwei Pharmaceutical Co., Ltd.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55621-003_08ad180e-e87c-ba6f-e063-6394a90a2bc7	55621-003	HUMAN OTC DRUG	TheraPlus	Plus	CLOTRIMAZOLE	CREAM	TOPICAL	20130301		OTC MONOGRAPH DRUG	M005	Zhejiang Jingwei Pharmaceutical Co., Ltd.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55621-004_08831525-5717-3c3d-e063-6394a90a5aed	55621-004	HUMAN OTC DRUG	TheraPlus	Plus	Menthol	OINTMENT	TOPICAL	20130301		OTC MONOGRAPH DRUG	M017	Zhejiang Jingwei Pharmaceutical Co., Ltd.	MENTHOL; MENTHYL SALICYLATE, (+/-)-	10; 15	g/100g; g/100g			N	20241231
55621-005_0884a753-f425-506b-e063-6394a90ac93e	55621-005	HUMAN OTC DRUG	TheraPlus	Plus	Phenylephrine HCI	OINTMENT	TOPICAL	20130301		OTC MONOGRAPH DRUG	M015	Zhejiang Jingwei Pharmaceutical Co., Ltd.	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55621-006_08846c1b-91cd-aadf-e063-6294a90accfa	55621-006	HUMAN OTC DRUG	Family Wellness		PHENYLEPHRINE HCL, PETROLATUM, MINERAL	OINTMENT	RECTAL; TOPICAL	20131101		OTC MONOGRAPH DRUG	M015	Zhejiang Jingwei Pharmaceutical Co., Ltd.	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55621-007_0882dc65-a451-daec-e063-6394a90a10ff	55621-007	HUMAN OTC DRUG	Family Wellness		DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE	CREAM	TOPICAL	20131101		OTC MONOGRAPH DRUG	M017	Zhejiang Jingwei Pharmaceutical Co., Ltd.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55621-008_08831cd8-6e2b-b895-e063-6394a90a6cf4	55621-008	HUMAN OTC DRUG	Family Wellness		Hydrocortisone	CREAM	TOPICAL	20130301		OTC MONOGRAPH DRUG	M017	Zhejiang Jingwei Pharmaceutical Co., Ltd.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55621-010_0884b4eb-7fc4-b2c7-e063-6294a90aa02e	55621-010	HUMAN OTC DRUG	Assured		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20141030		OTC MONOGRAPH DRUG	M017	Zhejiang Jingwei Pharmaceutical Co., Ltd.	LIDOCAINE HYDROCHLORIDE	2.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55621-011_0884bc8d-70c2-80db-e063-6294a90a6582	55621-011	HUMAN OTC DRUG	Assured	Bikini Smooth Cream	LIDOCAINE	CREAM	TOPICAL	20151030		OTC MONOGRAPH DRUG	M015	Zhejiang Jingwei Pharmaceutical Co., Ltd.	LIDOCAINE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55621-012_08835b51-a1a6-985b-e063-6294a90a14c9	55621-012	HUMAN OTC DRUG	Family Wellness		GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, PETROLATUM	CREAM	TOPICAL	20160714		OTC MONOGRAPH DRUG	M015	Zhejiang Jingwei Pharmaceutical Co., Ltd.	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55621-016_08ad56e9-b3d4-3128-e063-6394a90ab417	55621-016	HUMAN OTC DRUG	Family Wellness		BENZOCAINE, RESORCINOL	CREAM	TOPICAL	20170820		OTC MONOGRAPH DRUG	M017	Zhejiang Jingwei Pharmaceutic Al Co., Ltd.	BENZOCAINE; RESORCINOL	20; 3	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55621-017_08ad180e-e886-ba6f-e063-6394a90a2bc7	55621-017	HUMAN OTC DRUG	Modesa	Acne Treatment	BENZOYL PEROXIDE	CREAM	TOPICAL	20170820		OTC MONOGRAPH DRUG	M006	Zhejiang Jingwei Pharmaceutic Al Co., Ltd.	BENZOYL PEROXIDE	10	g/100g			N	20241231
55621-018_08846c1b-91dd-aadf-e063-6294a90accfa	55621-018	HUMAN OTC DRUG	Assured		HYDROCORTISONE	CREAM	TOPICAL	20180525		OTC MONOGRAPH DRUG	M017	Zhejiang Jingwei Pharmaceutic Al Co., Ltd.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55629-010_906fa458-697b-4e53-bce8-ea6cdfaaaa32	55629-010	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210119		OTC MONOGRAPH NOT FINAL	part356	ONE2ZEE LIMITED LIABILITY COMPANY	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
55629-011_d67fcfe3-e54b-4450-9db2-756f4e492fbd	55629-011	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20210205		OTC MONOGRAPH FINAL	part341	ONE2ZEE LIMITED LIABILITY COMPANY	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55629-012_c241475a-30cb-4d0b-8b46-cb19a013ad05	55629-012	HUMAN OTC DRUG	acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210301		OTC MONOGRAPH FINAL	part341	ONE2ZEE LIMITED LIABILITY COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55629-014_b3138148-0c71-4451-b305-7cc16b0af517	55629-014	HUMAN OTC DRUG	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20210301		OTC MONOGRAPH FINAL	part341	ONE2ZEE LIMITED LIABILITY COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55629-016_58f4d081-7771-435a-8160-8d016641bae5	55629-016	HUMAN OTC DRUG	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Doxylamine Succinate		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20210302		OTC MONOGRAPH FINAL	part341	ONE2ZEE LIMITED LIABILITY COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55629-017_2385d841-0306-4b08-9f9d-0e66283de312	55629-017	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210302		OTC MONOGRAPH FINAL	part332	ONE2ZEE LIMITED LIABILITY COMPANY	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
55636-000_362e5a8b-2411-46e7-9ca2-390eb41147fb	55636-000	HUMAN OTC DRUG	Promescent Delay Wipes		Benzocaine	DRESSING	TOPICAL	20210609		OTC MONOGRAPH DRUG	M017	Absorption	BENZOCAINE	70	g/1000g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55636-590_45dc32bb-0c64-47dc-abde-de1cf5a68a42	55636-590	HUMAN OTC DRUG	Promescent		Lidicaine	SPRAY	TOPICAL	20130111		OTC MONOGRAPH DRUG	M017	Absorption	LIDOCAINE	10	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55651-005_94758d53-757f-0955-e053-2a95a90a4ca2	55651-005	HUMAN OTC DRUG	Eye Drops Regular		tetrahydrozoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20030828		OTC MONOGRAPH FINAL	part349	KC Pharmaceuticals, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
55651-008_94599912-bd08-4193-e053-2995a90a290d	55651-008	HUMAN OTC DRUG	Artificial Tears		polyvinyl alcohol, povidone	SOLUTION/ DROPS	OPHTHALMIC	20031125		OTC MONOGRAPH FINAL	part349	KC Pharmaceuticals, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE, UNSPECIFIED	5; 6	mg/mL; mg/mL			N	20241231
55651-017_f5462642-b431-d2cc-e053-2995a90ae7f5	55651-017	HUMAN OTC DRUG	Leader Lubricant Eye Drops 30ct		Polyethylene Glycol 400, Propylene Glycol	LIQUID	OPHTHALMIC	20190718		OTC MONOGRAPH FINAL	part349	KC Pharmaceuticals, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
55651-024_efe45397-b808-74f5-e053-2a95a90a9eef	55651-024	HUMAN OTC DRUG	Eye Drops AC		tetrahydrozoline hydrochloride, zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20031023		OTC MONOGRAPH FINAL	part349	KC Pharmaceuticals, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.5; 2.5	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
55651-025_946137b5-8d92-7b05-e053-2a95a90a43fc	55651-025	HUMAN OTC DRUG	Eye Drops Advanced Relief		tetrahydrozoline hydrochloride, polyethylene glycol 400, dextran 70, povidone	SOLUTION/ DROPS	OPHTHALMIC	20031209		OTC MONOGRAPH FINAL	part349	KC Pharmaceuticals, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
55651-030_0d29b49a-71d6-b6b9-e063-6294a90a9247	55651-030	HUMAN OTC DRUG	Medics Choice Lubricant Eye Drops		carboxymethylcellulose sodium	SOLUTION	OPHTHALMIC	20200210		OTC MONOGRAPH DRUG	M018	K.C. Pharmaceuticals, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
55651-059_0d29e40f-48bd-800a-e063-6394a90a48d9	55651-059	HUMAN OTC DRUG	Medics Choice Eye Drops Maximum Redness Relief		glycerin, naphazoline hydrochloride	SOLUTION	OPHTHALMIC	20230327		OTC MONOGRAPH DRUG	M018	K.C. Pharmaceuticals, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
55651-250_f1a2bfe5-ef9f-92b7-e053-2995a90a4aa3	55651-250	HUMAN OTC DRUG	Meijer Multi-Symptom Relief		polyethylene glycol, tetrahydrozoline hydrochloride, zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20230109		OTC MONOGRAPH FINAL	part349	K.C. Pharmaceuticals, Inc.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	1; .05; .25	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
55651-870_efe45218-4dd7-1baa-e053-2995a90a004b	55651-870	HUMAN OTC DRUG	DG Maximum Strength Redness Relief		glycerin, naphazoline HCl	SOLUTION	OPHTHALMIC	20200131		OTC MONOGRAPH FINAL	part349	K.C. Pharmaceuticals, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
55670-040_db5bd99e-8046-4d1a-e053-2995a90ab9f7	55670-040	HUMAN OTC DRUG	Moore Medical Honey Lemon Cough Drops		Menthol Cough Drops	LOZENGE	ORAL	20160201	20240830	OTC MONOGRAPH FINAL	part341	Moore Medical LLC	MENTHOL	8.6	mg/1			N	
55670-060_dd178eaf-090b-0a2d-e053-2a95a90ac43a	55670-060	HUMAN OTC DRUG	Moore Medical Menthol Eucalyptus Cough Drops		Menthol Cough Drops	LOZENGE	ORAL	20160201	20240830	OTC MONOGRAPH FINAL	part341	Moore Medical LLC	MENTHOL	7	mg/1			N	
55670-122_c69de816-9d14-b8ae-e053-2995a90a01ad	55670-122	HUMAN OTC DRUG	Moore Medical Non Aspirin		Acetaminophen	TABLET, FILM COATED	ORAL	20081230	20240401	OTC MONOGRAPH NOT FINAL	part343	Moore Medical LLC	ACETAMINOPHEN	325	mg/1			N	
55670-150_e0cd70f1-19fd-0a60-e053-2995a90ade43	55670-150	HUMAN OTC DRUG	Moore Medical Sinus Pain and Pressure Relief		ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET	ORAL	20081230	20240731	OTC MONOGRAPH FINAL	part341	Moore Medical LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55670-163_db5bc6a8-ce7a-d366-e053-2995a90a608b	55670-163	HUMAN OTC DRUG	MooreBrand Phenylephrine		PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20081230	20241231	OTC MONOGRAPH FINAL	part341	Moore Medical LLC	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55670-467_c69de816-9d13-b8ae-e053-2995a90a01ad	55670-467	HUMAN OTC DRUG	Moore Medical Non Aspirin		Acetaminophen	TABLET, FILM COATED	ORAL	20081230	20240401	OTC MONOGRAPH NOT FINAL	part343	Moore Medical LLC	ACETAMINOPHEN	325	mg/1			N	
55670-468_f6dc0ad2-77b8-ec14-e053-6394a90ad058	55670-468	HUMAN OTC DRUG	Moore Medical Extra Strength Non Aspirin		Acetaminophen	TABLET, FILM COATED	ORAL	20081230	20250201	OTC MONOGRAPH NOT FINAL	part343	Moore Medical LLC	ACETAMINOPHEN	500	mg/1			N	
55670-474_da57b311-87e7-4b20-e053-2a95a90a632c	55670-474	HUMAN OTC DRUG	Moore Medical Bismuth		BISMUTH SUBSALICYLATE	TABLET, CHEWABLE	ORAL	20140401	20240731	OTC MONOGRAPH FINAL	part335	Moore Medical LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	
55670-710_cc6eb737-6715-7cd2-e053-2995a90af54c	55670-710	HUMAN OTC DRUG	Ammonia Inhalant		Ammonia	AEROSOL	RESPIRATORY (INHALATION)	20171129	20250101	UNAPPROVED DRUG OTHER		Moore Medical LLC	AMMONIA	.045	g/.3mL			N	
55670-805_c81ab47a-d324-d44b-e053-2995a90a6aa7	55670-805	HUMAN OTC DRUG	moorebrand Ibuprofen		I buprofen 200 mg	TABLET, FILM COATED	ORAL	20160201	20240131	ANDA	ANDA075010	Moore Medical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55670-810_ebdd6f2f-3c81-3513-e053-2995a90ae0e8	55670-810	HUMAN OTC DRUG	Anesthetic		benzocaine	GEL	TOPICAL	20120712	20240531	OTC MONOGRAPH NOT FINAL	part356	Moore Medical LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
55670-850_da475fdf-8f03-33a6-e053-2995a90a71ae	55670-850	HUMAN OTC DRUG	MoreBrand Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20190204	20240331	ANDA	ANDA079174	Moore Medical	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55670-956_cc6eaf8e-4f83-6e92-e053-2995a90a19e3	55670-956	HUMAN OTC DRUG	Medicaine Swabs		Benzocaine	SWAB	TOPICAL	20171129	20240601	UNAPPROVED DRUG OTHER		Moore Medical LLC	BENZOCAINE; MENTHOL	.12; .006	g/.6mL; g/.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
55681-015_0e713b70-588e-b758-e063-6394a90a5b73	55681-015	HUMAN OTC DRUG	Procure gel		MENTHOL	GEL	TOPICAL	20160919		OTC MONOGRAPH DRUG	M017	TWIN MED, LLC	MENTHOL	5	g/100g			N	20251231
55681-165_0e71410a-2acf-3f21-e063-6294a90a5381	55681-165	HUMAN OTC DRUG	Miconazole nitrate		Antifungal	POWDER	TOPICAL	20220819		OTC MONOGRAPH DRUG	M005	TWIN MED, LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20251231
55681-211_0e7194f0-660f-db75-e063-6394a90ac72e	55681-211	HUMAN OTC DRUG	procure		PETROLATUM	OINTMENT	TOPICAL	20130205		OTC MONOGRAPH DRUG	M016	TWIN MED, LLC	PETROLATUM	1	g/g			N	20251231
55681-215_0e71ee72-6d8d-ed3d-e063-6294a90a6f77	55681-215	HUMAN OTC DRUG	PROCURE VITAMIN A AND D	Skin Protectant	petrolatum	OINTMENT	TOPICAL	20131206		OTC MONOGRAPH DRUG	M016	TWIN MED, LLC	PETROLATUM	93.4	g/100g			N	20251231
55681-216_0e71885d-e85f-73f9-e063-6294a90a1213	55681-216	HUMAN OTC DRUG	ProcureTriple Antibiotic	Triple Antibiotic	BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B	OINTMENT	TOPICAL	20130205		OTC MONOGRAPH DRUG	M004	TWIN MED, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	U/g; mg/g; U/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
55681-218_0e719ec0-f5ba-fad1-e063-6394a90a8705	55681-218	HUMAN OTC DRUG	procureFirst Aid Antibio	First Aid Antibiotic	BACITRACIN	OINTMENT	TOPICAL	20130205		OTC MONOGRAPH DRUG	M004	TWIN MED, LLC	BACITRACIN ZINC	500	U/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20251231
55681-224_0e7170c6-aa4c-73ff-e063-6294a90a2d00	55681-224	HUMAN OTC DRUG	procure		Hydrocortisone Acetate	OINTMENT	TOPICAL	20130205		OTC MONOGRAPH DRUG	M017	TWIN MED, LLC	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
55681-301_0e12d44c-f957-c1b1-e063-6394a90a7483	55681-301	HUMAN OTC DRUG	MUCUS RELIEF	GUAIFENESIN EXTENDED-RELEASE 600 mg	GUAIFENESIN	TABLET	ORAL	20220302		ANDA	ANDA213420	TWIN MED LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
55681-302_0e12b3c6-357a-b0dc-e063-6394a90a8ea4	55681-302	HUMAN OTC DRUG	CETIRIZINE HYDROCHLORIDE	10 MG	CETIRIZINE HYDROCHLORIDE	TABLET	ORAL	20220302		ANDA	ANDA209274	TWIN MED, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
55681-303_0e12d44c-f956-c1b1-e063-6394a90a7483	55681-303	HUMAN OTC DRUG	ALLERGY RELIEF	10 mg	LORATADINE	TABLET	ORAL	20220302		ANDA	ANDA210722	TWIN MED LLC	LORATADINE	10	mg/1			N	20251231
55681-304_0e71ee72-6d88-ed3d-e063-6294a90a6f77	55681-304	HUMAN OTC DRUG	PROCURE		Zinc Oxide	OINTMENT	TOPICAL	20130523		OTC MONOGRAPH DRUG	M016	TWIN MED, LLC	ZINC OXIDE	20	g/100g			N	20251231
55681-306_c9a11bc6-0680-4030-871e-599417fccf57	55681-306	HUMAN OTC DRUG	Omeprazole		OMEPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220414		ANDA	ANDA207891	Twin Med LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55681-311_f7f18eb7-a4bb-b7f6-e053-6394a90a0f74	55681-311	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 400 mg	TABLET	ORAL	20220701		OTC MONOGRAPH FINAL	part341	TWIN MED LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55681-331_f7f1bb4e-df0f-8a7b-e053-6294a90a9c47	55681-331	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	TABLET	ORAL	20221010		OTC MONOGRAPH FINAL	part331	TWIN MED LLC	SODIUM BICARBONATE	650	mg/1	Alkalinizing Activity [MoA]		N	20241231
55681-341_f7f1bb4e-df0e-8a7b-e053-6294a90a9c47	55681-341	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220128		ANDA	ANDA215822	TWIN MED LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55681-342_f7f1bb4e-df0e-8a7b-e053-6294a90a9c47	55681-342	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220128		ANDA	ANDA215822	TWIN MED LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55681-410_0e71885d-e860-73f9-e063-6294a90a1213	55681-410	HUMAN OTC DRUG	HEMORRHOIDALCREAMPROCURE		Phenylephrine HCl, Petrolatum, Mineral Oil	CREAM	TOPICAL	20221005		OTC MONOGRAPH DRUG	M015	TWIN MED, LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
55681-750_fc892c8e-6255-e85c-e053-6394a90a61c2	55681-750	HUMAN OTC DRUG	Lemon		Glycerin	SWAB	ORAL	20230525		OTC MONOGRAPH NOT FINAL	part356	TwinMed LLC	GLYCERIN	.3	g/4g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
55681-751_fc8b53f4-00c6-fe3f-e053-6294a90adaaa	55681-751	HUMAN OTC DRUG	Povidone Iodine		POVIDONE-IODINE	SWAB	TOPICAL	20230525		OTC MONOGRAPH NOT FINAL	part333A	TwinMed LLC	POVIDONE-IODINE	.1	g/g			N	20241231
55681-752_fcf275c4-af7f-b185-e053-6394a90a06b5	55681-752	HUMAN OTC DRUG	Povidone Iodine		POVIDONE-IODINE	SWAB	TOPICAL	20230530		OTC MONOGRAPH NOT FINAL	part333A	TwinMed LLC	POVIDONE-IODINE	.1	g/1			N	20241231
55681-753_fcf35e90-9509-38c6-e053-6294a90aad54	55681-753	HUMAN OTC DRUG	Povidone Iodine		POVIDONE-IODINE	SWAB	TOPICAL	20230530		OTC MONOGRAPH NOT FINAL	part333A	TwinMed LLC	POVIDONE-IODINE	.1	g/1			N	20241231
55700-006_959fba9e-a677-4ba0-8a6b-a654be8ac66e	55700-006	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20090702		ANDA	ANDA040907	Lake Erie Medical DBA Quality Care Products LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
55700-016_f8e478fd-612d-4d25-a349-48c3fb48e291	55700-016	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Lake Erie Medical DBA Quality Care Products LLC	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
55700-029_e5f94d87-883f-4b59-8fd5-22d325235509	55700-029	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20130927		ANDA	ANDA201384	Quality Care Products LLC	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
55700-048_37069cfc-d4b2-4bcb-ac01-6d6b4216bb78	55700-048	HUMAN OTC DRUG	Terocin		Lidocaine, Menthol	PATCH	TOPICAL	20130501	20260430	OTC MONOGRAPH DRUG	M017	Quality Care Products LLC	LIDOCAINE; MENTHOL	600; 600	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
55700-058_0c80ec7f-9050-4879-9f62-5d39902c47d1	55700-058	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20180713		ANDA	ANDA071307	Quality Care Products, LLC	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55700-122_70cb44cc-de5b-4ed6-a49c-08038d05d1a7	55700-122	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20120105		ANDA	ANDA091605	Lake Erie Medical DBA Quality Care Products LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55700-142_8f3cbdd7-1ece-4c10-acb6-b78c7c5338b3	55700-142	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20140502		NDA AUTHORIZED GENERIC	NDA020612	Quality Care Products LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55700-174_e604777e-1c77-47e6-9256-14fece270470	55700-174	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	Quality Care Products LLC	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
55700-203_d7b7d646-240b-4fe4-aa72-36bd7286e69b	55700-203	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Quality Care Products LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
55700-208_d7b7d646-240b-4fe4-aa72-36bd7286e69b	55700-208	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Quality Care Products LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
55700-209_d7b7d646-240b-4fe4-aa72-36bd7286e69b	55700-209	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Quality Care Products LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
55700-217_5f7dfb59-773a-4d27-8c13-b812f489b135	55700-217	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20150220		ANDA	ANDA076343	Lake Erie Medical DBA Quality Care Products LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-218_7099f07d-27b6-4803-8c37-c0f91238aa15	55700-218	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Quality Care Products LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-221_d2e795b9-fdb9-4aef-962e-93c87eec99ce	55700-221	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20140709		ANDA	ANDA040712	Quality Care Products LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
55700-225_8747d1ea-bf27-4623-bda4-77fb7002f0ff	55700-225	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20150227		ANDA	ANDA077670	Quality Care Products, LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-226_597d7e79-d630-4e42-9865-8407b64e2487	55700-226	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Lake Erie Medical DBA Quality Care Products LLC	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-227_3ac87963-d6a8-4cda-9a59-284ebbec4676	55700-227	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Quality Care Products LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-232_fde0d64b-c90b-4c41-8ec6-1d971abb92e6	55700-232	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Quality Care Products LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55700-239_7b064e6b-5783-43ae-b61c-9c1c36b35099	55700-239	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20150325		ANDA	ANDA078722	Quality Care Products LLC	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
55700-268_69ed6ec3-6cf5-4e83-ac82-a3d92637aae7	55700-268	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Quality Care Products LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
55700-298_f8df99d9-6fbb-41da-a252-460b95c29187	55700-298	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	Quality Care Products LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
55700-316_72323192-695f-42fe-851b-ece80d29d925	55700-316	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Lake Erie Medical DBA Quality Care Products LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-349_8045940a-78db-47ac-897f-72ce63ad7cd3	55700-349	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20130630		ANDA	ANDA202104	Quality Care Products LLC	MORPHINE SULFATE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
55700-357_3869568d-23fb-4934-8e79-29a68260ebf7	55700-357	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Lake Erie Medical DBA Quality Care Products LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
55700-362_a83262b7-5678-479b-8d11-807b2c272fe4	55700-362	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Lake Erie Medical DBA Quality Care Products LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-394_133f07ff-8dfd-4eac-be2e-41a9734e43d7	55700-394	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA073449	Lake Erie Medical DBA Quaity Care Products LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
55700-408_eeddb575-26b6-472e-a31d-983ca704bc18	55700-408	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051201		ANDA	ANDA077241	Lake Erie Medical DBA Quality Care Products LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
55700-410_aedf975d-dee1-4bd2-97be-e9cada1b8716	55700-410	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078490	Quality Care Products LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55700-415_ed2f2c10-3be0-47fe-b781-2e54246b9eac	55700-415	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Quality Care Products LLC	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55700-424_4ff747a2-5451-403a-97c8-c8743495e89c	55700-424	HUMAN PRESCRIPTION DRUG	acetic acid		acetic acid	SOLUTION	AURICULAR (OTIC)	20100122		NDA	NDA012179	Quality Care Products LLC	ACETIC ACID	20.65	mg/mL			N	20241231
55700-428_ee5210dc-9b4d-4682-a95d-bef9649b3a75	55700-428	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20151019		ANDA	ANDA203636	Lake Erie Medical DBA Quality Care Products LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55700-445_435ce444-23bf-45bc-a95a-597585afb250	55700-445	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Quality Care Products LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-446_435ce444-23bf-45bc-a95a-597585afb250	55700-446	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Quality Care Products LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-452_a5613d26-c9f1-4599-b175-06811c8728a5	55700-452	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Lake Erie Medical DBA Quality Care Products LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
55700-479_2c94511d-5a70-4161-b075-f34924f199be	55700-479	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Quality Care Products LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55700-480_2c94511d-5a70-4161-b075-f34924f199be	55700-480	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20170113		ANDA	ANDA076164	Quality Care Products LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55700-492_b7f0325a-c019-4327-8a44-bccf0feb509f	55700-492	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20170127		ANDA	ANDA071745	Quality Care Products, LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55700-494_b2888a59-65ec-4142-ab8a-0a6acf9ef956	55700-494	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Quality Care Products, LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-501_71e974b0-909a-4af4-879c-341cc0054415	55700-501	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Quality Care Products LLC	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55700-503_3993aa59-7a19-4e7b-a834-eacf49671eae	55700-503	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Lake Erie Medical DBA Quality Care Products LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-509_622455fc-2653-4895-9d48-af093f9abafe	55700-509	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	Quality Care Products, LLC	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
55700-510_d7fca014-4ba2-47d6-9984-d97403bbc813	55700-510	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161129		NDA AUTHORIZED GENERIC	NDA021875	Quality Care Products LLC	ARMODAFINIL	250	mg/1		CIV	N	20241231
55700-523_8f12e70f-d2a7-4012-b3b6-d4100bb4eeb0	55700-523	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20140101	20240831	OTC MONOGRAPH DRUG	M017	Lake Erie Medical DBA Quality Care Products LLC	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
55700-524_52696968-aac3-4946-befe-6258642f410f	55700-524	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20151106		ANDA	ANDA202894	Lake Erie Medical DBA Quality Care Products LLC	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55700-532_9b8593ea-f02a-480d-aca5-12d3a0b9ab8e	55700-532	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	Quality Care Products LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
55700-541_7aa1f125-789d-4c41-917b-2e879b430beb	55700-541	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20170811		ANDA	ANDA078925	Lake Erie Medical DBA Quality Care Products LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55700-543_7aa1f125-789d-4c41-917b-2e879b430beb	55700-543	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20170811		ANDA	ANDA078925	Lake Erie Medical DBA Quality Care Products LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
55700-547_de4aa6ec-5411-4455-8ee7-e806a3f7f629	55700-547	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20170811		ANDA	ANDA076164	Quality Care Products LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
55700-564_53b9baeb-46cd-4db0-8400-4c0c664ef3d6	55700-564	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20171208		ANDA	ANDA074569	Quality Care Products, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
55700-573_c642a0d5-0c6e-447b-b534-2476c67a5e4c	55700-573	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		ANDA	ANDA204170	Lake Erie Medical DBA Quality Care Products LLC	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
55700-575_71670b16-6828-4018-addc-cf6d9fc5279b	55700-575	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20180105		ANDA	ANDA207616	Quality Care Products, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55700-580_176e30a2-660e-4874-8c08-649c356d6fa8	55700-580	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20180112	20250430	OTC MONOGRAPH DRUG	M009	Lake Erie Medical DBA Quality Care Products LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55700-581_ccfc9728-6d81-45b8-96d0-7182950b3051	55700-581	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20180119		ANDA	ANDA202929	Quality Care Products LLC	ESZOPICLONE	2	mg/1		CIV	N	20241231
55700-585_cebf9370-de04-4960-8290-6e49b5d6b726	55700-585	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Lake Erie Medical DBA Quality Care Products LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55700-591_05da3eba-6809-41fc-b02d-a357a57e4b09	55700-591	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20180309	20281019	ANDA	ANDA202769	Quality Care Products LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55700-592_08e42176-f1fa-44cd-b285-8099d1ebf028	55700-592	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180407		ANDA	ANDA076004	Quality Care Products LLC	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-597_0be26ea2-6947-47b9-8eb0-96b2426607e6	55700-597	HUMAN PRESCRIPTION DRUG	Fentanyl System		Fentanyl	PATCH	TRANSDERMAL	20180413		ANDA	ANDA202097	Lake Erie Medical DBA Quality Care Products LLC	FENTANYL	25	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
55700-598_8a8957ac-ad7a-4de3-9e28-70b68cf7652f	55700-598	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180413		ANDA	ANDA209037	Lake Erie Medical DBA Quality Care Products LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
55700-599_65c3ce57-7d5a-4f61-aa27-e8a731301172	55700-599	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20180413		ANDA	ANDA077797	Lake Erie Medical DBA Quality Care Products LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-600_0f12f50f-7087-46e7-a2e6-356b4c566c9f	55700-600	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180413		ANDA	ANDA202446	Quality Care Products LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55700-605_a66fa8f3-117b-47f5-a1e2-8b2fc5edf426	55700-605	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20180420		ANDA	ANDA208706	Quality Care Products LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55700-607_8a368941-8a2a-43d5-a6b1-f48e2111f9f7	55700-607	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20180420		ANDA	ANDA204590	Lake Erie Medical DBA Quality Care Products LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-610_ee80932e-4cd1-402e-9be5-5f8727e7f6ee	55700-610	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20180504		ANDA	ANDA202929	Quality Care Products LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
55700-611_add2f0eb-9bef-4f25-925f-4f5ac4ad2b5b	55700-611	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20180504		ANDA	ANDA090624	Quality Care Products LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
55700-613_969f5731-f772-4675-885e-83d87b6ae3bc	55700-613	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20180504		ANDA	ANDA204590	Quality Care Products LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-619_f4b472d0-271a-46ee-8944-d996518dce6e	55700-619	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180511		ANDA	ANDA202446	Lake Erie Medical DBA Quality Care Products LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55700-621_e9cebfc0-10ee-403d-8b8f-922b38a8c517	55700-621	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20180518		ANDA	ANDA202929	Lake Erie Medical DBA Quality Care Products LLC	ESZOPICLONE	1	mg/1		CIV	N	20241231
55700-624_b7ed2b36-bcd3-403b-b6ae-e8b511b41729	55700-624	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20180518		ANDA	ANDA075795	Lake Erie Medical DBA Quality Care Products LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
55700-625_a919faeb-1332-4d6e-a885-e9c1641e67c0	55700-625	HUMAN PRESCRIPTION DRUG	Naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20180518		ANDA	ANDA078486	Quality Care Products, LLC	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-626_b0956a08-9251-467a-8d5c-711a862eebb1	55700-626	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180518		ANDA	ANDA090170	Lake Erie Medical DBA Quality Care Products LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
55700-627_42375fc5-e0f8-4aef-acce-d1374118e800	55700-627	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20180518		ANDA	ANDA078539	Quality Care Products LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55700-628_87922ff5-6e15-4594-ba30-48bc4cf574d3	55700-628	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20180518		ANDA	ANDA208706	Quality Care Products LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55700-629_e9a478b9-1d03-4258-85a9-d0bb5a88c649	55700-629	HUMAN OTC DRUG	Senna-Lax		Sennosides	TABLET, FILM COATED	ORAL	20180525	20251130	OTC MONOGRAPH DRUG	M007	Lake Erie Medical DBA Quality Care Products LLC	SENNOSIDES	8.6	mg/1			N	
55700-631_8fc12712-574c-4eb5-9859-174e2c34d3d2	55700-631	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20180525		ANDA	ANDA078539	Quality Care Products LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55700-640_a216165c-73ae-483d-a43f-423928c5e25e	55700-640	HUMAN PRESCRIPTION DRUG	SSD Cream		Silver Sulfadiazine	CREAM	TOPICAL	20180615		NDA	NDA018578	Lake Erie Medical DBA Quality Care Products LLC	SILVER SULFADIAZINE	10	g/1000g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
55700-643_1af9bb31-c636-416c-92e2-ed5f70542972	55700-643	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180622		ANDA	ANDA202446	Lake Erie Medical DBA Quality Care Products LLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55700-646_f9529cba-9179-4b1e-9f4b-4c48406b09ac	55700-646	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20180706		ANDA	ANDA077739	Quality Care Products LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55700-652_c952c1eb-96c0-4181-8ac9-b849ed5d2788	55700-652	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA209037	Lake Erie Medical DBA Quality Care Products LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
55700-660_8e52309b-4212-4150-8a2f-e46e93129e9a	55700-660	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180726		ANDA	ANDA202446	Lake Erie Medical DBA Quality Care Products LLC	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55700-666_aafda697-71b0-4b0d-8333-f0f4617dc51e	55700-666	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20180810		ANDA	ANDA090564	Quality Care Products, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
55700-668_f4663cfa-ac39-4720-b692-cc966fc9d0f0	55700-668	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20180817		ANDA	ANDA075520	Quality Care Products LLC	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55700-669_c40bfcd1-bebd-43f7-b856-d517d077a485	55700-669	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20180817		ANDA	ANDA090564	Quality Care Products LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
55700-670_180060de-07ab-4cad-a02b-0b9631abbeb7	55700-670	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20180817		ANDA	ANDA207405	Lake Erie Medical DBA Quality Care Products LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55700-672_edbada61-430f-49c9-8774-067dab043903	55700-672	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20180824		ANDA	ANDA090469	Lake Erie Medical DBA Quality Care Products LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
55700-675_8b8f82bc-f88b-42c9-9fce-2284c00d1256	55700-675	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac	GEL	TOPICAL	20180831		ANDA	ANDA208077	Lake Erie Medical DBA Quality Care Products LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-677_079656cc-19eb-40f8-bdd8-31db53c44454	55700-677	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180907		ANDA	ANDA203814	Lake Erie Medical DBA Quality Care Products LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
55700-680_533beb98-972a-4057-87f2-bf7f72591fb2	55700-680	HUMAN PRESCRIPTION DRUG	FLUTICASONE		fluticasone propionate	SPRAY, METERED	NASAL	20180907		ANDA	ANDA078492	Lake Erie Medical DBA Quality Care Products LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55700-681_b11d7486-8377-425b-b147-56e6242ad9b4	55700-681	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20180907		ANDA	ANDA207810	Lake Erie Medical DBA Quality Care Products LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55700-682_0ca97d06-9339-4609-8ac5-282a28546293	55700-682	HUMAN PRESCRIPTION DRUG	SULINDAC		SULINDAC	TABLET	ORAL	20180914		ANDA	ANDA072711	Lake Erie Medical DBA Quality Care Products LLC	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-683_45ada93f-ca8e-4bc9-8737-e81044f60d3b	55700-683	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180914		ANDA	ANDA090170	Lake Erie Medical DBA Quality Care Products LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
55700-704_a217b4e7-d428-47f7-99a2-a6ac697b8004	55700-704	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070925	Quality Care Products, LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55700-709_3ddb6c9f-d6d4-4bbc-87fc-7de9d1c4963b	55700-709	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20181214		ANDA	ANDA040903	Quality Care Products, LLC	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55700-714_b695409b-f301-4ac4-893d-a1340483d248	55700-714	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20190104		ANDA	ANDA077538	Quality Care Products, LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55700-721_629780d0-f66d-4aa7-9d51-7e365732ad99	55700-721	HUMAN OTC DRUG	LidoPro Patch		Lidocaine, Menthol, and Methyl Salicylate	PATCH	TOPICAL	20190125	20260831	OTC MONOGRAPH DRUG	M017	Quality Care Products, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	4; 5; 4	mg/100mg; mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
55700-723_c280bd75-59e8-4f97-bf00-82179c17cccd	55700-723	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20190208		ANDA	ANDA205115	Quality Care Products, LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55700-727_4cfb0094-3c6c-4342-8762-813e1765754b	55700-727	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190222		ANDA	ANDA208706	Quality Care Products, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55700-729_9eafe700-75df-47cd-a666-265b10c04eee	55700-729	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20190308		ANDA	ANDA200839	Quality Care Products, LLC	LEVOFLOXACIN	500	mg/1			N	20241231
55700-731_9fac2856-f510-40a2-ad19-806e7b2aad24	55700-731	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	20190315		ANDA	ANDA207531	Quality Care Products LLC	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
55700-732_f6dca29f-2eb6-4d5f-bc3a-fd4192aa884d	55700-732	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20190318		ANDA	ANDA062396	Quality Care Products, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
55700-735_9cda37d7-14d0-451c-a980-f8872a90d465	55700-735	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20190322		ANDA	ANDA206116	Quality Care Products, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-737_dba1f762-8ef6-4efd-abf6-45c37ff04b03	55700-737	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20190329		ANDA	ANDA077568	Quality Care Products, LLC	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
55700-739_08b58cb8-b488-4156-a25e-760783530880	55700-739	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20190405		ANDA	ANDA206923	Quality Care Products, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
55700-747_594d65af-ea99-4463-a0c3-23c671730bbd	55700-747	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20190426		ANDA	ANDA207444	Quality Care Products, LLC	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
55700-748_0060f479-6df1-1cb1-e063-6394a90a2de3	55700-748	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190517	20260228	ANDA	ANDA077449	Quality Care Products, LLC	FENTANYL	50	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
55700-749_0060f479-6df1-1cb1-e063-6394a90a2de3	55700-749	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190426	20260228	ANDA	ANDA077449	Quality Care Products, LLC	FENTANYL	12	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
55700-750_f5b5de5f-c7b6-479b-8e7c-8cdcfee11505	55700-750	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20190426		ANDA	ANDA075317	Quality Care Products, LLC	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
55700-753_0060f479-6df1-1cb1-e063-6394a90a2de3	55700-753	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190517	20251231	ANDA	ANDA077449	Quality Care Products, LLC	FENTANYL	25	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
55700-754_e32b9498-9ec6-4c72-a62e-abfb41746525	55700-754	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20190517		ANDA	ANDA077443	Quality Care Products, LLC	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55700-755_e32b9498-9ec6-4c72-a62e-abfb41746525	55700-755	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20190517		ANDA	ANDA077443	Quality Care Products, LLC	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55700-756_3cfa11b1-123b-4ef2-9444-25daa728835d	55700-756	HUMAN PRESCRIPTION DRUG	eletriptan hydrobromide		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA205186	Quality Care Products, LLC	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-757_fd6bee29-d327-45c3-a5f8-160cd3d9eb27	55700-757	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA076004	Quality Care Products, LLC	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-759_c7356307-4040-4541-aeb4-b8ebc9515c2c	55700-759	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20190524		ANDA	ANDA078327	Quality Care Products, LLC	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-760_624666ad-f09b-4bcf-9c5b-ed036ab6673a	55700-760	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20190531		ANDA	ANDA088619	Quality Care Products, LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55700-761_c369d27e-0abb-4a72-b6ec-1704f22d2f9e	55700-761	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190607		ANDA	ANDA207402	Quality Care Products, LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
55700-766_0bac83c0-e419-4045-8fc1-99d38c03098a	55700-766	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20190621		ANDA	ANDA085082	Quality Care Products, LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
55700-767_6e90a3dc-a277-4c41-a177-087cb37d63cd	55700-767	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20190621		ANDA	ANDA208644	Quality Care Products, LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55700-772_0060f479-6df1-1cb1-e063-6394a90a2de3	55700-772	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190719	20260131	ANDA	ANDA077449	Quality Care Products, LLC	FENTANYL	75	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
55700-773_effa3499-cd79-420b-bb68-b619f3bcc289	55700-773	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Quality Care Products, LLC	PREGABALIN	100	mg/1		CV	N	20251231
55700-774_effa3499-cd79-420b-bb68-b619f3bcc289	55700-774	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Quality Care Products, LLC	PREGABALIN	50	mg/1		CV	N	20251231
55700-775_effa3499-cd79-420b-bb68-b619f3bcc289	55700-775	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Quality Care Products, LLC	PREGABALIN	75	mg/1		CV	N	20251231
55700-778_95a5a449-8810-49a0-a97e-4f488a80f571	55700-778	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20190726		ANDA	ANDA078203	Quality Care Products, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55700-779_577769dc-9077-456f-bd70-17045ea9ec50	55700-779	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA076143	Quality Care Products, LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55700-780_821e05ce-82aa-4ec3-a1b0-da0f4d8ab5d3	55700-780	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA203244	Quality Care Products, LLC	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-787_fb085334-e3ec-4bc3-a5eb-f707fec26118	55700-787	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20190830		ANDA	ANDA078216	Quality Care Products, LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-790_ddfcba4e-0411-45b2-b11d-b5029978c015	55700-790	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20190913		ANDA	ANDA202882	Quality Care Products, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55700-802_017bd5ee-fbb7-4f85-97e0-08371797c4bc	55700-802	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20191011		ANDA	ANDA209686	Quality Care Products, LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55700-804_b21b50c8-d0d7-498f-8c55-9c9bd4c21cbf	55700-804	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20191011		ANDA	ANDA208677	Quality Care Products, LLC	PREGABALIN	50	mg/1		CV	N	20241231
55700-805_b21b50c8-d0d7-498f-8c55-9c9bd4c21cbf	55700-805	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20191011		ANDA	ANDA208677	Quality Care Products, LLC	PREGABALIN	75	mg/1		CV	N	20241231
55700-810_4a20261e-13a0-4596-8895-8c1bdc1e0e7c	55700-810	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20191018		ANDA	ANDA205253	Quality Care Products, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
55700-812_5bbfe1fb-6164-4261-a51f-a5af5b0310d7	55700-812	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20191025		ANDA	ANDA090858	Quality Care Products, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-813_f14b0c15-b8e3-4a4c-aa40-23c6dc4c89b7	55700-813	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20191011		ANDA	ANDA090174	Quality Care Products, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55700-815_f6bcd4cf-720e-4e59-9b09-94f4eab52032	55700-815	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20191108		ANDA	ANDA203244	Quality Care Products, LLC	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-816_09e50fc0-1bcc-4ef4-b57e-6d26c25ebcdd	55700-816	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20191108		ANDA	ANDA090555	Quality Care Products, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55700-817_b21b50c8-d0d7-498f-8c55-9c9bd4c21cbf	55700-817	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20191108		ANDA	ANDA208677	Quality Care Products, LLC	PREGABALIN	100	mg/1		CV	N	20241231
55700-818_6ef9489b-85e4-4896-9fc7-ca365bd0e053	55700-818	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20191114		ANDA	ANDA078032	Quality Care Products, LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
55700-820_298f61c9-0cf3-46a2-9391-b22756e166ba	55700-820	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20191122		ANDA	ANDA210497	Quality Care Products, LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55700-823_b01de3c0-0c66-439e-9d3c-a07bf2081d75	55700-823	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20191127		ANDA	ANDA211487	Quality Care Products, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
55700-827_380865b5-56ca-40c6-b91d-72eadd910b09	55700-827	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20191203		ANDA	ANDA208677	Quality Care Products, LLC	PREGABALIN	25	mg/1		CV	N	20241231
55700-829_32ade6b7-f4de-4872-8b50-69652f901a53	55700-829	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20191213		ANDA	ANDA204279	Quality Care Products, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55700-830_efb8fb85-6440-41f8-a8ee-ffe6b46dcdfb	55700-830	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20191211		ANDA	ANDA074569	Quality Care Products, LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55700-837_eed9721c-3708-4cd1-8790-aa1e4342ccb3	55700-837	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20200110		ANDA	ANDA202330	Quality Care Products, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
55700-838_ec0b14e1-bb94-49ea-ba85-ce0954d8c520	55700-838	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20200117		ANDA	ANDA078216	Quality Care Products, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-840_829e8900-2efa-4953-8947-390e82cb9b21	55700-840	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Quality Care Products, LLC	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-842_51b6b055-5fdb-41e4-89bb-9036f6bdc20d	55700-842	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20200207	20251130	OTC MONOGRAPH DRUG	M013	Quality Care Products, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
55700-845_94060e86-591b-4500-93c3-8bfbc38d94db	55700-845	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20200228		ANDA	ANDA078420	Quality Care Products, LLC	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-847_94d20e63-1254-4c9b-af22-32a99ba4779f	55700-847	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20200306		ANDA	ANDA078032	Quality Care Products, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-849_50d97375-a844-4a40-bb4c-a14841d42684	55700-849	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA210497	Quality Care Products, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55700-850_c664de61-872f-4cd5-bbd0-cbedf7fb2a19	55700-850	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20200320		ANDA	ANDA202882	Quality Care Products, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55700-851_d29e2a24-0515-475f-90c1-e50edb3198b6	55700-851	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20200320		ANDA	ANDA078216	Quality Care Products, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-855_aed859a7-4f8f-44a4-bdb0-463ad3b42de6	55700-855	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200403		ANDA	ANDA205253	Quality Care Products, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
55700-859_cb5e26fd-8274-462f-9afb-20ed52cdd750	55700-859	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA208250	Quality Care Products, LLC	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
55700-860_51526968-e7cc-4232-9c82-ca427804334f	55700-860	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20200501		ANDA	ANDA040156	Quality Care Products, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55700-863_b0abbc69-6bfb-456e-851c-3ef086afecbe	55700-863	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200526		ANDA	ANDA210986	Quality Care Products, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-864_e9e9c8cd-c2ee-4e92-8665-466dcc5c2a29	55700-864	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20200925		ANDA	ANDA075964	Quality Care Products, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
55700-865_d7d32b09-8ea2-433d-b496-240ad15fa1fd	55700-865	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200528		ANDA	ANDA209605	Quality Care Products, LLC	TIZANIDINE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55700-866_161ed6e2-3324-4d17-a7a7-8a2c8f9a1145	55700-866	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20200602		ANDA	ANDA204597	Quality Care Products, LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-869_aa37484f-ea24-4c97-9fe0-b2b920f1652c	55700-869	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20200611		ANDA	ANDA210907	Quality Care Products, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
55700-874_a5b15fa3-6a2e-4e28-a1ef-060befdb0556	55700-874	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20200728		ANDA	ANDA212650	Quality Care Products, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
55700-876_4e6fc934-97c4-4a4d-b14e-1ae747028d04	55700-876	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20200721		ANDA	ANDA210138	Quality Care Products, LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
55700-882_f2b8e81a-5d18-498b-bd5a-fa35a522a22e	55700-882	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20201002		ANDA	ANDA090635	Quality Care Products, LLC	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
55700-884_98d1f7b9-e9d2-4570-8f06-4782d2d7bc83	55700-884	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20201006		ANDA	ANDA077859	Quality Care Products, LLC	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
55700-886_763501f8-0c85-4471-b660-55a1875ff7da	55700-886	HUMAN PRESCRIPTION DRUG	diclofenac epolamine		Diclofenac Epolamine	SYSTEM	TOPICAL	20201023	20250131	NDA AUTHORIZED GENERIC	NDA021234	Quality Care Products, LLC	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55700-888_0ed66628-d2d3-4bd2-b107-f7cfcd2136b2	55700-888	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210226		ANDA	ANDA212517	Quality Care Products, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-890_399fab7e-dd9c-4093-be57-8dd55f999973	55700-890	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20210210		ANDA	ANDA040489	Quality Care Products, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-891_b21b50c8-d0d7-498f-8c55-9c9bd4c21cbf	55700-891	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20201208		ANDA	ANDA208677	Quality Care Products, LLC	PREGABALIN	150	mg/1		CV	N	20241231
55700-892_67d1b976-44c2-425b-8c0c-7d777fb2d6b7	55700-892	HUMAN PRESCRIPTION DRUG	LACTULOSE		Lactulose	SOLUTION	ORAL	20210122		ANDA	ANDA074623	Quality Care Products, LLC	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55700-893_1103ebf8-c9c7-43d8-93ad-39d67e5c35a7	55700-893	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20210104		ANDA	ANDA201722	Quality Care Products, LLC	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
55700-894_0e1a7d8c-e87d-4596-8b5b-0d887966f858	55700-894	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20210305		ANDA	ANDA090278	Quality Care Products, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-895_85e71d53-d996-4e70-83a6-16ce3fb25582	55700-895	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210114		ANDA	ANDA211347	Quality Care Products, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
55700-897_d2f48b05-f5fe-4167-a542-77712431f90c	55700-897	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20210126		ANDA	ANDA201003	Quality Care Products, LLC	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55700-899_4a977e87-9bf1-40f6-b1ea-911912aebba9	55700-899	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20210204		ANDA	ANDA078327	Quality Care Products, LLC	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-903_beeae248-3022-4aaf-82fe-da862f31baf5	55700-903	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20210318		ANDA	ANDA201504	Quality Care Products, LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55700-904_42b1424a-8ec3-4e05-b07b-b1e33a23bc27	55700-904	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20210326		ANDA	ANDA208677	Quality Care Products, LLC	PREGABALIN	300	mg/1		CV	N	20241231
55700-907_f7ed3eaf-7bfa-4e9e-8b7d-ffce9de3a9f4	55700-907	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20210413		ANDA	ANDA207237	Quality Care Products, LLC	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
55700-908_bfaf2d3b-3440-4d5a-9575-978d90149898	55700-908	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20210415		NDA AUTHORIZED GENERIC	NDA020503	Quality Care Products, LLC	ALBUTEROL SULFATE	108	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
55700-909_c301917f-4989-4477-b9dc-2f01e180a1bb	55700-909	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20210507		ANDA	ANDA203974	Quality Care Products, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
55700-910_cb458ab5-7a28-42e6-ae1c-90eaa216551d	55700-910	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210520		ANDA	ANDA202825	Quality Care Products, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-911_0e6eda0b-8dd0-4f70-a549-234678a9212d	55700-911	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20210817		ANDA	ANDA203695	Quality Care Products, LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
55700-913_66071adc-f000-4826-b07c-122ec16b806e	55700-913	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	Quality Care Products, LLC	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
55700-914_681071cd-686c-4ff0-a14f-e67abcc0bcfc	55700-914	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210611		ANDA	ANDA212277	Quality Care Products, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55700-916_adc32b90-c6c9-4580-9caf-4250aaf2893e	55700-916	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210713		ANDA	ANDA076658	Quality Care Products, LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55700-920_9b65e391-250f-4563-a635-bfeb381ee07a	55700-920	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20210729		ANDA	ANDA209587	Quality Care Products, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
55700-922_87589df0-c858-44fe-9b5e-770865751a01	55700-922	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20210817		ANDA	ANDA040682	Quality Care Products, LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
55700-923_7d54d9b9-d32a-4662-a995-b2554acfdfc4	55700-923	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20210816		ANDA	ANDA040682	Quality Care Products, LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
55700-925_9f8fc591-1c0c-4ec8-96bd-718545d32f19	55700-925	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20211005		ANDA	ANDA213324	Quality Care Products, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-926_9f8fc591-1c0c-4ec8-96bd-718545d32f19	55700-926	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20211005		ANDA	ANDA213324	Quality Care Products, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-927_848deabc-5b58-46b5-b638-0e82d19ec72b	55700-927	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20210827		ANDA	ANDA076255	Quality Care Products, LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55700-929_f73c090d-20b0-4f0c-9a60-6336aa6eb5df	55700-929	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20210909		ANDA	ANDA074342	Quality Care Products, LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
55700-930_467c1937-fa5d-4a50-a700-11a8f02d6cd6	55700-930	HUMAN OTC DRUG	Laxacin		Docusate sodium and sennosides	TABLET	ORAL	20210910	20240831	OTC MONOGRAPH DRUG	M007	Quality Care Products, LLC	DOCUSATE SODIUM; SENNOSIDES A AND B	50; 8.6	mg/1; mg/1			N	
55700-931_f0ef5387-e301-4776-8b67-bd2a23532824	55700-931	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium 1.5%		Diclofenac Sodium Topical	SOLUTION	TOPICAL	20211027		ANDA	ANDA204132	Quality Care Products, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-932_12220f2e-0380-4bbc-a287-c0627229cf34	55700-932	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20220201		ANDA	ANDA206463	Quality Care; Products, LLC	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55700-935_46669e62-1d76-4467-beeb-633dad1093b8	55700-935	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20210909		ANDA	ANDA203154	Quality Care Products, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55700-936_95ea9dc9-6680-461d-8259-2d53a199ad85	55700-936	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20210903		ANDA	ANDA078327	Quality Care Products, LLC	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-937_ee4ef576-1c41-4fce-9196-2e7ec3d4103b	55700-937	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210914		ANDA	ANDA202330	Quality Care Products, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
55700-938_a00d2ac8-384f-4140-a9ab-02cc011982bb	55700-938	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20210910		ANDA	ANDA079163	Quality Care Products, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55700-939_a00d2ac8-384f-4140-a9ab-02cc011982bb	55700-939	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20210910		ANDA	ANDA079163	Quality Care Products, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
55700-940_59b00ed0-766b-45d8-936f-eaa3846d2676	55700-940	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210910		ANDA	ANDA078703	Quality Care Products, LLC	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55700-941_0036c43b-c903-4979-a972-6259b3d9b0f7	55700-941	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20210910		ANDA	ANDA201504	Quality Care Products, LLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
55700-942_f123f157-ef8f-4791-adec-9350a5edf41a	55700-942	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20210910		ANDA	ANDA203062	Quality Care Products, LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-943_d9e15c7d-5175-4f00-b782-17a6a55edd13	55700-943	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET	ORAL	20210913		ANDA	ANDA204041	Quality Care Products, LLC	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-944_d9e15c7d-5175-4f00-b782-17a6a55edd13	55700-944	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET	ORAL	20210913		ANDA	ANDA204041	Quality Care Products, LLC	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-945_78cf225c-e076-41bb-89c9-21e535d28a7e	55700-945	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210928		ANDA	ANDA077253	Quality Care Products, LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
55700-946_00942461-1909-49a6-83d0-7c5b6a3b744c	55700-946	HUMAN OTC DRUG	ACETAMINOPHEN 500 MG		ACETAMINOPHEN	TABLET	ORAL	20211007	20240131	OTC MONOGRAPH DRUG	M013	Quality Care Products, LLC	ACETAMINOPHEN	500	mg/1			N	
55700-947_5583b017-1bac-4172-afcb-bf279f23930b	55700-947	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20210922		ANDA	ANDA203154	Quality Care Products, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
55700-948_b4ec8f7c-a2c5-4051-aa28-a52102bf8baf	55700-948	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210927		ANDA	ANDA202825	Quality Care Products, LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-949_f05ce781-4631-4d62-a792-70571ec8978c	55700-949	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20211207		ANDA	ANDA204989	Quality Care Products, LLC	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-950_f05ce781-4631-4d62-a792-70571ec8978c	55700-950	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20211216		ANDA	ANDA204989	Quality Care Products, LLC	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-951_5ebd3bae-aa54-4b0a-8791-01dfb7757ab3	55700-951	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20220106		ANDA	ANDA089853	Quality Care Products, LLC	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-953_21478456-112d-4767-a9ed-7135a9084cac	55700-953	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20211215		ANDA	ANDA203512	Quality Care Products, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
55700-954_c00931a4-86f5-4bc5-9ed1-072d3ad83efc	55700-954	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20220118		ANDA	ANDA040188	Quality Care Products, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
55700-957_2244921d-c337-48f9-b439-b5707ef44e17	55700-957	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20220121		ANDA	ANDA202180	Quality Care Products, LLC	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
55700-958_0d62abfd-27fd-42d2-885e-dc752ca042d2	55700-958	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20220125		ANDA	ANDA203062	Quality Care Products, LLC	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-961_ed37c219-8d7e-4c6d-b770-87d6f0fe8fd6	55700-961	HUMAN PRESCRIPTION DRUG	Dexamethasone		dexamethasone	TABLET	ORAL	20220131		ANDA	ANDA088481	Quality Care Products, LLC	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55700-963_d5fb61f6-e810-4de4-a77f-45eafbbc0171	55700-963	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20220217		NDA AUTHORIZED GENERIC	NDA021908	Quality Care Products, LLC	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
55700-964_1cccbdbd-8885-4505-b6af-296d0afdb58b	55700-964	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20220310		ANDA	ANDA208677	Quality Care Products, LLC	PREGABALIN	200	mg/1		CV	N	20241231
55700-966_c537e514-91dd-4ed4-96e6-2d7c204bb4d7	55700-966	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20220331		ANDA	ANDA203818	Quality Care Products, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-968_b9f15e01-5d03-49d3-ae1e-e0cb899a2cb6	55700-968	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20220713		ANDA	ANDA203512	Quality Care Products, LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
55700-969_4bfce669-d7c0-4725-a4ff-5dc27f1a157b	55700-969	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20220719		ANDA	ANDA078284	Quality Care Products, LLC	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
55700-971_c7eaf52c-4d8f-4324-8188-11ca74868c75	55700-971	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20220602	20260331	ANDA	ANDA213592	Quality Care Products, LLC	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	
55700-973_0aade8f7-8563-4189-86b6-6804445ff89f	55700-973	HUMAN PRESCRIPTION DRUG	Fentanyl System		Fentanyl	PATCH	TRANSDERMAL	20220509		ANDA	ANDA202097	Quality Care Products, LLC	FENTANYL	50	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
55700-974_47d1cae6-516f-42a7-838b-c97715f9f2e9	55700-974	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20220607		ANDA	ANDA214099	Quality Care Products, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
55700-975_e55787b4-f4be-46e7-ba7d-4e784e85ddf9	55700-975	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220616		ANDA	ANDA212277	Quality Care Products, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
55700-976_d0e07953-4bfb-4c82-892a-d230a1ac6acf	55700-976	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220719		ANDA	ANDA211143	Quality Care Products, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
55700-977_79158958-96ec-4c06-b689-329210805cc2	55700-977	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220712		ANDA	ANDA202825	Quality Care Products, LLC	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-979_d7d21170-506b-48b9-a464-434e9fb054e3	55700-979	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20220708		ANDA	ANDA076230	Quality Care Products, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
55700-980_c809c81f-d7c7-4bc1-8c08-b5905afa97d8	55700-980	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20220721		ANDA	ANDA206298	Quality Care Products, LLC	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-981_77971f19-d9e8-4452-ad42-5ed8a9224a4a	55700-981	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220809		NDA AUTHORIZED GENERIC	NDA021777	Quality Care Products, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-984_480722cc-d8ef-4a17-820a-775b3040bbcb	55700-984	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	20220928		ANDA	ANDA040545	Quality Care Products, LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
55700-985_358c3d1a-23cf-4e10-b79f-5b739f713aa9	55700-985	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride Nasal Spray	INHALANT	NASAL	20221011		NDA AUTHORIZED GENERIC	NDA208411	Quality Care Products, LLC	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
55700-987_6f5c91c2-f211-4e38-ae49-32985597c2ee	55700-987	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20221108		ANDA	ANDA212517	Quality Care Products, LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-988_170cbf79-e3d8-40d4-843c-93f55c820557	55700-988	HUMAN PRESCRIPTION DRUG	MOVANTIK		naloxegol oxalate	TABLET, FILM COATED	ORAL	20221122		NDA	NDA204760	Quality Care Products, LLC	NALOXEGOL OXALATE	25	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
55700-989_94684570-69ff-459b-a216-c97443f511b8	55700-989	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20221122		ANDA	ANDA075229	Quality Care Products, LLC	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55700-990_c41652e2-a51a-4c9e-94d5-05fc2ab84b6c	55700-990	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20221215		ANDA	ANDA040489	Quality Care Products, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
55700-991_556e84de-7528-4b83-962d-d03ce9968e9e	55700-991	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20221227		ANDA	ANDA040400	Quality Care Products, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
55700-992_faf96025-1af6-47a3-8ad0-ad3381e519e6	55700-992	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20230406		ANDA	ANDA040409	Quality Care Products, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
55700-993_38206b44-29ed-4c70-aca9-4bcb4637eaa8	55700-993	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20230117		ANDA	ANDA090939	Quality Care Products, LLC	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
55700-994_c48adcb8-8953-4128-94c9-f71368ef909f	55700-994	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20230111		ANDA	ANDA077987	Quality Care Products, LLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55700-995_7138000b-171c-456e-bbc2-d761966ae8c5	55700-995	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20230117		ANDA	ANDA090162	Quality Care Products, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
55700-996_026eb608-d56b-4ee7-85a0-75fbf904dcda	55700-996	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20230124		ANDA	ANDA200503	Quality Care Products, LLC	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
55700-997_ddf870b3-d3b9-40e9-9120-64f6582eff79	55700-997	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20230207		ANDA	ANDA208708	Quality Care Products, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
55700-998_1f775b5d-e819-4326-9e07-528fe885b731	55700-998	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA207752	Quality Care Products, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
55700-999_55d66fd6-9cad-4fca-8a3d-1bfa57a8a160	55700-999	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20230124		ANDA	ANDA208622	Quality Care Products, LLC	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
55703-001_f900c8d7-dd39-eee9-e053-6394a90a9afe	55703-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19990301		UNAPPROVED MEDICAL GAS		Northwest Respiratory Services	OXYGEN	992	L/1000L			N	20241231
55711-064_c2296401-f32e-33b5-e053-2a95a90ae8b9	55711-064	HUMAN OTC DRUG	Original Extra Strong All Natural Fishermans Friend Menthol Cough Suppressant		Menthol	LOZENGE	ORAL	20100810		OTC MONOGRAPH FINAL	part341	Lofthouse of Fleetwood, Ltd.	MENTHOL	10	mg/1			N	20241231
55711-064_c2382b68-fdd1-5272-e053-2a95a90a68ef	55711-064	HUMAN OTC DRUG	Original Extra Strong All Natural Fishermans Friend Menthol Cough Suppressant		Menthol	LOZENGE	ORAL	20100810		OTC MONOGRAPH FINAL	part341	Lofthouse of Fleetwood, Ltd.	MENTHOL	10	mg/1			N	20241231
55711-064_c238726c-d28b-4157-e053-2995a90adc96	55711-064	HUMAN OTC DRUG	Original Extra Strong All Natural Fishermans Friend Menthol Cough Suppressant		Menthol	LOZENGE	ORAL	20100810		OTC MONOGRAPH FINAL	part341	Lofthouse of Fleetwood, Ltd.	MENTHOL	10	mg/1			N	20241231
55711-064_c59e47a7-9635-0c5c-e053-2995a90a443c	55711-064	HUMAN OTC DRUG	Original Extra Strong All Natural Fishermans Friend Menthol Cough Suppressant		Menthol	LOZENGE	ORAL	20100908		OTC MONOGRAPH FINAL	part341	Lofthouse of Fleetwood, Ltd.	MENTHOL	10	mg/1			N	20241231
55711-070_c2390fc5-82b6-5c9c-e053-2995a90a4f2c	55711-070	HUMAN OTC DRUG	Sugar Free Cherry Fishermans Friend Menthol Cough Suppressant		Menthol	LOZENGE	ORAL	20100810		OTC MONOGRAPH FINAL	part341	Lofthouse of Fleetwood, Ltd.	MENTHOL	6.9	mg/1			N	20241231
55711-070_c239790c-ed22-1468-e053-2a95a90ab8c9	55711-070	HUMAN OTC DRUG	Sugar Free Cherry Fishermans Friend Menthol Cough Suppressant		Menthol	LOZENGE	ORAL	20100810		OTC MONOGRAPH FINAL	part341	Lofthouse of Fleetwood, Ltd.	MENTHOL	6.9	mg/1			N	20241231
55711-071_c24b12b7-b4a4-1a4c-e053-2a95a90a05d3	55711-071	HUMAN OTC DRUG	Sugar Free Honey-Lemon Fishermans Friend Menthol Cough Suppressant		Menthol	LOZENGE	ORAL	20190502		OTC MONOGRAPH FINAL	part341	Lofthouse of Fleetwood, Ltd.	MENTHOL	5.52	mg/1			N	20241231
55714-1519_017e4c93-c747-8b4e-e063-6294a90a6ef5	55714-1519	HUMAN OTC DRUG	Allergies		Apis mellifica, Echinacea, Hydrastis canadensis, Taraxacum officinale, Aconitum napellus, Aethusa cynapium, Agaricus muscarius, Aletris farinosa, Alfalfa, Allium cepa, Allium sativum, Ambrosia artemisiaefolia, Arsenicum album, Artemisia vulgaris, Arundo mauritanica, Avena sativa, Belladonna, Bellis perrenis, Bovista, Bromium, Bryonia, Caffeinum, Calcarea carbonica, Calluna vulgaris, flos, Capsicum annuum, Cat hair, Chamomilla, Chelidonium majus, Chenopodium anthelminticum, Cinnamomum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; AETHUSA CYNAPIUM; ALETRIS FARINOSA ROOT; ALFALFA; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; AMBROSIA ARTEMISIIFOLIA; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; ARUNDO PLINIANA ROOT; ASCORBIC ACID; ASTACUS ASTACUS; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BELLIS PERENNIS; BLACK MUSTARD SEED; BROMINE; BRYONIA ALBA ROOT; CAFFEINE; CALLUNA VULGARIS FLOWERING TOP; CANIS LUPUS FAMILIARIS HAIR; CAPSICUM; CHELIDONIUM MAJUS; CINNAMON; CLAVICEPS PURPUREA SCLEROTIUM; CORN SILK; COW MILK; CYNARA SCOLYMUS LEAF; DATURA STRAMONIUM; DROSERA ANGLICA; DYSPHANIA AMBROSIOIDES; ECHINACEA, UNSPECIFIED; EGG SHELL, COOKED; ELYMUS REPENS ROOT; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM; FAGUS SYLVATICA NUT; FELIS CATUS HAIR; FRAXINUS AMERICANA BARK; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; HYOSCYAMUS NIGER; JUGLANS REGIA LEAF; JUNIPERUS VIRGINIANA TWIG; LACTOSE, UNSPECIFIED FORM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; MATRICARIA CHAMOMILLA; MENTHA PIPERITA; NUTMEG; ONION; ONOSMODIUM VIRGINIANUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM IODIDE; PROTORTONIA CACTI; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; RHODODENDRON TOMENTOSUM LEAFY TWIG; ROSA X DAMASCENA FLOWERING TOP; SACCHARIN; SACCHAROMYCES CEREVISIAE; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SODIUM NITRATE; SOLANUM DULCAMARA TOP; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SUCROSE; SULFUR; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 6; 15; 15; 15; 16; 16; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 6; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 16; 15; 16; 16; 16; 16; 15; 6; 15; 15; 15; 16; 15; 15; 15; 15; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Ascorbic Acid [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylxanthine [EPC], Milk Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-1521_b4cab676-1b20-c131-e053-2a95a90a4c71	55714-1521	HUMAN OTC DRUG	Bedwetting		Echinacea, Hydrastis canadensis, Passiflora incarnata, Valeriana officinalis, Belladonna, Cantharis, Causticum, Equisetum hyemale, Ferrum metallicum, Gelsemium sempervirens, Humulus lupulus, Kali phosphoricum, Lycopodium clavatum, Natrum muriaticum, Plantago major, Pulsatilla, Rhus aromatica, Sabal serrulata, Thyroidinum, Verbascum thapsus	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ATROPA BELLADONNA; CAUSTICUM; DIBASIC POTASSIUM PHOSPHATE; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HOPS; IRON; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PASSIFLORA INCARNATA FLOWERING TOP; PLANTAGO MAJOR; SAW PALMETTO; SODIUM CHLORIDE; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERBASCUM THAPSUS	15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55714-1523_9d626292-7abc-1afb-e053-2995a90a2818	55714-1523	HUMAN OTC DRUG	Constipation		Echinacea, Iris versicolor, Phytolacca decandra, Taraxacum officinale, Abies nigra, Aesculus hippocastanum, Aloe, Alumina, Bryonia, Carbo vegetabilis, Chelidonium majus, Collinsonia canadensis, Graphite, Hydrastis canadensis 15x, Kali carbonicum 15x, Lycopodium clavatum 15x, Magnesia muriatica 15x, Mezereum, Nux vomica, Podophyllum peltatum, Rhamnus purshiana, Sanicula, Selenium metallicum, Sepia, Silicea, Tabacum, Veratrum album, Zincum metallicum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLLINSONIA CANADENSIS ROOT; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GOLDENSEAL; GRAPHITE; HORSE CHESTNUT; IRIS VERSICOLOR ROOT; KRAMERIA LAPPACEA ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; PHYTOLACCA AMERICANA ROOT; PICEA MARIANA RESIN; PODOPHYLLUM; POTASSIUM CARBONATE; SANICULA EUROPAEA LEAF; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; VERATRUM ALBUM ROOT; ZINC	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1524_9d721e40-5ba7-bf38-e053-2995a90aaf33	55714-1524	HUMAN OTC DRUG	Detoxifier		Cynara scolymus, Solidago virgaurea, Taraxacum officinale, Benzoicum acidum, Berberis vulgaris, Bryonia, Cantharis, Carduus benedictus, Carduus marianus,Ceanothus americanus, Chelidonium majus, Chionanthus virginica, Cinchona officinalis, Dioscorea villosa, Dolichos pruriens, Iris versicolor, Juniperus communis, Ptelea trifoliata, Taraxacum officinale, Nux vomica, Uricum acidum.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	10; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 10; 10; 10; 10; 10; 6; 15; 10; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1525_9d732596-4e9d-55b4-e053-2995a90af5ba	55714-1525	HUMAN OTC DRUG	Diarrhea		Aesculus hippocastanum, Juglans regia, Valeriana officinalis, Aconitum napellus, Argentum nitricum, Arsenicum album, Baptisia tinctoria, Bryonia, Carbo vegetabilis, Chamomilla, Cinchona officinalis, Collinsonia canadensis, Colocynthis, Elaterium, Gelsemium sempervirens, Ipecacuanha, Iris versicolor, Lycopodium clavatum, Magnesia carbonica, Phosphorus, Podophyllum peltatum, Rheum, Sulphur, Tabacum, Vaccinium myrtillus	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BILBERRY; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; COLLINSONIA CANADENSIS ROOT; ECBALLIUM ELATERIUM FRUIT; GELSEMIUM SEMPERVIRENS ROOT; HORSE CHESTNUT; IPECAC; IRIS VERSICOLOR ROOT; JUGLANS REGIA LEAF; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; PHOSPHORUS; PODOPHYLLUM; RHEUM OFFICINALE ROOT; SILVER NITRATE; SULFUR; TOBACCO LEAF; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55714-1527_9d76338a-c0ed-e826-e053-2a95a90af3e1	55714-1527	HUMAN OTC DRUG	Fever-Infection		Chamomilla, Echinacea Hydrastis canadensis, Aconitum napellus, Arsenicum album, Belladonna, Bryonia, Camphora, Cina, Cinchona officinalis, Eupatorium perfoliatum, Ferrum phosphoricum, Gelsemium sempervirens, Hepar sulphuris calcareum, Ignatia amara, Natrum muriaticum, Nux vomica, Phosphorus, Pulsatilla, Salix nigra, Veratrum viride, Influenzinum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ARTEMISIA CINA PRE-FLOWERING TOP; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAMPHOR (NATURAL); CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MATRICARIA CHAMOMILLA; PHOSPHORUS; SALIX NIGRA BARK; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VERATRUM VIRIDE ROOT	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 30; 30; 6; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1529_9db1327c-6747-76cb-e053-2995a90a6e27	55714-1529	HUMAN OTC DRUG	Sniffles		Echinacea, Aconitum napellus, Aralia quinquefolia, Arsenicum album, Bryonia, Euphrasia officinalis, Gaultheria procumbens, Gelsemium sempervirens, Histaminum hydrochloricum, Hydrastis canadensis, Kali bichromicum, Lycopodium clavatum, Nux vomica, Phosphorus, Pulsatilla, Rhus toxicodendron, Salvia officinalis, Sticta pulmonaria, Thuja occidentalis, Verbascum thapsus, Sinusitisinum, Influenzinum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GAULTHERIA PROCUMBENS TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LOBARIA PULMONARIA; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; POTASSIUM DICHROMATE; SAGE; SINUSITISINUM; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1530_9db3023e-a042-5403-e053-2a95a90a89eb	55714-1530	HUMAN OTC DRUG	Teething-Colic		Chamomilla, Valeriana officinalis, Aconitum napellus, Apis mellifica, Baptisia tinctoria, Belladonna, Borax, Bryonia, Calcarea carbonica, Calcarea phosphorica, Chamomilla, Chelidonium majus, Coffea cruda, Collinsonia canadensis, Colocynthis, Kreosotum, Magnesia phosphorica, Nux vomica, Podophyllum peltatum, Rheum, Scutellaria lateriflora, Silicea, Terebinthina, Zingiber officinale	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; ARABICA COFFEE BEAN; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CITRULLUS COLOCYNTHIS FRUIT PULP; COLLINSONIA CANADENSIS ROOT; GINGER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PODOPHYLLUM; RHEUM OFFICINALE ROOT; SCUTELLARIA LATERIFLORA WHOLE; SILICON DIOXIDE; SODIUM BORATE; STRYCHNOS NUX-VOMICA SEED; TRIBASIC CALCIUM PHOSPHATE; TURPENTINE OIL; VALERIAN; WOOD CREOSOTE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-1531_9dc2df22-ee9f-4f4d-e053-2995a90a44a3	55714-1531	HUMAN OTC DRUG	Tummy Upset		Chamomilla, Echinacea, Iris versicolor, Ruta graveolens, Taraxacum officinale, Aloe, Angelica sinensis radix, Antimonium , Argentum nitricum, Arnica montana, Arsenicum album, Baptisia tinctoria, Bismuthum metallicum, Bryonia, Cinchona officinalis, Graphites, Hydrastis canadensis, Ipecacuanha, Lachesis mutus, Lycopodium clavatum, Myrrha, Natrum carbonicum, Nux vomica, Phosphorus, Pulsatilla, Zingiber officinale.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ANTIMONY TRISULFIDE; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; GINGER; GOLDENSEAL; GRAPHITE; IPECAC; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; MYRRH; PHOSPHORUS; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 6; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1533_b4cbad8a-2b8f-66b0-e053-2a95a90ab94f	55714-1533	HUMAN OTC DRUG	Post - Vaccination		Influenzinum, Morbillinum, Pertussinum, Aconitum nap., Alumina, Antimon. tart., Arsenicum alb., Baptisia, Belladonna, Bryonia, Cinchona, Crotalus horridus, Gelsemium, Kali bic., Lachesis, Ledum, Merc. viv., Mezereum, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Silicea, Sulphur, Thuja occ., Vaccinium, Apis mel., Echinacea, Hypericum	LIQUID	ORAL	20190603		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALUMINUM OXIDE; ANTIMONY POTASSIUM TARTRATE; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BILBERRY; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYPERICUM PERFORATUM; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LACHESIS MUTA VENOM; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MERCURY; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 30; 6; 30; 30; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-1534_9d60affa-3adb-2517-e053-2a95a90abf74	55714-1534	HUMAN OTC DRUG	Bowel-Digestive Care		Echinacea, Juglans regia, Antimonium crudum, Argentum nitricum, Arsenicum album, Baptisia tinctoria, Bismuthum metallicum, Bryonia, Chamomilla, Cinchona officinalis, Iris versicolor, Kali bichromicum, Lachesis mutus, Lycopodium clavatum, Magnesia carbonica, Nux vomica, Phosphorus, Podophyllum peltatum, Pulsatilla, Raphanus sativus, Rhus toxicodendron, Tabacum, Verbascum thapsus, Zingiber officinale	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; GINGER; IRIS VERSICOLOR ROOT; JUGLANS REGIA LEAF; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; PHOSPHORUS; PODOPHYLLUM; POTASSIUM DICHROMATE; RADISH; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-1536_da6fd3dc-1acf-1cb1-e053-2a95a90a08cd	55714-1536	HUMAN OTC DRUG	Airway Ease		Influenzinum, Antimon. tart., Arsenicum alb., Bryonia, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Histaminum hydrochloricum, Hydrastis, Kali bic., Kali carb., Kali iod., Myrrha, Nat. sulphuricum, Nux vom., Phosphorus, Pulsatilla, Rumex crisp., Sambucus nig., Spongia, Tussilago farfara, Verbascum, Echinacea, Lappa.	LIQUID	ORAL	20191101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ANGLICA; ECHINACEA, UNSPECIFIED; EUCALYPTUS GUM; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1537_da717cf0-54b0-c4e2-e053-2995a90ac97c	55714-1537	HUMAN OTC DRUG	Ear Care		Echinacea, Hydrastis canadensis, Apis mellifica, Arsenicum album, Belladonna, Bryonia, Capsicum annuum, Causticum, Cinchona officinalis, Conium maculatum, Dulcamara, Ferrum phosphoricum, Hepar sulphuris calcareum, Kali sulphuricum, Lycopodium clavatum, Mercurius vivus, Mezereum, Phosphorus, Plantago major, Pulsatilla, Silicea, Verbascum thapsus, Tellurium metallicum, Influenzinum	LIQUID	ORAL	20220307		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LYCOPODIUM CLAVATUM SPORE; MERCURY; PHOSPHORUS; PLANTAGO MAJOR; POTASSIUM SULFATE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; TELLURIUM; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 16; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-1538_ff5f3962-3ef4-fddb-e053-6394a90afc33	55714-1538	HUMAN OTC DRUG	Hypercalm-Mental Focus		Chamomilla, Echinacea, Hypericum perforatum, Passiflora incarnata, Aconitum napellus, Adrenalinum, Argentum nit., Arsenicum album, Baptisia tinctoria, Chamomilla, Coffea cruda, Cypripedium pubescens, Digitalis purpurea, Gelsemium sempervirens, Humulus lupulus, Hyoscyamus niger, Ignatia amara, Impatiens glandulifera flos, Iodium, Lachesis mutus, Lycopodium clavatum, Natrum muriaticum, Nux vomica, Scutellaria lateriflora, Staphysagria, Stramonium, Theridion, Veratrum viride	LIQUID	ORAL	20230601		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; HOPS; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; VERATRUM VIRIDE ROOT	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-1719_017eb0c4-e7df-4545-e063-6294a90aa1c5	55714-1719	HUMAN OTC DRUG	Allergies		Apis mellifica, Echinacea, Hydrastis canadensis, Taraxacum officinale, Aconitum napellus, Aethusa cynapium, Agaricus muscarius, Aletris farinosa, Alfalfa, Allium cepa, Allium sativum, Ambrosia artemisiaefolia, Arsenicum album, Artemisia vulgaris, Arundo mauritanica, Avena sativa, Belladonna, Bellis perrenis, Bovista, Bromium, Bryonia, Caffeinum, Calcarea carbonica, Calluna vulgaris, flos, Capsicum annuum, Cat hair, Chamomilla, Chelidonium majus, Chenopodium anthelminticum, Cinnamomum	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; AETHUSA CYNAPIUM; ALETRIS FARINOSA ROOT; ALFALFA; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; AMBROSIA ARTEMISIIFOLIA; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; ARUNDO PLINIANA ROOT; ASCORBIC ACID; ASTACUS ASTACUS; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BELLIS PERENNIS; BLACK MUSTARD SEED; BROMINE; BRYONIA ALBA ROOT; CAFFEINE; CALLUNA VULGARIS FLOWERING TOP; CANIS LUPUS FAMILIARIS HAIR; CAPSICUM; CHELIDONIUM MAJUS; CINNAMON; CLAVICEPS PURPUREA SCLEROTIUM; CORN SILK; COW MILK; CYNARA SCOLYMUS LEAF; DATURA STRAMONIUM; DROSERA ANGLICA; DYSPHANIA AMBROSIOIDES; ECHINACEA, UNSPECIFIED; EGG SHELL, COOKED; ELYMUS REPENS ROOT; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM; FAGUS SYLVATICA NUT; FELIS CATUS HAIR; FRAXINUS AMERICANA BARK; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; HYOSCYAMUS NIGER; JUGLANS REGIA LEAF; JUNIPERUS VIRGINIANA TWIG; LACTOSE, UNSPECIFIED FORM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; MATRICARIA CHAMOMILLA; MENTHA PIPERITA; NUTMEG; ONION; ONOSMODIUM VIRGINIANUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM IODIDE; PROTORTONIA CACTI; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; RHODODENDRON TOMENTOSUM LEAFY TWIG; ROSA X DAMASCENA FLOWERING TOP; SACCHARIN; SACCHAROMYCES CEREVISIAE; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SODIUM NITRATE; SOLANUM DULCAMARA TOP; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SUCROSE; SULFUR; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 6; 15; 15; 15; 16; 16; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 6; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 16; 15; 16; 16; 16; 16; 15; 6; 15; 15; 15; 16; 15; 15; 15; 15; 16	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Ascorbic Acid [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylxanthine [EPC], Milk Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-1721_b4cad4d4-26db-f71d-e053-2995a90a298e	55714-1721	HUMAN OTC DRUG	Bedwetting		Echinacea, Hydrastis canadensis, Passiflora incarnata, Valeriana officinalis, Belladonna, Cantharis, Causticum, Equisetum hyemale, Ferrum metallicum, Gelsemium sempervirens, Humulus lupulus, Kali phosphoricum, Lycopodium clavatum, Natrum muriaticum, Plantago major, Pulsatilla, Rhus aromatica, Sabal serrulata, Thyroidinum, Verbascum thapsus	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ATROPA BELLADONNA; CAUSTICUM; DIBASIC POTASSIUM PHOSPHATE; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HOPS; IRON; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PASSIFLORA INCARNATA FLOWERING TOP; PLANTAGO MAJOR; SAW PALMETTO; SODIUM CHLORIDE; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERBASCUM THAPSUS	15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55714-1723_9d63b1dc-0748-707a-e053-2995a90a5310	55714-1723	HUMAN OTC DRUG	Constipation		Echinacea, Iris versicolor, Phytolacca decandra, Taraxacum officinale, Abies nigra, Aesculus hippocastanum, Aloe, Alumina, Bryonia, Carbo vegetabilis, Chelidonium majus, Collinsonia canadensis, Graphite, Hydrastis canadensis 15x, Kali carbonicum 15x, Lycopodium clavatum 15x, Magnesia muriatica 15x, Mezereum, Nux vomica, Podophyllum peltatum, Rhamnus purshiana, Sanicula, Selenium metallicum, Sepia, Silicea, Tabacum, Veratrum album, Zincum metallicum	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLLINSONIA CANADENSIS ROOT; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GOLDENSEAL; GRAPHITE; HORSE CHESTNUT; IRIS VERSICOLOR ROOT; KRAMERIA LAPPACEA ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; PHYTOLACCA AMERICANA ROOT; PICEA MARIANA RESIN; PODOPHYLLUM; POTASSIUM CARBONATE; SANICULA EUROPAEA LEAF; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; VERATRUM ALBUM ROOT; ZINC	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1724_9d72d9af-b907-513f-e053-2a95a90adaec	55714-1724	HUMAN OTC DRUG	Detoxifier		Cynara scolymus, Solidago virgaurea, Taraxacum officinale, Benzoicum acidum, Berberis vulgaris, Bryonia, Cantharis, Carduus benedictus, Carduus marianus,Ceanothus americanus, Chelidonium majus, Chionanthus virginica, Cinchona officinalis, Dioscorea villosa, Dolichos pruriens, Iris versicolor, Juniperus communis, Ptelea trifoliata, Taraxacum officinale, Nux vomica, Uricum acidum.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	10; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 10; 10; 10; 10; 10; 6; 15; 10; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1729_9db41b31-5bbd-5239-e053-2a95a90a45ad	55714-1729	HUMAN OTC DRUG	Sniffles		Echinacea, Aconitum napellus, Aralia quinquefolia, Arsenicum album, Bryonia, Euphrasia officinalis, Gaultheria procumbens, Gelsemium sempervirens, Histaminum hydrochloricum, Hydrastis canadensis, Kali bichromicum, Lycopodium clavatum, Nux vomica, Phosphorus, Pulsatilla, Rhus toxicodendron, Salvia officinalis, Sticta pulmonaria, Thuja occidentalis, Verbascum thapsus, Sinusitisinum, Influenzinum	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GAULTHERIA PROCUMBENS TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LOBARIA PULMONARIA; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; POTASSIUM DICHROMATE; SAGE; SINUSITISINUM; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1730_9db46b30-5d89-0b17-e053-2995a90a42f8	55714-1730	HUMAN OTC DRUG	Teething-Colic		Chamomilla, Valeriana officinalis, Aconitum napellus, Apis mellifica, Baptisia tinctoria, Belladonna, Borax, Bryonia, Calcarea carbonica, Calcarea phosphorica, Chamomilla, Chelidonium majus, Coffea cruda, Collinsonia canadensis, Colocynthis, Kreosotum, Magnesia phosphorica, Nux vomica, Podophyllum peltatum, Rheum, Scutellaria lateriflora, Silicea, Terebinthina, Zingiber officinale	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; ARABICA COFFEE BEAN; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CITRULLUS COLOCYNTHIS FRUIT PULP; COLLINSONIA CANADENSIS ROOT; GINGER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PODOPHYLLUM; RHEUM OFFICINALE ROOT; SCUTELLARIA LATERIFLORA WHOLE; SILICON DIOXIDE; SODIUM BORATE; STRYCHNOS NUX-VOMICA SEED; TRIBASIC CALCIUM PHOSPHATE; TURPENTINE OIL; VALERIAN; WOOD CREOSOTE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-1731_9dc3059c-3a3c-5810-e053-2a95a90ab0ba	55714-1731	HUMAN OTC DRUG	Tummy Upset		Chamomilla, Echinacea, Iris versicolor, Ruta graveolens, Taraxacum officinale, Aloe, Angelica sinensis radix, Antimonium , Argentum nitricum, Arnica montana, Arsenicum album, Baptisia tinctoria, Bismuthum metallicum, Bryonia, Cinchona officinalis, Graphites, Hydrastis canadensis, Ipecacuanha, Lachesis mutus, Lycopodium clavatum, Myrrha, Natrum carbonicum, Nux vomica, Phosphorus, Pulsatilla, Zingiber officinale.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ANTIMONY TRISULFIDE; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; GINGER; GOLDENSEAL; GRAPHITE; IPECAC; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; MYRRH; PHOSPHORUS; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 6; 15; 15; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1733_b4cbb7b6-cb6c-9721-e053-2995a90a2b2c	55714-1733	HUMAN OTC DRUG	Post-Vaccination		Influenzinum, Morbillinum, Pertussinum, Aconitum nap., Alumina, Antimon. tart., Arsenicum alb., Baptisia, Belladonna, Bryonia, Cinchona, Crotalus horridus, Gelsemium, Kali bic., Lachesis, Ledum, Merc. viv., Mezereum, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Silicea, Sulphur, Thuja occ., Vaccinium, Apis mel., Echinacea, Hypericum	PELLET	ORAL	20190603		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALUMINUM OXIDE; ANTIMONY POTASSIUM TARTRATE; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BILBERRY; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYPERICUM PERFORATUM; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LACHESIS MUTA VENOM; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MERCURY; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 30; 6; 30; 30; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-1736_da6fdeb6-48be-2a91-e053-2995a90ad34a	55714-1736	HUMAN OTC DRUG	Airway Ease		Influenzinum, Antimon. tart., Arsenicum alb., Bryonia, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Histaminum hydrochloricum, Hydrastis, Kali bic., Kali carb., Kali iod., Myrrha, Nat. sulphuricum, Nux vom., Phosphorus, Pulsatilla, Rumex crisp., Sambucus nig., Spongia, Tussilago farfara, Verbascum, Echinacea, Lappa.	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ANGLICA; ECHINACEA, UNSPECIFIED; EUCALYPTUS GUM; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-1737_da807eb3-34a4-61b9-e053-2995a90a0e21	55714-1737	HUMAN OTC DRUG	Ear Care		Echinacea, Hydrastis canadensis, Apis mellifica, Arsenicum album, Belladonna, Bryonia, Capsicum annuum, Causticum, Cinchona officinalis, Conium maculatum, Dulcamara, Ferrum phosphoricum, Hepar sulphuris calcareum, Kali sulphuricum, Lycopodium clavatum, Mercurius vivus, Mezereum, Phosphorus, Plantago major, Pulsatilla, Silicea, Verbascum thapsus, Tellurium metallicum, Influenzinum	PELLET	ORAL	20220307		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LYCOPODIUM CLAVATUM SPORE; MERCURY; PHOSPHORUS; PLANTAGO MAJOR; POTASSIUM SULFATE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; TELLURIUM; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 16; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-1738_ff60427d-49e3-b5f4-e053-6294a90ad12c	55714-1738	HUMAN OTC DRUG	Hypercalm-Mental Focus		Chamomilla, Echinacea, Hypericum perforatum, Passiflora incarnata, Aconitum napellus, Adrenalinum, Argentum nit., Arsenicum album, Baptisia tinctoria, Chamomilla, Coffea cruda, Cypripedium pubescens, Digitalis purpurea, Gelsemium sempervirens, Humulus lupulus, Hyoscyamus niger, Ignatia amara, Impatiens glandulifera flos, Iodium, Lachesis mutus, Lycopodium clavatum, Natrum muriaticum, Nux vomica, Scutellaria lateriflora, Staphysagria, Stramonium, Theridion, Veratrum viride	PELLET	ORAL	20230601		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; HOPS; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; VERATRUM VIRIDE ROOT	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2380_b4dd86c7-e1b0-5767-e053-2995a90a8221	55714-2380	HUMAN OTC DRUG	Accident - Injury Rescue		Aconitum nap, Arnica, Bellis, Calendula, Echinacea, Gelsemium, Hamamelis, Hypericum, Ledum, Phosphorus, Rhus toxicodendron, Ruta, Staphysag., Symphytum, Hydrastis canadensis.	LIQUID	ORAL	20181017		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; PHOSPHORUS; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-2382_b4dd6692-6cb8-a808-e053-2995a90ade14	55714-2382	HUMAN OTC DRUG	Aches - Pains		Aconitum nap., Arg. nit., Arnica, Bryonia, Colchicum, Guaiacum, Hypericum, Kalmia, Phosphorus, Phytolacca, Pulsatilla, Rhus toxicodendron, Ruta, Sarcolacticum ac., Sticta, Stramonium, Hamamelis, Taraxacum,	LIQUID	ORAL	20181026		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; DATURA STRAMONIUM; GUAIAC; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; KALMIA LATIFOLIA LEAF; LACTIC ACID, L-; LOBARIA PULMONARIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-2383_b4ddae41-8d61-1b6a-e053-2995a90a6247	55714-2383	HUMAN OTC DRUG	Aches - Pains		Aconitum nap., Arg. nit., Arnica, Bryonia, Colchicum, Guaiacum, Hypericum, Kalmia, Phosphorus, Phytolacca, Pulsatilla, Rhus toxicodendron, Ruta, Sarcolacticum ac., Sticta, Stramonium, Hamamelis, Taraxacum,	PELLET	ORAL	20181026		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; DATURA STRAMONIUM; GUAIAC; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; KALMIA LATIFOLIA LEAF; LACTIC ACID, L-; LOBARIA PULMONARIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
55714-2384_b4ddcbcc-e892-1c05-e053-2995a90a63a0	55714-2384	HUMAN OTC DRUG	Acne		Antimon. crud., Arsenicum alb., Aur. met., Berber. aqui., Bovista, Carbo veg., Causticum, Chelidonium majus, Dulcamara, Graphites, Hepar sulph. calc., Hydrocotyle, Kali brom., Kali iod., Ledum, Lycopodium, Nux vom., Silicea, Sulphur iod., Zinc. met., Echinacea, Juglans regia, Lappa, Taraxacum	LIQUID	ORAL	20181031		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC CATION (3+); CALCIUM SULFIDE; CAUSTICUM; CENTELLA ASIATICA; CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; ENGLISH WALNUT; GIANT PUFFBALL; GOLD; GRAPHITE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; MAHONIA AQUIFOLIUM ROOT BARK; POTASSIUM BROMIDE; POTASSIUM IODIDE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; TARAXACUM OFFICINALE; ZINC	15; 15; 6; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
55714-2385_b4ddcbcc-e895-1c05-e053-2995a90a63a0	55714-2385	HUMAN OTC DRUG	Acne		Antimon. crud., Arsenicum alb., Aur. met., Berber. aqui., Bovista, Carbo veg., Causticum, Chelidonium majus, Dulcamara, Graphites, Hepar sulph. calc., Hydrocotyle, Kali brom., Kali iod., Ledum, Lycopodium, Nux vom., Silicea, Sulphur iod., Zinc. met., Echinacea, Juglans regia, Lappa, Taraxacum	PELLET	ORAL	20181031		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC CATION (3+); CALCIUM SULFIDE; CAUSTICUM; CENTELLA ASIATICA; CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; ENGLISH WALNUT; GIANT PUFFBALL; GOLD; GRAPHITE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; MAHONIA AQUIFOLIUM ROOT BARK; POTASSIUM BROMIDE; POTASSIUM IODIDE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; TARAXACUM OFFICINALE; ZINC	15; 15; 6; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
55714-2386_9b8fbf3a-5c1e-db8f-e053-2995a90adc37	55714-2386	HUMAN OTC DRUG	Appetite - Craving Control		Anacardium orientale, Antimon.crud., Arg. nit., Berber. vulg., Bryonia, Chelidonium majus, Digitalis, Graphites, Humulus,Iris versicolor, Kali carb., Lycopodium, Nat. carb.,Nat. sulphuricum, Nux vom., Pulsatilla, Rhus. toxicodendron, Scutellaria lateriflora, Sepia,Stramonium, Chamomilla, Passiflora, Valeriana.	LIQUID	ORAL	20181029		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; DATURA STRAMONIUM; DIGITALIS; GRAPHITE; HOPS; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SCUTELLARIA LATERIFLORA; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2387_9b8f3c43-80eb-e2ba-e053-2995a90ab9a8	55714-2387	HUMAN OTC DRUG	Appetite - Craving Control		Anacardium orientale, Antimon.crud., Arg. nit., Berber. vulg., Bryonia, Chelidonium majus, Digitalis, Graphites, Humulus,Iris versicolor, Kali carb., Lycopodium, Nat. carb.,Nat. sulphuricum, Nux vom., Pulsatilla, Rhus. toxicodendron, Scutellaria lateriflora, Sepia,Stramonium, Chamomilla, Passiflora, Valeriana.	PELLET	ORAL	20181029		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; DATURA STRAMONIUM; DIGITALIS; GRAPHITE; HOPS; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SCUTELLARIA LATERIFLORA; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2388_b4de0dee-104c-e63f-e053-2995a90a7ba6	55714-2388	HUMAN OTC DRUG	Bladder - Kidney		Apis mel., Berber. vulg., Bryonia, Cantharis, Cinchona, Equisetum hyemale, Ferrum phosphoricum, Gelsemium, Juniperus com., Pareira, Phosphorus, Plantago, Pulsatilla, Sabal, Terebinthina, Uva-ursi, Echinacea, Hydrastis, Lappa, Solidago	LIQUID	ORAL	20180801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; JUNIPER BERRY; LYTTA VESICATORIA; PHOSPHORUS; PLANTAGO MAJOR; PULSATILLA VULGARIS; SAW PALMETTO; SOLIDAGO VIRGAUREA FLOWERING TOP; TURPENTINE	15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2389_b4de1feb-cd61-26b5-e053-2995a90a9270	55714-2389	HUMAN OTC DRUG	Bladder - Kidney		Apis mel., Berber. vulg., Bryonia, Cantharis, Cinchona, Equisetum hyemale, Ferrum phosphoricum, Gelsemium, Juniperus com., Pareira, Phosphorus, Plantago, Pulsatilla, Sabal, Terebinthina, Uva-ursi, Echinacea, Hydrastis, Lappa, Solidago	PELLET	ORAL	20181030		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; JUNIPER BERRY; LYTTA VESICATORIA; PHOSPHORUS; PLANTAGO MAJOR; PULSATILLA VULGARIS; SAW PALMETTO; SOLIDAGO VIRGAUREA FLOWERING TOP; TURPENTINE	15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2390_b4df5511-fb26-4c08-e053-2995a90af434	55714-2390	HUMAN OTC DRUG	Blues - Mood - Emotions		Angelica sinensis radix, Aralia quinquefolia, Arg. nit., Arsenicum alb., Berber. aqui., Capsicum , Cinchona, Digitalis, Gelsemium, Hypericum, Ignatia, Iodium, Kali brom., Kali carb., Mag. phos., Nat. carb., Nat. mur., Phosphorus, Salix nigra, Sanguinaria, Sepia, Stramonium, Echinacea, Ginkgo	LIQUID	ORAL	20181031		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; CAPSICUM; CINCHONA OFFICINALIS BARK; DATURA STRAMONIUM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HYPERICUM PERFORATUM; IODINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MAHONIA AQUIFOLIUM ROOT BARK; PHOSPHORUS; POTASSIUM BROMIDE; POTASSIUM CARBONATE; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
55714-2391_b4df5c52-9e6b-13e7-e053-2995a90abbca	55714-2391	HUMAN OTC DRUG	Blues - Mood - Emotions		Angelica sinensis radix, Aralia quinquefolia, Arg. nit., Arsenicum alb., Berber. aqui., Capsicum , Cinchona, Digitalis, Gelsemium, Hypericum, Ignatia, Iodium, Kali brom., Kali carb., Mag. phos., Nat. carb., Nat. mur., Phosphorus, Salix nigra, Sanguinaria, Sepia, Stramonium, Echinacea, Ginkgo	PELLET	ORAL	20181031		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; CAPSICUM; CINCHONA OFFICINALIS BARK; DATURA STRAMONIUM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HYPERICUM PERFORATUM; IODINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MAHONIA AQUIFOLIUM ROOT BARK; PHOSPHORUS; POTASSIUM BROMIDE; POTASSIUM CARBONATE; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
55714-2394_b4df8965-99b3-4349-e053-2a95a90a5e3c	55714-2394	HUMAN OTC DRUG	Breast Care		Bufo rana, Apis mel., Asterias rubens, Belladonna, Bryonia, Calc. carb., Chamomilla, Chimaphila umbellata, Cinchona, Conium, Croton, Echinacea, Graphites, Helonias dioica, Lachesis, Merc. viv., Phellandrium aquaticum Phosphorus, Phytolacca, Pulsatilla, Sanguinaria, Silicea, Hamamelis, Ruta, Taraxacum	LIQUID	ORAL	20181105		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ASTERIAS RUBENS; ATROPA BELLADONNA; BRYONIA ALBA ROOT; BUFO BUFO CUTANEOUS GLAND; CHAMAELIRIUM LUTEUM ROOT; CHIMAPHILA UMBELLATA; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; CROTON TIGLIUM SEED; ECHINACEA, UNSPECIFIED; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LACHESIS MUTA VENOM; MATRICARIA RECUTITA; MERCURY; OENANTHE AQUATICA FRUIT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; RUTA GRAVEOLENS FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2396_b4e04b20-bbf4-5eae-e053-2995a90a7e49	55714-2396	HUMAN OTC DRUG	Bug Bites - Itch Stopper		Pyrogenium, Apis mel., Aranea diadema, Arnica, Arsenicum alb., Azadirachta indica, Bryonia, Caladium seguinum, Calendula, Formica, Grindelia, Hypericum, Lachesis, Latrodectus mactans, Ledum, Mezereum, Nux vom., Pulex irritans, Rhus toxicodendron, Tarentula cubensis, Tarentula hispana, Theridion, Thuja occ., Vespa crabro, Echinacea, Hamamelis, Solidago	LIQUID	ORAL	20181105		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARANEUS DIADEMATUS; ARNICA MONTANA; ARSENIC TRIOXIDE; AZADIRACHTA INDICA BARK; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CITHARACANTHUS SPINICRUS; DAPHNE MEZEREUM BARK; DIEFFENBACHIA SEGUINE; ECHINACEA, UNSPECIFIED; FORMICA RUFA; GRINDELIA HIRSUTULA FLOWERING TOP; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; LYCOSA TARANTULA; PULEX IRRITANS; RANCID BEEF; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VESPA CRABRO	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 6; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2402_9b926809-65dc-4e5b-e053-2995a90add10	55714-2402	HUMAN OTC DRUG	Cell Salts		Calc. fluor., Calc. phos., Calc.sulph., Ferrum phosphoricum, Kali mur., Kali phos., Kali sulph., Mag. phos., Nat. mur., Nat. phos., Nat.sulphuricum, Silicea	LIQUID	ORAL	20181107		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-2403_b4e08832-b3db-58cd-e053-2a95a90ab14b	55714-2403	HUMAN OTC DRUG	Cell Salts		Calc. fluor., Calc. phos., Calc.sulph., Ferrum phosphoricum, Kali mur., Kali phos., Kali sulph., Mag. phos., Nat. mur., Nat. phos., Nat.sulphuricum, Silicea	PELLET	ORAL	20181107		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-2404_b4e0ae97-f187-58c9-e053-2a95a90a0da2	55714-2404	HUMAN OTC DRUG	Cold Hands - Feet		Histaminum hydrochloricum,Thyroidinum, Aconitum nap., Arsenicum alb., Bryonia, Cactus, Calc. fluor., Ceanothus, Cinchona, Convallaria, Digitalis, Gelsemium, Glonoinum, Hydrocoyle, Kali carb., Lachesis, Naja, nat carb., Nat mur., Nux vom., Phosphorus, Pullsatilla, Rhus toxicodendron, Strophanthus hispidus, Sulphur, Echinacea	LIQUID	ORAL	20181108		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CEANOTHUS AMERICANUS LEAF; CENTELLA ASIATICA; CINCHONA OFFICINALIS BARK; CONVALLARIA MAJALIS; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; LACHESIS MUTA VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SELENICEREUS GRANDIFLORUS STEM; SODIUM CARBONATE; SODIUM CHLORIDE; STROPHANTHUS HISPIDUS SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-2406_da713283-6759-5474-e053-2a95a90a70d4	55714-2406	HUMAN OTC DRUG	Cold - Sinus		Influenza A Virus, Influenza B Virus, Aralia quinquefolia, Arsenicum alb., Bryonia, Euphrasia, Gaultheria procubens, Gelsemium, Hepar sulph. calc., Histaminum hydrochloricum, Hydrastis, Kali bic., Merc. viv., Phosphorus, Pulsatilla, Rhus toxicodendron, Sabadilla, Salvia, Sticta, Verbascum, Echinacea	LIQUID	ORAL	20181109		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GAULTHERIA PROCUMBENS TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LOBARIA PULMONARIA; MERCURY; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SAGE; SCHOENOCAULON OFFICINALE SEED; SINUSITISINUM; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55714-2407_da707e07-9b58-6423-e053-2995a90a33b3	55714-2407	HUMAN OTC DRUG	Cold - Sinus		Influenza A Virus, Influenza B Virus, Aralia quinquefolia, Arsenicum alb., Bryonia, Euphrasia, Gaultheria procubens, Gelsemium, Hepar sulph. calc., Histaminum hydrochloricum, Hydrastis, Kali bic., Merc. viv., Phosphorus, Pulsatilla, Rhus toxicodendron, Sabadilla, Salvia, Sticta, Verbascum, Echinacea	PELLET	ORAL	20181109		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GAULTHERIA PROCUMBENS TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LOBARIA PULMONARIA; MERCURY; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SAGE; SCHOENOCAULON OFFICINALE SEED; SINUSITISINUM; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15	[hp_X]/g; [hp_C]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55714-2408_9b953128-5502-1926-e053-2a95a90aa0d2	55714-2408	HUMAN OTC DRUG	Cold Sores		Arsenicum alb., Bryonia, Cantharis, Chelidonium majus, Cistus canadensis, Conium, Croton, Dulcamara, Graphites, Kali bic., Lycopodium, Mezereum, Nux vom., Petroleum, Pulsatilla, Ranunc. bulb., Rhus toxicodendron, Sarsaparilla, Sepia, Sulphur, Thuja occ., Echinacea, Hypericum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; HELIANTHEMUM CANADENSE; HYPERICUM PERFORATUM; KEROSENE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; POTASSIUM DICHROMATE; RANUNCULUS BULBOSUS; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2412_b4e15f8c-3af4-71fe-e053-2a95a90a003e	55714-2412	HUMAN OTC DRUG	Constipation		Abies nig., Aesculus hipp., Aloe, Alumina, Bryonia, Carbo veg., Chelidonium majus, Collinsonia , Graphites, Hydrastis, Kali carb., Lycopodium, Mag. mur., Mezereum, Nux vom., Podoph. pelt., Rhamnus purshiana, Sanicula, Selenium, Sepia, Silicea, Tabacum, Veratrum alb., Zinc.met., Echinacea, Iris versicolor, Phytolacca, Taraxacum	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLLINSONIA CANADENSIS ROOT; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; FRANGULA PURSHIANA BARK; GOLDENSEAL; GRAPHITE; HORSE CHESTNUT; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; PHYTOLACCA AMERICANA ROOT; PICEA MARIANA RESIN; PODOPHYLLUM; POTASSIUM CARBONATE; SANICULA EUROPAEA LEAF; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; VERATRUM ALBUM ROOT; ZINC	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-2413_b4e15f8c-3af7-71fe-e053-2a95a90a003e	55714-2413	HUMAN OTC DRUG	Constipation		Abies nig., Aesculus hipp., Aloe, Alumina, Bryonia, Carbo veg., Chelidonium majus, Collinsonia , Graphites, Hydrastis, Kali carb., Lycopodium, Mag. mur., Mezereum, Nux vom., Podoph. pelt., Rhamnus purshiana, Sanicula, Selenium, Sepia, Silicea, Tabacum, Veratrum alb., Zinc.met., Echinacea, Iris versicolor, Phytolacca, Taraxacum	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLLINSONIA CANADENSIS ROOT; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; FRANGULA PURSHIANA BARK; GOLDENSEAL; GRAPHITE; HORSE CHESTNUT; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; PHYTOLACCA AMERICANA ROOT; PICEA MARIANA RESIN; PODOPHYLLUM; POTASSIUM CARBONATE; SANICULA EUROPAEA LEAF; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; VERATRUM ALBUM ROOT; ZINC	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-2414_da7041b6-092f-6531-e053-2995a90a712d	55714-2414	HUMAN OTC DRUG	Cough - Airway		Influenza A Virus, Influenza B Virus, Antimon. tart., Arsenicum alb., Bryonia, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Histaminum hydrochloricum, Hydrastis, Kali bic., Kali carb.,Kali iod., Myrrha, Nat. sulphuricum, Nux vom., Phosphorus, Pulsatilla, Rumex crisp., Sambucus nig., Spongia, Tussilago farfara, Verbascum, Echinacea, Lappa	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ROTUNDIFOLIA FLOWERING TOP; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS LEAF; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2415_da704abd-4e5f-f32e-e053-2a95a90a2830	55714-2415	HUMAN OTC DRUG	Cough - Airway		Influenza A Virus, Influenza B Virus, Antimon. tart., Arsenicum alb., Bryonia, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Histaminum hydrochloricum, Hydrastis, Kali bic., Kali carb.,Kali iod., Myrrha, Nat. sulphuricum, Nux vom., Phosphorus, Pulsatilla, Rumex crisp., Sambucus nig., Spongia, Tussilago farfara, Verbascum, Echinacea, Lappa	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ROTUNDIFOLIA FLOWERING TOP; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS LEAF; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2416_9ba83571-3554-d31f-e053-2a95a90a6efd	55714-2416	HUMAN OTC DRUG	Dairy-Grain-Nightshades		Iris vers., Solidago, Antimon. crud., Arg. nit., Arsenicum alb., Avena, Baptisia, Belladonna, Bryonia, Capsicum, Carduus ben., Cinchona, Dulcamara, Fagopyrum, Gelsemium, Hyoscyamus, Ipecac., Lac vac., Lachesis, Lycopodium, Nat. mur., Phos., Podoph. pelt., Pulsatilla, Rhus tox., Sac. lac., Secale, Sepia, Stramonium, Tabacum, Triticum, Ustilago maidis, Verbascum, Lycopersicum, Solanum nig., Solanum tub., Stigmata, Torula cerevisiae.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAPSICUM; CENTAUREA BENEDICTA; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; CORN SILK; COW MILK; DATURA STRAMONIUM; ELYMUS REPENS ROOT; FAGOPYRUM ESCULENTUM; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; IPECAC; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LACTOSE, UNSPECIFIED FORM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PODOPHYLLUM; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SOLIDAGO VIRGAUREA FLOWERING TOP; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; USTILAGO MAYDIS; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 16; 16; 16; 6; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2419_b4e1c678-878e-07b1-e053-2a95a90a909e	55714-2419	HUMAN OTC DRUG	Detoxifier		Uricum acidum, Benzoicum acidum, Berber. vulg., Bryonia, Cantharis, Carduus benedictus, Ceanothus, Chelidonium majus, Chionanthus virginica, Cinchona, Dioscorea, Dolichos, Iris versicolor, Juniperus com., Nux vom.,Ptelea,Taraxacum, Carduus mar., Cynara scolymus, Solidago	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SILYBUM MARIANUM SEED; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	10; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 10; 10; 10; 10; 10; 6; 15; 10; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2420_b4f0a92e-e0c8-822a-e053-2995a90a4087	55714-2420	HUMAN OTC DRUG	Diarrhea		Pyrogenium, Aconitum nap., Arg. nit., Arsenicum alb., Baptisia, Bryonia, Carbo veg., Chamomilla, Cinchona, Collinsonia, Colocynthis, Elaterium, Gelsemium, Ipecac., Iris versicolor, Lycopodium, Podoph. pelt., Raphanus, Tabacum, Vaccinium, Zingiber, Aesculus hipp., Juglans regia	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BILBERRY; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; COLLINSONIA CANADENSIS ROOT; ECBALLIUM ELATERIUM FRUIT; ENGLISH WALNUT; GELSEMIUM SEMPERVIRENS ROOT; GINGER; HORSE CHESTNUT; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; PODOPHYLLUM; RADISH; RANCID BEEF; SILVER NITRATE; TOBACCO LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2422_9ba990cb-3b69-15b5-e053-2a95a90aa0bd	55714-2422	HUMAN OTC DRUG	Dust-Mold-Dander		Iris versicolor, Solidago virgaurea, Antimonium crudum, Apis mellifica, Arsenicum album, Baptisia tinctoria, Blatta orientalis, Bromium, Bryonia, Candida albicans, Carduus benedictus, Cat hair, Chelidonium majus, Cinchona officinalis, Dog hair, Histaminum hydrochloricum, House dust, Ipecacuanha, Lycopodium clavatum, Nux vomica, Podophyllum peltatum, Rhus toxicodendron, Secale cornutum, Silicea, Ustilago maidis, Torula cerevisiae.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BLATTA ORIENTALIS; BROMINE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CANIS LUPUS FAMILIARIS HAIR; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; FELIS CATUS HAIR; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; PODOPHYLLUM; SACCHAROMYCES CEREVISIAE; SILICON DIOXIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; USTILAGO MAYDIS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 16; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dander [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2423_9bb84bd2-87dc-ed3e-e053-2a95a90ad1b3	55714-2423	HUMAN OTC DRUG	Dust-Mold-Dander		Iris versicolor, Solidago virgaurea, Antimonium crudum, Apis mellifica, Arsenicum album, Baptisia tinctoria, Blatta orientalis, Bromium, Bryonia, Candida albicans, Carduus benedictus, Cat hair, Chelidonium majus, Cinchona officinalis, Dog hair, Histaminum hydrochloricum, House dust, Ipecacuanha, Lycopodium clavatum, Nux vomica, Podophyllum peltatum, Rhus toxicodendron, Secale cornutum, Silicea, Ustilago maidis, Torula cerevisiae.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BLATTA ORIENTALIS; BROMINE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CANIS LUPUS FAMILIARIS HAIR; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; FELIS CATUS HAIR; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; PODOPHYLLUM; SACCHAROMYCES CEREVISIAE; SILICON DIOXIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; USTILAGO MAYDIS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 16; 15; 6; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dander [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2426_9bb95991-6f82-9f63-e053-2a95a90a7073	55714-2426	HUMAN OTC DRUG	Ear Ringing		Aconitum nap., Baryta carb., Baryta mur., Capsicum, Causticum, Chenopodium anthelminticum, Chininum sulphuricum, Cinchona, Glonoinum, Graphites, Hydrastis, Kali bic., Kali mur., Lycopodium, Phosphorus, Pulsatilla, Salicylicum ac., Tabacum, Thiosinaminum, Viola odorata	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALLYLTHIOUREA; BARIUM CARBONATE; BARIUM CHLORIDE DIHYDRATE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; DYSPHANIA AMBROSIOIDES; GOLDENSEAL; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; QUININE SULFATE; SALICYLIC ACID; TOBACCO LEAF; VIOLA ODORATA	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
55714-2427_b4f49f06-d9f7-0d09-e053-2a95a90ac5f0	55714-2427	HUMAN OTC DRUG	Ear Ringing		Aconitum nap., Baryta carb., Baryta mur., Capsicum, Causticum, Chenopodium anthelminticum, Chininum sulphuricum, Cinchona, Glonoinum, Graphites, Hydrastis, Kali bic., Kali mur., Lycopodium, Phosphorus, Pulsatilla, Salicylicum ac., Tabacum, Thiosinaminum, Viola odorata	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALLYLTHIOUREA; BARIUM CARBONATE; BARIUM CHLORIDE DIHYDRATE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; DYSPHANIA AMBROSIOIDES; GOLDENSEAL; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; QUININE SULFATE; SALICYLIC ACID; TOBACCO LEAF; VIOLA ODORATA	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
55714-2428_9b407e15-ff54-d803-e053-2995a90ae7c5	55714-2428	HUMAN OTC DRUG	Ear Wax Build-Up		Elaps corallinus, Alumina, Carbo veg., Causticum, Conium, Graphites, Kali bic.,Kali mur., Lachesis, Lycopodium, Petroleum, Pulsatilla, Sabadilla, Sepia, Silicea, Spongia, Verbascum, Viola odorata	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALUMINUM OXIDE; CAUSTICUM; CONIUM MACULATUM FLOWERING TOP; GRAPHITE; LACHESIS MUTA VENOM; LIQUID PETROLEUM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SCHOENOCAULON OFFICINALE SEED; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; VERBASCUM THAPSUS; VIOLA ODORATA	15; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
55714-2430_9bba1eb0-f411-2ce6-e053-2a95a90a9aa8	55714-2430	HUMAN OTC DRUG	Eczema - Skin Care		Antimon. crud., Arsenicum alb., Berber. vulg., Bovista, Bryonia, Cantharis, Chelidonium majus, Croton, Dulcamara, Graphites, Hepar sulph. calc., Lycopodium, Mezereum, Nux vom., Petroleum, Pulex irritans, Pulsatilla, Rhus toxicodendron, Sarsaparilla, Sepia, Sulphur iod., Echinacea, Rumex crisp., Taraxacum, Urtica ur.	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GIANT PUFFBALL; GRAPHITE; KEROSENE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULEX IRRITANS; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SARSAPARILLA; SEPIA OFFICINALIS JUICE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2431_b4f5467e-5f76-768f-e053-2995a90aed48	55714-2431	HUMAN OTC DRUG	Eczema - Skin Care		Antimon. crud., Arsenicum alb., Berber. vulg., Bovista, Bryonia, Cantharis, Chelidonium majus, Croton, Dulcamara, Graphites, Hepar sulph. calc., Lycopodium, Mezereum, Nux vom., Petroleum, Pulex irritans, Pulsatilla, Rhus toxicodendron, Sarsaparilla, Sepia, Sulphur iod., Echinacea, Rumex crisp., Taraxacum, Urtica ur.	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GIANT PUFFBALL; GRAPHITE; KEROSENE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULEX IRRITANS; PULSATILLA VULGARIS; RUMEX CRISPUS ROOT; SARSAPARILLA; SEPIA OFFICINALIS JUICE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2432_b4f57520-e5e4-8c3e-e053-2995a90ab38b	55714-2432	HUMAN OTC DRUG	Edema - Fluid Retention		Elaps corallinus, Apis mel., Arsenicum alb., Cantharis, Cinchona, Colchicum, Convallaria, Crotalus horridus, Digitalis, Juniperus com., Lachesis, Merc. viv., Naja, Nat. carb., Nat.sulphuricum, Rhus toxicodendron, Sambucus nig., Strophanthus hispidus, Thuja occ., Vipera berus, Echinacea, Lappa, Solidago, Taraxacum, Urtica ur.	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; JUNIPER BERRY; LACHESIS MUTA VENOM; LYTTA VESICATORIA; MERCURY; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; SAMBUCUS NIGRA FLOWERING TOP; SODIUM CARBONATE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STROPHANTHUS HISPIDUS SEED; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; VIPERA BERUS VENOM	15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 30; 15; 15; 15; 15; 6; 15; 6; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2434_b4f4bf9f-d252-a951-e053-2a95a90ad028	55714-2434	HUMAN OTC DRUG	Eye Care		Aconitum nap., Allium cepa, Arsenicum alb., Bryonia, Calendula, Chelidonium majus, Cineraria, Euphrasia, Graphites, Lycopodium, Merc. corros., Nux vom., Phosphorus, Phytolacca, Picricum ac., Pulsatilla, Rhus toxicodendron, Sulphur, Echinacea	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GRAPHITE; JACOBAEA MARITIMA; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; ONION; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PICRIC ACID; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED; SULFUR; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2435_b4f4bf9f-d255-a951-e053-2a95a90ad028	55714-2435	HUMAN OTC DRUG	Eye Care		Aconitum nap., Allium cepa, Arsenicum alb., Bryonia, Calendula, Chelidonium majus, Cineraria, Euphrasia, Graphites, Lycopodium, Merc. corros., Nux vom., Phosphorus, Phytolacca, Picricum ac., Pulsatilla, Rhus toxicodendron, Sulphur, Echinacea	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GRAPHITE; JACOBAEA MARITIMA; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; ONION; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PICRIC ACID; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED; SULFUR; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2436_b4f4a598-017c-7ad0-e053-2a95a90a421a	55714-2436	HUMAN OTC DRUG	Fatigue Fighter		Aconitum nap., Adrenalinum, Aralia quinquefolia, Arnica, Arsenicum alb., Baptisia, Bryonia, Cantharis, Chelidonium majus, Cinchona, Iodium, Kali carb., Kali iod., Lachesis, Lycopodium, Lycopus virginicus, Nat. mur., Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Sabal, Thyroidinum, Echinacea, Gingko, Phytolacca.	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ANEMONE PULSATILLA; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; POTASSIUM IODIDE; SAW PALMETTO; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2437_b4f4df3b-ef67-f287-e053-2995a90a9f50	55714-2437	HUMAN OTC DRUG	Fatigue Fighter		Aconitum nap., Adrenalinum, Aralia quinquefolia, Arnica, Arsenicum alb., Baptisia, Bryonia, Cantharis, Chelidonium majus, Cinchona, Iodium, Kali carb., Kali iod., Lachesis, Lycopodium, Lycopus virginicus, Nat. mur., Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Sabal, Thyroidinum, Echinacea, Gingko, Phytolacca.	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ANEMONE PULSATILLA; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; POTASSIUM IODIDE; SAW PALMETTO; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2438_b4f501d4-ae0b-a190-e053-2a95a90aae3a	55714-2438	HUMAN OTC DRUG	Feminine Comfort		Agaricus musc., Arsenicum alb., Aur. met., Berber. aqui., Caladium seguinum, Candida albicans, Cantharis, Conium, Graphites, Helonias dioica, Hydrastis, Kali carb., Kreosotum, Lycopodium, Merc. viv., Murex purpurea, Nat. mur., Nitricum ac., Pulsatilla, Rhus toxicodendron, Sepia, Sulphur, Tarentula hispana, Thuja occ., Zinc. met., Apis mel., Hamamelis	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; BERBERIS AQUIFOLIUM ROOT BARK; CANDIDA ALBICANS; CHAMAELIRIUM LUTEUM ROOT; CONIUM MACULATUM FLOWERING TOP; DIEFFENBACHIA SEGUINE; GOLD; GOLDENSEAL; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; LYTTA VESICATORIA; MERCURY; NITRIC ACID; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; WOOD CREOSOTE; ZINC	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2440_9bbd2635-7a31-3c39-e053-2a95a90a2cc9	55714-2440	HUMAN OTC DRUG	Fever - Infection		Anthracinum, Influenza A Virus, Influenza B Virus, Pyrogenium, Aconitum nap., Antimon. tart., Arnica, Arsenicum alb., Baptisia, Belladonna, Bryonia, Cantharis, Chamomilla, Cinchona, Eupatorium perf., Ferrum metallicum, Gelsemium, Hepar sulph.calc., Iodium, Lachesis, Merc. viv., Phosphorus, Pulsatilla, Rhus toxicodendron, Salix nigra, Verbascum, Apis mel., Echinacea, Hydrastis	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IODINE; IRON; LACHESIS MUTA VENOM; LYTTA VESICATORIA; MATRICARIA RECUTITA; MERCURY; PHOSPHORUS; PULSATILLA VULGARIS; RANCID BEEF; SALIX NIGRA BARK; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 30; 15; 15; 15; 15; 6; 15; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2441_9bbd57f3-5969-901d-e053-2995a90ad350	55714-2441	HUMAN OTC DRUG	Fever - Infection		Anthracinum, Influenza A Virus, Influenza B Virus, Pyrogenium, Aconitum nap., Antimon. tart., Arnica, Arsenicum alb., Baptisia, Belladonna, Bryonia, Cantharis, Chamomilla, Cinchona, Eupatorium perf., Ferrum metallicum, Gelsemium, Hepar sulph.calc., Iodium, Lachesis, Merc. viv., Phosphorus, Pulsatilla, Rhus toxicodendron, Salix nigra, Verbascum, Apis mel., Echinacea, Hydrastis	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IODINE; IRON; LACHESIS MUTA VENOM; LYTTA VESICATORIA; MATRICARIA RECUTITA; MERCURY; PHOSPHORUS; PULSATILLA VULGARIS; RANCID BEEF; SALIX NIGRA BARK; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 30; 15; 15; 15; 15; 6; 15; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2442_b4f59a58-af38-4835-e053-2995a90a7f38	55714-2442	HUMAN OTC DRUG	Flu Care		Influenza A Virus, Influenza B Virus, Histaminum hydrochloricum, Aconitum nap., Aralia quinquefolia, Arsenicum alb., Baptisia, Bryonia, Cinchona, Eupatorium perf., Gelsemium, Ipecac., Kali carb., Nux vom., Phosphorus, Rhus toxicodendron, Echinacea	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IPECAC; PHOSPHORUS; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	10; 10; 15; 10; 10; 10; 6; 10; 10; 15; 30; 30; 10; 10; 10; 15; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2443_b4f5a166-46a9-7a3a-e053-2a95a90a582f	55714-2443	HUMAN OTC DRUG	Flu Care		Influenza A Virus, Influenza B Virus, Histaminum hydrochloricum, Aconitum nap., Aralia quinquefolia, Arsenicum alb., Baptisia, Bryonia, Cinchona, Eupatorium perf., Gelsemium, Ipecac., Kali carb., Nux vom., Phosphorus, Rhus toxicodendron, Echinacea	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IPECAC; PHOSPHORUS; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	10; 10; 15; 10; 10; 10; 6; 10; 10; 15; 30; 30; 10; 10; 10; 15; 10	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2448_b556909e-c4c8-0dd2-e053-2a95a90add40	55714-2448	HUMAN OTC DRUG	Hair-Scalp		Apis mel., Arsenicum alb., Calc. carb., Dulcamara, Graphites, Hepar sulph. calc., Hydrastis, Hydrofluoricum acidum, Kali carb., Lycopodium, Mezereum, Oleander, Petroleum, Phosphoricum ac., Phosphorus, Rhus toxicodendron, Selenium, Sepia, Silicea, Sulphur, Thuja occ.	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; CALCIUM SULFIDE; DAPHNE MEZEREUM BARK; GOLDENSEAL; GRAPHITE; HYDROFLUORIC ACID; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NERIUM OLEANDER LEAF; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; POTASSIUM CARBONATE; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2450_9bcd43b4-68f5-3804-e053-2995a90a1ff7	55714-2450	HUMAN OTC DRUG	Hangover Help		Agaricus musc., Arsenicum alb., Bismuthum metallicum, Bryonia, Capsicum, Carbo veg., Glonoinum, Ipecac., Iris versicolor, Laurocerasus, Lycopodium, Mezereum, Nux vom., Pulsatilla, Ranunc. bulb. , Theridion, Veratrum alb., Zinc. met., Zingiber, Chamomilla, Passiflora, Valeriana	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BISMUTH; BRYONIA ALBA ROOT; CAPSICUM; DAPHNE MEZEREUM BARK; GINGER; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; NITROGLYCERIN; PASSIFLORA INCARNATA FLOWERING TOP; PRUNUS LAUROCERASUS LEAF; RANUNCULUS BULBOSUS; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; VALERIAN; VERATRUM ALBUM ROOT; ZINC	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
55714-2453_b557ee00-296b-1e4d-e053-2995a90a85b5	55714-2453	HUMAN OTC DRUG	Headache		Elaps corallinus, Arsenicum alb., Belladonna, Bryonia, Carduus benedictus, Cimicifuga, Coffea cruda, Convallaria, Crotalus horridus, Digitalis, Gelsemium, Glonoinum, Ignatia, Lachesis, Merc. viv., Naja, Nux vom., Phosphorus, Rhus toxicodendron, Sanguinaria, Secale, Vipera berus, Apis mel., Hypericum, Thuja occ..	LIQUID	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BLACK COHOSH; BRYONIA ALBA ROOT; CENTAUREA BENEDICTA; CLAVICEPS PURPUREA SCLEROTIUM; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; MERCURY; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; SANGUINARIA CANADENSIS ROOT; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VIPERA BERUS VENOM	6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 30; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vasodilation [PE]		N	20241231
55714-2454_b557fc03-864c-77b9-e053-2995a90a6352	55714-2454	HUMAN OTC DRUG	Headache		Elaps corallinus, Arsenicum alb., Belladonna, Bryonia, Carduus benedictus, Cimicifuga, Coffea cruda, Convallaria, Crotalus horridus, Digitalis, Gelsemium, Glonoinum, Ignatia, Lachesis, Merc. viv., Naja, Nux vom., Phosphorus, Rhus toxicodendron, Sanguinaria, Secale, Vipera berus, Apis mel., Hypericum, Thuja occ..	PELLET	ORAL	20190131		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BLACK COHOSH; BRYONIA ALBA ROOT; CENTAUREA BENEDICTA; CLAVICEPS PURPUREA SCLEROTIUM; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; MERCURY; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; SANGUINARIA CANADENSIS ROOT; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VIPERA BERUS VENOM	6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 30; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vasodilation [PE]		N	20241231
55714-2455_9bd03fbe-6e0d-6c26-e053-2995a90a7572	55714-2455	HUMAN OTC DRUG	Heavy Metal Detox		Allium sativum, Aluminium metallicum, Arg. met., Aur. met., Baryta carb., Beryllium metallicum, Bismuthum metallicum, Cadmium metallicum, Calc. fluor., Carbo veg., Chelidonium majus, Cinchona, Cobaltum met., Cuprum met., Glycyrrhiza glabra, Hydrofluoricum acidum, Iris versicolor, Manganum metallicum, Merc. viv., Niccolum metallicum, Osmium metallicum, Platinum met., Plumb. met., Stannum met., Strontium carb., Thallium metallicum, Titanium metallicum, Carduus mar., Taraxacum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALUMINUM; BARIUM CARBONATE; BERYLLIUM; BISMUTH; CADMIUM; CALCIUM FLUORIDE; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; COBALT; COPPER; GARLIC; GLYCYRRHIZA GLABRA; GOLD; HYDROFLUORIC ACID; IRIS VERSICOLOR ROOT; LEAD; MANGANESE; MERCURY; MILK THISTLE; NICKEL; OSMIUM; PLATINUM; SILVER; STRONTIUM CARBONATE; TARAXACUM OFFICINALE; THALLIUM; TIN; TITANIUM	15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 16; 6; 15; 15; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
55714-2456_9c07cc66-6a79-770a-e053-2a95a90a585c	55714-2456	HUMAN OTC DRUG	Heavy Metal Detox		Allium sativum, Aluminium metallicum, Arg. met., Aur. met., Baryta carb., Beryllium metallicum, Bismuthum metallicum, Cadmium metallicum, Calc. fluor., Carbo veg., Chelidonium majus, Cinchona, Cobaltum met., Cuprum met., Glycyrrhiza glabra, Hydrofluoricum acidum, Iris versicolor, Manganum metallicum, Merc. viv., Niccolum metallicum, Osmium metallicum, Platinum met., Plumb. met., Stannum met., Strontium carb., Thallium metallicum, Titanium metallicum, Carduus mar., Taraxacum	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALUMINUM; BARIUM CARBONATE; BERYLLIUM; BISMUTH; CADMIUM; CALCIUM FLUORIDE; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; COBALT; COPPER; GARLIC; GLYCYRRHIZA GLABRA; GOLD; HYDROFLUORIC ACID; IRIS VERSICOLOR ROOT; LEAD; MANGANESE; MERCURY; MILK THISTLE; NICKEL; OSMIUM; PLATINUM; SILVER; STRONTIUM CARBONATE; TARAXACUM OFFICINALE; THALLIUM; TIN; TITANIUM	15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 16; 6; 15; 15; 16	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
55714-2459_9c0a4d52-7d11-cc3b-e053-2a95a90a6697	55714-2459	HUMAN OTC DRUG	Hives-Rashes		Antimon. crud., Apis mel., Arsenicum alb., Berber. vulg., Bovista, Bryonia, Cantharis, Chelidonium majus, Croton, Dulcamara, Graphites, Histaminum hydrochloricum, Lycopodium, Mezereum, Nux vom., Petroleum, Pulex irritans, Pulsatilla, Rhus toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex crisp., Taraxacum, Urtica ur.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; KEROSENE; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULEX IRRITANS; RUMEX CRISPUS ROOT; SMILAX ORNATA ROOT; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2460_9c0a9375-d5f8-fe71-e053-2995a90a13b6	55714-2460	HUMAN OTC DRUG	Hives-Rashes		Antimon. crud., Apis mel., Arsenicum alb., Berber. vulg., Bovista, Bryonia, Cantharis, Chelidonium majus, Croton, Dulcamara, Graphites, Histaminum hydrochloricum, Lycopodium, Mezereum, Nux vom., Petroleum, Pulex irritans, Pulsatilla, Rhus toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex crisp., Taraxacum, Urtica ur.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; KEROSENE; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULEX IRRITANS; RUMEX CRISPUS ROOT; SMILAX ORNATA ROOT; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2462_9c0cafd4-d414-c765-e053-2995a90a968c	55714-2462	HUMAN OTC DRUG	Hyperactivity-Mental Focus		Adrenalinum, Tarentula cubensis, Aconitum nap., Arg. nit., Arsenicum alb., Baptisia, Chamomilla, Cypripedium, Digitalis, Gelsemium, Humulus, Ignatia, Impatiens glandulifera flos, Iodium, Lachesis, Lycopodium, Nat. mur., Nux vom., Scutellaria lateriflora, Staphysag., Stramonium, Theridion, Echinacea, Gingko, Hypericum, Passiflora	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CITHARACANTHUS SPINICRUS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HOPS; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2463_9c0cdcc5-5af7-3679-e053-2a95a90a8b0e	55714-2463	HUMAN OTC DRUG	Incontinence		Aloe, Arg. nit., Arsenicum alb., Belladonna, Benzoicum acidum, Bryonia, Cantharis, Causticum, Equisetum hyemale, Ferrum metallicum, Gelsemium, Ignatia, Kali phos., Lycopodium, Nat. mur., Nitricum ac., Plantago, Pulsatilla, Rhus aromatica , Sabal, Secale, Sepia, Staphysag.,Stramonium, Thyroidinum, Verbascum, Echinacea, Hydrastis	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CLAVICEPS PURPUREA SCLEROTIUM; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; IRON; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; NITRIC ACID; PLANTAGO MAJOR; POTASSIUM PHOSPHATE, DIBASIC; RHUS AROMATICA ROOT BARK; SAW PALMETTO; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; THYROID, UNSPECIFIED; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
55714-2464_9c0d859a-42e9-087c-e053-2995a90af15b	55714-2464	HUMAN OTC DRUG	Incontinence		Aloe, Arg. nit., Arsenicum alb., Belladonna, Benzoicum acidum, Bryonia, Cantharis, Causticum, Equisetum hyemale, Ferrum metallicum, Gelsemium, Ignatia, Kali phos., Lycopodium, Nat. mur., Nitricum ac., Plantago, Pulsatilla, Rhus aromatica , Sabal, Secale, Sepia, Staphysag.,Stramonium, Thyroidinum, Verbascum, Echinacea, Hydrastis	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CLAVICEPS PURPUREA SCLEROTIUM; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; IRON; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; NITRIC ACID; PLANTAGO MAJOR; POTASSIUM PHOSPHATE, DIBASIC; RHUS AROMATICA ROOT BARK; SAW PALMETTO; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; THYROID, UNSPECIFIED; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
55714-2465_9c1c1525-9753-275d-e053-2a95a90acf43	55714-2465	HUMAN OTC DRUG	Indigestion-Gas		Chamomilla, Echinacea, Iris versicolor, Ruta graveolens, Taraxacum officinale, Aloe, Angelica sinensis radix, Antimonium , Argentum nitricum, Arnica montana, Arsenicum album, Baptisia tinctoria, Bismuthum metallicum, Bryonia, Cinchona officinalis, Graphites, Hydrastis canadensis, Ipecacuanha, Lachesis mutus, Lycopodium clavatum, Myrrha, Natrum carbonicum, Nux vomica, Phosphorus, Pulsatilla, Zingiber officinale.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ANTIMONY TRISULFIDE; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; GINGER; GOLDENSEAL; GRAPHITE; IPECAC; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; MYRRH; PHOSPHORUS; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 6; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2466_9dc33c6a-5d55-4e77-e053-2995a90ab526	55714-2466	HUMAN OTC DRUG	Indigestion-Gas		Chamomilla, Echinacea, Iris versicolor, Ruta graveolens, Taraxacum officinale, Aloe, Angelica sinensis radix, Antimonium , Argentum nitricum, Arnica montana, Arsenicum album, Baptisia tinctoria, Bismuthum metallicum, Bryonia, Cinchona officinalis, Graphites, Hydrastis canadensis, Ipecacuanha, Lachesis mutus, Lycopodium clavatum, Myrrha, Natrum carbonicum, Nux vomica, Phosphorus, Pulsatilla, Zingiber officinale.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ANTIMONY TRISULFIDE; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; GINGER; GOLDENSEAL; GRAPHITE; IPECAC; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; MYRRH; PHOSPHORUS; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 6; 15; 15; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2467_9c1e6de7-75af-5fd6-e053-2995a90af4a1	55714-2467	HUMAN OTC DRUG	Inflammation		Anthracinum, Pyrogenium, Aconitum nap., Aloe, Apis mel., Arnica, Arsenicum alb., Baptisia, Belladonna, Bryonia, Cantharis, Chelidonium majus, Crotalus horridus, Ferrum phosphoricum, Gaultheria procumbens, Hepar sulph. calc., Iodium, Lachesis, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Veratrum viride, Verbascum, Echinacea	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALOE; ANEMONE PULSATILLA; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GAULTHERIA PROCUMBENS TOP; IODINE; LACHESIS MUTA VENOM; LYTTA VESICATORIA; PHOSPHORUS; RANCID BEEF; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VERATRUM VIRIDE ROOT; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2468_09436912-7807-a0e0-e063-6394a90ae8a2	55714-2468	HUMAN OTC DRUG	Inflammation		Anthracinum, Pyrogenium, Aconitum nap., Aloe, Apis mel., Arnica, Arsenicum alb., Baptisia, Belladonna, Bryonia, Cantharis, Chelidonium majus, Crotalus horridus, Ferrum phosphoricum, Gaultheria procumbens, Hepar sulph. calc., Iodium, Lachesis, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Veratrum viride, Verbascum, Echinacea	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALOE; ANEMONE PULSATILLA; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GAULTHERIA PROCUMBENS TOP; IODINE; LACHESIS MUTA VENOM; LYTTA VESICATORIA; PHOSPHORUS; RANCID BEEF; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VERATRUM VIRIDE ROOT; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2471_9c21c935-4ebd-1efd-e053-2995a90aa156	55714-2471	HUMAN OTC DRUG	Jet Lag		Echinacea, Alumina, Aralia quinquefolia, Argentum, Arnica montana, Arsenicum album, Baptisia tinctoria, Bryonia, Cantharis, Chelidonium majus, Conium maculatum, Gelsemium sempervirens, Iodium, Kali carbonicum, Kali iodatum, Lycopodium clavatum, Lycopus virginicus, Natrum muriaticum, Nux vomica, Phosphorus, Phytolacca decandra, Pulsatilla, Rhus toxicodendron, Sabal serrulata, Thyroidinum.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALUMINUM OXIDE; AMERICAN GINSENG; ANEMONE PULSATILLA; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; IODINE; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; POTASSIUM IODIDE; SAW PALMETTO; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2473_9c3150f1-d7b0-176d-e053-2995a90a9052	55714-2473	HUMAN OTC DRUG	Leg Cramps-Swelling		Echinacea, Argentum nitricum, Bryonia, Calcarea carbonica, Colocynthis, Convallaria majalis, Crotalus horridus, Cuprum metallicum, Digitalis , Gelsemium sempervirens, Hypericum perforatum, Kali carbonicum, Lachesis mutus, Lathyrus sativus, Lilium tigrinum, Magnesia phosphorica, Nux vomica, Rhus toxicodendron, Silicea, Stramonium, Veratrum viride, Elaps	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; CONVALLARIA MAJALIS; COPPER; CROTALUS HORRIDUS HORRIDUS VENOM; DATURA STRAMONIUM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LATHYRUS SATIVAS SEED; LILIUM LANCIFOLIUM WHOLE FLOWERING; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MICRURUS CORALLINUS VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; SILICON DIOXIDE; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VERATRUM VIRIDE ROOT	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-2474_09425ade-9c7f-ca75-e063-6294a90a8c9a	55714-2474	HUMAN OTC DRUG	Leg Cramps-Swelling		Echinacea, Argentum nitricum, Bryonia, Calcarea carbonica, Colocynthis, Convallaria majalis, Crotalus horridus, Cuprum metallicum, Digitalis , Gelsemium sempervirens, Hypericum perforatum, Kali carbonicum, Lachesis mutus, Lathyrus sativus, Lilium tigrinum, Magnesia phosphorica, Nux vomica, Rhus toxicodendron, Silicea, Stramonium, Veratrum viride, Elaps	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; CONVALLARIA MAJALIS; COPPER; CROTALUS HORRIDUS HORRIDUS VENOM; DATURA STRAMONIUM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LATHYRUS SATIVAS SEED; LILIUM LANCIFOLIUM WHOLE FLOWERING; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MICRURUS CORALLINUS VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; SILICON DIOXIDE; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VERATRUM VIRIDE ROOT	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-2475_9c336389-41c9-64de-e053-2995a90aca7a	55714-2475	HUMAN OTC DRUG	Libido		Hydrastis canadensis, Thuja occidentalis, Agnus castus, Aralia quinquefolia, Baryta carbonica, Berberis vulgaris, Bryonia, Caladium seguinum, Cantharis, Causticum, Chelidonium majus, Cinchona officinalis, Conium maculatum, Gaultheria procumbens, Graphites, Kali carbonicum, Lycopodium clavatum, Nux vomica, Onosmodium virginianum, Phosphorus, Sabal serrulata, Selenium metallicum, Sepia, Silicea, Staphysagria	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CAUSTICUM; CHASTE TREE FRUIT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; GAULTHERIA PROCUMBENS TOP; GOLDENSEAL; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; ONOSMODIUM VIRGINIANUM; PHOSPHORUS; POTASSIUM CARBONATE; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2476_9c3488de-bf4f-0152-e053-2995a90a6780	55714-2476	HUMAN OTC DRUG	Libido		Hydrastis canadensis, Thuja occidentalis, Agnus castus, Aralia quinquefolia, Baryta carbonica, Berberis vulgaris, Bryonia, Caladium seguinum, Cantharis, Causticum, Chelidonium majus, Cinchona officinalis, Conium maculatum, Gaultheria procumbens, Graphites, Kali carbonicum, Lycopodium clavatum, Nux vomica, Onosmodium virginianum, Phosphorus, Sabal serrulata, Selenium metallicum, Sepia, Silicea, Staphysagria	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CAUSTICUM; CHASTE TREE FRUIT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; GAULTHERIA PROCUMBENS TOP; GOLDENSEAL; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; ONOSMODIUM VIRGINIANUM; PHOSPHORUS; POTASSIUM CARBONATE; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2477_9c353bf9-ca89-7db6-e053-2995a90a0de9	55714-2477	HUMAN OTC DRUG	Lymphatic Care		Echinacea, Solidago, Taraxacum, Asterias, Aur. met., Belladonna, Benzoicum ac., Berber. vulg., Bryonia, Calc. carb., Cantharis, Carduus mar., Ceanothus, Chelidonium maj., Chionanthus, Cinchona, Dioscorea, Iris vers., Nat. carb., Nux vom., Ptelea..	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ASTERIAS RUBENS; ATROPA BELLADONNA; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; DIOSCOREA VILLOSA TUBER; ECHINACEA, UNSPECIFIED; GOLD; IRIS VERSICOLOR ROOT; LYTTA VESICATORIA; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PTELEA TRIFOLIATA BARK; SODIUM CARBONATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	10; 15; 10; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 10; 10; 10; 10; 10; 6; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
55714-2478_9c36201a-2154-0600-e053-2995a90a6bbf	55714-2478	HUMAN OTC DRUG	Lymphatic Care		Echinacea, Solidago, Taraxacum, Asterias, Aur. met., Belladonna, Benzoicum ac., Berber. vulg., Bryonia, Calc. carb., Cantharis, Carduus mar., Ceanothus, Chelidonium maj., Chionanthus, Cinchona, Dioscorea, Iris vers., Nat. carb., Nux vom., Ptelea..	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ASTERIAS RUBENS; ATROPA BELLADONNA; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; DIOSCOREA VILLOSA TUBER; ECHINACEA, UNSPECIFIED; GOLD; IRIS VERSICOLOR ROOT; LYTTA VESICATORIA; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PTELEA TRIFOLIATA BARK; SODIUM CARBONATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	10; 15; 10; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 10; 10; 10; 10; 10; 6; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
55714-2479_9c470baa-87c3-53d2-e053-2a95a90a364b	55714-2479	HUMAN OTC DRUG	Menopause		Elaps corallinus, Agnus, Angelica sinensis radix, Arsenicum alb., Bryonia, Cantharis, Caulophyllum, Cimicifuga, Cinchona, Crotalus horridus, Damiana, Glonoinum, Helonias dioica, Ignatia, Kali carb., Lachesis, Naja, Nux vom., Phosphorus, Pulsatilla, Salix nigra, Sanguinaria, Sepia, Echinacea, Valeriana	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA ROOT; CAULOPHYLLUM THALICTROIDES ROOT; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; LACHESIS MUTA VENOM; LYTTA VESICATORIA; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; POTASSIUM CARBONATE; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TURNERA DIFFUSA LEAFY TWIG; VALERIAN	10; 10; 15; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 30; 10; 10; 10; 10; 10; 10; 10; 10; 15; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-2480_9c4879c5-468b-c2da-e053-2a95a90ace24	55714-2480	HUMAN OTC DRUG	Menopause		Elaps corallinus, Agnus, Angelica sinensis radix, Arsenicum alb., Bryonia, Cantharis, Caulophyllum, Cimicifuga, Cinchona, Crotalus horridus, Damiana, Glonoinum, Helonias dioica, Ignatia, Kali carb., Lachesis, Naja, Nux vom., Phosphorus, Pulsatilla, Salix nigra, Sanguinaria, Sepia, Echinacea, Valeriana	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA ROOT; CAULOPHYLLUM THALICTROIDES ROOT; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; LACHESIS MUTA VENOM; LYTTA VESICATORIA; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; POTASSIUM CARBONATE; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TURNERA DIFFUSA LEAFY TWIG; VALERIAN	10; 10; 15; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 30; 10; 10; 10; 10; 10; 10; 10; 10; 15; 10; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-2481_9c49666c-3409-47e6-e053-2a95a90ad7a5	55714-2481	HUMAN OTC DRUG	Menstrual - PMS		Angelica sinensis radix, Arsenicum alb., Bryonia, Caulophyllum, Cimicifuga, Cinchona, Dioscorea, Folliculinum, Gelsemium, Lachesis, Lilium, Lycopodium, Millefolium, Nux vom., Pulsatilla, Sabina, Secale, Sepia,Thlaspi, Viburnum op., Zingiber, Echinacea, Valeriana	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACHILLEA MILLEFOLIUM; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA ROOT; CAPSELLA BURSA-PASTORIS; CAULOPHYLLUM THALICTROIDES ROOT; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; DIOSCOREA VILLOSA TUBER; ECHINACEA, UNSPECIFIED; ESTRONE; GELSEMIUM SEMPERVIRENS ROOT; GINGER; JUNIPERUS SABINA LEAFY TWIG; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; VALERIAN; VIBURNUM OPULUS BARK	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2482_092fe390-ff03-13f2-e063-6394a90a5221	55714-2482	HUMAN OTC DRUG	Menstrual - PMS		Angelica sinensis radix, Arsenicum alb., Bryonia, Caulophyllum, Cimicifuga, Cinchona, Dioscorea, Folliculinum, Gelsemium, Lachesis, Lilium, Lycopodium, Millefolium, Nux vom., Pulsatilla, Sabina, Secale, Sepia,Thlaspi, Viburnum op., Zingiber, Echinacea, Valeriana	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACHILLEA MILLEFOLIUM; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA ROOT; CAPSELLA BURSA-PASTORIS; CAULOPHYLLUM THALICTROIDES ROOT; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; DIOSCOREA VILLOSA TUBER; ECHINACEA, UNSPECIFIED; ESTRONE; GELSEMIUM SEMPERVIRENS ROOT; GINGER; JUNIPERUS SABINA LEAFY TWIG; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; VALERIAN; VIBURNUM OPULUS BARK	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2483_9c4a4f6d-b0eb-4420-e053-2a95a90a048d	55714-2483	HUMAN OTC DRUG	Morning Sickness-Nausea		Chamomilla, Hydrastis canadensis, Iris versicolor, Bismuthum metallicum, Bryonia, Cimicifuga racemosa, Gossypium herbaceum, Ipecacuanha, Kreosotum, Lycopodium clavatum, Magnesia carbonica, Nux vomica, Pulsatilla, Sepia, Symphoricarpus racemosus, Tabacum, Zingiber officinale.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; BISMUTH; BLACK COHOSH; BRYONIA ALBA ROOT; GINGER; GOLDENSEAL; GOSSYPIUM HERBACEUM ROOT BARK; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SYMPHORICARPOS ALBUS FRUIT; TOBACCO LEAF; WOOD CREOSOTE	15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2485_9c5a9555-ba18-7ea5-e053-2a95a90a10ec	55714-2485	HUMAN OTC DRUG	Motion Sickness		Echinacea, Hypericum perforatum, Passiflora incarnata, Valeriana officinalis, Absinthium, Aconitum napellus, Antimonium tartaricum, Belladonna, Bryonia, Carbolicum acidum, Colchicum autumnale, Conium maculatum, Ferrum metallicum, Gelsemium sempervirens, Glonoinum, Hyoscyamus niger, Ipecacuanha, Iris versicolor, Lycopodium clavatum, Nux vomica, Petroleum, Phosphorus, Sepia, Symphoricarpus racemosus, Tabacum, Theridion, Zingiber officinale.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINGER; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; IPECAC; IRIS VERSICOLOR ROOT; IRON; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; PASSIFLORA INCARNATA FLOWERING TOP; PHENOL; PHOSPHORUS; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SYMPHORICARPOS ALBUS FRUIT; THERIDION CURASSAVICUM; TOBACCO LEAF; VALERIAN; WORMWOOD	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-2486_9c5a4018-0232-e92b-e053-2995a90a4016	55714-2486	HUMAN OTC DRUG	Motion Sickness		Echinacea, Hypericum perforatum, Passiflora incarnata, Valeriana officinalis, Absinthium, Aconitum napellus, Antimonium tartaricum, Belladonna, Bryonia, Carbolicum acidum, Colchicum autumnale, Conium maculatum, Ferrum metallicum, Gelsemium sempervirens, Glonoinum, Hyoscyamus niger, Ipecacuanha, Iris versicolor, Lycopodium clavatum, Nux vomica, Petroleum, Phosphorus, Sepia, Symphoricarpus racemosus, Tabacum, Theridion, Zingiber officinale.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINGER; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; IPECAC; IRIS VERSICOLOR ROOT; IRON; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; PASSIFLORA INCARNATA FLOWERING TOP; PHENOL; PHOSPHORUS; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SYMPHORICARPOS ALBUS FRUIT; THERIDION CURASSAVICUM; TOBACCO LEAF; VALERIAN; WORMWOOD	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-2487_9c5c735f-5842-37d1-e053-2995a90ae48c	55714-2487	HUMAN OTC DRUG	Muscle Ease		Chamomilla, Phytolacca decandra, Ruta graveolens, Symphytum officinale, Aconitum napellus, Antimonium tartaricum, Argentum nitricum, Arnica montana, Bryonia, Chamomilla, Chelidonium majus, Cimicifuga racemosa, Eupatorium perfoliatum, Hypericum perforatum, Nux vomica, Rhus toxicodendron, Ruta graveolens, Sarcolacticum acidum, Stramonium, Strychninum.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ARNICA MONTANA; BLACK COHOSH; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COMFREY ROOT; DATURA STRAMONIUM; EUPATORIUM PERFOLIATUM FLOWERING TOP; HYPERICUM PERFORATUM; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; PHYTOLACCA AMERICANA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRITE; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2488_9c5b8025-9c5a-997e-e053-2a95a90ac6ce	55714-2488	HUMAN OTC DRUG	Muscle Ease		Chamomilla, Phytolacca decandra, Ruta graveolens, Symphytum officinale, Aconitum napellus, Antimonium tartaricum, Argentum nitricum, Arnica montana, Bryonia, Chamomilla, Chelidonium majus, Cimicifuga racemosa, Eupatorium perfoliatum, Hypericum perforatum, Nux vomica, Rhus toxicodendron, Ruta graveolens, Sarcolacticum acidum, Stramonium, Strychninum.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ARNICA MONTANA; BLACK COHOSH; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COMFREY ROOT; DATURA STRAMONIUM; EUPATORIUM PERFOLIATUM FLOWERING TOP; HYPERICUM PERFORATUM; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; PHYTOLACCA AMERICANA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRITE; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2491_9c5dc37c-9307-bc2d-e053-2995a90a414f	55714-2491	HUMAN OTC DRUG	Nervousness - Anxiety		Passiflora incarnata, Valeriana officinalis, Aconitum napellus, Ambra grisea, Anacardium orientale, Argentum nitricum, Asafoetida, Bryonia, Chamomilla, Cimicifuga racemosa, Coffea cruda, Cypripedium pubescens, Gelsemium sempervirens, Hyoscyamus niger, Hypericum perforatum, Ignatia amara, Kali phosphoricum, Nux vomica, Sambucus nigra, Strychninum, Theridion, Valeriana officinalis.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMBERGRIS; ARABICA COFFEE BEAN; BLACK COHOSH; BRYONIA ALBA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DIBASIC POTASSIUM PHOSPHATE; FERULA ASSA-FOETIDA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; STRYCHNINE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2492_9c9498ef-96cc-31a9-e053-2a95a90acbc8	55714-2492	HUMAN OTC DRUG	Nervousness - Anxiety		Passiflora incarnata, Valeriana officinalis, Aconitum napellus, Ambra grisea, Anacardium orientale, Argentum nitricum, Asafoetida, Bryonia, Chamomilla, Cimicifuga racemosa, Coffea cruda, Cypripedium pubescens, Gelsemium sempervirens, Hyoscyamus niger, Hypericum perforatum, Ignatia amara, Kali phosphoricum, Nux vomica, Sambucus nigra, Strychninum, Theridion, Valeriana officinalis.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMBERGRIS; ARABICA COFFEE BEAN; BLACK COHOSH; BRYONIA ALBA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DIBASIC POTASSIUM PHOSPHATE; FERULA ASSA-FOETIDA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; STRYCHNINE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2493_9b306877-ceb4-524e-e053-2a95a90ae90d	55714-2493	HUMAN OTC DRUG	Panic Button		Aconitum nap., Apis mel., Arnica, Arsenicum alb., Belladonna, Bellis, Bryonia, Calendula, Chamomilla, Cistus canadensis, Ferrum phosphoricum, Histaminum hydrochloricum, Hypericum, Ignatia, Mezereum, Ornithogalum, Passiflora, Phosphorus, Prunus spin., Rhus toxicodendron, Sarcolacticum ac., Sulphur, Veratrum alb., Valeriana.	LIQUID	ORAL	20190801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; DAPHNE MEZEREUM BARK; FERROSOFERRIC PHOSPHATE; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; ORNITHOGALUM UMBELLATUM; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PRUNUS SPINOSA FLOWER BUD; STRYCHNOS IGNATII SEED; SULFUR; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERATRUM ALBUM ROOT	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2494_9b3f31ec-6894-609e-e053-2a95a90ae6b8	55714-2494	HUMAN OTC DRUG	Panic Button		Aconitum nap., Apis mel., Arnica, Arsenicum alb., Belladonna, Bellis, Bryonia, Calendula, Chamomilla, Cistus canadensis, Ferrum phosphoricum, Histaminum hydrochloricum, Hypericum, Ignatia, Mezereum, Ornithogalum, Passiflora, Phosphorus, Prunus spin., Rhus toxicodendron, Sarcolacticum ac., Sulphur, Veratrum alb., Valeriana.	PELLET	ORAL	20190801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; DAPHNE MEZEREUM BARK; FERROSOFERRIC PHOSPHATE; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; ORNITHOGALUM UMBELLATUM; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PRUNUS SPINOSA FLOWER BUD; STRYCHNOS IGNATII SEED; SULFUR; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERATRUM ALBUM ROOT	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2495_9c9626cf-a0f5-311c-e053-2a95a90ab228	55714-2495	HUMAN OTC DRUG	Parasites		Juglans regia, Abrotanum, Aesculus hippocastanum, Allium sativum, Arsenicum album, Artemisia vulgaris, Baptisia tinctoria, Cina, Cuprum metallicum, Filix mas, Granatum, Ipecacuanha, Lachesis mutus, Lycopodium clavatum, Mercurius vivus, Naphthalinum, Natrum muriaticum, Nux vomica, Pulsatilla, Ratanhia, Ruta graveolens, Sabadilla, Santoninum, Silicea, Spigelia anthelmia, Terebinthina, Teucrium marum, Thymolum, Zingiber officinale.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ARTEMISIA ABROTANUM FLOWERING TOP; ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; BAPTISIA TINCTORIA ROOT; COPPER; DRYOPTERIS FILIX-MAS ROOT; GARLIC; GINGER; HORSE CHESTNUT; IPECAC; JUGLANS REGIA LEAF; KRAMERIA LAPPACEA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURY; NAPHTHALENE; PUNICA GRANATUM ROOT BARK; RUTA GRAVEOLENS FLOWERING TOP; SANTONIN; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SODIUM CHLORIDE; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM; THYMOL; TURPENTINE OIL	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2496_9c972291-71c7-b588-e053-2995a90ab657	55714-2496	HUMAN OTC DRUG	Parasites		Juglans regia, Abrotanum, Aesculus hippocastanum, Allium sativum, Arsenicum album, Artemisia vulgaris, Baptisia tinctoria, Cina, Cuprum metallicum, Filix mas, Granatum, Ipecacuanha, Lachesis mutus, Lycopodium clavatum, Mercurius vivus, Naphthalinum, Natrum muriaticum, Nux vomica, Pulsatilla, Ratanhia, Ruta graveolens, Sabadilla, Santoninum, Silicea, Spigelia anthelmia, Terebinthina, Teucrium marum, Thymolum, Zingiber officinale.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ARTEMISIA ABROTANUM FLOWERING TOP; ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; BAPTISIA TINCTORIA ROOT; COPPER; DRYOPTERIS FILIX-MAS ROOT; GARLIC; GINGER; HORSE CHESTNUT; IPECAC; JUGLANS REGIA LEAF; KRAMERIA LAPPACEA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURY; NAPHTHALENE; PUNICA GRANATUM ROOT BARK; RUTA GRAVEOLENS FLOWERING TOP; SANTONIN; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SODIUM CHLORIDE; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM; THYMOL; TURPENTINE OIL	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2497_9c978687-b14c-46b1-e053-2995a90a1306	55714-2497	HUMAN OTC DRUG	Poison Ivy		Xerophyllum asphodeloides, Aconitum nap., Anacardium orientale, Apis mel., Bryonia, Cantharis, Croton, Graphites, Grindelia, Mezereum, Nux vom., Ranunc. bulb., Rhus toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex crisp.,Taraxacum, Urtica ur.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; BRYONIA ALBA ROOT; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; GRINDELIA HIRSUTULA FLOWERING TOP; LYTTA VESICATORIA; RANUNCULUS BULBOSUS; RUMEX CRISPUS ROOT; SEMECARPUS ANACARDIUM JUICE; SMILAX ORNATA ROOT; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; XEROPHYLLUM ASPHODELOIDES	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2498_9c999f9a-dbbf-67e8-e053-2995a90a1c2b	55714-2498	HUMAN OTC DRUG	Poison Ivy		Xerophyllum asphodeloides, Aconitum nap., Anacardium orientale, Apis mel., Bryonia, Cantharis, Croton, Graphites, Grindelia, Mezereum, Nux vom., Ranunc. bulb., Rhus toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex crisp.,Taraxacum, Urtica ur.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; BRYONIA ALBA ROOT; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; GRINDELIA HIRSUTULA FLOWERING TOP; LYTTA VESICATORIA; RANUNCULUS BULBOSUS; RUMEX CRISPUS ROOT; SEMECARPUS ANACARDIUM JUICE; SMILAX ORNATA ROOT; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; XEROPHYLLUM ASPHODELOIDES	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 6; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2499_9c9a4de7-2eb2-240c-e053-2995a90a8b23	55714-2499	HUMAN OTC DRUG	Pollen-Weeds		Ginkgo biloba, Hydrastis canadensis, Taraxacum officinale, Adrenalinum , Aletris farinosa, Alfalfa, Allium cepa, Antimonium tartaricum, Arsenicum album, Artemisia vulgaris, Baptisia tinctoria, Bellis perennis, Berberis vulgaris, Bryonia, Calluna vulgaris, flos, Chelidonium majus, Chenopodium anthelminticum, Dioscorea vilosa, Euphrasia officinalis, Fagus sylvatica, Fraxinus americana, Gelsemium sempervirens, Histaminum hydrochloricum, Kali bichromicum, Kali iodatum, Lachesis mutus, Lilium tigrinum,	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALETRIS FARINOSA ROOT; ALFALFA; ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALLUNA VULGARIS FLOWERING TOP; CHELIDONIUM MAJUS; DIOSCOREA VILLOSA TUBER; DYSPHANIA AMBROSIOIDES; ELYMUS REPENS ROOT; EPINEPHRINE; EUPHRASIA STRICTA; FAGUS SYLVATICA NUT; FRAXINUS AMERICANA BARK; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; JUNIPERUS VIRGINIANA TWIG; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; ONION; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; ROSA DAMASCENA FLOWERING TOP; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SCHOENOCAULON OFFICINALE SEED; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 6; 15; 16; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 16; 15; 15; 15; 15; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2500_9caafbca-c8f8-d898-e053-2995a90a357a	55714-2500	HUMAN OTC DRUG	Pollen-Weeds		Ginkgo biloba, Hydrastis canadensis, Taraxacum officinale, Adrenalinum , Aletris farinosa, Alfalfa, Allium cepa, Antimonium tartaricum, Arsenicum album, Artemisia vulgaris, Baptisia tinctoria, Bellis perennis, Berberis vulgaris, Bryonia, Calluna vulgaris, flos, Chelidonium majus, Chenopodium anthelminticum, Dioscorea vilosa, Euphrasia officinalis, Fagus sylvatica, Fraxinus americana, Gelsemium sempervirens, Histaminum hydrochloricum, Kali bichromicum, Kali iodatum, Lachesis mutus, Lilium tigrinum,	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALETRIS FARINOSA ROOT; ALFALFA; ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALLUNA VULGARIS FLOWERING TOP; CHELIDONIUM MAJUS; DIOSCOREA VILLOSA TUBER; DYSPHANIA AMBROSIOIDES; ELYMUS REPENS ROOT; EPINEPHRINE; EUPHRASIA STRICTA; FAGUS SYLVATICA NUT; FRAXINUS AMERICANA BARK; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; JUNIPERUS VIRGINIANA TWIG; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; ONION; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; ROSA DAMASCENA FLOWERING TOP; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SCHOENOCAULON OFFICINALE SEED; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 6; 15; 16; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 16; 15; 15; 15; 15; 16	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2503_9ca8f252-a150-3990-e053-2995a90af8d7	55714-2503	HUMAN OTC DRUG	Prostate		Thyroidinum, Baryta carb., Berber. vulg., Bryonia, Calc. carb., Cinchona, Conium, Digitalis, Ferrum picricum, Hydrastis, Iodium, Lycopodium, Nux vom., Pareira, Pulsatilla, Sabal, Selenium, Staphysag., Thuja occ.,Trifolium pratense, Echinacea, Lappa, Solidago	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARCTIUM LAPPA ROOT; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; FERRIC PICRATE; GOLDENSEAL; IODINE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SAW PALMETTO; SELENIUM; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER	15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Iron [CS], Non-Standardized Plant Allergenic Extract [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2510_9cacb7cd-bc3e-6362-e053-2a95a90aad94	55714-2510	HUMAN OTC DRUG	Rosacea		Echinacea, Taraxacum officinale, Arsenicum album, Arsenicum bromatum, Carbo animalis, Causticum, Hydrocotyle asiatica, Kali bromatum, Kali iodatum, Kreosotum, Lycopodium clavatum, Nux vomica, Petroleum, Rhus toxicodendron, Sepia, Sulphur	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIBROMIDE; ARSENIC TRIOXIDE; CARBO ANIMALIS; CAUSTICUM; CENTELLA ASIATICA; ECHINACEA, UNSPECIFIED; KEROSENE; LYCOPODIUM CLAVATUM SPORE; POTASSIUM BROMIDE; POTASSIUM IODIDE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; WOOD CREOSOTE	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2512_9cbe1fc0-5e16-55a2-e053-2a95a90aead5	55714-2512	HUMAN OTC DRUG	Sciatica-Nerve Care		Aconitum nap., Ammonium benzoicum, Arsenicum alb., Benzoicum acidum, Bryonia, Causticum, Cinchona, Colchicum, Gnaphalium polycephalum, Iris versicolor, Kali iod., Ledum, Lithium carb., Nux vom., Phytolacca, Rhus toxicoderon, Ruta, Sambucus nig., Strychninum, Hypericum, Urtica ur	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMMONIUM BENZOATE; ARSENIC TRIOXIDE; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; HYPERICUM PERFORATUM; IRIS VERSICOLOR ROOT; LITHIUM CARBONATE; PHYTOLACCA AMERICANA ROOT; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2513_9cbd76c6-78cd-4e58-e053-2a95a90a2347	55714-2513	HUMAN OTC DRUG	Sciatica-Nerve Care		Aconitum nap., Ammonium benzoicum, Arsenicum alb., Benzoicum acidum, Bryonia, Causticum, Cinchona, Colchicum, Gnaphalium polycephalum, Iris versicolor, Kali iod., Ledum, Lithium carb., Nux vom., Phytolacca, Rhus toxicoderon, Ruta, Sambucus nig., Strychninum, Hypericum, Urtica ur	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMMONIUM BENZOATE; ARSENIC TRIOXIDE; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; HYPERICUM PERFORATUM; IRIS VERSICOLOR ROOT; LITHIUM CARBONATE; PHYTOLACCA AMERICANA ROOT; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2514_9cbdac7b-d800-79bf-e053-2a95a90ac45a	55714-2514	HUMAN OTC DRUG	Shingles		Chamomilla, Echinacea, Apis mellifica, Arsenicum album, Asterias rubens, Cantharis, Cistus canadensis, Croton tiglium, Dolichos pruriens, Dulcamara, Graphites, Grindelia, Hypericum perforatum, Iris versicolo, Lycopodium clavatum, Mezereum, Ranunculus bulbosus, Rhus toxicodendron, Staphysagria, Sulphur, Thuja occidentalis, Zincum metallicum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ASTERIAS RUBENS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GRAPHITE; GRINDELIA HIRSUTULA FLOWERING TOP; HELIANTHEMUM CANADENSE; HYPERICUM PERFORATUM; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; MATRICARIA CHAMOMILLA; MUCUNA PRURIENS FRUIT TRICHOME; RANUNCULUS BULBOSUS; SOLANUM DULCAMARA TOP; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2515_9cbf2d13-b82a-2683-e053-2a95a90a4d55	55714-2515	HUMAN OTC DRUG	Shingles		Chamomilla, Echinacea, Apis mellifica, Arsenicum album, Asterias rubens, Cantharis, Cistus canadensis, Croton tiglium, Dolichos pruriens, Dulcamara, Graphites, Grindelia, Hypericum perforatum, Iris versicolo, Lycopodium clavatum, Mezereum, Ranunculus bulbosus, Rhus toxicodendron, Staphysagria, Sulphur, Thuja occidentalis, Zincum metallicum	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ASTERIAS RUBENS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GRAPHITE; GRINDELIA HIRSUTULA FLOWERING TOP; HELIANTHEMUM CANADENSE; HYPERICUM PERFORATUM; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; MATRICARIA CHAMOMILLA; MUCUNA PRURIENS FRUIT TRICHOME; RANUNCULUS BULBOSUS; SOLANUM DULCAMARA TOP; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2518_9cc3322f-890e-ed71-e053-2a95a90a323c	55714-2518	HUMAN OTC DRUG	Snore-Soothe		Echinacea, Bryonia, Camphora, Cistus canadensis, Drosera, Hepar sulphuris calcareum, Hydrastis canadensis, Ignatia amara, Iodium, Kali bichromicum, Kali iodatum, Phosphorus, Pulsatilla, Sabadilla, Silicea, Sticta pulmonaria, Sulphur, Teucrium marum, Verbascum thapsus, Arsenicum album, Belladonna, Histaminum hydrochloricum, Lac caninum, Nux vomica	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAMPHOR (NATURAL); CANIS LUPUS FAMILIARIS MILK; DROSERA ANGLICA; ECHINACEA, UNSPECIFIED; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; IODINE; LOBARIA PULMONARIA; PHOSPHORUS; POTASSIUM DICHROMATE; POTASSIUM IODIDE; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR; TEUCRIUM MARUM; VERBASCUM THAPSUS	10; 15; 15; 10; 10; 10; 15; 10; 6; 10; 10; 15; 10; 10; 10; 10; 10; 10; 10; 10; 15; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2520_9cd61789-fc2c-3d54-e053-2995a90a5a34	55714-2520	HUMAN OTC DRUG	Sports Recovery		Echinacea, Hydrastis canadensis, Hypericum perforatum, Symphytum officinale, Apis mellifica, Arnica montana, Bellis perennis, Bryonia, Calendula officinalis, Chamomilla, Cinchona officinalis, Gelsemium sempervirens, Hamamelis virginiana, Hypericum perforatum, Lacticum acidum, Ledum palustre, Phosphorus, Rhus toxicodendron, Ruta graveolens, Sarcolacticum acidum, Staphysagria, Symphytum officinale	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CINCHONA OFFICINALIS BARK; COMFREY ROOT; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LACTIC ACID, DL-; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2522_9d221e4e-739c-2034-e053-2a95a90a7cb1	55714-2522	HUMAN OTC DRUG	Stage Fright-Fear		Passiflora incarnata, Valeriana officinalis, Aconitum napellus, Anacardium orientale, Argentum nitricum, Arsenicum album, Cypripedium pubescens, Gelsemium sempervirens, Ignatia amara, Kali carbonicum, Lycopodium clavatum, Natrum muriaticum, Phosphorus, Sambucus nigra, Sepia, Staphysagria, Stramonium, Tarentula hispana, Theridion	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; POTASSIUM CARBONATE; SAMBUCUS NIGRA FLOWERING TOP; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; THERIDION CURASSAVICUM; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
55714-2524_9d22bedb-9f9e-8421-e053-2a95a90acf4a	55714-2524	HUMAN OTC DRUG	Stress-Tension		Chamomilla, Hypericum perforatum, Valeriana officinalis, Aconitum napellus, Argentum nitricum, Aurum metallicum, Baptisia, Bryonia, Chelidonium majus, Cimicifuga racemosa, Conium maculatum, Gelsemium sempervirens, Ignatia amara, Kali carbonicum, Lachesis mutus, Lilium tigrinum, Lycopodium clavatum, Natrum carbonicum, Natrum muriaticum, Phosphoricum acidum, Phosphorus, Picricum acidum, Plumbum metallicum, Sepia, Staphysagria, Stramonium, Thuja occidentalis, Zincum metallicum.	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; BAPTISIA TINCTORIA ROOT; BLACK COHOSH; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LEAD; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PHOSPHORIC ACID; PHOSPHORUS; PICRIC ACID; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; THUJA OCCIDENTALIS LEAFY TWIG; VALERIAN; ZINC	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC]		N	20241231
55714-2525_9d234ceb-7fdc-eaf0-e053-2a95a90a9faf	55714-2525	HUMAN OTC DRUG	Stress-Tension		Chamomilla, Hypericum perforatum, Valeriana officinalis, Aconitum napellus, Argentum nitricum, Aurum metallicum, Baptisia, Bryonia, Chelidonium majus, Cimicifuga racemosa, Conium maculatum, Gelsemium sempervirens, Ignatia amara, Kali carbonicum, Lachesis mutus, Lilium tigrinum, Lycopodium clavatum, Natrum carbonicum, Natrum muriaticum, Phosphoricum acidum, Phosphorus, Picricum acidum, Plumbum metallicum, Sepia, Staphysagria, Stramonium, Thuja occidentalis, Zincum metallicum.	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; BAPTISIA TINCTORIA ROOT; BLACK COHOSH; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LEAD; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PHOSPHORIC ACID; PHOSPHORUS; PICRIC ACID; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; THUJA OCCIDENTALIS LEAFY TWIG; VALERIAN; ZINC	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC]		N	20241231
55714-2526_9d26010e-aa00-4887-e053-2995a90a109d	55714-2526	HUMAN OTC DRUG	Swimmers Friend		Antimonium tart., Arnica montana, Bellis perennis, Bryonia, Calcarea carbonica, Capsicum annuum, Chelidonium majus, Cuprum metallicum, Digitalis purpurea, Drosera, Lachesis mutus, Lacticum acidum, Ledum palustre, Magnesia carbonica, Manganum aceticum, Nux vomica, Phytolacca decandra, Rhus toxicodendron, Ruta graveolens, Sarcolacticum acidum, Sulphuricum acidum, Verbascum thapsus, Vipera berus	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY POTASSIUM TARTRATE; ARNICA MONTANA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CAPSICUM; CHELIDONIUM MAJUS; COPPER; DIGITALIS; DROSERA ANGLICA; LACHESIS MUTA VENOM; LACTIC ACID, DL-; LACTIC ACID, L-; MAGNESIUM CARBONATE; MANGANESE ACETATE TETRAHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS; VIPERA BERUS VENOM	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2528_9d27c35e-ebb2-e2af-e053-2995a90ab33d	55714-2528	HUMAN OTC DRUG	Teeth-Gums		Chamomilla, Echinacea, Aconitum napellus, Arnica montana, Arsenicum album, Baptisia tinctoria, Belladonna, Bryonia, Calendula officinalis, Chamomilla, Chelidonium majus, Crotalus horridus, Gelsemium sempervirens, Hepar sulphuris calcareum, Kreosotum, Mercurius vivus, Myrrha, Nux vomica, Phosphorus, Phytolacca decandra, Plantago major, Rhus toxicodendron, Silicea, Staphysagria	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA; MERCURY; MYRRH; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; WOOD CREOSOTE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2529_9d38ba56-6640-4dd2-e053-2995a90a2f89	55714-2529	HUMAN OTC DRUG	Teeth-Gums		Chamomilla, Echinacea, Aconitum napellus, Arnica montana, Arsenicum album, Baptisia tinctoria, Belladonna, Bryonia, Calendula officinalis, Chamomilla, Chelidonium majus, Crotalus horridus, Gelsemium sempervirens, Hepar sulphuris calcareum, Kreosotum, Mercurius vivus, Myrrha, Nux vomica, Phosphorus, Phytolacca decandra, Plantago major, Rhus toxicodendron, Silicea, Staphysagria	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA; MERCURY; MYRRH; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; WOOD CREOSOTE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2530_9d369a34-c6c5-dd99-e053-2995a90a46be	55714-2530	HUMAN OTC DRUG	Throat Care		Echinacea, Aconitum nap., Apis mel., Arum drac., Belladonna, Bryonia, Cajuputum, Ferrum phos., Glycyrrhiza, Kali bic., Lachesis, Menta pip., Merc. viv., Naja, Nat. carb., Nat sulphuricum, Nitricum ac., Nux vom., Phos., Phytolacca, Pulsatilla, Spongia, Stannum met., Sticta, Thuja occ., Ulmus fulv., Verbascum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; APIS MELLIFERA; ARISAEMA DRACONTIUM ROOT; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CAJUPUT OIL; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GLYCYRRHIZA GLABRA; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; MENTHA PIPERITA; MERCURY; NAJA NAJA VENOM; NITRIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SODIUM CARBONATE; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA WHOLE; THUJA OCCIDENTALIS LEAFY TWIG; TIN; ULMUS RUBRA BARK; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2534_9d38eac0-9d7b-1274-e053-2995a90a189a	55714-2534	HUMAN OTC DRUG	Tobacco Withdrawal		Arsenicum alb., Benzoicum acidum, Berber. vulg., Bryonia, Caladium seguinum, Cantharis, Ceanothus, Chelidonium majus, Chionanthus virginica, Cinchona, Daphne indica, Ignatia, Iris versicolor, Lycopodium, Nicotinum, Nux vom., Rhus toxicodendron, Scutellaria lateriflora, Tabacum, Echinacea, Taraxacum, Valeriana	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIOXIDE; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; DAPHNE ODORA BARK; DIEFFENBACHIA SEGUINE; ECHINACEA, UNSPECIFIED; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; NICOTINE; SCUTELLARIA LATERIFLORA WHOLE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cholinergic Nicotinic Agonist [EPC], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nicotine [CS], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2535_9d39968e-baac-c8f2-e053-2a95a90addb6	55714-2535	HUMAN OTC DRUG	Tobacco Withdrawal		Arsenicum alb., Benzoicum acidum, Berber. vulg., Bryonia, Caladium seguinum, Cantharis, Ceanothus, Chelidonium majus, Chionanthus virginica, Cinchona, Daphne indica, Ignatia, Iris versicolor, Lycopodium, Nicotinum, Nux vom., Rhus toxicodendron, Scutellaria lateriflora, Tabacum, Echinacea, Taraxacum, Valeriana	PELLET	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIOXIDE; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; DAPHNE ODORA BARK; DIEFFENBACHIA SEGUINE; ECHINACEA, UNSPECIFIED; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; NICOTINE; SCUTELLARIA LATERIFLORA WHOLE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cholinergic Nicotinic Agonist [EPC], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nicotine [CS], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2538_9d3a6ba0-3c82-a62d-e053-2995a90a16ea	55714-2538	HUMAN OTC DRUG	Vitality		Echinacea, Lappa major, Solidago virgaurea, Taraxacum officinale, Adrenalinum, Aloe, Arsenicum album, Baptisia tinctoria, Berberis aquifolium, Berberis vulgaris, Bryonia, Chelidonium majus, Crotalus horridus, Digitalis purpurea, Ferrum metallicum, Glonoinum, Hydrocotyle asiatica, Iodium, Iris versicolor, Lachesis mutus, Lycopodium clavatum, Natrum muriaticum, Nux vomica, Rhus toxicodendron, Ruta graveolens, Thuja occidentalis, Thyroidinum, Glycyrrhiza glabra	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BERBERIS AQUIFOLIUM ROOT BARK; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CENTELLA ASIATICA; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GLYCYRRHIZA GLABRA; IODINE; IRIS VERSICOLOR ROOT; IRON; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2540_9d3b9121-f487-07c5-e053-2a95a90a772b	55714-2540	HUMAN OTC DRUG	Vitiligo		Echinacea, Iris versicolor, Rumex crispus, Berberis vulgaris, Bovista, Dolichos pruriens, Hura brasiliensis, Hydrocotyle asiatica, Lycopodium clavatum, Mezereum, Rhus toxicodendron, Sepia, Taraxacum officinale, Thuja occidentalis, Urtica urens, Arsenicum album	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; CENTELLA ASIATICA; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; HURA CREPITANS SAP; IRIS VERSICOLOR ROOT; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; MUCUNA PRURIENS FRUIT TRICHOME; RUMEX CRISPUS ROOT; SEPIA OFFICINALIS JUICE; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 10; 10; 10; 10; 10; 6; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-2544_b5560b7f-8cdc-201f-e053-2995a90a50a3	55714-2544	HUMAN OTC DRUG	Food Additives		Iris versicolor, Solidago virgaurea, Aconitum napellus, Agaricus muscarius, Allium cepa, Allium sativum, Antimonium crudum, Arsenicum album, Baptisia tinctoria, Bovista, Caffeinum, Capsicum annuum, Cinchona officinalis, Cinnamomum, Coccus cacti, Cynara scolymus, Fragaria vesca, Gelsemium sempervirens, Histaminum hydrochloricum, Ipecacuanha, Jequerity, Juglans regia, Lachesis mutus, Ledum palustre, Lycopodium clavatum, Mentha piperita, Natrum muriaticum, Nux moschata,	LIQUID	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; ASCORBIC ACID; ASTACUS ASTACUS; BAPTISIA TINCTORIA ROOT; BLACK MUSTARD SEED; CAFFEINE; CAPSICUM; CINCHONA OFFICINALIS BARK; CINNAMON; CYNARA SCOLYMUS LEAF; EGG SHELL, COOKED; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; HISTAMINE DIHYDROCHLORIDE; IPECAC; IRIS VERSICOLOR ROOT; JUGLANS REGIA LEAF; LACHESIS MUTA VENOM; LACTOSE, UNSPECIFIED FORM; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; MENTHA PIPERITA; NUTMEG; ONION; PHOSPHORUS; PODOPHYLLUM; PROTORTONIA CACTI; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHARIN; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SODIUM NITRITE; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SOLIDAGO VIRGAUREA FLOWERING TOP; SUCROSE; SULFUR; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; USTILAGO MAYDIS	15; 15; 15; 15; 15; 16; 15; 15; 15; 16; 16; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 16; 16; 16; 16; 6; 16; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-2545_b5560b7f-8cdd-201f-e053-2995a90a50a3	55714-2545	HUMAN OTC DRUG	Food Additives		Iris versicolor, Solidago virgaurea, Aconitum napellus, Agaricus muscarius, Allium cepa, Allium sativum, Antimonium crudum, Arsenicum album, Baptisia tinctoria, Bovista, Caffeinum, Capsicum annuum, Cinchona officinalis, Cinnamomum, Coccus cacti, Cynara scolymus, Fragaria vesca, Gelsemium sempervirens, Histaminum hydrochloricum, Ipecacuanha, Jequerity, Juglans regia, Lachesis mutus, Ledum palustre, Lycopodium clavatum, Mentha piperita, Natrum muriaticum, Nux moschata,	PELLET	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; ASCORBIC ACID; ASTACUS ASTACUS; BAPTISIA TINCTORIA ROOT; BLACK MUSTARD SEED; CAFFEINE; CAPSICUM; CINCHONA OFFICINALIS BARK; CINNAMON; CYNARA SCOLYMUS LEAF; EGG SHELL, COOKED; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; HISTAMINE DIHYDROCHLORIDE; IPECAC; IRIS VERSICOLOR ROOT; JUGLANS REGIA LEAF; LACHESIS MUTA VENOM; LACTOSE, UNSPECIFIED FORM; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; MENTHA PIPERITA; NUTMEG; ONION; PHOSPHORUS; PODOPHYLLUM; PROTORTONIA CACTI; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHARIN; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SODIUM NITRITE; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SOLIDAGO VIRGAUREA FLOWERING TOP; SUCROSE; SULFUR; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; USTILAGO MAYDIS	15; 15; 15; 15; 15; 16; 15; 15; 15; 16; 16; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 16; 16; 16; 16; 6; 16; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-2548_9b8f888f-1d60-1404-e053-2995a90aed89	55714-2548	HUMAN OTC DRUG	Bowel - Digestive Care		Bismuthum metallicum, Antimon.crud., Arg. nit., Arsenicum alb., Baptisia, Bryonia, Chamomilla, Cinchona, Iris versicolor, Kali bic., Lachesis, Lycopodium, Mag. carb., Nux vom., Phosphorus, Podoph. pelt., Pulsatilla, Raphanus, Rhus toxicodendron, Tabacum, Verbascum, Zingiber, Echinacea, Juglans regia.	LIQUID	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; ENGLISH WALNUT; GINGER; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA RECUTITA; PHOSPHORUS; PODOPHYLLUM; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; RADISH; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_M]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2549_b4df6f47-e518-db1c-e053-2a95a90a6265	55714-2549	HUMAN OTC DRUG	Bowel - Digestive Care		Bismuthum metallicum, Antimon.crud., Arg. nit., Arsenicum alb., Baptisia, Bryonia, Chamomilla, Cinchona, Iris versicolor, Kali bic., Lachesis, Lycopodium, Mag. carb., Nux vom., Phosphorus, Podoph. pelt., Pulsatilla, Raphanus, Rhus toxicodendron, Tabacum, Verbascum, Zingiber, Echinacea, Juglans regia.	PELLET	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; ENGLISH WALNUT; GINGER; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA RECUTITA; PHOSPHORUS; PODOPHYLLUM; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; RADISH; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_M]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2550_d17c7496-2179-203e-e053-2995a90ab008	55714-2550	HUMAN OTC DRUG	Rheumatic-Joint Care		Uricum acidum, Aconitum nap.,Apis mel., Arnica, Arsenicum alb, Belladonna,Benzoicum acidum, Bryonia, Calc. carb., Chamomilla, Cinchona, Colchicum, Eupatorium perf., Gaultheriaprocumbens, Guaiacum, Iodium, Kali bic, Kalmia,Ledum, Pulsatilla, Rhus toxicodendron, Ruta,Sabina, Strychninum, Lappa, Phytolacca, Symphytum,	LIQUID	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BENZOIC ACID; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GAULTHERIA PROCUMBENS TOP; GUAIACUM OFFICINALE RESIN; IODINE; JUNIPERUS SABINA LEAFY TWIG; KALMIA LATIFOLIA LEAF; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNINE; TOXICODENDRON PUBESCENS LEAF; URIC ACID	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2551_9cae7d07-19f6-f661-e053-2995a90a944d	55714-2551	HUMAN OTC DRUG	Rheumatic-Joint Care		Uricum acidum, Aconitum nap.,Apis mel., Arnica, Arsenicum alb, Belladonna,Benzoicum acidum, Bryonia, Calc. carb., Chamomilla, Cinchona, Colchicum, Eupatorium perf., Gaultheriaprocumbens, Guaiacum, Iodium, Kali bic, Kalmia,Ledum, Pulsatilla, Rhus toxicodendron, Ruta,Sabina, Strychninum, Lappa, Phytolacca, Symphytum,	PELLET	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BENZOIC ACID; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GAULTHERIA PROCUMBENS TOP; GUAIACUM OFFICINALE RESIN; IODINE; JUNIPERUS SABINA LEAFY TWIG; KALMIA LATIFOLIA LEAF; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNINE; TOXICODENDRON PUBESCENS LEAF; URIC ACID	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2552_9b40d686-643a-d187-e053-2995a90a43fb	55714-2552	HUMAN OTC DRUG	Prime		Ginkgo biloba, Ruta graveolens, Agnus castus, Allium sativum, Ambra grisea, Angelica sinensis radix, Aralia quinquefolia, Arnica montana, Arsenicum album, Avena sativa, Baptisia tinctoria, Baryta carbonica, Bryonia, Cantharis, Lachesis mutus, Lycopodium clavatum, Nux vomica, Phosphoricum acidum, Pulsatilla, Ruta graveolens, Sabal serrulata, Selenium metallicum, Zincum metallicum.	LIQUID	ORAL	20190801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMBERGRIS; AMERICAN GINSENG; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; BRYONIA ALBA ROOT; CHASTE TREE FRUIT; GARLIC; GINKGO; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PHOSPHORIC ACID; RUTA GRAVEOLENS FLOWERING TOP; SAW PALMETTO; SELENIUM; STRYCHNOS NUX-VOMICA SEED; ZINC	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2553_b55b5356-1174-c606-e053-2a95a90a9c3f	55714-2553	HUMAN OTC DRUG	Varicose Veins		Elaps corallinus, Crotalus horridus, Bryonia, Calc. fluor., Carduus mar., Cholesterinum, Cinchona, Digitalis, Hamamelis, Hydrofluoricum acidum, Lachesis, Lycopodium, Naja, Pulsatilla, Vipera berus, Zinc. met., Aesculus hipp., Echinacea	LIQUID	ORAL	20190830		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CHOLESTEROL; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; HYDROFLUORIC ACID; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; PULSATILLA VULGARIS; SILYBUM MARIANUM SEED; VIPERA BERUS VENOM; ZINC	15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 30; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-2554_9b2e21ce-f827-67bb-e053-2995a90adf56	55714-2554	HUMAN OTC DRUG	Restless Leg		Mygale, Agaricus musc., Causticum, Cinchona, Conium, Cuprum met., Gelsemium, Hyoscyamus, Hypericum, Kali carb., Mag. carb., Merc. viv., Nux vom., Plumb. met., Rhus toxicodendron, Secale, Strychninum, Tarentula hispana, Valeriana, Verbascum, Zinc. met., Chamomilla,Passiflora	LIQUID	ORAL	20190801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY; AVICULARIA AVICULARIA; CAUSTICUM; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; COPPER; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; LEAD; LYCOSA TARANTULA; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; MERCURY; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERBASCUM THAPSUS; ZINC	15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2555_9b3eeeca-e485-db46-e053-2995a90a432a	55714-2555	HUMAN OTC DRUG	Restless Leg		Mygale, Agaricus musc., Causticum, Cinchona, Conium, Cuprum met., Gelsemium, Hyoscyamus, Hypericum, Kali carb., Mag. carb., Merc. viv., Nux vom., Plumb. met., Rhus toxicodendron, Secale, Strychninum, Tarentula hispana, Valeriana, Verbascum, Zinc. met., Chamomilla,Passiflora	PELLET	ORAL	20190801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY; AVICULARIA AVICULARIA; CAUSTICUM; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; COPPER; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; LEAD; LYCOSA TARANTULA; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; MERCURY; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERBASCUM THAPSUS; ZINC	15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2556_b5561d52-3959-4d98-e053-2995a90a8039	55714-2556	HUMAN OTC DRUG	Fungus Fighter		Candida albicans, Sanicula, Tellurium metallicum, Torula cerevisiae, Antimon. crud., Arsenicum alb., Baryta carb., Bryonia, Calc. carb., Carbo veg., Cuprum met., Dulcamara, Graphites, Kali carb., Lachesis, Lycopodium, Mezereum, Nitricum ac., Phosphorus, Phytolacca, Sepia, Silicea, Sulphur, Sulphuricum ac., Zinc. met., Apis mel., Thuja occ.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BARIUM CARBONATE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; COPPER; DAPHNE MEZEREUM BARK; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SACCHAROMYCES CEREVISIAE; SANICULA EUROPAEA LEAF; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG; ZINC	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 16; 15; 15; 15; 15; 15; 16; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2557_9b4276af-b739-3293-e053-2a95a90ad022	55714-2557	HUMAN OTC DRUG	Fungus Fighter		Candida albicans, Sanicula, Tellurium metallicum, Torula cerevisiae, Antimon. crud., Arsenicum alb., Baryta carb., Bryonia, Calc. carb., Carbo veg., Cuprum met., Dulcamara, Graphites, Kali carb., Lachesis, Lycopodium, Mezereum, Nitricum ac., Phosphorus, Phytolacca, Sepia, Silicea, Sulphur, Sulphuricum ac., Zinc. met., Apis mel., Thuja occ.	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BARIUM CARBONATE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; COPPER; DAPHNE MEZEREUM BARK; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SACCHAROMYCES CEREVISIAE; SANICULA EUROPAEA LEAF; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG; ZINC	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 16; 15; 15; 15; 15; 15; 16; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2559_b4e1c89b-c7c5-07ab-e053-2a95a90ac12c	55714-2559	HUMAN OTC DRUG	Detoxifier		Uricum acidum, Benzoicum acidum, Berber. vulg., Bryonia, Cantharis, Carduus benedictus, Ceanothus, Chelidonium majus, Chionanthus virginica, Cinchona, Dioscorea, Dolichos, Iris versicolor, Juniperus com., Nux vom.,Ptelea,Taraxacum, Carduus mar., Cynara scolymus, Solidago,Taraxacum	LIQUID	ORAL	20191202		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	10; 10; 10; 10; 10; 10; 10; 10; 6; 10; 10; 10; 10; 10; 10; 10; 6; 15; 10; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2560_9e52147c-c3aa-52f7-e053-2995a90a1321	55714-2560	HUMAN OTC DRUG	I-Waker		Apis mellifica, Echinacea, Hydrastis canadensis, Thuja occidentalis, Aconitum napellus, Agaricus muscarius, Allium sativum, Aloe, Arnica montana, Arsenicum album, Baptisia tinctoria, Belladonna, Bryonia, Calcarea carbonica, Calendula officinalis, Capsicum annuum, Carduus marianus, Hepar sulphuris calcareum, Iodium, Lachesis mutus, Lycopodium clavatum, Mercurius vivus, Nux vomica, Phosphorus, Pulsatilla, Rhus toxicodendron, Salvia officinalis, Selenium metallicum, Taraxacum officinale, Tarentula hispana,	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALOE; AMANITA MUSCARIA FRUITING BODY; ANEMONE PULSATILLA; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; AZADIRACHTA INDICA BARK; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CAPSICUM; ECHINACEA, UNSPECIFIED; GARLIC; GINGER; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; MERCURY; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SAGE; SELENIUM; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC	15; 15; 15; 15; 6; 15; 15; 15; 16; 16; 15; 15; 15; 15; 15; 6; 15; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-2561_a035f2bf-2f5e-0a50-e053-2995a90a8d9c	55714-2561	HUMAN OTC DRUG	Just In Case		Aconitum napellus, Arnica montana, Bryonia, Echinacea, Ledum palustre, Arsenicum album, Cenchris contortrix, Crotalus cascavella, Crotalus horridus, Lachesis mutus, Mercurius corrosivus, Naja tripudians, Phosphorus, Toxicophis pugnax, Vipera berus, Elaps corallinus, Heloderma.	LIQUID	ORAL	20200302		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AGKISTRODON CONTORTRIX VENOM; AGKISTRODON PISCIVORUS VENOM; ARNICA MONTANA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CROTALUS DURISSUS TERRIFICUS VENOM; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; HELODERMA HORRIDUM VENOM; LACHESIS MUTA VENOM; MERCURIC CHLORIDE; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; VIPERA BERUS VENOM	10; 15; 15; 10; 15; 10; 15; 15; 10; 30; 15; 15; 30; 15; 15; 10; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-2562_a603fcb4-a171-4b63-e053-2995a90a91a0	55714-2562	HUMAN OTC DRUG	Hay Fever		Apis mellifica, Echinacea, Hydrastis canadensis, Taraxacum officinale, Aconitum napellus, Alfalfa, Allium cepa, Ambrosia artemisiaefolia, Ammonium carbonicum, Aralia racemosa, Arsenicum album, Artemisia vulgaris, Arundo mauritanica, Bellis perennis, Berberis vulgaris, Bryonia, Calluna vulgaris, flos, Chelidonium majus, Chenopodium anthelminticum, Cistus canadensis, Drosera, Dulcamara, Eupatorium perfoliatum, Euphrasia officinalis, Fagus sylvatica, Fraxinus americana, Gelsemium sempervirens	LIQUID	ORAL	20200518		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALFALFA; AMBROSIA ARTEMISIIFOLIA; AMMONIUM CARBONATE; ANEMONE PULSATILLA; APIS MELLIFERA; ARALIA RACEMOSA ROOT; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; ARUNDO PLINIANA ROOT; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALLUNA VULGARIS FLOWERING TOP; CHELIDONIUM MAJUS; DATURA STRAMONIUM; DROSERA ANGLICA; DYSPHANIA AMBROSIOIDES; ECHINACEA, UNSPECIFIED; ELYMUS REPENS ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; FAGUS SYLVATICA NUT; FRAXINUS AMERICANA BARK; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; ONION; ONOSMODIUM VIRGINIANUM; PARTHENIUM HYSTEROPHORUS; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM DICHROMATE; POTASSIUM IODIDE; QUERCUS ROBUR NUT; RHODODENDRON TOMENTOSUM LEAFY TWIG; ROSA X DAMASCENA FLOWERING TOP; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 16; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-2564_b5971c5b-0539-0e97-e053-2a95a90a8121	55714-2564	HUMAN OTC DRUG	Thyroid-Adrenal		Adrenalinum, Thyroidinum, Aloe, Calc. carb., Chelidonium majus, Conium, Graphites, Iodium, Lachesis, Lycopodium, Lycopus virginicus, Phytolacca, Rhus toxicodendron, Silicea, Spongia, Echinacea	LIQUID	ORAL	20201030		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GRAPHITE; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SILICON DIOXIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2565_b597504a-c668-225c-e053-2a95a90ac704	55714-2565	HUMAN OTC DRUG	Thyroid-Adrenal		Adrenalinum, Thyroidinum, Aloe, Calc. carb., Chelidonium majus, Conium, Graphites, Iodium, Lachesis, Lycopodium, Lycopus virginicus, Phytolacca, Rhus toxicodendron, Silicea, Spongia, Echinacea	PELLET	ORAL	20201030		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GRAPHITE; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SILICON DIOXIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2566_c68caf17-6adc-5ce2-e053-2995a90a5655	55714-2566	HUMAN OTC DRUG	Candid- Y		Adrenalinum, Candida albicans, Thyroidinum, Torula cerevisiae, Triticum, Ustilago maidis, Antimon. crud, Arsenicum alb., Baptisia, Berber. aqui., Bryonia, Calc. phos., Cinchona, Helonias dioica, Hydrastis, Iodium, Iris versicolor, Kali carb., Lachesis, Lycopodium, Merc. viv., Nat.carb., Nat. phos, Nitricum ac., Phosphorus, Podoph. pelt, Pulsatilla, Sepia, Echinacea, Ginkgo, Juglans regia, Lappa, Thuja occ.	LIQUID	ORAL	20210201		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CHAMAELIRIUM LUTEUM ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; ELYMUS REPENS ROOT; ENGLISH WALNUT; EPINEPHRINE; GINKGO; GOLDENSEAL; IODINE; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAHONIA AQUIFOLIUM ROOT BARK; MERCURY; NITRIC ACID; PHOSPHORUS; PODOPHYLLUM; POTASSIUM CARBONATE; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM CARBONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TRIBASIC CALCIUM PHOSPHATE; USTILAGO MAYDIS	15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Nut Proteins [EXT], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2567_c68ea97b-67c2-dbcf-e053-2995a90a64c7	55714-2567	HUMAN OTC DRUG	Candid-Y		Adrenalinum, Candida albicans, Thyroidinum, Torula cerevisiae, Triticum, Ustilago maidis, Antimon. crud, Arsenicum alb., Baptisia, Berber. aqui., Bryonia, Calc. phos., Cinchona, Helonias dioica, Hydrastis, Iodium, Iris versicolor, Kali carb., Lachesis, Lycopodium, Merc. viv., Nat.carb., Nat. phos, Nitricum ac., Phosphorus, Podoph. pelt, Pulsatilla, Sepia, Echinacea, Ginkgo, Juglans regia, Lappa, Thuja occ.	PELLET	ORAL	20210201		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CHAMAELIRIUM LUTEUM ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; ELYMUS REPENS ROOT; ENGLISH WALNUT; EPINEPHRINE; GINKGO; GOLDENSEAL; IODINE; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAHONIA AQUIFOLIUM ROOT BARK; MERCURY; NITRIC ACID; PHOSPHORUS; PODOPHYLLUM; POTASSIUM CARBONATE; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM CARBONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TRIBASIC CALCIUM PHOSPHATE; USTILAGO MAYDIS	15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 6; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Nut Proteins [EXT], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2568_c6a08953-15c4-797d-e053-2a95a90a7a0c	55714-2568	HUMAN OTC DRUG	I-Sleep		Absinthium, Anacardium orientale, Arg. nit., Arsenicum alb., Belladonna, Bryonia, Calc. carb., Camphora, Chamomilla, Cimicifuga, Cinchona, Coffea cruda, Cypripedium, Gelsemium, Humulus, Hyoscyamus, Ignatia, Kali brom., Nux vom., Passiflora, Pulsatilla, Scutellaria lateriflora, Sepia, Thuja occ., Valeriana	LIQUID	ORAL	20210201		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BLACK COHOSH; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); CINCHONA OFFICINALIS BARK; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; GELSEMIUM SEMPERVIRENS ROOT; HOPS; HYOSCYAMUS NIGER; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM BROMIDE; SCUTELLARIA LATERIFLORA WHOLE; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VALERIAN; WORMWOOD	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2569_c6a0f7de-6eae-1ef8-e053-2995a90ad239	55714-2569	HUMAN OTC DRUG	I-Sleep		Absinthium, Anacardium orientale, Arg. nit., Arsenicum alb., Belladonna, Bryonia, Calc. carb., Camphora, Chamomilla, Cimicifuga, Cinchona, Coffea cruda, Cypripedium, Gelsemium, Humulus, Hyoscyamus, Ignatia, Kali brom., Nux vom., Passiflora, Pulsatilla, Scutellaria lateriflora, Sepia, Thuja occ., Valeriana	PELLET	ORAL	20210201		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BLACK COHOSH; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); CINCHONA OFFICINALIS BARK; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; GELSEMIUM SEMPERVIRENS ROOT; HOPS; HYOSCYAMUS NIGER; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM BROMIDE; SCUTELLARIA LATERIFLORA WHOLE; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VALERIAN; WORMWOOD	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2570_c69e98f2-440d-4e73-e053-2995a90a8dcf	55714-2570	HUMAN OTC DRUG	Hemorrhoids		Elaps corallinus, Aesculus hipp., Aloe, Arsenicum alb., Bryonia, Calc. fluor., Capsicum, Collinsonia, Crotalus horridus, Hamamelis, Hydrofluoricum acidum, Hypericum, Lachesis, Lycopodium, Millefolium, Naja, Nux vom., Paeonia, Plantago, Quercus glandium spiritus, Ratanhia, Vipera berus, Echinacea, Solidago, Urtica ur.	LIQUID	ORAL	20210315		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACHILLEA MILLEFOLIUM; ALOE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CAPSICUM; COLLINSONIA CANADENSIS ROOT; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; HYDROFLUORIC ACID; HYPERICUM PERFORATUM; KRAMERIA LAPPACEA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; PAEONIA OFFICINALIS ROOT; PLANTAGO MAJOR; QUERCUS ROBUR NUT; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; URTICA URENS; VIPERA BERUS VENOM	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 6; 15; 6; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2571_c69f4926-c5ca-63a0-e053-2a95a90a2ca6	55714-2571	HUMAN OTC DRUG	Hemorrhoids		Elaps corallinus, Aesculus hipp., Aloe, Arsenicum alb., Bryonia, Calc. fluor., Capsicum, Collinsonia, Crotalus horridus, Hamamelis, Hydrofluoricum acidum, Hypericum, Lachesis, Lycopodium, Millefolium, Naja, Nux vom., Paeonia, Plantago, Quercus glandium spiritus, Ratanhia, Vipera berus, Echinacea, Solidago, Urtica ur.	PELLET	ORAL	20210315		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACHILLEA MILLEFOLIUM; ALOE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CAPSICUM; COLLINSONIA CANADENSIS ROOT; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; HYDROFLUORIC ACID; HYPERICUM PERFORATUM; KRAMERIA LAPPACEA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; PAEONIA OFFICINALIS ROOT; PLANTAGO MAJOR; QUERCUS ROBUR NUT; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; URTICA URENS; VIPERA BERUS VENOM	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 6; 15; 6; 16	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-2572_c67b3a39-ef79-5e81-e053-2a95a90a4786	55714-2572	HUMAN OTC DRUG	Post - Vaccination		Influenzinum, Morbillinum, Pertussinum, Aconitum nap., Alumina, Antimon. tart., Arsenicum alb., Baptisia, Belladonna, Bryonia, Cinchona, Crotalus horridus, Gelsemium, Kali bic., Lachesis, Ledum, Merc. viv., Mezereum, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Silicea, Sulphur, Thuja occ., Vaccinium, Apis mel., Echinacea, Hypericum	LIQUID	ORAL	20210503		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALUMINUM OXIDE; ANTIMONY POTASSIUM TARTRATE; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BILBERRY; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYPERICUM PERFORATUM; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LACHESIS MUTA VENOM; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MERCURY; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 30; 6; 30; 30; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-2573_da80c009-6096-d43b-e053-2995a90ae724	55714-2573	HUMAN OTC DRUG	Ear Care		Influenzinum, Tellurium metallicum, Apis mel., Arsenicum alb., Belladonna, Bryonia, Capsicum, Causticum, Cinchona, Conium, Dulcamara, Ferrum phosphoricum, Hepar sulph. calc.,Kali sulph., Lycopodium, Merc. viv., Mezereum, Phosphorus, Plantago, Pulsatilla, Silicea, Verbascum, Echinacea, Hydrastis	LIQUID	ORAL	20220307		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LYCOPODIUM CLAVATUM SPORE; MERCURY; PHOSPHORUS; PLANTAGO MAJOR; POTASSIUM SULFATE; PULSATILLA VULGARIS; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; TELLURIUM; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-2574_da81b250-4bfd-2fa6-e053-2995a90ad140	55714-2574	HUMAN OTC DRUG	Ear Care		Influenzinum, Tellurium metallicum, Apis mel., Arsenicum alb., Belladonna, Bryonia, Capsicum, Causticum, Cinchona, Conium, Dulcamara, Ferrum phosphoricum, Hepar sulph. calc.,Kali sulph., Lycopodium, Merc. viv., Mezereum, Phosphorus, Plantago, Pulsatilla, Silicea, Verbascum, Echinacea, Hydrastis	PELLET	ORAL	20220307		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LYCOPODIUM CLAVATUM SPORE; MERCURY; PHOSPHORUS; PLANTAGO MAJOR; POTASSIUM SULFATE; PULSATILLA VULGARIS; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; TELLURIUM; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-2575_016b6571-8d96-0aba-e063-6394a90abc73	55714-2575	HUMAN OTC DRUG	Sick Stopper		Echinacea, Aconitum napellus, Agaricus muscarius, Aralia quinquefolia, Baptisia tinctoria, Bryonia, Chelidonium majus, Eupatorium perfoliatum, Hepar sulphuris calcareum, Lachesis mutus, Lycopodium clavatum, Rhus toxicodendron, Sanguinaria canadensis, Sulphur, Thuja occidentalis, Bufo rana, Nux vomica, Anthracinum, Influenzinum, Pyrogenium	LIQUID	ORAL	20230726		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMANITA MUSCARIA FRUITING BODY; AMERICAN GINSENG; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; BUFO BUFO CUTANEOUS GLAND; CALCIUM SULFIDE; CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 30; 15; 15; 15; 15; 15; 6; 15; 30; 30; 15; 15; 30; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2576_f03153d0-bb06-441a-e053-2a95a90ae672	55714-2576	HUMAN OTC DRUG	Warts		Antimon. crud., Bryonia, Calc.carb., Causticum, Dulcamara, Graphites, Lycopodium, Merc. sulph. rub., Nat. carb., Nitricum ac., Nux vom., Rhus toxicodendron, Sabina, Sepia, Silicea, Staphysag., Sulphur, Thuja occ., Taraxacum	LIQUID	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; BRYONIA ALBA ROOT; CAUSTICUM; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; JUNIPERUS SABINA LEAFY TWIG; LYCOPODIUM CLAVATUM SPORE; MERCURIC SULFIDE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CARBONATE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2577_f031cc09-247e-5958-e053-2a95a90a1311	55714-2577	HUMAN OTC DRUG	Warts		Antimon. crud., Bryonia, Calc.carb., Causticum, Dulcamara, Graphites, Lycopodium, Merc. sulph. rub., Nat. carb., Nitricum ac., Nux vom., Rhus toxicodendron, Sabina, Sepia, Silicea, Staphysag., Sulphur, Thuja occ., Taraxacum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; BRYONIA ALBA ROOT; CAUSTICUM; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; JUNIPERUS SABINA LEAFY TWIG; LYCOPODIUM CLAVATUM SPORE; MERCURIC SULFIDE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CARBONATE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-2579_febf5942-5eca-f19b-e053-6294a90a32c1	55714-2579	HUMAN OTC DRUG	Hyperactivity-Mental Focus		Adrenalinum, Aconitum nap., Arg. nit., Arsenicum alb., Baptisia, Chamomilla, Cypripedium, Digitalis, Gelsemium, Humulus, Ignatia, Impatiens glandulifera flos, Iodium, Lachesis, Lycopodium, Nat. mur., Nux vom., Scutellaria lateriflora, Staphysag., Stramonium, Theridion, Echinacea, Gingko, Hypericum, Passiflora	LIQUID	ORAL	20230703		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HOPS; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2580_fececb65-2bc7-1954-e053-6394a90ad851	55714-2580	HUMAN OTC DRUG	Hyperactivity-Mental Focus		Adrenalinum, Aconitum nap., Arg. nit., Arsenicum alb., Baptisia, Chamomilla, Cypripedium, Digitalis, Gelsemium, Humulus, Ignatia, Impatiens glandulifera flos, Iodium, Lachesis, Lycopodium, Nat. mur., Nux vom., Scutellaria lateriflora, Staphysag., Stramonium, Theridion, Echinacea, Gingko, Hypericum, Passiflora	PELLET	ORAL	20230703		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HOPS; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-2584_017f025d-6fca-ec96-e063-6394a90a4e44	55714-2584	HUMAN OTC DRUG	Allergies		Apis mellifica, Echinacea, Hydrastis canadensis, Taraxacum officinale, Aconitum napellus, Aethusa cynapium, Agaricus muscarius, Aletris farinosa, Alfalfa, Allium cepa, Allium sativum, Ambrosia artemisiaefolia, Arsenicum album, Artemisia vulgaris, Arundo mauritanica, Avena sativa, Belladonna, Bellis perrenis, Bovista, Bromium, Bryonia, Caffeinum, Calcarea carbonica, Calluna vulgaris, flos, Capsicum annuum, Cat hair, Chamomilla, Chelidonium majus, Chenopodium anthelminticum, Cinnamomum	LIQUID	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; AETHUSA CYNAPIUM; ALETRIS FARINOSA ROOT; ALFALFA; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; AMBROSIA ARTEMISIIFOLIA; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; ARUNDO PLINIANA ROOT; ASCORBIC ACID; ASTACUS ASTACUS; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BELLIS PERENNIS; BLACK MUSTARD SEED; BROMINE; BRYONIA ALBA ROOT; CAFFEINE; CALLUNA VULGARIS FLOWERING TOP; CANIS LUPUS FAMILIARIS HAIR; CAPSICUM; CHELIDONIUM MAJUS; CINNAMON; CLAVICEPS PURPUREA SCLEROTIUM; CORN SILK; COW MILK; CYNARA SCOLYMUS LEAF; DATURA STRAMONIUM; DROSERA ANGLICA; DYSPHANIA AMBROSIOIDES; ECHINACEA, UNSPECIFIED; EGG SHELL, COOKED; ELYMUS REPENS ROOT; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM; FAGUS SYLVATICA NUT; FELIS CATUS HAIR; FRAXINUS AMERICANA BARK; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; HYOSCYAMUS NIGER; JUGLANS REGIA LEAF; JUNIPERUS VIRGINIANA TWIG; LACTOSE, UNSPECIFIED FORM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; MATRICARIA CHAMOMILLA; MENTHA PIPERITA; NUTMEG; ONION; ONOSMODIUM VIRGINIANUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM IODIDE; PROTORTONIA CACTI; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; RHODODENDRON TOMENTOSUM LEAFY TWIG; ROSA X DAMASCENA FLOWERING TOP; SACCHARIN; SACCHAROMYCES CEREVISIAE; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SODIUM NITRATE; SOLANUM DULCAMARA TOP; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SUCROSE; SULFUR; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 6; 15; 15; 15; 16; 16; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 6; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 16; 15; 16; 16; 16; 16; 15; 6; 15; 15; 15; 16; 15; 15; 15; 15; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Ascorbic Acid [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylxanthine [EPC], Milk Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-2585_018e17ed-a686-9861-e063-6294a90acc7a	55714-2585	HUMAN OTC DRUG	Allergies		Apis mellifica, Echinacea, Hydrastis canadensis, Taraxacum officinale, Aconitum napellus, Aethusa cynapium, Agaricus muscarius, Aletris farinosa, Alfalfa, Allium cepa, Allium sativum, Ambrosia artemisiaefolia, Arsenicum album, Artemisia vulgaris, Arundo mauritanica, Avena sativa, Belladonna, Bellis perrenis, Bovista, Bromium, Bryonia, Caffeinum, Calcarea carbonica, Calluna vulgaris, flos, Capsicum annuum, Cat hair, Chamomilla, Chelidonium majus, Chenopodium anthelminticum, Cinnamomum	PELLET	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; AETHUSA CYNAPIUM; ALETRIS FARINOSA ROOT; ALFALFA; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; AMBROSIA ARTEMISIIFOLIA; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; ARUNDO PLINIANA ROOT; ASCORBIC ACID; ASTACUS ASTACUS; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BELLIS PERENNIS; BLACK MUSTARD SEED; BROMINE; BRYONIA ALBA ROOT; CAFFEINE; CALLUNA VULGARIS FLOWERING TOP; CANIS LUPUS FAMILIARIS HAIR; CAPSICUM; CHELIDONIUM MAJUS; CINNAMON; CLAVICEPS PURPUREA SCLEROTIUM; CORN SILK; COW MILK; CYNARA SCOLYMUS LEAF; DATURA STRAMONIUM; DROSERA ANGLICA; DYSPHANIA AMBROSIOIDES; ECHINACEA, UNSPECIFIED; EGG SHELL, COOKED; ELYMUS REPENS ROOT; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM; FAGUS SYLVATICA NUT; FELIS CATUS HAIR; FRAXINUS AMERICANA BARK; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; HYOSCYAMUS NIGER; JUGLANS REGIA LEAF; JUNIPERUS VIRGINIANA TWIG; LACTOSE, UNSPECIFIED FORM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; MATRICARIA CHAMOMILLA; MENTHA PIPERITA; NUTMEG; ONION; ONOSMODIUM VIRGINIANUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM IODIDE; PROTORTONIA CACTI; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; RHODODENDRON TOMENTOSUM LEAFY TWIG; ROSA X DAMASCENA FLOWERING TOP; SACCHARIN; SACCHAROMYCES CEREVISIAE; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SODIUM NITRATE; SOLANUM DULCAMARA TOP; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SUCROSE; SULFUR; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 6; 15; 15; 15; 16; 16; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 6; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 16; 15; 16; 16; 16; 16; 15; 6; 15; 15; 15; 16; 15; 15; 15; 15; 16	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Ascorbic Acid [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylxanthine [EPC], Milk Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-4721_b5e2e34e-5bbb-b085-e053-2995a90adc9f	55714-4721	HUMAN OTC DRUG	Parasites		Abrotanum, Aesculus hipp., Allium sativum, Arsenicum alb., Artemisia, Baptisia, Cina, Cuprum met., Filix mas, Granatum, Ipecac, Lachesis, Lycopodium, Merc. viv, Naphthalinum, Nat. mur., Nux vom., Pulsatilla, Ratanhia, Ruta, Sabadilla, Santoninum, Silicea, Spigelia anth., Terebinthina, Teucrium marum, Thymolum, Zingiber, Juglans regia	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ARTEMISIA ABROTANUM FLOWERING TOP; ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; BAPTISIA TINCTORIA ROOT; COPPER; DRYOPTERIS FILIX-MAS ROOT; GARLIC; GINGER; HORSE CHESTNUT; IPECAC; JUGLANS REGIA LEAF; KRAMERIA LAPPACEA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURY; NAPHTHALENE; PUNICA GRANATUM ROOT BARK; RUTA GRAVEOLENS FLOWERING TOP; SANTONIN; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; SODIUM CHLORIDE; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM; THYMOL; TURPENTINE OIL	20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4732_b5e505a7-ca35-0d0a-e053-2a95a90ae77b	55714-4732	HUMAN OTC DRUG	Tobacco Withdrawal		Arsenicum alb., Benzoicum acidum, Berber. vulg., Bryonia, Caladium seguinum, Cantharis, Ceanothus, Chelidonium majus, Chionanthus virginica, Cinchona, Daphne indica, Ignatia, Iris versicolor, Lycopodium, Nicotinum, Nux vom., Rhus toxicodendron, Scutellaria lateriflora, Tabacum, Echinacea, Taraxacum, Valeriana	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIOXIDE; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; DAPHNE ODORA BARK; DIEFFENBACHIA SEGUINE; ECHINACEA, UNSPECIFIED; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; NICOTINE; SCUTELLARIA LATERIFLORA WHOLE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cholinergic Nicotinic Agonist [EPC], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nicotine [CS], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4748_b59505bb-8a53-335b-e053-2995a90a3c98	55714-4748	HUMAN OTC DRUG	Incontinence		Aloe, Arg. nit., Arsenicum alb., Belladonna, Benzoicum acidum, Bryonia, Cantharis, Causticum, Equisetum hyemale, Ferrum metallicum, Gelsemium, Ignatia, Kali phos., Lycopodium, Nat. mur., Nitricum ac., Plantago, Pulsatilla, Rhus aromatica , Sabal, Secale, Sepia, Staphysag.,Stramonium, Thyroidinum, Verbascum, Echinacea, Hydrastis	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CLAVICEPS PURPUREA SCLEROTIUM; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; IRON; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; NITRIC ACID; PLANTAGO MAJOR; POTASSIUM PHOSPHATE, DIBASIC; RHUS AROMATICA ROOT BARK; SAW PALMETTO; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; THYROID, UNSPECIFIED; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
55714-4749_b5ab03e7-dae4-7b87-e053-2995a90a42fc	55714-4749	HUMAN OTC DRUG	Menstrual - PMS		Angelica sinensis radix, Arsenicum alb., Bryonia, Caulophyllum, Cimicifuga, Cinchona, Dioscorea, Folliculinum, Gelsemium, Lachesis, Lilium, Lycopodium, Millefolium, Nux vom., Pulsatilla, Sabina, Secale, Sepia,Thlaspi, Viburnum op., Zingiber, Echinacea, Valeriana	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACHILLEA MILLEFOLIUM; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA ROOT; CAPSELLA BURSA-PASTORIS; CAULOPHYLLUM THALICTROIDES ROOT; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; DIOSCOREA VILLOSA TUBER; ECHINACEA, UNSPECIFIED; ESTRONE; GELSEMIUM SEMPERVIRENS ROOT; GINGER; JUNIPERUS SABINA LEAFY TWIG; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; VALERIAN; VIBURNUM OPULUS BARK	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4750_b5e3258f-a3e7-82ec-e053-2995a90aa0d6	55714-4750	HUMAN OTC DRUG	Post - Vaccination		Influenzinum, Morbillinum, Pertussinum, Aconitum nap., Alumina, Antimon. tart., Arsenicum alb., Baptisia, Belladonna, Bryonia, Cinchona, Crotalus horridus, Gelsemium, Kali bic., Lachesis, Ledum, Merc. viv., Mezereum, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Silicea, Sulphur, Thuja occ., Vaccinium, Apis mel., Echinacea, Hypericum	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALUMINUM OXIDE; ANTIMONY POTASSIUM TARTRATE; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BILBERRY; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYPERICUM PERFORATUM; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LACHESIS MUTA VENOM; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MERCURY; PHOSPHORUS; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 30; 6; 30; 30; 15; 15; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4751_b5827c57-cec4-947e-e053-2995a90ad297	55714-4751	HUMAN OTC DRUG	Diabase		Cynara, Echinacea, Iris vers., Thuja occ., Urtica ur., Arg. met., Arsenicum alb., Aur. met., Bovista, Bryonia, Chelidonium maj., Chionanthus, Gaultheria, Helonias, Iris vers., Lycopodium, Nux vom., Phos., Rhus tox., Sabal, Syzygium	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHAMAELIRIUM LUTEUM ROOT; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CYNARA SCOLYMUS LEAF; ECHINACEA, UNSPECIFIED; GAULTHERIA PROCUMBENS TOP; GOLD; IRIS VERSICOLOR ROOT; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; SAW PALMETTO; SILVER; STRYCHNOS NUX-VOMICA SEED; SYZYGIUM CUMINI SEED; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
55714-4753_b5e57356-d97b-7432-e053-2995a90af6d0	55714-4753	HUMAN OTC DRUG	Warts - Moles - Skin Tags		Antimon. crud., Bryonia, Calc.carb., Causticum, Dulcamara, Graphites, Lycopodium, Merc. sulph. rub., Nat. carb., Nitricum ac., Nux vom., Rhus toxicodendron, Sabina, Sepia, Silicea, Staphysag., Sulphur, Thuja occ., Taraxacum	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; BRYONIA ALBA ROOT; CAUSTICUM; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; JUNIPERUS SABINA LEAFY TWIG; LYCOPODIUM CLAVATUM SPORE; MERCURIC SULFIDE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CARBONATE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4754_b582ac44-b5b9-f54f-e053-2995a90a132b	55714-4754	HUMAN OTC DRUG	Digestive Care		Bismuthum metallicum, Antimon.crud., Arg. nit., Arsenicum alb., Baptisia, Bryonia, Chamomilla, Cinchona, Iris versicolor, Kali bic., Lachesis, Lycopodium, Mag. carb., Nux vom., Phosphorus, Podoph. pelt., Pulsatilla, Raphanus, Rhus toxicodendron, Tabacum, Verbascum, Zingiber, Echinacea, Juglans regia.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; GINGER; IRIS VERSICOLOR ROOT; JUGLANS REGIA LEAF; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; PHOSPHORUS; PODOPHYLLUM; POTASSIUM DICHROMATE; RADISH; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_M]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-4755_b582a7bc-3726-3fbd-e053-2995a90a8aa3	55714-4755	HUMAN OTC DRUG	Digestive Care		Bismuthum metallicum, Antimon.crud., Arg. nit., Arsenicum alb., Baptisia, Bryonia, Chamomilla, Cinchona, Iris versicolor, Kali bic., Lachesis, Lycopodium, Mag. carb., Nux vom., Phosphorus, Podoph. pelt., Pulsatilla, Raphanus, Rhus toxicodendron, Tabacum, Verbascum, Zingiber, Echinacea, Juglans regia.	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BISMUTH; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; GINGER; IRIS VERSICOLOR ROOT; JUGLANS REGIA LEAF; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; PHOSPHORUS; PODOPHYLLUM; POTASSIUM DICHROMATE; RADISH; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_M]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-4756_b5a89c6f-d9dc-6b12-e053-2a95a90a4a80	55714-4756	HUMAN OTC DRUG	Joint Care		Uricum acidum, Aconitum nap.,Apis mel., Arnica, Arsenicum alb, Belladonna,Benzoicum acidum, Bryonia, Calc. carb., Chamomilla, Cinchona, Colchicum, Eupatorium perf., Gaultheriaprocumbens, Guaiacum, Iodium, Kali bic, Kalmia,Ledum, Pulsatilla, Rhus toxicodendron, Ruta,Sabina, Strychninum, Lappa, Phytolacca, Symphytum,	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BENZOIC ACID; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GAULTHERIA PROCUMBENS TOP; GUAIACUM OFFICINALE RESIN; IODINE; JUNIPERUS SABINA LEAFY TWIG; KALMIA LATIFOLIA LEAF; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNINE; TOXICODENDRON PUBESCENS LEAF; URIC ACID	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4757_b5a90367-424b-4bdf-e053-2995a90aefa4	55714-4757	HUMAN OTC DRUG	Joint Care		Uricum acidum, Aconitum nap.,Apis mel., Arnica, Arsenicum alb, Belladonna,Benzoicum acidum, Bryonia, Calc. carb., Chamomilla, Cinchona, Colchicum, Eupatorium perf., Gaultheriaprocumbens, Guaiacum, Iodium, Kali bic, Kalmia,Ledum, Pulsatilla, Rhus toxicodendron, Ruta,Sabina, Strychninum, Lappa, Phytolacca, Symphytum,	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BENZOIC ACID; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GAULTHERIA PROCUMBENS TOP; GUAIACUM OFFICINALE RESIN; IODINE; JUNIPERUS SABINA LEAFY TWIG; KALMIA LATIFOLIA LEAF; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNINE; TOXICODENDRON PUBESCENS LEAF; URIC ACID	15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4758_b5e36a93-cb90-f1a1-e053-2995a90a5580	55714-4758	HUMAN OTC DRUG	Prostate		Thyroidinum, Baryta carb., Berber. vulg., Bryonia, Calc. carb., Cinchona, Conium, Digitalis, Ferrum picricum, Hydrastis, Iodium, Lycopodium, Nux vom., Pareira, Pulsatilla, Sabal, Selenium, Staphysag., Thuja occ.,Trifolium pratense, Echinacea, Lappa, Solidago	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARCTIUM LAPPA ROOT; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; FERRIC PICRATE; GOLDENSEAL; IODINE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SAW PALMETTO; SELENIUM; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER	15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Iron [CS], Non-Standardized Plant Allergenic Extract [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4759_b5ab99d9-2e9f-5578-e053-2995a90a81b3	55714-4759	HUMAN OTC DRUG	Muscle-Tendon		Aconitum nap., Antimon. tart.,Arg. nit., Arnica, Bryonia, Chamomilla,Chelidonium majus, Cimicifuga, Eupatorium perf.,Hypericum, Nux vom., Rhus toxicodendron, Ruta,Sarcolacticum ac., Stramonium, Strychninum,Chamomilla, Phytolacca, Ruta, Symphytum.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ARNICA MONTANA; BLACK COHOSH; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COMFREY ROOT; DATURA STRAMONIUM; EUPATORIUM PERFOLIATUM FLOWERING TOP; HYPERICUM PERFORATUM; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; PHYTOLACCA AMERICANA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4760_b5a82541-b1ac-6fe7-e053-2a95a90a2a25	55714-4760	HUMAN OTC DRUG	Inflammation-Fever		Anthracinum, Pyrogenium, Aconitum nap., Aloe, Apis mel., Arnica, Arsenicum alb., Baptisia, Belladonna, Bryonia, Cantharis, Chelidonium majus, Crotalus horridus, Ferrum phosphoricum, Gaultheria procumbens, Hepar sulph. calc., Iodium, Lachesis, Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Veratrum viride, Verbascum, Echinacea	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALOE; ANEMONE PULSATILLA; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GAULTHERIA PROCUMBENS TOP; IODINE; LACHESIS MUTA VENOM; LYTTA VESICATORIA; PHOSPHORUS; RANCID BEEF; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VERATRUM VIRIDE ROOT; VERBASCUM THAPSUS	20; 20; 20; 20; 20; 20; 20; 35; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 35; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4761_b5e3619a-e327-5ccb-e053-2995a90ad159	55714-4761	HUMAN OTC DRUG	Rashes-Hives		Antimon. crud., Apis mel., Arsenicum alb., Berber. vulg., Bovista, Bryonia, Cantharis, Chelidonium majus, Croton, Dulcamara, Graphites, Histaminum hydrochloricum, Lycopodium, Mezereum, Nux vom., Petroleum, Pulex irritans, Pulsatilla, Rhus toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex crisp., Taraxacum, Urtica ur.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; KEROSENE; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULEX IRRITANS; RUMEX CRISPUS ROOT; SMILAX ORNATA ROOT; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4762_b5e37394-50e9-7930-e053-2a95a90a6b2a	55714-4762	HUMAN OTC DRUG	Rashes-Hives		Antimon. crud., Apis mel., Arsenicum alb., Berber. vulg., Bovista, Bryonia, Cantharis, Chelidonium majus, Croton, Dulcamara, Graphites, Histaminum hydrochloricum, Lycopodium, Mezereum, Nux vom., Petroleum, Pulex irritans, Pulsatilla, Rhus toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex crisp., Taraxacum, Urtica ur.	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; KEROSENE; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULEX IRRITANS; RUMEX CRISPUS ROOT; SMILAX ORNATA ROOT; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4763_b5e35e91-1a9e-8b4e-e053-2a95a90a7bff	55714-4763	HUMAN OTC DRUG	Prime of Life		Agnus, Allium sativum, Ambra, Angelica sinensis radix, Aralia quinquefolia, Arnica, Arsenicum alb., Avena, Baptisia, Baryta carb., Bryonia, Cantharis, Lachesis, Lycopodium, Nux vom., Phosphoricum ac., Pulsatilla, Ruta, Sabal, Selenium, Zinc. met., Ginkgo	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMBERGRIS; AMERICAN GINSENG; ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARNICA MONTANA; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; BRYONIA ALBA ROOT; CHASTE TREE; GARLIC; GINKGO; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PHOSPHORIC ACID; RUTA GRAVEOLENS FLOWERING TOP; SAW PALMETTO; SELENIUM; STRYCHNOS NUX-VOMICA SEED; ZINC	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4764_b5822ae1-27c9-68ed-e053-2a95a90acc27	55714-4764	HUMAN OTC DRUG	Constipation		Abies nig., Aesculus hipp., Aloe, Alumina, Bryonia, Carbo veg., Chelidonium majus, Collinsonia , Graphites, Hydrastis, Kali carb., Lycopodium, Mag. mur., Mezereum, Nux vom., Podoph. pelt., Rhamnus purshiana, Sanicula, Selenium, Sepia, Silicea, Tabacum, Veratrum alb., Zinc.met., Echinacea, Iris versicolor, Phytolacca, Taraxacum	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALOE; ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COLLINSONIA CANADENSIS ROOT; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GOLDENSEAL; GRAPHITE; HORSE CHESTNUT; IRIS VERSICOLOR ROOT; KRAMERIA LAPPACEA ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; PHYTOLACCA AMERICANA ROOT; PICEA MARIANA RESIN; PODOPHYLLUM; POTASSIUM CARBONATE; SANICULA EUROPAEA LEAF; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TOBACCO LEAF; VERATRUM ALBUM ROOT; ZINC	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-4765_b5808f18-f5c3-7d5a-e053-2a95a90a3467	55714-4765	HUMAN OTC DRUG	CardCare		Echinacea, Hypericum, Valeriana, Aconitum nap., Arsenicum alb., Aur. met., Baryta carb., Benzoicum ac., Berber. vulg., Bryonia, Calc. fluor., Cantharis, Ceanothus, Chelidonium maj., Chionanthus, Cinchona, Convallaria, Crotalus hor., Digitalis, Gelsemium, Glonoinum, Hydrofluoricum ac. Kali iod., Lachesis, Lycopus, Naja, Nux vom., Phos., Pulsatilla, Rhus tox., Vipera, Elaps.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BARIUM CARBONATE; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HYDROFLUORIC ACID; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; POTASSIUM IODIDE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VIPERA BERUS VENOM	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 30; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
55714-4766_b5e2c778-0084-650d-e053-2a95a90a95aa	55714-4766	HUMAN OTC DRUG	Panic Ease		Aconitum nap., Apis mel., Arnica, Arsenicum alb., Belladonna, Bellis, Bryonia, Calendula, Chamomilla, Cistus canadensis, Ferrum phosphoricum, Histaminum hydrochloricum, Hypericum, Ignatia, Mezereum, Ornithogalum, Passiflora, Phosphorus, Prunus spin., Rhus toxicodendron, Sarcolacticum ac., Sulphur, Veratrum alb., Valeriana.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; DAPHNE MEZEREUM BARK; FERROSOFERRIC PHOSPHATE; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; ORNITHOGALUM UMBELLATUM; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PRUNUS SPINOSA FLOWER BUD; STRYCHNOS IGNATII SEED; SULFUR; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERATRUM ALBUM ROOT	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4767_da70af90-a25b-fdbd-e053-2a95a90a9548	55714-4767	HUMAN OTC DRUG	Cold - Cough		Influenza A Virus, Influenza B Virus, Antimon. tart., Arsenicum alb., Bryonia, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Histaminum hydrochloricum, Hydrastis, Kali bic., Kali carb.,Kali iod., Myrrha, Nat. sulphuricum, Nux vom., Phosphorus, Pulsatilla, Rumex crisp., Sambucus nig., Spongia, Tussilago farfara, Verbascum, Echinacea, Lappa	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ANGLICA; ECHINACEA, UNSPECIFIED; EUCALYPTUS GUM; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4768_da70f37b-78c3-b247-e053-2a95a90afb8f	55714-4768	HUMAN OTC DRUG	Cold-Cough		Echinacea, Lappa, Antimon. tart., Arsenicum alb., Bryonia, Chelidonium maj., Cinchona, Drosera, Eucalyptus, Histaminum hydrochloricum, Hydrastis, Kali bic., Kali carb., Kali iod., Myrrha, Nat. sulphuricum, Nux vom., Phos., Pulsatilla, Rumex crisp., Sambucus nig., Spongia, Tussilago far., Verbascum, Influenzinum.	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ANGLICA; ECHINACEA, UNSPECIFIED; EUCALYPTUS GUM; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4769_b592ade1-a61b-0588-e053-2995a90aa070	55714-4769	HUMAN OTC DRUG	Female Femroids		Hydrastis canadensis, Thuja occidentalis, Arsenicum album, Calcarea iodata, Carbo animalis, Conium maculatum, Graphites, Hydrastis canadensis, Iodium, Kreosotum, Lachesis mutus, Phosphorus, Sabina, Secale cornutum, Sepia, Silicea, Thlaspi bursa-pastoris, Thuja occidentalis, Thyroidinum, Trillium pendulum, Ustilago maidis.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIOXIDE; CALCIUM IODIDE; CAPSELLA BURSA-PASTORIS; CARBO ANIMALIS; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; GOLDENSEAL; GRAPHITE; IODINE; JUNIPERUS SABINA LEAFY TWIG; LACHESIS MUTA VENOM; PHOSPHORUS; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TRILLIUM ERECTUM ROOT; USTILAGO MAYDIS; WOOD CREOSOTE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
55714-4771_b582c419-8c44-edc6-e053-2a95a90ae52f	55714-4771	HUMAN OTC DRUG	Distress-Mood-Sadness		Angelica sinensis radix, Aralia quinquefolia, Arg. nit., Arsenicum alb., Berber. aqui., Capsicum , Cinchona, Digitalis, Gelsemium, Hypericum, Ignatia, Iodium, Kali brom., Kali carb., Mag. phos., Nat. carb., Nat. mur., Phosphorus, Salix nigra, Sanguinaria, Sepia, Stramonium, Echinacea, Ginkgo	LIQUID	ORAL	20180902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BERBERIS AQUIFOLIUM ROOT BARK; CAPSICUM; CINCHONA OFFICINALIS BARK; DATURA STRAMONIUM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HYPERICUM PERFORATUM; IODINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHOSPHORUS; POTASSIUM BROMIDE; POTASSIUM CARBONATE; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
55714-4772_b582999c-14bf-6f3e-e053-2a95a90a2eeb	55714-4772	HUMAN OTC DRUG	Distress-Mood-Sadness		Angelica sinensis radix, Aralia quinquefolia, Arg. nit., Arsenicum alb., Berber. aqui., Capsicum , Cinchona, Digitalis, Gelsemium, Hypericum, Ignatia, Iodium, Kali brom., Kali carb., Mag. phos., Nat. carb., Nat. mur., Phosphorus, Salix nigra, Sanguinaria, Sepia, Stramonium, Echinacea, Ginkgo	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BERBERIS AQUIFOLIUM ROOT BARK; CAPSICUM; CINCHONA OFFICINALIS BARK; DATURA STRAMONIUM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HYPERICUM PERFORATUM; IODINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHOSPHORUS; POTASSIUM BROMIDE; POTASSIUM CARBONATE; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
55714-4773_b5e5161c-36d2-aa11-e053-2995a90a4241	55714-4773	HUMAN OTC DRUG	Varicose Veins		Elaps corallinus, Crotalus horridus, Bryonia, Calc. fluor., Carduus mar., Cholesterinum, Cinchona, Digitalis, Hamamelis, Hydrofluoricum acidum, Lachesis, Lycopodium, Naja, Pulsatilla, Vipera berus, Zinc. met., Aesculus hipp., Echinacea	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CHOLESTEROL; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; HYDROFLUORIC ACID; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; MILK THISTLE; NAJA NAJA VENOM; VIPERA BERUS VENOM; ZINC	15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 30; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-4774_b5928f0a-8a3c-6765-e053-2995a90a9011	55714-4774	HUMAN OTC DRUG	Eye Floaters		Aloe, Carbo vegetabilis, Causticum, Chelidonium majus, Cholesterinum, Cinchona officinalis, Colchicum autumnale, Cyclamen europaeum, Gelsemium sempervirens, Kali carbonicum, Mercurius vivus, Phosphorus, Physostigma venenosum, Prunus spinosa, Senega officinalis, Sepia, Sulphur, Tabacum.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALOE; CAUSTICUM; CHELIDONIUM MAJUS; CHOLESTEROL; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; CYCLAMEN PURPURASCENS TUBER; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; MERCURY; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; POLYGALA SENEGA ROOT; POTASSIUM CARBONATE; PRUNUS SPINOSA FLOWER BUD; SEPIA OFFICINALIS JUICE; SULFUR; TOBACCO LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55714-4775_b5825378-1d06-2593-e053-2a95a90a3ed8	55714-4775	HUMAN OTC DRUG	Connec-T		Echinacea, Solidago virgaurea, Taraxacum officinale, Arsenicum album, Baptisia tinctoria, Berberis aquifolium, Calcarea fluorica, Capsicum annuum, Carduus marianus, Cinchona officinalis, Iodium, Kali carbonicum, Lachesis mutus, Magnesia carbonica, Mercurius vivus, Natrum carbonicum, Natrum muriaticum, Natrum sulphuricum, Phosphorus, Phytolacca decandra, Secale cornutum, Thymus serpyllum, Thuja occidentalis, Thyroidinum, Verbascum thapsus.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BERBERIS AQUIFOLIUM ROOT BARK; CALCIUM FLUORIDE; CAPSICUM; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; ECHINACEA, UNSPECIFIED; IODINE; LACHESIS MUTA VENOM; MAGNESIUM CARBONATE; MERCURY; MILK THISTLE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SODIUM CARBONATE; SODIUM CHLORIDE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; THYMUS SERPYLLUM; THYROID, UNSPECIFIED; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-4776_b5800d61-1126-40a7-e053-2a95a90acf9d	55714-4776	HUMAN OTC DRUG	BronCare		Echinacea, Lappa, Rumex crisp., Antimon. tart., Arsenicum alb., Bryonia, Camphora, Chelidonium maj., Cinchona, Drosera, Eucalyptus, Hepar sulph. calc., Histaminum hydrochloricum, Ipecac., Kali bic., Kali carb., Kali iod., Lycopodium, Myrrha, Nat. sulphuricum, Nux vom., Phos., Pulsatilla, Sainguinaria, Spongia, Stannum met., Tussilago far., Verbascum, Influenzinum	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAMPHOR (NATURAL); CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ANGLICA; ECHINACEA, UNSPECIFIED; EUCALYPTUS GUM; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IPECAC; LYCOPODIUM CLAVATUM SPORE; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; RUMEX CRISPUS ROOT; SANGUINARIA CANADENSIS ROOT; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TIN; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4778_b5e44078-0ba2-c029-e053-2995a90aefcf	55714-4778	HUMAN OTC DRUG	Sinu-S		Echinacea, Hydrastis canadensis, Arsenicum iodatum, Bryonia, Cistus canadensis, Hepar sulphuris calcareum, Histaminum hydrochloricum, Hydrastis canadensis, Iodium, Kali bichromicum, Kali iodatum, Mercurius iodatus ruber, Mercurius vivus, Nux vomica, Phosphorus Pulsatilla, Sabadilla, Sticta , Verbascum thapsus, Sinusitisinum	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; ECHINACEA, UNSPECIFIED; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; IODINE; LOBARIA PULMONARIA; MERCURIC IODIDE; MERCURY; PHOSPHORUS; POTASSIUM DICHROMATE; POTASSIUM IODIDE; SCHOENOCAULON OFFICINALE SEED; SINUSITISINUM; STRYCHNOS NUX-VOMICA SEED; VERBASCUM THAPSUS	15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4779_b5831377-9794-efa2-e053-2995a90a1e24	55714-4779	HUMAN OTC DRUG	Dizzi-V		Absinthium, Aconitum nap., Antimon. tart., Belladonna, Bryonia, Carbolicum acidum, Colchicum, Conium, Ferrum metallicum, Gelsemium, Glonoinum, Hyoscyamus, Ipecac., Iris versicolor, Lycopodium, Nux vom., Petroleum, Phosphorus, Sepia, Symphoricarpus racemosus, Tabacum, Theridion, Zingiber, Echinacea, Hypericum, Passiflora, Valeriana	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINGER; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; IPECAC; IRIS VERSICOLOR ROOT; IRON; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; PASSIFLORA INCARNATA FLOWERING TOP; PHENOL; PHOSPHORUS; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SYMPHORICARPOS ALBUS FRUIT; THERIDION CURASSAVICUM; TOBACCO LEAF; VALERIAN; WORMWOOD	20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 11; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-4780_b5831b82-5211-2453-e053-2a95a90a03da	55714-4780	HUMAN OTC DRUG	Dizzi-V		Absinthium, Aconitum nap., Antimon. tart., Belladonna, Bryonia, Carbolicum acidum, Colchicum, Conium, Ferrum metallicum, Gelsemium, Glonoinum, Hyoscyamus, Ipecac., Iris versicolor, Lycopodium, Nux vom., Petroleum, Phosphorus, Sepia, Symphoricarpus racemosus, Tabacum, Theridion, Zingiber, Echinacea, Hypericum, Passiflora, Valeriana	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GINGER; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; IPECAC; IRIS VERSICOLOR ROOT; IRON; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; PASSIFLORA INCARNATA FLOWERING TOP; PHENOL; PHOSPHORUS; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SYMPHORICARPOS ALBUS FRUIT; THERIDION CURASSAVICUM; TOBACCO LEAF; VALERIAN; WORMWOOD	20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 11; 20	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-4781_b57f92c2-85fa-ce67-e053-2a95a90a9221	55714-4781	HUMAN OTC DRUG	Blad-R		Apis mel., Berber. vulg., Bryonia, Cantharis, Cinchona, Equisetum hyemale, Ferrum phosphoricum, Gelsemium, Juniperus com., Pareira, Phosphorus, Plantago, Pulsatilla, Sabal, Terebinthina, Uva-ursi, Echinacea, Hydrastis, Lappa, Solidago	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EQUISETUM HYEMALE; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; JUNIPER BERRY; LYTTA VESICATORIA; PHOSPHORUS; PLANTAGO MAJOR; SAW PALMETTO; SOLIDAGO VIRGAUREA FLOWERING TOP; TURPENTINE OIL	20; 20; 11; 20; 20; 20; 20; 20; 11; 20; 20; 20; 11; 20; 20; 20; 20; 20; 11; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4783_b5abb3d5-39f4-3349-e053-2a95a90aada7	55714-4783	HUMAN OTC DRUG	Nervousness - Anxiety		Aconitum nap., Ambra, Anacardium orientale, Arg. nit., Asafoetida, Bryonia, Chamomilla, Cimicifuga, Coffea cruda, Cypripedium, Gelsemium, Hyoscyamus, Hypericum, Ignatia, Kali phos., Nux vom., Sambucus nig., Strychninum, Theridion, Valeriana, Passiflora	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMBERGRIS; ARABICA COFFEE BEAN; BLACK COHOSH; BRYONIA ALBA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DIBASIC POTASSIUM PHOSPHATE; FERULA ASSA-FOETIDA RESIN; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; STRYCHNINE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM; VALERIAN	20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4785_b5940dc3-eaa9-1964-e053-2a95a90a35d3	55714-4785	HUMAN OTC DRUG	G-Inflamm		Chamomilla, Echinacea, Iris versicolor, Ruta graveolens, Taraxacum officinale, Antimonium crudum, Argentum nitricum, Arsenicum album, Baptisia tinctoria, Bismuthum metallicum, Bryonia, Cinchona officinalis, Colocynthis, Graphites, Hepar sulphuris calcareum, Hydrastis canadensis, Ipecacuanha, Kali bichromicum, Kali carbonicum, Lycopodium clavatum, Magnesia carbonica, Magnesia phosphorica, Nux vomica, Phosphorus, Podophyllum peltatum, Pulsatilla, Zingiber officinale.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BISMUTH; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; ECHINACEA, UNSPECIFIED; GINGER; GOLDENSEAL; GRAPHITE; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; PHOSPHORUS; PODOPHYLLUM; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; RUTA GRAVEOLENS FLOWERING TOP; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-4786_b5aae85f-4c52-e3b4-e053-2995a90adb9b	55714-4786	HUMAN OTC DRUG	Mega Menses		Apis mellifica, Hamamelis virginiana, Hydrastis canadensis, Aletris farinosa, Apocynum cannabinum, Cinchona officinalis, Cinnamomum, Conium maculatum, Helonias dioica, Lilium tigrinum, Millefolium, Phosphorus, Secale cornutum, Thlaspi bursa-pastoris, Trillium pendulum.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACHILLEA MILLEFOLIUM; ALETRIS FARINOSA ROOT; APIS MELLIFERA; APOCYNUM CANNABINUM ROOT; CAPSELLA BURSA-PASTORIS; CHAMAELIRIUM LUTEUM ROOT; CINCHONA OFFICINALIS BARK; CINNAMON; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LILIUM LANCIFOLIUM WHOLE FLOWERING; PHOSPHORUS; TRILLIUM ERECTUM ROOT	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4787_b5e39110-3c2f-7a2c-e053-2a95a90a9c31	55714-4787	HUMAN OTC DRUG	Restless Leg		Mygale, Agaricus musc., Causticum, Cinchona, Conium, Cuprum met., Gelsemium, Hyoscyamus, Hypericum, Kali carb., Mag. carb., Merc. viv., Nux vom., Plumb. met., Rhus toxicodendron, Secale, Strychninum, Tarentula hispana, Valeriana, Verbascum, Zinc. met., Chamomilla,Passiflora	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY; AVICULARIA AVICULARIA; CAUSTICUM; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; COPPER; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; LEAD; LYCOSA TARANTULA; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; MERCURY; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VERBASCUM THAPSUS; ZINC	15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4788_b592c526-4f77-c676-e053-2995a90ae63b	55714-4788	HUMAN OTC DRUG	Fungal		Candida albicans, Sanicula, Tellurium metallicum, Torula cerevisiae, Antimon. crud., Arsenicum alb., Baryta carb., Bryonia, Calc. carb., Carbo veg., Cuprum met., Dulcamara, Graphites, Kali carb., Lachesis, Lycopodium, Mezereum, Nitricum ac., Phosphorus, Phytolacca, Sepia, Silicea, Sulphur, Sulphuricum ac., Zinc. met., Apis mel., Thuja occ.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BARIUM CARBONATE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; COPPER; DAPHNE MEZEREUM BARK; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SACCHAROMYCES CEREVISIAE; SANICULA EUROPAEA LEAF; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG; ZINC	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 16; 15; 15; 15; 15; 15; 16; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4789_b5abd43f-3366-a1ae-e053-2995a90ae92b	55714-4789	HUMAN OTC DRUG	Oral Care-Gingivitis		Aconitum nap., Arnica, Arsenicum alb., Baptisia, Belladonna, Bryonia, Calendula, Chamomilla, Chelidonium majus, Crotalus horridus, Gelsemium, Hepar sulph. calc., Kreosotum, Merc. viv., Myrrha, Nux vom., Phosphorus, Phytolacca, Plantago, Rhus toxicodendron, Silicea, Staphysag., Echinacea	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CHELIDONIUM MAJUS; CROTALUS HORRIDUS HORRIDUS VENOM; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA; MERCURY; MYRRH; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; WOOD CREOSOTE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4790_b57eb850-8be7-891c-e053-2995a90a5c46	55714-4790	HUMAN OTC DRUG	Acne - Cystic Acne		Echinacea, juglans regia, lappa major, taraxacum officinale, antimonium crudum, arsenicum album, aurum metallicum, berberis aquifolium, Bovista, carbo vegetabilis, causticum, chelidonium majus, dulcamara, graphites, hepar sulphuris calcareum, hydrocotyle asiatica, kali bromatum, kali iodatum, ledum palustre, lycopdium clavatum, nux vomica, Sulphur iodatum, zincum metallicum, silicea	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; ARCTIUM LAPPA WHOLE; ARSENIC TRIOXIDE; BERBERIS AQUIFOLIUM WHOLE; CALCIUM SULFIDE; CALVATIA GIGANTEA WHOLE; CAUSTICUM; CENTELLA ASIATICA; CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; GOLD; GRAPHITE; JUGLANS REGIA WHOLE; LEDUM PALUSTRE WHOLE; LYCOPODIUM CLAVATUM WHOLE; POTASSIUM BROMIDE; POTASSIUM IODIDE; SILICON DIOXIDE; SOLANUM DULCAMARA WHOLE; STRYCHNOS NUX-VOMICA WHOLE; SULFUR IODIDE; TARAXACUM OFFICINALE; ZINC	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55714-4791_b57f2b98-dd9a-789c-e053-2a95a90af013	55714-4791	HUMAN OTC DRUG	Appetite - Craving Control		Chamomilla, Passiflora, Valeriana, Anacardium, Antimon. crud., Arg. nit., Berber. vulg., Bryonia, Chelidonium maj., Digitalis, Graphites, Humulus, Iris vers., Kali carb., Lycopodium, Nat. carb., Nat. sulphuricum, Nux vom., Pulsatilla, Rhus tox., Scutellaria, Sepia, Stramonium	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; DATURA STRAMONIUM; DIGITALIS; GRAPHITE; HOPS; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; SCUTELLARIA LATERIFLORA WHOLE; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN	20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4792_b5833e07-1e76-a4c8-e053-2a95a90a9351	55714-4792	HUMAN OTC DRUG	Drainer		Cynara scolymus, Solidago virgaurea, Taraxacum officinale, Benzoicum acidum, Berberis vulgaris, Bryonia, Cantharis, Carduus benedictus, Carduus marianus, Ceanothus americanus, Chelidonium majus, Chionanthus virginica, Cinchona officinalis, Dioscorea villosa, Dolichos pruriens, Iris versicolor, Juniperus communis, Nux vomica, Ptelea trifoliata, Taraxacum officinale, Uricum.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4793_b5836d3e-1725-5a73-e053-2995a90a607d	55714-4793	HUMAN OTC DRUG	Drainer		Cynara scolymus, Solidago virgaurea, Taraxacum officinale, Benzoicum acidum, Berberis vulgaris, Bryonia, Cantharis, Carduus benedictus, Carduus marianus, Ceanothus americanus, Chelidonium majus, Chionanthus virginica, Cinchona officinalis, Dioscorea villosa, Dolichos pruriens, Iris versicolor, Juniperus communis, Nux vomica, Ptelea trifoliata, Taraxacum officinale, Uricum.	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4794_0995fcbb-a9a7-90f0-e063-6294a90a289c	55714-4794	HUMAN OTC DRUG	Throat Care		Echinacea, Aconitum nap., Apis mel., Arum drac., Belladonna, Bryonia, Cajuputum, Ferrum phos., Glycyrrhiza, Kali bic., Lachesis, Menta pip., Merc. viv., Naja, Nat. carb., Nat sulphuricum, Nitricum ac., Nux vom., Phos., Phytolacca, Pulsatilla, Spongia, Stannum met., Sticta, Thuja occ., Ulmus fulv., Verbascum	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; APIS MELLIFERA; ARISAEMA DRACONTIUM ROOT; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CAJUPUT OIL; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GLYCYRRHIZA GLABRA; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; MENTHA PIPERITA; MERCURY; NAJA NAJA VENOM; NITRIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SODIUM CARBONATE; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA WHOLE; THUJA OCCIDENTALIS LEAFY TWIG; TIN; ULMUS RUBRA BARK; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4795_b5a8599f-63db-12ab-e053-2995a90a91bc	55714-4795	HUMAN OTC DRUG	Injury-Rescue		Aconitum nap, Arnica, Bellis, Calendula, Echinacea, Gelsemium, Hamamelis, Hypericum, Ledum, Phosphorus, Rhus toxicodendron, Ruta, Staphysag., Symphytum, Hydrastis canadensis.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARNICA MONTANA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-4796_9bb81542-c2ad-e744-e053-2a95a90ac2a6	55714-4796	HUMAN OTC DRUG	Dust-Mold-Dander		Iris versicolor, Solidago virgaurea, Antimonium crudum, Apis mellifica, Arsenicum album, Baptisia tinctoria, Blatta orientalis, Bromium, Bryonia, Candida albicans, Carduus benedictus, Cat hair, Chelidonium majus, Cinchona officinalis, Dog hair, Histaminum hydrochloricum, House dust, Ipecacuanha, Lycopodium clavatum, Nux vomica, Podophyllum peltatum, Rhus toxicodendron, Secale cornutum, Silicea, Ustilago maidis, Torula cerevisiae.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; APIS MELLIFERA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BLATTA ORIENTALIS; BROMINE; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CANIS LUPUS FAMILIARIS HAIR; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; FELIS CATUS HAIR; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; PODOPHYLLUM; SACCHAROMYCES CEREVISIAE; SILICON DIOXIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; USTILAGO MAYDIS	20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 21; 20; 11; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dander [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4798_b594757c-7858-f918-e053-2995a90a1277	55714-4798	HUMAN OTC DRUG	Headache-Migraine		Elaps corallinus, Arsenicum alb., Belladonna, Bryonia, Carduus benedictus, Cimicifuga, Coffea cruda, Convallaria, Crotalus horridus, Digitalis, Gelsemium, Glonoinum, Ignatia, Lachesis, Merc. viv., Naja, Nux vom., Phosphorus, Rhus toxicodendron, Sanguinaria, Secale, Vipera berus, Apis mel., Hypericum, Thuja occ..	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BLACK COHOSH; BRYONIA ALBA ROOT; CENTAUREA BENEDICTA; CLAVICEPS PURPUREA SCLEROTIUM; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; MERCURY; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; SANGUINARIA CANADENSIS ROOT; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; VIPERA BERUS VENOM	6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 30; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vasodilation [PE]		N	20241231
55714-4799_b583fbea-e1f6-6bed-e053-2995a90a86fe	55714-4799	HUMAN OTC DRUG	Eczema - Skin Care		Antimon. crud., Arsenicum alb., Berber. vulg., Bovista, Bryonia, Cantharis, Chelidonium majus, Croton, Dulcamara, Graphites, Hepar sulph. calc., Lycopodium, Mezereum, Nux vom., Petroleum, Pulex irritans, Pulsatilla, Rhus toxicodendron, Sarsaparilla, Sepia, Sulphur iod., Echinacea, Rumex crisp., Taraxacum, Urtica ur.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; KEROSENE; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PULEX IRRITANS; RUMEX CRISPUS ROOT; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR IODIDE; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 11; 20; 11	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4800_b5aac7bb-52f7-7f8e-e053-2a95a90a1ae6	55714-4800	HUMAN OTC DRUG	Menopause		Elaps corallinus, Agnus, Angelica sinensis radix, Arsenicum alb., Bryonia, Cantharis, Caulophyllum, Cimicifuga, Cinchona, Crotalus horridus, Damiana, Glonoinum, Helonias dioica, Ignatia, Kali carb., Lachesis, Naja, Nux vom., Phosphorus, Pulsatilla, Salix nigra, Sanguinaria, Sepia, Echinacea, Valeriana	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA ROOT; CAULOPHYLLUM THALICTROIDES ROOT; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; LACHESIS MUTA VENOM; LYTTA VESICATORIA; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; POTASSIUM CARBONATE; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TURNERA DIFFUSA LEAFY TWIG; VALERIAN	15; 15; 20; 15; 15; 15; 15; 15; 15; 15; 11; 15; 15; 35; 15; 15; 15; 15; 15; 15; 15; 15; 20; 15; 11	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
55714-4801_b5e2eb33-ec1d-b6b9-e053-2995a90a7384	55714-4801	HUMAN OTC DRUG	Poison Ivy		Xerophyllum asphodeloides, Aconitum nap., Anacardium orientale, Apis mel., Bryonia, Cantharis, Croton, Graphites, Grindelia, Mezereum, Nux vom., Ranunc. bulb., Rhus toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex crisp.,Taraxacum, Urtica ur.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; APIS MELLIFERA; BRYONIA ALBA ROOT; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; GRINDELIA HIRSUTULA FLOWERING TOP; LYTTA VESICATORIA; RANUNCULUS BULBOSUS; RUMEX CRISPUS ROOT; SEMECARPUS ANACARDIUM JUICE; SMILAX ORNATA ROOT; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; XEROPHYLLUM ASPHODELOIDES	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 15; 15; 15; 6; 15; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4802_b594ccb7-140f-8e68-e053-2a95a90a79d4	55714-4802	HUMAN OTC DRUG	Herpes Sores		Arsenicum alb., Bryonia, Cantharis, Chelidonium majus, Cistus canadensis, Conium, Croton, Dulcamara, Graphites, Kali bic., Lycopodium, Mezereum, Nux vom., Petroleum, Pulsatilla, Ranunc. bulb., Rhus toxicodendron, Sarsaparilla, Sepia, Sulphur, Thuja occ., Echinacea, Hypericum	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; GRAPHITE; HELIANTHEMUM CANADENSE; HYPERICUM PERFORATUM; KEROSENE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; POTASSIUM DICHROMATE; RANUNCULUS BULBOSUS; SEPIA OFFICINALIS JUICE; SMILAX ORNATA ROOT; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4803_b5e3c3ce-a444-ea15-e053-2995a90af813	55714-4803	HUMAN OTC DRUG	Sciatica-Back Care		Aconitum nap., Ammonium benzoicum, Arsenicum alb., Benzoicum acidum, Bryonia, Causticum, Cinchona, Colchicum, Gnaphalium polycephalum, Iris versicolor, Kali iod., Ledum, Lithium carb., Nux vom., Phytolacca, Rhus toxicoderon, Ruta, Sambucus nig., Strychninum, Hypericum, Urtica ur	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMMONIUM BENZOATE; ARSENIC TRIOXIDE; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; HYPERICUM PERFORATUM; IRIS VERSICOLOR ROOT; LITHIUM CARBONATE; PHYTOLACCA AMERICANA ROOT; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; STRYCHNINE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4804_b5e30eb6-f814-bb45-e053-2995a90a2c93	55714-4804	HUMAN OTC DRUG	Pollen-Weeds		Ginkgo biloba, Hydrastis canadensis, Taraxacum officinale, Adrenalinum , Aletris farinosa, Alfalfa, Allium cepa, Antimonium tartaricum, Arsenicum album, Artemisia vulgaris, Baptisia tinctoria, Bellis perennis, Berberis vulgaris, Bryonia, Calluna vulgaris, flos, Chelidonium majus, Chenopodium anthelminticum, Dioscorea vilosa, Euphrasia officinalis, Fagus sylvatica, Fraxinus americana, Gelsemium sempervirens, Histaminum hydrochloricum, Kali bichromicum, Kali iodatum, Lachesis mutus, Lilium tigrinum,	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALETRIS FARINOSA ROOT; ALFALFA; ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALLUNA VULGARIS FLOWERING TOP; CHELIDONIUM MAJUS; DIOSCOREA VILLOSA TUBER; DYSPHANIA AMBROSIOIDES; ELYMUS REPENS ROOT; EPINEPHRINE; EUPHRASIA STRICTA; FAGUS SYLVATICA NUT; FRAXINUS AMERICANA BARK; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; JUNIPERUS VIRGINIANA TWIG; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; ONION; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; ROSA DAMASCENA FLOWERING TOP; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SCHOENOCAULON OFFICINALE SEED; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 11; 20; 21; 20; 20; 20; 20; 20; 21; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 21; 20; 20; 20; 20; 21	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-4805_b5949d46-1ffc-a9f6-e053-2995a90a7a92	55714-4805	HUMAN OTC DRUG	Heavy Metal-Amalga Detox		Allium sativum, Aluminium metallicum, Arg. met., Aur. met., Baryta carb., Beryllium metallicum, Bismuthum metallicum, Cadmium metallicum, Calc. fluor., Carbo veg., Chelidonium majus, Cinchona, Cobaltum met., Cuprum met., Glycyrrhiza glabra, Hydrofluoricum acidum, Iris versicolor, Manganum metallicum, Merc. viv., Niccolum metallicum, Osmium metallicum, Platinum met., Plumb. met., Stannum met., Strontium carb., Thallium metallicum, Titanium metallicum, Carduus mar., Taraxacum	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ALUMINUM; BARIUM CARBONATE; BERYLLIUM; BISMUTH; CADMIUM; CALCIUM FLUORIDE; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; COBALT; COPPER; GARLIC; GLYCYRRHIZA GLABRA; GOLD; HYDROFLUORIC ACID; IRIS VERSICOLOR ROOT; LEAD; MANGANESE; MERCURY; MILK THISTLE; NICKEL; OSMIUM; PLATINUM; SILVER NITRATE; STRONTIUM CARBONATE; TARAXACUM OFFICINALE; THALLIUM; TIN; TITANIUM	20; 20; 20; 21; 20; 20; 20; 20; 20; 20; 20; 20; 21; 20; 20; 20; 20; 20; 20; 20; 20; 21; 20; 20; 21; 11; 20; 20; 21	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
55714-4808_b5e4f066-b55b-6fbf-e053-2995a90a8cbd	55714-4808	HUMAN OTC DRUG	Tinnitus		Aconitum nap., Baryta carb., Baryta mur., Capsicum, Causticum, Chenopodium anthelminticum, Chininum sulphuricum, Cinchona, Glonoinum, Graphites, Hydrastis, Kali bic., Kali mur., Lycopodium, Phosphorus, Pulsatilla, Salicylicum ac., Tabacum, Thiosinaminum, Viola odorata	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALLYLTHIOUREA; ANEMONE PULSATILLA; BARIUM CARBONATE; BARIUM CHLORIDE DIHYDRATE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; DYSPHANIA AMBROSIOIDES; GOLDENSEAL; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; QUININE SULFATE; SALICYLIC ACID; TOBACCO LEAF; VIOLA ODORATA	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
55714-4809_9c1ca5be-1b0b-e244-e053-2995a90a4795	55714-4809	HUMAN OTC DRUG	Gas-Indigestion		Chamomilla, Echinacea, Iris versicolor, Ruta graveolens, Taraxacum officinale, Antimonium crudum, Arsenicum album, Baptisia tinctoria, Bryonia, Carbo vegetabilis, Chelidonium majus, Cinchona officinalis, Colchicum autumnale, Daphne indica, Ipecacuanha, Iris versicolor, Kali carbonicum, Kreosotum, Lachesis mutus, Lycopodium clavatum, Magnesia carbonica, Mercurius vivus, Nux vomica, Phosphorus, Pulsatilla, Spigelia anthelmia, Sulphur, Pyrogenium	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACTIVATED CHARCOAL; ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; DAPHNE ODORA BARK; ECHINACEA, UNSPECIFIED; IPECAC; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; MERCURY; PHOSPHORUS; POTASSIUM CARBONATE; RANCID BEEF; RUTA GRAVEOLENS FLOWERING TOP; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; WOOD CREOSOTE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 6; 15; 15; 15; 30; 6; 15; 15; 15; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4810_b5943091-6c09-08d3-e053-2995a90ac912	55714-4810	HUMAN OTC DRUG	Glauco		Aconitum napellus, Aurum metallicum, Belladonna, Causticum, Cinchona officinalis, Colchicum autumnale, Euphrasia officinalis, Gelsemium sempervirens, Nux vomica, Osmium metallicum, Phosphorus, Physostigma venenosum, Rhus toxicodendron, Spigelia anthelmia.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; GOLD; OSMIUM; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
55714-4811_b5aaaa60-8337-51a8-e053-2a95a90ab186	55714-4811	HUMAN OTC DRUG	Lymphatic Drainer		Echinacea, Solidago, Taraxacum, Asterias, Aur. met., Belladonna, Benzoicum ac., Berber. vulg., Bryonia, Calc. carb., Cantharis, Carduus mar., Ceanothus, Chelidonium maj., Chionanthus, Cinchona, Dioscorea, Iris vers., Nat. carb., Nux vom., Ptelea..	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ASTERIAS RUBENS; ATROPA BELLADONNA; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; DIOSCOREA VILLOSA TUBER; ECHINACEA, UNSPECIFIED; GOLD; IRIS VERSICOLOR ROOT; LYTTA VESICATORIA; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PTELEA TRIFOLIATA BARK; SODIUM CARBONATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
55714-4812_b5924b1f-3082-cd6e-e053-2a95a90ac950	55714-4812	HUMAN OTC DRUG	Edema		Elaps corallinus, Apis mel., Arsenicum alb., Cantharis, Cinchona, Colchicum, Convallaria, Crotalus horridus, Digitalis, Juniperus com., Lachesis, Merc. viv., Naja, Nat. carb., Nat.sulphuricum, Rhus toxicodendron, Sambucus nig., Strophanthus hispidus, Thuja occ., Vipera berus, Echinacea, Lappa, Solidago, Taraxacum, Urtica ur.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	APIS MELLIFERA; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; JUNIPER BERRY; LACHESIS MUTA VENOM; LYTTA VESICATORIA; MERCURY; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; SAMBUCUS NIGRA FLOWERING TOP; SODIUM CARBONATE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STROPHANTHUS HISPIDUS SEED; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; VIPERA BERUS VENOM	20; 11; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 35; 20; 20; 20; 20; 11; 20; 11; 20; 20; 11; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4813_b5ab37d8-22b7-62db-e053-2a95a90a3794	55714-4813	HUMAN OTC DRUG	Multi-System		Aconitum napellus, Antimonium tartaricum, Aralia quinquefolia, Arnica montana, Arsenicum album, Baptisia tinctoria, Bryonia, Cantharis, Chelidonium majus, Cinchona officinalis, Echinacea, Iodium, Kali carbonicum, Kali iodatum, Lachesis mutus, Lycopodium clavatum, Lycopus virginicus, Natrum muriaticum, Nux vomica, Phosphorus, Phytolacca decandra, Pulsatilla, Rhus toxicodendron, Sabal serrulata, Candida albicans, Thyroidinum, Ustilago maidis, Aspergillus niger, Cladosporium	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARNICA MONTANA; ARSENIC TRIOXIDE; ASPERGILLUS NIGER VAR. NIGER; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CLADOSPORIUM HERBARUM; ECHINACEA, UNSPECIFIED; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; POTASSIUM IODIDE; SAW PALMETTO; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF; USTILAGO MAYDIS	10; 10; 10; 10; 10; 10; 15; 10; 10; 15; 10; 10; 15; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 15; 10; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4814_b592a02c-0487-f4ae-e053-2995a90a7f93	55714-4814	HUMAN OTC DRUG	Exhaustion		Aconitum nap., Adrenalinum, Aralia quinquefolia, Arnica, Arsenicum alb., Baptisia, Bryonia, Cantharis, Chelidonium majus, Cinchona, Iodium, Kali carb., Kali iod., Lachesis, Lycopodium, Lycopus virginicus, Nat. mur., Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Sabal, Thyroidinum, Echinacea, Gingko, Phytolacca.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ANEMONE PULSATILLA; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GINKGO; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; POTASSIUM IODIDE; SAW PALMETTO; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 11; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-4821_b5a841f9-0988-a261-e053-2995a90a8d01	55714-4821	HUMAN OTC DRUG	Influenza		Influenza A Virus, Influenza B Virus, Histaminum hydrochloricum, Aconitum nap., Aralia quinquefolia, Arsenicum alb., Baptisia, Bryonia, Cinchona, Eupatorium perf., Gelsemium, Ipecac., Kali carb., Nux vom., Phosphorus, Rhus toxicodendron, Echinacea	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IPECAC; PHOSPHORUS; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	15; 15; 20; 15; 15; 15; 11; 15; 15; 20; 35; 35; 15; 15; 15; 20; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4822_b5a89c6f-d9d8-6b12-e053-2a95a90a4a80	55714-4822	HUMAN OTC DRUG	Intestia		Echinacea, Iris versicolor, Urtica urens, Arsenicum album, Baptisia tinctoria, Bryonia, Cinchona officinalis, Collinsonia canadensis, Dioscorea villosa, I odium, Iris versicolor, Lachesis mutus, Lycopodium clavatum, Natrum carbonicum, Natrum muriaticum, Nux vomica, Phosphorus, Podophyllum peltatum, Pulsatilla, Rhus toxicodendron, Pyrogenium	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; COLLINSONIA CANADENSIS ROOT; DIOSCOREA VILLOSA TUBER; ECHINACEA, UNSPECIFIED; IODINE; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PODOPHYLLUM; RANCID BEEF; SODIUM CARBONATE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4823_b5e5161c-36db-aa11-e053-2995a90a4241	55714-4823	HUMAN OTC DRUG	V-Fem Care		Agaricus musc., Arsenicum alb., Aur. met., Berber. aqui., Caladium seguinum, Candida albicans, Cantharis, Conium, Graphites, Helonias dioica, Hydrastis, Kali carb., Kreosotum, Lycopodium, Merc. viv., Murex purpurea, Nat. mur., Nitricum ac., Pulsatilla, Rhus toxicodendron, Sepia, Sulphur, Tarentula hispana, Thuja occ., Zinc. met., Apis mel., Hamamelis	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; BERBERIS AQUIFOLIUM ROOT BARK; CANDIDA ALBICANS; CHAMAELIRIUM LUTEUM ROOT; CONIUM MACULATUM FLOWERING TOP; DIEFFENBACHIA SEGUINE; GOLD; GOLDENSEAL; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; LYTTA VESICATORIA; MERCURY; NITRIC ACID; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; WOOD CREOSOTE; ZINC	20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4824_b5abc2cd-f30b-6b6b-e053-2995a90ab586	55714-4824	HUMAN OTC DRUG	Neuro-Care		Chamomilla, Hypericum perforatum, Aconitum napellus, Argentum nitricum, Arsenicum album, Belladonna, Bryonia, Cinchona officinalis, Gelsemium sempervirens, Hypericum perforatum, Ignatia amara, Kalmia latifolia, Lachesis mutus, Lycopodium clavatum, Magnesia phosphorica, Mezereum, Phosphorus, Pulsatilla, Rhus toxicodendron, Stramonium, Strychninum, Verbascum thapsus.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; DAPHNE MEZEREUM BARK; DATURA STRAMONIUM; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; KALMIA LATIFOLIA LEAF; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; PHOSPHORUS; SILVER NITRITE; STRYCHNINE; STRYCHNOS IGNATII SEED; TOXICODENDRON PUBESCENS LEAF; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-4826_b5a909c3-7ca5-ba64-e053-2a95a90a66b8	55714-4826	HUMAN OTC DRUG	Libido		Agnus, Aralia quinquefolia, Baryta carb., Berber. vulg., Bryonia, Caladium seguinum, Cantharis, Causticum, Chelidonium majus, Cinchona, Conium, Gaultheria procumbens, Graphites, Kali carb., Lycopodium, Nux vom., Onosmodium virginianum, Phosphorus, Sabal, Selenium, Sepia, Silicea, Staphysag., Hydrastis, Thuja occ	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	AMERICAN GINSENG; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CAUSTICUM; CHASTE TREE FRUIT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; GAULTHERIA PROCUMBENS TOP; GOLDENSEAL; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; ONOSMODIUM VIRGINIANUM; PHOSPHORUS; POTASSIUM CARBONATE; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4827_b5aaba49-f865-3b55-e053-2995a90abcf4	55714-4827	HUMAN OTC DRUG	MacDee		Aconitum napellus, Aurum metallicum, Baryta carbonica, Belladonna, Crotalus horridus, Euphrasia officinalis, Gelsemium sempervirens, Hamamelis virginiana, Lachesis mutus, Mercurius vivus, Phosphorus, Picricum acidum, Plumbum metallicum, Pulsatilla, Rhus toxicodendron, Stramonium, Theridion, Elaps corallinus.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ATROPA BELLADONNA; BARIUM CARBONATE; CROTALUS HORRIDUS HORRIDUS VENOM; DATURA STRAMONIUM; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LACHESIS MUTA VENOM; LEAD; MERCURY; MICRURUS CORALLINUS VENOM; PHOSPHORUS; PICRIC ACID; THERIDION CURASSAVICUM; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55714-4828_b5804ae4-1b82-3f5f-e053-2a95a90a440d	55714-4828	HUMAN OTC DRUG	Breast Care - Fibrocystic		Bufo rana, Apis mel., Asterias rubens, Belladonna, Bryonia, Calc. carb., Chamomilla, Chimaphila umbellata, Cinchona, Conium, Croton, Echinacea, Graphites, Helonias dioica, Lachesis, Merc. viv., Phellandrium aquaticum Phosphorus, Phytolacca, Pulsatilla, Sanguinaria, Silicea, Hamamelis, Ruta, Taraxacum	LIQUID	ORAL	20180902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ASTERIAS RUBENS; ATROPA BELLADONNA; BRYONIA ALBA ROOT; BUFO BUFO CUTANEOUS GLAND; CHAMAELIRIUM LUTEUM ROOT; CHIMAPHILA UMBELLATA; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; CROTON TIGLIUM SEED; ECHINACEA, UNSPECIFIED; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA; MERCURY; OENANTHE AQUATICA FRUIT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; TARAXACUM OFFICINALE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55714-4829_b592a627-ebcc-ce60-e053-2a95a90a0127	55714-4829	HUMAN OTC DRUG	Fear		Aconitum nap., Anacardium orientale, Arg. nit., Arsenicum alb., Cypripedium, Gelsemium, Ignatia, Kali carb., Lycopodium, Nat.mur., Phosphorus, Sambucus nig., Sepia, Staphysag., Stramonium, Tarentula hispana, Theridion, Passiflora, Valeriana	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; POTASSIUM CARBONATE; SAMBUCUS NIGRA FLOWERING TOP; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; THERIDION CURASSAVICUM; VALERIAN	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-4830_b5e53534-9fa9-7e76-e053-2a95a90a4102	55714-4830	HUMAN OTC DRUG	Viral		Echinacea, Hydrastis canadensis, Aconitum napellus, Antimonium tartaricum, Arnica montana, Arsenicum album, Baptisia tinctoria, Belladonna, Bryonia, Cantharis, Chamomilla, Gaultheria procumbens, Hepar sulphuris calcareum, Iodium, Lachesis mutus, Lycopodium clavatum, Mercurius vivus, Phosphorus, Pulsatilla, Rhus toxicodendron, Trifolium pratense, Influenzinum, Morbillinum.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; ECHINACEA, UNSPECIFIED; GAULTHERIA PROCUMBENS TOP; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; MATRICARIA CHAMOMILLA; MEASLES VIRUS; MERCURY; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER	15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 30; 30; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55714-4831_b580b104-efba-331f-e053-2a95a90a0d60	55714-4831	HUMAN OTC DRUG	Cell Salts		Calc. fluor., Calc. phos., Calc.sulph., Ferrum phosphoricum, Kali mur., Kali phos., Kali sulph., Mag. phos., Nat. mur., Nat. phos., Nat.sulphuricum, Silicea	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55714-4832_b5826a01-76d7-071e-e053-2995a90ae511	55714-4832	HUMAN OTC DRUG	Dairy-Grain-Nightshade		Iris vers., Solidago, Antimon. crud., Arg. nit., Arsenicum alb., Avena, Baptisia, Belladonna, Bryonia, Capsicum, Carduus ben., Cinchona, Dulcamara, Fagopyrum, Gelsemium, Hyoscyamus, Ipecac., Lac vac., Lachesis, Lycopodium, Nat. mur., Phos., Podoph. pelt., Pulsatilla, Rhus tox., Sac. lac., Secale, Sepia, Stramonium, Tabacum, Triticum, Ustilago maidis, Verbascum, Lycopersicum, Solanum nig., Solanum tub., Stigmata, Torula cerevisiae.	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAPSICUM; CENTAUREA BENEDICTA; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; CORN SILK; COW MILK; DATURA STRAMONIUM; ELYMUS REPENS ROOT; FAGOPYRUM ESCULENTUM; GELSEMIUM SEMPERVIRENS ROOT; HYOSCYAMUS NIGER; IPECAC; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LACTOSE, UNSPECIFIED FORM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PODOPHYLLUM; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SOLIDAGO VIRGAUREA FLOWERING TOP; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; USTILAGO MAYDIS; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 16; 16; 16; 6; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-4833_b594fef2-a1e9-77fe-e053-2995a90ae094	55714-4833	HUMAN OTC DRUG	Hyperactivity-Mental Focus		Adrenalinum, Tarentula cubensis, Aconitum nap., Arg. nit., Arsenicum alb., Baptisia, Chamomilla, Cypripedium, Digitalis, Gelsemium, Humulus, Ignatia, Impatiens glandulifera flos, Iodium, Lachesis, Lycopodium, Nat. mur., Nux vom., Scutellaria lateriflora, Staphysag., Stramonium, Theridion, Echinacea, Gingko, Hypericum, Passiflora	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CITHARACANTHUS SPINICRUS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HOPS; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM	20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 11; 20; 11; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-4834_b5943e3c-c4e6-1640-e053-2a95a90aa836	55714-4834	HUMAN OTC DRUG	Hay Fever		apis mel., echinacea, hydrastis, taraxacum, aconitum nap., alfalfa, allium cepa, ambrosia, ammon. carb., aralia rac., arsenicum alb., artemisia., arundo, bellis, berber. vulg., bryonia, calluna vulgaris, flos., chelidonium maj., chenopodium anth.,cistus canadensis, drosera, dulcamara, eupatorium perf., euphrasia, fagus syl., frax. amer., gelsemium, hepar sulph. calc., histamine hydrochloricum, kali bic., kali iod., lachesis, ledum, lilium, lycopodium, nat. mur	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALFALFA; AMBROSIA ARTEMISIIFOLIA; AMMONIUM CARBONATE; ANEMONE PULSATILLA; APIS MELLIFERA; ARALIA RACEMOSA ROOT; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; ARUNDO PLINIANA ROOT; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; DATURA STRAMONIUM; DROSERA ANGLICA; DYSPHANIA AMBROSIOIDES; ECHINACEA, UNSPECIFIED; ELYMUS REPENS ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; FAGUS SYLVATICA NUT; FRAXINUS AMERICANA BARK; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; ONION; ONOSMODIUM VIRGINIANUM; PARTHENIUM HYSTEROPHORUS; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM DICHROMATE; POTASSIUM IODIDE; QUERCUS ROBUR NUT; RHODODENDRON TOMENTOSUM LEAFY TWIG; ROSA X DAMASCENA FLOWERING TOP; SALIX NIGRA BARK; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLANUM DULCAMARA TOP; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES	15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 16; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-4835_b592be70-7b8e-a0e3-e053-2995a90a3621	55714-4835	HUMAN OTC DRUG	Food Additives		Iris versicolor, Solidago virgaurea, Aconitum napellus, Agaricus muscarius, Allium cepa, Allium sativum, Antimonium crudum, Arsenicum album, Baptisia tinctoria, Bovista, Caffeinum, Capsicum annuum, Cinchona officinalis, Cinnamomum, Coccus cacti, Cynara scolymus, Fragaria vesca, Gelsemium sempervirens, Histaminum hydrochloricum, Ipecacuanha, Jequerity, Juglans regia, Lachesis mutus, Ledum palustre, Lycopodium clavatum, Mentha piperita, Natrum muriaticum, Nux moschata,	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; ASCORBIC ACID; ASTACUS ASTACUS; BAPTISIA TINCTORIA ROOT; BLACK MUSTARD SEED; CAFFEINE; CAPSICUM; CINCHONA OFFICINALIS BARK; CINNAMON; CYNARA SCOLYMUS LEAF; EGG SHELL, COOKED; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; HISTAMINE DIHYDROCHLORIDE; IPECAC; IRIS VERSICOLOR ROOT; JUGLANS REGIA LEAF; LACHESIS MUTA VENOM; LACTOSE, UNSPECIFIED FORM; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; MENTHA PIPERITA; NUTMEG; ONION; PHOSPHORUS; PODOPHYLLUM; PROTORTONIA CACTI; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHARIN; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SODIUM NITRITE; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SOLIDAGO VIRGAUREA FLOWERING TOP; SUCROSE; SULFUR; TOXICODENDRON PUBESCENS LEAF; URTICA URENS; USTILAGO MAYDIS	15; 15; 15; 15; 15; 16; 15; 15; 15; 16; 16; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15; 15; 16; 16; 16; 16; 6; 16; 15; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-4836_b57f7b94-52ec-583c-e053-2995a90a8cbf	55714-4836	HUMAN OTC DRUG	Bact-In		Echinacea, Hydrastis canadensis, Iris versicolor, Urtica urens, Aconitum napellus, Arnica montana, Arsenicum album, Baptisia tinctoria, Bryonia, Hydrastis canadensis, Iodium, Lachesis mutus, Nux vomica, Phosphorus, Pulsatilla, Rhus toxicodendron, Anthracinum, Pyrogenium	LIQUID	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARNICA MONTANA; ARSENIC TRIOXIDE; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; ECHINACEA, UNSPECIFIED; GOLDENSEAL; IODINE; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; PHOSPHORUS; RANCID BEEF; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	15; 15; 15; 15; 30; 15; 15; 6; 15; 15; 6; 15; 15; 30; 15; 15; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4837_b580f381-9542-19fb-e053-2995a90af977	55714-4837	HUMAN OTC DRUG	Childbirth Care		Arnica montana, Caulophyllum thalictroides, Cimicifuga racemosa, Gelsemium sempervirens, Pulsatilla.	PELLET	ORAL	20190902		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARNICA MONTANA; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; GELSEMIUM SEMPERVIRENS ROOT	15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
55714-4838_b5a8a504-f16a-1208-e053-2995a90ae746	55714-4838	HUMAN OTC DRUG	I-Waker		Apis mellifica, Echinacea, Hydrastis canadensis, Thuja occidentalis, Aconitum napellus, Agaricus muscarius, Allium sativum, Aloe, Arnica montana, Arsenicum album, Baptisia tinctoria, Belladonna, Bryonia, Calcarea carbonica, Calendula officinalis, Capsicum annuum, Carduus marianus, Hepar sulphuris calcareum, Iodium, Lachesis mutus, Lycopodium clavatum, Mercurius vivus, Nux vomica, Phosphorus, Pulsatilla, Rhus toxicodendron, Salvia officinalis, Selenium metallicum, Taraxacum officinale, Tarentula hispana,	LIQUID	ORAL	20200630		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ALOE; AMANITA MUSCARIA FRUITING BODY; ANEMONE PULSATILLA; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; AZADIRACHTA INDICA BARK; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CAPSICUM; ECHINACEA, UNSPECIFIED; GARLIC; GINGER; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; MERCURY; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SAGE; SELENIUM; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC	15; 15; 15; 15; 6; 15; 15; 15; 16; 16; 15; 15; 15; 15; 15; 6; 15; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-4840_a5281830-e6f3-0ae7-e053-2995a90a8ed6	55714-4840	HUMAN OTC DRUG	BronCare		Echinacea, Lappa, Rumex crisp., Antimon. tart., Arsenicum alb., Bryonia, Camphora, Chelidonium maj., Cinchona, Drosera, Eucalyptus, Hepar sulph. calc., Histaminum hydrochloricum, Ipecac., Kali bic., Kali carb., Kali iod., Lycopodium, Myrrha, Nat. sulphuricum, Nux vom., Phos., Pulsatilla, Sainguinaria, Spongia, Stannum met., Tussilago far., Verbascum, Influenzinum	PELLET	ORAL	20200518		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAMPHOR (NATURAL); CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ANGLICA; ECHINACEA, UNSPECIFIED; HISTAMINE DIHYDROCHLORIDE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; IPECAC; LYCOPODIUM CLAVATUM SPORE; MYRRH; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM DICHROMATE; POTASSIUM IODIDE; RUMEX CRISPUS ROOT; SANGUINARIA CANADENSIS ROOT; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; TIN; TUSSILAGO FARFARA; VERBASCUM THAPSUS	15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 30; 30; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4842_b56f2ba6-382d-2418-e053-2a95a90af2ce	55714-4842	HUMAN OTC DRUG	Thyroid-Adrenal		Adrenalinum, Thyroidinum, Aloe, Calc. carb., Chelidonium majus, Conium, Graphites, Iodium, Lachesis, Lycopodium, Lycopus virginicus, Phytolacca, Rhus toxicodendron, Silicea, Spongia, Echinacea	LIQUID	ORAL	20201030		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALOE; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GRAPHITE; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SILICON DIOXIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-4843_c6a37533-c042-57a1-e053-2a95a90a9a30	55714-4843	HUMAN OTC DRUG	Candid-Y		Adrenalinum, Candida albicans, Thyroidinum, Torula cerevisiae, Triticum, Ustilago maidis, Antimon. crud, Arsenicum alb., Baptisia, Berber. aqui., Bryonia, Calc. phos., Cinchona, Helonias dioica, Hydrastis, Iodium, Iris versicolor, Kali carb., Lachesis, Lycopodium, Merc. viv., Nat.carb., Nat. phos, Nitricum ac., Phosphorus, Podoph. pelt, Pulsatilla, Sepia, Echinacea, Ginkgo, Juglans regia, Lappa, Thuja occ.	LIQUID	ORAL	20210201		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CANDIDA ALBICANS; CHAMAELIRIUM LUTEUM ROOT; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; ELYMUS REPENS ROOT; ENGLISH WALNUT; EPINEPHRINE; GINKGO; GOLDENSEAL; IODINE; IRIS VERSICOLOR ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAHONIA AQUIFOLIUM ROOT BARK; MERCURY; NITRIC ACID; PHOSPHORUS; PODOPHYLLUM; POTASSIUM CARBONATE; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE; SODIUM CARBONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TRIBASIC CALCIUM PHOSPHATE; USTILAGO MAYDIS	20; 20; 11; 20; 20; 20; 20; 20; 20; 11; 20; 11; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 21; 20; 20; 20; 11; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Nut Proteins [EXT], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-4844_c6f0540b-bc90-3bb8-e053-2995a90ada53	55714-4844	HUMAN OTC DRUG	I-Sleep		Absinthium, Anacardium orientale, Arg. nit., Arsenicum alb., Belladonna, Bryonia, Calc. carb., Camphora, Chamomilla, Cimicifuga, Cinchona, Coffea cruda, Cypripedium, Gelsemium, Humulus, Hyoscyamus, Ignatia, Kali brom., Nux vom., Passiflora, Pulsatilla, Scutellaria lateriflora, Sepia, Thuja occ., Valeriana	LIQUID	ORAL	20210201		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BLACK COHOSH; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); CINCHONA OFFICINALIS BARK; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; GELSEMIUM SEMPERVIRENS ROOT; HOPS; HYOSCYAMUS NIGER; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM BROMIDE; SCUTELLARIA LATERIFLORA WHOLE; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VALERIAN; WORMWOOD	20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 11; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4845_c6f30a38-ec25-7129-e053-2995a90abbc5	55714-4845	HUMAN OTC DRUG	Hemorrhoids		Elaps corallinus, Aesculus hipp., Aloe, Arsenicum alb., Bryonia, Calc. fluor., Capsicum, Collinsonia, Crotalus horridus, Hamamelis, Hydrofluoricum acidum, Hypericum, Lachesis, Lycopodium, Millefolium, Naja, Nux vom., Paeonia, Plantago, Quercus glandium spiritus, Ratanhia, Vipera berus, Echinacea, Solidago, Urtica ur.	LIQUID	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACHILLEA MILLEFOLIUM; ALOE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CAPSICUM; COLLINSONIA CANADENSIS ROOT; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; HYDROFLUORIC ACID; HYPERICUM PERFORATUM; KRAMERIA LAPPACEA ROOT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; PAEONIA OFFICINALIS ROOT; PLANTAGO MAJOR; QUERCUS ROBUR NUT; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; URTICA URENS; VIPERA BERUS VENOM	20; 20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 35; 20; 20; 20; 20; 11; 20; 11; 21	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
55714-4846_da821e18-7dab-2f4e-e053-2995a90ac2d6	55714-4846	HUMAN OTC DRUG	Ear Care		Influenzinum, Tellurium metallicum, Apis mel., Arsenicum alb., Belladonna, Bryonia, Capsicum, Causticum, Cinchona, Conium, Dulcamara, Ferrum phosphoricum, Hepar sulph. calc.,Kali sulph., Lycopodium, Merc. viv., Mezereum, Phosphorus, Plantago, Pulsatilla, Silicea, Verbascum, Echinacea, Hydrastis	LIQUID	ORAL	20220307		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CAPSICUM; CAUSTICUM; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DAPHNE MEZEREUM BARK; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LYCOPODIUM CLAVATUM SPORE; MERCURY; PHOSPHORUS; PLANTAGO MAJOR; POTASSIUM SULFATE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; TELLURIUM; VERBASCUM THAPSUS	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 6; 30; 30; 15; 15; 15; 15; 15; 15; 15; 16; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55714-4847_eff981d9-abe5-a113-e053-2a95a90abfec	55714-4847	HUMAN OTC DRUG	Cataracc		Arsenicum alb., Bryonia, Calc. fluor., Calendula, Causticum, Conium, Euphrasia, Hydrofluoricum ac., Iodium, Ledum, Naphthalinum, Nat. mur., Nux vom., Phos., Pulsatilla, Sepia, Silicea, Tellurium, Thiosinaminum, Zinc. met.	LIQUID	ORAL	20220930		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ALLYLTHIOUREA; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; CAUSTICUM; CONIUM MACULATUM FLOWERING TOP; EUPHRASIA STRICTA; HYDROFLUORIC ACID; IODINE; NAPHTHALENE; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; TELLURIUM; ZINC	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 16; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4848_fb45e5e2-93c8-da49-e053-6294a90a35d1	55714-4848	HUMAN OTC DRUG	HBP		Ruta graveolens, Valeriana officinalis, Adrenalinum, Arsenicum iodatum, Aurum metallicum, Baryta carbonica, Bryonia, Cactus grandiflorus, Chelidonium majus, Cinchona officinalis, Crotalus horridus, Digitalis purpurea, Glonoinum, Kali carbonicum, Kali iodatum, Lachesis mutus, Naja tripudians, Nux vomica, Veratrum album, Vipera berus, Viscum album, Elaps corallinus.	LIQUID	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARSENIC TRIIODIDE; BARIUM CARBONATE; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; EPINEPHRINE; GOLD; LACHESIS MUTA VENOM; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; POTASSIUM CARBONATE; POTASSIUM IODIDE; RUTA GRAVEOLENS FLOWERING TOP; SELENICEREUS GRANDIFLORUS STEM; STRYCHNOS NUX-VOMICA SEED; VALERIAN; VERATRUM ALBUM ROOT; VIPERA BERUS VENOM; VISCUM ALBUM FRUITING TOP	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 30; 15; 15; 15; 15; 6; 15; 15; 6; 15; 16; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-4849_f0328097-e5d1-3532-e053-2a95a90a93f0	55714-4849	HUMAN OTC DRUG	Warts		Antimon. crud., Bryonia, Calc.carb., Causticum, Dulcamara, Graphites, Lycopodium, Merc. sulph. rub., Nat. carb., Nitricum ac., Nux vom., Rhus toxicodendron, Sabina, Sepia, Silicea, Staphysag., Sulphur, Thuja occ., Taraxacum	LIQUID	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; BRYONIA ALBA ROOT; CAUSTICUM; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; JUNIPERUS SABINA LEAFY TWIG; LYCOPODIUM CLAVATUM SPORE; MERCURIC SULFIDE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CARBONATE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4850_f032effa-c270-9e7e-e053-2995a90a9593	55714-4850	HUMAN OTC DRUG	Warts		Antimon. crud., Bryonia, Calc.carb., Causticum, Dulcamara, Graphites, Lycopodium, Merc. sulph. rub., Nat. carb., Nitricum ac., Nux vom., Rhus toxicodendron, Sabina, Sepia, Silicea, Staphysag., Sulphur, Thuja occ., Taraxacum	PELLET	ORAL	20221219		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ANTIMONY TRISULFIDE; BRYONIA ALBA ROOT; CAUSTICUM; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; JUNIPERUS SABINA LEAFY TWIG; LYCOPODIUM CLAVATUM SPORE; MERCURIC SULFIDE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CARBONATE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55714-4852_fed060c8-4f42-d865-e053-6294a90a5008	55714-4852	HUMAN OTC DRUG	Hyperactivity-Mental Focus		Adrenalinum, Aconitum nap., Arg. nit., Arsenicum alb., Baptisia, Chamomilla, Cypripedium, Digitalis, Gelsemium, Humulus, Ignatia, Impatiens glandulifera flos, Iodium, Lachesis, Lycopodium, Nat. mur., Nux vom., Scutellaria lateriflora, Staphysag., Stramonium, Theridion, Echinacea, Gingko, Hypericum, Passiflora	LIQUID	ORAL	20230703		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; ECHINACEA, UNSPECIFIED; EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; HOPS; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; IODINE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THERIDION CURASSAVICUM	20; 20; 20; 20; 20; 20; 20; 11; 20; 20; 11; 20; 11; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
55714-4853_0634351f-fae4-a8e3-e063-6294a90a3b60	55714-4853	HUMAN OTC DRUG	CardCare		Echinacea, Hypericum, Valeriana, Aconitum nap., Arsenicum alb., Aur. met., Baryta carb., Benzoicum ac., Berber. vulg., Bryonia, Calc. fluor., Cantharis, Ceanothus, Chelidonium maj., Chionanthus, Cinchona, Convallaria, Crotalus hor., Digitalis, Gelsemium, Glonoinum, Hydrofluoricum ac. Kali iod., Lachesis, Lycopus, Naja, Nux vom., Phos., Pulsatilla, Rhus tox., Vipera, Elaps.	LIQUID	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BARIUM CARBONATE; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CONVALLARIA MAJALIS; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; ECHINACEA, UNSPECIFIED; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HYDROFLUORIC ACID; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LYCOPUS VIRGINICUS; LYTTA VESICATORIA; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; NITROGLYCERIN; PHOSPHORUS; POTASSIUM IODIDE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; VALERIAN; VIPERA BERUS VENOM	15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 6; 15; 15; 15; 30; 15; 15; 15; 15; 15; 15; 6; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
55714-4855_0631d415-6d36-2877-e063-6294a90a9c82	55714-4855	HUMAN OTC DRUG	Allergies		Apis mellifica, Echinacea, Hydrastis canadensis, Taraxacum officinale, Aconitum napellus, Aethusa cynapium, Agaricus muscarius, Aletris farinosa, Alfalfa, Allium cepa, Allium sativum, Ambrosia artemisiaefolia, Arsenicum album, Artemisia vulgaris, Arundo mauritanica, Avena sativa, Belladonna, Bellis perrenis, Bovista, Bromium, Bryonia, Caffeinum, Calcarea carbonica, Calluna vulgaris, flos, Capsicum annuum, Cat hair, Chamomilla, Chelidonium majus, Chenopodium anthelminticum, Cinnamomum	LIQUID	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ABRUS PRECATORIUS SEED; ACONITUM NAPELLUS; AETHUSA CYNAPIUM; ALETRIS FARINOSA ROOT; ALFALFA; ALLYLTHIOUREA; ALPINE STRAWBERRY; AMANITA MUSCARIA FRUITING BODY; AMBROSIA ARTEMISIIFOLIA; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; APIS MELLIFERA; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; ARUNDO PLINIANA ROOT; ASCORBIC ACID; ASTACUS ASTACUS; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BELLIS PERENNIS; BLACK MUSTARD SEED; BROMINE; BRYONIA ALBA ROOT; CAFFEINE; CALLUNA VULGARIS FLOWERING TOP; CANIS LUPUS FAMILIARIS HAIR; CAPSICUM; CHELIDONIUM MAJUS; CINNAMON; CLAVICEPS PURPUREA SCLEROTIUM; CORN SILK; COW MILK; CYNARA SCOLYMUS LEAF; DATURA STRAMONIUM; DROSERA ANGLICA; DYSPHANIA AMBROSIOIDES; ECHINACEA, UNSPECIFIED; EGG SHELL, COOKED; ELYMUS REPENS ROOT; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM; FAGUS SYLVATICA NUT; FELIS CATUS HAIR; FRAXINUS AMERICANA BARK; GARLIC; GELSEMIUM SEMPERVIRENS ROOT; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; HYOSCYAMUS NIGER; JUGLANS REGIA LEAF; JUNIPERUS VIRGINIANA TWIG; LACTOSE, UNSPECIFIED FORM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; MATRICARIA CHAMOMILLA; MENTHA PIPERITA; NUTMEG; ONION; ONOSMODIUM VIRGINIANUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM IODIDE; PROTORTONIA CACTI; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; RHODODENDRON TOMENTOSUM LEAFY TWIG; ROSA X DAMASCENA FLOWERING TOP; SACCHARIN; SACCHAROMYCES CEREVISIAE; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SODIUM NITRATE; SOLANUM DULCAMARA TOP; SOLANUM LYCOPERSICUM; SOLANUM NIGRUM WHOLE; SOLANUM TUBEROSUM; SUCROSE; SULFUR; TARAXACUM OFFICINALE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSA	20; 20; 20; 20; 20; 20; 20; 20; 20; 21; 20; 11; 20; 20; 20; 21; 21; 20; 20; 20; 21; 20; 20; 20; 20; 20; 20; 20; 20; 20; 21; 20; 20; 20; 20; 20; 11; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 21; 11; 20; 20; 20; 20; 20; 21; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 21; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 21; 20; 20; 20; 20; 20; 21; 20; 21; 21; 21; 21; 20; 11; 20; 20; 20; 21; 20; 20; 20; 20; 21	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Ascorbic Acid [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylxanthine [EPC], Milk Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Salivary Proteins and Peptides [CS], Seed Storage Proteins [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC], Xanthines [CS]		N	20241231
55714-6216_b623dfb3-052a-6820-e053-2a95a90a4c4b	55714-6216	HUMAN PRESCRIPTION DRUG	Human Papilloma Virus (HPV)		Human Papilloma Virus (HPV)	LIQUID	ORAL	20110901		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	HUMAN PAPILLOMAVIRUS	30	[hp_C]/mL			N	20241231
55714-6521_b6b05988-94d4-a549-e053-2995a90a821a	55714-6521	HUMAN OTC DRUG	Symphytum officinale		Symphytum officinale	LIQUID	ORAL	20110901		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	COMFREY ROOT	15	[hp_X]/mL			N	20241231
55714-6612_b69ddf6a-cff9-4b82-e053-2995a90a6047	55714-6612	HUMAN PRESCRIPTION DRUG	Parathyroid		Parathyroid	LIQUID	ORAL	20110901		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	HUMAN PARATHYROID	15	[hp_X]/mL			N	20241231
55714-6680_b6bfd3f8-1335-3e37-e053-2a95a90acee5	55714-6680	HUMAN OTC DRUG	Thyroid Mix		Thyroid Mix	LIQUID	ORAL	20180101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	THYROID, UNSPECIFIED	31	[hp_C]/mL			N	20241231
55714-6715_b69bee21-1603-aa0f-e053-2a95a90a05a4	55714-6715	HUMAN OTC DRUG	MMR (Measles, Mumps, Rubella)		MMR (Measles, Mumps, Rubella)	LIQUID	ORAL	20180101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	MEASLES VIRUS; MUMPS VIRUS; RUBELLA VIRUS	31; 31; 31	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
55714-9001_9e00953a-ef8a-0705-e053-2995a90a82ff	55714-9001	HUMAN OTC DRUG	Borrelia Burgdorferi		Borrelia Burgdorferi	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BORRELIA BURGDORFERI	30	[hp_C]/mL			N	20241231
55714-9002_9e02d6ee-fe7a-7215-e053-2995a90acdc3	55714-9002	HUMAN OTC DRUG	Dopamine		Dopamine	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	DOPAMINE	30	[hp_C]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
55714-9003_9e0350f6-ac53-a9ce-e053-2995a90af039	55714-9003	HUMAN OTC DRUG	Epstein-Barr Virus		Epstein-Barr Virus	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	HUMAN HERPESVIRUS 4	30	[hp_C]/mL			N	20241231
55714-9004_9e03873d-ea0c-a891-e053-2995a90ab7f2	55714-9004	HUMAN OTC DRUG	Progesterone		Progesterone	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	PROGESTERONE	15	[hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
55714-9005_9e03f0dd-6cef-7f9e-e053-2a95a90a8a27	55714-9005	HUMAN OTC DRUG	Serotonin (Human)		Serotonin (Human)	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	SEROTONIN	30	[hp_C]/mL			N	20241231
55714-9008_9e3b3276-d117-2875-e053-2a95a90a0351	55714-9008	HUMAN OTC DRUG	Arnica montana		Arnica montana	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARNICA MONTANA	200	[hp_C]/mL			N	20241231
55714-9009_9e3bdd63-56b7-78c1-e053-2a95a90a0d3b	55714-9009	HUMAN OTC DRUG	Arnica montana		Aconitum napellus	PELLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	ARNICA MONTANA	30	[hp_C]/g			N	20241231
55714-9011_0a0cf5e8-378f-99bc-e063-6294a90a1694	55714-9011	HUMAN OTC DRUG	Pertussinum		Pertussinum	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED	30	[hp_C]/mL			N	20241231
55714-9012_9e67eef4-c4ae-d665-e053-2995a90a1548	55714-9012	HUMAN OTC DRUG	Rhus toxicodendron		Rhus toxicodendron	PELLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	TOXICODENDRON PUBESCENS LEAF	30	[hp_C]/g			N	20241231
55714-9013_9e3eb16f-9945-4964-e053-2a95a90aacbd	55714-9013	HUMAN OTC DRUG	Thuja occidentalis		Thuja occidentalis	LIQUID	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/mL			N	20241231
55714-9014_9e3ed149-5623-a2d9-e053-2a95a90aee89	55714-9014	HUMAN OTC DRUG	Thuja occidentalis		Thuja occidentalis	PELLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/g			N	20241231
55714-9019_e20b4111-4c6c-18c4-e053-2995a90a5e22	55714-9019	HUMAN OTC DRUG	Bryonia		Bryonia	LIQUID	ORAL	20220622		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	BRYONIA ALBA ROOT	10	[hp_X]/L			N	20241231
55714-9020_e2350279-05a6-1c74-e053-2995a90a5751	55714-9020	HUMAN OTC DRUG	Rhus tox		Rhus tox	LIQUID	ORAL	20220622		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	TOXICODENDRON PUBESCENS LEAF	10	[hp_X]/L			N	20241231
55714-9021_f912a363-35ba-8b6d-e053-6294a90a07eb	55714-9021	HUMAN OTC DRUG	Chamomilla		Chamomilla	LIQUID	ORAL	20230411		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	MATRICARIA CHAMOMILLA	7	[hp_X]/L			N	20241231
55714-9022_f9135130-75ee-e44e-e053-6394a90a9d8e	55714-9022	HUMAN OTC DRUG	Mercurius solubilis		Mercurius solubilis	LIQUID	ORAL	20230411		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	MERCURIUS SOLUBILIS	12	[hp_X]/L			N	20241231
55714-9023_f913ff17-b570-003e-e053-6294a90a5536	55714-9023	HUMAN OTC DRUG	Sulphur		Sulphur	LIQUID	ORAL	20230411		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	SULFUR	9	[hp_X]/L			N	20241231
55714-9024_fb471672-91d5-9aed-e053-6294a90a74d3	55714-9024	HUMAN OTC DRUG	Argentum metallicum		Argentum metallicum	LIQUID	ORAL	20230509		UNAPPROVED HOMEOPATHIC		Newton Laboratories, Inc.	SILVER	30	[hp_X]/L			N	20241231
55715-001_0b7644c8-2bc8-c4d0-e063-6394a90aa6bc	55715-001	HUMAN OTC DRUG	Zepol Topical Analgesic		Camphor, Menthol	OINTMENT	TOPICAL	20091005		OTC MONOGRAPH DRUG	M017	Laboratorios Zepol S.A.	CAMPHOR (SYNTHETIC); MENTHOL	6.55; 6.55	g/100g; g/100g			N	20241231
55715-002_0b7644d3-9fd8-b562-e063-6294a90ae44b	55715-002	HUMAN OTC DRUG	Manzatin-E Diaper Rash Skin Protectant		Zinc Oxide	OINTMENT	TOPICAL	20091001		OTC MONOGRAPH DRUG	M016	Laboratorios Zepol S.A.	ZINC OXIDE	18	g/100g			N	20241231
55715-004_0b7653e2-ce90-c9a8-e063-6394a90a814c	55715-004	HUMAN OTC DRUG	Zany Antiseptic Gel		ALCOHOL	GEL	TOPICAL	20201101		OTC MONOGRAPH DRUG	M003	Laboratorios Zepol S.A.	ALCOHOL	.7	mL/mL			N	20241231
55715-005_0b7655c5-a49d-c9a5-e063-6394a90a177d	55715-005	HUMAN OTC DRUG	Manzatin Diaper Rash Skin Protectant		ZINC OXIDE	OINTMENT	TOPICAL	20211101		OTC MONOGRAPH DRUG	M016	Laboratorios Zepol S.A.	ZINC OXIDE	180	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
55715-006_0b764e6c-d79d-bffa-e063-6294a90a98c0	55715-006	HUMAN OTC DRUG	Tree frog		COMFREY ROOT, ROSEMARY	GEL	TOPICAL	20230516		UNAPPROVED HOMEOPATHIC		Laboratorios Zepol S.A.	COMFREY ROOT; ROSEMARY	10; 1	[hp_X]/g; [hp_X]/g			N	20241231
55715-007_0b76573c-b315-bf01-e063-6294a90a4e98	55715-007	HUMAN OTC DRUG	Tree frog		COMFREY ROOT, ROSEMARY	GEL	TOPICAL	20230516		UNAPPROVED HOMEOPATHIC		Laboratorios Zepol S.A.	COMFREY ROOT; ROSEMARY	10; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
55724-211_365fcc75-022b-4c79-a57e-6279bea62b01	55724-211	HUMAN PRESCRIPTION DRUG	Eucrisa		crisaborole	OINTMENT	TOPICAL	20170130		NDA	NDA207695	Pfizer Laboratories Div Pfizer Inc	CRISABOROLE	20	mg/g	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
55728-100_07eecc9b-267f-c6c3-e063-6394a90a2e89	55728-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19780102		NDA	NDA205767	A & B Welding Supply Co.	OXYGEN	990	mL/L			N	20241231
55728-200_07eec224-b9e2-c6c5-e063-6394a90acb30	55728-200	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20120109		NDA	NDA205766	A & B Welding Supply Co.	NITROGEN	990	mL/L			N	20241231
55741-224_ae997d0c-8097-dc21-0cc8-7763170761cf	55741-224	HUMAN OTC DRUG	Doans	Extra Strength	Magnesium salicylate	TABLET	ORAL	20160524		OTC MONOGRAPH NOT FINAL	part343	Dr. Reddy's Laboratories Inc.	MAGNESIUM SALICYLATE	580	mg/1			N	20241231
55741-446_0cd860f9-20a0-c8f1-843a-c0a6097c03b0	55741-446	HUMAN OTC DRUG	Habitrol	Step 3	Nicotine Transdermal System Patch	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180713		NDA	NDA020076	Dr. Reddy's Laboratories Inc.	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55741-447_0cd860f9-20a0-c8f1-843a-c0a6097c03b0	55741-447	HUMAN OTC DRUG	Habitrol	Step 2	Nicotine Transdermal System Patch	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180713		NDA	NDA020076	Dr. Reddy's Laboratories Inc.	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55741-448_0cd860f9-20a0-c8f1-843a-c0a6097c03b0	55741-448	HUMAN OTC DRUG	Habitrol	Step 1	Nicotine Transdermal System Patch	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180713		NDA	NDA020076	Dr. Reddy's Laboratories Inc.	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55741-449_9ac19ce7-c3ea-49ed-424a-5f37f2e800a5	55741-449	HUMAN OTC DRUG	nicotine	transdermal system	nicotine	KIT	TRANSDERMAL	20150514		NDA	NDA020076	Dr. Reddy's Laboratories Inc.						N	20241231
55741-524_01a04fc3-a1d7-b8eb-6c0f-08ab1fa59a67	55741-524	HUMAN OTC DRUG	Comtrex Cough and Cold	Day/Night	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Chlorpheniramine Maleate	KIT		20160524		OTC MONOGRAPH FINAL	part341	Dr. Reddy's Laboratories Inc.						N	20241231
5575-0001_f1d85298-b4bc-23fd-e053-2995a90afa7b	5575-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140224		UNAPPROVED MEDICAL GAS		Ecumed Inc dba Aronson Medical	OXYGEN	99	L/100L			N	20241231
55758-001_d21a2c9d-1a4b-b53a-e053-2a95a90a177f	55758-001	HUMAN OTC DRUG	DoloEar		atropa belladonna, apis mellifera, aristolochia clematitis root, matricaria recutita, lachesis muta venom, and thuja Occidentalis leafy twig	SOLUTION/ DROPS	AURICULAR (OTIC)	20130523		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	APIS MELLIFERA; ARISTOLOCHIA CLEMATITIS ROOT; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MATRICARIA RECUTITA; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 6; 6; 6	[hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55758-007_066d33e8-5631-7786-e063-6394a90adc20	55758-007	HUMAN OTC DRUG	SanaTos Childrens Mucus Relief Cough		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	LIQUID	ORAL	20131010		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55758-009_a709dcb1-508b-c4a2-e053-2995a90a69d5	55758-009	HUMAN OTC DRUG	SanaTos Severe Cold and Cough Nighttime		Acetaminophen, Diphenhydramine hydrochloride, and Phenylephrine hydrochloride	GRANULE, FOR SOLUTION	ORAL	20140220		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-010_a70979fb-c597-0e70-e053-2995a90ab78d	55758-010	HUMAN OTC DRUG	SanaTos Severe Cold and Cough Day Time		Acetaminophen, Dextromethorphan hydrobromide, and Phenylephrine hydrochloride	GRANULE, FOR SOLUTION	ORAL	20140220		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-012_09bba642-59c9-c2cd-e063-6394a90a69e6	55758-012	HUMAN OTC DRUG	Vitapirena		ACETAMINOPHEN	GRANULE, FOR SOLUTION	ORAL	20231025		OTC MONOGRAPH DRUG	M013	Pharmadel LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55758-013_05421acd-5d5f-bdb4-e063-6394a90a80d1	55758-013	HUMAN OTC DRUG	SanaTos Children Cough and Congestion Cherry		DEXTROMETHORPHAN HBr and GUAIFENESIN	LIQUID	ORAL	20160101		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55758-014_09086612-90a7-f548-e063-6294a90aa5e0	55758-014	HUMAN OTC DRUG	Dolex Flex		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230901		ANDA	ANDA078682	Pharmadel LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55758-026_0546523b-06b9-587a-e063-6394a90aa843	55758-026	HUMAN OTC DRUG	Dolex	Children Pain and Fever	ACETAMINOPHEN	SUSPENSION	ORAL	20230101		OTC MONOGRAPH NOT FINAL	part343	Pharmadel LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
55758-037_82472413-ce98-406e-e053-2a91aa0aba1d	55758-037	HUMAN OTC DRUG	Bebelyn Constipation		Alumina, Bryonia alba, Chamomilla, Nux vomica, Plumbum met, Silicea, Sulphur	LIQUID	ORAL	20170109		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	ALUMINUM OXIDE; BRYONIA ALBA ROOT; CHAMOMILE; LEAD; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; SULFUR	4; 4; 5; 4; 4; 4; 4	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
55758-038_824523d7-d8d4-2fed-e053-2991aa0ac8a6	55758-038	HUMAN OTC DRUG	Bebelyn Teething		Aconitum, Calcarea phos, Chamomilla,Magnesia phos	LIQUID	ORAL	20170109		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	ACONITUM NAPELLUS; CHAMOMILE; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; TRIBASIC CALCIUM PHOSPHATE	6; 20; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55758-039_f6f741c5-87eb-63e4-e053-6294a90ad783	55758-039	HUMAN OTC DRUG	Parche Leon		Capsaicin, Camphor, Menthol	PATCH	TOPICAL	20200228		OTC MONOGRAPH NOT FINAL	part348	Pharmadel LLC	CAMPHOR (SYNTHETIC); CAPSAICIN; MENTHOL, UNSPECIFIED FORM	3; .025; 1.25	g/1; g/1; g/1			N	20241231
55758-040_ef5b0db6-8f0b-4f8e-e053-2995a90a22b7	55758-040	HUMAN OTC DRUG	Parche de Leon		Lidocaine, Menthol	PATCH	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part348	Pharmadel LLC	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55758-048_f91123b7-f4d5-6b11-e053-6294a90a9536	55758-048	HUMAN OTC DRUG	Rapidol Naproxen		Naproxen sodium	TABLET, COATED	ORAL	20191009		ANDA	ANDA091353	Pharmadel LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55758-055_0ab11691-5b2a-55fc-e063-6394a90aa328	55758-055	HUMAN OTC DRUG	Sanatos Multi Symptom Daytime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCI	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M013	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-056_0abf71d1-f688-1218-e063-6294a90a436c	55758-056	HUMAN OTC DRUG	Sanatos Nighttime Multi Symptoms		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M013	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55758-102_df031309-2779-00cf-e053-2a95a90a5eea	55758-102	HUMAN OTC DRUG	Cura Hongo	Antifungal	Clotrimazole	CREAM	TOPICAL	20220531		OTC MONOGRAPH FINAL	part333C	Pharmadel	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55758-107_e051799e-a051-17cd-e053-2995a90afafb	55758-107	HUMAN OTC DRUG	Kofal Fuerte		Methyl Salicylate	OINTMENT	TOPICAL	20151203		OTC MONOGRAPH NOT FINAL	part348	PHARMADEL LLC	METHYL SALICYLATE	15	g/100g			N	20241231
55758-108_e05171a3-8305-e597-e053-2995a90abb7d	55758-108	HUMAN OTC DRUG	Kofal Original		Methyl Salicylate	OINTMENT	TOPICAL	20151203		OTC MONOGRAPH NOT FINAL	part348	PHARMADEL LLC	METHYL SALICYLATE	12	g/100g			N	20241231
55758-109_e0518098-3923-bea0-e053-2995a90a23b3	55758-109	HUMAN OTC DRUG	Kofal		Methyl Salicylate	OINTMENT	TOPICAL	20200121		OTC MONOGRAPH NOT FINAL	part348	Pharmadel LLC	METHYL SALICYLATE	10.5	g/100g			N	20241231
55758-142_9922b450-cf89-5ab5-e053-2995a90a8b5a	55758-142	HUMAN OTC DRUG	SanaTos Day and Night Multi Symptom		Acetaminophen,Dextromethorphan HBr,Doxylamine succinate	KIT	ORAL	20180930		OTC MONOGRAPH NOT FINAL	part341	Pharmadel						N	20241231
55758-253_0bf2ddb2-5d5d-1839-e063-6294a90ad075	55758-253	HUMAN OTC DRUG	El Piojito Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101028		OTC MONOGRAPH DRUG	M031	Pharmadel	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
55758-300_e0f46a69-5cea-6eab-e053-2a95a90a8435	55758-300	HUMAN OTC DRUG	OptimV Anti-Itch	Maximum Strength	Benzocaine, Resorcinol	CREAM	TOPICAL	20220601		OTC MONOGRAPH NOT FINAL	part348	Pharmadel	BENZOCAINE; RESORCINOL	20; 3	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55758-304_ac3c264f-da36-a474-e053-2a95a90abdad	55758-304	HUMAN OTC DRUG	Dolex Children		Ibuprofen	LIQUID	ORAL	20200807		ANDA	ANDA210602	Pharmadel LLC	IBUPROFEN	100	mg/100mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55758-306_088bacc1-0192-4745-e063-6394a90a67c0	55758-306	HUMAN OTC DRUG	Dolex Forte		Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20130324		OTC MONOGRAPH DRUG	M013	Pharmadel LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55758-307_d57ac4cd-47af-488b-e053-2995a90a7c62	55758-307	HUMAN OTC DRUG	SanaTos Mucus Relief Cold Toddlers		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20171017		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	2.5; 50	mg/2.5mL; mg/2.5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55758-310_0542f88c-b29d-d32c-e063-6294a90ab9ee	55758-310	HUMAN OTC DRUG	Dolex Flex		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20191031		ANDA	ANDA206999	Pharmadel LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55758-311_0a1d578c-3260-6795-e063-6294a90a3142	55758-311	HUMAN OTC DRUG	SanaTos X		Acetaminophen, Dextromethorphan HBr,Guaifenesin, Phenylephrine HCI	LIQUID	ORAL	20181203		OTC MONOGRAPH DRUG	M013	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-313_a7457170-bd84-bbfe-e053-2995a90aadda	55758-313	HUMAN OTC DRUG	ANTIGRIP Nighttime		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCI	POWDER, FOR SOLUTION	ORAL	20190328		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 4; 20; 10	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-314_a745e8c6-85c1-7109-e053-2995a90a0fb4	55758-314	HUMAN OTC DRUG	ANTIGRIP Daytime		Acetaminophen, Dextromethorphan HBr , Phenylephrine HCI	POWDER, FOR SOLUTION	ORAL	20190328		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-318_861eb4e4-093d-33b6-e053-2a91aa0ab778	55758-318	HUMAN OTC DRUG	DESINTOX		Antimonium crudum,Argentum nitricum,Cholesterinum, Robinia pseudo-acacia,Carbo vegetabilis,Cinchona,Aesculus hippocastanum,Arnica montana,Berberis vulgaris,Ceanothus americanus, Cynara scolymus,Equisetum arvense,Erigeron canadensis,Fucus vesiculosus,Ginkgo biloba,Hamamelis virginiana,Helonias dioica,Hydrastis canadensis,Hydrastis canadensis,Lappa major,Lespedeza capitata,Raphanus sativus,Taraxacum officinale,Viburnum prunifolium,Vitis vinifera,Ranunculus bulbosus	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARNICA MONTANA; BERBERIS VULGARIS ROOT BARK; CEANOTHUS AMERICANUS LEAF; CHAMAELIRIUM LUTEUM ROOT; CINCHONA BARK; CYNARA SCOLYMUS LEAF; EQUISETUM ARVENSE TOP; ERIGERON CANADENSIS; FUCUS VESICULOSUS; GINKGO; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; LESPEDEZA CAPITATA FLOWERING TOP; RADISH; RANUNCULUS BULBOSUS; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; TARAXACUM OFFICINALE; VIBURNUM PRUNIFOLIUM BARK; VITIS VINIFERA WHOLE	9; 10; 6; 6; 6; 6; 6; 8; 6; 6; 6; 6; 10; 6; 6; 6; 6; 6; 4; 10; 10; 6; 6; 6	[hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
55758-319_b4c9a653-6f50-7c98-e053-2995a90ada37	55758-319	HUMAN OTC DRUG	Rapidol Sodium Bicarbonate		Sodium Bicarbonate	POWDER	ORAL	20201123		OTC MONOGRAPH FINAL	part331	Pharmadel LLC	SODIUM BICARBONATE	2.6	g/2.6g	Alkalinizing Activity [MoA]		N	20241231
55758-322_d56a071c-a748-5397-e053-2995a90aad8b	55758-322	HUMAN OTC DRUG	SanaTos Turbo	Max Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20200903		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-323_d56a6b0e-0bfc-713b-e053-2995a90adfbd	55758-323	HUMAN OTC DRUG	SanaTos Boost		DEXTROMETHORPHAN HBR	LIQUID	ORAL	20200903		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/100mL; mg/100mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55758-324_04ce1d62-f498-029f-e063-6394a90a8260	55758-324	HUMAN OTC DRUG	Dolodent		Arnica Montana, Chamomilla, Hecla lava, Hypericum, Asafoedida	LIQUID	BUCCAL	20171101		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	ARNICA MONTANA; CHAMOMILE; FERULA ASSA-FOETIDA RESIN; HEKLA LAVA; HYPERICUM PERFORATUM	30; 30; 6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55758-326_f93aa87d-e500-ff38-e053-6294a90ad0d4	55758-326	HUMAN OTC DRUG	Dolex Fem		Acetaminophen, Caffeine, Pyrilamine Maleate	TABLET, COATED	ORAL	20201001		OTC MONOGRAPH NOT FINAL	part343	Pharmadel LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
55758-327_0a0c8264-1d28-ab50-e063-6394a90abbce	55758-327	HUMAN OTC DRUG	DoloEar		Apis Melifica, Aristolochia Clematitis, Belladonna, Chamomilla, Lachesis Mutus, Thuja Occidentalis	SOLUTION/ DROPS	AURICULAR (OTIC)	20130523		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	APIS MELLIFERA; ARISTOLOCHIA CLEMATITIS ROOT; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 6; 6; 6	[hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55758-331_f4221c43-4a3e-e4ad-e053-2995a90a3095	55758-331	HUMAN OTC DRUG	Rapidol Stomach Relief		BISMUTH SUBSALICYLATE	LIQUID	ORAL	20221208		OTC MONOGRAPH FINAL	part335	Pharmadel LLC	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
55758-360_bf8de3da-762a-6112-e053-2995a90a8e16	55758-360	HUMAN OTC DRUG	FlexSport Roll On		Methyl Salicylate	LIQUID	TOPICAL	20210404		OTC MONOGRAPH FINAL	part348	Pharmadel LLC	METHYL SALICYLATE	15	g/100g			N	20241231
55758-361_df260190-89e6-b338-e053-2995a90a32cb	55758-361	HUMAN OTC DRUG	SanaTos Multi Symptom		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCI	TABLET	ORAL	20200801		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 15; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-362_e5ea9e50-2b4c-1070-e053-2a95a90abba6	55758-362	HUMAN OTC DRUG	Rapidol Aspirin Display 2x25		Aspirin	TABLET, COATED	ORAL	20220810		OTC MONOGRAPH FINAL	part343	Pharmadel LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55758-363_00d9ab0d-ff26-784f-e063-6294a90a8497	55758-363	HUMAN OTC DRUG	Rapidol Aspirin		Aspirin	TABLET, COATED	ORAL	20230801		OTC MONOGRAPH NOT FINAL	part343	Pharmadel LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55758-372_f8c383c1-d1b6-ceaa-e053-6294a90a6053	55758-372	HUMAN OTC DRUG	Dolex Acetaminophen 500mg	Extra Strength	ACETAMINOPHEN	CAPSULE, COATED	ORAL	20230407		OTC MONOGRAPH NOT FINAL	part343	Pharmadel LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55758-373_fe96a673-f1ee-1aa0-e053-6394a90ac3df	55758-373	HUMAN OTC DRUG	El Valle Gentian Violet		Gentian Violet 1%	LIQUID	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part333A	Pharmadel LLC	GENTIAN VIOLET	10	mg/mL			N	20241231
55758-374_fe1d860a-1ca5-c800-e053-6394a90abd03	55758-374	HUMAN OTC DRUG	El Valle Decolorized Iodine		Alcohol	TINCTURE	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part333A	Pharmadel LLC	ALCOHOL	.48	mg/mL			N	20241231
55758-375_fe1cefd9-542c-0d5a-e053-6394a90a575a	55758-375	HUMAN OTC DRUG	El Valle Merthiolate		Benzalkonium Chloride	LIQUID	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part333A	Pharmadel LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
55758-376_fe1f1408-b0cc-67a4-e053-6394a90ad609	55758-376	HUMAN OTC DRUG	Kofal	Max Power	Menthol	OINTMENT	TOPICAL	20230610		OTC MONOGRAPH NOT FINAL	part348	Pharmadel LLC	MENTHOL, UNSPECIFIED FORM	1.25	g/100g			N	20241231
55758-377_fe96eead-1723-c05d-e053-6394a90a850f	55758-377	HUMAN OTC DRUG	Ubredol		Methyl Salicylate	OINTMENT	TOPICAL	20230620		OTC MONOGRAPH NOT FINAL	part348	Pharmadel LLC	METHYL SALICYLATE	10	g/100g			N	20241231
55758-378_025d76f2-ab64-c811-e063-6394a90ae161	55758-378	HUMAN OTC DRUG	Milagroso		Methyl Salicylate	OINTMENT	TOPICAL	20230610		OTC MONOGRAPH NOT FINAL	part348	Pharmadel LLC	METHYL SALICYLATE	10	g/100g			N	20241231
55758-379_fdcaaa56-a27e-5bd9-e053-6294a90a1160	55758-379	HUMAN OTC DRUG	Sulfaderm		Sulfur	OINTMENT	TOPICAL	20230610		OTC MONOGRAPH FINAL	M006	Pharmadel LLC	SULFUR	10	g/100g			N	20241231
55758-400_09c282c0-4e67-8772-e063-6294a90ae4dd	55758-400	HUMAN OTC DRUG	Dolodent	Max Strength	Arnica Montana, Asafoedida, Chamomilla, Hecla lava, Hypericum	LIQUID	BUCCAL	20231201		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	ARNICA MONTANA; CHAMOMILE; FERULA ASSA-FOETIDA RESIN; HEKLA LAVA; HYPERICUM PERFORATUM	30; 30; 6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55758-401_04cd8bf5-9759-8d87-e063-6394a90afbb7	55758-401	HUMAN OTC DRUG	DoloEar		Apis Melifica, Aristolochia Clematitis, Belladonna, Chamomilla, Lachesis Mutus, Thuja Occidentalis	SOLUTION/ DROPS	AURICULAR (OTIC)	20230907		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	APIS MELLIFERA; ARISTOLOCHIA CLEMATITIS ROOT; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 6; 6; 6	[hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
55758-403_0517e283-81da-5b52-e063-6294a90a4eaf	55758-403	HUMAN OTC DRUG	Rapidol Arnica		ARNICA MONTANA	GEL	TOPICAL	20201030		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	ARNICA MONTANA WHOLE	1	[hp_X]/100g			N	20241231
55758-405_051ec8dc-02d0-e8f7-e063-6294a90a378e	55758-405	HUMAN OTC DRUG	Rapidol Arnica		Arnica Montana	TABLET	ORAL	20180830		UNAPPROVED HOMEOPATHIC		PHARMADEL LLC	ARNICA MONTANA	30	[hp_C]/1			N	20241231
55758-406_0427bbc9-f4cd-0eb6-e063-6294a90a7199	55758-406	HUMAN OTC DRUG	Urodel		Cantharis, Clematis, Cubeba, Echinacea, Ranunculus bulbosus, Sabal Serrulata, Staphysagria, Uva Ursi	TABLET, CHEWABLE	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Pharmadel LLC	ARCTOSTAPHYLOS UVA-URSI LEAF; CLEMATIS RECTA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA ANGUSTIFOLIA; LYTTA VESICATORIA; PIPER CUBEBA FRUIT; RANUNCULUS BULBOSUS; SAW PALMETTO	6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
55758-407_0670c33e-8a3d-ae00-e063-6294a90a165b	55758-407	HUMAN OTC DRUG	Tabcin	Extra Strength	Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl,	CAPSULE, LIQUID FILLED	ORAL	20231002		OTC MONOGRAPH FINAL	part341	Pharmadel LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55758-415_0a5fc0ef-ba33-bb0b-e063-6394a90af7d9	55758-415	HUMAN OTC DRUG	Sanatos	Multi Symptom Daytime	Acetaminophen, Dextromethorphan HBr	LIQUID	ORAL	20231201		OTC MONOGRAPH DRUG	M013	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/30mL; mg/30mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55758-416_0abf6f57-b512-0aa9-e063-6294a90ae605	55758-416	HUMAN OTC DRUG	Sanatos	Multi Symptoms Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20231201		OTC MONOGRAPH DRUG	M013	Pharmadel LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55785-123_082b49bf-4f2a-b480-e063-6394a90a0ac6	55785-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070917		UNAPPROVED MEDICAL GAS		Apache Oxy-Med, Inc.	OXYGEN	99	L/100L			N	20241231
55789-1221_710fda9f-82c2-41dd-8c9b-cba2b64a65d6	55789-1221	HUMAN OTC DRUG	Mineral SPF 30 Brush-On Sun Defense		TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20191231		OTC MONOGRAPH NOT FINAL	part352	Mineral Fusion brands	TITANIUM DIOXIDE; ZINC OXIDE	173; 200	mg/g; mg/g			N	20241231
55789-2400_72dedddb-d1c2-4361-b760-89b597be955b	55789-2400	HUMAN OTC DRUG	Perfecting Mineral Beauty Balm with SPF 9		Titanium Dioxide	CREAM	TOPICAL	20130401		OTC MONOGRAPH NOT FINAL	part352	Mineral Fusion Natural Brands LLC	TITANIUM DIOXIDE	39	mg/mL			N	20241231
55789-2401_d59b0bff-ce62-46fb-bc16-126c45eb7bd7	55789-2401	HUMAN OTC DRUG	Illuminating Mineral Beauty Balm with SPF 9		Titanium Dioxide	CREAM	TOPICAL	20130401		OTC MONOGRAPH NOT FINAL	part352	Mineral Fusion Natural Brands LLC	TITANIUM DIOXIDE	74	mg/mL			N	20241231
55789-3109_f118fa7c-c2ca-4e0e-a041-fa63f60265de	55789-3109	HUMAN OTC DRUG	Mineral SPF 40 Moisturizer		Zinc Oxide and Titanium dioxide	LOTION	TOPICAL	20121210		OTC MONOGRAPH NOT FINAL	part352	Mineral Fusion brands	TITANIUM DIOXIDE; ZINC OXIDE	7.5; 5	g/100mL; g/100mL			N	20241231
55792-007_1906f1b3-9423-4a47-b417-ffe3f075535e	55792-007	HUMAN PRESCRIPTION DRUG	Elliotts B		sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate	INJECTION	INTRATHECAL	20130604		NDA	NDA020577	Lukare Medical, LLC	ANHYDROUS DEXTROSE; CALCIUM CHLORIDE; MAGNESIUM SULFATE, UNSPECIFIED; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE	8; 2; 3; 3; 19; 73; 2	mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55801-338_76be9a7f-c5c3-441a-8d5a-ac7c229b899e	55801-338	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20231005		ANDA	ANDA207178	Appco Pharma LLC	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
55801-339_76be9a7f-c5c3-441a-8d5a-ac7c229b899e	55801-339	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20231005		ANDA	ANDA207178	Appco Pharma LLC	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
55801-340_76be9a7f-c5c3-441a-8d5a-ac7c229b899e	55801-340	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20231005		ANDA	ANDA207178	Appco Pharma LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
55801-527_897d1512-3e1a-469e-bcb9-131e514ed562	55801-527	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210601		ANDA	ANDA214908	Appco Pharma LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55801-528_897d1512-3e1a-469e-bcb9-131e514ed562	55801-528	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210601		ANDA	ANDA214908	Appco Pharma LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55801-529_897d1512-3e1a-469e-bcb9-131e514ed562	55801-529	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210601		ANDA	ANDA214908	Appco Pharma LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55801-530_897d1512-3e1a-469e-bcb9-131e514ed562	55801-530	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210601		ANDA	ANDA214908	Appco Pharma LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55801-531_897d1512-3e1a-469e-bcb9-131e514ed562	55801-531	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepn Hydrochloride	CAPSULE	ORAL	20210601		ANDA	ANDA214908	Appco Pharma LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
55806-020_0e851341-3b0a-dc79-e063-6394a90afbca	55806-020	HUMAN PRESCRIPTION DRUG	methazolamide		methazolamide	TABLET	ORAL	19940718	20250531	ANDA	ANDA040062	Effcon Laboratories, Inc.	METHAZOLAMIDE	50	mg/1			N	
55814-101_06be9e28-b6b3-a4e4-e063-6294a90a3400	55814-101	HUMAN OTC DRUG	HAND SANITIZING	LAVENDER	ALCOHOL	SPRAY	TOPICAL	20120218		OTC MONOGRAPH DRUG	M003	DR. BRONNER'S MAGIC SOAPS	ALCOHOL	62	mL/100mL			N	20241231
55814-102_06bea783-c3d7-cd73-e063-6394a90ac1c5	55814-102	HUMAN OTC DRUG	ORGANIC HAND SANITIZER	PEPPERMINT	ALCOHOL	SPRAY	TOPICAL	20190203		OTC MONOGRAPH DRUG	M003	DR. BRONNER'S MAGIC SOAPS	ALCOHOL	62	mL/100mL			N	20241231
55858-001_08b47781-8f1b-db0d-e063-6294a90af561	55858-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Augusta Health dba Care Home Medical	OXYGEN	99	L/100L			N	20241231
55863-155_03a8c5b9-b081-8b10-e063-6294a90ac578	55863-155	HUMAN OTC DRUG	SOFTCIDE		CHLOROXYLENOL	SOAP	TOPICAL	20170410		OTC MONOGRAPH NOT FINAL	part333A	Erie Scientific LLC	CHLOROXYLENOL	.001	mg/100mL			N	20241231
55873-001_8278dd4f-78ff-49a8-997c-9bc93a2cc3a7	55873-001	HUMAN OTC DRUG	OralLine Secure		SODIUM FLUORIDE	PASTE, DENTIFRICE	ORAL	19660101		OTC MONOGRAPH FINAL	part355	J.M. Murray Center Inc.	SODIUM FLUORIDE	.15	g/100g			N	20241231
55873-002_8278dd4f-78ff-49a8-997c-9bc93a2cc3a7	55873-002	HUMAN OTC DRUG	OralLine		SODIUM FLUORIDE	GEL, DENTIFRICE	ORAL	19660101		OTC MONOGRAPH FINAL	part355	J.M. Murray Center Inc.	SODIUM FLUORIDE	.15	g/100g			N	20241231
55882-3455_bbdc4b76-0889-43cf-904b-796840d36cd9	55882-3455	HUMAN OTC DRUG	Hello Charcoal		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20200910	20241230	OTC MONOGRAPH FINAL	part355	Hello Products LLC	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	
55882-3477_23e3d618-3f1d-43b2-8432-112a71d5e92a	55882-3477	HUMAN OTC DRUG	Hello Whitening		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20200908	20251230	OTC MONOGRAPH FINAL	part355	Hello Products LLC	SODIUM MONOFLUOROPHOSPHATE	1.1	mg/g			N	
55882-6100_eeae6d56-7360-4a60-9f7d-f2f7fb1598c9	55882-6100	HUMAN OTC DRUG	Hello	Naturally Whitening	Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20181005	20241031	OTC MONOGRAPH FINAL	part355	Hello Products LLC	SODIUM MONOFLUOROPHOSPHATE	1.5	mg/g			N	
55882-6102_8f7653e7-d3f2-4c85-b160-0d1d7e9cc1a5	55882-6102	HUMAN OTC DRUG	Hello	naturally fresh antiseptic	Menthol, Unspecified Form	MOUTHWASH	DENTAL	20190109	20250131	OTC MONOGRAPH NOT FINAL	part356	Hello Products LLC	MENTHOL, UNSPECIFIED FORM	.2	g/100mL			N	
55882-6112_b9fdcce4-e271-43d2-b7d2-030bde0bbc42	55882-6112	HUMAN OTC DRUG	Hello	Juicy Grape Fluoride	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210301	20241231	OTC MONOGRAPH FINAL	part355	Hello Products LLC	SODIUM FLUORIDE	1.5	mg/g			N	
55882-6115_a37a49bf-8491-4b0b-8b05-d8b0b816c109	55882-6115	HUMAN OTC DRUG	Hello		zinc oxide	STICK	TOPICAL	20210615	20240331	OTC MONOGRAPH FINAL	part352	Hello Products LLC	ZINC OXIDE	9.2	g/100g			N	
55882-6117_a7e671ab-0da1-4b51-b86c-fee15df53b1d	55882-6117	HUMAN OTC DRUG	Hello	Bye Bye Bacteria Fluoride	SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20220103	20240630	OTC MONOGRAPH FINAL	part355	Hello Products LLC	SODIUM MONOFLUOROPHOSPHATE	1.5	mg/g			N	
55910-001_f0538c61-ffb1-4219-b2fd-3a13fc95a0b0	55910-001	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20120111		OTC MONOGRAPH NOT FINAL	part333E	Dolgencorp LLC	POVIDONE-IODINE	10	mg/mL			N	20241231
55910-008_c702bcf8-8d1c-a398-e053-2995a90ad685	55910-008	HUMAN OTC DRUG	Dollar General Studio Selection Sun Sunscreen Broad Spectrum SPF 85 with Aloe		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180308		OTC MONOGRAPH NOT FINAL	part352	Dolgencorp, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
55910-009_6619b5b2-87f3-4d82-afbf-323a7c28272f	55910-009	HUMAN OTC DRUG	DG Health Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20150818		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55910-010_33d4a55e-479e-4e65-b9b6-b81de88bd488	55910-010	HUMAN OTC DRUG	dg health childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20150423		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
55910-012_91304e32-e011-41d0-a9a5-94a99d81f3d1	55910-012	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate,Otisalate, Octocrylene	SPRAY	TOPICAL	20191001		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 225; 250; 1000	mg/g; mg/g; mg/g; mg/g			N	20241231
55910-020_7b37ea97-327e-401a-b91f-d95fa8a3deec	55910-020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	PASTE	TOPICAL	20120510		OTC MONOGRAPH FINAL	part347	DOLGENCORP, LLC	ZINC OXIDE	400	mg/g			N	20241231
55910-021_e7e76e9a-dd13-4c5e-bb75-ce3588ae10e5	55910-021	HUMAN OTC DRUG	Pain and Fever Relief	Infants	Acetaminophen	SUSPENSION	ORAL	20150430	20250430	OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN	160	mg/5mL			N	
55910-029_f3950a61-a48f-7e0d-e053-2995a90a5afb	55910-029	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Nail Pen	LIQUID	TOPICAL	20160112		OTC MONOGRAPH FINAL	part333C	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
55910-030_9af580f8-30cd-4934-b376-abea5e1a1c03	55910-030	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20150224		OTC MONOGRAPH FINAL	part355	Old East Main Co	SODIUM FLUORIDE	.2	mg/mL			N	20241231
55910-031_2f61ceeb-5f78-44cc-bd7b-55af94d25892	55910-031	HUMAN OTC DRUG	Childrens Plus Flu		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan Hydrobromide, Phenylephrine HCI	SUSPENSION	ORAL	20150531		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-032_c703a796-d2a2-3825-e053-2995a90a0699	55910-032	HUMAN OTC DRUG	Dollar General Studio Selection Sun Tanning Dry Oil Broad Spectrum SPF 15 Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20181012		OTC MONOGRAPH NOT FINAL	part352	Dolgencorp, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
55910-033_66e4807c-3e92-44d7-b586-d31b41b3d2a9	55910-033	HUMAN OTC DRUG	Mucus Relief Cold and Sinus	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20140630	20250131	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
55910-034_0c94060a-bdd1-6ceb-e063-6394a90a745f	55910-034	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20100629		OTC MONOGRAPH DRUG	M003	Dolgencorp, LLC	SALICYLIC ACID	19.8	mg/g			N	20241231
55910-036_c70904e9-dfce-6bcc-e053-2a95a90a8fe6	55910-036	HUMAN OTC DRUG	Dollar General Studio Selection Sun Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151026		OTC MONOGRAPH NOT FINAL	part352	Dolgencorp, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-037_a16964f7-fc49-4084-b7d0-5d27fe08f6d6	55910-037	HUMAN OTC DRUG	Fast Acting Mucus Relief	Maximum Strength Severe Cough and Congestion	dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20141031		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-038_428c6f89-0ee6-46a1-84ae-3361f7b58638	55910-038	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	19931021		OTC MONOGRAPH NOT FINAL	part334	Old East Main, CO	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-039_b9df8f65-47cb-4130-a41d-5eeb51d7ac8a	55910-039	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCL	TABLET	ORAL	20190701		ANDA	ANDA077946	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-043_671e7bdf-43c7-4cc8-9103-b3ef4f8a9ab7	55910-043	HUMAN OTC DRUG	Childrens Plus Multi Symptom Cold		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	SUSPENSION	ORAL	20150430	20250430	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55910-046_010df084-4c51-46b8-b132-6ea94ec87c2e	55910-046	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200730		ANDA	ANDA207753	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-048_10680f5d-abef-4d85-8dbb-a4db4b1084be	55910-048	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	20241231
55910-050_ed371939-c2c9-4984-ac2b-25734a368e76	55910-050	HUMAN OTC DRUG	dg health Ibuprofen pm		diphenhydramine citrate and ibuprofen	TABLET, FILM COATED	ORAL	20100124		ANDA	ANDA079113	Dolgencorp Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-051_082aacba-f5e2-ec11-e063-6294a90ae8d6	55910-051	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	5.4	mg/1			N	20241231
55910-051_082ab09e-bd1d-c376-e063-6294a90ab081	55910-051	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	5.4	mg/1			N	20241231
55910-052_082abf79-da0c-17d7-e063-6294a90ab293	55910-052	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	5.8	mg/1			N	20241231
55910-052_082ac306-753e-8305-e063-6394a90ace25	55910-052	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20160722		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	5.8	mg/1			N	20241231
55910-053_082ac306-753f-8305-e063-6394a90ace25	55910-053	HUMAN OTC DRUG	Honey Lemon cough drops		menthol	LOZENGE	ORAL	20160722		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	7.5	mg/1			N	20241231
55910-053_082ac877-9268-3f10-e063-6294a90a3db5	55910-053	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	7.5	mg/1			N	20241231
55910-058_082adb41-6488-f599-e063-6394a90a225b	55910-058	HUMAN OTC DRUG	Strawberry Cough Drops		Menthol	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	2.7	mg/1			N	20241231
55910-059_082ae4e1-7d3d-403e-e063-6294a90a004a	55910-059	HUMAN OTC DRUG	Sugar Free Menthol Cough Drops		Menthol	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	5.8	mg/1			N	20241231
55910-061_27b5bd1d-a265-4cb0-afd9-992aa045159e	55910-061	HUMAN OTC DRUG	DG Health Antibiotic		Neomycin, Polymyxin B, Pramoxine HCl	CREAM	TOPICAL	20110114		OTC MONOGRAPH FINAL	part333B	Dolgencorp Inc	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55910-062_082af01e-d21a-1a22-e063-6394a90ae6b3	55910-062	HUMAN OTC DRUG	sugar free honey lemon cough drops		menthol	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	7.6	mg/1			N	20241231
55910-063_b6cb653a-7e8e-4e72-8b3c-bddd9f8ec9eb	55910-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20090413		OTC MONOGRAPH FINAL	part347	Dolgencorp, LLC	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL			N	20241231
55910-064_082b0bee-fb96-a5b9-e063-6294a90a2913	55910-064	HUMAN OTC DRUG	herbal cough drops		menthol	LOZENGE	ORAL	20160616		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	4.8	mg/1			N	20241231
55910-065_082b1c18-137a-002e-e063-6294a90ab3a9	55910-065	HUMAN OTC DRUG	cherry sore throat lozenge		Benzocaine	LOZENGE	ORAL	20150817		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55910-069_1c9b4bb7-3220-43c4-b905-c634a8f3b0a4	55910-069	HUMAN OTC DRUG	Pure petroleum		White Petrolatum	JELLY	TOPICAL	19981115		OTC MONOGRAPH FINAL	part347	Old East Main CO.	PETROLATUM	1	g/g			N	20241231
55910-070_082b3a52-0b72-b29b-e063-6394a90a4acb	55910-070	HUMAN OTC DRUG	Assorted Fruit Flavor Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20160322		OTC MONOGRAPH DRUG	M001	Dollar General Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-073_082b2368-cd08-6a1a-e063-6394a90a0ff7	55910-073	HUMAN OTC DRUG	Berry Breezer Throat Drops		Pectin	LOZENGE	ORAL	20160322		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	PECTIN	7	mg/1			N	20241231
55910-074_496e3d2d-84ba-44e3-85e0-be8898766b83	55910-074	HUMAN OTC DRUG	DG Health Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20100201		ANDA	ANDA077349	Dolgencorp, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-077_082b36b2-f93b-566f-e063-6294a90a6461	55910-077	HUMAN OTC DRUG	Heartburn and Gas Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170228		OTC MONOGRAPH DRUG	M001	DOLGENCORP, LLC	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
55910-081_35ea44ff-3f0f-4a4c-919f-5447d3c470ba	55910-081	HUMAN OTC DRUG	dg health miconazole 3		Miconazole nitrate	KIT		20100222		ANDA	ANDA075329	Dolgencorp Inc						N	20241231
55910-082_082b2d73-4fb4-684d-e063-6394a90ac665	55910-082	HUMAN OTC DRUG	SF Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20180712		OTC MONOGRAPH DRUG	M012	Dolgencorp, LLC	MENTHOL	7.6	mg/1			N	20241231
55910-086_be95c5eb-7897-4493-8db9-640f0f32e45f	55910-086	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20150123		OTC MONOGRAPH DRUG	M505G(a)(3)	OLD EAST MAIN CO.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
55910-088_7769fdbb-be39-7fc6-e053-2991aa0aa088	55910-088	HUMAN OTC DRUG	Rexall ICE COLD ANALGESIC		Menthol	GEL	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp, LLC	MENTHOL	2	g/100g			N	20241231
55910-089_082b534e-71d0-ad23-e063-6294a90a5dfc	55910-089	HUMAN OTC DRUG	DG Health Antacid Berry Bites		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190412		OTC MONOGRAPH DRUG	M001	Dolgencorp, LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-091_a6c1e37f-b80a-4ba9-ad70-4e50d9901093	55910-091	HUMAN OTC DRUG	Allergy	Childrens Allergy	Diphenhydramine Hydrochloride	LIQUID	ORAL	20150630	20250131	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-094_db87d659-4b69-4a77-b080-11880b9c7da8	55910-094	HUMAN OTC DRUG	DG Health nasal decongestant pe	maximum strength	Phenylephrine Hydrochloride	TABLET	ORAL	20100129		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-099_c8e6a32e-d418-41dd-9c34-dd01b50950b3	55910-099	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20040819		OTC MONOGRAPH NOT FINAL	part356	Old East Main CO	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-102_ff22cccb-726e-40a1-b3dc-41e8eb3c4906	55910-102	HUMAN OTC DRUG	dg health childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20160420		ANDA	ANDA074937	Dolgencorp, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-105_d22bcaba-5bf1-3bfe-e053-2a95a90a6866	55910-105	HUMAN OTC DRUG	Rexall Medicated WipesHemorrhoidal wipe	Hemorrhoidal wipes with witch hazel	witch hazel	CLOTH	TOPICAL	20120101		OTC MONOGRAPH FINAL	part346	Dolgencorp, LLC	WITCH HAZEL	129	g/258g			N	20241231
55910-107_927164ac-0c11-c142-e053-2a95a90af8ec	55910-107	HUMAN OTC DRUG	RexallEar Relief Ear Drops		MATRICARIA CHAMOMILLA, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20150801		UNAPPROVED HOMEOPATHIC		Dolgencorp LLC	MATRICARIA CHAMOMILLA; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
55910-109_fb7ff287-49de-f4ae-11fd-1b7726814156	55910-109	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution	Twice Daily	Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20211201		ANDA	ANDA209619	DOLGENCORP, LLC	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
55910-111_d54cf1d7-adbc-f66f-1e6d-a3409a481bb8	55910-111	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20190717		ANDA	ANDA076502	Dollar General	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-114_c52e515b-52c9-4048-a1e3-9717264e535a	55910-114	HUMAN OTC DRUG	Night Time Sleep Aid		Diphenhydramine HCl	LIQUID	ORAL	20150331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-115_e901ef10-8b53-4a25-b958-bd4cf40fe78e	55910-115	HUMAN OTC DRUG	DG health Extra Strength	Antacid	Smooth Dissolve Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	DOLGENCORP, LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-122_64b2982d-491e-42e7-b65e-7abf5530b935	55910-122	HUMAN OTC DRUG	dg health nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230519		ANDA	ANDA076779	Dolgencorp Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-125_ff99a7ee-3e54-4bf4-9cf1-a8d4b8b25790	55910-125	HUMAN OTC DRUG	Ibuprofen PM		Ibuprofen, Diphenhydramine HCL	CAPSULE, LIQUID FILLED	ORAL	20160229		ANDA	ANDA210676	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-128_d87bf868-c741-4abb-9512-52be1a710f3c	55910-128	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20161021		OTC MONOGRAPH FINAL	part358H	DOLGENCORP, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
55910-129_35db8622-b371-474d-96b2-b73aeafa5855	55910-129	HUMAN OTC DRUG	Allergy Relief	All Day	Cetirizine HCl	TABLET	ORAL	20130517		ANDA	ANDA078780	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-131_860ba80c-9c2c-44c5-ada8-83eb8309686a	55910-131	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20191226	20250131	OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SENNOSIDES	8.6	mg/1			N	
55910-134_f2d5ca97-1482-49e6-87cc-1b08812208ad	55910-134	HUMAN OTC DRUG	Back and Body	Extra Strength	Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20040412		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-137_322694b2-3eea-6d77-c34d-f3a726a9f268	55910-137	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution	Once Daily	Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20211201		ANDA	ANDA209752	DOLGENCORP, LLC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
55910-141_100f10dc-6a57-458c-baad-84659756ffc8	55910-141	HUMAN OTC DRUG	dg health heartburn prevention	original strength	Famotidine	TABLET, FILM COATED	ORAL	20100310		ANDA	ANDA075400	Dolgencorp, LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55910-144_f27b1e7d-0bb5-b8fb-e053-2995a90a8041	55910-144	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20210709		OTC MONOGRAPH NOT FINAL	part333A	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
55910-149_8dfb9634-1ddf-4ea0-8aba-9d709ee537df	55910-149	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-153_5e561172-ba67-4d0d-8d29-a59f9dd43c58	55910-153	HUMAN OTC DRUG	Simply Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH DRUG	M032	Old East Main Co.	PYRITHIONE ZINC	10	mg/mL			N	20241231
55910-157_117da2a6-ec40-4dd3-9848-3012ab0538f5	55910-157	HUMAN OTC DRUG	Coated Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20140531		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55910-161_497d5a56-fbf1-4500-a3e5-f5bcaa4a98fb	55910-161	HUMAN OTC DRUG	dg health infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20120503		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
55910-163_128f7842-7a44-4605-9a0d-10da8a9b3660	55910-163	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20060513		OTC MONOGRAPH DRUG	M021	Dolgencorp, LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
55910-164_f27b00c9-b1fb-28b9-e053-2a95a90a9e4e	55910-164	HUMAN OTC DRUG	Miconazole Nitrate 2%		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20190603		OTC MONOGRAPH FINAL	part333C	Dolgencorp, Inc. (Dollar General & Rexall)	MICONAZOLE NITRATE	1.3	g/131g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55910-166_6e4962c3-9425-4b77-a9da-045db77f35ec	55910-166	HUMAN OTC DRUG	DG Health childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20160502		ANDA	ANDA074937	Dolgencorp, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-168_602ea210-f7d1-43eb-a162-899645e09f9e	55910-168	HUMAN OTC DRUG	Womens Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20230223		OTC MONOGRAPH DRUG	505G(a)(3)	DOLGENCORP, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-170_9cc55414-1ca3-4200-9a0a-f04b136db4e4	55910-170	HUMAN OTC DRUG	Sport		Avobenzone, Homosalate, Octisalate, Octisalate	SPRAY	TOPICAL	20191101		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 2250; 250; 8	g/g; g/g; g/g; g/g			N	20241231
55910-171_cbc65148-95fd-4dc6-b01f-2b81ce7d3265	55910-171	HUMAN OTC DRUG	Antiseptic Oral Cleanser		Hydrogern Peroxide	MOUTHWASH	ORAL	20090419		OTC MONOGRAPH NOT FINAL	part356	OLD EAST MAIN CO.	HYDROGEN PEROXIDE	150	mg/100L			N	20241231
55910-176_e08f6085-d26e-518a-e053-2995a90a0495	55910-176	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180817		NDA	NDA021855	DOLGENCORP, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
55910-177_f80bc6ae-a70e-4819-af9b-e02c1c880d83	55910-177	HUMAN OTC DRUG	Sunburn Relief		Lidocaine HCl 0.5%	GEL	TOPICAL	20191230		OTC MONOGRAPH NOT FINAL	part348	Old East Main CO	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55910-180_abc56f19-5aaa-464c-9f3d-8adb0f0fa95b	55910-180	HUMAN OTC DRUG	Healing for Babies		Petrolatum	OINTMENT	TOPICAL	20120301		OTC MONOGRAPH FINAL	part347	OLD EAST MAIN CO	PETROLATUM	410	mg/g			N	20241231
55910-183_fa4a63cf-e1e5-4f2b-ac95-00bb0eee1467	55910-183	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20190904		OTC MONOGRAPH NOT FINAL	part334	OLD EAST MAIN CO	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-186_19c3a748-6221-4454-b0aa-05f0ad1f290f	55910-186	HUMAN OTC DRUG	dg health sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20150511		OTC MONOGRAPH FINAL	part338	Dolgencorp, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-188_5a384227-03db-4e6d-8e1d-ad8d4d1e8e80	55910-188	HUMAN OTC DRUG	DG Health Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20131220		OTC MONOGRAPH FINAL	part346	Dolgencorp, LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-190_0af8a7c6-8f55-4696-9315-6d11224ea28c	55910-190	HUMAN OTC DRUG	Laxative	Enteric Coated	Bisacodyl	TABLET, COATED	ORAL	20130620	20240620	OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55910-191_f83188b7-1b97-4568-ab6e-2ba48d311026	55910-191	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	20200730		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-192_0a35f0c9-696d-e38a-e063-6294a90afb5c	55910-192	HUMAN OTC DRUG	Homeopathic Tea Tree Oil Lice		Eucalyptus globulus, Natrum muriaticum	SHAMPOO	TOPICAL	20231115		UNAPPROVED HOMEOPATHIC		DOLGENCORP, LLC	EUCALYPTUS GLOBULUS LEAF; SODIUM CHLORIDE	2; 2	[hp_X]/mL; [hp_X]/mL			N	20241231
55910-194_cba751e1-5ffd-49da-a40f-a03e921b1368	55910-194	HUMAN OTC DRUG	dg health heartburn prevention		Famotidine	TABLET, FILM COATED	ORAL	20100214		ANDA	ANDA077351	Dolgencorp Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55910-197_9bcf0bae-dc0d-454f-8d77-6a80a3c55bb0	55910-197	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210430		ANDA	ANDA078682	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-204_01d9f722-be63-c8a2-e063-6394a90a87e2	55910-204	HUMAN OTC DRUG	Regular Strength Stomach Relief		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20230918		OTC MONOGRAPH FINAL	M008	DOLGENCORP, INC.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
55910-207_0747c5a7-e037-43f7-98e6-f72b9a7f771e	55910-207	HUMAN OTC DRUG	No Drip		Extra Moisturizing Nasal Mist	SPRAY	NASAL	20200909		OTC MONOGRAPH FINAL	part341	DOLGENCORP, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55910-209_a5b300f9-daba-418b-b9f9-d2838586ea54	55910-209	HUMAN OTC DRUG	DG Health Triple Antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20150623		OTC MONOGRAPH FINAL	part333B	Dolgencorp, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55910-210_95270d46-2515-454b-904d-6dd41044ea3f	55910-210	HUMAN OTC DRUG	DG health Extra Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	DOLGENCORP, LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
55910-211_5b2f319c-02fc-4092-b219-eeda2efc056e	55910-211	HUMAN OTC DRUG	Isopropyl		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20040811		OTC MONOGRAPH NOT FINAL	part333A	OLD EAST MAIN CO.	ISOPROPYL ALCOHOL	462	mg/mL			N	20241231
55910-215_4fc10791-9c76-4c1f-9ad4-e940ab75191c	55910-215	HUMAN OTC DRUG	dg health omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200710		NDA	NDA022032	Dolgencorp, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55910-218_a1a4f54c-5c62-4438-8fd4-b389e3bb4f04	55910-218	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20110630		OTC MONOGRAPH NOT FINAL	part347	DOLGENCORP, LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
55910-222_0bf1aefe-adaa-b1a2-e063-6394a90afa6c	55910-222	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20190517		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-223_0bf24454-c104-5ce6-e063-6294a90a4b80	55910-223	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190521		OTC MONOGRAPH DRUG	M007	Dolgencorp, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
55910-224_c50cb5a2-ac3e-4a6d-aced-104929209332	55910-224	HUMAN OTC DRUG	dg health anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20091228		ANDA	ANDA075232	Dolgencorp, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
55910-225_756dbcc4-e1ec-4fc8-9456-dfd5a8aa0172	55910-225	HUMAN OTC DRUG	rexall anti itch	maximum strength relief	Hydrocortisone	CREAM	TOPICAL	20100831		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp, LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-226_dc3d950b-34ae-473c-ae86-0195dcc09d3e	55910-226	HUMAN OTC DRUG	Alert		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	DOLGENCORP, LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
55910-227_db016743-d349-4dd5-8a6e-fd078e241be8	55910-227	HUMAN OTC DRUG	DG Health Pain Reliever		Acetaminophen	TABLET, COATED	ORAL	20100221		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55910-235_3468b17a-aa88-40b6-9e69-b3a23dc0ff0b	55910-235	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20110126		OTC MONOGRAPH FINAL	part347	OLD EAST MAIN CO.	PETROLATUM	838	g/g			N	20241231
55910-241_470fee97-daab-4967-9c0e-77bacfb2ccd8	55910-241	HUMAN OTC DRUG	DG Health Allergy Relief		levocetirizine dihydrochloride	TABLET, FILM COATED	ORAL	20210617		ANDA	ANDA211983	Dolgencorp, LLC	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-245_e49e6de1-060f-4b2f-a111-471abc2da551	55910-245	HUMAN OTC DRUG	Laxative pills	Maximum Strength	Sennosides	TABLET	ORAL	20131230		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SENNOSIDES	25	mg/1			N	20241231
55910-248_ffe7e354-0a75-4a5e-801c-c1de53e88b33	55910-248	HUMAN OTC DRUG	Medicated Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20100907		OTC MONOGRAPH FINAL	part341	Doldgecorp, LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	kg/100kg; kg/100kg; kg/100kg			N	20241231
55910-249_e774ecc9-8a3f-410c-933c-ab277775ce3b	55910-249	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19930804		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55910-250_6b0b227f-b5a4-48ef-9969-e2b924911ee8	55910-250	HUMAN OTC DRUG	dg health esomeprazole magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200714		ANDA	ANDA207193	Dolgencorp, LLC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55910-251_ac53f720-2836-46e8-8c36-0d8290cb036d	55910-251	HUMAN OTC DRUG	DG Health Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20150520		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
55910-253_4e8da5a9-c728-46e4-b9f1-b0e8f4b04eff	55910-253	HUMAN OTC DRUG	womans laxative		Bisacodyl	TABLET, COATED	ORAL	20180630	20250630	OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
55910-255_9f4deb6a-a97f-436f-b127-a86223a6f578	55910-255	HUMAN OTC DRUG	dg health ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20100427		ANDA	ANDA075217	Dolgencorp, LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-256_86d1602a-8c2f-ec9d-e053-2a91aa0aa265	55910-256	HUMAN OTC DRUG	Dollar General Vapor Steam		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20111102		OTC MONOGRAPH FINAL	part341	DOLGENCORP, LLC	CAMPHOR (SYNTHETIC)	.623	g/10mL			N	20241231
55910-264_39393598-f814-44e4-b135-76ca48801211	55910-264	HUMAN OTC DRUG	Acne Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20140218		OTC MONOGRAPH FINAL	part333D	Old East Main Co.	BENZOYL PEROXIDE	104	mg/10g			N	20241231
55910-265_cebd2a86-9932-4cc5-8ddc-255fd3a20382	55910-265	HUMAN OTC DRUG	Vapor Inhaler	levmetamfetamine nasal decongestant, DG health	Levmetamfetamine	INHALANT	NASAL	20210223		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc.	LEVMETAMFETAMINE	50	mg/1			N	20241231
55910-268_e62aea26-a9f1-4122-9f4d-c2f8f5018596	55910-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20200730	20250131	OTC MONOGRAPH NOT FINAL	part356	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	HYDROGEN PEROXIDE	2.65	mL/100mL			N	
55910-269_0c774d83-58dd-d9b3-e063-6394a90a6f7a	55910-269	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine Hydrochloride	TABLET	ORAL	20231220		ANDA	ANDA078933	DOLGENCORP, INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-272_b4805298-2f22-4750-bbef-96a6480fc7ff	55910-272	HUMAN OTC DRUG	Dollar General Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20220623		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-273_a11474d3-cdf9-4ade-a610-e8ef2e3ecd0d	55910-273	HUMAN OTC DRUG	DG health Ultra Strength	Assorted Fruit Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190517		OTC MONOGRAPH FINAL	part331	DOLGENCORP, LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
55910-275_231b5cf2-31e0-42ac-ba1e-8a7725119ec6	55910-275	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333A	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
55910-276_d07055d0-1479-47a8-bb2a-a76601eef7bf	55910-276	HUMAN OTC DRUG	DG Health Sinus PE		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20150804		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-277_72722022-a114-4691-875e-ec020cbde87d	55910-277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333A	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
55910-279_bce9c831-dfe7-42a7-b533-d34c9bade468	55910-279	HUMAN OTC DRUG	rexall hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140828		OTC MONOGRAPH FINAL	part346	Dolgencorp Inc	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-280_ac54d450-15a8-4dfa-9115-c428e390862a	55910-280	HUMAN OTC DRUG	DG Health Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20200624		ANDA	ANDA078104	Dolgencorp, LLC	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-282_f66383d7-f9b3-42cd-805d-b9c47d19a4e6	55910-282	HUMAN OTC DRUG	Pain Relief	Childrens	Acetaminophen	SUSPENSION	ORAL	20150430		OTC MONOGRAPH DRUG	M013	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN	160	mg/5mL			N	20241231
55910-284_52281782-6681-4da6-a800-1931ac7394c7	55910-284	HUMAN OTC DRUG	DG Health Tussin		Acetaminophen, diphenhydramine HCl, phenylephrine HCl	SOLUTION	ORAL	20160801		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-285_ada163e1-58ca-44a9-a3ee-5ba7edae9e53	55910-285	HUMAN OTC DRUG	DG Health DayTime SEVERE Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE	ORAL	20230808		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-286_38f677ed-83ea-4521-8de3-c9166f77acf1	55910-286	HUMAN OTC DRUG	DG Health NightTime SEVERE Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE	ORAL	20230808		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-293_ffee94e2-9fcb-472a-b393-f1ef2aab3bf6	55910-293	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20240108		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
55910-295_54d05990-6257-4705-ba5f-e6376b69031a	55910-295	HUMAN OTC DRUG	Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20100714		OTC MONOGRAPH NOT FINAL	part348	OLD EAST MAIN CO	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-297_96ff7b71-7b2a-48e8-8840-f1ecc109baf3	55910-297	HUMAN OTC DRUG	Childrens Plus Cough and Runny Nose		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide	SUSPENSION	ORAL	20150831		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-299_bdc17c20-6c53-4fa5-9c59-efe3ee2d1cdf	55910-299	HUMAN OTC DRUG	Health		Cetylpyridinium chloride	MOUTHWASH	ORAL	20080721		OTC MONOGRAPH DRUG	505G(a)(3)	Old East Main. Co	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
55910-300_31ee4e2c-59da-4448-987f-28954c740e30	55910-300	HUMAN OTC DRUG	DG Health Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20140327		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-302_1f27f251-04b7-4d30-8595-d4d0300c150b	55910-302	HUMAN OTC DRUG	DG health childrens pain relief		Acetaminophen	SUSPENSION	ORAL	20120909		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
55910-304_8d91485e-b7e6-483a-9bfc-a72e045e66a0	55910-304	HUMAN OTC DRUG	dg health nasal	original	oxymetazoline hydrochloride	SPRAY	NASAL	20100108		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55910-306_8bac7057-0897-4019-9910-ca29e2a9d2d2	55910-306	HUMAN OTC DRUG	dg health clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	Dolgencorp, LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-307_302f8c4a-5f47-4f9c-b598-4f9c6dd3b4ce	55910-307	HUMAN OTC DRUG	dg health lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210609		ANDA	ANDA202319	Dolgencorp Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55910-309_ea430070-1a1b-4c52-aa51-46c7db4ebc07	55910-309	HUMAN OTC DRUG	Cough Relief	Adult	Dextromethorphan HBr	LIQUID	ORAL	20150831		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-311_86b8e76e-2c92-400c-b679-6a35fec5a516	55910-311	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20050623		OTC MONOGRAPH DRUG	M032	OLD EAST MAIN CO.	PYRITHIONE ZINC	10	mg/mL			N	20241231
55910-312_f27b0f72-80c7-473c-e053-2995a90aacc8	55910-312	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20150513		OTC MONOGRAPH FINAL	part358B	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
55910-313_8f46bd59-3a6d-1cdb-bb8b-505c109e7e62	55910-313	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190615		NDA	NDA020076	DOLGENCORP, LLC	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-315_f48d0b2e-95da-4b5e-8703-a94ce5be6627	55910-315	HUMAN OTC DRUG	DG health Ultra Strength	Assorted Berry Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	DOLGENCORP, LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-318_07819cc2-ec53-4fbe-86c6-ce69de14dad7	55910-318	HUMAN OTC DRUG	Mouth Rinse		EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL	MOUTHWASH	ORAL	20010111		OTC MONOGRAPH NOT FINAL	part356	Old East Main Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-319_7f5e9d1c-dce6-4d00-822a-c31e92f4c563	55910-319	HUMAN OTC DRUG	DG Health Hydrocortisone	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20100130		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-320_e1faf2b9-33ef-96bb-e053-2995a90a1faf	55910-320	HUMAN OTC DRUG	Dollar General	Maximum Strength	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120	20250430	OTC MONOGRAPH NOT FINAL	part356	Dolgencorp LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	
55910-324_e1faed1f-c99e-2484-e053-2a95a90ab6a4	55910-324	HUMAN OTC DRUG	DG Health	Restore and Defend Sensitive	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190211	20240430	OTC MONOGRAPH NOT FINAL	part356	Dolgencorp, LLC	STANNOUS FLUORIDE	.454	g/100g			N	
55910-327_cbc65377-1784-41a9-8812-5a53a3f38f50	55910-327	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	DOLGENCORP, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-329_35d03036-3185-4af2-ba80-51550eb2e5fa	55910-329	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-330_611ebafc-c024-4a34-8310-67055526fa41	55910-330	HUMAN OTC DRUG	DG Health Medicated Anti-Itch	Analgesic	Menthol, Unspecified Form and Pramoxine Hydrochloride	CREAM	TOPICAL	20080102		OTC MONOGRAPH NOT FINAL	part347	DOLGENCORP, LLC	MENTHOL, UNSPECIFIED FORM; PRAMOXINE HYDROCHLORIDE	10; 10	mg/g; mg/g			N	20241231
55910-331_b359104b-8264-40e5-a01e-1eb79997c892	55910-331	HUMAN OTC DRUG	Rexall Hemorrhoidal		Glycerin, Phenylephrine Hydrochloride, Pramoxine Hydrochloride, and Petrolatum	CREAM	TOPICAL	20140301		OTC MONOGRAPH FINAL	part346	Dolegencorp,LLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	.144; .15; .0025; .1	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-332_9a97910f-603a-4076-9f40-52d48160a526	55910-332	HUMAN OTC DRUG	Rexall Hemorrhoidal Cooling Gel		Witch Hazel and Phenylephrine Hydrochloride	CREAM	TOPICAL	20140318		OTC MONOGRAPH FINAL	part346	DOLGENCORP, LLC	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	.0025; .5	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-335_c72068af-72d0-478a-81c0-e42c4b5cb106	55910-335	HUMAN OTC DRUG	dg health night time cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110817		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-336_d5a0f196-9f51-4c1f-bbc5-b158ab11baa8	55910-336	HUMAN OTC DRUG	Mucus Relief	Cold Flu and Sore Throat Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-339_c1d634e7-eed9-407c-94d5-61c3d52b557c	55910-339	HUMAN OTC DRUG	Saline Laxative Cherry	Laxative	Sodium Phosphate, Dibasic and Sodium Phosphate, Monobasic, Unspecified Form	LIQUID	ORAL	20160315		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp Inc.	SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	2.7; 7.2	g/45mL; g/45mL			N	20241231
55910-340_41b0b57b-0ebc-40e9-800f-fc099d38e325	55910-340	HUMAN OTC DRUG	Rexall Athletes Foot		Clotrimazole	CREAM	TOPICAL	20171001		OTC MONOGRAPH FINAL	part333C	Dollar General	CLOTRIMAZOLE	.01	mg/10g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55910-341_1a596f0e-1a72-46dc-83fd-c18afa3e7618	55910-341	HUMAN OTC DRUG	Athletes Foot	Antifungal	TOLNAFTATE	CREAM	TOPICAL	20171001		OTC MONOGRAPH FINAL	part333C	Dollar General	TOLNAFTATE	.01	mg/10g			N	20241231
55910-342_4d1f2d84-0a38-4c25-a42a-8a917119df75	55910-342	HUMAN OTC DRUG	DG Poly Antibiotic	First Aid Antibiotic	Bacitracin and Polymyxin B Sulfate	OINTMENT	TOPICAL	20100614		OTC MONOGRAPH FINAL	part333B	Dollar General	BACITRACIN; POLYMYXIN B SULFATE	500; 10000	U/g; U/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55910-343_96ce9c57-b335-438d-808b-500728a0834a	55910-343	HUMAN OTC DRUG	Rexall Jock Itch		Clotrimazole	CREAM	TOPICAL	20171001		OTC MONOGRAPH FINAL	part333C	Dollar General	CLOTRIMAZOLE	.01	mg/10g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55910-344_fb243550-4a96-406d-8002-a541b1913381	55910-344	HUMAN OTC DRUG	DG Anti-Itch		Diphenhydramine hydrochloride and Zinc acetate	CREAM	TOPICAL	20110517		OTC MONOGRAPH NOT FINAL	part348	Dollar General	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; .1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-345_7ca84473-a4d6-4c8c-a03b-d38c703ae0ea	55910-345	HUMAN OTC DRUG	Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210506		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-346_f3a4cfbf-19d0-05ee-e053-2a95a90a4ac0	55910-346	HUMAN OTC DRUG	Rexall	Maximum Strength	Benzocaine	LIQUID	ORAL	20150101		OTC MONOGRAPH NOT FINAL	part356	Rexall	BENZOCAINE	20	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55910-348_fd495c97-b6fe-43a0-a9bc-df5e4eb24067	55910-348	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20030102	20240708	OTC MONOGRAPH DRUG	505G(a)(3)	DOLGENCORP, LLC	SENNOSIDES	25	mg/1			N	
55910-353_ed483940-a3d7-49d2-a28a-f146a186c84b	55910-353	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20150121		OTC MONOGRAPH FINAL	part358H	DOLGENCORP, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
55910-354_63a3714e-4be6-46b6-8430-75f6df21979c	55910-354	HUMAN OTC DRUG	Daily Baby		Dimethicone	LOTION	TOPICAL	20150810		OTC MONOGRAPH FINAL	part347	Old East Main CO.	DIMETHICONE	13.1	mg/g	Skin Barrier Activity [PE]		N	20241231
55910-357_628976ec-eeb4-4b27-8167-af9491e1ff23	55910-357	HUMAN OTC DRUG	dg health antacid		Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20140509		OTC MONOGRAPH FINAL	part331	Dolgencorp, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-359_5b08f0ff-9696-4056-9431-9c12d4191ccd	55910-359	HUMAN OTC DRUG	dg health tussin dm	adult	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20100222		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-360_f32e4188-df96-8e51-e053-2995a90a10f5	55910-360	HUMAN OTC DRUG	DG health	Sensitive Maximum Strength	Potassium nitrate, Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190213		OTC MONOGRAPH NOT FINAL	part356	Dolgencorp, LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
55910-361_0d2a0dd7-13fc-60d6-e063-6294a90a044e	55910-361	HUMAN OTC DRUG	DG Health Advanced Relief Eye Drops		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200126		OTC MONOGRAPH DRUG	M018	Dolgencorp LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
55910-362_0d2a0dd7-13fd-60d6-e063-6294a90a044e	55910-362	HUMAN OTC DRUG	DG Health Dry Eye Relief		glycerin, hypromellose, polypropylene glycol 400	SOLUTION	OPHTHALMIC	20200127		OTC MONOGRAPH DRUG	M018	Dolgencorp LLC	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
55910-363_0d2a132b-84bf-7b07-e063-6294a90af042	55910-363	HUMAN OTC DRUG	DG Original Eye Drops		tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200127		OTC MONOGRAPH DRUG	M018	Dolgencorp LLC	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
55910-364_0d2a2122-0b85-9022-e063-6394a90a1136	55910-364	HUMAN OTC DRUG	DG Lubricant Eye Drops		polyethylene glycol 400, propylene glycol	SOLUTION	OPHTHALMIC	20200127		OTC MONOGRAPH DRUG	M018	Dolgencorp LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
55910-365_903999e6-0b5d-41d7-b4dd-224c3c625109	55910-365	HUMAN OTC DRUG	Chocolated Laxative	Regular Strength Sennosides Stimulant Laxative, DG health	Sennosides	TABLET, CHEWABLE	ORAL	20210223		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp Inc.	SENNOSIDES	15	mg/1			N	20241231
55910-366_d9326bea-cb62-4cae-a9c6-0ae0fc580465	55910-366	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-372_8d7b0582-8a39-492d-93f9-05564f7a69e7	55910-372	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20150331	20240426	OTC MONOGRAPH FINAL	part335	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55910-374_493d5a66-5d53-4cea-9df0-b5eaec08292c	55910-374	HUMAN OTC DRUG	DG Health migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20091204		ANDA	ANDA075794	Dolgencorp, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-376_9ca7888c-aa54-47b6-a040-fe6d74566350	55910-376	HUMAN OTC DRUG	Sore throat	cherry	Phenol	SPRAY	ORAL	20180331		OTC MONOGRAPH DRUG	M022	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	PHENOL	1.4	g/100mL			N	20241231
55910-378_63718d09-5af9-49c2-b2e2-00d868e059cd	55910-378	HUMAN OTC DRUG	Triacting Daytime Cold Cough	Childrens	Dextromethorphan HBr, Phenylephrine HCl	SYRUP	ORAL	20140530		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	5; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-379_13e7f577-9831-4531-ae5f-a70ccd57e1ef	55910-379	HUMAN OTC DRUG	dg health allergy	childrens	Diphenhydramine Hydrochloride	SOLUTION	ORAL	20100129		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-383_5c01543d-1af7-4309-9b71-1fe22c536391	55910-383	HUMAN OTC DRUG	dg health anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181009		ANDA	ANDA209837	Dolgencorp, LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
55910-384_0f647349-7e5c-4bc8-9838-c536aac943eb	55910-384	HUMAN OTC DRUG	DG Health Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20130702		ANDA	ANDA091135	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-390_a9e4de82-a662-4aa5-9a4e-04564de8ae7b	55910-390	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength	Acetaminophen, Caffeine and Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
55910-396_40da5dbe-4d5d-42cc-b3b9-4e11da128b0f	55910-396	HUMAN OTC DRUG	dg health milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20140507		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-398_a5d0ee70-d528-4a53-bf01-7bb13b364ed0	55910-398	HUMAN OTC DRUG	dg health tussin		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230322		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-399_e177a580-dbcd-6a37-e053-2995a90a6fb8	55910-399	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20220712		ANDA	ANDA079205	DOLGENCORP, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-404_f27b2301-ca2d-d1af-e053-2a95a90a969f	55910-404	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20150629		OTC MONOGRAPH FINAL	part358F	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SALICYLIC ACID	.17	g/9mL			N	20241231
55910-408_98ce90d4-24f1-468a-b762-33f1075e70f5	55910-408	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20160229	20240426	ANDA	ANDA078682	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55910-409_f27b0f89-56cd-8b3b-e053-2a95a90ab318	55910-409	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20130513		OTC MONOGRAPH FINAL	part358F	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SALICYLIC ACID	40	mg/91			N	20241231
55910-410_f27b03c7-6d46-5ca5-e053-2a95a90adfdf	55910-410	HUMAN OTC DRUG	Undecylenic Acid		Anti-Fungal Nail Solution	LIQUID	TOPICAL	20140227		OTC MONOGRAPH FINAL	part333C	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	UNDECYLENIC ACID	7.5	g/30mL			N	20241231
55910-412_f27b3518-d5c2-1229-e053-2a95a90ab56f	55910-412	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20130513		OTC MONOGRAPH FINAL	part333C	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	MICONAZOLE NITRATE	1.3	g/131g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55910-419_96050d99-6f83-478a-bf92-2f6991355f39	55910-419	HUMAN OTC DRUG	DG Health Childrens Mucus Relief Cough		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20091114		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-421_aea6d718-406d-48bf-98d0-6b7f657812da	55910-421	HUMAN OTC DRUG	DG Health night time cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20180619		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-422_f0306b64-e6f8-476c-e053-2a95a90a2576	55910-422	HUMAN OTC DRUG	DG Health Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20150903		OTC MONOGRAPH FINAL	part343	DOLGENCORP, INC	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55910-424_e28665bb-8c9f-4a4d-9577-fd725b5307e0	55910-424	HUMAN OTC DRUG	DG health arthritis pain		diclofenac sodium	GEL	TOPICAL	20201208		ANDA	ANDA211253	Dolgencorp Inc	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-428_a1dad3fe-bd8a-41ae-abdb-de38a329b2a0	55910-428	HUMAN OTC DRUG	DG Health Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20100117		OTC MONOGRAPH FINAL	part332	Dolgencorp, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
55910-431_4eb783bc-9e8f-4908-85e4-502cd6a104a2	55910-431	HUMAN OTC DRUG	dg health sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20100124		OTC MONOGRAPH FINAL	part338	Dolgencorp Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-432_d48cb6fb-b84f-41c8-adc5-d108817eb062	55910-432	HUMAN OTC DRUG	dg health day time severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20190906		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-436_f8e561ec-8f6e-425b-9559-31a83747fe5e	55910-436	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH DRUG	M008	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55910-437_504b79e7-6bc4-46eb-ae59-f4ef54299e5f	55910-437	HUMAN OTC DRUG	dg health pain relief pm	extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20091121		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-439_de9647aa-d28e-40e0-8a2a-b18d57660297	55910-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130222		OTC MONOGRAPH NOT FINAL	part333A	Old East Main	ALCOHOL	700	mg/mL			N	20241231
55910-440_ab650fe0-25f0-417d-a819-e313fb173bc7	55910-440	HUMAN OTC DRUG	Extra Strength Headache Relief		acetaminophen, aspirin, and caffeine	TABLET, COATED	ORAL	20210501		OTC MONOGRAPH NOT FINAL	part343	Dollar General	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-441_464d436a-79b0-45b4-8b5f-51dc2de2d8e4	55910-441	HUMAN OTC DRUG	DG health dual pain reliever		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230510		ANDA	ANDA214836	Dolgencorp Inc	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-442_25e13317-68a8-4378-bb61-e65369309fa7	55910-442	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
55910-443_ed294a08-f86a-48f6-b29c-ed3ee4442ac8	55910-443	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20180331		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-446_dd069641-b671-4dd8-9454-f5cda345dfd3	55910-446	HUMAN OTC DRUG	dg health triple antibiotic		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20200106		OTC MONOGRAPH FINAL	part333B	Dolgencorp, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55910-448_673d42d8-b484-4232-bc91-19d83db63550	55910-448	HUMAN OTC DRUG	dg health migraine relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220602		ANDA	ANDA075794	Dolgencorp Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-454_fb7d1883-0820-446c-bdb9-ad661b709911	55910-454	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, FILM COATED	ORAL	20230223		OTC MONOGRAPH DRUG	505G(a)(3)	DOLGENCORP, LLC	SENNOSIDES	25	mg/1			N	20241231
55910-455_3911fe1e-135b-49d2-b5f5-1defed74e49d	55910-455	HUMAN OTC DRUG	Allergy Multi-Symptom		Acetaminophen, Chlorpheniramine Maleate and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050628		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-457_b8887167-1884-4bee-886d-0022189e87e9	55910-457	HUMAN OTC DRUG	Dollar General Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20210331		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, LLC	BISACODYL	10	mg/2000mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-458_d731452e-b34f-4301-8bc7-e29425253a61	55910-458	HUMAN OTC DRUG	dg health all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20100108		ANDA	ANDA078336	Dolgencorp Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-459_29e700ac-4948-4c2b-b916-2671bde29aee	55910-459	HUMAN OTC DRUG	dg health cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110815		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-460_2037f827-cfa8-4183-8eb2-aa24d666a508	55910-460	HUMAN OTC DRUG	Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-462_6791c6b2-69ac-409f-951f-35e43db22090	55910-462	HUMAN OTC DRUG	dg health allergy		diphenhydramine hydrochloride	CAPSULE	ORAL	20100222		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-464_2f5517fd-44ae-4e6c-89e9-8292be5d865e	55910-464	HUMAN OTC DRUG	Allergy Plus Sinus Headache		Acetaminophen, Diphenhydramine HCl and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050615		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-466_ba71ade3-85ca-45bc-abf9-ddeb387a7037	55910-466	HUMAN OTC DRUG	Sinus and Headache	Daytime	Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-467_e4d03182-b935-4831-8ed0-42a26c5d70bf	55910-467	HUMAN OTC DRUG	dg health aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20091204		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55910-469_aa37400b-1537-4d3b-9264-1ee62815aafe	55910-469	HUMAN OTC DRUG	rexall bismuth		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20120928		OTC MONOGRAPH FINAL	part335	Dolgencorp Inc	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
55910-479_6baec6fd-59c5-470d-bfe2-142729eda35c	55910-479	HUMAN OTC DRUG	DG Health Allergy		Diphenhydramine Hydrochloride	TABLET	ORAL	20100130		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-481_43926764-f8d1-42b4-b55b-0524d9ff98f3	55910-481	HUMAN OTC DRUG	DG Health Naproxen Sodium		naproxen sodium	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA074661	Dolgencorp, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-482_c9d256d7-9b52-4ccb-87fc-7c5eb517347b	55910-482	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20180731	20240426	OTC MONOGRAPH FINAL	part335	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55910-483_31788f41-4983-4e76-9e4c-f2db05ccdd1b	55910-483	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20151031	20240126	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-484_d1fe85c1-5021-4b18-ae28-fc3c26c42cae	55910-484	HUMAN OTC DRUG	dg health pain reliever	extra strength	Acetaminophen	TABLET	ORAL	20091005		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55910-486_f23e939f-cead-4f07-9bf0-9b4bd3e6161d	55910-486	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20151209	20240426	OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SENNOSIDES A AND B	8.6	mg/1			N	
55910-487_0ec72b26-2b69-4820-9bb4-7e98f558772f	55910-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160331	20240119	OTC MONOGRAPH FINAL	part347	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
55910-490_26e428c1-973a-452a-8ae5-f10039366bc6	55910-490	HUMAN OTC DRUG	DG Health Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20160425		ANDA	ANDA074661	Dolgencorp, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-491_e33aa3bb-da08-47f1-b12c-f8d9c0fd505c	55910-491	HUMAN OTC DRUG	Pain Reliever	Regular Strength	Acetaminophen	TABLET	ORAL	20160229	20240126	OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN	325	mg/1			N	
55910-499_c1c4d4c8-334f-4ba7-a5a3-ea7cc437b6c2	55910-499	HUMAN OTC DRUG	dg health cold and flu severe		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20140527		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-500_470678cd-4593-487e-ab08-664a2f7d7d72	55910-500	HUMAN OTC DRUG	dg health naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20131121		ANDA	ANDA074661	Dolgencorp, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-503_d537f6fc-c7b3-4866-b0c2-22f176f8f52c	55910-503	HUMAN OTC DRUG	Dg Health Ibuprofen		ibuprofen	SUSPENSION	ORAL	20100222		ANDA	ANDA075217	Dolgencorp, LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-504_91e105cb-3533-487d-b96c-b3f2abae8c86	55910-504	HUMAN OTC DRUG	DG health hydrocortisone		hydrocortisone	CREAM	TOPICAL	20201211		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp, LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-505_8e765a2b-aaae-474e-83cb-ab02ce0c1085	55910-505	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-506_3f0591d3-a365-4ea2-9117-17d3533f47a3	55910-506	HUMAN OTC DRUG	DG Health Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20170414		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55910-507_fe433609-e3f8-4ea6-8282-ca2871bfaf0f	55910-507	HUMAN OTC DRUG	rexall nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20210326		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55910-509_3c21cca4-63f7-4f9c-b27f-f537ea3ed43a	55910-509	HUMAN OTC DRUG	DG HEALTH MULTI SYMPTOM SEVERE COLD		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20170522		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-510_4a3bd9f5-ad43-4974-bd50-d090173828c1	55910-510	HUMAN OTC DRUG	DG Health Regular Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190520		OTC MONOGRAPH FINAL	part331	DOLGENCORP, LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-511_485c9389-8383-48b2-82ad-0fe1c56f5b85	55910-511	HUMAN OTC DRUG	DG Health Nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20160703		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55910-513_6e161afd-0705-442f-8026-50d55c69be88	55910-513	HUMAN OTC DRUG	dg health ibuprofen		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210908		ANDA	ANDA203599	Dolgencorp Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-515_0a631a62-48c9-4f6d-b291-73849d16a0db	55910-515	HUMAN OTC DRUG	Severe Cold and Flu Relief	Daytime	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-516_02c396b5-6809-460f-b550-ee7e837ff9fb	55910-516	HUMAN OTC DRUG	DG Health tussin cf	adult cough and cold	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20100522		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-518_08a4a334-392a-5c0e-e063-6294a90ab721	55910-518	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20231026		ANDA	ANDA078682	DOLGENCORP INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-521_b212f505-a545-4e5a-84d8-35b96ad4f463	55910-521	HUMAN OTC DRUG	rexall ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20100914		ANDA	ANDA076359	Dolgencorp, LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-525_88d1d9aa-577b-4798-9e2b-66db8f27f872	55910-525	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160630	20240126	OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
55910-529_359bfa79-7eb0-4324-a893-5f8b3af049d2	55910-529	HUMAN OTC DRUG	Sinus Severe	Daytime	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-532_2d8aee56-ab8d-4e1a-a568-dd355ae69b5a	55910-532	HUMAN OTC DRUG	Rexall Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20110517		ANDA	ANDA076779	Dolgencorp, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-536_1dc3f87f-e64d-4d7c-9157-11589d19b416	55910-536	HUMAN OTC DRUG	Rexall Antibiotic		Bacitracin	OINTMENT	TOPICAL	20150922		OTC MONOGRAPH FINAL	part333B	Dolgencorp, LLC	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
55910-537_549dfa15-c9a7-4381-9539-cce11d628c59	55910-537	HUMAN OTC DRUG	Mucus Relief Congestion Cough	Maximum Strength Severe Congestion and Cough	dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-540_c49c4a77-fc0f-449f-a680-3502b74d5e34	55910-540	HUMAN OTC DRUG	DGH Advanced Formula Scar Skin Protectant		Allantoin	GEL	TOPICAL	20211209		OTC MONOGRAPH FINAL	part347	Dolgencorp Inc	ALLANTOIN	5	mg/g			N	20241231
55910-541_98f72d61-cffe-4c0d-b236-220bddc025b5	55910-541	HUMAN OTC DRUG	DG Health Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20110114		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp, LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-550_c0d191a9-3091-4f42-aea1-04c5a9dfede4	55910-550	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230707		ANDA	ANDA212385	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCOSANOL	100	mg/g			N	20241231
55910-552_cd63fc06-3ea0-4e38-a744-976ada520fdd	55910-552	HUMAN OTC DRUG	Eye Allergy Relief		Pheniramine Maleate and Naphazoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20150701		NDA	NDA020065	DOLGENCORP, LLC	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.2675; 3.15	mg/mL; mg/mL			N	20241231
55910-562_2ef0bda0-f49e-4e10-84d5-ec4a368003fb	55910-562	HUMAN OTC DRUG	Mucus Relief Severe Congestion Cough Night Time Cold and Flu	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	KIT		20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)						N	20241231
55910-563_267d9075-9556-4a06-8fcf-bcd8f167f891	55910-563	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55910-564_7341e48d-4692-4176-848d-7cdf648533a0	55910-564	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191101		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 8	g/g; g/g; g/g; g/g			N	20241231
55910-569_0e9f0056-3916-0c6d-e063-6394a90a86db	55910-569	HUMAN OTC DRUG	Sensitivity and Gum		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20240111		OTC MONOGRAPH DRUG	M021	DG Health (Rexall)	STANNOUS FLUORIDE	.15	g/100g			N	20251231
55910-572_be22e45b-342c-4922-a077-bd9f91ffc2f8	55910-572	HUMAN OTC DRUG	dg health night time severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20200710		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-573_f2fccc81-136a-4a8d-94dd-6d19446c1f44	55910-573	HUMAN OTC DRUG	Cold and Flu	Severe Day Time / Night Time	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	KIT		20050804		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC						N	20241231
55910-575_2a65e578-eefd-4d1e-ad97-08939a044ebe	55910-575	HUMAN OTC DRUG	DG health mucus dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180702		ANDA	ANDA207602	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-576_23dcb627-c867-435f-9d1a-a9f49e58b58f	55910-576	HUMAN OTC DRUG	DG Health Cold and Flu Severe		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230628		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-577_9edf9c96-35bc-4e69-b4e3-0c70d8b7122d	55910-577	HUMAN OTC DRUG	Rexall Sterile Eye Wash		Eye Wash	SOLUTION	OPHTHALMIC	20130101		OTC MONOGRAPH FINAL	part349	Dolgencorp Inc	WATER	.9905	mL/mL			N	20241231
55910-578_cc74f02b-8cc6-489a-bb7d-7c2fab17e15a	55910-578	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831	20240831	OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	
55910-580_fa820568-e1c6-45cc-9a84-dc859a723c18	55910-580	HUMAN OTC DRUG	Rexall Daytime Nighttime Cold Flu		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20140525		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC						N	20241231
55910-582_cc06969a-7a55-4ccd-af3f-8527f866f6a2	55910-582	HUMAN OTC DRUG	dg baby vitamins a and d		Lanolin, Petrolatum	OINTMENT	TOPICAL	20100108		OTC MONOGRAPH FINAL	part347	Dolgencorp Inc	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
55910-583_51403f07-0018-4a18-bf27-fcbd2132d4e8	55910-583	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20171001	20240419	OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	
55910-584_ad6f0055-65f7-40a3-adf8-452eedbbf567	55910-584	HUMAN OTC DRUG	DM Cough and Congestion Relief	Adult non-Drowsy Sugar Free	Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20160430		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-588_052b95fa-714d-46ba-b3ab-32fb84b5cc2c	55910-588	HUMAN OTC DRUG	Rexall Antacid Advanced		Aluminum Hydroxide, Magnesium Hydroxide, Simethicone	SUSPENSION	ORAL	20140610		OTC MONOGRAPH FINAL	part332	Dolgencorp Inc	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-589_8db3e7c2-51a9-4598-b746-9ab36dcca4b7	55910-589	HUMAN OTC DRUG	Ultra		Chloroxylenol 0.3%	LIQUID	TOPICAL	20170117		OTC MONOGRAPH DRUG	M505G(a)(3)	Old East Main Co	CHLOROXYLENOL	3	mg/mL			N	20241231
55910-590_2107303e-919c-474f-bf9a-3a65c01bf162	55910-590	HUMAN OTC DRUG	Childrens Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20230613		OTC MONOGRAPH DRUG	M001	DOLGENCORP, LLC	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-593_a08322da-8cd6-4d38-9c45-b6d52d057137	55910-593	HUMAN OTC DRUG	DG Health Esomeprazole Magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Dolgencorp, LLC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55910-594_c18c40ae-19c8-4699-842a-43a5c4c236d5	55910-594	HUMAN OTC DRUG	dg health allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20210617		ANDA	ANDA076011	Dolgencorp, LLC	LORATADINE	10	mg/1			N	20241231
55910-598_5fce2a94-c261-4ca9-8ea5-3fd0beee420b	55910-598	HUMAN OTC DRUG	DG Health Tussin		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20180625		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-599_42dfc0b7-6e91-4862-9b36-e99cfe93c06e	55910-599	HUMAN OTC DRUG	Cold and Flu Relief	Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-600_d96a8a98-1259-4d65-8290-0d71d040f0ca	55910-600	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55910-604_724a64e3-0ba6-444c-a414-57bd5763f41e	55910-604	HUMAN OTC DRUG	dg health ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20091003		ANDA	ANDA072096	Dolgencorp, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-605_007607c4-a24e-45c7-935a-8d0df7059ee9	55910-605	HUMAN OTC DRUG	DG health Extra Strength	Assorted Fruits Antacid	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH FINAL	part331	DOLGENCORP, LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-606_40785e2d-188d-4ca4-9736-c8833f20e210	55910-606	HUMAN OTC DRUG	DG Health nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170414		ANDA	ANDA206393	Dolgencorp, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-607_5d408906-2f60-4801-b338-38fffda283ce	55910-607	HUMAN OTC DRUG	DG Health childrens allergy relief nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20200611		ANDA	ANDA207957	Dolgencorp, LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-609_f9239aa4-b3d0-4817-b639-61ad1383f707	55910-609	HUMAN OTC DRUG	dg health aller ease		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20220607		ANDA	ANDA212971	Dolgencorp Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-611_2227e32c-4b45-4ad9-98f0-10570a0615f2	55910-611	HUMAN OTC DRUG	dg health childrens allergy		Loratadine	SOLUTION	ORAL	20190612		ANDA	ANDA075728	Dolgencorp, LLC	LORATADINE	5	mg/5mL			N	20241231
55910-613_35ca6af6-c1d3-46a8-94f3-824628db3d4e	55910-613	HUMAN OTC DRUG	Sinus Pressure, Pain and Cough		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20230630		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-615_a15e9567-c779-4e89-8834-5d655ced4734	55910-615	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20190904		OTC MONOGRAPH NOT FINAL	part334	OLD EAST MAIN CO	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-618_1f1c9e93-a799-41d8-95fa-e53c3aaeb91d	55910-618	HUMAN OTC DRUG	dg health allergy relief		diphenhydramine Hydrochloride	CAPSULE	ORAL	20181016		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-620_117a500e-bea4-4184-aecb-9ac95f56fc12	55910-620	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20121003	20240405	OTC MONOGRAPH FINAL	part336	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
55910-623_42b58928-e8e5-49e4-b49e-498d77d64fcd	55910-623	HUMAN OTC DRUG	dg health nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20200930		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55910-624_9423efe7-82e9-454e-a06d-a247e3d84319	55910-624	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191030		OTC MONOGRAPH DRUG	M008	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55910-626_dcadab99-cd4b-4e17-ba89-a9a9f80ed9d0	55910-626	HUMAN OTC DRUG	dg health mucus er max		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20221020		ANDA	ANDA213420	Dolgencorp Inc	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55910-627_771d4e1d-2424-4288-a0ff-9d854766a76b	55910-627	HUMAN OTC DRUG	Ultra Fine Mist	Sinus Relief	Oxymetazoline Hydrochloride	SPRAY	NASAL	20200918		OTC MONOGRAPH FINAL	part341	DOLGENCORP, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55910-628_61adc226-e40c-4434-8763-487ec8530f89	55910-628	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160217		OTC MONOGRAPH NOT FINAL	part333A	OLD EAST MAIN CO.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
55910-629_086a0a53-7092-4dc8-9c5e-0bd78337fedf	55910-629	HUMAN OTC DRUG	dg health allergy relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20210603		ANDA	ANDA202538	Dolgencorp, LLC	LORATADINE	10	mg/1			N	20241231
55910-630_f061e1fd-a951-4e16-b9c8-02686298649b	55910-630	HUMAN OTC DRUG	DG Health pain relief		acetaminophen	TABLET, FILM COATED	ORAL	20201112		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55910-631_58290eea-dc5c-4838-a44c-9ce05b1aafca	55910-631	HUMAN OTC DRUG	Dollar General Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20191003		UNAPPROVED DRUG OTHER		Dolgencorp, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
55910-632_f2e44a6a-96b2-ebc7-e053-2a95a90ab2f6	55910-632	HUMAN OTC DRUG	DG Health Sterile Saline Mist		Sodium Chloride	SPRAY	NASAL	20230122		UNAPPROVED DRUG OTHER		DG Health	SODIUM CHLORIDE	.9	g/100g			N	20241231
55910-633_05123d4a-adb9-4641-9c22-5eeb7cbe36fe	55910-633	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20160226		OTC MONOGRAPH NOT FINAL	part333A	Old East Main CO	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
55910-634_7322cbab-db42-488e-ac50-d514a36f5371	55910-634	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets	Maximum Strength	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190228		ANDA	ANDA209692	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-636_6768e9a3-f05a-431f-9893-2a3c87d1b7b8	55910-636	HUMAN OTC DRUG	dg health cold and flu relief		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20180625		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-637_4bb3f6f9-0885-4984-b111-275fed7bc22b	55910-637	HUMAN OTC DRUG	Ultra Bismuth		Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part335	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55910-638_0995e648-9f30-9d3f-e063-6394a90ab072	55910-638	HUMAN OTC DRUG	MAXIMUM STRENGTH ADVANCED ANTACID		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20210201		OTC MONOGRAPH DRUG	M001	DOLGENCORP, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-639_4f9068bc-e3d3-4d29-bf38-3736b12eb9db	55910-639	HUMAN OTC DRUG	dg health headache relief		acetaminophen, aspirin, caffeine	TABLET, COATED	ORAL	20210908		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-643_478dd93e-16d8-4610-a495-30f2e9bd843a	55910-643	HUMAN OTC DRUG	dg health day time severe cold and flu relief night time severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20210526		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC						N	20241231
55910-646_27dc9e09-fc4f-4b66-a303-177725f3a513	55910-646	HUMAN OTC DRUG	dg health hydrocortisone		Hydrocortisone	LOTION	TOPICAL	20201228		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp, LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-647_98492b9f-8f48-42dd-b026-c37dcdc5f888	55910-647	HUMAN OTC DRUG	dg health ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20210616		ANDA	ANDA072096	Dolgencorp, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-648_3e71d910-25e6-4ef2-bdf7-436b1d91209a	55910-648	HUMAN OTC DRUG	Epsom Salt		MAGNESIUM SULFATE	GRANULE	ORAL	20201102		OTC MONOGRAPH NOT FINAL	part334	Old East Main Co.	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-649_0995f09f-c344-a152-e063-6394a90aa945	55910-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	LIQUID	ORAL	20210201		OTC MONOGRAPH DRUG	M007	DOLGENCORP, INC.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-651_8352756a-7703-4f25-980c-1087d8c8223b	55910-651	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180930	20250131	ANDA	ANDA206999	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55910-653_a5b9034a-bbdc-431a-8d4c-b52b596ac826	55910-653	HUMAN OTC DRUG	Eczema Relief		Colloidal Oatmeal	OINTMENT	TOPICAL	20211207		OTC MONOGRAPH FINAL	part347	OLD EAST MAIN CO	OATMEAL	10	mg/11g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55910-655_3ac4a56c-6859-4e5c-834c-738c3abb43fd	55910-655	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-656_67dc22ef-503e-40d4-a1fc-0b226e47a9ef	55910-656	HUMAN OTC DRUG	DG Health Cold and Flu Relief		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20090927		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-658_3974745a-4572-4b23-b2ea-05b4a41b73c4	55910-658	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20200105		OTC MONOGRAPH NOT FINAL	part333A	Old East Main CO.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
55910-660_f2f23228-fc32-2678-e053-2995a90a599d	55910-660	HUMAN OTC DRUG	DG 4x Medicated Tooth and Gum Cream		Benzocaine	CREAM	ORAL	20201028		OTC MONOGRAPH NOT FINAL	part356	Dollar General	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .26; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55910-661_cef6bc5e-3cc9-4dbc-acaf-9baa46d3b442	55910-661	HUMAN OTC DRUG	dg health pain relief		Acetaminophen	TABLET	ORAL	20141021		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55910-662_8a1d2f63-1b91-40ba-8fe3-2aec1e13eb75	55910-662	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231025		ANDA	ANDA207868	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-664_274c25e9-2b43-4056-915e-c2ff6871c7f0	55910-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19940729		OTC MONOGRAPH DRUG	M505G(a)(3)	Old East Main CO	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-665_a8383769-ce8b-43eb-b1a6-5d73e7fcf30d	55910-665	HUMAN OTC DRUG	dg health heartburn prevention		famotidine	TABLET, FILM COATED	ORAL	20220602		ANDA	ANDA077351	Dolgencorp Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55910-668_4f88babf-95fc-4f08-afea-3a157e9dc4ec	55910-668	HUMAN OTC DRUG	dg health cough	night time	Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20091121		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-672_f2caea4f-0dc9-4aa1-818c-50a385fd7b97	55910-672	HUMAN OTC DRUG	Warming Epsom Rub		Menthol	GRANULE, FOR SOLUTION	TOPICAL	20150505		OTC MONOGRAPH NOT FINAL	part348	OLD EAST MAIN CO	MENTHOL	12.5	mg/mL			N	20241231
55910-679_9d34c7c6-3899-4ff8-b8fe-6a5884b73732	55910-679	HUMAN OTC DRUG	DG Health Antibiotic		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20150926		OTC MONOGRAPH FINAL	part333B	Dolgencorp, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
55910-682_8f50f78e-95ee-4f10-8512-37340f1f9f53	55910-682	HUMAN OTC DRUG	Bismuth	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20180731	20240412	OTC MONOGRAPH FINAL	part335	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	1050	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
55910-683_7f9d997c-6e34-41db-bea6-df0f88e10627	55910-683	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20170531	20240126	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-685_e623eadd-a3af-4781-812c-3f88893131f2	55910-685	HUMAN OTC DRUG	Rexall Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20100819		ANDA	ANDA074937	Dolgencorp, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-686_1c471678-24be-4e1c-968e-1329889aeee9	55910-686	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20190331		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-687_7f26daad-9d87-4c91-91e6-da5b584fc10f	55910-687	HUMAN OTC DRUG	Sleep Aid	Night Time	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20240104		OTC MONOGRAPH DRUG	M010	DOLGENCORP, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
55910-689_9c5ceda4-40d7-4e4a-9608-c3478eee3aab	55910-689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine Maleate, Dextromethorphan HBr	TABLET, COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-690_d4ad1cc4-8aa0-4cde-a166-6e320669ea31	55910-690	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET	ORAL	20150331	20250131	OTC MONOGRAPH FINAL	part336	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-691_5c09ccea-dce1-4ac6-84f8-47644f36512b	55910-691	HUMAN OTC DRUG	Pain Reliever	Regular Strength	Acetaminophen	TABLET	ORAL	20180430	20250430	OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN	325	mg/1			N	
55910-692_e7fe1fd0-490b-4fd1-817c-d7d71ae204c8	55910-692	HUMAN OTC DRUG	DG health Extra Strength	Antacid Wintergreen flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190514		OTC MONOGRAPH FINAL	part331	DOLGENCORP, LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
55910-695_ba7daf77-69c9-4e58-b5f7-eba3fac1c048	55910-695	HUMAN OTC DRUG	Dollar General Headache Powders		Aspirin and Caffeine	POWDER	ORAL	20210331		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
55910-696_4bcdd579-0eb5-4eb2-a377-7657ce694d44	55910-696	HUMAN OTC DRUG	DG health sinus severe		Oxymetazoline hydrochloride	SPRAY	NASAL	20180524		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
55910-697_b5a7aa73-a74e-49c9-a9c5-f731f99cc3c1	55910-697	HUMAN OTC DRUG	dg health pain relief		Acetaminophen	TABLET	ORAL	20190701		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	325	mg/1			N	20241231
55910-698_8c3aedbe-c817-4088-85ea-79a3128c056d	55910-698	HUMAN OTC DRUG	DG Health Miconazole		Miconazole nitrate	CREAM	VAGINAL	20200318		ANDA	ANDA074760	Dolgencorp, LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55910-699_eba98b0b-bc85-4d05-8875-86b85bd462b4	55910-699	HUMAN OTC DRUG	rexall all day allergy relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20120906		ANDA	ANDA078336	Dolgencorp, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-701_e0a8514a-37e3-4519-bd17-f32dc3022eae	55910-701	HUMAN OTC DRUG	rexall pain relief		Acetaminophen	TABLET	ORAL	20100807		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp Inc	ACETAMINOPHEN	500	mg/1			N	20241231
55910-702_af12b140-704c-45c4-800a-2aea2814faee	55910-702	HUMAN OTC DRUG	rexall sleep aid		Diphenhydramine Hydrochloride	TABLET	ORAL	20100929		OTC MONOGRAPH FINAL	part338	Dolgencorp, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-705_65ab7dbe-a7f0-4824-96b3-10a2f22b2a3d	55910-705	HUMAN OTC DRUG	rexall lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101119		OTC MONOGRAPH FINAL	part358G	Dolgencorp Inc	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
55910-709_76deb4a4-947a-45ab-b8a1-f77e74f89156	55910-709	HUMAN OTC DRUG	dg health tussin		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20180910		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-710_ba7d3995-c992-457c-a628-f036d77cc638	55910-710	HUMAN OTC DRUG	dg health all day allergy		Cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210526		ANDA	ANDA207235	Dolgencorp, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-712_6d19783d-2856-4a86-9f5c-6cc26b4ca33e	55910-712	HUMAN OTC DRUG	dg health omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220608		NDA	NDA022032	Dolgencorp Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55910-713_33f158a0-84ee-44bb-bf0a-07b521ce8470	55910-713	HUMAN OTC DRUG	DG health omperazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180626		NDA	NDA209400	Dolgencorp Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55910-714_994382ef-d914-4ece-a629-80be902d3a84	55910-714	HUMAN OTC DRUG	DG Health Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20190715		ANDA	ANDA204226	Dolgencorp, LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-716_3967e01f-1a80-4738-94ba-87cdfd1b1ac4	55910-716	HUMAN OTC DRUG	Severe cold and flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine HCI	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-718_8760e78a-a15c-4078-80a3-dd2f7aaf01df	55910-718	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20231025		ANDA	ANDA075209	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	LORATADINE	10	mg/1			N	20241231
55910-719_6746e852-2080-4272-acfa-99b898727c03	55910-719	HUMAN OTC DRUG	DG Health Cold Max		acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20160520		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-722_3aae16e9-caa8-4cb5-9d3d-40d11cc8e7b2	55910-722	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20200630	20250630	ANDA	ANDA208754	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCOSANOL	100	mg/g			N	
55910-726_86fb08f2-2c15-45b4-89ab-01aeaf0ccaf4	55910-726	HUMAN OTC DRUG	Sunscreen		Octinoxate, Octisalate, Zinc oxide	CREAM	TOPICAL	20191001		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO.	OCTINOXATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	562; 250; 1000; 1000	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
55910-727_8a81aee7-39b5-4477-ac1d-09af03d4337c	55910-727	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20171121		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO.	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	26.49; 132.45; 44.15; 52.98	mg/g; mg/g; mg/g; mg/g			N	20241231
55910-729_2e684b9a-3c6d-4383-9633-95e0d721af3e	55910-729	HUMAN OTC DRUG	dg health naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190612		ANDA	ANDA074661	Dolgencorp, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-731_76043021-1ced-40da-8b62-fa2de5c2839d	55910-731	HUMAN OTC DRUG	dg health tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20190301		ANDA	ANDA075915	Dolgencorp, LLC	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55910-732_1001b92f-7ea8-4824-ac1c-c2f556d6c970	55910-732	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20190331		ANDA	ANDA207342	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55910-733_736efc31-9702-4a6a-9626-56df15aa5ccd	55910-733	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190331		ANDA	ANDA209692	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-734_fa4920bf-1184-48a3-aa4a-c7d44437aadf	55910-734	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20181231	20241227	OTC MONOGRAPH FINAL	part338	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-736_d3b9b97e-8215-40ff-8e38-a05dddb22ecf	55910-736	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20181231	20241227	OTC MONOGRAPH FINAL	part338	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-737_264cc891-cdd1-4be6-bd8e-ef4215a3fd6a	55910-737	HUMAN OTC DRUG	DG Health Cold and Flu Relief		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20140520		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-739_686d00f8-11fe-4cca-9c5e-a8a9c43b0565	55910-739	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20190331		ANDA	ANDA207342	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55910-741_bfa2693b-87f5-479d-8a9f-79a0d5ce3511	55910-741	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-743_be35a067-b3c0-4f22-ba86-0a04ac0c5da7	55910-743	HUMAN OTC DRUG	Night Time Cold and Flu Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180630	20240119	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
55910-746_a95401cc-349e-435a-b953-4d8fd1f54744	55910-746	HUMAN OTC DRUG	DG health mucus dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230126		ANDA	ANDA207602	Dolgencorp Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-747_d1baa6ee-b5ad-4040-945e-202f7424be83	55910-747	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20211004		OTC MONOGRAPH NOT FINAL	part356	Old East Main Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-748_307c61c9-238c-48eb-ab5c-97e2c1dd78d4	55910-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-749_c6f99018-1274-4b0f-9d13-0f0d6df3c9ec	55910-749	HUMAN OTC DRUG	DG Health 8 Hour Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170224		ANDA	ANDA075077	Dolgencorp, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
55910-750_b01c67b5-f4b8-4ddb-8ee3-7572a0676d3c	55910-750	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180831	20250131	ANDA	ANDA206999	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55910-755_42e8cbc8-59a8-4093-8fff-4c5eb97f57c1	55910-755	HUMAN OTC DRUG	rexall dm cough and congestion relief		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20181206		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-757_f85c12fe-fbaa-495e-b2a0-42fe4097e5dd	55910-757	HUMAN OTC DRUG	Mucus Relief Congestion and Headache	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCL	LIQUID	ORAL	20190601		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-758_b514b589-d965-4a21-91b3-fab4019e9d96	55910-758	HUMAN OTC DRUG	dg health ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220503		ANDA	ANDA077349	Dolgencorp Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-759_f41dcc64-739c-1734-e053-2a95a90a2b0b	55910-759	HUMAN OTC DRUG	DG Health Pain Relieving		Lidocaine HCl	CREAM	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part348	DOLGENCORP, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55910-760_f41dcc9c-49a2-4849-e053-2995a90ab9f4	55910-760	HUMAN OTC DRUG	DG Health Maximum Strength Cold n Hot		Lidocaine HCl, Menthol	CREAM	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part348	DOLGENCORP, LLC	LEVOMENTHOL; LIDOCAINE HYDROCHLORIDE	10; 40	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55910-762_595d7ebf-eac5-4923-931a-a16fd3069093	55910-762	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	20241231
55910-763_d948968d-c9a7-4ffb-b4a7-3af37d45d40a	55910-763	HUMAN OTC DRUG	dg health cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20140525		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-766_1721f2e3-f387-4234-b466-76ecf6c50a67	55910-766	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET	ORAL	20191030	20251231	OTC MONOGRAPH DRUG	M009	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-767_1c6bb41b-8d3f-4dd7-832a-d14e79146aa4	55910-767	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Phenylephrine HCI DoxylamineSucinate	KIT		20180331	20251231	OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)						N	
55910-768_b2b3bc96-02e0-4dd9-ae60-2bb24ba3ae89	55910-768	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170430		ANDA	ANDA079174	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-769_c0e35029-ea16-7107-e053-2a95a90a020a	55910-769	HUMAN OTC DRUG	Effervescent Orange Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20150915		OTC MONOGRAPH FINAL	part341	DOLGENCORP, LLC	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-772_1bb2f1e6-0d34-4791-9076-8175253504a1	55910-772	HUMAN OTC DRUG	Sleep Aid	Night Time	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20230630		OTC MONOGRAPH DRUG	M010	DOLGENCORP, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-773_45d7ebb6-2c85-4499-8266-546d25dc3afc	55910-773	HUMAN OTC DRUG	DG Health Allergy Relief Nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160919		ANDA	ANDA207957	Dolgencorp Inc	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
55910-776_81f12484-ddf7-49c6-b530-3a81d62ab40d	55910-776	HUMAN OTC DRUG	dg health adult tussin		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220511		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-790_5a6061dd-1451-415e-8b73-fa11fee84dc3	55910-790	HUMAN OTC DRUG	Infants Gas Relief Drops		Simethicone	EMULSION	ORAL	20200114		OTC MONOGRAPH FINAL	part332	DOLGENCORP INC	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
55910-791_7582a344-1322-4bf2-9d99-d432507f13d6	55910-791	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20230512		ANDA	ANDA075010	DOLGENCORP, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-796_82839169-3e6f-4af2-9512-4c4cf7b25823	55910-796	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20231101		ANDA	ANDA078697	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-797_1bb153c7-e918-4147-8733-bdb804289c70	55910-797	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20191030		OTC MONOGRAPH DRUG	M016	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
55910-801_7a255665-dad4-4e8d-b7e8-52eeab203fea	55910-801	HUMAN OTC DRUG	Severe Cold and Cough Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20170331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-802_ceeeb016-8e46-40b8-9923-8a4270475f45	55910-802	HUMAN OTC DRUG	dg health nasal four		Phenylephrine hydrochloride	SPRAY	NASAL	20210616		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-803_6591ec36-b801-40f0-88f8-a3683370e1ef	55910-803	HUMAN OTC DRUG	Baby Eczema Therapy		Colloidal oatmeal	CREAM	TOPICAL	20160411		OTC MONOGRAPH FINAL	part347	OLD EAST MAIN CO.	OATMEAL	10.4	kg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
55910-804_cf11659d-437b-4fd9-9bbe-80bd13e3fa6f	55910-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20110126		OTC MONOGRAPH NOT FINAL	part333A	Old East Main. CO	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
55910-806_7945abc1-7b40-42c9-9bd8-25424596c485	55910-806	HUMAN OTC DRUG	dg health allergy relief		Loratadine	TABLET	ORAL	20120413		ANDA	ANDA076301	Dolgencorp Inc	LORATADINE	10	mg/1			N	20241231
55910-807_df3b4ed6-4d77-4b93-9e50-9ee20c4b3987	55910-807	HUMAN OTC DRUG	dg health childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20190715		ANDA	ANDA210033	Dolgencorp, LLC	LORATADINE	5	mg/1			N	20241231
55910-810_fca07026-a950-4f59-ad55-c0446cd83f83	55910-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20100316		OTC MONOGRAPH NOT FINAL	part333A	OLD EAST MAIN CO	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
55910-811_40bc9a11-e9b8-4035-aa2a-1aa1ae50b401	55910-811	HUMAN OTC DRUG	dg health cold and flu relief		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20180620		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC						N	20241231
55910-812_23a1347f-f594-4201-b5ca-278109dd6213	55910-812	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
55910-813_dfc5d655-ff54-453e-ae6a-298130932c82	55910-813	HUMAN OTC DRUG	dg health day time severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20200702		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-814_3ffa405e-bc85-4614-afd0-7a8dfc288dad	55910-814	HUMAN OTC DRUG	dg health acid reducer		famotidine	TABLET, FILM COATED	ORAL	20220615		ANDA	ANDA077351	Dolgencorp Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
55910-816_f2f2232c-2deb-267c-e053-2995a90af2f6	55910-816	HUMAN OTC DRUG	DG 3x Medicated Toothache adn Gum Gel		Benzocaine	GEL	ORAL	20201028		OTC MONOGRAPH NOT FINAL	part356	Dollar General	BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	20; .26; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
55910-818_ef956c4f-2955-466c-a8dd-eec9e0d68a96	55910-818	HUMAN OTC DRUG	Sugar Free Cough and Chest Congestion Relief	Adult	Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20180831		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-821_52bd78d0-34ba-4fe5-8978-ecb48e884b27	55910-821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20150115		OTC MONOGRAPH FINAL	part333D	Old East Main CO	SALICYLIC ACID	21	mg/mL			N	20241231
55910-822_8a258666-d549-408c-9708-0b0c1a7a9219	55910-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	19890705		OTC MONOGRAPH FINAL	part347	OLD EAST MAIN CO.	WITCH HAZEL	979	mg/mL			N	20241231
55910-826_df7140a4-4611-4d05-8d09-b1e080299ba9	55910-826	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	CREAM	TOPICAL	20120214		OTC MONOGRAPH NOT FINAL	part348	OLD EAST MAIN CO	ZINC OXIDE	130	mg/g			N	20241231
55910-827_16dfebd0-9a63-4368-a69f-167ffb7dc7e1	55910-827	HUMAN OTC DRUG	Dollar General		Nasal Phenylephrine hydrochloride	SPRAY	NASAL	20190520		OTC MONOGRAPH FINAL	part341	DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-828_c2729204-a4e4-4e7b-b738-d383c4032c79	55910-828	HUMAN OTC DRUG	dg health 8 hr arthritis pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA075077	Dolgencorp Inc	ACETAMINOPHEN	650	mg/1			N	20241231
55910-829_385986df-49f4-453e-ad64-b85f9cd884eb	55910-829	HUMAN OTC DRUG	Stool Softener Laxative	Plus Stimulant	docusate sodium and sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
55910-830_f1afb906-0fa9-4441-84f6-f4b34944dc3c	55910-830	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20220316		ANDA	ANDA202300	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-831_4e6884d3-da95-4f7d-929a-23a0f81d5ced	55910-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20100916		OTC MONOGRAPH NOT FINAL	part334	DOLGENCORP, LLC	MINERAL OIL	999	mg/mL			N	20241231
55910-833_0d05b2d9-49ac-4687-e063-6294a90ab626	55910-833	HUMAN OTC DRUG	Medicated Chest Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20231225		OTC MONOGRAPH DRUG	M012	DOLGENCORP, INC.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
55910-834_0d05f2d6-747e-27e1-e063-6394a90a1797	55910-834	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen, Diphenhydramine HCl	TABLET	ORAL	20231225		OTC MONOGRAPH DRUG	M013	DOLGENCORP, INC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-835_0c8655bc-43e3-2b67-e063-6394a90aafa3	55910-835	HUMAN OTC DRUG	Rexall Earwax Removal		CARBAMIDE PEROXIDE	KIT		20190101		OTC MONOGRAPH DRUG	M014	Dolgencorp LLC						N	20241231
55910-837_bab3a6d0-92d0-41f3-aaad-4a5e26e01829	55910-837	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20200319		OTC MONOGRAPH DRUG	M008	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
55910-838_6979539d-b28d-4f91-839e-4976a20d1034	55910-838	HUMAN OTC DRUG	Cold Flu and Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20190131	20250131	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55910-839_a133bb1f-1125-4bd1-8597-a6d18896990e	55910-839	HUMAN OTC DRUG	dg health childrens mucus relief		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20150506		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-840_f27b1c16-e5c6-a72a-e053-2a95a90ac17c	55910-840	HUMAN OTC DRUG	Lidocaine		Burn Relief	AEROSOL, SPRAY	TOPICAL	20170508		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55910-841_f27b3997-081f-0c6b-e053-2a95a90a7167	55910-841	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20170731		OTC MONOGRAPH FINAL	part333C	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	MICONAZOLE NITRATE	1.3	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
55910-842_f27ac05c-4cc2-42f8-e053-2995a90a5e7b	55910-842	HUMAN OTC DRUG	Lidocaine		Burn Relief	AEROSOL, SPRAY	TOPICAL	20171219		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55910-844_85b7189f-597a-418b-b153-6f15ff24ac3d	55910-844	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20180930	20240426	OTC MONOGRAPH FINAL	part335	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
55910-845_7b738852-79b8-4317-a4e6-236c7668629b	55910-845	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228		ANDA	ANDA206568	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-846_ffae36fd-2fb7-4afb-a7f8-29c700a477fb	55910-846	HUMAN OTC DRUG	dg health clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230408		ANDA	ANDA090685	Dolgencorp Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-847_0bf2680a-32cc-b0d9-e063-6294a90a3333	55910-847	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200312		ANDA	ANDA079174	Dolgencorp, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-849_fd9e64b0-ba6e-4e5b-9323-22c06090e693	55910-849	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228	20250228	ANDA	ANDA206568	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55910-851_6523a38b-07c3-4285-ba4a-dca2134a48cc	55910-851	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20220103	20250331	ANDA	ANDA202807	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55910-853_170c4f0a-d8ed-483b-a376-c14c24c99fa0	55910-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	20241231
55910-854_a662cc95-9cef-4ee0-a4bd-c75b20392d78	55910-854	HUMAN OTC DRUG	Naproxen Sodium PM		Naproxen Sodium	TABLET	ORAL	20181231	20250930	ANDA	ANDA209726	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55910-855_66d01cda-85df-4c23-8bd6-e073ea34ce05	55910-855	HUMAN OTC DRUG	Stool Softener Laxative	Plus Stimulant	docusate sodium and sennosides	TABLET	ORAL	20200630		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
55910-856_dfa0efe8-ca0f-4aa9-bccd-9cdac7aef39d	55910-856	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20180430	20250131	ANDA	ANDA200888	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
55910-857_f27b3997-081d-0c6b-e053-2a95a90a7167	55910-857	HUMAN OTC DRUG	Medicated Corn Remover		Salicylic Acid	PATCH	TOPICAL	20151101		OTC MONOGRAPH FINAL	part358F	Dolgencorp, Inc. (Dollar General & Rexall)	SALICYLIC ACID	40	mg/91			N	20241231
55910-858_c06049dc-3d9a-419f-81e1-f64234ba6b9e	55910-858	HUMAN OTC DRUG	dg health naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20200710		ANDA	ANDA208499	Dolgencorp, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-859_62f90b18-0fca-474c-8c27-fbb45c80a911	55910-859	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCOSANOL	100	mg/g			N	20241231
55910-860_f9999a8f-f080-4e4c-b79f-d116790f164a	55910-860	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCL	CAPSULE	ORAL	20191227	20241231	OTC MONOGRAPH DRUG	M010	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-862_0bf1e036-6597-b65a-e063-6394a90ac606	55910-862	HUMAN OTC DRUG	COLD and FLU		ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200312		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-864_84a6f072-fd8a-4b1f-b41c-8a2c3c35d133	55910-864	HUMAN OTC DRUG	50% Rubbing		Isopropyl Alcohol	LIQUID	TOPICAL	20141008		OTC MONOGRAPH NOT FINAL	part333A	Old East Main CO	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
55910-865_45efc5af-b41b-4a85-8061-5aaab62cf5d3	55910-865	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200430	20250131	OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
55910-867_46e3046f-0aea-4848-b5ab-bac4ff0c7f2e	55910-867	HUMAN OTC DRUG	DG Health Anti Diarrheal		loperamide HCl	SOLUTION	ORAL	20220727		ANDA	ANDA091292	Dolgencorp Inc	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
55910-869_9dd64006-febe-4ca4-b6f4-69cc3386a421	55910-869	HUMAN OTC DRUG	Mucus Relief Cold Flu Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20191129	20250131	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
55910-870_0d2a1257-456d-889e-e063-6394a90aa294	55910-870	HUMAN OTC DRUG	DG Maximum Strength Redness Relief		glycerin, naphazoline HCl	SOLUTION	OPHTHALMIC	20200131		OTC MONOGRAPH DRUG	M018	Dolgencorp, Inc	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
55910-871_80e8c894-ec83-49b3-afa1-d432444df5bf	55910-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	19891115		OTC MONOGRAPH NOT FINAL	part333A	DOLGENCORP, LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
55910-872_b2fbb998-5136-40a1-b7a0-4abba7d42c04	55910-872	HUMAN OTC DRUG	rexall night time cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20120909		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-873_c0955f29-60a5-f070-e053-2a95a90ac60e	55910-873	HUMAN OTC DRUG	Dollar General Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20150914		OTC MONOGRAPH FINAL	part341	DOLGENCORP, LLC	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-874_54ecedcf-1776-437a-9a02-cd472f8c7d1c	55910-874	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191101		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
55910-877_030b220c-52c0-4d2e-844b-19961a32c14a	55910-877	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalat, Octocrylene	LOTION	TOPICAL	20191115		OTC MONOGRAPH FINAL	part352	DOLGENCORP, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 1000	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-878_528fbc46-e5f8-4a77-b29f-7646afdf33d1	55910-878	HUMAN OTC DRUG	Childrens Allergy		Cetirizine HCl	LIQUID	ORAL	20180430	20250131	ANDA	ANDA090474	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
55910-879_ea52d799-44b7-455b-9374-2ca6dcbe843e	55910-879	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20220304		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	250	mg/1			N	20241231
55910-880_6d76a04a-94d9-4bf6-bb33-6f6309930abb	55910-880	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20191129		ANDA	ANDA091314	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
55910-882_21f9f42a-8d75-485e-afe7-dfca79253b21	55910-882	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20210910		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SENNOSIDES	8.6	mg/1			N	20241231
55910-883_2b5f96e9-f327-45ce-8a20-df9224c03638	55910-883	HUMAN OTC DRUG	DG Health Cold n Hot Pain Relieving	Topical Analgesic	menthol, unspecified form	LIQUID	TOPICAL	20191227		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp Inc	MENTHOL, UNSPECIFIED FORM	160	mg/mL			N	20241231
55910-884_a8ee8c27-f992-4c92-aa65-3435143faead	55910-884	HUMAN OTC DRUG	DG Health Cold Zone Pain Relieving	Topical Analgesic	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part348	Dolgencorp Inc	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
55910-885_149dc320-ace1-4878-ba9e-30534f602d64	55910-885	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20210910		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	SENNOSIDES	8.6	mg/1			N	20241231
55910-886_d0096e87-3311-40f6-a986-de2525459595	55910-886	HUMAN OTC DRUG	Mucus Relief All in One	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20190331		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-889_a3010278-8ddb-4213-b8c4-481389828911	55910-889	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190917		OTC MONOGRAPH NOT FINAL	part333A	OLD EAST MAIN CO	ALCOHOL	62	mL/100mL			N	20241231
55910-890_cc4139a9-99ac-452d-bde3-2df5da7ca8f7	55910-890	HUMAN OTC DRUG	Cold and Allergy	Maximum Strength	Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20130430	20240126	OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
55910-891_acbde07b-da2e-47d9-9400-a28058f8addb	55910-891	HUMAN OTC DRUG	Allergy	Childrens Allergy	Diphenhydramine Hydrochloride	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-892_f9c20045-2698-d9b2-e053-6294a90a2b11	55910-892	HUMAN OTC DRUG	8 hr Arthritis Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20230429		ANDA	ANDA215486	DOLGENCORP, INC.	ACETAMINOPHEN	650	mg/1			N	20241231
55910-895_f9c35f34-c494-2573-e053-6294a90aee3a	55910-895	HUMAN OTC DRUG	8 hr Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20230429		ANDA	ANDA215486	DOLGENCORP, INC.	ACETAMINOPHEN	650	mg/1			N	20241231
55910-897_6febba31-625a-48f8-bb1a-a85ef3a376a0	55910-897	HUMAN OTC DRUG	DG Health Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20100206		ANDA	ANDA074937	Dolgencorp Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-898_4f80678c-bbc9-4d44-b9d5-76606b258503	55910-898	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	19981208		OTC MONOGRAPH DRUG	M032	OLD EAST MAIN CO	PYRITHIONE ZINC	10	mg/mL			N	20241231
55910-899_b14fb65b-fbd4-4ed4-bc14-63f0f6dd6dac	55910-899	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	LIQUID	ORAL	20180331		OTC MONOGRAPH DRUG	M010	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-900_1030c584-c737-4f50-bb29-c88f4e9744e7	55910-900	HUMAN OTC DRUG	dg health cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20180924		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-901_f0b3ed7d-1622-3990-e053-2995a90ae520	55910-901	HUMAN OTC DRUG	ibuprofen		ibuprofen	TABLET, COATED	ORAL	20191209		ANDA	ANDA091239	DOLGENCORP INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-903_e3b17984-58fd-665f-e053-2a95a90a1fe7	55910-903	HUMAN OTC DRUG	Dollar General Cold-Hot Medicated Patches		MENTHOL	PATCH	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	DOLGENCORP, LLC	MENTHOL	5	g/100g			N	20241231
55910-904_bf99fa83-c3be-4052-b5b6-ad91997cb034	55910-904	HUMAN OTC DRUG	DG Health Mucus ER		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20221121		ANDA	ANDA078912	Dolgencorp, LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
55910-905_c4b713a0-12d6-4462-9e92-a089641e93df	55910-905	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20211012		OTC MONOGRAPH NOT FINAL	part333A	Old East Main Co.	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
55910-907_acda51ce-4d24-4aaa-ad3f-8f8f0b987884	55910-907	HUMAN OTC DRUG	Dollar General Medicated Pain Relief Patch		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	DOLGENCORP, LLC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
55910-909_a4c6b400-7fa6-4ad1-9d39-d34621eb91a6	55910-909	HUMAN OTC DRUG	dg health sleep aid		Doxylamine Succinate	TABLET	ORAL	20230517		ANDA	ANDA040167	Dolgencorp Inc	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
55910-910_21f1f789-d0d7-4782-b934-b388d0a313e4	55910-910	HUMAN OTC DRUG	Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20230430		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-912_e39d1360-a56c-529e-e053-2a95a90a2fd1	55910-912	HUMAN OTC DRUG	Dollar General Pain Relieving Patch with Lidocaine		LIDOCAINE	PATCH	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	DOLGENCORP, LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
55910-913_44109c8e-e6ce-4bf9-9a20-ab8599e54f26	55910-913	HUMAN OTC DRUG	dg health triacting	night time cold and cough	Diphenhydramine HCl, Phenylephrine HCl	SOLUTION	ORAL	20091114		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-915_e5ce6ad1-c26f-4990-9f78-d7b495338dbc	55910-915	HUMAN OTC DRUG	dg health omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20100214		NDA	NDA022032	Dolgencorp, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
55910-916_180ef9c1-c22f-418f-8a46-85593b1f6459	55910-916	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20191227		OTC MONOGRAPH FINAL	part338	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-918_508da6aa-7bf9-4708-8bc9-c2c4e7fb4ed1	55910-918	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230501		ANDA	ANDA079038	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-919_effec53f-13a5-6b02-e053-2995a90a2dff	55910-919	HUMAN OTC DRUG	Rexall Sinus Wash System	Soft Tip Squeeze bottle	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20210517		UNAPPROVED DRUG OTHER		Dolgencorp, LLC						N	20241231
55910-921_03d73ed0-dd09-453c-b096-f2322a33754b	55910-921	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20230106		OTC MONOGRAPH DRUG	M032	Old East Main Co.	PYRITHIONE ZINC	10	mg/mL			N	20241231
55910-924_d93c0965-6c8f-42da-bbdb-e56287468a17	55910-924	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalatem, Octisalate, Octocrylene	LOTION	TOPICAL	20191008		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 1000; 202.5; 640	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-925_81f33883-89ce-43a6-a1ca-43a5a893a1de	55910-925	HUMAN OTC DRUG	Sinus Pressure and Pain	Maximum Strength	Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20050623		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-927_d828a993-0322-419d-bcc6-0738eda30758	55910-927	HUMAN OTC DRUG	Cold and Head Congestion	Severe	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-928_b33d104b-0b4d-40c6-8345-c2c740327331	55910-928	HUMAN OTC DRUG	DG Health Cold and Flu Severe		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230629		OTC MONOGRAPH FINAL	part341	Dolgencorp Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-929_e34488b7-b31e-4c88-90bf-e889ae396c88	55910-929	HUMAN OTC DRUG	Sunscreen		Avobenzon, Homosalate,Octisalate,Octocrylene	LOTION	TOPICAL	20190805		OTC MONOGRAPH FINAL	part352	Old East Main Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 1000; 202.5; 640	mg/mL; min/mL; mg/mL; mg/mL			N	20241231
55910-930_7fae39be-7b63-443c-a917-2df562135a84	55910-930	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20230228		ANDA	ANDA209274	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-931_46d7ad56-5167-4c4f-b09a-4c35a1af8025	55910-931	HUMAN OTC DRUG	Daytime Nighttime Severe Cold and Flu Relief		Acetaminophen Dextromethorphan HBr Guaifenesin Phenylephrine HCI DoxylamineSucinate	KIT		20180331		OTC MONOGRAPH DRUG	M012	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)						N	20241231
55910-933_e4a9d5f3-ae17-404a-8260-e9d2cdd85067	55910-933	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20231025		ANDA	ANDA204833	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-934_6baa66e7-93df-43d9-a301-5d9c14274c99	55910-934	HUMAN OTC DRUG	dg health all day allergy		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220327		ANDA	ANDA213105	Dolgencorp Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-936_6af9bb65-4db7-4833-8ae2-d9f1b9c03412	55910-936	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230629		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
55910-937_d5552e25-ee4e-4554-848c-d2f74249247f	55910-937	HUMAN OTC DRUG	baby		Sunscreen	LOTION	TOPICAL	20210813		OTC MONOGRAPH FINAL	part352	Old East Main CO.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 1000; 202.5; 640	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-938_fb6c3922-9965-493e-8ae7-472165b59531	55910-938	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20221230		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	20241231
55910-939_35156a5c-4256-4b0a-919f-32fac375260a	55910-939	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20221215		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	20241231
55910-940_2e234b26-1ebf-4f6e-ba32-f74268e0275b	55910-940	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190708		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
55910-942_3de0137f-a2da-467c-aed5-4afb6dfddca4	55910-942	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20160118		OTC MONOGRAPH DRUG	M032	DOLGENCORP, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
55910-943_c1d7a4e9-d116-4e18-ad9b-f1ab07888af9	55910-943	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20190601		OTC MONOGRAPH DRUG	M009	DOLGENCORP, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
55910-945_db38418f-8fa7-4b87-a7c5-f0d98ad02c7e	55910-945	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20140725		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
55910-946_3101e6ac-60ef-4214-b07a-1454399f4b46	55910-946	HUMAN OTC DRUG	dg health infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20111119		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
55910-947_c5d46570-953a-4c26-a4a4-6ab6e1058dbf	55910-947	HUMAN OTC DRUG	Acne Wash		Salicylic Acid	LOTION	TOPICAL	20080608		OTC MONOGRAPH FINAL	part333D	Old East Main.CO	SALICYLIC ACID	20	mg/mL			N	20241231
55910-948_70ef25f5-accf-4c6e-a76c-15ad3028c2b9	55910-948	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20180201		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ACETAMINOPHEN	160	mg/1			N	20241231
55910-952_c6da66d8-dc63-44d2-9800-4406b9f3ae00	55910-952	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20130306		OTC MONOGRAPH NOT FINAL	part333A	OLD EAST MAIN CO.	ALCOHOL	70	mL/100mL			N	20241231
55910-953_96daedd3-28a4-4baa-9f6e-a8e0dc3305c0	55910-953	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190331		ANDA	ANDA206568	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
55910-954_c79f24d5-7cc1-6e65-e053-2995a90a0b96	55910-954	HUMAN OTC DRUG	Extra Gentle Laxative		BISACODYL	TABLET, DELAYED RELEASE	ORAL	20210724		OTC MONOGRAPH NOT FINAL	part334	DOLGENCORP INC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-957_b1a961d6-357a-415e-94f2-a063b3021943	55910-957	HUMAN OTC DRUG	Rexall Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130808		ANDA	ANDA203690	Dolgencorp, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
55910-958_6059d95d-2a7e-42e7-971c-9c0b5b5e0413	55910-958	HUMAN OTC DRUG	DG Health Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20130710		ANDA	ANDA091135	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
55910-959_c0f38c37-078a-316f-e053-2a95a90adbeb	55910-959	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210724		OTC MONOGRAPH FINAL	part341	DOLGENCORP, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-960_56c616f2-f60a-408e-8b74-b3b9c2177caf	55910-960	HUMAN OTC DRUG	Menstrual Complete Gelcaps		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, COATED	ORAL	20230125		OTC MONOGRAPH NOT FINAL	part343	Dolgencorp Inc	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
55910-961_038eef13-46af-4be4-9a2f-04dbb9be9e62	55910-961	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	OLD EAST MAIN CO.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
55910-962_8c57e59d-a6eb-4d05-a75d-d5040aa7e4f5	55910-962	HUMAN OTC DRUG	Cold and Allergy		Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20190601		OTC MONOGRAPH DRUG	M012	DOLGENCORP, LLC	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-963_e6e80e68-7ffa-4569-a292-0481129ec85d	55910-963	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20220915		ANDA	ANDA208754	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCOSANOL	100	mg/g			N	20241231
55910-964_9b8e4e98-f13f-48f6-a82d-7db451e6cff9	55910-964	HUMAN OTC DRUG	dg health flu and severe cold and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20110524		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-965_1ed16215-647b-472c-b37c-4fdba85f6cf9	55910-965	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20191201		OTC MONOGRAPH FINAL	part347	Old East Main CO	PETROLATUM	340	mg/100g			N	20241231
55910-967_7c14882c-1e8b-44eb-abab-a254b78e56c1	55910-967	HUMAN OTC DRUG	Menstrual Pain Relief	Maximum Strength / Multi Symptom	Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	DOLGENCORP, LLC	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
55910-968_2771b54b-52c9-459f-bc7f-d8b86a2c2cbe	55910-968	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20220304		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM	100	mg/1			N	20241231
55910-969_cb8318f3-b926-455b-9900-a25ed352baec	55910-969	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20211012		OTC MONOGRAPH NOT FINAL	part333A	Old East Main Co.	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
55910-970_e6b05fb3-9c47-4086-b8a0-c539aae087f5	55910-970	HUMAN OTC DRUG	dg health allergy relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20210617		ANDA	ANDA076011	Dolgencorp, LLC	LORATADINE	10	mg/1			N	20241231
55910-971_5d1e6a55-dbe0-4651-bfad-8982503889b5	55910-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20211001		OTC MONOGRAPH FINAL	part355	OLD EAST MAIN CO.	SODIUM FLUORIDE	.02	mg/mL			N	20241231
55910-972_e451ecfb-cf1b-c622-e053-2a95a90a4d4b	55910-972	HUMAN OTC DRUG	Dollar General Cold-Hot Medicated Patches		MENTHOL	PATCH	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	DOLGENCORP, LLC	MENTHOL	5	g/1			N	20241231
55910-978_207aac7c-d5f5-40c5-9f80-196df028bff1	55910-978	HUMAN OTC DRUG	Stool Softener Laxative	Plus Stimulant	docusate sodium and sennosides	TABLET	ORAL	20200630		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
55910-979_a6b9a15a-32c7-4f11-bbef-c34a50d8f61b	55910-979	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	20171023		OTC MONOGRAPH NOT FINAL	part334	OLD EAST MAIN CO	CASTOR OIL	1	mL/mL			N	20241231
55910-980_fb2f6357-3f7e-479f-901d-9e2535e16492	55910-980	HUMAN OTC DRUG	DG Health adult tussin multi symptom cold		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20181109		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-981_43029691-00a6-4b9a-9e02-3406cfa25927	55910-981	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCL	LIQUID	ORAL	20220204		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
55910-982_931bdf8d-0a37-4ef4-b4fd-8e7b2b552dd4	55910-982	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20230401		OTC MONOGRAPH FINAL	part341	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-983_f30c222d-cd24-4dec-bd9f-e2b300940ad0	55910-983	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210118		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
55910-984_3d775636-ca34-4b40-8515-092b96248193	55910-984	HUMAN OTC DRUG	Chloroxylenol		Chloroxylenol	LIQUID	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Old East Main Co	CHLOROXYLENOL	3.09	mg/mL			N	20241231
55910-985_31de3e6f-53da-4472-be5f-e512e7879420	55910-985	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20231001		ANDA	ANDA075209	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	LORATADINE	10	mg/1			N	20241231
55910-987_01ffbf59-1970-49ef-8df1-74da228f1642	55910-987	HUMAN OTC DRUG	DG Health Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20160504		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-994_aca685da-0d76-495a-b170-98d4cb7f9546	55910-994	HUMAN OTC DRUG	dg health cold plus flu relief		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20091002		OTC MONOGRAPH FINAL	part341	Dolgencorp, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55910-999_afbb57ab-c30d-45ef-a3fb-33b8dc19b048	55910-999	HUMAN OTC DRUG	Rexall Ready to use 4pk	LAXATIVE	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20180625		OTC MONOGRAPH NOT FINAL	part334	Dolgencorp, LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
55913-001_0bb316c0-d935-2480-e063-6294a90ac21f	55913-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091202		UNAPPROVED MEDICAL GAS		Pulmonaire Service, Inc.	OXYGEN	99	L/100L			N	20241231
55926-0024_0e3ca0e7-da1e-46de-83ba-ee01586ea61a	55926-0024	HUMAN OTC DRUG	EmuAid		Silver	OINTMENT	TOPICAL	20140116		UNAPPROVED HOMEOPATHIC		Speer Laboratories, LLC	SILVER	10	[hp_X]/59mL			N	20241231
55926-0025_e4f6e6a3-fca6-4159-b040-714c3919886b	55926-0025	HUMAN OTC DRUG	emuaidMAX		Silver	OINTMENT	TOPICAL	20140122		UNAPPROVED HOMEOPATHIC		Speer Laboratories, LLC	SILVER	10	[hp_X]/100mL			N	20241231
55926-0026_1b832911-da07-4a6a-9a23-a269dee0bf25	55926-0026	HUMAN OTC DRUG	EMUAID Pain Relieving		Menthol, Unspecified Form	CREAM	TOPICAL	20230609		OTC MONOGRAPH NOT FINAL	part348	Speer Laboratories LLC	MENTHOL, UNSPECIFIED FORM	2.4	g/120g			N	20241231
55926-0027_9d31bf43-415d-410a-8c41-a641b9698849	55926-0027	HUMAN OTC DRUG	emuaidMAX Concentrate		Silver	LIQUID	TOPICAL	20230301		UNAPPROVED HOMEOPATHIC		Speer Laboratories, LLC	SILVER	10	[hp_X]/100mL			N	20241231
55926-0028_fa5fa68e-cf8b-4821-b79d-129cba5eab52	55926-0028	HUMAN OTC DRUG	EMUAID Pain Relief		Menthol	CREAM	TOPICAL	20231114		OTC MONOGRAPH DRUG	M017	Speer Laboratories LLC	MENTHOL, UNSPECIFIED FORM	2.4	g/120g			N	20241231
55959-133_8cc3c07e-26e2-409a-9ce7-83d96d26a5c1	55959-133	HUMAN OTC DRUG	DoloMax Cold Cough		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	TABLET	ORAL	20210705		OTC MONOGRAPH FINAL	part341	BENARD INDUSTRIES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
55959-171_25fc0425-0cc9-4119-9226-12366eeadc16	55959-171	HUMAN OTC DRUG	DOLO- NeuroBion	Acetaminophen 500mg	Acetaminophen	TABLET, FILM COATED	ORAL	20160504		OTC MONOGRAPH NOT FINAL	part343	BENARD INDUSTRIES INC	ACETAMINOPHEN	500	mg/1			N	20241231
55959-179_fe7f4c90-c5ec-d662-e053-6294a90a3961	55959-179	HUMAN OTC DRUG	DOLO - NeuroBion Acetaminophen Max	Extended-Release 650 mg	Acetaminophen	TABLET	ORAL	20230619		ANDA	ANDA211544	BENARD INDUSTRIES INC	ACETAMINOPHEN	650	mg/1			N	20241231
56062-003_5dbe16b7-31a3-4973-94cd-f53e51f1fa12	56062-003	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20080917		OTC MONOGRAPH FINAL	part333D	Publix Super Markets	SALICYLIC ACID	19.8	mg/g			N	20241231
56062-004_75e20ee2-e626-48dc-913c-8cc968e6fd6d	56062-004	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20100226		OTC MONOGRAPH FINAL	part355	Publix Super Markets, Inc.,	SODIUM FLUORIDE	.2	mg/mL			N	20241231
56062-020_0b784283-ec4a-45db-86b3-097e4fdb2a8a	56062-020	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200330		ANDA	ANDA209339	Publix	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
56062-027_acb0db8d-96fe-4e9b-aa2d-ba4419b4bd38	56062-027	HUMAN OTC DRUG	Aspirin	Enteric Safety Coated	Aspirin	TABLET, COATED	ORAL	20130815	20240126	OTC MONOGRAPH FINAL	part343	Publix Supermarkets, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
56062-030_d00d292c-8ded-4c17-e053-2995a90ae6f3	56062-030	HUMAN OTC DRUG	stay awake		CAFFEINE	TABLET	ORAL	20200831		OTC MONOGRAPH FINAL	part340	PUBLIX SUPER MARKETS INC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
56062-050_726da18f-09ef-4378-bdb3-abd5d6513642	56062-050	HUMAN OTC DRUG	ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20110915		ANDA	ANDA079113	Publix Super Markets Inc	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-056_f829b223-8473-4951-8753-0614a12a64fb	56062-056	HUMAN OTC DRUG	nitetime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20140217		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
56062-057_4b931f7f-aeea-4236-a123-7210f065e915	56062-057	HUMAN OTC DRUG	profen ib	infants	ibuprofen	SUSPENSION	ORAL	20010629		ANDA	ANDA075217	Publix Super Markets Inc	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-063_bd35cbd2-3b23-4b40-87af-906dbb9502fe	56062-063	HUMAN OTC DRUG	Aspirin	Enteric Safety Coated	Aspirin	TABLET	ORAL	20230731		OTC MONOGRAPH FINAL	part343	Publix Supermarkets, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
56062-064_5d7277f2-7f67-4fc5-b96e-5977e3a61a49	56062-064	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20211008		ANDA	ANDA213105	Publix Supermarkets, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-069_eae0f5f8-3a27-4ca1-87bd-699978aa3a67	56062-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20090113		OTC MONOGRAPH FINAL	part347	Publix Super Markets, Inc	PETROLATUM	1	g/g			N	20241231
56062-070_6094c588-e509-441a-862d-545fddf5d6d0	56062-070	HUMAN OTC DRUG	minoxidil		Minoxidil	SOLUTION	TOPICAL	20211216		ANDA	ANDA075357	Publix Super Markets Inc	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
56062-072_64da413c-09a1-4c84-8a2c-47e43f2e37a2	56062-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19980106		OTC MONOGRAPH NOT FINAL	part356	Publix Super Markets	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
56062-074_550a97ea-8c58-4eb2-9732-e66a0136d61b	56062-074	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060322		ANDA	ANDA077349	Publix Super Markets Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-080_ee5222be-8caa-4797-bcc5-b81f0d2af9bc	56062-080	HUMAN OTC DRUG	Athletes Foot		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Publix Super Markets Inc.	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
56062-081_f45ec6e6-36f9-4286-8a66-c97646ce2de3	56062-081	HUMAN OTC DRUG	miconazole 3 day		Miconazole nitrate	KIT		20090626		ANDA	ANDA075329	Publix Super Markets Inc						N	20241231
56062-084_0d2a132b-84c0-7b07-e063-6294a90af042	56062-084	HUMAN OTC DRUG	Publix Advanced Relief Eye Drops		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	Publix Super Markets, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
56062-094_4f870e02-92ed-4df9-84d8-718e199960ad	56062-094	HUMAN OTC DRUG	nasal decongestant pe	non drowsy	Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20050610		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-102_8e627df1-a0dd-4371-879e-fa6624c9a3a8	56062-102	HUMAN OTC DRUG	childrens allergy		Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Publix Super Markets Inc	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-106_45637c21-0eef-4f25-a346-2598812d40ef	56062-106	HUMAN OTC DRUG	Childrens Allergy		Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	Publix Super Markets Inc	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-107_4cc04013-3ffb-4572-a53b-e5a2890c6430	56062-107	HUMAN OTC DRUG	allergy relief nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160908		ANDA	ANDA207957	Publix Super Markets Inc	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
56062-111_ade9acd2-126f-4612-b761-3f9c83fcc773	56062-111	HUMAN OTC DRUG	allergy relief		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220207		ANDA	ANDA213105	Publix Super Markets Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-117_422f715c-59b5-4146-9729-4ef1ecc608ac	56062-117	HUMAN OTC DRUG	lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120810		ANDA	ANDA202319	Publix Super Markets Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
56062-118_ee9de889-3a41-4e37-e053-2a95a90a2ee4	56062-118	HUMAN OTC DRUG	aspirin		ASPIRIN	TABLET, COATED	ORAL	20200501		OTC MONOGRAPH NOT FINAL	part343	PUBLIX SUPER MARKETS INC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
56062-130_3416c263-d362-4067-a8be-4daa7849061f	56062-130	HUMAN OTC DRUG	childrens pain relief		Acetaminophen	SUSPENSION	ORAL	20200918		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
56062-131_fe9a64cc-8824-4984-acf5-7973561fb243	56062-131	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170802		ANDA	ANDA203599	Publix Super Markets Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-132_7248df5f-1005-4e3f-9949-7d14c4ed8f82	56062-132	HUMAN OTC DRUG	childrens allergy	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Publix Super Markets Inc	LORATADINE	5	mg/5mL			N	20241231
56062-141_3caf6ae8-be15-40a1-8c85-6663df6316bd	56062-141	HUMAN OTC DRUG	acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20091123		ANDA	ANDA075400	Publix Super Markets Inc	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
56062-144_6be676e7-93bc-4b1c-914e-478b8346242a	56062-144	HUMAN OTC DRUG	Mucus D ER		Guaifenesin, pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160623		ANDA	ANDA091071	Publix Super Markets Inc	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-147_f555a490-aec9-49ff-bb4c-df6c685c07a5	56062-147	HUMAN OTC DRUG	allergy relief d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200212		ANDA	ANDA210719	Publix Super Markets Inc	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-153_4e1adec6-3064-479c-afaa-f399b282399a	56062-153	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20090113		OTC MONOGRAPH DRUG	M032	Publix Super Markets, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
56062-161_c53c5863-f402-48eb-b40e-6105548c9ba1	56062-161	HUMAN OTC DRUG	Pain Relief		Acetaminophen	SUSPENSION	ORAL	20111129		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
56062-163_e7d10ca4-4f30-4427-828c-54fd27c9da2c	56062-163	HUMAN OTC DRUG	Anticavity Fluoride Rinse		SODIUM FLUORIDE	MOUTHWASH	ORAL	20110720		OTC MONOGRAPH DRUG	M021	Publix Super Markets, Inc	SODIUM FLUORIDE	1	mg/mL			N	20241231
56062-166_0e9458a6-23c4-446b-b10c-1d46d72ea236	56062-166	HUMAN OTC DRUG	profen ib		Ibuprofen	SUSPENSION	ORAL	20031118		ANDA	ANDA074937	Publix Super Markets Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-175_3ade3d7f-1f7f-4baf-83f4-9169253dac46	56062-175	HUMAN OTC DRUG	pain relief	childrens	Acetaminophen	SUSPENSION	ORAL	20030828		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
56062-176_19b1b73a-80a8-4602-b2ac-9998b0c0dab4	56062-176	HUMAN OTC DRUG	Allergy Relief D		Cetirizine HCl, Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20100311		ANDA	ANDA077170	Publix Super Markets Inc	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-188_efaa2b58-c5f8-40bd-8b2e-acc14bd8a606	56062-188	HUMAN OTC DRUG	Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20131202		OTC MONOGRAPH FINAL	part346	Publix Super Markets Inc	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-192_af0bdd05-cac1-806c-e053-2995a90a5993	56062-192	HUMAN OTC DRUG	pain relief		Acetaminophen	TABLET, COATED	ORAL	20200501		OTC MONOGRAPH NOT FINAL	part343	PUBLIX SUPER MARKETS INC	ACETAMINOPHEN	500	mg/1			N	20241231
56062-194_7f4c0fdf-c55f-402b-a0a1-1b5e18e1bbea	56062-194	HUMAN OTC DRUG	maximum strength		Famotidine	TABLET, FILM COATED	ORAL	20071203		ANDA	ANDA077351	Publix Super Markets Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
56062-197_cdc45516-2bb1-2516-e053-2a95a90ad6b4	56062-197	HUMAN OTC DRUG	Cold Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20190913		OTC MONOGRAPH FINAL	part341	PUBLIX SUPER MARKETS INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-198_cdc45516-2bc9-2516-e053-2a95a90ad6b4	56062-198	HUMAN OTC DRUG	Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20190913		OTC MONOGRAPH FINAL	part341	PUBLIX SUPER MARKETS INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-202_4a14695d-3713-4a66-a9cd-20d9e1f955e1	56062-202	HUMAN OTC DRUG	minoxidil	for women	minoxidil	SOLUTION	TOPICAL	20110404		ANDA	ANDA075357	Publix Super Markets Inc	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
56062-204_66e11982-5f63-42f5-a33c-1badc5a65d94	56062-204	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	Publix Super Markets Inc	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-205_158a2f95-6caa-4431-8dec-b09472166be0	56062-205	HUMAN OTC DRUG	Therapeutic T Plus		Coal Tar	SHAMPOO	TOPICAL	20071012		OTC MONOGRAPH FINAL	part358H	Publix Super Markets, Inc.	COAL TAR	25	mg/mL			N	20241231
56062-224_fecfbc74-028e-4f2e-bd73-01ef03e18e63	56062-224	HUMAN OTC DRUG	anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030319		ANDA	ANDA075232	Publix Super Markets Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
56062-227_395751a6-cb6d-4d11-bf3c-23ed9dffa557	56062-227	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20071126		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	500	mg/1			N	20241231
56062-241_e64a7b19-099a-447c-89bf-fee1f2c9036a	56062-241	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210226		OTC MONOGRAPH NOT FINAL	part334	Publix Supermarkets, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
56062-248_42e911ad-5f73-4305-8db7-cfb4ed876876	56062-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20210412		OTC MONOGRAPH FINAL	part341	Publix	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	kg/g; kg/g; kg/g			N	20241231
56062-263_cdc31720-8746-4cfb-8f4b-c44153b8846e	56062-263	HUMAN OTC DRUG	dual action complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20181106		ANDA	ANDA077355	Publix Super Markets Inc	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-264_6228f441-8380-407f-b843-4a7d35229c38	56062-264	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	SOLUTION	ORAL	20210817		OTC MONOGRAPH NOT FINAL	part334	PUBLIX SUPER MARKETS, INC.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-266_888d7a44-cc3d-4538-b371-bb1e6872f841	56062-266	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	SOLUTION	ORAL	20210817		OTC MONOGRAPH NOT FINAL	part334	PUBLIX SUPER MARKETS, INC.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-272_bc1f8a1e-1d07-4983-aa27-e259e73e2f32	56062-272	HUMAN OTC DRUG	sinus relief	non drowsy	Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20071126		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-274_29ec1a8b-9626-43ba-be90-4612b1efd982	56062-274	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19980824		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
56062-279_286ea631-808b-4621-a0bb-bb139f7f5f32	56062-279	HUMAN OTC DRUG	hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140908		OTC MONOGRAPH FINAL	part346	Publix Super Markets Inc	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-283_bb30feaa-e667-45a4-824d-00215efaf08d	56062-283	HUMAN OTC DRUG	lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210727		ANDA	ANDA202319	Publix Super Markets Inc	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
56062-294_f73fe89a-cc89-4fac-9e8d-5a13c6d5100b	56062-294	HUMAN OTC DRUG	minoxidil foam		Minoxidil	AEROSOL, FOAM	TOPICAL	20130617		ANDA	ANDA091344	Publix Super Markets Inc	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
56062-299_ede4e754-b35a-4344-9856-aa20b4f8763f	56062-299	HUMAN OTC DRUG	Zestymint Antiseptic		cetylpyridinium chloride	MOUTHWASH	ORAL	20080506		OTC MONOGRAPH NOT FINAL	part356	Publix Super Markets, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
56062-306_54331f8b-54e5-4560-8365-856b900d8b94	56062-306	HUMAN OTC DRUG	clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091214		ANDA	ANDA090685	Publix Super Markets Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-310_c9ac179f-86c3-418d-85aa-8473447ab8dd	56062-310	HUMAN OTC DRUG	tussin	expectorant for adults	Guaifenesin	SOLUTION	ORAL	20040213		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	GUAIFENESIN	200	mg/10mL			N	20241231
56062-311_ac2795e0-c6c9-453b-818c-59beb9deb68a	56062-311	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20101005		OTC MONOGRAPH DRUG	M032	Publix Super Markets, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
56062-318_3294c09a-912a-48ac-9389-950c8f7aadbe	56062-318	HUMAN OTC DRUG	Original Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19910611		OTC MONOGRAPH NOT FINAL	part356	Publix	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
56062-319_ecf374b1-ab84-42dd-8d0f-75ca01f96c34	56062-319	HUMAN OTC DRUG	severe cold and flu		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, COATED	ORAL	20150408		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-322_8813c38a-0b02-4256-bddd-9eeb2973f15d	56062-322	HUMAN OTC DRUG	minoxidil		minoxidil	SOLUTION	TOPICAL	20210525		ANDA	ANDA075598	Publix Super Markets Inc	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
56062-326_3214132d-0ecb-46d4-acab-236248df2e9d	56062-326	HUMAN OTC DRUG	Magnesium Citrate	Saline Laxative	Magnesium citrate	LIQUID	ORAL	20190228	20240228	OTC MONOGRAPH NOT FINAL	part334	Publix Supermarkets, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
56062-327_d4787ce2-9900-4dd3-bbaa-074121635744	56062-327	HUMAN OTC DRUG	laxative		bisacodyl	TABLET, DELAYED RELEASE	ORAL	20210915		OTC MONOGRAPH DRUG	505G(a)(3)	Publix Super Markets Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-329_4ba92572-6a4b-4858-b487-420b07831b63	56062-329	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20190228	20240228	OTC MONOGRAPH NOT FINAL	part334	Publix Supermarkets, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
56062-334_0423e815-de92-425c-ad82-422c5751c4e8	56062-334	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	OIL	ORAL; TOPICAL	20170228		OTC MONOGRAPH NOT FINAL	part334	Publix Supermarkets, Inc.	MINERAL OIL	100	mg/100mL			N	20241231
56062-335_0e05af1a-727f-4dd6-ba8f-408f2d20e6f6	56062-335	HUMAN OTC DRUG	Nitetime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20111121		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
56062-344_155c6af4-3105-42b8-9a46-3614e02d39cd	56062-344	HUMAN OTC DRUG	stop smoking aid		Nicotine Polacrilex	LOZENGE	ORAL	20060412		ANDA	ANDA077007	Publix Super Markets Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-357_bfaab607-dc52-42f0-b276-a1b32468adb3	56062-357	HUMAN OTC DRUG	Regular Strength	antacid anti gas	Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	19940912		OTC MONOGRAPH FINAL	part331	Publix Super Markets Inc	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-359_aa5a9529-feb4-4fb4-8c7e-1a60391c3da5	56062-359	HUMAN OTC DRUG	Tussin DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20140210		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
56062-368_0eac0a41-64ad-48e9-b4b1-8fb50d88de59	56062-368	HUMAN OTC DRUG	All Day Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	19971229		ANDA	ANDA074661	Publix Super Markets Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-370_4e23ded7-b46d-4990-af1a-fbcc0f55de79	56062-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20150105		OTC MONOGRAPH NOT FINAL	part333A	Publix Super Markets, Inc.,	ALCOHOL	70	mL/100mL			N	20241231
56062-371_903025c2-bfaa-4d73-a12e-dda4b2f31535	56062-371	HUMAN OTC DRUG	cold relief	multi symptom	Acetaminophen, Dextromethorphan hbr, Phenylephrine hcl	TABLET, FILM COATED	ORAL	20150921		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-372_2a3bc508-68a1-4d51-8197-916737ffd75f	56062-372	HUMAN OTC DRUG	Stomach Relief	Original Formula	Bismuth subsalicylate	LIQUID	ORAL	20141231	20240731	OTC MONOGRAPH FINAL	part335	Publix Supermarkets, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
56062-374_f6b9208f-bbb9-457c-90a9-71a910ffd8db	56062-374	HUMAN OTC DRUG	migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20021226		ANDA	ANDA075794	Publix Super Markets Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
56062-376_cc45f9cf-25f0-4913-bff9-52694e7d86fd	56062-376	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140930		OTC MONOGRAPH DRUG	M022	Publix Supermarkets, Inc.	PHENOL	1.4	g/100mL			N	20241231
56062-377_0d03bd15-9f03-4d3b-a85d-8c6838110db0	56062-377	HUMAN OTC DRUG	Sore Throat	Menthol	Phenol	SPRAY	ORAL	20140930		OTC MONOGRAPH DRUG	M022	Publix Supermarkets, Inc.	PHENOL	1.4	g/100mL			N	20241231
56062-379_62c6e1b6-3dc9-4b29-b6e1-f47abb95bcb0	56062-379	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine HCl	SOLUTION	ORAL	20140211		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-384_7fdef905-ee32-40a3-b87c-73d36ae25910	56062-384	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20140225		ANDA	ANDA091135	Publix Super Markets Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
56062-399_efb6db39-55b7-3864-e053-2995a90a9fb0	56062-399	HUMAN OTC DRUG	sinus pressure pain and cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210301		OTC MONOGRAPH FINAL	part341	PUBLIX SUPER MARKETS INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-401_928409d8-7cff-4a7a-8d68-a9f1e21c8279	56062-401	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20220701		NDA	NDA022032	Publix Super Markets Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
56062-403_029f2d23-2604-4bdb-a03f-26607117599a	56062-403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20150123		OTC MONOGRAPH NOT FINAL	part333A	Publix Super Markets	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
56062-404_72c62831-c091-4359-bab2-83993c3b99e5	56062-404	HUMAN OTC DRUG	profen ib		Ibuprofen	SUSPENSION/ DROPS	ORAL	20150219		ANDA	ANDA075217	Publix Super Markets Inc	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-409_f6993bc5-550c-42b5-aee3-60f08302360a	56062-409	HUMAN OTC DRUG	stay awake		Caffeine	TABLET	ORAL	19980106		OTC MONOGRAPH FINAL	part340	Publix Super Markets Inc	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
56062-416_458a5aee-4aea-4dc3-aa88-3f1cf2e5b47f	56062-416	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, FILM COATED	ORAL	19880915		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
56062-417_60cf142a-0e66-46cc-87bd-8a88b07c3ca7	56062-417	HUMAN OTC DRUG	daytime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20180830		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-421_f0309597-bfe6-56eb-e053-2995a90a55d5	56062-421	HUMAN OTC DRUG	Publix Fast Relief Effervescent		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20111110		OTC MONOGRAPH FINAL	part343	Publix Super Markets Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
56062-423_645177a7-1d43-439b-9e23-75d5a7822d98	56062-423	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, SUGAR COATED	ORAL	20011013		ANDA	ANDA074567	Publix Super Markets Inc	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-428_c393f5e9-6b2b-4978-877b-ad8a71306b6d	56062-428	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA078699	Publix Supermarkets, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-429_c393f5e9-6b2b-4978-877b-ad8a71306b6d	56062-429	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA078697	Publix Supermarkets, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-431_63914432-08ab-4acb-8f71-fb1be3601776	56062-431	HUMAN OTC DRUG	sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20010724		OTC MONOGRAPH FINAL	part338	Publix Super Markets Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-432_59b6666a-6bf0-4e0f-b92d-7e9d62d50515	56062-432	HUMAN OTC DRUG	Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19930909		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-434_4aaccc01-d702-4a3b-bfa6-d1b4934c72b3	56062-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130822		OTC MONOGRAPH NOT FINAL	part356	Publix Super Markets	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
56062-435_473c5690-a0ef-442d-bd48-c04328f9cf40	56062-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150915		OTC MONOGRAPH FINAL	part355	PUBLIX SUPER MARKETS, INC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
56062-437_5af205e9-51d7-4bd1-a5ff-b2a31b350e34	56062-437	HUMAN OTC DRUG	pain relief pm	extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19930922		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-459_cce743ec-2294-4d2f-8912-82214bb77d91	56062-459	HUMAN OTC DRUG	nighttime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20111107		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
56062-460_2cbdfa21-39b7-4582-9db7-134113865366	56062-460	HUMAN OTC DRUG	sinus severe		Acetaminophen, guaifenesin, phenylephrine HCl	TABLET, COATED	ORAL	20180105		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-462_c3bb7947-f335-41ab-8ecb-83c1cf8d95c5	56062-462	HUMAN OTC DRUG	allergy		diphenhydramine hydrochloride	CAPSULE	ORAL	19930831		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-467_ce572094-c0a0-4772-a626-15ee59b9d18e	56062-467	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19990702		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
56062-479_83fe13a2-7a0b-43f7-af6b-5a12410f7b9a	56062-479	HUMAN OTC DRUG	allergy		Diphenhydramine Hydrochloride	TABLET	ORAL	19980507		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-484_6a83b9d1-5e61-411e-b902-450c9c66b1d7	56062-484	HUMAN OTC DRUG	pain relief	extra strength	Acetaminophen	TABLET	ORAL	19880915		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	500	mg/1			N	20241231
56062-490_c84587f0-899a-4088-a158-62131501c7e8	56062-490	HUMAN OTC DRUG	all day relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	19971229		ANDA	ANDA074661	Publix Super Markets Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-503_a8eef673-113c-4ea4-80da-e27d388b4314	56062-503	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Fruit	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079044	Publix Supermarkets, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-504_a8eef673-113c-4ea4-80da-e27d388b4314	56062-504	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Fruit	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079038	Publix Supermarkets, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-511_37b3e1b3-2c85-45ae-959d-9d33c5c9d685	56062-511	HUMAN OTC DRUG	antidiarrheal multi symptom relief		loperamide hydrochloride, simethicone	TABLET	ORAL	20200803		ANDA	ANDA209837	Publix Super Markets Inc	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
56062-516_33378107-6a17-40b7-a996-a77e999cc879	56062-516	HUMAN OTC DRUG	Tussin CF		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	19930319		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-517_e8670326-8f51-488e-be41-67d3e108ea30	56062-517	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060503		ANDA	ANDA077349	Publix Super Markets Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-525_aadad937-5b3a-4856-a974-2ee6d8757d55	56062-525	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20170331	20240331	OTC MONOGRAPH NOT FINAL	part343	Publix Supermarkets, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
56062-526_de419bf1-bd40-41df-9349-29b45b816289	56062-526	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20030819		ANDA	ANDA076134	Publix Super Markets Inc	LORATADINE	10	mg/1			N	20241231
56062-544_48b1634f-b960-4d1b-af7c-87e88a32d0a1	56062-544	HUMAN OTC DRUG	arthritis pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20071126		ANDA	ANDA075077	Publix Super Markets Inc	ACETAMINOPHEN	650	mg/1			N	20241231
56062-555_80e35c89-92c7-4256-8129-4e727f864e03	56062-555	HUMAN OTC DRUG	allergy relief d		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180423		ANDA	ANDA076050	Publix Super Markets Inc	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-571_d77d306f-1e48-47d8-a6c0-21941477acb0	56062-571	HUMAN OTC DRUG	allergy relief		fexofenadine hcl	TABLET, FILM COATED	ORAL	20120130		ANDA	ANDA076447	Publix Super Markets Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-578_379727d8-8ba4-42a6-a639-6119f2c612c9	56062-578	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190228	20240228	OTC MONOGRAPH NOT FINAL	part334	Publix Supermarkets, Inc.	DOCUSATE SODIUM	100	mg/1			N	
56062-580_b0c4a4a1-a61f-4a06-aac7-c41a78d6e9ba	56062-580	HUMAN OTC DRUG	Daytime PE Nitetime		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20140707		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc						N	20241231
56062-588_6e273eb0-b505-4522-8867-ed56e7509d7d	56062-588	HUMAN OTC DRUG	Maximum Strength	Antacid Anti Gas	Aluminum Hydroxide, Magnesium Hydroxide, Simethicone	SUSPENSION	ORAL	20071126		OTC MONOGRAPH FINAL	part332	Publix Super Markets Inc	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-590_9893be20-a44e-46dd-83f2-b443c57d21d3	56062-590	HUMAN OTC DRUG	pain relief		acetaminophen	SUSPENSION	ORAL	20111230		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
56062-602_6a259c1b-d6f3-4e0e-bc92-f7c2a62484cd	56062-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20140905		OTC MONOGRAPH NOT FINAL	part334	Publix Super Markets, Inc	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-604_42166a6e-a38b-446b-837e-3cf2e52a8a3d	56062-604	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880915		ANDA	ANDA072096	Publix Super Markets Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-607_c7895a24-5b0b-44a4-b8ed-dfe8febcd666	56062-607	HUMAN OTC DRUG	adult tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220721		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
56062-608_c3f157ee-d166-4097-b85d-a59cb3185eee	56062-608	HUMAN OTC DRUG	Nicotine Polacrilex	Original Flavor	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA074507	Publix Supermarkets, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-609_c3f157ee-d166-4097-b85d-a59cb3185eee	56062-609	HUMAN OTC DRUG	Nicotine Polacrilex	Origianl Flavor	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA074707	Publix Supermarkets, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-619_a2572dff-8402-4a94-b4cd-dd072e16657b	56062-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	19930319		OTC MONOGRAPH FINAL	part347	Publix Super Markets Inc	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
56062-624_6fba5d9f-9cbb-42cd-81fd-a76ad5f80a08	56062-624	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH DRUG	M008	Publix Supermarkets, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
56062-647_df58a6c4-9b5a-4fee-9362-2a7fc7ab6fa4	56062-647	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880915		ANDA	ANDA072096	Publix Super Markets Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-649_09a6ec32-81af-6da6-e063-6294a90abb46	56062-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20210801		OTC MONOGRAPH DRUG	M007	Publix	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-650_9e1989c4-fe43-436f-9807-b2cd894c7ab7	56062-650	HUMAN OTC DRUG	rapid release pain relief		Acetaminophen	TABLET, FILM COATED	ORAL	20160325		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	500	mg/1			N	20241231
56062-656_2fac46c1-4f5d-44e1-b81f-7e54c97f3d8b	56062-656	HUMAN OTC DRUG	day time	non drowsy	acetaminophen, dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060608		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-657_6bf84460-289f-46c7-8635-01edb5df969f	56062-657	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20031118		OTC MONOGRAPH FINAL	part332	Publix Super Markets Inc	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
56062-664_82bd66d5-35eb-4441-95ba-d66ab8f8dc78	56062-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19940330		OTC MONOGRAPH NOT FINAL	part356	Publix Super Markets, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
56062-666_0d2a2c09-c202-7960-e063-6394a90a4290	56062-666	HUMAN OTC DRUG	Publix Artificial Tears Eye Drops		polyvinyl alcohol, povidone	SOLUTION/ DROPS	OPHTHALMIC	20230320		OTC MONOGRAPH DRUG	M018	Publix Super Markets, Inc.	POLYVINYL ALCOHOL; POVIDONE	500; 600	mg/100mL; mg/100mL			N	20241231
56062-668_1931f66b-4077-4049-bd8b-e20cc04e0c9a	56062-668	HUMAN OTC DRUG	NItetime	cough	Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20030120		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
56062-676_f0b06d49-f4b3-4379-99d2-22aa0b50f3ac	56062-676	HUMAN OTC DRUG	Womens Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20210922		OTC MONOGRAPH DRUG	505G(a)(3)	Publix Super Markets Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-717_6d40d85c-5e43-44ff-b7bf-88a1cfd5c7ca	56062-717	HUMAN OTC DRUG	daytime nitetime		Acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20180925		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc						N	20241231
56062-724_9b95d4b9-6adc-4dd8-bc41-6324baf336af	56062-724	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Publix Super Markets Inc	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
56062-727_351f5322-55cc-41eb-a309-dcdc9418085b	56062-727	HUMAN OTC DRUG	milk of magnesia		magnesium hydroxide	SUSPENSION	ORAL	20190408		OTC MONOGRAPH NOT FINAL	part334	Publix Super Markets Inc	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-737_77378a99-a7d6-43e3-a936-8d35c8442387	56062-737	HUMAN OTC DRUG	Stomach Relief	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part335	Publix Supermarkets, Inc.	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
56062-741_4f1e8498-d89c-4000-af70-54c4d2dc486d	56062-741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20190228	20250228	ANDA	ANDA207235	Publix Supermarkets, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
56062-747_70d19f27-fc07-4742-9b2c-3ad6f6616db7	56062-747	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl, Menthol	GEL	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part348	Publix Super Markets, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL	7; 2	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
56062-748_6421258e-dbec-4bec-a66f-8dd51a0a584d	56062-748	HUMAN OTC DRUG	All Day Relief		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20190630		ANDA	ANDA208363	Publix Supermarkets, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-766_77125c1f-2b1b-473b-9a9e-13e1fd547586	56062-766	HUMAN OTC DRUG	Infants Pain Relief		Acetaminophen	SUSPENSION	ORAL	20201020		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
56062-789_0d2a2122-0b86-9022-e063-6394a90a1136	56062-789	HUMAN OTC DRUG	Publix Moisturizing Relief Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20200101		OTC MONOGRAPH DRUG	M018	Publix Super Markets, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
56062-790_0d2a2122-0b87-9022-e063-6394a90a1136	56062-790	HUMAN OTC DRUG	Publix High Performance Eye Drops		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20200101		OTC MONOGRAPH DRUG	M018	Publix Super Markets, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
56062-798_994c849a-a30c-473b-87fd-ce7fc9a0a535	56062-798	HUMAN OTC DRUG	Minoxidil		Minoxidil	SOLUTION	TOPICAL	20101025		ANDA	ANDA075598	Publix Super Markets Inc	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
56062-801_ad361f5c-e976-404f-b2a9-4316f5a43885	56062-801	HUMAN OTC DRUG	Childrens Ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20200312		ANDA	ANDA076359	Publix Super Markets Inc	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-804_675e71ad-8fde-401c-8d37-15e51d981dbb	56062-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20130322		OTC MONOGRAPH NOT FINAL	part333A	Publix Super Markets, Inc	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
56062-810_9563384e-f388-4168-bdc9-9ee058f5a176	56062-810	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20130322		OTC MONOGRAPH NOT FINAL	part333A	Publix Super Markets, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
56062-822_710b242c-2f41-4f53-88ef-3503eddba789	56062-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20160623		OTC MONOGRAPH FINAL	part347	Publix Super Markets, Inc	WITCH HAZEL	841	mg/mL			N	20241231
56062-826_0ac18643-77b2-ace9-e063-6394a90a9c82	56062-826	HUMAN OTC DRUG	Publix Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20130101		OTC MONOGRAPH DRUG	M003	Publix Super Markets, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
56062-842_c9ac140e-5f02-4136-be9e-9f8142cfe330	56062-842	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20190731	20240731	OTC MONOGRAPH FINAL	part335	Publix Supermarkets, Inc.	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
56062-845_25dd4a10-4593-4508-b729-f25708a3cc7e	56062-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH FINAL	part344	PUBLIX SUPER MARKETS, INC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
56062-847_bdd76b8f-ab6c-477a-81d1-74256944dd62	56062-847	HUMAN OTC DRUG	allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20220114		ANDA	ANDA212971	Publix Super Markets Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-867_5f0b0098-f88c-406a-800e-b0437ec6f7ec	56062-867	HUMAN OTC DRUG	Aspirin	Enteric Safety Coated	Aspirin	TABLET	ORAL	20190731		OTC MONOGRAPH FINAL	part343	Publix Supermarkets, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
56062-871_e19938bd-67f3-4fd5-a1d4-c28e34190d9c	56062-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20021107		OTC MONOGRAPH NOT FINAL	part333A	Publix Super Markets, Inc	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
56062-873_0bbafd05-edd9-4ec9-b5f8-78bdd3890517	56062-873	HUMAN OTC DRUG	stop smoking aid		Nicotine Polacrilex	LOZENGE	ORAL	20060412		ANDA	ANDA077007	Publix Super Markets Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
56062-878_77b718b7-6951-4fe8-9330-202d60152f35	56062-878	HUMAN OTC DRUG	arthritis pain reliever		diclofenac sodium	GEL	TOPICAL	20210201		ANDA	ANDA211253	Publix Super Markets Inc	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-897_27170beb-9e33-4e75-8434-9a4ee22f2d41	56062-897	HUMAN OTC DRUG	profen IB	childrens	Ibuprofen	SUSPENSION	ORAL	20010913		ANDA	ANDA074937	Publix Super Markets Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
56062-900_0970b1b1-1571-45a1-86e1-c2e85d12efff	56062-900	HUMAN OTC DRUG	DYE-FREE CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20200901		ANDA	ANDA210088	PUBLIX SUPER MARKETS, INC	LORATADINE	5	mg/1			N	20241231
56062-909_4d1c971d-a441-4e4d-8c6f-a239f1c5be9a	56062-909	HUMAN OTC DRUG	All Day Moisture		Octinoxate, Zinc Oxide	LOTION	TOPICAL	20160317		OTC MONOGRAPH FINAL	part352	Publix	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
56062-915_503a2e18-602b-439b-95fb-31d39d496f7b	56062-915	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080512		NDA	NDA022032	Publix Super Markets Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
56062-934_0c078193-f279-425a-b123-f1e0063e740d	56062-934	HUMAN OTC DRUG	Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210924		OTC MONOGRAPH DRUG	M013	Publix Super Markets Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
56062-939_acd5c107-c9fc-42fd-baf2-714888f59bd4	56062-939	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	Publix Super Markets Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56062-942_697dc828-76eb-4396-8ef0-9e9f06f81b10	56062-942	HUMAN OTC DRUG	burnrelief		Lidocaine HCl	GEL	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part348	Publix	LIDOCAINE HYDROCHLORIDE	5.05	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
56062-944_5cd148d9-17e8-4496-89bd-f3241b99710e	56062-944	HUMAN OTC DRUG	hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20120914		OTC MONOGRAPH FINAL	part346	Publix Super Markets Inc	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-946_231019d4-69bc-480c-84bd-7bcf6df30eca	56062-946	HUMAN OTC DRUG	infants pain relief		Acetaminophen	SUSPENSION	ORAL	20210209		OTC MONOGRAPH NOT FINAL	part343	Publix Super Markets Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
56062-947_57091c50-5ae6-47ec-b7a2-32747b8e173d	56062-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20090512		OTC MONOGRAPH FINAL	part333D	Publix	SALICYLIC ACID	20.6	mg/mL			N	20241231
56062-952_9b7337c0-9e02-4742-a426-69e3e78582d7	56062-952	HUMAN OTC DRUG	Epsom Salt		MAGNESIUM SULFATE	GRANULE	ORAL	20130703		OTC MONOGRAPH NOT FINAL	part334	Publix Super Markets, Inc.,	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
56062-964_4c6f1707-e991-4c24-82a2-6b5c74eea35c	56062-964	HUMAN OTC DRUG	flu and severe cold and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20110929		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-971_9f24528a-d326-4596-868c-6998e0338a9a	56062-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20191008		OTC MONOGRAPH FINAL	part355	publix	SODIUM FLUORIDE	.02	mg/mL			N	20241231
56062-987_0aa941bf-1a83-4c81-bc94-d4c91740c391	56062-987	HUMAN OTC DRUG	Cold and Cough DM		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20140210		OTC MONOGRAPH FINAL	part341	Publix Super Markets Inc	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
56062-990_dbe033b9-a76e-4880-8b1d-61d8eda23a20	56062-990	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20190731		ANDA	ANDA210088	PUBLIX SUPER MARKETS INC	LORATADINE	5	mg/1			N	20241231
56104-001_f32c5cc7-f874-1a4b-e053-2a95a90adcb6	56104-001	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20130101		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	TOLNAFTATE	1.5	g/150g			N	20241231
56104-006_f32c6784-9b50-1194-e053-2995a90ac3d6	56104-006	HUMAN OTC DRUG	Lidocaine		Burn Relief Spray	AEROSOL, SPRAY	TOPICAL	20130101		OTC MONOGRAPH NOT FINAL	part348	Premier Brands of America Inc.	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
56104-008_f32c0949-7b79-ea02-e053-2a95a90a3188	56104-008	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Spray Powder	AEROSOL, POWDER	TOPICAL	20130101		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	TOLNAFTATE	1.3	g/113g			N	20241231
56104-009_f32c5cc7-f872-1a4b-e053-2a95a90adcb6	56104-009	HUMAN OTC DRUG	Cornex		Corn and Callus Liquid Remover	LIQUID	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	.17	g/g			N	20241231
56104-010_f32c38bb-ba54-e11e-e053-2995a90a759e	56104-010	HUMAN OTC DRUG	Salicylic Acid		Ultra Thin Corn Removers	PATCH	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/91			N	20241231
56104-011_f32b8a44-0c78-5eae-e053-2a95a90a08de	56104-011	HUMAN OTC DRUG	Salicylic Acid		Corn Removers	PATCH	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/91			N	20241231
56104-013_f32c6365-3c0c-69b4-e053-2995a90a374a	56104-013	HUMAN OTC DRUG	Salicylic acid		Callus Removers	PATCH	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/41			N	20241231
56104-014_f39bfb73-18b1-7da3-e053-2995a90ace1c	56104-014	HUMAN OTC DRUG	Salicylic acid		Extra Thick Callus Removers	PATCH	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/41			N	20241231
56104-015_f32c50b4-cf5a-1c63-e053-2a95a90a7e06	56104-015	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief Continuous Spray	AEROSOL, SPRAY	TOPICAL	20130101		OTC MONOGRAPH NOT FINAL	part348	Premier Brands of America Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.5; .075	g/88mL; g/88mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
56104-016_f32c7619-a17e-3c53-e053-2a95a90a08cf	56104-016	HUMAN OTC DRUG	Tolnaftate		Antifungal TolnaftateLiquid Continuous Spray	AEROSOL, SPRAY	TOPICAL	20130101		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	TOLNAFTATE	1.5	g/150g			N	20241231
56104-017_f32c4937-c5c6-23c8-e053-2995a90a1202	56104-017	HUMAN OTC DRUG	Salicylic Acid		Wart Removers	PATCH	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358B	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/181			N	20241231
56104-024_0a478e25-0782-6851-e063-6394a90a588d	56104-024	HUMAN OTC DRUG	Salicylic acid		One-Step Wart Remover Tan	PLASTER	TOPICAL	20130601	20240131	OTC MONOGRAPH DRUG	M028	Premier Brands of America Inc.	SALICYLIC ACID	.4	g/141			N	
56104-025_f32bf61a-1e99-596d-e053-2a95a90a8c12	56104-025	HUMAN OTC DRUG	Wart Remover Liquid		Wart Remover Liquid	LIQUID	TOPICAL	20151028		OTC MONOGRAPH FINAL	part358B	Premier Brands of America Inc.	SALICYLIC ACID	.17	g/9mL			N	20241231
56104-026_f31f648c-67f7-1701-e053-2a95a90af734	56104-026	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20180119		OTC MONOGRAPH FINAL	part358B	Premier Brands of America Inc.	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
56104-031_f32c7619-a17d-3c53-e053-2a95a90a08cf	56104-031	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus No Touch Spray	AEROSOL, SPRAY	TOPICAL	20130101		OTC MONOGRAPH NOT FINAL	part348	Premier Brands of America Inc.	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/177mL; mg/177mL; mg/177mL			N	20241231
56104-035_f32bce98-e4f5-9f56-e053-2a95a90aeeee	56104-035	HUMAN OTC DRUG	Witch Hazel		Witch Hazel Spray	SPRAY	TOPICAL	20170301		OTC MONOGRAPH FINAL	part347	Premier Brands of America Inc	WITCH HAZEL	146	g/170g			N	20241231
56104-036_f32c0949-7b77-ea02-e053-2a95a90a3188	56104-036	HUMAN OTC DRUG	Tolnaftate		Tolnaftate Powder Spray Talc Free	AEROSOL, SPRAY	TOPICAL	20170522		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	TOLNAFTATE	1.3	g/130g			N	20241231
56104-037_f32bcd08-5ba5-e23f-e053-2995a90ac2a9	56104-037	HUMAN OTC DRUG	Tolnaftate		Tolnaftate Jock Itch Powder Spray - Talc Free	AEROSOL, SPRAY	TOPICAL	20171031		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	TOLNAFTATE	1.3	g/130g			N	20241231
56104-038_f32bceda-1d11-322d-e053-2995a90aae1b	56104-038	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray Talc Free	AEROSOL, SPRAY	TOPICAL	20170610		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc	MICONAZOLE NITRATE	1.3	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
56104-039_f31f65df-839d-cf53-e053-2995a90a86bc	56104-039	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20170403		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
56104-040_f31f65df-839c-cf53-e053-2995a90a86bc	56104-040	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20180103		OTC MONOGRAPH NOT FINAL	part333A	Premier Brands of America Inc.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
56104-114_f32c1428-e0a9-1c95-e053-2a95a90a7397	56104-114	HUMAN OTC DRUG	Undecylenic Acid Liquid		Anti-Fungal Liquid	LIQUID	TOPICAL	20130101		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	UNDECYLENIC ACID	.25	g/g			N	20241231
56104-131_f31f4b39-f9dd-3bc7-e053-2a95a90a4bc9	56104-131	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Powder Spray Talc Free	AEROSOL, POWDER	TOPICAL	20181203		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
56104-141_f32c7961-bb01-4793-e053-2a95a90a1d05	56104-141	HUMAN OTC DRUG	Miconazole nitrate		Antifungal Miconazole Liquid Continuous Spray	AEROSOL, SPRAY	TOPICAL	20130101		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	MICONAZOLE NITRATE	3	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
56104-237_f32c50b4-cf57-1c63-e053-2a95a90a7e06	56104-237	HUMAN OTC DRUG	Wart Remover Gel		Wart Remover Gel	GEL	TOPICAL	20130101		OTC MONOGRAPH FINAL	part358B	Premier Brands of America Inc.	SALICYLIC ACID	.17	g/g			N	20241231
56104-241_f32ca617-66e5-41d8-e053-2a95a90ae40a	56104-241	HUMAN OTC DRUG	Undecylenic Acid Liquid		Antifungal pen	LIQUID	TOPICAL	20210101		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
56104-244_f31c7594-0452-322d-e053-2a95a90aa65f	56104-244	HUMAN OTC DRUG	Salicylic acid		Callus Removers	PATCH	TOPICAL	20220616		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/41			N	20241231
56104-245_f31c7594-0451-322d-e053-2a95a90aa65f	56104-245	HUMAN OTC DRUG	Liquid Wart Remover		Salicylic Acid	LIQUID	TOPICAL	20220616		OTC MONOGRAPH FINAL	part358F	Premier Brands of America, Inc.	SALICYLIC ACID	.17	g/9mL			N	20241231
56104-246_f31c6018-4ef3-fb52-e053-2995a90ae764	56104-246	HUMAN OTC DRUG	Premier Solutions Liquid Bandage		Benzethonium chloride Dyclonine hydrochloride	LIQUID	TOPICAL	20220616		OTC MONOGRAPH NOT FINAL	part333A	Premier Brands of America, Inc.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/10mL; mg/10mL			N	20241231
56104-247_f31c6018-4ef1-fb52-e053-2995a90ae764	56104-247	HUMAN OTC DRUG	Premier Solutions Antifungal Tolnaftate Liquid		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20220616		OTC MONOGRAPH FINAL	part333C	Premier Brands of America, Inc.	TOLNAFTATE	.15	g/150g			N	20241231
56104-248_f31c68e3-9f71-1975-e053-2995a90a43f5	56104-248	HUMAN OTC DRUG	Premier Solutions Antifungal Tolnaftate Powder		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20220311		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	TOLNAFTATE	1.3	g/130g			N	20241231
56104-249_f31c6018-4eef-fb52-e053-2995a90ae764	56104-249	HUMAN OTC DRUG	Medicated Corn Removers		Salicylic Acid	PATCH	TOPICAL	20220713		OTC MONOGRAPH FINAL	part358F	Premier Brands of America, Inc.	SALICYLIC ACID	40	mg/91			N	20241231
56104-250_f32cc999-16e8-0bcb-e053-2a95a90a05b8	56104-250	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone Continuous Spray	AEROSOL, SPRAY	TOPICAL	20211220		OTC MONOGRAPH NOT FINAL	part348	Premier Brands of America, Inc.	HYDROCORTISONE	1.13	g/113g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
56104-251_f32cd367-d0e6-212b-e053-2995a90ad731	56104-251	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus Spray	AEROSOL, SPRAY	TOPICAL	20211220		OTC MONOGRAPH NOT FINAL	part348	Premier Brands of America, Inc.	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g			N	20241231
56104-252_f31c3891-4e13-c69a-e053-2a95a90a4e09	56104-252	HUMAN OTC DRUG	Foot Odor Control Powder		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20210929		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	TOLNAFTATE	1.3	g/113g			N	20241231
56104-253_f31c3d85-e386-c40b-e053-2a95a90a75a1	56104-253	HUMAN OTC DRUG	Anti- Fungal Miconazole Nitrate		Miconazole Nitrate	POWDER	TOPICAL	20220411		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
56104-255_f31c77ce-928f-2d59-e053-2995a90a8ae1	56104-255	HUMAN OTC DRUG	Premier Solutions Liquid Corn and Callus Remover		Salicylic Acid	LIQUID	TOPICAL	20220615		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
56104-256_f31c3d85-e388-c40b-e053-2a95a90a75a1	56104-256	HUMAN OTC DRUG	Antifungal Miconazole		Miconazole Nitrate	AEROSOL, SPRAY	TOPICAL	20210929		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
56104-258_f5640112-4f71-f7f3-e053-2995a90a2acc	56104-258	HUMAN OTC DRUG	Salicylic Acid		Clear Medicated Corn removers	PATCH	TOPICAL	20220222		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/121			N	20241231
56104-259_f5628101-e8c6-3f8e-e053-2995a90ac4f6	56104-259	HUMAN OTC DRUG	Salicylic Acid		Clear Medicated Corn removers	PATCH	TOPICAL	20220222		OTC MONOGRAPH FINAL	part358F	Premier Brands of America Inc.	SALICYLIC ACID	40	mg/121			N	20241231
56104-260_f31c3d85-e389-c40b-e053-2a95a90a75a1	56104-260	HUMAN OTC DRUG	Medicated Wart Remover		Salicylic acid	PATCH	TOPICAL	20220713		OTC MONOGRAPH FINAL	part358F	Premier Brands of America, Inc.	SALICYLIC ACID	.4	g/181			N	20241231
56104-500_052d8421-fd21-dd55-e063-6294a90a1e34	56104-500	HUMAN OTC DRUG	Anti-fungal Powder Miconazole Nitrate		Miconazole Nitrate	POWDER	TOPICAL	20230912		OTC MONOGRAPH FINAL	part333C	Premier Brands of America Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
56104-501_051c57c9-2819-4144-e063-6294a90a705d	56104-501	HUMAN OTC DRUG	Liquid Callus Remover		Salicylic Acid	LIQUID	TOPICAL	20230911		OTC MONOGRAPH FINAL	part358B	Premier Brands of America Inc.	SALICYLIC ACID	170	mg/mL			N	20241231
56104-502_052a2c05-950f-fcde-e063-6294a90aba6b	56104-502	HUMAN OTC DRUG	Liquid Bandage		Benzethonium chloride Plus Dyclonine hydrochloride	LIQUID	TOPICAL	20230911		OTC MONOGRAPH NOT FINAL	part333A	Premier Brands of America Inc.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	2; 7.5	mg/mL; mg/mL			N	20241231
56130-002_0710c649-799a-25b5-e063-6294a90a82bb	56130-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130101		NDA	NDA205865	All Gas & Welding Supplies Co., Inc.	OXYGEN	990	mL/L			N	20241231
56130-003_0710e208-5b32-3c72-e063-6394a90a4dac	56130-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20220103		NDA	NDA205866	All Gas & Welding Supplies Co., Inc.	NITROGEN	990	mL/L			N	20241231
56131-701_86417b48-cd9f-b034-e053-2a91aa0adfcd	56131-701	HUMAN OTC DRUG	Instant Foaming Hand Sanitizer		Alcohol	SOAP	TOPICAL	20160601		OTC MONOGRAPH NOT FINAL	part333E	RD Food Service DBA Restaurant Depot	ALCOHOL	.62	mL/mL			N	20241231
56131-711_abbbe84e-167e-4c25-e053-2995a90ab627	56131-711	HUMAN OTC DRUG	RD Food Service DBA Restaurant Depot		benzalkonium chloride	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333E	RD Food Service DBA Restaurant Depot	BENZALKONIUM CHLORIDE	.13	1/mL			N	20241231
56131-800_abbcb3d9-be8c-1432-e053-2995a90a7c2e	56131-800	HUMAN OTC DRUG	Skyline Professional Instant Foaming Hand Sanitizer		Alcohol	SOAP	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	RD Food Service DBA Restaurant Depot	ALCOHOL	.7	mL/mL			N	20241231
56136-000_f3d77ca0-62fb-4797-8979-29c7b288c7c0	56136-000	HUMAN OTC DRUG	At Home Signature Collection Hand Sanitizer	Autumn Evening	Alcohol	GEL	TOPICAL	20220617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-012_bc12b77c-8093-4835-8103-7bf1ee185d7b	56136-012	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Woodland Springs	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-013_fdbf7417-1b46-4dc1-aa98-e57f8dd87f2f	56136-013	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Coral Sands	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-014_f156a163-c0e0-4afa-99e1-863475aa7c9a	56136-014	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Fig Eucalyptus	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-015_500deaef-f2b4-438f-bac5-0f90ca43ccf2	56136-015	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Line Dried Linen	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-016_c6c74ba0-cb4d-442f-98fe-740f1e6b4753	56136-016	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Passion Fruit Prosecco	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-017_cc32043f-4436-4d7d-a3ea-1464bec3a498	56136-017	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Sugar Blossom	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-018_0e06446f-4e8e-4b2a-ab7f-d7fdec9c6908	56136-018	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Sheer Peony	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-019_dafd8cb0-d66b-4626-9472-c3c2746d8ad3	56136-019	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Twilight Pomelo	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-020_6947cda6-e11d-4350-9f22-271ff6449862	56136-020	HUMAN OTC DRUG	Signature Collection Hand Sanitizer	Vanilla Oak	Alcohol	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-021_7ed0bf57-ddd2-4864-a95f-f0dd7fa0b511	56136-021	HUMAN OTC DRUG	Foaming Mousse Anti-Bacterial Hand Sanitizer	Cherry Scented	ALCOHOL	AEROSOL, FOAM	TOPICAL	20181128		OTC MONOGRAPH NOT FINAL	part333A	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-022_5bf6fe8f-c188-4232-bf86-38442c270196	56136-022	HUMAN OTC DRUG	Foaming Mousse Anti-Bacterial Hand Sanitizer	Pineapple Scented	ALCOHOL	AEROSOL, FOAM	TOPICAL	20181128		OTC MONOGRAPH NOT FINAL	part333A	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-023_32a4fe9f-f783-48c8-b0af-defdaada998d	56136-023	HUMAN OTC DRUG	Foaming Mousse Anti-Bacterial Hand Sanitizer	Pink Grapefruit Scented	ALCOHOL	AEROSOL, FOAM	TOPICAL	20181128		OTC MONOGRAPH NOT FINAL	part333A	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-024_514fb944-8c34-43d8-ab3e-15e04337513b	56136-024	HUMAN OTC DRUG	BEST ACCESSORY GROUP COTTON CANDY SCENTED HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20190730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-025_5600306d-42bc-4120-bbf7-3f7c186b176a	56136-025	HUMAN OTC DRUG	BEST ACCESSORY GROUP SWEET STRAWBERRY SCENTED HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20190730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-027_8b23a21e-3e11-4230-9d31-b91b928da046	56136-027	HUMAN OTC DRUG	Sanitizerx Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200511		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
56136-028_eb848d29-7c64-4e3c-a57e-79e0a1881d42	56136-028	HUMAN OTC DRUG	Lemon Fresh Antibacterial Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-029_b95ab4b6-5ecc-4c75-acef-d88483478b4d	56136-029	HUMAN OTC DRUG	COTTON CANDY SCENTED HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-030_7eae23b3-e30f-44b5-b070-23e2e11bf9e4	56136-030	HUMAN OTC DRUG	SWEET STRAWBERRY SCENTED HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-031_f6d23305-d869-43f4-9996-54ef790358bc	56136-031	HUMAN OTC DRUG	HAND SANITIZER Advanced Formula	aloe and vitamin E	Alcohol	GEL	TOPICAL	20200509		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-032_815aba4d-d389-4e61-bfd5-f23a682952a0	56136-032	HUMAN OTC DRUG	HAND SANITIZER Advanced Formula	aloe and vitamin E	Alcohol	GEL	TOPICAL	20200509		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-033_3f5a8866-c057-4bcc-89fd-35e994e9d3df	56136-033	HUMAN OTC DRUG	HAND SANITIZER Advanced Formula	aloe and vitamin E	Alcohol	GEL	TOPICAL	20200509		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-034_f0bea9b3-c6a9-4288-b839-9c958bdcc773	56136-034	HUMAN OTC DRUG	HAND SANITIZER Advanced Formula	aloe and vitamin E	Alcohol	GEL	TOPICAL	20200509		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-035_7f788535-34fc-4f35-80e2-a1a2e9a025c7	56136-035	HUMAN OTC DRUG	HAND SANITIZER Advanced Formula	aloe and vitamin E	Alcohol	GEL	TOPICAL	20200509		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-036_3c905942-52ac-4f31-b772-cd8b97a4ffbe	56136-036	HUMAN OTC DRUG	Bye Bye Germs HAND SANITIZER Advanced Formula	aloe and vitamin E	Alcohol	GEL	TOPICAL	20200509		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-037_d058c807-b4a6-47a0-b035-ba3640de14ca	56136-037	HUMAN OTC DRUG	Puppicorn Strawberry Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-038_cc7f0cd7-08a7-4553-a6a9-2d692d016bd3	56136-038	HUMAN OTC DRUG	Puppicorn Cotton Candy Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-039_ad056516-89cd-4ffd-8be6-f3741a8ffbe6	56136-039	HUMAN OTC DRUG	At Home Signature Collection Hand Sanitizer	Vanilla Pumpkin	Alcohol	GEL	TOPICAL	20220617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-040_af4cc97a-f661-4442-a065-f5e315a6ad15	56136-040	HUMAN OTC DRUG	At Home Signature Collection Hand Sanitizer	Pumpkin Spice	Alcohol	GEL	TOPICAL	20220617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-041_4a4d79df-7a77-45ee-ba62-8e1a86e4a725	56136-041	HUMAN OTC DRUG	My Beauty Spot Hand Sanitizer Lavender Frost Scented		Alcohol	GEL	TOPICAL	20200713		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-042_5c76d055-4186-49c0-922f-4f8236490cdc	56136-042	HUMAN OTC DRUG	My Beauty Spot Hand Sanitizer Wild Berries Scented		Alcohol	GEL	TOPICAL	20200713		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-043_60b8a643-100d-4fca-98ac-fa0600734e03	56136-043	HUMAN OTC DRUG	My Beauty Spot Hand Sanitizer Cool Fall Breeze Scented		Alcohol	GEL	TOPICAL	20200713		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-044_95331185-4e0b-4866-9a37-c8c808286c62	56136-044	HUMAN OTC DRUG	At Home Signature Collection Hand Sanitizer	Harvest Apple	Alcohol	GEL	TOPICAL	20220617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	700	mg/mL			N	20241231
56136-046_ccba1822-23f6-46cf-a6b8-7f383b2c0bb2	56136-046	HUMAN OTC DRUG	Hand Sanitizer Lemon Lime Fizzer Scented		Alcohol	GEL	TOPICAL	20200714		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-047_c9a8b18b-481a-49c4-9b7c-acd7765aaa6f	56136-047	HUMAN OTC DRUG	Hand Sanitizer Wild Rasp Berry Scented		Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-048_e3978dd8-9018-4386-8866-b012b321bdae	56136-048	HUMAN OTC DRUG	Hand Sanitizer Vanilla Ice Cream Scented		Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-049_2bcf8339-bef2-4363-85a5-4fa9ee3ebca3	56136-049	HUMAN OTC DRUG	Hand Sanitizer Mango Papaya Popcicle Scented		Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-051_7e405971-1d53-4193-94ea-6fe039e2a517	56136-051	HUMAN OTC DRUG	Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-052_9860dce3-0bb8-4fd9-ba67-f4916f49a378	56136-052	HUMAN OTC DRUG	Hand Sanitizer Mint Cream Scented		Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-053_c6d875d6-47a1-411b-a919-19fb7c1f4612	56136-053	HUMAN OTC DRUG	Hand Sanitizer Vanilla Sugar Scented		Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-054_5bbbd3e2-e768-4bf9-bcb4-9cfaeef9764b	56136-054	HUMAN OTC DRUG	Sweet Pea Anti-bacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200826		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-055_8b283d5b-fd14-4cc8-92dd-c7fb992b5f2a	56136-055	HUMAN OTC DRUG	Lemon Verbena anti-bacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200826		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-056_1aeb55ac-e7ca-4bc8-b52e-93a278910324	56136-056	HUMAN OTC DRUG	Sweet Heart Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-057_6a7eea7c-ddb1-4c2e-bf22-ab50603ccc5f	56136-057	HUMAN OTC DRUG	Sweet Heart Antibacterial Hand Sanitizer Strawberry Scented		Alcohol	GEL	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-058_7d009662-3836-4d91-8cb3-d1c1a050d316	56136-058	HUMAN OTC DRUG	Sweet Heart Antibacterial Hand Sanitizer Tropical Fruit Scented		Alcohol	GEL	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-060_ef10bfca-51e6-4602-a2b8-81e216c3fa5e	56136-060	HUMAN OTC DRUG	Hand Sanitizer Water Melon Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-061_1505b720-7c2b-4e4a-87d0-cae15d5254af	56136-061	HUMAN OTC DRUG	Hand Sanitizer Wild Rasp Berry Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-062_b5eef421-9b42-42c5-8ad1-ec492ff23d80	56136-062	HUMAN OTC DRUG	Hand Sanitizer Apple Tart Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-063_5029c9d9-33c7-49ba-aaa3-f7c94fe454d9	56136-063	HUMAN OTC DRUG	Hand Sanitizer Kiwi Avo Smoothie Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-064_06633883-6b67-4bc1-b302-e476df6699be	56136-064	HUMAN OTC DRUG	Hand Sanitizer Juicy Pine Apple Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-065_3752289a-71fb-45c2-a6ba-a473b53d774e	56136-065	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Apple Blast Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-066_4eb86214-ed6c-46b9-abda-5290dbe20384	56136-066	HUMAN OTC DRUG	Anti-bacterial Hand Sanitizer Warm Vanilla Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-067_152d7c31-1b12-47e4-9dd8-4b48a9e89064	56136-067	HUMAN OTC DRUG	Anti-bacterial Hand Sanitizer Peppermint Cream Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-068_71798b08-6fad-4e37-9c80-998dfe7af1cd	56136-068	HUMAN OTC DRUG	Anti-bacterial Hand Sanitizer Caramel Taffy Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-070_44dd4395-2770-41a5-9cfb-79f7e1d08b97	56136-070	HUMAN OTC DRUG	Hand Sanitizer Sparkling Berry		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-071_ef77d392-ca5e-484c-8e94-385a88eb0339	56136-071	HUMAN OTC DRUG	Hand Sanitizer Sparkling Melon		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-072_be1d978e-0825-4129-ab87-644dc5d436e3	56136-072	HUMAN OTC DRUG	Hand Sanitizer Peach Cream Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-073_5c4bc134-1bae-4150-b1b7-d38192cc9e9f	56136-073	HUMAN OTC DRUG	Hand Sanitizer Cherry Frosting Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-074_5ec04f32-5908-4b18-b6fa-594f610b988d	56136-074	HUMAN OTC DRUG	Mermaid Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-075_3799f075-275d-42cb-a96d-3c06e2402845	56136-075	HUMAN OTC DRUG	Mermaid Squad Hand Sanitizer Berry Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-076_15afa80f-87b9-436d-8c22-c56a38cb8adb	56136-076	HUMAN OTC DRUG	Born To Shine Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-077_244e2e0f-4395-40ab-8dae-2f449273138b	56136-077	HUMAN OTC DRUG	Born To Shine Hand Sanitizer Candy Apple Scented		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-078_005dc4a7-0b3c-4a7c-8990-4dbfd7d11313	56136-078	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Bubble Gum		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-079_790fe94e-715f-4cdb-90a6-303f751fb298	56136-079	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Cotton Candy		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-080_525c5f16-4d91-4542-acb2-128c5478bed8	56136-080	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Blueberry		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-081_7685a62b-6c76-449f-90ab-29d42f85199e	56136-081	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Strawberry		Alcohol	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-082_555974c6-a3e2-4843-a017-39becfa43dcb	56136-082	HUMAN OTC DRUG	Antibacterial Hand Wash for Kids Cotton Candy Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-083_c06389fe-2274-430d-97be-ab4290dd8670	56136-083	HUMAN OTC DRUG	Antibacterial Hand Wash for Kids Pineapple and Coconut Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-084_e20ceb60-d9a1-41d5-ba10-399e9a151f64	56136-084	HUMAN OTC DRUG	Unicorn Antibacterial Hand Wash mint chocolate scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-085_4b071032-a4a6-465b-8b8d-9a14f19d7c04	56136-085	HUMAN OTC DRUG	Mermaid Squad Antibacterial Hand Wash Cotton Candy Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-086_62ee52cc-94af-463c-b2ce-ae38ef6fa3f5	56136-086	HUMAN OTC DRUG	Follow the Rainbow Antibacterial Hand Wash Watermelon Ice Pop Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-087_e967e4ee-7443-4219-9953-ec117a641c11	56136-087	HUMAN OTC DRUG	Unicorn Antibacterial Hand Sanitizer mint chocolate scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-088_4c6c2994-861c-4f9c-aaf6-c816081883fe	56136-088	HUMAN OTC DRUG	mermaid vibes Antibacterial Hand Sanitizer cotton candy scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-089_fa430bf6-41d1-4603-a5cf-6b8ad412de59	56136-089	HUMAN OTC DRUG	Follow the Rainbow Antibacterial Hand Sanitizer Watermelon Ice Pop scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-090_e99b3f1d-bc13-4799-8b06-47f6be1e7e7a	56136-090	HUMAN OTC DRUG	Unicorn Antibacterial Hand Sanitizer Strawberry scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-091_901f5790-addd-4557-802e-279e3e89f78e	56136-091	HUMAN OTC DRUG	Unicorn Antibacterial Hand Sanitizer cotton candy scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-092_f5b4eb1e-1287-4235-bf14-0f3233e4fe2a	56136-092	HUMAN OTC DRUG	Unicorn Antibacterial Hand Sanitizer Fruit Punch scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-093_5ea06e22-327d-42ce-95e3-6b4d336b8a75	56136-093	HUMAN OTC DRUG	Follow the Rainbow Antibacterial Hand Sanitizer Sweet Berries scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-094_7f5b43c4-5d3c-46e6-b488-22a6bb7846e2	56136-094	HUMAN OTC DRUG	Follow the Rainbow Antibacterial Hand Sanitizer Watermelon Ice Pop scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-095_a36e4866-1b2d-4d41-bb15-0b88cb7dae65	56136-095	HUMAN OTC DRUG	Follow the Rainbow Antibacterial Hand Sanitizer Coconut Milk scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-096_170eaeaa-d16c-4035-aaf1-e813ade421b3	56136-096	HUMAN OTC DRUG	mermaid squad Antibacterial Hand Sanitizer Strawberry cake scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-097_e0a49d34-9e91-4bcf-baea-4b239b899a73	56136-097	HUMAN OTC DRUG	mermaid vibes Antibacterial Hand Sanitizer Blueberry shake scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-098_10c41ca3-afad-4f8a-a487-674a2c2ff0fd	56136-098	HUMAN OTC DRUG	mermaid vibes Antibacterial Hand Sanitizer mint chocolate scented		Alcohol	GEL	TOPICAL	20200730		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-161_d6dd2bee-a70b-4b59-8e36-6757ababfc7f	56136-161	HUMAN OTC DRUG	Vanilla Ice Cream Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20220121		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-162_5c268ad1-bd87-4161-a31f-c43dc084fc08	56136-162	HUMAN OTC DRUG	Cotton Candy Scented Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20220121		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-163_bbc8e408-8dc8-42f1-bbe6-e776170e2e07	56136-163	HUMAN OTC DRUG	Birthday Cake Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20220121		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-164_3cc955e0-a9d4-4900-8405-e8691e2709bd	56136-164	HUMAN OTC DRUG	Raspberry Cooler Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20220121		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-201_62e98cec-5803-4ee2-8711-035362f92c12	56136-201	HUMAN OTC DRUG	Winter Bloom Scented Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-202_7bf0259c-ccb9-468a-8a5f-9fab89e31ef4	56136-202	HUMAN OTC DRUG	Pine Forest Scented Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-203_8240263f-c4d4-4131-a9e3-be2ad3ea8f25	56136-203	HUMAN OTC DRUG	Frosted Berries Scented Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-204_fbdf26b5-90d9-4f1a-ad44-7a3fe3d0e569	56136-204	HUMAN OTC DRUG	Lavender Frost Scented Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-205_fbe9f41d-043b-4266-9973-99b715c8746a	56136-205	HUMAN OTC DRUG	Lavender Frost Scented Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-206_3f0a24b3-0eb1-44ad-81ea-11bd0133fe27	56136-206	HUMAN OTC DRUG	Candy Apple Scented Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-207_9f043520-c390-4e54-bbee-f583cd207a8f	56136-207	HUMAN OTC DRUG	Candy Apple Scented Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-208_ca8ea240-88b8-4db6-9838-4e088a53f1ab	56136-208	HUMAN OTC DRUG	Cool Mint Scented Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-209_3fe6d336-f67d-49b8-a9c5-631c4f3d2426	56136-209	HUMAN OTC DRUG	Cool Mint Scented Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-211_f9179ba2-a6f9-48c0-aeb9-1636aa2cd009	56136-211	HUMAN OTC DRUG	On The Go HAND SANITIZER	with Vitamin E	Alcohol	SPRAY	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-212_3f27a4d4-85c7-4a4a-82bf-968593fa4598	56136-212	HUMAN OTC DRUG	On The Go HAND SANITIZER Lavender Fields	with Vitamin E	Alcohol	SPRAY	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-213_3225deb9-db11-4a57-bfb4-504c5743833e	56136-213	HUMAN OTC DRUG	On The Go HAND SANITIZER Blushing Rose	with Vitamin E	Alcohol	SPRAY	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-214_8455e67c-08f9-40a5-a10c-4fad9328979e	56136-214	HUMAN OTC DRUG	On The Go HAND SANITIZER Coconut Breeze	with Vitamin E	Alcohol	SPRAY	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-215_70d7fc97-fb23-4492-9be2-8a88e870b482	56136-215	HUMAN OTC DRUG	On The Go HAND SANITIZER Eucalyptus Mint	with Vitamin E	Alcohol	SPRAY	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-216_44d82bbb-0750-4ef1-b397-bffb6af83509	56136-216	HUMAN OTC DRUG	On The Go HAND SANITIZER Vanilla Vibes	with Vitamin E	Alcohol	SPRAY	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-217_71354ae5-d050-4b6b-8c32-d285a85d67bc	56136-217	HUMAN OTC DRUG	On The Go HAND SANITIZER White Jasmine	with Vitamin E	Alcohol	SPRAY	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-221_06b88b54-b267-488e-8548-0be45feed61c	56136-221	HUMAN OTC DRUG	On The Go HAND SANITIZER Lavender Fields		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-223_1631a139-08a1-4978-a938-8265523b1b1f	56136-223	HUMAN OTC DRUG	On The Go HAND SANITIZER Blushing Rose		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-224_2ebc703d-378f-4add-b8d8-c092d77ef448	56136-224	HUMAN OTC DRUG	On The Go HAND SANITIZER Coconut Breeze		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-225_5bf97ee4-135d-4d74-9671-fd9996de9a1e	56136-225	HUMAN OTC DRUG	On The Go HAND SANITIZER Eucalyptus Mint		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-226_a3df068f-ab9c-489c-84fe-45d25e51bd55	56136-226	HUMAN OTC DRUG	On The Go HAND SANITIZER Vanilla Vibes		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-227_d649290a-7dca-4f49-b8d3-5399afdde562	56136-227	HUMAN OTC DRUG	On The Go HAND SANITIZER White Jasmine		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-231_f19b2228-48de-4397-bac4-1b1b0556049a	56136-231	HUMAN OTC DRUG	BYE BYE GERMS HAND SANITIZER Vanilla Sugar		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-232_e0ae6561-abb2-4e01-bdf9-09ff0ce4ce91	56136-232	HUMAN OTC DRUG	BYE BYE GERMS HAND SANITIZER Cranberry		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-233_8ed174e8-e240-44a9-93d1-1c49e4e2821d	56136-233	HUMAN OTC DRUG	BYE BYE GERMS HAND SANITIZER Pine and eucaluptus		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-234_d67539c3-3baf-44c1-9241-87452076f38d	56136-234	HUMAN OTC DRUG	BYE BYE GERMS HAND SANITIZER Sugar Cookie		Alcohol	GEL	TOPICAL	20201009		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-301_17e84074-87b8-4bfd-bd5f-1d4912baa85b	56136-301	HUMAN OTC DRUG	Bye Bye Germs HAND SANITIZER	aloe and vitamin E	Alcohol	GEL	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-302_1daf894c-43b8-40b8-b0eb-f42aeee7dba2	56136-302	HUMAN OTC DRUG	OPALINE Hand Sanitizer		Alcohol	GEL	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
56136-303_6ed92b31-7f99-4d13-a127-ff7a31cf5e3d	56136-303	HUMAN OTC DRUG	Unscented Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-304_83035341-e2a2-4f5d-9bec-cc923e764794	56136-304	HUMAN OTC DRUG	Fresh Lemons Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-305_c65da998-7ad9-4618-b523-1aa565881c00	56136-305	HUMAN OTC DRUG	OPALINE Antibacterial and Moisturizing Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
56136-306_75dd62e2-8eb2-47a6-ba59-4caba187b20e	56136-306	HUMAN OTC DRUG	Fragrance Free Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-307_17a67dc8-ceea-4ed5-90ec-e5bd407ff802	56136-307	HUMAN OTC DRUG	BYE BYE GERMS Antibacterial Hand Wash with Aloe and Tea Tree enriched with Vitamin E		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-308_654c1f19-b828-4021-9c51-3056f56f9a49	56136-308	HUMAN OTC DRUG	Fustin Alcohol Wipes		ALCOHOL	SWAB	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333A	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
56136-309_749fd87e-f522-4d95-b5d8-2b4c55146a70	56136-309	HUMAN OTC DRUG	BYE BYE GERMS Antibacterial Hand Wash with Orange Zest and Vitamin C		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-310_f649324b-0d45-4bad-aae8-573f4241e29f	56136-310	HUMAN OTC DRUG	JUSOFON Hand Sanitizer		Alcohol	GEL	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
56136-311_2eebd30f-5e3e-4792-83d4-d88e3c1fdd6b	56136-311	HUMAN OTC DRUG	Bye Bye Germs HAND SANITIZER	aloe and vitamin E	Alcohol	LIQUID	TOPICAL	20200713		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-312_17d0d3be-f3c2-4c6c-bc01-b9b7c97856e2	56136-312	HUMAN OTC DRUG	NewRain Hand Sanitizer		Alcohol	GEL	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
56136-313_391786e6-4b5b-44ef-8007-8fed9d989b99	56136-313	HUMAN OTC DRUG	MY BEAUTY SPOT Aromatherapy Antibacterial Hand Wash with Vitamin E and Aloe Vera (lavender scented))		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200605		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-314_1c7e5148-c013-4c37-af38-a5cf61354bda	56136-314	HUMAN OTC DRUG	MY BEAUTY SPOT Aromatherapy Antibacterial Hand Wash with Vitamin E and Aloe Vera (lemongrass scented))		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200605		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-315_913e6a4c-5b05-416d-99fd-bc7a9f280135	56136-315	HUMAN OTC DRUG	MY BEAUTY SPOT Aromatherapy Antibacterial Hand Wash with Vitamin E and Aloe Vera (coconut scented)		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200605		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-316_292dc383-f4af-4820-a69c-3a27e5dda1b4	56136-316	HUMAN OTC DRUG	MY BEAUTY SPOT Aromatherapy Antibacterial Hand Wash with Vitamin E and Aloe Vera (cherry blossom scented)		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200605		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-321_08c57544-75ee-4e87-a4c4-649b0bd31270	56136-321	HUMAN OTC DRUG	MY BEAUTY SPOT Antibacterial Hand Wash Cherry Blossom Scented	Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-322_852df19e-6b51-457a-906f-4df32eb48a0d	56136-322	HUMAN OTC DRUG	Antibacterial Refreshing Hand Wash Aloe Vera Scented	with Softening aloe vera and vitamin E	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-323_78e0399c-cae6-41ac-a25e-667c5981f08a	56136-323	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Lavnder Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-324_d865452e-249d-4a7c-99b9-edffeeffaabb	56136-324	HUMAN OTC DRUG	My Beauty Spot Antibacterial Hand Sanitizer French Lavnder Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-325_fe89270d-0376-4a52-920a-44b5a5e3dbc0	56136-325	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Fresh Lemon Scented	with vitamin E and Moisturizers	Alcohol	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-326_7b26a8e0-a1c3-4083-a69d-8a5ab93827e5	56136-326	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Lemon Verbena Scented	vitamin E and Moisturizers	Alcohol	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-327_419d2272-3a6d-4102-b43d-c296aaab07c1	56136-327	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Coconut Scented		Alcohol	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-328_9e0b06b5-b278-4fd8-9400-794ddf0a0efb	56136-328	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Lavnder Scented		Alcohol	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-331_e8ecaa58-5c8f-4090-b2b4-220a0f8d999f	56136-331	HUMAN OTC DRUG	Aromatherapy Rituals Hand Wash Tea Tree and Peppermint		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/100mL			N	20241231
56136-332_7ac91732-418f-4fc9-838b-0f1365226efb	56136-332	HUMAN OTC DRUG	Aromatherapy Rituals Hand Wash Tea Tree and Citrus		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/100mL			N	20241231
56136-333_ebf038cb-45ea-45a9-80e4-1640b9000513	56136-333	HUMAN OTC DRUG	Aromatherapy Rituals Hand Wash Tea Tree and Lavender		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/100mL			N	20241231
56136-334_573db45c-25df-4ded-84e5-c0af6da5b1e4	56136-334	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Original UnScented		Alcohol	GEL	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-335_c401c907-52ab-4a32-99bd-004f094d02d8	56136-335	HUMAN OTC DRUG	Hand Sanitizer Juicy Orange Scented		Alcohol	GEL	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-336_d3d686cd-2700-4552-a2e0-606058d5aa2f	56136-336	HUMAN OTC DRUG	Hand Sanitizer Blue Berries Scented		Alcohol	GEL	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-337_85d6ca3b-5201-42c2-8c75-9475bbb30306	56136-337	HUMAN OTC DRUG	Hand Sanitizer Straw Berry Scented		Alcohol	GEL	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-338_81371666-218b-418d-addd-db9dd626e458	56136-338	HUMAN OTC DRUG	Hand Sanitizer Water Melon Scented		Alcohol	GEL	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-339_cfd8f87a-3d0a-4ca6-967b-3aeb40493266	56136-339	HUMAN OTC DRUG	Hand Sanitizer Fresh Kiwi Scented		Alcohol	GEL	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-340_70f1076f-86e7-47c6-a19f-02004a69ddfd	56136-340	HUMAN OTC DRUG	Hand Sanitizer Rasp Berry Scented		Alcohol	GEL	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-341_d3bcda56-6d22-438f-9837-dea27d4fbc09	56136-341	HUMAN OTC DRUG	Sweet Shimmer Hand Sanitizer Toasted Vanilla		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-342_8e4cd406-6356-47f3-b7f0-412d333d472c	56136-342	HUMAN OTC DRUG	Whipped Vanilla Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-343_a363ed37-774b-4f2e-b9a9-393a2c6277fd	56136-343	HUMAN OTC DRUG	Merry Berry Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-344_0f05fab6-e0ca-4a78-9068-1ef02fa560a3	56136-344	HUMAN OTC DRUG	Berry Tart Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-345_1e4ecff5-6c39-46b7-a895-4d5e46e837e3	56136-345	HUMAN OTC DRUG	Sugar Cookie Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-346_29dd30a7-668f-4df9-a2e4-8ed77adde508	56136-346	HUMAN OTC DRUG	Frosted Cranberry Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-347_2cc37fe4-b0b8-4105-b0e6-7f4abbb75f85	56136-347	HUMAN OTC DRUG	White Citrus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-348_8808644d-5d75-4479-9676-1752483c5409	56136-348	HUMAN OTC DRUG	groovi beauty Rainbow Sprinkles Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-349_a9671a7a-3360-4986-9a2c-f391520731f5	56136-349	HUMAN OTC DRUG	groovi beauty Bubbly Bellini Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-350_fbfa2534-37df-4fd9-871f-6315c85ae4a3	56136-350	HUMAN OTC DRUG	groovi beauty Fresh Baked Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-351_2d90ff61-64c3-4bd9-ac62-cffce009d8b9	56136-351	HUMAN OTC DRUG	groovi beauty Toasted Vanilla Hand Sanitizer		Alcohol	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	66	mL/100mL			N	20241231
56136-352_9c38816f-5d00-4733-ae5e-c5000a0b4799	56136-352	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Dragon Fruit Scented		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-353_c2600410-7b68-4334-85dc-513d4ca97b68	56136-353	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Strawberry Scented		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-354_23f62f11-3ad0-4a4d-8b2f-7ba721feef2e	56136-354	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Sweet Berries Scented		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-355_5830a21a-1543-4e78-8840-d5655d9c5b4b	56136-355	HUMAN OTC DRUG	Vanilla cupcake Frosting Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-356_4efde724-7502-4508-b3c9-bdff89830130	56136-356	HUMAN OTC DRUG	Fluffy MarshMallow Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-357_f03807ec-121b-450c-9e84-40628517dbe2	56136-357	HUMAN OTC DRUG	Gingersbread House Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-358_5e900563-2079-467a-8a1b-31e6634ce53b	56136-358	HUMAN OTC DRUG	Candy Coated Apple Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-359_ecc83787-40bd-4547-8881-cef9ac8e8ed8	56136-359	HUMAN OTC DRUG	Ice Cream Cone Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-360_91b17e2f-1fc6-4abb-bfcd-18c45522127a	56136-360	HUMAN OTC DRUG	Vanilla Sugar Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-361_30c8163e-6ee7-4abb-89e2-1b389cd9f6f8	56136-361	HUMAN OTC DRUG	Gumball Madness Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-362_87765e12-2c6b-4ca1-a7a5-9f3cd6be1b69	56136-362	HUMAN OTC DRUG	Kiwi Burst Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-363_acabc1ae-8f69-4d5e-8274-112a8e831bc3	56136-363	HUMAN OTC DRUG	Berry Blast Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-364_70cee040-8459-415c-9f5e-f64e66e038dc	56136-364	HUMAN OTC DRUG	Apple Splash Anti-Bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-365_fb13d06f-cf81-44d2-846d-fd385c12d236	56136-365	HUMAN OTC DRUG	Vanilla Sugar Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-366_a9e36ad3-c68c-426c-8851-ea1216a1fc25	56136-366	HUMAN OTC DRUG	Sweet Coconut Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-367_5005f4bd-07f6-4c3c-a176-135a5ab0821e	56136-367	HUMAN OTC DRUG	Jelly Candy Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-370_9d1ce2b0-ebf7-44fe-9b67-0769ca0fb151	56136-370	HUMAN OTC DRUG	scented antibacterial hand sanitizer		Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-371_1ab0fa86-fd0e-41f7-8f23-5cd7d3597886	56136-371	HUMAN OTC DRUG	dailycare Antibacterial hand sanitizr unscented		Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-372_7a125d8e-3768-468d-91c4-19301ddb53c1	56136-372	HUMAN OTC DRUG	Dailycare hand sanitizer Ocean Breeze Scented		Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-373_fade43ec-65b2-4131-b660-ad45cde88000	56136-373	HUMAN OTC DRUG	Daily essentials antibacterial hand sanitizer Aloe Vera Scented		Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-374_49090f4a-2d49-4c2c-b680-675fe981afc7	56136-374	HUMAN OTC DRUG	Daily essentials antibacterial hand sanitizer Lavender Scented		Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-375_ff242339-606e-4c46-86bb-32b196008a70	56136-375	HUMAN OTC DRUG	Antibacterial Refreshing Hand Wash Coconut Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-376_82d2f6a6-a4f0-4b9d-941f-98401d6a0d0a	56136-376	HUMAN OTC DRUG	Antibacterial Refreshing Hand Wash Lemon Lime Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-377_36e910f3-d1c2-46dc-af9b-5a21fc55b89e	56136-377	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Cherry Blossom Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-378_d256ea78-e672-45fb-b92e-b27e0cd6d6f6	56136-378	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Coconut Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-379_6e82bf25-536f-4f75-9418-046fb180bbf8	56136-379	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Lemongrass Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-380_991c3400-cbe4-44fd-a622-da6538fcd411	56136-380	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Peppermint Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-381_ff4e5195-45d7-4aa3-9317-6532655e642b	56136-381	HUMAN OTC DRUG	MY BEAUTY SPOT Antibacterial Hand Wash Coconut Scented	Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-382_8c6a8a9d-539f-410a-b50b-9567e80c1102	56136-382	HUMAN OTC DRUG	MY BEAUTY SPOT Antibacterial Hand Wash Lavender Scented	Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-383_0d146896-70ab-4b71-80be-0068c254ccd8	56136-383	HUMAN OTC DRUG	MY BEAUTY SPOT Antibacterial Hand Wash Lemongrass Scented	Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-384_a27ca4e9-a9bb-4322-9029-5dc9f5aba5d0	56136-384	HUMAN OTC DRUG	MY BEAUTY SPOT Antibacterial Hand Wash Peppermint Scented	Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-385_cf0d7f38-b168-41a3-97d1-100c0f0a0e07	56136-385	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Cherry Blossom scented	With Vitamin E and Aloe Vera	Alcohol	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-386_68fb6357-5ad7-44ff-b9da-fcf4f53c612f	56136-386	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Vanilla Almond scented	With Vitamin E and Aloe Vera	Alcohol	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-387_a7f84438-b254-4c82-810f-503c8bc4b1fb	56136-387	HUMAN OTC DRUG	Antibacterial Hand Sanitizer Hawaiian Coconut Scented	With Vitamin E and Aloe Vera	Alcohol	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-388_9948012a-aba7-4d28-bf29-48e2b5e8c534	56136-388	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Wash Lemon Verbena Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-389_aed4a17a-0b84-4a78-83c5-bd15f9bc52a4	56136-389	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Wash Lavender Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-390_94f389ef-3145-485b-bec4-251275c75127	56136-390	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Wash Chamomile Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-391_7c08ca76-a320-472b-953c-8d9c7c210f92	56136-391	HUMAN OTC DRUG	Antibacterial Hand Wash Lavender Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-392_dce9fc07-afc2-4b97-92b4-6a4b60d204db	56136-392	HUMAN OTC DRUG	Antibacterial Hand Wash Sage Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-393_4813d271-485e-4288-b7de-66768419e68a	56136-393	HUMAN OTC DRUG	Antibacterial Hand Wash Cotton Blossom Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-394_43191c65-5e8d-491b-b9bf-f31f95ee8d36	56136-394	HUMAN OTC DRUG	Antibacterial Hand Wash Fresh Citrus Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-395_ba72d0c4-30cf-4914-98e6-daee9bdc8393	56136-395	HUMAN OTC DRUG	Antibacterial Hand Wash Cool Coconut Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-396_fdb31993-546f-47a7-9ed4-5a0564162c14	56136-396	HUMAN OTC DRUG	Antibacterial Hand Wash Peach Splash Scented		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-397_0e2a6d5d-5b6a-4d71-bd6d-5540e282a7dc	56136-397	HUMAN OTC DRUG	Laura Ashley Antibacterial Hand Sanitizer Aloe Vera Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-398_91db9639-3c5f-4e93-95ca-f95ced530a46	56136-398	HUMAN OTC DRUG	Laura Ashley Antibacterial Hand Sanitizer Pink Peony Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-399_e3604c7d-45c1-4018-9587-6704dc712819	56136-399	HUMAN OTC DRUG	Laura Ashley Antibacterial Hand Sanitizer Cotton Blossom Scented	with vitamin E and aloe vera	Alcohol	GEL	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-401_c987446f-85f6-4181-ab26-d5c6115349d6	56136-401	HUMAN OTC DRUG	HAND SANITIZER	aloe and vitamin E	Alcohol	SPRAY	TOPICAL	20200930		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-411_e91b6faa-0e9d-4f14-ab96-f6e0735a2e69	56136-411	HUMAN OTC DRUG	Aromatherapy Hand Sanitizer chamomile and lavender		Alcohol	GEL	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-412_ce925627-b65b-4c61-a7a6-76f38ea760a1	56136-412	HUMAN OTC DRUG	Aromatherapy Hand Sanitizer Charcoal and Caffeine		Alcohol	GEL	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-413_5e94c322-b0b3-47f2-99c0-617f7b3964b6	56136-413	HUMAN OTC DRUG	Aromatherapy Hand Sanitizer eucalyptus and spearmint		Alcohol	GEL	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-414_371294af-171c-4959-b7a3-7fff68dbd802	56136-414	HUMAN OTC DRUG	Aromatherapy Hand Sanitizer Red Poppy and Hemp		Alcohol	GEL	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-416_974174bf-901f-4439-a81c-e22a2832a4d7	56136-416	HUMAN OTC DRUG	Aromatherapy Hand Sanitizer English Rose and Hemp		Alcohol	GEL	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-417_198fed16-5ae3-4564-ad3c-8960ddad70a9	56136-417	HUMAN OTC DRUG	Aromatherapy Hand Sanitizer Lavender and Chamomile		Alcohol	GEL	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-418_c77a0e8f-964b-46ba-aeb4-28525c38d257	56136-418	HUMAN OTC DRUG	Aromatherapy Hand Sanitizer Lemongrass and Sweet Orange		Alcohol	GEL	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-419_7ff85340-9249-42d2-bbe8-22579b5c6993	56136-419	HUMAN OTC DRUG	Dailycare Antibacterial Hand Sanitizer Original Unscented		Alcohol	GEL	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-421_cd85c142-bd11-4eb0-ba11-6793798fdbfe	56136-421	HUMAN OTC DRUG	You Are My Sunshine Antibacterial Hand Sanitizer Blueberry scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-422_f5d443b3-8acf-47fd-8929-4c79b0ea823c	56136-422	HUMAN OTC DRUG	You Are My Sunshine Antibacterial Hand Sanitizer Cotton Candy scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-423_5273629d-46e0-4a74-9203-83c8c55bdb94	56136-423	HUMAN OTC DRUG	You Are My Sunshine Antibacterial Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-424_eda463b3-50fa-4805-a8c8-9d3f5a141e3c	56136-424	HUMAN OTC DRUG	You Are My Sunshine Antibacterial Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-425_0b307b0c-46c3-4383-95c5-7ae798d101ae	56136-425	HUMAN OTC DRUG	You Are A Magical Unicorn Antibacterial Hand Sanitizer Berry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-426_4b3b81b2-120e-4e42-91a8-55bd5c3d63b0	56136-426	HUMAN OTC DRUG	You Are A Magical Unicorn Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-427_4cdc0601-4139-47c9-b103-f327f174ec84	56136-427	HUMAN OTC DRUG	You Are A Magical Unicorn Antibacterial Hand Sanitizer Strawberry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-428_3ece512a-bd12-4558-b1f1-bd2000c1ef9a	56136-428	HUMAN OTC DRUG	You Are A Magical Unicorn Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-429_74aa5a39-6ed8-424a-b7c6-a7443508e5f7	56136-429	HUMAN OTC DRUG	You Are A Magical Unicorn Antibacterial Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-431_6d1cdca1-5bf8-4dec-a204-11e0ac579547	56136-431	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Mixed Berries Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-432_204aa747-84e0-471d-b237-e88380983a78	56136-432	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Strawberry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-433_9bc40c20-6035-4a43-8491-e20aa10a5209	56136-433	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Mixed Berries Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-434_23bc285c-f22b-480b-9d1c-5a0a6daf85d4	56136-434	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Strawberry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-435_a2e8d576-fbf8-4437-ac35-2ead0c165e24	56136-435	HUMAN OTC DRUG	Anti-Bac Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-436_7a273746-8d9c-4a84-9149-c613e59d4b97	56136-436	HUMAN OTC DRUG	Keep Your Hands Clean Antibacterial Hand Sanitizer Berry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-437_4ed03f66-3c0d-4a79-8ce1-f3ce3e142191	56136-437	HUMAN OTC DRUG	Keep Your Hands Clean Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-438_7668dd51-db52-4b0b-9e66-8473ea9ea714	56136-438	HUMAN OTC DRUG	Keep Your Hands Clean Antibacterial Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-439_221ebbc7-94ab-4e1b-b6d5-dd5dd000c73f	56136-439	HUMAN OTC DRUG	Keep Your Hands Clean Antibacterial Hand Sanitizer Berry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-440_db76cde5-483f-4010-9196-e3c3de1eb346	56136-440	HUMAN OTC DRUG	Keep Your Hands Clean Antibacterial Hand Sanitizer Strawberry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-441_728a1163-b4cc-4269-a176-43ceeec278f4	56136-441	HUMAN OTC DRUG	Keep Your Hands Clean Antibacterial Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-451_c16a3460-99a5-4be9-98f9-c0237dc5cf58	56136-451	HUMAN OTC DRUG	Girls Rule The World Antibacterial Hand Sanitizer Berry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-452_b6150154-a60b-41c3-8e27-2e428d21924e	56136-452	HUMAN OTC DRUG	Girls Rule The World Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-453_ef29a14a-d6c4-4404-85c6-723a4d466e11	56136-453	HUMAN OTC DRUG	Girls Rule The World Antibacterial Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-454_137206cd-b1e2-4c7d-8309-3cd4bda3732d	56136-454	HUMAN OTC DRUG	Girls Rule The World Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-455_2819edf6-60fb-4577-aa7a-48f1634c1948	56136-455	HUMAN OTC DRUG	Girls Rule The World Antibacterial Hand Sanitizer Berry Scented		Alcohol	GEL	TOPICAL	20201018		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-460_3210e3c8-83c0-42c9-a3f5-f517b6388027	56136-460	HUMAN OTC DRUG	Spatherapy Hand Sanitizer With Aloe Vera		Alcohol	GEL	TOPICAL	20201020		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-462_9aa1539c-aed5-457d-b27f-562b418245d7	56136-462	HUMAN OTC DRUG	RBX Hand Sanitizer Lemon Scented	Alloe Vera and Vitamin E	Alcohol	GEL	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-463_e1a2579c-c3d2-4d5a-8e66-4b4a64deb58e	56136-463	HUMAN OTC DRUG	RBX Hand Sanitizer Ocean Scented	Alloe Vera and Vitamin E	Alcohol	GEL	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-464_8100321d-d171-45dd-afa5-c3aea47a699f	56136-464	HUMAN OTC DRUG	RBX Hand Sanitizer Unscented	Alloe Vera and Vitamin E	Alcohol	GEL	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-471_63485884-5b6e-4b84-a6d1-724148b58382	56136-471	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Wash Lavender Scented	With Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201112		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-472_167cbd28-088c-4ff8-9252-1c9f742e7fcc	56136-472	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Wash Lemongrass Scented	With Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20201112		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-473_a3a96e0e-2d9d-41e2-bb53-1c89fd4f44f8	56136-473	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Wash Coconut Scented	With Vitamin E and Aloe Vera	BENZALKONIUM CHLORIDE	GEL	TOPICAL	20201112		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-474_7ef01de8-e0c8-416a-ac55-8ce8b2b47b04	56136-474	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Lavender Scented	with Vitamin E and Aloe Vera	Alcohol	GEL	TOPICAL	20201112		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-475_5ee2a098-508d-4901-b00b-ab394f12c47c	56136-475	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Lemongrass Scented	With Vitamin E and Aloe Vera	Alcohol	GEL	TOPICAL	20201112		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-476_b7695a35-e771-4ece-8ad7-ee457b578e04	56136-476	HUMAN OTC DRUG	Aromatherapy Antibacterial Hand Sanitizer Coconut Scented	With Vitamin E and Aloe Vera	Alcohol	GEL	TOPICAL	20201112		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-481_2367562c-03d3-4a14-8736-222ae55cda30	56136-481	HUMAN OTC DRUG	Ben Sherman Antibacterial Hand Wash Charcoal Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-482_9f33ddd4-b095-4499-95fb-6e656d65f6a2	56136-482	HUMAN OTC DRUG	Ben Sherman Antibacterial Hand Wash Reserve Blend Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-483_9b280251-03c6-4e23-81db-de9ec1fd3a26	56136-483	HUMAN OTC DRUG	Ben Sherman Antibacterial Hand Wash Sandalwood Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-484_1e9ea701-4e40-4a31-b1d0-f48d02f093a4	56136-484	HUMAN OTC DRUG	Ben Sherman Antibacterial Hand Wash Suede Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-485_75b506e1-798b-4b97-8d15-07105ee4ba27	56136-485	HUMAN OTC DRUG	Ben Sherman Antibacterial Hand Sanitizer Sandalwood Scented		ALCOHOL	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-486_4a017f67-1aba-47f9-84cb-23bf3c0973a8	56136-486	HUMAN OTC DRUG	Ben Sherman Antibacterial Hand Sanitizer Suede Scented		ALCOHOL	LIQUID	TOPICAL	20201115		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-487_f27e29e0-c739-494c-be73-a84c4f317c63	56136-487	HUMAN OTC DRUG	Ben Sherman Antibacterial Hand Sanitizer Unscented		ALCOHOL	LIQUID	TOPICAL	20201115		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-491_cbd04de5-af20-4e73-be97-4fb262038a34	56136-491	HUMAN OTC DRUG	Body Glove For Men Antibacterial Hand Wash Charcoal and Bamboo Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-492_2d7f3f9a-171c-4d95-bc28-d0412fa903f3	56136-492	HUMAN OTC DRUG	Body Glove For Men Antibacterial Hand Wash Hemp and Lemongrass Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-493_77851e3e-75ab-430a-b20d-8fc99ef28840	56136-493	HUMAN OTC DRUG	Body Glove For Men Antibacterial Hand Wash Sea and Surf Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-494_3741524a-f838-4279-899b-5344ec32d53b	56136-494	HUMAN OTC DRUG	Body Glove For Men Antibacterial Hand Wash Tea Tree and Vitamin E Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-496_a59560f3-5bef-4b98-8dd1-92f22f8b009f	56136-496	HUMAN OTC DRUG	Body Glove For Men Antibacterial Hand Sanitizer Charcoal and Bamboo Scented		ALCOHOL	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-497_71436244-e4bb-4ec2-86d9-057bb8dcdc00	56136-497	HUMAN OTC DRUG	Body Glove For Men Antibacterial Hand Sanitizer Tea Tree and Vitamin E Scented		ALCOHOL	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-498_8b80f590-639b-44df-a181-ec4910bd4ec7	56136-498	HUMAN OTC DRUG	Body Glove For Men Antibacterial Hand Sanitizer Unscented		ALCOHOL	LIQUID	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-501_6bc75066-20b3-4ece-826e-9ee007402d55	56136-501	HUMAN OTC DRUG	RBX For Men Antibacterial Hand Wash Aloe Vera and Tea Tree Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201115		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-502_0a26136d-e76d-4788-ae50-124c3edc74f8	56136-502	HUMAN OTC DRUG	RBX For Men Antibacterial Hand Wash Cedarwood Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-503_b088f3a8-4ef9-442c-b938-ff1ce0b02dd5	56136-503	HUMAN OTC DRUG	RBX For Men Antibacterial Hand Wash Eucalyptus Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-505_bcf6c87e-4a40-461d-a62a-43c82e7c67e1	56136-505	HUMAN OTC DRUG	RBX For Men Antibacterial Hand Sanitizer Cedarwood Scented		ALCOHOL	LIQUID	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-506_e58eea50-0604-4fb4-a0a4-96dfaeb7af74	56136-506	HUMAN OTC DRUG	RBX For Men Antibacterial Hand Sanitizer Unscented		ALCOHOL	LIQUID	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-511_5f4f878c-bf5c-4edd-bead-9b5b8446b14b	56136-511	HUMAN OTC DRUG	You Are My Sunshine Antibacterial Hand Sanitizer Watermelon Scented		Alcohol	GEL	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-512_39a10ee6-3c68-4d03-ac9a-1e6ae4f84c5f	56136-512	HUMAN OTC DRUG	Girls Rule The World Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-513_4a55b0cb-4608-44ce-ab4e-f21bf187680f	56136-513	HUMAN OTC DRUG	You Are My Sunshine Antibacterial Hand Wash Watermelon Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-514_f7286ff2-4fbb-4928-8ed2-4ad4b30fa322	56136-514	HUMAN OTC DRUG	Anti-Bac Hand Wash Strawberry Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-515_7f542509-68cc-4654-986d-c0a6f3f86a80	56136-515	HUMAN OTC DRUG	Keep Your Hands Clean Antibacterial Hand Wash Strawberry Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-516_2269c2bc-5be1-4bd1-9c0a-c9784e1f5d38	56136-516	HUMAN OTC DRUG	Girls Rule The World Antibacterial Hand Wash Berry Scented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.5	mg/mL			N	20241231
56136-518_317eea61-c768-4d78-9c36-7ac44712e9bc	56136-518	HUMAN OTC DRUG	You Are My Sunshine Antibacterial Hand Sanitizer Cotton Candy Scented		Alcohol	GEL	TOPICAL	20201128		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	65	mL/100mL			N	20241231
56136-520_5c1c316c-35c3-43aa-a752-3393fa6575c3	56136-520	HUMAN OTC DRUG	RBX For Men Antibacterial Hand Sanitizer Aloe Vera and Tea Tree Scented		ALCOHOL	LIQUID	TOPICAL	20210106		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56136-601_e5132ae6-31b7-462a-bb1e-d31bffe0d472	56136-601	HUMAN OTC DRUG	Vanilla Sugar Cupcake Hand Sanitizer		Alcohol	GEL	TOPICAL	20210714		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-602_922975ce-dedc-4a55-afb5-46313341eca3	56136-602	HUMAN OTC DRUG	Mocha latte scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20210714		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-603_ad963de3-1cc6-4684-9c88-ae4723461ba8	56136-603	HUMAN OTC DRUG	Pina Colada Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20210714		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-604_0bf35104-2989-4b90-9f96-5208148290e0	56136-604	HUMAN OTC DRUG	Berry Punch Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20210714		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-605_069c8f1b-267c-4f72-ac5a-521f4efba6be	56136-605	HUMAN OTC DRUG	Vanilla Ice Cream Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20210714		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-606_d41e2008-6b20-4872-ac07-86fad8ed1cdf	56136-606	HUMAN OTC DRUG	Salted Pecan Caramels Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20210714		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-611_651fcef5-03f6-42a8-b0f9-800d60da6980	56136-611	HUMAN OTC DRUG	Vanilla Sugar Scented Anti-Bacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20210720		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-612_678329d1-09ef-44da-aabe-7be3c0cf0e1e	56136-612	HUMAN OTC DRUG	Gingerbread House Scented Anti-Bacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20210720		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-613_3fcd0a68-1b7c-4833-a437-5240499f89ac	56136-613	HUMAN OTC DRUG	Peppermint Cream Scented Anti-Bacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20210720		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-614_19bd3812-0824-4f30-a9bd-0118fa46057b	56136-614	HUMAN OTC DRUG	Candy Coated Apple Scented Anti-Bacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20210720		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-620_6fd5738e-58ea-42c6-8295-e3806aaae007	56136-620	HUMAN OTC DRUG	Peppermint Fruit anti-bacterial Scented Hand Sanitizer		Alcohol	GEL	TOPICAL	20220617		OTC MONOGRAPH NOT FINAL	part333E	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
56136-645_0b57cdc0-3b52-26fd-e063-6394a90ad4fa	56136-645	HUMAN OTC DRUG	Meijer Wet wipes antibacterial hand wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	Ganzhou Olivee Cosmetic Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
56136-730_cbcc8c81-aacb-43b2-8800-e5f2f5df0a67	56136-730	HUMAN OTC DRUG	Brompton and Langley Moisturizing Hand Sanitizer Lavnder Vanilla		Alcohol	GEL	TOPICAL	20231016		OTC MONOGRAPH DRUG	M003	Ganzhou Olivee Cosmetic Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
56152-0100_08196eff-dcc4-63f5-e063-6294a90af435	56152-0100	HUMAN OTC DRUG	Impeccable Skin Moisturizing Face Sunscreen Broad Spectrum SPF 30		Zinc Oxide	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M020	Cosmetic Enterprises LTD	ZINC OXIDE	15	g/100g			N	20241231
56152-0101_08196eff-dcce-63f5-e063-6294a90af435	56152-0101	HUMAN OTC DRUG	Sunscreen Broad Spectrum SPF 30 Light Tropical Scent		Zinc Oxide	CREAM	TOPICAL	20220224		OTC MONOGRAPH DRUG	M020	Cosmetic Enterprises Ltd	ZINC OXIDE	14.57	g/100mL			N	20241231
56152-0250_039ac054-3eb3-5beb-e063-6394a90a561a	56152-0250	HUMAN OTC DRUG	30 day Acne Treatment Kit		Salicylic Acid, Benzoyl Peroxide	KIT	TOPICAL	20230823		OTC MONOGRAPH FINAL	M006	Cosmetic Enterprises Ltd						N	20241231
56152-1470_08190e98-f479-9f11-e063-6294a90a9cfd	56152-1470	HUMAN OTC DRUG	Pleasure Balm	Kama Sutra	Benzocaine	GEL	TOPICAL	20130912		OTC MONOGRAPH DRUG	M017	Cosmetic Enterprises Ltd	BENZOCAINE	5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
56152-4008_08184612-d897-f6ac-e063-6294a90a7afa	56152-4008	HUMAN OTC DRUG	SPF 50 Face Sunscreen	Bioelements	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20160104		OTC MONOGRAPH DRUG	M020	Cosmetic Enterprises Ltd	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 7; 5; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
56152-4009_08181605-ead2-ccbf-e063-6294a90aba2a	56152-4009	HUMAN OTC DRUG	Breakout Control	Bioelements	Benzoyl Peroxide	CREAM	TOPICAL	20130614		OTC MONOGRAPH DRUG	M006	Cosmetic Enterprises Ltd	BENZOYL PEROXIDE	5	g/100mL			N	20241231
56152-4012_0818e617-0c7e-fa99-e063-6294a90a8457	56152-4012	HUMAN OTC DRUG	Anti Bac Acne Clearing		Benzoyl Peroxide	LOTION	TOPICAL	20190114		OTC MONOGRAPH DRUG	M006	Cosmetic Enterprise Ltd	BENZOYL PEROXIDE	5	g/100mL			N	20241231
56152-5000_08183bd1-1ba5-9b53-e063-6394a90ad0af	56152-5000	HUMAN OTC DRUG	Clear Acne Body	Paulas Choice	Salicylic Acid	SPRAY	TOPICAL	20160809		OTC MONOGRAPH DRUG	M006	Cosmetic Enterprises Ltd	SALICYLIC ACID	2	g/118mL			N	20241231
56152-5001_08187e3e-ac0d-01bc-e063-6294a90a95ad	56152-5001	HUMAN OTC DRUG	Skin Balancing Ultra Sheer Daily Defence SPF 30	Paulas Choice	Avobenzone, Homosalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20160812		OTC MONOGRAPH DRUG	M020	Cosmetic Enterprises Ltd	AVOBENZONE; HOMOSALATE; OCTOCRYLENE; OXYBENZONE	3; 7; 2; 4	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
56152-5002_081854a2-5c11-4a6a-e063-6394a90a6e81	56152-5002	HUMAN OTC DRUG	Clear Exfoliating Solution	Paulas Choice	Salicylic Acid	CREAM	TOPICAL	20160809		OTC MONOGRAPH DRUG	M006	Cosmetic Enterprises Ltd	SALICYLIC ACID	2	g/100mL			N	20241231
56152-5003_081873e7-cfa3-c168-e063-6394a90a7dd5	56152-5003	HUMAN OTC DRUG	Resist Wrinkle Defense SPF 30	Paulas Choice	Zinc Oxide	CREAM	TOPICAL	20160810		OTC MONOGRAPH DRUG	M020	Cosmetic Enterprises Ltd	ZINC OXIDE	13	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
56152-5004_08187e3e-ac17-01bc-e063-6294a90a95ad	56152-5004	HUMAN OTC DRUG	Active Radiance Day Moisture SPF 30		Avobenzone, Octinoxate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20170301		OTC MONOGRAPH DRUG	M020	COSMETIC ENTERPRISES LTD	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 5; 5; 2.4; 5	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
56152-5010_0818c37b-d0d6-f836-e063-6294a90ae1c3	56152-5010	HUMAN OTC DRUG	NexGen Sunscreen Broad Spectrum SPF 36	Doc Martins	Octinoxate, Oxybenzone, Octocrylene, Avobenzone	CREAM	TOPICAL	20170321		OTC MONOGRAPH DRUG	M020	Cosmetic Enterprises Ltd.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	3; 7; 4; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
56152-5012_0819874a-b25d-0ffc-e063-6394a90ae4d2	56152-5012	HUMAN OTC DRUG	Purifying Clay Mask		Salicylic Acid	CREAM	TOPICAL	20180705		OTC MONOGRAPH DRUG	M006	Cosmetic Enterprises Ltd	SALICYLIC ACID	.5	g/100mL			N	20241231
56153-001_0882cdf9-4ea8-b9a8-e063-6394a90aa9b6	56153-001	HUMAN OTC DRUG	Colgate Anticavity Kit		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20130510		OTC MONOGRAPH DRUG	M021	Ming Fai Industrial (Shenzhen) Co. Ltd	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
56153-002_0882dc65-a430-daec-e063-6394a90a10ff	56153-002	HUMAN OTC DRUG	Colgate Anticavity Kit		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20130510		OTC MONOGRAPH DRUG	M021	Ming Fai Industrial (Shenzhen) Co. Ltd	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
56194-500_f1eb10de-7b12-cac4-e053-2995a90a6d8e	56194-500	HUMAN OTC DRUG	Witch Hazel		Medicated Hemorrhoidal Wipes	CLOTH	TOPICAL	20211007		OTC MONOGRAPH FINAL	part346	Giant Eagle	WITCH HAZEL	50	g/1001			N	20241231
56194-502_e873d569-5ea0-9f6c-e053-2a95a90ac3ce	56194-502	HUMAN OTC DRUG	Giant Eagle		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part333E	GIANT EAGLE	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
56194-503_f2e07fe9-9230-0a9c-e053-2995a90a785a	56194-503	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part333A	Giant Eagle	ALCOHOL	65	mL/100mL			N	20241231
56194-550_eea128ce-1dee-42fb-e053-2a95a90aef73	56194-550	HUMAN OTC DRUG	Witch Hazel		Medicated Hemorrhoidal Wipes	CLOTH	TOPICAL	20211007		OTC MONOGRAPH FINAL	part346	Giant Eagle	WITCH HAZEL	50	g/1001			N	20241231
56194-575_eea2edc5-e6d4-78fd-e053-2a95a90ab7fc	56194-575	HUMAN OTC DRUG	Giant Eagle Antibacterial Hand Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20220622		OTC MONOGRAPH NOT FINAL	part333A	Giant Eagle	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
57237-001_263d7933-2aa7-4fb5-9d69-cbda98b8c0eb	57237-001	HUMAN PRESCRIPTION DRUG	Lansoprazole, Amoxicillin, Clarithromycin		Lansoprazole, Amoxicillin, Clarithromycin	KIT		20161014		ANDA	ANDA206006	Rising Pharma Holdings, Inc.						N	20241231
57237-002_22c1a427-9e01-4d27-840b-b008f656039d	57237-002	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20070919		ANDA	ANDA078164	Rising Health, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
57237-003_34a8feda-b045-4c18-97e4-ab50c7f398e2	57237-003	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Rising Pharma Holdings, Inc.	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
57237-004_34a8feda-b045-4c18-97e4-ab50c7f398e2	57237-004	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Rising Pharma Holdings, Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
57237-005_34a8feda-b045-4c18-97e4-ab50c7f398e2	57237-005	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Rising Pharma Holdings, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
57237-006_34a8feda-b045-4c18-97e4-ab50c7f398e2	57237-006	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Rising Pharma Holdings, Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
57237-007_b241e47c-68cf-4753-b5ad-b3bcc0381280	57237-007	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Rising Health, LLC	MIRTAZAPINE	7.5	mg/1			N	20241231
57237-008_b241e47c-68cf-4753-b5ad-b3bcc0381280	57237-008	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Rising Health, LLC	MIRTAZAPINE	15	mg/1			N	20241231
57237-009_b241e47c-68cf-4753-b5ad-b3bcc0381280	57237-009	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Rising Health, LLC	MIRTAZAPINE	30	mg/1			N	20241231
57237-010_b241e47c-68cf-4753-b5ad-b3bcc0381280	57237-010	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Rising Health, LLC	MIRTAZAPINE	45	mg/1			N	20241231
57237-011_be37fd85-02db-4998-b1a1-1e6149b64b39	57237-011	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20051208		ANDA	ANDA077376	Rising Health, LLC	MIRTAZAPINE	15	mg/1			N	20241231
57237-012_be37fd85-02db-4998-b1a1-1e6149b64b39	57237-012	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20051208		ANDA	ANDA077376	Rising Health, LLC	MIRTAZAPINE	30	mg/1			N	20241231
57237-013_be37fd85-02db-4998-b1a1-1e6149b64b39	57237-013	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20060228		ANDA	ANDA077376	Rising Health, LLC	MIRTAZAPINE	45	mg/1			N	20241231
57237-014_f273697f-874b-457d-8165-8847ee121ba0	57237-014	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Rising Pharma Holdings, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
57237-017_8ff91c21-8ce4-429c-a808-5693fa0ad63a	57237-017	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Rising Pharma Holdings, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-018_8ff91c21-8ce4-429c-a808-5693fa0ad63a	57237-018	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Rising Pharma Holdings, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-019_8ff91c21-8ce4-429c-a808-5693fa0ad63a	57237-019	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Rising Pharma Holdings, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-023_a2d61d45-9096-4bd2-896c-19c3d1d58e51	57237-023	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	Rising Health, LLC	GLYBURIDE; METFORMIN HYDROCHLORIDE	1.25; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
57237-024_a2d61d45-9096-4bd2-896c-19c3d1d58e51	57237-024	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	Rising Health, LLC	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
57237-025_a2d61d45-9096-4bd2-896c-19c3d1d58e51	57237-025	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	Rising Health, LLC	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
57237-026_575c1e7b-80be-4520-ad70-3f2444c47e55	57237-026	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium and Hydrochlorothiazide		Fosinopril Sodium and Hydrochlorothiazide	TABLET	ORAL	20090709		ANDA	ANDA079245	Rising Health, LLC	FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
57237-027_575c1e7b-80be-4520-ad70-3f2444c47e55	57237-027	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium and Hydrochlorothiazide		Fosinopril Sodium and Hydrochlorothiazide	TABLET	ORAL	20090709		ANDA	ANDA079245	Rising Health, LLC	FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
57237-028_bb57a4a5-90fa-452e-95a0-b49f3cd753b8	57237-028	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	Rising Pharma Holdings, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
57237-029_bb57a4a5-90fa-452e-95a0-b49f3cd753b8	57237-029	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	Rising Pharma Holdings, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
57237-030_57892f5d-741f-4b9c-a8d0-c076275c244d	57237-030	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Rising Pharma Holdings, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
57237-031_57892f5d-741f-4b9c-a8d0-c076275c244d	57237-031	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Rising Pharma Holdings, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
57237-032_c63ccb26-1533-44b2-b46f-eca8ac36a67f	57237-032	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	Rising Pharma Holdings, Inc.	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
57237-033_c63ccb26-1533-44b2-b46f-eca8ac36a67f	57237-033	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	Rising Pharma Holdings, Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
57237-034_2c52810a-d567-4165-a67f-0f89654d37f6	57237-034	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130		ANDA	ANDA065381	Rising Health, LLC	CEFPROZIL	125	mg/5mL			N	20241231
57237-035_2c52810a-d567-4165-a67f-0f89654d37f6	57237-035	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130		ANDA	ANDA065381	Rising Health, LLC	CEFPROZIL	250	mg/5mL			N	20241231
57237-036_b192fc39-cb49-48a2-b84d-f6ab97b022b3	57237-036	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA065340	Rising Health, LLC	CEFPROZIL	250	mg/1			N	20241231
57237-037_b192fc39-cb49-48a2-b84d-f6ab97b022b3	57237-037	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA065340	Rising Health, LLC	CEFPROZIL	500	mg/1			N	20241231
57237-040_2334dad4-7145-499c-959b-bdd69a400ffb	57237-040	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Rising Health, LLC	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
57237-041_2334dad4-7145-499c-959b-bdd69a400ffb	57237-041	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Rising Health, LLC	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
57237-042_4ec96aea-22c4-4483-8a16-f8d7d7ca7d29	57237-042	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Rising Health, LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
57237-043_4ec96aea-22c4-4483-8a16-f8d7d7ca7d29	57237-043	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Rising Health, LLC	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
57237-044_77856a0c-7c55-4fcd-b1f0-b1d734eb475c	57237-044	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	Rising Pharma Holdings, Inc.	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
57237-045_77856a0c-7c55-4fcd-b1f0-b1d734eb475c	57237-045	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	Rising Pharma Holdings, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
57237-047_6be62cdd-0c69-46dc-90f5-e659917a4bdc	57237-047	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	Rising Pharma Holdings, Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
57237-048_6be62cdd-0c69-46dc-90f5-e659917a4bdc	57237-048	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	Rising Pharma Holdings, Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
57237-049_80e8753b-304a-4f05-89af-850a65c12294	57237-049	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20110329		ANDA	ANDA090957	Rising Health, LLC	GALANTAMINE HYDROBROMIDE	4	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
57237-050_80e8753b-304a-4f05-89af-850a65c12294	57237-050	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20110329		ANDA	ANDA090957	Rising Health, LLC	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
57237-051_80e8753b-304a-4f05-89af-850a65c12294	57237-051	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20110329		ANDA	ANDA090957	Rising Health, LLC	GALANTAMINE HYDROBROMIDE	12	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
57237-058_58871799-5e17-4b86-b8cd-4866c3f9ecf7	57237-058	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET, FILM COATED	ORAL	20060329		ANDA	ANDA065308	Rising Health, LLC	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
57237-059_58871799-5e17-4b86-b8cd-4866c3f9ecf7	57237-059	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET, FILM COATED	ORAL	20060329		ANDA	ANDA065308	Rising Health, LLC	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
57237-061_62d045bb-28d3-4812-a54a-4f2fed4317a6	57237-061	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20131105		ANDA	ANDA203687	Rising Health, LLC	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
57237-062_bc17d0c5-3fa7-4eae-b3e5-2bec46d228f4	57237-062	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	Rising Health, LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
57237-063_267ea2f0-19c1-4021-b012-d517646d3b4b	57237-063	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150708		ANDA	ANDA202821	Rising Health, LLC	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
57237-064_267ea2f0-19c1-4021-b012-d517646d3b4b	57237-064	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150708		ANDA	ANDA202821	Rising Health, LLC	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
57237-065_267ea2f0-19c1-4021-b012-d517646d3b4b	57237-065	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150708		ANDA	ANDA202821	Rising Health, LLC	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
57237-075_1bca9893-dae4-4bf5-8fd0-069a63a04fba	57237-075	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Rising Pharma Holdings, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
57237-076_1bca9893-dae4-4bf5-8fd0-069a63a04fba	57237-076	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Rising Pharma Holdings, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
57237-077_ccccb1d7-654d-4de0-bb54-465bce04ccb2	57237-077	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Rising Pharma Holdings, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
57237-078_ccccb1d7-654d-4de0-bb54-465bce04ccb2	57237-078	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Rising Pharma Holdings, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
57237-085_fe9e14e3-4fde-4a95-8470-f8b952931be6	57237-085	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203062	Rising Health, LLC	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
57237-086_fe9e14e3-4fde-4a95-8470-f8b952931be6	57237-086	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203062	Rising Health, LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
57237-087_2a91da8c-3afc-463c-a49a-bbf0cec9cf2a	57237-087	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Rising Health, LLC	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
57237-088_2a91da8c-3afc-463c-a49a-bbf0cec9cf2a	57237-088	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Rising Health, LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
57237-089_d23bafb0-f78e-4ba8-aac8-76c4a003cd5c	57237-089	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070612		ANDA	ANDA078438	Rising Health, LLC	TRANDOLAPRIL	1	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
57237-090_d23bafb0-f78e-4ba8-aac8-76c4a003cd5c	57237-090	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070612		ANDA	ANDA078438	Rising Health, LLC	TRANDOLAPRIL	2	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
57237-091_d23bafb0-f78e-4ba8-aac8-76c4a003cd5c	57237-091	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070612		ANDA	ANDA078438	Rising Health, LLC	TRANDOLAPRIL	4	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
57237-096_dc557eec-44d4-4442-82eb-8366e13bb5c4	57237-096	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	Rising Health, LLC	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
57237-097_b2fb91e9-4ba3-478c-b9a4-0a49131d9918	57237-097	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20130425		ANDA	ANDA065349	Rising Health, LLC	CEFADROXIL	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
57237-098_b2fb91e9-4ba3-478c-b9a4-0a49131d9918	57237-098	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20130425		ANDA	ANDA065349	Rising Health, LLC	CEFADROXIL	500	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
57237-099_a4bc0c7e-f8b5-4a15-98dc-00709b1aa658	57237-099	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	Rising Health, LLC	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
57237-100_7ed0dc8f-3931-47b3-95aa-bc17455273f0	57237-100	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Rising Pharma Holdings, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
57237-101_7ed0dc8f-3931-47b3-95aa-bc17455273f0	57237-101	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Rising Pharma Holdings, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
57237-102_7ed0dc8f-3931-47b3-95aa-bc17455273f0	57237-102	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Rising Pharma Holdings, Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
57237-106_6be62cdd-0c69-46dc-90f5-e659917a4bdc	57237-106	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	Rising Pharma Holdings, Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
57237-108_b535c254-d780-411b-8bc2-5552efc3e028	57237-108	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	Rising Health, LLC	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-109_b535c254-d780-411b-8bc2-5552efc3e028	57237-109	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	Rising Health, LLC	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-110_b535c254-d780-411b-8bc2-5552efc3e028	57237-110	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	Rising Health, LLC	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-114_975ddd3a-2c45-492c-9800-98b2e421dbac	57237-114	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120830		ANDA	ANDA079060	Rising Pharma Holdings, Inc.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
57237-119_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-119	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-120_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-120	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-121_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-121	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-122_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-122	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-123_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-123	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-124_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-124	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-125_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-125	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-126_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-126	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-127_bab28da8-ce52-4caf-a5ef-8fa777aca739	57237-127	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Rising Health, LLC	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
57237-138_fac44006-96dc-4660-93e6-9b4b5206c78c	57237-138	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Rising Health, LLC	TORSEMIDE	5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
57237-139_fac44006-96dc-4660-93e6-9b4b5206c78c	57237-139	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Rising Health, LLC	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
57237-140_fac44006-96dc-4660-93e6-9b4b5206c78c	57237-140	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Rising Health, LLC	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
57237-141_fac44006-96dc-4660-93e6-9b4b5206c78c	57237-141	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Rising Health, LLC	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
57237-142_66f0b132-780a-401e-874f-05712097f2d7	57237-142	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Rising Health, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	2.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-143_66f0b132-780a-401e-874f-05712097f2d7	57237-143	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Rising Health, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-144_66f0b132-780a-401e-874f-05712097f2d7	57237-144	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Rising Health, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-145_66f0b132-780a-401e-874f-05712097f2d7	57237-145	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Rising Health, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-146_66f0b132-780a-401e-874f-05712097f2d7	57237-146	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Rising Health, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-147_66f0b132-780a-401e-874f-05712097f2d7	57237-147	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Rising Health, LLC	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
57237-149_5351a614-1575-42fe-8238-b00aec72485d	57237-149	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	POWDER, FOR SUSPENSION	ORAL	20090918		ANDA	ANDA079150	Rising Pharma Holdings, Inc.	FLUCONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
57237-150_5351a614-1575-42fe-8238-b00aec72485d	57237-150	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	POWDER, FOR SUSPENSION	ORAL	20090918		ANDA	ANDA079150	Rising Pharma Holdings, Inc.	FLUCONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
57237-154_ddc5eac5-d586-4790-86f3-c587b76c9e1f	57237-154	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Rising Health, LLC	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
57237-155_ddc5eac5-d586-4790-86f3-c587b76c9e1f	57237-155	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Rising Health, LLC	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
57237-156_d82191e9-7f7d-4cf9-a824-ed636996b25f	57237-156	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA202632	Rising Health, LLC	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
57237-157_6070a5ca-f58f-4638-9369-691333687b3a	57237-157	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20140122		ANDA	ANDA203820	Rising Health, LLC	REPAGLINIDE	.5	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
57237-158_6070a5ca-f58f-4638-9369-691333687b3a	57237-158	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20140122		ANDA	ANDA203820	Rising Health, LLC	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
57237-159_6070a5ca-f58f-4638-9369-691333687b3a	57237-159	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20140122		ANDA	ANDA203820	Rising Health, LLC	REPAGLINIDE	2	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
57237-160_91140e7d-133e-4ffe-8fee-7011e14d93b5	57237-160	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Rising Health, LLC	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57237-161_91140e7d-133e-4ffe-8fee-7011e14d93b5	57237-161	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Rising Health, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57237-162_91140e7d-133e-4ffe-8fee-7011e14d93b5	57237-162	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Rising Health, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57237-164_e5ef567c-556d-4df2-a369-b0e7cd1058b9	57237-164	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Rising Health, LLC	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-165_e5ef567c-556d-4df2-a369-b0e7cd1058b9	57237-165	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Rising Health, LLC	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-166_e5ef567c-556d-4df2-a369-b0e7cd1058b9	57237-166	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Rising Health, LLC	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-167_e5ef567c-556d-4df2-a369-b0e7cd1058b9	57237-167	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Rising Health, LLC	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-168_6868866c-8cda-4b35-81f0-bd7a2adbf27c	57237-168	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Rising Pharma Holdings, Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-169_6868866c-8cda-4b35-81f0-bd7a2adbf27c	57237-169	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Rising Pharma Holdings, Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-170_6868866c-8cda-4b35-81f0-bd7a2adbf27c	57237-170	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Rising Pharma Holdings, Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-171_6868866c-8cda-4b35-81f0-bd7a2adbf27c	57237-171	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Rising Pharma Holdings, Inc.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
57237-172_4da7fe70-bb28-43f2-97b6-66d130e6c72f	57237-172	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-173_4da7fe70-bb28-43f2-97b6-66d130e6c72f	57237-173	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-174_4da7fe70-bb28-43f2-97b6-66d130e6c72f	57237-174	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-175_4da7fe70-bb28-43f2-97b6-66d130e6c72f	57237-175	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-176_4da7fe70-bb28-43f2-97b6-66d130e6c72f	57237-176	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57237-180_46b7e157-d66a-4d77-895f-2e892bc310c8	57237-180	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Rising Health, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
57237-181_46b7e157-d66a-4d77-895f-2e892bc310c8	57237-181	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Rising Health, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
57237-182_46b7e157-d66a-4d77-895f-2e892bc310c8	57237-182	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Rising Health, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
57237-183_46b7e157-d66a-4d77-895f-2e892bc310c8	57237-183	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Rising Health, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
57237-184_46b7e157-d66a-4d77-895f-2e892bc310c8	57237-184	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Rising Health, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
57237-185_46b7e157-d66a-4d77-895f-2e892bc310c8	57237-185	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Rising Health, LLC	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
57237-204_ff1828e1-ee17-4b2c-a687-8390d891ce75	57237-204	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Rising Health, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
57237-205_ff1828e1-ee17-4b2c-a687-8390d891ce75	57237-205	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Rising Health, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
57237-206_ff1828e1-ee17-4b2c-a687-8390d891ce75	57237-206	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Rising Health, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
57237-212_c57471f5-705e-4b79-9a2c-d63a4fea9134	57237-212	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA202096	Rising Health, LLC	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
57237-213_c57471f5-705e-4b79-9a2c-d63a4fea9134	57237-213	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA202096	Rising Health, LLC	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
57237-217_81b3aacd-cb8d-4fd3-837e-4e80d6ac914f	57237-217	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride and Metformin Hydrochloride		Pioglitazone Hydrochloride and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20130213		ANDA	ANDA200823	Rising Health, LLC	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	500; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
57237-218_81b3aacd-cb8d-4fd3-837e-4e80d6ac914f	57237-218	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride and Metformin Hydrochloride		Pioglitazone Hydrochloride and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20130213		ANDA	ANDA200823	Rising Health, LLC	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	850; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
57237-219_604f1836-cbae-4c50-8a62-dbf250408439	57237-219	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Rising Health, LLC	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
57237-220_604f1836-cbae-4c50-8a62-dbf250408439	57237-220	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Rising Health, LLC	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
57237-221_604f1836-cbae-4c50-8a62-dbf250408439	57237-221	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Rising Health, LLC	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
57237-222_a51fdbb0-bbca-4a29-8227-fd640666344c	57237-222	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Rising Health, LLC	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
57237-223_a51fdbb0-bbca-4a29-8227-fd640666344c	57237-223	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Rising Health, LLC	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
57237-224_a51fdbb0-bbca-4a29-8227-fd640666344c	57237-224	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Rising Health, LLC	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
57237-225_a51fdbb0-bbca-4a29-8227-fd640666344c	57237-225	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Rising Health, LLC	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
57237-232_0c6cd0b3-4a26-4feb-8900-945f732b4c97	57237-232	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Rising Health, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
57237-233_0c6cd0b3-4a26-4feb-8900-945f732b4c97	57237-233	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Rising Health, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
57237-239_42f774a0-495e-4fa4-a629-0da2c204c986	57237-239	HUMAN PRESCRIPTION DRUG	ZALEPLON		ZALEPLON	CAPSULE	ORAL	20080606		ANDA	ANDA078829	Rising Health, LLC	ZALEPLON	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
57237-240_42f774a0-495e-4fa4-a629-0da2c204c986	57237-240	HUMAN PRESCRIPTION DRUG	ZALEPLON		ZALEPLON	CAPSULE	ORAL	20080606		ANDA	ANDA078829	Rising Health, LLC	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
57237-255_c57471f5-705e-4b79-9a2c-d63a4fea9134	57237-255	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA202468	Rising Health, LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
57237-266_09330886-13f8-44cc-98d2-883f3e0514b4	57237-266	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20161018		ANDA	ANDA071611	Rising Health, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
57237-274_151d0872-60a8-434b-ab57-41b9e9fde999	57237-274	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	SOLUTION	ORAL	20161121		ANDA	ANDA077695	Rising Health, LLC	LAMIVUDINE	10	mg/mL	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
57237-301_f16c77f8-50d2-4ebf-b9ab-8512ee2044d2	57237-301	HUMAN OTC DRUG	Senna Syrup		Sennosides	LIQUID	ORAL	20220927		OTC MONOGRAPH NOT FINAL	part334	Rising Health, LLC	SENNOSIDES	8.8	mg/5mL			N	20241231
57237-302_27cc0354-cbe7-4404-ad0c-7d301c75c0fa	57237-302	HUMAN OTC DRUG	Aspirin 81		Aspirin	TABLET	ORAL	20221025		OTC MONOGRAPH NOT FINAL	part343	Rising Health, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57237-304_72363f52-63b2-430a-9ca7-b467b14f329c	57237-304	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20230810		OTC MONOGRAPH NOT FINAL	part343	Rising Pharma Holdings, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
57237-305_df7eb81b-567c-4367-8231-6627c3fa93c7	57237-305	HUMAN OTC DRUG	Diphenhydramine Oral Liquid		Diphenhydramine Hydrochloride	LIQUID	ORAL	20221219		OTC MONOGRAPH FINAL	part341	Rising Health, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57237-310_8ae7fe96-353e-4597-bb10-2c237bd6430f	57237-310	HUMAN OTC DRUG	Senna Syrup		Sennosides	LIQUID	ORAL	20230523		OTC MONOGRAPH NOT FINAL	part334	Rising Health, LLC	SENNOSIDES	8.8	mg/5mL			N	20241231
57237-312_89958dcf-99cf-4c41-bc16-480e87e02eee	57237-312	HUMAN OTC DRUG	Dextromethorphan HBr. and Guaifenesin		Dextromethorphan HBr. and Guaifenesin	SOLUTION	ORAL	20230612		OTC MONOGRAPH FINAL	part341	Rising Pharma Holdings, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57237-313_89958dcf-99cf-4c41-bc16-480e87e02eee	57237-313	HUMAN OTC DRUG	Dextromethorphan HBr. and Guaifenesin		Dextromethorphan HBr. and Guaifenesin	SOLUTION	ORAL	20230612		OTC MONOGRAPH FINAL	part341	Rising Pharma Holdings, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57237-314_89c66f6b-a021-4605-9eb7-1bab14a27838	57237-314	HUMAN OTC DRUG	Milk of Magnesia		magnesium hydroxide	SUSPENSION	ORAL	20230705		OTC MONOGRAPH FINAL	part331	Rising Pharma Holdings, Inc.	MAGNESIUM HYDROXIDE	2400	mg/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57237-316_ab66959e-fe45-468f-aebd-87087d1f6738	57237-316	HUMAN OTC DRUG	Aluminum Hydroxide, Magnesium Hydroxide and Simethicone		Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone	SUSPENSION	ORAL	20230815		OTC MONOGRAPH FINAL	part331	Rising Pharma Holdings, Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	1200; 120; 1200	mg/30mL; mg/30mL; mg/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57237-320_782fbcdc-b95a-4411-b254-a7d9f19e9d9f	57237-320	HUMAN OTC DRUG	Nicotine	Mini	nicotine polacrilex	LOZENGE	ORAL	20230810		ANDA	ANDA207868	Rising Pharma Holdings, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
57237-321_782fbcdc-b95a-4411-b254-a7d9f19e9d9f	57237-321	HUMAN OTC DRUG	Nicotine	Mini	nicotine polacrilex	LOZENGE	ORAL	20230810		ANDA	ANDA207868	Rising Pharma Holdings, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
57237-322_af30fe4f-c148-4987-822f-18bbd0ef0161	57237-322	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230810		ANDA	ANDA078699	Rising Pharma Holdings, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
57237-323_9f9d4c1c-5641-4fef-a4d9-8c66d5602ee4	57237-323	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230810		ANDA	ANDA078697	Rising Pharma Holdings, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
57237-324_ab66959e-fe45-468f-aebd-87087d1f6738	57237-324	HUMAN OTC DRUG	Aluminum Hydroxide, Magnesium Hydroxide and Simethicone		Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone	SUSPENSION	ORAL	20230705		OTC MONOGRAPH FINAL	part331	Rising Pharma Holdings, Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	2400; 240; 2400	mg/30mL; mg/30mL; mg/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57237-325_95f14418-8815-4c9c-a384-fb80daae152f	57237-325	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20230824		OTC MONOGRAPH NOT FINAL	part334	Rising Pharma Holdings, Inc.	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
57237-326_3d67b8bc-8559-4539-8c33-285b5948c83b	57237-326	HUMAN OTC DRUG	Glycerin	Children	Glycerin	SUPPOSITORY	RECTAL	20230824		OTC MONOGRAPH NOT FINAL	part334	Rising Pharma Holdings, Inc.	GLYCERIN	1.2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
57237-327_b43e0a3d-ffe6-42e0-83d1-5d9c2c46a86d	57237-327	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	SUPPOSITORY	RECTAL	20230824		OTC MONOGRAPH NOT FINAL	part334	Rising Pharma Holdings, Inc.	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57237-330_033f49f6-f96a-4c44-9c80-fc5d581c3af1	57237-330	HUMAN OTC DRUG	URO-PAIN	Maximum Strength	Phenazopyridine Hydrochloride	TABLET	ORAL	20231206		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20251231
57237-331_87a9fce7-4a16-4d25-84da-ee961c430efa	57237-331	HUMAN OTC DRUG	URO-PAIN		Phenazopyridine Hydrochloride	TABLET	ORAL	20231206		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20251231
57237-332_7de0855a-1d70-49b9-85a2-d25806e13f20	57237-332	HUMAN OTC DRUG	URO-PAIN Dual Action	Antibacterial Protection	Methenamine, Sodium salicylate	TABLET	ORAL	20231206		UNAPPROVED DRUG OTHER		Rising Pharma Holdings, Inc.	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20251231
57243-001_0d3325c7-f314-42ca-a1eb-e2410d7bd934	57243-001	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20151122		OTC MONOGRAPH NOT FINAL	part333A	Salado Sales Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
57243-069_bd155acb-0888-4b95-b3c6-6db40e0662af	57243-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20030604		OTC MONOGRAPH FINAL	part347	Salado Sales, Inc	PETROLATUM	1	g/g			N	20241231
57243-120_4a9f8454-d28e-49e3-b179-5fe244770ffb	57243-120	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Salado Sales, Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
57243-157_0ba58ed5-d926-4daf-a9f0-d8a491ba5f10	57243-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Salado Sales, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57243-159_caf6d153-3587-453e-8f77-774d0096a353	57243-159	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin and caffeine	TABLET, FILM COATED	ORAL	19921117		OTC MONOGRAPH DRUG	M013	Salado Sales, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
57243-175_c232194e-c46c-410c-9de0-b4a553be3399	57243-175	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	Salado Sales, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
57243-189_bda29745-ae0f-4765-9e2e-9a47a378d3ab	57243-189	HUMAN OTC DRUG	Sleep		Diphenhydramine HCl	TABLET	ORAL	19900410		OTC MONOGRAPH DRUG	M010	Salado Sales, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57243-190_cf14c72d-7bb3-4c80-abe5-85be7548acff	57243-190	HUMAN OTC DRUG	Complete Allergy Medicine		Diphenhydramine HCl	CAPSULE	ORAL	19900315		OTC MONOGRAPH DRUG	M012	Salado Sales, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57243-200_9874d1db-f339-49f9-8225-ca61c05f1d64	57243-200	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20180416		ANDA	ANDA208314	McLane Company, Inc.	LORATADINE	10	mg/1			N	20241231
57243-226_94bb9844-beb9-4fa4-ab7f-894bc876185a	57243-226	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	Salado Sales, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
57243-235_8f8534a8-19c5-4f28-a33e-5fa6eaa5695d	57243-235	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19940515		OTC MONOGRAPH DRUG	M013	Salado Sales, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57243-291_4ac280f7-a0aa-4fe7-9582-dcff1ae6fd7e	57243-291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Salado Sales, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57243-370_582fe274-1163-464d-9212-0ac67870b1a4	57243-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333A	Salado Sales Inc.	ALCOHOL	70	mL/100mL			N	20241231
57243-403_e1eafee7-c433-44e0-89dc-19db566b3a19	57243-403	HUMAN OTC DRUG	Less Drowsy Formula Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20020624		OTC MONOGRAPH DRUG	M009	Salado Sales, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
57243-453_fd0aa040-0d49-46a4-84f2-7b019e33a9a5	57243-453	HUMAN OTC DRUG	SU PHEDRINE PE	Non-Drowsy, Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Salado Sales, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57243-501_99da41d1-ae1e-4a3a-b51a-11bed23be8bf	57243-501	HUMAN OTC DRUG	Nite-Time	COLD/FLU ORIGINAL	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20120116		OTC MONOGRAPH DRUG	M013	Salado Sales, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57243-502_21dee833-1f0b-4ac7-a662-169dc2fc6d0a	57243-502	HUMAN OTC DRUG	Nite-TimeCOLD/FLU CHERRY	COLD/FLU CHERRY	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20120131		OTC MONOGRAPH DRUG	M013	Salado Sales, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57243-503_0019a922-379e-42b7-9443-8e313504ce1b	57243-503	HUMAN OTC DRUG	TUSSIN COUGH	EXPECTORANT COUGH SUPRESSANT DM	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	LIQUID	ORAL	20120101		OTC MONOGRAPH DRUG	M012	Salado Sales, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57243-506_49c1c962-2dba-479b-b98a-a70e9d7dd68b	57243-506	HUMAN OTC DRUG	Daytime	Non-Drowsy COLD/FLU	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20120905		OTC MONOGRAPH DRUG	M013	Salado Sales, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57243-557_a16ba06a-8dfa-4da4-9639-7393b027d767	57243-557	HUMAN OTC DRUG	STOMACH RELIEF		BISMUTH SUBSALICYLATE	SUSPENSION	ORAL	20181001		OTC MONOGRAPH DRUG	M008	Consumer Value Products, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
57243-560_73299bfb-a381-44a1-96bc-03a96aec0e9d	57243-560	HUMAN OTC DRUG	Cold-Flu Relief	Multi Symptom	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, COATED	ORAL	20080329		OTC MONOGRAPH DRUG	M012	Salado Sales, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57243-628_5e99f971-b8d2-4d0c-8529-c0b905bac69a	57243-628	HUMAN OTC DRUG	Antibacterial Foaming Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20231114		OTC MONOGRAPH DRUG	M003	Salado Sales Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
57243-664_21f059b1-40c7-48c2-af98-04ddc6e81c56	57243-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20100604		OTC MONOGRAPH NOT FINAL	part356	Salado Sales, Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
57243-810_57f777da-ea88-41bf-a2d5-2dc815f74588	57243-810	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20030604		OTC MONOGRAPH NOT FINAL	part333A	Salado Sales, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
57243-871_945d67be-02cd-4947-b60e-2c1c8ed62dc9	57243-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20030604		OTC MONOGRAPH NOT FINAL	part333A	Salado Sales, Inc	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
57287-100_1c36b79c-3c82-44ea-92b8-ff8aaba03150	57287-100	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20130311		NDA	NDA206023	Jernigan Healthcare, Inc.	OXYGEN	99	L/100L			N	20241231
57297-844_832d95f1-f7d2-492c-8aa7-dec00ded687a	57297-844	HUMAN PRESCRIPTION DRUG	Kurvelo		Levonorgestrel and Ethinyl Estradiol	KIT		20200318		ANDA	ANDA091408	LUPIN LIMITED						N	20241231
57297-852_415e14cb-df0a-456a-b2b1-8dfcd5f8ef2d	57297-852	HUMAN OTC DRUG	My Way		levonorgestrel	TABLET	ORAL	20170425		ANDA	ANDA201446	LUPIN LIMITED	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
57337-032_fc0fcbd0-374f-54c4-e053-6294a90aba7e	57337-032	HUMAN OTC DRUG	Oil-Free Foaming Acne Wash	Tea Tree Oil	Salicylic Acid	GEL	TOPICAL	20131120		OTC MONOGRAPH FINAL	part333D	Rejoice International	SALICYLIC ACID	3	g/150g			N	20241231
57337-052_087f5ceb-0e96-0c3a-e063-6394a90acfc7	57337-052	HUMAN OTC DRUG	XtraCare Ice Cold Topical Analgesic Gel		Menthol	GEL	TOPICAL	20140130		OTC MONOGRAPH DRUG	M017	Rejoice International	MENTHOL	3	g/227g			N	20241231
57337-060_9271963d-69ec-7b77-e053-2a95a90a4221	57337-060	HUMAN OTC DRUG	XtraCare Creamy Petroleum Jelly		Petrolatum	JELLY	TOPICAL	20140218		OTC MONOGRAPH FINAL	part347	Rejoice International	PETROLATUM	38	g/127g			N	20241231
57337-061_9271963d-6a0f-7b77-e053-2a95a90a4221	57337-061	HUMAN OTC DRUG	XtraCare Creamy Petroleum Jelly		Petrolatum	JELLY	TOPICAL	20140218		OTC MONOGRAPH FINAL	part347	Rejoice International	PETROLATUM	38	g/127g			N	20241231
57337-062_9271a4fb-363b-2af5-e053-2a95a90a7dcf	57337-062	HUMAN OTC DRUG	XtraCare Wet Wipes		Benzethonium Chloride	SWAB	TOPICAL	20140313		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	BENZETHONIUM CHLORIDE	3	mg/100mg			N	20241231
57337-064_9271a4fb-3648-2af5-e053-2a95a90a7dcf	57337-064	HUMAN OTC DRUG	XtraCare 2 in 1 Hair Cleanse and Condition	Coconut Water	Pyrithione Zinc	SHAMPOO	TOPICAL	20140827		OTC MONOGRAPH FINAL	part358H	Rejoice International Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
57337-065_9271a4fb-3655-2af5-e053-2a95a90a7dcf	57337-065	HUMAN OTC DRUG	XtraCare 2 in 1 Hair Cleanse and Condition	Green Apple	Pyrithione Zinc	SHAMPOO	TOPICAL	20140827		OTC MONOGRAPH FINAL	part358H	Rejoice International Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
57337-066_9271a4fb-3660-2af5-e053-2a95a90a7dcf	57337-066	HUMAN OTC DRUG	Wet Wipes		benzethonium chloride	CLOTH	TOPICAL	20141208		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	BENZETHONIUM CHLORIDE	.3	g/1			N	20241231
57337-067_92719e2f-a1e5-0d1d-e053-2a95a90a47be	57337-067	HUMAN OTC DRUG	Wet Wipes		benzethonium chloride	CLOTH	TOPICAL	20141208		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	BENZETHONIUM CHLORIDE	.3	g/1			N	20241231
57337-068_9271d0dd-f4f6-e779-e053-2a95a90af316	57337-068	HUMAN OTC DRUG	Wet Wipes		benzethonium chloride	CLOTH	TOPICAL	20141208		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	BENZETHONIUM CHLORIDE	.3	g/1			N	20241231
57337-069_926fa34d-339b-981c-e053-2995a90ab94c	57337-069	HUMAN OTC DRUG	XtraCare Antibacterial Hand Cleanse	Fresh Citrus	Triclosan	SOAP	TOPICAL	20130903		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International, Inc.	TRICLOSAN	3.3	mg/221mL			N	20241231
57337-071_9271d677-c949-f54b-e053-2a95a90a60bd	57337-071	HUMAN OTC DRUG	XtraCare Cucumber Melon		ethyl alcohol	GEL	TOPICAL	20150217		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	ALCOHOL	62	g/100g			N	20241231
57337-072_9271d677-c954-f54b-e053-2a95a90a60bd	57337-072	HUMAN OTC DRUG	XtraCare Lavender Chamomile		ethyl alcohol	GEL	TOPICAL	20150217		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	ALCOHOL	62	g/100g			N	20241231
57337-073_9271e7b9-a2a1-bc51-e053-2995a90a1f9f	57337-073	HUMAN OTC DRUG	XtraCare Sweet Pea Blossom		ethyl alcohol	GEL	TOPICAL	20150217		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	ALCOHOL	62	g/100g			N	20241231
57337-074_9271e7b9-a2ab-bc51-e053-2995a90a1f9f	57337-074	HUMAN OTC DRUG	XtraCare Warm Vanilla		ethyl alcohol	GEL	TOPICAL	20150217		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International	ALCOHOL	62	g/100g			N	20241231
57337-075_edbf34dc-07d7-183d-e053-2a95a90ae61f	57337-075	HUMAN OTC DRUG	Petroleum Jelly		white petrolatum	CREAM	TOPICAL	20150615		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	PETROLATUM	99	g/100g			N	20241231
57337-076_edbf1175-173c-ca65-e053-2995a90a73c8	57337-076	HUMAN OTC DRUG	Baby Petroleum Jelly		white petrolatum	CREAM	TOPICAL	20150615		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	PETROLATUM	99	g/100g			N	20241231
57337-077_edbf34dc-07e3-183d-e053-2a95a90ae61f	57337-077	HUMAN OTC DRUG	Petroleum Jelly		white petrolatum	CREAM	TOPICAL	20150615		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	PETROLATUM	99	g/100g			N	20241231
57337-078_edbf34dc-07ed-183d-e053-2a95a90ae61f	57337-078	HUMAN OTC DRUG	Medicated Foot Powder		menthol	POWDER	TOPICAL	20150615		OTC MONOGRAPH NOT FINAL	part348	Rejoice International Inc.	MENTHOL	1	g/100g			N	20241231
57337-079_edf711ed-63c1-f6f9-e053-2a95a90acf1b	57337-079	HUMAN OTC DRUG	Medicated Body Powder		menthol	POWDER	TOPICAL	20150615		OTC MONOGRAPH NOT FINAL	part348	Rejoice International Inc.	MENTHOL; ZINC OXIDE	.15; 1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
57337-080_92725538-5e5c-331e-e053-2995a90a7010	57337-080	HUMAN OTC DRUG	Acne wash facial cleanser pink grapefruit		Salicylic Acid	LIQUID	TOPICAL	20160801		OTC MONOGRAPH FINAL	part333D	Rejoice International Corp	SALICYLIC ACID	2	g/200mL			N	20241231
57337-081_927368dc-d932-5684-e053-2a95a90abccc	57337-081	HUMAN OTC DRUG	Acne wash facial cleanser Tea tree oil		Salicylic Acid	LIQUID	TOPICAL	20160801		OTC MONOGRAPH FINAL	part333D	Rejoice International Corp.	SALICYLIC ACID	2	g/200mL			N	20241231
57337-082_92737d55-7efc-50d0-e053-2a95a90ac7af	57337-082	HUMAN OTC DRUG	Instant Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20170425		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Corp.	ALCOHOL	62	mL/100mL			N	20241231
57337-083_92739231-93dc-651d-e053-2995a90a7339	57337-083	HUMAN OTC DRUG	Instant Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20170425		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Corp.	ALCOHOL	62	mL/100mL			N	20241231
57337-084_92739023-26c2-3ca7-e053-2995a90a8bc0	57337-084	HUMAN OTC DRUG	Instant Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20170425		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Corp.	ALCOHOL	62	mL/100mL			N	20241231
57337-085_92739231-9404-651d-e053-2995a90a7339	57337-085	HUMAN OTC DRUG	Instant Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20170421		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Corp.	ALCOHOL	70	mL/100mL			N	20241231
57337-086_9273a22f-6986-096f-e053-2995a90a9323	57337-086	HUMAN OTC DRUG	Triclosan Free Antibacterial	Antibacterial	Chloroxylenol	LIQUID	TOPICAL	20170425		UNAPPROVED DRUG OTHER		Rejoice International Corp.	CHLOROXYLENOL	.3	g/100mL			N	20241231
57337-087_9273a22f-699d-096f-e053-2995a90a9323	57337-087	HUMAN OTC DRUG	Triclosan Free Antibacterial 7.5 oz original	Antibacterial	Chloroxylenol	LIQUID	TOPICAL	20170606		UNAPPROVED DRUG OTHER		Rejoice International Corp.	CHLOROXYLENOL	.3	g/100mL			N	20241231
57337-088_92739023-26cd-3ca7-e053-2995a90a8bc0	57337-088	HUMAN OTC DRUG	Triclosan Free Antibacterial 7.5 oz (Ocean)	Antibacterial	Chloroxylenol	LIQUID	TOPICAL	20170606		UNAPPROVED DRUG OTHER		Rejoice International Corp.	CHLOROXYLENOL	.3	g/100mL			N	20241231
57337-089_9273a22f-69ac-096f-e053-2995a90a9323	57337-089	HUMAN OTC DRUG	Triclosan Free Antibacterial 7.5 oz (Strawberry Pomegranate)	Antibacterial	Chloroxylenol	LIQUID	TOPICAL	20170606		UNAPPROVED DRUG OTHER		Rejoice International Corp.	CHLOROXYLENOL	.3	g/100mL			N	20241231
57337-090_9273a22f-69b7-096f-e053-2995a90a9323	57337-090	HUMAN OTC DRUG	Triclosan Free Antibacterial 7.5 oz (Fresh Citrus)	Antibacterial	Chloroxylenol	LIQUID	TOPICAL	20170606		UNAPPROVED DRUG OTHER		Rejoice International Corp.	CHLOROXYLENOL	.3	g/100mL			N	20241231
57337-093_9273afd7-c014-5be8-e053-2995a90afd73	57337-093	HUMAN OTC DRUG	Instant Hand Sanitizer	2oz Bonus pack	Ethyl Alcohol	LIQUID	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Inc.	ALCOHOL	70	mL/100mL			N	20241231
57337-094_9273afd7-c01e-5be8-e053-2995a90afd73	57337-094	HUMAN OTC DRUG	Hand Sanitizer w/ Carabiner (Strawberry Scented)	2oz Bonus pack	Ethyl Alcohol	LIQUID	TOPICAL	20180611		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Inc.	ALCOHOL	70	mL/100mL			N	20241231
57337-095_9273afd7-c029-5be8-e053-2995a90afd73	57337-095	HUMAN OTC DRUG	Hand Sanitizer w/ Carabiner (Lemon Scented)	2oz Bonus pack	Ethyl Alcohol	LIQUID	TOPICAL	20180611		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Inc.	ALCOHOL	70	mL/100mL			N	20241231
57337-096_9273afd7-c032-5be8-e053-2995a90afd73	57337-096	HUMAN OTC DRUG	Hand Sanitizer w/ Carabiner (Watermelon Scented)	2oz Bonus pack	Ethyl Alcohol	LIQUID	TOPICAL	20180611		OTC MONOGRAPH NOT FINAL	part333E	Rejoice International Inc.	ALCOHOL	70	mL/100mL			N	20241231
57337-097_9273bf56-2773-0971-e053-2995a90ac683	57337-097	HUMAN OTC DRUG	Vaporizing Chest Rub 4 oz.		Camphor, Eucalyptus Oil, Menthol	OINTMENT	TOPICAL	20180720		OTC MONOGRAPH NOT FINAL	part348	Rejoice International Inc.	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100mL; g/100mL; g/100mL			N	20241231
57337-098_9273bf56-277d-0971-e053-2995a90ac683	57337-098	HUMAN OTC DRUG	Alike Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20180723		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	DIMETHICONE	1.2	g/100mL	Skin Barrier Activity [PE]		N	20241231
57337-099_9273bf56-27b8-0971-e053-2995a90ac683	57337-099	HUMAN OTC DRUG	Vaporizing Chest Rub 4 oz.	3 pk	Camphor, Eucalyptus Oil, Menthol	OINTMENT	TOPICAL	20180720		OTC MONOGRAPH NOT FINAL	part348	Rejoice International Inc.	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100mL; g/100mL; g/100mL			N	20241231
57337-100_8384b028-7b9c-2a7b-e053-2a91aa0a342c	57337-100	HUMAN OTC DRUG	Oatmeal Skin Relief Calming .	8oz	Dimethicone	LOTION	TOPICAL	20190307		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	DIMETHICONE	3	g/227g	Skin Barrier Activity [PE]		N	20241231
57337-101_83966e75-3cf0-410b-e053-2a91aa0a90f3	57337-101	HUMAN OTC DRUG	Eczema Care Moisturizing	3 oz.	Colloidal Oatmeal	LOTION	TOPICAL	20190308		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
57337-104_99748785-8322-7bbf-e053-2a95a90a16c9	57337-104	HUMAN OTC DRUG	Witch Hazel Pore Clarifying Toner	8 oz	Salicylic Acid 2%	GEL	TOPICAL	20191211		OTC MONOGRAPH FINAL	part333D	Ningbo Rejoice International	SALICYLIC ACID	20	mg/mL			N	20241231
57337-107_a0313458-814e-a34e-e053-2995a90af5d1	57337-107	HUMAN OTC DRUG	Hand Sanitizer 1.8 oz Antiseptic		Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	REJOICE INTERNATIONAL CORP.	ALCOHOL	70	mL/100mL			N	20241231
57337-110_a2666106-afe9-0c26-e053-2a95a90a5259	57337-110	HUMAN OTC DRUG	Hand Sanitizer 1.8 oz Lemon Ice		Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-111_a2676506-fe5b-31ce-e053-2995a90ac3d2	57337-111	HUMAN OTC DRUG	Hand Sanitizer 1.8 oz Watermelon Scented	1.8 oz.	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-112_a2677c78-958e-3b1a-e053-2995a90a6ae0	57337-112	HUMAN OTC DRUG	Hand Sanitizer 1.8 oz Strawberry Scented		Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-114_a2695f96-ef8d-bba6-e053-2a95a90a243e	57337-114	HUMAN OTC DRUG	Hand Sanitizer Vitamin E and Aloe Vera	2 oz. 2 pk	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-115_a26a76a5-8359-4b97-e053-2a95a90afa00	57337-115	HUMAN OTC DRUG	Hand Sanitizer 8 oz. Vitamin E	70 v/v	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-116_a26a4be9-85d6-2724-e053-2a95a90a0b02	57337-116	HUMAN OTC DRUG	Hand Sanitizer Vitamin E and Aloe Vera		Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-117_a26a866a-bb60-4b5f-e053-2995a90a9745	57337-117	HUMAN OTC DRUG	Hand Sanitizer Original	1.8 oz	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-118_a269e739-8a4d-cd1d-e053-2995a90afd2e	57337-118	HUMAN OTC DRUG	Hand Sanitizer Antibacterial Vitamin E	2 oz. 2 pk	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-119_a269a222-95cc-098c-e053-2995a90a21e7	57337-119	HUMAN OTC DRUG	Hand Sanitizer Vitamin E		Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-120_a690013d-64d8-599d-e053-2995a90a31bb	57337-120	HUMAN OTC DRUG	Hand Sanitizer Antibacterial	Vitamin E	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-121_a73641e2-1c19-867f-e053-2995a90a7310	57337-121	HUMAN OTC DRUG	Hand Sanitizer Antibacterial	Vitamin E	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-122_a875f832-9e76-1fdb-e053-2995a90aab11	57337-122	HUMAN OTC DRUG	Hand Sanitizer Antibacterial	Vitamin E	Ethyl Alcohol	LIQUID	TOPICAL	20200305		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-123_b08eabd0-8fc0-807c-e053-2a95a90ab9d9	57337-123	HUMAN OTC DRUG	Hand Sanitizer 2pk Lemon	2oz	ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-124_b08ec92b-e63d-2dab-e053-2995a90a0948	57337-124	HUMAN OTC DRUG	Hand Sanitizer Original	8oz	ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-125_b08f294d-90b0-9efd-e053-2995a90afd14	57337-125	HUMAN OTC DRUG	Hand Sanitizer with Clip	1.8oz	ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-126_b08f294d-90b1-9efd-e053-2995a90afd14	57337-126	HUMAN OTC DRUG	Hand Sanitizer 2pk Aloe	2oz	ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-127_b08f3bf1-f55e-5c68-e053-2a95a90ac3ac	57337-127	HUMAN OTC DRUG	Hand Sanitizer Aloe	2oz	ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-128_b191461a-bd83-f543-e053-2995a90a3c43	57337-128	HUMAN OTC DRUG	Hand Sanitizer 2pk Lavender	2oz	ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-129_b1913d77-e241-f983-e053-2995a90a8531	57337-129	HUMAN OTC DRUG	Hand Sanitizer Lavender	2oz	ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-130_b08fa21b-ebb3-2b27-e053-2995a90a1ad2	57337-130	HUMAN OTC DRUG	Hand Sanitizer Pouch		ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-131_b08fabd7-1984-100d-e053-2a95a90a200e	57337-131	HUMAN OTC DRUG	Hand Sanitizer 24ct Pouch		ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-132_b08fd0f3-e163-96d9-e053-2a95a90a12bb	57337-132	HUMAN OTC DRUG	Hand Sanitizer	2oz	ALCOHOL	SPRAY	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-133_b0a4159a-cb06-4ce6-e053-2995a90a76e7	57337-133	HUMAN OTC DRUG	Hand Sanitizer Lemon	2oz	ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-134_b1914894-4263-fa69-e053-2995a90a4ff9	57337-134	HUMAN OTC DRUG	Hand Sanitizer Aloe	8oz	ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-135_bc07a905-b733-5e44-e053-2a95a90a4db9	57337-135	HUMAN OTC DRUG	Hand Sanitizer Coconut and Lime	3oz	ALCOHOL	LIQUID	TOPICAL	20210223		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-136_bc07e6a9-08e3-69c5-e053-2995a90aa1f3	57337-136	HUMAN OTC DRUG	Hand Sanitizer Cucumber and Melon	3oz	ALCOHOL	LIQUID	TOPICAL	20210223		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-137_bc0822bb-103b-93e8-e053-2a95a90a61c9	57337-137	HUMAN OTC DRUG	Hand Sanitizer Pomegranate and Vanilla	3oz	ALCOHOL	LIQUID	TOPICAL	20210223		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Rejoice International	ALCOHOL	70	mL/100mL			N	20241231
57337-138_c055af0a-ec0a-217c-e053-2995a90a54da	57337-138	HUMAN OTC DRUG	XtraCare Oatmeal Daily Moisturizing	8 oz	Dimethicone	LOTION	TOPICAL	20210419		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	DIMETHICONE	1.3	g/100g	Skin Barrier Activity [PE]		N	20241231
57337-139_c0670b60-46f2-9d9d-e053-2995a90a8c19	57337-139	HUMAN OTC DRUG	XtraCare Oatmeal Daily Moisturizing	8 oz	Dimethicone	LOTION	TOPICAL	20210419		OTC MONOGRAPH FINAL	part347	Rejoice International Inc.	DIMETHICONE	1.3	g/100g	Skin Barrier Activity [PE]		N	20241231
57337-140_03f4a507-df40-e265-e063-6294a90acd11	57337-140	HUMAN OTC DRUG	Hand sanitizer 8oz with vitamin E		Ethyl Alcohol 70%	LIQUID	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part333A	REJOICE INTERNATIONAL CORP.	ALCOHOL	70	mL/100mL			N	20241231
57337-141_03f81aee-1ba2-c6f0-e063-6294a90a4963	57337-141	HUMAN OTC DRUG	Hand sanitizer 8oz with aloe vera		Ethyl Alcohol 70%	LIQUID	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part333A	REJOICE INTERNATIONAL CORP.	ALCOHOL	70	mL/100mL			N	20241231
57337-142_03f86736-96a7-0fba-e063-6294a90a5614	57337-142	HUMAN OTC DRUG	Hand sanitizer 16.9oz with vitamin E		Ethyl Alcohol 70%	LIQUID	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part333A	REJOICE INTERNATIONAL CORP.	ALCOHOL	70	mL/100mL			N	20241231
57337-143_04fd3bbe-172a-a748-e063-6394a90a9655	57337-143	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk with aloe vera		Ethyl Alcohol 70%	GEL	TOPICAL	20230910		OTC MONOGRAPH NOT FINAL	part333A	Rejoice International Corp.	ALCOHOL	70	mL/100mL			N	20241231
57337-145_04fe378d-ee1c-ad52-e063-6294a90ae146	57337-145	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk lemon		Ethyl Alcohol 70%	GEL	TOPICAL	20230910		OTC MONOGRAPH NOT FINAL	part333A	Rejoice International Corp.	ALCOHOL	70	mL/100mL			N	20241231
57337-146_05204984-f14d-c666-e063-6394a90a1ee4	57337-146	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk lavender		Ethyl Alcohol 70%	GEL	TOPICAL	20230910		OTC MONOGRAPH NOT FINAL	part333A	Rejoice International Corp.	ALCOHOL	70	mL/100mL			N	20241231
57337-147_06da0cc1-95f3-4f88-e063-6394a90a25ea	57337-147	HUMAN OTC DRUG	Hand sanitizer 1.8oz with extra clip original		Ethyl Alcohol	GEL	TOPICAL	20231004		OTC MONOGRAPH DRUG	M003	Rejoice International Corp.	ALCOHOL	70	mL/100mL			N	20241231
57337-148_06dc1730-216b-8b4d-e063-6294a90a4184	57337-148	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk original		Ethyl Alcohol	GEL	TOPICAL	20231004		OTC MONOGRAPH DRUG	M003	Rejoice International Corp.	ALCOHOL	70	mL/100mL			N	20241231
57337-149_06de40a2-45c0-bf4b-e063-6294a90a586c	57337-149	HUMAN OTC DRUG	SPOT ACNE TREATMENT 0.75OZ		Benzoyl Peroxide	GEL	TOPICAL	20231004		OTC MONOGRAPH DRUG	M006	Rejoice International Corp.	BENZOYL PEROXIDE	2.5	g/100g			N	20241231
57337-150_06df07f7-e4c6-ccef-e063-6394a90a9f3c	57337-150	HUMAN OTC DRUG	PERSISTENT BODY ACNE WASH 8.5OZ		Salicylic Acid	LIQUID	TOPICAL	20231004		OTC MONOGRAPH DRUG	M006	Rejoice International Corp.	SALICYLIC ACID	1	mg/100mL			N	20241231
57337-151_0ba98cdf-489f-dc2a-e063-6294a90adb38	57337-151	HUMAN OTC DRUG	Diaper Rash Cream 2.5oz		Zinc Oxide	CREAM	TOPICAL	20231204		OTC MONOGRAPH DRUG	M016	Rejoice International Corp.	ZINC OXIDE	.4	g/g			N	20241231
57337-152_0c49fe8b-f19a-6ca7-e063-6294a90a41e7	57337-152	HUMAN OTC DRUG	Dry Orignal Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231212		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
57337-153_0c4c6ea8-2877-eb20-e063-6394a90a4cf3	57337-153	HUMAN OTC DRUG	Dry Orignal Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231212		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
57337-154_0c4c3d3c-afa1-baba-e063-6294a90a30eb	57337-154	HUMAN OTC DRUG	Dry Sweat Shield 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231212		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
57337-155_0c4d2f90-f8c7-2776-e063-6394a90aa0d7	57337-155	HUMAN OTC DRUG	Dry Shower Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231212		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
57337-156_0c5a674d-a71a-a4a6-e063-6294a90a86ea	57337-156	HUMAN OTC DRUG	Dry Shower Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231213		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
57337-157_0c5c1ba7-8450-8c94-e063-6394a90ac25c	57337-157	HUMAN OTC DRUG	Dry Sweat Shield 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231213		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
57337-158_0c5dfbec-3ccd-5d19-e063-6394a90a956c	57337-158	HUMAN OTC DRUG	Dry Original Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231213		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
57337-159_0c5eac3e-1fc5-4960-e063-6294a90a61c1	57337-159	HUMAN OTC DRUG	Dry Cooling Essence 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231213		OTC MONOGRAPH DRUG	M019	Rejoice International Corp.	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
57344-004_94bd0c4b-51b0-6579-e053-2995a90a5d5c	57344-004	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20120413		OTC MONOGRAPH NOT FINAL	part343	AAA Pharmaceutical, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
57344-018_925021bb-d1b4-03b8-e053-2995a90a4243	57344-018	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, COATED	ORAL	20170901		OTC MONOGRAPH NOT FINAL	part343	AAA Pharmaceutical, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57344-080_92507885-2626-205c-e053-2995a90a1592	57344-080	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20170701		OTC MONOGRAPH NOT FINAL	part343	AAA Pharmaceutical, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57344-090_94e265d8-7fba-2ee9-e053-2a95a90a4993	57344-090	HUMAN OTC DRUG	Diphenhydramine		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120413		OTC MONOGRAPH FINAL	part341	AAA Pharmaceutical, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57344-091_94e23223-3771-3c15-e053-2a95a90a4f48	57344-091	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20181005		OTC MONOGRAPH FINAL	part338	AAA Pharmaceutical, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57344-095_92509909-ab38-57ae-e053-2a95a90aaa9d	57344-095	HUMAN OTC DRUG	Acetaminophen PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20121001		OTC MONOGRAPH FINAL	part341	AAA Pharmaceutical, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57344-109_925c495d-0c37-4c6b-e053-2a95a90ad1a4	57344-109	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20121001		ANDA	ANDA079129	AAA Pharmaceutical, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57344-110_94bdba04-ef9e-be1b-e053-2995a90a4ccf	57344-110	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20140901		ANDA	ANDA079129	AAA Pharmaceutical, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57344-131_94e265d8-7fcb-2ee9-e053-2a95a90a4993	57344-131	HUMAN OTC DRUG	Phenylephrine Hydrochloride		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120413		OTC MONOGRAPH FINAL	part341	AAA Pharmaceutical, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57344-144_925ba05d-3533-9b07-e053-2995a90a6709	57344-144	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20120401		ANDA	ANDA079096	AAA Pharmaceutical, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57344-145_925129db-e54a-b33e-e053-2995a90abbfa	57344-145	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20120401		ANDA	ANDA079096	AAA Pharmaceutical, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57344-146_925b26fe-914a-49fc-e053-2a95a90ac07e	57344-146	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20170901		OTC MONOGRAPH NOT FINAL	part343	AAA Pharmaceutical, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57344-163_efb6df59-bb66-06da-e053-2a95a90a35fc	57344-163	HUMAN OTC DRUG	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120802		OTC MONOGRAPH FINAL	part341	AAA Pharmaceutical, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57344-170_e996400f-1613-6066-e053-2995a90a5ad5	57344-170	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20150101		OTC MONOGRAPH NOT FINAL	part343	AAA Pharmaceutical, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
57344-185_925382ee-b0df-636d-e053-2a95a90a2411	57344-185	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20181001		ANDA	ANDA079205	AAA Pharmaceutical, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57344-193_dd2d1af9-217a-07ae-e053-2995a90a7202	57344-193	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20200814		ANDA	ANDA210722	AAA PHARMACEUTICAL, INC.	LORATADINE	10	mg/1			N	20241231
57344-194_dd2d0397-1615-a154-e053-2a95a90a6d25	57344-194	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20181001		ANDA	ANDA209274	AAA PHARMACEUTICAL, INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57344-205_faca928e-d1ae-095c-e053-6294a90a716a	57344-205	HUMAN OTC DRUG	Migraine Relief		ACETAMINOPHEN, ASPIRIN and CAFFEINE	TABLET	ORAL	20230503		ANDA	ANDA214039	AAA PHARMACEUTICAL, INC.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
57344-292_dcf470ed-47bf-0bb5-e053-2995a90afdff	57344-292	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210706		ANDA	ANDA211075	AAA PHARMACEUTICAL, INC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57344-811_af0b1d80-3e15-c056-e053-2995a90ae552	57344-811	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200201		ANDA	ANDA202312	AAA PHARMACEUTICAL, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57344-923_ec81b0c8-a7ec-ade1-e053-2995a90aefab	57344-923	HUMAN OTC DRUG	Sinus and Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	AAA Pharmaceutical, Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57344-928_af0b1b08-e23d-6399-e053-2a95a90ac12d	57344-928	HUMAN OTC DRUG	Allergy Multi Symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	AAA PHARMACEUTICAL, INC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57348-897_5e312c74-ca1a-4075-84e1-ed30cae395ed	57348-897	HUMAN OTC DRUG	Super Colon Cleanse		SENNOSIDES	CAPSULE	ORAL	20180916	20260430	OTC MONOGRAPH DRUG	505G(a)(3)	Health Plus Inc.	SENNOSIDES	8.3	mg/1			N	
57349-220_f59fc458-1188-49e2-b3b4-704682778cf6	57349-220	HUMAN OTC DRUG	EyS Eye Wash		Water	SOLUTION	OPHTHALMIC	20200901		OTC MONOGRAPH FINAL	part349	Eyes-Plus LLC	WATER	14.85	mL/15mL			N	20241231
57362-465_09ecc74c-d48a-b58a-e063-6394a90a6a65	57362-465	HUMAN OTC DRUG	Zylast Antiseptic		Ethyl Alcohol	GEL	TOPICAL	20150424		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative BioDefense	ALCOHOL	44.9	mL/59.1mL			N	20241231
57362-466_050d4721-0bd7-0fdc-e063-6394a90aa7ff	57362-466	HUMAN OTC DRUG	Zylast Antiseptic S		Ethyl Alcohol	LIQUID	TOPICAL	20190115		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative BioDefense	ALCOHOL	760	mL/1000mL			N	20241231
57362-467_050d7188-449a-68e3-e063-6394a90af600	57362-467	HUMAN OTC DRUG	ZylastXP Antiseptic Foaming		Benzethonium Chloride	SOAP	TOPICAL	20150406		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative Biodefense	BENZETHONIUM CHLORIDE	2	mg/mL			N	20241231
57362-468_050d6202-97f5-7c43-e063-6294a90a1d74	57362-468	HUMAN OTC DRUG	Zylast Antiseptic K		Benzalkonium Chloride	LOTION	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative Biodefense	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
57362-469_050d6202-97f6-7c43-e063-6294a90a1d74	57362-469	HUMAN OTC DRUG	Antiseptic Wipes		Zylast Hand Wipes	SWAB	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	Westwood Laboratories	ALCOHOL	76	mL/100mL			N	20241231
57362-523_069631e8-21ec-6349-e063-6294a90a1cf4	57362-523	HUMAN OTC DRUG	CleanBoss Hand Sanitizer		Alcohol	GEL	TOPICAL	20220201		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative Biodefense, Inc	ALCOHOL	76	mL/100mL			N	20241231
57362-524_06964c76-1601-8400-e063-6394a90ad192	57362-524	HUMAN OTC DRUG	CleanBoss Hand Sanitizing Gel		Ethyl Alcohol	GEL	TOPICAL	20220201		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative Biodefense	ALCOHOL	76	mL/100mL			N	20241231
57362-525_06964cfb-fe51-3de1-e063-6294a90a9d86	57362-525	HUMAN OTC DRUG	CleanBoss Hand Sanitizing Gel		Ethyl Alcohol	GEL	TOPICAL	20220201		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative Biodefense	ALCOHOL	76	mL/100mL			N	20241231
57362-568_05733f84-6bf7-9f6a-e063-6294a90ac5c9	57362-568	HUMAN OTC DRUG	Hand Sanitizing Wipes		Hand Sanitizing Wipes	SWAB	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	Innovative Biodefense	ALCOHOL	76	mL/100mL			N	20241231
57366-0001_08b4632c-2433-6046-e063-6294a90a1527	57366-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19951220		UNAPPROVED MEDICAL GAS		MedQuest, Inc.	OXYGEN	99	L/100L			N	20241231
57377-025_0772432d-186d-a80a-e063-6294a90a8e17	57377-025	HUMAN PRESCRIPTION DRUG	Estra-25		estradiol pellet	PELLET, IMPLANTABLE	SUBCUTANEOUS	20170101		UNAPPROVED DRUG OTHER		Advanced Pharmaceutical Technology, Inc.	ESTRADIOL	25	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
57377-050_0772432d-186d-a80a-e063-6294a90a8e17	57377-050	HUMAN PRESCRIPTION DRUG	Estra-50		Estradiol pellet	PELLET, IMPLANTABLE	SUBCUTANEOUS	20170101		UNAPPROVED DRUG OTHER		Advanced Pharmaceutical Technology, Inc.	ESTRADIOL	50	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
57377-060_e0056294-f01b-d902-e053-2a95a90ad711	57377-060	HUMAN PRESCRIPTION DRUG	Testozole		Testosterone,USP	PELLET, IMPLANTABLE	SUBCUTANEOUS	20210101		UNAPPROVED DRUG OTHER		Advanced Pharmaceutical Technology, Inc.	ANASTROZOLE; TESTOSTERONE	4; 60	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]	CIII	N	20241231
57424-708_ab96343c-6dd2-2e6f-e053-2995a90a4499	57424-708	HUMAN OTC DRUG	Hi-Tech		Chloroxylenol	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333A	Economical Janitorial Supplies	CHLOROXYLENOL	3.75	mg/mL			N	20241231
57468-708_ab95e630-ecd5-1431-e053-2a95a90ac50a	57468-708	HUMAN OTC DRUG	Pearlescent		Chloroxylenol	SOAP	TOPICAL	20130318		OTC MONOGRAPH NOT FINAL	part333A	Boelter Companies Inc.	CHLOROXYLENOL	3.75	mg/mL			N	20241231
57479-102_03aeed00-2028-0b57-e063-6394a90a8b47	57479-102	HUMAN OTC DRUG	POISON OAK AND IVY		HYDROCORTISONE, PHENOL	GEL	TOPICAL	20230824		OTC MONOGRAPH NOT FINAL	part348	DeMartini Spring Hill Pharmacy, Inc.	HYDROCORTISONE; PHENOL	1.3; .54	g/103mL; g/103mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
57483-005_38e97042-b4b6-4ee3-8733-84cce07fbb05	57483-005	HUMAN OTC DRUG	FlutiCare	Nasal Alergy	fluticasone propionate (glucocorticoid)	SPRAY, METERED	NASAL	20170922		ANDA	ANDA207957	Innovus Pharmaceuticals Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
57483-101_decac180-c70c-437b-8f6f-1fd59a4176bc	57483-101	HUMAN OTC DRUG	Apeaz Ultra		camphor (synthetic), menthol, and methyl salicylate cream	CREAM	TOPICAL	20180205		OTC MONOGRAPH NOT FINAL	part348	Innovus Pharmaceuticals, Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	4; 7.5; 10	mg/g; mg/g; mg/g			N	20241231
57483-120_a4e92bd2-8f75-4acc-9b75-df8332bd4cc4	57483-120	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20230525		ANDA	ANDA206877	INNOVUS PHARMACEUTICALS, INC.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57483-221_3eef29f3-b072-41f8-82af-27b356889b12	57483-221	HUMAN OTC DRUG	Neuriterx		Capsaicin 0.05%	CREAM	TOPICAL	20210202		OTC MONOGRAPH DRUG	M	Innovus Pharmaceuticals, Inc.	CAPSAICIN	.05	g/100g			N	20241231
57483-225_a32039b7-8475-4ec5-abaf-07f9aee3954b	57483-225	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230525		ANDA	ANDA209339	INNOVUS PHARMACEUTICALS, INC.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57483-230_f672cd27-4516-4e54-8c4f-8bbdc22dfabd	57483-230	HUMAN OTC DRUG	Crcle Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET	ORAL	20201218		ANDA	ANDA211075	Innovus Pharmaceuticals, Inc.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57483-240_f672cd27-4516-4e54-8c4f-8bbdc22dfabd	57483-240	HUMAN OTC DRUG	Crcle Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET	ORAL	20201218		ANDA	ANDA211075	Innovus Pharmaceuticals, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57483-250_b1644d9c-353b-44bf-b3f9-9bd8b83976f2	57483-250	HUMAN OTC DRUG	Crcle Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20210630		ANDA	ANDA209274	Innovus Pharmaceuticals, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57483-270_77d8fc95-d94b-42f5-97ae-b5ff59ef638b	57483-270	HUMAN OTC DRUG	Crcle Guaifenesin Extended-Release Tablets, 600 mg		Guaifenesin Extended-Release	TABLET	ORAL	20200910		ANDA	ANDA213420	Innovus Pharmaceuticals, Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
57483-280_77d8fc95-d94b-42f5-97ae-b5ff59ef638b	57483-280	HUMAN OTC DRUG	Crcle Guaifensin Extended Release Tablet, 1200 mg		Guaifensin Extended-Release	TABLET	ORAL	20200910		ANDA	ANDA213420	Innovus Pharmaceuticals, Inc.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
57483-350_b5d11dbf-dc78-4354-968e-f98c362df158	57483-350	HUMAN OTC DRUG	Nasova Ear Drying Drops		Isopropyl Alcohol 95%	SOLUTION/ DROPS	AURICULAR (OTIC)	20211102		OTC MONOGRAPH DRUG	M	Innovus Pharmaceuticals, Inc.	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
57483-410_cd6eb255-a89d-40c5-90a0-13f907ab0ad5	57483-410	HUMAN OTC DRUG	Xyralid Hemorrhoidal		Hemorrhoidal Suppositories	SUPPOSITORY	RECTAL	20180325		OTC MONOGRAPH FINAL	part346	Innovus Pharmaceuticals, Inc.	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	88.5; .26	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
57483-530_36bf641f-2d8d-44ee-a5db-36d1135eebeb	57483-530	HUMAN OTC DRUG	Regoxidine	(For Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20190102		ANDA	ANDA209074	Innovus Pharmaceuticals, Inc.	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
57483-535_c9f9d76b-9250-4950-90b8-a5883a6c6bff	57483-535	HUMAN OTC DRUG	Regoxidine		Minoxidil	SOLUTION	TOPICAL	20210520		ANDA	ANDA076239	Innovus Pharmaceuticals Inc.	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
57483-540_61359d4f-de10-41f1-a795-f2ae3bda5b1d	57483-540	HUMAN OTC DRUG	Regoxidine	(For Women)	Minoxidil	AEROSOL, FOAM	TOPICAL	20190422		ANDA	ANDA209074	Innovus Pharmaceuticals, Inc.	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
57483-542_f62533e8-74ce-4d06-8394-2c96fe5a49c4	57483-542	HUMAN OTC DRUG	Regoxidine		Minoxidil	SOLUTION	TOPICAL	20210419		ANDA	ANDA078176	Innovus Pharmaceuticals Inc.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
57483-596_59143e11-f5ea-462d-a283-929ece6ba550	57483-596	HUMAN OTC DRUG	Crcle Diclofenac Sodium Topical Gel 1%		Diclofenac Sodium Topical Gel 1%	GEL	TOPICAL	20220110		ANDA	ANDA210986	Innovus Pharmaceuticals Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57483-610_5ca5c652-e112-4803-805b-9207e4474a0e	57483-610	HUMAN OTC DRUG	Octiq Lubricant Eye Drops		Dextran 70 Hypromellose	SOLUTION/ DROPS	OPHTHALMIC	20211114		OTC MONOGRAPH DRUG	M	Innovus Pharmaceuticals, Inc.	DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)	1; 3	mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
57483-740_ce5c9fdc-0c50-4315-8f11-e00c9810abd0	57483-740	HUMAN OTC DRUG	omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200806		ANDA	ANDA210593	INNOVUS PHARMACEUTICALS, INC.	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57483-840_7535a309-1a67-4f50-911b-7cf570322931	57483-840	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20200810		ANDA	ANDA207891	INNOVUS PHARMACEUTICALS, INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57483-900_35efed44-c129-4bd6-8547-de9f88468907	57483-900	HUMAN OTC DRUG	Esomeprazole		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200814		ANDA	ANDA212866	INNOVUS PHARMACEUTICALS, INC.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57483-950_41da41be-9966-4fff-9064-e9817ccbd5dd	57483-950	HUMAN OTC DRUG	Allervarx		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20220530		ANDA	ANDA213294	Innovus Pharmaceuticals, Inc.	LORATADINE	10	mg/1			N	20241231
57483-955_75ab8cfc-561a-4990-b19c-2a5740d953f6	57483-955	HUMAN OTC DRUG	Allervarx		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20220604		ANDA	ANDA212795	Innovus Pharmaceuticals, Inc.	LORATADINE	5	mg/1			N	20241231
57511-0001_ec56455c-d616-93aa-e053-2a95a90a6dbc	57511-0001	HUMAN PRESCRIPTION DRUG	Just Right 5000		1.1% Sodium Fluoride Toothpaste	GEL, DENTIFRICE	TOPICAL	20200805		UNAPPROVED DRUG OTHER		Elevate Oral Care	SODIUM FLUORIDE	1.1	g/100g			N	20241231
57511-0002_bad82b94-c958-6d44-e053-2a95a90a0a5d	57511-0002	HUMAN PRESCRIPTION DRUG	Just Right 5000		1.1% Sodium Fluoride Toothpaste	GEL, DENTIFRICE	TOPICAL	20200828		UNAPPROVED DRUG OTHER		Elevate Oral Care	SODIUM FLUORIDE	1.1	g/100g			N	20241231
57511-0003_bad81d85-b4fb-324b-e053-2a95a90aac73	57511-0003	HUMAN PRESCRIPTION DRUG	Just Right 5000		1.1% Sodium Fluoride Toothpaste	GEL, DENTIFRICE	TOPICAL	20200828		UNAPPROVED DRUG OTHER		Elevate Oral Care	SODIUM FLUORIDE	1.1	g/100g			N	20241231
57511-0005_d92b84db-2203-33cc-e053-2a95a90a1753	57511-0005	HUMAN PRESCRIPTION DRUG	Allday 5000		1.1% Sodium Fluoride Toothpaste	PASTE, DENTIFRICE	TOPICAL	20220531		UNAPPROVED DRUG OTHER		Elevate Oral Care	SODIUM FLUORIDE	1.1	g/100g			N	20241231
57511-0101_ce424ed3-a1ee-5d16-e053-2a95a90a34ff	57511-0101	HUMAN OTC DRUG	FluoriMax 5000		1.1% Sodium Fluoride Toothpaste	PASTE, DENTIFRICE	TOPICAL	20150201		OTC MONOGRAPH FINAL	part355	Elevate Oral Care	SODIUM FLUORIDE	1.1	g/100g			N	20241231
57511-0102_ec571f65-5ee6-5de7-e053-2a95a90af041	57511-0102	HUMAN OTC DRUG	FluoriMax 5000 Sensitive		1.1% Sodium Fluoride with 5% Potassium Nitrate Toothpaste	PASTE, DENTIFRICE	TOPICAL	20170801	20241031	UNAPPROVED DRUG OTHER		Elevate Oral Care	POTASSIUM NITRATE; SODIUM FLUORIDE	5; 1.1	g/100g; g/100g			N	
57511-0201_08f2f8ae-fa67-47c6-e063-6394a90a752f	57511-0201	HUMAN OTC DRUG	Stance		0.63% Stannous Fluoride Concentrate Rinse	RINSE	TOPICAL	20160825		OTC MONOGRAPH DRUG	M021	Elevate Oral Care	STANNOUS FLUORIDE	1.2	mg/mL			N	20241231
57511-0202_08f2f8ae-fa68-47c6-e063-6394a90a752f	57511-0202	HUMAN OTC DRUG	Stance		0.63% Stannous Fluoride Concentrate Rinse	RINSE	TOPICAL	20160825		OTC MONOGRAPH DRUG	M021	Elevate Oral Care	STANNOUS FLUORIDE	1.2	mg/mL			N	20241231
57511-0503_ae32b0a2-e430-6a56-e053-2a95a90a0b00	57511-0503	HUMAN PRESCRIPTION DRUG	FluoriMax 5000 Sensitive		1.1% Sodium Fluoride with 5% Potassium Nitrate Toothpaste	PASTE, DENTIFRICE	TOPICAL	20200831		UNAPPROVED DRUG OTHER		Elevate Oral Care	POTASSIUM NITRATE; SODIUM FLUORIDE	5; 1.1	g/100g; g/100g			N	20241231
57511-0503_d9f232c0-d155-536b-e053-2995a90af37d	57511-0503	HUMAN PRESCRIPTION DRUG	FluoriMax 5000 Sensitive		1.1% Sodium Fluoride with 5% Potassium Nitrate Toothpaste	PASTE, DENTIFRICE	TOPICAL	20220615		UNAPPROVED DRUG OTHER		Elevate Oral Care	POTASSIUM NITRATE; SODIUM FLUORIDE	5; 1.1	g/100g; g/100g			N	20241231
57511-0504_ae45ae2d-a220-0a05-e053-2995a90a4d5e	57511-0504	HUMAN PRESCRIPTION DRUG	FluoriMax 5000		1.1% Sodium Fluoride Toothpaste	PASTE, DENTIFRICE	TOPICAL	20200901		UNAPPROVED DRUG OTHER		Elevate Oral Care	SODIUM FLUORIDE	1.1	g/100g			N	20241231
57511-0504_d9e462d9-f0fe-4168-e053-2995a90a95b2	57511-0504	HUMAN PRESCRIPTION DRUG	FluoriMax 5000		1.1% Sodium Fluoride Toothpaste	PASTE, DENTIFRICE	TOPICAL	20220615		UNAPPROVED DRUG OTHER		Elevate Oral Care	SODIUM FLUORIDE	1.1	g/100g			N	20241231
57511-0611_08f2fbb3-2fcf-508c-e063-6394a90a6091	57511-0611	HUMAN OTC DRUG	Povi-One		Povidone-Iodine 10% Topical	LIQUID	TOPICAL	20230301		OTC MONOGRAPH DRUG	505G(a)(3)	Elevate Oral Care	POVIDONE-IODINE	1	mg/10mL			N	20241231
57524-015_c52b41b9-8f8b-4430-bfd1-dcd04fb2a3bd	57524-015	HUMAN OTC DRUG	Neutralyze Clearing Serum		Salicylic Acid	GEL	TOPICAL	20200115		OTC MONOGRAPH FINAL	part333D	Kantian Skincare, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
57538-003_3294993c-17d8-4ee3-99e7-d33b8751f3af	57538-003	HUMAN OTC DRUG	AXE BRAND MEDICATED		MENTHOL, CAMPHOR AND METHYL SALICYLATE	OIL	TOPICAL	20010413		OTC MONOGRAPH NOT FINAL	part348	LEUNG KAI FOOK MEDICAL CO PTE LTD	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	5; 16; 15	g/100mL; g/100mL; g/100mL			N	20241231
57554-110_0c86d49a-27f1-7f18-e063-6394a90ad534	57554-110	HUMAN OTC DRUG	DermaWound Wound Care		povidone-iodine	OINTMENT	TOPICAL	20130408		OTC MONOGRAPH DRUG	M003	Progressive Doctors, LLC	POVIDONE-IODINE	10	g/100g			N	20241231
57554-120_0c870cce-24cb-9f40-e063-6394a90a0c76	57554-120	HUMAN OTC DRUG	DermaWound Wound Care Venous Stasis		benzocaine hydrochloride	OINTMENT	TOPICAL	20140201		OTC MONOGRAPH DRUG	M017	Progressive Doctors, LLC	BENZOCAINE	1.27	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
57556-001_091be2dc-522a-f35e-e063-6394a90a8b34	57556-001	HUMAN OTC DRUG	Homeopathic Arnica Drops		ARNICA MONTANA 6x	LOZENGE	ORAL	20200501		UNAPPROVED DRUG OTHER		Historical Remedies LLP	ARNICA MONTANA WHOLE	6	[hp_X]/1			N	20241231
57556-004_091c26eb-6c45-170a-e063-6294a90a0715	57556-004	HUMAN OTC DRUG	Homeopathic Stress Mints		Agrimonia Eupatoria 3x, Matricaria Chamomilla 12x, Arnica Montana 12x, Phosphoric Acid 12x, Avena Sativa Flowering Top 3x, Strychnos Ignatii Seed 12x, anemone pulsatilla 12x, Aconitum Napellus 12x, Strychnos Nux Vomica Seed 12x	LOZENGE	ORAL	20200501		UNAPPROVED DRUG OTHER		Historical Remedies LLP	ACONITUM NAPELLUS; AGRIMONIA EUPATORIA; ARNICA MONTANA WHOLE; AVENA SATIVA FLOWERING TOP; MATRICARIA CHAMOMILLA WHOLE; PHOSPHORIC ACID; PULSATILLA VULGARIS WHOLE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED	12; 3; 12; 3; 12; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57556-006_091c024a-c65e-209a-e063-6394a90a749f	57556-006	HUMAN OTC DRUG	Homeopathic Calm Drops		Arsenic Trioxide 30c, Matricaria Chamomilla12x, Arabica Coffee Bean 30x, Potassium Carbonate30c, Strychnos Ignatii Seed30x, lachesis Muta Venom12x, Phosphoric Acid 3x, Anemone Pulsatilla 12c, Valerian 30c, Aconitum Napellus 6x, Chloride ion 12x, Strychnos Nux-Vomica Seed 30c	LOZENGE	ORAL	20200501		UNAPPROVED HOMEOPATHIC		HISTORICAL REMEDIES LLP.	ACONITUM NAPELLUS WHOLE; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; LACHESIS MUTA VENOM; MATRICARIA CHAMOMILLA; PHOSPHORIC ACID; POTASSIUM CARBONATE; PULSATILLA VULGARIS WHOLE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VALERIAN	6; 30; 30; 12; 12; 3; 30; 12; 12; 30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57556-007_091c41fb-e8ea-1233-e063-6294a90acebd	57556-007	HUMAN OTC DRUG	Homeopathic Pick Up Drops		Gelsemium Sempervirens ROOT 12x, Matricaria Chamomilla12x, Arnica Montana Whole 12x,, Phosphoric Acid 12x, Anemone Pulsatilla 12x, Aconitum Napellus 12x, Strychnos Nux-Vomica Seed 12x	LOZENGE	ORAL	20200501		UNAPPROVED HOMEOPATHIC		HISTORICAL REMEDIES LLP.	ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA; PHOSPHORIC ACID; PULSATILLA VULGARIS WHOLE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57556-008_091c024a-c668-209a-e063-6394a90a749f	57556-008	HUMAN OTC DRUG	Homeopathic Moon drops		Arsenic cation 30x, Matricaria Chamomilla 6x, Arabica Coffee Bean 12x, Gelsemium Sempervirens Root 12x, Strychnos Ignatii Seed 30x, Lycopodium Clavatum Spore 30x, Sodium Chloride 30x, Strychnos Nux Vomica Seed 30x, Valerian 12c,	LOZENGE	ORAL	20200501		UNAPPROVED DRUG OTHER		Historical Remedies LLP	ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA WHOLE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VALERIAN	12; 30; 12; 30; 6; 30; 30; 30; 12	[hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57556-010_08b32515-9fcd-e0b0-e063-6294a90a3cb3	57556-010	HUMAN OTC DRUG	Aconitum napellus		Aconite	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Historical Remedies	ACONITUM NAPELLUS	12	[hp_X]/g			N	20241231
57556-012_08b32515-9fd9-e0b0-e063-6294a90a3cb3	57556-012	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Historical Remedies	ATROPA BELLADONNA	12	[hp_X]/g			N	20241231
57556-015_08b3608f-5bf0-0538-e063-6394a90a2bff	57556-015	HUMAN OTC DRUG	Ipecacuanha		Ipecac	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Historical Remedies	IPECAC	12	[hp_X]/g			N	20241231
57556-016_091c3ffa-21d6-4fb3-e063-6394a90a98a6	57556-016	HUMAN OTC DRUG	Nux vomica		Nux vomica	PELLET	ORAL	20220615		UNAPPROVED HOMEOPATHIC		Historical Remedies	STRYCHNOS NUX-VOMICA SEED	12	[hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57556-017_08b35c69-6893-66d2-e063-6294a90a1c69	57556-017	HUMAN OTC DRUG	Pulsatilla		Pulsatilla	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Historical Remedies	ANEMONE PULSATILLA	12	[hp_X]/g			N	20241231
57582-101_ab8258a7-91c0-4bcd-a359-a09b16ab5c35	57582-101	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	Tianjin Tianyao Pharmaceuticals Co., Ltd.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
57582-211_30949e07-504d-43c2-b0d1-1c26dcaed176	57582-211	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200225		ANDA	ANDA207872	Tianjin Tianyao Pharmaceuticals Co., Ltd.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57582-212_30949e07-504d-43c2-b0d1-1c26dcaed176	57582-212	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200225		ANDA	ANDA207872	Tianjin Tianyao Pharmaceuticals Co., Ltd.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57582-213_30949e07-504d-43c2-b0d1-1c26dcaed176	57582-213	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200225		ANDA	ANDA207872	Tianjin Tianyao Pharmaceuticals Co., Ltd.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57582-214_30949e07-504d-43c2-b0d1-1c26dcaed176	57582-214	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200225		ANDA	ANDA207872	Tianjin Tianyao Pharmaceuticals Co., Ltd.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57597-043_602aeae0-6814-1f8e-e053-2a91aa0a2aae	57597-043	HUMAN OTC DRUG	Wong To Yick	External Analgesic	Camphor Menthol Methyl Salicylate	OIL	TOPICAL	20111115		OTC MONOGRAPH NOT FINAL	part348	Wong To Yick Wood Lock Ointment Ltd	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	1; 1.6; 5	mg/10mL; mg/10mL; mg/10mL			N	20241231
57598-111_61aef626-b8bb-483a-9328-429f011d2a08	57598-111	HUMAN OTC DRUG	Koong Yick Hung Fa		Methyl Salicylate	OIL	TOPICAL	20210204		OTC MONOGRAPH DRUG	M017	Ling Nam Medicine Factory (H.K.) Ltd.	METHYL SALICYLATE	25	g/100mL			N	20241231
57598-112_a9b29cb3-2b08-4a1b-ab95-54cbb66be3e3	57598-112	HUMAN OTC DRUG	Ling Nam Hung Far		Methyl Salicylate	OIL	TOPICAL	20210225		OTC MONOGRAPH DRUG	M017	Ling Nam Medicine Factory (H.K.) Ltd.	METHYL SALICYLATE	25	g/100mL			N	20241231
57598-221_cca9573d-d2ed-45bc-997a-3e3f5aa229b1	57598-221	HUMAN OTC DRUG	Koong Yick Hak Kwai Oil		Turpentine Oil	OIL	TOPICAL	20210225		OTC MONOGRAPH DRUG	M017	Ling Nam Medicine Factory (H.K.) Ltd.	TURPENTINE	46	g/100mL			N	20241231
57598-223_7a54295f-7f8b-421f-9a11-166a39f8575e	57598-223	HUMAN OTC DRUG	Ling Nam Hak Kwai Oil		Turpentine Oil	OIL	TOPICAL	20210225		OTC MONOGRAPH DRUG	M017	Ling Nam Medicine Factory (H.K.) Ltd.	TURPENTINE	46	g/100mL			N	20241231
57598-888_a0fb0f8a-e2ad-4432-961e-c9c7c6862265	57598-888	HUMAN OTC DRUG	Ultra Balm		Menthol and Methyl Salicylate	OINTMENT	TOPICAL	20130801		OTC MONOGRAPH DRUG	M017	Ling Nam Medicine Factory (H.K.) Ltd.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	140; 232	mg/g; mg/g			N	20241231
57619-303_0e8993a7-39d0-7950-e063-6394a90a05fa	57619-303	HUMAN OTC DRUG	Splash Tears		Hypromellose	SOLUTION/ DROPS	OPHTHALMIC	20200513		OTC MONOGRAPH DRUG	M018	LABORATORIOS SOPHIA, S.A. DE C.V.	HYPROMELLOSE 2910 (4000 MPA.S)	.2	g/100mL			N	20251231
57619-304_fb341385-67f2-c4cb-e053-6294a90aea52	57619-304	HUMAN OTC DRUG	Splash Redness Reliever		Hypromellose, Naphazoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20230425		OTC MONOGRAPH FINAL	part349	LABORATORIOS SOPHIA, S.A. DE C.V.	HYPROMELLOSE 2910 (4000 MPA.S); NAPHAZOLINE HYDROCHLORIDE	.2; .02	g/100mL; g/100mL			N	20241231
57619-400_0e8998e9-f3a7-7cd3-e063-6394a90a52a4	57619-400	HUMAN OTC DRUG	Manzanilla	Sophia	Chamomile (Matricaria Chamomilla L.)	SOLUTION/ DROPS	OPHTHALMIC	20100412		UNAPPROVED HOMEOPATHIC		LABORATORIOS SOPHIA, S.A. DE C.V.	MATRICARIA RECUTITA	3	[hp_X]/mL			N	20251231
57627-107_925b0ca6-5f50-4e43-aae4-62eb661f73ef	57627-107	HUMAN OTC DRUG	Lip Conditioner SPF 15	Merle Norman	OCTINOXATE,OCTISALATE	JELLY	TOPICAL	20110421		OTC MONOGRAPH NOT FINAL	part352	Merle Norman	OCTINOXATE; OCTISALATE	.278; .185	g/3.7g; g/3.7g			N	20241231
57627-108_eb7c34f9-a3f9-3858-e053-2995a90aef89	57627-108	HUMAN OTC DRUG	Foundation Primer Plus SPF 15	MERLE NORMAN	octinoxate, octisalate	CREAM	TOPICAL	20110422		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics	OCTINOXATE; OCTISALATE	2.63; 1.75	g/35g; g/35g			N	20241231
57627-110_ce1abb37-3f3d-4c30-b278-dcc029991fcd	57627-110	HUMAN OTC DRUG	Lasting Foundation SPF 12	Merle Norman	TITANIUM DIOXIDE	CREAM	TOPICAL	20110422		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc	TITANIUM DIOXIDE	2.4	g/30g			N	20241231
57627-113_5a5ff94d-4c04-46cb-bb76-64943513c02f	57627-113	HUMAN OTC DRUG	Flawless Effect Liquid Foundation SPF 15	Merle Norman	OCTINOXATE, OXYBENZONE	LIQUID	TOPICAL	20110425		OTC MONOGRAPH NOT FINAL	part352	Merle Norman	OCTINOXATE; OXYBENZONE	2.25; .9	g/30g; g/30g			N	20241231
57627-123_17baa492-66b9-41d2-8127-8bebb952356d	57627-123	HUMAN OTC DRUG	Bare Perfecting Makeup	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120822		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-124_9171e664-133a-4d6c-8861-b26729a9da0b	57627-124	HUMAN OTC DRUG	Vanilla Perfecting Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120822		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-125_71d43332-21c1-4642-8769-5f83b89c27b8	57627-125	HUMAN OTC DRUG	Ivory Perfecting Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120822		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-126_aa617356-6e87-495c-9ed7-42274f4b1b99	57627-126	HUMAN OTC DRUG	Alabaster Perfecting Makeup SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120907		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-128_a54153f9-65d9-4f07-ad86-d672dc6018ae	57627-128	HUMAN OTC DRUG	Creamy Beige Perfecting Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120822		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-129_a3bc632d-64f3-4090-ae75-ef8772b3b43a	57627-129	HUMAN OTC DRUG	Simply Beige Perfecting makeup SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120822		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	30; 30	g/30mL; g/30mL			N	20241231
57627-130_7a5faa82-c140-4b27-b0b5-fda1c2794d3d	57627-130	HUMAN OTC DRUG	Soft Bisque Perfecting Makeup SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120826		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-133_228ffdbb-63ae-4468-b543-3c62419e4539	57627-133	HUMAN OTC DRUG	Delicate Beige Perfecting Makeup SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120822		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-149_1ab91736-dcc6-4471-844c-afdcea851105	57627-149	HUMAN OTC DRUG	Anti-Aging Complex SPF 30	Merle Norman	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	EMULSION	TOPICAL	20121108		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.93; 2.48; 1.24; .729; 1.55	g/31g; g/31g; g/31g; g/31g; g/31g			N	20241231
57627-150_2b5e2b91-1cf9-4d94-81b3-2bbb7acec979	57627-150	HUMAN OTC DRUG	Anti-Aging Complex Eye Treatment	Merle Norman	Octinoxate, Zinc Oxide	LOTION	TOPICAL	20121109		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics	OCTINOXATE; ZINC OXIDE	1.18; 1.04	g/16g; g/16g			N	20241231
57627-151_66087f1a-f6dd-4f30-b65a-4adb0e3f59d0	57627-151	HUMAN OTC DRUG	Sheer Defense Tinted Moisturizer SPF 15 L10	Merle Norman	Octinoxate, Titanium Dioxide	LIQUID	TOPICAL	20121206		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 5.12	g/100g; g/100g			N	20241231
57627-152_bb41ce56-8c81-40dd-aef0-23e3850a2bb1	57627-152	HUMAN OTC DRUG	Sheer Defense Tinted Moisturizer SPF15 L20	Merle Norman	Octinoxate, Titanium Dioxide	LIQUID	TOPICAL	20121207		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 5.02	g/100g; g/100g			N	20241231
57627-153_c377f243-778b-404c-b06b-53e3bb8ffd50	57627-153	HUMAN OTC DRUG	Sheer Defense Tinted Moisturizer Broad Spectrum SPF 15 M50	Merle Norman	Octinoxate, Titanium Dioxide	LIQUID	TOPICAL	20121210		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 4.19	g/100g; g/100g			N	20241231
57627-154_4c9e3a60-105b-4061-8f5a-6871aadf2134	57627-154	HUMAN OTC DRUG	Sheer Defense Tinted Moisturizer Broad Spectrum SPF 15 MD 70	Merle Norman	Octinoxate, Titanium Dioxide	LIQUID	TOPICAL	20121210		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 3.67	g/100g; g/100g			N	20241231
57627-155_28de5883-86e4-44ea-9dfe-e6e9b9f4487e	57627-155	HUMAN OTC DRUG	Sheer Defense Tinted Moisturizer SPF 15 ML 30	Merle Norman	Octinoxate, Titanium Dioxide	LIQUID	TOPICAL	20121211		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 4.79	g/100g; g/100g			N	20241231
57627-156_a61adf54-bacf-4568-a40f-4260b2d894a6	57627-156	HUMAN OTC DRUG	Sheer Defense Tinted Moisturizer SPF 15 ML 40	Merle Norman	Octinoxate, Titanium Dioxide	LIQUID	TOPICAL	20121212		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc.	OCTINOXATE; TITANIUM DIOXIDE	2.6; 15.3	g/35g; g/35g			N	20241231
57627-157_c2c76313-5960-6975-e053-2a95a90a21d1	57627-157	HUMAN OTC DRUG	Bare Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-159_c2c76313-5960-6975-e053-2a95a90a21d1	57627-159	HUMAN OTC DRUG	Porcelain Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-160_c2c76313-5960-6975-e053-2a95a90a21d1	57627-160	HUMAN OTC DRUG	Alabaster Beige Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-161_c2c76313-5960-6975-e053-2a95a90a21d1	57627-161	HUMAN OTC DRUG	Creamy Beige Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-162_c2c76313-5960-6975-e053-2a95a90a21d1	57627-162	HUMAN OTC DRUG	Simply Beige Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-163_c2c76313-5960-6975-e053-2a95a90a21d1	57627-163	HUMAN OTC DRUG	Soft Bisque Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-164_c2c76313-5960-6975-e053-2a95a90a21d1	57627-164	HUMAN OTC DRUG	Sand Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-165_c2c76313-5960-6975-e053-2a95a90a21d1	57627-165	HUMAN OTC DRUG	Medium Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-166_c2c76313-5960-6975-e053-2a95a90a21d1	57627-166	HUMAN OTC DRUG	Sandy Beige Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-167_c2c76313-5960-6975-e053-2a95a90a21d1	57627-167	HUMAN OTC DRUG	Delicate Beige Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-169_c2c76313-5960-6975-e053-2a95a90a21d1	57627-169	HUMAN OTC DRUG	Ivory Expert Finish Makeup Broad Spectrum SPF 25	Merle Norman	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20131020		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	4; 5.2	g/100g; g/100g			N	20241231
57627-170_ee643b8b-a0a6-4b70-a6d0-23750dc4ef7a	57627-170	HUMAN OTC DRUG	CC Cream Broad Spectrum SPF 30	Merle Norman	Homosalate, Octinoxate, Oxybenzone, Titanium Dioxide	CREAM	TOPICAL	20140619		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics	HOMOSALATE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE	7; 2.5; 2; 4.1	g/100g; g/100g; g/100g; g/100g			N	20241231
57627-173_6cd40be6-660c-48c2-910e-800609497790	57627-173	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Porcelain	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-174_4eeb9167-9a5e-4e3f-81cc-7af758469557	57627-174	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Sesame	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-175_d731711b-3923-477d-931f-964d87caf1ae	57627-175	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Ivory	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-176_0e9ef07b-36c8-4225-9f76-629493e4de65	57627-176	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Alabaster Beige	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-177_9bc85c68-bf47-423e-9c51-14773e8d3678	57627-177	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Alabaster	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-178_d06f5a92-e9e9-4554-8a59-11c74cb73eef	57627-178	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Creamy Beige	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-179_c4ffbe4a-87de-49df-9bc9-4bfea8a49c1d	57627-179	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Simply Beige	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-180_2422250f-6200-40e1-b60b-4622a0b9b2f9	57627-180	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Soft Bisque	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-181_8bcba2c8-89b1-4278-bc26-6760c0cace6c	57627-181	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Quiet Rose	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-182_71a24ebc-93f7-49a5-806d-c12b1a1932d0	57627-182	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Sandy Beige	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-183_39252952-1787-4a39-b449-d71ac8d0df58	57627-183	HUMAN OTC DRUG	Timeless Illuminating Makeup SPF 30 Pure Beige	Merle Norman	Octinoxate, Oxybenzone	CREAM	TOPICAL	20170124		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; OXYBENZONE	7.5; 2	g/100mL; g/100mL			N	20241231
57627-185_c29df42f-af22-7345-e053-2a95a90a60bd	57627-185	HUMAN OTC DRUG	Alabaster Beige Perfecting Makeup SPF 25	Merle Norman	octinoxate, Titanium Dioxide	EMULSION	TOPICAL	20120822		OTC MONOGRAPH NOT FINAL	part352	Merle Norman Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE	2.25; 2.13	g/30mL; g/30mL			N	20241231
57627-186_d5c97cdc-7f99-1a4f-e053-2995a90a089b	57627-186	HUMAN OTC DRUG	Preventage Firming Defense Creme Normal/ Oily Broad Spectrum SPF 15		Avobenzone, Octocrylene	CREAM	TOPICAL	20220117		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics	AVOBENZONE; OCTOCRYLENE	1.9; 9.4	g/100g; g/100g			N	20241231
57627-201_e8b66c88-8d30-4d21-ac61-118ac3d38ddf	57627-201	HUMAN OTC DRUG	Acne Defense Spot Treatment	Merle Norman	Salicylic Acid	GEL	TOPICAL	20170714		OTC MONOGRAPH FINAL	part358H	Merle Norman Cosmetics, Inc	SALICYLIC ACID	2	g/100g			N	20241231
57627-202_0794a375-64b8-448b-8f50-5633ad7f054b	57627-202	HUMAN OTC DRUG	Acne defense Daily Treatment Serum	Merle Norman	Benzoyl Peroxide	GEL	TOPICAL	20170714		OTC MONOGRAPH FINAL	part333D	Merle Norman Cosmetics	BENZOYL PEROXIDE	2.5	g/100g			N	20241231
57627-203_d0dc5744-82d2-2f51-e053-2a95a90a3972	57627-203	HUMAN OTC DRUG	Preventage Firming Defense Creme Normal/Dry Broad Spectrum SPF 15		Avobenzone, Octocrylene	CREAM	TOPICAL	20211115		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc.	AVOBENZONE; OCTOCRYLENE	1.9; 9.4	g/100g; g/100g			N	20241231
57627-204_d10272ea-aede-5759-e053-2a95a90a3ab3	57627-204	HUMAN OTC DRUG	ANTI-AGING COMPLEX BROAD SPECTRUM SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20211129		OTC MONOGRAPH FINAL	part352	Merle Norman Cosmetics, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 8; 4; 2.35; 5	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
57648-002_e3a8d96b-12f2-485e-9ee4-cda63df56524	57648-002	HUMAN OTC DRUG	The Magic Bullet		Bisacodyl	SUPPOSITORY	RECTAL	20040101		OTC MONOGRAPH NOT FINAL	part334	Concepts in Confidence	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57660-000_0d773370-d63a-c88c-e063-6394a90ae4d0	57660-000	HUMAN OTC DRUG	PLAQUE HD ANTICAVITY FRESH MINT FLAVOR	Professional Plaque-Identifying	SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20130610		OTC MONOGRAPH DRUG	M021	TJA Health LLC	SODIUM FLUORIDE	.14	g/100g			N	20241231
57660-001_0d77541c-d75e-96b1-e063-6294a90ac54b	57660-001	HUMAN OTC DRUG	PLAQUE HD ANTICAVITY BERRY BUBBLE GUM FLAVOR	Professional Plaque-Identifying	SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20140319		OTC MONOGRAPH DRUG	M021	TJA Health LLC	SODIUM FLUORIDE	.14	g/100g			N	20241231
57660-003_0d77552d-f0ac-de1c-e063-6394a90a1c45	57660-003	HUMAN OTC DRUG	Plaque Refresh Remineralizing Rinse Fresh Mint		SODIUM FLUORIDE	LIQUID	TOPICAL	20220101		OTC MONOGRAPH DRUG	M021	TJA Health LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
57660-004_0d773e41-50c8-7c54-e063-6294a90aff1f	57660-004	HUMAN OTC DRUG	Coconut Foaming Hand Sanitizer With Natural Vitamin E and Almond Oil		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220301		OTC MONOGRAPH DRUG	505G(a)(3)	TJA Health LLC	BENZALKONIUM CHLORIDE	1.2	mg/mL			N	20241231
57664-014_f291a9f6-4b36-753c-e053-2a95a90a181a	57664-014	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	20221003		ANDA	ANDA073137	Sun Pharmaceutical Industries, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
57664-020_0e924cf6-5375-28c4-e063-6294a90a4ac4	57664-020	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20201229		NDA AUTHORIZED GENERIC	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
57664-021_0e924cf6-5375-28c4-e063-6294a90a4ac4	57664-021	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20201229		NDA AUTHORIZED GENERIC	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
57664-022_0e924cf6-5375-28c4-e063-6294a90a4ac4	57664-022	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20201229		NDA AUTHORIZED GENERIC	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	25	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
57664-023_0e924cf6-5375-28c4-e063-6294a90a4ac4	57664-023	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20201229		NDA AUTHORIZED GENERIC	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
57664-024_0e924cf6-5375-28c4-e063-6294a90a4ac4	57664-024	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20201229		NDA AUTHORIZED GENERIC	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	35	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
57664-025_0e924cf6-5375-28c4-e063-6294a90a4ac4	57664-025	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20201229		NDA AUTHORIZED GENERIC	NDA021951	Sun Pharmaceutical Industries, Inc.	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
57664-026_f291a9f6-4b36-753c-e053-2a95a90a181a	57664-026	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	20221003		ANDA	ANDA073137	Sun Pharmaceutical Industries, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
57664-046_0b77417a-5789-8818-e063-6294a90ad2e3	57664-046	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	CAPSULE	ORAL	20230825		ANDA	ANDA214484	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-047_0b77417a-5789-8818-e063-6294a90ad2e3	57664-047	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	CAPSULE	ORAL	20230825		ANDA	ANDA214484	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-048_0b77417a-5789-8818-e063-6294a90ad2e3	57664-048	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	CAPSULE	ORAL	20230825		ANDA	ANDA214484	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-049_0b77417a-5789-8818-e063-6294a90ad2e3	57664-049	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	CAPSULE	ORAL	20230825		ANDA	ANDA214484	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-050_0b77417a-5789-8818-e063-6294a90ad2e3	57664-050	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	CAPSULE	ORAL	20230825		ANDA	ANDA214484	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-051_0b77417a-5789-8818-e063-6294a90ad2e3	57664-051	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	CAPSULE	ORAL	20230825		ANDA	ANDA214484	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-052_0b77417a-5789-8818-e063-6294a90ad2e3	57664-052	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	CAPSULE	ORAL	20230825		ANDA	ANDA214484	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-053_f291a9f6-4b36-753c-e053-2a95a90a181a	57664-053	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20221003		ANDA	ANDA073137	Sun Pharmaceutical Industries, Inc.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
57664-062_278f897d-b963-43a5-ae16-58267d1aecd4	57664-062	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20210127		ANDA	ANDA214574	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-075_278f897d-b963-43a5-ae16-58267d1aecd4	57664-075	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20210127		ANDA	ANDA214574	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-083_0b77417a-5789-8818-e063-6294a90ad2e3	57664-083	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA214134	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-084_0b77417a-5789-8818-e063-6294a90ad2e3	57664-084	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA214134	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-085_0b77417a-5789-8818-e063-6294a90ad2e3	57664-085	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA214134	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-086_0b77417a-5789-8818-e063-6294a90ad2e3	57664-086	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA214134	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-087_0b77417a-5789-8818-e063-6294a90ad2e3	57664-087	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA214134	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-088_0b77417a-5789-8818-e063-6294a90ad2e3	57664-088	HUMAN PRESCRIPTION DRUG	LISDEXAMFETAMINE DIMESYLATE		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20230825		ANDA	ANDA214134	Sun Pharmaceutical Industries, Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-162_0e91f855-67c8-037b-e063-6294a90a0a54	57664-162	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	Sun Pharmaceutical Industries, Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
57664-166_0e91f855-67c8-037b-e063-6294a90a0a54	57664-166	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	Sun Pharmaceutical Industries, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
57664-167_0e91f855-67c8-037b-e063-6294a90a0a54	57664-167	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	Sun Pharmaceutical Industries, Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
57664-187_11c23682-e42c-4e33-b67f-acdcc8be3b38	57664-187	HUMAN PRESCRIPTION DRUG	oxycodone hydrochloride		oxycodone hydrochloride	TABLET	ORAL	20090512		ANDA	ANDA090659	Sun Pharmaceutical Industries, Inc.	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
57664-211_5dab493f-f2b8-4841-9332-1d9d97451460	57664-211	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20171108		ANDA	ANDA075713	Sun Pharmaceutical Industries, Inc.	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
57664-223_11c23682-e42c-4e33-b67f-acdcc8be3b38	57664-223	HUMAN PRESCRIPTION DRUG	oxycodone hydrochloride		oxycodone hydrochloride	TABLET	ORAL	20090512		ANDA	ANDA090659	Sun Pharmaceutical Industries, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
57664-224_11c23682-e42c-4e33-b67f-acdcc8be3b38	57664-224	HUMAN PRESCRIPTION DRUG	oxycodone hydrochloride		oxycodone hydrochloride	TABLET	ORAL	20090512		ANDA	ANDA090659	Sun Pharmaceutical Industries, Inc.	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
57664-228_0c91d9bb-b8d7-7f0a-e063-6394a90afaee	57664-228	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20130816		ANDA	ANDA090710	Sun Pharmaceutical Industries, Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-229_0c91d9bb-b8d7-7f0a-e063-6394a90afaee	57664-229	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20130816		ANDA	ANDA090710	Sun Pharmaceutical Industries, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-230_0c91d9bb-b8d7-7f0a-e063-6394a90afaee	57664-230	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20130816		ANDA	ANDA090710	Sun Pharmaceutical Industries, Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-231_163dd253-35bc-4eb8-8bfc-a3ec65c9da14	57664-231	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20160415		ANDA	ANDA201722	Sun Pharmaceutical Industries, Inc.	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
57664-232_163dd253-35bc-4eb8-8bfc-a3ec65c9da14	57664-232	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20160415		ANDA	ANDA201722	Sun Pharmaceutical Industries, Inc.	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
57664-233_163dd253-35bc-4eb8-8bfc-a3ec65c9da14	57664-233	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20160415		ANDA	ANDA201722	Sun Pharmaceutical Industries, Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
57664-241_5dab493f-f2b8-4841-9332-1d9d97451460	57664-241	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20050819		ANDA	ANDA075713	Sun Pharmaceutical Industries, Inc.	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
57664-336_dc7bba4e-0db3-8ebb-e053-2a95a90aed98	57664-336	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200305		ANDA	ANDA211715	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-337_dc7bba4e-0db3-8ebb-e053-2a95a90aed98	57664-337	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200305		ANDA	ANDA211715	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-338_dc7bba4e-0db3-8ebb-e053-2a95a90aed98	57664-338	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200305		ANDA	ANDA211715	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-339_dc7bba4e-0db3-8ebb-e053-2a95a90aed98	57664-339	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200305		ANDA	ANDA211715	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-340_dc7bba4e-0db3-8ebb-e053-2a95a90aed98	57664-340	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200305		ANDA	ANDA211715	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-341_dc7bba4e-0db3-8ebb-e053-2a95a90aed98	57664-341	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200305		ANDA	ANDA211715	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-345_5dab493f-f2b8-4841-9332-1d9d97451460	57664-345	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20021115		ANDA	ANDA075713	Sun Pharmaceutical Industries, Inc.	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
57664-347_5dab493f-f2b8-4841-9332-1d9d97451460	57664-347	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20021115		ANDA	ANDA075713	Sun Pharmaceutical Industries, Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
57664-370_11c23682-e42c-4e33-b67f-acdcc8be3b38	57664-370	HUMAN PRESCRIPTION DRUG	oxycodone hydrochloride		oxycodone hydrochloride	TABLET	ORAL	20121119		ANDA	ANDA090659	Sun Pharmaceutical Industries, Inc.	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
57664-371_11c23682-e42c-4e33-b67f-acdcc8be3b38	57664-371	HUMAN PRESCRIPTION DRUG	oxycodone hydrochloride		oxycodone hydrochloride	TABLET	ORAL	20121119		ANDA	ANDA090659	Sun Pharmaceutical Industries, Inc.	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
57664-376_0d0cbfc3-ae27-b481-e063-6394a90a917c	57664-376	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	TABLET	ORAL	20130926		ANDA	ANDA201231	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
57664-377_0c56ff9e-0efa-b144-e063-6394a90a7968	57664-377	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Sun Pharmaceutical Industries, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
57664-378_0d0cbfc3-ae27-b481-e063-6394a90a917c	57664-378	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	TABLET	ORAL	20130926		ANDA	ANDA201231	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
57664-379_0d0cbfc3-ae27-b481-e063-6394a90a917c	57664-379	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	TABLET	ORAL	20130926		ANDA	ANDA201231	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
57664-392_08f549f6-460f-485c-e063-6294a90a2a3f	57664-392	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57664-393_08f549f6-460f-485c-e063-6294a90a2a3f	57664-393	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57664-394_08f549f6-460f-485c-e063-6294a90a2a3f	57664-394	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57664-395_08f549f6-460f-485c-e063-6294a90a2a3f	57664-395	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57664-396_08f549f6-460f-485c-e063-6294a90a2a3f	57664-396	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Sun Pharmaceutical Industries, Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
57664-397_7274fdaf-11f8-2b2f-e053-2991aa0ad3f6	57664-397	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020129		ANDA	ANDA075967	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
57664-435_7274fdaf-11f8-2b2f-e053-2991aa0ad3f6	57664-435	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020129		ANDA	ANDA075967	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
57664-437_7c0b9ff4-d4ba-4621-af1e-03b68e31ea47	57664-437	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20150217		ANDA	ANDA076363	Sun Pharmaceutical Industries, Inc.	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
57664-441_7c0b9ff4-d4ba-4621-af1e-03b68e31ea47	57664-441	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20150217		ANDA	ANDA076363	Sun Pharmaceutical Industries, Inc.	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
57664-474_7274fdaf-11f8-2b2f-e053-2991aa0ad3f6	57664-474	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020129		ANDA	ANDA075967	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
57664-477_0e91f855-67c8-037b-e063-6294a90a0a54	57664-477	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	Sun Pharmaceutical Industries, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
57664-499_f5e842da-4922-4f1d-b2e0-a4c0be71e2a6	57664-499	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Sun Pharmaceutical Industries, Inc.	MIRTAZAPINE	15	mg/1			N	20241231
57664-500_f5e842da-4922-4f1d-b2e0-a4c0be71e2a6	57664-500	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Sun Pharmaceutical Industries, Inc.	MIRTAZAPINE	30	mg/1			N	20241231
57664-501_f5e842da-4922-4f1d-b2e0-a4c0be71e2a6	57664-501	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Sun Pharmaceutical Industries, Inc.	MIRTAZAPINE	45	mg/1			N	20241231
57664-502_5e8ef5b3-9f58-46a7-833c-31ef018ea9a0	57664-502	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Sun Pharmaceutical Industries, Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
57664-503_5e8ef5b3-9f58-46a7-833c-31ef018ea9a0	57664-503	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Sun Pharmaceutical Industries, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
57664-506_0e91f855-67c8-037b-e063-6294a90a0a54	57664-506	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA076670	Sun Pharmaceutical Industries, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
57664-507_ef44872c-ba5e-d69b-e053-2a95a90adb55	57664-507	HUMAN PRESCRIPTION DRUG	citalopram hydrobromide		citalopram hydrobromide	TABLET	ORAL	20150529		ANDA	ANDA077032	Sun Pharmaceutical Industries, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
57664-508_ef44872c-ba5e-d69b-e053-2a95a90adb55	57664-508	HUMAN PRESCRIPTION DRUG	citalopram hydrobromide		citalopram hydrobromide	TABLET	ORAL	20150529		ANDA	ANDA077032	Sun Pharmaceutical Industries, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
57664-510_f5e842da-4922-4f1d-b2e0-a4c0be71e2a6	57664-510	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Sun Pharmaceutical Industries, Inc.	MIRTAZAPINE	7.5	mg/1			N	20241231
57664-537_0aec7684-04b3-485d-a030-3ca9843d097f	57664-537	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN		TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20051216		ANDA	ANDA077184	Sun Pharmaceutical Industries, Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
57664-596_1086cd9a-8975-4c42-a120-f8b70c9a7bdb	57664-596	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20150408		ANDA	ANDA202126	Sun Pharmaceuticals Industries, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
57664-606_0da4b745-d498-8823-e063-6394a90a4524	57664-606	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA205135	Sun Pharmaceutical Industries, Inc.	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
57664-607_0da4b745-d498-8823-e063-6394a90a4524	57664-607	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA205135	Sun Pharmaceutical Industries, Inc.	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
57664-608_0da4b745-d498-8823-e063-6394a90a4524	57664-608	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA205135	Sun Pharmaceutical Industries, Inc.	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
57664-609_0da4b745-d498-8823-e063-6394a90a4524	57664-609	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200820		ANDA	ANDA205135	Sun Pharmaceutical Industries, Inc.	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
57664-621_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-621	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-622_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-622	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-623_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-623	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-624_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-624	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-625_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-625	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-626_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-626	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-628_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-628	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-629_dfada2f5-18f1-4d93-96ad-7cbca3e712e5	57664-629	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate hydrochloride		Dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211105		ANDA	ANDA206734	Sun Pharmaceutical Industries, Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-641_d2851400-1396-4c04-800b-88ba5a2c7aca	57664-641	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-642_d2851400-1396-4c04-800b-88ba5a2c7aca	57664-642	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-643_d2851400-1396-4c04-800b-88ba5a2c7aca	57664-643	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-644_d2851400-1396-4c04-800b-88ba5a2c7aca	57664-644	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-645_d2851400-1396-4c04-800b-88ba5a2c7aca	57664-645	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-646_d2851400-1396-4c04-800b-88ba5a2c7aca	57664-646	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-647_d2851400-1396-4c04-800b-88ba5a2c7aca	57664-647	HUMAN PRESCRIPTION DRUG	Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate		Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate	TABLET	ORAL	20030909		ANDA	ANDA040480	Sun Pharmaceutical Industries, Inc.	AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57664-648_eca591c9-75f8-2cbb-e053-2a95a90a7cf4	57664-648	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20160212		ANDA	ANDA089286	Sun Pharmaceutical Industries, Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
57664-649_eca591c9-75f8-2cbb-e053-2a95a90a7cf4	57664-649	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20160212		ANDA	ANDA089286	Sun Pharmaceutical Industries, Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
57664-655_a0a57e6d-d85e-46df-b564-bc522691031a	57664-655	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	19940127		ANDA	ANDA074063	Sun Pharmaceutical Industries, Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
57664-656_a0a57e6d-d85e-46df-b564-bc522691031a	57664-656	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	19940127		ANDA	ANDA074063	Sun Pharmaceutical Industries, Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
57664-663_60ad5be0-889c-4179-8584-f5c779c7c136	57664-663	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Sun Pharmaceutical Industries, Inc.	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
57664-664_60ad5be0-889c-4179-8584-f5c779c7c136	57664-664	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Sun Pharmaceutical Industries, Inc.	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
57664-665_60ad5be0-889c-4179-8584-f5c779c7c136	57664-665	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Sun Pharmaceutical Industries, Inc.	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
57664-666_60ad5be0-889c-4179-8584-f5c779c7c136	57664-666	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Sun Pharmaceutical Industries, Inc.	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
57664-682_aaefa755-b3ef-40d9-b05c-d5a5bda47c1a	57664-682	HUMAN PRESCRIPTION DRUG	Linezolid		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20170201		ANDA	ANDA207354	Sun Pharmaceutical Industries, Inc.	LINEZOLID	200	mg/100mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
57664-683_aaefa755-b3ef-40d9-b05c-d5a5bda47c1a	57664-683	HUMAN PRESCRIPTION DRUG	Linezolid		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20170201		ANDA	ANDA207354	Sun Pharmaceutical Industries, Inc.	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
57664-687_e716bdbf-7efa-43ba-ad8f-d34cb5119bed	57664-687	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Sun Pharmaceutical Industries, Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
57664-688_e716bdbf-7efa-43ba-ad8f-d34cb5119bed	57664-688	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Sun Pharmaceutical Industries, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
57664-689_e716bdbf-7efa-43ba-ad8f-d34cb5119bed	57664-689	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Sun Pharmaceutical Industries, Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
57664-690_e716bdbf-7efa-43ba-ad8f-d34cb5119bed	57664-690	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Sun Pharmaceutical Industries, Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
57664-691_e716bdbf-7efa-43ba-ad8f-d34cb5119bed	57664-691	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Sun Pharmaceutical Industries, Inc.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
57664-692_e716bdbf-7efa-43ba-ad8f-d34cb5119bed	57664-692	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Sun Pharmaceutical Industries, Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
57664-698_11282b21-1ccc-404b-9876-eeefb8872c4c	57664-698	HUMAN PRESCRIPTION DRUG	HALCINONIDE		HALCINONIDE	CREAM	TOPICAL	20210522		NDA AUTHORIZED GENERIC	NDA017556	Sun Pharmaceutical Industries, Inc.	HALCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
57664-745_ef7cf939-f51c-47f9-bf9e-a36f1b94daac	57664-745	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20130711		ANDA	ANDA077571	Sun Pharmaceutical Industries, Inc.	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
57664-747_ef7cf939-f51c-47f9-bf9e-a36f1b94daac	57664-747	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20130711		ANDA	ANDA077571	Sun Pharmaceutical Industries, Inc.	REPAGLINIDE	2	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
57664-761_cb7adb60-886b-4415-9b04-b6d37712bbe0	57664-761	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET	ORAL	20180618		ANDA	ANDA201691	Sun Pharmaceutical Industries, Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
57664-762_c8d66299-8019-4a8f-b86d-445551196692	57664-762	HUMAN PRESCRIPTION DRUG	Levorphanol Tartrate		Levorphanol Tartrate	TABLET	ORAL	20210617		ANDA	ANDA213906	Sun Pharmaceutical Industries, Inc.	LEVORPHANOL TARTRATE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
57664-768_efa46505-78df-53ff-e053-2a95a90a309a	57664-768	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20200102		ANDA	ANDA211641	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
57664-769_efa46505-78df-53ff-e053-2a95a90a309a	57664-769	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20200615		ANDA	ANDA211641	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
57664-770_efa46505-78df-53ff-e053-2a95a90a309a	57664-770	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20200102		ANDA	ANDA211641	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
57664-783_1eefcd3c-91bf-4f3c-a43c-5dc1c826b789	57664-783	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20170329		ANDA	ANDA078654	Sun Pharmaceutical Industries, Inc.	CLONAZEPAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
57664-784_1eefcd3c-91bf-4f3c-a43c-5dc1c826b789	57664-784	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20170329		ANDA	ANDA078654	Sun Pharmaceutical Industries, Inc.	CLONAZEPAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
57664-785_1eefcd3c-91bf-4f3c-a43c-5dc1c826b789	57664-785	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20170329		ANDA	ANDA078654	Sun Pharmaceutical Industries, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
57664-786_1eefcd3c-91bf-4f3c-a43c-5dc1c826b789	57664-786	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20170329		ANDA	ANDA078654	Sun Pharmaceutical Industries, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
57664-787_1eefcd3c-91bf-4f3c-a43c-5dc1c826b789	57664-787	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET, ORALLY DISINTEGRATING	ORAL	20170329		ANDA	ANDA078654	Sun Pharmaceutical Industries, Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
57664-796_e97e6623-9454-4d2f-8cbc-d84db5f0b5ce	57664-796	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026	20240731	NDA AUTHORIZED GENERIC	NDA200175	Sun Pharmaceutical Industries, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
57664-797_e97e6623-9454-4d2f-8cbc-d84db5f0b5ce	57664-797	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026	20240430	NDA AUTHORIZED GENERIC	NDA200175	Sun Pharmaceutical Industries, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
57664-799_e97e6623-9454-4d2f-8cbc-d84db5f0b5ce	57664-799	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026	20240630	NDA AUTHORIZED GENERIC	NDA200175	Sun Pharmaceutical Industries, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
57664-800_e97e6623-9454-4d2f-8cbc-d84db5f0b5ce	57664-800	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026	20240531	NDA AUTHORIZED GENERIC	NDA200175	Sun Pharmaceutical Industries, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
57664-808_99a58060-516b-4066-8b0c-652d5c96740b	57664-808	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20170724		ANDA	ANDA040684	Sun Pharmaceutical Industries, Inc.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
57664-851_2794845c-0ea8-4bd7-847a-c222bdf948fe	57664-851	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20130513		ANDA	ANDA090867	Sun Pharmaceutical Industries, Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
57664-852_2794845c-0ea8-4bd7-847a-c222bdf948fe	57664-852	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20130513		ANDA	ANDA090867	Sun Pharmaceutical Industries, Inc.	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
57664-853_2794845c-0ea8-4bd7-847a-c222bdf948fe	57664-853	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20130513		ANDA	ANDA090867	Sun Pharmaceutical Industries, Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
57664-854_c280d53e-9455-4942-9baa-b79e14adb10a	57664-854	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090217	Sun Pharmaceutical Industries, Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
57664-855_c280d53e-9455-4942-9baa-b79e14adb10a	57664-855	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090217	Sun Pharmaceutical Industries, Inc.	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
57664-856_c280d53e-9455-4942-9baa-b79e14adb10a	57664-856	HUMAN PRESCRIPTION DRUG	Minocycline		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090217	Sun Pharmaceutical Industries, Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
57665-101_0aab355d-bbe3-5a46-e063-6294a90a971f	57665-101	HUMAN PRESCRIPTION DRUG	ABELCET		amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl-	INJECTION	INTRAVENOUS	20101018		NDA	NDA050724	Leadiant Biosciences, Inc.	AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-	5; 3.4; 1.5	mg/mL; mg/mL; mg/mL	Lipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
57670-000_0c5b67fe-115a-254e-e063-6394a90a07ce	57670-000	HUMAN OTC DRUG	restorsea Rejuvenating Day SPF 30 Broad Spectrum UVA UVB with Vibransea Complex		ZINC OXIDE	LOTION	TOPICAL	20121224		OTC MONOGRAPH DRUG	M020	RESTORSEA INC	ZINC OXIDE	20	g/100g			N	20241231
57677-063_fc5cc31c-b374-1abe-e053-6294a90a47f5	57677-063	HUMAN OTC DRUG	DAILY LIGHT GUARD DEFENSE FLUID BROAD SPECTRUM SPF 30		TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	M020	Aveda Corporation	TITANIUM DIOXIDE; ZINC OXIDE	63; 41	mg/mL; mg/mL			N	20241231
57677-064_0150ad54-b6d2-e6c7-e063-6394a90a5998	57677-064	HUMAN OTC DRUG	AVEDA OUTER PEACE ACNE RELIEF PADS		SALICYLIC ACID	SOLUTION	TOPICAL	20210517		OTC MONOGRAPH FINAL	M006	Aveda Corporation	SALICYLIC ACID	15	mg/g			N	20241231
57677-065_017aa02e-f8f0-f400-e063-6294a90a4abe	57677-065	HUMAN OTC DRUG	AVEDA SCALP REMEDY DADRUFF		SALICYLIC ACID	SOLUTION	TOPICAL	20221206	20240910	OTC MONOGRAPH DRUG	M032	Aveda Corporation	SALICYLIC ACID	20	mg/mL			N	
57687-200_d93f5881-c7e6-ba4c-e053-2a95a90a366e	57687-200	HUMAN OTC DRUG	Bach Original Flower Remedies Agrimony		AGRIMONIA EUPATORIA	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelsons Bach USA Limited	AGRIMONIA EUPATORIA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-201_e72aaf20-7519-0386-e053-2995a90a5b52	57687-201	HUMAN OTC DRUG	Bach Original Flower Remedies Aspen		POPULUS TREMULA	SOLUTION	ORAL	20220901		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	POPULUS TREMULA FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-202_db488632-dac5-76af-e053-2a95a90adbef	57687-202	HUMAN OTC DRUG	Bach Original Flower Remedies Beech		FAGUS SYLVATICA	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	FAGUS SYLVATICA FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-203_e99c417f-c3d1-79f8-e053-2a95a90a66b7	57687-203	HUMAN OTC DRUG	Bach Original Flower Remedies Centaury		Centaurium umbellatum	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CENTAURIUM ERYTHRAEA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-204_ea4fa548-9df7-8603-e053-2995a90a7a71	57687-204	HUMAN OTC DRUG	Bach Original Flower Remedies Cerato		CERATOSTIGMA WILLMOTTIANUM	SOLUTION	ORAL	20220901		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CERATOSTIGMA WILLMOTTIANUM FLOWER	5	[hp_X]/.095mL			N	20241231
57687-205_e547b32b-cd9e-4b8e-e053-2a95a90a9d2d	57687-205	HUMAN OTC DRUG	Bach Original Flower Remedies Cherry Plum		Prunus cerasifera	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	PRUNUS CERASIFERA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-206_e9ade461-b61e-2872-e053-2995a90ad089	57687-206	HUMAN OTC DRUG	Bach Original Flower Remedies Chestnut Bud		Aesculus hippocastanum	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS HIPPOCASTANUM WHOLE	5	[hp_X]/.095mL			N	20241231
57687-207_e9af0f3a-57e5-5558-e053-2a95a90a8953	57687-207	HUMAN OTC DRUG	Bach Original Flower Remedies Chicory		Cichorium intybus	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CICHORIUM INTYBUS FLOWER	5	[hp_X]/.095mL			N	20241231
57687-208_e9af9bd4-805e-06f5-e053-2995a90aadc4	57687-208	HUMAN OTC DRUG	Bach Original Flower Remedies Clematis		Clematis vitalba	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CLEMATIS VITALBA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-209_e9aff44b-dabd-6449-e053-2995a90a86c1	57687-209	HUMAN OTC DRUG	Bach Original Flower Remedies Crab Apple		Malus pumila	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	MALUS PUMILA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-210_e9d454d5-e897-5182-e053-2995a90af4ed	57687-210	HUMAN OTC DRUG	Bach Original Flower Remedies Elm		Ulmus procera	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ULMUS PROCERA FLOWERING TWIG	5	[hp_X]/.095mL			N	20241231
57687-211_e9d4bacf-5bc9-b7df-e053-2995a90ab28e	57687-211	HUMAN OTC DRUG	Bach Original Flower Remedies Gentian		Gentiana amarella	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	GENTIANELLA AMARELLA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-212_e9d5553c-92d2-2fc8-e053-2995a90a050e	57687-212	HUMAN OTC DRUG	Bach Original Flower Remedies Gorse		Ulex europaeus	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ULEX EUROPAEUS FLOWER	5	[hp_X]/.095mL			N	20241231
57687-213_e9d6cf65-2178-765e-e053-2a95a90acebc	57687-213	HUMAN OTC DRUG	Bach Original Flower Remedies Heather		Calluna vulgaris	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CALLUNA VULGARIS FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-214_e9d6d33a-2f49-1d4a-e053-2a95a90a2bcf	57687-214	HUMAN OTC DRUG	Bach Original Flower Remedies Holly		Ilex aquifolium	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ILEX AQUIFOLIUM FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-215_e9d78226-a653-5476-e053-2995a90a59b2	57687-215	HUMAN OTC DRUG	Bach Original Flower Remedies Honeysuckle		Lonicera caprifolium	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	LONICERA CAPRIFOLIUM FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-216_e9e4ce05-bad3-156c-e053-2a95a90a550b	57687-216	HUMAN OTC DRUG	Bach Original Flower Remedies Hornbeam		Carpinus betulus	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CARPINUS BETULUS FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-217_e9e695ce-f75c-f13f-e053-2a95a90a2a7d	57687-217	HUMAN OTC DRUG	Bach Original Flower Remedies Impatiens		Impatiens glandulifera	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	IMPATIENS GLANDULIFERA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-218_e713556e-028d-0f4c-e053-2995a90a9e9f	57687-218	HUMAN OTC DRUG	Bach Original Flower Remedies Larch		Larix decidua flowering top	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	LARIX DECIDUA FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-219_e7293bba-7388-dac2-e053-2a95a90a1cb8	57687-219	HUMAN OTC DRUG	Bach Original Flower Remedies Mimulus		Mimulus guttatus flowering top	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	MIMULUS GUTTATUS FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-220_e9e6cba7-0709-422f-e053-2995a90abdee	57687-220	HUMAN OTC DRUG	Bach Original Flower Remedies Mustard		Sinapis arvensis	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	SINAPIS ARVENSIS FLOWERING/FRUITING TOP	5	[hp_X]/.095mL			N	20241231
57687-221_e9e787e6-6cc3-303e-e053-2a95a90adcea	57687-221	HUMAN OTC DRUG	Bach Original Flower Remedies Oak		Quercus robur	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	QUERCUS ROBUR FLOWER	5	[hp_X]/.095mL			N	20241231
57687-222_e9e7e7c5-b012-df38-e053-2995a90a15b2	57687-222	HUMAN OTC DRUG	Bach Original Flower Remedies Olive		Olea europaea	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	OLEA EUROPAEA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-223_e9ea74ea-a0ab-e255-e053-2995a90a7ca4	57687-223	HUMAN OTC DRUG	Bach Original Flower Remedies Pine		Pinus sylvestris	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	PINUS SYLVESTRIS FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-224_e9eaf840-a4cb-6e0b-e053-2995a90a2366	57687-224	HUMAN OTC DRUG	Bach Original Flower Remedies Red Chestnut		Aesculus carnea	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS CARNEA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-225_ea240330-bb55-4970-e053-2a95a90aef97	57687-225	HUMAN OTC DRUG	Bach Original Flower Remedies Rock Rose		Helianthemum nummularium	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	HELIANTHEMUM NUMMULARIUM FLOWER	5	[hp_X]/.095mL			N	20241231
57687-226_ea242559-1619-3354-e053-2a95a90a1a95	57687-226	HUMAN OTC DRUG	Bach Original Flower Remedies Rock Water		water	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	WATER	5	[hp_X]/.095mL			N	20241231
57687-227_ea25f205-40b7-7ce1-e053-2a95a90a7b40	57687-227	HUMAN OTC DRUG	Bach Original Flower Remedies Scleranthus		Scleranthus annus	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	SCLERANTHUS ANNUUS FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-228_ea2638fa-8f4d-e378-e053-2995a90afaac	57687-228	HUMAN OTC DRUG	Bach Original Flower Remedies Star of Bethlehem		Ornithogalum umbellatum	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ORNITHOGALUM UMBELLATUM FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-229_ea26b83d-f35b-45b6-e053-2a95a90a36fc	57687-229	HUMAN OTC DRUG	Bach Original Flower Remedies Sweet Chestnut		Castanea sativa	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CASTANEA SATIVA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-230_ea26ff25-e619-0f60-e053-2995a90a230d	57687-230	HUMAN OTC DRUG	Bach Original Flower Remedies Vervain		Verbena officinalis	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	VERBENA OFFICINALIS FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-231_ea279f04-6615-efa3-e053-2a95a90a1a00	57687-231	HUMAN OTC DRUG	Bach Original Flower Remedies Vine		Vitis vinifera	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	VITIS VINIFERA FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-232_ea27d90a-70ac-667a-e053-2995a90aa322	57687-232	HUMAN OTC DRUG	Bach Original Flower Remedies Walnut		Juglans regia	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	JUGLANS REGIA FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-233_ea4daadf-e73c-6e39-e053-2a95a90a8ca2	57687-233	HUMAN OTC DRUG	Bach Original Flower Remedies Water Violet		Hottonia palustris	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	HOTTONIA PALUSTRIS FLOWER	5	[hp_X]/.095mL			N	20241231
57687-234_ea4e7cf9-3eb7-f7cd-e053-2995a90a081c	57687-234	HUMAN OTC DRUG	Bach Original Flower Remedies White Chestnut		Aesculus hippocastanum	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS HIPPOCASTANUM FLOWER	5	[hp_X]/.095mL			N	20241231
57687-235_ea4eba83-bc82-6424-e053-2a95a90ab692	57687-235	HUMAN OTC DRUG	Bach Original Flower Remedies Wild Oat		Bromus ramosus	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	BROMUS RAMOSUS FLOWER	5	[hp_X]/.095mL			N	20241231
57687-236_ea4eec6c-83bc-fe4e-e053-2995a90af880	57687-236	HUMAN OTC DRUG	Bach Original Flower Remedies Wild Rose		Rosa canina	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ROSA CANINA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-237_ea4f5bb0-1485-1fde-e053-2a95a90abace	57687-237	HUMAN OTC DRUG	Bach Original Flower Remedies Willow		Salix vitellina	SOLUTION	ORAL	20220920		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	SALIX ALBA FLOWERING TOP	5	[hp_X]/.095mL			N	20241231
57687-238_ba088441-31af-45e2-a492-7fbe8c2290c1	57687-238	HUMAN OTC DRUG	Rescue Remedy Kids		HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, and ORNITHOGALUM UMBELLATUM	SOLUTION	ORAL	20080301		UNAPPROVED HOMEOPATHIC		Nelson Bach USA, Ltd.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	20241231
57687-239_fbb8e162-f752-4d93-8ab5-f0197aca88c5	57687-239	HUMAN OTC DRUG	Rescue Remedy		HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, and ORNITHOGALUM UMBELLATUM	SOLUTION	ORAL	19930809		UNAPPROVED HOMEOPATHIC		Nelson Bach USA, Ltd.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	20241231
57687-240_203666c2-8130-4653-94f0-9441909953a4	57687-240	HUMAN OTC DRUG	Rescue		Helianthemum nummularium flower, Clematis vitalba flower, Impatiens glandulifera flower, Prunus cerasifera flower, Ornithogalum umbellatum, and Malus domestica flower	CREAM	TOPICAL	20091001		UNAPPROVED HOMEOPATHIC		Nelson Bach USA, Ltd.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; MALUS DOMESTICA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5; 5	[hp_X]/.5g; [hp_X]/.5g; [hp_X]/.5g; [hp_X]/.5g; [hp_X]/.5g; [hp_X]/.5g			N	20241231
57687-241_829d0a68-985d-446b-b783-9b3a8c87404e	57687-241	HUMAN OTC DRUG	Rescue Remedy		HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, and ORNITHOGALUM UMBELLATUM	SOLUTION	ORAL	20050712		UNAPPROVED HOMEOPATHIC		Nelson Bach USA, Ltd.	CLEMATIS VITALBA WHOLE; HELIANTHEMUM NUMMULARIUM WHOLE; IMPATIENS GLANDULIFERA WHOLE; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA WHOLE	5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	20241231
57687-242_7a9c455d-8060-4269-a866-18018e722d24	57687-242	HUMAN OTC DRUG	Rescue Sleep		HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, ORNITHOGALUM UMBELLATUM, and AESCULUS HIPPOCASTANUM FLOWER	SOLUTION	ORAL	20060421		UNAPPROVED HOMEOPATHIC		Nelson Bach USA, Ltd.	AESCULUS HIPPOCASTANUM FLOWER; CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	20241231
57687-243_2f53909d-5759-4527-baad-b688feea2a5f	57687-243	HUMAN OTC DRUG	Rescue Sleep	Dropper	Helianthemum nummularium flower, Clematis vitalba flower, Impatiens glandulifera flower, Prunus cerasifera flower, Ornithogalum Umbellatum Whole, and Aesculus hippocastanum flower	SOLUTION	ORAL	20201201		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS HIPPOCASTANUM FLOWER; CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	20241231
57687-244_d835f573-29e8-71c4-e053-2a95a90adf17	57687-244	HUMAN OTC DRUG	Rescue Sleep Kids	Dropper	helianthemum nummularium flower, clematis vitalba flower, impatiens glandulifera flower, prunus cerasifera flower, ornithogalum umbellatum whole, and aesculus hippocastanum flower	SOLUTION	ORAL	20210101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS HIPPOCASTANUM FLOWER; CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	20241231
57687-245_a12289cc-277e-4265-a82a-f36a606a5034	57687-245	HUMAN OTC DRUG	Bach Pastilles Orange and Elderflower		Helianthemum nummularium whole, Prunus cerasifera whole, Ornithogalum umbellatum, Clematis vitalba whole, and Impatiens glandulifera whole	LOZENGE	ORAL	20061120		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CLEMATIS VITALBA WHOLE; HELIANTHEMUM NUMMULARIUM WHOLE; IMPATIENS GLANDULIFERA WHOLE; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA WHOLE	5; 5; 5; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
57687-247_0c8a42c7-ba54-4a94-b6b5-38aebd31a223	57687-247	HUMAN OTC DRUG	Rescue Pastille Black Currant		Helianthemum nummularium flower, Clematis Vitalba Top, Impatiens glandulifera flower, Prunus cerasifera flower, and Ornithogalum umbellatum	LOZENGE	ORAL	20150831		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Ltd	CLEMATIS VITALBA WHOLE; HELIANTHEMUM NUMMULARIUM WHOLE; IMPATIENS GLANDULIFERA WHOLE; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA WHOLE	5; 5; 5; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
57687-250_108bd065-88a8-4574-ae8d-06a2e729cb66	57687-250	HUMAN OTC DRUG	Bach Original Flower Remedies		Agrimonia eupatoria	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AGRIMONIA EUPATORIA	5	[hp_X]/.095mL			N	20241231
57687-251_c8a26534-5f1f-417a-9325-7d934f5f9049	57687-251	HUMAN OTC DRUG	Bach Original Flower Remedies		Populus Tremula Whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	POPULUS TREMULA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-252_271bd638-464e-4f6b-ace7-f7c77829f1ac	57687-252	HUMAN OTC DRUG	Bach Original Flower Remedies		FAGUS SYLVATICA WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	FAGUS SYLVATICA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-253_6202dac0-aebd-44d1-a349-a59c144bb733	57687-253	HUMAN OTC DRUG	Bach Original Flower Remedies		Centaurium Erythraea	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CENTAURIUM ERYTHRAEA	5	[hp_X]/.095mL			N	20241231
57687-254_0041ad5f-850e-4fed-bb64-627a3cd15582	57687-254	HUMAN OTC DRUG	Bach Original Flower Remedies		CERATOSTIGMA WILLMOTTIANUM WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CERATOSTIGMA WILLMOTTIANUM WHOLE	5	[hp_X]/.095mL			N	20241231
57687-255_d03e47d4-cfe7-4779-84c7-a3f4a29b44e2	57687-255	HUMAN OTC DRUG	Bach Original Flower Remedies		PRUNUS CERASIFERA WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	PRUNUS CERASIFERA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-256_c7f80952-7832-42f4-8e9e-7fcdb8d26e09	57687-256	HUMAN OTC DRUG	Bach Original Flower Remedies		Aesculus hippocastanum whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS HIPPOCASTANUM WHOLE	5	[hp_X]/.095mL			N	20241231
57687-257_2857fc6d-9f52-47fe-a8cf-9b3613b1d9c2	57687-257	HUMAN OTC DRUG	Bach Original Flower Remedies		CICHORIUM INTYBUS WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CICHORIUM INTYBUS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-258_1d0e5d56-026c-44a7-937b-f2a82ec51b37	57687-258	HUMAN OTC DRUG	Bach Original Flower Remedies		Clematis Vitalba Top	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CLEMATIS VITALBA TOP	5	[hp_X]/.095mL			N	20241231
57687-259_b2ffb7b1-0214-4823-8571-7eee0a255bd9	57687-259	HUMAN OTC DRUG	Bach Original Flower Remedies		Malus Sylvestris Whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	MALUS SYLVESTRIS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-260_b3d39696-c7a6-4a62-a108-39edb0e90861	57687-260	HUMAN OTC DRUG	Bach Original Flower Remedies		Ulmus Procera Whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ULMUS MINOR WHOLE	5	[hp_X]/.095mL			N	20241231
57687-261_7dc78bcf-24f4-4c3b-ae07-8ead7a22e87d	57687-261	HUMAN OTC DRUG	Bach Original Flower Remedies		GENTIANELLA AMARELLA WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	GENTIANELLA AMARELLA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-262_acc71597-44ad-4209-a006-4a5fb73daf4c	57687-262	HUMAN OTC DRUG	Bach Original Flower Remedies		Ulex europaeus flower	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ULEX EUROPAEUS FLOWER	5	[hp_X]/.095mL			N	20241231
57687-263_a24e0d59-cf82-4322-916e-bed081e7cff1	57687-263	HUMAN OTC DRUG	Bach Original Flower Remedies		CARLINA VULGARIS WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CARLINA VULGARIS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-264_bd06821d-1210-4e7a-ad87-baf9a2ed1756	57687-264	HUMAN OTC DRUG	Bach Original Flower Remedies Holly		Ilex Aquifolium Fruiting Top	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ILEX AQUIFOLIUM FRUITING TOP	5	[hp_X]/.095mL			N	20241231
57687-265_332241f0-fe30-41be-bcb8-5efa5d61366e	57687-265	HUMAN OTC DRUG	Bach Original Flower Remedies		LONICERA CAPRIFOLIUM WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	LONICERA CAPRIFOLIUM WHOLE	5	[hp_X]/.095mL			N	20241231
57687-266_ab51915e-e5eb-48b2-af59-22d533b719ca	57687-266	HUMAN OTC DRUG	Bach Original Flower Remedies Hornbeam		Carpinus Betulus Flower	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CARPINUS BETULUS FLOWER	5	[hp_X]/.095mL			N	20241231
57687-267_576376f5-a346-43e8-8369-8a29bc717282	57687-267	HUMAN OTC DRUG	Bach Original Flower Remedies		Impatiens glandulifera flower	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	IMPATIENS GLANDULIFERA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-268_5850cd50-756d-4b70-aeb8-1219e79a06b6	57687-268	HUMAN OTC DRUG	Bach Original Flower Remedies		Larix decidua whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	LARIX DECIDUA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-269_f6d4852e-8fd0-408c-9747-a2b7eb167f12	57687-269	HUMAN OTC DRUG	Bach Original Flower Remedies		Mimulus guttatus whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	MIMULUS GUTTATUS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-270_7e185f81-6a5d-48f6-95f3-59b6ce33146e	57687-270	HUMAN OTC DRUG	Bach Original Flower Remedies		SINAPIS ARVENSIS WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	SINAPIS ARVENSIS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-271_07a85bfe-2fb9-4267-b082-40e9b58d2cce	57687-271	HUMAN OTC DRUG	Bach Original Flower Remedies		QUERCUS ROBUR WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	QUERCUS ROBUR WHOLE	5	[hp_X]/.095mL			N	20241231
57687-272_c4512a5f-5880-4aeb-980e-4c9f92659046	57687-272	HUMAN OTC DRUG	Bach Original Flower Remedies		OLEA EUROPAEA FLOWER	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	OLEA EUROPAEA FLOWER	5	[hp_X]/.095mL			N	20241231
57687-273_54f82cf8-2737-4321-bacc-3db61065ed4e	57687-273	HUMAN OTC DRUG	Bach Original Flower Remedies		PINUS SYLVESTRIS WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	PINUS SYLVESTRIS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-274_d82156a2-9406-40dc-e053-2a95a90a5b74	57687-274	HUMAN OTC DRUG	Bach Original Flower Remedies		AESCULUS CARNEA WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS X CARNEA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-275_6d8b7622-7b96-43b0-9712-ed6ed7c1f6cf	57687-275	HUMAN OTC DRUG	Bach Original Flower Remedies		Helianthemum nummularium whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	HELIANTHEMUM NUMMULARIUM WHOLE	5	[hp_X]/.095mL			N	20241231
57687-276_7d33fcc4-5804-44c0-9bd1-329ce3322198	57687-276	HUMAN OTC DRUG	Bach Original Flower Remedies		Water	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	WATER	5	[hp_X]/.095mL			N	20241231
57687-277_5a8fa039-328b-4449-b52c-1b99ac782325	57687-277	HUMAN OTC DRUG	Bach Original Flower Remedies		Scleranthus annuus whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	SCLERANTHUS ANNUUS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-278_6d09b3e9-372d-4e99-9561-e13e81d88447	57687-278	HUMAN OTC DRUG	Bach Original Flower Remedies		Ornithogalum umbellatum	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ORNITHOGALUM UMBELLATUM WHOLE	5	[hp_X]/.095mL			N	20241231
57687-279_f6fcdd17-ceb3-471b-9571-86a8939a8c64	57687-279	HUMAN OTC DRUG	Bach Original Flower Remedies		CASTANEA SATIVA WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CASTANEA SATIVA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-280_c87dc604-304f-42bb-a851-6e9aa984188c	57687-280	HUMAN OTC DRUG	Bach Original Flower Remedies		Verbena officinalis	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	VERBENA OFFICINALIS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-281_4b4ae1bc-1af6-4cc3-b3bd-e60f9d83171a	57687-281	HUMAN OTC DRUG	Bach Original Flower Remedies		Vitis Vinifera whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	VITIS VINIFERA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-282_86146b18-ade5-4280-b86a-9f3e42657a5b	57687-282	HUMAN OTC DRUG	Bach Original Flower Remedies		Juglans regia whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	JUGLANS REGIA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-283_905e8cad-1d4d-4b4d-8567-6c6f6b296f6a	57687-283	HUMAN OTC DRUG	Bach Original Flower Remedies		Hottonia palustris flower	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	HOTTONIA PALUSTRIS FLOWER	5	[hp_X]/.095mL			N	20241231
57687-284_cfc0cd58-3e24-4d45-aae3-473782b74e8d	57687-284	HUMAN OTC DRUG	Bach Original Flower Remedies		AESCULUS HIPPOCASTANUM FLOWER	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	AESCULUS HIPPOCASTANUM FLOWER	5	[hp_X]/.095mL			N	20241231
57687-285_a0ef09c9-98f2-4b1f-b002-a77a5ca74e3b	57687-285	HUMAN OTC DRUG	Bach Original Flower Remedies		Bromus Ramosus Whole	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	BROMUS RAMOSUS WHOLE	5	[hp_X]/.095mL			N	20241231
57687-286_1c7b35f1-d358-483f-a2a1-630dfc32b029	57687-286	HUMAN OTC DRUG	Bach Original Flower Remedies		Rosa Canina Fruit	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	ROSA CANINA FRUIT	5	[hp_X]/.095mL			N	20241231
57687-287_4d11cc5c-872f-492d-9f79-5429bcf937bf	57687-287	HUMAN OTC DRUG	Bach Original Flower Remedies		SALIX ALBA WHOLE	SOLUTION	ORAL	20020101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	SALIX ALBA WHOLE	5	[hp_X]/.095mL			N	20241231
57687-291_d835f573-29d8-71c4-e053-2a95a90adf17	57687-291	HUMAN OTC DRUG	Rescue Sleep		Helianthemum nummularium flower, Clematis vitalba flower, Impatiens glandulifera flower, Prunus cerasifera flower, Ornithogalum umbellatum, and Aesculus hippocastanum flower	CAPSULE, LIQUID FILLED	ORAL	20100224		UNAPPROVED HOMEOPATHIC		Nelson Bach USA, Ltd.	AESCULUS HIPPOCASTANUM FLOWER; CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
57687-300_59eaeb45-946a-4102-8287-4a1e61344c7c	57687-300	HUMAN OTC DRUG	Rescue Pastilles Cranberry		HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, and ORNITHOGALUM UMBELLATUM	LOZENGE	ORAL	20120801		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Ltd	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
57687-301_d835e31b-5549-3267-e053-2995a90abfc5	57687-301	HUMAN OTC DRUG	Rescue Pearls		HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, AND ORNITHOGALUM UMBELLATUM	CAPSULE, LIQUID FILLED	ORAL	20120901		UNAPPROVED HOMEOPATHIC		Nelson Bach USA, Ltd.	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
57687-303_5cc91b47-4615-438b-bd9e-fc346754da84	57687-303	HUMAN OTC DRUG	Rescue Pastille Lemon		HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA TOP, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, and ORNITHOGALUM UMBELLATUM	LOZENGE	ORAL	20140130		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Ltd	CLEMATIS VITALBA TOP; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
57687-305_c848cafd-570c-d496-e053-2a95a90a2347	57687-305	HUMAN OTC DRUG	Rescue Energy		Clematis Vitalba Whole, Helianthemum Nummularium Whole, Impatiens Glandulifera Whole, Olea Europaea Flower, Ornithogalum Umbellatum, and Prunus Cerasifera Whole	SOLUTION	ORAL	20070208	20250531	UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CLEMATIS VITALBA WHOLE; HELIANTHEMUM NUMMULARIUM WHOLE; IMPATIENS GLANDULIFERA WHOLE; OLEA EUROPAEA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA WHOLE	5; 5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	
57687-306_89586230-f6d4-4aa8-a749-d25f84756a0d	57687-306	HUMAN OTC DRUG	Rescue Remedy	Dropper	Helianthemum nummularium flower, Clematis vitalba flower, Impatiens glandulifera flower, Prunus cerasifera flower, and ORNITHOGALUM UMBELLATUM WHOLE	SOLUTION	ORAL	20220301		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM WHOLE; PRUNUS CERASIFERA FLOWER	5; 5; 5; 5; 5	[hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL; [hp_X]/.095mL			N	20241231
57687-311_06311e45-7194-a60d-e063-6294a90a95ec	57687-311	HUMAN OTC DRUG	Bach Clarity of Mind Focus Kit		White Chestnut, Scleranthus, Clematis	KIT		20231101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited						N	20241231
57687-312_06598a7a-eed9-bd68-e063-6294a90a4f8b	57687-312	HUMAN OTC DRUG	Bach Emotional Ups and Downs Mental Energy Kit		Mustard, Hornbeam, Olive	KIT		20231101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited						N	20241231
57687-313_066bc3ce-69cf-fba8-e063-6394a90ac463	57687-313	HUMAN OTC DRUG	Bach Fear No More Bravery Kit		Aspen, Cherry Plum, Rock Rose	KIT		20231101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited						N	20241231
57687-314_074c734c-2ed3-2b85-e063-6294a90a6662	57687-314	HUMAN OTC DRUG	Bach Get it Done Motivation Kit		Elm, Impatiens, Vervain	KIT		20231101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited						N	20241231
57687-315_074d88a8-a87a-f65c-e063-6394a90a3cda	57687-315	HUMAN OTC DRUG	Bach Hope and Joy Comfort Kit		Star of Bethlehem, Gorse, Sweet Chestnut	KIT		20231101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited						N	20241231
57687-316_07d6467d-e0ac-107a-e063-6394a90acb3a	57687-316	HUMAN OTC DRUG	Bach Ready to Go Travel Kit		Cherry Plum, Clematis, Impatiens, Rock Rose, Star of Bethlehem, Scleranthus, Walnut	KIT		20231101		UNAPPROVED HOMEOPATHIC		Nelson Bach USA Limited						N	20241231
57707-050_07f17ba5-4432-23ac-e063-6294a90a2e74	57707-050	HUMAN OTC DRUG	Male Genital Desensitizer	Stud 100	Lidocane	SPRAY, METERED	TOPICAL	20130313		OTC MONOGRAPH DRUG	M017	Pound International Corp	LIDOCAINE	9.6	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
57716-001_0b4b5470-86f6-cf88-e063-6294a90a1ad5	57716-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20040401		NDA	NDA206023	Sky Oxygen	OXYGEN	990	mL/L			N	20241231
57782-397_d66445c2-3e1d-458a-9c62-d4fc2ef4ec8f	57782-397	HUMAN OTC DRUG	Cromolyn Sodium		Cromolyn Sodium	SPRAY, METERED	NASAL	20010703		ANDA	ANDA075702	Bausch & Lomb Incorporated	CROMOLYN SODIUM	5.2	mg/1	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
57799-001_092d7b7d-c5a2-6e45-e063-6394a90ab8e3	57799-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Allegheny Health Network Home Medical Equipment LLC	OXYGEN	99	L/100L			N	20241231
57800-001_0bc48a47-231c-d69c-e063-6394a90a84c5	57800-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19940401		UNAPPROVED MEDICAL GAS		Lincare Inc.	OXYGEN	99	L/100L			N	20241231
57826-420_ba5d3100-49aa-2fd0-e053-2a95a90aec1b	57826-420	HUMAN PRESCRIPTION DRUG	Haemonetics Anticoagulant Sodium Citrate		TRISODIUM CITRATE DIHYDRATE	SOLUTION	EXTRACORPOREAL	20130110		NDA	BN980123	Haemonetics Corporation	TRISODIUM CITRATE DIHYDRATE	40	mg/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
57826-455_b09089ac-5238-65bb-e053-2995a90aabd0	57826-455	HUMAN PRESCRIPTION DRUG	Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)		CITRIC ACID MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, ANHYDROUS DEXTROSE	SOLUTION	EXTRACORPOREAL	20130110		NDA	BN000127	Haemonetics Corporation	ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	464; 32.7; 22.2; 263	mg/mL; mg/mL; mg/mL; mg/mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
57826-460_af0c5490-6267-ef76-e053-2995a90ae68c	57826-460	HUMAN PRESCRIPTION DRUG	Haemonetics Additive Solution Formula 3 (AS-3)		CITRIC ACID MONOHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM CHLORIDE, ADENINE, ANHYDROUS DEXTROSE, TRISODIUM CITRATE DIHYDRATE	SOLUTION	EXTRACORPOREAL	20130110		NDA	BN000127	Haemonetics Corporation	ADENINE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE	3; 100; 4.2; 41; 27.6; 58.8	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
57837-001_0b39196d-61a7-aa3a-e063-6294a90a4feb	57837-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20140623		UNAPPROVED MEDICAL GAS		Community Surgical Supply of Toms River Inc	OXYGEN	992	mL/L			N	20241231
57841-1150_23124460-5e8c-46a8-b2a7-9ee4f94b58ca	57841-1150	HUMAN PRESCRIPTION DRUG	Talicia		omeprazole magnesium, amoxicillin and rifabutin	CAPSULE, DELAYED RELEASE	ORAL	20200309		NDA	NDA213004	RedHill Biopharma Ltd	AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN	250; 10; 12.5	mg/1; mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Penicillin-class Antibacterial [EPC], Penicillins [CS], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA], Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
57841-1200_9377a845-abf1-4c32-84e6-51ee3473c9d2	57841-1200	HUMAN PRESCRIPTION DRUG	Aemcolo		Rifamycin	TABLET, DELAYED RELEASE	ORAL	20210701		NDA	NDA210910	RedHill Biopharma Ltd	RIFAMYCIN	194	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
57841-1201_9377a845-abf1-4c32-84e6-51ee3473c9d2	57841-1201	HUMAN PRESCRIPTION DRUG	Aemcolo		Rifamycin	TABLET, DELAYED RELEASE	ORAL	20210701		NDA	NDA210910	RedHill Biopharma Ltd	RIFAMYCIN	194	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
57841-1300_3da484be-32a1-4265-b58e-fa55b7acd59a	57841-1300	HUMAN PRESCRIPTION DRUG	MOVANTIK		naloxegol oxalate	TABLET, FILM COATED	ORAL	20201001		NDA	NDA204760	RedHill Biopharma Ltd	NALOXEGOL OXALATE	12.5	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
57841-1301_3da484be-32a1-4265-b58e-fa55b7acd59a	57841-1301	HUMAN PRESCRIPTION DRUG	MOVANTIK		naloxegol oxalate	TABLET, FILM COATED	ORAL	20201001		NDA	NDA204760	RedHill Biopharma Ltd	NALOXEGOL OXALATE	25	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
57844-019_305baa45-88c4-4a2c-9086-2ddafc27cf9d	57844-019	HUMAN PRESCRIPTION DRUG	Adipex-P		Phentermine Hydrochloride	CAPSULE	ORAL	19900930	20240229	ANDA	ANDA088023	Teva Pharmaceuticals USA, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	
57844-105_7853fa49-c842-4de6-a1f2-fffd03a755a9	57844-105	HUMAN PRESCRIPTION DRUG	Adderall		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20141113		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57844-110_7853fa49-c842-4de6-a1f2-fffd03a755a9	57844-110	HUMAN PRESCRIPTION DRUG	Adderall		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20140203		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57844-112_7853fa49-c842-4de6-a1f2-fffd03a755a9	57844-112	HUMAN PRESCRIPTION DRUG	Adderall		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20140618		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57844-115_7853fa49-c842-4de6-a1f2-fffd03a755a9	57844-115	HUMAN PRESCRIPTION DRUG	Adderall		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20140630		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57844-117_7853fa49-c842-4de6-a1f2-fffd03a755a9	57844-117	HUMAN PRESCRIPTION DRUG	Adderall		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20150303		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57844-120_7853fa49-c842-4de6-a1f2-fffd03a755a9	57844-120	HUMAN PRESCRIPTION DRUG	Adderall		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20140211		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57844-130_7853fa49-c842-4de6-a1f2-fffd03a755a9	57844-130	HUMAN PRESCRIPTION DRUG	Adderall		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	TABLET	ORAL	20140206		ANDA	ANDA040422	Teva Pharmaceuticals USA, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
57844-140_305baa45-88c4-4a2c-9086-2ddafc27cf9d	57844-140	HUMAN PRESCRIPTION DRUG	Adipex-P		Phentermine Hydrochloride	TABLET	ORAL	20201208		ANDA	ANDA085128	Teva Pharmaceuticals USA, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
57844-208_3e563fe2-9ad4-4458-83cf-588188f46ba6	57844-208	HUMAN PRESCRIPTION DRUG	GALZIN		Zinc Acetate	CAPSULE	ORAL	19970303		NDA	NDA020458	Teva Pharmaceuticals USA, Inc.	ZINC ACETATE	50	mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
57844-215_3e563fe2-9ad4-4458-83cf-588188f46ba6	57844-215	HUMAN PRESCRIPTION DRUG	GALZIN		Zinc Acetate	CAPSULE	ORAL	19970303		NDA	NDA020458	Teva Pharmaceuticals USA, Inc.	ZINC ACETATE	25	mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
57869-123_0a479c1e-d60f-7889-e063-6394a90a0f69	57869-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110831		UNAPPROVED MEDICAL GAS		Maag Prescription Center, LLC	OXYGEN	99	L/100L			N	20241231
57883-403_04c6f39e-2c3a-c0c6-e063-6394a90a1f76	57883-403	HUMAN PRESCRIPTION DRUG	Plexion		SULFACETAMIDE SODIUM, SULFUR	CREAM	TOPICAL	20050901	20240131	UNAPPROVED DRUG OTHER		Brava Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	
57883-404_9a9e13b8-3bc2-8223-e053-2995a90ac060	57883-404	HUMAN PRESCRIPTION DRUG	Plexion		SULFACETAMIDE SODIUM, SULFUR	CLOTH	TOPICAL	20050901		UNAPPROVED DRUG OTHER		Brava Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
57883-405_04c6f8c5-13da-a698-e063-6394a90ad24a	57883-405	HUMAN PRESCRIPTION DRUG	Plexion		SULFACETAMIDE SODIUM, SULFUR	LOTION	TOPICAL	20050901	20240131	UNAPPROVED DRUG OTHER		Brava Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	
57884-3041_05e0099c-4a6e-4ca4-e063-6394a90ae073	57884-3041	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170809		ANDA	ANDA207252	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
57884-3042_05e0099c-4a6e-4ca4-e063-6394a90ae073	57884-3042	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170809		ANDA	ANDA207252	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	DOCETAXEL	80	mg/4mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
57884-3043_05e0099c-4a6e-4ca4-e063-6394a90ae073	57884-3043	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170809		ANDA	ANDA207252	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	DOCETAXEL	160	mg/8mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
57893-302_04c6f92e-b32d-39a3-e063-6294a90a7d2a	57893-302	HUMAN PRESCRIPTION DRUG	Vytone		HYDROCORTISONE ACETATE, IODOQUINOL	CREAM	TOPICAL	20110729	20250131	UNAPPROVED DRUG OTHER		Artesa Labs, LLC	HYDROCORTISONE ACETATE; IODOQUINOL	19; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
57894-030_d9c13b29-5863-427e-878d-23ae57012d85	57894-030	HUMAN PRESCRIPTION DRUG	REMICADE		INFLIXIMAB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19980824		BLA	BLA103772	Janssen Biotech, Inc.	INFLIXIMAB	100	mg/10mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
57894-050_03865989-303a-10fc-e063-6394a90ac80b	57894-050	HUMAN PRESCRIPTION DRUG	AKEEGA		NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE	TABLET, FILM COATED	ORAL	20230811		NDA	NDA216793	Janssen Biotech, Inc.	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE MONOHYDRATE	500; 50	mg/1; mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
57894-054_ee551e9d-d258-4539-ab89-3597643d9d2c	57894-054	HUMAN PRESCRIPTION DRUG	Stelara		ustekinumab	SOLUTION	INTRAVENOUS	20160923		BLA	BLA761044	Janssen Biotech, Inc.	USTEKINUMAB	130	mg/26mL	Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20241231
57894-060_ee551e9d-d258-4539-ab89-3597643d9d2c	57894-060	HUMAN PRESCRIPTION DRUG	STELARA		ustekinumab	INJECTION, SOLUTION	SUBCUTANEOUS	20090925		BLA	BLA125261	Janssen Biotech, Inc.	USTEKINUMAB	45	mg/.5mL	Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20241231
57894-061_ee551e9d-d258-4539-ab89-3597643d9d2c	57894-061	HUMAN PRESCRIPTION DRUG	STELARA		ustekinumab	INJECTION, SOLUTION	SUBCUTANEOUS	20090925		BLA	BLA125261	Janssen Biotech, Inc.	USTEKINUMAB	90	mg/mL	Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20241231
57894-070_0aad0e31-d37e-4a67-e063-6294a90ac9b0	57894-070	HUMAN PRESCRIPTION DRUG	Simponi		golimumab	INJECTION, SOLUTION	SUBCUTANEOUS	20090425		BLA	BLA125289	Janssen Biotech, Inc.	GOLIMUMAB	50	mg/.5mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
57894-071_0aad0e31-d37e-4a67-e063-6294a90ac9b0	57894-071	HUMAN PRESCRIPTION DRUG	Simponi		golimumab	INJECTION, SOLUTION	SUBCUTANEOUS	20130515		BLA	BLA125289	Janssen Biotech, Inc.	GOLIMUMAB	100	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
57894-100_03865989-303a-10fc-e063-6394a90ac80b	57894-100	HUMAN PRESCRIPTION DRUG	AKEEGA		NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE	TABLET, FILM COATED	ORAL	20230811		NDA	NDA216793	Janssen Biotech, Inc.	ABIRATERONE ACETATE; NIRAPARIB TOSYLATE MONOHYDRATE	500; 100	mg/1; mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
57894-111_0d94e55a-8ea5-c58a-e063-6394a90ada9e	57894-111	CELLULAR THERAPY	CARVYKTI		ciltacabtagene autoleucel	INJECTION, SUSPENSION	INTRAVENOUS	20220228		BLA	BLA125746	Janssen Biotech, Inc	CILTACABTAGENE AUTOLEUCEL	100000000	1/1			N	20241231
57894-150_376d387d-4ec7-4b0a-9a8d-c2d6870f3b39	57894-150	HUMAN PRESCRIPTION DRUG	Zytiga		abiraterone acetate	TABLET	ORAL	20110428		NDA	NDA202379	Janssen Biotech, Inc.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
57894-160_5b95c131-42b2-4cda-bd00-101b93199f95	57894-160	HUMAN PRESCRIPTION DRUG	INFLIXIMAB		INFLIXIMAB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211005		BLA	BLA103772	Janssen Biotech, Inc.	INFLIXIMAB	100	mg/10mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
57894-195_376d387d-4ec7-4b0a-9a8d-c2d6870f3b39	57894-195	HUMAN PRESCRIPTION DRUG	Zytiga		Abiraterone acetate	TABLET, FILM COATED	ORAL	20170417		NDA	NDA202379	Janssen Biotech, Inc.	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
57894-350_00d8fc3f-a495-cd29-e063-6294a90a976d	57894-350	HUMAN PRESCRIPTION DRUG	SIMPONI ARIA		golimumab	SOLUTION	INTRAVENOUS	20130719		BLA	BLA125433	Janssen Biotech, Inc.	GOLIMUMAB	50	mg/4mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
57894-449_02e74249-51cc-aa03-e063-6394a90af5ab	57894-449	HUMAN PRESCRIPTION DRUG	TECVAYLI		teclistamab	INJECTION	SUBCUTANEOUS	20221025		BLA	BLA761291	Janssen Biotech, Inc.	TECLISTAMAB	10	mg/mL			N	20241231
57894-450_02e74249-51cc-aa03-e063-6394a90af5ab	57894-450	HUMAN PRESCRIPTION DRUG	TECVAYLI		teclistamab	INJECTION	SUBCUTANEOUS	20221025		BLA	BLA761291	Janssen Biotech, Inc.	TECLISTAMAB	90	mg/mL			N	20241231
57894-469_0333c380-455e-03c1-e063-6394a90a998d	57894-469	HUMAN PRESCRIPTION DRUG	TALVEY		talquetamab	INJECTION	SUBCUTANEOUS	20230809		BLA	BLA761342	Janssen Biotech, Inc.	TALQUETAMAB	3	mg/1.5mL			N	20241231
57894-470_0333c380-455e-03c1-e063-6394a90a998d	57894-470	HUMAN PRESCRIPTION DRUG	TALVEY		talquetamab	INJECTION	SUBCUTANEOUS	20230809		BLA	BLA761342	Janssen Biotech, Inc.	TALQUETAMAB	40	mg/mL			N	20241231
57894-501_0e9bd298-6994-1bbb-e063-6394a90a3d70	57894-501	HUMAN PRESCRIPTION DRUG	Rybrevant		Amivantamab	INJECTION	INTRAVENOUS	20210521		BLA	BLA761210	Janssen Biotech, Inc.	AMIVANTAMAB	350	mg/1			N	20251231
57894-502_0aac2082-de78-31cb-e063-6394a90a5b78	57894-502	HUMAN PRESCRIPTION DRUG	DARZALEX		Daratumumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20151116		BLA	BLA761036	Janssen Biotech, Inc.	DARATUMUMAB	100	mg/5mL	Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]		N	20241231
57894-503_0b3a8b34-5dd8-e8d8-e063-6294a90a980b	57894-503	HUMAN PRESCRIPTION DRUG	Darzalex Faspro		daratumumab and hyaluronidase-fihj (human recombinant)	INJECTION	SUBCUTANEOUS	20200501		BLA	BLA761145	Janssen Biotech, Inc.	DARATUMUMAB; HYALURONIDASE (HUMAN RECOMBINANT)	1800; 30000	mg/15mL; U/15mL	Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC], Endoglycosidase [EPC], Glycoside Hydrolases [CS]		N	20241231
57894-505_0aac2082-de78-31cb-e063-6394a90a5b78	57894-505	HUMAN PRESCRIPTION DRUG	Darzalex IV		Daratumumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20211015		BLA	BLA761036	Janssen Biotech, Inc.	DARATUMUMAB	100	mg/5mL	Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]		N	20241231
57894-640_09bab28f-d731-f2e7-e063-6294a90a1b79	57894-640	HUMAN PRESCRIPTION DRUG	Tremfya		Guselkumab	INJECTION	SUBCUTANEOUS	20170713		BLA	BLA761061	Janssen Biotech, Inc.	GUSELKUMAB	100	mg/mL	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]		N	20241231
57896-102_07ee2cb2-70df-6b8a-e063-6394a90a3e97	57896-102	HUMAN OTC DRUG	Regular Strength Pain Relief		Acetaminophen	TABLET	ORAL	19890101		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN	325	mg/1			N	20241231
57896-104_07ffdb86-143d-65f0-e063-6394a90a6b8a	57896-104	HUMAN OTC DRUG	Regular Strength Pain Relief		Acetaminophen	TABLET	ORAL	20200401		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN	325	mg/1			N	20241231
57896-110_fd76c85d-0489-3ac7-e053-6394a90ac903	57896-110	HUMAN OTC DRUG	Vitamin A and D		Petrolatum	OINTMENT	TOPICAL	20230113		OTC MONOGRAPH FINAL	part347	Geri-care Pharmaceutials Corp	PETROLATUM	76	g/100g			N	20241231
57896-114_ee29217a-412c-d23c-e053-2a95a90a9770	57896-114	HUMAN OTC DRUG	White Petrolatum		petrolatum	OINTMENT	TOPICAL	20200501	20240801	OTC MONOGRAPH FINAL	part347	GERI-CARE PHARMACEUTICAL CORP	PETROLATUM	1	g/g			N	
57896-116_0df90998-7898-1a47-e063-6394a90a075a	57896-116	HUMAN OTC DRUG	Analgesic Balm		Menthol 10%, Methyl Salicylate 15%	CREAM	TOPICAL	20210730		OTC MONOGRAPH DRUG	M017	Geri-Care Pharmaceuticals, Corp	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20251231
57896-131_08274e34-5890-a548-e063-6294a90af932	57896-131	HUMAN OTC DRUG	Dibucaine		Dibucaine 1%	OINTMENT	TOPICAL	20200922		OTC MONOGRAPH DRUG	M017	Geri-Care Pharmaceuticals, Corp	DIBUCAINE	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
57896-139_0904e5d4-6c9c-156d-e063-6294a90a4a7d	57896-139	HUMAN OTC DRUG	Oral Pain Relief		BENZOCAINE	GEL	ORAL	20210301		OTC MONOGRAPH DRUG	M022	GERI-CARE PHARMACEUTICAL CORP	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
57896-140_ed8601c1-3c09-e44c-1ac5-7f5b5d7dc650	57896-140	HUMAN OTC DRUG	DICLOFENAC SODIUM		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20211005		ANDA	ANDA210986	GERI-CARE PHARMACEUTICALS CORP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57896-143_0df8f032-44e7-2544-e063-6394a90a0413	57896-143	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate.	OINTMENT	TOPICAL	20220401		OTC MONOGRAPH DRUG	M004	Geri-Care Pharmaceuticals, Corp	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
57896-145_0df8f032-44e8-2544-e063-6394a90a0413	57896-145	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20220401		OTC MONOGRAPH DRUG	M004	Geri-Care Pharmaceuticals, Corp.	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20251231
57896-146_fd67566a-1066-019d-e053-6394a90a415c	57896-146	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part348	Geri-Care Pharmaceuticals, Corp	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
57896-147_e771ec9d-7a4e-4381-a97f-eee52e05293c	57896-147	HUMAN OTC DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230811		ANDA	ANDA204306	GERI-CARE PHARMACEUTICAL CORP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57896-164_f40a29cf-0c10-b06e-e053-2a95a90a0f59	57896-164	HUMAN OTC DRUG	White Petrolatum		Petrolatum	OINTMENT	TOPICAL	20230106		OTC MONOGRAPH FINAL	part347	Geri-Care Pharmaceuticals, Corp	PETROLATUM	100	g/100g			N	20241231
57896-181_08f3abb6-28fc-cc3d-e063-6394a90accee	57896-181	HUMAN OTC DRUG	Artificial Tears		Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20180601		OTC MONOGRAPH DRUG	M018	Geri-Care Pharmaceuticals, Corp	GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400	.002; .002; .01	mg/mg; mg/mg; mg/mg	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
57896-199_09a769e6-0aed-0a17-e063-6394a90a85d6	57896-199	HUMAN OTC DRUG	TOLNAFTATE ANTIFUNGAL		TOLNAFTATE	POWDER	TOPICAL	20110801		OTC MONOGRAPH DRUG	M005	Geri-Care Pharmaceuticals, Corp	TOLNAFTATE	1	g/100g			N	20241231
57896-201_080099b7-8ee7-e20a-e063-6294a90ab01e	57896-201	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET	ORAL	19890101		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN	500	mg/1			N	20241231
57896-204_07ffcfcc-742b-efbf-e063-6294a90a1e27	57896-204	HUMAN OTC DRUG	Extra Strength Acetaminophen		Acetaminophen	TABLET	ORAL	20180701		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN	500	mg/1			N	20241231
57896-206_09bc0d2f-dbe2-d130-e063-6294a90ae622	57896-206	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF		Acetaminophen	SUSPENSION	ORAL	20190601		OTC MONOGRAPH DRUG	M013	GERI-CARE PHARMACEUTICAL CORP	ACETAMINOPHEN	500	mg/15mL			N	20241231
57896-216_08153881-06e3-0fbe-e063-6294a90aae4c	57896-216	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEVER		ACETAMINOPHEN, ASPIRIN AND CAFFEINE	TABLET, FILM COATED	ORAL	20200201		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
57896-221_0761fb5a-1cc0-a6a1-e063-6294a90a29af	57896-221	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET	ORAL	19890101		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN	500	mg/1			N	20241231
57896-222_08153530-4ef6-7adb-e063-6394a90a9078	57896-222	HUMAN OTC DRUG	Extra Strength Acetaminophen		Acetaminophen	TABLET	ORAL	20180801		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN	500	mg/1			N	20241231
57896-251_08157e2c-2c6f-1487-e063-6394a90a1092	57896-251	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	CAPSULE, GELATIN COATED	ORAL	20070601		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN	500	mg/1			N	20241231
57896-255_f7f77bd4-57c3-148a-e053-6294a90a0f9b	57896-255	HUMAN OTC DRUG	Arthritis Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230301		ANDA	ANDA076200	GERI-CARE PHARMACEUTICAL CORP	ACETAMINOPHEN	650	mg/1			N	20241231
57896-268_92c22593-dafa-20a8-e053-2a95a90a365d	57896-268	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, EXTENDED RELEASE	ORAL	20190701		ANDA	ANDA211544	GERI-CARE PHARMACEUTICAL CORP	ACETAMINOPHEN	650	mg/1			N	20241231
57896-291_098582e5-b374-7521-e063-6394a90a2232	57896-291	HUMAN OTC DRUG	Geri-Tussin	DM	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20230331		OTC MONOGRAPH DRUG	M012	Geri-Care Pharmaceuticals, Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57896-292_08a2221c-3817-8f50-e063-6294a90a36f1	57896-292	HUMAN OTC DRUG	EXTRA STRENGTH GAS RELIEF		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200301		OTC MONOGRAPH DRUG	M002	Geri-Care Pharmaceuticals, Corp	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
57896-293_09866b9c-aa17-45eb-e063-6394a90a4903	57896-293	HUMAN OTC DRUG	Geri-Tussin		Guaifenesin	LIQUID	ORAL	20230331		OTC MONOGRAPH DRUG	M012	Geri-Care Pharmaceuticals, Corp	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
57896-304_0bdcf009-4dd7-e3d1-e063-6394a90ace29	57896-304	HUMAN OTC DRUG	Stool Softener with Laxative		Docusate Sodium and Sennosides	TABLET, FILM COATED	ORAL	20191201		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Care Pharmaceutical Corp	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
57896-324_081543aa-75fd-799c-e063-6394a90aed4a	57896-324	HUMAN OTC DRUG	Extra Strength Night Time Pain Medicine		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20220601		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57896-333_08797b66-d897-3a8c-e063-6394a90ad36d	57896-333	HUMAN OTC DRUG	Saline		Nasal	SPRAY	NASAL	20200930		OTC MONOGRAPH DRUG	M018	GERI-CARE PHARMACEUTICAL CORP	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
57896-378_088f57a1-ea8f-0807-e063-6294a90ab366	57896-378	HUMAN OTC DRUG	Travel-Ease		Meclizine HCl	TABLET	ORAL	20220501		OTC MONOGRAPH DRUG	M009	Geri-Care Pharmaceutical Corp	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
57896-381_0815b17c-f9ac-9e0f-e063-6394a90aa3d8	57896-381	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20060101		ANDA	ANDA076497	Geri-Care Pharmaceutical Corp	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
57896-401_08173bad-d29e-d916-e063-6394a90a609f	57896-401	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000101		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceutical Corp	DOCUSATE SODIUM	100	mg/1			N	20241231
57896-413_cafb91c4-38df-40cd-b5fa-9afaa395affe	57896-413	HUMAN OTC DRUG	GeriCare Docusate Sodium Liquid		Docusate Sodium	LIQUID	ORAL	20201001		OTC MONOGRAPH NOT FINAL	part334	GERI-CARE PHARMACEUTICALS, CORP	DOCUSATE SODIUM	50	mg/5mL			N	20241231
57896-415_0bdd08c0-83ed-e84a-e063-6394a90adb77	57896-415	HUMAN OTC DRUG	Geri-kot		SENNOSIDES	TABLET	ORAL	20221201		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Care Pharmaceutical Corp	SENNOSIDES	8.6	mg/1			N	20241231
57896-421_0866a49c-bfa4-1450-e063-6294a90aee44	57896-421	HUMAN OTC DRUG	STOOL SOFTENER		docusate sodium	TABLET	ORAL	20150901		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceuticals, Corp	DOCUSATE SODIUM	100	mg/1			N	20241231
57896-423_f5f5c74c-3def-b0d2-e053-2a95a90abefd	57896-423	HUMAN OTC DRUG	GeriCare Docusate Sodium Liquid		Docusate Sodium	LIQUID	ORAL	20230301		OTC MONOGRAPH NOT FINAL	part334	GERI-CARE PHARMACEUTICALS, CORP	DOCUSATE SODIUM	50	mg/5mL			N	20241231
57896-424_08649f2e-5f73-5ba0-e063-6294a90a5fd1	57896-424	HUMAN OTC DRUG	Docusate Calcium		Stool Softener	CAPSULE, LIQUID FILLED	ORAL	20000101		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceutical Corp	DOCUSATE CALCIUM	240	mg/1			N	20241231
57896-426_0a34593a-4c33-3ddd-e063-6394a90a58c1	57896-426	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200401		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceutical Corp	DOCUSATE SODIUM	250	mg/1			N	20241231
57896-441_0bdc50c8-211b-04d5-e063-6294a90a8657	57896-441	HUMAN OTC DRUG	stimulant laxative enteric coated		Bisacodyl	TABLET	ORAL	20000101		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Care Pharmaceutical Corp	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-443_08f39ac5-9534-bc11-e063-6394a90ad71e	57896-443	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	SUPPOSITORY	RECTAL	20191101		OTC MONOGRAPH DRUG	M007	GERI-CARE PHARMACEUTICAL CORP	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-454_0bdd1f3e-0b05-f050-e063-6394a90a954d	57896-454	HUMAN OTC DRUG	Geri-kot		Standardized Senna Concentrate	TABLET	ORAL	20180401		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Care Pharmaceutical Corp	SENNOSIDES	8.6	mg/1			N	20241231
57896-459_0864ed71-500d-61cd-e063-6294a90a110e	57896-459	HUMAN OTC DRUG	Fiber Laxative		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20040101		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceutical Corp	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
57896-489_ee3ad47b-8219-3bc4-e053-2a95a90af736	57896-489	HUMAN OTC DRUG	POLYETHYLENE GLYCOL 3350		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20140501		ANDA	ANDA090812	Geri-Care Pharmaceutical Corp	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-490_f0c44850-fe07-4c48-bb9c-ded2c7fb822b	57896-490	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20221027		ANDA	ANDA203928	Gericare Pharmaceuticals	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-555_0b61e01d-3531-d2a1-e063-6294a90a513c	57896-555	HUMAN OTC DRUG	SENNA-PLUS		Sennosides and Docusate Sodium	TABLET	ORAL	20190501		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Care Pharmaceutical Corp	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
57896-619_09a8019b-b747-463f-e063-6394a90af5d0	57896-619	HUMAN OTC DRUG	GERI-LANTA MAXIMUM STRENGTH		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20000101		OTC MONOGRAPH DRUG	M001	Geri-Care Pharmaceuticals, Corp	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-624_09a7c60a-df32-0baa-e063-6394a90a4fcc	57896-624	HUMAN OTC DRUG	GERI-LANTA SUPREME CHERRY		calcium carbonate, magnesium hydroxide	SUSPENSION	ORAL	20000101		OTC MONOGRAPH DRUG	M001	Geri-Care Pharmaceuticals, Corp	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	400; 135	mg/5mL; mg/5mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-629_09a7e4fb-b16d-2fb6-e063-6394a90ae85f	57896-629	HUMAN OTC DRUG	GERI-LANTA ANTACID ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20000101		OTC MONOGRAPH DRUG	M001	Geri-Care Pharmaceuticals, Corp	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-639_09a8052f-96ec-0590-e063-6294a90aeed8	57896-639	HUMAN OTC DRUG	GERI-MOX ANTACID ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20000101		OTC MONOGRAPH DRUG	M001	Geri-Care Pharmaceuticals, Corp	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-647_09a7738c-4c9a-11cc-e063-6394a90ae25e	57896-647	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	LIQUID	ORAL	20000101		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceuticals, Corp	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-648_09a78453-8622-afed-e063-6294a90add8f	57896-648	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20000101		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceuticals, Corp	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-649_09a7af47-4239-1e8b-e063-6394a90a99ef	57896-649	HUMAN OTC DRUG	MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	LIQUID	ORAL	20000101		OTC MONOGRAPH DRUG	M007	Geri-Care Pharmaceuticals, Corp	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57896-658_ee1323ad-ce93-901e-e053-2995a90aba18	57896-658	HUMAN OTC DRUG	Allergy relief		Loratadine	TABLET	ORAL	20200201		ANDA	ANDA075209	Geri-Care Pharmaceutical Corp	LORATADINE	10	mg/1			N	20241231
57896-661_fb1ddd5a-08f1-42da-9f2c-0caac942cd17	57896-661	HUMAN OTC DRUG	Geri-Tussin	DM	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Geri-Care Pharmaceuticals, Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57896-683_088ce5b2-c47b-79db-e063-6394a90a5772	57896-683	HUMAN OTC DRUG	Geri-Dryl allergy relief		Diphenhydramine HCl	TABLET, COATED	ORAL	20200401		OTC MONOGRAPH DRUG	M012	Geri-Care Pharmaceutical Corp	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57896-693_79aa55a5-bb64-4fca-9f3e-8f69095b5c44	57896-693	HUMAN OTC DRUG	Geri-Tussin		Guaifenesin	LIQUID	ORAL	20190501		OTC MONOGRAPH FINAL	part341	Geri-Care Pharmaceuticals, Corp	GUAIFENESIN	100	mg/5mL			N	20241231
57896-694_088cfefb-881a-6961-e063-6294a90a4e98	57896-694	HUMAN OTC DRUG	EXTRA STRENGTH GAS RELIEF		Simethicone	TABLET, CHEWABLE	ORAL	20200301		OTC MONOGRAPH DRUG	M002	Geri-Care Pharmaceuticals, Corp	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
57896-714_088ce4aa-e0dd-6372-e063-6294a90ac941	57896-714	HUMAN OTC DRUG	MUCUS RELIEF		Guaifenesin	TABLET	ORAL	20210201		OTC MONOGRAPH DRUG	M012	Geri-Care Pharmaceuticals, Corp	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
57896-736_63e3a228-2d0b-483a-ac93-13f58987826d	57896-736	HUMAN OTC DRUG	Guaiasorb	DM	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20191001		OTC MONOGRAPH FINAL	part341	Geri-Care Pharmaceuticals, Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57896-739_098692be-efb4-5175-e063-6394a90a1ac2	57896-739	HUMAN OTC DRUG	GUAIASORB	DM	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20230331		OTC MONOGRAPH DRUG	M012	Geri-Care Pharmaceuticals, Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
57896-758_413c3c8f-57c6-4c2a-8589-87340ebb96d3	57896-758	HUMAN OTC DRUG	GeriCare Sorbitol Solution		Sorbitol	LIQUID	RECTAL	20200101		OTC MONOGRAPH NOT FINAL	part334	GERI-CARE PHARMACEUTICALS, CORP	SORBITOL	70	mg/100mL			N	20241231
57896-759_08f44528-66bd-21ff-e063-6394a90a1972	57896-759	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20130401		ANDA	ANDA078878	Gericare Pharmaceuticals	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57896-763_088cf0b9-6b06-4fcd-e063-6394a90aa69b	57896-763	HUMAN OTC DRUG	CALCIUM CARBONATE CHEWABLE ANTACID		calcium carbonate	TABLET, CHEWABLE	ORAL	20040101		OTC MONOGRAPH DRUG	M001	Geri-Care Pharmaceutical Corp	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
57896-785_08a1d725-5489-d285-e063-6294a90addc0	57896-785	HUMAN OTC DRUG	Nighttime Sleep-aid		Diphenhydramine HCl	TABLET	ORAL	20040101		OTC MONOGRAPH DRUG	M010	Geri-Care Pharmaceutical Corp	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57896-791_08a1e77e-79cf-fc5a-e063-6294a90aa903	57896-791	HUMAN OTC DRUG	SIMETHICONE		Simethicone	TABLET, CHEWABLE	ORAL	20040101		OTC MONOGRAPH DRUG	M002	Geri-Care Pharmaceuticals, Corp	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
57896-794_08a22901-0291-5ad6-e063-6294a90aebdd	57896-794	HUMAN OTC DRUG	MUCUS RELIEF		Guaifenesin	TABLET	ORAL	20040101		OTC MONOGRAPH DRUG	M012	Geri-Care Pharmaceuticals, Corp	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
57896-798_091b57c6-f9b1-6a51-e063-6294a90a403f	57896-798	HUMAN OTC DRUG	INFANTS GAS RELIEF		Simethicone	SUSPENSION	ORAL	20140501		OTC MONOGRAPH DRUG	M002	Geri-Care Pharmaceuticals, Corp	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
57896-799_08a201f2-64a2-552e-e063-6394a90a0686	57896-799	HUMAN OTC DRUG	GAS RELIEF		Simethicone	TABLET, CHEWABLE	ORAL	20200201		OTC MONOGRAPH DRUG	M002	Geri-Care Pharmaceuticals, Corp	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
57896-901_1758b4e7-a67c-4b38-8aa6-ec26bc842259	57896-901	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19930804		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceuticals, Corp	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57896-911_08a2ccbb-df0b-d39d-e063-6394a90a5e9b	57896-911	HUMAN OTC DRUG	Low Strength Chewable Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19950101		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57896-921_08a3b4e3-69e1-e206-e063-6294a90af268	57896-921	HUMAN OTC DRUG	Regular Strength Enteric coated aspirin		Aspirin	TABLET, COATED	ORAL	20000701		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57896-941_08f1bde2-f476-2d2f-e063-6294a90a6f93	57896-941	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20040101		ANDA	ANDA075010	Geri-Care Pharmaceutical Corp	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57896-954_ed87a146-ed3b-e754-e053-2a95a90aefdb	57896-954	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20190101		ANDA	ANDA204872	Geri-Care Pharmaceutical Corp	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
57896-960_9a633bfa-188d-dd42-e053-2995a90ad3aa	57896-960	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20181106		ANDA	ANDA207740	GERICARE PHARMACEUTICALS	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
57896-974_08a1af20-70f6-8c75-e063-6394a90a5ec1	57896-974	HUMAN OTC DRUG	Allergy Relief	4 Hour	Chlorpheniramine maleate	TABLET	ORAL	20190701		OTC MONOGRAPH DRUG	M012	Geri-Care Pharmaceutical Corp	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57896-980_c89d0ae1-b6c6-4856-86a3-2e693d7c1827	57896-980	HUMAN OTC DRUG	Geri Dryl		Diphenhydramine HCl	LIQUID	ORAL	20191001		OTC MONOGRAPH FINAL	part341	GERI-CARE PHARMACEUTICALS, CORP	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
57896-981_0a0bc2e1-cc4d-5dc1-e063-6394a90aadb1	57896-981	HUMAN OTC DRUG	Adult Low Dose Enteric Coated Aspirin		Aspirin	TABLET, COATED	ORAL	20000701		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57896-983_08f2001c-1943-4c74-e063-6294a90af38f	57896-983	HUMAN OTC DRUG	Adult Low Dose Enteric Coated Aspirin		Aspirin	TABLET, COATED	ORAL	20210701		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57896-984_08f23a35-96d0-0872-e063-6394a90a5cf8	57896-984	HUMAN OTC DRUG	Adult Low Dose Enteric Coated Aspirin		Aspirin	TABLET, COATED	ORAL	20220401		OTC MONOGRAPH DRUG	M013	Geri-Care Pharmaceutical Corp	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
57913-2804_eb8c999d-4ff8-7844-e053-2995a90aaea5	57913-2804	HUMAN OTC DRUG	Beyond SPF UV Defense Masque SPF 30		Sunscreen	LOTION	TOPICAL	20230515		OTC MONOGRAPH FINAL	M020	Erno Laszlo, Inc.	ZINC OXIDE	20.4	g/100mL			N	20241231
57913-2832_0bf0b9a5-62d1-6095-e063-6394a90a37c6	57913-2832	HUMAN OTC DRUG	Phelityl Day SPF 15		Avobenzone and Octinoxate	LOTION	TOPICAL	20130410		OTC MONOGRAPH DRUG	M020	Erno Laszlo, Inc.	AVOBENZONE; OCTINOXATE	20; 50	mg/mL; mg/mL			N	20241231
57913-2833_0bf0cfa0-f0c1-3ef5-e063-6294a90a7948	57913-2833	HUMAN OTC DRUG	Firmarine Moisturizer SPF 30		Avobenzone, Octinoxate, and Octisalate	LOTION	TOPICAL	20130410		OTC MONOGRAPH DRUG	M020	Erno Laszlo, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/mL; mg/mL; mg/mL			N	20241231
57915-001_0983ce78-0971-ebda-e063-6394a90aa89c	57915-001	HUMAN OTC DRUG	GERMSTARORIGINAL		Isopropyl Alcohol	SOLUTION	TOPICAL	20000101		OTC MONOGRAPH DRUG	M003	Soaptronic, LLC	ISOPROPYL ALCOHOL	700	g/1000g			N	20241231
57915-004_098405eb-dfb4-dadd-e063-6294a90acb10	57915-004	HUMAN OTC DRUG	germstar Original unscented		Isopropyl Alcohol	SOLUTION	TOPICAL	20000101		OTC MONOGRAPH DRUG	M003	Soaptronic, LLC	ISOPROPYL ALCOHOL	700	g/1000g			N	20241231
57915-005_0983f643-282c-be85-e063-6294a90a82b1	57915-005	HUMAN OTC DRUG	germstarCitrus		Ethyl Alcohol	SOLUTION	TOPICAL	20000101		OTC MONOGRAPH DRUG	M003	Soaptronic, LLC	ALCOHOL	630	g/1000g			N	20241231
57915-007_09840943-b40c-13d3-e063-6394a90a2f67	57915-007	HUMAN OTC DRUG	germstarLuxe		Ethyl Alcohol	SOLUTION	TOPICAL	20170201		OTC MONOGRAPH DRUG	M003	Soaptronic, LLC	ALCOHOL	630	g/1000g			N	20241231
57915-008_098413ae-997c-dbad-e063-6294a90ad961	57915-008	HUMAN OTC DRUG	Germstar Premium Hand Sanitizer		Ethyl Alcohol	SOLUTION	TOPICAL	20170301		OTC MONOGRAPH DRUG	M003	Soaptronic LLC	ALCOHOL	630	g/1000g			N	20241231
57915-009_0983af62-d93c-e9cd-e063-6394a90a4c8c	57915-009	HUMAN OTC DRUG	germstarGel		Ethyl Alcohol	SOLUTION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M003	Soaptronic, LLC	ALCOHOL	630	g/1000g			N	20241231
57915-020_09836e72-2012-9a47-e063-6294a90aded2	57915-020	HUMAN OTC DRUG	germstarONE		Ethyl Alcohol	SOLUTION	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Soaptronic, LLC	ALCOHOL	630	g/1000g			N	20241231
57915-021_0983eead-2bed-c364-e063-6294a90a1b95	57915-021	HUMAN OTC DRUG	germstarONE unscented		Ethyl Alcohol	SOLUTION	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Soaptronic, LLC	ALCOHOL	630	g/1000g			N	20241231
57924-001_0c8f22fa-65e5-2c97-e063-6294a90ae68c	57924-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110103		UNAPPROVED MEDICAL GAS		Ross Medical Supply Co. Inc.	OXYGEN	991	mL/L			N	20241231
57955-0261_9bb49cad-be85-48a5-b164-48b71cda0316	57955-0261	HUMAN OTC DRUG	Back, Muscle and Joint Relief		Aesculus hipp, Arnica, Bellis, Bryonia, Calc carb, Calc fluor, Cimicifuga, Cobaltum met, Gnaphalium poly, Hypericum, Kali carb, Kali phos, Mag phos, Oxalicum ac, Phos, Rhus tox, Ruta, Zinc met	LIQUID	ORAL	20220223		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; COBALT; DIBASIC POTASSIUM PHOSPHATE; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OXALIC ACID DIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57955-0756_cb9296ae-b4eb-4a0c-bc99-c45dcf9c0e38	57955-0756	HUMAN OTC DRUG	Regional Allergies Rocky Mtns. U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Agrimonia eupatoria, Agrostemma githago, Ailanthus glandulosus, Allium cepa, Arum triphyllum, Arundo mauritanica, Cortisone aceticum, Cynodon dactylon, Equisetum hyemale, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Kali muriaticum, Natrum muriaticum, Platanus, Populus candicans, RNA, Sabadilla, Solidago virgaurea.	LIQUID	ORAL	20220713		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AGRIMONIA EUPATORIA WHOLE; AGROSTEMMA GITHAGO SEED; AILANTHUS ALTISSIMA FLOWERING TWIG; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CORTICOTROPIN; CORTISONE ACETATE; CYNODON DACTYLON WHOLE; EPINEPHRINE; EQUISETUM HYEMALE WHOLE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; ONION; PLATANUS OCCIDENTALIS WHOLE; POPULUS BALSAMIFERA LEAF BUD; POTASSIUM CHLORIDE; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-0762_62203afb-e5d2-4c05-a47f-9dd7d7522048	57955-0762	HUMAN OTC DRUG	Regional Allergies Southern U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Alnus serrulata, Arum triphyllum, Arundo mauritanica, Carduus benedictus, Cichorium intybus, Cortisone aceticum, Dolichos pruriens, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Juglans cinerea, Kali muriaticum, Nasturtium aquaticum, Natrum muriaticum, Rhus tox, RNA, Sabadilla, Sassafras officinale.	LIQUID	ORAL	20220930		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; ALNUS SERRULATA BARK; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CENTAUREA BENEDICTA; CHICORY ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; JUGLANS CINEREA BRANCH BARK/ROOT BARK; MUCUNA PRURIENS FRUIT TRICHOME; NASTURTIUM OFFICINALE; ONION; POTASSIUM CHLORIDE; SACCHAROMYCES CEREVISIAE RNA; SASSAFRAS ALBIDUM ROOT BARK; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-1162_82c978e4-d0ce-4e75-9b73-279ffc0d1aac	57955-1162	HUMAN OTC DRUG	Arthritis and Joint Relief		Actaea, Aesculus hipp, Arnica, Bellis, Bryonia, Calc carb, Calc fluor, Causticum, Cimicifuga, Formicum acidum,Hypericum, Ledum, Lithium carb, Mag phos, Phos, Phytolacca, Pulsatilla, Rhododendron, Rhus tox, Ruta, Salicylicum ac, Sepia, Zinc met.	LIQUID	ORAL	20220201		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACTAEA SPICATA ROOT; ARNICA MONTANA; BELLIS PERENNIS WHOLE; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CAUSTICUM; FORMIC ACID; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; LITHIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA PATENS WHOLE; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SALICYLIC ACID; SEPIA OFFICINALIS JUICE; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57955-1814_b5e2fdbe-365e-41e5-9da4-e1aa31c87b7f	57955-1814	HUMAN OTC DRUG	Aquaflora High Potency 9		Abies canadensis, Agaricus muscarius, Allium cepa, Allium sativum, Aloe, Antimonium crudum, Asafoetida, Borax, Candida albicans, Candida parapsilosis, Carpinus betulus, flos, Ignatia amara, Lachesis mutus, Lycopodium clavatum, Malus pumila, flos, Olea europaea, flos, Phosphoricum acidum, Phytolacca decandra, Pulsatilla, Sabadilla, Sticta pulmonaria, Sulphur, Thuja occidentalis.	LIQUID	ORAL	20220223		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ALOE; AMANITA MUSCARIA FRUITING BODY; ANTIMONY TRISULFIDE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CARPINUS BETULUS FLOWERING TOP; FERULA ASSA-FOETIDA RESIN; GARLIC; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; LYCOPODIUM CLAVATUM SPORE; MALUS DOMESTICA FLOWER; OLEA EUROPAEA FLOWER; ONION; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS WHOLE; SCHOENOCAULON OFFICINALE SEED; SODIUM BORATE; STRYCHNOS IGNATII SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TSUGA CANADENSIS BARK	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
57955-2712_0bd017d0-2a2f-472b-b732-840d363fb604	57955-2712	HUMAN OTC DRUG	Allergies Northeast U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Agraphis, Allium cepa, Arum triph, Arundo mauritanica, Collinsonia, Cortisone aceticum, Euphrasia, Galphimia, Histaminum hydrochloricum, Kali mur, Nat mur, RNA, Rumex crisp, Sabadilla, Salvia, Tanacetum, Trifolium prat, Vinca	LIQUID	ORAL	20220518		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; COLLINSONIA CANADENSIS ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; HYACINTHOIDES NON-SCRIPTA WHOLE; ONION; PERVINCA MINOR WHOLE; POTASSIUM CHLORIDE; RUMEX CRISPUS ROOT; SACCHAROMYCES CEREVISIAE RNA; SAGE; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; TANACETUM VULGARE TOP; TRIFOLIUM PRATENSE FLOWER	12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2714_0ee2f6c9-73c0-40ac-898f-25b0f1fe8ded	57955-2714	HUMAN OTC DRUG	Allergies Rocky Mtns U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Agrimona Eup, Agrimonia, Ailanthus, Allium cepa, Arum triph, Arundo mauritanica, Cortisone aceticum, Cynodon, Equisetum hyem, Euphrasia, Galphimia, Histaminum hydrochloricum, Kali mur, Nat mur, Platanus, Populus can, RNA, Sabadilla, Solidago	LIQUID	ORAL	20220722		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AGRIMONIA EUPATORIA WHOLE; AGROSTEMMA GITHAGO SEED; AILANTHUS ALTISSIMA FLOWERING TWIG; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CORTICOTROPIN; CORTISONE ACETATE; CYNODON DACTYLON WHOLE; EPINEPHRINE; EQUISETUM HYEMALE WHOLE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; ONION; PLATANUS OCCIDENTALIS WHOLE; POPULUS BALSAMIFERA LEAF BUD; POTASSIUM CHLORIDE; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2717_6c71152b-0888-417b-bf1d-e329f98bb8b7	57955-2717	HUMAN OTC DRUG	Allergies Pacific U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin (30X, 100X), Alfalfa, Allium cepa, Arum triph, Arundo mauritanica, Bellis, Conium, Cortisone aceticum, Equisetum hyem, Euphrasia, Fagopyrum, Galphimia, Histaminum hydrochloricum, Kali mur, Millefolium, Nat mur, Prunus spin, RNA, Sabadilla, Solidago	LIQUID	ORAL	20220713		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACHILLEA MILLEFOLIUM WHOLE; ADENOSINE CYCLIC PHOSPHATE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; BELLIS PERENNIS WHOLE; CONIUM MACULATUM FLOWERING TOP; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EQUISETUM HYEMALE WHOLE; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM WHOLE; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; MEDICAGO SATIVA WHOLE; ONION; POTASSIUM CHLORIDE; PRUNUS SPINOSA FLOWER BUD; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2722_f909e5b4-5ef8-48b7-9228-86a3a56e6fb4	57955-2722	HUMAN OTC DRUG	Allergies Desert U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Alfalfa, Allium cepa, Ambrosia, Arum triph, Arundo mauritanica, Cortisone aceticum, Erechtites, Erigeron, Euonymus atrop, Euphrasia, Galphimia, Nat mur, RNA, Sabadilla, Stramonium, Triticum	LIQUID	ORAL	20220606		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CORTICOTROPIN; CORTISONE ACETATE; DATURA STRAMONIUM; ELYMUS REPENS ROOT; EPINEPHRINE; ERECHTITES HIERACIIFOLIUS WHOLE; ERIGERON CANADENSIS WHOLE; EUONYMUS ATROPURPUREUS BRANCH BARK/ROOT BARK; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; MEDICAGO SATIVA WHOLE; ONION; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE	12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2803_c9f04cc2-a78b-4e5c-8c2e-9440bcf14b9c	57955-2803	HUMAN OTC DRUG	Advanced Arnica Plus		Arnica montana, Arnica montana, radix, Bellis perennis, Bryonia, Hypericum perforatum, Lithium carbonicum, Magnesia phosphorica, Phytolacca decandra, Rhus tox, Ruta graveolens	LIQUID	ORAL	20220926		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ARNICA MONTANA ROOT; ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BRYONIA ALBA ROOT; HYPERICUM PERFORATUM WHOLE; LITHIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYTOLACCA AMERICANA ROOT; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57955-2805_964bf63f-43be-483d-82f4-0ab25c738c25	57955-2805	HUMAN OTC DRUG	Allergies and Hay Fever Reliever		Allium cepa, Ambrosia artemisiaefolia, Arsenicum album, Arum triphyllum, Arundo mauritanica, Euphrasia officinalis, Galphimia glauca, Histaminum hydrocholoricum, Kali bichromicum, Naphthalinum, Natrum muriaticum, Sabadilla, Solidago virgaurea, Sticta pulmonaria, Wyethia helenioides.	LIQUID	ORAL	20220531		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARSENIC TRIOXIDE; ARUNDO PLINIANA ROOT; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LOBARIA PULMONARIA; NAPHTHALENE; ONION; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; WYETHIA HELENIOIDES ROOT	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
57955-2806_10f2b00e-dea8-4006-94bd-3097730ebfd4	57955-2806	HUMAN OTC DRUG	Regional Allergies Desert U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenalinum, Adrenalinum, Allium cepa, Ambrosia artemisiaefolia, Arum triphyllum, Arundo mauritanica, Cortisone aceticum, Erechtites hieracifolia, Erigeron canadensis, Euonymus atropurpureus, Euphrasia officinalis, Galphimia glauca,Histaminum hydrochloricum, Kali muriaticum, Natrum muriaticum, RNA, Sabadilla, Stramonium, Triticum repens	LIQUID	ORAL	20220418		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CORTICOTROPIN; CORTISONE ACETATE; DATURA STRAMONIUM; ELYMUS REPENS ROOT; EPINEPHRINE; ERECHTITES HIERACIIFOLIUS WHOLE; ERIGERON CANADENSIS WHOLE; EUONYMUS ATROPURPUREUS BRANCH BARK/ROOT BARK; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; MEDICAGO SATIVA WHOLE; ONION; POTASSIUM CHLORIDE; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE	12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2807_59b78c88-6319-4d4a-976d-eff6129dcc03	57955-2807	HUMAN OTC DRUG	Regional Allergies Great Lakes U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Ambrosia artemisiaefolia, Arum triphyllum, Arundo mauritanica, Chelidonium majus, Chenopodium vulvaria, Cichorium intybus, Cortisone aceticum, Euphrasia officinalis, Galphimia glauca, Hedera helix, Histaminum hydrochloricum, Juglans cinerea, Kali muriaticum, Natrum muriaticum, Pulsatilla, RNA, Sabadilla, Teucrium scorodonia.	LIQUID	ORAL	20220414		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CHELIDONIUM MAJUS WHOLE; CHENOPODIUM VULVARIA WHOLE; CHICORY ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HEDERA HELIX FLOWERING TWIG; HISTAMINE DIHYDROCHLORIDE; JUGLANS CINEREA BRANCH BARK/ROOT BARK; ONION; POTASSIUM CHLORIDE; PULSATILLA VULGARIS WHOLE; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; TEUCRIUM SCORODONIA FLOWERING TOP	12; 12; 12; 12; 112; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2808_a4364512-ec42-4268-ae9a-57a4be838e26	57955-2808	HUMAN OTC DRUG	Regional Allergies Northeastern U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Agraphis nutans, Allium cepa, Arum triphyllum, Arundo mauritanica, Collinsonia canadensis, Cortisone aceticum, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum,Kali muriaticum, Natrum muriaticum, RNA, Rumex crispus, Sabadilla, Salvia officinalis, Tanacetum vulgare, Trifolium pratense, Vinca minor	LIQUID	ORAL	20220518		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; COLLINSONIA CANADENSIS ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; HYACINTHOIDES NON-SCRIPTA WHOLE; ONION; PERVINCA MINOR WHOLE; POTASSIUM CHLORIDE; RUMEX CRISPUS ROOT; SACCHAROMYCES CEREVISIAE RNA; SAGE; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; TANACETUM VULGARE TOP; TRIFOLIUM PRATENSE FLOWER	12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2809_4e6e8c05-945b-4b8d-bd7b-f07ee01e4bc8	57955-2809	HUMAN OTC DRUG	Regional Allergies Pacific U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Alfalfa, Allium cepa, Arum triphyllum, Arundo mauritanica, Bellis perennis, Conium maculatum, Cortisone aceticum, Equisetum hyemale, Euphrasia officinalis, Fagopyrum esculentum, Galphimia glauca, Histaminum hydrochloricum, Kali muriaticum, Millefolium, Natrum muriaticum, Prunus spinosa, RNA, Sabadilla, Solidago virgaurea.	LIQUID	ORAL	20220411		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACHILLEA MILLEFOLIUM WHOLE; ADENOSINE CYCLIC PHOSPHATE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; BELLIS PERENNIS WHOLE; CONIUM MACULATUM FLOWERING TOP; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EQUISETUM HYEMALE WHOLE; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM WHOLE; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; MEDICAGO SATIVA WHOLE; ONION; POTASSIUM CHLORIDE; PRUNUS SPINOSA FLOWER BUD; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2810_85430f46-62ff-427d-8198-5eae0ef0ceea	57955-2810	HUMAN OTC DRUG	Regional Allergies Plains U.S.		Absinthium, Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Ambrosia artemisiaefolia, Arum triphyllum, Arundo mauritanica, Caulophyllum thalictroides, Conium maculatum, Cortisone aceticum, Euphrasia officinalis, Fagopyrum esculentum, Galphimia glauca, Histaminum hydrochloricum, Kali muriaticum, Melilotus officinalis, Natrum muriaticum, RNA, Rumex crispus, Sabadilla, Secale cornutum	LIQUID	ORAL	20220411		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CAULOPHYLLUM THALICTROIDES ROOT; CLAVICEPS PURPUREA SCLEROTIUM; CONIUM MACULATUM FLOWERING TOP; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; FAGOPYRUM ESCULENTUM WHOLE; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; MELILOTUS OFFICINALIS TOP; ONION; POTASSIUM CHLORIDE; RUMEX CRISPUS ROOT; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; WORMWOOD	12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2813_cebb25af-55e4-457c-9ce5-1085feb40106	57955-2813	HUMAN OTC DRUG	Regional Allergies Southwestern U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Arum triphyllum,Arundo mauritanica, Asarum canadense, Cortisone aceticum, Eupatorium aromaticum, Euphrasia officinalis, Fraxinus americana, Galphimia glauca, Helianthus annuus, Histaminum hydrochloricum, Juniperus virginiana, Kali muriaticum, Natrum muriaticum, Plantago major, RNA, Rumex crispus, Sabadilla, Senecio jacobaea.	LIQUID	ORAL	20220422		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AGERATINA AROMATICA ROOT; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; ASARUM CANADENSE ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; FRAXINUS AMERICANA BARK; GALPHIMIA GLAUCA FLOWERING TOP; HELIANTHUS ANNUUS FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; JACOBAEA VULGARIS WHOLE; JUNIPERUS VIRGINIANA OIL; ONION; PLANTAGO MAJOR WHOLE; POTASSIUM CHLORIDE; RUMEX CRISPUS ROOT; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE	12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2817_717db916-0a68-4917-a4bc-7ea5bf48278e	57955-2817	HUMAN OTC DRUG	Skin Irritations and Itch Relief		Agaricus muscarius, Alumina, Anagallis arvensis, Antimonium tartaricum, Apis mellifica, Arsenicum album, Arsenicum iodatum, Bovista, Causticum, Dolichos pruriens, Fagopyrum esculentum, Graphites, Kali muriaticum, Muriaticum acidum, Oleander, Petroleum, Pix liquida, Radium bromatum, Rhus toxicodendron, Selenium metallicum, Sulphur, Urtica urens.	LIQUID	ORAL	20221207		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ALUMINUM OXIDE; AMANITA MUSCARIA FRUITING BODY; ANTIMONY POTASSIUM TARTRATE; APIS MELLIFERA; ARSENIC TRIIODIDE; ARSENIC TRIOXIDE; CAUSTICUM; FAGOPYRUM ESCULENTUM WHOLE; GRAPHITE; HYDROCHLORIC ACID; KEROSENE; LYCOPERDON UTRIFORME FRUITING BODY; LYSIMACHIA ARVENSIS WHOLE; MUCUNA PRURIENS FRUIT TRICHOME; NERIUM OLEANDER LEAF; PINE TAR; POTASSIUM CHLORIDE; RADIUM BROMIDE; SELENIUM; SULFUR; TOXICODENDRON PUBESCENS LEAF; URTICA URENS WHOLE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 12; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
57955-2819_c54c21c9-42ea-42dd-864f-551c8f9d951e	57955-2819	HUMAN OTC DRUG	Appetite and Weight with P.H.A.T.		Adrenalinum, Adrenocorticotrophin, Agrimonia eupatoria, flos, Anacardium orientale, Antimonium crudum, Calcarea carbonica, Castanea sativa, flos, Cortisone aceticum, Fucus vesiculosus, Hypothalamus, Kali bichromicum, Oleander, Pituitarum posterium, Sabadilla, Staphysagria, Thyroidinum.	LIQUID	ORAL	20220825		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AGRIMONIA EUPATORIA FLOWER; ANTIMONY TRISULFIDE; BOS TAURUS HYPOTHALAMUS; CASTANEA SATIVA FLOWER; CORTICOTROPIN; CORTISONE ACETATE; DELPHINIUM STAPHISAGRIA SEED; EPINEPHRINE; FUCUS VESICULOSUS; NERIUM OLEANDER LEAF; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED; SEMECARPUS ANACARDIUM JUICE; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIED	10; 10; 10; 10; 30; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Catecholamine [EPC], Catecholamines [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-2822_5323fafe-1c8e-40d3-93bd-0558b3c7c712	57955-2822	HUMAN OTC DRUG	Back, Muscle and Joint Relief		Aesculus hippocastanum, Arnica montana, Bellis perennis, Bryonia, Calcarea carbonica, Calcarea fluorica, Cimicifuga racemosa, Cobaltum metallicum, Gnaphalium polycephalum, Hypericum perforatum, Kali carbonicum, Kali phosphoricum, Magnesia phosphorica,Oxalicum acidum, Phosphorus, Rhus tox, Ruta graveolens, Zincum metallicum	LIQUID	ORAL	20220825		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; COBALT; DIBASIC POTASSIUM PHOSPHATE; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OXALIC ACID DIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57955-2826_195e8b16-1024-405b-8365-c99bfb640ee2	57955-2826	HUMAN OTC DRUG	Gout Symptom Formula		Ammonium phosphoricum, Belladonna, Colchicum autumnale, Formicum acidum, Fraxinus excelsior, Ledum palustre, Natrum carbonicum, Nux vomica, Urtica urens.	LIQUID	ORAL	20220622		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AMMONIUM PHOSPHATE, DIBASIC; ATROPA BELLADONNA; COLCHICUM AUTUMNALE BULB; FORMIC ACID; FRAXINUS EXCELSIOR LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; URTICA URENS WHOLE	10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57955-2828_7c51bf46-03f3-4215-9156-1236908217e1	57955-2828	HUMAN OTC DRUG	Lungs and Bronchial Relief		Ammonium carbonicum, Antimonium arsenicicum, Antimonium tartaricum, Arsenicum album, Bromium, Carbo vegetabilis, Chlorinum, Kali carbonicum, Lobelia inflata, Stannum metallicum, Sulphuricum acidum	LIQUID	ORAL	20211215		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACTIVATED CHARCOAL; AMMONIUM CARBONATE; ANTIMONY ARSENATE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BROMINE; CHLORINE; LOBELIA INFLATA WHOLE; POTASSIUM CARBONATE; SULFURIC ACID; TIN	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
57955-2830_b55c5c7f-af50-4866-b6db-baaa08908c2d	57955-2830	HUMAN OTC DRUG	Headache Relief		Belladonna, Bryonia, Capsicum annuum, Chininum arsenicosum, Coffea cruda, Gelsemium sempervirens, Glonoinum, Ignatia amara, Kali bichromicum, Lycopodium clavatum, Natrum muriaticum, Nux vomica, Sanguinaria canadensis, Spigelia anthelmia, Sulphur	LIQUID	ORAL	20220722		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ARABICA COFFEE BEAN; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CAPSICUM; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; POTASSIUM DICHROMATE; QUININE ARSENITE; SANGUINARIA CANADENSIS ROOT; SODIUM CHLORIDE; SPIGELIA ANTHELMIA WHOLE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE], Vegetable Proteins [CS]		N	20241231
57955-2833_a66f2953-ffdd-4d72-b350-0b339331e9f0	57955-2833	HUMAN OTC DRUG	Restless Leg Symptom Relief		Arsenicum album, Bufo rana, Causticum, Chamomilla, Crotalus horridus, Digitalis purpurea, Lachesis mutus, Lilium tigrinum, Pulsatilla, Rhus tox, Sulphur, Tarentula hispana, Viscum album, Zincum metallicum	LIQUID	ORAL	20220722		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ARSENIC TRIOXIDE; BUFO BUFO CUTANEOUS GLAND; CAUSTICUM; CROTALUS HORRIDUS HORRIDUS VENOM; DIGITALIS; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOSA TARANTULA; MATRICARIA CHAMOMILLA WHOLE; PULSATILLA VULGARIS WHOLE; SULFUR; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUITING TOP; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
57955-2845_fa38d784-bc15-4bc2-a2b6-c525dff18d49	57955-2845	HUMAN OTC DRUG	Migraine Relief		Gelsemium sempervirens, Glonoinum, Iris versicolor, Kali carbonicum, Lycopodium clavatum, Natrum muriaticum, Niccolum metallicum, Nux vomica, Sanguinaria canadensis, Secale cornutum, Spigelia anthelmia, Sulphur.	LIQUID	ORAL	20220222		UNAPPROVED HOMEOPATHIC		King Bio Inc.	CLAVICEPS PURPUREA SCLEROTIUM; GELSEMIUM SEMPERVIRENS ROOT; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; NICKEL; NITROGLYCERIN; POTASSIUM CARBONATE; SANGUINARIA CANADENSIS ROOT; SODIUM CHLORIDE; SPIGELIA ANTHELMIA WHOLE; STRYCHNOS NUX-VOMICA SEED; SULFUR	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
57955-3001_00f8f02d-132c-4912-b65b-5878fa603e1d	57955-3001	HUMAN OTC DRUG	Sciatiplex		Aesculus hippocastanum, Ammonium muriaticum, Arsenicum album, Belladonna, Capsicum annuum, Causticum, Colchicum autumnale, Colocynthis, Gnaphalium polycephalum, Hypericum, Ignatia amara, Kalmia, Magnesia phosphorica, Rhus tox, Ruta.	LIQUID	ORAL	20220201		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AMMONIUM CHLORIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAPSICUM; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; KALMIA LATIFOLIA LEAF; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS IGNATII SEED; TOXICODENDRON PUBESCENS LEAF	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
57955-3004_b5b97d8c-d4bf-4954-8b63-e06306ae64e7	57955-3004	HUMAN OTC DRUG	Advanced Arnica Plus		Arnica montana, Arnica montana, radix, Bellis perennis, Bryonia, Hypericum perforatum, Lithium carbonicum, Magnesia phasphorica, Phytolacca decandra, Rhus toxicdendron, Ruta gravedens	LIQUID	ORAL	20220127		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ARNICA MONTANA ROOT; ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BRYONIA ALBA ROOT; HYPERICUM PERFORATUM WHOLE; LITHIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHYTOLACCA AMERICANA ROOT; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57955-3017_d618bac8-8486-4f85-a9b3-0a5164a919cd	57955-3017	HUMAN OTC DRUG	Candida		Abies canadensis, Agaricus musc, Allium cepa, Allium sativum, Aloe, Antimonium crudum, Asafoetida, Borax, Candida albicans, Candida parapsilosis, Carpinus betulus, flos, Ignatia amara, Lachesis mutus, Lycopodium clavatum, Malus pumila, flos, Olea europaea, flos, Phosphoricum acidum, Phytolacca decandra, Pulsatilla, Sabadilla, Sticta pulmonaria, Sulphur, Thuja occidentalis.	LIQUID	ORAL	20220201		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ALOE; AMANITA MUSCARIA FRUITING BODY; ANTIMONY TRISULFIDE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CARPINUS BETULUS FLOWERING TOP; FERULA ASSA-FOETIDA RESIN; GARLIC; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; LYCOPODIUM CLAVATUM SPORE; MALUS DOMESTICA FLOWER; OLEA EUROPAEA FLOWER; ONION; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PULSATILLA PATENS WHOLE; SCHOENOCAULON OFFICINALE SEED; SODIUM BORATE; STRYCHNOS IGNATII SEED; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; TSUGA CANADENSIS BARK	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL; [hp_X]/236mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
57955-3720_3da65a43-1ab6-4f8e-b6bb-7bbd139b6c21	57955-3720	HUMAN OTC DRUG	Allergies Southwest U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Arum triph, Arundo, Asarum can, Cortisone aceticum, Eupatorium arom, Euphrasia, Frax amer, Galphimia, Helianthus, Histaminum hydrochloricum, Juniperus virg, Kali mur, Nat mur, Plantago, RNA, Rumex crisp, Sabadilla, Senecio jac	LIQUID	ORAL	20220427		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AGERATINA AROMATICA ROOT; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; ASARUM CANADENSE ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; FRAXINUS AMERICANA BARK; GALPHIMIA GLAUCA FLOWERING TOP; HELIANTHUS ANNUUS FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; JACOBAEA VULGARIS WHOLE; JUNIPERUS VIRGINIANA TWIG; ONION; PLANTAGO MAJOR WHOLE; POTASSIUM CHLORIDE; RUMEX CRISPUS ROOT; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE	12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-3721_59ece124-d644-41a0-bec6-0f748ae6fc69	57955-3721	HUMAN OTC DRUG	Allergies Southern U.S.		Adenosinum cycloposphorcum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Alnus ser, Arum triph, Arundo, Carduus ben, Cichorium int, Cortisone aceticum, Dolichos, Euphrasia, Galphimia, Histaminum hydrochloricum, Juglans cin, Kali mur, Nasturtium, Nat mur, Rhus tox RNA, Sabaadilla, Sassafras.	LIQUID	ORAL	20220427		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; ALNUS SERRULATA BARK; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CENTAUREA BENEDICTA; CHICORY ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; JUGLANS CINEREA BRANCH BARK/ROOT BARK; MUCUNA PRURIENS FRUIT TRICHOME; NASTURTIUM OFFICINALE; ONION; POTASSIUM CHLORIDE; SACCHAROMYCES CEREVISIAE RNA; SASSAFRAS ALBIDUM ROOT BARK; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-3724_731d68ba-dca1-4b9b-b738-0b412c878d79	57955-3724	HUMAN OTC DRUG	Allergies Great Lakes U.S.		Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Ambrosia, Arum triph, Arundo, Chelidonium maj, Chenopodium vul, Cichorium int, Cortisone aceticum, Euphrasia, Galphimia, Hedera, Histaminum hydrochloricum, Juglans cin, Kali mur, Nat mur, Pulsatilla, RNA, Sabadilla, Teucrium scor	LIQUID	ORAL	20220422		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ADENOSINE CYCLIC PHOSPHATE; AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CHELIDONIUM MAJUS WHOLE; CHENOPODIUM VULVARIA WHOLE; CHICORY ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HEDERA HELIX FLOWERING TWIG; HISTAMINE DIHYDROCHLORIDE; JUGLANS CINEREA BRANCH BARK/ROOT BARK; ONION; POTASSIUM CHLORIDE; PULSATILLA VULGARIS WHOLE; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; TEUCRIUM SCORODONIA FLOWERING TOP	12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-5122_f6425a03-ae81-44e0-a884-cf569a7e3e13	57955-5122	HUMAN OTC DRUG	Snore Control		Bromium, Chamomilla, Cinchona officinalis, Cuprum metallicum, Helleborus niger, Laurocerasus, Nux vomica, Phosphoricum acidum, Rhus tox, Silicea, Stramonium, Zincum metallicum.	LIQUID	ORAL	20221206		UNAPPROVED HOMEOPATHIC		King Bio Inc.	BROMINE; CINCHONA OFFICINALIS BARK; COPPER; DATURA STRAMONIUM; HELLEBORUS NIGER ROOT; MATRICARIA CHAMOMILLA WHOLE; PHOSPHORIC ACID; PRUNUS LAUROCERASUS LEAF; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57955-5276_7e3dbf25-5d50-45da-8270-a572d01b3ab2	57955-5276	HUMAN OTC DRUG	Ear Ringing		Arnica montana, Calcarea carbonica, Chenopodium anthelminticum, Chininum salicylicum, Cimicifuga racemosa, Coffea tosta, Kali iodatum, Kalmia latifolia, Magnesia carbonica, Manganum aceticum, Manganum carbonicum, Mercurius vivus, Natrum salicylicum, Salicylicum acidum, Thiosinaminum, Thyroidinum.	LIQUID	ORAL	20221205		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ALLYLTHIOUREA; ARNICA MONTANA WHOLE; BLACK COHOSH; COFFEA ARABICA SEED, ROASTED; DYSPHANIA AMBROSIOIDES WHOLE; KALMIA LATIFOLIA LEAF; MAGNESIUM CARBONATE; MANGANESE ACETATE TETRAHYDRATE; MANGANESE CARBONATE; MERCURY; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM IODIDE; QUININE SALICYLATE; SALICYLIC ACID; SODIUM SALICYLATE; THYROID, UNSPECIFIED	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Magnetic Resonance Contrast Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Paramagnetic Contrast Agent [EPC]		N	20241231
57955-5638_defa9438-5676-40e8-9a13-7d0035c3a989	57955-5638	HUMAN OTC DRUG	Sleep Aid		Aconitum napellus, Aesculus hippocastanum, flos, Arsenicum album, Avena sativa, Belladonna, Camphora, Cinchona officinalis, Coffea cruda, Cypripedium pubescens, Hyoscyamus niger, Kali phosphoricum, Ignatia amara, Passiflora incarnata, Phosphorus, Pulsatilla, Valeriana officinalis.	LIQUID	ORAL	20220816		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACONITUM NAPELLUS WHOLE; AESCULUS HIPPOCASTANUM FLOWER; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; CAMPHOR (NATURAL); CINCHONA OFFICINALIS BARK; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DIBASIC POTASSIUM PHOSPHATE; HYOSCYAMUS NIGER; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; STRYCHNOS IGNATII SEED; VALERIAN	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
57955-6031_b9287675-2fb2-4a48-bd06-3093ea3b81fd	57955-6031	HUMAN OTC DRUG	Sciatic Nerve Formula		Aesculus hippocastanum, Ammonium muriaticum, Arsenicum album, Belladonna, Capsicum annuum, Causticum, Colchicum autumnale, Colocynthis, Gnaphalium polycephalum, Ignatia amara, Hypericum perforatum, Magnesia phosphorica, Rhus tox, Ruta graveolens	LIQUID	ORAL	20221019		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AMMONIUM CHLORIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAPSICUM; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; KALMIA LATIFOLIA LEAF; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS IGNATII SEED; TOXICODENDRON PUBESCENS LEAF	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
57955-6163_be7da797-0cf7-4c02-8f8c-1377fe51b5ec	57955-6163	HUMAN OTC DRUG	Arthritis Pain and Joint Relief		Actaea spicata, Aesculus hippocastanum, Arnica montana, Bellis perennis, Bryonia, Calcarea carbonica, Calcarea fluorica, Causticum, Cimicifuga racemosa, Formicum acidum, Hypericum perforatum, Ledum palustre, Lithium carbonicum, Magnesia phosphorica, Phosphorus, Phytolacca decandra, Pulsatilla, Rhododendron chrysanthum, Rhus tox, Ruta graveolens, Salicylicum acidum, Sepia, Zincum metallicum	LIQUID	ORAL	20220916		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACTAEA SPICATA ROOT; ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM FLUORIDE; CAUSTICUM; FORMIC ACID; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; LITHIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS WHOLE; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SALICYLIC ACID; SEPIA OFFICINALIS JUICE; TOXICODENDRON PUBESCENS LEAF; ZINC	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mood Stabilizer [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
57955-7006_b8e7765b-0eca-4404-818d-9e1cdcca1988	57955-7006	HUMAN OTC DRUG	Menopause Relief		Amyl nitrosum, Calcarea carbonica, Caulophyllum thalictroides, Cimicifuga racemosa, Ferrum metallicum, Gelsemium sempervirens, Lachesis mutus, Pulsatilla, Sanguinaria canadensis, Sepia, Sulphur, Sulphuricum acidum.	LIQUID	ORAL	20220612		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AMYL NITRITE; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; GELSEMIUM SEMPERVIRENS ROOT; IRON; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS WHOLE; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SULFUR; SULFURIC ACID	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
57955-9001_58721359-1e89-40a2-acf7-965d902f26bf	57955-9001	HUMAN OTC DRUG	911 Adrenal Burnout and Fatigue		Aceticum ac, Adrenalinum, Adrenocorticotrophin, Aesculus hipp, flos, Alfalfa, Alpha-lipoic ac, Ambra, Argentum nitricum, Avena, Bryonia, Carboneum oxygenisatum, Carpinus betulus, flos, Citricum ac, DNA, Fumaricum ac, Gelsemium, Hepar sulph culc, Hypothalamus suis, Kali phos, Lacticum ac, Lecithin, Nat mur, Oxalicum acidum, Phosphoricum acidum, Pituitarum posterium, Sarcolacticum acidum, Selenium metallicum, Sepia, Silicea, Succinicum acidum, Thyroidinum	LIQUID	ORAL	20220622		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACETIC ACID; AESCULUS HIPPOCASTANUM FLOWER; ALPHA LIPOIC ACID; AMBERGRIS; ANHYDROUS CITRIC ACID; APRINOCARSEN; AVENA SATIVA FLOWERING TOP; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CARBON MONOXIDE; CARPINUS BETULUS FLOWERING TOP; CORTICOTROPIN; DIBASIC POTASSIUM PHOSPHATE; EPINEPHRINE; FUMARIC ACID; GELSEMIUM SEMPERVIRENS ROOT; HERRING SPERM DNA; LACTIC ACID, DL-; LACTIC ACID, L-; MEDICAGO SATIVA WHOLE; OXALIC ACID DIHYDRATE; PHOSPHORIC ACID; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SILVER NITRATE; SODIUM CHLORIDE; SUCCINIC ACID; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIED	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 30; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Acidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Decreased Coagulation Factor Activity [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
57955-9002_5cf2899a-f527-4f6a-96a9-2391e3590a2e	57955-9002	HUMAN OTC DRUG	Allergy Hay Fever Reliever		Allium cepa, Ambrosia artemisiaefolia, Arsenicum album, Arum triphyllum, Arundo mauritanica, Euphrasia officinalis, Naphthalinum, Natrum muriaticum, Sabadilla, Wyethia helenioides	LIQUID	ORAL	20220422		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; ARISAEMA TRIPHYLLUM ROOT; ARSENIC TRIOXIDE; ARUNDO PLINIANA ROOT; EUPHRASIA STRICTA; NAPHTHALENE; ONION; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; WYETHIA HELENIOIDES ROOT	10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
57955-9003_075117c2-63c8-4ee1-ad99-fb96eb58b498	57955-9003	HUMAN OTC DRUG	911 Stress and Anxiety		Aconitum napellus, Alfalfa, Apis mellifica, Avena sativa, Chamomilla, Cistus canadensis, Clematis vitalba, flos, Histaminum hydrochloricum, Ignatia amara, Impatiens glandulifera, flos, Kali phosphoricum, Lilium tigrinum, Ornithogalum umbellatum, flos, Passiflora incarnata, Phosphorus, Prunus cerasidera, flos, Pulsatilla, Valeriana officinalis.	LIQUID	ORAL	20220612		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACONITUM NAPELLUS WHOLE; APIS MELLIFERA; AVENA SATIVA FLOWERING TOP; CLEMATIS VITALBA FLOWER; DIBASIC POTASSIUM PHOSPHATE; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; IMPATIENS GLANDULIFERA FLOWER; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA CHAMOMILLA WHOLE; MEDICAGO SATIVA WHOLE; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PRUNUS CERASIFERA FLOWER; PULSATILLA VULGARIS WHOLE; STRYCHNOS IGNATII SEED; VALERIAN	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
57955-9004_3ab7a0fe-cbe1-4eb5-a466-dbaee1046441	57955-9004	HUMAN OTC DRUG	First Aid Mind and Body		Aconitum napellus, Apis mellifica, Arnica montana, Arsenicum album, Belladonna, Bellis perennis, Bryonia, Calendula officinalis, Chamomilla, Cistus canadensis, Clematis erecta, Clematis vitalba, flos, Ferrum phosphoricum, Histaminum hydrochloricum, Hypericum perforatum, Ignatia amara, Impatiens glandulifera, flos, Ornithogalum umbellatum, flos, Passiflora incarnata, Phosphorus, Prunus cerasifera, flos, Rhus tox, Sulphur, Symphytum officinale, Trifolium pratense, Veratrum album	LIQUID	ORAL	20220622		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACONITUM NAPELLUS WHOLE; APIS MELLIFERA; ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS WHOLE; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS RECTA FLOWERING TOP; CLEMATIS VITALBA FLOWER; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA CHAMOMILLA WHOLE; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PRUNUS CERASIFERA FLOWER; STRYCHNOS IGNATII SEED; SULFUR; TOXICODENDRON PUBESCENS LEAF; TRIFOLIUM PRATENSE FLOWER; VERATRUM ALBUM ROOT	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
57955-9005_4ac50f31-204b-4b16-ae87-f8c757aa82da	57955-9005	HUMAN OTC DRUG	Stress and Anxiety		Aconitum napellus, Alfala, Apis mellifica, Avena sativa, Chamomilla, Cistus canadensis, Clematis vitalba, flos, Histaminum hydrochloricum, Ignatia amara, Impatiens glandulifera, flos, Kali Phosphoricum, Lilium tigrinum, Ornithogalum umbellatum, flos, Passiflora incarnata, Phosphorus, Prunus cerasifera, flos, Pulsatilla, Valeriana officinalis	LIQUID	ORAL	20220818		UNAPPROVED HOMEOPATHIC		King Bio Inc.	ACONITUM NAPELLUS WHOLE; APIS MELLIFERA; AVENA SATIVA FLOWERING TOP; CLEMATIS VITALBA FLOWER; DIBASIC POTASSIUM PHOSPHATE; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; IMPATIENS GLANDULIFERA FLOWER; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA CHAMOMILLA WHOLE; MEDICAGO SATIVA WHOLE; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PRUNUS CERASIFERA FLOWER; PULSATILLA VULGARIS WHOLE; STRYCHNOS IGNATII SEED; VALERIAN	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
57955-9150_0da7d88d-6cf3-4963-9ae8-ad37cc83c39d	57955-9150	HUMAN OTC DRUG	Good Mood Enhancer		Agrimonia eupatoria, flos, Anacardium orientale, Aurum metallicum, Avena sativa, Borago officinalis, Calcarea carbonica, Capsicum annuum, Carpinus betulus, flos, Cimicifuga racemosa, Cinchona officinalis, Hypericum perforatum, Ignatia amara, Kali bromatum, Larix decidua, flos, Natrum carbonicum, Natrum sulphuricum, Phosphoricum acidum, Phosphorus, Pulsatilla, Sepia, Sinapis arvensis, flos, Tabacum	LIQUID	ORAL	20221117		UNAPPROVED HOMEOPATHIC		King Bio Inc.	AGRIMONIA EUPATORIA FLOWER; AVENA SATIVA FLOWERING TOP; BLACK COHOSH; BORAGE; CAPSICUM; CARPINUS BETULUS FLOWERING TOP; CINCHONA OFFICINALIS BARK; GOLD; HYPERICUM PERFORATUM WHOLE; LARIX DECIDUA FLOWERING TOP; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; POTASSIUM BROMIDE; PULSATILLA VULGARIS WHOLE; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CARBONATE; SODIUM SULFATE; STRYCHNOS IGNATII SEED; TOBACCO LEAF	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
57957-0007_8d33aa23-9eeb-4bfe-aedb-515f62bddfb1	57957-0007	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19760101		UNAPPROVED MEDICAL GAS		Bernens Convalescent Pharmacy, Inc	OXYGEN	99	L/100L			N	20241231
57959-123_0c8f143e-7839-a75c-e063-6394a90a6c83	57959-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20151202		UNAPPROVED MEDICAL GAS		Home Care Equipment, Inc.	OXYGEN	99	L/100L			N	20241231
57962-007_2bf1f784-726b-4a33-9e04-25925f28323c	57962-007	HUMAN PRESCRIPTION DRUG	Imbruvica		Ibrutinib	SUSPENSION	ORAL	20220824		NDA	NDA217003	Pharmacyclics LLC	IBRUTINIB	70	mg/mL	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
57962-014_2bf1f784-726b-4a33-9e04-25925f28323c	57962-014	HUMAN PRESCRIPTION DRUG	Imbruvica		Ibrutinib	TABLET, FILM COATED	ORAL	20180216		NDA	NDA210563	Pharmacyclics LLC	IBRUTINIB	140	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
57962-070_2bf1f784-726b-4a33-9e04-25925f28323c	57962-070	HUMAN PRESCRIPTION DRUG	Imbruvica		Ibrutinib	CAPSULE	ORAL	20171220		NDA	NDA205552	Pharmacyclics LLC	IBRUTINIB	70	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
57962-140_2bf1f784-726b-4a33-9e04-25925f28323c	57962-140	HUMAN PRESCRIPTION DRUG	Imbruvica		Ibrutinib	CAPSULE	ORAL	20131113		NDA	NDA205552	Pharmacyclics LLC	IBRUTINIB	140	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
57962-280_2bf1f784-726b-4a33-9e04-25925f28323c	57962-280	HUMAN PRESCRIPTION DRUG	Imbruvica		Ibrutinib	TABLET, FILM COATED	ORAL	20180216		NDA	NDA210563	Pharmacyclics LLC	IBRUTINIB	280	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
57962-420_2bf1f784-726b-4a33-9e04-25925f28323c	57962-420	HUMAN PRESCRIPTION DRUG	Imbruvica		Ibrutinib	TABLET, FILM COATED	ORAL	20180216		NDA	NDA210563	Pharmacyclics LLC	IBRUTINIB	420	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
57962-560_2bf1f784-726b-4a33-9e04-25925f28323c	57962-560	HUMAN PRESCRIPTION DRUG	Imbruvica		Ibrutinib	TABLET, FILM COATED	ORAL	20180216		NDA	NDA210563	Pharmacyclics LLC	IBRUTINIB	560	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
57970-100_948f52da-c121-4d45-9a8f-273ecd90a1da	57970-100	HUMAN PRESCRIPTION DRUG	DALVANCE		Dalbavancin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20140523		NDA	NDA021883	Allergan, Inc.	DALBAVANCIN HYDROCHLORIDE	500	mg/25mL	Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [EXT]		N	20241231
57993-001_0a235a45-bec7-83d1-e063-6394a90a800d	57993-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20101026		UNAPPROVED MEDICAL GAS		Sanford HealthCare Accessories, LLC	OXYGEN	99	L/100L			N	20241231
58037-001_f0f0e4cd-3147-4c1a-e053-2995a90a64eb	58037-001	HUMAN OTC DRUG	Medicated Body	Powder	MENTHOL	POWDER	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part348	New Pride Corp	MENTHOL	.42	g/283g			N	20241231
58037-002_f0f11f77-4fcb-ea5c-e053-2a95a90a4449	58037-002	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20221229		OTC MONOGRAPH NOT FINAL	part333A	New Pride Corp	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
58037-003_f0f223ee-733a-3c89-e053-2a95a90a78bd	58037-003	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70%		Isopropyl Alcohol	LIQUID	TOPICAL	20221229		OTC MONOGRAPH NOT FINAL	part333A	New Pride Corp	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
58037-004_f158ad51-b773-257f-e053-2a95a90a5558	58037-004	HUMAN OTC DRUG	91% Isopropyl Rubbing Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20210114		OTC MONOGRAPH NOT FINAL	part333A	New Pride Corp	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
58037-005_f159058a-cbcb-a7b6-e053-2a95a90a2b6d	58037-005	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 50% WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333A	New Pride Corp	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
58037-007_f15a23ba-0b05-8969-e053-2a95a90a84d7	58037-007	HUMAN OTC DRUG	91% ISOPROPYL RUBBING ALCOHOL WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20200811		OTC MONOGRAPH NOT FINAL	part333A	New Pride Corp	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
58037-008_f6626023-4858-518b-e053-2a95a90a9821	58037-008	HUMAN OTC DRUG	Epsom Salts		Magnesium Sulfate	GRANULE	ORAL	20190709		OTC MONOGRAPH NOT FINAL	part334	NEW PRIDE CORP	MAGNESIUM SULFATE HEPTAHYDRATE	100	g/100g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58037-009_0b78f7ce-5e37-a003-e063-6394a90aea4a	58037-009	HUMAN OTC DRUG	Petrolatum Jelly		Petrolatum	JELLY	TOPICAL	20161015		OTC MONOGRAPH DRUG	M016	NEW PRIDE CORP	PETROLATUM	100	g/100g			N	20241231
58037-010_f6647680-5702-0580-e053-2995a90a2629	58037-010	HUMAN OTC DRUG	Vaporising Chest Rub		Camphor, Menthol, Eucalyptus Oil	CREAM	TOPICAL	20220214		OTC MONOGRAPH FINAL	part341	New Pride Corp	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
58037-102_d57be6ce-79cc-b625-e053-2a95a90a93a7	58037-102	HUMAN OTC DRUG	HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200627		OTC MONOGRAPH NOT FINAL	part333A	Pride Products Corp.	ALCOHOL	62	mL/100mL			N	20241231
58037-201_f8bbc7bc-6d4c-e06f-e053-6394a90a3b16	58037-201	HUMAN OTC DRUG	MAXX PRO DRY ANTIPERSPIRANT AND DEODORANT COOL BLAST		aluminum chlorohydrate	STICK	TOPICAL	20230401		OTC MONOGRAPH FINAL	M019	New Pride Corp	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
58037-202_f8f7f605-10dc-a62e-e053-6394a90ac669	58037-202	HUMAN OTC DRUG	SIMPLY BODYCARE ANTIPERSPIRANT DEODORANT FRESH		aluminum chlorohydrate	STICK	TOPICAL	20230401		OTC MONOGRAPH FINAL	M019	New Pride Corp	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
58037-203_f8f83929-e41e-db8a-e053-6294a90a8a88	58037-203	HUMAN OTC DRUG	SIMPLY BODYCARE ANTIPERSPIRANT DEODORANT CHERRY BLOSSOM		aluminum chlorohydrate	STICK	TOPICAL	20230401		OTC MONOGRAPH FINAL	M019	New Pride Corp	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
58037-204_f9c153f9-dfb6-5c7e-e053-6294a90a4417	58037-204	HUMAN OTC DRUG	PHARMACY BEST ICE		MENTHOL	GEL	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	New Pride Corp	MENTHOL	1	g/100g			N	20241231
58037-205_fa0c55eb-cad4-42a5-e053-6394a90af4ea	58037-205	HUMAN OTC DRUG	SIMPLY BODYCARE DANDRUFF		pyrithione zinc	SHAMPOO	TOPICAL	20230401		OTC MONOGRAPH FINAL	M032	New Pride Corp	PYRITHIONE ZINC	.5	g/100mL			N	20241231
58037-211_0c9e60e1-df2b-bc30-e063-6394a90a5048	58037-211	HUMAN OTC DRUG	70% ISOPROPYL RUBBING ALCOHOL WITH WINTERGREEN		Isopropyl Alcohol	LIQUID	TOPICAL	20230105		OTC MONOGRAPH DRUG	M003	New Pride Corp	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
58048-0004_0fdfd134-6049-4a2d-8a4d-447c8b570803	58048-0004	HUMAN OTC DRUG	Lyme and Co-Infection Nosode		Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Chlamydia Trachomatis, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Prowazekii, Encephalitis Nosode, Ledum Palustre	LIQUID	ORAL	20190129	20240307	UNAPPROVED HOMEOPATHIC		Bhp Holdings, Inc.	ANGELICA ARCHANGELICA ROOT; ANHYDROUS CITRIC ACID; ARNICA MONTANA; BABESIA MICROTI; BORRELIA BURGDORFERI; CAUSTICUM; CHLAMYDIA TRACHOMATIS; GOLDENSEAL; HUMAN HERPESVIRUS 5; JAPANESE ENCEPHALITIS VIRUS; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; RICKETTSIA PROWAZEKII; SUS SCROFA CARTILAGE; TOXICODENDRON PUBESCENS LEAF; YUCCA FILAMENTOSA	2; 6; 8; 12; 12; 6; 12; 5; 6; 12; 12; 30; 8; 8; 8; 4; 3; 8; 3; 6; 3	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
58048-0005_88e0c163-99e8-45bb-8911-8d29370dd909	58048-0005	HUMAN OTC DRUG	Lyme and Co-Infection Nosode		Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Nosode (rickettsia prowazekii), Chlamydia Trachomatis, Ledum Palustre	LIQUID	ORAL	20200317	20270919	UNAPPROVED HOMEOPATHIC		Bhp Holdings, Inc.	ANGELICA ARCHANGELICA ROOT; ANHYDROUS CITRIC ACID; ARNICA MONTANA; BABESIA MICROTI; BORRELIA BURGDORFERI; CAUSTICUM; CHLAMYDIA TRACHOMATIS; GOLDENSEAL; HUMAN HERPESVIRUS 5; LATRODECTUS MACTANS; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; RICKETTSIA PROWAZEKII; SUS SCROFA CARTILAGE; TOXICODENDRON PUBESCENS LEAF; YUCCA FILAMENTOSA	2; 6; 8; 12; 12; 6; 12; 5; 6; 12; 30; 8; 8; 8; 4; 3; 8; 4; 6; 3	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
58048-0006_53dad825-4744-4b41-8974-831a37af78f5	58048-0006	HUMAN OTC DRUG	LY-CO		Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Nosode (rickettsia prowazekii), Chlamydia Trachomatis, Ledum Palustre	LIQUID	ORAL	20230601		UNAPPROVED HOMEOPATHIC		Bhp Holdings, Inc.	ANGELICA ARCHANGELICA ROOT; ANHYDROUS CITRIC ACID; ARNICA MONTANA WHOLE; BORRELIA BURGDORFERI; CAUSTICUM; CHLAMYDIA TRACHOMATIS; GOLDENSEAL; HUMAN HERPESVIRUS 5; LATRODECTUS MACTANS; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID DIHYDRATE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; RHODODENDRON TOMENTOSUM LEAFY TWIG; RICKETTSIA PROWAZEKII; SUS SCROFA CARTILAGE; TOXICODENDRON PUBESCENS LEAF; YUCCA FILAMENTOSA WHOLE	2; 6; 8; 12; 6; 12; 5; 6; 12; 8; 8; 8; 4; 3; 30; 8; 4; 6; 3	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58049-123_0cdefed6-644b-c34c-e063-6394a90a4099	58049-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091028		UNAPPROVED MEDICAL GAS		Respiratory Home Care and Convalescent Supply Inc	OXYGEN	99	L/100L			N	20241231
58060-002_cdc03368-9c60-d716-e053-2995a90a0963	58060-002	HUMAN PRESCRIPTION DRUG	Radiogardase		Prussian blue insoluble capsules	CAPSULE	ORAL	20100324		NDA	NDA021626	Heyl Chem.-pharm. Fabrik GmbH & Co. KG	FERRIC FERROCYANIDE	500	mg/1	Chelating Activity [MoA], Decorporation Agent [EPC], Ion Exchange Activity [MoA]		N	20241231
58064-408_078747dd-ce4a-6714-e063-6394a90aedf8	58064-408	HUMAN PRESCRIPTION DRUG	buprenorphine transdermal system		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20220517		ANDA	ANDA207490	LTS Therapy Systems, LLC	BUPRENORPHINE	20	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58089-001_07630b4a-271d-09cb-e063-6294a90a258c	58089-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091202		UNAPPROVED MEDICAL GAS		Manuel Enterprises, Inc. dba Nepenthe Home Medical Equipment	OXYGEN	99	L/100L			N	20241231
58118-0025_f1ea65fe-0b6f-c643-e053-2995a90aefaa	58118-0025	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	Clinical Solutions Wholsesale	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
58118-0041_f1ec1cd7-3ef0-27bf-e053-2a95a90a3db0	58118-0041	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150316		ANDA	ANDA040616	Clinical Solutions Wholesale, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
58118-0176_0e76c642-8fc8-c0b6-e063-6394a90a413e	58118-0176	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20091008		ANDA	ANDA078633	Clinical Solutions Wholesale, LLC	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
58118-0177_0e76c642-8fc8-c0b6-e063-6394a90a413e	58118-0177	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20091008		ANDA	ANDA078633	Clinical Solutions Wholesale, LLC	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
58118-0377_0e85bc3d-4f3c-00d3-e063-6294a90a847a	58118-0377	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Clinical Solutions Wholesale, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
58118-0485_0e85c22f-4438-16b4-e063-6394a90a8600	58118-0485	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	Clinical Solutions Wholesale, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
58118-0501_0e85a5c9-76a8-f621-e063-6394a90a8782	58118-0501	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20171025		ANDA	ANDA207276	Clinical Solutions Wholesale, LLC	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
58118-0502_0e859e75-928c-e576-e063-6294a90a8421	58118-0502	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20171025		ANDA	ANDA207276	Clinical Solutions Wholesale, LLC	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
58118-0626_0e85cd9d-0f26-8950-e063-6294a90a33f7	58118-0626	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Clinical Solutions Wholesale, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20251231
58118-0832_0e852f9b-ed29-bc08-e063-6394a90a28db	58118-0832	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20200326		ANDA	ANDA074569	Clinical Solutions Wholesale, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-0904_0e85cd9d-0f29-8950-e063-6294a90a33f7	58118-0904	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20190215		ANDA	ANDA078203	Clinical Solutions Wholesale, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-1033_0e85dcfa-d9dd-5fbb-e063-6394a90aeae6	58118-1033	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20190219		ANDA	ANDA083116	Clinical Solutions Wholesale, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-1095_0e85cd9d-0f29-8950-e063-6294a90a33f7	58118-1095	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20190215		ANDA	ANDA078203	Clinical Solutions Wholesale, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-1096_0e85cd9d-0f29-8950-e063-6294a90a33f7	58118-1096	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20190215		ANDA	ANDA078203	Clinical Solutions Wholesale, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-1590_0e85cd9d-0f2a-8950-e063-6294a90a33f7	58118-1590	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20181212		ANDA	ANDA084769	Clinical Solutions Wholesale, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-1626_0e8814e5-056b-eef6-e063-6394a90a23cd	58118-1626	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20221130		UNAPPROVED DRUG OTHER		Clinical Solutions Wholesale, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20251231
58118-3925_0e85cd9d-0f2b-8950-e063-6294a90a33f7	58118-3925	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20190809		ANDA	ANDA071307	Clinical Solutions Wholesale, LLC	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-3926_0e85da3b-5f92-55cd-e063-6394a90a7599	58118-3926	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20190801		ANDA	ANDA071321	Clinical Solutions Wholesale, LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-4047_0e85c568-114e-e644-e063-6294a90a1a74	58118-4047	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	Clinical Solutions Wholesale, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
58118-4484_0e76cd12-9f35-c98f-e063-6394a90ad9fb	58118-4484	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190227		ANDA	ANDA040419	Clinical Solutions Wholesale, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
58118-8005_0e89609b-bd43-291f-e063-6294a90a623e	58118-8005	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate		Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate	TABLET	SUBLINGUAL	20171213		ANDA	ANDA207000	Clinical Solutions Wholesale, LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
58118-8020_0e89609b-bd43-291f-e063-6294a90a623e	58118-8020	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate		Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate	TABLET	SUBLINGUAL	20171213		ANDA	ANDA207000	Clinical Solutions Wholesale, LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
58125-0001_0d822af5-f3a0-e5dc-e063-6394a90ad068	58125-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19940526		UNAPPROVED MEDICAL GAS		Resp-I-Care, Inc.	OXYGEN	99	L/100L			N	20241231
58128-0001_0d821209-600a-639a-e063-6294a90ace97	58128-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19900504		UNAPPROVED MEDICAL GAS		Family Medical Supply, LLC	OXYGEN	99	L/100L			N	20241231
58133-010_fc73dde9-9df5-beca-e053-6394a90aaf0d	58133-010	HUMAN OTC DRUG	Control Menstrual Cramp Relief		Menthol	CREAM	TOPICAL	20230524		OTC MONOGRAPH NOT FINAL	part348	Cosmetic Specialty Labs, Inc.	MENTHOL	3	g/100mL			N	20241231
58133-591_f5c4c3c0-62f8-c3d9-e053-2995a90a0b41	58133-591	HUMAN OTC DRUG	LUMINA Natures Creation UNVEILED		Menthol	CREAM	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part348	Cosmetic Specialty Labs, Inc.	MENTHOL	4	g/100mL			N	20241231
58133-959_facf11e0-8ffd-754c-e053-6394a90af918	58133-959	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	Cosmetic Specialty Labs, Inc.	ALCOHOL	75	mL/100mL			N	20241231
58133-959_facff02c-29bf-95ce-e053-6294a90a5132	58133-959	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	Cosmetic Specialty Labs, Inc.	ALCOHOL	75	mL/100mL			N	20241231
58133-959_fad06aad-4ef0-ba68-e053-6394a90a817e	58133-959	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	Cosmetic Specialty Labs, Inc.	ALCOHOL	75	mL/100mL			N	20241231
58133-959_fad07aaf-6a66-f244-e053-6394a90a4c3a	58133-959	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	Cosmetic Specialty Labs, Inc.	ALCOHOL	75	mL/100mL			N	20241231
58133-959_fad08107-5626-2028-e053-6294a90a1b22	58133-959	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	Cosmetic Specialty Labs, Inc.	ALCOHOL	75	mL/100mL			N	20241231
58133-959_fad0eef2-c3ec-c522-e053-6294a90acc3b	58133-959	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	Cosmetic Specialty Labs, Inc.	ALCOHOL	75	mL/100mL			N	20241231
58133-959_fad0f1c4-16ef-92e8-e053-6394a90a7366	58133-959	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	Cosmetic Specialty Labs, Inc.	ALCOHOL	75	mL/100mL			N	20241231
58151-078_355bcdce-0481-48ba-8ebd-2009106aaf77	58151-078	HUMAN PRESCRIPTION DRUG	Cardura	XL	doxazosin mesylate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20240104		NDA	NDA021269	Viatris Specialty LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
58151-079_355bcdce-0481-48ba-8ebd-2009106aaf77	58151-079	HUMAN PRESCRIPTION DRUG	Cardura	XL	doxazosin mesylate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20240104		NDA	NDA021269	Viatris Specialty LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
58151-082_2a1d89c9-468d-49f1-af9d-584253c6ceae	58151-082	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	20231011		NDA	NDA020998	Viatris Specialty LLC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
58151-083_2a1d89c9-468d-49f1-af9d-584253c6ceae	58151-083	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	20230912		NDA	NDA020998	Viatris Specialty LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
58151-084_2a1d89c9-468d-49f1-af9d-584253c6ceae	58151-084	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	20240110		NDA	NDA020998	Viatris Specialty LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
58151-085_2a1d89c9-468d-49f1-af9d-584253c6ceae	58151-085	HUMAN PRESCRIPTION DRUG	CELEBREX		Celecoxib	CAPSULE	ORAL	20230912		NDA	NDA020998	Viatris Specialty LLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
58151-103_d7274947-4f88-47ee-a39f-bd5ac46fcf8d	58151-103	HUMAN PRESCRIPTION DRUG	Detrol LA		tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20240110		NDA	NDA021228	Viatris Specialty LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
58151-104_d7274947-4f88-47ee-a39f-bd5ac46fcf8d	58151-104	HUMAN PRESCRIPTION DRUG	Detrol LA		tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20240110		NDA	NDA021228	Viatris Specialty LLC	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
58151-125_f1795f7c-8bad-4e9e-a11d-3c099b11b059	58151-125	HUMAN PRESCRIPTION DRUG	Effexor	XR	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20231010		NDA	NDA020699	Viatris Specialty LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
58151-126_f1795f7c-8bad-4e9e-a11d-3c099b11b059	58151-126	HUMAN PRESCRIPTION DRUG	Effexor	XR	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20231010		NDA	NDA020699	Viatris Specialty LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
58151-127_f1795f7c-8bad-4e9e-a11d-3c099b11b059	58151-127	HUMAN PRESCRIPTION DRUG	Effexor	XR	VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20231010		NDA	NDA020699	Viatris Specialty LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
58151-155_a60cc18b-0631-4cf0-b021-9f52224ece65	58151-155	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	20240103		NDA	NDA020702	Viatris Specialty LLC	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
58151-156_a60cc18b-0631-4cf0-b021-9f52224ece65	58151-156	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	20240103		NDA	NDA020702	Viatris Specialty LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
58151-157_a60cc18b-0631-4cf0-b021-9f52224ece65	58151-157	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	20240103		NDA	NDA020702	Viatris Specialty LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
58151-158_a60cc18b-0631-4cf0-b021-9f52224ece65	58151-158	HUMAN PRESCRIPTION DRUG	Lipitor		atorvastatin calcium	TABLET, FILM COATED	ORAL	20240103		NDA	NDA020702	Viatris Specialty LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
58151-245_f280bbd8-2af2-444a-bd96-e409337ca6dd	58151-245	HUMAN PRESCRIPTION DRUG	Lyrica CR		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231227		NDA	NDA209501	Viatris Specialty LLC	PREGABALIN	82.5	mg/1		CV	N	20241231
58151-246_f280bbd8-2af2-444a-bd96-e409337ca6dd	58151-246	HUMAN PRESCRIPTION DRUG	Lyrica CR		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231227		NDA	NDA209501	Viatris Specialty LLC	PREGABALIN	165	mg/1		CV	N	20241231
58151-247_f280bbd8-2af2-444a-bd96-e409337ca6dd	58151-247	HUMAN PRESCRIPTION DRUG	Lyrica CR		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231227		NDA	NDA209501	Viatris Specialty LLC	PREGABALIN	330	mg/1		CV	N	20241231
58151-574_fda754f6-d0f3-4dce-a17a-927d64f912f7	58151-574	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230925		NDA	NDA019839	Viatris Specialty LLC	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
58151-575_fda754f6-d0f3-4dce-a17a-927d64f912f7	58151-575	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230925		NDA	NDA019839	Viatris Specialty LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
58151-576_fda754f6-d0f3-4dce-a17a-927d64f912f7	58151-576	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230925		NDA	NDA019839	Viatris Specialty LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
58151-601_fda754f6-d0f3-4dce-a17a-927d64f912f7	58151-601	HUMAN PRESCRIPTION DRUG	Zoloft		sertraline hydrochloride	SOLUTION, CONCENTRATE	ORAL	20230925		NDA	NDA020990	Viatris Specialty LLC	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
58160-726_911cf96f-a720-4ac9-b4fa-fc0b50d798be	58160-726	VACCINE	Hiberix		Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)	KIT		20231220		BLA	BLA125347	GlaxoSmithKline Biologicals SA						N	20241231
58160-740_f5020a4f-f6dd-438b-b30d-07de348e143d	58160-740	VACCINE	Rotarix		Rotavirus Vaccine, Live, Oral	SOLUTION	ORAL	20230201		BLA	BLA125265	GlaxoSmithKline Biologicals SA	HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN	1000	[CCID_50]/mL	Actively Acquired Immunity [PE], Live Attenuated Rotavirus Vaccine [EPC], Rotavirus Vaccines [CS], Vaccines, Attenuated [CS]		N	20241231
58160-810_1c62b333-2223-46cc-9732-91605e24366b	58160-810	VACCINE	INFANRIX		Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed	SUSPENSION	INTRAMUSCULAR	20090724		BLA	BLA103647	GlaxoSmithKline Biologicals SA	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	25; 8; 25; 10; 25	ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20251231
58160-811_8eae86dd-525d-4bb2-a7b9-59e0ac5079c3	58160-811	VACCINE	PEDIARIX		Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined	INJECTION, SUSPENSION	INTRAMUSCULAR	20090724		BLA	BLA103907	GlaxoSmithKline Biologicals SA	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	25; 8; 25; 10; 25; 10; 40; 8; 32	ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL; [iU]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20251231
58160-812_c47ef6b8-d7c2-4faf-81e3-94c93283a69d	58160-812	VACCINE	KINRIX		Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20080709		BLA	BLA125260	GlaxoSmithKline Biologicals SA	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	25; 8; 25; 10; 25; 40; 8; 32	[iU]/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL; [iU]/.5mL; [iU]/.5mL; [iU]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20251231
58160-815_8c08d49a-7015-4d79-97eb-628f9a652877	58160-815	VACCINE	TWINRIX		Hepatitis A and Hepatitis B (Recombinant) Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20070607		BLA	BLA103850	GlaxoSmithKline Biologicals SA	HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED); HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN	720; 20	[iU]/mL; ug/mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20241231
58160-818_911cf96f-a720-4ac9-b4fa-fc0b50d798be	58160-818	VACCINE	Hiberix		Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)	KIT		20151221		BLA	BLA125347	GlaxoSmithKline Biologicals SA						N	20241231
58160-819_864c964b-45aa-4c06-bbd7-2da63e6b3220	58160-819	VACCINE	Shingrix		Zoster Vaccine Recombinant, Adjuvanted	KIT		20171020	20250823	BLA	BLA125614	GlaxoSmithKline Biologicals SA						N	
58160-820_f25e726b-979d-4103-9958-a3e7ce6c7d4d	58160-820	VACCINE	ENGERIX-B		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR	20070425		BLA	BLA103239	GlaxoSmithKline Biologicals SA	HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN	10	ug/.5mL			N	20251231
58160-821_f25e726b-979d-4103-9958-a3e7ce6c7d4d	58160-821	VACCINE	ENGERIX-B		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR	20070328		BLA	BLA103239	GlaxoSmithKline Biologicals SA	HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN	20	ug/mL			N	20251231
58160-823_864c964b-45aa-4c06-bbd7-2da63e6b3220	58160-823	VACCINE	Shingrix		Zoster Vaccine Recombinant, Adjuvanted	KIT		20171020		BLA	BLA125614	GlaxoSmithKline Biologicals SA						N	20241231
58160-824_b2c5c971-1259-4284-a9f6-8c9fd3de63e3	58160-824	VACCINE	Priorix		Measels, Mumps, and Rubella Vaccine, Live	KIT		20220603		BLA	BLA125748	GlaxoSmithKline Biologicals SA						N	20241231
58160-825_679958ad-6e70-4c9c-a3d8-669a66d0a901	58160-825	VACCINE	HAVRIX		Hepatitis A Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20070216		BLA	BLA103475	GlaxoSmithKline Biologicals SA	HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)	720	[iU]/.5mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20251231
58160-826_679958ad-6e70-4c9c-a3d8-669a66d0a901	58160-826	VACCINE	HAVRIX		Hepatitis A Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20070413		BLA	BLA103475	GlaxoSmithKline Biologicals SA	HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)	1440	[iU]/mL	Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]		N	20251231
58160-827_654b10e1-a83a-4b3a-b615-3f49200dc319	58160-827	VACCINE	Menveo		Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine	INJECTION, SOLUTION	INTRAMUSCULAR	20221209		BLA	BLA125300	GlaxoSmithKline Biologicals SA	NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN	10; 5; 5; 5	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Meningococcal Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
58160-842_881b9be3-f10f-49a1-a282-0137c431477b	58160-842	VACCINE	BOOSTRIX		Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed	SUSPENSION	INTRAMUSCULAR	20090724		BLA	BLA125106	GlaxoSmithKline Biologicals SA	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)	8; 2.5; 8; 5; 2.5	ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20251231
58160-848_1e50f275-002e-413f-a840-66ee3cb3740c	58160-848	VACCINE	Arexvy		Respiratory Syncytial Visus Vaccine Recombinant, Adjuvanted	KIT		20230503		BLA	BLA125775	GlaxoSmithKline Biologicals SA						N	20241231
58160-854_f5020a4f-f6dd-438b-b30d-07de348e143d	58160-854	VACCINE	ROTARIX		Rotavirus Vaccine, Live, Oral	KIT		20110113	20250224	BLA	BLA125265	GlaxoSmithKline Biologicals SA						N	
58160-909_b7bc1c7f-c68b-42e7-b5c4-6b718e49909c	58160-909	VACCINE	FLUARIX QUADRIVALENT	2023/2024	influenza virus vaccine	SUSPENSION	INTRAMUSCULAR	20230630	20240630	BLA	BLA125127	GlaxoSmithKline Biologicals SA	INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
58160-955_654b10e1-a83a-4b3a-b615-3f49200dc319	58160-955	VACCINE	Menveo		Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine	KIT		20170301		BLA	BLA125300	GlaxoSmithKline Biologicals SA						N	20241231
58160-964_6aaf45e1-7af5-4d94-be4f-72eeadc2e0d9	58160-964	VACCINE	RabAvert		Rabies Vaccine	KIT		20161219	20240131	BLA	BLA103334	GlaxoSmithKline Biologicals SA						N	
58160-976_e2944037-5f4d-40ae-a962-51df041f5078	58160-976	VACCINE	Bexsero		NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN	INJECTION, SUSPENSION	INTRAMUSCULAR	20161201		BLA	BLA125546	GlaxoSmithKline Biologicals SA	NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN	50; 50; 50; 25	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	20241231
58166-001_d46518b1-b6c1-405e-ad85-d00093f9d621	58166-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20130401		NDA	NDA205840	Lynarc Welding Supplies & Material, Inc.	OXYGEN	99	L/100L			N	20241231
58181-3040_f80c4ec7-83d2-8ac9-e053-6294a90aad85	58181-3040	HUMAN PRESCRIPTION DRUG	Gleostine		lomustine	CAPSULE, GELATIN COATED	ORAL	20140818		NDA	NDA017588	NextSource Biotechnology, LLC	LOMUSTINE	10	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
58181-3041_f80c4ec7-83d2-8ac9-e053-6294a90aad85	58181-3041	HUMAN PRESCRIPTION DRUG	Gleostine		lomustine	CAPSULE, GELATIN COATED	ORAL	20140818		NDA	NDA017588	NextSource Biotechnology, LLC	LOMUSTINE	40	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
58181-3042_f80c4ec7-83d2-8ac9-e053-6294a90aad85	58181-3042	HUMAN PRESCRIPTION DRUG	Gleostine		lomustine	CAPSULE, GELATIN COATED	ORAL	20140818		NDA	NDA017588	NextSource Biotechnology, LLC	LOMUSTINE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
58228-0691_0e241343-db65-3f1c-e063-6394a90ab538	58228-0691	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	Prostat First Aid LLC	ALCOHOL	70	mL/100mL			N	20251231
58228-2009_f76d7d18-0fa2-d943-e053-6294a90ac20a	58228-2009	HUMAN OTC DRUG	Triple Antibiotic		Triple Antibiotic	OINTMENT	TOPICAL	20230410		OTC MONOGRAPH FINAL	part333B	ProStat First Aid	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
58228-2010_0e25c936-e40b-e23c-e063-6294a90ac0e4	58228-2010	HUMAN OTC DRUG	Burn Ease		Burn Ease	GEL	TOPICAL	20240108		OTC MONOGRAPH DRUG	M017	ProStat First Aid LLC	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
58228-2011_0e11238b-e5f3-075f-e063-6394a90aa825	58228-2011	HUMAN OTC DRUG	Antiseptic Wipes		Antiseptic Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	ProStat First Aid LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20251231
58228-2044_f70a442e-7ba8-4860-e053-6394a90ac2bd	58228-2044	HUMAN OTC DRUG	First Aid Burn Cream		First Aid Burn Cream	CREAM	TOPICAL	20230410		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE (C12-C16); LIDOCAINE HYDROCHLORIDE	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-2045_f707bda4-074b-6406-e053-6394a90a7ae1	58228-2045	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone 1%	CREAM	TOPICAL	20230410		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
58228-2078_0e2182ed-7b04-6ed2-e063-6394a90a56b3	58228-2078	HUMAN OTC DRUG	Alcohol Wipes		Alcohol Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	ProStat First Aid LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20251231
58228-2176_0e2149ea-3316-22a9-e063-6394a90a26f1	58228-2176	HUMAN OTC DRUG	Alcohol Wipes		Alcohol Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	ProStat First Aid LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20251231
58228-2204_0e20252a-5ecc-2526-e063-6294a90a8cde	58228-2204	HUMAN OTC DRUG	Sting Relief Wipes		Sting Relief Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M017	ProStat First Aid LLC	BENZOCAINE; ISOPROPYL ALCOHOL	6; 60	mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
58228-2205_00772636-8266-a937-e063-6294a90a438a	58228-2205	HUMAN OTC DRUG	PS-2205 BZK Antiseptic Towelettes		PS-2205 BZK Antiseptic Towelettes	SWAB	TOPICAL	20230731		OTC MONOGRAPH NOT FINAL	part333A	ProStat First Aid LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
58228-2261_0072f8de-fc07-d529-e063-6294a90a08db	58228-2261	HUMAN OTC DRUG	PS-2261 Triple Antibiotic, 0.5g		PS-2261 Triple Antibiotic, 0.5g	OINTMENT	TOPICAL	20230731		OTC MONOGRAPH FINAL	part333B	ProStat First Aid LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
58228-2309_0037a1a4-d748-2567-e063-6394a90a721c	58228-2309	HUMAN OTC DRUG	First Aid Burn Cream		First Aid Burn Cream	CREAM	TOPICAL	20230731		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	13; 50	mg/10000mg; mg/10000mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-2362_01c87dff-57e1-017a-e063-6394a90a1600	58228-2362	HUMAN OTC DRUG	PS-2362 Hand Sanitizer 0.9g packet		PS-2362 Hand Sanitizer 0.9g packet	GEL	TOPICAL	20230811		OTC MONOGRAPH NOT FINAL	part333A	ProStat First Aid LLC	ALCOHOL	70	mL/100mL			N	20241231
58228-2404_0e120fed-3226-520b-e063-6394a90a9f9e	58228-2404	HUMAN OTC DRUG	Antiseptic Wipes		Antiseptic Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	ProStat First Aid LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20251231
58228-2510_0e21211d-e99b-03c8-e063-6394a90a0492	58228-2510	HUMAN OTC DRUG	Alcohol Wipes		Alcohol Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	ProStat First Aid LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20251231
58228-2610_0e0ca589-834c-495b-e063-6394a90afbd0	58228-2610	HUMAN OTC DRUG	Alcohol Wipes		Alcohol Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	Front Line Safety	ISOPROPYL ALCOHOL	.7	mL/mL			N	20251231
58228-2677_ff5bb628-8ef8-4540-e053-6394a90a55ed	58228-2677	HUMAN OTC DRUG	2677 First Aid Burn Cream		2677 First Aid Burn Cream	CREAM	TOPICAL	20230721		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	13; 50	mg/10000mg; mg/10000mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-2895_0050de33-914c-f76d-e063-6394a90a7fab	58228-2895	HUMAN OTC DRUG	PS - 2895 Triple Antibiotic , 0.5g		PS - 2895 Triple Antibiotic , 0.5g	OINTMENT	TOPICAL	20230731		OTC MONOGRAPH FINAL	part333B	Prostat First Aid LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
58228-2896_0074e7bf-8c63-a5a7-e063-6394a90a63fc	58228-2896	HUMAN OTC DRUG	PS-2896 Hydrocortisone Cream 1%, 0.9g		PS-2896 Hydrocortisone Cream 1%, 0.9g	CREAM	TOPICAL	20230731		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
58228-3831_f71b98b4-22d1-0124-e053-6394a90ae4cf	58228-3831	HUMAN OTC DRUG	Burn Ease		Burn Ease	GEL	TOPICAL	20230410		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-3832_f71eb4f5-2281-5867-e053-6394a90aac57	58228-3832	HUMAN OTC DRUG	Burn Ease		Burn Ease	GEL	TOPICAL	20230410		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-3866_004d00a5-9d00-29ff-e063-6294a90aeb8c	58228-3866	HUMAN OTC DRUG	PS-3866 Burn Ease, 0.9g		PS-3866 Burn Ease, 0.9g	GEL	TOPICAL	20230731		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-3883_004aa18f-3a98-f454-e063-6394a90afcff	58228-3883	HUMAN OTC DRUG	Burn Ease, 3.5g		Burn Ease, 3.5g	GEL	TOPICAL	20230731		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-3885_004c6deb-2845-a0d0-e063-6394a90ae5e4	58228-3885	HUMAN OTC DRUG	PS-3885 Burn Ease, 3.5g		PS-3885 Burn Ease, 3.5g	GEL	TOPICAL	20230731		OTC MONOGRAPH NOT FINAL	part348	ProStat First Aid LLC	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58228-6210_0e34cb09-d8c7-f8c0-e063-6294a90a0be0	58228-6210	HUMAN OTC DRUG	Burn Ease		Burn Ease	GEL	TOPICAL	20240108		OTC MONOGRAPH DRUG	M017	Front Line Safety	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
58228-6211_0e1f3653-d75f-9c9e-e063-6294a90ab639	58228-6211	HUMAN OTC DRUG	Antiseptic Wipes		Antiseptic Wipes	SWAB	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	Front Line Safety	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20251231
58228-8691_0e21f466-d6ee-79c4-e063-6394a90ae988	58228-8691	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	ProStat First Aid LLC	ALCOHOL	70	mL/100mL			N	20251231
58247-001_50eedede-6c38-4456-bc80-9dc71daf66ff	58247-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19810101		UNAPPROVED MEDICAL GAS		Respitek Inc	OXYGEN	99	L/100L			N	20241231
58264-0004_e080c64c-d75d-080d-e053-2a95a90ad59f	58264-0004	HUMAN OTC DRUG	D-4		QUININE ARSENITE, PHOSPHORIC ACID, MATRICARIA CHAMOMILLA, CITRULLUS COLOCYNTHIS FRUIT PULP, MERCURIC CHLORIDE, VERATRUM ALBUM ROOT, BAPTISIA TINCTORIA, FERROSOFERRIC PHOSPHATE, NERIUM OLEANDER LEAF, and TOXICODENDRON PUBESCENS LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BAPTISIA TINCTORIA; CITRULLUS COLOCYNTHIS FRUIT PULP; FERROSOFERRIC PHOSPHATE; MATRICARIA CHAMOMILLA; MERCURIC CHLORIDE; NERIUM OLEANDER LEAF; PHOSPHORIC ACID; QUININE ARSENITE; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	4; 6; 8; 4; 5; 6; 3; 12; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC]		N	20241231
58264-0005_e080c742-676c-6262-e053-2995a90a5516	58264-0005	HUMAN OTC DRUG	D-5		Silver nitrate, Strychnos nux-vomica seed, Lycopodium clavatum spore, Semecarpus anacardium juice, Scrophularia nodosa, Atropa belladonna, Arsenic trioxide, Activated charcoal, Matricaria chamomilla, and Chelidonium majus	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CHELIDONIUM MAJUS; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; SCROPHULARIA NODOSA; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED	8; 4; 4; 3; 5; 2; 1; 6; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0006_e080d1ec-1471-648b-e053-2a95a90af2a0	58264-0006	HUMAN OTC DRUG	D-6		aconitum napellus, bryonia alba whole, eupatorium perfoliatum flowering top, gelsemium sempervirens root, causticum, camphor (natural), eucalyptus globulus leaf, baptisia tinctoria, ferrosoferric phosphate, and schoenocaulon officinale seed	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; BAPTISIA TINCTORIA; BRYONIA ALBA WHOLE; CAMPHOR (NATURAL); CAUSTICUM; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; SCHOENOCAULON OFFICINALE SEED	4; 4; 4; 3; 6; 3; 3; 8; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0008_f12900e1-d15a-7c2c-e053-2995a90a70e7	58264-0008	HUMAN OTC DRUG	D-8		SPONGIA OFFICINALIS SKELETON, ROASTED, CAUSTICUM, LACHESIS MUTA VENOM, CALCIUM SULFIDE, THYMUS SERPYLLUM, ANTIMONY POTASSIUM TARTRATE, ACONITUM NAPELLUS, AND DROSERA ROTUNDIFOLIA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; ANTIMONY POTASSIUM TARTRATE; CALCIUM SULFIDE; CAUSTICUM; DROSERA ROTUNDIFOLIA; LACHESIS MUTA VENOM; SPONGIA OFFICINALIS SKELETON, ROASTED; THYMUS SERPYLLUM	6; 6; 5; 6; 4; 8; 4; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0009_e080d1ec-1483-648b-e053-2a95a90af2a0	58264-0009	HUMAN OTC DRUG	D-9		Cupric acetate, Ipecac, Magnesium phosphate, Dibasic trihydrate, Drosera rotundifolia, Atropa belladonna, Hyoscyamus niger, Onion, Corallium rubrum exoskeleton, and Lobaria pulmonaria	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ATROPA BELLADONNA; CORALLIUM RUBRUM EXOSKELETON; CUPRIC ACETATE; DROSERA ROTUNDIFOLIA; HYOSCYAMUS NIGER; IPECAC; LOBARIA PULMONARIA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ONION	4; 12; 6; 6; 4; 6; 4; 30; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
58264-0010_e080dbbf-bfbe-558d-e053-2a95a90acbf3	58264-0010	HUMAN OTC DRUG	D-10		Sepia officinalis whole, Sanguinaria canadensis root, Sulfuric acid, Black cohosh, and Lachesis muta venom	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLACK COHOSH; LACHESIS MUTA VENOM; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS WHOLE; SULFURIC ACID	4; 12; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0011_e082b62a-5b47-c759-e053-2995a90a9c16	58264-0011	HUMAN OTC DRUG	D-11		BERBERIS VULGARIS ROOT BARK, SOLANUM DULCAMARA WHOLE, TOXICODENDRON PUBESCENS LEAF, STRYCHNOS NUX-VOMICA SEED, Causticum, TRIBASIC CALCIUM PHOSPHATE, and RHODODENDRON AUREUM LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BERBERIS VULGARIS ROOT BARK; CAUSTICUM; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA WHOLE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	4; 6; 4; 4; 4; 4; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0012_e082c24c-9c64-6fc7-e053-2995a90a6c68	58264-0012	HUMAN OTC DRUG	D-12		POTASSIUM IODIDE, CALCIUM IODIDE, ARSENIC TRIIODIDE, BARIUM CHLORIDE DIHYDRATE, NITROGLYCERIN, conium maculatum flowering top, Arnica montana, Phosphorus, and GOLD TRICHLORIDE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; ARSENIC TRIIODIDE; BARIUM CHLORIDE DIHYDRATE; CALCIUM IODIDE; CONIUM MACULATUM FLOWERING TOP; GOLD TRICHLORIDE; NITROGLYCERIN; PHOSPHORUS; POTASSIUM IODIDE	3; 6; 6; 3; 5; 6; 5; 5; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
58264-0013_e082b62a-5b57-c759-e053-2995a90a9c16	58264-0013	HUMAN OTC DRUG	D-13		HORSE CHESTNUT, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, PAEONIA OFFICINALIS ROOT, STRYCHNOS NUX-VOMICA SEED, GRAPHITE, SULFUR, COLLINSONIA CANADENSIS ROOT, POTASSIUM CARBONATE, LYCOPODIUM CLAVATUM SPORE, and NITRIC ACID	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	COLLINSONIA CANADENSIS ROOT; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PAEONIA OFFICINALIS ROOT; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SULFUR	4; 8; 3; 2; 5; 6; 3; 6; 4; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0014_e082b62a-5b77-c759-e053-2995a90a9c16	58264-0014	HUMAN OTC DRUG	D14		Avena sativa whole, Valeriana officinalis whole, Humulus lupulus whole, Arabica coffee bean, Strychnos ignatii whole, zinc valerate dihydrate, Ammonium bromide, Chamomile, Eschscholzia Californica, and Passiflora incarnata whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AMMONIUM BROMIDE; ARABICA COFFEE BEAN; AVENA SATIVA WHOLE; CHAMOMILE; ESCHSCHOLZIA CALIFORNICA; HUMULUS LUPULUS WHOLE; PASSIFLORA INCARNATA WHOLE; STRYCHNOS IGNATII WHOLE; VALERIANA OFFICINALIS WHOLE; ZINC VALERATE DIHYDRATE	3; 4; 1; 4; 2; 2; 2; 6; 1; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0015_e082cf14-c684-4b4b-e053-2a95a90ace7a	58264-0015	HUMAN OTC DRUG	D-15		ROSA CANINA FRUIT, ANAMIRTA COCCULUS SEED, PHOSPHORIC ACID, CHAMAELIRIUM LUTEUM ROOT, STRYCHNOS IGNATII SEED, ZINC, and HONEY	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANAMIRTA COCCULUS SEED; CHAMAELIRIUM LUTEUM ROOT; HONEY; PHOSPHORIC ACID; ROSA CANINA FRUIT; STRYCHNOS IGNATII SEED; ZINC	6; 6; 1; 3; 1; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0016_e082cd8b-6461-1eb2-e053-2995a90ae16d	58264-0016	HUMAN OTC DRUG	D-16		black cohosh, iris versicolor root, sanguinaria canadensis root, gelsemium sempervirens root, and spigelia anthelmia	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLACK COHOSH; GELSEMIUM SEMPERVIRENS ROOT; IRIS VERSICOLOR ROOT; SANGUINARIA CANADENSIS ROOT; SPIGELIA ANTHELMIA	4; 3; 2; 2; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0017_e082cf14-c6a2-4b4b-e053-2a95a90ace7a	58264-0017	HUMAN OTC DRUG	D17		Naja Naja Whole, Scrophularia nodosa, Lactic Acid, DL-, and Radium bromide	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	LACTIC ACID, DL-; NAJA NAJA WHOLE; RADIUM BROMIDE; SCROPHULARIA NODOSA	4; 30; 30; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0018_e082bcf2-86d8-28fb-e053-2a95a90a6593	58264-0018	HUMAN OTC DRUG	D-18		BERBERIS VULGARIS ROOT BARK, LYTTA VESICATORIA, EQUISETUM HYEMALE, EUTROCHIUM PURPUREUM ROOT, and SOLANUM DULCAMARA STEM	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BERBERIS VULGARIS ROOT BARK; EQUISETUM HYEMALE; EUTROCHIUM PURPUREUM ROOT; LYTTA VESICATORIA; SOLANUM DULCAMARA STEM	4; 6; 3; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0019_e082e0ce-fb73-2062-e053-2995a90ade11	58264-0019	HUMAN OTC DRUG	D-19		BOS TAURUS THYMUS, THYROID, UNSPECIFIED, BOS TAURUS PITUITARY GLAND, POSTERIOR, BOS TAURUS PANCREAS, BOS TAURUS ADRENAL GLAND, and BOS TAURUS TESTICLE	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS PANCREAS; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS TESTICLE; BOS TAURUS THYMUS; THYROID, UNSPECIFIED	12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0020_e082bcf2-86b9-28fb-e053-2a95a90a6593	58264-0020	HUMAN OTC DRUG	D-20		Bos taurus thymus, Thyroid, unspecified, Bos taurus pituitary gland, posterior, Bos taurus pancreas, Bos taurus adrenal gland, and Bos taurus ovary	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS OVARY; BOS TAURUS PANCREAS; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS THYMUS; THYROID, UNSPECIFIED	12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0022_e082bcf2-86c8-28fb-e053-2a95a90a6593	58264-0022	HUMAN OTC DRUG	D-22		naja naja venom, grindelia hirsutula flowering top, and lachesis muta venom	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	GRINDELIA HIRSUTULA FLOWERING TOP; LACHESIS MUTA VENOM; NAJA NAJA VENOM	4; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0023_e082c24c-9c73-6fc7-e053-2995a90a6c68	58264-0023	HUMAN OTC DRUG	D-23		ARSENIC TRIOXIDE, DAPHNE MEZEREUM BARK, TOXICODENDRON PUBESCENS LEAF, SULFUR, and APIS MELLIFERA	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; DAPHNE MEZEREUM BARK; SULFUR; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0024_e082b62a-5b67-c759-e053-2995a90a9c16	58264-0024	HUMAN OTC DRUG	D-24		BRYONIA ALBA ROOT, RANUNCULUS BULBOSUS, CITRULLUS COLOCYNTHIS FRUIT PULP, BLACK COHOSH, SODIUM SULFATE ANHYDROUS, and POTASSIUM CARBONATE	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLACK COHOSH; BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; POTASSIUM CARBONATE; RANUNCULUS BULBOSUS; SODIUM SULFATE ANHYDROUS	6; 4; 8; 6; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0025_e082cd8b-6452-1eb2-e053-2995a90ae16d	58264-0025	HUMAN OTC DRUG	D-25		Chimaphila umbellata, Clematis recta flowering top, Populus tremula whole, Anemone pratensis, Saw palmetto, Chondrodendron tomentosum root, Sulfur, Conium maculatum flowering top, and Ferric picrate	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; CHIMAPHILA UMBELLATA; CHONDRODENDRON TOMENTOSUM ROOT; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; FERRIC PICRATE; POPULUS TREMULA WHOLE; SAW PALMETTO; SULFUR	3; 3; 2; 3; 5; 4; 3; 2; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58264-0026_e082cf14-c693-4b4b-e053-2a95a90ace7a	58264-0026	HUMAN OTC DRUG	D-26		FERROUS IODIDE, PHOSPHORIC ACID, SULFUR IODIDE, CALCIUM IODIDE, and NITRIC ACID	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALCIUM IODIDE; FERROUS IODIDE; NITRIC ACID; PHOSPHORIC ACID; SULFUR IODIDE	12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
58264-0027_e082d43d-70bf-2e65-e053-2995a90ac108	58264-0027	HUMAN OTC DRUG	D-27		BERBERIS VULGARIS ROOT BARK, NITRIC ACID, CALCIUM FLUORIDE, LYCOPODIUM CLAVATUM SPORE, RUBIA TINCTORUM ROOT, and SMILAX ORNATA ROOT	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BERBERIS VULGARIS ROOT BARK; CALCIUM FLUORIDE; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; RUBIA TINCTORUM ROOT; SMILAX ORNATA ROOT	3; 12; 5; 6; 2; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0028_e082cd8b-6471-1eb2-e053-2995a90ae16d	58264-0028	HUMAN OTC DRUG	D-28		CLAVICEPS PURPUREA SCLEROTIUM, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, SAFFRON, FERROSOFERRIC PHOSPHATE, SULFURIC ACID, and HORSE CHESTNUT	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CLAVICEPS PURPUREA SCLEROTIUM; FERROSOFERRIC PHOSPHATE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; SAFFRON; SULFURIC ACID	6; 8; 6; 2; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0029_e082cf14-c6b2-4b4b-e053-2a95a90ace7a	58264-0029	HUMAN OTC DRUG	D-29		theridion curassavicum, conium maculatum flowering top, anamirta cocculus seed, and silver nitrate	SOLUTION/ DROPS	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; SILVER NITRATE; THERIDION CURASSAVICUM	30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0030_e082efe4-b6c2-19a9-e053-2995a90a26c1	58264-0030	HUMAN OTC DRUG	D-30		Strontium salicylate, Methenamine, Colchicum autumnale Bulb, Black Cohosh, Arnica Montana, Calendula officinalis Flowering Top, Solanum dulcamara whole, Hypericum perforatum, Strychnos nux-vomica seed, Atropa belladonna, Echinacea angustifolia, Hamamelis virginiana Root bark/stem bark, Achillea millefolium, and Toxicodendron pubescens leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACHILLEA MILLEFOLIUM; ARNICA MONTANA; ATROPA BELLADONNA; BLACK COHOSH; CALENDULA OFFICINALIS FLOWERING TOP; COLCHICUM AUTUMNALE BULB; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; METHENAMINE; SOLANUM DULCAMARA WHOLE; STRONTIUM SALICYLATE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	3; 3; 3; 3; 3; 5; 3; 3; 3; 4; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0031_e082f0fd-2a00-5e53-e053-2a95a90afa46	58264-0031	HUMAN OTC DRUG	D-31		Araneus diadematus, Arsenic triiodide, Ceanothus americanus leaf, Cinchona officinalis bark, Ferric Chloride Hexahydrate, Lycopodium clavatum spore, and Sulfur	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARANEUS DIADEMATUS; ARSENIC TRIIODIDE; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; FERRIC CHLORIDE HEXAHYDRATE; LYCOPODIUM CLAVATUM SPORE; SULFUR	30; 12; 6; 6; 6; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58264-0032_e082f91d-980f-1838-e053-2a95a90afe75	58264-0032	HUMAN OTC DRUG	D-32		nitric acid, atropa belladonna, pilocarpus jaborandii whole, potassium carbonate, lachesis muta venom, sambucus nigra flowering top, sepia officinalis juice, sanguinaria canadensis root, veratrum album root, and sage	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc	ATROPA BELLADONNA; LACHESIS MUTA VENOM; NITRIC ACID; PILOCARPUS JABORANDII WHOLE; POTASSIUM CARBONATE; SAGE; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; VERATRUM ALBUM ROOT	12; 30; 12; 4; 6; 30; 4; 6; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0033_e08302d1-63ad-c461-e053-2a95a90a4073	58264-0033	HUMAN OTC DRUG	D-33		ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; ATROPA BELLADONNA; BUFO BUFO CUTANEOUS GLAND; COPPER; SILICON DIOXIDE; ZINC	30; 30; 200; 12; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
58264-0034_e082efe4-b6d1-19a9-e053-2995a90a26c1	58264-0034	HUMAN OTC DRUG	D-34		OYSTER SHELL CALCIUM CARBONATE, CRUDE, CALCIUM FLUORIDE, CALCIUM HYPOPHOSPHITE, TRIBASIC CALCIUM PHOSPHATE, Hekla lava, DAPHNE MEZEREUM BARK, MERCURIC OXIDE, SILICON DIOXIDE, and MATRICARIA CHAMOMILLA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALCIUM FLUORIDE; CALCIUM HYPOPHOSPHITE; DAPHNE MEZEREUM BARK; HEKLA LAVA; MATRICARIA CHAMOMILLA; MERCURIC OXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE	12; 6; 6; 12; 6; 12; 30; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
58264-0035_e08300c6-7261-b02e-e053-2a95a90a0d80	58264-0035	HUMAN OTC DRUG	D-35		Aconitum napellus, Oyster shell calcium carbonate, crude, Matricaria chamomilla, Citrullus colocynthis fruit pulp, Strychnos ignatii seed, Delphinium staphisagria seed, and Bryonia alba Root	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; DELPHINIUM STAPHISAGRIA SEED; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; STRYCHNOS IGNATII SEED	6; 30; 12; 8; 4; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0036_e08300c6-7271-b02e-e053-2a95a90a0d80	58264-0036	HUMAN OTC DRUG	D-36		Amanita muscaria fruiting body, Strychnos ignatii seed, Lachesis muta venom, Magnesium phosphate, dibasic trihydrate, Phosphorus, and Zinc valerate dihydrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AMANITA MUSCARIA FRUITING BODY; LACHESIS MUTA VENOM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHOSPHORUS; STRYCHNOS IGNATII SEED; ZINC VALERATE DIHYDRATE	12; 30; 12; 30; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0037_e083159f-a6c7-240a-e053-2995a90a7c6c	58264-0037	HUMAN OTC DRUG	D-37		ALUMINUM OXIDE, BRYONIA ALBA ROOT, CITRULLUS COLOCYNTHIS FRUIT PULP, LACHESIS MUTA VENOM, LYCOPODIUM CLAVATUM SPORE, MERCURIC CHLORIDE, STRYCHNOS NUX-VOMICA SEED, LEAD ACETATE ANHYDROUS, and SULFUR	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALUMINUM OXIDE; BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; LACHESIS MUTA VENOM; LEAD ACETATE ANHYDROUS; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; STRYCHNOS NUX-VOMICA SEED; SULFUR	12; 4; 4; 30; 12; 4; 8; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0038_e0830806-83a7-9077-e053-2995a90aab0f	58264-0038	HUMAN OTC DRUG	D-38		Apis mellifera, Apis mellifera venom, Arsenic trioxide, Bryonia alba Root, and Sulfur	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; APIS MELLIFERA VENOM; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; SULFUR	6; 12; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0039_e08302d1-63bd-c461-e053-2a95a90a4073	58264-0039	HUMAN OTC DRUG	D-39		LACHESIS MUTA VENOM, LYCOPODIUM CLAVATUM SPORE, PALLADIUM, SAXIFRAGA GRANULATA WHOLE, and Vespa crabro	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; PALLADIUM; SAXIFRAGA GRANULATA WHOLE; VESPA CRABRO	30; 30; 12; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0040_e082f0fd-29e0-5e53-e053-2a95a90afa46	58264-0040	HUMAN OTC DRUG	D-40		PHOSPHORIC ACID, LYCOPODIUM CLAVATUM SPORE, SODIUM SULFATE, CLAVICEPS PURPUREA SCLEROTIUM, URANYL NITRATE HEXAHYDRATE, PHASEOLUS VULGARIS WHOLE, and ARSENIC TRIOXIDE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARSENIC TRIOXIDE; CLAVICEPS PURPUREA SCLEROTIUM; LYCOPODIUM CLAVATUM SPORE; PHASEOLUS VULGARIS WHOLE; PHOSPHORIC ACID; SODIUM SULFATE; URANYL NITRATE HEXAHYDRATE	8; 4; 30; 12; 12; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0041_e082f0fd-29f0-5e53-e053-2a95a90afa46	58264-0041	HUMAN OTC DRUG	D-41		phosphoric acid, chaste tree, cinchona officinalis bark, turnera diffusa leafy twig, phosphorus, sepia officinalis juice, bos taurus testicle, and conium maculatum flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS TESTICLE; CHASTE TREE; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; PHOSPHORIC ACID; PHOSPHORUS; SEPIA OFFICINALIS JUICE; TURNERA DIFFUSA LEAFY TWIG	12; 8; 12; 30; 12; 6; 30; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0042_e08300c6-7243-b02e-e053-2a95a90a0d80	58264-0042	HUMAN OTC DRUG	D-42		HORSE CHESTNUT, ATROPA BELLADONNA, CALCIUM FLUORIDE, MILK THISTLE, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, DAPHNE MEZEREUM BARK, ANEMONE PRATENSIS, CLAVICEPS PURPUREA SCLEROTIUM, VIPERA BERUS VENOM, and BOS TAURUS PLACENTA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; ATROPA BELLADONNA; BOS TAURUS PLACENTA; CALCIUM FLUORIDE; CLAVICEPS PURPUREA SCLEROTIUM; DAPHNE MEZEREUM BARK; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; MILK THISTLE; VIPERA BERUS VENOM	30; 12; 30; 30; 30; 12; 6; 30; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0043_e08300c6-7252-b02e-e053-2a95a90a0d80	58264-0043	HUMAN OTC DRUG	D-43		Arsenic trioxide, Atropa belladonna, Bryonia alba Root, Activated charcoal, Bos taurus pituitary gland, posterior, Sodium sulfate, Veratrum album Root, Eriodictyon californicum leaf, Sodium chloride, and Dibasic potassium phosphate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BOS TAURUS PITUITARY GLAND, POSTERIOR; BRYONIA ALBA ROOT; DIBASIC POTASSIUM PHOSPHATE; ERIODICTYON CALIFORNICUM LEAF; SODIUM CHLORIDE; SODIUM SULFATE; VERATRUM ALBUM ROOT	30; 6; 30; 30; 12; 30; 12; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0044_e0830806-8378-9077-e053-2995a90aab0f	58264-0044	HUMAN OTC DRUG	D-44		CRATAEGUS LAEVIGATA FRUIT, PRUNUS LAUROCERASUS LEAF, NERIUM OLEANDER LEAF, and CYTISUS SCOPARIUS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CRATAEGUS LAEVIGATA FRUIT; CYTISUS SCOPARIUS WHOLE; NERIUM OLEANDER LEAF; PRUNUS LAUROCERASUS LEAF	1; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0045_e0830806-8388-9077-e053-2995a90aab0f	58264-0045	HUMAN OTC DRUG	D-45		Silver nitrate, Arnica montana, Arum maculatum Root, Oyster shell calcium carbonate, crude, and Phosphorus	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; ARUM MACULATUM ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SILVER NITRATE	30; 12; 30; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0046_f17b7d67-ba4c-9958-e053-2a95a90a0662	58264-0046	HUMAN OTC DRUG	D-46		Ferrosoferric phosphate, Lithium carbonate, Sodium sulfate, Strychnos nux-vomica seed, Rhododendron Aureum Leaf, and Filipendula ulmaria root	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FERROSOFERRIC PHOSPHATE; FILIPENDULA ULMARIA ROOT; LITHIUM CARBONATE; RHODODENDRON AUREUM LEAF; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0047_e083159f-a6d6-240a-e053-2995a90a7c6c	58264-0047	HUMAN OTC DRUG	D-47		FERULA ASSA-FOETIDA RESIN, ARABICA COFFEE BEAN, NITROGLYCERIN, STRYCHNOS IGNATII SEED, LACHESIS MUTA VENOM, MOSCHUS MOSCHIFERUS MUSK SAC RESIN, and ANEMONE PRATENSIS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; ARABICA COFFEE BEAN; FERULA ASSA-FOETIDA RESIN; LACHESIS MUTA VENOM; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; NITROGLYCERIN; STRYCHNOS IGNATII SEED	30; 30; 12; 30; 12; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
58264-0048_e0831e6c-aa36-5a56-e053-2a95a90a4b5a	58264-0048	HUMAN OTC DRUG	D-48		picric acid, bryonia alba root, cinchona officinalis bark, solanum dulcamara whole, potassium carbonate, phosphorus, sepia officinalis juice, silicon dioxide, lycopodium clavatum spore, and ferrosoferric phosphate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BRYONIA ALBA ROOT; CINCHONA OFFICINALIS BARK; FERROSOFERRIC PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PICRIC ACID; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SOLANUM DULCAMARA WHOLE	12; 6; 12; 30; 30; 8; 6; 6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0049_e083159f-a6e6-240a-e053-2995a90a7c6c	58264-0049	HUMAN OTC DRUG	D-49		ARSENIC TRIOXIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, MERCURIC SULFIDE, POTASSIUM DICHROMATE, Mercurius solubilis, ANEMONE PRATENSIS, SEPIA OFFICINALIS JUICE, and SULFUR	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; ARSENIC TRIOXIDE; MERCURIC SULFIDE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; SEPIA OFFICINALIS JUICE; SULFUR	12; 12; 12; 30; 30; 12; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0050_e083443f-9a14-2ad6-e053-2995a90ad38f	58264-0050	HUMAN OTC DRUG	D-50		Horse chestnut, Citrullus colocynthis fruit pulp, Black cohosh, Sodium chloride, Strychnos nux-vomica seed, Phytolacca americana root, and Strontium carbonate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLACK COHOSH; CITRULLUS COLOCYNTHIS FRUIT PULP; HORSE CHESTNUT; PHYTOLACCA AMERICANA ROOT; SODIUM CHLORIDE; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED	4; 6; 6; 8; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0051_e08349cf-2585-e2fa-e053-2995a90ae362	58264-0051	HUMAN OTC DRUG	D-51		Atropa belladonna, Iodine, Lycopus virginicus, Sodium chloride, Hekla lava, and Calcium Hexafluorosilicate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ATROPA BELLADONNA; CALCIUM HEXAFLUOROSILICATE; HEKLA LAVA; IODINE; LYCOPUS VIRGINICUS; SODIUM CHLORIDE	30; 12; 12; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0052_e0834cf5-f57c-b4d1-e053-2995a90a9df6	58264-0052	HUMAN OTC DRUG	D-52		AETHUSA CYNAPIUM, APOMORPHINE HYDROCHLORIDE, ANAMIRTA COCCULUS SEED, COLCHICUM AUTUMNALE BULB, IPECAC, STRYCHNOS NUX-VOMICA SEED, VERATRUM ALBUM ROOT, and KEROSENE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AETHUSA CYNAPIUM; ANAMIRTA COCCULUS SEED; APOMORPHINE HYDROCHLORIDE; COLCHICUM AUTUMNALE BULB; IPECAC; KEROSENE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	6; 12; 12; 12; 8; 12; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dopamine Agonists [MoA], Dopaminergic Agonist [EPC], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0053_e083505d-a59f-36a2-e053-2a95a90a0dc2	58264-0053	HUMAN OTC DRUG	D-53		AMMONIUM BROMIDE, BROMINE, CALCIUM SULFIDE, POTASSIUM BROMIDE, RHODODENDRON TOMENTOSUM LEAFY TWIG, SODIUM BROMIDE, SODIUM CHLORIDE, and BOS TAURUS PLACENTA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AMMONIUM BROMIDE; BOS TAURUS PLACENTA; BROMINE; CALCIUM SULFIDE; POTASSIUM BROMIDE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SODIUM BROMIDE; SODIUM CHLORIDE	12; 12; 12; 12; 12; 12; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0054_e083505d-a5ae-36a2-e053-2a95a90a0dc2	58264-0054	HUMAN OTC DRUG	D-54		dibasic potassium phosphate, sepia officinalis juice, lycopodium clavatum spore, phosphorus, gelsemium sempervirens root, atropa belladonna, arsenic trioxide, and semecarpus anacardium juice	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; DIBASIC POTASSIUM PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE	30; 12; 6; 12; 30; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0055_e083505d-a5cc-36a2-e053-2a95a90a0dc2	58264-0055	HUMAN OTC DRUG	D-55		Comfrey root, Arnica montana, Calendula officinalis flowering top, Echinacea angustifolia, Hamamelis virginiana root bark/stem bark, Atropa Belladonna, Ruta graveolens flowering top, and Toxicodendron pubescens leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; ATROPA BELLADONNA; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	3; 4; 3; 6; 3; 4; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0056_e0834cf5-f5a9-b4d1-e053-2995a90a9df6	58264-0056	HUMAN OTC DRUG	D56		artemisia cina pre-flowering top, tanacetum vulgare whole, artemisia vulgaris whole, dryopteris filix-mas root, mercuric chloride, and graphite	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS WHOLE; DRYOPTERIS FILIX-MAS ROOT; GRAPHITE; MERCURIC CHLORIDE; TANACETUM VULGARE WHOLE	4; 1; 2; 30; 6; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0057_e08365af-d6dc-240b-e053-2995a90acd18	58264-0057	HUMAN OTC DRUG	D-57		Arsenic triiodide, Phosphorus, Teucrium scorodonia flowering top, Silicon dioxide, Oyster shell calcium carbonate, crude, and Lycopodium clavatum spore	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARSENIC TRIIODIDE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SILICON DIOXIDE; TEUCRIUM SCORODONIA FLOWERING TOP	6; 30; 30; 30; 30; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0058_e08365af-d6fa-240b-e053-2995a90acd18	58264-0058	HUMAN OTC DRUG	D-58		adonis vernalis, convallaria majalis, helleborus niger root, digitalis, crataegus laevigata fruit, and drimia maritima bulb	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ADONIS VERNALIS; CONVALLARIA MAJALIS; CRATAEGUS LAEVIGATA FRUIT; DIGITALIS; DRIMIA MARITIMA BULB; HELLEBORUS NIGER ROOT	2; 2; 1; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0059_e0836408-fe09-748e-e053-2995a90a79b0	58264-0059	HUMAN OTC DRUG	D-59		Fucus vesiculosus, Spongia officinalis skeleton, roasted, Graphite, Oyster shell calcium carbonate, crude, Sodium sulfate, and Croton oil	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CROTON OIL; FUCUS VESICULOSUS; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED	4; 3; 12; 12; 2; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0060_e083443f-9a23-2ad6-e053-2995a90ad38f	58264-0060	HUMAN OTC DRUG	D-60		calcium sulfide, juglans regia fruit rind, immature, juglans regia leaf, myosotis arvensis, smilax ornata root, fumaria officinalis flowering top, araneus diadematus, scrophularia nodosa, conium maculatum flowering top, and galium aparine	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARANEUS DIADEMATUS; CALCIUM SULFIDE; CONIUM MACULATUM FLOWERING TOP; FUMARIA OFFICINALIS FLOWERING TOP; GALIUM APARINE; JUGLANS REGIA FRUIT RIND, IMMATURE; JUGLANS REGIA LEAF; MYOSOTIS ARVENSIS; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT	12; 12; 30; 6; 12; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0061_e083443f-9a32-2ad6-e053-2995a90ad38f	58264-0061	HUMAN OTC DRUG	D-61		tobacco leaf, salix nigra bark, camphor (natural), turpentine oil, berberis vulgaris root bark, solanum dulcamara whole, strychnos nux-vomica seed, rhododendron aureum leaf, and toxicodendron pubescens leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BERBERIS VULGARIS ROOT BARK; CAMPHOR (NATURAL); RHODODENDRON AUREUM LEAF; SALIX NIGRA BARK; SOLANUM DULCAMARA WHOLE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; TURPENTINE OIL	2; 6; 3; 3; 2; 2; 12; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0062_e08349cf-2594-e2fa-e053-2995a90ae362	58264-0062	HUMAN OTC DRUG	D-62		Arisaema triphyllum root, Atropa belladonna, Ferrosoferric phosphate, Mercurius solubilis, and Anemone pratensis	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; ARISAEMA TRIPHYLLUM ROOT; ATROPA BELLADONNA; FERROSOFERRIC PHOSPHATE; MERCURIUS SOLUBILIS	4; 3; 4; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0063_e0834cf5-f58b-b4d1-e053-2995a90a9df6	58264-0063	HUMAN OTC DRUG	D-63		EPINEPHRINE, HORSE CHESTNUT, CUPRIC ACETATE, POTENTILLA ANSERINA WHOLE, CLAVICEPS PURPUREA SCLEROTIUM, TOBACCO LEAF, and VERATRUM ALBUM ROOT	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC ACETATE; EPINEPHRINE; HORSE CHESTNUT; POTENTILLA ANSERINA WHOLE; TOBACCO LEAF; VERATRUM ALBUM ROOT	4; 6; 6; 2; 2; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
58264-0064_e083505d-a5bd-36a2-e053-2a95a90a0dc2	58264-0064	HUMAN OTC DRUG	D-64		chamaelirium luteum root, potassium arsenite anhydrous, phosphorus, lead, and solidago virgaurea flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CHAMAELIRIUM LUTEUM ROOT; LEAD; PHOSPHORUS; POTASSIUM ARSENITE ANHYDROUS; SOLIDAGO VIRGAUREA FLOWERING TOP	3; 12; 6; 4; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0065_e0834cf5-f59a-b4d1-e053-2995a90a9df6	58264-0065	HUMAN OTC DRUG	D-65		Arsenic trioxide, Berberis aquifolium root bark, Oyster shell calcium carbonate, crude, Graphite, Centella asiatica, and Sodium chloride	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARSENIC TRIOXIDE; BERBERIS AQUIFOLIUM ROOT BARK; CENTELLA ASIATICA; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE	12; 1; 3; 12; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0066_e083505d-a5db-36a2-e053-2a95a90a0dc2	58264-0066	HUMAN OTC DRUG	D-66		visnaga daucoides fruit, iberis amara seed, leonurus cardiaca, nerium oleander leaf, cytisus scoparius whole, and ferula sumbul root	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CYTISUS SCOPARIUS WHOLE; FERULA SUMBUL ROOT; IBERIS AMARA SEED; LEONURUS CARDIACA; NERIUM OLEANDER LEAF; VISNAGA DAUCOIDES FRUIT	6; 2; 3; 2; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0067_e0836408-fdeb-748e-e053-2995a90a79b0	58264-0067	HUMAN OTC DRUG	D-67		Ammonium Carbonate, Hydrogen Cyanide, Camphor (Natural), Activated Charcoal, Crotalus Durissus Terrificus Venom, Tobacco Leaf, Veratrum Album Root, and Spigelia Anthelmia	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; AMMONIUM CARBONATE; CAMPHOR (NATURAL); CROTALUS DURISSUS TERRIFICUS VENOM; HYDROGEN CYANIDE; SPIGELIA ANTHELMIA; TOBACCO LEAF; VERATRUM ALBUM ROOT	30; 6; 4; 12; 6; 6; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0068_e08365af-d6eb-240b-e053-2995a90acd18	58264-0068	HUMAN OTC DRUG	D-68		croton oil, daphne mezereum bark, sodium chloride, and toxicodendron pubescens leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CROTON OIL; DAPHNE MEZEREUM BARK; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	6; 3; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0069_e0836408-fdfa-748e-e053-2995a90a79b0	58264-0069	HUMAN OTC DRUG	D-69		ARSENIC TRIOXIDE, CITRULLUS COLOCYNTHIS FRUIT PULP, Ranunculus bulbosus, and TOXICODENDRON PUBESCENS LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARSENIC TRIOXIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; RANUNCULUS BULBOSUS; TOXICODENDRON PUBESCENS LEAF	12; 12; 3; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0070_f902c526-51c2-0a95-e053-6394a90ada86	58264-0070	HUMAN OTC DRUG	D-70		ACONITUM NAPELLUS, SIMABA CEDRON SEED, CITRULLUS COLOCYNTHIS FRUIT PULP, KALMIA LATIFOLIA LEAF, and VERBASCUM THAPSUS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; CITRULLUS COLOCYNTHIS FRUIT PULP; KALMIA LATIFOLIA LEAF; SIMABA CEDRON SEED; VERBASCUM THAPSUS	4; 6; 3; 4; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0071_e08375a2-1424-ed51-e053-2995a90a2730	58264-0071	HUMAN OTC DRUG	D-71		Aconitum napellus, Arsenic Trioxide, Citrullus Colocynthis Fruit Pulp, Pseudognaphalium Obtusifolium, and Magnesium Phosphate, Dibasic Trihydrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM	4; 30; 4; 8; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0072_e0837a9c-24cf-017c-e053-2a95a90a7256	58264-0072	HUMAN OTC DRUG	D-72		Apis mellifera, Citrullus colocynthis fruit pulp, Lycopodium clavatum spore, Momordica balsamina immature fruit, and Phosphorus	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; CITRULLUS COLOCYNTHIS FRUIT PULP; LYCOPODIUM CLAVATUM SPORE; MOMORDICA BALSAMINA IMMATURE FRUIT; PHOSPHORUS	5; 6; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0073_e0837f5a-3067-fcb3-e053-2995a90a2302	58264-0073	HUMAN OTC DRUG	D-73		sulfuric acid, silver, arnica montana, bryonia alba root, causticum, and rhododendron tomentosum leafy twig	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; BRYONIA ALBA ROOT; CAUSTICUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; SILVER; SULFURIC ACID	4; 4; 12; 4; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0074_e08371b9-e0e3-681e-e053-2a95a90ac6af	58264-0074	HUMAN OTC DRUG	D-74		TRIBASIC CALCIUM PHOSPHATE, CAUSTICUM, FERROSOFERRIC PHOSPHATE, DIBASIC POTASSIUM PHOSPHATE, ANEMONE PRATENSIS, and SEPIA OFFICINALIS JUICE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; CAUSTICUM; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; SEPIA OFFICINALIS JUICE; TRIBASIC CALCIUM PHOSPHATE	12; 30; 12; 8; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0075_e08371b9-e0c5-681e-e053-2a95a90ac6af	58264-0075	HUMAN OTC DRUG	D-75		Caulophyllum thalictroides root, Matricaria chamomilla, Black cohosh, Cupric acetate, Magnesium phosphate, dibasic trihydrate, and Viburnum opulus bark	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; CUPRIC ACETATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; VIBURNUM OPULUS BARK	3; 3; 4; 6; 30; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0076_e0bae787-8753-0f30-e053-2a95a90abe45	58264-0076	HUMAN OTC DRUG	D-76		Lobelia inflata, Strychnos ignatii seed, Avena sativa Flowering top, Dibasic potassium phosphate, Selenicereus grandiflorus stem, Glutamine, Taurine, and Thiamine Hydrochloride	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AVENA SATIVA FLOWERING TOP; DIBASIC POTASSIUM PHOSPHATE; GLUTAMINE; LOBELIA INFLATA; SELENICEREUS GRANDIFLORUS STEM; STRYCHNOS IGNATII SEED; TAURINE; THIAMINE HYDROCHLORIDE	1; 2; 4; 1; 3; 6; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
58264-0078_e0bac471-994c-1e4c-e053-2a95a90a28c8	58264-0078	HUMAN OTC DRUG	D-77		Ammonium carbonate, Apis mellifera, Arsenic trioxide, Grindelia hirsutula flowering top, Echinacea angustifolia, and Crotalus horridus horridus venom	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AMMONIUM CARBONATE; APIS MELLIFERA; ARSENIC TRIOXIDE; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; GRINDELIA HIRSUTULA FLOWERING TOP	12; 30; 30; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0079_e0bae787-8762-0f30-e053-2a95a90abe45	58264-0079	HUMAN OTC DRUG	D-78		Hypericum perforatum, Lachesis muta venom, Lytta vesicatoria, Echinacea angustifolia, Sodium Chloride, and Plantago major	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ECHINACEA ANGUSTIFOLIA; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LYTTA VESICATORIA; PLANTAGO MAJOR; SODIUM CHLORIDE	6; 30; 30; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0080_e0bae390-0bd9-159f-e053-2a95a90ac095	58264-0080	HUMAN OTC DRUG	D-79		urtica urens, toxicodendron pubescens leaf, and echinacea angustifolia	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ECHINACEA ANGUSTIFOLIA; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	2; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0081_e0baf5c9-bcdf-366b-e053-2995a90a6343	58264-0081	HUMAN OTC DRUG	D-80		Baptisia tinctoria Root, LACHESIS MUTA VENOM, Echinacea angustifolia, Bryonia Alba Root, Aconitum napellus, Solidago virgaurea Flowering top, and Avena sativa Flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; AVENA SATIVA FLOWERING TOP; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA; LACHESIS MUTA VENOM; SOLIDAGO VIRGAUREA FLOWERING TOP	3; 1; 3; 3; 3; 10; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0082_f1282068-c4c4-7094-e053-2a95a90a9d9f	58264-0082	HUMAN OTC DRUG	D81		PASSIFLORA INCARNATA WHOLE, SMILAX ORNATA WHOLE, PHYTOLACCA AMERICANA ROOT, STILLINGIA SYLVATICA ROOT, TRIFOLIUM PRATENSE WHOLE, ARCTIUM LAPPA WHOLE, PRUNUS DULCIS WHOLE, FRANGULA PURSHIANA BARK, BERBERIS VULGARIS WHOLE, GLYCYRRHIZA GLABRA WHOLE, and LARREA DIVARICATA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARCTIUM LAPPA WHOLE; BERBERIS VULGARIS WHOLE; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA WHOLE; LARREA DIVARICATA WHOLE; PASSIFLORA INCARNATA WHOLE; PHYTOLACCA AMERICANA ROOT; PRUNUS DULCIS WHOLE; SMILAX ORNATA WHOLE; STILLINGIA SYLVATICA ROOT; TRIFOLIUM PRATENSE WHOLE	1; 1; 1; 1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0083_e0baf5c9-bcee-366b-e053-2995a90a6343	58264-0083	HUMAN OTC DRUG	D82		Achillea Millefolium, Arnica montana, Hypericum perforatum, Horse Chestnut, and Viscum Album Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACHILLEA MILLEFOLIUM; ARNICA MONTANA; HORSE CHESTNUT; HYPERICUM PERFORATUM; VISCUM ALBUM WHOLE	3; 6; 2; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0084_e0baf5c9-bccf-366b-e053-2995a90a6343	58264-0084	HUMAN OTC DRUG	D83		Candida albicans	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CANDIDA ALBICANS	6	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0085_e0baffb5-7d52-5f66-e053-2995a90a9018	58264-0085	HUMAN OTC DRUG	D-83-1		Candida albicans	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CANDIDA ALBICANS	30	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0086_e0bae787-8771-0f30-e053-2a95a90abe45	58264-0086	HUMAN OTC DRUG	D-83-2		Candida albicans	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0087_e0bb0be8-dfee-0d74-e053-2a95a90a05ce	58264-0087	HUMAN OTC DRUG	D-83-3		Candida albicans	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CANDIDA ALBICANS	200	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0088_e0bb0be8-dffd-0d74-e053-2a95a90a05ce	58264-0088	HUMAN OTC DRUG	D-83-4		Candida albicans	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CANDIDA ALBICANS	500	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0089_e0bb0bc6-ccf5-ce6d-e053-2995a90a377f	58264-0089	HUMAN OTC DRUG	D83-5		Candida albicans	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CANDIDA ALBICANS	500	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0090_e0baffb5-7d61-5f66-e053-2995a90a9018	58264-0090	HUMAN OTC DRUG	D-84		Milk thistle, Bos taurus bile, Sulfur, Thallous acetate, and Activated charcoal	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; BOS TAURUS BILE; MILK THISTLE; SULFUR; THALLOUS ACETATE	10; 12; 3; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0091_e0bb15df-0d6f-4b5b-e053-2995a90af4d2	58264-0091	HUMAN OTC DRUG	D-85		HYDRANGEA ARBORESCENS ROOT, SAW PALMETTO, CORN SILK, ELYMUS REPENS ROOT, AGATHOSMA CRENULATA LEAF, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, and DIBASIC POTASSIUM PHOSPHATE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AGATHOSMA CRENULATA LEAF; CORN SILK; DIBASIC POTASSIUM PHOSPHATE; ELYMUS REPENS ROOT; HYDRANGEA ARBORESCENS ROOT; SAW PALMETTO; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	1; 1; 1; 1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0092_e0bb089e-4302-2589-e053-2a95a90ab3e2	58264-0092	HUMAN OTC DRUG	D-86		Arnica montana, Silicon dioxide, Sodium chloride, Lead acetate anhydrous, Selenicereus grandiflorus stem, Tribasic calcium phosphate, and Potassium iodide	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; LEAD ACETATE ANHYDROUS; POTASSIUM IODIDE; SELENICEREUS GRANDIFLORUS STEM; SILICON DIOXIDE; SODIUM CHLORIDE; TRIBASIC CALCIUM PHOSPHATE	30; 6; 6; 6; 30; 30; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0093_e0bb0be8-e01b-0d74-e053-2a95a90a05ce	58264-0093	HUMAN OTC DRUG	D-87		PHYTOLACCA AMERICANA ROOT, SPONGIA OFFICINALIS SKELETON, ROASTED, Fucus vesiculosus, THYROID, UNSPECIFIED, OYSTER SHELL CALCIUM CARBONATE, CRUDE, Arginine, Tyrosine, and Niacin	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARGININE; FUCUS VESICULOSUS; NIACIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID, UNSPECIFIED; TYROSINE	4; 5; 4; 8; 5; 5; 8; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
58264-0094_e0bb0bc6-ccd7-ce6d-e053-2995a90a377f	58264-0094	HUMAN OTC DRUG	D-88		Cocculus indicus, natrum muriaticum, Helonias dioica, Calcarea phosphoricum, Ignatia amara, Magnesia phosphoricum, Cimicifuga racemosa, Passiflora incarnata, Valeriana officinalis, Sepia, Kalium phosphoricum, Zincum metallicum, Pituitary, Adrenal, Ovarian	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANAMIRTA COCCULUS SEED; BLACK COHOSH; BOS TAURUS ADRENAL GLAND; BOS TAURUS OVARY; BOS TAURUS PITUITARY GLAND, POSTERIOR; CHAMAELIRIUM LUTEUM ROOT; DIBASIC POTASSIUM PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PASSIFLORA INCARNATA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; TRIBASIC CALCIUM PHOSPHATE; VALERIAN; ZINC	6; 4; 6; 6; 6; 5; 6; 6; 4; 10; 12; 6; 12; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0096_e0bb089e-4311-2589-e053-2a95a90ab3e2	58264-0096	HUMAN OTC DRUG	D-90		Silver, Echinacea angustifolia, and Ferrosoferric phosphate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; SILVER	6; 15; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0097_e0bb2c78-5691-dbdf-e053-2a95a90aa9f7	58264-0097	HUMAN OTC DRUG	D-91		Apis mellifera and Atropa belladonna	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; ATROPA BELLADONNA	10; 12	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0098_e0bb0bc6-cce6-ce6d-e053-2995a90a377f	58264-0098	HUMAN OTC DRUG	D-92		Chelidonium majus, Turmeric, Magnesium sulfate heptahydrate, Mercury, and Taraxacum officinale	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CHELIDONIUM MAJUS; MAGNESIUM SULFATE HEPTAHYDRATE; MERCURY; TARAXACUM OFFICINALE; TURMERIC	10; 10; 15; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0099_e0bb2c78-56a0-dbdf-e053-2a95a90aa9f7	58264-0099	HUMAN OTC DRUG	D-93		Potassium acetate, Antimony trisulfide, Saffron, Umbilicus Rupestris, Corallium rubrum exoskeleton, Bos taurus pancreas, and Quercus alba wood	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANTIMONY TRISULFIDE; BOS TAURUS PANCREAS; CORALLIUM RUBRUM EXOSKELETON; POTASSIUM ACETATE; QUERCUS ALBA WOOD; SAFFRON; UMBILICUS RUPESTRIS	30; 15; 10; 6; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
58264-0100_e0bb15df-0d60-4b5b-e053-2995a90af4d2	58264-0100	HUMAN OTC DRUG	D-94		oyster shell calcium carbonate, crude, strychnos ignatii seed, sepia officinalis juice, bos taurus adrenal gland, and prunus spinosa flower bud	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS ADRENAL GLAND; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PRUNUS SPINOSA FLOWER BUD; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED	15; 10; 8; 15; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0101_e0bb2c78-56af-dbdf-e053-2a95a90aa9f7	58264-0101	HUMAN OTC DRUG	D-95		THYROID, UNSPECIFIED, FERROUS ARSENATE, and SPONGIA OFFICINALIS SKELETON, ROASTED	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FERROUS ARSENATE; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID, UNSPECIFIED	10; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0102_e0bb1968-985c-555d-e053-2a95a90a5602	58264-0102	HUMAN OTC DRUG	D-96		Catnip, Matricaria chamomilla, Ginger, and Mentha piperita	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CATNIP; GINGER; MATRICARIA CHAMOMILLA; MENTHA PIPERITA	3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0103_e0bb3d4e-6ebc-70e2-e053-2995a90a7ede	58264-0103	HUMAN OTC DRUG	D-97		Aluminum oxide, Silver, Silver nitrate, Arsenic trioxide, Mercurius solubilis, Calomel, Mercuric iodide, Lead, Lead iodide, Chelidonium majus, Zinc, Solidago virgaurea flowering top, and Citric acid monohydrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALUMINUM OXIDE; ARSENIC TRIOXIDE; CALOMEL; CHELIDONIUM MAJUS; CITRIC ACID MONOHYDRATE; LEAD; LEAD IODIDE; MERCURIC IODIDE; MERCURIUS SOLUBILIS; SILVER; SILVER NITRATE; SOLIDAGO VIRGAUREA FLOWERING TOP; ZINC	14; 14; 14; 3; 2; 14; 14; 14; 14; 14; 14; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
58264-0104_e0bb0be8-e00c-0d74-e053-2a95a90a05ce	58264-0104	HUMAN OTC DRUG	D-98		STRYCHNOS NUX-VOMICA SEED, MATRICARIA CHAMOMILLA, ANEMONE PRATENSIS, SODIUM CHLORIDE, CALCIUM SULFIDE, GOLD, DAPHNE MEZEREUM BARK, PLATINUM, and BERBERIS VULGARIS ROOT BARK	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PRATENSIS; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; DAPHNE MEZEREUM BARK; GOLD; MATRICARIA CHAMOMILLA; PLATINUM; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	10; 3; 11; 10; 11; 10; 11; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
58264-0105_e0bb3d4e-6ecb-70e2-e053-2995a90a7ede	58264-0105	HUMAN OTC DRUG	D-99		atropa belladonna, nitroglycerin, lactic acid, unspecified form, scrophularia nodosa, aloe, radium bromide, potassium iodide, sus scrofa bone marrow, zinc, and citric acid monohydrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALOE; ATROPA BELLADONNA; CITRIC ACID MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; NITROGLYCERIN; POTASSIUM IODIDE; RADIUM BROMIDE; SCROPHULARIA NODOSA; SUS SCROFA BONE MARROW; ZINC	6; 6; 2; 6; 6; 6; 21; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
58264-0106_e0bb2181-6c3e-5aed-e053-2995a90afc23	58264-0106	HUMAN OTC DRUG	D-100		Fucus vesiculosus	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FUCUS VESICULOSUS	3	[hp_X]/mL			N	20241231
58264-0107_e0bb4918-5e5e-9595-e053-2995a90ad221	58264-0107	HUMAN OTC DRUG	D-101		Wormwood, Arsenic trioxide, Garlic, Amoeba proteus, Ammonium phosphate, dibasic, Activated charcoal, Cinchona officinalis bark, and Veratrum album root	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; AMMONIUM PHOSPHATE, DIBASIC; AMOEBA PROTEUS; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; GARLIC; VERATRUM ALBUM ROOT; WORMWOOD	8; 6; 12; 6; 4; 6; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0108_e0bbaa1d-931d-1bc4-e053-2a95a90ab74a	58264-0108	HUMAN OTC DRUG	D-102		GARLIC, ALOE, MYCOBACTERIUM TUBERCULOSIS, EUCALYPTUS GLOBULUS LEAF, CANIS LUPUS FAMILIARIS MILK, COW MILK, RANCID BEEF, DELPHINIUM STAPHISAGRIA SEED, STAPHYLOCOCCUS EPIDERMIDIS, Staphylococcus haemolyticus, Staphylococcus simulans, STREPTOCOCCUS PYOGENES, and SULFUR	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALOE; CANIS LUPUS FAMILIARIS MILK; COW MILK; DELPHINIUM STAPHISAGRIA SEED; EUCALYPTUS GLOBULUS LEAF; GARLIC; MYCOBACTERIUM TUBERCULOSIS; RANCID BEEF; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS PYOGENES; SULFUR	6; 30; 30; 12; 12; 12; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0109_e0bb4d81-b381-e5b9-e053-2a95a90a90fa	58264-0109	HUMAN OTC DRUG	D-103		Aluminum oxide, Silver, Gold, Beryllium, Cadmium, Copper, Calcium sulfide, Mercuric sulfate, Molybdenum, Nickel, Plantago major, Platinum, Lead, Anemone pratensis, Selenium, and Tin	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALUMINUM OXIDE; ANEMONE PRATENSIS; BERYLLIUM; CADMIUM; CALCIUM SULFIDE; COPPER; GOLD; LEAD; MERCURIC SULFATE; MOLYBDENUM; NICKEL; PLANTAGO MAJOR; PLATINUM; SELENIUM; SILVER; TIN	30; 6; 30; 30; 12; 30; 30; 30; 30; 30; 30; 4; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
58264-0110_e0bbad8a-45a4-5917-e053-2995a90ac8d1	58264-0110	HUMAN OTC DRUG	D-104		Apium graveolens whole, Asclepias incarnata root, Calcium arsenate, Camphor (Natural), Echinacea angustifolia, Eupatorium perfoliatum flowering top, Euphrasia stricta, Ferrous iodide, Ichthammol, Scabies Lesion Lysate (Human), Thuja occidentalis leafy twig, and Trifolium repens flower	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIUM GRAVEOLENS WHOLE; ASCLEPIAS INCARNATA ROOT; CALCIUM ARSENATE; CAMPHOR (NATURAL); ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; FERROUS IODIDE; ICHTHAMMOL; SCABIES LESION LYSATE (HUMAN); THUJA OCCIDENTALIS LEAFY TWIG; TRIFOLIUM REPENS FLOWER	6; 4; 12; 12; 4; 6; 6; 6; 12; 30; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0111_e0bb5131-e57c-8c16-e053-2a95a90a9f3e	58264-0111	HUMAN OTC DRUG	D-105		Bos taurus adrenal gland, Apis mellifera, Arsenic trioxide, Lytta vesicatoria, Bos taurus lymph vessel, Magnesium phosphate, dibasic trihydrate, Toxicodendron pubescens leaf, Urtica urens, Pyridoxine hydrochloride, and Ascorbic acid	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ASCORBIC ACID; BOS TAURUS ADRENAL GLAND; BOS TAURUS LYMPH VESSEL; LYTTA VESICATORIA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PYRIDOXINE HYDROCHLORIDE; TOXICODENDRON PUBESCENS LEAF; URTICA URENS	12; 30; 3; 6; 6; 12; 6; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
58264-0112_e0bbaa1d-932d-1bc4-e053-2a95a90ab74a	58264-0112	HUMAN OTC DRUG	D-106		betaine hydrochloride, bos taurus bile, pancrelipase lipase, beef liver, sodium phosphate, dibasic, heptahydrate, bos taurus pancreas, pepsin, and sus scrofa stomach	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BEEF LIVER; BETAINE HYDROCHLORIDE; BOS TAURUS BILE; BOS TAURUS PANCREAS; PANCRELIPASE LIPASE; PEPSIN; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SUS SCROFA STOMACH	6; 3; 6; 6; 3; 3; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Methylating Activity [MoA], Methylating Agent [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0113_e0bb4d81-b390-e5b9-e053-2a95a90a90fa	58264-0113	HUMAN OTC DRUG	D-107		Actaea Spicata Root, Arnica montana, Caulophyllum thalictroides Root, Magnesium phosphate, dibasic trihydrate, Oxalic acid, Sepia officinalis juice, Cola acuminata seed, Stellaria media, and Toxicodendron pubescens leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTAEA SPICATA ROOT; ARNICA MONTANA; CAULOPHYLLUM THALICTROIDES ROOT; COLA ACUMINATA SEED; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OXALIC ACID; SEPIA OFFICINALIS JUICE; STELLARIA MEDIA; TOXICODENDRON PUBESCENS LEAF	30; 6; 30; 6; 6; 8; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0115_e0bb5131-e58b-8c16-e053-2a95a90a9f3e	58264-0115	HUMAN OTC DRUG	D-109		ATROPA BELLADONNA, VIROLA SEBIFERA RESIN, SILICON DIOXIDE, CALCIUM FLUORIDE, SODIUM BORATE, GOLD, BAPTISIA TINCTORIA ROOT, MERCURIC CYANIDE, CALOMEL, and CORNUS RUGOSA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; CALCIUM FLUORIDE; CALOMEL; CORNUS RUGOSA WHOLE; GOLD; MERCURIC CYANIDE; SILICON DIOXIDE; SODIUM BORATE; VIROLA SEBIFERA RESIN	6; 4; 8; 8; 9; 8; 8; 8; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
58264-0116_e0bbc0c5-9c21-b058-e053-2a95a90a6446	58264-0116	HUMAN OTC DRUG	D-110		arnica montana, hypericum perforatum, phosphorus, rancid beef, ruta graveolens flowering top, ferrosoferric phosphate, lachesis muta venom, hamamelis virginiana root bark/stem bark, and calendula officinalis flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; PHOSPHORUS; RANCID BEEF; RUTA GRAVEOLENS FLOWERING TOP	12; 6; 6; 12; 12; 12; 12; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0117_e0bb5f74-da51-7a81-e053-2995a90a4f27	58264-0117	HUMAN OTC DRUG	D-111		matricaria chamomilla, rheum officinale root, atropa belladonna, arabica coffee bean, tribasic calcium phosphate, calcium fluoride, magnesium phosphate, dibasic trihydrate, oyster shell calcium carbonate, crude, and wood creosote	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARABICA COFFEE BEAN; ATROPA BELLADONNA; CALCIUM FLUORIDE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; RHEUM OFFICINALE ROOT; TRIBASIC CALCIUM PHOSPHATE; WOOD CREOSOTE	6; 4; 8; 4; 30; 8; 4; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0118_e0bbc47e-9032-19e9-e053-2995a90ad66c	58264-0118	HUMAN OTC DRUG	D-112		Lachesis Muta venom, Silicon dioxide, Sodium chloride, Ranunculus bulbosus, Aconitum napellus, Activated charcoal, Nitroglycerin, Oyster shell calcium carbonate, crude, Anemone pratensis, Plantago major, arsenic trioxide, and Magnesium phosphate, dibasic trihydrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; ACTIVATED CHARCOAL; ANEMONE PRATENSIS; ARSENIC TRIOXIDE; LACHESIS MUTA VENOM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NITROGLYCERIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PLANTAGO MAJOR; RANUNCULUS BULBOSUS; SILICON DIOXIDE; SODIUM CHLORIDE	4; 8; 4; 6; 12; 4; 6; 8; 4; 4; 8; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nitrate Vasodilator [EPC], Nitrates [CS], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vasodilation [PE]		N	20241231
58264-0119_e0bb5f74-da60-7a81-e053-2995a90a4f27	58264-0119	HUMAN OTC DRUG	D-113		nitric acid, potassium chlorate, virola sebifera resin, and Mercurius solubilis	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	MERCURIUS SOLUBILIS; NITRIC ACID; POTASSIUM CHLORATE; VIROLA SEBIFERA RESIN	30; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
58264-0120_f6f7d369-64f0-0ed9-e053-6294a90a40fa	58264-0120	HUMAN OTC DRUG	D-114		AlumInum metallicum, Ailanthus, Baptisia tinctoria, Fragaria vesca, Yoscyamus niger, Muriaticum acid	SOLUTION	SUBLINGUAL	20230315		UNAPPROVED HOMEOPATHIC		DNA Labs	AILANTHUS ALTISSIMA FLOWERING TWIG; ALUMINUM; BAPTISIA TINCTORIA ROOT; FRAGARIA VESCA FRUIT; HYDROCHLORIC ACID; HYOSCYAMUS NIGER	30; 30; 30; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0121_e0bb6793-ec32-4aa0-e053-2995a90a5f29	58264-0121	HUMAN OTC DRUG	D-115		Causticum, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, IODINE, ARSENIC TRIOXIDE, BARIUM CARBONATE, Echinacea angustifolia, ALUMINUM, ANTIMONY TRISULFIDE, STRYCHNOS NUX-VOMICA SEED, DELPHINIUM STAPHISAGRIA SEED, SULFURIC ACID, CALCIUM SULFIDE, and SILVER NITRATE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALUMINUM; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; BARIUM CARBONATE; CALCIUM SULFIDE; CAUSTICUM; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; IODINE; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID	9; 8; 4; 8; 8; 12; 4; 4; 6; 6; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0122_e0bbc47e-9041-19e9-e053-2995a90ad66c	58264-0122	HUMAN OTC DRUG	D-116		OYSTER SHELL CALCIUM CARBONATE, CRUDE, TRIBASIC CALCIUM PHOSPHATE, CALCIUM FLUORIDE, WOOD CREOSOTE, and THUJA OCCIDENTALIS LEAFY TWIG	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALCIUM FLUORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; THUJA OCCIDENTALIS LEAFY TWIG; TRIBASIC CALCIUM PHOSPHATE; WOOD CREOSOTE	12; 8; 4; 8; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0123_e0bb6793-ec41-4aa0-e053-2995a90a5f29	58264-0123	HUMAN OTC DRUG	D-117		ATROPA BELLADONNA and SILICON DIOXIDE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ATROPA BELLADONNA; SILICON DIOXIDE	6; 8	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0124_e0cde703-1ff1-405a-e053-2a95a90a42f0	58264-0124	HUMAN OTC DRUG	D-118		Toxicodendron pubescens leaf, Punica granatum root bark, Arisaema triphyllum root, and Kerosene	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARISAEMA TRIPHYLLUM ROOT; KEROSENE; PUNICA GRANATUM ROOT BARK; TOXICODENDRON PUBESCENS LEAF	30; 6; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0125_e0bb6e68-14a7-4dec-e053-2995a90abe11	58264-0125	HUMAN OTC DRUG	D-119		Plantago major, Delphinium staphisagria seed, Matricaria chamomilla, Sepia officinalis juice, Arnica montana, Hypericum perforatum, Strychnos nux-vomica seed, Spigelia anthelmia, Iron, Barium carbonate, Veratrum album root, Calcium fluoride, Antipyrine, and Bismuth subnitrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANTIPYRINE; ARNICA MONTANA; BARIUM CARBONATE; BISMUTH SUBNITRATE; CALCIUM FLUORIDE; DELPHINIUM STAPHISAGRIA SEED; HYPERICUM PERFORATUM; IRON; MATRICARIA CHAMOMILLA; PLANTAGO MAJOR; SEPIA OFFICINALIS JUICE; SPIGELIA ANTHELMIA; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	12; 6; 8; 8; 8; 12; 6; 8; 30; 6; 6; 6; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0126_e0cdf048-699a-ac77-e053-2a95a90afc48	58264-0126	HUMAN OTC DRUG	D-120		Calcium fluoride, Bismuth Subnitrate, Zinc, Mercuric Chloride, Toxicodendron pubescens leaf, Antimony trisulfide, Barium carbonate, Echinacea angustifolia, Iodine, Phosphoric acid, Potassium carbonate, Dibasic potassium phosphate, and Thuja occidentalis Leafy twig	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANTIMONY TRISULFIDE; BARIUM CARBONATE; BISMUTH SUBNITRATE; CALCIUM FLUORIDE; DIBASIC POTASSIUM PHOSPHATE; ECHINACEA ANGUSTIFOLIA; IODINE; MERCURIC CHLORIDE; PHOSPHORIC ACID; POTASSIUM CARBONATE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; ZINC	8; 8; 6; 8; 4; 4; 4; 6; 4; 6; 4; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Bismuth [CS], Bismuth [EPC]		N	20241231
58264-0127_e0bb71f7-9f75-6fe3-e053-2a95a90a92e1	58264-0127	HUMAN OTC DRUG	D-121		Calcium Fluoride	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALCIUM FLUORIDE	8	[hp_X]/mL			N	20241231
58264-0128_e0cdeccf-c333-318a-e053-2a95a90ac401	58264-0128	HUMAN OTC DRUG	D-122		TRIBASIC CALCIUM PHOSPHATE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	TRIBASIC CALCIUM PHOSPHATE	6	[hp_X]/mL			N	20241231
58264-0129_e0bb6793-ec50-4aa0-e053-2995a90a5f29	58264-0129	HUMAN OTC DRUG	D-123		CALCIUM SULFATE ANHYDROUS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALCIUM SULFATE ANHYDROUS	6	[hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
58264-0130_e0cdf9e9-d6b8-f3c4-e053-2995a90a2099	58264-0130	HUMAN OTC DRUG	D-124		FERROSOFERRIC PHOSPHATE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FERROSOFERRIC PHOSPHATE	6	[hp_X]/mL			N	20241231
58264-0131_e0bb7ab6-ea7a-6b65-e053-2995a90a13c0	58264-0131	HUMAN OTC DRUG	D-125		Potassium Chloride	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	POTASSIUM CHLORIDE	6	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
58264-0132_e0cdfe86-bd69-08ed-e053-2a95a90ad1a5	58264-0132	HUMAN OTC DRUG	D-126		DIBASIC POTASSIUM PHOSPHATE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	DIBASIC POTASSIUM PHOSPHATE	6	[hp_X]/mL			N	20241231
58264-0133_e0bb7903-d8c7-2bff-e053-2a95a90a0773	58264-0133	HUMAN OTC DRUG	D-127		POTASSIUM SULFATE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	POTASSIUM SULFATE	6	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
58264-0134_e0ce02fe-04dc-5851-e053-2a95a90aa3f2	58264-0134	HUMAN OTC DRUG	D-128		Magnesium phosphate, dibasic trihydrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0135_e0bb8212-1509-0aff-e053-2995a90a1e22	58264-0135	HUMAN OTC DRUG	D-129		Sodium chloride	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SODIUM CHLORIDE	6	[hp_X]/mL			N	20241231
58264-0136_e0ce093d-5012-77bf-e053-2995a90aaf3f	58264-0136	HUMAN OTC DRUG	D-130		Sodium phosphate, dibasic, heptahydrate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_X]/mL			N	20241231
58264-0137_e0bb858d-176b-2bfa-e053-2995a90a312a	58264-0137	HUMAN OTC DRUG	D-131		Sodium sulfate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SODIUM SULFATE	6	[hp_X]/mL			N	20241231
58264-0138_e0ce093d-5023-77bf-e053-2995a90aaf3f	58264-0138	HUMAN OTC DRUG	D-132		SILICON DIOXIDE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SILICON DIOXIDE	8	[hp_X]/mL			N	20241231
58264-0139_e0bb858d-177a-2bfa-e053-2995a90a312a	58264-0139	HUMAN OTC DRUG	D-133		Calcium fluoride, Silicon dioxide, Tribasic calcium phosphate, Calcium sulfate anhydrous, Ferrosoferric phosphate, Potassium chloride, Dibasic potassium phosphate, Potassium sulfate, Magnesium phosphate, dibasic trihydrate, Sodium phosphate, dibasic, heptahydrate, Sodium chloride, and Sodium sulfate	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	8; 6; 6; 6; 6; 6; 6; 8; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0140_e0ce0ba0-dba3-8ad7-e053-2995a90aa365	58264-0140	HUMAN OTC DRUG	D134		BLACK COHOSH, BRYONIA ALBA WHOLE, TOXICODENDRON PUBESCENS WHOLE, ARNICA MONTANA, Causticum, FERROSOFERRIC PHOSPHATE, SODIUM SULFATE ANHYDROUS, STRYCHNOS NUX-VOMICA SEED, RHODODENDRON AUREUM WHOLE, CITRULLUS COLOCYNTHIS WHOLE, SOLANUM DULCAMARA WHOLE, KALMIA LATIFOLIA WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARSENIC TRIOXIDE, and TRIBASIC CALCIUM PHOSPHATE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA WHOLE; CAUSTICUM; CITRULLUS COLOCYNTHIS WHOLE; FERROSOFERRIC PHOSPHATE; KALMIA LATIFOLIA WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; RHODODENDRON AUREUM WHOLE; SODIUM SULFATE ANHYDROUS; SOLANUM DULCAMARA WHOLE; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS WHOLE; TRIBASIC CALCIUM PHOSPHATE	5; 8; 3; 4; 6; 6; 6; 6; 6; 6; 6; 6; 6; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0141_e0bb8cb3-59ec-3cfe-e053-2a95a90af040	58264-0141	HUMAN OTC DRUG	D-135		selenicereus grandiflorus stem, crataegus laevigata fruit, and spigelia anthelmia	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CRATAEGUS LAEVIGATA FRUIT; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA	2; 2; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0144_e0bb907f-72e7-59e2-e053-2995a90a1d9f	58264-0144	HUMAN OTC DRUG	D-137		Apis mellifera, Arsenic trioxide, Baptisia tinctoria, Atropa belladonna, Echinacea purpurea, Eupatorium perfoliatum whole, Gelsemium sempervirens whole, Calcium sulfide, Rancid beef, Sulfur, Silicon dioxide, and Thuja occidentalis leafy twig	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA; CALCIUM SULFIDE; ECHINACEA PURPUREA; EUPATORIUM PERFOLIATUM WHOLE; GELSEMIUM SEMPERVIRENS WHOLE; RANCID BEEF; SILICON DIOXIDE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 6; 6; 6; 6; 6; 12; 12; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0145_e0ce02fe-04ec-5851-e053-2a95a90aa3f2	58264-0145	HUMAN OTC DRUG	D-136		somatropin, long-(arg3)insulin-like growth factor-i, arsenic trioxide, saw palmetto, platinum, oyster shell calcium carbonate, crude, bos taurus adrenal cortex, bos taurus pituitary gland, posterior, thyroid, unspecified, and bos taurus hypothalamus	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARSENIC TRIOXIDE; BOS TAURUS ADRENAL CORTEX; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND, POSTERIOR; LONG-(ARG3)INSULIN-LIKE GROWTH FACTOR-I; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PLATINUM; SAW PALMETTO; SOMATROPIN; THYROID, UNSPECIFIED	6; 12; 12; 12; 12; 12; 30; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
58264-0146_e0ce0fd4-5564-a99f-e053-2995a90aa4eb	58264-0146	HUMAN OTC DRUG	D-138		garlic, viscum album fruiting top, olea europaea flower bud, prunus dulcis flower, pyridoxine hydrochloride, cyanocobalamin, folic acid, potassium iodide, and cholesterol	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; GARLIC; OLEA EUROPAEA FLOWER BUD; POTASSIUM IODIDE; PRUNUS DULCIS FLOWER; PYRIDOXINE HYDROCHLORIDE; VISCUM ALBUM FRUITING TOP	6; 6; 4; 1; 1; 3; 1; 3; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC]		N	20241231
58264-0158_f6f9a849-6724-600c-e053-6294a90a6e7f	58264-0158	HUMAN OTC DRUG	D-149		Bromine	SOLUTION	SUBLINGUAL	20230315		UNAPPROVED HOMEOPATHIC		DNA Labs	BROMINE	1000	[hp_X]/mL			N	20241231
58264-0159_f70b39c6-9f43-f5c1-e053-6394a90a1d43	58264-0159	HUMAN OTC DRUG	D-150		Chlorinum	SOLUTION	SUBLINGUAL	20230316		UNAPPROVED HOMEOPATHIC		DNA Labs	CHLORINE	1000	[hp_X]/mL			N	20241231
58264-0161_e0ce2df5-d7ce-e0ca-e053-2995a90ae233	58264-0161	HUMAN OTC DRUG	D-152		Arsenic trioxide, Strychnos nux-vomica seed, Aconitum napellus, Gold, Causticum, Hyoscyamus Niger leaf, Lachesis Muta whole, Daphne mezereum whole, Anemone pulsatilla, Sulfur, and Veratrum viride Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACONITUM NAPELLUS; ANEMONE PULSATILLA; ARSENIC TRIOXIDE; CAUSTICUM; DAPHNE MEZEREUM WHOLE; GOLD; HYOSCYAMUS NIGER LEAF; LACHESIS MUTA WHOLE; STRYCHNOS NUX-VOMICA SEED; SULFUR; VERATRUM VIRIDE WHOLE	12; 6; 12; 12; 6; 30; 12; 12; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
58264-0163_e830774e-35c9-7309-e053-2995a90ae043	58264-0163	HUMAN OTC DRUG	D-139		Arsenicum album, Belladonna, Calcarea carbonica, Carbo vegetabilis, Ferrum phosphoricum, Lycopodium, Natrum phosphoricum, Nux vomica, Phosphorus, Pulsatilla, Hydrastis	SOLUTION	SUBLINGUAL	20220908		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; ANEMONE PRATENSIS; ARSENIC TRIIODIDE; ATROPA BELLADONNA; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6; 6; 3; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0164_f5500c3e-acc0-39fa-e053-2a95a90a879d	58264-0164	HUMAN OTC DRUG	D-153		Juglans regia leaf, Lachesis, Calcarea carbonica, Lycopodium, Phosphorus, Magnesium Phosphate	SOLUTION	SUBLINGUAL	20230211		UNAPPROVED HOMEOPATHIC		DNA Labs	JUGLANS REGIA LEAF; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS	1; 30; 30; 6; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0165_f53fc0d0-6fb8-60bc-e053-2995a90a9092	58264-0165	HUMAN OTC DRUG	D-154		Anamirta cocculus, Arabica coffee bean, Arsenicum album, Calcarea carbonica, Graphite, Nux vomica, Phosphorus, Potassium carbonate, Sulfur	SOLUTION	SUBLINGUAL	20230221		UNAPPROVED HOMEOPATHIC		DNA Labs	ANAMIRTA COCCULUS SEED; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SULFUR	12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0166_f5512f34-08f1-b0f6-e053-2a95a90ab5bd	58264-0166	HUMAN OTC DRUG	D-155		Arsenicum album, Carbo vegetabilis, Ipecacuanha, Nux vomica, Sulfur	SOLUTION	SUBLINGUAL	20230222		UNAPPROVED HOMEOPATHIC		DNA Labs	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; IPECAC; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0199_f1b734a7-267a-a517-e053-2995a90a5c47	58264-0199	HUMAN OTC DRUG	N-1	Adrenal Energizer	BERBERIS VULGARIS WHOLE, VISCUM ALBUM WHOLE, SOLIDAGO VIRGAUREA WHOLE, BOS TAURUS ADRENAL GLAND, Arnica montana, DIBASIC POTASSIUM PHOSPHATE, and SUS SCROFA SPLEEN	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; BERBERIS VULGARIS WHOLE; BOS TAURUS ADRENAL GLAND; DIBASIC POTASSIUM PHOSPHATE; SOLIDAGO VIRGAUREA WHOLE; SUS SCROFA SPLEEN; VISCUM ALBUM WHOLE	8; 4; 200; 6; 4; 200; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0200_e0cfbe82-b5c7-bedc-e053-2995a90a6804	58264-0200	HUMAN OTC DRUG	N-2		SELENICEREUS GRANDIFLORUS WHOLE, CRATAEGUS LAEVIGATA WHOLE, DIBASIC POTASSIUM PHOSPHATE, Arnica montana, VALERIANA OFFICINALIS WHOLE, Spigelia anthelmia, and BEEF HEART	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; BEEF HEART; CRATAEGUS LAEVIGATA WHOLE; DIBASIC POTASSIUM PHOSPHATE; SELENICEREUS GRANDIFLORUS WHOLE; SPIGELIA ANTHELMIA; VALERIANA OFFICINALIS WHOLE	6; 200; 3; 6; 3; 8; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0201_e0cfc8fd-7dc5-4ab1-e053-2995a90a5f3b	58264-0201	HUMAN OTC DRUG	N-3		BERBERIS VULGARIS WHOLE, LYCOPODIUM CLAVATUM WHOLE, SMILAX ORNATA WHOLE, RUBIA TINCTORUM WHOLE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, and PORK KIDNEY	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BERBERIS VULGARIS WHOLE; LYCOPODIUM CLAVATUM WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK KIDNEY; RUBIA TINCTORUM WHOLE; SMILAX ORNATA WHOLE	4; 4; 30; 200; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0202_e0cfc8fd-7da7-4ab1-e053-2995a90a5f3b	58264-0202	HUMAN OTC DRUG	N-4		Chelidonium majus, Bryonia alba root, STRYCHNOS NUX-VOMICA SEED, LYCOPODIUM CLAVATUM WHOLE, MAMMAL LIVER, SODIUM SULFATE, and MILK THISTLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; LYCOPODIUM CLAVATUM WHOLE; MAMMAL LIVER; MILK THISTLE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED	4; 4; 4; 200; 4; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0203_e0cfd392-e240-559e-e053-2995a90a14e8	58264-0203	HUMAN OTC DRUG	N-5		Phosphorus, TRIBASIC CALCIUM PHOSPHATE, FERROSOFERRIC PHOSPHATE, ACTIVATED CHARCOAL, TIN, and BEEF LUNG	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; BEEF LUNG; FERROSOFERRIC PHOSPHATE; PHOSPHORUS; TIN; TRIBASIC CALCIUM PHOSPHATE	30; 200; 6; 12; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0204_e0cfcbd0-03d3-8710-e053-2a95a90afd84	58264-0204	HUMAN OTC DRUG	N-6		Apis mellifera, Atropa belladonna, Lachesis muta whole, Echinacea angustifolia, Scrophularia nodosa, Ferrous iodide, and Bos taurus lymph	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; ATROPA BELLADONNA; BOS TAURUS LYMPH; ECHINACEA ANGUSTIFOLIA; FERROUS IODIDE; LACHESIS MUTA WHOLE; SCROPHULARIA NODOSA	6; 6; 200; 4; 12; 12; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0205_e0cfd392-e24f-559e-e053-2995a90a14e8	58264-0205	HUMAN OTC DRUG	N-7		Apis mellifera, Clematis recta whole, Anemone Pulsatilla, Chimaphila umbellata, Sus scrofa testicle, Chaste Tree, and Sepia Officinalis juice	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; CHASTE TREE; CHIMAPHILA UMBELLATA; CLEMATIS RECTA WHOLE; SEPIA OFFICINALIS JUICE; SUS SCROFA TESTICLE	5; 6; 4; 4; 4; 10; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0206_f1f34899-e883-61a5-e053-2a95a90a7642	58264-0206	HUMAN OTC DRUG	N-8		SILICON DIOXIDE, ATROPA BELLADONNA, CITRULLUS COLOCYNTHIS FRUIT PULP, BLACK COHOSH, ANEMONE PULSATILLA, SEPIA OFFICINALIS JUICE, PALLADIUM, APIS MELLIFERA, and BOS TAURUS OVARY	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ATROPA BELLADONNA; BLACK COHOSH; BOS TAURUS OVARY; CITRULLUS COLOCYNTHIS FRUIT PULP; PALLADIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE	6; 6; 6; 6; 200; 6; 10; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0207_e0cfd90b-e094-28f1-e053-2995a90ae66b	58264-0207	HUMAN OTC DRUG	N-9		Phosphorus, CITRULLUS COLOCYNTHIS FRUIT PULP, IRIS VERSICOLOR WHOLE, LYCOPODIUM CLAVATUM WHOLE, MOMORDICA BALSAMINA WHOLE, and BOS TAURUS PANCREAS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS PANCREAS; CITRULLUS COLOCYNTHIS FRUIT PULP; IRIS VERSICOLOR WHOLE; LYCOPODIUM CLAVATUM WHOLE; MOMORDICA BALSAMINA WHOLE; PHOSPHORUS	200; 6; 4; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0208_e0cfd1e3-eafe-3dd3-e053-2995a90aca07	58264-0208	HUMAN OTC DRUG	N-10		SODIUM CHLORIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, SEPIA OFFICINALIS JUICE, IODINE, LYCOPODIUM CLAVATUM WHOLE, and BOS TAURUS PITUITARY GLAND, POSTERIOR	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS PITUITARY GLAND, POSTERIOR; IODINE; LYCOPODIUM CLAVATUM WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE	200; 30; 30; 12; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0209_e0cfd513-5435-6ba0-e053-2a95a90a2fda	58264-0209	HUMAN OTC DRUG	N-11		CINCHONA OFFICINALIS BARK, PHOSPHORIC ACID, ANEMONE PULSATILLA, Phosphorus, PICRIC ACID, DIBASIC POTASSIUM PHOSPHATE, BOS TAURUS PITUITARY GLAND, POSTERIOR, BOS TAURUS ADRENAL GLAND, SUS SCROFA TESTICLE, and BOS TAURUS PROSTATE GLAND	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PULSATILLA; BOS TAURUS ADRENAL GLAND; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS PROSTATE GLAND; CINCHONA OFFICINALIS BARK; DIBASIC POTASSIUM PHOSPHATE; PHOSPHORIC ACID; PHOSPHORUS; PICRIC ACID; SUS SCROFA TESTICLE	6; 200; 200; 200; 6; 6; 6; 6; 6; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0210_e0cfd1e3-eb0e-3dd3-e053-2995a90aca07	58264-0210	HUMAN OTC DRUG	N-12		Phosphoric Acid, Cinchona officinalis Bark, Anemone pulsatilla, Phosphorus, Picric acid, Magnesium Phosphate, Dibasic Trihydrate, Viburnum opulus Whole, Bos taurus pituitary gland, posterior, Bos taurus ovary, Bos taurus adrenal gland, and Thyroid, Unspecified	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PULSATILLA; BOS TAURUS ADRENAL GLAND; BOS TAURUS OVARY; BOS TAURUS PITUITARY GLAND, POSTERIOR; CINCHONA OFFICINALIS BARK; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHOSPHORIC ACID; PHOSPHORUS; PICRIC ACID; THYROID, UNSPECIFIED; VIBURNUM OPULUS WHOLE	6; 200; 200; 200; 6; 6; 6; 6; 6; 200; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0211_e0cfdec7-78f8-ad59-e053-2a95a90afea8	58264-0211	HUMAN OTC DRUG	N-13		Ceanothus americanus leaf, Urtica urens, Sodium Chloride, Lachesis muta whole, Cinchona officinalis Bark, Lycopodium clavatum Whole, Ferric chloride hexahydrate, and Sus scrofa spleen	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; FERRIC CHLORIDE HEXAHYDRATE; LACHESIS MUTA WHOLE; LYCOPODIUM CLAVATUM WHOLE; SODIUM CHLORIDE; SUS SCROFA SPLEEN; URTICA URENS	4; 8; 6; 12; 6; 6; 200; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58264-0212_e0cfd1e3-eb1e-3dd3-e053-2995a90aca07	58264-0212	HUMAN OTC DRUG	N-14		Fucus vesiculosus, Sodium chloride, Lycopus virginicus, Spongia officinalis skeleton, roasted, Potassium iodide, Calcium iodide, Thyroid, Unspecified, Bos taurus adrenal gland, Bos Taurus Pituitary Gland, Posterior, Bos taurus thymus, and Sus scrofa spleen	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS THYMUS; CALCIUM IODIDE; FUCUS VESICULOSUS; LYCOPUS VIRGINICUS; POTASSIUM IODIDE; SODIUM CHLORIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA SPLEEN; THYROID, UNSPECIFIED	200; 200; 200; 6; 4; 6; 6; 6; 4; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
58264-0213_e0cfe349-8cf8-0e9b-e053-2995a90aeaec	58264-0213	HUMAN OTC DRUG	N-15		Echinacea angustifolia, Baptisia tinctoria, POTASSIUM CHLORIDE, CALCIUM SULFIDE, FERROUS IODIDE, SULFUR IODIDE, and BOS TAURUS THYMUS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BAPTISIA TINCTORIA; BOS TAURUS THYMUS; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; FERROUS IODIDE; POTASSIUM CHLORIDE; SULFUR IODIDE	4; 200; 8; 4; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
58264-0214_f1b6f475-7b02-e24e-e053-2a95a90a041f	58264-0214	HUMAN OTC DRUG	N-16		mgo energizer	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ASCORBIC ACID; BEEF HEART; BOS TAURUS ADRENAL GLAND; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS THYMUS; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; GLYCINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MAMMAL LIVER; PORK BRAIN; POTASSIUM CHLORIDE; POTASSIUM SULFATE; PYRIDOXINE HYDROCHLORIDE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SUS SCROFA DUODENUM; SUS SCROFA LUNG; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; THYROID, UNSPECIFIED; TRIBASIC CALCIUM PHOSPHATE; TRIPE	3; 200; 200; 200; 200; 30; 30; 30; 30; 4; 30; 200; 200; 30; 30; 3; 30; 30; 30; 30; 200; 200; 200; 200; 200; 30; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
58264-0215_e0cfd392-e27c-559e-e053-2995a90a14e8	58264-0215	HUMAN OTC DRUG	N-17		Zinc, Selenium, Bos taurus thymus, Sus Scrofa Spleen, Bos taurus lymph, Bos taurus adrenal gland, Arginine, Cystine, Echinacea angustifolia, Thiamine, Pyridoxine hydrochloride, and Ascorbic acid	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARGININE; ASCORBIC ACID; BOS TAURUS ADRENAL GLAND; BOS TAURUS LYMPH; BOS TAURUS THYMUS; CYSTINE; ECHINACEA ANGUSTIFOLIA; PYRIDOXINE HYDROCHLORIDE; SELENIUM; SUS SCROFA SPLEEN; THIAMINE; ZINC	4; 3; 200; 200; 200; 4; 6; 3; 6; 200; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
58264-0216_e0cfde48-efd6-ac9a-e053-2a95a90aaaae	58264-0216	HUMAN OTC DRUG	N-18		OYSTER SHELL CALCIUM CARBONATE, CRUDE, SEPIA OFFICINALIS JUICE, SILICON DIOXIDE, NITRIC ACID, and SUS SCROFA PINEAL GLAND	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SUS SCROFA PINEAL GLAND	12; 30; 30; 30; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0217_f1288169-6834-2e13-e053-2995a90a2114	58264-0217	HUMAN OTC DRUG	N-19		Formica rufa, POTASSIUM CARBONATE, KALMIA LATIFOLIA WHOLE, ZANTHOXYLUM AMERICANUM BARK, and BOS TAURUS PARATHYROID GLAND	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS PARATHYROID GLAND; FORMICA RUFA; KALMIA LATIFOLIA WHOLE; POTASSIUM CARBONATE; ZANTHOXYLUM AMERICANUM BARK	200; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0218_e0cfd513-5445-6ba0-e053-2a95a90a2fda	58264-0218	HUMAN OTC DRUG	N-20		STRYCHNOS NUX-VOMICA SEED, ARSENIC TRIOXIDE, ACTIVATED CHARCOAL, SILVER NITRATE, MARSDENIA CUNDURANGO WHOLE, TRIPE, and SUS SCROFA DUODENUM	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; MARSDENIA CUNDURANGO WHOLE; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA DUODENUM; TRIPE	10; 6; 6; 6; 4; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0219_e0cfdec7-790a-ad59-e053-2a95a90afea8	58264-0219	HUMAN OTC DRUG	N-21		calcium fluoride, silicon dioxide, euphrasia stricta, ruta graveolens whole, gelsemium sempervirens whole, physostigma venenosum whole, anemone pulsatilla, sodium chloride, and sus scrofa eye	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PULSATILLA; CALCIUM FLUORIDE; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS WHOLE; PHYSOSTIGMA VENENOSUM WHOLE; RUTA GRAVEOLENS WHOLE; SILICON DIOXIDE; SODIUM CHLORIDE; SUS SCROFA EYE	8; 6; 6; 6; 4; 6; 6; 12; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0221_e0cfdec7-791c-ad59-e053-2a95a90afea8	58264-0221	HUMAN OTC DRUG	N-23		Anemone pulsatilla, Phosphorus, SILICON DIOXIDE, NITRIC ACID, ARSENIC TRIOXIDE, TOXICODENDRON PUBESCENS WHOLE, and BOS TAURUS HYPOTHALAMUS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BOS TAURUS HYPOTHALAMUS; NITRIC ACID; PHOSPHORUS; SILICON DIOXIDE; TOXICODENDRON PUBESCENS WHOLE	6; 12; 200; 6; 6; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0222_e0cfde48-efe9-ac9a-e053-2a95a90aaaae	58264-0222	HUMAN OTC DRUG	N-24		METABOLIN	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARGININE; BOS TAURUS ADRENAL GLAND; BOS TAURUS PAROTID GLAND; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS PROSTATE GLAND; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CYSTEINE; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; GLUTAMINE; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SUS SCROFA PINEAL GLAND; THYROID, UNSPECIFIED; TRIBASIC CALCIUM PHOSPHATE	12; 200; 200; 200; 200; 30; 30; 12; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 200; 200; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0223_e0cff264-112d-7c69-e053-2a95a90aa0b9	58264-0223	HUMAN OTC DRUG	N-25		SERENOA REPENS WHOLE, AGATHOSMA CRENULATA WHOLE, Chimaphila umbellata, ELYMUS REPENS WHOLE, SELENIUM, and BOS TAURUS PROSTATE GLAND	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AGATHOSMA CRENULATA WHOLE; BOS TAURUS PROSTATE GLAND; CHIMAPHILA UMBELLATA; ELYMUS REPENS WHOLE; SELENIUM; SERENOA REPENS WHOLE	2; 200; 3; 3; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0224_e0cfe349-8d0c-0e9b-e053-2995a90aeaec	58264-0224	HUMAN OTC DRUG	N-26		BARIUM CHLORIDE DIHYDRATE, CONIUM MACULATUM WHOLE, Arnica montana, PHOSPHORIC ACID, DIBASIC POTASSIUM PHOSPHATE, FERROSOFERRIC PHOSPHATE, and PORK BRAIN	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARNICA MONTANA; BARIUM CHLORIDE DIHYDRATE; CONIUM MACULATUM WHOLE; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; PHOSPHORIC ACID; PORK BRAIN	6; 6; 12; 6; 6; 6; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0225_e0cfff02-6340-c2c4-e053-2995a90aa5ab	58264-0225	HUMAN OTC DRUG	N-27		arnica montana, milk thistle, sus scrofa cerebrum, cinchona officinalis bark, ginkgo biloba whole, lecithin, soybean, lithium carbonate, achillea millefolium, phosphoric acid, pork brain, alnus glutinosa whole, and rosmarinus officinalis flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACHILLEA MILLEFOLIUM; ALNUS GLUTINOSA WHOLE; ARNICA MONTANA; CINCHONA OFFICINALIS BARK; GINKGO BILOBA WHOLE; LECITHIN, SOYBEAN; LITHIUM CARBONATE; MILK THISTLE; PHOSPHORIC ACID; PORK BRAIN; ROSMARINUS OFFICINALIS FLOWERING TOP; SUS SCROFA CEREBRUM	3; 1; 3; 6; 6; 12; 30; 3; 30; 200; 1; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Mood Stabilizer [EPC]		N	20241231
58264-0230_f0ffc043-bfe4-5986-e053-2995a90a7ec1	58264-0230	HUMAN OTC DRUG	N-22		APIS MELLIFERA, PILOCARPUS MICROPHYLLUS LEAF, TRIFOLIUM REPENS WHOLE, ATROPA BELLADONNA, BARIUM CARBONATE, FERROSOFERRIC PHOSPHATE, POTASSIUM DICHROMATE, PHYTOLACCA AMERICANA WHOLE, ANEMONE PULSATILLA, MERCURIUS SOLUBILIS and BOS TAURUS PAROTID GLAND	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANEMONE PULSATILLA; APIS MELLIFERA; ATROPA BELLADONNA; BARIUM CARBONATE; BOS TAURUS PAROTID GLAND; FERROSOFERRIC PHOSPHATE; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA WHOLE; PILOCARPUS MICROPHYLLUS LEAF; POTASSIUM DICHROMATE; TRIFOLIUM REPENS WHOLE	6; 4; 5; 6; 200; 6; 9; 6; 4; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0246_ded81363-ca6c-0129-e053-2a95a90a65cb	58264-0246	HUMAN OTC DRUG	T-1		AGRIMONIA EUPATORIA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AGRIMONIA EUPATORIA	30	[hp_X]/mL			N	20241231
58264-0247_ded81370-b714-414e-e053-2995a90a7c9c	58264-0247	HUMAN OTC DRUG	T-2		POPULUS TREMULOIDES WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	POPULUS TREMULOIDES WHOLE	30	[hp_X]/mL			N	20241231
58264-0248_ded82b4d-07cd-58cb-e053-2995a90ab371	58264-0248	HUMAN OTC DRUG	T-3		Fagus Sylvatica Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FAGUS SYLVATICA WHOLE	30	[hp_X]/mL			N	20241231
58264-0249_ded83083-1a27-16fc-e053-2a95a90a8d99	58264-0249	HUMAN OTC DRUG	T-4		CENTAURIUM ERYTHRAEA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CENTAURIUM ERYTHRAEA	30	[hp_X]/mL			N	20241231
58264-0250_ded83aa1-d604-18b4-e053-2a95a90a3d8f	58264-0250	HUMAN OTC DRUG	T-5		CERATOSTIGMA WILLMOTTIANUM WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CERATOSTIGMA WILLMOTTIANUM WHOLE	30	[hp_X]/mL			N	20241231
58264-0251_ded84859-c824-6425-e053-2995a90ad660	58264-0251	HUMAN OTC DRUG	T-6		PRUNUS CERASIFERA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	PRUNUS CERASIFERA WHOLE	30	[hp_X]/mL			N	20241231
58264-0252_ded85917-341c-08f4-e053-2a95a90a4b24	58264-0252	HUMAN OTC DRUG	T-7		AESCULUS HIPPOCASTANUM WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AESCULUS HIPPOCASTANUM WHOLE	30	[hp_X]/mL			N	20241231
58264-0253_ded86292-2f34-3c77-e053-2995a90a1425	58264-0253	HUMAN OTC DRUG	T-8		Cichorium intybus Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CICHORIUM INTYBUS WHOLE	30	[hp_X]/mL			N	20241231
58264-0254_ded87c29-9a3e-1e64-e053-2a95a90a6547	58264-0254	HUMAN OTC DRUG	T-9		CLEMATIS VITALBA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CLEMATIS VITALBA WHOLE	30	[hp_X]/mL			N	20241231
58264-0255_df660f27-bd07-b324-e053-2a95a90a2877	58264-0255	HUMAN OTC DRUG	T-10		Malus pumila Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	MALUS PUMILA WHOLE	30	[hp_X]/mL			N	20241231
58264-0256_df24b2dc-4fc1-8df0-e053-2995a90ac763	58264-0256	HUMAN OTC DRUG	T-11		Ulmus minor whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ULMUS MINOR WHOLE	30	[hp_X]/mL			N	20241231
58264-0257_df24a9d9-145a-71ac-e053-2a95a90a1e58	58264-0257	HUMAN OTC DRUG	T-12		Gentianella amarella Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	GENTIANELLA AMARELLA WHOLE	30	[hp_X]/mL			N	20241231
58264-0258_df24a9d9-145b-71ac-e053-2a95a90a1e58	58264-0258	HUMAN OTC DRUG	T-13		ULEX EUROPAEUS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ULEX EUROPAEUS WHOLE	30	[hp_X]/mL			N	20241231
58264-0259_df24b90a-1937-4c4c-e053-2995a90a291b	58264-0259	HUMAN OTC DRUG	T-14		CALLUNA VULGARIS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALLUNA VULGARIS WHOLE	30	[hp_X]/mL			N	20241231
58264-0260_ded88efc-a9a1-4dc7-e053-2995a90a4c87	58264-0260	HUMAN OTC DRUG	T-15		ILEX AQUIFOLIUM WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ILEX AQUIFOLIUM WHOLE	30	[hp_X]/mL			N	20241231
58264-0261_df24b9ef-f5e0-9282-e053-2a95a90afe22	58264-0261	HUMAN OTC DRUG	T-16		Lonicera caprifolium Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	LONICERA CAPRIFOLIUM WHOLE	30	[hp_X]/mL			N	20241231
58264-0262_ded8a497-d7a9-0b1b-e053-2995a90acb67	58264-0262	HUMAN OTC DRUG	T-17		Carpinus betulus Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CARPINUS BETULUS WHOLE	30	[hp_X]/mL			N	20241231
58264-0263_df24de41-f51c-f0f3-e053-2995a90a850f	58264-0263	HUMAN OTC DRUG	T-18		Impatiens glandulifera Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	IMPATIENS GLANDULIFERA WHOLE	30	[hp_X]/mL			N	20241231
58264-0264_df24de41-f51d-f0f3-e053-2995a90a850f	58264-0264	HUMAN OTC DRUG	T-19		LARIX DECIDUA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	LARIX DECIDUA WHOLE	30	[hp_X]/mL			N	20241231
58264-0265_df24de41-f51e-f0f3-e053-2995a90a850f	58264-0265	HUMAN OTC DRUG	T-20		Mimulus guttatus whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	MIMULUS GUTTATUS WHOLE	30	[hp_X]/mL			N	20241231
58264-0266_df24de41-f51f-f0f3-e053-2995a90a850f	58264-0266	HUMAN OTC DRUG	T-21		SINAPIS ARVENSIS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SINAPIS ARVENSIS WHOLE	30	[hp_X]/mL			N	20241231
58264-0267_df2507ba-766e-4c8b-e053-2a95a90a50d9	58264-0267	HUMAN OTC DRUG	T-22		Quercus robur Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	QUERCUS ROBUR WHOLE	30	[hp_X]/mL			N	20241231
58264-0268_df2509a8-ba0a-e1b9-e053-2a95a90af056	58264-0268	HUMAN OTC DRUG	T-23		OLEA EUROPAEA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	OLEA EUROPAEA WHOLE	30	[hp_X]/mL			N	20241231
58264-0269_df2507ba-766f-4c8b-e053-2a95a90a50d9	58264-0269	HUMAN OTC DRUG	T-24		PINUS SYLVESTRIS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	PINUS SYLVESTRIS WHOLE	30	[hp_X]/mL			N	20241231
58264-0270_df250d62-e041-1fca-e053-2995a90af6fe	58264-0270	HUMAN OTC DRUG	T-25		AESCULUS X CARNEA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AESCULUS X CARNEA WHOLE	30	[hp_X]/mL			N	20241231
58264-0271_df24f3aa-8b71-79bc-e053-2a95a90adfe2	58264-0271	HUMAN OTC DRUG	T-26		Helianthemum nummularium Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	HELIANTHEMUM NUMMULARIUM WHOLE	30	[hp_X]/mL			N	20241231
58264-0272_df250d62-e042-1fca-e053-2995a90af6fe	58264-0272	HUMAN OTC DRUG	T-27		WATER	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	WATER	30	[hp_X]/mL			N	20241231
58264-0273_df2509a8-ba0b-e1b9-e053-2a95a90af056	58264-0273	HUMAN OTC DRUG	T-28		SCLERANTHUS ANNUUS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SCLERANTHUS ANNUUS WHOLE	30	[hp_X]/mL			N	20241231
58264-0274_df251592-d8e5-3455-e053-2a95a90a8145	58264-0274	HUMAN OTC DRUG	T-29		Ornithogalum umbellatum	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ORNITHOGALUM UMBELLATUM	30	[hp_X]/mL			N	20241231
58264-0275_df2509a8-ba0e-e1b9-e053-2a95a90af056	58264-0275	HUMAN OTC DRUG	T-30		Castanea sativa Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CASTANEA SATIVA WHOLE	30	[hp_X]/mL			N	20241231
58264-0276_df2509a8-ba0f-e1b9-e053-2a95a90af056	58264-0276	HUMAN OTC DRUG	T-31		Verbena officinalis	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	VERBENA OFFICINALIS	30	[hp_X]/mL			N	20241231
58264-0277_df250d62-e043-1fca-e053-2995a90af6fe	58264-0277	HUMAN OTC DRUG	T-32		VITIS VINIFERA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	VITIS VINIFERA WHOLE	30	[hp_X]/mL			N	20241231
58264-0278_df251c33-9f6a-7300-e053-2995a90acaeb	58264-0278	HUMAN OTC DRUG	T-33		Juglans regia Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	JUGLANS REGIA WHOLE	30	[hp_X]/mL			N	20241231
58264-0279_df251c33-9f6b-7300-e053-2995a90acaeb	58264-0279	HUMAN OTC DRUG	T-34		Hottonia palustris Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	HOTTONIA PALUSTRIS WHOLE	30	[hp_X]/mL			N	20241231
58264-0280_df25242b-84da-ee33-e053-2995a90a9c40	58264-0280	HUMAN OTC DRUG	T-35		AESCULUS HIPPOCASTANUM WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AESCULUS HIPPOCASTANUM WHOLE	30	[hp_X]/mL			N	20241231
58264-0281_df25242b-84db-ee33-e053-2995a90a9c40	58264-0281	HUMAN OTC DRUG	T-36		Bromus ramosus Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BROMUS RAMOSUS WHOLE	30	[hp_X]/mL			N	20241231
58264-0282_ded94fd0-2275-2cac-e053-2a95a90aec46	58264-0282	HUMAN OTC DRUG	T-37		ROSA CANINA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ROSA CANINA WHOLE	30	[hp_X]/mL			N	20241231
58264-0283_df250d62-e044-1fca-e053-2995a90af6fe	58264-0283	HUMAN OTC DRUG	T-38		SALIX ALBA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SALIX ALBA WHOLE	30	[hp_X]/mL			N	20241231
58264-0284_df3bf46e-a9e0-da0b-e053-2a95a90a72db	58264-0284	HUMAN OTC DRUG	T-39		Ornithogalum umbellatum, Helianthemum nummularium whole, Impatiens glandulifera whole, Prunus cerasifera whole, and Clematis vitalba whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CLEMATIS VITALBA WHOLE; HELIANTHEMUM NUMMULARIUM WHOLE; IMPATIENS GLANDULIFERA WHOLE; ORNITHOGALUM UMBELLATUM; PRUNUS CERASIFERA WHOLE	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0285_f18ce38a-8552-8cde-e053-2a95a90a68a6	58264-0285	HUMAN OTC DRUG	T-40		Matricaria Chamomilla Flowering Top, Larix Decidua Flowering Top, Mimulus Guttatus Flowering Top, Lavandula Angustifolia Subsp. Angustifolia Flower, Elm, and Garlic	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ELM; GARLIC; LARIX DECIDUA FLOWERING TOP; LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWER; MATRICARIA CHAMOMILLA FLOWERING TOP; MIMULUS GUTTATUS FLOWERING TOP	5; 5; 5; 5; 5; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0286_dea12637-7dc8-5f0d-e053-2995a90a7a87	58264-0286	HUMAN OTC DRUG	T-41		NEW VITALITY	SOLUTION	SUBLINGUAL	20220516		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACHILLEA MILLEFOLIUM FLOWER; ALLIUM SATIVUM WHOLE; ARNICA MONTANA FLOWER; ECHINACEA PURPUREA FLOWERING TOP; ERIODICTYON CALIFORNICUM FLOWERING TOP; OLEA EUROPAEA FLOWER; PRUNELLA VULGARIS FLOWER; ROSA CANINA FLOWER	30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0287_ddeb4358-f841-5198-e053-2995a90a0c3a	58264-0287	HUMAN OTC DRUG	T-42		BUTTERFLY PEA	SOLUTION	SUBLINGUAL	20220516		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CLITORIA TERNATEA FLOWER	30	[hp_X]/mL			N	20241231
58264-0293_dfde503b-de5d-c5e1-e053-2995a90ae3cd	58264-0293	HUMAN OTC DRUG	A-1		CAPRA HIRCUS SKIN, FELIS CATUS SKIN, BOS TAURUS SKIN, CANIS LUPUS FAMILIARIS SKIN, EQUUS CABALLUS SKIN, CAPRA HIRCUS HAIR, and Sheep Wool	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS SKIN; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS HAIR; CAPRA HIRCUS SKIN; EQUUS CABALLUS SKIN; FELIS CATUS SKIN; SHEEP WOOL	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Standardized Animal Skin Allergenic Extract [EPC]		N	20241231
58264-0294_dfde5ae9-014a-7dba-e053-2995a90a0a98	58264-0294	HUMAN OTC DRUG	A-2		Soybean, Lima Bean, Kidney Bean, String Bean, Black-eyed Pea, and Pea	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLACK-EYED PEA; KIDNEY BEAN; LIMA BEAN; PEA; SOYBEAN; STRING BEAN	30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
58264-0295_dfde84bc-e770-7e2f-e053-2995a90a474f	58264-0295	HUMAN OTC DRUG	A-3		Blackberry, Blueberry, Cranberry, Raspberry, and Strawberry	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLACKBERRY; BLUEBERRY; CRANBERRY; RASPBERRY; STRAWBERRY	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0296_dfde8860-0165-a8d9-e053-2a95a90a2d46	58264-0296	HUMAN OTC DRUG	A-4		COCOA, COFFEE BEAN, and TEA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	COCOA; COFFEE BEAN; TEA LEAF	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS]		N	20241231
58264-0297_dfde8c9a-55a7-471f-e053-2a95a90ab693	58264-0297	HUMAN OTC DRUG	A-5		SUCROSE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SUCROSE	30	[hp_X]/mL			N	20241231
58264-0298_dfde90f6-280b-3407-e053-2a95a90ad2a4	58264-0298	HUMAN OTC DRUG	A-6		Lemon, Orange, and Grapefruit	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	GRAPEFRUIT; LEMON; ORANGE	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0299_dfde94df-bb04-7e88-e053-2a95a90a1a2a	58264-0299	HUMAN OTC DRUG	A-7		CASEIN, CASEIN, LACTOCOCCUS LACTIS CULTURED, AGED, COW MILK, and GOAT MILK	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CASEIN; CASEIN, LACTOCOCCUS LACTIS CULTURED, AGED; COW MILK; GOAT MILK	30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Caseins [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0300_f0ec5c76-3345-d633-e053-2995a90a05fd	58264-0300	HUMAN OTC DRUG	A-8		DECIDUOUS TREE MIX	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; ACER SACCHARUM POLLEN; ALNUS RHOMBIFOLIA POLLEN; ALNUS RUBRA POLLEN; ALNUS SERRULATA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; POPULUS BALSAMIFERA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
58264-0301_dfde90f6-281b-3407-e053-2a95a90ad2a4	58264-0301	HUMAN OTC DRUG	A-9		House dust	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	HOUSE DUST	30	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], House Dust [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized House Dust Allergenic Extract [EPC]		N	20241231
58264-0302_dfde9e72-91eb-831e-e053-2995a90a54e1	58264-0302	HUMAN OTC DRUG	A-10		QUERCUS RUBRA WHOLE, QUERCUS VELUTINA WHOLE, QUERCUS ALBA WOOD, QUERCUS KELLOGGII WHOLE, QUERCUS AGRIFOLIA WHOLE, and QUERCUS GARRYANA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	QUERCUS AGRIFOLIA WHOLE; QUERCUS ALBA WOOD; QUERCUS GARRYANA WHOLE; QUERCUS KELLOGGII WHOLE; QUERCUS RUBRA WHOLE; QUERCUS VELUTINA WHOLE	30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0303_dfdea155-5ae8-9390-e053-2a95a90a6e6e	58264-0303	HUMAN OTC DRUG	A-11		EGG WHITE and EGG YOLK	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	EGG WHITE; EGG YOLK	30; 30	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0304_dfdea56f-6761-84a5-e053-2995a90aee87	58264-0304	HUMAN OTC DRUG	A-12		JUNIPERUS ASHEI POLLEN, JUNIPERUS VIRGINIANA POLLEN, TAMARIX GALLICA POLLEN, CUPRESSUS ARIZONICA POLLEN, TAXODIUM DISTICHUM POLLEN, JUNIPERUS MONOSPERMA POLLEN, JUNIPERUS PINCHOTII POLLEN, JUNIPERUS SCOPULORUM POLLEN, PINUS TAEDA POLLEN, PINUS STROBUS POLLEN, and PINUS ECHINATA POLLEN	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CUPRESSUS ARIZONICA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS MONOSPERMA POLLEN; JUNIPERUS PINCHOTII POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN; TAMARIX GALLICA POLLEN; TAXODIUM DISTICHUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
58264-0305_e0326a83-f024-c249-e053-2a95a90a3131	58264-0305	HUMAN OTC DRUG	A-13		GALLUS GALLUS FEATHER, ANAS PLATYRHYNCHOS FEATHER, and ANSER ANSER FEATHER	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
58264-0306_e03265ca-02b6-6e33-e053-2a95a90a1947	58264-0306	HUMAN OTC DRUG	A-14		Cod, Unspecified, Flounder, Unspecified, Halibut, Unspecified, Mackerel, Unspecified, Tuna, Unspecified, and Salmon, Unspecified	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	COD, UNSPECIFIED; FLOUNDER, UNSPECIFIED; HALIBUT, UNSPECIFIED; MACKEREL, UNSPECIFIED; SALMON, UNSPECIFIED; TUNA, UNSPECIFIED	30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0307_e0327bd0-4afd-131e-e053-2a95a90a58e3	58264-0307	HUMAN OTC DRUG	A-15		Apple, Apricot, Banana, Cherry, Grape, Peach, Pineapple, Pear, and Strawberry	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APPLE; APRICOT; BANANA; CHERRY; GRAPE; PEACH; PEAR; PINEAPPLE; STRAWBERRY	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0308_e0327ae6-8b3c-3f8a-e053-2a95a90a5802	58264-0308	HUMAN OTC DRUG	A-16		Barley, Corn, Oat, and Wheat	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BARLEY; CORN; OAT; WHEAT	30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0309_e0328134-63f0-744c-e053-2995a90aaf0e	58264-0309	HUMAN OTC DRUG	A-17		Barley, Corn, Oat, WHITE RICE, Rye, and Wheat	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BARLEY; CORN; OAT; RYE; WHEAT; WHITE RICE	30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
58264-0310_e0328134-63e1-744c-e053-2995a90aaf0e	58264-0310	HUMAN OTC DRUG	A-18		Ceiba Pentandra Seed, Powdered Cellulose, and Bombyx Mori Fiber	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOMBYX MORI FIBER; CEIBA PENTANDRA SEED; POWDERED CELLULOSE	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Silk [CS]		N	20241231
58264-0311_e032855e-7291-5842-e053-2a95a90a91d3	58264-0311	HUMAN OTC DRUG	A-19		SOLENOPSIS INVICTA, PERIPLANETA AMERICANA, MUSCA DOMESTICA, BOMBYX MORI WHOLE, and AEDES TAENIORHYNCHUS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AEDES TAENIORHYNCHUS; BOMBYX MORI WHOLE; MUSCA DOMESTICA; PERIPLANETA AMERICANA; SOLENOPSIS INVICTA	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0312_e032855e-7281-5842-e053-2a95a90a91d3	58264-0312	HUMAN OTC DRUG	A-20		Beef, Pork, Lamb, Chicken, and Turkey	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BEEF; CHICKEN; LAMB; PORK; TURKEY	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Meat Proteins [EXT], Meat Proteins [EXT], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT], Poultry Proteins [EXT]		N	20241231
58264-0313_e0328bae-7d90-2f58-e053-2995a90a41d7	58264-0313	HUMAN OTC DRUG	A-21		ALTERNARIA ALTERNATA, ASPERGILLUS NIGER VAR. NIGER, COCHLIOBOLUS SPICIFER, GIBBERELLA FUJIKUROI, COCHLIOBOLUS SATIVUS, CLADOSPORIUM BRUHNEI, MUCOR PLUMBEUS, PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM, AUREOBASIDIUM PULLULANS VAR. PULLUTANS, and RHIZOPUS STOLONIFER	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CLADOSPORIUM BRUHNEI; COCHLIOBOLUS SATIVUS; COCHLIOBOLUS SPICIFER; GIBBERELLA FUJIKUROI; MUCOR PLUMBEUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; RHIZOPUS STOLONIFER	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0314_e032855e-72a1-5842-e053-2a95a90a91d3	58264-0314	HUMAN OTC DRUG	A-22		ASPERGILLUS FLAVUS, ASPERGILLUS FUMIGATUS, EUROTIUM HERBARIORUM, ASPERGILLUS NIDULANS, ASPERGILLUS NIGER VAR. NIGER, PENICILLIUM CAMEMBERTI, PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM, PENICILLIUM DIGITATUM, and PENICILLIUM ROQUEFORTI	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; EUROTIUM HERBARIORUM; PENICILLIUM CAMEMBERTI; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM ROQUEFORTI	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0315_e0328134-63ff-744c-e053-2995a90aaf0e	58264-0315	HUMAN OTC DRUG	A-23		Almond, Cashew, BRAZIL NUT, Pecan, Peanut, Coconut, Black Walnut, English Walnut, COTTON SEED, Flax seed, and Sesame Seed	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALMOND; BLACK WALNUT; BRAZIL NUT; CASHEW; COCONUT; COTTON SEED; ENGLISH WALNUT; FLAX SEED; PEANUT; PECAN; SESAME SEED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Nut Proteins [EXT], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0317_e032a45d-883e-c00f-e053-2995a90a8544	58264-0317	HUMAN OTC DRUG	A-25		GRINDELIA CILIATA POLLEN, DYSPHANIA BOTRYS POLLEN, XANTHIUM STRUMARIUM POLLEN, LEUCANTHEMUM VULGARE POLLEN, TARAXACUM OFFICINALE POLLEN, LONICERA JAPONICA FLOWER, IVA ANNUA POLLEN, ARTEMISIA VULGARIS POLLEN, and AMARANTHUS RETROFLEXUS POLLEN	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AMARANTHUS RETROFLEXUS POLLEN; ARTEMISIA VULGARIS POLLEN; DYSPHANIA BOTRYS POLLEN; GRINDELIA CILIATA POLLEN; IVA ANNUA POLLEN; LEUCANTHEMUM VULGARE POLLEN; LONICERA JAPONICA FLOWER; TARAXACUM OFFICINALE POLLEN; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
58264-0318_e0328f6b-c58d-a85e-e053-2a95a90ab938	58264-0318	HUMAN OTC DRUG	A-26		ARTEMISIA LUDOVICIANA POLLEN and ARTEMISIA TRIDENTATA POLLEN	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN	30; 30	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
58264-0319_e032bc23-bdbb-53fc-e053-2a95a90aff1f	58264-0319	HUMAN OTC DRUG	A-27		ATRIPLEX POLYCARPA POLLEN, ATRIPLEX LENTIFORMIS POLLEN, and ATRIPLEX CANESCENS POLLEN	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN	30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
58264-0320_e032bc76-54cb-6576-e053-2995a90a7eb7	58264-0320	HUMAN OTC DRUG	A-28		QUAHOG, UNSPECIFIED, BLUE CRAB, EDIBLE OYSTER, SHRIMP, UNSPECIFIED, and SCALLOP, UNSPECIFIED	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BLUE CRAB; EDIBLE OYSTER; QUAHOG, UNSPECIFIED; SCALLOP, UNSPECIFIED; SHRIMP, UNSPECIFIED	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT], Shellfish Proteins [EXT], Shellfish Proteins [EXT], Shellfish Proteins [EXT]		N	20241231
58264-0321_e032bc76-54da-6576-e053-2995a90a7eb7	58264-0321	HUMAN OTC DRUG	A-29		Cinnamon, Garlic, Ginger, Mustard seed, unspecified, and Nutmeg	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CINNAMON; GARLIC; GINGER; MUSTARD SEED, UNSPECIFIED; NUTMEG	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0322_e032c07f-9f8a-5b0b-e053-2a95a90af1cc	58264-0322	HUMAN OTC DRUG	A-30		TOBACCO LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	TOBACCO LEAF	30	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58264-0323_e032c07f-9f99-5b0b-e053-2a95a90af1cc	58264-0323	HUMAN OTC DRUG	A-31		Potato, Sweet potato, Zucchini, Tomato, and Cucumber	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CUCUMBER; POTATO; SWEET POTATO; TOMATO; ZUCCHINI	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
58264-0324_e032c4ca-e609-1911-e053-2a95a90ad730	58264-0324	HUMAN OTC DRUG	A-32		Broccoli, Cabbage, Carrot, Turnip, and Cauliflower	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BROCCOLI; CABBAGE; CARROT; CAULIFLOWER; TURNIP	30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
58264-0325_e032bc23-bdca-53fc-e053-2a95a90aff1f	58264-0325	HUMAN OTC DRUG	A-33		Celery, Cultivated Mushroom, Lettuce, Green olive, Green Bell Pepper, Spinach, and Onion	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CELERY; CULTIVATED MUSHROOM; GREEN BELL PEPPER; GREEN OLIVE; LETTUCE; ONION; SPINACH	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
58264-0326_e032c4ca-e618-1911-e053-2a95a90ad730	58264-0326	HUMAN OTC DRUG	A-34		SACCHAROMYCES CEREVISIAE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SACCHAROMYCES CEREVISIAE	30	[hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
58264-0327_e032bc23-bdd9-53fc-e053-2a95a90aff1f	58264-0327	HUMAN OTC DRUG	A-35		Bos taurus adrenal gland, Onion, Garlic, Amanita muscaria fruiting body, Avena sativa flowering top, Activated charcoal, Arabica coffee bean, Histamine dihydrochloride, Hydrangea arborescens root, Skim milk, Corn silk, and Elymus repens whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACTIVATED CHARCOAL; AMANITA MUSCARIA FRUITING BODY; ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; BOS TAURUS ADRENAL GLAND; CORN SILK; ELYMUS REPENS WHOLE; GARLIC; HISTAMINE DIHYDROCHLORIDE; HYDRANGEA ARBORESCENS ROOT; ONION; SKIM MILK	30; 30; 30; 30; 6; 30; 30; 30; 30; 4; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
58264-0328_e032d4d3-7360-16bf-e053-2995a90ac94e	58264-0328	HUMAN OTC DRUG	A-36		BOS TAURUS ADRENAL GLAND, Agrimonia eupatoria, Bellis perennis, CAMPHOR (NATURAL), MATRICARIA CHAMOMILLA, Equisetum hyemale, FRAXINUS AMERICANA BARK, Formica rufa, HISTAMINE DIHYDROCHLORIDE, IODINE, POTASSIUM DICHROMATE, CANIS LUPUS FAMILIARIS MILK, SODIUM CHLORIDE, ANEMONE PULSATILLA, SALIX NIGRA BARK, and TOBACCO LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AGRIMONIA EUPATORIA; ANEMONE PULSATILLA; BELLIS PERENNIS; BOS TAURUS ADRENAL GLAND; CAMPHOR (NATURAL); CANIS LUPUS FAMILIARIS MILK; EQUISETUM HYEMALE; FORMICA RUFA; FRAXINUS AMERICANA BARK; HISTAMINE DIHYDROCHLORIDE; IODINE; MATRICARIA CHAMOMILLA; POTASSIUM DICHROMATE; SALIX NIGRA BARK; SODIUM CHLORIDE; TOBACCO LEAF	30; 4; 30; 6; 30; 30; 6; 12; 30; 30; 6; 12; 12; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS]		N	20241231
58264-0329_f3e781a8-d24f-5176-e053-2a95a90aac2e	58264-0329	HUMAN OTC DRUG	A-24		Agrostis gigantea pollen, Festuca pratensis pollen, Poa pratensis pollen, Dactylis glomerata pollen, Phleum pratense pollen, Anthoxanthum odoratum pollen, Lolium Perenne Pollen, Medicago sativa pollen, Trifolium pratense pollen, Solidago canadensis pollen, Ambrosia acanthicarpa pollen, Ambrosia psilostachya pollen, Ambrosia trifida pollen, Ambrosia Artemisiifolia pollen, Xanthium strumarium pollen, Chenopodium album pollen, Amaranthus retroflexus pollen, and Cynodon dactylon pollen	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AGROSTIS GIGANTEA POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; CHENOPODIUM ALBUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; FESTUCA PRATENSIS POLLEN; LOLIUM PERENNE POLLEN; MEDICAGO SATIVA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; TRIFOLIUM PRATENSE POLLEN; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
58264-0340_e06acd62-733c-171d-e053-2a95a90ad1ad	58264-0340	HUMAN OTC DRUG	AM-1		MARSDENIA CUNDURANGO WHOLE, DIBASIC POTASSIUM PHOSPHATE, and LYCOSA TARANTULA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	DIBASIC POTASSIUM PHOSPHATE; LYCOSA TARANTULA; MARSDENIA CUNDURANGO WHOLE	8; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0341_e06a4d34-c621-b469-e053-2a95a90a3358	58264-0341	HUMAN OTC DRUG	AM-2		COLCHICUM AUTUMNALE WHOLE, SODIUM SULFATE ANHYDROUS, and NAJA NAJA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	COLCHICUM AUTUMNALE WHOLE; NAJA NAJA WHOLE; SODIUM SULFATE ANHYDROUS	12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0342_e06f2aff-9666-4ebf-e053-2a95a90a5ab5	58264-0342	HUMAN OTC DRUG	AM-3		Cinchona officinalis Bark, Potassium Chlorate, and Lachesis Muta Whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CINCHONA OFFICINALIS BARK; LACHESIS MUTA WHOLE; POTASSIUM CHLORATE	10; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
58264-0343_e06f2a32-0eb9-6bd1-e053-2a95a90a0a7f	58264-0343	HUMAN OTC DRUG	AM-4		VISCUM ALBUM WHOLE, CALCIUM FLUORIDE, and ANDROCTONUS AUSTRALIS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ANDROCTONUS AUSTRALIS WHOLE; CALCIUM FLUORIDE; VISCUM ALBUM WHOLE	12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0344_e06f2a32-0ec9-6bd1-e053-2a95a90a0a7f	58264-0344	HUMAN OTC DRUG	AM-5		HELLEBORUS NIGER WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, and BOS TAURUS BILE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BOS TAURUS BILE; HELLEBORUS NIGER WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58264-0345_e06f3210-87f6-8975-e053-2995a90ab4db	58264-0345	HUMAN OTC DRUG	AM-6		WOOD CREOSOTE, POTASSIUM SULFATE, and ARANEUS DIADEMATUS	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ARANEUS DIADEMATUS; POTASSIUM SULFATE; WOOD CREOSOTE	12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
58264-0346_e06f2a32-0ed8-6bd1-e053-2a95a90a0a7f	58264-0346	HUMAN OTC DRUG	AM-7		Strychnos nux-vomica seed, Sodium Phosphate, Dibasic, Heptahydrate, and BUFO BUFO WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BUFO BUFO WHOLE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED	12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
58264-0347_e06f39b4-48a8-7ebb-e053-2a95a90a2f1d	58264-0347	HUMAN OTC DRUG	AM-8		Atropa belladonna, Calcium Sulfate Anhydrous, and Formica rufa	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ATROPA BELLADONNA; CALCIUM SULFATE ANHYDROUS; FORMICA RUFA	8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
58264-0348_e06f2aff-9677-4ebf-e053-2a95a90a5ab5	58264-0348	HUMAN OTC DRUG	AM-9		Spigelia anthelmia, Silicon dioxide, and Corallium rubrum whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CORALLIUM RUBRUM WHOLE; SILICON DIOXIDE; SPIGELIA ANTHELMIA	10; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0349_e06f2a32-0ee7-6bd1-e053-2a95a90a0a7f	58264-0349	HUMAN OTC DRUG	AM-10		Nerium oleander leaf, Tribasic calcium phosphate, and Carbo animalis	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CARBO ANIMALIS; NERIUM OLEANDER LEAF; TRIBASIC CALCIUM PHOSPHATE	10; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0350_e06f2aff-9686-4ebf-e053-2a95a90a5ab5	58264-0350	HUMAN OTC DRUG	AM-11		Arnica Montana, Sodium Chloride, and APIS MELLIFERA	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	APIS MELLIFERA; ARNICA MONTANA; SODIUM CHLORIDE	12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
58264-0351_e06f4399-5c53-8481-e053-2995a90af916	58264-0351	HUMAN OTC DRUG	AM-12		STRYCHNOS IGNATII WHOLE, FERROSOFERRIC PHOSPHATE, and SEPIA OFFICINALIS JUICE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FERROSOFERRIC PHOSPHATE; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII WHOLE	8; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0352_e06f39b4-48b7-7ebb-e053-2a95a90a2f1d	58264-0352	HUMAN OTC DRUG	AM-13		CARBON DISULFIDE, SILVER NITRATE, CORALLIUM RUBRUM WHOLE, CUPRIC ARSENITE, ASIAN GINSENG, Hypericum perforatum, LATHYRUS SATIVUS WHOLE, PICRIC ACID, SELENIUM, DATURA STRAMONIUM WHOLE, and ZINC	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ASIAN GINSENG; CARBON DISULFIDE; CORALLIUM RUBRUM WHOLE; CUPRIC ARSENITE; DATURA STRAMONIUM WHOLE; HYPERICUM PERFORATUM; LATHYRUS SATIVUS WHOLE; PICRIC ACID; SELENIUM; SILVER NITRATE; ZINC	3; 30; 30; 8; 30; 6; 30; 12; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0353_e06f4721-7e3c-bd39-e053-2a95a90ae0d7	58264-0353	HUMAN OTC DRUG	AM-14		SILVER, CALCIUM IODIDE, LYTTA VESICATORIA, COPPER, FERROUS IODIDE, GOLDENSEAL, IODINE, DAPHNE MEZEREUM BARK, PHOSPHORIC ACID, Phosphorus, TOXICODENDRON PUBESCENS LEAF, and RUMEX CRISPUS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALCIUM IODIDE; COPPER; DAPHNE MEZEREUM BARK; FERROUS IODIDE; GOLDENSEAL; IODINE; LYTTA VESICATORIA; PHOSPHORIC ACID; PHOSPHORUS; RUMEX CRISPUS WHOLE; SILVER; TOXICODENDRON PUBESCENS LEAF	8; 12; 30; 8; 6; 6; 6; 6; 30; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Inhibit Ovum Fertilization [PE]		N	20241231
58264-0364_e0f593aa-4722-9b73-e053-2995a90ab1eb	58264-0364	HUMAN OTC DRUG	G-1		ABIES ALBA LEAFY TWIG	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ABIES ALBA LEAFY TWIG	1	[hp_X]/mL			N	20241231
58264-0365_e0f5a881-4e4e-4afb-e053-2995a90aed26	58264-0365	HUMAN OTC DRUG	G-2		Acer campestre leaf bud	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ACER CAMPESTRE LEAF BUD	1	[hp_X]/mL			N	20241231
58264-0366_e0f5a9e6-e74c-8ca5-e053-2a95a90acd43	58264-0366	HUMAN OTC DRUG	G-3		Aesculus hippocastanum leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	AESCULUS HIPPOCASTANUM LEAF	1	[hp_X]/mL			N	20241231
58264-0367_e0f5a9e6-e75b-8ca5-e053-2a95a90acd43	58264-0367	HUMAN OTC DRUG	G-4		Alnus glutinosa leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALNUS GLUTINOSA LEAF	1	[hp_X]/mL			N	20241231
58264-0368_e0f5b4c8-79da-1c22-e053-2a95a90a88a5	58264-0368	HUMAN OTC DRUG	G-5		ALNUS VIRIDIS SUBSP. CRISPA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALNUS VIRIDIS SUBSP. CRISPA LEAF	1	[hp_X]/mL			N	20241231
58264-0369_e0f5aef4-0533-5e5d-e053-2995a90a3e73	58264-0369	HUMAN OTC DRUG	G-6		Parthenocissus quinquefolia leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	PARTHENOCISSUS QUINQUEFOLIA LEAF	1	[hp_X]/mL			N	20241231
58264-0370_e0f5bbed-b1be-da60-e053-2995a90a78d3	58264-0370	HUMAN OTC DRUG	G-7		BETULA PUBESCENS FLOWER BUD and BETULA PENDULA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BETULA PENDULA LEAF; BETULA PUBESCENS FLOWER BUD	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0371_e0f5bbed-b1ce-da60-e053-2995a90a78d3	58264-0371	HUMAN OTC DRUG	G-8		Carpinus betulus flower bud	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CARPINUS BETULUS FLOWER BUD	1	[hp_X]/mL			N	20241231
58264-0372_e0f5b4c8-79e9-1c22-e053-2a95a90a88a5	58264-0372	HUMAN OTC DRUG	G-9		CASTANEA SATIVA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CASTANEA SATIVA LEAF	1	[hp_X]/mL			N	20241231
58264-0373_e0f47b14-6979-4057-e053-2995a90a3eeb	58264-0373	HUMAN OTC DRUG	G-10		CEDRUS LIBANI WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CEDRUS LIBANI WHOLE	1	[hp_X]/mL			N	20241231
58264-0374_e0f47b14-6988-4057-e053-2995a90a3eeb	58264-0374	HUMAN OTC DRUG	G-11		CERCIS SILIQUASTRUM WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CERCIS SILIQUASTRUM WHOLE	1	[hp_X]/mL			N	20241231
58264-0375_e0f5b4c8-79f8-1c22-e053-2a95a90a88a5	58264-0375	HUMAN OTC DRUG	G-12		citrus x limon flowering top oil	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CITRUS X LIMON FLOWERING TOP OIL	1	[hp_X]/mL			N	20241231
58264-0376_e0f47b14-6999-4057-e053-2995a90a3eeb	58264-0376	HUMAN OTC DRUG	G-13		CORNUS SANGUINEA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CORNUS SANGUINEA WHOLE	1	[hp_X]/mL			N	20241231
58264-0377_e0f5d25c-d4cb-a501-e053-2995a90a3004	58264-0377	HUMAN OTC DRUG	G-14		CORYLUS AVELLANA FLOWER BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CORYLUS AVELLANA FLOWER BUD	1	[hp_X]/mL			N	20241231
58264-0378_e0f5d552-b635-2777-e053-2995a90a42d2	58264-0378	HUMAN OTC DRUG	G-15		Hawthorn leaf with flower	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	HAWTHORN LEAF WITH FLOWER	1	[hp_X]/mL			N	20241231
58264-0379_e0f5d836-c32d-24f2-e053-2995a90a2363	58264-0379	HUMAN OTC DRUG	G-16		FAGUS SYLVATICA FLOWER BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FAGUS SYLVATICA FLOWER BUD	1	[hp_X]/mL			N	20241231
58264-0380_e0f4636e-18c5-28f5-e053-2995a90ac4e4	58264-0380	HUMAN OTC DRUG	G-17		FICUS CARICA FLOWER BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FICUS CARICA FLOWER BUD	1	[hp_X]/mL			N	20241231
58264-0381_e0f652c8-7633-653c-e053-2a95a90afb0f	58264-0381	HUMAN OTC DRUG	G-18		FRAXINUS EXCELSIOR LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FRAXINUS EXCELSIOR LEAF	1	[hp_X]/mL			N	20241231
58264-0382_e0f65602-5d3f-7261-e053-2a95a90afab2	58264-0382	HUMAN OTC DRUG	G-19		ILEX AQUIFOLIUM LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ILEX AQUIFOLIUM LEAF	1	[hp_X]/mL			N	20241231
58264-0383_e0f65999-38cd-5352-e053-2995a90a0d9b	58264-0383	HUMAN OTC DRUG	G-20		Juglans Regia Flowering Top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	JUGLANS REGIA FLOWERING TOP	1	[hp_X]/mL			N	20241231
58264-0384_e0f65cf1-1f4a-fdfa-e053-2a95a90a372c	58264-0384	HUMAN OTC DRUG	G-21		JUNIPERUS COMMUNIS STEM	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	JUNIPERUS COMMUNIS STEM	1	[hp_X]/mL			N	20241231
58264-0385_e0f6605e-87cf-2e52-e053-2995a90a1f21	58264-0385	HUMAN OTC DRUG	G-22		LIGUSTRUM VULGARE WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	LIGUSTRUM VULGARE WHOLE	1	[hp_X]/mL			N	20241231
58264-0386_e0f6605e-87de-2e52-e053-2995a90a1f21	58264-0386	HUMAN OTC DRUG	G-23		Lonicera japonica top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	LONICERA JAPONICA TOP	1	[hp_X]/mL			N	20241231
58264-0387_e0f65cf1-1f59-fdfa-e053-2a95a90a372c	58264-0387	HUMAN OTC DRUG	G-24		Olea Europaea flower bud	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	OLEA EUROPAEA FLOWER BUD	1	[hp_X]/mL			N	20241231
58264-0388_e0f667b9-0d69-0c3f-e053-2995a90ad5a2	58264-0388	HUMAN OTC DRUG	G-25		Pinus mugo leafy twig	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	PINUS MUGO LEAFY TWIG	1	[hp_X]/mL			N	20241231
58264-0389_e0f65cf1-1f68-fdfa-e053-2a95a90a372c	58264-0389	HUMAN OTC DRUG	G-26		PLATANUS ORIENTALIS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	PLATANUS ORIENTALIS WHOLE	1	[hp_X]/mL			N	20241231
58264-0390_e0f67019-321f-26ac-e053-2995a90ae939	58264-0390	HUMAN OTC DRUG	G-27		POPULUS NIGRA LEAF BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	POPULUS NIGRA LEAF BUD	1	[hp_X]/mL			N	20241231
58264-0391_e0f67019-322f-26ac-e053-2995a90ae939	58264-0391	HUMAN OTC DRUG	G-28		PRUNUS DULCIS FLOWER	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	PRUNUS DULCIS FLOWER	1	[hp_X]/mL			N	20241231
58264-0392_e0f6769c-f8d4-09d3-e053-2995a90a97c7	58264-0392	HUMAN OTC DRUG	G-29		QUERCUS ROBUR FLOWER BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	QUERCUS ROBUR FLOWER BUD	1	[hp_X]/mL			N	20241231
58264-0394_e0f67019-323f-26ac-e053-2995a90ae939	58264-0394	HUMAN OTC DRUG	G-31		ROSA CANINA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ROSA CANINA LEAF	1	[hp_X]/mL			N	20241231
58264-0395_e0f67da8-f875-74ed-e053-2a95a90a7e93	58264-0395	HUMAN OTC DRUG	G-32		rosmarinus officinalis flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ROSMARINUS OFFICINALIS FLOWERING TOP	1	[hp_X]/mL			N	20241231
58264-0396_e0f6769c-f8e6-09d3-e053-2995a90a97c7	58264-0396	HUMAN OTC DRUG	G-33		RUBUS IDAEUS LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	RUBUS IDAEUS LEAF	1	[hp_X]/mL			N	20241231
58264-0397_e0f68398-3ed8-97f7-e053-2a95a90ae6e9	58264-0397	HUMAN OTC DRUG	G-34		RUBUS FRUTICOSUS LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	RUBUS FRUTICOSUS LEAF	1	[hp_X]/mL			N	20241231
58264-0398_e0f6867c-3cf8-dc0c-e053-2995a90addde	58264-0398	HUMAN OTC DRUG	G-35		SECALE CEREALE WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SECALE CEREALE WHOLE	1	[hp_X]/mL			N	20241231
58264-0399_e0f68398-3ee8-97f7-e053-2a95a90ae6e9	58264-0399	HUMAN OTC DRUG	G-36		SEQUOIADENDRON GIGANTEUM WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SEQUOIADENDRON GIGANTEUM WHOLE	1	[hp_X]/mL			N	20241231
58264-0400_e0f68c6c-f0e7-b11e-e053-2995a90aedf8	58264-0400	HUMAN OTC DRUG	G-37		SORBUS DOMESTICA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SORBUS DOMESTICA WHOLE	1	[hp_X]/mL			N	20241231
58264-0401_e0f68f87-131a-bfd3-e053-2a95a90a3df2	58264-0401	HUMAN OTC DRUG	G-38		syringa vulgaris flower	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	SYRINGA VULGARIS FLOWER	1	[hp_X]/mL			N	20241231
58264-0402_e0f69263-8384-e558-e053-2995a90a6b33	58264-0402	HUMAN OTC DRUG	G-39		TAMARIX GALLICA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	TAMARIX GALLICA WHOLE	1	[hp_X]/mL			N	20241231
58264-0403_f2f6a569-9a1f-c3fa-e053-2a95a90aa1c8	58264-0403	HUMAN OTC DRUG	G-40		TILIA TOMENTOSA BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	TILIA TOMENTOSA BUD	1	[hp_X]/mL			N	20241231
58264-0404_e0f69263-83a3-e558-e053-2995a90a6b33	58264-0404	HUMAN OTC DRUG	G-41		ULMUS GLABRA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ULMUS GLABRA WHOLE	1	[hp_X]/mL			N	20241231
58264-0405_e0f69c3b-b25b-2ca9-e053-2995a90a2fea	58264-0405	HUMAN OTC DRUG	G-42		VACCINIUM VITIS-IDAEA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	VACCINIUM VITIS-IDAEA LEAF	1	[hp_X]/mL			N	20241231
58264-0406_e0f69c3b-b26a-2ca9-e053-2995a90a2fea	58264-0406	HUMAN OTC DRUG	G-43		VIBURNUM LANTANA FLOWER BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	VIBURNUM LANTANA FLOWER BUD	1	[hp_X]/mL			N	20241231
58264-0407_e0f69c3b-b27a-2ca9-e053-2995a90a2fea	58264-0407	HUMAN OTC DRUG	G-44		VISCUM ALBUM STEM	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	VISCUM ALBUM STEM	1	[hp_X]/mL			N	20241231
58264-0408_e0f69c3b-b289-2ca9-e053-2995a90a2fea	58264-0408	HUMAN OTC DRUG	G-45		vitis vinifera flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	VITIS VINIFERA FLOWERING TOP	1	[hp_X]/mL			N	20241231
58264-0409_e0f6ac81-a135-dcc1-e053-2995a90a18e1	58264-0409	HUMAN OTC DRUG	G-46		ZEA MAYS SUBSP. MAYS WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ZEA MAYS SUBSP. MAYS WHOLE	1	[hp_X]/mL			N	20241231
58264-0410_e0f6ac81-a145-dcc1-e053-2995a90a18e1	58264-0410	HUMAN OTC DRUG	G-47		rosmarinus officinalis flowering top and juniperus communis stem	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	JUNIPERUS COMMUNIS STEM; ROSMARINUS OFFICINALIS FLOWERING TOP	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0411_e0f6ac81-a155-dcc1-e053-2995a90a18e1	58264-0411	HUMAN OTC DRUG	G-48		BETULA PUBESCENS FLOWER BUD and JUNIPERUS COMMUNIS STEM	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BETULA PUBESCENS FLOWER BUD; JUNIPERUS COMMUNIS STEM	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0412_e0f6b507-31c8-277e-e053-2995a90a71c9	58264-0412	HUMAN OTC DRUG	G-49		vaccinium vitis-idaea leaf and calluna vulgaris flowering top	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CALLUNA VULGARIS FLOWERING TOP; VACCINIUM VITIS-IDAEA LEAF	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0413_e0f6b7cf-61eb-9b70-e053-2995a90a7607	58264-0413	HUMAN OTC DRUG	G-50		VACCINIUM VITIS-IDAEA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	VACCINIUM VITIS-IDAEA LEAF	1	[hp_X]/mL			N	20241231
58264-0414_e0f6b507-31d7-277e-e053-2995a90a71c9	58264-0414	HUMAN OTC DRUG	G-51		FICUS CARICA FLOWER BUD and ALNUS GLUTINOSA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ALNUS GLUTINOSA LEAF; FICUS CARICA FLOWER BUD	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0415_e0f6bd3f-08d6-5ae8-e053-2995a90a6f4b	58264-0415	HUMAN OTC DRUG	G-52		VIBURNUM LANTANA FLOWER BUD and CORYLUS AVELLANA FLOWER BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CORYLUS AVELLANA FLOWER BUD; VIBURNUM LANTANA FLOWER BUD	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0416_e0f6b507-31e6-277e-e053-2995a90a71c9	58264-0416	HUMAN OTC DRUG	G-53		HAWTHORN LEAF WITH FLOWER, CORNUS SANGUINEA WHOLE, and syringa vulgaris flower	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CORNUS SANGUINEA WHOLE; HAWTHORN LEAF WITH FLOWER; SYRINGA VULGARIS FLOWER	1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
58264-0417_e0f6ceda-da9b-8655-e053-2a95a90a35a0	58264-0417	HUMAN OTC DRUG	G-54		POPULUS NIGRA LEAF BUD and CORNUS SANGUINEA WHOLE	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CORNUS SANGUINEA WHOLE; POPULUS NIGRA LEAF BUD	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0418_e0f6c6b7-c4be-6d55-e053-2995a90af104	58264-0418	HUMAN OTC DRUG	G-55		SORBUS DOMESTICA WHOLE and CASTANEA SATIVA LEAF	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CASTANEA SATIVA LEAF; SORBUS DOMESTICA WHOLE	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0419_e0f6bd3f-08e5-5ae8-e053-2995a90a6f4b	58264-0419	HUMAN OTC DRUG	G-56		ulmus glabra whole and cedrus libani whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CEDRUS LIBANI WHOLE; ULMUS GLABRA WHOLE	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0420_e0f6c6b7-c4cd-6d55-e053-2995a90af104	58264-0420	HUMAN OTC DRUG	G-57		TILIA TOMENTOSA BUD and FICUS CARICA FLOWER BUD	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	FICUS CARICA FLOWER BUD; TILIA TOMENTOSA BUD	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0421_e0f6ceda-daaa-8655-e053-2a95a90a35a0	58264-0421	HUMAN OTC DRUG	G-58		Juglans regia flowering top and Sequoiadendron giganteum whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	JUGLANS REGIA FLOWERING TOP; SEQUOIADENDRON GIGANTEUM WHOLE	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0422_e0f6bd3f-08f4-5ae8-e053-2995a90a6f4b	58264-0422	HUMAN OTC DRUG	G-59		Populus nigra leaf bud and Cornus sanguinea whole	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	CORNUS SANGUINEA WHOLE; POPULUS NIGRA LEAF BUD	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0423_e0f6bd3f-0904-5ae8-e053-2995a90a6f4b	58264-0423	HUMAN OTC DRUG	G-60		Juniperus communis stem and Betula pendula leaf	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	BETULA PENDULA LEAF; JUNIPERUS COMMUNIS STEM	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0424_e0f6dfcd-ef7e-3b83-e053-2a95a90a3ce2	58264-0424	HUMAN OTC DRUG	G-61		Rosa canina leaf and Viburnum lantana flower bud	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	ROSA CANINA LEAF; VIBURNUM LANTANA FLOWER BUD	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58264-0425_e0f6dfcd-ef8e-3b83-e053-2a95a90a3ce2	58264-0425	HUMAN OTC DRUG	G-62		Vitis Vinifera Flowering Top and Pinus Mugo Leafy Twig	SOLUTION	SUBLINGUAL	19900101		UNAPPROVED HOMEOPATHIC		DNA Labs, Inc.	PINUS MUGO LEAFY TWIG; VITIS VINIFERA FLOWERING TOP	1; 1	[hp_X]/mL; [hp_X]/mL			N	20241231
58265-006_f27ab7ec-8a14-7dd7-e053-2a95a90aa93a	58265-006	HUMAN OTC DRUG	O24 Pain Neutralizer		Arnica montana	SPRAY	TOPICAL	20230117		UNAPPROVED HOMEOPATHIC		O24 Naturals, LLC	ARNICA MONTANA	2	[hp_X]/30g			N	20241231
58265-007_f27ab7ec-8a14-7dd7-e053-2a95a90aa93a	58265-007	HUMAN OTC DRUG	O24 Pain Neutralizer		Arnica montana	LIQUID	TOPICAL	20230117		UNAPPROVED HOMEOPATHIC		O24 Naturals, LLC	ARNICA MONTANA	2	[hp_X]/9.4g			N	20241231
58274-007_f7f0e7b0-bb83-48a8-b29d-6d05be0d15b2	58274-007	HUMAN OTC DRUG	Brush on Block Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide 15%, Zinc Oxide 12%	POWDER	TOPICAL	20151015		OTC MONOGRAPH NOT FINAL	part352	SPF Ventures, LLC	TITANIUM DIOXIDE; ZINC OXIDE	15; 12	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
58274-008_ba18921b-1f2d-4f1c-b232-76ec2d554314	58274-008	HUMAN OTC DRUG	Brush on Block Nude Tint Protective Lip Oil Broad Spectrum SPF 32		TITANIUM DIOXIDE, ZINC OXIDE	LIQUID	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part352	SPF Ventures, LLC	TITANIUM DIOXIDE; ZINC OXIDE	45; 35	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
58274-010_f2b72f00-b657-32a4-e053-2995a90a8940	58274-010	HUMAN OTC DRUG	Brush on Block Sheer Genius Broad Spectrum SPF 50		Zinc Oxide 12%	LOTION	TOPICAL	20221213		OTC MONOGRAPH NOT FINAL	part352	SPF Ventures, LLC	ZINC OXIDE	12	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
58274-011_f2b7e27b-60ce-4864-e053-2995a90abbf5	58274-011	HUMAN OTC DRUG	Brush on Block Mineral Powder Sunscreen Translucent		Titanium Dioxide, Zinc Oxide	POWDER	TOPICAL	20230120		OTC MONOGRAPH NOT FINAL	part352	SPF Ventures, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.06; .21	g/g; g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
58276-015_3a01082a-8989-4fbe-a202-d1b015aa6d79	58276-015	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19820101		UNAPPROVED MEDICAL GAS		Pieri Inc dba McKnight Medical Equipment	OXYGEN	99	L/100L			N	20241231
58284-208_b0804b3a-4243-4028-80cf-d0c6ef65ca05	58284-208	HUMAN PRESCRIPTION DRUG	BRIXADI		BUPRENORPHINE	INJECTION	SUBCUTANEOUS	20230606		NDA	NDA210136	Braeburn Inc.	BUPRENORPHINE	8	mg/.16mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58284-216_b0804b3a-4243-4028-80cf-d0c6ef65ca05	58284-216	HUMAN PRESCRIPTION DRUG	BRIXADI		BUPRENORPHINE	INJECTION	SUBCUTANEOUS	20230606		NDA	NDA210136	Braeburn Inc.	BUPRENORPHINE	16	mg/.32mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58284-224_b0804b3a-4243-4028-80cf-d0c6ef65ca05	58284-224	HUMAN PRESCRIPTION DRUG	BRIXADI		BUPRENORPHINE	INJECTION	SUBCUTANEOUS	20230606		NDA	NDA210136	Braeburn Inc.	BUPRENORPHINE	24	mg/.48mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58284-228_b0804b3a-4243-4028-80cf-d0c6ef65ca05	58284-228	HUMAN PRESCRIPTION DRUG	BRIXADI		BUPRENORPHINE	INJECTION	SUBCUTANEOUS	20230606		NDA	NDA210136	Braeburn Inc.	BUPRENORPHINE	128	mg/.36mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58284-232_b0804b3a-4243-4028-80cf-d0c6ef65ca05	58284-232	HUMAN PRESCRIPTION DRUG	BRIXADI		BUPRENORPHINE	INJECTION	SUBCUTANEOUS	20230606		NDA	NDA210136	Braeburn Inc.	BUPRENORPHINE	32	mg/.64mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58284-264_b0804b3a-4243-4028-80cf-d0c6ef65ca05	58284-264	HUMAN PRESCRIPTION DRUG	BRIXADI		BUPRENORPHINE	INJECTION	SUBCUTANEOUS	20230606		NDA	NDA210136	Braeburn Inc.	BUPRENORPHINE	64	mg/.18mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58284-296_b0804b3a-4243-4028-80cf-d0c6ef65ca05	58284-296	HUMAN PRESCRIPTION DRUG	BRIXADI		BUPRENORPHINE	INJECTION	SUBCUTANEOUS	20230606		NDA	NDA210136	Braeburn Inc.	BUPRENORPHINE	96	mg/.27mL	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
58292-004_ff96d682-da0a-e576-e053-6294a90a8c7f	58292-004	HUMAN OTC DRUG	FORMULA 4 PAIN		Lidocaine HCl, Menthol	GEL	TOPICAL	20230422		OTC MONOGRAPH NOT FINAL	part348	Lifequest Creations LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58292-005_ff9730da-7762-1902-e053-6394a90a015d	58292-005	HUMAN OTC DRUG	FORMULA 4 PAIN		Lidocaine HCl, Menthol	CREAM	TOPICAL	20230507		OTC MONOGRAPH NOT FINAL	part348	Lifequest Creations LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58311-1000_07622070-c3ae-bfdf-e063-6394a90aeb37	58311-1000	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19650101		NDA	NDA205767	Young Welding Supply, Inc	OXYGEN	990	mL/L			N	20241231
58311-4444_0762048c-6f5c-bff3-e063-6294a90abb66	58311-4444	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19650101		NDA	NDA205766	Young Welding Supply, Inc	NITROGEN	99	L/100L			N	20241231
58331-030_ee02700b-98ed-9de2-e053-2995a90adc04	58331-030	HUMAN OTC DRUG	Croc Bloc Broad Spectrum SPF 30 FPS Ecran Solaire		HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, and Avobenzone	LOTION	TOPICAL	20130515		OTC MONOGRAPH NOT FINAL	part352	Degil Safety Products (1989) Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 10.5; 5; 2; 2	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
58331-050_ee029008-bcc8-4619-e053-2a95a90a399a	58331-050	HUMAN OTC DRUG	CROC BLOC BROAD SPECTRUM SPF 50 FPS ECRAN SOLAIRE		homosalate, octisalate, octocrylene, oxybenzone, and avobenzone	LOTION	TOPICAL	20200218		OTC MONOGRAPH NOT FINAL	part352	Degil Safety Products (1989) Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 13; 5; 7; 4	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
58354-117_f6f8c887-b6f3-236a-e053-6394a90a0833	58354-117	HUMAN OTC DRUG	Dyrax-Q Tab		Bisacodyl, Docusate Sodium	TABLET	ORAL	20191025		OTC MONOGRAPH NOT FINAL	part334	Cho-A Pharm.Co.,Ltd.	BISACODYL; DOCUSATE SODIUM	5; 16.75	mg/161mg; mg/161mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58356-001_08028904-49cb-1659-e063-6394a90a9573	58356-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19850101		NDA	NDA205767	Lampton Welding Supply Company, Inc	OXYGEN	99	L/100L			N	20241231
58356-002_08025e53-5dc3-37f7-e063-6394a90a50c9	58356-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19850101		NDA	NDA205766	Lampton Welding Supply Company, Inc	NITROGEN	99	L/100L			N	20241231
58368-003_0eb10bd7-a4f0-c438-e063-6394a90abc08	58368-003	HUMAN OTC DRUG	NeoRelief for Menstrual Pain and Cramps		Homeopathic pain relief gel	GEL	TOPICAL	20180427		UNAPPROVED HOMEOPATHIC		BioLyte Laboratories, LLC	APIS MELLIFERA; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; BLACK COHOSH; BRYONIA ALBA ROOT; CAULOPHYLLUM THALICTROIDES ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; CYCLAMEN PURPURASCENS TUBER; FRANGULA CALIFORNICA BARK; GELSEMIUM SEMPERVIRENS ROOT; JUNIPERUS SABINA LEAFY TWIG; LILIUM LANCIFOLIUM WHOLE FLOWERING; POTASSIUM CARBONATE; SARACA INDICA BARK; SELENICEREUS GRANDIFLORUS STEM; TILIA X EUROPAEA FLOWER; VIBURNUM OPULUS BARK	4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
58368-005_f34215cf-a667-31a5-e053-2995a90afc94	58368-005	HUMAN OTC DRUG	NEORELIEF FOR PAIN		topical gel for pain	GEL	TOPICAL	20170201		UNAPPROVED HOMEOPATHIC		BioLyte Laboratories, LLC	ACTAEA SPICATA ROOT; ALTHAEA OFFICINALIS ROOT; ARNICA MONTANA; ATROPA BELLADONNA ROOT; BELLIS PERENNIS; BLACK COHOSH; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CAULOPHYLLUM THALICTROIDES ROOT; CAUSTICUM; FRANGULA CALIFORNICA BARK; GUAIACUM OFFICINALE RESIN; HORSE CHESTNUT; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; LITHIUM CARBONATE; POTASSIUM CARBONATE; RHODODENDRON AUREUM LEAF; RUTA GRAVEOLENS FLOWERING TOP; SALICYLIC ACID; STELLARIA MEDIA; TOXICODENDRON PUBESCENS LEAF	4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Mood Stabilizer [EPC]		N	20241231
58368-096_f1f3e87d-3f47-6b50-e053-2995a90a6cc8	58368-096	HUMAN OTC DRUG	Capsiva		Capsicum Annuum, Arnica Montana	GEL	TOPICAL	20190601		UNAPPROVED HOMEOPATHIC		BioLyte Laboratories, LLC	ARNICA MONTANA; CAPSICUM	6; 6	[hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
58368-102_f1f3fb63-7ef8-95d2-e053-2995a90a4c0d	58368-102	HUMAN OTC DRUG	Capsiva		Capsicum Annuum, Arnica Montana	GEL	TOPICAL	20190601		UNAPPROVED HOMEOPATHIC		BioLyte Laboratories, LLC	ARNICA MONTANA; CAPSICUM	6; 6	[hp_X]/g; [hp_X]/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
58394-012_dc09bc6b-177b-45f1-8fce-e1b1c3e9c4ba	58394-012	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20080801		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-013_dc09bc6b-177b-45f1-8fce-e1b1c3e9c4ba	58394-013	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20080801		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-014_dc09bc6b-177b-45f1-8fce-e1b1c3e9c4ba	58394-014	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20080801		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-015_dc09bc6b-177b-45f1-8fce-e1b1c3e9c4ba	58394-015	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20080801		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-016_dd76bb0b-bc9e-404d-90ea-9aaa7f09944c	58394-016	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20100813		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-022_dd76bb0b-bc9e-404d-90ea-9aaa7f09944c	58394-022	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20111201		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-023_dd76bb0b-bc9e-404d-90ea-9aaa7f09944c	58394-023	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20111201		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-024_dd76bb0b-bc9e-404d-90ea-9aaa7f09944c	58394-024	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20110801		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-025_dd76bb0b-bc9e-404d-90ea-9aaa7f09944c	58394-025	PLASMA DERIVATIVE	Xyntha		antihemophilic factor (recombinant)	KIT		20110801		BLA	BLA125264	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-633_2aac4a08-e47d-418e-99e6-b9872304a7dc	58394-633	PLASMA DERIVATIVE	BeneFIX		coagulation factor ix (recombinant)	KIT		19970201		BLA	BLA103677	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-634_2aac4a08-e47d-418e-99e6-b9872304a7dc	58394-634	PLASMA DERIVATIVE	BeneFIX		coagulation factor ix (recombinant)	KIT		19970201		BLA	BLA103677	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-635_2aac4a08-e47d-418e-99e6-b9872304a7dc	58394-635	PLASMA DERIVATIVE	BeneFIX		coagulation factor ix (recombinant)	KIT		19970201		BLA	BLA103677	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-636_2aac4a08-e47d-418e-99e6-b9872304a7dc	58394-636	PLASMA DERIVATIVE	BeneFIX		coagulation factor ix (recombinant)	KIT		20070706		BLA	BLA103677	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58394-637_2aac4a08-e47d-418e-99e6-b9872304a7dc	58394-637	PLASMA DERIVATIVE	BeneFIX		coagulation factor ix (recombinant)	KIT		20120201		BLA	BLA103677	Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC						N	20241231
58400-001_0720fdf5-8dec-4e33-827d-003654c676b4	58400-001	HUMAN OTC DRUG	Micronized Benzoyl Peroxide Treatment		Benzoyl Peroxide	GEL	TOPICAL	20120601		OTC MONOGRAPH DRUG	M006	Pharmco Laboratories Inc.	BENZOYL PEROXIDE	25	mg/g			N	20251231
58400-003_827b1a9f-70ed-4b5a-80c6-ec249ec22969	58400-003	HUMAN OTC DRUG	Micronized Benzoyl Peroxide Treatment		Benzoyl Peroxide	GEL	TOPICAL	20120601		OTC MONOGRAPH DRUG	M006	Pharmco Laboratories Inc.	BENZOYL PEROXIDE	100	mg/g			N	20251231
58400-007_15a7def9-02ea-4381-afd4-59901130dd69	58400-007	HUMAN OTC DRUG	Daily Facial Moisturizer SPF 35		Octinoxate and Avobenzone	LOTION	TOPICAL	20120601		OTC MONOGRAPH DRUG	M020	Pharmco Laboratories Inc.	AVOBENZONE; OCTINOXATE	25; 40	mg/g; mg/g			N	20251231
58400-009_1440605b-a17e-4497-99ad-7ef4a90285b6	58400-009	HUMAN OTC DRUG	Benzoyl Peroxide Cleanser		Benzoyl Peroxide	GEL	TOPICAL	20161201		OTC MONOGRAPH DRUG	M006	Pharmco Laboratories Inc.	BENZOYL PEROXIDE	35	mg/g			N	20251231
58400-010_7110d632-21f2-48ea-bec0-f83c2649dc90	58400-010	HUMAN OTC DRUG	Hand Sanitizer with aloe vera		Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	M003	Pharmco Laboratories, Inc.	ALCOHOL	70	mL/100mL			N	20251231
58400-011_38d27de4-6832-457c-8628-1d0196432165	58400-011	HUMAN OTC DRUG	Hand Sanitizer	CA73	Alcohol	LIQUID	TOPICAL	20200501		OTC MONOGRAPH DRUG	M003	Pharmco Laboratories, Inc.	ALCOHOL	70	mL/100mL			N	20251231
58400-012_13cd6a59-0598-4a84-8f67-7f6cacfdb7a2	58400-012	HUMAN OTC DRUG	Hand Sanitizer	CA75	Alcohol	LIQUID	TOPICAL	20200501		OTC MONOGRAPH DRUG	M003	Pharmco Laboratories, Inc.	ALCOHOL	70	mL/100mL			N	20251231
58404-001_0802489a-3810-cc8b-e063-6294a90a9b4e	58404-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130501		NDA	NDA205865	Industrial Welding & Tool Supply, Ltd.	OXYGEN	995	mL/L			N	20241231
58404-002_080237a1-7936-ce26-e063-6294a90a9df4	58404-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20130501		NDA	NDA205866	Industrial Welding & Tool Supply, Ltd.	NITROGEN	995	mL/L			N	20241231
58406-010_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-010	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20190607		BLA	BLA103795	Immunex Corporation	ETANERCEPT	25	mg/.5mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-021_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-021	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20190607		BLA	BLA103795	Immunex Corporation	ETANERCEPT	50	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-032_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-032	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20190607		BLA	BLA103795	Immunex Corporation	ETANERCEPT	50	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-044_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-044	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20190607		BLA	BLA103795	Immunex Corporation	ETANERCEPT	50	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-055_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-055	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20200305		BLA	BLA103795	Immunex Corporation	ETANERCEPT	25	mg/.5mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-425_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-425	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	KIT		20030102		BLA	BLA103795	Immunex Corporation						N	20241231
58406-435_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-435	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20051006		BLA	BLA103795	Immunex Corporation	ETANERCEPT	50	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-445_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-445	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20051110		BLA	BLA103795	Immunex Corporation	ETANERCEPT	50	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-455_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-455	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20051110		BLA	BLA103795	Immunex Corporation	ETANERCEPT	25	mg/.5mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58406-456_29187b7c-d166-45e4-bc8c-4cbf71a67702	58406-456	HUMAN PRESCRIPTION DRUG	ENBREL		etanercept	SOLUTION	SUBCUTANEOUS	20170929		BLA	BLA103795	Immunex Corporation	ETANERCEPT	50	mg/mL	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
58407-010_0763e5e4-4182-da53-e063-6294a90aca3e	58407-010	HUMAN OTC DRUG	STAHIST TP		Phenylephrine HCL and Triprolidine HCL	TABLET	ORAL	20200525		OTC MONOGRAPH DRUG	M012	Magna Pharmaceuticals, Inc.	PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	10; 2.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58407-625_07737712-83d6-fd68-e063-6294a90a4b5c	58407-625	HUMAN OTC DRUG	STAHIST AD		CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE	TABLET	ORAL	20111220		OTC MONOGRAPH DRUG	M012	Magna Pharmaceuticals, Inc.	CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	25; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
58411-101_7cf0cb08-78a7-306c-e053-2a91aa0ae822	58411-101	HUMAN OTC DRUG	SHISEIDO IBUKI PROTECTIVE MOISTURIZER		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	EMULSION	TOPICAL	20130801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1903; 5633; 1522; 761	mg/76.12g; mg/76.12g; mg/76.12g; mg/76.12g			N	20241231
58411-121_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-121	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	FAIR IVORY	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-122_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-122	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	LIGHT BEIGE	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-123_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-123	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	LIGHT IVORY	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-124_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-124	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	LIGHT OCHRE	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-125_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-125	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	MEDIUM BEIGE	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-126_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-126	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	MEDIUM IVORY	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-127_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-127	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	MEDIUM OCHRE	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-128_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-128	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	DARK BEIGE	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-129_7cf0df6c-a1ae-a663-e053-2a91aa0ac50f	58411-129	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE COMPACT (REFILL)	DARK IVORY	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	POWDER	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	888; 600; 1416	mg/12g; mg/12g; mg/12g			N	20241231
58411-130_7d6ab961-cbf6-ef66-e053-2a91aa0a26e6	58411-130	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	LIGHT BEIGE	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	644; 2814	mg/33.9g; mg/33.9g			N	20241231
58411-131_7d6ab961-cbf6-ef66-e053-2a91aa0a26e6	58411-131	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	LIGHT IVORY	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	644; 2814	mg/33.9g; mg/33.9g			N	20241231
58411-132_7d6ab961-cbf6-ef66-e053-2a91aa0a26e6	58411-132	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	LIGHT OCHRE	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	644; 2814	mg/33.9g; mg/33.9g			N	20241231
58411-133_7d6ab961-cbf6-ef66-e053-2a91aa0a26e6	58411-133	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	MEDIUM BEIGE	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	644; 2814	mg/33.9g; mg/33.9g			N	20241231
58411-134_7d6ab961-cbf6-ef66-e053-2a91aa0a26e6	58411-134	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	MEDIUM IVORY	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	644; 2814	mg/33.9g; mg/33.9g			N	20241231
58411-135_7d6ab961-cbf6-ef66-e053-2a91aa0a26e6	58411-135	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	DARK BEIGE	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	644; 2814	mg/33.9g; mg/33.9g			N	20241231
58411-136_7d6ab961-cbf6-ef66-e053-2a91aa0a26e6	58411-136	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	DARK IVORY	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	644; 2814	mg/33.9g; mg/33.9g			N	20241231
58411-137_7d6ab961-cc0d-ef66-e053-2a91aa0a26e6	58411-137	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	FAIR IVORY	OCTINOXATE and TITANIUM DIOXIDE	STICK	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	261; 648	mg/9g; mg/9g			N	20241231
58411-138_7d6ab961-cc0d-ef66-e053-2a91aa0a26e6	58411-138	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	FAIR OCHRE	OCTINOXATE and TITANIUM DIOXIDE	STICK	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	261; 648	mg/9g; mg/9g			N	20241231
58411-139_7d6ab961-cc0d-ef66-e053-2a91aa0a26e6	58411-139	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	BEIGE	OCTINOXATE and TITANIUM DIOXIDE	STICK	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	261; 648	mg/9g; mg/9g			N	20241231
58411-140_7d6ab961-cc0d-ef66-e053-2a91aa0a26e6	58411-140	HUMAN OTC DRUG	SHISEIDO UV PROTECTIVE FOUNDATION	OCHRE	OCTINOXATE and TITANIUM DIOXIDE	STICK	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	261; 648	mg/9g; mg/9g			N	20241231
58411-142_7d6ab961-cc20-ef66-e053-2a91aa0a26e6	58411-142	HUMAN OTC DRUG	SHISEIDO ULTIMATE SUN PROTECTION		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	SPRAY	TOPICAL	20140401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3.98; 19.89; 6.63; 3.32; 6.63	mg/132.6g; mg/132.6g; mg/132.6g; mg/132.6g; mg/132.6g			N	20241231
58411-194_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-194	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-195_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-195	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-196_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-196	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-197_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-197	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O40	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-198_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-198	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O50	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-199_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-199	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O60	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-200_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-200	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	B10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-201_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-201	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	B20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-202_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-202	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	B30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-203_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-203	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	BF20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-204_f3fcd67b-b4b5-435a-8bbf-872cc47fd131	58411-204	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	WB20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20140901		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1617; 825	mg/30mL; mg/30mL			N	20241231
58411-206_7cf319bf-a1bb-60d9-e053-2991aa0a94a9	58411-206	HUMAN OTC DRUG	CLE DE PEAU BEAUTE SHEER FLUID VEIL		AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	CREAM	TOPICAL	20140901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	771; 2282; 617	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-237_7df47be5-ab9d-5b67-e053-2a91aa0a6956	58411-237	HUMAN OTC DRUG	CLE DE PEAU BEAUTE SYNACTIF DAYTIME MOISTURIZER n		AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	CREAM	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	518; 1532; 414	mg/20mL; mg/20mL; mg/20mL			N	20241231
58411-239_7cf1e3de-8d17-0f73-e053-2a91aa0ab977	58411-239	HUMAN OTC DRUG	SHISEIDO GLOW ENHANCING PRIMER		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20150201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	773; 2287; 927; 309	mg/30mL; mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-241_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-241	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	I10	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-242_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-242	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O10	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-243_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-243	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O20	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-244_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-244	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O30	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-245_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-245	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O40	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-246_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-246	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O50	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-247_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-247	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O60	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-248_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-248	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	B10	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-249_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-249	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	B20	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-250_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-250	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	B30	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-251_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-251	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	BF20	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-252_12fe8c16-9e47-4aa6-baee-9862c337162b	58411-252	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	WB20	OCTINOXATE and TITANIUM DIOXIDE	POWDER	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	319; 363	mg/11g; mg/11g			N	20241231
58411-253_934d88e8-7244-49f9-b0e1-419f4d2ab0d2	58411-253	HUMAN OTC DRUG	SHISEIDO ULTIMATE SUN PROTECTION		OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE, and ZINC OXIDE	LOTION	TOPICAL	20150201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	8406; 3408; 1590; 18630	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
58411-254_b9dec41e-cdf6-4eee-ba26-c26fb415ffcc	58411-254	HUMAN OTC DRUG	SHISEIDO ULTIMATE SUN PROTECTION		OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20150201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4255; 1725; 805; 9430	mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-255_7d6ae847-fcbd-28a3-e053-2991aa0a9cc5	58411-255	HUMAN OTC DRUG	SHISEIDO BENEFIANCE WRINKLERESIST24 PROTECTIVE HAND REVITALIZER		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1922; 3767; 3844; 1153	mg/75mL; mg/75mL; mg/75mL; mg/75mL			N	20241231
58411-261_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-261	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Neutral 1	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-262_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-262	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Neutral 2	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-263_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-263	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Neutral 3	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-264_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-264	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Neutral 4	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-265_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-265	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Rose 2	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-266_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-266	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Rose 3	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-267_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-267	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Rose 4	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-268_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-268	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Golden 2	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-269_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-269	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Golden 3	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-270_4f903124-5a35-4cde-8e01-13c87acdee3a	58411-270	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN LASTING FOUNDATION	Golden 4	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	911; 754	mg/30mL; mg/30mL			N	20241231
58411-272_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-272	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	I10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-273_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-273	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-274_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-274	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-275_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-275	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-276_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-276	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	B10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-277_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-277	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	B20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-278_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-278	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	B30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-279_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-279	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	BF20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-280_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-280	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O40	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-281_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-281	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O50	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-282_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-282	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	O60	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-283_7cf1e53b-fe43-7089-e053-2991aa0a411e	58411-283	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	WB20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20160801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1072; 292	mg/21mL; mg/21mL			N	20241231
58411-284_7d6ae847-fcdf-28a3-e053-2991aa0a9cc5	58411-284	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	IVORY	OCTINOXATE	STICK	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	306	mg/9g			N	20241231
58411-285_7d6ae847-fcdf-28a3-e053-2991aa0a9cc5	58411-285	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	OCHER	OCTINOXATE	STICK	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	306	mg/9g			N	20241231
58411-286_7d6ae847-fcdf-28a3-e053-2991aa0a9cc5	58411-286	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	MOCHA	OCTINOXATE	STICK	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	306	mg/9g			N	20241231
58411-287_7d6ae847-fcdf-28a3-e053-2991aa0a9cc5	58411-287	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FOUNDATION	BEIGE	OCTINOXATE	STICK	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	306	mg/9g			N	20241231
58411-288_7cf21ffd-918e-27b9-e053-2991aa0a874d	58411-288	HUMAN OTC DRUG	CLE DE PEAU BEAUTE UV PROTECTIVE LIP TREATMENT		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	STICK	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	100; 196; 120; 80	mg/4g; mg/4g; mg/4g; mg/4g			N	20241231
58411-289_7cf25316-216f-29bc-e053-2a91aa0ab049	58411-289	HUMAN OTC DRUG	CLE DE PEAU BEAUTE UV PROTECTIVE VERY HIGH PROTECTION FOR BODY		OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE, and ZINC OXIDE	EMULSION	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	5678; 2302; 1151; 14808	mg/75mL; mg/75mL; mg/75mL; mg/75mL			N	20241231
58411-291_7cf1e3de-8d3a-0f73-e053-2a91aa0ab977	58411-291	HUMAN OTC DRUG	CLE DE PEAU BEAUTE UV PROTECTIVE		OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE	CREAM	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	3870; 1569; 8577	mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-292_7cf25316-219a-29bc-e053-2a91aa0ab049	58411-292	HUMAN OTC DRUG	CLE DE PEAU BEAUTE UV PROTECTIVE TINTED	IVORY	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2449; 993; 1522	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-293_7cf25316-219a-29bc-e053-2a91aa0ab049	58411-293	HUMAN OTC DRUG	CLE DE PEAU BEAUTE UV PROTECTIVE TINTED	OCHER	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2449; 993; 1522	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-294_7cf25316-219a-29bc-e053-2a91aa0ab049	58411-294	HUMAN OTC DRUG	CLE DE PEAU BEAUTE UV PROTECTIVE TINTED	DARK	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2449; 993; 1522	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-295_7cf27f1b-c08e-7e5f-e053-2991aa0a0ac0	58411-295	HUMAN OTC DRUG	SHISEIDO WHITE LUCENT ALL DAY BRIGHTENER N		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1283; 3796; 1539; 513	mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-296_70395394-3a76-4b85-a874-e1569ef39c84	58411-296	HUMAN OTC DRUG	SHISEIDO WHITE LUCENT ONMAKEUP SPOT CORRECTING SERUM	NATURAL LIGHT	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	138; 123	mg/4mL; mg/4mL			N	20241231
58411-297_70395394-3a76-4b85-a874-e1569ef39c84	58411-297	HUMAN OTC DRUG	SHISEIDO WHITE LUCENT ONMAKEUP SPOT CORRECTING SERUM	NATURAL	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	138; 123	mg/4mL; mg/4mL			N	20241231
58411-302_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-302	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Neutral 1	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-303_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-303	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Neutral 2	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-304_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-304	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Neutral 3	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-305_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-305	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Neutral 4	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-306_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-306	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Neutral 5	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-307_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-307	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Rose 2	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-308_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-308	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Rose 3	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-309_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-309	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Rose 4	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-310_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-310	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Rose 5	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-311_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-311	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Golden 2	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-312_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-312	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Golden 3	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-313_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-313	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Golden 4	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-314_7cf28e2f-29dd-27bf-e053-2991aa0a27b2	58411-314	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN GLOW LUMINIZING FLUID FOUNDATION	Golden 5	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1655; 676	mg/30mL; mg/30mL			N	20241231
58411-315_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-315	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	I10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-316_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-316	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	O10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-317_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-317	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	O20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-318_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-318	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	O30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-319_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-319	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	O40	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-320_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-320	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	O50	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-321_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-321	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	O60	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-322_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-322	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	B10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-323_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-323	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	B20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-324_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-324	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	B30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-326_80c1861c-3d8e-4000-b4fe-9ce7d90bfd7d	58411-326	HUMAN OTC DRUG	CLE DE PEAU BEAUTE THE FOUNDATION	WB20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1228; 1039	mg/27mL; mg/27mL			N	20241231
58411-327_7cf28e2f-2a30-27bf-e053-2991aa0a27b2	58411-327	HUMAN OTC DRUG	Shiseido Future Solution LX Total Protective		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	EMULSION	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1136; 5606; 1515; 758	mg/75mL; mg/75mL; mg/75mL; mg/75mL			N	20241231
58411-328_2668be02-92ec-4cff-b6de-55d103544607	58411-328	HUMAN OTC DRUG	Shiseido Future Solution LX Total Protective E		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1017; 3763; 1526; 763	mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-329_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-329	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Golden 1	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2036	mg/30mL			N	20241231
58411-330_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-330	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Golden 2	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-331_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-331	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Golden 3	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-332_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-332	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Golden 4	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-333_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-333	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Neutral 1	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-334_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-334	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Neutral 2	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-335_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-335	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Neutral 3	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-336_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-336	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Neutral 4	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-337_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-337	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Rose 2	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-338_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-338	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Rose 3	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-339_7cf28e2f-2a50-27bf-e053-2991aa0a27b2	58411-339	HUMAN OTC DRUG	SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E	Rose 4	OCTINOXATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	1832	mg/30mL			N	20241231
58411-345_bfc16e3d-3ec8-4a78-a0c9-3fb994b27603	58411-345	HUMAN OTC DRUG	SHISEIDO SUN PROTECTION EYE		OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE	CREAM	TOPICAL	20121201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	479; 495; 1749	mg/16.5g; mg/16.5g; mg/16.5g			N	20241231
58411-346_b6e0e911-134b-4c71-b60a-b8707484a73c	58411-346	HUMAN OTC DRUG	SHISEIDO URBAN ENVIRONMENT	oil-FREE UV PROTECTOR	OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE	LOTION	TOPICAL	20121001		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICA INC.	OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	1557; 953; 3971	mg/31.77g; mg/31.77g; mg/31.77g			N	20241231
58411-347_6af27151-dfdd-41a4-81d0-0d493a2ed688	58411-347	HUMAN OTC DRUG	SHISEIDO URBAN ENVIRONMENT UV PROTECTION		OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE	CREAM	TOPICAL	20121001		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	1583; 1638; 5788	mg/54.6g; mg/54.6g; mg/54.6g			N	20241231
58411-348_693ece25-c1cd-4ceb-ba3e-15190d527a5a	58411-348	HUMAN OTC DRUG	SHISEIDO EXTRA SMOOTH SUN PROTECTION N		OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE	CREAM	TOPICAL	20130201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	2766; 1694; 7056	mg/56.45g; mg/56.45g; mg/56.45g			N	20241231
58411-349_2f505a5b-2e88-4822-ade2-5822af259fce	58411-349	HUMAN OTC DRUG	SHISEIDO EXTRA SMOOTH SUN PROTECTION N		OCTINOXATE, OCTOCRYLENE, and ZINC OXIDE	LOTION	TOPICAL	20130201		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	5424; 3321; 13.84	mg/110.7g; mg/110.7g; g/110.7g			N	20241231
58411-351_871fa8a1-03db-49fa-b195-e6919002fbc6	58411-351	HUMAN OTC DRUG	SHISEIDO BENEFIANCE NUTRIPERFECT DAY		AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	CREAM	TOPICAL	20121101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	1286; 3807; 1029	mg/51.45g; mg/51.45g; mg/51.45g			N	20241231
58411-353_7cf2d5a4-09e7-2d2d-e053-2a91aa0a93c6	58411-353	HUMAN OTC DRUG	CLE DE PEAU BEAUTE CONCEALER	IVORY	TITANIUM DIOXIDE	STICK	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-354_7cf2d5a4-09e7-2d2d-e053-2a91aa0a93c6	58411-354	HUMAN OTC DRUG	CLE DE PEAU BEAUTE CONCEALER	OCHER	TITANIUM DIOXIDE	STICK	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-355_7cf2d5a4-09e7-2d2d-e053-2a91aa0a93c6	58411-355	HUMAN OTC DRUG	CLE DE PEAU BEAUTE CONCEALER	BEIGE	TITANIUM DIOXIDE	STICK	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-356_7cf2d5a4-09e7-2d2d-e053-2a91aa0a93c6	58411-356	HUMAN OTC DRUG	CLE DE PEAU BEAUTE CONCEALER	HONEY	TITANIUM DIOXIDE	STICK	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-357_7cf2d5a4-09e7-2d2d-e053-2a91aa0a93c6	58411-357	HUMAN OTC DRUG	CLE DE PEAU BEAUTE CONCEALER	ALMOND	TITANIUM DIOXIDE	STICK	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-358_7cf2d5a4-09e7-2d2d-e053-2a91aa0a93c6	58411-358	HUMAN OTC DRUG	CLE DE PEAU BEAUTE CONCEALER	MOCHA	TITANIUM DIOXIDE	STICK	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-359_7cf2d5a4-09fc-2d2d-e053-2a91aa0a93c6	58411-359	HUMAN OTC DRUG	SHISEIDO ULTIMATE SUN PROTECTION		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1288; 2524; 2575; 1545	mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-364_7cf2da9e-b020-d215-e053-2a91aa0a549e	58411-364	HUMAN OTC DRUG	SHISEIDO ESSENTIAL ENERGY DAY		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1020; 2550; 3773; 1530; 765	mg/50mL; mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-365_7cf2da9e-b031-d215-e053-2a91aa0a549e	58411-365	HUMAN OTC DRUG	SHISEIDO CLEAR stick UV PROTECTOR		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20180201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	375; 1500; 735; 750; 750; 450	mg/15g; mg/15g; mg/15g; mg/15g; mg/15g; mg/15g			N	20241231
58411-427_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-427	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	I10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-428_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-428	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	O10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-429_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-429	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	O20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-430_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-430	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	O30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-431_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-431	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	O40	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 624	mg/12g; mg/12g			N	20241231
58411-432_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-432	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	O50	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 624	mg/12g; mg/12g			N	20241231
58411-433_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-433	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	O60	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 624	mg/12g; mg/12g			N	20241231
58411-434_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-434	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	B10	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-435_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-435	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	B20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-436_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-436	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	B30	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-437_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-437	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	BF20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-438_392b8372-cbe0-48e1-b678-c2025ed51e81	58411-438	HUMAN OTC DRUG	cle de peau beaute radiant cream to powder foundation	WB20	OCTINOXATE and TITANIUM DIOXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	408; 516	mg/12g; mg/12g			N	20241231
58411-439_48b92c4e-c985-4051-affa-11a9d2de9182	58411-439	HUMAN OTC DRUG	SHISEIDO BENEFIANCE WRINKLE SMOOTHING DAY		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20180601		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1032; 2580; 3818; 1548; 774	mg/50mL; mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-445_cf5e45e2-6d46-4a2c-832a-0ed5108c71da	58411-445	HUMAN OTC DRUG	SHISEIDO SPORTS HYDROBB COMPACT	LIGHT	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	588; 360; 1608	mg/12g; mg/12g; mg/12g			N	20241231
58411-446_cf5e45e2-6d46-4a2c-832a-0ed5108c71da	58411-446	HUMAN OTC DRUG	SHISEIDO SPORTS HYDROBB COMPACT	MEDIUM	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	588; 360; 1608	mg/12g; mg/12g; mg/12g			N	20241231
58411-447_cf5e45e2-6d46-4a2c-832a-0ed5108c71da	58411-447	HUMAN OTC DRUG	SHISEIDO SPORTS HYDROBB COMPACT	MEDIUM DARK	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	588; 360; 1608	mg/12g; mg/12g; mg/12g			N	20241231
58411-448_cf5e45e2-6d46-4a2c-832a-0ed5108c71da	58411-448	HUMAN OTC DRUG	SHISEIDO SPORTS HYDROBB COMPACT	DARK	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	588; 360; 1608	mg/12g; mg/12g; mg/12g			N	20241231
58411-449_cf5e45e2-6d46-4a2c-832a-0ed5108c71da	58411-449	HUMAN OTC DRUG	SHISEIDO SPORTS HYDROBB COMPACT	VERY DARK	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	588; 360; 1608	mg/12g; mg/12g; mg/12g			N	20241231
58411-450_e42ce52a-1ffa-47b8-b915-fc3fe795146a	58411-450	HUMAN OTC DRUG	SHISEIDO SPORTS BB	LIGHT	OCTINOXATE and TITANIUM DIOXIDE	LOTION	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1815; 5558	mg/30mL; mg/30mL			N	20241231
58411-451_e42ce52a-1ffa-47b8-b915-fc3fe795146a	58411-451	HUMAN OTC DRUG	SHISEIDO SPORTS BB	MEDIUM	OCTINOXATE and TITANIUM DIOXIDE	LOTION	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1815; 5558	mg/30mL; mg/30mL			N	20241231
58411-454_eb56f3cf-531d-4022-ba6e-489d8d0e7d3d	58411-454	HUMAN OTC DRUG	CLE DE PEAU BEAUTE PROTECTIVE FORTIFYING n		avobenzone, octinoxate, octocrylene, and oxybenzone	EMULSION	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	3200; 9472; 2560; 1280	mg/125mL; mg/125mL; mg/125mL; mg/125mL			N	20241231
58411-455_5bc01e07-7b00-48bd-8988-d50df503b787	58411-455	HUMAN OTC DRUG	CLE DE PEAU BEAUTE PROTECTIVE FORTIFYING n		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1030; 2524; 2575; 1030	mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
58411-458_9bffdf19-7980-4cda-8f64-a645985c957f	58411-458	HUMAN OTC DRUG	SHISEIDO THE MAKEUP FOUNDATION	I20	TITANIUM DIOXIDE	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	400	mg/10g			N	20241231
58411-459_9bffdf19-7980-4cda-8f64-a645985c957f	58411-459	HUMAN OTC DRUG	SHISEIDO THE MAKEUP FOUNDATION	I40	TITANIUM DIOXIDE	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	400	mg/10g			N	20241231
58411-460_9bffdf19-7980-4cda-8f64-a645985c957f	58411-460	HUMAN OTC DRUG	SHISEIDO THE MAKEUP FOUNDATION	I60	TITANIUM DIOXIDE	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	400	mg/10g			N	20241231
58411-461_9bffdf19-7980-4cda-8f64-a645985c957f	58411-461	HUMAN OTC DRUG	SHISEIDO THE MAKEUP FOUNDATION	B20	TITANIUM DIOXIDE	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	400	mg/10g			N	20241231
58411-462_9bffdf19-7980-4cda-8f64-a645985c957f	58411-462	HUMAN OTC DRUG	SHISEIDO THE MAKEUP FOUNDATION	B40	TITANIUM DIOXIDE	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	400	mg/10g			N	20241231
58411-463_6e02788a-052d-433d-8dca-c9d6de092b74	58411-463	HUMAN OTC DRUG	SHISEIDO WHITE LUCENT DAY		AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	1.285; 3.8036; 1.542	g/50mL; g/50mL; g/50mL			N	20241231
58411-477_42b45aca-3841-4681-9dd5-168e5d5ac46d	58411-477	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O70	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.6611; .8475	g/30mL; mg/30mL			N	20241231
58411-478_42b45aca-3841-4681-9dd5-168e5d5ac46d	58411-478	HUMAN OTC DRUG	CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION	O80	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.6611; .8475	g/30mL; mg/30mL			N	20241231
58411-479_2af1e16c-35f8-4b2e-9711-e1abd4d62787	58411-479	HUMAN OTC DRUG	SHISEIDO VITAL PERFECTION UPLIFTING AND FIRMING DAY		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and HOMOSALATE	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	1.278; 2.557; 3.785; 1.534	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
58411-480_a7d1a327-5297-40ac-83c0-1a4d5a1fa4d4	58411-480	HUMAN OTC DRUG	SHISEIDO ULTIMATE SUN PROTECTOR		OCTISALATE, TITANIUM DIOXIDE, OCTOCRYLENE, and ZINC OXIDE	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	3.105; 4.347; 2.359; 12.047	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
58411-481_af22ecf0-cac8-4c7f-ad90-d588ac171083	58411-481	HUMAN OTC DRUG	SHISEIDO ULTIMATE SUN PROTECTOR		octisalate, homosalate, octocrylene, and avobenzone	LOTION	TOPICAL	20200101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	23; 100; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58411-482_33562033-6702-42ce-8b3a-6a3c3b2e1df0	58411-482	HUMAN OTC DRUG	SHISEIDO FUTURE solution LX UNIVERSAL DEFENSE E		OCTISALATE, OCTOCRYLENE, and ZINC OXIDE	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	2.523; 3.532; 7.723	g/50mL; g/50mL; g/50mL			N	20241231
58411-483_caf0c559-abea-48a9-94cb-dc67d71e1a73	58411-483	HUMAN OTC DRUG	CLE DE PEAU BEAUTE CORRECTING VEIL n		ENSULIZOLE, OCTINOXATE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	ENSULIZOLE; OCTINOXATE; TITANIUM DIOXIDE	.386; 1.119; .9264	g/37mL; g/37mL; g/37mL			N	20241231
58411-484_2ce453cc-1b14-471a-8753-5a8c64035111	58411-484	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 110 ALABASTER		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-485_2ce453cc-1b14-471a-8753-5a8c64035111	58411-485	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 120 IVORY		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-486_2ce453cc-1b14-471a-8753-5a8c64035111	58411-486	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 130 OPAL		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-487_2ce453cc-1b14-471a-8753-5a8c64035111	58411-487	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 140 PORCELAIN		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-488_2ce453cc-1b14-471a-8753-5a8c64035111	58411-488	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 150 LACE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-489_2ce453cc-1b14-471a-8753-5a8c64035111	58411-489	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 160 SHELL		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-490_2ce453cc-1b14-471a-8753-5a8c64035111	58411-490	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 210 BIRCH		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-491_2ce453cc-1b14-471a-8753-5a8c64035111	58411-491	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 220 LINEN		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-492_2ce453cc-1b14-471a-8753-5a8c64035111	58411-492	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 230 ALDER		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-493_2ce453cc-1b14-471a-8753-5a8c64035111	58411-493	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 240 QUARTZ		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-494_2ce453cc-1b14-471a-8753-5a8c64035111	58411-494	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 250 SAND		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-495_2ce453cc-1b14-471a-8753-5a8c64035111	58411-495	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 260 CASHMERE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-496_2ce453cc-1b14-471a-8753-5a8c64035111	58411-496	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 310 SILK		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-497_2ce453cc-1b14-471a-8753-5a8c64035111	58411-497	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 320 PINE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-498_2ce453cc-1b14-471a-8753-5a8c64035111	58411-498	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 330 BAMBOO		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-499_2ce453cc-1b14-471a-8753-5a8c64035111	58411-499	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 340 OAK		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-500_2ce453cc-1b14-471a-8753-5a8c64035111	58411-500	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 350 MAPLE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-501_2ce453cc-1b14-471a-8753-5a8c64035111	58411-501	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 360 CITRINE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-502_2ce453cc-1b14-471a-8753-5a8c64035111	58411-502	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 410 SUNSTONE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-503_2ce453cc-1b14-471a-8753-5a8c64035111	58411-503	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 420 BRONZE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.001	g/30mL; g/30mL			N	20241231
58411-504_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-504	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 430 CEDAR		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-505_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-505	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 440 AMBER		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-506_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-506	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 450 COPPER		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-507_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-507	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 460 TOPAZ		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-508_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-508	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 510 SUEDE		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-509_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-509	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 520 ROSEWOOD		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-510_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-510	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 530 HENNA		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-511_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-511	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 540 MAHOGANY		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-512_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-512	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 550 JASPER		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-513_6fc1caac-0bfb-400b-993c-68a0ec2199ea	58411-513	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 560 OBSIDIAN		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190901		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; .345	g/30mL; g/30mL			N	20241231
58411-535_d2430121-cf15-4f9a-90e0-81614983acc0	58411-535	HUMAN OTC DRUG	Hydrating Anti-Bacterial Hand Sanitizer		ALCOHOL	LOTION	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333E	SHISEIDO AMERICAS CORPORATION	ALCOHOL	70	mL/100mL			N	20241231
58411-536_f72bcc36-3355-4d3f-8223-700fed362dec	58411-536	HUMAN OTC DRUG	SHISEIDO SPORTS BB DARK		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20190301		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.81545; 5.5575	g/30mL; g/30mL			N	20241231
58411-561_8594bee0-f67e-45ac-924d-2a5cd4ba502a	58411-561	HUMAN OTC DRUG	CLE DE PEAU BEAUTE PROTECTIVE FORTIFYING n		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	EMULSION	TOPICAL	20200301		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	.93; 2.7528; .744; .372	g/30mL; g/30mL; g/30mL; g/30mL			N	20241231
58411-562_78fe2dc7-c7b5-46f1-9d4b-2e9ab9ebc75d	58411-562	HUMAN OTC DRUG	CLE DE PEAU BEAUTE PROTECTIVE FORTIFYING n		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	EMULSION	TOPICAL	20200301		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	.2472; .60564; .618; .2472	g/12mL; g/12mL; g/12mL; g/12mL			N	20241231
58411-563_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-563	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	110	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-564_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-564	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	120	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-565_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-565	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	130	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-566_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-566	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	140	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-567_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-567	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	150	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-568_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-568	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	160	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-569_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-569	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	210	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-570_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-570	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	220	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-571_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-571	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	230	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-572_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-572	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	240	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-573_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-573	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	250	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-574_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-574	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	260	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-575_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-575	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	310	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-576_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-576	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	320	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-577_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-577	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	330	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-578_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-578	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	340	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-579_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-579	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	350	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-580_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-580	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	360	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-581_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-581	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	410	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-582_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-582	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	420	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-583_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-583	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	430	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-584_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-584	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	440	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-585_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-585	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	450	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-586_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-586	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	460	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-587_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-587	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	510	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-588_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-588	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	520	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-589_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-589	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	530	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-590_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-590	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	540	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-591_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-591	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	550	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-592_fade0d6d-a44e-4a2c-8a2a-4676ec029882	58411-592	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN RADIANT LIFTING FOUNDATION	560	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20200920		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	2.484; .36	g/30mL; g/30mL			N	20251231
58411-616_e20c68a1-9762-4287-a1e6-001c39639ccf	58411-616	HUMAN OTC DRUG	SHISEIDO CLEAR SUNSCREEN SPF 50 Plus		AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	STICK	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	500; 2000; 1000; 2000	mg/20g; mg/20g; mg/20g; mg/20g			N	20241231
58411-617_ff7068d7-aac2-4610-b2ab-b01dfcda9474	58411-617	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER	BUFF	TITANIUM DIOXIDE	STICK	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-618_ff7068d7-aac2-4610-b2ab-b01dfcda9474	58411-618	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER	HAZELNUT	TITANIUM DIOXIDE	STICK	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-619_ff7068d7-aac2-4610-b2ab-b01dfcda9474	58411-619	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER	NUTMEG	TITANIUM DIOXIDE	STICK	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-620_ff7068d7-aac2-4610-b2ab-b01dfcda9474	58411-620	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER	COCOA	TITANIUM DIOXIDE	STICK	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-621_ff7068d7-aac2-4610-b2ab-b01dfcda9474	58411-621	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER	ESPRESSO	TITANIUM DIOXIDE	STICK	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-622_ff7068d7-aac2-4610-b2ab-b01dfcda9474	58411-622	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER	TOFFEE	TITANIUM DIOXIDE	STICK	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-623_7f41a73f-3fd4-4a89-b860-bb635e79740a	58411-623	HUMAN OTC DRUG	cle de peau BEAUTE LONG-LASTING HYDRATING VEIL		AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	.795; 2.38; .635	g/30mL; g/30mL; g/30mL			N	20241231
58411-627_e3297c17-4740-4d05-88b6-5d6ed6f31ecc	58411-627	HUMAN OTC DRUG	SHISEIDO URBAN ENVIRONMENT oil-FREE UV PROTECTOR		zinc oxide, homosalate, octocrylene, and octisalate	EMULSION	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	2.65; 2.65; 2.65; 5.16	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
58411-628_ca3efed4-cea4-4fc2-94ad-a6a4d8922c22	58411-628	HUMAN OTC DRUG	SHISEIDO BENEFIANCE WRINKLERESIST24 DAY		AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	1.94; 5.83; 1.55	g/75mL; g/75mL; g/75mL			N	20241231
58411-629_93ef9789-3ddd-47a0-bb67-7fdda500da36	58411-629	HUMAN OTC DRUG	SHISEIDO BENEFIANCE WRINKLERESIST24 DAY		AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	CREAM	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	1.28; 3.85; 1.02	g/50mL; g/50mL; g/50mL			N	20241231
58411-630_b806f97b-6825-40a6-b364-c6c44b6da004	58411-630	HUMAN OTC DRUG	SHISEIDO REFINING MAKEUP PRIMER		OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.69; 2.53	g/30mL; g/30mL			N	20241231
58411-631_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-631	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	I10	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-632_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-632	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O10	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-634_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-634	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O40	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-635_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-635	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B40	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-636_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-636	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B50	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-637_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-637	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B60	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-638_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-638	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B70	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-639_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-639	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B80	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-640_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-640	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B90	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-641_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-641	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O30	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-642_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-642	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O50	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-643_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-643	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O60	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-644_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-644	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O70	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-645_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-645	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O80	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-646_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-646	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O90	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-647_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-647	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O100	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-648_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-648	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B10	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-649_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-649	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B20	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-650_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-650	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B30	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-651_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-651	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	B100	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-652_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-652	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	BF10	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-653_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-653	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	BF50	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-654_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-654	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	BF60	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-655_28da85e2-c112-4f8e-8cef-316c4b3ae9e3	58411-655	HUMAN OTC DRUG	cle de peau BEAUTE RADIANT FOUNDATION N	O20	octinoxate and titanium dioxide	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1.07; .3	g/21mL; g/21mL			N	20241231
58411-656_bbb78269-467f-4b05-8267-38f52ad19758	58411-656	HUMAN OTC DRUG	SHISEIDO ESSENTIAL ENERGY HYDRATING DAY		HOMOSALATE, OCTOCRYLENE, OCTISALATE, and AVOBENZONE	EMULSION	TOPICAL	20210501		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.012; 2.53; 2.53; 2.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
58411-657_5372d970-e30f-48ff-b10f-2b2f74dfccc9	58411-657	HUMAN OTC DRUG	SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER		TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE	EMULSION	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	ENSULIZOLE; OCTINOXATE; TITANIUM DIOXIDE	.428; 1.71; 1.77	g/40mL; g/40mL; g/40mL			N	20241231
58411-658_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-658	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	1	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-659_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-659	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	2	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-660_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-660	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	3	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-661_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-661	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	4	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-662_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-662	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	5	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-663_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-663	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	7	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-664_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-664	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	8	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-665_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-665	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	9	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-666_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-666	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	10	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-667_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-667	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	11	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-668_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-668	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	12	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-669_15776259-d96c-4dc6-ad67-2abe51d8bc38	58411-669	HUMAN OTC DRUG	cle de peau BEAUTE CONCEALER N	13	TITANIUM DIOXIDE	STICK	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE	80	mg/5g			N	20241231
58411-670_0925ed68-22fe-456d-bb88-9c8dcfae64ea	58411-670	HUMAN OTC DRUG	SHISEIDO URBAN ENVIRONMENT Oil-Free SUNSCREEN SPF 42		ensulizole, homosalate, octisalate, and zinc oxide	EMULSION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	ENSULIZOLE; HOMOSALATE; OCTISALATE; ZINC OXIDE	.4; 5.4; 1.8; 5.6	g/30mL; g/30mL; g/30mL; g/30mL			N	20241231
58411-671_27da4c26-d21f-4dfb-8993-d820774363b5	58411-671	HUMAN OTC DRUG	SHISEIDO URBAN ENVIRONMENT FRESH-MOISTURE SUNSCREEN SPF 42		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.2; 5.2; 2.6; 2.6	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
58411-672_60c7c1d3-3dbc-4722-83e1-68a33764535f	58411-672	HUMAN OTC DRUG	SHISEIDO URBAN ENVIRONMENT oil-free MINERAL SUNSCREEN SPF 42		TITANIUM DIOXIDE AND ZINC OXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	SHISEIDO AMERICAS CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	1.8; 5	g/30mL; g/30mL			N	20251231
58411-673_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-673	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	115 Fair Shirakaba	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-674_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-674	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	125 Fair Asterid	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-675_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-675	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	215 Light Buna	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-676_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-676	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	225 Light Magnolia	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-677_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-677	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	235 Light Hiba	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-678_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-678	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	315 Medium Matsu	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-679_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-679	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	325 Medium Keyaki	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-680_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-680	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	335 Medium Katsura	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-681_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-681	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	415 Tan Kwanzan	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-682_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-682	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	425 Tan Ume	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-683_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-683	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	515 Deep Tsubaki	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-684_9a6ca257-766b-450d-ba58-ea6bb16c4bed	58411-684	HUMAN OTC DRUG	SHISEIDO SYNCHRO SKIN SELF-REFRESHING TINT	525 Deep Kuromoji	OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20191216		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2010; 900; 600	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-838_132674e9-a0c0-4135-9b0c-0cb829f387a0	58411-838	HUMAN OTC DRUG	cle de peau BEAUTE BRIGHTENING ENHANCER VEIL		OCTINOXATE, OCTOCRYLENE, and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	2220; 750; 1980	mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-839_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-839	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O50 TAN OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-840_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-840	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	I10 VERY LIGHT IVORY	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-841_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-841	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O10 LIGHT OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-842_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-842	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O20 LIGHT MEDIUM OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-843_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-843	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O30 MEDIUM OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-844_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-844	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O40 LIGHT TAN OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-845_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-845	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O60 DEEP TAN OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-846_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-846	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O80 DEEP OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-847_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-847	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	O100 RICH DEEP OCHER	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-848_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-848	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	B10 LIGHT BEIGE	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-849_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-849	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	B20 LIGHT MEDIUM BEIGE	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-850_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-850	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	B30 MEDIUM BEIGE	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-851_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-851	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	B40 LIGHT TAN BEIGE	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-852_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-852	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	B50 TAN BEIGE	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-853_763cd595-8828-4fe5-80ce-0b6b0ffbb5a4	58411-853	HUMAN OTC DRUG	cle de peau BEAUTE THE FOUNDATION N	BF10 LIGHT BUFF	OCTINOXATE and TITANIUM DIOXIDE	EMULSION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE; TITANIUM DIOXIDE	1092; 924	mg/28mL; mg/28mL			N	20241231
58411-854_b4941780-891a-4967-8fd5-dc73705c2a90	58411-854	HUMAN OTC DRUG	SHISEIDO URBAN ENVIRONMENT VITA-CLEAR SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	EMULSION	TOPICAL	20211225		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	690; 3000; 1500; 1500	mg/30mL; mg/30mL; mg/30mL; mg/30mL			N	20241231
58411-855_80eef7cf-cd3c-4253-8334-67317c805453	58411-855	HUMAN OTC DRUG	cle de peau BEAUTE UV PROTECTIVE N		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.2167; 5.29; 2.645; 2.645	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
58411-856_296d61b8-94b2-4fb9-89d0-dcf157e943b4	58411-856	HUMAN OTC DRUG	cle de peau BEAUTE PROTECTIVE LIP TREATMENT	SPF 25	AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	EMULSION	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	100; 196; 120	mg/4g; mg/4g; mg/4g			N	20241231
58411-857_1696bacb-6334-448b-967b-405722d41e94	58411-857	HUMAN OTC DRUG	cle de peau BEAUTE PROTECTIVE FORTIFYING n		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220701		OTC MONOGRAPH FINAL	part352	SHISEIDO AMERICAS CORPORATION	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.031; 2.52595; 2.5775; 1.031	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
58411-858_4c02d40e-3497-458f-9c28-def86ef64250	58411-858	HUMAN OTC DRUG	cle de peau BEAUTE UV PROTECTIVE FOR BODY n		ENSULIZOLE, OCTISALATE, OCTOCRYLENE, and ZINC OXIDE	EMULSION	TOPICAL	20240101		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	ENSULIZOLE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	2.384; 5.96; 5.96; 23.1248	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
58411-859_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-859	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	110	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-860_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-860	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	120	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-861_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-861	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	130	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-862_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-862	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	140	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-863_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-863	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	150	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-864_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-864	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	160	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-865_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-865	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	210	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-866_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-866	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	220	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-867_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-867	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	230	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-868_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-868	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	240	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-869_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-869	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	250	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-870_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-870	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	260	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-871_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-871	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	310	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-872_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-872	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	320	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-873_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-873	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	330	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-874_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-874	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	340	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-875_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-875	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	350	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-876_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-876	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	360	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-877_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-877	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	410	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-878_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-878	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	420	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-879_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-879	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	430	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-880_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-880	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	440	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-881_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-881	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	450	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-882_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-882	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	460	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-883_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-883	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	510	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-884_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-884	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	520	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-885_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-885	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	530	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-886_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-886	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	540	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58411-887_ae944c08-6133-4cf1-88a9-62db3247e5e9	58411-887	HUMAN OTC DRUG	SHISEIDO REVITALESSENCE SKIN GLOW FOUNDATION	550	OCTINOXATE	EMULSION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	SHISEIDO AMERICAS CORPORATION	OCTINOXATE	2.30805	g/30mL			N	20241231
58414-0017_54b2fd4f-faf2-4ff1-adde-effab0a5ea1e	58414-0017	HUMAN OTC DRUG	Exuviance Daily Acne Peel		SALICYLIC ACID	LIQUID	TOPICAL	20180615		OTC MONOGRAPH FINAL	part333D	NeoStrata Company Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
58414-0018_8bfc85eb-2bbe-465f-8d79-b78ad2bd3cdb	58414-0018	HUMAN OTC DRUG	NeoStrata Sheer Physical Protection	Sunscreen Broad Spectrum SPF 50	Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20180901		OTC MONOGRAPH NOT FINAL	part352	NeoStrata Company Inc.	TITANIUM DIOXIDE; ZINC OXIDE	70; 60	mg/mL; mg/mL			N	20241231
58414-0019_3996c3ce-e34e-42fe-b480-57b83d7c2bda	58414-0019	HUMAN OTC DRUG	NeoStrata Enlighten Skin Brightener	with Sunscreen Broad Spectrum SPF 35	Octinoxate, Octisalate, and Avobenzone	CREAM	TOPICAL	20181201		OTC MONOGRAPH NOT FINAL	part352	NeoStrata Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/g; mg/g; mg/g			N	20241231
58414-0020_6de11366-745c-404c-88a8-596ae9581174	58414-0020	HUMAN OTC DRUG	NeoStrata Sheer Hydration	Sunscreen Broad Spectrum SPF 40	Octinoxate, Octisalate, and Avobenzone	LOTION	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part352	NeoStrata Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/mL; mg/mL; mg/mL			N	20241231
58414-0023_7de9a932-3111-4401-988f-476a94ac715e	58414-0023	HUMAN OTC DRUG	Exuviance Age Reverse Day Repair	with Sunscreen Broad Spectrum SPF 30	avobenzone, octinoxate, and octisalate	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	NeoStrata Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/g; mg/g; mg/g			N	20241231
58414-0024_05313c50-e29a-47eb-bb9a-7cb723132963	58414-0024	HUMAN OTC DRUG	Exuviance Daily Corrector	with Sunsreen Broad Spectrum SPF 35	Octinoxate, Octisalate, and Avobenzone	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	NeoStrata Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/g; mg/g; mg/g			N	20241231
58414-0025_86cc7e4a-300e-4f6b-ae14-9a99ce9622b3	58414-0025	HUMAN OTC DRUG	Exuviance Skin Caring BB Fluid	with Sunscreen Broad Spectrum SPF 50	Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	NeoStrata Company Inc.	TITANIUM DIOXIDE; ZINC OXIDE	70; 60	mg/mL; mg/mL			N	20241231
58414-3042_487cca3c-16e3-41c8-a990-d25d4a0740d6	58414-3042	HUMAN OTC DRUG	NeoStrata Skin Active Matrix Support	SPF 30	AVOBENZONE, OCTINOXATE, and OCTISALATE	CREAM	TOPICAL	20130718		OTC MONOGRAPH NOT FINAL	part352	NeoStrata Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/g; mg/g; mg/g			N	20241231
58418-002_02873842-0389-a582-e063-6394a90a3e20	58418-002	HUMAN OTC DRUG	2000DL-CL30		promo spf30	LOTION	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part352	Tropical Enterprises International, Inc.	AVOBENZONE; OCTOCRYLENE	.9; 2.34	g/30mL; g/30mL			N	20241231
58418-003_02488abf-ed5b-4fe5-e063-6294a90a90ef	58418-003	HUMAN OTC DRUG	2000DL-CL30V		SPF30 BS vanilla	LOTION	TOPICAL	20231001		OTC MONOGRAPH NOT FINAL	part352	Tropical Enterprises International, Inc.	AVOBENZONE; OCTOCRYLENE	.9; 2.34	g/30mL; g/30mL			N	20241231
58418-004_0286fa54-d7cb-a08b-e063-6294a90aaa86	58418-004	HUMAN OTC DRUG	2000DL-CL30T		SPF30 BS Tropical	LOTION	TOPICAL	20231001		OTC MONOGRAPH NOT FINAL	part352	Tropical Enterprises International, Inc.	AVOBENZONE; OCTOCRYLENE	.9; 2.34	g/30mL; g/30mL			N	20241231
58418-821_0325924c-47ac-bfc2-e063-6294a90a5905	58418-821	HUMAN OTC DRUG	Arctiva Eczema Cream		Eczema Cream	CREAM	TOPICAL	20230201		OTC MONOGRAPH FINAL	M016	Tropical. Enterprises International, Inc.	OATMEAL	1	g/130mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58418-822_024d6559-f7d0-f243-e063-6294a90a8cdc	58418-822	HUMAN OTC DRUG	Arctiva Psoriasis Cream		Psoriasis Cream	CREAM	TOPICAL	20230201		OTC MONOGRAPH FINAL	M032	Tropical Enterprises International, Inc.	SALICYLIC ACID	2.6	g/130mL			N	20241231
58418-827_0249cfdf-b7c5-f27d-e063-6294a90aaa26	58418-827	HUMAN OTC DRUG	Therapain Plus		menthol roll-on	LIQUID	TOPICAL	20230825		OTC MONOGRAPH FINAL	M015	Tropical Enterprises International, Inc.	MENTHOL	2	g/100mL			N	20241231
58443-0123_aa8122dd-0266-12aa-e053-2a95a90aaf8e	58443-0123	HUMAN OTC DRUG	Lidocaine Plus	Maximum Strength Pain Relieving Cream	Lidocaine Hydrochloride	CREAM	TOPICAL	20070302		OTC MONOGRAPH NOT FINAL	part348	Prime Enterprises Inc.	LIDOCAINE HYDROCHLORIDE	39.2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58443-0194_9c59cd3a-9b28-731b-e053-2995a90aa963	58443-0194	HUMAN OTC DRUG	Lifecell	BROAD SPECTRUM SPF 50 BB SHEER	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20151005		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 27.5; 20	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0240_ca90a053-663f-b8d7-e053-2a95a90aa534	58443-0240	HUMAN OTC DRUG	United Spirit of America	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20160811		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	44.6; 39.6	mg/mL; mg/mL			N	20241231
58443-0249_cf6c0659-992b-f49f-e053-2a95a90a9795	58443-0249	HUMAN OTC DRUG	H Plus Holdings	Nourishing	Salicylic Acid	RINSE	TOPICAL	20190613		OTC MONOGRAPH FINAL	part358H	Prime Enterprises	SALICYLIC ACID	17.575	mg/mL			N	20241231
58443-0251_e77a87ff-f90a-cb12-e053-2995a90aba11	58443-0251	HUMAN OTC DRUG	Australian Gold	SPF 50 Sunscreen with Instant Bronzer	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20171011	20240430	OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.73; 99.1; 49.55; 27.25	mg/mL; mg/mL; mg/mL; mg/mL			N	
58443-0258_0e9ae860-2165-dfc5-e063-6394a90aaac9	58443-0258	HUMAN OTC DRUG	Warrior	Broad Spectrum SPF 30 Sunscreen Minerals Formula	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180305	20250331	OTC MONOGRAPH DRUG	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	36.33; 31.14	mg/mL; mg/mL			N	
58443-0265_b8a590bb-c01a-9ed9-e053-2a95a90af8c8	58443-0265	HUMAN OTC DRUG	Australian Gold	Botanicals Sunscreen 70 Minerals	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20181029		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	43.604; 49.55	mg/mL; mg/mL			N	20241231
58443-0268_e9b8a309-86f9-852d-e053-2a95a90add1a	58443-0268	HUMAN OTC DRUG	Performance Brands Steel Releaf	Pain Relieving Liquid	Lidocaine Hydrochloride, Menthol	LIQUID	TOPICAL	20190702	20241031	OTC MONOGRAPH NOT FINAL	part348	Prime Enterprises, Inc.	LIDOCAINE; MENTHOL	38; 9.5	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
58443-0270_b8b6216d-f913-1893-e053-2a95a90a73a5	58443-0270	HUMAN OTC DRUG	Australian Gold	Instant Bronzer 30 sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20191031		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.63; 76.575; 51.05; 51.05	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0274_b8b6d1a7-c07d-bdd8-e053-2995a90a6e2f	58443-0274	HUMAN OTC DRUG	Australian Gold	SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191031		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.7; 74.25; 49.5; 49.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0276_b8b8c415-f9bf-f75f-e053-2995a90ac393	58443-0276	HUMAN OTC DRUG	Australian Gold	SPF 15 Sunscreen	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191031		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	19.6; 49; 19.6	mg/mL; mg/mL; mg/mL			N	20241231
58443-0278_a446bdf8-0cbc-5c9b-e053-2995a90a7fe7	58443-0278	HUMAN OTC DRUG	Australian Gold	Instant Bronzer Broad Spectrum SPF 4 Sunscreen	Avobenzone, and Octocrylene	SPRAY	TOPICAL	20191016		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTOCRYLENE	10; 10	mg/mL; mg/mL			N	20241231
58443-0279_b8b8fb0c-75d7-2a5b-e053-2995a90af9c4	58443-0279	HUMAN OTC DRUG	Australian Gold	Instant Bronzer SPF 8 Sunscreen	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191031		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	9.35; 28.05; 18.7	mg/mL; mg/mL; mg/mL			N	20241231
58443-0281_b8ba7ebc-95c2-4b24-e053-2995a90a09cb	58443-0281	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190206		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.55; 73.875; 49.25; 49.25	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0282_b8bac567-efd1-b397-e053-2995a90a2544	58443-0282	HUMAN OTC DRUG	Panama Jack	SPF 8	Avobenzone, Octocrylene	LOTION	TOPICAL	20190215		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTOCRYLENE	19.68; 19.68	mg/mL; mg/mL			N	20241231
58443-0283_b8c9d28f-a200-b10a-e053-2a95a90a3e19	58443-0283	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 15	Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20190215		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	19.74; 49.35; 19.74	mg/mL; mg/mL; mg/mL			N	20241231
58443-0284_b8c9f57e-dd60-132b-e053-2a95a90a2bef	58443-0284	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190328		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.94; 74.85; 49.9; 49.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0285_b8ca20a6-bd6d-a923-e053-2a95a90a195b	58443-0285	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190328		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.73; 99.1; 49.55; 49.55	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0286_b8ca2c62-7447-4b50-e053-2995a90ab6d2	58443-0286	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 100	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190401		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.97; 149.85; 49.95; 99.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0287_b8cae052-44a3-6256-e053-2995a90a418a	58443-0287	HUMAN OTC DRUG	Panama Jack	SPF 4 Dark Tanning Oil	Octocrylene	OIL	TOPICAL	20190304		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	OCTOCRYLENE	16.72	mg/mL			N	20241231
58443-0288_b8cb255a-416e-b4c0-e053-2a95a90a83e5	58443-0288	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190206		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.67; 98.9; 49.45; 49.45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0289_b8cbb6c4-310a-6c6d-e053-2a95a90a2d9d	58443-0289	HUMAN OTC DRUG	Panama Jack	SPF 4	Octocrylene	LOTION	TOPICAL	20190201		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	OCTOCRYLENE	19.12	mg/mL			N	20241231
58443-0297_a4991831-7dcc-c459-e053-2995a90aff91	58443-0297	HUMAN OTC DRUG	Vibriance	Sunscreen Broad Spectrum SPF 50	Octinoxate, Zinc Oxide	LOTION	TOPICAL	20190923		OTC MONOGRAPH FINAL	part352	Prime Enterprises	OCTINOXATE; ZINC OXIDE	80.475; 96.57	mg/mL; mg/mL			N	20241231
58443-0310_a4d83a92-8172-5a90-e053-2a95a90a8755	58443-0310	HUMAN OTC DRUG	frida	70 Alcohol plus Aloe Hand Sanitizer	Ethyl Alcohol	GEL	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333A	Prime Enterprises	ALCOHOL	70	mL/100mL			N	20241231
58443-0311_a5019be3-5206-7c8e-e053-2995a90a131f	58443-0311	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 15 Sunscreen	Octisalate, Avobenzone, Octocrylene	SPRAY	TOPICAL	20191008		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	19.4; 48.5; 19.4	mg/mL; mg/mL; mg/mL			N	20241231
58443-0312_a5107610-4caf-261c-e053-2a95a90a937f	58443-0312	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 30 Sunscreen	Octisalate, Avobenzone, Octocrylene, Homosalate	SPRAY	TOPICAL	20191030		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.1; 72.75; 48.5; 48.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0313_a5151f4f-2674-40fd-e053-2995a90a5d15	58443-0313	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 15 Sunscreen	Octisalate, Avobenzone, Octocrylene	LOTION	TOPICAL	20191018		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	19.4; 48.5; 19.4	mg/mL; mg/mL; mg/mL			N	20241231
58443-0315_bf520272-03e8-66d1-e053-2a95a90adfd4	58443-0315	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210127		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42.8; 42.8	mg/mL; mg/mL			N	20241231
58443-0317_ca7950f9-0e6a-5014-e053-2995a90a5cc0	58443-0317	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20201201		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	44; 44	mg/mL; mg/mL			N	20241231
58443-0318_e9bada66-834f-fe2d-e053-2a95a90a26ca	58443-0318	HUMAN OTC DRUG	Austalian Gold	SPF 6 Sunscreen LOW PROTECTION	n/a	SPRAY	TOPICAL	20170130		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	9; 7.65; 4.5	mg/mL; mg/mL; mg/mL			N	20241231
58443-0320_a563ad5a-8af8-10c0-e053-2a95a90ab7c7	58443-0320	HUMAN OTC DRUG	Oscar	Anti Perspirant Deodorant	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20151105		OTC MONOGRAPH FINAL	part350	Prime Enterprises, Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	.2	g/g			N	20241231
58443-0323_a5659844-d58a-6245-e053-2a95a90accae	58443-0323	HUMAN OTC DRUG	Ulta Beauty	Broad Spectrum SPF 50 Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20200304		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27.87; 92.9; 46.45; 25.55; 37.16	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0324_a574081b-ad79-3fbd-e053-2a95a90a48b0	58443-0324	HUMAN OTC DRUG	Aloe Up	Broad Spectrum SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20160420		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 35	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0328_a57669ce-c1f0-777b-e053-2a95a90a4bff	58443-0328	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190328		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.73; 99.1; 49.55; 49.55	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0333_a6027c1e-04a2-6eb1-e053-2a95a90a606f	58443-0333	HUMAN OTC DRUG	Austalian Gold	Sensitive Sun protection SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20200619		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.28; 97.6; 48.8; 48.8	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0339_a8739ddd-c228-44e0-e053-2a95a90a9dca	58443-0339	HUMAN OTC DRUG	Eternal Spirit Beauty	SPF 50Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	SPRAY	TOPICAL	20180111		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	26.4; 88; 44; 24.2; 35.2	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0341_adcd123d-edb6-0bc1-e053-2a95a90a5085	58443-0341	HUMAN OTC DRUG	Glad Skin	Eczema Cream	Colloidal Oatmeal	LOTION	TOPICAL	20191206		OTC MONOGRAPH FINAL	part347	Prime Enterprises	OATMEAL	.175	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58443-0364_b11569ac-7f56-df22-e053-2a95a90a94c0	58443-0364	HUMAN OTC DRUG	Everyman Jack	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20200630		OTC MONOGRAPH FINAL	part352	Prime Enterprises	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.94; 99.8; 49.9; 49.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0370_e9a994d7-532a-ae86-e053-2995a90a9a19	58443-0370	HUMAN OTC DRUG	Sky Wellness	Max Pain Relief	Lidocaine Hydrochloride, Menthol	STICK	TOPICAL	20190501	20241231	OTC MONOGRAPH NOT FINAL	part348	Prime Enterprises	LIDOCAINE HYDROCHLORIDE; MENTHOL	38.48; 9.62	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
58443-0374_b259c01f-bafb-713b-e053-2995a90a5e26	58443-0374	HUMAN OTC DRUG	Australian Gold	SPF 70	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201211		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 147; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0375_b592a02c-048f-f4ae-e053-2995a90a7f93	58443-0375	HUMAN OTC DRUG	Australian Gold	SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201210		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.67; 74.18; 49.45; 49.45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0377_b594757c-7855-f918-e053-2995a90a1277	58443-0377	HUMAN OTC DRUG	Australian Gold	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201217		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0381_b83f36ea-4103-2883-e053-2995a90a644f	58443-0381	HUMAN OTC DRUG	Australian Gold	SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191008		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	19.4; 48.5; 19.4	mg/mL; mg/mL; mg/mL			N	20241231
58443-0387_b8a6622d-9ec1-0255-e053-2995a90ae431	58443-0387	HUMAN OTC DRUG	Australian Gold	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20200302		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27.51; 91.7; 45.85; 45.85	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0388_b8e39038-d68d-3c1a-e053-2a95a90ab922	58443-0388	HUMAN OTC DRUG	Warrior	SPF 50	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20201202		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	41; 41	mg/mL; mg/mL			N	20241231
58443-0393_ca54fd0f-2e07-1447-e053-2a95a90ae7ce	58443-0393	HUMAN OTC DRUG	Ulta	SPF 45	Zinc Oxide	POWDER	TOPICAL	20210304		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	ZINC OXIDE	.25	g/g			N	20241231
58443-0394_bf3a962f-13c6-58e2-e053-2995a90ab7f4	58443-0394	HUMAN OTC DRUG	Ulta	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	24.75; 61.88; 41.25; 41.25	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0395_bf3d7e62-90a0-b61e-e053-2a95a90ae846	58443-0395	HUMAN OTC DRUG	Ulta	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20210219		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27.36; 91.2; 45.6; 91.2	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0398_ba85b5fc-338e-d288-e053-2a95a90a03c3	58443-0398	HUMAN OTC DRUG	Black Girl Sunscreen	SPF45	Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20210119		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	23.7; 79; 39.5; 39.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0400_bf4eea4e-3b4a-4212-e053-2a95a90a8ccc	58443-0400	HUMAN OTC DRUG	Hurley	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190130		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0404_bf55077c-9856-a5df-e053-2a95a90a55c0	58443-0404	HUMAN OTC DRUG	Ulta	Broad Spectrum SPF 30	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180316		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	31.5; 31.5	mg/mL; mg/mL			N	20241231
58443-0406_e9ba5865-f2a5-2acb-e053-2a95a90a2757	58443-0406	HUMAN OTC DRUG	Sun Basics	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210526	20240531	OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.31; 97.7; 48.85; 48.85	mg/mL; mg/mL; mg/mL; mg/mL			N	
58443-0407_e9ba7235-a053-4b0d-e053-2a95a90a22f4	58443-0407	HUMAN OTC DRUG	Sun Basics	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210524	20240531	OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.31; 97.7; 48.85; 48.85	mg/mL; mg/mL; mg/mL; mg/mL			N	
58443-0408_ca7c0fba-bf0f-b5e6-e053-2995a90a17d8	58443-0408	HUMAN OTC DRUG	Soft Services	Clearing Mist	Salicylic Acid	SPRAY	TOPICAL	20210701		OTC MONOGRAPH FINAL	part333D	Prime Enterprises, Inc.	SALICYLIC ACID	9.72	mg/mL			N	20241231
58443-0409_c9fee58f-9d14-4ac9-e053-2a95a90a094e	58443-0409	HUMAN OTC DRUG	Australian Gold	SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210713		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.87; 77.175; 51.45; 51.45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0410_ca3e9fde-2ec6-bb05-e053-2a95a90a3951	58443-0410	HUMAN OTC DRUG	Everyman Jack	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20210731		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27; 90; 45; 45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0411_ca6804e4-8982-4004-e053-2995a90a7508	58443-0411	HUMAN OTC DRUG	H Plus Holdings	Nourishing	Hydrocortisone Acetate	SHAMPOO	TOPICAL	20190612		OTC MONOGRAPH NOT FINAL	part348	Prime Enterprises, Inc.	HYDROCORTISONE	10.2	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
58443-0413_ca797172-c042-f8f8-e053-2995a90a5e32	58443-0413	HUMAN OTC DRUG	Eternal Spirit Beauty	Broad Spectrum SPF 30	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20160201		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	31.2; 41.6	mg/mL; mg/mL			N	20241231
58443-0414_ca8eb97a-b04b-4639-e053-2995a90a6ca4	58443-0414	HUMAN OTC DRUG	United Spirit of America	Anti Perspirant Deodorant	Aluminum Chlorohydrate	STICK	TOPICAL	20210617		OTC MONOGRAPH FINAL	part350	Prime Enterprises, Inc.	ALUMINUM CHLOROHYDRATE	290.25	mg/mL			N	20241231
58443-0416_cb7d7894-aafd-382d-e053-2a95a90a716c	58443-0416	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 30 Sunscreen	Octisalate, Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20200310		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.15; 100.5; 50.25; 35.175	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0417_cb96bbbd-bd31-4c59-e053-2a95a90a606a	58443-0417	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 30 Sunscreen	Octisalate, Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20200310		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.15; 100.5; 50.25; 35.175	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0418_cb80ea60-77b1-f427-e053-2a95a90a9ae6	58443-0418	HUMAN OTC DRUG	Bask Suncare	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190122		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.16; 72.9; 48.6; 48.6	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0419_cba4648d-c830-6b21-e053-2995a90a9704	58443-0419	HUMAN OTC DRUG	ALOE UP	Broad Spectrum SPF 30 Sunscreen	Octisalate, Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20200310		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.15; 100.5; 50.25; 35.175	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0421_e77b1ac7-d74e-cd0a-e053-2995a90a31fb	58443-0421	HUMAN OTC DRUG	Lea Black	Broad Spectrum SPF 30 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210601	20240630	OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30.84; 30.84	mg/mL; mg/mL			N	
58443-0422_cc2174fc-0ede-c11a-e053-2a95a90a6984	58443-0422	HUMAN OTC DRUG	DermaSwiss	Broad Spectrum SPF 50 Mineral	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20191120		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42.36; 42.36	mg/mL; mg/mL			N	20241231
58443-0423_cc21dc29-c731-6833-e053-2a95a90a8fc9	58443-0423	HUMAN OTC DRUG	Bask	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190122		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.16; 72.9; 48.6; 48.6	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0424_cc235e7b-b82e-d41e-e053-2995a90ada56	58443-0424	HUMAN OTC DRUG	Unsun	Broad Spectrum SPF 30 Mineral	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20190304		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	31.26; 31.26	mg/mL; mg/mL			N	20241231
58443-0425_cf700dde-1a27-73f1-e053-2a95a90a4fce	58443-0425	HUMAN OTC DRUG	Unsun	Broad Spectrum SPF 30 Mineral	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20211005		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30.51; 30.51	mg/mL; mg/mL			N	20241231
58443-0426_cc313f3a-849e-113b-e053-2995a90a8ba4	58443-0426	HUMAN OTC DRUG	LifeCell	Broad Spectrum SPF 30 Mineral	Octinoxate, Zinc Oxide	CREAM	TOPICAL	20151023		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	OCTINOXATE; ZINC OXIDE	30.03; 30.03	mg/mL; mg/mL			N	20241231
58443-0427_cf6f72b5-f1ec-2822-e053-2a95a90aa6f4	58443-0427	HUMAN OTC DRUG	LifeCell	Broad Spectrum SPF 30 Mineral	Octinoxate, Zinc Oxide	CREAM	TOPICAL	20150808		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	OCTINOXATE; ZINC OXIDE	29.25; 29.25	mg/mL; mg/mL			N	20241231
58443-0428_cc32ebe1-13c4-7f2e-e053-2a95a90a6568	58443-0428	HUMAN OTC DRUG	Duradry	Deodorant stick	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20210119		OTC MONOGRAPH FINAL	part350	Prime Enterprises Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/g			N	20241231
58443-0429_cf7052ed-2f9d-4920-e053-2a95a90ae977	58443-0429	HUMAN OTC DRUG	Duradry	Deodorant stick	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20210104		OTC MONOGRAPH FINAL	part350	Prime Enterprises Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/g			N	20241231
58443-0436_cf44408e-263b-37cd-e053-2995a90a531f	58443-0436	HUMAN OTC DRUG	Infinitek Paris	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20190520		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	41.84; 41.84	mg/mL; mg/mL			N	20241231
58443-0437_021a20ce-df8b-d89b-e063-6394a90a89ef	58443-0437	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.46; 98.2; 49.1; 49.1	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0437_cf45d3d0-cd23-5878-e053-2995a90a14ca	58443-0437	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201211		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.46; 98.2; 49.1; 49.1	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0439_cf6fdc1f-7fb4-2f88-e053-2a95a90aac15	58443-0439	HUMAN OTC DRUG	LifeCell	Broad Spectrum SPF 30 Mineral	Octinoxate, Zinc Oxide	CREAM	TOPICAL	20151023		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	OCTINOXATE; ZINC OXIDE	30.54; 30.54	mg/mL; mg/mL			N	20241231
58443-0452_d2080b57-b80e-4f23-e053-2995a90ad852	58443-0452	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190522		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.89; 72.23; 48.15; 48.15	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0459_d21c4558-5bad-8b3a-e053-2995a90aaef7	58443-0459	HUMAN OTC DRUG	Australian Gold	BROAD SPECTRUM SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201123		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.07; 96.9; 48.45; 48.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0477_d22f1996-2fac-58cd-e053-2995a90af5e2	58443-0477	HUMAN OTC DRUG	Hurley	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20200416		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.37; 73.43; 48.95; 48.95	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0496_d4363f61-773e-b829-e053-2a95a90ab964	58443-0496	HUMAN OTC DRUG	United Spirit of America	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20211228		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	45.5; 39.6	mg/mL; mg/mL			N	20241231
58443-0499_d578e12c-c245-fdd1-e053-2995a90af506	58443-0499	HUMAN OTC DRUG	Abella	Sunscreen Tinted SPF35 Medium	Octinoxate, Zinc Oxide	LOTION	TOPICAL	20210816		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	OCTINOXATE; ZINC OXIDE	30.4; 30.4	mg/mL; mg/mL			N	20241231
58443-0500_d579bb5f-1134-8dc4-e053-2995a90ad033	58443-0500	HUMAN OTC DRUG	Abella	Sunscreen Tinted SPF35 Dark	Octinoxate, Zinc Oxide	LOTION	TOPICAL	20210816		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	OCTINOXATE; ZINC OXIDE	30.3; 30.3	mg/mL; mg/mL			N	20241231
58443-0501_d57aaae6-469b-9597-e053-2995a90a3605	58443-0501	HUMAN OTC DRUG	Australian Gold	SPF 30 Sport Ultra Chill	Octisalate, Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20190703		OTC MONOGRAPH NOT FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.79; 74.48; 49.65; 49.65	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0505_d58c853d-dc26-1e79-e053-2a95a90a3b3e	58443-0505	HUMAN OTC DRUG	Australian Gold	BROAD SPECTRUM SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210608		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.86; 96.2; 48.1; 48.1	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0509_d58e9a2a-afc4-3f27-e053-2a95a90a34ab	58443-0509	HUMAN OTC DRUG	Black Girl Sunscreen	SPF 50 broad Spectrum	Homosalate, Octocrylene, Octisalate, Zinc Oxide	LOTION	TOPICAL	20211124		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0511_e542fa4a-634c-d19a-e053-2a95a90a8861	58443-0511	HUMAN OTC DRUG	Sun Basics	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210423	20240531	OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.95; 72.38; 48.25; 48.25	mg/mL; mg/mL; mg/mL; mg/mL			N	
58443-0512_e5430c99-650d-3637-e053-2a95a90ad9e5	58443-0512	HUMAN OTC DRUG	Sun Basics	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210506	20240531	OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.19; 72.98; 48.65; 48.65	mg/mL; mg/mL; mg/mL; mg/mL			N	
58443-0516_d5c89ddc-516a-51c0-e053-2a95a90aadbf	58443-0516	HUMAN OTC DRUG	Soleil Toujours	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20210727		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	23.94; 59.85; 39.9; 39.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0518_d5c9d527-4d72-662f-e053-2a95a90af07c	58443-0518	HUMAN OTC DRUG	Soleil Toujours	Broad Spectrum SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20160830		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	25.11; 62.78; 41.85	mg/mL; mg/mL; mg/mL			N	20241231
58443-0519_d5cd6565-27ff-4836-e053-2995a90a785f	58443-0519	HUMAN OTC DRUG	Sunshine and Glitter	Broad Spectrum SPF 50 Glamingo Glitter Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211213		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	31; 102; 51; 51	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0520_d5ce3881-40b0-22e8-e053-2a95a90a982f	58443-0520	HUMAN OTC DRUG	Sunshine and Glitter	Broad Spectrum SPF 50 Glamingo Glitter Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211208		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 99; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0521_d5cea478-27fa-6815-e053-2995a90a9f7b	58443-0521	HUMAN OTC DRUG	Sunshine and Glitter	Broad Spectrum SPF 50 Rainbow Glitter Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211215		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 101; 51; 51	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0522_d5cef233-ea63-1e41-e053-2a95a90acea3	58443-0522	HUMAN OTC DRUG	Shamrock Sun	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20191212		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.04; 96.8; 48.4; 48.4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0523_dfc6742d-a5ad-58e2-e053-2a95a90a7ff6	58443-0523	HUMAN OTC DRUG	United Spirit of America	Hand Sanitizer	Ethyl Alcohol	GEL	TOPICAL	20190613		OTC MONOGRAPH NOT FINAL	part333A	Prime Enterprises	ALCOHOL	606.2	mg/mL			N	20241231
58443-0524_d6092993-86f5-8040-e053-2995a90a4a82	58443-0524	HUMAN OTC DRUG	Suntone	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210209		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0525_d60a18ee-c38c-3a69-e053-2a95a90ad5c8	58443-0525	HUMAN OTC DRUG	Suntone	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210209		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0526_d60aa1a6-a75c-7261-e053-2995a90a5f27	58443-0526	HUMAN OTC DRUG	Suntone	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210210		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0527_d6810239-7abb-12ff-e053-2a95a90afc96	58443-0527	HUMAN OTC DRUG	Ulta	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20211228		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	26.25; 87.5; 43.75; 87.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0528_d72270ac-f2cd-33b0-e053-2995a90a564d	58443-0528	HUMAN OTC DRUG	Warrior	Broad Spectrum SPF 50 Sunscreen Minerals Formula	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20211014		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	46.58; 41.4	mg/mL; mg/mL			N	20241231
58443-0529_d72319b6-8979-715a-e053-2a95a90af041	58443-0529	HUMAN OTC DRUG	Australian Gold	Aloe Freeze Gel with Lidocaine	Lidocaine Hydrochloride	GEL	TOPICAL	20151116		OTC MONOGRAPH NOT FINAL	part348	Prime Enterprises, Inc.	LIDOCAINE	4.81	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58443-0530_d72425d3-dfd2-fd5b-e053-2995a90a7b11	58443-0530	HUMAN OTC DRUG	Australian Gold	Botanical Mineral Sunscreen Broad Spectrum SPF 30	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20161012		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30.6; 30.6	mg/mL; mg/mL			N	20241231
58443-0531_d724a94e-0e41-d06e-e053-2a95a90a939b	58443-0531	HUMAN OTC DRUG	Black Girl Sunscreen	Sunscreen SPF 30 broad Spectrum	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20171003		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.24; 100.8; 50.4; 27.72	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0533_d733eea0-13ef-73da-e053-2995a90aad4b	58443-0533	HUMAN OTC DRUG	Duradry	Antiperspirant Deoderant	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20210125		OTC MONOGRAPH FINAL	part350	Prime Enterprises, Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/mL			N	20241231
58443-0534_d734b27c-7b80-79bc-e053-2995a90ab506	58443-0534	HUMAN OTC DRUG	Duradry	Antiperspirant	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20210202		OTC MONOGRAPH FINAL	part350	Prime Enterprises, Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	199	mg/mL			N	20241231
58443-0537_e84146e2-98f1-c75a-e053-2a95a90a05eb	58443-0537	HUMAN OTC DRUG	Sun Basics	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220211		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.04; 96.8; 48.4; 48.4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0538_e6987af9-f1d1-6b30-e053-2995a90a102c	58443-0538	HUMAN OTC DRUG	Sun Basics	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220211		OTC MONOGRAPH FINAL	part352	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.04; 96.8; 48.4; 48.4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0547_d9a2caf8-365e-2044-e053-2a95a90a3e3c	58443-0547	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190328		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.25; 73.13; 48.75; 48.75	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0548_dd2c44c3-9355-2d00-e053-2a95a90ad08d	58443-0548	HUMAN OTC DRUG	Glad Skin	Eczema Cream	Colloidal Oatmeal	LOTION	TOPICAL	20191206		OTC MONOGRAPH FINAL	part347	Prime Enterprises	OATMEAL	.175	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58443-0549_dd2d1459-14b1-3b0a-e053-2a95a90a306b	58443-0549	HUMAN OTC DRUG	Glad Skin	Eczema Cream	Colloidal Oatmeal	LOTION	TOPICAL	20200616		OTC MONOGRAPH FINAL	part347	Prime Enterprises	OATMEAL	.175	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
58443-0550_dd2dc09a-3b66-0dd6-e053-2a95a90abcfb	58443-0550	HUMAN OTC DRUG	Frida Mom	Healing Foam	Salicylic Acid	AEROSOL, FOAM	TOPICAL	20220421		OTC MONOGRAPH FINAL	part346	Prime Enterprises, Inc.	WITCH HAZEL	510	mg/mL			N	20241231
58443-0551_ddcee338-4ea2-60bc-e053-2a95a90a5ca3	58443-0551	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220304		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	41.2; 41.2	mg/mL; mg/mL			N	20241231
58443-0552_ddcfb342-fa0a-9780-e053-2995a90a520c	58443-0552	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220304		OTC MONOGRAPH FINAL	part352	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42.4; 42.4	mg/mL; mg/mL			N	20241231
58443-0554_e65df0f4-667a-6711-e053-2995a90a7161	58443-0554	HUMAN OTC DRUG	Summer Camp Enviro UV	Broad Spectrum SPF 50	Octisalate, Avobenzone, Homosalate	SPRAY	TOPICAL	20220608		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	26; 86; 43	mg/mL; mg/mL; mg/mL			N	20241231
58443-0556_e6708022-9be2-1964-e053-2995a90ae534	58443-0556	HUMAN OTC DRUG	Sun Basics	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220405		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 73.5; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0557_e670daa7-a1ca-8ab3-e053-2a95a90aa17d	58443-0557	HUMAN OTC DRUG	Sun Basics Sport	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220405		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 73.5; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0558_e840fba4-86fc-9da0-e053-2995a90a221a	58443-0558	HUMAN OTC DRUG	Bask	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220609		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 73.5; 49; 49	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0559_e698c716-9293-2f1c-e053-2995a90a0084	58443-0559	HUMAN OTC DRUG	Aloe Up	Broad Spectrum SPF 50 Sunscreen	Octisalate, Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20201103		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.79; 148.95; 49.65; 99.4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0560_e699354b-76d2-53dd-e053-2995a90a8876	58443-0560	HUMAN OTC DRUG	Aloe Up	Broad Spectrum SPF 50 Sunscreen	Octisalate, Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20220601		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.79; 148.95; 49.65; 99.4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0562_e7791c85-8378-6973-e053-2a95a90ad05c	58443-0562	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220720		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	41; 41	mg/mL; mg/mL			N	20241231
58443-0563_e779fc98-9854-25b4-e053-2995a90a3926	58443-0563	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220708		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	41.6; 41.6	mg/mL; mg/mL			N	20241231
58443-0564_e8045126-1af2-9f1b-e053-2995a90a4b58	58443-0564	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220210		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.07; 96.9; 48.45; 48.45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0565_e805102d-0a6f-1476-e053-2995a90a7316	58443-0565	HUMAN OTC DRUG	Panama Jack	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220210		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.07; 96.9; 48.45; 48.45	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0568_e8187941-7f85-5cca-e053-2995a90ae44c	58443-0568	HUMAN OTC DRUG	Australian Gold	Botanical Tinted Face Mineral Sunscreen Broad Spectrum SPF 50	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210127		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	41.4; 41.4	mg/mL; mg/mL			N	20241231
58443-0569_e8191e18-766f-1f76-e053-2a95a90a5649	58443-0569	HUMAN OTC DRUG	ULTA beauty	Broad Spectrum SPF 50 Mineral	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210429		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42.36; 42.36	mg/mL; mg/mL			N	20241231
58443-0571_e81a3ff9-87ea-afed-e053-2995a90a2427	58443-0571	HUMAN OTC DRUG	Sun Bad	Broad Spectrum SPF 50 Mineral	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220713		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42.4; 42.4	mg/mL; mg/mL			N	20241231
58443-0573_e81bb9b4-ea37-8362-e053-2995a90a90c1	58443-0573	HUMAN OTC DRUG	Elizabeth Mott	Face Primer Broad Spectrum SPF 30	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220418		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30.69; 30.69	mg/mL; mg/mL			N	20241231
58443-0574_e81c7081-e8cc-e84d-e053-2995a90a9962	58443-0574	HUMAN OTC DRUG	Goldie Locks	Sheer Mineral Sunscreen Broad Spectrum SPF 30	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220623		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30.78; 30.78	mg/mL; mg/mL			N	20241231
58443-0576_e922be05-48ee-ea35-e053-2a95a90a8ff4	58443-0576	HUMAN OTC DRUG	NF Skin	SPF 30 Broad Spectrum Moisturizer	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220621		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30.9; 30.9	mg/mL; mg/mL			N	20241231
58443-0577_e931b874-c5c1-5b00-e053-2a95a90a5f8d	58443-0577	HUMAN OTC DRUG	Barunu	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220511		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.89; 96.3; 48.15; 48.15	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0579_ed0bac0a-3ce3-6ae7-e053-2995a90ab0cb	58443-0579	HUMAN OTC DRUG	Trump Golf	Broad Spectrum SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220204		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 35	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0580_ed0c223a-d26b-1ab4-e053-2a95a90ad205	58443-0580	HUMAN OTC DRUG	Palm Island	Broad Spectrum SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220412		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 35	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0581_ed0cc0e2-f460-0bc6-e053-2995a90a0fda	58443-0581	HUMAN OTC DRUG	Palm Island	Broad Spectrum SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220412		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 35	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0582_ed10dfda-193c-7f53-e053-2a95a90a72f7	58443-0582	HUMAN OTC DRUG	Palm Island	Broad Spectrum SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220204		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 35	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0583_ed114db5-b63c-6e24-e053-2a95a90a3dbb	58443-0583	HUMAN OTC DRUG	Palm Island	Broad Spectrum SPF 50 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220210		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.51; 152.53; 50.85; 101.7	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0584_ed22ef48-08e7-f4cf-e053-2a95a90a7871	58443-0584	HUMAN OTC DRUG	Palm Island	Broad Spectrum SPF 50 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220210		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.51; 152.53; 50.85; 101.7	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0585_ed23dfff-1d9d-4100-e053-2995a90af487	58443-0585	HUMAN OTC DRUG	Hook Ya	SPF 50 Sport Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220609		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	43.6; 43.6	g/mL; g/mL			N	20241231
58443-0587_ed38972e-2873-1990-e053-2a95a90a44d9	58443-0587	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201211		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.94; 99.8; 49.9; 49.9	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0588_ed9d3eb0-320a-212f-e053-2a95a90a4df4	58443-0588	HUMAN OTC DRUG	Australian Gold	SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20210122		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	19.4; 48.5; 19.4	g/mL; g/mL; g/mL			N	20241231
58443-0590_edc6cfad-2921-733d-e053-2995a90a7b2b	58443-0590	HUMAN OTC DRUG	Sunshine and Glitter	Broad Spectrum SPF 50 Glamingo Glitter Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211208		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.1; 97; 48.5; 48.5	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0591_edfd9a4a-1179-0902-e053-2a95a90ab8d3	58443-0591	HUMAN OTC DRUG	Sunshine and Glitter	Broad Spectrum SPF 50 Glamingo Glitter Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211208		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.04; 96.8; 48.4; 48.4	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0592_edfe5f33-4c24-5580-e053-2a95a90ae638	58443-0592	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20161013		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42.16; 42.16	g/mL; g/mL			N	20241231
58443-0593_ee01026c-006b-f5c4-e053-2995a90adaef	58443-0593	HUMAN OTC DRUG	Australian Gold	Instant Bronzer SPF 8 Sunscreen	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191021		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	9.8; 29.4; 19.6	g/mL; g/mL; g/mL			N	20241231
58443-0598_ee297c73-df43-5589-e053-2a95a90a4a7c	58443-0598	HUMAN OTC DRUG	NO-AD	Broad Spectrum Sport SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211001		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.89; 96.3; 48.15; 48.15	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0599_ee29cd47-4cd0-5b76-e053-2a95a90acc5e	58443-0599	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 50 kids	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210930		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.19; 97.3; 48.65; 48.65	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0600_ee29dc3f-9dc1-5356-e053-2995a90aaaba	58443-0600	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 85	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211017		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.49; 98.3; 49.15; 98.3	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0600_f8ab23e6-9fc9-0f77-e053-6394a90a2365	58443-0600	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 85	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211017		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.49; 98.3; 49.15; 98.3	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0601_ee29e813-fea9-3119-e053-2995a90ae4b2	58443-0601	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210909		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.19; 72.9; 48.6; 48.6	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0601_f8aaf064-0ab0-206c-e053-6294a90a77c7	58443-0601	HUMAN OTC DRUG	NO-AD	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210909		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.19; 72.9; 48.6; 48.6	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0602_f0495e32-5eb7-3336-e053-2995a90aa11f	58443-0602	HUMAN OTC DRUG	Australian Gold	SPF 30 Sport Ultra Chill	Octisalate, Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20191014		OTC MONOGRAPH NOT FINAL	part352	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.79; 74.48; 49.65; 49.65	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0603_f1da0b28-3ff8-49c9-e053-2995a90aa4fa	58443-0603	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 15 Sunscreen	Octisalate, Avobenzone, Octocrylene	LOTION	TOPICAL	20191017		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	20; 50; 20	mg/mL; mg/mL; mg/mL			N	20241231
58443-0604_f1dbb0a6-67b4-41b0-e053-2a95a90a8bec	58443-0604	HUMAN OTC DRUG	Australian Gold	Instant Bronzer 30 sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20191017		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.19; 72.98; 48.65; 48.65	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0605_f1ef6314-42a9-f863-e053-2995a90afe45	58443-0605	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201219		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.55; 98.5; 49.25; 49.25	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0606_f1ff1093-4a3b-6b56-e053-2995a90ada7f	58443-0606	HUMAN OTC DRUG	Black Girl Sunscreen	Sungloss for Lips	Lidocaine Hydrochloride	GEL	TOPICAL	20230110		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	26.7; 40.05; 44.5; 80.1	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0607_f2a2eddf-2fe2-5625-e053-2a95a90aaf80	58443-0607	HUMAN OTC DRUG	NO-AD	Broad Spectrum Sport SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211001		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.89; 96.3; 48.15; 48.15	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0609_f5dab12d-c8d9-6ac3-e053-2995a90aa7d2	58443-0609	HUMAN OTC DRUG	Australian Gold	SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201123		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.09; 75.23; 50.15; 50.15	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0610_f5db63e0-e9f6-ec67-e053-2995a90a6f90	58443-0610	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 4	Avobenzone, Octocrylene	OIL	TOPICAL	20201222		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; OCTOCRYLENE	9; 9	mg/mL; mg/mL			N	20241231
58443-0611_f601d5d1-869e-27cc-e053-2a95a90add2b	58443-0611	HUMAN OTC DRUG	Australian Gold	Broad Spectrum SPF 50 Sunscreen	Octisalate, Avobenzone, Octocrylene, Homosalate	SPRAY	TOPICAL	20171026		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.7; 99.1; 49.6; 49.6	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0612_f605b408-6cf2-2d55-e053-2a95a90a3364	58443-0612	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 30 Sunscreen	Octisalate, Avobenzone, Octocrylene, Homosalate	SPRAY	TOPICAL	20191030		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.8; 75.15; 48; 48	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0613_f60649ca-19a7-8ca8-e053-2a95a90a4cb2	58443-0613	HUMAN OTC DRUG	Australian Gold	SPF 15 Sunscreen	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20191211		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	19.4; 49; 19.4	mg/mL; mg/mL; mg/mL			N	20241231
58443-0614_f65455d7-04a8-6217-e053-2995a90a7c90	58443-0614	HUMAN OTC DRUG	Australian Gold	SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20191214		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.25; 73.13; 48.75; 48.75	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0615_f67b6719-ab93-3fa6-e053-2995a90afa2a	58443-0615	HUMAN OTC DRUG	BASK	Broad Spectrum SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190130		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 99; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0617_f71f5d39-ac40-58ae-e053-6394a90aaf8d	58443-0617	HUMAN OTC DRUG	Australian Gold	Instant Bronzer SPF 4 Sunscreen	Avobenzone, Octocrylene	SPRAY	TOPICAL	20191016		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; OCTOCRYLENE	9.9; 9.9	mg/mL; mg/mL			N	20241231
58443-0618_f75891d8-e875-1502-e053-6394a90a5598	58443-0618	HUMAN OTC DRUG	Austalian Gold	Sensitive Sun protection SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20200204		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.58; 98.6; 49.3; 49.3	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0620_fa2e5b1b-f3a1-11fe-e053-6394a90a4988	58443-0620	HUMAN OTC DRUG	Paulas Choice	Anti-Redness	Salicylic Acid	SPRAY	TOPICAL	20230425		OTC MONOGRAPH FINAL	M006	Prime Enterprises, Inc.	SALICYLIC ACID	20.6	mg/mL			N	20241231
58443-0621_fc5e60f8-32a5-ebe2-e053-6294a90a95c3	58443-0621	HUMAN OTC DRUG	Frida Mom	Healing Foam	Witch Hazel	AEROSOL, FOAM	TOPICAL	20220421		OTC MONOGRAPH FINAL	M015	Prime Enterprises, Inc.	WITCH HAZEL	510	mg/mL			N	20241231
58443-0622_0075b813-93d9-c835-e063-6394a90a884c	58443-0622	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 50 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221209		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	44; 44	mg/mL; mg/mL			N	20241231
58443-0623_00762731-7b5d-b443-e063-6294a90a4335	58443-0623	HUMAN OTC DRUG	Austalian Gold	Broad Spectrum SPF 30 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221214		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30.6; 30.6	mg/mL; mg/mL			N	20241231
58443-0624_00b5909d-4964-86cc-e063-6394a90ab2fa	58443-0624	HUMAN OTC DRUG	Australian Gold	Botanicals Sunscreen 70 Minerals	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230717		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	43.82; 49.8	mg/mL; mg/mL			N	20241231
58443-0625_00c45ba8-b933-f7b0-e063-6394a90affd0	58443-0625	HUMAN OTC DRUG	Black Girl Sunscreen	SPF 50 broad Spectrum	Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20190422		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	28.77; 143.85; 47.95	mg/mL; mg/mL; mg/mL			N	20241231
58443-0626_00d7fdf5-f07b-e036-e063-6294a90ae19a	58443-0626	HUMAN OTC DRUG	Australian Gold Face Stick	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20230718		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28; 92; 46; 46	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0627_00d88975-4cf9-898b-e063-6394a90adf85	58443-0627	HUMAN OTC DRUG	BeYou	Broad Spectrum SPF 40 Sunscreen	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230519		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42; 42	mg/mL; mg/mL			N	20241231
58443-0628_020c2762-5251-57dc-e063-6294a90a1867	58443-0628	HUMAN OTC DRUG	United Spirit	Sunscreen Broad Spectrum SPF 50	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230803		OTC MONOGRAPH FINAL	M020	Prime Enterprises	TITANIUM DIOXIDE; ZINC OXIDE	44.145; 39.24	mg/mL; mg/mL			N	20241231
58443-0629_021990b8-d54c-44c6-e063-6294a90aa8f4	58443-0629	HUMAN OTC DRUG	Black Girl Sunscreen	SPF 45	Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	28.5; 95; 47.5; 95	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0630_0219c8f9-58fd-9fb4-e063-6394a90a2611	58443-0630	HUMAN OTC DRUG	Australian Gold	SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.09; 75.23; 50.15; 50.15	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0631_0219f330-81bd-c67f-e063-6394a90a4da9	58443-0631	HUMAN OTC DRUG	Aloe Up	Broad Spectrum SPF 30 Sunscreen	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 35	g/mL; g/mL; g/mL; g/mL			N	20241231
58443-0632_021a3ae9-d824-faa9-e063-6394a90acbb0	58443-0632	HUMAN OTC DRUG	Black Girl Sunscreen	SPF 50	Octocrylene, Octisalate, Homosalate, Avobenzone	GEL	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	26.7; 40.05; 44.5; 80.1	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0633_021ab50a-2829-3fcd-e063-6294a90a315e	58443-0633	HUMAN OTC DRUG	Australian Gold	Instant Bronzer Broad Spectrum SPF 4 Sunscreen	Avobenzone, Octocrylene	SPRAY	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; OCTOCRYLENE	10; 10	mg/mL; mg/mL			N	20241231
58443-0634_021b08c8-a0f6-fb35-e063-6394a90acf97	58443-0634	HUMAN OTC DRUG	Australian Gold	SPF 30 Sport Ultra Chill	Octisalate, Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.1; 72.75; 48.5; 48.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0635_021b55c0-e2ac-21c5-e063-6394a90a29ef	58443-0635	HUMAN OTC DRUG	United Spirit of America	Anti Perspirant Deodorant	Aluminum Chlorohydrate	STICK	TOPICAL	20230804		OTC MONOGRAPH FINAL	M019	Prime Enterprises, Inc.	ALUMINUM CHLOROHYDRATE	290.25	mg/mL			N	20241231
58443-0636_021ba779-7489-724a-e063-6394a90abe3e	58443-0636	HUMAN OTC DRUG	Black Girl Sunscreen	Sunscreen SPF 30 broad Spectrum	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 26.95	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0637_021c34ef-c334-3a84-e063-6394a90a1ce6	58443-0637	HUMAN OTC DRUG	Black Girl Sunscreen	Sunscreen SPF 30 broad Spectrum	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 26.95	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0638_021c4bae-1808-1267-e063-6294a90abd3e	58443-0638	HUMAN OTC DRUG	Black Girl Sunscreen	Sunscreen SPF 30 broad Spectrum	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 26.95	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0639_021c9663-dedd-b7e1-e063-6394a90a9a2c	58443-0639	HUMAN OTC DRUG	Black Girl Sunscreen	Sunscreen SPF 30 broad Spectrum	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20230804		OTC MONOGRAPH FINAL	M020	Prime Enterprises Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.4; 98; 49; 26.95	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0641_092ba1a1-d2c4-953f-e063-6394a90a9119	58443-0641	HUMAN OTC DRUG	Florida Glow	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210723		OTC MONOGRAPH DRUG	M020	Prime Enterprises, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.3; 101; 50.5; 50.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58443-0642_08f319c4-c745-b995-e063-6294a90a5c3d	58443-0642	HUMAN OTC DRUG	Australian Gold	Instant Bronzer Broad Spectrum SPF 6 Sunscreen	Avobenzone, Octocrylene	SPRAY	TOPICAL	20220318		OTC MONOGRAPH DRUG	M020	Prime Enterprises Inc.	AVOBENZONE; OCTOCRYLENE	10; 10	mg/mL; mg/mL			N	20241231
58443-0643_09056903-7f8d-530f-e063-6294a90a9d57	58443-0643	HUMAN OTC DRUG	Australian Gold	SPF 15	Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20220913		OTC MONOGRAPH DRUG	M020	Prime Enterprises, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	20.02; 50.05; 20.02	g/mL; g/mL; g/mL			N	20241231
58443-0644_0c6759b5-b40b-f424-e063-6394a90ac84f	58443-0644	HUMAN OTC DRUG	Warrior	Broad Spectrum SPF 50 Sunscreen Minerals Formula	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220315		OTC MONOGRAPH DRUG	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	44.46; 41.4	mg/mL; mg/mL			N	20241231
58443-0645_0e9bab6d-ce8c-9405-e063-6294a90a2001	58443-0645	HUMAN OTC DRUG	Warrior	Broad Spectrum SPF 30 Sunscreen Minerals Formula	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Prime Enterprises Inc.	TITANIUM DIOXIDE; ZINC OXIDE	29.7; 29.7	mg/mL; mg/mL			N	20251231
58466-108_09fdb229-f1d1-472d-b46d-cb39336c889e	58466-108	HUMAN OTC DRUG	celazome	Moisturizing SPF 29 Active with DNArescue	OXYBENZONE, OCTINOXATE, OCTISALATE, and HOMOSALATE	CREAM	TOPICAL	20151001		OTC MONOGRAPH FINAL	part352	Dermazone Solutions, Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	50; 75; 50; 60	mg/g; mg/g; mg/g; mg/g			N	20241231
58466-109_358947f9-958b-446a-8acb-0c22117b729d	58466-109	HUMAN OTC DRUG	78 x 36 SPF 30 Active		ZINC OXIDE	CREAM	TOPICAL	20231001		OTC MONOGRAPH NOT FINAL	part352	Dermazone Solutions, Inc.	ZINC OXIDE	.2	g/g			N	20241231
58468-0021_feab8d73-10a8-0b43-e053-6294a90a079f	58468-0021	HUMAN PRESCRIPTION DRUG	Renagel		sevelamer hydrochloride	TABLET, FILM COATED	ORAL	20080606	20240131	NDA	NDA021179	Genzyme Corporation	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
58468-0030_a62de867-ea60-47eb-873a-788223a1181f	58468-0030	HUMAN PRESCRIPTION DRUG	Thyrogen		THYROTROPIN ALFA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	19981130		BLA	BLA020898	Genzyme Corporation	THYROTROPIN ALFA	.9	mg/mL	Thyroid Stimulating Hormone [EPC], Thyrotropin [CS]		N	20241231
58468-0040_3a3c1bad-6f7f-4300-8aa4-b4cfe8d0fc57	58468-0040	HUMAN PRESCRIPTION DRUG	Fabrazyme		AGALSIDASE BETA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20081217		BLA	BLA103979	Genzyme Corporation	AGALSIDASE BETA	5	mg/mL	Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
58468-0041_3a3c1bad-6f7f-4300-8aa4-b4cfe8d0fc57	58468-0041	HUMAN PRESCRIPTION DRUG	Fabrazyme		AGALSIDASE BETA	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20081217		BLA	BLA103979	Genzyme Corporation	AGALSIDASE BETA	5	mg/mL	Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
58468-0050_30470c72-f91b-4074-99d6-3d5e265b1542	58468-0050	HUMAN PRESCRIPTION DRUG	XENPOZYME		olipudase alfa-rpcp	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220829		BLA	BLA761261	Genzyme Corporation	OLIPUDASE ALFA	20	mg/5.1mL			N	20241231
58468-0051_30470c72-f91b-4074-99d6-3d5e265b1542	58468-0051	HUMAN PRESCRIPTION DRUG	XENPOZYME		olipudase alfa-rpcp	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220829		BLA	BLA761261	Genzyme Corporation	OLIPUDASE ALFA	4	mg/1.1mL			N	20241231
58468-0070_edbce68b-32ac-4d60-b0d8-b8f5a1c23815	58468-0070	HUMAN PRESCRIPTION DRUG	ALDURAZYME		laronidase	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20030430		BLA	BLA125058	Genzyme Corporation	LARONIDASE	2.9	mg/5mL	Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
58468-0080_bac1226d-def9-40ff-8d4e-8a07195b1e48	58468-0080	HUMAN PRESCRIPTION DRUG	Thymoglobulin		Anti-thymocyte Globulin (Rabbit)	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19981230		BLA	BLA103869	Genzyme Corporation	LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN	5	mg/mL	Antibody-Surface Protein Interactions [MoA], Immunoglobulin G [EPC], Immunoglobulins [CS], Increased T Lymphocyte Destruction [PE], Lymphocyte Function Alteration [PE]		N	20241231
58468-0123_72a16d8d-b0d8-417b-a4a2-df580a8ac79d	58468-0123	HUMAN PRESCRIPTION DRUG	Hectorol		DOXERCALCIFEROL	INJECTION, SOLUTION	INTRAVENOUS	20081208		NDA	NDA021027	Genzyme Corporation	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
58468-0127_72a16d8d-b0d8-417b-a4a2-df580a8ac79d	58468-0127	HUMAN PRESCRIPTION DRUG	Hectorol		DOXERCALCIFEROL	INJECTION, SOLUTION	INTRAVENOUS	20081208		NDA	NDA021027	Genzyme Corporation	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
58468-0130_0628a5f3-f306-0766-e063-6294a90ab89c	58468-0130	HUMAN PRESCRIPTION DRUG	Renvela		SEVELAMER CARBONATE	TABLET, FILM COATED	ORAL	20090812		NDA	NDA022127	Genzyme Corporation	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58468-0131_0628a5f3-f306-0766-e063-6294a90ab89c	58468-0131	HUMAN PRESCRIPTION DRUG	Renvela		SEVELAMER CARBONATE	POWDER, FOR SUSPENSION	ORAL	20090812		NDA	NDA022318	Genzyme Corporation	SEVELAMER CARBONATE	2400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58468-0132_0628a5f3-f306-0766-e063-6294a90ab89c	58468-0132	HUMAN PRESCRIPTION DRUG	Renvela		SEVELAMER CARBONATE	POWDER, FOR SUSPENSION	ORAL	20090812		NDA	NDA022318	Genzyme Corporation	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58468-0133_0628a5f3-f306-0766-e063-6294a90ab89c	58468-0133	HUMAN PRESCRIPTION DRUG	Renvela		SEVELAMER CARBONATE	TABLET, FILM COATED	ORAL	20090812		NDA	NDA022127	Genzyme Corporation	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58468-0160_52d74849-273f-4e53-a00c-830276743008	58468-0160	HUMAN PRESCRIPTION DRUG	Lumizyme		ALGLUCOSIDASE ALFA	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20100524		BLA	BLA125291	Genzyme Corporation	ALGLUCOSIDASE ALFA	5	mg/mL	Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
58468-0200_afd2b23d-4200-435e-b792-c5bcdb79f353	58468-0200	HUMAN PRESCRIPTION DRUG	LEMTRADA		ALEMTUZUMAB	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20141118		BLA	BLA103948	Genzyme Corporation	ALEMTUZUMAB	12	mg/1.2mL	CD52-directed Antibody Interactions [MoA], CD52-directed Cytolytic Antibody [EPC]		N	20241231
58468-0210_6376f9aa-fb14-4e8d-988a-a9d0bf1a530c	58468-0210	HUMAN PRESCRIPTION DRUG	Aubagio		teriflunomide	TABLET, FILM COATED	ORAL	20130501		NDA	NDA202992	Genzyme Corporation	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20251231
58468-0211_6376f9aa-fb14-4e8d-988a-a9d0bf1a530c	58468-0211	HUMAN PRESCRIPTION DRUG	Aubagio		teriflunomide	TABLET, FILM COATED	ORAL	20130501		NDA	NDA202992	Genzyme Corporation	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20251231
58468-0220_a085dae3-3dab-441e-88ab-ad5b89abebac	58468-0220	HUMAN PRESCRIPTION DRUG	Cerdelga		eliglustat	CAPSULE	ORAL	20140903		NDA	NDA205494	Genzyme Corporation	ELIGLUSTAT	84	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
58468-0225_192903b6-2fd3-4a53-9735-dbfa362840fc	58468-0225	HUMAN PRESCRIPTION DRUG	Cablivi		caplacizumab	KIT		20190206		BLA	BLA761112	Genzyme Corporation						N	20241231
58468-0357_39f22f61-9b1a-4923-a4d5-36ef6bec9fe0	58468-0357	HUMAN PRESCRIPTION DRUG	Campath		ALEMTUZUMAB	INJECTION	INTRAVENOUS	20091130		BLA	BLA103948	Genzyme Corporation	ALEMTUZUMAB	30	mg/mL	CD52-directed Antibody Interactions [MoA], CD52-directed Cytolytic Antibody [EPC]		N	20241231
58468-0426_90cb031c-63cf-4132-aedf-2e55dd989496	58468-0426	HUMAN PRESCRIPTION DRUG	Nexviazyme	ngpt	avalglucosidase alfa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210806		BLA	BLA761194	Genzyme Corporation	AVALGLUCOSIDASE ALFA	100	mg/10mL	Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
58468-4663_9e757e42-8100-4d39-bce5-6fe119534495	58468-4663	HUMAN PRESCRIPTION DRUG	Cerezyme		IMIGLUCERASE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19940523		BLA	BLA020367	Genzyme Corporation	IMIGLUCERASE	40	U/mL	Glucosylceramidase [CS], Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]		N	20241231
58468-7820_3124b7b5-1652-4ca3-9c31-715932a5da7c	58468-7820	HUMAN PRESCRIPTION DRUG	CAPRELSA		Vandetanib	TABLET, FILM COATED	ORAL	20110725		NDA	NDA022405	Genzyme Corporation	VANDETANIB	100	mg/1	Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA]		N	20241231
58468-7840_3124b7b5-1652-4ca3-9c31-715932a5da7c	58468-7840	HUMAN PRESCRIPTION DRUG	CAPRELSA		Vandetanib	TABLET, FILM COATED	ORAL	20110725		NDA	NDA022405	Genzyme Corporation	VANDETANIB	300	mg/1	Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA]		N	20241231
58468-7860_a8442300-a9bd-466b-ae0c-57531cf15820	58468-7860	HUMAN PRESCRIPTION DRUG	CAPRELSA		Vandetanib	TABLET, FILM COATED	ORAL	20220624		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Genzyme Corporation	VANDETANIB	300	mg/1	Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA]		N	20241231
58481-000_0d002df9-0e85-f8be-e063-6394a90a09bc	58481-000	HUMAN OTC DRUG	SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20130624		OTC MONOGRAPH DRUG	M020	Session Savers Sunscreen LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58498-123_f57962e0-c739-d91c-e053-2995a90a0dd6	58498-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070522		UNAPPROVED MEDICAL GAS		Olympic Ambulance Inc. DBA Olympic Oxygen Service	OXYGEN	99	L/100L			N	20241231
58503-001_ed342298-08d5-b0ab-e053-2995a90ad238	58503-001	HUMAN OTC DRUG	2-Pack Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	36.7	mL/59.2mL			N	20241231
58503-002_ed342298-08d6-b0ab-e053-2995a90ad238	58503-002	HUMAN OTC DRUG	Sweet Pea Blossom Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	147	mL/237mL			N	20241231
58503-003_ed3420a9-0274-1b7c-e053-2a95a90afd38	58503-003	HUMAN OTC DRUG	Cucumber Melon Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	147	mL/237mL			N	20241231
58503-004_edb1530c-441e-030c-e053-2a95a90ad662	58503-004	HUMAN OTC DRUG	Warm Vanilla Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	147	mL/237mL			N	20241231
58503-005_edb154ef-b22c-6f3f-e053-2995a90ad389	58503-005	HUMAN OTC DRUG	Hand Sanitizer with Moisturizers		Ethyl Alcohol	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	147	mL/237mL			N	20241231
58503-006_edb151ff-b97a-030a-e053-2a95a90a0981	58503-006	HUMAN OTC DRUG	Hand Sanitizer with Moisturizers	Vitamin E and Aloe	Ethyl Alcohol	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	147	mL/237mL			N	20241231
58503-007_edb156ce-6526-42fa-e053-2a95a90a4057	58503-007	HUMAN OTC DRUG	Ice Cold Topical Analgesic Gel		Menthol	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part348	China Ningbo Shangge Cosmetic Technology Corp.	MENTHOL	2.84	mg/227mg			N	20241231
58503-008_edb1695d-1c92-157f-e053-2a95a90a020e	58503-008	HUMAN OTC DRUG	Hand Cleanse	Refill	Triclosan	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	7.5	mg/500mg			N	20241231
58503-009_edb156ce-6527-42fa-e053-2a95a90a4057	58503-009	HUMAN OTC DRUG	Hand Cleanse		Triclosan	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	7.5	mg/500mg			N	20241231
58503-010_edb1695d-1c93-157f-e053-2a95a90a020e	58503-010	HUMAN OTC DRUG	Hand Cleanse - Ocean Fresh		Triclosan	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	7.5	mg/500mg			N	20241231
58503-011_93f48a33-47da-88bd-e053-2a95a90ae37a	58503-011	HUMAN OTC DRUG	Hand Cleanse - Strawberry Pomegranate		Triclosan	GEL	TOPICAL	20130524		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	7.5	mg/500mg			N	20241231
58503-012_edb1695d-1c94-157f-e053-2a95a90a020e	58503-012	HUMAN OTC DRUG	Instant Hand Sanitizer Aloe Vera		Ethyl Alcohol	GEL	TOPICAL	20130703		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	146	mL/236mL			N	20241231
58503-013_edb170d9-f5ed-83aa-e053-2995a90a162d	58503-013	HUMAN OTC DRUG	Instant Hand Sanitizer - Ice Clear		Ethyl Alcohol	GEL	TOPICAL	20130705		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	37	mL/60mL			N	20241231
58503-014_edb1695d-1c95-157f-e053-2a95a90a020e	58503-014	HUMAN OTC DRUG	Instant Hand Sanitizer - Clear		Ethyl Alcohol	GEL	TOPICAL	20130705		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	147	mL/237mL			N	20241231
58503-015_edb174ce-e890-1579-e053-2a95a90ae75f	58503-015	HUMAN OTC DRUG	Instant Hand Sanitizer - Cocoa Butter		Ethyl Alcohol	GEL	TOPICAL	20130705		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	147	mL/237mL			N	20241231
58503-016_edb1a506-428b-81ae-e053-2a95a90a7532	58503-016	HUMAN OTC DRUG	Liquid Hand Cleanse		Triclosan	GEL	TOPICAL	20130705		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	10	mg/500mg			N	20241231
58503-017_edb1a6e6-d7ff-3e5d-e053-2a95a90a5bda	58503-017	HUMAN OTC DRUG	Instant Hand Sanitizer - Original		Ethyl Alcohol	GEL	TOPICAL	20130705		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	33	mL/53mL			N	20241231
58503-018_edb1a6e6-d800-3e5d-e053-2a95a90a5bda	58503-018	HUMAN OTC DRUG	Instant Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20130705		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	ALCOHOL	6	mL/10mL			N	20241231
58503-019_edb1a506-428c-81ae-e053-2a95a90a7532	58503-019	HUMAN OTC DRUG	XtraCare Antibacterial Hand Cleanse	Fresh Citrus	Triclosan	SOAP	TOPICAL	20130903		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	3.3	mg/221mL			N	20241231
58503-020_edb1ab1c-10a2-2141-e053-2a95a90aad49	58503-020	HUMAN OTC DRUG	XtraCare Antibacterial Hand Cleanse	Mountain Spring	Triclosan	SOAP	TOPICAL	20130903		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	3.3	mg/221mL			N	20241231
58503-021_edb1ab1c-10a3-2141-e053-2a95a90aad49	58503-021	HUMAN OTC DRUG	XtraCare Antibacterial Hand Cleanse	Original	Triclosan	SOAP	TOPICAL	20130903		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	3.3	mg/221mL			N	20241231
58503-022_edb1aeca-c493-81b0-e053-2a95a90a6575	58503-022	HUMAN OTC DRUG	XtraCare Antibacterial Hand Cleanse	Original	Triclosan	SOAP	TOPICAL	20130903		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	.15	g/100mL			N	20241231
58503-023_edb1b0fc-6239-211a-e053-2a95a90aba4a	58503-023	HUMAN OTC DRUG	XtraCare Antibacterial Hand Cleanse	Strawberry Pomegranate	Triclosan	SOAP	TOPICAL	20130830		OTC MONOGRAPH NOT FINAL	part333E	China Ningbo Shangge Cosmetic Technology Corp.	TRICLOSAN	3.3	mg/221mL			N	20241231
58503-024_edb1b2be-e3b7-305d-e053-2995a90aea9a	58503-024	HUMAN OTC DRUG	XtraCare Anti-Dandruff Hair Cleanse	Cocoa and Shea Butter	PYRITHIONE ZINC	SHAMPOO	TOPICAL	20131009		OTC MONOGRAPH FINAL	part358H	China Ningbo Shangge Cosmetic Technology Corp.	PYRITHIONE ZINC	20	mg/400mg			N	20241231
58503-025_edb1b0fc-623b-211a-e053-2a95a90aba4a	58503-025	HUMAN OTC DRUG	XtraCare Anti-Dandruff Conditioner	Coconut and Shea Butter	PYRITHIONE ZINC	LOTION/SHAMPOO	TOPICAL	20131009		OTC MONOGRAPH FINAL	part358H	China Ningbo Shangge Cosmetic Technology Corp.	PYRITHIONE ZINC	20	mg/400mg			N	20241231
58503-026_9261ee35-188f-7431-e053-2995a90a08ed	58503-026	HUMAN OTC DRUG	XtraCare Anti-Dandruff Hair Cleanse	mint and eucalyptus	PYRITHIONE ZINC	SHAMPOO	TOPICAL	20131009		OTC MONOGRAPH FINAL	part358H	China Ningbo Shangge Cosmetic Technology Corp.	PYRITHIONE ZINC	20	mg/400mg			N	20241231
58503-027_9261ee35-189b-7431-e053-2995a90a08ed	58503-027	HUMAN OTC DRUG	XtraCare Anti-Dandruff Conditioner	mint and eucalyptus	PYRITHIONE ZINC	LOTION/SHAMPOO	TOPICAL	20131009		OTC MONOGRAPH FINAL	part358H	China Ningbo Shangge Cosmetic Technology Corp.	PYRITHIONE ZINC	20	mg/400mg			N	20241231
58503-028_92621d0b-5d30-371f-e053-2a95a90aa0be	58503-028	HUMAN OTC DRUG	XtraCare Anti-Dandruff Hair Cleanse	for normal hair	PYRITHIONE ZINC	SHAMPOO	TOPICAL	20131009		OTC MONOGRAPH FINAL	part358H	China Ningbo Shangge Cosmetic Technology Corp.	PYRITHIONE ZINC	20	mg/400mg			N	20241231
58503-029_92621d0b-5d3b-371f-e053-2a95a90aa0be	58503-029	HUMAN OTC DRUG	XtraCare Anti-Dandruff Hair Cleanse	for sensitive hair	PYRITHIONE ZINC	SHAMPOO	TOPICAL	20131009		OTC MONOGRAPH FINAL	part358H	China Ningbo Shangge Cosmetic Technology Corp.	PYRITHIONE ZINC	20	mg/400mg			N	20241231
58503-030_92622d18-2f4e-ae41-e053-2995a90ac4c9	58503-030	HUMAN OTC DRUG	Acne Body Wash		Salicylic Acid	GEL	TOPICAL	20131118		OTC MONOGRAPH FINAL	part333D	China Ningbo Shangge Cosmetic Technology Corp.	SALICYLIC ACID	7	mg/354mg			N	20241231
58503-031_92622d18-2f5b-ae41-e053-2995a90ac4c9	58503-031	HUMAN OTC DRUG	Oil-Free Foaming Acne Wash		Salicylic Acid	GEL	TOPICAL	20131118		OTC MONOGRAPH FINAL	part333D	China Ningbo Shangge Cosmetic Technology Corp,	SALICYLIC ACID	3	g/150g			N	20241231
58503-032_fc1278d8-abb0-3090-e053-6394a90a55de	58503-032	HUMAN OTC DRUG	Oil-Free Foaming Acne Wash	Tea Tree Oil	Salicylic Acid	GEL	TOPICAL	20131120		OTC MONOGRAPH FINAL	part333D	China Ningbo Shangge Cosmetic Technology Corp.	SALICYLIC ACID	3	g/150g			N	20241231
58503-168_06e07266-6482-e7ef-e063-6294a90a9395	58503-168	HUMAN OTC DRUG	SPOT ACNE TREATMENT 0.75OZ		Benzoyl Peroxide	GEL	TOPICAL	20231004		OTC MONOGRAPH DRUG	M006	China Ningbo Shangge Cosmetics Technology Corp.	BENZOYL PEROXIDE	2.5	g/100g			N	20241231
58503-169_074083e0-414f-0ad7-e063-6394a90a6243	58503-169	HUMAN OTC DRUG	PERSISTENT BODY ACNE WASH 8.5OZ		Salicylic Acid	LIQUID	TOPICAL	20231009		OTC MONOGRAPH DRUG	M006	China Ningbo Shangge Cosmetics Technology Corp.	SALICYLIC ACID	1	mg/100mL			N	20241231
58503-170_0baaab8c-1135-394f-e063-6394a90afa07	58503-170	HUMAN OTC DRUG	Diaper Rash Cream 2.5oz		Zinc Oxide	CREAM	TOPICAL	20231204		OTC MONOGRAPH DRUG	M016	China Ningbo Shangge Cosmetics Technology Corp.	ZINC OXIDE	.4	g/g			N	20241231
58518-010_fe8a0337-2934-4350-aa94-ee26d6266fac	58518-010	HUMAN OTC DRUG	Environmental Defense		ZINC OXIDE	CREAM	TOPICAL	20130718		OTC MONOGRAPH NOT FINAL	part352	Avasol LLC	ZINC OXIDE	225	mg/100mL			N	20241231
58518-020_a7732aa0-cfd7-42a1-bfe3-e13fd2d723ba	58518-020	HUMAN OTC DRUG	Surfers Barrier		ZINC OXIDE	STICK	TOPICAL	20130718		OTC MONOGRAPH NOT FINAL	part352	Avasol LLC	ZINC OXIDE	24.5	g/100g			N	20241231
58518-021_c616bbb2-56e9-4a1d-8974-2e20a4aacd98	58518-021	HUMAN OTC DRUG	SURFERS BARRIER SPF 50		ZINC OXIDE, TITANIUM DIOXIDE	STICK	TOPICAL	20200102		OTC MONOGRAPH NOT FINAL	part352	Avasol LLC	TITANIUM DIOXIDE; ZINC OXIDE	6; 24.5	g/100g; g/100g			N	20241231
58518-030_b38abeca-fd41-42ec-a94e-3ec182c37f6b	58518-030	HUMAN OTC DRUG	Pro Formula		ZINC OXIDE, TITANIUM DIOXIDE	STICK	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	Avasol LLC	TITANIUM DIOXIDE; ZINC OXIDE	6; 24.5	g/100g; g/100g			N	20241231
58518-040_6a186274-a41c-485d-8911-7392b853fa64	58518-040	HUMAN OTC DRUG	Barrier Cream		ZINC OXIDE	CREAM	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Avasol LLC	ZINC OXIDE	100	mg/100mL			N	20241231
58552-130_08751c7f-e001-8f9d-e063-6394a90a30af	58552-130	HUMAN OTC DRUG	Giltuss Cough and Cold		Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	SOLUTION	ORAL	20181002		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	15; 300; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-131_0874f27e-12f4-aacf-e063-6294a90acccd	58552-131	HUMAN OTC DRUG	Giltuss Childrens Cough and Cold		Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	SOLUTION	ORAL	20181107		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	7.5; 150; 5	mg/2.5mL; mg/2.5mL; mg/2.5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-132_0875838e-f4f1-86bd-e063-6394a90ad2e3	58552-132	HUMAN OTC DRUG	Giltuss HBP Cough and Chest Congestion		Dextromethorphan hydrobromide, Guaifenesin	SOLUTION	ORAL	20181113		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-133_0874aef0-813f-3a20-e063-6294a90af74e	58552-133	HUMAN OTC DRUG	Giltuss Childrens Cough and Chest Congestion		Dextromethorphan hydrobromide, Guaifenesin	SOLUTION	ORAL	20181002		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-134_08754bfc-ff96-e11e-e063-6394a90a6540	58552-134	HUMAN OTC DRUG	Giltuss Diabetic	Cough and Cold	Dextromethorphan hydrobromide, Guaifenesin	SOLUTION	ORAL	20181017		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-135_08741352-8ee7-1603-e063-6394a90a93a1	58552-135	HUMAN OTC DRUG	Giltuss Bucalsep		Benzocaine, Menthol, Zinc chloride	SPRAY	ORAL; TOPICAL	20180726		OTC MONOGRAPH DRUG	M022	Gil Pharmaceutical Corp	BENZOCAINE; MENTHOL; ZINC CHLORIDE	6.5; .1; .12	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
58552-136_0875a10f-0567-d648-e063-6394a90a99b5	58552-136	HUMAN OTC DRUG	Giltuss MultiSymptom Cold and Flu		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	SOLUTION	ORAL	20181002		OTC MONOGRAPH DRUG	M012	Giltuss Pharmaceutical Corp	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 4; 13; 10	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-137_0874fce4-0e32-ed3b-e063-6294a90adb7a	58552-137	HUMAN OTC DRUG	Giltuss Childrens MultiSymptom Cold and Flu		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	SOLUTION	ORAL	20181002		OTC MONOGRAPH DRUG	M012	Giltuss Pharmaceutical Corp	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 6.5; 5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-138_0873ffa1-295d-4800-e063-6294a90ad366	58552-138	HUMAN OTC DRUG	Giltuss Allergy Plus	Cough and Congestion	CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20181002		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 20; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-139_0874573f-0021-e21a-e063-6394a90affa9	58552-139	HUMAN OTC DRUG	Giltuss Childrens Allergy Plus	Cough and Congestion	CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20181107		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-140_08758be7-7836-412f-e063-6294a90adb7e	58552-140	HUMAN OTC DRUG	Giltuss Honey Cough and Chest Congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20200622		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-141_08738f7b-3446-4076-e063-6294a90ab9d2	58552-141	HUMAN OTC DRUG	Childrens Giltuss Honey Cough and Chest Congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20200622		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-142_0875ab1f-0e03-fd9d-e063-6394a90a6e04	58552-142	HUMAN OTC DRUG	Giltuss Severe Sinus		Oxymetazoline HCl	SPRAY	NASAL	20200728		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
58552-143_087596c9-2fe7-6d04-e063-6294a90a9df4	58552-143	HUMAN OTC DRUG	Giltuss Honey DM Cough		Dextromethorphan HBr	SOLUTION	ORAL	20200622		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-144_0873b36b-c381-9a53-e063-6294a90aee0e	58552-144	HUMAN OTC DRUG	Childrens Giltuss Honey DM Cough		Dextromethorphan HBr	SOLUTION	ORAL	20200622		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-145_08757ae7-755a-793a-e063-6394a90a2b58	58552-145	HUMAN OTC DRUG	Giltuss EX Expectorant		Guaifenesin	SOLUTION	ORAL	20200622		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	GUAIFENESIN	400	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58552-146_0870672d-1a02-f336-e063-6294a90a29bb	58552-146	HUMAN OTC DRUG	Childrens Giltuss EX Expectorant		Guaifenesin	SOLUTION	ORAL	20200622		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	GUAIFENESIN	200	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58552-149_087557b0-9a90-0c55-e063-6394a90a77dd	58552-149	HUMAN OTC DRUG	GILTUSS DIABETIC DM		Dextromethorphan HBr	SOLUTION	ORAL	20230809		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-150_0bbd8b25-8a8e-00dd-e063-6294a90ac1e0	58552-150	HUMAN OTC DRUG	Giltuss DM		Dextromethorphan HBR	SYRUP	ORAL	20230627		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58552-322_0875d715-7070-0155-e063-6294a90a3cec	58552-322	HUMAN OTC DRUG	PHENAGIL		PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE	TABLET	ORAL	20121214		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	3.5; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-331_0876e6b6-0455-ec5b-e063-6394a90abf0e	58552-331	HUMAN OTC DRUG	Giltuss Cough and Cold		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET	ORAL	20210401		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	28; 388; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-332_0877054f-1f52-e585-e063-6294a90a16b3	58552-332	HUMAN OTC DRUG	Giltuss Sinus and Chest Congestion		Guaifenesin, Phenylephrine HCl	TABLET	ORAL	20210401		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	388; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-333_0876f72f-256b-bd5f-e063-6294a90a24f6	58552-333	HUMAN OTC DRUG	Giltuss D Allergy and Congestion		Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20161117		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	3.5; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-334_0876db1e-b8db-cd5a-e063-6394a90ab2b3	58552-334	HUMAN OTC DRUG	Giltuss Allergy Plus		Chlophedianol HCl, Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20210401		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	CHLOPHEDIANOL HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	24; 3.5; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-335_0875bfe3-2938-298f-e063-6394a90a88cd	58552-335	HUMAN OTC DRUG	Giltuss TR		Guaifenesin,Dextromethorphan HBr,Phenylephrine HCl	TABLET	ORAL	20220107		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	29; 390; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-336_0873c8b3-c1b9-6ef0-e063-6394a90aa7f3	58552-336	HUMAN OTC DRUG	Gilphex		Guaifenesin, Phenylephrine HCl	TABLET	ORAL	20220505		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp.	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	390; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58552-337_0875cad9-99b4-4d4f-e063-6394a90a3bbc	58552-337	HUMAN OTC DRUG	PHENAGIL		Chlorpheniramine maleate, Dextromethorphan HBr and Phenylephrine HCL	TABLET	ORAL	20220526		OTC MONOGRAPH DRUG	M012	Gil Pharmaceutical Corp.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	3.5; 29; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58559-002_3c595637-ebd2-43db-b40f-1f5ac2dbe234	58559-002	HUMAN OTC DRUG	Relief Pain Relieving Cream		MENTHOL	CREAM	TOPICAL	20040522		OTC MONOGRAPH DRUG	M017	Corganics, LP	MENTHOL	3	g/100g			N	20241231
58575-183_f51751ff-fab2-aaf1-e053-2995a90a5a8e	58575-183	HUMAN OTC DRUG	Choice	Hand Sanitize	Ethyl Alcohol	GEL	TOPICAL	20200102	20240711	OTC MONOGRAPH NOT FINAL	part333E	Inopak. Ltd	ALCOHOL	70	mL/100mL			N	
58575-406_f51760a8-5f6e-c8cf-e053-2995a90accfa	58575-406	HUMAN OTC DRUG	CharmTex Anti Bacterial		Parachlorometaxylenol	LIQUID	TOPICAL	20180101	20240113	OTC MONOGRAPH NOT FINAL	part333A	Inopak, Ltd.	CHLOROXYLENOL	.3	mg/mL			N	
58575-407_f51767d1-96b9-fd0e-e053-2995a90a2fb0	58575-407	HUMAN OTC DRUG	Choice Liquid Antibacterial		Parachlorometaxylenol	LIQUID	TOPICAL	20180101	20240728	OTC MONOGRAPH NOT FINAL	part333A	Inopak, Ltd.	CHLOROXYLENOL	.3	mg/mL			N	
58575-516_f5177ac5-c749-3703-e053-2995a90a0119	58575-516	HUMAN OTC DRUG	INOFOAM Antibacterial	Foaming Hand Wash	Chloroxylenol	LIQUID	TOPICAL	20210215	20240519	OTC MONOGRAPH NOT FINAL	part333E	Inopak, Ltd	CHLOROXYLENOL	.3	g/100mL			N	
58575-523_f5178976-cb3c-2b26-e053-2995a90aba5f	58575-523	HUMAN OTC DRUG	INODERM Style Antibacterial		Chloroxylenol	LIQUID	TOPICAL	20210420	20240722	OTC MONOGRAPH NOT FINAL	part333E	Inopak, Ltd	CHLOROXYLENOL	.3	g/100mL			N	
58578-0407_0ccd339a-0bf9-4c42-a722-b6c013fa1c44	58578-0407	HUMAN OTC DRUG	CloSYS Silver Healthy Gums		Cetylpyridinium Chloride	LIQUID	ORAL	20230315		OTC MONOGRAPH DRUG	M022	Rowpar Pharmaceuticals, Inc.	CETYLPYRIDINIUM CHLORIDE	.75	g/mL			N	20241231
58578-0517_f8d73290-2f64-490f-a603-efc11de6ccca	58578-0517	HUMAN OTC DRUG	CloSYS Silver Sensitive Mouth Rinse	Fluoride Rinse	Sodium Fluoride	RINSE	ORAL	20230101		OTC MONOGRAPH DRUG	M021	Rowpar Pharmaceuticals, Inc.	SODIUM FLUORIDE	.02	g/100mL			N	20241231
58578-0749_61e8a01e-1781-4d20-8ac6-9b22cd627f2c	58578-0749	HUMAN OTC DRUG	CloSYS		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL; ORAL	20171020		OTC MONOGRAPH DRUG	M021	Rowpar Pharmaceuticals, Inc.	SODIUM FLUORIDE	1.1	mg/g			N	20241231
58578-0759_3632d54e-66b6-4041-994b-0acf89d91cd2	58578-0759	HUMAN OTC DRUG	CloSYS		Sodium fluoride	PASTE, DENTIFRICE	ORAL	20200106		OTC MONOGRAPH DRUG	M021	Rowpar Pharmaceuticals, Inc.	SODIUM FLUORIDE	.916	mg/g			N	20241231
58578-1234_7d0332cd-7e4a-4bd9-ab32-8ca98a2d6e2b	58578-1234	HUMAN OTC DRUG	CloSYS	Fluoride Rinse	Sodium Fluoride	RINSE	ORAL	20160218		OTC MONOGRAPH DRUG	M021	Rowpar Pharmaceuticals, Inc.	SODIUM FLUORIDE	.05	g/100mL			N	20241231
58593-225_4391a66f-77c6-43e1-8399-fc6557dd264c	58593-225	HUMAN OTC DRUG	Rompe Pecho	SF FLU	Dextromethorphan, Brompheniramine Maleate, Phenylephrine Hydrochloride	LIQUID	ORAL	20071001		OTC MONOGRAPH DRUG	M012	Efficient Laboratories Inc	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	10; 10; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58593-235_ea002c0f-7bdb-4781-81a0-cbd755caf4f3	58593-235	HUMAN OTC DRUG	Rompe Pecho	CF	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL	LIQUID	ORAL	20071001		OTC MONOGRAPH DRUG	M012	Efficient Laboratories Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58593-255_fbd30955-dbad-8dce-e053-6394a90ae78f	58593-255	HUMAN OTC DRUG	Cough Out		Guaifenesin	LIQUID	ORAL	19970701		OTC MONOGRAPH FINAL	part341	Efficient Laboratories Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58593-265_4c7ed4f1-8ff3-4917-bb01-79d65c2946e8	58593-265	HUMAN OTC DRUG	Rompe Pecho	SF	Guaifenesin	LIQUID	ORAL	19990301		OTC MONOGRAPH DRUG	M012	Efficient Laboratories, Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58593-275_6c62ace8-13ec-4e50-a43f-677d47c3aba7	58593-275	HUMAN OTC DRUG	Rompe Pecho	DM	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20011001		OTC MONOGRAPH DRUG	M012	Efficient Laboratories Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58593-276_8eec2294-fffd-4129-abe5-253ff5dd334b	58593-276	HUMAN OTC DRUG	Rompe Pechito	DM for Kids	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20230801		OTC MONOGRAPH DRUG	M012	Efficient Laboratories Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 50	mg/2.5mL; mg/2.5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58593-285_d218b760-fd47-049d-e053-2a95a90a1dd2	58593-285	HUMAN OTC DRUG	Hongo Killer		Tolnaftate	AEROSOL, POWDER	TOPICAL	20020301		OTC MONOGRAPH FINAL	part333C	Efficient Laboratories Inc	TOLNAFTATE	.1	g/10g			N	20241231
58593-295_fbd315ee-745c-8fdd-e053-6394a90aab67	58593-295	HUMAN OTC DRUG	Mielim y mas		Dextromethorphan	LIQUID	ORAL	19970201		OTC MONOGRAPH FINAL	part341	Efficient Laboratories Inc.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58593-601_020757af-f371-b1ea-e063-6294a90aedf3	58593-601	HUMAN OTC DRUG	Hongo Killer		undecylenic acid	SPRAY	TOPICAL	20130701		OTC MONOGRAPH FINAL	part333C	Efficient Laboratories Inc	UNDECYLENIC ACID	2	mg/10mL			N	20241231
58593-625_d230435a-3ba8-2a2d-e053-2995a90a2989	58593-625	HUMAN OTC DRUG	Hongo Killer		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20041001		OTC MONOGRAPH FINAL	part333C	Efficient Laboratories Inc	MICONAZOLE NITRATE	.2	g/10g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
58593-780_025a45e6-c192-f848-e063-6394a90a1e29	58593-780	HUMAN OTC DRUG	Finafta		Ethyl Alcohol, Salicylic Acid, Benzocaine	LIQUID	TOPICAL	19911001	20260601	OTC MONOGRAPH NOT FINAL	part356	Efficient Laboratories Inc.	ALCOHOL; BENZOCAINE; SALICYLIC ACID	60; 5; 1	mL/100mL; mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
58593-782_d230102e-3eb7-4ace-e053-2a95a90a5b3c	58593-782	HUMAN OTC DRUG	Finafta	MultiOral	Benzocaine	SPRAY	ORAL	20040901		OTC MONOGRAPH NOT FINAL	part356	Efficient Laboratories Inc.	BENZOCAINE	7.5	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
58593-783_5e9fcd9a-779f-423e-909a-29eb285b8302	58593-783	HUMAN OTC DRUG	Finafta		Benzocaine, Glycerin	LIQUID	TOPICAL	20230915		OTC MONOGRAPH DRUG	M022	Efficient Laboratories Inc.	BENZOCAINE; GLYCERIN	5; 33	mg/100mL; mg/100mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
58593-826_d2302e4d-65d7-9ab6-e053-2a95a90a1465	58593-826	HUMAN OTC DRUG	Hongo Killer		Undecylenic Acid	LIQUID	TOPICAL	20120701		OTC MONOGRAPH FINAL	part333C	Efficient Laboratories Inc	UNDECYLENIC ACID	25	mg/100mL			N	20241231
58593-828_d8516750-8675-4831-a047-2e80477fc4a6	58593-828	HUMAN OTC DRUG	Rompe Pecho Max Multi Symptoms		Acetaminophen, Dextromethophan HBr, Phenylephrine HCl, Guaifenesin	LIQUID	ORAL	20140101		OTC MONOGRAPH DRUG	M012	EFFICIENT LABORATORIES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58593-829_c881ef01-e40d-4844-9e16-7b36176c198d	58593-829	HUMAN OTC DRUG	Rompe Pecho	EX	Guaifenesin	LIQUID	ORAL	20150101		OTC MONOGRAPH DRUG	M012	Efficient Laboratories Inc	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58593-830_9b87dc12-539e-4eba-b1bd-b4767fd0a4f2	58593-830	HUMAN OTC DRUG	Rompe Pecho	Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	LIQUID	ORAL	20190901		OTC MONOGRAPH DRUG	M012	EFFICIENT LABORATORIES INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58596-003_eb0096fe-dcf6-2ac6-e053-2a95a90aa8a1	58596-003	HUMAN OTC DRUG	Mucus Relief Xpect		Guaifensin, Dextromethorphan	TABLET	ORAL	20210517		OTC MONOGRAPH FINAL	M012	Selgel Mxico, S.A. de C.V.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58602-002_8d6fedf1-392e-46fe-990c-364782bbc53d	58602-002	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20210616		ANDA	ANDA209179	Aurohealth LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
58602-003_0e1bcb06-be48-4efc-82e2-516582e02348	58602-003	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20210616		ANDA	ANDA209179	Aurohealth LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-006_62755e3b-8ffa-4e22-85f4-f252ff70ba44	58602-006	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	Aurohealth LLC	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
58602-007_56afd9f1-e262-4e17-8e68-0ef767cd4338	58602-007	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Aurohealth LLC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
58602-008_ad55d9b1-17b3-4a17-a4a3-d95ba2943959	58602-008	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20200813		ANDA	ANDA209179	Aurohealth LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-009_0fabfa45-4924-4b70-aae0-9cc26152a852	58602-009	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	Aurohealth LLC	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
58602-010_5ae3f89c-57dd-4def-adf2-17aa10864b2b	58602-010	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Aurohealth LLC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
58602-012_8fb16daa-340d-45a0-ab22-e028d77e2476	58602-012	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	Aurohealth LLC	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
58602-013_223ca879-71fd-4a04-94d1-ae8aae206948	58602-013	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Aurohealth LLC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
58602-028_56e4d904-4c1b-4af3-b96f-b0cb70ad8d17	58602-028	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride Allergy		Cetirizine Hydrochloride	SOLUTION	ORAL	20150624		ANDA	ANDA090750	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-030_d46defa2-560d-44bb-8b5b-423ab7d32e52	58602-030	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride Hives Relief		Cetirizine Hydrochloride	SOLUTION	ORAL	20150624		ANDA	ANDA090750	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-422_2775dfed-a43a-4ecd-b8ff-e8de3b839a34	58602-422	HUMAN OTC DRUG	Childrens Allergy Relief		Cetirizine Hydrochloride	SOLUTION	ORAL	20100202		ANDA	ANDA090750	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-423_3a36de14-2887-45e9-acc0-608fb1f73157	58602-423	HUMAN OTC DRUG	Loratadine		Loratadine Oral	SOLUTION	ORAL	20180629		ANDA	ANDA208931	Aurohealth LLC	LORATADINE	5	mg/5mL			N	20241231
58602-424_d9672ecf-66fe-4ce6-b4ca-9953a7f63a24	58602-424	HUMAN OTC DRUG	Childrens Allergy Relief		Cetirizine Hydrochloride	SOLUTION	ORAL	20100202		ANDA	ANDA090750	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-426_a75ff860-f7e0-4e19-846b-fbe33e0e1dfd	58602-426	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride Oral	SUSPENSION	ORAL	20230523		ANDA	ANDA213466	Aurohealth LLC	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-444_20de18b2-3201-416c-bf55-eedc5f4bf66b	58602-444	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-445_20de18b2-3201-416c-bf55-eedc5f4bf66b	58602-445	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-446_667df879-9494-4c60-8b28-1cedec09bab0	58602-446	HUMAN OTC DRUG	Cetirizine Hydrochloride (Hives Relief)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-447_667df879-9494-4c60-8b28-1cedec09bab0	58602-447	HUMAN OTC DRUG	Cetirizine Hydrochloride (Hives Relief)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-604_2f4dbc24-881d-4d45-a3b8-17e12f675cfa	58602-604	HUMAN OTC DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230510		ANDA	ANDA204306	Aurohealth LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-605_d550d462-ab7c-4703-9e6d-3b2360abac7d	58602-605	HUMAN OTC DRUG	Alcaftadine		Alcaftadine	SOLUTION/ DROPS	OPHTHALMIC	20230623		ANDA	ANDA210659	Aurohealth LLC	ALCAFTADINE	2.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-606_2f4dbc24-881d-4d45-a3b8-17e12f675cfa	58602-606	HUMAN OTC DRUG	Diclofenac Sodium		Diclofenac sodium	KIT		20230510		ANDA	ANDA204306	Aurohealth LLC						N	20241231
58602-609_2a599579-b2b0-4423-8e30-fe04bf815870	58602-609	HUMAN OTC DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230811		ANDA	ANDA204306	Aurohealth LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-701_0ea6d174-57a9-419a-b16b-40404087d1a8	58602-701	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	20151215		ANDA	ANDA206548	Aurohealth LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
58602-702_94169799-0508-439b-93c5-132b9e6ae767	58602-702	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20180416		ANDA	ANDA208314	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-703_4f6fe4bd-b825-44a1-8264-74c664f76746	58602-703	HUMAN OTC DRUG	Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230308		ANDA	ANDA212409	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-705_eae812ef-42f7-4f61-8b94-fea12e621da0	58602-705	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Aurohealth LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
58602-706_e2591701-c1be-44d3-af95-4c3275b00d5a	58602-706	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Aurohealth LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
58602-708_09bd3935-526d-4ad1-898a-4f0d9499ebb9	58602-708	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20220322		ANDA	ANDA208865	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-712_8723bcba-a23c-4853-98fc-901911ec66c9	58602-712	HUMAN OTC DRUG	Fem Choice morning after		Levonorgestrel	TABLET	ORAL	20220126		ANDA	ANDA206867	Aurohealth LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
58602-713_1100648c-6b9f-49c9-94d0-c40f24fe5c27	58602-713	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20220322		ANDA	ANDA208865	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-714_9a2ece26-41bb-4d24-b45c-114b37885a4e	58602-714	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Aurohealth LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58602-715_4947ad8f-54dd-4ef4-a6b3-78cb24f0e5fb	58602-715	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Aurohealth LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58602-716_1bbefda2-d3c5-4d31-b3ec-7da077e41157	58602-716	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	CAPSULE	ORAL	20220816		ANDA	ANDA209107	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-717_39af6dfa-e822-43a5-bd1a-338cf5da89ce	58602-717	HUMAN OTC DRUG	Diphenhydramine HCl and Ibuprofen		Diphenhydramine HCl and Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20221209		ANDA	ANDA210676	Aurohealth LLC	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-721_d65db291-ef1d-4893-a22a-f29315fc2eb5	58602-721	HUMAN OTC DRUG	Athentia Next		Levonorgestrel	TABLET	ORAL	20151208		ANDA	ANDA206867	Aurohealth LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
58602-722_cfe6fb63-2897-4e76-8288-1389f363b3c4	58602-722	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX MINI	LOZENGE	ORAL	20221103		ANDA	ANDA215357	Aurohealth LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-723_85f05cc6-ae2e-4338-8c1e-c681c2f90858	58602-723	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX MINI	LOZENGE	ORAL	20221103		ANDA	ANDA215357	Aurohealth LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-729_35a88ff7-5830-4d37-bc76-1cce55f61ab1	58602-729	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Aurohealth LLC	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-730_8dc5ff95-f3d6-4b7d-ad77-748dd56aa808	58602-730	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20161109		ANDA	ANDA207229	Aurohealth LLC	ACETAMINOPHEN	650	mg/1			N	20241231
58602-735_bbb2cb82-450d-4de7-8803-06f815926a90	58602-735	HUMAN OTC DRUG	Naproxen Sodium HEADACHE PAIN		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210714		ANDA	ANDA205497	Aurohealth LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-736_2987b63d-f4d2-4def-acb3-e25a1fc231d7	58602-736	HUMAN OTC DRUG	Naproxen Sodium BACK AND MUSCLE PAIN		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210714		ANDA	ANDA205497	Aurohealth LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-737_13a4a083-3e10-423b-b1ec-d95bcc90221e	58602-737	HUMAN OTC DRUG	Naproxen Sodium HEADACHE PAIN		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210714		ANDA	ANDA205497	Aurohealth LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-738_b3527c73-0bda-4a78-846d-eb9b60a64250	58602-738	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20160318		ANDA	ANDA205497	Aurohealth LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-739_1aa74622-ebf8-49b5-b7d6-eb67597eda96	58602-739	HUMAN OTC DRUG	Naproxen Sodium BACK AND MUSCLE PAIN		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210714		ANDA	ANDA205497	Aurohealth LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-744_8f9af970-c068-4d8c-8f90-b32efdd5409a	58602-744	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-745_0b44d6cf-d21e-741a-e063-6294a90a05ff	58602-745	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20210107		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	500	mg/1			N	20241231
58602-746_0b451b78-386d-5ec1-e063-6394a90a79a7	58602-746	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20220218		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	500	mg/1			N	20241231
58602-754_0b463c9c-6ad9-20df-e063-6394a90a427a	58602-754	HUMAN OTC DRUG	Aurophen Regular Strength		Acetaminophen	TABLET	ORAL	20160226		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	325	mg/1			N	20241231
58602-755_0b45d2e0-f876-1f31-e063-6294a90aa24f	58602-755	HUMAN OTC DRUG	Aurophen Extra Strength for Adults		Acetaminophen	TABLET	ORAL	20160226		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	500	mg/1			N	20241231
58602-760_0b448607-8f69-f9b8-e063-6394a90ae841	58602-760	HUMAN OTC DRUG	Acetaminophen and Diphenhydramine hydrochloride		Acetaminophen and Diphenhydramine hydrochloride	TABLET	ORAL	20210105		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-765_0b4657e8-afb1-4401-e063-6394a90ae9e1	58602-765	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	TABLET, CHEWABLE	ORAL	20170913		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	160	mg/1			N	20241231
58602-766_0b4770a7-60d3-f27f-e063-6394a90a16a6	58602-766	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	TABLET, CHEWABLE	ORAL	20170913		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	160	mg/1			N	20241231
58602-768_f9ab5a36-5608-4d0d-9465-bd497382f6bb	58602-768	HUMAN OTC DRUG	DAYTIME COLD AND FLU MULTI-SYMPTOM RELIEF		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE	ORAL	20191231		OTC MONOGRAPH FINAL	part341	Aurohealth LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58602-771_0b45ad4e-d9d9-d463-e063-6294a90a195d	58602-771	HUMAN OTC DRUG	Aurophen Extra Strength for Adults		Acetaminophen	TABLET	ORAL	20200821		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	500	mg/1			N	20241231
58602-773_0b458b7d-7add-0991-e063-6294a90a697d	58602-773	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20211018		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	500	mg/1			N	20241231
58602-774_0b45ff6e-f4aa-ffdd-e063-6394a90ab825	58602-774	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20220618		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	160	mg/1			N	20241231
58602-775_0b4563cf-6c4a-fcd5-e063-6294a90ae597	58602-775	HUMAN OTC DRUG	Acetaminophen Regular Strength		Acetaminophen	TABLET	ORAL	20220202		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	325	mg/1			N	20241231
58602-776_0b4541a6-ce74-d7e6-e063-6294a90aa709	58602-776	HUMAN OTC DRUG	Acetaminophen Extra Strength		Acetaminophen	TABLET	ORAL	20220902		OTC MONOGRAPH DRUG	M013	Aurohealth LLC	ACETAMINOPHEN	500	mg/1			N	20241231
58602-801_19309ddd-73dc-462a-afaa-899834a2d783	58602-801	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20171108		ANDA	ANDA208865	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-802_5e6a6cce-b25c-4d6c-9d58-b4db175c6f8e	58602-802	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20171108		ANDA	ANDA208865	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-803_08c50304-67d6-4733-84e4-5a686afa04f3	58602-803	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine HCl		Ibuprofen and Pseudoephedrine HCl	CAPSULE, LIQUID FILLED	ORAL	20171201		ANDA	ANDA209235	Aurohealth LLC	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-804_5f73d533-1e3b-4e36-8bea-6076b9d0a9b5	58602-804	HUMAN OTC DRUG	Pseudoephedrine HCl		Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20170609		ANDA	ANDA209008	Aurohealth LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-805_3e8f5acd-e6b3-405d-afb3-b94691c522fe	58602-805	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20180409		ANDA	ANDA209017	Aurohealth LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58602-806_926879b5-84de-436c-b0ed-3310c07b8523	58602-806	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	CAPSULE	ORAL	20180720		ANDA	ANDA209107	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-807_b11d0f1c-af6e-4e8b-bc4e-7ea188a69ff2	58602-807	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171030		ANDA	ANDA209116	Aurohealth LLC	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-808_30494d65-a846-4f13-a076-242f193e4651	58602-808	HUMAN OTC DRUG	Cetirizine Hydrochloride (Hives Relief)		Cetirizine Hydrochloride	CAPSULE	ORAL	20180720		ANDA	ANDA209107	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-809_c9272322-ef75-4eab-b92a-bc8ea73340a4	58602-809	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016		ANDA	ANDA209339	Aurohealth LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-810_7fc201de-1528-481d-8aa1-167de18cc828	58602-810	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20191021		ANDA	ANDA210453	Aurohealth LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58602-811_2408f4ab-3a57-426b-98fe-3f5e92b7572b	58602-811	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20191021		ANDA	ANDA210453	Aurohealth LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58602-812_20de18b2-3201-416c-bf55-eedc5f4bf66b	58602-812	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-813_667df879-9494-4c60-8b28-1cedec09bab0	58602-813	HUMAN OTC DRUG	Cetirizine Hydrochloride (Hives Relief)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-814_8cd3b0a3-8a94-4cca-a6a7-f144a826f122	58602-814	HUMAN OTC DRUG	Diphenhydramine HCl and Ibuprofen		Diphenhydramine HCl and Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190214		ANDA	ANDA210676	Aurohealth LLC	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-815_0c5f73ce-0559-4ee3-9e73-a79f6316ce8a	58602-815	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20201214		ANDA	ANDA211059	Aurohealth LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
58602-816_638a9664-4129-46fd-9ba1-d660a7366c9f	58602-816	HUMAN OTC DRUG	Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold		Naproxen Sodium and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220601		ANDA	ANDA211360	Aurohealth LLC	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-817_663a4a3d-c77c-44a8-a082-ee65baf3c6af	58602-817	HUMAN OTC DRUG	ACETAMINOPHEN ASPIRIN AND CAFFEINE		acetaminophen, aspirin and caffeine	TABLET, FILM COATED	ORAL	20220202		ANDA	ANDA211695	Aurohealth LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
58602-818_a057241d-a655-4847-9d2d-d45293f45d87	58602-818	HUMAN OTC DRUG	Loratadine		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20230324		ANDA	ANDA211900	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-819_c1e447e8-3d9f-42b9-8ddc-c2e6b16700a8	58602-819	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA205497	Aurohealth LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-821_7564581a-2a15-4c0e-8ae9-459a760613a9	58602-821	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-822_8c4a0d00-73a8-4ec6-86b8-d96b3f758cdc	58602-822	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016		ANDA	ANDA209339	Aurohealth LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-823_dfb8e997-ede6-41d0-9903-a17879b9f021	58602-823	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-824_981430ca-ddfa-4f5c-9293-f981c28b68f4	58602-824	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Aurohealth LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58602-825_bfc6c45a-a92e-4726-90be-d3eff00ce1d4	58602-825	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Aurohealth LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58602-826_e4613912-d989-455e-8d1b-6c63bdb731ea	58602-826	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Aurohealth LLC	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-828_1ad81b32-80e7-438c-a998-f22c7bd94448	58602-828	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Aurohealth LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
58602-829_2c754c84-0a16-4a5c-8ba7-9abbb780eeb4	58602-829	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Aurohealth LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
58602-830_5c099ee7-0679-45af-ac3d-d8e77d12e809	58602-830	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-831_de409efa-eff4-47fb-a6c6-a22be0587553	58602-831	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20180416		ANDA	ANDA208314	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-832_10a8a74b-11d1-490e-87e7-d705fe0e7602	58602-832	HUMAN OTC DRUG	Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache		Naproxen Sodium and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220601		ANDA	ANDA211360	Aurohealth LLC	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-833_a5c30654-6571-4675-85dd-1d3f2e0cd74a	58602-833	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20200325		ANDA	ANDA213203	Aurohealth LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-834_155630ff-fa82-449a-a485-2891c60e25d8	58602-834	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20200325		ANDA	ANDA213203	Aurohealth LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-835_bc65a833-389c-4726-9c08-e10e03ef7bf7	58602-835	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX	LOZENGE	ORAL	20210803		ANDA	ANDA213266	Aurohealth LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-836_83285d4f-3413-49d8-8fd2-f2d7df565f53	58602-836	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX	LOZENGE	ORAL	20210803		ANDA	ANDA213266	Aurohealth LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-837_19097902-a5e6-423a-8569-31c569cd3cdb	58602-837	HUMAN OTC DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20230428		ANDA	ANDA213201	Aurohealth LLC	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-838_d7e91d1f-bab7-4037-935f-78a362ccf789	58602-838	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20200911		ANDA	ANDA213557	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-839_3e30c415-104c-4ce5-ac18-c06575f28b1b	58602-839	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, COATED	ORAL	20230310		ANDA	ANDA213565	Aurohealth LLC	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
58602-840_034bcbad-f57f-4338-a193-7a5aa9f09aa6	58602-840	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	TABLET, DELAYED RELEASE	ORAL	20230712		ANDA	ANDA214473	Aurohealth LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-841_469e25fc-10cd-4ca3-9576-8fd6ae335187	58602-841	HUMAN OTC DRUG	Econ Morning After		Levonorgestrel	TABLET	ORAL	20151208		ANDA	ANDA206867	Aurohealth LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
58602-843_4a614548-3e17-4ead-97d2-634996a5b490	58602-843	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE	ORAL	20200715		ANDA	ANDA207753	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-845_e93e89bf-4540-418c-a12b-bdc6b19fd062	58602-845	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20200516		ANDA	ANDA205497	Aurohealth LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-846_7448a2ff-f69f-4f25-a029-cd881817690a	58602-846	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200516		ANDA	ANDA209339	Aurohealth LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-847_e24be27d-9c5e-4ff5-ae6d-96a6c1b6e710	58602-847	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20200516		ANDA	ANDA208314	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-848_a6d7d03c-376d-44a2-8708-d9f89fc4d3ad	58602-848	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200516		ANDA	ANDA207229	Aurohealth LLC	ACETAMINOPHEN	650	mg/1			N	20241231
58602-849_4527c967-25f5-463f-a07d-655e9149e8b7	58602-849	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20200516		ANDA	ANDA206941	Aurohealth LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58602-850_2b1b9b0d-5109-4a55-b2f7-69c3b13bcd60	58602-850	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200516		ANDA	ANDA206877	Aurohealth LLC	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
58602-852_43c94480-78d1-4a23-91d4-1d49fea72cb7	58602-852	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE	ORAL	20220718		ANDA	ANDA207753	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-853_af251c56-1fce-46a6-bd52-cca3425b96f9	58602-853	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200813		ANDA	ANDA210453	Aurohealth LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58602-854_5102e242-4d27-4b1f-8a65-2b52ba3f2276	58602-854	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX MINI	LOZENGE	ORAL	20220513		ANDA	ANDA215357	Aurohealth LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-855_169c7976-f865-4716-953d-383e435d67c5	58602-855	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX MINI	LOZENGE	ORAL	20220513		ANDA	ANDA215357	Aurohealth LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-856_5dd50c8b-790e-4b8e-829c-3cf2828661b7	58602-856	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20200911		ANDA	ANDA213557	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-858_d0b03d99-477f-4250-ac84-576b1baf2eed	58602-858	HUMAN OTC DRUG	Ibuprofen Minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230914		ANDA	ANDA215777	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-859_f2f76f8d-f875-4087-9a92-1fe36c5d3e44	58602-859	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20210302		ANDA	ANDA206531	Aurohealth LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
58602-860_99f8f81a-d083-48c1-a923-4ed0dfcd989f	58602-860	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20210212		ANDA	ANDA213557	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-862_c6f65c7b-e626-4ef3-910d-03702cac03bf	58602-862	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20210218		ANDA	ANDA213557	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-863_0b6e8c63-a76c-4184-a9cc-9691378c3ee5	58602-863	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	CAPSULE	ORAL	20210312		ANDA	ANDA209107	Aurohealth LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58602-864_c6c563dc-1026-4eb2-8d38-01d9656ded75	58602-864	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210311		ANDA	ANDA210453	Aurohealth LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58602-865_42a46a38-1d5a-4fbe-99a3-8bdb05ed16e2	58602-865	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210311		ANDA	ANDA210453	Aurohealth LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58602-866_64d04085-ea27-4284-b0b6-977c52af1da7	58602-866	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20221019		ANDA	ANDA207229	Aurohealth LLC	ACETAMINOPHEN	650	mg/1			N	20241231
58602-867_21c1f5c5-19fa-4a59-bad3-ea85fd37471b	58602-867	HUMAN OTC DRUG	Ibuprofen and Diphenhydramine Citrate		Ibuprofen and Diphenhydramine Citrate	TABLET, COATED	ORAL	20220531		ANDA	ANDA216204	Aurohealth LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-868_525b4db8-d35b-4d35-84fa-ed4b1f2f8a33	58602-868	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20210224		ANDA	ANDA211059	Aurohealth LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
58602-869_969e77a4-e566-4673-ae7e-f4df5d1d8966	58602-869	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20210224		ANDA	ANDA211059	Aurohealth LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
58602-870_93ebbb23-a9f0-4519-9793-c9056be39f23	58602-870	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	20220322		ANDA	ANDA206548	Aurohealth LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
58602-871_cbe945ca-7eb6-4de5-99cf-ba323a091621	58602-871	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20210224		ANDA	ANDA206941	Aurohealth LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58602-873_92dc61ae-1880-4337-84ea-6eb601b78812	58602-873	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20211227		ANDA	ANDA207229	Aurohealth LLC	ACETAMINOPHEN	650	mg/1			N	20241231
58602-879_e1b49257-d226-457f-8f2d-9a757a65bbcb	58602-879	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE	ORAL	20220906		ANDA	ANDA207753	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-881_a6e04fe7-23d3-47d7-9f18-5c4298fbc28b	58602-881	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20220618		ANDA	ANDA208477	Aurohealth LLC	LORATADINE	10	mg/1			N	20241231
58602-882_20f3adf2-9058-4420-ac3b-1da54420a1d2	58602-882	HUMAN OTC DRUG	ACETAMINOPHEN ASPIRIN AND CAFFEINE		acetaminophen, aspirin and caffeine	TABLET, FILM COATED	ORAL	20220623		ANDA	ANDA211695	Aurohealth LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
58602-887_2c7c5349-06c9-401a-88e9-8f91ddb7f91a	58602-887	HUMAN OTC DRUG	Diphenhydramine HCl and Ibuprofen		Diphenhydramine HCl and Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20220810		ANDA	ANDA210676	Aurohealth LLC	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-891_7bde29a7-b671-463b-8c32-7bdd3eeb7e6d	58602-891	HUMAN OTC DRUG	After Banger		Levonorgestrel	TABLET	ORAL	20230323		ANDA	ANDA206867	Aurohealth LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
58602-892_5ee40793-0121-4b8f-b20d-3178bbe262e2	58602-892	HUMAN OTC DRUG	ITHAPPENZ MORNING AFTER		Levonorgestrel	TABLET	ORAL	20221114		ANDA	ANDA206867	Aurohealth LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
58602-902_f2654aa5-8bb3-4f27-9495-0d31c18bf5f8	58602-902	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE	ORAL	20180629		ANDA	ANDA207753	Aurohealth LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58602-903_dcc0b057-3d5e-4aeb-ac31-478d7a2f47fa	58602-903	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX	LOZENGE	ORAL	20220624		ANDA	ANDA213266	Aurohealth LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-904_810932e0-a982-400a-b43d-b847152f685b	58602-904	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX	LOZENGE	ORAL	20220624		ANDA	ANDA213266	Aurohealth LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-905_56a1c778-fc3b-4848-a7e0-b1e4f0a8fbc2	58602-905	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX	LOZENGE	ORAL	20211029		ANDA	ANDA213266	Aurohealth LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58602-906_cbf094d4-2357-426d-8205-9b59c332854f	58602-906	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX	LOZENGE	ORAL	20211029		ANDA	ANDA213266	Aurohealth LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
58604-214_74de5d5c-4622-48f3-8837-9175cd504915	58604-214	HUMAN PRESCRIPTION DRUG	ADDYI		flibanserin	TABLET, FILM COATED	ORAL	20150818		NDA	NDA022526	Sprout Pharmaceuticals, Inc.	FLIBANSERIN	100	mg/1	P-Glycoprotein Inhibitors [MoA]		N	20241231
58624-5003_fa1d8388-2758-87d2-e053-6294a90ac85d	58624-5003	HUMAN OTC DRUG	Calcium Polycarbophil		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20230412		OTC MONOGRAPH NOT FINAL	part334	SHANDONG XINHUA PHARMACEUTICAL CO., LTD.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
58624-7007_f604b9db-87f1-3a33-e053-2995a90a7560	58624-7007	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220405		ANDA	ANDA207095	Shandong Xinhua Pharmaceutical Co., Ltd.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58624-7008_f6408497-ca24-228f-e053-2995a90ae91d	58624-7008	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220405		ANDA	ANDA207095	Shandong Xinhua Pharmaceutical Co., Ltd.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58624-7009_f604b9db-87f1-3a33-e053-2995a90a7560	58624-7009	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220405		ANDA	ANDA207095	Shandong Xinhua Pharmaceutical Co., Ltd.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58624-7010_f6408497-ca24-228f-e053-2995a90ae91d	58624-7010	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220405		ANDA	ANDA207095	Shandong Xinhua Pharmaceutical Co., Ltd.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58624-7011_f604b9db-87f1-3a33-e053-2995a90a7560	58624-7011	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220405		ANDA	ANDA207095	Shandong Xinhua Pharmaceutical Co., Ltd.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58624-7012_f6408497-ca24-228f-e053-2995a90ae91d	58624-7012	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220405		ANDA	ANDA207095	Shandong Xinhua Pharmaceutical Co., Ltd.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
58632-001_0802129d-1bbb-2371-e063-6394a90aa730	58632-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20050701		NDA	NDA205712	GIBBS WELDING SUPPLY, INC.	OXYGEN	990	mL/L			N	20241231
58632-002_0801f94f-1860-573f-e063-6394a90ad85a	58632-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20050701		NDA	NDA205713	GIBBS WELDING SUPPLY, INC.	NITROGEN	990	mL/L			N	20241231
58632-003_080216bf-b976-8e8d-e063-6294a90ac8de	58632-003	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20201012		NDA	NDA205859	GIBBS WELDING SUPPLY, INC.	AIR	1000	mL/L			N	20241231
58657-118_0c32911a-402d-01d8-e063-6294a90a9a90	58657-118	HUMAN OTC DRUG	Sodium Chloride	Normal Salt	sodium chloride	TABLET	ORAL	20210923		OTC MONOGRAPH DRUG	M018	Method Pharmaceuticals	SODIUM CHLORIDE	1	g/1			N	20241231
58657-120_0c1d07d4-560b-35b0-e063-6294a90acd99	58657-120	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20180725		OTC MONOGRAPH DRUG	M001	Method Pharmaceuticals, LLC	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58657-151_0c1d54d5-6bd4-71c7-e063-6394a90a7ea4	58657-151	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20180209		ANDA	ANDA211064	Method Pharmaceuticals, LLC	FOLIC ACID	1	mg/1			N	20241231
58657-160_0c1dd419-8c73-b9f3-e063-6394a90aebee	58657-160	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SODIUM FLUORIDE	.25	mg/1			N	20241231
58657-161_0c1dd419-8c73-b9f3-e063-6394a90aebee	58657-161	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SODIUM FLUORIDE	.5	mg/1			N	20241231
58657-162_0c1dd419-8c73-b9f3-e063-6394a90aebee	58657-162	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SODIUM FLUORIDE	1	mg/1			N	20241231
58657-163_0c3292fd-db02-4639-e063-6394a90a2f3b	58657-163	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; .25; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
58657-164_0c1d3550-91ee-41e4-e063-6294a90a7d22	58657-164	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; .5; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
58657-165_0c32e4de-2ef0-39ad-e063-6294a90a5bfe	58657-165	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; 1; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
58657-170_0c32fde1-7dac-76c4-e063-6394a90af95f	58657-170	HUMAN PRESCRIPTION DRUG	M-Natal Plus		Vitamin A, Vitamin C, Vitamin D, Vitamin E, Thiamine, Riboflavin, Niacin, Vitamin B6, Folic Acid, Vitamin B12, Calcium, Iron, Zinc, Copper	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		METHOD PHARMACEUTICALS, LLC	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; CALCIUM; COPPER; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE; VITAMIN A; VITAMIN D; ZINC	22; 120; 200; 2; 12; 27; 1; 20; 10; 3; 1.84; 4000; 400; 25	[iU]/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calcium [CS], Calcium [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
58657-322_0c3326d3-6aed-830a-e063-6394a90a2dd5	58657-322	HUMAN PRESCRIPTION DRUG	Sodium Fluoride		Sodium Fluoride	SOLUTION/ DROPS	ORAL	20180815		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
58657-323_0c566022-bdd8-fc5c-e063-6294a90a3cba	58657-323	HUMAN PRESCRIPTION DRUG	Tri-Vite Drops with Fluoride		ASCORBIC ACID, SODIUM FLUORIDE, VITAMIN A and VITAMIN D	SOLUTION	ORAL	20180725		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	ASCORBIC ACID; SODIUM FLUORIDE; VITAMIN A; VITAMIN D	35; .25; 1500; 400	mg/mL; mg/mL; [iU]/mL; [iU]/mL	Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin C [EPC]		N	20241231
58657-324_0c5649e7-f979-76d0-e063-6394a90afbfa	58657-324	HUMAN PRESCRIPTION DRUG	Tri-Vite Drops with Fluoride		ASCORBIC ACID, SODIUM FLUORIDE, VITAMIN A and VITAMIN D	SOLUTION	ORAL	20180725		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	ASCORBIC ACID; SODIUM FLUORIDE; VITAMIN A; VITAMIN D	35; .5; 1500; 400	mg/mL; mg/mL; [iU]/mL; [iU]/mL	Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin C [EPC]		N	20241231
58657-325_0c566022-bddc-fc5c-e063-6294a90a3cba	58657-325	HUMAN PRESCRIPTION DRUG	Multi-Vitamin with Fluoride		VITAMIN A, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL ACETATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, CYANOCOBALAMIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE and SODIUM FLUORIDE	LIQUID	ORAL	20170224		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL SUCCINATE, D-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	5; 35; 400; 2; 8; .4; .6; .25; .5; 1500	[iU]/mL; mg/mL; [iU]/mL; ug/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; [iU]/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Photoabsorption [MoA], Photoenhancer [EPC], Photosensitizing Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
58657-326_0c566d40-6d5f-8dfc-e063-6394a90a00a9	58657-326	HUMAN PRESCRIPTION DRUG	Multi-Vitamin with Fluoride		VITAMIN A, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL ACETATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, CYANOCOBALAMIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE and SODIUM FLUORIDE	LIQUID	ORAL	20170224		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL SUCCINATE, D-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	5; 35; 400; 2; 8; .4; .6; .5; .5; 1500	[iU]/mL; mg/mL; [iU]/mL; ug/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; [iU]/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Photoabsorption [MoA], Photoenhancer [EPC], Photosensitizing Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
58657-327_0c56731e-441a-869a-e063-6394a90a43a3	58657-327	HUMAN PRESCRIPTION DRUG	Multi-Vitamin Drops with Fluoride and Iron		VITAMIN A, ASCORBIC ACID, CHOLECALCIFEROL, ALPHA-TOCOPHEROL ACETATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, Ferrous sulfate and SODIUM FLUORIDE	LIQUID	ORAL	20170224		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL SUCCINATE, D-; ASCORBIC ACID; CHOLECALCIFEROL; FERROUS SULFATE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	5; 35; 400; 10; 8; .4; .6; .25; .5; 1500	[iU]/mL; mg/mL; [iU]/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; [iU]/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Photoabsorption [MoA], Photoenhancer [EPC], Photosensitizing Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
58657-454_0c1cc5ba-7438-062d-e063-6294a90ae544	58657-454	HUMAN PRESCRIPTION DRUG	Me NaPhos MB Hyo 1		Urinary Antiseptic Antispasmodic	TABLET	ORAL	20151201		UNAPPROVED DRUG OTHER		Method Pharmaceuticals	HYOSCYAMINE SULFATE ANHYDROUS; METHENAMINE; METHYLENE BLUE ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.12; 81.6; 10.8; 40.8	mg/1; mg/1; mg/1; mg/1	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
58657-456_0c5695c4-e9ea-03c2-e063-6294a90a0a9d	58657-456	HUMAN PRESCRIPTION DRUG	Uro-MP		Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate	CAPSULE	ORAL	20141201		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS	.12; 118; 10; 36; 40.8	mg/1; mg/1; mg/1; mg/1; mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
58657-468_0c595c30-6eae-a7a3-e063-6394a90afd83	58657-468	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE 10% AND SULFUR 5% Emollient Cream		SODIUM SULFACETAMIDE 10% AND SULFUR 5% Emollient Cream	CREAM	TOPICAL	20220515		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
58657-469_0c59876a-50c2-b56c-e063-6394a90a94a8	58657-469	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 8% and Sulfur 4% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Method Pharmaceuticals	SULFACETAMIDE SODIUM; SULFUR	80; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
58657-471_0c599de8-185c-bd96-e063-6394a90ab7db	58657-471	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10% and Sulfur 2% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Method Pharmaceuticals	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
58657-472_0c59c0f1-3ba6-c948-e063-6394a90a04e6	58657-472	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide and Sulfur		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
58657-473_0c59dadf-cb30-d28e-e063-6394a90ac3a1	58657-473	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9% and Sulfur 4% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Method Pharmaceuticals	SULFACETAMIDE SODIUM; SULFUR	90; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
58657-474_0c59dadf-cb37-d28e-e063-6394a90ac3a1	58657-474	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Method Pharmaceuticals	SULFACETAMIDE SODIUM; SULFUR	90; 45	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
58657-477_0c5a0c6b-b579-dd72-e063-6394a90aa2a4	58657-477	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide		Sodium Sulfacetamide	LIQUID	TOPICAL	20220115		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
58657-478_0c5a0409-72f8-dd9b-e063-6394a90ae6a7	58657-478	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		selenium sulfide	SHAMPOO	TOPICAL	20150601		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	SELENIUM SULFIDE	22.5	mg/mL			N	20241231
58657-487_0c5a32a4-bee3-e8dc-e063-6394a90af072	58657-487	HUMAN PRESCRIPTION DRUG	Urea 40 Percent		Urea	CREAM	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	UREA	400	mg/g			N	20241231
58657-489_099511f4-df00-725f-e063-6294a90a4695	58657-489	HUMAN PRESCRIPTION DRUG	Urea Cream 40 Percent		Urea	CREAM	TOPICAL	20231031		UNAPPROVED DRUG OTHER		Method Pharmaceuticals, LLC	UREA	400	mg/g			N	20241231
58657-500_0c5a0409-72fe-dd9b-e063-6394a90ae6a7	58657-500	HUMAN OTC DRUG	Codeine-Guaifenesin		Codeine Phosphate and Guaifenesin	SOLUTION	ORAL	20140401		OTC MONOGRAPH DRUG	M012	Method Pharmaceuticals, LLC	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
58657-505_0c5adf4a-963a-2810-e063-6394a90aed54	58657-505	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan Hydrobromide		Guaifenesin and Dextromethorphan Hydrobromide	SYRUP	ORAL	20160614		OTC MONOGRAPH DRUG	M012	Method Pharmaceuticals	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58657-509_0c5ad83f-9daa-0349-e063-6394a90aeaca	58657-509	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	LIQUID	ORAL	20160209		OTC MONOGRAPH DRUG	M012	Method Pharmaceuticals, LLC	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58657-518_0c5b3774-cdce-a3f0-e063-6294a90ae079	58657-518	HUMAN OTC DRUG	Senna Syrup		Natural Vegetable Laxative	LIQUID	ORAL	20210928		OTC MONOGRAPH DRUG	M007	Method Pharmaceuticals	SENNOSIDES	8.8	mg/5mL			N	20241231
58657-525_0c5b86f1-c329-510a-e063-6394a90a0b56	58657-525	HUMAN OTC DRUG	M-PAP		Acetaminophen	LIQUID	ORAL	20190801		OTC MONOGRAPH DRUG	M013	Method Pharmaceuticals, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
58657-528_0c5bb478-7c61-4a3d-e063-6294a90a1000	58657-528	HUMAN OTC DRUG	M-Dryl		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20190801		OTC MONOGRAPH DRUG	M012	Method Pharmaceuticals, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58657-602_0c3e9af8-ebf1-f66c-e063-6394a90a23c2	58657-602	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Method Pharmaceuticals, LLC	LABETALOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
58657-603_0c3e9af8-ebf1-f66c-e063-6394a90a23c2	58657-603	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Method Pharmaceuticals, LLC	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
58657-604_0c3e9af8-ebf1-f66c-e063-6394a90a23c2	58657-604	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Method Pharmaceuticals, LLC	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
58657-647_0c3e9e88-d81b-efea-e063-6394a90ade82	58657-647	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Method Pharmaceuticals, LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
58657-648_0c3e9e88-d81b-efea-e063-6394a90ade82	58657-648	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Method Pharmaceuticals, LLC	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
58657-649_0c3e9e88-d81b-efea-e063-6394a90ade82	58657-649	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Method Pharmaceuticals, LLC	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
58657-675_0c46d258-125f-6587-e063-6294a90a716c	58657-675	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	Method Pharmaceuticals, LLC	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
58657-676_0c46d258-125f-6587-e063-6294a90a716c	58657-676	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	Method Pharmaceuticals, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
58657-700_0c1d92a3-1e88-710c-e063-6294a90a6ec0	58657-700	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Method Pharmaceuticals, LLC	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
58657-701_0c1d92a3-1e88-710c-e063-6294a90a6ec0	58657-701	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Method Pharmaceuticals, LLC	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
58657-702_0c1d92a3-1e88-710c-e063-6294a90a6ec0	58657-702	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Method Pharmaceuticals, LLC	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
58657-703_0c1d92a3-1e88-710c-e063-6294a90a6ec0	58657-703	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Method Pharmaceuticals, LLC	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
58657-704_0c1d92a3-1e88-710c-e063-6294a90a6ec0	58657-704	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Method Pharmaceuticals, LLC	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
58657-705_0c1d92a3-1e88-710c-e063-6294a90a6ec0	58657-705	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Method Pharmaceuticals, LLC	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
58657-810_0c17ced8-4a2e-ab5a-e063-6394a90adff7	58657-810	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		PYRIDOSTIGMINE BROMIDE	TABLET	ORAL	20190601		ANDA	ANDA211181	Method Pharmaceuticals, LLC	PYRIDOSTIGMINE BROMIDE	30	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
58668-0961_0c0b153f-1ec8-a0f9-e063-6294a90aefcd	58668-0961	HUMAN OTC DRUG	CLARINS Super Restorative Day Illuminating lifting replenishing BROAD SPECTRUM - SPF 20 - Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	CREAM	TOPICAL	20130729		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins S.A.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 27	mg/mL; mg/mL; mg/mL			N	20241231
58668-1618_0c0b124c-c306-bd43-e063-6294a90aa41f	58668-1618	HUMAN OTC DRUG	CLARINS UV PLUS ANTI-POLLUTION SUNSCREEN MULTI-PROTECTION BROAD SPECTRUM SPF 50 Oil-Free -LIGHT		HOMOSALATE,OCTOCRYLENE,OXYBENZONE,TITANIUM DIOXIDE	CREAM	TOPICAL	20150922		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	HOMOSALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	40; 40; 15; 84	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58668-1619_0c0af59a-cf22-9225-e063-6294a90af080	58668-1619	HUMAN OTC DRUG	Clarins UV PLUS ANTI-POLLUTION B.S. SPF 50, Sunscreen Multi-Protection Tint Medium		HOMOSALATE,OCTOCRYLENE,OXYBENZONE,TITANIUM DIOXIDE	LIQUID	TOPICAL	20150922		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	HOMOSALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	40; 40; 15; 84	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58668-1621_0c0b0ec4-43da-1b1f-e063-6394a90a3d90	58668-1621	HUMAN OTC DRUG	CLARINS UV PLUS ANTI-POLLUTION SUNSCREEN MULTI-PROTECTION BROAD SPECTRUM SPF 50 Oil-Free -DEEP		HOMOSALATE,OCTOCRYLENE,OXYBENZONE,TITANIUM DIOXIDE	CREAM	TOPICAL	20150922		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	HOMOSALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	40; 40; 15; 84	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58668-2951_076d3c5b-8dd9-cf0e-e063-6294a90aa0e7	58668-2951	HUMAN OTC DRUG	CLARINS UV PLUS ANTI-POLLUTION BROAD SPECTRUM SPF 50 NON-TINTED Sunscreen Multi-Protection		HOMOSALATE, OCTOCRYLENE, OXYBENZONE, TITANIUM DIOXIDE	LIQUID	TOPICAL	20140916		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	HOMOSALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	40; 40; 15; 109	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58668-5971_0c83afd6-4227-38ba-e063-6394a90a0fce	58668-5971	HUMAN OTC DRUG	CLARINS - ROLL-ON DEODORANT Aluminum Chlorohydrate - Antiperspirant, long-lasting, Alcohol-free		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20210201		OTC MONOGRAPH DRUG	M019	Laboratoires Clarins	ALUMINUM CHLOROHYDRATE	140	mg/mL			N	20241231
58668-9611_0c0aef9b-7265-0f3d-e063-6394a90aa271	58668-9611	HUMAN OTC DRUG	Multi-Active Jour SPF 20 Broad Spectrum Sunscreen		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	CREAM	TOPICAL	20150924		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 90; 27	mg/mL; mg/mL; mg/mL			N	20241231
58668-9918_0c0b03d9-8b24-12d2-e063-6394a90a92c4	58668-9918	HUMAN OTC DRUG	CLARINS - EXTRA-FIRMING JOUR SPF 15 - Wrinkle, Firming Day all skin types - Broad Spectrum SPF 15 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	CREAM	TOPICAL	20171005		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 90; 65	mg/mL; mg/mL; mg/mL			N	20241231
58668-9920_0c0b153f-1eda-a0f9-e063-6294a90aefcd	58668-9920	HUMAN OTC DRUG	CLARINS - MULTI-INTENSIVE JOUR SUPER RESTORATIVE DAY BROAD SPECTRUM - SPF 15 - SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230401		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58668-9921_0bbf5398-06e7-74fb-e063-6294a90a81c7	58668-9921	HUMAN OTC DRUG	CLARINS BROAD SPECTRUM SPF 50 Dry Touch Facial Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 27; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58668-9922_0bbf07bd-4010-4f2a-e063-6294a90a1ed4	58668-9922	HUMAN OTC DRUG	CLARINS BROAD SPECTRUM SPF 50 Sunscreen Body		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE,	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Laboratoires Clarins	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 100; 75; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
58700-001_0ce4da74-dbb9-1b02-e063-6294a90abdf6	58700-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130327		UNAPPROVED MEDICAL GAS		Texas Medical, Inc.	OXYGEN	99	L/100L			N	20241231
58701-001_0882dc65-a446-daec-e063-6394a90a10ff	58701-001	HUMAN OTC DRUG	First Class Kit		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20130510		OTC MONOGRAPH DRUG	M021	American Airlines, Inc.	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
58701-002_0882fd73-856d-83da-e063-6294a90a8921	58701-002	HUMAN OTC DRUG	Business Class Kit		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20130510		OTC MONOGRAPH DRUG	M021	American Airlines, Inc.	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
58716-433_0c92bf65-23d6-3a92-e063-6294a90a39a7	58716-433	HUMAN PRESCRIPTION DRUG	OBREDON		Hydrocodone Bitartrate and Guaifenesin	SOLUTION	ORAL	20141230		NDA	NDA205474	Sovereign Pharmaceuticals, LLC	GUAIFENESIN; HYDROCODONE BITARTRATE	200; 2.5	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
58722-9093_a9eb2ac9-8294-48ec-81cc-879cdcee2eaa	58722-9093	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19840101		NDA	NDA205865	Triweld Industries, Inc.	OXYGEN	99	L/100L			N	20241231
58722-9094_a9eb2ac9-8294-48ec-81cc-879cdcee2eaa	58722-9094	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19840101		NDA	NDA205865	Triweld Industries, Inc.	OXYGEN	99	L/100L			N	20241231
58733-001_0882dc65-a43b-daec-e063-6394a90a10ff	58733-001	HUMAN OTC DRUG	United Airlines Business Class Kit		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20130510		OTC MONOGRAPH DRUG	M021	United Airlines	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
58790-000_f988872b-5780-457e-ad90-2ba437581e36	58790-000	HUMAN OTC DRUG	TheraTears Lubricant		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	19950101		OTC MONOGRAPH FINAL	part349	MEDTECH PRODUCTS INC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	2.5	mg/mL			N	20241231
58790-001_a536ead7-0286-4223-873b-4129c70a2175	58790-001	HUMAN OTC DRUG	TheraTears Lubricant		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	19990701		OTC MONOGRAPH FINAL	part349	MEDTECH PRODUCTS INC	CARBOXYMETHYLCELLULOSE SODIUM	2.5	mg/mL			N	20241231
58790-002_7fa25608-0b89-4e34-a2d8-1e64b46db208	58790-002	HUMAN OTC DRUG	TheraTears		carboxymethylcellulose sodium	GEL	OPHTHALMIC	20021201		OTC MONOGRAPH FINAL	part349	MEDTECH PRODUCTS INC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	10	mg/mL			N	20241231
58790-003_7fa25608-0b89-4e34-a2d8-1e64b46db208	58790-003	HUMAN OTC DRUG	TheraTears		carboxymethylcellulose sodium	GEL	OPHTHALMIC	20181207		OTC MONOGRAPH FINAL	part349	MEDTECH PRODUCTS INC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	10	mg/mL			N	20241231
58790-007_bdf0c6be-3cf1-43ba-a7ac-c3e8aa02024e	58790-007	HUMAN OTC DRUG	TheraTears Extra		Carboxymethylcellulose Sodium, Unspecified Form	SOLUTION/ DROPS	OPHTHALMIC	20180416		OTC MONOGRAPH FINAL	part349	MEDTECH PRODUCTS INC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	2.5	mg/mL			N	20241231
58790-010_735d60b9-9999-4e46-827c-abf2a2b70401	58790-010	HUMAN OTC DRUG	TheraTears Extra		Carboxymethylcellulose Sodium, Unspecified	SOLUTION/ DROPS	OPHTHALMIC	20210121		OTC MONOGRAPH FINAL	part349	MEDTECH PRODUCTS INC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	2.5	mg/mL			N	20241231
58809-063_f1ed85b7-e565-7344-e053-2a95a90a5eda	58809-063	HUMAN OTC DRUG	TEXACLEAR FAST ACTING ALLERGY RELIEF		Chlophedianol Hydrochloride, Pyrilamine Maleate	LIQUID	ORAL	20141021		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, Inc.	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	25; 50	mg/57mL; mg/57mL			N	20241231
58809-116_0370aa49-e4ba-004c-e063-6294a90ab667	58809-116	HUMAN OTC DRUG	TexaClear Nighttime Sleep-Aid		Diphenhydramine HCl	LIQUID	ORAL	20160615		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
58809-186_0206a352-b87c-2c6f-e063-6394a90a2aaf	58809-186	HUMAN OTC DRUG	TexaClear		Allergy Relief	TABLET	ORAL	20151201		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, INC	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	25; 50	mg/1; mg/1			N	20241231
58809-187_0c040c32-811e-87b0-e063-6294a90a6255	58809-187	HUMAN OTC DRUG	VANACOF XP Cough / Chest Congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20231206		OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	18; 396	mg/15mL; mg/15mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58809-189_0c7c6099-e68f-89e9-e063-6394a90a2b7d	58809-189	HUMAN OTC DRUG	VANACOF CP Allergy / Cough		Chlophedianol HCl, Pyrilamine Maleate	SOLUTION	ORAL	20231206		OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	12.5; 25	mg/15mL; mg/15mL			N	20241231
58809-190_0c7f3f80-b27d-9526-e063-6394a90a7a1c	58809-190	HUMAN OTC DRUG	VanaCof 2		Chlophedianol HCI, Dexchlorpheniramine Maleate	SOLUTION	ORAL	20231214		OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE	12.5; 1	mg/5mL; mg/5mL			N	20241231
58809-198_0e871247-506a-9c91-e063-6394a90a525c	58809-198	HUMAN OTC DRUG	VanaTab DM		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET	ORAL	20170301		OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	9; 198; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
58809-206_0b273fe1-0b64-ec03-e063-6294a90a5ab6	58809-206	HUMAN OTC DRUG	TexaClear Homeopathic Allergy Relief		Over 100 Extracts	SOLUTION/ DROPS	ORAL	20200801	20250101	UNAPPROVED HOMEOPATHIC		GM Pharmaceuticals, INC	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; ALLENROLFEA OCCIDENTALIS POLLEN; ALNUS RHOMBIFOLIA POLLEN; AMARANTHUS HYBRIDUS POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA BIDENTATA POLLEN; AMBROSIA CONFERTIFLORA POLLEN; AMBROSIA DUMOSA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS WHOLE; ATRIPLEX CANESCENS POLLEN; BACCHARIS HALIMIFOLIA WHOLE; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA OCCIDENTALIS WHOLE; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA CORDIFORMIS WHOLE; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; CHENOPODIUM ALBUM POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DACTYLIS GLOMERATA POLLEN; DISTICHLIS SPICATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GUTIERREZIA SAROTHRAE WHOLE; HYDRASTIS CANADENSIS WHOLE; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPER BERRY; JUNIPERUS DEPPEANA WHOLE; JUNIPERUS OSTEOSPERMA POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM LUCIDUM WHOLE; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MELALEUCA QUINQUENERVIA POLLEN; MORUS ALBA WHOLE; MORUS RUBRA POLLEN; MYRRH; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS PONDEROSA POLLEN; PINUS STROBUS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS FREMONTII POLLEN; POPULUS NIGRA POLLEN; QUERCUS ALBA WHOLE; QUERCUS GAMBELII POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS NIGRA POLLEN; QUERCUS RUBRA BARK; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA WHOLE; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALSOLA KALI WHOLE; SECALE CEREALE POLLEN; SOLIDAGO CANADENSIS WHOLE; SORGHUM HALEPENSE POLLEN; TAXODIUM DISTICHUM POLLEN; THUJA OCCIDENTALIS LEAF; THUJA PLICATA LEAF; TRIADICA SEBIFERA WHOLE; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 30; 30; 30; 30; 30; 30; 30; 6; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 30; 30; 30; 6; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	
58809-208_0b2776c0-5061-d382-e063-6294a90a13e2	58809-208	HUMAN OTC DRUG	Texaclear homeopathic Allergy Releif	plus cedar fever	over 100 extracts trees,weeds and grasses	TABLET	ORAL	20201001	20250101	UNAPPROVED HOMEOPATHIC		GM Pharmaceuticals INC	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALLENROLFEA OCCIDENTALIS POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; ALNUS RHOMBIFOLIA POLLEN; AMARANTHUS HYBRIDUS POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA BIDENTATA POLLEN; AMBROSIA CONFERTIFLORA POLLEN; AMBROSIA DUMOSA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA LUDOVICIANA WHOLE; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS WHOLE; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA WHOLE; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA OCCIDENTALIS WHOLE; BROUSSONETIA PAPYRIFERA POLLEN; CARPINUS CAROLINIANA WHOLE; CARYA ALBA POLLEN; CARYA CORDIFORMIS WHOLE; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; CEDRUS DEODARA WOOD; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; DISTICHLIS SPICATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GUTIERREZIA SAROTHRAE WHOLE; HOLCUS LANATUS POLLEN; HYDRASTIS CANADENSIS WHOLE; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUNIPER BERRY; JUNIPERUS ASHEI POLLEN; JUNIPERUS DEPPEANA WHOLE; JUNIPERUS MONOSPERMA POLLEN; JUNIPERUS OSTEOSPERMA POLLEN; JUNIPERUS PINCHOTII POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM LUCIDUM WHOLE; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MELALEUCA QUINQUENERVIA POLLEN; MORUS ALBA WHOLE; MORUS RUBRA POLLEN; MYRRH; OSTRYA VIRGINIANA WHOLE; PASCOPYRUM SMITHII POLLEN; PASPALUM NOTATUM POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS NIGRA POLLEN; PINUS PONDEROSA POLLEN; PINUS STROBUS BARK; PINUS STROBUS POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS FREMONTII POLLEN; POPULUS NIGRA POLLEN; PROSOPIS PALLIDA POLLEN; QUERCUS ALBA WHOLE; QUERCUS GAMBELII POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS NIGRA POLLEN; QUERCUS RUBRA BARK; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA WHOLE; QUERCUS VIRGINIANA POLLEN; RORIPPA NASTURTIUM-AQUATICUM; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SECALE CEREALE POLLEN; SOLIDAGO CANADENSIS WHOLE; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII WHOLE; TAMARIX GALLICA POLLEN; TAXODIUM DISTICHUM POLLEN; THUJA OCCIDENTALIS LEAF; THUJA PLICATA LEAF; TRIGONELLA FOENUM-GRAECUM WHOLE; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS CRASSIFOLIA WHOLE; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	12; 12; 12; 12; 6; 12; 30; 12; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 30; 30; 6; 30; 30; 6; 12; 5; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 30; 6; 6; 6; 5; 6; 12; 6; 12; 12; 12; 30; 6; 5; 30; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 6; 6; 12; 12; 12; 5; 12; 12; 6; 6; 6; 5; 12; 12; 12; 12; 12; 12; 30; 12; 6; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 5; 30; 30; 12; 6; 30; 6; 12; 12; 12; 12; 12; 5; 6; 12; 12; 12; 12; 30; 30; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	
58809-209_0b27559c-882e-b387-e063-6394a90a0a74	58809-209	HUMAN OTC DRUG	TexaClear Homeopathic Allergy Relief	Cedar Fever	Over 100 Extracts	SOLUTION/ DROPS	ORAL	20200831	20250101	UNAPPROVED HOMEOPATHIC		GM Pharmaceuticals, INC	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALLENROLFEA OCCIDENTALIS POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; ALNUS RHOMBIFOLIA POLLEN; AMARANTHUS HYBRIDUS POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA BIDENTATA POLLEN; AMBROSIA CONFERTIFLORA POLLEN; AMBROSIA DUMOSA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA LUDOVICIANA WHOLE; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS WHOLE; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA WHOLE; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA OCCIDENTALIS WHOLE; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARPINUS CAROLINIANA WHOLE; CARYA ALBA POLLEN; CARYA CORDIFORMIS WHOLE; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; CEDRUS DEODARA WOOD; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; DISTICHLIS SPICATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GUTIERREZIA SAROTHRAE WHOLE; HOLCUS LANATUS POLLEN; HYDRASTIS CANADENSIS WHOLE; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPER BERRY; JUNIPERUS ASHEI POLLEN; JUNIPERUS DEPPEANA WHOLE; JUNIPERUS MONOSPERMA POLLEN; JUNIPERUS OSTEOSPERMA POLLEN; JUNIPERUS PINCHOTII POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM LUCIDUM WHOLE; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MELALEUCA QUINQUENERVIA POLLEN; MORUS ALBA WHOLE; MORUS RUBRA POLLEN; MYRRH; OSTRYA VIRGINIANA WHOLE; PASCOPYRUM SMITHII POLLEN; PASPALUM NOTATUM POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS NIGRA POLLEN; PINUS PONDEROSA POLLEN; PINUS STROBUS BARK; PINUS STROBUS POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS FREMONTII POLLEN; POPULUS NIGRA POLLEN; PROSOPIS PALLIDA POLLEN; QUERCUS ALBA WHOLE; QUERCUS GAMBELII POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS NIGRA POLLEN; QUERCUS RUBRA BARK; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA WHOLE; QUERCUS VIRGINIANA POLLEN; RORIPPA NASTURTIUM-AQUATICUM; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SALSOLA KALI WHOLE; SECALE CEREALE POLLEN; SOLIDAGO CANADENSIS WHOLE; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII WHOLE; TAMARIX GALLICA POLLEN; TAXODIUM DISTICHUM POLLEN; THUJA OCCIDENTALIS LEAF; THUJA PLICATA LEAF; TRIADICA SEBIFERA WHOLE; TRIGONELLA FOENUM-GRAECUM WHOLE; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS CRASSIFOLIA WHOLE; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	12; 12; 12; 12; 12; 6; 12; 30; 12; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 30; 30; 6; 30; 30; 6; 12; 5; 30; 12; 12; 12; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 30; 6; 6; 6; 5; 6; 12; 6; 12; 12; 12; 30; 6; 5; 30; 30; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 6; 6; 12; 12; 12; 5; 12; 12; 6; 6; 6; 5; 12; 12; 12; 12; 12; 12; 30; 12; 6; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 5; 30; 30; 12; 30; 6; 30; 6; 12; 12; 12; 12; 12; 12; 5; 6; 12; 12; 12; 12; 30; 30; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	
58809-211_0b27559c-8839-b387-e063-6394a90a0a74	58809-211	HUMAN OTC DRUG	Dayclear Allergy Relief		Allergy releif	LIQUID	ORAL	20170701	20240531	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals INC	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	25; 50	mg/30mL; mg/30mL			N	
58809-213_0a381fc2-c14e-0f8c-e063-6294a90ab810	58809-213	HUMAN OTC DRUG	TexaClear All Season Allergy Relief		Antigens All Zones Grasses Trees and Weeds. Baptisia tinctoria, Echinacea, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Urtica urens	SOLUTION/ DROPS	SUBLINGUAL	20231110		UNAPPROVED HOMEOPATHIC		GM Pharmaceuticals, INC	ACACIA DEALBATA POLLEN; ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA BIDENTATA POLLEN; AMBROSIA CONFERTIFLORA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX WRIGHTII POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA NIGRA POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DISTICHLIS SPICATA POLLEN; ECHINACEA ANGUSTIFOLIA ROOT; EUCALYPTUS GLOBULUS POLLEN; EUPATORIUM CAPILLIFOLIUM POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; HESPEROCYPARIS ARIZONICA POLLEN; HOLCUS LANATUS POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS OCCIDENTALIS POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; MELALEUCA QUINQUENERVIA POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRICA CERIFERA POLLEN; MYRRH; NASTURTIUM OFFICINALE; OLEA EUROPAEA POLLEN; PASPALUM NOTATUM POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS GAMBELII POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS NIGRA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VIRGINIANA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SALSOLA KALI POLLEN; SCHINUS MOLLE POLLEN; SECALE CEREALE POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; SYAGRUS ROMANZOFFIANA POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; URTICA DIOICA POLLEN; URTICA URENS WHOLE; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 5; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
58809-214_0a5d6a91-b725-778c-e063-6394a90a5b45	58809-214	HUMAN OTC DRUG	TexaClear Texas Allergy Relief plus Cedar Fever		Antigens All Zones Grasses Trees and Weeds. Baptisia tinctoria, Echinacea, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Urtica urens	SOLUTION/ DROPS	SUBLINGUAL	20231110		UNAPPROVED HOMEOPATHIC		GM Pharmaceuticals, INC	ACACIA DEALBATA POLLEN; ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA BIDENTATA POLLEN; AMBROSIA CONFERTIFLORA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX WRIGHTII POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA NIGRA POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DISTICHLIS SPICATA POLLEN; ECHINACEA ANGUSTIFOLIA ROOT; EUCALYPTUS GLOBULUS POLLEN; EUPATORIUM CAPILLIFOLIUM POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; HESPEROCYPARIS ARIZONICA POLLEN; HOLCUS LANATUS POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS OCCIDENTALIS POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; MELALEUCA QUINQUENERVIA POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRICA CERIFERA POLLEN; MYRRH; NASTURTIUM OFFICINALE; OLEA EUROPAEA POLLEN; PASPALUM NOTATUM POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS GAMBELII POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS NIGRA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VIRGINIANA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SALSOLA KALI POLLEN; SCHINUS MOLLE POLLEN; SECALE CEREALE POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; SYAGRUS ROMANZOFFIANA POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; URTICA DIOICA POLLEN; URTICA URENS WHOLE; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 5; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
58809-215_09bed6d1-db40-47c4-e063-6394a90a88bf	58809-215	HUMAN OTC DRUG	TexaClear Texas Allergy Relief plus Cedar Fever		Antigens All Zones Grasses, Trees, and Weeds. Baptisia tinctoria, Echinacea, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Urtica urens	TABLET, CHEWABLE	ORAL	20231110		UNAPPROVED HOMEOPATHIC		GM Pharmaceuticals, INC	ACACIA DEALBATA POLLEN; ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA BIDENTATA POLLEN; AMBROSIA CONFERTIFLORA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX WRIGHTII POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA NIGRA POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DISTICHLIS SPICATA POLLEN; ECHINACEA ANGUSTIFOLIA ROOT; EUCALYPTUS GLOBULUS POLLEN; EUPATORIUM CAPILLIFOLIUM POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; HESPEROCYPARIS ARIZONICA POLLEN; HOLCUS LANATUS POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS OCCIDENTALIS POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; MELALEUCA QUINQUENERVIA POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRICA CERIFERA POLLEN; MYRRH; NASTURTIUM OFFICINALE; OLEA EUROPAEA POLLEN; PASPALUM NOTATUM POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS ECHINATA POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS GAMBELII POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS NIGRA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VIRGINIANA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SALSOLA KALI POLLEN; SCHINUS MOLLE POLLEN; SECALE CEREALE POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; SYAGRUS ROMANZOFFIANA POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; URTICA DIOICA POLLEN; URTICA URENS WHOLE; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 5; 6; 6; 5; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 5; 6; 6	[hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min; [hp_X]/min	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
58809-216_0b50308b-0e15-eefc-e063-6294a90adf4b	58809-216	HUMAN OTC DRUG	TexaClear Kids Daytime Cough and Chest Congestion		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20231025		OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/15mL; mg/15mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58809-217_0b616cb8-b8d8-651b-e063-6394a90a4080	58809-217	HUMAN OTC DRUG	TexaClear Severe Cough, Cold and Flu		Choline Salicylate, Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20231025		OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHOLINE SALICYLATE; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	870; 20; 200	mg/30mL; mg/30mL; mg/30mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
58809-218_0b619327-ee50-6c40-e063-6394a90adff0	58809-218	HUMAN OTC DRUG	TexaClear Pain and Chest Congestion Relief		Choline Salicylate,Guaifenesin	LIQUID	ORAL	20231025		OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHOLINE SALICYLATE; GUAIFENESIN	870; 200	mg/30mL; mg/30mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
58809-221_0b2780ac-ab93-dadd-e063-6394a90a83ca	58809-221	HUMAN OTC DRUG	DAYCLEAR ALLERGY RELIEF		Chlophedianol HCl, Pyrilamine Maleate	TABLET	ORAL	20180813	20240229	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	25; 50	mg/1; mg/1			N	
58809-346_0b27559c-883b-b387-e063-6394a90a0a74	58809-346	HUMAN OTC DRUG	TEXACLEAR CONGESTION AND PAIN SINUS RELIEF		Choline Salicylate,Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20141021	20240930	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHOLINE SALICYLATE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	870; 200; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
58809-360_03207e46-c44f-7b8e-e063-6294a90a5739	58809-360	HUMAN OTC DRUG	Texaclear Fast Acting Allergy Relief		Chlophedianol Hydrochloride, Pyrilamine Maleate	LIQUID	ORAL	20141021		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, INC	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	25; 50	mg/30mL; mg/30mL			N	20241231
58809-372_0b27af73-e2af-0312-e063-6294a90a693e	58809-372	HUMAN OTC DRUG	TEXACLEAR NIGHT TIME COUGH COLD/FLU		Choline Salicylate, Diphenhydramine Hydrochloride, Phenylephrine Hydrochloride	LIQUID	ORAL	20141023	20241031	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHOLINE SALICYLATE; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	870; 50; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
58809-375_0b774da7-33a2-8cdd-e063-6294a90a8439	58809-375	HUMAN OTC DRUG	Z-Bum		Diaper Rash Cream	CREAM	TOPICAL	20151201		OTC MONOGRAPH DRUG	M016	GM Pharmaceuticals, INC	ZINC OXIDE	22	g/100g			N	20241231
58809-389_0388b2f3-05a5-efdd-e063-6294a90a49c6	58809-389	HUMAN OTC DRUG	TEXACLEAR PAIN RELIEVER		Caffeine, Choline salicylate	LIQUID	ORAL	20171214		OTC MONOGRAPH NOT FINAL	part343	GM Pharmaceuticals, INC	CAFFEINE; CHOLINE SALICYLATE	65; 870	mg/30mL; mg/30mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
58809-391_0b27dbe0-9ed8-90d1-e063-6294a90acffc	58809-391	HUMAN OTC DRUG	TEXACLEAR DAYTIME COUGH COLD/FLU		Choline Salicylate, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20141021	20240831	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	CHOLINE SALICYLATE; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	870; 20; 200; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
58809-555_02abdf72-4dde-715e-e063-6394a90a91e7	58809-555	HUMAN OTC DRUG	VANACOF DM		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20130601		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	18; 200; 10	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58809-650_0befcd6a-990f-210f-e063-6394a90a3dfc	58809-650	HUMAN OTC DRUG	Vanalice		Piperonyl butoxide, Pyrethrum	GEL	TOPICAL	20180805		OTC MONOGRAPH DRUG	M031	GM Pharmaceuticals, INC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	35; 3	mg/mL; mg/mL			N	20241231
58809-651_02a87c6b-3c6d-5942-e063-6294a90aa452	58809-651	HUMAN OTC DRUG	Childrens PediaClear PD		TRIPROLIDINE HYDROCHLORIDE	LIQUID	ORAL	20190701		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, INC	TRIPROLIDINE HYDROCHLORIDE	1.25	mg/2mL			N	20241231
58809-729_0b281455-f2ce-fe79-e063-6394a90aadd6	58809-729	HUMAN OTC DRUG	Nasopen	PE	Phenylephrine Hydrochloride, Thonzylamine Hydrochloride	LIQUID	ORAL	20121003	20241130	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE	10; 50	mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
58809-770_02a81b7a-6679-87b8-e063-6294a90a9bb9	58809-770	HUMAN OTC DRUG	Childrens PediaClear 8		Pyrilamine Maleate	LIQUID	ORAL	20190819		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, INC	PYRILAMINE MALEATE	12.5	mg/15mL			N	20241231
58809-925_0b4dfd5e-6422-40e9-e063-6294a90a3fda	58809-925	HUMAN OTC DRUG	TexaClear Kids Allergy		Chlophedianol HCl Pyrilamine Maleate	LIQUID	ORAL	20160615		OTC MONOGRAPH DRUG	M12	GM Pharmaceuticals, Inc.	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	12.5; 25	mg/30mL; mg/30mL			N	20241231
58809-940_0b282941-3f2d-0cb1-e063-6394a90ac4fd	58809-940	HUMAN OTC DRUG	TexaClear Kids Congestion Stuffy Nose		Phenylephrine Hydrochloride	LIQUID	ORAL	20190801	20241031	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	PHENYLEPHRINE HYDROCHLORIDE	2.5	mg/15mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
58809-950_0b282f06-3147-8ed1-e063-6294a90a6cd5	58809-950	HUMAN OTC DRUG	TexaClear Kids Cough and Cold		Dextromethorphan HBr Guaifenesin Phenyephrine HCl	LIQUID	ORAL	20150615	20241231	OTC MONOGRAPH DRUG	M012	GM Pharmaceuticals, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
58809-999_02e794d3-e6b6-8ee7-e063-6394a90ab69d	58809-999	HUMAN OTC DRUG	VANACOF		Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, and Pseudoephedrine Hydrochloride	LIQUID	ORAL	20080422		OTC MONOGRAPH FINAL	part341	GM Pharmaceuticals, INC	CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	12.5; 1; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
58831-1100_b4a09ee0-e1a1-4135-9a4e-07aafdfdd90c	58831-1100	HUMAN OTC DRUG	EGF FGF DNA UV SHIELD		Ethylhexyl Methoxycinnamate, Titanium Dioxide, Ethylhexyl Salicylate	CREAM	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part352	Dermaesthetics Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	3.24; 2.04; 3	g/60mL; g/60mL; g/60mL			N	20241231
58878-001_0ce33d08-1f26-a37e-e063-6294a90aaaf6	58878-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20191112		UNAPPROVED MEDICAL GAS		Shasta Welding Supply, Inc.	OXYGEN	99	L/100L			N	20241231
58892-101_0a70fda6-2b12-4c04-a701-360590f38dbb	58892-101	HUMAN OTC DRUG	TiZO Photoceutical AM Replenish - Tinted		Zinc Oxide	CREAM	TOPICAL	20151013		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	160	mg/g			N	20241231
58892-105_a68da628-72ff-4602-bb4b-aea806cfc735	58892-105	HUMAN OTC DRUG	TiZO Photoceutical Environmental Skin Protectant		Dimethicone	GEL	TOPICAL	20180620		OTC MONOGRAPH FINAL	part352	Fallien Cosmeceuticals, LTD	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
58892-107_4b6239f5-95d9-4e4d-94eb-7f03ab64bab2	58892-107	HUMAN OTC DRUG	TiZO Photoceutical AM Replenish Non-Tinted		Zinc Oxide	CREAM	TOPICAL	20180305		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	160	mg/g			N	20241231
58892-108_ef21cd49-ad5b-4a87-afef-829ac55d855a	58892-108	HUMAN OTC DRUG	TiZO Sheer Botanicals Non-Tinted		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190415		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-113_c99218ee-a759-416e-bf2c-a5ea6f1d2bab	58892-113	HUMAN OTC DRUG	TiZO Eye Renewal SPF 20 (Non-Tinted)		Zinc Oxide	CREAM	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	90	mg/g			N	20241231
58892-122_b91e7b01-f9a2-402d-b551-5726edbeeb6e	58892-122	HUMAN OTC DRUG	TiZO Mineral Stick - Tinted SPF 45		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	40; 55	mg/g; mg/g			N	20241231
58892-123_cb2cfff5-5a20-49a1-9c47-545e15323e9b	58892-123	HUMAN OTC DRUG	TiZO Mineral Stick Non-Tinted SPF 45		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	40; 55	mg/g; mg/g			N	20241231
58892-124_1d2f2ef3-f560-4af2-b2d7-e6f8caea9524	58892-124	HUMAN OTC DRUG	CoTZ Lip Balm		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20190415		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	40; 55	mg/g; mg/g			N	20241231
58892-128_adbec839-40b0-4307-9376-c985814f9097	58892-128	HUMAN OTC DRUG	TiZO Mineral Sun Defense SPF 50		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	100; 30	mg/g; mg/g			N	20241231
58892-130_e4bede6b-1586-4d6f-ba2e-5b772efd0a1b	58892-130	HUMAN OTC DRUG	TiZO SheerFoam		Titanium Dioxide, Zinc Oxide	AEROSOL, FOAM	TOPICAL	20120420		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-170_72ab5d86-87d0-498b-9394-7315ba2973aa	58892-170	HUMAN OTC DRUG	CoTZ Flawless Complexion		Zinc Oxide	CREAM	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	200	mg/g			N	20241231
58892-230_15e1f0ba-c6e7-4bbe-ac6f-0107472fbac8	58892-230	HUMAN OTC DRUG	TiZO SheerFoam - Tinted		Titanium Dioxide, Zinc Oxide	AEROSOL, FOAM	TOPICAL	20120420		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-317_34e356b2-215d-481f-94d4-e35e7953abea	58892-317	HUMAN OTC DRUG	TiZO Ultra Zinc SPF 40 (Non-Tinted)		Zinc Oxide	CREAM	TOPICAL	20150215		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	200	mg/g			N	20241231
58892-319_8b9989fb-ac88-47af-b9d8-4112b252124a	58892-319	HUMAN OTC DRUG	TiZO Ultra Zinc SPF 40 (Tinted)		Zinc Oxide	CREAM	TOPICAL	20150115		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	200	mg/g			N	20241231
58892-330_bdc224d0-3dde-4c30-99a2-f6bb608de539	58892-330	HUMAN OTC DRUG	CoTZ Silky Foam Non-Tinted		Titanium Dioxide, Zinc Oxide	AEROSOL, FOAM	TOPICAL	20161129		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-339_2c90fbfd-3449-4a54-91b5-d51c63f3e630	58892-339	HUMAN OTC DRUG	TiZO Tinted Lip Protection SPF 45		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	40; 55	mg/g; mg/g			N	20241231
58892-348_a4283ade-af62-4800-accf-3861b87629d8	58892-348	HUMAN OTC DRUG	CoTZ Face Prime and Protect SPF 40 (Non-Tinted)		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20181115		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
58892-349_6625710b-df56-4379-8f4f-8d1da05cf30d	58892-349	HUMAN OTC DRUG	CoTZ Mineral Suns Stick - Tinted SPF 45		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	40; 55	mg/g; mg/g			N	20241231
58892-354_5c0ec22e-9d6a-47a5-823c-eb70ec4a799e	58892-354	HUMAN OTC DRUG	CoTZ Face Prime and Protect SPF 40 (Tinted)		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20120626		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
58892-360_9080b7e7-0a7d-49a6-b8fa-39f015b39447	58892-360	HUMAN OTC DRUG	CoTZ Face Moisture		Zinc Oxide	CREAM	TOPICAL	20190204		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	160	mg/g			N	20241231
58892-410_d4efacba-8247-489c-a34a-46d72e878732	58892-410	HUMAN OTC DRUG	CoTZ Sensitive		Zinc Oxide	CREAM	TOPICAL	20150215		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	200	mg/g			N	20241231
58892-430_04d6f889-9620-4dd2-bce2-cbbb5c717784	58892-430	HUMAN OTC DRUG	CoTZ Silky Foam - Tinted		Titanium Dioxide, Zinc Oxide	AEROSOL, FOAM	TOPICAL	20161129		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-602_11e45407-0f0a-4fe4-8df2-9c6b82fd87b5	58892-602	HUMAN OTC DRUG	CoTZ Pure Botanicals		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190121		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-603_799f230f-cbe5-4740-9db1-24103eaa89a4	58892-603	HUMAN OTC DRUG	CoTZ Kids Pure Botanicals		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190415		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-604_db472e03-526b-4e50-8c6a-c3b96ada958f	58892-604	HUMAN OTC DRUG	CoTZ Sport Non-Tinted		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
58892-618_1017da7d-eee5-4605-b4fe-5353c7781be9	58892-618	HUMAN OTC DRUG	CoTZ Baby		Zinc Oxide	CREAM	TOPICAL	20190102		OTC MONOGRAPH NOT FINAL	part352	Fallien Cosmeceuticals, LTD	ZINC OXIDE	200	mg/g			N	20241231
58914-170_cac080ef-887e-4b68-beb8-b0f90b86f458	58914-170	HUMAN PRESCRIPTION DRUG	Carafate		Sucralfate	SUSPENSION	ORAL	19931216		NDA	NDA019183	Allergan, Inc.	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
58914-171_3474d978-fb23-4234-83bf-ceb675296299	58914-171	HUMAN PRESCRIPTION DRUG	Carafate		Sucralfate	TABLET	ORAL	19811030		NDA	NDA018333	Allergan, Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
58914-301_3b37d47a-55a8-4d71-bd48-c9494caeb546	58914-301	HUMAN PRESCRIPTION DRUG	Rectiv		nitroglycerin	OINTMENT	RECTAL	20110621		NDA	NDA021359	Allergan, Inc.	NITROGLYCERIN	4	mg/g	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
58914-501_606ce6e4-c2ee-44f2-b9eb-8ecdb7a99c93	58914-501	HUMAN PRESCRIPTION DRUG	Canasa		Mesalamine	SUPPOSITORY	RECTAL	20010105		NDA	NDA021252	Allergan, Inc.	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
58914-601_3d322704-6e38-4d2e-a481-f417a711676b	58914-601	HUMAN PRESCRIPTION DRUG	Pylera		Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride	CAPSULE	ORAL	20130801		NDA	NDA050786	Allergan, Inc.	BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE	140; 125; 125	mg/1; mg/1; mg/1	Bismuth [CS], Bismuth [EPC], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
58914-785_43c4e4e7-970e-4d46-9a5a-e832e3846d26	58914-785	HUMAN PRESCRIPTION DRUG	Urso 250		Ursodiol	TABLET, FILM COATED	ORAL	19971210		NDA	NDA020675	Allergan, Inc.	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
58914-790_43c4e4e7-970e-4d46-9a5a-e832e3846d26	58914-790	HUMAN PRESCRIPTION DRUG	Urso Forte		Ursodiol	TABLET, FILM COATED	ORAL	19971210		NDA	NDA020675	Allergan, Inc.	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
58930-201_fe0b888c-bcf2-e078-e053-6294a90aff5e	58930-201	HUMAN OTC DRUG	AHC Natural Perfection Fresh Sun stick		Homosalate, Octinoxate, Octisalate	STICK	TOPICAL	20230613		OTC MONOGRAPH FINAL	part352	CARVERKOREA Co.,Ltd.	HOMOSALATE; OCTINOXATE; OCTISALATE	9; 6.5; 4.2	g/100g; g/100g; g/100g			N	20241231
58933-003_079f16f2-c392-2b45-e063-6394a90abef7	58933-003	HUMAN OTC DRUG	VICKS VapoRub		Camphor (synthetic), Eucalyptus oil, Menthol	OINTMENT	TOPICAL	20180402		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufactura S de RL de CV	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.047; .012; .026	g/g; g/g; g/g			N	20241231
58933-005_0bd800f0-38b9-4203-e063-6294a90aee0e	58933-005	HUMAN OTC DRUG	Crest Cavity Protection	Regular	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20150201		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-008_0bd70001-6b06-38f2-e063-6394a90a61ea	58933-008	HUMAN OTC DRUG	Crest Tartar Protection		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	19921106		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-009_0bd81050-6c27-3b29-e063-6394a90a0454	58933-009	HUMAN OTC DRUG	Crest Tartar Protection	Fresh Mint Gel	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	19950616		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-011_0b66554f-e39d-866d-e063-6394a90a5146	58933-011	HUMAN OTC DRUG	Pepto Bismol	CHEWABLES	Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20040630		OTC MONOGRAPH DRUG	M008	Procter & Gamble Manufactura S de RL de CV	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
58933-012_0bd800f0-38ba-4203-e063-6294a90aee0e	58933-012	HUMAN OTC DRUG	Crest Kids Advanced Color Changing		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20230101		OTC MONOGRAPH DRUG	M022	Procter & Gamble Manufactura, S de R.L. de C.V.	SODIUM MONOFLUOROPHOSPHATE	1.6	mg/g			N	20241231
58933-013_06fc9219-440e-449d-e063-6394a90a9bd3	58933-013	HUMAN OTC DRUG	Pepto Bismol	CHEWABLES	Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20040630		OTC MONOGRAPH DRUG	M008	Procter & Gamble Manufactura S de RL de CV	BISMUTH SUBSALICYLATE	525	mg/21			N	20241231
58933-017_070fd6a3-2715-19c6-e063-6394a90ad1dc	58933-017	HUMAN OTC DRUG	POCKET PEPTO Pepto Bismol		Bismuth subsalicylate	TABLET	ORAL	20190601		OTC MONOGRAPH DRUG	M008	Procter & Gamble Manufactura S de RL de CV	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
58933-020_0bd81050-6c29-3b29-e063-6394a90a0454	58933-020	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Whitening plus Scope	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20110701		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-021_07ffc7b1-97b9-09ba-e063-6294a90a521c	58933-021	HUMAN OTC DRUG	Crest Complete Multi-Benefit	Whitening plus Scope	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20230802		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-023_07ecc6a7-bbde-35cf-e063-6394a90a2180	58933-023	HUMAN OTC DRUG	Crest Kids	SparkleFun Bubblegum	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230802		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-045_0bd830b3-c29f-4c94-e063-6394a90ae752	58933-045	HUMAN OTC DRUG	Crest	Strawberry	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230802		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-046_0bc9e7af-3657-6f3a-e063-6394a90aa0db	58933-046	HUMAN OTC DRUG	Crest	Bubblegum	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230802		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Mxico, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-047_0bd81067-6775-4959-e063-6394a90acd00	58933-047	HUMAN OTC DRUG	Crest	Bubblegum	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230802		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Mxico, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-048_0bd80a2b-533f-40d7-e063-6294a90aecf5	58933-048	HUMAN OTC DRUG	Crest	Strawberry	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230802		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-049_07eedc8b-adb8-52d9-e063-6394a90ae841	58933-049	HUMAN OTC DRUG	Kids Crest Cavity Protection	Sparkle Fun	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20020905		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-171_fbfa23c2-dade-4f45-e053-6394a90a4fef	58933-171	HUMAN OTC DRUG	Crest	Strawberry	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20181218		OTC MONOGRAPH FINAL	part355	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-174_0bd81050-6c2d-3b29-e063-6394a90a0454	58933-174	HUMAN OTC DRUG	Crest	Bubblegum	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20181218		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Mxico, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-391_0b394f61-3c0c-0099-e063-6394a90a143a	58933-391	HUMAN OTC DRUG	Pepto-Bismol	Diarrhea	Bismuth subsalicylate	TABLET	ORAL	20180301	20260630	OTC MONOGRAPH DRUG	M008	Procter & Gamble Manufacturing Mxico, S. de R.L. de C.V.	BISMUTH SUBSALICYLATE	525	mg/1			N	
58933-446_070d025c-05d1-8f7e-e063-6394a90ad541	58933-446	HUMAN OTC DRUG	Pepto	Kids	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20050720		OTC MONOGRAPH DRUG	M001	Procter & Gamble Manufactura S de RL de CV	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
58933-470_0bd80a2b-5340-40d7-e063-6294a90aecf5	58933-470	HUMAN OTC DRUG	Crest Anti-Cavity	Regular	SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20080801		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura S de RL de CV	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-476_070d0fc2-c07e-5f13-e063-6294a90a877d	58933-476	HUMAN OTC DRUG	Pepto-Bismol		Bismuth subsalicylate	TABLET	ORAL	20040630		OTC MONOGRAPH DRUG	M008	Procter & Gamble Manufactura S de RL de CV	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
58933-478_07100573-509b-53cf-e063-6394a90a92db	58933-478	HUMAN OTC DRUG	Pepto-Bismol	ULTRA	Bismuth subsalicylate	TABLET	ORAL	20180201		OTC MONOGRAPH DRUG	M008	Procter & Gamble Manufactura, S. de R.L. de C.V.	BISMUTH SUBSALICYLATE	525	mg/1			N	20241231
58933-539_07daf3a4-1b2e-dac7-e063-6394a90a4dcc	58933-539	HUMAN OTC DRUG	VIcks Flu Therapy	Severe Cold and Flu Day	acetaminophen, dextromethorphan hydrobromide, and phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20190417		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Mxico, S. de R.L. de C.V.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/5g; mg/5g; mg/5g	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58933-542_07fec6d6-dc3a-e24e-e063-6394a90aca31	58933-542	HUMAN OTC DRUG	Vicks DayQuil NyQuil HOT REMEDY RAPID RELIEF MULTI-SYMPTOM	Cold and Flu plus Congestion	Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Phenylephrine HCl	KIT	ORAL	20220720		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufactura S de RL de CV						N	20241231
58933-544_078b733e-08fe-d25b-e063-6294a90a2e4b	58933-544	HUMAN OTC DRUG	Vicks VapoRub		Camphor (synthetic), Eucalyptus oil, and Menthol	OINTMENT	TOPICAL	19930730		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufactura S de RL de CV	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
58933-550_07fe1eae-eb8e-de4b-e063-6394a90a267c	58933-550	HUMAN OTC DRUG	Vicks DayQuil HOT REMEDY RAPID RELIEF MULTI-SYMPTOM	Cold and Flu plus Congestion	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20230322		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufactura S de RL de CV	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/5g; mg/5g; mg/5g	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58933-551_07fe247b-9a08-88f4-e063-6294a90ae555	58933-551	HUMAN OTC DRUG	Vicks NyQuil HOT REMEDY RAPID RELIEF MULTI-SYMPTOM	Cold and Flu plus Congestion	Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20230322		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufactura S de RL de CV	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/5g; mg/5g; mg/5g	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
58933-595_078b2bd6-a56d-c676-e063-6394a90a82ff	58933-595	HUMAN OTC DRUG	Vicks childrens VapoRub		Camphor (synthetic), Eucalyptus oil, Menthol	OINTMENT	TOPICAL	20190926		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufactura S de RL de CV	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
58933-671_07de9f34-aa3d-8453-e063-6394a90aeb49	58933-671	HUMAN OTC DRUG	Vicks VapoRub		Camphor (synthetic), Eucalyptus oil, and Menthol	OINTMENT	TOPICAL	19930730		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufactura S de RL de CV	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.047; .012; .026	g/g; g/g; g/g			N	20241231
58933-680_07e9c65c-52e4-9e0a-e063-6394a90a671d	58933-680	HUMAN OTC DRUG	Vicks VapoDrops	Cough Relief	Menthol	LOZENGE	ORAL	20090430	20240229	OTC MONOGRAPH DRUG	M022	Procter & Gamble Manufactura S de RL de CV	MENTHOL	3.3	mg/1			N	
58933-868_0bd830b3-c2a2-4c94-e063-6394a90ae752	58933-868	HUMAN OTC DRUG	Crest	Fresh and White	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20150309		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-878_0bd8630d-9d16-7c5e-e063-6294a90a4550	58933-878	HUMAN OTC DRUG	Crest 3D White	Radiant Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20160704		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-879_0bd85bbb-bf49-609f-e063-6394a90a2c0b	58933-879	HUMAN OTC DRUG	Crest 3D White Stain Eraser		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20160704		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-881_0bd86700-db3f-91f6-e063-6294a90a80c2	58933-881	HUMAN OTC DRUG	Crest 3D White	Fresh Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230802		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufactura, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58933-926_07de2b7e-96f2-162d-e063-6394a90a4488	58933-926	HUMAN OTC DRUG	VIcks Flu Therapy	Severe Cold and Flu Night	acetaminophen, diphenhydramine hydrochloride, and phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20190417	20240128	OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Mxico, S. de R.L. de C.V.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/5g; mg/5g; mg/5g	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
58933-932_f4ae3d75-0288-2c94-e053-2a95a90a48b2	58933-932	HUMAN OTC DRUG	Crest 3D White	Stain Eraser Icy Clean Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190701		OTC MONOGRAPH FINAL	part355	Procter & Gamble Manufacturing Mxico, S. de R.L. de C.V.	SODIUM FLUORIDE	1.5	mg/g			N	20241231
58960-001_08b94fd4-4084-fe6e-e063-6394a90a9daa	58960-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130327		UNAPPROVED MEDICAL GAS		Cardiopulmonary Services Inc dba CPS Medical, Inc.	OXYGEN	99	L/100L			N	20241231
58980-011_d63c8e51-f999-4e81-bd4c-d7814b7655eb	58980-011	HUMAN OTC DRUG	BACITRACIN ZINC		BACITRACIN ZINC	OINTMENT	TOPICAL	20170915		OTC MONOGRAPH FINAL	part333B	STRATUS PHARMACEUTICALS INC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
58980-012_a01f570e-e689-4c0d-abb3-1ee61883a2a2	58980-012	HUMAN OTC DRUG	BACITRACIN ZINC		BACITRACIN ZINC and POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20170915		OTC MONOGRAPH FINAL	part333B	STRATUS PHARMACEUTICALS INC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
58980-350_eec7129d-a680-4233-acef-e8db8c490da2	58980-350	HUMAN OTC DRUG	WHITE PETROLATUM		PETROLATUM	OINTMENT	TOPICAL	20190712		OTC MONOGRAPH FINAL	part347	STRATUS PHARMACEUTICALS INC	PETROLATUM	5	[USP'U]/5g			N	20241231
58980-409_688973a2-6be6-480a-af80-f97f24fa5205	58980-409	HUMAN OTC DRUG	Stratuscare Glycerin Laxative Pediatric		Glycerin	SUPPOSITORY	RECTAL	20140601		OTC MONOGRAPH NOT FINAL	part334	Stratus Pharmaceuticals	GLYCERIN	1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
58980-410_8779e80e-d3a1-4617-b4e4-6ab2eeabd0ec	58980-410	HUMAN OTC DRUG	Stratuscare Adult Glycerin		Glycerin	SUPPOSITORY	RECTAL	20140530		OTC MONOGRAPH NOT FINAL	part334	Stratus Pharmaceuticals	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
58980-415_5a4c9462-becd-451e-bffa-0e0397cc4d81	58980-415	HUMAN OTC DRUG	Stratuscare Bisacodyl		Bisacodyl	SUPPOSITORY	RECTAL	20140530		OTC MONOGRAPH NOT FINAL	part334	Stratus Pharmaceuticals	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
58980-615_1a4b6380-30cb-4126-b288-cd670c21e686	58980-615	HUMAN OTC DRUG	ARCTIC RELIEF		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20170915		OTC MONOGRAPH NOT FINAL	part348	STRATUS PHARMACEUTICALS INC	MENTHOL, UNSPECIFIED FORM	3.969	g/113.4g			N	20241231
58980-818_fa7abfcb-49d5-412f-88ab-68af39fd0f5d	58980-818	HUMAN OTC DRUG	Azolen		Miconazole Nitrate	TINCTURE	TOPICAL	20170915		OTC MONOGRAPH FINAL	part333C	Stratus Pharmaceuticals, Inc.	MICONAZOLE NITRATE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
58980-819_2e94984c-a24d-46df-8d98-4051110efe75	58980-819	HUMAN OTC DRUG	AZOLEN		MICONAZOLE NITRATE	LIQUID	TOPICAL	20230914		OTC MONOGRAPH FINAL	part333C	STRATUS PHARMACEUTICALS INC	MICONAZOLE NITRATE	2	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
58980-820_d61f6260-2eae-4911-a499-8bc12abf0b6d	58980-820	HUMAN OTC DRUG	Castellani Paint		Phenol	LIQUID	TOPICAL	20140401		OTC MONOGRAPH NOT FINAL	part333A	Stratus Pharamceuticals	PHENOL	15	mg/mL			N	20241231
58980-823_c07360a1-780f-4ddc-b44f-dd1984ddb15b	58980-823	HUMAN OTC DRUG	LIDOCAINE		LIDOCAINE	CREAM	TOPICAL	20190812		OTC MONOGRAPH FINAL	part346	STRATUS PHARMACEUTICALS INC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
58987-001_7d3a9253-2c02-4cc8-ac42-be363963e314	58987-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19850101		UNAPPROVED MEDICAL GAS		Enos Home Oxygen Therapy, Inc.	OXYGEN	99.5	L/100L			N	20241231
58988-0018_e3575286-2db0-d528-e053-2a95a90a19a8	58988-0018	HUMAN OTC DRUG	Redness reliever and Lubricant		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline HCl	LIQUID	OPHTHALMIC	20131206		OTC MONOGRAPH FINAL	part349	Promex, LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
58988-1080_b60909fc-e262-4ad4-bb96-e09b71b38e1c	58988-1080	HUMAN OTC DRUG	Estomaquil Polvo		BISMUTH SUBSALICYLATE	POWDER	ORAL	20040102		OTC MONOGRAPH DRUG	M008	ProMex LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
58988-1100_fb3b1e57-8fd4-423d-918c-adc61479e8b6	58988-1100	HUMAN OTC DRUG	OIDO SANA		ISOPROPYL ALCOHOL	SOLUTION	AURICULAR (OTIC)	20060531		OTC MONOGRAPH FINAL	part344	ProMex LLC	ISOPROPYL ALCOHOL	.95	g/mL			N	20241231
58988-1170_4d1e0271-73eb-4265-a701-33a742b81483	58988-1170	HUMAN OTC DRUG	Cuadriderma		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, and PRAMOXINE HYDROCHLORIDE	OINTMENT	TOPICAL	20130531		OTC MONOGRAPH FINAL	part333B	ProMex LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
58988-1760_590596c7-cde5-419a-b5d2-759b8d996fba	58988-1760	HUMAN OTC DRUG	Pyrantel Pamoate		Pyrantel Pamoate	TABLET	ORAL	20020927		OTC MONOGRAPH FINAL	part357B	ProMex LLC	PYRANTEL PAMOATE	180	mg/1			N	20241231
58988-1770_d804e4d7-ff72-4250-8ce0-904254f81156	58988-1770	HUMAN OTC DRUG	Pyrantel Pamoate		Pyrantel Pamoate	SUSPENSION	ORAL	20020927		OTC MONOGRAPH FINAL	part357B	ProMex LLC	PYRANTEL PAMOATE	144	mg/mL			N	20241231
59011-271_0ad98704-4667-0bb6-39e5-2a196440a39c	59011-271	HUMAN PRESCRIPTION DRUG	Hysingla ER		hydrocodone bitartrate	TABLET, EXTENDED RELEASE	ORAL	20150115		NDA	NDA206627	Purdue Pharma LP	HYDROCODONE BITARTRATE	20	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
59011-272_0ad98704-4667-0bb6-39e5-2a196440a39c	59011-272	HUMAN PRESCRIPTION DRUG	Hysingla ER		hydrocodone bitartrate	TABLET, EXTENDED RELEASE	ORAL	20150115		NDA	NDA206627	Purdue Pharma LP	HYDROCODONE BITARTRATE	30	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
59011-273_0ad98704-4667-0bb6-39e5-2a196440a39c	59011-273	HUMAN PRESCRIPTION DRUG	Hysingla ER		hydrocodone bitartrate	TABLET, EXTENDED RELEASE	ORAL	20150115		NDA	NDA206627	Purdue Pharma LP	HYDROCODONE BITARTRATE	40	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
59011-274_0ad98704-4667-0bb6-39e5-2a196440a39c	59011-274	HUMAN PRESCRIPTION DRUG	Hysingla ER		hydrocodone bitartrate	TABLET, EXTENDED RELEASE	ORAL	20150115		NDA	NDA206627	Purdue Pharma LP	HYDROCODONE BITARTRATE	60	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
59011-275_0ad98704-4667-0bb6-39e5-2a196440a39c	59011-275	HUMAN PRESCRIPTION DRUG	Hysingla ER		hydrocodone bitartrate	TABLET, EXTENDED RELEASE	ORAL	20150115		NDA	NDA206627	Purdue Pharma LP	HYDROCODONE BITARTRATE	80	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
59011-276_0ad98704-4667-0bb6-39e5-2a196440a39c	59011-276	HUMAN PRESCRIPTION DRUG	Hysingla ER		hydrocodone bitartrate	TABLET, EXTENDED RELEASE	ORAL	20150115		NDA	NDA206627	Purdue Pharma LP	HYDROCODONE BITARTRATE	100	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
59011-277_0ad98704-4667-0bb6-39e5-2a196440a39c	59011-277	HUMAN PRESCRIPTION DRUG	Hysingla ER		hydrocodone bitartrate	TABLET, EXTENDED RELEASE	ORAL	20150115		NDA	NDA206627	Purdue Pharma LP	HYDROCODONE BITARTRATE	120	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
59011-410_f4a58829-1861-cd58-ee6b-bf1cf28e164a	59011-410	HUMAN PRESCRIPTION DRUG	OxyContin		oxycodone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100808		NDA	NDA022272	Purdue Pharma LP	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
59011-415_f4a58829-1861-cd58-ee6b-bf1cf28e164a	59011-415	HUMAN PRESCRIPTION DRUG	OxyContin		oxycodone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100808		NDA	NDA022272	Purdue Pharma LP	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
59011-420_f4a58829-1861-cd58-ee6b-bf1cf28e164a	59011-420	HUMAN PRESCRIPTION DRUG	OxyContin		oxycodone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100808		NDA	NDA022272	Purdue Pharma LP	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
59011-430_f4a58829-1861-cd58-ee6b-bf1cf28e164a	59011-430	HUMAN PRESCRIPTION DRUG	OxyContin		oxycodone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100808		NDA	NDA022272	Purdue Pharma LP	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
59011-440_f4a58829-1861-cd58-ee6b-bf1cf28e164a	59011-440	HUMAN PRESCRIPTION DRUG	OxyContin		oxycodone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100808		NDA	NDA022272	Purdue Pharma LP	OXYCODONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
59011-460_f4a58829-1861-cd58-ee6b-bf1cf28e164a	59011-460	HUMAN PRESCRIPTION DRUG	OxyContin		oxycodone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100808		NDA	NDA022272	Purdue Pharma LP	OXYCODONE HYDROCHLORIDE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
59011-480_f4a58829-1861-cd58-ee6b-bf1cf28e164a	59011-480	HUMAN PRESCRIPTION DRUG	OxyContin		oxycodone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100808		NDA	NDA022272	Purdue Pharma LP	OXYCODONE HYDROCHLORIDE	80	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
59011-750_58b7eb54-365b-f415-16d2-82f07261cd57	59011-750	HUMAN PRESCRIPTION DRUG	Butrans		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110214		NDA	NDA021306	Purdue Pharma LP	BUPRENORPHINE	5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
59011-751_58b7eb54-365b-f415-16d2-82f07261cd57	59011-751	HUMAN PRESCRIPTION DRUG	Butrans		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110214		NDA	NDA021306	Purdue Pharma LP	BUPRENORPHINE	10	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
59011-752_58b7eb54-365b-f415-16d2-82f07261cd57	59011-752	HUMAN PRESCRIPTION DRUG	Butrans		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110214		NDA	NDA021306	Purdue Pharma LP	BUPRENORPHINE	20	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
59011-757_58b7eb54-365b-f415-16d2-82f07261cd57	59011-757	HUMAN PRESCRIPTION DRUG	Butrans		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110214		NDA	NDA021306	Purdue Pharma LP	BUPRENORPHINE	7.5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
59011-758_58b7eb54-365b-f415-16d2-82f07261cd57	59011-758	HUMAN PRESCRIPTION DRUG	Butrans		buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20110214		NDA	NDA021306	Purdue Pharma LP	BUPRENORPHINE	15	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
59011-960_497b844c-417a-4d6c-8eac-d4f276fdd7f5	59011-960	HUMAN PRESCRIPTION DRUG	NALMEFENE HYDROCHLORIDE		NALMEFENE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220208		ANDA	ANDA212955	Purdue Pharma L.P.	NALMEFENE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
59050-101_f3ae2c8a-4f5e-c3c1-e053-2995a90ae6f3	59050-101	HUMAN OTC DRUG	Sting Relief Wipe		Benzocaine and Isopropyl Alcohol	SWAB	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part333A	Changzhou Maokang Medical Products Co., Ltd	BENZOCAINE; ISOPROPYL ALCOHOL	60; 600	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59050-242_09c50182-b83a-0605-e063-6394a90afc75	59050-242	HUMAN OTC DRUG	MK Alcohol Swabstick Sterile		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20140312		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59050-244_09c4d16d-1290-7f9d-e063-6294a90a91b0	59050-244	HUMAN OTC DRUG	MK Alcohol Swabstick Sterile		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20140312		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59050-257_09c54740-0ed6-2005-e063-6394a90a59e7	59050-257	HUMAN OTC DRUG	MK Povidone-Iodine Swabstick Sterile		POVIDONE-IODINE	LIQUID	TOPICAL	20170804		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59050-258_09c4efc8-aa9d-7fad-e063-6294a90acd22	59050-258	HUMAN OTC DRUG	MK Povidone Iodine Swabstick Sterile		POVIDONE-IODINE	PATCH	TOPICAL	20170927		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/g			N	20241231
59050-259_09c5612a-6454-ed3a-e063-6394a90aabd3	59050-259	HUMAN OTC DRUG	MK MaoKang Medical Povidone Iodine Swabsticks		POVIDONE-IODINE	SWAB	TOPICAL	20201111		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	10	mg/mL			N	20241231
59050-260_09d66546-85f2-27f4-e063-6394a90a4c33	59050-260	HUMAN OTC DRUG	BZK Antiseptic Swabsticks 4 Triple		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20211130		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
59050-261_09d66546-8600-27f4-e063-6394a90a4c33	59050-261	HUMAN OTC DRUG	Povidone-lodine Swabsticks Triple		POVIDONE-IODINE	LIQUID	TOPICAL	20211130		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/g			N	20241231
59050-262_09d68aa1-8481-2367-e063-6394a90a4d6e	59050-262	HUMAN OTC DRUG	BZK Antiseptic Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20211130		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
59050-263_09c4efc8-aaac-7fad-e063-6294a90acd22	59050-263	HUMAN OTC DRUG	BZK Cleansing Swabsticks 4 Triple		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20220310		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.33	mg/g			N	20241231
59050-264_09c4d16d-129e-7f9d-e063-6294a90a91b0	59050-264	HUMAN OTC DRUG	BZK Antiseptic Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20220310		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
59050-265_09c5103d-db44-1196-e063-6394a90a3305	59050-265	HUMAN OTC DRUG	Amsino 10 Povidone-Iodine Solution 3 4 Fluid Ounce		POVIDONE-IODINE	LIQUID	TOPICAL	20230228		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59050-266_09c5103d-db53-1196-e063-6394a90a3305	59050-266	HUMAN OTC DRUG	Alcohol Swabstick Isopropyl Alcohol 70		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20230330		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59050-267_09c4d16d-12ad-7f9d-e063-6294a90a91b0	59050-267	HUMAN OTC DRUG	Moakang Povidone-Iodine Scrub Winged Sponges		POVIDONE-IODINE	SOLUTION	TOPICAL	20230720		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59050-268_09c50182-b895-0605-e063-6394a90afc75	59050-268	HUMAN OTC DRUG	Maokang 3 Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20230830		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
59050-269_09c4efc8-aaba-7fad-e063-6294a90acd22	59050-269	HUMAN OTC DRUG	Maokang 10 Povidone Iodine		POVIDONE-IODINE	OINTMENT	TOPICAL	20230830		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/g			N	20241231
59050-270_09c5103d-db61-1196-e063-6394a90a3305	59050-270	HUMAN OTC DRUG	Povidone Iodine Swabsticks		POVIDONE-IODINE	SOLUTION	TOPICAL	20230905		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/g			N	20241231
59050-271_0a239c0d-2ff2-1090-e063-6294a90a5ab3	59050-271	HUMAN OTC DRUG	Maokang Povidone Iodine Swabsticks 3s		POVIDONE-IODINE	SOLUTION	TOPICAL	20231102		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co.,Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59050-331_09c54740-0ee7-2005-e063-6394a90a59e7	59050-331	HUMAN OTC DRUG	MK BZK Antiseptic Towelette Non-Sterile		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20190223		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59050-331_0c7cd738-676f-c3f5-e063-6394a90aee5c	59050-331	HUMAN OTC DRUG	MK BZK Antiseptic Towelette Non-Sterile		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140411		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59050-332_09c50182-b8a2-0605-e063-6394a90afc75	59050-332	HUMAN OTC DRUG	MK BZK Antiseptic Towelette Sterile		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140312		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59050-414_09c54740-0ef5-2005-e063-6394a90a59e7	59050-414	HUMAN OTC DRUG	MK Sting Relief Pads		BENZOCAINE, ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20140609		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	BENZOCAINE; ISOPROPYL ALCOHOL	60; 600	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59050-415_0e5856d2-a32c-15ea-e063-6394a90ad0a0	59050-415	HUMAN OTC DRUG	Sting and Bite Relief Pads		Benzocaine, Isopropyl Alcohol	LIQUID	TOPICAL	20240107		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd.	BENZOCAINE; ISOPROPYL ALCOHOL	60; 600	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
59050-434_09c50182-b8b0-0605-e063-6394a90afc75	59050-434	HUMAN OTC DRUG	MK BZK Swab Non-Sterile		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140411		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59050-444_0c8c432a-0586-8701-e063-6394a90a5d96	59050-444	HUMAN OTC DRUG	MK Alcohol Prep Pads Medium		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20140312		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59050-444_0d0c9785-5193-ef91-e063-6294a90a92b2	59050-444	HUMAN OTC DRUG	MK Alcohol Prep Pads Medium		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20140312		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59050-448_09c54740-0f02-2005-e063-6394a90a59e7	59050-448	HUMAN OTC DRUG	MK Alcohol Prep Pads Large		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20140411		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59050-455_0a3e519c-ecd6-d487-e063-6294a90a1f47	59050-455	HUMAN OTC DRUG	Prep non sterile		POVIDONE-IODINE	PATCH	TOPICAL	20180629		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	10	g/100g			N	20241231
59050-456_0a3e519c-ece5-d487-e063-6294a90a1f47	59050-456	HUMAN OTC DRUG	Prep Pad Sterile		POVIDONE-IODINE	PATCH	TOPICAL	20180629		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	10	g/100g			N	20241231
59050-458_04be4c2f-742c-7058-e063-6394a90a460d	59050-458	HUMAN OTC DRUG	Prep Pad Sterile		POVIDONE-IODINE	PATCH	TOPICAL	20231010		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd.	POVIDONE-IODINE	10	g/100g			N	20251231
59050-458_0e65d5b4-50ef-c9df-e063-6294a90a11b8	59050-458	HUMAN OTC DRUG	Prep Pad Sterile		POVIDONE-IODINE	PATCH	TOPICAL	20231027		OTC MONOGRAPH DRUG	M003	Changzhou Maokang Medical Products Co., Ltd.	POVIDONE-IODINE	10	g/100g			N	20251231
59050-552_09c713b2-ce30-7359-e063-6394a90a0257	59050-552	HUMAN OTC DRUG	sterile		POVIDONE-IODINE	PATCH	TOPICAL	20180629		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	10	g/100g			N	20241231
59050-553_0a3e77f1-d221-d62d-e063-6294a90a99c9	59050-553	HUMAN OTC DRUG	Non-sterile		POVIDONE-IODINE	PATCH	TOPICAL	20180629		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	10	g/100g			N	20241231
59050-554_09c712f0-9404-428b-e063-6394a90ad096	59050-554	HUMAN OTC DRUG	Povidone-Iodine Solution Sterile		POVIDONE-IODINE	LIQUID	TOPICAL	20191022		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59050-559_09c74a62-2016-0863-e063-6294a90ab44d	59050-559	HUMAN OTC DRUG	Povidone-Iodine Scrub Solution		POVIDONE-IODINE	SOLUTION	TOPICAL	20200610		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	75	mg/mL			N	20241231
59050-651_09c727e0-016d-4b43-e063-6394a90abe69	59050-651	HUMAN OTC DRUG	Povidone-Iodine Paint Solution		POVIDONE-IODINE	SOLUTION	TOPICAL	20200610		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59050-654_09c713eb-f3f9-4842-e063-6294a90a1760	59050-654	HUMAN OTC DRUG	TWO PVP-I SCRUB STICKS		POVIDONE-IODINE	SPONGE	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59050-658_0c6746b7-c400-05e3-e063-6394a90a9d80	59050-658	HUMAN OTC DRUG	Povidone-Iodine Prep Sterile		Povidone-Iodine	SPONGE	TOPICAL	20150427		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/g			N	20241231
59050-754_09c713eb-f407-4842-e063-6294a90a1760	59050-754	HUMAN OTC DRUG	TWO PVP-I SCRUB LARGE WINGED SPONGES		POVIDONE-IODINE	SPONGE	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Changzhou Maokang Medical Products Co., Ltd	POVIDONE-IODINE	100	mg/mL			N	20241231
59051-7100_01414006-6cbc-16fa-e063-6394a90adeab	59051-7100	HUMAN OTC DRUG	Companion Hand Sanitizer		hand sanitizer	LIQUID	TOPICAL	20170605		OTC MONOGRAPH NOT FINAL	part333E	Neogen Corporation	ALCOHOL	338.82	g/L			N	20241231
59054-002_c8c2c28c-78a0-0a5a-e053-2995a90ae390	59054-002	HUMAN OTC DRUG	ACADEMY SPORT SMART CARE KIDS SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190117		OTC MONOGRAPH NOT FINAL	part352	ACADEMY, LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
59054-880_42836d50-8548-4c84-be25-96b01416d489	59054-880	HUMAN OTC DRUG	Academy SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20160720		OTC MONOGRAPH NOT FINAL	part352	ACADEMY, LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	1.5; 15; 5; 1.2; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
59062-0120_6dc0331d-bcc1-489d-aa50-9d592c298341	59062-0120	HUMAN OTC DRUG	BABYGANICS SPF 50 Plus SUNSCREEN		ZINC OXIDE, OCTISALATE, and OCTOCRYLENE	SPRAY	TOPICAL	20190701		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba Babyganics	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 60; 112	mg/mL; mg/mL; mg/mL			N	20241231
59062-0175_bb064d2a-af0b-49b5-9141-998c8c4b6295	59062-0175	HUMAN OTC DRUG	kids SPF 50plus sunscreen continuous		ZINC OXIDE and OCTISALATE	SPRAY	TOPICAL	20181215		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	OCTISALATE; ZINC OXIDE	50; 150	mg/g; mg/g			N	20241231
59062-1000_aa527c33-9299-4d68-9eb0-c086186d06cc	59062-1000	HUMAN OTC DRUG	SPF 50 plus Sunscreen		Titanium Dioxide, OCTISALATE, and ZINC OXIDE	LOTION	TOPICAL	20170724		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	50; 30; 60	mg/mL; mg/mL; mg/mL			N	20241231
59062-1001_f3ca0977-4121-4da8-9a14-e4fcdd2e932d	59062-1001	HUMAN OTC DRUG	SPF 50 Mineral Sunscreen	Babyganics	titanium dioxide and zinc oxide	LOTION	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	31.6; 120	mg/mL; mg/mL			N	20241231
59062-1100_7856809b-65da-484d-9912-b09a7fc9f721	59062-1100	HUMAN OTC DRUG	Kids SPF 50 Plus Sunscreen		Titanium Dioxide, OCTISALATE, and ZINC OXIDE	LOTION	TOPICAL	20170724		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	50; 30; 60	mg/mL; mg/mL; mg/mL			N	20241231
59062-1101_f3ca0977-4121-4da8-9a14-e4fcdd2e932d	59062-1101	HUMAN OTC DRUG	SPF 50 Mineral Sunscreen	bkids	titanium dioxide and zinc oxide	LOTION	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	31.6; 120	mg/mL; mg/mL			N	20241231
59062-1200_1b144c6f-8c4c-45bd-ac9f-665b4119f156	59062-1200	HUMAN OTC DRUG	SPF 50 plus Sunscreen	All Mineral Active Ingredients	TITANIUM DIOXIDE and ZINC OXIDE	STICK	TOPICAL	20130621		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	79; 67	mg/g; mg/g			N	20241231
59062-1207_84a18760-a9e0-40c5-bf54-aad5fd4740c7	59062-1207	HUMAN OTC DRUG	BabyGanics Sunscreen	50 SPF	OCTINOXATE, OCTISALATE, and ZINC OXIDE	SPRAY	TOPICAL	20130621		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 112	mg/mL; mg/mL; mg/mL			N	20241231
59062-1219_3dc9c9ae-0376-48b4-8002-e5298ab41a2f	59062-1219	HUMAN OTC DRUG	BABYGANICS DIAPER RASH		ZINC OXIDE	CREAM	TOPICAL	20130621		OTC MONOGRAPH FINAL	part347	KAS Direct LLC dba BabyGanics	ZINC OXIDE	150	mg/g			N	20241231
59062-1227_eaedc1f5-5b46-4ec1-bb93-563f43f5396c	59062-1227	HUMAN OTC DRUG	BabyGanics Sunscreen	30SPF	TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20130621		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	30; 30	mg/mL; mg/mL			N	20241231
59062-1229_545e5c16-05d7-4571-a32e-4b8a60026cc1	59062-1229	HUMAN OTC DRUG	BabyGanics Sunscreen	30 SPF	ZINC OXIDE, OCTINOXATE, and OCTISALATE	SPRAY	TOPICAL	20130621		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	OCTINOXATE; OCTISALATE; ZINC OXIDE	50; 40; 112	mg/mL; mg/mL; mg/mL			N	20241231
59062-1303_5b42eded-33a3-47a6-9a33-550d6966552f	59062-1303	HUMAN OTC DRUG	BABYGANICS ECZEMA		OATMEAL	LOTION	TOPICAL	20130621		OTC MONOGRAPH FINAL	part347	KAS Direct LLC dba BabyGanics	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59062-1305_c98d9c03-2e70-4d88-94c0-f5152e787ed1	59062-1305	HUMAN OTC DRUG	eczema care skin protectant		OATMEAL	LOTION	TOPICAL	20190408		OTC MONOGRAPH FINAL	part347	KAS Direct LLC dba BabyGanics	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59062-1743_eb0c80ed-e5fa-44a0-ae79-2e32cf6b0288	59062-1743	HUMAN OTC DRUG	Eczema Spot Treatment	Skin Protectant	OATMEAL	LOTION	TOPICAL	20190315		OTC MONOGRAPH FINAL	part347	KAS Direct LLC dba BabyGanics	OATMEAL	50	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59062-2200_1b144c6f-8c4c-45bd-ac9f-665b4119f156	59062-2200	HUMAN OTC DRUG	Kids SPF 50 plus Sunscreen	All Mineral Active Ingredients	TITANIUM DIOXIDE and ZINC OXIDE	STICK	TOPICAL	20130621		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	79; 67	mg/g; mg/g			N	20241231
59062-2201_a2fee866-8e4d-48c1-976d-8d7e5aac8fcc	59062-2201	HUMAN OTC DRUG	SPF 50 Mineral Sunscreen	bkids	Zinc Oxide	STICK	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	ZINC OXIDE	216	mg/g			N	20241231
59062-2202_5290a47a-ce6b-4c9b-9a10-0252774505f1	59062-2202	HUMAN OTC DRUG	Babyganics Sheer Blend SPF50 Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	KAS Direct LLC dba BabyGanics	ZINC OXIDE	20	g/100mL			N	20241231
59062-2203_2cdded10-903a-4303-bbba-c4b1af12f5c3	59062-2203	HUMAN OTC DRUG	Babyganics Kids Sheer Blend SPF50 Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	KAS Direct LLC dba BabyGanics	ZINC OXIDE	20	g/100mL			N	20241231
59062-2210_a79c4be1-5458-4bd8-87de-915ca12bfdb4	59062-2210	HUMAN OTC DRUG	SPF50 Plus Mineral Sunscreen		Zinc oxide and Titanium dioxide	SPRAY	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	3.5; 7.25	g/100mL; g/100mL			N	20241231
59062-2300_45ab3fdb-1800-47cb-9fb6-9c0dc22df85f	59062-2300	HUMAN OTC DRUG	Kids SPF50Plus Mineral Sunscreen Rollerball Totally Tropical		Zinc oxide and Titanium dioxide	SPRAY	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	3.5; 7.25	g/100mL; g/100mL			N	20241231
59062-2400_d0b8490b-2664-440a-9b4d-929b3a0c2c58	59062-2400	HUMAN OTC DRUG	Kids SPF50 Plus Mineral Sunscreen Continuous Totally Tropical		zinc oxide and titanium dioxide	SPRAY	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics	TITANIUM DIOXIDE; ZINC OXIDE	3.5; 7.25	g/100g; g/100g			N	20241231
59062-3000_d8f27e2f-1f95-4d99-92fb-cb66559e4a09	59062-3000	HUMAN OTC DRUG	BabyGanics Alcohol Free Foaming Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20130815		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.1	mg/mL			N	20241231
59062-3001_f7e98c81-3583-426f-a46d-d842bd0c2fac	59062-3001	HUMAN OTC DRUG	BabyGanics Alcohol-Free Foaming Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220601		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.12	mg/mL			N	20241231
59062-4000_de16de6d-0eee-4137-818d-86a0f5c502f1	59062-4000	HUMAN OTC DRUG	BabyGanics Alcohol-Free Foaming Hand Sanitizer Mandarin		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20130815		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.1	mg/mL			N	20241231
59062-4001_427299ed-b7e7-4216-aa56-65279a466482	59062-4001	HUMAN OTC DRUG	BabyGanics Alcohol-Free Foaming Hand Sanitizer Mandarin		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220601		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.12	mg/mL			N	20241231
59062-4100_59bc6bac-aad8-4630-a150-666384c2cde2	59062-4100	HUMAN OTC DRUG	BabyGanics Kids Alcohol Free Foaming Hand Sanitizer Berry Berry		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.1	mg/mL			N	20241231
59062-4101_945a28ae-21a1-4ba2-8aed-8e907e449c19	59062-4101	HUMAN OTC DRUG	BabyGanics Kids Alcohol Free Foaming Hand Sanitizer Berry Berry		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220606		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.12	mg/mL			N	20241231
59062-4200_59bc6bac-aad8-4630-a150-666384c2cde2	59062-4200	HUMAN OTC DRUG	BabyGanics Kids Alcohol Free Foaming Hand Sanitizer Cupcake		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.1	mg/mL			N	20241231
59062-4201_945a28ae-21a1-4ba2-8aed-8e907e449c19	59062-4201	HUMAN OTC DRUG	BabyGanics Kids Alcohol Free Foaming Hand Sanitizer Cupcake		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220606		OTC MONOGRAPH NOT FINAL	part333E	KAS Direct LLC dba BabyGanics	BENZALKONIUM CHLORIDE	.12	mg/mL			N	20241231
59062-5000_32fd48bc-22cc-4ff8-b92e-af946e9cc1f7	59062-5000	HUMAN OTC DRUG	baby essentials gift set		Benzalkonium Chloride	KIT		20150101		OTC MONOGRAPH FINAL	part333E	KAS Direct LLC dba BabyGanics						N	20241231
59062-5100_bb3ca7dd-8b3d-4ef1-9dd8-caa1bbd20d8a	59062-5100	HUMAN OTC DRUG	suncare essentials		Titanium Dioxide, Octisalate, and Zinc Oxide	KIT		20170101		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics						N	20241231
59062-5200_7f16e117-310e-418d-84c9-c2344b3532e9	59062-5200	HUMAN OTC DRUG	outdoor adventure set		Zinc Oxide, Titanium Dioxide, and Octisalate	KIT		20190101		OTC MONOGRAPH NOT FINAL	part352	KAS Direct LLC dba BabyGanics						N	20241231
59087-001_078bd3e2-5707-d418-e063-6394a90afe9f	59087-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19980305		UNAPPROVED MEDICAL GAS		Orange Coast Respiratory Care Services, Inc.	OXYGEN	99	L/100L			N	20241231
59088-083_f20482b1-5741-4a96-e053-2995a90a1d90	59088-083	HUMAN PRESCRIPTION DRUG	Migranow		sumatriptan succinate, camphor, menthol	KIT		20160418		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-093_b3b7a321-7e43-5ce3-e053-2a95a90a6721	59088-093	HUMAN PRESCRIPTION DRUG	Inflammacin		diclofenac sodium, capsaicin	KIT		20160111		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-104_cd86c009-e9ca-4b68-b85d-28b0bdcfbef7	59088-104	HUMAN PRESCRIPTION DRUG	Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20110601		UNAPPROVED DRUG OTHER		PureTek Corporation	SODIUM FLUORIDE	.25	mg/1			N	20241231
59088-105_90a18708-82e0-4dc8-adee-e908f3d356c7	59088-105	HUMAN PRESCRIPTION DRUG	Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20110601		UNAPPROVED DRUG OTHER		PureTek Corporation	SODIUM FLUORIDE	.5	mg/1			N	20241231
59088-106_295f929c-f202-4d4a-987d-203ef5260592	59088-106	HUMAN PRESCRIPTION DRUG	Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20110601		UNAPPROVED DRUG OTHER		PureTek Corporation	SODIUM FLUORIDE	1	mg/1			N	20241231
59088-107_f394a520-91ce-3c9a-e053-2a95a90a80e3	59088-107	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20110601		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A	10; 24; 10; 4.5; 300; 13.5; 1.05; 1.2; 36; .25; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-108_e7bc2555-570e-f3a7-e053-2995a90af55b	59088-108	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20110601		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A	10; 24; 10; 4.5; 300; 13.5; 1.05; 1.2; 36; .5; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-109_e4aac9f1-db2e-72e9-e053-2a95a90a3b54	59088-109	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20110601		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A	10; 24; 10; 4.5; 300; 13.5; 1.05; 1.2; 36; 1; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-112_f2048b24-433b-98ba-e053-2995a90a5e85	59088-112	HUMAN PRESCRIPTION DRUG	PureVit DualFe Plus		Ferrous Fumarate, Polysaccharide Iron Complex	CAPSULE	ORAL	20110601		UNAPPROVED DRUG OTHER		PureTek Corporation	CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; IRON DEXTRAN; MANGANESE SULFATE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; ZINC SULFATE	10; .8; 15; 53; 1; 53; 1.3; 30; 5; 6; 200; 10; 18.2	mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Iron [CS], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
59088-156_0a100e7d-3a8e-2d8b-e063-6394a90a3203	59088-156	HUMAN PRESCRIPTION DRUG	Menatrol		Folate, Multivitamin	CAPSULE	ORAL	20231218		UNAPPROVED DRUG OTHER		PureTek Corporation	CALCIUM CARBONATE; CHOLECALCIFEROL; LEVOMEFOLATE CALCIUM; MAGNESIUM OXIDE; PYRIDOXINE HYDROCHLORIDE; RHUBARB	220; 600; 1000; 100; 1.5; 4	mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Folate Analog [EPC], Folic Acid [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-158_0b67e8de-d81d-0fda-e063-6394a90ac229	59088-158	HUMAN PRESCRIPTION DRUG	Davimet-M		Multivitamin	TABLET, CHEWABLE	ORAL	20231130		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CHOLECALCIFEROL; LEVOMEFOLATE CALCIUM; METHYLCOBALAMIN; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; VITAMIN A	10; 24; 10; 1000; 4.5; 13.5; 1.05; 1.2; 36; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Folate Analog [EPC], Folic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-163_f2048d71-679b-98f8-e053-2995a90a533a	59088-163	HUMAN PRESCRIPTION DRUG	Folixapure		Folic Acid, Vitamin D3	TABLET	ORAL	20200710		UNAPPROVED DRUG OTHER		PureTek Corporation	FOLIC ACID; VITAMIN D	1; 125	mg/1; ug/1	Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-164_f2048b24-433c-98ba-e053-2995a90a5e85	59088-164	HUMAN PRESCRIPTION DRUG	Vitrexyl		Folic Acid	TABLET	ORAL	20200829		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-165_f2047f00-c3fe-3e18-e053-2a95a90af35f	59088-165	HUMAN PRESCRIPTION DRUG	Vitrexyl plus Iron		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20200824		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 27; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-166_f4352f0b-31d1-310c-e053-2a95a90a4d1d	59088-166	HUMAN PRESCRIPTION DRUG	Prenatrix		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20200829		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHOLINE BITARTRATE; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 55; 45; 10; 27; 1000; 200; 2.6; 50; 20; 150; 50; 3.4; 70; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-167_f204b4b3-176f-8839-e053-2a95a90a7115	59088-167	HUMAN PRESCRIPTION DRUG	Vitrexate		Folic Acid	TABLET	ORAL	20201130		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-168_f204b6b0-92ad-3c22-e053-2995a90ad0aa	59088-168	HUMAN PRESCRIPTION DRUG	Vitrexate FE		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20201130		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 27; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-169_f43540c0-7416-78c3-e053-2995a90aa2d4	59088-169	HUMAN PRESCRIPTION DRUG	Prenatryl		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20201130		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHOLINE BITARTRATE; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 55; 45; 10; 27; 1000; 200; 2.6; 50; 20; 150; 50; 3.4; 70; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-171_f204b4b3-176f-8839-e053-2a95a90a7115	59088-171	HUMAN PRESCRIPTION DRUG	Vitranol		Folic Acid	TABLET	ORAL	20210111		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-172_f43540c0-7416-78c3-e053-2995a90aa2d4	59088-172	HUMAN PRESCRIPTION DRUG	Prometa		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210111		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHOLINE BITARTRATE; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 55; 45; 10; 27; 1000; 200; 2.6; 50; 20; 150; 50; 3.4; 70; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-173_f204a9ea-3fd7-10f6-e053-2995a90ae9d9	59088-173	HUMAN PRESCRIPTION DRUG	Vitranol Fe		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210104		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 27; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-176_f204b6b0-92af-3c22-e053-2995a90ad0aa	59088-176	HUMAN PRESCRIPTION DRUG	Venexa		Folic Acid	TABLET	ORAL	20210129		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-177_f204c835-2fb4-27b1-e053-2995a90a43b9	59088-177	HUMAN PRESCRIPTION DRUG	Venexa FE		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210129		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 27; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-178_f204cb09-a4d3-e54e-e053-2a95a90ad982	59088-178	HUMAN PRESCRIPTION DRUG	Pretrate		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210201		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHOLINE BITARTRATE; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 55; 45; 10; 27; 1000; 200; 2.6; 50; 20; 150; 50; 3.4; 70; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-180_f204ced9-4611-0544-e053-2a95a90ac1f3	59088-180	HUMAN PRESCRIPTION DRUG	Zintrexyl-C		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210211		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; BIOTIN; BORON; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CUPROUS OXIDE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PANTOTHENIC ACID; POTASSIUM CHLORIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	45; 250; 100; 25; 75; 13.75; 37.5; 1; 13; 9; 500; 37.5; .75; 25; 22.5; 15; 24.5; 25; 6; 3.35; 30; 3.25; 1500; 15	mg/1; mg/1; ug/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-181_f204c835-2fb5-27b1-e053-2995a90a43b9	59088-181	HUMAN PRESCRIPTION DRUG	Folitin-Z		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210211		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; BIOTIN; BORON; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CUPROUS OXIDE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PANTOTHENIC ACID; POTASSIUM CHLORIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	45; 250; 100; 25; 75; 13.75; 37.5; 1; 13; 9; 500; 37.5; .75; 25; 22.5; 15; 24.5; 25; 6; 3.35; 30; 3.25; 1500; 15	mg/1; mg/1; ug/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-182_f204c835-2fb6-27b1-e053-2995a90a43b9	59088-182	HUMAN PRESCRIPTION DRUG	Ribotin-E		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210211		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; BIOTIN; BORON; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CUPROUS OXIDE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PANTOTHENIC ACID; POTASSIUM CHLORIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	45; 250; 100; 25; 75; 13.75; 37.5; 1; 13; 9; 500; 37.5; .75; 25; 22.5; 15; 24.5; 25; 6; 3.35; 30; 3.25; 1500; 15	mg/1; mg/1; ug/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-184_f204c835-2fb7-27b1-e053-2995a90a43b9	59088-184	HUMAN PRESCRIPTION DRUG	DermacinRx Purefoltin		Folic Acid, Vitamin D3	TABLET	ORAL	20210503		UNAPPROVED DRUG OTHER		PureTek Corporation	FOLIC ACID; VITAMIN D	1; 125	mg/1; ug/1	Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-185_f204c835-2fb8-27b1-e053-2995a90a43b9	59088-185	HUMAN PRESCRIPTION DRUG	Folditam		Folic Acid, Vitamin D3	TABLET	ORAL	20210902		UNAPPROVED DRUG OTHER		PureTek Corporation	FOLIC ACID; VITAMIN D	1; 250	mg/1; ug/1	Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-186_f204c835-2fb9-27b1-e053-2995a90a43b9	59088-186	HUMAN PRESCRIPTION DRUG	Ventrixyl		Folic Acid	TABLET	ORAL	20210518		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-187_f204c835-2fba-27b1-e053-2995a90a43b9	59088-187	HUMAN PRESCRIPTION DRUG	Ventrixyl Fe		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20210811		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 27; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-193_f204b6f6-942d-4261-e053-2995a90a963a	59088-193	HUMAN PRESCRIPTION DRUG	Vitramyn		Folic Acid	TABLET	ORAL	20210820		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-200_f204b6f6-942f-4261-e053-2995a90a963a	59088-200	HUMAN PRESCRIPTION DRUG	Foltamin		Folic Acid, Vitamin D3	TABLET	ORAL	20211129		UNAPPROVED DRUG OTHER		PureTek Corporation	FOLIC ACID; VITAMIN D	1; 125	mg/1; ug/1	Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-202_0e9c8b23-1813-585e-e063-6394a90ac23e	59088-202	HUMAN OTC DRUG	Menticam		Camphor,Menthol, Methyl Salicylate	CREAM	TOPICAL	20231026		OTC MONOGRAPH DRUG	M017	PureTek Corporation	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	4; 7.5; 10	g/85g; g/85g; g/85g			N	20251231
59088-203_0e9b1d24-d456-eeb7-e063-6394a90a427e	59088-203	HUMAN OTC DRUG	Menticam		Camphor, Menthol, Methyl Salicylate	GEL	TOPICAL	20231026		OTC MONOGRAPH DRUG	M017	PureTek Corporation	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	4; 10; 30	g/100g; g/100g; g/100g			N	20251231
59088-209_febffc84-e65f-e811-e053-6294a90a0ad1	59088-209	HUMAN PRESCRIPTION DRUG	Hydroxym		HYDROCORTISONE	GEL	TOPICAL	20230712		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE	2	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59088-210_f7aa7b4f-3cb5-6113-e053-6394a90a4188	59088-210	HUMAN PRESCRIPTION DRUG	Urea 39.5% with 2% Salicylic Acid		Urea, Salicylic Acid	CREAM	TOPICAL	20230324		UNAPPROVED DRUG OTHER		PureTek Corporation	SALICYLIC ACID; UREA	2; 39.5	g/100g; g/100g			N	20241231
59088-214_fd699cfb-8ca0-ebb8-e053-6394a90ace4a	59088-214	HUMAN PRESCRIPTION DRUG	Salicate		Salicylic Acid 10%	GEL	TOPICAL	20231013		UNAPPROVED DRUG OTHER		PureTek Coproration	SALICYLIC ACID	10	mg/100mL			N	20241231
59088-215_f824de86-9491-2e6b-e053-6294a90a6f2a	59088-215	HUMAN OTC DRUG	Mencylate	Pain Relieving	Menthol, Methyl Salicylate	CREAM	TOPICAL	20230324		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	MENTHOL; METHYL SALICYLATE	20; 100	mg/mL; mg/mL			N	20241231
59088-227_fc745524-9b5b-e6d9-e053-6394a90ae7ba	59088-227	HUMAN PRESCRIPTION DRUG	SALYCIM		SALICYLIC ACID	CREAM	TOPICAL	20231206		UNAPPROVED DRUG OTHER		PURETEK CORPORATION	SALICYLIC ACID	60	mg/g			N	20241231
59088-244_a1d9a187-696c-a2f2-e053-2a95a90afc3e	59088-244	HUMAN OTC DRUG	CVS Feminine Intimate Powder		Miconazole Nitrate	POWDER	TOPICAL	20190531		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59088-264_0c407982-192e-4c61-e063-6294a90a05d7	59088-264	HUMAN PRESCRIPTION DRUG	Mycozyl HC		Tolnaftate, Hydrocortisone	LIQUID	TOPICAL	20231211		UNAPPROVED DRUG OTHER		PURETEK CORPORATION	HYDROCORTISONE; TOLNAFTATE	.0667; .1	g/10mL; g/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59088-268_f204d934-e913-49e2-e053-2995a90a2383	59088-268	HUMAN OTC DRUG	CVS Maximum Strength Feminine Anti-Itch Cream		Hydrocortisone	CREAM	TOPICAL	20190531		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59088-283_f204d934-e914-49e2-e053-2995a90a2383	59088-283	HUMAN OTC DRUG	Camphotrex		camphor, menthol	GEL	TOPICAL	20160412		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	CAMPHOR (SYNTHETIC); MENTHOL	4; 10	g/100g; g/100g			N	20241231
59088-299_e68c450b-96b4-30c0-e053-2995a90a9ed0	59088-299	HUMAN OTC DRUG	GenRx Anti-Bacterial Gel		Alcohol	LIQUID	TOPICAL	20200318		OTC MONOGRAPH NOT FINAL	part333A	PureTek Corporation	ALCOHOL	62	mL/100mL			N	20241231
59088-301_0bb91f61-b61a-c894-e063-6394a90ae51c	59088-301	HUMAN PRESCRIPTION DRUG	Folixate		Folate, Vitamin D3	TABLET	ORAL	20231205		UNAPPROVED DRUG OTHER		PureTek Corporation	LEVOMEFOLATE CALCIUM; VITAMIN D	1000; 125	ug/1; ug/1	Folate Analog [EPC], Folic Acid [CS], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-308_06ff69f7-1dec-b5c8-e063-6394a90a300f	59088-308	HUMAN PRESCRIPTION DRUG	Lidotral Five Percent with Menthol		Lidocaine Hydrochloride, Menthol	LIQUID	TOPICAL	20231006		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE; MENTHOL	50; 30	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-310_03c88b38-3b75-2487-e063-6394a90ac87b	59088-310	HUMAN OTC DRUG	DermacinRx Penetral Cream		Capsaicin	CREAM	TOPICAL	20150609		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	CAPSICUM OLEORESIN	.25	mg/mL			N	20241231
59088-315_a12715c0-77f3-7716-e053-2995a90a06d3	59088-315	HUMAN OTC DRUG	GenRx Hand Sanitizing		Benzalkonium Chloride	SPRAY	TOPICAL	20200318		OTC MONOGRAPH NOT FINAL	part333E	PureTek Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59088-333_f204ced9-4614-0544-e053-2a95a90ac1f3	59088-333	HUMAN OTC DRUG	Skin Repair Complex		Dimethicone	CREAM	TOPICAL	20150501		OTC MONOGRAPH FINAL	part347	PureTek Corporation	DIMETHICONE	50	mg/mL	Skin Barrier Activity [PE]		N	20241231
59088-334_f204d934-e915-49e2-e053-2995a90a2383	59088-334	HUMAN PRESCRIPTION DRUG	DermacinRx Surgical ComboPak		Chlorhexidine Gluconate Surgical Combo Kit	KIT		20150428		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-343_fae1beeb-828c-4303-e053-6294a90a08fc	59088-343	HUMAN PRESCRIPTION DRUG	DermacinRx Lexitral PharmaPak		diclofenac sodium, capsaicin	KIT		20151106	20240430	UNAPPROVED DRUG OTHER		PureTek Corporation						N	
59088-365_fae1b57d-f6ac-cc93-e053-6394a90a2d2d	59088-365	HUMAN PRESCRIPTION DRUG	Xrylix		Diclofenac Sodium	KIT		20160301	20240430	UNAPPROVED DRUG OTHER		PureTek Corporation						N	
59088-371_36a4cb7d-d1e8-4056-8344-c9f110820fcc	59088-371	HUMAN PRESCRIPTION DRUG	DermacinRx Lidotral		Lidocaine Hydrochloride	CREAM	TOPICAL	20151203		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE	38.8	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-372_d10218d5-f6de-cd8d-e053-2a95a90a56f8	59088-372	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20151104	20281019	ANDA	ANDA202769	PureTek Corporation	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59088-391_b3d8b9fa-070b-1020-e053-2a95a90a294d	59088-391	HUMAN PRESCRIPTION DRUG	DermacinRx Clorhexacin		Mupirocin Ointment	KIT		20160602		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-396_0e8a0e16-9a09-8e3b-e063-6294a90ac934	59088-396	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	CUTANEOUS	20160229		ANDA	ANDA200675	PureTek Corporation	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
59088-413_a75d25a7-1e23-717f-e053-2a95a90a6d93	59088-413	HUMAN OTC DRUG	Hand Sanitizing with Lavender Oil		Alcohol	GEL	TOPICAL	20200605		OTC MONOGRAPH NOT FINAL	part333A	PureTek Corporation	ALCOHOL	62	mL/100mL			N	20241231
59088-429_d9450f79-6270-8222-e053-2a95a90a0a48	59088-429	HUMAN PRESCRIPTION DRUG	Lydexa 4.12%		Lidocaine Hydrochloride	CREAM	TOPICAL	20200710		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE	41.2	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-430_f204edc7-fadd-5b36-e053-2a95a90af89b	59088-430	HUMAN PRESCRIPTION DRUG	Lidocort		LIDOCAINE HCL - HYDROCORTISONE ACETATE	CREAM	RECTAL; TOPICAL	20200901		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE	5; 30	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE]		N	20241231
59088-432_f204ed3a-fdd8-ab55-e053-2995a90aa29f	59088-432	HUMAN PRESCRIPTION DRUG	Radiaura Skin Recovery		Lidocaine HCl - Hydrocortisone Acetate	CREAM	TOPICAL	20210902		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE	10; 30	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE]		N	20241231
59088-433_f204ed3a-fdd9-ab55-e053-2995a90aa29f	59088-433	HUMAN OTC DRUG	Circata		Capsaicin	CREAM	TOPICAL	20210902		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	CAPSICUM OLEORESIN	.05	g/100g			N	20241231
59088-434_b1a8e78c-57f0-1f3e-e053-2995a90acbd5	59088-434	HUMAN OTC DRUG	Capasil	Pain Relieving	Menthol, Methyl Salicylate	CREAM	TOPICAL	20201014		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	MENTHOL; METHYL SALICYLATE	20; 100	mg/mL; mg/mL			N	20241231
59088-435_f3ab1d93-19fa-0e49-e053-2995a90a3dfa	59088-435	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230116		ANDA	ANDA203818	PureTek Corporation	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59088-441_f204b6f6-9444-4261-e053-2995a90a963a	59088-441	HUMAN OTC DRUG	Mycozyl AC		Clotrimazole	CREAM	TOPICAL	20210406		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59088-442_f204ed3a-fde8-ab55-e053-2995a90aa29f	59088-442	HUMAN OTC DRUG	Mycozyl AP		Miconazole Nitrate	POWDER	TOPICAL	20201208		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	MICONAZOLE NITRATE	2	g/85g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59088-443_07edd043-4ac5-b2de-e063-6394a90af25d	59088-443	HUMAN PRESCRIPTION DRUG	Mycozyl AL		Tolnaftate	LIQUID	TOPICAL	20231017		UNAPPROVED DRUG OTHER		PURETEK CORPORATION	TOLNAFTATE	.1	g/10mL			N	20241231
59088-443_f204ed3a-fde9-ab55-e053-2995a90aa29f	59088-443	HUMAN OTC DRUG	Mycozyl AL		Tolnaftate	LIQUID	TOPICAL	20210609		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	TOLNAFTATE	.3	g/30mL			N	20241231
59088-444_f204ed3a-fded-ab55-e053-2995a90aa29f	59088-444	HUMAN OTC DRUG	Atrix Clarifying Toner		Salicylic Acid	LIQUID	TOPICAL	20210105		OTC MONOGRAPH FINAL	part333D	PureTek Corporation	SALICYLIC ACID	20	mg/mL			N	20241231
59088-445_f204ed3a-fdee-ab55-e053-2995a90aa29f	59088-445	HUMAN OTC DRUG	Atrix Antibacterial Wash		Salicylic Acid	LIQUID	TOPICAL	20210105		OTC MONOGRAPH FINAL	part333D	PURETEK CORPORATION	SALICYLIC ACID	20	mg/mL			N	20241231
59088-446_f204f9db-04cd-5c3a-e053-2995a90a7eb3	59088-446	HUMAN OTC DRUG	Atrix Acne Treatment		Salicylic Acid	CREAM	TOPICAL	20210406		OTC MONOGRAPH FINAL	part333D	PureTek Corporation	SALICYLIC ACID	20	mg/mL			N	20241231
59088-447_b2d71f92-018f-183e-e053-2995a90a5db0	59088-447	HUMAN PRESCRIPTION DRUG	Foltrexyl		Folic Acid, Vitamin D3	TABLET	ORAL	20201029		UNAPPROVED DRUG OTHER		PureTek Corporation	FOLIC ACID; VITAMIN D	1; 125	mg/1; ug/1	Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-466_f204ed3a-fdf3-ab55-e053-2995a90aa29f	59088-466	HUMAN PRESCRIPTION DRUG	Lidogel		Lidocaine HCl	GEL	TOPICAL	20210721		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE	28	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-475_f2051c68-cdd9-58b2-e053-2995a90a6b48	59088-475	HUMAN PRESCRIPTION DRUG	Lidorex		Lidocaine HCl	GEL	TOPICAL	20211025		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE	28	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-476_f2051c68-cddd-58b2-e053-2995a90a6b48	59088-476	HUMAN OTC DRUG	Micotrin AC		Clotrimazole	CREAM	TOPICAL	20211025		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59088-477_f2051fcb-c697-89a7-e053-2a95a90a415a	59088-477	HUMAN OTC DRUG	Micotrin AL		Tolnaftate	LIQUID	TOPICAL	20211025		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	TOLNAFTATE	.3	g/30mL			N	20241231
59088-478_f2051fcb-c69c-89a7-e053-2a95a90a415a	59088-478	HUMAN OTC DRUG	Micotrin AP		Miconazole Nitrate	POWDER	TOPICAL	20211025		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	MICONAZOLE NITRATE	2	g/85g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59088-479_d5923cc2-19c3-1e42-e053-2995a90a6a08	59088-479	HUMAN OTC DRUG	Circatrix		Capsaicin	CREAM	TOPICAL	20220114		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	CAPSICUM OLEORESIN	.05	g/100g			N	20241231
59088-480_f2051c68-cde0-58b2-e053-2995a90a6b48	59088-480	HUMAN PRESCRIPTION DRUG	Foliflex		Ferrous Fumarate, Folic Acid	TABLET	ORAL	20211025		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; BIOTIN; BORON; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CUPROUS OXIDE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PANTOTHENIC ACID; POTASSIUM CHLORIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	45; 250; 100; 25; 75; 13.75; 37.5; 1; 13; 9; 500; 37.5; .75; 25; 22.5; 15; 24.5; 25; 6; 3.35; 30; 3.25; 1500; 15	mg/1; mg/1; ug/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-483_cf715e54-c411-1e8f-e053-2995a90a076d	59088-483	HUMAN PRESCRIPTION DRUG	Lidotran		Lidocaine Hydrochloride	CREAM	TOPICAL	20220919		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE	38.8	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-488_d5f3bb66-a41e-1a0f-e053-2a95a90addde	59088-488	HUMAN OTC DRUG	Camphotrol		camphor, menthol	GEL	TOPICAL	20220118		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	CAMPHOR (SYNTHETIC); MENTHOL	4; 10	g/100g; g/100g			N	20241231
59088-489_da5d8eae-8d63-d354-e053-2995a90a7999	59088-489	HUMAN PRESCRIPTION DRUG	Urea 41%		Urea	CREAM	TOPICAL	20220607		UNAPPROVED DRUG OTHER		PureTek Corporation	UREA	410	mg/g			N	20241231
59088-524_d5922f8a-7f55-7e96-e053-2a95a90a70a1	59088-524	HUMAN PRESCRIPTION DRUG	Dotremin		Folic Acid, Vitamin D3	TABLET	ORAL	20220114		UNAPPROVED DRUG OTHER		PureTek Corporation	FOLIC ACID; VITAMIN D	1; 250	mg/1; ug/1	Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-525_d825970d-7bf4-c79f-e053-2995a90a6103	59088-525	HUMAN PRESCRIPTION DRUG	Multitam		Folic Acid	TABLET	ORAL	20220117		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM NICOTINATE; CYANOCOBALAMIN; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC OXIDE	30; 120; 200; 20; 35; 8; 1000; 200; 2.3; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-563_be0a852e-f302-4990-a4ac-f6dbd9474285	59088-563	HUMAN OTC DRUG	DermacinRx Zinc Oxide Skin Healing		Zinc Oxide	PASTE	TOPICAL	20160803		OTC MONOGRAPH FINAL	part347	PureTek Corporation	ZINC OXIDE	200	mg/g			N	20241231
59088-568_f20534c0-4cbf-31f7-e053-2995a90a6879	59088-568	HUMAN OTC DRUG	DermacinRx Skin Moisturizing Ultra SPF 50 Sunscreen		avobenzone, octinoxate, octisalate, titanium dioxide	LOTION	TOPICAL	20170216		OTC MONOGRAPH FINAL	part352	PureTek Corporation	AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	25; 30; 30; 12.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59088-587_9f30958e-2a0e-4a06-a834-1cba30bdf3c3	59088-587	HUMAN OTC DRUG	PharmapureRx Menthotral		lidocaine, menthol	CREAM	TOPICAL	20170803		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE ANHYDROUS; MENTHOL	38.8; 30	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-594_f20534c0-4cc0-31f7-e053-2995a90a6879	59088-594	HUMAN PRESCRIPTION DRUG	PharmapureRx Lidocaine HCl 4.12%		Lidocaine Hydrochloride	CREAM	TOPICAL	20171002		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE	41.2	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-596_d9ba1ca8-8882-11bb-e053-2995a90a5846	59088-596	HUMAN OTC DRUG	DiaSinc		Benzalkonium Chloride	SPRAY	TOPICAL	20230324		OTC MONOGRAPH NOT FINAL	part333E	PureTek Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59088-623_f94f2eac-1161-10bb-e053-6294a90a8f49	59088-623	HUMAN OTC DRUG	Dimopair		Dimethicone	CREAM	TOPICAL	20230329		OTC MONOGRAPH FINAL	part347	PureTek Corporation	DIMETHICONE	50	mg/mL	Skin Barrier Activity [PE]		N	20241231
59088-627_de990834-00db-0c7a-e053-2995a90a7c37	59088-627	HUMAN OTC DRUG	Zinctral		Zinc Oxide	PASTE	TOPICAL	20230324		OTC MONOGRAPH FINAL	part347	PureTek Corporation	ZINC OXIDE	20	g/100g			N	20241231
59088-630_dc2d2783-2a72-cb7c-e053-2995a90a9961	59088-630	HUMAN PRESCRIPTION DRUG	Naprotin		Naproxen , Capsaicin	KIT		20220927		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-640_de9842ba-0255-8ae1-e053-2995a90a0664	59088-640	HUMAN OTC DRUG	Micomitin Antifungal		Tolnaftate	LIQUID	TOPICAL	20230830		OTC MONOGRAPH FINAL	part333C	PureTek Corporation	TOLNAFTATE	.3	g/30mL			N	20241231
59088-643_e052d2c2-7a3e-37be-e053-2a95a90af21c	59088-643	HUMAN PRESCRIPTION DRUG	Dexatran		Multivitamin	CAPSULE	CUTANEOUS; ORAL	20230215		UNAPPROVED DRUG OTHER		PureTek Corporation	CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM SULFATE HEPTAHYDRATE; MANGANESE SULFATE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; ZINC SULFATE	10; .8; 15; 18; 1; 6.9; 1.3; 30; 5; 6; 200; 10; 18.2	mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
59088-659_0ccf48d9-b6ef-d809-e063-6294a90ab507	59088-659	HUMAN PRESCRIPTION DRUG	Livita Adults		Folate, Multivitamin	LIQUID	ORAL	20231215		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, D-; ASCORBIC ACID; BIOTIN; CALCIUM CITRATE; CALCIUM PANTOTHENATE; CHOLECALCIFEROL; CHOLINE BITARTRATE; INULIN; LEVOMEFOLATE CALCIUM; MAGNESIUM CITRATE; METHYLCOBALAMIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC PICOLINATE	20.1; 200; 30; 200; 5; 10; 200; 500; 1000; 100; 2.4; 8; 1.7; 1.3; 1.2; 900; 2	mg/mL; mg/mL; ug/mL; mg/mL; mg/mL; ug/mL; mg/mL; mg/mL; ug/mL; mg/mL; ug/mL; mg/mL; mg/mL; mg/mL; mg/mL; ug/mL; mg/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Folate Analog [EPC], Folic Acid [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-660_0ca12bbf-0b01-3432-e063-6294a90a8c45	59088-660	HUMAN PRESCRIPTION DRUG	Livita Children		Folate, Multivitamin	LIQUID	ORAL	20231218		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, D-; ASCORBIC ACID; BIOTIN; CALCIUM CITRATE; CALCIUM PANTOTHENATE; CHOLECALCIFEROL; CHOLINE BITARTRATE; INULIN; LEVOMEFOLATE CALCIUM; MAGNESIUM CITRATE; METHYLCOBALAMIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; VITAMIN A ACETATE; ZINC PICOLINATE	10; 66.67; 10; 66.67; 1.67; 3.33; 66.67; 166.67; 333; 33.33; .8; 2.67; .57; .43; .4; 300; .67	mg/mL; mg/mL; ug/mL; mg/mL; mg/mL; ug/mL; mg/mL; mg/mL; ug/mL; mg/mL; ug/mL; mg/mL; mg/mL; mg/mL; mg/mL; ug/mL; mg/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Folate Analog [EPC], Folic Acid [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-695_0c67d713-8906-2a32-e063-6394a90a8510	59088-695	HUMAN PRESCRIPTION DRUG	Davimet		Multivitamin	TABLET, CHEWABLE	ORAL	20220919		UNAPPROVED DRUG OTHER		PureTek Corporation	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; VITAMIN A	10; 24; 10; 4.5; 1667; 13.5; 1.05; 1.2; 36; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-698_ea2adf3e-cea5-43b2-e053-2995a90a89a6	59088-698	HUMAN PRESCRIPTION DRUG	Urea 39.5%		Urea	CREAM	TOPICAL	20230120		UNAPPROVED DRUG OTHER		PureTek Corporation	UREA	395	mg/g			N	20241231
59088-709_f2052af0-ff53-a86b-e053-2a95a90a970a	59088-709	HUMAN PRESCRIPTION DRUG	VennGel One		diclofenac sodium, isopropyl alcohol	KIT		20180502		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-712_b3ca4f65-2215-b30b-e053-2a95a90a85f9	59088-712	HUMAN PRESCRIPTION DRUG	LidoPure Patch		Lidocaine	KIT		20180606		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-713_f2052af0-ff59-a86b-e053-2a95a90a970a	59088-713	HUMAN OTC DRUG	Atrix System 1		Salicylic Acid	KIT		20211025		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-715_f20534c0-4ccc-31f7-e053-2995a90a6879	59088-715	HUMAN PRESCRIPTION DRUG	Lidotor		Lidocaine and Prilocaine	KIT	TOPICAL	20211217		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-716_fae1a312-56f6-ba8c-e053-6394a90a2114	59088-716	HUMAN PRESCRIPTION DRUG	Diclotrex		diclofenac sodium, camphor, menthol	KIT	TOPICAL	20181023	20240430	UNAPPROVED DRUG OTHER		PureTek Corporation						N	
59088-722_b3c8f469-3b77-8a60-e053-2995a90acb23	59088-722	HUMAN PRESCRIPTION DRUG	Lidoxryl		Lidocaine	KIT		20181023		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-724_b3ca019e-98e0-1007-e053-2a95a90a1690	59088-724	HUMAN PRESCRIPTION DRUG	Methocarb 500-EZS		Methocarbamol	KIT		20181023		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-725_b43e4780-f902-89d9-e053-2a95a90a6792	59088-725	HUMAN PRESCRIPTION DRUG	Gaba 300-EZS		Gabapentin	KIT		20181022		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-727_f2052af0-ff5f-a86b-e053-2a95a90a970a	59088-727	HUMAN PRESCRIPTION DRUG	Clofenax		Diclofenac Sodium, Kinesiology tape	KIT		20201209		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-730_f3095546-7f72-2665-e053-2995a90aff07	59088-730	HUMAN PRESCRIPTION DRUG	Triasil		Triamcinolone Acetonide	KIT		20230120		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-731_016ca0e2-0e4b-d469-e063-6294a90a4bb3	59088-731	HUMAN PRESCRIPTION DRUG	Xyliderm		Lidocaine, Isopropyl Alcohol	KIT		20230705		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-754_b4920f9f-1f45-d0df-e053-2995a90a80eb	59088-754	HUMAN PRESCRIPTION DRUG	Fluopar		fluocinonide, dimethicone	KIT		20140114		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-755_f2051c68-cdea-58b2-e053-2995a90a6b48	59088-755	HUMAN PRESCRIPTION DRUG	Fluocinol Pak		FLUOCINONIDE	KIT		20200702		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-756_f2051c68-cdec-58b2-e053-2995a90a6b48	59088-756	HUMAN PRESCRIPTION DRUG	IBUPAK		Ibuprofen	KIT	ORAL	20200522		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-771_60455df5-377e-4d76-9607-3d9a646fa241	59088-771	HUMAN PRESCRIPTION DRUG	Lidocaine HCl - Hydrocortisone Acetate		Lidocaine HCl and Hydrocortisone Acetate	CREAM	RECTAL	20110701		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE	10; 30	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE]		N	20241231
59088-772_f2054b5e-a881-1bd5-e053-2a95a90a015c	59088-772	HUMAN PRESCRIPTION DRUG	Sumansetron		sumatriptan succinate, ondansetron	KIT		20210101		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-778_f2054cd2-838e-7f92-e053-2995a90a9acc	59088-778	HUMAN OTC DRUG	Miconatate		Miconazole Nitrate and Tolnaftate	KIT		20210902		OTC MONOGRAPH FINAL	part333C	PureTek Corporation						N	20241231
59088-784_f951c6fe-b37a-c086-e053-6294a90a7deb	59088-784	HUMAN PRESCRIPTION DRUG	DermacinRx Lexitral PharmaPak II		diclofenac sodium, capsaicin	KIT		20220302	20240430	UNAPPROVED DRUG OTHER		PureTek Corporation						N	
59088-785_f951d678-06c1-7196-e053-6394a90ab32a	59088-785	HUMAN PRESCRIPTION DRUG	Diclotrex		diclofenac sodium, camphor, menthol	KIT	TOPICAL	20220302	20240430	UNAPPROVED DRUG OTHER		PureTek Corporation						N	
59088-786_0d0f04ad-5b77-49d8-e063-6394a90a99e1	59088-786	HUMAN PRESCRIPTION DRUG	LiquiCal with Magnesium		Multivitamin	LIQUID	ORAL	20231227		UNAPPROVED DRUG OTHER		PureTek Corporation	CALCIUM CITRATE; CHOLECALCIFEROL; MAGNESIUM CITRATE; ZINC CITRATE	168; 66; 48; 1.4	mg/mL; [iU]/mL; mg/mL; mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-795_04cf0026-e299-ffd5-e063-6294a90aca1f	59088-795	HUMAN PRESCRIPTION DRUG	Folcyteine		Multivitamin	TABLET	ORAL	20230914		UNAPPROVED DRUG OTHER		PureTek Corporation	ACETYLCYSTEINE; CALCIUM CITRATE; CHOLECALCIFEROL; FOLIC ACID; MAGNESIUM CITRATE	200; 47; 800; 1000; 16	mg/1; mg/1; [iU]/1; ug/1; mg/1	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Decreased Respiratory Secretion Viscosity [PE], Increased Coagulation Factor Activity [PE], Increased Glutathione Concentration [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mucolytic [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Reduction Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin D [CS], Vitamin D [EPC]		N	20241231
59088-801_042765e5-bd76-8224-e063-6394a90a141b	59088-801	HUMAN PRESCRIPTION DRUG	Lextol		Diclofenac Sodium, Capsaicin	KIT		20230830		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-805_f205510b-90f7-770f-e053-2995a90a7fb0	59088-805	HUMAN PRESCRIPTION DRUG	DermacinRx ZRM Pak		lidocaine, dimethicone	KIT		20160512		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-807_f2054cd2-8390-7f92-e053-2995a90a9acc	59088-807	HUMAN PRESCRIPTION DRUG	DermacinRx PHN Pak		lidocaine	KIT		20160517		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-816_7b16704a-a5d4-418c-84e0-5ad846744433	59088-816	HUMAN PRESCRIPTION DRUG	Lidocaine HCl - Hydrocortisone Acetate		Lidocaine HCl and Hydrocortisone Acetate	CREAM	RECTAL	20110701		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE	20; 20	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE]		N	20241231
59088-817_c332ca77-8e3a-4343-8d72-030af5d834b0	59088-817	HUMAN PRESCRIPTION DRUG	Lidocaine HCl - Hydrocortisone Acetate	with Aloe	Lidocaine HCl and Hydrocortisone Acetate	GEL	RECTAL	20110701		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE	5.5; 28	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE]		N	20241231
59088-819_f2054b5e-a884-1bd5-e053-2a95a90a015c	59088-819	HUMAN PRESCRIPTION DRUG	Lidocaine HCl - Hydrocortisone Acetate		Lidocaine HCl and Hydrocortisone Acetate	CREAM	RECTAL; TOPICAL	20110701		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE	5; 30	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE]		N	20241231
59088-829_a344d3df-d4e8-581c-e053-2a95a90a2f8e	59088-829	HUMAN OTC DRUG	GenRx Daily Defense Skin Repairing		Dimethicone	CREAM	TOPICAL	20130108		OTC MONOGRAPH FINAL	part347	PureTek Corporation	DIMETHICONE	17.5	mg/mL	Skin Barrier Activity [PE]		N	20241231
59088-838_3b04f4b3-5d07-4f70-a702-736638d3e193	59088-838	HUMAN PRESCRIPTION DRUG	Lidocaine HCl - Hydrocortisone Acetate		Lidocaine HCl and Hydrocortisone Acetate	GEL	RECTAL	20110622		UNAPPROVED DRUG OTHER		PureTek Corporation	HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE	25; 30	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE]		N	20241231
59088-893_b3d99068-2170-6ca3-e053-2995a90aae7f	59088-893	HUMAN PRESCRIPTION DRUG	DermacinRx Therazole Pak		clotrimazole and betamethasone dipropionate, zinc oxide	KIT		20160809		UNAPPROVED DRUG OTHER		PureTek Corporation						N	20241231
59088-905_fd8e4856-3784-4850-e053-6294a90a95b6	59088-905	HUMAN PRESCRIPTION DRUG	Lidocan		Lidocaine 5%	PATCH	TOPICAL	20200514		ANDA	ANDA209190	PURETEK CORPORATION	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-907_0c577d6d-c11e-146d-e063-6394a90a701a	59088-907	HUMAN PRESCRIPTION DRUG	Lidocan III		Lidocaine 5%	PATCH	TOPICAL	20200514		ANDA	ANDA209190	PURETEK CORPORATION	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59088-962_f2054cd2-8391-7f92-e053-2995a90a9acc	59088-962	HUMAN OTC DRUG	MyoRx	Pain Relieving	Menthol	CREAM	TOPICAL	20100128		OTC MONOGRAPH NOT FINAL	part348	PureTek Corporation	MENTHOL	20	mg/mL			N	20241231
59088-997_d5b00129-67ae-4003-8c9b-06b79fd1296b	59088-997	HUMAN PRESCRIPTION DRUG	Lidocaine HCl		Lidocaine HCl	CREAM	TOPICAL	20110613		UNAPPROVED DRUG OTHER		PureTek Corporation	LIDOCAINE HYDROCHLORIDE	30	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59110-081_3a277de2-ce1b-4a93-9933-22744ebfce08	59110-081	HUMAN OTC DRUG	QSC Foam Fresh Antimicrobial Hand		Chloroxylenol	LIQUID	TOPICAL	20080401		OTC MONOGRAPH NOT FINAL	part333E	Triple S a.k.a Standardized Sanitation Systems, Inc	CHLOROXYLENOL	.003	mg/mL			N	20241231
59110-082_776c389a-fe26-4d25-bc89-363972b089dd	59110-082	HUMAN OTC DRUG	QSC TF Ambre Antibacterial Wash		Chloroxylenol	LIQUID	TOPICAL	20080401		OTC MONOGRAPH NOT FINAL	part333E	Triple S a.k.a Standardized Sanitation Systems, Inc	CHLOROXYLENOL	.003	mg/mL			N	20241231
59110-400_8f21ce99-3f33-4d3d-bc73-c7e85982c4a0	59110-400	HUMAN OTC DRUG	Elevate TF Foam Skin Care Advance Antibacterial Foam Hand Cleaner		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Triple S a.k.a Standardized Sanitation Systems, Inc	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
59110-401_86c28f37-cd10-419c-9c0c-65d7b40eeb88	59110-401	HUMAN OTC DRUG	HygienePoint Advance Antibacterial F oam Hand Cleaner		Benzalkonium Chloride	LIQUID	TOPICAL	20180228		OTC MONOGRAPH NOT FINAL	part333E	Triple S a.k.a Standardized Sanitation Systems, Inc	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
59115-041_cb87b82e-ef92-4f64-a6c2-204e6aa3c7c8	59115-041	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070205		ANDA	ANDA065291	Hikma Pharmaceutical	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
59115-123_749d60f9-44ef-4609-a4da-4ba1d8140447	59115-123	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19900901		ANDA	ANDA062396	Hikma Pharmaceutical	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
59118-837_09d72589-140d-349f-e063-6294a90a4d95	59118-837	HUMAN OTC DRUG	Osteo Bi-Flex JOINT HEALTH PAIN RELIEVING		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20170801		OTC MONOGRAPH DRUG	M017	Rexall Sundown, LLC	MENTHOL; METHYL SALICYLATE	50; 100	mg/g; mg/g			N	20241231
59137-282_24ba2683-bb19-4b75-aecf-eba780472b61	59137-282	HUMAN PRESCRIPTION DRUG	Ixinity		coagulation factor IX (recombinant)	KIT		20170512		BLA	BLA125426	Medexus Pharma, Inc.						N	20251231
59137-283_24ba2683-bb19-4b75-aecf-eba780472b61	59137-283	HUMAN PRESCRIPTION DRUG	Ixinity		coagulation factor IX (recombinant)	KIT		20170512		BLA	BLA125426	Medexus Pharma, Inc.						N	20251231
59137-284_24ba2683-bb19-4b75-aecf-eba780472b61	59137-284	HUMAN PRESCRIPTION DRUG	Ixinity		coagulation factor IX (recombinant)	KIT		20170512		BLA	BLA125426	Medexus Pharma, Inc.						N	20251231
59137-287_24ba2683-bb19-4b75-aecf-eba780472b61	59137-287	HUMAN PRESCRIPTION DRUG	Ixinity		coagulation factor IX (recombinant)	KIT		20170512		BLA	BLA125426	Medexus Pharma, Inc.						N	20251231
59137-288_24ba2683-bb19-4b75-aecf-eba780472b61	59137-288	HUMAN PRESCRIPTION DRUG	Ixinity		coagulation factor IX (recombinant)	KIT		20170512		BLA	BLA125426	Medexus Pharma, Inc.						N	20251231
59137-289_24ba2683-bb19-4b75-aecf-eba780472b61	59137-289	HUMAN PRESCRIPTION DRUG	Ixinity		coagulation factor IX (recombinant)	KIT		20170512		BLA	BLA125426	Medexus Pharma, Inc.						N	20251231
59137-505_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-505	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	7.5	mg/.15mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-510_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-510	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	10	mg/.2mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-515_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-515	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	12.5	mg/.25mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-520_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-520	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	15	mg/.3mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-525_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-525	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	17.5	mg/.35mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-530_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-530	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	20	mg/.4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-535_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-535	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	22.5	mg/.45mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-540_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-540	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	25	mg/.5mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-550_169bcfc1-0a66-474e-9a3d-ddc365dde380	59137-550	HUMAN PRESCRIPTION DRUG	Rasuvo		methotrexate	INJECTION, SOLUTION	SUBCUTANEOUS	20140710		NDA	NDA205776	Medexus Pharma Inc.	METHOTREXATE SODIUM	30	mg/.6mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59137-570_f1eb64e8-05c0-931b-e053-2995a90a2fe8	59137-570	HUMAN PRESCRIPTION DRUG	Hexatrione	2%	triamcinolone hexacetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR	20210303		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Medexus Pharma, Inc.	TRIAMCINOLONE HEXACETONIDE	40	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59148-006_54fce3dd-d985-44ac-a5d8-d44be28fb2fa	59148-006	HUMAN PRESCRIPTION DRUG	ABILIFY		ARIPIPRAZOLE	TABLET	ORAL	20021115		NDA	NDA021436	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-007_54fce3dd-d985-44ac-a5d8-d44be28fb2fa	59148-007	HUMAN PRESCRIPTION DRUG	ABILIFY		ARIPIPRAZOLE	TABLET	ORAL	20021115		NDA	NDA021436	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-008_54fce3dd-d985-44ac-a5d8-d44be28fb2fa	59148-008	HUMAN PRESCRIPTION DRUG	ABILIFY		ARIPIPRAZOLE	TABLET	ORAL	20021115		NDA	NDA021436	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-009_54fce3dd-d985-44ac-a5d8-d44be28fb2fa	59148-009	HUMAN PRESCRIPTION DRUG	ABILIFY		ARIPIPRAZOLE	TABLET	ORAL	20021115		NDA	NDA021436	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-010_54fce3dd-d985-44ac-a5d8-d44be28fb2fa	59148-010	HUMAN PRESCRIPTION DRUG	ABILIFY		ARIPIPRAZOLE	TABLET	ORAL	20021115		NDA	NDA021436	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-011_54fce3dd-d985-44ac-a5d8-d44be28fb2fa	59148-011	HUMAN PRESCRIPTION DRUG	ABILIFY		ARIPIPRAZOLE	TABLET	ORAL	20021115		NDA	NDA021436	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-018_8f12a17b-6fbd-4db0-bea1-867f1f2b7d7b	59148-018	HUMAN PRESCRIPTION DRUG	ABILIFY MAINTENA		aripiprazole	KIT		20130228		NDA	NDA202971	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-019_8f12a17b-6fbd-4db0-bea1-867f1f2b7d7b	59148-019	HUMAN PRESCRIPTION DRUG	ABILIFY MAINTENA		aripiprazole	KIT		20130228		NDA	NDA202971	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-020_17d25d59-6f09-4e2e-9c87-382d4f780e4f	59148-020	HUMAN PRESCRIPTION DRUG	SAMSCA		tolvaptan	TABLET	ORAL	20090519		NDA	NDA022275	Otsuka America Pharmaceutical, Inc.	TOLVAPTAN	15	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
59148-021_17d25d59-6f09-4e2e-9c87-382d4f780e4f	59148-021	HUMAN PRESCRIPTION DRUG	SAMSCA		tolvaptan	TABLET	ORAL	20090519		NDA	NDA022275	Otsuka America Pharmaceutical, Inc.	TOLVAPTAN	30	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
59148-029_e9560dde-6499-413d-abc5-9f4b5ed8504f	59148-029	HUMAN PRESCRIPTION DRUG	Abilify MyCite		ARIPIPRAZOLE	TABLET WITH SENSOR	ORAL	20180131		NDA	NDA207202	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-030_e9560dde-6499-413d-abc5-9f4b5ed8504f	59148-030	HUMAN PRESCRIPTION DRUG	Abilify MyCite		ARIPIPRAZOLE	TABLET WITH SENSOR	ORAL	20180131		NDA	NDA207202	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-031_e9560dde-6499-413d-abc5-9f4b5ed8504f	59148-031	HUMAN PRESCRIPTION DRUG	Abilify MyCite		ARIPIPRAZOLE	TABLET WITH SENSOR	ORAL	20180131		NDA	NDA207202	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-032_e9560dde-6499-413d-abc5-9f4b5ed8504f	59148-032	HUMAN PRESCRIPTION DRUG	Abilify MyCite		ARIPIPRAZOLE	TABLET WITH SENSOR	ORAL	20180131		NDA	NDA207202	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-033_e9560dde-6499-413d-abc5-9f4b5ed8504f	59148-033	HUMAN PRESCRIPTION DRUG	Abilify MyCite		ARIPIPRAZOLE	TABLET WITH SENSOR	ORAL	20180131		NDA	NDA207202	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-034_e9560dde-6499-413d-abc5-9f4b5ed8504f	59148-034	HUMAN PRESCRIPTION DRUG	Abilify MyCite		ARIPIPRAZOLE	TABLET WITH SENSOR	ORAL	20180131		NDA	NDA207202	Otsuka America Pharmaceutical, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-035_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-035	HUMAN PRESCRIPTION DRUG	Rexulti		brexpiprazole	TABLET	ORAL	20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.	BREXPIPRAZOLE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-036_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-036	HUMAN PRESCRIPTION DRUG	Rexulti		brexpiprazole	TABLET	ORAL	20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.	BREXPIPRAZOLE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-037_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-037	HUMAN PRESCRIPTION DRUG	Rexulti		brexpiprazole	TABLET	ORAL	20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.	BREXPIPRAZOLE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-038_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-038	HUMAN PRESCRIPTION DRUG	Rexulti		brexpiprazole	TABLET	ORAL	20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.	BREXPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-039_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-039	HUMAN PRESCRIPTION DRUG	Rexulti		brexpiprazole	TABLET	ORAL	20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.	BREXPIPRAZOLE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-040_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-040	HUMAN PRESCRIPTION DRUG	Rexulti		brexpiprazole	TABLET	ORAL	20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.	BREXPIPRAZOLE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59148-042_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-042	HUMAN PRESCRIPTION DRUG	Rexulti		BREXPIPRAZOLE	KIT		20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-044_57cc61f4-a0f8-46c1-a328-9605180f266e	59148-044	HUMAN PRESCRIPTION DRUG	Rexulti		BREXPIPRAZOLE	KIT		20150710		NDA	NDA205422	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-045_8f12a17b-6fbd-4db0-bea1-867f1f2b7d7b	59148-045	HUMAN PRESCRIPTION DRUG	ABILIFY MAINTENA		aripiprazole	KIT		20141008		NDA	NDA202971	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-046_cb51f321-5384-4486-bcc5-8d86550cae3e	59148-046	HUMAN PRESCRIPTION DRUG	Dacogen		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060502	20240831	NDA	NDA021790	Otsuka America Pharmaceutical, Inc.	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	
59148-053_99646f6f-58d9-4f4b-a17f-f4d43288ff4a	59148-053	HUMAN PRESCRIPTION DRUG	Nuedexta		dextromethorphan hydrobromide and quinidine sulfate	CAPSULE, GELATIN COATED	ORAL	20230103		NDA	NDA021879	Otsuka America Pharmaceutical, Inc	DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE	20; 10	mg/1; mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59148-070_2745864d-fe8a-4035-a57a-0a64efc0c9fe	59148-070	HUMAN PRESCRIPTION DRUG	BUSULFEX		busulfan	INJECTION	INTRAVENOUS	19990204		NDA	NDA020954	Otsuka America Pharmaceutical, Inc.	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
59148-072_8f12a17b-6fbd-4db0-bea1-867f1f2b7d7b	59148-072	HUMAN PRESCRIPTION DRUG	ABILIFY MAINTENA		aripiprazole	KIT		20141008		NDA	NDA202971	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-079_7d0942d7-af91-43ce-a85c-6d49976f06ee	59148-079	HUMAN PRESCRIPTION DRUG	Jynarque		tolvaptan	KIT		20200113		NDA	NDA204441	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-080_7d0942d7-af91-43ce-a85c-6d49976f06ee	59148-080	HUMAN PRESCRIPTION DRUG	Jynarque		tolvaptan	KIT		20200113		NDA	NDA204441	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-082_7d0942d7-af91-43ce-a85c-6d49976f06ee	59148-082	HUMAN PRESCRIPTION DRUG	JYNARQUE		tolvaptan	TABLET	ORAL	20180423		NDA	NDA204441	Otsuka America Pharmaceutical, Inc.	TOLVAPTAN	15	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
59148-083_7d0942d7-af91-43ce-a85c-6d49976f06ee	59148-083	HUMAN PRESCRIPTION DRUG	JYNARQUE		tolvaptan	TABLET	ORAL	20180423		NDA	NDA204441	Otsuka America Pharmaceutical, Inc.	TOLVAPTAN	30	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
59148-087_7d0942d7-af91-43ce-a85c-6d49976f06ee	59148-087	HUMAN PRESCRIPTION DRUG	Jynarque		tolvaptan	KIT		20180423		NDA	NDA204441	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-088_7d0942d7-af91-43ce-a85c-6d49976f06ee	59148-088	HUMAN PRESCRIPTION DRUG	Jynarque		tolvaptan	KIT		20180423		NDA	NDA204441	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-089_7d0942d7-af91-43ce-a85c-6d49976f06ee	59148-089	HUMAN PRESCRIPTION DRUG	Jynarque		tolvaptan	KIT		20180423		NDA	NDA204441	Otsuka America Pharmaceutical, Inc.						N	20241231
59148-102_1a7e9b25-5e3a-49ad-8bb8-86c480399ff8	59148-102	HUMAN PRESCRIPTION DRUG	Abilify Asimtufii		Aripiprazole	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20230427		NDA	NDA217006	Otsuka America Pharmaceutical, Inc	ARIPIPRAZOLE	720	mg/2.4mL	Atypical Antipsychotic [EPC]		N	20241231
59148-114_1a7e9b25-5e3a-49ad-8bb8-86c480399ff8	59148-114	HUMAN PRESCRIPTION DRUG	Abilify Asimtufii		Aripiprazole	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20230427		NDA	NDA217006	Otsuka America Pharmaceutical, Inc	ARIPIPRAZOLE	960	mg/3.2mL	Atypical Antipsychotic [EPC]		N	20241231
59190-416_0c0756fc-65fd-e814-e063-6294a90a32bf	59190-416	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030515		UNAPPROVED MEDICAL GAS		Ascension Via Christi Home Medical Wichita, LLC	OXYGEN	99	L/100L			N	20241231
59208-001_f381a4ac-4770-6536-e053-2995a90a9954	59208-001	HUMAN OTC DRUG	Conazol		Miconazole Nitrate	CREAM	TOPICAL	20190301		OTC MONOGRAPH FINAL	M005	Laboratorios Liomont, S.A. de C.V.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59208-002_89080d3c-70e2-7f07-e053-2995a90a6230	59208-002	HUMAN OTC DRUG	CICLOFERON		benzalkonium chloride and lidocaine hydrochloride	GEL	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part348	Laboratorios Liomont, S.A. de C.V.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 20	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59212-001_c124072c-1f16-4359-942d-e48a3b593ff2	59212-001	HUMAN PRESCRIPTION DRUG	Dibenzyline		Phenoxybenzamine Hydrochloride	CAPSULE	ORAL	19530126		NDA	NDA008708	Concordia Pharmaceuticals Inc.	PHENOXYBENZAMINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59212-002_ca00e551-999b-48d9-9306-095c961c06e3	59212-002	HUMAN PRESCRIPTION DRUG	Dyrenium		Triamterene	CAPSULE	ORAL	19991001		NDA	NDA013174	Concordia Pharmaceuticals Inc.	TRIAMTERENE	50	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
59212-003_ca00e551-999b-48d9-9306-095c961c06e3	59212-003	HUMAN PRESCRIPTION DRUG	Dyrenium		Triamterene	CAPSULE	ORAL	19990101		NDA	NDA013174	Concordia Pharmaceuticals Inc.	TRIAMTERENE	100	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
59212-111_e834bedb-32de-4f3a-b9f3-cb5f4804d046	59212-111	HUMAN PRESCRIPTION DRUG	Nilandron		Nilutamide	TABLET	ORAL	20130715		NDA	NDA020169	Concordia Pharmaceuticals Inc.	NILUTAMIDE	150	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
59212-200_9f852c9b-350d-4d1a-a54a-85151ccad544	59212-200	HUMAN PRESCRIPTION DRUG	Uroxatral		Alfuzosin HCl	TABLET, EXTENDED RELEASE	ORAL	20130603		NDA	NDA021287	Concordia Pharmaceuticals Inc.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59212-240_65e512ed-5838-46e1-81ae-3fe98bbca7dd	59212-240	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	TABLET	ORAL	20120930		NDA	NDA020405	Concordia Pharmaceuticals Inc.	DIGOXIN	.0625	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
59212-242_65e512ed-5838-46e1-81ae-3fe98bbca7dd	59212-242	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	TABLET	ORAL	20120930		NDA	NDA020405	Concordia Pharmaceuticals Inc.	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
59212-249_65e512ed-5838-46e1-81ae-3fe98bbca7dd	59212-249	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	TABLET	ORAL	20120930		NDA	NDA020405	Concordia Pharmaceuticals Inc.	DIGOXIN	.25	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
59212-422_1bac18c3-7e0c-4391-a763-479b6e26b960	59212-422	HUMAN PRESCRIPTION DRUG	Donnatal		phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide	ELIXIR	ORAL	19801230		UNAPPROVED DRUG OTHER		Concordia Pharmaceuticals Inc.	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
59212-423_1bac18c3-7e0c-4391-a763-479b6e26b960	59212-423	HUMAN PRESCRIPTION DRUG	Donnatal		phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide	ELIXIR	ORAL	19801230		UNAPPROVED DRUG OTHER		Concordia Pharmaceuticals Inc.	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
59212-425_29d98e6b-05f6-4719-bda4-66d681279738	59212-425	HUMAN PRESCRIPTION DRUG	Donnatal		PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE	TABLET	ORAL	19801230		UNAPPROVED DRUG OTHER		Concordia Pharmaceuticals Inc.	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/1; mg/1; mg/1; mg/1	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
59212-447_62d9e217-415e-477a-a4f6-a340db01b902	59212-447	HUMAN PRESCRIPTION DRUG	PARNATE		tranylcypromine sulfate	TABLET, FILM COATED	ORAL	20130114		NDA	NDA012342	Concordia Pharmaceuticals Inc.	TRANYLCYPROMINE SULFATE	10	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
59212-562_3daeac21-611e-4b97-82bb-82ab25ce3db4	59212-562	HUMAN PRESCRIPTION DRUG	Plaquenil		Hydroxychloroquine Sulfate	TABLET	ORAL	20130628		NDA	NDA009768	Concordia Pharmaceuticals Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
59212-601_1629bcf4-47bc-4203-878f-c7daeb6e8fc7	59212-601	HUMAN PRESCRIPTION DRUG	PANRETIN		alitretinoin	GEL	TOPICAL	20190910		NDA	NDA020886	Concordia Pharmaceuticals Inc.	ALITRETINOIN	60	mg/60g	Retinoid [EPC], Retinoids [CS]		N	20241231
59212-680_93089228-c3a5-4e71-baac-58a930480f2b	59212-680	HUMAN PRESCRIPTION DRUG	Zonegran		Zonisamide	CAPSULE	ORAL	20000327		NDA	NDA020789	Concordia Pharmaceuticals Inc.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
59212-681_93089228-c3a5-4e71-baac-58a930480f2b	59212-681	HUMAN PRESCRIPTION DRUG	Zonegran		Zonisamide	CAPSULE	ORAL	20000327		NDA	NDA020789	Concordia Pharmaceuticals Inc.	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
59212-700_e5eab968-b004-4c92-9a7b-e9f20b4b1134	59212-700	HUMAN PRESCRIPTION DRUG	Orapred	ODT	prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING	ORAL	20060601		NDA	NDA021959	Concordia Pharmaceuticals Inc.	PREDNISOLONE SODIUM PHOSPHATE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59212-701_e5eab968-b004-4c92-9a7b-e9f20b4b1134	59212-701	HUMAN PRESCRIPTION DRUG	Orapred	ODT	prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING	ORAL	20060601		NDA	NDA021959	Concordia Pharmaceuticals Inc.	PREDNISOLONE SODIUM PHOSPHATE	15	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59212-702_e5eab968-b004-4c92-9a7b-e9f20b4b1134	59212-702	HUMAN PRESCRIPTION DRUG	Orapred	ODT	prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING	ORAL	20060601		NDA	NDA021959	Concordia Pharmaceuticals Inc.	PREDNISOLONE SODIUM PHOSPHATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59212-705_4e407b8d-c8ad-4907-9246-45685ee55052	59212-705	HUMAN PRESCRIPTION DRUG	Salagen		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20190901		NDA	NDA020237	Concordia Pharmaceuticals Inc.	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
59212-775_4e407b8d-c8ad-4907-9246-45685ee55052	59212-775	HUMAN PRESCRIPTION DRUG	Salagen		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20190901		NDA	NDA020237	Concordia Pharmaceuticals Inc.	PILOCARPINE HYDROCHLORIDE	7.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
59228-103_dd463d5c-cb68-c72f-e053-2a95a90a0ecc	59228-103	HUMAN OTC DRUG	SINOFRESH	NASAL AND SINUS CARE	EUCALYPTUS GLOBULUS LEAF, POTASSIUM DICHROMATE	LIQUID	TOPICAL	20140530		UNAPPROVED DRUG OTHER		EMS Contract Packaging	EUCALYPTUS GLOBULUS LEAF; POTASSIUM DICHROMATE	20; 30	[hp_X]/100mL; [hp_X]/100mL			N	20241231
59228-104_dd46426d-7112-0d40-e053-2995a90a7e1a	59228-104	HUMAN OTC DRUG	HOLY WATER MERCY IN A BOTTLE		LIDOCAINE HCL, BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20190425		OTC MONOGRAPH NOT FINAL	part348	EMS Contract Packaging	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.1; 4	g/1000mL; g/1000mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59228-105_dd46464c-1b3a-6b27-e053-2995a90a246f	59228-105	HUMAN OTC DRUG	ANTISEPTIC SINOFRESH KOOL BLAST THROAT		MENTHA PIPERITA	SPRAY	ORAL	20200928		UNAPPROVED DRUG OTHER		EMS Contract Packaging	MENTHA PIPERITA	3	[hp_X]/100mL			N	20241231
59228-501_ecfa9109-e93e-ad4e-e053-2a95a90a372b	59228-501	HUMAN OTC DRUG	INSTANT HAND SANITIZER WITH ALOE	66.5% ETHYL ALCOHOL	ETHYL ALCOHOL	GEL	TOPICAL	20221018		OTC MONOGRAPH NOT FINAL	part333A	Ems Acquisition Corp.	ALCOHOL	66.5	mL/100mL			N	20241231
59247-001_082b2ef3-c42b-9174-e063-6394a90a336d	59247-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20090926		UNAPPROVED MEDICAL GAS		GSH Home Med Care, Inc. dba WellSpan Medical Equipment	OXYGEN	99	L/100L			N	20241231
59256-001_0c86777f-3d1a-5e1d-e063-6294a90a2369	59256-001	HUMAN OTC DRUG	Audiologists Choice Earwax Removal System		CARBAMIDE PEROXIDE	LIQUID	TOPICAL	20141128		OTC MONOGRAPH DRUG	M014	Oaktree Products Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
59256-004_0c57e5c6-fdce-bbe6-e063-6294a90ae743	59256-004	HUMAN OTC DRUG	Audiologist Anti-itch		HYDROCORTISONE	CREAM	TOPICAL	20130210		OTC MONOGRAPH DRUG	M017	OAKTREE PRODUCTS, INC.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59256-836_0c7fd25e-6acf-1a54-e063-6294a90af27d	59256-836	HUMAN OTC DRUG	Audiologists Choice Earwax Removal Aid Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20160601		OTC MONOGRAPH DRUG	M014	Oaktree Products Inc	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
59262-240_e7022d4f-c1d3-4a94-88d3-8ff9fffde6ef	59262-240	HUMAN OTC DRUG	Sinus Relief		Kali bichromicum, Luffa operculata, Sabadilla	SPRAY	NASAL	20130702		UNAPPROVED HOMEOPATHIC		Similasan Corporation	LUFFA OPERCULATA FRUIT; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
59262-241_76f74dfb-319a-488c-bbe4-14cf17200568	59262-241	HUMAN OTC DRUG	Nasal Allergy Relief		cardiospermum halicacabum flowering top, galphimia glauca flowering top, luffa operculata fruit and schoenocaulon officinale seed	SPRAY	NASAL	20100515		UNAPPROVED HOMEOPATHIC		Similasan Corporation	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
59262-245_3cefe660-945b-428c-979a-362b3a68a856	59262-245	HUMAN OTC DRUG	Kids Nasal Allergy Relief		cardiospermum halicacabum flowering top, galphimia glauca flowering top, luffa operculata fruit and schoenocaulon officinale seed	SPRAY	NASAL	20190215		UNAPPROVED HOMEOPATHIC		Similasan Corporation	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
59262-265_b6ade568-ba3a-42a5-9cc1-7ee79d6315b1	59262-265	HUMAN OTC DRUG	Kids Cough and Cold Relief Plus Echinacea, Nighttime		atropa belladonna, matricaria recutita, copper, drosera rotundifolia flowering top, echinacea pallida, ferrosoferric phosphate, polygala senega root and zinc	SYRUP	ORAL	20160201		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; COPPER; DROSERA ROTUNDIFOLIA FLOWERING TOP; ECHINACEA PALLIDA; FERROSOFERRIC PHOSPHATE; MATRICARIA RECUTITA; POLYGALA SENEGA ROOT; ZINC	6; 12; 4; 6; 12; 8; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
59262-266_fc05b1b0-c6c8-4041-a3c9-e731432b5a1e	59262-266	HUMAN OTC DRUG	Kids Cold and Mucus Relief Plus Echinacea		atropa belladonna, drosera rotundifolia flowering top, echinacea pallida, prunus laurocerasus leaf, rumex crispus root, linum catharticum, verbascum thapsus and zinc	SYRUP	ORAL	20160201		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; DROSERA ROTUNDIFOLIA FLOWERING TOP; ECHINACEA PALLIDA; LINUM CATHARTICUM; PRUNUS LAUROCERASUS LEAF; RUMEX CRISPUS ROOT; VERBASCUM THAPSUS; ZINC	6; 4; 6; 6; 4; 4; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
59262-271_1b18a824-a70c-4420-8943-372d29521192	59262-271	HUMAN OTC DRUG	Similasan Earache Relief		CHAMOMILE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20130702		UNAPPROVED HOMEOPATHIC		Similasan Corporation	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-272_3470eb8c-9fe4-43a8-82ab-29ebc65f0b11	59262-272	HUMAN OTC DRUG	Ear Wax Relief		causticum, graphite, lachesis muta venom and lycopodium clavatum spore	SOLUTION	AURICULAR (OTIC)	20030601		UNAPPROVED HOMEOPATHIC		Similasan Corporation	CAUSTICUM; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE	12; 15; 12; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-275_7ec5b3b9-d805-4529-9617-079605b5fecf	59262-275	HUMAN OTC DRUG	Ear Ringing Remedy		ALLYLTHIOUREA, ARNICA MONTANA FLOWER, CALCIUM SULFIDE, ERIODICTYON CALIFORNICUM LEAF, LACHESIS MUTA VENOM, LYCOPODIUM CLAVATUM SPORE, QUININE SULFATE, SILICA DIMETHYL SILYLATE	SOLUTION	AURICULAR (OTIC)	20180101		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ALLYLTHIOUREA; ARNICA MONTANA FLOWER; CALCIUM SULFIDE; ERIODICTYON CALIFORNICUM LEAF; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; QUININE SULFATE; SILICA DIMETHYL SILYLATE	15; 15; 12; 12; 15; 12; 12; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL	Antimalarial [EPC]		N	20241231
59262-276_9055bf93-f2ed-42ae-8415-637b0f93cdf1	59262-276	HUMAN OTC DRUG	Kids Earache Relief		Matricaria recutita, Mercurius Solubilis, Anemone patens and Sulphur	SOLUTION	AURICULAR (OTIC)	20180720		UNAPPROVED HOMEOPATHIC		Similasan Corporation	MATRICARIA CHAMOMILLA; MERCURIUS SOLUBILIS; PULSATILLA PATENS WHOLE; SULFUR	10; 15; 12; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-278_9f99bd78-dea0-435f-aab3-06fe239195c9	59262-278	HUMAN OTC DRUG	Swimmers Ear Relief		ANEMONE PULSATILLA, GRAPHITE and SULFUR	LIQUID	AURICULAR (OTIC)	20201215		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ANEMONE PULSATILLA; GRAPHITE; SULFUR	12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
59262-346_6b382327-892b-4c5a-87cb-c1956c56c300	59262-346	HUMAN OTC DRUG	Allergy Eye Relief		apis mellifera, euphrasia stricta and schoenocaulon officinale seed	SOLUTION/ DROPS	OPHTHALMIC	19850101		UNAPPROVED HOMEOPATHIC		Similasan Corporation	APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
59262-347_81bf57bf-a622-496a-856f-9b37b67dcda9	59262-347	HUMAN OTC DRUG	Computer Eye Relief		Conium maculatum and Natrium muriaticum and Ruta graveolens and Senega officinalis	SOLUTION/ DROPS	OPHTHALMIC	20130702		UNAPPROVED HOMEOPATHIC		Similasan Corporation	CONIUM MACULATUM FLOWERING TOP; POLYGALA SENEGA ROOT; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE	6; 6; 6; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
59262-350_a0b01b13-72d5-44ee-8164-9505189d06b0	59262-350	HUMAN OTC DRUG	Stye Eye Relief		conium maculatum flowering top, graphite and sulfur	SOLUTION/ DROPS	OPHTHALMIC	20050102		UNAPPROVED HOMEOPATHIC		Similasan Corporation	CONIUM MACULATUM FLOWERING TOP; GRAPHITE; SULFUR	6; 12; 12	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-353_69c0ddc0-83ad-4305-8849-eaec9d0a7a92	59262-353	HUMAN OTC DRUG	Allergy Eye Relief		Apis Mellifera and Euphrasia Stricta and Schoenocaulon Officinale Seed	SOLUTION/ DROPS	OPHTHALMIC	20130702		UNAPPROVED HOMEOPATHIC		Similasan Corporation	APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/.4mL; [hp_X]/.4mL; [hp_X]/.4mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
59262-360_2c212019-a1e6-4fd0-9da9-a9d5b6e2d3f8	59262-360	HUMAN OTC DRUG	Aging Eye Relief		jacobaea maritima, sodium chloride and ruta graveolens flowering top	SOLUTION/ DROPS	OPHTHALMIC	20140401		UNAPPROVED HOMEOPATHIC		Similasan Corporation	JACOBAEA MARITIMA; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE	6; 6; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-361_6cd22fb6-31bf-4971-bd0c-6cfd49cf0041	59262-361	HUMAN OTC DRUG	Kids Allergy Eye Relief		Apis and Euphrasia and Pulsatilla and Sabadilla	SOLUTION/ DROPS	OPHTHALMIC	20130702		UNAPPROVED HOMEOPATHIC		Similasan Corporation	APIS MELLIFERA; EUPHRASIA STRICTA; PULSATILLA VULGARIS; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
59262-364_d59de1c4-6935-4eb3-bebb-502be1cd64ee	59262-364	HUMAN OTC DRUG	Allergy Eye Relief		apis mellifera, euphrasia stricta, schoenocaulon officinale seed	SOLUTION/ DROPS	OPHTHALMIC	20150413		UNAPPROVED HOMEOPATHIC		Similasan Corporation	APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
59262-365_60c1a687-1e43-4007-9eae-cc616f111d0e	59262-365	HUMAN OTC DRUG	Pink Eye Relief		Belladonna, Euphrasia officinalis, Hepar sulphuris	SOLUTION/ DROPS	OPHTHALMIC	20170201		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA	6; 12; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-373_0c795def-1b89-42fc-bb6d-285e0e8703e2	59262-373	HUMAN OTC DRUG	Complete Eye Relief		atropa belladonna, euphrasia stricta and mercuric chloride	SOLUTION/ DROPS	OPHTHALMIC	20190215		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-374_124b7379-b6b5-4b2b-8df2-06373ba8dd7f	59262-374	HUMAN OTC DRUG	Dry Eye Relief		atropa belladonna, euphrasia stricta and mercuric chloride	SOLUTION/ DROPS	OPHTHALMIC	20190215		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-375_d5c9262c-2fe5-4492-a85a-1cab9de1126c	59262-375	HUMAN OTC DRUG	Dry Eye Relief		Atropa Belladonna and Euphrasia Stricta and Mercuric Chloride	SOLUTION/ DROPS	OPHTHALMIC	20190301		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/.4mL; [hp_X]/.4mL; [hp_X]/.4mL			N	20241231
59262-376_57bc88f1-8161-4dae-a023-069eebe7083f	59262-376	HUMAN OTC DRUG	Dry Eye Relief Trial Size 15x		Belladonna, Euphrasia officinalis, Mercurius sublimatus,	SOLUTION/ DROPS	OPHTHALMIC	20210708		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE	6; 6; 15	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-377_8d22a90e-f0ed-4d3e-876d-54440123255c	59262-377	HUMAN OTC DRUG	Pink Eye Nighttime		Belladonna, Euphrasia officinalis, Hepar sulphuris	GEL	OPHTHALMIC	20201109		UNAPPROVED HOMEOPATHIC		Similasan Corporation	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA	6; 12; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
59262-700_0e0a38f3-d1c5-9b98-e063-6394a90a80dc	59262-700	HUMAN OTC DRUG	iVizia Dry Eye		Povidone	SOLUTION/ DROPS	OPHTHALMIC	20211129		OTC MONOGRAPH DRUG	M018	Similasan Corporation	POVIDONE	25	mg/5mL			N	20251231
59262-700_0e0a80c9-b262-91ae-e063-6294a90a7694	59262-700	HUMAN OTC DRUG	iVizia Dry Eye		Povidone	SOLUTION/ DROPS	OPHTHALMIC	20210930		OTC MONOGRAPH DRUG	M017	Similasan Corporation	POVIDONE	25	mg/5mL			N	20251231
59262-700_0e0c5e5c-adb5-1b9e-e063-6394a90a4283	59262-700	HUMAN OTC DRUG	iVizia Dry Eye		Povidone	SOLUTION/ DROPS	OPHTHALMIC	20211129		OTC MONOGRAPH DRUG	M018	Similasan Corporation	POVIDONE	50	mg/10mL			N	20251231
59262-701_941cec6d-9879-4153-b834-e12008196994	59262-701	HUMAN OTC DRUG	iVizia Lubricant Eye for Severe Night Dry Eyes		Povidone	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20211014		OTC MONOGRAPH FINAL	part349	Similasan Corporation	POVIDONE	2.5	mg/.5g			N	20241231
59267-4315_09aad84c-c106-4768-848a-11e6d34f3899	59267-4315	VACCINE	Pfizer-BioNTech Covid-19 Vaccine		covid-19 vaccine, mrna	INJECTION, SUSPENSION	INTRAMUSCULAR	20230911		EMERGENCY USE AUTHORIZATION		Pfizer Manufacturing Belgium NV	RAXTOZINAMERAN	.0158	mg/1.58mL			N	20241231
59267-4331_09aad84c-c106-4768-848a-11e6d34f3899	59267-4331	VACCINE	Pfizer-BioNTech Covid-19 Vaccine		covid-19 vaccine, mrna	INJECTION, SUSPENSION	INTRAMUSCULAR	20230911		EMERGENCY USE AUTHORIZATION		Pfizer Manufacturing Belgium NV	RAXTOZINAMERAN	.0158	mg/.48mL			N	20241231
59276-416_713cf5aa-b2f4-442a-abdb-47f107c5faa3	59276-416	HUMAN OTC DRUG	Real Eyewash		Eyewash	SOLUTION	OPHTHALMIC	20150130		NDA	NDA022305	Oliver Landon Intl Inc.	WATER	.983	mL/mL			N	20241231
59294-000_08052624-b8b6-78e9-e063-6294a90ae503	59294-000	HUMAN OTC DRUG	Alcohol Prep Pad		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20130711		OTC MONOGRAPH DRUG	M003	Global Healthcare	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
59294-001_08143945-c1e1-075b-e063-6394a90ad5de	59294-001	HUMAN OTC DRUG	Alcohol Prep Pad		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20130711		OTC MONOGRAPH DRUG	M003	Global Healthcare	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
59301-001_0a47e104-7110-9022-e063-6394a90a5974	59301-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110831		UNAPPROVED MEDICAL GAS		Oxygen Support Systems Inc	OXYGEN	99	L/100L			N	20241231
59310-111_d4ba573d-49f5-444d-8b91-11764ea3de8f	59310-111	HUMAN PRESCRIPTION DRUG	AirDuo Digihaler		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	55; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-114_8fd236af-c81c-46e9-819e-b37891da2662	59310-114	HUMAN PRESCRIPTION DRUG	ArmonAir Digihaler		Fluticasone Propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208798	Teva Respiratory, LLC	FLUTICASONE PROPIONATE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-117_af8a51e2-e673-4dde-8fb7-c2f8197e50b0	59310-117	HUMAN PRESCRIPTION DRUG	ProAir Digihaler		albuterol sulfate	INHALANT	RESPIRATORY (INHALATION)	20191004		NDA	NDA205636	Teva Respiratory, LLC	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-129_d4ba573d-49f5-444d-8b91-11764ea3de8f	59310-129	HUMAN PRESCRIPTION DRUG	AirDuo Digihaler		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	113; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-136_d4ba573d-49f5-444d-8b91-11764ea3de8f	59310-136	HUMAN PRESCRIPTION DRUG	AirDuo Digihaler		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	232; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-200_8fd236af-c81c-46e9-819e-b37891da2662	59310-200	HUMAN PRESCRIPTION DRUG	ArmonAir Digihaler		Fluticasone Propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208798	Teva Respiratory, LLC	FLUTICASONE PROPIONATE	113	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-302_742842ea-9ee4-4223-920f-07eed06499f8	59310-302	HUMAN PRESCRIPTION DRUG	QVAR REDIHALER		Beclomethasone Dipropionate HFA	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180215		NDA	NDA207921	Teva Respiratory, LLC	BECLOMETHASONE DIPROPIONATE	40	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-304_742842ea-9ee4-4223-920f-07eed06499f8	59310-304	HUMAN PRESCRIPTION DRUG	QVAR REDIHALER		Beclomethasone Dipropionate HFA	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180215		NDA	NDA207921	Teva Respiratory, LLC	BECLOMETHASONE DIPROPIONATE	80	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-311_8fd236af-c81c-46e9-819e-b37891da2662	59310-311	HUMAN PRESCRIPTION DRUG	ArmonAir Digihaler		Fluticasone Propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208798	Teva Respiratory, LLC	FLUTICASONE PROPIONATE	232	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-406_e9df165d-79e9-4f86-8446-00995793a36b	59310-406	HUMAN PRESCRIPTION DRUG	QNASL		Beclomethasone Dipropionate	AEROSOL, METERED	NASAL	20190102		NDA	NDA202813	Teva Respiratory, LLC	BECLOMETHASONE DIPROPIONATE	40	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-410_e9df165d-79e9-4f86-8446-00995793a36b	59310-410	HUMAN PRESCRIPTION DRUG	QNASL		Beclomethasone dipropionate	AEROSOL, METERED	NASAL	20190102		NDA	NDA202813	Teva Respiratory, LLC	BECLOMETHASONE DIPROPIONATE	80	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-505_8fd236af-c81c-46e9-819e-b37891da2662	59310-505	HUMAN PRESCRIPTION DRUG	ArmonAir Digihaler		fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208798	Teva Respiratory, LLC	FLUTICASONE PROPIONATE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-510_d4ba573d-49f5-444d-8b91-11764ea3de8f	59310-510	HUMAN PRESCRIPTION DRUG	AirDuo Digihaler		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	55; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-515_8fd236af-c81c-46e9-819e-b37891da2662	59310-515	HUMAN PRESCRIPTION DRUG	ArmonAir Digihaler		fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208798	Teva Respiratory, LLC	FLUTICASONE PROPIONATE	113	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-520_d4ba573d-49f5-444d-8b91-11764ea3de8f	59310-520	HUMAN PRESCRIPTION DRUG	AirDuo Digihaler		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	113; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-525_8fd236af-c81c-46e9-819e-b37891da2662	59310-525	HUMAN PRESCRIPTION DRUG	ArmonAir Digihaler		fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208798	Teva Respiratory, LLC	FLUTICASONE PROPIONATE	232	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59310-530_d4ba573d-49f5-444d-8b91-11764ea3de8f	59310-530	HUMAN PRESCRIPTION DRUG	AirDuo Digihaler		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20200915		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	232; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-540_af8a51e2-e673-4dde-8fb7-c2f8197e50b0	59310-540	HUMAN PRESCRIPTION DRUG	ProAir Digihaler		Albuterol Sulfate	POWDER, METERED	RESPIRATORY (INHALATION)	20191004		NDA	NDA205636	Teva Respiratory, LLC	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-579_6aab0200-1a77-4658-b899-86e1d5524089	59310-579	HUMAN PRESCRIPTION DRUG	PROAIR	HFA	Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20121203	20240621	NDA	NDA021457	Teva Respiratory, LLC	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	
59310-580_6b472e7e-aa6c-468b-a76a-5c432d09d47f	59310-580	HUMAN PRESCRIPTION DRUG	ProAir RespiClick		Albuterol Sulfate	POWDER, METERED	RESPIRATORY (INHALATION)	20150423		NDA	NDA205636	Teva Respiratory, LLC	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-610_c3617953-03c5-4746-bfdb-e731faf705d7	59310-610	HUMAN PRESCRIPTION DRUG	CINQAIR		Reslizumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160418		BLA	BLA761033	Teva Respiratory, LLC	RESLIZUMAB	10	mg/mL	Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]		N	20241231
59310-805_367991c3-5ac3-4682-8646-7ee6b971665f	59310-805	HUMAN PRESCRIPTION DRUG	AirDuo RespiClick		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170412		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	55; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-812_367991c3-5ac3-4682-8646-7ee6b971665f	59310-812	HUMAN PRESCRIPTION DRUG	AirDuo RespiClick		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170420		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	113; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59310-822_367991c3-5ac3-4682-8646-7ee6b971665f	59310-822	HUMAN PRESCRIPTION DRUG	AirDuo RespiClick		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170412		NDA	NDA208799	Teva Respiratory, LLC	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	232; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
59316-001_57c77fac-ce39-41ee-9578-6977826d908d	59316-001	HUMAN OTC DRUG	Biofreeze Foot Cream		MENTHOL	CREAM	TOPICAL	20210312		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	100	mg/g			N	20241231
59316-002_b3a7c30b-7927-46ab-81ae-9fc25ecda859	59316-002	HUMAN OTC DRUG	Biofreeze Foot Pain Relief Set		MENTHOL	KIT		20210312		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC						N	20241231
59316-003_b58456b8-d43d-4d47-8ffe-91c594ab331c	59316-003	HUMAN OTC DRUG	2 in 1 Relief Value Pack		MENTHOL	KIT		20200930	20241231	OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC						N	
59316-004_cefc6ed9-1763-44cd-a74e-52a1b8b7d704	59316-004	HUMAN OTC DRUG	Biofreeze Flexible Relief Strip		MENTHOL	PATCH	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	56	mg/g			N	20241231
59316-005_0c66fe5b-db9f-d667-e063-6394a90a8ce6	59316-005	HUMAN OTC DRUG	Biofreeze Overnight Relief		Menthol, Unspecified Form	PATCH	TOPICAL	20220201		OTC MONOGRAPH DRUG	M017	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	.3	g/6g			N	20241231
59316-101_b884afb9-3926-4096-b881-e78633f4033e	59316-101	HUMAN OTC DRUG	Biofreeze		Menthol	GEL	TOPICAL	20160825		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	35	mg/mL			N	20241231
59316-102_0a0e1685-b635-7e21-e063-6394a90a5324	59316-102	HUMAN OTC DRUG	BIOFREEZE		MENTHOL	GEL	TOPICAL	20120103		OTC MONOGRAPH DRUG	M017	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
59316-103_d96383ae-567c-4db9-a812-ecbed5d8f782	59316-103	HUMAN OTC DRUG	Biofreeze Colorless		MENTHOL	GEL	TOPICAL	20120103		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
59316-104_0e77224c-d682-ad31-e063-6294a90a9032	59316-104	HUMAN OTC DRUG	Biofreeze		MENTHOL	SPRAY	TOPICAL	20101101		OTC MONOGRAPH DRUG	M017	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	100	mg/mL			N	20251231
59316-111_6629d632-0387-4861-9731-78339bfe11d4	59316-111	HUMAN OTC DRUG	PERFORM COOL and SOOTHING PAIN RELIEVING		MENTHOL	GEL	TOPICAL	20150518		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	35	mg/mL			N	20241231
59316-112_8be06192-9594-45be-b69f-8499984b559b	59316-112	HUMAN OTC DRUG	PERFORM COOL AND SOOTHING PAIN RELIEVING ROLL-ON		MENTHOL	GEL	TOPICAL	20150518		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	35	mg/mL			N	20241231
59316-114_9bbad470-03b6-494d-8fd8-eb4094083c76	59316-114	HUMAN OTC DRUG	Biofreeze		MENTHOL	SPRAY	TOPICAL	20140219		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	105	mg/mL			N	20241231
59316-115_0a0d9ae0-678a-3114-e063-6294a90aa085	59316-115	HUMAN OTC DRUG	Biofreeze Professional		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20160603		OTC MONOGRAPH DRUG	M017	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	50	mg/mL			N	20241231
59316-116_5e5ada5b-b4eb-4184-867b-cae378b92216	59316-116	HUMAN OTC DRUG	Biofreeze Professional Colorless		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20160603		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	50	mg/mL			N	20241231
59316-117_01d40815-74a1-4d3d-a385-6d34ab5b6823	59316-117	HUMAN OTC DRUG	Biofreeze Professional Roll-On		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20160603		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	50	mg/mL			N	20241231
59316-118_6d8d76c9-0a45-45d7-8116-2c7a8286415c	59316-118	HUMAN OTC DRUG	Biofreeze Professional Colorless Roll-On		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20160603		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	50	mg/mL			N	20241231
59316-120_fc1f8b61-3ba1-4976-9eb1-ca9993f4478f	59316-120	HUMAN OTC DRUG	Biofreeze Professional		MENTHOL, UNSPECIFIED FORM	SPRAY	TOPICAL	20160603		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	105	mg/mL			N	20241231
59316-121_f5c8c08b-c7c1-f84d-e053-2a95a90add15	59316-121	HUMAN OTC DRUG	Biofreeze Overnight Gel		Menthol	GEL	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL	40	mg/mL			N	20241231
59316-205_4ff5f42d-b3f3-4a5e-8024-0be6ba968503	59316-205	HUMAN OTC DRUG	Biofreeze Roll-On		MENTHOL	GEL	TOPICAL	20130117		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
59316-206_de5b2a64-eaf4-4b57-9a10-82c488409b25	59316-206	HUMAN OTC DRUG	Biofreeze Colorless Roll-On		MENTHOL	GEL	TOPICAL	20130117		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
59316-207_f67d7b7a-8923-73f6-e053-2995a90a2e80	59316-207	HUMAN OTC DRUG	Biofreeze Overnight Roll-on		Menthol	GEL	TOPICAL	20230316		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL	40	mg/mL			N	20241231
59316-307_ed78a5df-7ec0-4775-b153-f7cb24da278a	59316-307	HUMAN OTC DRUG	Biofreeze Pain Relief		MENTHOL, UNSPECIFIED FORM	CREAM	TOPICAL	20180307	20241231	OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	100	mg/mL			N	
59316-830_f351f6fb-cd2b-4083-9a28-7e1188cafef8	59316-830	HUMAN OTC DRUG	Biofreeze Precision Relief Pen		MENTHOL	LIQUID	TOPICAL	20201231		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	105	mg/mL			N	20241231
59316-832_fc7650d7-9519-8154-e053-6294a90ac72b	59316-832	HUMAN OTC DRUG	Biofreeze Day and Overnight		Menthol	KIT		20230522		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC						N	20241231
59316-833_0d0b73d5-a427-d939-e063-6394a90aae57	59316-833	HUMAN OTC DRUG	Biofreeze		MENTHOL	SPRAY	TOPICAL	20230710		OTC MONOGRAPH DRUG	M017	RB Health (US) LLC	MENTHOL	105	mg/mL			N	20241231
59316-834_0d0b4a3f-7d7f-06fe-e063-6294a90af7ed	59316-834	HUMAN OTC DRUG	Biofreeze Professional		MENTHOL, UNSPECIFIED FORM	AEROSOL, SPRAY	TOPICAL	20230710		OTC MONOGRAPH DRUG	M017	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	105	mg/mL			N	20241231
59316-869_0ea103c6-c9ed-02ed-e063-6394a90a3851	59316-869	HUMAN OTC DRUG	Biofreeze		MENTHOL	CREAM	TOPICAL	20200321		OTC MONOGRAPH DRUG	M017	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	100	mg/g			N	20251231
59316-887_769ab26b-3d03-4951-9e5d-389255cf2ede	59316-887	HUMAN OTC DRUG	Biofreeze	Menthol	Menthol, Unspecified form	KIT		20220310		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC						N	20241231
59316-888_67e4c7e5-1d4b-4907-9858-6dd47deaf5ea	59316-888	HUMAN OTC DRUG	Biofreeze Foot Pain Relief Set		MENTHOL	KIT		20200127	20241231	OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC						N	
59316-889_496291a9-f78c-472e-9ac2-80c15283e2ce	59316-889	HUMAN OTC DRUG	Biofreeze Patch Multi Pack		MENTHOL	KIT		20190130	20241231	OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC						N	
59316-990_99dcb648-61e7-49cb-a75b-974f407d3c4d	59316-990	HUMAN OTC DRUG	Biofreeze Foot		MENTHOL	CREAM	TOPICAL	20200127	20241231	OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	100	mg/g			N	
59316-991_f41659e9-93b6-4682-baf3-ba5375106dea	59316-991	HUMAN OTC DRUG	Biofreeze Foam		MENTHOL	LIQUID	TOPICAL	20200127		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	70	mg/mL			N	20241231
59316-992_f8ed2a1c-90e8-4f1e-9ff4-d09deed1bd5d	59316-992	HUMAN OTC DRUG	Biofreeze	Menthol	Menthol, Unspecified Form	PATCH	TOPICAL	20220304		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	.05	g/g			N	20241231
59316-993_21bb2f06-3d7b-43e3-865f-d9e50ac82e51	59316-993	HUMAN OTC DRUG	Biofreeze		MENTHOL	PATCH	TOPICAL	20190130	20241231	OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	.05	g/g			N	
59316-993_61a08021-18c7-4d2b-8097-a93d2fe97941	59316-993	HUMAN OTC DRUG	Biofreeze		MENTHOL	PATCH	TOPICAL	20190130	20241231	OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	MENTHOL, UNSPECIFIED FORM	.05	g/g			N	
59316-994_e5b342cb-77eb-4555-e053-2a95a90ac7f1	59316-994	HUMAN OTC DRUG	Iso-Quin		ALCOHOL	GEL	TOPICAL	20170518	20241231	OTC MONOGRAPH NOT FINAL	part333E	Performance Health, LLC	ALCOHOL	680	mg/mL			N	
59316-995_e5b3695c-7190-66de-e053-2a95a90a68c5	59316-995	HUMAN OTC DRUG	Skin-Lube		ALCOHOL	OINTMENT	TOPICAL	20170518	20241231	OTC MONOGRAPH FINAL	part347	Performance Health, LLC	DIMETHICONE; PETROLATUM	15; 850	mg/g; mg/g	Skin Barrier Activity [PE]		N	
59316-996_e5b3695c-7183-66de-e053-2a95a90a68c5	59316-996	HUMAN OTC DRUG	Red Hot		CAPSAICIN	OINTMENT	TOPICAL	20170519	20241231	OTC MONOGRAPH NOT FINAL	part348	Performance Health, LLC	CAPSAICIN	.05	g/100g			N	
59316-997_e5b3259f-496f-6c3e-e053-2995a90a7431	59316-997	HUMAN OTC DRUG	Iso-Quin		ALCOHOL	LIQUID	TOPICAL	20170519	20241231	OTC MONOGRAPH NOT FINAL	part333E	Performance Health, LLC	ALCOHOL	650	mg/mL			N	
59316-998_e5b32c77-40ca-f645-e053-2995a90ad296	59316-998	HUMAN OTC DRUG	Cramergesic		MENTHOL, METHYL SALICYLATE	OINTMENT	TOPICAL	20170519	20241231	OTC MONOGRAPH NOT FINAL	part348	Performance Health, LLC	MENTHOL; METHYL SALICYLATE	1.9; 13.7	g/100g; g/100g			N	
59316-999_e5b3882e-1ef8-923a-e053-2a95a90ab807	59316-999	HUMAN OTC DRUG	Atomic Balm		METHYL SALICYLATE, CAPSAICIN	OINTMENT	TOPICAL	20170519	20241231	OTC MONOGRAPH NOT FINAL	part348	Performance Health, LLC	CAPSAICIN; METHYL SALICYLATE	.025; 12.5	g/100g; g/100g			N	
59321-031_a409336a-eca8-4ee1-acd9-67cd0332b1e0	59321-031	HUMAN OTC DRUG	SHU JIN LU		CAMPHOR AND MENTHOL	SPRAY	TOPICAL	20110407		OTC MONOGRAPH NOT FINAL	part348	GUANGXI YULIN PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); MENTHOL	5.5; 5.5	g/100mL; g/100mL			N	20241231
59321-032_8f97dd3b-138e-4e61-a262-b27d80eeb2a4	59321-032	HUMAN OTC DRUG	JIN GU WANG		CAMPHOR AND MENTHOL	SPRAY	TOPICAL	20110407		OTC MONOGRAPH NOT FINAL	part348	GUANGXI YULIN PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); MENTHOL	5.5; 5.5	g/100mL; g/100mL			N	20241231
59321-033_4dec2f72-e9bc-4fb9-b0c8-ed1ab3d521a5	59321-033	HUMAN OTC DRUG	YUN XIANG JING		MENTHOL	LINIMENT	PERCUTANEOUS; TRANSDERMAL	20021008		OTC MONOGRAPH NOT FINAL	part348	GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD	MENTHOL	3	g/100mL			N	20241231
59321-055_6ada155e-94c3-4f5e-a1bc-217fd94915d4	59321-055	HUMAN OTC DRUG	ZHENG GU SHUI		CAMPHOR, MENTHOL	LINIMENT	PERCUTANEOUS; TRANSDERMAL	20001019		OTC MONOGRAPH NOT FINAL	part348	GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD	CAMPHOR (SYNTHETIC); MENTHOL	5.6; 5.6	g/100mL; g/100mL			N	20241231
59321-056_9e724f91-a184-4909-8dd3-16cc9fdbe549	59321-056	HUMAN OTC DRUG	ULTRA STRENGTH ZHENG GU SHUI		MENTHOL AND CAMPHOR	LINIMENT	PERCUTANEOUS	20230404		OTC MONOGRAPH NOT FINAL	part348	GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD	CAMPHOR (SYNTHETIC); MENTHOL	4.1; 4.1	g/100mL; g/100mL			N	20241231
59336-001_63fcf79e-d003-4c83-b711-8ece11ea5d98	59336-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20131212		NDA	NDA205767	JW Welding Supplies & Tools	OXYGEN	99	L/100L			N	20241231
59338-775_69a91fd4-deed-452e-b700-ea68b6e85421	59338-775	HUMAN PRESCRIPTION DRUG	Feraheme		ferumoxytol	INJECTION	INTRAVENOUS	20090713		NDA	NDA022180	AMAG Pharmaceuticals, Inc.	FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE	510	mg/17mL	Iron [CS], Parenteral Iron Replacement [EPC]		N	20241231
59353-002_1175d3cc-6861-4334-a2a6-c4b0bcf47bbc	59353-002	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Vifor (International) Inc.	EPOETIN	2000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-003_1175d3cc-6861-4334-a2a6-c4b0bcf47bbc	59353-003	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Vifor (International) Inc.	EPOETIN	3000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-004_1175d3cc-6861-4334-a2a6-c4b0bcf47bbc	59353-004	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Vifor (International) Inc.	EPOETIN	4000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-010_1175d3cc-6861-4334-a2a6-c4b0bcf47bbc	59353-010	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180618		BLA	BLA125545	Vifor (International) Inc.	EPOETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-065_37e5352c-127f-47d1-b28d-6d06ebbd1f9b	59353-065	HUMAN PRESCRIPTION DRUG	Korsuva		Difelikefalin	INJECTION, SOLUTION	INTRAVENOUS	20210111		NDA	NDA214916	Vifor (International) Inc.	DIFELIKEFALIN ACETATE	50	ug/mL			N	20241231
59353-120_1175d3cc-6861-4334-a2a6-c4b0bcf47bbc	59353-120	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200911		BLA	BLA125545	Vifor (International) Inc.	EPOETIN	20000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-220_1175d3cc-6861-4334-a2a6-c4b0bcf47bbc	59353-220	HUMAN PRESCRIPTION DRUG	RETACRIT		epoetin alfa-epbx	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200911		BLA	BLA125545	Vifor (International) Inc.	EPOETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-400_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-400	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	30	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-401_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-401	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	50	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-402_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-402	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	75	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-403_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-403	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	100	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-404_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-404	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	150	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-405_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-405	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	200	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-406_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-406	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	250	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-407_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-407	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	120	ug/.3mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59353-408_6a6a2c0d-5fb1-480a-bd41-f959544baef2	59353-408	HUMAN PRESCRIPTION DRUG	Mircera		Methoxy polyethylene glycol-epoetin beta	INJECTION, SOLUTION	INTRAVENOUS	20141024		BLA	BLA125164	Vifor (International) Inc.	METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA	360	ug/.6mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59365-5030_8baefa7d-b10c-43ea-b847-3429b51145e7	59365-5030	HUMAN PRESCRIPTION DRUG	TRIMO SAN		Oxyquinoline Sulfate and Sodium Lauryl Sulfate	JELLY	VAGINAL	19770401		UNAPPROVED DRUG OTHER		CooperSurgical, Inc.	OXYQUINOLINE SULFATE; SODIUM LAURYL SULFATE	.25; .1	mg/g; mg/g			N	20241231
59365-5128_aaef7f8a-da44-4f2c-9bf9-2f077698fcdc	59365-5128	HUMAN PRESCRIPTION DRUG	ParaGard T 380A		Copper	INTRAUTERINE DEVICE	INTRAUTERINE	20171102		NDA	NDA018680	CooperSurgical, Inc.	COPPER	313.4	mg/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
59365-6061_46e962e9-3413-4ca2-9f0f-1b6e11a49b2a	59365-6061	HUMAN PRESCRIPTION DRUG	Leep RediKit		mepivacaine hydrochloride, lidocaine hydrochloride, epinephrine bitartrate, iodine, potassium iodide, ferric subsulfate	KIT		20150531		UNAPPROVED DRUG OTHER		CooperSurgical, Inc.						N	20241231
59378-001_080250a0-64ab-c5ba-e063-6394a90a10c4	59378-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130701		NDA	NDA205767	Jayco Industrial Supply Inc	OXYGEN	995	mL/L			N	20241231
59385-021_d8541d8a-992a-4b62-8518-ecd85f480e67	59385-021	HUMAN PRESCRIPTION DRUG	BELBUCA		buprenorphine hydrochloride	FILM, SOLUBLE	BUCCAL	20170901		NDA	NDA207932	BioDelivery Sciences International Inc	BUPRENORPHINE HYDROCHLORIDE	75	ug/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
59385-022_d8541d8a-992a-4b62-8518-ecd85f480e67	59385-022	HUMAN PRESCRIPTION DRUG	BELBUCA		buprenorphine hydrochloride	FILM, SOLUBLE	BUCCAL	20171001		NDA	NDA207932	BioDelivery Sciences International Inc	BUPRENORPHINE HYDROCHLORIDE	150	ug/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
59385-023_d8541d8a-992a-4b62-8518-ecd85f480e67	59385-023	HUMAN PRESCRIPTION DRUG	BELBUCA		buprenorphine hydrochloride	FILM, SOLUBLE	BUCCAL	20170901		NDA	NDA207932	BioDelivery Sciences International Inc	BUPRENORPHINE HYDROCHLORIDE	300	ug/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
59385-024_d8541d8a-992a-4b62-8518-ecd85f480e67	59385-024	HUMAN PRESCRIPTION DRUG	BELBUCA		buprenorphine hydrochloride	FILM, SOLUBLE	BUCCAL	20170821		NDA	NDA207932	BioDelivery Sciences International Inc	BUPRENORPHINE HYDROCHLORIDE	450	ug/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
59385-025_d8541d8a-992a-4b62-8518-ecd85f480e67	59385-025	HUMAN PRESCRIPTION DRUG	BELBUCA		buprenorphine hydrochloride	FILM, SOLUBLE	BUCCAL	20170824		NDA	NDA207932	BioDelivery Sciences International Inc	BUPRENORPHINE HYDROCHLORIDE	600	ug/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
59385-026_d8541d8a-992a-4b62-8518-ecd85f480e67	59385-026	HUMAN PRESCRIPTION DRUG	BELBUCA		buprenorphine hydrochloride	FILM, SOLUBLE	BUCCAL	20171001		NDA	NDA207932	BioDelivery Sciences International Inc	BUPRENORPHINE HYDROCHLORIDE	750	ug/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
59385-027_d8541d8a-992a-4b62-8518-ecd85f480e67	59385-027	HUMAN PRESCRIPTION DRUG	BELBUCA		buprenorphine hydrochloride	FILM, SOLUBLE	BUCCAL	20170811		NDA	NDA207932	BioDelivery Sciences International Inc	BUPRENORPHINE HYDROCHLORIDE	900	ug/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
59385-041_e28338cb-0ff5-4938-a82f-0d855ad3b587	59385-041	HUMAN PRESCRIPTION DRUG	SYMPROIC		naldemedine	TABLET	ORAL	20190614		NDA	NDA208854	BioDelivery Sciences International Inc	NALDEMEDINE TOSYLATE	.2	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
59385-055_942cdd49-03ae-42ee-a866-a2ab78873d38	59385-055	HUMAN PRESCRIPTION DRUG	ELYXYB - celecoxib		celecoxib	LIQUID	ORAL	20220101		NDA	NDA212157	BioDelivery Sciences International Inc	CELECOXIB	120	mg/4.8mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59390-140_28125c1a-d1b0-4763-9b5e-07b4cfc2d889	59390-140	HUMAN PRESCRIPTION DRUG	Ofloxacin ophthalmic		Ofloxacin	SOLUTION	OPHTHALMIC	20130531		ANDA	ANDA202692	Altaire Pharmaceuticals Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
59390-149_0561ff06-43b4-493e-93f7-b778fc829036	59390-149	HUMAN PRESCRIPTION DRUG	Diclofenac		Diclofenac Sodium	SOLUTION/ DROPS	OPHTHALMIC	20151116		ANDA	ANDA203383	Altaire Pharmaceuticals Inc.	DICLOFENAC SODIUM	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59390-156_0c0ec51d-1d03-a16d-e063-6294a90afd94	59390-156	HUMAN OTC DRUG	Multi-Action Relief		polyvinyl alcohol, povidone and tetrahydrozoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20090509		OTC MONOGRAPH DRUG	M018	Altaire Pharmaceuticals Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	5; 6; .5	mg/mL; mg/mL; mg/mL			N	20241231
59390-177_b78fd969-ee4c-0ea0-e053-2a95a90a480d	59390-177	HUMAN OTC DRUG	Naphazoline HCI And Pheniramine Maleate		NAPHAZOLINE HYDROCHLORIDE , PHENIRAMINE MALEATE	SOLUTION/ DROPS	OPHTHALMIC	20101006		ANDA	ANDA078208	Altaire Pharmaceuticals Inc.	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.27; 3.15	mg/mL; mg/mL			N	20241231
59390-182_3e98cefc-43d0-40bf-80be-651f17a39d4f	59390-182	HUMAN PRESCRIPTION DRUG	Goniotaire		HYPROMELLOSE 2906 (4000 MPA.S)	SOLUTION	OPHTHALMIC	20020118		UNAPPROVED DRUG OTHER		Altaire Pharmaceuticals Inc.	HYPROMELLOSE 2906 (4000 MPA.S)	25	mg/mL			N	20241231
59390-183_0c0e9c0d-61f5-e63b-e063-6294a90ac0d9	59390-183	HUMAN OTC DRUG	Altachlore Sodium Chloride Hypertonicity		Sodium Chloride	SOLUTION/ DROPS	OPHTHALMIC	20020924		OTC MONOGRAPH DRUG	M018	Altaire Pharmaceuticals Inc.	SODIUM CHLORIDE	50	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
59390-192_5190a5bc-5820-4874-bbe7-32576266a72f	59390-192	HUMAN PRESCRIPTION DRUG	HOMATROPINE HYDROBROMIDE OPHTHALMIC		Homatropine Hydrobromide	SOLUTION	OPHTHALMIC	20180601		UNAPPROVED DRUG OTHER		Altaire Pharmaceuticals Inc.	HOMATROPINE HYDROBROMIDE	50	mg/mL	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
59390-198_0c0e9c0d-6205-e63b-e063-6294a90ac0d9	59390-198	HUMAN OTC DRUG	Altalube		Mineral oil and petrolatum	OINTMENT	OPHTHALMIC	20020201		OTC MONOGRAPH DRUG	M018	Altaire Pharmaceuticals Inc.	MINERAL OIL; PETROLATUM	150; 850	mg/g; mg/g			N	20241231
59390-205_bb57078b-c74f-41e3-bcaf-51225b4fb526	59390-205	HUMAN PRESCRIPTION DRUG	Fluorescein Sodium and Proparacaine Hydrochloride		Fluorescein Sodium and Proparacaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20000614		UNAPPROVED DRUG OTHER		Altaire Pharmaceuticals Inc.	FLUORESCEIN SODIUM; PROPARACAINE HYDROCHLORIDE	2.5; 5	mg/mL; mg/mL	Diagnostic Dye [EPC], Dyes [MoA], Local Anesthesia [PE], Local Anesthetic [EPC]		N	20241231
59390-217_f31149b7-60fc-4cef-8270-5eb8ff2b42bb	59390-217	HUMAN PRESCRIPTION DRUG	Ciprofloxacin HCl Ophthalmic		Ciprofloxacin Hydrochloride	SOLUTION	OPHTHALMIC	20180504		ANDA	ANDA204613	Altaire Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
59390-218_22a50c28-e476-4966-b68c-065a4b8e157f	59390-218	HUMAN PRESCRIPTION DRUG	ALTAFLUOR		Fluorescein Sodium and Benoxinate Hydrochloride	SOLUTION	OPHTHALMIC	20180301		NDA	NDA208582	Altaire Pharmaceuticals Inc.	BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM	4; 2.5	mg/mL; mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
59397-3310_5b69b7ee-5a5c-4386-93f6-5f2f7ad240c3	59397-3310	HUMAN OTC DRUG	OFF Bite and Itch Relief First Aid Antiseptic		Benzocaine, Phenol, Camphor	SOLUTION	TOPICAL	20131101		OTC MONOGRAPH DRUG	M017	S. C. Johnson & Son, Inc.	BENZOCAINE; CAMPHOR (NATURAL); PHENOL	5; 3; 1.35	mg/100mL; mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59400-001_f528165d-0def-a4e1-e053-2a95a90ad3b8	59400-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20220923		UNAPPROVED MEDICAL GAS		BayCare Home Care, Inc.	OXYGEN	210	mL/L			N	20241231
59400-005_f528165d-0def-a4e1-e053-2a95a90ad3b8	59400-005	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	LIQUID	RESPIRATORY (INHALATION)	20220923		UNAPPROVED MEDICAL GAS		BayCare Home Care, Inc.	OXYGEN	210	mg/kg			N	20241231
59417-101_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-101	HUMAN PRESCRIPTION DRUG	Vyvanse		lisdexamfetamine dimesylate	CAPSULE	ORAL	20140830		NDA	NDA021977	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-102_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-102	HUMAN PRESCRIPTION DRUG	Vyvanse		lisdexamfetamine dimesylate	CAPSULE	ORAL	20071210		NDA	NDA021977	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-103_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-103	HUMAN PRESCRIPTION DRUG	Vyvanse		lisdexamfetamine dimesylate	CAPSULE	ORAL	20070223		NDA	NDA021977	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-104_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-104	HUMAN PRESCRIPTION DRUG	Vyvanse		lisdexamfetamine dimesylate	CAPSULE	ORAL	20071210		NDA	NDA021977	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-105_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-105	HUMAN PRESCRIPTION DRUG	Vyvanse		lisdexamfetamine dimesylate	CAPSULE	ORAL	20070223		NDA	NDA021977	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-106_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-106	HUMAN PRESCRIPTION DRUG	Vyvanse		lisdexamfetamine dimesylate	CAPSULE	ORAL	20071210		NDA	NDA021977	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-107_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-107	HUMAN PRESCRIPTION DRUG	Vyvanse		lisdexamfetamine dimesylate	CAPSULE	ORAL	20070223		NDA	NDA021977	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-115_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-115	HUMAN PRESCRIPTION DRUG	Vyvanse		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20170128		NDA	NDA208510	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-116_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-116	HUMAN PRESCRIPTION DRUG	Vyvanse		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20170128		NDA	NDA208510	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-117_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-117	HUMAN PRESCRIPTION DRUG	Vyvanse		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20170128		NDA	NDA208510	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-118_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-118	HUMAN PRESCRIPTION DRUG	Vyvanse		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20170128		NDA	NDA208510	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-119_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-119	HUMAN PRESCRIPTION DRUG	Vyvanse		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20170128		NDA	NDA208510	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59417-120_756b98a0-fada-44b2-a606-f2e71ef8cc84	59417-120	HUMAN PRESCRIPTION DRUG	Vyvanse		LISDEXAMFETAMINE DIMESYLATE	TABLET, CHEWABLE	ORAL	20170128		NDA	NDA208510	Takeda Pharmaceuticals America, Inc.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59427-005_049d205e-5cac-ed4c-e063-6394a90a7b7b	59427-005	HUMAN OTC DRUG	SUPER SPOT REMOVER ACNE TREATMENT		SALICYLIC ACID	GEL	TOPICAL	20120401		OTC MONOGRAPH FINAL	M006	ORIGINS NATURAL RESOURCES INC.	SALICYLIC ACID	15	mg/mL			N	20241231
59427-010_0b777305-9b82-a155-e063-6294a90af017	59427-010	HUMAN OTC DRUG	A PERFECT WORLD SPF 40 AGE DEFENSE BROAD SPECTRUM MOISTURIZER WITH WHITE TEA		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20170601		OTC MONOGRAPH DRUG	M020	ORIGINS NATURAL RESOURCES INC.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 80; 75; 45; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59427-012_09a4a43c-cdaf-6788-e063-6294a90a37c8	59427-012	HUMAN OTC DRUG	PLANTSCRIPTION SPF 25 POWER ANTI-AGING oil FREE BROAD SPECTRUM		AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	CREAM	TOPICAL	20171115		OTC MONOGRAPH DRUG	M020	ORIGINS NATURAL RESOURCES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 45; 28	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59427-013_049e4b7c-dae1-0ebb-e063-6294a90a264c	59427-013	HUMAN OTC DRUG	VITAZING SPF 15 ENERGY BOOSTING MOISTURIZER WITH MANGOSTEEN BROAD SPECTRUM SPF 15		avobenzone, octisalate, and octocrylene	CREAM	TOPICAL	20170101		OTC MONOGRAPH FINAL	M020	ORIGINS NATURAL RESOURCES INC.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 30; 27	mg/mL; mg/mL; mg/mL			N	20241231
59427-014_09a51aab-4aec-860f-e063-6294a90aa135	59427-014	HUMAN OTC DRUG	PRETTY IN BLOOM SPF 20		titanium dioxide and zinc oxide	LOTION	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	ORIGINS NATURAL RESOURCES INC.	TITANIUM DIOXIDE; ZINC OXIDE	25; 61	mg/mL; mg/mL			N	20241231
59427-015_052d8d8d-d650-e604-e063-6294a90a38c8	59427-015	HUMAN OTC DRUG	CLEAR IMPROVEMENT PORE CLEARING MOISTURIZER		Salicylic acid	LOTION	TOPICAL	20190923		OTC MONOGRAPH DRUG	M020	ORIGINS NATURAL RESOURCES INC.	SALICYLIC ACID	10	mg/mL			N	20241231
59427-016_04a29f66-b659-092e-e063-6394a90a5bea	59427-016	HUMAN OTC DRUG	ORIGINS GINZING ENERGY-BOOSTING TINTED MOISTURIZER BROAD SPECTRUM SPF 40		OCTINOXATE, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, and ZINC OXIDE	LIQUID	TOPICAL	20210426		OTC MONOGRAPH FINAL	M020	ORIGINS NATURAL RESOURCES INC.	OCTINOXATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	75; 20; 20; 30; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59427-112_05186b1d-9408-fe1f-e063-6294a90a1f0d	59427-112	HUMAN OTC DRUG	DR. ANDREW WEIL FOR ORIGINS	MEGA-BRIGHT SPF 30 SKIN TONE CORRECTING oil FREE MOISTURIZER BROAD SPECTRUM SPF 30	HOMOSALATE, OCTISALATE, AVOBENZONE, and OCTOCRYLENE	CREAM	TOPICAL	20131101		OTC MONOGRAPH FINAL	M020	ORIGINS NATURAL RESOURCES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 27	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59427-113_051acbc2-7bef-4059-e063-6394a90a115b	59427-113	HUMAN OTC DRUG	DR ANDREW WEILS FOR ORIGINS	MEGA-DEFENSE ADVANCED DAILY UV DEFENDER BROAD SPECTRUM SPF 45	TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20160215		OTC MONOGRAPH DRUG	M020	ORIGINS NATURAL RESOURCES INC.	TITANIUM DIOXIDE; ZINC OXIDE	63; 40	mg/mL; mg/mL			N	20241231
59427-114_051acbc2-7bf1-4059-e063-6394a90a115b	59427-114	HUMAN OTC DRUG	PLANTSCRIPTION SPF 25 POWER ANTI AGING BROAD SPECTRUM 25		AVOBENZONE, HOMOSALATE, OCTISLATE, and OCTOCRYLENE	CREAM	TOPICAL	20170101		OTC MONOGRAPH DRUG	M020	ORIGINS NATURAL RESOURCES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 45; 28	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59427-116_0e106c03-4c26-5bfb-e063-6294a90ab3e1	59427-116	HUMAN OTC DRUG	GINZING SPF 30 DAILY MOISTURIZER		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	CREAM	TOPICAL	20240104		OTC MONOGRAPH DRUG	M020	ORIGINS NATURAL RESOURCES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 45; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
59428-068_2e1c2b77-d16d-4160-9f47-13e11237e009	59428-068	HUMAN OTC DRUG	Pain Reliever		Naproxen Sodium	TABLET	ORAL	20170531	20250531	ANDA	ANDA079096	Productos Zapotol Corp.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59428-135_ce1c26b7-9cfe-a22e-e053-2995a90a706c	59428-135	HUMAN OTC DRUG	Zapotol Bacitracin		Bacitracin	CREAM	TOPICAL	20140806		OTC MONOGRAPH FINAL	part333B	Zapatol Corp.	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
59428-281_e5a7d20e-9709-401f-9b81-f2dbb7e1f0c2	59428-281	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	LIQUID	ORAL	20180331	20250331	OTC MONOGRAPH NOT FINAL	part343	Productos Zapotol Corp.	ACETAMINOPHEN	160	mg/5mL			N	
59428-403_db8b060c-4f61-7bc4-e053-2995a90aa789	59428-403	HUMAN OTC DRUG	Quadrydern		Hydrocortisone	CREAM	TOPICAL	20200311		OTC MONOGRAPH NOT FINAL	part348	Productos Zapotol Corp	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59428-848_27919763-f421-4319-af54-00d57f89f90f	59428-848	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20190331	20250331	OTC MONOGRAPH FINAL	part341	Productos Zapotol Corp.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
59434-134_09d72d1b-d32e-923b-e063-6394a90a0cfc	59434-134	HUMAN OTC DRUG	ALA-SEPTIC		SALICYLIC ACID	LOTION	TOPICAL	20210301		OTC MONOGRAPH DRUG	M032	Ala-Septic Pharmaceutical Research LLC	SALICYLIC ACID	20	mg/g			N	20241231
59448-001_1033fd25-ca1d-463f-aa02-b956579b6a95	59448-001	HUMAN OTC DRUG	Instant Hand Antiseptic		ETHYL ALCOHOL	GEL	TOPICAL	20151218		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc	ALCOHOL	62	mL/100mL			N	20241231
59448-002_50b9b20a-6ccb-4d70-bc0c-b623adf6bba4	59448-002	HUMAN OTC DRUG	Instant Hand Antiseptic		Benzalkonium Chloride	GEL	TOPICAL	20180601		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc	BENZALKONIUM CHLORIDE	.095	mg/100mL			N	20241231
59448-003_789cb41f-47e4-4113-9d20-fc36a1dea122	59448-003	HUMAN OTC DRUG	Instant Hand Antiseptic		Benzalkonium Chloride	GEL	TOPICAL	20181127		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc	BENZALKONIUM CHLORIDE	.095	mg/100mL			N	20241231
59448-004_308608f1-1d1e-4e86-9d39-229cc246caf6	59448-004	HUMAN OTC DRUG	Instant Hand Antiseptic		Alcohol	GEL	TOPICAL	20191015		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc	ALCOHOL	62	mL/100mL			N	20241231
59448-008_a8794ec0-cedb-43b3-8de0-65fd68f33ee3	59448-008	HUMAN OTC DRUG	Instant Hand Antiseptic		ALCOHOL	GEL	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc	ALCOHOL	62	mL/100mL			N	20241231
59448-010_1980fb68-55ce-491f-b842-156bfc89071e	59448-010	HUMAN OTC DRUG	BENZALKONIUM CHLORIDE		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
59448-100_8fcf0bfa-03c7-4f8f-a247-28d3463ded03	59448-100	HUMAN OTC DRUG	NewYork-Presbyterian Amenity		Sodium Monofluorophospate	KIT		20130701		OTC MONOGRAPH FINAL	part355	ASP Global, LLc						N	20241231
59448-200_33811f37-b50b-4629-9f46-828cb16e4406	59448-200	HUMAN OTC DRUG	Northside Hospital Amenity Kit		Alcohol and Sodium Monofluorophospate	KIT		20160118		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-201_66ebc39b-2b05-49fa-938c-8f3e25e8ebbc	59448-201	HUMAN OTC DRUG	Northside Hospital Amenity Kit--GI Dept		Alcohol	KIT		20160118		OTC MONOGRAPH DRUG	M003	ASP Global, LLc						N	20251231
59448-203_9baf6e0b-42e5-4695-bc20-163e755d89b3	59448-203	HUMAN OTC DRUG	Northside Hospital C-Section Mothers Bag		Alcohol and Sodium Monofluorophospate	KIT		20170415		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-205_55e7e92a-5e0c-4f38-8eb7-1b18e8a389da	59448-205	HUMAN OTC DRUG	Northside Hospital Mothers Bag		ALCOHOL and SODIUM MONOFLUOROPHOSPHATE	KIT		20171019		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-206_0be18906-1200-4b2e-9169-792b946bbc53	59448-206	HUMAN OTC DRUG	Northside Hospital H.E.A.R.T. Strings Bag		ALCOHOL and SODIUM MONOFLUOROPHOSPHATE	KIT		20171120		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-207_53763459-0de5-4169-b868-e16290f45c96	59448-207	HUMAN OTC DRUG	Northside Hospital C-Section Mothers Tote		Alcohol and Sodium Monofluorophospate	KIT		20220517		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-208_35e00cd7-a2ad-409c-8219-0d4ca6960142	59448-208	HUMAN OTC DRUG	Northside Hospital H.E.A.R.T. Strings Tote		Alcohol and Sodium Monofluorophospate	KIT		20220518		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-209_6d278f5e-bec6-4e8e-823b-018d8b37f5f6	59448-209	HUMAN OTC DRUG	Northside Hospital Mothers Vaginal Tote		Alcohol and Sodium Monoflurophospate	KIT		20220517		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-210_5a1c4eef-2dc0-4602-892f-953e72f5d0c9	59448-210	HUMAN OTC DRUG	Northside Hospital C-Section Mothers		ALCOHOL and SODIUM MONOFLUOROPHOSPHATE	KIT		20221202		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-211_50c26bae-cd34-4e5f-a746-0787c2a55db2	59448-211	HUMAN OTC DRUG	Northside Hospital Mothers Vaginal		ALCOHOL and SODIUM MONOFLUOROPHOSPHATE	KIT		20221202		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-212_6b9c4f25-e52f-4e04-ab2d-7861686cfd81	59448-212	HUMAN OTC DRUG	Northside Hospital H.E.A.R.T. Strings		ALCOHOL and SODIUM MONOFLUOROPHOSPHATE	KIT		20221202		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-300_84746c78-996d-492a-890e-3a691b4d56e6	59448-300	HUMAN OTC DRUG	Memorial Sloan Kettering Cancer Center Amenity Kit		Sodium Monofluorophosphate	KIT		20170401		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-400_aca5ba3f-a8ad-49b0-9961-c4d4b802cee8	59448-400	HUMAN OTC DRUG	Englewood Amenity		Benzalkonium Chloride and SODIUM MONOFLUOROPHOSPHATE	KIT		20180613		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-500_e1be6e6c-3286-43ae-9833-d54f78fb6210	59448-500	HUMAN OTC DRUG	Univ of Vermont Medical Center Amenity		Benzalkonium Chloride and SODIUM MONOFLUOROPHOSPHATE	KIT		20181205		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-600_dcfee2b1-6c43-44bd-80c5-77b23d2e21a2	59448-600	HUMAN OTC DRUG	Sarasota Memorial Amenity		Alcohol and Sodium Monofluorophosphate	KIT		20191008		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-700_099f2754-c061-4dc8-bbe3-fe8b55402806	59448-700	HUMAN OTC DRUG	Emory Johns Creek Amenity		Alcohol and Sodium Monofluorophospate	KIT		20200727		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-800_c56b9c6d-eede-4bf1-8ab4-8a02573f5c48	59448-800	HUMAN OTC DRUG	Wellstar Amenity		Benzalkonium Chloride and SODIUM MONOFLUOROPHOSPHATE	KIT		20211001		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59448-900_e42ef9a4-ecc9-4595-9bfa-6b8d3c8fba94	59448-900	HUMAN OTC DRUG	Baylor Scott and White Hybrid Comfort		BENZALKONIUM CHLORIDE	KIT		20220315		OTC MONOGRAPH NOT FINAL	part333E	ASP Global, LLc						N	20241231
59450-001_03760c52-9773-e2ff-5826-4160c7ba7b35	59450-001	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150825		NDA	NDA020076	The Kroger Co.	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59450-002_03760c52-9773-e2ff-5826-4160c7ba7b35	59450-002	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150825		NDA	NDA020076	The Kroger Co.	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59450-003_03760c52-9773-e2ff-5826-4160c7ba7b35	59450-003	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150825		NDA	NDA020076	The Kroger Co.	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59450-012_272675b2-9db3-9e39-affe-6723b3ede96e	59450-012	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium 20.6mg Capsules	CAPSULE, DELAYED RELEASE	ORAL	20160101		ANDA	ANDA078878	The Kroger Co.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59450-210_9a38a0c9-f2c8-489d-9dbd-9f0a0990de13	59450-210	HUMAN OTC DRUG	Minoxidil	5% (For Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20221018		ANDA	ANDA209074	Kroger Company	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59450-211_41419988-5dbf-4f47-92d0-0f6f6b6513e9	59450-211	HUMAN OTC DRUG	Minoxidil	(For Women)	Minoxidil	AEROSOL, FOAM	TOPICAL	20221018		ANDA	ANDA209074	Kroger Company	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59450-471_e8013364-cbf1-4b9d-a574-7d4e7838c255	59450-471	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	The Kroger Co	ALCOHOL	62	mL/100mL			N	20241231
59450-713_f035b906-5d5a-4eac-e053-2a95a90a7d90	59450-713	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221213		OTC MONOGRAPH FINAL	part341	The Kroger CO	MENTHOL	5.4	mg/1			N	20241231
59450-714_f05dffc1-20c1-ddd6-e053-2995a90aab21	59450-714	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221213		OTC MONOGRAPH FINAL	part341	The Kroger CO	MENTHOL	5.4	mg/1			N	20241231
59450-715_f6d977ce-bbcb-f1cc-e053-6394a90acc96	59450-715	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230313		OTC MONOGRAPH FINAL	part341	The Kroger CO	MENTHOL	7.5	mg/1			N	20241231
59450-716_f6da2e42-d74a-5c80-e053-6294a90ae6db	59450-716	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230313		OTC MONOGRAPH FINAL	part341	The Kroger CO	MENTHOL	7.5	mg/1			N	20241231
59450-717_f6da36d3-496e-2336-e053-6394a90a0f83	59450-717	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230313		OTC MONOGRAPH FINAL	part341	The Kroger CO	MENTHOL	7.5	mg/1			N	20241231
59450-814_0d2a132b-84c1-7b07-e063-6294a90af042	59450-814	HUMAN OTC DRUG	Kroger Eye Drops Artificial Tears		Polyvinyl alcohol, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20230320		OTC MONOGRAPH DRUG	M018	The Kroger Company	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
59450-901_5c560168-b089-4f4f-9243-52892b05488f	59450-901	HUMAN OTC DRUG	Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20230321		OTC MONOGRAPH NOT FINAL	part356	Kroger	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59450-924_5b3f4672-17c5-4d24-b93f-bef9747c49fb	59450-924	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211201		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59450-934_74b29836-223c-42ab-b9b8-979d842ec96f	59450-934	HUMAN OTC DRUG	Sheer Touch Sunscreen SPF 100		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231107		OTC MONOGRAPH DRUG	MM020	Kroger Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
59450-935_4509b60e-a543-4c37-a7de-bd1fdb791356	59450-935	HUMAN OTC DRUG	Sheer Touch Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231107		OTC MONOGRAPH DRUG	MM020	Kroger Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
59450-939_a0a39240-e832-4ecf-8e10-6e8fab0238a0	59450-939	HUMAN OTC DRUG	Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231107		OTC MONOGRAPH DRUG	M020	Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
59450-940_0d91ba05-40b1-4e5f-9eb6-76050e3309d6	59450-940	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231107		OTC MONOGRAPH DRUG	M020	Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
59450-941_64860c2d-78a6-41d1-ba5b-e96c633d5c77	59450-941	HUMAN OTC DRUG	Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231107		OTC MONOGRAPH DRUG	M020	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
59450-942_07d69d4d-c642-4695-a0e7-86b703374267	59450-942	HUMAN OTC DRUG	Sunscreen for Kids SPF 50		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M020	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
59450-943_2d934e29-84bf-497d-8c2c-186cf2fd93a3	59450-943	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M020	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
59450-953_c0f3b1f5-b2cd-4879-8849-8571f22ad285	59450-953	HUMAN OTC DRUG	Antigingivitis/Antiplaque		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20231113		OTC MONOGRAPH DRUG	M505G(a)(3)	Kroger	CETYLPYRIDINIUM CHLORIDE	.5	mg/mL			N	20241231
59450-954_6d539f42-77c5-4d3a-8a98-d8801020f961	59450-954	HUMAN OTC DRUG	Moisturizing Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231109		OTC MONOGRAPH DRUG	M020	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
59450-955_b5488f11-0df4-41a9-87df-d996f3ad4458	59450-955	HUMAN OTC DRUG	Moisturizing Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231109		OTC MONOGRAPH DRUG	M020	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
59450-956_018073a1-6bb0-4e12-946c-0186562fe02d	59450-956	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231109		OTC MONOGRAPH DRUG	M020	Kroger	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
59450-978_441a023b-b6e9-416e-9e31-a5a6f82ff727	59450-978	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211206		OTC MONOGRAPH FINAL	part352	The Kroger Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59450-997_716590f8-09f3-4bb4-b67c-e1c6fb5e7076	59450-997	HUMAN OTC DRUG	Antigingivitis/Antiplaque		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20220922		OTC MONOGRAPH NOT FINAL	part356	The Kroger Co	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
59467-318_8ee07c81-4fb0-40ed-9ea3-6de3b43fd1e1	59467-318	HUMAN PRESCRIPTION DRUG	MITIGARE		Colchicine	CAPSULE	ORAL	20141001		NDA	NDA204820	Hikma Specialty USA Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20241231
59467-679_323cf7b3-8ee2-4018-8762-80605b57f6dc	59467-679	HUMAN PRESCRIPTION DRUG	KLOXXADO		Naloxone HCL	SPRAY	NASAL	20210803		NDA	NDA212045	Hikma Specialty USA Inc.	NALOXONE HYDROCHLORIDE	8	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
59467-700_d6cac74c-1bfc-4745-8a35-27f03686c86c	59467-700	HUMAN PRESCRIPTION DRUG	Ryaltris		olopatadine hydrochloride and mometasone furoate	SPRAY, METERED	NASAL	20220815		NDA	NDA211746	HIKMA SPECIALTY USA INC.	MOMETASONE FUROATE MONOHYDRATE; OLOPATADINE HYDROCHLORIDE	25; 665	ug/1; ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
59469-005_48fd43fb-8418-4d4e-bbaa-4cb1a2343eec	59469-005	HUMAN OTC DRUG	AILGENO		Amanita muscaria Fruiting Body, Arsenic trioxide, Milk Thistle, Ceanothus americanus Leaf, Cinchona officinalis Bark, Glechoma hederacea Flowering Top, Grindelia hirsutula whole, and Sodium chloride	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	AMANITA MUSCARIA FRUITING BODY; ARSENIC TRIOXIDE; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; GLECHOMA HEDERACEA FLOWERING TOP; GRINDELIA HIRSUTULA WHOLE; MILK THISTLE; SODIUM CHLORIDE	4; 6; 4; 6; 6; 6; 15; 12	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-024_bd3d8481-1db1-4698-af9e-5c79e10bd34e	59469-024	HUMAN OTC DRUG	LacticPlus		Lactic Acid, DL-	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	LACTIC ACID, DL-	200	[hp_X]/100mL			N	20241231
59469-032_e3b50a80-d21e-4899-a4c4-50fea6d83bb2	59469-032	HUMAN OTC DRUG	OKOUBAKA		Okoubaka aubrevillei Bark	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Natuheilmittel GmbH	OKOUBAKA AUBREVILLEI BARK	2	[hp_X]/50mL			N	20241231
59469-038_a8b74e4c-2f25-42f2-bd53-a9814fe8c3e6	59469-038	HUMAN OTC DRUG	Zellulisan		horse chestnut, arnica montana, betula pendula leaf, hedera helix flowering twig, ledum palustre twig, melilotus officinalis top, toxicodendron pubescens leaf, and sulfur	OINTMENT	TOPICAL	20110220		UNAPPROVED HOMEOPATHIC		Pekana-Naturheilmittel GmbH	ARNICA MONTANA WHOLE; BETULA PENDULA LEAF; HEDERA HELIX FLOWERING TWIG; HORSE CHESTNUT; MELILOTUS OFFICINALIS TOP; RHODODENDRON TOMENTOSUM LEAFY TWIG; SULFUR; TOXICODENDRON PUBESCENS LEAF	8; 8; 6; 4; 4; 3; 15; 8	[hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g			N	20241231
59469-047_9927497a-a45b-490f-ab54-edd6d19ce2b0	59469-047	HUMAN OTC DRUG	FORMIPLUS		Artemisia abrotanum Flowering Top and Formic Acid	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARTEMISIA ABROTANUM FLOWERING TOP; FORMIC ACID	4; 200	[hp_X]/100mL; [hp_X]/100mL			N	20241231
59469-050_80b2be75-852a-40d8-b9d0-40e74b31fe34	59469-050	HUMAN OTC DRUG	RADINEX		Onion, Arctium lappa Root, Bellis Perennis, Glechoma hederacea Flowering Top, Hedera helix Flowering Twig, Juglans regia Whole, Sempervivum tectorum Leaf, and Viscum album Fruiting Top	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARCTIUM LAPPA ROOT; BELLIS PERENNIS WHOLE; GLECHOMA HEDERACEA FLOWERING TOP; HEDERA HELIX FLOWERING TWIG; JUGLANS REGIA WHOLE; ONION; SEMPERVIVUM TECTORUM LEAF; VISCUM ALBUM FRUITING TOP	3; 4; 6; 4; 6; 2; 12; 6	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
59469-058_9ca68189-a423-4c95-8e4e-67b7c14d25f4	59469-058	HUMAN OTC DRUG	HELMIN		Onion, Artemisia abrotanum Flowering Top, Artemisia cina Pre-Flowering Top, Cupric Oxide, Okoubaka aubrevillei Bark, Schoenocaulon officinale Seed, and Spigelia Anthelmia	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARTEMISIA ABROTANUM FLOWERING TOP; ARTEMISIA CINA PRE-FLOWERING TOP; CUPRIC OXIDE; OKOUBAKA AUBREVILLEI BARK; ONION; SCHOENOCAULON OFFICINALE SEED; SPIGELIA ANTHELMIA WHOLE	8; 12; 12; 4; 6; 6; 4	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
59469-060_5882f99c-53c3-428c-9991-2e409eaaf9d4	59469-060	HUMAN OTC DRUG	SUPREN		Arsenic Trioxide, Sulfuric Acid, Chamaelirium luteum Root, Goldenseal, Wood Creosote, Lemna minor, Magnesium fluoride, and Silicon Dioxide	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARSENIC TRIOXIDE; CHAMAELIRIUM LUTEUM ROOT; GOLDENSEAL; LEMNA MINOR WHOLE; MAGNESIUM FLUORIDE; SILICON DIOXIDE; SULFURIC ACID; WOOD CREOSOTE	12; 12; 12; 12; 12; 12; 8; 12	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
59469-066_63d764d3-3f6c-4445-ac66-40ef9869b161	59469-066	HUMAN OTC DRUG	KELAN		Silicon Dioxide, Arnica montana Root, Graphite, Hypericum Perforatum, Ledum Palustre Twig, Magnesium fluoride, Magnesium Sulfate Heptahydrate, and Ruta graveolens Flowering Top	OINTMENT	CUTANEOUS	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARNICA MONTANA ROOT; GRAPHITE; HYPERICUM PERFORATUM WHOLE; MAGNESIUM FLUORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE	12; 6; 6; 12; 12; 12; 12; 6	[hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59469-101_4146151a-07b7-4e50-9c91-b34e933c1bee	59469-101	HUMAN OTC DRUG	apo-PULM		Onion, Bryonia Dioica Root, Hedera helix Flowering Twig, Hyoscyamus Niger, Phosphorus, Polygala senega Root, Antimony potassium tartrate, and Pulmonaria officinalis Whole	SYRUP	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ANTIMONY POTASSIUM TARTRATE; BRYONIA DIOICA ROOT; HEDERA HELIX FLOWERING TWIG; HYOSCYAMUS NIGER; ONION; PHOSPHORUS; POLYGALA SENEGA ROOT; PULMONARIA OFFICINALIS WHOLE	6; 4; 8; 4; 4; 10; 4; 4	[hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
59469-102_3634624b-0eb8-490f-b9b5-1a0ae69ab805	59469-102	HUMAN OTC DRUG	apo-STOM		Antimony trisulfide, Atropa bella-donna Flowering Top, Colchicum autumnale Bulb, Citrullus colocynthis Fruit Pulp, Sodium phosphate, Strychnos nux-vomica Seed, Robinia pseudoacacia Bark, and Achillea millefolium Flowering Top	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ACHILLEA MILLEFOLIUM FLOWERING TOP; ANTIMONY TRISULFIDE; ATROPA BELLA-DONNA FLOWERING TOP; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; ROBINIA PSEUDOACACIA BARK; SODIUM PHOSPHATE; STRYCHNOS NUX-VOMICA SEED	2606; 8; 4; 4; 6; 6; 4; 4	mg/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
59469-104_d0974a83-5638-481c-8b47-77c313f15dd1	59469-104	HUMAN OTC DRUG	apo-TUSS		Arum Maculatum Root, Bryonia Dioica Root, Protortonia Cacti, Cupric Acetate, Gelsemium sempervirens Root, Hedera helix Flowering Twig, Lactuca virosa, and Horseradish	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARUM MACULATUM ROOT; BRYONIA DIOICA ROOT; CUPRIC ACETATE; GELSEMIUM SEMPERVIRENS ROOT; HEDERA HELIX FLOWERING TWIG; HORSERADISH; LACTUCA VIROSA WHOLE; PROTORTONIA CACTI	4; 4; 4; 4; 6; 4; 4; 2	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59469-106_5f7e7812-2809-4491-9306-d5452a65d788	59469-106	HUMAN OTC DRUG	apo-HEPAT		Chionanthus virginicus Bark, Iberis amara Seed, Lycopodium clavatum Spore, Mandragora officinarum Root, Phosphorus, Peumus boldus Leaf, Cynara scolymus Whole, and Taraxacum officinale Whole	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CHIONANTHUS VIRGINICUS ROOT BARK; CYNARA SCOLYMUS WHOLE; IBERIS AMARA SEED; LYCOPODIUM CLAVATUM SPORE; MANDRAGORA OFFICINARUM ROOT; PEUMUS BOLDUS LEAF; PHOSPHORUS; TARAXACUM OFFICINALE WHOLE	2; 8; 6; 4; 12; 6; 10; 8	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-107_483153ee-06a3-4e5a-ae22-47532d8d77cc	59469-107	HUMAN OTC DRUG	apo-INFEKT		Ailanthus altissima Whole, Silver Nitrate, Cinchona Officinalis Bark, Lachesis Muta Venom, Cynanchum Vincetoxicum Leaf, Echinacea, unspecified, Marrubium Vulgare, and Nasturtium officinale Whole	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	AILANTHUS ALTISSIMA WHOLE; CINCHONA OFFICINALIS BARK; ECHINACEA, UNSPECIFIED; LACHESIS MUTA VENOM; MARRUBIUM VULGARE WHOLE; NASTURTIUM OFFICINALE WHOLE; SILVER NITRATE; VINCETOXICUM HIRUNDINARIA LEAF	3; 8; 12; 12; 6; 6; 6; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-111_01178dd0-c70a-4938-9090-b8fd7a44ed11	59469-111	HUMAN OTC DRUG	DERCUT		Helianthemum canadense, Centella asiatica Flowering Top, Daphne mezereum Bark, Ranunculus Bulbosus, Smilax Regelii Root, Fumaria officinalis Flowering Top, Ledum Palustre Twig, and Viola tricolor	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CENTELLA ASIATICA FLOWERING TOP; DAPHNE MEZEREUM BARK; FUMARIA OFFICINALIS FLOWERING TOP; HELIANTHEMUM CANADENSE; RANUNCULUS BULBOSUS WHOLE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SMILAX ORNATA ROOT; VIOLA TRICOLOR WHOLE	4; 12; 6; 3; 4; 6; 12; 4	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-112_21cd4bc8-e0bb-40f2-bd88-1ea1be9430c3	59469-112	HUMAN OTC DRUG	ITIRES		Barium Carbonate, Calcium Iodide, Helianthemum canadense, Conium maculatum Flowering Top, Scrophularia nodosa, Echinacea, unspecified, Galium Aparine, and Juglans regia Whole	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	BARIUM CARBONATE; CALCIUM IODIDE; CONIUM MACULATUM FLOWERING TOP; ECHINACEA, UNSPECIFIED; GALIUM APARINE WHOLE; HELIANTHEMUM CANADENSE; JUGLANS REGIA WHOLE; SCROPHULARIA NODOSA WHOLE	8; 8; 6; 12; 6; 12; 6; 4	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
59469-116_78ed18a7-da36-4ead-be28-92693f46c272	59469-116	HUMAN OTC DRUG	PROALLER		Ailanthus altissima Whole, Okoubaka aubrevillei Bark, Euphrasia Stricta, Gratiola officinalis, Juglans regia Whole, Smilax Regelii Root, and Taraxacum officinale Whole	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel	AILANTHUS ALTISSIMA WHOLE; EUPHRASIA STRICTA; GRATIOLA OFFICINALIS WHOLE; JUGLANS REGIA WHOLE; OKOUBAKA AUBREVILLEI BARK; SMILAX ORNATA ROOT; TARAXACUM OFFICINALE WHOLE	4; 3; 4; 6; 3; 8; 12	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-118_d384c139-469a-4e9c-a705-61d81ca44ba2	59469-118	HUMAN OTC DRUG	RICURA		Paprika, Mercuric Sulfide, Wood Creosote, Luffa Operculata Fruit, Thuja Occidentalis Leafy Twig, Echinacea, Unspecified, Plantago Major Leaf, and Sanicula Europaea Top	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ECHINACEA, UNSPECIFIED; LUFFA OPERCULATA FRUIT; MERCURIC SULFIDE; PAPRIKA; PLANTAGO MAJOR LEAF; SANICULA EUROPAEA TOP; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	12; 6; 12; 4; 6; 6; 6; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
59469-122_5b96c654-6f25-43f0-b240-a1502fefc009	59469-122	HUMAN OTC DRUG	FERRODONNA		arsenic trioxide, ceanothus americanus leaf, cinchona officinalis bark, cobaltous nitrate, cupric sulfate, iron, manganese acetate, and sodium chloride	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARSENIC TRIOXIDE; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; COBALTOUS NITRATE; CUPRIC SULFATE; IRON; MANGANESE ACETATE; SODIUM CHLORIDE	12; 5; 4; 6; 6; 12; 6; 12	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59469-123_c3556492-a3e5-46f2-9107-707371d16be1	59469-123	HUMAN OTC DRUG	SPECI-CHOL		Chionanthus virginicus Bark, Eichhornia crassipes Whole, Hedera helix Flowering Twig, Iberis amara Seed, Iris versicolor Root, Nutmeg, Phosphorus, and Glechoma hederacea Flowering Top	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CHIONANTHUS VIRGINICUS ROOT BARK; EICHHORNIA CRASSIPES WHOLE; GLECHOMA HEDERACEA FLOWERING TOP; HEDERA HELIX FLOWERING TWIG; IBERIS AMARA SEED; IRIS VERSICOLOR ROOT; NUTMEG; PHOSPHORUS	3; 2; 698; 6; 3; 3; 4; 10	[hp_X]/50mL; [hp_X]/50mL; mg/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
59469-130_7b291567-96a5-4023-91c2-e9cafc019bc1	59469-130	HUMAN OTC DRUG	apo-DOLOR		Aconitum Napellus, Semecarpus anacardium Fruit, Bryonia Dioica Root, Gelsemium sempervirens Root, Menyanthes trifoliata, Piper methysticum Root, Schoenocaulon officinale Seed, and Spigelia Anthelmia	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ACONITUM NAPELLUS WHOLE; BRYONIA DIOICA ROOT; GELSEMIUM SEMPERVIRENS ROOT; MACROPIPER METHYSTICUM ROOT; MENYANTHES TRIFOLIATA WHOLE; SCHOENOCAULON OFFICINALE SEED; SEMECARPUS ANACARDIUM FRUIT; SPIGELIA ANTHELMIA WHOLE	12; 3; 4; 8; 3; 3; 6; 3	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-131_9ed39c86-6061-4b0b-8691-c9d6adee55f5	59469-131	HUMAN OTC DRUG	GLAUTARAKT		Gold Trichloride, Solanum dulcamara Top, Euphrasia Stricta, Nitroglycerin, Hedera helix Flowering Twig, Ruta graveolens Flowering Top, Tobacco Leaf, and Cynara scolymus Whole	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CYNARA SCOLYMUS WHOLE; EUPHRASIA STRICTA; GOLD TRICHLORIDE; HEDERA HELIX FLOWERING TWIG; NITROGLYCERIN; RUTA GRAVEOLENS FLOWERING TOP; SOLANUM DULCAMARA TOP; TOBACCO LEAF	8; 2; 6; 8; 6; 6; 3; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vasodilation [PE]		N	20241231
59469-133_eac362c3-95fe-4916-b408-014484204823	59469-133	HUMAN OTC DRUG	DEFAETON		Peumus boldus Leaf, Dioscorea villosa Tuber, Strychnos ignatii Seed, Cynara scolymus Whole, Fumaria officinalis Whole, Frangula Alnus Bark, and Rheum officinale Root	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CYNARA SCOLYMUS WHOLE; DIOSCOREA VILLOSA TUBER; FRANGULA ALNUS BARK; FUMARIA OFFICINALIS WHOLE; PEUMUS BOLDUS LEAF; RHEUM OFFICINALE ROOT; STRYCHNOS IGNATII SEED	12; 4; 8; 6; 6; 8; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-134_0cab30b5-68eb-44ed-aaf1-a41f725a8d8e	59469-134	HUMAN OTC DRUG	apo-RHEUM		ARNICA MONTANA ROOT, BRYONIA DIOICA ROOT, COLCHICUM AUTUMNALE BULB, SOLANUM DULCAMARA TOP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, GUAIACUM OFFICINALE RESIN, and TARAXACUM OFFICINALE WHOLE	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARNICA MONTANA ROOT; BRYONIA DIOICA ROOT; COLCHICUM AUTUMNALE BULB; GUAIACUM OFFICINALE RESIN; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; SOLANUM DULCAMARA TOP; TARAXACUM OFFICINALE WHOLE	12; 4; 12; 6; 4; 12; 12	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-135_113e7959-7805-4223-be50-076a55215ced	59469-135	HUMAN OTC DRUG	PSY-stabil		Phosphoric Acid, Amanita muscaria Fruiting Body, Semecarpus anacardium Fruit, Avena sativa Flowering Top, Cinchona officinalis Bark, Strychnos ignatii Seed, Schoenocaulon officinale Seed, and Piper methysticum Root	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	AMANITA MUSCARIA FRUITING BODY; AVENA SATIVA FLOWERING TOP; CINCHONA OFFICINALIS BARK; MACROPIPER METHYSTICUM ROOT; PHOSPHORIC ACID; SCHOENOCAULON OFFICINALE SEED; SEMECARPUS ANACARDIUM FRUIT; STRYCHNOS IGNATII SEED	6; 1; 3; 8; 3; 4; 10; 4	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-138_d5fc8058-6238-444a-a718-1eedb4b81b91	59469-138	HUMAN OTC DRUG	ZELLULISAN		arnica montana root, ledum palustre twig, toxicodendron pubescens shoot, sulfur, horse chestnut, betula pendula leaf, hedera helix flowering twig, and melilotus officinalis top	OINTMENT	CUTANEOUS	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARNICA MONTANA ROOT; BETULA PENDULA LEAF; HEDERA HELIX FLOWERING TWIG; HORSE CHESTNUT; MELILOTUS OFFICINALIS TOP; RHODODENDRON TOMENTOSUM LEAFY TWIG; SULFUR; TOXICODENDRON PUBESCENS SHOOT	8; 8; 6; 4; 4; 3; 15; 8	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
59469-140_fb347aec-4719-4086-9abd-1c79936b818f	59469-140	HUMAN OTC DRUG	MUNDIPUR		Bryonia Dioica Root, Colchicum autumnale Bulb, Sodium Carbonate, Phytolacca americana Root, Berberis Vulgaris Root Bark, Cynara scolymus Whole, Harpagophytum procumbens Root, and Ledum Palustre Twig	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	BERBERIS VULGARIS ROOT BARK; BRYONIA DIOICA ROOT; COLCHICUM AUTUMNALE BULB; CYNARA SCOLYMUS WHOLE; HARPAGOPHYTUM PROCUMBENS ROOT; PHYTOLACCA AMERICANA ROOT; RHODODENDRON TOMENTOSUM LEAFY TWIG; SODIUM CARBONATE	6; 4; 12; 8; 12; 4; 6; 4	[hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL			N	20241231
59469-141_2989c3c6-5187-4615-8c71-31912aa57a10	59469-141	HUMAN OTC DRUG	HABIFAC		Formic Acid, Nitric Acid, Baptisia tinctoria Root, Graphite, Calcium sulfide, Thuja occidentalis Leafy Twig, Cynanchum Vincetoxicum Leaf, and Glechoma hederacea Flowering Top	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	BAPTISIA TINCTORIA ROOT; CALCIUM SULFIDE; FORMIC ACID; GLECHOMA HEDERACEA FLOWERING TOP; GRAPHITE; NITRIC ACID; THUJA OCCIDENTALIS LEAFY TWIG; VINCETOXICUM HIRUNDINARIA LEAF	5; 8; 8; 4; 8; 6; 10; 8	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-143_7aca5451-c6f8-4820-a3a7-a1820546f734	59469-143	HUMAN OTC DRUG	CLAUPAREST		Araneus diadematus, Arnica montana Root, Cupric Acetate, Mandragora officinarum Root, Lead Acetate Anhydrous, Tobacco Leaf, Melilotus officinalis Top, and Ruta graveolens Flowering Top	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARANEUS DIADEMATUS; ARNICA MONTANA ROOT; CUPRIC ACETATE; LEAD ACETATE ANHYDROUS; MANDRAGORA OFFICINARUM ROOT; MELILOTUS OFFICINALIS TOP; RUTA GRAVEOLENS FLOWERING TOP; TOBACCO LEAF	9; 4; 4; 6; 6; 4; 4; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59469-144_173bff27-c289-47b5-be66-c41a4f5d0ce3	59469-144	HUMAN OTC DRUG	PLEVENT		Peumus boldus Leaf, Cynara scolymus Whole, Equisetum arvense Top, Leonurus cardiaca Flowering Top, Solidago virgaurea Flowering Top, and Taraxacum officinale Whole	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CYNARA SCOLYMUS WHOLE; EQUISETUM ARVENSE TOP; LEONURUS CARDIACA FLOWERING TOP; PEUMUS BOLDUS LEAF; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE WHOLE	12; 6; 4; 8; 12; 8	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-148_e6251f15-ccf0-4fa7-9a93-c7f86251023c	59469-148	HUMAN OTC DRUG	inflamyar		Arnica montana Root, Bryonia Dioica Root, Guaiacum officinale Resin, Toxicodendron Pubescens Shoot, Bellis Perennis, Ledum Palustre Twig, Ruta graveolens Flowering Top, and Viscum album Fruiting Top	OINTMENT	CUTANEOUS	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARNICA MONTANA ROOT; BELLIS PERENNIS WHOLE; BRYONIA DIOICA ROOT; GUAIACUM OFFICINALE RESIN; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS SHOOT; VISCUM ALBUM FRUITING TOP	12; 8; 4; 4; 4; 6; 12; 4	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
59469-153_737b125d-ff36-44d8-8530-0df981265402	59469-153	HUMAN OTC DRUG	OSS-regen		Phosphoric Acid, Angostura Bark, Ferula Assa-Foetida Resin, Bellis Perennis, Bryonia Dioica Root, Guaiacum officinale Resin, Ruta graveolens Flowering Top, and Equisetum arvense Top	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ANGOSTURA BARK; BELLIS PERENNIS WHOLE; BRYONIA DIOICA ROOT; EQUISETUM ARVENSE TOP; FERULA ASSA-FOETIDA RESIN; GUAIACUM OFFICINALE RESIN; PHOSPHORIC ACID; RUTA GRAVEOLENS FLOWERING TOP	4; 3; 4; 2481; 3; 3; 3; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; mg/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
59469-157_f076c9c6-31a0-4dff-b7cc-66e08f5ab00e	59469-157	HUMAN OTC DRUG	Thuja		Thuja occidentalis leafy twig	LIQUID	ORAL	20050501		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	THUJA OCCIDENTALIS LEAFY TWIG	3	[hp_X]/50mL			N	20241231
59469-158_ea8d652c-1583-4429-9d09-928b215a9275	59469-158	HUMAN OTC DRUG	apo-ENTERIT		Citrullus colocynthis Fruit Pulp, Podophyllum, Veratrum album Root, Artemisia abrotanum Flowering Top, Cynara scolymus Whole, and Potentilla anserina Flowering Top	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARTEMISIA ABROTANUM FLOWERING TOP; CITRULLUS COLOCYNTHIS FRUIT PULP; CYNARA SCOLYMUS WHOLE; PODOPHYLLUM; POTENTILLA ANSERINA FLOWERING TOP; VERATRUM ALBUM ROOT	760; 4; 2137; 4; 1092; 4	mg/50mL; [hp_X]/50mL; mg/50mL; [hp_X]/50mL; mg/50mL; [hp_X]/50mL			N	20241231
59469-163_e736def8-aafc-46c8-b3fa-d33a04cd281c	59469-163	HUMAN OTC DRUG	PSY-stabil		Phosphoric Acid, Amanita muscaria Fruiting Body, Semecarpus anacardium Fruit, Avena sativa Flowering Top, Cinchona officinalis Bark, Strychnos ignatii Seed, Schoenocaulon officinale Seed, and Piper methysticum Root	SOLUTION/ DROPS	ORAL	20081211		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	AMANITA MUSCARIA FRUITING BODY; AVENA SATIVA FLOWERING TOP; CINCHONA OFFICINALIS BARK; MACROPIPER METHYSTICUM ROOT; PHOSPHORIC ACID; SCHOENOCAULON OFFICINALE SEED; SEMECARPUS ANACARDIUM FRUIT; STRYCHNOS IGNATII SEED	6; 1; 3; 8; 3; 4; 10; 4	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
59469-165_182e395f-92e8-4dc4-be96-7ecf0261ea92	59469-165	HUMAN OTC DRUG	INFLAMYAR		Arnica montana Root, Bellis Perennis, Bryonia Dioica Root, Guaiacum officinale Resin, Ledum Palustre Twig, Ruta graveolens Flowering Top, Toxicodendron Pubescens Shoot, and Viscum album Fruiting Top	SOLUTION/ DROPS	ORAL	20080412		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARNICA MONTANA ROOT; BELLIS PERENNIS WHOLE; BRYONIA DIOICA ROOT; GUAIACUM OFFICINALE RESIN; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS SHOOT; VISCUM ALBUM FRUITING TOP	4; 4; 4; 6; 12; 4; 8; 4	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
59469-170_4efadbef-b181-4951-9f2f-847a27b4a187	59469-170	HUMAN OTC DRUG	Inflamyar		arnica montana, bellis perennis, bryonia cretica subsp. dioica root, guaiacum officinale resin, ledum palustre twig, toxicodendron pubescens leaf, ruta graveolens flowering top, and viscum album fruit	OINTMENT	TOPICAL	20101201		UNAPPROVED HOMEOPATHIC		Pekana-Naturheilmittel GmbH	ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BRYONIA DIOICA ROOT; GUAIACUM OFFICINALE RESIN; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUIT	12; 8; 4; 4; 4; 6; 12; 4	[hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g			N	20241231
59469-172_881b458b-9908-4f15-b509-20febb2c291e	59469-172	HUMAN OTC DRUG	Inflamyar		ARNICA MONTANA, BELLIS PERENNIS, BRYONIA CRETICA SUBSP. DIOICA ROOT, GUAIACUM OFFICINALE RESIN, LEDUM PALUSTRE TWIG, RUTA GRAVEOLENS WHOLE, TOXICODENDRON PUBESCENS LEAF, and VISCUM ALBUM FRUIT	PELLET	ORAL	20110901		UNAPPROVED HOMEOPATHIC		Pekana-Naturheilmittel GmbH	ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; BRYONIA DIOICA ROOT; GUAIACUM OFFICINALE RESIN; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS WHOLE; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM FRUIT	4; 4; 4; 6; 12; 4; 8; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
59469-201_3a627c71-037e-40c1-bd17-604157667dd2	59469-201	HUMAN OTC DRUG	BOLYM-EX Drops		Benzoic Acid, Formic Acid, Aristolochia Clematitis Root, FERULA ASSA-FOETIDA RESIN, Avena Sativa Flowering Top, Berberis Vulgaris Root Bark, CALCIUM PHOSPHATE, UNSPECIFIED FORM, Capsella bursa-pastoris, Galium aparine, Daphne Mezereum Bark, and Piper Methysticum Root	LIQUID	ORAL	20150601		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARISTOLOCHIA CLEMATITIS ROOT; AVENA SATIVA FLOWERING TOP; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; CALCIUM PHOSPHATE, UNSPECIFIED FORM; CAPSELLA BURSA-PASTORIS WHOLE; DAPHNE MEZEREUM BARK; FERULA ASSA-FOETIDA RESIN; FORMIC ACID; GALIUM APARINE WHOLE; MACROPIPER METHYSTICUM ROOT	24; 4; 5; 5; 8; 5; 8; 5; 5; 5; 10	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Ammonium Ion Binding Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Nitrogen Binding Agent [EPC]		N	20241231
59469-203_4b306ab8-afab-472a-a86e-acae6307650e	59469-203	HUMAN OTC DRUG	VULPUR		Silver Nitrate, Armoracia rusticana whole, Cinnamomum verum whole, Wood Creosote, Capsella bursa-pastoris, Calendula Officinalis Flowering Top, Achillea Millefolium, and Salvia officinalis flowering top	SOLUTION/ DROPS	ORAL	20171001		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ACHILLEA MILLEFOLIUM WHOLE; ARMORACIA RUSTICANA WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; CAPSELLA BURSA-PASTORIS WHOLE; CINNAMOMUM VERUM WHOLE; SALVIA OFFICINALIS FLOWERING TOP; SILVER NITRATE; WOOD CREOSOTE	8; 4; 8; 4; 12; 8; 6; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-301_4d19cb5d-3526-4bd8-af97-8ace1615350b	59469-301	HUMAN OTC DRUG	AKUTUR		BENZOIC ACID, NITRIC ACID, Apis mellifera, Lytta vesicatoria, Populus tremuloides Bark, ANEMONE PRATENSIS Flowering TOP, GINGER, and Solidago virgaurea Flowering Top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Nautrheilmittel GmbH	APIS MELLIFERA; BENZOIC ACID; GINGER; LYTTA VESICATORIA; NITRIC ACID; POPULUS TREMULOIDES BARK; PULSATILLA PRATENSIS FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP	3; 4; 3; 4; 6; 2; 4; 2208	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; mg/50mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
59469-302_317b4b69-0711-42ff-9895-b075cee0cea0	59469-302	HUMAN OTC DRUG	apo-OEDEM		Horse Chestnut, Apocynum cannabinum Root, Convallaria majalis Flowering Top, Helleborus niger Root, Thuja occidentalis Leafy Twig, Sambucus nigra Flowering Top, Filipendula ulmaria Root, and Corn Silk	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel Gmbh	APOCYNUM CANNABINUM ROOT; CONVALLARIA MAJALIS FLOWERING TOP; CORN SILK; FILIPENDULA ULMARIA ROOT; HELLEBORUS NIGER ROOT; HORSE CHESTNUT; SAMBUCUS NIGRA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	3; 12; 4; 6; 4; 4; 4; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-303_815b9de3-2368-4bf3-9294-1e3dbb13cf41	59469-303	HUMAN OTC DRUG	BRONCHI-PERTU		BRYONIA DIOICA ROOT, PROTORTONIA CACTI, GUAIACUM OFFICINALE RESIN, OENANTHE AQUATICA FRUIT, PHOSPHORUS, ANTIMONY POTASSIUM TARTRATE, USNEA BARBATA, and GRINDELIA HIRSUTULA WHOLE	SYRUP	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ANTIMONY POTASSIUM TARTRATE; BRYONIA DIOICA ROOT; GRINDELIA HIRSUTULA WHOLE; GUAIACUM OFFICINALE RESIN; OENANTHE AQUATICA FRUIT; PHOSPHORUS; PROTORTONIA CACTI; USNEA BARBATA	6; 3; 8; 3; 4; 6; 2; 12	[hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL; [hp_X]/125mL			N	20241231
59469-304_a68d96c9-c25c-48db-b807-9628b9721117	59469-304	HUMAN OTC DRUG	co-HYPERT		Sodium Tetrachloroaurate, Barium Carbonate, Anamirta cocculus seed, Iberis amara Seed, Magnesium chloride, Ferula Sumbul Root, Melilotus officinalis Top, and Viscum album Fruiting Top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel Gmbh	ANAMIRTA COCCULUS SEED; BARIUM CARBONATE; FERULA SUMBUL ROOT; IBERIS AMARA SEED; MAGNESIUM CHLORIDE; MELILOTUS OFFICINALIS TOP; SODIUM TETRACHLOROAURATE; VISCUM ALBUM FRUITING TOP	4; 8; 6; 4; 6; 3; 6; 3	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59469-305_7ee0a73a-1bb7-4e4e-80b2-d1ef6920c069	59469-305	HUMAN OTC DRUG	DALEKTRO N		SILVER NITRATE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, COBALTOUS NITRATE HEXAHYDRATE, CUPRIC ACETATE, IRON, POTASSIUM CARBONATE, MAGNESIUM CHLORIDE, MANGANESE ACETATE TETRAHYDRATE, SELENIUM, SILICON DIOXIDE, and ZINC PHOSPHIDE	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Natruheilmittel GmbH	COBALTOUS NITRATE HEXAHYDRATE; CUPRIC ACETATE; IRON; MAGNESIUM CHLORIDE; MANGANESE ACETATE TETRAHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; SELENIUM; SILICON DIOXIDE; SILVER NITRATE; ZINC PHOSPHIDE	6; 12; 6; 4; 8; 6; 4; 12; 12; 6; 12	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59469-306_28ef7cc8-b305-4431-b400-3625a6213d3a	59469-306	HUMAN OTC DRUG	DEMYC		RANUNCULUS BULBOSUS, Delphinium staphisagria Seed, MACROPIPER METHYSTICUM ROOT, Anagallis arvensis, Calendula officinalis Flowering Top, and SAGE	SOLUTION/ DROPS	TOPICAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CALENDULA OFFICINALIS FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LYSIMACHIA ARVENSIS WHOLE; PIPER METHYSTICUM ROOT; RANUNCULUS BULBOSUS WHOLE; SAGE	806; 6; 237; 8; 5; 774	mg/20mL; [hp_X]/20mL; mg/20mL; [hp_X]/20mL; [hp_X]/20mL; mg/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59469-307_b1a5b968-4f80-4329-8e35-94ad7d7aa04e	59469-307	HUMAN OTC DRUG	DERCUT		euphorbia resinifera resin, goldenseal, wood creosote, toxicodendron pubescens shoot, sempervivum tectorum leaf, bellis perennis, vinca minor, and viola tricolor	OINTMENT	CUTANEOUS	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	BELLIS PERENNIS WHOLE; EUPHORBIA RESINIFERA RESIN; GOLDENSEAL; PERVINCA MINOR WHOLE; SEMPERVIVUM TECTORUM LEAF; TOXICODENDRON PUBESCENS SHOOT; VIOLA TRICOLOR WHOLE; WOOD CREOSOTE	8; 4; 4; 3; 3; 8; 2; 6	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
59469-308_b023e71a-50d7-4782-95aa-2daad697fda2	59469-308	HUMAN OTC DRUG	GLUCOREKT		LACTIC ACID, DL-, Sulfuric Acid, Onion, Chionanthus virginicus Bark, Phosphorus, Zinc Sulfate Heptahydrate, Corn Silk, and Syzygium cumini Fruit	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CHIONANTHUS VIRGINICUS ROOT BARK; CORN SILK; LACTIC ACID, DL-; ONION; PHOSPHORUS; SULFURIC ACID; SYZYGIUM CUMINI FRUIT; ZINC SULFATE HEPTAHYDRATE	3; 669; 6; 4; 10; 6; 3; 3	[hp_X]/50mL; mg/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
59469-309_d5273f5c-c438-4f63-b7a6-fc209c1ff1c4	59469-309	HUMAN OTC DRUG	ITIRES		Arnica montana Root, CALCIUM FLUORIDE, CALCIUM IODIDE, Clematis recta Flowering Top, Scrophularia nodosa, Conium maculatum Flowering Top, HORSE CHESTNUT, and Hedera helix Flowering Twig	OINTMENT	CUTANEOUS	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARNICA MONTANA ROOT; CALCIUM FLUORIDE; CALCIUM IODIDE; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; HEDERA HELIX FLOWERING TWIG; HORSE CHESTNUT; SCROPHULARIA NODOSA WHOLE	8; 8; 6; 4; 6; 6; 4; 2	[hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g; [hp_X]/35g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
59469-310_2ac5dadc-a1d4-4f2b-a6a3-a2ec087429c4	59469-310	HUMAN OTC DRUG	JUVE-CAL		Artemisia Abrotanum Flowering Top, Phosphoric Acid, Silver Nitrate, Barium Carbonate, Lycopodium Clavatum Spore, Delphinium Staphisagria Seed, Calcium Hypophosphite, And Cinchona Officinalis Bark	SYRUP	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARTEMISIA ABROTANUM FLOWERING TOP; BARIUM CARBONATE; CALCIUM HYPOPHOSPHITE; CINCHONA OFFICINALIS BARK; DELPHINIUM STAPHISAGRIA SEED; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; SILVER NITRATE	8; 12; 4; 8; 6; 12; 4; 6	[hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
59469-311_ffbcdaef-9ad8-4a94-8ee2-ced689a31acb	59469-311	HUMAN OTC DRUG	KLIFEM		aletris farinosa root, graphite, chamaelirium luteum root, pilocarpus jaborandii leaf, lachesis muta venom, anemone pratensis flowering top, sanguinaria canadensis root, and lamium album flowering top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ALETRIS FARINOSA ROOT; CHAMAELIRIUM LUTEUM ROOT; GRAPHITE; LACHESIS MUTA VENOM; LAMIUM ALBUM FLOWERING TOP; PILOCARPUS JABORANDII LEAF; PULSATILLA PRATENSIS FLOWERING TOP; SANGUINARIA CANADENSIS ROOT	4; 3; 8; 8; 1475; 3; 3; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; mg/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-312_c5c2c613-31d3-45b0-8c2d-673caac13b8c	59469-312	HUMAN OTC DRUG	NEU-regen		Silver Nitrate, Chinchona officinalis Bark, Conium maculatum Flowering Top, Strychnos nux-vomica Seed, Delphinium staphisagria Seed, Macropiper Methysticum Root, Avena sativa Flowering Top, and Asian Ginseng	SYRUP	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ASIAN GINSENG; AVENA SATIVA FLOWERING TOP; CINCHONA OFFICINALIS BARK; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; PIPER METHYSTICUM ROOT; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED	561; 3061; 4; 6; 6; 8; 6; 4	mg/250mL; mg/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL; [hp_X]/250mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
59469-313_78966d8c-4e59-42a5-b818-a4f191e94ae0	59469-313	HUMAN OTC DRUG	OPSONAT		silver nitrate, sulfuric acid, bellis perennis, lytta vesicatoria, gratiola officinalis, goldenseal, lachesis muta venom, and glechoma hederacea flowering top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	BELLIS PERENNIS WHOLE; GLECHOMA HEDERACEA FLOWERING TOP; GOLDENSEAL; GRATIOLA OFFICINALIS WHOLE; LACHESIS MUTA VENOM; LYTTA VESICATORIA; SILVER NITRATE; SULFURIC ACID	1; 1602; 5; 4; 8; 4; 6; 6	[hp_X]/100mL; mg/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
59469-314_2d2d5f9d-97c8-424f-83e1-d2f7dddee82d	59469-314	HUMAN OTC DRUG	PROSCENAT		SULFURIC ACID, Lytta vesicatoria, Conium maculatum Flowering Top, Selenium, Delphinium staphisagria Seed, Nasturtium officinale Whole, and Ononis spinosa Whole	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; LYTTA VESICATORIA; NASTURTIUM OFFICINALE WHOLE; ONONIS SPINOSA WHOLE; SELENIUM; SULFURIC ACID	4; 6; 4; 1852; 2564; 8; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; mg/50mL; mg/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-315_8ddbd870-0a08-4be8-8d59-b56c164cd02f	59469-315	HUMAN OTC DRUG	RENELIX		Benzoic Acid, Nitric Acid, Apis mellifera, Berberis Vulgaris Root Bark, Colchicum autumnale Bulb, Protortonia Cacti, Solidago virgaurea Flowering Top, and Capsella bursa-pastoris Top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	APIS MELLIFERA; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; CAPSELLA BURSA-PASTORIS TOP; COLCHICUM AUTUMNALE BULB; NITRIC ACID; PROTORTONIA CACTI; SOLIDAGO VIRGAUREA FLOWERING TOP	4; 4; 3; 510; 12; 6; 631; 2913	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; mg/50mL; [hp_X]/50mL; [hp_X]/50mL; mg/50mL; mg/50mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
59469-316_132810e3-4dff-4f49-9578-1318b30aefee	59469-316	HUMAN OTC DRUG	SEPTONSIL		Ailanthus altissima Whole, Atropa bella-donna Flowering Top, Barium Carbonate, Lachesis Muta Venom, Phytolacca americana Root, Clematis recta Flowering Top, Echinacea, unspecified, and Teucrium scorodonia Flowering Top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	AILANTHUS ALTISSIMA WHOLE; ATROPA BELLA-DONNA FLOWERING TOP; BARIUM CARBONATE; CLEMATIS RECTA FLOWERING TOP; ECHINACEA, UNSPECIFIED; LACHESIS MUTA VENOM; PHYTOLACCA AMERICANA ROOT; TEUCRIUM SCORODONIA FLOWERING TOP	3; 4; 8; 4; 6; 8; 4; 12	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-317_1f94400b-1e66-45f9-bc6a-83caa2e9dd36	59469-317	HUMAN OTC DRUG	SOMCUPIN		Silver nitrate, Sodium Tetrachloroaurate, Arabica Coffee Bean, Delphinium staphisagria Seed, Lactuca virosa, Zinc Valerate Dihydrate, Eschscholzia Californica Flowering Top, and Avena sativa Flowering Top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; ESCHSCHOLZIA CALIFORNICA FLOWERING TOP; LACTUCA VIROSA WHOLE; SILVER NITRATE; SODIUM TETRACHLOROAURATE; ZINC VALERATE DIHYDRATE	10; 2670; 6; 12; 4; 6; 6; 5	[hp_X]/50mL; mg/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
59469-318_bc66ed42-ef11-45cb-b2b0-5bdb4ae53fbb	59469-318	HUMAN OTC DRUG	TOXEX		SILVER NITRATE, BRYONIA DIOICA ROOT, Clematis recta Flowering Top, GOLDENSEAL, Echinacea, unspecified, GALIUM APARINE, Glechoma hederacea Flowering Top, and RHODODENDRON TOMENTOSUM LEAFY TWIG	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	BRYONIA CRETICA SUBSP. DIOICA ROOT; CLEMATIS RECTA FLOWERING TOP; ECHINACEA, UNSPECIFIED; GALIUM APARINE WHOLE; GLECHOMA HEDERACEA FLOWERING TOP; GOLDENSEAL; RHODODENDRON TOMENTOSUM LEAFY TWIG; SILVER NITRATE	4; 4; 12; 6; 6; 5; 6; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-319_25975778-438f-499f-9f7d-ee6697c6a18f	59469-319	HUMAN OTC DRUG	UPELVA		CYCLAMEN PURPURASCENS TUBER, Chamaelirium luteum Root, HYPERICUM PERFORATUM, Potassium carbonate, Delphinium staphisagria Seed, Datura stramonium Flowering Top, Viburnum opulus Bark, and ZANTHOXYLUM AMERICANUM BARK	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CHAMAELIRIUM LUTEUM ROOT; CYCLAMEN PURPURASCENS TUBER; DATURA STRAMONIUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; HYPERICUM PERFORATUM WHOLE; POTASSIUM CARBONATE; VIBURNUM OPULUS BARK; ZANTHOXYLUM AMERICANUM BARK	4; 3; 10; 6; 3; 4; 1; 3	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
59469-320_8a02a404-808c-448f-b58e-354fb66e6dcf	59469-320	HUMAN OTC DRUG	MUCAN		amanita muscaria fruiting body, garlic, aristolochia clematitis whole, simaba cedron seed, goldenseal, okoubaka aubrevillei bark, and vincetoxicum hirundinaria leaf	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	AMANITA MUSCARIA FRUITING BODY; ARISTOLOCHIA CLEMATITIS WHOLE; GARLIC; GOLDENSEAL; HOMALOLEPIS CEDRON SEED; OKOUBAKA AUBREVILLEI BARK; VINCETOXICUM HIRUNDINARIA LEAF	6; 12; 6; 12; 6; 6; 5	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59469-321_33ce0ab6-8bec-468d-9f7c-522779c4827d	59469-321	HUMAN OTC DRUG	CitriPlus		juglans regia whole and anhydrous citric acid	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Natuheilmittel GmbH	ANHYDROUS CITRIC ACID; JUGLANS REGIA WHOLE	4; 5	[hp_X]/100mL; [hp_X]/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
59469-322_a5ca548c-769d-43a5-a201-f6c544197a85	59469-322	HUMAN OTC DRUG	VISCUM		VISCUM ALBUM FRUITING TOP	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Natuheilmittel GmbH	VISCUM ALBUM FRUITING TOP	3	[hp_X]/50mL			N	20241231
59469-323_f9f8ce45-cc62-4715-876e-b4d38c2cc32f	59469-323	HUMAN OTC DRUG	apo-STRUM		CALCIUM FLUORIDE, Conium maculatum Flowering Top, LOPHOPHYTUM LEANDRII, Hedera helix Flowering Twig, MAGNESIUM CARBONATE, Cytisus scoparius Flowering Top, SELENICEREUS GRANDIFLORUS WHOLE, and GALIUM APARINE	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CALCIUM FLUORIDE; CONIUM MACULATUM FLOWERING TOP; CYTISUS SCOPARIUS FLOWERING TOP; GALIUM APARINE WHOLE; HEDERA HELIX FLOWERING TWIG; LOPHOPHYTUM LEANDRII; MAGNESIUM CARBONATE; SELENICEREUS GRANDIFLORUS WHOLE	8; 6; 6; 584; 3; 4; 8; 4	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; mg/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59469-324_ee10404e-1016-4ab0-a62e-fa8c54a39f3b	59469-324	HUMAN OTC DRUG	CARDINORMA		Arnica montana Root, Activated Charcoal, Potassium carbonate, Lachesis Muta Venom, Nerium oleander Leaf, Tobacco Leaf, Peumus boldus Leaf, and SELENICEREUS GRANDIFLORUS WHOLE	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ACTIVATED CHARCOAL; ARNICA MONTANA ROOT; LACHESIS MUTA VENOM; NERIUM OLEANDER LEAF; PEUMUS BOLDUS LEAF; POTASSIUM CARBONATE; SELENICEREUS GRANDIFLORUS WHOLE; TOBACCO LEAF	8; 4; 8; 4; 4; 4; 4; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59469-325_85be782e-ba79-437a-b7da-b7c41f7c0145	59469-325	HUMAN OTC DRUG	coro-CALM		aconitum napellus, Selenicereus grandiflorus Whole, arabica coffee bean, lobelia inflata, ferula sumbul root, Convallaria majalis Flowering Top, prunus laurocerasus leaf, and Leonurus cardiaca Flowering Top	SOLUTION/ DROPS	ORAL	20190624		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ACONITUM NAPELLUS WHOLE; ARABICA COFFEE BEAN; CONVALLARIA MAJALIS FLOWERING TOP; FERULA SUMBUL ROOT; LEONURUS CARDIACA FLOWERING TOP; LOBELIA INFLATA WHOLE; PRUNUS LAUROCERASUS LEAF; SELENICEREUS GRANDIFLORUS WHOLE	6; 10; 12; 4; 6; 4; 3; 2	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
59469-326_6387520c-6680-4a9b-93a4-784538ed47c9	59469-326	HUMAN OTC DRUG	CANGUST		Horse Chestnut, Arnica montana Root, Gold Trichloride, Activated Charcoal, Lachesis Muta Venom, Prunus laurocerasus Leaf, Strophanthus gratus Seed, and Tobacco Leaf	SOLUTION/ DROPS	ORAL	20190108		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	ACTIVATED CHARCOAL; ARNICA MONTANA ROOT; GOLD TRICHLORIDE; HORSE CHESTNUT; LACHESIS MUTA VENOM; PRUNUS LAUROCERASUS LEAF; STROPHANTHUS GRATUS SEED; TOBACCO LEAF	8; 4; 6; 2; 8; 3; 4; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59469-327_fc4d8ad2-067f-466e-8f7c-71bec35e46c7	59469-327	HUMAN OTC DRUG	DerCution		CENTELLA ASIATICA, RANUNCULUS BULBOSUS, DELPHINIUM STAPHISAGRIA SEED, CALENDULA OFFICINALIS flowering TOP, ECHINACEA, UNSPECIFIED, RHODODENDRON TOMENTOSUM LEAFY TWIG, and VIOLA TRICOLOR	LOTION	CUTANEOUS	20200121		UNAPPROVED HOMEOPATHIC		PEKANA Naturheilmittel GmbH	CALENDULA OFFICINALIS FLOWERING TOP; CENTELLA ASIATICA WHOLE; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA, UNSPECIFIED; RANUNCULUS BULBOSUS WHOLE; RHODODENDRON TOMENTOSUM LEAFY TWIG; VIOLA TRICOLOR WHOLE	8; 3; 6; 8; 4; 4; 4	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
59469-328_be36d70e-4658-4d73-ade0-e38ad855ea9e	59469-328	HUMAN OTC DRUG	LivCalm		ALOE FEROX LEAF, ACTIVATED CHARCOAL, GOLDENSEAL, STRYCHNOS NUX-VOMICA SEED, OKOUBAKA AUBREVILLEI BARK, and BERBERIS VULGARIS ROOT BARK	SOLUTION/ DROPS	ORAL	20200114		UNAPPROVED HOMEOPATHIC		PEKANA Natuheilmittel GmbH	ACTIVATED CHARCOAL; ALOE FEROX LEAF; BERBERIS VULGARIS ROOT BARK; GOLDENSEAL; OKOUBAKA AUBREVILLEI BARK; STRYCHNOS NUX-VOMICA SEED	6; 6; 12; 6; 6; 6	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
59503-0544_bb7fa81f-b4fe-4440-bc2c-d2ed3da0c62e	59503-0544	HUMAN OTC DRUG	Chemseptic		CHLOROXYLENOL	SOAP	TOPICAL	20040330		OTC MONOGRAPH NOT FINAL	part333E	Rochester Midland Corporation	CHLOROXYLENOL	3	mg/mL			N	20241231
59503-2605_1376cce6-6a19-4e2b-b838-bc2930895b35	59503-2605	HUMAN OTC DRUG	Hand San		ALCOHOL	LIQUID	TOPICAL	20210311		OTC MONOGRAPH NOT FINAL	part333E	Rochester Midland Corporation	ALCOHOL	.7	mL/mL			N	20241231
59503-6265_31880937-9d33-4503-bcfe-bdbebe51768b	59503-6265	HUMAN OTC DRUG	Balma Septic Antiseptic Hand Wash		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20170509		OTC MONOGRAPH NOT FINAL	part333E	Rochester Midland Corporation	BENZALKONIUM CHLORIDE	25	mg/mL			N	20241231
59522-001_092d466b-e3da-41b9-e063-6394a90aded0	59522-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Armscare, Inc.	OXYGEN	99	L/100L			N	20241231
59534-001_2feb95ea-3e28-4716-a83c-85b8ae63fde5	59534-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19920502		NDA	NDA206023	Richmond Oxygen Company Inc.	OXYGEN	99	L/100L			N	20241231
59534-002_dcb08e7c-f573-41a0-a068-2ec7017319c7	59534-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19920502		NDA	NDA206024	Richmond Oxygen Company Inc.	NITROGEN	99	L/100L			N	20241231
59555-002_82c5c64e-0a48-401c-b864-7128b9239a49	59555-002	HUMAN OTC DRUG	Industrial Itch and Pain Relief		DIPHENHYDRAMINE HYDROCHLORIDE and Zinc Acetate	LIQUID	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part348	R & R Lotion, Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59555-010_e969f3e2-6f53-4a2e-8ed7-ca63a6ccfcb4	59555-010	HUMAN OTC DRUG	Rugid Itch and Pain Relief		DIPHENHYDRAMINE HYDROCHLORIDE and Zinc Acetate	LIQUID	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part348	R & R Lotion, Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59555-102_f68d426e-62ed-4474-b46b-76c23662b331	59555-102	HUMAN OTC DRUG	Industrial Strength Sunscreen		Zinc Oxide, Octinoxate, Octisalate, and Oxybenzone	LOTION	TOPICAL	20151221		OTC MONOGRAPH NOT FINAL	part352	R & R Lotion, Inc	OCTINOXATE; OCTISALATE; OXYBENZONE; ZINC OXIDE	59; 38; 47; 64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59555-106_44d5e9f0-2de1-47d3-80e9-7b01fb2cf3a1	59555-106	HUMAN OTC DRUG	Pura Vida Sunscreen		Zinc Oxide, Octinoxate, Octisalate, and Oxybenzone	LOTION	TOPICAL	20151221		OTC MONOGRAPH NOT FINAL	part352	R & R Lotion, Inc	OCTINOXATE; OCTISALATE; OXYBENZONE; ZINC OXIDE	59; 38; 47; 64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59555-110_855bd0a5-13a5-42ef-8765-9f7105902462	59555-110	HUMAN OTC DRUG	Rugid Sunscreen		Zinc Oxide, Octinoxate, Octisalate, and Oxybenzone	LOTION	TOPICAL	20151221		OTC MONOGRAPH NOT FINAL	part352	R & R Lotion, Inc	OCTINOXATE; OCTISALATE; OXYBENZONE; ZINC OXIDE	59; 38; 47; 64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59555-200_8e3dacdf-97bc-43fb-91ed-3ffb90e3b290	59555-200	HUMAN OTC DRUG	I.C. Ivy Block		ZINC ACETATE	LOTION	TOPICAL	20210921		OTC MONOGRAPH FINAL	part347	R & R Lotion, Inc	ZINC ACETATE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59555-230_9977d446-e162-4dcb-9926-3be2739d72a1	59555-230	HUMAN OTC DRUG	IC Ivy Relief		diphenhydramine hydrochloride and Zinc Acetate	LIQUID	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part348	R & R Lotion, Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59555-302_ab80a6eb-1f36-459a-8bc2-b3edba4967d5	59555-302	HUMAN OTC DRUG	Industrial Strength Waterless Hand Cleaner		Benzalkonium Chloride	LOTION	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part333A	R & R Lotion, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59555-401_ab817c88-b905-48bd-a950-31685299c203	59555-401	HUMAN OTC DRUG	I.C. Hand Sanitizer		Benzalkonium Chloride	AEROSOL, FOAM	TOPICAL	20140615		OTC MONOGRAPH NOT FINAL	part333A	R&R Lotion, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
59555-403_833a6046-1478-48f4-bd46-0a9c0dda2f84	59555-403	HUMAN OTC DRUG	Techni-Pro Foaming Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20220310		OTC MONOGRAPH NOT FINAL	part333A	R & R Lotion, Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
59555-501_a9749b81-3888-4f22-a522-69c693aa165e	59555-501	HUMAN OTC DRUG	I.C. Antibacterial Hand Cleaner with Pumice		Benzalkonium Chloride	SOAP	TOPICAL	20210701		OTC MONOGRAPH NOT FINAL	part333A	R & R Lotion, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59555-701_cb004d42-6195-457c-9c1e-42d4fe9c5439	59555-701	HUMAN OTC DRUG	I.C. Antibacterial Hand Cleaner		Benzalkonium Chloride	SOAP	TOPICAL	20210701		OTC MONOGRAPH NOT FINAL	part333A	R & R Lotion, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59555-703_5d9ee114-0018-441b-93d2-d963e39668e6	59555-703	HUMAN OTC DRUG	Techni-Pro Antibacterial Hand Cleaner		Benzalkonium Chloride	SOAP	TOPICAL	20220310		OTC MONOGRAPH NOT FINAL	part333A	R & R Lotion, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59555-903_da397ccb-7150-47d1-996d-a4f26d58d79e	59555-903	HUMAN OTC DRUG	I.C. Sanitizer and Re-Moisturizer with Benzalkonium Chloride		Benzalkonium Chloride	LOTION	TOPICAL	20151221		OTC MONOGRAPH NOT FINAL	part333A	R & R Lotion, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59555-910_4a569601-3f60-4478-bb31-d7556a1ae94c	59555-910	HUMAN OTC DRUG	Rugid Outdoors Hand Sanitizer Benzalkonium Chloride		Benzalkonium Chloride	LOTION	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part333A	R & R Lotion, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
59556-282_7a2ca863-fe8b-4ee6-9a63-40276db84b77	59556-282	HUMAN OTC DRUG	Levonorgestrel Tablet, 1.5 mg		Levonorgestrel Tablet, 1.5 mg	TABLET	ORAL	20220913		ANDA	ANDA202380	Strides Pharma Inc	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
59556-286_18f8537b-15ab-4597-aa74-396d684ff624	59556-286	HUMAN OTC DRUG	Optionelle		Levonorgestrel Tablet, 1.5 mg	TABLET	ORAL	20220915		ANDA	ANDA202380	Strides Pharma Inc	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
59556-301_0df121d3-d783-620c-e063-6294a90acdab	59556-301	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET	ORAL	20210810		ANDA	ANDA212795	Strides Pharma Inc	LORATADINE	5	mg/1			N	20251231
59556-762_27cb56bb-5999-476f-913a-e739f568bd6e	59556-762	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20160825		ANDA	ANDA203928	Strides Pharma Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59556-805_ea87a1e7-61da-4204-b8fb-82a028bba42f	59556-805	HUMAN OTC DRUG	IBUPROFEN	IMMEDIATE RELEASE	IBUPROFEN	TABLET, COATED	ORAL	20160826		ANDA	ANDA207052	Strides Pharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-806_ea87a1e7-61da-4204-b8fb-82a028bba42f	59556-806	HUMAN OTC DRUG	IBUPROFEN	IMMEDIATE RELEASE	IBUPROFEN	TABLET, COATED	ORAL	20160826		ANDA	ANDA207052	Strides Pharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-811_145307ef-a92d-41b6-adea-24f4fc91b285	59556-811	HUMAN OTC DRUG	IBUPROFEN	IMMEDIATE RELEASE	IBUPROFEN	TABLET, COATED	ORAL	20180629		ANDA	ANDA206989	Strides Pharma Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-812_145307ef-a92d-41b6-adea-24f4fc91b285	59556-812	HUMAN OTC DRUG	IBUPROFEN	IMMEDIATE RELEASE	IBUPROFEN	TABLET, COATED	ORAL	20180629		ANDA	ANDA206989	Strides Pharma Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-850_f65dc1fd-8443-4a2f-8a9c-65f6cf6ca50f	59556-850	HUMAN OTC DRUG	Pediacare Childrens Cough And Congestion		dextromethorphan hydrobromide and guaifenesin	LIQUID	ORAL	20100712		OTC MONOGRAPH FINAL	part341	Strides Pharma Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59556-851_47e170ff-bf79-4ebb-8d6e-eb561633cd25	59556-851	HUMAN OTC DRUG	PediaCare Multi Symptom Cold		Acetaminophen,Chlorpheniramine maleate,Dextromethorphan HBr,Phenylephrine HCl	LIQUID	ORAL	20100709		OTC MONOGRAPH FINAL	part341	Strides Pharma Inc	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59556-852_bcc0968d-99b0-4857-886a-c60358ce4b10	59556-852	HUMAN OTC DRUG	Pediacare-Cough-RunnyNose		acetaminophen,chlorpheniramine maleate,dextromethorphan	LIQUID	ORAL	20100709		OTC MONOGRAPH FINAL	part341	Strides Pharma Inc	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59556-853_c7e57512-6d5f-41ba-b3cb-fb9e43c2f73c	59556-853	HUMAN OTC DRUG	Pediacare SIMETHICONE ANTIGAS		simethicone	EMULSION	ORAL	20110801		OTC MONOGRAPH FINAL	part332	Strides Pharma Inc	DIMETHICONE; SILICON DIOXIDE	.211; .011	g/mL; g/mL	Skin Barrier Activity [PE]		N	20241231
59556-854_db20f8ca-8b1d-471c-a5e3-870a7431ad17	59556-854	HUMAN OTC DRUG	PediaCare Childrens Fever Reducer Pain Reliever Cherry		Acetaminophen	LIQUID	ORAL	20100708		OTC MONOGRAPH NOT FINAL	part343	Strides Pharma Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
59556-855_1f4159ad-d58c-4519-932b-030cc2735514	59556-855	HUMAN OTC DRUG	Ibuprofen	Immediate Release	Ibuprofen	TABLET, COATED	ORAL	20110404		ANDA	ANDA091355	Strides Pharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-855_ae1a9b4d-727b-4396-b1da-252817480125	59556-855	HUMAN OTC DRUG	Ibuprofen	Immediate Release	Ibuprofen	TABLET, COATED	ORAL	20220318		ANDA	ANDA091355	Strides Pharma Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-856_1f4159ad-d58c-4519-932b-030cc2735514	59556-856	HUMAN OTC DRUG	Ibuprofen	Immediate Release	Ibuprofen	TABLET, COATED	ORAL	20110404		ANDA	ANDA091355	Strides Pharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-856_ae1a9b4d-727b-4396-b1da-252817480125	59556-856	HUMAN OTC DRUG	Ibuprofen	Immediate Release	Ibuprofen	TABLET, COATED	ORAL	20220318		ANDA	ANDA091355	Strides Pharma Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-857_9eaf5381-212b-4400-8d73-ae39d0a1c9a2	59556-857	HUMAN OTC DRUG	IBUPROFEN	Immediate Release	IBUPROFEN	TABLET, COATED	ORAL	20220318		ANDA	ANDA079129	Strides Pharma Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-858_9eaf5381-212b-4400-8d73-ae39d0a1c9a2	59556-858	HUMAN OTC DRUG	IBUPROFEN	Immediate Release	IBUPROFEN	TABLET, COATED	ORAL	20220318		ANDA	ANDA079129	Strides Pharma Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59556-882_0d278505-f077-4d6e-885c-d1dc624e84e2	59556-882	HUMAN OTC DRUG	Loratadine		loratadine	CAPSULE, LIQUID FILLED	ORAL	20210601		ANDA	ANDA211926	Strides Pharma Inc	LORATADINE	10	mg/1			N	20241231
59556-894_ecf83e2f-6c1b-40ec-8acb-3bd99051ea66	59556-894	HUMAN OTC DRUG	cetirizine hydrochloride		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170721		ANDA	ANDA205291	Strides Pharma Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59556-917_0df1189a-9973-e8b7-e063-6294a90a61a3	59556-917	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210810		ANDA	ANDA213294	Strides Pharma Inc	LORATADINE	10	mg/1			N	20251231
59556-959_2a06f8a8-0779-471c-aa1b-11abaa211f12	59556-959	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20211022		ANDA	ANDA213070	Strides Pharma Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
59572-102_48519e23-13a4-4128-8077-cf9efcf59ca7	59572-102	HUMAN PRESCRIPTION DRUG	VIDAZA		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20040705		NDA	NDA050794	Celgene Corporation	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
59572-205_58b287d1-24f5-4dfe-84ca-898a8a5b9302	59572-205	HUMAN PRESCRIPTION DRUG	Thalomid		Thalidomide	CAPSULE	ORAL	20030620		NDA	NDA020785	Celgene Corporation	THALIDOMIDE	50	mg/1	Decreased Immunologically Active Molecule Activity [PE]		N	20241231
59572-210_58b287d1-24f5-4dfe-84ca-898a8a5b9302	59572-210	HUMAN PRESCRIPTION DRUG	Thalomid		Thalidomide	CAPSULE	ORAL	20030620		NDA	NDA020785	Celgene Corporation	THALIDOMIDE	100	mg/1	Decreased Immunologically Active Molecule Activity [PE]		N	20241231
59572-215_58b287d1-24f5-4dfe-84ca-898a8a5b9302	59572-215	HUMAN PRESCRIPTION DRUG	Thalomid		Thalidomide	CAPSULE	ORAL	20070320		NDA	NDA020785	Celgene Corporation	THALIDOMIDE	150	mg/1	Decreased Immunologically Active Molecule Activity [PE]		N	20241231
59572-220_58b287d1-24f5-4dfe-84ca-898a8a5b9302	59572-220	HUMAN PRESCRIPTION DRUG	Thalomid		Thalidomide	CAPSULE	ORAL	20030620		NDA	NDA020785	Celgene Corporation	THALIDOMIDE	200	mg/1	Decreased Immunologically Active Molecule Activity [PE]		N	20241231
59572-402_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb	59572-402	HUMAN PRESCRIPTION DRUG	Revlimid		Lenalidomide	CAPSULE	ORAL	20120416		NDA	NDA021880	Celgene Corporation	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-405_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb	59572-405	HUMAN PRESCRIPTION DRUG	Revlimid		Lenalidomide	CAPSULE	ORAL	20051227		NDA	NDA021880	Celgene Corporation	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-410_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb	59572-410	HUMAN PRESCRIPTION DRUG	Revlimid		Lenalidomide	CAPSULE	ORAL	20051227		NDA	NDA021880	Celgene Corporation	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-415_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb	59572-415	HUMAN PRESCRIPTION DRUG	Revlimid		Lenalidomide	CAPSULE	ORAL	20060629		NDA	NDA021880	Celgene Corporation	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-420_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb	59572-420	HUMAN PRESCRIPTION DRUG	Revlimid		Lenalidomide	CAPSULE	ORAL	20130606		NDA	NDA021880	Celgene Corporation	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-425_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb	59572-425	HUMAN PRESCRIPTION DRUG	Revlimid		Lenalidomide	CAPSULE	ORAL	20060629		NDA	NDA021880	Celgene Corporation	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-501_5f520860-0d2c-496d-8206-11f89c61a6c8	59572-501	HUMAN PRESCRIPTION DRUG	Pomalyst		pomalidomide	CAPSULE	ORAL	20130218		NDA	NDA204026	Celgene Corporation	POMALIDOMIDE	1	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-502_5f520860-0d2c-496d-8206-11f89c61a6c8	59572-502	HUMAN PRESCRIPTION DRUG	Pomalyst		pomalidomide	CAPSULE	ORAL	20130218		NDA	NDA204026	Celgene Corporation	POMALIDOMIDE	2	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-503_5f520860-0d2c-496d-8206-11f89c61a6c8	59572-503	HUMAN PRESCRIPTION DRUG	Pomalyst		pomalidomide	CAPSULE	ORAL	20130218		NDA	NDA204026	Celgene Corporation	POMALIDOMIDE	3	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-504_5f520860-0d2c-496d-8206-11f89c61a6c8	59572-504	HUMAN PRESCRIPTION DRUG	Pomalyst		pomalidomide	CAPSULE	ORAL	20130218		NDA	NDA204026	Celgene Corporation	POMALIDOMIDE	4	mg/1	Thalidomide Analog [EPC]		N	20241231
59572-515_1cc6ca63-93cd-47b5-a894-60323f930a60	59572-515	CELLULAR THERAPY	Abecma		idecabtagene vicleucel	SUSPENSION	INTRAVENOUS	20210326		BLA	BLA125736	Celgene Corporation	IDECABTAGENE VICLEUCEL	300000000	1/1			N	20251231
59572-705_01043cba-240a-4cbc-9466-fded4c738efb	59572-705	HUMAN PRESCRIPTION DRUG	Idhifa		enasidenib mesylate	TABLET, FILM COATED	ORAL	20170801		NDA	NDA209606	Celgene Corporation	ENASIDENIB MESYLATE	50	mg/1	Isocitrate Dehydrogenase 2 Inhibitor [EPC], Isocitrate Dehydrogenase 2 Inhibitors [MoA]		N	20251231
59572-710_01043cba-240a-4cbc-9466-fded4c738efb	59572-710	HUMAN PRESCRIPTION DRUG	Idhifa		enasidenib mesylate	TABLET, FILM COATED	ORAL	20170801		NDA	NDA209606	Celgene Corporation	ENASIDENIB MESYLATE	100	mg/1	Isocitrate Dehydrogenase 2 Inhibitor [EPC], Isocitrate Dehydrogenase 2 Inhibitors [MoA]		N	20251231
59572-711_cd7a015f-9e8e-496e-9c70-cf3c630b779e	59572-711	HUMAN PRESCRIPTION DRUG	Reblozyl		Luspatercept	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20191108		BLA	BLA761136	Celgene Corporation	LUSPATERCEPT	25	mg/1	Erythroid Maturation Agent [EPC], Increased Erythroid Cell Production [PE]		N	20241231
59572-720_e9e69209-db31-45b6-8793-9767983facf7	59572-720	HUMAN PRESCRIPTION DRUG	Inrebic		Fedratinib Hydrochloride	CAPSULE	ORAL	20190816		NDA	NDA212327	Celgene Corporation	FEDRATINIB HYDROCHLORIDE	100	mg/1			N	20241231
59572-730_5a9f7082-45d4-478c-9757-4e7b884e1951	59572-730	HUMAN PRESCRIPTION DRUG	ONUREG		azacitidine	TABLET, FILM COATED	ORAL	20200901		NDA	NDA214120	Celgene Corporation	AZACITIDINE	200	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
59572-740_5a9f7082-45d4-478c-9757-4e7b884e1951	59572-740	HUMAN PRESCRIPTION DRUG	ONUREG		azacitidine	TABLET, FILM COATED	ORAL	20200901		NDA	NDA214120	Celgene Corporation	AZACITIDINE	300	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
59572-775_cd7a015f-9e8e-496e-9c70-cf3c630b779e	59572-775	HUMAN PRESCRIPTION DRUG	Reblozyl		Luspatercept	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20191108		BLA	BLA761136	Celgene Corporation	LUSPATERCEPT	75	mg/1	Erythroid Maturation Agent [EPC], Increased Erythroid Cell Production [PE]		N	20241231
59572-810_695f45ec-a0d4-42d7-8e43-9d54fe330792	59572-810	HUMAN PRESCRIPTION DRUG	ZEPOSIA	7-Day Starter Pack	ozanimod hydrochloride	KIT		20200327		NDA	NDA209899	Celgene Corporation						N	20241231
59572-820_695f45ec-a0d4-42d7-8e43-9d54fe330792	59572-820	HUMAN PRESCRIPTION DRUG	ZEPOSIA		ozanimod hydrochloride	CAPSULE	ORAL	20200327		NDA	NDA209899	Celgene Corporation	OZANIMOD HYDROCHLORIDE	.92	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
59572-890_695f45ec-a0d4-42d7-8e43-9d54fe330792	59572-890	HUMAN PRESCRIPTION DRUG	ZEPOSIA	Starter Kit	ozanimod hydrochloride	KIT		20200327		NDA	NDA209899	Celgene Corporation						N	20241231
59572-984_08c46856-2700-4885-ba5d-dced9d8056e1	59572-984	HUMAN PRESCRIPTION DRUG	ISTODAX		romidepsin	KIT		20100104		NDA	NDA022393	Celgene Corporation						N	20241231
59578-125_0bc809db-5be3-d962-e063-6394a90a6dca	59578-125	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20130522		NDA	NDA205852	Linde Inc.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
59578-499_0bc7d02b-46e6-4f40-e063-6294a90a6be3	59578-499	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20130528		NDA	NDA205850	Linde Inc.	NITROGEN	990	mL/L			N	20241231
59578-721_0bc7dffb-8d7a-d296-e063-6394a90a8197	59578-721	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130522		NDA	NDA205849	Linde Inc.	OXYGEN	990	mL/L			N	20241231
59579-002_0a47184c-b152-f163-e063-6394a90a4d89	59579-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20071001		NDA	NDA205850	Praxair Distribution, Inc.	NITROGEN	990	mL/L			N	20241231
59579-003_f2a2c952-fc39-17c6-e053-2a95a90a3393	59579-003	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20080901		NDA	NDA205852	Praxair Distribution, Inc.	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
59579-004_0a46e000-747c-330b-e063-6294a90afdc9	59579-004	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	20071001		NDA	NDA209989	Praxair Distribution, Inc.	NITROUS OXIDE	990	mL/L			N	20241231
59579-005_f2a2bb5d-8375-40d9-e053-2995a90a7fac	59579-005	HUMAN PRESCRIPTION DRUG	Helium		Helium	GAS	RESPIRATORY (INHALATION)	20071201		NDA	NDA205912	Praxair Distribution, Inc.	HELIUM	990	mL/L			N	20241231
59579-006_0a47184c-b153-f163-e063-6394a90a4d89	59579-006	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20020501		NDA	NDA205910	Praxair Distribution, Inc.	AIR	1000	mL/L			N	20241231
59579-008_f2a2cbb5-5a68-7514-e053-2995a90a572c	59579-008	HUMAN PRESCRIPTION DRUG	Carbon Dioxide Oxygen Mix		Carbon Dioxide Oxygen Mix	GAS	RESPIRATORY (INHALATION)	20071001		NDA	NDA205849	Praxair Distribution, Inc	CARBON DIOXIDE; OXYGEN	300; 700	mL/L; mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
59579-009_f2a2d230-7939-7bed-e053-2995a90a2f08	59579-009	HUMAN PRESCRIPTION DRUG	Helium Oxygen mixture		Helium Oxygen mixture	GAS	RESPIRATORY (INHALATION)	20070801		NDA AUTHORIZED GENERIC	NDA205851	Praxair Distribution, Inc.	HELIUM; OXYGEN	800; 200	mL/L; mL/L			N	20241231
59579-010_f2a2d8f1-6967-140d-e053-2a95a90a9178	59579-010	HUMAN PRESCRIPTION DRUG	Helium Oxygen Nitrogen mixture		Helium Oxygen Nitrogen mixture	GAS	RESPIRATORY (INHALATION)	20051001		NDA AUTHORIZED GENERIC	NDA205851	Praxair Distribution, Inc.	HELIUM; NITROGEN; OXYGEN	200; 300; 500	mL/L; mL/L; mL/L			N	20241231
59579-101_f2a2d8f1-696b-140d-e053-2a95a90a9178	59579-101	HUMAN PRESCRIPTION DRUG	Noxivent 101		Noxivent 101	GAS	RESPIRATORY (INHALATION)	20181004		ANDA	ANDA207141	Linde Gas & Equipment Inc	NITRIC OXIDE	100	mg/L	Vasodilation [PE], Vasodilator [EPC]		N	20241231
59579-102_f2a2da3b-553e-0c8e-e053-2a95a90a765e	59579-102	HUMAN PRESCRIPTION DRUG	Noxivent 102		Noxivent 102	GAS	RESPIRATORY (INHALATION)	20181004		ANDA	ANDA207141	Linde Gas & Equipment Inc	NITRIC OXIDE	800	mg/L	Vasodilation [PE], Vasodilator [EPC]		N	20241231
59584-138_8fdba792-e919-4fc5-956e-d26f94b3c3cf	59584-138	STANDARDIZED ALLERGENIC	Candin		Candida albicans Skin Test Antigen	INJECTION, SOLUTION	INTRADERMAL	19951201		BLA	BLA103257	Nielsen BioSciences, Inc.	CANDIDA ALBICANS	1	U/.1mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
59584-140_3a56ec3d-de4e-4854-854e-1f1f8583d8a0	59584-140	HUMAN PRESCRIPTION DRUG	Spherusol		Coccidioides immitis Spherule-Derived Skin Test Antigen	INJECTION, SOLUTION	INTRADERMAL	20110729		BLA	BLA125354	Nielsen BioSciences, Inc.	COCCIDIOIDES IMMITIS SPHERULE	12.7	ug/mL	Antigens, Fungal [CS], Cell-mediated Immunity [PE], Skin Test Antigen [EPC]		N	20241231
59608-017_f0659479-00d6-477c-9435-a00ac55b003e	59608-017	HUMAN OTC DRUG	TENA Proskin protective cream		Zinc oxide	CREAM	TOPICAL	20221025		OTC MONOGRAPH FINAL	part347	Essity HMS North America Inc	ZINC OXIDE	130	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59617-0010_0983430b-490a-bcaf-e063-6394a90a04b8	59617-0010	STANDARDIZED ALLERGENIC	Oralair	100 IR	ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20140430		BLA	BLA125471	Stallergenes	ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	100; 100; 100; 100; 100	[IR]/1; [IR]/1; [IR]/1; [IR]/1; [IR]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
59617-0015_0983430b-490a-bcaf-e063-6394a90a04b8	59617-0015	STANDARDIZED ALLERGENIC	Oralair	300 IR	ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20140430		BLA	BLA125471	Stallergenes	ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	300; 300; 300; 300; 300	[IR]/1; [IR]/1; [IR]/1; [IR]/1; [IR]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
59617-0016_0983430b-490a-bcaf-e063-6394a90a04b8	59617-0016	STANDARDIZED ALLERGENIC	Oralair	300 IR	ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20140430		BLA	BLA125471	Stallergenes	ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	300; 300; 300; 300; 300	[IR]/1; [IR]/1; [IR]/1; [IR]/1; [IR]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
59617-0020_0983430b-490a-bcaf-e063-6394a90a04b8	59617-0020	STANDARDIZED ALLERGENIC	Oralair		ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHELUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	KIT		20140430		BLA	BLA125471	Stallergenes						N	20241231
59617-0025_0983430b-490a-bcaf-e063-6394a90a04b8	59617-0025	STANDARDIZED ALLERGENIC	Oralair		ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHELUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	KIT		20140430		BLA	BLA125471	Stallergenes						N	20241231
59623-001_6f5dab3c-439e-42cb-97c6-116ff4b6ccda	59623-001	HUMAN OTC DRUG	Seasonal Allergy Formula		Hydrastis Canadensis, Kali Muriaticum, Gelsemium Sempervirens, Kali Bichromicum, Sabadilla, Histaminum, House Dust, Grass Mix, Trees Mix, Weeds Mix	LIQUID	ORAL	20130722		UNAPPROVED HOMEOPATHIC		Integrative Healing Institute, LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; ACER SACCHARUM POLLEN; ALNUS RUBRA POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; ANTHOXANTHUM ODORATUM; ARTEMISIA VULGARIS POLLEN; BARLEY; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PUBESCENS FLOWER BUD; BROMUS SECALINUS POLLEN; CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; CYNODON DACTYLON POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; JUGLANS REGIA POLLEN; JUNIPERUS VIRGINIANA POLLEN; MELILOTUS OFFICINALIS TOP; MORUS RUBRA POLLEN; PHLEUM PRATENSE TOP; PINUS NIGRA POLLEN; PINUS STROBUS POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS MARILANDICA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; RUMEX ACETOSELLA POLLEN; SCHOENOCAULON OFFICINALE SEED; SOLIDAGO VIRGAUREA POLLEN; SORGHUM HALEPENSE POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN; ULMUS RUBRA POLLEN; ZEA MAYS POLLEN	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 12; 4; 30; 12; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 12; 6; 6; 6; 6; 6; 6; 12; 6; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE]		N	20241231
59623-004_d44aa30d-28a8-26e6-e053-2a95a90ae854	59623-004	HUMAN OTC DRUG	Breathe Easier Formula		Cupressus Aus, Eucalyptus, Mentha Pip, Origanum, Pinus Syl, Salvia, Kali Iod, Euphorbium, Galphimia, Hydrastis, Luffa, Pulsatilla, Hepar Suplh Calc, Histaminum, Kali Bic.	SPRAY	NASAL	20130923		UNAPPROVED HOMEOPATHIC		Integrative Healing Institute, LLC	CALCIUM SULFIDE; CUPRESSUS SEMPERVIRENS FRUITING LEAFY TWIG; EUCALYPTUS GLOBULUS LEAF; EUPHORBIA RESINIFERA RESIN; GALPHIMIA GLAUCA FLOWERING TOP; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; MENTHA PIPERITA; ORIGANUM MAJORANA WHOLE; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PULSATILLA VULGARIS; SAGE	12; 3; 3; 6; 6; 6; 12; 6; 3; 3; 3; 12; 4; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59623-006_d44a9071-16fb-6335-e053-2995a90a0078	59623-006	HUMAN OTC DRUG	Cedar X Formula		Olibanum, Thuja Occidentalis, Gelsemium Sempervirens, Allium Cepa, Antimonium Tartaricum, Hepar Sulphuris Calcareum, Juniperus Communis.	LIQUID	ORAL	20131105		UNAPPROVED HOMEOPATHIC		Integrative Healing Institute, LLC	ANTIMONY POTASSIUM TARTRATE; CALCIUM SULFIDE; FRANKINCENSE; GELSEMIUM SEMPERVIRENS ROOT; JUNIPER BERRY; ONION; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 3; 4; 30; 6; 3	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
59623-007_d44aa30d-28b8-26e6-e053-2a95a90ae854	59623-007	HUMAN OTC DRUG	Soothing Respiratory Rub		Chamomilla, Myrrha, Rosmarinus, Ruta, Symphytum, Antimon Tart.	GEL	TOPICAL	20150218		UNAPPROVED HOMEOPATHIC		Integrative Healing Institute, LLC	ANTIMONY POTASSIUM TARTRATE; COMFREY ROOT; MATRICARIA RECUTITA; MYRRH; ROSMARINUS OFFICINALIS FLOWERING TOP; RUTA GRAVEOLENS FLOWERING TOP	6; 6; 3; 3; 3; 5	[hp_C]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
59623-013_d44a97a1-1a62-0e54-e053-2995a90a20a0	59623-013	HUMAN OTC DRUG	Mold Relief Formula		Kali Muriaticum, Gelsemium, Kali Bichromicum, Sabadilla, Histaminum, Mold Mix.	LIQUID	ORAL	20160501		UNAPPROVED HOMEOPATHIC		Integrative Healing Institute, LLC	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOLETUS SATANAS FRUITING BODY; BOTRYTIS CINEREA; CANDIDA ALBICANS; COCHLIOBOLUS SATIVUS; FUSARIUM OXYSPORUM; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; PASSALORA FULVA; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; RHIZOPUS STOLONIFER; SCHOENOCAULON OFFICINALE SEED; USTILAGO MAYDIS	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 6; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
59627-002_3ff19956-a793-4256-bff4-7f7443d7238a	59627-002	HUMAN PRESCRIPTION DRUG	Avonex		Interferon Beta-1a	INJECTION, SOLUTION	INTRAMUSCULAR	20030523		BLA	BLA103628	Biogen Inc.	INTERFERON BETA-1A	30	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
59627-003_3ff19956-a793-4256-bff4-7f7443d7238a	59627-003	HUMAN PRESCRIPTION DRUG	Avonex Pen		Interferon Beta-1a	INJECTION, SOLUTION	INTRAMUSCULAR	20030523		BLA	BLA103628	Biogen Inc.	INTERFERON BETA-1A	30	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
59627-222_3ff19956-a793-4256-bff4-7f7443d7238a	59627-222	HUMAN PRESCRIPTION DRUG	AVONEX		interferon beta-1a	KIT	INTRAMUSCULAR	20140829		BLA	BLA103628	Biogen Inc.						N	20241231
59627-333_3ff19956-a793-4256-bff4-7f7443d7238a	59627-333	HUMAN PRESCRIPTION DRUG	AVONEX		interferon beta-1a	KIT	INTRAMUSCULAR	20140829		BLA	BLA103628	Biogen Inc.						N	20241231
59630-266_6dbb05d2-bf2c-4617-8e51-b5dfa80c0ce9	59630-266	HUMAN PRESCRIPTION DRUG	Fetroja		Cefiderocol sulfate tosylate	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20200131		NDA	NDA209445	Shionogi Inc.	CEFIDEROCOL SULFATE TOSYLATE	1	g/10mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
59630-551_b520c88c-9064-4ffe-b33c-81fdfe795cad	59630-551	HUMAN PRESCRIPTION DRUG	Mulpleta		Lusutrombopag	TABLET, FILM COATED	ORAL	20180827		NDA	NDA210923	SHIONOGI INC.	LUSUTROMBOPAG	3	mg/1			N	20241231
59630-574_e45e2672-48e2-480a-8f08-252cfadbcaa4	59630-574	HUMAN PRESCRIPTION DRUG	FORTAMET		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20040427		NDA	NDA021574	Shionogi Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
59630-575_e45e2672-48e2-480a-8f08-252cfadbcaa4	59630-575	HUMAN PRESCRIPTION DRUG	FORTAMET		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20040427		NDA	NDA021574	Shionogi Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
59630-580_852c6ccd-b5b5-491d-945e-828b51e24751	59630-580	HUMAN PRESCRIPTION DRUG	Osphena		Ospemifene	TABLET, FILM COATED	ORAL	20130226	20250731	NDA	NDA203505	Shionogi Inc.	OSPEMIFENE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	
59630-750_8f37b9b2-4400-417d-ab4f-f8d97acdd89a	59630-750	HUMAN PRESCRIPTION DRUG	Methylin		Methylphenidate Hydrochloride	SOLUTION	ORAL	20021219		NDA	NDA021419	SHIONOGI INC.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59630-755_8f37b9b2-4400-417d-ab4f-f8d97acdd89a	59630-755	HUMAN PRESCRIPTION DRUG	Methylin		Methylphenidate Hydrochloride	SOLUTION	ORAL	20021219		NDA	NDA021419	SHIONOGI INC.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
59640-000_80fab118-4144-4f6b-a3cf-500139bb54a8	59640-000	HUMAN OTC DRUG	minoxidil topical		Minoxidil	SOLUTION	TOPICAL	20211231		ANDA	ANDA075357	H E B	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59640-001_6e81be4c-6597-46e1-87e6-a52539f9694f	59640-001	HUMAN OTC DRUG	Acid Controller		famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA077351	H E B	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
59640-010_35a9d2f1-4be7-46b3-9171-94554b606be2	59640-010	HUMAN OTC DRUG	tussin severe		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230329		OTC MONOGRAPH FINAL	part341	H E B	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59640-022_f3a83cc0-2388-49a7-ae02-d0894e20cacc	59640-022	HUMAN OTC DRUG	heartburn prevention		Cimetidine	TABLET, FILM COATED	ORAL	20221104		ANDA	ANDA075285	H E B	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
59640-023_71f282a6-8ecc-41d4-9cda-7d70950669fe	59640-023	HUMAN OTC DRUG	acid reducer		famotidine	TABLET, FILM COATED	ORAL	20221219		ANDA	ANDA077351	H E B	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
59640-047_24fc0782-d84c-449f-a2e9-71d2e755614c	59640-047	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220328		NDA	NDA022032	H E B	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59640-100_9175a566-0b63-49ac-9573-9f20960504a4	59640-100	HUMAN OTC DRUG	tussin		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220422		OTC MONOGRAPH FINAL	part341	H E B	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59640-797_7a653744-4743-42bc-bc05-195a8abee466	59640-797	HUMAN OTC DRUG	clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230117		ANDA	ANDA090685	H E B	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59640-864_c4fb9b50-2ee7-4599-b157-5a4b942f5947	59640-864	HUMAN OTC DRUG	50% Isopropyl Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	H E B	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
59651-001_354169df-ed1d-4279-97c9-1d1d987dccc6	59651-001	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Aurobindo Pharma Limited	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59651-002_354169df-ed1d-4279-97c9-1d1d987dccc6	59651-002	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Aurobindo Pharma Limited	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59651-003_354169df-ed1d-4279-97c9-1d1d987dccc6	59651-003	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Aurobindo Pharma Limited	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59651-007_c2e840f6-e3a8-4524-a36e-2ce70d67cf2a	59651-007	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20181009		ANDA	ANDA209201	Aurobindo Pharma Limited	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59651-008_c2e840f6-e3a8-4524-a36e-2ce70d67cf2a	59651-008	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20181009		ANDA	ANDA209201	Aurobindo Pharma Limited	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59651-009_49873158-5c0a-41da-86a2-369ef6b0cbc8	59651-009	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221223		ANDA	ANDA209081	Aurobindo Pharma Limited	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59651-010_49873158-5c0a-41da-86a2-369ef6b0cbc8	59651-010	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221223		ANDA	ANDA209081	Aurobindo Pharma Limited	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59651-018_8539231f-47da-402e-b05d-16c45cc3670c	59651-018	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20180201		ANDA	ANDA209236	Aurobindo Pharma Limited	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
59651-019_8539231f-47da-402e-b05d-16c45cc3670c	59651-019	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20180201		ANDA	ANDA209236	Aurobindo Pharma Limited	NIACIN	750	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
59651-020_8539231f-47da-402e-b05d-16c45cc3670c	59651-020	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20180201		ANDA	ANDA209236	Aurobindo Pharma Limited	NIACIN	1000	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
59651-021_b32611f3-50ec-45bb-a671-ea10cec7829d	59651-021	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20230120		ANDA	ANDA202660	Aurobindo Pharma Limited	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
59651-025_610c2bc5-bcb5-4c98-b000-6e31f625eaf2	59651-025	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20190419		ANDA	ANDA209371	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	125; 31.25	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
59651-026_610c2bc5-bcb5-4c98-b000-6e31f625eaf2	59651-026	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20190419		ANDA	ANDA209371	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 62.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
59651-029_7bc1835a-cc34-4b65-a6b5-f290aee806b4	59651-029	HUMAN PRESCRIPTION DRUG	Lo-Zumandimine		Drospirenone and Ethinyl Estradiol	KIT		20180227		ANDA	ANDA209632	Aurobindo Pharma Limited						N	20241231
59651-030_7cec3990-8d5f-4585-8bbc-fe2556cf69f5	59651-030	HUMAN PRESCRIPTION DRUG	Zumandimine		Drospirenone and Ethinyl Estradiol	KIT		20180326		ANDA	ANDA209407	Aurobindo Pharma Limited						N	20241231
59651-032_5e0ae9e4-a6b1-4fe0-af6d-56173af7a09f	59651-032	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen Oral	SUSPENSION	ORAL	20180216		ANDA	ANDA209178	Aurobindo Pharma Limited	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59651-052_2f9c913f-507a-4f6d-b98d-5d53b40e6ca9	59651-052	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170825		ANDA	ANDA209838	Aurobindo Pharma Limited	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
59651-054_9dba612c-2f8f-43b5-89b1-f2e1a968124a	59651-054	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET	ORAL	20230228		ANDA	ANDA209638	Aurobindo Pharma Limited	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
59651-055_9dba612c-2f8f-43b5-89b1-f2e1a968124a	59651-055	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET	ORAL	20230228		ANDA	ANDA209638	Aurobindo Pharma Limited	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
59651-083_b5797a1a-863d-4398-a7c5-6358d3cf85ac	59651-083	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	CAPSULE, DELAYED RELEASE	ORAL	20221222		ANDA	ANDA210385	Aurobindo Pharma Limited	DIMETHYL FUMARATE	120	mg/1			N	20241231
59651-084_b5797a1a-863d-4398-a7c5-6358d3cf85ac	59651-084	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	CAPSULE, DELAYED RELEASE	ORAL	20221222		ANDA	ANDA210385	Aurobindo Pharma Limited	DIMETHYL FUMARATE	240	mg/1			N	20241231
59651-085_88910ad0-6dc3-4a47-8a6b-5c6ee79f2a93	59651-085	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231128		ANDA	ANDA210677	Aurobindo Pharma Limited	DARUNAVIR PROPYLENE GLYCOLATE	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59651-086_88910ad0-6dc3-4a47-8a6b-5c6ee79f2a93	59651-086	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231128		ANDA	ANDA210677	Aurobindo Pharma Limited	DARUNAVIR PROPYLENE GLYCOLATE	800	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59651-087_d8729e42-dbbd-4954-9ce0-298743a15a06	59651-087	HUMAN PRESCRIPTION DRUG	SEVELAMER HYDROCHLORIDE		SEVELAMER HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230711		ANDA	ANDA212599	Aurobindo Pharma Limited	SEVELAMER HYDROCHLORIDE	400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
59651-088_d8729e42-dbbd-4954-9ce0-298743a15a06	59651-088	HUMAN PRESCRIPTION DRUG	SEVELAMER HYDROCHLORIDE		SEVELAMER HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230711		ANDA	ANDA212599	Aurobindo Pharma Limited	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
59651-095_c929225c-13f9-40fa-a691-206e5e292816	59651-095	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181210		ANDA	ANDA210626	Aurobindo Pharma Limited	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59651-096_c929225c-13f9-40fa-a691-206e5e292816	59651-096	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181210		ANDA	ANDA210626	Aurobindo Pharma Limited	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59651-104_bc89f4aa-996f-4afd-b572-2032239755ab	59651-104	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		Eletriptan Hydrobromide	TABLET, FILM COATED	ORAL	20190115		ANDA	ANDA210708	Aurobindo Pharma Limited	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
59651-105_bc89f4aa-996f-4afd-b572-2032239755ab	59651-105	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		Eletriptan Hydrobromide	TABLET, FILM COATED	ORAL	20180216		ANDA	ANDA210708	Aurobindo Pharma Limited	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
59651-110_2b34e679-a365-4ab6-ad17-a44a5b35f856	59651-110	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	SOLUTION	ORAL	20190129		ANDA	ANDA210479	Aurobindo Pharma Limited	ARIPIPRAZOLE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
59651-113_04f80eb2-8171-4e18-93e4-514440e84b75	59651-113	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20231025		ANDA	ANDA210741	Aurobindo Pharma Limited	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
59651-114_04f80eb2-8171-4e18-93e4-514440e84b75	59651-114	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20231025		ANDA	ANDA210741	Aurobindo Pharma Limited	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
59651-118_eb3e192c-26aa-42dd-8eae-2b8ee97dc021	59651-118	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20190122		ANDA	ANDA210740	Aurobindo Pharma Limited	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-119_eb3e192c-26aa-42dd-8eae-2b8ee97dc021	59651-119	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20190122		ANDA	ANDA210740	Aurobindo Pharma Limited	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-120_eb3e192c-26aa-42dd-8eae-2b8ee97dc021	59651-120	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20190122		ANDA	ANDA210740	Aurobindo Pharma Limited	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-129_faec0c96-e264-6fee-e053-6394a90a23ca	59651-129	HUMAN PRESCRIPTION DRUG	TOBRAMYCIN		TOBRAMYCIN	SOLUTION	RESPIRATORY (INHALATION)	20210122		ANDA	ANDA210871	Aurobindo Pharma Limited	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
59651-136_b785dba5-f0b0-4f74-8845-e845432932c0	59651-136	HUMAN PRESCRIPTION DRUG	Emzahh		NORETHINDRONE	TABLET	ORAL	20230106		ANDA	ANDA216796	Aurobindo Pharma Limited	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59651-137_0947c8ed-1953-4d5b-92af-8dcc5d24f4b5	59651-137	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20211217		ANDA	ANDA211053	Aurobindo Pharma Limited	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-138_0947c8ed-1953-4d5b-92af-8dcc5d24f4b5	59651-138	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20211217		ANDA	ANDA211053	Aurobindo Pharma Limited	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-139_0947c8ed-1953-4d5b-92af-8dcc5d24f4b5	59651-139	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20211217		ANDA	ANDA211053	Aurobindo Pharma Limited	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-140_0947c8ed-1953-4d5b-92af-8dcc5d24f4b5	59651-140	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20211217		ANDA	ANDA211053	Aurobindo Pharma Limited	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-146_b5de1a51-8312-467a-9522-2e6a4046266d	59651-146	HUMAN PRESCRIPTION DRUG	Carbidopa		Carbidopa	TABLET	ORAL	20191021		ANDA	ANDA211055	Aurobindo Pharma Limited	CARBIDOPA	25	mg/1			N	20241231
59651-152_ca1ea154-249d-4175-bc27-a2576e7c32f3	59651-152	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20181026		ANDA	ANDA211285	Aurobindo Pharma Limited	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
59651-153_ca1ea154-249d-4175-bc27-a2576e7c32f3	59651-153	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20181026		ANDA	ANDA211285	Aurobindo Pharma Limited	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
59651-165_a805c27a-1154-4aac-9af8-bbd755be027f	59651-165	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20230309		ANDA	ANDA211640	Aurobindo Pharma Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	100; 150	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20251231
59651-166_a805c27a-1154-4aac-9af8-bbd755be027f	59651-166	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20230309		ANDA	ANDA211640	Aurobindo Pharma Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	133; 200	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20251231
59651-167_a805c27a-1154-4aac-9af8-bbd755be027f	59651-167	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20230309		ANDA	ANDA211640	Aurobindo Pharma Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	167; 250	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20251231
59651-173_c324b8bc-894f-48c0-a754-0b07f2543898	59651-173	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	Aurobindo Pharma Limited	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-174_c324b8bc-894f-48c0-a754-0b07f2543898	59651-174	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	Aurobindo Pharma Limited	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-175_c324b8bc-894f-48c0-a754-0b07f2543898	59651-175	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	Aurobindo Pharma Limited	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-176_c324b8bc-894f-48c0-a754-0b07f2543898	59651-176	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	Aurobindo Pharma Limited	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-177_c324b8bc-894f-48c0-a754-0b07f2543898	59651-177	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	Aurobindo Pharma Limited	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-180_fa07788d-4ff6-4578-9ccf-4cebb84e3515	59651-180	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole	TABLET, FILM COATED	ORAL	20190111		ANDA	ANDA211717	Aurobindo Pharma Limited	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
59651-182_ce7eea99-c2b2-41c8-b577-3e7f3a29b739	59651-182	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20200130		ANDA	ANDA210454	Aurobindo Pharma Limited	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
59651-183_08ec99ba-a06f-89c0-e063-6294a90a306e	59651-183	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	SOLUTION	RESPIRATORY (INHALATION)	20200420		ANDA	ANDA211888	Aurobindo Pharma Limited	ALBUTEROL SULFATE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
59651-184_08ec99ba-a06f-89c0-e063-6294a90a306e	59651-184	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	SOLUTION	RESPIRATORY (INHALATION)	20200420		ANDA	ANDA211888	Aurobindo Pharma Limited	ALBUTEROL SULFATE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
59651-201_05957860-eab3-4172-9877-455540d0c922	59651-201	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20210920		ANDA	ANDA212232	Aurobindo Pharma Limited	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
59651-202_05957860-eab3-4172-9877-455540d0c922	59651-202	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20210920		ANDA	ANDA212232	Aurobindo Pharma Limited	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
59651-203_05957860-eab3-4172-9877-455540d0c922	59651-203	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20210920		ANDA	ANDA212232	Aurobindo Pharma Limited	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
59651-204_aabd86be-2d1e-46dc-a31f-9a3cb28e94f4	59651-204	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET	ORAL	20180417		ANDA	ANDA210604	Aurobindo Pharma Limited	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
59651-205_aabd86be-2d1e-46dc-a31f-9a3cb28e94f4	59651-205	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET	ORAL	20180417		ANDA	ANDA210604	Aurobindo Pharma Limited	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
59651-206_e9d10eaa-cf9c-469e-82ef-5af7285f2c86	59651-206	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20230511		ANDA	ANDA212607	Aurobindo Pharma Limited	NITROFURANTOIN MONOHYDRATE	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
59651-214_962105c0-2e59-4d00-805a-f28f76088ef5	59651-214	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SPRAY, METERED	NASAL	20200508		ANDA	ANDA212289	Aurobindo Pharma Limited	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59651-215_35fa9463-da73-4fe5-9725-104546488e14	59651-215	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SPRAY, METERED	NASAL	20201112	20241231	ANDA	ANDA212775	Aurobindo Pharma Limited	AZELASTINE HYDROCHLORIDE	205.5	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59651-216_097cd3a3-5257-414b-acfd-ce8bdf605d97	59651-216	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID		FENOFIBRIC ACID	CAPSULE, DELAYED RELEASE	ORAL	20190725		ANDA	ANDA212598	Aurobindo Pharma Limited	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
59651-217_097cd3a3-5257-414b-acfd-ce8bdf605d97	59651-217	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID		FENOFIBRIC ACID	CAPSULE, DELAYED RELEASE	ORAL	20190725		ANDA	ANDA212598	Aurobindo Pharma Limited	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
59651-224_1b4631d4-f6d3-421f-915f-7bf11d835710	59651-224	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		pilocarpine hydrochloride	TABLET, FILM COATED	ORAL	20190813		ANDA	ANDA212377	Aurobindo Pharma Limited	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
59651-225_1b4631d4-f6d3-421f-915f-7bf11d835710	59651-225	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		pilocarpine hydrochloride	TABLET, FILM COATED	ORAL	20190813		ANDA	ANDA212377	Aurobindo Pharma Limited	PILOCARPINE HYDROCHLORIDE	7.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
59651-232_2b75c20c-9dcc-4a63-854a-e9cdd2d7c1fb	59651-232	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20210602		ANDA	ANDA070886	Aurobindo Pharma Limited	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59651-233_2b75c20c-9dcc-4a63-854a-e9cdd2d7c1fb	59651-233	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20210602		ANDA	ANDA070886	Aurobindo Pharma Limited	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59651-234_2b75c20c-9dcc-4a63-854a-e9cdd2d7c1fb	59651-234	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20210602		ANDA	ANDA070886	Aurobindo Pharma Limited	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59651-236_71f053c2-8d0d-41a1-8630-2d797eced799	59651-236	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, FILM COATED	ORAL	20200724		ANDA	ANDA212434	Aurobindo Pharma Limited	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
59651-240_4fc727d6-1273-4b16-8e1a-2e9bf37ab137	59651-240	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20200723		ANDA	ANDA212773	Aurobindo Pharma Limited	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
59651-241_4fc727d6-1273-4b16-8e1a-2e9bf37ab137	59651-241	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20200723		ANDA	ANDA212773	Aurobindo Pharma Limited	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
59651-246_244b746c-92a3-404c-999f-7f1794de6e60	59651-246	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200810		ANDA	ANDA212774	Aurobindo Pharma Limited	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59651-247_244b746c-92a3-404c-999f-7f1794de6e60	59651-247	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200810		ANDA	ANDA212774	Aurobindo Pharma Limited	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59651-248_244b746c-92a3-404c-999f-7f1794de6e60	59651-248	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200810		ANDA	ANDA212774	Aurobindo Pharma Limited	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59651-251_0e8ddc52-ada5-4611-8a26-59b74f1eb2a8	59651-251	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20211029		ANDA	ANDA201893	Aurobindo Pharma Limited	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-252_0e8ddc52-ada5-4611-8a26-59b74f1eb2a8	59651-252	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20211029		ANDA	ANDA201893	Aurobindo Pharma Limited	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-256_b59b252f-8b73-4f72-8d01-4d2076c18fa6	59651-256	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191025		ANDA	ANDA202445	Aurobindo Pharma Limited	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-257_b59b252f-8b73-4f72-8d01-4d2076c18fa6	59651-257	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191025		ANDA	ANDA202445	Aurobindo Pharma Limited	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-258_b59b252f-8b73-4f72-8d01-4d2076c18fa6	59651-258	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191025		ANDA	ANDA202445	Aurobindo Pharma Limited	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-268_46e7be05-f8c9-4a43-bafe-3dc5271c0b9c	59651-268	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20170512	20251031	ANDA	ANDA206928	Aurobindo Pharma Limited	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
59651-269_46e7be05-f8c9-4a43-bafe-3dc5271c0b9c	59651-269	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20170512	20251231	ANDA	ANDA206928	Aurobindo Pharma Limited	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
59651-270_46e7be05-f8c9-4a43-bafe-3dc5271c0b9c	59651-270	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20170512	20251130	ANDA	ANDA206928	Aurobindo Pharma Limited	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
59651-271_08114092-fa12-4f58-b08e-03cadf9f726b	59651-271	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230331		ANDA	ANDA213052	Aurobindo Pharma Limited	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59651-272_08114092-fa12-4f58-b08e-03cadf9f726b	59651-272	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230331		ANDA	ANDA213052	Aurobindo Pharma Limited	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59651-273_08114092-fa12-4f58-b08e-03cadf9f726b	59651-273	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230331		ANDA	ANDA213052	Aurobindo Pharma Limited	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59651-275_74fbce90-fe9b-4483-8060-0d5d8be8e5d3	59651-275	HUMAN PRESCRIPTION DRUG	ROFLUMILAST		ROFLUMILAST	TABLET	ORAL	20230417		ANDA	ANDA213298	Aurobindo Pharma Limited	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
59651-276_1c4fc726-3f5b-4b12-a66e-727c5133d1d9	59651-276	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230221		ANDA	ANDA213096	Aurobindo Pharma Limited	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-277_1c4fc726-3f5b-4b12-a66e-727c5133d1d9	59651-277	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230221		ANDA	ANDA213096	Aurobindo Pharma Limited	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-278_1c4fc726-3f5b-4b12-a66e-727c5133d1d9	59651-278	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230221		ANDA	ANDA213096	Aurobindo Pharma Limited	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
59651-279_42423449-9cfb-417f-aaf1-260434c63023	59651-279	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Aurobindo Pharma Limited	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
59651-280_42423449-9cfb-417f-aaf1-260434c63023	59651-280	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Aurobindo Pharma Limited	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
59651-282_42423449-9cfb-417f-aaf1-260434c63023	59651-282	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Aurobindo Pharma Limited	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
59651-291_8bdb47c5-9d19-4d59-94c8-62c117525e7f	59651-291	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET, FILM COATED	ORAL	20231127		ANDA	ANDA213163	Aurobindo Pharma Limited	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
59651-292_8bdb47c5-9d19-4d59-94c8-62c117525e7f	59651-292	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET, FILM COATED	ORAL	20231127		ANDA	ANDA213163	Aurobindo Pharma Limited	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
59651-295_eb70b7ff-f9f0-41d0-901a-f4c04ae9ed46	59651-295	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20210719		ANDA	ANDA213361	Aurobindo Pharma Limited	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
59651-296_eb70b7ff-f9f0-41d0-901a-f4c04ae9ed46	59651-296	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20210719		ANDA	ANDA213361	Aurobindo Pharma Limited	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
59651-297_eb70b7ff-f9f0-41d0-901a-f4c04ae9ed46	59651-297	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20210719		ANDA	ANDA213361	Aurobindo Pharma Limited	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
59651-299_a596c715-8e30-43c1-aba3-4fe5de6729fa	59651-299	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20200814		ANDA	ANDA213358	Aurobindo Pharma Limited	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
59651-300_a596c715-8e30-43c1-aba3-4fe5de6729fa	59651-300	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20200814		ANDA	ANDA213358	Aurobindo Pharma Limited	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
59651-305_13956b60-a22d-4ee8-af95-460830ebfbc9	59651-305	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20230817		ANDA	ANDA089853	Aurobindo Pharma Limited	CHLORZOXAZONE	375	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59651-306_13956b60-a22d-4ee8-af95-460830ebfbc9	59651-306	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20200803		ANDA	ANDA089853	Aurobindo Pharma Limited	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59651-307_13956b60-a22d-4ee8-af95-460830ebfbc9	59651-307	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20230817		ANDA	ANDA089853	Aurobindo Pharma Limited	CHLORZOXAZONE	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59651-308_c5c43c68-b722-4a22-ab0a-b6e30476518e	59651-308	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20200408		ANDA	ANDA213286	Aurobindo Pharma Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
59651-309_c5c43c68-b722-4a22-ab0a-b6e30476518e	59651-309	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20200408		ANDA	ANDA213286	Aurobindo Pharma Limited	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
59651-313_18b4e0d7-e29b-46ad-99bc-032eeee0d214	59651-313	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		TIMOLOL MALEATE	SOLUTION	OPHTHALMIC	20230323		ANDA	ANDA213540	Aurobindo Pharma Limited	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-314_086d2603-7faf-4e75-a161-cf464f73593b	59651-314	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200324		ANDA	ANDA213544	Aurobindo Pharma Limited	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59651-315_086d2603-7faf-4e75-a161-cf464f73593b	59651-315	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200324		ANDA	ANDA213544	Aurobindo Pharma Limited	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59651-316_086d2603-7faf-4e75-a161-cf464f73593b	59651-316	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200324		ANDA	ANDA213544	Aurobindo Pharma Limited	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59651-324_24ea8dcc-5014-4559-b49f-1bc4134415be	59651-324	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20200610		ANDA	ANDA213265	Aurobindo Pharma Limited	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
59651-327_75f26681-a079-4ff3-9fff-75526041374c	59651-327	HUMAN PRESCRIPTION DRUG	PHENOXYBENZAMINE HYDROCHLORIDE		PHENOXYBENZAMINE HYDROCHLORIDE	CAPSULE	ORAL	20230508		ANDA	ANDA215600	Aurobindo Pharma Limited	PHENOXYBENZAMINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59651-329_2fcb1880-c88e-4c82-829e-6177a07814c4	59651-329	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	GRANULE	ORAL	20200218		ANDA	ANDA213471	Aurobindo Pharma Limited	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
59651-331_bf0234fe-1b94-44fb-a06d-86af5c5c07ea	59651-331	HUMAN PRESCRIPTION DRUG	FLUCYTOSINE		FLUCYTOSINE	CAPSULE	ORAL	20200501		ANDA	ANDA213665	Aurobindo Pharma Limited	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
59651-332_bf0234fe-1b94-44fb-a06d-86af5c5c07ea	59651-332	HUMAN PRESCRIPTION DRUG	FLUCYTOSINE		FLUCYTOSINE	CAPSULE	ORAL	20200501		ANDA	ANDA213665	Aurobindo Pharma Limited	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
59651-333_f89dffb1-5c4b-48aa-90b4-74043fc9b690	59651-333	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20200514		ANDA	ANDA213657	Aurobindo Pharma Limited	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
59651-334_f89dffb1-5c4b-48aa-90b4-74043fc9b690	59651-334	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20200514		ANDA	ANDA213657	Aurobindo Pharma Limited	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
59651-337_d54fa38e-b049-473a-a37f-adfa4714e073	59651-337	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA213662	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
59651-338_d54fa38e-b049-473a-a37f-adfa4714e073	59651-338	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA213662	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
59651-339_d54fa38e-b049-473a-a37f-adfa4714e073	59651-339	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA213662	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
59651-340_10b47ea5-bb68-423a-8b11-2af248d3c15f	59651-340	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA213967	Aurobindo Pharma Limited	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59651-341_10b47ea5-bb68-423a-8b11-2af248d3c15f	59651-341	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20200812		ANDA	ANDA213967	Aurobindo Pharma Limited	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59651-342_f022fe20-76ac-4825-8986-6e1ec95b0b21	59651-342	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA213885	Aurobindo Pharma Limited	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
59651-343_f022fe20-76ac-4825-8986-6e1ec95b0b21	59651-343	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA213885	Aurobindo Pharma Limited	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
59651-344_f022fe20-76ac-4825-8986-6e1ec95b0b21	59651-344	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA213885	Aurobindo Pharma Limited	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
59651-345_f022fe20-76ac-4825-8986-6e1ec95b0b21	59651-345	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA213885	Aurobindo Pharma Limited	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
59651-346_f022fe20-76ac-4825-8986-6e1ec95b0b21	59651-346	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA213885	Aurobindo Pharma Limited	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
59651-347_f022fe20-76ac-4825-8986-6e1ec95b0b21	59651-347	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230306		ANDA	ANDA213885	Aurobindo Pharma Limited	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
59651-348_379c4370-fc78-436b-b2e8-f347329adc4f	59651-348	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET, FILM COATED	ORAL	20210329		ANDA	ANDA213652	Aurobindo Pharma Limited	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
59651-349_379c4370-fc78-436b-b2e8-f347329adc4f	59651-349	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET, FILM COATED	ORAL	20210329		ANDA	ANDA213652	Aurobindo Pharma Limited	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
59651-353_7efdbe23-503a-4f38-a0b6-c003033f0de7	59651-353	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	CAPSULE, LIQUID FILLED	ORAL	20220314		ANDA	ANDA213875	Aurobindo Pharma Limited	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59651-360_f742b3fb-5152-40a6-841d-55cd7bb3474b	59651-360	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Aurobindo Pharma Limited	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59651-361_f742b3fb-5152-40a6-841d-55cd7bb3474b	59651-361	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Aurobindo Pharma Limited	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59651-362_f742b3fb-5152-40a6-841d-55cd7bb3474b	59651-362	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Aurobindo Pharma Limited	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59651-366_804c01db-b518-4b30-a712-666b8a5b79b2	59651-366	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	POWDER, FOR SOLUTION	ORAL	20210929		ANDA	ANDA213899	Aurobindo Pharma Limited	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
59651-367_4aaea88b-e0fd-45e3-bb02-604bf8ee9b5b	59651-367	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	TABLET	ORAL	20220510		ANDA	ANDA215601	Aurobindo Pharma Limited	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
59651-375_eb94f573-c790-4392-95a4-ff99a81a181f	59651-375	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214387	Aurobindo Pharma Limited	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
59651-376_eb94f573-c790-4392-95a4-ff99a81a181f	59651-376	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214387	Aurobindo Pharma Limited	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
59651-377_eb94f573-c790-4392-95a4-ff99a81a181f	59651-377	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214387	Aurobindo Pharma Limited	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
59651-378_dcf4edca-de05-4f9b-b78c-feda19a49891	59651-378	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20200817		ANDA	ANDA077645	Aurobindo Pharma Limited	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
59651-379_dcf4edca-de05-4f9b-b78c-feda19a49891	59651-379	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20200817		ANDA	ANDA077645	Aurobindo Pharma Limited	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
59651-380_dcf4edca-de05-4f9b-b78c-feda19a49891	59651-380	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20200817		ANDA	ANDA077645	Aurobindo Pharma Limited	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
59651-381_7d11010e-cf0f-4315-aced-7927a486a1ef	59651-381	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20230320		ANDA	ANDA216440	Aurobindo Pharma Limited	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-382_7d11010e-cf0f-4315-aced-7927a486a1ef	59651-382	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20230320		ANDA	ANDA216440	Aurobindo Pharma Limited	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-383_7d11010e-cf0f-4315-aced-7927a486a1ef	59651-383	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20230320		ANDA	ANDA216440	Aurobindo Pharma Limited	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59651-389_270d4008-311a-4f5c-905e-95f14bd9f700	59651-389	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Aurobindo Pharma Limited	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
59651-390_270d4008-311a-4f5c-905e-95f14bd9f700	59651-390	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Aurobindo Pharma Limited	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
59651-391_270d4008-311a-4f5c-905e-95f14bd9f700	59651-391	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Aurobindo Pharma Limited	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
59651-392_270d4008-311a-4f5c-905e-95f14bd9f700	59651-392	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Aurobindo Pharma Limited	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
59651-393_270d4008-311a-4f5c-905e-95f14bd9f700	59651-393	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Aurobindo Pharma Limited	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
59651-394_535a5fb7-5e52-41c8-94d9-6e36fb1c19d6	59651-394	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	Aurobindo Pharma Limited	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
59651-395_535a5fb7-5e52-41c8-94d9-6e36fb1c19d6	59651-395	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	Aurobindo Pharma Limited	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
59651-397_48aa0395-66b8-4d58-ba4c-7faf68268525	59651-397	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20230331		ANDA	ANDA214477	Aurobindo Pharma Limited	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
59651-401_618a6357-a388-44d9-b5e4-e61a37c4a196	59651-401	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20220324		ANDA	ANDA214404	Aurobindo Pharma Limited	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
59651-404_7a208302-90f3-45d0-94fc-9fb38591c543	59651-404	HUMAN PRESCRIPTION DRUG	MEMANTINE HYDROCHLORIDE		MEMANTINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20210809		ANDA	ANDA214651	Aurobindo Pharma Limited	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
59651-405_7a208302-90f3-45d0-94fc-9fb38591c543	59651-405	HUMAN PRESCRIPTION DRUG	MEMANTINE HYDROCHLORIDE		MEMANTINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20210809		ANDA	ANDA214651	Aurobindo Pharma Limited	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
59651-406_7a208302-90f3-45d0-94fc-9fb38591c543	59651-406	HUMAN PRESCRIPTION DRUG	MEMANTINE HYDROCHLORIDE		MEMANTINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20210809		ANDA	ANDA214651	Aurobindo Pharma Limited	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
59651-407_7a208302-90f3-45d0-94fc-9fb38591c543	59651-407	HUMAN PRESCRIPTION DRUG	MEMANTINE HYDROCHLORIDE		MEMANTINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20210809		ANDA	ANDA214651	Aurobindo Pharma Limited	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
59651-408_7a208302-90f3-45d0-94fc-9fb38591c543	59651-408	HUMAN PRESCRIPTION DRUG	MEMANTINE HYDROCHLORIDE		MEMANTINE HYDROCHLORIDE	KIT		20210809		ANDA	ANDA214651	Aurobindo Pharma Limited						N	20241231
59651-410_d8b0c2f4-f5ad-41c2-8fec-89bb043785a0	59651-410	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20231016		ANDA	ANDA214474	Aurobindo Pharma Limited	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
59651-411_d8b0c2f4-f5ad-41c2-8fec-89bb043785a0	59651-411	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20231016		ANDA	ANDA214474	Aurobindo Pharma Limited	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
59651-412_d8b0c2f4-f5ad-41c2-8fec-89bb043785a0	59651-412	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20231016		ANDA	ANDA214474	Aurobindo Pharma Limited	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
59651-413_6d820911-f50e-46a4-8174-c4ee89f6792e	59651-413	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		HYDROCORTISONE	TABLET	ORAL	20230717		ANDA	ANDA214649	Aurobindo Pharma Limited	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-414_6d820911-f50e-46a4-8174-c4ee89f6792e	59651-414	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		HYDROCORTISONE	TABLET	ORAL	20230717		ANDA	ANDA214649	Aurobindo Pharma Limited	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-415_6d820911-f50e-46a4-8174-c4ee89f6792e	59651-415	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		HYDROCORTISONE	TABLET	ORAL	20230717		ANDA	ANDA214649	Aurobindo Pharma Limited	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-420_3d83326f-3922-484b-9518-e53259bc9e3f	59651-420	HUMAN PRESCRIPTION DRUG	sildenafil CITRATE		sildenafil CITRATE	POWDER, FOR SUSPENSION	ORAL	20221223		ANDA	ANDA214773	Aurobindo Pharma Limited	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
59651-421_9dc2249e-2171-4102-a42d-b4e395ec8a32	59651-421	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20221128		ANDA	ANDA214849	Aurobindo Pharma Limited	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
59651-422_d08d8aa5-76a4-417a-a308-7d195865522f	59651-422	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride		Cevimeline Hydrochloride	CAPSULE	ORAL	20230418		ANDA	ANDA215056	Aurobindo Pharma Limited	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
59651-424_afbc2a33-5eb2-4f01-91e9-07d8050da6ce	59651-424	HUMAN PRESCRIPTION DRUG	Etyqa		ESTRADIOL AND NORETHINDRONE ACETATE	TABLET, FILM COATED	ORAL	20230630		ANDA	ANDA214729	Aurobindo Pharma Limited	ESTRADIOL; NORETHINDRONE ACETATE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59651-425_afbc2a33-5eb2-4f01-91e9-07d8050da6ce	59651-425	HUMAN PRESCRIPTION DRUG	Etyqa		ESTRADIOL AND NORETHINDRONE ACETATE	TABLET, FILM COATED	ORAL	20230630		ANDA	ANDA214729	Aurobindo Pharma Limited	ESTRADIOL; NORETHINDRONE ACETATE	.5; .1	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59651-426_1c728291-eb83-4a41-8125-4d3ae1980ddc	59651-426	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	Aurobindo Pharma Limited	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59651-427_1c728291-eb83-4a41-8125-4d3ae1980ddc	59651-427	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	Aurobindo Pharma Limited	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59651-428_1c728291-eb83-4a41-8125-4d3ae1980ddc	59651-428	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	Aurobindo Pharma Limited	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59651-429_d1038d80-ef7d-456a-9f47-0c5df1ca8811	59651-429	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210331		ANDA	ANDA214728	Aurobindo Pharma Limited	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
59651-430_d1038d80-ef7d-456a-9f47-0c5df1ca8811	59651-430	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210331		ANDA	ANDA214728	Aurobindo Pharma Limited	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
59651-431_d1038d80-ef7d-456a-9f47-0c5df1ca8811	59651-431	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210331		ANDA	ANDA214728	Aurobindo Pharma Limited	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
59651-436_2bcd56ee-4497-4b8d-84db-a1470c77827b	59651-436	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220208		ANDA	ANDA214982	Aurobindo Pharma Limited	DIGOXIN	.0625	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
59651-437_2bcd56ee-4497-4b8d-84db-a1470c77827b	59651-437	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220208		ANDA	ANDA214982	Aurobindo Pharma Limited	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
59651-438_2bcd56ee-4497-4b8d-84db-a1470c77827b	59651-438	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220208		ANDA	ANDA214982	Aurobindo Pharma Limited	DIGOXIN	.25	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
59651-441_25d243f2-4969-4aae-956a-9ed9247ab487	59651-441	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA203494	Aurobindo Pharma Limited	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
59651-444_1e08a87f-624a-4993-a773-8c660c27b6af	59651-444	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir hydrochloride powder,	FOR SOLUTION	ORAL	20221117		ANDA	ANDA215124	Aurobindo Pharma Limited	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
59651-450_1d4b4b61-79da-4b6f-bb19-056d111bf400	59651-450	HUMAN PRESCRIPTION DRUG	Lifitegrast		Lifitegrast	FOR SOLUTION	OPHTHALMIC	20231107		ANDA	ANDA215063	Aurobindo Pharma Limited	LIFITEGRAST	50	mg/mL	Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]		N	20241231
59651-452_d1588c37-9da9-4ccb-b78a-64234938a115	59651-452	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	CAPSULE	ORAL	20230927		ANDA	ANDA215449	Aurobindo Pharma Limited	TOPIRAMATE	15	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
59651-453_d1588c37-9da9-4ccb-b78a-64234938a115	59651-453	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	CAPSULE	ORAL	20230927		ANDA	ANDA215449	Aurobindo Pharma Limited	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
59651-455_dd93a40f-92ab-47ac-9083-b8a7a0b18ad6	59651-455	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20220322		ANDA	ANDA215444	Aurobindo Pharma Limited	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
59651-456_a887b72a-8896-48b9-8e91-9d4bb49faaed	59651-456	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20221128		ANDA	ANDA216537	Aurobindo Pharma Limited	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
59651-457_a887b72a-8896-48b9-8e91-9d4bb49faaed	59651-457	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20221128		ANDA	ANDA216537	Aurobindo Pharma Limited	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
59651-458_a887b72a-8896-48b9-8e91-9d4bb49faaed	59651-458	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20221128		ANDA	ANDA216537	Aurobindo Pharma Limited	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
59651-484_7b33767f-a520-4470-8f3f-4e86b38d615a	59651-484	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20211116		ANDA	ANDA215671	Aurobindo Pharma Limited	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-485_b1ac4c92-e1fd-4015-b172-0932790ae019	59651-485	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20220328		ANDA	ANDA215672	Aurobindo Pharma Limited	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-486_b1ac4c92-e1fd-4015-b172-0932790ae019	59651-486	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20220328		ANDA	ANDA215672	Aurobindo Pharma Limited	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-487_b1ac4c92-e1fd-4015-b172-0932790ae019	59651-487	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20220328		ANDA	ANDA215672	Aurobindo Pharma Limited	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-488_b1ac4c92-e1fd-4015-b172-0932790ae019	59651-488	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20220328		ANDA	ANDA215672	Aurobindo Pharma Limited	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-489_b1ac4c92-e1fd-4015-b172-0932790ae019	59651-489	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20220328		ANDA	ANDA215672	Aurobindo Pharma Limited	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-491_070f1937-50a5-457f-bef5-4e597014e26d	59651-491	HUMAN PRESCRIPTION DRUG	PREDNISOLONE		PREDNISOLONE	TABLET	ORAL	20230317		ANDA	ANDA215673	Aurobindo Pharma Limited	PREDNISOLONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-493_37761c4f-4378-472e-a41b-6a1d40575cb7	59651-493	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	SUSPENSION	ORAL	20220331		ANDA	ANDA216331	Aurobindo Pharma Limited	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
59651-494_82e51c75-fb78-4ad3-8bce-5e0581d60014	59651-494	HUMAN PRESCRIPTION DRUG	ambrisentan		ambrisentan	TABLET, FILM COATED	ORAL	20220721		ANDA	ANDA216531	Aurobindo Pharma Limited	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
59651-495_82e51c75-fb78-4ad3-8bce-5e0581d60014	59651-495	HUMAN PRESCRIPTION DRUG	ambrisentan		ambrisentan	TABLET, FILM COATED	ORAL	20220721		ANDA	ANDA216531	Aurobindo Pharma Limited	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
59651-499_9de2de56-614f-4294-8794-d30758cf5f70	59651-499	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20211007		ANDA	ANDA087871	Aurobindo Pharma Limited	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
59651-500_9de2de56-614f-4294-8794-d30758cf5f70	59651-500	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20211007		ANDA	ANDA087871	Aurobindo Pharma Limited	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
59651-501_9de2de56-614f-4294-8794-d30758cf5f70	59651-501	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20211007		ANDA	ANDA087871	Aurobindo Pharma Limited	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
59651-504_7c07e339-3aae-4c77-a170-e6715bbe7563	59651-504	HUMAN PRESCRIPTION DRUG	NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE		norethindrone and ethinyl estradiol and ferrous fumarate	KIT		20231206		ANDA	ANDA216558	Aurobindo Pharma Limited						N	20241231
59651-505_9ad4f149-44f3-4f75-b873-6affc1054b91	59651-505	HUMAN PRESCRIPTION DRUG	RAMELTEON		RAMELTEON	TABLET, FILM COATED	ORAL	20230710		ANDA	ANDA215972	Aurobindo Pharma Limited	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
59651-516_e24b08eb-4693-41c7-81cb-b536947f7070	59651-516	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET, FILM COATED	ORAL	20220520		ANDA	ANDA216454	Aurobindo Pharma Limited	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
59651-524_0fda7521-a452-4bac-953d-7d464d75ca22	59651-524	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20230914		ANDA	ANDA216419	Aurobindo Pharma Limited	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
59651-529_337707cc-4ed9-4121-bfff-c5015e5eca9d	59651-529	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	SOLUTION	ORAL	20240108		ANDA	ANDA216458	Aurobindo Pharma Limited	ENALAPRIL MALEATE	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
59651-530_3ecafc1e-979a-4aff-a276-18fc0b110491	59651-530	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20220622		ANDA	ANDA216342	Aurobindo Pharma Limited	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59651-531_3ecafc1e-979a-4aff-a276-18fc0b110491	59651-531	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20220622		ANDA	ANDA216342	Aurobindo Pharma Limited	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59651-532_3ecafc1e-979a-4aff-a276-18fc0b110491	59651-532	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20220622		ANDA	ANDA216342	Aurobindo Pharma Limited	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59651-539_55810c9d-1140-40b8-a297-210a84afc05a	59651-539	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA216557	Aurobindo Pharma Limited	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59651-540_55810c9d-1140-40b8-a297-210a84afc05a	59651-540	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA216557	Aurobindo Pharma Limited	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59651-541_55810c9d-1140-40b8-a297-210a84afc05a	59651-541	HUMAN PRESCRIPTION DRUG	ISOSORBIDE MONONITRATE		ISOSORBIDE MONONITRATE	TABLET, EXTENDED RELEASE	ORAL	20221107		ANDA	ANDA216557	Aurobindo Pharma Limited	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59651-550_cea464d0-6064-41ba-be81-73aa0de7632d	59651-550	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	CAPSULE	ORAL	20231031		ANDA	ANDA216554	Aurobindo Pharma Limited	AMPICILLIN TRIHYDRATE	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
59651-551_cea464d0-6064-41ba-be81-73aa0de7632d	59651-551	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	CAPSULE	ORAL	20231031		ANDA	ANDA216554	Aurobindo Pharma Limited	AMPICILLIN TRIHYDRATE	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
59651-563_6dff9196-8591-43ee-97cc-71b195641aba	59651-563	HUMAN PRESCRIPTION DRUG	RUFINAMIDE		RUFINAMIDE	SUSPENSION	ORAL	20221026		ANDA	ANDA216549	Aurobindo Pharma Limited	RUFINAMIDE	40	mg/mL			N	20241231
59651-565_faee6e2d-1b9c-4121-bc22-41313539b366	59651-565	HUMAN PRESCRIPTION DRUG	DICLOXACILLIN SODIUM		DICLOXACILLIN SODIUM	CAPSULE	ORAL	20220923		ANDA	ANDA216845	Aurobindo Pharma Limited	DICLOXACILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
59651-566_faee6e2d-1b9c-4121-bc22-41313539b366	59651-566	HUMAN PRESCRIPTION DRUG	DICLOXACILLIN SODIUM		DICLOXACILLIN SODIUM	CAPSULE	ORAL	20220923		ANDA	ANDA216845	Aurobindo Pharma Limited	DICLOXACILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
59651-573_48c6a773-7cde-4271-876a-4570a301f43a	59651-573	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	SOLUTION	ORAL	20220926		ANDA	ANDA216804	Aurobindo Pharma Limited	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
59651-575_a7cfa38f-b4db-40d3-8821-3f7c85e2727e	59651-575	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20220927		ANDA	ANDA216798	Aurobindo Pharma Limited	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
59651-576_a7cfa38f-b4db-40d3-8821-3f7c85e2727e	59651-576	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20220927		ANDA	ANDA216798	Aurobindo Pharma Limited	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
59651-585_c70c734f-2431-4414-bb94-4adda4985e5d	59651-585	HUMAN PRESCRIPTION DRUG	BUDESONIDE		BUDESONIDE	SUSPENSION	RESPIRATORY (INHALATION)	20231129		ANDA	ANDA216667	Aurobindo Pharma Limited	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-589_0e8ddc52-ada5-4611-8a26-59b74f1eb2a8	59651-589	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20220607		ANDA	ANDA201893	Aurobindo Pharma Limited	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
59651-590_7aca002e-a538-4715-9121-a17bdb7f200c	59651-590	HUMAN PRESCRIPTION DRUG	Pyrimethamine		Pyrimethamine	TABLET	ORAL	20221025		ANDA	ANDA216983	Aurobindo Pharma Limited	PYRIMETHAMINE	25	mg/1	Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
59651-616_d9ffc833-d902-41cb-8e8e-6bbba8e65b9e	59651-616	HUMAN PRESCRIPTION DRUG	Rufinamide		rufinamide	TABLET, FILM COATED	ORAL	20230616		ANDA	ANDA217230	Aurobindo Pharma Limited	RUFINAMIDE	200	mg/1			N	20241231
59651-617_d9ffc833-d902-41cb-8e8e-6bbba8e65b9e	59651-617	HUMAN PRESCRIPTION DRUG	Rufinamide		rufinamide	TABLET, FILM COATED	ORAL	20230616		ANDA	ANDA217230	Aurobindo Pharma Limited	RUFINAMIDE	400	mg/1			N	20241231
59651-624_3eb584dc-f72d-4545-96fa-ab3d47be41ce	59651-624	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	CAPSULE	ORAL	20240105		ANDA	ANDA217828	Aurobindo Pharma Limited	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
59651-652_2f799120-0d08-47cd-8183-a98f0267c845	59651-652	HUMAN PRESCRIPTION DRUG	DIAZEPAM		DIAZEPAM	TABLET	ORAL	20231214		ANDA	ANDA217843	Aurobindo Pharma Limited	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59651-653_2f799120-0d08-47cd-8183-a98f0267c845	59651-653	HUMAN PRESCRIPTION DRUG	DIAZEPAM		DIAZEPAM	TABLET	ORAL	20231214		ANDA	ANDA217843	Aurobindo Pharma Limited	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59651-654_2f799120-0d08-47cd-8183-a98f0267c845	59651-654	HUMAN PRESCRIPTION DRUG	DIAZEPAM		DIAZEPAM	TABLET	ORAL	20231214		ANDA	ANDA217843	Aurobindo Pharma Limited	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59651-657_26c314ea-077e-490b-826b-2aafcb6e9564	59651-657	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20231026		ANDA	ANDA217879	Aurobindo Pharma Limited	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59651-658_26c314ea-077e-490b-826b-2aafcb6e9564	59651-658	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20231026		ANDA	ANDA217879	Aurobindo Pharma Limited	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59651-659_26c314ea-077e-490b-826b-2aafcb6e9564	59651-659	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20231026		ANDA	ANDA217879	Aurobindo Pharma Limited	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59651-686_e73764e7-e666-4ad3-a029-04a528dc1c9e	59651-686	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230818		ANDA	ANDA218055	Aurobindo Pharma Limited	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
59651-687_e73764e7-e666-4ad3-a029-04a528dc1c9e	59651-687	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230818		ANDA	ANDA218055	Aurobindo Pharma Limited	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
59651-688_e73764e7-e666-4ad3-a029-04a528dc1c9e	59651-688	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230818		ANDA	ANDA218055	Aurobindo Pharma Limited	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
59651-689_e73764e7-e666-4ad3-a029-04a528dc1c9e	59651-689	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230818		ANDA	ANDA218055	Aurobindo Pharma Limited	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
59651-691_8d142533-4e87-4030-8fe9-4fc7473b0442	59651-691	HUMAN PRESCRIPTION DRUG	LOPERAMIDE HYDROCHLORIDE		LOPERAMIDE HYDROCHLORIDE	CAPSULE	ORAL	20230905		ANDA	ANDA218122	Aurobindo Pharma Limited	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
59651-719_ec746016-eed0-4e37-bb9c-cb430c8a7f07	59651-719	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230508		ANDA	ANDA040319	Aurobindo Pharma Limited	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
59651-720_d81b93f8-bebc-455e-82b6-9a3de3f82e92	59651-720	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20230425		ANDA	ANDA040317	Aurobindo Pharma Limited	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
59651-722_b1582eb7-af35-45d5-a52e-0e380d08527d	59651-722	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230117		ANDA	ANDA075150	Aurobindo Pharma Limited	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59651-723_b1582eb7-af35-45d5-a52e-0e380d08527d	59651-723	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230117		ANDA	ANDA075150	Aurobindo Pharma Limited	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59651-724_b1582eb7-af35-45d5-a52e-0e380d08527d	59651-724	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230117		ANDA	ANDA075150	Aurobindo Pharma Limited	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59651-728_e52db116-14f2-437d-8097-0150193d4655	59651-728	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20231206		ANDA	ANDA065253	Aurobindo Pharma Limited	CEPHALEXIN	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
59651-732_c0e49a22-d422-4848-8c2f-aab37b527b16	59651-732	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	OINTMENT	TOPICAL	20230928		ANDA	ANDA075057	Aurobindo Pharma Limited	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59651-740_450fc33f-0716-47fe-b810-f10f372ab98a	59651-740	HUMAN PRESCRIPTION DRUG	Rhuzdah		norethindrone and ethinyl estradiol tablet	KIT		20221011		ANDA	ANDA207585	Aurobindo Pharma Limited						N	20241231
59651-753_bac7a3bd-df62-4b82-853c-f4d6ea650c62	59651-753	HUMAN PRESCRIPTION DRUG	nitrofurantoin (macrocrystals)		nitrofurantoin (macrocrystals)	CAPSULE	ORAL	20230512		ANDA	ANDA074967	Aurobindo Pharma Limited	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
59651-758_b9179b81-5a7f-4eed-94b5-6b9539073974	59651-758	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20231207		ANDA	ANDA077739	Aurobindo Pharma Limited	METOPROLOL TARTRATE	37.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
59651-760_b9179b81-5a7f-4eed-94b5-6b9539073974	59651-760	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20231207		ANDA	ANDA077739	Aurobindo Pharma Limited	METOPROLOL TARTRATE	75	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
59651-775_6f3145d7-f3c9-4456-a77d-d04c54f24668	59651-775	HUMAN PRESCRIPTION DRUG	SOTALOL HYDROCHLORIDE		SOTALOL HYDROCHLORIDE	TABLET	ORAL	20230629		ANDA	ANDA077616	Aurobindo Pharma Limited	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
59651-776_6f3145d7-f3c9-4456-a77d-d04c54f24668	59651-776	HUMAN PRESCRIPTION DRUG	SOTALOL HYDROCHLORIDE		SOTALOL HYDROCHLORIDE	TABLET	ORAL	20230629		ANDA	ANDA077616	Aurobindo Pharma Limited	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
59651-777_6f3145d7-f3c9-4456-a77d-d04c54f24668	59651-777	HUMAN PRESCRIPTION DRUG	SOTALOL HYDROCHLORIDE		SOTALOL HYDROCHLORIDE	TABLET	ORAL	20230629		ANDA	ANDA077616	Aurobindo Pharma Limited	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
59651-780_84794a52-b717-488c-8533-6425c83d405f	59651-780	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA206928	Aurobindo Pharma Limited	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
59651-781_84794a52-b717-488c-8533-6425c83d405f	59651-781	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA206928	Aurobindo Pharma Limited	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
59651-782_84794a52-b717-488c-8533-6425c83d405f	59651-782	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA206928	Aurobindo Pharma Limited	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
59651-795_a06f7017-84c2-4dd4-8811-904470b7a9d2	59651-795	HUMAN PRESCRIPTION DRUG	nitrofurantoin (macrocrystals)		nitrofurantoin (macrocrystals)	CAPSULE	ORAL	20230517		ANDA	ANDA077025	Aurobindo Pharma Limited	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
59651-807_beb3c7f2-c0f4-41d9-a903-63a6847e0997	59651-807	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		MECLIZINE	TABLET	ORAL	20230914		ANDA	ANDA202640	Aurobindo Pharma Limited	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
59651-808_beb3c7f2-c0f4-41d9-a903-63a6847e0997	59651-808	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		MECLIZINE	TABLET	ORAL	20230914		ANDA	ANDA202640	Aurobindo Pharma Limited	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
59651-809_beb3c7f2-c0f4-41d9-a903-63a6847e0997	59651-809	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		MECLIZINE	TABLET	ORAL	20230914		ANDA	ANDA202640	Aurobindo Pharma Limited	MECLIZINE HYDROCHLORIDE	50	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
59651-839_773eb919-7d48-4ba2-af58-aa169f0ea75f	59651-839	HUMAN PRESCRIPTION DRUG	TRANEXAMIC ACID		TRANEXAMIC ACID	TABLET	ORAL	20231204		ANDA	ANDA205133	Aurobindo Pharma Limited	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
59651-840_e6d4fc3d-4169-44f1-bcb9-1188de40d4e5	59651-840	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE HYDROCHLORIDE	TABLET	ORAL	20230807		ANDA	ANDA074796	Aurobindo Pharma Limited	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59651-841_e6d4fc3d-4169-44f1-bcb9-1188de40d4e5	59651-841	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE HYDROCHLORIDE	TABLET	ORAL	20230807		ANDA	ANDA074796	Aurobindo Pharma Limited	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
59672-0916_1bc6f470-8c5a-4057-bdf8-a111b45ef862	59672-0916	HUMAN OTC DRUG	NO-WEAK-NAILS		GRAPHITE, THUJA OCCIDENTALIS LEAFY TWIG, and SILICON DIOXIDE	TABLET	ORAL	20140915		UNAPPROVED HOMEOPATHIC		Miers Laboratories	GRAPHITE; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG	30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
59672-1516_212a6c69-1fb5-4d94-ac5d-4f5470792a70	59672-1516	HUMAN OTC DRUG	Drink Ease		avena sativa flowering top, capsicum, strychnos nux-vomica seed, veratrum album root, and zinc	TABLET	ORAL	20220128		UNAPPROVED HOMEOPATHIC		Miers Laboratories	AVENA SATIVA FLOWERING TOP; CAPSICUM; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT; ZINC	30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
59672-1716_faf5e575-9860-4fb2-810a-29e02ba7cb21	59672-1716	HUMAN OTC DRUG	TRIP EASE		Sodium Borate, Anamirta Cocculus Seed, Gelsemium Sempervirens Root, Wood Creosote, Toxicodendron Pubescens Leaf, and Tobacco Leaf	TABLET	ORAL	20230805		UNAPPROVED HOMEOPATHIC		Miers Laboratories	ANAMIRTA COCCULUS SEED; GELSEMIUM SEMPERVIRENS ROOT; SODIUM BORATE; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; WOOD CREOSOTE	30; 30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
59676-030_066d8997-4ab0-06b4-e063-6394a90aa39d	59676-030	HUMAN PRESCRIPTION DRUG	BALVERSA		Erdafitinib	TABLET, FILM COATED	ORAL	20190412		NDA	NDA212018	Janssen Products LP	ERDAFITINIB	3	mg/1	Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Fibroblast Growth Factor Receptor Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59676-040_066d8997-4ab0-06b4-e063-6394a90aa39d	59676-040	HUMAN PRESCRIPTION DRUG	BALVERSA		Erdafitinib	TABLET, FILM COATED	ORAL	20190412		NDA	NDA212018	Janssen Products LP	ERDAFITINIB	4	mg/1	Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Fibroblast Growth Factor Receptor Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59676-050_066d8997-4ab0-06b4-e063-6394a90aa39d	59676-050	HUMAN PRESCRIPTION DRUG	BALVERSA		Erdafitinib	TABLET, FILM COATED	ORAL	20190412		NDA	NDA212018	Janssen Products LP	ERDAFITINIB	5	mg/1	Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Fibroblast Growth Factor Receptor Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59676-278_0823bccc-f79a-400b-a8bf-8e0988f7a158	59676-278	HUMAN PRESCRIPTION DRUG	EDURANT		rilpivirine hydrochloride	TABLET, FILM COATED	ORAL	20110520		NDA	NDA202022	Janssen Products, LP	RILPIVIRINE HYDROCHLORIDE	25	mg/1	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
59676-302_0919c57c-7a9a-ce38-e063-6394a90a18ea	59676-302	HUMAN PRESCRIPTION DRUG	PROCRIT		Erythropoietin	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890601		BLA	BLA103234	Janssen Products, LP	ERYTHROPOIETIN	2000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59676-303_0919c57c-7a9a-ce38-e063-6394a90a18ea	59676-303	HUMAN PRESCRIPTION DRUG	PROCRIT		Erythropoietin	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890601		BLA	BLA103234	Janssen Products, LP	ERYTHROPOIETIN	3000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59676-304_0919c57c-7a9a-ce38-e063-6394a90a18ea	59676-304	HUMAN PRESCRIPTION DRUG	PROCRIT		Erythropoietin	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890601		BLA	BLA103234	Janssen Products, LP	ERYTHROPOIETIN	4000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59676-310_0919c57c-7a9a-ce38-e063-6394a90a18ea	59676-310	HUMAN PRESCRIPTION DRUG	PROCRIT		Erythropoietin	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890601		BLA	BLA103234	Janssen Products, LP	ERYTHROPOIETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59676-312_0919c57c-7a9a-ce38-e063-6394a90a18ea	59676-312	HUMAN PRESCRIPTION DRUG	PROCRIT		Erythropoietin	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890601		BLA	BLA103234	Janssen Products, LP	ERYTHROPOIETIN	10000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59676-320_0919c57c-7a9a-ce38-e063-6394a90a18ea	59676-320	HUMAN PRESCRIPTION DRUG	PROCRIT		Erythropoietin	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890601		BLA	BLA103234	Janssen Products, LP	ERYTHROPOIETIN	20000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59676-340_0919c57c-7a9a-ce38-e063-6394a90a18ea	59676-340	HUMAN PRESCRIPTION DRUG	PROCRIT		Erythropoietin	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19890601		BLA	BLA103234	Janssen Products, LP	ERYTHROPOIETIN	40000	[iU]/mL	Erythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]		N	20241231
59676-562_02fd607e-f780-dd47-e063-6394a90aad7d	59676-562	HUMAN PRESCRIPTION DRUG	PREZISTA		darunavir	TABLET, FILM COATED	ORAL	20080308		NDA	NDA021976	Janssen Products LP	DARUNAVIR ETHANOLATE	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59676-563_02fd607e-f780-dd47-e063-6394a90aad7d	59676-563	HUMAN PRESCRIPTION DRUG	PREZISTA		darunavir	TABLET, FILM COATED	ORAL	20090114		NDA	NDA021976	Janssen Products LP	DARUNAVIR ETHANOLATE	75	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59676-564_02fd607e-f780-dd47-e063-6394a90aad7d	59676-564	HUMAN PRESCRIPTION DRUG	PREZISTA		darunavir	TABLET, FILM COATED	ORAL	20090427		NDA	NDA021976	Janssen Products LP	DARUNAVIR ETHANOLATE	150	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59676-565_02fd607e-f780-dd47-e063-6394a90aad7d	59676-565	HUMAN PRESCRIPTION DRUG	PREZISTA		darunavir	SUSPENSION	ORAL	20111216		NDA	NDA202895	Janssen Products LP	DARUNAVIR ETHANOLATE	100	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59676-566_02fd607e-f780-dd47-e063-6394a90aad7d	59676-566	HUMAN PRESCRIPTION DRUG	PREZISTA		darunavir	TABLET, FILM COATED	ORAL	20121109		NDA	NDA021976	Janssen Products LP	DARUNAVIR ETHANOLATE	800	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59676-570_02fc6f4f-330d-b32e-e063-6294a90a028a	59676-570	HUMAN PRESCRIPTION DRUG	Intelence		etravirine	TABLET	ORAL	20080118		NDA	NDA022187	Janssen Products LP	ETRAVIRINE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59676-571_02fc6f4f-330d-b32e-e063-6294a90a028a	59676-571	HUMAN PRESCRIPTION DRUG	Intelence		etravirine	TABLET	ORAL	20101222		NDA	NDA022187	Janssen Products LP	ETRAVIRINE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59676-572_02fc6f4f-330d-b32e-e063-6294a90a028a	59676-572	HUMAN PRESCRIPTION DRUG	Intelence		etravirine	TABLET	ORAL	20120326		NDA	NDA022187	Janssen Products LP	ETRAVIRINE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
59676-575_02fc8dd6-7aed-29fb-e063-6394a90acf70	59676-575	HUMAN PRESCRIPTION DRUG	PREZCOBIX		DARUNAVIR ETHANOLATE and COBICISTAT	TABLET, FILM COATED	ORAL	20150131		NDA	NDA205395	Janssen Products LP	COBICISTAT; DARUNAVIR ETHANOLATE	150; 800	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59676-600_0e3961a5-725a-f825-e063-6394a90ad85d	59676-600	HUMAN PRESCRIPTION DRUG	ERLEADA		Apalutamide	TABLET, FILM COATED	ORAL	20180214		NDA	NDA210951	Janssen Products, LP	APALUTAMIDE	60	mg/1			N	20251231
59676-604_0e3961a5-725a-f825-e063-6394a90ad85d	59676-604	HUMAN PRESCRIPTION DRUG	ERLEADA		Apalutamide	TABLET, FILM COATED	ORAL	20180214		NDA	NDA210951	Janssen Products, LP	APALUTAMIDE	240	mg/1			N	20251231
59676-610_8218989c-639a-11ea-bb8e-0434fc2ca371	59676-610	HUMAN PRESCRIPTION DRUG	YONDELIS		Trabectedin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151023		NDA	NDA207953	Janssen Products, LP	TRABECTEDIN	.05	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
59676-701_07ec67e8-a3f2-a416-e063-6294a90a881e	59676-701	HUMAN PRESCRIPTION DRUG	SIRTURO		Bedaquiline Fumarate	TABLET	ORAL	20121228		NDA	NDA204384	Janssen Products, LP	BEDAQUILINE FUMARATE	100	mg/1	Diarylquinoline Antimycobacterial [EPC], Diarylquinolines [CS]		N	20241231
59676-702_07ec67e8-a3f2-a416-e063-6294a90a881e	59676-702	HUMAN PRESCRIPTION DRUG	SIRTURO		Bedaquiline Fumarate	TABLET	ORAL	20200527		NDA	NDA204384	Janssen Products, LP	BEDAQUILINE FUMARATE	20	mg/1	Diarylquinoline Antimycobacterial [EPC], Diarylquinolines [CS]		N	20241231
59676-800_03342109-cd66-bd0f-e063-6394a90aaf40	59676-800	HUMAN PRESCRIPTION DRUG	Symtuza		Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide	TABLET, FILM COATED	ORAL	20180717		NDA	NDA210455	Janssen Products LP	COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE	150; 800; 200; 10	mg/1; mg/1; mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
59723-101_0e21c76b-c5ef-7155-e063-6394a90a338f	59723-101	HUMAN OTC DRUG	Compliance Dishwashing Liquid and Antibacterial Hand		PCMX	SOAP	TOPICAL	20220805		OTC MONOGRAPH DRUG	505G(a)(3)	Royal Paper Corp.	CHLOROXYLENOL	1	g/L			N	20251231
59726-011_267acfba-56cf-48d4-8357-ef01ffc3eba3	59726-011	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20210625		OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
59726-012_4a226f9f-95f7-47bf-8f9e-741ecea07fe1	59726-012	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20210625		ANDA	ANDA208077	P & L Development, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-013_1aace36d-99bb-4f66-80cd-2c179f12f103	59726-013	HUMAN OTC DRUG	Arthritis Pain Reliever	Extended Release	Acetaminophen	TABLET	ORAL	20200430		ANDA	ANDA211544	P & L Development, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
59726-028_d91e1a29-2447-4cdd-af33-733c15f0f969	59726-028	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20171231	20241231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
59726-030_178f162b-66f9-4a42-a742-1784bab19b68	59726-030	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20171231	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
59726-031_b3a97075-de79-4c09-9a0f-563135549203	59726-031	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20150105	20250105	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-032_448c4930-1c5c-4eb8-8139-e7140cee7a31	59726-032	HUMAN OTC DRUG	Pain Reliever PM	extra strength	Acetaminophen Diphenhydramine HCI	TABLET, COATED	ORAL	20171231	20251231	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-041_5d7c80d4-634d-480d-99c6-2948fdf6b9d0	59726-041	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180131	20241227	ANDA	ANDA207235	P & L Development, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-043_7b502d88-92b1-42d4-91b7-5c0367fcff15	59726-043	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180731	20240726	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
59726-046_c6feb159-979a-479e-ae12-3b80c7e2135d	59726-046	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20201204		ANDA	ANDA207753	P & L Development, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-049_38737744-a494-4ecc-ba7b-10d1f50f40d6	59726-049	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190531	20250531	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
59726-050_493a50a7-d887-4528-8164-7da78f946710	59726-050	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20190531	20241227	OTC MONOGRAPH FINAL	part341	P & L Development, LLC						N	
59726-056_6e82983e-c3bf-42e2-a9b0-eb9cb86cb935	59726-056	HUMAN OTC DRUG	Acid Reducer		Esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20201231		ANDA	ANDA212088	P & L Development, LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59726-058_13931f66-c648-4e9e-94b9-1cc99744bd27	59726-058	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210625		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
59726-059_6bbf482b-311b-4833-8001-4edccf5c9a8c	59726-059	HUMAN OTC DRUG	Stool Softener Laxative	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210416		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
59726-063_8781c73d-663f-4d59-8d9c-df1700ed9a3f	59726-063	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20210528		ANDA	ANDA213105	P & L Development, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-064_b3d95019-74c3-4770-bb22-24e9b1a91ad6	59726-064	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCL	CAPSULE	ORAL	20210528		ANDA	ANDA213105	P & L Development, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-065_8ccd7226-f303-4e8a-aac9-2ec7b87b757e	59726-065	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20210813		OTC MONOGRAPH FINAL	part343	P & L Development, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59726-072_fa56a785-b9ed-4b25-91a5-e9bcf577fe4b	59726-072	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20171231	20241227	OTC MONOGRAPH FINAL	part341	P & L Development, LLC						N	
59726-078_b407b247-79c4-486b-9062-8b41de4c2ba8	59726-078	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180131	20250131	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	100	mg/1			N	
59726-084_661486da-69ac-4f33-b507-d22b6f62a6e1	59726-084	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		docusate sodium and sennosides	TABLET	ORAL	20180131	20240426	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
59726-087_2b5aaa17-0050-4bf0-8459-5e36603301ca	59726-087	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20180131	20240426	OTC MONOGRAPH FINAL	part347	P & L Development, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
59726-097_52f641a2-6b2b-429c-b119-cafe9dd203d3	59726-097	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20190830	20250830	OTC MONOGRAPH FINAL	part347	P & L Development, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
59726-107_192c443b-f963-44e2-b60c-88351d8eec37	59726-107	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20121207	20240426	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	GUAIFENESIN	400	mg/1			N	
59726-112_43689c10-4322-47c6-bbf7-bfc07f2ee979	59726-112	HUMAN OTC DRUG	Cold Sore Treatment		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	P & L Development, LLC	DOCOSANOL	100	mg/g			N	20241231
59726-114_b5cb0f08-5e1a-4e80-896a-7f83571a8f3e	59726-114	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20231130		ANDA	ANDA090962	P & L Development, LLC	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
59726-115_37efd9ba-3937-4d45-ba81-9112c37f07ec	59726-115	HUMAN OTC DRUG	Minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20230505		ANDA	ANDA208092	P & L Development, LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59726-116_bc1b69b4-eaee-46e0-8b3a-f340ea7abdb3	59726-116	HUMAN OTC DRUG	Minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20230505		ANDA	ANDA208092	P & L Development, LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59726-123_59151400-570d-4c78-ba7f-52c84cf864ec	59726-123	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230331		ANDA	ANDA202300	P & L Development, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-125_4ff4ff0d-4061-4f82-aa4b-02f6e52cfb3d	59726-125	HUMAN OTC DRUG	Minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20231001		ANDA	ANDA208092	P & L Development, LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59726-129_c1883c17-0359-404a-a354-b238911e29f3	59726-129	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	TABLET	ORAL	20100901		ANDA	ANDA078780	P & L Development, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-138_a54c8af1-220b-4fb8-bfea-59ae42870c19	59726-138	HUMAN OTC DRUG	Emergency Contraceptive		Levonorgestrel	TABLET	ORAL	20230801		ANDA	ANDA205329	P & L Development, LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
59726-141_7b51fe83-3dce-4c76-8e20-92d26e25290c	59726-141	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
59726-142_87035b39-4365-4996-a06c-2cbb87eed548	59726-142	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
59726-152_745e18f8-a51b-4afd-b21d-78e4dadba4e3	59726-152	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20231231		OTC MONOGRAPH DRUG	M002	P & L Development, LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
59726-168_6f93a6a2-dc31-4c93-9561-e7018c32d250	59726-168	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET	ORAL	20180331	20250331	ANDA	ANDA079096	P & L Development, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59726-169_4f58c6a0-3f3c-42b6-a35b-d0d31c574ec8	59726-169	HUMAN OTC DRUG	All Day Pain Relief		Naproxen sodium	TABLET	ORAL	20140228		ANDA	ANDA079096	P & L Development, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-174_94741bae-2520-4a59-bd4c-f875a5090a9d	59726-174	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	P & L Development, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-179_854a1a2a-f71c-4f0a-988d-11c1028cff7e	59726-179	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20191129	20251129	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	250	mg/1			N	
59726-190_462d7428-ce48-41a8-ac8d-e97b6375e90b	59726-190	HUMAN OTC DRUG	Laxative	Enteric Coated	Bisacodyl	TABLET, COATED	ORAL	20100901	20241227	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
59726-198_47d8f2db-4752-4b42-bf2a-617e0e98af27	59726-198	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20191030	20241030	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
59726-199_c856b608-111d-47fa-ac48-2cf13445866d	59726-199	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210129	20251231	ANDA	ANDA078682	P & L Development, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59726-201_4f0552ac-8487-4b9e-8cf8-cef505ab386c	59726-201	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20191030	20241030	OTC MONOGRAPH FINAL	part341	P & L Development, LLC						N	
59726-227_76ec167a-eb8e-441a-9e26-3c012c4757d9	59726-227	HUMAN OTC DRUG	Aspirin	Low Dose Safety Coated	Aspirin	TABLET	ORAL	20130301	20241231	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
59726-256_efe968e6-695e-4827-b317-336b14888e0b	59726-256	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET	ORAL	20140328	20241228	ANDA	ANDA091353	P & L Development, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59726-257_c421d243-3502-410d-9541-d7381061dcdf	59726-257	HUMAN OTC DRUG	Stool Softener		DOCUSATE CALCIUM	CAPSULE, LIQUID FILLED	ORAL	20140430	20240426	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE CALCIUM	240	mg/1			N	
59726-258_2c0b9f44-3802-4d8a-a800-9f236293afd6	59726-258	HUMAN OTC DRUG	STOOL SOFTENER	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20140430	20240405	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	250	mg/1			N	
59726-262_841335d5-8673-44b0-8a9b-2aeed0b7e53c	59726-262	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20190401		ANDA	ANDA207868	P & L Development, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59726-297_374eac2d-56c9-4973-acb1-710620384e70	59726-297	HUMAN OTC DRUG	Omeprazole		Omeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20200602	20251231	ANDA	ANDA206582	P & L Development, LLC	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
59726-370_210d2759-aedc-407c-bbcb-b2f0105c26f6	59726-370	HUMAN OTC DRUG	Enteric Coated Aspirin	regular strength	Aspirin	TABLET, COATED	ORAL	20160331	20240126	OTC MONOGRAPH FINAL	part343	P & L Development, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
59726-399_9dff28f5-d10b-4876-ab2d-e04677092ed3	59726-399	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20191030	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
59726-405_8acb0ca2-7583-4cb8-a159-869eb205b138	59726-405	HUMAN OTC DRUG	Sleep-Aid	Nighttime	Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20171231	20240426	OTC MONOGRAPH FINAL	part338	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-447_84b9c4f5-bce2-4325-beae-b983cf06f6c5	59726-447	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET	ORAL	20141130	20251130	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-471_3025fdc9-a071-444a-8960-e2f9330b076e	59726-471	HUMAN OTC DRUG	Night time cold and flu	multi symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20150731	20240726	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
59726-487_52363d26-2cce-4f20-9f5c-7ead7a11e812	59726-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160131	20240426	OTC MONOGRAPH FINAL	part347	P & L Development, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
59726-494_9700b5c7-af7e-461e-b9c3-eac5a81d1137	59726-494	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET	ORAL	20160331		OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
59726-504_522a2c28-06ff-4216-9eec-1ba076cf46fb	59726-504	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20160331	20250331	ANDA	ANDA079112	P & L Development, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-505_c3126fd1-a1be-41e0-be8e-9ce666b7e26b	59726-505	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20180131		ANDA	ANDA204507	P & L Development, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-525_038eb3da-fa5f-409c-9360-8fc0c2cd3c2b	59726-525	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160630	20240628	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
59726-530_6654046b-56ee-42e0-a211-58031f4c0255	59726-530	HUMAN OTC DRUG	Ultra Strength Gas Relief		SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20110901	20240901	OTC MONOGRAPH FINAL	part332	P & L Development, LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
59726-564_0e656d13-42ab-456f-830c-08f5373bdade	59726-564	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCL	TABLET, COATED	ORAL	20191001		ANDA	ANDA204097	P & L Development, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-568_daa8320e-a291-426c-9a4c-13fe9d5814a2	59726-568	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170331	20240426	ANDA	ANDA079174	P & L Development, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59726-578_4e0cabc0-f5b0-4f9b-a04e-f47787b925b1	59726-578	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831	20240831	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	100	mg/1			N	
59726-635_bcc27e7c-0e64-4822-89bc-a269003999f4	59726-635	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20180930	20241227	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-660_6fbebbe8-c775-4241-b142-916a3dfb4e3d	59726-660	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20160930	20250930	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-661_4ce53f61-df15-4abd-bb7c-fcf1929720b6	59726-661	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170831	20250831	ANDA	ANDA079174	P & L Development, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59726-669_562b15d7-4b70-44cc-acde-54f0269728bc	59726-669	HUMAN OTC DRUG	ArthritisPain Relief		Acetaminophen	TABLET	ORAL	20210430		ANDA	ANDA207035	P & L Development, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
59726-671_ff9d6939-96a0-4c4d-9aa2-b2e82521e0c7	59726-671	HUMAN OTC DRUG	Muscle Pain Relief		Acetaminophen	TABLET	ORAL	20220204		ANDA	ANDA207035	P & L Development, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
59726-692_e7d252c7-b35e-42f1-acd7-b1b9b5043070	59726-692	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET	ORAL	20171231	20240426	OTC MONOGRAPH FINAL	part336	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-701_4fdf332d-16ba-4a04-826e-43bfd0fe116a	59726-701	HUMAN OTC DRUG	IAllergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20210820		ANDA	ANDA204507	P & L Development, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-729_be01539e-f6ea-4607-a208-ebe79ee26e5c	59726-729	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		docusate sodium and sennosides	TABLET	ORAL	20180930	20251231	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
59726-731_05d2695d-b138-4b0b-a6b5-6616a3eb9af1	59726-731	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20210326	20251231	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	SENNOSIDES	8.6	mg/1			N	
59726-732_afbf933d-389f-4b09-a3d4-509c8a0176c5	59726-732	HUMAN OTC DRUG	Gas Relief	Ultra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20181231	20240426	OTC MONOGRAPH FINAL	part332	P & L Development, LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
59726-733_0e098c1a-0f24-4501-96ec-843b10368d6e	59726-733	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20181231		ANDA	ANDA209692	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59726-736_291ecce4-0e29-4a9b-8271-59f6c3119599	59726-736	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20171231	20240126	OTC MONOGRAPH FINAL	part338	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-737_374eac2d-56c9-4973-acb1-710620384e70	59726-737	HUMAN OTC DRUG	Omeprazole		Omeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20200602	20251231	ANDA	ANDA206582	P & L Development, LLC	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
59726-739_702aba71-187e-4efd-9f28-7f752c419d21	59726-739	HUMAN OTC DRUG	All Day Allergy		Cetirizine HCL	TABLET	ORAL	20190701	20241227	ANDA	ANDA077946	P & L Development, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-741_f94c66a4-1f06-4f41-9209-c2943a76f050	59726-741	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20210129		ANDA	ANDA207235	P & L Development, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-742_58878820-7dd6-45eb-b417-8426cc09a39d	59726-742	HUMAN OTC DRUG	Daytime Cold Flu	multi Symptom	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20180731	20240126	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
59726-743_d183fddd-0c14-4123-bcb1-8e7a5995ca3e	59726-743	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180430	20240426	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
59726-745_30553e6a-fb51-473a-a17e-f082acf0e8d0	59726-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180930		ANDA	ANDA206568	P & L Development, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-748_3e946f06-b434-4f9b-b996-93461f5c679e	59726-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20220225		ANDA	ANDA208363	P & L Development, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-751_5d16c415-50bc-4068-a664-ad12f8a2351c	59726-751	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE	ORAL	20201204		ANDA	ANDA202807	P & L Development, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-755_07707b86-ba94-4970-837a-72bc9112fd1d	59726-755	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
59726-758_8478c0ed-6eb2-404b-a86c-5fa12d5b413c	59726-758	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20180930	20240726	ANDA	ANDA075209	P & L Development, LLC	LORATADINE	10	mg/1			N	
59726-760_ad9450db-aaad-4f7a-9c32-f3e1f33c0923	59726-760	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCL	CAPSULE	ORAL	20191129		OTC MONOGRAPH DRUG	M012	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-766_148e93ad-f92c-4686-ada3-d28a789eb04a	59726-766	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCL	TABLET	ORAL	20191129	20241129	OTC MONOGRAPH FINAL	part336	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-773_0a88223e-fe8b-4d7b-b1b5-9b9d00329373	59726-773	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200327		OTC MONOGRAPH DRUG	M002	P & L Development, LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
59726-778_d7e1c581-6946-4dc1-950f-01d5d13edb74	59726-778	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
59726-801_5fd5ee47-31da-4953-983b-f97af845ef65	59726-801	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20210820		ANDA	ANDA204507	P & L Development, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-806_ccea5857-8691-4ed2-ac21-d637f9ec634c	59726-806	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	TABLET	ORAL	20180630		ANDA	ANDA209274	P & L Development, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-816_56c200ee-5dd0-45bf-a1e8-5ff306616dc5	59726-816	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCL	CAPSULE	ORAL	20191129		OTC MONOGRAPH DRUG	M012	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-829_bc4ceb13-ec8f-4d49-b1bc-c4f5f07d2243	59726-829	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		docusate sodium and sennosides	TABLET	ORAL	20181231	20251231	OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
59726-831_c246a2ea-0678-45ef-bd73-806d49908557	59726-831	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20190331		ANDA	ANDA207342	P & L Development, LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
59726-832_99cd20f2-e0d1-4bb9-be62-a578391a463f	59726-832	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20190331	20250331	ANDA	ANDA207342	P & L Development, LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
59726-833_d0d72889-0f6f-4238-a880-18a15b5b42d7	59726-833	HUMAN OTC DRUG	Mucus DM Extended Release		Dextromethorphan Hydrobromide and Guaifenesin	TABLET	ORAL	20190101		ANDA	ANDA209692	P & L Development, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59726-842_b152d013-2bbf-48f4-aed4-6832a57d9f09	59726-842	HUMAN OTC DRUG	Daytime Cold Flu	multi Symptom	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCI	CAPSULE, LIQUID FILLED	ORAL	20180531	20240531	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
59726-843_ec023bd6-8498-4f57-b1b0-8845acddc699	59726-843	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20201231		ANDA	ANDA206568	P & L Development, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59726-844_1a0bf47b-b6c6-4e9c-b8cc-19d3fa0a0727	59726-844	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20180331	20240329	OTC MONOGRAPH FINAL	part341	P & L Development, LLC						N	
59726-848_45cc93c4-06dd-4992-8ecd-b53f0625e81e	59726-848	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190630		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59726-849_32753548-f754-4808-b18f-360e67cd4c5f	59726-849	HUMAN OTC DRUG	Night time cold and flu	multi symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190531	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
59726-850_c229a8bf-d157-476f-a44d-efb3b7c698ff	59726-850	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20190331		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59726-852_994e8414-28eb-4afc-9c09-256530db48c8	59726-852	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
59726-853_2e1d9971-8f5c-422a-84f6-b2aa331f99b8	59726-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
59726-855_0c05a171-b678-4475-9b50-22e0e42a060e	59726-855	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		docusate sodium and sennosides	TABLET	ORAL	20200430		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
59726-857_80e090f1-511b-47ad-a279-2f84b075ef1b	59726-857	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20200131	20251231	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
59726-863_441b737b-4ed7-4ae8-8023-b073c4e348b1	59726-863	HUMAN OTC DRUG	Pain Reliever PM	extra strength	Acetaminophen Diphenhydramine HCL	TABLET, COATED	ORAL	20191129	20251130	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-865_516d0a82-8811-4892-b0a3-edd630e461ab	59726-865	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200529	20250529	OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
59726-866_6d495b52-b485-4cca-a71e-4bb37c816a04	59726-866	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCL	TABLET	ORAL	20190731	20241231	OTC MONOGRAPH FINAL	part336	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
59726-867_437d856e-da72-42d7-82a3-8886ec18e101	59726-867	HUMAN OTC DRUG	Low Dose Aspirin	Enteric Safety-Coated	Aspirin	TABLET	ORAL	20190331		OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59726-868_cb2a2e60-e3ae-4d80-9efa-95859b0dbdba	59726-868	HUMAN OTC DRUG	Pain Reliever PM	extra strength	Acetaminophen Diphenhydramine HCL	TABLET, COATED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part343	P & L Development, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-873_f1d3fa09-e933-44f8-85d4-1db4b88153cf	59726-873	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200430		OTC MONOGRAPH FINAL	part332	P & L Development, LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
59726-877_09a73a90-80b6-43e8-aa58-c35b4d58fb67	59726-877	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA208754	P & L Development, LLC	DOCOSANOL	100	mg/g			N	20241231
59726-878_a4f8cdde-4c57-45e1-8a8b-17c1bfd88ab6	59726-878	HUMAN OTC DRUG	Stool Softener with Stimulant Laxative		docusate sodium and sennosides	TABLET	ORAL	20200529		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
59726-879_e2a732be-1111-44d1-8cf0-24c4c13b6d49	59726-879	HUMAN OTC DRUG	Stool Softener Laxative	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part334	P & L Development, LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
59726-888_6a1f5d6f-7159-4498-872e-e4a163c7a79d	59726-888	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20210528		ANDA	ANDA091314	P & L Development, LLC	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
59726-890_5ef44e5c-629a-475d-bebe-d7a04c68e31c	59726-890	HUMAN OTC DRUG	Acti PE		Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20150228	20240126	OTC MONOGRAPH FINAL	part341	P & L Development, LLC	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
59726-897_34212e40-6a03-40c2-af51-80e278fb1ed3	59726-897	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20190731		OTC MONOGRAPH FINAL	part347	P & L Development, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
59726-898_4853cdd0-10f0-4733-9ff0-40f1f2d734c1	59726-898	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20191030		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59726-899_c09c9ecc-931d-4a0a-8a28-929bbdd17967	59726-899	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20191030		OTC MONOGRAPH FINAL	part341	P & L Development, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59726-901_8bf7e227-8d02-47d8-abff-e3abe073c33c	59726-901	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20210326		OTC MONOGRAPH FINAL	part341	P & L Development, LLC						N	20241231
59726-912_27cf4062-a8b8-4a2a-a90c-06b505cd8733	59726-912	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200131	20251231	ANDA	ANDA209716	P & L Development, LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
59726-915_1a4f8278-eb88-4f8e-b419-c2abb5328f28	59726-915	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20191030		ANDA	ANDA075209	P & L Development, LLC	LORATADINE	10	mg/1			N	20241231
59726-916_09922d84-bef7-43cf-8825-27bbc481f33d	59726-916	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20210326		OTC MONOGRAPH FINAL	part338	P & L Development, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59726-922_e3ca66e1-8d74-4cc1-8658-fe4cf8c54c0f	59726-922	HUMAN OTC DRUG	Cold Sore Treatment		Docosanol	CREAM	TOPICAL	20230715		ANDA	ANDA208754	P & L Development, LLC	DOCOSANOL	100	mg/g			N	20241231
59726-924_3a93fdcf-bd3a-48ed-9821-48947cc2ac2a	59726-924	HUMAN OTC DRUG	Cold Sore Treatment		Docosanol	CREAM	TOPICAL	20210528		ANDA	ANDA208754	P & L Development, LLC	DOCOSANOL	100	mg/g			N	20241231
59726-988_222ad9fe-4c25-493e-8eea-98f554ef9c1f	59726-988	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20210528		ANDA	ANDA074164	P & L Development, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59726-989_d9017236-cc5c-4959-91f8-8d0d1b36db60	59726-989	HUMAN OTC DRUG	Miconazole 3 Combination Pack		Miconazole Nitrate	KIT		20210625		ANDA	ANDA074926	P & L Development, LLC						N	20241231
59735-140_3bff8bfc-bcab-4aff-e054-00144ff8d46c	59735-140	HUMAN OTC DRUG	Nuance Salma Hayek Renewed Radiance Brightening BB Cream Broad Spectrum SPF 30 Sunscreen		Nuance Salma Hayek Renewed Radiance Brightening BB Cream Broad Spectrum SPF 30 Sunscreen	LOTION	TOPICAL	20160908		OTC MONOGRAPH FINAL	part352	Mana Products	OCTINOXATE; TITANIUM DIOXIDE	7.5; 10	g/100g; g/100g			N	20241231
59735-150_4316f872-e167-1497-e054-00144ff8d46c	59735-150	HUMAN OTC DRUG	DERMAdoctor DD Cream Dermatologically Defining BB Cream Broad Spectrum SPF 30		DERMAdoctor DD Cream Dermatologically Defining BB Cream Broad Spectrum SPF 30	LOTION	TOPICAL	20161207		OTC MONOGRAPH FINAL	part352	Mana Products	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 12.05	g/100g; g/100g			N	20241231
59735-160_491f8925-b1e8-3372-e054-00144ff8d46c	59735-160	HUMAN OTC DRUG	Your Name Cosmetics Brightening CC Cream Broad Spectrum SPF 20		Your Name Cosmetics Brightening CC Cream Broad Spectrum SPF 20	LOTION	TOPICAL	20170221		OTC MONOGRAPH FINAL	part352	Mana Products	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	7.5; 5; .99	g/100g; g/100g; g/100g			N	20241231
59735-170_63a167f4-e0f0-2ac6-e053-2991aa0a7c2e	59735-170	HUMAN OTC DRUG	Your Name Cosmetics Mineral Sheet Tint Broad Spectrum SPF 20		Your Name Cosmetics Mineral Sheet Tint Broad Spectrum SPF 20	LOTION	TOPICAL	20180125		OTC MONOGRAPH FINAL	part352	Mana Products	TITANIUM DIOXIDE	5	g/100g			N	20241231
59735-172_0e241d78-f079-13fd-e063-6394a90af3bf	59735-172	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-173_0e240290-f11e-8cc4-e063-6294a90a74f0	59735-173	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-174_0e2410be-09f1-e59f-e063-6294a90a9e02	59735-174	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20- HONEY GLOW		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-175_0e243b04-3fc7-02ff-e063-6294a90af4c2	59735-175	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20-ALMOND		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-176_0e243af2-a620-387a-e063-6394a90af822	59735-176	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20-PALE BEIGE		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-177_0e244020-fee1-0438-e063-6294a90a32ae	59735-177	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20-LIGHT		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-178_0e246668-b5e4-2210-e063-6294a90a3b5a	59735-178	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20-MEDIUM		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-179_0e246e70-6ec4-5711-e063-6394a90a3879	59735-179	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20- MEDIUM DEEP		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-180_0e246668-b5e7-2210-e063-6294a90a3b5a	59735-180	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20-DEEP		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-181_0e246e70-6ecc-5711-e063-6394a90a3879	59735-181	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20-FAIR GLOW		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-182_0e249417-9e09-4f10-e063-6394a90a8734	59735-182	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20- SUN GLOW		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-183_0e249cae-aaab-396a-e063-6294a90ab801	59735-183	HUMAN OTC DRUG	YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20- ALABASTER		YOUR NAME MINERAL SHEER TINT	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-184_0e373e16-e57d-4e88-e063-6394a90a3ca9	59735-184	HUMAN OTC DRUG	YOUR NAME TINTED PRIMER BROAD SPECTRUM SPF 20- LIGHT		YOUR NAME TINTED PRIMER	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	MANA Products, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 5	g/36mL; g/36mL			N	20251231
59735-186_0e36f174-0355-37ad-e063-6394a90a29b6	59735-186	HUMAN OTC DRUG	YOUR NAME TINTED PRIMER BROAD SPECTRUM SPF 20- MEDIUM		YOUR NAME TINTED PRIMER	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	MANA Products, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 5	g/36mL; g/36mL			N	20251231
59735-187_0e36f174-0361-37ad-e063-6394a90a29b6	59735-187	HUMAN OTC DRUG	YOUR NAME TINTED PRIMER BROAD SPECTRUM SPF 20- MEDIUM-DEEP		YOUR NAME TINTED PRIMER	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	MANA Products, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 5	g/36mL; g/36mL			N	20251231
59735-188_0e370c3c-c135-ab78-e063-6294a90a2a6a	59735-188	HUMAN OTC DRUG	YOUR NAME TINTED PRIMER BROAD SPECTRUM SPF 20- DEEP		YOUR NAME TINTED PRIMER	CREAM	TOPICAL	20110201		OTC MONOGRAPH DRUG	M020	MANA Products, Inc.	OCTINOXATE; TITANIUM DIOXIDE	7.5; 5	g/36mL; g/36mL			N	20251231
59735-202_0e11d96c-8cfd-3acb-e063-6294a90acf48	59735-202	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-203_0e118d42-8786-22d2-e063-6394a90a0093	59735-203	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-204_0e11e888-aa83-1f42-e063-6294a90a4d0a	59735-204	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-205_0e11c18d-29ad-1a43-e063-6294a90a8929	59735-205	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-206_0e11b53d-9240-2cfb-e063-6394a90ae916	59735-206	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-207_0e11b361-de50-234f-e063-6294a90ab5e7	59735-207	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKNI TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-208_0e11b53d-9238-2cfb-e063-6394a90ae916	59735-208	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-209_0e11b361-de4d-234f-e063-6294a90ab5e7	59735-209	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-210_0e1197e8-7b5c-14aa-e063-6294a90a9654	59735-210	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-213_0e112379-dcfc-bfaf-e063-6294a90a5804	59735-213	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-214_0e114466-6233-10f2-e063-6394a90a1f98	59735-214	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-215_0e1132f3-c6da-0b63-e063-6394a90a833a	59735-215	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-216_0e111df1-2ab0-016e-e063-6394a90a458e	59735-216	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-217_0e111df1-2aae-016e-e063-6394a90a458e	59735-217	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-218_0e10e958-a17f-a224-e063-6294a90abb9c	59735-218	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-219_0e10e958-a179-a224-e063-6294a90abb9c	59735-219	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-220_0e10b601-8615-78a3-e063-6294a90aa309	59735-220	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-221_0e10aad9-c864-397e-e063-6294a90a8db4	59735-221	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-222_0e107541-6b4e-601a-e063-6294a90a8a0c	59735-222	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-223_0e107a4a-a970-d03c-e063-6394a90af89b	59735-223	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-224_0e105d5d-66e1-d05c-e063-6394a90a761a	59735-224	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-225_0e1068bb-e2d0-4820-e063-6294a90a9161	59735-225	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-226_0e104326-fa20-342a-e063-6294a90ad236	59735-226	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-227_0e1051e8-e29d-3961-e063-6294a90ac38a	59735-227	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-228_0e10203b-c2f6-1793-e063-6294a90a420c	59735-228	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-229_0e0f43f5-9b24-9af8-e063-6294a90a00ad	59735-229	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		Brightening Skin Tint	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-230_0e0f6dfc-5582-9ac6-e063-6294a90a669a	59735-230	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-231_0e0f6dfc-5580-9ac6-e063-6294a90a669a	59735-231	HUMAN OTC DRUG	TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30		BRIGHTENING SKIN TINT	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS	AVOBENZONE; OCTISALATE	3; 5	g/30mL; g/30mL			N	20251231
59735-338_0e0f365b-5fa9-6774-e063-6394a90a25c4	59735-338	HUMAN OTC DRUG	NATURIUM Dew-Glow Moisturizer SPF 50		NATURIUM Dew-Glow Moisturizer SPF 50	CREAM	TOPICAL	20221101		OTC MONOGRAPH DRUG	M020	MANA Products, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	g/mL; g/mL; g/mL			N	20251231
59735-401_0e126a0c-f158-a6f1-e063-6394a90afe8d	59735-401	HUMAN OTC DRUG	LC FOUNDATION SPF 15		LC FOUNDATION SPF 15	CREAM	TOPICAL	20200825		OTC MONOGRAPH DRUG	M020	MANA Products INC.	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/100g; g/100g			N	20251231
59735-420_0e1327fe-5112-c93b-e063-6394a90a78e3	59735-420	HUMAN OTC DRUG	RICH GIRL HAND SPF 25		RICH GIRL HAND	CREAM	TOPICAL	20120515		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	AVOBENZONE; OCTINOXATE; OCTISALATE	2; 7.5; 5	g/100g; g/100g; g/100g			N	20251231
59735-422_0e39a064-e31d-11e7-e063-6394a90a0670	59735-422	HUMAN OTC DRUG	Stick Foundation SPF WARM TAN		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-423_0e3991bb-a3d8-3bb4-e063-6294a90ab9e6	59735-423	HUMAN OTC DRUG	Stick Foundation SPF NEO NUDE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-424_0e395ee2-36e6-d60a-e063-6394a90a82b1	59735-424	HUMAN OTC DRUG	Stick Foundation SPF ROSE GOLD		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-425_0e397a8c-ff0e-350e-e063-6294a90ab744	59735-425	HUMAN OTC DRUG	Stick Foundation SPF ICED GOLD		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-426_0e392d2c-03ec-0245-e063-6294a90aca7a	59735-426	HUMAN OTC DRUG	Stick Foundation SPF DARK COFFEE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-427_0e393717-d996-ecad-e063-6394a90a01f9	59735-427	HUMAN OTC DRUG	Stick Foundation SPF RICH BRONZE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-428_0e392d2c-03ed-0245-e063-6294a90aca7a	59735-428	HUMAN OTC DRUG	Stick Foundation SPF WALNUT		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-429_0e38fe52-a591-d6b1-e063-6394a90a651b	59735-429	HUMAN OTC DRUG	Stick Foundation SPF SOFT CREME		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-430_ea931bef-199b-3b8d-e053-2a95a90a8825	59735-430	HUMAN OTC DRUG	Stick Foundation SPF		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-431_0e385d92-c1a1-a465-e063-6394a90a0d31	59735-431	HUMAN OTC DRUG	Stick Foundation SPF PALE BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-432_0e38c4d0-c7c0-c69e-e063-6394a90a1cf4	59735-432	HUMAN OTC DRUG	Stick Foundation SPF NATURAL BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-433_0e38c827-22a0-c226-e063-6294a90a3b97	59735-433	HUMAN OTC DRUG	Stick Foundation SPF FAWN		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-434_0e38cb03-78c6-a6df-e063-6294a90ab52a	59735-434	HUMAN OTC DRUG	Stick Foundation SPF-CREME BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-435_0e38c4d0-c7e2-c69e-e063-6394a90a1cf4	59735-435	HUMAN OTC DRUG	Stick Foundation SPF SANDY BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-436_0e38ca12-cd24-affb-e063-6394a90a357b	59735-436	HUMAN OTC DRUG	Stick Foundation SPF TENDER BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-437_0e38ca12-cd27-affb-e063-6394a90a357b	59735-437	HUMAN OTC DRUG	Stick Foundation SPF ALMOND		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-438_0e38f630-eaca-ce23-e063-6394a90ac49c	59735-438	HUMAN OTC DRUG	Stick Foundation SPF CAMEO BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-439_0e38fe52-a58f-d6b1-e063-6394a90a651b	59735-439	HUMAN OTC DRUG	Stick Foundation SPF LUMINIZER		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-440_0e0f43f5-9b1f-9af8-e063-6294a90a00ad	59735-440	HUMAN OTC DRUG	KEEP IT CLEAR ACNE FOAM CLEANSER		KEEP IT CLEAR ACNE FOAM CLEANSER	CREAM	TOPICAL	20211224		OTC MONOGRAPH DRUG	M006	MANA PRODUCTS,INC.	SALICYLIC ACID	2	g/100g			N	20251231
59735-441_0e3a18d7-94c1-7f26-e063-6294a90a7273	59735-441	HUMAN OTC DRUG	Stick Foundation SPF TOASTED ALMOND		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-442_0e3a0d9e-a536-6abb-e063-6294a90a2e26	59735-442	HUMAN OTC DRUG	Stick Foundation SPF HONEY BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-443_0e3a2404-ef76-3874-e063-6394a90a7883	59735-443	HUMAN OTC DRUG	Stick Foundation SPF WARM BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-444_0e3a1fe9-ae1c-32f1-e063-6394a90aec2b	59735-444	HUMAN OTC DRUG	Stick Foundation SPF SOFT BEIGE		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-445_0e3a4320-5cac-3eb0-e063-6394a90a389e	59735-445	HUMAN OTC DRUG	Stick Foundation SPF IVORY		Stick Foundation	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	7.5; 5; 2	g/100g; g/100g; g/100g			N	20251231
59735-450_0e127c48-e131-a961-e063-6394a90a3174	59735-450	HUMAN OTC DRUG	PHOTO FINISH FOUNDATION PRIMER SPF 20		PHOTO FINISH FOUNDATION PRIMER SPF 20	CREAM	TOPICAL	20120527		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE	2; 15; 5	g/100g; g/100g; g/100g			N	20251231
59735-460_0e121c58-39b9-5dd1-e063-6294a90a9d88	59735-460	HUMAN OTC DRUG	TARTE AMAZONIAN CLAY BB TINTED MOISTURIZER BROAD SPECTRUM SPF 20 SUNSCREEN		TARTE AMAZONIAN CLAY BB TINTED MOISTURIZER BROAD SPECTRUM SPF 20 SUNSCREEN	CREAM	TOPICAL	20040501		OTC MONOGRAPH DRUG	M020	MANA PRODUCT, INC.	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/100g; g/100g			N	20251231
59735-475_0e1277bb-5992-5ba4-e063-6394a90a2638	59735-475	HUMAN OTC DRUG	PHELITYL DAY SPF 15		PHELITYL DAY SPF 15	CREAM	TOPICAL	20130410		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	AVOBENZONE; OCTINOXATE	2; 5	g/100g; g/100g			N	20251231
59735-480_0e12c408-83cd-15b4-e063-6294a90a93f3	59735-480	HUMAN OTC DRUG	FIRMARINE MOISTURIZER SPF 30		FIRMARINE MOISTURIZER SPF 30	CREAM	TOPICAL	20130410		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	AVOBENZONE; OCTINOXATE; OCTISALATE	3; 7.5; 5	g/100g; g/100g; g/100g			N	20251231
59735-500_0e11f733-450f-4dda-e063-6294a90a0f89	59735-500	HUMAN OTC DRUG	CHINA DOLL FOUNDATION BROAD SPECTRUM SPF 15		CHINA DOLL FOUNDATION BROAD SPECTRUM SPF 15	CREAM	TOPICAL	20131212		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 2.97	g/100g; g/100g			N	20251231
59735-550_0e129a45-40de-b056-e063-6394a90adeb4	59735-550	HUMAN OTC DRUG	EVEN TRUE NUTRITIVE SKIN MOISTURIZER SPF 15		EVEN TRUE NUTRITIVE SKIN MOISTURIZER SPF 15	CREAM	TOPICAL	20120901		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS, INC.	AVOBENZONE; OCTINOXATE	3; 7.5	g/100g; g/100g			N	20251231
59735-565_0e126599-b66d-e447-e063-6294a90a968c	59735-565	HUMAN OTC DRUG	DD Cream Dermatologically Defining BB Cream Broad Spectrum SPF 30		DD Cream Dermatologically Defining BB Cream Broad Spectrum SPF 30	CREAM	TOPICAL	20161212		OTC MONOGRAPH DRUG	M020	MANA Products, INC.	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 12.05	g/100g; g/100g			N	20251231
59735-614_0e0f039e-0555-7963-e063-6294a90a1de1	59735-614	HUMAN OTC DRUG	DAILY SUPERGOOP DOSE BIORETINOL MINERAL SPF 40		DAILY DOSE BIORETINOL MINERAL SPF 40	LOTION	TOPICAL	20221018		OTC MONOGRAPH DRUG	M020	MANA Products, INC	ZINC OXIDE	16.5	g/100mL			N	20251231
59735-800_0e11ed82-c5f7-41a6-e063-6294a90ab1d1	59735-800	HUMAN OTC DRUG	RETEXTURIZING PRIMER BROAD SPECTRUM SPF 20		RETEXTURIZING PRIMER BROAD SPECTRUM SPF 20	CREAM	TOPICAL	20170101		OTC MONOGRAPH DRUG	M020	MANA PRODUCTS,INC.	AVOBENZONE; OCTINOXATE; OCTISALATE	2; 7.5; 5	g/100g; g/100g; g/100g			N	20251231
59735-850_0e209831-72fa-5f32-e063-6294a90a6b8b	59735-850	HUMAN OTC DRUG	YOUNG CLARITI MINERAL BRIGHTENING SHEER TINT BROAD SPECTRUM SPF 20- PORCELAIN		YOUNG CLARITI MINERAL BRIGHTENING SHEER TINT - PORCELAIN	CREAM	TOPICAL	20230228		OTC MONOGRAPH DRUG	M020	Mana Product, Inc	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59735-851_0e2077a1-bcdf-d932-e063-6394a90a3b06	59735-851	HUMAN OTC DRUG	YOUNG CLARITI MINERAL BRIGHTENING SHEER TINT BROADSPECTRUM SPF 20		BRIGHTENING SHEER TINT	CREAM	TOPICAL	20230228		OTC MONOGRAPH DRUG	M020	MANA Products , Inc.	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
59746-001_f7ee0424-d881-4ae1-98be-e8863a8f78fe	59746-001	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	JUBILANT CADISTA PHARMACEUTICALS INC.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-002_f7ee0424-d881-4ae1-98be-e8863a8f78fe	59746-002	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	JUBILANT CADISTA PHARMACEUTICALS INC.	METHYLPREDNISOLONE	8	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-003_f7ee0424-d881-4ae1-98be-e8863a8f78fe	59746-003	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	JUBILANT CADISTA PHARMACEUTICALS INC.	METHYLPREDNISOLONE	16	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-010_3d37969d-a76c-453d-b243-3cc5a44c97ff	59746-010	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20111104		ANDA	ANDA090839	Jubilant Cadista Pharmaceuticals Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59746-015_f7ee0424-d881-4ae1-98be-e8863a8f78fe	59746-015	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	JUBILANT CADISTA PHARMACEUTICALS INC.	METHYLPREDNISOLONE	32	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-020_3d37969d-a76c-453d-b243-3cc5a44c97ff	59746-020	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20111104		ANDA	ANDA090839	Jubilant Cadista Pharmaceuticals Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59746-030_3d37969d-a76c-453d-b243-3cc5a44c97ff	59746-030	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20111104		ANDA	ANDA090839	Jubilant Cadista Pharmaceuticals Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59746-040_3d37969d-a76c-453d-b243-3cc5a44c97ff	59746-040	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20111104		ANDA	ANDA090839	Jubilant Cadista Pharmaceuticals Inc.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59746-050_3d37969d-a76c-453d-b243-3cc5a44c97ff	59746-050	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20111104		ANDA	ANDA090839	Jubilant Cadista Pharmaceuticals Inc.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59746-113_aeb0f87c-6809-496d-8162-72c2e405bde0	59746-113	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine Maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	JUBILANT CADISTA PHARMACEUTICALS INC.	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
59746-115_aeb0f87c-6809-496d-8162-72c2e405bde0	59746-115	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	JUBILANT CADISTA PHARMACEUTICALS INC.	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
59746-121_9fbce799-a4af-48b2-95c8-4f5bcb5a5833	59746-121	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	JUBILANT CADISTA PHARMACEUTICALS INC.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
59746-122_9fbce799-a4af-48b2-95c8-4f5bcb5a5833	59746-122	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA040659	JUBILANT CADISTA PHARMACEUTICALS INC.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
59746-171_a8972d19-5cd5-441c-a552-048116a069e8	59746-171	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20050606		ANDA	ANDA040611	JUBILANT CADISTA PHARMACEUTICALS INC.	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-172_8f8e4122-8f0a-4020-8389-73d3e195a14f	59746-172	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	JUBILANT CADISTA PHARMACEUTICALS INC.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-173_8f8e4122-8f0a-4020-8389-73d3e195a14f	59746-173	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	JUBILANT CADISTA PHARMACEUTICALS INC.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-175_8f8e4122-8f0a-4020-8389-73d3e195a14f	59746-175	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	JUBILANT CADISTA PHARMACEUTICALS INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-177_cad3a28c-244f-42be-83f3-89f8ad45482d	59746-177	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20060404		ANDA	ANDA077563	Jubilant Cadista Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59746-211_cad3a28c-244f-42be-83f3-89f8ad45482d	59746-211	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20060404		ANDA	ANDA077563	Jubilant Cadista Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59746-216_38b9eb6b-2df6-4a73-8220-c13a7ab1908e	59746-216	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Jubilant Cadista Pharmaceuticals Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59746-217_38b9eb6b-2df6-4a73-8220-c13a7ab1908e	59746-217	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Jubilant Cadista Pharmaceuticals Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59746-218_38b9eb6b-2df6-4a73-8220-c13a7ab1908e	59746-218	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Jubilant Cadista Pharmaceuticals Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59746-245_1b6d2994-08fa-45c3-8dec-a206fe163f5e	59746-245	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA079132	JUBILANT CADISTA PHARMACEUTICALS INC.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
59746-246_1b6d2994-08fa-45c3-8dec-a206fe163f5e	59746-246	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA079132	JUBILANT CADISTA PHARMACEUTICALS INC.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
59746-247_1b6d2994-08fa-45c3-8dec-a206fe163f5e	59746-247	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA079132	JUBILANT CADISTA PHARMACEUTICALS INC.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
59746-248_1b6d2994-08fa-45c3-8dec-a206fe163f5e	59746-248	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA079132	JUBILANT CADISTA PHARMACEUTICALS INC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
59746-279_bd1bbdbe-e0cf-48d5-9526-b3f4c330be7e	59746-279	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA202280	Jubilant Cadista Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
59746-280_bd1bbdbe-e0cf-48d5-9526-b3f4c330be7e	59746-280	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20231201		ANDA	ANDA202280	Jubilant Cadista Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
59746-281_bd1bbdbe-e0cf-48d5-9526-b3f4c330be7e	59746-281	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA202280	Jubilant Cadista Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
59746-284_2efbec5f-dcdb-4b75-91e7-45d34a40569b	59746-284	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110901		ANDA	ANDA090901	Jubilant Cadista Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59746-324_40211dd2-c21e-45a4-a8d4-04febf925f52	59746-324	HUMAN PRESCRIPTION DRUG	valacyclovir hydrochloride		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	20120405		ANDA	ANDA201506	Jubilant Cadista Pharmaceuticals Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
59746-325_40211dd2-c21e-45a4-a8d4-04febf925f52	59746-325	HUMAN PRESCRIPTION DRUG	valacyclovir hydrochloride		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	20120405		ANDA	ANDA201506	Jubilant Cadista Pharmaceuticals Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
59746-333_a4fc53e2-2556-4fcc-b6fb-32a256a2c3f7	59746-333	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 25 mg		losartan potassium	TABLET	ORAL	20120918		ANDA	ANDA201170	Jubilant Cadista Pharmaceuticals Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-334_a4fc53e2-2556-4fcc-b6fb-32a256a2c3f7	59746-334	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 50 mg		losartan potassium	TABLET	ORAL	20120918		ANDA	ANDA201170	Jubilant Cadista Pharmaceuticals Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-335_a4fc53e2-2556-4fcc-b6fb-32a256a2c3f7	59746-335	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 100 mg		losartan potassium	TABLET	ORAL	20120918		ANDA	ANDA201170	Jubilant Cadista Pharmaceuticals Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-337_39170a18-cec0-466f-9cc1-ed4aed89c1e0	59746-337	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	JUBILANT CADISTA PHARMACEUTICALS INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59746-338_39170a18-cec0-466f-9cc1-ed4aed89c1e0	59746-338	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	JUBILANT CADISTA PHARMACEUTICALS INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59746-339_39170a18-cec0-466f-9cc1-ed4aed89c1e0	59746-339	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	JUBILANT CADISTA PHARMACEUTICALS INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59746-360_19dac7b6-bb3f-43a9-b64e-2126d4bff9c1	59746-360	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	Jubilant Cadista Pharmaceuticals Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-361_19dac7b6-bb3f-43a9-b64e-2126d4bff9c1	59746-361	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	Jubilant Cadista Pharmaceuticals Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-362_19dac7b6-bb3f-43a9-b64e-2126d4bff9c1	59746-362	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	Jubilant Cadista Pharmaceuticals Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-363_19dac7b6-bb3f-43a9-b64e-2126d4bff9c1	59746-363	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	Jubilant Cadista Pharmaceuticals Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-382_69ecf531-05af-4750-a9df-fec6ee7e3a8a	59746-382	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE, GELATIN COATED	ORAL	20080211		ANDA	ANDA078391	JUBILANT CADISTA PHARMACEUTICALS INC.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59746-383_f5ff6fc2-dd2d-4f3b-8e05-ec0e952f0f21	59746-383	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Jubilant Cadista Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59746-384_f5ff6fc2-dd2d-4f3b-8e05-ec0e952f0f21	59746-384	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Jubilant Cadista Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59746-385_f5ff6fc2-dd2d-4f3b-8e05-ec0e952f0f21	59746-385	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Jubilant Cadista Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59746-386_f5ff6fc2-dd2d-4f3b-8e05-ec0e952f0f21	59746-386	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Jubilant Cadista Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59746-447_88691191-8b85-44f3-b802-e170d776ad87	59746-447	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20150224		ANDA	ANDA203534	Jubilant Cadista Pharmaceuticals Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-448_88691191-8b85-44f3-b802-e170d776ad87	59746-448	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20150224		ANDA	ANDA203534	Jubilant Cadista Pharmaceuticals Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-449_88691191-8b85-44f3-b802-e170d776ad87	59746-449	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20150224		ANDA	ANDA203534	Jubilant Cadista Pharmaceuticals Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
59746-700_71faef93-5aa0-4d3b-a039-adf3bc8967c1	59746-700	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215483	JUBILANT CADISTA PHARMACEUTICALS INC.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-701_71faef93-5aa0-4d3b-a039-adf3bc8967c1	59746-701	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215483	JUBILANT CADISTA PHARMACEUTICALS INC.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-702_71faef93-5aa0-4d3b-a039-adf3bc8967c1	59746-702	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215483	JUBILANT CADISTA PHARMACEUTICALS INC.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-703_71faef93-5aa0-4d3b-a039-adf3bc8967c1	59746-703	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215483	JUBILANT CADISTA PHARMACEUTICALS INC.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-704_71faef93-5aa0-4d3b-a039-adf3bc8967c1	59746-704	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215483	JUBILANT CADISTA PHARMACEUTICALS INC.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-710_e9402f3a-49dc-49d9-8ddf-cd940bfb28a8	59746-710	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine HCl	CAPSULE	ORAL	20191201		ANDA	ANDA212218	JUBILANT CADISTA PHARMACEUTICALS INC.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-711_e9402f3a-49dc-49d9-8ddf-cd940bfb28a8	59746-711	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine HCl	CAPSULE	ORAL	20191201		ANDA	ANDA212218	JUBILANT CADISTA PHARMACEUTICALS INC.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-712_e9402f3a-49dc-49d9-8ddf-cd940bfb28a8	59746-712	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine HCl	CAPSULE	ORAL	20191201		ANDA	ANDA212218	JUBILANT CADISTA PHARMACEUTICALS INC.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
59746-735_cad3a28c-244f-42be-83f3-89f8ad45482d	59746-735	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20171009		ANDA	ANDA077563	Jubilant Cadista Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
59746-760_51e6a425-96fd-4941-8c4d-4ba8c5dfb762	59746-760	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		Chlorthalidone	TABLET	ORAL	20210331		ANDA	ANDA211320	JUBILANT CADISTA PHARMACEUTICALS,INC.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
59746-761_51e6a425-96fd-4941-8c4d-4ba8c5dfb762	59746-761	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		Chlorthalidone	TABLET	ORAL	20210331		ANDA	ANDA211320	JUBILANT CADISTA PHARMACEUTICALS,INC.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
59746-762_fe288eb7-1d33-1783-e053-6394a90aee8f	59746-762	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20220222		ANDA	ANDA211013	Jubilant Cadista Pharmaceuticals Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
59746-781_9a3f825d-2817-439c-a5fa-3290e0c6d808	59746-781	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20230930		ANDA	ANDA217840	JUBILANT CADISTA PHARMACEUTICALS INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
59746-782_8f8e4122-8f0a-4020-8389-73d3e195a14f	59746-782	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20220601		ANDA	ANDA040362	JUBILANT CADISTA PHARMACEUTICALS INC.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-783_8f8e4122-8f0a-4020-8389-73d3e195a14f	59746-783	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20220601		ANDA	ANDA040362	JUBILANT CADISTA PHARMACEUTICALS INC.	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59746-789_0cf065ec-f920-4361-e063-6294a90a14ae	59746-789	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20220820		ANDA	ANDA216594	Jubilant Cadista Pharmaceuticals Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
59746-790_0cf065ec-f920-4361-e063-6294a90a14ae	59746-790	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20220820		ANDA	ANDA216594	Jubilant Cadista Pharmaceuticals Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
59746-791_0cf065ec-f920-4361-e063-6294a90a14ae	59746-791	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20220820		ANDA	ANDA216594	Jubilant Cadista Pharmaceuticals Inc.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
59762-0016_e2115f5c-d0e8-4d80-9632-e8a13a341c4e	59762-0016	HUMAN PRESCRIPTION DRUG	clindamycin palmitate hydrochloride		clindamycin palmitate hydrochloride	SOLUTION	ORAL	19860407		ANDA	ANDA062644	Greenstone LLC	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
59762-0028_cf4a35ba-0266-4b37-99a4-2c855c519cb1	59762-0028	HUMAN PRESCRIPTION DRUG	Diclofenac sodium and Misoprostol		Diclofenac sodium and Misoprostol	TABLET, FILM COATED	ORAL	20121101		NDA AUTHORIZED GENERIC	NDA020607	Greenstone LLC	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
59762-0029_cf4a35ba-0266-4b37-99a4-2c855c519cb1	59762-0029	HUMAN PRESCRIPTION DRUG	Diclofenac sodium and Misoprostol		Diclofenac sodium and Misoprostol	TABLET, FILM COATED	ORAL	20121101		NDA AUTHORIZED GENERIC	NDA020607	Greenstone LLC	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
59762-0033_88636f2a-c14f-4082-b71d-0493ac9db772	59762-0033	HUMAN PRESCRIPTION DRUG	Sildenafil		sildenafil	TABLET, FILM COATED	ORAL	20120927	20260731	NDA AUTHORIZED GENERIC	NDA021845	Greenstone LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
59762-0034_5fffb31a-af32-4514-95e7-7ff2fa9708ce	59762-0034	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		sildenafil citrate	TABLET, FILM COATED	ORAL	20171201		NDA AUTHORIZED GENERIC	NDA020895	Greenstone LLC	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
59762-0035_5fffb31a-af32-4514-95e7-7ff2fa9708ce	59762-0035	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		sildenafil citrate	TABLET, FILM COATED	ORAL	20171201		NDA AUTHORIZED GENERIC	NDA020895	Greenstone LLC	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
59762-0036_5fffb31a-af32-4514-95e7-7ff2fa9708ce	59762-0036	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		sildenafil citrate	TABLET, FILM COATED	ORAL	20171201		NDA AUTHORIZED GENERIC	NDA020895	Greenstone LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
59762-0047_54db46da-89c1-477f-b2c0-4782c685a690	59762-0047	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate Extended Release		tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20160122		NDA AUTHORIZED GENERIC	NDA021228	Greenstone LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
59762-0048_54db46da-89c1-477f-b2c0-4782c685a690	59762-0048	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate Extended Release		tolterodine tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20141230		NDA AUTHORIZED GENERIC	NDA021228	Greenstone LLC	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
59762-0049_36aa0fde-f192-4963-a581-49df3e5295f4	59762-0049	HUMAN PRESCRIPTION DRUG	Methylprednisolone		methylprednisolone	TABLET	ORAL	20130325		NDA AUTHORIZED GENERIC	NDA011153	Greenstone LLC	METHYLPREDNISOLONE	8	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59762-0050_36aa0fde-f192-4963-a581-49df3e5295f4	59762-0050	HUMAN PRESCRIPTION DRUG	Methylprednisolone		methylprednisolone	TABLET	ORAL	20130325		NDA AUTHORIZED GENERIC	NDA011153	Greenstone LLC	METHYLPREDNISOLONE	16	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59762-0051_36aa0fde-f192-4963-a581-49df3e5295f4	59762-0051	HUMAN PRESCRIPTION DRUG	Methylprednisolone		methylprednisolone	TABLET	ORAL	20130325		NDA AUTHORIZED GENERIC	NDA011153	Greenstone LLC	METHYLPREDNISOLONE	32	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59762-0055_0c8b7958-a09e-458d-a10d-67cedde6c205	59762-0055	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	TABLET	ORAL	20180819		NDA AUTHORIZED GENERIC	NDA011839	Greenstone LLC	MEDROXYPROGESTERONE ACETATE	2.5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59762-0056_0c8b7958-a09e-458d-a10d-67cedde6c205	59762-0056	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	TABLET	ORAL	19590603		NDA AUTHORIZED GENERIC	NDA011839	Greenstone LLC	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59762-0057_05d6a5d1-b761-4ef7-b24b-49b3144578c5	59762-0057	HUMAN PRESCRIPTION DRUG	Alprazolam	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA AUTHORIZED GENERIC	NDA021434	Greenstone LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-0058_0c8b7958-a09e-458d-a10d-67cedde6c205	59762-0058	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	TABLET	ORAL	20180820		NDA AUTHORIZED GENERIC	NDA011839	Greenstone LLC	MEDROXYPROGESTERONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59762-0059_05d6a5d1-b761-4ef7-b24b-49b3144578c5	59762-0059	HUMAN PRESCRIPTION DRUG	Alprazolam	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA AUTHORIZED GENERIC	NDA021434	Greenstone LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-0066_05d6a5d1-b761-4ef7-b24b-49b3144578c5	59762-0066	HUMAN PRESCRIPTION DRUG	Alprazolam	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA AUTHORIZED GENERIC	NDA021434	Greenstone LLC	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-0067_3a1b63cb-9b02-4749-a9af-31810f34aff9	59762-0067	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	SOLUTION, CONCENTRATE	ORAL	20180515		NDA AUTHORIZED GENERIC	NDA020990	Greenstone LLC	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
59762-0068_05d6a5d1-b761-4ef7-b24b-49b3144578c5	59762-0068	HUMAN PRESCRIPTION DRUG	Alprazolam	XR	alprazolam	TABLET, EXTENDED RELEASE	ORAL	20030117		NDA AUTHORIZED GENERIC	NDA021434	Greenstone LLC	ALPRAZOLAM	3	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-0073_fee2d4d5-f4d1-4e9b-a895-c50147e18157	59762-0073	HUMAN PRESCRIPTION DRUG	Hydrocortisone		hydrocortisone	TABLET	ORAL	20130220		NDA AUTHORIZED GENERIC	NDA008697	Greenstone LLC	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59762-0074_fee2d4d5-f4d1-4e9b-a895-c50147e18157	59762-0074	HUMAN PRESCRIPTION DRUG	Hydrocortisone		hydrocortisone	TABLET	ORAL	20130220		NDA AUTHORIZED GENERIC	NDA008697	Greenstone LLC	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59762-0075_fee2d4d5-f4d1-4e9b-a895-c50147e18157	59762-0075	HUMAN PRESCRIPTION DRUG	Hydrocortisone		hydrocortisone	TABLET	ORAL	20130220		NDA AUTHORIZED GENERIC	NDA008697	Greenstone LLC	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59762-0104_7b3ff1b5-4283-4f8f-ba00-bfa61ad247f0	59762-0104	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET, DELAYED RELEASE	ORAL	20050505		NDA AUTHORIZED GENERIC	NDA007073	Greenstone LLC	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
59762-0117_c3d5de78-0345-4b06-9adc-61923c4ea43d	59762-0117	HUMAN PRESCRIPTION DRUG	MESALAMINE		MESALAMINE	CAPSULE, DELAYED RELEASE	ORAL	20190510		NDA AUTHORIZED GENERIC	NDA204412	Greenstone LLC	MESALAMINE	400	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
59762-0118_ab9f428f-63b5-4a31-9fba-83006da5d1ca	59762-0118	HUMAN PRESCRIPTION DRUG	Mesalamine		mesalamine	SUPPOSITORY	RECTAL	20181207		NDA AUTHORIZED GENERIC	NDA021252	Greenstone LLC	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
59762-0119_6b44fc9c-896a-4247-9aa2-a032601e7388	59762-0119	HUMAN PRESCRIPTION DRUG	phenelzine sulfate		Phenelzine Sulfate	TABLET, FILM COATED	ORAL	20110323		NDA AUTHORIZED GENERIC	NDA011909	Greenstone LLC	PHENELZINE SULFATE	15	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
59762-0131_ba126bd6-1248-4772-b387-94d046a05085	59762-0131	HUMAN PRESCRIPTION DRUG	SILVER SULFADIAZINE		silver sulfadiazine	CREAM	TOPICAL	20180115		NDA AUTHORIZED GENERIC	NDA017381	Greenstone LLC	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
59762-0140_b9180abb-8377-462a-bb71-35670419d796	59762-0140	HUMAN PRESCRIPTION DRUG	Piroxicam		piroxicam	CAPSULE	ORAL	20140303		NDA AUTHORIZED GENERIC	NDA018147	Greenstone LLC	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59762-0145_b9180abb-8377-462a-bb71-35670419d796	59762-0145	HUMAN PRESCRIPTION DRUG	Piroxicam		piroxicam	CAPSULE	ORAL	20140303		NDA AUTHORIZED GENERIC	NDA018147	Greenstone LLC	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59762-0170_d6623422-e8aa-4aae-bed3-62b47a05c636	59762-0170	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20140121		NDA AUTHORIZED GENERIC	NDA020771	Greenstone LLC	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
59762-0220_46a33cf7-f5c5-4afb-b464-27a36773fe52	59762-0220	HUMAN PRESCRIPTION DRUG	quinapril hydrochloride and hydrochlorothiazide		quinapril hydrochloride and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19991228		NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59762-0222_46a33cf7-f5c5-4afb-b464-27a36773fe52	59762-0222	HUMAN PRESCRIPTION DRUG	quinapril hydrochloride and hydrochlorothiazide		quinapril hydrochloride and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19991228		NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59762-0223_46a33cf7-f5c5-4afb-b464-27a36773fe52	59762-0223	HUMAN PRESCRIPTION DRUG	quinapril hydrochloride and hydrochlorothiazide		quinapril hydrochloride and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19991228		NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59762-0260_75686c8b-ed8a-4665-a6e2-635e1ca17159	59762-0260	HUMAN PRESCRIPTION DRUG	Colestipol Hydrochloride		Colestipol Hydrochloride	GRANULE, FOR SUSPENSION	ORAL	19770404		NDA AUTHORIZED GENERIC	NDA017563	Greenstone LLC	COLESTIPOL HYDROCHLORIDE	5	g/5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
59762-0333_6adbddea-8360-49c1-a2e7-793dbeb92417	59762-0333	HUMAN PRESCRIPTION DRUG	Latanoprost		Latanoprost	SOLUTION	OPHTHALMIC	20101115		NDA AUTHORIZED GENERIC	NDA020597	Greenstone LLC	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
59762-0386_e60f5321-1303-4e5e-bfde-1e55bcdbd712	59762-0386	HUMAN PRESCRIPTION DRUG	Disopyramide Phosphate		disopyramide phosphate	CAPSULE, GELATIN COATED	ORAL	20190423		NDA AUTHORIZED GENERIC	NDA017447	Greenstone LLC	DISOPYRAMIDE PHOSPHATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
59762-0400_e60f5321-1303-4e5e-bfde-1e55bcdbd712	59762-0400	HUMAN PRESCRIPTION DRUG	Disopyramide Phosphate		disopyramide phosphate	CAPSULE, GELATIN COATED	ORAL	20190423		NDA AUTHORIZED GENERIC	NDA017447	Greenstone LLC	DISOPYRAMIDE PHOSPHATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
59762-0401_5c4d360b-19a9-4288-aa1e-631cfe48d8a6	59762-0401	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20170925		NDA AUTHORIZED GENERIC	NDA018333	Greenstone LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
59762-0405_46438c0a-27ea-4772-95b8-8f178d73278f	59762-0405	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20020517		NDA AUTHORIZED GENERIC	NDA020835	Greenstone LLC	RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE	30.1; 4.9	mg/1; mg/1	Bisphosphonate [EPC], Bisphosphonate [EPC], Diphosphonates [CS], Diphosphonates [CS]		N	20241231
59762-0406_46438c0a-27ea-4772-95b8-8f178d73278f	59762-0406	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20080422		NDA AUTHORIZED GENERIC	NDA020835	Greenstone LLC	RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE	129; 21	mg/1; mg/1	Bisphosphonate [EPC], Bisphosphonate [EPC], Diphosphonates [CS], Diphosphonates [CS]		N	20241231
59762-0407_66f7f167-ae4f-4e79-a8bb-6a5b710748e4	59762-0407	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		risedronate sodium	TABLET, DELAYED RELEASE	ORAL	20180302		NDA AUTHORIZED GENERIC	NDA022560	Greenstone LLC	RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE	30.1; 4.9	mg/1; mg/1	Bisphosphonate [EPC], Bisphosphonate [EPC], Diphosphonates [CS], Diphosphonates [CS]		N	20241231
59762-0450_6c649a52-e86b-4a36-8de4-143297ab0bfa	59762-0450	HUMAN PRESCRIPTION DRUG	Colestipol Hydrochloride		Colestipol Hydrochloride	TABLET	ORAL	19940719		NDA AUTHORIZED GENERIC	NDA020222	Greenstone LLC	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
59762-0489_b666655d-d14b-4758-9a65-ef34d028e1a5	59762-0489	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		nitroglycerin	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20160826		NDA AUTHORIZED GENERIC	NDA021134	Greenstone LLC	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59762-0531_7c5003a4-991e-4555-8786-6c7b3e574c44	59762-0531	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20121009		NDA AUTHORIZED GENERIC	NDA008762	Greenstone LLC	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
59762-0540_2b8b8b6b-c447-47ae-8e63-b8ff8c1f092c	59762-0540	HUMAN PRESCRIPTION DRUG	Glipizide	XL	glipizide	TABLET, EXTENDED RELEASE	ORAL	20130529		NDA AUTHORIZED GENERIC	NDA020329	Greenstone LLC	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
59762-0541_2b8b8b6b-c447-47ae-8e63-b8ff8c1f092c	59762-0541	HUMAN PRESCRIPTION DRUG	Glipizide	XL	glipizide	TABLET, EXTENDED RELEASE	ORAL	20130529		NDA AUTHORIZED GENERIC	NDA020329	Greenstone LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
59762-0542_2b8b8b6b-c447-47ae-8e63-b8ff8c1f092c	59762-0542	HUMAN PRESCRIPTION DRUG	Glipizide	XL	glipizide	TABLET, EXTENDED RELEASE	ORAL	20130529		NDA AUTHORIZED GENERIC	NDA020329	Greenstone LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
59762-0707_f6f4138a-351e-a1dc-e053-6394a90ad79a	59762-0707	HUMAN PRESCRIPTION DRUG	diclofenac epolamine		Diclofenac Epolamine	SYSTEM	TOPICAL	20200102	20250131	NDA AUTHORIZED GENERIC	NDA021234	Greenstone LLC	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59762-0800_d6623422-e8aa-4aae-bed3-62b47a05c636	59762-0800	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20140121		NDA AUTHORIZED GENERIC	NDA020771	Greenstone LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
59762-0934_bcd954c5-e00b-4c27-b0b8-868f1bb32ceb	59762-0934	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20171215		NDA AUTHORIZED GENERIC	NDA021266	Greenstone LLC	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-0935_bcd954c5-e00b-4c27-b0b8-868f1bb32ceb	59762-0935	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	POWDER, FOR SUSPENSION	ORAL	20131216		NDA AUTHORIZED GENERIC	NDA021630	Greenstone LLC	VORICONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-0936_bcd954c5-e00b-4c27-b0b8-868f1bb32ceb	59762-0936	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20180605		NDA AUTHORIZED GENERIC	NDA021266	Greenstone LLC	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-1001_b7ea5d5d-e82c-413d-a729-3657fa8b1a90	59762-1001	HUMAN PRESCRIPTION DRUG	Sirolimus		SIROLIMUS	TABLET, SUGAR COATED	ORAL	20140107		NDA AUTHORIZED GENERIC	NDA021110	Greenstone LLC	SIROLIMUS	.5	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
59762-1002_b7ea5d5d-e82c-413d-a729-3657fa8b1a90	59762-1002	HUMAN PRESCRIPTION DRUG	Sirolimus		SIROLIMUS	TABLET, SUGAR COATED	ORAL	20141027		NDA AUTHORIZED GENERIC	NDA021110	Greenstone LLC	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
59762-1003_b7ea5d5d-e82c-413d-a729-3657fa8b1a90	59762-1003	HUMAN PRESCRIPTION DRUG	Sirolimus		SIROLIMUS	TABLET, SUGAR COATED	ORAL	20141027		NDA AUTHORIZED GENERIC	NDA021110	Greenstone LLC	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
59762-1004_9e2ef788-bc3f-48df-80c3-8e4c8864b85e	59762-1004	HUMAN PRESCRIPTION DRUG	nifedipine		nifedipine	CAPSULE	ORAL	20130325		NDA AUTHORIZED GENERIC	NDA018482	Greenstone LLC	NIFEDIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
59762-1005_fde5cfe8-549f-4b73-ba75-b621b6310eaf	59762-1005	HUMAN PRESCRIPTION DRUG	Cabergoline		cabergoline	TABLET	ORAL	20140922		NDA AUTHORIZED GENERIC	NDA020664	Greenstone LLC	CABERGOLINE	.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
59762-1006_b7c541bb-0864-480d-b9a4-660a7d6c1f9b	59762-1006	HUMAN PRESCRIPTION DRUG	Ziprasidone		ziprasidone	CAPSULE	ORAL	20211103	20260131	NDA AUTHORIZED GENERIC	NDA020825	Greenstone LLC	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	
59762-1008_b7c541bb-0864-480d-b9a4-660a7d6c1f9b	59762-1008	HUMAN PRESCRIPTION DRUG	Ziprasidone		ziprasidone	CAPSULE	ORAL	20230531	20250930	NDA AUTHORIZED GENERIC	NDA020825	Greenstone LLC	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	
59762-1012_b7c541bb-0864-480d-b9a4-660a7d6c1f9b	59762-1012	HUMAN PRESCRIPTION DRUG	Ziprasidone		ziprasidone	CAPSULE	ORAL	20230531	20250930	NDA AUTHORIZED GENERIC	NDA020825	Greenstone LLC	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	
59762-1014_b7c541bb-0864-480d-b9a4-660a7d6c1f9b	59762-1014	HUMAN PRESCRIPTION DRUG	Ziprasidone		ziprasidone	CAPSULE	ORAL	20230531	20250930	NDA AUTHORIZED GENERIC	NDA020825	Greenstone LLC	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	
59762-1061_05102a98-c4a7-49b3-9626-41dacb5ecbfe	59762-1061	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20120807		NDA AUTHORIZED GENERIC	NDA012462	Greenstone LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
59762-1091_46223fd4-2904-47f1-a3fd-865ab495394d	59762-1091	HUMAN PRESCRIPTION DRUG	Asenapine		asenapine maleate	TABLET	SUBLINGUAL	20200501		NDA AUTHORIZED GENERIC	NDA022117	Greenstone LLC	ASENAPINE MALEATE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59762-1205_236b686f-30fa-4114-9a59-63aa2582a80d	59762-1205	HUMAN PRESCRIPTION DRUG	Sirolimus		sirolimus	SOLUTION	ORAL	20190722		NDA AUTHORIZED GENERIC	NDA021083	Greenstone LLC	SIROLIMUS	1	mg/mL	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
59762-1206_c5a9326e-d241-478d-9673-666faa4a0fc6	59762-1206	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		liothyronine sodium	TABLET	ORAL	20190206		NDA AUTHORIZED GENERIC	NDA010379	Greenstone LLC	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
59762-1207_c5a9326e-d241-478d-9673-666faa4a0fc6	59762-1207	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		liothyronine sodium	TABLET	ORAL	20190624		NDA AUTHORIZED GENERIC	NDA010379	Greenstone LLC	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
59762-1208_c5a9326e-d241-478d-9673-666faa4a0fc6	59762-1208	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		liothyronine sodium	TABLET	ORAL	20190624		NDA AUTHORIZED GENERIC	NDA010379	Greenstone LLC	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
59762-1210_75ecd77b-67b2-40eb-83da-d7c7ae3db412	59762-1210	HUMAN PRESCRIPTION DRUG	Desvenlafaxine Succinate		desvenlafaxine succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		NDA AUTHORIZED GENERIC	NDA021992	Greenstone LLC	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
59762-1211_75ecd77b-67b2-40eb-83da-d7c7ae3db412	59762-1211	HUMAN PRESCRIPTION DRUG	Desvenlafaxine Succinate		desvenlafaxine succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		NDA AUTHORIZED GENERIC	NDA021992	Greenstone LLC	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
59762-1222_75ecd77b-67b2-40eb-83da-d7c7ae3db412	59762-1222	HUMAN PRESCRIPTION DRUG	Desvenlafaxine Succinate		desvenlafaxine succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		NDA AUTHORIZED GENERIC	NDA021992	Greenstone LLC	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
59762-1307_1b3d891d-8efc-4273-b580-0a75c79a7e57	59762-1307	HUMAN PRESCRIPTION DRUG	Linezolid		linezolid	TABLET, FILM COATED	ORAL	20151012		NDA AUTHORIZED GENERIC	NDA021130	Greenstone LLC	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
59762-1308_eb2638f8-973d-4495-84ea-37e4a7553d86	59762-1308	HUMAN PRESCRIPTION DRUG	Linezolid		linezolid	SUSPENSION	ORAL	20150518		NDA AUTHORIZED GENERIC	NDA021132	Greenstone LLC	LINEZOLID	100	mg/5mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
59762-1342_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1342	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20251130	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	25	mg/1		CV	N	
59762-1344_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1344	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20251031	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	50	mg/1		CV	N	
59762-1346_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1346	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20250430	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	75	mg/1		CV	N	
59762-1348_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1348	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20250831	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	100	mg/1		CV	N	
59762-1350_75d0a783-da69-408a-98a0-473c4c25fa5c	59762-1350	HUMAN PRESCRIPTION DRUG	Rifabutin		rifabutin	CAPSULE	ORAL	20140407		NDA AUTHORIZED GENERIC	NDA050689	Greenstone LLC	RIFABUTIN	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
59762-1351_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1351	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20250930	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	150	mg/1		CV	N	
59762-1354_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1354	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20250531	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	200	mg/1		CV	N	
59762-1360_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1360	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20240531	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	225	mg/1		CV	N	
59762-1364_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1364	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20250831	NDA AUTHORIZED GENERIC	NDA021446	Greenstone LLC	PREGABALIN	300	mg/1		CV	N	
59762-1515_9abcea86-3b63-4e25-be0a-f689fdaea3a2	59762-1515	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210	20240831	NDA AUTHORIZED GENERIC	NDA020998	Greenstone LLC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59762-1516_9abcea86-3b63-4e25-be0a-f689fdaea3a2	59762-1516	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210	20251231	NDA AUTHORIZED GENERIC	NDA020998	Greenstone LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59762-1517_9abcea86-3b63-4e25-be0a-f689fdaea3a2	59762-1517	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210	20250831	NDA AUTHORIZED GENERIC	NDA020998	Greenstone LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59762-1518_9abcea86-3b63-4e25-be0a-f689fdaea3a2	59762-1518	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210	20240831	NDA AUTHORIZED GENERIC	NDA020998	Greenstone LLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
59762-1576_de58ee06-bf58-47f0-a2ae-e4bae6888889	59762-1576	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	SOLUTION	ORAL	20190729		NDA AUTHORIZED GENERIC	NDA022488	Greenstone LLC	PREGABALIN	20	mg/mL		CV	N	20241231
59762-1710_3147e815-4286-4ff6-be95-98bbeb51a8b9	59762-1710	HUMAN PRESCRIPTION DRUG	Eplerenone		eplerenone	TABLET, FILM COATED	ORAL	20020927		NDA AUTHORIZED GENERIC	NDA021437	Greenstone LLC	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59762-1720_3147e815-4286-4ff6-be95-98bbeb51a8b9	59762-1720	HUMAN PRESCRIPTION DRUG	Eplerenone		eplerenone	TABLET, FILM COATED	ORAL	20020927		NDA AUTHORIZED GENERIC	NDA021437	Greenstone LLC	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
59762-2002_b7c541bb-0864-480d-b9a4-660a7d6c1f9b	59762-2002	HUMAN PRESCRIPTION DRUG	Ziprasidone		ziprasidone hydrochloride	CAPSULE	ORAL	20010205	20240531	NDA AUTHORIZED GENERIC	NDA020825	Greenstone LLC	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	
59762-2003_b7c541bb-0864-480d-b9a4-660a7d6c1f9b	59762-2003	HUMAN PRESCRIPTION DRUG	Ziprasidone		ziprasidone hydrochloride	CAPSULE	ORAL	20010205	20240531	NDA AUTHORIZED GENERIC	NDA020825	Greenstone LLC	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	
59762-2004_b7c541bb-0864-480d-b9a4-660a7d6c1f9b	59762-2004	HUMAN PRESCRIPTION DRUG	Ziprasidone		ziprasidone hydrochloride	CAPSULE	ORAL	20010205	20240430	NDA AUTHORIZED GENERIC	NDA020825	Greenstone LLC	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	
59762-2010_509c2375-720b-4d55-b37b-74bbc511b930	59762-2010	HUMAN PRESCRIPTION DRUG	amlodipine besylate		amlodipine besylate	TABLET	ORAL	20190624		NDA AUTHORIZED GENERIC	NDA019787	Greenstone LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
59762-2012_46223fd4-2904-47f1-a3fd-865ab495394d	59762-2012	HUMAN PRESCRIPTION DRUG	Asenapine		asenapine maleate	TABLET	SUBLINGUAL	20200501		NDA AUTHORIZED GENERIC	NDA022117	Greenstone LLC	ASENAPINE MALEATE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59762-2058_88636f2a-c14f-4082-b71d-0493ac9db772	59762-2058	HUMAN PRESCRIPTION DRUG	Sildenafil		sildenafil	POWDER, FOR SUSPENSION	ORAL	20190911	20240930	NDA AUTHORIZED GENERIC	NDA203109	Greenstone LLC	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
59762-2135_509c2375-720b-4d55-b37b-74bbc511b930	59762-2135	HUMAN PRESCRIPTION DRUG	amlodipine besylate		amlodipine besylate	TABLET	ORAL	20190624		NDA AUTHORIZED GENERIC	NDA019787	Greenstone LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
59762-2198_43791da6-4e96-4aef-9afe-4ee047f5e7e1	59762-2198	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	TABLET, FILM COATED	ORAL	20190513		NDA AUTHORIZED GENERIC	NDA050711	Greenstone LLC	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59762-2242_509c2375-720b-4d55-b37b-74bbc511b930	59762-2242	HUMAN PRESCRIPTION DRUG	amlodipine besylate		amlodipine besylate	TABLET	ORAL	20190624		NDA AUTHORIZED GENERIC	NDA019787	Greenstone LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
59762-2250_2cdff9b3-e3df-4428-83ce-c72022e174e7	59762-2250	HUMAN PRESCRIPTION DRUG	Ethosuximide		Ethosuximide	CAPSULE	ORAL	20151012		NDA AUTHORIZED GENERIC	NDA012380	Greenstone LLC	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
59762-2321_b0a8457a-1f2b-49cc-83e3-20a10096458f	59762-2321	HUMAN PRESCRIPTION DRUG	Eletriptan		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170724	20240131	NDA AUTHORIZED GENERIC	NDA021016	Greenstone LLC	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	
59762-2322_b0a8457a-1f2b-49cc-83e3-20a10096458f	59762-2322	HUMAN PRESCRIPTION DRUG	Eletriptan		eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170724	20240331	NDA AUTHORIZED GENERIC	NDA021016	Greenstone LLC	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	
59762-2350_2646752a-b2e8-4167-bf80-6ed8fa869917	59762-2350	HUMAN PRESCRIPTION DRUG	Ethosuximide		Ethosuximide	SOLUTION	ORAL	20200221		ANDA	ANDA080258	Greenstone LLC	ETHOSUXIMIDE	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
59762-2410_c9c2403b-beac-4968-9761-e737f20a8f41	59762-2410	HUMAN PRESCRIPTION DRUG	Doxazosin		doxazosin	TABLET	ORAL	20211103		NDA AUTHORIZED GENERIC	NDA019668	Greenstone LLC	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59762-2420_c9c2403b-beac-4968-9761-e737f20a8f41	59762-2420	HUMAN PRESCRIPTION DRUG	Doxazosin		doxazosin	TABLET	ORAL	20211019		NDA AUTHORIZED GENERIC	NDA019668	Greenstone LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59762-2440_c9c2403b-beac-4968-9761-e737f20a8f41	59762-2440	HUMAN PRESCRIPTION DRUG	Doxazosin		doxazosin	TABLET	ORAL	20230118		NDA AUTHORIZED GENERIC	NDA019668	Greenstone LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59762-2480_c9c2403b-beac-4968-9761-e737f20a8f41	59762-2480	HUMAN PRESCRIPTION DRUG	Doxazosin		doxazosin	TABLET	ORAL	20211019		NDA AUTHORIZED GENERIC	NDA019668	Greenstone LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59762-2858_6daee0f1-af87-43f8-8fed-b63560d087a1	59762-2858	HUMAN PRESCRIPTION DRUG	EXEMESTANE		Exemestane	TABLET, SUGAR COATED	ORAL	20110401		NDA AUTHORIZED GENERIC	NDA020753	Greenstone LLC	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
59762-2888_46223fd4-2904-47f1-a3fd-865ab495394d	59762-2888	HUMAN PRESCRIPTION DRUG	Asenapine		asenapine maleate	TABLET	SUBLINGUAL	20200501		NDA AUTHORIZED GENERIC	NDA022117	Greenstone LLC	ASENAPINE MALEATE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
59762-3051_68dc46fd-76e7-4019-a29f-f0d4b4aa7c7f	59762-3051	HUMAN PRESCRIPTION DRUG	azithromycin		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	19990212		NDA AUTHORIZED GENERIC	NDA050693	Greenstone LLC	AZITHROMYCIN DIHYDRATE	1	g/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59762-3110_43791da6-4e96-4aef-9afe-4ee047f5e7e1	59762-3110	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	POWDER, FOR SUSPENSION	ORAL	19951019		NDA AUTHORIZED GENERIC	NDA050710	Greenstone LLC	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59762-3120_43791da6-4e96-4aef-9afe-4ee047f5e7e1	59762-3120	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	POWDER, FOR SUSPENSION	ORAL	19951019		NDA AUTHORIZED GENERIC	NDA050710	Greenstone LLC	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59762-3130_43791da6-4e96-4aef-9afe-4ee047f5e7e1	59762-3130	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	POWDER, FOR SUSPENSION	ORAL	19951019		NDA AUTHORIZED GENERIC	NDA050710	Greenstone LLC	AZITHROMYCIN DIHYDRATE	900	mg/22.5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59762-3140_43791da6-4e96-4aef-9afe-4ee047f5e7e1	59762-3140	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	POWDER, FOR SUSPENSION	ORAL	19951019		NDA AUTHORIZED GENERIC	NDA050710	Greenstone LLC	AZITHROMYCIN DIHYDRATE	1200	mg/30mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
59762-3304_b666655d-d14b-4758-9a65-ef34d028e1a5	59762-3304	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		nitroglycerin	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20160826		NDA AUTHORIZED GENERIC	NDA021134	Greenstone LLC	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59762-3328_6ce09171-8979-41dd-91d6-ea2360a4c5e3	59762-3328	HUMAN PRESCRIPTION DRUG	clindamycin hydrochloride		clindamycin hydrochloride	CAPSULE	ORAL	19700522		NDA AUTHORIZED GENERIC	NDA050162	Greenstone LLC	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
59762-3717_d7d1a422-a8cb-4cbe-ba53-d74bfbf3f2a3	59762-3717	HUMAN PRESCRIPTION DRUG	Triazolam		triazolam	TABLET	ORAL	19821115		NDA AUTHORIZED GENERIC	NDA017892	Greenstone LLC	TRIAZOLAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-3718_d7d1a422-a8cb-4cbe-ba53-d74bfbf3f2a3	59762-3718	HUMAN PRESCRIPTION DRUG	Triazolam		triazolam	TABLET	ORAL	19821115		NDA AUTHORIZED GENERIC	NDA017892	Greenstone LLC	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-3719_5d89edd5-dc6d-4537-80fa-7a9afce8e373	59762-3719	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Greenstone LLC	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-3720_5d89edd5-dc6d-4537-80fa-7a9afce8e373	59762-3720	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Greenstone LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-3721_5d89edd5-dc6d-4537-80fa-7a9afce8e373	59762-3721	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Greenstone LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-3722_5d89edd5-dc6d-4537-80fa-7a9afce8e373	59762-3722	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Greenstone LLC	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
59762-3743_e1ea8570-8c55-4f1b-a295-48036629b6d7	59762-3743	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	GEL	TOPICAL	19870107		NDA AUTHORIZED GENERIC	NDA050615	Greenstone LLC	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
59762-3744_e1ea8570-8c55-4f1b-a295-48036629b6d7	59762-3744	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	LOTION	TOPICAL	19890531		NDA AUTHORIZED GENERIC	NDA050600	Greenstone LLC	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
59762-4030_184209aa-0634-4072-b238-3e8243ed032d	59762-4030	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20040317	20240531	NDA AUTHORIZED GENERIC	NDA020235	Greenstone LLC	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
59762-4135_184209aa-0634-4072-b238-3e8243ed032d	59762-4135	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20040317	20240229	NDA AUTHORIZED GENERIC	NDA020235	Greenstone LLC	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
59762-4440_36aa0fde-f192-4963-a581-49df3e5295f4	59762-4440	HUMAN PRESCRIPTION DRUG	Methylprednisolone		methylprednisolone	TABLET	ORAL	20111011		NDA AUTHORIZED GENERIC	NDA011153	Greenstone LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59762-4537_5887c59f-4735-42d2-8780-2b17ae4ed18c	59762-4537	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	19921029		NDA AUTHORIZED GENERIC	NDA020246	Greenstone LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59762-4538_5887c59f-4735-42d2-8780-2b17ae4ed18c	59762-4538	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	19921029		NDA AUTHORIZED GENERIC	NDA020246	Greenstone LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
59762-4921_b666655d-d14b-4758-9a65-ef34d028e1a5	59762-4921	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		nitroglycerin	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20160826		NDA AUTHORIZED GENERIC	NDA021134	Greenstone LLC	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
59762-5000_61940836-9642-4983-bb6c-27ee91d0b56c	59762-5000	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20030701		NDA AUTHORIZED GENERIC	NDA007073	Greenstone LLC	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
59762-5007_76aef3e4-6ba0-4fde-a23c-d063b4afd41c	59762-5007	HUMAN PRESCRIPTION DRUG	misoprostol		MISOPROSTOL	TABLET	ORAL	20091227		NDA AUTHORIZED GENERIC	NDA019268	Greenstone LLC	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
59762-5008_76aef3e4-6ba0-4fde-a23c-d063b4afd41c	59762-5008	HUMAN PRESCRIPTION DRUG	misoprostol		MISOPROSTOL	TABLET	ORAL	20091227		NDA AUTHORIZED GENERIC	NDA019268	Greenstone LLC	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
59762-5009_e2586122-3686-434d-98f9-5234aac83fa8	59762-5009	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	CREAM	VAGINAL	19920811		NDA AUTHORIZED GENERIC	NDA050680	Greenstone LLC	CLINDAMYCIN PHOSPHATE	20	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
59762-5010_6ce09171-8979-41dd-91d6-ea2360a4c5e3	59762-5010	HUMAN PRESCRIPTION DRUG	clindamycin hydrochloride		clindamycin hydrochloride	CAPSULE	ORAL	19700522		NDA AUTHORIZED GENERIC	NDA050162	Greenstone LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
59762-5014_b6ddaadd-618e-4190-a60b-32d2844ad1b0	59762-5014	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		spironolactone and hydrochlorothiazide	TABLET, FILM COATED	ORAL	19780101		NDA AUTHORIZED GENERIC	NDA012616	Greenstone LLC	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59762-5015_82a4842a-0afa-4450-aa0b-8b8bad45120b	59762-5015	HUMAN PRESCRIPTION DRUG	Fluconazole		fluconazole	TABLET	ORAL	19900129		NDA AUTHORIZED GENERIC	NDA019949	Greenstone LLC	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-5016_82a4842a-0afa-4450-aa0b-8b8bad45120b	59762-5016	HUMAN PRESCRIPTION DRUG	Fluconazole		fluconazole	TABLET	ORAL	19900129		NDA AUTHORIZED GENERIC	NDA019949	Greenstone LLC	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-5017_82a4842a-0afa-4450-aa0b-8b8bad45120b	59762-5017	HUMAN PRESCRIPTION DRUG	Fluconazole		fluconazole	TABLET	ORAL	19900129		NDA AUTHORIZED GENERIC	NDA019949	Greenstone LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-5018_82a4842a-0afa-4450-aa0b-8b8bad45120b	59762-5018	HUMAN PRESCRIPTION DRUG	Fluconazole		fluconazole	TABLET	ORAL	19900129		NDA AUTHORIZED GENERIC	NDA019949	Greenstone LLC	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-5029_82a4842a-0afa-4450-aa0b-8b8bad45120b	59762-5029	HUMAN PRESCRIPTION DRUG	Fluconazole		fluconazole	POWDER, FOR SUSPENSION	ORAL	19931223		NDA AUTHORIZED GENERIC	NDA020090	Greenstone LLC	FLUCONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-5030_82a4842a-0afa-4450-aa0b-8b8bad45120b	59762-5030	HUMAN PRESCRIPTION DRUG	Fluconazole		fluconazole	POWDER, FOR SUSPENSION	ORAL	19931223		NDA AUTHORIZED GENERIC	NDA020090	Greenstone LLC	FLUCONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
59762-5050_184209aa-0634-4072-b238-3e8243ed032d	59762-5050	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	SUSPENSION	ORAL	20110329		NDA AUTHORIZED GENERIC	NDA021129	Greenstone LLC	GABAPENTIN	250	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
59762-5210_1a091f70-5a1a-4c53-9930-2e1ee10c667d	59762-5210	HUMAN PRESCRIPTION DRUG	Phenytoin Infatabs		Phenytoin	TABLET, CHEWABLE	ORAL	20121227		ANDA	ANDA084427	Greenstone LLC	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
59762-5225_46a33cf7-f5c5-4afb-b464-27a36773fe52	59762-5225	HUMAN PRESCRIPTION DRUG	quinapril and hydrochlorothiazide		quinapril and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211025		NDA AUTHORIZED GENERIC	NDA020125	Greenstone LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
59762-5310_8c2a08db-e2f0-4324-a8f0-6371ddd910b5	59762-5310	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20170116		NDA AUTHORIZED GENERIC	NDA017442	Greenstone LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59762-5320_8c2a08db-e2f0-4324-a8f0-6371ddd910b5	59762-5320	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20170116		NDA AUTHORIZED GENERIC	NDA017442	Greenstone LLC	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59762-5350_8c2a08db-e2f0-4324-a8f0-6371ddd910b5	59762-5350	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20170116		NDA AUTHORIZED GENERIC	NDA017442	Greenstone LLC	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
59762-5420_66f69849-8bbf-47ec-8ff4-e5c45d856755	59762-5420	HUMAN PRESCRIPTION DRUG	Hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20200715		NDA AUTHORIZED GENERIC	NDA011459	Greenstone LLC	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
59762-6002_fcadb9d0-958e-4d05-97a7-5b18dbf6e230	59762-6002	HUMAN PRESCRIPTION DRUG	oxaprozin		oxaprozin	TABLET, FILM COATED	ORAL	20130327		NDA AUTHORIZED GENERIC	NDA018841	Greenstone LLC	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59762-6721_f5bda790-fb33-4fee-88cf-cd45581f2b81	59762-6721	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20140404		NDA AUTHORIZED GENERIC	NDA021540	Greenstone LLC	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
59762-6723_f5bda790-fb33-4fee-88cf-cd45581f2b81	59762-6723	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Atorvastatin calcium		amlodipine besylate and atorvastatin calcium	TABLET, FILM COATED	ORAL	20140404		NDA AUTHORIZED GENERIC	NDA021540	Greenstone LLC	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
59764-004_45a1b454-700f-403d-8571-278f2ad6e8fc	59764-004	HUMAN OTC DRUG	Hy-G-Clenz		Benzalkonium Chloride	LIQUID	TOPICAL	20221219		UNAPPROVED DRUG OTHER		Micronova Manufacturing, Inc.	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20251231
59767-004_6b6ec566-325a-4038-8f90-8c02e617ad06	59767-004	HUMAN PRESCRIPTION DRUG	PERTZYE		pancrelipase	CAPSULE, DELAYED RELEASE	ORAL	20161006		BLA	BLA022175	Digestive Care, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	15125; 4000; 14375	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
59767-008_6b6ec566-325a-4038-8f90-8c02e617ad06	59767-008	HUMAN PRESCRIPTION DRUG	PERTZYE		pancrelipase	CAPSULE, DELAYED RELEASE	ORAL	20120517		BLA	BLA022175	Digestive Care, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	30250; 8000; 28750	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
59767-016_6b6ec566-325a-4038-8f90-8c02e617ad06	59767-016	HUMAN PRESCRIPTION DRUG	PERTZYE		pancrelipase	CAPSULE, DELAYED RELEASE	ORAL	20120517		BLA	BLA022175	Digestive Care, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	60500; 16000; 57500	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
59767-024_6b6ec566-325a-4038-8f90-8c02e617ad06	59767-024	HUMAN PRESCRIPTION DRUG	PERTZYE		pancrelipase	CAPSULE, DELAYED RELEASE	ORAL	20170713		BLA	BLA022175	Digestive Care, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	90750; 24000; 86250	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
59779-003_a2d0c194-0485-4a90-a8d0-e9f4835928dc	59779-003	HUMAN OTC DRUG	Poly Bacitracin		Bacitracin Zinc, Polymyxin B Sulfate	OINTMENT	TOPICAL	20050103	20241231	OTC MONOGRAPH DRUG	M004	CVS Pharmacy	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
59779-004_ae1ec587-53d9-4a70-ae37-a1cc095130ff	59779-004	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20040408		OTC MONOGRAPH FINAL	part355	CVS Pharmacy, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
59779-022_eb2f24b7-1a12-449e-9992-f10b2e3c7e4f	59779-022	HUMAN OTC DRUG	heartburn relief		Cimetidine	TABLET, FILM COATED	ORAL	20090807		ANDA	ANDA075285	CVS Pharmacy	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
59779-032_cc1eb007-3e3c-4f47-baae-15fcb7601b2f	59779-032	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20101214		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy, Inc	SALICYLIC ACID	19.8	mg/g			N	20241231
59779-033_b829a423-3d0e-4ed3-84b7-91bfb9b88ca3	59779-033	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20100408		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
59779-045_9d03e672-5260-4f5e-aca0-3fff596334b5	59779-045	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20110404		OTC MONOGRAPH FINAL	part346	CVS Pharmacy	WITCH HAZEL	860	mg/mL			N	20241231
59779-050_70115ff4-e656-4cd9-a154-7f591264b28c	59779-050	HUMAN OTC DRUG	ibuprofen pm		diphenhydramine citrate and ibuprofen	TABLET, FILM COATED	ORAL	20090217		ANDA	ANDA079113	CVS Pharmacy	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-059_aac36d38-9794-44f2-86ab-392476019575	59779-059	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20130313		OTC MONOGRAPH DRUG	505G(a)(3)	CVS Pharmacy, Inc	ALCOHOL	70	mL/100mL			N	20241231
59779-069_56897396-d320-45a3-a1f3-14080ece4887	59779-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	19920715		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	PETROLATUM	1	g/g			N	20241231
59779-070_784deac0-5031-4768-9c51-07044e9d22a3	59779-070	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20131018		OTC MONOGRAPH DRUG	505G(a)(3)	CVS Pharmacy, Inc	ALCOHOL	70	mL/100mL			N	20241231
59779-072_ffc74dbd-83b9-493d-a209-a46dfe365a0d	59779-072	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	19950809		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59779-074_55de9f94-89b2-4bfb-a41d-6660ba6e7a6d	59779-074	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060217		ANDA	ANDA077349	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-079_3b2188b3-a3f5-4c0a-ad6b-6f87a61aa39d	59779-079	HUMAN OTC DRUG	Clean Apple		Pyrithione zinc	SHAMPOO	TOPICAL	20131206		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy, Inc	PYRITHIONE ZINC	1	g/mL			N	20241231
59779-080_6d072b0f-c058-4263-b3e1-30e8ee4fab83	59779-080	HUMAN OTC DRUG	CVS Pharmacy	Athletes Foot	Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	CVS Pharmacy	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
59779-086_a31c667c-ba55-47fa-821b-ca4689ffa75f	59779-086	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20090105		OTC MONOGRAPH FINAL	part347	CVS Pharamacy, Inc	PETROLATUM	410	mg/g			N	20241231
59779-091_210692d8-79ab-4a79-8bfc-3a53325e4199	59779-091	HUMAN OTC DRUG	All Day Moisture		Octinoxate, zinc oxide	LOTION	TOPICAL	20060228		OTC MONOGRAPH FINAL	part352	CVS Pharmacy, Inc	OCTINOXATE; ZINC OXIDE	60; 30	mg/mL; mg/mL			N	20241231
59779-097_f2293b18-c775-a562-e053-2a95a90a154d	59779-097	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Spray	AEROSOL, SPRAY	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	MICONAZOLE NITRATE	3	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59779-099_2ed17234-378d-48b6-91a0-3b309a82718c	59779-099	HUMAN OTC DRUG	CVS	Cortisone	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59779-112_9a9ab3b3-9300-4cd0-8eec-b832c9d4ccef	59779-112	HUMAN OTC DRUG	Nasal Decongestant	Non-Drowsy	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59779-115_f2294b71-d99a-42f1-e053-2995a90a385a	59779-115	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/91			N	20241231
59779-116_f2295b92-5859-757d-e053-2995a90a61bf	59779-116	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/41			N	20241231
59779-122_f32d188e-93f3-6f31-e053-2a95a90a0e35	59779-122	HUMAN OTC DRUG	CVS	Extra Whitening	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
59779-123_f32d1a51-a635-6430-e053-2a95a90a7504	59779-123	HUMAN OTC DRUG	CVS	Maximum Strength	Benzocaine	PASTE, DENTIFRICE	TOPICAL	20110120		OTC MONOGRAPH FINAL	part348	CVS Pharmacy	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59779-126_99807b9f-d8f2-4393-98df-f33ab6ef7137	59779-126	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20140124		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-134_303f7a30-bf27-4607-9219-655ac26ca727	59779-134	HUMAN OTC DRUG	Stool Softener		DOCUSATE CALCIUM	CAPSULE, LIQUID FILLED	ORAL	20140430	20241227	OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE CALCIUM	240	mg/1			N	
59779-136_f228876e-53d1-eaa4-e053-2995a90ae301	59779-136	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Medicated Discs	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358B	CVS Pharmacy	SALICYLIC ACID	40	mg/181			N	20241231
59779-141_8cf57b16-a2f3-4599-afb2-758fefc2a2b4	59779-141	HUMAN OTC DRUG	acid controller	original strength	Famotidine	TABLET, FILM COATED	ORAL	20091017		ANDA	ANDA075400	CVS Pharmacy	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
59779-143_c70db256-759f-4d2a-ae98-32f143cf31de	59779-143	HUMAN OTC DRUG	Back and Body	Extra Strength	Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20040412		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
59779-153_214a6907-d69d-4be7-a865-cb836dd2e3f6	59779-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
59779-157_2dc4cfd7-1fbd-43c2-8d54-66ed1eb44619	59779-157	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59779-161_f64ee396-aa26-4a58-8823-f90e31f47f08	59779-161	HUMAN OTC DRUG	infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20111013		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-163_9ff65334-17df-4272-85c7-110e409fffb2	59779-163	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20080915		OTC MONOGRAPH FINAL	part355	CVS Pharmacy, Inc	SODIUM FLUORIDE	.1	mg/mL			N	20241231
59779-164_e258cf7a-cea7-434a-b444-ae8fd48ef47b	59779-164	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20090518		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	ALCOHOL	610	mg/mL			N	20241231
59779-166_bdee50fe-5949-4c6b-b9af-835d9873f184	59779-166	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20020827		ANDA	ANDA074937	CVS Pharmacy	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-174_f2296249-6be3-af59-e053-2a95a90ae5d8	59779-174	HUMAN OTC DRUG	Calamine Plus Pramoxine HCl		Calamine Plus Spray	AEROSOL, SPRAY	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.345; 2.72; 24.16	mg/116g; mg/116g; mg/116g			N	20241231
59779-178_f22977a5-f7ab-d668-e053-2995a90a8474	59779-178	HUMAN OTC DRUG	Undecylenic Acid Liquid		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	UNDECYLENIC ACID	7.5	g/30g			N	20241231
59779-194_0704adf2-2860-434f-859d-f52dad4a2ec6	59779-194	HUMAN OTC DRUG	acid controller		Famotidine	TABLET, FILM COATED	ORAL	20060928		ANDA	ANDA077351	CVS Pharmacy	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
59779-199_9534b480-1289-448f-9a44-fa5c4552cf36	59779-199	HUMAN OTC DRUG	miconazole 1	yeast infection relief	Miconazole nitrate	KIT		20100608		ANDA	ANDA079114	CVS Pharmacy						N	20241231
59779-201_79489d1f-e8ac-4d72-96a4-5a4c44de5182	59779-201	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20100512		ANDA	ANDA090821	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-202_44080a08-eb5c-47b8-8b3a-a10af3731d84	59779-202	HUMAN OTC DRUG	hair regrowth	treatment for women	minoxidil	SOLUTION	TOPICAL	19900415		ANDA	ANDA075357	CVS Pharmacy	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59779-204_f3cca5a2-319c-42d3-b655-3b01b9785c12	59779-204	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	CVS Pharmacy	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59779-213_2bafe916-7795-40b1-a957-a650be934c31	59779-213	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20010619		OTC MONOGRAPH FINAL	part355	CVS Pharmacy, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
59779-219_c580cae6-7be4-4307-b8d9-a92b2c94de4d	59779-219	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20151122		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	ALCOHOL	70	mL/100mL			N	20241231
59779-263_4205cd89-6763-4437-83b9-f8b30d64ec87	59779-263	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	19910615		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-274_d961996e-761a-4edd-a9ea-ba1e115b3db1	59779-274	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19970220		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59779-275_88a2b086-6627-49ea-b06c-492575a9a539	59779-275	HUMAN OTC DRUG	Severe Sinus Pain and Congestion	Daytime	acetaminophen, guaifenesin, phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-279_bdd8d723-3b46-4441-bddb-3c35574a1faf	59779-279	HUMAN OTC DRUG	hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20140911		OTC MONOGRAPH FINAL	part346	CVS Pharmacy	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-281_2fe8c62a-d334-4035-917d-5a341757bdfd	59779-281	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20020315		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy	PYRITHIONE ZINC	10.4	mg/mL			N	20241231
59779-291_70cc0bc5-95ea-44db-811b-e26e3261e429	59779-291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-294_61ece748-bae1-4c3d-9222-9618274318ce	59779-294	HUMAN OTC DRUG	hair regrowth treatment for men		Minoxidil	AEROSOL, FOAM	TOPICAL	20120302		ANDA	ANDA091344	CVS Pharmacy	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
59779-296_c0e51a46-f914-49ae-b10f-aaea46fd30ba	59779-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20090512		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
59779-299_ef79e93b-24cb-4b1d-b1e3-bb2eac54bc6f	59779-299	HUMAN OTC DRUG	CVS Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20070501		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
59779-305_ca3cfac9-2fbc-4c26-aa36-8a27a74a75cd	59779-305	HUMAN OTC DRUG	Clotrimazole 1%	Athletes Foot	Clotrimazole	CREAM	TOPICAL	19930831		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59779-306_e1b3935a-40fa-47f9-b5b1-3cacceaa0ea5	59779-306	HUMAN OTC DRUG	purelax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	CVS Pharmacy	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-308_1a4e39dc-8bd8-4c64-b6e9-8a266dc64281	59779-308	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20140228		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-313_da59bc1c-06c8-4a10-a26a-00c365c02093	59779-313	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20040507		ANDA	ANDA075217	CVS Pharmacy	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-319_794fda80-31e5-4728-ba23-30de6e70cf7f	59779-319	HUMAN OTC DRUG	Cortisone	Plus Aloe Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20120222	20241231	OTC MONOGRAPH DRUG	M017	CVS Pharmacy	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
59779-327_f3a35d99-8dbf-47aa-9be4-84e4e22b6675	59779-327	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	CVS Pharmacy	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-332_0907ce9b-0518-b842-e063-6294a90a2afb	59779-332	HUMAN OTC DRUG	milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	19920810		OTC MONOGRAPH DRUG	M007	CVS Pharmacy	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-334_4237de73-bb26-4032-aab9-a420c72000ca	59779-334	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin and Caffeine	TABLET, FILM COATED	ORAL	20080313		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
59779-335_1f040b8b-9b1c-4579-b90c-8170689bbf6b	59779-335	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110816		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-337_ee70a730-0ae9-492f-bc08-c48483adf861	59779-337	HUMAN OTC DRUG	Eye Wash		water	SOLUTION	OPHTHALMIC	20100831		OTC MONOGRAPH FINAL	part349	CVS Pharmacy	WATER	99.05	mL/100mL			N	20241231
59779-344_e83a0b9f-e43a-4c69-9664-fc650acabfb8	59779-344	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060222		ANDA	ANDA077007	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-350_221ca774-b2a3-492f-a07d-635cfcb2a9dc	59779-350	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	CVS Pharmacy	ACETAMINOPHEN	650	mg/1			N	20241231
59779-359_480736b2-c35c-434d-9208-a4db299d5b1e	59779-359	HUMAN OTC DRUG	Tussin DM	Adult cough and chest congestion	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19910924		OTC MONOGRAPH DRUG	M004	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-363_abe87a58-3f3e-432a-93c0-27c697ad453f	59779-363	HUMAN OTC DRUG	Cold and Cough	childrens	Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20060817		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-367_4b45bee0-9caa-4110-b37d-0dace2cc097f	59779-367	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-374_34071859-042b-4006-9112-0f79158d8976	59779-374	HUMAN OTC DRUG	migraine relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20020827		ANDA	ANDA075794	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
59779-381_db8b060c-4f62-7bc4-e053-2995a90aa789	59779-381	HUMAN OTC DRUG	CVS CAPSAICIN		CAPSAICIN	CREAM	TOPICAL	20141013		OTC MONOGRAPH NOT FINAL	part348	CVS PHARMACY	CAPSAICIN	.1	g/100g			N	20241231
59779-384_fb4c811d-1bec-468f-87ae-38702b49ac57	59779-384	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120828		ANDA	ANDA091135	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-385_f2295b92-5857-757d-e053-2995a90a61bf	59779-385	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20140710		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/10mL; mg/10mL			N	20241231
59779-388_37037788-dd4f-4914-a817-93d27f6760be	59779-388	HUMAN OTC DRUG	nasal mist		Oxymetazoline HCl	SPRAY	NASAL	20020904		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
59779-390_e6dc876c-f80a-41c6-b344-881ba812c286	59779-390	HUMAN OTC DRUG	nose		Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	19910918		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-404_d4584f3c-abb1-48b1-8012-672d082231a5	59779-404	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, CHEWABLE	ORAL	20020529		OTC MONOGRAPH DRUG	M009	CVS Pharmacy	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
59779-419_4f94151d-7cdb-4d41-8043-a4bc8b28b825	59779-419	HUMAN OTC DRUG	chest congestion	childrens plus cough	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20090311		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-423_f22979dc-e80a-3461-e053-2a95a90a39d0	59779-423	HUMAN OTC DRUG	Allantoin		Advanced Derma Spray	AEROSOL, SPRAY	TOPICAL	20150415		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	ALLANTOIN	.425	g/85g			N	20241231
59779-425_0403988a-008c-4315-a5b0-471ffa8f9350	59779-425	HUMAN OTC DRUG	Allergy relief		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20110831		ANDA	ANDA076447	CVS Pharmacy	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-430_d1a8e5cf-b479-49f6-82b2-d6bd127d622d	59779-430	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, SUGAR COATED	ORAL	20011011		ANDA	ANDA074567	CVS Pharmacy	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
59779-432_b8c7b7c7-2bf9-4a04-a67f-44c21778c8b4	59779-432	HUMAN OTC DRUG	Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19870715		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59779-433_7ce87d86-d872-4b6e-8964-3eb363a31bb0	59779-433	HUMAN OTC DRUG	tussin		Dextromethorphan Hydrobromide	SOLUTION	ORAL	19920513		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-434_c63a9a64-67f6-41b4-b041-2f9b48efa39a	59779-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20140501		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59779-438_0d8ca1c4-ec7f-442d-91ec-b8eb692fda08	59779-438	HUMAN OTC DRUG	Ibuprofen	Dye Free	Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-439_436e6af8-372c-40cd-9841-f581a4a8d0da	59779-439	HUMAN OTC DRUG	Aspirin	Low Strength, Enteric	Aspirin	TABLET, DELAYED RELEASE	ORAL	20130503		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59779-441_d1f23abd-1170-435d-b5f1-ab34a4a2d314	59779-441	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		Doxylamine succinate	TABLET	ORAL	19970723		ANDA	ANDA040167	CVS Pharmacy	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
59779-443_7a076691-b19b-517b-f9ab-51bf0ac10335	59779-443	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150806		NDA	NDA020076	CVS Pharmacy	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-444_db8b060c-4f63-7bc4-e053-2995a90aa789	59779-444	HUMAN OTC DRUG	CVS Maximum Strength Boil Relief		Benzocaine	OINTMENT	TOPICAL	20141013		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy, Inc.	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59779-445_7a076691-b19b-517b-f9ab-51bf0ac10335	59779-445	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150806		NDA	NDA020076	CVS Pharmacy	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-448_7a076691-b19b-517b-f9ab-51bf0ac10335	59779-448	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20150806		NDA	NDA020076	CVS Pharmacy	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-458_9dea1557-2dd4-48a6-88fa-f36b10e37de4	59779-458	HUMAN OTC DRUG	Allergy Relief	Indoor and Outdoor Allergies	Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20090114		ANDA	ANDA078336	CVS Pharmacy	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-459_9fbc8c17-d7a0-4c46-a412-c75ec53b3a65	59779-459	HUMAN OTC DRUG	nighttime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20110812		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-466_49245254-ab02-4f49-a462-64976de096a7	59779-466	HUMAN OTC DRUG	SINUS PAIN AND CONGESTION	DAYTIME	Acetaminophen and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-467_6fad2bdc-bda7-4eca-99c8-f37fdc88ed1b	59779-467	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19920825		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59779-500_f2295765-1334-28d4-e053-2995a90a647c	59779-500	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358B	CVS Pharmacy	SALICYLIC ACID	.17	mg/15mL			N	20241231
59779-501_83ea435f-fdc4-43a1-bb2d-d5f03cc8d77f	59779-501	HUMAN OTC DRUG	Bacitracin		bacitracin zinc	OINTMENT	TOPICAL	20060425	20241231	OTC MONOGRAPH DRUG	M004	CVS Pharmacy	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	
59779-503_0d18d15f-5220-4817-8887-15108c1064a7	59779-503	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080229		NDA	NDA022032	CVS Pharmacy	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59779-508_aac03106-806f-bc8c-056c-bed65497dd54	59779-508	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20141119		ANDA	ANDA076667	CVS Pharmacy	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
59779-509_c09e93d4-7159-47b8-852c-2b407260446e	59779-509	HUMAN OTC DRUG	Childrens Allergy Relief		Cetirizine HCl	SOLUTION	ORAL	20150922		ANDA	ANDA204226	CVS Pharmacy	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-510_b886e679-57c8-4725-bc47-8e005cddc1ce	59779-510	HUMAN OTC DRUG	CVS Pharmacy	ITCH RELIEF ANTIFUNGAL	Clotrimazole	CREAM	TOPICAL	20130110		OTC MONOGRAPH DRUG	M005	CVS Pharmacy	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59779-511_f2294af7-5f0d-3441-e053-2995a90ae708	59779-511	HUMAN OTC DRUG	Tolnafate		Foot and Sneaker Spray	AEROSOL, SPRAY	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	TOLNAFTATE	1.3	g/113g			N	20241231
59779-512_bebb0f9f-4a53-46fb-8df4-66341f8345ac	59779-512	HUMAN OTC DRUG	Severe Cough and Cold		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20170607		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-514_185e0b57-7540-4c6d-bbab-3ec1ac2fdff6	59779-514	HUMAN OTC DRUG	CVS	Antifungal Ringworm	Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH DRUG	M005	CVS Pharmacy	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59779-517_3df66a32-06c8-4b01-9337-1067b3f88cf8	59779-517	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20060427		ANDA	ANDA077349	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-528_a6cabd7d-4312-4e21-a04d-bc8bbeafbdfb	59779-528	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20100108		ANDA	ANDA076134	CVS Pharmacy	LORATADINE	10	mg/1			N	20241231
59779-534_094a6186-10c3-ed17-e063-6394a90a601a	59779-534	HUMAN OTC DRUG	CVS Motion Sickness Fast Melting		meclizine hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20150827		OTC MONOGRAPH DRUG	M009	CVS Pharmacy, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
59779-536_6d064cf8-c408-429b-b677-39ad97a48605	59779-536	HUMAN OTC DRUG	BACITRACIN		Bacitracin	OINTMENT	TOPICAL	20050608		OTC MONOGRAPH DRUG	M004	CVS Pharmacy	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
59779-541_e80449f4-1554-735f-e053-2a95a90a7a34	59779-541	HUMAN OTC DRUG	CVS foaming muscle relief		Magnesium Sulfate heptahydrate	LIQUID	TOPICAL	20220906		UNAPPROVED HOMEOPATHIC		CVS Health	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/506mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-543_cde349d0-8cc7-4c1b-9582-7e81880f7d7b	59779-543	HUMAN OTC DRUG	Severe Allergy And Sinus Headache	Maximum Strength	Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20070627		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 25; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-545_06c1eb1f-005b-1942-e063-6294a90a27f4	59779-545	HUMAN OTC DRUG	cherry sore throat lozenge		Benzocaine	LOZENGE	ORAL	20150518		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59779-563_9b1dc47b-ccc7-43fc-9e23-78b50318a79e	59779-563	HUMAN OTC DRUG	muscle rub		Menthol, Methyl salicylate	CREAM	TOPICAL	20140206		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
59779-566_69dd98a7-3a5e-4c8b-a1e7-78cb8aedebd3	59779-566	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20090105		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	PETROLATUM	1	g/g			N	20241231
59779-567_eae96c71-888e-4fcd-bdcb-97de77cba4a3	59779-567	HUMAN OTC DRUG	daytime nighttime	multi symptom cold and flu relief	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20120727		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
59779-569_f2295b92-585b-757d-e053-2995a90a61bf	59779-569	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/41			N	20241231
59779-570_f2295b92-585c-757d-e053-2995a90a61bf	59779-570	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/91			N	20241231
59779-572_f22979dc-e807-3461-e053-2a95a90a39d0	59779-572	HUMAN OTC DRUG	Tolnaftate		Antifungal Continuous Liquid Spray	AEROSOL, SPRAY	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	TOLNAFTATE	1.5	g/150g			N	20241231
59779-579_227f1efc-59b8-45af-b07e-bf778d7f9dfd	59779-579	HUMAN OTC DRUG	fever reducing	childrens	Acetaminophen	SUPPOSITORY	RECTAL	20100121		ANDA	ANDA070607	CVS Pharmacy	ACETAMINOPHEN	120	mg/1			N	20241231
59779-580_6e980235-4aa7-4876-b079-f700dc31c7e1	59779-580	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150327		NDA	NDA022032	CVS Pharmacy	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59779-582_f32d514e-0e72-9f99-e053-2995a90ad370	59779-582	HUMAN OTC DRUG	CVS Pharmacy	Maximum Strength	Benzocaine	GEL, DENTIFRICE	ORAL	20110120		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59779-585_a487c7b6-3b81-4267-a817-942db48394a5	59779-585	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20090320		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-589_f0ca936a-20ff-4024-9a60-74207a106699	59779-589	HUMAN OTC DRUG	Dandruff		Selenium sulfide	SHAMPOO	TOPICAL	20121209		OTC MONOGRAPH FINAL	part358H	CVS	SELENIUM SULFIDE	10	mg/mL			N	20241231
59779-590_7ed3dfb3-a6ba-430c-9efe-9e5fd50a1f7b	59779-590	HUMAN OTC DRUG	infants pain and fever		acetaminophen	SUSPENSION	ORAL	19930430		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-594_4aa1485d-4dc9-405d-8f19-b80274ea28f7	59779-594	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20160630	20241227	OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
59779-596_33b62a7f-acda-4744-ad29-b3f3022cf7fe	59779-596	HUMAN OTC DRUG	Antacid	Childrens	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20180801		OTC MONOGRAPH DRUG	M001	CVS Pharmacy	CALCIUM CARBONATE	400	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
59779-597_e0ac8687-a678-4e2f-a29c-69b0bc42ffb7	59779-597	HUMAN OTC DRUG	Severe Nighttime Severe Daytime		acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20131227		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
59779-600_6e0d0b56-f154-491a-80bc-2983f637d3a1	59779-600	HUMAN OTC DRUG	Aspirin	Enteric Coated	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59779-603_c34f9fa1-e11c-48c6-b868-9f2a46d6a7ef	59779-603	HUMAN OTC DRUG	Severe Daytime		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20131227		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-604_f7be939f-88fe-4c26-8fa7-bd544feb608b	59779-604	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20010710		ANDA	ANDA072096	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-607_08916882-0aa3-1cc4-e063-6294a90afe1b	59779-607	HUMAN OTC DRUG	Medicated Wipes	Hemorrhoidal Wipes with Witch Hazel	Witch Hazel	CLOTH	TOPICAL	20100101		OTC MONOGRAPH DRUG	M015	CVS Pharmacy	WITCH HAZEL	.5	g/g			N	20241231
59779-612_fcd12ede-e8d4-463d-9304-6e347c03d265	59779-612	HUMAN OTC DRUG	allergy relief		Loratadine	TABLET	ORAL	20050104		ANDA	ANDA076301	CVS Pharmacy	LORATADINE	10	mg/1			N	20241231
59779-634_72efd514-5cb9-4b24-8ccd-58fcd34b0a80	59779-634	HUMAN OTC DRUG	childrens multi symptom cold		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20160611		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-636_4b4c5897-e989-4797-b515-81bb7d64c217	59779-636	HUMAN OTC DRUG	CVS Health Maximum Strength		Antacid and Antigas	TABLET, CHEWABLE	ORAL	20150914		OTC MONOGRAPH FINAL	part332	CVS Pharmacy,Inc.	CALCIUM CARBONATE; DIMETHICONE	1000; 60	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
59779-644_06c1eb1f-005c-1942-e063-6294a90a27f4	59779-644	HUMAN OTC DRUG	honey lemon sore throat lozenges		Benzocaine	LOZENGE	ORAL	20150518		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	BENZOCAINE; MENTHOL	15; 2.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59779-646_b7601434-406c-45f5-8725-aaace204d8f5	59779-646	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20160430	20241227	OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	
59779-647_679ec1b5-1f8f-4039-b180-ca4927c99395	59779-647	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20010731		ANDA	ANDA072096	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-648_1a3bfbcb-86a4-418c-aa46-626567bef8d3	59779-648	HUMAN OTC DRUG	Severe Congestion and Cough	Multi-Symptom Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20150720		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-650_9adbed3e-d0eb-46ad-9e4c-57a8287380d9	59779-650	HUMAN OTC DRUG	tussin	adult chest congestion	Guaifenesin	SOLUTION	ORAL	19870715		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
59779-653_08284fe6-80ab-1d3d-e063-6294a90acea2	59779-653	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20150518		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	MENTHOL	5.4	mg/1			N	20241231
59779-655_082859b4-48ba-6754-e063-6394a90a6a2e	59779-655	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20150518		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
59779-656_1fb9a72d-fc3e-4a9b-8224-a6cedd8ac707	59779-656	HUMAN OTC DRUG	Daytime	Non Drowsy	acetaminophen, dextromethorphan hbr, phenylephrine hcl	SOLUTION	ORAL	20060609		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-659_082853cf-9eec-6eea-e063-6294a90ab4f2	59779-659	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20150518		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	MENTHOL	7.5	mg/1			N	20241231
59779-660_95f22d69-91a0-4a10-9410-da06fe131dd9	59779-660	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	20020904		ANDA	ANDA074937	CVS Pharmacy	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-664_99403f4e-b609-42a5-82d8-fe2da92dae7f	59779-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19920915		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59779-668_a9037881-d0b8-4bca-8450-8fbe7d12b650	59779-668	HUMAN OTC DRUG	nighttime cough		Dextromethorphan Hydrobromide, Doxylamine Succinate	SOLUTION	ORAL	20020923		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-674_0346b3bb-5daf-4a8d-a1b1-0653a1c33c2f	59779-674	HUMAN OTC DRUG	CVS	SPF 30 Sport	AVOBENZONE, HOMOSALATE, OCTOCRYLENE	SPRAY	TOPICAL	20151020		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2; 7; 5	g/100g; g/100g; g/100g			N	20241231
59779-675_53733145-5709-4d50-9863-1740c72c7d63	59779-675	HUMAN OTC DRUG	CVS Health Ultra Strength Natural Antacid	Peppermint Flavor	Antacid Tablets	TABLET, CHEWABLE	ORAL	20150817		OTC MONOGRAPH FINAL	part331	CVS Pharmacy,Inc.	CALCIUM CARBONATE	1000	mg/1			N	20241231
59779-676_dfedc621-67dc-43e4-bcdf-4cb0ac860d30	59779-676	HUMAN OTC DRUG	C-Lax Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	CVS Pharmacy	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-677_8769b897-a4af-4848-91c2-e73e232a53b9	59779-677	HUMAN OTC DRUG	Cold and Flu Relief	Non-Drowsy / Daytime Severe / Nighttime Severe	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20150801	20241123	OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	
59779-681_60379158-fb34-4515-8ce0-66d1c7b549eb	59779-681	HUMAN OTC DRUG	CVS Clear Face SPF 30 3 oz		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160602		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 13; 5; 2; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
59779-685_9669d9c1-01a3-4843-8776-ec644151025e	59779-685	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20090630		ANDA	ANDA074937	CVS Pharmacy	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-686_bac7993a-d971-4192-a9f9-61fd744c178f	59779-686	HUMAN OTC DRUG	DayTime NightTime Cold/Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCi	KIT		20160731		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
59779-691_493629d2-e829-4ed9-be16-b41bad1584ab	59779-691	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20220603		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-693_1c8263a3-b601-471c-b580-f8d5c295ad9b	59779-693	HUMAN OTC DRUG	NightTime Cold and Flu		Acetaminophen, Diphenhydramine HCi, Phenylephrine HCi	LIQUID	ORAL	20220603		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-695_08286fdb-5989-719a-e063-6294a90a4301	59779-695	HUMAN OTC DRUG	sugar free menthol cough drops		menthol	LOZENGE	ORAL	20150518		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
59779-697_06c1eb9b-2ef6-1bc3-e063-6394a90a00c2	59779-697	HUMAN OTC DRUG	sugar free honey lemon cough drops		menthol	LOZENGE	ORAL	20150518		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	7.6	mg/1			N	20241231
59779-697_08287b0a-4591-c19c-e063-6294a90ab8cd	59779-697	HUMAN OTC DRUG	sugar free honey lemon cough drops		menthol	LOZENGE	ORAL	20160804		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	MENTHOL	7.6	mg/1			N	20241231
59779-700_bb2dd75a-8219-405a-93ec-a8116e505cdf	59779-700	HUMAN OTC DRUG	anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030224		ANDA	ANDA075232	CVS Pharmacy	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
59779-703_dcfaf9dd-eada-4fd1-84f0-ef0bc2dc5029	59779-703	HUMAN OTC DRUG	12 Hour Nasal Decongestant		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19991201		ANDA	ANDA075153	CVS Pharmacy	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59779-706_968956d5-113a-4156-95de-b04275393ef5	59779-706	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20130401		OTC MONOGRAPH DRUG	505G(a)(3)	CVS Pharmacy	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-707_b7f96908-f2cd-4581-bf69-46b146b00ca7	59779-707	HUMAN OTC DRUG	arthritis		Trolamine Salicylate	CREAM	TOPICAL	20050610		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	TROLAMINE SALICYLATE	10	g/100g			N	20241231
59779-708_d3a43dc1-7ece-4cee-88ed-52238abd5a64	59779-708	HUMAN OTC DRUG	Itch Relief		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20050608		OTC MONOGRAPH DRUG	M017	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-709_f65a143e-3052-482f-a57b-8bc778d0187c	59779-709	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150327		ANDA	ANDA091135	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-718_c4180df5-0a76-4cb6-b26a-c89b6aab515c	59779-718	HUMAN OTC DRUG	tioconazole 1		Tioconazole	OINTMENT	VAGINAL	20151112		ANDA	ANDA075915	CVS Pharmacy	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
59779-726_5d337a98-525b-4a39-a10d-f0de491ce2ce	59779-726	HUMAN OTC DRUG	ALLERGY RELIEF-D		Loratadine and Pseudoephedrine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140207		ANDA	ANDA076557	CVS Pharmacy	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
59779-729_097f3a57-0025-4d06-e063-6294a90a314e	59779-729	HUMAN OTC DRUG	CVS Cools Itch Fast		Hydrocortisone	GEL	TOPICAL	20141013		OTC MONOGRAPH DRUG	M016	CVS Pharmacy, Inc.	HYDROCORTISONE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59779-732_9a11d3ba-dd24-4026-b65b-0eecac3eb3aa	59779-732	HUMAN OTC DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole, sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20160715		ANDA	ANDA201361	CVS Pharmacy	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
59779-734_f6359bc1-d870-4440-9e18-594b2bb949b3	59779-734	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130213		ANDA	ANDA203690	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-738_62bb0cdc-a218-4608-9b38-d113f293c98c	59779-738	HUMAN OTC DRUG	Acid Reducer Plus Antacid		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160211		ANDA	ANDA077355	CVS Pharmacy	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-743_f3bc9507-5950-1502-e053-2995a90a38b8	59779-743	HUMAN OTC DRUG	CVS Pharmacy	Maximum Strength	Benzocaine	LIQUID	DENTAL	20150101		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59779-746_3752196f-6127-4319-98b1-2690001aa5ab	59779-746	HUMAN OTC DRUG	Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20160410		ANDA	ANDA078104	CVS Pharmacy	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59779-747_eea2edc5-e6d1-78fd-e053-2a95a90ab7fc	59779-747	HUMAN OTC DRUG	CVS Health	Medicated	WITCH HAZEL	CLOTH	TOPICAL	20151124		OTC MONOGRAPH FINAL	part346	CVS Pharmacy	WITCH HAZEL	500	mg/1			N	20241231
59779-748_06c185cb-27d0-8ec9-e063-6394a90a9097	59779-748	HUMAN OTC DRUG	Assorted Fruit Antacid Flavor Chews		calcium carbonate	TABLET, CHEWABLE	ORAL	20150601		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
59779-754_80f6b21d-5ac7-4472-a9ea-e8f02fa7753c	59779-754	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20090715		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-756_09d63292-e687-b371-e063-6294a90a70c0	59779-756	HUMAN OTC DRUG	CVS Health Isopropyl Rubbing Alcohol		Isopropyl Alcohol	CLOTH	TOPICAL	20170119		OTC MONOGRAPH DRUG	M003	CVS Health	ISOPROPYL ALCOHOL	.7	g/g			N	20241231
59779-760_802c3df3-a092-48e2-a6e4-ab5db721b069	59779-760	HUMAN OTC DRUG	severe cough and cold		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20100914		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-763_dbec8e64-98f0-4ec5-bcf3-d4607c959389	59779-763	HUMAN OTC DRUG	Severe Nighttime		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	SOLUTION	ORAL	20131227		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-765_f229388d-50ac-092a-e053-2995a90aecac	59779-765	HUMAN OTC DRUG	Witch Hazel		Witch Hazel Spray	SPRAY	TOPICAL	20170301		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	WITCH HAZEL	146	g/170g			N	20241231
59779-767_098133de-cdae-76df-e063-6294a90a2f7d	59779-767	HUMAN OTC DRUG	Antiseptic Skin Cleanser		CHLORHEXIDINE GLUCONATE 4%	LIQUID	TOPICAL	20110831		NDA	NDA019125	CVS Pharmacy, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
59779-768_3905737f-509e-419a-9933-c49ca8c93d77	59779-768	HUMAN OTC DRUG	Multi Symptom Severe Cold and Nighttime Severe Cold and Cough		Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Phenylephrine HCl	KIT		20150921		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.						N	20241231
59779-769_9227dbb4-56c1-453f-b012-de16f5836879	59779-769	HUMAN OTC DRUG	Lice Treatment		Permethrin	LOTION	TOPICAL	20160503		ANDA	ANDA076090	CVS Pharmacy	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
59779-770_bf916a21-136f-935f-e053-2995a90a5066	59779-770	HUMAN OTC DRUG	CVS Medicated Heat 1 ct		Capsaicin	PATCH	TOPICAL	20140916		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy, Inc.	CAPSAICIN	.025	g/g			N	20241231
59779-773_a19a2156-8c0e-4381-8599-1a5557569a9a	59779-773	HUMAN OTC DRUG	Miconazole 3 Combination Pack		Miconazole Nitrate	KIT		20010301		ANDA	ANDA074926	CVS Pharmacy						N	20241231
59779-777_46643cbb-edd8-1292-e054-00144ff8d46c	59779-777	HUMAN OTC DRUG	NUANCE Salma Hayek Renewed Radiance Moisturizing Day Cream Broad Spectrum SPF 30 Sunscreen		NUANCE Salma Hayek Renewed Radiance Moisturizing Day Cream Broad Spectrum SPF 30 Sunscreen	LOTION	TOPICAL	20170118		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE	3; 7.5; 5	g/100g; g/100g; g/100g			N	20241231
59779-779_67e76c15-dc4d-4b80-a1e9-233c82d9c6f1	59779-779	HUMAN OTC DRUG	SINUS PAIN AND CONGESTION		Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl	KIT		20050726		OTC MONOGRAPH DRUG	M012	CVS Pharmacy						N	20241231
59779-785_86d1319b-eb0c-4fcb-8425-e63b9a06b4f9	59779-785	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20150831		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-787_3e15a1f9-c93e-4cdb-865c-68bfa63d3323	59779-787	HUMAN OTC DRUG	CVS Health Sinus Relief		oxymetazoline hydrochloride	SPRAY	NASAL	20150421		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.	OXYMETAZOLINE HYDROCHLORIDE	.0005	g/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
59779-790_f41d748c-21d1-2b36-e053-2a95a90afd67	59779-790	HUMAN OTC DRUG	CVS Health Medicated Chest Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20150901		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
59779-791_f94d5441-671c-d590-e053-6394a90abe72	59779-791	HUMAN OTC DRUG	CVS Health Cold and Hot Pain Relieving	Extra Strength	menthol, methyl salicylate	CREAM	TOPICAL	20161003		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 300	mg/g; mg/g			N	20241231
59779-792_f41d871a-0663-5afc-e053-2a95a90a28e3	59779-792	HUMAN OTC DRUG	CVS Health Muscle Rub	Ultra Strength	camphor, menthol, methyl salicylate	CREAM	TOPICAL	20161003		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
59779-793_1ccf7ffb-3b53-48a4-acc6-e52f249fcc05	59779-793	HUMAN OTC DRUG	CVS Health Childrens Allergy Relief		Diphenhydramine hydrochloride	LIQUID	ORAL	20150907		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-797_3dbf52bb-5467-4545-92f7-6134d1e63dc7	59779-797	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20160105		ANDA	ANDA074661	CVS Pharmacy	NAPROXEN SODIUM	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-802_883e818a-cc2a-4252-bee3-b295d28bfed1	59779-802	HUMAN OTC DRUG	Sinus PE Pressure plus Pain	MAXIMUM STRENGTH	Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20050623		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-804_7a7d3ef1-abfa-44fb-a6eb-d290c0c69af3	59779-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	19920715		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	ISOPROPYL ALCOHOL	.91	mg/mL			N	20241231
59779-808_0ac1aa80-a655-d251-e063-6294a90aca89	59779-808	HUMAN OTC DRUG	CVS Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20110101		OTC MONOGRAPH DRUG	M003	CVS Pharmacy	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59779-815_f32d73d9-90a3-e93b-e053-2995a90a0b47	59779-815	HUMAN OTC DRUG	CVS Pharmacy	Enamel Guard	Fluoride	PASTE, DENTIFRICE	DENTAL	20121001		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	POTASSIUM NITRITE; SODIUM FLUORIDE	5; .15	g/100g; g/100g			N	20241231
59779-817_bf6bcaaa-1d94-4232-8e41-394db47f2d85	59779-817	HUMAN OTC DRUG	nasal	sinus	oxymetazoline hydrochloride	SPRAY	NASAL	19991005		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
59779-822_926bb39f-482f-4a4b-96b6-73b56f485833	59779-822	HUMAN OTC DRUG	Antibiotic and Pain Relief	Maximum Strength	Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine Hydrochloride	CREAM	TOPICAL	20110101		OTC MONOGRAPH DRUG	M016	CVS Pharmacy	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
59779-823_5e900ecc-7701-4d6d-a908-37c68eb6c66c	59779-823	HUMAN OTC DRUG	Triple Antibiotic and Pain Relief	Maximum Strength	bacitracin zinc, neomycin sulfate, polymyxin b sulfate and pramoxine hydrochloride	OINTMENT	TOPICAL	20050103	20241231	OTC MONOGRAPH DRUG	M004	CVS Pharmacy	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
59779-824_25f18dd2-1503-410f-8d25-f0fc3a4b43f7	59779-824	HUMAN OTC DRUG	Tension Headache	Aspirin Free	Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20070117		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
59779-826_e9989239-e31b-4115-9737-2aa4e32de868	59779-826	HUMAN OTC DRUG	Therapeutic Plus		Coal Tar	SHAMPOO	TOPICAL	20020524		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy, Inc	COAL TAR	25	mg/mL			N	20241231
59779-830_fcfda45e-73cb-4421-e053-6294a90a2fbf	59779-830	HUMAN OTC DRUG	Mouth Sore Relief	Professional Strength	Benzocaine	LIQUID	ORAL	20091001		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
59779-836_62d9661a-1574-4ec2-8e2e-ceab4b32b166	59779-836	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20131206		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy, Inc	PYRITHIONE ZINC	10.3	mg/mL			N	20241231
59779-837_7190ad84-4bc3-4101-af56-d314486d12cf	59779-837	HUMAN OTC DRUG	allergy relief	childrens	Cetirizine HCl	SOLUTION	ORAL	20150911		ANDA	ANDA204226	CVS Pharmacy	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-838_c91b5525-6afb-4fea-afcb-9c4578075975	59779-838	HUMAN OTC DRUG	CVS Health Four Actions Nasal Decongestant		Phenylephrine hydrochloride	SPRAY	NASAL	20150401		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-839_e9c043c4-5753-43a0-9470-cd261e87bb98	59779-839	HUMAN OTC DRUG	Miconazole 3		Miconazole nitrate	KIT		20140228		ANDA	ANDA076357	CVS Pharmacy						N	20241231
59779-845_da9e97c3-6f9f-4c5e-b387-851a7425e777	59779-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20150626		OTC MONOGRAPH FINAL	part344	CVS Pharmacy, Inc	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
59779-850_6392da7f-f874-4e07-aba1-0c2186493e5c	59779-850	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20160315		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy, Inc.	COAL TAR	1.02	mg/mL			N	20241231
59779-855_c7e8af13-d9dc-4c92-9348-daa95e652867	59779-855	HUMAN OTC DRUG	Tartar control		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130105		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59779-861_e30e7fae-c452-4c41-bfd1-697ab3b071a6	59779-861	HUMAN OTC DRUG	Oil Free Moisturizer		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20160225		OTC MONOGRAPH FINAL	part352	CVS Pharmacy	AVOBENZONE; OCTINOXATE; OCTISALATE	30.6; 76.5; 51	mg/mL; mg/mL; mg/mL			N	20241231
59779-862_4a34f1a9-9492-41a9-a218-f8fa9e718532	59779-862	HUMAN OTC DRUG	Acid Reducer Plus Antacid		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20160211		ANDA	ANDA077355	CVS Pharmacy	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
59779-869_5cd56325-8fa1-41c8-9c63-926f6e6418d2	59779-869	HUMAN OTC DRUG	Childrens Allergy Relief	Dye Free	Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20150320		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-871_cb258ac0-1e08-4e6b-8e3c-4cfee722ab9b	59779-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	19920715		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
59779-873_2a685000-7697-49e7-a70e-e5bbfa928878	59779-873	HUMAN OTC DRUG	nicotine		Nicotine polacrilex	LOZENGE	ORAL	20060222		ANDA	ANDA077007	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-874_748aacd4-c3c2-43b1-a417-1b33eec41168	59779-874	HUMAN OTC DRUG	allergy relief	childrens	Diphenhydramine HCl	SOLUTION	ORAL	20150903		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-878_6f0c85d8-2fcc-47ee-b864-a394cb49e390	59779-878	HUMAN OTC DRUG	cortisone		Hydrocortisone	LOTION	TOPICAL	20120410		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
59779-879_d747cb6b-733d-45c3-a89d-8911f48683fd	59779-879	HUMAN OTC DRUG	PMS Relief	Maximum Strength	Acetaminophen, Pamabrom, Pyrilamine Maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
59779-883_0ef30f66-0bb5-40fd-9801-8b5542274b04	59779-883	HUMAN OTC DRUG	CVS Health Anti-Diarrheal Vanilla		Bismuth subsalicylate	SUSPENSION	ORAL	20150811		OTC MONOGRAPH FINAL	part335	CVS Pharmacy,Inc.	BISMUTH SUBSALICYLATE	262	mg/15mL			N	20241231
59779-884_ea2945ff-421a-4167-9450-0c2c33b2b726	59779-884	HUMAN OTC DRUG	Allergy Relief	Childrens	cetirizine Hydrochloride	SOLUTION	ORAL	20100818		ANDA	ANDA090254	CVS Pharmacy	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-893_1f7fd9fb-9e67-414b-bfbe-9a23381f7eb5	59779-893	HUMAN OTC DRUG	CVS Health Nighttime Sleep-Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20150211		OTC MONOGRAPH FINAL	part338	CVS Pharmacy,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-893_3a0cf0e2-c98f-403c-85d6-22151e90a53a	59779-893	HUMAN OTC DRUG	CVS Health Nighttime Sleep-Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20150922		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-893_eca10974-0d7f-478b-ac72-58c0cbe4d671	59779-893	HUMAN OTC DRUG	CVS Health Nighttime Sleep-Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20160714		OTC MONOGRAPH FINAL	part338	CVS Pharmacy,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-894_ae424c58-58b7-4187-beb6-1c8335451388	59779-894	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen, Aspirin, Diphenhydramine citrate	TABLET, FILM COATED	ORAL	20160831		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE	250; 250; 38	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59779-895_7dd90b88-ee88-408b-a60a-c2ea0242a21f	59779-895	HUMAN OTC DRUG	CVS Health Sore Throat Fast Relief Oral Anesthetic		Phenol	SPRAY	ORAL	20150818		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy,Inc.	PHENOL	1.4	g/100mL			N	20241231
59779-897_2bdc7b96-e823-4260-8e69-ad12d96be47c	59779-897	HUMAN OTC DRUG	ibuprofen	childrens	Ibuprofen	SUSPENSION	ORAL	19990107		ANDA	ANDA074937	CVS Pharmacy	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-898_ebdda38f-6549-4a29-9a57-e170fd6d28c5	59779-898	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20090512		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59779-910_f41d0c0f-5cd5-4242-e053-2995a90ab449	59779-910	HUMAN OTC DRUG	CVS Health Maximum Strength Lidocaine Pain Relief Cream Plus Menthol		Lidocaine HCl, Menthol	CREAM	TOPICAL	20201214		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	LEVOMENTHOL; LIDOCAINE HYDROCHLORIDE	10; 40	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59779-911_780df643-74fa-455b-a01e-920bd3e841bc	59779-911	HUMAN OTC DRUG	CVS Sheer SFP 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20150714		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
59779-914_4efc4879-cae3-4f61-b205-32b62f006a66	59779-914	HUMAN OTC DRUG	naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20150722		ANDA	ANDA074661	CVS Pharmacy	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-919_cef8b9ed-1794-4ae1-a679-a75d51f99788	59779-919	HUMAN OTC DRUG	tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19941207		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-922_f19aa2b9-314f-df1e-e053-2a95a90a9a19	59779-922	HUMAN OTC DRUG	CVS Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20131016		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59779-923_ed065a87-d70a-441e-a87c-8844edd25878	59779-923	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59779-926_83591a87-bb64-41ea-ab9b-229b1d49fe8d	59779-926	HUMAN OTC DRUG	Flu and Severe Cold	Daytime Relief	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	LIQUID	ORAL	20150531	20241227	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
59779-930_fa2f1ceb-0037-43af-89c6-ccb4413f360a	59779-930	HUMAN OTC DRUG	Menstrual Relief		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
59779-942_122f4c0a-d034-43fe-a9f4-c4a15abfc12a	59779-942	HUMAN OTC DRUG	Tartar Control Plus		eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130913		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59779-944_a7883afc-7ebc-4dcd-b4b0-037f0e586692	59779-944	HUMAN OTC DRUG	Hemorrhoidal		glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum	CREAM	TOPICAL	20080206		OTC MONOGRAPH FINAL	part346	CVS Pharmacy	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-945_920e7fc5-78de-4ba9-afea-a7133da16c25	59779-945	HUMAN OTC DRUG	ASPIRIN	Low Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20140725		OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59779-946_8d40ef34-c780-4ecb-9f5a-457e95cedb4e	59779-946	HUMAN OTC DRUG	infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20111214		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
59779-957_77978c1e-ef74-4103-9966-86e368f68de3	59779-957	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130213		ANDA	ANDA203690	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
59779-958_1050b33f-4bfe-49cf-9764-006619ed9647	59779-958	HUMAN OTC DRUG	Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20130716		ANDA	ANDA091135	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
59779-959_309435f5-4348-4235-8bb3-13f9b222dc8e	59779-959	HUMAN OTC DRUG	CVS Pharmacy		Saline Laxative	ENEMA	RECTAL	20130308		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
59779-960_d8876a67-ab60-4217-b801-1b028e9f6bd1	59779-960	HUMAN OTC DRUG	anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20030421		ANDA	ANDA075232	CVS Pharmacy	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
59779-961_88191c8d-9086-46db-8241-48b5f1dd1f97	59779-961	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20141120		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
59779-962_0d9217f0-1e3c-4527-9366-37991f720045	59779-962	HUMAN OTC DRUG	Sinus PE plus Allergy	Maximum Strength	Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20050609		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
59779-971_9de1b817-5799-4976-b544-d15ecf96c21a	59779-971	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20140129		ANDA	ANDA074937	CVS Pharmacy	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59779-995_434a2693-9d77-4a1f-8701-184cf11d8668	59779-995	HUMAN OTC DRUG	infants ibuprofen		ibuprofen	SUSPENSION	ORAL	19991108		ANDA	ANDA075217	CVS Pharmacy	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
59788-001_0c02fa25-1eb5-b8da-e063-6394a90af29d	59788-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19860501		NDA	NDA205712	Arcet Equipment Company dba Arc3 Gases North	OXYGEN	995	mL/L			N	20241231
59788-002_0c03269f-ebe7-c3b0-e063-6394a90a4c64	59788-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20070115		NDA	NDA205713	Arcet Equipment Company dba Arc3 Gases North	NITROGEN	990	mL/L			N	20241231
59788-003_0c030374-8430-b68a-e063-6394a90af734	59788-003	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20200513		NDA	NDA205764	Arcet Equipment Company dba Arc3 Gases North	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
59800-1365_ef847088-ee15-4977-a333-cac0a4ccbe19	59800-1365	HUMAN OTC DRUG	Muca Clear		GUAIFENESIN	TABLET	ORAL	20200924		OTC MONOGRAPH DRUG	M012	Schwabe North America, Inc	GUAIFENESIN	200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
59800-3656_b83fb126-816a-4340-8594-8f71dc229bef	59800-3656	HUMAN OTC DRUG	vClear Berry Dissolving Tablets		Pelargonium sidoides, Aconitum Napellus, Bryonia, Eucalyptus Globulus, Eupatorium Perfoliatum, Gelsemium Sempervirens, Ipecacuanha, Phosphorus	TABLET, CHEWABLE	ORAL	20200924		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
59800-8001_054416e6-f028-451d-9638-6b45593b5c9a	59800-8001	HUMAN OTC DRUG	ViraClear EPs 7630 Original		Pelargonium sidoides	LIQUID	ORAL	20090824		UNAPPROVED HOMEOPATHIC		Schwabe North America	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/30mL			N	20241231
59800-8002_f921b7d4-2c11-4867-be19-ec9740026efe	59800-8002	HUMAN OTC DRUG	ViraClear EPs 7630 Cherry Flavor		Pelargonium sidoides	LIQUID	ORAL	20090824		UNAPPROVED HOMEOPATHIC		Schwabe North America, Inc	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/120mL			N	20241231
59842-012_06d33b7f-69fc-472f-e063-6294a90a7624	59842-012	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091006		UNAPPROVED MEDICAL GAS		Fitzsimmons Surgical Supply, Inc	OXYGEN	99	L/100L			N	20241231
59860-002_0a44c9f8-1222-64f5-e063-6394a90a6ad7	59860-002	HUMAN OTC DRUG	First Street Hand Sanitizer fresh lemon		ALCOHOL	LIQUID	TOPICAL	20210715		OTC MONOGRAPH DRUG	M003	SMART & FINAL STORES LLC	ALCOHOL	70	mL/100mL			N	20241231
59883-004_0a96438c-733f-8bce-e063-6394a90a0ce7	59883-004	HUMAN OTC DRUG	Fluoridex		Stannous Fluoride Rinse	LIQUID	ORAL	20160111		OTC MONOGRAPH DRUG	M021	DEN-MAT HOLDINGS, LLC	STANNOUS FLUORIDE	1.53	mg/g			N	20241231
59883-015_82f8ac58-f94c-255b-e053-2a91aa0aceb7	59883-015	HUMAN PRESCRIPTION DRUG	FLUORIDEX		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20170106		UNAPPROVED DRUG OTHER		DEN-MAT HOLDINGS, LLC.	SODIUM FLUORIDE	5	mg/g			N	20241231
59883-016_82f8ac58-f95d-255b-e053-2a91aa0aceb7	59883-016	HUMAN PRESCRIPTION DRUG	FLUORIDEX		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20161230		UNAPPROVED DRUG OTHER		DEN-MAT HOLDINGS, LLC.	SODIUM FLUORIDE	5	mg/g			N	20241231
59883-017_0a9634f3-de9e-6b35-e063-6394a90a9db5	59883-017	HUMAN OTC DRUG	Perio Daily Defense		Hydrogen Peroxide	GEL	DENTAL	20190116		OTC MONOGRAPH DRUG	M022	DEN-MAT HOLDINGS, LLC.	HYDROGEN PEROXIDE	17	mg/g			N	20241231
59883-017_e77b0956-0c5c-26d7-e053-2a95a90add9b	59883-017	HUMAN OTC DRUG	Perio Daily Defense		Hydrogen Peroxide	GEL	TOPICAL	20220831		OTC MONOGRAPH NOT FINAL	part356	Den-Mat Holdings, LLC	HYDROGEN PEROXIDE	17	mg/g			N	20241231
59883-018_0a0d08d7-e3f3-d98d-e063-6394a90af5e9	59883-018	HUMAN OTC DRUG	PerioRestore		Hydrogen Peroxide	GEL	DENTAL	20190715		OTC MONOGRAPH DRUG	M022	DEN-MAT HOLDINGS, LLC.	HYDROGEN PEROXIDE	17	mg/g			N	20241231
59883-020_82f8eacb-a214-3080-e053-2a91aa0a6a07	59883-020	HUMAN PRESCRIPTION DRUG	FLUORIDEX		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20170103		UNAPPROVED DRUG OTHER		DEN-MAT HOLDINGS, LLC.	SODIUM FLUORIDE	5	mg/g			N	20241231
59883-030_020d58ac-51bc-19a2-e063-6394a90aedf6	59883-030	HUMAN PRESCRIPTION DRUG	FLUORIDEX		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20170106		UNAPPROVED DRUG OTHER		DENT-MAT HOLDINGS, LLC.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 5	mg/g; mg/g			N	20241231
59883-031_020d58ac-51ab-19a2-e063-6394a90aedf6	59883-031	HUMAN PRESCRIPTION DRUG	FLUORIDEX		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20161221		UNAPPROVED DRUG OTHER		DENT-MAT HOLDINGS, LLC.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 5	mg/g; mg/g			N	20241231
59883-175_7a8e1379-7dd2-4d3f-9c06-240ceffc64d6	59883-175	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20090618		ANDA	ANDA077789	Den-mat Holdings, Llc	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
59883-404_0cdea808-d8ee-73b5-e063-6294a90a71bf	59883-404	HUMAN OTC DRUG	kids kare		Stannous Fluoride	GEL	DENTAL; ORAL	20171012		OTC MONOGRAPH DRUG	M021	DEN-MAT HOLDINGS, LLC.	STANNOUS FLUORIDE	.969	mg/g			N	20241231
59883-405_e27482fb-51b4-1f64-e053-2995a90a4dd9	59883-405	HUMAN OTC DRUG	ClearArc		Stannous Fluoride gel	GEL	TOPICAL	20220707		OTC MONOGRAPH FINAL	part355	Den-Mat Holdings, LLC	STANNOUS FLUORIDE	.969	mg/g			N	20241231
59883-600_fd187009-9be9-5326-e053-6294a90a538b	59883-600	HUMAN OTC DRUG	Oral Pro Care		Cavity Protection Gel	GEL	TOPICAL	20230614		OTC MONOGRAPH FINAL	part355	Den-Mat Holdings, LLC	STANNOUS FLUORIDE	.969	mg/g			N	20241231
59883-718_0cdea817-1b4d-498a-e063-6294a90a4b94	59883-718	HUMAN OTC DRUG	Kids Kare		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL; ORAL	20171026		OTC MONOGRAPH DRUG	M021	DEN-MAT HOLDINGS, LLC.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
59883-720_0a95fcbe-e811-031d-e063-6294a90aec1b	59883-720	HUMAN OTC DRUG	Pro-Den Rx		Stannous Fluoride	RINSE	ORAL	20081031		OTC MONOGRAPH DRUG	M021	Den-mat Holdings, Llc	STANNOUS FLUORIDE	1.53	mg/g			N	20241231
59883-820_82f9290a-dfa2-1ba2-e053-2991aa0a41f4	59883-820	HUMAN OTC DRUG	Pro-Den Rx		Sodium Fluoride	GEL	ORAL	20081031		OTC MONOGRAPH FINAL	part355	DEN-MAT HOLDINGS, LLC	SODIUM FLUORIDE	4.3	g/g			N	20241231
59883-821_8349a34e-ac6f-79c3-e053-2a91aa0a857a	59883-821	HUMAN OTC DRUG	Pro-Den Rx		Sodium Fluoride	GEL	ORAL	20081121		OTC MONOGRAPH FINAL	part355	DEN-MAT HOLDINGS, LLC	SODIUM FLUORIDE	4.3	g/g			N	20241231
59883-824_82f925fe-19ca-720a-e053-2a91aa0a9b27	59883-824	HUMAN PRESCRIPTION DRUG	Pro-Den Rx		Sodium Fluoride	GEL	ORAL	20090120		UNAPPROVED DRUG OTHER		Den-mat Holdings, Llc	SODIUM FLUORIDE	4.3	g/g			N	20241231
59883-911_6a0ff4f9-a7f9-1e75-e053-2991aa0a2782	59883-911	HUMAN PRESCRIPTION DRUG	Pro-Den Rx		Sodium Fluoride	RINSE	ORAL	20081021		UNAPPROVED DRUG OTHER		Den-Mat Holdings, Llc	SODIUM FLUORIDE	9	mg/mL			N	20241231
59883-920_82f8dd55-36df-0de0-e053-2991aa0a6bbf	59883-920	HUMAN PRESCRIPTION DRUG	Pro-Den Rx		Sodium Fluoride	RINSE	ORAL	20081021		UNAPPROVED DRUG OTHER		Den-mat Holdings, Llc	SODIUM FLUORIDE	.9	mg/mL			N	20241231
59898-140_5fc13f20-632f-7cf3-e053-2a91aa0aee0f	59898-140	HUMAN OTC DRUG	EBSL-5		Lidocaine Hydrochloride	KIT		20140611		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies						N	20241231
59898-160_5fc0f081-b7a6-22e3-e053-2991aa0a4324	59898-160	HUMAN OTC DRUG	EBSS-5		Lidocaine Hydrochloride	KIT		20140611		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies						N	20241231
59898-170_5fc0e70e-35a7-6fdd-e053-2a91aa0ad0b3	59898-170	HUMAN OTC DRUG	FSK-5		Lidocaine Hydrochloride	KIT		20140611		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies						N	20241231
59898-180_5fc11494-a75c-7010-e053-2a91aa0afd34	59898-180	HUMAN OTC DRUG	IWK-5		Lidocaine Hydrochloride	KIT		20140612		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies						N	20241231
59898-200_b6d998cb-999d-2226-e053-2a95a90aec39	59898-200	HUMAN OTC DRUG	Burn Jel		Lidocaine Hydrochloride	GEL	TOPICAL	20100417		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies	LIDOCAINE HYDROCHLORIDE	2	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59898-201_b7027975-d7aa-68b2-e053-2a95a90a05bd	59898-201	HUMAN OTC DRUG	Burn Mist		Lidocaine Hydrochloride	SPRAY	TOPICAL	20100517		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies	LIDOCAINE HYDROCHLORIDE	2	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59898-202_5f4b670a-63df-dfc4-e053-2991aa0a4b1c	59898-202	HUMAN OTC DRUG	Burn Jel Plus		Gel for Burns	GEL	TOPICAL	20100410		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies	LIDOCAINE HYDROCHLORIDE	2.5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59898-401_b70375bd-ddfd-b150-e053-2a95a90a3bc1	59898-401	HUMAN OTC DRUG	First Aid Antiseptic		Benzalkonium chloride	SPRAY	TOPICAL	20100522		OTC MONOGRAPH NOT FINAL	part333A	Water-Jel Technologies	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
59898-402_b70405f8-755f-2b87-e053-2995a90a09a0	59898-402	HUMAN OTC DRUG	Isopro First Aid		Isopropyl Alcohol	SPRAY	TOPICAL	20100523		OTC MONOGRAPH NOT FINAL	part333A	Water-Jel Technologies	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
59898-420_eeba6f9b-9e33-5b62-e053-2995a90a948b	59898-420	HUMAN OTC DRUG	Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20100415		OTC MONOGRAPH NOT FINAL	part333E	Water-Jel Technologies	ALCOHOL	62	mL/100mL			N	20241231
59898-500_5f4b97f0-64af-6766-e053-2a91aa0abc98	59898-500	HUMAN OTC DRUG	Unburn		Lidocaine hydrochloride	GEL	TOPICAL	20130317		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies	LIDOCAINE HYDROCHLORIDE	2.5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59898-510_5f39ef62-2d41-a330-e053-2991aa0a7181	59898-510	HUMAN OTC DRUG	Unburn		Lidocaine hydrochloride	SPRAY	TOPICAL	20140201		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies	LIDOCAINE HYDROCHLORIDE	2.5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59898-720_b703a69b-a18d-1e8c-e053-2a95a90a0474	59898-720	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20101107		OTC MONOGRAPH FINAL	part333B	Water-Jel Technologies	BACITRACIN ZINC	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
59898-730_b704747a-4761-3134-e053-2995a90a6016	59898-730	HUMAN OTC DRUG	Water-Jel Neomycin Antibiotic		First Aid Ointment	OINTMENT	TOPICAL	20100331		OTC MONOGRAPH FINAL	part333B	Water-Jel Technologies	NEOMYCIN SULFATE	3.5	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
59898-740_5e332a38-e153-d2c4-e053-2a91aa0abb49	59898-740	HUMAN OTC DRUG	Water-Jel 3-in-1 Antibiotic		Bacitracin zinc, Polymyxin B Sulfate, Neomycin Sulfate	OINTMENT	TOPICAL	20100330		OTC MONOGRAPH FINAL	part333B	Water-Jel Technologies	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	417.8; 3.5; 5322.8	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
59898-805_b70fb82c-4c5d-e4c7-e053-2995a90aa022	59898-805	HUMAN OTC DRUG	MUSCLE		Menthol	GEL	TOPICAL	20100419		OTC MONOGRAPH NOT FINAL	part348	WATER-JEL TECHNOLOGIES	MENTHOL	3.5	g/100mL			N	20241231
59898-810_b70f3703-29da-94b4-e053-2a95a90a8bb9	59898-810	HUMAN OTC DRUG	Itch Relief		Diphenhydramine Hydrochloride	SPRAY	TOPICAL	20100925		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies, LLC.	DIPHENHYDRAMINE HYDROCHLORIDE	2	g/100mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
59898-902_5f3a0aa8-f1a3-6d47-e053-2a91aa0a77fa	59898-902	HUMAN OTC DRUG	First Aid Burn		Benzalkonium Chloride, Lidocaine Hydrochloride	CREAM	TOPICAL	20100420		OTC MONOGRAPH NOT FINAL	part348	Water-Jel Technologies	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
59899-002_09495cdc-6fd1-9f95-e063-6394a90a7d5c	59899-002	HUMAN OTC DRUG	enfuselle Acne Clarifying		SALICYLIC ACID	LOTION	TOPICAL	20130808		OTC MONOGRAPH DRUG	M006	Shaklee Corporation	SALICYLIC ACID	5	mg/mL			N	20241231
59899-007_0949a165-7664-8fc6-e063-6294a90a9cb3	59899-007	HUMAN OTC DRUG	enfuselle BODY SUNSCREEN BROAD SPECTRUM SPF 30		HOMOSALATE, OCTISALATE, AVOBENZONE, and OCTOCRYLENE	LOTION	TOPICAL	20131111		OTC MONOGRAPH DRUG	M020	Shaklee Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
59899-010_0949bf30-fab9-b9ff-e063-6394a90ad4dc	59899-010	HUMAN OTC DRUG	Youth 1 Activating BB Cream SPF 30 Light		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20170809		OTC MONOGRAPH DRUG	M020	Shaklee Corporation	TITANIUM DIOXIDE; ZINC OXIDE	23.6; 63	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59899-011_0949a165-7675-8fc6-e063-6294a90a9cb3	59899-011	HUMAN OTC DRUG	Youth 2 Activating BB Cream SPF 30 Light Medium		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20170809		OTC MONOGRAPH DRUG	M020	Shaklee Corporation	TITANIUM DIOXIDE; ZINC OXIDE	23.6; 63	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59899-012_0949ca0e-975d-8e96-e063-6294a90a64d8	59899-012	HUMAN OTC DRUG	Youth 3 Activating BB Cream SPF 30 Medium		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20170809		OTC MONOGRAPH DRUG	M020	Shaklee Corporation	TITANIUM DIOXIDE; ZINC OXIDE	23.6; 63	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59899-013_0949b0a5-28ff-b0ad-e063-6394a90a2a3b	59899-013	HUMAN OTC DRUG	Youth 4 Activating BB Cream SPF 30 Dark		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20170809		OTC MONOGRAPH DRUG	M020	Shaklee Corporation	TITANIUM DIOXIDE; ZINC OXIDE	23.6; 63	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59899-020_ebe12e78-b8c1-0f12-e053-2a95a90aa73c	59899-020	HUMAN OTC DRUG	Shaklee Essentials Desert Wind Roll-On Antiperspirant		Aluminum Chlorohydrate	LOTION	TOPICAL	20170605	20240701	OTC MONOGRAPH FINAL	part350	Shaklee Corporation	ALUMINUM CHLOROHYDRATE	160	mg/mL			N	
59899-022_0949a165-7685-8fc6-e063-6294a90a9cb3	59899-022	HUMAN OTC DRUG	Joint and Muscle Pain		MENTHOL	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	M017	Shaklee Corporation	MENTHOL	50	mg/g			N	20241231
59899-023_09c282c0-4e41-8772-e063-6294a90ae4dd	59899-023	HUMAN OTC DRUG	Shaklee Youth Age Defense Mineral Moisturizer SPF 30		TITANIUM DIOXIDE	CREAM	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	Shaklee Corporation	TITANIUM DIOXIDE	42	mg/mL			N	20241231
59900-117_805fcd8e-62a0-be42-e053-2a91aa0a7814	59900-117	HUMAN OTC DRUG	Smart San Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20081201		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc	ALCOHOL	620	mL/1000mL			N	20241231
59900-118_868043a2-e4b0-6b5d-e053-2a91aa0ac033	59900-118	HUMAN OTC DRUG	Smart San Alcohol Free Hand Sanitizer Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20090715		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc	BENZALKONIUM CHLORIDE	1	g/1000mL			N	20241231
59900-121_b76459d8-747c-86f9-e053-2a95a90ab654	59900-121	HUMAN OTC DRUG	Smart San Hand Sanitizer		Alcohol	GEL	TOPICAL	20201226		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	ALCOHOL	64	mL/100mL			N	20241231
59900-122_80a4bd1e-f395-4f44-a62a-f8812af71202	59900-122	HUMAN OTC DRUG	ALPET E3 HAND SANITIZER		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20190426		OTC MONOGRAPH NOT FINAL	part333A	Best Sanitizers, Inc.	ISOPROPYL ALCOHOL	76	mL/100mL			N	20241231
59900-123_a3f0edf9-2cf7-49de-b2bc-b2ce80716e35	59900-123	HUMAN OTC DRUG	ALPET E3 PLUS HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20190426		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	ALCOHOL	71	mL/100mL			N	20241231
59900-124_06244bb2-2cf3-458b-a2c8-8e23c63147a1	59900-124	HUMAN OTC DRUG	SMART SAN HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20190510		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	ALCOHOL	65	mm/100mL			N	20241231
59900-125_d9f42e60-80f6-0d33-e053-2995a90a66da	59900-125	HUMAN OTC DRUG	ALPET E3 HAND SANITIZER FOAM		ALCOHOL	LIQUID	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	ALCOHOL	62	mL/100mL			N	20241231
59900-126_a5ef9c43-c363-40dd-af01-03e7472d6da8	59900-126	HUMAN OTC DRUG	SMART SAN HAND SANITIZER FRAGRANCE-FREE		ALCOHOL	LIQUID	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	ALCOHOL	71	mL/100mL			N	20241231
59900-127_4840907f-f0b3-4f41-8f02-5b309d25c36a	59900-127	HUMAN OTC DRUG	SoftenSure Foam Antimicrobial		CHLOROXYLENOL	LIQUID	TOPICAL	20190515		OTC MONOGRAPH NOT FINAL	part333A	Best Sanitizers, Inc.	CHLOROXYLENOL	10	mg/mL			N	20241231
59900-128_e34ab6f9-e3c2-43ae-95ab-f75b512a2a89	59900-128	HUMAN OTC DRUG	ALPET E2 Sanitizing Foam		CHLOROXYLENOL	LIQUID	TOPICAL	20190514		OTC MONOGRAPH NOT FINAL	part333A	Best Sanitizers, Inc.	CHLOROXYLENOL	15	mg/mL			N	20241231
59900-129_34f26f9a-551e-4063-823f-bad983560acc	59900-129	HUMAN OTC DRUG	SMART SAN HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20190426		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	ALCOHOL	64	mL/100mL			N	20241231
59900-130_7e830d5a-c8e5-539d-e053-2a91aa0a3590	59900-130	HUMAN OTC DRUG	Alpet Q E2		Benzalkonium Chloride	LIQUID	TOPICAL	20090715		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc	BENZALKONIUM CHLORIDE	1.2	g/1000mL			N	20241231
59900-208_7ea191f7-3423-36b8-e053-2a91aa0a43c0	59900-208	HUMAN OTC DRUG	Alpet E2 Sanitizing Foam		Chloroxylenol	SOAP	TOPICAL	20080201		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizer, Inc.	CHLOROXYLENOL	15	g/1000mL			N	20241231
59900-211_7ea243e7-a319-2571-e053-2991aa0a7c68	59900-211	HUMAN OTC DRUG	Soften Sure Foam Antimicrobial		Chloroxylenol	LIQUID	TOPICAL	20080901		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc	CHLOROXYLENOL	10	g/1000mL			N	20241231
59900-214_a9506e61-1f02-43e1-9fea-eeed351cc3d8	59900-214	HUMAN OTC DRUG	ALPET QE2 SANITIZING FOAM		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20190503		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	BENZALKONIUM CHLORIDE	1.2	mg/mL			N	20241231
59900-215_31a32a1b-2828-46c0-a7c0-d175bad997fe	59900-215	HUMAN OTC DRUG	HACCP Q E2 Sanitizing		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20190503		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc.	BENZALKONIUM CHLORIDE	1.2	mg/mL			N	20241231
59900-350_b3eeabce-7903-30ea-e053-2995a90a2867	59900-350	HUMAN OTC DRUG	Alsoft V professional hand sanitizer		Alcohol	SPRAY	TOPICAL	20201027		OTC MONOGRAPH NOT FINAL	part333E	Best Santizers, Inc.	ALCOHOL	78	mL/100mL			N	20241231
59900-351_b3ec9444-0fe1-6597-e053-2a95a90ac236	59900-351	HUMAN OTC DRUG	Alsoft W hand sanitizer		Alcohol	GEL	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333A	Best Sanitizers, Inc	ALCOHOL	78.3	mL/100mL			N	20241231
59900-718_7e827559-06ca-1e7b-e053-2991aa0ae2a2	59900-718	HUMAN OTC DRUG	HACCP QE2		Benzalkonium Chloride	LIQUID	TOPICAL	20140716		OTC MONOGRAPH NOT FINAL	part333E	Best Sanitizers, Inc	BENZALKONIUM CHLORIDE	1200	ug/mL			N	20241231
59900-757_0eaf12ac-e559-0d2d-e063-6294a90ad9e7	59900-757	HUMAN OTC DRUG	Mirador Health Foaming Alcohol Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20240111		OTC MONOGRAPH DRUG	505G(a)(3)	Best Sanitizers, Inc.	ALCOHOL	74	mL/100mL			N	20251231
59917-102_0cf861f5-7a8c-9ba4-e063-6294a90a601f	59917-102	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE	EXTENDED RELEASE	POTASSIUM CHLORIDE	CAPSULE	ORAL	20180401		ANDA	ANDA208864	Adare Pharmaceuticals Inc	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
59917-103_0cf861f5-7a8c-9ba4-e063-6294a90a601f	59917-103	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE	EXTENDED RELEASE	POTASSIUM CHLORIDE	CAPSULE	ORAL	20180401		ANDA	ANDA208864	Adare Pharmaceuticals Inc	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
59922-631_5d48b527-3cbb-44e3-aadf-94f2d0bf1445	59922-631	HUMAN PRESCRIPTION DRUG	Auryxia		ferric citrate	TABLET, FILM COATED	ORAL	20140917		NDA	NDA205874	Akebia Therapeutics, Inc.	TETRAFERRIC TRICITRATE DECAHYDRATE	210	mg/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
59923-604_f4b6988f-58a9-4593-e053-2a95a90afe36	59923-604	HUMAN PRESCRIPTION DRUG	Fludarabine Phosphate		Fludarabine Phosphate	INJECTION	INTRAVENOUS	20191231		ANDA	ANDA090724	Areva Pharmaceuticals	FLUDARABINE PHOSPHATE	25	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
59923-723_b8e44f52-4f51-e904-e053-2a95a90a1438	59923-723	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, COATED	ORAL	20200301		ANDA	ANDA208302	Areva Pharmaceuticals	IMATINIB MESYLATE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59923-724_b8e44f52-4f51-e904-e053-2a95a90a1438	59923-724	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, COATED	ORAL	20200301		ANDA	ANDA208302	Areva Pharmaceuticals	IMATINIB MESYLATE	400	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59923-725_b8e4409c-f659-4c6d-e053-2a95a90a2526	59923-725	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA211960	Areva Pharmaceuticals	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59923-726_b8e4409c-f659-4c6d-e053-2a95a90a2526	59923-726	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA211960	Areva Pharmaceuticals	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59923-727_b8e4409c-f659-4c6d-e053-2a95a90a2526	59923-727	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA211960	Areva Pharmaceuticals	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
59924-001_0761b91e-565f-f275-e063-6294a90abcf0	59924-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19460101		NDA	NDA205889	Plains Welding Supply, Inc.	OXYGEN	992	mL/L			N	20241231
59958-200_dd44885a-09bd-e29d-e053-2995a90abc50	59958-200	HUMAN OTC DRUG	Anhydrous SPF 30		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20110301		OTC MONOGRAPH NOT FINAL	part352	Owen Biosciences, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	10.2; 3.7	g/100g; g/100g			N	20241231
59958-200_dd449031-7973-e899-e053-2a95a90a0f4d	59958-200	HUMAN OTC DRUG	Anhydrous SPF 30		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20090901		OTC MONOGRAPH FINAL	part352	Owen Biosciences, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	10.2; 3.7	g/100g; g/100g			N	20241231
59958-200_dd451187-2dbd-783d-e053-2995a90ab7c8	59958-200	HUMAN OTC DRUG	Anhydrous SPF 30		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20110301		OTC MONOGRAPH NOT FINAL	part352	Owen Biosciences, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	10.2; 3.7	g/100g; g/100g			N	20241231
59958-201_f2683782-5010-fd77-e053-2a95a90ab1df	59958-201	HUMAN OTC DRUG	Dermaroller Anhydrous Sunscreen	SPF 30	Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20110301		OTC MONOGRAPH NOT FINAL	part352	Owen Biosciences, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	10.2; 3.7	g/100g; g/100g			N	20241231
59958-202_f2682ce3-8cf9-df80-e053-2a95a90ac08a	59958-202	HUMAN OTC DRUG	SFL SUNSCREEN - SOL DEFENSE	SPF 30	Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20120911		OTC MONOGRAPH FINAL	part352	Owen Biosciences Inc.	TITANIUM DIOXIDE; ZINC OXIDE	10.2; 3.7	g/100g; g/100g			N	20241231
59958-220_f268501f-9087-3831-e053-2995a90a09b2	59958-220	HUMAN OTC DRUG	Sente Daily Repair Complex	SPF 30	Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20150402		OTC MONOGRAPH FINAL	part352	Owen Biosciences, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	9.95; 3.72	g/100g; g/100g			N	20241231
59958-230_f268501f-9083-3831-e053-2995a90a09b2	59958-230	HUMAN OTC DRUG	Live Ultimate Facial Sunscreen SPF30	SPF 30	Zinc Oxide	CREAM	TOPICAL	20150505		OTC MONOGRAPH FINAL	part352	Owen Biosciences Inc	ZINC OXIDE	21	g/100g			N	20241231
59958-240_f2677662-4b08-54e7-e053-2995a90a6c9d	59958-240	HUMAN OTC DRUG	Skinfuse Shield	SPF 30	Zinc Oxide	CREAM	TOPICAL	20151117		OTC MONOGRAPH FINAL	part352	Owen Biosciences, Inc.	ZINC OXIDE	21	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59958-240_f2680582-45d8-5d46-e053-2a95a90a0973	59958-240	HUMAN OTC DRUG	Skinfuse Shield	SPF 30	Zinc Oxide	CREAM	TOPICAL	20151111		OTC MONOGRAPH FINAL	part352	Owen Biosciences, Inc.	ZINC OXIDE	21	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59958-401_f267acca-a7d2-9873-e053-2a95a90a5087	59958-401	HUMAN OTC DRUG	SLMD Spot Treatment		Benzoyl Peroxide	GEL	TOPICAL	20170322		OTC MONOGRAPH FINAL	part333D	Owen Biosciences, Inc.	BENZOYL PEROXIDE	10	g/100g			N	20241231
59958-402_f267a49e-2622-0768-e053-2a95a90a8258	59958-402	HUMAN OTC DRUG	SLMD AM Benzoyl Peroxide Acne Treatment		Benzoyl Peroxide	GEL	TOPICAL	20170322		OTC MONOGRAPH FINAL	part333D	Owen Biosciences, Inc.	BENZOYL PEROXIDE	2.5	g/100g			N	20241231
59958-403_f267a962-f6e2-5922-e053-2a95a90affdc	59958-403	HUMAN OTC DRUG	SLMD Moisturizer with SPF		Sunscreen	LOTION	TOPICAL	20170405		OTC MONOGRAPH FINAL	part352	Owen Biosciences, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	2.5; 7.5; 1.5; 3.5	g/100g; g/100g; g/100g; g/100g			N	20241231
59958-404_f26776e7-b857-7c8a-e053-2a95a90aae97	59958-404	HUMAN OTC DRUG	Chem Free SPF 30		Zinc Oxide	CREAM	TOPICAL	20170719		OTC MONOGRAPH FINAL	part352	Owen Biosciences, Inc.	ZINC OXIDE	21	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
59958-405_f2670aa7-f83e-e0d4-e053-2a95a90a95f1	59958-405	HUMAN OTC DRUG	SLMD Salicylic Acid Body Wash		Salicylic Acid	LIQUID	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333D	Owen Biosciences Inc.	SALICYLIC ACID	2	g/100g			N	20241231
59958-407_f2679813-2829-ce9e-e053-2995a90a96f8	59958-407	HUMAN OTC DRUG	SLMD Silver Sulfur Acne Cream		Sulfur	CREAM	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333D	Owen Biosciences Inc.	SULFUR	3	g/100g			N	20241231
59958-408_f2684b4f-05d1-604c-e053-2a95a90afca5	59958-408	HUMAN OTC DRUG	Cream Oil Sunscreen		Zinc Oxide, Titanium Dioxide Sunscreen	CREAM	TOPICAL	20200404		OTC MONOGRAPH FINAL	part352	Owen Biosciences, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	1.25; 21	g/100g; g/100g			N	20241231
59958-500_f2683aff-6dc1-6344-e053-2995a90a2f15	59958-500	HUMAN OTC DRUG	Hand Sanitizer with Aloe		65% Ethyl Alcohol	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	Owen Biosciences, Inc.	ALCOHOL	65	g/100g			N	20241231
59958-500_f2686353-d07e-6cbe-e053-2995a90a7252	59958-500	HUMAN OTC DRUG	Hand Sanitizer with Aloe		65% Ethyl Alcohol	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	Owen Biosciences, Inc.	ALCOHOL	65	g/100g			N	20241231
59958-500_f26864a1-9648-3c2c-e053-2a95a90a0f1f	59958-500	HUMAN OTC DRUG	Hand Sanitizer with Aloe		65% Ethyl Alcohol	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	Owen Biosciences, Inc.	ALCOHOL	65	g/100g			N	20241231
59958-500_f2687bd5-4308-3281-e053-2a95a90a0506	59958-500	HUMAN OTC DRUG	Hand Sanitizer with Aloe		65% Ethyl Alcohol	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	Owen Biosciences, Inc.	ALCOHOL	65	g/100g			N	20241231
59958-500_f26889a6-68c9-1918-e053-2995a90a3068	59958-500	HUMAN OTC DRUG	Hand Sanitizer with Aloe		65% Ethyl Alcohol	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	Owen Biosciences, Inc.	ALCOHOL	65	g/100g			N	20241231
59958-500_f268a751-fee8-2454-e053-2995a90a45b8	59958-500	HUMAN OTC DRUG	Hand Sanitizer with Aloe		65% Ethyl Alcohol	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	Owen Biosciences, Inc.	ALCOHOL	65	g/100g			N	20241231
59958-500_f268a751-fee9-2454-e053-2995a90a45b8	59958-500	HUMAN OTC DRUG	Hand Sanitizer with Aloe		65% Ethyl Alcohol	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	Owen Biosciences, Inc.	ALCOHOL	65	g/100g			N	20241231
59958-601_dabd3b95-01d4-014c-e053-2a95a90a0fec	59958-601	HUMAN OTC DRUG	FHF Elevated Shade 100% Mineral Sunscreen		sunscreen	LOTION	TOPICAL	20220321		OTC MONOGRAPH FINAL	part352	Owen Biosciences Inc	ZINC OXIDE	.21	g/g			N	20241231
59961-151_f6420629-b5f9-910e-e053-2a95a90ad30c	59961-151	HUMAN OTC DRUG	Travel Savvy Non-Aspirin		Acetaminophen 325mg	TABLET, COATED	ORAL	20141013		OTC MONOGRAPH NOT FINAL	part343	Bellegrove Medical Supply, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
59961-616_02e6c515-b2c9-8055-e063-6294a90aded1	59961-616	HUMAN OTC DRUG	Travel Savvy Aspirin		Aspirin	TABLET, COATED	ORAL	20210215		OTC MONOGRAPH NOT FINAL	part343	Bellegrove Medical Supply, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
59961-620_02e6c515-b2c9-8055-e063-6294a90aded1	59961-620	HUMAN OTC DRUG	Travel Savvy Aspirin		Aspirin	TABLET, COATED	ORAL	20210215	20240401	OTC MONOGRAPH NOT FINAL	part343	Bellegrove Medical Supply, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
59970-253_486f7612-526e-14d1-e054-00144ff88e88	59970-253	HUMAN OTC DRUG	Vida Mia Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101028		OTC MONOGRAPH FINAL	part358G	Navarro Discount Pharmacies, LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
59998-101_0e9ca1bf-c34d-2b8d-e063-6294a90a0bf5	59998-101	HUMAN OTC DRUG	BIOCENCE		EUCALYPTOL THYMOL	LOTION	TOPICAL	20121026		OTC MONOGRAPH DRUG	M003	Bio-Germ Protection LLC	EUCALYPTOL; THYMOL	.091; .063	g/100mL; g/100mL			N	20251231
59998-102_0e8bfce4-0e9e-7673-e063-6394a90a528f	59998-102	HUMAN OTC DRUG	BIOCENCE		EUCALYPTOL THYMOL	SPRAY	TOPICAL	20121026		OTC MONOGRAPH DRUG	M003	Bio-Germ Protection LLC	EUCALYPTOL; THYMOL	.091; .063	g/100mL; g/100mL			N	20251231
59998-201_0970df5b-b952-ec1b-e063-6394a90a3d5d	59998-201	HUMAN OTC DRUG	BIOCENCE		EUCALYPTOL, THYMOL	LOTION	TOPICAL	20121026		UNAPPROVED HOMEOPATHIC		Bio-Germ Protection LLC	EUCALYPTOL; THYMOL	.091; .063	g/100mL; g/100mL			N	20241231
59998-202_0970e36b-9058-e445-e063-6394a90af7e9	59998-202	HUMAN OTC DRUG	BIOCENCE		EUCALYPTOL THYMOL	SPRAY	TOPICAL	20121026		UNAPPROVED HOMEOPATHIC		Bio-Germ Protection LLC	EUCALYPTOL; THYMOL	.091; .063	g/100mL; g/100mL			N	20241231
60000-020_8f0def42-6000-4167-b11d-e157fd9aadeb	60000-020	HUMAN OTC DRUG	Zinc Oxide		ZINC OXIDE	OINTMENT	TOPICAL	20220707		OTC MONOGRAPH FINAL	part347	AHOLD U.S.A., INC.	ZINC OXIDE	400	mg/g			N	20241231
60000-057_9c159223-d3f0-48ae-9e4f-f5896838c034	60000-057	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Ahold U.S.A., Inc,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
60000-058_bab0bd5d-74e4-48cb-9990-6f5944c3d3dc	60000-058	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Ahold U.S.A., Inc,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
60000-069_86e82e89-95f6-48f3-9532-ff2454d5ea92	60000-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20230124		OTC MONOGRAPH FINAL	part347	Ahold U.S.A., Inc.	PETROLATUM	1	g/g			N	20241231
60000-109_685be4c9-9bc4-4325-bb42-08eeebb05c9e	60000-109	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016		ANDA	ANDA209339	Ahold U.S.A., Inc,	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60000-326_09d64076-c0e0-fb0e-e063-6394a90aa4d5	60000-326	HUMAN OTC DRUG	Care One 70 Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20170116		OTC MONOGRAPH DRUG	M003	Ahold U.S.A., Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
60000-911_d35a1976-61c9-a97a-e053-2a95a90a961a	60000-911	HUMAN OTC DRUG	PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part348	Ahold U.S.A., Inc,	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
60000-950_d84e29dc-9c76-4b9c-a260-9d04c5f83bc1	60000-950	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	Ahold U.S.A., Inc,	LORATADINE	10	mg/1			N	20241231
60055-334_8b7c01d9-7eae-41df-af40-3996cdbfe353	60055-334	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F-18	INJECTION, SOLUTION	INTRAVENOUS	20101120		ANDA	ANDA203920	Jubilant DraxImage Inc., dba Jubilant Radiopharma	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20251231
60184-001_d16e9f88-8c4a-48f4-bba6-dbd5b991d8eb	60184-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19640106		NDA	NDA205849	Huber Supply Co. Inc.	OXYGEN	99	L/100L			N	20241231
60215-411_a50243c2-8846-7aab-e053-2995a90aaec6	60215-411	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose	F18	Fludeoxyglucose F18	INJECTION	INTRAVENOUS	20111206		ANDA	ANDA203246	The University of Texas MD Anderson Cancer Center	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
60219-1031_ae13db8f-27e2-420a-b909-99d0347e6286	60219-1031	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170921		ANDA	ANDA207514	Amneal Pharmaceuticals NY LLC						N	20241231
60219-1076_86f55896-8861-4245-b930-2f8a2a16836d	60219-1076	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20150202		ANDA	ANDA074069	Amneal Pharmaceuticals NY LLC	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
60219-1100_19e73c0c-28f8-45c4-9b1e-295a5df9ae50	60219-1100	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline	CAPSULE	ORAL	20160628		ANDA	ANDA207289	Amneal Pharmaceuticals NY LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60219-1144_e90bc5d7-0c7a-428d-a42d-8057bbe530f3	60219-1144	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231209		ANDA	ANDA212493	Amneal Pharmaceuticals NY LLC	DARUNAVIR	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
60219-1145_e90bc5d7-0c7a-428d-a42d-8057bbe530f3	60219-1145	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231209		ANDA	ANDA212493	Amneal Pharmaceuticals NY LLC	DARUNAVIR	800	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
60219-1155_568673d1-c35a-43ac-8ab1-ad5a4c4afcd4	60219-1155	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60219-1156_568673d1-c35a-43ac-8ab1-ad5a4c4afcd4	60219-1156	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60219-1157_568673d1-c35a-43ac-8ab1-ad5a4c4afcd4	60219-1157	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60219-1158_568673d1-c35a-43ac-8ab1-ad5a4c4afcd4	60219-1158	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60219-1165_1573d572-86a8-4783-8ddc-36761b4e54bf	60219-1165	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone	TABLET	ORAL	20230428		ANDA	ANDA208327	Amneal Pharmaceuticals NY LLC	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
60219-1420_39f09c3f-1ddd-44fb-a71e-18d9a9486654	60219-1420	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA209745	Amneal Pharmaceuticals NY LLC	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60219-1421_39f09c3f-1ddd-44fb-a71e-18d9a9486654	60219-1421	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA209745	Amneal Pharmaceuticals NY LLC	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60219-1424_79109efd-de23-4074-a16c-d2af11c81c3e	60219-1424	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	TABLET	ORAL	20230427		ANDA	ANDA210042	Amneal Pharmaceuticals NY LLC	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
60219-1425_e7834744-005f-474a-8d95-58d1bd2c4ea1	60219-1425	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	FOR SOLUTION	ORAL	20231207		ANDA	ANDA210155	Amneal Pharmaceuticals NY LLC	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
60219-1503_06cf5298-0269-4079-813f-4a215ed5863a	60219-1503	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin	SUSPENSION	ORAL	20231202		ANDA	ANDA211204	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
60219-1504_06cf5298-0269-4079-813f-4a215ed5863a	60219-1504	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin	SUSPENSION	ORAL	20231202		ANDA	ANDA211204	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
60219-1522_337430fd-0525-4a97-abe0-2c61bd47c1b3	60219-1522	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20220810		ANDA	ANDA210674	Amneal Pharmaceuticals NY LLC	TETRACYCLINE HYDROCHLORIDE	250	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
60219-1523_337430fd-0525-4a97-abe0-2c61bd47c1b3	60219-1523	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20220810		ANDA	ANDA210674	Amneal Pharmaceuticals NY LLC	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
60219-1531_68940467-149f-42a5-a366-f0ff0db6a938	60219-1531	HUMAN PRESCRIPTION DRUG	levonorgestrel and ethinyl estradiol		levonorgestrel and ethinyl estradiol	KIT		20160229		ANDA	ANDA201108	Amneal Pharmaceuticals NY LLC						N	20241231
60219-1544_d5c8be39-92f9-47cc-b93e-f87dbb134933	60219-1544	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20180517		ANDA	ANDA210577	Amneal Pharmaceuticals NY LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
60219-1573_304a9796-0a38-4c9c-8bae-a5139fadda35	60219-1573	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20220410		ANDA	ANDA210043	Amneal Pharmaceuticals NY LLC	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-1574_304a9796-0a38-4c9c-8bae-a5139fadda35	60219-1574	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20220410		ANDA	ANDA210043	Amneal Pharmaceuticals NY LLC	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-1585_6cb30deb-0a3d-4686-bcab-3f7cfbe5ac23	60219-1585	HUMAN PRESCRIPTION DRUG	fluorometholone ophthalmic suspension		fluorometholone	SUSPENSION/ DROPS	OPHTHALMIC	20230109		ANDA	ANDA216348	Amneal Pharmaceuticals NY LLC	FLUOROMETHOLONE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
60219-1586_6cb30deb-0a3d-4686-bcab-3f7cfbe5ac23	60219-1586	HUMAN PRESCRIPTION DRUG	fluorometholone ophthalmic suspension		fluorometholone	SUSPENSION/ DROPS	OPHTHALMIC	20230109		ANDA	ANDA216348	Amneal Pharmaceuticals NY LLC	FLUOROMETHOLONE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
60219-1617_13aef4a7-884b-4e22-8481-d3ce08ff6a6f	60219-1617	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	FOR SOLUTION	ORAL	20231125		ANDA	ANDA210902	Amneal Pharmaceuticals NY LLC	POTASSIUM CHLORIDE	1.5	g/1.58g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
60219-1640_2170123e-12f4-40ee-847b-d70582a23d50	60219-1640	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220329		ANDA	ANDA212570	Amneal Pharmaceuticals NY LLC	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
60219-1641_2170123e-12f4-40ee-847b-d70582a23d50	60219-1641	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220329		ANDA	ANDA212570	Amneal Pharmaceuticals NY LLC	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
60219-1642_988e8614-7312-4959-b95d-66bc249cbc18	60219-1642	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	CAPSULE	ORAL	20220107		ANDA	ANDA212569	Amneal Pharmaceuticals NY LLC	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
60219-1649_10d2049f-580a-4add-abab-77e458ccb246	60219-1649	HUMAN PRESCRIPTION DRUG	brexpiprazole		brexpiprazole	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA213562	Amneal Pharmaceuticals NY LLC	BREXPIPRAZOLE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60219-1650_10d2049f-580a-4add-abab-77e458ccb246	60219-1650	HUMAN PRESCRIPTION DRUG	brexpiprazole		brexpiprazole	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA213562	Amneal Pharmaceuticals NY LLC	BREXPIPRAZOLE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60219-1651_10d2049f-580a-4add-abab-77e458ccb246	60219-1651	HUMAN PRESCRIPTION DRUG	brexpiprazole		brexpiprazole	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA213562	Amneal Pharmaceuticals NY LLC	BREXPIPRAZOLE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60219-1652_10d2049f-580a-4add-abab-77e458ccb246	60219-1652	HUMAN PRESCRIPTION DRUG	brexpiprazole		brexpiprazole	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA213562	Amneal Pharmaceuticals NY LLC	BREXPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60219-1653_10d2049f-580a-4add-abab-77e458ccb246	60219-1653	HUMAN PRESCRIPTION DRUG	brexpiprazole		brexpiprazole	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA213562	Amneal Pharmaceuticals NY LLC	BREXPIPRAZOLE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60219-1654_10d2049f-580a-4add-abab-77e458ccb246	60219-1654	HUMAN PRESCRIPTION DRUG	brexpiprazole		brexpiprazole	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA213562	Amneal Pharmaceuticals NY LLC	BREXPIPRAZOLE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60219-1673_a71c32fb-217f-4f59-a646-daef4b3b5aa1	60219-1673	HUMAN PRESCRIPTION DRUG	thiothixene		thiothixene	CAPSULE	ORAL	20220303		ANDA	ANDA215456	Amneal Pharmaceuticals NY LLC	THIOTHIXENE	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
60219-1674_a71c32fb-217f-4f59-a646-daef4b3b5aa1	60219-1674	HUMAN PRESCRIPTION DRUG	thiothixene		thiothixene	CAPSULE	ORAL	20220303		ANDA	ANDA215456	Amneal Pharmaceuticals NY LLC	THIOTHIXENE	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
60219-1675_a71c32fb-217f-4f59-a646-daef4b3b5aa1	60219-1675	HUMAN PRESCRIPTION DRUG	thiothixene		thiothixene	CAPSULE	ORAL	20220303		ANDA	ANDA215456	Amneal Pharmaceuticals NY LLC	THIOTHIXENE	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
60219-1676_a71c32fb-217f-4f59-a646-daef4b3b5aa1	60219-1676	HUMAN PRESCRIPTION DRUG	thiothixene		thiothixene	CAPSULE	ORAL	20220303		ANDA	ANDA215456	Amneal Pharmaceuticals NY LLC	THIOTHIXENE	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
60219-1677_a4dbc267-9c88-40a3-8aa6-353eeff8274f	60219-1677	HUMAN PRESCRIPTION DRUG	chlordiazepoxide hydrochloride and clidinium bromide		chlordiazepoxide hydrochloride and clidinium bromide	CAPSULE	ORAL	20211025		ANDA	ANDA215555	Amneal Pharmaceuticals NY LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
60219-1705_a97da048-9373-4bb0-a18b-a8ac3d3f3db1	60219-1705	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20210804		ANDA	ANDA213385	Amneal Pharmaceuticals NY LLC	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-1706_a97da048-9373-4bb0-a18b-a8ac3d3f3db1	60219-1706	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20210804		ANDA	ANDA213385	Amneal Pharmaceuticals NY LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-1707_5db920ec-a2c5-4564-b136-e8e210246c48	60219-1707	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	Amneal Pharmaceuticals NY LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-1708_5db920ec-a2c5-4564-b136-e8e210246c48	60219-1708	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	Amneal Pharmaceuticals NY LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-1720_328e5245-4fe7-432d-a025-7cead4bf85d2	60219-1720	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20210614		ANDA	ANDA214196	Amneal Pharmaceuticals NY LLC	ETRAVIRINE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60219-1721_328e5245-4fe7-432d-a025-7cead4bf85d2	60219-1721	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20210614		ANDA	ANDA214196	Amneal Pharmaceuticals NY LLC	ETRAVIRINE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60219-1722_328e5245-4fe7-432d-a025-7cead4bf85d2	60219-1722	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20210614		ANDA	ANDA214196	Amneal Pharmaceuticals NY LLC	ETRAVIRINE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60219-1748_2af4941e-cde9-42d7-8594-e92cf960f307	60219-1748	HUMAN PRESCRIPTION DRUG	Atropine		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20220719		ANDA	ANDA214752	Amneal Pharmaceuticals NY LLC	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60219-1749_2af4941e-cde9-42d7-8594-e92cf960f307	60219-1749	HUMAN PRESCRIPTION DRUG	Atropine		atropine sulfate	SOLUTION/ DROPS	OPHTHALMIC	20220719		ANDA	ANDA214752	Amneal Pharmaceuticals NY LLC	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60219-1750_2af4941e-cde9-42d7-8594-e92cf960f307	60219-1750	HUMAN PRESCRIPTION DRUG	Atropine		atropine sulfate	SOLUTION/ DROPS	OPHTHALMIC	20220719		ANDA	ANDA214752	Amneal Pharmaceuticals NY LLC	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60219-1751_8148bd41-7822-4d86-b60e-d6b01060d3a8	60219-1751	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180628		ANDA	ANDA202023	Amneal Pharmaceuticals NY LLC	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
60219-1752_8148bd41-7822-4d86-b60e-d6b01060d3a8	60219-1752	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180628		ANDA	ANDA202023	Amneal Pharmaceuticals NY LLC	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
60219-1753_8148bd41-7822-4d86-b60e-d6b01060d3a8	60219-1753	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180628		ANDA	ANDA202023	Amneal Pharmaceuticals NY LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
60219-1754_1573d572-86a8-4783-8ddc-36761b4e54bf	60219-1754	HUMAN PRESCRIPTION DRUG	ABIRATERONE ACETATE		ABIRATERONE	TABLET	ORAL	20230428		ANDA	ANDA208327	Amneal Pharmaceuticals NY LLC	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
60219-2009_8f6d7e3c-16ba-43d4-81c0-c37f810e2c44	60219-2009	HUMAN PRESCRIPTION DRUG	tiopronin		tiopronin	TABLET, DELAYED RELEASE	ORAL	20230816		ANDA	ANDA216278	Amneal Pharmaceuticals NY LLC	TIOPRONIN	300	mg/1	Cystine Disulfide Reduction [MoA], N-substituted Glycines [CS], Reducing and Complexing Thiol [EPC]		N	20241231
60219-2033_3979736e-dac3-41a1-a3d7-d17b593a56da	60219-2033	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221		ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
60219-2034_3979736e-dac3-41a1-a3d7-d17b593a56da	60219-2034	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		CARBIDOPA and LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20221221		ANDA	ANDA076521	Amneal Pharmaceuticals NY LLC	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
60219-2036_86f55896-8861-4245-b930-2f8a2a16836d	60219-2036	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20211108		ANDA	ANDA074069	Amneal Pharmaceuticals NY LLC	AZATHIOPRINE	75	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
60219-2037_86f55896-8861-4245-b930-2f8a2a16836d	60219-2037	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20211108		ANDA	ANDA074069	Amneal Pharmaceuticals NY LLC	AZATHIOPRINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
60219-2038_1ecda8a1-7680-41a0-8b4f-00c3c4ef9b14	60219-2038	HUMAN PRESCRIPTION DRUG	prochlorperazine maleate		prochlorperazine maleate	TABLET, FILM COATED	ORAL	20230421		ANDA	ANDA216598	Amneal Pharmaceuticals NY LLC	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60219-2039_1ecda8a1-7680-41a0-8b4f-00c3c4ef9b14	60219-2039	HUMAN PRESCRIPTION DRUG	prochlorperazine maleate		prochlorperazine maleate	TABLET, FILM COATED	ORAL	20230421		ANDA	ANDA216598	Amneal Pharmaceuticals NY LLC	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60219-2043_45fe45ec-a642-4a82-97fb-0077bd2f55bf	60219-2043	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20210901		ANDA	ANDA215106	Amneal Pharmaceuticals NY LLC	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-2044_45fe45ec-a642-4a82-97fb-0077bd2f55bf	60219-2044	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20210901		ANDA	ANDA215106	Amneal Pharmaceuticals NY LLC	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-2045_8d9dfe98-c0ba-44aa-a349-33c8d0a8bbdf	60219-2045	HUMAN PRESCRIPTION DRUG	theophylline		theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327		ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
60219-2046_8d9dfe98-c0ba-44aa-a349-33c8d0a8bbdf	60219-2046	HUMAN PRESCRIPTION DRUG	theophylline		theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327		ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
60219-2056_eec9dd88-1e0a-476b-8728-3cbd15427c9d	60219-2056	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20220912		ANDA	ANDA216295	Amneal Pharmaceuticals NY LLC	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60219-2095_d5148a5e-b782-4d22-b1fb-e350648a9155	60219-2095	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180826		ANDA	ANDA209721	Amneal Pharmaceuticals NY LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
60219-2132_d003a652-9c70-4580-9d06-d7390398d399	60219-2132	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	TABLET, FILM COATED	ORAL	20221109		ANDA	ANDA216599	Amneal Pharmaceuticals NY LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60219-2135_aa23a2bb-6b54-43ec-ba44-dc4fcbb0d8f5	60219-2135	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	TABLET	ORAL	20220701		ANDA	ANDA090606	Amneal Pharmaceuticals NY LLC	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
60219-2348_1d10f961-04a4-4332-a2ba-86ba99ba027e	60219-2348	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20230213		ANDA	ANDA076003	Amneal Pharmaceuticals NY LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
60219-5511_a9fe7e08-3cf0-474a-9642-a7edd33386f3	60219-5511	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20220622		ANDA	ANDA076509	Amneal Pharmaceuticals NY LLC	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60219-5522_a9fe7e08-3cf0-474a-9642-a7edd33386f3	60219-5522	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20220622		ANDA	ANDA076509	Amneal Pharmaceuticals NY LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60219-5922_fceac8ec-dd40-4a49-bdb4-5b02a759a4a3	60219-5922	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		PILOCARPINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20070501		ANDA	ANDA077248	Amneal Pharmaceuticals NY LLC	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
60232-0006_21e18883-f579-425a-a460-1e601e1b30be	60232-0006	HUMAN OTC DRUG	Private Label SPF45 Water Resistant Paraben Free Sunscreen		Octinoxate, Octisalate, Zinc Oxide Sunscreen	LOTION	TOPICAL	20110831		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 30; 80	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-0007_4e399a9d-b92c-4483-962a-4d65f8cddc30	60232-0007	HUMAN OTC DRUG	Private Label Moisturizing Oil Free Paraben Free SPF43		Sunscreen	LOTION	TOPICAL	20100507		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 25; 75	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-0008_c9d33e9b-77bd-4ca7-b228-f49318307a70	60232-0008	HUMAN OTC DRUG	Private Label Super Light Oil-Free SPF45		2.75% Octinsalate, 7.50% Octinoxate, 8.00% Zinc Oxide Sunscreen	LOTION	TOPICAL	20110322		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 27.5; 80	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-0009_6f337fb6-6e77-4f2d-8c68-b54dbb366947	60232-0009	HUMAN OTC DRUG	Private Label Antifungal Barrier Cream		2% Miconazole Nitrate Cream	CREAM	TOPICAL	20101122		OTC MONOGRAPH DRUG	M017	Swiss-American CDMO, LLC	MICONAZOLE NITRATE	20	g/1000g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
60232-0021_f7c97350-746d-4edc-868e-7c1e4d7478e1	60232-0021	HUMAN OTC DRUG	Skin Protectant Cream 43% Petrolatum		43% Petrolaum Skin Protectant	CREAM	TOPICAL	20130902		OTC MONOGRAPH DRUG	M016	Swiss-American CDMO, LLC	PETROLATUM	43	g/1000g			N	20241231
60232-0022_49a5cc77-a8f6-47e1-83ea-dbf7b1c609b6	60232-0022	HUMAN OTC DRUG	Antiseptic Wash		0.130% Benzalkonium Antiseptic Wash	LIQUID	TOPICAL	20130905		OTC MONOGRAPH DRUG	M003	Swiss-American CDMO, LLC	BENZALKONIUM CHLORIDE	1.3	g/1000g			N	20241231
60232-0027_b8151402-d6f3-439b-b90a-849472a21c67	60232-0027	HUMAN OTC DRUG	Image Skincare Prevention Plus Daily Defense Lip Enhancer		zinc oxide lip sunscreen	CREAM	TOPICAL	20200102		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	ZINC OXIDE	110	g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-0035_6a3535ae-574f-48d8-bfc0-5b38f54c93ee	60232-0035	HUMAN OTC DRUG	Private Label SPF 50 80 min Water Resistant		homosalate, octisalate, zinc oxide sunscreen	CREAM	TOPICAL	20201201		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	100; 50; 165	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-0036_fe000ceb-250f-465c-81cf-ed3d78f0e7f4	60232-0036	HUMAN OTC DRUG	Private Label Sunscreen SPF35 40min WR RE126-202		homosalate, zinc oxide sunscreen	LOTION	TOPICAL	20231109		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	90; 50; 100	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-0044_6943f1b5-dc1d-49af-a51e-4c4bb778c45b	60232-0044	HUMAN OTC DRUG	Physical Sunscreen SPF50 80 min WR 159-100		titanium dioxide, titanium dioxide sunscreen	LOTION	TOPICAL	20231109		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	TITANIUM DIOXIDE; ZINC OXIDE	42.3; 182.8	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-1022_0daf8536-f2de-4a7c-be0d-827b8eb8d718	60232-1022	HUMAN OTC DRUG	Image Skincare Prevention Plus Daily Ultimate Protection		homosalate, octisalate, octocrylene, zinc oxide sunscreen	CREAM	TOPICAL	20200131		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 60; 90	g/1000g; g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-1026_a4187d17-fa7f-4566-b874-5894563ed47c	60232-1026	HUMAN OTC DRUG	Image Prevention Plus Professional Ultimate Protection Moisturizer SPF50		homosalate, octisalate, octocrylene, zinc oxide sunscreen	CREAM	TOPICAL	20200131		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	110; 50; 60; 90	g/1000g; g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-1830_94652e72-a0f1-46f1-8698-89b8c39690f6	60232-1830	HUMAN OTC DRUG	Image Prevention Refiner Primer SPF50		Zinc oxide, titanium dioxide sunscreen	CREAM	TOPICAL	20200306		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	TITANIUM DIOXIDE; ZINC OXIDE	50; 210	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60232-3537_88ede635-3a2c-45af-9e56-854ac5c125d9	60232-3537	HUMAN OTC DRUG	Image MD Restoring Lip Enhancer SPF15		sunscreen	CREAM	TOPICAL	20220317		OTC MONOGRAPH DRUG	M020	Swiss-American CDMO, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	g/1000g; g/1000g; g/1000g; g/1000g			N	20241231
60258-150_ae70d9a8-5a8b-4a25-8357-0c475a100fef	60258-150	HUMAN PRESCRIPTION DRUG	SF 5000 Plus		1.1% Sodium Fluoride Prescription Dental Cream	CREAM	DENTAL	19991112		UNAPPROVED DRUG OTHER		Cypress Pharmaceutical, Inc.	SODIUM FLUORIDE	5	mg/g			N	20241231
60258-151_58792242-e746-40e6-b549-83cd5f2b7ac5	60258-151	HUMAN PRESCRIPTION DRUG	SF		1.1% Sodium Fluoride	GEL	DENTAL	19991201		UNAPPROVED DRUG OTHER		Cypress Pharmaceutical, Inc.	SODIUM FLUORIDE	11	mg/g			N	20241231
60267-311_9b5328bf-b20d-4fc6-b776-12338075a66c	60267-311	HUMAN PRESCRIPTION DRUG	Sodium Nitrite		Sodium Nitrite	INJECTION, SOLUTION	INTRAVENOUS	20120214		NDA	NDA203922	Hope Pharmaceuticals	SODIUM NITRITE	30	mg/mL			N	20241231
60267-705_bcb32b5b-c09d-4e6a-81bb-d102fb684761	60267-705	HUMAN PRESCRIPTION DRUG	Sodium Thiosulfate		Sodium Thiosulfate	INJECTION, SOLUTION	INTRAVENOUS	20120214		NDA	NDA203923	Hope Pharmaceuticals	SODIUM THIOSULFATE	250	mg/mL			N	20241231
60267-812_ee3078f8-02f0-4362-b1b5-4feaf5dca2ef	60267-812	HUMAN PRESCRIPTION DRUG	NITHIODOTE		Sodium Nitrite and Sodium Thiosulfate	KIT		20110114		NDA	NDA201444	Hope Pharmaceuticals						N	20241231
60289-282_8d0813cc-f6bf-4e45-94bc-87ebc0dcd90c	60289-282	HUMAN OTC DRUG	AHAVA ACTIVE DEADSEA MINERALS	TIME TO ENERGIZE AGE CONTROL MOISTURIZING BROAD SPECTRUM SPF15	Avobenzone, Octisalate, and Octocrylene	CREAM	TOPICAL	20130725		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 27	mg/mL; mg/mL; mg/mL			N	20241231
60289-283_0f4fa875-1d97-429c-b4e6-72fa8408572a	60289-283	HUMAN OTC DRUG	BEAUTY BEFORE AGE	AHAVA UPLIFT DAY broad spectrum SPF 20	Homosalate, Octisalate, and Avobenzone	CREAM	TOPICAL	20150515		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE	1.5; 3.5; 2.5	g/50mL; g/50mL; g/50mL			N	20241231
60289-284_badb5549-537c-4240-8346-926879eaa23e	60289-284	HUMAN OTC DRUG	Mineral Radiance Energizing Day BS SPF 15		Avobenzone, Homosalate, and Octisalate	CREAM	TOPICAL	20161115		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
60289-285_56743821-0f88-4ca1-be6a-53f4ceb1752b	60289-285	HUMAN OTC DRUG	EXTREME	AHAVA Extreme Daily Firmness And Protection Broad Spectrum SPF30	Homosalate, Octisalate, Avobenzone, Ensulizole, and Octocrylene	LOTION	TOPICAL	20190515		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; ENSULIZOLE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.495; 1; 3.5; 2.5; .43	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
60289-286_cb5ee8e5-d75a-4aac-9023-60974f9eb4f7	60289-286	HUMAN OTC DRUG	APPLE OF SODOM	Deep Wrinkle Broad Spectrum SPF30	Avobenzone, Ensulizole, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20200401		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; ENSULIZOLE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.495; .5; 3.5; 2.5; .43	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
60289-287_0f44b4c0-301b-4873-abea-c87b7155175c	60289-287	HUMAN OTC DRUG	EVEN TONE and RADIANCE	CC Color Correction Skin Protection SPF30	Avobenzone, Ensulizole, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20200420		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; ENSULIZOLE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.9; .6; 2.1; 1.5; .261	g/30mL; g/30mL; g/30mL; g/30mL; g/30mL			N	20241231
60289-291_2aa67d0d-37f2-47af-82e7-8ed91f9d8501	60289-291	HUMAN OTC DRUG	Dead Sea Natural	Face Moisturizer Broad Spectrum SPF 20	avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20200520		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 27	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
60289-295_95149fe8-ab97-4292-9643-602c43559797	60289-295	HUMAN OTC DRUG	LUMIOR	Exclusive Day Broad Spectrum SPF 20	avobenzone, homosalate, and octisalate	CREAM	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
60289-296_fe9c50eb-f5c3-49a9-b90a-b08dd3c49e44	60289-296	HUMAN OTC DRUG	LUMIOR	Men Facial Moisturizer Broad Spectrum SPF 15	Avobenzone, Octisalate, and Octocrylene	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 27.4	mg/mL; mg/mL; mg/mL			N	20241231
60289-297_352da5f4-8283-4208-bfb8-0c4a3fb63f35	60289-297	HUMAN OTC DRUG	LUMIOR	Daylight Moisturizer Broad Spectrum SPF 20	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 27	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
60289-298_2aec0257-598a-404c-8863-8057a05f050c	60289-298	HUMAN OTC DRUG	LUMIOR Empowered Day Moisturizer Broad Spectrum SPF 15		Avobenzone, Homosalate, and Octisalate	CREAM	TOPICAL	20210201		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
60289-299_d0bd6bb3-6a0b-4771-b4dd-6ec6f8b1acdc	60289-299	HUMAN OTC DRUG	AHAVA Protecting Body SPF30		Avobenzone, Ensulizole, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220512		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; ENSULIZOLE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	4.5; 3; 10.5; 7.5; 1.305	g/150mL; g/150mL; g/150mL; g/150mL; g/150mL			N	20241231
60289-300_828ce22a-6a89-442f-9a3d-eb72806505d2	60289-300	HUMAN OTC DRUG	AHAVA Protecting Moisturizing SPF50		Avobenzone, Ensulizole, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20220606		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; ENSULIZOLE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.02998; .02; .1; .05; .1	g/mL; g/mL; g/mL; g/mL; g/mL			N	20241231
60289-301_609964b9-537d-4fa9-b20f-bd815cb1aaff	60289-301	HUMAN OTC DRUG	AHAVA MultiVitamin Day SPF30		Avobenzone, Ensulizole, Octisalate, and Octocrylene	CREAM	TOPICAL	20230225		OTC MONOGRAPH NOT FINAL	part352	AHAVA - Dead Sea Laboratories Ltd	AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE	30; 30; 50; 80.7	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
60289-347_79994235-b40b-4f9f-a261-fec6b4396b62	60289-347	HUMAN OTC DRUG	AHAVA ACTIVE DEADSEA MINERALS	AHAVA Age Control Even Tone Moisturizer Broad Spectrum SPF 20	Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20130102		OTC MONOGRAPH DRUG	M020	AHAVA Dead Sea Laboratories Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 27	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
60290-043_0df401f2-d25b-dd62-e063-6294a90a35f4	60290-043	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	UMEDICA LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
60290-044_0df401f2-d25b-dd62-e063-6294a90a35f4	60290-044	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	UMEDICA LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
60290-045_0df401f2-d25b-dd62-e063-6294a90a35f4	60290-045	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	UMEDICA LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
60290-046_0df401f2-d25b-dd62-e063-6294a90a35f4	60290-046	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET	ORAL	20230801		ANDA	ANDA207626	UMEDICA LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
60290-057_0cf15f29-e5b9-95c2-e063-6394a90acda0	60290-057	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium Tablets	TABLET, FILM COATED	ORAL	20220512		ANDA	ANDA215750	UMEDICA LABORATORIES PRIVATE LIMITED	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60290-058_0df3f392-1033-8c5d-e063-6294a90a847e	60290-058	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20220820		ANDA	ANDA216594	UMEDICA LABORATORIES PRIVATE LIMITED	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
60290-059_0df3f392-1033-8c5d-e063-6294a90a847e	60290-059	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20220820		ANDA	ANDA216594	UMEDICA LABORATORIES PRIVATE LIMITED	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
60290-060_0df3f392-1033-8c5d-e063-6294a90a847e	60290-060	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20220820		ANDA	ANDA216594	UMEDICA LABORATORIES PRIVATE LIMITED	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
60306-115_7e8bf677-a974-4eab-8a49-3fab03ebc752	60306-115	HUMAN OTC DRUG	Brace Relief		Benzocaine	GEL	ORAL	20050103		OTC MONOGRAPH FINAL	part333B	InfaLab,Inc	BENZOCAINE	9	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
60319-1001_98daa928-8680-4e7a-e053-2a95a90ad104	60319-1001	HUMAN OTC DRUG	Premium Whitening		HYDROGEN PEROXIDE	GEL, DENTIFRICE	DENTAL	20110913		UNAPPROVED DRUG OTHER		Hankuk Bowonbio Co., Ltd	HYDROGEN PEROXIDE	35	mL/100mL			N	20241231
60319-2001_98daaafc-6214-48da-e053-2a95a90af865	60319-2001	HUMAN OTC DRUG	Noble S Plus		SILVER	PASTE, DENTIFRICE	DENTAL	20110919		UNAPPROVED DRUG OTHER		Hankuk Bowonbio Co., Ltd	SILVER	.7	g/100g			N	20241231
60319-3001_990201fb-aea2-cf20-e053-2995a90a1ace	60319-3001	HUMAN OTC DRUG	Noble G Plus		XYLITOL	PASTE, DENTIFRICE	DENTAL	20121130		UNAPPROVED DRUG OTHER		Hankuk Bowonbio Co., Ltd	XYLITOL	.7	g/100g			N	20241231
60319-4001_98ee91f0-4a19-51dd-e053-2995a90a35a5	60319-4001	HUMAN OTC DRUG	Noble 1 Plus		XYLITOL	POWDER, DENTIFRICE	DENTAL	20121130		UNAPPROVED DRUG OTHER		Hankuk Bowonbio Co., Ltd	XYLITOL	.7	g/100g			N	20241231
60319-5001_990201fb-aeac-cf20-e053-2995a90a1ace	60319-5001	HUMAN OTC DRUG	Tooth Whole White		HYDROGEN PEROXIDE	PASTE, DENTIFRICE	DENTAL	20151220		UNAPPROVED DRUG OTHER		Hankuk Bowonbio Co., Ltd	HYDROGEN PEROXIDE	2.14	g/100g			N	20241231
60367-002_0801d892-9ba5-d8f1-e063-6294a90aae25	60367-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19750101		NDA	NDA205767	County Welding Supply Co.	OXYGEN	998	mL/L			N	20241231
60379-100_0b521905-680f-a034-e063-6394a90a0c26	60379-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070601		UNAPPROVED MEDICAL GAS		Providence Home Medical Equipment	OXYGEN	1	L/L			N	20241231
60396-5555_ec71b0c7-1857-9baf-e053-2a95a90aa229	60396-5555	HUMAN OTC DRUG	Zinxation Bulk Sunscreen		Zinc Oxide	CREAM	TOPICAL	20221102		OTC MONOGRAPH NOT FINAL	part352	Advance ZincTek Limited	ZINC OXIDE	25	kg/100kg			N	20241231
60429-016_0ce4bf5c-f4f6-0b9e-e063-6294a90a59a9	60429-016	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20120821		ANDA	ANDA091558	Golden State Medical Supply, Inc.	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
60429-017_0ce4bf5c-f4f6-0b9e-e063-6294a90a59a9	60429-017	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20140819		ANDA	ANDA091558	Golden State Medical Supply, Inc.	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
60429-020_091e9b00-2b80-4dd9-e063-6394a90a949d	60429-020	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	TABLET	ORAL	19990615		ANDA	ANDA075319	Golden State Medical Supply, Inc.	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60429-025_0257bce3-ccce-cf28-e063-6394a90a1773	60429-025	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19920124		ANDA	ANDA073457	Golden State Medical Supply, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60429-026_0257bce3-ccce-cf28-e063-6394a90a1773	60429-026	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19920124		ANDA	ANDA073457	Golden State Medical Supply, Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60429-027_0257bce3-ccce-cf28-e063-6394a90a1773	60429-027	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19990426		ANDA	ANDA073457	Golden State Medical Supply, Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60429-032_0e892003-98df-bbc6-e063-6294a90a5233	60429-032	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20020227		ANDA	ANDA075948	Golden State Medical Supply, Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
60429-035_03ade119-6c46-a742-e063-6394a90a8ce2	60429-035	HUMAN PRESCRIPTION DRUG	Primaquine Phosphate		Primaquine Phosphate	TABLET	ORAL	20140225		ANDA	ANDA204476	Golden State Medical Supply	PRIMAQUINE PHOSPHATE	15	mg/1	Antimalarial [EPC]		N	20241231
60429-042_f75d1839-d07f-f4f8-e053-6394a90a3bc2	60429-042	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Golden State Medical Supply, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
60429-047_0d84ba89-cad0-f78e-e063-6294a90ae277	60429-047	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20140403		ANDA	ANDA203126	Golden State Medical Supply, Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60429-048_0d84ba89-cad0-f78e-e063-6294a90ae277	60429-048	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20140403		ANDA	ANDA203126	Golden State Medical Supply, Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60429-049_0d84ba89-cad0-f78e-e063-6294a90ae277	60429-049	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20140403		ANDA	ANDA203126	Golden State Medical Supply, Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60429-059_0d853c08-0001-c8c0-e063-6394a90af81a	60429-059	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	CAPSULE	ORAL	20090504		ANDA	ANDA065520	Golden State Medical Supply, Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
60429-061_0ce4e200-4054-17db-e063-6294a90a368e	60429-061	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Golden State Medical Supply, Inc.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60429-062_0ce4e200-4054-17db-e063-6294a90a368e	60429-062	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Golden State Medical Supply, Inc.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60429-063_0ce4e200-4054-17db-e063-6294a90a368e	60429-063	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Golden State Medical Supply, Inc.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60429-069_f75d5844-509f-5a9d-e053-6394a90a6147	60429-069	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20030702		ANDA	ANDA065095	Golden State Medical Supply, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60429-070_0d853c08-0001-c8c0-e063-6394a90af81a	60429-070	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	TABLET, FILM COATED	ORAL	20090504		ANDA	ANDA065521	Golden State Medical Supply, Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
60429-085_0b682a6d-dee5-9f2f-e063-6394a90afb81	60429-085	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141028		ANDA	ANDA203855	Golden State Medical Supply, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60429-086_0b682a6d-dee5-9f2f-e063-6394a90afb81	60429-086	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141028		ANDA	ANDA203855	Golden State Medical Supply, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60429-087_0b682a6d-dee5-9f2f-e063-6394a90afb81	60429-087	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141028		ANDA	ANDA203855	Golden State Medical Supply, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60429-089_0b682a6d-dee5-9f2f-e063-6394a90afb81	60429-089	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141028		ANDA	ANDA203855	Golden State Medical Supply, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60429-090_0b682a6d-dee5-9f2f-e063-6394a90afb81	60429-090	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20141028		ANDA	ANDA203855	Golden State Medical Supply, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60429-095_02f8ec15-a008-de2d-e063-6394a90aa6fc	60429-095	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021	20240131	ANDA	ANDA088292	Golden State Medical Supply, Inc.	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	
60429-096_02f8ec15-a008-de2d-e063-6394a90aa6fc	60429-096	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021	20240131	ANDA	ANDA088262	Golden State Medical Supply, Inc.	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
60429-097_02f8ec15-a008-de2d-e063-6394a90aa6fc	60429-097	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021	20240831	ANDA	ANDA088276	Golden State Medical Supply, Inc.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
60429-098_798c75b7-a86c-7b69-e053-2a91aa0ac43e	60429-098	HUMAN PRESCRIPTION DRUG	Trospium Chloride		Trospium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20140718		ANDA	ANDA091289	Golden State Medical Supply, Inc.	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60429-099_0ce57040-0162-0c43-e063-6394a90a52eb	60429-099	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20071030		ANDA	ANDA077002	Golden State Medical Supply, Inc.	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
60429-100_0ce57040-0162-0c43-e063-6394a90a52eb	60429-100	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20071030		ANDA	ANDA077002	Golden State Medical Supply, Inc.	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
60429-111_f76b7d7b-6170-8304-e053-6294a90a0451	60429-111	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130911		ANDA	ANDA203769	Golden State Medical Supply, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60429-112_f76b7d7b-6170-8304-e053-6294a90a0451	60429-112	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130911		ANDA	ANDA203769	Golden State Medical Supply, Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60429-113_f76b7d7b-6170-8304-e053-6294a90a0451	60429-113	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130911		ANDA	ANDA203769	Golden State Medical Supply, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60429-118_d9e4ccc0-0553-2253-e053-2a95a90a2021	60429-118	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20111021	20240131	ANDA	ANDA200958	Golden State Medical Supply, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
60429-119_d9e4ccc0-0553-2253-e053-2a95a90a2021	60429-119	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20111021	20240430	ANDA	ANDA200958	Golden State Medical Supply, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
60429-164_0ce5aefa-2f29-28fc-e063-6394a90a4ead	60429-164	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Golden State Medical Supply, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60429-165_0ce5aefa-2f29-28fc-e063-6394a90a4ead	60429-165	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Golden State Medical Supply, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60429-166_0ce5aefa-2f29-28fc-e063-6394a90a4ead	60429-166	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Golden State Medical Supply, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60429-173_f76c9efd-9456-872f-e053-6394a90ad168	60429-173	HUMAN PRESCRIPTION DRUG	CITALOPRAM		citalopram	TABLET, FILM COATED	ORAL	20050429		ANDA	ANDA077045	Golden State Medical Supply, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60429-174_f76c9efd-9456-872f-e053-6394a90ad168	60429-174	HUMAN PRESCRIPTION DRUG	CITALOPRAM		citalopram	TABLET, FILM COATED	ORAL	20050429		ANDA	ANDA077045	Golden State Medical Supply, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60429-175_f76c9efd-9456-872f-e053-6394a90ad168	60429-175	HUMAN PRESCRIPTION DRUG	CITALOPRAM		citalopram	TABLET, FILM COATED	ORAL	20050429		ANDA	ANDA077045	Golden State Medical Supply, Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60429-176_0d858357-a729-af8b-e063-6294a90aa78a	60429-176	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	TABLET	ORAL	19970606		ANDA	ANDA074871	Golden State Medical Supply, Inc.	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
60429-177_ec95b299-aa12-e89f-e053-2a95a90a5a28	60429-177	HUMAN PRESCRIPTION DRUG	Bicalutamide		Bicalutamide	TABLET, FILM COATED	ORAL	20090706		ANDA	ANDA078917	Golden State Medical Supply, Inc.	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
60429-183_02705b22-bc4f-1594-e063-6394a90a82ea	60429-183	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123	20251130	ANDA	ANDA075657	Golden State Medical Supply, Inc.	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	
60429-184_02705b22-bc4f-1594-e063-6394a90a82ea	60429-184	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123	20251130	ANDA	ANDA075657	Golden State Medical Supply, Inc.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	
60429-185_02705b22-bc4f-1594-e063-6394a90a82ea	60429-185	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123	20251130	ANDA	ANDA075657	Golden State Medical Supply, Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	
60429-186_02705b22-bc4f-1594-e063-6394a90a82ea	60429-186	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123	20251130	ANDA	ANDA075657	Golden State Medical Supply, Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	
60429-195_0d9a78ed-d0b7-bb26-e063-6394a90acaca	60429-195	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20070912		ANDA	ANDA077538	Golden State Medical Supply, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60429-196_0ce5fac2-63b8-b029-e063-6294a90ae0f9	60429-196	HUMAN PRESCRIPTION DRUG	Disulfiram		Disulfiram	TABLET	ORAL	20130808		ANDA	ANDA091681	Golden State Medical Supply, Inc.	DISULFIRAM	250	mg/1	Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]		N	20241231
60429-222_ff0efbc2-d7b3-9783-e053-6394a90a384f	60429-222	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA077714	Golden State Medical Supply, Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
60429-243_e72b5a1f-7039-7615-e053-2995a90a96eb	60429-243	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	19980430		ANDA	ANDA075078	Golden State Medical Supply, Inc.	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-244_e72b5a1f-7039-7615-e053-2995a90a96eb	60429-244	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	19980430		ANDA	ANDA075078	Golden State Medical Supply, Inc.	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-259_02e9b46e-3e1c-0efe-e063-6394a90ae050	60429-259	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	19860825		ANDA	ANDA071017	Golden State Medical Supply, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
60429-265_02fa8d3f-1fc3-041c-e063-6394a90a95ac	60429-265	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	19990224	20241231	ANDA	ANDA075340	Golden State Medical Supply, Inc.	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	
60429-311_e72b5a1f-7039-7615-e053-2995a90a96eb	60429-311	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	19980311		ANDA	ANDA075074	Golden State Medical Supply, Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-312_e72b5a1f-7039-7615-e053-2995a90a96eb	60429-312	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20000425		ANDA	ANDA075074	Golden State Medical Supply, Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-313_e6d9606c-ac46-b89c-e053-2995a90ac780	60429-313	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Golden State Medical Supply, Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-314_e6d9606c-ac46-b89c-e053-2995a90ac780	60429-314	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Golden State Medical Supply, Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-315_e6d9606c-ac46-b89c-e053-2995a90ac780	60429-315	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313	20240131	ANDA	ANDA076174	Golden State Medical Supply, Inc.	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
60429-321_e41c73ad-1d51-574c-e053-2995a90a705d	60429-321	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20141029		ANDA	ANDA203907	Golden State Medical Supply, Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
60429-322_e41c73ad-1d51-574c-e053-2995a90a705d	60429-322	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20141029		ANDA	ANDA203907	Golden State Medical Supply, Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
60429-349_091edbe4-0487-8b6a-e063-6294a90a3670	60429-349	HUMAN PRESCRIPTION DRUG	Levetiracetam	Extended-Release	levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110912		ANDA	ANDA091261	Golden State Medical Supply, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60429-350_091edbe4-0487-8b6a-e063-6294a90a3670	60429-350	HUMAN PRESCRIPTION DRUG	Levetiracetam	Extended-Release	levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110912		ANDA	ANDA091261	Golden State Medical Supply, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60429-353_0d856c35-3d47-1b6c-e063-6294a90a13d7	60429-353	HUMAN PRESCRIPTION DRUG	LAMIVUDINE		lamivudine	TABLET, FILM COATED	ORAL	20111202		ANDA	ANDA091606	Golden State Medical Supply, Inc.	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60429-354_0d856c35-3d47-1b6c-e063-6294a90a13d7	60429-354	HUMAN PRESCRIPTION DRUG	LAMIVUDINE		lamivudine	TABLET, FILM COATED	ORAL	20111202		ANDA	ANDA091606	Golden State Medical Supply, Inc.	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60429-377_f76f7ef6-421d-ab64-e053-6394a90a43e0	60429-377	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100917		ANDA	ANDA090596	Golden State Medical Supply, Inc.	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
60429-378_f76f7ef6-421d-ab64-e053-6394a90a43e0	60429-378	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100917		ANDA	ANDA090596	Golden State Medical Supply, Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
60429-379_f76f7ef6-421d-ab64-e053-6394a90a43e0	60429-379	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100917		ANDA	ANDA090596	Golden State Medical Supply, Inc.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
60429-381_e65f8d69-6188-61c9-e053-2995a90acc41	60429-381	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20071214		ANDA	ANDA040734	Golden State Medical Supply, Inc.	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
60429-421_fabd5d9c-5da4-9ede-e053-6294a90a29c1	60429-421	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	Golden State Medical Supply, Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-422_fabd5d9c-5da4-9ede-e053-6294a90a29c1	60429-422	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	Golden State Medical Supply, Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60429-433_f038969c-7110-1318-e053-2995a90a1bdc	60429-433	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	19880808	20241231	ANDA	ANDA072423	Golden State Medical Supply, Inc.	MEGESTROL ACETATE	40	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	
60429-434_f038e738-ab06-4c16-e053-2995a90ae616	60429-434	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, COATED	ORAL	20090909	20240930	ANDA	ANDA077463	Golden State Medical Supply, Inc.	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	
60429-437_e7a46af6-bac4-613b-e053-2a95a90a8856	60429-437	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20101018	20240331	ANDA	ANDA078540	Golden State Medical Supply, Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	
60429-443_0cf8e1ea-f8c8-5bb4-e063-6394a90ab70d	60429-443	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	19991112		NDA	NDA020076	Golden State Medical Supply, Inc.	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60429-444_0cf8e1ea-f8c8-5bb4-e063-6394a90ab70d	60429-444	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	19991112		NDA	NDA020076	Golden State Medical Supply, Inc.	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60429-445_0cf8e1ea-f8c8-5bb4-e063-6394a90ab70d	60429-445	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	19991112		NDA	NDA020076	Golden State Medical Supply, Inc.	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60429-491_d44dcb62-450f-4b34-e053-2a95a90aa6db	60429-491	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20151026		ANDA	ANDA203179	Golden State Medical Supply, Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
60429-495_07f28474-6c23-a746-e063-6394a90a252c	60429-495	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20160506		ANDA	ANDA203887	Golden State Medical Supply, Inc.	DAPSONE	25	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
60429-496_07f28474-6c23-a746-e063-6394a90a252c	60429-496	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	TABLET	ORAL	20160506		ANDA	ANDA203887	Golden State Medical Supply, Inc.	DAPSONE	100	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
60429-506_f7704175-5a85-f62f-e053-6394a90ab4dc	60429-506	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	19870807		ANDA	ANDA071620	Golden State Medical Supply, Inc.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60429-507_f7704175-5a85-f62f-e053-6394a90ab4dc	60429-507	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	19870807		ANDA	ANDA071620	Golden State Medical Supply, Inc.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60429-508_f26a2008-4dd4-4fdf-e053-2995a90a9b21	60429-508	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	Golden State Medical Supply, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
60429-588_0270c6f4-9bc1-501f-e063-6394a90a068e	60429-588	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20020619		ANDA	ANDA075977	Golden State Medical Supply, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
60429-589_f783a197-5aa8-8240-e053-6394a90a3dfd	60429-589	HUMAN PRESCRIPTION DRUG	butalbital, acetaminophen and caffeine		butalbital, acetaminophen and caffeine	TABLET	ORAL	19870121	20241031	ANDA	ANDA089175	Golden State Medical Supply, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	
60429-590_f26a3ca5-e20d-67bc-e053-2a95a90a05c8	60429-590	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20001020		ANDA	ANDA040409	Golden State Medical Supply, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
60429-591_f26a3ca5-e20d-67bc-e053-2a95a90a05c8	60429-591	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20000908		ANDA	ANDA040405	Golden State Medical Supply, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
60429-592_f26a3ca5-e20d-67bc-e053-2a95a90a05c8	60429-592	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20000726		ANDA	ANDA040400	Golden State Medical Supply, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
60429-620_0270e242-a2d3-bda2-e063-6394a90a7ba7	60429-620	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Golden State Medical Supply, Inc.	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60429-621_0270e242-a2d3-bda2-e063-6394a90a7ba7	60429-621	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Golden State Medical Supply, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60429-622_0270e242-a2d3-bda2-e063-6394a90a7ba7	60429-622	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Golden State Medical Supply, Inc.	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60429-623_0270e242-a2d3-bda2-e063-6394a90a7ba7	60429-623	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Golden State Medical Supply, Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60429-624_0270e242-a2d3-bda2-e063-6394a90a7ba7	60429-624	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Golden State Medical Supply, Inc.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60429-625_0270e242-a2d3-bda2-e063-6394a90a7ba7	60429-625	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Golden State Medical Supply, Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60429-632_02e9fcb6-a4fc-ed47-e063-6394a90a7976	60429-632	HUMAN PRESCRIPTION DRUG	Eszopiclone		eszopiclone	TABLET, FILM COATED	ORAL	20130326		ANDA	ANDA091151	Golden State Medical Supply, Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
60429-633_02e9fcb6-a4fc-ed47-e063-6394a90a7976	60429-633	HUMAN PRESCRIPTION DRUG	Eszopiclone		eszopiclone	TABLET, FILM COATED	ORAL	20130326		ANDA	ANDA091151	Golden State Medical Supply, Inc.	ESZOPICLONE	2	mg/1		CIV	N	20241231
60429-634_02e9fcb6-a4fc-ed47-e063-6394a90a7976	60429-634	HUMAN PRESCRIPTION DRUG	Eszopiclone		eszopiclone	TABLET, FILM COATED	ORAL	20130326		ANDA	ANDA091151	Golden State Medical Supply, Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
60429-643_063230d0-7c80-77d9-e063-6294a90a7b34	60429-643	HUMAN PRESCRIPTION DRUG	IBANDRONATE SODIUM		IBANDRONATE SODIUM	TABLET, FILM COATED	ORAL	20120319		ANDA	ANDA078948	Golden State Medical Supply, Inc.	IBANDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60429-664_0e894347-e1b5-0247-e063-6294a90ac0a6	60429-664	HUMAN PRESCRIPTION DRUG	MOMETASONE FUROATE		MOMETASONE FUROATE	SPRAY, METERED	NASAL	20160322		ANDA	ANDA091161	Golden State Medical Supply, Inc.	MOMETASONE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
60429-665_f784b3c5-39be-1cac-e053-6294a90a0315	60429-665	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20140203		ANDA	ANDA091182	Golden State Medical Supply, Inc.	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60429-666_f784b3c5-39be-1cac-e053-6294a90a0315	60429-666	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20140203		ANDA	ANDA091182	Golden State Medical Supply, Inc.	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60429-721_f9ce18ff-e988-7d70-e053-6294a90a1f95	60429-721	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Golden State Medical Supply, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
60429-734_091f4195-a70a-ae35-e063-6294a90a3e89	60429-734	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030730		ANDA	ANDA075356	Golden State Medical Supply, Inc.	PAROXETINE HYDROCHLORIDE ANHYDROUS	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60429-735_091f4195-a70a-ae35-e063-6294a90a3e89	60429-735	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030730		ANDA	ANDA075356	Golden State Medical Supply, Inc.	PAROXETINE HYDROCHLORIDE ANHYDROUS	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60429-736_091f4195-a70a-ae35-e063-6294a90a3e89	60429-736	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030730		ANDA	ANDA075356	Golden State Medical Supply, Inc.	PAROXETINE HYDROCHLORIDE ANHYDROUS	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60429-737_091f4195-a70a-ae35-e063-6294a90a3e89	60429-737	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030730		ANDA	ANDA075356	Golden State Medical Supply, Inc.	PAROXETINE HYDROCHLORIDE ANHYDROUS	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60429-746_f784d83b-ca50-6a67-e053-6294a90a46e1	60429-746	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Golden State Medical Supply, Inc.	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60429-747_f784d83b-ca50-6a67-e053-6294a90a46e1	60429-747	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Golden State Medical Supply, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60429-748_0ab2fbff-aa4f-fdd6-e063-6294a90a916b	60429-748	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20020926		ANDA	ANDA076140	Golden State Medical Supply, Inc.	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60429-749_0ab2fbff-aa4f-fdd6-e063-6294a90a916b	60429-749	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20020926	20250228	ANDA	ANDA076140	Golden State Medical Supply, Inc.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	
60429-750_0ab2fbff-aa4f-fdd6-e063-6294a90a916b	60429-750	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20020926	20250630	ANDA	ANDA076140	Golden State Medical Supply, Inc.	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	
60429-751_0ab2fbff-aa4f-fdd6-e063-6294a90a916b	60429-751	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20020926	20250630	ANDA	ANDA076140	Golden State Medical Supply, Inc.	SOTALOL HYDROCHLORIDE	240	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	
60429-765_0e8a3395-03eb-af4f-e063-6294a90a4a70	60429-765	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120302		ANDA	ANDA077561	Golden State Medical Supply, Inc.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20251231
60429-766_0e8a3395-03eb-af4f-e063-6294a90a4a70	60429-766	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120302		ANDA	ANDA077561	Golden State Medical Supply, Inc.	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20251231
60429-767_0e8a3395-03eb-af4f-e063-6294a90a4a70	60429-767	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120302		ANDA	ANDA077561	Golden State Medical Supply, Inc.	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20251231
60429-768_0e8a3395-03eb-af4f-e063-6294a90a4a70	60429-768	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120302		ANDA	ANDA077561	Golden State Medical Supply, Inc.	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20251231
60429-834_eedf8836-f5e3-2acb-e053-2a95a90ab36d	60429-834	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971022		ANDA	ANDA040197	Golden State Medical Supply, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
60429-839_9af07b4a-4982-368d-e053-2995a90aa1e7	60429-839	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160826		ANDA	ANDA208191	Golden State Medical Supply, Inc.	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
60429-840_9af07b4a-4982-368d-e053-2995a90aa1e7	60429-840	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160826		ANDA	ANDA208191	Golden State Medical Supply, Inc.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
60429-841_9af07b4a-4982-368d-e053-2995a90aa1e7	60429-841	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160826		ANDA	ANDA208191	Golden State Medical Supply, Inc.	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
60429-846_d9e48c91-a1fc-3dc7-e053-2995a90a6486	60429-846	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET, FILM COATED	ORAL	20141104		ANDA	ANDA203511	Golden State Medical Supply, Inc.	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
60429-867_02f8893f-ecce-54ea-e063-6394a90ac2c7	60429-867	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170324	20241031	ANDA	ANDA205468	Golden State Medical Supply	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
60429-876_a8ede90d-776b-816a-e053-2a95a90a8667	60429-876	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20070228		ANDA	ANDA077797	Golden State Medical Supply	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60429-880_e0e32c41-be29-311c-e053-2995a90a7cd7	60429-880	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20170426		ANDA	ANDA200909	Golden State Medical Supply, Inc.	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60429-893_02720556-3a7a-fbc3-e063-6394a90a153c	60429-893	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET	ORAL	20160114	20250731	ANDA	ANDA205348	Golden State Medical Supply, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	
60429-914_e5fe0aed-7a52-c606-e053-2995a90af8a7	60429-914	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170118		ANDA	ANDA081297	Golden State Medical Supply, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
60429-918_f045dced-b8e6-fcb0-e053-2995a90a69c3	60429-918	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20090922		ANDA	ANDA077911	Golden State Medical Supply, Inc.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60429-919_f045dced-b8e6-fcb0-e053-2995a90a69c3	60429-919	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20090922		ANDA	ANDA077911	Golden State Medical Supply, Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60429-920_f045dced-b8e6-fcb0-e053-2995a90a69c3	60429-920	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20090922		ANDA	ANDA077911	Golden State Medical Supply, Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60429-927_e5fe0aed-7a52-c606-e053-2995a90af8a7	60429-927	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170118		ANDA	ANDA081297	Golden State Medical Supply, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
60429-934_93523dc4-62e6-cc27-e053-2995a90a5cbb	60429-934	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	20001024		ANDA	ANDA075687	Golden State Medical Supply, Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60429-960_0e8a911a-4cc9-c38d-e063-6394a90afb17	60429-960	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150602		ANDA	ANDA201408	Golden State Medical Supply, Inc.	GUANFACINE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
60429-961_0e8a911a-4cc9-c38d-e063-6394a90afb17	60429-961	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150602		ANDA	ANDA201408	Golden State Medical Supply, Inc.	GUANFACINE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
60429-962_0e8a911a-4cc9-c38d-e063-6394a90afb17	60429-962	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150602		ANDA	ANDA201408	Golden State Medical Supply, Inc.	GUANFACINE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
60429-963_0e8a911a-4cc9-c38d-e063-6394a90afb17	60429-963	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20150602		ANDA	ANDA201408	Golden State Medical Supply, Inc.	GUANFACINE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
60429-966_e093cf70-8086-7c50-e053-2995a90a1bb4	60429-966	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Golden State Medical Supply, Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60429-967_e093cf70-8086-7c50-e053-2995a90a1bb4	60429-967	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Golden State Medical Supply, Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60429-968_e093cf70-8086-7c50-e053-2995a90a1bb4	60429-968	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Golden State Medical Supply, Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60429-969_e093cf70-8086-7c50-e053-2995a90a1bb4	60429-969	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Golden State Medical Supply, Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60429-970_e093cf70-8086-7c50-e053-2995a90a1bb4	60429-970	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	Golden State Medical Supply, Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60429-971_f792b6f9-347e-9ca0-e053-6294a90a6f1b	60429-971	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890516		ANDA	ANDA072575	Golden State Medical Supply, Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60429-972_f792b6f9-347e-9ca0-e053-6294a90a6f1b	60429-972	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890516		ANDA	ANDA072575	Golden State Medical Supply, Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60429-973_f792b6f9-347e-9ca0-e053-6294a90a6f1b	60429-973	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890516		ANDA	ANDA072575	Golden State Medical Supply, Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60429-975_02948d59-b8f3-8f22-e063-6394a90a9858	60429-975	HUMAN PRESCRIPTION DRUG	IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20121001		ANDA	ANDA202496	Golden State Medical Supply, Inc.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
60429-982_0d85ccec-ad1b-e151-e063-6294a90a4fc5	60429-982	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA207311	Golden State Medical Supply, Inc.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
60429-995_08928c7d-97a1-17d2-e063-6294a90ad8b5	60429-995	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	INJECTION	SUBCUTANEOUS	20130916		ANDA	ANDA200183	Golden State Medical Supply, Inc.	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
60432-065_09c50182-b848-0605-e063-6394a90afc75	60432-065	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20081125		ANDA	ANDA065431	Morton Grove Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 62.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
60456-876_17bece1f-d3f3-4999-a47a-067f0d99c915	60456-876	HUMAN OTC DRUG	Antibacterial Foamy Mango High Foaming Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170117		OTC MONOGRAPH NOT FINAL	part333E	Carpet Rentals, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
60468-005_f54d6351-da06-808b-e053-2a95a90ae4cb	60468-005	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		LOPERAMIDE HYDROCHLORIDE	CAPSULE	ORAL	20200925		ANDA	ANDA215001	allphamed Pharbil Arzneimittel GmbH	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
60492-0075_c674037f-dc4d-4ce3-ae71-4fc6089ccb2e	60492-0075	PLASMA DERIVATIVE	BAT		Botulism Antitoxin Heptavalent	LIQUID	INTRAVENOUS	20130301		BLA	BLA125462	Emergent BIoSolutions Canada Inc.	EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2	4500; 3300; 3000; 600; 5100; 3000; 600	[iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL			N	20241231
60492-0173_3bb56e1d-118d-44b5-8768-fe1f47818977	60492-0173	HUMAN PRESCRIPTION DRUG	CNJ-016		Vaccinia Immune Globulin (Human)	INJECTION	INTRAVENOUS	20050501		BLA	BLA125109	Emergent BioSolutions Canada Inc.	HUMAN VACCINIA VIRUS IMMUNE GLOBULIN	1	[iU]/mL	Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
60492-0249_3d4260fd-6286-4678-be4c-e7cf294c6434	60492-0249	PLASMA DERIVATIVE	Anthrasil		Anthrax immune globulin (human)	LIQUID	INTRAVENOUS	20151005		BLA	BLA125562	Emergent BioSolutions Canada Inc.	ANTHRAX IMMUNE GLOBULIN HUMAN	60	[iU]/35mL			N	20241231
60505-0014_146609dc-5bb2-60a4-27dc-0e7bfc072381	60505-0014	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20010730		ANDA	ANDA074943	Apotex Corp.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60505-0015_146609dc-5bb2-60a4-27dc-0e7bfc072381	60505-0015	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20010730		ANDA	ANDA074943	Apotex Corp.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60505-0016_146609dc-5bb2-60a4-27dc-0e7bfc072381	60505-0016	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20010730		ANDA	ANDA074943	Apotex Corp.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60505-0033_f96bc30c-f6a0-8913-979a-c65d53fa7bdc	60505-0033	HUMAN PRESCRIPTION DRUG	PENTOXIFYLLINE		PENTOXIFYLLINE	TABLET, EXTENDED RELEASE	ORAL	19990610		ANDA	ANDA075191	Apotex Corp.	PENTOXIFYLLINE	400	mg/1	Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]		N	20241231
60505-0039_07bc97c5-d009-eb29-36af-d4c22467b555	60505-0039	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20030501		ANDA	ANDA075419	Apotex Corp.	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-0040_07bc97c5-d009-eb29-36af-d4c22467b555	60505-0040	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20030501		ANDA	ANDA075419	Apotex Corp.	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-0041_15c18ed3-bf10-909a-71ef-e63e2e9d3194	60505-0041	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	Apotex Corp.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-0042_b3ecb971-b130-f9df-e36d-826e9b827fee	60505-0042	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20060320		ANDA	ANDA075677	Apotex Corp.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60505-0055_6391b446-8e79-eb32-cbb5-b0bb8fcf1eb9	60505-0055	HUMAN PRESCRIPTION DRUG	SELEGILINE HYDROCHLORIDE		SELEGILINE HYDROCHLORIDE	CAPSULE	ORAL	19970715		ANDA	ANDA075321	Apotex Corp.	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
60505-0065_9cf7ffb8-cd12-61a0-3fd9-6300604b90f3	60505-0065	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20031111		ANDA	ANDA076048	Apotex Corp	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60505-0080_1fc1a2cf-5e7e-1cde-6dea-b0deb10cfac7	60505-0080	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Apotex Corp.	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60505-0081_1fc1a2cf-5e7e-1cde-6dea-b0deb10cfac7	60505-0081	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Apotex Corp.	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60505-0082_1fc1a2cf-5e7e-1cde-6dea-b0deb10cfac7	60505-0082	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Apotex Corp.	SOTALOL HYDROCHLORIDE	240	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60505-0083_17c7bfb9-ae58-35df-6bb4-8fe62c6302a5	60505-0083	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Apotex Corp.	PAROXETINE HYDROCHLORIDE ANHYDROUS	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-0084_17c7bfb9-ae58-35df-6bb4-8fe62c6302a5	60505-0084	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Apotex Corp.	PAROXETINE HYDROCHLORIDE ANHYDROUS	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-0093_6b5e535a-5a10-4be3-b036-f1ff67c0faf9	60505-0093	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Apotex Corp.	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60505-0094_6b5e535a-5a10-4be3-b036-f1ff67c0faf9	60505-0094	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Apotex Corp.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60505-0095_6b5e535a-5a10-4be3-b036-f1ff67c0faf9	60505-0095	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Apotex Corp.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60505-0096_6b5e535a-5a10-4be3-b036-f1ff67c0faf9	60505-0096	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Apotex Corp.	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60505-0097_17c7bfb9-ae58-35df-6bb4-8fe62c6302a5	60505-0097	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Apotex Corp.	PAROXETINE HYDROCHLORIDE ANHYDROUS	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-0101_17c7bfb9-ae58-35df-6bb4-8fe62c6302a5	60505-0101	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Apotex Corp.	PAROXETINE HYDROCHLORIDE ANHYDROUS	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-0102_15c18ed3-bf10-909a-71ef-e63e2e9d3194	60505-0102	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	Apotex Corp.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-0133_3582b52c-03f9-8fae-7a88-3564cd78ddef	60505-0133	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, GELATIN COATED	ORAL	20020529		ANDA	ANDA065040	Apotex Corp.	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60505-0134_3582b52c-03f9-8fae-7a88-3564cd78ddef	60505-0134	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, GELATIN COATED	ORAL	20020529		ANDA	ANDA065040	Apotex Corp.	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60505-0141_74c771a5-d24d-4efe-8b7d-7af899581728	60505-0141	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Apotex Corp.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60505-0142_74c771a5-d24d-4efe-8b7d-7af899581728	60505-0142	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Apotex Corp.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60505-0145_9cf7ffb8-cd12-61a0-3fd9-6300604b90f3	60505-0145	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20031111		ANDA	ANDA076048	Apotex Corp	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60505-0146_9cf7ffb8-cd12-61a0-3fd9-6300604b90f3	60505-0146	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA076048	Apotex Corp	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60505-0147_15dc2335-77ec-5f3a-631a-ac1f401a8a80	60505-0147	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20050124		ANDA	ANDA076471	Apotex Corp.	LORATADINE	10	mg/1			N	20241231
60505-0157_fdc870db-3c2d-6595-a738-765341bb0835	60505-0157	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Apotex Corp	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-0158_fdc870db-3c2d-6595-a738-765341bb0835	60505-0158	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Apotex Corp	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-0159_1fc1a2cf-5e7e-1cde-6dea-b0deb10cfac7	60505-0159	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Apotex Corp.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60505-0164_d0b07fab-e13d-db55-d9ca-5ee0fbd39a9b	60505-0164	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	TABLET	ORAL	20010710		ANDA	ANDA075902	Apotex Corp	FLUVOXAMINE MALEATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-0165_d0b07fab-e13d-db55-d9ca-5ee0fbd39a9b	60505-0165	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	TABLET	ORAL	20010710		ANDA	ANDA075902	Apotex Corp	FLUVOXAMINE MALEATE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-0166_d0b07fab-e13d-db55-d9ca-5ee0fbd39a9b	60505-0166	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	TABLET	ORAL	20010710		ANDA	ANDA075902	Apotex Corp	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-0168_c85a4c64-16f9-5817-e7e6-eb03aaadc3aa	60505-0168	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Apotex Corp.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-0169_c85a4c64-16f9-5817-e7e6-eb03aaadc3aa	60505-0169	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Apotex Corp.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-0170_c85a4c64-16f9-5817-e7e6-eb03aaadc3aa	60505-0170	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Apotex Corp.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-0183_629021d1-1ccd-ed40-643e-17704ad0e848	60505-0183	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20020901		ANDA	ANDA075948	Apotex Corp.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60505-0222_1fc1a2cf-5e7e-1cde-6dea-b0deb10cfac7	60505-0222	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030909		ANDA	ANDA076214	Apotex Corp.	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60505-0223_1fc1a2cf-5e7e-1cde-6dea-b0deb10cfac7	60505-0223	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030909		ANDA	ANDA076214	Apotex Corp.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60505-0224_1fc1a2cf-5e7e-1cde-6dea-b0deb10cfac7	60505-0224	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030909		ANDA	ANDA076214	Apotex Corp.	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
60505-0247_450f978e-312a-8804-8ce6-bde4f93b526d	60505-0247	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Apotex Corp.	MIRTAZAPINE	15	mg/1			N	20241231
60505-0248_450f978e-312a-8804-8ce6-bde4f93b526d	60505-0248	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Apotex Corp.	MIRTAZAPINE	30	mg/1			N	20241231
60505-0249_450f978e-312a-8804-8ce6-bde4f93b526d	60505-0249	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Apotex Corp.	MIRTAZAPINE	45	mg/1			N	20241231
60505-0251_35ea6051-a0fd-835e-472c-ea92db999c7e	60505-0251	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20040116		ANDA	ANDA076533	Apotex Corp.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-0252_35ea6051-a0fd-835e-472c-ea92db999c7e	60505-0252	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20040116		ANDA	ANDA076533	Apotex Corp.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-0253_c03163e2-7ad1-27ba-e830-e73781ca2a39	60505-0253	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076274	Apotex Corp.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
60505-0257_9ce2fc5c-13ed-1b31-c284-d21c1ddbc8ef	60505-0257	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20060307		ANDA	ANDA077414	Apotex Corp.	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
60505-0258_9ce2fc5c-13ed-1b31-c284-d21c1ddbc8ef	60505-0258	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20060307		ANDA	ANDA077414	Apotex Corp.	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
60505-0363_914c3a93-4247-5c3a-5352-cb5539c5f90a	60505-0363	HUMAN PRESCRIPTION DRUG	Ofloxacin Otic		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20040514		ANDA	ANDA076527	Apotex Corp.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
60505-0402_1f56da5f-da6f-9fff-98eb-182f368b7d9e	60505-0402	HUMAN PRESCRIPTION DRUG	PAXIL		paroxetine hydrochloride	SUSPENSION	ORAL	20110101	20251130	NDA	NDA020710	Apotex Corp	PAROXETINE HYDROCHLORIDE	10	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
60505-0404_07a57d29-3a0d-8490-6f91-09e85257a0b3	60505-0404	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	SOLUTION	ORAL	20151008		ANDA	ANDA204094	Apotex Corp.	ARIPIPRAZOLE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
60505-0405_2c45ed04-e92f-1b2f-bfbc-5ac5e711de55	60505-0405	HUMAN PRESCRIPTION DRUG	Lacosamide Oral Solution		lacosamide	SOLUTION	ORAL	20230614		ANDA	ANDA206355	Apotex Corp.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
60505-0406_398b2cf9-88d9-c5c3-9a88-1a3e725fdc76	60505-0406	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20220509		ANDA	ANDA207714	Apotex Corp.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-0560_eeb3b6ed-6b07-ffba-9540-bf1e1c9a29e8	60505-0560	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20190301		ANDA	ANDA076513	Apotex Corp.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
60505-0564_0b0dc768-aace-22c7-dca9-5096922956b0	60505-0564	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		brimonidine tartrate	SOLUTION/ DROPS	OPHTHALMIC	20220131		ANDA	ANDA078479	Apotex Corp.	BRIMONIDINE TARTRATE	1.5	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60505-0577_bf56b59d-9af8-851f-58ef-30e28f961a81	60505-0577	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		brimonidine tartrate	SOLUTION/ DROPS	OPHTHALMIC	20230902		ANDA	ANDA078480	Apotex Corp.	BRIMONIDINE TARTRATE	1	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60505-0578_2c25b4fe-8e7d-ab2d-4ead-3e2ab8b43c5e	60505-0578	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SOLUTION/ DROPS	INTRAOCULAR	20091201		ANDA	ANDA078621	Apotex Corp.	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
60505-0582_76dd6301-e3f6-b645-a4a3-3322a2553e2c	60505-0582	HUMAN PRESCRIPTION DRUG	Moxifloxacin		moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20170701		ANDA	ANDA090080	Apotex Corp.	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
60505-0583_40d46a24-a16f-facd-d2aa-6d3731cf053b	60505-0583	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20181008		ANDA	ANDA090449	Apotex Corp.	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
60505-0589_163f1094-1376-46fa-05fc-b979a9998bb1	60505-0589	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution		Brimonidine Tartrate and Timolol Maleate	SOLUTION	OPHTHALMIC	20221019		ANDA	ANDA091442	Apotex Corp.	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
60505-0593_3f350014-e39c-c916-b2a0-c96e030cc329	60505-0593	HUMAN PRESCRIPTION DRUG	Travoprost		travoprost	SOLUTION	OPHTHALMIC	20191218		ANDA	ANDA203431	Apotex Corp.	TRAVOPROST	.04	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
60505-0791_653e31af-e1ac-249d-d743-b4a9007ae51a	60505-0791	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240831	ANDA	ANDA078990	Apotex Corp.	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
60505-0792_653e31af-e1ac-249d-d743-b4a9007ae51a	60505-0792	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240831	ANDA	ANDA078990	Apotex Corp.	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
60505-0793_653e31af-e1ac-249d-d743-b4a9007ae51a	60505-0793	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240831	ANDA	ANDA078990	Apotex Corp.	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
60505-0794_653e31af-e1ac-249d-d743-b4a9007ae51a	60505-0794	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240831	ANDA	ANDA078990	Apotex Corp.	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
60505-0795_653e31af-e1ac-249d-d743-b4a9007ae51a	60505-0795	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240831	ANDA	ANDA078990	Apotex Corp.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
60505-0796_653e31af-e1ac-249d-d743-b4a9007ae51a	60505-0796	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240831	ANDA	ANDA078990	Apotex Corp.	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
60505-0798_653e31af-e1ac-249d-d743-b4a9007ae51a	60505-0798	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190131	20240831	ANDA	ANDA078990	Apotex Corp.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	
60505-0813_58497edc-37e4-5219-4845-7572f7664b7c	60505-0813	HUMAN PRESCRIPTION DRUG	Butorphanol Tartrate		Butorphanol Tartrate	SPRAY	NASAL	20021204		ANDA	ANDA075499	Apotex Corp.	BUTORPHANOL TARTRATE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
60505-0815_1359fd38-fc25-b6e0-2780-b00a5434efd9	60505-0815	HUMAN PRESCRIPTION DRUG	DESMOPRESSIN ACETATE		DESMOPRESSIN ACETATE	SPRAY	NASAL	20201130		ANDA	ANDA076703	Apotex Corp.	DESMOPRESSIN ACETATE	10	ug/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
60505-0823_abf8f5b7-cb7b-5a7d-08da-f0b7fee1907d	60505-0823	HUMAN PRESCRIPTION DRUG	Calcitonin Salmon		Calcitonin Salmon	SPRAY, METERED	NASAL	20081209		ANDA	ANDA076396	Apotex Corp.	CALCITONIN SALMON	200	[iU]/1	Calcitonin [CS], Calcitonin [EPC]		N	20241231
60505-0826_5817f135-603d-97c9-6076-2aa22ab6bf26	60505-0826	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY, METERED	NASAL	20200526		ANDA	ANDA076156	Apotex Corp.	IPRATROPIUM BROMIDE	21	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60505-0827_770e1e7b-4827-5130-cbb5-cef76c2a25fc	60505-0827	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		ipratropium bromide	SPRAY, METERED	NASAL	20200526		ANDA	ANDA076155	Apotex Corp.	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60505-0829_77643290-8a0d-2f0d-6ab1-f0bb58332418	60505-0829	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20070919		ANDA	ANDA077538	Apotex Corp.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-0830_353e9a85-7703-2f8b-a9c7-583d8b45bbc2	60505-0830	HUMAN PRESCRIPTION DRUG	MOMETASONE FUROATE		MOMETASONE FUROATE	SPRAY, METERED	NASAL	20160322		ANDA	ANDA091161	Apotex Corp.	MOMETASONE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-0833_f88209b8-1bb8-bb32-c415-36da6f6a982e	60505-0833	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		azelastine hydrochloride	SPRAY, METERED	NASAL	20100301		ANDA	ANDA077954	Apotex Corp.	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
60505-0845_b23450d3-7f6f-8250-fe8d-a64be165e5a9	60505-0845	HUMAN PRESCRIPTION DRUG	Olopatadine Hydrochloride		olopatadine hydrochloride	SPRAY, METERED	NASAL	20141027		ANDA	ANDA091572	Apotex Corp.	OLOPATADINE HYDROCHLORIDE	665	ug/1	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
60505-0953_1f724690-1bfd-6f4d-26a4-57960e9fe3ed	60505-0953	HUMAN PRESCRIPTION DRUG	Azelastine hydrochloride and Fluticasone propionate		Azelastine hydrochloride and Fluticasone propionate	SPRAY, METERED	NASAL	20200302		ANDA	ANDA207712	Apotex Corp.	AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE	137; 50	ug/1; ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
60505-0955_26f59974-077c-2573-f26f-8537de11de8a	60505-0955	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20170725		ANDA	ANDA208150	Apotex Corp.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
60505-1003_4f05f476-9226-f83f-0269-5d985ba5e0e3	60505-1003	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20091207		ANDA	ANDA076109	Apotex Corp.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-1005_387c9a69-d911-e8f1-411e-5b3e060b2c31	60505-1005	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20171127		ANDA	ANDA204936	Apotex Corp	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60505-1316_d7c7dbe3-a039-0098-be01-2e2597a707ec	60505-1316	HUMAN PRESCRIPTION DRUG	PAROXETINE HYDROCHLORIDE		paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190809		NDA	NDA020936	Apotex Corp	PAROXETINE HYDROCHLORIDE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-1317_d7c7dbe3-a039-0098-be01-2e2597a707ec	60505-1317	HUMAN PRESCRIPTION DRUG	PAROXETINE HYDROCHLORIDE		paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190809		NDA	NDA020936	Apotex Corp	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-1318_d7c7dbe3-a039-0098-be01-2e2597a707ec	60505-1318	HUMAN PRESCRIPTION DRUG	PAROXETINE HYDROCHLORIDE		paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190809		NDA	NDA020936	Apotex Corp	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-1320_c82988de-2daa-96bc-d446-0607f9f83c35	60505-1320	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Apotex Corp	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60505-1321_c82988de-2daa-96bc-d446-0607f9f83c35	60505-1321	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Apotex Corp	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60505-1323_c85a4c64-16f9-5817-e7e6-eb03aaadc3aa	60505-1323	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Apotex Corp.	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-1325_c82988de-2daa-96bc-d446-0607f9f83c35	60505-1325	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Apotex Corp	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60505-2502_74333ed0-641b-34da-d913-50d2d5979444	60505-2502	HUMAN PRESCRIPTION DRUG	LEFLUNOMIDE		LEFLUNOMIDE	TABLET	ORAL	20050913		ANDA	ANDA077090	Apotex Corp.	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
60505-2503_74333ed0-641b-34da-d913-50d2d5979444	60505-2503	HUMAN PRESCRIPTION DRUG	LEFLUNOMIDE		LEFLUNOMIDE	TABLET	ORAL	20050913		ANDA	ANDA077090	Apotex Corp.	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
60505-2521_b0e1c8ca-e2f8-970d-74d1-5031794c6516	60505-2521	HUMAN PRESCRIPTION DRUG	cilostazol		cilostazol	TABLET	ORAL	20111018		ANDA	ANDA077030	Apotex Corp.	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
60505-2522_b0e1c8ca-e2f8-970d-74d1-5031794c6516	60505-2522	HUMAN PRESCRIPTION DRUG	cilostazol		cilostazol	TABLET	ORAL	20111018		ANDA	ANDA077030	Apotex Corp.	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
60505-2526_3a1310d4-1f19-c8ed-8a75-de278b4812c8	60505-2526	HUMAN PRESCRIPTION DRUG	Modafinil		modafinil	TABLET	ORAL	20140203		ANDA	ANDA077667	Apotex Corp.	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
60505-2527_3a1310d4-1f19-c8ed-8a75-de278b4812c8	60505-2527	HUMAN PRESCRIPTION DRUG	Modafinil		modafinil	TABLET	ORAL	20140203		ANDA	ANDA077667	Apotex Corp.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
60505-2528_356479f9-f99e-f6f2-be88-b586f982f4d2	60505-2528	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120514		ANDA	ANDA077561	Apotex Corp.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-2529_356479f9-f99e-f6f2-be88-b586f982f4d2	60505-2529	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120514		ANDA	ANDA077561	Apotex Corp.	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-2530_356479f9-f99e-f6f2-be88-b586f982f4d2	60505-2530	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120514		ANDA	ANDA077561	Apotex Corp.	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-2531_356479f9-f99e-f6f2-be88-b586f982f4d2	60505-2531	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120514		ANDA	ANDA077561	Apotex Corp.	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-2575_2be1cede-a19a-d9a0-9d1e-8c0234499750	60505-2575	HUMAN PRESCRIPTION DRUG	Balsalazide Disodium		Balsalazide Disodium	CAPSULE	ORAL	20071228		ANDA	ANDA077883	Apotex Corp.	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
60505-2578_7b4530b2-1793-e48c-c5d5-7b30d0e2e117	60505-2578	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Apotex Corp.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-2579_7b4530b2-1793-e48c-c5d5-7b30d0e2e117	60505-2579	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Apotex Corp.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-2580_7b4530b2-1793-e48c-c5d5-7b30d0e2e117	60505-2580	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Apotex Corp.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-2648_85204d4d-bb88-8501-3497-fc52aa1fc003	60505-2648	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20120206		ANDA	ANDA078868	Apotex Corp.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-2649_85204d4d-bb88-8501-3497-fc52aa1fc003	60505-2649	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20120206		ANDA	ANDA078868	Apotex Corp.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-2650_85204d4d-bb88-8501-3497-fc52aa1fc003	60505-2650	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20120206		ANDA	ANDA078868	Apotex Corp.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-2653_47dcea56-2e30-3451-0dd0-6efb7b633377	60505-2653	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20081117		ANDA	ANDA071258	Apotex Corp	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60505-2654_47dcea56-2e30-3451-0dd0-6efb7b633377	60505-2654	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20081117		ANDA	ANDA071196	Apotex Corp	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60505-2655_47dcea56-2e30-3451-0dd0-6efb7b633377	60505-2655	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20081117		ANDA	ANDA071196	Apotex Corp	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60505-2656_e096e537-fdad-acac-655f-51d34ce61186	60505-2656	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	Apotex Corp.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60505-2657_e096e537-fdad-acac-655f-51d34ce61186	60505-2657	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	Apotex Corp.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60505-2659_47dcea56-2e30-3451-0dd0-6efb7b633377	60505-2659	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20090105		ANDA	ANDA071196	Apotex Corp	TRAZODONE HYDROCHLORIDE	300	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60505-2671_7b4530b2-1793-e48c-c5d5-7b30d0e2e117	60505-2671	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Apotex Corp.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-2673_f94369e4-9c71-08c4-afbb-558f67e87662	60505-2673	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150724	20250630	ANDA	ANDA078583	Apotex Corp	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	
60505-2674_f94369e4-9c71-08c4-afbb-558f67e87662	60505-2674	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150724	20250630	ANDA	ANDA078583	Apotex Corp	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	
60505-2675_f94369e4-9c71-08c4-afbb-558f67e87662	60505-2675	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150724	20250630	ANDA	ANDA078583	Apotex Corp	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	
60505-2676_f94369e4-9c71-08c4-afbb-558f67e87662	60505-2676	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150724	20241231	ANDA	ANDA078583	Apotex Corp	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	
60505-2795_77c290aa-f814-b887-4f81-8b33233d65d3	60505-2795	HUMAN PRESCRIPTION DRUG	IBANDRONATE SODIUM		IBANDRONATE SODIUM	TABLET, FILM COATED	ORAL	20120319		ANDA	ANDA078948	Apotex Corp	IBANDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60505-2805_242fcc01-8921-f67d-41b8-01bcb51957e2	60505-2805	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20120323		ANDA	ANDA078986	Apotex Corp.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60505-2806_242fcc01-8921-f67d-41b8-01bcb51957e2	60505-2806	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20120323		ANDA	ANDA078986	Apotex Corp.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60505-2807_242fcc01-8921-f67d-41b8-01bcb51957e2	60505-2807	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20120323		ANDA	ANDA078986	Apotex Corp.	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60505-2830_fc4958e4-0a62-858c-334a-734bb9cb028a	60505-2830	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	Apotex Corp.	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-2831_fc4958e4-0a62-858c-334a-734bb9cb028a	60505-2831	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	Apotex Corp.	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-2832_fc4958e4-0a62-858c-334a-734bb9cb028a	60505-2832	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	Apotex Corp.	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-2833_fc4958e4-0a62-858c-334a-734bb9cb028a	60505-2833	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	Apotex Corp.	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-2834_fc4958e4-0a62-858c-334a-734bb9cb028a	60505-2834	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	Apotex Corp.	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-2835_fc4958e4-0a62-858c-334a-734bb9cb028a	60505-2835	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	Apotex Corp.	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-2836_fc4958e4-0a62-858c-334a-734bb9cb028a	60505-2836	HUMAN PRESCRIPTION DRUG	Atomoxetine Hydrochloride		atomoxetine hydrochloride	CAPSULE	ORAL	20180521		ANDA	ANDA078983	Apotex Corp.	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60505-2850_3659a5a6-5ddb-580e-debc-993b44879f2b	60505-2850	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230908		ANDA	ANDA079013	Apotex Corp.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60505-2900_50f696f5-66b5-d09b-748d-2b9d6d3cf500	60505-2900	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA079179	Apotex Corp	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
60505-2901_50f696f5-66b5-d09b-748d-2b9d6d3cf500	60505-2901	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA079179	Apotex Corp	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
60505-2965_b6c80629-1f0c-6254-87ef-4b93ee8077eb	60505-2965	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20120821		ANDA	ANDA091558	Apotex Corp	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
60505-2966_b6c80629-1f0c-6254-87ef-4b93ee8077eb	60505-2966	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20140819		ANDA	ANDA091558	Apotex Corp	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
60505-3075_f94369e4-9c71-08c4-afbb-558f67e87662	60505-3075	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150724	20241231	ANDA	ANDA078583	Apotex Corp	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	
60505-3096_03428ba0-f6f3-be31-dc50-def19fdd4184	60505-3096	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20140611		ANDA	ANDA090877	Apotex Corp.	RISEDRONATE SODIUM	75	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60505-3097_03428ba0-f6f3-be31-dc50-def19fdd4184	60505-3097	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20140611		ANDA	ANDA090877	Apotex Corp.	RISEDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60505-3110_76246803-b79b-a433-1082-7c7aee0ff09d	60505-3110	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Apotex Corp.	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3111_76246803-b79b-a433-1082-7c7aee0ff09d	60505-3111	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Apotex Corp.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3112_76246803-b79b-a433-1082-7c7aee0ff09d	60505-3112	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Apotex Corp.	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3113_76246803-b79b-a433-1082-7c7aee0ff09d	60505-3113	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Apotex Corp.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3114_76246803-b79b-a433-1082-7c7aee0ff09d	60505-3114	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Apotex Corp.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3120_b8fb9dfe-0239-148f-b60e-7dfc9e8c8bb5	60505-3120	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20130726		ANDA	ANDA202252	Apotex Corp.	FENOFIBRATE	43	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60505-3121_b8fb9dfe-0239-148f-b60e-7dfc9e8c8bb5	60505-3121	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20130726		ANDA	ANDA202252	Apotex Corp.	FENOFIBRATE	130	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60505-3140_76246803-b79b-a433-1082-7c7aee0ff09d	60505-3140	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Apotex Corp.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3165_03428ba0-f6f3-be31-dc50-def19fdd4184	60505-3165	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA090877	Apotex Corp.	RISEDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60505-3170_2adf18de-70b2-d827-15ef-a8bd56c1dff7	60505-3170	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20140930		ANDA	ANDA090973	Apotex Corp.	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
60505-3245_f7191297-4faf-fa02-2240-bcd9ef691fec	60505-3245	HUMAN PRESCRIPTION DRUG	FAMCICLOVIR		FAMCICLOVIR	TABLET, FILM COATED	ORAL	20111220		ANDA	ANDA091480	Apotex Corp.	FAMCICLOVIR	125	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60505-3246_f7191297-4faf-fa02-2240-bcd9ef691fec	60505-3246	HUMAN PRESCRIPTION DRUG	FAMCICLOVIR		FAMCICLOVIR	TABLET, FILM COATED	ORAL	20111220		ANDA	ANDA091480	Apotex Corp.	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60505-3247_f7191297-4faf-fa02-2240-bcd9ef691fec	60505-3247	HUMAN PRESCRIPTION DRUG	FAMCICLOVIR		FAMCICLOVIR	TABLET, FILM COATED	ORAL	20111220		ANDA	ANDA091480	Apotex Corp.	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60505-3250_89329f0d-d91e-a85e-2085-67e3a435d9c3	60505-3250	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20140103		ANDA	ANDA202941	Apotex Corp.	LAMIVUDINE	100	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60505-3251_bbf358fa-e61a-1522-02f7-a3e252d4c5e6	60505-3251	HUMAN PRESCRIPTION DRUG	LAMIVUDINE		lamivudine	TABLET, FILM COATED	ORAL	20111202		ANDA	ANDA091606	Apotex Corp.	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60505-3252_bbf358fa-e61a-1522-02f7-a3e252d4c5e6	60505-3252	HUMAN PRESCRIPTION DRUG	LAMIVUDINE		lamivudine	TABLET, FILM COATED	ORAL	20111202		ANDA	ANDA091606	Apotex Corp.	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60505-3275_f0e96ab3-d3a5-4061-74a8-d4eb8b9ec393	60505-3275	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Apotex Corp.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3276_f0e96ab3-d3a5-4061-74a8-d4eb8b9ec393	60505-3276	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Apotex Corp.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3277_f0e96ab3-d3a5-4061-74a8-d4eb8b9ec393	60505-3277	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Apotex Corp.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3278_f0e96ab3-d3a5-4061-74a8-d4eb8b9ec393	60505-3278	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Apotex Corp.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60505-3280_ce4aeb08-98cd-b031-9262-1bccd2f16f95	60505-3280	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110912		ANDA	ANDA091261	Apotex Corp.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60505-3438_15dbe4d9-0a0a-8200-10aa-cea445230c24	60505-3438	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	TABLET	ORAL	19970706		ANDA	ANDA074871	Apotex Corp.	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
60505-3478_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3478	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3479_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3479	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3483_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3483	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3484_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3484	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3488_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3488	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3489_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3489	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3492_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3492	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3493_a8614d7b-ff0d-a02c-983a-d0745908a702	60505-3493	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Apotex Corp.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60505-3517_ce4aeb08-98cd-b031-9262-1bccd2f16f95	60505-3517	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110912		ANDA	ANDA091261	Apotex Corp.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60505-3518_ce4aeb08-98cd-b031-9262-1bccd2f16f95	60505-3518	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150225		ANDA	ANDA202958	Apotex Corp.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60505-3532_c03163e2-7ad1-27ba-e830-e73781ca2a39	60505-3532	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA076274	Apotex Corp.	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
60505-3613_b320350d-ea25-000d-b064-9316b177edca	60505-3613	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230126		ANDA	ANDA201962	Apotex Corp	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
60505-3614_b320350d-ea25-000d-b064-9316b177edca	60505-3614	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230126		ANDA	ANDA201962	Apotex Corp	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
60505-3793_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3793	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	25	mg/1		CV	N	20241231
60505-3794_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3794	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	50	mg/1		CV	N	20241231
60505-3795_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3795	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	75	mg/1		CV	N	20241231
60505-3796_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3796	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	100	mg/1		CV	N	20241231
60505-3797_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3797	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	150	mg/1		CV	N	20241231
60505-3798_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3798	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	200	mg/1		CV	N	20241231
60505-3799_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3799	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	225	mg/1		CV	N	20241231
60505-3800_0f4d3db6-ce2b-24c0-c1ab-3988d084b951	60505-3800	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	ApotexCorp	PREGABALIN	300	mg/1		CV	N	20241231
60505-3847_62e5be41-22d8-a91d-794c-7d88cea28fe6	60505-3847	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150603		ANDA	ANDA204197	Apotex Corp.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-3848_62e5be41-22d8-a91d-794c-7d88cea28fe6	60505-3848	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150603		ANDA	ANDA204197	Apotex Corp.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-3849_62e5be41-22d8-a91d-794c-7d88cea28fe6	60505-3849	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150603		ANDA	ANDA204197	Apotex Corp.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60505-3882_df6ea395-23cb-70b9-dd8e-681bb29a8d27	60505-3882	HUMAN PRESCRIPTION DRUG	Tetrabenazine		tetrabenazine	TABLET	ORAL	20200618		ANDA	ANDA206093	Apotex Corp.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
60505-3883_df6ea395-23cb-70b9-dd8e-681bb29a8d27	60505-3883	HUMAN PRESCRIPTION DRUG	Tetrabenazine		tetrabenazine	TABLET	ORAL	20200618		ANDA	ANDA206093	Apotex Corp.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
60505-3927_272b5d40-bb77-134c-6a51-8e97d6227543	60505-3927	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Apotex Corp.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-3928_272b5d40-bb77-134c-6a51-8e97d6227543	60505-3928	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Apotex Corp.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-3929_272b5d40-bb77-134c-6a51-8e97d6227543	60505-3929	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Apotex Corp.	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-3930_272b5d40-bb77-134c-6a51-8e97d6227543	60505-3930	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Apotex Corp.	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60505-3947_5eb01084-8cee-6b67-1359-718c759ce65c	60505-3947	HUMAN PRESCRIPTION DRUG	Adefovir dipivoxil		adefovir dipivoxil	TABLET	ORAL	20180925		ANDA	ANDA205459	Apotex Corp.	ADEFOVIR DIPIVOXIL	10	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60505-3952_9cf7ffb8-cd12-61a0-3fd9-6300604b90f3	60505-3952	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20031111		ANDA	ANDA076048	Apotex Corp	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60505-4033_934f92b6-6be7-6fd4-cc64-8dd575526863	60505-4033	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE	ORAL	20211216		ANDA	ANDA209437	Apotex Corp	ICOSAPENT ETHYL	1	g/1			N	20241231
60505-4202_b6c64d8b-a518-2d8d-507d-8cbab0cdef8b	60505-4202	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210625	20240331	ANDA	ANDA208740	Apotex Corp.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	
60505-4317_4c608abc-bf94-af08-1ad9-04d18d633ae2	60505-4317	HUMAN PRESCRIPTION DRUG	tolvaptan		tolvaptan	TABLET	ORAL	20221214		ANDA	ANDA207605	Apotex Corp.	TOLVAPTAN	15	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
60505-4318_4c608abc-bf94-af08-1ad9-04d18d633ae2	60505-4318	HUMAN PRESCRIPTION DRUG	tolvaptan		tolvaptan	TABLET	ORAL	20220705		ANDA	ANDA207605	Apotex Corp.	TOLVAPTAN	30	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
60505-4327_5ba56b70-bda3-48eb-d1b6-1732f0223f57	60505-4327	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone Acetate	TABLET	ORAL	20181123		ANDA	ANDA208453	Apotex Corp.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
60505-4332_ac42a298-c4dd-8807-9dd0-fbcd6440552b	60505-4332	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod	CAPSULE	ORAL	20221018		ANDA	ANDA207993	Apotex Corp.	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
60505-4372_a7aa93ce-0ba7-16ef-1940-29ad937e7d70	60505-4372	HUMAN PRESCRIPTION DRUG	vilazodone hydrochloride		vilazodone hydrochloride	TABLET	ORAL	20231026		ANDA	ANDA208228	Apotex Corp.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
60505-4373_a7aa93ce-0ba7-16ef-1940-29ad937e7d70	60505-4373	HUMAN PRESCRIPTION DRUG	vilazodone hydrochloride		vilazodone hydrochloride	TABLET	ORAL	20231026		ANDA	ANDA208228	Apotex Corp.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
60505-4374_a7aa93ce-0ba7-16ef-1940-29ad937e7d70	60505-4374	HUMAN PRESCRIPTION DRUG	vilazodone hydrochloride		vilazodone hydrochloride	TABLET	ORAL	20231026		ANDA	ANDA208228	Apotex Corp.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
60505-4377_31ba7ff4-1f0d-b163-436d-61a1ec70ce44	60505-4377	HUMAN PRESCRIPTION DRUG	PAXIL	CR	paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110101		NDA	NDA020936	Apotex Corp	PAROXETINE HYDROCHLORIDE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-4378_31ba7ff4-1f0d-b163-436d-61a1ec70ce44	60505-4378	HUMAN PRESCRIPTION DRUG	PAXIL	CR	paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110101		NDA	NDA020936	Apotex Corp	PAROXETINE HYDROCHLORIDE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-4379_31ba7ff4-1f0d-b163-436d-61a1ec70ce44	60505-4379	HUMAN PRESCRIPTION DRUG	PAXIL	CR	paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110101		NDA	NDA020936	Apotex Corp	PAROXETINE HYDROCHLORIDE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-4382_125cf22f-0f34-f43e-2a3e-db865e84b4e0	60505-4382	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, COATED	ORAL	20190801		ANDA	ANDA209243	Apotex Corp.	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60505-4384_125cf22f-0f34-f43e-2a3e-db865e84b4e0	60505-4384	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, COATED	ORAL	20190801		ANDA	ANDA209243	Apotex Corp.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60505-4462_2adf18de-70b2-d827-15ef-a8bd56c1dff7	60505-4462	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20140930	20250531	ANDA	ANDA090973	Apotex Corp.	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	
60505-4477_337cbfd7-bc82-6223-2720-2b5b4659e644	60505-4477	HUMAN PRESCRIPTION DRUG	teriflunomide		teriflunomide	TABLET, FILM COATED	ORAL	20230906		ANDA	ANDA209601	Apotex Corp	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
60505-4478_337cbfd7-bc82-6223-2720-2b5b4659e644	60505-4478	HUMAN PRESCRIPTION DRUG	teriflunomide		teriflunomide	TABLET, FILM COATED	ORAL	20230906		ANDA	ANDA209601	Apotex Corp	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
60505-4512_5fb92c16-3e0f-f445-ede2-9e6db77c6e10	60505-4512	HUMAN PRESCRIPTION DRUG	Gefitinib		Gefitinib	TABLET	ORAL	20230808		ANDA	ANDA209532	Apotex Corp.	GEFITINIB	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
60505-4517_260482ca-6214-7d67-830d-3d048c4941f6	60505-4517	HUMAN PRESCRIPTION DRUG	PAXIL		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20190311		NDA	NDA020031	Apotex Corp	PAROXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-4518_260482ca-6214-7d67-830d-3d048c4941f6	60505-4518	HUMAN PRESCRIPTION DRUG	PAXIL		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20190311		NDA	NDA020031	Apotex Corp	PAROXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-4519_260482ca-6214-7d67-830d-3d048c4941f6	60505-4519	HUMAN PRESCRIPTION DRUG	PAXIL		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20190311		NDA	NDA020031	Apotex Corp	PAROXETINE HYDROCHLORIDE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-4520_260482ca-6214-7d67-830d-3d048c4941f6	60505-4520	HUMAN PRESCRIPTION DRUG	PAXIL		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20190311		NDA	NDA020031	Apotex Corp	PAROXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60505-4532_d0acaa12-91f3-f88f-ddf5-036e57dfc05c	60505-4532	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230309		ANDA	ANDA211022	Apotex Corp.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
60505-4533_d0acaa12-91f3-f88f-ddf5-036e57dfc05c	60505-4533	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA211022	Apotex Corp.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
60505-4534_d0acaa12-91f3-f88f-ddf5-036e57dfc05c	60505-4534	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA211022	Apotex Corp.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
60505-4535_d0acaa12-91f3-f88f-ddf5-036e57dfc05c	60505-4535	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA211022	Apotex Corp.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
60505-4536_d0acaa12-91f3-f88f-ddf5-036e57dfc05c	60505-4536	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230309		ANDA	ANDA211022	Apotex Corp.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
60505-4537_d0acaa12-91f3-f88f-ddf5-036e57dfc05c	60505-4537	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA211022	Apotex Corp.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
60505-4552_ac315931-07c2-84f0-5a22-cd422464e943	60505-4552	HUMAN PRESCRIPTION DRUG	Ambrisentan		AMBRISENTAN	TABLET, FILM COATED	ORAL	20220919		ANDA	ANDA210701	Apotex Corp.	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
60505-4553_ac315931-07c2-84f0-5a22-cd422464e943	60505-4553	HUMAN PRESCRIPTION DRUG	Ambrisentan		AMBRISENTAN	TABLET, FILM COATED	ORAL	20220919		ANDA	ANDA210701	Apotex Corp.	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
60505-4630_63e0d9d4-3eb3-2015-35ca-65921091cc49	60505-4630	HUMAN PRESCRIPTION DRUG	CycloSPORINE, Modfied		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20191105		ANDA	ANDA210721	Apotex Corp.	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60505-4631_63e0d9d4-3eb3-2015-35ca-65921091cc49	60505-4631	HUMAN PRESCRIPTION DRUG	CycloSPORINE, Modfied		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20191105		ANDA	ANDA210721	Apotex Corp.	CYCLOSPORINE	50	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60505-4632_63e0d9d4-3eb3-2015-35ca-65921091cc49	60505-4632	HUMAN PRESCRIPTION DRUG	CycloSPORINE, Modfied		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20191105		ANDA	ANDA210721	Apotex Corp.	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60505-4642_2bdfb562-e6ba-467f-85fb-0004741f04fb	60505-4642	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20171016		ANDA	ANDA205897	Apotex Corp.	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
60505-4643_2bdfb562-e6ba-467f-85fb-0004741f04fb	60505-4643	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20171016		ANDA	ANDA205897	Apotex Corp.	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
60505-4665_2d32bb85-3df0-b9c6-0fd1-bf559cdc6550	60505-4665	HUMAN PRESCRIPTION DRUG	Tasimelteon		Tasimelteon	CAPSULE	ORAL	20240105		ANDA	ANDA211607	Apotex Corp.	TASIMELTEON	20	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20251231
60505-4696_dc5730d7-2909-9e52-4377-df3b8bd6902c	60505-4696	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20200626		ANDA	ANDA213310	Apotex Corp.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
60505-4700_16eb522c-ad07-2a12-3ff2-fc4c67f4b20e	60505-4700	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride Extended-Release		Metformin Hydrochloride Extended-Release	TABLET	ORAL	20230814		ANDA	ANDA213356	Apotex Corp.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60505-4701_16eb522c-ad07-2a12-3ff2-fc4c67f4b20e	60505-4701	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride Extended-Release		Metformin Hydrochloride Extended-Release	TABLET	ORAL	20230814		ANDA	ANDA213356	Apotex Corp.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60505-4702_6f8f3eeb-8d08-4611-9667-c4d61310d743	60505-4702	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA209333	Apotex Corp.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60505-4703_6f8f3eeb-8d08-4611-9667-c4d61310d743	60505-4703	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA209333	Apotex Corp.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60505-4739_b689d5da-6754-ca61-6ce4-3b32d8e72396	60505-4739	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20231109		ANDA	ANDA216944	Apotex Corp.	LISDEXAMFETAMINE DIMESYLATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
60505-4740_b689d5da-6754-ca61-6ce4-3b32d8e72396	60505-4740	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20231109		ANDA	ANDA216944	Apotex Corp.	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
60505-4741_b689d5da-6754-ca61-6ce4-3b32d8e72396	60505-4741	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20231109		ANDA	ANDA216944	Apotex Corp.	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
60505-4742_b689d5da-6754-ca61-6ce4-3b32d8e72396	60505-4742	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20231109		ANDA	ANDA216944	Apotex Corp.	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
60505-4743_b689d5da-6754-ca61-6ce4-3b32d8e72396	60505-4743	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20231109		ANDA	ANDA216944	Apotex Corp.	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
60505-4744_b689d5da-6754-ca61-6ce4-3b32d8e72396	60505-4744	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20231109		ANDA	ANDA216944	Apotex Corp.	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
60505-4745_b689d5da-6754-ca61-6ce4-3b32d8e72396	60505-4745	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	CAPSULE	ORAL	20231109		ANDA	ANDA216944	Apotex Corp.	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
60505-4754_5f407df1-e37c-c364-ee2c-176f323b64af	60505-4754	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20220922		ANDA	ANDA215566	Apotex Corp.	CLORAZEPATE DIPOTASSIUM	3.75	mg/mg	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60505-4755_5f407df1-e37c-c364-ee2c-176f323b64af	60505-4755	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20220922		ANDA	ANDA215566	Apotex Corp.	CLORAZEPATE DIPOTASSIUM	7.5	mg/mg	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60505-4756_5f407df1-e37c-c364-ee2c-176f323b64af	60505-4756	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20220922		ANDA	ANDA215566	Apotex Corp.	CLORAZEPATE DIPOTASSIUM	15	mg/mg	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60505-4764_0b559376-5181-40da-8b69-461bf4d1238e	60505-4764	HUMAN PRESCRIPTION DRUG	abiraterone acetate		Abiraterone acetate	TABLET, FILM COATED	ORAL	20210716		ANDA	ANDA212462	Apotex Corp.	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
60505-4765_cd7db833-6a04-3e59-5432-326867309b61	60505-4765	HUMAN PRESCRIPTION DRUG	APO-VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20210716	20250331	UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Apotex Corp	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	
60505-4766_cd7db833-6a04-3e59-5432-326867309b61	60505-4766	HUMAN PRESCRIPTION DRUG	APO-VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20210716	20240731	UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Apotex Corp	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	
60505-4768_6fcc98ce-3cdc-056e-c844-db357b5d9c63	60505-4768	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230412		ANDA	ANDA216649	Apotex Corp.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60505-4769_6fcc98ce-3cdc-056e-c844-db357b5d9c63	60505-4769	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230412		ANDA	ANDA216649	Apotex Corp.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60505-4770_6fcc98ce-3cdc-056e-c844-db357b5d9c63	60505-4770	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230412		ANDA	ANDA216649	Apotex Corp.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60505-4771_6fcc98ce-3cdc-056e-c844-db357b5d9c63	60505-4771	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20230412		ANDA	ANDA216649	Apotex Corp.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60505-4772_8972a527-009d-4a37-a768-41e29b5ec81d	60505-4772	HUMAN PRESCRIPTION DRUG	vilazodone		vilazodone hydrochloride	TABLET	ORAL	20220604		NDA AUTHORIZED GENERIC	NDA022567	Apotex Corp	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
60505-4773_8972a527-009d-4a37-a768-41e29b5ec81d	60505-4773	HUMAN PRESCRIPTION DRUG	Vilazodone		vilazodone hydrochloride	TABLET	ORAL	20220604		NDA AUTHORIZED GENERIC	NDA022567	Apotex Corp	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
60505-4774_8972a527-009d-4a37-a768-41e29b5ec81d	60505-4774	HUMAN PRESCRIPTION DRUG	Vilazodone		vilazodone hydrochloride	TABLET	ORAL	20220604		NDA AUTHORIZED GENERIC	NDA022567	Apotex Corp	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
60505-4779_7b6a3e37-5935-6be7-54c3-a12c40099868	60505-4779	HUMAN PRESCRIPTION DRUG	Pazopanib		Pazopanib	TABLET	ORAL	20231019		ANDA	ANDA217713	Apotex Corp.	PAZOPANIB	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
60505-5306_1f221986-0557-b251-5dd3-ca1e1c980180	60505-5306	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20070609		ANDA	ANDA077309	Apotex Corp.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60505-5307_1f221986-0557-b251-5dd3-ca1e1c980180	60505-5307	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20060313		ANDA	ANDA077309	Apotex Corp.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60505-6050_a3521915-44b4-37d6-312c-4c52b2f02057	60505-6050	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502	20281231	ANDA	ANDA205533	Apotex Corp	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	
60505-6065_202567b8-18b5-b634-8abb-1330ecf90e82	60505-6065	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525	20281231	ANDA	ANDA203774	Apotex Corp	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	
60505-6066_202567b8-18b5-b634-8abb-1330ecf90e82	60505-6066	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525	20281231	ANDA	ANDA203774	Apotex Corp	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	
60505-6067_44211c2e-973c-0a0c-9033-88bb0b1d9c92	60505-6067	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525	20281231	ANDA	ANDA209085	Apotex Corp	PEMETREXED DISODIUM	1000	mg/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	
60505-6068_110d8c2f-f95e-ad2f-a9e3-0dd7e1cbe7a5	60505-6068	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525	20281231	ANDA	ANDA209851	Apotex Corp	PEMETREXED DISODIUM	750	mg/30mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	
60505-6095_ca137215-7cdc-3164-dcaf-e2817710942f	60505-6095	HUMAN PRESCRIPTION DRUG	Bendamustine Hydrochloride		Bendamustine Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230619		ANDA	ANDA204230	Apotex Corp	BENDAMUSTINE HYDROCHLORIDE	25	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
60505-6096_ca137215-7cdc-3164-dcaf-e2817710942f	60505-6096	HUMAN PRESCRIPTION DRUG	Bendamustine Hydrochloride		bendamustine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230619		ANDA	ANDA204230	Apotex Corp	BENDAMUSTINE HYDROCHLORIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
60505-6097_75ca1077-00cc-4742-debb-8340ceb3fb4f	60505-6097	HUMAN PRESCRIPTION DRUG	Ibandronate Sodium		ibandronate sodium	INJECTION	INTRAVENOUS	20160113		ANDA	ANDA204222	Apotex Corp.	IBANDRONATE SODIUM	3	mg/3mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60505-6098_e0e9a483-52c4-16dd-6a44-71c5af5fd80c	60505-6098	HUMAN PRESCRIPTION DRUG	Tigecycline		TIGECYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190409		ANDA	ANDA204439	Apotex Corp	TIGECYCLINE	50	mg/5mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
60505-6111_59a86a77-90ac-ef70-22bc-d564452527be	60505-6111	HUMAN PRESCRIPTION DRUG	Bepotastine Besilate		Bepotastine Besilate	SOLUTION/ DROPS	OPHTHALMIC	20211108	20240825	ANDA	ANDA206066	Apotex Corp.	BEPOTASTINE BESYLATE	15	mg/mL	Histamine-1 Receptor Antagonist [EPC]		N	
60505-6116_c8a5d697-0c13-04ae-e111-dc5894c68bee	60505-6116	HUMAN PRESCRIPTION DRUG	Regadenoson		regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20230310		ANDA	ANDA207604	Apotex Corp.	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
60505-6119_3bd3b503-a4eb-57f7-1fb0-88324b5b5b2f	60505-6119	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210212	20240731	ANDA	ANDA208366	Apotex Corp.	MICAFUNGIN	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	
60505-6120_3bd3b503-a4eb-57f7-1fb0-88324b5b5b2f	60505-6120	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210212	20240731	ANDA	ANDA208366	Apotex Corp.	MICAFUNGIN	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	
60505-6128_a6ea9cfb-560c-4601-a774-70d2e85ed04c	60505-6128	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20171130		ANDA	ANDA203380	Apotex Corp.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
60505-6129_0a582c6f-407e-6fea-bdf9-250a06409532	60505-6129	HUMAN OTC DRUG	Budesonide		Budesonide	SPRAY, METERED	NASAL	20160419		ANDA	ANDA078949	Apotex Corp.	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6130_9cb405b9-961c-4508-b545-fb9e9b11a348	60505-6130	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160526		ANDA	ANDA203711	Apotex Corp.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60505-6132_f9549f5e-0be1-4e68-9d91-c2bd316b936d	60505-6132	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20170104		ANDA	ANDA204368	Apotex Corp.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
60505-6142_0cc0d080-4c7a-8c89-e063-6394a90ae645	60505-6142	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203661	Apotex Corp.	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6143_0c85a6e9-ce7a-2903-e063-6294a90ad28b	60505-6143	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190328		ANDA	ANDA209217	Apotex Corp.	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6144_12c44be3-e077-4579-ad2e-868b503eadb5	60505-6144	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20171114		ANDA	ANDA203704	Apotex Corp.	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6145_12c44be3-e077-4579-ad2e-868b503eadb5	60505-6145	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20171114		ANDA	ANDA203704	Apotex Corp.	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6146_e1dbb0ac-a9df-41c4-acb2-3e3f5732f7ef	60505-6146	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170330		ANDA	ANDA203704	Apotex Corp.	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6147_e1dbb0ac-a9df-41c4-acb2-3e3f5732f7ef	60505-6147	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170330		ANDA	ANDA203704	Apotex Corp.	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6148_0432e6c3-ad77-726c-e063-6294a90a798c	60505-6148	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203702	Apotex Corp.	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6149_0432e6c3-ad77-726c-e063-6294a90a798c	60505-6149	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203702	Apotex Corp.	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6150_7e33cb12-f475-450f-9df3-9158dea19877	60505-6150	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190121		ANDA	ANDA209218	Apotex Corp.	CEFTRIAXONE SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6151_0432e6c3-ad77-726c-e063-6294a90a798c	60505-6151	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203702	Apotex Corp.	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6152_0432e6c3-ad77-726c-e063-6294a90a798c	60505-6152	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203702	Apotex Corp.	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6156_57da72a4-4eb8-4171-b6b0-fe0900059146	60505-6156	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190315		ANDA	ANDA204959	Apotex Corp.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
60505-6157_57da72a4-4eb8-4171-b6b0-fe0900059146	60505-6157	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190315		ANDA	ANDA204959	Apotex Corp.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
60505-6159_57da72a4-4eb8-4171-b6b0-fe0900059146	60505-6159	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190315		ANDA	ANDA204959	Apotex Corp.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
60505-6162_beb8202a-22fd-e801-73e6-2ab7101ed57b	60505-6162	HUMAN PRESCRIPTION DRUG	MEMANTINE		memantine hydrochloride	SOLUTION	ORAL	20180430		ANDA	ANDA209955	Apotex Corp.	MEMANTINE HYDROCHLORIDE	2	mg/mL	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
60505-6166_4a5dc052-c951-8cae-a9f0-5597926c2016	60505-6166	HUMAN PRESCRIPTION DRUG	Clofarabine		clofarabine	INJECTION	INTRAVENOUS	20180101	20250131	ANDA	ANDA209775	Apotex Corp.	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	
60505-6169_fe9be6a8-4667-52e6-eff8-6f0f1c60c0f8	60505-6169	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20200805		ANDA	ANDA209860	Apotex Corp.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
60505-6179_7ce03303-804b-88ff-f5dc-20043e2a9378	60505-6179	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200610	20250331	ANDA	ANDA210246	Apotex Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
60505-6180_7ce03303-804b-88ff-f5dc-20043e2a9378	60505-6180	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200610	20251130	ANDA	ANDA210246	Apotex Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
60505-6181_7ce03303-804b-88ff-f5dc-20043e2a9378	60505-6181	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200610	20250930	ANDA	ANDA210246	Apotex Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
60505-6182_7ce03303-804b-88ff-f5dc-20043e2a9378	60505-6182	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200610	20250930	ANDA	ANDA210246	Apotex Corp.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
60505-6184_6af7ad10-19fc-9b86-0daa-554214eb0d9f	60505-6184	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20211007		ANDA	ANDA211067	Apotex Corp	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
60505-6185_6af7ad10-19fc-9b86-0daa-554214eb0d9f	60505-6185	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20211007	20240831	ANDA	ANDA211067	Apotex Corp	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
60505-6188_eb740dd6-6012-57c7-e091-0758b39f04b8	60505-6188	HUMAN PRESCRIPTION DRUG	Teriparatide		Teriparatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231116		ANDA	ANDA211097	Apotex Corp.	TERIPARATIDE	250	ug/mL	Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]		N	20241231
60505-6193_2de9b395-3c91-48db-bf14-b2c63fd577c0	60505-6193	HUMAN PRESCRIPTION DRUG	Palonosetron		Palonosetron Hydrochloride	INJECTION	INTRAVENOUS	20180919		ANDA	ANDA205648	Apotex Corp.	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
60505-6196_0c5d06ec-0530-f60c-e063-6394a90a79b9	60505-6196	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190402		ANDA	ANDA207647	Apotex Corp	ERTAPENEM SODIUM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
60505-6197_8fcdc880-ec8f-4e92-f5a5-4b6683f75f42	60505-6197	HUMAN PRESCRIPTION DRUG	Sirolimus		SIROLIMUS	SOLUTION	ORAL	20200520	20250331	ANDA	ANDA211406	Apotex Corp	SIROLIMUS	1	mg/mL	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	
60505-6202_7ca927a8-cd1c-4a40-bdf3-12a3ff28eb3a	60505-6202	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	EMULSION	OPHTHALMIC	20220207		NDA AUTHORIZED GENERIC	NDA050790	Apotex Corp	CYCLOSPORINE	.5	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60505-6205_e52a1e38-b42d-5466-0267-d4afc20ce567	60505-6205	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20190111		ANDA	ANDA208150	Apotex Corp.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6214_5d2a3299-fbbf-4d00-ad37-13a5fcc632f6	60505-6214	HUMAN PRESCRIPTION DRUG	ICATIBANT		icatibant acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20210415		ANDA	ANDA212081	Apotex Corp.	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
60505-6221_a9c3f5e2-ee04-a6e7-313c-ec1f4c890060	60505-6221	HUMAN OTC DRUG	Olopatadine hydrochloride		Olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20221006		ANDA	ANDA078350	Apotex Corp.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
60505-6222_a5cfb475-5968-b0f0-1772-b6ae0f040898	60505-6222	HUMAN OTC DRUG	Olopatadine hydrochloride		Olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20221006		ANDA	ANDA090918	Apotex Corp.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
60505-6225_56264bc2-3508-40f2-991b-dbaa98509f2d	60505-6225	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate/Timolol Maleate		brimonidine tartrate, timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20220119		NDA AUTHORIZED GENERIC	NDA021398	Apotex Corp	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
60505-6226_a53aeada-3f69-94e9-51fe-7f5d962232eb	60505-6226	HUMAN PRESCRIPTION DRUG	Atropine		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20211126		ANDA	ANDA215624	Apotex Corp.	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60505-6228_95e96765-57bc-fc7b-dee2-5e9000250196	60505-6228	HUMAN PRESCRIPTION DRUG	Bendamustine Hydrochloride		Bendamustine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230426		NDA	NDA215033	Apotex Corp	BENDAMUSTINE HYDROCHLORIDE	25	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
60505-6229_0d64e4bc-6ac6-3e05-e063-6294a90aaa71	60505-6229	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220223		ANDA	ANDA215316	APOTEX CORP.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
60505-6230_7325d86b-947f-41a1-bf26-7e988fd17b2e	60505-6230	HUMAN PRESCRIPTION DRUG	Paclitaxel protein-bound particles for injectable suspension (albumin-bound)		Paclitaxel	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20220401		NDA AUTHORIZED GENERIC	NDA021660	Apotex Corp.	PACLITAXEL	100	mg/20mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
60505-6231_0cc0d080-4c7a-8c89-e063-6394a90ae645	60505-6231	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220318		ANDA	ANDA203661	Apotex Corp.	CEFAZOLIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6236_056c4911-ada8-d21c-cfc2-db538c573a21	60505-6236	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate		Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20211105		ANDA	ANDA207384	Apotex Corp.	DEFEROXAMINE MESYLATE	500	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
60505-6237_056c4911-ada8-d21c-cfc2-db538c573a21	60505-6237	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate		Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20211105		ANDA	ANDA207384	Apotex Corp.	DEFEROXAMINE MESYLATE	2	g/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
60505-6238_529df8e2-50b4-fe3c-b245-f5d3238b15eb	60505-6238	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate		Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220328		ANDA	ANDA207384	Apotex Corp.	DEFEROXAMINE MESYLATE	500	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
60505-6243_90d68812-6ff8-4372-a838-b415162dd40e	60505-6243	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220901		ANDA	ANDA203661	Apotex Corp.	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6244_0c841753-3bec-fb8a-e063-6294a90a0d2b	60505-6244	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220901		ANDA	ANDA209217	Apotex Corp.	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6245_dcfcbe55-750e-4f29-9ebe-fbf25d4083cd	60505-6245	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220901		ANDA	ANDA203704	Apotex Corp.	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6246_dcfcbe55-750e-4f29-9ebe-fbf25d4083cd	60505-6246	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220901		ANDA	ANDA203704	Apotex Corp.	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60505-6249_993fb3fd-75bd-6373-f0e6-20888619c8d1	60505-6249	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231205		ANDA	ANDA217695	Apotex Corp.	DEXAMETHASONE	.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6250_993fb3fd-75bd-6373-f0e6-20888619c8d1	60505-6250	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231205		ANDA	ANDA217695	Apotex Corp.	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6251_993fb3fd-75bd-6373-f0e6-20888619c8d1	60505-6251	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231101		ANDA	ANDA217695	Apotex Corp.	DEXAMETHASONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6252_993fb3fd-75bd-6373-f0e6-20888619c8d1	60505-6252	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231205		ANDA	ANDA217695	Apotex Corp.	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6253_993fb3fd-75bd-6373-f0e6-20888619c8d1	60505-6253	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231101		ANDA	ANDA217695	Apotex Corp.	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6254_993fb3fd-75bd-6373-f0e6-20888619c8d1	60505-6254	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231101		ANDA	ANDA217695	Apotex Corp.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6255_993fb3fd-75bd-6373-f0e6-20888619c8d1	60505-6255	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231205		ANDA	ANDA217695	Apotex Corp.	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60505-6262_74fbd7fc-fcac-4103-a01d-4953cd8c9409	60505-6262	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230926		ANDA	ANDA217243	Apotex Corp.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
60505-6271_7fbef712-f67a-a63b-2054-9b5799bcb245	60505-6271	HUMAN PRESCRIPTION DRUG	Azacitidine		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20231011		ANDA	ANDA215905	Apotex Corp	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
60505-6272_3bd941f7-1566-4b52-8b1f-48b2636deff6	60505-6272	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230701		ANDA	ANDA203380	Apotex Corp.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
60505-6277_0d0f8dab-8203-e3f8-e063-6294a90ab1d3	60505-6277	HUMAN PRESCRIPTION DRUG	CISplatin		CISplatin	INJECTION, SOLUTION	INTRAVENOUS	20230606		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Apotex Corp.	CISPLATIN	50	mg/50mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
60505-6282_0e68e276-b0df-4f03-e063-6394a90a22b9	60505-6282	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20070118		ANDA	ANDA077861	Apotex Corp.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20251231
60505-7006_005d170d-692f-f040-e063-6394a90aa0a4	60505-7006	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20251231	ANDA	ANDA077449	Apotex Corp.	FENTANYL	25	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7007_005d170d-692f-f040-e063-6394a90aa0a4	60505-7007	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260228	ANDA	ANDA077449	Apotex Corp.	FENTANYL	50	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7008_005d170d-692f-f040-e063-6394a90aa0a4	60505-7008	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260131	ANDA	ANDA077449	Apotex Corp.	FENTANYL	75	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7009_005d170d-692f-f040-e063-6394a90aa0a4	60505-7009	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260131	ANDA	ANDA077449	Apotex Corp.	FENTANYL	100	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7010_005d170d-692f-f040-e063-6394a90aa0a4	60505-7010	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160122	20260228	ANDA	ANDA077449	Apotex Corp.	FENTANYL	12	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7011_005d170d-692f-f040-e063-6394a90aa0a4	60505-7011	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20251231	ANDA	ANDA077449	Apotex Corp.	FENTANYL	25	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7012_005d170d-692f-f040-e063-6394a90aa0a4	60505-7012	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260228	ANDA	ANDA077449	Apotex Corp.	FENTANYL	50	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7013_005d170d-692f-f040-e063-6394a90aa0a4	60505-7013	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260131	ANDA	ANDA077449	Apotex Corp.	FENTANYL	75	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7014_005d170d-692f-f040-e063-6394a90aa0a4	60505-7014	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260131	ANDA	ANDA077449	Apotex Corp.	FENTANYL	100	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7015_005d170d-692f-f040-e063-6394a90aa0a4	60505-7015	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190724	20250630	ANDA	ANDA077449	Apotex Corp.	FENTANYL	37.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7016_005d170d-692f-f040-e063-6394a90aa0a4	60505-7016	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190724	20250630	ANDA	ANDA077449	Apotex Corp.	FENTANYL	62.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7017_005d170d-692f-f040-e063-6394a90aa0a4	60505-7017	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190724	20250630	ANDA	ANDA077449	Apotex Corp.	FENTANYL	87.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7064_ffcc845e-9b63-318b-e053-6294a90acddd	60505-7064	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	19971020		ANDA	ANDA074612	Apotex Corp	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60505-7065_ffcc845e-9b63-318b-e053-6294a90acddd	60505-7065	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	19971020		ANDA	ANDA074612	Apotex Corp	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60505-7066_ffcc845e-9b63-318b-e053-6294a90acddd	60505-7066	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	19971020		ANDA	ANDA074612	Apotex Corp	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60505-7080_6319f139-d677-f101-0a24-28aa1c03f316	60505-7080	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20260228	ANDA	ANDA077449	Apotex Corp.	FENTANYL	12	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7081_6319f139-d677-f101-0a24-28aa1c03f316	60505-7081	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20251231	ANDA	ANDA077449	Apotex Corp.	FENTANYL	25	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7082_6319f139-d677-f101-0a24-28aa1c03f316	60505-7082	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20260228	ANDA	ANDA077449	Apotex Corp.	FENTANYL	50	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7083_6319f139-d677-f101-0a24-28aa1c03f316	60505-7083	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20260131	ANDA	ANDA077449	Apotex Corp.	FENTANYL	75	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7084_6319f139-d677-f101-0a24-28aa1c03f316	60505-7084	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20260131	ANDA	ANDA077449	Apotex Corp.	FENTANYL	100	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7085_6319f139-d677-f101-0a24-28aa1c03f316	60505-7085	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20250630	ANDA	ANDA077449	Apotex Corp.	FENTANYL	37.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7086_6319f139-d677-f101-0a24-28aa1c03f316	60505-7086	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20250630	ANDA	ANDA077449	Apotex Corp.	FENTANYL	62.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7087_6319f139-d677-f101-0a24-28aa1c03f316	60505-7087	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20180110	20250630	ANDA	ANDA077449	Apotex Corp.	FENTANYL	87.5	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60505-7088_ffccbce6-dcde-80fe-e053-6394a90af67d	60505-7088	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190111		ANDA	ANDA074612	Apotex Corp.	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60505-7089_ffccbce6-dcde-80fe-e053-6394a90af67d	60505-7089	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190111		ANDA	ANDA074612	Apotex Corp.	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60505-7090_ffccbce6-dcde-80fe-e053-6394a90af67d	60505-7090	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190111		ANDA	ANDA074612	Apotex Corp.	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
60541-0391_f65416ab-51ba-21f6-e053-2995a90a9d9e	60541-0391	HUMAN OTC DRUG	Glo Skin		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20220401		OTC MONOGRAPH FINAL	part352	Glo Skin Beauty	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
60546-001_06e81950-e1c0-2958-e063-6294a90a32d7	60546-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170509		UNAPPROVED MEDICAL GAS		At Home Medical, Inc.	OXYGEN	99	L/100L			N	20241231
60560-1072_0a9d64bf-c45b-9bcf-e063-6394a90ac790	60560-1072	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091215		UNAPPROVED MEDICAL GAS		Johns Hopkins Pharmaquip	OXYGEN	99	L/100L			N	20241231
60563-001_0c43cba0-df2f-c340-e063-6394a90a778e	60563-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20111024		UNAPPROVED MEDICAL GAS		Virginia Medical and Respiratory Equipment Inc	OXYGEN	99	L/100L			N	20241231
60564-0001_50a9eb76-08c8-4e17-a42b-d2ee7c17349c	60564-0001	HUMAN OTC DRUG	Liquid Serotonin		Serotonin	LIQUID	ORAL	20140314		UNAPPROVED HOMEOPATHIC		Pain and Stress Center Products	SEROTONIN HYDROCHLORIDE	3	[hp_X]/mL			N	20251231
60564-0003_9f3f0f81-720b-42ba-b7de-cef61aec8369	60564-0003	HUMAN OTC DRUG	Neuro Links		5-Methoxytryptamine, Acetylcholine Chloride, Dopamine Hydrochloride, Gaba (Gamma-Aminobutyric Acid), Histaminum Hydrochloricum, L-Dopa, Melatonin, Norepinephrine (Bitartrate), Phenethylamine (Hydrochloride), Serotonin (Hydrochloride), Taurine, Tyramine	LIQUID	ORAL	20190122		UNAPPROVED HOMEOPATHIC		Pain & Stress Center Products	.GAMMA.-AMINOBUTYRIC ACID; 5-METHOXYTRYPTAMINE; ACETYLCHOLINE CHLORIDE; DOPAMINE HYDROCHLORIDE; HISTAMINE DIHYDROCHLORIDE; LEVODOPA; MELATONIN; NOREPINEPHRINE BITARTRATE; PHENETHYLAMINE HYDROCHLORIDE; SEROTONIN HYDROCHLORIDE; TAURINE; TYRAMINE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20251231
60568-123_07ff0e6e-1bd5-9a0b-e063-6394a90a081c	60568-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20180901		UNAPPROVED MEDICAL GAS		Mountain West Medical Supply LLC	OXYGEN	99	L/100L			N	20241231
60596-1072_06d6db9b-bdce-f15f-e063-6294a90a7e2a	60596-1072	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20060403		UNAPPROVED MEDICAL GAS		Banner Home Medical Equipment	OXYGEN	99	L/100L			N	20241231
60615-0001_0b3c162f-839d-09f8-e063-6294a90a76d8	60615-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20010109		UNAPPROVED MEDICAL GAS		Advance Medical Services, Inc. dba Petersen Medical	OXYGEN	99	L/100L			N	20241231
60630-077_bd751b9a-a6c1-47ca-8c3d-32d3ad657c2c	60630-077	HUMAN OTC DRUG	DenTek Instant Pain Relief	Maximum Strength	Benzocaine	LIQUID	DENTAL; TOPICAL	20150731		OTC MONOGRAPH NOT FINAL	part356	DenTek Oral Care, Inc.	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
60631-040_af23aeaf-1efa-46f0-aed0-f9d5221e67fd	60631-040	HUMAN PRESCRIPTION DRUG	Edarbi		Azilsartan kamedoxomil	TABLET	ORAL	20130201		NDA	NDA200796	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	AZILSARTAN KAMEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Blocker [EPC], Angiotensin 2 Type 1 Receptor Antagonists [MoA], Decreased Blood Pressure [PE]		N	20241231
60631-080_af23aeaf-1efa-46f0-aed0-f9d5221e67fd	60631-080	HUMAN PRESCRIPTION DRUG	Edarbi		Azilsartan kamedoxomil	TABLET	ORAL	20130201		NDA	NDA200796	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	AZILSARTAN KAMEDOXOMIL	80	mg/1	Angiotensin 2 Receptor Blocker [EPC], Angiotensin 2 Type 1 Receptor Antagonists [MoA], Decreased Blood Pressure [PE]		N	20241231
60631-412_3721b545-05e7-4dd6-bba0-01caca3c2d6f	60631-412	HUMAN PRESCRIPTION DRUG	Edarbyclor		Azilsartan kamedoxomil and chlorthalidone	TABLET	ORAL	20130201		NDA	NDA202331	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE	40; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Blocker [EPC], Angiotensin 2 Type 1 Receptor Antagonists [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
60631-425_3721b545-05e7-4dd6-bba0-01caca3c2d6f	60631-425	HUMAN PRESCRIPTION DRUG	Edarbyclor		Azilsartan kamedoxomil and chlorthalidone	TABLET	ORAL	20130201		NDA	NDA202331	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE	40; 25	mg/1; mg/1	Angiotensin 2 Receptor Blocker [EPC], Angiotensin 2 Type 1 Receptor Antagonists [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
60635-118_d70c9c19-2cf6-4e5c-84ee-518dc0cee18b	60635-118	HUMAN PRESCRIPTION DRUG	Varithena		polidocanol	KIT		20140710		NDA	NDA205098	Biocompatibles, Inc.						N	20241231
60635-133_d70c9c19-2cf6-4e5c-84ee-518dc0cee18b	60635-133	HUMAN PRESCRIPTION DRUG	Varithena		polidocanol	KIT		20131125		NDA	NDA205098	Biocompatibles, Inc.						N	20241231
60637-117_08995375-3878-550a-e063-6394a90a41bb	60637-117	HUMAN OTC DRUG	Justice Cranberry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190826		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-118_089922f1-b00c-4d5a-e063-6294a90ac757	60637-118	HUMAN OTC DRUG	Justice Glitter Berry Scented Anti-bacterial Hand Sanitizer	A	ALCOHOL	GEL	TOPICAL	20190826		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-119_089913c3-ea89-d5d9-e063-6394a90a9732	60637-119	HUMAN OTC DRUG	Justice Glitter Berry Scented Anti-bacterial Hand Sanitizer	Llama	ALCOHOL	GEL	TOPICAL	20190826		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-120_08995375-3887-550a-e063-6394a90a41bb	60637-120	HUMAN OTC DRUG	Justice Bubbling Blueberry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190715		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-121_08996402-6523-a52c-e063-6294a90afcd7	60637-121	HUMAN OTC DRUG	Justice Sparkling Strawberry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190715		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-122_089944c7-6a07-2b30-e063-6394a90a11ba	60637-122	HUMAN OTC DRUG	Justice Vanilla Vibes Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190715		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-123_08996402-6531-a52c-e063-6294a90afcd7	60637-123	HUMAN OTC DRUG	Justice Confetti Cupcake Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190715		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-124_089944c7-69f9-2b30-e063-6394a90a11ba	60637-124	HUMAN OTC DRUG	Justice Rainbow Raspberry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190715		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-140_0949a165-7647-8fc6-e063-6294a90a9cb3	60637-140	HUMAN OTC DRUG	Justice Cucumber And Melon Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200206		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-141_089955fe-6f7a-fb63-e063-6294a90a84fa	60637-141	HUMAN OTC DRUG	Justice Rainbow Berry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200206		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-142_08996402-653f-a52c-e063-6294a90afcd7	60637-142	HUMAN OTC DRUG	Justice Rainbow Peach Mango Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200206		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-143_08997b3f-b8b2-3551-e063-6294a90ac3c0	60637-143	HUMAN OTC DRUG	Justice Vanilla Sprinkles Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200206		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-144_08997fee-21a0-58ff-e063-6294a90a66a3	60637-144	HUMAN OTC DRUG	Justice Watermelon and Strawberry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200206		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-191_089948f1-8e91-3775-e063-6294a90a05e2	60637-191	HUMAN OTC DRUG	Justice Moonstone Melon Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20191008		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-192_0899798b-a3be-0a6b-e063-6394a90a61bd	60637-192	HUMAN OTC DRUG	Justice Amazing Melon Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20191008		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc	ALCOHOL	620	mg/mL			N	20241231
60637-193_089955fe-6f88-fb63-e063-6294a90a84fa	60637-193	HUMAN OTC DRUG	Justice Rainbow Raspberry Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20191008		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-194_089948f1-8e9f-3775-e063-6294a90a05e2	60637-194	HUMAN OTC DRUG	Justice Diamond Vanilla Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20191008		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-195_08996332-bbe6-0192-e063-6294a90a4692	60637-195	HUMAN OTC DRUG	Justice be Happy Citrus Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20191008		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-208_0895e93e-a478-a749-e063-6294a90a0182	60637-208	HUMAN OTC DRUG	Justice BFF BERRY Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170125		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	14.88	g/30mL			N	20241231
60637-209_09496bf0-c3e8-886c-e063-6294a90a0f4a	60637-209	HUMAN OTC DRUG	Justice WATERMELON Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170125		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	14.88	g/30mL			N	20241231
60637-210_0895d66c-a6b8-3c76-e063-6294a90acc02	60637-210	HUMAN OTC DRUG	Justice MAGICAL MELON Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170125		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	14.88	g/30mL			N	20241231
60637-211_08997fee-21bb-58ff-e063-6294a90a66a3	60637-211	HUMAN OTC DRUG	Justice Pinapple Pizazz Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170125		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	14.88	g/30mL			N	20241231
60637-214_08962bdf-6c5f-4cb7-e063-6394a90a6c6d	60637-214	HUMAN OTC DRUG	Justice Rainbow Raspberry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170415		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc	ALCOHOL	620	mg/mL			N	20241231
60637-215_0895e93e-a482-a749-e063-6294a90a0182	60637-215	HUMAN OTC DRUG	Justice Outta This World Vanilla Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170415		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc	ALCOHOL	620	mg/mL			N	20241231
60637-216_09496bf0-c3f2-886c-e063-6294a90a0f4a	60637-216	HUMAN OTC DRUG	Justice Berry Blast Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170415		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc	ALCOHOL	620	mg/mL			N	20241231
60637-217_0895f4e7-2d98-7b31-e063-6394a90a8370	60637-217	HUMAN OTC DRUG	Justice Fruit Punch Scented Anti bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170415		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc	ALCOHOL	620	mg/mL			N	20241231
60637-218_09498613-bc17-97fe-e063-6294a90af512	60637-218	HUMAN OTC DRUG	Justice Meow Mint Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170415		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc	ALCOHOL	620	mg/mL			N	20241231
60637-219_0895e93e-a490-a749-e063-6294a90a0182	60637-219	HUMAN OTC DRUG	Justice Berry Scented Anti-bacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20180620		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/100mL			N	20241231
60637-227_08996332-bbf4-0192-e063-6294a90a4692	60637-227	HUMAN OTC DRUG	Justice Vanilla Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190420		OTC MONOGRAPH DRUG	505G(a)(3)	TWEEN BRANDS, INC	ALCOHOL	620	mg/mL			N	20241231
60637-228_0899754e-fc30-0c22-e063-6394a90adf3b	60637-228	HUMAN OTC DRUG	Justice Berry Scented Anti-bacterial Hand Sanitizer	BFF	ALCOHOL	GEL	TOPICAL	20190921		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-229_089ef12a-0343-4e3c-e063-6394a90afa1a	60637-229	HUMAN OTC DRUG	Justice Cotton Candy Scented Anti-bacterial Hand Sanitizer	Cat	ALCOHOL	GEL	TOPICAL	20190921		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-230_0899798b-a3cd-0a6b-e063-6394a90a61bd	60637-230	HUMAN OTC DRUG	Justice Berry Scented Anti-bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190419		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-231_089efd8c-3ede-ac12-e063-6294a90a8c05	60637-231	HUMAN OTC DRUG	Justice Cotton Candy Scented Anti bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190419		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-232_089ef958-730e-a974-e063-6294a90a1865	60637-232	HUMAN OTC DRUG	Justice Grape Scented Anti bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190419		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-240_0897a03b-9ba6-0203-e063-6394a90a84ac	60637-240	HUMAN OTC DRUG	JUSTICE 194011 HEART IT ANTIBAC BLACKBERRY AND VANILLA SCENTED ANTI-BACTERIAL HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands, Inc.	ALCOHOL	.62	mL/mL			N	20241231
60637-300_08997b3f-b8c1-3551-e063-6294a90ac3c0	60637-300	HUMAN OTC DRUG	Justice Flamingo Berry Scented Anti bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20191230		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-301_08997bec-8f7f-2d24-e063-6294a90ad9f7	60637-301	HUMAN OTC DRUG	Justice Sweet Pineapple Scented Anti bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20191230		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc.	ALCOHOL	620	mg/mL			N	20241231
60637-302_089635d0-6998-12ca-e063-6294a90a7987	60637-302	HUMAN OTC DRUG	Justice 198824 You Rock Antibacterial Cotton Candy Blueberry Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Tween Brands,Inc.	ALCOHOL	.62	mL/mL			N	20241231
60648-7200_0141429c-3199-24fd-e063-6294a90a4f9d	60648-7200	HUMAN OTC DRUG	Companion		Companion Antibacterial Hand Soap	LIQUID	TOPICAL	20201104		OTC MONOGRAPH NOT FINAL	part333E	Preserve International	BENZALKONIUM CHLORIDE	2.9	mg/L			N	20241231
60648-8600_015604dd-076c-66c4-e063-6294a90a298e	60648-8600	HUMAN OTC DRUG	SureKill Hand Sanitizer		hand sanitizer	LIQUID	TOPICAL	20230725		OTC MONOGRAPH NOT FINAL	part333E	Preserve Inc	ALCOHOL	338.82	g/L			N	20241231
60665-003_cf863586-21cb-3bef-e053-2995a90abcbf	60665-003	HUMAN OTC DRUG	Sambrosa	Night	DOXYLAMINE SUCCINATE	SYRUP	ORAL	20200110		OTC MONOGRAPH FINAL	part341	Sambrosa Care, Inc.	DOXYLAMINE SUCCINATE	9.78	mg/3mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
60687-100_0c7d2775-609c-9027-e063-6294a90a18a4	60687-100	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20150512		ANDA	ANDA079082	American Health Packaging	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
60687-104_e895f490-4bc7-52d9-e053-2a95a90aaacd	60687-104	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20210323		ANDA	ANDA074754	American Health Packaging	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-105_ea3cd6bd-a90a-10b6-e053-2a95a90a6c76	60687-105	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	20160405		ANDA	ANDA040159	American Health Packaging	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
60687-111_07ec28f7-1858-031d-e063-6394a90aeee5	60687-111	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20151110		ANDA	ANDA091269	American Health Packaging	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60687-112_066bf818-60e8-7ea2-e063-6394a90a4334	60687-112	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, COATED	ORAL	20160203		ANDA	ANDA078921	American Health Packaging	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
60687-113_04d8ff7c-23f1-c626-e063-6294a90a77c5	60687-113	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200729		ANDA	ANDA070974	American Health Packaging	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60687-119_03b0d2d3-2f8b-df54-e063-6394a90a8bcb	60687-119	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20150922		NDA AUTHORIZED GENERIC	NDA020838	American Health Packaging	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60687-121_066bf818-60eb-7ea2-e063-6394a90a4334	60687-121	HUMAN PRESCRIPTION DRUG	Acamprosate Calcium		Acamprosate Calcium	TABLET, DELAYED RELEASE	ORAL	20151027		ANDA	ANDA202229	American Health Packaging	ACAMPROSATE CALCIUM	333	mg/1			N	20241231
60687-122_0bf52bc7-0d17-a7c6-e063-6394a90aada4	60687-122	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20150910		ANDA	ANDA040256	American Health Packaging	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-123_07ec28f7-1858-031d-e063-6394a90aeee5	60687-123	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20160217		ANDA	ANDA091269	American Health Packaging	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60687-124_04d8ff7c-23f1-c626-e063-6294a90a77c5	60687-124	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200730		ANDA	ANDA070975	American Health Packaging	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60687-127_e9c54cdf-4941-1d20-e053-2995a90afd9c	60687-127	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20161013		ANDA	ANDA090973	American Health Packaging	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
60687-129_066c10ae-f335-f3d6-e063-6294a90abfc1	60687-129	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20151027		OTC MONOGRAPH NOT FINAL	part334	American Health Packaging	DOCUSATE SODIUM	100	mg/1			N	20241231
60687-130_03b0d2d3-2f8b-df54-e063-6394a90a8bcb	60687-130	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20151027		NDA AUTHORIZED GENERIC	NDA020838	American Health Packaging	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60687-134_0bf52bc7-0d17-a7c6-e063-6394a90aada4	60687-134	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20150914		ANDA	ANDA040256	American Health Packaging	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-143_0427e1fa-ccf1-265f-e063-6394a90a26c7	60687-143	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20150909		ANDA	ANDA203686	American Health Packaging	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60687-145_0bf52bc7-0d17-a7c6-e063-6394a90aada4	60687-145	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20151005		ANDA	ANDA040392	American Health Packaging	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-149_e4cade66-565c-0ae3-e053-2a95a90a2b9a	60687-149	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20160307		ANDA	ANDA091649	American Health Packaging	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
60687-152_0c5326b6-43a3-2d7e-e063-6294a90a136c	60687-152	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20151019		ANDA	ANDA090836	American Health Packaging	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60687-155_0427e1fa-ccf1-265f-e063-6394a90a26c7	60687-155	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160404		ANDA	ANDA203686	American Health Packaging	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60687-156_0b383884-d083-5cc5-e063-6394a90a2f68	60687-156	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	TABLET, CHEWABLE	ORAL	20151202		ANDA	ANDA200565	American Health Packaging	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-157_0bf37191-de62-82e3-e063-6294a90ad493	60687-157	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150605		ANDA	ANDA205064	American Health Packaging	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-161_ea3c5390-0bf8-c56e-e053-2a95a90a8573	60687-161	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20160219		ANDA	ANDA077580	American Health Packaging	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
60687-162_0427e1fa-ccf1-265f-e063-6394a90a26c7	60687-162	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20151015		ANDA	ANDA203686	American Health Packaging	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60687-163_0c5326b6-43a3-2d7e-e063-6294a90a136c	60687-163	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20151019		ANDA	ANDA090836	American Health Packaging	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60687-168_0bf37191-de62-82e3-e063-6294a90ad493	60687-168	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150609		ANDA	ANDA205064	American Health Packaging	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-169_0c7d86f4-3635-aa4a-e063-6294a90aed63	60687-169	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20161202		ANDA	ANDA077987	American Health Packaging	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60687-173_ea3d1bd9-5fef-09b4-e053-2a95a90a4eb8	60687-173	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150803		ANDA	ANDA090048	American Health Packaging	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
60687-178_0c7d86f4-3635-aa4a-e063-6294a90aed63	60687-178	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20170214		ANDA	ANDA077987	American Health Packaging	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60687-179_0bf37191-de62-82e3-e063-6294a90ad493	60687-179	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150609		ANDA	ANDA205064	American Health Packaging	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-184_ea3d1bd9-5fef-09b4-e053-2a95a90a4eb8	60687-184	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20150820		ANDA	ANDA090048	American Health Packaging	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
60687-188_ea3fb07f-0008-8a55-e053-2a95a90a8243	60687-188	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET, FILM COATED	ORAL	20160602		ANDA	ANDA203437	American Health Packaging	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
60687-190_0c7d86f4-3635-aa4a-e063-6294a90aed63	60687-190	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20170215		ANDA	ANDA077987	American Health Packaging	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60687-191_0bf37191-de62-82e3-e063-6294a90ad493	60687-191	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150605		ANDA	ANDA205064	American Health Packaging	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-192_0c3d0a93-6853-2a35-e063-6294a90a8235	60687-192	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160215		ANDA	ANDA078340	American Health Packaging	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
60687-195_fa4248e4-64a7-6843-e053-6394a90a3d02	60687-195	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20161116		ANDA	ANDA074984	American Health Packaging	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-199_e6ebd4cc-7452-62d8-e053-2a95a90a805b	60687-199	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20160509		ANDA	ANDA077921	American Health Packaging	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-202_0bf37191-de62-82e3-e063-6294a90ad493	60687-202	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150605		ANDA	ANDA205064	American Health Packaging	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-203_0c3d0a93-6853-2a35-e063-6294a90a8235	60687-203	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20160215		ANDA	ANDA078340	American Health Packaging	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
60687-206_fa4248e4-64a7-6843-e053-6394a90a3d02	60687-206	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20170112		ANDA	ANDA074984	American Health Packaging	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-210_f9e008fa-c4dd-df1d-e053-6294a90af7e5	60687-210	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20160608		ANDA	ANDA078103	American Health Packaging	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60687-211_05f296fd-22ef-0cbe-e063-6394a90ab28f	60687-211	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20160909		ANDA	ANDA090554	American Health Packaging	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60687-213_0bf37191-de62-82e3-e063-6294a90ad493	60687-213	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150605		ANDA	ANDA205064	American Health Packaging	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-215_097f15e2-af82-3c13-e063-6294a90a4c3b	60687-215	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA078703	American Health Packaging	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-216_0644e941-6367-aa83-e063-6394a90aa350	60687-216	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20160812		ANDA	ANDA206217	American Health Packaging	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60687-217_fa4248e4-64a7-6843-e053-6394a90a3d02	60687-217	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20170321		ANDA	ANDA074984	American Health Packaging	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-224_df644d27-3fe8-7821-e053-2995a90a2891	60687-224	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20160707		ANDA	ANDA077836	American Health Packaging	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
60687-226_097f15e2-af82-3c13-e063-6294a90a4c3b	60687-226	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170714		ANDA	ANDA078703	American Health Packaging	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-227_ea3fb07f-0006-8a55-e053-2a95a90a8243	60687-227	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	TABLET	ORAL	20170124		ANDA	ANDA071199	American Health Packaging	LEUCOVORIN CALCIUM	25	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
60687-228_fa4248e4-64a7-6843-e053-6394a90a3d02	60687-228	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20170727		ANDA	ANDA074984	American Health Packaging	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-229_ea3fda1e-efea-6d95-e053-2995a90adada	60687-229	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20170103		ANDA	ANDA073192	American Health Packaging	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
60687-230_ea3f8253-7784-c365-e053-2995a90ad26b	60687-230	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20161115		ANDA	ANDA077869	American Health Packaging	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
60687-231_0814dd5c-4568-739e-e063-6394a90ac8bc	60687-231	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20170130		ANDA	ANDA077397	American Health Packaging	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60687-234_0297105f-082e-f3de-e063-6394a90a50d6	60687-234	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA079170	American Health Packaging	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60687-241_03b0d2d3-2f8b-df54-e063-6394a90a8bcb	60687-241	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20161007		NDA AUTHORIZED GENERIC	NDA020838	American Health Packaging	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60687-242_0814dd5c-4568-739e-e063-6394a90ac8bc	60687-242	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20170111		ANDA	ANDA077397	American Health Packaging	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60687-244_eb90443d-cb1d-b3a4-e053-2995a90a29e1	60687-244	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	LIQUID	ORAL	20180601		ANDA	ANDA077849	American Health Packaging	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60687-245_0297105f-082e-f3de-e063-6394a90a50d6	60687-245	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160926		ANDA	ANDA079170	American Health Packaging	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60687-249_fdf36f6d-d16d-4ad7-e053-6294a90afbd3	60687-249	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20171027		ANDA	ANDA203052	American Health Packaging	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-252_e945be96-cfd1-270a-e053-2a95a90acb72	60687-252	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	SOLUTION	ORAL	20190107		ANDA	ANDA091483	American Health Packaging	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60687-253_0814dd5c-4568-739e-e063-6394a90ac8bc	60687-253	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20170619		ANDA	ANDA077397	American Health Packaging	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60687-256_0297105f-082e-f3de-e063-6394a90a50d6	60687-256	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160921		ANDA	ANDA079170	American Health Packaging	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60687-258_fdb7331a-d02a-8b2a-e053-6294a90adfcd	60687-258	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	SOLUTION	ORAL	20170331	20240229	ANDA	ANDA091156	American Health Packaging	THEOPHYLLINE ANHYDROUS	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	
60687-262_e7892073-a56b-5f17-e053-2995a90a4cf2	60687-262	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	SOLUTION	ORAL	20191017	20240131	ANDA	ANDA070868	American Health Packaging	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
60687-266_ea3fb59b-b936-9bba-e053-2a95a90a046f	60687-266	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene	TABLET	ORAL	20161109		ANDA	ANDA090842	American Health Packaging	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
60687-267_fdb74c89-255b-ab2b-e053-6294a90a098b	60687-267	HUMAN OTC DRUG	Siladryl Allergy Medicine		Diphenhydramine Hydrochloride	LIQUID	ORAL	20200605	20241130	OTC MONOGRAPH FINAL	part341	American Health Packaging	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
60687-271_027e995f-a9ef-64e6-e063-6394a90a3e84	60687-271	HUMAN PRESCRIPTION DRUG	Azithromycin Monohydrate		Azithromycin Monohydrate	TABLET	ORAL	20170125	20240430	ANDA	ANDA065399	American Health Packaging	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
60687-272_f67dca25-ff7c-4a53-e053-2995a90afe99	60687-272	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20180523		ANDA	ANDA065496	American Health Packaging	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60687-273_f67b37f7-82e3-e03c-e053-2995a90ab626	60687-273	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20170523		ANDA	ANDA203503	American Health Packaging	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-275_ec5679f5-2e45-2a4e-e053-2a95a90a8b48	60687-275	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20190110		ANDA	ANDA040521	American Health Packaging	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-278_f5b0937e-33f1-697a-e053-2995a90a2e7b	60687-278	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		hydrocodone bitartrate and homatropine methylbromide	SYRUP	ORAL	20220603	20240331	ANDA	ANDA088008	American Health Packaging	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	
60687-281_fa41631a-c47b-da12-e053-6294a90abb9a	60687-281	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170602		ANDA	ANDA075520	American Health Packaging	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60687-282_027e995f-a9ef-64e6-e063-6394a90a3e84	60687-282	HUMAN PRESCRIPTION DRUG	Azithromycin Monohydrate		Azithromycin Monohydrate	TABLET	ORAL	20170213	20240229	ANDA	ANDA065398	American Health Packaging	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
60687-283_f67dca25-ff7c-4a53-e053-2995a90afe99	60687-283	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20230310		ANDA	ANDA065496	American Health Packaging	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60687-286_025791f3-b49b-0a07-e063-6294a90a15cf	60687-286	HUMAN PRESCRIPTION DRUG	Bromocriptine Mesylate		Bromocriptine Mesylate	TABLET	ORAL	20170727	20240930	ANDA	ANDA074631	American Health Packaging	BROMOCRIPTINE MESYLATE	2.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	
60687-292_03b12aa6-e5d4-47d7-e063-6294a90a907f	60687-292	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20170517		ANDA	ANDA203034	American Health Packaging	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
60687-293_fa41631a-c47b-da12-e053-6294a90abb9a	60687-293	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170706		ANDA	ANDA075520	American Health Packaging	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60687-294_f67b37f7-82e3-e03c-e053-2995a90ab626	60687-294	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20180221		ANDA	ANDA203503	American Health Packaging	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-299_ea3f7a34-1111-ec11-e053-2a95a90acb17	60687-299	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE	ORAL	20170407		ANDA	ANDA205080	American Health Packaging	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60687-302_e0dca90d-9f91-3c1a-e053-2a95a90a6f79	60687-302	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170415		ANDA	ANDA203455	American Health Packaging	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-303_03b12aa6-e5d4-47d7-e063-6294a90a907f	60687-303	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20170321		ANDA	ANDA203034	American Health Packaging	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
60687-304_ea3f6631-a724-1904-e053-2995a90aa4d9	60687-304	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20171117		ANDA	ANDA074505	American Health Packaging	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60687-309_ea3f7a34-1112-ec11-e053-2a95a90acb17	60687-309	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20180207		ANDA	ANDA204239	American Health Packaging	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
60687-312_fe921295-fc1c-a976-e053-6394a90a8990	60687-312	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA077284	American Health Packaging	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60687-313_e0dca90d-9f91-3c1a-e053-2a95a90a6f79	60687-313	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170415		ANDA	ANDA203455	American Health Packaging	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-314_005ee01b-d5f7-7e50-e063-6294a90a0a3e	60687-314	HUMAN PRESCRIPTION DRUG	Azithromycin Monohydrate		Azithromycin Monohydrate	TABLET	ORAL	20170701	20240430	ANDA	ANDA065400	American Health Packaging	AZITHROMYCIN MONOHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
60687-315_ea3f6631-a724-1904-e053-2995a90aa4d9	60687-315	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20171117		ANDA	ANDA074505	American Health Packaging	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60687-317_ea3d1e1c-d308-2266-e053-2995a90ac5bd	60687-317	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20170810		ANDA	ANDA089286	American Health Packaging	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
60687-319_026e33a3-2338-09d2-e063-6294a90a73f6	60687-319	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine	CAPSULE, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA203016	American Health Packaging	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60687-325_0291d144-01d1-ea86-e063-6394a90a5ec6	60687-325	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180123		ANDA	ANDA077321	American Health Packaging	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60687-326_0c7a8230-ef27-a02d-e063-6294a90a541f	60687-326	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170908		ANDA	ANDA079016	American Health Packaging	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60687-327_ec1d56e8-36b9-cc44-e053-2a95a90a3133	60687-327	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine	TABLET	ORAL	20171106		ANDA	ANDA201109	American Health Packaging	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-328_e2865a18-de03-086a-e053-2995a90ac4ed	60687-328	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20170817		ANDA	ANDA207179	American Health Packaging	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
60687-330_026e33a3-2338-09d2-e063-6294a90a73f6	60687-330	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine	CAPSULE, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA203016	American Health Packaging	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60687-333_0291d144-01d1-ea86-e063-6394a90a5ec6	60687-333	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180123		ANDA	ANDA077321	American Health Packaging	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60687-336_f2f6d651-32df-4537-e053-2995a90a063b	60687-336	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20180119		ANDA	ANDA065062	American Health Packaging	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60687-338_ec1d56e8-36b9-cc44-e053-2a95a90a3133	60687-338	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine	TABLET	ORAL	20170927		ANDA	ANDA201109	American Health Packaging	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-340_0280893c-8a9d-8aeb-e063-6294a90af72a	60687-340	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20180129		ANDA	ANDA076143	American Health Packaging	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60687-344_ea3f6631-a725-1904-e053-2995a90aa4d9	60687-344	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20171101		ANDA	ANDA065285	American Health Packaging	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60687-345_ea3f5929-0eea-517b-e053-2995a90a1f33	60687-345	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol Capsules 0.25 mcg	CAPSULE	ORAL	20190123		ANDA	ANDA091356	American Health Packaging	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
60687-349_ec1d56e8-36b9-cc44-e053-2a95a90a3133	60687-349	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine	TABLET	ORAL	20171011		ANDA	ANDA201109	American Health Packaging	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-351_0280893c-8a9d-8aeb-e063-6294a90af72a	60687-351	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20180129		ANDA	ANDA076143	American Health Packaging	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60687-356_f6ca681e-1e14-ee1c-e053-6394a90a2b93	60687-356	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20180831	20240331	ANDA	ANDA204713	American Health Packaging	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
60687-357_e923c8a3-3aea-7848-e053-2995a90aa7e6	60687-357	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20180828	20240331	ANDA	ANDA040350	American Health Packaging	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
60687-358_ea3cb158-5ed1-3869-e053-2a95a90a33cb	60687-358	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	CAPSULE	ORAL	20180314		NDA	NDA204820	American Health Packaging	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
60687-360_ec1d56e8-36b9-cc44-e053-2a95a90a3133	60687-360	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine	TABLET	ORAL	20170925		ANDA	ANDA201109	American Health Packaging	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-368_f6ca681e-1e14-ee1c-e053-6394a90a2b93	60687-368	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20180403	20240331	ANDA	ANDA204713	American Health Packaging	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
60687-369_e0dff4cd-6b3e-0c8b-e053-2995a90a226b	60687-369	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20181004		ANDA	ANDA084285	American Health Packaging	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60687-370_e923c8a3-3aea-7848-e053-2995a90aa7e6	60687-370	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20180913	20240229	ANDA	ANDA040350	American Health Packaging	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
60687-371_ec1d56e8-36b9-cc44-e053-2a95a90a3133	60687-371	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine	TABLET	ORAL	20180627		ANDA	ANDA201109	American Health Packaging	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-373_fe9438d1-92d2-a724-e053-6394a90ae8d5	60687-373	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20180906		ANDA	ANDA209234	American Health Packaging	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
60687-375_ea3cf898-8169-9375-e053-2a95a90ac7d1	60687-375	HUMAN PRESCRIPTION DRUG	DRONABINOL		DRONABINOL	CAPSULE	ORAL	20180716		ANDA	ANDA078292	American Health Packaging	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
60687-377_f9d8b6f5-e87c-b66f-e053-6294a90aae4f	60687-377	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20231010		ANDA	ANDA203346	American Health Packaging	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-379_f6ca681e-1e14-ee1c-e053-6394a90a2b93	60687-379	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20180404	20240131	ANDA	ANDA204713	American Health Packaging	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
60687-380_e0dff4cd-6b3e-0c8b-e053-2995a90a226b	60687-380	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20181206		ANDA	ANDA040230	American Health Packaging	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60687-381_0bf52bc7-0cfd-a7c6-e063-6394a90aada4	60687-381	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20180621		ANDA	ANDA209373	American Health Packaging	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
60687-382_ec1d56e8-36b9-cc44-e053-2a95a90a3133	60687-382	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine	TABLET	ORAL	20171003		ANDA	ANDA201109	American Health Packaging	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-384_fd2b9b29-5304-dced-e053-6394a90affd8	60687-384	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20180802		NDA AUTHORIZED GENERIC	NDA018225	American Health Packaging	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
60687-385_0c53fe8c-e49d-ab3a-e063-6394a90a3424	60687-385	HUMAN PRESCRIPTION DRUG	Colesevelam Hydrochloride		Colesevelam Hydrochloride	TABLET, COATED	ORAL	20180809		ANDA	ANDA091600	American Health Packaging	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
60687-386_ea3cf898-8169-9375-e053-2a95a90ac7d1	60687-386	HUMAN PRESCRIPTION DRUG	DRONABINOL		DRONABINOL	CAPSULE	ORAL	20180809		ANDA	ANDA078292	American Health Packaging	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
60687-387_e0dcfec3-cf21-4940-e053-2995a90a0042	60687-387	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20180910		ANDA	ANDA077746	American Health Packaging	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60687-388_f9d8b6f5-e87c-b66f-e053-6294a90aae4f	60687-388	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20231010		ANDA	ANDA203346	American Health Packaging	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-389_fdb70fe0-c9fb-8628-e053-6394a90a328e	60687-389	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20180801	20250228	NDA AUTHORIZED GENERIC	NDA022352	American Health Packaging	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	
60687-390_f4ac0499-854c-2fab-e053-2a95a90ad516	60687-390	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180925		ANDA	ANDA090617	American Health Packaging	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-391_e6ece23c-cbd8-4041-e053-2995a90a31fb	60687-391	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20190215		ANDA	ANDA077210	American Health Packaging	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
60687-394_ea3d088b-e730-f932-e053-2995a90ada5a	60687-394	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20181226		ANDA	ANDA075693	American Health Packaging	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60687-395_ea3d0506-0a95-974c-e053-2a95a90a1f71	60687-395	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20181226		ANDA	ANDA077839	American Health Packaging	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
60687-396_02971864-8e5c-dbdc-e063-6394a90a5166	60687-396	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20230627		ANDA	ANDA210211	American Health Packaging	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
60687-397_0c7f669a-55fb-dd1a-e063-6294a90a1ed1	60687-397	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	TABLET, DELAYED RELEASE	ORAL	20181011		ANDA	ANDA091640	American Health Packaging	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
60687-398_e0dcfec3-cf21-4940-e053-2995a90a0042	60687-398	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20180910		ANDA	ANDA077746	American Health Packaging	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60687-402_f4ac0499-854c-2fab-e053-2a95a90ad516	60687-402	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180925		ANDA	ANDA090617	American Health Packaging	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-404_0771cca8-3a97-014e-e063-6394a90ab1b8	60687-404	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20190102		ANDA	ANDA206433	American Health Packaging	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-405_ea3ce1f4-00f1-0655-e053-2a95a90aaad7	60687-405	HUMAN PRESCRIPTION DRUG	IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20181215		ANDA	ANDA202496	American Health Packaging	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
60687-406_f42186e9-98bc-5c9d-e053-2995a90a00d1	60687-406	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20190322		ANDA	ANDA204037	American Health Packaging	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60687-407_02971864-8e5c-dbdc-e063-6394a90a5166	60687-407	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20190415		ANDA	ANDA210211	American Health Packaging	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
60687-408_0c43f52c-3a3f-c0e7-e063-6294a90a7e9e	60687-408	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	TABLET, DELAYED RELEASE	ORAL	20190417		ANDA	ANDA203286	American Health Packaging	MESALAMINE	800	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
60687-409_e0dcfec3-cf21-4940-e053-2995a90a0042	60687-409	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20180910		ANDA	ANDA077746	American Health Packaging	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
60687-410_ea3f5799-f6b2-6653-e053-2a95a90a4544	60687-410	HUMAN PRESCRIPTION DRUG	Methylergonovine Maleate		Methylergonovine Maleate	TABLET	ORAL	20181101		ANDA	ANDA210424	American Health Packaging	METHYLERGONOVINE MALEATE	.2	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
60687-413_f4ac0499-854c-2fab-e053-2a95a90ad516	60687-413	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180925		ANDA	ANDA078889	American Health Packaging	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-415_0771cca8-3a97-014e-e063-6394a90ab1b8	60687-415	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20190102		ANDA	ANDA206433	American Health Packaging	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-416_0bb72c70-b071-4c4d-e063-6394a90a9f73	60687-416	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190219	20250630	ANDA	ANDA203814	American Health Packaging	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
60687-417_e8d16cfa-b362-718d-e053-2995a90af7d4	60687-417	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	SOLUTION	ORAL	20190619		ANDA	ANDA211023	American Health Packaging	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
60687-418_02971864-8e5c-dbdc-e063-6394a90a5166	60687-418	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20190415		ANDA	ANDA210211	American Health Packaging	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
60687-419_ea3cc5d1-454a-1e81-e053-2995a90a3509	60687-419	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190523		ANDA	ANDA209755	American Health Packaging	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-420_e78dac38-f023-6ba5-e053-2995a90a35de	60687-420	HUMAN PRESCRIPTION DRUG	Ritonavir		Ritonavir	TABLET, FILM COATED	ORAL	20181227		ANDA	ANDA206614	American Health Packaging	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
60687-422_fa41e1f6-c168-ede8-e053-6294a90afdda	60687-422	HUMAN PRESCRIPTION DRUG	Amantadine		Amantadine	CAPSULE	ORAL	20190501		ANDA	ANDA208966	American Health Packaging	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
60687-423_04ca1c40-b93e-aeaf-e063-6294a90a34a7	60687-423	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20190117		ANDA	ANDA209718	American Health Packaging	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
60687-426_0771cca8-3a97-014e-e063-6394a90ab1b8	60687-426	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20190225		ANDA	ANDA206433	American Health Packaging	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-428_fa418d76-2a84-d5e0-e053-6294a90a1e21	60687-428	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20190826		ANDA	ANDA078341	American Health Packaging	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
60687-429_ad531eda-e838-8769-e053-2a95a90ad41f	60687-429	HUMAN OTC DRUG	MILK OF MAGNESIA ORIGINAL		Magnesium Hydroxide	LIQUID	ORAL	20200901		OTC MONOGRAPH NOT FINAL	part334	American Health Packaging	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
60687-430_ea3cc5d1-454a-1e81-e053-2995a90a3509	60687-430	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209755	American Health Packaging	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-431_03339124-dcfe-328e-e063-6394a90a68dc	60687-431	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20190529		ANDA	ANDA203928	American Health Packaging	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
60687-432_04c8b131-4b98-c30f-e063-6294a90a6e7a	60687-432	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20190503		ANDA	ANDA205253	American Health Packaging	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60687-433_03b0aee4-8048-de63-e063-6394a90a6635	60687-433	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20190815		ANDA	ANDA210086	American Health Packaging	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60687-435_ea3f8253-7781-c365-e053-2995a90ad26b	60687-435	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20200129		ANDA	ANDA203584	American Health Packaging	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
60687-436_030d2343-d2d4-4c21-e063-6294a90a293e	60687-436	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20190710		ANDA	ANDA204776	American Health Packaging	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-437_05b96522-58bc-b20d-e063-6294a90acaf9	60687-437	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20190910		ANDA	ANDA204742	American Health Packaging	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60687-438_fb462351-aaf5-2a21-e053-6294a90a8135	60687-438	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	20190614		ANDA	ANDA090456	American Health Packaging	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
60687-439_fa4220a7-36e2-c9c4-e053-6394a90a1db8	60687-439	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190716		ANDA	ANDA207743	American Health Packaging	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-441_ea3cc5d1-454a-1e81-e053-2995a90a3509	60687-441	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209755	American Health Packaging	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-443_04c8b131-4b98-c30f-e063-6294a90a6e7a	60687-443	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20190314		ANDA	ANDA205253	American Health Packaging	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60687-444_03b0aee4-8048-de63-e063-6394a90a6635	60687-444	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20190812		ANDA	ANDA210086	American Health Packaging	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60687-446_0c8d16b4-0e5a-c200-e063-6394a90aee71	60687-446	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20190930		ANDA	ANDA078558	American Health Packaging	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-447_030d2343-d2d4-4c21-e063-6294a90a293e	60687-447	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20190710		ANDA	ANDA204776	American Health Packaging	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-448_f06f67b5-7fc3-8ba8-e053-2995a90a4752	60687-448	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	ELIXIR	ORAL	20191104	20240229	UNAPPROVED DRUG OTHER		American Health Packaging	PHENOBARBITAL	20	mg/5mL		CIV	N	
60687-449_d4ca2d57-6f56-645c-e053-2a95a90a825a	60687-449	HUMAN PRESCRIPTION DRUG	Sevelamer Hydrochloride		Sevelamer Hydrochloride	TABLET, FILM COATED	ORAL	20191001		ANDA	ANDA204724	American Health Packaging	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
60687-450_fa4220a7-36e2-c9c4-e053-6394a90a1db8	60687-450	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190716		ANDA	ANDA207743	American Health Packaging	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-451_e0dedd11-7ac9-0344-e053-2995a90a80fe	60687-451	HUMAN PRESCRIPTION DRUG	EPLERENONE		EPLERENONE	TABLET, FILM COATED	ORAL	20190508		ANDA	ANDA208283	American Health Packaging	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
60687-452_ea3cc5d1-454a-1e81-e053-2995a90a3509	60687-452	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209755	American Health Packaging	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-453_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-453	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191104		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-454_04c8b131-4b98-c30f-e063-6294a90a6e7a	60687-454	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20190315		ANDA	ANDA205253	American Health Packaging	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60687-455_0c9264f7-1841-f6db-e063-6294a90a3f09	60687-455	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone	TABLET	ORAL	20191101		ANDA	ANDA208327	American Health Packaging	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
60687-457_0c8d16b4-0e5a-c200-e063-6394a90aee71	60687-457	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20190531		ANDA	ANDA078558	American Health Packaging	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-459_e39f6600-3dbf-cdfa-e053-2995a90a46d4	60687-459	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20191111		ANDA	ANDA205618	American Health Packaging	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-461_fa4220a7-36e2-c9c4-e053-6394a90a1db8	60687-461	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190716		ANDA	ANDA207743	American Health Packaging	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-462_ea3fd61a-7ea6-388d-e053-2995a90a621e	60687-462	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20191101		ANDA	ANDA209686	American Health Packaging	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60687-463_ea3cc5d1-454a-1e81-e053-2995a90a3509	60687-463	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209755	American Health Packaging	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-464_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-464	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200103		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-465_04c87ef2-b95a-d11d-e063-6294a90a165f	60687-465	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20190606		ANDA	ANDA205936	American Health Packaging	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
60687-468_0c8d16b4-0e5a-c200-e063-6394a90aee71	60687-468	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200325		ANDA	ANDA078558	American Health Packaging	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-470_e39f6600-3dbf-cdfa-e053-2995a90a46d4	60687-470	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20191111		ANDA	ANDA205618	American Health Packaging	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-472_04a7aca9-e99a-0b07-e063-6294a90a0dc9	60687-472	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20191118		ANDA	ANDA201722	American Health Packaging	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
60687-473_ea3fda1e-efe7-6d95-e053-2995a90adada	60687-473	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190725		ANDA	ANDA210432	American Health Packaging	PREGABALIN	25	mg/1		CV	N	20241231
60687-475_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-475	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191029		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-476_04c87ef2-b95a-d11d-e063-6294a90a165f	60687-476	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20190606		ANDA	ANDA205936	American Health Packaging	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
60687-479_05cc41b4-129c-262c-e063-6394a90ac2a2	60687-479	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	20200103		ANDA	ANDA075712	American Health Packaging	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60687-480_00b5027a-4427-16fd-e063-6294a90a4a13	60687-480	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20220304	20250630	ANDA	ANDA206928	American Health Packaging	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
60687-481_ea4d58ee-5500-043b-e053-2a95a90aadcc	60687-481	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	TABLET	SUBLINGUAL	20200206		ANDA	ANDA207276	American Health Packaging	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
60687-483_04a7aca9-e99a-0b07-e063-6294a90a0dc9	60687-483	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20191210		ANDA	ANDA201722	American Health Packaging	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
60687-484_ea3fda1e-efe7-6d95-e053-2995a90adada	60687-484	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190725		ANDA	ANDA210432	American Health Packaging	PREGABALIN	50	mg/1		CV	N	20241231
60687-486_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-486	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191028		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-487_04c87ef2-b95a-d11d-e063-6294a90a165f	60687-487	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20190606		ANDA	ANDA205936	American Health Packaging	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
60687-488_04102cb9-e9e7-d953-e063-6394a90ab551	60687-488	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20190821		ANDA	ANDA078925	American Health Packaging	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60687-491_ead63d52-4733-0499-e053-2a95a90a213b	60687-491	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200218		ANDA	ANDA078250	American Health Packaging	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-492_ea4d58ee-5500-043b-e053-2a95a90aadcc	60687-492	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	TABLET	SUBLINGUAL	20200206		ANDA	ANDA207276	American Health Packaging	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
60687-493_03739675-7bed-0ad9-e063-6294a90ab2f0	60687-493	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200625	20241130	ANDA	ANDA090700	American Health Packaging	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	
60687-494_041105eb-ee3d-62cd-e063-6394a90a1d2f	60687-494	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	CAPSULE	ORAL	20200221		ANDA	ANDA065410	American Health Packaging	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
60687-495_ea3fda1e-efe7-6d95-e053-2995a90adada	60687-495	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190725		ANDA	ANDA210432	American Health Packaging	PREGABALIN	75	mg/1		CV	N	20241231
60687-496_04102cb9-e9e7-d953-e063-6394a90ab551	60687-496	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20190822		ANDA	ANDA078925	American Health Packaging	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60687-497_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-497	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191101		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-503_027dd00e-0c1d-6107-e063-6394a90af5b1	60687-503	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20220815	20241130	ANDA	ANDA211555	American Health Packaging	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
60687-504_03739675-7bed-0ad9-e063-6294a90ab2f0	60687-504	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200716	20240531	ANDA	ANDA090700	American Health Packaging	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	
60687-506_ea3fda1e-efe7-6d95-e053-2995a90adada	60687-506	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190725		ANDA	ANDA210432	American Health Packaging	PREGABALIN	100	mg/1		CV	N	20241231
60687-507_ec1b2b77-1a4d-4593-e053-2995a90a152b	60687-507	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20200123		ANDA	ANDA078926	American Health Packaging	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-508_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-508	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191101		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-513_e93835ae-d284-717b-e053-2a95a90a4845	60687-513	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20200417		ANDA	ANDA062396	American Health Packaging	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60687-514_027dd00e-0c1d-6107-e063-6394a90af5b1	60687-514	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20221103		ANDA	ANDA211555	American Health Packaging	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
60687-515_03739675-7bed-0ad9-e063-6294a90ab2f0	60687-515	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220719	20240430	ANDA	ANDA078906	American Health Packaging	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	
60687-517_ea3fda1e-efe7-6d95-e053-2995a90adada	60687-517	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190725		ANDA	ANDA210432	American Health Packaging	PREGABALIN	150	mg/1		CV	N	20241231
60687-518_ec1b2b77-1a4d-4593-e053-2995a90a152b	60687-518	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20191127		ANDA	ANDA078926	American Health Packaging	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-519_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-519	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191025		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-523_0636fd5f-e75a-990f-e063-6394a90a636d	60687-523	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20200611		ANDA	ANDA212411	American Health Packaging	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
60687-524_d55552e8-44fc-3de7-e053-2995a90a71d1	60687-524	HUMAN PRESCRIPTION DRUG	Budesonide Inhalation		Budesonide Inhalation	SUSPENSION	RESPIRATORY (INHALATION)	20191215		ANDA	ANDA210897	American Health Packaging	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-525_eb90ae02-4f44-66bc-e053-2995a90a73f2	60687-525	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20191031		ANDA	ANDA210570	American Health Packaging	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
60687-526_e9470130-83f9-d591-e053-2a95a90a34b8	60687-526	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20200409		ANDA	ANDA070772	American Health Packaging	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
60687-527_e41b83b6-d1a6-b758-e053-2995a90a3afe	60687-527	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20200911		ANDA	ANDA211145	American Health Packaging	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
60687-530_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-530	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191024		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-532_f2b6016c-cbef-4f69-e053-2a95a90a75d8	60687-532	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200625	20240229	ANDA	ANDA211009	American Health Packaging	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
60687-534_0293429b-79ec-fa1a-e063-6394a90a21cb	60687-534	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20201021		ANDA	ANDA210692	American Health Packaging	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
60687-535_fd2b9b29-5304-dced-e053-6394a90affd8	60687-535	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20200713		NDA AUTHORIZED GENERIC	NDA018225	American Health Packaging	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
60687-538_ae6954a6-dd48-4925-e053-2a95a90a392b	60687-538	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20200915		ANDA	ANDA205467	American Health Packaging	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
60687-540_06e76ca9-ea3c-5e57-e063-6294a90a89e9	60687-540	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20211220		ANDA	ANDA076363	American Health Packaging	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
60687-541_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-541	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20191024		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-543_f2b6016c-cbef-4f69-e053-2a95a90a75d8	60687-543	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200625	20240430	ANDA	ANDA211009	American Health Packaging	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
60687-544_e41af6bd-28f1-d7f1-e053-2995a90a831e	60687-544	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20200818		ANDA	ANDA074569	American Health Packaging	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-548_0771cca8-3a97-014e-e063-6394a90ab1b8	60687-548	HUMAN PRESCRIPTION DRUG	Clozapine		Clozapine	TABLET	ORAL	20200707		ANDA	ANDA206433	American Health Packaging	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-549_e5d36034-acbc-6703-e053-2a95a90ad0bb	60687-549	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20200819		ANDA	ANDA210054	American Health Packaging	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
60687-550_e9470130-83f9-d591-e053-2a95a90a34b8	60687-550	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20200320		ANDA	ANDA070772	American Health Packaging	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
60687-551_06e76ca9-ea3c-5e57-e063-6294a90a89e9	60687-551	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20211220		ANDA	ANDA076363	American Health Packaging	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
60687-552_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-552	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210105		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.2	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-553_07ea8a3a-35fd-4030-e063-6394a90ac9d0	60687-553	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	20201028		ANDA	ANDA080937	American Health Packaging	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
60687-554_f2b6016c-cbef-4f69-e053-2a95a90a75d8	60687-554	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200625	20240430	ANDA	ANDA211009	American Health Packaging	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
60687-555_e41af6bd-28f1-d7f1-e053-2995a90a831e	60687-555	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20200820		ANDA	ANDA074569	American Health Packaging	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-556_0aae27ca-3c76-6c5f-e063-6394a90af463	60687-556	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, DELAYED RELEASE	ORAL	20210420		ANDA	ANDA207873	American Health Packaging	MESALAMINE	400	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
60687-558_ea3fda1e-efe8-6d95-e053-2995a90adada	60687-558	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20220210		ANDA	ANDA090478	American Health Packaging	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60687-559_ea3cc34a-b911-e50a-e053-2995a90a758e	60687-559	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20200325		ANDA	ANDA090200	American Health Packaging	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60687-560_0bc7def9-b167-c348-e063-6294a90a275c	60687-560	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20200917		ANDA	ANDA203820	American Health Packaging	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
60687-563_0b243528-5fa0-8a1b-e063-6294a90aa114	60687-563	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200325		ANDA	ANDA209713	American Health Packaging	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60687-565_f2b6016c-cbef-4f69-e053-2a95a90a75d8	60687-565	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200625	20240331	ANDA	ANDA211009	American Health Packaging	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	
60687-566_c8bb9cd5-e0f9-3c23-e053-2995a90a388e	60687-566	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	SOLUTION	ORAL	20210901		NDA AUTHORIZED GENERIC	NDA019891	American Health Packaging	HYDROMORPHONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60687-567_0c7a8230-ef27-a02d-e063-6294a90a541f	60687-567	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20201207		ANDA	ANDA079016	American Health Packaging	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
60687-568_ea3cc34a-b911-e50a-e053-2995a90a758e	60687-568	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20200325		ANDA	ANDA090200	American Health Packaging	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60687-570_0398f3f9-c806-3a05-e063-6394a90a3317	60687-570	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20200818		ANDA	ANDA090865	American Health Packaging	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60687-572_ea3f2ca8-e075-f820-e053-2995a90a5631	60687-572	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20210421		ANDA	ANDA071745	American Health Packaging	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60687-574_eb6b0851-c4d1-363e-e053-2a95a90a5134	60687-574	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20200819	20240731	ANDA	ANDA091689	American Health Packaging	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	
60687-575_fe93c0ce-bee8-bad7-e053-6294a90ae973	60687-575	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	20210305		ANDA	ANDA090034	American Health Packaging	RIFAMPIN	150	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
60687-576_079e1418-8f21-1c6e-e063-6394a90a6ddb	60687-576	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20210615		ANDA	ANDA075873	American Health Packaging	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-577_0813a29f-760f-2fc3-e063-6294a90a607d	60687-577	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20210610		ANDA	ANDA078110	American Health Packaging	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60687-578_04c9c667-03a5-0dea-e063-6394a90ae6da	60687-578	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	CAPSULE	ORAL	20201027		ANDA	ANDA205301	American Health Packaging	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
60687-579_0c432e3b-9a27-6215-e063-6394a90a3220	60687-579	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20210511		ANDA	ANDA076855	American Health Packaging	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60687-580_01e0d051-0cf2-323d-e063-6294a90a1a67	60687-580	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20201218		ANDA	ANDA090858	American Health Packaging	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-581_0398f3f9-c806-3a05-e063-6394a90a3317	60687-581	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20200813		ANDA	ANDA090865	American Health Packaging	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60687-582_b9420188-fb99-13e1-e053-2a95a90af419	60687-582	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20210115		ANDA	ANDA207029	American Health Packaging	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-583_c29b638c-8adf-3172-e053-2995a90a60dd	60687-583	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20210601		ANDA	ANDA211623	American Health Packaging	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60687-584_e33a784b-7952-c868-e053-2995a90a1858	60687-584	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20220123		ANDA	ANDA076921	American Health Packaging	MIRTAZAPINE	7.5	mg/1			N	20241231
60687-585_e8baeb3d-6d9e-4d64-e053-2995a90a846f	60687-585	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20210202		ANDA	ANDA078281	American Health Packaging	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60687-586_fe93c0ce-bee8-bad7-e053-6294a90ae973	60687-586	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	20210309		ANDA	ANDA090034	American Health Packaging	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
60687-587_ea3f9f16-ad99-6b39-e053-2a95a90a339e	60687-587	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210621		ANDA	ANDA070322	American Health Packaging	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-588_0813a29f-760f-2fc3-e063-6294a90a607d	60687-588	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20210609		ANDA	ANDA078110	American Health Packaging	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60687-590_0c432e3b-9a27-6215-e063-6394a90a3220	60687-590	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		hydromorphone hydrochloride	TABLET	ORAL	20210511		ANDA	ANDA076855	American Health Packaging	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60687-591_01e0d051-0cf2-323d-e063-6294a90a1a67	60687-591	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210106		ANDA	ANDA090858	American Health Packaging	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-592_0398f3f9-c806-3a05-e063-6394a90a3317	60687-592	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20200810		ANDA	ANDA090865	American Health Packaging	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
60687-593_ea3f8253-7783-c365-e053-2995a90ad26b	60687-593	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20210312		ANDA	ANDA040412	American Health Packaging	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60687-594_c29b638c-8adf-3172-e053-2995a90a60dd	60687-594	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20210601		ANDA	ANDA211623	American Health Packaging	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
60687-595_0c943ad1-4622-b6b8-e063-6294a90a2b99	60687-595	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20210309		ANDA	ANDA206530	American Health Packaging	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
60687-596_e7160b63-dbc0-24dd-e053-2995a90aefc2	60687-596	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	CAPSULE, COATED PELLETS	ORAL	20210309		ANDA	ANDA206134	American Health Packaging	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-598_ea3f9f16-ad99-6b39-e053-2a95a90a339e	60687-598	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20211019		ANDA	ANDA070322	American Health Packaging	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-599_e9af5019-a051-3646-e053-2a95a90aaec0	60687-599	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20210501		ANDA	ANDA213665	American Health Packaging	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
60687-602_01e0d051-0cf2-323d-e063-6294a90a1a67	60687-602	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20201215		ANDA	ANDA090858	American Health Packaging	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-603_ea798f52-951a-6540-e053-2a95a90a5dfc	60687-603	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20220131		ANDA	ANDA090624	American Health Packaging	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
60687-604_f90f81a7-9b40-450a-e053-6394a90abdcb	60687-604	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20211231	20241031	ANDA	ANDA202800	American Health Packaging	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	
60687-605_ea3fb59b-b937-9bba-e053-2a95a90a046f	60687-605	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20211025		ANDA	ANDA076900	American Health Packaging	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-606_f9da8d01-46a3-8499-e053-6394a90a722c	60687-606	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20220607		ANDA	ANDA090066	American Health Packaging	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-607_04d9d31e-bb21-f75f-e063-6294a90ab4fe	60687-607	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211130		ANDA	ANDA204082	American Health Packaging	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60687-608_e9c35b18-6037-eeb0-e053-2a95a90aecab	60687-608	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20210804		ANDA	ANDA078490	American Health Packaging	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60687-609_ea3f9f16-ad99-6b39-e053-2a95a90a339e	60687-609	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20211209		ANDA	ANDA070322	American Health Packaging	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-610_e9af5019-a051-3646-e053-2a95a90aaec0	60687-610	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20210501		ANDA	ANDA213665	American Health Packaging	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
60687-612_e9c4b493-2198-5761-e053-2a95a90a6e01	60687-612	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA205536	American Health Packaging	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60687-614_ea798f52-951a-6540-e053-2a95a90a5dfc	60687-614	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20220103		ANDA	ANDA090624	American Health Packaging	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
60687-615_f90f81a7-9b40-450a-e053-6394a90abdcb	60687-615	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20211213	20240630	ANDA	ANDA202800	American Health Packaging	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	
60687-616_00edd7b8-7ab8-2396-e063-6394a90a9e11	60687-616	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20211022	20241031	ANDA	ANDA077789	American Health Packaging	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	
60687-617_0680cd58-87c0-90d5-e063-6294a90ac862	60687-617	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	TABLET	ORAL	20211018	20250131	ANDA	ANDA212451	American Health Packaging	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
60687-618_f2b3f57f-2f75-6c75-e053-2995a90a1e27	60687-618	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20210809		ANDA	ANDA090856	American Health Packaging	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60687-619_0c7e63a3-9934-5224-e063-6394a90a1e6a	60687-619	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20220425		ANDA	ANDA211556	American Health Packaging	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
60687-620_eb8ff8cb-a2b6-71aa-e053-2995a90a56d5	60687-620	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20211111		ANDA	ANDA072801	American Health Packaging	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
60687-622_e77b1ac7-d74f-cd0a-e053-2995a90a31fb	60687-622	HUMAN OTC DRUG	Sennosides and Docusate Sodium		Sennosides and Docusate Sodium	TABLET	ORAL	20210803		OTC MONOGRAPH NOT FINAL	part334	American Health Packaging	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
60687-623_e9c4b493-2198-5761-e053-2a95a90a6e01	60687-623	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210629		ANDA	ANDA205536	American Health Packaging	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60687-624_cec877f4-46e9-0b41-e053-2a95a90ad940	60687-624	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20211001		ANDA	ANDA213827	American Health Packaging	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
60687-626_fb485cd3-492c-0af8-e053-6394a90a6561	60687-626	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20220310		ANDA	ANDA205601	American Health Packaging	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
60687-627_e272e14c-637c-4b5f-e053-2a95a90a3a8c	60687-627	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20220315		ANDA	ANDA072926	American Health Packaging	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-628_0c3cd174-be75-06db-e063-6294a90a3e8c	60687-628	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20211201		ANDA	ANDA211648	American Health Packaging	POTASSIUM CHLORIDE	1.5	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
60687-629_f2b3f57f-2f75-6c75-e053-2995a90a1e27	60687-629	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20210624		ANDA	ANDA090856	American Health Packaging	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60687-630_dafec323-4e3d-f49b-e053-2995a90ae636	60687-630	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20220323		ANDA	ANDA078671	American Health Packaging	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-631_eb8ff8cb-a2b6-71aa-e053-2995a90a56d5	60687-631	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20220124		ANDA	ANDA070184	American Health Packaging	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
60687-632_e0c84d0f-629d-32d5-e053-2995a90ada23	60687-632	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20220414		ANDA	ANDA076368	American Health Packaging	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
60687-633_fd171379-1046-e2a5-e053-6394a90a20bd	60687-633	HUMAN PRESCRIPTION DRUG	Nitrofurantoin	(monohydrate/macrocrystals)	Nitrofurantoin monohydrate/macrocrystals	CAPSULE	ORAL	20220404		ANDA	ANDA207372	American Health Packaging	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
60687-634_e9c4b493-2198-5761-e053-2a95a90a6e01	60687-634	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210625		ANDA	ANDA205536	American Health Packaging	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60687-635_cec877f4-46e9-0b41-e053-2a95a90ad940	60687-635	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20211001		ANDA	ANDA213827	American Health Packaging	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
60687-636_f897c11f-0a85-90a7-e053-6394a90afb48	60687-636	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20220820	20240731	ANDA	ANDA077851	American Health Packaging	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
60687-637_fb485cd3-492c-0af8-e053-6394a90a6561	60687-637	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20220314		ANDA	ANDA205601	American Health Packaging	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
60687-638_e272e14c-637c-4b5f-e053-2a95a90a3a8c	60687-638	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20220325		ANDA	ANDA072927	American Health Packaging	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-639_fe954f78-f8ad-a583-e053-6394a90a60a6	60687-639	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20220106		ANDA	ANDA214065	American Health Packaging	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
60687-640_f1ec0615-f2e6-59c1-e053-2a95a90a3297	60687-640	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210920		ANDA	ANDA206145	American Health Packaging	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60687-641_fe8fe1ef-2eef-bb73-e053-6394a90a673c	60687-641	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20220907		ANDA	ANDA203828	American Health Packaging	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-642_eac9e401-d680-ee2c-e053-2a95a90a7213	60687-642	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20220104		ANDA	ANDA207510	American Health Packaging	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60687-647_f897c11f-0a85-90a7-e053-6394a90afb48	60687-647	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20220820	20240831	ANDA	ANDA077851	American Health Packaging	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
60687-648_d619a95f-ac46-6881-e053-2995a90a62a1	60687-648	HUMAN PRESCRIPTION DRUG	Varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20220201		ANDA	ANDA201785	American Health Packaging	VARENICLINE TARTRATE	1	mg/1	Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
60687-649_e272e14c-637c-4b5f-e053-2a95a90a3a8c	60687-649	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211007		ANDA	ANDA072928	American Health Packaging	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-650_fdf5fdec-e01a-f081-e053-6394a90a5410	60687-650	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20220620		ANDA	ANDA214242	American Health Packaging	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
60687-651_025765c9-619a-7e54-e063-6394a90afde3	60687-651	HUMAN OTC DRUG	Mucinex DM		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20220714	20240229	NDA	NDA021620	American Health Packaging	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
60687-652_fe8fe1ef-2eef-bb73-e053-6394a90a673c	60687-652	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20220907		ANDA	ANDA203828	American Health Packaging	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-653_0ccff397-b399-433e-e063-6294a90a6a40	60687-653	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20221020		ANDA	ANDA208864	American Health Packaging	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
60687-655_0ccb9b36-b072-aea7-e063-6294a90ad058	60687-655	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20221202	20240731	ANDA	ANDA076635	American Health Packaging	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	
60687-656_db5df505-a76e-1cc5-e053-2995a90aa946	60687-656	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20220401		ANDA	ANDA077321	American Health Packaging	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60687-657_dd441668-9466-0f12-e053-2995a90ac251	60687-657	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220415		ANDA	ANDA078993	American Health Packaging	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-658_e32b5442-ba0c-1901-e053-2a95a90ab054	60687-658	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20220419		ANDA	ANDA077863	American Health Packaging	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-659_01cfd289-d91a-a012-e063-6394a90a07f3	60687-659	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20220721		ANDA	ANDA078619	American Health Packaging	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60687-660_e0c8c78a-4ccc-75d3-e053-2a95a90a9c86	60687-660	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20220620		ANDA	ANDA040596	American Health Packaging	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-661_de57abb7-42d1-9ccd-e053-2995a90a24ef	60687-661	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20220401		ANDA	ANDA074260	American Health Packaging	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
60687-662_066bb8b2-07a7-3970-e063-6294a90a4797	60687-662	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	INHALANT	RESPIRATORY (INHALATION)	20230118		ANDA	ANDA209959	American Health Packaging	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
60687-663_f605cca1-4ba2-648b-e053-2995a90a3663	60687-663	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20230106		ANDA	ANDA207466	American Health Packaging	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60687-664_e5c1cd5a-fa60-704b-e053-2995a90a1ab7	60687-664	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20220820		ANDA	ANDA088617	American Health Packaging	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
60687-666_0ccb9b36-b072-aea7-e063-6294a90ad058	60687-666	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20221201	20240229	ANDA	ANDA076635	American Health Packaging	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	
60687-667_db5df505-a76e-1cc5-e053-2995a90aa946	60687-667	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20220401		ANDA	ANDA077321	American Health Packaging	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60687-668_dd441668-9466-0f12-e053-2995a90ac251	60687-668	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220415		ANDA	ANDA078993	American Health Packaging	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-669_f4224f83-f7e0-063a-e053-2a95a90afff0	60687-669	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220820		ANDA	ANDA040350	American Health Packaging	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
60687-670_e5d1e71e-2817-b092-e053-2a95a90ab1e5	60687-670	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		oxybutynin chloride	TABLET	ORAL	20220720		ANDA	ANDA075079	American Health Packaging	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
60687-671_f5ca0cc7-18cb-791a-e053-2a95a90a87e5	60687-671	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	ELIXIR	ORAL	20221219		UNAPPROVED DRUG OTHER		American Health Packaging	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
60687-672_ecf6c5bc-e7b7-bd02-e053-2a95a90ade07	60687-672	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20221017		ANDA	ANDA040511	American Health Packaging	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
60687-673_f5ca1d48-7f30-b826-e053-2a95a90a10dc	60687-673	HUMAN PRESCRIPTION DRUG	Nateglinide		nateglinide	TABLET	ORAL	20230112		ANDA	ANDA077463	American Health Packaging	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
60687-674_f67cae28-cd09-7936-e053-2a95a90ae923	60687-674	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230119		ANDA	ANDA078540	American Health Packaging	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
60687-675_e5c1cd5a-fa60-704b-e053-2995a90a1ab7	60687-675	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20220820		ANDA	ANDA088618	American Health Packaging	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
60687-676_0658b276-5fbd-19c8-e063-6294a90ae5a3	60687-676	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA214695	American Health Packaging	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
60687-677_f5ca4099-df86-0b12-e053-2995a90accf5	60687-677	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220919		ANDA	ANDA211820	American Health Packaging	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
60687-678_db5df505-a76e-1cc5-e053-2995a90aa946	60687-678	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20220401		ANDA	ANDA077321	American Health Packaging	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60687-679_f663d526-98fe-4fff-e053-2995a90a31f4	60687-679	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol fumarate	TABLET	ORAL	20230420		ANDA	ANDA078635	American Health Packaging	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60687-680_f4224f83-f7e0-063a-e053-2a95a90afff0	60687-680	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220820		ANDA	ANDA040350	American Health Packaging	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
60687-681_df38cee7-3088-38c0-e053-2995a90a11b3	60687-681	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20220525		ANDA	ANDA040625	American Health Packaging	FOLIC ACID	1	mg/1			N	20241231
60687-683_ecf772e1-71c7-f167-e053-2a95a90ad8b8	60687-683	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20221120		ANDA	ANDA090510	American Health Packaging	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60687-684_f5ca1d48-7f30-b826-e053-2a95a90a10dc	60687-684	HUMAN PRESCRIPTION DRUG	Nateglinide		nateglinide	TABLET	ORAL	20221229		ANDA	ANDA077463	American Health Packaging	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
60687-685_f67cae28-cd09-7936-e053-2a95a90ae923	60687-685	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230119		ANDA	ANDA078540	American Health Packaging	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
60687-686_e5c1cd5a-fa60-704b-e053-2995a90a1ab7	60687-686	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20220820		ANDA	ANDA088619	American Health Packaging	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
60687-687_0658b276-5fbd-19c8-e063-6294a90ae5a3	60687-687	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA214695	American Health Packaging	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
60687-688_f5ca4099-df86-0b12-e053-2995a90accf5	60687-688	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20221209		ANDA	ANDA211820	American Health Packaging	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
60687-689_e468c348-49e7-f694-e053-2995a90a99cd	60687-689	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20220720		ANDA	ANDA040855	American Health Packaging	BETHANECHOL CHLORIDE	10	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
60687-690_fe07e0e0-0734-a22a-e053-6394a90abc90	60687-690	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20230526		ANDA	ANDA075795	American Health Packaging	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60687-691_f5ca56a4-8fe3-1910-e053-2995a90acd2b	60687-691	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline	TABLET	ORAL	20220906		ANDA	ANDA065425	American Health Packaging	DEMECLOCYCLINE HYDROCHLORIDE	150	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
60687-692_f31c3d85-e38b-c40b-e053-2a95a90a75a1	60687-692	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20230120		ANDA	ANDA211567	American Health Packaging	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
60687-693_ee9e7d8e-d145-2b1e-e053-2995a90addb4	60687-693	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20221120		ANDA	ANDA077633	American Health Packaging	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
60687-694_e468ecf1-aa68-132d-e053-2a95a90afd0c	60687-694	HUMAN PRESCRIPTION DRUG	Methenamine Hippurate		Methenamine Hippurate	TABLET	ORAL	20220720		ANDA	ANDA212172	American Health Packaging	METHENAMINE HIPPURATE	1000	mg/1			N	20241231
60687-695_f31ccd6a-7804-41ec-e053-2a95a90a2ec0	60687-695	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20221220		ANDA	ANDA074415	American Health Packaging	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
60687-696_0bd81067-6754-4959-e063-6394a90acd00	60687-696	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20231128		ANDA	ANDA088496	American Health Packaging	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
60687-697_f2a00d8c-3c3e-72b9-e053-2995a90a7bf0	60687-697	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20221220		ANDA	ANDA209688	American Health Packaging	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
60687-698_0658b276-5fbd-19c8-e063-6294a90ae5a3	60687-698	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220603		ANDA	ANDA214695	American Health Packaging	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
60687-699_f902cdf7-78c6-35d3-e053-6394a90a3e5b	60687-699	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20230401		ANDA	ANDA210220	American Health Packaging	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
60687-700_e468c348-49e7-f694-e053-2995a90a99cd	60687-700	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20220720		ANDA	ANDA040855	American Health Packaging	BETHANECHOL CHLORIDE	25	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
60687-701_fe07e0e0-0734-a22a-e053-6394a90abc90	60687-701	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20230530		ANDA	ANDA075795	American Health Packaging	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60687-704_ee9e7d8e-d145-2b1e-e053-2995a90addb4	60687-704	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20221120		ANDA	ANDA077633	American Health Packaging	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
60687-705_f5ca56a4-8fe3-1910-e053-2995a90acd2b	60687-705	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline	TABLET	ORAL	20230119		ANDA	ANDA065425	American Health Packaging	DEMECLOCYCLINE HYDROCHLORIDE	300	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
60687-707_0bd81067-6754-4959-e063-6394a90acd00	60687-707	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20230524		ANDA	ANDA088487	American Health Packaging	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
60687-708_0ccb9b36-b074-aea7-e063-6294a90ad058	60687-708	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20230227	20241031	ANDA	ANDA210733	American Health Packaging	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
60687-709_e8d112d1-c511-1e79-e053-2995a90a3295	60687-709	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, FILM COATED	ORAL	20220920		ANDA	ANDA075938	American Health Packaging	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
60687-710_fd677c90-593a-dd68-e053-6394a90a2f51	60687-710	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine Hydrochloride	TABLET	ORAL	20231023		ANDA	ANDA214689	American Health Packaging	GUANFACINE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60687-711_f68c9ad7-303e-23fa-e053-2a95a90a7eb7	60687-711	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230131		ANDA	ANDA215939	American Health Packaging	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-713_ea5e7eff-0952-506f-e053-2995a90ab15b	60687-713	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20221120		ANDA	ANDA205566	American Health Packaging	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60687-714_0291de42-f8b0-5ae5-e063-6294a90a601e	60687-714	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate, 0.12% Oral Rinse		Chlorhexidine Gluconate, 0.12% Oral Rinse	SOLUTION	DENTAL	20230614		ANDA	ANDA075561	American Health Packaging	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
60687-715_f4aaf2d4-4c85-4728-e053-2995a90a22ac	60687-715	HUMAN PRESCRIPTION DRUG	Colestipol Hydrochloride		Colestipol Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA077510	American Health Packaging	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
60687-716_eb8d5c6f-ebac-07ad-e053-2a95a90a7de0	60687-716	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20221020		ANDA	ANDA065055	American Health Packaging	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60687-717_08171e41-8db5-67c3-e063-6394a90a0c12	60687-717	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20230327		ANDA	ANDA074185	American Health Packaging	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-718_081793ca-59e8-86cb-e063-6394a90a9d39	60687-718	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20221117		ANDA	ANDA215604	American Health Packaging	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-719_fb436c16-3f3d-0c7a-e053-6294a90a68a0	60687-719	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20230915		ANDA	ANDA212689	American Health Packaging	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
60687-720_f20224d9-1a68-6006-e053-2995a90a9181	60687-720	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20230109		ANDA	ANDA091606	American Health Packaging	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
60687-721_02e2264f-67f2-7957-e063-6394a90a735c	60687-721	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20240101		ANDA	ANDA077414	American Health Packaging	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
60687-722_f68c9ad7-303e-23fa-e053-2a95a90a7eb7	60687-722	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA215939	American Health Packaging	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-723_f41f0e08-996b-0f1b-e053-2995a90a6639	60687-723	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20230201		ANDA	ANDA090778	American Health Packaging	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60687-725_fa3cdfe4-91db-bc82-e053-6394a90a3b7a	60687-725	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20230705		ANDA	ANDA202038	American Health Packaging	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60687-727_0296e888-670a-c890-e063-6394a90af435	60687-727	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA203976	American Health Packaging	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
60687-728_08171e41-8db5-67c3-e063-6394a90a0c12	60687-728	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20231201		ANDA	ANDA074185	American Health Packaging	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60687-729_081793ca-59e8-86cb-e063-6394a90a9d39	60687-729	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230427		ANDA	ANDA215604	American Health Packaging	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-730_0c8e76bc-9d97-4fe5-e063-6394a90a746d	60687-730	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20230420		ANDA	ANDA201451	American Health Packaging	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
60687-732_02e2264f-67f2-7957-e063-6394a90a735c	60687-732	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20240101		ANDA	ANDA077414	American Health Packaging	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
60687-733_f68c9ad7-303e-23fa-e053-2a95a90a7eb7	60687-733	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20230127		ANDA	ANDA215939	American Health Packaging	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60687-734_f41f0e08-996b-0f1b-e053-2995a90a6639	60687-734	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20230201		ANDA	ANDA090778	American Health Packaging	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60687-735_f82577fd-bb2a-c676-e053-6294a90a564c	60687-735	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20230401		ANDA	ANDA076095	American Health Packaging	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
60687-736_fa3cdfe4-91db-bc82-e053-6394a90a3b7a	60687-736	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20230705		ANDA	ANDA202038	American Health Packaging	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60687-738_02935a29-75bc-0f18-e063-6294a90a1405	60687-738	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20230801		ANDA	ANDA211884	American Health Packaging	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
60687-739_f678dcd6-d004-0801-e053-2995a90a7dc9	60687-739	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	TABLET	ORAL	20230310		ANDA	ANDA209060	American Health Packaging	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
60687-740_fe9648f7-0109-16a8-e053-6294a90ae0ce	60687-740	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20230721		OTC MONOGRAPH NOT FINAL	part343	American Health Packaging	ACETAMINOPHEN	650	mg/20.3mL			N	20241231
60687-741_fd0139df-11f8-59b3-e053-6394a90a1375	60687-741	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20230915		ANDA	ANDA205987	American Health Packaging	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
60687-742_0296e85e-320d-b371-e063-6394a90a385e	60687-742	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET	ORAL	20230420		ANDA	ANDA065398	American Health Packaging	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
60687-743_0bcab4c1-507c-4dfe-e063-6294a90af06d	60687-743	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20231201		ANDA	ANDA210602	American Health Packaging	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60687-744_f8233a6a-b22e-ce03-e053-6394a90aa424	60687-744	HUMAN PRESCRIPTION DRUG	Dabigatran Etexilate		Dabigatran Etexilate	CAPSULE	ORAL	20230401		ANDA	ANDA207961	American Health Packaging	DABIGATRAN ETEXILATE MESYLATE	75	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
60687-745_f41f0e08-996b-0f1b-e053-2995a90a6639	60687-745	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20230201		ANDA	ANDA090778	American Health Packaging	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60687-746_f82577fd-bb2a-c676-e053-6294a90a564c	60687-746	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20230401		ANDA	ANDA076095	American Health Packaging	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
60687-747_fc5fe795-6b42-aecf-e053-6394a90af562	60687-747	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230523		ANDA	ANDA212244	American Health Packaging	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-749_03334708-83bc-a12c-e063-6394a90abbdb	60687-749	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20231001		ANDA	ANDA214534	American Health Packaging	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-750_05a42e3e-8a35-6112-e063-6394a90ab85c	60687-750	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET	ORAL	20231001		ANDA	ANDA203256	American Health Packaging	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
60687-751_fe9666d8-abf8-69dd-e053-6394a90a99cf	60687-751	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20230721		OTC MONOGRAPH NOT FINAL	part343	American Health Packaging	ACETAMINOPHEN	325	mg/10.15mL			N	20241231
60687-752_f8233a6a-b22e-ce03-e053-6394a90aa424	60687-752	HUMAN PRESCRIPTION DRUG	Dabigatran Etexilate		Dabigatran Etexilate	CAPSULE	ORAL	20230401		ANDA	ANDA207961	American Health Packaging	DABIGATRAN ETEXILATE MESYLATE	150	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
60687-753_0296e85e-320d-b371-e063-6394a90a385e	60687-753	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET	ORAL	20230801		ANDA	ANDA065399	American Health Packaging	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
60687-754_03380d95-6c5f-1701-e063-6294a90abb95	60687-754	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	GRANULE, FOR SUSPENSION	ORAL	20230820		ANDA	ANDA211813	American Health Packaging	LINEZOLID	100	mg/5mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
60687-755_0293429b-79eb-fa1a-e063-6394a90a21cb	60687-755	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	SOLUTION	ORAL	20230731		ANDA	ANDA070928	American Health Packaging	DIAZEPAM	5	mg/5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60687-758_fc5fe795-6b42-aecf-e053-6394a90af562	60687-758	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230523		ANDA	ANDA212244	American Health Packaging	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-760_fd269199-a8ed-0a4c-e053-6294a90a07ec	60687-760	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20230801		NDA	NDA022195	American Health Packaging	MORPHINE SULFATE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60687-761_03334708-83bc-a12c-e063-6394a90abbdb	60687-761	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20231001		ANDA	ANDA214534	American Health Packaging	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60687-762_0191bc62-aa7f-874a-e063-6294a90a95b9	60687-762	HUMAN OTC DRUG	Childrens Acetaminophen Oral Suspension		Acetaminophen	SUSPENSION	ORAL	20230801		OTC MONOGRAPH NOT FINAL	part343	American Health Packaging	ACETAMINOPHEN	160	mg/5mL			N	20241231
60687-765_038956dc-dd87-2583-e063-6294a90aa282	60687-765	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir Hydrochloride	POWDER, FOR SOLUTION	ORAL	20230820		ANDA	ANDA211475	American Health Packaging	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
60687-767_0191fcf7-ab8b-e583-e063-6294a90a7854	60687-767	HUMAN PRESCRIPTION DRUG	Pantoprazole sodium		Pantoprazole sodium	FOR SUSPENSION	ORAL	20230801		ANDA	ANDA217416	American Health Packaging	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60687-768_0df6f2d5-99bb-72fb-e063-6294a90a4dfa	60687-768	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20240101		ANDA	ANDA206928	American Health Packaging	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
60687-769_fc5fe795-6b42-aecf-e053-6394a90af562	60687-769	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230509		ANDA	ANDA212244	American Health Packaging	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-773_081793ca-59e8-86cb-e063-6394a90a9d39	60687-773	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231101		ANDA	ANDA217696	American Health Packaging	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60687-775_0c8e76bc-9d97-4fe5-e063-6394a90a746d	60687-775	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20230908		ANDA	ANDA201451	American Health Packaging	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
60687-780_fc5fe795-6b42-aecf-e053-6394a90af562	60687-780	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230523		ANDA	ANDA212244	American Health Packaging	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
60687-786_08ef24db-a50f-bd8d-e063-6394a90ad074	60687-786	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20231101		ANDA	ANDA208213	American Health Packaging	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
60687-788_0bb72c70-b071-4c4d-e063-6394a90a9f73	60687-788	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20231113		ANDA	ANDA203814	American Health Packaging	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
60687-794_03376605-1cad-91b4-e063-6394a90aa98d	60687-794	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20230820		ANDA	ANDA200495	American Health Packaging	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
60696-1234_30616512-3ae9-491d-9c76-f020c58c19f9	60696-1234	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19820101		NDA	NDA205820	Logan Health	OXYGEN	99	L/100L			N	20241231
60717-011_bbdfcf0d-2960-f6d6-e053-2a95a90a4c42	60717-011	HUMAN OTC DRUG	Thayers Blemish Clearing Balm		Salicylic Acid	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part333D	RNA PHARMA, LLC	SALICYLIC ACID	.02	g/1			N	20241231
60717-310_cb8234c4-c549-4b67-e053-2995a90af7d9	60717-310	HUMAN OTC DRUG	Aspire Scrub So Clean		Salicylic Acid	LOTION	TOPICAL	20210908		OTC MONOGRAPH FINAL	part333D	RNA PHARMA, LLC	SALICYLIC ACID	5	mg/mL			N	20241231
60717-311_cb92df75-8cf4-5711-e053-2995a90ab7b2	60717-311	HUMAN OTC DRUG	Aspire Cleanser So Fresh		Salicylic Acid	GEL	TOPICAL	20210909		OTC MONOGRAPH FINAL	part333D	RNA PHARMA, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
60717-312_cb93fd98-bea9-39dd-e053-2a95a90ac962	60717-312	HUMAN OTC DRUG	Aspire Treat So Deep		Salicylic Acid	GEL	TOPICAL	20210909		OTC MONOGRAPH FINAL	part333D	RNA PHARMA, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
60717-640_f0d39538-4426-1e09-e053-2a95a90a36c5	60717-640	HUMAN OTC DRUG	Every Man Jack Cedarwood Antiperspirant		Aluminum Chlorohydrate	STICK	TOPICAL	20221227		OTC MONOGRAPH FINAL	M019	RNA PHARMA, LLC	ALUMINUM CHLOROHYDRATE ANHYDROUS	.22	g/g			N	20241231
60717-642_f0d47894-fc92-15e0-e053-2a95a90a9b79	60717-642	HUMAN OTC DRUG	Every Man Jack Sea Salt Antiperspirant		Aluminum Chlorohydrate	STICK	TOPICAL	20221227		OTC MONOGRAPH FINAL	M019	RNA PHARMA, LLC	ALUMINUM CHLOROHYDRATE ANHYDROUS	.22	g/g			N	20241231
60717-644_f0d28f27-3d96-eb43-e053-2995a90a92fb	60717-644	HUMAN OTC DRUG	Every Man Jack Sandalwood Antiperspirant		Aluminum Chlorohydrate	STICK	TOPICAL	20221227		OTC MONOGRAPH FINAL	M019	RNA PHARMA, LLC	ALUMINUM CHLOROHYDRATE ANHYDROUS	.22	g/g			N	20241231
60717-720_bd5bf2c6-3660-cf28-e053-2a95a90abda1	60717-720	HUMAN OTC DRUG	Mielle illuminating face		Sunscreen	CREAM	TOPICAL	20210312		OTC MONOGRAPH NOT FINAL	part352	RNA PHARMA, LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	.025; .075; .05	g/1; g/1; g/1			N	20241231
60717-730_f0d5f671-cced-7a0b-e053-2a95a90a9e01	60717-730	HUMAN OTC DRUG	Aquation Anti-Chafe Cream		Zinc Oxide	LOTION	TOPICAL	20221227		OTC MONOGRAPH FINAL	M016	RNA PHARMA, LLC	ZINC OXIDE	.16	g/g			N	20241231
60717-901_cc711d96-ccc1-f67d-e053-2995a90a62bc	60717-901	HUMAN OTC DRUG	Duke Cannon Antiperspirant		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20210920		OTC MONOGRAPH FINAL	part350	RNA PHARMA, LLC	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/g			N	20241231
60717-903_cc72c311-cce3-79bc-e053-2995a90aa3b7	60717-903	HUMAN OTC DRUG	Duke Cannon Cooling Antiperspirant		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20210920		OTC MONOGRAPH FINAL	part350	RNA PHARMA, LLC	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/g			N	20241231
60717-904_cc738c6e-b0a3-2e94-e053-2995a90abd65	60717-904	HUMAN OTC DRUG	Duke Cooling Antiperspirant		Aluminum Zirconium tetrachlorohydrex GLY	STICK	TOPICAL	20210920		OTC MONOGRAPH FINAL	part350	RNA PHARMA, LLC	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/g			N	20241231
60717-905_cc745da1-e8b2-1e45-e053-2a95a90a7be3	60717-905	HUMAN OTC DRUG	Duke Cannon Fresh Antiperspirant		Aluminum Zirconium tetrachlorohydrex GLY	STICK	TOPICAL	20210920		OTC MONOGRAPH FINAL	part350	RNA PHARMA, LLC	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	.2	g/g			N	20241231
60717-906_cc86eead-7c6d-71e1-e053-2995a90ad1ef	60717-906	HUMAN OTC DRUG	Duke Cannon Standard Issue Face		Sunscreen	LOTION	TOPICAL	20210921		OTC MONOGRAPH FINAL	part352	RNA PHARMA, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	.03; .065; .075; .05; .02	g/mL; g/mL; g/mL; g/mL; g/mL			N	20241231
60723-041_0a3b49f2-017b-65f6-e063-6294a90a1ea2	60723-041	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20190401		ANDA	ANDA207516	Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd	RISEDRONATE SODIUM HEMI-PENTAHYDRATE	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60723-205_09ffa188-ce1d-a242-e063-6294a90ab033	60723-205	HUMAN PRESCRIPTION DRUG	Alendronate		ALENDRONATE SODIUM	TABLET	ORAL	20171205		ANDA	ANDA090258	Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60723-207_09ffa188-ce1d-a242-e063-6294a90ab033	60723-207	HUMAN PRESCRIPTION DRUG	Alendronate		ALENDRONATE SODIUM	TABLET	ORAL	20171205		ANDA	ANDA090258	Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
60742-003_0165717b-8ad7-315a-e063-6294a90afd75	60742-003	HUMAN OTC DRUG	LIVE CLEAN BABY		ZINC OXIDE	CREAM	TOPICAL	20150101	20240731	OTC MONOGRAPH FINAL	part346	BELVEDERE INTERNATIONAL INC.	ZINC OXIDE	15	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
60742-011_016569df-6816-1b1e-e063-6294a90ad515	60742-011	HUMAN OTC DRUG	Live Clean		Hand Sanitizer	GEL	TOPICAL	20200312	20250930	OTC MONOGRAPH NOT FINAL	part333E	Belvedere International Inc.	ALCOHOL	70	mL/100mL			N	
60758-119_e686f3cc-e473-4648-a5ee-18ad60dfbe6d	60758-119	HUMAN PRESCRIPTION DRUG	PREDNISOLONE ACETATE		prednisolone acetate	SUSPENSION/ DROPS	OPHTHALMIC	19970819		NDA AUTHORIZED GENERIC	NDA017011	Pacific Pharma, Inc.	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60758-188_e8707f8b-04a5-4389-8596-93e938730d7c	60758-188	HUMAN PRESCRIPTION DRUG	GENTAMICIN SULFATE		gentamicin sulfate	SOLUTION/ DROPS	OPHTHALMIC	19980105		ANDA	ANDA062452	Pacific Pharma, Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
60758-561_8d83334b-5349-4f47-abf8-1dee6a1c293a	60758-561	HUMAN PRESCRIPTION DRUG	Tazarotene		Tazarotene	CREAM	TOPICAL	20170415		NDA AUTHORIZED GENERIC	NDA021184	Pacific Pharma, Inc.	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
60758-615_7ecb9d42-bf69-47f3-bc89-fa904c804864	60758-615	HUMAN PRESCRIPTION DRUG	gatifloxacin		gatifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20150415		NDA AUTHORIZED GENERIC	NDA022548	Pacific Pharma, Inc.	GATIFLOXACIN	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
60758-670_eb56fc78-828d-4a57-853a-d7160679b035	60758-670	HUMAN PRESCRIPTION DRUG	DAPSONE		dapsone	GEL	TOPICAL	20171018		NDA AUTHORIZED GENERIC	NDA021794	Pacific Pharma, Inc.	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
60758-773_8fed7498-2d95-4878-b8a9-3a615a44f297	60758-773	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20131121		NDA AUTHORIZED GENERIC	NDA021528	Pacific Pharma, Inc.	KETOROLAC TROMETHAMINE	4	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60758-801_3b035879-5d3f-4e5a-8ff4-d7449997889b	60758-801	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	19970520		ANDA	ANDA074747	Pacific Pharma, Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60758-802_3b035879-5d3f-4e5a-8ff4-d7449997889b	60758-802	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	19970520		ANDA	ANDA074746	Pacific Pharma, Inc.	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60758-880_3f41fe3f-a808-49f3-a81a-629d8bacc39a	60758-880	HUMAN PRESCRIPTION DRUG	FLUOROMETHOLONE		fluorometholone	SOLUTION/ DROPS	OPHTHALMIC	19971031		NDA AUTHORIZED GENERIC	NDA016851	Pacific Pharma, Inc.	FLUOROMETHOLONE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60758-908_2d3f6e96-e511-4fb6-82c1-ec184a2b7a41	60758-908	HUMAN PRESCRIPTION DRUG	POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE		polymyxin B sulfate, trimethoprim sulfate	SOLUTION/ DROPS	OPHTHALMIC	19970429		NDA AUTHORIZED GENERIC	NDA050567	Pacific Pharma, Inc.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
60760-002_ef5421f8-d69b-a805-e053-2995a90af843	60760-002	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20151113		ANDA	ANDA040362	St. Mary's Medical Park Pharmacy	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60760-005_f06d097e-228c-3973-e053-2995a90ad4c9	60760-005	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	St Marys Medical Park Pharmacy	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-006_f06d097e-228c-3973-e053-2995a90ad4c9	60760-006	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	St Marys Medical Park Pharmacy	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-009_ded44f64-c51c-1454-e053-2995a90a908c	60760-009	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	St Marys Medical Park Pharmacy	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-017_0ccc30f4-b984-edd0-e063-6394a90a9d39	60760-017	HUMAN OTC DRUG	Muscle Rub		Menthol, Methyl salicylate	CREAM	TOPICAL	20110303		OTC MONOGRAPH DRUG	M017	St. Mary's Medical Park Pharmacy	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
60760-019_f06d097e-228c-3973-e053-2995a90ad4c9	60760-019	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	St Marys Medical Park Pharmacy	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-057_a2f0cb79-f136-64e9-e053-2995a90ad44c	60760-057	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20180302		ANDA	ANDA091368	St. Mary's Medical Park Pharmacy	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60760-058_8720ef93-26b5-0493-e053-2991aa0a8002	60760-058	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, EXTENDED RELEASE	ORAL	20190417		ANDA	ANDA076201	St. Mary's Medical Park Pharmacy	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-066_0c040468-cd48-efe0-e063-6394a90a4158	60760-066	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20181217		ANDA	ANDA203244	St. Mary's Medical Park Pharmacy	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-069_88c6feb2-b39f-56bd-e053-2a95a90a50f5	60760-069	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20151216		ANDA	ANDA090624	St. Mary's Medical Park Pharmacy	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
60760-069_ded422a2-f3ae-3f19-e053-2995a90a0fc9	60760-069	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20220201		ANDA	ANDA090624	St. Mary's Medical Park Pharmacy	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
60760-070_98d28bda-973b-ab1d-e053-2995a90a5ff7	60760-070	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20190227		ANDA	ANDA078916	St. Mary's Medical Park Pharmacy	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
60760-074_b69a3586-03d4-60cd-e053-2a95a90a00d3	60760-074	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Tablets	TABLET, COATED	ORAL	20190312		ANDA	ANDA208921	St Mary's Medical Park Pharmacy	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
60760-087_ef545c37-addf-340f-e053-2995a90aad16	60760-087	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20190418		ANDA	ANDA040659	St. Mary's Medical Park Pharmacy	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
60760-088_ded44f64-c51b-1454-e053-2995a90a908c	60760-088	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	St. Mary's Medical Park Pharmacy	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-090_e3b22f2c-24d8-abab-e053-2995a90a39f5	60760-090	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20171121		ANDA	ANDA077863	St. Mary's Medical Park Pharmacy	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-091_f06d2003-3e24-444a-e053-2995a90a153e	60760-091	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20190709		ANDA	ANDA077206	St. Mary's Medical Park Pharmacy	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-092_90b7ce00-cc37-3cd0-e053-2995a90a2c19	60760-092	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20190821		ANDA	ANDA208633	St Mary's Medical Park Pharmacy	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-093_7abbdad9-6b9e-300c-e053-2a91aa0a5b65	60760-093	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170619		ANDA	ANDA203695	St. Mary's Medical Park Pharmacy	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
60760-100_889091bd-1b21-f5bf-e053-2a95a90a999c	60760-100	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET	ORAL	20100422		ANDA	ANDA090564	St. Mary's Medical Park Pharmacy	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60760-112_92c3745d-8532-689b-e053-2a95a90af0a0	60760-112	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20190917		ANDA	ANDA202769	St. Mary's Medical Park Pharmacy	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-113_7a8db339-b98e-6fab-e053-2a91aa0a1247	60760-113	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20180314		ANDA	ANDA208963	St. Mary's Medical Park Pharmacy	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60760-121_ef538879-d19d-4f2b-e053-2995a90a4588	60760-121	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20110130		ANDA	ANDA077653	St. Marys Medical Park Pharmacy	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-134_f06e6e94-f0e4-7303-e053-2a95a90afa61	60760-134	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20171220		ANDA	ANDA203154	St. Mary's Medical Park Pharmacy	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
60760-139_f06e6ff6-2af3-06d0-e053-2995a90a88f6	60760-139	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20150429		ANDA	ANDA203154	St. Mary's Medical Park Pharmacy	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
60760-140_d27e4473-6f64-ddfe-e053-2a95a90a9a2c	60760-140	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	St. Mary's Medical Park Pharmacy	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-151_7acba366-852c-cba6-e053-2a91aa0a9980	60760-151	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA090074	St. Mary's Medical Park Pharmacy	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-152_88c6feb2-b3d7-56bd-e053-2a95a90a50f5	60760-152	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	St. Mary's Medical Park Pharmacy	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
60760-153_81a057d2-f3a7-4b3a-e053-2a91aa0af109	60760-153	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20171109		ANDA	ANDA075185	St. Mary's Medical Park Pharmacy	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-161_0cca6245-9d32-17ca-e063-6394a90a60c1	60760-161	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200116		OTC MONOGRAPH DRUG	M013	St. Mary's Medical Park Pharmacy	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
60760-165_903cb974-e615-1a0e-e053-2a95a90a4306	60760-165	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190812		ANDA	ANDA204720	St. Mary's Medical Park Pharmacy	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60760-170_0c05b1cc-f9ea-1af0-e063-6294a90aea2b	60760-170	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	St. Mary's Medical Park Pharmacy	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-179_02f82597-3221-b598-e063-6394a90a31a2	60760-179	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20180131		ANDA	ANDA040362	St. Mary's Medical Park Pharmacy	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60760-181_f06e4d37-5f31-d60c-e053-2995a90a4634	60760-181	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180427		ANDA	ANDA202446	St. Mary's Medical Park Pharmacy	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60760-187_8a1e6dab-5331-1ea4-e053-2a95a90a0e40	60760-187	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20190529		ANDA	ANDA090555	St. Mary's Medical Park Pharmacy	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-190_de5f6f48-4437-52d9-e053-2a95a90a2134	60760-190	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	St. Mary's Medical Park Pharmacy	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-194_87207a12-af6f-a01a-e053-2991aa0ab12f	60760-194	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20190419		ANDA	ANDA077066	St. Mary's Medical Park Pharmacy	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
60760-199_f06e6e94-f0e7-7303-e053-2a95a90afa61	60760-199	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-201_fbbd2166-5e8d-65f9-e053-6394a90aec35	60760-201	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20191010		ANDA	ANDA200675	St. Mary's Medical Park Pharmacy	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
60760-203_7acac128-27f4-0a85-e053-2991aa0a1713	60760-203	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20180508		ANDA	ANDA075845	St. Mary's Medical Park Pharmacy	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-205_f19dedf0-b685-2402-e053-2995a90aabe0	60760-205	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190905		ANDA	ANDA208677	St. Mary's Medical Park Pharmacy	PREGABALIN	50	mg/1		CV	N	20241231
60760-212_0c05b1cc-f9ef-1af0-e063-6294a90aea2b	60760-212	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160226		ANDA	ANDA202446	St. Mary's Medical Park Pharmacy	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60760-215_f06e8d19-c6ea-6cba-e053-2995a90a3adb	60760-215	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20030702		ANDA	ANDA065095	St Marys Medical Park Pharmacy	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60760-217_f06e8d5d-24c3-80a1-e053-2995a90aa4a9	60760-217	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20171214		ANDA	ANDA077293	St. Mary's Medical Park Pharmacy	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
60760-222_0cca7ef9-e941-24b2-e063-6394a90ac5e7	60760-222	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET	ORAL	20180216		OTC MONOGRAPH DRUG	M013	St. Mary's Medical Park Pharmacy	ACETAMINOPHEN	500	mg/1			N	20241231
60760-226_f06e8f22-b76e-f8fa-e053-2a95a90a8e2d	60760-226	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20140421		ANDA	ANDA075483	St Marys Medical Park Pharmacy	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-233_7a03063b-87fd-e765-e053-2a91aa0a2224	60760-233	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	St. Mary's Medical Park Pharmacy	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
60760-243_985a1aef-61bb-14fc-e053-2a95a90ab21f	60760-243	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20190812		ANDA	ANDA200981	St. Mary's Medical Park Pharmacy	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-248_f06e9242-c9fa-f3c9-e053-2a95a90a276a	60760-248	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20171226		ANDA	ANDA078181	St. Marys Medical Park Pharmacy	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60760-255_d27ebbc9-558a-127e-e053-2a95a90a0e3a	60760-255	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20171226		ANDA	ANDA040362	St. Marys Medical Park Pharmacy	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60760-256_9b2d4d76-52c3-1b2d-e053-2995a90abeb8	60760-256	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191212		ANDA	ANDA074052	St. Mary's Medical Park Pharmacy	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-262_9db30fed-a2c9-a3c1-e053-2a95a90afa0f	60760-262	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20200203		ANDA	ANDA070218	St. Mary's Medical Park Pharmacy	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-263_8abd00cd-9256-da09-e053-2995a90aa39c	60760-263	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20180719		ANDA	ANDA091283	St. Mary's Medical Park Pharmacy	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60760-264_7a8055b3-aa1b-346c-e053-2a91aa0a4a16	60760-264	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180508		ANDA	ANDA075492	St. Mary's Medical Park Pharmacy	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-275_9ef62325-3d18-39cd-e053-2a95a90ae719	60760-275	HUMAN PRESCRIPTION DRUG	Ergocalciferol Capsules,		Ergocalciferol Capsules,	CAPSULE	ORAL	20200217		ANDA	ANDA204276	St. Mary's Medical Park Pharmacy	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
60760-277_94569c47-6c51-1bcf-e053-2995a90aec39	60760-277	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20191002		ANDA	ANDA090469	St. Mary's Medical Park Pharmacy	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-285_f19dcd74-13a8-85ba-e053-2a95a90a673e	60760-285	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA088617	St Mary's Medical Park Pharmacy	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
60760-288_0c05ed7a-859b-973c-e063-6394a90ae129	60760-288	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	St. Mary's Medical Park Pharmacy	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
60760-289_a838352c-5a92-9c32-e053-2a95a90aa3a6	60760-289	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20200331		ANDA	ANDA204770	St. Mary's Medical Park Pharmacy	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
60760-293_afeb7651-d77b-ae29-e053-2995a90a822e	60760-293	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200916		NDA AUTHORIZED GENERIC	NDA018279	St. Mary's Medical Park Pharmacy	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
60760-294_7ad02cc4-7a57-7f0d-e053-2991aa0a4953	60760-294	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20180118		ANDA	ANDA091276	St. Mary's Medical Park Pharmacy	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-295_8a1d8fbb-096b-3d14-e053-2a95a90a288b	60760-295	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20190517		ANDA	ANDA200981	St. Mary's Medical Park Pharmacy	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-298_7a8e2c72-4cec-2680-e053-2991aa0a73d9	60760-298	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180314		ANDA	ANDA091134	St. Mary's Medical Park Pharmacy	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-304_a97d917a-6b6e-b9bd-e053-2a95a90afcce	60760-304	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20200616		ANDA	ANDA090555	St. Mary's Medical Park Pharmacy	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-305_7acfd809-956e-aa0b-e053-2a91aa0ab491	60760-305	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20140523		ANDA	ANDA090469	St Marys Medical Park Pharmacy	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-306_7acaaa54-3dfb-6ef3-e053-2a91aa0a384f	60760-306	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20160401		ANDA	ANDA090469	St Marys Medical Park Pharmacy	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-311_a9de93c3-0169-2836-e053-2995a90aa38d	60760-311	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA204597	St. Mary's Medical Park Pharmacy	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-313_a9e0467b-0112-1768-e053-2995a90a9e09	60760-313	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20200702		ANDA	ANDA077557	St. Mary's Medical Park Pharmacy	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-314_7ad086e3-91f8-fcb7-e053-2a91aa0acdfe	60760-314	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20150608		ANDA	ANDA074754	St. Marys Medical Park Pharmacy	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-315_8a1dde0a-7b38-a10a-e053-2995a90a2611	60760-315	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20190530		ANDA	ANDA040907	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-316_affda9fa-33c8-d875-e053-2a95a90a6420	60760-316	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200917		ANDA	ANDA075317	St. Mary's Medical Park Pharmacy	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60760-318_f19d9517-2849-516f-e053-2995a90ad6e1	60760-318	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20210114		ANDA	ANDA213864	St. Mary's Medical Park Pharmacy	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
60760-325_7b327707-642e-568f-e053-2a91aa0a112d	60760-325	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	St. Mary's Medical Park Pharmacy	ESZOPICLONE	2	mg/1		CIV	N	20241231
60760-327_f06e9bc0-c293-c5ce-e053-2995a90a2113	60760-327	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20201218		ANDA	ANDA075805	St. Mary's Medical Park Pharmacy	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
60760-329_b404115d-71a2-9657-e053-2995a90ab23e	60760-329	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20201116		ANDA	ANDA206928	St. Mary's Medical Park Pharmacy	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60760-332_0ccba2fd-17bc-c673-e063-6394a90a7b05	60760-332	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20200311		OTC MONOGRAPH DRUG	M012	St. Mary's Medical Park Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
60760-335_7b2fe0db-38f6-8791-e053-2a91aa0af059	60760-335	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20171215		ANDA	ANDA090460	St. Mary's Medical Park Pharmacy	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
60760-336_945604cf-55cd-8b12-e053-2a95a90ae823	60760-336	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20171215		ANDA	ANDA203458	St. Mary's Medical Park Pharmacy	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
60760-337_85018062-7cac-6928-e053-2991aa0a80ed	60760-337	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20170217		ANDA	ANDA065242	St. Marys Medical Park Pharmacy	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
60760-351_7a023fd2-27a2-300e-e053-2991aa0aa001	60760-351	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	St. Mary's Medical Park Pharmacy	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-352_7a024766-f7af-7685-e053-2a91aa0ab774	60760-352	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	St. Mary's Medical Park Pharmacy	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-357_7abb4461-54d8-1fdd-e053-2991aa0a6b12	60760-357	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	St. Mary's Medical Park Pharmacy	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-358_7abb38fd-8b56-b7bf-e053-2a91aa0aa6d6	60760-358	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20171214		ANDA	ANDA076180	St. Mary's Medical Park Pharmacy	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-359_7abb38fd-8b8d-b7bf-e053-2a91aa0aa6d6	60760-359	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	St. Mary's Medical Park Pharmacy	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-360_7abb38fd-8bc3-b7bf-e053-2a91aa0aa6d6	60760-360	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	St. Mary's Medical Park Pharmacy	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-363_960ecca3-1f56-71ae-e053-2a95a90acfc7	60760-363	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20191024		ANDA	ANDA208170	St. Mary's Medical Park Pharmacy	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-365_8ff1c0ac-8cdb-60cf-e053-2a95a90a5645	60760-365	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20180628		ANDA	ANDA208170	St. Mary's Medical Park Pharmacy	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-366_0c05e75e-4822-22e3-e063-6294a90a2a1e	60760-366	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20190215		ANDA	ANDA208170	St. Mary's Medical Park Pharmacy	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-367_0c6bf3ad-5cb1-b005-e063-6394a90a46b1	60760-367	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160603		ANDA	ANDA202446	St. Mary's Medical Park Pharmacy	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60760-368_a00e200b-ac2e-6ae2-e053-2995a90a97ac	60760-368	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20191021		ANDA	ANDA078420	St. Mary's Medical Park Pharmacy	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-369_bc910bed-480d-6efc-e053-2a95a90a5464	60760-369	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20191010		ANDA	ANDA078420	St. Mary's Medical Park Pharmacy	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-376_a449a3b6-1eaa-3d0f-e053-2a95a90a39df	60760-376	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20200423		ANDA	ANDA078384	St. Mary's Medical Park Pharmacy	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
60760-377_0c0623fb-df1b-a4da-e063-6294a90a41d2	60760-377	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20131006		ANDA	ANDA075964	St. Mary's Medical Park Pharmacy	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
60760-378_a6a941ce-2f8e-430e-e053-2a95a90ae53d	60760-378	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	St. Mary's Medical Park Pharmacy	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-380_a500b8fb-e32d-632d-e053-2a95a90ac22f	60760-380	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200506		ANDA	ANDA076059	St. Mary's Medical Park Pharmacy	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-382_e881db23-6527-c7d2-e053-2a95a90afc64	60760-382	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET, FILM COATED	ORAL	20220815		ANDA	ANDA075855	ST MARY'S MEDICAL PARK PHARMACY	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-386_f04754bc-d97e-2ee5-e053-2a95a90a397a	60760-386	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20180719		ANDA	ANDA091083	St. Mary's Medical Park Pharmacy	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-387_f047ed59-6369-4cab-e053-2a95a90abffd	60760-387	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20190412		ANDA	ANDA091083	St. Mary's Medical Park Pharmacy	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-390_a00e3e70-9122-aebe-e053-2995a90a68ba	60760-390	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200302		ANDA	ANDA076059	St. Mary's Medical Park Pharmacy	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-392_81a04c5e-55fe-339d-e053-2a91aa0a9a4d	60760-392	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20190211		NDA AUTHORIZED GENERIC	NDA018998	St. Mary's Medical Park Pharmacy	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-393_98d25ae5-7f16-a055-e053-2a95a90a33e4	60760-393	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20191128		ANDA	ANDA078032	St. Mary's Medical Park Pharmacy	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-398_85020df0-53d9-0509-e053-2991aa0ad800	60760-398	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20190320		ANDA	ANDA077584	St. Mary's Medical Park Pharmacy	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-401_7aca25ab-0978-371b-e053-2a91aa0a0fc0	60760-401	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20171215		ANDA	ANDA075520	St. Mary's Medical Park Pharmacy	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60760-404_d27e0eb1-06bc-0c36-e053-2995a90a3e77	60760-404	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20160203		ANDA	ANDA077927	St. Mary's Medical Park Pharmacy	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-419_7abbf67f-4992-7133-e053-2991aa0a673b	60760-419	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20160203		ANDA	ANDA077927	St. Mary's Medical Park Pharmacy	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-421_f06e92a0-b49e-0364-e053-2a95a90a7b3c	60760-421	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20180313		ANDA	ANDA207068	St. Mary's Medical Park Pharmacy	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-427_a6a97e62-7091-5934-e053-2995a90a8cf1	60760-427	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20200519		ANDA	ANDA207402	St. Mary's Medical Park Pharmacy	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
60760-430_affe4a45-9d75-8904-e053-2995a90a6a57	60760-430	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-437_fbc007aa-f589-e471-e053-6394a90ad910	60760-437	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20190320		ANDA	ANDA077443	St. Mary's Medical Park Pharmacy	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-438_ae6cfe0d-6686-2468-e053-2a95a90a0d99	60760-438	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200616		ANDA	ANDA076059	St. Mary's Medical Park Pharmacy	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-445_b2d5c742-17ba-a07b-e053-2995a90adab6	60760-445	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20201015		ANDA	ANDA203245	St. Mary's Medical Park Pharmacy	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60760-448_cbe4ddde-4b4c-a064-e053-2a95a90a094d	60760-448	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20201218		ANDA	ANDA077921	St. Mary's Medical Park Pharmacy	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-450_b96a08ae-b256-caca-e053-2995a90ab659	60760-450	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20210122		ANDA	ANDA204645	St. Mary's Medical Park Pharmacy	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60760-453_0cca7427-e215-8abf-e063-6294a90a5c43	60760-453	HUMAN OTC DRUG	Regular Strength Pain Relief		Acetaminophen	TABLET	ORAL	20210315		OTC MONOGRAPH DRUG	M013	St. Mary's Medical Park Pharmacy	ACETAMINOPHEN	325	mg/1			N	20241231
60760-455_f06ee1ba-63c9-7cc4-e053-2995a90a54e9	60760-455	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20190730		ANDA	ANDA077321	St Mary's Medical Park Pharmacy	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-456_f06eec16-1c20-815e-e053-2995a90afc14	60760-456	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20191009		ANDA	ANDA040596	St. Mary's Medical Park Pharmacy	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
60760-459_a500b8fb-e32a-632d-e053-2a95a90ac22f	60760-459	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20200506		ANDA	ANDA203245	St. Mary's Medical Park Pharmacy	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60760-461_0c0623fb-df22-a4da-e063-6294a90a41d2	60760-461	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190905		ANDA	ANDA208706	St. Mary's Medical Park Pharmacy	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-462_92218bcb-021b-eaff-e053-2995a90ae620	60760-462	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190905		ANDA	ANDA208706	St. Mary's Medical Park Pharmacy	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-466_7b324564-ca9e-7c37-e053-2a91aa0a2616	60760-466	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20180508		ANDA	ANDA202800	St. Mary's Medical Park Pharmacy	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
60760-469_bed99bed-3905-5278-e053-2a95a90aeab6	60760-469	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20210331		ANDA	ANDA203047	St. Mary's Medical Park Pharmacy	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60760-479_b4646f5d-7957-6a0c-e053-2a95a90a290b	60760-479	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	St. Mary's Medical Park Pharmacy	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-481_afeb2751-8e58-4877-e053-2995a90ac683	60760-481	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200916		ANDA	ANDA091604	St. Mary's Medical Park Pharmacy	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-484_ed1276b3-2cd6-10ae-e053-2a95a90a4a15	60760-484	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20210607		ANDA	ANDA065061	St. Mary's Medical Park Pharmacy	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
60760-485_0c062410-3533-aebd-e063-6394a90a269a	60760-485	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190903		ANDA	ANDA208677	St. Mary's Medical Park Pharmacy	PREGABALIN	75	mg/1		CV	N	20241231
60760-486_f19db86f-8c42-2f05-e053-2a95a90a5fde	60760-486	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20201222		ANDA	ANDA208677	St. Mary's Medical Park Pharmacy	PREGABALIN	200	mg/1		CV	N	20241231
60760-487_f19d8225-1125-2705-e053-2995a90ae289	60760-487	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20200916		ANDA	ANDA207402	St. Mary's Medical Park Pharmacy	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
60760-489_f19ddbec-d77c-a3f1-e053-2a95a90a65d5	60760-489	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20210521		ANDA	ANDA075410	St. Mary's Medical Park Pharmacy	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-492_b70f984d-fffd-0825-e053-2995a90aa9c4	60760-492	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20201209		ANDA	ANDA207206	St. Mary's Medical Park Pharmacy	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-493_be4c9922-06da-73a7-e053-2995a90a1daa	60760-493	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210304		ANDA	ANDA207206	St. Mary's Medical Park Pharmacy	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-494_8a82132b-c5ee-aa70-e053-2995a90acc46	60760-494	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20190604		ANDA	ANDA077614	St. Mary's Medical Park Pharmacy	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
60760-497_c50c4851-558e-4ea9-e053-2995a90a6129	60760-497	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20210611		ANDA	ANDA090564	St. Mary's Medical Park Pharmacy	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60760-499_b2d44728-72b8-d591-e053-2a95a90a8bbd	60760-499	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20201016		ANDA	ANDA202556	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-501_850242ce-1785-a974-e053-2991aa0a4387	60760-501	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20190320		ANDA	ANDA077584	St. Mary's Medical Park Pharmacy	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-502_a6a7fbd4-bec6-3d0f-e053-2a95a90a5780	60760-502	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20200512		ANDA	ANDA207370	St. Mary's Medical Park Pharmacy	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
60760-505_d1675538-dc96-2714-e053-2a95a90a01aa	60760-505	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210621		ANDA	ANDA076286	St. Mary's Medical Park Pharmacy	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60760-507_f20051cc-3367-0875-e053-2a95a90aedfb	60760-507	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190903		ANDA	ANDA208677	St. Mary's Medical Park Pharmacy	PREGABALIN	150	mg/1		CV	N	20241231
60760-508_7ac9171d-1a59-fe37-e053-2991aa0a0621	60760-508	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20171130		ANDA	ANDA075520	St. Mary's Medical Park Pharmacy	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60760-509_f19de6f9-8329-d383-e053-2a95a90a4bea	60760-509	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20210706		ANDA	ANDA208677	St Mary's Medical Park Pharmacy	PREGABALIN	300	mg/1		CV	N	20241231
60760-515_0c0649cc-4b2f-ddab-e063-6294a90a9f40	60760-515	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	St Marys Medical Park Pharmacy	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
60760-516_f06efb5f-1c24-3418-e053-2995a90a8fa5	60760-516	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20190114		ANDA	ANDA078203	St. Mary's Medical Park Pharmacy	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60760-517_c85ae572-9894-629e-e053-2995a90a23fc	60760-517	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20210706		ANDA	ANDA205101	St. Mary's Medical Park Pharmacy	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-519_e1aaa9d4-0605-3885-e053-2a95a90aff2d	60760-519	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20220510		ANDA	ANDA076230	St Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-523_ded43b3e-9705-4219-e053-2a95a90a73f2	60760-523	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20211228		ANDA	ANDA203769	St. Mary's Medical Park Pharmacy	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60760-524_e8814547-095a-0d8a-e053-2995a90ae095	60760-524	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	ST. MARY'S MEDICAL PARK PHARMACY	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-526_c4ff1df6-10a6-634a-e053-2a95a90ac4ce	60760-526	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20210607		ANDA	ANDA091166	St Mary's Medical Park Phcy	ESZOPICLONE	2	mg/1		CIV	N	20241231
60760-529_f0701d9a-fac1-e5b9-e053-2995a90afc79	60760-529	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20190205		ANDA	ANDA072096	St. Mary's Medical Park Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-532_b69a1f3b-42ef-2f0b-e053-2a95a90a510f	60760-532	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20190909		ANDA	ANDA078251	St. Mary's Medical Park Pharmacy	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
60760-534_0ccb65a9-784e-bce6-e063-6394a90a51c0	60760-534	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20210907		OTC MONOGRAPH DRUG	M013	St. Mary's Medical Park Pharmacy	ACETAMINOPHEN	500	mg/1			N	20241231
60760-535_9cbce27a-aec5-4828-e053-2a95a90a02e7	60760-535	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene, Hydrochlorothiazide	CAPSULE	ORAL	20140422		ANDA	ANDA201407	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-536_f6f310b7-a1e9-182a-e053-6394a90a16d6	60760-536	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20220615		ANDA	ANDA078643	St Mary's Medical Park Pharmacy	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-538_9858fcb5-0a39-e175-e053-2a95a90a87d4	60760-538	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride	ER	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171221		NDA AUTHORIZED GENERIC	NDA018553	St. Mary's Medical Park Pharmacy	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-539_f2f3e2ab-6dbd-dc2f-e053-2a95a90a3b93	60760-539	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20220617		ANDA	ANDA206560	ST. MARY'S MEDICAL PARK PHARMACY	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
60760-541_f2f3d86e-37de-974c-e053-2995a90abc71	60760-541	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20220622		ANDA	ANDA090624	ST. MARY'S MEDICAL PARK PHARMACY	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
60760-543_e55a9e50-61e8-2b3f-e053-2995a90a4b74	60760-543	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20220727		ANDA	ANDA078525	ST. MARY'S MEDICAL PARK PHARMACY	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
60760-545_c01fcaf6-a434-ec9a-e053-2995a90a0b65	60760-545	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210408		ANDA	ANDA070322	St. Mary's Medical Park Pharmacy	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-550_b67489c2-8447-3bf9-e053-2995a90a178a	60760-550	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20190220		ANDA	ANDA207507	St. Mary's Medical Park Pharmacy	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60760-552_d2453ea9-5e7f-3898-e053-2995a90a825c	60760-552	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20151112		ANDA	ANDA076004	St. Marys Medical Park Pharmacy	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-556_e3dd7463-3f88-e692-e053-2995a90ab6aa	60760-556	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20220713		ANDA	ANDA214548	ST. MARY'S MEDICAL PARK PHARMACY	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60760-558_f94bd3f3-07f2-1a4f-e053-6294a90a528a	60760-558	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20220413		ANDA	ANDA209912	ST. MARY'S MEDICAL PARK PHARMACY	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-559_fbe5be69-0732-4e89-e053-6294a90a6fe8	60760-559	HUMAN PRESCRIPTION DRUG	DULOXETINE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20230516		ANDA	ANDA206653	ST. MARY'S MEDICAL PARK PHARMACY	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-561_b2d3ba5f-f3ff-3a79-e053-2995a90a50fe	60760-561	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20201017		ANDA	ANDA091416	St. Mary's Medical Park Pharmacy	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-563_e3a3b453-20c3-80c1-e053-2a95a90a28b0	60760-563	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220622		ANDA	ANDA203699	ST. MARY'S MEDICAL PARK PHARMACY	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-564_e67351c5-4a85-8bed-e053-2a95a90a02dd	60760-564	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20220622		ANDA	ANDA212517	ST. MARY'S MEDICAL PARK PHARMACY	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-566_e55cd5cb-2279-a2c8-e053-2995a90a93af	60760-566	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20220727		ANDA	ANDA200981	ST. MARY'S MEDICAL PARK PHARMACY	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-567_e8823fbb-ac35-050a-e053-2995a90accac	60760-567	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20220825		ANDA	ANDA090469	ST. MARY'S MEDICAL PARK PHARMACY	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-568_7a8f022b-3f21-9409-e053-2a91aa0a34c8	60760-568	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180918		ANDA	ANDA204720	St. Mary's Medical Park Pharmacy	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60760-569_de5f9641-49c4-490a-e053-2a95a90af219	60760-569	HUMAN OTC DRUG	Allergy Relief	Non drowsy	Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	St Mary's Medical Park Pharmacy	LORATADINE	10	mg/1			N	20241231
60760-571_8501c87d-6a9b-1b85-e053-2991aa0a5d05	60760-571	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20190320		ANDA	ANDA091604	St. Mary's Medical Park Pharmacy	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
60760-572_eac58460-f797-274d-e053-2995a90a4c15	60760-572	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220930		ANDA	ANDA204901	ST. MARY'S MEDICAL PARK PHARMACY	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-574_052f687f-2265-9476-e063-6394a90a6ee9	60760-574	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20221031		ANDA	ANDA077619	ST. MARY'S MEDICAL PARK PHARMACY	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-575_ed266486-e4a6-9dd1-e053-2a95a90a80d3	60760-575	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20221031		ANDA	ANDA213273	ST. MARY'S MEDICAL PARK PHARMACY	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-576_edc4ccfc-0108-774f-e053-2a95a90a216e	60760-576	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20221031		ANDA	ANDA212026	ST. MARY'S MEDICAL PARK PHARMACY	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-577_0c06534b-c68a-b838-e063-6394a90ac405	60760-577	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20190911		ANDA	ANDA078235	ST. MARY'S MEDICAL PARK PHARMACY	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-578_f707f1a5-1020-bbb0-e053-6394a90a1986	60760-578	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20200803		ANDA	ANDA089853	ST. MARY'S MEDICAL PARK PHARMACY	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-579_faa7ae86-fdab-108c-e053-6394a90ae38d	60760-579	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230413		ANDA	ANDA078103	ST. MARY'S MEDICAL PARK PHARMACY	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-580_f94e5e28-f0b2-700a-e053-6394a90adb7b	60760-580	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230413		ANDA	ANDA078103	ST. MARY'S MEDICAL PARK PHARMACY	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-581_eac5f2df-119f-1465-e053-2a95a90a03f9	60760-581	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20220930		ANDA	ANDA040419	ST. MARY'S MEDICAL PARK PHARMACY	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
60760-582_ed11c8f8-fe6a-5ecf-e053-2a95a90a5821	60760-582	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20221017		ANDA	ANDA077614	ST. MARY'S MEDICAL PARK PHARMACY	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
60760-585_faa81dcb-64df-3f43-e053-6394a90a485b	60760-585	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230420		ANDA	ANDA078103	ST. MARY'S MEDICAL PARK PHARMACY	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-586_00b256d4-1691-cc3b-e063-6294a90a47ec	60760-586	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	ST. MARY'S MEDICAL PARK PHARMACY	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-587_cdb65308-1fae-f3b3-e053-2995a90abad9	60760-587	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20210923		ANDA	ANDA075657	St. Mary's Medical Park Pharmacy	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-588_087a7c74-9fa1-7762-e063-6394a90a6836	60760-588	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20180301		ANDA	ANDA202075	ST. MARY'S MEDICAL PARK PHARMACY	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
60760-590_0994403d-1203-49d4-e063-6294a90a6e95	60760-590	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	ST. MARY'S MEDICAL PARK PHARMACY	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-591_fda20838-972a-210e-e053-6294a90a2b02	60760-591	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	ST. MARY'S MEDICAL PARK PHARMACY	PREGABALIN	100	mg/1		CV	N	20241231
60760-592_faa7e1a5-7aaf-239c-e053-6394a90a9cd7	60760-592	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20230420		ANDA	ANDA209312	ST. MARY'S MEDICAL PARK PHARMACY	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-593_0a97c939-f4a9-92ee-e063-6294a90ab4cf	60760-593	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	ST. MARY'S MEDICAL PARK PHARMACY	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-596_f0497d76-bc2e-32b0-e053-2995a90afef1	60760-596	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20190429		ANDA	ANDA078329	St. Mary's Medical Park Pharmacy	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-597_f0498d3d-58c4-39c9-e053-2a95a90afeab	60760-597	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20190502		ANDA	ANDA078329	St. Mary's Medical Park Pharmacy	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-598_8afa2b0c-1051-5021-e053-2995a90a056f	60760-598	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20171226		ANDA	ANDA202433	St. Marys Medical Park Pharmacy	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60760-603_f4e955bc-e0ee-1cf9-e053-2a95a90aa787	60760-603	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20191021		ANDA	ANDA090796	St. Mary's Medical Park Pharmacy	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-604_a9f31e25-9560-5012-e053-2a95a90a52c0	60760-604	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20191016		ANDA	ANDA090796	St. Mary's Medical Park Pharmacy	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-605_0c068d27-9179-ee67-e063-6294a90a53fd	60760-605	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20171226		ANDA	ANDA090007	St. Marys Medical Park Pharmacy	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-606_cdb55e30-057a-5d3b-e053-2a95a90ae79c	60760-606	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20210830		ANDA	ANDA204313	St. Mary's Medical Park Pharmacy	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60760-609_0cca91d6-0bce-a81c-e063-6294a90a2613	60760-609	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET	ORAL	20220731		ANDA	ANDA210722	ST. MARY'S MEDICAL PARK PHARMACY	LORATADINE	10	mg/1			N	20241231
60760-610_85cd688a-25c6-194d-e053-2991aa0aa5d0	60760-610	HUMAN PRESCRIPTION DRUG	Labetalol HCl		Labetalol HCl	TABLET, FILM COATED	ORAL	20190405		ANDA	ANDA075113	St. Mary's Medical Park Pharmacy	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-612_7f81de84-0ad8-f050-e053-2a91aa0aa762	60760-612	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20181226		ANDA	ANDA077206	St. Mary's Medical Park Pharmacy	SERTRALINE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-614_cdb68210-952f-e8da-e053-2a95a90aec7e	60760-614	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20210923		ANDA	ANDA078925	St. Mary's Medical Park Pharmacy	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
60760-615_b403e752-6d49-128f-e053-2a95a90aa153	60760-615	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20201105		ANDA	ANDA210525	St. Mary's Medical Park Pharmacy	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60760-616_7ad086e3-91fe-fcb7-e053-2a91aa0acdfe	60760-616	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180821		ANDA	ANDA204106	St. Mary's Medical Park Pharmacy	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-619_d4c6f008-6ccf-60c7-e053-2a95a90a45df	60760-619	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20210907		ANDA	ANDA212254	St Mary's Medical Park Pharmacy	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-626_a8382b26-742d-15ea-e053-2995a90aba35	60760-626	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA062505	St. Mary's Medical Park Pharmacy	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60760-628_c8ad3090-0526-6aa5-e053-2a95a90a65cc	60760-628	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210727		ANDA	ANDA200908	St. Mary's Medical Park Pharmacy	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-634_cdb69427-048a-3751-e053-2995a90a3667	60760-634	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210923		ANDA	ANDA203894	St. Mary's Medical Park Pharmacy	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-636_0c069065-d8c6-1d0e-e063-6294a90ab407	60760-636	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	St. Mary's Medical Park Pharmacy	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-637_d27e5ce4-5af2-72eb-e053-2995a90a6f67	60760-637	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	St. Mary's Medical Park Pharmacy	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-638_de9a2d03-382d-ca89-e053-2a95a90acff6	60760-638	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20220503		ANDA	ANDA040230	St Mary's Medical Park Pharmacy	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
60760-639_e39f41ed-0903-9f0e-e053-2995a90ab36a	60760-639	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20220622		ANDA	ANDA202038	St Mary's Medical Park Pharmacy	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-642_b698e0e8-b632-8f02-e053-2a95a90a3e82	60760-642	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20181022		ANDA	ANDA077443	St Mary's Medical Park Pharmacy	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-643_8abceaca-3530-b97a-e053-2a95a90ae2f3	60760-643	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20190114		ANDA	ANDA077443	St. Mary's Medical Park Pharmacy	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-644_e3a4ab58-13df-ef77-e053-2a95a90ad8c2	60760-644	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20220711		ANDA	ANDA212517	ST. MARY'S MEDICAL PARK PHARMACY	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-645_e6735480-2f09-43d8-e053-2995a90a09f2	60760-645	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20220728		ANDA	ANDA091497	ST. MARY'S MEDICAL PARK PHARMACY	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60760-646_e8815323-26a9-4f59-e053-2995a90ab690	60760-646	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20220825		ANDA	ANDA202038	ST. MARY'S MEDICAL PARK PHARMACY	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-649_fbbfb101-b959-50c4-e053-6394a90a9318	60760-649	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20221025		ANDA	ANDA205129	ST. MARY'S MEDICAL PARK PHARMACY	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-651_e6731e26-9dae-37fc-e053-2a95a90a2b29	60760-651	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20220809		ANDA	ANDA207773	ST. MARY'S MEDICAL PARK PHARMACY	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60760-652_f06f1d6f-3919-4bba-e053-2995a90adcdc	60760-652	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20160329		ANDA	ANDA075677	St. Mary's Medical Park Pharmacy	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
60760-653_07ef855c-0674-1219-e063-6394a90a692e	60760-653	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20230516		ANDA	ANDA077929	ST. MARY'S MEDICAL PARK PHARMACY	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-654_f1759d52-c768-6f81-e053-2995a90aecf2	60760-654	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20221222		ANDA	ANDA078152	ST. MARY'S MEDICAL PARK PHARMACY	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-656_00b26226-4f3f-e9c4-e063-6294a90a7c1e	60760-656	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	ST. MARY'S MEDICAL PARK PHARMACY	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
60760-657_052fba08-69e1-135f-e063-6294a90a52ec	60760-657	HUMAN PRESCRIPTION DRUG	Lidocaine 5%		Lidocaine 5%	PATCH	TOPICAL	20230615		ANDA	ANDA209190	ST. MARY'S MEDICAL PARK PHARMACY	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
60760-658_00b17a8e-9d39-a8d4-e063-6294a90a153e	60760-658	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	ST. MARY'S MEDICAL PARK PHARMACY	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
60760-661_ded41ec4-9043-a23f-e053-2a95a90a279e	60760-661	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20210621		NDA AUTHORIZED GENERIC	NDA010721	St. Mary's Medical Park Pharmacy	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
60760-662_0994a032-bcfd-d389-e063-6294a90afbe0	60760-662	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20191101		ANDA	ANDA040702	ST. MARY'S MEDICAL PARK PHARMACY	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-663_0a99d16b-38ed-9e50-e063-6394a90a2af4	60760-663	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	ST. MARY'S MEDICAL PARK PHARMACY	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-664_c21278d8-a74c-7014-e053-2a95a90a823c	60760-664	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20210325		ANDA	ANDA203974	St. Mary's Medical Park Pharmacy	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
60760-668_0eb07135-101b-9c09-e063-6394a90aba10	60760-668	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20220415		ANDA	ANDA210616	ST. MARY'S MEDICAL PARK PHARMACY	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
60760-676_c32cef90-e57e-2a0e-e053-2a95a90ae037	60760-676	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20210521		ANDA	ANDA208921	St. Mary's Medical Park Pharmacy	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
60760-678_fc5fe7a0-42ee-b1c8-e053-6394a90a020c	60760-678	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	ST. MARY'S MEDICAL PARK PHARMACY	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
60760-679_e1aa611e-7960-a074-e053-2a95a90a914e	60760-679	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220301		ANDA	ANDA202882	St Mary's Medical Park Pharmacy	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-688_f17770e9-1342-696b-e053-2a95a90aa08f	60760-688	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	St Mary's Medical Park Pharmacy	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-693_9c56afa2-bffa-fa03-e053-2995a90a7437	60760-693	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20190903		ANDA	ANDA065243	St Mary's Medical Park Pharmacy	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
60760-694_cfd5333a-e312-470f-e053-2a95a90a03ae	60760-694	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20211028		ANDA	ANDA076286	St. Mary's Medical Park Pharmacy	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60760-694_de99f9ce-df1e-fe30-e053-2a95a90af942	60760-694	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20220509		ANDA	ANDA076286	St Mary's Medical Park Pharmacy	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60760-697_0ccbb268-ec5a-c8eb-e063-6394a90a44b4	60760-697	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH DRUG	M012	ST. MARY'S MEDICAL PARK PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
60760-700_07efb1df-d506-dfe4-e063-6294a90a214b	60760-700	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20191025		ANDA	ANDA206948	St. Mary's Medical Park Pharmacy	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
60760-707_b8b84751-ef69-2a28-e053-2995a90a8d79	60760-707	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20210107		ANDA	ANDA076796	St. Mary's Medical Park Pharmacy	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
60760-708_7a8e69ee-6ae4-60e4-e053-2a91aa0af9a4	60760-708	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20181022		ANDA	ANDA076796	St Mary's Medical Park Pharmacy	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
60760-709_85cd3f96-b84a-f192-e053-2991aa0aee98	60760-709	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20190328		ANDA	ANDA209288	St. Mary's Medical Park Pharmacy	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-712_f19ddbec-d781-a3f1-e053-2a95a90a65d5	60760-712	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20200304		ANDA	ANDA202882	St. Mary's Medical Park Pharmacy	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-713_d27f6885-dc43-90c1-e053-2995a90a6526	60760-713	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20180712		ANDA	ANDA078932	St. Mary's Medical Park Pharmacy	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-715_c6b490b9-bbc2-7109-e053-2a95a90a8e1a	60760-715	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20200825		ANDA	ANDA210525	St. Mary's Medical Park Pharmacy	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60760-719_cdb5c18b-079c-aad1-e053-2a95a90a0b0c	60760-719	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210727		ANDA	ANDA076416	St. Mary's Medical Park Pharmacy	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60760-721_00b2a93c-92dc-90c6-e063-6294a90a6d33	60760-721	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	ST. MARY'S MEDICAL PARK PHARMACY	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60760-723_0ccc0792-8150-e5c8-e063-6394a90a2ba8	60760-723	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20191009		ANDA	ANDA211343	ST. MARY'S MEDICAL PARK PHARMACY	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
60760-725_018d9f12-4c65-0f1d-e063-6294a90a348b	60760-725	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	ST. MARY'S MEDICAL PARK PHARMACY	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-728_fab61465-dff5-0498-e053-6294a90a9aec	60760-728	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20230421		ANDA	ANDA077653	ST. MARY'S MEDICAL PARK PHARMACY	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-736_f4e949c2-910e-18be-e053-2995a90aec97	60760-736	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20221208		ANDA	ANDA216441	ST. MARY'S MEDICAL PARK PHARMACY	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
60760-737_f049247b-f016-0ae4-e053-2a95a90a31f5	60760-737	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180821		ANDA	ANDA202825	St. Mary's Medical Park Pharmacy	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-738_f06f1ff2-c35e-2929-e053-2a95a90ad1c3	60760-738	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180809		ANDA	ANDA202825	St. Mary's Medical Park Pharmacy	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
60760-740_be4cc18b-0132-3050-e053-2a95a90ad63e	60760-740	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20201231		ANDA	ANDA204989	St. Mary's Medical Park Pharmacy	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-741_b7a29b99-ce24-950e-e053-2995a90a1934	60760-741	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20201222		ANDA	ANDA204989	St. Mary's Medical Park Pharmacy	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-742_e6732f27-6d02-539b-e053-2995a90a58ff	60760-742	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20220527		ANDA	ANDA205129	St Mary's Medical Park Pharmacy	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-743_f19dc2af-b2ec-3eac-e053-2995a90a28fb	60760-743	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20210128		ANDA	ANDA205101	St. Mary's Medical Park Pharmacy	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-766_0994403d-1201-49d4-e063-6294a90a6e95	60760-766	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	ST. MARY'S MEDICAL PARK PHARMACY	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-767_0291ba00-6119-b9fc-e063-6394a90ad04f	60760-767	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	ST. MARY'S MEDICAL PARK PHARMACY	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-770_f1772518-2081-7450-e053-2995a90a893a	60760-770	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20181115		ANDA	ANDA209312	St. Mary's Medical Park Pharmacy	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-772_f3bf6f98-f388-3249-e053-2995a90a2fbb	60760-772	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20221228		ANDA	ANDA203494	ST. MARY'S MEDICAL PARK PHARMACY	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
60760-773_f4e95ca1-502c-5305-e053-2995a90a5dc7	60760-773	HUMAN PRESCRIPTION DRUG	Ethacrynic Acid		Ethacrynic Acid	TABLET	ORAL	20230209		ANDA	ANDA211232	ST. MARY'S MEDICAL PARK PHARMACY	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
60760-777_7a809fd0-313c-3833-e053-2a91aa0ada4e	60760-777	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20180730		NDA AUTHORIZED GENERIC	NDA018998	St. Mary's Medical Park Pharmacy	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
60760-782_d27edbe7-6063-e0aa-e053-2a95a90a0cf2	60760-782	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20000818		ANDA	ANDA091283	St. Mary's Medical Park Pharmacy	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
60760-783_de5e7c85-5bf6-5b5f-e053-2995a90a1fba	60760-783	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20200221		ANDA	ANDA208358	St Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-784_ed2293f8-2b83-c3db-e053-2995a90ad46c	60760-784	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20221025		ANDA	ANDA211953	ST. MARY'S MEDICAL PARK PHARMACY	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-786_aaf931b3-41b8-696f-e053-2a95a90abc93	60760-786	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200720		ANDA	ANDA203835	St. Mary's Medical Park Pharmacy	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
60760-787_be648303-8e2c-ac0d-e053-2a95a90a821d	60760-787	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20210325		ANDA	ANDA074056	St Mary's Medical Park Pharmacy	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
60760-790_e4439f8f-be1e-47f8-e053-2995a90acb9a	60760-790	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220720		ANDA	ANDA208412	ST. MARY'S MEDICAL PARK PHARMACY	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60760-793_0ccc1d62-e5bb-07e4-e063-6294a90a634f	60760-793	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA206928	ST. MARY'S MEDICAL PARK PHARMACY	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60760-800_fc9df15f-22a5-f7a1-e053-6294a90a5b6d	60760-800	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230519		ANDA	ANDA202759	ST. MARY'S MEDICAL PARK PHARMACY	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
60760-803_f19d9517-284a-516f-e053-2995a90ad6e1	60760-803	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210802		ANDA	ANDA077253	St. Mary's Medical Park Pharmacy	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60760-804_7a8e2c72-4d99-2680-e053-2991aa0a73d9	60760-804	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20160401		ANDA	ANDA077253	St Marys Medical Park Pharmacy	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
60760-806_0c06c855-3cb5-5470-e063-6294a90a6639	60760-806	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20180425		ANDA	ANDA205253	St. Mary's Medical Park Pharmacy	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
60760-808_d16871e8-bd64-90e1-e053-2995a90a5aa1	60760-808	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20211117		ANDA	ANDA065211	St. Mary's Medical Park Pharmacy	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
60760-810_0a5fa90c-a1a8-a44d-e063-6394a90a1bf9	60760-810	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	St. Mary's Medical Park Pharmacy	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-811_7aca25ab-0948-371b-e053-2a91aa0a0fc0	60760-811	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170316		ANDA	ANDA075520	St. Mary's Medical Park Pharmacy	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
60760-814_ff5f2a6f-d2f3-8862-e053-6294a90a30c6	60760-814	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220504		ANDA	ANDA206943	St Mary's Medical Park Pharmacy	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-815_0c03bd0f-c1e2-72b2-e063-6294a90a9f54	60760-815	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20160719		ANDA	ANDA076639	ST. MARY'S MEDICAL PARK PHARMACY	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
60760-816_e1aad010-b3da-6cf4-e053-2a95a90a2786	60760-816	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	St Mary's Medical Park Pharmacy	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
60760-818_fe810eb9-a1d1-d8a9-e053-6394a90a9008	60760-818	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230406		ANDA	ANDA206943	ST. MARY'S MEDICAL PARK PHARMACY	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60760-823_b4649791-d170-45c0-e053-2a95a90a5217	60760-823	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20181115		ANDA	ANDA204590	St. Mary's Medical Park Pharmacy	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-824_7a03243a-df17-8a1c-e053-2991aa0a9f35	60760-824	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20180730		ANDA	ANDA204590	St. Mary's Medical Park Pharmacy	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-829_ef53a855-a5df-8e3e-e053-2a95a90a19f6	60760-829	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20221108		ANDA	ANDA076477	ST. MARY'S MEDICAL PARK PHARMACY	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-842_e5472945-20d6-1cd0-e053-2995a90afa72	60760-842	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20220727		ANDA	ANDA084657	St. Mary's Medical Park Pharmacy	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
60760-843_febe2ae0-5578-5fe0-e053-6294a90af4c3	60760-843	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	ST. MARY'S MEDICAL PARK PHARMACY	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
60760-853_099439f3-879a-7747-e063-6394a90a3706	60760-853	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	ST. MARY'S MEDICAL PARK PHARMACY	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
60760-854_0cca7427-e216-8abf-e063-6294a90a5c43	60760-854	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20210907		OTC MONOGRAPH DRUG	M013	St. Mary's Medical Park Pharmacy	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
60760-858_febeaf96-c9fb-c5a8-e053-6294a90ac179	60760-858	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20230615		ANDA	ANDA216629	ST. MARY'S MEDICAL PARK PHARMACY	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
60760-860_8a1eae05-bcbc-180c-e053-2995a90a349e	60760-860	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20190529		ANDA	ANDA076194	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-861_bc911eb3-52da-c42d-e053-2995a90a02b4	60760-861	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20210224		ANDA	ANDA076194	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-868_e1aa479f-a6a8-59b0-e053-2a95a90a7ab9	60760-868	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220331		ANDA	ANDA075757	St. Mary's Medical Park Pharmacy	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-880_9dc3059c-3a3e-5810-e053-2a95a90ab0ba	60760-880	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20200204		NDA AUTHORIZED GENERIC	NDA020612	St. Mary's Medical Park Pharmacy	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
60760-886_f2f42f36-6b0a-4140-e053-2a95a90af813	60760-886	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20230117		ANDA	ANDA077829	ST. MARY'S MEDICAL PARK PHARMACY	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
60760-889_ef53925b-2a8f-687b-e053-2a95a90af1a2	60760-889	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20220517		ANDA	ANDA078643	St Mary's Medical Park Pharmacy	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
60760-922_cb05d75f-066e-aca4-e053-2a95a90a4be3	60760-922	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20210902		ANDA	ANDA207152	St. Mary's Medical Park Pharmacy	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
60760-929_0eb1a257-a807-fe63-e063-6394a90a920f	60760-929	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	ST. MARY'S MEDICAL PARK PHARMACY	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
60760-930_0cca9eb4-c0f3-b91e-e063-6294a90a06db	60760-930	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19930804		OTC MONOGRAPH DRUG	M013	ST. MARY'S MEDICAL PARK PHARMACY	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
60760-932_c8aa48bb-c7cf-290f-e053-2995a90a78d5	60760-932	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20210709		ANDA	ANDA211495	St. Mary's Medical Park Pharmacy	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
60760-941_a19cb05b-6e35-b88c-e053-2a95a90a64e4	60760-941	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20200324		ANDA	ANDA075010	St. Mary's Medical Park Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
60760-951_0191629f-f9f4-6ad0-e063-6294a90a773f	60760-951	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	ST. MARY'S MEDICAL PARK PHARMACY	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
60760-968_cb6a684f-7f11-89df-e053-2a95a90acdee	60760-968	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20210907		ANDA	ANDA204058	St. Mary's Medical Park Pharmacy	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
60760-972_c212d3a2-8c5c-57e3-e053-2a95a90aea8b	60760-972	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20210506		ANDA	ANDA204237	St. Mary's Medical Park Pharmacy	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
60760-973_7bc0e2fa-5b9a-15e5-e053-2a91aa0a2e6a	60760-973	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130515		ANDA	ANDA090564	St Marys Medical Park Pharmacy	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60760-975_7bc0e2fa-5b9a-15e5-e053-2a91aa0a2e6a	60760-975	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20130515		ANDA	ANDA090564	St Marys Medical Park Pharmacy	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
60760-979_cadd40b0-18a7-a176-e053-2a95a90ae2fb	60760-979	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20210830		ANDA	ANDA211933	St Mary's Medical Park Pharmacy	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
60760-987_07f08a40-e514-e778-e063-6294a90ae300	60760-987	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	ST. MARY'S MEDICAL PARK PHARMACY	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
60762-112_06d8d1aa-a4cf-df5a-e063-6394a90a95d9	60762-112	HUMAN OTC DRUG	CA-REZZ NORISC	ANTIBACTERIAL SKIN CARE	BENZETHONIUM CHLORIDE	CREAM	TOPICAL	20180205		OTC MONOGRAPH NOT FINAL	part333A	FNC MEDICAL CORPORATION	BENZETHONIUM CHLORIDE	.2	g/100g			N	20241231
60762-113_06d8b1c1-16a9-e93a-e063-6294a90a8335	60762-113	HUMAN OTC DRUG	CA-REZZ - NORISC - INCONTINENT WASH		BENZETHONIUM CHLORIDE	SOLUTION	TOPICAL	20180205		OTC MONOGRAPH DRUG	M003	FNC MEDICAL CORPORATION	BENZETHONIUM CHLORIDE	.12	g/100mL			N	20241231
60762-151_06d84f53-1722-eb64-e063-6294a90a3274	60762-151	HUMAN OTC DRUG	CA-REZZ - LONG TERM CARE - INCONTINENT CLEANSER		BENZETHONIUM CHLORIDE	SOLUTION	TOPICAL	20180205		OTC MONOGRAPH DRUG	M003	FNC MEDICAL CORPORATION	BENZETHONIUM CHLORIDE	.12	g/100mL			N	20241231
60763-601_0e0ef369-a0e2-5320-e063-6394a90a353f	60763-601	HUMAN PRESCRIPTION DRUG	PURINETHOL		Mercaptopurine	TABLET	ORAL	20220115		NDA	NDA009053	Stason Pharmaceuticals, Inc.	MERCAPTOPURINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20251231
60768-001_078bd43a-7323-02ba-e063-6294a90a9ac2	60768-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130919		UNAPPROVED MEDICAL GAS		Gage Lucky 13 LLC dba Tecumseh Oxygen & Medical Supply	OXYGEN	99	L/100L			N	20241231
60781-1001_b6935dc5-37a7-4725-8287-860a8871e92e	60781-1001	HUMAN OTC DRUG	THINKSPORT	sunscreen SPF 50	zinc oxide	LOTION	TOPICAL	20110101		OTC MONOGRAPH DRUG	M020	thinkOperations,LLC	ZINC OXIDE	200	mg/mL			N	20241231
60781-1002_6209b611-2134-4974-b01b-9e3daf3f616c	60781-1002	HUMAN OTC DRUG	THINKSPORT	Kids sunscreen SPF 50	zinc oxide	LOTION	TOPICAL	20100101		OTC MONOGRAPH DRUG	M020	thinkOperations,LLC	ZINC OXIDE	200	mg/mL			N	20241231
60781-1003_e256956f-d969-4a13-8cd9-93461ba5a816	60781-1003	HUMAN OTC DRUG	THINKBABY	Baby Sunscreen SPF 50	zinc oxide	LOTION	TOPICAL	20130814		OTC MONOGRAPH DRUG	M020	thinkOperations,LLC	ZINC OXIDE	200	mg/mL			N	20241231
60781-1011_5b0c3d70-8f83-42ce-bec7-ca8f568d8766	60781-1011	HUMAN OTC DRUG	Think Every Day Face	Sunscreen SPF 30	zinc oxide	LOTION	TOPICAL	20200921		OTC MONOGRAPH DRUG	M020	thinkOperations,LLC	ZINC OXIDE	200	mg/mL			N	20241231
60781-2018_9795aef4-0498-4edc-b732-568c7aab0f79	60781-2018	HUMAN OTC DRUG	Thinkbaby	Diaper Rash	zinc oxide	CREAM	TOPICAL	20180101		OTC MONOGRAPH FINAL	part347	thinkOperations,LLC	ZINC OXIDE	140	mg/mL			N	20241231
60781-3001_e9dca96a-458d-45c5-87e0-99c280f53bc9	60781-3001	HUMAN OTC DRUG	Thinksport	Sunscreen SPF 18	zinc oxide	STICK	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	thinkOperations,LLC	ZINC OXIDE	105	ug/g			N	20241231
60781-4280_40bd99ed-1b90-4613-b24e-98478951737d	60781-4280	HUMAN OTC DRUG	Thinksport Clear Zinc	SPF 50	zinc oxide	LOTION	TOPICAL	20220902		OTC MONOGRAPH FINAL	part352	thinkOperations,LLC	ZINC OXIDE	234	mg/g			N	20241231
60781-4698_65ada1aa-ccb0-4fa6-9333-ab9fd11205f9	60781-4698	HUMAN OTC DRUG	Think Aloe and Tea Leaves	Zinc oxide	Zinc Oxide	LOTION	TOPICAL	20220702		OTC MONOGRAPH DRUG	M020	thinkOperations,LLC	ZINC OXIDE	200	mg/mL			N	20241231
60781-4700_683858e6-5fb7-43d8-8ea5-bfd80e575a98	60781-4700	HUMAN OTC DRUG	Think Kids Mineral	SPF 50	Zinc Oxide and Titanium Dioxide	AEROSOL, SPRAY	TOPICAL	20230530		OTC MONOGRAPH FINAL	part352	thinkOperations,LLC	TITANIUM DIOXIDE; ZINC OXIDE	34; 157	mg/mL; mg/mL			N	20241231
60781-4708_30ac40f6-56d4-4059-b030-3e19fa4d7f05	60781-4708	HUMAN OTC DRUG	Thinksport Mineral	SPF 50	zinc oxide and titanium dioxide	AEROSOL	TOPICAL	20230530		OTC MONOGRAPH FINAL	part352	thinkOperations,LLC	TITANIUM DIOXIDE; ZINC OXIDE	34; 157	mg/mL; mg/mL			N	20241231
60793-115_6609f23b-3c51-4d09-9174-089d213740fb	60793-115	HUMAN PRESCRIPTION DRUG	Cytomel		liothyronine sodium	TABLET	ORAL	19560508		NDA	NDA010379	Pfizer Laboratories Div Pfizer Inc	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
60793-116_6609f23b-3c51-4d09-9174-089d213740fb	60793-116	HUMAN PRESCRIPTION DRUG	Cytomel		liothyronine sodium	TABLET	ORAL	19560508		NDA	NDA010379	Pfizer Laboratories Div Pfizer Inc	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
60793-117_6609f23b-3c51-4d09-9174-089d213740fb	60793-117	HUMAN PRESCRIPTION DRUG	Cytomel		liothyronine sodium	TABLET	ORAL	19560508		NDA	NDA010379	Pfizer Laboratories Div Pfizer Inc	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
60793-205_258199dd-a80b-4794-8f8a-8e8c974bf5f1	60793-205	PLASMA DERIVATIVE	THROMBIN-JMI		thrombin, topical (bovine)	KIT		19950224		BLA	BLA102865	Pfizer Laboratories Div Pfizer Inc						N	20241231
60793-215_258199dd-a80b-4794-8f8a-8e8c974bf5f1	60793-215	PLASMA DERIVATIVE	THROMBIN-JMI		thrombin, topical (bovine)	KIT		19950224		BLA	BLA102865	Pfizer Laboratories Div Pfizer Inc						N	20241231
60793-217_258199dd-a80b-4794-8f8a-8e8c974bf5f1	60793-217	PLASMA DERIVATIVE	THROMBIN-JMI		thrombin, topical (bovine)	KIT		19950224		BLA	BLA102865	Pfizer Laboratories Div Pfizer Inc						N	20241231
60793-600_b36e05ec-fd01-415d-a7a6-7ad20db3934d	60793-600	HUMAN PRESCRIPTION DRUG	BICILLIN CR		penicillin G benzathine and penicillin G procaine	INJECTION, SUSPENSION	INTRAMUSCULAR	19530518		NDA	NDA050138	Pfizer Laboratories Div Pfizer Inc	PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE	600000; 600000	[iU]/2mL; [iU]/2mL	Penicillin-class Antibacterial [EPC], Penicillin-class Antibacterial [EPC], Penicillins [CS], Penicillins [CS]		N	20241231
60793-601_b36e05ec-fd01-415d-a7a6-7ad20db3934d	60793-601	HUMAN PRESCRIPTION DRUG	BICILLIN CR		penicillin G benzathine and penicillin G procaine	INJECTION, SUSPENSION	INTRAMUSCULAR	19530518		NDA	NDA050138	Pfizer Laboratories Div Pfizer Inc	PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE	600000; 600000	[iU]/2mL; [iU]/2mL	Penicillin-class Antibacterial [EPC], Penicillin-class Antibacterial [EPC], Penicillins [CS], Penicillins [CS]		N	20241231
60793-602_3728e76d-0129-4400-9c8c-759a4b8bf9f1	60793-602	HUMAN PRESCRIPTION DRUG	BICILLIN C-R 900/300		penicillin G benzathine and penicillin G procaine	INJECTION, SUSPENSION	INTRAMUSCULAR	19530518		NDA	NDA050138	Pfizer Laboratories Div Pfizer Inc	PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE	900000; 300000	[iU]/2mL; [iU]/2mL	Penicillin-class Antibacterial [EPC], Penicillin-class Antibacterial [EPC], Penicillins [CS], Penicillins [CS]		N	20241231
60793-700_f18fde4f-3c9c-47dd-8293-2ae2cbb57536	60793-700	HUMAN PRESCRIPTION DRUG	BICILLIN L-A		penicillin G benzathine	INJECTION, SUSPENSION	INTRAMUSCULAR	19520627		NDA	NDA050141	Pfizer Laboratories Div Pfizer Inc	PENICILLIN G BENZATHINE	600000	[iU]/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
60793-701_f18fde4f-3c9c-47dd-8293-2ae2cbb57536	60793-701	HUMAN PRESCRIPTION DRUG	BICILLIN L-A		penicillin G benzathine	INJECTION, SUSPENSION	INTRAMUSCULAR	19520627		NDA	NDA050141	Pfizer Laboratories Div Pfizer Inc	PENICILLIN G BENZATHINE	1200000	[iU]/2mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
60793-702_f18fde4f-3c9c-47dd-8293-2ae2cbb57536	60793-702	HUMAN PRESCRIPTION DRUG	BICILLIN L-A		penicillin G benzathine	INJECTION, SUSPENSION	INTRAMUSCULAR	19520627		NDA	NDA050141	Pfizer Laboratories Div Pfizer Inc	PENICILLIN G BENZATHINE	2400000	[iU]/4mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
60793-705_258199dd-a80b-4794-8f8a-8e8c974bf5f1	60793-705	PLASMA DERIVATIVE	THROMBIN-JMI		thrombin, topical (bovine)	KIT		19950224		BLA	BLA102865	Pfizer Laboratories Div Pfizer Inc						N	20241231
60793-850_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-850	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-851_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-851	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-852_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-852	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-853_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-853	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-854_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-854	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-855_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-855	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-856_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-856	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-857_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-857	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-858_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-858	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-859_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-859	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60793-860_e230c170-2a16-47d0-bce7-ac0414c192f7	60793-860	HUMAN PRESCRIPTION DRUG	LEVOXYL		levothyroxine sodium	TABLET	ORAL	20010525		NDA	NDA021301	Pfizer Laboratories Div Pfizer Inc	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
60833-001_0cdefca3-f043-a4d0-e063-6294a90a07e7	60833-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20080801		UNAPPROVED MEDICAL GAS		Lakeshore Respiratory Therapy Care Services, SC dba Lakeshore Respiratory Therapy Services, Inc.	OXYGEN	99	L/100L			N	20241231
60842-002_04afe7f9-83ba-4269-a6ce-3bcc61a106d8	60842-002	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride Injection, USP, Auto-Injector		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220228		NDA	NDA215457	Kaleo, Inc.	NALOXONE HYDROCHLORIDE	10	mg/.4mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
60842-021_a5b8e14d-7541-49b5-9759-1fea46623883	60842-021	HUMAN PRESCRIPTION DRUG	Auvi-Q		epinephrine	INJECTION, SOLUTION	INTRAMUSCULAR	20171117		NDA	NDA201739	kaleo, Inc	EPINEPHRINE	.1	mg/.1mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
60842-022_a5b8e14d-7541-49b5-9759-1fea46623883	60842-022	HUMAN PRESCRIPTION DRUG	Auvi-Q		epinephrine	INJECTION, SOLUTION	INTRAMUSCULAR	20121115		NDA	NDA201739	kaleo, Inc	EPINEPHRINE	.15	mg/.15mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
60842-023_a5b8e14d-7541-49b5-9759-1fea46623883	60842-023	HUMAN PRESCRIPTION DRUG	Auvi-Q		epinephrine	INJECTION, SOLUTION	INTRAMUSCULAR	20121115		NDA	NDA201739	kaleo, Inc	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
60846-2383_7f5c448c-f7f2-4494-adba-31e2a0ac3f95	60846-2383	HUMAN PRESCRIPTION DRUG	ZOMIG		zolmitriptan	TABLET, FILM COATED	ORAL	20230109		ANDA	ANDA207867	Amneal Pharmaceuticals LLC	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
60846-2384_7f5c448c-f7f2-4494-adba-31e2a0ac3f95	60846-2384	HUMAN PRESCRIPTION DRUG	ZOMIG		zolmitriptan	TABLET, FILM COATED	ORAL	20230109		ANDA	ANDA207867	Amneal Pharmaceuticals LLC	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
60846-501_9fc3a5a2-754a-4036-a68d-1da2c9d894f6	60846-501	HUMAN PRESCRIPTION DRUG	Pyridium		Phenazopyridine	TABLET, FILM COATED	ORAL	20140101		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
60846-502_9fc3a5a2-754a-4036-a68d-1da2c9d894f6	60846-502	HUMAN PRESCRIPTION DRUG	Pyridium		Phenazopyridine	TABLET, FILM COATED	ORAL	20140101		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
60849-123_09821113-103a-4133-e063-6394a90ac97f	60849-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Carolina Apothecary	OXYGEN	99	L/100L			N	20241231
60854-001_0b5902e8-05ab-ed12-e063-6394a90a96c6	60854-001	HUMAN OTC DRUG	ARNICA DE LA ABUELA		HETEROTHECA INULOIDES CASS, WINTERGREEN, BALSAM OF PERU	OINTMENT	TOPICAL	20160101		OTC MONOGRAPH DRUG	M017	LABORATORIOS BREMER, S.A.	BALSAM PERU; HETEROTHECA INULOIDES FLOWER; METHYL SALICYLATE	.88; .59; 1.48	g/104mL; g/104mL; g/104mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
60867-102_9391d6ad-4552-473e-8a42-26b71846acf4	60867-102	HUMAN OTC DRUG	safeHands		Benzalkonium chloride	LIQUID	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part333A	safeHands Distribution Ne, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
60867-150_58f6efa3-62a0-47b0-b482-38282f1fcbaf	60867-150	HUMAN OTC DRUG	safeHands Hand Sanitizer	Fragrance Free	BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210512		OTC MONOGRAPH NOT FINAL	part333A	Safehands Distribution Ne, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
60867-152_57c3aaf2-be92-4f2f-ac01-be52981e1925	60867-152	HUMAN OTC DRUG	safeHands Hand Sanitizer Clean Linen		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210512		OTC MONOGRAPH NOT FINAL	part333A	Safehands Distribution Ne, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
60875-100_0a22dd5e-4252-4c12-e063-6394a90a056a	60875-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Cammack's Pharmacies, Inc. dba Jim's Pharmacy	OXYGEN	992	mL/L			N	20241231
60892-601_074a329f-19f7-7ce2-e063-6294a90a5ff2	60892-601	HUMAN OTC DRUG	TriLipiderm	Broad Spectrum SPF 30	Butyl Methoxydibenzoylmethane, Ethylhexyl methoxycinnamate, Homosalate, Octocrylene	CREAM	TOPICAL	20140131		OTC MONOGRAPH DRUG	M020	TriLipid Research Institute, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	3; 10; 7.5; 2.7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
60892-602_070ecdfb-d6af-e673-e063-6394a90a6988	60892-602	HUMAN OTC DRUG	TriLipiderm	Protective Day	Homosalate, Ethylhexyl methoxycinnamate,Butyl Methoxydibenzoylmethane, Octocrylene	CREAM	TOPICAL	20181212		OTC MONOGRAPH DRUG	M020	TriLipid Research Institute, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	3; 10; 7.5; 2.7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
60892-605_09d73169-b492-45f7-e063-6394a90a1f48	60892-605	HUMAN OTC DRUG	TRILIPIDERM All-Body Moisture Retention Cream SPF-30		HOMOSALATE, OCTINOXATE, AVOBENZONE, OCTOCRYLENE	CREAM	TOPICAL	20230703		OTC MONOGRAPH DRUG	M020	Trilipid Research Institute, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	30; 100; 75; 27	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
60905-0020_097603dc-229f-2bef-e063-6294a90a1bdd	60905-0020	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT PORCELAIN		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0021_097603dc-22b1-2bef-e063-6294a90a1bdd	60905-0021	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT SHELL		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0022_097603dc-22c3-2bef-e063-6294a90a1bdd	60905-0022	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT SAND		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0023_0975bb48-24ad-e8bd-e063-6394a90ae8d9	60905-0023	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT BEIGE		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0024_0975eb87-fac3-1621-e063-6394a90a9880	60905-0024	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT HONEY		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0025_09762c30-4b62-386f-e063-6394a90a32d4	60905-0025	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT GOLD		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0026_09765c0a-8463-7ab1-e063-6394a90ae10e	60905-0026	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT GINGER		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0027_09762412-1b80-516e-e063-6294a90a6753	60905-0027	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT AMBER		TITANIUM DIOXIDE	LIQUID	TOPICAL	20130214		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0028_09762412-1b92-516e-e063-6294a90a6753	60905-0028	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT BROWN		TITANIUM DIOXIDE	LIQUID	TOPICAL	20140612		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0029_09762c8e-b9a8-ccc3-e063-6294a90aa7a3	60905-0029	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT SIENNA		TITANIUM DIOXIDE	LIQUID	TOPICAL	20140612		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0030_09764ab9-1a51-b42b-e063-6394a90a4a77	60905-0030	HUMAN OTC DRUG	Givenchy TEINT COUTURE Long Wearing Fluid Foundation with Sunscreen Broad Spectrum SPF 20 ELEGANT VANILLA		TITANIUM DIOXIDE	LIQUID	TOPICAL	20140612		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	29.2	mg/mL			N	20241231
60905-0040_09770368-7109-2f7c-e063-6294a90a81ff	60905-0040	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Porcelain		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0041_09772bfd-38cb-4721-e063-6294a90a7190	60905-0041	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Shell		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0042_0976ef49-ece5-1b67-e063-6294a90a4ec6	60905-0042	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Sand		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0043_09770368-7119-2f7c-e063-6294a90a81ff	60905-0043	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Beige		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0044_09772bfd-38e0-4721-e063-6294a90a7190	60905-0044	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Honey		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0045_09773e01-db7d-412c-e063-6394a90aec6d	60905-0045	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Gold		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0046_09773e01-db8d-412c-e063-6394a90aec6d	60905-0046	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Ginger		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0047_09772e4b-8196-3771-e063-6394a90a9516	60905-0047	HUMAN OTC DRUG	Givenchy Blurring Foundation Balm Bare Skin Perfector - Broad Spectrum SPF 15 Nude Amber		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20150325		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	39.96; 21.9	mg/mL; mg/mL			N	20241231
60905-0052_094536f1-3354-aa57-e063-6394a90a606a	60905-0052	HUMAN OTC DRUG	Givenchy PHOTO PERFEXION Fluid Foundation with sunscreen Broad Spectrum SPF 20 Shade 130 Perfect Rose		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20151212		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	29.97; 31.6	mg/mL; mg/mL			N	20241231
60905-0062_09772bfd-3901-4721-e063-6294a90a7190	60905-0062	HUMAN OTC DRUG	PRISME PRIMER Color Correcting Primer SPF 20 PA	Shade 02 ROSE	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20180201		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	40; 23.7	mg/mL; mg/mL			N	20241231
60905-0063_09774fe6-fc16-5067-e063-6394a90a7ee9	60905-0063	HUMAN OTC DRUG	PRISME PRIMER Color Correcting Primer SPF 20 PA	Shade 03 JAUNE	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20180201		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	40; 23.7	mg/mL; mg/mL			N	20241231
60905-0064_09774246-fd5f-5072-e063-6294a90a7c58	60905-0064	HUMAN OTC DRUG	PRISME PRIMER Color Correcting Primer SPF 20 PA	Shade 04 ABRICOT	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20180201		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	40; 23.7	mg/mL; mg/mL			N	20241231
60905-0065_097756da-c08f-4b76-e063-6394a90ae011	60905-0065	HUMAN OTC DRUG	PRISME PRIMER Color Correcting Primer SPF 20 PA	Shade 05 VERT	Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20180201		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	40; 23.7	mg/mL; mg/mL			N	20241231
60905-0600_09775af8-3290-523e-e063-6294a90a52d2	60905-0600	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Porcelain 01		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0601_0977693f-77bd-5fca-e063-6294a90af5bd	60905-0601	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Shell 02		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0602_09774246-fda3-5072-e063-6294a90a7c58	60905-0602	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Sand 03		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0603_097756da-c0b3-4b76-e063-6394a90ae011	60905-0603	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Beige 04		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0604_09774246-fdb3-5072-e063-6294a90a7c58	60905-0604	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Honey 05		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0605_097756da-c0c7-4b76-e063-6394a90ae011	60905-0605	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Gold 06		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0606_0977693f-77cf-5fca-e063-6294a90af5bd	60905-0606	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Ginger 07		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0607_09774246-fdc7-5072-e063-6294a90a7c58	60905-0607	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20 Mat Amber 08		TITANIUM DIOXIDE	CREAM	TOPICAL	20161202		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0610_09773e01-dbc3-412c-e063-6394a90aec6d	60905-0610	HUMAN OTC DRUG	MATISSIME VELVET - Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20	Mat Ivory 00	TITANIUM DIOXIDE	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0611_09773c72-e01d-4a81-e063-6294a90a25d3	60905-0611	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20	Mat Vanilla 3.5	TITANIUM DIOXIDE	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0612_09774246-fdd6-5072-e063-6294a90a7c58	60905-0612	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20	Cinnamon 09	TITANIUM DIOXIDE	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0613_097756da-c0d7-4b76-e063-6394a90ae011	60905-0613	HUMAN OTC DRUG	MATISSIME VELVET Radiant Mat Fluid Foundation with Sunscreen Broad Spectrum SPF 20	Mat Mocha 10	TITANIUM DIOXIDE	CREAM	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	TITANIUM DIOXIDE	31.6	mg/mL			N	20241231
60905-0801_09774fe6-fc3d-5067-e063-6394a90a7ee9	60905-0801	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y100		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0802_09777a9d-2db3-4f87-e063-6294a90ac139	60905-0802	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y105		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0803_097793b9-f7fd-8bf8-e063-6294a90a33be	60905-0803	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y110		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0804_09779b54-e903-8bdf-e063-6294a90aefe3	60905-0804	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P100		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0805_09777a9d-2dc3-4f87-e063-6294a90ac139	60905-0805	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P105		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0806_09779495-c48a-89be-e063-6294a90a021c	60905-0806	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P110		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0807_097793b9-f7ee-8bf8-e063-6294a90a33be	60905-0807	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P115		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0808_097793b9-f7df-8bf8-e063-6294a90a33be	60905-0808	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y200		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0809_097756da-c0f6-4b76-e063-6394a90ae011	60905-0809	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y205		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0810_09777af6-eaad-5ea5-e063-6394a90abeb4	60905-0810	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y210		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0811_097756da-c0e6-4b76-e063-6394a90ae011	60905-0811	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y215		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0812_0977693f-77ee-5fca-e063-6294a90af5bd	60905-0812	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P200		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0813_09776dcf-523a-7099-e063-6294a90a29b5	60905-0813	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P210		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0814_09773c72-e02c-4a81-e063-6294a90a25d3	60905-0814	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y300		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0815_0977693f-77df-5fca-e063-6294a90af5bd	60905-0815	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y305		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0816_09777af6-ea99-5ea5-e063-6394a90abeb4	60905-0816	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y310		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0817_09777a9d-2da0-4f87-e063-6294a90ac139	60905-0817	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y315		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0818_09777af6-ea8a-5ea5-e063-6394a90abeb4	60905-0818	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P300		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0819_09774fe6-fc2b-5067-e063-6394a90a7ee9	60905-0819	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y400		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0820_09773e01-dbb2-412c-e063-6394a90aec6d	60905-0820	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P400		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0821_09773c72-e00a-4a81-e063-6294a90a25d3	60905-0821	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P95		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190620		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0822_0977403a-2127-4389-e063-6394a90a2106	60905-0822	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y325		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190620		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0823_09773c72-dfe2-4a81-e063-6294a90a25d3	60905-0823	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P340		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190620		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0824_09774246-fd4b-5072-e063-6294a90a7c58	60905-0824	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P350		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190620		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0825_09772bfd-38f0-4721-e063-6294a90a7190	60905-0825	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P395		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190620		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0826_09770368-712a-2f7c-e063-6294a90a81ff	60905-0826	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N430		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190620		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0827_09770755-1d9b-11fa-e063-6294a90a17af	60905-0827	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N470		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190620		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0828_09773c72-dff4-4a81-e063-6294a90a25d3	60905-0828	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N365		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190901		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0829_09772e4b-81a7-3771-e063-6394a90a9516	60905-0829	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 P450		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190901		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0830_09773e01-db9e-412c-e063-6394a90aec6d	60905-0830	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N98		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191001		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0831_09774246-fd6f-5072-e063-6294a90a7c58	60905-0831	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 N203		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191001		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0832_09774246-fd80-5072-e063-6294a90a7c58	60905-0832	HUMAN OTC DRUG	TEINT COUTURE EVERWEAR 24h Wear Satin Finish Full Coverage and Comfort Broad Spectrum SPF 20 Y207		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191001		OTC MONOGRAPH DRUG	M020	LVMH FRAGRANCE BRANDS	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0833_097756da-c09f-4b76-e063-6394a90ae011	60905-0833	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	N104	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0834_09774246-fd91-5072-e063-6294a90a7c58	60905-0834	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	C110	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0835_09776dcf-5227-7099-e063-6294a90a29b5	60905-0835	HUMAN OTC DRUG	TEINT COUTURE CITY BALM - Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	N200	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0836_09776dcf-524c-7099-e063-6294a90a29b5	60905-0836	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	C205	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0837_09777a9d-2dd4-4f87-e063-6294a90ac139	60905-0837	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	W208	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0838_09774fe6-fc4f-5067-e063-6394a90a7ee9	60905-0838	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	N300	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0839_09777a9d-2de6-4f87-e063-6294a90ac139	60905-0839	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	C302	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0840_09777af6-eabd-5ea5-e063-6394a90abeb4	60905-0840	HUMAN OTC DRUG	TEINT COUTURE CITY BALM - Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	N312	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0841_0977a9be-c94f-98a1-e063-6294a90a7fbb	60905-0841	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	C345	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0842_09777af6-eace-5ea5-e063-6394a90abeb4	60905-0842	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	N405	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0843_0977b2c6-2cc8-7088-e063-6394a90aa487	60905-0843	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	W480	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0844_097793b9-f80d-8bf8-e063-6294a90a33be	60905-0844	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	N490	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0845_0977b136-9c19-7034-e063-6394a90a5df2	60905-0845	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	W370	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60905-0846_09779b54-e912-8bdf-e063-6294a90aefe3	60905-0846	HUMAN OTC DRUG	TEINT COUTURE CITY BALM Radiant Perfecting Skin Tint 24h Wear Moisturizer Urban Shield SPECTRUM SPF 25	W430	OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	LVMH Fragrance Brands	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
60913-006_0a54c252-6265-a246-e063-6294a90a05bf	60913-006	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20141006		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-007_0a531f5d-51cd-9f12-e063-6394a90ad5fa	60913-007	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20141006		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-008_0a533dba-d9bb-22dd-e063-6294a90aa5aa	60913-008	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20141105		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-009_0a539077-7814-e67a-e063-6294a90afe36	60913-009	HUMAN OTC DRUG	Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20150219		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-010_0a53773d-94a9-d03e-e063-6294a90a5a4d	60913-010	HUMAN OTC DRUG	Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20150226		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-017_0a53773d-94ad-d03e-e063-6294a90a5a4d	60913-017	HUMAN OTC DRUG	Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20150226		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-018_0a531f5d-51cc-9f12-e063-6394a90ad5fa	60913-018	HUMAN OTC DRUG	Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20150226		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-024_0a530917-8379-9465-e063-6294a90ac26f	60913-024	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20220916		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-025_0a54b585-b6e8-8f04-e063-6394a90a3ebc	60913-025	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20220920		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
60913-026_0a578bae-ad18-d812-e063-6394a90a7c88	60913-026	HUMAN OTC DRUG	CareTouch		Ethyl alcohol	CLOTH	TOPICAL	20221221		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ALCOHOL	.62	mL/mL			N	20241231
60913-031_0a54c635-7872-c1e3-e063-6394a90a2381	60913-031	HUMAN OTC DRUG	Sting and Bite		Benzocaine	SWAB	TOPICAL	20150223		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	BENZOCAINE	6	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
60913-038_0a54bdc3-15ae-9ce8-e063-6294a90a9b87	60913-038	HUMAN OTC DRUG	Alcohol Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20230907		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-041_0a537d61-8299-bad8-e063-6394a90acaa4	60913-041	HUMAN OTC DRUG	Alcohol Swab Sticks		Isopropyl Alcohol	SWAB	TOPICAL	20150601		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-051_0a533dba-d9bc-22dd-e063-6294a90aa5aa	60913-051	HUMAN OTC DRUG	Povidone Iodine Prep	Swabstick	Povidone Iodine	SOLUTION	TOPICAL	20150623		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
60913-060_0a54bdc3-15ac-9ce8-e063-6294a90a9b87	60913-060	HUMAN OTC DRUG	BZK Antiseptic	Towelette	Benzalkonium Chloride	SOLUTION	TOPICAL	20150701		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
60913-061_0a54cada-d6b7-c259-e063-6394a90af0a2	60913-061	HUMAN OTC DRUG	Lemon Glycerine	Swabsticks	Glycerine	SWAB	TOPICAL	20150714		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	GLYCERIN	7.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
60913-107_0a530f20-70dc-9350-e063-6294a90a1ce3	60913-107	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20210601		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-206_0a532499-a5fe-a333-e063-6394a90a19fd	60913-206	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20210816		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-207_0a535678-d3c7-c736-e063-6394a90ae334	60913-207	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20210816		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-217_0a530f20-70db-9350-e063-6294a90a1ce3	60913-217	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20211111		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
60913-415_0a53773d-94ac-d03e-e063-6294a90a5a4d	60913-415	HUMAN OTC DRUG	Hand Sanitizing Wipes		Ethyl alcohol	CLOTH	TOPICAL	20190806		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	ALCOHOL	.62	mL/mL			N	20241231
60913-416_0a52f20a-03d0-68a5-e063-6294a90a8687	60913-416	HUMAN OTC DRUG	Hand Sanitizing Wipes		ETHYL ALCOHOL	SWAB	TOPICAL	20210816		OTC MONOGRAPH DRUG	M003	Phoenix Healthcare Solutions LLC	ALCOHOL	.62	mL/mL			N	20241231
60913-999_0a531330-b388-79fa-e063-6394a90a5d55	60913-999	HUMAN OTC DRUG	Povidone Iodine Prep		Povidone Iodine	SWAB	TOPICAL	20150226		OTC MONOGRAPH DRUG	M003	PHOENIX HEALTHCARE SOLUTIONS, LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
60923-227_a4d98633-0944-4695-bd01-e57ee24df69b	60923-227	HUMAN PRESCRIPTION DRUG	AMONDYS 45		casimersen	INJECTION	INTRAVENOUS	20210225		NDA	NDA213026	Sarepta Therapeutics, Inc.	CASIMERSEN	50	mg/mL	Antisense Oligonucleotide [EPC], Increased Protein Synthesis [PE], Oligonucleotides, Antisense [CS]		N	20241231
60923-284_bc7aae14-1ae0-4b09-b42a-c3f5a9c7ce11	60923-284	HUMAN PRESCRIPTION DRUG	Exondys 51		eteplirsen	INJECTION	INTRAVENOUS	20160919		NDA	NDA206488	Sarepta Therapeutics, Inc.	ETEPLIRSEN	50	mg/mL	Antisense Oligonucleotide [EPC], Oligonucleotides, Antisense [CS]		N	20241231
60923-363_bc7aae14-1ae0-4b09-b42a-c3f5a9c7ce11	60923-363	HUMAN PRESCRIPTION DRUG	Exondys 51		eteplirsen	INJECTION	INTRAVENOUS	20160919		NDA	NDA206488	Sarepta Therapeutics, Inc.	ETEPLIRSEN	50	mg/mL	Antisense Oligonucleotide [EPC], Oligonucleotides, Antisense [CS]		N	20241231
60923-465_556ca30e-9f7f-478a-9ab7-281e2069f059	60923-465	HUMAN PRESCRIPTION DRUG	Vyondys 53		golodirsen	INJECTION	INTRAVENOUS	20191212		NDA	NDA211970	Sarepta Therapeutics, Inc.	GOLODIRSEN	50	mg/mL			N	20241231
60923-501_80df21b6-b985-4b52-af98-e4da9506954a	60923-501	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-502_80df21b6-b985-4b52-af98-e4da9506954a	60923-502	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-503_80df21b6-b985-4b52-af98-e4da9506954a	60923-503	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-504_80df21b6-b985-4b52-af98-e4da9506954a	60923-504	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-505_80df21b6-b985-4b52-af98-e4da9506954a	60923-505	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-506_80df21b6-b985-4b52-af98-e4da9506954a	60923-506	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-507_80df21b6-b985-4b52-af98-e4da9506954a	60923-507	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-508_80df21b6-b985-4b52-af98-e4da9506954a	60923-508	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-509_80df21b6-b985-4b52-af98-e4da9506954a	60923-509	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-510_80df21b6-b985-4b52-af98-e4da9506954a	60923-510	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-511_80df21b6-b985-4b52-af98-e4da9506954a	60923-511	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-512_80df21b6-b985-4b52-af98-e4da9506954a	60923-512	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-513_80df21b6-b985-4b52-af98-e4da9506954a	60923-513	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-514_80df21b6-b985-4b52-af98-e4da9506954a	60923-514	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-515_80df21b6-b985-4b52-af98-e4da9506954a	60923-515	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-516_80df21b6-b985-4b52-af98-e4da9506954a	60923-516	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-517_80df21b6-b985-4b52-af98-e4da9506954a	60923-517	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-518_80df21b6-b985-4b52-af98-e4da9506954a	60923-518	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-519_80df21b6-b985-4b52-af98-e4da9506954a	60923-519	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-520_80df21b6-b985-4b52-af98-e4da9506954a	60923-520	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-521_80df21b6-b985-4b52-af98-e4da9506954a	60923-521	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-522_80df21b6-b985-4b52-af98-e4da9506954a	60923-522	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-523_80df21b6-b985-4b52-af98-e4da9506954a	60923-523	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-524_80df21b6-b985-4b52-af98-e4da9506954a	60923-524	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-525_80df21b6-b985-4b52-af98-e4da9506954a	60923-525	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-526_80df21b6-b985-4b52-af98-e4da9506954a	60923-526	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-527_80df21b6-b985-4b52-af98-e4da9506954a	60923-527	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-528_80df21b6-b985-4b52-af98-e4da9506954a	60923-528	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-529_80df21b6-b985-4b52-af98-e4da9506954a	60923-529	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-530_80df21b6-b985-4b52-af98-e4da9506954a	60923-530	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-531_80df21b6-b985-4b52-af98-e4da9506954a	60923-531	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-532_80df21b6-b985-4b52-af98-e4da9506954a	60923-532	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-533_80df21b6-b985-4b52-af98-e4da9506954a	60923-533	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-534_80df21b6-b985-4b52-af98-e4da9506954a	60923-534	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-535_80df21b6-b985-4b52-af98-e4da9506954a	60923-535	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-536_80df21b6-b985-4b52-af98-e4da9506954a	60923-536	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-537_80df21b6-b985-4b52-af98-e4da9506954a	60923-537	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-538_80df21b6-b985-4b52-af98-e4da9506954a	60923-538	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-539_80df21b6-b985-4b52-af98-e4da9506954a	60923-539	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-540_80df21b6-b985-4b52-af98-e4da9506954a	60923-540	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-541_80df21b6-b985-4b52-af98-e4da9506954a	60923-541	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-542_80df21b6-b985-4b52-af98-e4da9506954a	60923-542	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-543_80df21b6-b985-4b52-af98-e4da9506954a	60923-543	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-544_80df21b6-b985-4b52-af98-e4da9506954a	60923-544	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-545_80df21b6-b985-4b52-af98-e4da9506954a	60923-545	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-546_80df21b6-b985-4b52-af98-e4da9506954a	60923-546	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-547_80df21b6-b985-4b52-af98-e4da9506954a	60923-547	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-548_80df21b6-b985-4b52-af98-e4da9506954a	60923-548	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-549_80df21b6-b985-4b52-af98-e4da9506954a	60923-549	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-550_80df21b6-b985-4b52-af98-e4da9506954a	60923-550	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-551_80df21b6-b985-4b52-af98-e4da9506954a	60923-551	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-552_80df21b6-b985-4b52-af98-e4da9506954a	60923-552	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-553_80df21b6-b985-4b52-af98-e4da9506954a	60923-553	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-554_80df21b6-b985-4b52-af98-e4da9506954a	60923-554	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-555_80df21b6-b985-4b52-af98-e4da9506954a	60923-555	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-556_80df21b6-b985-4b52-af98-e4da9506954a	60923-556	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-557_80df21b6-b985-4b52-af98-e4da9506954a	60923-557	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-558_80df21b6-b985-4b52-af98-e4da9506954a	60923-558	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-559_80df21b6-b985-4b52-af98-e4da9506954a	60923-559	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-560_80df21b6-b985-4b52-af98-e4da9506954a	60923-560	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60923-561_80df21b6-b985-4b52-af98-e4da9506954a	60923-561	HUMAN PRESCRIPTION DRUG	ELEVIDYS		delandistrogene moxeparvovec-rokl	KIT	INTRAVENOUS	20230622		BLA	BLA125781	Sarepta Therapeutics, Inc.						N	20241231
60933-018_08c02640-add8-7579-e063-6294a90a30fe	60933-018	HUMAN OTC DRUG	Simple Hygiene Alcohol Free Foam Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	FULLER INDUSTRIES, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
60933-050_08c081f1-aa70-988c-e063-6394a90ab87a	60933-050	HUMAN OTC DRUG	CleanGenic Antibacterial Foam Hand		CHLOROXYLENOL	SOAP	TOPICAL	20220117		OTC MONOGRAPH DRUG	505G(a)(3)	Fuller Industries, Inc	CHLOROXYLENOL	5	mg/.001L			N	20241231
60933-056_08c00442-1f05-3715-e063-6294a90a4891	60933-056	HUMAN OTC DRUG	Franklin cleaning technology antibacterial hand		CHLOROXYLENOL	LIQUID	TOPICAL	20230428		OTC MONOGRAPH DRUG	505G(a)(3)	Fuller Industries, Inc	CHLOROXYLENOL	3	mg/mL			N	20241231
60933-062_08c02640-ade8-7579-e063-6294a90a30fe	60933-062	HUMAN OTC DRUG	Simple Hygiene foaming hand Sanitizer 62		ALCOHOL	LIQUID	TOPICAL	20200520		OTC MONOGRAPH DRUG	505G(a)(3)	FULLER INDUSTRIES, INC	ALCOHOL	.62	mL/mL			N	20241231
60933-106_08bff442-7d29-56d5-e063-6394a90a6477	60933-106	HUMAN OTC DRUG	Simple Hygiene Antibacterial Foam Hand		CHLOROXYLENOL	SOAP	TOPICAL	20220201		OTC MONOGRAPH DRUG	505G(a)(3)	Fuller Industries, LLC	CHLOROXYLENOL	5	mg/mL			N	20241231
60933-200_08c07ef8-6cc8-bd48-e063-6294a90a51b9	60933-200	HUMAN OTC DRUG	Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	AEROSOL, FOAM	TOPICAL	20170901		OTC MONOGRAPH DRUG	505G(a)(3)	FULLER INDUSTRIES, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
60933-210_08c07ef8-6cd5-bd48-e063-6294a90a51b9	60933-210	HUMAN OTC DRUG	Simple Hygiene Antibacterial Hand		CHLOROXYLENOL	AEROSOL, FOAM	TOPICAL	20170901		OTC MONOGRAPH DRUG	505G(a)(3)	FULLER INDUSTRIES, INC	CHLOROXYLENOL	5	mg/mL			N	20241231
60933-220_08c081f1-aa55-988c-e063-6394a90ab87a	60933-220	HUMAN OTC DRUG	Simple Hygiene Hand Sanitizer		ALCOHOL	AEROSOL, FOAM	TOPICAL	20170901		OTC MONOGRAPH DRUG	505G(a)(3)	FULLER INDUSTRIES, INC	ALCOHOL	620	mg/mL			N	20241231
60934-002_0c0ec51d-1cf2-a16d-e063-6294a90afd94	60934-002	HUMAN OTC DRUG	Spot Correction		SULFUR	CREAM	TOPICAL	20170111		OTC MONOGRAPH DRUG	M006	HydroPeptide LLC	SULFUR	30	mg/mL			N	20241231
60934-003_0c0e9c0d-61e0-e63b-e063-6294a90ac0d9	60934-003	HUMAN OTC DRUG	Solar Defense Non Tinted		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170111		OTC MONOGRAPH DRUG	M020	HydroPeptide LLC	TITANIUM DIOXIDE; ZINC OXIDE	30; 70	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60934-004_0c0ea0e9-50dd-e63d-e063-6294a90a0a93	60934-004	HUMAN OTC DRUG	Solar Defense Body		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20170112		OTC MONOGRAPH DRUG	M020	HydroPeptide LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
60934-005_0c0e9512-2d15-e1ff-e063-6294a90aea1a	60934-005	HUMAN OTC DRUG	Solar Defense Tinted		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170111		OTC MONOGRAPH DRUG	M020	HydroPeptide LLC	TITANIUM DIOXIDE; ZINC OXIDE	25; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60934-010_0c83bd92-3b18-bc7b-e063-6294a90afa19	60934-010	HUMAN OTC DRUG	HydroPeptide S.P.F. Sun Protection Friends		TITANIUM DIOXIDE, ZINC OXIDE	KIT		20210101		OTC MONOGRAPH DRUG	M020	HydroPeptide LLC						N	20241231
60934-011_ce9d9647-0817-1467-e053-2995a90aede2	60934-011	HUMAN OTC DRUG	HydroPeptide Solar Defense Hand Guard		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	HydroPeptide LLC	TITANIUM DIOXIDE; ZINC OXIDE	12.5; 25	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60934-013_0c83cb14-c7b2-3b79-e063-6394a90a4d77	60934-013	HUMAN OTC DRUG	HydroPeptide Solar Defense Mineral		ZINC OXIDE	CREAM	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	HydroPeptide LLC	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
60951-602_cd5483ae-0af6-459c-a134-d8c0aecff46c	60951-602	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20000526		ANDA	ANDA040330	Par Pharmaceutical, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60951-700_cd5483ae-0af6-459c-a134-d8c0aecff46c	60951-700	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20030306		ANDA	ANDA040330	Par Pharmaceutical, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60951-701_cd5483ae-0af6-459c-a134-d8c0aecff46c	60951-701	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20030306		ANDA	ANDA040330	Par Pharmaceutical, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60951-712_cd5483ae-0af6-459c-a134-d8c0aecff46c	60951-712	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20030306		ANDA	ANDA040330	Par Pharmaceutical, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
60954-001_88900fb4-bb29-2736-e053-2995a90a9dda	60954-001	HUMAN OTC DRUG	Muscular Balm		Capsaicin Menthol Methyl Salicylate	OINTMENT	TOPICAL	20100514		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma, PT	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.15; 13.5; 30	g/100g; g/100g; g/100g			N	20241231
60954-002_da33ffbe-b4a9-5420-e053-2a95a90a22db	60954-002	HUMAN OTC DRUG	Eagle	Medicated	Menthol Methyl Salicylate	OIL	TOPICAL	20220304		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma, PT	MENTHOL; METHYL SALICYLATE	14.5; 30	g/100mL; g/100mL			N	20241231
60954-003_04c18209-3e3e-c283-e063-6394a90ac917	60954-003	HUMAN OTC DRUG	Geliga	Muscular Balm	menthol, methyl salicylate	OINTMENT	TOPICAL	20230703		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma, PT	MENTHOL; METHYL SALICYLATE	13.5; 29.95	g/100g; g/100g			N	20241231
60954-004_04c0b2b7-c7ab-12c2-e063-6394a90a3acf	60954-004	HUMAN OTC DRUG	Geliga	Muscular	menthol, methyl salicylate	CREAM	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma, PT	MENTHOL; METHYL SALICYLATE	3; 10	g/100g; g/100g			N	20241231
60954-005_e272d1ce-30af-815f-e053-2a95a90aeb8b	60954-005	HUMAN OTC DRUG	Eagle Medicated Oil	Refreshing	Menthol, Methyl Salicylate	OIL	TOPICAL	20220620		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma, PT	MENTHOL; METHYL SALICYLATE	14; 15	g/100mL; g/100mL			N	20241231
60954-007_e272f955-1264-f8b8-e053-2a95a90a2aaf	60954-007	HUMAN OTC DRUG	Eagle	Medicated Aromatic	Camphor Menthol Methyl Salicylate	OIL	TOPICAL	20220620		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma, PT	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	7; 16; 35	g/100mL; g/100mL; g/100mL			N	20241231
60954-008_e2c5efb9-ee9e-9d68-e053-2a95a90ab128	60954-008	HUMAN OTC DRUG	Eagle	Medicated	Menthol Methyl Salicylate	OIL	TOPICAL	20120620		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma	MENTHOL; METHYL SALICYLATE	14.5; 30	g/100mL; g/100mL			N	20241231
60954-010_c8453b30-7103-5731-e053-2995a90a8eb6	60954-010	HUMAN OTC DRUG	Eagle Balm		Camphor Menthol	OINTMENT	TOPICAL	20190415		OTC MONOGRAPH NOT FINAL	part348	Eagle Indo Pharma, PT	CAMPHOR (SYNTHETIC); MENTHOL	11; 15	g/100g; g/100g			N	20241231
60954-012_09235f26-2263-6ca2-e063-6394a90ad8f1	60954-012	HUMAN OTC DRUG	Eagle Brand	Medicated Roll On Refresh	camphor, menthol	OIL	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	PT. EAGLE INDO PHARMA	CAMPHOR (SYNTHETIC); MENTHOL	2.2; 14	g/100mL; g/100mL			N	20251231
60954-013_09260c31-56a4-07aa-e063-6394a90a95fd	60954-013	HUMAN OTC DRUG	Eagle Brand	Medicated Oil Refresh	camphor, menthol	OIL	TOPICAL	20231102		OTC MONOGRAPH DRUG	M017	PT. EAGLE INDO PHARMA	CAMPHOR (SYNTHETIC); MENTHOL	2.2; 14	g/100mL; g/100mL			N	20251231
60954-200_0822bcde-a8ae-be95-e063-6294a90ad208	60954-200	HUMAN OTC DRUG	Eagle Brand	Muscular Balm	menthol, methyl salicylate	OINTMENT	TOPICAL	20150514		OTC MONOGRAPH DRUG	M017	PT. EAGLE INDO PHARMA	MENTHOL; METHYL SALICYLATE	13.5; 29.95	g/100g; g/100g			N	20241231
60954-201_0ebcb864-66e2-f55c-e063-6394a90aa40a	60954-201	HUMAN OTC DRUG	Eagle Brand	Eagle Balm	camphor, menthol	OINTMENT	TOPICAL	20231204		OTC MONOGRAPH DRUG	M017	PT. EAGLE INDO PHARMA	CAMPHOR (SYNTHETIC); MENTHOL	4; 15.5	g/100g; g/100g			N	20251231
60977-141_a677d997-e5d4-418c-8a32-32692b30988d	60977-141	HUMAN PRESCRIPTION DRUG	Protopam Chloride		pralidoxime chloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19650310		NDA	NDA014134	Baxter Healthcare Corporation	PRALIDOXIME CHLORIDE	1	g/20mL	Cholinesterase Reactivator [EPC], Cholinesterase Reactivators [MoA]		N	20241231
60977-145_3611913b-b54f-4f60-a738-4f650400ccff	60977-145	HUMAN PRESCRIPTION DRUG	DAPZURA RT		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220125		NDA	NDA213645	Baxter Healthcare Corporation	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
60980-002_0802489a-380e-cc8b-e063-6294a90a9b4e	60980-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030101		NDA	NDA205865	Indian River Oxygen, Inc.	OXYGEN	998	mL/L			N	20241231
60986-1003_d2bff30e-76c3-bd97-e053-2995a90ac97a	60986-1003	HUMAN OTC DRUG	Allernest		Formicum acidum, Lachesis mutus, luffa Operculata. Petroleum, Rhus Toxicodebdron, Aralai racemosa,Galphimia glauca, thuja occidentalis, Urtica dicica and Cardiospermum	LIQUID	ORAL	20111118		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ARALIA RACEMOSA ROOT; CARDIOSPERMUM HALICACABUM FLOWERING TOP; FORMIC ACID; GALPHIMIA GLAUCA FLOWERING TOP; KEROSENE; LACHESIS MUTA VENOM; LUFFA OPERCULATA FRUIT; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF; URTICA DIOICA	4; 3; 12; 4; 6; 8; 6; 4; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
60986-1004_d2c035dd-f90d-29ad-e053-2a95a90a3380	60986-1004	HUMAN OTC DRUG	Lymphonest		Echinacea augustifolia, Scrophularia nodosa, Abrotanum, Petroleum, Aloe socotrina, Mercurius solubilis, Crotalus horiidus, Thuja occidentalis, Lachesis mutus, Aristolochia clematitis	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ALOE; ARISTOLOCHIA CLEMATITIS ROOT; ARTEMISIA ABROTANUM FLOWERING TOP; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; KEROSENE; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; SCROPHULARIA NODOSA; THUJA OCCIDENTALIS LEAFY TWIG	1; 6; 3; 10; 1; 3; 8; 12; 1; 10	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-1008_d2bfd2b8-d3b7-e3bf-e053-2995a90a2901	60986-1008	HUMAN OTC DRUG	Cholenest		Rhamnus purshiana, Carduus marianus, Taraxacum officinale, Chelidonium majus, Leptandra virginica, Myrica cerifera, Berberis vulgaris, Natrum sulphuricum, Magnesia phosphorica, Cuprum metallicum	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; COPPER; FRANGULA PURSHIANA BARK; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MORELLA CERIFERA ROOT BARK; SILYBUM MARIANUM SEED; SODIUM SULFATE; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT	2; 1; 8; 1; 8; 2; 1; 6; 1; 2	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
60986-1009_d2beb390-9a0c-0dfb-e053-2995a90ad31d	60986-1009	HUMAN OTC DRUG	Sabal Serrulatum		Sabal serulatum, Lycopodium clavatum, Pareira brava	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	CHONDRODENDRON TOMENTOSUM ROOT; LYCOPODIUM CLAVATUM SPORE; SAW PALMETTO	4; 4; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-1011_d2be879f-8cb9-56a9-e053-2a95a90a3c9f	60986-1011	HUMAN OTC DRUG	Rubus		Rubus Fruticosus, Iris Germanica, Vaccinium Myrtillus, Syzygium Jambolanum, Okoubaka Aubrevillei	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	BILBERRY; BLACKBERRY; IRIS X GERMANICA ROOT; OKOUBAKA AUBREVILLEI BARK; SYZYGIUM CUMINI SEED	3; 2; 4; 6; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-1014_0bdffebb-52e0-ba99-e063-6394a90ac071	60986-1014	HUMAN OTC DRUG	Contessa		Alchemilla Vulgaris, Asperula Odorata, Chamomilla, Viola Odorata, Cinchona Officinalis, Mentha Piperita, Rosmarinus Officinalis, Valeriana Officinalis, Helonia Dioica, Agnus Castus, Ambra Grisea, Cimicifuga Racemosa, Convallaria Majalis, Crocus Sativus, Cyclamen Europaeum, Damiana, Hydrastis Canadensis, Caulophyllum Thalictroides, Lilium Tigrinum, Senecio Aureus, Staphysagria, Naja Tripudians	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ALCHEMILLA XANTHOCHLORA FLOWERING TOP; AMBERGRIS; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; CONVALLARIA MAJALIS; CYCLAMEN PURPURASCENS TUBER; DELPHINIUM STAPHISAGRIA SEED; GALIUM ODORATUM; GOLDENSEAL; LILIUM LANCIFOLIUM FLOWERING TOP; MATRICARIA RECUTITA; MENTHA PIPERITA; NAJA NAJA VENOM; PACKERA AUREA; ROSMARINUS OFFICINALIS FLOWERING TOP; SAFFRON; TURNERA DIFFUSA LEAFY TWIG; VALERIAN; VIOLA ODORATA	1; 3; 3; 4; 2; 3; 2; 3; 3; 4; 1; 3; 4; 1; 1; 8; 4; 1; 3; 3; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-1015_0be0cc34-ec75-b6b7-e063-6294a90aadfc	60986-1015	HUMAN OTC DRUG	HYDRASTIS		hydrastis canadensis, lycopodium clavatum, ephedra vulgaris, mezereum, petroleum, pulsatilla, thuja occidentalis	SPRAY	NASAL	20230102		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC	DAPHNE MEZEREUM BARK; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; KEROSENE; LYCOPODIUM CLAVATUM SPORE; PULSATILLA VULGARIS; THUJA OCCIDENTALIS LEAFY TWIG	3; 3; 4; 8; 3; 3; 10	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-1019_d2bf5b96-6ae5-93a3-e053-2995a90a7a34	60986-1019	HUMAN OTC DRUG	Lithium		Lithium Bromatum	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	LITHIUM BROMIDE	3	[hp_X]/mL	Mood Stabilizer [EPC]		N	20241231
60986-1020_d2bee4a0-08d1-e818-e053-2995a90ac0ed	60986-1020	HUMAN OTC DRUG	Solidago		Solidago Virgaurea, Uva-Ursi, Pareira Brava, Sabal Serrulata, Populus Tremuloides, Staphysagria, Cantharis, Terebinthia, Borax	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ARCTOSTAPHYLOS UVA-URSI LEAF; CHONDRODENDRON TOMENTOSUM ROOT; DELPHINIUM STAPHISAGRIA SEED; LARIX DECIDUA RESIN; LYTTA VESICATORIA; POPULUS TREMULOIDES BARK; SAW PALMETTO; SODIUM BORATE; SOLIDAGO VIRGAUREA FLOWERING TOP	1; 3; 3; 6; 4; 2; 1; 8; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
60986-1027_d2c00402-4ffc-a314-e053-2a95a90acc05	60986-1027	HUMAN OTC DRUG	Aesculus		Potentilla Anserina, Aesculus Hippocastanum, Ustilago Maidis, Secale Cornutum, Ruta Graveolens	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ARGENTINA ANSERINA FLOWERING TOP; CLAVICEPS PURPUREA SCLEROTIUM; HORSE CHESTNUT; RUTA GRAVEOLENS WHOLE; USTILAGO MAYDIS	1; 4; 1; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
60986-1028_dd1e5aa6-a476-edca-e053-2995a90acca8	60986-1028	HUMAN PRESCRIPTION DRUG	CACTUS		Crataegus laevigata, Cactus grandiflorus, convallaria majalis, camphor, kalmia latifolia, spigelia anthelmia, Lachesis mutus, Arnica montana, tabacum, glonoinum	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ARNICA MONTANA; CAMPHOR (NATURAL); CONVALLARIA MAJALIS; CRATAEGUS LAEVIGATA WHOLE; KALMIA LATIFOLIA LEAF; LACHESIS MUTA VENOM; NITROGLYCERIN; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA; TOBACCO LEAF	6; 2; 3; 1; 4; 8; 8; 2; 4; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vasodilation [PE]		N	20241231
60986-1030_ffec5f0c-d6cb-14ac-e053-6394a90a5d99	60986-1030	HUMAN OTC DRUG	LYCOPUS		LYCOPUS VIRGINICUS, SPONGIA TOSTA, LOPHOPHYTUM LEANDRII, CHININUM ARSENICOSUM, CALCAREA PHOSPHORICA, MAGNESIA PHOSPHORICA	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	LOPHOPHYTUM LEANDRII; LYCOPUS VIRGINICUS; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; QUININE ARSENITE; SPONGIA OFFICINALIS SKELETON, ROASTED; TRIBASIC CALCIUM PHOSPHATE	6; 1; 8; 6; 1; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
60986-1032_e1711c08-0dfd-6267-e053-2a95a90a1cd7	60986-1032	HUMAN OTC DRUG	Polygonum		Polygonum Aviculare, Acorus Calamus, Rhus Toxicodendron, Gnaphalium Polycephalum, Rhododendron Chrysanthum, Colocynthis, Colchicum Autumnale, Kali Iodatum, Ichthyolum, Symphytum Officinale	LIQUID	ORAL	20220614		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ACORUS CALAMUS WHOLE; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; ICHTHAMMOL; POLYGONUM AVICULARE TOP; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	1; 3; 3; 6; 3; 1; 4; 2; 3; 4	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-1033_0be0dbd9-2ee9-e6d4-e063-6294a90aad61	60986-1033	HUMAN OTC DRUG	Female Tonic		Alchemilla Vulgaris, Asperula Odorata, Chamomilla, Viola Odorata, Cinchona Officinalis, Mentha Piperita, Rosmarinus Officinalis, Valeriana Officinalis, Helonia Dioica, Agnus Castus, Cimicifuga Racemosa, Convallaria Majalis, Crocus Sativus, Cyclamen Europaeum, Damiana, Hydrastis Canadensis, Caulophyllum Thalictroides, Lilium Tigrinum, Senecio Aureus, Staphysagria, Naja Tripudians	LIQUID	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	ALCHEMILLA XANTHOCHLORA FLOWERING TOP; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; CHAMAELIRIUM LUTEUM ROOT; CHASTE TREE; CINCHONA OFFICINALIS BARK; CONVALLARIA MAJALIS; CYCLAMEN PURPURASCENS TUBER; DELPHINIUM STAPHISAGRIA SEED; GALIUM ODORATUM; GOLDENSEAL; LILIUM LANCIFOLIUM FLOWERING TOP; MATRICARIA RECUTITA; MENTHA PIPERITA; NAJA NAJA VENOM; PACKERA AUREA; ROSMARINUS OFFICINALIS FLOWERING TOP; SAFFRON; TURNERA DIFFUSA LEAFY TWIG; VALERIAN; VIOLA ODORATA	1; 3; 4; 2; 3; 2; 3; 3; 4; 1; 3; 4; 1; 1; 8; 4; 1; 3; 3; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-1040_0be0dbd9-2eea-e6d4-e063-6294a90aad61	60986-1040	HUMAN OTC DRUG	Acusine		Hydrastis Canadensis, Lycopodium Clavatum, Ephedra Vulgaris, Mezereum, Petroleum, Pulsatilla, Thuja Occidentalis	SPRAY	NASAL	20211224		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC	DAPHNE MEZEREUM BARK; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; KEROSENE; LYCOPODIUM CLAVATUM SPORE; PULSATILLA VULGARIS; THUJA OCCIDENTALIS LEAFY TWIG	3; 3; 4; 8; 3; 3; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
60986-2020_dca2a913-bd6b-eae2-e053-2995a90ac61f	60986-2020	HUMAN OTC DRUG	ECHINACEA		ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS	TABLET, ORALLY DISINTEGRATING	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; FUCUS VESICULOSUS; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POLYGALA SENEGA ROOT; SILICON DIOXIDE; SODIUM TETRACHLOROAURATE; TRIBASIC CALCIUM PHOSPHATE	4; 1; 5; 4; 2; 8; 5; 4; 4; 5; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
60986-2025_dd1d4f7c-d47a-2aa6-e053-2a95a90a238a	60986-2025	HUMAN OTC DRUG	Luffa		Luffa, Hydrastis Canadensis, Mercurius Sulph. Rub, Allium Cepa, Natrum Muriticum, Phosphorus, Eupatorium Perf, Sticta	TABLET, ORALLY DISINTEGRATING	ORAL	19920301		UNAPPROVED HOMEOPATHIC		Marco Pharma International LLC.	EUPATORIUM PERFOLIATUM FLOWERING TOP; GOLDENSEAL; LOBARIA PULMONARIA; LUFFA ACUTANGULA FRUIT; MERCURIC SULFIDE; ONION; PHOSPHORUS; SODIUM CHLORIDE	5; 4; 2; 6; 4; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
60986-2030_d2bcc010-0beb-afe7-e053-2a95a90a4a0b	60986-2030	HUMAN OTC DRUG	ABB		ACONITUM NAPELLUS, BRYONIA ALBA, BELLADONNA	LIQUID	ORAL	20150122		UNAPPROVED HOMEOPATHIC		MARCO PHARMA INTERNATIONAL LLC	ACONITUM NAPELLUS; BELLADONNA LEAF; BRYONIA ALBA WHOLE	3; 3; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
60986-2035_d2bd2918-7621-070e-e053-2995a90a4ee3	60986-2035	HUMAN OTC DRUG	ABC		ACONITUM NAPELLUS, BELLADONNA, CHAMOMILLA	LIQUID	ORAL	20150122		UNAPPROVED HOMEOPATHIC		MARCO PHARMA INTERNATIONAL LLC	ACONITUM NAPELLUS; BELLADONNA LEAF; MATRICARIA RECUTITA	3; 3; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
61010-2017_c6888728-7159-406d-ac79-1f51c69699e4	61010-2017	HUMAN OTC DRUG	Antiseptic		alcohol	CLOTH	TOPICAL	20170501		OTC MONOGRAPH NOT FINAL	part333E	Safetec of America, Inc.	ALCOHOL	665	mL/L			N	20241231
61010-5111_d6138e2e-98eb-4fc7-bea2-600dcc8a4f57	61010-5111	HUMAN OTC DRUG	Instant Hand Sanitizer		alcohol	GEL	TOPICAL	20130807		OTC MONOGRAPH NOT FINAL	part333E	Safetec of America, Inc.	ALCOHOL	665	mg/L			N	20241231
61010-5400_1abe5da8-6f91-4fb6-bc8f-8e618e68a5db	61010-5400	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SPRAY	TOPICAL	20120216		OTC MONOGRAPH NOT FINAL	part333A	Safetec of America, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
61010-6103_f2d4968d-3ae7-43f5-a9d4-93b38c7f6463	61010-6103	HUMAN OTC DRUG	Sunscreen		Homosalate, Octinoxate, Octisalate, Oxybenzone	LOTION	TOPICAL	20070313		OTC MONOGRAPH NOT FINAL	part352	Safetec of America, Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	6; 7.5; 5; 5	mg/g; mg/g; mg/g; mg/g			N	20241231
61010-8100_0444088e-5d06-41ce-9504-d3c5cc719b4f	61010-8100	HUMAN OTC DRUG	Pain Relief		benzocaine	LIQUID	TOPICAL	20100501		OTC MONOGRAPH NOT FINAL	part356	Safetec of America, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
61010-8201_86c6172a-9af2-4c13-afe8-c1b84a54093d	61010-8201	HUMAN OTC DRUG	Analgesic		menthol	SPRAY	TOPICAL	20180901		OTC MONOGRAPH NOT FINAL	part348	Safetec of America, Inc.	MENTHOL	70	mg/L			N	20241231
61010-8202_a4cdd5eb-fbda-4f99-b737-452a1487adfd	61010-8202	HUMAN OTC DRUG	Analgesic		menthol	GEL	TOPICAL	20180901		OTC MONOGRAPH NOT FINAL	part348	Safetec of America, Inc.	MENTHOL	70	mg/L			N	20241231
61012-740_d43a540b-bea6-2055-e053-2995a90a25fb	61012-740	HUMAN OTC DRUG	Cantu Guava Ginger Anti Dandruff		Salicylic Acid	SHAMPOO	TOPICAL	20211228		OTC MONOGRAPH FINAL	part358H	PDC Brands	SALICYLIC ACID	.03	g/mL			N	20241231
61037-414_f0b7b337-be39-2e5f-e053-2995a90a3c8c	61037-414	HUMAN OTC DRUG	Chlorhexidine Gluconate Solution 0.75% Antiseptic		Chlorhexidine Gluconate Solution 0.75% Antiseptic	SOLUTION	TOPICAL	20140930		NDA	NDA020111	Bajaj Medical, LLC	CHLORHEXIDINE GLUCONATE	.75	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
61037-446_f0b7ae90-a7e0-3787-e053-2995a90a8120	61037-446	HUMAN OTC DRUG	Hand Sanitizer Gel		ETHYL ALCOHOL	GEL	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333E	Bajaj Medical, LLC	ALCOHOL	.7	mL/mL			N	20241231
61037-469_0dfd551e-3e6f-769f-e063-6294a90ad610	61037-469	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate, 0.12% Oral Rinse Solution		Chlorhexidine Gluconate, 0.12% Oral Rinse Solution	SOLUTION	DENTAL	20211117		ANDA	ANDA075561	Bajaj Medical, LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20251231
61037-471_f0b79991-a87f-2b4b-e053-2995a90a8690	61037-471	HUMAN PRESCRIPTION DRUG	Lactulose Solution		Lactulose Solution USP, 10 g/15 mL	SOLUTION	ORAL; RECTAL	20211014		ANDA	ANDA076645	Bajaj Medical, LLC	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61037-475_f0b7b337-be36-2e5f-e053-2995a90a3c8c	61037-475	HUMAN OTC DRUG	Hand Sanitizer Gel		ETHYL ALCOHOL	GEL	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333E	Bajaj Medical, LLC	ALCOHOL	.7	mL/mL			N	20241231
61037-479_05327ca6-4e7d-a811-e063-6294a90acaff	61037-479	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SYRUP	ORAL	20230912		ANDA	ANDA090191	BAJAJ MEDICAL, LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61041-211_6ec02439-2b1e-4ad6-9a95-80f8f613be82	61041-211	HUMAN OTC DRUG	XEROSTOM		SODIUM FLUORIDE	MOUTHWASH	ORAL	20131115	20241031	OTC MONOGRAPH FINAL	part355	Bio Cosmetics	SODIUM FLUORIDE	.559	mg/mL			N	
61041-211_84f546fd-e17a-44bd-b792-60ae08e17693	61041-211	HUMAN OTC DRUG	XEROSTOM		SODIUM FLUORIDE	MOUTHWASH	ORAL	20150206	20241031	OTC MONOGRAPH FINAL	part355	Bio Cosmetics	SODIUM FLUORIDE	.559	mg/mL			N	
61041-212_784e6176-6041-40eb-aff1-a4c9be5e885d	61041-212	HUMAN OTC DRUG	XEROSTOM		SODIUM FLUORIDE	PASTE	ORAL	20131108	20250430	OTC MONOGRAPH FINAL	part355	Bio Cosmetics S L	SODIUM FLUORIDE	2.2	mg/g			N	
61041-212_cda81f4b-2173-4591-815e-d9e24828edb0	61041-212	HUMAN OTC DRUG	XEROSTOM		SODIUM FLUORIDE	PASTE	ORAL	20150206	20250430	OTC MONOGRAPH FINAL	part355	Bio Cosmetics S L	SODIUM FLUORIDE	2.2	mg/g			N	
61047-120_b7c89702-0e51-40fd-e053-2a95a90acd2d	61047-120	HUMAN OTC DRUG	Lamisil AT Cream		Terbinafine Hydrochloride	CREAM	TOPICAL	20200220		NDA	NDA020980	Voyant Beauty Inc.	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
61047-202_fa66f019-6d16-903d-e053-6394a90a1188	61047-202	HUMAN OTC DRUG	MINERAL ICE		Menthol	GEL	TOPICAL	20160208		OTC MONOGRAPH NOT FINAL	part348	Voyant Beauty, Inc.	MENTHOL	.02	g/g			N	20241231
61065-2001_fc0251d6-68ed-d86f-e053-6294a90aaac5	61065-2001	HUMAN OTC DRUG	MIRAPHARM 22		PANAX QUINQUEFOLIUS (RED GINSENG)	CAPSULE	ORAL	20150206		UNAPPROVED DRUG OTHER		MIRAPHARM., Inc.	PANAX QUINQUEFOLIUS WHOLE	.06	g/1			N	20241231
61077-001_33480d1d-e2b4-45fa-9398-4c9a9d37a66f	61077-001	HUMAN OTC DRUG	H-Warts Formula		Phytolacca decandra, Thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils	PHYTOLACCA AMERICANA ROOT; THUJA OCCIDENTALIS LEAFY TWIG	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-003_2df8a87d-63f3-4a56-9eeb-1e244f7747c5	61077-003	HUMAN OTC DRUG	H-Hemorrhoids Formula		Aesculus hippocastanum, Collinsonia canadensis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils	AESCULUS HIPPOCASTANUM FLOWER; COLLINSONIA CANADENSIS ROOT	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-005_b6a0fff6-0ded-49d8-be48-a2a2d17bcd53	61077-005	HUMAN OTC DRUG	H-BI Hemorrhoids Formula		calendula officinallis, hamamelis virginiana	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	12; 6	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-011_0cfc9079-0c6e-96d6-e063-6394a90a1e2d	61077-011	HUMAN OTC DRUG	H-Shingles Formula		calendula officinalis, iris versicolor, ranunculus bulbosus	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils	CALENDULA OFFICINALIS FLOWERING TOP; IRIS VERSICOLOR ROOT; RANUNCULUS BULBOSUS	12; 12; 12	[hp_C]/11mL; [hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-019_3c2fb525-15ec-4666-944f-00db6b4ae3f0	61077-019	HUMAN OTC DRUG	H- Eczema Formula		anacardium orientale, iris versicolor	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils	IRIS VERSICOLOR ROOT; SEMECARPUS ANACARDIUM JUICE	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-020_8d32a590-f3d8-4237-b0dd-6a94389dc1d2	61077-020	HUMAN OTC DRUG	H-Acne Formula		calendula officinalis, nux vomica, silicea	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12	[hp_C]/11mL; [hp_C]/11mL; [hp_C]/11mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61077-021_0fd474ab-5177-438d-bcb5-30dad4090ae0	61077-021	HUMAN OTC DRUG	H-Athletes Foot Formula		calendula officinalis, lycopodium clavatum, thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 12	[hp_C]/11mL; [hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-026_9aa21c0f-49b8-732c-e053-2995a90a9908	61077-026	HUMAN OTC DRUG	H-Molluscum Formula		calendula officinalis, thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-028_b5c33f8d-e9c9-4d40-bfe4-824a791a201d	61077-028	HUMAN OTC DRUG	H-Skin Tags Formula		calendula officinalis, thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-034_4740d10b-0449-43de-b057-ae3772c33ed6	61077-034	HUMAN OTC DRUG	H-Arthritis Formula		apium graveolens, arnica montana	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	ARNICA MONTANA; CELERY SEED	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-036_efb6fcab-fd09-4d35-ac13-909cb0d9a9d8	61077-036	HUMAN OTC DRUG	H-Fissures Formula		calendula officinalis, chamomilla	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; MATRICARIA RECUTITA	12; 6	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-038_e75430fd-b06b-41ce-8f15-008433a3f80d	61077-038	HUMAN OTC DRUG	H-Headaches Formula		apium graveolens, nux vomica	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CELERY SEED; STRYCHNOS NUX-VOMICA SEED	12; 12	[hp_C]/11mL; [hp_C]/11mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61077-039_024f6acd-4bd0-461d-b756-6e837e380901	61077-039	HUMAN OTC DRUG	H-Scars Formula		calendula officinallis, silicea	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-047_fe1859e8-e697-9503-e053-6294a90a72b7	61077-047	HUMAN OTC DRUG	H-Psoriasis Formula		calendula officinalis, iris versicolor	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; IRIS VERSICOLOR ROOT	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-088_ae6f5253-fbbe-494b-bffd-bc88f0c54aa3	61077-088	HUMAN OTC DRUG	H-Jock Itch Formula		calendula officinalis, thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-096_fe3883e6-d0ec-4b3f-a824-50db14098eeb	61077-096	HUMAN OTC DRUG	H-Varicose Veins Formula		Aesculus hippocastanum, Collinsonia canadensis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	COLLINSONIA CANADENSIS ROOT; HORSE CHESTNUT	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-101_c1e07d15-a070-4f94-ac02-de36b19f2374	61077-101	HUMAN OTC DRUG	SP1 Formula		phytolacca decandra, thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	PHYTOLACCA AMERICANA ROOT; THUJA OCCIDENTALIS LEAFY TWIG	15; 15	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-117_9c1c9028-cf29-3b3f-e053-2a95a90a0711	61077-117	HUMAN OTC DRUG	H-Insomnia Formula		apium graveolens, salvia officinalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CELERY SEED; SAGE	6; 6	[hp_C]/11mL; [hp_C]/11mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61077-118_60aff70b-dbd8-49a4-8d7a-c4ad61d66545	61077-118	HUMAN OTC DRUG	Sleep Aid Formula		apium graveolens, salvia officinalis	OIL	TOPICAL	20161122		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CELERY SEED; SAGE	6; 6	[hp_C]/11mL; [hp_C]/11mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61077-121_34491b5f-1c37-4c7d-9093-0ee74062fbc2	61077-121	HUMAN OTC DRUG	H-Rosacea Formula		belladonna, nux vomica	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	ATROPA BELLADONNA; STRYCHNOS NUX-VOMICA SEED	6; 12	[hp_C]/11mL; [hp_C]/11mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61077-123_d330fe6f-dd60-4838-b828-f02aaabfb984	61077-123	HUMAN OTC DRUG	H-Nail Fungus Formula		calendula officinalis, silicea, thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 12	[hp_C]/11mL; [hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-125_70226e31-d06a-4e8f-b9ba-b0742f63ee46	61077-125	HUMAN OTC DRUG	H-Moles Formula		calendula officinalis, phytolacca decandra, thuja occidentalis	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; PHYTOLACCA AMERICANA ROOT; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 12	[hp_C]/11mL; [hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-127_9aa23254-43f3-3bf7-e053-2a95a90aa2b7	61077-127	HUMAN OTC DRUG	H-Cold Sores Formula		calendula officinalis, ranunculus bulbosus	OIL	TOPICAL	20131106		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	CALENDULA OFFICINALIS FLOWERING TOP; RANUNCULUS BULBOSUS	12; 12	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-133_ea536ed7-275d-4fbf-b7f4-627d1795b88d	61077-133	HUMAN OTC DRUG	H-Age Spots Formula		Thuja occidentalis	OIL	TOPICAL	20141029		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	THUJA OCCIDENTALIS LEAFY TWIG	12	[hp_C]/11mL			N	20241231
61077-135_9aa259dc-9f48-08c7-e053-2a95a90ad45d	61077-135	HUMAN OTC DRUG	H-Gout Formula		Arnica montana, Rhododendron	OIL	TOPICAL	20141029		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	ARNICA MONTANA; RHODODENDRON AUREUM LEAF	12; 6	[hp_C]/11mL; [hp_C]/11mL			N	20241231
61077-137_d4f4c4db-cca2-4d7f-b869-bc9231667875	61077-137	HUMAN OTC DRUG	H-Joint and Muscle Formula		Arnica montana, Bellis perennis, Chamomilla	OIL	TOPICAL	20160219		UNAPPROVED HOMEOPATHIC		Healing Natural Oils LLC	ARNICA MONTANA; BELLIS PERENNIS; MATRICARIA RECUTITA	12; 30; 6	[hp_C]/11mL; [hp_C]/11mL; [hp_C]/11mL			N	20241231
61096-1002_0dcaa720-41e1-4075-8c0a-329c4d0f59f6	61096-1002	HUMAN OTC DRUG	Cold and Flu Relief		Allium cepa, Antimon tart, Arnica, Baptisia, Eupatorium perf, Gelsemium, Kali bic, Lachesis, Mer iod rub, Sticta , Sulphur iod, Urtica ur	LIQUID	ORAL	20190219		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ANTIMONY POTASSIUM TARTRATE; ARNICA MONTANA WHOLE; BAPTISIA TINCTORIA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; LACHESIS MUTA VENOM; LOBARIA PULMONARIA; MERCURIC IODIDE; ONION; POTASSIUM DICHROMATE; SULFUR IODIDE; URTICA URENS WHOLE	200; 4; 4; 200; 200; 200; 200; 200; 30; 200; 200; 200	[hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
61096-1003_927b54cf-b2a1-4037-836d-94d40c3c9e3c	61096-1003	HUMAN OTC DRUG	AllergEase		Allium cepa, Apis mellifica, Aralia rac, Arundo, Baptisia, Echinacea, Euphrasia, Gelsemium, Histaminum, Lycopodium, Rhus tox, Sabadilla, Sanguinaria, Urtica ur.	LIQUID	ORAL	20190226		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	APIS MELLIFERA; ARALIA RACEMOSA ROOT; ARUNDO PLINIANA ROOT; BAPTISIA TINCTORIA ROOT; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; ONION; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEED; TOXICODENDRON PUBESCENS LEAF; URTICA URENS WHOLE	4; 6; 30; 4; 4; 6; 200; 12; 6; 6; 200; 6; 200; 200	[hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
61096-1005_666bb4e8-1238-4f06-906b-301f623f6494	61096-1005	HUMAN OTC DRUG	DigestivEase		Arsenicum alb, Calc sulph, Carbo an, Carbo veg, Cinchona, Hydrastis, Nox vom, Ornithogalum, Pyrogenium, Silicea	LIQUID	ORAL	20190424		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; CALCIUM SULFATE ANHYDROUS; CARBO ANIMALIS; CINCHONA OFFICINALIS BARK; GOLDENSEAL; ORNITHOGALUM UMBELLATUM WHOLE; RANCID BEEF; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	12; 200; 200; 12; 200; 12; 12; 200; 12; 200	[hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61096-1022_85655dbc-090e-4797-9e75-44a7a66e665b	61096-1022	HUMAN OTC DRUG	Hair and Nail Tonic		Avena, DNA, Elaeis, Glandula suprarenalis suis, Hamamelis, Hepar suis, Kali sulph, Nat mur, Nicotinamidum, Phosphoricum ac, Pituitarum posterium, Riboflavinum, Thiaminum hydrochloricum, Thuja occ, Thyroidinum, Urtica ur.	LIQUID	ORAL	20190308		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	AVENA SATIVA FLOWERING TOP; ELAEIS GUINEENSIS FRUIT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HERRING SPERM DNA; NIACINAMIDE; PHOSPHORIC ACID; PORK LIVER; POTASSIUM SULFATE; RIBOFLAVIN; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; THIAMINE HYDROCHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; URTICA URENS WHOLE	4; 15; 4; 12; 6; 4; 6; 30; 8; 200; 30; 10; 6; 200; 30; 4	[hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
61096-1027_b9b592f2-7467-46c8-989f-c61e4a599375	61096-1027	HUMAN OTC DRUG	Acne Tonic		Anthracinum, Antimonium crud, Apis mel, Carbo an, Hamamelis, Hepar suis, Hydrocotyle, Kali brom, Merc corros, Nat sulphuricum, Pyrogenium, Radium brom, Sanguinaria canadensis, Sulphur iod, Thuja occ, Urtica ur	LIQUID	ORAL	20190308		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ANTIMONY TRISULFIDE; APIS MELLIFERA; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; CARBO ANIMALIS; CENTELLA ASIATICA WHOLE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MERCURIC CHLORIDE; PORK LIVER; POTASSIUM BROMIDE; RADIUM BROMIDE; RANCID BEEF; SANGUINARIA CANADENSIS ROOT; SODIUM SULFIDE NONAHYDRATE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS WHOLE	30; 4; 200; 12; 30; 4; 200; 6; 30; 200; 30; 4; 200; 200; 200; 4	[hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61096-1032_572c0451-f66b-4cb3-baa5-36bfad0843b7	61096-1032	HUMAN OTC DRUG	Arnica Power		Arnica montana	LIQUID	ORAL	20190308		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ARNICA MONTANA WHOLE	3	[hp_X]/41mL			N	20241231
61096-1033_a13b4408-295b-455f-9073-d648321ecd50	61096-1033	HUMAN OTC DRUG	Brain Power		Arnica, Baryta carb, Calc phos, Ginkgo, Hamamelis, Millefolium, Phosphoricum ac	LIQUID	ORAL	20190228		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ACHILLEA MILLEFOLIUM WHOLE; ARNICA MONTANA WHOLE; BARIUM CARBONATE; GINKGO; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; PHOSPHORIC ACID; TRIBASIC CALCIUM PHOSPHATE	4; 4; 30; 6; 4; 30; 30	[hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
61096-1035_c9c603b9-ac5b-4086-b0dc-8df2001024e8	61096-1035	HUMAN OTC DRUG	Rejuvenation Plus		Aralia quin, Arnica, Avena, Baryta carb, Carduus mar, DNA, Hepar suis, Medulla ossis suis, Pancreas suis, Phosphoricum ac, Pituitarum posterium, Thuja occ	LIQUID	ORAL	20140317		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	AMERICAN GINSENG; ARNICA MONTANA WHOLE; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; HERRING SPERM DNA; MILK THISTLE; PHOSPHORIC ACID; PORK LIVER; SUS SCROFA BONE MARROW; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAFY TWIG	4; 4; 6; 30; 12; 4; 4; 6; 6; 6; 12; 30	[hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL			N	20241231
61096-1038_a031c7df-bb8c-4d37-83de-e3b4bc3c829d	61096-1038	HUMAN OTC DRUG	ImmunoBooster		Arsenicum alb, Baptisia, Echinacea, Medulla ossis suis, Merc corros, Sulphur iod, thuja occ	LIQUID	ORAL	20190308		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; ECHINACEA, UNSPECIFIED; MERCURIC CHLORIDE; SULFUR IODIDE; SUS SCROFA BONE MARROW; THUJA OCCIDENTALIS LEAFY TWIG	200; 4; 4; 200; 200; 6; 200	[hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL			N	20241231
61096-1039_a1e18dfe-1f76-47cc-b4dd-68241b773a3e	61096-1039	HUMAN OTC DRUG	Body Balance		Aralia quin, Arnica, Avena, Carduus mar, Elaeis, Glandula suprarenalis suis, Nat mur, Phosphoricum ac, Thuja occ	LIQUID	ORAL	20190228		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	AMERICAN GINSENG; ARNICA MONTANA WHOLE; AVENA SATIVA FLOWERING TOP; ELAEIS GUINEENSIS FRUIT; MILK THISTLE; PHOSPHORIC ACID; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; THUJA OCCIDENTALIS LEAFY TWIG	4; 4; 4; 15; 4; 200; 30; 12; 200	[hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL			N	20241231
61096-2001_ae2f0ccf-6bd3-4eef-a393-97872b061b37	61096-2001	HUMAN OTC DRUG	SleepEase		Aquilegia, Avena, Chamomilla, Coffea cruda, Cypripedium, Humulus, Kali phos, Passiflora, Valeriana, Zinc met	LIQUID	ORAL	20190424		UNAPPROVED HOMEOPATHIC		Eight & Company L.L.C	AQUILEGIA VULGARIS; ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; DIBASIC POTASSIUM PHOSPHATE; HOPS; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; VALERIAN; ZINC	4; 200; 4; 4; 12; 4; 4; 4; 4; 12	[hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61096-2004_299a01a5-9347-4937-97fd-d63a179d58d3	61096-2004	HUMAN OTC DRUG	Diet Power		Apis Mellifica, Boldo, Fucus Vesiculosus, Galium Aparine, Gambogia, Hamamelis Virginiana, Hepar Suis, Histaminum hydrochloricum, Pancreas Suis, Thuja Occidentalis	LIQUID	ORAL	20210216		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	APIS MELLIFERA; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; GAMBOGE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HISTAMINE DIHYDROCHLORIDE; PEUMUS BOLDUS LEAF; PORK LIVER; SUS SCROFA PANCREAS; THUJA OCCIDENTALIS LEAFY TWIG	6; 4; 4; 12; 4; 200; 4; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61096-2006_3647b51b-5ca9-4bef-972f-249dc933a183	61096-2006	HUMAN OTC DRUG	Sprayology Stress Relief		Agnus, Avena, Cinchona, Humulus, Hyoscyamus, Ignatia, Passiflora, Valeriana	LIQUID	ORAL	20190325		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	AVENA SATIVA FLOWERING TOP; CHASTE TREE; CINCHONA OFFICINALIS BARK; HOPS; HYOSCYAMUS NIGER; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; VALERIAN	4; 6; 6; 4; 200; 4; 200; 4	[hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61096-2007_f669b985-aeb6-d304-e053-2a95a90ad166	61096-2007	HUMAN OTC DRUG	Sprayology TravelEase		Apis mel, Carbo veg, Carduus mar, Cocculus, Ignatia, Nux vom, Passiflora, Tabacum	LIQUID	ORAL	20190212		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ACTIVATED CHARCOAL; ANAMIRTA COCCULUS SEED; APIS MELLIFERA; MILK THISTLE; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	200; 30; 200; 4; 4; 200; 30; 6	[hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61096-2014_f1b3d020-ea0b-4147-8422-d0970b145b44	61096-2014	HUMAN OTC DRUG	MenoPower		Arnica, Glonoinum, Lachesis, Oophorinum, Salvia, Sanguinaria, Sepia	LIQUID	ORAL	20190308		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ARNICA MONTANA WHOLE; LACHESIS MUTA VENOM; NITROGLYCERIN; SAGE; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SUS SCROFA OVARY	200; 200; 200; 4; 200; 200; 30	[hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vasodilation [PE]		N	20241231
61096-2023_75c8d3f9-71f3-485a-bc4a-7b5e1f179690	61096-2023	HUMAN OTC DRUG	Life Detoxer		Carduus mar, Hepar suis, Merc solub, Mucosa nas, Plumb met	LIQUID	ORAL	20190308		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	LEAD; MERCURIUS SOLUBILIS; MILK THISTLE; PORK LIVER; SUS SCROFA NASAL MUCOSA	200; 200; 4; 6; 6	[hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL			N	20241231
61096-2030_8a59da2d-dcc2-452e-95cf-821a949e2fbc	61096-2030	HUMAN OTC DRUG	Party Relief		Arsenicum alb, Avena, Bryonia, Capsicum, Carbo an, Carduus mar, Chelidonium maj, Hepar suis, Kali iod, Lapis, Radium brom, Taraxacum, Thuja occ	LIQUID	ORAL	20190312		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BRYONIA ALBA ROOT; CALCIUM HEXAFLUOROSILICATE; CAPSICUM; CARBO ANIMALIS; CHELIDONIUM MAJUS WHOLE; MILK THISTLE; PORK LIVER; POTASSIUM IODIDE; RADIUM BROMIDE; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG	200; 4; 200; 200; 6; 200; 200; 4; 6; 200; 200; 4; 200	[hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
61096-2034_a9a63249-8739-46b3-af64-7b76f0c1ebcf	61096-2034	HUMAN OTC DRUG	Woman Power		Agnus, Aralia quin, Arnica, Damiana, Lactuca, Nat mur, Onosmodium virginianum, Oophorinum, Phosphoricum ac, Pituitarum posterium, Salix nig, Sepia, Thuja occ	LIQUID	ORAL	20190325		UNAPPROVED HOMEOPATHIC		Eight and Company L.L.C	AMERICAN GINSENG; ARNICA MONTANA; CHASTE TREE; LACTUCA VIROSA; ONOSMODIUM VIRGINIANUM WHOLE; PHOSPHORIC ACID; SALIX NIGRA BARK; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TURNERA DIFFUSA LEAFY TWIG	4; 4; 4; 6; 30; 200; 4; 30; 30; 30; 12; 30; 4	[hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_C]/41mL; [hp_X]/41mL; [hp_C]/41mL; [hp_X]/41mL			N	20241231
61128-001_080481fe-639f-0252-e063-6294a90a3b13	61128-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20071201		NDA	NDA205712	Super Gas, Inc.	OXYGEN	992	L/1000L			N	20241231
61128-002_0804636f-d994-8566-e063-6294a90a1a4e	61128-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20071201		NDA	NDA205713	Super Gas, Inc.	NITROGEN	992	L/1000L			N	20241231
61139-572_d0dc0cd2-c599-4a03-866d-c1d0db482777	61139-572	HUMAN OTC DRUG	Antibacterial Foam		Benzalkonium Chloride	SOLUTION	TOPICAL	20201202		OTC MONOGRAPH NOT FINAL	part333A	Office Max	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
61139-701_62cbd32e-f057-47b5-ae8d-288c8dc63606	61139-701	HUMAN OTC DRUG	Hand Sanitizer	Fragrance Free	Ethyl Alcohol	SOLUTION	TOPICAL	20160602		OTC MONOGRAPH NOT FINAL	part333A	Office Max	ALCOHOL	70	mg/mL			N	20241231
61140-001_0c7e8671-e704-563e-e063-6294a90a4590	61140-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100830		UNAPPROVED MEDICAL GAS		John S. Posen	OXYGEN	99	L/100L			N	20241231
61145-101_f03dedc7-ebfd-39af-e053-2a95a90a0e6c	61145-101	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20170927		ANDA	ANDA075185	REPHARM LLC	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61145-102_f03dedc7-ebfd-39af-e053-2a95a90a0e6c	61145-102	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20170927		ANDA	ANDA075185	REPHARM LLC	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61152-100_eb057157-743e-abd9-e053-2995a90a30a5	61152-100	HUMAN OTC DRUG	SnoreStop Chewable Fast tabs 60		atropa belladonna,ephedra distachya flowering twig,histamine dihydrochloride,goldenseal,potassium dichromate,strychnos nux-vomica seed,teucrium marum	TABLET, CHEWABLE	ORAL	20120801		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc	ATROPA BELLADONNA; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM	6; 6; 6; 12; 6; 6; 6	[hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61152-195_eb01551c-9f48-77a5-e053-2995a90a5a33	61152-195	HUMAN OTC DRUG	SnoreStop 60 FastTabs		atropa belladonna,ephedra distachya flowering twig,histamine dihydrochloride,goldenseal,potassium dichromate,strychnos nux-vomica seed,teucrium marum	TABLET, CHEWABLE	ORAL	20120917		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc	ATROPA BELLADONNA; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM	6; 6; 6; 12; 6; 6; 6	[hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301; [hp_X]/301	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61152-196_7d67400a-735c-4db9-e053-2a91aa0ae85b	61152-196	HUMAN OTC DRUG	Snore Stop Extinguisher Throat		atropa belladonna, ephedra distachya flowering twig, histamine dihydrochloride, goldenseal, potassium dichromate, strychnos nux-vomica seed, teucrium marum	SPRAY	ORAL	20120815		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals	ATROPA BELLADONNA; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM	6; 6; 6; 12; 6; 6; 6	[hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61152-196_eadd60e6-8f8c-654e-e053-2a95a90a58eb	61152-196	HUMAN OTC DRUG	Snore Stop Extinguisher Throat		atropa belladonna, ephedra distachya flowering twig, histamine dihydrochloride, goldenseal, potassium dichromate, strychnos nux-vomica seed, teucrium marum	SPRAY	ORAL	20121228		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc	ATROPA BELLADONNA; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM	6; 6; 6; 12; 6; 6; 6	[hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61152-199_e194696f-0a7f-f303-e053-2a95a90a3c90	61152-199	HUMAN OTC DRUG	SnoreStop NasoSpray 60		strychnos nux-vomica seed,atropa belladonna,ephedra distachya flowering twig,goldenseal,potassium dichromate,teucrium marum,histamine dihydrochloride liquid	LIQUID	NASAL	20120918		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc.	ATROPA BELLADONNA; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; N.ALPHA.-METHYLHISTAMINE DIHYDROCHLORIDE; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM	6; 6; 6; 12; 6; 6; 6	[hp_X]/9mL; [hp_X]/9mL; [hp_X]/9mL; [hp_X]/9mL; [hp_X]/9mL; [hp_X]/9mL; [hp_X]/9mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61152-200_ed116c62-4776-3e77-e053-2995a90a32b0	61152-200	HUMAN OTC DRUG	SnoreStop Double Action		atropa belladonna,ephedra distachya flowering twig,histamine dihydrochloride,goldenseal,potassium dichromate,strychnos nux-vomica seed,teucrium marum	KIT	NASAL; ORAL	20220801		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc						N	20241231
61152-300_ebd027d5-6334-f2f8-e053-2995a90a5ba3	61152-300	HUMAN OTC DRUG	SnoreStop Starter Kit 60		atropa belladonna,ephedra distachya flowering twig,histamine dihydrochloride,goldenseal,potassium dichromate,strychnos nux-vomica seed,teucrium marum	KIT	NASAL; ORAL	20220801		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc						N	20241231
61152-300_ed769147-dfc1-3ebc-e053-2995a90a9ead	61152-300	HUMAN OTC DRUG	SnoreStop Starter Kit 60		atropa belladonna,ephedra distachya flowering twig,histamine dihydrochloride,goldenseal,potassium dichromate,strychnos nux-vomica seed,teucrium marum	KIT	NASAL; ORAL	20220801		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc						N	20241231
61152-400_eb536834-9dbd-cc33-e053-2995a90a94e5	61152-400	HUMAN OTC DRUG	SnoreStop Extinguisher 120		atropa belladonna, ephedra distachya flowering twig, histamine dihydrochloride, goldenseal, potassium dichromate, strychnos nux-vomica seed, teucrium marum	SPRAY	ORAL	20220801		UNAPPROVED HOMEOPATHIC		Green Pharmaceuticals Inc	ATROPA BELLADONNA; EPHEDRA DISTACHYA FLOWERING TWIG; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM	6; 6; 6; 12; 6; 6; 6	[hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL; [hp_X]/4.5mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61168-101_1e3c3d48-f5f5-4db1-82f2-8e30fc86048a	61168-101	HUMAN PRESCRIPTION DRUG	KYBELLA		Deoxycholic Acid	INJECTION, SOLUTION	SUBCUTANEOUS	20150608		NDA	NDA206333	Kythera Biopharmaceuticals Inc.	DEOXYCHOLIC ACID	20	mg/2mL	Cytolytic Agent [EPC], Decreased Cell Membrane Integrity [PE]		N	20241231
61197-103_f2b77c4f-f182-76cb-e053-2995a90a6cc1	61197-103	HUMAN OTC DRUG	Pacifica Bacne Warrior		Salicylic Acid	SPRAY	TOPICAL	20230120		OTC MONOGRAPH FINAL	M006	Pacifica Beauty, LLC	SALICYLIC ACID	2	g/100mg			N	20241231
61197-120_f43590c7-84c1-6eb8-e053-2a95a90a01a7	61197-120	HUMAN OTC DRUG	Acne Defense Face Wash		Salicylic Acid	LIQUID	TOPICAL	20230208		OTC MONOGRAPH FINAL	M006	Pacifica Beauty, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
61197-121_f44bcd96-dbf9-5718-e053-2a95a90adc34	61197-121	HUMAN OTC DRUG	Acne Warrior Clearing Astringent		Salicylic Acid	LIQUID	TOPICAL	20230209		OTC MONOGRAPH FINAL	M006	Pacifica Beauty, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
61197-122_f44c0be7-9566-0068-e053-2a95a90a9705	61197-122	HUMAN OTC DRUG	Dry It Out Acne Spot Treatment		Salicylic Acid	GEL	TOPICAL	20230209		OTC MONOGRAPH FINAL	M006	Pacifica Beauty, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
61197-123_f45b4c77-45a4-f480-e053-2995a90a36be	61197-123	HUMAN OTC DRUG	Acne Warrior Body Wash		Salicylic Acid	LIQUID	TOPICAL	20230210		OTC MONOGRAPH FINAL	M006	Pacifica Beauty, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
61197-205_f2f53cf9-3718-07ff-e053-2a95a90a03fb	61197-205	HUMAN OTC DRUG	Glow Baby Brightening Setting Mist SPF 45		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230123		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
61197-206_f2f5e0bd-6543-1687-e053-2995a90a1cca	61197-206	HUMAN OTC DRUG	Sun Plus Skincare SPF 30 Mineral Face Shade Coconut Probiotic		Zinc Oxide	CREAM	TOPICAL	20230123		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	16	g/100mg			N	20241231
61197-207_f309b3fc-4606-ecb7-e053-2a95a90adb0b	61197-207	HUMAN OTC DRUG	Sun Plus Skincare SPF 30 Mineral Sunscreen Coconut Probiotic		Zinc Oxide	SPRAY	TOPICAL	20230124		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	14.5	g/100mL			N	20241231
61197-208_f31d6bb0-e67a-66bd-e053-2a95a90a75a1	61197-208	HUMAN OTC DRUG	Sun Plus Skincare SPF 30 Mineral Bronzing Sunscreen Coconut Glow		Zinc Oxide	LIQUID	TOPICAL	20230125		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	14.5	g/100mL			N	20241231
61197-209_f3448692-7632-7f6f-e053-2995a90ab53e	61197-209	HUMAN OTC DRUG	Sun Plus Skincare SPF 50 Mineral Bronzing Body Butter Coconut		Zinc Oxide	CREAM	TOPICAL	20230127		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	22	g/100mL			N	20241231
61197-211_f34542ef-d740-07a3-e053-2995a90a6c80	61197-211	HUMAN OTC DRUG	Sun Plus Skincare SPF 50 Sport Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230127		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61197-212_f44964ed-cfc1-f96b-e053-2a95a90a4d09	61197-212	HUMAN OTC DRUG	Sun Plus Skincare SPF 30 Sea and C Sheer Sunscreen		Octisalate, Octocrylene, Zinc Oxide	SPRAY	TOPICAL	20230209		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	4.9; 7.6; 7	g/100mL; g/100mL; g/100mL			N	20241231
61197-213_f3949830-f798-1fac-e053-2a95a90a6a41	61197-213	HUMAN OTC DRUG	Mattify and Protect Daily Priming SPF 35		Octocrylene, Zinc Oxide	SPRAY	TOPICAL	20230131		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	OCTOCRYLENE; ZINC OXIDE	7.6; 6	g/100mL; g/100mL			N	20241231
61197-214_f3bd0036-db0f-91e9-e053-2a95a90a1066	61197-214	HUMAN OTC DRUG	Sea and C Glow Bronzing Body Oil SPF 20		Avobenzone, Octisalate, Octocrylene	LIQUID	TOPICAL	20230202		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL			N	20241231
61197-215_f3bddf82-90c1-4d79-e053-2995a90a1074	61197-215	HUMAN OTC DRUG	Set and Protect Matte Sheer Setting Mist SPF 45		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230202		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61197-216_f3d3b228-c856-a9b9-e053-2995a90a13f4	61197-216	HUMAN OTC DRUG	Sea and C Sheer Face Serum		Avobenzone, Homosalate, Octisalate, Octocrylene	LIQUID	TOPICAL	20230203		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61197-217_f3d3eee2-a5da-113b-e053-2995a90a7057	61197-217	HUMAN OTC DRUG	Glow Baby Super Lit SPF 30		Zinc Oxide	SPRAY	TOPICAL	20230203		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	20.8	g/100mL			N	20241231
61197-218_f421cbf7-cfaf-5eae-e053-2995a90ab35c	61197-218	HUMAN OTC DRUG	Kind Tint SPF 30		Zinc Oxide	LIQUID	TOPICAL	20230207		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	20.8	g/100mL			N	20241231
61197-219_0324275f-13bd-e7b8-e063-6294a90a6902	61197-219	HUMAN OTC DRUG	Future Youth Daily Turnaround Hydrating Moisturizer SPF 50		Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20230625		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61197-300_f44aac1c-d5e2-200f-e053-2a95a90a7aff	61197-300	HUMAN OTC DRUG	Ultra CC Radiant Foundation Broad Spectrum SPF 17 Cool-Deep		Zinc Oxide	CREAM	TOPICAL	20230209		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	11.4	g/100mL			N	20241231
61197-301_f45a5c5d-35d1-4cb4-e053-2a95a90a6289	61197-301	HUMAN OTC DRUG	Ultra CC Radiant Foundation Broad Spectrum SPF 17 Warm-Tan		Zinc Oxide	CREAM	TOPICAL	20230210		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	11.4	g/100mL			N	20241231
61197-302_f4504aed-48e0-6174-e053-2995a90a136e	61197-302	HUMAN OTC DRUG	Ultra CC Radiant Foundation Broad Spectrum SPF 17 Neutral-Fair		Zinc Oxide	CREAM	TOPICAL	20230209		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	11.4	g/100mL			N	20241231
61197-303_f44fdfeb-4355-5884-e053-2a95a90ae231	61197-303	HUMAN OTC DRUG	Ultra CC Radiant Foundation Broad Spectrum SPF 17 Warm-Medium		Zinc Oxide	CREAM	TOPICAL	20230209		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	SALICYLIC ACID	11.4	g/100mL			N	20241231
61197-304_f44b7997-5f57-7d39-e053-2a95a90ae94c	61197-304	HUMAN OTC DRUG	Ultra CC Radiant Foundation Broad Spectrum SPF 17 Natural-Medium		Zinc Oxide	CREAM	TOPICAL	20230209		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	11.4	g/100mL			N	20241231
61197-305_f45ac8b0-4ccd-50a5-e053-2995a90a95b3	61197-305	HUMAN OTC DRUG	Ultra CC Radiant Foundation Broad Spectrum SPF 17 Light-Warm		Zinc Oxide	CREAM	TOPICAL	20230210		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	11.4	g/100mL			N	20241231
61197-410_f44a4fc5-3359-5966-e053-2995a90add56	61197-410	HUMAN OTC DRUG	Acne Warrior Body Scrub		Salicylic Acid	CREAM	TOPICAL	20230209		OTC MONOGRAPH FINAL	M006	Pacifica Beauty, LLC	SALICYLIC ACID	2	g/100g			N	20241231
61197-510_f449da32-5adf-2c78-e053-2a95a90a27a1	61197-510	HUMAN OTC DRUG	Vegan Collagen Every Day SPF 30		Avobenzone, Homosalate, Octocrylene, Octyl Salicylate	LOTION	TOPICAL	20230209		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61197-610_febd3092-e9c9-7be0-e053-6394a90a60ff	61197-610	HUMAN OTC DRUG	Sun Plus Skincare SPF 30 Mineral Bronzing Face Shade Coconut Glow		Zinc Oxide	LOTION	TOPICAL	20230120		OTC MONOGRAPH FINAL	M020	Pacifica Beauty, LLC	ZINC OXIDE	20	g/100mL			N	20241231
61245-145_f642181a-ed71-c3c9-e053-2a95a90a2967	61245-145	HUMAN OTC DRUG	Direct Safety Aspirin Free		Acetaminophen	TABLET, FILM COATED	ORAL	20130531		OTC MONOGRAPH NOT FINAL	part343	Conney Safety Products, LLC	ACETAMINOPHEN	325	mg/1			N	20241231
61245-175_f600fab8-2ac8-84d1-e053-2995a90a67ea	61245-175	HUMAN OTC DRUG	Direct Safety Extra Strength Aspirin Free		Acetaminophen	TABLET, FILM COATED	ORAL	20130531		OTC MONOGRAPH NOT FINAL	part343	Conney Safety Products, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
61245-616_02e6ba01-c019-cae0-e063-6394a90ac67e	61245-616	HUMAN OTC DRUG	Direct Safety Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20210215		OTC MONOGRAPH NOT FINAL	part343	Direct Safety	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
61245-620_02e6ba01-c019-cae0-e063-6394a90ac67e	61245-620	HUMAN OTC DRUG	Direct Safety Aspirin		Aspirin	TABLET, COATED	ORAL	20210215	20240401	OTC MONOGRAPH NOT FINAL	part343	Direct Safety	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
61269-066_37dbf815-076b-462c-9af0-494c3b700b8a	61269-066	HUMAN OTC DRUG	Minoxidil		Minoxidil	SOLUTION	TOPICAL	20231206		ANDA	ANDA074588	H2-Pharma, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
61269-094_4162d466-6dd6-406e-ba78-253eb04f394b	61269-094	HUMAN OTC DRUG	Minoxidil		Minoxidil	SOLUTION	TOPICAL	20220425		ANDA	ANDA075518	H2-Pharma, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
61269-105_0f6793ee-6f8a-4afb-8ba5-44345960859b	61269-105	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20210510	20241031	OTC MONOGRAPH FINAL	part333B	H2-Pharma, LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	
61269-220_1e5b4178-017f-429d-b0d9-bc11863cd67e	61269-220	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20210629		ANDA	ANDA074165	H2-Pharma, LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
61269-380_e0ed7e4a-7b77-488c-9864-e09e4dad8289	61269-380	HUMAN PRESCRIPTION DRUG	PYLERA		BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE	CAPSULE	ORAL	20231001		NDA	NDA050786	H2-Pharma, LLC	BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE	140; 125; 125	mg/1; mg/1; mg/1	Bismuth [CS], Bismuth [EPC], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
61269-385_5bf2f641-254d-484c-9970-3f8729c7aff7	61269-385	HUMAN PRESCRIPTION DRUG	BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE		BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE	CAPSULE	ORAL	20230731		NDA	NDA050786	H2-Pharma, LLC	BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE	140; 125; 125	mg/1; mg/1; mg/1	Bismuth [CS], Bismuth [EPC], Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS], Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
61269-402_33674726-17dc-4d3a-a2cb-67175ac76382	61269-402	HUMAN PRESCRIPTION DRUG	DROXIA		HYDROXYUREA	CAPSULE	ORAL	20090601		NDA	NDA016295	H2-Pharma LLC	HYDROXYUREA	200	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
61269-403_33674726-17dc-4d3a-a2cb-67175ac76382	61269-403	HUMAN PRESCRIPTION DRUG	DROXIA		HYDROXYUREA	CAPSULE	ORAL	20090601		NDA	NDA016295	H2-Pharma LLC	HYDROXYUREA	300	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
61269-404_33674726-17dc-4d3a-a2cb-67175ac76382	61269-404	HUMAN PRESCRIPTION DRUG	DROXIA		HYDROXYUREA	CAPSULE	ORAL	20090601		NDA	NDA016295	H2-Pharma LLC	HYDROXYUREA	400	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
61269-410_839c17f5-4739-4ace-93b0-c6fd1a5710d2	61269-410	HUMAN PRESCRIPTION DRUG	ETOPOPHOS		etoposide phosphate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090601		NDA	NDA020457	H2-Pharma, LLC	ETOPOSIDE PHOSPHATE	100	mg/1	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
61269-460_db470b78-cc2c-455f-a430-078a78a625df	61269-460	HUMAN PRESCRIPTION DRUG	Xenical		orlistat	CAPSULE	ORAL	20101217		NDA	NDA020766	H2-Pharma LLC	ORLISTAT	120	mg/1	Intestinal Lipase Inhibitor [EPC], Lipase Inhibitors [MoA]		N	20241231
61269-470_ece8fe89-a71f-45c3-a9b0-1349a5ac0c9d	61269-470	HUMAN PRESCRIPTION DRUG	Xeloda		capecitabine	TABLET, FILM COATED	ORAL	19980430		NDA	NDA020896	H2-Pharma, LLC	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
61269-475_ece8fe89-a71f-45c3-a9b0-1349a5ac0c9d	61269-475	HUMAN PRESCRIPTION DRUG	Xeloda		capecitabine	TABLET, FILM COATED	ORAL	19980430		NDA	NDA020896	H2-Pharma, LLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
61269-480_599f9fda-c2aa-4f06-80fd-9f985a6183d0	61269-480	HUMAN PRESCRIPTION DRUG	Valcyte		valganciclovir	TABLET, FILM COATED	ORAL	20010329		NDA	NDA021304	H2-Pharma, LLC	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
61269-485_599f9fda-c2aa-4f06-80fd-9f985a6183d0	61269-485	HUMAN PRESCRIPTION DRUG	Valcyte		valganciclovir hydrochloride	POWDER, FOR SOLUTION	ORAL	20090828		NDA	NDA022257	H2-Pharma, LLC	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
61269-509_3fc56099-e230-4b2d-add8-1db3f558c1dd	61269-509	HUMAN PRESCRIPTION DRUG	PULMICORT	FLEXHALER	Budesonide	AEROSOL, POWDER	RESPIRATORY (INHALATION)	20070319		NDA	NDA021949	H2-Pharma LLC	BUDESONIDE	90	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61269-518_3fc56099-e230-4b2d-add8-1db3f558c1dd	61269-518	HUMAN PRESCRIPTION DRUG	PULMICORT	FLEXHALER	Budesonide	AEROSOL, POWDER	RESPIRATORY (INHALATION)	20070319		NDA	NDA021949	H2-Pharma LLC	BUDESONIDE	180	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61269-527_53bebdb2-1a62-40b9-8cd3-407cc2a70037	61269-527	HUMAN OTC DRUG	Childrens Allergy		fexofenadine hydrochloride	SUSPENSION	ORAL	20220718		ANDA	ANDA203330	H2-Pharma, LLC	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61269-565_5b9dc5e8-fe64-4769-bd00-65987c88fa1a	61269-565	HUMAN PRESCRIPTION DRUG	ORLISTAT		orlistat	CAPSULE	ORAL	20220601		NDA AUTHORIZED GENERIC	NDA020766	H2-Pharma LLC	ORLISTAT	120	mg/1	Intestinal Lipase Inhibitor [EPC], Lipase Inhibitors [MoA]		N	20241231
61269-605_d2cbf23d-9483-4a85-9e0e-2e75561202ee	61269-605	HUMAN PRESCRIPTION DRUG	Klonopin		Clonazepam	TABLET	ORAL	19750602		NDA	NDA017533	H2-Pharma, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61269-610_d2cbf23d-9483-4a85-9e0e-2e75561202ee	61269-610	HUMAN PRESCRIPTION DRUG	Klonopin		Clonazepam	TABLET	ORAL	19750602		NDA	NDA017533	H2-Pharma, LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61269-620_d2cbf23d-9483-4a85-9e0e-2e75561202ee	61269-620	HUMAN PRESCRIPTION DRUG	Klonopin		Clonazepam	TABLET	ORAL	19750602		NDA	NDA017533	H2-Pharma, LLC	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61269-630_0862bfd3-af21-4d39-b301-15300f571a14	61269-630	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19970623		NDA	NDA020592	H2-Pharma LLC	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-631_0862bfd3-af21-4d39-b301-15300f571a14	61269-631	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	H2-Pharma LLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-632_0862bfd3-af21-4d39-b301-15300f571a14	61269-632	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	H2-Pharma LLC	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-633_0862bfd3-af21-4d39-b301-15300f571a14	61269-633	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	H2-Pharma LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-634_0862bfd3-af21-4d39-b301-15300f571a14	61269-634	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	20000110		NDA	NDA020592	H2-Pharma LLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-635_0862bfd3-af21-4d39-b301-15300f571a14	61269-635	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	20010301		NDA	NDA020592	H2-Pharma LLC	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-640_0862bfd3-af21-4d39-b301-15300f571a14	61269-640	HUMAN PRESCRIPTION DRUG	ZYPREXA	Intramuscular	Olanzapine	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR	20040401		NDA	NDA021253	H2-Pharma LLC	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]		N	20241231
61269-650_0862bfd3-af21-4d39-b301-15300f571a14	61269-650	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20000601		NDA	NDA021086	H2-Pharma LLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-651_0862bfd3-af21-4d39-b301-15300f571a14	61269-651	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20000601		NDA	NDA021086	H2-Pharma LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-652_0862bfd3-af21-4d39-b301-15300f571a14	61269-652	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20010901		NDA	NDA021086	H2-Pharma LLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-653_0862bfd3-af21-4d39-b301-15300f571a14	61269-653	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20010901		NDA	NDA021086	H2-Pharma LLC	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61269-660_e1d8108e-ee35-46db-9f64-2e117862e6fc	61269-660	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20091211		NDA	NDA022173	H2-Pharma LLC						N	20241231
61269-661_e1d8108e-ee35-46db-9f64-2e117862e6fc	61269-661	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20091211		NDA	NDA022173	H2-Pharma LLC						N	20241231
61269-662_e1d8108e-ee35-46db-9f64-2e117862e6fc	61269-662	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20091211		NDA	NDA022173	H2-Pharma LLC						N	20241231
61269-730_03eea790-4814-4dd3-8cbf-20a3bc96ea0d	61269-730	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20210412		ANDA	ANDA074164	H2-Pharma, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
61269-730_99d7e457-231a-4766-b90a-ba6963b2525c	61269-730	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20210315		ANDA	ANDA074164	H2-Pharma, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
61269-735_ebf2d330-f3ae-47cb-bf87-dbdd0e5c2be8	61269-735	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	20210629		OTC MONOGRAPH FINAL	part333C	H2-Pharma, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
61269-736_a45a6435-e711-43b1-8f7b-92915a7a090d	61269-736	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	SUPPOSITORY	VAGINAL	20210524		ANDA	ANDA073507	H2-Pharma, LLC	MICONAZOLE NITRATE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
61269-835_18c105ec-bcb3-4506-a91f-f70675f234f3	61269-835	HUMAN PRESCRIPTION DRUG	HYDREA		HYDROXYUREA	CAPSULE	ORAL	20090601		NDA	NDA016295	H2-Pharma LLC	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
61269-981_8cde6b29-52f7-463f-9914-0b93771d87c7	61269-981	HUMAN OTC DRUG	DOCOSANOL		DOCOSANOL	CREAM	TOPICAL	20210629		ANDA	ANDA208754	H2-Pharma, LLC	DOCOSANOL	100	mg/g			N	20241231
61269-989_29a71b87-09b6-46e5-955a-86c63a618e48	61269-989	HUMAN OTC DRUG	DOCOSANOL		DOCOSANOL	CREAM	TOPICAL	20230718		ANDA	ANDA212385	H2-Pharma, LLC	DOCOSANOL	100	mg/g			N	20241231
61284-0011_06ef3495-2b9e-b148-e063-6394a90abdc4	61284-0011	HUMAN OTC DRUG	Truwell Kids Dentiwash		sodium fluoride	LIQUID	DENTAL	20231005		OTC MONOGRAPH DRUG	M021	ECOWORLDPHARM CO.,LTD	SODIUM FLUORIDE	.02	g/100mL			N	20241231
61284-0012_06f02221-73a3-87e5-e063-6394a90ab951	61284-0012	HUMAN OTC DRUG	Truwell Dentiwash		sodium fluoride	LIQUID	DENTAL	20231005		OTC MONOGRAPH DRUG	M021	ECOWORLDPHARM CO.,LTD	SODIUM FLUORIDE	.05	g/100mL			N	20241231
61284-0013_06f0ddf8-e05d-56ec-e063-6294a90abcfa	61284-0013	HUMAN OTC DRUG	Truwell Dentiwash		sodium fluoride	LIQUID	DENTAL	20231005		OTC MONOGRAPH DRUG	M021	ECOWORLDPHARM CO.,LTD	SODIUM FLUORIDE	.05	g/100mL			N	20241231
61296-005_eeda681d-4315-6039-e053-2a95a90aea5f	61296-005	HUMAN OTC DRUG	BIOSOLIS Sun SPF50		TITANIUM DIOXIDE	CREAM	TOPICAL	20190201	20240430	OTC MONOGRAPH NOT FINAL	part352	Pro Vera SA	TITANIUM DIOXIDE	159	mg/mL			N	
61296-009_eedacb84-418c-ba11-e053-2a95a90af750	61296-009	HUMAN OTC DRUG	BIOSOLIS Face Anti Aging SPF30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190201	20240430	OTC MONOGRAPH NOT FINAL	part352	Pro Vera SA	TITANIUM DIOXIDE; ZINC OXIDE	97; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
61296-013_0e993203-3e89-5fbd-e063-6294a90a0636	61296-013	HUMAN OTC DRUG	BIOSOLIS Sunscreen Broadspectrum SPF30		ZINC OXIDE	CREAM	TOPICAL	20220107	20250430	OTC MONOGRAPH DRUG	M020	Pro Vera SA	ZINC OXIDE	188	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
61296-014_0e993203-3e8d-5fbd-e063-6294a90a0636	61296-014	HUMAN OTC DRUG	BIOSOLIS Sunscreen Broadspectrum SPF50 KIDS		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220107	20250430	OTC MONOGRAPH DRUG	M020	Pro Vera SA	TITANIUM DIOXIDE; ZINC OXIDE	100; 135	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
61296-015_0e9956da-6dae-1d02-e063-6294a90a8796	61296-015	HUMAN OTC DRUG	BIOSOLIS Sunscreen broadspectrum SPF30		ZINC OXIDE	CREAM	TOPICAL	20220107	20250430	OTC MONOGRAPH DRUG	M020	Pro Vera SA	ZINC OXIDE	188	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
61296-016_0e995eaf-1e87-306e-e063-6394a90a5d3f	61296-016	HUMAN OTC DRUG	BIOSOLIS sunscreen broadspectrum SPF50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220107	20250331	OTC MONOGRAPH DRUG	M020	Pro Vera SA	TITANIUM DIOXIDE; ZINC OXIDE	108; 142	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
61296-017_0e99626b-7593-3342-e063-6394a90a4498	61296-017	HUMAN OTC DRUG	BIOSOLIS Face Sunscreen Broadspectrum SPF50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220107	20241231	OTC MONOGRAPH DRUG	M020	Pro Vera SA	TITANIUM DIOXIDE; ZINC OXIDE	100; 152	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
61296-018_0e994d2d-30e4-9da3-e063-6294a90a088c	61296-018	HUMAN OTC DRUG	BIOSOLIS Face Sunscreen broad spectrum SPF30		ZINC OXIDE	CREAM	TOPICAL	20220107	20241231	OTC MONOGRAPH DRUG	M020	Pro Vera SA	ZINC OXIDE	188	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
61307-017_03a8fa2d-97a7-9f63-e063-6394a90afe68	61307-017	HUMAN OTC DRUG	E2 Hand Sanitizer		E2 Hand Sanitizer	SOLUTION	TOPICAL	20151210		OTC MONOGRAPH NOT FINAL	part333A	US Chemical Corporation	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
61307-056_03a8bd37-d222-2a2d-e063-6294a90a0406	61307-056	HUMAN OTC DRUG	Hand Sanitizing Gel		Instant Hand Sanitizing Gel	GEL	TOPICAL	20130507		OTC MONOGRAPH NOT FINAL	part333A	US Chemical Corporation	ALCOHOL	62	mL/100mL			N	20241231
61307-060_03a8bd37-d223-2a2d-e063-6294a90a0406	61307-060	HUMAN OTC DRUG	Antibacterial Hand		Antiseptic Hand Soap	SOAP	TOPICAL	20130613		OTC MONOGRAPH NOT FINAL	part333A	US Chemical Corporation	CHLOROXYLENOL	.3	g/100mL			N	20241231
61307-213_03a8d733-d4d1-c48f-e063-6294a90a8621	61307-213	HUMAN OTC DRUG	Indulgence/ProPower		Benzalkonium Chloride	SOAP	TOPICAL	20170130		OTC MONOGRAPH NOT FINAL	part333E	U S Chemical Corporation	BENZALKONIUM CHLORIDE	2.5	mg/L			N	20241231
61307-640_03a8c5b9-b07f-8b10-e063-6294a90ac578	61307-640	HUMAN OTC DRUG	Foaming Antibacterial Hand		Lavish Antibacterial	SOAP	TOPICAL	20181028		OTC MONOGRAPH NOT FINAL	part333A	US Chemical Corporation	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
61307-688_03a8fa2d-97a5-9f63-e063-6394a90afe68	61307-688	HUMAN OTC DRUG	Foaming Hand Sanitizer		Indulgence Hand Sanitizer	SOLUTION	TOPICAL	20120703		OTC MONOGRAPH NOT FINAL	part333A	US Chemical Corporation	ALCOHOL	62	mL/100mL			N	20241231
61314-014_b31b68aa-4a89-4f56-ac33-e4151495af13	61314-014	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	OPHTHALMIC	20080214		ANDA	ANDA078031	Sandoz Inc	DICLOFENAC SODIUM	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61314-016_ca203740-1e54-4289-9a1f-f2086fec4f46	61314-016	HUMAN PRESCRIPTION DRUG	Proparacaine Hydrochloride		Proparacaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20000605		ANDA	ANDA080027	Sandoz Inc.	PROPARACAINE HYDROCHLORIDE	5	mg/mL	Local Anesthesia [PE], Local Anesthetic [EPC]		N	20241231
61314-019_764fec18-11c4-4320-a834-83c80c7040d2	61314-019	HUMAN PRESCRIPTION DRUG	DORZOLAMIDE HYDROCHLORIDE		dorzolamide hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20090601		ANDA	ANDA078981	Sandoz Inc	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
61314-030_07a80111-46ec-47cd-a4b8-8d105b3de46a	61314-030	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION	OPHTHALMIC	20100102		ANDA	ANDA090604	Sandoz Inc	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61314-044_0db13470-fcc5-4378-86ab-20f36277ab3c	61314-044	HUMAN PRESCRIPTION DRUG	Trifluridine		trifluridine	SOLUTION	OPHTHALMIC	20010514		ANDA	ANDA074311	Sandoz Inc	TRIFLURIDINE	10	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
61314-126_dadb701d-db91-4b27-9a1b-4dc9cf55e6bd	61314-126	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	SOLUTION	OPHTHALMIC	20091105		ANDA	ANDA076583	Sandoz Inc	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61314-143_fc9610bf-feea-4d14-8fd4-03b29cc7ec72	61314-143	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION	OPHTHALMIC	20030917		ANDA	ANDA076254	Sandoz Inc	BRIMONIDINE TARTRATE	2	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
61314-144_438268db-a283-47f0-a437-0d683d674098	61314-144	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION	OPHTHALMIC	20101002		NDA	NDA021764	Sandoz Inc	BRIMONIDINE TARTRATE	1.5	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
61314-203_c719c269-c2d9-4826-99f3-43317efaaedb	61314-203	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		pilocarpine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19960221		NDA AUTHORIZED GENERIC	NDA200890	Sandoz Inc	PILOCARPINE HYDROCHLORIDE	10	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
61314-204_c719c269-c2d9-4826-99f3-43317efaaedb	61314-204	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		pilocarpine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19960221		NDA AUTHORIZED GENERIC	NDA200890	Sandoz Inc	PILOCARPINE HYDROCHLORIDE	20	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
61314-206_c719c269-c2d9-4826-99f3-43317efaaedb	61314-206	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		pilocarpine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19960221		NDA AUTHORIZED GENERIC	NDA200890	Sandoz Inc	PILOCARPINE HYDROCHLORIDE	40	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
61314-224_815aa1e1-3a75-453c-98db-cf918bcc7c29	61314-224	HUMAN PRESCRIPTION DRUG	Timolol GFS		timolol maleate	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	19981224		NDA	NDA020963	Sandoz Inc	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61314-225_815aa1e1-3a75-453c-98db-cf918bcc7c29	61314-225	HUMAN PRESCRIPTION DRUG	Timolol GFS		timolol maleate	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	19981224		NDA	NDA020963	Sandoz Inc	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61314-226_125193ed-ad68-4ddc-81d9-342d24577d40	61314-226	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	19960115		ANDA	ANDA074261	Sandoz Inc	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61314-227_125193ed-ad68-4ddc-81d9-342d24577d40	61314-227	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	19960115		ANDA	ANDA074262	Sandoz Inc	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61314-237_4d6f900a-fa36-445e-80d5-54c8cc5baf34	61314-237	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION/ DROPS	OPHTHALMIC	19990629		ANDA	ANDA075282	Sandoz Inc	CROMOLYN SODIUM	40	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
61314-238_c89793f0-318b-4481-8fc0-e9cb0dcc5244	61314-238	HUMAN PRESCRIPTION DRUG	Carteolol Hydrochloride		Carteolol Hydrochloride	SOLUTION	OPHTHALMIC	20000105		ANDA	ANDA075476	Sandoz Inc	CARTEOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61314-245_c30e555b-1a79-4c3e-b79d-8c1d950fd832	61314-245	HUMAN PRESCRIPTION DRUG	Betaxolol Hydrochloride		Betaxolol Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20000515		NDA AUTHORIZED GENERIC	NDA019270	Sandoz Inc	BETAXOLOL HYDROCHLORIDE	5.6	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61314-308_8d1b371d-f84a-4054-9a54-7cde00000f81	61314-308	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		azelastine hydrochloride	SOLUTION/ DROPS	INTRAOCULAR	20130321		ANDA	ANDA202305	Sandoz Inc	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61314-318_66b6af40-d900-4391-af20-aac49feaa59d	61314-318	HUMAN PRESCRIPTION DRUG	ZARXIO		filgrastim-sndz	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20150306		BLA	BLA125553	Sandoz Inc.	FILGRASTIM	300	ug/.5mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
61314-320_0f71b717-d3f6-4b3b-87d2-60327ea5831f	61314-320	HUMAN PRESCRIPTION DRUG	Olopatadine Hydrochloride		olopatadine hydrochloride	SPRAY, METERED	NASAL	20150401		NDA AUTHORIZED GENERIC	NDA021861	Sandoz Inc	OLOPATADINE HYDROCHLORIDE	665	ug/100uL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
61314-326_66b6af40-d900-4391-af20-aac49feaa59d	61314-326	HUMAN PRESCRIPTION DRUG	ZARXIO		filgrastim-sndz	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20150306		BLA	BLA125553	Sandoz Inc.	FILGRASTIM	480	ug/.8mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
61314-327_3468792f-63ef-4916-8ed1-8214f327d9dd	61314-327	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761071	Sandoz Inc.	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
61314-354_2fbad93e-d3da-4a31-9a78-66a923ce78ba	61314-354	HUMAN PRESCRIPTION DRUG	Tropicamide		Tropicamide	SOLUTION/ DROPS	OPHTHALMIC	20000609		ANDA	ANDA084305	Sandoz Inc	TROPICAMIDE	5	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
61314-355_51620df4-8e34-4ffa-bf5a-077efc3a1911	61314-355	HUMAN PRESCRIPTION DRUG	Tropicamide		Tropicamide	SOLUTION/ DROPS	OPHTHALMIC	20000613		ANDA	ANDA084306	Sandoz Inc	TROPICAMIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
61314-396_6b554ca9-699a-4d71-8e46-0130c675ca3c	61314-396	HUMAN PRESCRIPTION DRUG	Cyclopentolate Hydrochloride		Cyclopentolate Hydrochloride	SOLUTION	OPHTHALMIC	20020822		ANDA	ANDA084110	Sandoz Inc.	CYCLOPENTOLATE HYDROCHLORIDE	10	mg/mL			N	20241231
61314-454_5f7d6cf0-6300-4c73-a848-e9da6adf1680	61314-454	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761071	Sandoz Inc	ADALIMUMAB	80	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
61314-473_5f7d6cf0-6300-4c73-a848-e9da6adf1680	61314-473	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761071	Sandoz Inc	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
61314-476_5f7d6cf0-6300-4c73-a848-e9da6adf1680	61314-476	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761071	Sandoz Inc	ADALIMUMAB	20	mg/.2mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
61314-509_5f7d6cf0-6300-4c73-a848-e9da6adf1680	61314-509	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761071	Sandoz Inc	ADALIMUMAB	10	mg/.1mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
61314-517_5f7d6cf0-6300-4c73-a848-e9da6adf1680	61314-517	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	KIT		20230701		BLA	BLA761071	Sandoz Inc						N	20241231
61314-531_5f7d6cf0-6300-4c73-a848-e9da6adf1680	61314-531	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	KIT		20230701		BLA	BLA761071	Sandoz Inc						N	20241231
61314-547_a5bc334a-1e68-4075-a44d-6ee123586b58	61314-547	HUMAN PRESCRIPTION DRUG	Latanoprost		Latanoprost	SOLUTION	OPHTHALMIC	20110107		ANDA	ANDA091449	Sandoz Inc	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
61314-628_85cac791-8812-41fb-8809-8c64bfc6214c	61314-628	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim	SOLUTION	OPHTHALMIC	19980416		ANDA	ANDA064211	Sandoz Inc	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
61314-630_c28e6969-112d-49ae-b037-f09954e99f3e	61314-630	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		neomycin sulfate, polymyxin b sulfate and dexamethasone	SUSPENSION	OPHTHALMIC	19960221		ANDA	ANDA062341	Sandoz Inc.	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
61314-631_f61c2856-891f-41ad-aa5f-1ab6dc4a0509	61314-631	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin and Polymyxin B Sulfates and Dexamethasone	OINTMENT	OPHTHALMIC	19960221		NDA AUTHORIZED GENERIC	NDA050065	Sandoz Inc	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
61314-633_0c93c787-01e7-494d-9cf7-ca549ab66e14	61314-633	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION	OPHTHALMIC	19960405		ANDA	ANDA062196	Sandoz Inc	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
61314-637_4752a92c-81ff-4366-8e5c-9f126d4c01b2	61314-637	HUMAN PRESCRIPTION DRUG	Prednisolone Acetate		Prednisolone Acetate	SUSPENSION/ DROPS	OPHTHALMIC	19941215		NDA AUTHORIZED GENERIC	NDA017469	Sandoz Inc	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61314-641_15cc1b8f-5a7f-4cfb-8c65-9d35f7c0f30f	61314-641	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SUSPENSION	OPHTHALMIC	20030509		ANDA	ANDA062874	Sandoz Inc	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
61314-643_505c82ff-86c3-4269-96cb-faae872c7539	61314-643	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19950109		ANDA	ANDA062535	Sandoz Inc	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
61314-645_99d0c7c1-3bf0-4491-b093-551555f7e80c	61314-645	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SUSPENSION	AURICULAR (OTIC)	20030317		ANDA	ANDA062488	Sandoz Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
61314-646_a3e39398-1292-491a-a063-4f9406be7dce	61314-646	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SOLUTION	AURICULAR (OTIC)	20030318		ANDA	ANDA062423	Sandoz Inc	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [iU]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
61314-647_280b0ea8-161b-4f29-bc0c-a535497ed31b	61314-647	HUMAN PRESCRIPTION DRUG	Tobramycin and Dexamethasone		Tobramycin and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20090102		NDA AUTHORIZED GENERIC	NDA050592	Sandoz Inc	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61314-656_1c86f423-a99a-4e4d-9502-42799a9d40e6	61314-656	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	Sandoz Inc	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
61314-665_e67e69ac-f1e7-4e41-b7a3-63a14da106da	61314-665	HUMAN PRESCRIPTION DRUG	Apraclonidine		Apraclonidine	SOLUTION	OPHTHALMIC	20090719		NDA AUTHORIZED GENERIC	NDA020258	Sandoz Inc	APRACLONIDINE HYDROCHLORIDE	5.75	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
61314-672_20dfbbfa-5c67-4ac4-a90a-a7dd29395e71	61314-672	HUMAN PRESCRIPTION DRUG	Gatifloxacin		gatifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20161003		ANDA	ANDA204227	Sandoz Inc	GATIFLOXACIN	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
61314-701_6936177e-fec2-4ec0-b81d-af6d0bd43dc6	61314-701	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		Sulfacetamide Sodium	SOLUTION	OPHTHALMIC	20030325		ANDA	ANDA089560	Sandoz Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
61314-866_287d94a9-83b1-4a7c-8186-0018f7c4415f	61314-866	HUMAN PRESCRIPTION DRUG	ZIEXTENZO		pegfilgrastim-bmez	INJECTION	SUBCUTANEOUS	20191104		BLA	BLA761045	Sandoz Inc	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
61328-010_0389bab7-04fc-7cfc-e063-6394a90a22d8	61328-010	HUMAN OTC DRUG	ECZEMA HAND RELIEF		COLLOIDAL OATMEAL	CREAM	TOPICAL	20231001		OTC MONOGRAPH FINAL	M016	Skinfix, Inc.	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61328-106_aa4f4099-06db-400a-95d3-b9ecec6bbf7d	61328-106	HUMAN OTC DRUG	SKINFIX HAND REPAIR		OATMEAL	CREAM	TOPICAL	20140702		OTC MONOGRAPH FINAL	part347	Skinfix, Inc.	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61328-112_fb801d20-9bed-1c71-e053-6394a90a6e95	61328-112	HUMAN OTC DRUG	ECZEMA DERMATITIS RELIEF BALM		COLLOIDAL OATMEAL	CREAM	TOPICAL	20231001		OTC MONOGRAPH FINAL	M016	Skinfix, Inc.	OATMEAL	5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61328-119_b707b1b5-c318-40e2-82c8-530d851f02a4	61328-119	HUMAN OTC DRUG	EXTRA STRENGTH BODY		Colloidal Oatmeal	CREAM	TOPICAL	20220130		OTC MONOGRAPH FINAL	part347	Skinfix, Inc.	OATMEAL	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61328-120_e4377d37-37ae-4e52-9483-88bc563a91c9	61328-120	HUMAN OTC DRUG	911		Allantoin	OINTMENT	TOPICAL	20181226		OTC MONOGRAPH FINAL	part347	Skinfix, Inc.	ALLANTOIN	.5	g/100g			N	20241231
61328-121_060105d3-505b-4b16-8f2e-747523bbf7f6	61328-121	HUMAN OTC DRUG	DERMATITIS FACE BALM		Colloidal Oatmeal	OINTMENT	TOPICAL	20220203		OTC MONOGRAPH FINAL	part347	Skinfix, Inc.	OATMEAL	5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61328-122_860fce63-4fc8-40d1-84a2-a4dbef451fd7	61328-122	HUMAN OTC DRUG	TARGETED BODY BALM		Oatmeal	OINTMENT	TOPICAL	20150523		OTC MONOGRAPH FINAL	part347	Skinfix, Inc.	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61328-210_0e673ba3-ea94-c414-e063-6294a90ac794	61328-210	HUMAN OTC DRUG	ECZEMA INTENSIVE DAILY RELIEF BODY		colloidal oatmeal cream	CREAM	TOPICAL	20240107		OTC MONOGRAPH DRUG	M016	Skinfix, Inc.	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
61328-403_a798a616-6a75-4693-810b-1115076b75c7	61328-403	HUMAN OTC DRUG	BHA CLEANSER	2%	SALICYLIC ACID	LOTION	TOPICAL	20220204		OTC MONOGRAPH FINAL	part333D	Skinfix, Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
61328-404_81ef9a0d-80ad-4347-aa2a-57c1d9010f72	61328-404	HUMAN OTC DRUG	ACNE SPOT TREATMENT	2% BHA	SALICYLIC ACID	CREAM	TOPICAL	20210316		OTC MONOGRAPH FINAL	part333D	Skinfix, Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
61330-123_06d2f36c-85fd-af08-e063-6394a90aa424	61330-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20151027		UNAPPROVED MEDICAL GAS		Brevard Medical Equipment	OXYGEN	99	L/100L			N	20241231
61333-201_f26671ed-4f4f-56bd-e053-2a95a90a41f6	61333-201	HUMAN OTC DRUG	Lights Povidone Iodine Solution		POVIDONE-IODINE	SOLUTION	TOPICAL	20140222		OTC MONOGRAPH FINAL	part333C	Lights Medical Manufacture Co., Ltd.	POVIDONE-IODINE	1.18	g/118mL			N	20241231
61333-202_0b30d1c8-f15a-abd8-e063-6394a90ad02b	61333-202	HUMAN OTC DRUG	Lights Povidone Iodine Solution		POVIDONE-IODINE	SOLUTION	TOPICAL	20140322		OTC MONOGRAPH DRUG	M003	Lights Medical Manufacture Co., Ltd.	POVIDONE-IODINE	1.18	g/118mL			N	20241231
61333-203_f7e4f8db-7ae9-177a-e053-6294a90af792	61333-203	HUMAN OTC DRUG	Lights Povidone Iodine Prep Pad		POVIDONE-IODINE	SOLUTION	TOPICAL	20151015		OTC MONOGRAPH FINAL	part333C	Lights Medical Manufacture Co., Ltd.	POVIDONE-IODINE	1	g/100g			N	20241231
61333-204_0b30b9da-c249-732f-e063-6394a90a2635	61333-204	HUMAN OTC DRUG	Lights Povindone Iodine Swabstick		POVIDONE-IODINE	SOLUTION	TOPICAL	20190301		OTC MONOGRAPH DRUG	M003	Lights Medical Manufacture Co., Ltd.	POVIDONE-IODINE	1	g/100g			N	20241231
61333-205_0b30c8ca-933b-ffb0-e063-6294a90a7376	61333-205	HUMAN OTC DRUG	Lights Povindone Iodine Scrub		POVIDONE-IODINE	SOLUTION	TOPICAL	20190718		OTC MONOGRAPH DRUG	M003	Lights Medical Manufacture Co., Ltd.	POVIDONE-IODINE	.75	g/100g			N	20241231
61333-206_f26659dd-8805-6aeb-e053-2a95a90a3003	61333-206	HUMAN OTC DRUG	Lights Isopropyl Alcohol Prep Pads		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20190801		OTC MONOGRAPH NOT FINAL	part333A	Lights Medical Manufacture Co., Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
61333-208_f26664cf-8ab3-7556-e053-2995a90a965c	61333-208	HUMAN OTC DRUG	LIGHTS Swabstick		benzalkonium chloride	SOLUTION	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333E	Lights Medical Manufacture Co., Ltd.	BENZALKONIUM CHLORIDE	.133	g/100g			N	20241231
61333-212_f87aa328-0dd1-d119-e053-6394a90ae6a0	61333-212	HUMAN OTC DRUG	Lights Povindone Iodine Swabstick		POVIDONE-IODINE	SWAB	TOPICAL	20230403		OTC MONOGRAPH FINAL	part333C	Lights Medical Manufacture Co., Ltd.	POVIDONE-IODINE	1	g/100g			N	20241231
61333-213_0eb8ec72-623f-a0d7-e063-6394a90aa3f2	61333-213	HUMAN OTC DRUG	LIGHTS Insect Sting Relief Pad		BENZOCAINE	SOLUTION	TOPICAL	20240111		OTC MONOGRAPH DRUG	M017	Lights Medical Manufacture Co., Ltd.	ALCOHOL; BENZOCAINE	60; 6	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
61333-500_f26664cf-8ab5-7556-e053-2995a90a965c	61333-500	HUMAN OTC DRUG	BZK Antiseptic		benzalkonium chloride	SWAB	TOPICAL	20210602		OTC MONOGRAPH NOT FINAL	part333E	Lights Medical Manufacture Co., Ltd.	BENZALKONIUM CHLORIDE	.13	mg/100mg			N	20241231
61344-452_eec8516e-27ac-d690-e053-2995a90a48d2	61344-452	HUMAN OTC DRUG	Uremol		Urea	LOTION	TOPICAL	20190531		UNAPPROVED DRUG OTHER		Odan Laboratories Ltd	UREA	100	mg/mL			N	20241231
61344-455_0a9c19bf-c110-d61f-e063-6294a90aeead	61344-455	HUMAN OTC DRUG	Uremol 20% cream		Urea	CREAM	TOPICAL	20190531		UNAPPROVED DRUG OTHER		Odan Laboratories Ltd	UREA	200	mg/g			N	20241231
61352-001_8b7c860d-ce11-4385-9be5-6aa377705103	61352-001	HUMAN OTC DRUG	Clinicians Complex		Sulfur	LOTION	TOPICAL	20131211		OTC MONOGRAPH FINAL	part333D	Cosmed Dermaceuticals, Inc.	SULFUR	100	mg/g			N	20241231
61352-004_41213645-a51b-41f6-bdca-e92df5bd2a8c	61352-004	HUMAN OTC DRUG	Total Sun Protection		Octinoxate, Octisalate, Oxybenzone, Zinc Oxide	LOTION	TOPICAL	20130801		OTC MONOGRAPH FINAL	part352	Cosmed Dermaceuticals, Inc.	OCTINOXATE; OCTISALATE; OXYBENZONE; ZINC OXIDE	75; 30; 30; 40	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61354-017_f45cbf13-de13-51eb-e053-2995a90a7a55	61354-017	HUMAN OTC DRUG	Powder		Zinc Oxide	POWDER	TOPICAL	20211028		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	ZINC OXIDE	24.5	g/100g			N	20241231
61354-018_f45cc5c4-246f-1c07-e053-2995a90a8244	61354-018	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211227		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-019_f45cc409-ae5c-76bb-e053-2a95a90ae04c	61354-019	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211227		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-024_f45cbf13-de0f-51eb-e053-2995a90a7a55	61354-024	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-025_f45d25d2-9308-5858-e053-2a95a90a7f7b	61354-025	HUMAN OTC DRUG	cream		Octinoxate, Oxybenzone	CREAM	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development	OCTINOXATE; OXYBENZONE	7.49; 2	mg/100mg; mg/100mg			N	20241231
61354-026_f45d0878-c1b5-4f9e-e053-2a95a90a2aa6	61354-026	HUMAN OTC DRUG	cream		Octinoxate, Oxybenzone	CREAM	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development	OCTINOXATE; OXYBENZONE	7.49; 2	mg/100mg; mg/100mg			N	20241231
61354-027_f45cbf13-de0e-51eb-e053-2995a90a7a55	61354-027	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-028_f45cbf6d-5fbc-52a3-e053-2995a90a66a1	61354-028	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-029_f45cbf13-ddf9-51eb-e053-2995a90a7a55	61354-029	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-030_f45d8012-5c88-5d96-e053-2995a90a74b6	61354-030	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Oxygen Development LLC	ZINC OXIDE	19.72	mg/100mg			N	20241231
61354-030_f45d874c-7c7e-8863-e053-2995a90aeeb3	61354-030	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	ZINC OXIDE	19.72	mg/100mg			N	20241231
61354-031_f45d4373-f5c0-a720-e053-2a95a90ac957	61354-031	HUMAN OTC DRUG	MOISTURIZER		AVOBENZONE, OXYBENZONE, OCTISALATE, HOMOSALATE, OCTOCRYLENE	CREAM	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 1; 5	mg/100mg; mg/100mg; mg/100mg; mg/100mg; mg/100mg			N	20241231
61354-032_f45d0098-02ce-f8d6-e053-2a95a90ae8aa	61354-032	HUMAN OTC DRUG	MOISTURIZER		AVOBENZONE, OCTINOXATE	CREAM	TOPICAL	20210226		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	AVOBENZONE; OCTINOXATE	3; 7.49	mg/100mg; mg/100mg			N	20241231
61354-033_f45d0098-02cf-f8d6-e053-2a95a90ae8aa	61354-033	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	ZINC OXIDE	19.72	mg/100mg			N	20241231
61354-034_f45c64a5-75d2-d1aa-e053-2a95a90aa58b	61354-034	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-035_f45d48dd-ede5-06b9-e053-2995a90a1607	61354-035	HUMAN OTC DRUG	MOISTURIZER		AVOBENZONE, OXYBENZONE, OCTISALATE, HOMOSALATE, OCTOCRYLENE	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 1; 5	mg/100mg; mg/100mg; mg/100mg; mg/100mg; mg/100mg			N	20241231
61354-036_f45cbae9-a410-1c6e-e053-2995a90a1bdf	61354-036	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-037_f45cb065-5fd6-07f9-e053-2a95a90a7b94	61354-037	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-038_f45c931f-0c19-9814-e053-2a95a90a9cdc	61354-038	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.4	mL/100mL			N	20241231
61354-039_d4b3eb40-c9d8-f356-e053-2a95a90a9a57	61354-039	HUMAN OTC DRUG	Moisturizer		Avobenzone	CREAM	TOPICAL	20220103		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	3; 7.29; 3; 2	g/100g; g/100g; g/100g; g/100g			N	20241231
61354-040_f45d16b8-0f7a-1a9f-e053-2a95a90a0253	61354-040	HUMAN OTC DRUG	Foundation		Octinoxate	EMULSION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE	4.9965	mg/100mg			N	20241231
61354-040_f45d2f79-ec5f-9e7f-e053-2995a90a48fa	61354-040	HUMAN OTC DRUG	Foundation		Octinoxate	EMULSION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE	4.9965	mg/100mg			N	20241231
61354-040_f45d2f79-ec60-9e7f-e053-2995a90a48fa	61354-040	HUMAN OTC DRUG	Foundation		Octinoxate	EMULSION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE	4.9965	mg/100mg			N	20241231
61354-040_f45d31b8-5ba7-bf48-e053-2995a90a547b	61354-040	HUMAN OTC DRUG	Foundation		Octinoxate	EMULSION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE	4.9965	mg/100mg			N	20241231
61354-041_d4c411de-efab-7866-e053-2995a90aadb0	61354-041	HUMAN OTC DRUG	Moisturizer		Avobenzone	CREAM	TOPICAL	20220104		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 1; 5	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
61354-042_d4c8204e-596c-5978-e053-2995a90a3dfc	61354-042	HUMAN OTC DRUG	Moisturizer		Zinc Oxide	LOTION	TOPICAL	20220104		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	ZINC OXIDE	17.68	mg/100mg			N	20241231
61354-043_d550fbe8-cb49-1037-e053-2995a90a0cac	61354-043	HUMAN OTC DRUG	Powder		Zinc Oxide	POWDER	TOPICAL	20220111		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	8.6; 10	g/100g; g/100g			N	20241231
61354-044_d551e722-8de6-d0b1-e053-2995a90a6c90	61354-044	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20220111		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	70.47	mL/100mL			N	20241231
61354-045_d55258fe-ba5d-5f18-e053-2a95a90adf23	61354-045	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20220111		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	70.47	mL/100mL			N	20241231
61354-046_d55381c7-e604-28cc-e053-2995a90a7e3b	61354-046	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	GEL	TOPICAL	20220111		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ISOPROPYL ALCOHOL	70.92	mL/100mL			N	20241231
61354-047_f3cf2641-92cd-67b2-e053-2a95a90ab73b	61354-047	HUMAN OTC DRUG	Sunscreen		Homosalate, Octocrylene, Octisalate, Avobenzone	GEL	TOPICAL	20220214		OTC MONOGRAPH FINAL	part352	Oxygen Development, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	mg/100mg; mg/100mg; mg/100mg; mg/100mg			N	20241231
61354-048_ddceca1d-3b13-f711-e053-2a95a90aa542	61354-048	HUMAN OTC DRUG	MOISTURIZER		ZINC OXIDE	CREAM	TOPICAL	20220429		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	ZINC OXIDE	22.4	mg/100mg			N	20241231
61354-051_f45ce071-a724-d5ee-e053-2995a90ada5b	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45cf528-2bfa-ff03-e053-2a95a90ad530	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45cf528-2bfb-ff03-e053-2a95a90ad530	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210226		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45cf528-2bfc-ff03-e053-2a95a90ad530	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45cfb71-4323-ac58-e053-2995a90a3d9e	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210226		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45cfb71-4324-ac58-e053-2995a90a3d9e	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d0098-02d0-f8d6-e053-2a95a90ae8aa	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d03b3-a139-43ea-e053-2a95a90ab892	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d04ad-d3f5-11be-e053-2995a90a1b5b	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d04ad-d3f6-11be-e053-2995a90a1b5b	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d04ad-d3f9-11be-e053-2995a90a1b5b	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d0878-c1b2-4f9e-e053-2a95a90a2aa6	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d0878-c1b3-4f9e-e053-2a95a90a2aa6	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d0878-c1b4-4f9e-e053-2a95a90a2aa6	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d0878-c1b6-4f9e-e053-2a95a90a2aa6	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d0980-06f4-49b4-e053-2a95a90a8ff1	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d0980-06f5-49b4-e053-2a95a90a8ff1	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d120b-1246-370a-e053-2995a90af808	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d120b-1247-370a-e053-2995a90af808	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d16b8-0f79-1a9f-e053-2a95a90a0253	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d1c0e-a8f1-4dad-e053-2995a90ae7f1	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d5975-e224-1eb7-e053-2a95a90a0f7f	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d5975-e225-1eb7-e053-2a95a90a0f7f	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d597b-1b3c-43de-e053-2995a90a8883	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d597b-1b3d-43de-e053-2995a90a8883	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d62ef-6791-1867-e053-2995a90aa5a6	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d62ef-6792-1867-e053-2995a90aa5a6	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d6b8d-6549-5e3d-e053-2a95a90a7b6b	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d7b92-0973-07c9-e053-2a95a90af8a7	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d8437-b266-5399-e053-2a95a90a80dd	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d8437-b267-5399-e053-2a95a90a80dd	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_f45d84fa-9957-6954-e053-2a95a90a41cd	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_fe8019be-970c-4b5f-e053-6294a90aa7cb	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_fe801d1f-0c6c-6289-e053-6394a90ad472	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_fe801d1f-0c70-6289-e053-6394a90ad472	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_fe80793a-f463-428c-e053-6394a90ad6a5	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-051_fe80992b-818b-dfca-e053-6294a90a9bef	61354-051	HUMAN OTC DRUG	Cream		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	OXYGEN DEVELOPMENT, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.55; 3.5	mg/100mg; mg/100mg			N	20241231
61354-052_f45d03b3-a13a-43ea-e053-2a95a90ab892	61354-052	HUMAN OTC DRUG	powder		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	Oxygen development	TITANIUM DIOXIDE; ZINC OXIDE	8.6; 10	mg/100mg; mg/100mg			N	20241231
61354-052_f45d0980-06f3-49b4-e053-2a95a90a8ff1	61354-052	HUMAN OTC DRUG	powder		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20210225		OTC MONOGRAPH FINAL	part352	Oxygen development	TITANIUM DIOXIDE; ZINC OXIDE	8.6; 10	mg/100mg; mg/100mg			N	20241231
61354-052_f45d2f79-ec62-9e7f-e053-2995a90a48fa	61354-052	HUMAN OTC DRUG	powder		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen development	TITANIUM DIOXIDE; ZINC OXIDE	8.6; 10	mg/100mg; mg/100mg			N	20241231
61354-053_de1ce543-68a5-4fc0-e053-2a95a90a31ba	61354-053	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium dioxide	LOTION	TOPICAL	20220503		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-054_de211188-af53-2ad6-e053-2995a90a1ec9	61354-054	HUMAN OTC DRUG	cream		Zinc oxide, Titanium dioxide	LOTION	TOPICAL	20220503		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-055_de30870a-0834-c258-e053-2995a90ae99b	61354-055	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium oxide	LOTION	TOPICAL	20220504		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-056_de322a82-4974-c700-e053-2a95a90a2228	61354-056	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium dioxide	LOTION	TOPICAL	20220504		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-057_de3286f9-8049-56cc-e053-2a95a90a5a71	61354-057	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium dioxide	LOTION	TOPICAL	20220504		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-058_de34a4e6-5921-4dd1-e053-2995a90a0ee8	61354-058	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium oxide	LOTION	TOPICAL	20220504		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-059_de350368-89fd-4a42-e053-2995a90a422f	61354-059	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium dioxide	LOTION	TOPICAL	20220504		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-061_f45d31b8-5ba5-bf48-e053-2995a90a547b	61354-061	HUMAN OTC DRUG	powder		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development	TITANIUM DIOXIDE; ZINC OXIDE	15.09; 17.55	g/100g; g/100g			N	20241231
61354-061_f45d31b8-5ba6-bf48-e053-2995a90a547b	61354-061	HUMAN OTC DRUG	powder		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development	TITANIUM DIOXIDE; ZINC OXIDE	15.09; 17.55	g/100g; g/100g			N	20241231
61354-061_f45d4373-f5bf-a720-e053-2a95a90ac957	61354-061	HUMAN OTC DRUG	powder		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development	TITANIUM DIOXIDE; ZINC OXIDE	15.09; 17.55	g/100g; g/100g			N	20241231
61354-061_f45d48dd-ede6-06b9-e053-2995a90a1607	61354-061	HUMAN OTC DRUG	powder		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20210223		OTC MONOGRAPH FINAL	part352	Oxygen Development	TITANIUM DIOXIDE; ZINC OXIDE	15.09; 17.55	g/100g; g/100g			N	20241231
61354-062_de594e52-867a-2d54-e053-2995a90afb1e	61354-062	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium dioxide	LOTION	TOPICAL	20220506		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-063_de59c3df-f3f0-2f24-e053-2a95a90acaa0	61354-063	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium diosxide	LOTION	TOPICAL	20220506		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-064_de5a11ba-8483-dabc-e053-2a95a90ac0c1	61354-064	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium dioxide	LOTION	TOPICAL	20220506		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-065_de5b921a-8bfb-640a-e053-2a95a90a3041	61354-065	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium dioxide	LOTION	TOPICAL	20220506		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-066_de5cbb94-1275-7f5e-e053-2995a90aeeef	61354-066	HUMAN OTC DRUG	Cream		Zinc oxide, Titanium Dioxide	LOTION	TOPICAL	20220506		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-069_e60f741d-7bb5-0cf9-e053-2a95a90aa60b	61354-069	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220812		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-070_f45d6381-56f8-5b7e-e053-2a95a90a1df8	61354-070	HUMAN OTC DRUG	Cream		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE; ZINC OXIDE	5; 5	mg/100mg; mg/100mg			N	20241231
61354-070_f45d6b8d-6546-5e3d-e053-2a95a90a7b6b	61354-070	HUMAN OTC DRUG	cream		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE; ZINC OXIDE	5; 5	mg/100mg; mg/100mg			N	20241231
61354-070_f45d6b8d-6547-5e3d-e053-2a95a90a7b6b	61354-070	HUMAN OTC DRUG	cream		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE; ZINC OXIDE	5; 5	mg/100mg; mg/100mg			N	20241231
61354-070_f45d6b8d-6548-5e3d-e053-2a95a90a7b6b	61354-070	HUMAN OTC DRUG	cream		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	OCTINOXATE; ZINC OXIDE	5; 5	mg/100mg; mg/100mg			N	20241231
61354-071_e6104c33-b057-fc8d-e053-2995a90a5f5c	61354-071	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220812		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-072_e61069a2-3dd6-7a68-e053-2995a90a931b	61354-072	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220812		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-073_e65d5a6d-85d7-2568-e053-2995a90a8d6b	61354-073	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-074_e65d9aad-af41-485f-e053-2a95a90a1f1e	61354-074	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-075_e65e5d44-5164-53b4-e053-2a95a90a0b7d	61354-075	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-076_e65ec78f-2178-4f14-e053-2a95a90a6144	61354-076	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-077_e66027e0-54d3-70be-e053-2a95a90ab6ab	61354-077	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-078_e6607a71-7413-6a7b-e053-2995a90a3108	61354-078	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-079_e660c87e-2b06-029a-e053-2995a90a6677	61354-079	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
61354-080_f45d16b8-0f7e-1a9f-e053-2a95a90a0253	61354-080	HUMAN OTC DRUG	Cream		Titanium Dioxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE	17	mg/100mg			N	20241231
61354-080_f45d221f-9c56-2588-e053-2a95a90a1e76	61354-080	HUMAN OTC DRUG	Cream		Titanium Dioxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE	17	mg/100mg			N	20241231
61354-080_f45d221f-9c57-2588-e053-2a95a90a1e76	61354-080	HUMAN OTC DRUG	Cream		Titanium Dioxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE	17	mg/100mg			N	20241231
61354-080_f45d319f-0fa2-c392-e053-2995a90a26da	61354-080	HUMAN OTC DRUG	Cream		Titanium Dioxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen Development LLC	TITANIUM DIOXIDE	17	mg/100mg			N	20241231
61354-081_e715df51-25f7-298a-e053-2a95a90a0464	61354-081	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20220825		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-082_e724e10c-4f05-b03d-e053-2a95a90a754c	61354-082	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20220826		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-083_e7757228-2748-0ae5-e053-2a95a90ac31c	61354-083	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20220830		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-084_e7763ac1-d05c-7f8f-e053-2995a90a6c15	61354-084	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20220830		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-085_e776d7ee-d30e-e3dd-e053-2995a90a8cfa	61354-085	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20220830		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-086_e776f37b-869c-5861-e053-2995a90a19f5	61354-086	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20220830		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-087_e7772981-a648-3218-e053-2a95a90ad227	61354-087	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20220830		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-088_e77748ac-2f7b-5fb9-e053-2a95a90a0eaf	61354-088	HUMAN OTC DRUG	Cream		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20220830		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.49	mg/100mg; mg/100mg			N	20241231
61354-089_f3bb0b9d-bab0-4770-e053-2995a90a9571	61354-089	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230202		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	ZINC OXIDE	24.05	mg/100mg			N	20241231
61354-090_f45d8012-5c87-5d96-e053-2995a90a74b6	61354-090	HUMAN OTC DRUG	Sunscreen		Zinc Oxide	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	part352	Oxygen development	ZINC OXIDE	24	mg/100mg			N	20241231
61354-091_f77f6887-f715-9d0a-e053-6394a90ab050	61354-091	HUMAN OTC DRUG	Liquid		Salicylic acid	LIQUID	TOPICAL	20230322		OTC MONOGRAPH FINAL	M006	Oxygen Development LLC	SALICYLIC ACID	2	mg/100mg			N	20241231
61354-092_fe1a3691-aa68-28f8-e053-6394a90aa9a8	61354-092	HUMAN OTC DRUG	MIST		SALICYLIC ACID	LIQUID	TOPICAL	20230614		OTC MONOGRAPH FINAL	part333D	OXYGEN DEVELOPMENT, LLC	SALICYLIC ACID	.5	mg/100mg			N	20241231
61354-093_fe4526cd-cb7a-6504-e053-6394a90a37e6	61354-093	HUMAN OTC DRUG	Powder		Zinc Oxide	POWDER	TOPICAL	20230616		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	ZINC OXIDE	24.5	mg/100mg			N	20241231
61354-094_fea9a85f-0532-9427-e053-6394a90abeb1	61354-094	HUMAN OTC DRUG	Zinc Oxide		Cream	CREAM	TOPICAL	20230621		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-094_fece2ad8-c591-34ab-e053-6394a90a7328	61354-094	HUMAN OTC DRUG	Zinc Oxide		Cream	CREAM	TOPICAL	20230621		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-095_fecd33f4-920d-8f7f-e053-6294a90a8dcf	61354-095	HUMAN OTC DRUG	Zinc Oxide		Cream	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-095_fece05b7-cac0-5c2d-e053-6294a90acbce	61354-095	HUMAN OTC DRUG	Zinc Oxide		Cream	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-096_fece05b7-cac3-5c2d-e053-6294a90acbce	61354-096	HUMAN OTC DRUG	Zinc Oxide		Cream	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-097_fece6ae3-bd67-5dfa-e053-6294a90a1b65	61354-097	HUMAN OTC DRUG	Zinc Oxide		Cream	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-098_fece4ad8-390f-3112-e053-6294a90a3fe7	61354-098	HUMAN OTC DRUG	Zinc Oxide		Cream	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-099_ff0b2dc9-c372-4bb6-e053-6394a90aefad	61354-099	HUMAN OTC DRUG	cream		Salicylic Acid	LOTION	TOPICAL	20230626		OTC MONOGRAPH FINAL	M006	Oxygen Development LLC	SALICYLIC ACID	1.5	mg/100mg			N	20241231
61354-100_ff1d9abc-592a-a14f-e053-6294a90a6fc0	61354-100	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-101_ff1d2e9f-6893-9183-e053-6394a90ae812	61354-101	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-102_ff1df868-6110-81d3-e053-6294a90a7c1c	61354-102	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-103_ff1e491d-d4e5-d7d6-e053-6294a90a416c	61354-103	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-104_ff1e4328-4409-f7cd-e053-6294a90ab2db	61354-104	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-105_ff1e9699-e5eb-621e-e053-6394a90a5479	61354-105	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-106_ff1e72e6-1112-9b97-e053-6294a90a5e07	61354-106	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-107_ff1e72e6-1113-9b97-e053-6294a90a5e07	61354-107	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-108_ff1ee9a1-7d79-c8c8-e053-6294a90a13bd	61354-108	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-109_ff1ee9a1-7d84-c8c8-e053-6294a90a13bd	61354-109	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-110_ff1f0ba1-57b4-eea5-e053-6394a90a5ee7	61354-110	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.54; 3.498	mg/100mg; mg/100mg			N	20241231
61354-111_ffd74c89-4226-758e-e053-6394a90a7d88	61354-111	HUMAN OTC DRUG	Cream		zinc oxide	CREAM	TOPICAL	20230706		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	ZINC OXIDE	18.8	mg/100mg			N	20241231
61354-112_ffd74c89-4232-758e-e053-6394a90a7d88	61354-112	HUMAN OTC DRUG	Cream		zinc oxide	CREAM	TOPICAL	20230706		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	ZINC OXIDE	18.8	mg/100mg			N	20241231
61354-113_ffe88375-5bd5-61ff-e053-6294a90a05c8	61354-113	HUMAN OTC DRUG	Cream		zinc oxide	CREAM	TOPICAL	20230706		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	ZINC OXIDE	18.8	mg/100mg			N	20241231
61354-114_ffe8d444-454c-bd49-e053-6294a90ad20f	61354-114	HUMAN OTC DRUG	Cream		zinc oxide	CREAM	TOPICAL	20230706		OTC MONOGRAPH FINAL	M020	Oxygen Development LLC	ZINC OXIDE	18.8	mg/100mg			N	20241231
61354-115_08a1e862-b55b-fb84-e063-6294a90a016a	61354-115	HUMAN OTC DRUG	Cream		Zinc Oxide	CREAM	TOPICAL	20231026		OTC MONOGRAPH DRUG	M020	Oxygen Development LLC	ZINC OXIDE	21.76	mg/100mg			N	20241231
61354-117_08b52f29-c1a1-c673-e063-6294a90a9a7a	61354-117	HUMAN OTC DRUG	Powder		Titanium Dioxide	POWDER	TOPICAL	20231027		OTC MONOGRAPH DRUG	M020	Oxygen Development LLC	FERRIC OXIDE RED; TITANIUM DIOXIDE	1.75; 10	mg/100mg; mg/100mg			N	20241231
61354-118_08b7e48d-ea9b-b522-e063-6394a90acad7	61354-118	HUMAN OTC DRUG	Powder		Titanium Dioxide	POWDER	TOPICAL	20231027		OTC MONOGRAPH DRUG	M020	Oxygen Development LLC	FERRIC OXIDE RED; TITANIUM DIOXIDE	1.75; 10	mg/100mg; mg/100mg			N	20241231
61354-119_08b81258-0f6f-2ced-e063-6294a90a72ff	61354-119	HUMAN OTC DRUG	Powder		Titanium Dioxide	POWDER	TOPICAL	20231027		OTC MONOGRAPH DRUG	M020	Oxygen Development LLC	FERRIC OXIDE RED; TITANIUM DIOXIDE	1.75; 10	mg/100mg; mg/100mg			N	20241231
61362-2150_6f065a2a-5cda-4a9d-b181-6c68abc7db26	61362-2150	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19600101		NDA	NDA205849	Reliance Bottle Gas Company Inc. dba Reliance Oxygen & Equipment Co.	OXYGEN	99	L/100L			N	20241231
61369-401_f1ec7607-56cf-4ee1-e053-2a95a90a54ea	61369-401	HUMAN OTC DRUG	KLENSKIN HAND SANITIZING MIST		ETHYL ALCOHOL	SPRAY	TOPICAL	20200606		OTC MONOGRAPH NOT FINAL	part333A	CoLabs Intl. Corp	ALCOHOL	80	mL/100mL			N	20241231
61387-248_00efda74-d414-04be-e063-6294a90a6d98	61387-248	HUMAN OTC DRUG	White Petrolatum		CheryLee MD Sensitive Skin Care TrueLipids Double Action Boo-Boo Bum	OINTMENT	TOPICAL	20140301		OTC MONOGRAPH FINAL	M015	Claridei Laboratories, Inc.	PETROLATUM	50	g/100g			N	20241231
61387-249_02956b3d-82cb-a8a3-e063-6394a90a42e1	61387-249	HUMAN OTC DRUG	White Petrolatum		CheryLee MD Sensitive Skin Care TrueLipids Relieve and Protect Ointment	OINTMENT	TOPICAL	20140301		OTC MONOGRAPH FINAL	M015	Claridei Laboratories, Inc.	PETROLATUM	50	g/100g			N	20241231
61387-250_00efd56e-dee9-6ff2-e063-6394a90acfb8	61387-250	HUMAN OTC DRUG	White Petrolatum		CherylLee MD Sensitive Skin Care TrueLipids TrueLips Lip Balm	OINTMENT	TOPICAL	20140301		OTC MONOGRAPH FINAL	M015	Claridei Laboratories, Inc.	PETROLATUM	50	g/100g			N	20241231
61387-251_01580e8e-93f4-afeb-e063-6294a90a6cbc	61387-251	HUMAN OTC DRUG	Crash Cream		White Petrolatum	OINTMENT	TOPICAL	20230728		OTC MONOGRAPH FINAL	M016	Claridei Laboratories	WHITE PETROLATUM	50	g/100g			N	20241231
61387-252_037395dc-5b97-052e-e063-6394a90a26e4	61387-252	HUMAN OTC DRUG	TrueLipids 1% Hydrocortisone Barrier Cream		Hydrocortisone	CREAM	TOPICAL	20230810		OTC MONOGRAPH NOT FINAL	part348	Claridei Laboratories	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61393-0003_eb09cf61-2555-b7e4-e053-2995a90a4bb8	61393-0003	HUMAN PRESCRIPTION DRUG	Oxygen Compressed UN 1072 Refrigerated UN 1073		OXYGEN	GAS	RESPIRATORY (INHALATION)	20180119		UNAPPROVED DRUG OTHER		RCC Medical Supply	OXYGEN	1	L/L			N	20241231
61398-0828_07ead6cf-8eb8-2884-e063-6294a90aad67	61398-0828	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091202		UNAPPROVED MEDICAL GAS		Complete Care Inc	OXYGEN	99	L/100L			N	20241231
61420-0001_06d6afc1-a826-ba88-e063-6394a90ad1d4	61420-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091023		UNAPPROVED MEDICAL GAS		Dillon Medical Supply	OXYGEN	99	L/100L			N	20241231
61426-123_0c43a406-573a-9b8e-e063-6294a90aad1a	61426-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130531		UNAPPROVED MEDICAL GAS		Sobaks Home Medical, Inc.	OXYGEN	99	L/100L			N	20241231
61442-101_544dfee7-435e-6f28-e054-00144ff8d46c	61442-101	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Carlsbad Technology, Inc.	DICLOFENAC SODIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61442-102_544dfee7-435e-6f28-e054-00144ff8d46c	61442-102	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Carlsbad Technology, Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61442-103_544dfee7-435e-6f28-e054-00144ff8d46c	61442-103	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Carlsbad Technology, Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61442-112_ec0b7750-b169-d1c6-e053-2995a90aadec	61442-112	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Carlsbad Technology, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61442-113_ec0b7750-b169-d1c6-e053-2995a90aadec	61442-113	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Carlsbad Technology, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61442-114_588e5f89-5d51-2522-e053-2991aa0ae0c0	61442-114	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20170817		ANDA	ANDA206261	Carlsbad Technology, Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61442-115_ec0ba17e-68ab-d914-e053-2a95a90ae01d	61442-115	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	Carlsbad Technology, Inc.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61442-116_ec0ba17e-68ab-d914-e053-2a95a90ae01d	61442-116	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	Carlsbad Technology, Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61442-117_ec0ba17e-68ab-d914-e053-2a95a90ae01d	61442-117	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	Carlsbad Technology, Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61442-121_f6cc4c26-79fb-bd74-e053-6394a90a04e4	61442-121	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Carlsbad Technology, Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
61442-122_f6cc4c26-79fb-bd74-e053-6394a90a04e4	61442-122	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Carlsbad Technology, Inc	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
61442-126_f4ebaa8b-4803-d3da-e053-2a95a90afc31	61442-126	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Carlsbad Technology, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61442-127_f4ebaa8b-4803-d3da-e053-2a95a90afc31	61442-127	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Carlsbad Technology, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61442-141_b18075c3-0ee9-12af-e053-2a95a90a9d89	61442-141	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Carlsbad Technology, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61442-142_b18075c3-0ee9-12af-e053-2a95a90a9d89	61442-142	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Carlsbad Technology, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61442-143_b18075c3-0ee9-12af-e053-2a95a90a9d89	61442-143	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Carlsbad Technology, Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61442-171_33045f3a-7875-439d-a6e4-60df32a821d3	61442-171	HUMAN PRESCRIPTION DRUG	Cefaclor		Cefaclor	CAPSULE	ORAL	20080731		ANDA	ANDA065146	Carlsbad Technology, Inc.	CEFACLOR	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
61442-172_33045f3a-7875-439d-a6e4-60df32a821d3	61442-172	HUMAN PRESCRIPTION DRUG	Cefaclor		Cefaclor	CAPSULE	ORAL	20080731		ANDA	ANDA065146	Carlsbad Technology, Inc.	CEFACLOR	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
61442-223_f64157cf-236a-25e8-e053-2995a90aaf4a	61442-223	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Carlsbad Technology, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
61442-431_02ad45e1-9fba-78af-e063-6394a90ac429	61442-431	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Carlsbad Technology, Inc.	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61442-432_02ad45e1-9fba-78af-e063-6394a90ac429	61442-432	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Carlsbad Technology, Inc.	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61442-433_02ad45e1-9fba-78af-e063-6394a90ac429	61442-433	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Carlsbad Technology, Inc.	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61476-104_692b3911-b195-4499-9790-37e0812b3cde	61476-104	PLASMA DERIVATIVE	Alyglo		Human immunoglobulin G	LIQUID	INTRAVENOUS	20231215		BLA	BLA125743	GC Biopharma Corp.	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
61477-210_fd8e383e-dedc-f08b-e053-6394a90ab47a	61477-210	HUMAN OTC DRUG	ALOE UP PRO SPF 50 ADVANCED FORMULA	ULTRA SPORT SUNSCREEN	AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20140224		OTC MONOGRAPH NOT FINAL	part352	Aloe Care International, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	3; 5; 6; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61477-214_fd8e237c-9e15-39e1-e053-6394a90a3008	61477-214	HUMAN OTC DRUG	ALOE UP NATURAL LIP ICE SUNSCREEN		OCTINOXATE, OXYBENZONE	LIPSTICK	TOPICAL	20140224		OTC MONOGRAPH NOT FINAL	part352	Aloe Care International, LLC	OCTINOXATE; OXYBENZONE	2; 4.5	g/100g; g/100g			N	20241231
61477-223_fd8e237c-9e17-39e1-e053-6394a90a3008	61477-223	HUMAN OTC DRUG	ALOE UP KIDS SPORT SUNSCREEN	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20140224		OTC MONOGRAPH NOT FINAL	part352	Aloe Care International, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 15	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61480-105_d44a6335-b07b-6659-e053-2995a90a1eee	61480-105	HUMAN OTC DRUG	PSORIASIS		Niccolum Sulphuricum, Natrum Bromatum, Zincum Bromatum, Kali Bromatum, Kali Sulphuricum.	LIQUID	ORAL	20161212		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	NICKEL SULFATE HEXAHYDRATE; POTASSIUM BROMIDE; POTASSIUM SULFATE; SODIUM BROMIDE; ZINC BROMIDE	3; 1; 4; 2; 4	[hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
61480-124_eeb57e23-4659-a6f0-e053-2995a90a3c75	61480-124	HUMAN PRESCRIPTION DRUG	Psorizide Ultra		Potassium Bromide, Nickel Sulfate, and Zinc Bromide	TABLET	ORAL	19971001		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	NICKEL SULFATE; POTASSIUM BROMIDE; ZINC BROMIDE	1; 1; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61480-125_d44a5f4a-ca8d-5c53-e053-2a95a90af661	61480-125	HUMAN OTC DRUG	ECZEMA		Niccolum Sulphuricum, Kali Bromatum, Kali Muriaticum, Hepar Sulphuris Calcareum, Kali Bichromicum, Kali Sulphuricum, Sulphur.	TABLET, CHEWABLE	ORAL	20160501		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	CALCIUM SULFIDE; NICKEL SULFATE HEXAHYDRATE; POTASSIUM BROMIDE; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; POTASSIUM SULFATE; SULFUR	3; 3; 1; 1; 3; 3; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
61480-127_eeb57d40-ab18-9d38-e053-2995a90afe65	61480-127	HUMAN PRESCRIPTION DRUG	Eczemol		Potassium Bromide, Nickel Sulfate, and Sulfur	TABLET	ORAL	20011115		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	NICKEL SULFATE; POTASSIUM BROMIDE; SULFUR	1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
61480-137_eeb58dfe-fcc0-9d51-e053-2a95a90a6468	61480-137	HUMAN PRESCRIPTION DRUG	Acunol		Nickel Sulfate, Potassium Bromide, Sodium Bromide, Zinc Sulfate Anhydrous, and Sulfur	TABLET	ORAL	20060418		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	NICKEL SULFATE; POTASSIUM BROMIDE; SODIUM BROMIDE; SULFUR; ZINC SULFATE ANHYDROUS	1; 1; 1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61480-145_d44a68e4-3576-6192-e053-2a95a90a49a8	61480-145	HUMAN OTC DRUG	ACNE		Niccolum Sulphuricum, Kali Bromatum, Zincum Oxydatum, Hepar Sulphuris Calcareum, Sulphur.	TABLET, CHEWABLE	ORAL	20160501		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	CALCIUM SULFIDE; NICKEL SULFATE HEXAHYDRATE; POTASSIUM BROMIDE; SULFUR; ZINC OXIDE	3; 3; 1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61480-255_eeb41ad5-cdc9-51bb-e053-2995a90a3704	61480-255	HUMAN PRESCRIPTION DRUG	Psorizide Forte		Nickel Sulfate, Potassium Bromide, and Fumaric Acid	TABLET	ORAL	20011115		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	FUMARIC ACID; NICKEL SULFATE; POTASSIUM BROMIDE	1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
61480-310_d44a68e4-354a-6192-e053-2a95a90a49a8	61480-310	HUMAN OTC DRUG	DANDRUFF		Kali Bromatum, Kali Muriaticum, Kali Sulphuricum, Natrum Muriaticum, Sulphur, Calcarea Carbonica, Niccolum Sulphuricum.	TABLET	ORAL	20170524		UNAPPROVED HOMEOPATHIC		PLYMOUTH HEALTHCARE PRODUCTS LLC	NICKEL SULFATE HEXAHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM BROMIDE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM CHLORIDE; SULFUR	3; 3; 1; 1; 1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
61481-0020_5a1d61c8-41ac-4aae-b4bb-2aaef581ff82	61481-0020	HUMAN OTC DRUG	KINeSYS	Analgesic Sport	METHYL SALICYLATE and MENTHOL	STICK	TOPICAL	20120531		OTC MONOGRAPH NOT FINAL	part348	Wilc Healthcare Inc	MENTHOL; METHYL SALICYLATE	15; 30	g/100g; g/100g			N	20241231
61481-0036_7a4116fe-20cf-465c-a44c-858d8e898752	61481-0036	HUMAN OTC DRUG	Kinesys		Zinc Oxide	CREAM	TOPICAL	20180926		OTC MONOGRAPH NOT FINAL	part348	Wilc Healthcare Inc	ZINC OXIDE	25	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61481-0045_4816feb1-df45-4363-b815-afb59f1ae732	61481-0045	HUMAN OTC DRUG	KINESYS	SPF 30 SOLID SUNSCREEN	OCTINOXATE, OCTISALATE, OXYBENZONE, and TITANIUM DIOXIDE	STICK	TOPICAL	20120620		OTC MONOGRAPH NOT FINAL	part352	Wilc Healthcare Inc	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	7.5; 5; 4.5; 1	g/100g; g/100g; g/100g; g/100g			N	20241231
61481-3001_271a5052-efb6-433b-8fc1-2a9191768666	61481-3001	HUMAN OTC DRUG	Kinesys Broad Spectrum SPF 30 Alcohol-Free Performance Sunscreen - Fragrance Free		OCTINOXATE, OCTOCRYLENE, OCTISALATE, and Avobenzone	SPRAY	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part352	Wilc Healthcare Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7.5; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61481-3002_ef4c4cb7-c31f-4cdd-a45b-c2e351753abe	61481-3002	HUMAN OTC DRUG	Kinesys	Broad Spectrum SPF 30 Kids Alcohol-Free Sunscreen	OCTINOXATE, OCTOCRYLENE, OCTISALATE, and Avobenzone	SPRAY	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part352	Wilc Healthcare Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7.5; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61481-3003_73aacd8d-689f-4ec8-bcfb-6caebdb37a13	61481-3003	HUMAN OTC DRUG	Kinesys	Broad Spectrum SPF 30 Alcohol-Free Sunscreen - Mango Scent	OCTINOXATE, OCTOCRYLENE, OCTISALATE, and AVOBENZONE	SPRAY	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part352	Wilc Healthcare Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7.5; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61481-3005_cbf726cb-9c27-4f75-8f6b-c2e705ae3ced	61481-3005	HUMAN OTC DRUG	Kinesys Broad Spectrum SPF 50 Alcohol Free Sunscreen		Octocrylene, Octinoxate, Homosalate, Octisalate, and Avobenzone	SPRAY	TOPICAL	20150327		OTC MONOGRAPH NOT FINAL	part352	Wilc Healthcare Inc	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 75; 75; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
61481-3006_5ebd9a6c-4b6e-4c45-ab7e-d0a8b8627ce2	61481-3006	HUMAN OTC DRUG	Kinesys		OCTINOXATE, OCTOCRYLENE, OCTISALATE, and AVOBENZONE	SPRAY	TOPICAL	20180511		OTC MONOGRAPH NOT FINAL	part352	Wilc Healthcare Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7.5; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61500-5527_0772c336-4026-9bc9-e063-6394a90aa1af	61500-5527	HUMAN OTC DRUG	Topricin		Aesculus hippocastanum, Arnica montana, Belladonna, Crotalus horridus, Echinacea, Graphites, Heloderma, Lachesis mutus, Naja tripudians, Rhus toxicodendron, Ruta graveolens	CREAM	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Topical BioMedics, Inc.	AESCULUS HIPPOCASTANUM FLOWER; ARNICA MONTANA; ATROPA BELLADONNA; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; GRAPHITE; HELODERMA HORRIDUM VENOM; LACHESIS MUTA VENOM; NAJA NAJA VENOM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 8; 6; 6; 8; 8; 8; 6; 6	[hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g; [hp_X]/170g			N	20241231
61500-5547_f19b7ae4-dc8a-0af7-e053-2a95a90a3156	61500-5547	HUMAN OTC DRUG	Topricin		aesculus hippocastanum, arnica montana, belladonna, calendula officinalis, crotalus horridus, echinacea, graphites, heloderma horridum, lachesis mutus, naja tripudians, phosphorus, rhus toxicodendron, ruta graveolens, sulfur	CREAM	TOPICAL	20160518	20260401	UNAPPROVED HOMEOPATHIC		Topical BioMedics, Inc.	AESCULUS HIPPOCASTANUM FLOWER; ARNICA MONTANA; ATROPA BELLADONNA; CALENDULA OFFICINALIS FLOWERING TOP; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; GRAPHITE; HELODERMA HORRIDUM VENOM; LACHESIS MUTA VENOM; NAJA NAJA VENOM; PHOSPHORUS; RUTA GRAVEOLENS FLOWERING TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 4; 8; 4; 6; 8; 8; 8; 9; 6; 8; 8	[hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g; [hp_X]/227g			N	
61504-002_f3ce30b9-2447-ea65-e053-2995a90ae065	61504-002	HUMAN OTC DRUG	First Street Dishwasing Concentrate and Antimicrobial Hand		CHLOROXYLENOL	SOAP	TOPICAL	20131218		OTC MONOGRAPH NOT FINAL	part333E	Amerifoods Trading Company	CHLOROXYLENOL	3	mg/mL			N	20241231
61504-080_09086102-c886-f56b-e063-6294a90afe27	61504-080	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20231030		OTC MONOGRAPH DRUG	M013	AMERIFOODS TRADING COMPANY	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
61504-090_092d4666-dc81-1c0f-e063-6294a90a7aaf	61504-090	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20231030		OTC MONOGRAPH DRUG	M012	AMERIFOODS TRADING COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61504-095_092d2bb0-6011-4256-e063-6394a90ab2c4	61504-095	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20231030		OTC MONOGRAPH DRUG	M013	AMERIFOODS TRADING COMPANY	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61504-104_09083a11-e010-d76d-e063-6294a90a7981	61504-104	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20231030		OTC MONOGRAPH DRUG	M013	AMERIFOODS TRADING COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
61504-109_092d62e1-196d-60e2-e063-6394a90a7eb3	61504-109	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20231030		ANDA	ANDA079174	AMERIFOODS TRADING COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61504-110_092d5414-61fc-61bd-e063-6394a90a0100	61504-110	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20231030		ANDA	ANDA079174	AMERIFOODS TRADING COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61504-119_092d36bd-2ffb-57cf-e063-6394a90a9433	61504-119	HUMAN OTC DRUG	Severe Sinus Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20231030		OTC MONOGRAPH DRUG	M012	AMERIFOODS TRADING COMPANY	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
61504-131_092d2bb0-6027-4256-e063-6394a90ab2c4	61504-131	HUMAN OTC DRUG	Sinus Congestion PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20231030		OTC MONOGRAPH DRUG	M012	AMERIFOODS TRADING COMPANY	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
61504-145_092d62e1-1983-60e2-e063-6394a90a7eb3	61504-145	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20231030		ANDA	ANDA079096	AMERIFOODS TRADING COMPANY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61504-163_092d36bd-3013-57cf-e063-6394a90a9433	61504-163	HUMAN OTC DRUG	Severe Cold and Flu Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20231030		OTC MONOGRAPH DRUG	M012	AMERIFOODS TRADING COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
61504-192_092d5198-d6e3-10b7-e063-6294a90ac4d8	61504-192	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20231030		ANDA	ANDA211075	AMERIFOODS TRADING COMPANY	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61504-193_092d4d23-3789-2281-e063-6294a90aa7e9	61504-193	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20231030		ANDA	ANDA210722	AMERIFOODS TRADING COMPANY	LORATADINE	10	mg/1			N	20241231
61504-194_092d4666-dc93-1c0f-e063-6294a90a7aaf	61504-194	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20231030		ANDA	ANDA209274	Amerifoods Trading Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61504-501_872ff503-d254-46ad-91ce-e88cb39f86fe	61504-501	HUMAN OTC DRUG	First Street Antimicrobial Hand Wash		CHLOROXYLENOL	SOAP	TOPICAL	20230829		UNAPPROVED DRUG OTHER		Amerifoods Trading Company	CHLOROXYLENOL	3	mg/mL			N	20241231
61504-810_ac732097-505a-4a28-ac58-af2d6c0f3bac	61504-810	HUMAN OTC DRUG	IRIS		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part333A	AMERIFOODS TRADING COMPANY	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
61504-871_6618c41c-882b-4aaf-8f9f-ff4b8f08a22a	61504-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20170209		OTC MONOGRAPH NOT FINAL	part333A	Amerifoods Trading Co	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
61520-001_06d66676-1f78-235a-e063-6294a90abf14	61520-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070522		UNAPPROVED MEDICAL GAS		Premier Medical Distribution	OXYGEN	99	L/100L			N	20241231
61543-0154_0973aae6-55c2-5f1a-e063-6394a90a9848	61543-0154	HUMAN OTC DRUG	Solar Sense SPF 50 Daily Facial Sunscreen		HOMOSALATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20200708		OTC MONOGRAPH DRUG	M020	CCA Industries, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
61543-1502_d741e08c-11d9-4756-bc79-228aab723371	61543-1502	HUMAN OTC DRUG	Plus White Extra Whitening		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20180131		OTC MONOGRAPH FINAL	part355	CCA Industries LLC	SODIUM MONOFLUOROPHOSPHATE	.83	g/100g			N	20241231
61543-1554_0524f242-92ea-4fe0-a8f8-8bbea4df59cc	61543-1554	HUMAN OTC DRUG	Plus White Smokers Whitening		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	ORAL	20180131		OTC MONOGRAPH FINAL	part355	CCA Industries, Inc.	SODIUM MONOFLUOROPHOSPHATE	.83	g/100g			N	20241231
61543-1606_64660295-7970-46b2-b789-77c6a5f4ec53	61543-1606	HUMAN OTC DRUG	Plus White Extra Whitening		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	ORAL	20180131		OTC MONOGRAPH FINAL	part355	CCA Industries, Inc.	SODIUM MONOFLUOROPHOSPHATE	.83	g/100g			N	20241231
61543-1702_739b719f-e282-400b-b991-f9d995fa4d70	61543-1702	HUMAN OTC DRUG	Plus White Coffee		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	ORAL	20180630		OTC MONOGRAPH FINAL	part355	CCA Industries, Inc.	SODIUM MONOFLUOROPHOSPHATE	.83	g/100g			N	20241231
61543-1751_af060a95-bec3-4f9c-85c6-e98454637efb	61543-1751	HUMAN OTC DRUG	Plus White		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	ORAL	20180522		OTC MONOGRAPH FINAL	part355	CCA Industries, Inc.	SODIUM MONOFLUOROPHOSPHATE	.83	g/100g			N	20241231
61558-100_0cfc113b-9dab-5c47-e063-6394a90aa9b3	61558-100	HUMAN OTC DRUG	Eron Healing Tonic		Zinc Pyrithione	SHAMPOO	TOPICAL	20131230		UNAPPROVED DRUG OTHER		Geumseong TK	PANTHENOL; PYRITHIONE ZINC	2.5; 3	g/500mL; g/500mL			N	20241231
61566-201_827f7254-b032-39d4-e053-2991aa0acc99	61566-201	HUMAN OTC DRUG	Burn Relief Professional	Bio-Kool	Lidocaine - 4%	CREAM	TOPICAL	20130115		OTC MONOGRAPH NOT FINAL	part348	Kool-Down Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
61566-279_8281047f-2f91-ea48-e053-2991aa0a0f9d	61566-279	HUMAN OTC DRUG	Burn Relief Extra Strength	Kool-Down	Lidocaine - 3.9%	CREAM	TOPICAL	20130415		OTC MONOGRAPH NOT FINAL	part348	Kool-Down Inc	LIDOCAINE	3.9	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
61567-001_080308f6-2f73-4f66-e063-6394a90a7b9d	61567-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19940101		NDA	NDA205849	Ali-Rob, Inc. dba Southern Oxygen & Welding Supply	OXYGEN	990	mL/L			N	20241231
61567-002_0a5ef7df-9c19-56a4-e063-6394a90ab3ad	61567-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20231101		NDA	NDA205891	Ali-Rob, Inc. dba Southern Oxygen & Welding Supply	NITROGEN	990	mL/L			N	20241231
61570-072_e2bbaf86-ad94-4452-a6a5-80e70dd351e2	61570-072	HUMAN PRESCRIPTION DRUG	MENEST		esterified estrogens	TABLET, FILM COATED	ORAL	19770928		ANDA	ANDA084951	Pfizer Laboratories Div Pfizer Inc	ESTROGENS, ESTERIFIED	.3	mg/1			N	20241231
61570-073_e2bbaf86-ad94-4452-a6a5-80e70dd351e2	61570-073	HUMAN PRESCRIPTION DRUG	MENEST		esterified estrogens	TABLET, FILM COATED	ORAL	19770928		ANDA	ANDA084948	Pfizer Laboratories Div Pfizer Inc	ESTROGENS, ESTERIFIED	.625	mg/1			N	20241231
61570-074_e2bbaf86-ad94-4452-a6a5-80e70dd351e2	61570-074	HUMAN PRESCRIPTION DRUG	MENEST		esterified estrogens	TABLET, FILM COATED	ORAL	19770928		ANDA	ANDA084950	Pfizer Laboratories Div Pfizer Inc	ESTROGENS, ESTERIFIED	1.25	mg/1			N	20241231
61570-075_e2bbaf86-ad94-4452-a6a5-80e70dd351e2	61570-075	HUMAN PRESCRIPTION DRUG	MENEST		esterified estrogens	TABLET, FILM COATED	ORAL	20180917		ANDA	ANDA084949	Pfizer Laboratories Div Pfizer Inc	ESTROGENS, ESTERIFIED	2.5	mg/1			N	20241231
61570-110_ac92039f-c6f1-4099-bc12-b0df7a16d179	61570-110	HUMAN PRESCRIPTION DRUG	ALTACE		ramipril	CAPSULE	ORAL	19910128		NDA	NDA019901	Pfizer Laboratories Div Pfizer Inc	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61570-111_ac92039f-c6f1-4099-bc12-b0df7a16d179	61570-111	HUMAN PRESCRIPTION DRUG	ALTACE		ramipril	CAPSULE	ORAL	19910128		NDA	NDA019901	Pfizer Laboratories Div Pfizer Inc	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61570-112_ac92039f-c6f1-4099-bc12-b0df7a16d179	61570-112	HUMAN PRESCRIPTION DRUG	ALTACE		ramipril	CAPSULE	ORAL	19910128		NDA	NDA019901	Pfizer Laboratories Div Pfizer Inc	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61570-120_ac92039f-c6f1-4099-bc12-b0df7a16d179	61570-120	HUMAN PRESCRIPTION DRUG	ALTACE		ramipril	CAPSULE	ORAL	19910128		NDA	NDA019901	Pfizer Laboratories Div Pfizer Inc	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61570-131_0c251e48-c62b-432a-b221-d240c4913f41	61570-131	HUMAN PRESCRIPTION DRUG	SILVADENE		silver sulfadiazine	CREAM	TOPICAL	19731126		NDA	NDA017381	Pfizer Laboratories Div Pfizer Inc	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
61577-1010_0d6044d4-9c65-4014-8bd1-62d6193570eb	61577-1010	HUMAN OTC DRUG	DR. WOLFES WARM THERAPY		MENTHOL AND CAMPHOR	GEL	TOPICAL	20230309		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-1020_5a2b5025-4f43-4a9b-9603-cd18682da95c	61577-1020	HUMAN OTC DRUG	DR WOLFES COOL THERAPY		MENTHOL	GEL	TOPICAL	20230309		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-1112_14f5ac2c-5fb2-45e3-ab46-7f2f1e778dfd	61577-1112	HUMAN OTC DRUG	LOS POBLANOS LAVENDER HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200406		OTC MONOGRAPH NOT FINAL	part333A	SOMBRA COSMETICS	ALCOHOL	65	mL/100mL			N	20241231
61577-1112_6bb4f947-a624-4012-943e-a91befd265b0	61577-1112	HUMAN OTC DRUG	LOS POBLANOS LAVENDER HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	SOMBRA COSMETICS	ALCOHOL	65	mL/100mL			N	20241231
61577-2280_7cbef24a-b265-4235-8613-ceb45b9d874a	61577-2280	HUMAN OTC DRUG	SORE NO MORE		MENTHOL CAMPHOR	GEL	TOPICAL	20230308		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-2301_b78a84a7-a36e-4715-b50c-2b96adedc506	61577-2301	HUMAN OTC DRUG	MUSCLE EASE		MENTHOL CAMPHOR	GEL	TOPICAL	20230214		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-3216_745ebcb7-b9b1-415e-825f-0e72b075d066	61577-3216	HUMAN OTC DRUG	SOMBRA WARM THERAPY		MENTHOL CAMPHOR	GEL	TOPICAL	20220518		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-3221_5fe37a57-1a13-4f93-af5a-9c1899c2c066	61577-3221	HUMAN OTC DRUG	SOMBRA COOL THERAPY		MENTHOL	GEL	TOPICAL	20220517		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-3234_969d96cc-62f1-41ba-90f4-823ca0be85a7	61577-3234	HUMAN OTC DRUG	SORE NO MORE WARM THERAPY		MENTHOL AND CAMPHOR	GEL	TOPICAL	20220516		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-3235_76dd9025-47ed-45b8-8325-3454371a1688	61577-3235	HUMAN OTC DRUG	SORE NO MORE COOL THERAPY		MENTHOL	GEL	TOPICAL	20220518		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-3242_1d46cec7-0850-4f22-b377-01f95474f9ae	61577-3242	HUMAN OTC DRUG	RE-LEVE		MENTHOL	GEL	TOPICAL	20230308		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS	MENTHOL	.06	g/g			N	20241231
61577-3385_3062ed70-db5e-427b-81e4-6379beedf4a4	61577-3385	HUMAN OTC DRUG	HERBAL FREEZE		MENTHOL	SPRAY	TOPICAL	20230308		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-3501_d19dcdcb-6ae5-4c9d-aac7-b6097a290abb	61577-3501	HUMAN OTC DRUG	GREEN BAMBOO		MENTHOL CAMPHOR	GEL	TOPICAL	20230309		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-3610_7af0ed5a-07a7-4ef9-a1c6-c316f9e8314c	61577-3610	HUMAN OTC DRUG	DEEP REMEDY		MENTHOL CAMPHOR	GEL	TOPICAL	20211223		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-4020_61ae97fa-54a7-4a90-a7a0-287b8f34fe5e	61577-4020	HUMAN OTC DRUG	SOMBRA WARM THERAPY		MENTHOL CAMPHOR	GEL	TOPICAL	20230310		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-4030_683bcc7b-edda-4eca-8eb1-6e24db6994ee	61577-4030	HUMAN OTC DRUG	SOMBRA COOL THERAPY		MENTHOL	GEL	TOPICAL	20230303		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-4040_aff29efc-56b8-4501-861a-2366133e695f	61577-4040	HUMAN OTC DRUG	SORE NO MORE WARM THERAPY		MENTHOL and CAMPHOR	GEL	TOPICAL	20230308		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-4050_41c574fb-6a5b-4e13-86e5-254c73572e04	61577-4050	HUMAN OTC DRUG	SORE NO MORE COOL THERAPY		MENTHOL	GEL	TOPICAL	20230303		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-4080_56677612-579a-4d2b-a9c7-12bc4e51461c	61577-4080	HUMAN OTC DRUG	HealQu Warm Therapy Gel		MENTHOL CAMPHOR	GEL	TOPICAL	20230309		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-4300_c8185580-9c90-48bc-8c87-dbe17f3ae959	61577-4300	HUMAN OTC DRUG	NUMM COOL FREEZE		MENTHOL	GEL	TOPICAL	20230321		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-4400_ccf59c68-2f75-4da5-8ad0-d79e928d87f4	61577-4400	HUMAN OTC DRUG	NUMM WARM SIZZLE		MENTHOL CAMPHOR	GEL	TOPICAL	20231011		OTC MONOGRAPH DRUG	M	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-5042_74d847cf-8bd2-4705-9d63-5bfccd766ee8	61577-5042	HUMAN OTC DRUG	RE-LEVE FOOTLUBE PAIN RELIEF		MENTHOL	GEL	TOPICAL	20221128		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.03	g/g			N	20241231
61577-5310_9bac8f27-53c1-43f6-951e-5fae62fc2447	61577-5310	HUMAN OTC DRUG	Snap Crack Natural Pain Relieving Gel		Menthol Camphor	GEL	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics INC	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-5320_e3dd1604-3317-498f-a6fd-cce38c73fdef	61577-5320	HUMAN OTC DRUG	NVCARE		MENTHOL	GEL	TOPICAL	20230308		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-7010_1c6027a2-9c58-4ebf-87f6-b8952d5aef54	61577-7010	HUMAN OTC DRUG	Sombra Plus CBD 1000mg Warm Theapy		MENTHOL, CAMPHOR	GEL	TOPICAL	20220519		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics INC	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-7012_ae4a0051-51c5-405b-9ecb-f5d3bb327512	61577-7012	HUMAN OTC DRUG	Sore No More Warm Therapry Plus CBD 2000mg		Menthol Camphor	GEL	TOPICAL	20220523		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC)	.03	g/g			N	20241231
61577-7021_308b71d0-4b0a-4ca6-b27c-b74e53fbd90d	61577-7021	HUMAN OTC DRUG	SORE NO MORE PLUS CBD 2000MG COOL THERAPY		MENTHOL	GEL	TOPICAL	20220523		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	MENTHOL	.06	g/g			N	20241231
61577-7100_253162ce-6b3d-4502-8ad3-2f4964f9cd61	61577-7100	HUMAN OTC DRUG	SOMBRA PLUS CBD 1000MG COOL THERAPY		MENTHOL	GEL	TOPICAL	20220520		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics Inc.	MENTHOL	.06	g/g			N	20241231
61577-7101_ca0b28e8-c25f-4414-9345-ea3c2dc0a436	61577-7101	HUMAN OTC DRUG	SOMBRA PLUS CBD 2000MG COOL THERAPY		MENTHOL	GEL	TOPICAL	20220524		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics Inc.	MENTHOL	.06	g/g			N	20241231
61577-7120_d5c92f18-6d11-41f5-a386-ac8e62f15d60	61577-7120	HUMAN OTC DRUG	Sombra Plus CBD 2000mg Warm Theapy		Menthol Camphor	GEL	TOPICAL	20220524		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics INC	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-7365_d51b8d1f-94ef-4b7f-aec7-6b2edaf6480e	61577-7365	HUMAN OTC DRUG	PAIN NO MORE THERAPY		MENTHOL CAMPHOR	GEL	TOPICAL	20230308		OTC MONOGRAPH NOT FINAL	part348	SOMBRA COSMETICS INC.	CAMPHOR (SYNTHETIC); MENTHOL	.03; .03	g/g; g/g			N	20241231
61577-8120_f734d5e0-e435-4834-bf8e-4fa614d1fd4c	61577-8120	HUMAN OTC DRUG	Arthritis Pain Relief Cream		Histamine Dihydrochloride	CREAM	TOPICAL	20191209		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics, Inc.	HISTAMINE DIHYDROCHLORIDE	.00025	g/g			N	20241231
61577-8121_55e24830-444f-4eef-a26b-ea8e93a24a4c	61577-8121	HUMAN OTC DRUG	Australian Dream Back Pain		Histamine Dihydrochloride	CREAM	TOPICAL	20220610		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics, Inc.	HISTAMINE DIHYDROCHLORIDE	.0005	g/g			N	20241231
61577-8220_f6c7ee2a-de64-46a9-9d94-f62987675c28	61577-8220	HUMAN OTC DRUG	Australian Dream Power 4 Muscle and Joint Pain Relief Cream		Camphor, Menthol, Capsacin, Methyl Salicylate	CREAM	TOPICAL	20230510		OTC MONOGRAPH NOT FINAL	part348	Sombra Cosmetics, Inc.	CAMPHOR (SYNTHETIC); CAPSAICIN; MENTHOL; METHYL SALICYLATE	.03; .025; .03; .1	g/g; g/g; g/g; g/g			N	20241231
61580-123_075ea4f1-909a-3bd3-e063-6394a90a1cb7	61580-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20120119		UNAPPROVED MEDICAL GAS		Florida Palliative Equipment L.L.C. dba Accent Medical	OXYGEN	99	L/100L			N	20241231
61589-0201_23a6a29d-fc7a-4eca-924e-5743f15a66b3	61589-0201	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Cool Vanilla		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0202_e82ce3c3-e5c0-4638-ae35-82280629c631	61589-0202	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0203_2dd4ffb4-b885-44e8-895e-85110a935637	61589-0203	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Cool Beige		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0204_692f99c3-8f48-495a-9e4d-c443ade1200a	61589-0204	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Calico		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0205_ea9d02fa-a130-492d-b30b-2f41c9d017c5	61589-0205	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Beige		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0206_a98d2928-edbd-41ce-9fdc-76934e495fb4	61589-0206	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Cool Ivory		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0207_6cf078ff-ecb9-4e30-95ee-965f3522b412	61589-0207	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Porcelain		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0208_9155464d-e68a-4f1c-964e-1b49e09e93ab	61589-0208	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Wheat		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0209_dc2f491e-e682-4efc-a4ff-4dd492dad593	61589-0209	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0210_794a0f5a-9447-4e82-a7b2-5b1a3a4f9822	61589-0210	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0211_9b42246b-4c4c-4afe-b4cd-d04f12457cc3	61589-0211	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Toffee		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0212_0da8cf2e-2c37-46c0-acc2-50434a38264e	61589-0212	HUMAN OTC DRUG	No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Chestnut		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	6.5; 5; 4.25	g/30g; g/30g; g/30g			N	20241231
61589-0213_afa033f8-e8e3-4d63-9452-adba45c70bdb	61589-0213	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0214_e274fa3f-2cc5-46db-bba7-4e770af324d3	61589-0214	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0215_3952aedd-a1b2-4e3c-83eb-9e139cbdae02	61589-0215	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Latte		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0216_b006e04f-e749-4753-9885-100fe1363211	61589-0216	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0217_6199e194-d71a-4699-9c1d-b003c9f2411e	61589-0217	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Bamboo		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0218_474fddff-1864-4c61-b59b-4404c95c7836	61589-0218	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Latte		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0219_44ae9f3e-7163-4434-8b9e-c0d889609ee0	61589-0219	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Latte		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0220_0363220f-9346-450b-a9c5-231b82f5f72b	61589-0220	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Creme		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0221_bdac7052-3f39-4045-bb75-c5315910476b	61589-0221	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Deeply Bronze		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0222_eef4b2f3-8345-4337-8d05-36c4155ef49e	61589-0222	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Dune		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0223_3657e02b-dd8e-4524-a0ba-9bafbb20eca8	61589-0223	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Sand		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0224_09796e73-cf6d-442b-8b5f-82c4fa88c0be	61589-0224	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Latte		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0225_eac1e0ee-969d-41c4-9fcc-05bf72c198be	61589-0225	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Toffee		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0226_40d211f9-35da-4fdf-ab05-a4a7d866bc7b	61589-0226	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Sepia		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0227_a31cb543-a0ec-48fd-8ca3-dec0e67717ef	61589-0227	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Willow		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0228_3e320306-2df0-4b2c-ac6c-e40e9d07df77	61589-0228	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Wheat		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0229_7eca1358-5ce8-4af7-a3da-a404422c135c	61589-0229	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Beige		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0230_21308013-e46b-4ec9-9c52-767007a22f43	61589-0230	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Warm Beige		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0231_5d9cd506-429e-4bab-9c43-7fe8a174c5e2	61589-0231	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Ivory		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0232_70fbcf51-ef13-4d8a-affd-bd615448393f	61589-0232	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Calico		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0233_65ec0bb3-8015-46e6-b2ae-af1023aa8aee	61589-0233	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Deeply Honey		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0234_d54ddf32-b0b0-42c1-a886-bc19a5622927	61589-0234	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Hazelnut		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0235_43db2d5b-bb5a-4376-96c6-f105ff0f666b	61589-0235	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Honey		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0236_9b12957b-d235-4a9a-ace0-5305b94ba9a5	61589-0236	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Warm Ivory		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0237_eefed1f6-40d1-422b-9fe0-ee7db4e4bee4	61589-0237	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Warm Ivory		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0238_cf2c9dd4-2ea0-4f94-b22e-dc76edee0521	61589-0238	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Warm Ivory		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-0239_d4ee7a3c-8fbc-4ecd-9936-5fcd54f9012b	61589-0239	HUMAN OTC DRUG	No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Warm Ivory		Octinoxate, Titanium Dioixide, Octisalate	CREAM	TOPICAL	20210629		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	1.95; 1.5; 1.275	g/30g; g/30g; g/30g			N	20241231
61589-1842_9c3282b9-14d3-4107-bed9-aec417e3dcca	61589-1842	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Chestnut		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1843_88cc73e6-ef21-4bae-96f1-250b926c3f62	61589-1843	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1844_c30dbf36-02a9-4e49-9b1b-2d3f795b68db	61589-1844	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1846_faa2c3de-05ab-440d-b903-4ae521fb15a3	61589-1846	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1848_afde84ec-34b4-4a71-b31e-1ee082864ceb	61589-1848	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1849_7f1ffb6c-4aff-4e28-b666-6956424cac03	61589-1849	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1850_3e7d1d57-cd8c-4149-9e15-bf604b37cf82	61589-1850	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1852_f1c81ba0-13ed-4353-ae1e-3d39eee1253d	61589-1852	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1855_a3b02c01-0d22-4636-adc5-ac41940420a7	61589-1855	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1856_b2d29319-5a67-4c43-88e7-e691e8b8b5ef	61589-1856	HUMAN OTC DRUG	No7 Stay Perfect Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20150710		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE	7.5	g/30g			N	20241231
61589-1921_15507bd7-996a-4333-8526-ffab9dcfa3fd	61589-1921	HUMAN OTC DRUG	No7 City Light Tinted Moisturiser Sunscreen Broad Spectrum SPF 15 Fair		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20161214		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 1; 2	g/50g; g/50g; g/50g			N	20241231
61589-1922_94bb81a0-f27a-48c8-9a12-7118341e39df	61589-1922	HUMAN OTC DRUG	No7 City Light Tinted Moisturiser Sunscreen Broad Spectrum SPF 15 Medium		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20161214		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 1; 2	g/50g; g/50g; g/50g			N	20241231
61589-1923_c8a63eb6-adb9-41e0-9ff9-e8721ba89f6e	61589-1923	HUMAN OTC DRUG	No7 City Light Tinted Moisturiser Sunscreen Broad Spectrum SPF 15 Medium Dark		Avobenzone, Octisalate, Octocrylene	CREAM	TOPICAL	20161214		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 1; 2	g/50g; g/50g; g/50g			N	20241231
61589-8101_bcacf567-54e7-4fe7-b527-e29e166429b6	61589-8101	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Calico		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8102_2b9b1d6a-abc8-46b6-8a64-6bbe92fe5538	61589-8102	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Cool Vanilla		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8103_a01cb993-acd6-4a37-ac5d-5d31ae67ee27	61589-8103	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Warm Ivory		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8104_50bf89be-d51f-495e-b7db-5c9f7a596e08	61589-8104	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Cool Ivory		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8105_ae42b8b4-c602-4b4a-948c-2ca389f70e7f	61589-8105	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Cool Beige		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8106_47c6db68-e1b5-469d-a674-77c5c256f1de	61589-8106	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Warm Beige		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8107_fbf95bdb-7278-4e7f-a110-41751533fba6	61589-8107	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Deeply Beige		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8108_2853b342-3aee-4d37-9b57-8220a11b2126	61589-8108	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Honey		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8109_cefb57ae-4843-4526-bd6c-8b4cd4ef8f22	61589-8109	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Wheat		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8110_2fe2db6e-0e42-4caa-a00e-0edb6cf70bed	61589-8110	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Latte		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-8111_e31afeb4-ff13-4333-92ef-b8520958f011	61589-8111	HUMAN OTC DRUG	No7 Beautifully Matte Foundation Sunscreen Broad Spectrum SPF 15 Chestnut		Octinoxate	CREAM	TOPICAL	20160701		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9501_7d890a77-841a-4e5a-a5f9-ac5873059448	61589-9501	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Calico		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9502_69cc345e-f2ff-462c-9cf4-032dd9c6b39e	61589-9502	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Cool Vanilla		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9503_f678936a-4b7a-4f16-bf3b-095b6176c723	61589-9503	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Warm Ivory		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9504_8339388a-187b-48e2-b2be-995dec98c836	61589-9504	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Cool Ivory		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9505_69d6cb17-d099-41c0-82f9-08b8dc202c7a	61589-9505	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Warm Beige		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9506_90219062-3646-45b8-9213-85e7003ead31	61589-9506	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Warm Beige		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9507_5d83c816-fa09-40bc-b3dd-d03f38ce4ba8	61589-9507	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Deep Beige		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9508_2756fac1-9a71-4289-80ed-bd2fa2f0a371	61589-9508	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Wheat		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9509_bd6736cc-b647-43c2-acda-f13c12a48a1c	61589-9509	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Deep Honey		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9510_164b4a36-5872-4fde-be71-2711d9237dc5	61589-9510	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Honey		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9511_287f8491-881c-4f4f-8890-2910f8dd3d0a	61589-9511	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Cool Honey		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9512_7e905975-23c0-4af5-ac65-bcf06a474900	61589-9512	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Latte		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9513_26ba275a-3749-4afd-9893-eff7ddedee2b	61589-9513	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Toffee		Octinoxate	CREAM	TOPICAL	20180121		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .5	g/30g; g/30g			N	20241231
61589-9514_21e23c0e-1bba-42b7-b10c-36ead306b90a	61589-9514	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Wheat		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9515_a1f16930-f554-45e8-98cb-4183a3e8108a	61589-9515	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Toffee		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9516_58c648de-5bf5-4b8b-9147-95fb6e6d964e	61589-9516	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Latte		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9517_478ee6de-4030-40de-b76d-5a995a8b24d0	61589-9517	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Sandalwood		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9518_dcb9206e-1b9e-40ec-be06-e40dd016a53d	61589-9518	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Sepia		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9519_e28fd050-403d-4b99-88f5-774b73ba670d	61589-9519	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Shell		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9520_919cf8f8-9a03-4953-b47c-f21dabff7de7	61589-9520	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Tawny		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9521_766b19c6-7cf1-4f2c-91b3-614d5316592b	61589-9521	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Tawny		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9522_e932b033-1e09-4bc0-988a-c9b1c1c36118	61589-9522	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Warm Sand		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9523_055bfb58-b9cc-40cb-ac06-22a3f9921e72	61589-9523	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Willow		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9524_0e4c1428-05d3-4ae9-b1dd-66cbc83786b8	61589-9524	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Hazelnut		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9525_a09efeaa-94b1-40c4-b0e4-0969515ec710	61589-9525	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211104		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9526_483013ac-f385-41c8-8480-08730841ce73	61589-9526	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Calico		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211104		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9527_df0f0745-54d0-4b19-8d3d-be15b421b480	61589-9527	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Cool Vanilla		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211104		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9528_53f5c300-3f7a-4093-b633-9fb16d1be17b	61589-9528	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Warm Ivory		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9529_823407cf-f584-4225-895d-3915bac95184	61589-9529	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Cool Ivory		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211104		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9530_00fae876-ee56-4e96-acef-9aea17fa2ee0	61589-9530	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Warm Beige		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9531_92895bf7-331d-4e87-bfaa-f029f99ac29a	61589-9531	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Cool Beige		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9532_6195c019-923b-40f3-b7b1-874453711cc1	61589-9532	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Honey		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9533_4a99570d-6d7e-4a5a-b220-32589ca917b9	61589-9533	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Wheat		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9534_5e60922b-36e4-4f16-b87f-5766c94d0cac	61589-9534	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Latte		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9535_259166c3-3de8-4409-b1e5-c9c08856ac8d	61589-9535	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Tawny		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9536_816b64de-f463-45d7-8ced-e5d77396d1dc	61589-9536	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Dune		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9537_db4daecd-2cd1-443d-971e-80be45e3012d	61589-9537	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Bamboo		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9538_9460a64b-b520-43d4-a4e2-f18f7458095f	61589-9538	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Amber		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9539_2e9e8e9c-37ba-4e90-aed6-d845306fdced	61589-9539	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Hazelnut		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211109		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9540_1f951cc2-b964-47b6-ab1b-3cc9bd58620e	61589-9540	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Chestnut		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211109		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9541_0de5af4a-7ce5-475c-93c7-bca2f814254c	61589-9541	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Cedar		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211109		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9542_5c49371e-ea9a-4df8-9493-985f4157df40	61589-9542	HUMAN OTC DRUG	No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Umber		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20211109		OTC MONOGRAPH NOT FINAL	part352	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	2.1; .51	g/30g; g/30g			N	20241231
61589-9543_2197df07-0726-4297-9687-63732ade7ec5	61589-9543	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9544_0b821e55-8b05-45e7-b965-417f5f48bca1	61589-9544	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9545_96c80fed-4876-4d43-832e-1bd69110fd3f	61589-9545	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9546_123dab83-4458-4632-be98-1482ac347342	61589-9546	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9547_18dffb5d-8a33-4e07-b502-48ea791d2eb9	61589-9547	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9548_aec6b127-d037-48f3-89d8-78d7de32d8c0	61589-9548	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9549_92818430-c683-4e2a-85e9-7e498feee077	61589-9549	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9550_f8dc9064-60a4-42da-b2d8-96ecde0eb38d	61589-9550	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9551_a7c45e82-e9e0-45ca-b2f3-83fed3d86f90	61589-9551	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9552_d4132ceb-745b-4993-a448-a5448074b3ed	61589-9552	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9553_5d3f782d-82eb-4e6d-9e4e-1787f5d68815	61589-9553	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9554_041349dc-4d68-4687-908a-11165b0e266c	61589-9554	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Warm Beige		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9555_3301b4bb-6645-4100-8c2e-77e6ba82f42d	61589-9555	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9556_a2ca4a17-a1fb-4c2c-90e0-ae5340107d54	61589-9556	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61589-9557_178f9c16-0798-4fe9-9cf6-082d4089b0fa	61589-9557	HUMAN OTC DRUG	No7 Lift and Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum SPF 15 Porcelain		Octinoxate, Titanium Dioxide	CREAM	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	BCM Cosmetique SAS	OCTINOXATE; TITANIUM DIOXIDE	1.5; .51	g/30g; g/30g			N	20241231
61594-003_fa220a8b-1c18-0dac-e053-6294a90a4385	61594-003	HUMAN OTC DRUG	Theraworx Relief Muscle Cramp and Spasm Relief		MAGNESIUM SULFATE HEPTAHYDRATE	AEROSOL, FOAM	TOPICAL	20170722		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/210mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-004_fa23148e-fb1d-8f67-e053-6294a90aebd1	61594-004	HUMAN OTC DRUG	Theraworx Relief Muscle Cramp and Spasm Relief		MAGNESIUM SULFATE HEPTAHYDRATE	SPRAY, METERED	TOPICAL	20170722		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/210mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-006_fa23189d-83cb-4796-e053-6294a90a0ce0	61594-006	HUMAN OTC DRUG	Theraworx Relief		MAGNESIUM SULFATE HEPTAHYDRATE	LIQUID	TOPICAL	20181108		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/101mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-007_fa231dce-da3c-6b83-e053-6394a90af290	61594-007	HUMAN OTC DRUG	Theraworx Relief		MAGNESIUM SULFATE HEPTAHYDRATE	LIQUID	TOPICAL	20181108		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/506mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-010_fa232638-86ca-780a-e053-6394a90a30a2	61594-010	HUMAN OTC DRUG	PHUEL		MAGNESIUM SULFATE HEPTAHYDRATE	SOLUTION	TOPICAL	20181107		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-011_fa232638-86cb-780a-e053-6394a90a30a2	61594-011	HUMAN OTC DRUG	PHUEL		MAGNESIUM SULFATE HEPTAHYDRATE	SPRAY	TOPICAL	20181107		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-013_fa2336c3-14e3-920c-e053-6294a90a7f71	61594-013	HUMAN OTC DRUG	Theraworx Relief Joint Discomfort and Inflammation		FRANKINCENSE	LIQUID	TOPICAL	20190101		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	FRANKINCENSE	8	[hp_X]/210mL			N	20241231
61594-020_fa2348f9-1227-b787-e053-6394a90a4863	61594-020	HUMAN OTC DRUG	Theraworx Nerve Relief Foam		ONION, HYPERICUM PERFORATUM WHOLE, SANGUINARIA CANADENSIS ROOT	AEROSOL, FOAM	TOPICAL	20220201		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	HYPERICUM PERFORATUM WHOLE; ONION; SANGUINARIA CANADENSIS ROOT	10; 10; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
61594-021_fa2372ee-b30f-9ddd-e053-6394a90af5b9	61594-021	HUMAN OTC DRUG	Theraworx Relief for Foot Cramps Foam		MAGNESIUM SULFATE, UNSPECIFIED FORM	AEROSOL, FOAM	TOPICAL	20220201		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE, UNSPECIFIED FORM	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-025_004bbcd7-9ac8-5809-e063-6294a90a2526	61594-025	HUMAN OTC DRUG	Theraworx Relief for Muscle Cramps Roll On		MAGNESIUM SULFATE, UNSPECIFIED FORM	AEROSOL, FOAM	TOPICAL	20220404		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE, UNSPECIFIED FORM	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-026_0c5326b6-43dd-2d7e-e063-6294a90a136c	61594-026	HUMAN OTC DRUG	Theraworx Relief for Muscle Cramps		MAGNESIUM SULFATE, UNSPECIFIED FORM	SPRAY	TOPICAL	20230802		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	MAGNESIUM SULFATE, UNSPECIFIED FORM	6	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61594-027_0437aa5f-57f9-973a-e063-6294a90a9b30	61594-027	HUMAN OTC DRUG	Theraworx Joint Relief Roll On		FRANKINCENSE	LIQUID	TOPICAL	20230115		UNAPPROVED HOMEOPATHIC		AVADIM HOLDINGS, INC.	FRANKINCENSE	8	[hp_X]/mL			N	20241231
61598-450_08b52ade-592d-c69d-e063-6294a90adc5c	61598-450	HUMAN OTC DRUG	Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20121012		OTC MONOGRAPH DRUG	505G(a)(3)	LTC Products Inc.	ALCOHOL	70	mL/100mL			N	20241231
61601-1217_d54bf170-443a-4688-bbee-422e11606f4d	61601-1217	HUMAN OTC DRUG	Eve Lom Daily Protection Broad Spectrum SPF 50 Sunscreen		Homosalate, Octisalate, Oxybenzone, Avobenzone, Octinoxate and Octocrylene	CREAM	TOPICAL	20140602		OTC MONOGRAPH NOT FINAL	part352	Space Brands Limited	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.15; .5; .15; .25; .135; .25	g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL			N	20241231
61621-430_5702e779-9297-4ffd-aab8-bdf28a23c4fc	61621-430	HUMAN PRESCRIPTION DRUG	Dsuvia		Sufentanil	TABLET	SUBLINGUAL	20181102		NDA	NDA209128	AcelRx Pharmaceuticals, Inc.	SUFENTANIL	30	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
61626-0098_b948d6fe-3899-39a1-e053-2995a90ae64c	61626-0098	HUMAN PRESCRIPTION DRUG	Flu Immune		Anas barbarie hepatis et cordis extractum	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/59mL			N	20241231
61626-0099_b9492b5a-9070-4f3c-e053-2a95a90a6650	61626-0099	HUMAN PRESCRIPTION DRUG	PAIN RELIEF		Arnica, Chamomilla, Hypericum, Ignatia, Symphytum	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ARNICA MONTANA; COMFREY ROOT; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; STRYCHNOS IGNATII SEED	12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
61626-0100_b9491337-22cb-60be-e053-2995a90a2ca0	61626-0100	HUMAN PRESCRIPTION DRUG	Day and Night Vitals		Allium sat, Aloe, Arsenicum alb, Berber vulg, Calc phos, Ceanothus, Chelidonium maj, Cholesterinum, Clematis erecta, Condurango, Gambogia, Hamamelis, Kali brom, Kali phos, Lycopodium, Nat carb, Passiflora, Senna, Silicea, Solidago, Spigelia anth, Spongia, Veratrum vir	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ALOE VERA LEAF; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHOLESTEROL; CLEMATIS RECTA FLOWERING TOP; DIBASIC POTASSIUM PHOSPHATE; GAMBOGE; GARLIC; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; PASSIFLORA INCARNATA TOP; POTASSIUM BROMIDE; SENNA LEAF; SILICON DIOXIDE; SODIUM CARBONATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SPIGELIA ANTHELMIA; SPONGIA OFFICINALIS SKELETON, ROASTED; TRIBASIC CALCIUM PHOSPHATE; VERATRUM VIRIDE ROOT	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61626-0101_b9491337-22d8-60be-e053-2995a90a2ca0	61626-0101	HUMAN PRESCRIPTION DRUG	Yin-Yang Balance		Adamas, Agaricus musc, Agnus, Aletris, Angelica sin, Arg nit, Arnica, Avena, Baryta, Graphites, Kali brom, Kreosotum, Lycopodium, Ocimum sanc, Phosphoricum ac, Selenium, Sepia, Thuja occ.	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ALETRIS FARINOSA ROOT; AMANITA MUSCARIA FRUITING BODY; ANGELICA SINENSIS ROOT; ARNICA MONTANA; AVENA SATIVA FLOWERING TOP; BARIUM IODIDE; CHASTE TREE; DIAMOND; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; OCIMUM TENUIFLORUM TOP; PHOSPHORIC ACID; POTASSIUM BROMIDE; SELENIUM; SEPIA OFFICINALIS JUICE; SILVER NITRATE; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
61626-0102_b9491337-22e4-60be-e053-2995a90a2ca0	61626-0102	HUMAN OTC DRUG	Earth		Aur met, Arg nit, Causticum, Cinchona, Condurango, Ceanothus, Euphrasia, Fucus, Gallicum ac, Iris vers, Net carb, Nitricum ac, Phosphorus.	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	CAUSTICUM; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; EUPHRASIA STRICTA; FUCUS VESICULOSUS; GALLIC ACID MONOHYDRATE; GOLD; IRIS VERSICOLOR ROOT; MARSDENIA CONDURANGO BARK; NITRIC ACID; PHOSPHORUS; SILVER NITRATE; SODIUM CARBONATE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
61626-0103_b9491337-22f1-60be-e053-2995a90a2ca0	61626-0103	HUMAN OTC DRUG	Metal		Aluminia, Ammon carb, Anacardium, Antimon crud, Hydrastis, Ignatia, Mag phos, Nat mur, Nitricum ac, Osmium, Paraffinum, Senna, Silicea, Spongia	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ALUMINUM OXIDE; AMMONIUM CARBONATE; ANACARDIUM OCCIDENTALE FRUIT; ANTIMONY TRISULFIDE; GOLDENSEAL; MAGNESIUM PHOSPHATE, DIBASIC; NITRIC ACID; OSMIUM; PARAFFIN; SENNA LEAF; SILICON DIOXIDE; SODIUM CHLORIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS IGNATII SEED	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
61626-0104_b9492369-ac4d-7b94-e053-2995a90ad837	61626-0104	HUMAN OTC DRUG	Water		Aconitum nap, Arsenicum alb, Borax, Calc phos, Gelsenium, Lycopodium, Phosphoricum ac, Picricum ac, Plumb met, Solidago	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; GELSEMIUM SEMPERVIRENS ROOT; LEAD; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PICRIC ACID; SODIUM BORATE; SOLIDAGO VIRGAUREA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
61626-0105_b948f152-15af-664f-e053-2995a90a3550	61626-0105	HUMAN OTC DRUG	Wood		Belladonna, Berber vulg, Carduus mar, Chelidonium maj, Cholesterinum, Colocynthis, Kali carb, Nat phos, Nitricum ac, Nux vom, Platinum met, Sepia	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CHOLESTEROL; CITRULLUS COLOCYNTHIS FRUIT PULP; MILK THISTLE; NITRIC ACID; PLATINUM; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61626-0106_b9492b5a-907e-4f3c-e053-2a95a90a6650	61626-0106	HUMAN PRESCRIPTION DRUG	Fire		Apil mel, Baptisia, Baryta carb, Hamamelis, Kali brom, Kali phos, Lachesis, Lilium, Petroleum, Phosphoricum ac, Spigelia anth, Sulphur, Veratrum vir	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	APIS MELLIFERA; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; DIBASIC POTASSIUM PHOSPHATE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; KEROSENE; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM BULB; PHOSPHORIC ACID; POTASSIUM BROMIDE; SPIGELIA ANTHELMIA; SULFUR; VERATRUM VIRIDE ROOT	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61626-0107_b9492b5a-908a-4f3c-e053-2a95a90a6650	61626-0107	HUMAN PRESCRIPTION DRUG	Para Solve		Calc carb, Chenopodium anth, Cina, Croton, Filix Mas, Gambocia, Granatum, Lycopodium, Merc corros, Nat phos, Santoninum, Senna, Spigelia anth, Stannum met, Tanacetum, Teuricum mar, Zingiber	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ARTEMISIA CINA PRE-FLOWERING TOP; CROTON TIGLIUM SEED; DRYOPTERIS FILIX-MAS ROOT; DYSPHANIA AMBROSIOIDES; GAMBOGE; GINGER; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PUNICA GRANATUM ROOT BARK; SANTONIN; SENNA LEAF; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SPIGELIA ANTHELMIA; TANACETUM VULGARE TOP; TEUCRIUM MARUM; TIN	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61626-0108_b96ae7f1-7d4e-a211-e053-2995a90ab6e2	61626-0108	HUMAN OTC DRUG	Flora Plus		Aloe, Alumina, Antimon crud, Arg nit, Chelidonium maj, Gambogia, Graphites, Hydrastis, Lycopodium, Silicea	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ALOE VERA LEAF; ALUMINUM OXIDE; ANTIMONY TRISULFIDE; CHELIDONIUM MAJUS; GAMBOGE; GOLDENSEAL; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; SILICON DIOXIDE; SILVER NITRATE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL			N	20241231
61626-0109_b96aea12-116c-582d-e053-2a95a90a9525	61626-0109	HUMAN PRESCRIPTION DRUG	Allergy		Allium sat, Anacardium, Apis mel, Gambogia, Merc solub, Nat carb, Nitricum ac, Nux vom, Phosphorus, Pulsatilla, Sulphur	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		Net Remedies	ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; APIS MELLIFERA; GAMBOGE; GARLIC; MERCURIUS SOLUBILIS; NITRIC ACID; PHOSPHORUS; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SULFUR	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61626-0110_b96afb52-959c-21a7-e053-2995a90a28a7	61626-0110	HUMAN PRESCRIPTION DRUG	ER 911		Aconitum nap, Apis mel, Arnica, Arsenicum alb, Belladonna, Bellis, Bryonia, Calendula, Chamomilla, Cistus canadensis, Clematis erecta, Ferrum phos, Histaminum, Hypericum, Ignatia, Impatiens glan flos, Ornithogalum, Passiflora, Phosphorus, Prunus cerasifera, Rhus tox, Sulphur, Symphytum, Vertarum alb	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		Net Remedies	ACONITUM NAPELLUS; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS RECTA FLOWERING TOP; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; HELIANTHEMUM CANADENSE; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA CHAMOMILLA; ORNITHOGALUM UMBELLATUM; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PRUNUS CERASIFERA FLOWER; STRYCHNOS IGNATII SEED; SULFUR; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61626-0111_b96b0433-4a2c-726c-e053-2a95a90a9dba	61626-0111	HUMAN PRESCRIPTION DRUG	Scars-Adhesions		Calc fluor, Causticum, Graphites, Hydrofluoricum ac, Lachesis, Plumb met, Rhus tox, Sepia, Silicea, Thiosinaminum	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ALLYLTHIOUREA; CALCIUM FLUORIDE; CAUSTICUM; GRAPHITE; HYDROFLUORIC ACID; LACHESIS MUTA VENOM; LEAD; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL			N	20241231
61626-0112_b96b096e-67b9-b334-e053-2995a90a34c9	61626-0112	HUMAN PRESCRIPTION DRUG	Visceral Polarity		Aconitum nap, Arg nit, Chininum pur, Echinacea purp, Plum met, Sepia, Sulphuricum ac	LIQUID	ORAL	20181204		UNAPPROVED HOMEOPATHIC		NET Remedies	ACONITUM NAPELLUS; ECHINACEA PURPUREA; FERRIC FERROCYANIDE; GELSEMIUM SEMPERVIRENS ROOT; HOPS; LEAD; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; QUININE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Chelating Activity [MoA], Decorporation Agent [EPC], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61649-021_0aaf392b-0d68-de6f-e063-6294a90a539b	61649-021	HUMAN OTC DRUG	Attitude mineral sunscreen tropical SPF 30		Zinc oxide	CREAM	TOPICAL	20231124		OTC MONOGRAPH DRUG	M020	9055-7588 Quebec Inc. DBA Attitude	ZINC OXIDE	20	g/100g			N	20241231
61649-022_0aafdc07-3ad7-860e-e063-6394a90ae572	61649-022	HUMAN OTC DRUG	Attitude mineral sunscreen orange blossom SPF 30		Zinc oxide	CREAM	TOPICAL	20231218		OTC MONOGRAPH DRUG	M020	9055-7588 Quebec Inc. DBA Attitude	ZINC OXIDE	20	g/100g			N	20241231
61649-030_0022e80f-8895-11b5-e063-6294a90a5b81	61649-030	HUMAN OTC DRUG	Attitude mineral sunscreen unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-031_0022e80f-88a4-11b5-e063-6294a90a5b81	61649-031	HUMAN OTC DRUG	Attitude mineral sunscreen tropical SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-032_0022e63f-6142-29f0-e063-6294a90aff98	61649-032	HUMAN OTC DRUG	Attitude mineral sunscreen orange blossom SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-033_0022fee2-7ae9-f186-e063-6394a90aefb8	61649-033	HUMAN OTC DRUG	Attitude tinted mineral sunscreen unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-034_0022fee2-7af9-f186-e063-6394a90aefb8	61649-034	HUMAN OTC DRUG	Attitude Kids mineral sunscreen tropical SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-035_0022fee2-7b07-f186-e063-6394a90aefb8	61649-035	HUMAN OTC DRUG	Attitude Oatmeal sensitive mineral sunscreen unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-038_0022fee2-7b23-f186-e063-6394a90aefb8	61649-038	HUMAN OTC DRUG	Attitude Kids mineral sunscreen unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-040_0022e63f-6133-29f0-e063-6294a90aff98	61649-040	HUMAN OTC DRUG	Attitude mineral sunscreen face unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-041_0022d2ab-5121-ed9b-e063-6294a90ad452	61649-041	HUMAN OTC DRUG	Attitude tinted mineral sunscreen face unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-042_00232275-64b8-9d37-e063-6294a90a1acb	61649-042	HUMAN OTC DRUG	Attitude Kids mineral sunscreen face unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-043_0022fee2-7b15-f186-e063-6394a90aefb8	61649-043	HUMAN OTC DRUG	Attitude Oatmeal sensitive mineral sunscreen face unscented SPF 30		Zinc oxide	STICK	TOPICAL	20220202		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	20	g/100g			N	20241231
61649-068_00232275-64c6-9d37-e063-6294a90a1acb	61649-068	HUMAN OTC DRUG	Attitude Oceanly Phyto-Sun Tinted - SPF 15 - Broad Spectrum Sunscreen		ZINC OXIDE	STICK	TOPICAL	20230125		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	10	g/100g			N	20241231
61649-110_0aae7707-2353-eaef-e063-6294a90a660a	61649-110	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	ZINC OXIDE	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M020	9055-7588 Quebec Inc. DBA Attitude	ZINC OXIDE	20	g/100g			N	20241231
61649-120_0ab0490f-572b-c926-e063-6394a90af878	61649-120	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	ZINC OXIDE	CREAM	TOPICAL	20231218		OTC MONOGRAPH DRUG	M020	9055-7588 Quebec Inc. DBA Attitude	ZINC OXIDE	20	g/100g			N	20241231
61649-160_0a9c8a7e-6719-3db3-e063-6294a90a6754	61649-160	HUMAN OTC DRUG	Attitude Kids mineral sunscreen unscented SPF 30		Zinc oxide	CREAM	TOPICAL	20231124		OTC MONOGRAPH DRUG	M020	9055-7588 Qubec Inc. DBA Attitude	ZINC OXIDE	20	g/100g			N	20241231
61649-162_0aad0e31-d3f7-4a67-e063-6294a90ac9b0	61649-162	HUMAN OTC DRUG	Attitude Kids Oatmeal sensitive mineral sunscreen unscented SPF 30		Zinc oxide	CREAM	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	9055-7588 Quebec Inc. DBA Attitude	ZINC OXIDE	20	g/100g			N	20241231
61649-165_0aad8f54-bc1a-0f40-e063-6294a90a1513	61649-165	HUMAN OTC DRUG	Attitude Oatmeal sensitive mineral sunscreen unscented SPF 30		Zinc oxide	CREAM	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	9055-7588 Quebec Inc. DBA Attitude	ZINC OXIDE	20	g/100g			N	20241231
61649-260_00283894-ddc7-0faa-e063-6394a90ae47c	61649-260	HUMAN OTC DRUG	Attitude Diaper Cream Zinc Unscented		Zinc oxide	STICK	TOPICAL	20230724		OTC MONOGRAPH FINAL	M016	9055-7588 Quebec Inc. (Attitude)	ZINC OXIDE	15	g/100g			N	20241231
61649-293_09d3c8c0-74d6-f49d-e063-6394a90a4815	61649-293	HUMAN OTC DRUG	ATTITUDE Super Leaves Hand Sanitizer Lemon Leaves		Ethyl alcohol	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	9055-7588 Quebec Inc. DBA Attitude	ALCOHOL	78.8	mL/100mL			N	20241231
61649-390_09d2fef3-00b4-9ee1-e063-6394a90ae344	61649-390	HUMAN OTC DRUG	ATTITUDE Super Leaves Hand Sanitizer Olive Leaves		Ethyl alcohol	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	9055-7588 Quebec Inc. DBA Attitude	ALCOHOL	78.8	mL/100mL			N	20241231
61649-398_0e84924c-69ea-2aae-e063-6294a90a1b0d	61649-398	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	ALCOHOL	SOLUTION	TOPICAL	20201115	20240331	OTC MONOGRAPH DRUG	505G(a)(3)	BIO SPECTRA	ALCOHOL	72	mL/100mL			N	
61649-513_09bee97d-a8e5-7c9c-e063-6294a90a0412	61649-513	HUMAN OTC DRUG	ATTITUDE Little Leaves Hand Sanitizer Vanilla and Pear		Ethyl alcohol	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	9055-7588 Quebec Inc. DBA Attitude	ALCOHOL	78.8	mL/100mL			N	20241231
61649-713_09d21713-f27a-489c-e063-6394a90a6779	61649-713	HUMAN OTC DRUG	ATTITUDE Little Leaves Hand Sanitizer Watermelon and Coconut		Ethyl alcohol	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	9055-7588 Quebec Inc. DBA Attitude	ALCOHOL	78.8	mL/100mL			N	20241231
61649-723_041303f9-38d1-7d0c-e063-6294a90a388e	61649-723	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20210515		OTC MONOGRAPH FINAL	part355	Attitude DBA 9055-7588 Qubec Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
61649-724_0022e80f-88f5-11b5-e063-6294a90a5b81	61649-724	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20210515		OTC MONOGRAPH FINAL	part355	Attitude DBA 9055-7588 Qubec Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
61649-725_00235822-ef2a-6fb5-e063-6394a90a0864	61649-725	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20210515		OTC MONOGRAPH FINAL	part355	Attitude DBA 9055-7588 Qubec Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
61649-730_00235822-ef36-6fb5-e063-6394a90a0864	61649-730	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20210515		OTC MONOGRAPH FINAL	part355	Attitude DBA 9055-7588 Qubec Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
61649-731_00235e8f-beff-f184-e063-6394a90af11f	61649-731	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20210515		OTC MONOGRAPH FINAL	part355	Attitude DBA 9055-7588 Qubec Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
61649-732_0ac00633-b99a-529a-e063-6294a90ab5a9	61649-732	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20240101		OTC MONOGRAPH DRUG	M021	9055-7588 Quebec Inc. DBA Attitude	SODIUM FLUORIDE	.243	g/100g			N	20241231
61649-733_00230ce6-519d-44d0-e063-6294a90a5f26	61649-733	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride and Potassium nitrate	PASTE, DENTIFRICE	DENTAL	20210515		OTC MONOGRAPH NOT FINAL	part356	Attitude DBA 9055-7588 Qubec Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .243	g/100g; g/100g			N	20241231
61649-734_00235822-ef44-6fb5-e063-6394a90a0864	61649-734	HUMAN OTC DRUG	BIO SPECTRA	ATTITUDE	Sodium fluoride	GEL, DENTIFRICE	DENTAL	20210515		OTC MONOGRAPH FINAL	part355	Attitude DBA 9055-7588 Qubec Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
61649-743_00236aa4-69b4-a0ab-e063-6394a90ac283	61649-743	HUMAN OTC DRUG	Attitude Adult Fluoride-free - Sensitive - Spearmint		Potassium nitrate	GEL, DENTIFRICE	ORAL	20220601		OTC MONOGRAPH NOT FINAL	part356	Attitude DBA 9055-7588 Qubec Inc.	POTASSIUM NITRATE	5	g/100g			N	20241231
61649-813_09d2894d-46c1-be92-e063-6294a90aea37	61649-813	HUMAN OTC DRUG	ATTITUDE Little Leaves Hand Sanitizer - Mango		Ethyl alcohol	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	9055-7588 Quebec Inc. DBA Attitude	ALCOHOL	78.8	mL/100mL			N	20241231
61649-893_09d39169-e868-d2b1-e063-6394a90a892c	61649-893	HUMAN OTC DRUG	ATTITUDE Super Leaves Hand Sanitizer Orange Leaves		Ethyl alcohol	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	505G(a)(3)	9055-7588 Quebec Inc. DBA Attitude	ALCOHOL	78.8	mL/100mL			N	20241231
61649-983_00235e8f-bf0d-f184-e063-6394a90af11f	61649-983	HUMAN OTC DRUG	Attitude - Leaves Bar - Lip Balm - SPF 15 - Mango		ZINC OXIDE	STICK	TOPICAL	20220204		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	10	g/100g			N	20241231
61649-985_00235e8f-bf1b-f184-e063-6394a90af11f	61649-985	HUMAN OTC DRUG	Attitude - Lip Balm - SPF 15 - Coconut		Zinc oxide	STICK	TOPICAL	20220204		OTC MONOGRAPH FINAL	M020	Attitude DBA 9055-7588 Qubec Inc.	ZINC OXIDE	10	g/100g			N	20241231
61657-0003_b97072b4-ce34-7403-e053-2a95a90aa376	61657-0003	HUMAN OTC DRUG	Allerhale		ARS ALB, PHOS,NUX VOM, PULS, SULPH, EUP, SOL, ECHI, BAPT	LIQUID	ORAL	20110901		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro West	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; ECHINACEA, UNSPECIFIED; EUPHRASIA STRICTA; GARLIC; ONION; PHOSPHORUS; PULSATILLA VULGARIS; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	12; 3; 3; 12; 3; 12; 12; 12; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
61657-0006_b9708571-5b82-4644-e053-2995a90a6a12	61657-0006	HUMAN OTC DRUG	Anxiolix		ARSENICUM ALBUM ,SCUTELLARIA LATERIFLORA,PHOSPHORUS,LACHESIS MUTUS,PULSATILLA,PASSIFLORA INCARNATA,ACONITE,VALERIANA OFFICINALIS,CALCAREA CARBONICA,IGNATIA AMARA	LIQUID	ORAL	20110601		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro West	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; PULSATILLA VULGARIS; SCUTELLARIA LATERIFLORA; STRYCHNOS IGNATII SEED; VALERIAN	12; 12; 15; 12; 3; 12; 12; 3; 12; 3	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
61657-0052_b9708571-5b91-4644-e053-2995a90a6a12	61657-0052	HUMAN OTC DRUG	BACTOFLAM		ECHINACEA,BAPTISIA,APIS MELLIFICA ,FERRUM PHOSPHORICUM ,	LIQUID	ORAL	20110610		UNAPPROVED HOMEOPATHIC		WHITE MANUFACTURING INC. DBA MICRO WEST	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA, UNSPECIFIED; FERRUM PHOSPHORICUM; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 3; 3; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61657-0101_b97067fc-edb0-7e5d-e053-2a95a90afde5	61657-0101	HUMAN OTC DRUG	CAND-EX		LYCOPODIUM,NUX VOMICA,BORAX,ASAFOETIDA,NUX MOSCHATA,GENTIANA LUTEA,KREOSOTUM,CALCAREA CARBONICA,SEPIA,PHOSPHORIC ACID,ECHINACEA,PULSATILLA,BAPTISIA,	LIQUID	ORAL	19930801		UNAPPROVED HOMEOPATHIC		WHITE MANUFACTURING INC. DBA MICRO WEST	ASAFETIDA; BAPTISIA TINCTORIA; ECHINACEA, UNSPECIFIED; GENTIANA LUTEA ROOT; LYCOPODIUM CLAVATUM SPORE; NUTMEG; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SODIUM BORATE; STRYCHNOS NUX-VOMICA SEED; WOOD CREOSOTE	12; 3; 3; 3; 30; 12; 12; 12; 30; 30; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61657-0208_b96fe6d5-43c0-3149-e053-2995a90a9fbb	61657-0208	HUMAN OTC DRUG	Whole System EEP		MERCURIUS CORROSIVUS,NUX VOMICA,HYOSCYAMINUM,CARCINOSINUM,GRAPHITES,ZINCUM METALLICUM,LILIUM TIGRINUM,CINCHONA OFFICINALIS,CAUSTICUM,COFFEA CRUDA,BELLADONNA,IGNATIA AMARA,SCROPHULARIA NODOSA,SPONGIA TOSTA ,CEANOTHUS AMERICANUS,SENNA,HYDRASTIS CANADENSIS,CONDURANGO,CHELIDONIUM MAJUS,PITUITARY GLAND, BOS TAURUS,PANCREAS SUIS,LYCOPODIUM CLAVATUM,BERBERIS VULGARIS,	LIQUID	ORAL	20050521		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARABICA COFFEE BEAN; ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; BOS TAURUS PITUITARY GLAND; CAUSTICUM; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; GOLDENSEAL; GRAPHITE; HUMAN BREAST TUMOR CELL; HYOSCYAMINE; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; MERCURIC CHLORIDE; SCROPHULARIA NODOSA; SENNA LEAF; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; ZINC	1; 1; 12; 12; 5; 6; 3; 5; 3; 2; 10; 10; 5; 12; 3; 12; 15; 3; 6; 200; 10; 12; 3	[hp_M]/30mL; [hp_M]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_M]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_M]/30mL; [hp_X]/30mL; [hp_M]/30mL; [hp_M]/30mL; [hp_M]/30mL; [hp_M]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_M]/30mL; [hp_X]/30mL; [hp_M]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61657-0526_b9702a01-501b-c715-e053-2995a90addd6	61657-0526	HUMAN OTC DRUG	Met-Tox		Arsenicum Album, Avena Sativa,Lycopodium Clavatum,Natrum Muriaticum,Nux Vomica,Phytolacca DecandraRhamnus Frangula,Solidago Virgaurea,Trifolium Pratense,Heavy Metal Nosodes	LIQUID	ORAL	20060124		UNAPPROVED HOMEOPATHIC		wHITE mANUFACTURING INC DBA MICRO-WEST	ACTIVATED CHARCOAL; ALUMINUM; ANTIMONY; ARSENIC; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BARIUM; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BORON; BROMINE; CADMIUM; CALCIUM; CERIUM; CESIUM; CHLORIDE ION; CHROMIUM; COBALT; COPPER; DYSPROSIUM; ERBIUM; EUROPIUM; FLUORIDE ION; FRANGULA ALNUS BARK; GADOLINIUM; GALLIUM; GOLD; HAFNIUM; HOLMIUM; HYDROGEN; INDIUM; IODINE; IRIDIUM; IRON; LEAD; LITHIUM; LUTETIUM; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MERCURY; MOLYBDENUM; NEODYMIUM; NIOBIUM; NITROGEN; OSMIUM; PALLADIUM; PHYTOLACCA AMERICANA ROOT; PLATINUM; POTASSIUM; PRASEODYMIUM; RHODIUM; RUBIDIUM; RUTHENIUM; SAMARIUM; SCANDIUM; SELENIUM; SILICON; SILVER; SODIUM; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM; STRYCHNOS NUX-VOMICA SEED; SULFUR; TANTALUM; TELLURIUM; TERBIUM; THORIUM; TIN; TITANIUM; TRIFOLIUM PRATENSE FLOWER; VANADIUM; YTTERBIUM; YTTRIUM; ZINC; ZIRCONIUM	12; 12; 12; 12; 12; 3; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Calcium [CS], Calcium [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Mood Stabilizer [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
61657-0904_b9705c08-0b3b-234c-e053-2995a90a4321	61657-0904	HUMAN OTC DRUG	Surgery/Trauma		HYPERICUM,ARNICA,SYMPHYTUM OFFICINALE, BELLIS PERENNIS, STAPHYSAGRIA	LIQUID	ORAL	20110701		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARNICA MONTANA FLOWER; BELLIS PERENNIS; COMFREY ROOT; DELPHINIUM STAPHISAGRIA SEED; ST. JOHN'S WORT	200; 12; 6; 12; 30	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
61657-0952_b9703d01-4e33-2718-e053-2a95a90aaf08	61657-0952	HUMAN OTC DRUG	Thyroid		IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,	LIQUID	ORAL	19960826		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARSENIC TRIIODIDE; BARIUM CARBONATE; FUCUS VESICULOSUS; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS; SPONGILLA LACUSTRIS; THYROID, UNSPECIFIED	12; 12; 3; 12; 12; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
61657-0955_b96fb4f1-3476-1867-e053-2a95a90a2279	61657-0955	HUMAN OTC DRUG	Total Aluminum		Aluminum Metal	LIQUID	ORAL	20110930		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ALUMINUM	12	[hp_X]/30mL			N	20241231
61657-0961_b9703ce2-3dc1-11b5-e053-2a95a90aed81	61657-0961	HUMAN OTC DRUG	TOTAL MERCURY		MERCURIUS VIVUS	LIQUID	ORAL	20110101		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	MERCURY	12	[hp_X]/30mL			N	20241231
61657-0974_b9702889-9e53-da42-e053-2995a90a45de	61657-0974	HUMAN OTC DRUG	TOTAL PRO-JES		ADRENAL,BELLADONNA,CHELIDONIUM,DIOSCOREAVILLOSA,FOLLICULINUM,HYPOTHALAMUS,ARGININE,LILIumTIGRINIUM,LIVER,OOPHORINUM,PINEAL,PITUITARINUM,PLACENTANIUM,PROGESTERONE	LIQUID	ORAL	20110915		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. BDA Micro-West	ARGININE; ATROPA BELLADONNA; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PINEAL GLAND; BOS TAURUS PITUITARY GLAND; CHELIDONIUM MAJUS; DIOSCOREA VILLOSA ROOT; EPINEPHRINE; ESTRONE; LILIUM LANCIFOLIUM FLOWERING TOP; MAMMAL LIVER; PROGESTERONE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SULFUR; SUS SCROFA OVARY; SUS SCROFA PLACENTA	6; 6; 6; 6; 6; 6; 6; 6; 6; 12; 6; 6; 12; 12; 12; 6; 6	[hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], Progesterone [CS], Progesterone [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
61657-1026_b97044f4-0e78-5eb0-e053-2995a90a8021	61657-1026	HUMAN OTC DRUG	Vermafuge -AG	Lycopodium	NUX VOMICA,ARSENICUM ALBUM,CINCHONA OFFICINALIS,CAPSICUM ANNUUM,NITRIC ACID,MERCURIUSCORROSIVUS,BELLADONNA,CAJUPUTUM,LYCOPODIUM CLAVATUM,PHOSPHORUS,PHYTOLACCA DECANDRA,RHAMNUS PURSHIANA,FRAGARIA VESCA	LIQUID	ORAL	19930803		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ALPINE STRAWBERRY; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAJUPUT OIL; CAPSICUM; CINCHONA OFFICINALIS BARK; FRANGULA PURSHIANA BARK; LYCOPODIUM CLAVATUM SPORE; MERCURIC CHLORIDE; NITRIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 4; 3; 12; 3; 12; 12; 12; 12; 6; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
61657-2104_b970a9e9-d62b-1700-e053-2a95a90a3898	61657-2104	HUMAN OTC DRUG	CHRON SINO		Arsenicum alb, Baptisia, Echinacea, Hydrastis, Kali bic, Mag phos, Merc solub, Phytolacca, Pulsatilla, Rhus tox, Sepia	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ANEMONE PULSATILLA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SEPIA OFFICINALIS JUICE; TOXICODENDRON PUBESCENS LEAF	12; 12; 3; 3; 5; 12; 12; 3; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61657-2327_b9708710-9f11-3fb9-e053-2995a90a17ea	61657-2327	HUMAN OTC DRUG	HPZ		Echinacea, Gelsemium, Hydrastis, Hypericum, Lycopodium, Nat mur, Nitricum ac, Ranunc bulb, Rhus tox, Thuja occ	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ECHINACEA PURPUREA; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; RANUNCULUS BULBOSUS; SODIUM CHLORIDE; ST. JOHN'S WORT; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	3; 12; 3; 12; 12; 12; 12; 3; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
61657-2968_b9709104-7ac1-f144-e053-2a95a90a3712	61657-2968	HUMAN OTC DRUG	TOTAL FLU CLD 1		Arsenicum alb, Baptisia, Bryonia, Causticum, Cinchona, Dulcamara, Echinacea purp, Eucalyptus, Eupatorium perf, Gelsemium, Influenzinum, Lachesis, Phytolacca, Rhus tox, Sarcolacticum ac, Sulphur, Wyethia. Anas barbariae	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CAUSTICUM; CINCHONA OFFICINALIS BARK; ECHINACEA PURPUREA; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS; LACHESIS MUTA VENOM; LACTIC ACID, L-; PHYTOLACCA AMERICANA ROOT; SOLANUM DULCAMARA TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF; WYETHIA HELENIOIDES ROOT	10; 10; 10; 35; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
61657-2969_b970a6fb-f11e-3d46-e053-2995a90a28cd	61657-2969	HUMAN PRESCRIPTION DRUG	TOTAL TRI-ESTRO		Adrenalinum, Cimicifuga, Ignatia, Lecithin, Nicotinamidum, Oophorinum, Sepia.	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	BLACK COHOSH; EGG PHOSPHOLIPIDS; EPINEPHRINE; NIACINAMIDE; SEPIA OFFICINALIS JUICE; STRYCHNOS IGNATII SEED; SUS SCROFA OVARY	10; 10; 10; 10; 10; 10; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
61657-2970_b9709104-7acf-f144-e053-2a95a90a3712	61657-2970	HUMAN OTC DRUG	TOTAL ANDRO BAL		Cholesterinum, Damiana, DNA, Hypothalamus, Lecithin, Phosphoricum ac, Sabal	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	BOS TAURUS HYPOTHALAMUS; CHOLESTEROL; EGG PHOSPHOLIPIDS; HERRING SPERM DNA; PHOSPHORIC ACID; SAW PALMETTO; TURNERA DIFFUSA LEAFY TWIG	18; 10; 18; 10; 18; 18; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
61657-2971_b970a6fb-f113-3d46-e053-2995a90a28cd	61657-2971	HUMAN PRESCRIPTION DRUG	TOTAL FEM BAL		Adrenalinum, Cholesterinum, Folliculinum, Hypothalamus, Oophorinum, Pulsatilla	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ANEMONE PULSATILLA; BOS TAURUS HYPOTHALAMUS; CHOLESTEROL; EPINEPHRINE; ESTRONE; SUS SCROFA OVARY	10; 10; 10; 10; 10; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
61658-002_0c465fb6-c0e8-4cab-9a5c-a2295bc0271d	61658-002	HUMAN OTC DRUG	ARTHRITIS PAIN RELIEF		CAMPHOR, CAPSAICIN, METHYL SALICYLATE	PATCH	TOPICAL	20230807		OTC MONOGRAPH NOT FINAL	part348	YUNNAN BAIYAO GROUP CO., LTD.	CAMPHOR (SYNTHETIC); CAPSAICIN; METHYL SALICYLATE	128.04; 2.88; 168.03	mg/1; mg/1; mg/1			N	20241231
61658-003_6a659605-ca97-46ee-971f-6a8bd8c909ff	61658-003	HUMAN OTC DRUG	YNBY Pain Relieving		Camphor, Menthol, and Methyl Salicylate	PATCH	TOPICAL	20230925		OTC MONOGRAPH NOT FINAL	part348	YUNNAN BAIYAO GROUP CO., LTD.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	40.74; 51.84; 117.998	mg/1; mg/1; mg/1			N	20241231
61658-004_adb4475a-691d-4c01-8a23-b8088079f335	61658-004	HUMAN OTC DRUG	YNBY		Camphor, Menthol, and Methyl Salicylate	SPRAY	TOPICAL	20230921		OTC MONOGRAPH NOT FINAL	part348	YUNNAN BAIYAO GROUP CO., LTD.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.5; 4.5; 10	g/100mL; g/100mL; g/100mL			N	20241231
61658-102_066e522d-d780-2734-e063-6294a90a3d55	61658-102	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Menthol	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.4	mg/1			N	20241231
61658-113_fc8608d6-6a4a-d6fc-e053-6394a90a54e8	61658-113	HUMAN OTC DRUG	MGC Health		Cough Drops Menthol Sugar-Free	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.4	mg/1			N	20241231
61658-114_fc85e60b-f757-2a55-e053-6394a90a10fd	61658-114	HUMAN OTC DRUG	MGC Health		Cough Drops Honey	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	7.5	mg/1			N	20241231
61658-117_f59d7dfb-6e72-4687-e053-2a95a90aac4a	61658-117	HUMAN OTC DRUG	MGC Health		Cough Drops Assorted Citrus Vitamin C Sugar-Free	TABLET, CHEWABLE, EXTENDED RELEASE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	2.7	mg/2850mg			N	20241231
61658-121_fa3ae3a5-3f73-aa64-e053-6394a90a7336	61658-121	HUMAN OTC DRUG	MGC Health		Cough Drops Cherry	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.8	mg/1			N	20241231
61658-125_fa3aadc7-fff0-ea76-e053-6294a90aa6dc	61658-125	HUMAN OTC DRUG	MGC Health		Cough Drops Honey Sugar-Free	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	7.6	mg/1			N	20241231
61658-126_ff9a79e0-8d20-c5d1-e053-6294a90a8444	61658-126	HUMAN OTC DRUG	MGC Health		Cough Drops Assorted Citrus Vitamin C	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	2.7	mg/1			N	20241231
61658-127_043ef22b-5fff-a11b-e063-6394a90a25f2	61658-127	HUMAN OTC DRUG	MGC Health		Cough Drops Black Cherry Sugar Free	LOZENGE	ORAL	20230901		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.8	mg/1			N	20241231
61658-128_043ef22b-6001-a11b-e063-6394a90a25f2	61658-128	HUMAN OTC DRUG	MGC Health		Cough Drops Vanilla Honey	LOZENGE	ORAL	20230901		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	2.5	mg/1			N	20241231
61658-129_043f5818-8e6e-501b-e063-6294a90a79da	61658-129	HUMAN OTC DRUG	MGC Health		Cough Drops Creamy Strawberry	LOZENGE	ORAL	20230901		OTC MONOGRAPH NOT FINAL	part356	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL; PECTIN	2.5; 7	mg/1; mg/1			N	20241231
61658-150_066e7447-a3c0-8006-e063-6394a90a561e	61658-150	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Honey Lemon	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	7.5	mg/1			N	20241231
61658-202_066e879b-8e88-d3b6-e063-6394a90a3575	61658-202	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Cherry	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.8	mg/1			N	20241231
61658-509_066e7447-a3a4-8006-e063-6394a90a561e	61658-509	HUMAN OTC DRUG	DISCOUNT DRUG MART		Cough Drops Vitamin C Sugar-Free	LOZENGE	ORAL	20230927		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	2.7	mg/1			N	20241231
61658-616_00dcd6f5-664f-accd-e063-6294a90af6fe	61658-616	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Honey Lemon Sugar Free	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	7.6	mg/1			N	20241231
61658-617_00dce152-3544-fca7-e063-6294a90aefaf	61658-617	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Honey Lemon	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	7.5	mg/1			N	20241231
61658-673_00dcdb58-6b83-0a1e-e063-6394a90a33a4	61658-673	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Vitamin C	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	2.7	mg/1			N	20241231
61658-674_00dd305a-ae6a-8801-e063-6294a90ac0ed	61658-674	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Cherry	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.8	mg/1			N	20241231
61658-675_00dd1c9b-c9bf-886a-e063-6294a90abdbf	61658-675	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Menthol	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.4	mg/1			N	20241231
61658-883_01952b8e-bd82-2b90-e063-6394a90a5210	61658-883	HUMAN OTC DRUG	Premier Value		Cough Drops Cherry	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.8	mg/1			N	20241231
61658-884_01952b49-7eeb-1856-e063-6294a90a9ad7	61658-884	HUMAN OTC DRUG	Premier Value		Cough Drops Honey Lemon	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	7.5	mg/1			N	20241231
61658-885_01953d68-e529-ea35-e063-6294a90a2f49	61658-885	HUMAN OTC DRUG	Premier Value		Cough Drops Menthol	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.4	mg/1			N	20241231
61658-886_01953018-5da7-7e51-e063-6294a90a0989	61658-886	HUMAN OTC DRUG	Premier Value		Cough Drops Black Cherry Sugar Free	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	YUNNAN BAIYAO GROUP CO., LTD	MENTHOL	5.8	mg/1			N	20241231
61666-003_6cc277de-6e57-44fe-8d38-1c96642e746b	61666-003	HUMAN OTC DRUG	Antimicrobial Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20030101		OTC MONOGRAPH NOT FINAL	part333E	Waxie Sanitary Supply	CHLOROXYLENOL	.003	mg/mL			N	20241231
61666-004_c951badf-ff88-4b91-bfac-af20cc70572f	61666-004	HUMAN OTC DRUG	WAXIECARE Pink Antibacterial Ltion So ap		CHLOROXYLENOL	LIQUID	TOPICAL	20020815		OTC MONOGRAPH NOT FINAL	part333E	Waxie Sanitary Supply	CHLOROXYLENOL	.003	mg/mL			N	20241231
61666-005_2803dc26-5760-4061-b3a2-5c916e1ce133	61666-005	HUMAN OTC DRUG	Antimicrobial Foam So ap with PCMX		Chloroxylenol	LIQUID	TOPICAL	20060615		OTC MONOGRAPH NOT FINAL	part333E	Waxie Sanitary Supply	CHLOROXYLENOL	.003	mg/mL			N	20241231
61666-007_310a6447-8547-40b9-8ace-54d3d7bf22dc	61666-007	HUMAN OTC DRUG	GRAND TOUCH Antimicrobial Ltion So ap		Chloroxylenol	LIQUID	TOPICAL	20100330		OTC MONOGRAPH NOT FINAL	part333E	Waxie Sanitary Supply	CHLOROXYLENOL	.003	mg/mL			N	20241231
61666-008_f6ffc4ce-0b8c-4cc7-a209-ab04df11bd3d	61666-008	HUMAN OTC DRUG	Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170415		OTC MONOGRAPH NOT FINAL	part333E	Waxie Sanitary Supply	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
61666-901_09d2bc09-6d91-bcf9-e063-6294a90af0a2	61666-901	HUMAN OTC DRUG	Waxie Antibacterial Hand		Chloroxylenol	SOAP	TOPICAL	20211202		OTC MONOGRAPH DRUG	505G(a)(3)	Waxie's Enterprises, LLC	CHLOROXYLENOL	2.5	g/L			N	20241231
61703-124_dbbf1725-7755-4bee-848a-2afc4bcf685c	61703-124	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20221017		NDA	NDA011719	Hospira, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
61703-150_895eb463-bd29-4047-a6c8-efb92473b38e	61703-150	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20220523		ANDA	ANDA076517	Hospira, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
61703-262_895eb463-bd29-4047-a6c8-efb92473b38e	61703-262	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20220523		ANDA	ANDA076517	Hospira, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
61703-303_1acab90c-081d-488d-b324-7909e49fe42f	61703-303	HUMAN PRESCRIPTION DRUG	CYTARABINE		CYTARABINE	INJECTION, SOLUTION	INTRAVENOUS	19900831		ANDA	ANDA072168	Hospira, Inc.	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
61703-304_0ced64e9-b655-4441-9845-7f1900356a54	61703-304	HUMAN PRESCRIPTION DRUG	Cytarabine		CYTARABINE	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19940228		ANDA	ANDA072945	Hospira, Inc.	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
61703-305_2f1e0d27-db5b-4e1c-bc4e-956da5dd7117	61703-305	HUMAN PRESCRIPTION DRUG	Cytarabine		CYTARABINE	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	19900604		ANDA	ANDA071868	Hospira, Inc.	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
61703-309_0becb036-e670-44df-b3ea-2f137982cc59	61703-309	HUMAN PRESCRIPTION DRUG	VinCRIStine Sulfate		VINCRISTINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20131127		ANDA	ANDA071484	Hospira, Inc.	VINCRISTINE SULFATE	1	mg/mL	Vinca Alkaloid [EPC], Vinca Alkaloids [CS]		N	20241231
61703-309_2d47361a-6d36-410c-a150-95b818426315	61703-309	HUMAN PRESCRIPTION DRUG	VinCRIStine Sulfate		VINCRISTINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	19960101		ANDA	ANDA071484	Hospira, Inc.	VINCRISTINE SULFATE	1	mg/mL	Vinca Alkaloid [EPC], Vinca Alkaloids [CS]		N	20241231
61703-319_efb905e7-5dd3-4906-9e21-c4433022417f	61703-319	HUMAN PRESCRIPTION DRUG	Cytarabine		CYTARABINE	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	19991122		ANDA	ANDA075383	Hospira, Inc.	CYTARABINE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
61703-323_6615dbd2-3bb4-40b5-8599-aa46bc0bc488	61703-323	HUMAN PRESCRIPTION DRUG	Bleomycin		BLEOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20000410		ANDA	ANDA065031	Hospira, Inc.	BLEOMYCIN SULFATE	30	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
61703-324_f19fc8a2-98f0-478c-8063-0596852cfccb	61703-324	HUMAN PRESCRIPTION DRUG	Pamidronate Disodium		PAMIDRONATE DISODIUM	INJECTION, SOLUTION	INTRAVENOUS	20051001		ANDA	ANDA075841	Hospira, Inc.	PAMIDRONATE DISODIUM	3	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
61703-325_f19fc8a2-98f0-478c-8063-0596852cfccb	61703-325	HUMAN PRESCRIPTION DRUG	Pamidronate Disodium		PAMIDRONATE DISODIUM	INJECTION, SOLUTION	INTRAVENOUS	20030728		ANDA	ANDA075841	Hospira, Inc.	PAMIDRONATE DISODIUM	6	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
61703-326_f19fc8a2-98f0-478c-8063-0596852cfccb	61703-326	HUMAN PRESCRIPTION DRUG	Pamidronate Disodium		PAMIDRONATE DISODIUM	INJECTION, SOLUTION	INTRAVENOUS	20051001		ANDA	ANDA075841	Hospira, Inc.	PAMIDRONATE DISODIUM	9	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
61703-332_6615dbd2-3bb4-40b5-8599-aa46bc0bc488	61703-332	HUMAN PRESCRIPTION DRUG	Bleomycin		BLEOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20000411		ANDA	ANDA065031	Hospira, Inc.	BLEOMYCIN SULFATE	15	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
61703-339_b233f1d4-8cf9-4671-834b-68dd06411f97	61703-339	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20041014		ANDA	ANDA076517	Hospira, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
61703-342_fe666b6c-20ba-4861-87b4-d8e45cfddb36	61703-342	HUMAN PRESCRIPTION DRUG	Paclitaxel		PACLITAXEL	INJECTION, SOLUTION	INTRAVENOUS	20040301		ANDA	ANDA076131	Hospira, Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
61703-343_536835bb-03d2-4a9d-8bb3-ded4bcaa31d0	61703-343	HUMAN PRESCRIPTION DRUG	Mitoxantrone		Mitoxantrone	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20060411		ANDA	ANDA076871	Hospira, Inc.	MITOXANTRONE HYDROCHLORIDE	2	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
61703-349_97675447-8e56-4d7d-a8ab-677b2897fab0	61703-349	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20080227		ANDA	ANDA077915	Hospira, Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
61703-350_9ca7f3b8-c3a3-49b4-9bed-402e8cf80906	61703-350	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050727		NDA	NDA011719	Hospira, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
61703-350_a70fd689-9446-44cc-bd40-77c997b50258	61703-350	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20140925		NDA	NDA011719	Hospira, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
61703-360_895eb463-bd29-4047-a6c8-efb92473b38e	61703-360	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20220523		ANDA	ANDA076517	Hospira, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
61703-363_9b334968-cb6e-4119-b6a7-a9f5c18add5b	61703-363	HUMAN PRESCRIPTION DRUG	Oxaliplatin		OXALIPLATIN	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20090810		ANDA	ANDA078813	Hospira, Inc.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
61703-408_9ca7f3b8-c3a3-49b4-9bed-402e8cf80906	61703-408	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20010226		NDA	NDA011719	Hospira, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
61703-408_a70fd689-9446-44cc-bd40-77c997b50258	61703-408	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20131111		NDA	NDA011719	Hospira, Inc.	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
61703-600_895eb463-bd29-4047-a6c8-efb92473b38e	61703-600	HUMAN PRESCRIPTION DRUG	Carboplatin		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20220523		ANDA	ANDA077059	Hospira, Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
61715-171_3bb43712-e06d-40a6-a89a-3319c1a5d7fc	61715-171	HUMAN OTC DRUG	Ear Wax Removal Drops	Preferred Plus Pharmacy	Carbamide Peroxide - 6.5%	SOLUTION/ DROPS	TOPICAL	20140609		OTC MONOGRAPH FINAL	part344	Kinray	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
61715-211_0d2a50a5-7e74-98df-e063-6394a90a097b	61715-211	HUMAN OTC DRUG	Preferred Plus Pharmacy Artificial Tears		polyvinyl alcohol, povidone	SOLUTION	OPHTHALMIC	20200529		OTC MONOGRAPH DRUG	M018	Kinray Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE, UNSPECIFIED	.5; .6	g/100mL; g/100mL			N	20241231
61715-212_0d2a55f9-19c7-74eb-e063-6294a90a700e	61715-212	HUMAN OTC DRUG	Preferred Plus Pharmacy Redness Relief Eye Drops		tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20200701		OTC MONOGRAPH DRUG	M018	Kinray	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
61715-253_486e4354-2d29-454d-e054-00144ff8d46c	61715-253	HUMAN OTC DRUG	Preferred Plus Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101028		OTC MONOGRAPH FINAL	part358G	Kinray	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
61727-103_46f3ff78-f5fd-6da1-e054-00144ff8d46c	61727-103	HUMAN OTC DRUG	StellaLife VEGA Oral Care Rinse		Rinse	RINSE	DENTAL	20161210		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories, Inc.	AZADIRACHTA INDICA BARK; CALENDULA OFFICINALIS FLOWER; ECHINACEA PURPUREA; PLANTAGO MAJOR	1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
61727-111_7d8a0adc-1750-98b8-e053-2a91aa0aee0c	61727-111	HUMAN OTC DRUG	Arnica Relief		arnica montana 30c tablet	TABLET	ORAL	20120706		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARNICA MONTANA	30	[hp_C]/1			N	20241231
61727-111_848c9a83-8038-dc04-e053-2a91aa0a5d78	61727-111	HUMAN OTC DRUG	Arnica Montana 30C		Arnica Montana	PELLET	SUBLINGUAL	20120611		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARNICA MONTANA	30	[hp_C]/1			N	20241231
61727-112_7d8df6df-1805-fd19-e053-2a91aa0a1e52	61727-112	HUMAN OTC DRUG	Arnica Relief		ARNICA MONTANA	CREAM	TOPICAL	20120410		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARNICA MONTANA	1	[hp_X]/56.7g			N	20241231
61727-114_705a8d0d-61ea-149d-e053-2a91aa0a6689	61727-114	HUMAN OTC DRUG	BRAZMEDICS ARNICA Cream		BRAZMEDICS ARNICA Cream	CREAM	TOPICAL	20180706		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARNICA MONTANA	1	[hp_X]/[hp_X]			N	20241231
61727-115_b701234a-0bd3-16d3-e053-2995a90a5b13	61727-115	HUMAN OTC DRUG	StellaLife VEGA Oral Care Recovery Kit		Kit	KIT	DENTAL; SUBLINGUAL; TOPICAL	20210108		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories, Inc.						N	20241231
61727-117_b701234a-0bd3-16d3-e053-2995a90a5b13	61727-117	HUMAN OTC DRUG	StellaLife VEGA Oral Care Gel		Gel	GEL	DENTAL; TOPICAL	20210108		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories, Inc.	ARNICA MONTANA; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; STRYCHNOS IGNATII SEED	18; 8; 3; 8; 3; 3; 10; 6; 5; 12; 8; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
61727-118_b701234a-0bd3-16d3-e053-2995a90a5b13	61727-118	HUMAN OTC DRUG	StellaLife VEGA Oral Care		Spray	SPRAY	DENTAL; SUBLINGUAL	20210108		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories, Inc.	ARNICA MONTANA; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; STRYCHNOS IGNATII SEED	18; 8; 3; 8; 3; 3; 10; 6; 5; 12; 8; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
61727-119_ca788280-e0db-67f5-e053-2995a90ab6c0	61727-119	HUMAN OTC DRUG	StellaLife VEGA Oral Care Coconut		Risne	RINSE	DENTAL	20210108		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories, Inc.	APIS MELLIFERA; AZADIRACHTA INDICA BARK; CALENDULA OFFICINALIS FLOWER; ECHINACEA PURPUREA; OKOUBAKA AUBREVILLEI BARK; PHOSPHORUS; PLANTAGO MAJOR; STRONTIUM; THUJA OCCIDENTALIS LEAFY TWIG	12; 1; 1; 1; 6; 12; 1; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61727-301_7d8e2589-62b9-471b-e053-2991aa0a08e8	61727-301	HUMAN OTC DRUG	Allergy Relief		onion, apis mellifera, drosera rotundifolia, euphrasia stricta, urtica urens	PELLET	SUBLINGUAL	20120608		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	APIS MELLIFERA; DROSERA ROTUNDIFOLIA; EUPHRASIA STRICTA; ONION; URTICA URENS	8; 8; 8; 8; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
61727-302_7d8e7859-7819-01ef-e053-2991aa0ad008	61727-302	HUMAN OTC DRUG	Arthritis Relief		ARNICA MONTANA, BRYONIA ALBA, CHAMOMILLA,HYPERICUM PERFORATUM, KALMIA LATIFOLIA LEAF,KALMIA LATIFOLIA LEAF	PELLET	SUBLINGUAL	20120731		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARNICA MONTANA; BRYONIA ALBA ROOT; HYPERICUM PERFORATUM; KALMIA LATIFOLIA LEAF; MATRICARIA RECUTITA; TOXICODENDRON PUBESCENS LEAF	18; 8; 8; 8; 8; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g			N	20241231
61727-303_82e5e06e-ffde-4d17-e053-2a91aa0a7688	61727-303	HUMAN OTC DRUG	Cold and Flu Relief		aconitum napellus, onion, arnica montana, atropa belladonna, solanum dulcamara top, eupatorium cannabinum, gelsemium sempervirens root	PELLET	SUBLINGUAL	20120705		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; EUPATORIUM CANNABINUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; ONION; SOLANUM DULCAMARA TOP	14; 8; 8; 8; 18; 8; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
61727-304_7df39522-e43f-9aa5-e053-2991aa0abc99	61727-304	HUMAN OTC DRUG	Constipation Relief		aluminum oxide, bryonia alba root, sodium chloride, graphite, silicon dioxide	PELLET	SUBLINGUAL	20120705		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ALUMINUM OXIDE; BRYONIA ALBA ROOT; GRAPHITE; SILICON DIOXIDE; SODIUM CHLORIDE	10; 8; 10; 10; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
61727-305_7df397a8-7a55-a514-e053-2991aa0a4ae9	61727-305	HUMAN OTC DRUG	Headache Relief		atropa belladonna, cyclamen purpurascens tuber, coffea arabica seed, roasted, iris versicolor root, strychnos nux-vomica seed, sanguinaria canadensis root, spigelia marilandica root, viburnum opulus bark	PELLET	SUBLINGUAL	20120720		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ATROPA BELLADONNA; COFFEA ARABICA SEED, ROASTED; CYCLAMEN PURPURASCENS TUBER; IRIS VERSICOLOR ROOT; SANGUINARIA CANADENSIS ROOT; SPIGELIA MARILANDICA ROOT; STRYCHNOS NUX-VOMICA SEED; VIBURNUM OPULUS BARK	8; 4; 8; 8; 8; 8; 9; 4	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61727-306_7df39a53-b456-3d2f-e053-2a91aa0a64b9	61727-306	HUMAN OTC DRUG	Hemorrhoids Relief		HORSE CHESTNUT,ALOE,HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK,NITRIC ACID,PAEONIA OFFICINALIS ROOT,SEPIA OFFICINALIS JUICE.	PELLET	SUBLINGUAL	20120720		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ALOE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; NITRIC ACID; PAEONIA OFFICINALIS ROOT; SEPIA OFFICINALIS JUICE	8; 8; 8; 8; 8; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g			N	20241231
61727-307_7df3a8f9-b2c3-0c85-e053-2a91aa0a884f	61727-307	HUMAN OTC DRUG	Insomnia Relief		Insomnia Relief	PELLET	SUBLINGUAL	20120720		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; DATURA STRAMONIUM; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED	14; 3; 8; 8; 8; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61727-308_7df3be22-b15d-52d5-e053-2a91aa0ab75b	61727-308	HUMAN OTC DRUG	Menopause Relief		BARIUM CARBONATE, ATROPA BELLADONNA, BLACK COHOSH, NITROGLYCERIN, LACHESIS MUTA VENOM, SILICON DIOXIDE	PELLET	SUBLINGUAL	20120723		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ATROPA BELLADONNA; BARIUM CARBONATE; BLACK COHOSH; LACHESIS MUTA VENOM; NITROGLYCERIN; SILICON DIOXIDE	8; 10; 8; 10; 8; 10	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
61727-309_7df3be22-b168-52d5-e053-2a91aa0ab75b	61727-309	HUMAN OTC DRUG	Muscular Pain Relief		ARNICA MONTANA, COPPER, POTASSIUM PHOSPHATE, DIBASIC, LACTIC ACID, DL-,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	SUBLINGUAL	20120723		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARNICA MONTANA; COPPER; LACTIC ACID, DL-; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM PHOSPHATE, DIBASIC	18; 10; 8; 10; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61727-310_7df3ccbb-5deb-774c-e053-2991aa0a2cb8	61727-310	HUMAN OTC DRUG	PMS Relief		copper, estrone, histamine dihydrochloride, magnesium phosphate, tribasic, pentahydrate, sodium sulfate	PELLET	SUBLINGUAL	20120723		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	COPPER; ESTRONE; HISTAMINE DIHYDROCHLORIDE; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; SODIUM SULFATE	10; 18; 8; 10; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61727-311_7df3be22-b17c-52d5-e053-2a91aa0ab75b	61727-311	HUMAN OTC DRUG	Sore Throat Relief		ACONITUM NAPELLUS,APIS MELLIFERA,ATROPA BELLADONNA,SOLANUM DULCAMARA TOP,MERCURIUS SOLUBILIS,PHYTOLACCA AMERICANA ROOT.	PELLET	SUBLINGUAL	20120724		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ACONITUM NAPELLUS; APIS MELLIFERA; ATROPA BELLADONNA; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; SOLANUM DULCAMARA TOP	10; 10; 10; 10; 8; 8	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61727-313_7df40a74-2df6-5003-e053-2a91aa0a7e23	61727-313	HUMAN OTC DRUG	Vigoril for Men		Silver nitrate, avena sativa flowering top, turnera diffusa leafy twig, lycopodium clavatum spore, phosphoric acid, selenium	TABLET	ORAL; SUBLINGUAL	20181227		UNAPPROVED HOMEOPATHIC		HomeoCare Laboratories, Inc.	AVENA SATIVA FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; SELENIUM; SILVER NITRATE; TURNERA DIFFUSA LEAFY TWIG	5; 5; 5; 5; 5; 5	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
61727-315_82fbfc25-3f57-460f-e053-2991aa0aad29	61727-315	HUMAN OTC DRUG	Tinnitus Relief		CINCHONA OFFICINALIS BARK,SALICYLIC ACID,QUININE SULFATE,FERRUM PHOSPHORICUM,POTASSIUM CHLORIDE,CALOMEL,ALLYLTHIOUREA,.	PELLET	SUBLINGUAL	20120724		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ALLYLTHIOUREA; CALOMEL; CINCHONA OFFICINALIS BARK; FERRUM PHOSPHORICUM; POTASSIUM CHLORIDE; QUININE SULFATE; SALICYLIC ACID	4; 4; 9; 4; 4; 9; 15	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Antimalarial [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
61727-318_7e58d849-dada-b924-e053-2991aa0aef01	61727-318	HUMAN OTC DRUG	Blatrol Bladder Relief		LYTTA VESICATORIA, CAUSTICUM, EQUISETUM HYEMALE, CHONDRODENDRON TOMENTOSUM ROOT, SAW PALMETTO, SEPIA OFFICINALIS JUICE, DELPHINIUM STAPHISAGRIA SEED	PELLET	SUBLINGUAL	20120618		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	CAUSTICUM; CHONDRODENDRON TOMENTOSUM ROOT; DELPHINIUM STAPHISAGRIA SEED; EQUISETUM HYEMALE; LYTTA VESICATORIA; SAW PALMETTO; SEPIA OFFICINALIS JUICE	5; 5; 5; 6; 6; 5; 5	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g			N	20241231
61727-319_7e58d660-4903-5cab-e053-2a91aa0ac70f	61727-319	HUMAN OTC DRUG	Hair-X Hair Loss Relief		CADMIUM SULFATE, GRAPHITE, PHOSPHORIC ACID, SILICON DIOXIDE, SELENIUM, THALLIUM, USTILAGO MAYDIS	PELLET	SUBLINGUAL	20120710		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	CADMIUM SULFATE; GRAPHITE; PHOSPHORIC ACID; SELENIUM; SILICON DIOXIDE; THALLIUM; USTILAGO MAYDIS	12; 4; 5; 5; 4; 7; 9	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
61727-323_7e58d660-4924-5cab-e053-2a91aa0ac70f	61727-323	HUMAN OTC DRUG	Sciatica Relief		ARNICA MONTANA FLOWER, BRYONIA ALBA WHOLE, MATRICARIA RECUTITA, PSEUDOGNAPHALIUM LUTEOALBUM LEAF, KALMIA LATIFOLIA LEAF, TOXICODENDRON PUBESCENS LEAF, VISCUM ALBUM LEAF	PELLET	SUBLINGUAL	20120723		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARNICA MONTANA FLOWER; BRYONIA ALBA WHOLE; HYPERICUM PERFORATUM; KALMIA LATIFOLIA LEAF; MATRICARIA RECUTITA; PSEUDOGNAPHALIUM LUTEOALBUM LEAF; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM LEAF	9; 4; 4; 4; 200; 5; 4; 6	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g			N	20241231
61727-324_7e58e649-2149-e929-e053-2991aa0a320b	61727-324	HUMAN OTC DRUG	EZ-Quit		ANTIMONY TRISULFIDE, DIEFFENBACHIA SEGUINE, STRYCHNOS IGNATII SEED, LOBELIA INFLATA, TOBACCO LEAF	PELLET	SUBLINGUAL	20120801		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ANTIMONY TRISULFIDE; DIEFFENBACHIA SEGUINE; LOBELIA INFLATA; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	5; 5; 5; 5; 5; 9	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61727-325_7e58d849-db23-b924-e053-2991aa0aef01	61727-325	HUMAN OTC DRUG	Ez-Slim		ANTIMONY TRISULFIDE,SEMECARPUS ANACARDIUM JUICE,FUCUS VESICULOSUS,BOS TAURUS HYPOTHALAMUS,SODIUM SULFATE,PHYTOLACCA AMERICANA ROOT,THYROID, UNSPECIFIED.	PELLET	SUBLINGUAL	20120706		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ANTIMONY TRISULFIDE; BOS TAURUS HYPOTHALAMUS; FUCUS VESICULOSUS; PHYTOLACCA AMERICANA ROOT; SEMECARPUS ANACARDIUM JUICE; SODIUM SULFATE; THYROID, UNSPECIFIED	5; 18; 1; 2; 5; 9; 8	[hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g			N	20241231
61727-326_7e58d849-db30-b924-e053-2991aa0aef01	61727-326	HUMAN OTC DRUG	Eczema Relief		ANTIMONY TRISULFIDE, APIS MELLIFERA, ARSENIC TRIOXIDE, ATROPA BELLADONNA, GRAPHITE, ARCTIUM LAPPA FRUIT, KEROSENE, SOLIDAGO CANADENSIS WHOLE, VIOLA TRICOLOR	PELLET	SUBLINGUAL	20120706		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ANTIMONY TRISULFIDE; APIS MELLIFERA; ARCTIUM LAPPA FRUIT; ARSENIC TRIOXIDE; ATROPA BELLADONNA; GRAPHITE; KEROSENE; SOLIDAGO CANADENSIS WHOLE; VIOLA TRICOLOR	5; 5; 4; 5; 5; 5; 5; 4; 4	[hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61727-328_7e58d849-db61-b924-e053-2991aa0aef01	61727-328	HUMAN OTC DRUG	Weight Gloss		SEMECARPUS ANACARDIUM JUICE,ANTIMONY TRISULFIDE,STRYCHNOS IGNATII SEED,BOS TAURUS HYPOTHALAMUS,SULFUR,COCOA.	LIPSTICK	TOPICAL	20120814		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ANTIMONY TRISULFIDE; BOS TAURUS HYPOTHALAMUS; COCOA; SEMECARPUS ANACARDIUM JUICE; STRYCHNOS IGNATII SEED; SULFUR	5; 5; 5; 5; 5; 5	[hp_C]/5mL; [hp_C]/5mL; [hp_C]/5mL; [hp_C]/5mL; [hp_C]/5mL; [hp_C]/5mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61727-330_7d538d9b-6a91-ffe3-e053-2a91aa0a8f47	61727-330	HUMAN OTC DRUG	Hangover Relief		ASAFETIDA,CAPSICUM,POTASSIUM DICHROMATE,COLA NUT,LACHESIS MUTA VENOM,STRYCHNOS NUX-VOMICA SEED,RANUNCULUS BULBOSUS,SULFURIC ACID,ZINC.	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ASAFETIDA; CAPSICUM; COLA NUT; LACHESIS MUTA VENOM; POTASSIUM DICHROMATE; RANUNCULUS BULBOSUS; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; ZINC	5; 5; 5; 5; 5; 7; 5; 5; 5	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
61727-331_848ca4be-1f89-b274-e053-2a91aa0ad774	61727-331	HUMAN OTC DRUG	Acid Reflux Relief		CAPSICUM, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, STRYCHNOS NUX-VOMICA SEED, ROBINIA PSEUDOACACIA BARK, SULFUR, SEPIA OFFICINALIS JUICE	PELLET	SUBLINGUAL	20120608		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	CAPSICUM; ROBINIA PSEUDOACACIA BARK; SEPIA OFFICINALIS JUICE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; SULFUR	7; 9; 5; 6; 9; 5	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
61727-333_7e58bc5a-9e1d-3e20-e053-2991aa0a4d35	61727-333	HUMAN OTC DRUG	Carpal Tunnel Relief		apis mellifera, arnica montana, caulophyllum robustum root, ruta graveolens flowering top, viola odorata	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	APIS MELLIFERA; ARNICA MONTANA; CAULOPHYLLUM ROBUSTUM ROOT; RUTA GRAVEOLENS FLOWERING TOP; VIOLA ODORATA	4; 4; 4; 4; 4	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
61727-334_7e58bc5a-9e11-3e20-e053-2991aa0a4d35	61727-334	HUMAN OTC DRUG	Leg Cramps Relief		CUPRIC ARSENITE, COPPER, POTASSIUM PHOSPHATE, DIBASIC, LACTIC ACID, L-,MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	COPPER; CUPRIC ARSENITE; LACTIC ACID, L-; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; POTASSIUM PHOSPHATE, DIBASIC	10; 10; 10; 10; 10	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
61727-335_7e58bc5a-9e06-3e20-e053-2991aa0a4d35	61727-335	HUMAN OTC DRUG	Sinus Relief		ASAFETIDA, ECHINACEA ANGUSTIFOLIA, CALCIUM SULFIDE, POTASSIUM DICHROMATE, LUFFA OPERCULATA WHOLE, SILICON DIOXIDE, SINUSITISINUM	PELLET	SUBLINGUAL	20120724		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ASAFETIDA; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; LUFFA OPERCULATA WHOLE; POTASSIUM DICHROMATE; SILICON DIOXIDE; SINUSITISINUM	8; 8; 12; 9; 18; 10; 18	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g			N	20241231
61727-336_7e58bc5a-9deb-3e20-e053-2991aa0a4d35	61727-336	HUMAN OTC DRUG	Skin Klear Acne Relief		tribasic calcium phosphate, fumaria officinalis flowering top, arctium lappa root, sodium chloride, saponaria officinalis root, silicon dioxide, solidago virgaurea flowering top, sulfur, viola tricolor	PELLET	SUBLINGUAL	20120724		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ARCTIUM LAPPA ROOT; FUMARIA OFFICINALIS FLOWERING TOP; SAPONARIA OFFICINALIS ROOT; SILICON DIOXIDE; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SULFUR; TRIBASIC CALCIUM PHOSPHATE; VIOLA TRICOLOR	4; 4; 4; 5; 12; 3; 5; 10; 4	[hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
61727-337_7e58bc5a-9e32-3e20-e053-2991aa0a4d35	61727-337	HUMAN OTC DRUG	EZ-Quit Control		antimony trisulfide, dieffenbachia seguine, cadmium sulfate, strychnos ignatii seed, lobelia inflata, strychnos nux-vomica seed, tobacco leaf	SPRAY	SUBLINGUAL	20120709		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ANTIMONY TRISULFIDE; CADMIUM SULFATE; DIEFFENBACHIA SEGUINE; LOBELIA INFLATA; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	5; 5; 5; 5; 5; 5; 8	[hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
61727-338_7e58351d-e93f-bd9c-e053-2991aa0ab3d0	61727-338	HUMAN OTC DRUG	EZ-Detox Super Drainage Formula		aesculus hippocastanum bark,antimony trisulfide,silver nitrate,arnica montana,berberis vulgaris whole,activated charcoal,ceanothus americanus whole,cholesterol,cinchona bark,cynara scolymus leaf,equisetum arvense top,conyza canadensis,fucus vesiculosus,ginkgo,hamamelis virginiana leaf,chamaelirium luteum root,goldenseal,arctium lappa root,lespedeza capitata flowering top,ranunculus bulbosus,daikon,robinia pseudoacacia bark,taraxacum palustre root,viburnum prunifolium bark,vitis vinifera whole	LIQUID	ORAL	20120709		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ACTIVATED CHARCOAL; AESCULUS HIPPOCASTANUM BARK; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARNICA MONTANA; BERBERIS VULGARIS WHOLE; CEANOTHUS AMERICANUS WHOLE; CHAMAELIRIUM LUTEUM ROOT; CHOLESTEROL; CINCHONA BARK; CONYZA CANADENSIS; CYNARA SCOLYMUS LEAF; DAIKON; EQUISETUM ARVENSE TOP; FUCUS VESICULOSUS; GINKGO; GOLDENSEAL; HAMAMELIS VIRGINIANA LEAF; LESPEDEZA CAPITATA FLOWERING TOP; RANUNCULUS BULBOSUS; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; TARAXACUM PALUSTRE ROOT; VIBURNUM PRUNIFOLIUM BARK; VITIS VINIFERA WHOLE	9; 6; 10; 6; 6; 6; 6; 6; 10; 8; 6; 6; 6; 6; 6; 10; 6; 6; 6; 4; 10; 10; 6; 6; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
61727-341_7e56fe4a-b927-ced1-e053-2991aa0ab89a	61727-341	HUMAN OTC DRUG	Influenzinum		Influenzinum 9C	PELLET	SUBLINGUAL	20121031		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	INFLUENZA A VIRUS; INFLUENZA B VIRUS	9; 9	[hp_C]/4g; [hp_C]/4g			N	20241231
61727-343_82fbd741-e798-cd82-e053-2991aa0a7cad	61727-343	HUMAN OTC DRUG	Thymuline		NONATHYMULIN	PELLET	SUBLINGUAL	20121109		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	NONATHYMULIN	9	[hp_C]/4g			N	20241231
61727-345_848cc82c-daea-777c-e053-2991aa0ad22b	61727-345	HUMAN OTC DRUG	ANACOCCINUM		CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	PELLET	SUBLINGUAL	20150930		UNAPPROVED HOMEOPATHIC		HomeoCare Laboratories	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
61727-353_84796173-945e-c70b-e053-2991aa0a4ee1	61727-353	HUMAN OTC DRUG	Bladder Irritation and UTI		Cantharis, Clematis, Cubeba, Echinacea, Ranunculus bulbosus, Sabal ser, Staphysagria, Uva ursi	TABLET, CHEWABLE	ORAL	20190319		UNAPPROVED HOMEOPATHIC		HomeoCare Laboratories, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; CLEMATIS RECTA FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; ECHINACEA ANGUSTIFOLIA; LYTTA VESICATORIA; PIPER CUBEBA FRUIT; RANUNCULUS BULBOSUS; SERENOA REPENS WHOLE	6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601; [hp_X]/601			N	20241231
61727-355_bf644511-a053-c622-e053-2995a90afd80	61727-355	HUMAN OTC DRUG	Breathe-Ease		ACONITUM NAPELLUS, ARSENIC TRIOXIDE, BLATTA ORIENTALIS, SOLANUM DULCAMARA TOP, IPECAC, NAPHTHALENE, QUEBRACHO BARK, PHOSPHORUS, HISTAMINE DIHYDROCHLORIDE	PELLET	SUBLINGUAL	20210401		UNAPPROVED HOMEOPATHIC		Homeocare Laboratories	ACONITUM NAPELLUS; ARSENIC CATION (3+); BLATTA ORIENTALIS; HISTAMINE; IPECAC; NAPHTHALENE; PHOSPHORUS; QUEBRACHO BARK; SOLANUM DULCAMARA TOP	10; 10; 7; 7; 6; 10; 8; 3; 10	[hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g; [hp_X]/4g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
61734-010_08770081-b38d-45f9-e063-6394a90a0dcf	61734-010	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20141008		OTC MONOGRAPH DRUG	M022	Delon Laboratories (1990) Ltd	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
61734-012_08776ee3-ea3e-db78-e063-6294a90aabc0	61734-012	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70		Isopropyl Alcohol	SOLUTION	TOPICAL	20100507		OTC MONOGRAPH DRUG	M003	Delon Laboratories (1990) Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
61734-021_0876bc42-b31b-3525-e063-6294a90a510e	61734-021	HUMAN OTC DRUG	Blue Ice Analgesic		Menthol	GEL	TOPICAL	20100507		OTC MONOGRAPH DRUG	M017	Delon Laboratories (1990) Ltd	MENTHOL	2	g/100g			N	20241231
61734-030_0bc56c7e-c723-20c1-e063-6394a90aabbf	61734-030	HUMAN OTC DRUG	Vaporizing Colds Rub		Menthol	OINTMENT	TOPICAL	20110524		OTC MONOGRAPH DRUG	M012	Delon Laboratories (1990) Ltd	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.73; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
61734-040_08798c6b-8592-d745-e063-6294a90ac471	61734-040	HUMAN OTC DRUG	Petroleum		Petrolatum	JELLY	TOPICAL	20100507	20251130	OTC MONOGRAPH DRUG	M016	Delon Laboratories (1990) Ltd	PETROLATUM	100	g/100g			N	
61734-040_0879fe0b-e40c-e1dc-e063-6294a90ac83b	61734-040	HUMAN OTC DRUG	Petroleum		Petrolatum	JELLY	TOPICAL	20171002	20251130	OTC MONOGRAPH DRUG	M016	Delon Laboratories (1990) Ltd	PETROLATUM	100	g/100g			N	
61734-050_08796e9b-40f3-7e24-e063-6294a90a4cc3	61734-050	HUMAN OTC DRUG	Babyfresh Petroleum Jelly		Petrolatum	JELLY	TOPICAL	20100507	20240531	OTC MONOGRAPH DRUG	M016	Delon Laboratories (1990) Ltd	PETROLATUM	99.7	g/100g			N	
61734-300_0877bcc1-b5c0-e18a-e063-6294a90a27b8	61734-300	HUMAN OTC DRUG	La Vaquita New Regular		Methyl Salicylate	OINTMENT	TOPICAL	20110301		OTC MONOGRAPH DRUG	M017	Delon Laboratories (1990) Ltd	MENTHOL; METHYL SALICYLATE	2; 10	g/100g; g/100g			N	20241231
61734-301_08782a4a-52b1-ece4-e063-6394a90a4b02	61734-301	HUMAN OTC DRUG	La Vaquita	New Extra	Methyl Salicylate, Menthol	OINTMENT	TOPICAL	20110426		OTC MONOGRAPH DRUG	M017	Delon Laboratories (1990) Ltd	MENTHOL; METHYL SALICYLATE	3; 12	g/100g; g/100g			N	20241231
61748-012_f12685de-eaf9-460f-95c5-ceb8ede88491	61748-012	HUMAN PRESCRIPTION DRUG	Pyrazinamide		Pyrazinamide	TABLET	ORAL	19950401		ANDA	ANDA081319	Akorn	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
61748-054_3a17b358-46b6-4e74-9788-ccb8acf9ca8f	61748-054	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	SYRUP	ORAL	20010301		ANDA	ANDA040251	Akorn	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/5mL			N	20241231
61755-005_16021fa7-8b7d-4c07-b1d9-9d9140ffdfdf	61755-005	HUMAN PRESCRIPTION DRUG	EYLEA		aflibercept	INJECTION, SOLUTION	INTRAVITREAL	20111121		BLA	BLA125387	Regeneron Pharmaceuticals, Inc.	AFLIBERCEPT	40	mg/mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
61755-008_0e71c952-eb36-4a46-b0fc-53f63812e033	61755-008	HUMAN PRESCRIPTION DRUG	LIBTAYO		cemiplimab-rwlc	INJECTION	INTRAVENOUS	20180928		BLA	BLA761097	Regeneron Pharmaceuticals, Inc.	CEMIPLIMAB	50	mg/mL			N	20251231
61755-010_5464d387-1c29-4d8e-86ef-c114a223d722	61755-010	HUMAN PRESCRIPTION DRUG	Evkeeza		evinacumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210211		BLA	BLA761181	Regeneron Pharmaceuticals, Inc.	EVINACUMAB	150	mg/mL	Angiopoietin-like 3 Inhibitor [EPC], Angiopoietin-like 3 Inhibitors [MoA]		N	20241231
61755-013_5464d387-1c29-4d8e-86ef-c114a223d722	61755-013	HUMAN PRESCRIPTION DRUG	Evkeeza		evinacumab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210211		BLA	BLA761181	Regeneron Pharmaceuticals, Inc.	EVINACUMAB	150	mg/mL	Angiopoietin-like 3 Inhibitor [EPC], Angiopoietin-like 3 Inhibitors [MoA]		N	20241231
61755-014_6ca44e1c-2b74-4c4a-b731-c7a86cd994e2	61755-014	HUMAN PRESCRIPTION DRUG	VEOPOZ		Pozelimab	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230818		BLA	BLA761339	Regeneron Pharmaceuticals, Inc.	POZELIMAB	200	mg/mL			N	20241231
61755-018_5069aba6-e8bf-4b91-a678-8ad3a2b67abc	61755-018	HUMAN PRESCRIPTION DRUG	Inmazeb		atoltivimab, maftivimab, and odesivimab-ebgn	INJECTION, SOLUTION	INTRAVENOUS	20201014		BLA	BLA761169	Regeneron Pharmaceuticals, Inc.	ATOLTIVIMAB; MAFTIVIMAB; ODESIVIMAB	241.7; 241.7; 241.7	mg/14.5mL; mg/14.5mL; mg/14.5mL			N	20241231
61755-019_5069aba6-e8bf-4b91-a678-8ad3a2b67abc	61755-019	HUMAN PRESCRIPTION DRUG	Inmazeb		atoltivimab, maftivimab, and odesivimab-ebgn	INJECTION, SOLUTION	INTRAVENOUS	20210729		BLA	BLA761169	Regeneron Pharmaceuticals, Inc.	ATOLTIVIMAB; MAFTIVIMAB; ODESIVIMAB	483.3; 483.3; 483.3	mg/14.5mL; mg/14.5mL; mg/14.5mL			N	20241231
61755-020_d5805356-71f3-4400-95b0-bb5454179566	61755-020	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20190215		BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	75	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
61755-021_d5805356-71f3-4400-95b0-bb5454179566	61755-021	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20190215		BLA	BLA125559	Regeneron Pharmaceuticals, Inc.	ALIROCUMAB	150	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
61755-024_60b18b8b-7459-4172-985a-f3fca1228d61	61755-024	HUMAN PRESCRIPTION DRUG	Casirivimab		Casirivimab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20201121		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.	CASIRIVIMAB	1332	mg/11.1mL			N	20241231
61755-025_60b18b8b-7459-4172-985a-f3fca1228d61	61755-025	HUMAN PRESCRIPTION DRUG	Imdevimab		Imdevimab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20201121		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.	IMDEVIMAB	1332	mg/11.1mL			N	20241231
61755-026_60b18b8b-7459-4172-985a-f3fca1228d61	61755-026	HUMAN PRESCRIPTION DRUG	Casirivimab		Casirivimab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20201121		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.	CASIRIVIMAB	300	mg/2.5mL			N	20241231
61755-027_60b18b8b-7459-4172-985a-f3fca1228d61	61755-027	HUMAN PRESCRIPTION DRUG	Imdevimab		Imdevimab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20201121		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.	IMDEVIMAB	300	mg/2.5mL			N	20241231
61755-035_60b18b8b-7459-4172-985a-f3fca1228d61	61755-035	HUMAN PRESCRIPTION DRUG	REGEN-COV		casirivimab and imdevimab	KIT		20210207		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.						N	20241231
61755-036_60b18b8b-7459-4172-985a-f3fca1228d61	61755-036	HUMAN PRESCRIPTION DRUG	REGEN-COV		casirivimab and imdevimab	KIT		20210207		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.						N	20241231
61755-037_60b18b8b-7459-4172-985a-f3fca1228d61	61755-037	HUMAN PRESCRIPTION DRUG	REGEN-COV		casirivimab and imdevimab	KIT		20210207		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.						N	20241231
61755-038_60b18b8b-7459-4172-985a-f3fca1228d61	61755-038	HUMAN PRESCRIPTION DRUG	REGEN-COV		casirivimab and imdevimab	KIT		20210207		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.						N	20241231
61755-039_60b18b8b-7459-4172-985a-f3fca1228d61	61755-039	HUMAN PRESCRIPTION DRUG	REGEN-COV		casirivimab and imdevimab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210603		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.	CASIRIVIMAB; IMDEVIMAB	600; 600	mg/10mL; mg/10mL			N	20241231
61755-042_60b18b8b-7459-4172-985a-f3fca1228d61	61755-042	HUMAN PRESCRIPTION DRUG	casirivimab with imdevimab		casirivimab and imdevimab	KIT		20210207		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.						N	20241231
61755-045_60b18b8b-7459-4172-985a-f3fca1228d61	61755-045	HUMAN PRESCRIPTION DRUG	casirivimab with imdevimab		casirivimab and imdevimab	KIT		20210207		UNAPPROVED DRUG OTHER		Regeneron Pharmaceuticals, Inc.						N	20241231
61755-050_0750f1a4-c2f7-42d1-a4f9-4e3a71ced886	61755-050	HUMAN PRESCRIPTION DRUG	EYLEA HD		aflibercept	INJECTION, SOLUTION	INTRAVITREAL	20230818		BLA	BLA761355	Regeneron Pharmaceuticals, Inc	AFLIBERCEPT	8	mg/.07mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
61755-051_0750f1a4-c2f7-42d1-a4f9-4e3a71ced886	61755-051	HUMAN PRESCRIPTION DRUG	EYLEA HD		aflibercept	INJECTION, SOLUTION	INTRAVITREAL	20230818		BLA	BLA761355	Regeneron Pharmaceuticals, Inc	AFLIBERCEPT	8	mg/.07mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
61787-443_6813564d-3c8c-4e02-9584-c9a78fcefe1e	61787-443	HUMAN OTC DRUG	ZOSTRIX HP		Capsaicin	CREAM	TOPICAL	20060109		OTC MONOGRAPH NOT FINAL	part348	MEDTECH PRODUCTS INC	CAPSAICIN	.75	mg/g			N	20241231
61787-513_3481758a-0a8d-4f00-a61b-7b7ddf552778	61787-513	HUMAN OTC DRUG	Diabetic Tussin DM		Dextromethorphan hydrobromide and Guaifenesin	LIQUID	ORAL	20200201		OTC MONOGRAPH FINAL	part341	MEDTECH PRODUCTS INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
61787-514_27e059a5-ece3-4fa7-8f12-59ae0c21bdd4	61787-514	HUMAN OTC DRUG	Diabetic Tussin Expectorant		Guaifenesin	LIQUID	ORAL	20200201		OTC MONOGRAPH FINAL	part341	MEDTECH PRODUCTS INC	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
61787-515_e4cd7371-f717-4109-bba6-c26dbaecedc7	61787-515	HUMAN OTC DRUG	Diabetic Tussin DM Maximum Strength		Dextromethorphan Hydrobromide and Guaifenesin	LIQUID	ORAL	20200201		OTC MONOGRAPH FINAL	part341	MEDTECH PRODUCTS INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
61787-516_3f09d224-c1f3-43fc-a177-c3d4d84ae725	61787-516	HUMAN OTC DRUG	Diabetic Tussin Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, and Diphenhydramine HCl	LIQUID	ORAL	20200201		OTC MONOGRAPH FINAL	part341	MEDTECH PRODUCTS INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DIPHENHYDRAMINE HYDROCHLORIDE	650; 20; 25	mg/10mL; mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
61787-556_29c8c84e-3b9a-40aa-88ca-d024bf2d2c1a	61787-556	HUMAN OTC DRUG	Zostrix High Potency Foot Pain Relief		capsaicin	CREAM	TOPICAL	20131022		OTC MONOGRAPH NOT FINAL	part348	MEDTECH PRODUCTS INC	CAPSAICIN	.75	mg/g			N	20241231
61805-110_089656e4-6de0-7be7-e063-6394a90a7703	61805-110	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200410		OTC MONOGRAPH DRUG	505G(a)(3)	Bath Concept Cosmetics (Dongguan) Co., Ltd	ALCOHOL	.62	mL/mL			N	20241231
61805-117_089f16c0-5020-e65c-e063-6394a90aa02b	61805-117	HUMAN OTC DRUG	Equate Beauty Quick Action Pads Salicylic Acid Acne Treatment		SALICYLIC ACID	CLOTH	TOPICAL	20210828		OTC MONOGRAPH DRUG	M006	Bath Concept Cosmetics (Dongguan) Co., Ltd	SALICYLIC ACID	20	mg/mL			N	20241231
61821-001_ceb6a328-0c61-4c6d-9152-3ce51abbd92c	61821-001	HUMAN OTC DRUG	DIE DA WAN HUA PAIN RELIEVING		TURPENTINE	OIL	TOPICAL	20030508		OTC MONOGRAPH NOT FINAL	part348	GUANGZHOU BAIYUNSHAN JINGXIUTANG PHARMACEUTICAL CO., LTD	TURPENTINE	6	g/100mL			N	20241231
61825-165_f394815c-a01c-de75-e053-2995a90af184	61825-165	HUMAN PRESCRIPTION DRUG	DORAL		Quazepam	TABLET	ORAL	20170719		NDA	NDA018708	Galt Pharmaceuticals, LLC	QUAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61825-302_f187b82e-e331-d676-e053-2995a90a98e7	61825-302	HUMAN PRESCRIPTION DRUG	ORPHENGESIC FORTE		Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20200608		ANDA	ANDA075141	Galt Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770; 60; 50	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Muscle Relaxant [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
61825-303_0e7b8449-3f4c-4045-e063-6394a90aaca2	61825-303	HUMAN PRESCRIPTION DRUG	Oravig		Miconazole	TABLET	BUCCAL	20211231		NDA	NDA022404	Galt Pharmaceuticals, LLC	MICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20251231
61825-305_0e7bccb0-630c-9661-e063-6394a90a29e9	61825-305	HUMAN PRESCRIPTION DRUG	Norgesic		Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20220516		ANDA	ANDA075141	Galt Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	385; 30; 25	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Muscle Relaxant [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20251231
61830-001_ae7c3c6f-3a4b-4588-9924-bea0ea1d9012	61830-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20140627		NDA	NDA205840	Gemstone Gas, LLC	OXYGEN	99	L/100L			N	20241231
61834-0001_0bf2d31c-270b-0b42-e063-6394a90a7d8a	61834-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100610		UNAPPROVED MEDICAL GAS		J & A Medical Home Care Inc.	OXYGEN	99	L/100L			N	20241231
61865-001_079c4119-bb19-34a4-e063-6294a90ad1f7	61865-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Midwest Medical Service, Inc.	OXYGEN	99	L/100L			N	20241231
61869-0001_f32e49a5-070f-a243-e053-2995a90a264b	61869-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20040201		UNAPPROVED MEDICAL GAS		Professionals PRN LLC dba Northside Oxygen & Medical Equipment	OXYGEN	99	L/100L			N	20241231
61874-075_22af8fe9-6dca-4a72-bb3d-941379ab6b21	61874-075	HUMAN PRESCRIPTION DRUG	Viberzi		Eluxadoline	TABLET, FILM COATED	ORAL	20151001		NDA	NDA206940	Allergan, Inc.	ELUXADOLINE	75	mg/1	Opioid mu-Receptor Agonists [MoA], mu-Opioid Receptor Agonist [EPC]	CIV	N	20241231
61874-100_22af8fe9-6dca-4a72-bb3d-941379ab6b21	61874-100	HUMAN PRESCRIPTION DRUG	Viberzi		Eluxadoline	TABLET, FILM COATED	ORAL	20151001		NDA	NDA206940	Allergan, Inc.	ELUXADOLINE	100	mg/1	Opioid mu-Receptor Agonists [MoA], mu-Opioid Receptor Agonist [EPC]	CIV	N	20241231
61874-115_e342dd19-ed3b-4a30-b5ea-a17b3638e741	61874-115	HUMAN PRESCRIPTION DRUG	Vraylar		cariprazine	CAPSULE, GELATIN COATED	ORAL	20150917		NDA	NDA204370	Allergan, Inc.	CARIPRAZINE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61874-130_e342dd19-ed3b-4a30-b5ea-a17b3638e741	61874-130	HUMAN PRESCRIPTION DRUG	Vraylar		cariprazine	CAPSULE, GELATIN COATED	ORAL	20150917		NDA	NDA204370	Allergan, Inc.	CARIPRAZINE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61874-145_e342dd19-ed3b-4a30-b5ea-a17b3638e741	61874-145	HUMAN PRESCRIPTION DRUG	Vraylar		cariprazine	CAPSULE, GELATIN COATED	ORAL	20150917		NDA	NDA204370	Allergan, Inc.	CARIPRAZINE	4.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61874-160_e342dd19-ed3b-4a30-b5ea-a17b3638e741	61874-160	HUMAN PRESCRIPTION DRUG	Vraylar		cariprazine	CAPSULE, GELATIN COATED	ORAL	20150917		NDA	NDA204370	Allergan, Inc.	CARIPRAZINE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61874-170_e342dd19-ed3b-4a30-b5ea-a17b3638e741	61874-170	HUMAN PRESCRIPTION DRUG	Vraylar		cariprazine	KIT	ORAL	20150917	20240531	NDA	NDA204370	Allergan, Inc.						N	
61877-0005_f737a40b-b962-46c4-9dd3-1f73bdb07c19	61877-0005	HUMAN OTC DRUG	Somaderm		Glandula Suprarenalis Suis, Thyroidinum (Bovine), HGH	GEL	TOPICAL	20180420	20240916	UNAPPROVED HOMEOPATHIC		Natural Life Foods Corporation dba XYGENYX	SOMATROPIN; SUS SCROFA ADRENAL GLAND; THYROID, BOVINE	30; 6; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	
61877-0007_d76e3302-87d9-45d7-8079-bda24188ad77	61877-0007	HUMAN OTC DRUG	Somaderm		Glandula Suprarenalis Suis, Thyroidinum (Bovine), HGH	GEL	TOPICAL	20190918		UNAPPROVED HOMEOPATHIC		Natural Life Foods Corporation dba XYGENYX	SOMATROPIN; SUS SCROFA ADRENAL GLAND; THYROID, BOVINE	30; 6; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
61877-0008_0d854b5f-506f-cdb6-e063-6394a90a2ade	61877-0008	HUMAN OTC DRUG	Somaderm AWE		Glandula Suprarenalis Suis, Thyroidinum (bovine), Hgh	GEL	TOPICAL	20230504	20260531	UNAPPROVED HOMEOPATHIC		Natural Life Foods Corporation dba XYGENYX	SOMATROPIN; SUS SCROFA ADRENAL GLAND; THYROID, BOVINE	30; 6; 8	[hp_X]/g; [hp_X]/g; [hp_X]/g	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	
61888-0202_ea360a6b-72b7-45c1-e053-2a95a90aaeb7	61888-0202	HUMAN PRESCRIPTION DRUG	Oxygen Refrigerated Liquid		OXYGEN	GAS	RESPIRATORY (INHALATION)	20071018		NDA	NDA206023	Elliot Hospital of the City of Manchester DBA: Home Medical Equipment and Infusion Services of Manchester & Southern N.H.	OXYGEN	.99	kg/kg			N	20241231
61903-001_08b42e54-2f8f-2978-e063-6394a90af105	61903-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20131101		UNAPPROVED MEDICAL GAS		Deaconess Home Services dba Deaconess Home Medical Equipment & Infusion	OXYGEN	99	L/100L			N	20241231
61919-003_f80e250f-f24a-21e7-e053-6394a90a8c88	61919-003	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20140101		ANDA	ANDA077309	DIRECT RX	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61919-004_861d65c9-fb38-b548-e053-2a91aa0a2366	61919-004	HUMAN PRESCRIPTION DRUG	FLUTICASONE		FLUTICASONE	SPRAY, METERED	NASAL	20140101		ANDA	ANDA078492	Direct RX	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-005_f80e5087-d760-6ed8-e053-6394a90a1b06	61919-005	HUMAN PRESCRIPTION DRUG	ALPRAZOLAM		ALPRAZOLAM	TABLET	ORAL	20140101		ANDA	ANDA074112	Direct Rx	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-007_f80e7872-5b20-fb4b-e053-6294a90ae2b3	61919-007	HUMAN PRESCRIPTION DRUG	CLOPIDOGREL		CLOPIDOGREL	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA090540	DIRECT RX	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
61919-009_f200a4c8-a6d4-86e0-e053-2a95a90a5a4e	61919-009	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA202717	DIRECT RX	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
61919-020_0254c9b3-a1c4-470c-e063-6394a90a1d79	61919-020	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		AMOXICILLIN AND CLAVULANATE POTASSIUM	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA091568	DIRECT RX	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
61919-022_f81d8dd5-466d-ed43-e053-6394a90aaef7	61919-022	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20140101		ANDA	ANDA089175	DIRECT RX	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
61919-023_f80f4daf-9758-d62b-e053-6294a90ae7c5	61919-023	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE		ACETAMINOPHEN AND CODEINE	TABLET	ORAL	20140101		ANDA	ANDA040779	DIRECT RX	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
61919-026_f3ce287d-171b-b95a-e053-2995a90a09fa	61919-026	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20140101		ANDA	ANDA072234	Direct_Rx	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
61919-032_0e877aee-bf02-d8cd-e063-6394a90a1171	61919-032	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	TABLET, FILM COATED	ORAL	20190821		ANDA	ANDA203458	Direct_Rx	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
61919-032_0e87aa19-bbe8-d384-e063-6294a90a9d0b	61919-032	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	TABLET, FILM COATED	ORAL	20190821		ANDA	ANDA203458	Direct_Rx	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
61919-032_0e87acda-b95f-eefa-e063-6394a90abb00	61919-032	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	TABLET, FILM COATED	ORAL	20170214		ANDA	ANDA203458	DIRECT RX	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
61919-033_f8100255-d8cd-8a8f-e053-6294a90a8ccc	61919-033	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20170213		ANDA	ANDA202929	DIRECT RX	ESZOPICLONE	2	mg/1		CIV	N	20241231
61919-042_f822dab7-f5de-4217-e053-6294a90ad1ab	61919-042	HUMAN PRESCRIPTION DRUG	DULOXETINE HYDROCHLORIDE		DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140101		ANDA	ANDA203088	DIRECT RX	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-047_f8231806-ab1c-78b8-e053-6294a90a593f	61919-047	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	TABLET	ORAL	20140101		ANDA	ANDA091179	Direct Rx	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
61919-052_0e884df8-756d-2374-e063-6394a90ab34a	61919-052	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL TARTRATE	TABLET	ORAL	20190821		ANDA	ANDA076670	Direct_Rx	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
61919-057_9c92f9ff-e7b8-975e-e053-2995a90a4a51	61919-057	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		CLINDAMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20160302		ANDA	ANDA065061	DIRECT RX	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
61919-057_f833ec76-6771-22a1-e053-6394a90a6b92	61919-057	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20150101		ANDA	ANDA065061	Direct Rx	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
61919-060_f8341438-aec1-984b-e053-6394a90a6e32	61919-060	HUMAN PRESCRIPTION DRUG	VOLTAREN		DICLOFENAC SODIUM D/R	TABLET, DELAYED RELEASE	ORAL	20160504		ANDA	ANDA077863	Direct_Rx	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-062_0e87784c-8aec-8268-e063-6294a90ad94c	61919-062	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20170210		ANDA	ANDA078203	DIRECT RX	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
61919-062_0e87be72-5652-c80f-e063-6294a90a58be	61919-062	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20190722		ANDA	ANDA078203	Direct_Rx	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
61919-073_fc5e0914-3e36-0be4-e053-6394a90aee7d	61919-073	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, COATED	ORAL	20180615		ANDA	ANDA076003	DIRECT RX	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
61919-074_f8c50156-09a6-2a89-e053-6294a90a2cd1	61919-074	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium D/R		Diclofenac Sodium D/R	TABLET, DELAYED RELEASE	ORAL	20140101		ANDA	ANDA075185	Direct RX	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-075_f8c50156-09a6-2a89-e053-6294a90a2cd1	61919-075	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium D/R		Diclofenac Sodium D/R	TABLET, DELAYED RELEASE	ORAL	20140101		ANDA	ANDA075185	Direct RX	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-076_9c5944f3-9329-b174-e053-2995a90ac030	61919-076	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190730		ANDA	ANDA202446	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-076_f900435b-0c76-6103-e053-6294a90afcc3	61919-076	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170216		ANDA	ANDA202446	DIRECT RX	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-082_eac637bb-0281-712f-e053-2995a90a0789	61919-082	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	CAPSULE	ORAL	20140101		ANDA	ANDA062676	DIRECT RX	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
61919-084_f68ca26b-bf6a-e107-e053-2995a90a6dd9	61919-084	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, FILM COATED	ORAL	20150101		ANDA	ANDA202152	Direct_Rx	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
61919-086_f9016249-b674-b218-e053-6294a90a4345	61919-086	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET	ORAL	20170310		ANDA	ANDA077397	DIRECT RX	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-087_f901a3ab-ec8f-7d86-e053-6394a90a3bee	61919-087	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, FILM COATED	ORAL	20190829		ANDA	ANDA078539	Direct_Rx	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
61919-093_066bf818-60e7-7ea2-e063-6394a90a4334	61919-093	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20190729		ANDA	ANDA078220	Direct_Rx	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
61919-093_e9ab3c4e-8cf5-a130-e053-2a95a90ae254	61919-093	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20140101		ANDA	ANDA078220	DIRECT RX	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
61919-095_0bb3c6e4-12fe-3371-e063-6394a90a42b0	61919-095	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20140101		ANDA	ANDA077241	DIRECT RX	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
61919-095_9c597550-4b67-876f-e053-2a95a90af2d8	61919-095	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20190729		ANDA	ANDA077241	Direct_Rx	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
61919-100_f9100b39-555b-683e-e053-6294a90ae9f7	61919-100	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20140101		ANDA	ANDA076001	Direct_Rx	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-106_0e997972-7ec7-5a7a-e063-6294a90aceac	61919-106	HUMAN PRESCRIPTION DRUG	gentamicin sulfate		gentamicin sulfate	SOLUTION/ DROPS	OPHTHALMIC	20140101		ANDA	ANDA062452	DIRECT RX	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
61919-108_040075dd-b43d-a0bd-e063-6394a90acbd1	61919-108	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20190807		ANDA	ANDA040362	Direct_Rx	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-108_83e7315a-6564-5c47-e053-2991aa0a7f00	61919-108	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20170626		ANDA	ANDA080356	DIRECT RX	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-117_853c5f0d-7a63-3744-e053-2991aa0a3885	61919-117	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170324		ANDA	ANDA202446	DIRECT RX	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-117_ea4e0478-850b-3f8b-e053-2995a90a7c4f	61919-117	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190813		ANDA	ANDA202446	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-117_ea4e1197-f6f1-72ee-e053-2a95a90af2ad	61919-117	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190814		ANDA	ANDA202446	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-118_f923e388-61c8-380f-e053-6394a90ad3b3	61919-118	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE		HYDROCODONE BITARTRATE	TABLET	ORAL	20140101		ANDA	ANDA040746	DIRECT RX	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-119_9c940e14-e16c-1bba-e053-2a95a90a5599	61919-119	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA202929	Direct_Rx	ESZOPICLONE	1	mg/1		CIV	N	20241231
61919-119_ffc232ba-3d15-a706-e053-6394a90a4cc5	61919-119	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20170329		ANDA	ANDA202929	DIRECT RX	ESZOPICLONE	1	mg/1		CIV	N	20241231
61919-130_9c9755b1-30ac-25b5-e053-2a95a90afc11	61919-130	HUMAN PRESCRIPTION DRUG	INDOMETHACIN		INDOMETHACIN	CAPSULE	ORAL	20190828		ANDA	ANDA091240	Direct_Rx	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-130_f91397ae-0f0d-580b-e053-6394a90ad8c0	61919-130	HUMAN PRESCRIPTION DRUG	INDOMETHACIN		INDOMETHACIN	CAPSULE	ORAL	20140101		ANDA	ANDA091240	DIRECT RX	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-135_f2026976-ae4b-a6ea-e053-2a95a90ae6ac	61919-135	HUMAN PRESCRIPTION DRUG	AMOXIL		AMOXICILLIN	TABLET, FILM COATED	ORAL	20160708		ANDA	ANDA065256	DIRECT RX	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
61919-136_dd2b07ad-bd69-ee94-e053-2a95a90a0bb5	61919-136	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20170717		ANDA	ANDA075932	Direct_Rx	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
61919-138_f914838a-9b9b-bd88-e053-6294a90a8983	61919-138	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA074754	DIRECT RX	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-139_d929b068-4c88-0c5c-e053-2995a90ab99a	61919-139	HUMAN PRESCRIPTION DRUG	ESCITALOPRAM OXALATE		ESCITALOPRAM OXALATE	TABLET	ORAL	20150101		ANDA	ANDA090939	Direct Rx	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-146_f9297a30-a8e5-2461-e053-6294a90a3a25	61919-146	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20140101		ANDA	ANDA040659	DIRECT RX	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
61919-148_f9a195e8-e094-672b-e053-6394a90a94e6	61919-148	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET	ORAL	20160322		ANDA	ANDA086988	DIRECT RX	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-153_0e87fe20-49cf-0435-e063-6294a90a298d	61919-153	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20220510		ANDA	ANDA077666	Direct_Rx	MIRTAZAPINE	15	mg/1			N	20251231
61919-154_f9298fad-1001-34ff-e053-6394a90a2f16	61919-154	HUMAN PRESCRIPTION DRUG	MIRTAZAPINE		MIRTAZAPINE	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA077666	DIRECT RX	MIRTAZAPINE	30	mg/1			N	20241231
61919-162_f924e41c-fcf4-944c-e053-6394a90a2783	61919-162	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160829		ANDA	ANDA078250	DIRECT RX	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-164_0b62c24c-b8a3-3966-e063-6394a90a1db6	61919-164	HUMAN PRESCRIPTION DRUG	INDOMETHACIN		INDOMETHACIN	CAPSULE	ORAL	20170420		ANDA	ANDA091276	DIRECT RX	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-166_0e87fe20-49d1-0435-e063-6294a90a298d	61919-166	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20190726		ANDA	ANDA202557	Direct_Rx	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20251231
61919-176_fd02b4c7-99e0-b5b9-e053-6294a90a8e46	61919-176	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE DR		OMEPRAZOLE DR	CAPSULE, DELAYED RELEASE	ORAL	20150101		ANDA	ANDA076048	Direct Rx	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-177_0e8801d7-3d7b-0116-e063-6394a90ad589	61919-177	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	20190829		ANDA	ANDA040284	Direct_Rx	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
61919-186_f9261f0d-fcef-339c-e053-6394a90a6f51	61919-186	HUMAN PRESCRIPTION DRUG	PHENTERMINE HYDROCHLORIDE		PHENTERMINE HYDROCHLORIDE	TABLET	ORAL	20201014		ANDA	ANDA040555	Direct_Rx	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
61919-191_f9266687-73d3-dac9-e053-6394a90ac2a1	61919-191	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	TABLET	ORAL	20190719		ANDA	ANDA083426	Direct_Rx	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
61919-196_f92942f8-fdc5-d5db-e053-6394a90ad519	61919-196	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		TIZANIDINE HYDROCHLORIDE	TABLET	ORAL	20140101		ANDA	ANDA091283	TIZANIDINE HYDROCHLORIDE	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-204_f93a6fc1-4d18-aa35-e053-6294a90a4f70	61919-204	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20170522		ANDA	ANDA075927	DIRECT RX	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-212_e9be945a-7c09-3253-e053-2995a90abab4	61919-212	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20220804		ANDA	ANDA076343	Direct_Rx	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-217_f93bb2ec-e340-b70e-e053-6394a90af57e	61919-217	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HCL		HYDROXYZINE HCL	TABLET	ORAL	20171030		ANDA	ANDA204279	DIRECT RX	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
61919-219_802187fa-e716-9f7c-e053-2991aa0ab7fc	61919-219	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20190123		ANDA	ANDA078332	Direct_Rx	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-219_ea4e4eac-3e30-5370-e053-2995a90a9cab	61919-219	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA078332	Direct_Rx	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-222_f94ccac0-73f7-d8a6-e053-6294a90a4a7a	61919-222	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140101		ANDA	ANDA090174	DIRECT RX	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-223_d6a9be39-ad74-984e-e053-2a95a90a4b96	61919-223	HUMAN PRESCRIPTION DRUG	Amitriptyline hcl		Amitriptyline hcl	TABLET, FILM COATED	ORAL	20220128		ANDA	ANDA202446	Direct Rx	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-225_f94ce91f-7d0a-f9c6-e053-6294a90ab939	61919-225	HUMAN PRESCRIPTION DRUG	RABERPRAZOLE SODIUM D/R		RABERPRAZOLE SODIUM D/R	TABLET, DELAYED RELEASE	ORAL	20190807		ANDA	ANDA202376	Direct_Rx	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-228_f202f8b0-d568-9117-e053-2a95a90a97bf	61919-228	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	TABLET	ORAL	20171030		ANDA	ANDA091179	DIRECT RX	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
61919-229_e9e5bc1f-a396-47b3-e053-2a95a90acbd7	61919-229	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET	ORAL	20140101		ANDA	ANDA075964	Direct Rx	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
61919-229_f9889885-5701-81ec-e053-6394a90a19b2	61919-229	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET	ORAL	20190820		ANDA	ANDA075964	Direct_Rx	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
61919-233_f2030f1c-9992-4b65-e053-2995a90ac5eb	61919-233	HUMAN PRESCRIPTION DRUG	POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE		POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE	SOLUTION/ DROPS	OPHTHALMIC	20140101		NDA AUTHORIZED GENERIC	NDA050567	DIRECT RX	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
61919-235_b85547d8-fce9-323d-e053-2995a90a4e7e	61919-235	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20140101		ANDA	ANDA040362	DIRECT RX	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-235_b85547d8-fcea-323d-e053-2995a90a4e7e	61919-235	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20190807		ANDA	ANDA040362	Direct_Rx	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-235_b855548f-ebbe-6dc8-e053-2995a90a6632	61919-235	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20190807		ANDA	ANDA040362	Direct_Rx	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-235_f95141d4-a2e7-ac15-e053-6394a90a5169	61919-235	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20190829		ANDA	ANDA040362	Direct_Rx	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-236_f9894bf4-b0e6-c1e1-e053-6294a90a4b3a	61919-236	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET	ORAL	20190808		ANDA	ANDA078916	Direct_Rx	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
61919-237_f2030d89-1515-cec9-e053-2a95a90ab8c3	61919-237	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	20140101		NDA	NDA018578	DIRECT RX	SILVER SULFADIAZINE	10	g/1000g			N	20241231
61919-242_a8ea7cbf-8e51-cc9b-e053-2a95a90aa751	61919-242	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		FUROSEMIDE	TABLET	ORAL	20200618		ANDA	ANDA077293	DIRECT RX	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
61919-243_bc02753e-e56b-2a4c-e053-2a95a90ae1a5	61919-243	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20140101		ANDA	ANDA078003	DIRECT RX	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-246_e9bde230-120e-6b5e-e053-2a95a90a89aa	61919-246	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20211008		ANDA	ANDA076164	Direct_Rx	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-249_dbfdf5a9-da2a-f558-e053-2a95a90ac97d	61919-249	HUMAN PRESCRIPTION DRUG	DIVALPROEX SODIUM		divalproex sodium	TABLET, DELAYED RELEASE	ORAL	20220406		ANDA	ANDA079163	DirectRx	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
61919-250_f2030f1c-9993-4b65-e053-2995a90ac5eb	61919-250	HUMAN PRESCRIPTION DRUG	GLIMEPIRIDE		GLIMEPIRIDE	TABLET	ORAL	20160204		ANDA	ANDA078181	DIRECT RX	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61919-251_f989cfc8-a38a-2083-e053-6294a90a2b1d	61919-251	HUMAN PRESCRIPTION DRUG	ETODOLAC		ETODOLAC	TABLET, FILM COATED	ORAL	20160829		ANDA	ANDA076004	DIRECT RX	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-255_e9be5c3b-4b19-7ad2-e053-2995a90a4a8b	61919-255	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20211021		ANDA	ANDA077293	Direct_Rx	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
61919-258_f989f14a-a2d7-6647-e053-6294a90ae058	61919-258	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET	ORAL	20150101		ANDA	ANDA091650	Direct_Rx	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-259_f9b3eea7-3819-ff40-e053-6394a90a4101	61919-259	HUMAN PRESCRIPTION DRUG	CITALOPRAM HYDROBROMIDE		CITALOPRAM HYDROBROMIDE	TABLET	ORAL	20210204		ANDA	ANDA078216	Direct Rx	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-261_f2126a96-6335-7052-e053-2a95a90af277	61919-261	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190816		ANDA	ANDA078722	Direct_Rx	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-264_a8261a8c-cf26-d681-e053-2995a90a60ab	61919-264	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		TEMAZEPAM	CAPSULE	ORAL	20150101		ANDA	ANDA071457	DirectRX	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-267_f98a9ad1-f6af-ef3f-e053-6294a90af2d1	61919-267	HUMAN PRESCRIPTION DRUG	CLONIDINE HYDROCHLORIDE		CLONIDINE HYDROCHLORIDE	TABLET	ORAL	20150101		ANDA	ANDA078895	DirectRX	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-270_f98af2e8-8ca4-75e2-e053-6394a90a5063	61919-270	HUMAN PRESCRIPTION DRUG	MINOCYCLINE HYDROCHLORIDE		MINOCYCLINE HYDROCHLORIDE	CAPSULE	ORAL	20180314		ANDA	ANDA065062	DirectRX	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
61919-276_f2150aa9-99ba-0c64-e053-2a95a90a1fde	61919-276	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20160317		ANDA	ANDA204446	DIRECT RX	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
61919-277_eac61874-4a12-7c85-e053-2995a90a5935	61919-277	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20151203		ANDA	ANDA075483	DirectRX	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
61919-279_0e881242-6142-027b-e063-6394a90ac8e2	61919-279	HUMAN PRESCRIPTION DRUG	ATENOLOL		ATENOLOL	TABLET	ORAL	20190917		ANDA	ANDA074056	Direct_Rx	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
61919-281_f2126c8d-5165-3721-e053-2995a90a1234	61919-281	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET	ORAL	20190808		ANDA	ANDA075805	Direct_Rx	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
61919-285_83e59e10-986f-e5c2-e053-2a91aa0af25e	61919-285	HUMAN PRESCRIPTION DRUG	NORTRIPTYLINE HCI		NORTRIPTYLINE HCI	CAPSULE	ORAL	20190311		ANDA	ANDA075520	Direct_Rx	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-285_ea4e4f18-ea93-2171-e053-2995a90ac2d2	61919-285	HUMAN PRESCRIPTION DRUG	NORTRIPTYLINE HCI		NORTRIPTYLINE HCI	CAPSULE	ORAL	20190821		ANDA	ANDA075520	Direct_Rx	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-285_ea4e5146-9c7a-ecaa-e053-2a95a90a2de7	61919-285	HUMAN PRESCRIPTION DRUG	NORTRIPTYLINE HCI		NORTRIPTYLINE HCI	CAPSULE	ORAL	20190822		ANDA	ANDA075520	Direct_Rx	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-287_b855548f-ebc2-6dc8-e053-2995a90a6632	61919-287	HUMAN PRESCRIPTION DRUG	GLIPIZIDE		GLIPIZIDE	TABLET	ORAL	20170220		ANDA	ANDA075795	DIRECT RX	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61919-287_b8555ee4-3ded-d01a-e053-2995a90a478c	61919-287	HUMAN PRESCRIPTION DRUG	GLIPIZIDE		GLIPIZIDE	TABLET	ORAL	20190820		ANDA	ANDA075795	Direct_Rx	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61919-287_ceb46d21-68c2-bd34-e053-2a95a90acb1d	61919-287	HUMAN PRESCRIPTION DRUG	GLIPIZIDE		GLIPIZIDE	TABLET	ORAL	20190820		ANDA	ANDA075795	Direct_Rx	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61919-289_8517c8f8-2e29-65de-e053-2991aa0a8675	61919-289	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA202446	Direct Rx	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-289_853c5f0d-7a63-3744-e053-2991aa0a3885	61919-289	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20190329		ANDA	ANDA202446	DIRECT RX	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-289_ea4e4f18-ea96-2171-e053-2995a90ac2d2	61919-289	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20190724		ANDA	ANDA202446	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-293_f98c2bae-8bc8-9c3c-e053-6294a90a831c	61919-293	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20190821		ANDA	ANDA040907	Direct_Rx	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-305_f98cc3be-cf50-e3d2-e053-6294a90a2ae0	61919-305	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE		CYCLOBENZAPRINE	TABLET, FILM COATED	ORAL	20161216		ANDA	ANDA090478	DIRECT RX	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-309_f99cf980-0243-611f-e053-6394a90ab543	61919-309	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20150101		ANDA	ANDA077912	DIRECT RX	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-311_f99cfe07-ae46-6bfe-e053-6394a90aa343	61919-311	HUMAN PRESCRIPTION DRUG	LOVASTATIN		LOVASTATIN	TABLET	ORAL	20140101		ANDA	ANDA078296	Direct Rx	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-312_c3f4ecb1-53e2-5894-e053-2995a90ade2e	61919-312	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		HYDRALAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190813		ANDA	ANDA086242	Direct_Rx	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
61919-313_b855a75d-8a33-86be-e053-2995a90a8e24	61919-313	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20140101		ANDA	ANDA090564	DIRECT RX	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
61919-313_b855a75d-8a35-86be-e053-2995a90a8e24	61919-313	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20190827		ANDA	ANDA090564	Direct_Rx	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
61919-313_f9b20343-a913-3973-e053-6394a90a8d56	61919-313	HUMAN PRESCRIPTION DRUG	METFORMIN Hydrochloride		METFORMIN Hydrochloride	TABLET	ORAL	20160408		ANDA	ANDA090564	DIRECT RX	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
61919-316_f99d4296-501d-b99f-e053-6394a90a7bca	61919-316	HUMAN PRESCRIPTION DRUG	PHENTERMINE HCL		PHENTERMINE HCL	CAPSULE	ORAL	20160708		ANDA	ANDA040886	DIRECT RX	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
61919-318_f6f310b7-a1ea-182a-e053-6394a90a16d6	61919-318	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET	ORAL	20210112		ANDA	ANDA076343	Direct_Rx	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-321_f2127f51-a0a9-9fe2-e053-2a95a90a8cd1	61919-321	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20150101		ANDA	ANDA040362	DirectRX	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-322_fb594428-cc55-6afa-e053-6394a90ab152	61919-322	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA075356	DIRECT RX	PAROXETINE HYDROCHLORIDE ANHYDROUS	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-324_f9b2370f-9dbb-cec1-e053-6294a90a6680	61919-324	HUMAN PRESCRIPTION DRUG	DICYCLOMINE HYDROCHLORIDE		DICYCLOMINE HYDROCHLORIDE	TABLET	ORAL	20140101		ANDA	ANDA085223	DIRECT RX	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
61919-326_f9b244f5-89d4-c2f0-e053-6294a90acd26	61919-326	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20140101		ANDA	ANDA080356	Direct_Rx	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-334_0e884df8-756d-2374-e063-6394a90ab34a	61919-334	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, EXTENDED RELEASE	ORAL	20210119		ANDA	ANDA078889	Direct_Rx	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
61919-338_c80d15e2-fc5c-8d53-e053-2a95a90a8d67	61919-338	HUMAN PRESCRIPTION DRUG	TRIAMTERENE AND HYDROCHLOROTHIAZIDE		TRIAMTERENE AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20151201		ANDA	ANDA071251	DirectRX	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-345_f2133373-5541-7bb7-e053-2a95a90ac3fc	61919-345	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20171011		ANDA	ANDA202825	Direct Rx	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-353_cc0e355a-0d92-3137-e053-2a95a90afa18	61919-353	HUMAN PRESCRIPTION DRUG	NORTRIPTYLINE HYDROCHLORIDE		NORTRIPTYLINE HYDROCHLORIDE	CAPSULE	ORAL	20210915		ANDA	ANDA075520	DIRECT RX	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-360_8e859901-e41d-420b-e053-2995a90ae09a	61919-360	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20190725		ANDA	ANDA204197	Direct_Rx	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-360_f99f2992-43db-0589-e053-6394a90a48cc	61919-360	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20160302		ANDA	ANDA204197	Direct_Rx	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-361_f99f64bc-6090-744b-e053-6294a90adb8d	61919-361	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	TABLET	ORAL	20161116		ANDA	ANDA076639	DIRECT RX	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
61919-363_f212fdf7-7cb3-ed89-e053-2a95a90ac688	61919-363	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	TABLET, FILM COATED	ORAL	20180314		ANDA	ANDA070044	DIRECT RX	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
61919-364_f9b11846-9b7a-c4b3-e053-6294a90a884e	61919-364	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		HYDROCORTISONE	CREAM	TOPICAL	20140101		ANDA	ANDA088799	DIRECT RX	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-365_f213487c-186f-e20e-e053-2995a90aef56	61919-365	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20140101		ANDA	ANDA040584	DIRECT RX	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-368_f9a195e8-e094-672b-e053-6394a90a94e6	61919-368	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET	ORAL	20190418		ANDA	ANDA090200	DIRECT RX	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-369_fc5dd4b0-0e34-858e-e053-6394a90a2714	61919-369	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET	ORAL	20200512		ANDA	ANDA076343	DirectRX	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-370_f9c55b1d-3413-d833-e053-6394a90aca13	61919-370	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20140101		ANDA	ANDA075382	Direct RX	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61919-371_f9b3a0ce-ac23-7eb0-e053-6394a90ab4ae	61919-371	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	TABLET	ORAL	20190814		ANDA	ANDA076639	Direct_Rx	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
61919-372_903cb974-e614-1a0e-e053-2a95a90a4306	61919-372	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20190816		ANDA	ANDA075483	Direct_Rx	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
61919-372_fc5dd378-9514-949b-e053-6394a90a3ca2	61919-372	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20170227		ANDA	ANDA075483	DIRECT RX	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
61919-374_8517c8f8-2e29-65de-e053-2991aa0a8675	61919-374	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180314		ANDA	ANDA202446	Direct Rx	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-374_ea4e5ab9-516c-7deb-e053-2a95a90a2830	61919-374	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA202446	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-376_5dcc0daa-1568-0f7a-e053-2991aa0ad28d	61919-376	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20171101		ANDA	ANDA075927	Direct RX	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-376_90b56ea3-7621-733a-e053-2995a90a11d8	61919-376	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20190822		ANDA	ANDA078250	Direct_Rx	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-376_90b5b879-d29f-c79b-e053-2a95a90a64fc	61919-376	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20190822		ANDA	ANDA078250	Direct_Rx	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-376_90b6672d-05f6-a6c3-e053-2a95a90a49f0	61919-376	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20190822		ANDA	ANDA078250	Direct_Rx	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-376_90b6b574-9b0e-517d-e053-2995a90a4556	61919-376	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20190822		ANDA	ANDA078250	Direct_Rx	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-376_a873e905-7ab2-f1ec-e053-2995a90a8df6	61919-376	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20190822		ANDA	ANDA078250	Direct_Rx	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-387_a23fa840-b83d-d01f-e053-2995a90a4ead	61919-387	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	TABLET, FILM COATED	ORAL	20180201		ANDA	ANDA203244	DIRECT RX	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-389_b855a75d-8a39-86be-e053-2995a90a8e24	61919-389	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20190813		ANDA	ANDA078216	Direct_Rx	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-389_f9b3eea7-3819-ff40-e053-6394a90a4101	61919-389	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20150101		ANDA	ANDA078216	Direct Rx	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-390_f9b34a5b-86c5-fe8e-e053-6394a90ad254	61919-390	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20150101		ANDA	ANDA078216	Direct Rx	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-394_8723c2a0-5ac8-92cb-e053-2991aa0a13c2	61919-394	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		RIZATRIPTAN BENZOATE	TABLET	ORAL	20180312		ANDA	ANDA204339	DIRECT RX	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
61919-395_f213eee7-863a-48ed-e053-2995a90a10f9	61919-395	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20180312		ANDA	ANDA202929	DIRECT RX	ESZOPICLONE	3	mg/1		CIV	N	20241231
61919-397_f9b34f61-b1e1-fe41-e053-6394a90aa7fc	61919-397	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20140101		ANDA	ANDA090564	Direct Rx	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
61919-401_0e877b33-af19-d857-e063-6394a90a08ea	61919-401	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		AMOXICILLIN	POWDER, FOR SUSPENSION	ORAL	20140101		ANDA	ANDA065334	DIRECT RX	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
61919-406_f8fd6555-3986-f4ac-e053-6294a90a3134	61919-406	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20171031		ANDA	ANDA202036	DIRECT RX	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-409_f213f115-3a81-073f-e053-2995a90a3ba8	61919-409	HUMAN PRESCRIPTION DRUG	DIAZEPAM		DIAZEPAM	TABLET	ORAL	20191118		ANDA	ANDA071321	Direct_Rx	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-409_f21415bc-c08a-13ac-e053-2995a90a88f4	61919-409	HUMAN PRESCRIPTION DRUG	DIAZEPAM		DIAZEPAM	TABLET	ORAL	20190711		ANDA	ANDA071321	Direct_Rx	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-409_f9c66404-1dbe-85b2-e053-6294a90a04c8	61919-409	HUMAN PRESCRIPTION DRUG	DIAZEPAM		DIAZEPAM	TABLET	ORAL	20190711		ANDA	ANDA071321	Direct_Rx	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-415_f9c6887d-d4d4-7a1a-e053-6394a90a239e	61919-415	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL TARTRATE	TABLET, FILM COATED	ORAL	20190812		ANDA	ANDA077739	Direct_Rx	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61919-422_f2140162-b4c0-36f3-e053-2995a90a7956	61919-422	HUMAN PRESCRIPTION DRUG	DULOXETINE		DULOXETINE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20190819		ANDA	ANDA203088	Direct_Rx	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-423_f9c730db-b2f7-54b8-e053-6294a90a2324	61919-423	HUMAN PRESCRIPTION DRUG	LOPERAMIDE HYDROCHLORIDE		LOPERAMIDE HYDROCHLORIDE	CAPSULE	ORAL	20140101		ANDA	ANDA073192	DIRECT RX	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
61919-426_02579894-261f-6c6d-e063-6294a90abbf1	61919-426	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA202801	DIRECT RX	LEVOFLOXACIN	500	mg/1			N	20241231
61919-429_f213f0a8-4096-18e3-e053-2995a90a19f2	61919-429	HUMAN PRESCRIPTION DRUG	CETIRIZINE HYDROCHLORIDE		CETIRIZINE HYDROCHLORIDE	TABLET	ORAL	20161222		ANDA	ANDA077829	DIRECT RX	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
61919-430_f9c8c5b2-643c-6ce4-e053-6294a90a36eb	61919-430	HUMAN PRESCRIPTION DRUG	AMOXICILLIN/CLAV POT		AMOXICILLIN/CLAV POT	TABLET	ORAL	20181031		ANDA	ANDA203824	DIRECT RX	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
61919-431_f215afbc-93ab-1803-e053-2a95a90a4fe1	61919-431	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA078155	DIRECT RX	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-432_f9c8e696-c96a-a80f-e053-6394a90a7c92	61919-432	HUMAN PRESCRIPTION DRUG	OXYCODONE/APAP		OXYCODONE/APAP	TABLET	ORAL	20160615		ANDA	ANDA202677	DIRECT RX	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
61919-434_06cf9954-2a1d-d2b7-e063-6394a90a7610	61919-434	HUMAN PRESCRIPTION DRUG	MELOXICAM		MELOXICAM	TABLET	ORAL	20140101		ANDA	ANDA077927	Direct Rx	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-434_8e6e86ac-4f26-332e-e053-2a95a90a31cf	61919-434	HUMAN PRESCRIPTION DRUG	MELOXICAM		MELOXICAM	TABLET	ORAL	20190724		ANDA	ANDA077927	Direct_Rx	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-434_912e6fdc-f82a-b6ee-e053-2995a90ac186	61919-434	HUMAN PRESCRIPTION DRUG	MELOXICAM		MELOXICAM	TABLET	ORAL	20190828		ANDA	ANDA077927	Direct_Rx	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-434_93c93038-3347-b075-e053-2995a90a0337	61919-434	HUMAN PRESCRIPTION DRUG	MELOXICAM		MELOXICAM	TABLET	ORAL	20190930		ANDA	ANDA077927	Direct_Rx	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-438_f9d8f2d2-d474-cd88-e053-6394a90ab7fc	61919-438	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		TEMAZEPAM	CAPSULE	ORAL	20140101		ANDA	ANDA071620	Direct Rx	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-439_f2140748-7694-de31-e053-2a95a90abf03	61919-439	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20190819		ANDA	ANDA090278	Direct_Rx	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-439_f2140c0c-7b2f-2096-e053-2995a90ad56e	61919-439	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20190819		ANDA	ANDA090278	Direct_Rx	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-440_02579894-261f-6c6d-e063-6294a90abbf1	61919-440	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	TABLET	ORAL	20180315		ANDA	ANDA076890	DIRECT RX	LEVOFLOXACIN	750	mg/1			N	20241231
61919-441_f9d8dd9e-4d59-a6c7-e053-6394a90a6020	61919-441	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		CLINDAMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20140101		ANDA	ANDA065061	DIRECT RX	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
61919-446_f2143778-2cb4-70cf-e053-2995a90afba8	61919-446	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA078155	Direct Rx	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-458_f214178a-081e-957e-e053-2995a90a828e	61919-458	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN MACROCRYSTALS		nitrofurantoin	CAPSULE	ORAL	20180228		NDA	NDA016620	DIRECT RX	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
61919-463_854089bc-92e0-38f3-e053-2991aa0a2ca7	61919-463	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUOROFEN	TABLET, FILM COATED	ORAL	20180312		ANDA	ANDA091625	DIRECT RX	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-463_f9a07d5a-f523-0572-e053-6394a90a8aba	61919-463	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUOROFEN	TABLET, FILM COATED	ORAL	20190822		ANDA	ANDA091625	Direct_Rx	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-467_fa16b30c-1bf8-d11f-e053-6294a90afd7e	61919-467	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		RABEPRAZOLE SODIUM	TABLET, DELAYED RELEASE	ORAL	20200302		ANDA	ANDA090678	DIRECT RX	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-469_06cf9954-2a1d-d2b7-e063-6394a90a7610	61919-469	HUMAN PRESCRIPTION DRUG	MELOXICAM		MELOXICAM	TABLET	ORAL	20140101		ANDA	ANDA077927	Direct Rx	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-471_9c59151b-2a8a-a008-e053-2a95a90a70d4	61919-471	HUMAN PRESCRIPTION DRUG	ALLOPURINOL		ALLOPURINOL	TABLET	ORAL	20190730		ANDA	ANDA203154	Direct_Rx	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
61919-471_b932a9e5-7d66-0bf1-e053-2995a90a4414	61919-471	HUMAN PRESCRIPTION DRUG	ALLOPURINOL		ALLOPURINOL	TABLET	ORAL	20180314		ANDA	ANDA203154	DIRECT RX	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
61919-473_875b4218-beb7-c7c2-e053-2995a90a897b	61919-473	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20180307		ANDA	ANDA205253	DIRECT RX	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
61919-473_ea4e5146-9c7e-ecaa-e053-2a95a90a2de7	61919-473	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20190812		ANDA	ANDA205253	Direct_Rx	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
61919-473_ea4e7175-9459-6be8-e053-2a95a90a507c	61919-473	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20190819		ANDA	ANDA205253	Direct_Rx	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
61919-478_eac602b2-deb0-d15b-e053-2995a90acc5a	61919-478	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20140101		ANDA	ANDA089859	DIRECT RX	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-482_fa2d2f81-13b7-95ff-e053-6394a90a854b	61919-482	HUMAN PRESCRIPTION DRUG	DULOXETINE HYDROCHLORIDE		DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20190816		ANDA	ANDA203088	Direct_Rx	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-483_f2147260-be6f-3f01-e053-2995a90ac7b6	61919-483	HUMAN PRESCRIPTION DRUG	DULOXETINE		DULOXETINE	CAPSULE, DELAYED RELEASE	ORAL	20140101		ANDA	ANDA090745	DIRECT RX	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-484_fa2d4799-efa8-3d8c-e053-6294a90a9e9f	61919-484	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE		ACETAMINOPHEN AND CODEINE	TABLET	ORAL	20190712		ANDA	ANDA040419	Direct_Rx	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
61919-485_f2147684-a853-54bb-e053-2995a90a736c	61919-485	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET	ORAL	20180314		ANDA	ANDA077147	DIRECT RX	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-491_e08b85e9-c5b7-29cf-e053-2a95a90aab40	61919-491	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		ciprofloxacin hydrochloride solution	SOLUTION/ DROPS	OPHTHALMIC	20180315		NDA	NDA019992	DIRECT RX	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
61919-493_0e88c9e2-8dbd-917c-e063-6294a90a6ec9	61919-493	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20190408		ANDA	ANDA208963	Direct Rx	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
61919-494_fa51bd10-9848-871c-e053-6394a90a6e5f	61919-494	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE		HYDROCODONE BITARTRATE	TABLET	ORAL	20140101		ANDA	ANDA040736	DIRECT RX	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-495_f2147684-a854-54bb-e053-2995a90a736c	61919-495	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20190812		ANDA	ANDA078627	Direct_Rx	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-499_f2148ade-16c3-8cb4-e053-2995a90a7ef3	61919-499	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	TABLET, FILM COATED	ORAL	20180326		ANDA	ANDA203458	DIRECT RX	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
61919-515_874aa629-1333-0c30-e053-2a95a90ac888	61919-515	HUMAN PRESCRIPTION DRUG	VALACYCLOVIR		VALACYCLOVIR	TABLET	ORAL	20190424		ANDA	ANDA077135	DirectRX	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61919-523_86ce400b-7c2f-5873-e053-2a91aa0af669	61919-523	HUMAN PRESCRIPTION DRUG	Lisinopril/HCTZ		Lisinopril/HCTZ	TABLET	ORAL	20190418		ANDA	ANDA076194	Direct_Rx	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-523_ea4e7175-945f-6be8-e053-2a95a90a507c	61919-523	HUMAN PRESCRIPTION DRUG	Lisinopril/HCTZ		Lisinopril/HCTZ	TABLET	ORAL	20190807		ANDA	ANDA076194	Direct_Rx	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-530_fa54508d-ac06-e461-e053-6394a90a6f99	61919-530	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20150101		ANDA	ANDA203834	Direct Rx	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61919-534_fb319a97-b3b3-3ce0-e053-6394a90a68a9	61919-534	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20190417		ANDA	ANDA090170	DirectRX	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
61919-537_f98cc3be-cf50-e3d2-e053-6294a90a2ae0	61919-537	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190404		ANDA	ANDA077797	DIRECT RX	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-545_fb32b042-6210-96fd-e053-6394a90a0a29	61919-545	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20140101		ANDA	ANDA090469	DIRECT RX	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
61919-547_fb484a4b-46c5-39ed-e053-6294a90ad216	61919-547	HUMAN PRESCRIPTION DRUG	LOVASTATIN		LOVASTATIN	TABLET	ORAL	20190821		ANDA	ANDA075991	Direct_Rx	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-552_fb32d999-e8f3-946b-e053-6294a90a189a	61919-552	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	TABLET, FILM COATED	ORAL	20190828		ANDA	ANDA078106	Direct_Rx	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-553_8385abd7-1529-0d7e-e053-2991aa0ac846	61919-553	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN		MOXIFLOXACIN	SOLUTION/ DROPS	OPHTHALMIC	20180730		ANDA	ANDA090080	DIRECT RX	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
61919-565_f9ddfe4f-20ce-fcf5-e053-6394a90aa680	61919-565	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, FILM COATED	ORAL	20190906		ANDA	ANDA078539	Direct_Rx	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
61919-573_fb33a191-cfaf-8326-e053-6294a90aa68d	61919-573	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20190729		ANDA	ANDA040627	Direct_Rx	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
61919-579_fb343f0b-d4af-9f52-e053-6394a90a75d8	61919-579	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20140101		ANDA	ANDA075022	Direct Rx	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
61919-580_f214c893-efe7-b30b-e053-2a95a90a4fb4	61919-580	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	CAPSULE	ORAL	20190821		ANDA	ANDA090510	Direct_Rx	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-588_a575bcb8-4790-1f7e-e053-2995a90a4b12	61919-588	HUMAN PRESCRIPTION DRUG	LIDOCAINE		LIDOCAINE	PATCH	CUTANEOUS	20200512		NDA AUTHORIZED GENERIC	NDA020612	DIRECT RX	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
61919-589_f214c7ce-fa19-b6e1-e053-2a95a90a24a7	61919-589	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191001		ANDA	ANDA077284	Direct_Rx	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
61919-597_fd766ed0-84b8-7422-e053-6294a90a1372	61919-597	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200723		ANDA	ANDA090404	DirectRX	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
61919-605_0e883a0f-ef15-109e-e063-6294a90aa908	61919-605	HUMAN PRESCRIPTION DRUG	CLONIDINE HYDROCHLORIDE		CLONIDINE HYDROCHLORIDE	TABLET	ORAL	20190404		ANDA	ANDA091368	DirectRX	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
61919-606_f214ef0d-2acc-3c76-e053-2a95a90ad41c	61919-606	HUMAN PRESCRIPTION DRUG	CEPHALEXIN		CEPHALEXIN	CAPSULE	ORAL	20190814		ANDA	ANDA090836	Direct_Rx	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
61919-607_fed03a1c-0eac-1f8e-e053-6394a90a04c0	61919-607	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20190418		ANDA	ANDA078203	DirectRX	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-608_fb4797df-5f1e-4954-e053-6294a90ad657	61919-608	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM	E/R	DICLOFENAC SODIUM	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190404		ANDA	ANDA075492	DIRECTRX	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-610_87388b8c-daa4-3fbb-e053-2a91aa0a3e9b	61919-610	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20190418		ANDA	ANDA209312	DirectRX	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-610_ea4e9687-1925-5707-e053-2995a90ad4c4	61919-610	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20190827		ANDA	ANDA209312	Direct_Rx	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-610_ea4ea482-a7f7-d4a0-e053-2995a90a5689	61919-610	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20190827		ANDA	ANDA209312	Direct_Rx	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-610_ea4ead7c-c78f-2d85-e053-2a95a90ab0b0	61919-610	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20190827		ANDA	ANDA209312	Direct_Rx	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-612_fb47aa70-eab7-2c34-e053-6394a90a8757	61919-612	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20150101		ANDA	ANDA202677	Direct rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
61919-613_fb47b45c-c93b-7b5d-e053-6294a90a2b81	61919-613	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20190819		ANDA	ANDA205253	Direct_Rx	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
61919-616_f9a195e8-e094-672b-e053-6394a90a94e6	61919-616	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20190418		ANDA	ANDA209312	DIRECT RX	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-617_f8fd6555-3986-f4ac-e053-6294a90a3134	61919-617	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20190424		ANDA	ANDA078932	DIRECT RX	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-618_86325900-d618-f02b-e053-2991aa0a8e99	61919-618	HUMAN PRESCRIPTION DRUG	HYDROCODONE /APAP		HYDROCODONE /APAP	TABLET	ORAL	20190410		ANDA	ANDA201013	DIRECTRX	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-618_ea4ea1f6-6ac0-5b5d-e053-2a95a90a3ae1	61919-618	HUMAN PRESCRIPTION DRUG	HYDROCODONE /APAP		HYDROCODONE /APAP	TABLET	ORAL	20190722		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-618_ea4ea482-a7f9-d4a0-e053-2995a90a5689	61919-618	HUMAN PRESCRIPTION DRUG	HYDROCODONE /APAP		HYDROCODONE /APAP	TABLET	ORAL	20190717		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-618_ea4ead5d-4576-2d81-e053-2a95a90abe5b	61919-618	HUMAN PRESCRIPTION DRUG	HYDROCODONE /APAP		HYDROCODONE /APAP	TABLET	ORAL	20190717		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-618_ea4ead5d-4579-2d81-e053-2a95a90abe5b	61919-618	HUMAN PRESCRIPTION DRUG	HYDROCODONE /APAP		HYDROCODONE /APAP	TABLET	ORAL	20190605		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-618_ea4ead7c-c793-2d85-e053-2a95a90ab0b0	61919-618	HUMAN PRESCRIPTION DRUG	HYDROCODONE /APAP		HYDROCODONE /APAP	TABLET	ORAL	20190722		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-619_ba85da62-6f2c-2ede-e053-2a95a90a5e01	61919-619	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	OINTMENT	TOPICAL	20210204		ANDA	ANDA087385	DIRECTRX	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-624_f2150aa9-99ba-0c64-e053-2a95a90a1fde	61919-624	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE MONOHYDRATE		DOXYCYCLINE MONOHYDRATE	CAPSULE	ORAL	20190405		ANDA	ANDA205115	DIRECT RX	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
61919-628_854089bc-92e0-38f3-e053-2991aa0a2ca7	61919-628	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20190329		ANDA	ANDA091625	DIRECT RX	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-628_fb47e2b8-5e53-72ad-e053-6394a90afcbb	61919-628	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20190820		ANDA	ANDA091625	Direct_Rx	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-631_fb47fdb5-04d6-e08b-e053-6294a90ac287	61919-631	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20190819		ANDA	ANDA205253	Direct_Rx	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
61919-632_fb47f149-9f1f-c7ec-e053-6294a90a358d	61919-632	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20181031		ANDA	ANDA091624	DIRECT RX	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-640_0e9979dd-42e6-3a3f-e063-6294a90ab555	61919-640	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	DIRECT RX	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
61919-640_8f9fbc86-2028-b203-e053-2a95a90af299	61919-640	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20190808		ANDA	ANDA090007	Direct_Rx	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-640_8f9fc8a2-0d11-12f1-e053-2995a90acf3d	61919-640	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20190808		ANDA	ANDA090007	Direct_Rx	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-640_fb591a28-d72a-377e-e053-6394a90a2903	61919-640	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20190819		ANDA	ANDA090007	Direct_Rx	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-642_0e98b2f4-6caf-f58b-e063-6394a90ab0ab	61919-642	HUMAN PRESCRIPTION DRUG	TOBRAMYCIN		TOBRAMYCIN	SOLUTION/ DROPS	OPHTHALMIC	20190423		ANDA	ANDA207444	DirectRX	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
61919-643_876b7723-ff81-7ccf-e053-2995a90a6fc3	61919-643	HUMAN PRESCRIPTION DRUG	CLARITHROMYCIN		CLARITHROMYCIN	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA203584	DirectRX	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
61919-643_fb590d51-3c00-a183-e053-6294a90af273	61919-643	HUMAN PRESCRIPTION DRUG	CLARITHROMYCIN		CLARITHROMYCIN	TABLET, FILM COATED	ORAL	20190812		ANDA	ANDA203584	Direct_Rx	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
61919-645_7cc4029e-5f4c-880a-e053-2991aa0a3264	61919-645	HUMAN PRESCRIPTION DRUG	SULFAMETH/TRIMETH-DS		SULFAMETH/TRIMETH-DS	TABLET	ORAL	20181211		ANDA	ANDA090624	DIRECT RX	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61919-645_87240462-3841-5045-e053-2991aa0a4341	61919-645	HUMAN PRESCRIPTION DRUG	SULFAMETH/TRIMETH-DS		SULFAMETH/TRIMETH-DS	TABLET	ORAL	20190422		ANDA	ANDA090624	DirectRX	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61919-645_8cb4ed51-aa28-f6e6-e053-2a95a90a7df5	61919-645	HUMAN PRESCRIPTION DRUG	Sulfameth/Trimeth-DS		Sulfameth/Trimeth-DS	TABLET	ORAL	20190702		ANDA	ANDA090624	Direct_Rx	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61919-645_8de58d77-c632-2b9d-e053-2995a90a54ea	61919-645	HUMAN PRESCRIPTION DRUG	Sulfameth/Trimeth-DS		Sulfameth/Trimeth-DS	TABLET	ORAL	20190717		ANDA	ANDA090624	Direct_Rx	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61919-645_8f72fca6-7dbb-641f-e053-2a95a90ad148	61919-645	HUMAN PRESCRIPTION DRUG	Sulfameth/Trimeth-DS		Sulfameth/Trimeth-DS	TABLET	ORAL	20190806		ANDA	ANDA090624	Direct_Rx	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61919-645_fb5919ec-f2fe-2123-e053-6394a90a1882	61919-645	HUMAN PRESCRIPTION DRUG	Sulfameth/Trimeth-DS		Sulfameth/Trimeth-DS	TABLET	ORAL	20190813		ANDA	ANDA090624	Direct_Rx	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61919-649_946783a7-500e-84d5-e053-2995a90a13f9	61919-649	HUMAN PRESCRIPTION DRUG	PENICILLIN V POTASSIUM		PENICILLIN V POTASSIUM	TABLET, FILM COATED	ORAL	20191008		ANDA	ANDA065435	Direct_Rx	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
61919-649_a87551af-c3c3-eee2-e053-2a95a90a96c3	61919-649	HUMAN PRESCRIPTION DRUG	PENICILLIN V POTASSIUM		PENICILLIN V POTASSIUM	TABLET, FILM COATED	ORAL	20190419		ANDA	ANDA065435	DirectRX	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
61919-650_ba85da62-6f2c-2ede-e053-2a95a90a5e01	61919-650	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	CREAM	TOPICAL	20190305		ANDA	ANDA085692	DIRECTRX	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-652_fb592223-b936-3aff-e053-6394a90a138b	61919-652	HUMAN PRESCRIPTION DRUG	ESCITALOPRAM		ESCITALOPRAM	TABLET, FILM COATED	ORAL	20150101		ANDA	ANDA202389	DirectRX	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-654_0514f788-1b07-9239-e063-6294a90a8ac2	61919-654	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230911		ANDA	ANDA203834	Direct_Rx	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
61919-656_8723c2a0-5ac8-92cb-e053-2991aa0a13c2	61919-656	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		RIZATRIPTAN BENZOATE	TABLET	ORAL	20190422		ANDA	ANDA202490	DIRECT RX	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
61919-658_fb594428-cc55-6afa-e053-6394a90ab152	61919-658	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED	ORAL	20190419		ANDA	ANDA077584	DIRECT RX	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-663_f2152dab-c7cf-3e59-e053-2995a90a3120	61919-663	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		ZOLPIDEM TARTRATE	TABLET	ORAL	20151202		ANDA	ANDA077903	DirectRX	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
61919-665_f9c8c5b2-643c-6ce4-e053-6294a90a36eb	61919-665	HUMAN PRESCRIPTION DRUG	AMOXICILLIN CLAV/POT		AMOXICILLIN CLAV/POT	TABLET, FILM COATED	ORAL	20181031		ANDA	ANDA204755	DIRECT RX	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
61919-678_d0ec973f-c1a9-6c03-e053-2995a90a60a7	61919-678	HUMAN PRESCRIPTION DRUG	PHENAZOPYRIDINE HYDROCHLORIDE		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190501		UNAPPROVED DRUG OTHER		DIRECT RX	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
61919-679_0c919291-ec05-93d2-e063-6294a90a4081	61919-679	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET	ORAL	20190807		ANDA	ANDA076343	Direct_Rx	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-681_fd766c38-e406-49e5-e053-6294a90aaf36	61919-681	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HCI		CYCLOBENZAPRINE HCI	TABLET, FILM COATED	ORAL	20190402		ANDA	ANDA078722	DIRECTRX	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-682_f99f2992-43db-0589-e053-6394a90a48cc	61919-682	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20211119		ANDA	ANDA204590	Direct_Rx	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-683_f21620df-a19b-7df4-e053-2995a90a00c8	61919-683	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA091625	Direct_Rx	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-685_ffc232ba-3d16-a706-e053-6394a90a4cc5	61919-685	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA078154	DIRECT RX	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-688_f215afbc-93ab-1803-e053-2a95a90a4fe1	61919-688	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20210908		ANDA	ANDA078155	DIRECT RX	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-689_7ab508e6-0ef1-3d17-e053-2991aa0ae1d7	61919-689	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		ALENDRONATE SODIUM	TABLET	ORAL	20181115		ANDA	ANDA076768	DIRECT RX	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
61919-690_fc5dd378-9514-949b-e053-6394a90a3ca2	61919-690	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20190326		ANDA	ANDA075483	DIRECT RX	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
61919-695_fb59a946-7f88-6fae-e053-6294a90a35ae	61919-695	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	TABLET	ORAL	20181109		ANDA	ANDA202556	Direct RX	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-700_7cc5510a-8778-3878-e053-2a91aa0a5d32	61919-700	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM D/R		PANTOPRAZOLE SODIUM D/R	TABLET, DELAYED RELEASE	ORAL	20181211		ANDA	ANDA090074	DIRECT RX	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-700_ea4ead7c-c796-2d85-e053-2a95a90ab0b0	61919-700	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM D/R		PANTOPRAZOLE SODIUM D/R	TABLET, DELAYED RELEASE	ORAL	20190829		ANDA	ANDA090074	Direct_Rx	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-700_ea4eba83-bc84-6424-e053-2a95a90ab692	61919-700	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM D/R		PANTOPRAZOLE SODIUM D/R	TABLET, DELAYED RELEASE	ORAL	20190828		ANDA	ANDA090074	Direct_Rx	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-702_84647b52-3c4d-31bb-e053-2991aa0a8a7e	61919-702	HUMAN PRESCRIPTION DRUG	Vitamin D		Vitamin D	CAPSULE, LIQUID FILLED	ORAL	20190319		ANDA	ANDA080704	DirectRX	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
61919-703_7a420aca-31e7-8e0c-e053-2a91aa0a1be0	61919-703	HUMAN PRESCRIPTION DRUG	TAMSULOSIN HYDROCHLORIDE		TAMSULOSIN HYDROCHLORIDE	CAPSULE	ORAL	20181109		ANDA	ANDA202433	DIRECT RX	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
61919-703_ea4ed022-70cf-b687-e053-2a95a90a9fad	61919-703	HUMAN PRESCRIPTION DRUG	TAMSULOSIN HYDROCHLORIDE		TAMSULOSIN HYDROCHLORIDE	CAPSULE	ORAL	20190717		ANDA	ANDA202433	Direct_Rx	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
61919-704_f21551a1-151a-1b6c-e053-2a95a90aa903	61919-704	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	TABLET, FILM COATED	ORAL	20190829		ANDA	ANDA200839	Direct_Rx	LEVOFLOXACIN	500	mg/1			N	20241231
61919-704_f2155472-cb0b-1bb5-e053-2a95a90a25dc	61919-704	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	TABLET, FILM COATED	ORAL	20190829		ANDA	ANDA200839	Direct_Rx	LEVOFLOXACIN	500	mg/1			N	20241231
61919-706_b8b663f9-02c4-18c9-e053-2a95a90a441d	61919-706	HUMAN PRESCRIPTION DRUG	ISENTRESS		ISENTRESS	TABLET, FILM COATED	ORAL	20190813		NDA	NDA022145	Direct_Rx	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
61919-706_d5e239df-4a66-354f-e053-2995a90a1a57	61919-706	HUMAN PRESCRIPTION DRUG	ISENTRESS		ISENTRESS	TABLET, FILM COATED	ORAL	20161221		NDA	NDA022145	DIRECT RX	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
61919-707_ff97ce4a-765d-540b-e053-6394a90ae328	61919-707	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20181219		ANDA	ANDA207068	DIRECT RX	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-708_0e994ad4-d03f-9670-e063-6294a90adad3	61919-708	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20190115		ANDA	ANDA207068	Direct_Rx	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
61919-709_7ab587c5-5f5c-079e-e053-2991aa0a6d81	61919-709	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20181115		ANDA	ANDA207068	DIRECT RX	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-716_f21546be-be21-4cc9-e053-2995a90af7cd	61919-716	HUMAN PRESCRIPTION DRUG	AMOXIL		AMOXICILLIN	POWDER, FOR SUSPENSION	ORAL	20160304		ANDA	ANDA065322	Direct_Rx	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
61919-717_7ea80b2f-1cfb-0eff-e053-2a91aa0ac86e	61919-717	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20190104		ANDA	ANDA076180	Direct_Rx	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-718_fb85633e-ba49-768d-e053-6294a90a6ceb	61919-718	HUMAN PRESCRIPTION DRUG	CLONIDINE HYDROCHLORIDE		CLONIDINE HYDROCHLORIDE	TABLET	ORAL	20150101		ANDA	ANDA078895	DirectRX	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-721_7f864dbe-4de1-b642-e053-2991aa0afad5	61919-721	HUMAN PRESCRIPTION DRUG	Lisinoril		Lisinopril	TABLET	ORAL	20190115		ANDA	ANDA076164	Direct_Rx	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-721_ea4ed022-70d0-b687-e053-2a95a90a9fad	61919-721	HUMAN PRESCRIPTION DRUG	Lisinoril		Lisinopril	TABLET	ORAL	20190828		ANDA	ANDA076164	Direct_Rx	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-722_7cc4b65d-5f7b-8755-e053-2991aa0a466f	61919-722	HUMAN PRESCRIPTION DRUG	GLIPIZIDE		GLIPIZIDE	TABLET	ORAL	20181211		ANDA	ANDA075795	DIRECT RX	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61919-722_7cc51ca3-2f68-8e76-e053-2991aa0a9016	61919-722	HUMAN PRESCRIPTION DRUG	GLIPIZIDE		GLIPIZIDE	TABLET	ORAL	20181211		ANDA	ANDA075795	DIRECT RX	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
61919-727_032135ee-7bd2-5cdf-e063-6394a90ad9a2	61919-727	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate ER		Metoprolol Succinate ER	TABLET, EXTENDED RELEASE	ORAL	20230817		ANDA	ANDA204106	Direct_Rx	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61919-728_7f807344-00da-91d3-e053-2a91aa0a161b	61919-728	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20190115		ANDA	ANDA078332	Direct_Rx	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-728_ea4ed2fb-2401-b22d-e053-2a95a90ad72c	61919-728	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA078332	Direct_Rx	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-729_7fbca6be-aab0-19d4-e053-2991aa0a72eb	61919-729	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20190118		ANDA	ANDA076768	Direct_Rx	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
61919-730_872365ca-0c2b-550a-e053-2a91aa0ab25a	61919-730	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20190422		ANDA	ANDA078332	DIRECT RX	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-730_ea4ed022-70d1-b687-e053-2a95a90a9fad	61919-730	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA078332	Direct_Rx	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-730_ea4ed2fb-2402-b22d-e053-2a95a90ad72c	61919-730	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA078332	Direct_Rx	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-736_86ce400b-7c2f-5873-e053-2a91aa0af669	61919-736	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20190123		ANDA	ANDA076164	Direct_Rx	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-739_cc7107fc-0dd8-f2fd-e053-2a95a90a5011	61919-739	HUMAN PRESCRIPTION DRUG	Benazepril		Benazepril	TABLET, COATED	ORAL	20190115		ANDA	ANDA076118	Direct_Rx	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
61919-743_f93bb2ec-e340-b70e-e053-6394a90af57e	61919-743	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		HYDROXYZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA088618	DIRECT RX	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
61919-746_912f0be8-e8a2-80cb-e053-2995a90a449e	61919-746	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20190828		ANDA	ANDA076180	Direct_Rx	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-746_c3f51e1c-db94-3037-e053-2a95a90ab253	61919-746	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20190828		ANDA	ANDA076180	Direct_Rx	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-747_f215a829-30cf-b78d-e053-2a95a90a7ac7	61919-747	HUMAN PRESCRIPTION DRUG	CEFUROXIME AXETIL		CEFUROXIME AXETIL	TABLET, FILM COATED	ORAL	20190813		ANDA	ANDA065496	Direct_Rx	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
61919-748_b932a9e5-7d66-0bf1-e053-2995a90a4414	61919-748	HUMAN PRESCRIPTION DRUG	ALLOPURINOL		ALLOPURINOL	TABLET	ORAL	20210118		ANDA	ANDA203154	DIRECT RX	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
61919-751_0e993cb8-eccb-240d-e063-6394a90a98e4	61919-751	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		ZOLPIDEM TARTRATE	TABLET	ORAL	20190819		ANDA	ANDA077903	Direct_Rx	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20251231
61919-753_b933a6b2-634c-39a9-e053-2a95a90a8417	61919-753	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20210118		ANDA	ANDA077073	DIRECT RX	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61919-754_0e993203-3e65-5fbd-e063-6294a90a0636	61919-754	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE	ER	METOPROLOL SUCCINATE	TABLET, EXTENDED RELEASE	ORAL	20190502		ANDA	ANDA204106	Direct_Rx	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
61919-755_fc5decf5-ab53-b6e5-e053-6394a90ac42f	61919-755	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET, FILM COATED	ORAL	20210112		ANDA	ANDA202659	DIRECT RX	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
61919-756_cc7107fc-0dd8-f2fd-e053-2a95a90a5011	61919-756	HUMAN PRESCRIPTION DRUG	BENAZEPRIL HYDROCHLORIDE		BENAZEPRIL HYDROCHLORIDE	TABLET, COATED	ORAL	20210920		ANDA	ANDA076118	Direct_Rx	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
61919-764_f215afbc-93ab-1803-e053-2a95a90a4fe1	61919-764	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20210118		ANDA	ANDA078103	DIRECT RX	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-772_eac58823-b7ff-51cc-e053-2995a90a69cd	61919-772	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, FILM COATED	ORAL	20190114		ANDA	ANDA203512	Direct_Rx	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
61919-773_fd02b4c7-99e0-b5b9-e053-6294a90a8e46	61919-773	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE DR		OMEPRAZOLE DR	CAPSULE, DELAYED RELEASE	ORAL	20150101		ANDA	ANDA076048	Direct Rx	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-774_fbf943c9-14f3-ebbf-e053-6394a90a7aa3	61919-774	HUMAN PRESCRIPTION DRUG	LIDOCAINE		LIDOCAINE	OINTMENT	TOPICAL	20190401		ANDA	ANDA205318	DIRECTRX	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
61919-782_9c59436c-7ba8-3cf8-e053-2a95a90a2863	61919-782	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20190729		ANDA	ANDA203245	Direct_Rx	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61919-782_b933a6b2-634c-39a9-e053-2a95a90a8417	61919-782	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20170220		ANDA	ANDA203245	DIRECT RX	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61919-782_d28f1c26-a799-f138-e053-2995a90ad87a	61919-782	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20170221		ANDA	ANDA203245	DIRECT RX	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61919-786_eac57eec-996a-fc06-e053-2995a90ac61c	61919-786	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20190114		ANDA	ANDA208898	Direct_Rx	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-787_849ef938-5310-a4d2-e053-2991aa0a1c70	61919-787	HUMAN PRESCRIPTION DRUG	BISOPROLOL FUMARATE		BISOPROLOL FUMARATE	TABLET	ORAL	20190321		ANDA	ANDA078635	DIRECTRX	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61919-790_05ca4898-2b5f-01cb-e063-6294a90ad1e2	61919-790	HUMAN PRESCRIPTION DRUG	VALSARTAN/HTCZ		VALSARTAN/HTCZ	TABLET, FILM COATED	ORAL	20190409		ANDA	ANDA203145	DIRECTRX	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-794_86e7dadc-9f78-2e0f-e053-2991aa0a5ec8	61919-794	HUMAN PRESCRIPTION DRUG	Propranolol HCL ER		Propranolol HCL ER	CAPSULE, EXTENDED RELEASE	ORAL	20190419		ANDA	ANDA078703	Direct Rx	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
61919-795_fbfa21d0-16e2-a214-e053-6294a90a27cb	61919-795	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	SOLUTION	OPHTHALMIC	20190723		ANDA	ANDA077568	Direct_Rx	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
61919-804_f8fd6555-3986-f4ac-e053-6294a90a3134	61919-804	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		VENLAFAXINE	TABLET	ORAL	20190502		ANDA	ANDA090555	DIRECT RX	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
61919-805_c936cb53-35a5-d89d-e053-2a95a90a2701	61919-805	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190226		ANDA	ANDA077073	DirectRX	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61919-807_fc112178-faf6-83f5-e053-6294a90aa17a	61919-807	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE	DR	OMEPRAZOLE	CAPSULE, DELAYED RELEASE	ORAL	20190502		ANDA	ANDA091672	DirexctRX	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-811_87d9280d-684f-f5f5-e053-2a95a90aefdf	61919-811	HUMAN PRESCRIPTION DRUG	TIZANDINE		TIZANDINE	TABLET	ORAL	20190501		ANDA	ANDA091283	DirectRX	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-811_ea4ec601-5972-1928-e053-2995a90adc38	61919-811	HUMAN PRESCRIPTION DRUG	TIZANDINE		TIZANDINE	TABLET	ORAL	20190819		ANDA	ANDA091283	Direct_Rx	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-811_ea4ed022-70d4-b687-e053-2a95a90a9fad	61919-811	HUMAN PRESCRIPTION DRUG	TIZANDINE		TIZANDINE	TABLET	ORAL	20190813		ANDA	ANDA091283	Direct_Rx	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-811_ea4ed9f5-e13b-ebef-e053-2a95a90a049b	61919-811	HUMAN PRESCRIPTION DRUG	TIZANDINE		TIZANDINE	TABLET	ORAL	20190930		ANDA	ANDA091283	Direct_Rx	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-811_ea4edbaa-3900-bf8c-e053-2995a90a0af1	61919-811	HUMAN PRESCRIPTION DRUG	TIZANDINE		TIZANDINE	TABLET	ORAL	20200108		ANDA	ANDA091283	DIRECT RX	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
61919-813_fc5dd378-9514-949b-e053-6394a90a3ca2	61919-813	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20190430		NDA AUTHORIZED GENERIC	NDA018998	DIRECT RX	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
61919-814_d28f1c26-a799-f138-e053-2995a90ad87a	61919-814	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20190429		ANDA	ANDA077073	DIRECT RX	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
61919-818_fc5e0914-3e36-0be4-e053-6394a90aee7d	61919-818	HUMAN PRESCRIPTION DRUG	TRAMADOL HCL	ER	TRAMADOL HCL	TABLET, EXTENDED RELEASE	ORAL	20190503		ANDA	ANDA200503	DIRECT RX	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
61919-823_fc5dd4b0-0e34-858e-e053-6394a90a2714	61919-823	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20150101		ANDA	ANDA090278	DirectRX	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-824_fc5dd378-9511-949b-e053-6394a90a3ca2	61919-824	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20140101		ANDA	ANDA090278	DIRECT RX	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-826_fc5decf5-ab53-b6e5-e053-6394a90ac42f	61919-826	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET, FILM COATED	ORAL	20160829		ANDA	ANDA203814	DIRECT RX	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
61919-827_a848991f-8647-3fde-e053-2995a90aa17e	61919-827	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE		DEXAMETHASONE	TABLET	ORAL	20200615		ANDA	ANDA084610	Direct Rx	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
61919-828_90a0f135-c49b-20b3-e053-2995a90a33af	61919-828	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20190821		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-828_90a1e58d-8d85-10e9-e053-2995a90a7449	61919-828	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20190821		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-828_fc5e0b78-20f2-e5a4-e053-6294a90a8ab7	61919-828	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20190821		ANDA	ANDA201013	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
61919-830_8a719215-d0d5-42fb-e053-2a95a90a60da	61919-830	HUMAN PRESCRIPTION DRUG	LEVERTIRACETAM		LEVERTIRACETAM	TABLET, FILM COATED	ORAL	20190603		ANDA	ANDA078993	Direct_Rx	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-832_0e87d7eb-8c0a-f72b-e063-6394a90aed9c	61919-832	HUMAN PRESCRIPTION DRUG	METAXALONE		METAXALONE	TABLET	ORAL	20190503		ANDA	ANDA204770	DIRECT RX	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
61919-832_8c3bc0a2-5c94-e1d6-e053-2995a90a0b83	61919-832	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20190626		ANDA	ANDA204770	Direct_Rx	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
61919-832_91432cd0-8405-8029-e053-2a95a90adc1b	61919-832	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20190829		ANDA	ANDA204770	Direct_Rx	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
61919-832_e9d273d2-69a6-7b81-e053-2a95a90a4c87	61919-832	HUMAN PRESCRIPTION DRUG	METAXALONE		METAXALONE	TABLET	ORAL	20200106		ANDA	ANDA204770	DIRECT RX	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
61919-837_8c175caf-cd49-071f-e053-2995a90aac48	61919-837	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20190624		ANDA	ANDA204590	Direct_Rx	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-837_8e87600d-bd9e-4861-e053-2995a90a3260	61919-837	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20190725		ANDA	ANDA204590	Direct_Rx	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-837_fc5e2428-7cc0-5cd3-e053-6394a90a7cd2	61919-837	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20190725		ANDA	ANDA204590	Direct_Rx	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-840_f215bd63-3820-508b-e053-2a95a90aaa48	61919-840	HUMAN PRESCRIPTION DRUG	CEFDINIR		CEFDINIR	CAPSULE	ORAL	20190429		ANDA	ANDA065434	DirectRX	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
61919-845_8a80a7b8-4069-5d38-e053-2995a90a3f1d	61919-845	HUMAN PRESCRIPTION DRUG	MINOCYCLINE HYDROCHLORIDE		MINOCYCLINE HYDROCHLORIDE	CAPSULE	ORAL	20190604		ANDA	ANDA065470	Direct_Rx	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
61919-846_87c141e1-61d9-4e09-e053-2a95a90a069f	61919-846	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HCL		HYDRALAZINE HCL	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA086242	DirectRX	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
61919-847_fd02b4c7-99e0-b5b9-e053-6294a90a8e46	61919-847	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE	ORAL	20200812		ANDA	ANDA091672	Direct Rx	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
61919-853_db70b191-976f-789e-e053-2995a90a1b0c	61919-853	HUMAN PRESCRIPTION DRUG	Nortriptyline HCL		Nortriptyline HCL	CAPSULE	ORAL	20190604		ANDA	ANDA075520	Direct_Rx	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
61919-856_f93bb2ec-e340-b70e-e053-6394a90af57e	61919-856	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HCL		HYDROXYZINE HCL	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA040602	DIRECT RX	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
61919-865_f9261f0d-fcef-339c-e053-6394a90a6f51	61919-865	HUMAN PRESCRIPTION DRUG	PHENTERMINE HCL C-IV		PHENTERMINE HCL C-IV	CAPSULE	ORAL	20190605		ANDA	ANDA091359	Direct_Rx	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
61919-869_d9cb1a44-d647-d9e9-e053-2995a90a24ff	61919-869	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20161025		ANDA	ANDA078619	DIRECT RX	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-871_f215bd63-3821-508b-e053-2a95a90aaa48	61919-871	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20190821		ANDA	ANDA207419	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
61919-871_f215c9d6-3317-67c8-e053-2995a90afbc3	61919-871	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20190821		ANDA	ANDA207419	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
61919-871_f215cc43-2261-59f6-e053-2995a90a3e0e	61919-871	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20190821		ANDA	ANDA207419	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
61919-878_0e993203-3e8c-5fbd-e063-6294a90a0636	61919-878	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190726		ANDA	ANDA203374	Direct_Rx	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
61919-880_f216106d-2255-fc25-e053-2a95a90aeff8	61919-880	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20190603		ANDA	ANDA087479	Direct_Rx	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
61919-881_8a7002e7-e020-43f9-e053-2a95a90a7191	61919-881	HUMAN PRESCRIPTION DRUG	VERAPAMIL HCL		VERAPAMIL HCL	TABLET	ORAL	20190603		ANDA	ANDA071881	Direct_Rx	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
61919-882_0e9cb2cf-9a08-48f6-e063-6294a90a3acc	61919-882	HUMAN PRESCRIPTION DRUG	DESVENLAFAXINE ER		DESVENLAFAXINE ER	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190604		ANDA	ANDA204172	Direct_Rx	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
61919-883_8a2f8ea0-bf2d-09b1-e053-2a95a90a105c	61919-883	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20190531		ANDA	ANDA078235	Direct_Rx	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-883_f6f310b7-a1ea-182a-e053-6394a90a16d6	61919-883	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20190531		ANDA	ANDA078235	Direct_Rx	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
61919-884_f216106d-2256-fc25-e053-2a95a90aeff8	61919-884	HUMAN PRESCRIPTION DRUG	Trimethobenzamide		Trimethobenzamide	CAPSULE	ORAL	20190703		ANDA	ANDA076546	Direct_Rx	TRIMETHOBENZAMIDE HYDROCHLORIDE	300	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
61919-885_df494ad8-11bf-dfeb-e053-2995a90ae5d9	61919-885	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20190801		ANDA	ANDA078619	Direct_Rx	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
61919-886_f216106d-2257-fc25-e053-2a95a90aeff8	61919-886	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20190801		ANDA	ANDA040659	Direct_Rx	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
61919-887_fd766a2d-a292-56a1-e053-6394a90ae271	61919-887	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190612		ANDA	ANDA209908	Direct_Rx	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
61919-892_fd766ed0-84b8-7422-e053-6294a90a1372	61919-892	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE	ER	TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140101		ANDA	ANDA201384	DirectRX	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
61919-893_fc5e0914-3e36-0be4-e053-6394a90aee7d	61919-893	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140101		ANDA	ANDA201384	DIRECT RX	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
61919-901_f2161bad-5b5a-23d4-e053-2a95a90a801f	61919-901	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HCL		CYCLOBENZAPRINE HCL	TABLET, FILM COATED	ORAL	20190815		ANDA	ANDA077797	Direct_Rx	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-901_f809e129-6100-cfb4-e053-6394a90aebf0	61919-901	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HCL		CYCLOBENZAPRINE HCL	TABLET, FILM COATED	ORAL	20190930		ANDA	ANDA077797	Direct_Rx	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-901_fd766c38-e406-49e5-e053-6294a90aaf36	61919-901	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HCL		CYCLOBENZAPRINE HCL	TABLET, FILM COATED	ORAL	20190404		ANDA	ANDA077797	DIRECTRX	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-903_87388b8c-daa4-3fbb-e053-2a91aa0a3e9b	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET	ORAL	20190423		ANDA	ANDA090200	DirectRX	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-903_911efaf9-3815-a899-e053-2a95a90a174a	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET	ORAL	20190827		ANDA	ANDA090200	Direct_Rx	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-903_fd766ed0-84ba-7422-e053-6294a90a1372	61919-903	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET	ORAL	20190829		ANDA	ANDA090200	Direct_Rx	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
61919-904_b8b66872-d422-1875-e053-2a95a90adb4e	61919-904	HUMAN PRESCRIPTION DRUG	DICYCLOMINE HYDROCHLORIDE		DICYCLOMINE HYDROCHLORIDE	TABLET	ORAL	20190815		ANDA	ANDA040230	Direct_Rx	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
61919-904_b8b66962-7e29-438c-e053-2a95a90a0e97	61919-904	HUMAN PRESCRIPTION DRUG	DICYCLOMINE HYDROCHLORIDE		DICYCLOMINE HYDROCHLORIDE	TABLET	ORAL	20180314		ANDA	ANDA040230	DIRECT RX	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
61919-905_f2161f2e-26ca-b0f8-e053-2995a90ac5b9	61919-905	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE		ACETAMINOPHEN AND CODEINE	TABLET	ORAL	20190703		ANDA	ANDA202800	Direct_Rx	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
61919-906_f213f115-3a81-073f-e053-2995a90a3ba8	61919-906	HUMAN PRESCRIPTION DRUG	DIAZEPAM		DIAZEPAM	TABLET	ORAL	20161101		ANDA	ANDA071322	Direct_Rx	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
61919-909_cdba624d-b0ca-0a5e-e053-2a95a90a4e25	61919-909	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20190828		ANDA	ANDA076180	Direct_Rx	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
61919-917_0e993203-3e8b-5fbd-e063-6294a90a0636	61919-917	HUMAN PRESCRIPTION DRUG	ZONISAMIDE		ZONISAMIDE	CAPSULE	ORAL	20190819		ANDA	ANDA077634	Direct_Rx	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20251231
61919-941_f21620a9-ccb5-d6aa-e053-2a95a90a7ced	61919-941	HUMAN PRESCRIPTION DRUG	LOVASTATIN		LOVASTATIN	TABLET	ORAL	20140101		ANDA	ANDA075991	Direct_Rx	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-956_f21620df-a19a-7df4-e053-2995a90a00c8	61919-956	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20190118		ANDA	ANDA091624	Direct_Rx	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
61919-960_f21620df-a19b-7df4-e053-2995a90a00c8	61919-960	HUMAN PRESCRIPTION DRUG	ibuprofen		ibuprofen	TABLET	ORAL	20190820		ANDA	ANDA075682	Direct_Rx	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
61919-967_f21620df-a19c-7df4-e053-2995a90a00c8	61919-967	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		GEMFIBROZIL	TABLET	ORAL	20190808		ANDA	ANDA077836	Direct_Rx	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
61919-970_f2162166-3d61-392f-e053-2a95a90a8fc1	61919-970	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20210902		ANDA	ANDA077912	DirectRx	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
61919-984_b8b714ce-e8b1-b458-e053-2995a90ae348	61919-984	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA078332	Direct_Rx	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-984_e9ab90a9-7b36-6dd2-e053-2995a90ae06a	61919-984	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20170224		ANDA	ANDA078332	DIRECT RX	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
61919-986_f21620df-a1a1-7df4-e053-2995a90a00c8	61919-986	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20140101		ANDA	ANDA090469	Direct Rx	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
61919-990_f2162e88-e493-6ac7-e053-2a95a90a1500	61919-990	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20190829		ANDA	ANDA090564	Direct_Rx	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
61919-990_f2162f23-5b63-66f2-e053-2a95a90a79cb	61919-990	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20190829		ANDA	ANDA090564	Direct_Rx	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
61919-991_d787b2ce-fed8-096b-e053-2a95a90afb3f	61919-991	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA091166	DirectRX	ESZOPICLONE	1	mg/1		CIV	N	20241231
61919-994_eac6ca9b-f61d-00b7-e053-2995a90ac920	61919-994	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		AMOXICILLIN	CAPSULE	ORAL	20161227		ANDA	ANDA065271	DIRECT RX	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
61924-198_0bd989c1-5718-7cb9-e063-6294a90abaf6	61924-198	HUMAN OTC DRUG	PERIGIENE		ANTIMICROBIAL DRUG PRODUCT	SOAP	TOPICAL	20111212		OTC MONOGRAPH DRUG	M003	Dermarite Industries LLC	CHLOROXYLENOL	.005	g/mL			N	20241231
61938-456_0648b0d7-498c-7d76-e063-6394a90abe1c	61938-456	HUMAN PRESCRIPTION DRUG	INFASURF		CALFACTANT	SUSPENSION	ENDOTRACHEAL	20110721		BLA	BLA020521	ONY Biotech Inc.	CALFACTANT	35.7	mg/mL	Alveolar Surface Tension Reduction [PE], Surfactant Activity [MoA], Surfactant [EPC]		N	20241231
61953-0001_01792464-a438-4623-9fb1-b1e3a5e745a8	61953-0001	PLASMA DERIVATIVE	HUMAN ALBUMIN GRIFOLS		ALBUMIN (HUMAN)	SOLUTION	INTRAVENOUS	19950217		BLA	BLA103352	GRIFOLS USA, LLC	ALBUMIN HUMAN	10	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
61953-0002_6bd34851-83d8-4c9e-9892-8b6118e0573f	61953-0002	PLASMA DERIVATIVE	HUMAN ALBUMIN GRIFOLS		ALBUMIN (HUMAN)	SOLUTION	INTRAVENOUS	20030611		BLA	BLA103352	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
61953-0004_9c118588-9cb5-4801-84a2-0c2faa2782a6	61953-0004	PLASMA DERIVATIVE	Flebogamma	DIF	Immune Globulin (Human)	INJECTION, SOLUTION	INTRAVENOUS	20061221		BLA	BLA125077	GRIFOLS USA, LLC	HUMAN IMMUNOGLOBULIN G	.05	g/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
61953-0005_2dc9ff6f-7460-4520-a5fa-e89d053ae8b0	61953-0005	PLASMA DERIVATIVE	FLEBOGAMMA DIF		IMMUNE GLOBULIN INTRAVENOUS (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20100727		BLA	BLA125077	GRIFOLS USA, LLC	HUMAN IMMUNOGLOBULIN G	5	g/50mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
61953-0011_d6dadd13-2c84-4e53-b87d-48ce0709a6c1	61953-0011	PLASMA DERIVATIVE	VISTASEAL		human fibrinogen, human thrombin	KIT		20191101		BLA	BLA125640	GRIFOLS USA, LLC						N	20241231
61953-0012_d6dadd13-2c84-4e53-b87d-48ce0709a6c1	61953-0012	PLASMA DERIVATIVE	VISTASEAL		human fibrinogen, human thrombin	KIT		20191101		BLA	BLA125640	GRIFOLS USA, LLC						N	20241231
61953-0013_d6dadd13-2c84-4e53-b87d-48ce0709a6c1	61953-0013	PLASMA DERIVATIVE	VISTASEAL		human fibrinogen, human thrombin	KIT		20191101		BLA	BLA125640	GRIFOLS USA, LLC						N	20241231
61953-0014_d6dadd13-2c84-4e53-b87d-48ce0709a6c1	61953-0014	PLASMA DERIVATIVE	VISTASEAL		human fibrinogen, human thrombin	KIT		20191101		BLA	BLA125640	GRIFOLS USA, LLC						N	20241231
61957-0900_09af4a3a-d7be-2a13-e063-6294a90ab3aa	61957-0900	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 010		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0901_0949ee74-d737-be55-e063-6294a90a72a6	61957-0901	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 020		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0902_094a0988-6405-c3bf-e063-6294a90afd28	61957-0902	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 021		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0903_094e40c1-13d7-13f1-e063-6394a90a7262	61957-0903	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 022		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0904_094e47f4-cb8c-4e24-e063-6294a90a47b1	61957-0904	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 023		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0905_094e51a0-2e3d-d46a-e063-6294a90a5789	61957-0905	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 030		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0906_094e47f4-cb9b-4e24-e063-6294a90a47b1	61957-0906	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 031		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0907_094e51a0-2e4c-d46a-e063-6294a90a5789	61957-0907	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 032		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0908_094a77af-4d56-fe24-e063-6294a90a7d38	61957-0908	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 040		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-0909_094a7cf6-31d9-0368-e063-6294a90abdd0	61957-0909	HUMAN OTC DRUG	CD CAPTURE TOTALE Triple Correcting Serum Foundation Wrinkles-Dark Spots-Radiance with sunscreen Broad Spectrum SPF 25 050		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20131227		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 31.6	mg/mL; mg/mL			N	20241231
61957-1112_094a77af-4d65-fe24-e063-6294a90a7d38	61957-1112	HUMAN OTC DRUG	CD HydraLife BB Creme Enhancing Sunscreen Moisturizer For Immediate Beauty Golden Peach Broad Spectrum SPF 30		OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE	CREAM	TOPICAL	20130103		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE	37.5; 10; 35.5	mg/mL; mg/mL; mg/mL			N	20241231
61957-1113_09af4a3a-d7cd-2a13-e063-6294a90ab3aa	61957-1113	HUMAN OTC DRUG	CD HydraLife BB Creme Enhancing Sunscreen Moisturizer For Immediate Beauty Luminous Beige Broad Spectrum SPF 30		OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE	CREAM	TOPICAL	20130103		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE	37.5; 10; 35.5	mg/mL; mg/mL; mg/mL			N	20241231
61957-2100_09af4fec-e2fa-2c8d-e063-6294a90af999	61957-2100	HUMAN OTC DRUG	CD DIORSKIN STAR Studio Makeup Spectacular Brightening with sunscreen Broad Spectrum SPF30 010		OCTINOXATE, TITANIUM DIOXIDE	LIQUID	TOPICAL	20140610		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	59.9; 35	mg/mL; mg/mL			N	20241231
61957-2120_094a7cf6-31e8-0368-e063-6294a90abdd0	61957-2120	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	Ivory 010	OCTINOXATE	LOTION	TOPICAL	20151102		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2121_09af4166-1e95-4169-e063-6294a90a7bbd	61957-2121	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	020 Light Beige	OCTINOXATE	LOTION	TOPICAL	20151102		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2122_09af6337-0cba-4cb7-e063-6294a90a0e4a	61957-2122	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	021 Linen	OCTINOXATE	LOTION	TOPICAL	20141012		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2123_09af702c-0d38-0ca1-e063-6394a90af440	61957-2123	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	023 Peach	OCTINOXATE	LOTION	TOPICAL	20141012		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2124_09af740a-d55e-452f-e063-6294a90ab2bc	61957-2124	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	030 Medium	OCTINOXATE	LOTION	TOPICAL	20141012		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2126_09af778f-6f32-51db-e063-6294a90a73c9	61957-2126	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	040 Honey Beige	OCTINOXATE	LOTION	TOPICAL	20141012		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2127_09af702c-0d47-0ca1-e063-6394a90af440	61957-2127	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	050 Dark Beige	OCTINOXATE	LOTION	TOPICAL	20141012		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2128_09af694f-d167-2b9c-e063-6394a90a4dfc	61957-2128	HUMAN OTC DRUG	DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25	060 Mocha	OCTINOXATE	LOTION	TOPICAL	20141012		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE	74.9	mg/mL			N	20241231
61957-2150_094a7cf6-31f7-0368-e063-6294a90abdd0	61957-2150	HUMAN OTC DRUG	CD DIORSKIN CITY DEFENSE Toxin Shield Pollution UV Advanced Protection with sunscreen Broad Spectrum SPF50		OCTINOXATE, OXYBENZONE, ZINC OXIDE	LIQUID	TOPICAL	20140924		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; OXYBENZONE; ZINC OXIDE	4.49; 2; 20.9	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61957-2200_09af4166-1ea4-4169-e063-6294a90a7bbd	61957-2200	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 010		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151021		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2201_09af6337-0cc9-4cb7-e063-6294a90a0e4a	61957-2201	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 020		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151021		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2202_094a77af-4d76-fe24-e063-6294a90a7d38	61957-2202	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 021		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151021		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2203_094a750b-99a0-e6eb-e063-6294a90ab4eb	61957-2203	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 022		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151021		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2204_094a55ba-24fe-f519-e063-6294a90aca17	61957-2204	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 023		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151021		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2205_094a7cf6-3206-0368-e063-6294a90abdd0	61957-2205	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 030		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151021		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2206_094a99da-2037-0836-e063-6394a90a0233	61957-2206	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 031		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151022		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2207_094a9e2c-a445-28be-e063-6294a90ac3af	61957-2207	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 032		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151022		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2208_094a77af-4d85-fe24-e063-6294a90a7d38	61957-2208	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 033		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151022		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2209_094aa360-39aa-0608-e063-6294a90adcd1	61957-2209	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 034		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151022		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2210_094a77af-4d94-fe24-e063-6294a90a7d38	61957-2210	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 035		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151022		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2211_094a93d5-d88f-1d3f-e063-6294a90a3b3b	61957-2211	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 040		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151022		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2212_094a9e2c-a454-28be-e063-6294a90ac3af	61957-2212	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 050		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151023		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2213_094a9e2c-a463-28be-e063-6294a90ac3af	61957-2213	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 060		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151023		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2214_094a7219-36c0-efba-e063-6394a90a317d	61957-2214	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 070		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151023		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2216_094a77af-4da3-fe24-e063-6294a90a7d38	61957-2216	HUMAN OTC DRUG	DIORSKIN FOREVER EVER WEAR Extreme Perfection Hold Makeup Base with Sunscreen SPF20 001		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20151023		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	40; 43.8	mg/mL; mg/mL			N	20241231
61957-2224_094ab8ae-f55d-0772-e063-6394a90a0bd9	61957-2224	HUMAN OTC DRUG	DIOR PRESTIGE LE NECTAR DE TEINT Exceptional Revitalizing Foundation Satin Radiance with Sunscreen Broad Spectrum SPF20 TINTS 010		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20160723		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 29.2	mg/mL; mg/mL			N	20241231
61957-2225_094a77af-4db2-fe24-e063-6294a90a7d38	61957-2225	HUMAN OTC DRUG	DIOR PRESTIGE LE NECTAR DE TEINT Exceptional Revitalizing Foundation Satin Radiance with Sunscreen Broad Spectrum SPF20 TINTS 020		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20160723		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 29.2	mg/mL; mg/mL			N	20241231
61957-2300_094aa360-39b9-0608-e063-6294a90adcd1	61957-2300	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH and PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 010		OCTINOXATE,TITANIUM DIOXIDE,ZINC OXIDE	EMULSION	TOPICAL	20201126		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.07; .0415; .098	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61957-2301_094a7cf6-3215-0368-e063-6294a90abdd0	61957-2301	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH and PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 020		OCTINOXATE,TITANIUM DIOXIDE,ZINC OXIDE	EMULSION	TOPICAL	20201126		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.07; .0415; .098	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61957-2302_094ac7f6-f89f-35b6-e063-6294a90afcbc	61957-2302	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH and PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 030		OCTINOXATE,TITANIUM DIOXIDE,ZINC OXIDE	EMULSION	TOPICAL	20201126		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.07; .0415; .098	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61957-2303_094a99da-2046-0836-e063-6394a90a0233	61957-2303	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH and PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 000		OCTINOXATE,TITANIUM DIOXIDE,ZINC OXIDE	EMULSION	TOPICAL	20201126		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.07; .0415; .098	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
61957-2400_094a99da-2057-0836-e063-6394a90a0233	61957-2400	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 0N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2401_094a99da-2067-0836-e063-6394a90a0233	61957-2401	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 1N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2402_094ad3fa-b36f-4ca0-e063-6294a90a3a85	61957-2402	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 1,5N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2403_094a9e2c-a472-28be-e063-6294a90ac3af	61957-2403	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 2N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2404_094ada26-76fc-3eb6-e063-6294a90a6674	61957-2404	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 2CR		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2405_094a9e2c-a482-28be-e063-6294a90ac3af	61957-2405	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 2W		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2406_094ad3fa-b37f-4ca0-e063-6294a90a3a85	61957-2406	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 3N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2407_094ae31d-8a66-2806-e063-6294a90ab515	61957-2407	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 4N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2408_094ada80-3669-484d-e063-6294a90ac26c	61957-2408	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 5N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2409_094ae843-d137-2edd-e063-6394a90a7f08	61957-2409	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 6N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2410_094ada80-3679-484d-e063-6294a90ac26c	61957-2410	HUMAN OTC DRUG	CAPTURE TOTALE C.E.L.L. ENERGY SUPER POTENT SERUM FOUNDATION BROAD SPECTRUM SPF 20 7N		ENSULIZOLE, OCTISALATE	EMULSION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	ENSULIZOLE; OCTISALATE	27; 45	mg/mL; mg/mL			N	20241231
61957-2601_094ae31d-8a76-2806-e063-6294a90ab515	61957-2601	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 tints 015		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20161014		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2603_094ae31d-8a85-2806-e063-6294a90ab515	61957-2603	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 tints 024		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20161014		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2604_094af31a-b78d-5e7b-e063-6294a90a72c2	61957-2604	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 tints 025		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20161014		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2605_094ad3fa-b38f-4ca0-e063-6294a90a3a85	61957-2605	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 tints 041		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20161014		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2608_094afbbe-82c5-4fe8-e063-6294a90a28c0	61957-2608	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 tints 045		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20161014		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2609_094ada26-770c-3eb6-e063-6294a90a6674	61957-2609	HUMAN OTC DRUG	DIORSKIN FOREVER Perfect Makeup Everlasting Wear Pore-Refining Effect with Sunscreen Broad Spectrum SPF 35 tints 051		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20161014		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2740_094ada80-3689-484d-e063-6294a90ac26c	61957-2740	HUMAN OTC DRUG	FOREVER SKIN VEIL Extreme Wear and Moisturizing Primer Correction, Protection, Illumination With Sunscreen Floral Extract-Enriched Broad Spectrum SPF20		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 72.3	mg/mL; mg/mL			N	20241231
61957-2900_094ac7f6-f8b0-35b6-e063-6294a90afcbc	61957-2900	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH AND PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 010		Octinoxate, Titanium dioxide, Zinc oxide	EMULSION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 41.5; 98	mg/g; mg/g; mg/g			N	20241231
61957-2901_094ad3fa-b39e-4ca0-e063-6294a90a3a85	61957-2901	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH AND PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 012		Octinoxate, Titanium dioxide, Zinc oxide	EMULSION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 41.5; 98	mg/g; mg/g; mg/g			N	20241231
61957-2902_094ae31d-8a94-2806-e063-6294a90ab515	61957-2902	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH AND PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 020		Octinoxate, Titanium dioxide, Zinc oxide	EMULSION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 41.5; 98	mg/g; mg/g; mg/g			N	20241231
61957-2903_094afbbe-82d4-4fe8-e063-6294a90a28c0	61957-2903	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH AND PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 025		Octinoxate, Titanium dioxide, Zinc oxide	EMULSION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 41.5; 98	mg/g; mg/g; mg/g			N	20241231
61957-2904_094bb5b0-5735-86ad-e063-6294a90a8ea7	61957-2904	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH AND PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 030		Octinoxate, Titanium dioxide, Zinc oxide	EMULSION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 41.5; 98	mg/g; mg/g; mg/g			N	20241231
61957-2905_094bba01-b273-3131-e063-6394a90aa122	61957-2905	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH AND PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 040		Octinoxate, Titanium dioxide, Zinc oxide	EMULSION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 41.5; 98	mg/g; mg/g; mg/g			N	20241231
61957-2906_09af1ccc-f787-79d4-e063-6394a90a81f7	61957-2906	HUMAN OTC DRUG	CAPTURE DREAMSKIN FRESH AND PERFECT CUSHION WITH SUNSCREEN BROAD SPECTRUM SPF 50 000		Octinoxate, Titanium dioxide, Zinc oxide	EMULSION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 41.5; 98	mg/g; mg/g; mg/g			N	20241231
61957-2910_094b9bf3-a944-5e2a-e063-6394a90a74dd	61957-2910	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	0,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2911_094bce30-1ee8-b578-e063-6294a90a2922	61957-2911	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	0N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2912_094bcaca-313d-8d9d-e063-6394a90ac595	61957-2912	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	1,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2913_094bce30-1ef8-b578-e063-6294a90a2922	61957-2913	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	1CR	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2914_094bc4ca-18a9-b44f-e063-6294a90ab48d	61957-2914	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	1N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2915_094bd248-4844-7264-e063-6394a90aa192	61957-2915	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	1W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2916_094bc953-4bef-ac05-e063-6294a90a14db	61957-2916	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	2,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2917_094bc4ca-18b8-b44f-e063-6294a90ab48d	61957-2917	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	2CR	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2918_094bce30-1f07-b578-e063-6294a90a2922	61957-2918	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	2N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2919_094bcaca-314c-8d9d-e063-6394a90ac595	61957-2919	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	2W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2920_094be948-02fa-85de-e063-6394a90a3935	61957-2920	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	2W0	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2921_094bce30-1f17-b578-e063-6294a90a2922	61957-2921	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	2WP	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2922_094bc2c8-029c-bd78-e063-6294a90a7220	61957-2922	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	3,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2923_094bce30-1f28-b578-e063-6294a90a2922	61957-2923	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	3C	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2924_094bbd13-40ef-b9db-e063-6294a90a4c95	61957-2924	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	3CR	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2925_094bfaa7-1647-b1eb-e063-6394a90ac29e	61957-2925	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	3N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2926_094bc2c8-02ab-bd78-e063-6294a90a7220	61957-2926	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	3W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2927_094bc953-4bff-ac05-e063-6294a90a14db	61957-2927	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	3W0	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2928_094e47f4-cbaa-4e24-e063-6294a90a47b1	61957-2928	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	3WP	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2929_094c1b3c-58f1-c136-e063-6394a90ac8b7	61957-2929	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	4,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2930_094bbd13-40fe-b9db-e063-6294a90a4c95	61957-2930	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	4,5W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2931_094bbd13-410f-b9db-e063-6294a90a4c95	61957-2931	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	4C	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2932_094c0a52-6237-ec28-e063-6294a90a5294	61957-2932	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	4N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2933_094c2824-90b4-c90b-e063-6294a90aaeda	61957-2933	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	4W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2934_094c2824-90c5-c90b-e063-6294a90aaeda	61957-2934	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	4W0	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2935_094c2f7b-d6e8-d7d7-e063-6394a90a5e50	61957-2935	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	4WP	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2936_094c332d-739a-f588-e063-6294a90ad058	61957-2936	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2937_094bfaa7-1657-b1eb-e063-6394a90ac29e	61957-2937	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	6N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2938_094c2f7b-d6f9-d7d7-e063-6394a90a5e50	61957-2938	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	7N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2939_094c1b3c-5900-c136-e063-6394a90ac8b7	61957-2939	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	8N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2940_094c2f7b-d709-d7d7-e063-6394a90a5e50	61957-2940	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration	9N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2941_094c332d-73aa-f588-e063-6294a90ad058	61957-2941	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration 1,5W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2942_094c4d23-d3ad-0085-e063-6294a90aeba2	61957-2942	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration 2,5W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2943_094c0a52-6247-ec28-e063-6294a90a5294	61957-2943	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration 6,5W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2944_094c332d-73b9-f588-e063-6294a90ad058	61957-2944	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h Wear Radiant Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Hydration 7W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2950_094c590f-f8d4-fa99-e063-6294a90a8996	61957-2950	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	0,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2951_094c2f7b-d718-d7d7-e063-6394a90a5e50	61957-2951	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	0N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2952_094c332d-73ca-f588-e063-6294a90ad058	61957-2952	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	1,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2953_094c622c-6090-9155-e063-6394a90ab31e	61957-2953	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	1C	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2954_094c64a1-57d1-0583-e063-6294a90a9df3	61957-2954	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	1CR	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2955_094c622c-609f-9155-e063-6394a90ab31e	61957-2955	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	1N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2956_094bfaa7-1667-b1eb-e063-6394a90ac29e	61957-2956	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	1W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2957_094c6d82-4177-15be-e063-6294a90ae0cb	61957-2957	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	2,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2958_094c622c-60b0-9155-e063-6394a90ab31e	61957-2958	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	2CR	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2959_094bfaa7-1676-b1eb-e063-6394a90ac29e	61957-2959	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	2N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2960_094c4d23-d3bc-0085-e063-6294a90aeba2	61957-2960	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	2W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2961_094c2f7b-d728-d7d7-e063-6394a90a5e50	61957-2961	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	2W0	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2962_094c622c-60bf-9155-e063-6394a90ab31e	61957-2962	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	2WP	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2963_094c332d-73d9-f588-e063-6294a90ad058	61957-2963	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	3,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2964_094c2f7b-d737-d7d7-e063-6394a90a5e50	61957-2964	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	3C	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2965_094c896a-cac3-2468-e063-6294a90a67f5	61957-2965	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	3CR	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2966_094c64a1-57e0-0583-e063-6294a90a9df3	61957-2966	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	3N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2967_094c622c-60ce-9155-e063-6394a90ab31e	61957-2967	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	3W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2968_094c4d23-d3cc-0085-e063-6294a90aeba2	61957-2968	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	3W0	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2969_094c64a1-57f1-0583-e063-6294a90a9df3	61957-2969	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	3WP	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2970_094c64a1-5800-0583-e063-6294a90a9df3	61957-2970	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	4,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2971_094c6d82-4186-15be-e063-6294a90ae0cb	61957-2971	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	4,5W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2972_094c6d82-4197-15be-e063-6294a90ae0cb	61957-2972	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	4C	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2973_094c6d82-41a6-15be-e063-6294a90ae0cb	61957-2973	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	4N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2974_094c6d82-41b7-15be-e063-6294a90ae0cb	61957-2974	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	4W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2975_094c6d82-41c6-15be-e063-6294a90ae0cb	61957-2975	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	4W0	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2976_094c4d23-d3db-0085-e063-6294a90aeba2	61957-2976	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	4WP	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2977_094c4d23-d3ec-0085-e063-6294a90aeba2	61957-2977	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2978_094c64a1-580f-0583-e063-6294a90a9df3	61957-2978	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	5W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2979_094cce37-8f04-22cb-e063-6294a90a784c	61957-2979	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	6,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2980_094efd8c-b47a-5230-e063-6394a90ace9f	61957-2980	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	6N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2981_094ef5ec-7636-6806-e063-6394a90a92e3	61957-2981	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	6W	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2982_094ef744-ac43-9d95-e063-6294a90a9a19	61957-2982	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	7,5N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2983_094eb008-9981-63b1-e063-6294a90a416e	61957-2983	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	7N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2984_094eb5b3-0ec1-56cb-e063-6394a90a5271	61957-2984	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	8N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2985_094f0181-bcd9-aed2-e063-6294a90a2642	61957-2985	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care	9N	OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	PARFUMS CHRISTIAN DIOR	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2986_094f05a0-6e53-b9aa-e063-6294a90a5b85	61957-2986	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care 1,5W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2987_094ef744-ac63-9d95-e063-6294a90a9a19	61957-2987	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care 2,5W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2988_094f0181-bce8-aed2-e063-6294a90a2642	61957-2988	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care 6,5W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-2989_094f0181-bcf9-aed2-e063-6294a90a2642	61957-2989	HUMAN OTC DRUG	FOREVER 24h Wear High Perfection Skin-Caring Foundation With Sunscreen BROAD SPECTRUM SPF 35 Lasting Comfort and Care 7W		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTINOXATE; TITANIUM DIOXIDE	30; 17.5	mg/mL; mg/mL			N	20241231
61957-3000_0b585632-4b2a-71d1-e063-6394a90ac57c	61957-3000	HUMAN OTC DRUG	ADVENT CALENDAR 2021		OCTINOXATE, TITANIUM DIOXIDE	KIT		20211201		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior						N	20241231
61957-3001_094f1535-5bd2-c477-e063-6294a90a457f	61957-3001	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 9N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3002_094edc61-8a3b-69a2-e063-6394a90af6ca	61957-3002	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 8N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3003_094f0f37-b034-b043-e063-6294a90ac9de	61957-3003	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 7W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3004_094f1535-5be3-c477-e063-6294a90a457f	61957-3004	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 7N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3005_094f25dd-487f-82cc-e063-6394a90ab8ec	61957-3005	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 7.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3006_094f05a0-6e62-b9aa-e063-6294a90a5b85	61957-3006	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 6W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3007_094f0181-bd0a-aed2-e063-6294a90a2642	61957-3007	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 6N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3008_094f2fcb-54fd-7cd4-e063-6394a90a6c75	61957-3008	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 6.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3009_094f25dd-4890-82cc-e063-6394a90ab8ec	61957-3009	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 6.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3010_094f25dd-48a1-82cc-e063-6394a90ab8ec	61957-3010	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3011_094f2b22-b24c-b4c9-e063-6294a90a11eb	61957-3011	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 9.4	mg/mL; mg/mL			N	20241231
61957-3012_094f05a0-6e85-b9aa-e063-6294a90a5b85	61957-3012	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 4WP		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3013_094f5c2e-ce4d-8dcf-e063-6394a90a8fbb	61957-3013	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 4WO		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3014_094f9a06-a65c-f993-e063-6294a90adf38	61957-3014	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 4W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3015_094f627a-1e8a-f200-e063-6294a90a9707	61957-3015	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 4N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3016_094f627a-1e9b-f200-e063-6294a90a9707	61957-3016	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 4C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3017_094f9a06-a66d-f993-e063-6294a90adf38	61957-3017	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 4.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3018_094f6fe8-9e22-95ef-e063-6394a90aa3df	61957-3018	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 4.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3019_094fa7eb-f861-e464-e063-6294a90a3e52	61957-3019	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 3WP		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3020_094faa6e-8515-a401-e063-6394a90ad08d	61957-3020	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 3WO		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3021_094f627a-1eac-f200-e063-6294a90a9707	61957-3021	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 3W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3022_094f8059-df2e-fb63-e063-6294a90a99b2	61957-3022	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 3N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3023_094f627a-1ebd-f200-e063-6294a90a9707	61957-3023	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 3CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3024_094fb46b-0c18-e5dd-e063-6294a90a83ec	61957-3024	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 3C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3025_094fa7eb-f872-e464-e063-6294a90a3e52	61957-3025	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 3.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3026_094f9a06-a67e-f993-e063-6294a90adf38	61957-3026	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 2WP		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3027_094fa9c5-581d-1084-e063-6294a90a90b0	61957-3027	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 2WO		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3028_094f8059-df3f-fb63-e063-6294a90a99b2	61957-3028	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 2W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3029_094fbc5c-582f-c215-e063-6394a90a844e	61957-3029	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 2N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3030_094fb46b-0c07-e5dd-e063-6294a90a83ec	61957-3030	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 2CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3031_094faf3d-0ad4-9ab8-e063-6394a90a7f7f	61957-3031	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 2.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3032_094fa9c5-580c-1084-e063-6294a90a90b0	61957-3032	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 2.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3033_094f8059-df1d-fb63-e063-6294a90a99b2	61957-3033	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 1W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3034_094f8059-df0c-fb63-e063-6294a90a99b2	61957-3034	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 1N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3035_094f6fe8-9e11-95ef-e063-6394a90aa3df	61957-3035	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 1CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3036_094f6fe8-9e02-95ef-e063-6394a90aa3df	61957-3036	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 1C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3037_094f68c3-04ff-873a-e063-6394a90a1995	61957-3037	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 1.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3038_094f627a-1e79-f200-e063-6294a90a9707	61957-3038	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 1.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3039_094f2b22-b25d-b4c9-e063-6294a90a11eb	61957-3039	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 0W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3040_094f2fcb-550e-7cd4-e063-6394a90a6c75	61957-3040	HUMAN OTC DRUG	FOREVER Transfer-proof 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 0N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3041_094f2b22-b23b-b4c9-e063-6294a90a11eb	61957-3041	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 0CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3042_094f05a0-6e74-b9aa-e063-6294a90a5b85	61957-3042	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 00		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3043_094f0181-bd1b-aed2-e063-6294a90a2642	61957-3043	HUMAN OTC DRUG	FOREVER Transfer-proof - 24h foundation High perfection Concentrated floral skincare with sunscreen Broad spectrum SPF 15 0.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	35; 37.6	mg/mL; mg/mL			N	20241231
61957-3101_094f2b22-b22b-b4c9-e063-6294a90a11eb	61957-3101	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 9N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3102_094f25dd-486f-82cc-e063-6394a90ab8ec	61957-3102	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 8N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3103_094f0f37-b045-b043-e063-6294a90ac9de	61957-3103	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 7W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3104_094f09c5-ecfa-9a1a-e063-6294a90adbdd	61957-3104	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 7N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3105_094f0f37-b024-b043-e063-6294a90ac9de	61957-3105	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 7.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3106_094f09c5-ecea-9a1a-e063-6294a90adbdd	61957-3106	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 6W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3107_094ef5ec-7647-6806-e063-6394a90a92e3	61957-3107	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 6N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3108_094ef744-ac52-9d95-e063-6294a90a9a19	61957-3108	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 6.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3109_094ef5ec-7626-6806-e063-6394a90a92e3	61957-3109	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 6.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3110_094edc61-8a2b-69a2-e063-6394a90af6ca	61957-3110	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3111_094edc61-8a1a-69a2-e063-6394a90af6ca	61957-3111	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 9.4	mg/mL; mg/mL			N	20241231
61957-3112_094eb5b3-0ed1-56cb-e063-6394a90a5271	61957-3112	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 4WP		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3113_094e8d2c-5add-7776-e063-6294a90aad7d	61957-3113	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 4WO		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3114_094e8d2c-5acd-7776-e063-6294a90aad7d	61957-3114	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 4W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3115_094ebd14-859a-6a6b-e063-6294a90a8f03	61957-3115	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 4N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3116_094eb5b3-0eb1-56cb-e063-6394a90a5271	61957-3116	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 4C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3117_094eb008-9971-63b1-e063-6294a90a416e	61957-3117	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 4.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3118_094e9370-4047-6708-e063-6294a90a2458	61957-3118	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 4.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3119_094ea465-0235-629d-e063-6294a90a6027	61957-3119	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 3WP		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3120_094e9edc-02f1-5306-e063-6394a90a7f46	61957-3120	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 3WO		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3121_094e8d2c-5abd-7776-e063-6294a90aad7d	61957-3121	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 3W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3122_094e9370-4036-6708-e063-6294a90a2458	61957-3122	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 3N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3123_094e8d2c-5aad-7776-e063-6294a90aad7d	61957-3123	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 3CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3124_094e47f4-cbb9-4e24-e063-6294a90a47b1	61957-3124	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 3C		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3125_094d5a01-ced5-5d45-e063-6394a90aac85	61957-3125	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 3.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3126_094d9e53-53e4-d14d-e063-6294a90a2851	61957-3126	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 2WP		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3127_094d3998-e2d6-7580-e063-6294a90a7f98	61957-3127	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 2WO		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3128_094d5ffb-2ee3-6b61-e063-6294a90a1a0d	61957-3128	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 2W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3129_094d5ffb-2ed2-6b61-e063-6294a90a1a0d	61957-3129	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 2N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3130_094d86db-2ba0-c6ea-e063-6294a90aece9	61957-3130	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 2CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3131_094d52ba-67c7-1f5d-e063-6294a90ac394	61957-3131	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 2.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3132_094d7a26-c1ee-653e-e063-6394a90a0f77	61957-3132	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 2.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3133_094d5ffb-2ec2-6b61-e063-6294a90a1a0d	61957-3133	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 1W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3134_094d52ba-67b6-1f5d-e063-6294a90ac394	61957-3134	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 1N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3135_094d5a01-cec5-5d45-e063-6394a90aac85	61957-3135	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 1CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3136_094d5ffb-2eb2-6b61-e063-6294a90a1a0d	61957-3136	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 1.5W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3137_094d5a01-ceb4-5d45-e063-6394a90aac85	61957-3137	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 1.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3138_094d52ba-67a6-1f5d-e063-6294a90ac394	61957-3138	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 0W		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3139_094cce37-8f24-22cb-e063-6294a90a784c	61957-3139	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 0N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3140_094cce37-8f13-22cb-e063-6294a90a784c	61957-3140	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 0CR		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3141_094d3998-e2c5-7580-e063-6294a90a7f98	61957-3141	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 00		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61957-3142_09af4a3a-d7ae-2a13-e063-6294a90ab3aa	61957-3142	HUMAN OTC DRUG	FOREVER SKIN GLOW 24h wear radiant foundation Perfection and hydration Concentrated floral skincare with suncreen Broad spectrum SPF 15 0.5N		OCTISALATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	Parfums Christian Dior	OCTISALATE; TITANIUM DIOXIDE	45; 42.3	mg/mL; mg/mL			N	20241231
61958-0401_741e31d6-533d-4da5-8a00-364d657ee3ab	61958-0401	HUMAN PRESCRIPTION DRUG	Viread		TENOFOVIR DISOPROXIL FUMARATE	TABLET, COATED	ORAL	20011026		NDA	NDA021356	Gilead Sciences, Inc.	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-0403_741e31d6-533d-4da5-8a00-364d657ee3ab	61958-0403	HUMAN PRESCRIPTION DRUG	Viread		TENOFOVIR DISOPROXIL FUMARATE	POWDER	ORAL	20120118		NDA	NDA022577	Gilead Sciences, Inc.	TENOFOVIR DISOPROXIL FUMARATE	40	mg/g	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-0404_741e31d6-533d-4da5-8a00-364d657ee3ab	61958-0404	HUMAN PRESCRIPTION DRUG	Viread		TENOFOVIR DISOPROXIL FUMARATE	TABLET, COATED	ORAL	20120118		NDA	NDA021356	Gilead Sciences, Inc.	TENOFOVIR DISOPROXIL FUMARATE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-0405_741e31d6-533d-4da5-8a00-364d657ee3ab	61958-0405	HUMAN PRESCRIPTION DRUG	Viread		TENOFOVIR DISOPROXIL FUMARATE	TABLET, COATED	ORAL	20120118		NDA	NDA021356	Gilead Sciences, Inc.	TENOFOVIR DISOPROXIL FUMARATE	200	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-0406_741e31d6-533d-4da5-8a00-364d657ee3ab	61958-0406	HUMAN PRESCRIPTION DRUG	Viread		TENOFOVIR DISOPROXIL FUMARATE	TABLET, COATED	ORAL	20120118		NDA	NDA021356	Gilead Sciences, Inc.	TENOFOVIR DISOPROXIL FUMARATE	250	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-0601_d392554c-dace-47f9-8b2f-1e2b29c98ea4	61958-0601	HUMAN PRESCRIPTION DRUG	Emtriva		EMTRICITABINE	CAPSULE	ORAL	20030702		NDA	NDA021500	Gilead Sciences, Inc.	EMTRICITABINE	200	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-0602_d392554c-dace-47f9-8b2f-1e2b29c98ea4	61958-0602	HUMAN PRESCRIPTION DRUG	Emtriva		EMTRICITABINE	SOLUTION	ORAL	20050928		NDA	NDA021896	Gilead Sciences, Inc.	EMTRICITABINE	10	mg/mL	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-0701_b1b66a9d-08cd-4bcc-8768-9691bd8689bf	61958-0701	HUMAN PRESCRIPTION DRUG	Truvada		emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20040802		NDA	NDA021752	Gilead Sciences, Inc	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-0703_b1b66a9d-08cd-4bcc-8768-9691bd8689bf	61958-0703	HUMAN PRESCRIPTION DRUG	Truvada		emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20160310		NDA	NDA021752	Gilead Sciences, Inc	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	100; 150	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-0704_b1b66a9d-08cd-4bcc-8768-9691bd8689bf	61958-0704	HUMAN PRESCRIPTION DRUG	Truvada		emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20160310		NDA	NDA021752	Gilead Sciences, Inc	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	133; 200	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-0705_b1b66a9d-08cd-4bcc-8768-9691bd8689bf	61958-0705	HUMAN PRESCRIPTION DRUG	Truvada		emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20160310		NDA	NDA021752	Gilead Sciences, Inc	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	167; 250	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-0801_b6b19f3a-0619-cb36-e053-2995a90a5254	61958-0801	HUMAN PRESCRIPTION DRUG	Letairis		AMBRISENTAN	TABLET, FILM COATED	ORAL	20070615		NDA	NDA022081	Gilead Sciences, Inc	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
61958-0802_b6b19f3a-0619-cb36-e053-2995a90a5254	61958-0802	HUMAN PRESCRIPTION DRUG	Letairis		AMBRISENTAN	TABLET, FILM COATED	ORAL	20070615		NDA	NDA022081	Gilead Sciences, Inc	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
61958-0901_e3d9f13f-c1a8-4024-b668-b1545293a6f7	61958-0901	HUMAN PRESCRIPTION DRUG	Cayston		aztreonam	KIT		20100222		NDA	NDA050814	Gilead Sciences, Inc.						N	20241231
61958-1004_3c62f26b-5dfd-40cf-bc8c-43a9124577e2	61958-1004	HUMAN PRESCRIPTION DRUG	Ranexa		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070212	20240131	NDA	NDA021526	Gilead Sciences, Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	
61958-1101_0fb2e5c4-f94a-4b12-b502-df7d58371018	61958-1101	HUMAN PRESCRIPTION DRUG	COMPLERA		emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20110810		NDA	NDA202123	Gilead Sciences, Inc.	EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE	200; 25; 300	mg/1; mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-1201_f2f65f0b-1902-4a49-bee3-f854b1863545	61958-1201	HUMAN PRESCRIPTION DRUG	Stribild		elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20120827		NDA	NDA203100	Gilead Sciences, Inc.	COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	150; 150; 200; 300	mg/1; mg/1; mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
61958-1401_4c7c1c0e-8107-4780-b8b9-cd0d443b74f6	61958-1401	HUMAN PRESCRIPTION DRUG	Tybost		COBICISTAT	TABLET, FILM COATED	ORAL	20140924		NDA	NDA203094	Gilead Sciences, Inc.	COBICISTAT	150	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
61958-1501_d0b160ff-8146-4893-86f0-1925fcd67ad9	61958-1501	HUMAN PRESCRIPTION DRUG	Sovaldi		SOFOSBUVIR	TABLET, FILM COATED	ORAL	20131206		NDA	NDA204671	Gilead Sciences, Inc.	SOFOSBUVIR	400	mg/1	Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1503_d0b160ff-8146-4893-86f0-1925fcd67ad9	61958-1503	HUMAN PRESCRIPTION DRUG	Sovaldi		SOFOSBUVIR	TABLET, FILM COATED	ORAL	20190828		NDA	NDA204671	Gilead Sciences, Inc.	SOFOSBUVIR	200	mg/1	Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1504_d0b160ff-8146-4893-86f0-1925fcd67ad9	61958-1504	HUMAN PRESCRIPTION DRUG	Sovaldi		SOFOSBUVIR	PELLET	ORAL	20190828		NDA	NDA212480	Gilead Sciences, Inc.	SOFOSBUVIR	150	mg/1	Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1505_d0b160ff-8146-4893-86f0-1925fcd67ad9	61958-1505	HUMAN PRESCRIPTION DRUG	Sovaldi		SOFOSBUVIR	PELLET	ORAL	20190828		NDA	NDA212480	Gilead Sciences, Inc.	SOFOSBUVIR	200	mg/1	Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1701_b925df27-bc19-4236-a82c-3194eb9a55f1	61958-1701	HUMAN PRESCRIPTION DRUG	Zydelig		idelalisib	TABLET, FILM COATED	ORAL	20140723		NDA	NDA205858	Gilead Sciences, Inc.	IDELALISIB	100	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
61958-1702_b925df27-bc19-4236-a82c-3194eb9a55f1	61958-1702	HUMAN PRESCRIPTION DRUG	Zydelig		idelalisib	TABLET, FILM COATED	ORAL	20140723		NDA	NDA205858	Gilead Sciences, Inc.	IDELALISIB	150	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
61958-1801_6122d2f4-19e4-4aae-89ce-bef7bfc5cb3e	61958-1801	HUMAN PRESCRIPTION DRUG	Harvoni		LEDIPASVIR and SOFOSBUVIR	TABLET, FILM COATED	ORAL	20141010		NDA	NDA205834	Gilead Sciences, Inc	LEDIPASVIR; SOFOSBUVIR	90; 400	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Nucleoside Analog [EXT], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1803_6122d2f4-19e4-4aae-89ce-bef7bfc5cb3e	61958-1803	HUMAN PRESCRIPTION DRUG	Harvoni		ledipasvir and sofosbuvir	TABLET, FILM COATED	ORAL	20190828		NDA	NDA205834	Gilead Sciences, Inc	LEDIPASVIR; SOFOSBUVIR	45; 200	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Nucleoside Analog [EXT], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1804_6122d2f4-19e4-4aae-89ce-bef7bfc5cb3e	61958-1804	HUMAN PRESCRIPTION DRUG	Harvoni		ledipasvir and sofosbuvir	PELLET	ORAL	20190828		NDA	NDA212477	Gilead Sciences, Inc	LEDIPASVIR; SOFOSBUVIR	45; 200	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Nucleoside Analog [EXT], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1805_6122d2f4-19e4-4aae-89ce-bef7bfc5cb3e	61958-1805	HUMAN PRESCRIPTION DRUG	Harvoni		ledipasvir and sofosbuvir	PELLET	ORAL	20190828		NDA	NDA212477	Gilead Sciences, Inc	LEDIPASVIR; SOFOSBUVIR	33.75; 150	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Nucleoside Analog [EXT], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-1901_a7b28a9f-4395-4552-8ba6-4ba9eb30809c	61958-1901	HUMAN PRESCRIPTION DRUG	Genvoya		elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide	TABLET	ORAL	20151105		NDA	NDA207561	Gilead Sciences, Inc.	COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	150; 150; 200; 10	mg/1; mg/1; mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
61958-2002_571559a0-e4c8-450f-9d29-0a1943330c6e	61958-2002	HUMAN PRESCRIPTION DRUG	DESCOVY		emtricitabine and tenofovir alafenamide	TABLET	ORAL	20160404		NDA	NDA208215	Gilead Sciences, Inc.	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	200; 25	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-2005_571559a0-e4c8-450f-9d29-0a1943330c6e	61958-2005	HUMAN PRESCRIPTION DRUG	DESCOVY		emtricitabine and tenofovir alafenamide	TABLET	ORAL	20220107		NDA	NDA208215	Gilead Sciences, Inc.	EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	120; 15	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-2101_2178fe00-9d08-4b76-bb2e-b4d8cbf33c43	61958-2101	HUMAN PRESCRIPTION DRUG	ODEFSEY		emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide	TABLET	ORAL	20160301		NDA	NDA208351	Gilead Sciences, Inc.	EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE	200; 25; 25	mg/1; mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-2201_40f3a9f4-caa0-4d29-8080-1815053c6553	61958-2201	HUMAN PRESCRIPTION DRUG	Epclusa		Velpatasvir and Sofosbuvir	TABLET, FILM COATED	ORAL	20160628		NDA	NDA208341	Gilead Sciences, Inc.	SOFOSBUVIR; VELPATASVIR	400; 100	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-2203_40f3a9f4-caa0-4d29-8080-1815053c6553	61958-2203	HUMAN PRESCRIPTION DRUG	Epclusa		Velpatasvir and Sofosbuvir	TABLET, FILM COATED	ORAL	20200319		NDA	NDA208341	Gilead Sciences, Inc.	SOFOSBUVIR; VELPATASVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-2204_40f3a9f4-caa0-4d29-8080-1815053c6553	61958-2204	HUMAN PRESCRIPTION DRUG	Epclusa		Velpatasvir and Sofosbuvir	PELLET	ORAL	20210610		NDA	NDA214187	Gilead Sciences, Inc.	SOFOSBUVIR; VELPATASVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-2205_40f3a9f4-caa0-4d29-8080-1815053c6553	61958-2205	HUMAN PRESCRIPTION DRUG	Epclusa		Velpatasvir and Sofosbuvir	PELLET	ORAL	20210610		NDA	NDA214187	Gilead Sciences, Inc.	SOFOSBUVIR; VELPATASVIR	150; 37.5	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-2301_2601d778-99cc-4b50-9c39-a5c0559cfc03	61958-2301	HUMAN PRESCRIPTION DRUG	VEMLIDY		tenofovir alafenamide	TABLET	ORAL	20161110		NDA	NDA208464	Gilead Sciences, Inc.	TENOFOVIR ALAFENAMIDE FUMARATE	25	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
61958-2401_e2a26547-0e73-442c-9a9b-b8e0ef1ab298	61958-2401	HUMAN PRESCRIPTION DRUG	Vosevi		SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR	TABLET, FILM COATED	ORAL	20170718		NDA	NDA209195	Gilead Sciences, Inc.	SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR	400; 100; 100	mg/1; mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Nucleoside Analog [EXT], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
61958-2501_12754803-c0a0-4971-8c17-8348aab6a417	61958-2501	HUMAN PRESCRIPTION DRUG	Biktarvy		bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20180207		NDA	NDA210251	Gilead Sciences, Inc.	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	50; 200; 25	mg/1; mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-2505_12754803-c0a0-4971-8c17-8348aab6a417	61958-2505	HUMAN PRESCRIPTION DRUG	Biktarvy		bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate	TABLET	ORAL	20211007		NDA	NDA210251	Gilead Sciences, Inc.	BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE	30; 120; 15	mg/1; mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
61958-2901_719b5296-b090-4720-98ce-00cee723fd91	61958-2901	HUMAN PRESCRIPTION DRUG	Veklury		remdesivir	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201101		NDA	NDA214787	Gilead Sciences, Inc.	REMDESIVIR	100	mg/1	SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]		N	20241231
61958-2902_719b5296-b090-4720-98ce-00cee723fd91	61958-2902	HUMAN PRESCRIPTION DRUG	Veklury		remdesivir	INJECTION	INTRAVENOUS	20220325		NDA	NDA214787	Gilead Sciences, Inc.	REMDESIVIR	5	mg/mL	SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]		N	20241231
61958-3001_bd4fa706-84af-4011-a69d-663fc0a3bf6b	61958-3001	HUMAN PRESCRIPTION DRUG	Sunlenca		LENACAPAVIR SODIUM	TABLET, FILM COATED	ORAL	20221222		NDA	NDA215974	Gilead Sciences	LENACAPAVIR SODIUM	300	mg/1			N	20241231
61958-3002_bd4fa706-84af-4011-a69d-663fc0a3bf6b	61958-3002	HUMAN PRESCRIPTION DRUG	Sunlenca		LENACAPAVIR SODIUM	KIT		20221222		NDA	NDA215973	Gilead Sciences						N	20241231
61959-001_eedfe43b-1019-19a0-e053-2995a90a7696	61959-001	HUMAN PRESCRIPTION DRUG	LIDODERM		Lidocaine Patch 5%	PATCH	TOPICAL	20230301		NDA	NDA020612	TPU Pharma, Inc.	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
61971-115_69d5e1fe-d9e9-4afa-bd62-8df032a34d32	61971-115	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20060606		ANDA	ANDA076817	Vista Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61971-120_69d5e1fe-d9e9-4afa-bd62-8df032a34d32	61971-120	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20060822		ANDA	ANDA076817	Vista Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
61990-0110_39b81cf4-5e27-4fa9-862f-1036db4d7568	61990-0110	HUMAN PRESCRIPTION DRUG	PIPERACILLIN AND TAZOBACTAM		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801	20240331	ANDA	ANDA207847	Apollo Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	
61990-0120_39b81cf4-5e27-4fa9-862f-1036db4d7568	61990-0120	HUMAN PRESCRIPTION DRUG	PIPERACILLIN AND TAZOBACTAM		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801	20240331	ANDA	ANDA207847	Apollo Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	
61990-0130_39b81cf4-5e27-4fa9-862f-1036db4d7568	61990-0130	HUMAN PRESCRIPTION DRUG	PIPERACILLIN AND TAZOBACTAM		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801	20240331	ANDA	ANDA207847	Apollo Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	
61990-0140_cba60311-1737-4dfb-8743-6bf7afe71e92	61990-0140	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801	20240331	ANDA	ANDA207848	Apollo Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	12; 1.5	g/60mL; g/60mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	
61990-0150_cba60311-1737-4dfb-8743-6bf7afe71e92	61990-0150	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801	20240331	ANDA	ANDA207848	Apollo Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	
61990-0211_a777109c-5929-4b97-9535-c9457fc9d797	61990-0211	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Apollo Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
61990-0212_a777109c-5929-4b97-9535-c9457fc9d797	61990-0212	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Apollo Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
61990-0213_a777109c-5929-4b97-9535-c9457fc9d797	61990-0213	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Apollo Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
61990-0411_a600354b-ceeb-4b6d-b2eb-597e6e31396b	61990-0411	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20200414	20240331	ANDA	ANDA212046	Apollo Pharmaceuticals Inc.	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	
61990-0611_91881d51-b73e-4bbe-9cf5-9b5f213e7db9	61990-0611	HUMAN PRESCRIPTION DRUG	tranexamic acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20190930	20240331	ANDA	ANDA212676	Apollo Pharmaceuticals Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	
61995-0022_0c542f25-fd0f-e6f1-e063-6394a90a5056	61995-0022	HUMAN OTC DRUG	J0832212 Jason Kids Sunscreen SPF45		Homosalate, Octyl Salicylate, Octocrylene, Avobenzone	LOTION	TOPICAL	20171207		OTC MONOGRAPH DRUG	M020	The Hain Celestial Group, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
61995-0029_0cf8cb8c-91b9-36c8-e063-6294a90a0e82	61995-0029	HUMAN OTC DRUG	Jason Dandruff Relief Treatment 2 in 1		Zinc Pyrithione	SHAMPOO	TOPICAL	20120419		OTC MONOGRAPH DRUG	M032	The Hain Celestial Group, Inc	PYRITHIONE ZINC	1	g/100g			N	20241231
61995-0030_0cf8e1ea-f8c6-5bb4-e063-6394a90ab70d	61995-0030	HUMAN OTC DRUG	J1003005 Jason Dandruff Relief		Sulfur, Salicylic Acid	SHAMPOO	TOPICAL	20171127		OTC MONOGRAPH DRUG	M032	The Hain Celestial Group, Inc.	SALICYLIC ACID; SULFUR	2.2; 2.4	g/100g; g/100g			N	20241231
61995-0371_0cf89b78-dce8-3c15-e063-6394a90a6114	61995-0371	HUMAN OTC DRUG	Very Emollient Body Daily Shade SPF15		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190701		OTC MONOGRAPH DRUG	M020	The Hain Celestial Group	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 7.5; 5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
61995-0387_0a490a7c-2d64-e6f8-e063-6394a90a7990	61995-0387	HUMAN OTC DRUG	Alba Botanica Kids SPF 50 Tropical Fruit		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Hain Celestial Group, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 14.7; 4.9; 7.6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61995-0388_0a48fc52-3c68-fd5b-e063-6394a90a3aef	61995-0388	HUMAN OTC DRUG	Alba Botanica Sport SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Hain Celestial Group, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 14.7; 4.9; 7.6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61995-0389_0a48d14a-1d82-f2ca-e063-6394a90ac98e	61995-0389	HUMAN OTC DRUG	Alba Botanica Hawaiian SPF 50 Coconut		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Hain Celestial Group, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 14.7; 4.9; 7.6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61995-0600_fd27ac30-a2c6-8f94-e053-6394a90a3954	61995-0600	HUMAN OTC DRUG	Jason Powersmile Fluoride Peppermint Anticavity		Sodium Fluoride	GEL	ORAL	20210201		OTC MONOGRAPH FINAL	part355	The Hain Celestial Group, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
61995-0601_fd653157-fcef-9d7c-e053-6394a90a9d49	61995-0601	HUMAN OTC DRUG	Jason Sea Fresh Anticavity Spearmint		Sodium Fluoride	GEL	ORAL	20210201		OTC MONOGRAPH FINAL	part355	The Hain Celestial Group, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
61995-0603_fd67bf60-7e0c-6e0c-e053-6294a90a82ce	61995-0603	HUMAN OTC DRUG	Jason Healthy Mouth Fluoride Cinnamon Anticavity		Sodium Fluoride	GEL	ORAL	20210201		OTC MONOGRAPH FINAL	part355	The Hain Celestial Group, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
61995-1606_0cf8d47a-612d-564e-e063-6394a90a60ff	61995-1606	HUMAN OTC DRUG	Avalon Organics Antidandruff		Salicylic Acid	SHAMPOO	TOPICAL	20160728		OTC MONOGRAPH DRUG	M016	The Hain Celestial Group, Inc.	SALICYLIC ACID	2	g/414g			N	20241231
61995-1607_0cf8e1ea-f869-5bb4-e063-6394a90ab70d	61995-1607	HUMAN OTC DRUG	Avalon Organics Antidandruff Conditioner		Salicylic Acid	RINSE	TOPICAL	20160824		OTC MONOGRAPH DRUG	M016	The Hain Celestial Group, Inc.	SALICYLIC ACID	2	g/397g			N	20241231
61995-2027_f54529d2-50c7-d68e-e053-2a95a90a78f1	61995-2027	HUMAN OTC DRUG	Hawaiian SPF 15 Aloe Sunscreen		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20190819		OTC MONOGRAPH FINAL	part352	The Hain Celestial Group, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
61995-2028_f543f176-3dd5-6fa0-e053-2995a90adaa3	61995-2028	HUMAN OTC DRUG	Hawaiian SPF 30 Aloe Sunscreen		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20190819		OTC MONOGRAPH FINAL	part352	The Hain Celestial Group, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
61995-2029_f5436909-7219-3921-e053-2a95a90ac699	61995-2029	HUMAN OTC DRUG	Alba Botanica SPF 50 Sunscreen		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20190819		OTC MONOGRAPH FINAL	part352	The Hain Celestial Group, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
61995-2033_0cf9320b-27a1-70cd-e063-6394a90afa36	61995-2033	HUMAN OTC DRUG	Alba Botanica Sheer Mineral SPF30		Zinc Oxide	LOTION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	The Hain Celestial Group, Inc.	ZINC OXIDE	24.1	g/100g			N	20241231
61995-2035_0cf9d0c6-b694-ab7b-e063-6394a90acc44	61995-2035	HUMAN OTC DRUG	Alba Botanica Sheer Mineral SPF50		Zinc Oxide	LOTION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	The Hain Celestial Group, Inc.	ZINC OXIDE	24.1	g/100g			N	20241231
61995-2060_0cf8c1ee-3390-42f9-e063-6394a90aa733	61995-2060	HUMAN OTC DRUG	AL0076001 Alba Botanica Acnedote Deep Pore Wash		Salicylic Acid	LOTION	TOPICAL	20171129		OTC MONOGRAPH DRUG	M006	The Hain Celestial Group, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
61995-2062_bfc790c0-64ff-4ccd-e053-2995a90a2ecc	61995-2062	HUMAN OTC DRUG	Alba Botanica Acnedote Oil Control		Salicylic Acid	LOTION	TOPICAL	20150806		OTC MONOGRAPH FINAL	part333D	The Hain Celestial Group, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
61995-2072_bfc8ea6a-7663-31cc-e053-2a95a90a97a9	61995-2072	HUMAN OTC DRUG	Alba Botanica VE Daily Shade SPF15 Body		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20170411		OTC MONOGRAPH NOT FINAL	part352	The Hain Celestial Group, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 7.5; 5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
61995-2384_ba9fa82f-d6df-782c-e053-2995a90a7317	61995-2384	HUMAN OTC DRUG	AL0038400 Alba Botanica Fast Fix Sun SPF30		Octocrylene, Octyl Salicylate, Zinc Oxide	STICK	TOPICAL	20171226		OTC MONOGRAPH NOT FINAL	part352	The Hain Celestial Group, Inc.	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	5; 10; 20	g/100g; g/100g; g/100g			N	20241231
61995-2404_ba9fa82f-d6de-782c-e053-2995a90a7317	61995-2404	HUMAN OTC DRUG	AL0040400 Alba VE Mineral Sunscreen SPF35		Zinc Oxide, Titanium Dioxide	SPRAY	TOPICAL	20160113		OTC MONOGRAPH NOT FINAL	part352	The Hain Celestial Group, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	6.8; 6.4	g/100g; g/100g			N	20241231
61995-2436_bfc790c0-64fb-4ccd-e053-2995a90a2ecc	61995-2436	HUMAN OTC DRUG	AL0043600 Alba Botanica VE Herbal Healing Body		Colloidal Oatmeal	LOTION	TOPICAL	20170912		OTC MONOGRAPH FINAL	part347	The Hain Celestial Group, Inc.	OATMEAL	.4	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
61995-2439_ec0cb2ed-c09b-b37f-e053-2a95a90a64e2	61995-2439	HUMAN OTC DRUG	J1002902 Jason Dandruff Relief 2in1 Treatment		Pyrithione Zinc	SHAMPOO	TOPICAL	20190626		OTC MONOGRAPH FINAL	part358H	The Hain Celestial Group Inc	PYRITHIONE ZINC	1.1	g/100g			N	20241231
61995-2753_0c56ebcf-9044-9e11-e063-6394a90ae325	61995-2753	HUMAN OTC DRUG	Alba Natural Acnedote Astringent		Salicylic Acid	LOTION	TOPICAL	20100121		OTC MONOGRAPH DRUG	M032	The Hain Celestial Group, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
61995-2764_eed146aa-98f7-51b8-e053-2a95a90aa023	61995-2764	HUMAN OTC DRUG	Alba Acnedote Invisible Treatment		Salicylic Acid	LOTION	TOPICAL	20131001		OTC MONOGRAPH FINAL	part333D	The Hain Celestial Group, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
61995-3012_0c586668-8d25-4660-e063-6394a90a0b1d	61995-3012	HUMAN OTC DRUG	Alba Botanica Even Advanced Moisturizer SPF15		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20160817		OTC MONOGRAPH DRUG	M020	The Hain Celestial Group, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100g; g/100g; g/100g			N	20241231
61995-3030_0cf855d4-4537-8f90-e063-6294a90ae0bc	61995-3030	HUMAN OTC DRUG	Alba Botanica Sheer Mineral SPF50		Zinc Oxide	LOTION	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	The Hain Celestial Group, Inc.	ZINC OXIDE	25	g/100g			N	20241231
61995-3031_f5422a20-7a62-8013-e053-2995a90af7a6	61995-3031	HUMAN OTC DRUG	Alba Botanica Sheer Mineral SPF30		Zinc Oxide	LOTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	The Hain Celestial Group, Inc.	ZINC OXIDE	25	g/100g			N	20241231
61995-3032_fe07d8ed-f65c-237f-e053-6294a90a637b	61995-3032	HUMAN OTC DRUG	Alba Botanica Sheer Mineral SPF 50		Zinc Oxide, Titanium Dioxide	AEROSOL	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	The Hain Celestial Group, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	4.3; 14.7	g/100g; g/100g			N	20241231
61995-3033_02ab7678-91a3-e3fb-e063-6294a90a75b9	61995-3033	HUMAN OTC DRUG	Alba Botanica Sensitive Mineral Sunscreen SPF 33		Zinc Oxide	AEROSOL	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	The Hain Celestial Group, Inc.	ZINC OXIDE	18.3	g/100g			N	20241231
61995-3035_0a48cbbe-eda8-ba34-e063-6394a90aec3f	61995-3035	HUMAN OTC DRUG	Alba Botanica Maximum Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Hain Celestial Group, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 14.7; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
61995-3036_0bcc1d51-0595-8a43-e063-6294a90a457f	61995-3036	HUMAN OTC DRUG	Alba Hemp SPF15		Avobenzone 3%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20190805		OTC MONOGRAPH DRUG	M020	The Hain Celestial Group	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100g; g/100g; g/100g			N	20241231
61995-3037_0bde7fd6-c1c6-eae8-e063-6294a90a9d0f	61995-3037	HUMAN OTC DRUG	Alba Sunscreen Lip Balm SPF 25		Zinc Oxide, Octocrylene, Octisalate	STICK	TOPICAL	20091027		OTC MONOGRAPH DRUG	M021	The Hain Celestial Group, Inc.	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	5; 10; 10	g/100g; g/100g; g/100g			N	20241231
61995-3761_0cf8b6ec-e81f-2ea2-e063-6294a90a7461	61995-3761	HUMAN OTC DRUG	AL00761 Alba Botanica Acnedote Face and Body Scrub		Salicylic Acid	CREAM	TOPICAL	20170606		OTC MONOGRAPH DRUG	M006	The Hain Celestial Group, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
62001-0330_27fd2e6c-3706-4a1b-9000-52be64c00199	62001-0330	HUMAN OTC DRUG	The Original Mane n Tail Daily Control 2 in 1 Anti Dandruff		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20090320		OTC MONOGRAPH FINAL	part358H	Straight Arrow Products Inc	PYRITHIONE ZINC	.01	g/.01g			N	20241231
62003-422_77ac33c1-43b6-4cd7-8fe5-4ae0e6eb9a43	62003-422	HUMAN OTC DRUG	Tiger Balm	Arthritis Rub	Camphor (Synthetic) and Menthol	CREAM	TOPICAL	20020610	20260228	OTC MONOGRAPH NOT FINAL	part348	Prince of Peace Enterprises, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 110	mg/mL; mg/mL			N	
62007-008_f3858857-8877-53b1-e053-2995a90abe2a	62007-008	HUMAN PRESCRIPTION DRUG	PCXX PINA COLADA APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-051_f385819b-741c-4643-e053-2995a90a51f0	62007-051	HUMAN PRESCRIPTION DRUG	PCXX VANILLA ORANGE ONE MINUTE FM		Sodium Fluoride	AEROSOL, FOAM	TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-052_f3856094-a559-6982-e053-2a95a90accb2	62007-052	HUMAN PRESCRIPTION DRUG	PCXX BUBBLEGUM APF F		Sodium Fluoride	AEROSOL, FOAM	TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-053_f38561ca-6f46-7a36-e053-2a95a90a38f6	62007-053	HUMAN PRESCRIPTION DRUG	PCXX GRAPE APF F		Sodium Fluoride	AEROSOL, FOAM	TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-055_f3856094-a55f-6982-e053-2a95a90accb2	62007-055	HUMAN PRESCRIPTION DRUG	PCXX STRAWBERRY APF F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-056_f385819b-741d-4643-e053-2995a90a51f0	62007-056	HUMAN PRESCRIPTION DRUG	PCXX CAPPUCCINO APF F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-057_f3857e8f-73b1-05db-e053-2a95a90a4fcc	62007-057	HUMAN PRESCRIPTION DRUG	PCXX RASPBERRY APF F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-059_f3857674-a85e-c83f-e053-2a95a90a66fa	62007-059	HUMAN PRESCRIPTION DRUG	PCXX PEPPERMINT APF F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-100_f3856094-a55b-6982-e053-2a95a90accb2	62007-100	HUMAN PRESCRIPTION DRUG	PCXX NO FLAVOR NEUTRAL F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20190224		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.02	g/g			N	20241231
62007-101_f38570f8-9d70-a899-e053-2995a90ad93c	62007-101	HUMAN PRESCRIPTION DRUG	PCXX VANILLA ORANGE NEUTRAL F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.02	g/g			N	20241231
62007-102_f385819b-741b-4643-e053-2995a90a51f0	62007-102	HUMAN PRESCRIPTION DRUG	PCXX PEPPERMINT NEUTRAL F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.02	g/g			N	20241231
62007-103_f3856094-a55d-6982-e053-2a95a90accb2	62007-103	HUMAN PRESCRIPTION DRUG	PCXX STRAWBERRY NEUTRAL F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20171121		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.02	g/g			N	20241231
62007-126_f38561ca-6f47-7a36-e053-2a95a90a38f6	62007-126	HUMAN PRESCRIPTION DRUG	PCXX BUGGLEGUM NEUTRAL GL		Sodium Fluoride	GEL	TOPICAL	20171117		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/g			N	20241231
62007-212_f3857377-fe84-df5c-e053-2995a90a2b68	62007-212	HUMAN PRESCRIPTION DRUG	PCXX NEUTRAL RNS GRAPE		FLUORIDE TREATMENT	RINSE	TOPICAL	20150417		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	2	mg/mL			N	20241231
62007-213_f3857377-fe82-df5c-e053-2995a90a2b68	62007-213	HUMAN PRESCRIPTION DRUG	PCXX NEUTRAL RMS BUBBLEGUM		FLUORIDE TREATMENT	RINSE	TOPICAL	20150420		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/mL			N	20241231
62007-214_f3856af7-bf47-9052-e053-2a95a90a28e5	62007-214	HUMAN PRESCRIPTION DRUG	PCXX NEUTRAL RNS WATERMELON		FLUORIDE TREATMENT	RINSE	TOPICAL	20150417		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	2	mg/g			N	20241231
62007-215_f3858fd1-5643-3b05-e053-2a95a90a58b9	62007-215	HUMAN PRESCRIPTION DRUG	PCXX NEUTRAL RNS PEPPERMINT		FLUORIDE TREATMENT	RINSE	DENTAL; TOPICAL	20190328		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	2	mg/mL			N	20241231
62007-303_f38570f8-9d6f-a899-e053-2995a90ad93c	62007-303	HUMAN PRESCRIPTION DRUG	PCXX SNF RNS GRAPE		Sodium Fluoride	RINSE	DENTAL; TOPICAL	20171124		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	STANNOUS FLUORIDE	16.4	mg/mL			N	20241231
62007-307_f38570f8-9d6e-a899-e053-2995a90ad93c	62007-307	HUMAN PRESCRIPTION DRUG	PCXX SNF RNS MINT		Sodium Fluoride	RINSE	DENTAL; TOPICAL	20190611		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	STANNOUS FLUORIDE	16.4	mg/mL			N	20241231
62007-308_f38561ca-6f4b-7a36-e053-2a95a90a38f6	62007-308	HUMAN PRESCRIPTION DRUG	PCXX SNF RNS STRAWBERRY		Sodium Fluoride	RINSE	DENTAL; TOPICAL	20190611		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	STANNOUS FLUORIDE	16.4	mg/mL			N	20241231
62007-316_f385819b-741e-4643-e053-2995a90a51f0	62007-316	HUMAN PRESCRIPTION DRUG	PCXX APF RNS GRAPE		Sodium Fluoride	RINSE	DENTAL; TOPICAL	20171124		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-317_f3856af7-bf45-9052-e053-2a95a90a28e5	62007-317	HUMAN PRESCRIPTION DRUG	PCXX APF RNS MINT		Sodium Fluoride	RINSE	DENTAL; TOPICAL	20190611		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-318_f38561ca-6f49-7a36-e053-2a95a90a38f6	62007-318	HUMAN PRESCRIPTION DRUG	PCXX APF RNS STRAWBERRY		Sodium Fluoride	RINSE	DENTAL; TOPICAL	20190611		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-801_f3857674-a867-c83f-e053-2a95a90a66fa	62007-801	HUMAN PRESCRIPTION DRUG	PCXX BANANA BERRY APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-802_f3856094-a55e-6982-e053-2a95a90accb2	62007-802	HUMAN PRESCRIPTION DRUG	PCXX BUBBLEGUM APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-803_f3857674-a866-c83f-e053-2a95a90a66fa	62007-803	HUMAN PRESCRIPTION DRUG	PCXX CHERRY APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-804_f3857674-a865-c83f-e053-2a95a90a66fa	62007-804	HUMAN PRESCRIPTION DRUG	PCXX MOCHA CAPPUCCINO APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-805_f385819b-741a-4643-e053-2995a90a51f0	62007-805	HUMAN PRESCRIPTION DRUG	PCXX MARSHMALLOW APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-806_f385819b-7419-4643-e053-2995a90a51f0	62007-806	HUMAN PRESCRIPTION DRUG	PCXX CREME DE MENTHE APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-809_f3857e8f-73b0-05db-e053-2a95a90a4fcc	62007-809	HUMAN PRESCRIPTION DRUG	PCXX RASPBERRY APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-810_f38570f8-9d71-a899-e053-2995a90ad93c	62007-810	HUMAN PRESCRIPTION DRUG	PCXX STRAWBERRY APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-811_f3857674-a860-c83f-e053-2a95a90a66fa	62007-811	HUMAN PRESCRIPTION DRUG	PCXX VANILLA ORANGE APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-812_f3856094-a55c-6982-e053-2a95a90accb2	62007-812	HUMAN PRESCRIPTION DRUG	PCXX GRAPE APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-813_f3856fda-71d4-2703-e053-2995a90a17a8	62007-813	HUMAN PRESCRIPTION DRUG	PCXX WATERMELON APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-814_f3855b02-347d-2afc-e053-2a95a90a9d65	62007-814	HUMAN PRESCRIPTION DRUG	PCXX COOL PEPPERMINT APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190204		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-820_f3857377-fe87-df5c-e053-2995a90a2b68	62007-820	HUMAN PRESCRIPTION DRUG	PCXX CREME DE MENTHE NEUTRAL GL		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/mL			N	20241231
62007-823_f3857674-a861-c83f-e053-2a95a90a66fa	62007-823	HUMAN PRESCRIPTION DRUG	PCXX VANILLA ORANGE NEUTRAL GL		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/mL			N	20241231
62007-825_f3857674-a864-c83f-e053-2a95a90a66fa	62007-825	HUMAN PRESCRIPTION DRUG	PCXX PEPPERMINT NEUTRAL GL		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/mL			N	20241231
62007-826_f3857674-a862-c83f-e053-2a95a90a66fa	62007-826	HUMAN PRESCRIPTION DRUG	PCXX RASPBERRY NEUTRAL GL		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/mL			N	20241231
62007-827_f3857674-a85f-c83f-e053-2a95a90a66fa	62007-827	HUMAN PRESCRIPTION DRUG	PCXX WATERMELON NEUTRAL GL		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/mL			N	20241231
62007-828_f3857377-fe86-df5c-e053-2995a90a2b68	62007-828	HUMAN PRESCRIPTION DRUG	PCXX ROOTBEER APF G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190223		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	27.2	mg/mL			N	20241231
62007-829_f3857377-fe88-df5c-e053-2995a90a2b68	62007-829	HUMAN PRESCRIPTION DRUG	PCXX MOCHA CAPPUCCINO NEUTRAL GL		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190222		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	20	mg/mL			N	20241231
62007-835_f3857674-a863-c83f-e053-2a95a90a66fa	62007-835	HUMAN PRESCRIPTION DRUG	PCXX ANTICARIES NO FLAVOR NE G		Sodium Fluoride	GEL	DENTAL; TOPICAL	20190223		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	11.1	mg/mL			N	20241231
62007-901_f3857377-fe83-df5c-e053-2995a90a2b68	62007-901	HUMAN PRESCRIPTION DRUG	PCXX VANILLA ORANGE NEUTRAL F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20190328		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.02	g/g			N	20241231
62007-902_f3857377-fe81-df5c-e053-2995a90a2b68	62007-902	HUMAN PRESCRIPTION DRUG	PCXX PEPPERMINT NEUTRAL F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20190328		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.02	g/g			N	20241231
62007-904_f3857377-fe85-df5c-e053-2995a90a2b68	62007-904	HUMAN PRESCRIPTION DRUG	PCXX BUBBLEGUM NEUTRAL F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20190224		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.02	g/g			N	20241231
62007-959_f3857e8f-73b3-05db-e053-2a95a90a4fcc	62007-959	HUMAN PRESCRIPTION DRUG	PCXX CHERRY APF F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20180224		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62007-970_f3857e8f-73b2-05db-e053-2a95a90a4fcc	62007-970	HUMAN PRESCRIPTION DRUG	PCXX LIME APF F		Sodium Fluoride	AEROSOL, FOAM	DENTAL; TOPICAL	20180224		UNAPPROVED DRUG OTHER		Ross Healthcare Inc.	SODIUM FLUORIDE	.0272	g/g			N	20241231
62011-0001_7e5e66a1-04d1-4452-91fe-e00ad2524421	62011-0001	HUMAN OTC DRUG	Health Mart infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20111213		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
62011-0004_6e54c776-81c5-45a3-8689-7c64d94197de	62011-0004	HUMAN OTC DRUG	health mart ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20111121		ANDA	ANDA075217	Strategic Sourcing Services LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0010_92e6cfea-37f4-4adc-844f-d10035e4aef6	62011-0010	HUMAN OTC DRUG	health mart childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20111129		ANDA	ANDA074937	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0011_97da0bbe-5363-41ca-92ec-dc96197dc5e7	62011-0011	HUMAN OTC DRUG	health mart ibuprofen		Ibuprofen	SUSPENSION	ORAL	20111121		ANDA	ANDA074937	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0012_fa0349b6-5c4c-484e-b68d-3920e6e048e3	62011-0012	HUMAN OTC DRUG	health mart ibuprofen		ibuprofen	SUSPENSION	ORAL	20111121		ANDA	ANDA075217	Strategic Sourcing Services LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0014_2937c42d-bcee-4f5c-9e5b-5d2415d7c64f	62011-0014	HUMAN OTC DRUG	health mart ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20111121		ANDA	ANDA072096	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0015_214d35f2-99d2-444c-8be1-dd4d3e4881f6	62011-0015	HUMAN OTC DRUG	Health Mart Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20111121		ANDA	ANDA072096	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0016_8dbaf09d-4bde-41f1-bce9-d7f8c01b132a	62011-0016	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20120409	20240426	ANDA	ANDA078682	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
62011-0017_deaa68c8-a4af-441d-aa6f-736633fea221	62011-0017	HUMAN OTC DRUG	Health Mart Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20111121		ANDA	ANDA074661	Strategic Sourcing Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0019_08f11cd9-4b3c-9104-e063-6394a90a4994	62011-0019	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20111101	20251231	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
62011-0023_42fbafce-03e3-4a8c-8442-78ac19edf138	62011-0023	HUMAN OTC DRUG	Health Mart Pain Relief		Acetaminophen	TABLET	ORAL	20111121		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
62011-0028_3cab6507-0ab2-49db-994f-4e4c89fc79b6	62011-0028	HUMAN OTC DRUG	health mart aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20111121		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
62011-0030_8c9e16df-1eed-402d-bb47-240810785f15	62011-0030	HUMAN OTC DRUG	health mart ibuprofen		Ibuprofen	SUSPENSION	ORAL	20111121		ANDA	ANDA074937	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0032_08f11cd9-4b39-9104-e063-6394a90a4994	62011-0032	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20111101	20251031	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	325	mg/1			N	
62011-0040_ed4b925f-838d-4260-b061-90b87e41aba4	62011-0040	HUMAN OTC DRUG	Health Mart Regular Strength Enteric Coated Aspirin		ASPIRIN	TABLET, COATED	ORAL	20120605	20240223	OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
62011-0047_da936c95-321d-4b04-978a-76229a8dadfa	62011-0047	HUMAN OTC DRUG	health mart nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20111121		ANDA	ANDA078325	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0048_6c577114-414e-4c39-a7b0-203a8b7fbb8a	62011-0048	HUMAN OTC DRUG	health mart nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20111121		ANDA	ANDA077007	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0049_ee9cdd92-36ab-5557-e053-2995a90a03c0	62011-0049	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20121213	20240630	OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	
62011-0060_8c736456-e6f6-472e-8903-4ff889294485	62011-0060	HUMAN OTC DRUG	HealthMart Chest Congestion Relief		Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62011-0061_8493d73c-bb8b-405a-ab21-9b2b16bf8ae6	62011-0061	HUMAN OTC DRUG	HealthMart Chest Congestion Relief DMDM	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0063_1d1a0673-4bd4-4b13-916b-c5948c3bb2f1	62011-0063	HUMAN OTC DRUG	Health Mart Cold and Cough	childrens	Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20120112		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0065_2b2888ba-07e1-4e80-ae5c-e00630624c55	62011-0065	HUMAN OTC DRUG	health mart daytime		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20120111		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0070_274a9206-33cf-4ae0-ad98-0df6981aa505	62011-0070	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine Hydrochloride		Ibuprofen and Pseudoephedrine Hydrochloride	TABLET, SUGAR COATED	ORAL	20011013		ANDA	ANDA074567	Strategic Sourcing Services LLC	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0071_b564f03b-b9de-41ae-9cd2-67cd193bc937	62011-0071	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Strategic Sourcing Services LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0071_e8ed87b4-21e4-44b4-9d7d-ef86b74e9a30	62011-0071	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170606		ANDA	ANDA076557	Strategic Sourcing Services LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0075_1f253f7d-4aae-40a2-982e-dfc92d49f18a	62011-0075	HUMAN OTC DRUG	Medicated Chest		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20120202	20250930	OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	
62011-0077_ceebf78a-8761-4be8-8ea7-7a4a20f5a971	62011-0077	HUMAN OTC DRUG	health mart nasal decongestant pe		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20111223		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0079_f997302a-5fdb-4bd1-b41c-7f289b6b202b	62011-0079	HUMAN OTC DRUG	health mart nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20120111		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
62011-0080_e3b76804-588c-4d00-8e51-5e0a62c065c0	62011-0080	HUMAN OTC DRUG	health mart nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20120112		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
62011-0085_072375a5-4803-47a9-85ae-afcd9a179690	62011-0085	HUMAN OTC DRUG	health mart nose		Phenylephrine hydrochloride	SOLUTION/ DROPS	NASAL	20120111		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0089_5d9d154b-8de6-4a99-95ab-54347972afc1	62011-0089	HUMAN OTC DRUG	health mart adult tussin		Guaifenesin	SOLUTION	ORAL	20120111		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	GUAIFENESIN	200	mg/10mL			N	20241231
62011-0090_597667c6-e1aa-46cf-b9e7-3939bb829669	62011-0090	HUMAN OTC DRUG	health mart adult tussin		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20120124		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0091_6874f2a6-fc9d-423d-b823-8a11f9a6effd	62011-0091	HUMAN OTC DRUG	health mart adult tussin		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20120111		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0092_680d0db2-ed1b-453b-bedb-bc12ba84f890	62011-0092	HUMAN OTC DRUG	health mart adult tussin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20120111		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0094_37c95664-ab9c-4292-999c-f0816f6830ab	62011-0094	HUMAN OTC DRUG	Health Mart Pharmacy Bacitracin Zinc	First Aid Antibiotic	bacitracin zinc	OINTMENT	TOPICAL	19901205		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
62011-0095_30c9b243-89be-4b28-b8f5-fdd59ad82d27	62011-0095	HUMAN OTC DRUG	Health Mart Pharmacy Hydrocortisone	Maximum Strength with Aloe	hydrocortisone	CREAM	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62011-0096_32b23237-eac9-4bbb-9996-73bbee407525	62011-0096	HUMAN OTC DRUG	Health Mart Pharmacy Hydrocortisone	Maximum Strength Plus 12 Moisturizers	hydrocortisone	CREAM	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62011-0097_8a6ffb07-b436-4620-ab68-edb82bbd01c0	62011-0097	HUMAN OTC DRUG	Double Antibiotic		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	TOPICAL	20120321		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
62011-0099_4750a2f4-db4b-4980-ab5e-e29c64902510	62011-0099	HUMAN OTC DRUG	Triple Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20120312		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
62011-0102_0d2a5fd3-778e-9bf1-e063-6294a90a4adb	62011-0102	HUMAN OTC DRUG	Health Mart Eye Drops Original Formula		tetrahydrozoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20120301		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
62011-0114_0cf3bc57-59ae-909e-e063-6394a90a3b52	62011-0114	HUMAN OTC DRUG	Health Mart Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Strategic Sourcing Services LLC	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62011-0116_0cf3bc57-59b0-909e-e063-6394a90a3b52	62011-0116	HUMAN OTC DRUG	Health Mart Iodides		Alcohol	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ALCOHOL	.48	mL/mL			N	20241231
62011-0117_0cf3bc57-59b2-909e-e063-6394a90a3b52	62011-0117	HUMAN OTC DRUG	Health Mart Iodine Tincture Mild		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	20110101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
62011-0118_f497126d-4cab-5723-e053-2995a90a1554	62011-0118	HUMAN OTC DRUG	HUMCO POVIDONE IODINE		povidone iodine 10%	LIQUID	TOPICAL	20110101	20240229	OTC MONOGRAPH NOT FINAL	part333A	Strategic Sourcing Services LLC	POVIDONE-IODINE	100	mg/mL			N	
62011-0119_969fa21b-687b-4df2-b198-5e27aab92c5d	62011-0119	HUMAN OTC DRUG	health mart lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20120228		OTC MONOGRAPH FINAL	part358G	Strategic Sourcing Services LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
62011-0123_0993239b-0a08-f9ae-e063-6294a90a9c12	62011-0123	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	LIQUID	ORAL	20120401	20250401	OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
62011-0124_09936494-17f0-1338-e063-6294a90a7dee	62011-0124	HUMAN OTC DRUG	MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	LIQUID	ORAL	20120401	20250301	OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
62011-0134_1dd28e70-a5d4-4e6b-af37-9cfbd2a33f26	62011-0134	HUMAN OTC DRUG	Health Mart fiber caplets		Methylcellulose	TABLET	ORAL	20191018		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	METHYLCELLULOSE (4000 CPS)	500	mg/1			N	20241231
62011-0140_d06c11f3-cd7a-4c20-a0a8-013bef76bddf	62011-0140	HUMAN OTC DRUG	Health Mart Stomach relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20191017		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
62011-0142_8a278960-d39a-4025-a0b0-b45b30ebe03e	62011-0142	HUMAN OTC DRUG	health mart famotidine		Famotidine	TABLET, FILM COATED	ORAL	20120320		ANDA	ANDA075400	Strategic Sourcing Services LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62011-0143_2dffcaab-9e28-4d19-bde0-25b337261a58	62011-0143	HUMAN OTC DRUG	Health Mart Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20120320		ANDA	ANDA077351	Strategic Sourcing Services LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62011-0149_09931f37-eb93-fa98-e063-6294a90ab8ae	62011-0149	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20120401	20241201	OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
62011-0150_0968d5fe-42b0-48ab-bacb-98daf940eb3c	62011-0150	HUMAN OTC DRUG	health mart anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20120320		ANDA	ANDA075232	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
62011-0152_ad87d7ec-6a62-4973-a84d-4499e44fb6c3	62011-0152	HUMAN OTC DRUG	Health Mart anti nausea		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20120320		UNAPPROVED DRUG OTHER		Strategic Sourcing Services LLC	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
62011-0153_34f27d36-c1ee-4f6e-a082-1dc4c57b4b75	62011-0153	HUMAN OTC DRUG	health mart clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20120320		ANDA	ANDA090685	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62011-0157_8aad241a-6ca6-4277-a341-d427a86b7c99	62011-0157	HUMAN OTC DRUG	health mart omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20120320		NDA	NDA022032	Strategic Sourcing Services LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62011-0170_bc4e84d1-0ab2-49b5-9bec-2457544b4798	62011-0170	HUMAN OTC DRUG	health mart nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20140402		ANDA	ANDA078326	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0171_cec0399a-9b5a-4af6-8d23-ee82eff4ce65	62011-0171	HUMAN OTC DRUG	health mart nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20111121		ANDA	ANDA077007	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0176_dd0dc951-95d3-40e2-90f8-0086e3ebf1c7	62011-0176	HUMAN OTC DRUG	Health Mart Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20120828		ANDA	ANDA091135	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0183_5acc3f02-2a9d-4f47-8146-844c17afd8c9	62011-0183	HUMAN OTC DRUG	Health Mart Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20130117		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
62011-0187_f17b1bb2-3b3b-471c-9496-c4853c2b5257	62011-0187	HUMAN OTC DRUG	infants gas relief drops		simethicone	EMULSION	ORAL	20191021		OTC MONOGRAPH FINAL	part332	Strategic Sourcing Services LLC	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
62011-0189_3be5e50c-d90a-480a-bc1d-55ba74fca3da	62011-0189	HUMAN OTC DRUG	gas relief		simethicone	TABLET, CHEWABLE	ORAL	20191021		OTC MONOGRAPH FINAL	part332	Strategic Sourcing Services LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
62011-0196_9515d294-f698-d904-e053-2995a90a5cbb	62011-0196	HUMAN OTC DRUG	Dry eye relief		Glycerin, Hypromellose, Polyethylene glycol	LIQUID	OPHTHALMIC	20130501		OTC MONOGRAPH FINAL	part349	Strategic Sourcing Services LLC	GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
62011-0199_2a4b76e5-3429-4431-9541-6971a04d2279	62011-0199	HUMAN OTC DRUG	Health Mart nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20130610		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0200_cdf4cd3c-002b-42e9-b78f-367cafd46658	62011-0200	HUMAN OTC DRUG	Health Mart Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20130702		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0203_db2f0887-2d60-4b3d-b240-926042df4e36	62011-0203	HUMAN OTC DRUG	Health Mart Lubricating Plus		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20130610		OTC MONOGRAPH FINAL	part349	Strategic Sourcing Services LLC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
62011-0213_736a69be-ea77-42a3-b0db-65d9cbe70417	62011-0213	HUMAN OTC DRUG	Health Mart Ibuprofen IB		Ibuprofen	TABLET, FILM COATED	ORAL	20131026		ANDA	ANDA077349	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0222_baad5c20-63e6-4daf-b802-73746f60e0cc	62011-0222	HUMAN OTC DRUG	Health Mart Ibuprofen IB		Ibuprofen	TABLET, FILM COATED	ORAL	20111121		ANDA	ANDA077349	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0229_7358caf9-d3c4-43a5-8649-46c7728819bf	62011-0229	HUMAN OTC DRUG	Healthmart Calcium Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20191021		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62011-0233_fab79e6e-1ae0-44cc-8924-4ecc90c65bbd	62011-0233	HUMAN OTC DRUG	health mart fexofenadine hydrochloride		fexofenadine hcl	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA076447	Strategic Sourcing Services LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0237_959a7599-24f9-6f18-e053-2995a90ae70a	62011-0237	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20140220		NDA	NDA019125	Strategic Sourcing Services, LLC	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
62011-0238_08f15e71-4e82-ef02-e063-6294a90a8978	62011-0238	HUMAN OTC DRUG	Pain Reliever Rapid Release		Acetaminophen	TABLET, COATED	ORAL	20141024	20260131	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	
62011-0240_ee9d2488-c33b-40ec-e053-2a95a90ae281	62011-0240	HUMAN OTC DRUG	Severe Sinus Congestion and Pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141027	20240831	OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
62011-0243_53ab9d49-7e4b-44b2-b4b7-9aeb51d69b93	62011-0243	HUMAN OTC DRUG	health mart migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20140422		ANDA	ANDA075794	Strategic Sourcing Services LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
62011-0245_005347fa-59da-4589-84b2-07fb0ae5e397	62011-0245	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140731	20250731	OTC MONOGRAPH NOT FINAL	part356	Strategic Sourcing Services LLC	PHENOL	1.4	g/100mL			N	
62011-0246_4b52c345-6a84-417b-bba1-f502d1d43eb8	62011-0246	HUMAN OTC DRUG	health mart childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20140919		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
62011-0247_823d27cd-3b88-4456-a9db-63e514be0364	62011-0247	HUMAN OTC DRUG	health mart pain and fever	childrens	Acetaminophen	SUSPENSION	ORAL	20140904		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
62011-0248_df3bce77-ec2e-4d95-a815-513edb5966dc	62011-0248	HUMAN OTC DRUG	health mart loratadine		Loratadine	TABLET	ORAL	20141002		ANDA	ANDA076301	Strategic Sourcing Services LLC	LORATADINE	10	mg/1			N	20241231
62011-0251_27ea1f65-86ef-44ff-97f5-da3de944a151	62011-0251	HUMAN OTC DRUG	health mart cough dm		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150428		ANDA	ANDA091135	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0254_0d2a828a-146f-a981-e063-6394a90a38d5	62011-0254	HUMAN OTC DRUG	Health Mart Lubricating Tears		Polyethylene glycol 400, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20150701		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
62011-0255_c8967af3-d41c-44b6-8138-58c7c06bea60	62011-0255	HUMAN OTC DRUG	health mart lice treatment		Permethrin	LOTION	TOPICAL	20150803		ANDA	ANDA076090	Strategic Sourcing Services LLC	PERMETHRIN	1	mg/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
62011-0256_6ffbe3eb-2d17-4ed8-b247-f026f6043e2a	62011-0256	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20150731		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0257_a1c04fc7-84e4-4e78-b54c-e5a2b91b3be7	62011-0257	HUMAN OTC DRUG	health mart childrens allergy plus congestion		diphenhydramine hcl, phenylephrine hcl	SOLUTION	ORAL	20180212		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	12.5; 5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0259_22a6c2c4-b1bf-41fc-99a9-d1b51c57926f	62011-0259	HUMAN OTC DRUG	Health Mart mucus relief d		Guaifenesin, pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20151221		ANDA	ANDA091071	Strategic Sourcing Services LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0262_e965db25-d153-4218-94c6-bd8390d86635	62011-0262	HUMAN OTC DRUG	NightTime Cold and Flu	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20151231	20240223	OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
62011-0267_0cf3d441-e435-9d0e-e063-6294a90ae918	62011-0267	HUMAN OTC DRUG	Health Mart Hydrogen Peroxide 3 Percent		hydrogen peroxide	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
62011-0268_0cf3cfaa-5efb-8a2f-e063-6394a90a179a	62011-0268	HUMAN OTC DRUG	Health Mart Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M016	Strategic Sourcing Services LLC	WITCH HAZEL	855	mg/mL			N	20241231
62011-0269_966f569f-fd93-4878-b004-9e16846eb87b	62011-0269	HUMAN OTC DRUG	health mart allergy relief nasal 24 hr		Fluticasone propionate	SPRAY, METERED	NASAL	20160529		ANDA	ANDA207957	Strategic Sourcing Services LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62011-0270_dbd4757f-c955-4168-b0d7-db1c97776fbc	62011-0270	HUMAN OTC DRUG	HealthMart Mineral Oil Single	Laxative	Mineral Oil	ENEMA	RECTAL	20120510		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	MINERAL OIL	118	g/118mL			N	20241231
62011-0271_53e836e2-68ea-4502-a51e-3cb0938e2eca	62011-0271	HUMAN OTC DRUG	HealthMart Saline Single	Laxative	Sodium Phosphate, Dibasic and Sodium Phosphate, Monobasic, Unspecified Form	ENEMA	RECTAL	20120320		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
62011-0272_0cf45d39-4247-be39-e063-6394a90a782d	62011-0272	HUMAN OTC DRUG	Health Mart Isopropyl Alcohol 91 Percent		Isopropyl Alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ISOPROPYL ALCOHOL	910	mg/mL			N	20241231
62011-0273_2d885507-911d-46df-aa71-05321a7788a4	62011-0273	HUMAN OTC DRUG	Stool Softener	with laxative	docusate sodium and sennosides	TABLET	ORAL	20151231	20250627	OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
62011-0276_686faf4c-5091-4552-935a-8ddb4deac6b4	62011-0276	HUMAN OTC DRUG	health mart dual action complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20160112		ANDA	ANDA077355	Strategic Sourcing Services LLC	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62011-0277_f2f629f2-8a0b-4c36-ad92-cb0a726e97c2	62011-0277	HUMAN OTC DRUG	laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325	20250316	OTC MONOGRAPH DRUG	505G(a)(3)	Strategic Sourcing Services, LLC (Health Mart)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
62011-0284_64d1e0bc-bf66-43fe-bb00-c02f3415dac7	62011-0284	HUMAN OTC DRUG	health mart childrens allergy relief		Diphenhydramine HCl	SOLUTION	ORAL	20160315		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0285_bb27e21c-a76e-4025-ba53-1996984faf4c	62011-0285	HUMAN OTC DRUG	Health Mart childrens all day allergy		cetirizine Hydrochloride	SOLUTION	ORAL	20160226		ANDA	ANDA090254	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0287_ee3b8c27-e623-c64c-e053-2995a90a0784	62011-0287	HUMAN OTC DRUG	CLEARLAX		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20160701		ANDA	ANDA090812	STRATEGIC SOURCING SERVICES LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62011-0291_08a20c11-01e3-89a2-e063-6294a90ab908	62011-0291	HUMAN OTC DRUG	GAS RELIEF		Simethicone	TABLET, CHEWABLE	ORAL	20160401	20250430	OTC MONOGRAPH DRUG	M002	STRATEGIC SOURCING SERVICES LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	
62011-0296_c8ab7f8d-58f1-4ee2-afe9-b3718a730f2e	62011-0296	HUMAN OTC DRUG	health mart hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20160508		OTC MONOGRAPH FINAL	part346	Strategic Sourcing Services LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0297_0d2a828a-1470-a981-e063-6394a90a38d5	62011-0297	HUMAN OTC DRUG	Health Mart Redness Relief		Glycerin, Naphazoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20150701		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
62011-0305_61dc2001-8e84-4287-9b52-68ae923c4a82	62011-0305	HUMAN OTC DRUG	Childrens Loratadine		Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	Strategic Sourcing Services LLC	LORATADINE	5	mg/5mL			N	20241231
62011-0306_166eaa7e-a180-438e-88b9-6b31bc794b7b	62011-0306	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170220		ANDA	ANDA077442	STRATEGIC SOURCING SERVICES LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0307_c712ccd9-8247-ebad-d975-6ea37888596e	62011-0307	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20160930		ANDA	ANDA078343	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0309_fc77fb12-cbd8-4605-87a9-f20e34114b49	62011-0309	HUMAN OTC DRUG	allergy relief		diphenhydramine HCl	CAPSULE	ORAL	19900315	20241015	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services, LLC (Health Mart)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0310_e6adcd32-f988-4daa-bde2-dc07bdf7651e	62011-0310	HUMAN OTC DRUG	allergy relief		diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302	20240808	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services, LLC (Health Mart)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0311_b5ef8552-ddbe-4707-872f-d3632c741738	62011-0311	HUMAN OTC DRUG	allergy relief		Chlorpheniramine maleate	TABLET	ORAL	19921219	20241212	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services, LLC (Health Mart)	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0312_4117b86a-d368-4004-aa4c-7d43e125e08f	62011-0312	HUMAN OTC DRUG	nasal decongestant	non-drowsy	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825	20240812	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services, LLC (Health Mart)	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
62011-0320_a06d8f0b-95d9-4f5e-9a5e-3bf28034650d	62011-0320	HUMAN OTC DRUG	Health Mart 24 hour nasal allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20161226		ANDA	ANDA078104	Strategic Sourcing Services LLC	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62011-0321_2d97de2d-f232-48e2-9463-3a0b044b22cd	62011-0321	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
62011-0322_e02d82f8-7692-4b31-9916-59ee44b928c8	62011-0322	HUMAN OTC DRUG	Health Mart childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20161031		ANDA	ANDA204226	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0323_ddeda4a6-126d-4938-ad67-1b4bc75927f2	62011-0323	HUMAN OTC DRUG	Health Mart Childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20161024		ANDA	ANDA204226	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0325_de65b7ba-3566-4b26-9e4f-8395a4990980	62011-0325	HUMAN OTC DRUG	HealthMart Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Strategic Sourcing Services LLC	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
62011-0332_0a760670-39d8-4580-aaa7-198fd8e27d31	62011-0332	HUMAN OTC DRUG	health mart esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170924		ANDA	ANDA207193	Strategic Sourcing Services LLC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62011-0335_37a0279a-2e67-4d7f-9004-2bdcd5b0d5d4	62011-0335	HUMAN OTC DRUG	Health Mart ibuprofen PM		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20170530		ANDA	ANDA079113	Strategic Sourcing Services LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0336_c07a0911-e3f4-4224-81a0-f0a7bdb89d97	62011-0336	HUMAN OTC DRUG	health mart pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170507		ANDA	ANDA075077	Strategic Sourcing Services LLC	ACETAMINOPHEN	650	mg/1			N	20241231
62011-0337_a2740af1-0bb3-4268-a378-b25333058fae	62011-0337	HUMAN OTC DRUG	Health Mart arthritis pain relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170516		ANDA	ANDA075077	Strategic Sourcing Services LLC	ACETAMINOPHEN	650	mg/1			N	20241231
62011-0339_2100e703-7f81-43f2-a20b-cfd711371ab2	62011-0339	HUMAN OTC DRUG	childrens chewables		acetaminophen	TABLET, CHEWABLE	ORAL	20050225	20250208	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services, LLC (Health Mart)	ACETAMINOPHEN	160	mg/1			N	
62011-0340_c7762f8c-8aaf-43ce-b4c4-62f9ef94889e	62011-0340	HUMAN OTC DRUG	stay awake		caffeine	TABLET	ORAL	19961121	20250214	OTC MONOGRAPH DRUG	M011	Strategic Sourcing Services, LLC (Health Mart)	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
62011-0341_3bc8f185-04b5-4d6c-aea9-6f42c3c9e954	62011-0341	HUMAN OTC DRUG	motion sickness		dimenhydrinate	TABLET	ORAL	19921201	20240915	OTC MONOGRAPH DRUG	M009	Strategic Sourcing Services, LLC (Health Mart)	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0343_53a6a8ed-d8c3-4ece-8346-93953a4e2c56	62011-0343	HUMAN OTC DRUG	nighttime sleep aid		diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610	20240919	OTC MONOGRAPH DRUG	M010	Strategic Sourcing Services, LLC (Health Mart)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0345_38be9c04-4932-402f-999e-c108b7d483e1	62011-0345	HUMAN OTC DRUG	motion sickness relief		meclizine HCl	TABLET	ORAL	20020624	20240210	OTC MONOGRAPH FINAL	part336	Strategic Sourcing Services, LLC (Health Mart)	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
62011-0348_c64d5bc9-4fd1-4bc1-891a-4ad9cd1c3306	62011-0348	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Strategic Sourcing Services LLC	LORATADINE	5	mg/5mL			N	20241231
62011-0353_edb5700d-a294-4006-9194-2bc97d375be8	62011-0353	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20090518	20250925	OTC MONOGRAPH NOT FINAL	part333A	Strategic Sourcing Services LLC	ALCOHOL	70	mL/100mL			N	
62011-0354_63c568cb-3a43-4ede-b318-dec7ba1389d2	62011-0354	HUMAN OTC DRUG	health mart allergy and congestion		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190305		ANDA	ANDA076050	Strategic Sourcing Services LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0356_ee9cf44c-6c96-228c-e053-2995a90a86f1	62011-0356	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20180301	20250331	OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0362_871769d0-c74d-49aa-b064-3810c672473c	62011-0362	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20190331		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62011-0364_f6ca1898-b5e3-5498-e053-6394a90aee93	62011-0364	HUMAN OTC DRUG	Senna-S		Sennosides and Docusate Sodium	TABLET	ORAL	20160201	20240331	OTC MONOGRAPH NOT FINAL	part334	STRATEGIC SOURCING SERVICES LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
62011-0365_b02cd78b-c3f0-425e-9849-d094c1020517	62011-0365	HUMAN OTC DRUG	health mart anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20181010		ANDA	ANDA209837	Strategic Sourcing Services LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
62011-0368_a749054e-24b7-464e-aeaf-8240a72a57a5	62011-0368	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0369_aed611bf-fb01-46af-a2fb-359f4379e5a5	62011-0369	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	Strategic Sourcing Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0371_ce44fbc4-2fc2-4b29-b6a2-e2d7ba4189f4	62011-0371	HUMAN OTC DRUG	health mart childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20190816		ANDA	ANDA210033	Strategic Sourcing Services LLC	LORATADINE	5	mg/1			N	20241231
62011-0372_979ec835-919a-4e81-a1d4-c52023f01324	62011-0372	HUMAN OTC DRUG	health mart adult tussin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180822		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0377_4d4b875c-890b-4d5d-8b32-b823557e8f0b	62011-0377	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180930		ANDA	ANDA207342	Strategic Sourcing Services LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62011-0378_69b14c9e-c986-4b00-a634-bc92a223cfa7	62011-0378	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20180930		ANDA	ANDA207342	Strategic Sourcing Services LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62011-0380_4cc1a904-eeed-4c78-ad5b-6c724fdb80f4	62011-0380	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62011-0381_47603f63-a0bc-4ff3-8929-7c87aff2c65a	62011-0381	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62011-0382_bd3e14ab-7aa6-4646-a757-17aa99ee71e7	62011-0382	HUMAN OTC DRUG	Guaifenesin Extended Release 600 mg		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20191017		ANDA	ANDA209215	Strategic Sourcing Services LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62011-0383_5f78c217-4623-44cb-978f-e39ffecd58b6	62011-0383	HUMAN OTC DRUG	health mart anti diarrheal		loperamide HCl	SOLUTION	ORAL	20180703		ANDA	ANDA091292	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
62011-0384_9c403265-995e-4616-919f-b0bd5693d871	62011-0384	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	TABLET	ORAL	20180831	20240228	ANDA	ANDA209274	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0385_ebd21472-49a1-4634-9e8f-eea4b3aa2112	62011-0385	HUMAN OTC DRUG	health mart anti diarrheal		Loperamide HCl	SUSPENSION	ORAL	20180731		ANDA	ANDA091292	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
62011-0386_e8ce772b-69c1-4802-8781-6cecf484914f	62011-0386	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180831	20250131	OTC MONOGRAPH DRUG	M007	Strategic Sourcing Services LLC	DOCUSATE SODIUM	100	mg/1			N	
62011-0387_07da5ac2-03f3-e68e-e063-6294a90a46ed	62011-0387	HUMAN OTC DRUG	SENNA		Sennosides	TABLET	ORAL	20181001	20240430	OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	SENNOSIDES	8.6	mg/1			N	
62011-0389_4ef996d0-b06e-4e4f-b307-bd0037a773f1	62011-0389	HUMAN OTC DRUG	NightTime Cold and Flu	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180930	20240531	OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
62011-0390_dfc6d50d-e754-c868-e053-2a95a90aafa8	62011-0390	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20181215		NDA	NDA021855	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
62011-0392_e8250dd8-1c07-412d-8836-7128352fc173	62011-0392	HUMAN OTC DRUG	Nighttime Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20190131	20251231	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
62011-0393_28b5d87f-d27d-4367-995a-ef2a04f5de44	62011-0393	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20181231	20250530	OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
62011-0394_7298724a-1dcb-4673-9899-1180a393c6df	62011-0394	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20181231	20250630	OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
62011-0395_abddf78b-66dd-4747-a990-751cff4c20cf	62011-0395	HUMAN OTC DRUG	Stool Softener	plus stimulant laxative	docusate sodium and sennosides	TABLET	ORAL	20181231	20250829	OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
62011-0396_2f5ffa22-168c-43c9-b5fe-7e93f6c2aa1a	62011-0396	HUMAN OTC DRUG	Naproxen Sodium PM		Naproxen Sodium	TABLET	ORAL	20190131		ANDA	ANDA209726	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0397_4f4cc847-7357-4909-b0eb-d200570c85d1	62011-0397	HUMAN OTC DRUG	Health Mart Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20191017		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62011-0398_711cd376-f7b8-434b-80af-e4070f86dee8	62011-0398	HUMAN OTC DRUG	Health Mart Regular Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190927		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62011-0399_90d5861a-5c9e-4916-a800-c84220801918	62011-0399	HUMAN OTC DRUG	Ibuprofen Minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228		ANDA	ANDA206568	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0401_1e35215c-96c4-44c6-b734-b247641618f8	62011-0401	HUMAN OTC DRUG	Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190520	20240809	ANDA	ANDA040564	Strategic Sourcing Services, LLC (Health Mart)	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
62011-0403_acbc5ec0-a724-4652-b49b-83f21d179344	62011-0403	HUMAN OTC DRUG	HealthMart Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20150213		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	BISACODYL	10	mg/2000mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62011-0405_ee9cfa0d-1298-55eb-e053-2995a90a6486	62011-0405	HUMAN OTC DRUG	Aspirin 325 mg		Aspirin	TABLET, DELAYED RELEASE	ORAL	20190517	20240731	OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
62011-0406_8cfe3ca0-2407-4041-97cd-2917888e3311	62011-0406	HUMAN OTC DRUG	Health Mart daytime		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20191209		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0407_cb722f08-70bc-4e0a-b262-f3d4241882af	62011-0407	HUMAN OTC DRUG	Health Mart childrens ibuprofen ib		Ibuprofen	TABLET, CHEWABLE	ORAL	20190603		ANDA	ANDA076359	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0409_ef3f4a31-cdcd-cbc3-5f0b-8148aca6f103	62011-0409	HUMAN OTC DRUG	Allergy Relief		Fexofenadine hydrochloride	TABLET	ORAL	20190909		ANDA	ANDA076502	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0411_e0431b2e-53c1-461f-9400-b53dbcb77329	62011-0411	HUMAN OTC DRUG	health mart allergy complete d		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200304		ANDA	ANDA210719	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0412_a8efe0af-233c-4955-bfa8-9f67a7d671bd	62011-0412	HUMAN OTC DRUG	HealthMart Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190912		UNAPPROVED DRUG OTHER		Strategic Sourcing Services LLC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
62011-0413_390bedec-4ee6-471f-a610-d0ae48d32e45	62011-0413	HUMAN OTC DRUG	health mart fexofenadine hydrochloride		Fexofenadine Hydrochloride	TABLET, FILM COATED	ORAL	20190821		ANDA	ANDA076447	Strategic Sourcing Services LLC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0414_fe7b94e1-bff1-d81d-4661-5f45a44e2836	62011-0414	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20191112		ANDA	ANDA078343	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0415_512d7fd1-1377-4435-b371-6fe40118ef61	62011-0415	HUMAN OTC DRUG	health mart lidocaine		LIDOCAINE	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20191015		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	LIDOCAINE	560	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62011-0416_a91cf00d-cc6a-42d5-ae36-ef9d5dcf73e8	62011-0416	HUMAN OTC DRUG	Nighttime Sleep Aid	Maximum Strength	Diphenhydramine HCL	CAPSULE	ORAL	20190930		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0417_1087098d-964e-4d49-b5e4-f987dc18a91c	62011-0417	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20201001		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
62011-0419_3f8d398f-ad97-4002-873f-efcbe23fbf43	62011-0419	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH FINAL	part347	Strategic Sourcing Services LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
62011-0420_11ccad3f-ac34-4a27-846f-1fe0b0663424	62011-0420	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCL	TABLET, COATED	ORAL	20191129		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0421_6afd3d8e-3e0d-4b25-aa60-cfdc63346611	62011-0421	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210129		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
62011-0423_ac01899c-3789-4e38-bb69-85b752b98384	62011-0423	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20191129		ANDA	ANDA209692	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0424_31da15ec-4709-47da-8250-34b95263e45b	62011-0424	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20191129		ANDA	ANDA209692	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
62011-0425_ea171dc7-b994-431a-aa54-0b82f923a3bf	62011-0425	HUMAN OTC DRUG	health mart nicotine polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20191207		ANDA	ANDA078547	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0426_8a1ecd9d-e056-443d-acdc-8eaf90658b40	62011-0426	HUMAN OTC DRUG	health mart nicotine polacrilex		Nicotine polacrilex	GUM, CHEWING	ORAL	20191207		ANDA	ANDA078546	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0427_8b625b70-c72b-42ae-b2c2-834960d853a4	62011-0427	HUMAN OTC DRUG	health mart nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20200113		ANDA	ANDA090821	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0428_5c0f3427-3e70-416f-8e6c-a7df6a931e62	62011-0428	HUMAN OTC DRUG	health mart nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20200114		ANDA	ANDA090821	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0429_66ae414f-4130-40ad-82f9-2508ab5ddfb7	62011-0429	HUMAN OTC DRUG	health mart nicotine polacrilex		nicotine polacrilex	LOZENGE	ORAL	20191226		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0430_10488ff8-b344-4b2f-af0d-238cdac10cfb	62011-0430	HUMAN OTC DRUG	health mart nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20191226		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
62011-0432_04cc3b25-71a8-4c52-bea6-59903233f2c0	62011-0432	HUMAN OTC DRUG	health mart adult aspirin		aspirin	TABLET, FILM COATED	ORAL	20200304		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
62011-0433_b54c9060-16d4-453c-bcbb-6844bafd3c02	62011-0433	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20191030		ANDA	ANDA208754	Strategic Sourcing Services LLC	DOCOSANOL	100	mg/g			N	20241231
62011-0434_32b0ba06-c121-423e-8cbc-9dc3e059e715	62011-0434	HUMAN OTC DRUG	health mart pain relief		acetaminophen	TABLET, FILM COATED	ORAL	20200122		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
62011-0435_667a22a9-d96b-4923-be7f-2f52602f103f	62011-0435	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191030		OTC MONOGRAPH DRUG	M008	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
62011-0436_e0c5ba18-eacb-4b30-8668-5ab8dc4b1ee0	62011-0436	HUMAN OTC DRUG	Ultra Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH DRUG	M008	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
62011-0437_c6d22c2d-e5f0-429d-870b-684bf5f8b8e9	62011-0437	HUMAN OTC DRUG	health mart day time cold and flu night time cold and flu		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20200122		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC						N	20241231
62011-0442_ee9d1fcf-3c89-32c8-e053-2a95a90aed5a	62011-0442	HUMAN OTC DRUG	Cold Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200603	20240630	OTC MONOGRAPH FINAL	part341	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
62011-0443_298ef643-063e-44d1-abd8-de5f6e73d838	62011-0443	HUMAN OTC DRUG	Dibromm Cold and Allergy Relief	childrens	Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20190131		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62011-0450_6d3846fb-ee80-4320-952f-0eba3e53437e	62011-0450	HUMAN OTC DRUG	Health Mart Arthritis Pain		diclofenac sodium	GEL	TOPICAL	20200603		ANDA	ANDA211253	Strategic Sourcing Services LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62011-0455_a651e527-95f4-2565-3ea0-dd5173944cd8	62011-0455	HUMAN OTC DRUG	Allergy and Congestion		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20200727		ANDA	ANDA076667	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0456_08f1586e-5baf-a5cb-e063-6394a90a32c4	62011-0456	HUMAN OTC DRUG	Allergy Multi symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200810	20241130	OTC MONOGRAPH DRUG	M012	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
62011-0460_8b863c2c-4cd3-45e7-ad10-7db07ae77a90	62011-0460	HUMAN OTC DRUG	Pain Reliever	Childrens	Acetaminophen	SUSPENSION	ORAL	20200630		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
62011-0461_74b80087-3877-4a51-a750-a4b1d87ecc33	62011-0461	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20200922		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
62011-0463_11807741-e679-49cf-8cb3-5c909e16401a	62011-0463	HUMAN OTC DRUG	health mart migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20200921		ANDA	ANDA075794	Strategic Sourcing Services LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
62011-0464_eb5a24a9-274e-4d63-8c79-afe5c6fdbc75	62011-0464	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20180425		OTC MONOGRAPH FINAL	part347	Strategic Sourcing Services LLC	PETROLATUM	1	g/g			N	20241231
62011-0465_997ec381-93be-48be-9db3-170e4c0bc3d0	62011-0465	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20160620		OTC MONOGRAPH NOT FINAL	part356	Strategic Sourcing Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62011-0466_e6dfb211-90d3-4e4d-b681-2f9033e5263e	62011-0466	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19980315		OTC MONOGRAPH NOT FINAL	part356	Strategic Sourcing Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62011-0467_74c369f1-7a9b-430b-8cd7-0950585ce680	62011-0467	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19951114		OTC MONOGRAPH NOT FINAL	part348	Strategic Sourcing Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62011-0468_b2632ba0-160a-dabe-6c3c-fa7ca577fb93	62011-0468	HUMAN OTC DRUG	Eye Allergy Itch Relief		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210315		ANDA	ANDA209752	Strategic Sourcing Specialists, LLC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
62011-0469_366fe549-39bb-095f-9833-5170e5bb6f94	62011-0469	HUMAN OTC DRUG	Eye Allergy Itch and Redness Relief		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20210315		ANDA	ANDA209619	Strategic Sourcing Specialists, LLC	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
62011-0471_7bef5b19-9273-4fd0-8768-5468683c799c	62011-0471	HUMAN OTC DRUG	health mart allergy relief		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20210421		ANDA	ANDA076447	Strategic Sourcing Services LLC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0474_f0403ba2-8fe3-4474-be18-d971227c0e51	62011-0474	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210625		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
62011-0475_07be87a3-54dc-4ddb-bd01-45444b4cf0ac	62011-0475	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine Hydrochloride		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171115		ANDA	ANDA212542	STRATEGIC SOURCING SERVICES LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
62011-0476_a2ea166f-0810-3dfe-b127-1c70eb2e1989	62011-0476	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride 60 mg	TABLET	ORAL	20210730		ANDA	ANDA076502	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62011-0481_bba6a4a7-1a05-42d8-83ea-10ba2978699f	62011-0481	HUMAN OTC DRUG	Healthmart Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20210908		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
62011-0482_47c71bfb-7e21-47a9-bc7e-f2584e19ec1c	62011-0482	HUMAN OTC DRUG	Healthmart Regular Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20210903		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62011-0483_0c86777f-3d2c-5e1d-e063-6294a90a2369	62011-0483	HUMAN OTC DRUG	HealthMart Ear Wax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	TOPICAL	20220225		OTC MONOGRAPH DRUG	M014	McKesson Corp via Strategic Sourcing Services LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
62011-0484_0c863def-7316-49f7-e063-6294a90a5d41	62011-0484	HUMAN OTC DRUG	HealthMart Earwax Removal Kit Ear wax drops and Bulb		CARBAMIDE PEROXIDE	KIT	TOPICAL	20220225		OTC MONOGRAPH DRUG	M014	McKesson Corp via Strategic Sourcing Services LLC						N	20241231
62011-0831_8a553406-8dd3-44c3-b87d-e90333a4d2f1	62011-0831	HUMAN OTC DRUG	Health Mart Pharmacy		Mineral	OIL	ORAL	20021113	20240811	OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	MINERAL OIL	999	mg/mL			N	
62011-2520_77fbef72-9f87-40a4-9589-c415c0d31029	62011-2520	HUMAN OTC DRUG	Health Mart severe cold cough and flu		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20151009		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62032-050_6341f266-5b3e-41a8-9239-d1ffa64c776d	62032-050	HUMAN OTC DRUG	Professional-C Suncare Broad Spectrum SPF 30	Sunscreen	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20140102		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 80; 50; 27.9; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62032-070_2af9c0fa-9906-47c1-84af-3ed7c0a78cdc	62032-070	HUMAN OTC DRUG	NU-DERM PHYSICAL UV	BROAD SPECTRUM SPF 32	ZINC OXIDE	LOTION	TOPICAL	20040101		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC	ZINC OXIDE	185	mg/g			N	20241231
62032-100_4d837819-2705-41b1-a0b0-240cdad9ef47	62032-100	HUMAN PRESCRIPTION DRUG	NU-DERM BLENDER	Skin Lightener and Blending	HYDROQUINONE	CREAM	TOPICAL	19880101		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
62032-101_4d837819-2705-41b1-a0b0-240cdad9ef47	62032-101	HUMAN PRESCRIPTION DRUG	NU-DERM CLEAR	Skin Bleaching and Corrector	HYDROQUINONE	CREAM	TOPICAL	19880101		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
62032-105_2e9d9417-8b73-4d00-9783-c0d14f1a9cbc	62032-105	HUMAN PRESCRIPTION DRUG	Obagi-C Rx system C-Therapy Night	Skin Lightening with Vitamins C and E	HYDROQUINONE	CREAM	TOPICAL	20100101		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
62032-106_72a56cdc-b88e-4c60-8e0e-3bdf68f8e17c	62032-106	HUMAN PRESCRIPTION DRUG	OBAGI C RX system C CLARIFYING SERUM		HYDROQUINONE	SOLUTION	TOPICAL	20100101		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC	HYDROQUINONE	40	mg/mL	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
62032-116_4d837819-2705-41b1-a0b0-240cdad9ef47	62032-116	HUMAN PRESCRIPTION DRUG	NU-DERM SUNFADER	Skin Lightener with Sunscreen (SPF 15) PABA FREE	HYDROQUINONE, OCTINOXATE, and OXYBENZONE	LOTION	TOPICAL	19840101		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC	HYDROQUINONE; OCTINOXATE; OXYBENZONE	40; 75; 55	mg/g; mg/g; mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
62032-122_a65d3895-8496-45b2-b273-70e6d4da4a02	62032-122	HUMAN PRESCRIPTION DRUG	OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily	SKIN LIGHTENING SERUM WITH VITAMIN C	HYDROQUINONE	LIQUID	TOPICAL	20100101		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC	HYDROQUINONE	40	mg/mL	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
62032-140_a2859154-a41c-472b-aced-7a77f609c2f2	62032-140	HUMAN OTC DRUG	SUN SHIELD BROAD SPECTRUM SPF 50 MATTE	SUNSCREEN	HOMOSALATE, OCTISALATE, and ZINC OXIDE	LOTION	TOPICAL	20190715		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	100; 50; 165	mg/g; mg/g; mg/g			N	20241231
62032-150_e88579ae-c406-470e-8283-169bf3a42fcb	62032-150	HUMAN OTC DRUG	Obagi	Sun Shield TINT Cool Sunscreen Broad Spectrum SPF 50	Homosalate, Octinoxate, Titanium dioxide, Zinc oxide	LOTION	TOPICAL	20191201		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC	HOMOSALATE; OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	8.5; 6.375; 2.703; 4.25	g/85g; g/85g; g/85g; g/85g			N	20241231
62032-160_aba674be-7709-4424-a7cb-180319280978	62032-160	HUMAN OTC DRUG	Obagi	Sun Shield TINT Warm Sunscreen Broad Spectrum SPF 50	Homosalate, Octinoxate, Titanium dioxide, Zinc oxide	LOTION	TOPICAL	20191201		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC	HOMOSALATE; OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	8.5; 6.375; 2.737; 4.25	g/85g; g/85g; g/85g; g/85g			N	20241231
62032-200_01f78b31-3956-4757-baf7-caaba26aeea1	62032-200	HUMAN OTC DRUG	NU-DERM HEALTHY SKIN PROTECTION	SPF 35	OCTINOXATE and ZINC OXIDE	CREAM	TOPICAL	20020101		OTC MONOGRAPH FINAL	part352	OBAGI COSMECEUTICAL LLC	OCTINOXATE; ZINC OXIDE	75; 90	mg/mL; mg/mL			N	20241231
62032-300_a76e015e-f360-42bc-bfe9-4b87de597cf5	62032-300	HUMAN OTC DRUG	Obagi 360 HydraFactor Moisturizing Broad Spectrum SPF 30	SUNSCREEN	AVOBENZONE, OCTINOXATE, OCTISALATE, and OXYBENZONE	CREAM	TOPICAL	20140102		OTC MONOGRAPH FINAL	part352	OBAGI COSMECEUTICAL LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	10; 75; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62032-303_d4c08815-1872-4601-9e58-916f26d0cb0b	62032-303	HUMAN OTC DRUG	VITAMIN C SUNCARE BROAD SPECTRUM SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20140102		OTC MONOGRAPH FINAL	part352	OBAGI COSMECEUTICALS LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 80; 50; 27.9; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62032-412_89fbce62-29f8-4a59-812f-869c5c7caa68	62032-412	HUMAN PRESCRIPTION DRUG	Tretinoin Cream		tretinoin	CREAM	TOPICAL	19740719		NDA	NDA017522	Obagi Cosmeceuticals LLC	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
62032-413_6ab5cf57-07a1-4222-8ff5-3960206df180	62032-413	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20140619		NDA AUTHORIZED GENERIC	NDA022070	Obagi Cosmeceuticals LLC	TRETINOIN	.05	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
62032-414_89fbce62-29f8-4a59-812f-869c5c7caa68	62032-414	HUMAN PRESCRIPTION DRUG	Tretinoin Cream		tretinoin	CREAM	TOPICAL	19880916		NDA	NDA019049	Obagi Cosmeceuticals LLC	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
62032-417_89fbce62-29f8-4a59-812f-869c5c7caa68	62032-417	HUMAN PRESCRIPTION DRUG	Tretinoin Cream		tretinoin	CREAM	TOPICAL	19730126		NDA	NDA017340	Obagi Cosmeceuticals LLC	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
62032-529_dfe2bad6-db86-46a3-a6c3-b8dcaaaad388	62032-529	HUMAN PRESCRIPTION DRUG	nu-derm system normal-dry	skin transformation	Hydroquinone, Octisalate and Zinc Oxide	KIT		20191202		UNAPPROVED DRUG OTHER		OBAGI COSMECEUTICAL LLC						N	20241231
62032-531_8e61e33d-afce-49b4-9f49-568cfe117c69	62032-531	HUMAN PRESCRIPTION DRUG	NU-DERM System NORMAL-Oily	SKIN TRANSFORMATION	HYDROQUINONE, HOMOSALATE, OCTISALATE, and ZINC OXIDE	KIT		20191202		UNAPPROVED DRUG OTHER		OBAGI COSMECEUTICAL LLC						N	20241231
62032-532_4658029d-7a8a-41fe-a789-5fb98d85d2e3	62032-532	HUMAN PRESCRIPTION DRUG	NU-DERM system NORMAL-DRY	SKIN TRANSFORMATION TRIAL	Hydroquinone, Homosalate, Octisalate, and Zinc Oxide	KIT		20191202		UNAPPROVED DRUG OTHER		OBAGI COSMECEUTICAL LLC						N	20241231
62032-533_4170abf2-d29d-478d-a605-7dd920d84388	62032-533	HUMAN PRESCRIPTION DRUG	NU-DERM system NORMAL-oily	SKIN TRANSFORMATION TRIAL	Hydroquinone, Homosalate, Octisalate, and Zinc Oxide	KIT		20191202		UNAPPROVED DRUG OTHER		OBAGI COSMECEUTICAL LLC						N	20241231
62032-534_79f3240f-32ed-4063-b6a5-df7ae4eba3ab	62032-534	HUMAN PRESCRIPTION DRUG	OBAGI-C RX system NORMAL-oily	SKIN INTERVENTION	HYDROQUINONE, HOMOSALATE, OCTISALATE AND ZINC OXIDE	KIT		20191202		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC						N	20241231
62032-535_f6846cdc-8173-4cd9-a330-902152168803	62032-535	HUMAN PRESCRIPTION DRUG	OBAGI-C RX System NORMAL-DRY	SKIN INTERVENTION	HYDROQUINONE, HOMOSALATE, OCTISALATE, AND ZINC OXIDE	KIT		20191202		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC						N	20241231
62032-538_18ca5273-e9b4-4ef6-865b-8cdb1437c634	62032-538	HUMAN OTC DRUG	Obagi Nu-Derm FX System Normal - Oily	Skin Transformation Complexion Brightening System	Homosalate, Octisalate, and Zinc Oxide	KIT		20191202		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC						N	20241231
62032-539_1d5eb59b-07b5-4c0f-8abf-ef15683a3eeb	62032-539	HUMAN OTC DRUG	Obagi Nu-Derm FX System Normal - Dry	Skin Transformation Complexion Brightening System	Homosalate, Octisalate, and Zinc Oxide	KIT		20191202		UNAPPROVED DRUG OTHER		Obagi Cosmeceuticals LLC						N	20241231
62032-580_5fb93b87-bc82-40e8-992c-df8b72a72855	62032-580	HUMAN OTC DRUG	Obagi 360		Avobenzone, Octinoxate, Octisalate, Oxybenzone	KIT		20150908		OTC MONOGRAPH FINAL	part352	OMP, Inc.						N	20241231
62032-602_fe954524-ff18-414d-989a-676a123a88c2	62032-602	HUMAN OTC DRUG	NEXT CELL MEDICAL	SOOTHING COMPLEX	Calming Lotion Broad Spectrum SPF 25 Sunscreen	LOTION	TOPICAL	20180205		OTC MONOGRAPH FINAL	part352	OMP, Inc.	TITANIUM DIOXIDE	480	mg/mL			N	20241231
62032-606_517168cf-df57-4b7f-9490-213413094f99	62032-606	HUMAN OTC DRUG	NEXT CELL MEDICAL	ACNE CLEANSING WIPES	2% Salicylic Acid Suitable for Oily or Acne-Prone Skin	SWAB	TOPICAL	20180205		OTC MONOGRAPH FINAL	part333D	OMP, Inc.	SALICYLIC ACID	20	mg/1			N	20241231
62032-607_f814f248-217b-4ea2-ae6c-90e598319da7	62032-607	HUMAN OTC DRUG	Obagi Medical Physical Defense Broad Spectrum Mineral Sunscreen SPF 40 by SUZANOBAGIMD		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20200401		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC	TITANIUM DIOXIDE; ZINC OXIDE	45; 128	mg/g; mg/g			N	20241231
62032-608_db102b4a-9d63-484c-b334-39daa14f01ab	62032-608	HUMAN OTC DRUG	Obagi Medical Physical Defense Broad Spectrum Mineral Sunscreen SPF 50 by SUZANOBAGIMD		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20200401		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC	TITANIUM DIOXIDE; ZINC OXIDE	58; 144	mg/g; mg/g			N	20241231
62032-610_d5672cf6-07e0-4ad8-9189-e3d64d729495	62032-610	HUMAN OTC DRUG	CLENZIDERM DAILY CARE FOAMING CLEANSER	ACNE TREATMENT	SALICYLIC ACID	LIQUID	TOPICAL	20070201		OTC MONOGRAPH FINAL	part333D	OBAGI COSMECEUTICAL LLC	SALICYLIC ACID	20	mg/mL			N	20241231
62032-611_9aaddd63-31a0-4b2d-a55f-bc4f67d7953d	62032-611	HUMAN OTC DRUG	CLENZIDERM THERAPEUTIC		BENZOYL PEROXIDE	LOTION	TOPICAL	20070701		OTC MONOGRAPH FINAL	part333D	Obagi Cosmeceuticals LLC	BENZOYL PEROXIDE	50	mg/mL			N	20241231
62032-612_ad00324e-3e14-4228-87b4-7ba97da0646d	62032-612	HUMAN OTC DRUG	CLENZIDERM PORE THERAPY	ACNE TREATMENT	SALICYLIC ACID	LIQUID	TOPICAL	20070201		OTC MONOGRAPH FINAL	part333D	Obagi Cosmeceuticals LLC	SALICYLIC ACID	20	mg/mL			N	20241231
62032-613_75a3409c-a851-4330-a9ba-4f270aa11ae7	62032-613	HUMAN OTC DRUG	clenziderm m.d. system	acne therapeutic system	SALICYLIC ACID AND BENZOYL PEROXIDE	KIT		20120101		OTC MONOGRAPH FINAL	part333D	OBAGI COSMECEUTICAL LLC						N	20241231
62032-614_cefd817c-db98-456c-a9c8-c1e475aaf913	62032-614	HUMAN OTC DRUG	CLENZIDERM THERAPEUTIC MOISTURIZER		GLYCERIN	CREAM	TOPICAL	20070701		OTC MONOGRAPH FINAL	part347	Obagi Cosmeceuticals LLC	GLYCERIN	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
62032-690_f6f6e219-4ef7-be3b-e053-6294a90a660d	62032-690	HUMAN OTC DRUG	Obagi Medical Way to Glow Kit		homosalate, octisalate, and zinc oxide	KIT		20230320		OTC MONOGRAPH FINAL	M020	Obagi Cosmeceuticals LLC						N	20241231
62032-693_fb408d6d-b04a-46e8-b837-6576195b69f8	62032-693	HUMAN OTC DRUG	Obagi Medical Back to Basics (Including Obagi Medical Professional-C Serum 20)		HOMOSALATE, OCTISALATE, and ZINC OXIDE	KIT		20220401		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC						N	20241231
62032-694_92e9f9e7-b3e8-45b3-a33c-eb3afb0bae4c	62032-694	HUMAN OTC DRUG	Obagi Medical Back to Basics (Including Obagi Medical Professional-C Serum 15)		homosalate, octisalate, and zinc oxide	KIT		20220401		OTC MONOGRAPH FINAL	part352	Obagi Cosmeceuticals LLC						N	20241231
62032-905_f796dd34-12af-24bc-e053-6294a90a2e25	62032-905	HUMAN OTC DRUG	Obagi Skintrinsiq Brightening Protocol		HOMOSALATE, OCTISALATE, AND ZINC OXIDE	KIT		20210801		OTC MONOGRAPH FINAL	M020	Obagi Cosmeceuticals LLC						N	20241231
62032-906_f7fcdec6-1f70-ab52-e053-6294a90a6281	62032-906	HUMAN OTC DRUG	Obagi Skintrinsiq Antioxidant Protocol		AVOBENZONE, HOMOSALATE, OCTISALATE. OCTOCRYLENE, and OXYBENZONE	KIT		20210801		OTC MONOGRAPH FINAL	M020	Obagi Cosmeceuticals LLC						N	20241231
62032-907_f7fcd71f-230f-dc86-e053-6394a90a7867	62032-907	HUMAN OTC DRUG	Obagi Skintrinsiq Antioxidant Protocol		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	KIT		20210801		OTC MONOGRAPH FINAL	M020	Obagi Cosmeceuticals LLC						N	20241231
62032-908_f7fcdec6-1f82-ab52-e053-6294a90a6281	62032-908	HUMAN OTC DRUG	Obagi Skintrinsiq Antioxidant Protocol		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	KIT		20210801		OTC MONOGRAPH FINAL	M020	Obagi Cosmeceuticals LLC						N	20241231
62032-909_f7fcdec6-1f96-ab52-e053-6294a90a6281	62032-909	HUMAN OTC DRUG	Obagi Skintrinsiq Clarifiying Protocol		salicylic acid, titanium dioxide, and zinc oxide	KIT		20210801		OTC MONOGRAPH FINAL	M020	Obagi Cosmeceuticals LLC						N	20241231
62032-910_f7fcde32-7c61-aa93-e053-6294a90abde0	62032-910	HUMAN OTC DRUG	Obagi Skintrinsiq Firming Protocol		TITANIUM DIOXIDE AND ZINC OXIDE	KIT		20210801		OTC MONOGRAPH FINAL	M020	Obagi Cosmeceuticals LLC						N	20241231
62037-559_b97da107-c56e-48ea-ba34-d3d64a5b9f46	62037-559	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20080825		ANDA	ANDA077419	Actavis Pharma, Inc.	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62037-560_b97da107-c56e-48ea-ba34-d3d64a5b9f46	62037-560	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20080825		ANDA	ANDA077419	Actavis Pharma, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62037-597_3f024ff2-56ff-480e-b639-c9b794318fbe	62037-597	HUMAN PRESCRIPTION DRUG	Cartia	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19980709		ANDA	ANDA074752	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-598_3f024ff2-56ff-480e-b639-c9b794318fbe	62037-598	HUMAN PRESCRIPTION DRUG	Cartia	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19980709		ANDA	ANDA074752	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-599_3f024ff2-56ff-480e-b639-c9b794318fbe	62037-599	HUMAN PRESCRIPTION DRUG	Cartia	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19980709		ANDA	ANDA074752	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-600_3f024ff2-56ff-480e-b639-c9b794318fbe	62037-600	HUMAN PRESCRIPTION DRUG	Cartia	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19980709		ANDA	ANDA074752	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-696_ef8c3181-0515-4824-98b4-7504dbab84e3	62037-696	HUMAN PRESCRIPTION DRUG	TAZTIA	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030410		ANDA	ANDA075401	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-697_ef8c3181-0515-4824-98b4-7504dbab84e3	62037-697	HUMAN PRESCRIPTION DRUG	TAZTIA	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030410		ANDA	ANDA075401	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-698_ef8c3181-0515-4824-98b4-7504dbab84e3	62037-698	HUMAN PRESCRIPTION DRUG	TAZTIA	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030410		ANDA	ANDA075401	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-699_ef8c3181-0515-4824-98b4-7504dbab84e3	62037-699	HUMAN PRESCRIPTION DRUG	TAZTIA	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030410		ANDA	ANDA075401	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-700_ef8c3181-0515-4824-98b4-7504dbab84e3	62037-700	HUMAN PRESCRIPTION DRUG	TAZTIA	XT	Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20030410		ANDA	ANDA075401	Actavis Pharma, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
62037-710_be46311f-81c9-4712-959a-83702701837f	62037-710	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20020410		ANDA	ANDA075604	Actavis Pharma, Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62037-720_be46311f-81c9-4712-959a-83702701837f	62037-720	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20020410		ANDA	ANDA075604	Actavis Pharma, Inc.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62037-725_059600af-abec-4e0a-a978-dfd77056a8c8	62037-725	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190304		ANDA	ANDA076772	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62037-726_059600af-abec-4e0a-a978-dfd77056a8c8	62037-726	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190304		ANDA	ANDA076772	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62037-727_059600af-abec-4e0a-a978-dfd77056a8c8	62037-727	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190304		ANDA	ANDA076655	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62037-734_059600af-abec-4e0a-a978-dfd77056a8c8	62037-734	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190304		ANDA	ANDA076772	Actavis Pharma, Inc.	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62037-999_35ff2bc9-0a0a-4dec-b8aa-77c4575c3846	62037-999	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20040818	20240831	ANDA	ANDA076368	Actavis Pharma, Inc.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
62045-4333_2237f904-1bb5-4759-b21e-7b925b7a399c	62045-4333	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA205865	NLR Welding Supply, Inc.	OXYGEN	99	L/100L			N	20241231
62045-6333_a808f719-a6c4-4c32-bd9f-ee247ee5f78d	62045-6333	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA205866	NLR Welding Supply, Inc.	NITROGEN	99	L/100L			N	20241231
62045-7333_7065763d-f0d6-4dc4-b419-ca16d8bc1edf	62045-7333	HUMAN PRESCRIPTION DRUG	CARBON DIOXIDE		CARBON DIOXIDE	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA206025	NLR Welding Supply, Inc.	CARBON DIOXIDE	99	L/100L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
62045-8333_e8dd0d30-3ed2-42cf-a9b6-f26484720a68	62045-8333	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	19860101		NDA	NDA206009	NLR Welding Supply, Inc.	NITROUS OXIDE	99	L/100L			N	20241231
62046-001_06d2f795-50ec-fb94-e063-6294a90ae3f6	62046-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170112		UNAPPROVED MEDICAL GAS		Cook Children's Home Health	OXYGEN	99	L/100L			N	20241231
62066-001_06e60c4e-75de-cc13-e063-6394a90a3e77	62066-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Jones County Medical Supplies, Inc. dba Jones County Medical Supply, Inc.	OXYGEN	99	L/100L			N	20241231
62082-055_0973ba09-955c-0fb9-e063-6294a90a4d13	62082-055	HUMAN OTC DRUG	PHARMACA Natural Mineral Sunscreen SPF-30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190520		OTC MONOGRAPH DRUG	M020	Pharmaca Integrative Pharmacy, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62082-057_0973bc65-d2e0-0fef-e063-6294a90a1290	62082-057	HUMAN OTC DRUG	PHARMACA Natural Mineral Sunscreen SPF-50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190520		OTC MONOGRAPH DRUG	M020	Pharmaca Integrative Pharmacy, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 225	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62085-1001_eede08be-4de6-4038-ac53-75db72a12475	62085-1001	HUMAN OTC DRUG	GIM		ASIAN GINSENG	LIQUID	TOPICAL	20140208		UNAPPROVED DRUG OTHER		Hee Dae Gim	ASIAN GINSENG	24	g/100mL			N	20241231
62097-0004_079db5ec-83df-a42f-e063-6394a90aa78f	62097-0004	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Boggs Gases div. Boggs Fire Equipment	NITROUS OXIDE	99	L/100L			N	20241231
62097-0005_079db405-aa15-a400-e063-6294a90a1489	62097-0005	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Boggs Gases div. Boggs Fire Equipment	NITROGEN	99	L/100L			N	20241231
62097-9937_079da64c-2dcb-608c-e063-6394a90aeb10	62097-9937	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19950928		UNAPPROVED MEDICAL GAS		Boggs Gases div. Boggs Fire Equipment	OXYGEN	99	L/100L			N	20241231
62106-0097_b00744c8-c5da-1933-e053-2a95a90ac67b	62106-0097	HUMAN OTC DRUG	UNDA 270		Equisetum arvense, Hypericum perforatum	CREAM	TOPICAL	20150601		UNAPPROVED HOMEOPATHIC		Seroyal USA	EQUISETUM ARVENSE TOP; HYPERICUM PERFORATUM	1; 1	[hp_X]/40g; [hp_X]/40g			N	20241231
62106-0117_c72dc8a8-5a42-fb8c-e053-2a95a90a9e5f	62106-0117	HUMAN OTC DRUG	SEPIA PLEX		Aconitum napellus, Cimicifuga racemosa, Lachesis mutus, Melissa officinalis, Platinum metallicum, Sanguinaria canadensis, Sepia, Sulphuricum acidum, Valeriana officinalis	LIQUID	ORAL	20170403		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS; BLACK COHOSH; LACHESIS MUTA VENOM; MELISSA OFFICINALIS; PLATINUM; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SULFURIC ACID; VALERIAN	6; 3; 8; 2; 8; 3; 3; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
62106-0232_06fc215e-be34-c127-e063-6294a90ade23	62106-0232	HUMAN OTC DRUG	THYROIDINUM 4CH		Oryctolagus cuniculus (Rabbit) Thyroid Gland	LIQUID	ORAL	20151201	20240430	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS THYROID	4	[hp_C]/30mL			N	
62106-0259_06835782-1d36-8f53-e063-6294a90a39ff	62106-0259	HUMAN OTC DRUG	HEPATINUM 4CH		Oryctolagus cuniculus (Rabbit) Liver	LIQUID	ORAL	20151215	20240229	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS LIVER	4	[hp_C]/30mL			N	
62106-0322_06fa08b7-fadd-e368-e063-6294a90afe88	62106-0322	HUMAN OTC DRUG	SURRENINUM 4CH		Oryctolagus cuniculus (Rabbit) Adrenal Gland	LIQUID	ORAL	20181221	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS ADRENAL GLAND	4	[hp_C]/30mL			N	
62106-0323_06fc4631-4309-0a85-e063-6394a90ab9c8	62106-0323	HUMAN OTC DRUG	THYROIDINUM 200K		Oryctolagus cuniculus (Rabbit) Thyroid Gland	LIQUID	ORAL	20190607	20240430	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS THYROID	200	[kp_C]/30mL			N	
62106-0601_c7be02d4-e0ba-336f-e053-2a95a90a795f	62106-0601	HUMAN OTC DRUG	Fungisode		Arsenicum album, Berberis vulgaris, Calcarea carbonica, Candida albicans, Carbo vegetabilis, Chelidonium majus, Echinacea purpurea, Hepar sulphuris calcareum, Kreosotum, Lycopodium clavatum, Mercurius solubilis, Muriaticum acidum, Nitricum acidum, Oxalicum acidum, Sepia officinalis, Sulphur	LIQUID	ORAL	20170802		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CANDIDA ALBICANS; CHELIDONIUM MAJUS ROOT; ECHINACEA PURPUREA FLOWERING TOP; HYDROCHLORIC ACID; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NITRIC ACID; OXALIC ACID DIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEPIA OFFICINALIS JUICE; SULFUR; WOOD CREOSOTE	7; 4; 4; 5; 12; 4; 3; 7; 5; 5; 5; 8; 8; 5; 4; 5	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
62106-0622_c7c0338a-9dbd-131d-e053-2a95a90a6252	62106-0622	HUMAN OTC DRUG	HAD		Atropinum sulphuricum, Berberis vulgaris, Bryonia, Carduus marianus, Chelidonium majus, Echinacea angustifolia, Lycopodium clavatum, Magnesia phosphorica, Oryctolagus cuniculus (Rabbit) Adrenal Gland, Oryctolagus cuniculus (Rabbit) Spleen, Zingiber officinale (Ginger) Rhizome	LIQUID	ORAL	20151125		UNAPPROVED HOMEOPATHIC		Seroyal USA	ATROPINE SULFATE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS ROOT; ECHINACEA, UNSPECIFIED; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MILK THISTLE; ORYCTOLAGUS CUNICULUS ADRENAL GLAND; ORYCTOLAGUS CUNICULUS SPLEEN	6; 3; 4; 3; 2; 2; 12; 6; 2; 10; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62106-0623_c7c0766c-5fa4-95e0-e053-2995a90ac48f	62106-0623	HUMAN OTC DRUG	HFE		Apis mellifica, Belladonna, Caulophyllum thalictroides, Cimicifuga racemosa, Dioscorea villosa, Gelsemium sempervirens, Helonias dioica, Magnesia phosphorica, Oryctolagus cuniculus (Rabbit) Adrenal Gland, Oryctolagus cuniculus (Rabbit) Ovary, Oryctolagus cuniculus (Rabbit) Uterus, Viburnum opulus	LIQUID	ORAL	20181218		UNAPPROVED HOMEOPATHIC		Seroyal USA	APIS MELLIFERA; ATROPA BELLADONNA; BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; CHAMAELIRIUM LUTEUM ROOT; DIOSCOREA VILLOSA ROOT; GELSEMIUM SEMPERVIRENS ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ORYCTOLAGUS CUNICULUS ADRENAL GLAND; ORYCTOLAGUS CUNICULUS OVARY; ORYCTOLAGUS CUNICULUS UTERUS; VIBURNUM OPULUS BARK	5; 4; 6; 4; 4; 4; 8; 10; 10; 10; 10; 2	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62106-0624_c7c0b02a-7c95-6504-e053-2a95a90acea6	62106-0624	HUMAN OTC DRUG	HHR		Arnica montana, Aurum muriaticum, Cactus grandiflorus, convallaria majalis, digitalis purpurea, oryctolagus cuniculus heart, spigelia marilandica, valeriana officinalis, veratrum album	LIQUID	SUBLINGUAL	20151213		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA ROOT; CONVALLARIA MAJALIS; DIGITALIS; GOLD TRICHLORIDE; ORYCTOLAGUS CUNICULUS HEART; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA MARILANDICA ROOT; VALERIAN; VERATRUM ALBUM ROOT	6; 3; 6; 6; 10; 3; 5; 3; 4	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
62106-0625_f38e873c-cc3c-f701-e053-2a95a90af213	62106-0625	HUMAN OTC DRUG	HKI		Atropinum sulphuricum, Benzoicum acidum, Berberis vulgaris, Calcarea carbonica, Colocynthis, Coccus cacti, Lapis albus, Lithium carbonicum, Lycopodium clavatum, Oryctolagus cuniculus kidney, Rubia tinctorum, Sarsaparilla, Urtica urens	LIQUID	SUBLINGUAL	20151214		UNAPPROVED HOMEOPATHIC		Seroyal USA	ATROPINE SULFATE; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; CALCIUM HEXAFLUOROSILICATE; CITRULLUS COLOCYNTHIS FRUIT PULP; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; ORYCTOLAGUS CUNICULUS KIDNEY; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PROTORTONIA CACTI; RUBIA TINCTORUM ROOT; SARSAPARILLA; URTICA URENS	6; 6; 5; 12; 6; 6; 5; 10; 12; 5; 4; 1; 1	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Ammonium Ion Binding Activity [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Mood Stabilizer [EPC], Nitrogen Binding Agent [EPC]		N	20241231
62106-0626_c7c0f394-1320-29c5-e053-2995a90ae2f5	62106-0626	HUMAN OTC DRUG	HLU PNEUMO DROPS		Arsenicum iodatum, Calcarea phosphorica, Carbo vegetabilis, Oryctolagus cuniculus lung, Phellandrium aquaticum, Silicea, Stannum metallicum, Sulphur, Thymus vulgaris	LIQUID	ORAL	20160327		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACTIVATED CHARCOAL; ARSENIC TRIIODIDE; OENANTHE AQUATICA FRUIT; ORYCTOLAGUS CUNICULUS LUNG; SILICON DIOXIDE; SULFUR; THYME; TIN; TRIBASIC CALCIUM PHOSPHATE	12; 7; 5; 10; 12; 12; 4; 10; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
62106-0629_c7c0f552-7c7c-7564-e053-2995a90a6421	62106-0629	HUMAN OTC DRUG	HPNP		Berberis vulgaris, Chelidonium majus, Kreosotum, Natrum sulphuricum, Oryctolagus cuniculus Kidney, Oryctolagus cuniculus Pancreatin, Phosphoricum acidum, Syzygium jambolanum, Vaccinium myrtillus	LIQUID	ORAL	20170619		UNAPPROVED HOMEOPATHIC		Seroyal USA	BERBERIS VULGARIS ROOT BARK; BILBERRY; CHELIDONIUM MAJUS ROOT; ORYCTOLAGUS CUNICULUS KIDNEY; ORYCTOLAGUS CUNICULUS PANCREATIN; PHOSPHORIC ACID; SODIUM SULFATE; SYZYGIUM CUMINI FRUIT; WOOD CREOSOTE	2; 2; 4; 10; 10; 4; 6; 10; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
62106-0630_c7c11adc-cd18-9900-e053-2995a90a0373	62106-0630	HUMAN OTC DRUG	HPTP		Arnica montana, Achillea millefolium, Erigeron canadensis, Hydrastis canadensis, Oryctolagus cuniculus, Sabina, Secale cornutum	LIQUID	SUBLINGUAL	20151026		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; ARNICA MONTANA ROOT; CLAVICEPS PURPUREA SCLEROTIUM; CONYZA CANADENSIS; GOLDENSEAL; JUNIPERUS SABINA LEAFY TWIG; ORYCTOLAGUS CUNICULUS ADRENAL GLAND; ORYCTOLAGUS CUNICULUS PITUITARY GLAND	6; 6; 8; 6; 6; 8; 10; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
62106-0631_f382fc1f-d3b7-7fa7-e053-2995a90a0eab	62106-0631	HUMAN OTC DRUG	HTHY		Calcarea carbonica, Calcarea iodata, Ferrum iodatum, Fucus vesiculosus, Hepar sulphuris calcareum, Kali iodatum, Lapis albus Calcium Fluosilicate, Oryctolagus cuniculus (Rabbit) Adrenal Gland, Oryctolagus cuniculus (Rabbit) Pituitary Gland, Oryctolagus cuniculus (Rabbit) Spleen, Oryctolagus cuniculus (Rabbit) Thymus Gland, Oryctolagus cuniculus (Rabbit) Thyroid Gland, Spongia tosta	LIQUID	ORAL	20151127		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALCIUM HEXAFLUOROSILICATE; CALCIUM IODIDE; CALCIUM SULFIDE; FERROUS IODIDE; FUCUS VESICULOSUS; ORYCTOLAGUS CUNICULUS ADRENAL GLAND; ORYCTOLAGUS CUNICULUS PITUITARY GLAND; ORYCTOLAGUS CUNICULUS SPLEEN; ORYCTOLAGUS CUNICULUS THYMUS; ORYCTOLAGUS CUNICULUS THYROID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM IODIDE; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 4; 8; 6; 6; 10; 10; 10; 10; 10; 8; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62106-0744_075ede4c-7b1c-8c1f-e063-6294a90adacd	62106-0744	HUMAN OTC DRUG	Fucus Complex		Fucus vesiculosus, spongia tosta, Badiaga	LIQUID	SUBLINGUAL	20150508	20260831	UNAPPROVED HOMEOPATHIC		Seroyal USA	FUCUS VESICULOSUS; SPONGIA OFFICINALIS SKELETON, ROASTED; SPONGILLA LACUSTRIS	1; 2; 3	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	
62106-1050_c71e44d6-d66c-6234-e053-2995a90af97c	62106-1050	HUMAN OTC DRUG	CALCAREA FLUORICA 6X		Calcium Fluoride	TABLET	SUBLINGUAL	20150210		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALCIUM FLUORIDE	6	[hp_X]/1			N	20241231
62106-1051_c71cd561-d700-6165-e053-2995a90a53a6	62106-1051	HUMAN OTC DRUG	CALCAREA PHOSPHORICA 6X		Calcium hydrogen phosphate dihydrate	TABLET	SUBLINGUAL	20150120		UNAPPROVED HOMEOPATHIC		Seroyal USA	TRIBASIC CALCIUM PHOSPHATE	6	[hp_X]/1			N	20241231
62106-1052_e33c2bf0-12c5-7d66-e053-2a95a90aea41	62106-1052	HUMAN OTC DRUG	CALCAREA SULFURICA 6X		Calcium Sulfate	TABLET	SUBLINGUAL	20170901		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALCIUM SULFATE ANHYDROUS	6	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62106-1053_c71d36c4-a11b-62e4-e053-2a95a90ab58a	62106-1053	HUMAN OTC DRUG	FERRUM PHOSPHORICUM 6X		Hydrated iron III phosphate	TABLET	SUBLINGUAL	20150430		UNAPPROVED HOMEOPATHIC		Seroyal USA	FERROSOFERRIC PHOSPHATE	6	[hp_X]/1			N	20241231
62106-1054_e33c6585-d77e-0547-e053-2a95a90ad493	62106-1054	HUMAN OTC DRUG	KALIUM MURIATICUM 6X		Potassium Chloride	TABLET	SUBLINGUAL	20151023		UNAPPROVED HOMEOPATHIC		Seroyal USA	POTASSIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62106-1055_c71d36c4-a11b-62e4-e053-2a95a90ab58a	62106-1055	HUMAN OTC DRUG	KALIUM PHOSPHORICUM 6X		Potassium dihydrogen phosphate	TABLET	SUBLINGUAL	20150501		UNAPPROVED HOMEOPATHIC		Seroyal USA	POTASSIUM PHOSPHATE, MONOBASIC	6	[hp_X]/1			N	20241231
62106-1056_e33c9914-4d57-0790-e053-2a95a90a79e8	62106-1056	HUMAN OTC DRUG	KALIUM SULFURICUM 6X		Potassium sulfate	TABLET	SUBLINGUAL	20180503		UNAPPROVED HOMEOPATHIC		Seroyal USA	POTASSIUM SULFATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62106-1057_c71cd561-d700-6165-e053-2995a90a53a6	62106-1057	HUMAN OTC DRUG	MAGNESIA PHOSPHORICA 6x		Magnesium hydrogen phosphate trihydrate	TABLET	SUBLINGUAL	20150120		UNAPPROVED HOMEOPATHIC		Seroyal USA	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62106-1058_e33d76f2-f4e6-3478-e053-2995a90ac970	62106-1058	HUMAN OTC DRUG	Natrium Muriaticum 6X		Sodium chloride	TABLET	SUBLINGUAL	20150210		UNAPPROVED HOMEOPATHIC		Seroyal USA	SODIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
62106-1059_c71d7cd0-09ad-bb0b-e053-2995a90ac703	62106-1059	HUMAN OTC DRUG	NATRIUM PHOSPHORICUM 6X		Sodium Phosphate	TABLET	SUBLINGUAL	20151023		UNAPPROVED HOMEOPATHIC		Seroyal USA	SODIUM PHOSPHATE	6	[hp_X]/1			N	20241231
62106-1060_c71d36c4-a11b-62e4-e053-2a95a90ab58a	62106-1060	HUMAN OTC DRUG	NATRIUM SULFURICUM 6X		Anhydrous sodium sulfate	TABLET	SUBLINGUAL	20150501		UNAPPROVED HOMEOPATHIC		Seroyal USA	SODIUM SULFATE	6	[hp_X]/1			N	20241231
62106-1061_c71e003c-988d-ad32-e053-2995a90a9a28	62106-1061	HUMAN OTC DRUG	SILICEA 6X		Silicea	TABLET	SUBLINGUAL	20150506		UNAPPROVED HOMEOPATHIC		Seroyal USA	SILICON DIOXIDE	6	[hp_X]/1			N	20241231
62106-1062_c71cd561-d700-6165-e053-2995a90a53a6	62106-1062	HUMAN OTC DRUG	CALCAREA CARBONICA 6X		Impure calcium carbonate	TABLET	SUBLINGUAL	20150120		UNAPPROVED HOMEOPATHIC		Seroyal USA	OYSTER SHELL CALCIUM CARBONATE, CRUDE	6	[hp_X]/1			N	20241231
62106-1100_ece42ac2-e879-2756-e053-2995a90a55cb	62106-1100	HUMAN OTC DRUG	Unda 1		Achillea millefolium	LIQUID	ORAL	20140701		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; ANGELICA ARCHANGELICA ROOT; ARCTOSTAPHYLOS UVA-URSI LEAF; EQUISETUM ARVENSE TOP; LARIX DECIDUA RESIN; LYCOPODIUM CLAVATUM SPORE; SILVER; VALERIAN	4; 4; 4; 4; 5; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1101_ebe194aa-984d-8373-e053-2995a90ae03e	62106-1101	HUMAN OTC DRUG	UNDA 2		Petroselinum sativum, Rhamnus frangula, Thlaspi bursa-pastoris, Juniperus communis, Asparagus officinalis, Berberis vulgaris, Genista tinctoria, Argentum metallicum	LIQUID	ORAL	20150526		UNAPPROVED HOMEOPATHIC		Seroyal USA	ASPARAGUS; BERBERIS VULGARIS ROOT BARK; CAPSELLA BURSA-PASTORIS; FRANGULA ALNUS BARK; GENISTA TINCTORIA; JUNIPER BERRY; PETROSELINUM CRISPUM; SILVER	4; 4; 4; 4; 4; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
62106-1102_c731175a-04a5-5d25-e053-2995a90a6082	62106-1102	HUMAN OTC DRUG	Unda 3		Equisetum arvense stem, Chamomilla, Condurango Bark, Viola tricolor, Boldo Leaf, Aluminium metallicum, Stannum metallicum	LIQUID	ORAL	20150507		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; EQUISETUM ARVENSE TOP; MARSDENIA CONDURANGO BARK; MATRICARIA RECUTITA; PEUMUS BOLDUS LEAF; TIN; VIOLA TRICOLOR	12; 4; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1103_c72e26cf-59a9-fae7-e053-2a95a90a6a00	62106-1103	HUMAN OTC DRUG	UNDA 4		Laurus nobilis, Condurango, Rhamnus frangula, Menyanthes trifoliata, Absinthium, Jateorhiza palmata, Argentum metallicum, Antimonium crudum	LIQUID	ORAL	20150601		UNAPPROVED HOMEOPATHIC		Seroyal USA	ANTIMONY TRISULFIDE; BAY LEAF; FRANGULA ALNUS BARK; JATEORHIZA CALUMBA ROOT; MARSDENIA CONDURANGO BARK; MENYANTHES TRIFOLIATA; SILVER; WORMWOOD	12; 4; 4; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
62106-1104_c73082d2-60ff-4cbf-e053-2a95a90a8f9b	62106-1104	HUMAN OTC DRUG	UNDA 5		Tormentilla, Tussilago farfara, Adiantum capillus-veneris, Glycyrrhiza glabra, Drosera, Grindelia, Inula helenium, Cuprum metallicum, Argentum metallicum	LIQUID	ORAL	20150602		UNAPPROVED HOMEOPATHIC		Seroyal USA	ADIANTUM CAPILLUS-VENERIS LEAF; COPPER; DROSERA ROTUNDIFOLIA FLOWERING TOP; GLYCYRRHIZA GLABRA; GRINDELIA HIRSUTULA FLOWERING TOP; INULA HELENIUM ROOT; POTENTILLA ERECTA ROOT; SILVER; TUSSILAGO FARFARA WHOLE	4; 12; 4; 4; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1105_ebe194aa-984d-8373-e053-2995a90ae03e	62106-1105	HUMAN OTC DRUG	UNDA 6		Senna Leaflet, Rhamnus frangula Bark, Carum carvi, Foeniculum vulgare, Illicium verum, Rhamnus cathartica, Argentum metallicum	LIQUID	ORAL	20150526		UNAPPROVED HOMEOPATHIC		Seroyal USA	CARAWAY SEED; FENNEL SEED; FRANGULA ALNUS BARK; ILLICIUM VERUM WHOLE; RHAMNUS CATHARTICA FRUIT; SENNA LEAF; SILVER	4; 4; 4; 4; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62106-1106_c731175a-04a5-5d25-e053-2995a90a6082	62106-1106	HUMAN OTC DRUG	Unda 7		Equisetum arvense, Uva-ursi, Juniperus communis, Cytisus scoparius, Hieraciumpilosella, Argentum metallicum	LIQUID	ORAL	20150507		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARCTOSTAPHYLOS UVA-URSI LEAF; CYTISUS SCOPARIUS FLOWERING TOP; EQUISETUM ARVENSE TOP; HIERACIUM PILOSELLA WHOLE; JUNIPERUS COMMUNIS WHOLE; SILVER	4; 4; 4; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1107_c73082d2-60ff-4cbf-e053-2a95a90a8f9b	62106-1107	HUMAN OTC DRUG	UNDA 8		Hamamelis virginiana, Millefolium, Equisetum arvense, Mercurialis perennis, Thlaspi bursa-pastoris, Cactus grandiflorus, Crataegus, Cuprum metallicum	LIQUID	ORAL	20150602		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; CAPSELLA BURSA-PASTORIS; COPPER; CRATAEGUS FRUIT; EQUISETUM ARVENSE BRANCH; HAMAMELIS VIRGINIANA BARK; MERCURIALIS PERENNIS; SELENICEREUS GRANDIFLORUS STEM	4; 4; 12; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
62106-1108_ebe194aa-984d-8373-e053-2995a90ae03e	62106-1108	HUMAN OTC DRUG	UNDA 9		Mentha piperita, Melissa officinalis, Salvia pratensis, Thymus vulgaris, Valeriana officinalis, Aurum metallicum, Plumbum metallicum	LIQUID	ORAL	20150527		UNAPPROVED HOMEOPATHIC		Seroyal USA	GOLD; LEAD; MELISSA OFFICINALIS; MENTHA PIPERITA; SALVIA PRATENSIS LEAF; THYMUS VULGARIS WHOLE; VALERIAN	12; 12; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1109_ecfa1477-78a8-d93d-e053-2995a90af9b8	62106-1109	HUMAN OTC DRUG	UNDA 10		Absinthium, Argentum metallicum, Equisetum arvense, Juniperus communis, Millefolium, Rhamnus frangula	LIQUID	ORAL	20150929		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; EQUISETUM ARVENSE BRANCH; FRANGULA ALNUS BARK; JUNIPER BERRY; SILVER; WORMWOOD	4; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1110_ecfa9109-e935-ad4e-e053-2a95a90a372b	62106-1110	HUMAN OTC DRUG	Unda 11		Asparagus officinalis Young Shoot, Mentha piperita Whole Plant, Millefolium Whole Plant,Thymus serpyllum Whole Plant, Crocus sativus Dried Stigma, Rosmarinus officinalis Flowering Twigs, Glechoma hederacea Whole Plant, Verbena officinalis Whole Plant, Uva-ursi Leaf, Cuprum metallicum	LIQUID	ORAL	20150224		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; ARCTOSTAPHYLOS UVA-URSI LEAF; ASPARAGUS; COPPER; GLECHOMA HEDERACEA; MENTHA PIPERITA; ROSMARINUS OFFICINALIS FLOWERING TOP; SAFFRON; THYMUS SERPYLLUM; VERBENA OFFICINALIS	4; 4; 4; 12; 4; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
62106-1112_ecfac63b-c330-06d2-e053-2995a90aecba	62106-1112	HUMAN OTC DRUG	Unda 13		Boldo Leaf, Ricinus communis Seed, Combretum raimbaultii Leaf, Jateorhiza palmata Root, Argentum metallicum	LIQUID	ORAL	20141217		UNAPPROVED HOMEOPATHIC		Seroyal USA	COMBRETUM MICRANTHUM LEAF; JATEORHIZA CALUMBA ROOT; PEUMUS BOLDUS LEAF; RICINUS COMMUNIS SEED; SILVER	4; 4; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1113_c73082d2-60ff-4cbf-e053-2a95a90a8f9b	62106-1113	HUMAN OTC DRUG	UNDA 14		Eucalyptus globulus, Inula helenium, Jateorhiza palmata, Camphora, Argentum metallicum, Aurum metallicum, Cuprum metallicum	LIQUID	ORAL	20150602		UNAPPROVED HOMEOPATHIC		Seroyal USA	CAMPHOR (NATURAL); COPPER; EUCALYPTUS GLOBULUS LEAF; GOLD; INULA HELENIUM ROOT; JATEORHIZA CALUMBA ROOT; SILVER	4; 12; 4; 12; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1114_ddbf25ea-80d2-5725-e053-2a95a90abacc	62106-1114	HUMAN OTC DRUG	UNDA 15		Allium cepa, Aurum metallicum, Eucalyptus globulus, Inula helenium, Trigonella foenum-graecum	LIQUID	ORAL	20150525		UNAPPROVED HOMEOPATHIC		Seroyal USA	EUCALYPTUS GLOBULUS LEAF; FENUGREEK SEED; GOLD; INULA HELENIUM ROOT; ONION	4; 4; 12; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
62106-1115_c731175a-04a5-5d25-e053-2995a90a6082	62106-1115	HUMAN OTC DRUG	Unda 16		Saxifraga granulata, Origanum vulgare, Lactuca virosa, Veronica officinalis, Ajuga reptans, Drosera, Senega officinalis, Aurum metallicum, Argentum metallicum	LIQUID	ORAL	20150507		UNAPPROVED HOMEOPATHIC		Seroyal USA	AJUGA REPTANS WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; GOLD; LACTUCA VIROSA; ORIGANUM VULGARE SUBSP. HIRTUM WHOLE; POLYGALA SENEGA ROOT; SAXIFRAGA GRANULATA WHOLE; SILVER; VERONICA OFFICINALIS FLOWERING TOP	4; 4; 12; 4; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1116_ecfce43b-7241-2f77-e053-2a95a90a26bd	62106-1116	HUMAN OTC DRUG	Unda 17		Jateorhiza palmata, Boldo Leaf, Rhamnus frangula, Scabiosa succisa Underground Parts, Valeriana officinalis, Dulcamara, Rumex crispus, Argentum metallicum	LIQUID	ORAL	20150206		UNAPPROVED HOMEOPATHIC		Seroyal USA	CHAMAELIRIUM LUTEUM ROOT; FRANGULA ALNUS BARK; JATEORHIZA CALUMBA ROOT; PEUMUS BOLDUS LEAF; RUMEX CRISPUS ROOT; SILVER; SOLANUM DULCAMARA STEM; VALERIAN	4; 4; 4; 4; 4; 12; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1117_ed104a9f-7380-4f7b-e053-2995a90af948	62106-1117	HUMAN OTC DRUG	Unda 18		Condurango, Lycopodium clavatum, Viburnum prunifolium, Thuja occidentalis, Camphora, Cuprum metallicum, Aluminium metallicum, Stibium metallicum	LIQUID	ORAL	20150206		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; ANTIMONY; CINNAMOMUM CAMPHORA WHOLE; COPPER; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; THUJA OCCIDENTALIS LEAFY TWIG; VIBURNUM PRUNIFOLIUM BARK	12; 12; 9; 12; 5; 5; 5; 5	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
62106-1118_ed104a9f-7381-4f7b-e053-2995a90af948	62106-1118	HUMAN OTC DRUG	UNDA 19		Aluminium metallicum, Drosera, Illicium verum, Mentha piperita, Senega officinalis	LIQUID	ORAL	20170403		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; DROSERA ROTUNDIFOLIA FLOWERING TOP; PEPPERMINT; POLYGALA SENEGA ROOT; STAR ANISE FRUIT	12; 5; 5; 4; 3	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1119_ddbf25ea-80d2-5725-e053-2a95a90abacc	62106-1119	HUMAN OTC DRUG	UNDA 20		Aluminium metallicum, Argentum metallicum, Arsenicum album, Aurum metallicum, Calendula officinalis, Condurango, Jacaranda caroba, Robinia pseudoacacia, Sabina	LIQUID	ORAL	20150525		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; ARSENIC TRIOXIDE; CALENDULA OFFICINALIS FLOWERING TOP; GOLD; JACARANDA CAROBA LEAF; JUNIPERUS SABINA LEAF; MARSDENIA CONDURANGO BARK; ROBINIA PSEUDOACACIA BARK; SILVER	12; 12; 4; 12; 4; 4; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1120_ddbf25ea-80d2-5725-e053-2a95a90abacc	62106-1120	HUMAN OTC DRUG	UNDA 21		Condurango, Calendula officinalis, Camphora, Hydrastis canadensis, Thuja occidentalis, Aluminium metallicum, Aurum metallicum	LIQUID	ORAL	20150526		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; CALENDULA OFFICINALIS FLOWERING TOP; CAMPHOR (NATURAL); GOLD; GOLDENSEAL; MARSDENIA CONDURANGO BARK; THUJA OCCIDENTALIS LEAFY TWIG	12; 4; 4; 12; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1121_c732aeb0-c867-9e33-e053-2a95a90a129e	62106-1121	HUMAN OTC DRUG	UNDA 22		Absinthium, Aconitum napellus, Argentum metallicum, Boldo Leaf, Chamomilla, Coffea tosta, Jateorhiza palmata, Manganum oxydatum nigrum, Salvia officinalis	LIQUID	ORAL	20150921		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS; COFFEA ARABICA SEED, ROASTED; JATEORHIZA CALUMBA ROOT; MANGANESE DIOXIDE; MATRICARIA RECUTITA; PEUMUS BOLDUS LEAF; SAGE; SILVER; WORMWOOD	4; 4; 4; 12; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1122_ed1057a6-61b8-96ab-e053-2a95a90ae050	62106-1122	HUMAN OTC DRUG	Unda 23		Equisetum arvense, Hypericum perforatum, Nux vomica, Quercus robur, Tormentilla,	LIQUID	ORAL	20151214		UNAPPROVED HOMEOPATHIC		Seroyal USA	EQUISETUM ARVENSE BRANCH; HYPERICUM PERFORATUM; POTENTILLA ERECTA ROOT; QUERCUS ROBUR TWIG BARK; STRYCHNOS NUX-VOMICA SEED	5; 5; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62106-1123_ed105a0b-e43d-f544-e053-2a95a90ada3d	62106-1123	HUMAN OTC DRUG	Unda 24		Crataegus Fruit, Passiflora incarnata, Boldo Leaf, Valeriana officinalis Root, Chamomilla, Aluminium metallicum	LIQUID	ORAL	20150224		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; CRATAEGUS FRUIT; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWERING TOP; PEUMUS BOLDUS LEAF; VALERIAN	12; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1124_c732aeb0-c867-9e33-e053-2a95a90a129e	62106-1124	HUMAN OTC DRUG	UNDA 25		Argentum metallicum, Crataegus, Gelsemium sempervirens, Hamamelis virginiana, Magnolia grandiflora, Spiraea ulmaria, Stannum metallicum, Valeriana officinalis	LIQUID	ORAL	20150921		UNAPPROVED HOMEOPATHIC		Seroyal USA	CRATAEGUS FRUIT; FILIPENDULA ULMARIA ROOT; GELSEMIUM SEMPERVIRENS ROOT; HAMAMELIS VIRGINIANA BARK; MAGNOLIA GRANDIFLORA FLOWER; SILVER; TIN; VALERIAN	4; 4; 4; 4; 4; 12; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1125_ed106c48-b013-392c-e053-2995a90ab778	62106-1125	HUMAN OTC DRUG	Unda 26		Myrtus communis, Apis mellifica, Argentum metallicum	LIQUID	ORAL	20150224		UNAPPROVED HOMEOPATHIC		Seroyal USA	APIS MELLIFERA; MYRTUS COMMUNIS TOP; SILVER	4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
62106-1126_c732aeb0-c867-9e33-e053-2a95a90a129e	62106-1126	HUMAN OTC DRUG	UNDA 27		Antimonium crudum, Borago officinalis, Cetraria islandica, Drosera, Mentha piperita, Senega officinalis	LIQUID	ORAL	20150921		UNAPPROVED HOMEOPATHIC		Seroyal USA	ANTIMONY TRISULFIDE; BORAGE; CETRARIA ISLANDICA SUBSP. ISLANDICA; DROSERA ROTUNDIFOLIA FLOWERING TOP; MENTHA PIPERITA; POLYGALA SENEGA ROOT	12; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1127_ed10726b-54cc-4ab6-e053-2a95a90afb86	62106-1127	HUMAN OTC DRUG	UNDA 28		Lactuca virosa, Taraxacum officinale, Sarsaparilla, Spiraea ulmaria, Condurango, Aluminium metallicum, Cuprum metallicum, Stannum metallicum	LIQUID	ORAL	20150610		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; COPPER; FILIPENDULA ULMARIA ROOT; LACTUCA VIROSA; MARSDENIA CONDURANGO BARK; SARSAPARILLA; TARAXACUM OFFICINALE WHOLE; TIN	12; 12; 4; 4; 4; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
62106-1128_ed107ed6-cf0a-1d5a-e053-2a95a90af33b	62106-1128	HUMAN OTC DRUG	UNDA 29		Absinthium, Allium cepa, Argentum metallicum, Betula pendula Sap, Lamium album, Salvia officinalis	LIQUID	ORAL	20150921		UNAPPROVED HOMEOPATHIC		Seroyal USA	BETULA PENDULA WOOD; LAMIUM ALBUM; ONION; SAGE; SILVER; WORMWOOD	4; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
62106-1129_c732e823-2199-47df-e053-2a95a90aecb1	62106-1129	HUMAN OTC DRUG	Unda 30		Glechoma hederacea, Jateorhiza palmata, Lactuca virosa, Plumbum metallicum, Sempervivum tectorum, Taraxacum officinale, Valeriana officinalis	LIQUID	ORAL	20151214		UNAPPROVED HOMEOPATHIC		Seroyal USA	GLECHOMA HEDERACEA; JATEORHIZA CALUMBA ROOT; LACTUCA VIROSA; LEAD; SEMPERVIVUM TECTORUM LEAF; TARAXACUM OFFICINALE WHOLE; VALERIAN	4; 4; 4; 12; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1130_ed107ed6-cf0b-1d5a-e053-2a95a90af33b	62106-1130	HUMAN OTC DRUG	UNDA 31		Argentum metallicum, Camphora, Carduus benedictus, Juniperus communis, Lappa major, Robinia pseudoacacia	LIQUID	ORAL	20160327		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARCTIUM LAPPA ROOT; CENTAUREA BENEDICTA; CINNAMOMUM CAMPHORA WHOLE; JUNIPERUS COMMUNIS WHOLE; ROBINIA PSEUDOACACIA BARK; SILVER	4; 4; 12; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1131_ed108a25-7e6b-6b6d-e053-2995a90a0e11	62106-1131	HUMAN OTC DRUG	UNDA 32		Aconitum napellus, Argentum metallicum,Borago officinalis, Camphora, Grindelia, Stannum metallicum	LIQUID	ORAL	20160922		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS; BORAGE; CAMPHOR (NATURAL); GRINDELIA HIRSUTULA FLOWERING TOP; SILVER; TIN	4; 4; 4; 4; 12; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1132_ed10914f-854a-9467-e053-2995a90af82f	62106-1132	HUMAN OTC DRUG	Unda 33		Allium cepa, Tilia europaea, Jateorhiza palmata, Viola tricolor, Boldo Leaf, Anacardium orientale Frui, Aluminium metallicum	LIQUID	ORAL	20150206		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; JATEORHIZA CALUMBA ROOT; ONION; PEUMUS BOLDUS LEAF; SEMECARPUS ANACARDIUM JUICE; TILIA X EUROPAEA FLOWER; VIOLA TRICOLOR	12; 4; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
62106-1133_ed10726b-54cc-4ab6-e053-2a95a90afb86	62106-1133	HUMAN OTC DRUG	UNDA 34		Humulus lupulus, Juniperus communis, Equisetum arvense, Hydrastis canadensis, Syzygium jambolanum, Aurum metallicum	LIQUID	ORAL	20150610		UNAPPROVED HOMEOPATHIC		Seroyal USA	EQUISETUM ARVENSE BRANCH; GOLD; GOLDENSEAL; HOPS; JUNIPERUS COMMUNIS WHOLE; SYZYGIUM CUMINI SEED	4; 12; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
62106-1134_ed10a243-116f-a82f-e053-2a95a90a0cf6	62106-1134	HUMAN OTC DRUG	UNDA 35		Aurum metallicum, Corallium rubrum Exoskeleton, Crataegus, Grindelia, Hamamelis virginiana, Mentha piperita, Myrtus communis	LIQUID	ORAL	20150910		UNAPPROVED HOMEOPATHIC		Seroyal USA	CORALLIUM RUBRUM EXOSKELETON; CRATAEGUS FRUIT; GOLD; GRINDELIA HIRSUTULA FLOWERING TOP; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MENTHA PIPERITA; MYRTUS COMMUNIS TOP	12; 4; 12; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1135_ed10a778-ddc9-c29c-e053-2995a90aa5c3	62106-1135	HUMAN OTC DRUG	Unda 36		Aconitum napellus, Aesculus hippocastanum, Aluminium metallicum, Chelidonium majus, Hamamelis virginiana, Hydrastis canadensis, Hypericum perforatum	LIQUID	ORAL	20151214		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS; ALUMINUM; CHELIDONIUM MAJUS ROOT; GOLDENSEAL; HAMAMELIS VIRGINIANA BARK; HORSE CHESTNUT; HYPERICUM PERFORATUM	4; 12; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1136_c7331890-9cd0-098e-e053-2a95a90ac5c3	62106-1136	HUMAN OTC DRUG	Unda 37		Petroselinum sativum, Calendula officinalis, Dulcamara, Lycopodium clavatum, Hypericum perforatum, Aurum metallicum, Argentummetallicum	LIQUID	ORAL	20150116		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALENDULA OFFICINALIS FLOWERING TOP; GOLD; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; PETROSELINUM CRISPUM; SILVER; SOLANUM DULCAMARA STEM	4; 12; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1137_ed107ed6-cf0a-1d5a-e053-2a95a90af33b	62106-1137	HUMAN OTC DRUG	UNDA 38		Aluminium metallicum, Argentum metallicum, Inula helenium, Sarsaparilla, Stigmata maidis, Valeriana officinalis	LIQUID	ORAL	20150921		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; CORN SILK; INULA HELENIUM ROOT; SARSAPARILLA; SILVER; VALERIAN	12; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1138_ebe17695-25c1-19f2-e053-2a95a90a66ba	62106-1138	HUMAN OTC DRUG	Unda 39		Asafoetida Gum Resin,Absinthium, Allium cepa, Tanacetum vulgare Aerial Parts, Cina Flower-heads, Dryopteris filix-mas Rhizome, Argentum metallicum	LIQUID	ORAL	20150116		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARTEMISIA CINA PRE-FLOWERING TOP; ASAFETIDA; DRYOPTERIS FILIX-MAS ROOT; ONION; SILVER; TANACETUM VULGARE TOP; WORMWOOD	6; 4; 6; 4; 12; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
62106-1139_ddbf25ea-80d2-5725-e053-2a95a90abacc	62106-1139	HUMAN OTC DRUG	UNDA 40		Capsicum annuum, Pilocarpus, Thymus vulgaris, Urtica urens, Aurum metallicum, Cuprum metallicum	LIQUID	ORAL	20150526		UNAPPROVED HOMEOPATHIC		Seroyal USA	CAPSICUM; COPPER; GOLD; PILOCARPUS JABORANDI LEAF; THYMUS VULGARIS WHOLE; URTICA URENS	4; 12; 12; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
62106-1140_ddbf25ea-80d2-5725-e053-2a95a90abacc	62106-1140	HUMAN OTC DRUG	UNDA 41		Primula veris, Rheum, Juglans regia, Sarsaparilla, Nux vomica, Symphytum officinale, Plumbum metallicum	LIQUID	ORAL	20150526		UNAPPROVED HOMEOPATHIC		Seroyal USA	COMFREY ROOT; ENGLISH WALNUT; LEAD; PRIMULA VERIS; RHEUM TANGUTICUM WHOLE; SARSAPARILLA; STRYCHNOS NUX-VOMICA SEED	6; 4; 12; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nut Proteins [EXT], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62106-1141_c7333ab3-5b52-3805-e053-2995a90a48fc	62106-1141	HUMAN OTC DRUG	Unda 42		Arnica montana, Aconitum napellus, Gelsemium sempervirens, Aurum metallicum, Cuprum metallicum	LIQUID	ORAL	20150116		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS; ARNICA MONTANA; COPPER; GELSEMIUM SEMPERVIRENS ROOT; GOLD	4; 4; 12; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1142_ed10aff6-7a4c-4115-e053-2995a90a9d1a	62106-1142	HUMAN OTC DRUG	UNDA 43		Aluminium metallicum, Asperula odorata, Equisetum arvense, Jateorhiza palmata, Marrubium vulgare, Ocimum basilicum, Stannum metallicum	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALUMINUM; BASIL; EQUISETUM ARVENSE TOP; GALIUM ODORATUM; JATEORHIZA CALUMBA ROOT; MARRUBIUM VULGARE; TIN	12; 4; 4; 4; 4; 4; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1143_e33beb53-7971-929e-e053-2995a90a6fa0	62106-1143	HUMAN OTC DRUG	Unda 44		Inula helenium Root, Juniperus communis berry, Uva-ursi Leaf, Dulcamara Stem and Leaf, Cytisus scoparius Aerial Parts, Stigmata maidis Style and Stigma, Argentum metallicum, Aurum metallicum	LIQUID	ORAL	20141217		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARCTOSTAPHYLOS UVA-URSI LEAF; CORN SILK; CYTISUS SCOPARIUS FLOWERING TOP; GOLD; INULA HELENIUM ROOT; JUNIPER BERRY; SILVER; SOLANUM DULCAMARA STEM	4; 4; 4; 12; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
62106-1144_c731175a-04a5-5d25-e053-2995a90a6082	62106-1144	HUMAN OTC DRUG	Unda 45		Equisetum arvense, Millefolium, Saxifraga granulata, Dulcamara, Uva-ursi, Argentum metallicum, Stannum metallicum	LIQUID	ORAL	20150507		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; ARCTOSTAPHYLOS UVA-URSI LEAF; EQUISETUM ARVENSE TOP; SAXIFRAGA GRANULATA WHOLE; SILVER; SOLANUM DULCAMARA TOP; TIN	5; 5; 5; 5; 12; 5; 12	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1145_ed10b66a-90db-2fed-e053-2995a90a8e0b	62106-1145	HUMAN OTC DRUG	Unda 46		Absinthium, Jateorhiza palmata Root, Condurango Bark, Mentha piperita, Aloe socotrina, Argentum metallicum	LIQUID	ORAL	20150209		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALOE; JATEORHIZA CALUMBA ROOT; MARSDENIA CONDURANGO BARK; MENTHA PIPERITA; SILVER; WORMWOOD	10; 4; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1146_ed10aff6-7a4c-4115-e053-2995a90a9d1a	62106-1146	HUMAN OTC DRUG	UNDA 47		Absinthium, Arnica montana, Aurum metallicum, Jateorhiza palmata, Rosmarinus officinalis, Stibium metallicum, Thymus vulgaris, Valeriana officinalis	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	ANTIMONY; ARNICA MONTANA ROOT; GOLD; JATEORHIZA CALUMBA ROOT; ROSEMARY; THYMUS VULGARIS WHOLE; VALERIAN; WORMWOOD	15; 6; 12; 6; 6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1147_c731175a-04a5-5d25-e053-2995a90a6082	62106-1147	HUMAN OTC DRUG	Unda 48		Condurango, Calendula officinalis, Lycopodium clavatum, Sabina, Thuja occidentalis, Aurum metallicum, Plumbum metallicum, Arsenicum album	LIQUID	ORAL	20150508		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARSENIC TRIOXIDE; CALENDULA OFFICINALIS FLOWERING TOP; GOLD; JUNIPERUS SABINA LEAF; LEAD; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; THUJA OCCIDENTALIS LEAFY TWIG	12; 4; 12; 4; 12; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1148_ed10c599-4cdf-6bf0-e053-2995a90a88b7	62106-1148	HUMAN OTC DRUG	UNDA 49		Aurum metallicum, Condurango Bark, Hypericum perforatum, Ocimum basilicum, Plumbum metallicum	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	BASIL; GOLD; HYPERICUM PERFORATUM; LEAD; MARSDENIA CONDURANGO BARK	5; 12; 5; 12; 5	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
62106-1149_c72e26cf-59a9-fae7-e053-2a95a90a6a00	62106-1149	HUMAN OTC DRUG	UNDA 50		Boldo Leaf, Senna Leaflet, Carduus marianus, Millefolium, Aluminium metallicum, Argentum metallicum	LIQUID	ORAL	20150601		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; ALUMINUM; PEUMUS BOLDUS LEAF; SENNA LEAF; SILVER; SILYBUM MARIANUM SEED	4; 12; 4; 4; 12; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1150_ed10c599-4cdf-6bf0-e053-2995a90a88b7	62106-1150	HUMAN OTC DRUG	UNDA 74		Boldo Leaf, Cynara scolymus, Hamamelis virginiana, Lycopodium clavatum, Sepia Inky Juice	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	CYNARA SCOLYMUS LEAF; HAMAMELIS VIRGINIANA BARK; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; SEPIA OFFICINALIS JUICE	4; 4; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1151_ed10c599-4cf5-6bf0-e053-2995a90a88b7	62106-1151	HUMAN OTC DRUG	UNDA 76		aloe, marrubium vulgare, orthosiphon stamineus, sarsaparilla, senna, viola tricolor	LIQUID	ORAL	20160518		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALOE; CLERODENDRANTHUS SPICATUS LEAF; MARRUBIUM VULGARE; SARSAPARILLA; SENNA LEAF; VIOLA TRICOLOR	10; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1152_c732aeb0-c867-9e33-e053-2a95a90a129e	62106-1152	HUMAN OTC DRUG	UNDA 12		Argentum metallicum, Aurum metallicum, Dulcamara, Fagopyrum esculentum, Illicium verum, Lappa major, Salvia officinalis, Sarsaparilla, Staphysagria, Viola tricolor	LIQUID	ORAL	20150921		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARCTIUM LAPPA ROOT; DELPHINIUM STAPHISAGRIA SEED; FAGOPYRUM ESCULENTUM; GOLD; SAGE; SARSAPARILLA; SILVER; SOLANUM DULCAMARA TOP; STAR ANISE FRUIT; VIOLA TRICOLOR	4; 12; 4; 12; 4; 4; 12; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
62106-1153_ed10d2a7-c18d-38ec-e053-2995a90a10ad	62106-1153	HUMAN OTC DRUG	Unda 203		Aesculus hippocastanum, Crataegus, Rheum, Stigmata maidis, Strophanthus gratus	LIQUID	ORAL	20160205		UNAPPROVED HOMEOPATHIC		Seroyal USA	CHINESE RHUBARB ROOT; CORN SILK; CRATAEGUS FRUIT; HORSE CHESTNUT; STROPHANTHUS GRATUS SEED	5; 5; 5; 5; 5	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1154_c7335cbe-8359-b482-e053-2a95a90a24ac	62106-1154	HUMAN OTC DRUG	UNDA 210		Boldo Leaf, Crataegus, Lactuca virosa, Passiflora incarnata, Valeriana officinalis	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	CRATAEGUS FRUIT; LACTUCA VIROSA; PASSIFLORA INCARNATA FLOWERING TOP; PEUMUS BOLDUS LEAF; VALERIAN	4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1155_c73082d2-60ff-4cbf-e053-2a95a90a8f9b	62106-1155	HUMAN OTC DRUG	UNDA 212		Menyanthes trifoliata, Viola tricolor, Hydrastis canadensis, Aloe socotrina	LIQUID	ORAL	20150602		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALOE; GOLDENSEAL; MENYANTHES TRIFOLIATA; VIOLA TRICOLOR	10; 10; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1156_ed10cda7-03ea-2f5e-e053-2a95a90a0500	62106-1156	HUMAN OTC DRUG	UNDA 219		Crataegus, Lactuca virosa, Passiflora incarnata, Thymus vulgaris, Valeriana officinalis	LIQUID	ORAL	20160327		UNAPPROVED HOMEOPATHIC		Seroyal USA	CRATAEGUS FRUIT; LACTUCA VIROSA; PASSIFLORA INCARNATA FLOWERING TOP; THYME; VALERIAN	4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
62106-1157_ed10dfda-193f-7f53-e053-2a95a90a72f7	62106-1157	HUMAN OTC DRUG	UNDA 220		Grindelia, Pilocarpus, Salvia officinalis, Senega officinalis, Stramonium, Valeriana officinalis	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	DATURA STRAMONIUM; GRINDELIA HIRSUTULA FLOWERING TOP; PILOCARPUS MICROPHYLLUS LEAF; POLYGALA SENEGA ROOT; SAGE; VALERIAN	6; 6; 6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1158_c73082d2-60ff-4cbf-e053-2a95a90a8f9b	62106-1158	HUMAN OTC DRUG	UNDA 226		Urtica dioica, Berberis vulgaris, Boldo, Juniperus communis, Aloe socotrina, Chelidonium majus	LIQUID	ORAL	20150602		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALOE; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; JUNIPER BERRY; PEUMUS BOLDUS LEAF; URTICA DIOICA	6; 6; 6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1159_ed10f0c8-8e7a-2f74-e053-2a95a90a2ed5	62106-1159	HUMAN OTC DRUG	Unda 228		Valeriana officinalis Root, Melissa officinalis Whole Plant, Verbena officinalis Whole Plant, Millefolium Whole Plant, Thymus vulgaris Aerial Parts, Passiflora incarnata Aerial Parts, Lactuca virosa Whole Plant	LIQUID	ORAL	20141217		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACHILLEA MILLEFOLIUM; LACTUCA VIROSA; MELISSA OFFICINALIS; PASSIFLORA INCARNATA FLOWERING TOP; THYME; VALERIAN; VERBENA OFFICINALIS	4; 4; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
62106-1160_ed11cd4e-d7ca-8446-e053-2995a90afd6e	62106-1160	HUMAN OTC DRUG	Unda 233		Rheum, Crataegus, Uva-ursi, Rhus toxicodendron, Hamamelis virginiana	LIQUID	ORAL	20150116		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARCTOSTAPHYLOS UVA-URSI LEAF; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HAWTHORN LEAF WITH FLOWER; RHEUM TANGUTICUM WHOLE; TOXICODENDRON PUBESCENS LEAF	4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1161_ed11e5b0-cdb0-1f9a-e053-2995a90a0f16	62106-1161	HUMAN OTC DRUG	UNDA 240		Equisetum arvense, Gentiana lutea, Salvia officinalis, Saxifraga granulata, Spiraea ulmaria	LIQUID	ORAL	20161214		UNAPPROVED HOMEOPATHIC		Seroyal USA	EQUISETUM ARVENSE BRANCH; FILIPENDULA ULMARIA ROOT; GENTIANA LUTEA ROOT; SAGE; SAXIFRAGA GRANULATA FLOWERING TOP	6; 6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1162_ecfa1477-78a8-d93d-e053-2995a90af9b8	62106-1162	HUMAN OTC DRUG	UNDA 243		Boldo Leaf, Cholesterinum, Combretum micranthum, Lycopodium clavatum, Podophyllum peltatum	LIQUID	ORAL	20150929		UNAPPROVED HOMEOPATHIC		Seroyal USA	CHOLESTEROL; COMBRETUM MICRANTHUM LEAF; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PODOPHYLLUM PELTATUM ROOT	12; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1163_ed123143-3d42-efb9-e053-2995a90a065c	62106-1163	HUMAN OTC DRUG	Unda 245		Rheum, Viburnum prunifolium, Thuja occidentalis, Pulsatilla, Fagopyrum esculentum	LIQUID	ORAL	20150119		UNAPPROVED HOMEOPATHIC		Seroyal USA	FAGOPYRUM ESCULENTUM; PULSATILLA VULGARIS; RHEUM TANGUTICUM WHOLE; THUJA OCCIDENTALIS LEAFY TWIG; VIBURNUM PRUNIFOLIUM BARK	4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1164_ed123cdf-4e72-2c64-e053-2995a90a59e3	62106-1164	HUMAN OTC DRUG	UNDA 248		Crataegus, Magnolia grandiflora, Passiflora incarnata, Strophanthus gratus	LIQUID	ORAL	20170704		UNAPPROVED HOMEOPATHIC		Seroyal USA	CRATAEGUS FRUIT; MAGNOLIA GRANDIFLORA FLOWER; PASSIFLORA INCARNATA FLOWERING TOP; STROPHANTHUS GRATUS SEED	4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1165_c73082d2-60ff-4cbf-e053-2a95a90a8f9b	62106-1165	HUMAN OTC DRUG	UNDA 258		Berberis vulgaris, Bryonia dioica, Lycopodium clavatum, Mercurialis annua, Hydrastis canadensis, Boldo, Solidago virgaurea	LIQUID	ORAL	20150602		UNAPPROVED HOMEOPATHIC		Seroyal USA	BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MERCURIALIS ANNUA FLOWERING TOP; PEUMUS BOLDUS LEAF; SOLIDAGO VIRGAUREA FLOWERING TOP	4; 4; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1166_c733a765-4fc8-33c0-e053-2995a90a499e	62106-1166	HUMAN OTC DRUG	UNDA 270		Calendula officinalis, Dulcamara, Equisetum arvense, Hypericum perforatum	LIQUID	ORAL	20171017		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALENDULA OFFICINALIS FLOWERING TOP; EQUISETUM ARVENSE BRANCH; HYPERICUM PERFORATUM; SOLANUM DULCAMARA STEM	4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1167_ed10dfda-193f-7f53-e053-2a95a90a72f7	62106-1167	HUMAN OTC DRUG	UNDA 273		Arnica montana, Equisetum arvense, Polygonum hydropiperoides, Rubus fruticosus, Verbascum densiflorum	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA ROOT; EQUISETUM ARVENSE BRANCH; PERSICARIA PUNCTATA; RUBUS FRUTICOSUS LEAF; VERBASCUM DENSIFLORUM FLOWERING TOP	4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1168_ebe194aa-984d-8373-e053-2995a90ae03e	62106-1168	HUMAN OTC DRUG	UNDA 295		Pulsatilla, Nux vomica, Aloe socotrina	LIQUID	ORAL	20150527		UNAPPROVED HOMEOPATHIC		Seroyal USA	ALOE; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED	6; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62106-1169_c733ec78-5b43-7a7c-e053-2995a90a2f9a	62106-1169	HUMAN OTC DRUG	UNDA 312		Angelica archangelica, Drosera, Grindelia, Lamium album, Pinus sylvestris, Rubus fruticosus, Senega officinalis	LIQUID	ORAL	20150923		UNAPPROVED HOMEOPATHIC		Seroyal USA	ANGELICA ARCHANGELICA ROOT; DROSERA ROTUNDIFOLIA FLOWERING TOP; GRINDELIA HIRSUTULA FLOWERING TOP; LAMIUM ALBUM; PINUS SYLVESTRIS LEAFY TWIG; POLYGALA SENEGA ROOT; RUBUS FRUTICOSUS LEAF	6; 6; 6; 6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1170_ed12a71d-e8f3-b336-e053-2a95a90a4f09	62106-1170	HUMAN OTC DRUG	UNDA 600		Berberis vulgaris, Rheum, Rhus toxicodendron	LIQUID	ORAL	20170505		UNAPPROVED HOMEOPATHIC		Seroyal USA	BERBERIS VULGARIS ROOT BARK; RHEUM OFFICINALE ROOT; TOXICODENDRON PUBESCENS SHOOT	6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1171_c733ec78-5b43-7a7c-e053-2995a90a2f9a	62106-1171	HUMAN OTC DRUG	UNDA 700		Berberis vulgaris, Calcarea fluorica	LIQUID	ORAL	20150923		UNAPPROVED HOMEOPATHIC		Seroyal USA	BERBERIS VULGARIS ROOT BARK; CALCIUM FLUORIDE	4; 12	[hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1172_ed10a243-116f-a82f-e053-2a95a90a0cf6	62106-1172	HUMAN OTC DRUG	UNDA 710		Apis mellifica, Calendula officinalis, Lycopodium clavatum, Dulcamara, Aurum metallicum	LIQUID	ORAL	20150910		UNAPPROVED HOMEOPATHIC		Seroyal USA	APIS MELLIFERA; CALENDULA OFFICINALIS FLOWERING TOP; GOLD; LYCOPODIUM CLAVATUM SPORE; SOLANUM DULCAMARA TOP	4; 4; 12; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
62106-1173_ed12fac1-c818-2486-e053-2995a90a0824	62106-1173	HUMAN OTC DRUG	UNDA 1000		Rubus fruticosus, Spongia tosta, Calendula officinalis, Drosera	LIQUID	ORAL	20150923		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALENDULA OFFICINALIS FLOWERING TOP; DROSERA ROTUNDIFOLIA FLOWERING TOP; RUBUS FRUTICOSUS LEAF; SPONGIA OFFICINALIS SKELETON, ROASTED	4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1174_ebe194aa-984d-8373-e053-2995a90ae03e	62106-1174	HUMAN OTC DRUG	UNDA 1001		Thymus vulgaris, Valeriana officinalis, Lactuca virosa, Passiflora incarnata	LIQUID	ORAL	20150527		UNAPPROVED HOMEOPATHIC		Seroyal USA	LACTUCA VIROSA; PASSIFLORA INCARNATA FLOWERING TOP; THYMUS VULGARIS WHOLE; VALERIAN	6; 6; 6; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1175_ed13065b-c454-641d-e053-2a95a90ace02	62106-1175	HUMAN OTC DRUG	UNDA 1002		Allium sativum, Bryonia dioica, Cynara scolymus, Hamamelis virginiana, Ranunculus ficaria, Rhus toxicodendron, Sarsaparilla	LIQUID	ORAL	20180504		UNAPPROVED HOMEOPATHIC		Seroyal USA	BRYONIA DIOICA ROOT; CYNARA SCOLYMUS LEAF; GARLIC; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; RANUNCULUS FICARIA; SARSAPARILLA; TOXICODENDRON PUBESCENS SHOOT	6; 4; 4; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62106-1176_c7335cbe-8359-b482-e053-2a95a90a24ac	62106-1176	HUMAN OTC DRUG	UNDA 202		Aurum metallicum, Calcarea fluorica, Cuprum metallicum, Gelsemium sempervirens, Sulphur	LIQUID	ORAL	20150922		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALCIUM FLUORIDE; COPPER; GELSEMIUM SEMPERVIRENS WHOLE; GOLD; SULFUR	12; 12; 4; 12; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-1177_dc794e74-8ef3-7942-e053-2a95a90a2bea	62106-1177	HUMAN OTC DRUG	Calendula Cream		Calendula officinalis	CREAM	TOPICAL	20150120		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/40g			N	20241231
62106-1179_ed11daca-52e5-90f4-e053-2a95a90aec4b	62106-1179	HUMAN OTC DRUG	Cheliderm Cream		Thuja occidentalis, Calendula officinalis	CREAM	TOPICAL	20170404		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALENDULA OFFICINALIS FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	1; 1	[hp_X]/40g; [hp_X]/40g			N	20241231
62106-1180_dc794e74-8ef3-7942-e053-2a95a90a2bea	62106-1180	HUMAN OTC DRUG	Arnica Cream		Arnica montana	CREAM	TOPICAL	20150120		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP	1; 1	[hp_X]/40g; [hp_X]/40g			N	20241231
62106-1183_ed11ed9c-1d48-d766-e053-2a95a90aa977	62106-1183	HUMAN OTC DRUG	ECHINASYR		Echinacea purpurea	LIQUID	ORAL	20150121		UNAPPROVED HOMEOPATHIC		Seroyal USA	ECHINACEA PURPUREA	18.125	g/125mL			N	20241231
62106-1192_c71c3286-bc19-2a97-e053-2995a90aeba2	62106-1192	HUMAN OTC DRUG	ALLIUM CEPA PLEX		Allium cepa, Belladonna, Euphrasia officinalis, Hydrastis canadensis, Kali bichromicum, Mercurius dulcis, Sambucus nigra	LIQUID	SUBLINGUAL	20151215		UNAPPROVED HOMEOPATHIC		Seroyal USA	ATROPA BELLADONNA WHOLE; CALOMEL; EUPHRASIA STRICTA; GOLDENSEAL; ONION; POTASSIUM DICHROMATE; SAMBUCUS NIGRA FLOWERING TOP	6; 6; 6; 6; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
62106-1194_c72c4b1e-d849-9aa6-e053-2995a90ac5b2	62106-1194	HUMAN OTC DRUG	Drosera Plex		Arnica montana, Belladonna, Cina, Coccus cacti, Corallium rubrum, Cuprum metallicum, Drosera, Ferrum phosphoricum, Ipecacuanha, Solidago virgaurea	LIQUID	SUBLINGUAL	20161214		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA ROOT; ARTEMISIA CINA FLOWER; ATROPA BELLADONNA WHOLE; COPPER; CORALLIUM RUBRUM EXOSKELETON; DROSERA ROTUNDIFOLIA FLOWERING TOP; FERRUM PHOSPHORICUM; IPECAC; PROTORTONIA CACTI; SOLIDAGO VIRGAUREA FLOWERING TOP	6; 6; 6; 6; 6; 6; 6; 6; 6; 2	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
62106-1195_ed11daca-52e6-90f4-e053-2a95a90aec4b	62106-1195	HUMAN OTC DRUG	LOBELIA PLEX		Antimonium sulphuratum aureum, Arsenicum iodatum, Blatta orientalis, Eriodictyon californicum, Ipecacuanha, Lobelia inflata, Natrum sulphuricum, Sambucus nigra, Senega officinalis	LIQUID	ORAL	20151216		UNAPPROVED HOMEOPATHIC		Seroyal USA	ANTIMONY PENTASULFIDE; ARSENIC TRIIODIDE; BLATTA ORIENTALIS; ERIODICTYON CALIFORNICUM LEAF; IPECAC; LOBELIA INFLATA; POLYGALA SENEGA ROOT; SAMBUCUS NIGRA FLOWERING TOP; SODIUM SULFATE	8; 8; 6; 3; 4; 8; 1; 1; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
62106-1196_ed11f0cb-f2b2-732a-e053-2a95a90a6c45	62106-1196	HUMAN OTC DRUG	UNDA 243		Boldo, Cholesterinum, Taraxacum officinale, Lycopodium clavatum, Podophyllum peltatum	LIQUID	ORAL	20200401		UNAPPROVED HOMEOPATHIC		Seroyal USA	CHOLESTEROL; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PODOPHYLLUM; TARAXACUM OFFICINALE	12; 4; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62106-1198_b13f4f29-5fa8-7903-e053-2995a90a5a70	62106-1198	HUMAN OTC DRUG	PAEONIA Plex		Aesculus hippocastanum,Arnica montana, Graphites, Hamamelis virginiana, Nitricum acidum, Nux vomica, Paeonia officinalis, Sulphur	LIQUID	SUBLINGUAL	20151020		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA ROOT; GRAPHITE; HAMAMELIS VIRGINIANA BARK; HORSE CHESTNUT; NITRIC ACID; PAEONIA OFFICINALIS ROOT; STRYCHNOS NUX-VOMICA SEED; SULFUR	4; 4; 4; 3; 4; 4; 4; 6	[hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62106-1200_c718c221-1754-e3b4-e053-2995a90a5aa7	62106-1200	HUMAN OTC DRUG	CARDUUS PLEX		belladonna, carduus marianus, chelidonium majus, cholesterinum, cinchona succirubra, colocynthis, leptandra virginica, lycopodium clavatum, podophyllum peltatum, taraxacum officinale	LIQUID	ORAL	20160518		UNAPPROVED HOMEOPATHIC		Seroyal USA	ATROPA BELLADONNA; CHELIDONIUM MAJUS; CHOLESTEROL; CINCHONA PUBESCENS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; CULVER'S ROOT; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PODOPHYLLUM PELTATUM ROOT; TARAXACUM OFFICINALE	4; 2; 4; 3; 6; 1; 4; 2; 4; 2	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
62106-1201_c71a3d87-ca58-3967-e053-2a95a90a2a3b	62106-1201	HUMAN OTC DRUG	Chelidonium Plex		Chelidonium majus, Carduus marianus, Solidago virgaurea, Berberis vulgaris, Dolichos pruriens, Iris versicolor, Ptelea trifoliata, Taraxacum officinale	LIQUID	ORAL	20141217		UNAPPROVED HOMEOPATHIC		Seroyal USA	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; IRIS VERSICOLOR ROOT; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE	10; 10; 10; 3; 10; 10; 3; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
62106-1202_ed11e5b0-cdb1-1f9a-e053-2995a90a0f16	62106-1202	HUMAN OTC DRUG	KALIUM CARBONICUM PLEX		Asafoetida, Carbo vegetabilis, Cinchona succirubra, Kali carbonicum, Lycopodium clavatum, Nux moschata, Nux vomica, Raphanus sativus var niger	LIQUID	SUBLINGUAL	20151216		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACTIVATED CHARCOAL; ASAFETIDA; CINCHONA PUBESCENS BARK; LYCOPODIUM CLAVATUM SPORE; NUTMEG; POTASSIUM CARBONATE; RAPHANUS SATIVUS; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62106-1205_075f36e1-10fa-e839-e063-6294a90a89d7	62106-1205	HUMAN OTC DRUG	ACIDUM PHOSPHORICUM PLEX		Anacardium orientale, Argentum nitricum, Arnica montana, Avena sativa, Gelsemium sempervirens, Kali phosphoricum, Phosphoricum acidum, Selenium metallicum	LIQUID	SUBLINGUAL	20151215	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA ROOT; AVENA SATIVA FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SELENIUM; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE	6; 3; 6; 6; 6; 6; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	
62106-1207_ed11e5b0-cdb2-1f9a-e053-2995a90a0f16	62106-1207	HUMAN OTC DRUG	CHOLESTERINUM PLEX		Cholesterinum, Cholesterinum, Hepatinum, Pulminum	LIQUID	ORAL	20170816		UNAPPROVED HOMEOPATHIC		Seroyal USA	CHOLESTEROL; ORYCTOLAGUS CUNICULUS LIVER; ORYCTOLAGUS CUNICULUS LUNG	9; 7; 7	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL			N	20241231
62106-1209_c72d4371-5687-79b0-e053-2995a90ab405	62106-1209	HUMAN OTC DRUG	JUNCTURINUM PLEX		Cartilaginum, Juncturinum, Ligamentinum, Osseinum,	LIQUID	SUBLINGUAL	20151022		UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS BONE; ORYCTOLAGUS CUNICULUS CARTILAGE; ORYCTOLAGUS CUNICULUS KNEE JOINT; ORYCTOLAGUS CUNICULUS LIGAMENT	5; 5; 5; 5	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL			N	20241231
62106-1229_ed11e5b0-cdb3-1f9a-e053-2995a90a0f16	62106-1229	HUMAN OTC DRUG	Angiplex		Arum triphyllum, Aconitum napellus, Apis mellifica, Belladonna, Phytolacca decandra, Kali bichromicum, Lachesis mutus, Mercurius solubilis	TABLET	SUBLINGUAL	20150119		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS; APIS MELLIFERA; ARISAEMA TRIPHYLLUM ROOT; ATROPA BELLADONNA; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE	8; 8; 4; 8; 10; 10; 8; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
62106-1233_ed11ed9c-1d49-d766-e053-2a95a90aa977	62106-1233	HUMAN OTC DRUG	PYROGENIUM PLEX		Arsenicum album, Hepar sulphuris calcareum, Hydrastis canadensis, Kali bichromicum, Kali iodatum, Pyrogenium	LIQUID	ORAL	20151216		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARSENIC TRIOXIDE; CALCIUM SULFIDE; GOLDENSEAL; POTASSIUM DICHROMATE; POTASSIUM IODIDE; RANCID BEEF	5; 5; 5; 5; 5; 6	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL			N	20241231
62106-1235_c71e791a-cfbb-6f52-e053-2995a90af4d4	62106-1235	HUMAN OTC DRUG	Melange combination		Calcarea sulphurica, Calcium phosphoricum, Kali muriaticum, Kalium phosphoricum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, Natrium sulfuricum, Calcarea fluorica, Ferrum phosphoricum, Silicea	TABLET	ORAL	20141212		UNAPPROVED HOMEOPATHIC		Seroyal USA	CALCIUM FLUORIDE; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE	12; 6; 6; 12; 6; 6; 6; 6; 12; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62106-1238_ed11e5b0-cdb5-1f9a-e053-2995a90a0f16	62106-1238	HUMAN OTC DRUG	ANTI-WART		Bufo rana, Buxus sempervirens, Juglans regia, Nitricum acidum, Oleander, Stannum metallicum, Sulphur, Taxus baccata, Thuja occidentalis, Vanadium metallicum	LIQUID	ORAL	20170403		UNAPPROVED HOMEOPATHIC		Seroyal USA	BUFO BUFO CUTANEOUS GLAND; BUXUS SEMPERVIRENS LEAFY TWIG; ENGLISH WALNUT; NERIUM OLEANDER LEAF; NITRIC ACID; SULFUR; TAXUS BACCATA WHOLE; THUJA OCCIDENTALIS LEAFY TWIG; TIN; VANADIUM	12; 6; 2; 6; 10; 10; 6; 8; 10; 10	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
62106-1322_c72da14a-dfce-c8a3-e053-2995a90a7983	62106-1322	HUMAN OTC DRUG	Passiflora Plex		Passiflora incarnata, Ignatia amara, Jalapa, Coffea cruda, Magnesium metalicum, Palladium metallicum, Tellurium metallicum, Phosphoricum acidum	LIQUID	SUBLINGUAL	20150209		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARABICA COFFEE BEAN; IPOMOEA PURGA ROOT; MAGNESIUM; PALLADIUM; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORIC ACID; STRYCHNOS IGNATII SEED; TELLURIUM	10; 8; 10; 10; 3; 14; 8; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62106-1400_075f24f2-c29a-14d1-e063-6294a90aea09	62106-1400	HUMAN OTC DRUG	Allergiplex		Apis mellifica, Pulmo anaphylactica, Pollantinum	TABLET	SUBLINGUAL	20150209	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	APIS MELLIFERA; BEE POLLEN; HISTAMINE	15; 30; 15	[hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	
62106-2612_ed11f0cb-f2b3-732a-e053-2a95a90a6c45	62106-2612	HUMAN OTC DRUG	CAN ALBEX 30X		Candida albicans	LIQUID	SUBLINGUAL	20160327		UNAPPROVED HOMEOPATHIC		Seroyal USA	CANDIDA ALBICANS	30	[hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
62106-3126_ed11ed9c-1d4f-d766-e053-2a95a90aa977	62106-3126	HUMAN OTC DRUG	Drosera Plex		Cough Syrup	SYRUP	ORAL	20170906		UNAPPROVED HOMEOPATHIC		Seroyal USA	DROSERA ROTUNDIFOLIA; HYOSCYAMUS NIGER; IPECAC; LACHESIS MUTA VENOM; OREGANO FLOWERING TOP; PAPAVER RHOEAS FLOWER; PULSATILLA PRATENSIS; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; SULFUR	3; 10; 6; 10; 7; 5; 8; 10; 10; 8	[hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL; [hp_X]/180mL			N	20241231
62106-3152_c71eb176-d09b-45b3-e053-2a95a90a53df	62106-3152	HUMAN OTC DRUG	CICATRISAN Cream		Calendula officinalis, Phytolacca decandra, Bryonia dioica, Balsamum peruvianum, Dulcamara	CREAM	TOPICAL	20150507		UNAPPROVED HOMEOPATHIC		Seroyal USA	BALSAM PERU; BRYONIA DIOICA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; PHYTOLACCA AMERICANA ROOT; SOLANUM DULCAMARA TOP	1; 1; 1; 1; 1	[hp_X]/40g; [hp_X]/40g; [hp_X]/40g; [hp_X]/40g; [hp_X]/40g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
62106-3159_c71ee0b8-3c79-07b1-e053-2995a90a28de	62106-3159	HUMAN OTC DRUG	Proctosan Cream		Ratanhia, Aesculus hippocastanum, Collinsonia canadensis, Paeonia officinalis, Negundo	CREAM	TOPICAL	20151217		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACER NEGUNDO INNER BARK; COLLINSONIA CANADENSIS ROOT; HORSE CHESTNUT; KRAMERIA LAPPACEA ROOT; PAEONIA OFFICINALIS ROOT	1; 1; 1; 1; 1	[hp_X]/40g; [hp_X]/40g; [hp_X]/40g; [hp_X]/40g; [hp_X]/40g			N	20241231
62106-3611_06fcc433-2504-8d19-e063-6294a90a156c	62106-3611	HUMAN OTC DRUG	X RAY		X ray	GRANULE	ORAL	20150825	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	ALCOHOL, X-RAY EXPOSED (1000 RAD)	6	[hp_X]/1			N	
62106-4808_06e5e953-a4ef-6c6f-e063-6294a90a8597	62106-4808	HUMAN OTC DRUG	PHOSPHORICUM ACIDUM		Orthophosphoric acid	GRANULE	ORAL	20150722	20241031	UNAPPROVED HOMEOPATHIC		Seroyal USA	PHOSPHORIC ACID	3	[hp_X]/1			N	
62106-4878_05f76de7-40ad-6860-e063-6294a90a9052	62106-4878	HUMAN OTC DRUG	ARSENICUM ALBUM		Arsenic trioxide	GRANULE	ORAL	20150126	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ARSENIC TRIOXIDE	6	[hp_X]/1			N	
62106-4893_05f76de7-40ae-6860-e063-6294a90a9052	62106-4893	HUMAN OTC DRUG	AURUM METALLICUM		Metallic gold	GRANULE	ORAL	20150320	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	GOLD	3	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
62106-4944_0632d36f-df5e-7cf1-e063-6294a90a1203	62106-4944	HUMAN OTC DRUG	CALCAREA CARBONICA		Impure calcium carbonate	GRANULE	ORAL	20150317	20240430	UNAPPROVED HOMEOPATHIC		Seroyal USA	OYSTER SHELL CALCIUM CARBONATE, CRUDE	1	[hp_X]/1			N	
62106-4961_06343ef1-058b-5bde-e063-6294a90a6147	62106-4961	HUMAN OTC DRUG	CALCAREA SULPHURICA		Calcium sulfate	GRANULE	ORAL	20150430	20240430	UNAPPROVED HOMEOPATHIC		Seroyal USA	CALCIUM SULFATE ANHYDROUS	1	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
62106-4986_064813bd-d4b4-b0d5-e063-6294a90ac2ab	62106-4986	HUMAN OTC DRUG	CAUSTICUM		Hahnemanns causticum	GRANULE	ORAL	20150325	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	CAUSTICUM	3	[hp_X]/1			N	
62106-5062_06835782-1d35-8f53-e063-6294a90a39ff	62106-5062	HUMAN OTC DRUG	HEKLA LAVA		Hekla lava	GRANULE	ORAL	20150128	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	HEKLA LAVA	1	[hp_X]/1			N	
62106-5064_06833e54-0dfc-dd3d-e063-6394a90a32a0	62106-5064	HUMAN OTC DRUG	HEPAR SULPHURIS CALCAREUM		Impure calcium sulfide	GRANULE	ORAL	20150318	20240331	UNAPPROVED HOMEOPATHIC		Seroyal USA	CALCIUM SULFIDE	1	[hp_X]/1			N	
62106-5145_06c0d0c7-4aee-7c72-e063-6294a90a63a7	62106-5145	HUMAN OTC DRUG	MAGNESIA PHOSPHORICA		Magnesium hydrogen phosphate	GRANULE	ORAL	20150318	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	MAGNESIUM PHOSPHATE, DIBASIC	1	[hp_X]/1			N	
62106-5206_075fbe4d-5b80-f1ab-e063-6294a90adec8	62106-5206	HUMAN OTC DRUG	NATRUM MURIATICUM		Sodium chloride	GRANULE	ORAL	20150129	20240831	UNAPPROVED HOMEOPATHIC		Seroyal USA	SODIUM CHLORIDE	1	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	
62106-5220_075fbe4d-5b82-f1ab-e063-6294a90adec8	62106-5220	HUMAN OTC DRUG	NATRUM SULPHURICUM		Disodium sulfate	GRANULE	ORAL	20150129	20240331	UNAPPROVED HOMEOPATHIC		Seroyal USA	SODIUM SULFATE	1	[hp_X]/1			N	
62106-5249_06e61bbe-dbb6-aa96-e063-6394a90af8b4	62106-5249	HUMAN OTC DRUG	PHOSPHORUS		Phosphorus	GRANULE	ORAL	20150129	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	PHOSPHORUS	4	[hp_X]/1			N	
62106-5301_06e86339-8bb2-2eac-e063-6394a90acde8	62106-5301	HUMAN OTC DRUG	SILICEA		Silica	GRANULE	ORAL	20150130	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	SILICON DIOXIDE	2	[hp_X]/1			N	
62106-5316_06f9e3d8-5663-b690-e063-6294a90ad832	62106-5316	HUMAN OTC DRUG	SULPHUR		Sublimed sulfur	GRANULE	ORAL	20150130	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	SULFUR	1	[hp_X]/1			N	
62106-5612_ed111e0d-5b8d-b34f-e053-2a95a90a50fb	62106-5612	HUMAN OTC DRUG	Can Albex 500X		Candida albicans	LIQUID	SUBLINGUAL	20151217		UNAPPROVED HOMEOPATHIC		Seroyal USA	CANDIDA ALBICANS	500	[hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
62106-5925_0682a5df-e126-6356-e063-6394a90a353d	62106-5925	HUMAN OTC DRUG	FOLLICULINUM		Folliculin	GRANULE	ORAL	20150128	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ESTRONE	3	[hp_X]/1			N	
62106-6607_06472efa-d156-d303-e063-6394a90a596b	62106-6607	HUMAN OTC DRUG	CANTHARIS		Cantharides	GRANULE	ORAL	20150318	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	LYTTA VESICATORIA	3	[hp_X]/1			N	
62106-6654_06c0570f-e100-0904-e063-6394a90a66b3	62106-6654	HUMAN OTC DRUG	LACHESIS MUTUS		Bushmaster	GRANULE	ORAL	20150128	20240331	UNAPPROVED HOMEOPATHIC		Seroyal USA	LACHESIS MUTA VENOM	8	[hp_X]/1			N	
62106-6870_ed11f0cb-f2b5-732a-e053-2a95a90a6c45	62106-6870	HUMAN OTC DRUG	Muco coccinum		KLEBSIELLA PNEUMONIAE	TABLET	SUBLINGUAL	20141015		UNAPPROVED HOMEOPATHIC		Seroyal USA	ANAEROCOCCUS TETRADIUS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; KLEBSIELLA PNEUMONIAE; MORAXELLA CATARRHALIS SUBSP. CATARRHALIS	200; 200; 200; 200; 200	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
62106-6903_06e79289-06c3-8a1c-e063-6294a90a0747	62106-6903	HUMAN OTC DRUG	PSORINUM		Psorinum	GRANULE	ORAL	20181221	20240831	UNAPPROVED HOMEOPATHIC		Seroyal USA	SCABIES LESION LYSATE (HUMAN)	200	[hp_C]/1			N	
62106-6973_06325283-dd20-d1e5-e063-6394a90af141	62106-6973	HUMAN OTC DRUG	BULBINUM		Medulla oblongata	GRANULE	ORAL	20150722	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS SPINAL CORD	3	[hp_X]/1			N	
62106-6977_0648086d-302c-059e-e063-6294a90af536	62106-6977	HUMAN OTC DRUG	CEREBELLINUM		Cerebellum	GRANULE	ORAL	20150319	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS HYPOTHALAMUS	6	[hp_X]/1			N	
62106-6978_06485034-4504-8ff1-e063-6294a90ac422	62106-6978	HUMAN OTC DRUG	CEREBRINUM		Cerebrum	GRANULE	ORAL	20150612	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS HYPOTHALAMUS	6	[hp_X]/1			N	
62106-6982_065d2e4f-1736-5f71-e063-6394a90ae996	62106-6982	HUMAN OTC DRUG	CORPUS CALLOSUM		Corpus callosum	GRANULE	ORAL	20150325	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS WHOLE	6	[hp_X]/1			N	
62106-6988_065d82f5-79ae-0e47-e063-6394a90a660a	62106-6988	HUMAN OTC DRUG	DIENCEPHALINUM		Diencephalon	GRANULE	ORAL	20150319	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS HYPOTHALAMUS	6	[hp_X]/1			N	
62106-6991_067050a7-bc95-f1cb-e063-6394a90a2817	62106-6991	HUMAN OTC DRUG	EPIPHYSINUM		Pineal gland	GRANULE	ORAL	20150812	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS BONE	6	[hp_X]/1			N	
62106-7012_06837fae-ec16-c48d-e063-6294a90a1260	62106-7012	HUMAN OTC DRUG	HEPATINUM		Liver	GRANULE	ORAL	20150319	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS LIVER	6	[hp_X]/1			N	
62106-7013_068623f9-0f86-50bc-e063-6294a90aea00	62106-7013	HUMAN OTC DRUG	HYPOPHYSINUM		Pituitary gland	GRANULE	ORAL	20150318	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS LUNG	1	[hp_X]/1			N	
62106-7016_06862daa-daee-2225-e063-6394a90ab87c	62106-7016	HUMAN OTC DRUG	HYPOTHALAMUS		Hypothalamus	GRANULE	ORAL	20150722	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS HYPOTHALAMUS	3	[hp_X]/1			N	
62106-7078_06c0a276-a264-b159-e063-6394a90a3c37	62106-7078	HUMAN OTC DRUG	LUTEINUM		Corpus luteum	GRANULE	ORAL	20150320	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	SUS SCROFA CORPUS LUTEUM	3	[hp_X]/1			N	
62106-7086_06c0be42-cdaf-5216-e063-6294a90a438b	62106-7086	HUMAN OTC DRUG	MEDULLOSSEINUM		Bone marrow	GRANULE	ORAL	20150722	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS BONE	6	[hp_X]/1			N	
62106-7094_06c1149d-23b5-d994-e063-6294a90a686e	62106-7094	HUMAN OTC DRUG	NERVINUM		Nerve	GRANULE	ORAL	20150325	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS SPINAL CORD	6	[hp_X]/1			N	
62106-7109_06d52ad5-a884-e49b-e063-6394a90a4228	62106-7109	HUMAN OTC DRUG	OOPHORINUM		Ovary	GRANULE	ORAL	20150323	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	SUS SCROFA OVARY	6	[hp_X]/1			N	
62106-7110_06d52ee3-dd55-c18d-e063-6294a90ac193	62106-7110	HUMAN OTC DRUG	PANCREATINUM		Pancreatin	GRANULE	ORAL	20150505	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS WHOLE	3	[hp_X]/1			N	
62106-7117_06e622cc-1dbf-b1fb-e063-6294a90a5bff	62106-7117	HUMAN OTC DRUG	PILINUM		Hair bulb	GRANULE	ORAL	20150505	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS HAIR	6	[hp_X]/1	Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Hair Allergenic Extract [EPC], Salivary Proteins and Peptides [CS]		N	
62106-7122_06e7cbf0-f46e-aad4-e063-6394a90ab642	62106-7122	HUMAN OTC DRUG	PULMINUM		Lung	GRANULE	ORAL	20150825	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS LUNG	6	[hp_X]/1			N	
62106-7124_06e7fd78-42dd-cfd0-e063-6394a90a9fea	62106-7124	HUMAN OTC DRUG	RENINUM		Kidney	GRANULE	ORAL	20150930	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS KIDNEY	3	[hp_X]/1			N	
62106-7130_06e87a0e-e9a2-7cf9-e063-6294a90a5c9c	62106-7130	HUMAN OTC DRUG	SPLENINUM		Spleen	GRANULE	ORAL	20150323	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	SUS SCROFA SPLEEN	6	[hp_X]/1			N	
62106-7133_06fa00f8-18d7-7127-e063-6394a90a2adf	62106-7133	HUMAN OTC DRUG	SURRENINUM		Adrenal gland	GRANULE	ORAL	20170823	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	ORYCTOLAGUS CUNICULUS ADRENAL GLAND	6	[hp_X]/1			N	
62106-7140_06fc2f50-86e6-f678-e063-6394a90a2394	62106-7140	HUMAN OTC DRUG	THYROIDINUM		Thyroid	GRANULE	ORAL	20150324	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	THYROID, UNSPECIFIED	6	[hp_X]/1			N	
62106-7197_05cefbf8-9d3d-7395-e063-6294a90af004	62106-7197	HUMAN OTC DRUG	ACONITUM NAPELLUS		Aconite	GRANULE	ORAL	20150121	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS	3	[hp_X]/1			N	
62106-7264_05cff7a0-8e24-b7d0-e063-6294a90a2aac	62106-7264	HUMAN OTC DRUG	ALLIUM CEPA		Onion	GRANULE	ORAL	20150407	20240430	UNAPPROVED HOMEOPATHIC		Seroyal USA	ONION	1	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	
62106-7385_05f7269d-46b9-b917-e063-6294a90acf76	62106-7385	HUMAN OTC DRUG	ARNICA MONTANA, RADIX		Mountain arnica	GRANULE	ORAL	20150126	20241031	UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA	3	[hp_X]/1			N	
62106-7474_05f77f3a-40cb-7150-e063-6294a90a7265	62106-7474	HUMAN OTC DRUG	BELLADONNA		Deadly nightshade	GRANULE	ORAL	20150126	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	ATROPA BELLADONNA	3	[hp_X]/1			N	
62106-7482_05f77f3a-40cc-7150-e063-6294a90a7265	62106-7482	HUMAN OTC DRUG	BERBERIS VULGARIS		Barberry	GRANULE	ORAL	20150430	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	BERBERIS VULGARIS ROOT BARK	3	[hp_X]/1			N	
62106-7530_0631d415-6d39-2877-e063-6294a90a9c82	62106-7530	HUMAN OTC DRUG	BRYONIA ALBA		White bryony	GRANULE	ORAL	20150319	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	BRYONIA ALBA ROOT	3	[hp_X]/1			N	
62106-7668_ed11bb54-f97b-2ac2-e053-2995a90ae858	62106-7668	HUMAN OTC DRUG	CINCHONA OFFICINALIS		Cinchona	GRANULE	ORAL	20150612		UNAPPROVED HOMEOPATHIC		Seroyal USA	CINCHONA OFFICINALIS BARK	2	[hp_X]/1			N	20241231
62106-7669_064887d4-6462-cdeb-e063-6394a90a2891	62106-7669	HUMAN OTC DRUG	CINCHONA SUCCIRUBRA		Red cinchona	GRANULE	ORAL	20181123	20240430	UNAPPROVED HOMEOPATHIC		Seroyal USA	CINCHONA PUBESCENS WHOLE	30	[kp_C]/1			N	
62106-7736_065cefa9-0a59-9354-e063-6394a90ac993	62106-7736	HUMAN OTC DRUG	COFFEA CRUDA		Coffee	GRANULE	ORAL	20150325	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	ARABICA COFFEE BEAN	1	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
62106-7747_065cd940-d7b4-6bf5-e063-6394a90a1e6d	62106-7747	HUMAN OTC DRUG	COLOCYNTHIS		Colocynth	GRANULE	ORAL	20150407	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	CITRULLUS COLOCYNTHIS FRUIT PULP	3	[hp_X]/1			N	
62106-7926_06702e06-7c90-e07b-e063-6394a90a5fb4	62106-7926	HUMAN OTC DRUG	DULCAMARA		Bittersweet	GRANULE	ORAL	20150612	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	SOLANUM DULCAMARA STEM	2	[hp_X]/1			N	
62106-8020_0670e997-a5d4-788e-e063-6394a90a8b2f	62106-8020	HUMAN OTC DRUG	EUPHRASIA OFFICINALIS		Euphrasy	GRANULE	ORAL	20150612	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	EUPHRASIA STRICTA	1	[hp_X]/1			N	
62106-8075_0683038c-f52f-cc4a-e063-6294a90acc2f	62106-8075	HUMAN OTC DRUG	Gelsemium Sempervirens		Yellow jessamine	GRANULE	ORAL	20150128	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	GELSEMIUM SEMPERVIRENS ROOT	3	[hp_X]/1			N	
62106-8192_06862daa-dae8-2225-e063-6394a90ab87c	62106-8192	HUMAN OTC DRUG	HYPERICUM PERFORATUM		St.Johns wort	GRANULE	ORAL	20150128	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	HYPERICUM PERFORATUM	3	[hp_X]/1			N	
62106-8200_06bee96c-d5dc-0f63-e063-6394a90a56f0	62106-8200	HUMAN OTC DRUG	IGNATIA AMARA		Ignatius bean	GRANULE	ORAL	20150129	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	STRYCHNOS IGNATII SEED	3	[hp_X]/1			N	
62106-8367_06c0d0c7-4aeb-7c72-e063-6294a90a63a7	62106-8367	HUMAN OTC DRUG	LYCOPODIUM CLAVATUM		Clubmoss	GRANULE	ORAL	20150320	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	LYCOPODIUM CLAVATUM SPORE	1	[hp_X]/1			N	
62106-8495_06c16bb3-2f72-948e-e063-6394a90a2d57	62106-8495	HUMAN OTC DRUG	NUX VOMICA		Poison nut	GRANULE	ORAL	20150129	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	STRYCHNOS NUX-VOMICA SEED	3	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
62106-8716_06e7c29f-a176-b89c-e063-6294a90af20f	62106-8716	HUMAN OTC DRUG	PULSATILLA		Wind flower	GRANULE	ORAL	20150129	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	PULSATILLA VULGARIS	1	[hp_X]/1			N	
62106-8767_06e81950-e1bc-2958-e063-6294a90a32d7	62106-8767	HUMAN OTC DRUG	RHUS TOXICODENDRON		Poison ivy	GRANULE	ORAL	20150123	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	TOXICODENDRON PUBESCENS LEAF	3	[hp_X]/1			N	
62106-8810_06e81cab-5e66-2443-e063-6294a90a3e03	62106-8810	HUMAN OTC DRUG	RUTA GRAVEOLENS		Rue	GRANULE	ORAL	20150130	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	RUTA GRAVEOLENS FLOWERING TOP	3	[hp_X]/1			N	
62106-8972_06e8b0d6-e70f-f391-e063-6294a90aacfa	62106-8972	HUMAN OTC DRUG	STAPHYSAGRIA		Stavesacre	GRANULE	ORAL	20150130	20240630	UNAPPROVED HOMEOPATHIC		Seroyal USA	DELPHINIUM STAPHISAGRIA SEED	4	[hp_X]/1			N	
62106-9001_06fb9fec-c49c-eeed-e063-6294a90adef9	62106-9001	HUMAN OTC DRUG	SYMPHYTUM OFFICINALE		Comfrey	GRANULE	ORAL	20150130	20240531	UNAPPROVED HOMEOPATHIC		Seroyal USA	COMFREY ROOT	1	[hp_X]/1			N	
62106-9052_06fbd39d-bca9-625b-e063-6294a90af948	62106-9052	HUMAN OTC DRUG	THUJA OCCIDENTALIS		White cedar	GRANULE	ORAL	20150320	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	THUJA OCCIDENTALIS LEAFY TWIG	1	[hp_X]/1			N	
62106-9118_06fc215e-be46-c127-e063-6294a90ade23	62106-9118	HUMAN OTC DRUG	URTICA URENS		Dwarf nettle	GRANULE	ORAL	20150727	20240731	UNAPPROVED HOMEOPATHIC		Seroyal USA	URTICA URENS	1	[hp_X]/1			N	
62106-9911_eceb2ab1-7e67-dd8c-e053-2a95a90aa848	62106-9911	HUMAN OTC DRUG	FEBRIPLEX		Aconitum napellus, Arnica montana, Belladonna, Eupatorium perfoliatum, Gelsemium sempervirens, Mercurius solubilis, Rhus toxicodendron	TABLET	ORAL	20170626		UNAPPROVED HOMEOPATHIC		Seroyal USA	ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; MERCURIUS SOLUBILIS; TOXICODENDRON PUBESCENS SHOOT	6; 8; 8; 10; 12; 10; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62106-9916_b13efa1f-d372-32f7-e053-2995a90a678c	62106-9916	HUMAN OTC DRUG	MEDULLOSSEINUM PLEX		Arnica montana, Calcarea phosphorica, Calendula officinalis, Hypericum perforatum, Medullosseinum, Pulsatilla, Ruta graveolens, Symphytum officinale	LIQUID	SUBLINGUAL	20151022		UNAPPROVED HOMEOPATHIC		Seroyal USA	ARNICA MONTANA ROOT; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; HYPERICUM PERFORATUM; ORYCTOLAGUS CUNICULUS SPINAL CORD; PULSATILLA VULGARIS; RUTA GRAVEOLENS FLOWERING TOP	5; 4; 5; 5; 5; 7; 5; 5	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62118-001_eaf11cdf-1981-b595-e053-2995a90a3784	62118-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20150303		NDA	NDA206023	Mountain Aire Medical Supply, Inc	OXYGEN	1	L/L			N	20241231
62135-003_f047b4df-c32e-1810-e053-2a95a90a7131	62135-003	HUMAN PRESCRIPTION DRUG	Lactulose		Lactulose	SOLUTION	ORAL	20181123		ANDA	ANDA209517	Chartwell RX, LLC.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62135-008_f1d8692b-deb3-d55f-e053-2a95a90ae615	62135-008	HUMAN PRESCRIPTION DRUG	Cholestyramine for Oral Suspension		Cholestyramine for Oral Suspension	POWDER	ORAL	19960815		ANDA	ANDA074561	Chartwell RX, LLC	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
62135-010_f1d7a3eb-c7dd-9b20-e053-2995a90a5f72	62135-010	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	SOLUTION	ORAL	19930628		ANDA	ANDA074028	Chartwell RX, LLC	AMANTADINE HYDROCHLORIDE	50	mg/5mL	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
62135-019_06d0ff27-0223-f1d3-e063-6394a90a5ad5	62135-019	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20180504		ANDA	ANDA210401	Chartwell RX, LLC	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
62135-020_f0499f8b-4272-7ca5-e053-2a95a90a1335	62135-020	HUMAN PRESCRIPTION DRUG	Hydrocortisone Rectal Suspension (Retention)		Hydrocortisone	SUSPENSION	RECTAL	19991203		ANDA	ANDA075172	Chartwell RX LLC	HYDROCORTISONE	100	mg/60mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-021_00b27899-e68e-e9d9-e063-6394a90a88cb	62135-021	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200306		ANDA	ANDA211412	Chartwell RX, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-022_00b27899-e68e-e9d9-e063-6394a90a88cb	62135-022	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200306		ANDA	ANDA211412	Chartwell RX, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-023_00b27899-e68e-e9d9-e063-6394a90a88cb	62135-023	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200306		ANDA	ANDA211412	Chartwell RX, LLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-039_06d0ff27-0223-f1d3-e063-6394a90a5ad5	62135-039	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20210312		ANDA	ANDA212173	Chartwell RX, LLC	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
62135-041_fd7660e2-8f7e-db7f-e053-6294a90a6447	62135-041	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20040423		ANDA	ANDA076483	Chartwell RX, LLC	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-042_fd7660e2-8f7e-db7f-e053-6294a90a6447	62135-042	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20040423		ANDA	ANDA076483	Chartwell RX, LLC	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-043_fd7660e2-8f7e-db7f-e053-6294a90a6447	62135-043	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20040423		ANDA	ANDA076483	Chartwell RX, LLC	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-051_fdb507a5-0211-0689-e053-6394a90a860a	62135-051	HUMAN PRESCRIPTION DRUG	Doxazosin mesylate		Doxazosin mesylate	TABLET	ORAL	20001018		ANDA	ANDA075646	Chartwell RX, LLC	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-052_fdb507a5-0211-0689-e053-6394a90a860a	62135-052	HUMAN PRESCRIPTION DRUG	Doxazosin mesylate		Doxazosin mesylate	TABLET	ORAL	20001018		ANDA	ANDA075646	Chartwell RX, LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-053_fdb507a5-0211-0689-e053-6394a90a860a	62135-053	HUMAN PRESCRIPTION DRUG	Doxazosin mesylate		Doxazosin mesylate	TABLET	ORAL	20001018		ANDA	ANDA075646	Chartwell RX, LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-054_fdb507a5-0211-0689-e053-6394a90a860a	62135-054	HUMAN PRESCRIPTION DRUG	Doxazosin mesylate		Doxazosin mesylate	TABLET	ORAL	20001018		ANDA	ANDA075646	Chartwell RX, LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-057_06fce480-76eb-a204-e063-6394a90a3bbc	62135-057	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride Oral Solution		Cetirizine Hydrochloride Oral Solution	SOLUTION	ORAL	20120511		ANDA	ANDA078876	Chartwell RX, LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62135-067_07715269-2987-93e0-e063-6394a90ad29c	62135-067	HUMAN PRESCRIPTION DRUG	INDOMETHACIN		INDOMETHACIN	CAPSULE	ORAL	19840806		NDA	NDA018829	Chartwell RX, LLC	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-068_077134d1-427f-6235-e063-6394a90abcf6	62135-068	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	19860305		ANDA	ANDA070651	Chartwell RX, LLC	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-114_f2b30440-0e0c-2670-e053-2995a90afa28	62135-114	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	ELIXIR	ORAL	20110511		ANDA	ANDA091188	Chartwell RX, LLC	DEXAMETHASONE	.5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-121_06fcec70-ae77-a194-e063-6394a90a6ffa	62135-121	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20061226		ANDA	ANDA077406	Chartwell RX, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62135-122_06fcec70-ae77-a194-e063-6394a90a6ffa	62135-122	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20061226		ANDA	ANDA077406	Chartwell RX, LLC	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62135-130_07704c03-166c-f45e-e063-6394a90a42b1	62135-130	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20040729		ANDA	ANDA076665	Chartwell RX, LLC	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62135-131_07704c03-166c-f45e-e063-6394a90a42b1	62135-131	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20040729		ANDA	ANDA076665	Chartwell RX, LLC	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62135-132_07704c03-166c-f45e-e063-6394a90a42b1	62135-132	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20040729		ANDA	ANDA076665	Chartwell RX, LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62135-133_07704c03-166c-f45e-e063-6394a90a42b1	62135-133	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20040729		ANDA	ANDA076665	Chartwell RX, LLC	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62135-141_f29febd6-5a0e-eb83-e053-2a95a90a5b7d	62135-141	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine mesylate	TABLET	ORAL	19920123		ANDA	ANDA081265	Chartwell RX, LLC.	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
62135-142_f29febd6-5a0e-eb83-e053-2a95a90a5b7d	62135-142	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine mesylate	TABLET	ORAL	19920123		ANDA	ANDA081265	Chartwell RX, LLC.	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
62135-144_f29febd6-5a0e-eb83-e053-2a95a90a5b7d	62135-144	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine mesylate	TABLET	ORAL	19920123		ANDA	ANDA081265	Chartwell RX, LLC.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
62135-145_f2b77c4f-f185-76cb-e053-2995a90a6cc1	62135-145	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20020225		ANDA	ANDA075280	Chartwell RX, LLC	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-146_f2b77c4f-f185-76cb-e053-2995a90a6cc1	62135-146	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20020225		ANDA	ANDA075280	Chartwell RX, LLC	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-160_04db7b6b-ff67-f380-e063-6394a90a80cd	62135-160	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	19930927		ANDA	ANDA074270	Chartwell RX, LLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
62135-173_f2a12fe6-693d-224c-e053-2995a90ae50e	62135-173	HUMAN PRESCRIPTION DRUG	Cortisone Acetate		Cortisone Acetate	TABLET	ORAL	19741017		ANDA	ANDA080694	Chartwell RX, LLC	CORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-176_06fcf9ba-dc95-b59b-e063-6394a90af541	62135-176	HUMAN PRESCRIPTION DRUG	OXAPROZIN		OXAPROZIN	TABLET	ORAL	20040902		ANDA	ANDA075987	Chartwell RX, LLC.	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-186_f292ea46-6114-c084-e053-2995a90a1a5e	62135-186	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	19760507		ANDA	ANDA085070	Chartwell RX, LLC	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-189_06d28eff-ac4e-5b9b-e063-6294a90a1497	62135-189	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		Albuterol Sulfate	SYRUP	ORAL	20070626		ANDA	ANDA077788	Chartwell RX, LLC	ALBUTEROL SULFATE	2	mg/5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
62135-191_06d3e4e6-38bb-e690-e063-6294a90af4d1	62135-191	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20180629		ANDA	ANDA091312	Chartwell RX, LLC.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
62135-192_f049c4ca-c996-fa6c-e053-2995a90a42bf	62135-192	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	TABLET	ORAL	20190701		ANDA	ANDA202420	Chartwell RX LLC	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62135-196_070c123e-88f8-2d9e-e063-6394a90a9da6	62135-196	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	SOLUTION	ORAL	20001222		ANDA	ANDA075782	Chartwell RX, LLC	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
62135-200_00225fc8-eb0d-a4cc-e063-6394a90a2acb	62135-200	HUMAN PRESCRIPTION DRUG	Methenamine Mandelate		Methenamine Mandelate	TABLET, FILM COATED	ORAL	20211001		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	METHENAMINE MANDELATE	500	mg/1			N	20241231
62135-201_00225fc8-eb0d-a4cc-e063-6394a90a2acb	62135-201	HUMAN PRESCRIPTION DRUG	Methenamine Mandelate		Methenamine Mandelate	TABLET, FILM COATED	ORAL	20211001		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	METHENAMINE MANDELATE	1000	mg/1			N	20241231
62135-205_ef9ec1a4-e198-4b75-e053-2995a90a489c	62135-205	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20010327		ANDA	ANDA040411	Chartwell RX, LLC	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
62135-206_ef9ec1a4-e198-4b75-e053-2995a90a489c	62135-206	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20010327		ANDA	ANDA040411	Chartwell RX, LLC	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
62135-210_ef3c00d0-5dbb-9c80-e053-2995a90ad18d	62135-210	HUMAN PRESCRIPTION DRUG	Folic acid		Folic Acid	TABLET	ORAL	20190530		ANDA	ANDA090035	Chartwell RX, LLC.	FOLIC ACID	1	mg/1			N	20241231
62135-220_06fce480-76fc-a204-e063-6394a90a3bbc	62135-220	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760615		ANDA	ANDA084678	Chartwell RX, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-221_06fce480-76fc-a204-e063-6394a90a3bbc	62135-221	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760615		ANDA	ANDA084041	Chartwell RX, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-222_06fce480-76fc-a204-e063-6394a90a3bbc	62135-222	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760615		ANDA	ANDA084679	Chartwell RX, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-225_00d7f688-41b8-3498-e063-6394a90a8a3c	62135-225	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		tetracycline hydrochloride	CAPSULE	ORAL	19880812		ANDA	ANDA062752	Chartwell RX, LLC.	TETRACYCLINE HYDROCHLORIDE	250	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
62135-236_f33fcf42-0b48-eed9-e053-2995a90abefb	62135-236	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	19830526		ANDA	ANDA088212	Chartwell RX, LLC	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
62135-241_f32c38bb-ba52-e11e-e053-2995a90a759e	62135-241	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190808		ANDA	ANDA040245	Chartwell RX, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
62135-242_06fce480-76fd-a204-e063-6394a90a3bbc	62135-242	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20170721		ANDA	ANDA207905	Chartwell RX, LLC	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
62135-250_06fcf9ba-dc97-b59b-e063-6394a90af541	62135-250	HUMAN PRESCRIPTION DRUG	Prednisolone		Prednisolone oral	SOLUTION	ORAL	20221120		ANDA	ANDA040323	Chartwell RX, LLC	PREDNISOLONE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-260_076168b0-0ad1-ab4e-e063-6294a90a12e4	62135-260	HUMAN PRESCRIPTION DRUG	Doxycycline Monohydrate		Doxycycline Monohydrate	CAPSULE	ORAL	19891229		NDA	NDA050641	Chartwell RX, LLC.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-261_076168b0-0ad1-ab4e-e063-6294a90a12e4	62135-261	HUMAN PRESCRIPTION DRUG	Doxycycline Monohydrate		Doxycycline Monohydrate	CAPSULE	ORAL	19891229		NDA	NDA050641	Chartwell RX, LLC.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-262_076168b0-0ad1-ab4e-e063-6294a90a12e4	62135-262	HUMAN PRESCRIPTION DRUG	Doxycycline Monohydrate		Doxycycline Monohydrate	CAPSULE	ORAL	19891229		NDA	NDA050641	Chartwell RX, LLC.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-263_076168b0-0ad1-ab4e-e063-6294a90a12e4	62135-263	HUMAN PRESCRIPTION DRUG	Doxycycline Monohydrate		Doxycycline Monohydrate	CAPSULE	ORAL	19891229		NDA	NDA050641	Chartwell RX, LLC.	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-266_00d7f688-41b8-3498-e063-6394a90a8a3c	62135-266	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		tetracycline hydrochloride	CAPSULE	ORAL	19880812		ANDA	ANDA062752	Chartwell RX, LLC.	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
62135-271_09469fd0-9cc6-3c18-e063-6394a90a1a5c	62135-271	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200826		ANDA	ANDA078745	Chartwell RX, LLC.	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-272_09469fd0-9cc6-3c18-e063-6394a90a1a5c	62135-272	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200826		ANDA	ANDA078745	Chartwell RX, LLC.	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-273_09469fd0-9cc6-3c18-e063-6394a90a1a5c	62135-273	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200826		ANDA	ANDA078745	Chartwell RX, LLC.	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-274_09469fd0-9cc6-3c18-e063-6394a90a1a5c	62135-274	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200826		ANDA	ANDA078745	Chartwell RX, LLC.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-302_f3056949-1373-20a1-e053-2995a90a9c72	62135-302	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	SYRUP	ORAL	20200417		ANDA	ANDA213125	Chartwell RX, LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62135-308_f2a0db9f-16a8-1603-e053-2995a90a79a3	62135-308	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	20210413		ANDA	ANDA076896	Chartwell RX, LLC.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
62135-309_f2a0db9f-16a8-1603-e053-2995a90a79a3	62135-309	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	20210413		ANDA	ANDA076896	Chartwell RX, LLC.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
62135-310_f2a0db9f-16a8-1603-e053-2995a90a79a3	62135-310	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	20210413		ANDA	ANDA076896	Chartwell RX, LLC.	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
62135-311_f2a0db9f-16a8-1603-e053-2995a90a79a3	62135-311	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	20220420		ANDA	ANDA076896	Chartwell RX, LLC.	CIPROFLOXACIN HYDROCHLORIDE	100	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
62135-315_f9244302-8654-6016-e053-6294a90ad64c	62135-315	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	20080420		ANDA	ANDA065390	Chartwell RX, LLC	RIFAMPIN	150	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
62135-316_f9244302-8654-6016-e053-6294a90ad64c	62135-316	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	20080420		ANDA	ANDA065390	Chartwell RX, LLC	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
62135-321_f174f4ef-f4e1-315d-e053-2a95a90a85a6	62135-321	HUMAN PRESCRIPTION DRUG	Methyldopa		Methyldopa	TABLET, FILM COATED	ORAL	19840629		NDA	NDA018934	Chartwell RX, LLC	METHYLDOPA	250	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62135-322_f174f4ef-f4e1-315d-e053-2a95a90a85a6	62135-322	HUMAN PRESCRIPTION DRUG	Methyldopa		Methyldopa	TABLET, FILM COATED	ORAL	19840629		NDA	NDA018934	Chartwell RX, LLC	METHYLDOPA	500	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62135-330_0025bd30-815e-eb49-e063-6294a90a1cba	62135-330	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		prednisolone sodium phosphate	SOLUTION	ORAL	20040525		ANDA	ANDA075988	Chartwell RX, LLC.	PREDNISOLONE SODIUM PHOSPHATE	5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-340_06fcec70-ae79-a194-e063-6394a90a6ffa	62135-340	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20160218		ANDA	ANDA206815	Chartwell RX, LLC	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
62135-350_06fce9d8-ee18-4486-e063-6394a90aeeb4	62135-350	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET	ORAL	20070625		ANDA	ANDA077303	Chartwell RX, LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62135-351_06fce9d8-ee18-4486-e063-6394a90aeeb4	62135-351	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET	ORAL	20070625		ANDA	ANDA077303	Chartwell RX, LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62135-392_f769c741-be58-76ca-e053-6394a90aa806	62135-392	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	KIT		20140305		ANDA	ANDA200563	Chartwell RX, LLC						N	20241231
62135-393_f769c741-be58-76ca-e053-6394a90aa806	62135-393	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	KIT		20140305		ANDA	ANDA200563	Chartwell RX, LLC						N	20241231
62135-400_0770c6f3-a76b-819c-e063-6294a90a3cd8	62135-400	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA202413	Chartwell RX, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-401_0770c6f3-a76b-819c-e063-6294a90a3cd8	62135-401	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20161123		ANDA	ANDA202413	Chartwell RX, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-402_0770c6f3-a76b-819c-e063-6294a90a3cd8	62135-402	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20161101		ANDA	ANDA202413	Chartwell RX, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-403_e7fe69b7-fd3d-4a34-e053-2a95a90aff40	62135-403	HUMAN PRESCRIPTION DRUG	PHENAZOPYRIDINE HYDROCHLORIDE		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
62135-404_e7fe69b7-fd3d-4a34-e053-2a95a90aff40	62135-404	HUMAN PRESCRIPTION DRUG	PHENAZOPYRIDINE HYDROCHLORIDE		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
62135-405_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-405	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
62135-406_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-406	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
62135-407_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-407	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
62135-408_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-408	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
62135-409_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-409	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	15	mg/1		CIV	N	20241231
62135-410_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-410	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	30	mg/1		CIV	N	20241231
62135-411_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-411	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	60	mg/1		CIV	N	20241231
62135-412_e8a75f4d-da7f-1158-e053-2995a90a3728	62135-412	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	PHENOBARBITAL	100	mg/1		CIV	N	20241231
62135-415_07708df6-bcd8-caf3-e063-6294a90a14ef	62135-415	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20220101		ANDA	ANDA215141	Chartwell RX, LLC	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-416_07708df6-bcd8-caf3-e063-6294a90a14ef	62135-416	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20220101		ANDA	ANDA215141	Chartwell RX, LLC	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-417_076171d0-730a-d126-e063-6394a90afafd	62135-417	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	POWDER, FOR SUSPENSION	ORAL	20080716		ANDA	ANDA065454	Chartwell RX LLC	DOXYCYCLINE	25	mg/5mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-418_07708df6-bcd8-caf3-e063-6294a90a14ef	62135-418	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20220101		ANDA	ANDA215141	Chartwell RX, LLC	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-419_07708df6-bcd8-caf3-e063-6294a90a14ef	62135-419	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20220101		ANDA	ANDA215141	Chartwell RX, LLC	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-420_06fd451b-ef5b-137f-e063-6394a90a8a2c	62135-420	HUMAN PRESCRIPTION DRUG	chlorpromazine hydrochloride		chlorpromazine hydrochloride	TABLET, SUGAR COATED	ORAL	20220205		ANDA	ANDA212630	Chartwell RX, LLC	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-421_06fd451b-ef5b-137f-e063-6394a90a8a2c	62135-421	HUMAN PRESCRIPTION DRUG	chlorpromazine hydrochloride		chlorpromazine hydrochloride	TABLET, SUGAR COATED	ORAL	20220205		ANDA	ANDA212630	Chartwell RX, LLC	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-422_06fd451b-ef5b-137f-e063-6394a90a8a2c	62135-422	HUMAN PRESCRIPTION DRUG	chlorpromazine hydrochloride		chlorpromazine hydrochloride	TABLET, SUGAR COATED	ORAL	20220202		ANDA	ANDA212630	Chartwell RX, LLC	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-423_06fd451b-ef5b-137f-e063-6394a90a8a2c	62135-423	HUMAN PRESCRIPTION DRUG	chlorpromazine hydrochloride		chlorpromazine hydrochloride	TABLET, SUGAR COATED	ORAL	20220205		ANDA	ANDA212630	Chartwell RX, LLC	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-424_06fd451b-ef5b-137f-e063-6394a90a8a2c	62135-424	HUMAN PRESCRIPTION DRUG	chlorpromazine hydrochloride		chlorpromazine hydrochloride	TABLET, SUGAR COATED	ORAL	20220205		ANDA	ANDA212630	Chartwell RX, LLC	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-425_efb6b453-333a-211d-e053-2995a90ae2d9	62135-425	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141031		ANDA	ANDA204744	Chartwell RX, LLC	PAROXETINE HYDROCHLORIDE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-426_efb6b453-333a-211d-e053-2995a90ae2d9	62135-426	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141031		ANDA	ANDA204744	Chartwell RX, LLC	PAROXETINE HYDROCHLORIDE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-427_efb6b453-333a-211d-e053-2995a90ae2d9	62135-427	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141031		ANDA	ANDA204744	Chartwell RX, LLC	PAROXETINE HYDROCHLORIDE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-428_02040f6b-875f-3662-e063-6394a90af8a6	62135-428	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	Chartwell RX, LLC	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62135-429_f043ffa5-9564-4a98-e053-2995a90af810	62135-429	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		Posaconazole Delayed-Release	TABLET	ORAL	20190828		ANDA	ANDA212411	Chartwell RX, LLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
62135-430_06fd3682-9361-c825-e063-6394a90a4cb3	62135-430	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20200817		ANDA	ANDA213555	Chartwell RX, LLC	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
62135-431_06fe77f7-a1e1-f066-e063-6294a90a7653	62135-431	HUMAN PRESCRIPTION DRUG	Disulfiram		Disulfiram	TABLET	ORAL	20121231		ANDA	ANDA091563	Chartwell RX, LLC	DISULFIRAM	250	mg/1	Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]		N	20241231
62135-432_06fe77f7-a1e1-f066-e063-6294a90a7653	62135-432	HUMAN PRESCRIPTION DRUG	Disulfiram		Disulfiram	TABLET	ORAL	20121231		ANDA	ANDA091563	Chartwell RX, LLC	DISULFIRAM	500	mg/1	Acetyl Aldehyde Dehydrogenase Inhibitors [MoA], Aldehyde Dehydrogenase Inhibitor [EPC]		N	20241231
62135-433_06d3d1f9-7127-84b0-e063-6394a90a1aea	62135-433	HUMAN PRESCRIPTION DRUG	butalbital, aspirin, and caffeine		butalbital, aspirin, and caffeine	CAPSULE	ORAL	19851011		ANDA	ANDA086996	Chartwell RX, LLC	ASPIRIN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	20241231
62135-434_06fcf9ba-dc98-b59b-e063-6394a90af541	62135-434	HUMAN PRESCRIPTION DRUG	Sodium Citrate and Citric Acid		Sodium Citrate and Citric Acid	SOLUTION	ORAL	20221208		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	CITRIC ACID MONOHYDRATE; SODIUM CITRATE	334; 500	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
62135-435_f045e926-689f-5d79-e053-2995a90a65d0	62135-435	HUMAN PRESCRIPTION DRUG	Potassium Citrate and Citric Acid		Potassium Citrate and Citric Acid	SOLUTION	ORAL	20221208		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE	334; 1100	mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
62135-436_f7059b1e-b7eb-8687-e053-6294a90a8c12	62135-436	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	Chartwell RX, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
62135-437_f68d13d6-27be-13e0-e053-2995a90af5e8	62135-437	HUMAN PRESCRIPTION DRUG	Prednisolone		Prednisolone	TABLET	ORAL	19740531		ANDA	ANDA080531	Chartwell RX, LLC	PREDNISOLONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-438_06fd1d6f-c016-0009-e063-6294a90aa7b8	62135-438	HUMAN PRESCRIPTION DRUG	Tricitrates		Tricitrates	SOLUTION	ORAL	20221208		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE; SODIUM CITRATE	334; 550; 500	mg/5mL; mg/5mL; mg/5mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
62135-439_f409a4d6-5e02-18ee-e053-2a95a90a090c	62135-439	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE	ORAL	20180430		ANDA	ANDA040833	Chartwell RX, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
62135-440_f8703b53-c89b-9014-e053-6294a90a4006	62135-440	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20180501		ANDA	ANDA040682	Chartwell RX, LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
62135-441_f8703b53-c89b-9014-e053-6294a90a4006	62135-441	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20180501		ANDA	ANDA040682	Chartwell RX, LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
62135-442_f54ea590-d28b-ff60-e053-2995a90af03d	62135-442	HUMAN PRESCRIPTION DRUG	linezolid		linezolid	TABLET	ORAL	20190425		ANDA	ANDA210702	Chartwell RX, LLC	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
62135-443_0bbb09cc-b1ec-c182-e063-6294a90a771b	62135-443	HUMAN PRESCRIPTION DRUG	Neomycin Sulfate		Neomycin Sulfate	TABLET	ORAL	20160610		ANDA	ANDA204435	Chartwell RX, LLC	NEOMYCIN SULFATE	500	mg/1	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
62135-444_f54ee2cf-f15e-0a1b-e053-2995a90a60b6	62135-444	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Chartwell RX, LLC	PREGABALIN	50	mg/1		CV	N	20241231
62135-445_f54ee2cf-f15e-0a1b-e053-2995a90a60b6	62135-445	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Chartwell RX, LLC	PREGABALIN	75	mg/1		CV	N	20241231
62135-446_f54ee2cf-f15e-0a1b-e053-2995a90a60b6	62135-446	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Chartwell RX, LLC	PREGABALIN	100	mg/1		CV	N	20241231
62135-447_f54ee2cf-f15e-0a1b-e053-2995a90a60b6	62135-447	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Chartwell RX, LLC	PREGABALIN	150	mg/1		CV	N	20241231
62135-448_01f1678e-eda6-e3a6-e063-6294a90a0bee	62135-448	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	Chartwell RX, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62135-449_01f1678e-eda6-e3a6-e063-6294a90a0bee	62135-449	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	Chartwell RX, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62135-450_f37f7393-fe99-d048-e053-2995a90a204d	62135-450	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	CAPSULE	ORAL	20201031		ANDA	ANDA205360	Chartwell RX, LLC	DOXERCALCIFEROL	.5	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
62135-451_f37f7393-fe99-d048-e053-2995a90a204d	62135-451	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	CAPSULE	ORAL	20201031		ANDA	ANDA205360	Chartwell RX, LLC	DOXERCALCIFEROL	1	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
62135-452_f37f7393-fe99-d048-e053-2995a90a204d	62135-452	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	CAPSULE	ORAL	20201031		ANDA	ANDA205360	Chartwell RX, LLC	DOXERCALCIFEROL	2.5	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
62135-453_f3ba9a53-66f7-a9d5-e053-2a95a90aa06a	62135-453	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20210416		ANDA	ANDA202271	Chartwell RX, LLC	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
62135-454_f3ba9a53-66f7-a9d5-e053-2a95a90aa06a	62135-454	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20210416		ANDA	ANDA202271	Chartwell RX, LLC	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
62135-455_f3ba9a53-66f7-a9d5-e053-2a95a90aa06a	62135-455	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20210416		ANDA	ANDA202271	Chartwell RX, LLC	ACARBOSE	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
62135-456_f3a603b2-1f9e-6780-e053-2a95a90adaa2	62135-456	HUMAN PRESCRIPTION DRUG	Diflunisal		Diflunisal	TABLET, FILM COATED	ORAL	20120308		ANDA	ANDA202845	Chartwell RX, LLC	DIFLUNISAL	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-457_f4999073-ee61-b0b4-e053-2a95a90a1035	62135-457	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20220627		ANDA	ANDA089763	Chartwell RX, LLC	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
62135-458_f4487d78-1daa-3f33-e053-2a95a90a6d92	62135-458	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Chartwell RX, LLC	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-459_f4487d78-1daa-3f33-e053-2a95a90a6d92	62135-459	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Chartwell RX, LLC	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-460_f4487d78-1daa-3f33-e053-2a95a90a6d92	62135-460	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Chartwell RX, LLC	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-461_f4487d78-1daa-3f33-e053-2a95a90a6d92	62135-461	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Chartwell RX, LLC	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-462_f7059b1e-b7b6-8687-e053-6294a90a8c12	62135-462	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA065064	Chartwell RX, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
62135-463_f59ed58b-4533-398d-e053-2995a90af546	62135-463	HUMAN PRESCRIPTION DRUG	amoxicillin and clavulanate potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	Chartwell RX, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
62135-466_ef9f6879-525d-e5a6-e053-2a95a90ad8be	62135-466	HUMAN PRESCRIPTION DRUG	TENOFOVIR DISOPROXIL FUMARATE		TENOFOVIR DISOPROXIL FUMARATE Tablets	TABLET, FILM COATED	ORAL	20180731		ANDA	ANDA206481	Chartwell RX, LLC.	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
62135-468_f94fdd84-ed2d-9f28-e053-6394a90a98fa	62135-468	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20010524		ANDA	ANDA084903	Chartwell RX, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62135-469_f496d69c-7705-e328-e053-2995a90ae589	62135-469	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	CAPSULE, LIQUID FILLED	ORAL	20221121		ANDA	ANDA210078	Chartwell RX, LLC	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-470_f305769c-bb95-51f8-e053-2995a90ad81e	62135-470	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20181228		ANDA	ANDA211496	Chartwell RX, LLC	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-471_f30578f2-f9ec-32bb-e053-2995a90a56b7	62135-471	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20181207		ANDA	ANDA211495	Chartwell RX, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-472_f6c85216-d9f9-c08e-e053-6294a90abb2e	62135-472	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210922		ANDA	ANDA077241	Chartwell RX, LLC	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
62135-473_f6c85216-d9f9-c08e-e053-6294a90abb2e	62135-473	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Chartwell RX, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
62135-474_f6c85216-d9f9-c08e-e053-6294a90abb2e	62135-474	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	Chartwell RX, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
62135-475_f6008bf5-e5ff-8a0c-e053-2995a90ae19d	62135-475	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20070419		ANDA	ANDA078214	Chartwell RX, LLC.	DANAZOL	50	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
62135-476_f6008bf5-e5ff-8a0c-e053-2995a90ae19d	62135-476	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20070419		ANDA	ANDA078214	Chartwell RX, LLC.	DANAZOL	100	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
62135-477_f6008bf5-e5ff-8a0c-e053-2995a90ae19d	62135-477	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20050928		ANDA	ANDA077246	Chartwell RX, LLC.	DANAZOL	200	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
62135-480_06d3d1f9-712c-84b0-e063-6394a90a1aea	62135-480	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	20180228		ANDA	ANDA065336	Chartwell RX, LLC	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62135-481_06d3d1f9-712c-84b0-e063-6394a90a1aea	62135-481	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	20180228		ANDA	ANDA065336	Chartwell RX, LLC	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62135-484_09cd5cb9-4fdf-f133-e063-6294a90af691	62135-484	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET, FILM COATED	ORAL	20050302		ANDA	ANDA076803	Chartwell RX, LLC	QUINAPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-485_09cd5cb9-4fdf-f133-e063-6294a90af691	62135-485	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET, FILM COATED	ORAL	20050302		ANDA	ANDA076803	Chartwell RX, LLC	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-486_09cd5cb9-4fdf-f133-e063-6294a90af691	62135-486	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET, FILM COATED	ORAL	20050302		ANDA	ANDA076803	Chartwell RX, LLC	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-487_09cd5cb9-4fdf-f133-e063-6294a90af691	62135-487	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET, FILM COATED	ORAL	20050302		ANDA	ANDA076803	Chartwell RX, LLC	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-488_f8844e80-ac38-50ce-e053-6394a90afd2b	62135-488	HUMAN PRESCRIPTION DRUG	Diethylpropion	Hydrochloride	Diethylpropion Hydrochloride	TABLET	ORAL	20110718		ANDA	ANDA200177	Chartwell RX, LLC.	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
62135-489_f8847d97-388f-40cb-e053-6394a90a94e9	62135-489	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride ER		Diethylpropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111024		ANDA	ANDA091680	Chartwell RX, LLC.	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
62135-490_06d374d1-be99-9d86-e063-6294a90a7043	62135-490	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20190228		ANDA	ANDA206037	Chartwell RX, LLC	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
62135-491_077134d1-4280-6235-e063-6394a90abcf6	62135-491	HUMAN PRESCRIPTION DRUG	LETROZOLE		Letrozole	TABLET, FILM COATED	ORAL	20190509		ANDA	ANDA205869	Chartwell RX, LLC	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
62135-492_f5de6968-3062-70d5-e053-2995a90af73e	62135-492	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20110926		ANDA	ANDA090695	Chartwell RX, LLC	LOXAPINE SUCCINATE	5	mg/1			N	20241231
62135-493_f5de6968-3062-70d5-e053-2995a90af73e	62135-493	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20110926		ANDA	ANDA090695	Chartwell RX, LLC	LOXAPINE SUCCINATE	10	mg/1			N	20241231
62135-494_06fd3608-5f72-dbcc-e063-6394a90a38a6	62135-494	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Griseofulvin	TABLET	ORAL	19820406		ANDA	ANDA061996	Chartwell RX, LLC.	GRISEOFULVIN	125	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
62135-495_06fd3608-5f72-dbcc-e063-6394a90a38a6	62135-495	HUMAN PRESCRIPTION DRUG	Ultramicrosize Griseofulvin		Griseofulvin	TABLET	ORAL	19820406		ANDA	ANDA061996	Chartwell RX, LLC.	GRISEOFULVIN	250	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
62135-496_f049abb5-36cc-9c9b-e053-2995a90a877e	62135-496	HUMAN PRESCRIPTION DRUG	Griseofulvin MICROSIZE		griseofulvin	TABLET	ORAL	19710909		ANDA	ANDA060569	Chartwell RX, LLC.	GRISEOFULVIN	500	mg/1	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
62135-497_f68d2204-a337-0e16-e053-2995a90ac545	62135-497	HUMAN PRESCRIPTION DRUG	NIACIN		Niacin	TABLET, EXTENDED RELEASE	ORAL	20170216		ANDA	ANDA203899	Chartwell RX, LLC	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
62135-498_f68d2204-a337-0e16-e053-2995a90ac545	62135-498	HUMAN PRESCRIPTION DRUG	NIACIN		Niacin	TABLET, EXTENDED RELEASE	ORAL	20170216		ANDA	ANDA203899	Chartwell RX, LLC	NIACIN	1000	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
62135-502_0770c6f3-a76a-819c-e063-6294a90a3cd8	62135-502	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	SOLUTION	ORAL	20130821		ANDA	ANDA201674	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/5mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-503_fabb605a-7752-4f0d-e053-6294a90a2c9c	62135-503	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA090678	Chartwell RX, LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62135-505_0773b8e2-dc37-e2ba-e063-6394a90ac4eb	62135-505	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190226		ANDA	ANDA211063	Chartwell RX, LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62135-506_0773b8e2-dc37-e2ba-e063-6394a90ac4eb	62135-506	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190226		ANDA	ANDA211063	Chartwell RX, LLC	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62135-507_f641f423-d483-4626-e053-2995a90a9c58	62135-507	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		OXYBUTYNIN CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	Chartwell RX, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62135-508_f641f423-d483-4626-e053-2995a90a9c58	62135-508	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		OXYBUTYNIN CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	Chartwell RX, LLC	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62135-509_f641f423-d483-4626-e053-2995a90a9c58	62135-509	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		OXYBUTYNIN CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	Chartwell RX, LLC	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62135-511_0770d841-d1e8-dc06-e063-6394a90abcb8	62135-511	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	ELIXIR	ORAL	20220720		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	HYOSCYAMINE SULFATE	.125	mg/5mL			N	20241231
62135-512_0770d841-d1e8-dc06-e063-6394a90abcb8	62135-512	HUMAN PRESCRIPTION DRUG	Hyoscyamine sulfate		Hyoscyamine sulfate	TABLET	ORAL	20221117		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
62135-513_0770d841-d1e8-dc06-e063-6394a90abcb8	62135-513	HUMAN PRESCRIPTION DRUG	Hyoscyamine sulfate		Hyoscyamine sulfate	SOLUTION	ORAL	20220801		UNAPPROVED DRUG OTHER		Chartwell RX, LLC	HYOSCYAMINE SULFATE	.125	mg/mL			N	20241231
62135-516_f45f04ea-5bbc-e8b6-e053-2a95a90a4d84	62135-516	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20060511		ANDA	ANDA077353	Chartwell RX, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
62135-517_f45f04ea-5bbc-e8b6-e053-2a95a90a4d84	62135-517	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20060511		ANDA	ANDA077353	Chartwell RX, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
62135-520_f1d5a637-0028-9d23-e053-2995a90a5b61	62135-520	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	SOLUTION	ORAL	19990129		ANDA	ANDA075039	Chartwell RX, LLC	OXYBUTYNIN CHLORIDE	5	mg/5mL	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62135-521_f94ffa54-bc26-69a2-e053-6394a90ae24d	62135-521	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Chartwell RX, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-522_f94ffa54-bc26-69a2-e053-6394a90ae24d	62135-522	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Chartwell RX, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-523_f94ffa54-bc26-69a2-e053-6394a90ae24d	62135-523	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20071003		ANDA	ANDA077127	Chartwell RX, LLC	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-524_f5ef3687-6d9c-1d2c-e053-2a95a90a4eca	62135-524	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20050325		ANDA	ANDA077152	Chartwell RX, LLC.	TERBUTALINE SULFATE	2.5	mg/1			N	20241231
62135-525_f5ef3687-6d9c-1d2c-e053-2a95a90a4eca	62135-525	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20050325		ANDA	ANDA077152	Chartwell RX, LLC.	TERBUTALINE SULFATE	5	mg/1			N	20241231
62135-526_f80d2bb5-cb7e-9695-e053-6294a90a9541	62135-526	HUMAN PRESCRIPTION DRUG	metoclopramide hydrochloride		metoclopramide hydrochloride	SOLUTION	ORAL	19921027		ANDA	ANDA073680	Chartwell RX, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
62135-527_06fd4e9f-bc97-0d5f-e063-6294a90ad352	62135-527	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20200424		ANDA	ANDA213110	Chartwell RX, LLC	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
62135-528_0101ed7b-0c5a-47f3-e063-6294a90a2e84	62135-528	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20170428		ANDA	ANDA207833	Chartwell RX, LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
62135-529_f9526375-a3ae-80d7-e053-6394a90ac4e4	62135-529	HUMAN PRESCRIPTION DRUG	TRIAMTERENE AND HYDROCHLOROTHIAZIDE		TRIAMTERENE AND HYDROCHLOROTHIAZIDE	CAPSULE	ORAL	20111209		ANDA	ANDA201407	Chartwell RX, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62135-530_f769d5c6-7ef4-b3d7-e053-6294a90a0b94	62135-530	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20030903		ANDA	ANDA075410	Chartwell RX, LLC	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62135-531_f838cf51-316e-ebe5-e053-6394a90a985f	62135-531	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	TABLET	ORAL	20191226		ANDA	ANDA209193	Chartwell RX, LLC	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
62135-532_f8393e68-050b-b60a-e053-6294a90a08f3	62135-532	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19981125		NDA	NDA020943	Chartwell RX, LLC	VERAPAMIL HYDROCHLORIDE	100	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-533_f9896056-592f-2738-e053-6394a90a51c9	62135-533	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Chartwell RX, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62135-534_f9896056-592f-2738-e053-6394a90a51c9	62135-534	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Chartwell RX, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62135-535_f68d40e5-9d6f-282b-e053-2a95a90af381	62135-535	HUMAN PRESCRIPTION DRUG	TELMISARTAN		TELMISARTAN	TABLET	ORAL	20201123		ANDA	ANDA078710	Chartwell RX, LLC.	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62135-536_f68d40e5-9d6f-282b-e053-2a95a90af381	62135-536	HUMAN PRESCRIPTION DRUG	TELMISARTAN		TELMISARTAN	TABLET	ORAL	20201123		ANDA	ANDA078710	Chartwell RX, LLC.	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62135-537_f68d40e5-9d6f-282b-e053-2a95a90af381	62135-537	HUMAN PRESCRIPTION DRUG	TELMISARTAN		TELMISARTAN	TABLET	ORAL	20201123		ANDA	ANDA078710	Chartwell RX, LLC.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62135-540_03fd1eb4-49a2-3e37-e063-6394a90aab2c	62135-540	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	SOLUTION	ORAL	20060614		ANDA	ANDA077629	Chartwell RX, LLC	CITALOPRAM HYDROBROMIDE	10	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-541_f99cbbae-ddbe-a1ab-e053-6294a90ab801	62135-541	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Chartwell RX, LLC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-542_f99cbbae-ddbe-a1ab-e053-6294a90ab801	62135-542	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Chartwell RX, LLC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-543_f99cbbae-ddbe-a1ab-e053-6294a90ab801	62135-543	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Chartwell RX, LLC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-544_f99cbbae-ddbe-a1ab-e053-6294a90ab801	62135-544	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Chartwell RX, LLC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-545_ff49d831-529a-4999-e053-6294a90ad40a	62135-545	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20080630		ANDA	ANDA040804	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-546_ff49d831-529a-4999-e053-6294a90ad40a	62135-546	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20080630		ANDA	ANDA040804	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-547_ff49d831-529a-4999-e053-6294a90ad40a	62135-547	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20080630		ANDA	ANDA040804	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-548_0771667a-b408-32a3-e063-6394a90ac68c	62135-548	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM solution		LEVETIRACETAM	SOLUTION	ORAL	20090304		ANDA	ANDA090263	Chartwell RX, LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62135-549_044c464b-af13-d50f-e063-6394a90ade25	62135-549	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	CONCENTRATE	ORAL	20090428		ANDA	ANDA079244	Chartwell RX, LLC	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-550_fbea0b55-586d-b7ea-e053-6394a90acb9a	62135-550	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	SOLUTION	ORAL	19970721		ANDA	ANDA081118	Chartwell RX, LLC	ISONIAZID	50	mg/5mL	Antimycobacterial [EPC]		N	20241231
62135-551_f769c12b-a22c-76f1-e053-6394a90a516b	62135-551	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20211222		ANDA	ANDA207029	Chartwell RX, LLC.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-552_f769c12b-a22c-76f1-e053-6394a90a516b	62135-552	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20211222		ANDA	ANDA207029	Chartwell RX, LLC.	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-553_04b754a5-5740-f71c-e063-6294a90aef67	62135-553	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19740627		ANDA	ANDA084275	Chartwell RX, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-555_070bd281-9773-c587-e063-6294a90a04a2	62135-555	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	SOLUTION	ORAL	20110127		ANDA	ANDA091342	Chartwell RX, LLC.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62135-556_06fd175e-7ec0-fe99-e063-6294a90ab489	62135-556	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	SOLUTION	ORAL	20110413		ANDA	ANDA091156	Chartwell RX, LLC	THEOPHYLLINE ANHYDROUS	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
62135-560_ef176370-710e-5cc3-e053-2a95a90a6494	62135-560	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200904		ANDA	ANDA210268	Chartwell RX, LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-561_ef176370-710e-5cc3-e053-2a95a90a6494	62135-561	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200904		ANDA	ANDA210268	Chartwell RX, LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-562_ef176370-710e-5cc3-e053-2a95a90a6494	62135-562	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200904		ANDA	ANDA210268	Chartwell RX, LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-563_ef176370-710e-5cc3-e053-2a95a90a6494	62135-563	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200904		ANDA	ANDA210268	Chartwell RX, LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-564_ef176370-710e-5cc3-e053-2a95a90a6494	62135-564	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20200904		ANDA	ANDA210268	Chartwell RX, LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-572_070c9e06-c772-6877-e063-6294a90a8e74	62135-572	HUMAN PRESCRIPTION DRUG	TERBINAFINE		Terbinafine	TABLET	ORAL	20070702		ANDA	ANDA078199	Chartwell RX, LLC	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
62135-573_f951e230-bf5d-95d1-e053-6294a90a11e8	62135-573	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-574_f951e230-bf5d-95d1-e053-6294a90a11e8	62135-574	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-575_f951e230-bf5d-95d1-e053-6294a90a11e8	62135-575	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-576_039ad604-bfb3-01e7-e063-6394a90a7b88	62135-576	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20170101		ANDA	ANDA077069	Chartwell RX, LLC	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-577_039ad604-bfb3-01e7-e063-6394a90a7b88	62135-577	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20130101		ANDA	ANDA077069	Chartwell RX, LLC	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-578_039ad604-bfb3-01e7-e063-6394a90a7b88	62135-578	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20130101		ANDA	ANDA077069	Chartwell RX, LLC	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-579_fbd606e2-06c5-9b1d-e053-6294a90a664c	62135-579	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Chartwell RX, LLC	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
62135-580_fbd606e2-06c5-9b1d-e053-6294a90a664c	62135-580	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Chartwell RX, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
62135-581_fbd606e2-06c5-9b1d-e053-6294a90a664c	62135-581	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Chartwell RX, LLC	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
62135-582_fbd606e2-06c5-9b1d-e053-6294a90a664c	62135-582	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Chartwell RX, LLC	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
62135-583_fbd5de64-0e52-4cc2-e053-6294a90a4cee	62135-583	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Chartwell RX, LLC	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62135-584_fbd5de64-0e52-4cc2-e053-6294a90a4cee	62135-584	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Chartwell RX, LLC	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62135-585_fbd5de64-0e52-4cc2-e053-6294a90a4cee	62135-585	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Chartwell RX, LLC	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62135-586_fabbbcae-de1c-bfad-e053-6394a90a515e	62135-586	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA075522	Chartwell RX, LLC	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
62135-587_fabbbcae-de1c-bfad-e053-6394a90a515e	62135-587	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20100607		ANDA	ANDA075522	Chartwell RX, LLC	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
62135-588_fabbbcae-de1c-bfad-e053-6394a90a515e	62135-588	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181115		ANDA	ANDA210822	Chartwell RX, LLC	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
62135-589_fbe9af29-5c55-d036-e053-6394a90aa886	62135-589	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20200428		ANDA	ANDA075479	Chartwell RX, LLC	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-590_fbe9af29-5c55-d036-e053-6394a90aa886	62135-590	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20200428		ANDA	ANDA075479	Chartwell RX, LLC	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-591_fbe9af29-5c55-d036-e053-6394a90aa886	62135-591	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	Chartwell RX, LLC	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-592_fbe9af29-5c55-d036-e053-6394a90aa886	62135-592	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	Chartwell RX, LLC	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-593_fbe51410-fcb2-29e9-e053-6394a90aa0e6	62135-593	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Chartwell RX, LLC	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-594_fbe51410-fcb2-29e9-e053-6394a90aa0e6	62135-594	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Chartwell RX, LLC	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-595_fbe51410-fcb2-29e9-e053-6394a90aa0e6	62135-595	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Chartwell RX, LLC	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-596_f047b4df-c2e2-1810-e053-2a95a90a7131	62135-596	HUMAN PRESCRIPTION DRUG	LymePak		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200401		NDA	NDA209844	Chartwell RX, LLC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-597_fbe51410-fcb2-29e9-e053-6394a90aa0e6	62135-597	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Chartwell RX, LLC	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-598_fbe51410-fcb2-29e9-e053-6394a90aa0e6	62135-598	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Chartwell RX, LLC	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-599_fbe51410-fcb2-29e9-e053-6394a90aa0e6	62135-599	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine Hydrochloride	TABLET	ORAL	20161101		ANDA	ANDA207433	Chartwell RX, LLC	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-606_0d6cc91d-1da2-25ae-e063-6394a90aa6a0	62135-606	HUMAN PRESCRIPTION DRUG	Propylthiouracil		Propylthiouracil	TABLET	ORAL	19820101		ANDA	ANDA080016	Chartwell RX, LLC	PROPYLTHIOURACIL	50	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
62135-607_fbd5e2b9-3939-65a5-e053-6294a90aeea7	62135-607	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20161027		ANDA	ANDA205530	Chartwell RX, LLC	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
62135-608_fbd5e2b9-3939-65a5-e053-6294a90aeea7	62135-608	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20161027		ANDA	ANDA205530	Chartwell RX, LLC	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
62135-609_ff0b9a2b-69bb-f802-e053-6294a90a080e	62135-609	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20170612		ANDA	ANDA209171	Chartwell RX, LLC	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
62135-610_fda2fadd-0c9c-a931-e053-6294a90ac3f5	62135-610	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE	ORAL	20180529		ANDA	ANDA091356	Chartwell RX, LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
62135-611_fda2fadd-0c9c-a931-e053-6294a90ac3f5	62135-611	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE	ORAL	20180529		ANDA	ANDA091356	Chartwell RX, LLC	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
62135-612_fbd5c1fd-732a-69f7-e053-6394a90a5cc2	62135-612	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA040904	Chartwell RX, LLC	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
62135-613_fed13d20-2b88-06c2-e053-6294a90a4219	62135-613	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20181001		ANDA	ANDA209553	Chartwell RX, LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
62135-614_fed13d20-2b88-06c2-e053-6294a90a4219	62135-614	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20181001		ANDA	ANDA209553	Chartwell RX, LLC	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
62135-615_f08573c8-02d4-3717-e053-2a95a90a2dda	62135-615	HUMAN PRESCRIPTION DRUG	CLARITHROMYCIN		Clarithromycin	TABLET, FILM COATED	ORAL	20070820		ANDA	ANDA065384	Chartwell RX, LLC.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-616_f08573c8-02d4-3717-e053-2a95a90a2dda	62135-616	HUMAN PRESCRIPTION DRUG	CLARITHROMYCIN		Clarithromycin	TABLET, FILM COATED	ORAL	20070820		ANDA	ANDA065384	Chartwell RX, LLC.	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-618_06fe1d81-11d3-f403-e063-6394a90ad65f	62135-618	HUMAN PRESCRIPTION DRUG	Diphenoxylate hydrochloride and atropine sulfate		Diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20201021		ANDA	ANDA207128	Chartwell RX, LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
62135-623_f5dd9ff4-5a07-c2c5-e053-2995a90a111a	62135-623	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20051110		ANDA	ANDA065277	Chartwell RX, LLC	DOXYCYCLINE HYCLATE	20	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-625_076171d0-730a-d126-e063-6394a90afafd	62135-625	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20210727		ANDA	ANDA062505	Chartwell RX LLC	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-626_076171d0-730a-d126-e063-6394a90afafd	62135-626	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Chartwell RX LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-630_0337689b-c5d5-d881-e063-6394a90aaec9	62135-630	HUMAN PRESCRIPTION DRUG	CIMETIDINE		CIMETIDINE	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074329	Chartwell RX, LLC	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62135-631_0337689b-c5d5-d881-e063-6394a90aaec9	62135-631	HUMAN PRESCRIPTION DRUG	CIMETIDINE		CIMETIDINE	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074329	Chartwell RX, LLC	CIMETIDINE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62135-632_0337689b-c5d5-d881-e063-6394a90aaec9	62135-632	HUMAN PRESCRIPTION DRUG	CIMETIDINE		CIMETIDINE	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074329	Chartwell RX, LLC	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62135-633_0337689b-c5d5-d881-e063-6394a90aaec9	62135-633	HUMAN PRESCRIPTION DRUG	CIMETIDINE		CIMETIDINE	TABLET, FILM COATED	ORAL	19940517		ANDA	ANDA074329	Chartwell RX, LLC	CIMETIDINE	800	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62135-640_0022e80f-88b2-11b5-e063-6294a90a5b81	62135-640	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200915		ANDA	ANDA212041	Chartwell RX, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-641_0022e80f-88b2-11b5-e063-6294a90a5b81	62135-641	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200915		ANDA	ANDA212041	Chartwell RX, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-642_0022e80f-88b2-11b5-e063-6294a90a5b81	62135-642	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200915		ANDA	ANDA212041	Chartwell RX, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-643_0022e80f-88b2-11b5-e063-6294a90a5b81	62135-643	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210304		ANDA	ANDA208920	Chartwell RX, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-644_0022e80f-88b2-11b5-e063-6294a90a5b81	62135-644	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210304		ANDA	ANDA208920	Chartwell RX, LLC	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-645_0022e80f-88b2-11b5-e063-6294a90a5b81	62135-645	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210304		ANDA	ANDA208920	Chartwell RX, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
62135-646_fd78567b-bcb0-c8a5-e053-6294a90a9e6c	62135-646	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20190801		ANDA	ANDA210847	Chartwell RX, LLC	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-647_fd78567b-bcb0-c8a5-e053-6294a90a9e6c	62135-647	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20190801		ANDA	ANDA210847	Chartwell RX, LLC	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-648_fd78567b-bcb0-c8a5-e053-6294a90a9e6c	62135-648	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20190801		ANDA	ANDA210847	Chartwell RX, LLC	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-649_00225fc8-eb12-a4cc-e063-6394a90a2acb	62135-649	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	SOLUTION	ORAL	20040303		ANDA	ANDA075006	Chartwell RX, LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
62135-660_fed06d00-3301-8631-e053-6294a90a39eb	62135-660	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20090709		ANDA	ANDA079164	Chartwell RX, LLC	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
62135-661_fed06d00-3301-8631-e053-6294a90a39eb	62135-661	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20090709		ANDA	ANDA079164	Chartwell RX, LLC	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
62135-662_fed06d00-3301-8631-e053-6294a90a39eb	62135-662	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20090709		ANDA	ANDA079164	Chartwell RX, LLC	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
62135-663_056ba459-06c7-c5c1-e063-6394a90a54bc	62135-663	HUMAN PRESCRIPTION DRUG	Tavaborole		Tavaborole	SOLUTION	TOPICAL	20210203		ANDA	ANDA211963	Chartwell RX, LLC	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
62135-667_0c3f4504-d57e-aa79-e063-6294a90ad5b8	62135-667	HUMAN PRESCRIPTION DRUG	Quinapril and Hydrochlorothiazide		Quinapril and Hydrochlorothiazide	TABLET	ORAL	20040331		ANDA	ANDA076374	Chartwell RX, LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62135-668_0c3f4504-d57e-aa79-e063-6294a90ad5b8	62135-668	HUMAN PRESCRIPTION DRUG	Quinapril and Hydrochlorothiazide		Quinapril and Hydrochlorothiazide	TABLET	ORAL	20040331		ANDA	ANDA076374	Chartwell RX, LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62135-669_0c3f4504-d57e-aa79-e063-6294a90ad5b8	62135-669	HUMAN PRESCRIPTION DRUG	Quinapril and Hydrochlorothiazide		Quinapril and Hydrochlorothiazide	TABLET	ORAL	20040331		ANDA	ANDA076374	Chartwell RX, LLC	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62135-671_fe7cbf82-9f32-327e-e053-6294a90aebc8	62135-671	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	TABLET	ORAL	19891205		ANDA	ANDA072151	Chartwell RX, LLC	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
62135-672_fe7cbf82-9f32-327e-e053-6294a90aebc8	62135-672	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	TABLET	ORAL	19891205		ANDA	ANDA072151	Chartwell RX, LLC	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
62135-680_0782ae1c-d904-d465-e063-6294a90a6676	62135-680	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020124		ANDA	ANDA075972	Chartwell RX, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62135-681_0782ae1c-d904-d465-e063-6294a90a6676	62135-681	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020124		ANDA	ANDA075972	Chartwell RX, LLC	METFORMIN HYDROCHLORIDE	625	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62135-682_0782ae1c-d904-d465-e063-6294a90a6676	62135-682	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020124		ANDA	ANDA075972	Chartwell RX, LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62135-683_0782ae1c-d904-d465-e063-6294a90a6676	62135-683	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020124		ANDA	ANDA075972	Chartwell RX, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62135-684_0782ae1c-d904-d465-e063-6294a90a6676	62135-684	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020124		ANDA	ANDA075972	Chartwell RX, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62135-696_06fce9d8-ee1b-4486-e063-6394a90aeeb4	62135-696	HUMAN PRESCRIPTION DRUG	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20201020		ANDA	ANDA213530	Chartwell RX, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
62135-700_04de67ce-c87b-d4bd-e063-6294a90a4392	62135-700	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19910628		ANDA	ANDA072943	Chartwell RX, LLC	AMOXAPINE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-701_04de67ce-c87b-d4bd-e063-6294a90a4392	62135-701	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19910628		ANDA	ANDA072944	Chartwell RX, LLC	AMOXAPINE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-702_04de67ce-c87b-d4bd-e063-6294a90a4392	62135-702	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19910628		ANDA	ANDA072878	Chartwell RX, LLC	AMOXAPINE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-703_04de67ce-c87b-d4bd-e063-6294a90a4392	62135-703	HUMAN PRESCRIPTION DRUG	Amoxapine		Amoxapine	TABLET	ORAL	19910628		ANDA	ANDA072879	Chartwell RX, LLC	AMOXAPINE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62135-706_0155ccec-81e2-8900-e063-6294a90afacd	62135-706	HUMAN PRESCRIPTION DRUG	lamivudine		lamivudine oral	SOLUTION	ORAL	20141031		ANDA	ANDA203564	Chartwell RX, LLC	LAMIVUDINE	10	mg/mL	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
62135-709_08a27469-5f81-6c91-e063-6394a90a1e2f	62135-709	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19880613		ANDA	ANDA089776	Chartwell RX, LLC	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
62135-710_f5ef3118-c399-ece2-e053-2a95a90a9a86	62135-710	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	Chartwell RX, LLC	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62135-711_f578e599-a8b6-35a6-e053-2a95a90a2725	62135-711	HUMAN PRESCRIPTION DRUG	Cephalexin		cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Chartwell RX, LLC.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62135-712_fe7e3cb3-7fbe-515c-e053-6394a90a5d5a	62135-712	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	OROPHARYNGEAL	20070227		ANDA	ANDA040708	Chartwell RX, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62135-713_ffe63870-181f-e007-e053-6294a90a074e	62135-713	HUMAN PRESCRIPTION DRUG	CLEMASTINE FUMARATE		CLEMASTINE FUMARATE	SYRUP	ORAL	19971217		ANDA	ANDA074884	Chartwell RX, LLC	CLEMASTINE FUMARATE	.67	mg/5mL			N	20241231
62135-714_01772713-c5c9-e7b7-e063-6294a90adfc3	62135-714	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	TABLET, DELAYED RELEASE	ORAL	20230603		ANDA	ANDA217337	Chartwell RX, LLC	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
62135-715_079bfd7b-b382-24f2-e063-6394a90a7d09	62135-715	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20150630		ANDA	ANDA077920	Chartwell RX, LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-716_079bfd7b-b382-24f2-e063-6394a90a7d09	62135-716	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20150630		ANDA	ANDA077920	Chartwell RX, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62135-717_0072410b-4bd5-f17e-e063-6394a90ac49e	62135-717	HUMAN PRESCRIPTION DRUG	CHLOROQUINE PHOSPHATE		chloroquine phosphate	TABLET, COATED	ORAL	20230320		ANDA	ANDA214756	Chartwell RX, LLC	CHLOROQUINE PHOSPHATE	500	mg/1	Antimalarial [EPC]		N	20241231
62135-718_02040f6b-875f-3662-e063-6394a90af8a6	62135-718	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Chartwell RX, LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62135-719_0153016e-274b-7b54-e063-6294a90a06a1	62135-719	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Chartwell RX, LLC	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-720_0153016e-274b-7b54-e063-6294a90a06a1	62135-720	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Chartwell RX, LLC	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-721_0153016e-274b-7b54-e063-6294a90a06a1	62135-721	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Chartwell RX, LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-722_0153016e-274b-7b54-e063-6294a90a06a1	62135-722	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET	ORAL	20220820		ANDA	ANDA076267	Chartwell RX, LLC	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
62135-723_030b7186-c612-aa8c-e063-6294a90a98a5	62135-723	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET	ORAL	20160819		ANDA	ANDA206975	Chartwell RX, LLC	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
62135-724_030b7186-c612-aa8c-e063-6294a90a98a5	62135-724	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET	ORAL	20160819		ANDA	ANDA206975	Chartwell RX, LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
62135-725_01f30c2f-a700-f4b5-e063-6294a90aae38	62135-725	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20120501		ANDA	ANDA091605	Chartwell RX, LLC	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-726_01f30c2f-a700-f4b5-e063-6294a90aae38	62135-726	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20120501		ANDA	ANDA091605	Chartwell RX, LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-727_00b37886-d2e2-ef44-e063-6394a90a8e4c	62135-727	HUMAN PRESCRIPTION DRUG	GUANFACINE HYDROCHLORIDE		guanfacine	TABLET	ORAL	20220901		ANDA	ANDA216399	Chartwell RX, LLC	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62135-728_00b37886-d2e2-ef44-e063-6394a90a8e4c	62135-728	HUMAN PRESCRIPTION DRUG	GUANFACINE HYDROCHLORIDE		guanfacine	TABLET	ORAL	20220901		ANDA	ANDA216399	Chartwell RX, LLC	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62135-729_0451d0ef-4b6f-a01b-e063-6294a90a9323	62135-729	HUMAN PRESCRIPTION DRUG	Escitalopram Oral Solution		Escitalopram Oral	SOLUTION	ORAL	20230612		ANDA	ANDA090477	Chartwell RX, LLC	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-730_09a5bddd-4b0f-696b-e063-6394a90a2d19	62135-730	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	LIQUID	ORAL	20040514		ANDA	ANDA076458	Chartwell RX, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62135-731_03aeed00-200f-0b57-e063-6394a90a8b47	62135-731	HUMAN PRESCRIPTION DRUG	Glipizide and metformin hcl		Glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20100629		ANDA	ANDA078728	Chartwell RX, LLC	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62135-732_03aeed00-200f-0b57-e063-6394a90a8b47	62135-732	HUMAN PRESCRIPTION DRUG	Glipizide and metformin hcl		Glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20100629		ANDA	ANDA078728	Chartwell RX, LLC	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62135-733_03aeed00-200f-0b57-e063-6394a90a8b47	62135-733	HUMAN PRESCRIPTION DRUG	Glipizide and metformin hcl		Glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20100629		ANDA	ANDA078728	Chartwell RX, LLC	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62135-734_0324275f-1397-e7b8-e063-6294a90a6902	62135-734	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20170227		ANDA	ANDA207201	Chartwell RX, LLC	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62135-735_0324275f-1397-e7b8-e063-6294a90a6902	62135-735	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20170227		ANDA	ANDA207201	Chartwell RX, LLC	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62135-736_0cde3360-2530-8f14-e063-6394a90a4307	62135-736	HUMAN PRESCRIPTION DRUG	Flurazepam Hydrochloride		Flurazepam Hydrochloride	CAPSULE	ORAL	19890330		ANDA	ANDA072368	Chartwell RX, LLC	FLURAZEPAM HYDROCHLORIDE	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-737_0cde3360-2530-8f14-e063-6394a90a4307	62135-737	HUMAN PRESCRIPTION DRUG	Flurazepam Hydrochloride		Flurazepam Hydrochloride	CAPSULE	ORAL	19890330		ANDA	ANDA072369	Chartwell RX, LLC	FLURAZEPAM HYDROCHLORIDE	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-738_01f1678e-eda6-e3a6-e063-6294a90a0bee	62135-738	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230502		ANDA	ANDA085182	Chartwell RX, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62135-739_02a58e02-2d9c-d68e-e063-6394a90a7cc1	62135-739	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE	ORAL	20101207		ANDA	ANDA202644	Chartwell RX, LLC	NIFEDIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-740_02a58e02-2d9c-d68e-e063-6394a90a7cc1	62135-740	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE	ORAL	20101207		ANDA	ANDA202644	Chartwell RX, LLC	NIFEDIPINE	20	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62135-741_02aa8309-9724-bf2a-e063-6394a90acfd9	62135-741	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	TABLET, FILM COATED	ORAL	20111031		ANDA	ANDA062474	Chartwell RX, LLC	NYSTATIN	500000	[USP'U]/1	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
62135-742_03c32696-1480-ce6f-e063-6294a90a1870	62135-742	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	TABLET, FILM COATED	ORAL	20160830		ANDA	ANDA204945	Chartwell RX, LLC	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62135-743_02aa6f29-e53b-a13c-e063-6394a90a5da2	62135-743	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20151015		ANDA	ANDA071881	Chartwell RX, LLC	VERAPAMIL HYDROCHLORIDE	40	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-744_02aa6f29-e53b-a13c-e063-6394a90a5da2	62135-744	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20110107		ANDA	ANDA071881	Chartwell RX, LLC	VERAPAMIL HYDROCHLORIDE	80	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-745_02aa6f29-e53b-a13c-e063-6394a90a5da2	62135-745	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20180720		ANDA	ANDA071881	Chartwell RX, LLC	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62135-749_07d7e199-ea8c-7e55-e063-6394a90afa67	62135-749	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20070124		ANDA	ANDA077785	Chartwell RX, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
62135-750_0567a880-528c-22e4-e063-6394a90a27f3	62135-750	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		HYDROXYZINE HYDROCHLORIDE	SYRUP	ORAL	19820412		ANDA	ANDA087294	Chartwell RX, LLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/5mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
62135-751_0428288d-4057-e853-e063-6294a90adb0c	62135-751	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	19870121		ANDA	ANDA089175	Chartwell RX, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
62135-767_06fe01aa-6ace-4ff5-e063-6294a90a5aaa	62135-767	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam Oral	SOLUTION	ORAL	20160624		ANDA	ANDA206477	Chartwell RX, LLC	DIAZEPAM	5	mg/5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-768_06fe01aa-6ace-4ff5-e063-6294a90a5aaa	62135-768	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam Oral Solution (Concentrate)	SOLUTION	ORAL	20140414		ANDA	ANDA204433	Chartwell RX, LLC	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-769_09184e1a-1808-d656-e063-6294a90aa6f8	62135-769	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19970930		ANDA	ANDA074925	Chartwell RX, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-770_09184e1a-1808-d656-e063-6294a90aa6f8	62135-770	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19970930		ANDA	ANDA074925	Chartwell RX, LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-771_09184e1a-1808-d656-e063-6294a90aa6f8	62135-771	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19970930		ANDA	ANDA074925	Chartwell RX, LLC	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62135-772_044c42cd-f3a3-0640-e063-6294a90ab5a5	62135-772	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20200130		ANDA	ANDA210454	Chartwell RX, LLC	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
62135-773_0b215199-0ce8-2d3b-e063-6294a90a5e8f	62135-773	HUMAN PRESCRIPTION DRUG	Trimethobenzamide Hydrochloride		Trimethobenzamide Hydrochloride	CAPSULE	ORAL	20231121		ANDA	ANDA205950	Chartwell RX, LLC	TRIMETHOBENZAMIDE HYDROCHLORIDE	300	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
62135-774_0b37359c-d3ac-b014-e063-6394a90aadfe	62135-774	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	SOLUTION	ORAL	19980925		ANDA	ANDA040026	Chartwell RX, LLC	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-775_09d35c34-11fb-3a5d-e063-6294a90ab172	62135-775	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170811		ANDA	ANDA207405	Chartwell RX, LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62135-776_0da8289c-3368-ccc4-e063-6294a90ad740	62135-776	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19781208		ANDA	ANDA062059	Chartwell RX, LLC	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
62135-777_0da8289c-3368-ccc4-e063-6294a90ad740	62135-777	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19781208		ANDA	ANDA062059	Chartwell RX, LLC	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
62135-780_0d206f53-a5c6-8568-e063-6294a90a5d1b	62135-780	HUMAN PRESCRIPTION DRUG	omega-3-acid ethyl esters		omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20200219		ANDA	ANDA211355	Chartwell RX, LLC	OMEGA-3-ACID ETHYL ESTERS	900	mg/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
62135-781_0905fb46-75f3-84b1-e063-6294a90a51f7	62135-781	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA200405	Chartwell RX, LLC	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
62135-782_0905fb46-75f3-84b1-e063-6294a90a51f7	62135-782	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA200405	Chartwell RX, LLC	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
62135-783_0877f70b-cb8f-778a-e063-6394a90aab21	62135-783	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET	ORAL	20200427		ANDA	ANDA211724	Chartwell RX, LLC	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
62135-784_0877f70b-cb8f-778a-e063-6394a90aab21	62135-784	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET	ORAL	20200427		ANDA	ANDA211724	Chartwell RX, LLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
62135-785_093266fb-469c-cdee-e063-6294a90abd8e	62135-785	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20200723		ANDA	ANDA213500	Chartwell RX, LLC	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
62135-789_09a72084-1b40-fa52-e063-6394a90acc76	62135-789	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20230326		ANDA	ANDA209173	Chartwell RX, LLC	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
62135-790_08a4de0f-3f84-f7d1-e063-6294a90a0f30	62135-790	HUMAN PRESCRIPTION DRUG	ETHOSUXIMIDE		ETHOSUXIMIDE	CAPSULE	ORAL	20150909		ANDA	ANDA200892	Chartwell RX, LLC	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62135-791_09435fb5-8698-8a7f-e063-6394a90a735b	62135-791	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20200222		ANDA	ANDA074787	Chartwell RX, LLC	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62135-792_09435fb5-8698-8a7f-e063-6394a90a735b	62135-792	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20200222		ANDA	ANDA074787	Chartwell RX, LLC	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62135-793_090482ce-faef-bb3b-e063-6394a90a705f	62135-793	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20091029		ANDA	ANDA077086	Chartwell RX, LLC	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
62135-794_090482ce-faef-bb3b-e063-6394a90a705f	62135-794	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20091029		ANDA	ANDA077086	Chartwell RX, LLC	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
62135-795_0a963bca-efca-8a5f-e063-6394a90aeae3	62135-795	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20171129		ANDA	ANDA205245	Chartwell RX, LLC	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
62135-796_0a963bca-efca-8a5f-e063-6394a90aeae3	62135-796	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20171129		ANDA	ANDA205245	Chartwell RX, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
62135-799_09beb76a-d3a7-3c1d-e063-6394a90a10b3	62135-799	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET	ORAL	20220710		ANDA	ANDA210163	Chartwell RX, LLC	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62135-800_09435fb5-8698-8a7f-e063-6394a90a735b	62135-800	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET	ORAL	20200222		ANDA	ANDA074787	Chartwell RX, LLC	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62135-802_0bd96241-0f79-5e68-e063-6294a90a57d0	62135-802	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	SUSPENSION	ORAL	20020605		ANDA	ANDA075714	Chartwell RX, LLC	CARBAMAZEPINE	100	mg/5mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
62135-803_0c52b0ce-c7f4-635f-e063-6394a90acd08	62135-803	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	SUSPENSION	ORAL	20200423		ANDA	ANDA212718	Chartwell RX, LLC	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
62135-804_0c52c16a-a032-5724-e063-6394a90a9b04	62135-804	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		PIOGLITAZONE HYDROCHLORIDE	TABLET	ORAL	20201028		ANDA	ANDA076798	Chartwell RX, LLC	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
62135-805_0c52c16a-a032-5724-e063-6394a90a9b04	62135-805	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		PIOGLITAZONE HYDROCHLORIDE	TABLET	ORAL	20201028		ANDA	ANDA076798	Chartwell RX, LLC	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
62135-806_0c52c16a-a032-5724-e063-6394a90a9b04	62135-806	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		PIOGLITAZONE HYDROCHLORIDE	TABLET	ORAL	20201028		ANDA	ANDA076798	Chartwell RX, LLC	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
62135-807_0cde0dc9-e005-761c-e063-6394a90a8d71	62135-807	HUMAN PRESCRIPTION DRUG	famotidine		famotidine	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA075786	Chartwell RX, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62135-808_0cde0dc9-e005-761c-e063-6394a90a8d71	62135-808	HUMAN PRESCRIPTION DRUG	famotidine		famotidine	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA075786	Chartwell RX, LLC	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62135-810_0c6989ce-16e8-613b-e063-6294a90ae473	62135-810	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate spray, metered		Fluticasone Propionate	SPRAY, METERED	NASAL	20120109		ANDA	ANDA078492	Chartwell RX, LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62135-895_f3ba0986-42cf-a016-e053-2995a90a7c9f	62135-895	HUMAN PRESCRIPTION DRUG	memantine		memantine	TABLET	ORAL	20180711		ANDA	ANDA090244	Chartwell RX, LLC	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
62135-896_f3ba0986-42cf-a016-e053-2995a90a7c9f	62135-896	HUMAN PRESCRIPTION DRUG	memantine		memantine	TABLET	ORAL	20180711		ANDA	ANDA090244	Chartwell RX, LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
62135-900_070bd281-9772-c587-e063-6294a90a04a2	62135-900	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20170928		ANDA	ANDA207797	Chartwell RX, LLC	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62135-901_070bd281-9772-c587-e063-6294a90a04a2	62135-901	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20170928		ANDA	ANDA207797	Chartwell RX, LLC	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62135-902_070bd281-9772-c587-e063-6294a90a04a2	62135-902	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20170928		ANDA	ANDA207797	Chartwell RX, LLC	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62135-903_070bd281-9772-c587-e063-6294a90a04a2	62135-903	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20170928		ANDA	ANDA207797	Chartwell RX, LLC	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62135-917_0782ae1c-d903-d465-e063-6294a90a6676	62135-917	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	SOLUTION	ORAL	20170515		ANDA	ANDA204599	Chartwell RX, LLC	LEVOCETIRIZINE DIHYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62135-929_070bbc43-2f78-c14c-e063-6294a90a61f6	62135-929	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	SOLUTION	ORAL	20150112		ANDA	ANDA202386	Chartwell RX, LLC	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615	62135-937	HUMAN PRESCRIPTION DRUG	Cholestyramine for Oral Suspension		Cholestyramine for Oral Suspension	POWDER	ORAL	19960815		ANDA	ANDA074562	Chartwell RX, LLC	CHOLESTYRAMINE	4	g/5.7g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
62135-943_0782c8ff-36e2-f0ac-e063-6294a90aa87b	62135-943	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	SOLUTION	ORAL	20151013		ANDA	ANDA204033	Chartwell RX, LLC	MEMANTINE HYDROCHLORIDE	2	mg/mL	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
62135-949_06fd9a7b-3b04-6e0c-e063-6394a90aba46	62135-949	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE		CYPROHEPTADINE HYDROCHLORIDE	SYRUP	ORAL	20170713		ANDA	ANDA203191	Chartwell RX, LLC	CYPROHEPTADINE HYDROCHLORIDE	2	mg/5mL			N	20241231
62135-960_ef9f56ad-c921-6fe7-e053-2a95a90a85af	62135-960	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	19731112		ANDA	ANDA080197	Chartwell RX, LLC.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
62135-968_f049ba4a-af6b-c769-e053-2a95a90aec9c	62135-968	HUMAN PRESCRIPTION DRUG	Griseofulvin		Griseofulvin (microsize)	SUSPENSION	ORAL	20050302		ANDA	ANDA065200	Chartwell RX, LLC.	GRISEOFULVIN	125	mg/5mL	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
62135-984_076171d0-730a-d126-e063-6394a90afafd	62135-984	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Chartwell RX LLC	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-985_076171d0-730a-d126-e063-6394a90afafd	62135-985	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Chartwell RX LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62135-991_02591199-8759-8e40-e063-6294a90afa7f	62135-991	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20120905		ANDA	ANDA090348	Chartwell RX, LLC	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62135-992_02591199-8759-8e40-e063-6294a90afa7f	62135-992	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20120905		ANDA	ANDA090348	Chartwell RX, LLC	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62135-993_02591199-8759-8e40-e063-6294a90afa7f	62135-993	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20120905		ANDA	ANDA090348	Chartwell RX, LLC	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62135-994_02591199-8759-8e40-e063-6294a90afa7f	62135-994	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20120905		ANDA	ANDA090348	Chartwell RX, LLC	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62137-001_b20a9a96-6ae2-3495-e053-2995a90a4aa2	62137-001	HUMAN PRESCRIPTION DRUG	Oxygen		OXYGEN	LIQUID	RESPIRATORY (INHALATION)	19950501		NDA	NDA205889	AMO Medical Oxygen, Inc.	OXYGEN	1000	g/L			N	20241231
62137-002_b20aa9ae-95ba-3266-e053-2995a90a22d0	62137-002	HUMAN PRESCRIPTION DRUG	Oxygen		OXYGEN	GAS	RESPIRATORY (INHALATION)	19950501		NDA	NDA205889	AMO Medical Oxygen, Inc.	OXYGEN	1	L/L			N	20241231
62144-5510_26e3210f-1bab-4ce6-8d9a-635c6c045deb	62144-5510	HUMAN OTC DRUG	ImproVue	Lubricant	HYPROMELLOSE 2208 (15000 MPA.S)	SOLUTION/ DROPS	OPHTHALMIC	20140625		OTC MONOGRAPH FINAL	part349	Oculus Surgical, Inc.	HYPROMELLOSE 2208 (15000 MPA.S)	17	mg/mL			N	20241231
62145-001_07e8b20a-f471-78ed-e063-6394a90a3340	62145-001	HUMAN PRESCRIPTION DRUG	Oxygen Refrigerated Liquid		Oxygen Refrigerated Liquid	GAS	RESPIRATORY (INHALATION)	20071018		UNAPPROVED MEDICAL GAS		Dallas Life Support Systems Inc	OXYGEN	999	mL/L			N	20241231
62145-002_07e8b20a-f471-78ed-e063-6394a90a3340	62145-002	HUMAN PRESCRIPTION DRUG	Oxygen Compressed Gas		Oxygen Compressed Gas	GAS	RESPIRATORY (INHALATION)	20071018		UNAPPROVED MEDICAL GAS		Dallas Life Support Systems Inc	OXYGEN	995	mL/L			N	20241231
62168-0084_d72763e4-9aca-4c07-bebd-380e22004e4d	62168-0084	HUMAN OTC DRUG	Icy Hot	Medicated	Menthol	PATCH	TOPICAL	20001101		OTC MONOGRAPH DRUG	505G(a)(3)	Lead Chemical Co., Ltd.	MENTHOL, UNSPECIFIED FORM	205.5	mg/1			N	20241231
62168-0584_759e2459-2d4c-4c0a-aeb2-d4bb282c3c75	62168-0584	HUMAN OTC DRUG	Aspercreme		Lidocaine	PATCH	TOPICAL	20160216		OTC MONOGRAPH NOT FINAL	part348	Lead Chemical Co. Ltd.	LIDOCAINE	246	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62168-0805_d72763e4-9aca-4c07-bebd-380e22004e4d	62168-0805	HUMAN OTC DRUG	Icy Hot	Medicated, Advanced Relief	Menthol	PATCH	TOPICAL	20121201	20240331	OTC MONOGRAPH DRUG	505G(a)(3)	Lead Chemical Co., Ltd.	MENTHOL, UNSPECIFIED FORM	210	mg/1			N	
62168-0843_d72763e4-9aca-4c07-bebd-380e22004e4d	62168-0843	HUMAN OTC DRUG	Icy Hot	Medicated, Back	Menthol	PATCH	TOPICAL	20030301	20240331	OTC MONOGRAPH DRUG	505G(a)(3)	Lead Chemical Co., Ltd.	MENTHOL, UNSPECIFIED FORM	428.5	mg/1			N	
62168-0847_d72763e4-9aca-4c07-bebd-380e22004e4d	62168-0847	HUMAN OTC DRUG	Icy Hot	Medicated, XL	Menthol	PATCH	TOPICAL	20071201		OTC MONOGRAPH DRUG	505G(a)(3)	Lead Chemical Co., Ltd.	MENTHOL, UNSPECIFIED FORM	750	mg/1			N	20241231
62168-0856_64ae4759-f450-4f5c-895b-078ab33802aa	62168-0856	HUMAN OTC DRUG	Icy Hot	Medicated, Back	Menthol	PATCH	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Lead Chemical Co., Ltd.	MENTHOL, UNSPECIFIED FORM	428.5	mg/1			N	20241231
62169-203_08a03736-b4de-28ed-e063-6294a90a9018	62169-203	HUMAN OTC DRUG	ANIOSGEL 85	NPC	Ethanol	GEL	TOPICAL	20140401		OTC MONOGRAPH DRUG	M003	Laboratoires Anios	ALCOHOL	377.5	mL/500mL			N	20241231
62175-106_81e3e7e0-b677-4948-9e04-6c3a44ea313b	62175-106	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET	ORAL	19930630		NDA AUTHORIZED GENERIC	NDA020215	Lannett Company, Inc.	ISOSORBIDE MONONITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
62175-107_81e3e7e0-b677-4948-9e04-6c3a44ea313b	62175-107	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET	ORAL	19930630		NDA AUTHORIZED GENERIC	NDA020215	Lannett Company, Inc.	ISOSORBIDE MONONITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
62175-114_e786b865-dc62-4018-9cb1-7056b7ca2cde	62175-114	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20030903		ANDA	ANDA075410	Lannett Company, Inc.	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-118_e786b865-dc62-4018-9cb1-7056b7ca2cde	62175-118	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20021104		ANDA	ANDA075410	Lannett Company, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-119_6d91cd6b-f0bf-4e23-97b2-8c659e6f8475	62175-119	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET, EXTENDED RELEASE	ORAL	19981030	20240331	ANDA	ANDA075155	Lannett Company, Inc.	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
62175-128_6d91cd6b-f0bf-4e23-97b2-8c659e6f8475	62175-128	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET, EXTENDED RELEASE	ORAL	19981030	20240331	ANDA	ANDA075155	Lannett Company, Inc.	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
62175-129_6d91cd6b-f0bf-4e23-97b2-8c659e6f8475	62175-129	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET, EXTENDED RELEASE	ORAL	19981030	20240331	ANDA	ANDA075155	Lannett Company, Inc.	ISOSORBIDE MONONITRATE	120	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
62175-136_e786b865-dc62-4018-9cb1-7056b7ca2cde	62175-136	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090123		ANDA	ANDA075410	Lannett Company, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-204_a4215d29-ef78-4b4d-9683-9dc4d35e345a	62175-204	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA200405	Lannett Company, Inc.	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
62175-205_a4215d29-ef78-4b4d-9683-9dc4d35e345a	62175-205	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA200405	Lannett Company, Inc.	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
62175-260_2b91b384-4c20-4162-a717-9dc53ea834cc	62175-260	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Lannett Company, Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62175-261_2b91b384-4c20-4162-a717-9dc53ea834cc	62175-261	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Lannett Company, Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62175-262_2b91b384-4c20-4162-a717-9dc53ea834cc	62175-262	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20071003		ANDA	ANDA077127	Lannett Company, Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62175-270_72bbc7a8-711b-47a6-8152-9409f4068929	62175-270	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	Lannett Company, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62175-271_72bbc7a8-711b-47a6-8152-9409f4068929	62175-271	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	Lannett Company, Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62175-272_72bbc7a8-711b-47a6-8152-9409f4068929	62175-272	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	Lannett Company, Inc.	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62175-302_dde0e5ce-043b-4ada-aa94-eab41e41bc17	62175-302	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA090678	Lannett Company, Inc.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-310_51ea16f5-1423-49c1-a07f-6d6721ecbc59	62175-310	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20130710		ANDA	ANDA091695	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62175-311_51ea16f5-1423-49c1-a07f-6d6721ecbc59	62175-311	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20130710		ANDA	ANDA091695	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62175-312_51ea16f5-1423-49c1-a07f-6d6721ecbc59	62175-312	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20130923		ANDA	ANDA091695	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62175-313_51ea16f5-1423-49c1-a07f-6d6721ecbc59	62175-313	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20130923		ANDA	ANDA091695	Lannett Company, Inc.	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
62175-320_9cf9ec57-4324-4d02-905d-8ac39a21295d	62175-320	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20170216		ANDA	ANDA203899	Lannett Company, Inc.	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
62175-322_9cf9ec57-4324-4d02-905d-8ac39a21295d	62175-322	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20170216		ANDA	ANDA203899	Lannett Company, Inc.	NIACIN	1000	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
62175-361_bd2457f5-22de-4e07-829c-1eadb77e0e9e	62175-361	HUMAN PRESCRIPTION DRUG	Monoket		isosorbide mononitrate	TABLET	ORAL	19930630		NDA	NDA020215	Lannett Company, Inc.	ISOSORBIDE MONONITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
62175-362_bd2457f5-22de-4e07-829c-1eadb77e0e9e	62175-362	HUMAN PRESCRIPTION DRUG	Monoket		isosorbide mononitrate	TABLET	ORAL	19930630		NDA	NDA020215	Lannett Company, Inc.	ISOSORBIDE MONONITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
62175-452_31880715-56ca-4d85-91f9-2ecb344fe314	62175-452	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20160919		ANDA	ANDA205022	Lannett Company, Inc.	BUPRENORPHINE; NALOXONE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
62175-458_31880715-56ca-4d85-91f9-2ecb344fe314	62175-458	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20160919		ANDA	ANDA205022	Lannett Company, Inc.	BUPRENORPHINE; NALOXONE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
62175-470_9474f942-d6d8-486b-8ea6-f8c561bb5014	62175-470	HUMAN PRESCRIPTION DRUG	Paroxetine Hydrochloride		Paroxetine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141031		ANDA	ANDA204744	Lannett Company, Inc.	PAROXETINE HYDROCHLORIDE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62175-471_9474f942-d6d8-486b-8ea6-f8c561bb5014	62175-471	HUMAN PRESCRIPTION DRUG	Paroxetine Hydrochloride		Paroxetine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141031		ANDA	ANDA204744	Lannett Company, Inc.	PAROXETINE HYDROCHLORIDE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62175-472_9474f942-d6d8-486b-8ea6-f8c561bb5014	62175-472	HUMAN PRESCRIPTION DRUG	Paroxetine Hydrochloride		Paroxetine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141031		ANDA	ANDA204744	Lannett Company, Inc.	PAROXETINE HYDROCHLORIDE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62175-485_c192b40f-4307-483e-bfa7-1619c2f58d7e	62175-485	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19981125		NDA	NDA020943	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	100	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-486_c192b40f-4307-483e-bfa7-1619c2f58d7e	62175-486	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19981125		NDA	NDA020943	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	200	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-487_c192b40f-4307-483e-bfa7-1619c2f58d7e	62175-487	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19981125		NDA	NDA020943	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-515_9d4be625-fedb-4b0a-bfcf-b8b513eeec8c	62175-515	HUMAN OTC DRUG	Lansoprazole	24 HR	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20170929		ANDA	ANDA207157	Lannett Company, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-570_465f8a37-f736-4a2e-9dbe-ef0a124b0f0e	62175-570	HUMAN PRESCRIPTION DRUG	VERELAN PM		verapamil hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19981125		NDA	NDA020943	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	100	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-571_465f8a37-f736-4a2e-9dbe-ef0a124b0f0e	62175-571	HUMAN PRESCRIPTION DRUG	VERELAN PM		verapamil hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19981125		NDA	NDA020943	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	200	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-572_465f8a37-f736-4a2e-9dbe-ef0a124b0f0e	62175-572	HUMAN PRESCRIPTION DRUG	VERELAN PM		verapamil hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19981125		NDA	NDA020943	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-580_43aa636e-a64e-43bc-9621-240b8946745b	62175-580	HUMAN PRESCRIPTION DRUG	VERELAN		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-581_43aa636e-a64e-43bc-9621-240b8946745b	62175-581	HUMAN PRESCRIPTION DRUG	VERELAN		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-582_43aa636e-a64e-43bc-9621-240b8946745b	62175-582	HUMAN PRESCRIPTION DRUG	VERELAN		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-583_43aa636e-a64e-43bc-9621-240b8946745b	62175-583	HUMAN PRESCRIPTION DRUG	VERELAN		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Lannett Company, Inc.	VERAPAMIL HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62175-617_cfbf12d8-f656-4b99-bd2e-fb11bab669e5	62175-617	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Lannett Company, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-618_cfbf12d8-f656-4b99-bd2e-fb11bab669e5	62175-618	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Lannett Company, Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-820_678b488f-ae82-4ff5-93dc-543855de8f1e	62175-820	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170901		ANDA	ANDA205563	Lannett Company, Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-840_678b488f-ae82-4ff5-93dc-543855de8f1e	62175-840	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170901		ANDA	ANDA205563	Lannett Company, Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62175-890_e20ad87d-3bf3-4d7d-a014-70dc5ef98e7f	62175-890	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	Lannett Company, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
62175-891_e20ad87d-3bf3-4d7d-a014-70dc5ef98e7f	62175-891	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	Lannett Company, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
62175-892_e20ad87d-3bf3-4d7d-a014-70dc5ef98e7f	62175-892	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	Lannett Company, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
62175-897_e20ad87d-3bf3-4d7d-a014-70dc5ef98e7f	62175-897	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	Lannett Company, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
62179-1234_0dfa89dc-96cc-e596-e063-6294a90a469d	62179-1234	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140718		UNAPPROVED MEDICAL GAS		Intermountain Home Care	OXYGEN	1	L/L			N	20251231
62185-0021_7e83edd8-2a67-47e8-b11a-96de547d2b80	62185-0021	HUMAN OTC DRUG	Professional Weight Maintenance		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Hepar Suis, Kidney (Suis), Methylcobalamin, Gambogia, Graphites, Nux Vomica, Phytolacca Decandra, 3-Acetyl-7-Oxo-Dehydroepiandrosterone, Adenosinum Triphosphoricum Dinatrum, Glucagon, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20160422	20240429	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GLUCAGON; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA HYPOTHALAMUS	30; 30; 6; 6; 12; 30; 12; 30; 30; 8; 12; 8; 8; 30; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antihypoglycemic Agent [EPC], Cell-mediated Immunity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
62185-0025_55654b26-48c7-45f0-9acd-5fc96259968b	62185-0025	HUMAN OTC DRUG	Brain Support		Acetylcholine Chloride, Adrenalinum, Dopamine Hydrochloride, GABA (Gamma-Aminobutyric Acid), Norepinephrine, Octopamine, Serotonin (Hydrochloride), Taurine, Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Pineal Gland (Suis), Thalamus Opticus (Suis)	LIQUID	ORAL	20161123	20240829	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; ADENOSINE CYCLIC PHOSPHATE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; NOREPINEPHRINE; OCTOPAMINE; SEROTONIN HYDROCHLORIDE; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; TAURINE	6; 6; 8; 6; 6; 6; 6; 6; 8; 8; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
62185-0026_a85ed329-89d5-4d51-89c7-f9f87e84f18f	62185-0026	HUMAN OTC DRUG	Insecticides/Pest/Food Additives Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Bisphenol A, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Phosphoricum Acidum, Selenium Metallicum, Zincum Metallicum, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum	LIQUID	ORAL	20191126	20260901	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BETA VULGARIS; BISPHENOL A; CHELIDONIUM MAJUS; COBALT; COPPER; FORMALDEHYDE; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE	12; 30; 30; 3; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
62185-0036_152a91bd-ff50-4b62-8b64-2e2d4c70fba1	62185-0036	HUMAN OTC DRUG	Insecticides/Pest/Food Additives Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Bisphenol A, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Phosphoricum Acidum, Selenium Metallicum, Zincum Metallicum, Bacillus Thuringiensis (BT Toxin), Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum	LIQUID	ORAL	20180815	20240415	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ARSENIC TRIOXIDE; ASPARTAME; BACILLUS THURINGIENSIS; BENZALKONIUM CHLORIDE; BETA VULGARIS; BISPHENOL A; CHELIDONIUM MAJUS; COBALT; COPPER; FORMALDEHYDE; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE	12; 30; 14; 30; 3; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
62185-0040_d8415f27-0e00-43d6-beab-82dae0a35ee8	62185-0040	HUMAN OTC DRUG	HGH Young Again		Agnus Castus, Ambra Grisea, Apiolum, Estradiol, Estriol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone, Proteus	LIQUID	ORAL	20181129	20240201	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ADENOSINE TRIPHOSPHATE DISODIUM; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; CHASTE TREE; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; THIOCTIC ACID; UBIDECARENONE	8; 6; 6; 8; 6; 8; 6; 6; 8; 8; 6; 6; 8; 8; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
62185-0041_826e42a3-8a29-4967-a559-c1776ae6ddbf	62185-0041	HUMAN OTC DRUG	Hormone Balance		Salsolinol Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo-Dehydroepiandrosterone-3B-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating Hormone	LIQUID	ORAL	20181130	20240208	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ALDOSTERONE; ANDROSTERONE; CHOLESTEROL; CORTISONE ACETATE; ESTRONE; FOLLITROPIN; PRASTERONE; PROGESTERONE; SALSOLINOL HYDROCHLORIDE, (+/-)-; SUS SCROFA OVARY; TESTOSTERONE	8; 12; 12; 8; 12; 8; 12; 6; 8; 6; 8; 8	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Gonadotropin [EPC], Gonadotropins [CS], Progesterone [CS], Progesterone [EPC]	CIII	N	
62185-0042_0339e435-aa2f-40ed-81c0-435f3b94feee	62185-0042	HUMAN OTC DRUG	Brain Support		Acetylcholine Chloride, Octopamine, Taurine, Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Pineal Gland (Suis), Thalamus Opticus (Suis), Adrenalinum, Dopamine Hydrochloride, GABA (Gamma-Aminobutyric Acid), Norepinephrine (Bitartrate), Serotonin (Hydrochloride)	LIQUID	ORAL	20190315	20240415	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; ADENOSINE CYCLIC PHOSPHATE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; NOREPINEPHRINE BITARTRATE; OCTOPAMINE; SEROTONIN HYDROCHLORIDE; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS; TAURINE	8; 6; 8; 8; 8; 8; 6; 8; 8; 8; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
62185-0043_ee165476-0e2f-48d6-88ed-8387c68ee647	62185-0043	HUMAN OTC DRUG	NS Support		Berberis Vulgaris, Cimicifuga Racemosa, Cinchona Officinalis, Colocynthis, Ledum Palustre, Ranunculus Bulbosus, Aesculus Hippocastanum, Cuprum Aceticum, Nadidum, Natrum Oxalaceticum, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, alpha-Lipoicum Acidum, Ammonium Muriaticum, Cartilago Suis, Discus Intervertebralis Suis, Picricum Acidum, Silicea, Argentum Metallicum, Calcarea Phosphorica, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Gnaphalium Polycephalum,	LIQUID	ORAL	20190315		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	AMMONIUM CHLORIDE; BERBERIS VULGARIS ROOT BARK; BLACK COHOSH; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; ENTEROBACTER CLOACAE; HORSE CHESTNUT; LEDUM PALUSTRE TWIG; MERCURIC OXIDE; NADIDE; NIACINAMIDE; PANTOTHENIC ACID; PICRIC ACID; PROTEUS MORGANII; PROTEUS VULGARIS; PSEUDOGNAPHALIUM OBTUSIFOLIUM; PYRIDOXINE HYDROCHLORIDE; RANUNCULUS BULBOSUS; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SILICON DIOXIDE; SILVER; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA CARTILAGE; SUS SCROFA INTERVERTEBRAL DISC; SUS SCROFA UMBILICAL CORD; THIAMINE HYDROCHLORIDE; THIOCTIC ACID; TRIBASIC CALCIUM PHOSPHATE	8; 4; 4; 4; 4; 6; 30; 6; 4; 10; 6; 6; 10; 8; 30; 30; 10; 6; 4; 6; 30; 8; 10; 6; 28; 10; 10; 8; 8; 10; 6; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
62185-0044_3d745f48-8ca9-4e82-a1e8-6b9bf60380b5	62185-0044	HUMAN OTC DRUG	Intercellular Detox		Ceanothus Americanus, Anacardium Orientale, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Oxalis Acetosella, Pulsatilla (Vulgaris), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Pancreas Suis, Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Veratrum Album, Mannan,	LIQUID	ORAL	20190315	20240315	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ANEMONE PULSATILLA; CEANOTHUS AMERICANUS LEAF; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; MANDRAGORA OFFICINARUM ROOT; MARSDENIA CONDURANGO BARK; MOMORDICA BALSAMINA IMMATURE FRUIT; OXALIS ACETOSELLA LEAF; PHOSPHORUS; PORK INTESTINE; POTASSIUM DICHROMATE; SEMECARPUS ANACARDIUM JUICE; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA BILE DUCT; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA EYE; SUS SCROFA GALLBLADDER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA ORAL MUCOSA; SUS SCROFA PANCREAS; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; VERATRUM ALBUM ROOT; WOOD CREOSOTE; YEAST MANNAN	6; 4; 6; 8; 10; 10; 6; 6; 6; 8; 8; 8; 6; 30; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8; 10; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
62185-0045_18b5de7d-57a4-426d-890b-9ed1fccb5d30	62185-0045	HUMAN OTC DRUG	D2 Organ Support		Solidago Virgaurea, Baptisia Tinctoria, Berberis Vulgaris, Equisetum Hyemale, Argentum Nitricum, Cantharis, Capsicum Annuum, Cuprum Sulphuricum, Orthosiphon Stamineus, Pareira Brava, Sarsaparilla (Smilax Regelii), Apis Venenum Purum, Barosma (Betulina), Mercurius Corrosivus, Pyelon (Suis), Terebinthina, Ureter (Suis), Urethra (Suis), Urinary Bladder (Suis), Glyoxal Trimer Dihydrate, Hepar Sulphuris Calcareum, Natrum Pyruvicum, Quercetin, Colibacillinum Cum Natrum Muriaticum, Dysentery Bacillus	LIQUID	ORAL	20190315	20240415	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	AGATHOSMA BETULINA LEAF; APIS MELLIFERA VENOM; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CAPSICUM; CHONDRODENDRON TOMENTOSUM ROOT; CLERODENDRANTHUS SPICATUS LEAF; CUPRIC SULFATE; EQUISETUM HYEMALE; ESCHERICHIA COLI; GLYOXAL TRIMER DIHYDRATE; LYTTA VESICATORIA; MERCURIC CHLORIDE; QUERCETIN; SHIGELLA DYSENTERIAE; SILVER NITRATE; SMILAX ORNATA ROOT; SODIUM PYRUVATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA RENAL PELVIS; SUS SCROFA URETER; SUS SCROFA URETHRA; SUS SCROFA URINARY BLADDER; TURPENTINE OIL	8; 8; 4; 4; 10; 6; 6; 6; 6; 4; 15; 10; 6; 8; 10; 30; 6; 6; 10; 3; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
62185-0046_73bfc890-e726-42a3-b17f-843ad9c89263	62185-0046	HUMAN OTC DRUG	D3 Organ Support		Dulcamara, Echinacea (Angustifolia), Aesculus Hippocastanum, Antimonium Tartaricum, Ascorbicum Acidum, Coccus Cacti, Galium Aparine, Gentiana Lutea, Geranium Robertianum, Pulsatilla (Vulgaris), Sarcolacticum Acidum, Conium Maculatum, Lymph Node (Suis), Sulphur, Glandula Suprarenalis Suis, Phenylalanine, Calcarea Phosphorica, Ferrum Phosphoricum, Hepar Suis, Hypothalamus Suis, Spleen (Suis), Cortisone Aceticum, Mercurius Solubilis, Baryta Carbonica, Glyphosate, Funiculus Umbilicalis Suis, Tonsil (Suis)	LIQUID	ORAL	20190318	20240415	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ASCORBIC ACID; BARIUM CARBONATE; BISPHENOL A; BROMINE; CHLORINE; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ECHINACEA ANGUSTIFOLIA; ESCHERICHIA COLI; FERROSOFERRIC PHOSPHATE; GALIUM APARINE; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; GLYPHOSATE; HORSE CHESTNUT; HYDROFLUORIC ACID; IODINE; LACTIC ACID, L-; LIOTHYRONINE; MERCURIUS SOLUBILIS; PHENYLALANINE; PORK LIVER; PROTORTONIA CACTI; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA TONSIL; SUS SCROFA UMBILICAL CORD; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6; 28; 12; 12; 12; 6; 13; 4; 30; 10; 6; 6; 6; 1000; 6; 12; 12; 8; 10; 13; 8; 10; 6; 9; 4; 8; 8; 12; 10; 8; 10; 6; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Coagulation Factor Activity [PE], Triiodothyronine [CS], Vitamin C [EPC], l-Triiodothyronine [EPC]		N	
62185-0047_81420c25-2a7c-47f8-b1f0-1fc2204cd1dd	62185-0047	HUMAN OTC DRUG	ChemDetox		Berberis Vulgaris, Glycyrrhiza Glabra, Lappa Major, Stillingia Sylvatica, Trifolium Pratense, Glandula Suprarenalis Suis, Hepar Suis, Lymph Node (Suis), Phytolacca Decandra, Thyroidinum (Suis), Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum, Selenium Metallicum, Salicylicum Acidum, Adrenocorticotrophin, Cortisone Aceticum, Eugenol, Stearyl Alcohol, Xylitol, Folliculinum, Benzoicum Acidum, Chlorinum, Potassium Sorbate, Sorbitol, Resorcinum	LIQUID	ORAL	20190318		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; ASARUM CANADENSE ROOT; BERBERIS VULGARIS ROOT BARK; BUTYLBENZENE; CARBON DISULFIDE; CHLORINE; GLYCYRRHIZA GLABRA; IRIDIUM; KEROSENE; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PHENOL; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PORK LIVER; SELENIUM; SORBITOL; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; SUS SCROFA ADRENAL GLAND; SUS SCROFA THYROID; TRIFOLIUM PRATENSE FLOWER	3; 12; 12; 3; 30; 12; 30; 3; 12; 30; 12; 12; 12; 12; 8; 8; 12; 30; 3; 12; 12; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62185-0048_1191aec6-3a43-4bd5-95fb-eb02e41a574c	62185-0048	HUMAN OTC DRUG	Intercellular Detox		Ceanothus Americanus, Anacardium Orientale, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Oxalis Acetosella, Pulsatilla (Pratensis), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Pancreas Suis, Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Veratrum Album, Mannose,	LIQUID	ORAL	20190517	20240718	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ANEMONE PRATENSIS; CEANOTHUS AMERICANUS LEAF; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; MANDRAGORA OFFICINARUM ROOT; MANNOSE, D-; MARSDENIA CONDURANGO BARK; MOMORDICA BALSAMINA IMMATURE FRUIT; OXALIS ACETOSELLA LEAF; PHOSPHORUS; PORK INTESTINE; POTASSIUM DICHROMATE; SEMECARPUS ANACARDIUM JUICE; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA BILE DUCT; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA EYE; SUS SCROFA GALLBLADDER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA ORAL MUCOSA; SUS SCROFA PANCREAS; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; VERATRUM ALBUM ROOT; WOOD CREOSOTE	6; 4; 6; 8; 10; 10; 8; 6; 6; 10; 8; 8; 8; 9; 30; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	
62185-0049_0a9a5ecc-f416-4068-a2cf-d7d52d9074bc	62185-0049	HUMAN OTC DRUG	HGH Young Again		Agnus Castus, Ambra Grisea, Petroselinum Sativum, Estradiol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone,	LIQUID	ORAL	20190903	20250508	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ADENOSINE TRIPHOSPHATE DISODIUM; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; CHASTE TREE; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; THIOCTIC ACID; UBIDECARENONE	8; 6; 30; 8; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	
62185-0050_4cbd78f0-c687-421e-8f4b-8b9c0479c7f5	62185-0050	HUMAN OTC DRUG	Hormone Balance		Acetaldehyde, Dopamine Hydrochloride, DHEA (Dehydroepiandrosterone), 7-Oxo-Dehydroepiandrosterone-3B-Acetate, Folliculinum, Oophorinum (Suis), Cholesterinum, Progesterone, Testosterone, Cortisone Aceticum, Aldosterone, Androsterone, Follicle Stimulating Hormone	LIQUID	ORAL	20190903		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ACETALDEHYDE; ALDOSTERONE; ANDROSTERONE; CHOLESTEROL; CORTISONE ACETATE; DOPAMINE HYDROCHLORIDE; ESTRONE; FOLLITROPIN; PROGESTERONE; SUS SCROFA OVARY; TESTOSTERONE	6; 6; 12; 12; 8; 12; 6; 8; 12; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Catecholamine [EPC], Catecholamines [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Gonadotropin [EPC], Gonadotropins [CS], Progesterone [CS], Progesterone [EPC]	CIII	N	20241231
62185-0053_84e5052d-6071-41ab-9d4d-9df721be00e0	62185-0053	HUMAN OTC DRUG	D2 Organ Support		Solidago Virgaurea, Baptisia Tinctoria, Berberis Vulgaris, Equisetum Hyemale, Argentum Nitricum, Cantharis, Capsicum Annuum, Cuprum Sulphuricum, Orthosiphon Stamineus, Pareira Brava, Sarsaparilla (Smilax Regelii), Barosma (Betulina), Mercurius Corrosivus, Pyelon (Suis), Terebinthina, Ureter (Suis), Urethra (Suis), Urinary Bladder (Suis), Acetaldehyde, Hepar Sulphuris Calcareum, Natrum Pyruvicum, Quercetin, Colibacillinum Cum Natrum Muriaticum, Apis Venenum Purum, Dysentery Bacillus	LIQUID	ORAL	20191122	20251223	UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ACETALDEHYDE; AGATHOSMA BETULINA LEAF; APIS MELLIFERA VENOM; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CAPSICUM; CHONDRODENDRON TOMENTOSUM ROOT; CLERODENDRANTHUS SPICATUS LEAF; CUPRIC SULFATE; EQUISETUM HYEMALE; ESCHERICHIA COLI; LYTTA VESICATORIA; MERCURIC CHLORIDE; QUERCETIN; SHIGELLA DYSENTERIAE; SILVER NITRATE; SMILAX ORNATA ROOT; SODIUM PYRUVATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA RENAL PELVIS; SUS SCROFA URETER; SUS SCROFA URETHRA; SUS SCROFA URINARY BLADDER; TURPENTINE OIL	10; 8; 18; 4; 4; 10; 6; 6; 6; 6; 4; 15; 6; 8; 10; 30; 6; 6; 10; 3; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
62185-0059_c36dfb1e-d3de-4def-9afb-e2338fb825ee	62185-0059	HUMAN OTC DRUG	Emotional Eating		Adenosinum Triphosphoricum Dinatrum, Adrenal Cortex (Suis), Bacopa Speciosa, Equol, Pantothenic Acid, Rhodiola, Stomach (Suis), Chininum Sulphuricum, Iodium, Lycopodium Clavatum, Phosphorus, Dopamine Hydrochloride, Thyroidinum (Suis), Cina, Serotonin (Hydrochloride), Oxytocin, Gambogia, Morgan Gaertner	LIQUID	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ADENOSINE TRIPHOSPHATE DISODIUM; ARTEMISIA CINA PRE-FLOWERING TOP; BACOPA MONNIERI WHOLE; DOPAMINE HYDROCHLORIDE; EQUOL, (+/-)-; GAMBOGE; IODINE; LYCOPODIUM CLAVATUM SPORE; OXYTOCIN ACETATE; PANTOTHENIC ACID; PHOSPHORUS; QUININE SULFATE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEDUM ROSEUM ROOT; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL CORTEX; SUS SCROFA STOMACH; THYROID, PORCINE	6; 8; 6; 8; 6; 14; 6; 6; 12; 6; 6; 6; 30; 6; 8; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
62185-0060_23b018be-033a-4461-afd5-fb75adb6fb3d	62185-0060	HUMAN OTC DRUG	Young Again		Agnus Castus, Ambra Grisea, Petroselinum Sativum, Estradiol, L-Dopa, Melatonin, Testosterone, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Nadidum, Pantothenic Acid, Sarcolacticum Acidum, Ubidecarenonum, Baryta Carbonica, Conium Maculatum, Selenium Metallicum, Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hepar Suis, Hypothalamus Suis, Lymph Node (Suis), Medulla Ossis Suis, Oophorinum (Suis), Orchitinum (Suis), Pancreas Suis, Spleen (Suis), Human Growth Hormone,	LIQUID	ORAL	20210419		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	.ALPHA.-LIPOIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; AMBERGRIS; APIOLE (PARSLEY); BARIUM CARBONATE; BOS TAURUS HYPOTHALAMUS; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; ESTRADIOL; ESTRONE; LACTIC ACID, L-; LEVODOPA; MELATONIN; NADIDE; PANTOTHENIC ACID; PETROSELINUM CRISPUM WHOLE; PORK LIVER; PROTEUS MORGANII; SELENIUM; SOMATROPIN; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA SPLEEN; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; UBIDECARENONE	8; 8; 6; 14; 8; 30; 6; 8; 6; 8; 8; 6; 6; 8; 8; 6; 30; 30; 8; 30; 30; 30; 30; 30; 30; 30; 30; 30; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Amino Acids, Aromatic [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Aromatic Amino Acid [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]	CIII	N	20241231
62185-0061_016773b2-4674-4f61-80b4-8d215f896b95	62185-0061	HUMAN OTC DRUG	D2 Organ Support		Solidago Virgaurea, Baptisia Tinctoria, Berberis Vulgaris, Equisetum Hyemale, Argentum Nitricum, Cantharis, Capsicum Annuum, Cuprum Sulphuricum, Orthosiphon Stamineus, Sarsaparilla (Smilax Regelii), Barosma (Betulina), Mercurius Corrosivus, Pareira Brava, Pyelon (Suis), Terebinthina, Ureter (Suis), Urethra (Suis), Urinary Bladder (Suis), Acetaldehyde, Hepar Sulphuris Calcareum, Natrum Pyruvicum, Quercetin, Colibacillinum Cum Natrum Muriaticum, Apis Venenum Purum, Dysentery Bacillus	LIQUID	ORAL	20210524		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ACETALDEHYDE; AGATHOSMA BETULINA LEAF; APIS MELLIFERA VENOM; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CAPSICUM; CHONDRODENDRON TOMENTOSUM ROOT; CLERODENDRANTHUS SPICATUS LEAF; CUPRIC SULFATE; EQUISETUM HYEMALE; ESCHERICHIA COLI; LYTTA VESICATORIA; MERCURIC CHLORIDE; QUERCETIN; SHIGELLA DYSENTERIAE; SILVER NITRATE; SMILAX ORNATA ROOT; SODIUM PYRUVATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA RENAL PELVIS; SUS SCROFA URETER; SUS SCROFA URETHRA; SUS SCROFA URINARY BLADDER; TURPENTINE OIL	10; 8; 18; 4; 4; 10; 6; 8; 6; 6; 4; 15; 6; 8; 10; 30; 6; 6; 10; 3; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
62185-0063_d630662f-16c7-4d67-8a92-a4536eb4d095	62185-0063	HUMAN OTC DRUG	Chip Cravings		Coumarinum, Quercetin, Rutin, Bamboo, Barley, Poppy Seed, Corn (Zea Mays), Flax Seed (Linum Usitatissimum), Buckwheat (Fagopyrum Esulentum), Millet, Milo, Oat, Rice, Rye, Lentils, Sesame, Amaranth, Soybean, Sugarcane (Saccharum Officinale), Sunflower Seed, Wheat, Amaranth, Avena Sativa, Natrum Sulphuricum, Sarcolacticum Acidum, Triticum Repens, Adrenocorticotrophin, Sycotic Co Bacillus	LIQUID	ORAL	20210608		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	AMARANTH; AVENA SATIVA FLOWERING TOP; BAMBUSA VULGARIS LEAF; BARLEY; BROWN RICE; BUCKWHEAT; CORN; CORTICOTROPIN; COUMARIN; ELYMUS REPENS ROOT; ENTEROCOCCUS FAECALIS; FLAX SEED; LACTIC ACID, L-; LENTIL; MILLET; OAT; POPPY SEED; QUERCETIN; RUTIN; RYE; SESAME SEED; SODIUM SULFATE; SORGHUM BICOLOR WHOLE; SOYBEAN; SUCROSE; SUNFLOWER SEED; WHEAT	9; 6; 9; 9; 9; 9; 9; 15; 6; 6; 30; 9; 6; 9; 9; 9; 9; 6; 6; 9; 9; 6; 9; 9; 9; 9; 9	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]	CII	N	20241231
62185-0064_491c7afc-453d-4bfd-8bf0-a859ef6df6e2	62185-0064	HUMAN OTC DRUG	Bread Cravings		Acetaldehyde, Coumarinum, Histaminum Hydrochloricum, Quercetin, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Adrenocorticotrophin, Sarcolacticum Acidum, Sepia, Adrenocorticotrophin, Faecalis (Alkaligenes)	LIQUID	ORAL	20210621		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ACETALDEHYDE; ALCALIGENES FAECALIS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CORTICOTROPIN HUMAN; COUMARIN; HISTAMINE DIHYDROCHLORIDE; LACTIC ACID, L-; QUERCETIN; SACCHAROMYCES CEREVISIAE; SEPIA OFFICINALIS JUICE	6; 30; 12; 12; 15; 6; 6; 6; 6; 10; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
62185-0065_b840ffd3-7d31-48c8-ad61-90eb16e950fe	62185-0065	HUMAN OTC DRUG	Insecticides/Pest/Food Additives Detox		Boldo, Carduus Marianus, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Bisphenol A, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Phosphoricum Acidum, Selenium Metallicum, Zincum Metallicum, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum	LIQUID	ORAL	20220513		UNAPPROVED HOMEOPATHIC		Dr. Donna Restivo DC	ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BISPHENOL A; CHELIDONIUM MAJUS WHOLE; COBALT; COPPER; FORMALDEHYDE SOLUTION; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; MILK THISTLE; PETROSELINUM CRISPUM WHOLE; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE, UNSPECIFIED FORM; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE	12; 30; 30; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
62191-013_7fb91dc0-2d55-4222-b1ca-1a1449ac8a87	62191-013	HUMAN OTC DRUG	Kandesn CC Cream	Medium	Sunscreen Broad Spectrum SPF30	CREAM	TOPICAL	20160901		OTC MONOGRAPH DRUG	part352	Sunrider Manufacturing L.P.	TITANIUM DIOXIDE; ZINC OXIDE	114; 55	mg/g; mg/g			N	20241231
62191-118_d20a202d-5ca9-42cf-93d7-a232586aa034	62191-118	HUMAN OTC DRUG	Kandesn CC Cream	Fair	Sunscreen Broad Spectrum SPF30	CREAM	TOPICAL	20160901		OTC MONOGRAPH DRUG	part352	Sunrider Manufacturing L.P.	TITANIUM DIOXIDE; ZINC OXIDE	114; 55	mg/g; mg/g			N	20241231
62191-213_6ecef147-1960-4128-852c-0dc7533ef808	62191-213	HUMAN OTC DRUG	Kandesn CC Cream	Light Medium	Sunscreen Broad Spectrum SPF30	CREAM	TOPICAL	20160901		OTC MONOGRAPH DRUG	part352	Sunrider Manufacturing L.P.	TITANIUM DIOXIDE; ZINC OXIDE	114; 55	mg/g; mg/g			N	20241231
62191-600_79ae5613-d373-4bb8-8c6d-5e02980eac03	62191-600	HUMAN OTC DRUG	OI LIN SUNMILK SUNSCREEN SPF 30		SUNSCREEN, TITANIUM DIOXIDE	EMULSION	TOPICAL	20170727		OTC MONOGRAPH DRUG	part352	Sunrider Manufacturing L.P.	TITANIUM DIOXIDE	100.8	mg/g			N	20241231
62191-801_e7f903bf-5dc5-4193-ac3b-83730535b674	62191-801	HUMAN OTC DRUG	Oi Lin Natural Emulsion SPF 30		SUNSCREEN, TITANIUM DIOXIDE	EMULSION	TOPICAL	20171002		OTC MONOGRAPH DRUG	part352	Sunrider Manufacturing L.P.	TITANIUM DIOXIDE	.65	g/g			N	20241231
62195-051_0ae7b44d-bb98-0f1b-e063-6294a90a20b2	62195-051	VACCINE	Ixiaro		Japanese Encephalitis Vaccine, Inactivated, Adsorbed	INJECTION, SUSPENSION	INTRAMUSCULAR	20090330		BLA	BLA125280	Vetter Pharma Fertigung GmbH & Co. KG	JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)	6	ug/.5mL	Actively Acquired Immunity [PE], Inactivated Japanese Encephalitis Virus Vaccine [EPC], Japanese Encephalitis Vaccines [CS], Vaccines, Inactivated [CS]		N	20241231
62206-0297_cd26b719-a61f-4173-e053-2995a90a7fb3	62206-0297	HUMAN OTC DRUG	Badger After-BUG Balm		Colloidal Oatmeal	STICK	TOPICAL	20200521		OTC MONOGRAPH FINAL	part347	W.S. Badger Company, Inc.	OATMEAL	10	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62206-4032_d10356de-5453-5a0e-e053-2995a90a4e14	62206-4032	HUMAN OTC DRUG	Badger Sport Clear Mineral Sunscreen SPF 40		ZINC OXIDE	CREAM	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	22.5	g/100g			N	20241231
62206-4709_cd28587a-f288-21fc-e053-2a95a90a0610	62206-4709	HUMAN OTC DRUG	Badger BROAD SPECTRUM SPF 15 Lip Balm		ZINC OXIDE	STICK	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	8	g/100g			N	20241231
62206-4710_cd291d22-57ee-387b-e053-2a95a90a3084	62206-4710	HUMAN OTC DRUG	Badger Active SPF 30 Clear Zinc Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20180210		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	18.75	g/100mL			N	20241231
62206-4712_ccd1b218-e145-74ee-e053-2995a90a9ddb	62206-4712	HUMAN OTC DRUG	Badger Baby Sunscreen Cream Broad Spectrum SPF 40		ZINC OXIDE	CREAM	TOPICAL	20210924		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	22.5	g/100mL			N	20241231
62206-4713_cdb77b15-9fd1-5f36-e053-2a95a90a1e12	62206-4713	HUMAN OTC DRUG	Badger Unscented Broad Spectrum SPF 30 Natural Mineral Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20190101	20240305	OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	15	g/100mL			N	
62206-4714_ccd3457c-f10e-490b-e053-2995a90a2f76	62206-4714	HUMAN OTC DRUG	Badger Clear Zinc Sunscreen Cream Broad Spectrum SPF 40		ZINC OXIDE	CREAM	TOPICAL	20210924		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	22.5	g/100mL			N	20241231
62206-4719_cd3d9628-6cea-36e0-e053-2a95a90a1265	62206-4719	HUMAN OTC DRUG	Badger Clear Zinc Sunscreen Cream Broad Spectrum SPF 40		ZINC OXIDE	CREAM	TOPICAL	20210211		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	22.5	g/100g			N	20241231
62206-5023_d21c275e-697b-e95e-e053-2a95a90ad633	62206-5023	HUMAN OTC DRUG	Badger Adventure Sport Clear Mineral Sunscreen SPF 50		ZINC OXIDE	CREAM	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	25	g/100g			N	20241231
62206-7117_cd29770b-4cbb-4171-e053-2995a90ae25a	62206-7117	HUMAN OTC DRUG	Badger Kids Broad Spectrum SPF 40 Natural Mineral Sunscreen Cream		ZINC OXIDE	CREAM	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	22.5	g/100mL			N	20241231
62206-7133_cd549cd1-8d0a-fbed-e053-2995a90a6e3d	62206-7133	HUMAN OTC DRUG	Badger Clear Lavender SPF 30 Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20191209	20240305	OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	18.75	g/100mL			N	
62206-7207_cd2afdbb-650b-3859-e053-2995a90aa225	62206-7207	HUMAN OTC DRUG	Badger Clear Sport SPF 35 Natural Mineral All Season Face Stick		ZINC OXIDE	STICK	TOPICAL	20191209		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	22.5	g/100g			N	20241231
62206-7209_cd2b1e7f-f5ad-3860-e053-2995a90af805	62206-7209	HUMAN OTC DRUG	Badger Clear Sport SPF 35 Kids All Season Face Stick		ZINC OXIDE	STICK	TOPICAL	20191209		OTC MONOGRAPH NOT FINAL	part352	W.S. Badger Company, Inc.	ZINC OXIDE	22.5	g/100g			N	20241231
62207-183_faddbd0b-3318-2121-e053-6294a90a27c2	62207-183	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, EXTENDED RELEASE	ORAL	20190418		ANDA	ANDA211544	Granules India Limited	ACETAMINOPHEN	650	mg/1			N	20241231
62207-188_faddbd0b-3318-2121-e053-6294a90a27c2	62207-188	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, EXTENDED RELEASE	ORAL	20190418		ANDA	ANDA211544	Granules India Limited	ACETAMINOPHEN	650	mg/1			N	20241231
62207-320_f37bc244-5479-3bfe-e053-2a95a90acf61	62207-320	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET	ORAL	20191114		ANDA	ANDA202312	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-321_f37bc244-5479-3bfe-e053-2a95a90acf61	62207-321	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET	ORAL	20191114		ANDA	ANDA202312	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-327_f4026a0a-c9cd-3850-e053-2995a90a459c	62207-327	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20210716		ANDA	ANDA091353	Granules India Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-328_f4026a0a-c9cd-3850-e053-2995a90a459c	62207-328	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20210716		ANDA	ANDA091353	Granules India Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-354_fa1010e8-df71-32f4-e053-6294a90a0078	62207-354	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150921		ANDA	ANDA091625	Granules India Limited	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-355_fa1010e8-df71-32f4-e053-6294a90a0078	62207-355	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150921		ANDA	ANDA091625	Granules India Limited	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-356_fa1010e8-df71-32f4-e053-6294a90a0078	62207-356	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150921		ANDA	ANDA091625	Granules India Limited	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-357_ba67be92-0460-58ae-e053-2995a90af488	62207-357	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20161117		ANDA	ANDA202312	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-358_ba67be92-0460-58ae-e053-2995a90af488	62207-358	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20161117		ANDA	ANDA202312	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-365_f37b04a6-8c5f-0644-e053-2995a90a40a0	62207-365	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20110101		ANDA	ANDA079174	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-366_f37b04a6-8c5f-0644-e053-2995a90a40a0	62207-366	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20110101		ANDA	ANDA079174	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-395_f37b04a6-8c5f-0644-e053-2995a90a40a0	62207-395	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20190813		ANDA	ANDA079174	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-396_f37b04a6-8c5f-0644-e053-2995a90a40a0	62207-396	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20190813		ANDA	ANDA079174	Granules India Limited	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-440_f42fde50-43ec-82d8-e053-2a95a90a9e3f	62207-440	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Tablet	TABLET	ORAL	20190704		ANDA	ANDA090564	Granules India Ltd	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62207-441_f42fde50-43ec-82d8-e053-2a95a90a9e3f	62207-441	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Tablet	TABLET	ORAL	20190704		ANDA	ANDA090564	Granules India Ltd	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62207-442_f42fde50-43ec-82d8-e053-2a95a90a9e3f	62207-442	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Tablet	TABLET	ORAL	20190704		ANDA	ANDA090564	Granules India Ltd	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62207-491_f339d906-49a1-e1c3-e053-2995a90a41e1	62207-491	HUMAN PRESCRIPTION DRUG	Metformin ER 500 mg		Metformin ER 500 mg	TABLET	ORAL	20180628		ANDA	ANDA209313	Granules India Ltd	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62207-492_f339d906-49a1-e1c3-e053-2995a90a41e1	62207-492	HUMAN PRESCRIPTION DRUG	Metformin ER 750 mg		Metformin ER 750 mg	TABLET	ORAL	20180628		ANDA	ANDA209313	Granules India Ltd	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62207-496_f339cb06-335b-2ecc-e053-2a95a90a4b3a	62207-496	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA213344	Granules India Ltd	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62207-497_f339cb06-335b-2ecc-e053-2a95a90a4b3a	62207-497	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA213344	Granules India Ltd	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62207-569_f38957f6-56f3-583b-e053-2995a90a473a	62207-569	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	TABLET, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA213420	Granules India Ltd	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62207-570_f38957f6-56f3-583b-e053-2995a90a473a	62207-570	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	TABLET, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA213420	Granules India Ltd	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62207-680_053d85f0-b442-d637-e063-6394a90a3fcb	62207-680	HUMAN OTC DRUG	Acetaminophen, Aspirin and Caffeine		Acetaminophen, Aspirin and Caffeine	TABLET	ORAL	20210415		ANDA	ANDA214039	Granules India Ltd	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
62207-697_f4cf2396-f17a-76ab-e053-2995a90a3232	62207-697	HUMAN OTC DRUG	Guaifenesin Extended-Release Tablets, 600mg		Guaifenesin Extended-Release	TABLET	ORAL	20200910		ANDA	ANDA213420	Granules India Ltd	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62207-698_f4cf2396-f17a-76ab-e053-2995a90a3232	62207-698	HUMAN OTC DRUG	Guaifensin Extended-Release Tablets, 1200 mg		Guaifensin Extended-Release	TABLET	ORAL	20200910		ANDA	ANDA213420	Granules India Ltd	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62207-726_f4032748-183f-5512-e053-2a95a90a9eaa	62207-726	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Granules India Ltd	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62207-727_f4032748-183f-5512-e053-2a95a90a9eaa	62207-727	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Granules India Ltd	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62207-728_f4026a0a-c9cd-3850-e053-2995a90a459c	62207-728	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20180608		ANDA	ANDA091353	Granules India Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-729_f4026a0a-c9cd-3850-e053-2995a90a459c	62207-729	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20180608		ANDA	ANDA091353	Granules India Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-739_f33adff8-806e-2a38-e053-2a95a90a5532	62207-739	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20230301		ANDA	ANDA215981	Granules India Ltd	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
62207-742_f9953d60-1a19-a3c1-e053-6394a90a5b42	62207-742	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan	TABLET	ORAL	20230308		ANDA	ANDA215959	Granules India Ltd	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62207-745_f33998b9-dc60-1f09-e053-2995a90a6ac8	62207-745	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20210415		ANDA	ANDA074140	Granules India Ltd	NAPROXEN SODIUM	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-746_f33998b9-dc60-1f09-e053-2995a90a6ac8	62207-746	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20210415		ANDA	ANDA074140	Granules India Ltd	NAPROXEN SODIUM	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-747_f33998b9-dc60-1f09-e053-2995a90a6ac8	62207-747	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20210415		ANDA	ANDA074140	Granules India Ltd	NAPROXEN SODIUM	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-750_0c3a7f55-1cf1-e6bf-e063-6294a90afccb	62207-750	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20110930		ANDA	ANDA091353	Granules India Limited	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-753_0c3a7f55-1cf1-e6bf-e063-6294a90afccb	62207-753	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20110930		ANDA	ANDA091353	Granules India Limited	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-754_a973e574-3a91-5895-e053-2995a90ada63	62207-754	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180515		ANDA	ANDA209312	Granules India Ltd	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
62207-761_f4026a0a-c9cd-3850-e053-2995a90a459c	62207-761	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20110930		ANDA	ANDA091353	Granules India Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-762_f4026a0a-c9cd-3850-e053-2995a90a459c	62207-762	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20110930		ANDA	ANDA091353	Granules India Ltd	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-764_f338db49-8e58-a55e-e053-2995a90a055b	62207-764	HUMAN OTC DRUG	Cetirizine hydrochloride		Cetirizine hydrochloride	TABLET, COATED	ORAL	20180528		ANDA	ANDA209274	Granules India Ltd	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62207-765_f38957f6-56f9-583b-e053-2995a90a473a	62207-765	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET	ORAL	20201218		ANDA	ANDA211075	Granules India Ltd	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62207-766_f38957f6-56f9-583b-e053-2995a90a473a	62207-766	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET	ORAL	20201218		ANDA	ANDA211075	Granules India Ltd	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62207-770_a973e574-3a91-5895-e053-2995a90ada63	62207-770	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180515		ANDA	ANDA209312	Granules India Ltd	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
62207-773_f33bf0be-f52e-a8c3-e053-2a95a90a033a	62207-773	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20190626		ANDA	ANDA210243	Granules India Ltd	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62207-774_f33bf0be-f52e-a8c3-e053-2a95a90a033a	62207-774	HUMAN OTC DRUG	Ranitidine	cool mint	Ranitidine	TABLET	ORAL	20190626		ANDA	ANDA210243	Granules India Ltd	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62207-787_9aadc2f2-d0ea-5297-e053-2995a90ac51e	62207-787	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20200101		ANDA	ANDA210722	Granules India Ltd	LORATADINE	10	mg/1			N	20241231
62207-787_f4a2d276-f864-5edf-e053-2a95a90ae0b2	62207-787	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20200108		ANDA	ANDA210722	Granules India Limited	LORATADINE	10	mg/1			N	20241231
62207-814_f444e5c3-25c1-e2fb-e053-2a95a90a2f08	62207-814	HUMAN OTC DRUG	Naproxen Sodium and Diphenhydramine HCl		Naproxen Sodium and Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210220		ANDA	ANDA213663	Granules India Ltd	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62207-827_f33af289-9086-0b0e-e053-2a95a90aa7b8	62207-827	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20230601		ANDA	ANDA216082	Granules India Ltd	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
62207-828_f33af289-9086-0b0e-e053-2a95a90aa7b8	62207-828	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20230601		ANDA	ANDA216082	Granules India Ltd	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
62207-839_f3387972-27b9-5186-e053-2995a90a41f1	62207-839	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	TABLET, EXTENDED RELEASE	ORAL	20201218		ANDA	ANDA213420	Granules India Ltd	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62207-840_f3387972-27b9-5186-e053-2995a90a41f1	62207-840	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	TABLET, EXTENDED RELEASE	ORAL	20201218		ANDA	ANDA213420	Granules India Ltd	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
62207-889_0a075ab9-bc48-dc0c-e063-6394a90aafde	62207-889	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET, FILM COATED	ORAL	20231107		ANDA	ANDA211075	Granules India Limited	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62207-891_0a075ab9-bc48-dc0c-e063-6394a90aafde	62207-891	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET, FILM COATED	ORAL	20231107		ANDA	ANDA211075	Granules India Limited	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62207-914_f33dc8f2-150e-89a7-e053-2a95a90a1c54	62207-914	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20230101		ANDA	ANDA214686	Granules India Ltd	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62207-915_f33dc8f2-150e-89a7-e053-2a95a90a1c54	62207-915	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20230101		ANDA	ANDA214686	Granules India Ltd	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62207-922_f4a98a82-542e-d86e-e053-2995a90a3aab	62207-922	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200915		ANDA	ANDA075360	Granules India Limited	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62207-923_f4a98a82-542e-d86e-e053-2995a90a3aab	62207-923	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200915		ANDA	ANDA075360	Granules India Limited	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62207-924_f4a98a82-542e-d86e-e053-2995a90a3aab	62207-924	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200915		ANDA	ANDA075360	Granules India Limited	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62207-926_eca48cc3-0a88-7c06-e053-2a95a90aa850	62207-926	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20210901		ANDA	ANDA075360	Granules India Limited	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62207-927_eca48cc3-0a88-7c06-e053-2a95a90aa850	62207-927	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20210901		ANDA	ANDA075360	Granules India Limited	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62207-928_eca48cc3-0a88-7c06-e053-2a95a90aa850	62207-928	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20210901		ANDA	ANDA075360	Granules India Limited	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62212-350_9aecb197-0617-4043-83e3-00e0abae5b0b	62212-350	HUMAN OTC DRUG	Amish Origins SPF 15 Lip Balm		Octinoxate, Octocrylene, Oxybenzone	STICK	TOPICAL	20150817		OTC MONOGRAPH NOT FINAL	part352	Amish Origins	OCTINOXATE; OCTOCRYLENE; OXYBENZONE	7.5; 2; 4	mg/g; mg/g; mg/g			N	20241231
62212-505_00b14e55-ede0-653d-e063-6394a90a3258	62212-505	HUMAN OTC DRUG	Menthol		Owell Naturals Pain Relief Cream	CREAM	TOPICAL	20230717		OTC MONOGRAPH NOT FINAL	part348	Amish Origins LLC	MENTHOL	8	g/100g			N	20241231
62217-001_649648c7-d296-be91-e053-2a91aa0aede5	62217-001	HUMAN OTC DRUG	Fruit of the Earth, Inc.	Luv That Sun SPF 30 Natural Mineral Sunscreen	titanium dioxide, zinc oxide	LOTION	TOPICAL	20180206		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	31.16; 40.4625	mg/mL; mg/mL			N	20241231
62217-002_64a21b89-0355-37e7-e053-2a91aa0a8f18	62217-002	HUMAN OTC DRUG	Fruit of the Earth, Inc.	Luv That Sun SPF 30 Natural Sunscreen	avobenzone, homosalate, octocrylene	LOTION	TOPICAL	20180207		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
62217-003_6491b1c3-d8f2-a9eb-e053-2a91aa0a11fe	62217-003	HUMAN OTC DRUG	Fruit of the Earth, Inc.	Luv That Sun Kids SPF 50 Natural Sunscreen	avobenzone, homosalate, octocrylene	LOTION	TOPICAL	20180206		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
62217-005_c8230122-05ce-12e8-e053-2a95a90a7d20	62217-005	HUMAN OTC DRUG	Fruit of the Earth	Block Up Kids SPF 50	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20140929		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-006_57d2549e-faf4-1791-e053-2a91aa0a7f63	62217-006	HUMAN OTC DRUG	Fruit of the Earth, Inc.	Ultra SPF 50 Moisturizing Sunscreen	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170512		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-009_57d213e3-fdcd-70b1-e053-2991aa0a2e9b	62217-009	HUMAN OTC DRUG	Fruit of the Earth	Block Up Sport SPF 30 Sunscreen	Avobenzone, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170516		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-012_4fa6b17b-88d9-0ed2-e054-00144ff8d46c	62217-012	HUMAN OTC DRUG	Fruit of the Earth	Sport SPF 50 Sunscreen Continuous	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170516		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-013_503ab067-0fe8-3d2c-e054-00144ff88e88	62217-013	HUMAN OTC DRUG	Fruit of the Earth	Block Up Kids SPF 50 Moisturizing Sunscreen	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170523		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-014_50466211-e6ce-351f-e054-00144ff8d46c	62217-014	HUMAN OTC DRUG	Fruit of the Earth	Block Up Sport SPF 50 Continuous Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170524		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-015_50478011-2721-53c0-e054-00144ff8d46c	62217-015	HUMAN OTC DRUG	Fruit of the Earth	Block Up Sport SPF 30 Continuous Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170524		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-016_504a78ca-42d8-2877-e054-00144ff88e88	62217-016	HUMAN OTC DRUG	Fruit of the Earth	Block Up Kids SPF 50 Continuous Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170524		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-017_57d2549e-fb2f-1791-e053-2a91aa0a7f63	62217-017	HUMAN OTC DRUG	Fruit of the Earth	Block Up Sport SPF 50 Moisturizing Sunscreen	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170524		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-018_57d2549e-fb3f-1791-e053-2a91aa0a7f63	62217-018	HUMAN OTC DRUG	Fruit of the Earth	Block Up Sport SPF 50 No Mess Sun	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	STICK	TOPICAL	20170525		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62217-019_505ace8b-823b-098a-e054-00144ff88e88	62217-019	HUMAN OTC DRUG	Fruit of the Earth	Block Up SPF 30 General Protection Sunscreen	Avobenzone, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170525		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-020_505b20b7-6635-1eef-e054-00144ff88e88	62217-020	HUMAN OTC DRUG	Fruit of the Earth	Block Up SPF 70 General Protection Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20180207		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-021_50ff3ed1-9a56-2b86-e054-00144ff88e88	62217-021	HUMAN OTC DRUG	Fruit of the Earth	Block Up SPF 30 Sunscreen	Avobenzone, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170602		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-024_57d2549e-fb4e-1791-e053-2a91aa0a7f63	62217-024	HUMAN OTC DRUG	Fruit of the Earth	Block Up Sport SPF 50 Sunscreen	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170602		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-026_5178bc1a-0f12-1e05-e054-00144ff8d46c	62217-026	HUMAN OTC DRUG	Fruit of the Earth	Block Up Lite Kids SPF 50 Continuous Sunscreen	Avobenzone, Homosalate, Octisalate, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170608		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	30; 150; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-027_f428d1d0-a27b-6b54-e053-2a95a90a38e4	62217-027	HUMAN OTC DRUG	Fruit of the Earth	Block Up Lite Broad Spectrum SPF 30 Continuous Sunscreen	Avobenzone, Homosalate, Octisalate, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20080513		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 150; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-028_518936b7-d39a-628c-e054-00144ff8d46c	62217-028	HUMAN OTC DRUG	Fruit of the Earth	Block Up Lite Broad Spectrum SPF 15 Continuous Sunscreen	Avobenzone, Homosalate, Octisalate, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170609		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-029_51898e43-6d05-13a8-e054-00144ff88e88	62217-029	HUMAN OTC DRUG	Fruit of the Earth	Block Up Dry Sport SPF 50 Continuous Sunscreen	Avobenzone, Homosalate, Octisalate, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170609		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	30; 150; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-041_c791e922-eeca-3543-e053-2995a90a79a4	62217-041	HUMAN OTC DRUG	FOTE CABANA BEACH CLUB WITH MANUKA HONEY AND ESSENTIAL OILS SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20180724		OTC MONOGRAPH NOT FINAL	part352	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/g; mg/g; mg/g			N	20241231
62217-042_c792580f-6649-be66-e053-2a95a90a7580	62217-042	HUMAN OTC DRUG	FOTE CABANA BEACH CLUB WITH MANUKA HONEY AND ESSENTIAL OILS SPF 8 DRY TANNING SUNSCREEN		HOMOSALATE, OCTISALATE	AEROSOL, SPRAY	TOPICAL	20190115		OTC MONOGRAPH NOT FINAL	part352	FRUIT OF THE EARTH, INC.	HOMOSALATE; OCTISALATE	70; 50	mg/g; mg/g			N	20241231
62217-043_c7930946-19fa-45b8-e053-2995a90a3557	62217-043	HUMAN OTC DRUG	FOTE CABANA BEACH CLUB WITH BLOOD ORANGE AND ESSENTIAL OILS SPF 8 DRY TANNING SUNSCREEN		HOMOSALATE, OCTISALATE	AEROSOL, SPRAY	TOPICAL	20190115		OTC MONOGRAPH NOT FINAL	part352	FRUIT OF THE EARTH, INC.	HOMOSALATE; OCTISALATE	70; 50	mg/g; mg/g			N	20241231
62217-046_ec584fe2-1c86-6ffd-e053-2995a90a379a	62217-046	HUMAN OTC DRUG	FOTE SPACOLOGY SKIN PROTECTANT		WHITE PETROLATUM	JELLY	TOPICAL	20180227		OTC MONOGRAPH FINAL	part346	FRUIT OF THE EARTH, INC.	PETROLATUM	100	g/100g			N	20241231
62217-050_c836a43e-35e6-ed91-e053-2995a90a3ce1	62217-050	HUMAN OTC DRUG	Fruit of the Earth	Block Up SPF 50	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20130419		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-052_c55ff706-c725-0c5f-e053-2995a90a6d06	62217-052	HUMAN OTC DRUG	FOTE SPORT SUNSCREEN SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20171115		OTC MONOGRAPH NOT FINAL	part352	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-054_c85e5338-451e-6d00-e053-2a95a90aed56	62217-054	HUMAN OTC DRUG	FOTE Unscented Hand Sanitizer		Alcohol	AEROSOL, SPRAY	TOPICAL	20200402		OTC MONOGRAPH NOT FINAL	part333A	Fruit of the Earth, Inc.	ALCOHOL	70	mg/100g			N	20241231
62217-055_c8abcffe-fc18-4498-e053-2995a90aed13	62217-055	HUMAN OTC DRUG	FOTE Citrus Hand Sanitizer		Alcohol	AEROSOL, SPRAY	TOPICAL	20200402		OTC MONOGRAPH NOT FINAL	part333A	Fruit of the Earth, Inc.	ALCOHOL	70	mg/100g			N	20241231
62217-060_c7316403-e498-0492-e053-2995a90ac5b8	62217-060	HUMAN OTC DRUG	Spa Cology Ultra Sheer Face and Body Sunscreen SPF 70		Avobenzone, Homosalate,Octisalate,Octocrylene,Oxybenzone	STICK	TOPICAL	20161206		OTC MONOGRAPH NOT FINAL	part352	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62217-061_c7803a34-ef9c-2301-e053-2a95a90a4cc7	62217-061	HUMAN OTC DRUG	Fruit of the Earth Cabana Beach Clubwith Blood Orange and Essential Oils SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20180223		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-062_c78123a1-4074-6404-e053-2a95a90a9e5e	62217-062	HUMAN OTC DRUG	Fruit of the Earth SpaCology Sport SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OXYBENZONE, OCTOCRYLENE	SPRAY	TOPICAL	20171114		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62217-063_c7821b2b-f42b-8d08-e053-2a95a90a6bc8	62217-063	HUMAN OTC DRUG	Fruit of the Earth Cabana Beach Club with Manuka Honey and Essential Oils SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20180530		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-064_c7900332-27a9-0c05-e053-2a95a90a44f1	62217-064	HUMAN OTC DRUG	Fruit of the Earth Cabana Beach Club with Mentha and Essential Oils SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20180530		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-066_c7914643-f1a6-4581-e053-2995a90acb13	62217-066	HUMAN OTC DRUG	Fruit of the Earth Cabana Beach Club with Blood Orange and Essential Oils SPF 30		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	SPRAY	TOPICAL	20180223		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/g; mg/g; mg/g			N	20241231
62217-067_c79472ea-a368-1328-e053-2a95a90a22d5	62217-067	HUMAN OTC DRUG	Fruit of The Earth Sun Town City Kids SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20191126		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-068_c795cf88-dbf8-1861-e053-2a95a90a32aa	62217-068	HUMAN OTC DRUG	Fruit of the Earth Sun Town City SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	SPRAY	TOPICAL	20191126		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/g; mg/g; mg/g			N	20241231
62217-069_c7a47b25-d045-1528-e053-2995a90ab10a	62217-069	HUMAN OTC DRUG	Fruit of the Earth Sun Town City SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191210		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-070_c7a833b9-5238-1b63-e053-2a95a90acdcd	62217-070	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Aloe Vera After Sun with Lidocaine HCL		LIDOCAINE	GEL	TOPICAL	20191209		OTC MONOGRAPH NOT FINAL	part348	Fruit of the Earth, Inc.	LIDOCAINE	8	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62217-071_c7a86931-1f4e-8c03-e053-2995a90aff4f	62217-071	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Dark Tanning Dry Oil SPF 8 Sunscreen		HOMOSALATE, OCTISALATE	SPRAY	TOPICAL	20191127		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	HOMOSALATE; OCTISALATE	70; 50	mg/g; mg/g			N	20241231
62217-072_c7aa1e58-f7b4-6b7f-e053-2995a90a957c	62217-072	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Dark Tanning SPF 8 Sunscreen		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191209		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	15; 50; 60	mg/mL; mg/mL; mg/mL			N	20241231
62217-073_c7aaa195-6fa1-de56-e053-2995a90aca56	62217-073	HUMAN OTC DRUG	Fruit of the Earth Sun Town City SPF 15 Sunscreen		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191211		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	15; 50; 60	mg/mL; mg/mL; mg/mL			N	20241231
62217-074_c7ba7a80-f862-73b4-e053-2995a90a805d	62217-074	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Baby SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191210		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-075_c7bab82d-a817-5154-e053-2995a90a8e47	62217-075	HUMAN OTC DRUG	Fruit of the Earth Sun Town City SPF 50 Zinc Sunscreen		OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	OCTOCRYLENE; ZINC OXIDE	40; 50	mg/mL; mg/mL			N	20241231
62217-076_c7bc1732-8cdf-9296-e053-2a95a90ac7a3	62217-076	HUMAN OTC DRUG	Fruit of the Earth Sun Town City SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20200212		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-077_c7bdd7a3-2e89-d881-e053-2a95a90a2ef9	62217-077	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Baby SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20200102		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-078_c80e0e42-2c71-80ec-e053-2a95a90a80eb	62217-078	HUMAN OTC DRUG	Fruit of the Earth Lip Balm SPF 30 Sunscreen Stick		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20130419		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-079_c85e5094-d443-55a9-e053-2995a90aed12	62217-079	HUMAN OTC DRUG	Fruit of the Earth Sun Town City SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191209		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-080_c85ef709-c883-8d32-e053-2995a90a79a7	62217-080	HUMAN OTC DRUG	Fruit of the Earth Cool Blue Aloe Vera Cooling		Menthol	GEL	TOPICAL	20130930		OTC MONOGRAPH NOT FINAL	part348	Fruit of the Earth, Inc.	MENTHOL	5	mg/g			N	20241231
62217-081_c8ac138f-5104-a865-e053-2a95a90a67b5	62217-081	HUMAN OTC DRUG	FOTE Citrus Hand Sanitizer		Alcohol	AEROSOL, SPRAY	TOPICAL	20200402		OTC MONOGRAPH NOT FINAL	part333A	Fruit of the Earth, Inc.	ALCOHOL	70	mg/100g			N	20241231
62217-082_c9645b41-2cee-5feb-e053-2a95a90ab969	62217-082	HUMAN OTC DRUG	Fruit of the Earth Cabana Beach Club Lip Balm with Blood Orange and Essential Oils SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20180530		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-083_c9645bf0-87bc-6eec-e053-2995a90a09b8	62217-083	HUMAN OTC DRUG	Fruit of the Earth Cabana Beach Club Lip Balm with Manuka Honey and Essential Oils SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20180530		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-084_c972b44c-d92e-8428-e053-2995a90a026a	62217-084	HUMAN OTC DRUG	Fruit of the Earth Cabana Beach Club Lip Balm with Mentha and Essential Oils SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20180530		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-085_cf7180d4-444c-3db8-e053-2995a90a5c82	62217-085	HUMAN OTC DRUG	Fruit of the Earth Meyer Lemon Scented Antibacterial Hand with Canadian Willowherb		BENZETHONIUM CHLORIDE	SOAP	TOPICAL	20210412		OTC MONOGRAPH NOT FINAL	part333A	FRUIT OF THE EARTH, INC.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62217-086_cf719aac-d847-45e5-e053-2a95a90aa23e	62217-086	HUMAN OTC DRUG	Fruit of the Earth Grapefruit Scented Antibacterial Hand with Canadian Willowherb		BENZETHONIUM CHLORIDE	SOAP	TOPICAL	20210412		OTC MONOGRAPH NOT FINAL	part333A	FRUIT OF THE EARTH, INC.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62217-087_cf71fd2b-abee-c942-e053-2995a90a21b1	62217-087	HUMAN OTC DRUG	Fruit of the Earth Honeysuckle Scented Antibacterial Hand with Canadian Willowherb		BENZETHONIUM CHLORIDE	SOAP	TOPICAL	20210412		OTC MONOGRAPH NOT FINAL	part333A	FRUIT OF THE EARTH, INC.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62217-095_d4caae4c-efbb-2453-e053-2995a90a5e5f	62217-095	HUMAN OTC DRUG	Fruit of the Earth Cool Blue Aloe Mist Continuous		Lidocaine Hydrochloride	SPRAY	TOPICAL	20140912		OTC MONOGRAPH NOT FINAL	part348	Fruit Of The Earth, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62217-150_d569d6e3-ede5-17c1-e053-2a95a90a4951	62217-150	HUMAN OTC DRUG	Spa Cology Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20171114		OTC MONOGRAPH NOT FINAL	part352	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62217-154_d5543c5b-aab0-53cc-e053-2a95a90a9a77	62217-154	HUMAN OTC DRUG	Spa Cology Skin Clearing Body Wash Salicylic Acid Acne Treatment Pink Grapefruit		SALICYLIC ACID	LIQUID	TOPICAL	20171114		OTC MONOGRAPH FINAL	part358B	Fruit of the Earth, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
62217-158_bafe63ab-7751-9554-e053-2a95a90a0f51	62217-158	HUMAN OTC DRUG	DUAL EFFECTS MOISTURIZER		SALICYLIC ACID	LOTION	TOPICAL	20171115		OTC MONOGRAPH FINAL	part333D	Fruit of the Earth, Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
62217-174_f04b502d-c93b-93c8-e053-2a95a90aa5e0	62217-174	HUMAN OTC DRUG	Fruit of the Earth Block Up	Broad Spectrum Baby SPF 50	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20110824		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-186_f04b8e98-9b94-7d07-e053-2995a90a5739	62217-186	HUMAN OTC DRUG	Fruit of the Earth Block Up	Broad Spectrum Sport SPF 50	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20110824		OTC MONOGRAPH NOT FINAL	part352	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-200_60a601b3-8ab7-7a45-e053-2a91aa0a2e0b	62217-200	HUMAN OTC DRUG	Fruit of the Earth Aloe Vera Cool Blue		Lidocaine Hydrochloride	GEL	TOPICAL	20140910		OTC MONOGRAPH NOT FINAL	part348	Fruit of the Earth, Inc.	LIDOCAINE	10	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62217-208_d61f70ec-2e8c-34a0-e053-2a95a90a325e	62217-208	HUMAN OTC DRUG	Fruit of the Earth	SPF 50 Kids Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20141204		OTC MONOGRAPH NOT FINAL	part352	Fruit Of The Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62217-240_f426de6b-5a16-cce9-e053-2a95a90aa609	62217-240	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Stick Mineral SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	STICK	TOPICAL	20220208		OTC MONOGRAPH FINAL	M020	Fruit of the Earth, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	70; 47	mg/g; mg/g			N	20241231
62217-241_f528294f-658e-1325-e053-2995a90a764e	62217-241	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Baby and Kids Mineral SPF 50 Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20220208		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30; 150	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62217-242_f42a0b1e-038e-4fab-e053-2995a90a5364	62217-242	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Baby and Kids Mineral SPF 50 Sunscreen		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20220207		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
62217-243_f4481bfc-a1b4-30f0-e053-2a95a90a7223	62217-243	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Mineral SPF 30 Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210929		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62217-244_f448e9c9-9c82-19c0-e053-2995a90a289b	62217-244	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Mineral SPF 30 Sunscreen		Zinc Oxide	SPRAY	TOPICAL	20210901		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	ZINC OXIDE	150	mg/g			N	20241231
62217-245_f451c472-1da0-1fbc-e053-2995a90a114e	62217-245	HUMAN OTC DRUG	Cabana Beach Club with Manuka Honey and Essential Oils SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20180530		OTC MONOGRAPH FINAL	M020	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-246_f452df14-8089-7b56-e053-2995a90a126b	62217-246	HUMAN OTC DRUG	Cabana Beach Club with Mentha and Essential Oils SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20180530		OTC MONOGRAPH FINAL	M020	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-247_f452df14-808d-7b56-e053-2995a90a126b	62217-247	HUMAN OTC DRUG	Cabana Beach Club with Blood Orange and Essential Oils SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20180530		OTC MONOGRAPH FINAL	M020	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-248_f45d16b8-0f7f-1a9f-e053-2a95a90a0253	62217-248	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Mineral SPF 50 Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210927		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	30; 150	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62217-249_f45d221f-9c55-2588-e053-2a95a90a1e76	62217-249	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Mineral SPF 50 Sunscreen		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20211007		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
62217-250_f5402884-0eb4-342b-e053-2995a90a10e5	62217-250	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Mineral SPF 70 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20211011		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-251_f540b0fe-29b7-05bd-e053-2995a90aeb78	62217-251	HUMAN OTC DRUG	Fruit of the Earth Sun Town City Mineral SPF 70 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20211013		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-252_f5414a7d-6470-63ae-e053-2a95a90acc11	62217-252	HUMAN OTC DRUG	Fruit of the Earth Vitamin E SPF 15 Sunscreen Daily Defense Moisturizer		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20050613		OTC MONOGRAPH FINAL	M020	FRUIT OF THE EARTH, INC.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	20; 75; 15; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-316_c7d17291-e5cd-4657-e053-2a95a90a507c	62217-316	HUMAN OTC DRUG	Fruit of the Earth	Sun Town City	Lip Balm SPF 30 Sunscreen Stick	STICK	TOPICAL	20200213		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-345_fa18e12a-6508-cfd2-e053-6394a90ada13	62217-345	HUMAN OTC DRUG	FRUIT OF THE EARTH 100 DRY TOUCH BROAD SPECTRUM SPF 100 FACE SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20151029		OTC MONOGRAPH FINAL	M020	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-350_c80cb090-b903-ac0d-e053-2995a90a1b45	62217-350	HUMAN OTC DRUG	Fruit of the Earth	Sport SPF 50	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160720		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 90; 75; 50; 15; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-400_fd66ee9b-5a25-776a-e053-6294a90a6559	62217-400	HUMAN OTC DRUG	Fruit of the Earth LUV THAT SUN Sport Sunscreen Continuous SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220916		OTC MONOGRAPH FINAL	M020	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-401_fd67b009-accd-6c7b-e053-6294a90ad80e	62217-401	HUMAN OTC DRUG	Fruit of the Earth LUV THAT SUN Sport Sunscreen Continuous SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220906		OTC MONOGRAPH FINAL	M020	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-402_fd67fa5d-f98f-c607-e053-6294a90aee2b	62217-402	HUMAN OTC DRUG	Fruit of the Earth LUV THAT SUN Sport Sunscreen Continuous SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20220914		OTC MONOGRAPH FINAL	M020	Fruit Of The Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62217-403_fd67fda2-9797-c5bb-e053-6294a90a7338	62217-403	HUMAN OTC DRUG	Fruit of the Earth LUV THAT SUN Kids Sunscreen Continuous SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220916		OTC MONOGRAPH FINAL	M020	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
62217-404_fd684602-658e-2cb8-e053-6294a90a7af0	62217-404	HUMAN OTC DRUG	Fruit of the Earth LUV THAT SUN Sport Sunscreen Ultra SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220906		OTC MONOGRAPH FINAL	M020	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-405_fd786a06-88b8-fa35-e053-6394a90a84a5	62217-405	HUMAN OTC DRUG	Fruit of the Earth LUV THAT SUN Kids Sunscreen Ultra SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220906		OTC MONOGRAPH FINAL	M020	FRUIT OF THE EARTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-827_f0599c70-4678-688c-e053-2995a90ac86e	62217-827	HUMAN OTC DRUG	Fruit of the Earth, Inc.	Luv That Sun SPF 30 Continuous	Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20160303		OTC MONOGRAPH NOT FINAL	part352	Fruit of the Earth, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62217-932_b5e53f61-ace7-c434-e053-2995a90a02bd	62217-932	HUMAN OTC DRUG	Fruit of the Earth	Acne Wash	SALICYLIC ACID	LIQUID	TOPICAL	20171116		OTC MONOGRAPH FINAL	part333D	Fruit Of The Earth, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
62221-935_09c2a084-c6bb-04eb-e063-6394a90adbcf	62221-935	HUMAN OTC DRUG	Sonacaine Topical Anesthetic With Menthol		LIDOCAINE	GEL	TOPICAL	20120502		OTC MONOGRAPH DRUG	M017	Filltech USA, LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62225-600_efc8de6e-47da-6111-e053-2a95a90a34e4	62225-600	HUMAN PRESCRIPTION DRUG	Omidria		phenylephrine and ketorolac	INJECTION, SOLUTION, CONCENTRATE	INTRAOCULAR	20140613		NDA	NDA205388	Omeros Corporation	KETOROLAC; PHENYLEPHRINE	2.88; 10.16	mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
62234-001_f448574f-21c5-cb0c-e053-2995a90a30bc	62234-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Pembroke Drug Center, Inc. dba Healthkeeperz	OXYGEN	99	L/100L			N	20241231
62250-619_06f9710a-798f-a99b-e063-6394a90a2e4b	62250-619	HUMAN PRESCRIPTION DRUG	Desloratadine		Desloratadine	TABLET	ORAL	20120515		ANDA	ANDA078355	Belcher Pharmaceuticals,LLC	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62250-660_06f95483-7080-8e4b-e063-6294a90a1992	62250-660	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE		SODIUM POLYSTYRENE SULFONATE	POWDER, FOR SUSPENSION	ORAL; RECTAL	20160315		ANDA	ANDA205727	Belcher Pharmaceuticals, LLC	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
62250-663_07499858-c7da-88c2-e063-6294a90ad5fc	62250-663	HUMAN PRESCRIPTION DRUG	Cefixime		cefixime	POWDER, FOR SUSPENSION	ORAL	20170315		ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62250-664_07499858-c7da-88c2-e063-6294a90ad5fc	62250-664	HUMAN PRESCRIPTION DRUG	Cefixime		cefixime	POWDER, FOR SUSPENSION	ORAL	20170315		ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	200	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62250-665_06f96225-77b9-97d9-e063-6394a90ace31	62250-665	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20180425		ANDA	ANDA206651	Belcher Pharmaceuticals,LLC	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
62250-666_06f96225-77b9-97d9-e063-6394a90ace31	62250-666	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus Capsules	CAPSULE	ORAL	20180425		ANDA	ANDA206651	Belcher Pharmaceuticals,LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
62250-667_06f96225-77b9-97d9-e063-6394a90ace31	62250-667	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus Capsules	CAPSULE	ORAL	20180425		ANDA	ANDA206651	Belcher Pharmaceuticals,LLC	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
62250-668_0749c985-733a-3311-e063-6394a90a8004	62250-668	HUMAN PRESCRIPTION DRUG	Cefixime		cefixime	POWDER, FOR SUSPENSION	ORAL	20170315		ANDA	ANDA206939	Belcher Pharmaceuticals,LLC	CEFIXIME	500	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62250-677_06f95c23-c907-982b-e063-6394a90a353f	62250-677	HUMAN PRESCRIPTION DRUG	Mefenamic Acid		Mefenamic Acid	CAPSULE	ORAL	20150625		ANDA	ANDA091608	Belcher Pharmaceuticals,LLC	MEFENAMIC ACID	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62250-690_06f909bd-1a8e-b916-e063-6394a90a1a54	62250-690	HUMAN PRESCRIPTION DRUG	Potassium Chloride for Oral Solution		Potassium Chloride for Oral Solution	POWDER, FOR SOLUTION	ORAL	20180606		ANDA	ANDA212183	Belcher Pharmaceuticals LLC	POTASSIUM CHLORIDE	1.5	g/1.58g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62250-713_06fd8984-8a0a-b19f-e063-6294a90a95d4	62250-713	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20230315		ANDA	ANDA216156	Belcher Pharmaceuticals LLC	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62250-714_06fd8984-8a0a-b19f-e063-6294a90a95d4	62250-714	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20230315		ANDA	ANDA216156	Belcher Pharmaceuticals LLC	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
62250-801_06fdc83d-789d-8ff3-e063-6394a90ad4d9	62250-801	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20221222		ANDA	ANDA062713	Belcher Pharmaceuticals, LLC	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62250-802_06fdc83d-789d-8ff3-e063-6394a90ad4d9	62250-802	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20221222		ANDA	ANDA062713	Belcher Pharmaceuticals, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
62257-012_6f7b59ed-b2be-4fbc-9b8f-1cd6d7b2ea9c	62257-012	HUMAN OTC DRUG	1012 Antimicrobial		CHLOROXYLENOL	SOAP	TOPICAL	20130501		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-061_15fc4cac-5d87-4ea4-9099-cd09f9ac2750	62257-061	HUMAN OTC DRUG	Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-086_d4b20d89-a5cb-58e8-e053-2995a90a6173	62257-086	HUMAN OTC DRUG	Lynx LX0869 Alcohol Free Hand San		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220106		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62257-122_f6945106-381f-479e-afee-b5b5b8d2b7c6	62257-122	HUMAN OTC DRUG	Hand-Aid		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-160_e5d5bf00-1f95-4c6f-b317-e4800f164f5b	62257-160	HUMAN OTC DRUG	Lynx Antibacterial		CHLOROXYLENOL	SOAP	TOPICAL	20060714		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-161_79f804a1-84de-432e-bd3e-21b93ce3daff	62257-161	HUMAN OTC DRUG	Lynx Foamy PCMX Antiseptic Hand and Body Wash 6876		CHLOROXYLENOL	SOAP	TOPICAL	20170207		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-265_793d0ac6-6740-43be-8333-b013387538a6	62257-265	HUMAN OTC DRUG	Aero Care Handy Quat Antiseptic Handwash		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20170217		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	BENZALKONIUM CHLORIDE	25	mg/mL			N	20241231
62257-380_fd8f9b33-2482-7a8c-e053-6294a90a7b52	62257-380	HUMAN OTC DRUG	LX0380 Lynx glacier fresh Antiseptic Hand and Body Wash 6380		CHLOROXYLENOL	SOAP	TOPICAL	20221212		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-416_cf687599-4267-48c5-a591-38d44ef435d6	62257-416	HUMAN OTC DRUG	Hand Sanitizer Island Escape		ALCOHOL	GEL	TOPICAL	20200421		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-457_b9691b23-b829-4faa-bda6-9b3ad9564612	62257-457	HUMAN OTC DRUG	QS Plus Plus Instant Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20201216		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62257-544_c0c10357-0bdb-464e-817d-aad253ebff03	62257-544	HUMAN OTC DRUG	Palm		CHLOROXYLENOL	SOAP	TOPICAL	19981221		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-606_239c502b-0bd7-4121-891f-0ce8c11e0b2c	62257-606	HUMAN OTC DRUG	Hand-E XL		ALCOHOL	GEL	TOPICAL	20050401		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-658_d4b3ec0b-c4f3-ab90-e053-2a95a90a27f2	62257-658	HUMAN OTC DRUG	Fast		ALCOHOL	LIQUID	TOPICAL	20211006		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-665_16f38728-a0d9-431d-80dd-dedcde3aa499	62257-665	HUMAN OTC DRUG	SANI SPRITZ II		ALCOHOL	LIQUID	TOPICAL	20200414		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-686_dd802057-c5fc-3458-e053-2a95a90a9b9f	62257-686	HUMAN OTC DRUG	Lynx LX0864 peachy-foam antiseptic handsoap		CHLOROXYLENOL	SOAP	TOPICAL	20220426		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-738_e49ce0c0-15ec-4dd7-acff-5862f0d8eb51	62257-738	HUMAN OTC DRUG	Sani-Spritz		ALCOHOL	LIQUID	TOPICAL	20091031		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-830_f48f695c-aed3-4313-8fcb-3fe9685bffa6	62257-830	HUMAN OTC DRUG	Hand Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20090409		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	620	mg/g			N	20241231
62257-855_ba745b8e-b601-4a18-917a-daa84f2d0b93	62257-855	HUMAN OTC DRUG	Fast		ALCOHOL	LIQUID	TOPICAL	20190708		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.62	mL/mL			N	20241231
62257-867_411db04e-86a1-4615-9bad-5b33a875da0f	62257-867	HUMAN OTC DRUG	Lynx san a foam		ALCOHOL	LIQUID	TOPICAL	20190710		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	ALCOHOL	.7	mL/mL			N	20241231
62257-875_46428e18-9344-4169-a239-04f6d8509abc	62257-875	HUMAN OTC DRUG	Sani Mango Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-876_2788dfd7-3155-4c9d-bf7b-247d10d88940	62257-876	HUMAN OTC DRUG	Sani Mango Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62257-950_ebd28b96-0b60-47b4-8e7d-fe6f8dd2f96d	62257-950	HUMAN OTC DRUG	Clear Choice Out of Sight		CHLOROXYLENOL	SOAP	TOPICAL	20140409		OTC MONOGRAPH NOT FINAL	part333E	ABC Compounding Co., Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
62273-001_08028cba-3e4e-c188-e063-6294a90a6c7a	62273-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19800101		NDA	NDA205849	Metro Welding Supply Corporation	OXYGEN	995	mL/L			N	20241231
62273-002_08028cba-3e4d-c188-e063-6294a90a6c7a	62273-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20120301		NDA	NDA205850	Metro Welding Supply Corporation	NITROGEN	995	mL/L			N	20241231
62273-003_08028cba-3e4c-c188-e063-6294a90a6c7a	62273-003	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20120301		NDA	NDA205910	Metro Welding Supply Corporation	AIR	1000	mL/L			N	20241231
62273-005_0802ac5f-caa9-0225-e063-6294a90ab398	62273-005	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20150317		NDA	NDA205704	Metro Welding Supply Corporation	NITROUS OXIDE	990	mL/L			N	20241231
62273-007_0802a852-5adb-f1cc-e063-6294a90a199f	62273-007	HUMAN PRESCRIPTION DRUG	Heliox		Heliox	GAS	RESPIRATORY (INHALATION)	20190328		NDA	NDA205849	Metro Welding Supply Corporation	OXYGEN	200	mL/L			N	20241231
62282-170_eec7463c-2e87-73e0-e053-2a95a90a972f	62282-170	HUMAN OTC DRUG	Vitamin C Daily Moisturizer	SPF 30	Octinoxate, Octisalate, Avobenzone, Octocrylene	LOTION	TOPICAL	20100601		OTC MONOGRAPH NOT FINAL	part352	Northwest Cosmetic Laboratories	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 7.5; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
62282-376_ec93e3c0-8ca1-a35e-e053-2995a90a5a3d	62282-376	HUMAN OTC DRUG	sunbetter Broad Spectrum SPF 75 Sunscreen Tone Smart		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part352	Northwest Cosmetic Laboratories LLC, D.B.A. Elevation Labs Idaho	TITANIUM DIOXIDE; ZINC OXIDE	35; 100	mg/mL; mg/mL			N	20241231
62282-377_ec93dee5-1c3a-d71a-e053-2a95a90aab4b	62282-377	HUMAN OTC DRUG	sunbetter Broad Spectrum SPF 70 Sunscreen Sheer		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part352	Northwest Cosmetic Laboratories, LLC D.B.A Elevation Labs Idaho	TITANIUM DIOXIDE; ZINC OXIDE	36; 100	mg/mL; mg/mL			N	20241231
62282-504_ff0ee7ef-00a8-1dae-e053-6294a90a059e	62282-504	HUMAN OTC DRUG	CliniCalm		Hydrocortisone	CREAM	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part348	Northwest Cosmetic Laboratories LLC, DBA Elevation Labs, Idaho	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62296-8292_d45165d4-d9aa-427b-b338-0512db3b2a4e	62296-8292	HUMAN OTC DRUG	ULTA FACE SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20150817		OTC MONOGRAPH NOT FINAL	part352	Ulta	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 13; 5; 2; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
62327-222_f217ac2f-f3e9-a646-e053-2995a90af407	62327-222	HUMAN PRESCRIPTION DRUG	Steritalc	2g	Talc	POWDER	INTRAPLEURAL	20171101		NDA	NDA205555	Novatech SA	TALC	2	g/50mL			N	20241231
62327-333_f217ac2f-f3e9-a646-e053-2995a90af407	62327-333	HUMAN PRESCRIPTION DRUG	Steritalc	3g	Talc	POWDER	INTRAPLEURAL	20171101		NDA	NDA205555	Novatech SA	TALC	3	g/10mL			N	20241231
62327-444_f217ac2f-f3e9-a646-e053-2995a90af407	62327-444	HUMAN PRESCRIPTION DRUG	Steritalc	4g	Talc	POWDER	INTRAPLEURAL	20170801		NDA	NDA205555	Novatech SA	TALC	4	g/50mL			N	20241231
62332-001_7e1efece-32bd-4484-985d-cd31e80c52d7	62332-001	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Alembic Pharmaceuticals Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62332-002_7e1efece-32bd-4484-985d-cd31e80c52d7	62332-002	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Alembic Pharmaceuticals Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
62332-003_b5b2c486-c0ac-4367-ad2f-a6960db71dff	62332-003	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-004_b5b2c486-c0ac-4367-ad2f-a6960db71dff	62332-004	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-005_b5b2c486-c0ac-4367-ad2f-a6960db71dff	62332-005	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-006_b5b2c486-c0ac-4367-ad2f-a6960db71dff	62332-006	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-007_b5b2c486-c0ac-4367-ad2f-a6960db71dff	62332-007	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20160322		ANDA	ANDA078894	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-008_8724b94d-b3fd-4844-a7fe-2be7982cf8f5	62332-008	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
62332-009_8724b94d-b3fd-4844-a7fe-2be7982cf8f5	62332-009	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
62332-010_8724b94d-b3fd-4844-a7fe-2be7982cf8f5	62332-010	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
62332-011_8724b94d-b3fd-4844-a7fe-2be7982cf8f5	62332-011	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
62332-012_8724b94d-b3fd-4844-a7fe-2be7982cf8f5	62332-012	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Alembic Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
62332-013_b1af5294-98eb-4c2c-9178-a057386fb3f7	62332-013	HUMAN PRESCRIPTION DRUG	LITHIUM CARBONATE	LITHIUM CARBONATE	LITHIUM CARBONATE	CAPSULE	ORAL	20161227		ANDA	ANDA079159	Alembic Pharmaceuticals Inc.	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
62332-014_b1af5294-98eb-4c2c-9178-a057386fb3f7	62332-014	HUMAN PRESCRIPTION DRUG	LITHIUM CARBONATE	LITHIUM CARBONATE	LITHIUM CARBONATE	CAPSULE	ORAL	20161227		ANDA	ANDA079159	Alembic Pharmaceuticals Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
62332-015_b1af5294-98eb-4c2c-9178-a057386fb3f7	62332-015	HUMAN PRESCRIPTION DRUG	LITHIUM CARBONATE	LITHIUM CARBONATE	LITHIUM CARBONATE	CAPSULE	ORAL	20161227		ANDA	ANDA079159	Alembic Pharmaceuticals Inc.	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
62332-016_215d26c5-b90f-4a96-96e3-50673f90ccd4	62332-016	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161201		ANDA	ANDA079067	Alembic Pharmaceuticals Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
62332-017_215d26c5-b90f-4a96-96e3-50673f90ccd4	62332-017	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161201		ANDA	ANDA079067	Alembic Pharmaceuticals Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
62332-018_836b8ba4-12b8-4288-9964-3f16d48bd875	62332-018	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	CAPSULE	ORAL	20161209		ANDA	ANDA079065	Alembic Pharmaceuticals Inc.	METRONIDAZOLE	375	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
62332-019_a2f676cd-53ae-4401-9553-a7d70c79bb0a	62332-019	HUMAN PRESCRIPTION DRUG	Meprobamate		Meprobamate	TABLET	ORAL	20160331		ANDA	ANDA090122	Alembic Pharmaceuticals Inc.	MEPROBAMATE	200	mg/1		CIV	N	20241231
62332-020_a2f676cd-53ae-4401-9553-a7d70c79bb0a	62332-020	HUMAN PRESCRIPTION DRUG	Meprobamate		Meprobamate	TABLET	ORAL	20160331		ANDA	ANDA090122	Alembic Pharmaceuticals Inc.	MEPROBAMATE	400	mg/1		CIV	N	20241231
62332-022_f7b45efa-71f6-497c-b22d-aa8789bce9d5	62332-022	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20160129		ANDA	ANDA090223	Alembic Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
62332-023_f7b45efa-71f6-497c-b22d-aa8789bce9d5	62332-023	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20160129		ANDA	ANDA090223	Alembic Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
62332-024_f7b45efa-71f6-497c-b22d-aa8789bce9d5	62332-024	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20160129		ANDA	ANDA090223	Alembic Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
62332-025_d9cbb2b7-6524-4587-9111-e3abfd2e888b	62332-025	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20160129		ANDA	ANDA090430	Alembic Pharmaceuticals Inc.	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
62332-026_d9cbb2b7-6524-4587-9111-e3abfd2e888b	62332-026	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20160129		ANDA	ANDA090430	Alembic Pharmaceuticals Inc.	THEOPHYLLINE ANHYDROUS	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
62332-027_53098d5e-c2e8-4cdd-8c65-53f3ea4ea89f	62332-027	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	Alembic Pharmaceuticals Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-028_53098d5e-c2e8-4cdd-8c65-53f3ea4ea89f	62332-028	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	Alembic Pharmaceuticals Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-029_53098d5e-c2e8-4cdd-8c65-53f3ea4ea89f	62332-029	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA090428	Alembic Pharmaceuticals Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-030_df304b5a-fe8d-4d60-b180-9a5293448d73	62332-030	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-031_df304b5a-fe8d-4d60-b180-9a5293448d73	62332-031	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-032_df304b5a-fe8d-4d60-b180-9a5293448d73	62332-032	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-033_df304b5a-fe8d-4d60-b180-9a5293448d73	62332-033	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-034_df304b5a-fe8d-4d60-b180-9a5293448d73	62332-034	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-035_df304b5a-fe8d-4d60-b180-9a5293448d73	62332-035	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-036_df304b5a-fe8d-4d60-b180-9a5293448d73	62332-036	HUMAN PRESCRIPTION DRUG	ROPINIROLE HYDROCHLORIDE		ROPINIROLE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA090429	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-037_ba4c007e-36b2-40f8-a6d2-14f1c36223b7	62332-037	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180205		ANDA	ANDA090607	Alembic Pharmaceuticals Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
62332-038_ba4c007e-36b2-40f8-a6d2-14f1c36223b7	62332-038	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180205		ANDA	ANDA090607	Alembic Pharmaceuticals Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
62332-039_ba4c007e-36b2-40f8-a6d2-14f1c36223b7	62332-039	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180205		ANDA	ANDA090607	Alembic Pharmaceuticals Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
62332-040_ba4c007e-36b2-40f8-a6d2-14f1c36223b7	62332-040	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180205		ANDA	ANDA090607	Alembic Pharmaceuticals Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
62332-041_ca735540-a911-4890-814d-a9b8d3d87bfc	62332-041	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20160701		ANDA	ANDA091236	Alembic Pharmaceuticals Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-042_ca735540-a911-4890-814d-a9b8d3d87bfc	62332-042	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20160701		ANDA	ANDA091236	Alembic Pharmaceuticals Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-043_ca735540-a911-4890-814d-a9b8d3d87bfc	62332-043	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20160701		ANDA	ANDA091236	Alembic Pharmaceuticals Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-044_d9c3b1ac-bbb0-4974-b337-88e247093c72	62332-044	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160520		ANDA	ANDA091367	Alembic Pharmaceuticals Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-045_d9c3b1ac-bbb0-4974-b337-88e247093c72	62332-045	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160520		ANDA	ANDA091367	Alembic Pharmaceuticals Inc.	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-046_d9c3b1ac-bbb0-4974-b337-88e247093c72	62332-046	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160520		ANDA	ANDA091367	Alembic Pharmaceuticals Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-047_d9c3b1ac-bbb0-4974-b337-88e247093c72	62332-047	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160520		ANDA	ANDA091367	Alembic Pharmaceuticals Inc.	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-048_63907fc7-5499-47e7-a977-d0e67ef67415	62332-048	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-049_63907fc7-5499-47e7-a977-d0e67ef67415	62332-049	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-050_63907fc7-5499-47e7-a977-d0e67ef67415	62332-050	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-051_a749e5f3-f0e7-41db-a3c6-ff6928d7f51f	62332-051	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20160523		ANDA	ANDA091370	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-052_a749e5f3-f0e7-41db-a3c6-ff6928d7f51f	62332-052	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20160523		ANDA	ANDA091370	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-053_a749e5f3-f0e7-41db-a3c6-ff6928d7f51f	62332-053	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091370	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	25; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-054_a9d083c3-cd05-49d4-bb39-66a079240e3e	62332-054	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Alembic Pharmaceuticals Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-055_a9d083c3-cd05-49d4-bb39-66a079240e3e	62332-055	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Alembic Pharmaceuticals Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-056_a9d083c3-cd05-49d4-bb39-66a079240e3e	62332-056	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Alembic Pharmaceuticals Inc.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-060_55b443a9-6652-4408-a91d-7aa4dbc457f9	62332-060	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20170621		ANDA	ANDA209119	Alembic Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-061_3d4cd663-0668-4504-8eb4-7cc73278dea7	62332-061	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20161201		ANDA	ANDA091369	Alembic Pharmaceuticals Inc.	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
62332-062_3d4cd663-0668-4504-8eb4-7cc73278dea7	62332-062	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20161201		ANDA	ANDA091369	Alembic Pharmaceuticals Inc.	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
62332-063_0044f1d7-613c-4611-8481-13032c8cb390	62332-063	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20220612		ANDA	ANDA091689	Alembic Pharmaceuticals Inc.	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62332-064_0044f1d7-613c-4611-8481-13032c8cb390	62332-064	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20220612		ANDA	ANDA091689	Alembic Pharmaceuticals Inc.	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62332-065_0044f1d7-613c-4611-8481-13032c8cb390	62332-065	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20220612		ANDA	ANDA091689	Alembic Pharmaceuticals Inc.	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62332-066_0044f1d7-613c-4611-8481-13032c8cb390	62332-066	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20220612		ANDA	ANDA091689	Alembic Pharmaceuticals Inc.	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62332-070_b3a6e9ad-418d-420f-bb45-9c1bc8df2337	62332-070	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20170302		ANDA	ANDA200645	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-075_9792a0a6-a48e-4998-9f5a-c9eaa144edea	62332-075	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, COATED	ORAL	20151013		ANDA	ANDA200891	Alembic Pharmaceuticals Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
62332-076_9792a0a6-a48e-4998-9f5a-c9eaa144edea	62332-076	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	TABLET, COATED	ORAL	20151013		ANDA	ANDA200891	Alembic Pharmaceuticals Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
62332-079_e388d02a-7d79-4146-8f24-17d63cf8040a	62332-079	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-080_e388d02a-7d79-4146-8f24-17d63cf8040a	62332-080	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-081_e388d02a-7d79-4146-8f24-17d63cf8040a	62332-081	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-082_e388d02a-7d79-4146-8f24-17d63cf8040a	62332-082	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-083_e388d02a-7d79-4146-8f24-17d63cf8040a	62332-083	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-084_855b1ec7-573c-417c-8485-0b36f728feaf	62332-084	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20201022		ANDA	ANDA213842	Alembic Pharmaceuticals Inc.	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-085_855b1ec7-573c-417c-8485-0b36f728feaf	62332-085	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20201022		ANDA	ANDA213842	Alembic Pharmaceuticals Inc.	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-086_855b1ec7-573c-417c-8485-0b36f728feaf	62332-086	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20201022		ANDA	ANDA213842	Alembic Pharmaceuticals Inc.	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-087_15db51b8-91c4-4091-acc2-437ebf993e90	62332-087	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160625		ANDA	ANDA202130	Alembic Pharmaceuticals Inc.	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-088_15db51b8-91c4-4091-acc2-437ebf993e90	62332-088	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160625		ANDA	ANDA202130	Alembic Pharmaceuticals Inc.	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-089_15db51b8-91c4-4091-acc2-437ebf993e90	62332-089	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20160625		ANDA	ANDA202130	Alembic Pharmaceuticals Inc.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-092_cd86384e-917a-41f3-9d71-900c45d83651	62332-092	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA201724	Alembic Pharmaceuticals Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62332-093_cd86384e-917a-41f3-9d71-900c45d83651	62332-093	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20160129		ANDA	ANDA201724	Alembic Pharmaceuticals Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62332-095_aafd90f5-d1c9-4542-a207-ac627e70b112	62332-095	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine	TABLET, FOR SUSPENSION	ORAL	20140411		ANDA	ANDA201168	Alembic Pharmaceuticals Inc.	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
62332-096_aafd90f5-d1c9-4542-a207-ac627e70b112	62332-096	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine	TABLET, FOR SUSPENSION	ORAL	20140411		ANDA	ANDA201168	Alembic Pharmaceuticals Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
62332-097_2f9c55ca-18c3-4475-9677-ef5a03dcbb13	62332-097	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160707		ANDA	ANDA202101	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-098_2f9c55ca-18c3-4475-9677-ef5a03dcbb13	62332-098	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160707		ANDA	ANDA202101	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-099_2f9c55ca-18c3-4475-9677-ef5a03dcbb13	62332-099	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160707		ANDA	ANDA202101	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-100_2f9c55ca-18c3-4475-9677-ef5a03dcbb13	62332-100	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160707		ANDA	ANDA202101	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-101_2f9c55ca-18c3-4475-9677-ef5a03dcbb13	62332-101	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160707		ANDA	ANDA202101	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-102_2f9c55ca-18c3-4475-9677-ef5a03dcbb13	62332-102	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160707		ANDA	ANDA202101	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-103_cfa46655-8cd1-4b23-9a7e-78f53a846f82	62332-103	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20160707		ANDA	ANDA202102	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-104_cfa46655-8cd1-4b23-9a7e-78f53a846f82	62332-104	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20160707		ANDA	ANDA202102	Alembic Pharmaceuticals Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-107_e82f4bb3-19cd-4cfc-ba45-56810d3ee60d	62332-107	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200620		ANDA	ANDA202786	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-108_e82f4bb3-19cd-4cfc-ba45-56810d3ee60d	62332-108	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200620		ANDA	ANDA202786	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-109_e82f4bb3-19cd-4cfc-ba45-56810d3ee60d	62332-109	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200620		ANDA	ANDA202786	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	6	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-110_e82f4bb3-19cd-4cfc-ba45-56810d3ee60d	62332-110	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200620		ANDA	ANDA202786	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	8	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-111_e82f4bb3-19cd-4cfc-ba45-56810d3ee60d	62332-111	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200620		ANDA	ANDA202786	Alembic Pharmaceuticals Inc.	ROPINIROLE HYDROCHLORIDE	12	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-112_64b6e625-c710-427a-abc3-8295a83123ae	62332-112	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20160731		ANDA	ANDA202871	Alembic Pharmaceuticals Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-113_64b6e625-c710-427a-abc3-8295a83123ae	62332-113	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20160731		ANDA	ANDA202871	Alembic Pharmaceuticals Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-114_64b6e625-c710-427a-abc3-8295a83123ae	62332-114	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20160731		ANDA	ANDA202871	Alembic Pharmaceuticals Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-115_6da62a99-ef66-42be-a270-ada286a4dc80	62332-115	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20151015		ANDA	ANDA202870	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 50	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
62332-116_6da62a99-ef66-42be-a270-ada286a4dc80	62332-116	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20151015		ANDA	ANDA202870	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
62332-117_6da62a99-ef66-42be-a270-ada286a4dc80	62332-117	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20151015		ANDA	ANDA202870	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	50; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
62332-119_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-119	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	25	mg/1		CV	N	20241231
62332-120_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-120	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	50	mg/1		CV	N	20241231
62332-121_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-121	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	75	mg/1		CV	N	20241231
62332-122_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-122	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	100	mg/1		CV	N	20241231
62332-123_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-123	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	150	mg/1		CV	N	20241231
62332-124_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-124	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	200	mg/1		CV	N	20241231
62332-125_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-125	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	225	mg/1		CV	N	20241231
62332-126_b028d3b8-e001-4d89-8f65-0dcaab52a7c9	62332-126	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA203459	Alembic Pharmaceuticals Inc.	PREGABALIN	300	mg/1		CV	N	20241231
62332-131_95e8d157-e834-4d1d-9520-8ee05f8ca69b	62332-131	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA203012	Alembic Pharmaceuticals Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-132_95e8d157-e834-4d1d-9520-8ee05f8ca69b	62332-132	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA203012	Alembic Pharmaceuticals Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-133_95e8d157-e834-4d1d-9520-8ee05f8ca69b	62332-133	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA203012	Alembic Pharmaceuticals Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-140_5697e57f-22df-45ef-b241-6c47df118ce2	62332-140	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	Alembic Pharmaceuticals Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-141_5697e57f-22df-45ef-b241-6c47df118ce2	62332-141	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	Alembic Pharmaceuticals Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-142_5697e57f-22df-45ef-b241-6c47df118ce2	62332-142	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	Alembic Pharmaceuticals Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-143_5697e57f-22df-45ef-b241-6c47df118ce2	62332-143	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	Alembic Pharmaceuticals Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-148_ed35da2c-cee5-4ad6-8291-3976882ce8cf	62332-148	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20170221		ANDA	ANDA204445	Alembic Pharmaceuticals Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
62332-149_3d59a106-2ba0-4f39-942c-1b4920c897a5	62332-149	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA204233	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-150_3d59a106-2ba0-4f39-942c-1b4920c897a5	62332-150	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA204233	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-151_3d59a106-2ba0-4f39-942c-1b4920c897a5	62332-151	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA204233	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-154_180f524e-cf28-4ede-b70c-07a004f7460e	62332-154	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-155_180f524e-cf28-4ede-b70c-07a004f7460e	62332-155	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-156_180f524e-cf28-4ede-b70c-07a004f7460e	62332-156	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-157_180f524e-cf28-4ede-b70c-07a004f7460e	62332-157	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-158_180f524e-cf28-4ede-b70c-07a004f7460e	62332-158	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-159_180f524e-cf28-4ede-b70c-07a004f7460e	62332-159	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-160_180f524e-cf28-4ede-b70c-07a004f7460e	62332-160	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA204518	Alembic Pharmaceuticals Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	3.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
62332-171_50c42e50-ab11-460a-a8f6-0edcd1b91613	62332-171	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Inc.	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
62332-172_50c42e50-ab11-460a-a8f6-0edcd1b91613	62332-172	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Inc.	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
62332-173_50c42e50-ab11-460a-a8f6-0edcd1b91613	62332-173	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Inc.	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
62332-174_50c42e50-ab11-460a-a8f6-0edcd1b91613	62332-174	HUMAN PRESCRIPTION DRUG	Lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA204974	Alembic Pharmaceuticals Inc.	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
62332-175_d347263f-9458-4986-be65-e626f490bb3b	62332-175	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106		ANDA	ANDA204973	Alembic Pharmaceuticals Inc.	FESOTERODINE FUMARATE	4	mg/1			N	20241231
62332-176_d347263f-9458-4986-be65-e626f490bb3b	62332-176	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106		ANDA	ANDA204973	Alembic Pharmaceuticals Inc.	FESOTERODINE FUMARATE	8	mg/1			N	20241231
62332-177_e1f76094-7702-4e7d-b447-e7e4734dddd3	62332-177	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-178_e1f76094-7702-4e7d-b447-e7e4734dddd3	62332-178	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-179_e1f76094-7702-4e7d-b447-e7e4734dddd3	62332-179	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-180_e1f76094-7702-4e7d-b447-e7e4734dddd3	62332-180	HUMAN PRESCRIPTION DRUG	Tadalafil		tadalafil	TABLET, COATED	ORAL	20190326		ANDA	ANDA204809	Alembic Pharmaceuticals Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-181_89bfee8d-1ddf-4fb2-a565-ce32f096a25d	62332-181	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20240110		ANDA	ANDA205074	Alembic Pharmaceuticals Inc.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
62332-182_89bfee8d-1ddf-4fb2-a565-ce32f096a25d	62332-182	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20240110		ANDA	ANDA205074	Alembic Pharmaceuticals Inc.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
62332-183_008b01d8-4425-4317-a172-4cc2a9e4e39d	62332-183	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA205233	Alembic Pharmaceuticals Inc.	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
62332-190_d93f60e8-39b0-4359-9aaa-2e02ac188b1f	62332-190	HUMAN PRESCRIPTION DRUG	Febuxostat		febuxostat	TABLET, COATED	ORAL	20190701		ANDA	ANDA205421	Alembic Pharmaceuticals Inc.	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
62332-191_d93f60e8-39b0-4359-9aaa-2e02ac188b1f	62332-191	HUMAN PRESCRIPTION DRUG	Febuxostat		febuxostat	TABLET, COATED	ORAL	20190701		ANDA	ANDA205421	Alembic Pharmaceuticals Inc.	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
62332-192_b7806d00-75b4-482e-8e83-d71a9ca8e012	62332-192	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, COATED	ORAL	20190520		ANDA	ANDA205575	Alembic Pharmaceuticals Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62332-193_b7806d00-75b4-482e-8e83-d71a9ca8e012	62332-193	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, COATED	ORAL	20190520		ANDA	ANDA205575	Alembic Pharmaceuticals Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62332-198_5857dc4b-097e-4ad6-ade9-b2eaaffe9251	62332-198	HUMAN PRESCRIPTION DRUG	Asenapine		Asenapine	TABLET	SUBLINGUAL	20201210		ANDA	ANDA206098	Alembic Pharmaceuticals Inc.	ASENAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-199_5857dc4b-097e-4ad6-ade9-b2eaaffe9251	62332-199	HUMAN PRESCRIPTION DRUG	Asenapine		Asenapine	TABLET	SUBLINGUAL	20201210		ANDA	ANDA206098	Alembic Pharmaceuticals Inc.	ASENAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-204_11cfe913-bd14-4c13-8352-647135ee2fbe	62332-204	HUMAN PRESCRIPTION DRUG	ITRACONAZOLE		itraconazole	CAPSULE	ORAL	20161216		ANDA	ANDA206741	Alembic Pharmaceuticals Inc.	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
62332-205_22831006-efb4-495c-9dfd-c2deab13d40c	62332-205	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-206_22831006-efb4-495c-9dfd-c2deab13d40c	62332-206	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-207_22831006-efb4-495c-9dfd-c2deab13d40c	62332-207	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-208_22831006-efb4-495c-9dfd-c2deab13d40c	62332-208	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET, FILM COATED	ORAL	20161201		ANDA	ANDA202713	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-209_ef7e32c5-7fa8-4179-927e-79d19a6f449e	62332-209	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20160625		ANDA	ANDA203010	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-210_ef7e32c5-7fa8-4179-927e-79d19a6f449e	62332-210	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20160625		ANDA	ANDA203010	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-211_ef7e32c5-7fa8-4179-927e-79d19a6f449e	62332-211	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20160625		ANDA	ANDA203010	Alembic Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62332-212_9e0407b2-399e-4f66-b092-59d24ff17727	62332-212	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-213_9e0407b2-399e-4f66-b092-59d24ff17727	62332-213	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-214_9e0407b2-399e-4f66-b092-59d24ff17727	62332-214	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-215_9e0407b2-399e-4f66-b092-59d24ff17727	62332-215	HUMAN PRESCRIPTION DRUG	Amlodipine besylate and Olmesartran medoxomil		Amlodipine besylate and Olmesartran medoxomil	TABLET, FILM COATED	ORAL	20170718		ANDA	ANDA207073	Alembic Pharmaceuticals Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-223_0f406336-e614-4427-89c7-bd26d3792590	62332-223	HUMAN PRESCRIPTION DRUG	DARIFENACIN		DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212		ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62332-224_0f406336-e614-4427-89c7-bd26d3792590	62332-224	HUMAN PRESCRIPTION DRUG	DARIFENACIN		DARIFENACIN	TABLET, EXTENDED RELEASE	ORAL	20171212		ANDA	ANDA207681	Alembic Pharmaceuticals Inc.	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62332-232_83531a56-aaeb-4c89-8435-fd0a6f8631e0	62332-232	HUMAN PRESCRIPTION DRUG	VILAZODONE HYDROCHLORIDE		VILAZODONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220604		ANDA	ANDA208202	Alembic Pharmaceuticals Inc.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
62332-233_83531a56-aaeb-4c89-8435-fd0a6f8631e0	62332-233	HUMAN PRESCRIPTION DRUG	VILAZODONE HYDROCHLORIDE		VILAZODONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220604		ANDA	ANDA208202	Alembic Pharmaceuticals Inc.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
62332-234_83531a56-aaeb-4c89-8435-fd0a6f8631e0	62332-234	HUMAN PRESCRIPTION DRUG	VILAZODONE HYDROCHLORIDE		VILAZODONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220604		ANDA	ANDA208202	Alembic Pharmaceuticals Inc.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
62332-235_6f3f29a2-8472-49eb-84dc-bb1420d86c94	62332-235	HUMAN PRESCRIPTION DRUG	Vardenafil		Vardenafil	TABLET, ORALLY DISINTEGRATING	ORAL	20181120		ANDA	ANDA208324	Alembic Pharmaceuticals Inc.	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-236_fb17a719-cf8a-4d04-885a-3908378c5216	62332-236	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Inc.	VARDENAFIL HYDROCHLORIDE	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-237_fb17a719-cf8a-4d04-885a-3908378c5216	62332-237	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Inc.	VARDENAFIL HYDROCHLORIDE	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-238_fb17a719-cf8a-4d04-885a-3908378c5216	62332-238	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Inc.	VARDENAFIL HYDROCHLORIDE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-239_fb17a719-cf8a-4d04-885a-3908378c5216	62332-239	HUMAN PRESCRIPTION DRUG	VARDENAFIL HYDROCHLORIDE		VARDENAFIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200805		ANDA	ANDA214031	Alembic Pharmaceuticals Inc.	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
62332-242_80f85fbd-5e1b-424d-b017-e3caa30131bb	62332-242	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20170407		ANDA	ANDA208698	Alembic Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62332-243_80f85fbd-5e1b-424d-b017-e3caa30131bb	62332-243	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20170407		ANDA	ANDA208698	Alembic Pharmaceuticals Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62332-244_e459e91d-20bc-4a85-a02e-8ba3c023902f	62332-244	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20170515		ANDA	ANDA208705	Alembic Pharmaceuticals Inc.	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-245_e459e91d-20bc-4a85-a02e-8ba3c023902f	62332-245	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20170515		ANDA	ANDA208705	Alembic Pharmaceuticals Inc.	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-246_81701dc2-0120-4139-afce-9648432800df	62332-246	HUMAN PRESCRIPTION DRUG	amantadine		amantadine	CAPSULE	ORAL	20170622		ANDA	ANDA208966	Alembic Pharmaceuticals Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
62332-248_fe6c3f23-06a7-4288-9a5d-ce7c11d3ca86	62332-248	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	CUTANEOUS	20180416		ANDA	ANDA209000	Alembic Pharmaceuticals Inc.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
62332-249_4a5ad077-7bdf-4f7b-9ade-32881749f4ab	62332-249	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20170731		ANDA	ANDA209165	Alembic Pharmaceuticals Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-250_4a5ad077-7bdf-4f7b-9ade-32881749f4ab	62332-250	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20170731		ANDA	ANDA209165	Alembic Pharmaceuticals Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-251_b375ae10-b984-4699-b0da-9d4cbfb18da9	62332-251	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20200129		ANDA	ANDA211791	Alembic Pharmaceuticals Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
62332-252_a6585638-3730-443c-895f-b54980943d21	62332-252	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20200129		ANDA	ANDA211792	Alembic Pharmaceuticals Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
62332-253_c043ed24-ba88-4465-a0bd-da8531778957	62332-253	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	TABLET, FILM COATED	ORAL	20200128		ANDA	ANDA211793	Alembic Pharmaceuticals Inc.	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
62332-313_c5365b66-ba34-49e2-b6bc-7df2ec13a029	62332-313	HUMAN PRESCRIPTION DRUG	TERIFLUNOMIDE		TERIFLUNOMIDE	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA209572	Alembic Pharmaceuticals Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
62332-314_c5365b66-ba34-49e2-b6bc-7df2ec13a029	62332-314	HUMAN PRESCRIPTION DRUG	TERIFLUNOMIDE		TERIFLUNOMIDE	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA209572	Alembic Pharmaceuticals Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
62332-315_0396b9a7-f3b3-41bc-a768-254c8b61163b	62332-315	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-316_0396b9a7-f3b3-41bc-a768-254c8b61163b	62332-316	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-317_0396b9a7-f3b3-41bc-a768-254c8b61163b	62332-317	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-318_0396b9a7-f3b3-41bc-a768-254c8b61163b	62332-318	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-319_0396b9a7-f3b3-41bc-a768-254c8b61163b	62332-319	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-320_0396b9a7-f3b3-41bc-a768-254c8b61163b	62332-320	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA209785	Alembic Pharmaceuticals Inc.	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-324_d58faf4c-c55c-47fc-928a-f56e8240a85c	62332-324	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121		ANDA	ANDA210060	Alembic Pharmaceuticals Inc.	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62332-325_d58faf4c-c55c-47fc-928a-f56e8240a85c	62332-325	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121		ANDA	ANDA210060	Alembic Pharmaceuticals Inc.	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62332-326_d58faf4c-c55c-47fc-928a-f56e8240a85c	62332-326	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191121		ANDA	ANDA210060	Alembic Pharmaceuticals Inc.	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62332-332_b01ef574-6fb7-42ad-8fd4-b821d78cac3e	62332-332	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606		ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
62332-333_b01ef574-6fb7-42ad-8fd4-b821d78cac3e	62332-333	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20190606		ANDA	ANDA210341	Alembic Pharmaceuticals Inc.	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
62332-338_f954a150-26a9-4b64-8e86-5d5bc4eedc43	62332-338	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	Alembic Pharmaceuticals Inc.	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62332-339_f954a150-26a9-4b64-8e86-5d5bc4eedc43	62332-339	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	Alembic Pharmaceuticals Inc.	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62332-340_f954a150-26a9-4b64-8e86-5d5bc4eedc43	62332-340	HUMAN PRESCRIPTION DRUG	MIDODRINE HYDROCHLORIDE		MIDODRINE HYDROCHLORIDE	TABLET	ORAL	20210122		ANDA	ANDA214734	Alembic Pharmaceuticals Inc.	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62332-341_5a3c0018-b0e2-4fe7-bec7-c075f50833ec	62332-341	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20181205		ANDA	ANDA210302	Alembic Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-342_5a3c0018-b0e2-4fe7-bec7-c075f50833ec	62332-342	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20181205		ANDA	ANDA210302	Alembic Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-343_5a3c0018-b0e2-4fe7-bec7-c075f50833ec	62332-343	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20181205		ANDA	ANDA210302	Alembic Pharmaceuticals Inc.	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62332-344_ea098e34-02fb-4604-9b93-f8543b8fef4b	62332-344	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20220201		ANDA	ANDA210459	Alembic Pharmaceuticals Inc.	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
62332-345_ea098e34-02fb-4604-9b93-f8543b8fef4b	62332-345	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20220201		ANDA	ANDA210459	Alembic Pharmaceuticals Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
62332-349_0fc40b26-f980-4768-9183-ca9d408fbadf	62332-349	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20190220		ANDA	ANDA210423	Alembic Pharmaceuticals Inc.	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
62332-350_1b98883d-5552-4efa-9201-da42ea253aae	62332-350	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200123		ANDA	ANDA213252	Alembic Pharmaceuticals Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-351_1b98883d-5552-4efa-9201-da42ea253aae	62332-351	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200123		ANDA	ANDA213252	Alembic Pharmaceuticals Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-352_ccb75cfe-a70a-457e-8384-d38f495515e9	62332-352	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200305		ANDA	ANDA210537	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	20	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-353_aa4aae2d-64ba-46bb-a1fc-67bafbad3787	62332-353	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA210536	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-360_383885fa-5b3f-487b-9f39-d46d511709e6	62332-360	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA210476	Alembic Pharmaceuticals Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-361_383885fa-5b3f-487b-9f39-d46d511709e6	62332-361	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA210476	Alembic Pharmaceuticals Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-362_92fc414f-1722-4a58-84ac-8c9f70d720a5	62332-362	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	20180618		ANDA	ANDA210527	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-363_92fc414f-1722-4a58-84ac-8c9f70d720a5	62332-363	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	20180618		ANDA	ANDA210527	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-364_2db5810d-7e77-4b31-b690-89cb47638872	62332-364	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Inc.	CLONAZEPAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-365_2db5810d-7e77-4b31-b690-89cb47638872	62332-365	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Inc.	CLONAZEPAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-366_2db5810d-7e77-4b31-b690-89cb47638872	62332-366	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-367_2db5810d-7e77-4b31-b690-89cb47638872	62332-367	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-368_2db5810d-7e77-4b31-b690-89cb47638872	62332-368	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET, ORALLY DISINTEGRATING	ORAL	20190701		ANDA	ANDA211033	Alembic Pharmaceuticals Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-379_f6347a33-09dd-4938-92eb-4bcc48a31cfa	62332-379	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Inc.	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-380_f6347a33-09dd-4938-92eb-4bcc48a31cfa	62332-380	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Inc.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-381_f6347a33-09dd-4938-92eb-4bcc48a31cfa	62332-381	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Inc.	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-382_f6347a33-09dd-4938-92eb-4bcc48a31cfa	62332-382	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Alembic Pharmaceuticals Inc.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62332-385_7aa21a37-6c25-44ce-869c-c1b2309398bd	62332-385	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20170630		ANDA	ANDA202700	Alembic Pharmaceuticals Inc.	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
62332-386_7aa21a37-6c25-44ce-869c-c1b2309398bd	62332-386	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20170630		ANDA	ANDA202700	Alembic Pharmaceuticals Inc.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
62332-387_3e969455-c98c-41c6-8ed8-d23d1d3d8ca0	62332-387	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA211744	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-388_3e969455-c98c-41c6-8ed8-d23d1d3d8ca0	62332-388	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA211744	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-389_4b5516b0-5fe8-45f0-a7f9-3bf05081e74f	62332-389	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	CAPSULE	ORAL	20210701		ANDA	ANDA211935	Alembic Pharmaceuticals Inc.	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
62332-390_4b5516b0-5fe8-45f0-a7f9-3bf05081e74f	62332-390	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	CAPSULE	ORAL	20210701		ANDA	ANDA211935	Alembic Pharmaceuticals Inc.	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
62332-391_4b5516b0-5fe8-45f0-a7f9-3bf05081e74f	62332-391	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	CAPSULE	ORAL	20210701		ANDA	ANDA211935	Alembic Pharmaceuticals Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
62332-397_b4e8041f-a6b6-4f91-afad-74183c368d3c	62332-397	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230828		ANDA	ANDA215661	Alembic Pharmaceuticals Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
62332-398_b4e8041f-a6b6-4f91-afad-74183c368d3c	62332-398	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230828		ANDA	ANDA215661	Alembic Pharmaceuticals Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
62332-402_cb14e324-18ae-4ad4-9ee8-471119484181	62332-402	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20230608		ANDA	ANDA211763	Alembic Pharmaceuticals Inc.	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-403_cb14e324-18ae-4ad4-9ee8-471119484181	62332-403	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20230608		ANDA	ANDA211763	Alembic Pharmaceuticals Inc.	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-404_cb14e324-18ae-4ad4-9ee8-471119484181	62332-404	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20230608		ANDA	ANDA211763	Alembic Pharmaceuticals Inc.	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-405_afb792df-ffe3-4c77-a9dc-5eb831b2401b	62332-405	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20191125		ANDA	ANDA211731	Alembic Pharmaceuticals Inc.	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62332-406_afb792df-ffe3-4c77-a9dc-5eb831b2401b	62332-406	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20191125		ANDA	ANDA211731	Alembic Pharmaceuticals Inc.	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62332-407_82f6f3ee-cfab-4483-9b7b-3dea57942cc2	62332-407	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20210805		ANDA	ANDA211822	Alembic Pharmaceuticals Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-408_82f6f3ee-cfab-4483-9b7b-3dea57942cc2	62332-408	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20210805		ANDA	ANDA211822	Alembic Pharmaceuticals Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-409_82f6f3ee-cfab-4483-9b7b-3dea57942cc2	62332-409	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		CLOMIPRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20210805		ANDA	ANDA211822	Alembic Pharmaceuticals Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-410_6d1323aa-ee46-43aa-bcf0-d83a36788a1c	62332-410	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211824	Alembic Pharmaceuticals Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62332-411_6d1323aa-ee46-43aa-bcf0-d83a36788a1c	62332-411	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20200615		ANDA	ANDA211824	Alembic Pharmaceuticals Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62332-412_6d1323aa-ee46-43aa-bcf0-d83a36788a1c	62332-412	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211824	Alembic Pharmaceuticals Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62332-413_5eebe63d-7334-45de-8681-3a065e3e7fc2	62332-413	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR		OSELTAMIVIR	CAPSULE	ORAL	20190625		ANDA	ANDA211823	Alembic Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
62332-414_5eebe63d-7334-45de-8681-3a065e3e7fc2	62332-414	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR		OSELTAMIVIR	CAPSULE	ORAL	20190625		ANDA	ANDA211823	Alembic Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
62332-415_5eebe63d-7334-45de-8681-3a065e3e7fc2	62332-415	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR		OSELTAMIVIR	CAPSULE	ORAL	20190625		ANDA	ANDA211823	Alembic Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
62332-423_ef882383-ae44-4dcc-a0fd-6e3ee971b57f	62332-423	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CREAM	TOPICAL	20231127		ANDA	ANDA212361	Alembic Pharmaceuticals Inc.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
62332-424_cff70a7e-cf8a-4700-8c55-23dd4fe8ae71	62332-424	HUMAN PRESCRIPTION DRUG	LIDOCAINE		LIDOCAINE	OINTMENT	TOPICAL	20181130		ANDA	ANDA211469	Alembic Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62332-425_5377c041-b6fc-4dde-ac96-bd9e4e94e456	62332-425	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	SPRAY	TOPICAL	20201130		ANDA	ANDA211191	Alembic Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.05	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-426_0158d843-67b2-4808-a4eb-d177ee1014a3	62332-426	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	Alembic Pharmaceuticals Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
62332-427_0158d843-67b2-4808-a4eb-d177ee1014a3	62332-427	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	Alembic Pharmaceuticals Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
62332-462_e476239f-aad2-4fa7-8413-cfbe80600697	62332-462	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20240110		ANDA	ANDA204232	Alembic Pharmaceuticals Inc.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
62332-463_e476239f-aad2-4fa7-8413-cfbe80600697	62332-463	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20240110		ANDA	ANDA204232	Alembic Pharmaceuticals Inc.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
62332-464_c1b57a7f-77fd-446d-a77f-20b916c91e1c	62332-464	HUMAN PRESCRIPTION DRUG	ERGOCALCIFEROL		ERGOCALCIFEROL	CAPSULE	ORAL	20180430		ANDA	ANDA040833	Alembic Pharmaceuticals Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
62332-465_18c68d3b-9ed4-4ae2-9d0c-0f0ba4c67611	62332-465	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	OINTMENT	TOPICAL	20190312		ANDA	ANDA211800	Alembic Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659	62332-467	HUMAN PRESCRIPTION DRUG	Tavaborole		Tavaborole	SOLUTION	TOPICAL	20201023		ANDA	ANDA212188	Alembic Pharmaceuticals Inc.	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
62332-478_1f593c6e-e832-4668-89fa-46904f7f5f8e	62332-478	HUMAN PRESCRIPTION DRUG	ENTACAPONE		ENTACAPONE	TABLET, FILM COATED	ORAL	20220106		ANDA	ANDA212601	Alembic Pharmaceuticals Inc.	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
62332-479_9f41a23e-cc34-4b25-871d-deeef997fe8d	62332-479	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220610		ANDA	ANDA212708	Alembic Pharmaceuticals Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
62332-480_9f41a23e-cc34-4b25-871d-deeef997fe8d	62332-480	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220610		ANDA	ANDA212708	Alembic Pharmaceuticals Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
62332-481_1a84ffe4-b0ad-44df-bd67-2c752e710e42	62332-481	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-482_1a84ffe4-b0ad-44df-bd67-2c752e710e42	62332-482	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-483_1a84ffe4-b0ad-44df-bd67-2c752e710e42	62332-483	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-484_1a84ffe4-b0ad-44df-bd67-2c752e710e42	62332-484	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20220104		ANDA	ANDA213075	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	200	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-485_8a3cef4a-5aa9-4126-956c-3aafe88653cd	62332-485	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	OINTMENT	TOPICAL	20191024		ANDA	ANDA212473	Alembic Pharmaceuticals Inc.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-486_698b0c8f-044f-4547-9498-142af5810f93	62332-486	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	SOLUTION	TOPICAL	20191024		ANDA	ANDA212881	Alembic Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-487_3140f5b7-c69d-4e9e-9f6d-23e74ede973e	62332-487	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac sodium	SOLUTION	TOPICAL	20221129		ANDA	ANDA212506	Alembic Pharmaceuticals, Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-488_9755812a-20b5-45f8-a591-a7a3af535857	62332-488	HUMAN PRESCRIPTION DRUG	TESTOSTERONE		TESTOSTERONE	SOLUTION	TOPICAL	20211208		ANDA	ANDA212882	Alembic Pharmaceuticals Inc.	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
62332-491_422e431a-5b1a-4f43-897d-dcad5343c8cf	62332-491	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200115		ANDA	ANDA213223	Alembic Pharmaceuticals Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-492_422e431a-5b1a-4f43-897d-dcad5343c8cf	62332-492	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200115		ANDA	ANDA213223	Alembic Pharmaceuticals Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-493_422e431a-5b1a-4f43-897d-dcad5343c8cf	62332-493	HUMAN PRESCRIPTION DRUG	Tizanidine Hydrochloride		Tizanidine Hydrochloride	CAPSULE	ORAL	20200115		ANDA	ANDA213223	Alembic Pharmaceuticals Inc.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-494_c778a5ee-2599-4d11-91b8-0dfef063d07e	62332-494	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-495_c778a5ee-2599-4d11-91b8-0dfef063d07e	62332-495	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-496_c778a5ee-2599-4d11-91b8-0dfef063d07e	62332-496	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-497_c778a5ee-2599-4d11-91b8-0dfef063d07e	62332-497	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-498_c778a5ee-2599-4d11-91b8-0dfef063d07e	62332-498	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230124		ANDA	ANDA213248	Alembic Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-499_aa4aae2d-64ba-46bb-a1fc-67bafbad3787	62332-499	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20210915		ANDA	ANDA210536	Alembic Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62332-501_fc73fdb0-aa8b-4b81-998e-b1739c93047e	62332-501	HUMAN PRESCRIPTION DRUG	OLOPATADINE HYDROCHLORIDE		olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20181207		ANDA	ANDA209919	Alembic Pharmaceuticals Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
62332-502_fb3ef8a7-46e3-4d8e-83df-117674d1c8aa	62332-502	HUMAN PRESCRIPTION DRUG	OLOPATADINE HYDROCHLORIDE		olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20190429		ANDA	ANDA209420	Alembic Pharmaceuticals Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
62332-505_e6c0ba52-5432-49da-9a9b-11c72400e0c5	62332-505	HUMAN PRESCRIPTION DRUG	Moxifloxacin ophthalmic solution		Moxifloxacin ophthalmic solution	SOLUTION/ DROPS	OPHTHALMIC	20190213		ANDA	ANDA209469	Alembic Pharmaceuticals Inc.	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
62332-506_9a578775-452f-4c9c-8563-e7a0a3dfe25d	62332-506	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride Ophthalmic Solution 0.05%		Azelastine Hydrochloride Ophthalmic Solution 0.05%	SOLUTION/ DROPS	OPHTHALMIC	20190320		ANDA	ANDA209620	Alembic Pharmaceuticals Inc.	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
62332-507_5f7905b7-a4e1-404e-9b05-2e0a99b4c047	62332-507	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20190412		ANDA	ANDA210263	Alembic Pharmaceuticals Inc.	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
62332-508_f921c629-7eef-4c9f-9636-b21cb6866a5b	62332-508	HUMAN PRESCRIPTION DRUG	Bromfenac Ophthalmic Solution 0.09%		Bromfenac Ophthalmic Solution 0.09%	SOLUTION/ DROPS	OPHTHALMIC	20190621		ANDA	ANDA210560	Alembic Pharmaceuticals Inc.	BROMFENAC SODIUM	1.035	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-510_ad5bbac2-dcd1-4592-ad0b-b1ee67224cb8	62332-510	HUMAN PRESCRIPTION DRUG	Travoprost Ophthalmic Solution USP, 0.004%	Travoprost	Travoprost Ophthalmic Solution USP, 0.004%	SOLUTION/ DROPS	OPHTHALMIC	20191220		ANDA	ANDA210458	Alembic Pharmaceuticals Inc.	TRAVOPROST	.04	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
62332-511_e236916e-a3fa-4b5a-a5ca-7f56575f8202	62332-511	HUMAN PRESCRIPTION DRUG	bimatoprost		bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20200121		ANDA	ANDA210515	Alembic Pharmaceuticals Inc.	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
62332-514_9c2bd447-15e1-4687-957f-cdb07e38cea4	62332-514	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210211		ANDA	ANDA211574	Alembic Pharmaceuticals Inc.	TREPROSTINIL	20	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
62332-515_9c2bd447-15e1-4687-957f-cdb07e38cea4	62332-515	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210211		ANDA	ANDA211574	Alembic Pharmaceuticals Inc.	TREPROSTINIL	50	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
62332-516_9c2bd447-15e1-4687-957f-cdb07e38cea4	62332-516	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210211		ANDA	ANDA211574	Alembic Pharmaceuticals Inc.	TREPROSTINIL	100	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
62332-517_9c2bd447-15e1-4687-957f-cdb07e38cea4	62332-517	HUMAN PRESCRIPTION DRUG	Treprostinil		Treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210211		ANDA	ANDA211574	Alembic Pharmaceuticals Inc.	TREPROSTINIL	200	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
62332-518_e2ff71c7-c594-4ef9-bf7b-65d59e795982	62332-518	HUMAN PRESCRIPTION DRUG	Tobramycin Ophthalmic Solution		Tobramycin Ophthalmic Solution	SOLUTION/ DROPS	OPHTHALMIC	20190419		ANDA	ANDA211847	Alembic Pharmaceuticals Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
62332-519_312b9b0b-609d-450f-aa5c-bdd9462f5dcf	62332-519	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride		Dorzolamide Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20190809		ANDA	ANDA212639	Alembic Pharmaceuticals Inc.	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
62332-532_ace640a6-8c80-4b26-92d3-f6bab258f245	62332-532	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Alembic Pharmaceuticals Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62332-533_ace640a6-8c80-4b26-92d3-f6bab258f245	62332-533	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Alembic Pharmaceuticals Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62332-534_ace640a6-8c80-4b26-92d3-f6bab258f245	62332-534	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20201202		ANDA	ANDA213251	Alembic Pharmaceuticals Inc.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62332-538_ee0b43e8-d8dd-4a74-aac2-ee828d85b364	62332-538	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20190212		ANDA	ANDA209660	Alembic Pharmaceuticals Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-539_ee0b43e8-d8dd-4a74-aac2-ee828d85b364	62332-539	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20190212		ANDA	ANDA209660	Alembic Pharmaceuticals Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-544_5857dc4b-097e-4ad6-ade9-b2eaaffe9251	62332-544	HUMAN PRESCRIPTION DRUG	Asenapine		Asenapine	TABLET	SUBLINGUAL	20210720		ANDA	ANDA206098	Alembic Pharmaceuticals Inc.	ASENAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
62332-545_dcd645b8-b1f0-46bc-b20e-83e5db80d01e	62332-545	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%		Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%	SOLUTION/ DROPS	OPHTHALMIC	20201122		ANDA	ANDA212942	Alembic Pharmaceuticals Inc.	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-546_dcd645b8-b1f0-46bc-b20e-83e5db80d01e	62332-546	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%		Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%	SOLUTION/ DROPS	OPHTHALMIC	20201122		ANDA	ANDA212942	Alembic Pharmaceuticals Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-547_a57f61fa-9340-451c-bab3-d2c594fdacc1	62332-547	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	CREAM	TOPICAL	20200131		ANDA	ANDA213291	Alembic Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-548_d7509c6a-bc2c-43c5-b56f-05ffce7f2ca0	62332-548	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	SHAMPOO	TOPICAL	20200526		ANDA	ANDA213290	Alembic Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-549_b8496968-29e2-4202-b7bc-9785242c23c4	62332-549	HUMAN PRESCRIPTION DRUG	ADAPALENE		ADAPALENE	GEL	TOPICAL	20200622		ANDA	ANDA213508	Alembic Pharmaceuticals Inc.	ADAPALENE	3	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
62332-550_160e48a2-8b51-48a5-a071-1e5688ce4219	62332-550	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	LOTION	TOPICAL	20200828		ANDA	ANDA213632	Alembic Pharmaceuticals Inc.	DESONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-552_62220e49-3381-41e3-a801-7f9a1e07c3b1	62332-552	HUMAN PRESCRIPTION DRUG	TESTOSTERONE		TESTOSTERONE	GEL	TRANSDERMAL	20210304		ANDA	ANDA213922	Alembic Pharmaceuticals Inc.	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
62332-553_7e904f7e-2cbb-4629-82e0-cec6fede4986	62332-553	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution		Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution	SOLUTION/ DROPS	OPHTHALMIC	20210504		ANDA	ANDA213099	Alembic Pharmaceuticals Inc.	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-554_ffa16afa-35e9-4845-a0e4-f8b290bd5da4	62332-554	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA209660	Alembic Pharmaceuticals Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-555_ffa16afa-35e9-4845-a0e4-f8b290bd5da4	62332-555	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA209660	Alembic Pharmaceuticals Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62332-565_78cde6f1-5cd7-428e-8ae8-e707d4d5f484	62332-565	HUMAN PRESCRIPTION DRUG	ERLOTINIB HYDROCHLORIDE		ERLOTINIB HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210709		ANDA	ANDA214719	Alembic Pharmaceuticals Inc.	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
62332-566_78cde6f1-5cd7-428e-8ae8-e707d4d5f484	62332-566	HUMAN PRESCRIPTION DRUG	ERLOTINIB HYDROCHLORIDE		ERLOTINIB HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210709		ANDA	ANDA214719	Alembic Pharmaceuticals Inc.	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
62332-567_78cde6f1-5cd7-428e-8ae8-e707d4d5f484	62332-567	HUMAN PRESCRIPTION DRUG	ERLOTINIB HYDROCHLORIDE		ERLOTINIB HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210709		ANDA	ANDA214719	Alembic Pharmaceuticals Inc.	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
62332-581_fb599351-3e43-452e-996f-f9623376845d	62332-581	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical	GEL	TOPICAL	20220915		ANDA	ANDA212351	Alembic Pharmaceuticals Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-582_940336fd-e363-47a3-b5e0-12b85bb6598f	62332-582	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		Lidocaine and Prilocaine	CREAM	TOPICAL	20220412		ANDA	ANDA213923	Alembic Pharmaceuticals Inc.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
62332-585_c98a4886-c5f9-425b-8770-7a753ba25fa8	62332-585	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20220315		ANDA	ANDA214186	Alembic Pharmaceuticals Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
62332-586_a031f12f-f832-4e10-a789-1a220a3ceabe	62332-586	HUMAN PRESCRIPTION DRUG	Amantadine		Amantadine	TABLET	ORAL	20201020		ANDA	ANDA214284	Alembic Pharmaceuticals Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
62332-598_ce72ab26-85a1-4fb5-a605-80bebe22f929	62332-598	HUMAN PRESCRIPTION DRUG	Bepotastine Besilate Ophthalmic Solution 1.5%		Bepotastine Besilate Ophthalmic Solution 1.5%	SOLUTION/ DROPS	OPHTHALMIC	20230405		ANDA	ANDA214588	Alembic Pharmaceuticals Inc.	BEPOTASTINE BESILATE	15	mg/mL	Histamine-1 Receptor Antagonist [EPC]		N	20241231
62332-599_84fec05c-9464-4148-a63c-05bfd6b88088	62332-599	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221102		ANDA	ANDA214456	Alembic Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-600_84fec05c-9464-4148-a63c-05bfd6b88088	62332-600	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221102		ANDA	ANDA214456	Alembic Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-601_84fec05c-9464-4148-a63c-05bfd6b88088	62332-601	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221102		ANDA	ANDA214456	Alembic Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62332-603_918dc4a5-ef02-4ab0-8664-7c02b23e37b6	62332-603	HUMAN PRESCRIPTION DRUG	BISOPROLOL FUMARATE		BISOPROLOL FUMARATE	TABLET, FILM COATED	ORAL	20190911		ANDA	ANDA204891	Alembic Pharmaceuticals Inc.	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-604_918dc4a5-ef02-4ab0-8664-7c02b23e37b6	62332-604	HUMAN PRESCRIPTION DRUG	BISOPROLOL FUMARATE		BISOPROLOL FUMARATE	TABLET, FILM COATED	ORAL	20190911		ANDA	ANDA204891	Alembic Pharmaceuticals Inc.	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62332-606_94f72537-2162-4b52-b96d-7d07b0f2b888	62332-606	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20210402		ANDA	ANDA214090	Alembic Pharmaceuticals Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
62332-607_b159d6c5-e3d7-4abf-a892-6084e5472f8a	62332-607	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221026		ANDA	ANDA214635	Alembic Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62332-618_1d719aa9-6f74-42a9-8010-b3d4f33d6f24	62332-618	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20221123		ANDA	ANDA215892	Alembic Pharmaceuticals Inc.	CYCLOPHOSPHAMIDE	25	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
62332-619_1d719aa9-6f74-42a9-8010-b3d4f33d6f24	62332-619	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20221123		ANDA	ANDA215892	Alembic Pharmaceuticals Inc.	CYCLOPHOSPHAMIDE	50	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
62332-620_3b584595-6ed0-49ae-a2a0-361850d0c80d	62332-620	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION	INTRAVENOUS	20221020		ANDA	ANDA216874	Alembic Pharmaceuticals Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
62332-621_3b584595-6ed0-49ae-a2a0-361850d0c80d	62332-621	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION	INTRAVENOUS	20221020		ANDA	ANDA216874	Alembic Pharmaceuticals Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
62332-622_3b584595-6ed0-49ae-a2a0-361850d0c80d	62332-622	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION	INTRAVENOUS	20221020		ANDA	ANDA216874	Alembic Pharmaceuticals Inc.	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
62332-624_e03b4a3e-9ee3-4573-b5b1-f30494eab016	62332-624	HUMAN PRESCRIPTION DRUG	MUPIROCIN		MUPIROCIN	CREAM	TOPICAL	20211201		ANDA	ANDA213053	Alembic Pharmaceuticals Inc.	MUPIROCIN CALCIUM	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
62332-627_b159d6c5-e3d7-4abf-a892-6084e5472f8a	62332-627	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221026		ANDA	ANDA214635	Alembic Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62332-628_b159d6c5-e3d7-4abf-a892-6084e5472f8a	62332-628	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221026		ANDA	ANDA214635	Alembic Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62332-629_b159d6c5-e3d7-4abf-a892-6084e5472f8a	62332-629	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221026		ANDA	ANDA214635	Alembic Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
62332-630_9615e360-9304-4704-aeff-0a5313decac1	62332-630	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20210906		ANDA	ANDA212646	Alembic Pharmaceuticals Inc.	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
62332-632_8f63061a-654b-41a0-b8c3-0caa0d1c36c6	62332-632	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20221208		ANDA	ANDA214396	Alembic Pharmaceuticals Inc.	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-633_affd4cbb-605a-4476-ba81-60748a661e51	62332-633	HUMAN PRESCRIPTION DRUG	Arformoterol tartrate		Arformoterol tartrate	SOLUTION	RESPIRATORY (INHALATION)	20220510		ANDA	ANDA214779	Alembic Pharmaceuticals Inc.	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
62332-637_54d2c795-1d41-47e5-8350-799fbcceb561	62332-637	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-638_54d2c795-1d41-47e5-8350-799fbcceb561	62332-638	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-639_54d2c795-1d41-47e5-8350-799fbcceb561	62332-639	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-640_54d2c795-1d41-47e5-8350-799fbcceb561	62332-640	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-645_54d2c795-1d41-47e5-8350-799fbcceb561	62332-645	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210423		ANDA	ANDA215076	Alembic Pharmaceuticals Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
62332-646_56acaace-062b-48f0-a75d-db44bf35120d	62332-646	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20100218		ANDA	ANDA078218	Alembic Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
62332-647_56acaace-062b-48f0-a75d-db44bf35120d	62332-647	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20100218		ANDA	ANDA078218	Alembic Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
62332-649_56acaace-062b-48f0-a75d-db44bf35120d	62332-649	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20201104		ANDA	ANDA078218	Alembic Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
62332-650_40cfb06b-7c7d-467f-8259-1c993ae84459	62332-650	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20221222		ANDA	ANDA215077	Alembic Pharmaceuticals Inc.	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
62332-655_a8dc3d21-f904-4048-a466-8954bb4575ab	62332-655	HUMAN PRESCRIPTION DRUG	Formoterol Fumarate		Formoterol Fumarate	SOLUTION	RESPIRATORY (INHALATION)	20211122		ANDA	ANDA215078	Alembic Pharmaceuticals Inc.	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
62332-659_d3e57606-6818-49db-911e-c6b664a2dd59	62332-659	HUMAN PRESCRIPTION DRUG	Carmustine		Carmustine	KIT		20231020		ANDA	ANDA215730	Alembic Pharmaceuticals Inc.						N	20241231
62332-661_66c10580-37cc-4061-ac10-1474ba0e60b8	62332-661	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate ophthalmic solution, 0.15%		Brimonidine Tartrate ophthalmic solution, 0.15%	SOLUTION/ DROPS	OPHTHALMIC	20230329		ANDA	ANDA215225	Alembic Pharmaceuticals Inc.	BRIMONIDINE TARTRATE	1.5	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62332-662_aa20e15f-fe78-4864-96d9-2bcf3c63dab4	62332-662	HUMAN PRESCRIPTION DRUG	ADAPALENE AND BENZOYL PEROXIDE		adapalene and benzoyl peroxide topical	GEL	TOPICAL	20220810		ANDA	ANDA214185	Alembic Pharmaceuticals Inc.	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
62332-663_d9f8e873-c1c9-400c-8c46-7abb23a99b88	62332-663	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20231030		ANDA	ANDA215718	Alembic Pharmaceuticals Inc.	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
62332-676_56256d08-66bc-4424-84d4-2db217e5f4d6	62332-676	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE	CHLORTHALIDONE	CHLORTHALIDONE	TABLET	ORAL	20220829		ANDA	ANDA216262	Alembic Pharmaceuticals Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62332-677_56256d08-66bc-4424-84d4-2db217e5f4d6	62332-677	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE	CHLORTHALIDONE	CHLORTHALIDONE	TABLET	ORAL	20220829		ANDA	ANDA216262	Alembic Pharmaceuticals Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62332-678_59e116c8-6ba0-4459-b71b-75ad9492ff14	62332-678	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20230228		ANDA	ANDA215744	Alembic Pharmaceuticals Inc.	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
62332-682_00ec9cfd-4b08-477f-852d-07c753f21a5c	62332-682	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20220503		ANDA	ANDA215839	Alembic Pharmaceuticals Inc.	DOCOSANOL	100	mg/g			N	20241231
62332-690_f3d0bd84-50f3-494b-a9be-c1cd5e88447e	62332-690	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20230615		ANDA	ANDA215810	Alembic Pharmaceuticals Inc.	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
62332-691_c8142eb6-b8f8-4db8-9f60-0197c908d85a	62332-691	HUMAN PRESCRIPTION DRUG	PRAZOSIN HYDROCHLORIDE		PRAZOSIN HYDROCHLORIDE	CAPSULE	ORAL	20230309		ANDA	ANDA217268	Alembic Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62332-692_c8142eb6-b8f8-4db8-9f60-0197c908d85a	62332-692	HUMAN PRESCRIPTION DRUG	PRAZOSIN HYDROCHLORIDE		PRAZOSIN HYDROCHLORIDE	CAPSULE	ORAL	20230309		ANDA	ANDA217268	Alembic Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62332-693_c8142eb6-b8f8-4db8-9f60-0197c908d85a	62332-693	HUMAN PRESCRIPTION DRUG	PRAZOSIN HYDROCHLORIDE		PRAZOSIN HYDROCHLORIDE	CAPSULE	ORAL	20230309		ANDA	ANDA217268	Alembic Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62332-706_cef8387c-5a39-4e07-94f4-0b9a6e5bad56	62332-706	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate and Timolol Maleate		Brimonidine Tartrate and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20230825		ANDA	ANDA215230	Alembic Pharmaceuticals Inc.	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
62332-707_4a0d8513-a88d-4a90-894a-149596fa31ad	62332-707	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	AEROSOL, FOAM	TOPICAL	20220421		ANDA	ANDA215838	Alembic Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62332-709_3b330307-f5b5-473f-a4dd-56a080a1b518	62332-709	HUMAN OTC DRUG	Olopatadine Hydrochloride		olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20210218		ANDA	ANDA209919	Alembic Pharmaceuticals Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
62332-710_75823e5d-562a-43c2-8365-6f3f9484c9bf	62332-710	HUMAN OTC DRUG	Olopatadine Hydrochloride		olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20210125		ANDA	ANDA209420	Alembic Pharmaceuticals Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
62332-724_7d9111a9-c8be-4823-b104-badc44eb08a5	62332-724	HUMAN PRESCRIPTION DRUG	MESALAMINE		MESALAMINE	CAPSULE, EXTENDED RELEASE	ORAL	20221103		ANDA	ANDA216967	Alembic Pharmaceuticals Inc.	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20251231
62332-732_69114afa-390f-4134-9055-d0b539d45c96	62332-732	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20221123		ANDA	ANDA216896	Alembic Pharmaceuticals Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-733_69114afa-390f-4134-9055-d0b539d45c96	62332-733	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20221123		ANDA	ANDA216896	Alembic Pharmaceuticals Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-734_69114afa-390f-4134-9055-d0b539d45c96	62332-734	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20221123		ANDA	ANDA216896	Alembic Pharmaceuticals Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62332-735_deb8b52f-3d59-4fc0-b454-7b484a3d535f	62332-735	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62332-736_deb8b52f-3d59-4fc0-b454-7b484a3d535f	62332-736	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62332-737_deb8b52f-3d59-4fc0-b454-7b484a3d535f	62332-737	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62332-738_deb8b52f-3d59-4fc0-b454-7b484a3d535f	62332-738	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62332-739_deb8b52f-3d59-4fc0-b454-7b484a3d535f	62332-739	HUMAN PRESCRIPTION DRUG	Chlorpromazine		Chlorpromazine	TABLET	ORAL	20230720		ANDA	ANDA217350	Alembic Pharmaceuticals Inc.	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
62332-744_fee5919a-554b-4767-8ab2-867de799a533	62332-744	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide hydrochloride and clidinium bromide		Chlordiazepoxide hydrochloride and clidinium bromide	CAPSULE	ORAL	20231004		ANDA	ANDA216969	Alembic Pharmaceuticals Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
62332-745_c76d9ab1-ce38-40ab-9a0c-cfce86d1d791	62332-745	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-746_c76d9ab1-ce38-40ab-9a0c-cfce86d1d791	62332-746	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Inc.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-747_c76d9ab1-ce38-40ab-9a0c-cfce86d1d791	62332-747	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Inc.	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-748_c76d9ab1-ce38-40ab-9a0c-cfce86d1d791	62332-748	HUMAN PRESCRIPTION DRUG	GUANFACINE		GUANFACINE	TABLET, EXTENDED RELEASE	ORAL	20230808		ANDA	ANDA217269	Alembic Pharmaceuticals Inc.	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
62332-749_31b081e9-14ff-4b24-a21f-14ab41d8c0f8	62332-749	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION/ DROPS	OPHTHALMIC	20230801		ANDA	ANDA216909	Alembic Pharmaceuticals Inc.	BRIMONIDINE TARTRATE	1	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
62332-751_12a1e070-c151-4a5c-9c36-c4a243c90cb3	62332-751	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20230303		ANDA	ANDA217295	Alembic Pharmaceuticals Inc.	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
62332-777_b7b88670-dd4a-4d55-9ffd-c8aba5d5af7c	62332-777	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		CARBOPROST TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20230615		ANDA	ANDA217198	Alembic Pharmaceuticals Inc.	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
62332-779_1d270cea-7292-445b-88e7-de542b657cb2	62332-779	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20231018		ANDA	ANDA217676	Alembic Pharmaceuticals Inc.	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
62337-415_074a1fcf-ad01-9e02-e063-6394a90ad9e3	62337-415	HUMAN OTC DRUG	Pyrantel Pamoate		PinwormTreatment	SUSPENSION	ORAL	20121017		OTC MONOGRAPH DRUG	M024	Neogen Corporation dba Columbia Laboratories	PYRANTEL PAMOATE	50	mg/mL			N	20241231
62363-001_08f613d7-05be-d582-e063-6394a90a6919	62363-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100104		UNAPPROVED MEDICAL GAS		Sandcreek Medical Sales and Rentals Inc	OXYGEN	99	L/100L			N	20241231
62371-1234_06fd70ae-8e23-90b7-e063-6294a90a0622	62371-1234	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100112		UNAPPROVED MEDICAL GAS		Dick's Home Care, Inc dba Dick's Homecare, Inc.	OXYGEN	99	L/100L			N	20241231
62372-400_0b79a8a8-a1ba-7326-e063-6294a90add63	62372-400	HUMAN OTC DRUG	Childrens Mylicon Tummy Relief for Kids		Antacid and Antigas	TABLET, CHEWABLE	ORAL	20180209		OTC MONOGRAPH DRUG	M002	Infirst Healthcare Inc.	CALCIUM CARBONATE; DIMETHICONE	400; 40	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
62372-410_0bb08753-8604-dcd1-e063-6294a90a4bd1	62372-410	HUMAN OTC DRUG	Childrens Mylicon All in One Tummy Relief for Kids		Antacid and Antigas	LIQUID	ORAL	20211124		OTC MONOGRAPH DRUG	M002	Infirst Healthcare Inc.	CALCIUM CARBONATE; DIMETHICONE	400; 40	mg/5mL; mg/5mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20251231
62372-500_0bb0b7ef-4268-0b60-e063-6294a90a090b	62372-500	HUMAN OTC DRUG	Mylanta Maximum Strength Classic Flavor		Antacid and Anti Gas Aluminum hydroxide Magnesium hydroxide and Simethicone	SUSPENSION	ORAL	20161110		OTC MONOGRAPH DRUG	M001	Infirst Healthcare Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
62372-500_23cf43f1-13d1-40e8-a0e4-213b2ab15bd3	62372-500	HUMAN OTC DRUG	Mylanta Maximum Strength Classic Flavor		antacid and anti gas aluminum hydroxide magnesium hydroxide and simethicone	SUSPENSION	ORAL	20161110		OTC MONOGRAPH FINAL	part331	Infirst Healthcare Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62372-500_ade9af6e-e8a0-487e-9952-1aeb5d75f3a1	62372-500	HUMAN OTC DRUG	Mylanta Maximum Strength Classic Flavor		antacid and anti gas aluminum hydroxide magnesium hydroxide and simethicone	SUSPENSION	ORAL	20161110		OTC MONOGRAPH FINAL	part331	Infirst Healthcare Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62372-504_0bb0df3b-05ce-5c5b-e063-6394a90ab91a	62372-504	HUMAN OTC DRUG	Mylanta Maximum Strength Vanilla Caramel Flavor		Antacid and Anti Gas Aluminum hydroxide Magnesium hydroxide and Simethicone	SUSPENSION	ORAL	20160321		OTC MONOGRAPH DRUG	M001	Infirst Healthcare Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
62372-510_0bb0c90d-29d2-327f-e063-6294a90a57af	62372-510	HUMAN OTC DRUG	Mylanta New Tonight Soothing Honey Chamomile		Calcium Carbonate,Magnesium hydroxide and Simethicone	SUSPENSION	ORAL	20160321		OTC MONOGRAPH DRUG	M001	Infirst Healthcare Inc.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 270	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
62372-510_33867788-4bd1-4d03-b742-711b6f15b637	62372-510	HUMAN OTC DRUG	MYLANTA NEW TONIGHT SOOTHING HONEY CHAMOMILE		Calcium Carbonate,Magnesium hydroxide and Simethicone	SUSPENSION	ORAL	20160321		OTC MONOGRAPH FINAL	part331	Infirst Healthcare Inc.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 270	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62372-551_0c441a11-2c3b-c0ef-e063-6294a90abc86	62372-551	HUMAN OTC DRUG	Mylanta One Antacid/Anti-Gas		Calcium carbonate, Magnesium hydroxide, Dimethicone	TABLET, CHEWABLE	ORAL	20210504		OTC MONOGRAPH DRUG	M001	Infirst Healthcare Inc.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1000; 80; 270	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62372-552_0c4462a1-c735-c0ec-e063-6294a90a5e0c	62372-552	HUMAN OTC DRUG	Mylanta One Antacid/Anti-Gas		Calcium carbonate, Magnesium hydroxide, Dimethicone	TABLET, CHEWABLE	ORAL	20210504		OTC MONOGRAPH DRUG	M001	Infirst Healthcare Inc.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1000; 80; 270	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62372-630_0bb18b4c-fbe3-8d2a-e063-6394a90a4f5c	62372-630	HUMAN OTC DRUG	Mylicon Infants Gas Relief Original		Simethicone	EMULSION	ORAL	20150331		OTC MONOGRAPH DRUG	M002	Infirst Healthcare	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20251231
62372-650_0bb1b812-762c-9bc2-e063-6394a90a79d2	62372-650	HUMAN OTC DRUG	Mylicon Infants Gas Relief Dye Free		Simethicone	EMULSION	ORAL	20150331		OTC MONOGRAPH DRUG	M002	Infirst Healthcare	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20251231
62372-796_0bb20520-82b8-a86d-e063-6394a90ae230	62372-796	HUMAN OTC DRUG	Mylanta Coat and Cool		Calcium Carbonate, Magnesium hydroxide, Simethicone	LIQUID	ORAL	20191028		OTC MONOGRAPH DRUG	M001	INFIRST HEALTHCARE INC.	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1200; 80; 270	mg/10mL; mg/10mL; mg/10mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
62372-800_0bb21396-9aaa-5edc-e063-6294a90a43bf	62372-800	HUMAN OTC DRUG	Mylanta Gas Minis Mint Flavor		Simethicone	TABLET, CHEWABLE	ORAL	20160321		OTC MONOGRAPH DRUG	M002	Infirst Healthcare Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
62372-801_0bb22980-478b-bc8c-e063-6394a90a1fee	62372-801	HUMAN OTC DRUG	Mylanta Gas Minis Assorted Fruit Flavor		Simethicone	TABLET, CHEWABLE	ORAL	20160321		OTC MONOGRAPH DRUG	M002	Infirst Healthcare Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
62379-101_0315740f-1a92-16b5-e063-6394a90a0416	62379-101	HUMAN OTC DRUG	Pain Reliveing Patch		Lidocaine 4%	PATCH	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part348	simple diagnostics	LIDOCAINE HYDROCHLORIDE	.4	g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62391-100_0c51dfc1-f8ba-2a95-e063-6294a90ad78f	62391-100	HUMAN OTC DRUG	BioFlexor	04	Menthol	GEL	TOPICAL	19980301		OTC MONOGRAPH DRUG	M017	Health Care Laboratories Inc.	MENTHOL	3	g/100g			N	20241231
62400-0004_08857028-70a5-8ae6-e063-6394a90aa6c0	62400-0004	HUMAN OTC DRUG	Hand Hero Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200507		OTC MONOGRAPH DRUG	505G(a)(3)	United Laboratories Manufacturing, LLC	ALCOHOL	.7	mL/mL			N	20241231
62400-0026_ed7e33e0-44fc-51ed-e053-2a95a90a6648	62400-0026	HUMAN OTC DRUG	DB Pain Relieving		PSEUDOGNAPHALIUM OBTUSIFOLIUM,APIS MELLIFERA,GELSEMIUM SEMPERVIRES ROOT	CREAM	TOPICAL	20170510		UNAPPROVED HOMEOPATHIC		United Laboratories Manufacturing, LLC	APIS MELLIFERA; GELSEMIUM SEMPERVIRENS ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM	3; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
62400-0032_ed7e5d96-0e5d-8876-e053-2995a90aa689	62400-0032	HUMAN OTC DRUG	Breathe Easy Chest		ARSENIC TRIOXIDE, IPECAC, PHOSPHORUS, POLYGALA SENEGA WHOLE, ANTIMONY POTASSIUM TARTRATE, BRYONIA ALBA WHOLE	CREAM	TOPICAL	20170716		UNAPPROVED HOMEOPATHIC		United Laboratories Manufacturing, LLC	ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA WHOLE; IPECAC; PHOSPHORUS; POLYGALA SENEGA WHOLE	6; 6; 3; 3; 6; 3	[hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g			N	20241231
62400-0033_ed7e6738-086b-470e-e053-2a95a90a3a67	62400-0033	HUMAN OTC DRUG	Pain Relieving Foot		APIS MELLIFERA PSEUDOGNAPHALIUM OBTUSIFOLIUM GELSEMIUM SEMPERVIRENS ROOT	CREAM	TOPICAL	20170505		UNAPPROVED HOMEOPATHIC		United Laboratories Manufacturing, LLC	APIS MELLIFERA; GELSEMIUM SEMPERVIRENS ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM	3; 6; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
62400-0034_ed7e6738-086c-470e-e053-2a95a90a3a67	62400-0034	HUMAN OTC DRUG	Arnica Pain Relief		ARNICA MONTANA	GEL	TOPICAL	20170620		UNAPPROVED HOMEOPATHIC		United Laboratories Manufacturing, LLC	ARNICA MONTANA	3	[hp_X]/113g			N	20241231
62400-0055_d825893d-e903-75d9-e053-2a95a90a477f	62400-0055	HUMAN OTC DRUG	Magnilife Knee pain relief gel		ARNICA MONTANA FLOWER, TOXICODENDRON PUBESCENS LEAF	GEL	TOPICAL	20220210		UNAPPROVED HOMEOPATHIC		United Laboratories Manufacturing, LLC	ARNICA MONTANA FLOWER; TOXICODENDRON PUBESCENS LEAF	1; 4	[hp_X]/g; [hp_X]/g			N	20241231
62428-701_8424948d-1715-340f-e053-2a91aa0a4f78	62428-701	HUMAN OTC DRUG	Alcohol Foaming Hand Sanitizer		Alcohol	SOAP	TOPICAL	20190314		OTC MONOGRAPH NOT FINAL	part333A	Lawson Prodcuts, Inc	ALCOHOL	.62	mL/mL			N	20241231
62428-759_abacb6f6-fe27-77db-e053-2a95a90ad6a2	62428-759	HUMAN OTC DRUG	Glacier Blue Antibacterial Foaming Skin Cleanser		benzalkonium chloride	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333E	Lawson Products, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62428-800_abbc76e0-219c-559b-e053-2a95a90a521a	62428-800	HUMAN OTC DRUG	Ocean Blue Foaming Hand Sanitizer		Alcohol	SOAP	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	Lawson Product, Inc	ALCOHOL	.7	mL/mL			N	20241231
62440-279_2c012329-4142-4ff2-8ea4-3a5645eea9e0	62440-279	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20140305		OTC MONOGRAPH NOT FINAL	part333A	Swinton Avenue Trading Ltd.Inc.	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
62440-370_5825cb86-ae05-4eb5-b88a-64b12dfb6bd6	62440-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20140801		OTC MONOGRAPH NOT FINAL	part333A	Swinton Avenue Trading Ltd, Inc.	ALCOHOL	70	mL/100mL			N	20241231
62440-439_d26c3c28-405d-4689-b8d3-77efa7c74b45	62440-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140730		OTC MONOGRAPH NOT FINAL	part333A	Swinton Avenue Trading LTD.Inc.	ALCOHOL	700	mg/mL			N	20241231
62447-0011_0802489a-3811-cc8b-e063-6294a90a9b4e	62447-0011	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19870101		NDA	NDA205767	Bradshaw's Industrial Supply, Inc. dba Interstate Welding Supply	OXYGEN	99	L/100L			N	20241231
62450-003_0acc9647-83bf-9175-e063-6294a90a7436	62450-003	HUMAN PRESCRIPTION DRUG	Agamree		vamorolone	SUSPENSION	ORAL	20231123		NDA	NDA215239	Purna Pharmaceuticals NV	VAMOROLONE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62467-265_ce35a3b6-d573-4caa-bdab-e21ed3a7bc9a	62467-265	HUMAN OTC DRUG	SAN E 2 Hand Wash 6265		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20181017		OTC MONOGRAPH NOT FINAL	part333E	The Roxxon Corporation	BENZALKONIUM CHLORIDE	25	mg/mL			N	20241231
62476-001_d3201ff6-8342-006a-e053-2995a90af089	62476-001	HUMAN OTC DRUG	Aquabain Antibacterial Passion Berrys		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-002_d32034b2-bc3e-979a-e053-2995a90a5324	62476-002	HUMAN OTC DRUG	Aquabain Antibacterial Fresh and Relax		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-003_d3203462-2c8a-13d8-e053-2a95a90ad94e	62476-003	HUMAN OTC DRUG	Aquabain Antibacterial Grapefruit		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-004_d32034b2-bc40-979a-e053-2995a90a5324	62476-004	HUMAN OTC DRUG	Aquabain Antibacterial Red Fruits		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-005_d3202743-4bda-792b-e053-2995a90a40d7	62476-005	HUMAN OTC DRUG	Aquabain Instant Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	ALCOHOL	91	mL/130mL			N	20241231
62476-006_05e4ca56-e0d5-8aa4-e063-6394a90a8055	62476-006	HUMAN OTC DRUG	DK12 Liquid Hand Oatmeal		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-007_01e228b0-80ac-2396-e063-6394a90a3852	62476-007	HUMAN OTC DRUG	DK12 Liquid Hand Fresh Energy		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-008_01e2e53e-4d82-66f0-e063-6294a90a8f21	62476-008	HUMAN OTC DRUG	DK12 Liquid Hand Creamy		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-009_021bca08-6bbe-de26-e063-6394a90a3b9f	62476-009	HUMAN OTC DRUG	Jabonito Kids Green Apple Liquid		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.31	g/237mL			N	20241231
62476-010_05e36111-ed4f-12de-e063-6294a90af639	62476-010	HUMAN OTC DRUG	DK12 Shower Gel Creamy		Benzalkonium Chloride 0.13%	GEL	TOPICAL	20230901		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-011_05e54056-4279-dcf4-e063-6294a90ae1a2	62476-011	HUMAN OTC DRUG	DK12 Shower Gel Fresh Energy		Benzalkonium Chloride 0.13%	GEL	TOPICAL	20230901		OTC MONOGRAPH NOT FINAL	part333A	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.65	g/500mL			N	20241231
62476-101_fea8244b-411b-614f-e053-6394a90a04ff	62476-101	HUMAN OTC DRUG	Jabon Avena		Benzalkonium Chloride 0.1%	SOAP	TOPICAL	20200501	20250331	OTC MONOGRAPH NOT FINAL	part333E	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.1	g/110g			N	
62476-102_febb6228-9c94-5f3c-e053-6394a90a05a6	62476-102	HUMAN OTC DRUG	Jabon Cremoso		Benzalkonium Chloride 0.1%	SOAP	TOPICAL	20200501	20250331	OTC MONOGRAPH NOT FINAL	part333E	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.1	g/110g			N	
62476-103_febbd42e-814f-778c-e053-6394a90af107	62476-103	HUMAN OTC DRUG	Jabon Fresh Energy		Benzalkonium Chloride 0.1%	SOAP	TOPICAL	20200501	20250331	OTC MONOGRAPH NOT FINAL	part333E	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.1	g/110g			N	
62476-104_fe16a6cb-0f53-677a-e053-6294a90a8391	62476-104	HUMAN OTC DRUG	DK12 Oatmeal Antibacterial and Moisturizing		Benzalkonium Chloride 0.1%	SOAP	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.1	g/110g			N	20241231
62476-105_fe800ff7-fee3-ad79-e053-6294a90a2181	62476-105	HUMAN OTC DRUG	DK12 Creamy Antibacterial and Moisturizing		Benzalkonium Chloride 0.1%	SOAP	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.1	g/110g			N	20241231
62476-106_fe80635d-9595-abf3-e053-6394a90aa78b	62476-106	HUMAN OTC DRUG	DK12 Fresh Energy Antibacterial and Moisturizing		Benzalkonium Chloride 0.1%	SOAP	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.1	g/110g			N	20241231
62476-107_fe9270c0-bf6c-f0ff-e053-6394a90ae8f1	62476-107	HUMAN OTC DRUG	DK12 Vitamin E Antibacterial and Moisturizing		Benzalkonium Chloride 0.1%	SOAP	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	Industria La Popular, S.A.	BENZALKONIUM CHLORIDE	.1	g/110g			N	20241231
62481-4565_07fe6213-8b52-248b-e063-6294a90ae070	62481-4565	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100104		UNAPPROVED MEDICAL GAS		Bay State Medical, Inc.	OXYGEN	99	L/100L			N	20241231
62484-0020_4ad66d0a-ed5b-4031-9334-64117247a8d4	62484-0020	HUMAN PRESCRIPTION DRUG	PURIXAN		Purixan	SUSPENSION	ORAL	20140428		NDA	NDA205919	Nova Laboratories, Ltd	MERCAPTOPURINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
62486-130_06d6564a-73da-a78a-e063-6294a90a82ab	62486-130	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Advocate Home Care Products	OXYGEN	99	L/100L			N	20241231
62541-201_0c404c87-1228-4c9f-e063-6294a90aad84	62541-201	HUMAN PRESCRIPTION DRUG	Qsymia		phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917		NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	3.75; 23	mg/1; mg/1	Appetite Suppression [PE], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
62541-202_0c404c87-1228-4c9f-e063-6294a90aad84	62541-202	HUMAN PRESCRIPTION DRUG	Qsymia		phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917		NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	7.5; 46	mg/1; mg/1	Appetite Suppression [PE], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
62541-203_0c404c87-1228-4c9f-e063-6294a90aad84	62541-203	HUMAN PRESCRIPTION DRUG	Qsymia		phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917		NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	11.25; 69	mg/1; mg/1	Appetite Suppression [PE], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
62541-204_0c404c87-1228-4c9f-e063-6294a90aad84	62541-204	HUMAN PRESCRIPTION DRUG	Qsymia		phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917		NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	15; 92	mg/1; mg/1	Appetite Suppression [PE], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
62541-401_0762a8f6-0b65-b236-e063-6294a90a75ee	62541-401	HUMAN PRESCRIPTION DRUG	PANCREAZE		PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE	CAPSULE, DELAYED RELEASE	ORAL	20160801		BLA	BLA022523	VIVUS LLC	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	15200; 2600; 8800	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
62541-402_0762a8f6-0b65-b236-e063-6294a90a75ee	62541-402	HUMAN PRESCRIPTION DRUG	PANCREAZE		PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE	CAPSULE, DELAYED RELEASE	ORAL	20100412		BLA	BLA022523	VIVUS LLC	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	24600; 4200; 14200	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
62541-403_0762a8f6-0b65-b236-e063-6294a90a75ee	62541-403	HUMAN PRESCRIPTION DRUG	PANCREAZE		PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE	CAPSULE, DELAYED RELEASE	ORAL	20100412		BLA	BLA022523	VIVUS LLC	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	61500; 10500; 35500	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
62541-404_0762a8f6-0b65-b236-e063-6294a90a75ee	62541-404	HUMAN PRESCRIPTION DRUG	PANCREAZE		PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE	CAPSULE, DELAYED RELEASE	ORAL	20100412		BLA	BLA022523	VIVUS LLC	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	98400; 16800; 56800	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
62541-405_0762a8f6-0b65-b236-e063-6294a90a75ee	62541-405	HUMAN PRESCRIPTION DRUG	PANCREAZE		PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE	CAPSULE, DELAYED RELEASE	ORAL	20100412		BLA	BLA022523	VIVUS LLC	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	83900; 21000; 54700	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
62541-406_0762a8f6-0b65-b236-e063-6294a90a75ee	62541-406	HUMAN PRESCRIPTION DRUG	PANCREAZE		PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE	CAPSULE, DELAYED RELEASE	ORAL	20210701		BLA	BLA022523	VIVUS LLC	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	149900; 37000; 97300	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
62542-301_e07a2d27-aecb-2268-e053-2995a90a03e8	62542-301	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex		Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20141023	20240531	ANDA	ANDA091671	Neos Therapeutics LP	CHLORPHENIRAMINE; HYDROCODONE	8; 10	mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	
62551-213_f219c41d-a661-2360-e053-2995a90a8e56	62551-213	HUMAN OTC DRUG	PHOTO-AGE SUNSCREEN	SPF 30	OCTINOXATE, TITANIUM DIOXIDE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	GEL	TOPICAL	20210812		OTC MONOGRAPH FINAL	part352	ADVANCED AESTHETICS	OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	7.5; 5; 1.5; 1; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
62559-111_54dcdbdd-ff40-4ed2-8298-fc61dddf0934	62559-111	HUMAN PRESCRIPTION DRUG	Cortenema		Hydrocortisone	ENEMA	RECTAL	20120810		NDA	NDA016199	ANI Pharmaceuticals, Inc.	HYDROCORTISONE	100	mg/60mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62559-138_73c5cf01-64d5-4ff5-a216-7df62ca45b3b	62559-138	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	ENEMA	RECTAL	20120816		NDA AUTHORIZED GENERIC	NDA016199	ANI Pharmaceuticals, Inc.	HYDROCORTISONE	100	mg/60mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62559-149_2eb8363e-bdf3-47ed-a670-b9be477bfdfe	62559-149	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20101222		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	1.25; 2.5	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
62559-150_2eb8363e-bdf3-47ed-a670-b9be477bfdfe	62559-150	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20101222		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	.625; 1.25	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
62559-151_f1b080b6-b661-45f4-ba18-8167792f1e7a	62559-151	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20151013		ANDA	ANDA204979	ANI Pharmaceuticals, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
62559-153_c1dbee66-b7da-4a4e-bfaf-e7fe65122c78	62559-153	HUMAN PRESCRIPTION DRUG	Opium Tincture Deodorized		morphine tincture	SOLUTION	ORAL	20110225		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	MORPHINE	1	g/100mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
62559-157_eb23102c-b563-4bf7-be2b-394e9cdad551	62559-157	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20200324		ANDA	ANDA202850	ANI Pharmaceuticals, Inc.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62559-158_2248c041-56a7-4471-88bb-dc0c3f5e5cce	62559-158	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20110809		NDA AUTHORIZED GENERIC	NDA021519	ANI Pharmaceuticals, Inc.	FLUVOXAMINE MALEATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62559-159_2248c041-56a7-4471-88bb-dc0c3f5e5cce	62559-159	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20110809		NDA AUTHORIZED GENERIC	NDA021519	ANI Pharmaceuticals, Inc.	FLUVOXAMINE MALEATE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62559-160_2248c041-56a7-4471-88bb-dc0c3f5e5cce	62559-160	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20110809		NDA AUTHORIZED GENERIC	NDA021519	ANI Pharmaceuticals, Inc.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
62559-165_06daee34-5164-4630-af92-bc43fa9c295d	62559-165	HUMAN PRESCRIPTION DRUG	Reglan		Metoclopramide Hydrochloride	TABLET	ORAL	20110705		NDA	NDA017854	ANI Pharmaceuticals, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
62559-166_06daee34-5164-4630-af92-bc43fa9c295d	62559-166	HUMAN PRESCRIPTION DRUG	Reglan		Metoclopramide Hydrochloride	TABLET	ORAL	20110705		NDA	NDA017854	ANI Pharmaceuticals, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
62559-167_6301585b-ed80-4a3e-b503-54ec254f14d0	62559-167	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	CAPSULE	ORAL	20160610		ANDA	ANDA205177	ANI Pharmaceuticals, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
62559-173_441002fd-1e82-482c-acab-560838b7118f	62559-173	HUMAN PRESCRIPTION DRUG	Nilutamide		Nilutamide	TABLET	ORAL	20160718		ANDA	ANDA207631	ANI Pharmaceuticals, Inc.	NILUTAMIDE	150	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
62559-190_a2914c9f-9e70-4b33-bdee-02120b4db97d	62559-190	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	SOLUTION	ORAL	20150518		ANDA	ANDA071402	ANI Pharmaceuticals, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
62559-205_6a2a26b3-dae9-4333-adf2-eb1ab2ff28ea	62559-205	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20210625		ANDA	ANDA074670	ANI Pharmaceuticals, Inc.	NICARDIPINE HYDROCHLORIDE	20	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62559-206_6a2a26b3-dae9-4333-adf2-eb1ab2ff28ea	62559-206	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20210625		ANDA	ANDA074670	ANI Pharmaceuticals, Inc.	NICARDIPINE HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
62559-225_69d62441-f780-44a9-91aa-43d3285b5b34	62559-225	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	TABLET	ORAL	20201216		ANDA	ANDA211629	ANI Pharmaceuticals, Inc.	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
62559-230_8b04edde-591a-42b6-a8a8-a27c0f042353	62559-230	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	ANI Pharmaceuticals, Inc.	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-231_8b04edde-591a-42b6-a8a8-a27c0f042353	62559-231	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	ANI Pharmaceuticals, Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-232_8b04edde-591a-42b6-a8a8-a27c0f042353	62559-232	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	ANI Pharmaceuticals, Inc.	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-235_d2a58d9e-e8a1-4288-a0ec-0a03469b11d6	62559-235	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20211122	20240331	ANDA	ANDA086944	ANI Pharmaceuticals, Inc.	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	
62559-240_8df9e9a6-7900-4cce-abe1-0408f30c0aa3	62559-240	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20141106		ANDA	ANDA040001	ANI Pharmaceuticals, Inc.	METHAZOLAMIDE	25	mg/1			N	20241231
62559-241_8df9e9a6-7900-4cce-abe1-0408f30c0aa3	62559-241	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20141106		ANDA	ANDA040001	ANI Pharmaceuticals, Inc.	METHAZOLAMIDE	50	mg/1			N	20241231
62559-250_4d739dbc-fed1-482c-8926-052f37ebf5dc	62559-250	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150309		ANDA	ANDA075126	ANI Pharmaceuticals, Inc.	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62559-251_4d739dbc-fed1-482c-8926-052f37ebf5dc	62559-251	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150201		ANDA	ANDA075126	ANI Pharmaceuticals, Inc.	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
62559-255_9634c327-d360-4d9e-83e6-c6d9885d615a	62559-255	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20220725		ANDA	ANDA074007	ANI Pharmaceuticals, Inc.	ACEBUTOLOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-256_9634c327-d360-4d9e-83e6-c6d9885d615a	62559-256	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20220725		ANDA	ANDA074007	ANI Pharmaceuticals, Inc.	ACEBUTOLOL HYDROCHLORIDE	400	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-265_a08cd27d-8499-4f49-8221-17f6c1d1ed5d	62559-265	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET	ORAL	20210701		ANDA	ANDA203256	ANI Pharmaceuticals, Inc.	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
62559-266_1a9af786-2f85-4f2d-8403-72ca751dff4b	62559-266	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	SOLUTION	ORAL	20240102		ANDA	ANDA073178	ANI Pharmaceuticals, Inc.	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
62559-275_37b4476d-5b9d-4016-b3e2-cbadaefe091d	62559-275	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203659	ANI Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-276_37b4476d-5b9d-4016-b3e2-cbadaefe091d	62559-276	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203659	ANI Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-277_37b4476d-5b9d-4016-b3e2-cbadaefe091d	62559-277	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203659	ANI Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-278_37b4476d-5b9d-4016-b3e2-cbadaefe091d	62559-278	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210917		ANDA	ANDA203659	ANI Pharmaceuticals, Inc.	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-280_75db0302-4a60-4b41-85fa-99ff2761ce56	62559-280	HUMAN PRESCRIPTION DRUG	LITHOBID		lithium carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140701		NDA	NDA018027	ANI Pharmaceuticals, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
62559-285_df66f7c6-20f6-436e-a5d5-784c3291388b	62559-285	HUMAN PRESCRIPTION DRUG	Oxistat		oxiconazole nitrate	LOTION	TOPICAL	20220912		NDA	NDA020209	ANI Pharmaceuticals, Inc.	OXICONAZOLE NITRATE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
62559-291_e6383fe0-7313-4a6c-b312-fd517e7d605c	62559-291	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA212779	ANI Pharmaceuticals, Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
62559-292_e6383fe0-7313-4a6c-b312-fd517e7d605c	62559-292	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA212779	ANI Pharmaceuticals, Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
62559-295_64aa5644-d882-4850-8fc2-eddc7dd12307	62559-295	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20211213		NDA AUTHORIZED GENERIC	NDA017854	ANI Pharmaceuticals, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
62559-296_64aa5644-d882-4850-8fc2-eddc7dd12307	62559-296	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20211213		NDA AUTHORIZED GENERIC	NDA017854	ANI Pharmaceuticals, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
62559-299_622c9804-0be0-4dec-a6ba-5cf4b5578a84	62559-299	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	OINTMENT	TOPICAL	20231113		NDA AUTHORIZED GENERIC	NDA013960	ANI Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62559-305_25f18a1a-2283-469b-a18f-e573fa72a1ee	62559-305	HUMAN PRESCRIPTION DRUG	Lipofen		fenofibrate	CAPSULE	ORAL	20210924		NDA	NDA021612	ANI Pharmaceuticals, Inc.	FENOFIBRATE	50	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62559-306_25f18a1a-2283-469b-a18f-e573fa72a1ee	62559-306	HUMAN PRESCRIPTION DRUG	Lipofen		fenofibrate	CAPSULE	ORAL	20210924		NDA	NDA021612	ANI Pharmaceuticals, Inc.	FENOFIBRATE	150	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62559-310_08498a35-cdc9-4e10-9ea1-37e8d5827521	62559-310	HUMAN PRESCRIPTION DRUG	Vancocin		vancomycin hydrochloride	CAPSULE	ORAL	20141117		NDA	NDA050606	ANI Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
62559-311_08498a35-cdc9-4e10-9ea1-37e8d5827521	62559-311	HUMAN PRESCRIPTION DRUG	Vancocin		vancomycin hydrochloride	CAPSULE	ORAL	20141117		NDA	NDA050606	ANI Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	250	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
62559-315_93b091eb-5756-458c-a11d-dca525a66a83	62559-315	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20220531		ANDA	ANDA074497	ANI Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62559-316_93b091eb-5756-458c-a11d-dca525a66a83	62559-316	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20211213		ANDA	ANDA074497	ANI Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
62559-325_f246332a-48f0-433f-9d1c-463c9ebd798f	62559-325	HUMAN PRESCRIPTION DRUG	PANDEL		Hydrocortisone Probutate	CREAM	TOPICAL	20220930		NDA	NDA020453	ANI Pharmaceuticals, Inc.	HYDROCORTISONE PROBUTATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62559-365_41b5193a-08da-4b44-bca5-2b076711c5c0	62559-365	HUMAN PRESCRIPTION DRUG	ApexiCon E		diflorasone diacetate	CREAM	TOPICAL	20221020		ANDA	ANDA076263	ANI Pharmaceuticals, Inc.	DIFLORASONE DIACETATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62559-376_31d5e1bf-b31b-4f4b-96ab-11a164a890ec	62559-376	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230104		ANDA	ANDA204504	ANI Pharmaceuticals, Inc.	FESOTERODINE FUMARATE	8	mg/1			N	20241231
62559-380_73bfdbfd-c561-4e95-bea0-8aa52c5c2799	62559-380	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	ANI Pharmaceuticals, Inc.	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-381_73bfdbfd-c561-4e95-bea0-8aa52c5c2799	62559-381	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	ANI Pharmaceuticals, Inc.	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-382_73bfdbfd-c561-4e95-bea0-8aa52c5c2799	62559-382	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	ANI Pharmaceuticals, Inc.	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-385_64ad4fa5-8381-41db-8d9b-62fa44843180	62559-385	HUMAN PRESCRIPTION DRUG	Veregen		sinecatechins	OINTMENT	TOPICAL	20221110		NDA	NDA021902	ANI Pharmaceuticals, Inc.	SINECATECHINS	150	mg/g			N	20241231
62559-390_2645f15a-e888-4066-9978-ec00a9fa38a4	62559-390	HUMAN PRESCRIPTION DRUG	vancomycin hydrochloride		vancomycin hydrochloride	CAPSULE	ORAL	20151026		NDA AUTHORIZED GENERIC	NDA050606	ANI Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
62559-391_2645f15a-e888-4066-9978-ec00a9fa38a4	62559-391	HUMAN PRESCRIPTION DRUG	vancomycin hydrochloride		vancomycin hydrochloride	CAPSULE	ORAL	20151026		NDA AUTHORIZED GENERIC	NDA050606	ANI Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	250	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
62559-395_3d380b5e-e346-4a47-ac95-faa37c6f2a51	62559-395	HUMAN PRESCRIPTION DRUG	COLESTIPOL HYDROCHLORIDE		COLESTIPOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA216517	ANI Pharmaceuticals, Inc.	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
62559-414_f30023ea-3dd8-4c80-b483-ffdad3600916	62559-414	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET	ORAL	20221107		ANDA	ANDA076342	ANI Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-415_f30023ea-3dd8-4c80-b483-ffdad3600916	62559-415	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET	ORAL	20221107		ANDA	ANDA076342	ANI Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-416_f30023ea-3dd8-4c80-b483-ffdad3600916	62559-416	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET	ORAL	20221107		ANDA	ANDA076342	ANI Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-417_f30023ea-3dd8-4c80-b483-ffdad3600916	62559-417	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET	ORAL	20221107		ANDA	ANDA076342	ANI Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-420_0880aa96-da8e-4143-a7af-803b46f83f5e	62559-420	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	ENEMA	RECTAL	20160513		NDA AUTHORIZED GENERIC	NDA019618	ANI Pharmaceuticals, Inc.	MESALAMINE	4	g/60mL	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
62559-430_d394bf44-0c53-45ca-8f84-752ebe461328	62559-430	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160401		ANDA	ANDA080706	ANI Pharmaceuticals, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62559-431_d394bf44-0c53-45ca-8f84-752ebe461328	62559-431	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160401		ANDA	ANDA080706	ANI Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62559-440_11761c65-093e-46b9-964f-2565fa92444d	62559-440	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20160927		ANDA	ANDA062055	ANI Pharmaceuticals, Inc.	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
62559-460_244b86cb-a567-4b19-bce6-fa6abd95d02d	62559-460	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20160413		NDA AUTHORIZED GENERIC	NDA021612	ANI Pharmaceuticals, Inc.	FENOFIBRATE	50	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62559-461_244b86cb-a567-4b19-bce6-fa6abd95d02d	62559-461	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20160413		NDA AUTHORIZED GENERIC	NDA021612	ANI Pharmaceuticals, Inc.	FENOFIBRATE	150	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
62559-490_a26cdbca-2573-43fe-bf94-dee4115314b3	62559-490	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170707		ANDA	ANDA086727	ANI Pharmaceuticals, Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
62559-510_7e38858b-fb63-42ec-bb6b-f241df610438	62559-510	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA074299	ANI Pharmaceuticals, Inc.	INDAPAMIDE	1.25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62559-511_7e38858b-fb63-42ec-bb6b-f241df610438	62559-511	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA074299	ANI Pharmaceuticals, Inc.	INDAPAMIDE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
62559-520_f1539deb-af35-4498-8e54-0771b679c47b	62559-520	HUMAN PRESCRIPTION DRUG	INDERAL	LA	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170428		NDA	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-521_f1539deb-af35-4498-8e54-0771b679c47b	62559-521	HUMAN PRESCRIPTION DRUG	INDERAL	LA	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170428		NDA	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-522_f1539deb-af35-4498-8e54-0771b679c47b	62559-522	HUMAN PRESCRIPTION DRUG	INDERAL	LA	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170428		NDA	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-523_f1539deb-af35-4498-8e54-0771b679c47b	62559-523	HUMAN PRESCRIPTION DRUG	INDERAL	LA	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170428		NDA	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-530_bd2b823e-3b57-46fa-869a-b648ae4d87d0	62559-530	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride	ER	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171221		NDA AUTHORIZED GENERIC	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-531_bd2b823e-3b57-46fa-869a-b648ae4d87d0	62559-531	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride	ER	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171221		NDA AUTHORIZED GENERIC	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-532_bd2b823e-3b57-46fa-869a-b648ae4d87d0	62559-532	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride	ER	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171221		NDA AUTHORIZED GENERIC	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-533_bd2b823e-3b57-46fa-869a-b648ae4d87d0	62559-533	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride	ER	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171221		NDA AUTHORIZED GENERIC	NDA018553	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-560_b38a0eb8-9ad4-4e83-98d8-0c3a0ce6fb13	62559-560	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20170508		ANDA	ANDA073609	ANI Pharmaceuticals, Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-561_b38a0eb8-9ad4-4e83-98d8-0c3a0ce6fb13	62559-561	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20170508		ANDA	ANDA073609	ANI Pharmaceuticals, Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-590_9cb2a67b-fb8f-47f6-9968-9d85e2620317	62559-590	HUMAN PRESCRIPTION DRUG	InnoPran XL		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180222		NDA	NDA021438	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-591_9cb2a67b-fb8f-47f6-9968-9d85e2620317	62559-591	HUMAN PRESCRIPTION DRUG	InnoPran XL		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180222		NDA	NDA021438	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-600_436ca7b3-819b-47ad-a6c0-6fbbe6740ff1	62559-600	HUMAN PRESCRIPTION DRUG	Inderal XL		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180222		NDA	NDA021438	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-601_436ca7b3-819b-47ad-a6c0-6fbbe6740ff1	62559-601	HUMAN PRESCRIPTION DRUG	Inderal XL		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180222		NDA	NDA021438	ANI Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62559-620_0c7e4211-bd19-4c88-ae5d-4ce6dcce0bd4	62559-620	HUMAN PRESCRIPTION DRUG	Cholestyramine		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20180626	20240531	ANDA	ANDA074554	ANI Pharmaceuticals, Inc.	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	
62559-630_25635db5-a227-445d-850a-a98c5f4772ff	62559-630	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20190325		ANDA	ANDA062055	ANI Pharmaceuticals, Inc.	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
62559-631_25635db5-a227-445d-850a-a98c5f4772ff	62559-631	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20190325		ANDA	ANDA062055	ANI Pharmaceuticals, Inc.	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
62559-640_690e8be9-d5c7-457b-a24e-9f5479d63562	62559-640	HUMAN PRESCRIPTION DRUG	ATACAND		Candesartan Cilexetil	TABLET	ORAL	20181001		NDA	NDA020838	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62559-641_690e8be9-d5c7-457b-a24e-9f5479d63562	62559-641	HUMAN PRESCRIPTION DRUG	ATACAND		Candesartan Cilexetil	TABLET	ORAL	20181001		NDA	NDA020838	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62559-642_690e8be9-d5c7-457b-a24e-9f5479d63562	62559-642	HUMAN PRESCRIPTION DRUG	ATACAND		Candesartan Cilexetil	TABLET	ORAL	20181001		NDA	NDA020838	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62559-643_690e8be9-d5c7-457b-a24e-9f5479d63562	62559-643	HUMAN PRESCRIPTION DRUG	ATACAND		Candesartan Cilexetil	TABLET	ORAL	20181001		NDA	NDA020838	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
62559-650_c6b145e4-1c41-4424-b527-7c4049d6f2bd	62559-650	HUMAN PRESCRIPTION DRUG	ATACAND HCT		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20181001		NDA	NDA021093	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-651_c6b145e4-1c41-4424-b527-7c4049d6f2bd	62559-651	HUMAN PRESCRIPTION DRUG	ATACAND HCT		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20181001		NDA	NDA021093	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-652_c6b145e4-1c41-4424-b527-7c4049d6f2bd	62559-652	HUMAN PRESCRIPTION DRUG	ATACAND HCT		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20181001		NDA	NDA021093	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 25	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-660_33cee64a-369b-4c75-afd4-ea97c006c25b	62559-660	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20180926		NDA AUTHORIZED GENERIC	NDA021093	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-661_33cee64a-369b-4c75-afd4-ea97c006c25b	62559-661	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20180926		NDA AUTHORIZED GENERIC	NDA021093	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-662_33cee64a-369b-4c75-afd4-ea97c006c25b	62559-662	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20180926		NDA AUTHORIZED GENERIC	NDA021093	ANI Pharmaceuticals, Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 25	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
62559-670_3a589722-d899-4dc9-9996-09f2138bb0e1	62559-670	HUMAN PRESCRIPTION DRUG	ARIMIDEX		Anastrozole	TABLET	ORAL	20180626		NDA	NDA020541	ANI Pharmaceuticals, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
62559-680_88aa17b6-89ad-4441-a72f-2fb3ce49de1a	62559-680	HUMAN PRESCRIPTION DRUG	CASODEX		Bicalutamide	TABLET	ORAL	20180626		NDA	NDA020498	ANI Pharmaceuticals, Inc.	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
62559-721_ee722f8c-05d6-43bc-825d-9496579032c4	62559-721	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20181016		NDA AUTHORIZED GENERIC	NDA017849	ANI Pharmaceuticals, Inc.	TERBUTALINE SULFATE	2.5	mg/1			N	20241231
62559-722_ee722f8c-05d6-43bc-825d-9496579032c4	62559-722	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20181016		NDA AUTHORIZED GENERIC	NDA017849	ANI Pharmaceuticals, Inc.	TERBUTALINE SULFATE	5	mg/1			N	20241231
62559-730_40dd3c85-6a78-4845-a5d9-d0f6c292f4ac	62559-730	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20180904		ANDA	ANDA202284	ANI Pharmaceuticals, Inc.	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62559-731_40dd3c85-6a78-4845-a5d9-d0f6c292f4ac	62559-731	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20180904		ANDA	ANDA202284	ANI Pharmaceuticals, Inc.	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62559-740_49785340-74d0-4d0d-99eb-c1f459dd9ca2	62559-740	HUMAN PRESCRIPTION DRUG	Thyroid		Thyroid	TABLET	ORAL	20230615		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	THYROID	15	mg/1			N	20241231
62559-741_49785340-74d0-4d0d-99eb-c1f459dd9ca2	62559-741	HUMAN PRESCRIPTION DRUG	Thyroid		Thyroid	TABLET	ORAL	20230615		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	THYROID	30	mg/1			N	20241231
62559-742_49785340-74d0-4d0d-99eb-c1f459dd9ca2	62559-742	HUMAN PRESCRIPTION DRUG	Thyroid		Thyroid	TABLET	ORAL	20230615		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	THYROID	60	mg/1			N	20241231
62559-743_49785340-74d0-4d0d-99eb-c1f459dd9ca2	62559-743	HUMAN PRESCRIPTION DRUG	Thyroid		Thyroid	TABLET	ORAL	20230615		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	THYROID	90	mg/1			N	20241231
62559-744_49785340-74d0-4d0d-99eb-c1f459dd9ca2	62559-744	HUMAN PRESCRIPTION DRUG	Thyroid		Thyroid	TABLET	ORAL	20230615		UNAPPROVED DRUG OTHER		ANI Pharmaceuticals, Inc.	THYROID	120	mg/1			N	20241231
62559-820_c142344e-c6b9-47b6-90aa-57a0686a40ed	62559-820	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200622		ANDA	ANDA074450	ANI Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-821_c142344e-c6b9-47b6-90aa-57a0686a40ed	62559-821	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200622		ANDA	ANDA074450	ANI Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-822_c142344e-c6b9-47b6-90aa-57a0686a40ed	62559-822	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200622		ANDA	ANDA074450	ANI Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
62559-830_dfd7551d-fc60-4b61-9b84-b26581b47ee9	62559-830	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	POWDER, FOR SOLUTION	ORAL	20190909		ANDA	ANDA061667	ANI Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	250	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
62559-841_fd5fe178-f204-4eeb-b9a0-a3d3eed3dc44	62559-841	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20211227	20241031	ANDA	ANDA084657	ANI Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
62559-842_fd5fe178-f204-4eeb-b9a0-a3d3eed3dc44	62559-842	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20211227	20241031	ANDA	ANDA084657	ANI Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
62559-860_bd6ee278-5424-4ea8-8d6c-bf7207ad16e5	62559-860	HUMAN PRESCRIPTION DRUG	Purified Cortrophin Gel		Repository Corticotropin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20211029		NDA	NDA008975	ANI Pharmaceuticals, Inc.	CORTICOTROPIN	80	[USP'U]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
62559-890_7da87dc4-afb1-410b-a7c1-63983812c859	62559-890	HUMAN PRESCRIPTION DRUG	Bicalutamide		Bicalutamide	TABLET	ORAL	20201026		NDA	NDA020498	ANI Pharmaceuticals, Inc.	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
62559-970_b7c0ae76-9769-488d-a087-1e355eb21b35	62559-970	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20210701		ANDA	ANDA209921	ANI Pharmaceuticals, Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
62559-980_3afb8221-d476-4c1b-949f-080c77e3a2a2	62559-980	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate (Emmolient)		Clobetasol Propionate	CREAM	TOPICAL	20210312	20240331	ANDA	ANDA075733	ANI Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
62559-990_9c703475-8b25-48f2-9cab-9069353c86f6	62559-990	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	ANI Pharmaceuticals, Inc.	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62559-991_9c703475-8b25-48f2-9cab-9069353c86f6	62559-991	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	ANI Pharmaceuticals, Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62559-992_9c703475-8b25-48f2-9cab-9069353c86f6	62559-992	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	ANI Pharmaceuticals, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62559-993_9c703475-8b25-48f2-9cab-9069353c86f6	62559-993	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	ANI Pharmaceuticals, Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
62569-000_ec834f5d-1de2-4c55-a5d1-bf1652a31c13	62569-000	HUMAN OTC DRUG	Genlabs Strike Bac Antibacterial Handsoap		CHLOROXYLENOL	SOAP	TOPICAL	20130829	20240715	UNAPPROVED DRUG OTHER		Genlabs Corporation	CHLOROXYLENOL	2.5	mg/.001L			N	
62569-003_ab0388c9-2682-4b06-9294-019e3490ce89	62569-003	HUMAN OTC DRUG	Strike Bac Antibacterial Handsoap		CHLOROXYLENOL	GEL	TOPICAL	20230208	20240715	UNAPPROVED DRUG OTHER		Genlabs Corporation	CHLOROXYLENOL	2.5	mg/mL			N	
62569-981_30fece0b-74f6-4239-b783-1c04e91dce84	62569-981	HUMAN OTC DRUG	Strike Bac Antibacterial Hand		Benzalkonium Chloride	LIQUID	TOPICAL	20231214		UNAPPROVED DRUG OTHER		Genlabs Corporation	BENZALKONIUM CHLORIDE	.13	kg/100kg			N	20241231
62583-001_eb01be3e-e6ad-7793-e053-2995a90a44f7	62583-001	HUMAN OTC DRUG	BRONCOLIN	Herbal extracts and Honey	Menthol	LOZENGE	ORAL	20140401		OTC MONOGRAPH FINAL	M012	BRONCOLIN, S.A. de C.V.	MENTHOL	7.5	mg/1			N	20241231
62583-002_eb01bb0e-3724-2e73-e053-2a95a90a1634	62583-002	HUMAN OTC DRUG	BRONCOLIN	Honey Eucalyptus	Menthol	LOZENGE	ORAL	20150401		OTC MONOGRAPH FINAL	M012	BRONCOLIN, S.A. de C.V.	MENTHOL	7.5	mg/1			N	20241231
62583-010_eb01a962-ab3a-18ec-e053-2995a90acdeb	62583-010	HUMAN OTC DRUG	BRONCOLIN	Honey Lemon	Menthol	LOZENGE	ORAL	20150401		OTC MONOGRAPH FINAL	M012	BRONCOLIN, S.A. de C.V.	MENTHOL	7.5	mg/1			N	20241231
62584-265_fa43ca4c-d4dc-586c-e053-6394a90adeb2	62584-265	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20100513		ANDA	ANDA077739	American Health Packaging	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62584-266_fa43ca4c-d4dc-586c-e053-6394a90adeb2	62584-266	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20100513		ANDA	ANDA077739	American Health Packaging	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62584-267_fa43ca4c-d4dc-586c-e053-6394a90adeb2	62584-267	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20100618		ANDA	ANDA077739	American Health Packaging	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
62584-693_06439ebd-4d74-c1ab-e063-6394a90a8870	62584-693	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline Hyclate	TABLET, COATED	ORAL	20130301		ANDA	ANDA065095	American Health Packaging	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
62584-733_ea74f8cf-430f-d326-e053-2a95a90a1c60	62584-733	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20080318		ANDA	ANDA086242	American Health Packaging	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
62584-734_ea74f8cf-430f-d326-e053-2a95a90a1c60	62584-734	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20080318		ANDA	ANDA086242	American Health Packaging	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
62584-812_0b92fa4e-ace4-7e15-e063-6294a90ab0e5	62584-812	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE, GELATIN COATED	ORAL	20071217		ANDA	ANDA072253	American Health Packaging	OXAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62584-813_0b92fa4e-ace4-7e15-e063-6294a90ab0e5	62584-813	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE, GELATIN COATED	ORAL	20071217		ANDA	ANDA072253	American Health Packaging	OXAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62584-814_0b92fa4e-ace4-7e15-e063-6294a90ab0e5	62584-814	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE, GELATIN COATED	ORAL	20071217		ANDA	ANDA072253	American Health Packaging	OXAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62584-897_e4a6402b-53e8-f3b6-e053-2a95a90a8016	62584-897	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20090819	20240229	ANDA	ANDA040625	American Health Packaging	FOLIC ACID	1	mg/1			N	
62584-984_0c7a2424-7363-cd10-e063-6394a90a5ce2	62584-984	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20040811		ANDA	ANDA040301	American Health Packaging	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
62584-994_0c7a2424-7363-cd10-e063-6394a90a5ce2	62584-994	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20050601		ANDA	ANDA040301	American Health Packaging	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
62587-219_62609808-7a83-1785-e053-2991aa0aaac3	62587-219	HUMAN OTC DRUG	YSNORE		DIOSCOREA VILLOSA ROOT, GINGER	SPRAY	NASAL	20140102		UNAPPROVED HOMEOPATHIC		Y Snore	DIOSCOREA VILLOSA ROOT; GINGER	2; 2	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62588-904_be1b787a-76af-f7a9-e053-2a95a90a0204	62588-904	HUMAN OTC DRUG	Earth Baby Diaper Rash Cream		Zinc Oxide	CREAM	TOPICAL	20190201	20241231	OTC MONOGRAPH FINAL	part347	Earth Baby, Inc	ZINC OXIDE	40	g/100g			N	
62588-908_a4e08c24-f8e7-dec4-e053-2a95a90a2a28	62588-908	HUMAN OTC DRUG	Hand Sanitizer Gel		Organic Ethyl Alcohol	GEL	TOPICAL	20200201	20240201	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62588-909_be1b9b72-f450-97f3-e053-2995a90ac8ba	62588-909	HUMAN OTC DRUG	Germ Buster Surface Mist		Organic Ethyl Alcohol	SPRAY	TOPICAL	20200201	20240201	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62588-910_be1b9b72-f44e-97f3-e053-2995a90ac8ba	62588-910	HUMAN OTC DRUG	Preface Earth Baby Hand Sanitizer Gel		Organic Ethyl Alcohol	GEL	TOPICAL	20200201	20240201	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62588-911_a3257431-f18a-120c-e053-2995a90a358b	62588-911	HUMAN OTC DRUG	Earth Baby Germ Buster Surface Mist		Organic Ethyl Alcohol	SPRAY	TOPICAL	20200201	20240201	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62588-912_be1b9b72-f44d-97f3-e053-2995a90ac8ba	62588-912	HUMAN OTC DRUG	Earth Baby Hand Sanitizer Gel		Ethyl Alcohol	GEL	TOPICAL	20200201	20240201	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62588-913_be1b9b72-f44f-97f3-e053-2995a90ac8ba	62588-913	HUMAN OTC DRUG	Earth Baby Germ Buster Surface Mist		Ethyl Alcohol	SPRAY	TOPICAL	20200201	20240301	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62588-914_a3480ef9-0770-278b-e053-2995a90a4eb9	62588-914	HUMAN OTC DRUG	Preface Earth Baby Hand Sanitizer Gel		Ethyl Alcohol	GEL	TOPICAL	20200201	20240201	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62588-915_a347f655-e438-867c-e053-2995a90a2cd0	62588-915	HUMAN OTC DRUG	Earth Baby Germ Buster Surface Mist		Ethyl Alcohol	SPRAY	TOPICAL	20200201	20240201	OTC MONOGRAPH NOT FINAL	part333A	Earth Baby, Inc	ALCOHOL	62	mL/100mL			N	
62598-001_09cdd16a-9638-47dd-e063-6294a90af8e4	62598-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140217		UNAPPROVED MEDICAL GAS		Millennium Medical Supply	OXYGEN	99	L/100L			N	20241231
62630-002_33d418fe-a3f7-4504-9942-069ffa304987	62630-002	HUMAN OTC DRUG	Prequimm		Argentum Nitricum, Colchicum Autumnale, Conium Maculatum, Ipecacuanha, Nux Vomica, Pulsatilla (Pratensis), Veratrum Album	TABLET	ORAL	20210824		UNAPPROVED HOMEOPATHIC		ZRG Detox, Inc.	COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; IPECAC; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	4; 4; 4; 6; 6; 5; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62638-001_09cd922d-258b-3903-e063-6394a90ae99a	62638-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170509		UNAPPROVED MEDICAL GAS		Home Medical Equipment Specialists, LLC	OXYGEN	99	L/100L			N	20241231
62654-139_aa07bb62-ef08-99e4-e053-2995a90ae4a8	62654-139	HUMAN OTC DRUG	CSI E3 Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200709		OTC MONOGRAPH NOT FINAL	part333E	Central Solutions Inc	ALCOHOL	70	mL/100mL			N	20241231
62654-140_aa1f8315-5fc6-4a77-b2f4-ac1426d73a1a	62654-140	HUMAN OTC DRUG	DermaCen Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20010101		OTC MONOGRAPH NOT FINAL	part333A	Central Solutions Inc	ALCOHOL	64.5	mL/100mL			N	20241231
62654-141_f355b368-076b-552c-e053-2a95a90a7486	62654-141	HUMAN OTC DRUG	DermaCen Non-Alcohol Foaming Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20100118		OTC MONOGRAPH NOT FINAL	part333A	Central Solutions Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
62654-142_f355b368-075d-552c-e053-2a95a90a7486	62654-142	HUMAN OTC DRUG	BOA VIDA Recovery Creme		DIMETHICONE	CREAM	TOPICAL	20110601		OTC MONOGRAPH FINAL	part347	Central Solutions Inc	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	20241231
62654-143_a1c2faab-f79c-51e1-e053-2a95a90aa9ab	62654-143	HUMAN OTC DRUG	DermaCen Instant Hand Sanitizer with Aloe		Alcohol	LIQUID	TOPICAL	20010101		OTC MONOGRAPH NOT FINAL	part333A	Central Solutions Inc	ALCOHOL	64.5	mL/100mL			N	20241231
62654-144_f355b008-e6ae-ffc0-e053-2a95a90a7e05	62654-144	HUMAN OTC DRUG	BOA VIDA Canopy		DIMETHICONE	CREAM	TOPICAL	20111101		OTC MONOGRAPH FINAL	part347	Central Solutions Inc	DIMETHICONE	2	g/100mL	Skin Barrier Activity [PE]		N	20241231
62654-145_f355a69d-3589-a779-e053-2a95a90a2b94	62654-145	HUMAN OTC DRUG	BOA VIDA Calvida		ZINC OXIDE	CREAM	TOPICAL	20111101		OTC MONOGRAPH FINAL	part347	Central Solutions Inc	ZINC OXIDE	20	g/100mL			N	20241231
62654-146_28c03caf-bcb6-4c9b-bd77-4bdf41ebe7b4	62654-146	HUMAN OTC DRUG	BOA VIDA Cleansing		DIMETHICONE	CREAM	TOPICAL	20111101		OTC MONOGRAPH FINAL	part347	Central Solutions Inc	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	20241231
62654-147_f119a53c-d97d-4a9a-9e31-e4e47283432f	62654-147	HUMAN OTC DRUG	BOA VIDA Antifungal		MICONAZOLE NITRATE	CREAM	TOPICAL	20180910		OTC MONOGRAPH FINAL	part333C	Central Solutions Inc	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
62654-148_f3555124-f1b6-0391-e053-2995a90af216	62654-148	HUMAN OTC DRUG	DermaCen Skin Protectant		Zinc oxide	CREAM	TOPICAL	20191206		OTC MONOGRAPH FINAL	part346	Central Solutions Inc	ZINC OXIDE	50	mg/mL			N	20241231
62654-149_d56b9930-b8b1-ad72-e053-2a95a90af590	62654-149	HUMAN OTC DRUG	DERMACEN FOAMING INSTANT HAND SANITIZER WITH ALOE		alcohol	SOLUTION	TOPICAL	20150301		OTC MONOGRAPH NOT FINAL	part333A	Central Solutions Inc	ALCOHOL	70	mL/100mL			N	20241231
62654-231_b6778c6e-5019-465d-b2f9-0a2685eb6719	62654-231	HUMAN OTC DRUG	DermaCen Antimicrobial-P Hand		CHLOROXYLENOL	LIQUID	TOPICAL	20010101		OTC MONOGRAPH NOT FINAL	part333A	Central Solutions Inc	CHLOROXYLENOL	.95	g/100mL			N	20241231
62654-232_91b4a79d-2cce-4b04-b461-0cd9616a1a37	62654-232	HUMAN OTC DRUG	DermaCen Antimicrobial-B Hand		Benzethonium Chloride	SOLUTION	TOPICAL	20180409		OTC MONOGRAPH NOT FINAL	part333A	Central Solutions Inc	BENZETHONIUM CHLORIDE	.13	g/100mL			N	20241231
62670-6545_48b13ec9-ee79-41c4-bc30-f28e5eb87e64	62670-6545	HUMAN OTC DRUG	Anti-Bacterial Hand	Luminous	ALCOHOL	SPRAY	TOPICAL	20231201	20240601	OTC MONOGRAPH NOT FINAL	part333E	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6546_074d7cec-4970-f8e4-e063-6394a90a9705	62670-6546	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Bright Christmas Morning	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6547_0982f62f-9140-9f50-e063-6394a90a7ef2	62670-6547	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Chasing Fireflies	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6548_09a9e6d3-12b7-26ec-e063-6294a90a6680	62670-6548	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Cozy Cashmere	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6549_09cdae13-2488-43f9-e063-6394a90af7f5	62670-6549	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Cranberry and Apple	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6550_0a0fd993-7beb-42d8-e063-6394a90a4e0e	62670-6550	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Frozen Lake	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6551_0a0fba59-94b0-3786-e063-6394a90af1a6	62670-6551	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Ghoul Friend	Alcohol	GEL	TOPICAL	20230717	20250717	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6552_0a100e76-513b-98d3-e063-6294a90adf47	62670-6552	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Gingerbread Bakery	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6555_0a1e4872-215a-f67b-e063-6294a90a59b7	62670-6555	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Golden Berry Mistletoe	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6557_0a1ef2ae-d2d0-7edf-e063-6394a90a4fd4	62670-6557	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	In The Stars	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6559_0a1f3d5d-13d3-97b3-e063-6394a90aa250	62670-6559	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Luminous	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6560_0a1f531e-55ea-7573-e063-6294a90aaa48	62670-6560	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Moonlit Graveyard	Alcohol	GEL	TOPICAL	20230717	20250717	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6561_0a1f677f-a248-8ef4-e063-6294a90a5f72	62670-6561	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Northern Brights	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6562_0a45f0f2-2a76-d802-e063-6394a90a91a8	62670-6562	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Pure Wonder	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6563_0a45f0f2-2a87-d802-e063-6394a90a91a8	62670-6563	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Rosemary and Mint	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6564_0a45f6b8-2049-cf1a-e063-6394a90aa16d	62670-6564	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Snowy Peach Berry	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6565_0a46135c-17b3-e732-e063-6294a90a0486	62670-6565	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Strawberry Snowflakes	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6566_0a4c1fcc-ab87-88ef-e063-6394a90a40b4	62670-6566	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Twisted Peppermint	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6567_0a4c51c7-08c7-a212-e063-6394a90adb30	62670-6567	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Vampire Blood	Alcohol	GEL	TOPICAL	20230717	20250717	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6568_0a5a4a8d-f950-3ca0-e063-6394a90a222a	62670-6568	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Vanilla Bean Noel	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6569_0a5a9c44-1450-541c-e063-6394a90aa3cd	62670-6569	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Vanilla Icicles	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6570_0a608d08-bcbd-fa31-e063-6394a90a97db	62670-6570	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Whiskey Reserve	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6571_0a609538-0e2e-7515-e063-6294a90afd25	62670-6571	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Winter Candy Apple	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6572_0a96eb15-0236-d297-e063-6394a90a965d	62670-6572	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Frosted Cranberry	Alcohol	GEL	TOPICAL	20230828	20250828	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6573_0a96ff82-df59-91ed-e063-6394a90afed7	62670-6573	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Pumpkin Cupcake	Alcohol	GEL	TOPICAL	20230828	20250828	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6574_0a972eaa-d72e-090b-e063-6294a90a264f	62670-6574	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Leaves	Alcohol	GEL	TOPICAL	20230828	20250828	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6575_0a9c39ca-ffc7-f0ca-e063-6394a90ad1b4	62670-6575	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Mountain Teakwood	Alcohol	GEL	TOPICAL	20230828	20250828	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6576_0a9cf85a-c17e-6890-e063-6394a90a93e9	62670-6576	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Marshmallow Pumpkin Latte	Alcohol	GEL	TOPICAL	20230828	20250828	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6577_0aaafd84-cf70-8a90-e063-6394a90afa45	62670-6577	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Orange and Clove	Alcohol	GEL	TOPICAL	20230925	20250925	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6578_0aab13de-04be-2a14-e063-6294a90aae11	62670-6578	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Mens Collection Woodlands	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6579_0aaaff5b-5c01-a493-e063-6294a90a520e	62670-6579	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Frosted Coconut Snowball	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6580_0aac9fc2-6c9e-6ffd-e063-6294a90a0abf	62670-6580	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Tree Farm	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6581_0aac6fdf-1f16-6cd0-e063-6294a90ad163	62670-6581	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Winterberry Ice	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6582_0aac8435-7553-7c7f-e063-6294a90ab20c	62670-6582	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Fresh Sparkling Snow	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6583_0aac1577-7082-c8dc-e063-6294a90a2e85	62670-6583	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Strawberry Kiwi	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6585_0aabf757-9dc2-0829-e063-6294a90ac036	62670-6585	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Pineapple Mango	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6586_0aabf757-9dbe-0829-e063-6294a90ac036	62670-6586	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Coconut Lime Verbena	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6587_0aabedf4-c0ce-de9a-e063-6394a90ad304	62670-6587	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Wildberry Lemonade	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6588_0aabf9c9-53ad-07ce-e063-6294a90ad417	62670-6588	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Iced Blue Lavender	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6589_0aabed26-1b33-955b-e063-6294a90aa3cf	62670-6589	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Rose Water and Ivy	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6590_0aabb8f4-e5e8-c4db-e063-6294a90a3351	62670-6590	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Yuzu and Ginger	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6591_0aabb8f4-e5df-c4db-e063-6294a90a3351	62670-6591	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Almond Blossom	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6592_0aab8c1b-4a23-9bf3-e063-6294a90a2881	62670-6592	HUMAN OTC DRUG	Anti Bacterial Hand Gel	Sundrenched Linen	Alcohol	GEL	TOPICAL	20231023	20251023	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6594_0a4a0de1-6fe9-bf9a-e063-6394a90a32d9	62670-6594	HUMAN OTC DRUG	AntiBacterialHandSpray	Chasing Fireflies	Alcohol	SPRAY	TOPICAL	20231116	20261116	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6596_0a4adf7a-efaa-99ad-e063-6294a90a4a7a	62670-6596	HUMAN OTC DRUG	AntiBacterialHandSpray	Purrfect Pumpkin	Alcohol	SPRAY	TOPICAL	20231116	20261116	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6597_0a4acfb6-75cc-0632-e063-6394a90af27b	62670-6597	HUMAN OTC DRUG	AntiBacterialHandSpray	Sweater Weather	Alcohol	SPRAY	TOPICAL	20231116	20261116	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6598_0a4a95ed-fd19-edd2-e063-6394a90a59e4	62670-6598	HUMAN OTC DRUG	AntiBacterialHandSpray	Twisted Peppermint	Alcohol	SPRAY	TOPICAL	20231116	20261116	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6599_0aabd11b-5909-6d40-e063-6294a90a386e	62670-6599	HUMAN OTC DRUG	AntiBacterialHandSpray	Vampire Blood	Alcohol	SPRAY	TOPICAL	20231116	20261116	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6600_0a366191-6c38-1435-e063-6294a90ab694	62670-6600	HUMAN OTC DRUG	AntiBacterialHandSpray	Afternoon Apple Picking	Alcohol	SPRAY	TOPICAL	20231115	20261115	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6601_0a4ab6fa-bf4f-fe6e-e063-6394a90aa6fc	62670-6601	HUMAN OTC DRUG	AntiBacterialHandSpray	Warm Vanilla Sugar	Alcohol	SPRAY	TOPICAL	20231116	20261116	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6602_0a4ac6d3-7086-0380-e063-6394a90a792a	62670-6602	HUMAN OTC DRUG	AntiBacterialHandSpray	Winter Candy Apple	Alcohol	SPRAY	TOPICAL	20231116	20261116	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	72	mL/100mL			N	
62670-6603_0a5a9c44-1463-541c-e063-6394a90aa3cd	62670-6603	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Flannel	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6604_0a5af906-f730-72c5-e063-6394a90ac545	62670-6604	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Pumpkin Apple	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6605_0a5b4d49-a55c-a420-e063-6394a90a5488	62670-6605	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Sweater Weather	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62670-6606_0a608d08-bcbf-fa31-e063-6394a90a97db	62670-6606	HUMAN OTC DRUG	Anti-Bacterial Hand Gel	Sweet Cinnamon Pumpkin	Alcohol	GEL	TOPICAL	20230731	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	Bath & Body Works, Inc.	ALCOHOL	71	mL/100mL			N	
62671-001_08b3874c-6657-0112-e063-6294a90a1c83	62671-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Vantage DME Partnership dba Vantage Home Medical Equipment and Services	OXYGEN	99	L/100L			N	20241231
62672-300_17d206d2-a7d5-4605-9626-b4c5ec099c6f	62672-300	HUMAN OTC DRUG	Osceola Supply Inc 6176		CHLOROXYLENOL	SOAP	TOPICAL	20160722		OTC MONOGRAPH NOT FINAL	part333E	OSCEOLA SUPPLY, INC.	CHLOROXYLENOL	6	mg/mL			N	20241231
62672-608_1b6b495a-980e-4a63-889a-3b177b925fee	62672-608	HUMAN OTC DRUG	Sani		ALCOHOL	GEL	TOPICAL	20030701		OTC MONOGRAPH NOT FINAL	part333E	Osceola Supply, Inc.	ALCOHOL	.7	mL/mL			N	20241231
62673-058_0cf45cd7-2e99-ca60-e063-6294a90a8704	62673-058	HUMAN OTC DRUG	Denorex Extra Strength		Salicylic Acid	SHAMPOO	TOPICAL	20091101		OTC MONOGRAPH DRUG	M032	Neoteric Cosmetics, Inc.	SALICYLIC ACID	.03	g/mL			N	20241231
62673-174_0cf451d0-472e-b28e-e063-6394a90ae1c1	62673-174	HUMAN OTC DRUG	Denorex Therapeutic		Coal Tar and Menthol	SHAMPOO	TOPICAL	20171213		OTC MONOGRAPH DRUG	M032	Neoteric Cosmetics, Inc.	COAL TAR; MENTHOL	.018; .015	g/mL; g/mL			N	20241231
62685-230_f183f9bf-5589-4a99-e053-2995a90a0878	62685-230	HUMAN OTC DRUG	Orbitol Fluoride Toothpaste with Baking Soda		sodium monofluorophosphate	PASTE	DENTAL	20210927		OTC MONOGRAPH FINAL	part355	tropical degil cosmetics industries ltd	SODIUM MONOFLUOROPHOSPHATE	1.1	g/100g			N	20241231
62685-232_f183f46a-c11e-f474-e053-2995a90a2256	62685-232	HUMAN OTC DRUG	Orbitol Fluoride Whitening Toothpaste		sodium monofluorophosphate	PASTE	DENTAL	20210927		OTC MONOGRAPH FINAL	part355	tropical degil cosmetics industries ltd	SODIUM MONOFLUOROPHOSPHATE	.8	g/100g			N	20241231
62685-233_f183ec44-2f32-8c9d-e053-2995a90aa73e	62685-233	HUMAN OTC DRUG	Orbitol Alpine Fresh Fluoride Whitening Toothpaste		sodium monofluorophosphate	PASTE	DENTAL	20210927		OTC MONOGRAPH FINAL	part355	tropical degil cosmetics industries ltd	SODIUM MONOFLUOROPHOSPHATE	.8	g/100g			N	20241231
62686-001_f278153f-2aca-6e78-e053-2a95a90a9b60	62686-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		McAbee Medical Inc.	OXYGEN	99	L/100L			N	20241231
62712-221_e0c76648-ee60-4b0f-a39f-0fd472b993c1	62712-221	HUMAN OTC DRUG	Free Hand		ALCOHOL	GEL	TOPICAL	20091001		OTC MONOGRAPH NOT FINAL	part333E	Atco International	ALCOHOL	.7	mL/mL			N	20241231
62712-457_add37490-5aff-463e-b518-2744f241e942	62712-457	HUMAN OTC DRUG	Clean Hands Instant Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20191004		OTC MONOGRAPH NOT FINAL	part333E	Atco International	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62712-665_126a486a-7307-46dc-914c-fde72d27897c	62712-665	HUMAN OTC DRUG	PRO SAN		ALCOHOL	LIQUID	TOPICAL	20200414		OTC MONOGRAPH NOT FINAL	part333E	Atco International	ALCOHOL	.7	mL/mL			N	20241231
62712-783_797284db-4179-42c0-8c5b-2266cd516d30	62712-783	HUMAN OTC DRUG	Quick San ll Hand Sanitizer Wipes		ALCOHOL	CLOTH	TOPICAL	20171218		OTC MONOGRAPH NOT FINAL	part333E	Atco International	ALCOHOL	620	mg/g			N	20241231
62713-801_eeb4dc05-f922-1cff-e053-2a95a90a1294	62713-801	HUMAN OTC DRUG	Allergena	Zone 1	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 1 Tree, Zone 1 Weed, Zone 1 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA VULGARIS POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS TOP; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; HOLCUS LANATUS POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; QUERCUS ALBA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-802_9d4cb5a8-4db6-08de-e053-2a95a90a9b89	62713-802	HUMAN OTC DRUG	Allergena	Zone 2	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 2 Tree, Zone 2 Weed, Zone 2 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA VULGARIS POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA OCCIDENTALIS POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS PENNSYLVANICA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM PERENNE POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASPALUM NOTATUM POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SORGHUM HALEPENSE POLLEN; TAXODIUM DISTICHUM POLLEN; ULMUS AMERICANA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE]		N	20241231
62713-803_9d639281-3778-0477-e053-2a95a90a75c7	62713-803	HUMAN OTC DRUG	Allergena	Zone 3	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 3 Tree, Zone 3 Weed, Zone 3 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA OCCIDENTALIS POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; CARYA ALBA POLLEN; CARYA ILLINOINENSIS POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-806_9d63a313-c941-daab-e053-2a95a90ac825	62713-806	HUMAN OTC DRUG	Allergena Trees, Weeds and Grasses - Zone 6		Allergena Trees, Weeds and Grasses - Zone 6	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA DRACUNCULUS POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CONFERTIFOLIA POLLEN; ATRIPLEX POLYCARPA POLLEN; ATRIPLEX WRIGHTII POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BROMUS INERMIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA ANGUSTIFOLIA; ELYMUS REPENS POLLEN; FENUGREEK SEED; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; JUNIPERUS OCCIDENTALIS POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; OLEA EUROPAEA POLLEN; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS NIGRA POLLEN; PINUS STROBUS POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; RORIPPA NASTURTIUM-AQUATICUM; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-807_9d6388f3-6416-d950-e053-2a95a90ac7fa	62713-807	HUMAN OTC DRUG	Allergena	Zone 7	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 7 Tree, Zone 7 Weed, Zone 7 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ATRIPLEX CANESCENS POLLEN; ATRIPLEX CONFERTIFOLIA POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA NIGRA POLLEN; BROMUS INERMIS POLLEN; CARYA ALBA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; GOLDENSEAL; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; QUERCUS VIRGINIANA POLLEN; RUMEX ACETOSELLA POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-808_9d63a3ec-3d7c-6a48-e053-2995a90ad657	62713-808	HUMAN OTC DRUG	Allergena	Zone 8	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 8 Tree, Zone 8 Weed, Zone 8 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS RUBRA POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; ATRIPLEX CONFERTIFOLIA POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA NIGRA POLLEN; BROMUS INERMIS POLLEN; CARYA ALBA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS REGIA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; PSEUDOTSUGA MENZIESII POLLEN; RUMEX ACETOSELLA POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SARCOBATUS VERMICULATUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-809_9d63603b-b87d-058b-e053-2a95a90a3139	62713-809	HUMAN OTC DRUG	Allergena	Zone 9	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 9 Tree, Zone 9 Weed, Zone 9 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; ATRIPLEX CANESCENS POLLEN; BAPTISIA TINCTORIA ROOT; BROMUS INERMIS POLLEN; BROMUS SECALINUS POLLEN; CHENOPODIUM ALBUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; JUGLANS NIGRA POLLEN; JUNIPERUS SCOPULORUM POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MYRRH; NASTURTIUM OFFICINALE; OLEA EUROPAEA POLLEN; PHLEUM PRATENSE POLLEN; PHOENIX DACTYLIFERA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS AGRIFOLIA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SORGHUM HALEPENSE POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE]		N	20241231
62713-810_9d6388f3-640a-d950-e053-2a95a90ac7fa	62713-810	HUMAN OTC DRUG	Allergena	Hawaii, Puerto Rico and the Virgin Islands	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Tropical Tree, Tropical Weed, Tropical Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; ALNUS RUBRA POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA VULGARIS POLLEN; BAPTISIA TINCTORIA ROOT; BROUSSONETIA PAPYRIFERA POLLEN; CHENOPODIUM ALBUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS POLLEN; FENUGREEK LEAF; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; JUGLANS NIGRA POLLEN; LIGUSTRUM VULGARE POLLEN; LOLIUM PERENNE POLLEN; MORELLA CERIFERA POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASPALUM NOTATUM POLLEN; PHOENIX DACTYLIFERA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; POA PRATENSIS POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SORGHUM HALEPENSE POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 3; 30; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC]		N	20241231
62713-811_9d63603b-b873-058b-e053-2a95a90a3139	62713-811	HUMAN OTC DRUG	Allergena	Mold Mix	Echinacea, Baptisia Tinctoria, Hydrastis Canadensis, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Trigonella Foenum-Graecum, Acremonium, Alternaria Tenuis, Aspergillus Mixture, Aureobasidium, Botrytis Cinerea, Chaetomium Globosum, Cladosporium Cladosporioides, Curvularia, Drechslera, Epicoccum Nigrum, Fusarium, Mucor, Neurospora, Nigrospora, Penicillium Mixture, Phoma Herbarum, Rhizopus, Rhodotorula Rubra, Stemphylium, Torula Cerevisiae, Trichoderma Lignorum, Trichophyton Mentagrophytes	LIQUID	ORAL	19990101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACREMONIUM STRICTUM; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BAPTISIA TINCTORIA ROOT; BOTRYTIS CINEREA; CHAETOMIUM GLOBOSUM; CLADOSPORIUM CLADOSPORIOIDES; COCHLIOBOLUS SPICIFER; ECHINACEA, UNSPECIFIED; EPICOCCUM NIGRUM; FENUGREEK LEAF; GOLDENSEAL; HAEMATONECTRIA HAEMATOCOCCA; KHUSKIA ORYZAE; MUCOR PLUMBEUS; MYRRH; NASTURTIUM OFFICINALE; NEUROSPORA SITOPHILA; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PHOMA EXIGUA VAR. EXIGUA; PHYTOLACCA AMERICANA ROOT; RHIZOPUS STOLONIFER; RHODOTORULA RUBRA; STEMPHYLIUM SARCINIFORME; TRICHODERMA VIRIDE; TRICHOPHYTON MENTAGROPHYTES	30; 30; 30; 30; 3; 30; 30; 30; 30; 3; 30; 3; 3; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
62713-814_ed8b7e4d-a427-6ac0-e053-2a95a90a4235	62713-814	HUMAN OTC DRUG	Allergena Fragrance		Allergena Fragrance	LIQUID	ORAL	20120901		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACTIVATED CHARCOAL; ARNICA MONTANA; CICUTA VIROSA ROOT; EUPHORBIA RESINIFERA RESIN; GOLDENSEAL; KEROSENE; LEAD; LYCOPERDON UTRIFORME FRUITING BODY; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SULFUR	8; 6; 6; 6; 4; 6; 8; 6; 8; 8; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
62713-820_b5829a37-5f13-67a6-e053-2a95a90af571	62713-820	HUMAN OTC DRUG	Allergena	Zone 2 Kids	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 2 Tree, Zone 2 Weed, Zone 2 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA VULGARIS POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA OCCIDENTALIS POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS PENNSYLVANICA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM PERENNE POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASPALUM NOTATUM POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SORGHUM HALEPENSE POLLEN; TAXODIUM DISTICHUM POLLEN; ULMUS AMERICANA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE]		N	20241231
62713-821_b5e5954f-1df3-2b58-e053-2995a90a627c	62713-821	HUMAN OTC DRUG	Allergena	Zone 3	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 3 Tree, Zone 3 Weed, Zone 3 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA OCCIDENTALIS POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; CARYA ALBA POLLEN; CARYA ILLINOINENSIS POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-822_b5839254-fc55-69f2-e053-2995a90a70ee	62713-822	HUMAN OTC DRUG	Allergena	Zone 7 Kids	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 7 Tree, Zone 7 Weed, Zone 7 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ATRIPLEX CANESCENS POLLEN; ATRIPLEX CONFERTIFOLIA POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA NIGRA POLLEN; BROMUS INERMIS POLLEN; CARYA ALBA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; GOLDENSEAL; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; QUERCUS VIRGINIANA POLLEN; RUMEX ACETOSELLA POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-823_b5e5ce93-b687-4851-e053-2a95a90adb86	62713-823	HUMAN OTC DRUG	Allergena	Zone 8	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 8 Tree, Zone 8 Weed, Zone 8 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS RUBRA POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; ATRIPLEX CONFERTIFOLIA POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA NIGRA POLLEN; BROMUS INERMIS POLLEN; CARYA ALBA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS REGIA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS SCOPULORUM POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; PSEUDOTSUGA MENZIESII POLLEN; RUMEX ACETOSELLA POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SARCOBATUS VERMICULATUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-824_b5e5f1a8-9623-2a1e-e053-2995a90a3003	62713-824	HUMAN OTC DRUG	Allergena	Zone 9	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 9 Tree, Zone 9 Weed, Zone 9 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; ATRIPLEX CANESCENS POLLEN; BAPTISIA TINCTORIA ROOT; BROMUS INERMIS POLLEN; BROMUS SECALINUS POLLEN; CHENOPODIUM ALBUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; JUGLANS NIGRA POLLEN; JUNIPERUS SCOPULORUM POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MYRRH; NASTURTIUM OFFICINALE; OLEA EUROPAEA POLLEN; PHLEUM PRATENSE POLLEN; PHOENIX DACTYLIFERA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS AGRIFOLIA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SORGHUM HALEPENSE POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE]		N	20241231
62713-914_9d639281-376b-0477-e053-2a95a90a75c7	62713-914	HUMAN OTC DRUG	Progena	Pancreas Plus	Acidum Phosphoricum, Berberis Vulgaris, Bilberry, Cheidonium Majus, Creosotum, Kidney, Natrum sulpuricum, Pancreas, Syzygium Jambolanum	LIQUID	ORAL	19850101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	BERBERIS VULGARIS ROOT BARK; BILBERRY; CHELIDONIUM MAJUS; PHOSPHORIC ACID; PORK KIDNEY; SODIUM SULFATE; SUS SCROFA PANCREAS; SYZYGIUM CUMINI SEED; WOOD CREOSOTE	2; 2; 4; 4; 6; 6; 6; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
62713-915_9d6388f3-6400-d950-e053-2a95a90ac7fa	62713-915	HUMAN OTC DRUG	Progena	Thyro Plus	Calcarea Iodata, Fucus Vesiculosus, Glandula Suprarenalis, Kali Iodatum, Pituitary, Spleen, Spongia Tosta, Thymus, Thyroidinum, Calcarea Carbonica, Ferrum Iodatum, Hepar Sulphuris Calcareum, Lapis Albus	LIQUID	ORAL	19850101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	CALCIUM HEXAFLUOROSILICATE; CALCIUM IODIDE; CALCIUM SULFIDE; FERROUS IODIDE; FUCUS VESICULOSUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM IODIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; THYROID, UNSPECIFIED	8; 4; 8; 8; 6; 8; 6; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62713-920_b5e45632-046e-02ed-e053-2a95a90aead3	62713-920	HUMAN OTC DRUG	Allergena Trees, Weeds and Grasses - Zone 6 Kids		Allergena Trees, Weeds and Grasses - Zone 6 Kids	LIQUID	ORAL	20111001		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA DRACUNCULUS POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA LUDOVICIANA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CONFERTIFOLIA POLLEN; ATRIPLEX POLYCARPA POLLEN; ATRIPLEX WRIGHTII POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BROMUS INERMIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA ANGUSTIFOLIA; ELYMUS REPENS POLLEN; FENUGREEK SEED; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; JUNIPERUS OCCIDENTALIS POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; OLEA EUROPAEA POLLEN; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS NIGRA POLLEN; PINUS STROBUS POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; RORIPPA NASTURTIUM-AQUATICUM; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-940_9d639dda-590c-707e-e053-2995a90a4dd6	62713-940	HUMAN OTC DRUG	Progena	Immugen	Aralia Quinquefolia, Echinacea, Phytolacca Decandra, Ascorbic Acid, Beta Carotene, Glandula Suprarenalis, Pyridoxinum Hydrochloricum, Spleen, Thymus, Selenium Metallicum, Vitamin E, Zincum Metallicum	LIQUID	ORAL	19850101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	.ALPHA.-TOCOPHEROL; .BETA.-CAROTENE; AMERICAN GINSENG; ASCORBIC ACID; ECHINACEA, UNSPECIFIED; PHYTOLACCA AMERICANA ROOT; PYRIDOXINE HYDROCHLORIDE; SELENIUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; ZINC	8; 6; 3; 6; 3; 3; 6; 8; 6; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
62713-950_b583d389-75cb-12f6-e053-2995a90ae860	62713-950	HUMAN OTC DRUG	Allergena	Texas Cedar Fever Kids	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Texas Tree, Texas Weed, Texas Grass	LIQUID	ORAL	20110101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-951_9ddb713d-1c1a-0c39-e053-2995a90a8f1b	62713-951	HUMAN OTC DRUG	Allergena	Texas Cedar Fever	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Texas Tree, Texas Weed, Texas Grass	LIQUID	ORAL	20200201		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-952_b5a760a9-9d5f-93e7-e053-2a95a90a739a	62713-952	HUMAN OTC DRUG	Allergena	Texas Trees Kids	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Texas Tree, Texas Weed, Texas Grass	LIQUID	ORAL	20110101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-953_b5843749-ded7-5374-e053-2a95a90af5ea	62713-953	HUMAN OTC DRUG	Allergena	Texas Trees	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Texas Tree, Texas Weed, Texas Grass	LIQUID	ORAL	20100101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-954_b5830ef2-33c4-4963-e053-2995a90af138	62713-954	HUMAN OTC DRUG	Allergena	Zone 5 Kids	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 5 Tree, Zone 5 Weed, Zone 5 Grass	LIQUID	ORAL	20110101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-955_b5844be2-94df-3e3f-e053-2995a90a6eb8	62713-955	HUMAN OTC DRUG	Allergena	Zone 5	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 5 Tree, Zone 5 Weed, Zone 5 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-956_bdd83445-beea-c3e4-e053-2a95a90a9cd9	62713-956	HUMAN OTC DRUG	Allergena	Texas Cedar Fever Tabs	Allergy Relief	TABLET, ORALLY DISINTEGRATING	ORAL	20210315		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; ALNUS RUBRA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA VULGARIS POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CUPRESSUS ARIZONICA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS PINCHOTII POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM PERENNE POLLEN; MORELLA CERIFERA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASPALUM NOTATUM POLLEN; PHOENIX DACTYLIFERA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS TREMULOIDES POLLEN; PSEUDOTSUGA MENZIESII POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; ROBINIA PSEUDOACACIA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SORGHUM HALEPENSE POLLEN; TAXODIUM DISTICHUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; ULMUS RUBRA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-958_beecba90-dd0a-c129-e053-2a95a90ac582	62713-958	HUMAN OTC DRUG	Allergena	Zone 4	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 4 Tree, Zone 4 Weed, Zone 4 Grass	LIQUID	ORAL	20210315		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-959_bf03178c-9dff-c562-e053-2a95a90a2b5e	62713-959	HUMAN OTC DRUG	Allergena	Zone 4 Kids	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 4 Tree, Zone 4 Weed, Zone 4 Grass	LIQUID	ORAL	20210315		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-960_b5e5661b-8a25-4d76-e053-2a95a90aa068	62713-960	HUMAN OTC DRUG	Allergena	Zone 1	Echinacea, Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Zone 1 Tree, Zone 1 Weed, Zone 1 Grass	LIQUID	ORAL	19870101		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACER NEGUNDO POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; ARTEMISIA ABSINTHIUM POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA VULGARIS POLLEN; AVENA SATIVA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA NIGRA POLLEN; BETULA POPULIFOLIA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS TOP; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; HOLCUS LANATUS POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS ALBA POLLEN; POPULUS NIGRA POLLEN; POPULUS TREMULOIDES POLLEN; QUERCUS ALBA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM VAR. CANADENSE POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-961_b6c13079-0ed7-0d79-e053-2a95a90a8d7c	62713-961	HUMAN OTC DRUG	Allergena	Seasonal Allergy Tabs	Allergy Relief	TABLET, ORALLY DISINTEGRATING	ORAL	20200511		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; AGROSTIS GIGANTEA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; ALNUS RUBRA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN; ARTEMISIA VULGARIS POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA LACINIOSA POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CUPRESSUS ARIZONICA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; EUCALYPTUS GLOBULUS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS PINCHOTII POLLEN; JUNIPERUS VIRGINIANA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM PERENNE POLLEN; MORELLA CERIFERA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASPALUM NOTATUM POLLEN; PHOENIX DACTYLIFERA POLLEN; PHYTOLACCA AMERICANA ROOT; PINUS STROBUS POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA PRATENSIS POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS TREMULOIDES POLLEN; PSEUDOTSUGA MENZIESII POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; ROBINIA PSEUDOACACIA POLLEN; RUMEX CRISPUS POLLEN; SALIX NIGRA POLLEN; SORGHUM HALEPENSE POLLEN; TAXODIUM DISTICHUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; ULMUS RUBRA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
62713-962_b5850718-73b8-4ce6-e053-2a95a90a6d3c	62713-962	HUMAN OTC DRUG	Allergena	Dust Plus Mite	Echinacea, Baptisia Tinctoria, Hydrastis Canadensis, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Trigonella Foenum-Graecum, Blatta Orientalis (Oriental Cockroach) HPUS, Dust Mite (D.Pteronyssinus, D. Farinae), Grain Dust (Barley, Corn, Millet, Oat, Rice, Wheat), House Dust (Mattress, Rug, Upholstery), Periplaneta Americana, Stannum Metallicum	LIQUID	ORAL	20181218		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	BAPTISIA TINCTORIA ROOT; BLATTA ORIENTALIS; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; ECHINACEA, UNSPECIFIED; FENUGREEK LEAF; GOLDENSEAL; HOUSE DUST; MYRRH; NASTURTIUM OFFICINALE; PERIPLANETA AMERICANA; PHYTOLACCA AMERICANA ROOT; TIN	3; 30; 30; 30; 3; 3; 3; 30; 3; 3; 30; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
62713-966_ccfb1fe8-e176-224f-e053-2a95a90a3340	62713-966	HUMAN OTC DRUG	Progena	Tick Bite Support	Avena sativa, Carduus marianus, Scrophularia nodosa, Solidago virgaurea, Arsenicum album, Cina, Conium maculatum, Gelsemium sempervirens, Lycopodium clavatum, Mercuris vivus, Phosphoricum acidum, Phosphorus, Selenium metallicum	LIQUID	ORAL	20211015		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ARSENIC TRIOXIDE; ARTEMISIA CINA PRE-FLOWERING TOP; AVENA SATIVA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; MERCURY; PHOSPHORIC ACID; PHOSPHORUS; SCROPHULARIA NODOSA; SELENIUM; SILYBUM MARIANUM SEED; SOLIDAGO VIRGAUREA FLOWERING TOP	30; 30; 3; 30; 30; 30; 30; 30; 30; 8; 30; 3; 3	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
62713-968_a1104f21-1a1c-7ac0-e053-2995a90ae36d	62713-968	HUMAN OTC DRUG	Allergena	Texas Cedar Fever	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Texas Tree, Texas Weed, Texas Grass	LIQUID	ORAL	20200309		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62713-969_a1116da3-b926-9a1b-e053-2995a90a108c	62713-969	HUMAN OTC DRUG	Allergena	Texas Cedar Fever	Echinacea,Baptisia tinctoria, Hydrastis canadensis, Myrrha, Nasturtium aquaticum, Phytolacca decandra, Trigonella foenum-graecum, Texas Tree, Texas Weed, Texas Grass	LIQUID	ORAL	20200309		UNAPPROVED HOMEOPATHIC		Meditrend, Inc. DBA Progena Professional Formulations	ACACIA POLLEN; ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARINUM POLLEN; AGROSTIS GIGANTEA POLLEN; AILANTHUS ALTISSIMA POLLEN; ALNUS INCANA SUBSP. RUGOSA POLLEN; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMARANTHUS SPINOSUS POLLEN; AMARANTHUS TUBERCULATUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; AMPHIACHYRIS DRACUNCULOIDES POLLEN; ARRHENATHERUM ELATIUS POLLEN; ARTEMISIA ANNUA POLLEN; ARTEMISIA FRIGIDA POLLEN; ARTEMISIA TRIDENTATA POLLEN; ARTEMISIA VULGARIS POLLEN; ATRIPLEX CANESCENS POLLEN; AVENA SATIVA POLLEN; BACCHARIS HALIMIFOLIA POLLEN; BAPTISIA TINCTORIA ROOT; BASSIA SCOPARIA POLLEN; BETULA LENTA POLLEN; BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BROMUS INERMIS POLLEN; BROUSSONETIA PAPYRIFERA POLLEN; CARYA ALBA POLLEN; CARYA CORDIFORMIS POLLEN; CARYA GLABRA POLLEN; CARYA ILLINOINENSIS POLLEN; CARYA OVATA POLLEN; CELTIS OCCIDENTALIS POLLEN; CHENOPODIUM ALBUM POLLEN; CHENOPODIUM AMBROSIOIDES POLLEN; CUPRESSUS ARIZONICA POLLEN; CYCLACHAENA XANTHIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; ECHINACEA, UNSPECIFIED; ELYMUS REPENS POLLEN; FAGUS GRANDIFOLIA POLLEN; FENUGREEK LEAF; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; FRAXINUS PENNSYLVANICA POLLEN; FRAXINUS VELUTINA POLLEN; GOLDENSEAL; IVA ANGUSTIFOLIA POLLEN; IVA ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; JUNIPERUS VIRGINIANA POLLEN; KOELERIA MACRANTHA POLLEN; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; LOLIUM MULTIFLORUM POLLEN; LOLIUM PERENNE POLLEN; MORUS ALBA POLLEN; MORUS RUBRA POLLEN; MYRRH; NASTURTIUM OFFICINALE; PASCOPYRUM SMITHII POLLEN; PHALARIS ARUNDINACEA POLLEN; PHLEUM PRATENSE POLLEN; PHYTOLACCA AMERICANA ROOT; PICEA PUNGENS POLLEN; PINUS NIGRA POLLEN; PINUS SYLVESTRIS POLLEN; PINUS TAEDA POLLEN; PLANTAGO LANCEOLATA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POA ANNUA POLLEN; POPULUS ALBA POLLEN; POPULUS DELTOIDES POLLEN; POPULUS DELTOIDES SUBSP. MONILIFERA POLLEN; POPULUS NIGRA POLLEN; PROSOPIS JULIFLORA POLLEN; QUERCUS ALBA POLLEN; QUERCUS MACROCARPA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS STELLATA POLLEN; QUERCUS VELUTINA POLLEN; RUMEX CRISPUS POLLEN; RUMEX OBTUSIFOLIUS POLLEN; SALIX NIGRA POLLEN; SALSOLA TRAGUS POLLEN; SOLIDAGO CANADENSIS POLLEN; SORGHUM BICOLOR POLLEN; SORGHUM HALEPENSE POLLEN; SORGHUM X DRUMMONDII POLLEN; TAXODIUM DISTICHUM POLLEN; TRITICUM AESTIVUM POLLEN; ULMUS AMERICANA POLLEN; ULMUS CRASSIFOLIA POLLEN; ULMUS PUMILA POLLEN; URTICA DIOICA POLLEN; XANTHIUM STRUMARIUM POLLEN; ZEA MAYS POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 30; 30; 3; 30; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 3; 3; 30; 30; 30; 3; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE]		N	20241231
62721-0470_faccd5d4-0723-f196-e053-6394a90ab701	62721-0470	HUMAN OTC DRUG	Lornamead	Natural White	Fluoride	PASTE, DENTIFRICE	DENTAL	20121201		OTC MONOGRAPH NOT FINAL	part356	Lornamead	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
62721-0473_dc25fed4-0e0d-10c2-e053-2a95a90ae726	62721-0473	HUMAN OTC DRUG	Natural White	Radiant White	Fluoride	PASTE, DENTIFRICE	DENTAL	20130101		OTC MONOGRAPH FINAL	part355	Lornamead	SODIUM FLUORIDE	.243	g/100g			N	20241231
62721-0474_f2f23228-fc33-2678-e053-2995a90a599d	62721-0474	HUMAN OTC DRUG	Natural White		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20220408		OTC MONOGRAPH NOT FINAL	part356	Lornamead	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
62741-0123_06d26cff-5239-f5c0-e063-6294a90a57f5	62741-0123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20090915		UNAPPROVED MEDICAL GAS		B&K Prescription Shop	OXYGEN	99	L/100L			N	20241231
62742-4065_b4fb84f2-76ba-3268-e053-2995a90ad551	62742-4065	HUMAN OTC DRUG	DermaClear BHA Cleanser		Salicylic Acid	LOTION	TOPICAL	20140502		OTC MONOGRAPH FINAL	part333D	Allure Labs Inc	SALICYLIC ACID	2	mg/mL			N	20241231
62742-4068_b615c468-f204-8b5c-e053-2a95a90a68c3	62742-4068	HUMAN OTC DRUG	Youth Protection SPF 30		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20151015		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	20; 186	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4069_b4fcd763-05cc-155a-e053-2a95a90ab2f5	62742-4069	HUMAN OTC DRUG	DermaClear Serum		Salicylic Acid	CREAM	TOPICAL	20140530		OTC MONOGRAPH FINAL	part333D	Allure Labs Inc	SALICYLIC ACID	20	mg/mL			N	20241231
62742-4074_b55f1da9-6077-5dad-e053-2a95a90a4be5	62742-4074	HUMAN OTC DRUG	Dermaclear Mask		Salicylic Acid	CREAM	TOPICAL	20150504		OTC MONOGRAPH FINAL	part333D	Allure Labs Inc,	SALICYLIC ACID	20	mg/g			N	20241231
62742-4075_b5869b7a-06de-16ea-e053-2995a90a05e7	62742-4075	HUMAN OTC DRUG	Dermaclear Spot Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20150505		OTC MONOGRAPH FINAL	part333D	Allure Labs Inc	BENZOYL PEROXIDE	100	mg/g			N	20241231
62742-4076_b55e159b-70d3-5f1e-e053-2a95a90afc5a	62742-4076	HUMAN OTC DRUG	DermaClear Pads		Salicylic Acid	LIQUID	TOPICAL	20150508		OTC MONOGRAPH FINAL	part333D	Allure Labs	SALICYLIC ACID	20	mg/g			N	20241231
62742-4077_b59a1b15-6485-5a52-e053-2a95a90a9614	62742-4077	HUMAN OTC DRUG	Post Treatment Balm		Hydrocortisone	CREAM	TOPICAL	20150512		OTC MONOGRAPH NOT FINAL	part348	Allure Labs Inc.	HYDROCORTISONE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62742-4078_b5ae4ab8-140c-7cf9-e053-2a95a90af4ec	62742-4078	HUMAN OTC DRUG	Solar Moisturizer SPF 30		Octinoxate, Oxybenzone, Octisalate, Avobenzone, Octocrylene	CREAM	TOPICAL	20191015		OTC MONOGRAPH FINAL	part352	Allure Labs Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 7.5; 5; 1.5; 6	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
62742-4091_24e37071-c31b-49b4-90be-9d40ba08f93a	62742-4091	HUMAN OTC DRUG	Pain Relief Cream		Trolamine Salicylate	CREAM	TOPICAL	20171127		OTC MONOGRAPH NOT FINAL	part348	ALLURE LABS INC.	TROLAMINE SALICYLATE	100	mg/g			N	20241231
62742-4094_390b4010-fd94-43d8-9f2b-a18504ac04da	62742-4094	HUMAN OTC DRUG	SheerZinc SPF 30 Tinted - SunKissed		Zinc Oxide	CREAM	TOPICAL	20171128		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	186	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4095_9da60d9f-0e6d-4749-ae54-d157c61038ee	62742-4095	HUMAN OTC DRUG	SheerZinc SPF 30 Tinted - Tan		Zinc Oxide	CREAM	TOPICAL	20171128		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	186	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4107_90190c04-8a2c-40ab-be29-1ff26c488935	62742-4107	HUMAN OTC DRUG	Acne Cleanser W/ Salicylic Acid		Salicylic Acid	CREAM	TOPICAL	20171201		OTC MONOGRAPH FINAL	part333D	Allure Labs, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
62742-4108_d41fde52-3d9e-472f-a726-47902ad7c537	62742-4108	HUMAN OTC DRUG	SheerZinc SPF 30 Tinted - Nude		Zinc Oxide	CREAM	TOPICAL	20171128		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	186	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4109_b86ffc05-9c22-30fe-e053-2a95a90a6100	62742-4109	HUMAN OTC DRUG	Clear Clear Zinc Solar Protection SPF 30		Zinc Oxide	CREAM	TOPICAL	20171204		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	ZINC OXIDE	170	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4110_c67cae15-f7cf-4b02-89f1-1d2446dd1573	62742-4110	HUMAN OTC DRUG	Light Tint Clear Zinc Solar Protection SPF 30		Zinc Oxide	CREAM	TOPICAL	20171204		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	ZINC OXIDE	170	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4112_c16655f8-97fb-4694-83d3-03aef3737a43	62742-4112	HUMAN OTC DRUG	Tinted Clear Zinc Solar Protection SPF 30		Zinc Oxide	CREAM	TOPICAL	20171204		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	ZINC OXIDE	176.7	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4114_b72caf9b-46e0-f30c-e053-2995a90a9b6d	62742-4114	HUMAN OTC DRUG	Kids Broad Spectrum SPF 35		Zinc Oxide	CREAM	TOPICAL	20171204		OTC MONOGRAPH FINAL	part352	Allure Labs Inc.	ZINC OXIDE	189	mg/g			N	20241231
62742-4115_b86e82bf-7c85-6fbe-e053-2995a90ae1a3	62742-4115	HUMAN OTC DRUG	Broad Spectrum SPF 35 ECO		Zinc Oxide	CREAM	TOPICAL	20180612		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	189	mg/g			N	20241231
62742-4116_6c11f330-eb2f-4110-be76-15ac208411e0	62742-4116	HUMAN OTC DRUG	Broad Spectrum SPF 30 for Face and Body		Zinc Oxide	CREAM	TOPICAL	20171204		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	186	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4117_410b0b2e-06a6-4333-8268-b3a679822435	62742-4117	HUMAN OTC DRUG	Cover Recover SPF 30 Ivory		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4118_bcc3d467-c712-4af6-8282-866ed7ec6832	62742-4118	HUMAN OTC DRUG	Cover Recover SPF 30 Cream		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4119_fb3ba74e-6e7e-4cc2-b618-7629c3132403	62742-4119	HUMAN OTC DRUG	Cover Recover SPF 30 Beige		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4120_8da3afad-b561-4863-8ab5-21a117883b33	62742-4120	HUMAN OTC DRUG	Cover Recover SPF 30 Cocoa		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4121_75a8359c-a197-4b33-a0e1-a710809a3e39	62742-4121	HUMAN OTC DRUG	Cover Recover SPF 30 Tawny		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4122_cf2e2d00-7336-44bc-90ad-ec96d001828f	62742-4122	HUMAN OTC DRUG	Cover Recover SPF 30 Warm Beige		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4123_eab0ec72-12d9-413b-afea-64e1bc753cd7	62742-4123	HUMAN OTC DRUG	Cover Recover SPF 30 Sand		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4124_bc6032e6-6ffd-4cab-8ca9-c4ffacc18d80	62742-4124	HUMAN OTC DRUG	Cover Recover SPF 30 Taupe		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171205		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4145_8e9f9e3a-6bd4-4a35-b859-ad14ff81e53b	62742-4145	HUMAN OTC DRUG	Pyratine XR Creme With Sunscreen Broad Spectrum SPF30		Zinc Oxide	CREAM	TOPICAL	20171207		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	186	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4152_a5fb13e4-54ec-496a-aaeb-dc387aa4ed3d	62742-4152	HUMAN OTC DRUG	Mineral Sunscreen Broad Spectrum SPF 45		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171211		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	73.6; 51.4	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4153_00a92501-f7cc-4f23-9d10-56e102b7ad41	62742-4153	HUMAN OTC DRUG	Mineral Sunscreen Moisturizer Broad Spectrum SPF 20		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171212		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	TITANIUM DIOXIDE; ZINC OXIDE	48; 50	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4154_5d997894-d0e9-43f9-9b06-d3dfff865b40	62742-4154	HUMAN OTC DRUG	Mineral Sunscreen Broad Spectrum SPF 30		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20171212		OTC MONOGRAPH FINAL	part352	Allure Labs, Inc	ZINC OXIDE	50	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4159_f0c8a73d-12dd-4d98-8a8f-4cf1e783d3dc	62742-4159	HUMAN OTC DRUG	Everyday Sheer Coverage Light Tint SPF 20		Zinc Oxide	CREAM	TOPICAL	20171215		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	177	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4160_2308726e-469c-4d07-86f5-5e99f0315a41	62742-4160	HUMAN OTC DRUG	Everyday Sheer Coverage Medium Tint SPF 20		Zinc Oxide	CREAM	TOPICAL	20171220		OTC MONOGRAPH FINAL	part352	Allure Labs Inc	ZINC OXIDE	177	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62742-4169_b392c601-8a30-414a-a63c-517c08537e0a	62742-4169	HUMAN OTC DRUG	Acne LotionSulfur	Sulfur	Sulfur	LOTION	TOPICAL	20181109		OTC MONOGRAPH FINAL	part333D	Allure Labs Inc	SULFUR	30	mg/mL			N	20241231
62742-4190_d6e90d14-7293-65f3-e053-2995a90a5819	62742-4190	HUMAN OTC DRUG	Skin Soothing Cream		Colloidal Oatmeal	CREAM	TOPICAL	20200824		OTC MONOGRAPH FINAL	part347	Allure Labs Inc	OATMEAL	1	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62742-4193_b5ea8f33-8f19-7464-e053-2a95a90a39b2	62742-4193	HUMAN OTC DRUG	Skin Renewing Cream		Salicylic Acid	CREAM	TOPICAL	20201207		OTC MONOGRAPH FINAL	part358H	Allure Labs	SALICYLIC ACID	1.8	mg/g			N	20241231
62742-4194_b5eb48a5-e885-3bf6-e053-2a95a90abb97	62742-4194	HUMAN OTC DRUG	Skin Soothing Cream - Nut Free		Colloidal Oatmeal	CREAM	TOPICAL	20201207		OTC MONOGRAPH FINAL	part347	Allure Labs	OATMEAL	1	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62742-4195_b629cb05-548f-4d60-e053-2a95a90aeefb	62742-4195	HUMAN OTC DRUG	DermaClear BHA Spot Treatment		Salicylic Acid	GEL	TOPICAL	20201210		OTC MONOGRAPH FINAL	part333D	Allure Labs	SALICYLIC ACID	2	mg/g			N	20241231
62742-4196_b63b99af-2ddc-3535-e053-2a95a90a65d5	62742-4196	HUMAN OTC DRUG	CBD Blue Light Defense SPF 30		Zinc Oxide	CREAM	TOPICAL	20201211		OTC MONOGRAPH FINAL	part352	Allure Labs	ZINC OXIDE	189	mg/g			N	20241231
62742-4198_b6b3102a-4155-2da2-e053-2995a90ae99f	62742-4198	HUMAN OTC DRUG	CBD Pain Relief Cream		Trolamine Salicylate	CREAM	TOPICAL	20201217		OTC MONOGRAPH NOT FINAL	part348	Allure Labs Inc	TROLAMINE SALICYLATE	100	mg/g			N	20241231
62742-4199_b6b45dac-41d1-1b55-e053-2a95a90acf61	62742-4199	HUMAN OTC DRUG	Sheer Zinc SPF 30		Zinc Oxide	CREAM	TOPICAL	20201217		OTC MONOGRAPH FINAL	part352	Allure Labs Inc.	ZINC OXIDE	186	mg/g			N	20241231
62742-4208_da87cbbf-12cb-3224-e053-2995a90a25e4	62742-4208	HUMAN OTC DRUG	Clear Cell Clarifying Acne		Benzoyl peroxide	LOTION	TOPICAL	20220321		OTC MONOGRAPH FINAL	part333D	Allure Labs	BENZOYL PEROXIDE	50	mg/g			N	20241231
62742-4209_dafc8e62-7c9a-1f6d-e053-2995a90a7791	62742-4209	HUMAN OTC DRUG	Broad Spectrum SPF30 Mineral Sunscreen		Zinc Oxide	CREAM	TOPICAL	20220324		OTC MONOGRAPH FINAL	part352	Allure Labs	ZINC OXIDE	21	g/100g			N	20241231
62742-4211_db9b5de2-c07d-0b21-e053-2995a90ae9a9	62742-4211	HUMAN OTC DRUG	Acne Oil Control Primer		Salicylic Acid	LIQUID	TOPICAL	20220401		OTC MONOGRAPH FINAL	part333D	Allure Labs	SALICYLIC ACID	20	mg/g			N	20241231
62742-4212_dbb27841-7c9f-6d00-e053-2a95a90a6ab1	62742-4212	HUMAN OTC DRUG	Daily Leave on Acne Treatment Mask		Benzoyl Peroxide	CREAM	TOPICAL	20220402		OTC MONOGRAPH FINAL	part333D	Allure Labs	BENZOYL PEROXIDE	25	mg/g			N	20241231
62742-4213_dc792777-d8b7-3ebc-e053-2a95a90abc3f	62742-4213	HUMAN OTC DRUG	I Conceal Flawless Foundation Broad Spectrum SPF 30 Sunscreen Deep Honey		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20220412		OTC MONOGRAPH FINAL	part352	Allure Labs	TITANIUM DIOXIDE; ZINC OXIDE	58; 85	mg/g; mg/g			N	20241231
62742-4214_dcba05ff-7a69-c5c0-e053-2a95a90a6129	62742-4214	HUMAN OTC DRUG	I Conceal Flawless Foundation Broad Spectrum SPF 30 Sunscreen Mahogany		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20220418		OTC MONOGRAPH FINAL	part352	Allure Labs	TITANIUM DIOXIDE; ZINC OXIDE	65; 85	mg/g; mg/g			N	20241231
62742-4216_e1e9dc90-247c-1e07-e053-2a95a90aec9d	62742-4216	HUMAN OTC DRUG	Penetrex(r) Arthritis Pain Relief		Capsaicin	CREAM	TOPICAL	20220620		UNAPPROVED DRUG OTHER		Allure Labs	CAPSAICIN	.025	g/100g			N	20241231
62742-4219_e82f99fd-c2f0-686f-e053-2a95a90a1dc9	62742-4219	HUMAN OTC DRUG	Joint and Muscle Pain Relief		Menthol	CREAM	TOPICAL	20220908		OTC MONOGRAPH FINAL	M015	Allure Labs	MENTHOL	1.5	g/100g			N	20241231
62742-4220_eb8e7109-b5ec-5cc1-e053-2995a90a486f	62742-4220	HUMAN OTC DRUG	MD Restoring daily Defense Moisturizer SPF 50		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20221021		OTC MONOGRAPH FINAL	M020	Allure Labs Inc	TITANIUM DIOXIDE; ZINC OXIDE	6.5; 8.7	g/100g; g/100g			N	20241231
62742-4221_ed883d63-777d-e924-e053-2995a90a162a	62742-4221	HUMAN OTC DRUG	Prevention Daily Tinted Moisturizer SPF 30		Zinc oxide and Titanium Dioxide	CREAM	TOPICAL	20221115		OTC MONOGRAPH FINAL	M020	Allure Labs Inc	TITANIUM DIOXIDE; ZINC OXIDE	4.7; 6	g/100g; g/100g			N	20241231
62742-4222_ee8c1a2b-36f0-6fd7-e053-2a95a90a9c01	62742-4222	HUMAN OTC DRUG	Tough Love Pain Relieving		Lidocaine HCl	CREAM	TOPICAL	20221128		OTC MONOGRAPH NOT FINAL	part348	Allure Labs Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
62742-4223_f0fb1b69-53f3-efff-e053-2995a90af9d4	62742-4223	HUMAN OTC DRUG	Prevention Daily Matte Moisturizer SPF 30		Zinc Oxide and Homosalate	CREAM	TOPICAL	20221229		OTC MONOGRAPH FINAL	M020	Allure Labs	HOMOSALATE; ZINC OXIDE	10; 9.3	g/100g; g/100g			N	20241231
62742-4224_f1761b09-9062-a052-e053-2a95a90a39c8	62742-4224	HUMAN OTC DRUG	Prevention Sun Serum SPF 30 Tinted		Zinc Oxide	CREAM	TOPICAL	20230104		OTC MONOGRAPH FINAL	M020	Allure Labs	ZINC OXIDE	15.6	g/100g			N	20241231
62742-4225_f188669f-7ba0-6e01-e053-2995a90afa3c	62742-4225	HUMAN OTC DRUG	Prevention Sun Serum SPF30		Zinc Oxide	CREAM	TOPICAL	20230105		OTC MONOGRAPH FINAL	M020	Allure Labs	ZINC OXIDE	15.6	g/100g			N	20241231
62742-4226_f19f6d9b-524a-27a6-e053-2a95a90a8a39	62742-4226	HUMAN OTC DRUG	Prevention Clear Solar Gel SPF30		Avobenzon, Octisalate and Octocrylene	CREAM	TOPICAL	20230106		OTC MONOGRAPH FINAL	M020	Allure LAbs	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.5; 5; 10	g/100g; g/100g; g/100g			N	20241231
62742-4227_fa54cf42-3ba8-b7b3-e053-6394a90aa7a0	62742-4227	HUMAN OTC DRUG	Skin Renewing Cream		Salicylic Acid	CREAM	TOPICAL	20230427		OTC MONOGRAPH FINAL	M032	Allure Labs	SALICYLIC ACID	1.8	g/100g			N	20241231
62742-4228_02e7fb00-203a-c4f8-e063-6294a90a418f	62742-4228	HUMAN OTC DRUG	OneSkin OS-01 SHIELD Broad Spectrum SPF 30 Mineral Sunscreen Tinted		Zinc Oxide	CREAM	TOPICAL	20230814		OTC MONOGRAPH FINAL	M020	Allure Labs	ZINC OXIDE	17.5	g/100g			N	20241231
62742-4229_02f9c859-8d7e-5146-e063-6394a90a57b5	62742-4229	HUMAN OTC DRUG	OneSkin OS-01 SHIELD Broad Spectrum SPF 30 Mineral Sunscreen Untinted		Zinc Oxide	CREAM	TOPICAL	20230815		OTC MONOGRAPH FINAL	M020	Allure Labs	ZINC OXIDE	17.5	g/100g			N	20241231
62742-4230_039e50c1-7b3e-d392-e063-6394a90a4b3c	62742-4230	HUMAN OTC DRUG	Quench and Protect Hydrating SPF30		Zinc dioxide and Titanium dioxide	CREAM	TOPICAL	20230823		OTC MONOGRAPH FINAL	M020	Allure Labs.	TITANIUM DIOXIDE; ZINC OXIDE	4.7; 6	g/100g; g/100g			N	20241231
62742-4231_039fba4b-720b-9199-e063-6394a90adbfb	62742-4231	HUMAN OTC DRUG	Tropical Topical Matte SPF30		Zinc Oxide	CREAM	TOPICAL	20230823		OTC MONOGRAPH FINAL	M020	Allure Labs	ZINC OXIDE	18.6	g/100g			N	20241231
62742-4232_08c9fc56-7d50-ebc5-e063-6294a90a5317	62742-4232	HUMAN OTC DRUG	SPF Elio Drops 30 Sheer		Zinc Oxide	CREAM	TOPICAL	20231028		OTC MONOGRAPH DRUG	M020	Allure Labs Inc	ZINC OXIDE	15.6	g/100g			N	20241231
62742-4233_08cbf8d6-8c28-1567-e063-6394a90a932e	62742-4233	HUMAN OTC DRUG	SPF Elio Drops 30 Glow		Zinc Oxide	CREAM	TOPICAL	20231028		OTC MONOGRAPH DRUG	M020	Allure Labs Inc	ZINC OXIDE	15.6	g/100g			N	20241231
62742-4234_0a710be0-562f-8368-e063-6294a90a3b1b	62742-4234	HUMAN OTC DRUG	EczemaHoneyBodyLotion		Colloidal Oatmeal	LOTION	TOPICAL	20231118		OTC MONOGRAPH DRUG	M016	Allure Labs	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
62742-4235_0bb4ec66-64bb-9583-e063-6394a90ac512	62742-4235	HUMAN OTC DRUG	Sea Clearly Translucent Gel Sunscreen BS SPF 50		Homosalate, Octocrylene, Octisalate, Avobenzone	GEL	TOPICAL	20231204		OTC MONOGRAPH DRUG	M020	Allure Labs	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
62742-4236_0bb7f0a4-13e0-7734-e063-6294a90a242b	62742-4236	HUMAN OTC DRUG	Clearly Zinq Mineral Gel Sunscreen BS SPF 60		Zinc Oxide	GEL	TOPICAL	20231204		OTC MONOGRAPH DRUG	M020	Allure Labs	ZINC OXIDE	24	g/100g			N	20241231
62742-4237_0bc829ff-34a1-03e9-e063-6294a90a10ae	62742-4237	HUMAN OTC DRUG	Sea Clearly Hydrating Facial SPF 35 Kinetin		Octocrylene, Octisalate,Homosalat, Avobenzone	CREAM	TOPICAL	20231205		OTC MONOGRAPH DRUG	M020	Allure Labs	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.5; 5; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
62742-4238_0bdf9f38-5764-a4d0-e063-6394a90a41dc	62742-4238	HUMAN OTC DRUG	CLEAROGEN 3		Benzoyl Peroxide	LOTION	TOPICAL	20231206		OTC MONOGRAPH DRUG	M006	Allure Labs	BENZOYL PEROXIDE	2.5	g/100g			N	20241231
62742-4239_0bf4c2d8-2fc0-a1c4-e063-6294a90ac130	62742-4239	HUMAN OTC DRUG	Foaming Cleanser		Salicylic Acid	LIQUID	TOPICAL	20231207		OTC MONOGRAPH DRUG	M006	Allure Labs	SALICYLIC ACID	2	g/100g			N	20241231
62742-4240_0c07e6e9-18c2-20da-e063-6294a90aa3c8	62742-4240	HUMAN OTC DRUG	Clarifying Toner		Salicylic Acid	LIQUID	TOPICAL	20231208		OTC MONOGRAPH DRUG	M006	Allure Labs	SALICYLIC ACID	1	g/100g			N	20241231
62742-4241_0c574a9a-edeb-d333-e063-6394a90a41e3	62742-4241	HUMAN OTC DRUG	6000X Elemental Screen BS SPF 30 Sunscreen		Zinc Oxide	CREAM	TOPICAL	20231212		OTC MONOGRAPH DRUG	M020	Allure Labs	ZINC OXIDE	18.9	g/100g			N	20241231
62742-4242_0c6ac094-cb5c-0f09-e063-6394a90a9eed	62742-4242	HUMAN OTC DRUG	Sheer Mineral Sunscreen Broad Spectrum SPF 30		Zinc Oxide	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M020	Allure Labs	ZINC OXIDE	18.6	g/100g			N	20241231
62742-4243_0d7072f8-e809-5270-e063-6294a90a1ffa	62742-4243	HUMAN OTC DRUG	Best Skin Days BS SPF 30		Zinc Oxide	CREAM	TOPICAL	20231226		OTC MONOGRAPH DRUG	M020	Allure Labs	ZINC OXIDE	21	g/100g			N	20241231
62742-4244_0e9d006c-2ea1-8228-e063-6394a90a65d6	62742-4244	HUMAN OTC DRUG	I Conceal Flawless Foundation BS SPF 30 Sunscreen SUEDE		Zinc Oxide and Titanium Dioxide	CREAM	TOPICAL	20240110		OTC MONOGRAPH DRUG	M020	Allure Labs	TITANIUM DIOXIDE; ZINC OXIDE	9.8; 8.5	g/100g; g/100g			N	20251231
62750-044_ceef53f6-433a-465d-afc2-f7cfb9225fc4	62750-044	HUMAN OTC DRUG	Zicam	Cold Remedy Rapidmelts Citrus	ZINC ACETATE ANHYDROUS and ZINC GLUCONATE	TABLET	ORAL	20111001		UNAPPROVED HOMEOPATHIC		Matrixx Initiatives, Inc.	ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	2; 1	[hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
62756-015_6c0ad3de-f509-4a28-be26-552c5c74a60d	62756-015	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20130617		ANDA	ANDA201720	Sun Pharmaceutical Industries, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
62756-016_6c0ad3de-f509-4a28-be26-552c5c74a60d	62756-016	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20130617		ANDA	ANDA201720	Sun Pharmaceutical Industries, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
62756-017_6c0ad3de-f509-4a28-be26-552c5c74a60d	62756-017	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20130617		ANDA	ANDA201720	Sun Pharmaceutical Industries, Inc.	TESTOSTERONE CYPIONATE	100	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
62756-059_4a908d55-af35-4d85-b188-37a7ffad2e71	62756-059	HUMAN PRESCRIPTION DRUG	epoprostenol		epoprostenol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210116		ANDA	ANDA210473	Sun Pharmaceutical Industries, Inc.	EPOPROSTENOL SODIUM	.5	mg/10mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
62756-060_4a908d55-af35-4d85-b188-37a7ffad2e71	62756-060	HUMAN PRESCRIPTION DRUG	epoprostenol		epoprostenol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210116		ANDA	ANDA210473	Sun Pharmaceutical Industries, Inc.	EPOPROSTENOL SODIUM	1.5	mg/10mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
62756-064_95c4da6c-5696-49d2-bd19-b5da64beb630	62756-064	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod	CAPSULE	ORAL	20221025		ANDA	ANDA208014	Sun Pharmaceutical Industries, Inc.	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
62756-071_d19d65d9-7bab-4a6f-9a79-ed3d32bd83d9	62756-071	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE SODIUM	GRANULE, DELAYED RELEASE	ORAL	20200701		ANDA	ANDA213725	Sun Pharmaceutical Industries, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62756-090_8e776908-1e91-4e7e-b3c1-e6fe8234ba75	62756-090	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20190504		ANDA	ANDA210760	Sun Pharmaceutical Industries, Inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
62756-091_10fdc3f5-de88-4bbb-9f3f-c0a0630d0222	62756-091	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20190501		ANDA	ANDA210761	Sun Pharmaceutical Industries, Inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
62756-129_079d1889-f4d7-41a5-951d-7a4efb28c4c4	62756-129	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190901		ANDA	ANDA077674	Sun Pharmaceutical Industries, Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62756-130_4044f1da-be9c-4766-b20c-4cd0f443d897	62756-130	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077050	Sun Pharmaceutical Industries, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62756-131_4044f1da-be9c-4766-b20c-4cd0f443d897	62756-131	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077050	Sun Pharmaceutical Industries, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62756-137_9b142aa6-eb1d-409c-bbed-aa567e0ed3e8	62756-137	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	CAPSULE	ORAL	20220201		ANDA	ANDA077242	Sun Pharmaceutical Industries, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-138_9b142aa6-eb1d-409c-bbed-aa567e0ed3e8	62756-138	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	CAPSULE	ORAL	20220201		ANDA	ANDA077242	Sun Pharmaceutical Industries, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-139_9b142aa6-eb1d-409c-bbed-aa567e0ed3e8	62756-139	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	CAPSULE	ORAL	20220201		ANDA	ANDA077242	Sun Pharmaceutical Industries, Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-142_69a60382-bf12-4627-baaf-2e0ac332b443	62756-142	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20060209		ANDA	ANDA077336	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62756-143_69a60382-bf12-4627-baaf-2e0ac332b443	62756-143	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20060209		ANDA	ANDA077336	Sun Pharmaceutical Industries, Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
62756-145_a905f5ce-ae1b-4511-acd3-62883a3e3546	62756-145	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20100701		ANDA	ANDA077131	Sun Pharmaceutical Industries, Inc.	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62756-146_a905f5ce-ae1b-4511-acd3-62883a3e3546	62756-146	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20100701		ANDA	ANDA077131	Sun Pharmaceutical Industries, Inc.	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62756-147_a905f5ce-ae1b-4511-acd3-62883a3e3546	62756-147	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20100701		ANDA	ANDA077131	Sun Pharmaceutical Industries, Inc.	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62756-148_a905f5ce-ae1b-4511-acd3-62883a3e3546	62756-148	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20100701		ANDA	ANDA077131	Sun Pharmaceutical Industries, Inc.	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62756-160_52595417-3e2e-4d58-9167-dd5b2bf1b082	62756-160	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100715		ANDA	ANDA090931	Sun Pharmaceutical Industries, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
62756-183_5cee2e11-dc01-4ea5-aa6b-b07bba5f3400	62756-183	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077794	Sun Pharmaceutical Industries, Inc.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-184_5cee2e11-dc01-4ea5-aa6b-b07bba5f3400	62756-184	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077794	Sun Pharmaceutical Industries, Inc.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-185_5cee2e11-dc01-4ea5-aa6b-b07bba5f3400	62756-185	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077794	Sun Pharmaceutical Industries, Inc.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-194_65890f83-ea1b-4342-b403-6ebe155bc357	62756-194	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20150617		ANDA	ANDA204293	Sun Pharmaceutical Industries, Inc.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62756-200_57975e74-e45b-4fd9-9718-bfc9690acae5	62756-200	HUMAN PRESCRIPTION DRUG	TIAGABINE HYDROCHLORIDE		TIAGABINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20111104		ANDA	ANDA077555	Sun Pharmaceutical Industries, Inc.	TIAGABINE HYDROCHLORIDE	2	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-202_9b142aa6-eb1d-409c-bbed-aa567e0ed3e8	62756-202	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	TABLET, FILM COATED	ORAL	20220901		ANDA	ANDA077525	Sun Pharmaceutical Industries, Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-204_9b142aa6-eb1d-409c-bbed-aa567e0ed3e8	62756-204	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	TABLET, FILM COATED	ORAL	20220901		ANDA	ANDA077525	Sun Pharmaceutical Industries, Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-224_57975e74-e45b-4fd9-9718-bfc9690acae5	62756-224	HUMAN PRESCRIPTION DRUG	TIAGABINE HYDROCHLORIDE		TIAGABINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20111104		ANDA	ANDA077555	Sun Pharmaceutical Industries, Inc.	TIAGABINE HYDROCHLORIDE	4	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-232_19d17bf3-2231-4af9-b1da-ca74f015b72d	62756-232	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		Loteprednol Etabonate	SUSPENSION/ DROPS	OPHTHALMIC	20210501		ANDA	ANDA212450	Sun Pharmaceutical Industries, Inc.	LOTEPREDNOL ETABONATE	5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
62756-233_608db2b7-39be-47ea-acd0-0a37dc2cd0df	62756-233	HUMAN PRESCRIPTION DRUG	Amphotericin B		Amphotericin B	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20220209		ANDA	ANDA212514	Sun Pharmaceutical Industries, Inc.	AMPHOTERICIN B	50	mg/1	Lipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
62756-238_8a24ef3b-b59a-4051-bf0d-a98eb6187ef2	62756-238	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20190901		ANDA	ANDA204668	Sun Pharmaceutical Industries, Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
62756-239_8a24ef3b-b59a-4051-bf0d-a98eb6187ef2	62756-239	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20190901		ANDA	ANDA204668	Sun Pharmaceutical Industries, Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
62756-240_4044f1da-be9c-4766-b20c-4cd0f443d897	62756-240	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	Sun Pharmaceutical Industries, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62756-258_d0c9002b-fa32-4ca8-862f-5286746df2cb	62756-258	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060317		ANDA	ANDA077634	Sun Pharmaceutical Industries, Inc.	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
62756-259_d0c9002b-fa32-4ca8-862f-5286746df2cb	62756-259	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060317		ANDA	ANDA077634	Sun Pharmaceutical Industries, Inc.	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
62756-260_d0c9002b-fa32-4ca8-862f-5286746df2cb	62756-260	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060317		ANDA	ANDA077634	Sun Pharmaceutical Industries, Inc.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
62756-277_9d97f601-a41c-48b7-8ba0-27bc75500e06	62756-277	HUMAN PRESCRIPTION DRUG	Arformoterol Tartrate		Arformoterol Tartrate	SOLUTION	RESPIRATORY (INHALATION)	20220528		ANDA	ANDA215385	Sun Pharmaceutical Industries, Inc.	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
62756-299_c89dfc75-606c-4a4e-9d2b-d907b492a837	62756-299	HUMAN PRESCRIPTION DRUG	phenytoin sodium		phenytoin sodium	CAPSULE, EXTENDED RELEASE	ORAL	20080630		ANDA	ANDA040731	Sun Pharmaceutical Industries, Inc.	PHENYTOIN SODIUM	200	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-301_6ac5c671-68ab-4347-9cd6-1fd6ef32b069	62756-301	HUMAN PRESCRIPTION DRUG	SEZABY		phenobarbital sodium	INJECTION	INTRAVENOUS	20221225		NDA	NDA215910	Sun Pharmaceutical Industries, Inc.	PHENOBARBITAL SODIUM	100	mg/1		CIV	N	20241231
62756-356_4044f1da-be9c-4766-b20c-4cd0f443d897	62756-356	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	Sun Pharmaceutical Industries, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
62756-368_09b3341a-4a9b-4db9-94b5-b74c034f409d	62756-368	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20220401		ANDA	ANDA090654	Sun Pharmaceutical Industries, Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
62756-369_09b3341a-4a9b-4db9-94b5-b74c034f409d	62756-369	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20220401		ANDA	ANDA090654	Sun Pharmaceutical Industries, Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	50; 100	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
62756-370_09b3341a-4a9b-4db9-94b5-b74c034f409d	62756-370	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate and Hydrochlorothiazide		Metoprolol Tartrate and Hydrochlorothiazide	TABLET	ORAL	20220401		ANDA	ANDA090654	Sun Pharmaceutical Industries, Inc.	HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE	25; 50	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
62756-377_f6cedf31-0870-404f-991f-20412238e74f	62756-377	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20190101		ANDA	ANDA207891	Sun Pharmaceutical Industries, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
62756-427_b8815234-f7d4-4a17-a8a5-b13214d8ced6	62756-427	HUMAN PRESCRIPTION DRUG	Ciprofloxacin and dexamethasone		Ciprofloxacin and dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20220901		ANDA	ANDA210470	Sun Pharmaceutical Industries, Inc.	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
62756-429_c3c3b8ae-9dac-40fc-8569-b26d6befbf01	62756-429	HUMAN PRESCRIPTION DRUG	Dalfampridine		Dalfampridine	TABLET, EXTENDED RELEASE	ORAL	20190522		ANDA	ANDA208292	Sun Pharmaceutical Industries, Inc.	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
62756-430_b0888aa2-be9d-4a45-81b2-a59493bc4892	62756-430	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET	ORAL	20100708		ANDA	ANDA091027	Sun Pharmaceutical Industries, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
62756-432_c89dfc75-606c-4a4e-9d2b-d907b492a837	62756-432	HUMAN PRESCRIPTION DRUG	phenytoin sodium		phenytoin sodium	CAPSULE, EXTENDED RELEASE	ORAL	20080630		ANDA	ANDA040731	Sun Pharmaceutical Industries, Inc.	PHENYTOIN SODIUM	300	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-457_91ce9c25-03a0-40d1-a463-60929a93114e	62756-457	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20070823		ANDA	ANDA077828	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
62756-459_9d5581f6-00f0-4185-b139-e57484bdadf7	62756-459	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	TABLET	SUBLINGUAL	20160217		ANDA	ANDA201760	Sun Pharmaceutical Industries, Inc.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
62756-460_9d5581f6-00f0-4185-b139-e57484bdadf7	62756-460	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	TABLET	SUBLINGUAL	20160217		ANDA	ANDA201760	Sun Pharmaceutical Industries, Inc.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
62756-461_91ce9c25-03a0-40d1-a463-60929a93114e	62756-461	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET, EXTENDED RELEASE	ORAL	20070823		ANDA	ANDA077828	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
62756-512_822e078d-ea93-4a4b-b640-2cc7174f5b52	62756-512	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200715		ANDA	ANDA090923	Sun Pharmaceutical Industries, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
62756-517_d77ed25a-588d-4d22-855f-f93ba5b4003c	62756-517	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20081028		ANDA	ANDA078536	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
62756-518_d77ed25a-588d-4d22-855f-f93ba5b4003c	62756-518	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20081028		ANDA	ANDA078536	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
62756-520_22ae72f3-2648-46ae-928f-f158ed0bcf27	62756-520	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA078295	Sun Pharmaceutical Industries, Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
62756-521_22ae72f3-2648-46ae-928f-f158ed0bcf27	62756-521	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA078295	Sun Pharmaceutical Industries, Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
62756-522_22ae72f3-2648-46ae-928f-f158ed0bcf27	62756-522	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA078295	Sun Pharmaceutical Industries, Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
62756-529_129770b0-b59a-4ee3-bc07-2168544c1424	62756-529	HUMAN PRESCRIPTION DRUG	desmopressin acetate		desmopressin acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140220		ANDA	ANDA091280	Sun Pharmaceutical Industries, Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
62756-529_ec29b269-1ce9-4199-ab07-a51d3e55d604	62756-529	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20130130		ANDA	ANDA091280	Sun Pharmaceutical Industries, Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
62756-538_9f3fe78f-5fa7-48ab-90cc-5c0ba82c1fb2	62756-538	HUMAN PRESCRIPTION DRUG	Riluzole		Riluzole	TABLET, FILM COATED	ORAL	20130618		ANDA	ANDA091417	Sun Pharmaceutical Industries, Inc.	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20241231
62756-568_88009dbf-bf02-432b-95d4-27a6934590b8	62756-568	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202		ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62756-569_88009dbf-bf02-432b-95d4-27a6934590b8	62756-569	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202		ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62756-570_88009dbf-bf02-432b-95d4-27a6934590b8	62756-570	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20191202		ANDA	ANDA209782	Sun Pharmaceutical Industries, Inc.	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
62756-589_af12cd5c-3963-4ef2-b819-a42343f0cb69	62756-589	HUMAN PRESCRIPTION DRUG	liothyronine sodium		liothyronine sodium	TABLET	ORAL	20191128		ANDA	ANDA091382	Sun Pharmaceutical Industries, Inc.	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
62756-590_af12cd5c-3963-4ef2-b819-a42343f0cb69	62756-590	HUMAN PRESCRIPTION DRUG	liothyronine sodium		liothyronine sodium	TABLET	ORAL	20191128		ANDA	ANDA091382	Sun Pharmaceutical Industries, Inc.	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
62756-591_af12cd5c-3963-4ef2-b819-a42343f0cb69	62756-591	HUMAN PRESCRIPTION DRUG	liothyronine sodium		liothyronine sodium	TABLET	ORAL	20191128		ANDA	ANDA091382	Sun Pharmaceutical Industries, Inc.	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
62756-707_b8c52970-05b0-43ea-9122-566998bf4524	62756-707	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-710_b8c52970-05b0-43ea-9122-566998bf4524	62756-710	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-711_b8c52970-05b0-43ea-9122-566998bf4524	62756-711	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-712_b8c52970-05b0-43ea-9122-566998bf4524	62756-712	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA090278	Sun Pharmaceutical Industries, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
62756-718_61d03fd1-1f93-4f6c-940c-e436ab1b63a9	62756-718	HUMAN OTC DRUG	Opcicon One-Step		levonorgestrel	TABLET	ORAL	20140912		ANDA	ANDA202635	Sun Pharmaceutical Industries, Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
62756-720_8f45ff33-3872-495f-a05d-e74e0b4dc0c4	62756-720	HUMAN OTC DRUG	My Choice TM		levonorgestrel	TABLET	ORAL	20180401		ANDA	ANDA202635	SUN PHARMACEUTICAL INDUSTRIES, INC.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
62756-723_f86715c5-932d-405d-b81d-286c86409b1e	62756-723	HUMAN OTC DRUG	AfterPlan		levonorgestrel	TABLET	ORAL	20170512		ANDA	ANDA202635	SUN PHARMACEUTICAL INDUSTRIES, INC.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
62756-796_018d25b7-b6bb-4aad-809c-8fae51ed9fed	62756-796	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Sun Pharmaceutical Industries, Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
62756-797_018d25b7-b6bb-4aad-809c-8fae51ed9fed	62756-797	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Sun Pharmaceutical Industries, Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
62756-798_018d25b7-b6bb-4aad-809c-8fae51ed9fed	62756-798	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Sun Pharmaceutical Industries, Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
62756-826_d95f19dc-a686-42c7-88dc-997659b803df	62756-826	HUMAN PRESCRIPTION DRUG	DOXOrubicin Hydrochloride		DOXOrubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20120220		ANDA	ANDA091418	Sun Pharmaceutical Industries, Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
62756-827_d95f19dc-a686-42c7-88dc-997659b803df	62756-827	HUMAN PRESCRIPTION DRUG	DOXOrubicin Hydrochloride		DOXOrubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20120220		ANDA	ANDA091418	Sun Pharmaceutical Industries, Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
62756-915_7d3c263b-b35c-44de-8971-2ed79b325a58	62756-915	HUMAN OTC DRUG	Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120929		ANDA	ANDA090922	Sun Pharmaceutical Industries, Inc.	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
62756-955_7bb96934-8c07-463e-b96e-cafaafb8d2dc	62756-955	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Sun Pharmaceutical Industries, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
62756-956_7bb96934-8c07-463e-b96e-cafaafb8d2dc	62756-956	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Sun Pharmaceutical Industries, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
62756-957_7bb96934-8c07-463e-b96e-cafaafb8d2dc	62756-957	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Sun Pharmaceutical Industries, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
62756-967_fb99b865-fb41-4c92-8db9-7953feed2394	62756-967	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20200501		ANDA	ANDA204556	Sun Pharmaceutical Industries, Inc.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
62756-968_fb99b865-fb41-4c92-8db9-7953feed2394	62756-968	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20200501		ANDA	ANDA204556	Sun Pharmaceutical Industries, Inc.	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
62756-969_8e28e801-4430-42d6-ac7a-22bed369bdf5	62756-969	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20170718		ANDA	ANDA201633	Sun Pharmaceutical Industries, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
62756-970_8e28e801-4430-42d6-ac7a-22bed369bdf5	62756-970	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20170718		ANDA	ANDA201633	Sun Pharmaceutical Industries, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
62756-985_d77ed25a-588d-4d22-855f-f93ba5b4003c	62756-985	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20210812		ANDA	ANDA078536	Sun Pharmaceutical Industries, Inc.	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
62767-102_0d0aca6a-61e3-c65e-e063-6294a90a6cf8	62767-102	HUMAN OTC DRUG	Sani-Foam Foaming Non-Alcohol Hand Sanitizer		Benzalkonium Chloride	SOAP	TOPICAL	20200124	20240930	OTC MONOGRAPH DRUG	505G(a)(3)	Multi Clean	BENZALKONIUM CHLORIDE	1	mg/mL			N	
62767-103_0d0991b5-b45f-8465-e063-6394a90aeb2b	62767-103	HUMAN OTC DRUG	Sani-Foam Foaming Non-Alcohol Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20231218		OTC MONOGRAPH DRUG	505G(a)(3)	Multi-Clean	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
62778-304_54c7f31b-4a91-4fa9-833f-3bc247440994	62778-304	HUMAN PRESCRIPTION DRUG	mesna		mesna	INJECTION, SOLUTION	INTRAVENOUS	20040223		ANDA	ANDA075739	Hikma Farmaceutica	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
62778-336_2ad79da8-b950-4f61-a650-2f146cd6c5e7	62778-336	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20230331		ANDA	ANDA040453	Hikma Farmaceutica	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
62778-348_6801857e-7f43-40a0-ba2e-f68ee23f0ead	62778-348	HUMAN PRESCRIPTION DRUG	Midazolam in Sodium Chloride		Midazolam in Sodium Chloride	INJECTION	INTRAVENOUS	20230519		ANDA	ANDA216159	Hikma Farmaceutica	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62778-349_6801857e-7f43-40a0-ba2e-f68ee23f0ead	62778-349	HUMAN PRESCRIPTION DRUG	Midazolam in Sodium Chloride		Midazolam in Sodium Chloride	INJECTION	INTRAVENOUS	20230519		ANDA	ANDA216159	Hikma Farmaceutica	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
62778-350_1292f1f9-7d3e-4a88-9251-bad58e533e72	62778-350	HUMAN PRESCRIPTION DRUG	Dobutamine		Dobutamine	INJECTION, SOLUTION	INTRAVENOUS	20230503		ANDA	ANDA074277	Hikma Farmaceutica	DOBUTAMINE HYDROCHLORIDE	12.5	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
62795-1003_e675e202-1eb8-4d16-b6bd-477631366d7a	62795-1003	HUMAN OTC DRUG	BHI Bodypure		.ALPHA.-LIPOIC ACID, AVENA SATIVA FLOWERING TOP, BERBERIS VULGARIS ROOT BARK, CAFFEINE, CHOLESTEROL, JUGLANS REGIA FLOWERING TOP, STRYCHNOS NUX-VOMICA SEED, KEROSENE, FRANGULA PURSHIANA BARK, RICINUS COMMUNIS SEED, SOLIDAGO VIRGAUREA FLOWERING TOP, URTICA URENS, VIOLA TRICOLOR, and ALCOHOL, X-RAY EXPOSED (1000 RAD)	TABLET	ORAL	20140830	20241231	UNAPPROVED HOMEOPATHIC		MediNatura Inc	.ALPHA.-LIPOIC ACID; ALCOHOL, X-RAY EXPOSED (1000 RAD); AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; CAFFEINE; CHOLESTEROL; FRANGULA PURSHIANA BARK; JUGLANS REGIA FLOWERING TOP; KEROSENE; RICINUS COMMUNIS SEED; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; URTICA URENS; VIOLA TRICOLOR	3; 12; 3; 6; 6; 10; 6; 6; 12; 3; 4; 30; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Xanthines [CS]		N	
62795-1004_37b2a59d-d1fe-402b-991d-d064e98f3ac4	62795-1004	HUMAN OTC DRUG	BHI Nausea		SEMECARPUS ANACARDIUM JUICE, SILVER NITRATE, ACTIVATED CHARCOAL, IPECAC,IODINE, ROBINIA PSEUDOACACIA BARK, and SEPIA OFFICINALIS JUICE	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACTIVATED CHARCOAL; IODINE; IPECAC; ROBINIA PSEUDOACACIA BARK; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE	12; 12; 6; 10; 6; 30; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1005_25f16472-f472-48be-a1f9-d5741bcf2686	62795-1005	HUMAN OTC DRUG	BHI Constipation		DIOSCOREA VILLOSA TUBER, SODIUM CHLORIDE, and STRYCHNOS NUX-VOMICA SEED	TABLET	ORAL	20140830		UNAPPROVED HOMEOPATHIC		MediNatura Inc	DIOSCOREA VILLOSA TUBER; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	4; 200; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62795-1006_6156e5c0-e77a-4cec-b0a1-27500a8e7db0	62795-1006	HUMAN OTC DRUG	BHI Calming		MATRICARIA RECUTITA, ARABICA COFFEE BEAN, HOPS, STRYCHNOS IGNATII SEED, MOSCHUS MOSCHIFERUS MUSK SAC RESIN, STRYCHNOS NUX-VOMICA SEED, PASSIFLORA INCARNATA FLOWERING TOP, SULFUR, VALERIAN, and VERATRUM ALBUM ROOT	TABLET	ORAL	20140830		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARABICA COFFEE BEAN; HOPS; MATRICARIA RECUTITA; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR; VALERIAN; VERATRUM ALBUM ROOT	10; 2; 2; 10; 2; 8; 30; 12; 2; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62795-1007_af2b8787-5aee-4b15-afe6-65f1beaa0201	62795-1007	HUMAN OTC DRUG	BHI Back		AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, and TOXICODENDRON PUBESCENS LEAF	TABLET	ORAL	20140830		UNAPPROVED HOMEOPATHIC		MediNatura Inc	AMMONIUM CHLORIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA RECUTITA; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF	6; 5; 6; 10; 5; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1008_3ab43885-f45b-4345-a219-f5d72f5fe66c	62795-1008	HUMAN OTC DRUG	BHI Flu Plus		ACONITUM NAPELLUS, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE, BRYONIA ALBA WHOLE, EUPATORIUM PERFOLIATUM FLOWERING TOP, IPECAC, LACHESIS MUTA VENOM,PHOSPHORUS, PULSATILLA VULGARIS, SULFUR, ZINC GLUCONATE, AND ZINC	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACONITUM NAPELLUS; BRYONIA ALBA WHOLE; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; EUPATORIUM PERFOLIATUM FLOWERING TOP; IPECAC; LACHESIS MUTA VENOM; PHOSPHORUS; PULSATILLA VULGARIS; SULFUR; ZINC; ZINC GLUCONATE	4; 4; 200; 4; 6; 12; 8; 6; 8; 3; 3	[hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
62795-1009_9ebffffe-062a-421d-b762-e3b5c7724ba9	62795-1009	HUMAN OTC DRUG	BHI Arnica Plus		ARNICA MONTANA ROOT	TABLET	ORAL	20140930	20260228	UNAPPROVED HOMEOPATHIC		MediNatura Inc.	ARNICA MONTANA ROOT	6	[hp_X]/1			N	
62795-1010_4a27cc40-0c2d-45d0-b6ef-3911afbedc7b	62795-1010	HUMAN OTC DRUG	BHI Arthritis		ARNICA MONTANA ROOT, BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA WHOLE, CAUSTICUM, CITRULLUS COLOCYNTHIS FRUIT PULP, SOLANUM DULCAMARA TOP, FERROSOFERRIC PHOSPHATE, LEDUM PALUSTRE TWIG, LYCOPODIUM CLAVATUM SPORE, RANUNCULUS BULBOSUS, RHODODENDRON AUREUM LEAF, TOXICODENDRON PUBESCENS LEAF , and SULFUR	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA ROOT; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA WHOLE; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; FERROSOFERRIC PHOSPHATE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; RANUNCULUS BULBOSUS; RHODODENDRON AUREUM LEAF; SOLANUM DULCAMARA TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF	6; 8; 4; 4; 5; 12; 6; 10; 8; 6; 6; 10; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1011_cccd1407-6de0-4d19-9305-92cf3d440173	62795-1011	HUMAN OTC DRUG	BHI Allergy		ANTIMONY TRISULFIDE, ARNICA MONTANA ROOT, FORMIC ACID, GRAPHITE, HISTAMINE DIHYDROCHLORIDE,STRYCHNOS IGNATII SEED, ARCTIUM LAPPA ROOT, LEDUM PALUSTRE TWIG, LYCOPODIUM CLAVATUM SPORE, PINE TAR, SELENIUM, SULFUR, SULFURIC ACID, TELLURIUM, THUJA OCCIDENTALIS LEAFY TWIG	TABLET	ORAL	20140830		UNAPPROVED HOMEOPATHIC		MediNatura	ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARNICA MONTANA ROOT; FORMIC ACID; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; PINE TAR; SELENIUM; STRYCHNOS IGNATII SEED; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG	10; 8; 6; 8; 10; 8; 8; 6; 10; 12; 6; 12; 30; 10; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1012_906bf8a5-cca6-4a15-9de3-4f4111da1c2f	62795-1012	HUMAN OTC DRUG	Mucus Relief		ANTIMONY POTASSIUM TARTRATE, ATROPA BELLADONNA, BRYONIA ALBA WHOLE, ANEMONE AMERICANA, HYOSCYAMUS NIGER, IPECAC, LOBELIA INFLATA, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED, and LOBARIA PULMONARIA	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ANEMONE HEPATICA VAR. OBTUSA; ANTIMONY POTASSIUM TARTRATE; ATROPA BELLADONNA; BRYONIA ALBA WHOLE; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYOSCYAMUS NIGER; IPECAC; LOBARIA PULMONARIA; LOBELIA INFLATA	6; 5; 6; 6; 30; 5; 6; 5; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1013_0fc9b5ab-6737-4997-b4a1-5d51755b5c22	62795-1013	HUMAN OTC DRUG	BHI Acne		SILVER NITRATE, ARNICA MONTANA, ATROPA BELLADONNA, BRYONIA ALBA ROOT, SOLANUM DULCAMARA TOP, ECHINACEA PURPUREA, CALCIUM SULFIDE, LACHESIS MUTA VENOM, PHYTOLACCA AMERICANA ROOT, PULSATILLA VULGARIS, RANCID BEEF, TOXICODENDRON PUBESCENS LEAF, and THUJA OCCIDENTALIS LEAFY TWIG	TABLET	ORAL	20140930	20250930	UNAPPROVED HOMEOPATHIC		MediNatura	ARNICA MONTANA; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; ECHINACEA PURPUREA; LACHESIS MUTA VENOM; PHYTOLACCA AMERICANA ROOT; PULSATILLA VULGARIS; RANCID BEEF; SILVER NITRATE; SOLANUM DULCAMARA TOP; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	8; 4; 5; 10; 2; 12; 6; 6; 12; 8; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1014_da52025d-30b4-457e-92b4-455b41476b4c	62795-1014	HUMAN OTC DRUG	BHI Throat		SILVER NITRATE, ARNICA MONTANA ROOT, ARISAEMA TRIPHYLLUM ROOT, OYSTER SHELL CALCIUM CARBONATE, CRUDE,ACTIVATED CHARCOAL, CAUSTICUM, HYOSCYAMUS NIGER, PARIS QUADRIFOLIA, PHOSPHORUS, and VERBASCUM THAPSUS	TABLET	ORAL	20150101	20260430	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACTIVATED CHARCOAL; ARISAEMA TRIPHYLLUM ROOT; ARNICA MONTANA ROOT; CAUSTICUM; HYOSCYAMUS NIGER; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PARIS QUADRIFOLIA; PHOSPHORUS; SILVER NITRATE; VERBASCUM THAPSUS	10; 4; 8; 6; 6; 30; 5; 10; 6; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1015_81de70ac-1a68-4608-a1e7-ca8aa6ef5b1b	62795-1015	HUMAN OTC DRUG	BHI Spasm Pain		ATROPINE SULFATE, ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CITRULLUS COLOCYNTHIS FRUIT PULP, and CUPRIC SULFATE	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACONITUM NAPELLUS; ATROPINE SULFATE; BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC SULFATE	4; 6; 4; 4; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
62795-1016_29e7a2ad-a3bb-4527-a81d-0c6b4dba65a5	62795-1016	HUMAN OTC DRUG	BHI Skin		BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, and SULFUR	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	BERBERIS VULGARIS ROOT BARK; GRAPHITE; HYDROFLUORIC ACID; LYCOPODIUM CLAVATUM SPORE; PETROLATUM; SEPIA OFFICINALIS JUICE; SULFUR; TOXICODENDRON PUBESCENS LEAF	6; 10; 10; 12; 10; 10; 12; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1017_fe477719-75f6-4273-9a61-5bc8ef7bdb47	62795-1017	HUMAN OTC DRUG	BHI Sinus		EUPHORBIA RESINIFERA RESIN, GOLDENSEAL, POTASSIUM DICHROMATE, POTASSIUM IODIDE, PHOSPHORUS, PULSATILLA VULGARIS, and THUJA OCCIDENTALIS LEAFY TWIG	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	EUPHORBIA RESINIFERA RESIN; GOLDENSEAL; PHOSPHORUS; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PULSATILLA VULGARIS; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 8; 6; 8; 4; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1019_28fb3178-9aac-406f-a82a-de53d0876f67	62795-1019	HUMAN OTC DRUG	BHI Migraine		ACETIC ACID, ARANEUS DIADEMATUS, ASAFETIDA, BRYONIA ALBA WHOLE, TRIBASIC CALCIUM PHOSPHATE, ACTIVATED CHARCOAL, CINCHONA OFFICINALIS BARK, MARSDENIA CONDURANGO BARK, TUBOCURARINE CHLORIDE, KALMIA LATIFOLIA LEAF, LYCOPODIUM CLAVATUM SPORE, SODIUM SULFATE, PHOSPHORIC ACID, PULSATILLA VULGARIS, CLAVICEPS PURPUREA SCLEROTIUM, and SILICON DIOXIDE	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACETIC ACID; ACTIVATED CHARCOAL; ARANEUS DIADEMATUS; ASAFETIDA; BRYONIA ALBA WHOLE; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; PHOSPHORIC ACID; PULSATILLA VULGARIS; SILICON DIOXIDE; SODIUM SULFATE; STRYCHNINE NITRATE; TRIBASIC CALCIUM PHOSPHATE; TUBOCURARINE CHLORIDE	6; 10; 8; 6; 30; 4; 6; 8; 6; 4; 6; 4; 10; 6; 8; 10; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
62795-1020_6647c7d7-3d0e-44f1-bc4b-9ec8fed27a14	62795-1020	HUMAN OTC DRUG	BHI Hemorrhoid		HORSE CHESTNUT, ALOE, COLLINSONIA CANADENSIS ROOT, VERONICASTRUM VIRGINICUM ROOT, HYDROCHLORIC ACID, STRYCHNOS NUX-VOMICA SEED, PAEONIA OFFICINALIS ROOT, and SULFUR	TABLET	ORAL	20150101		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ALOE; COLLINSONIA CANADENSIS ROOT; HORSE CHESTNUT; HYDROCHLORIC ACID; PAEONIA OFFICINALIS ROOT; STRYCHNOS NUX-VOMICA SEED; SULFUR; VERONICASTRUM VIRGINICUM ROOT	4; 4; 4; 6; 6; 5; 10; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62795-1021_23d3e637-436b-4ceb-9d95-71446bf9b145	62795-1021	HUMAN OTC DRUG	BHI Diarrhea		ALOE, ACTIVATED CHARCOAL, CITRULLUS COLOCYNTHIS FRUIT PULP, CUPRIC ACETATE, FERRUM PHOSPHORICUM, PODOPHYLLUM, POTENTILLA ERECTA ROOT, and VERATRUM ALBUM ROOT	TABLET	ORAL	20140830		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACTIVATED CHARCOAL; ALOE; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC ACETATE; FERRUM PHOSPHORICUM; PODOPHYLLUM; POTENTILLA ERECTA ROOT; VERATRUM ALBUM ROOT	12; 4; 6; 6; 10; 6; 4; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1022_6209f6c9-1970-4141-b24a-7bde03a00a86	62795-1022	HUMAN OTC DRUG	BHI Cough		ANTIMONY POTASSIUM TARTRATE, ATROPA BELLADONNA, BLATTA ORIENTALIS, BRYONIA ALBA WHOLE, ANEMONE AMERICANA, STAR ANISE, IPECAC, LOBELIA INFLATA, NAPHTHALENE, SODIUM SULFIDE NONAHYDRATE, ASPIDOSPERMA QUEBRACHO-BLANCO BARK, and STACHYS OFFICINALIS	TABLET	ORAL	20140830	20250331	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ANEMONE HEPATICA VAR. OBTUSA; ANTIMONY POTASSIUM TARTRATE; ASPIDOSPERMA QUEBRACHO-BLANCO BARK; ATROPA BELLADONNA; BLATTA ORIENTALIS; BRYONIA ALBA WHOLE; IPECAC; LOBELIA INFLATA; NAPHTHALENE; SODIUM SULFIDE NONAHYDRATE; STACHYS OFFICINALIS; STAR ANISE	5; 6; 6; 6; 8; 8; 4; 5; 6; 6; 4; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	
62795-1023_0796514f-7864-45a2-8894-9bb66517de72	62795-1023	HUMAN OTC DRUG	BHI Cold		PULSATILLA VULGARIS and SULFUR	TABLET	ORAL	20140830	20250228	UNAPPROVED HOMEOPATHIC		MediNatura Inc	PULSATILLA VULGARIS; SULFUR	6; 8	[hp_X]/1; [hp_X]/1			N	
62795-1024_091d5a34-dbbb-455e-9825-9b807711eca8	62795-1024	HUMAN OTC DRUG	WellMind Calming		AVENA SATIVA FLOWERING TOP, ARABICA COFFEE BEAN, PASSIFLORA INCARNATA FLOWERING TOP,SEPIA OFFICINALIS JUICE, and VALERIAN	TABLET	ORAL	20140830	20250730	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; SEPIA OFFICINALIS JUICE; VALERIAN	12; 2; 3; 4; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
62795-1027_5d140604-45be-4576-8eb3-bab6440d1c71	62795-1027	HUMAN OTC DRUG	ReBoost Immune		ACONITUM NAPELLUS,CYNANCHUM VINCETOXICUM ROOT, and SULFUR	TABLET	ORAL	20140930	20250331	UNAPPROVED HOMEOPATHIC		MediNatura	ACONITUM NAPELLUS; CYNANCHUM VINCETOXICUM ROOT; SULFUR	6; 5; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1028_87ff27cd-8892-43c1-9f09-bbaddb85b81d	62795-1028	HUMAN OTC DRUG	Clearlife		ANTIMONY TRISULFIDE, ARNICA MONTANA ROOT, EUPHRASIA STRICTA,FORMIC ACID,GRAPHITE,HISTAMINE DIHYDROCHLORIDE,STRYCHNOS IGNATII SEED, ARCTIUM LAPPA ROOT, LEDUM PALUSTRE TWIG, LYCOPODIUM CLAVATUM SPORE, PINE TAR, SELENIUM, SULFUR, SULFURIC ACID, TELLURIUM, and THUJA OCCIDENTALIS LEAFY TWIG	TABLET	ORAL	20140930	20250430	UNAPPROVED HOMEOPATHIC		MediNatura Inc.	ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARNICA MONTANA ROOT; EUPHRASIA STRICTA; FORMIC ACID; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; PINE TAR; SELENIUM; STRYCHNOS IGNATII SEED; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG	10; 8; 5; 6; 8; 10; 8; 7; 6; 10; 12; 6; 12; 21; 10; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1033_79c60c29-1a43-420c-bcf4-1adea6445e22	62795-1033	HUMAN OTC DRUG	T Relief Arthritis		ARNICA MONTANA, BRYONIA ALBA ROOT, SUS SCROFA CARTILAGE, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA PLACENTA, RHODODENDRON AUREUM LEAF,TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SULFUR, and COMFREY ROOT	TABLET	ORAL	20160301		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA; BRYONIA ALBA ROOT; COMFREY ROOT; LEDUM PALUSTRE TWIG; RHODODENDRON AUREUM LEAF; SANGUINARIA CANADENSIS ROOT; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	3; 3; 7; 6; 8; 3; 2; 6; 4; 6; 6; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1034_192c1cc3-f146-41ef-a532-e0fc1252f9ad	62795-1034	HUMAN OTC DRUG	T-Relief		ARNICA MONTANA WHOLE, CALENDULA OFFICINALIS FLOWERING TOP, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK,BAPTISIA TINCTORIA ROOT, BELLIS PERENNIS WHOLE, ECHINACEA ANGUSTIFOLIA WHOLE,ACONITUM NAPELLUS WHOLE,MATRICARIA CHAMOMILLA WHOLE,ACHILLEA MILLEFOLIUM WHOLE,ATROPA BELLADONNA,HYPERICUM PERFORATUM WHOLE,RUTA GRAVEOLENS FLOWERING TOP and COMFREY ROOT	TABLET, CHEWABLE	ORAL	20151201		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM WHOLE; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP	2; 3; 3; 3; 2; 2; 2; 8; 2; 2; 3; 2; 4	[hp_X]/1; [hp_M]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1038_4af5462c-6cf2-4fd1-af4e-429b398c917c	62795-1038	HUMAN OTC DRUG	T-Relief Pro		ACONITUM NAPELLUS, ARNICA MONTANA, BAPTISIA TINCTORIA ROOT, ATROPA BELLADONNA, BELLIS PERENNIS, CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA CHAMOMILLA, ECHINACEA UNSPECIFIED, HAMAMELIS VIRGINIANA ROOT BARK STEM, HYPERICUM PERFORATUM, RUTA GRAVEOLENS FLOWERING TOP, ACHILLEA MILLEFOLIUM and COMFREY ROOT	TABLET, CHEWABLE	ORAL	20180611	20260131	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; RUTA GRAVEOLENS FLOWERING TOP	2; 3; 3; 3; 2; 2; 2; 6; 2; 2; 3; 2; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1039_4899dee5-3011-4794-966f-3be10db2dedd	62795-1039	HUMAN OTC DRUG	T-Relief PRO Arthritis		ARNICA MONTANA, BRYONIA ALBA WHOLE, SUS SCROFA CARTILAGE,SOLANUM DULCAMARA TOP,SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD,RHODODENDRON TOMENTOSUM LEAFY TWIG,SUS SCROFA PLACENTA,RHODODENDRON AUREUM LEAF,TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SULFUR and COMFREY ROOT	TABLET	ORAL	20171213	20260327	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA; BRYONIA ALBA WHOLE; COMFREY ROOT; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; SANGUINARIA CANADENSIS ROOT; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	3; 3; 7; 8; 6; 3; 2; 6; 4; 6; 6; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1040_f166307e-e042-45bd-a6ae-7451092b34b5	62795-1040	HUMAN OTC DRUG	T-Relief Pro Spasm		ACONITUM NAPELLUS,AMANITA MUSCARIA FRUITING BODY, AMMONIUM BROMIDE, ATROPINE SULFATE, ATROPA BELLADONNA, MATRICARIA RECUTITA, CITRULLUS COLOCYNTHIS FRUIT PULP,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, PASSIFLORA INCARNATA FLOWERING TOP, and VERATRUM ALBUM ROOT	TABLET	ORAL	20171116	20250430	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACONITUM NAPELLUS; AMANITA MUSCARIA FRUITING BODY; AMMONIUM BROMIDE; ATROPA BELLADONNA; ATROPINE SULFATE; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC SULFATE; GELSEMIUM SEMPERVIRENS ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWERING TOP; VERATRUM ALBUM ROOT	6; 4; 4; 6; 6; 3; 6; 6; 6; 2; 2; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
62795-1041_ef7a3bff-c818-4f4c-bd31-98e1b7be7eee	62795-1041	HUMAN OTC DRUG	T-Relief Extra Strength		ARNICA MONTANA, CALENDULA OFFICINALIS FLOWERING, HAMAMELIS VIRGINIANA ROOT BARK/STEM, BAPTISIA TINCTORIA ROOT, BELLIS PERENNIS, ECHINACEA, UNSPECIFIED, ACONITUM NAPELLUS, MATRICARIA CHAMOMILLA, ACHILLEA MILLEFOLIUM, ATROPA BELLADONNA, HYPERICUM PERFORATUM, RUTA GRAVEOLENS FLOWERING TOP and COMFREY ROOT	TABLET, CHEWABLE	ORAL	20180201		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; RUTA GRAVEOLENS FLOWERING TOP	2; 3; 3; 3; 2; 2; 2; 6; 2; 2; 3; 2; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1042_da0a425e-b716-4f93-9903-c3db9058abaf	62795-1042	HUMAN OTC DRUG	Reboost		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GOLDENSEAL, LACHESIS MUTA VENOM, PHOSPHORUS, VINCETOXICUM HIRUNDINARIA ROOT, ZINC GLUCONATE, ZINC ACETATE ANHYDROUS, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE, IPECAC, SULFUR and INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED)	TABLET	ORAL	20200219	20250430	UNAPPROVED HOMEOPATHIC		MediNatura Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GOLDENSEAL; INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED); IPECAC; LACHESIS MUTA VENOM; PHOSPHORUS; SULFUR; VINCETOXICUM HIRUNDINARIA ROOT; ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	3; 3; 20; 6; 5; 19; 3; 10; 8; 4; 6; 2; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	
62795-1043_8cd4867a-3371-4833-a882-19528bfb6278	62795-1043	HUMAN OTC DRUG	WellMind Calming		MATRICARIA CHAMOMILLA WHOLE,ARABICA COFFEE BEAN,HOPS,STRYCHNOS IGNATII SEED,MOSCHUS MOSCHIFERUS MUSK SAC RESIN,STRYCHNOS NUX-VOMICA SEED,PASSIFLORA INCARNATA FLOWERING TOP,SULFUR,VALERIAN and VERATRUM ALBUM ROOT	TABLET	ORAL	20210428		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARABICA COFFEE BEAN; HOPS; MATRICARIA CHAMOMILLA WHOLE; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR; VALERIAN; VERATRUM ALBUM ROOT	10; 2; 2; 10; 2; 8; 30; 12; 2; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62795-1044_8b49b20a-1ee8-4625-8c04-280c39ef2197	62795-1044	HUMAN OTC DRUG	Reboost		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GOLDENSEAL, LACHESIS MUTA VENOM, PHOSPHORUS, VINCETOXICUM HIRUNDINARIA ROOT, ZINC GLUCONATE, ZINC ACETATE ANHYDROUS, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE, IPECAC, SULFUR	TABLET	ORAL	20220105		UNAPPROVED HOMEOPATHIC		MediNatura Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; PHOSPHORUS; SULFUR; VINCETOXICUM HIRUNDINARIA ROOT; ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	3; 3; 20; 6; 5; 3; 10; 8; 4; 6; 2; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
62795-1050_3d3455a0-af15-443f-9828-58ad03602727	62795-1050	HUMAN OTC DRUG	Clearlife Extra Strength		ONION, AMBROSIA ARTEMISIIFOLIA WHOLE, APIS MELLIFERA, ARNICA MONTANA WHOLE, EUPHRASIA STRICTA, GRAPHITE,GALPHIMIA GLAUCA FLOWERING TOP,PULSATILLA VULGARIS WHOLE, HISTAMINE DIHYDROCHLORIDE, PINE TAR, SCHOENOCAULON OFFICINALE SEED, SULFUR, SULFURIC ACID,TELLURIUM and THUJA OCCIDENTALIS LEAFY TWIG	TABLET	ORAL	20210106		UNAPPROVED HOMEOPATHIC		MediNatura Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; APIS MELLIFERA; ARNICA MONTANA; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; ONION; PINE TAR; PULSATILLA VULGARIS WHOLE; SCHOENOCAULON OFFICINALE SEED; SULFUR; SULFURIC ACID; TELLURIUM; THUJA OCCIDENTALIS LEAFY TWIG	3; 4; 5; 3; 3; 10; 8; 3; 10; 4; 6; 4; 20; 10; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
62795-1053_5b85f305-4463-4a4e-ac6f-c3265fcc96cc	62795-1053	HUMAN OTC DRUG	T Relief Arthritis Extra Strength		ARNICA MONTANA, BRYONIA ALBA ROOT, SUS SCROFA CARTILAGE, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG,SUS SCROFA PLACENTA, RHODODENDRON AUREUM LEAF,TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SULFUR, and COMFREY ROOT	TABLET	ORAL	20220405		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA; BRYONIA ALBA ROOT; COMFREY ROOT; LEDUM PALUSTRE TWIG; RHODODENDRON AUREUM LEAF; SANGUINARIA CANADENSIS ROOT; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	3; 3; 7; 6; 8; 3; 2; 6; 4; 6; 6; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1111_6da77fde-95ca-455a-8aa3-9738ce306498	62795-1111	HUMAN OTC DRUG	Dr. Hendel Appetite Control		OYSTER SHELL CALCIUM CARBONATE, CAPSICUM, IRON, FUCUS VESICULOSUS, GRAPHITE, STRYCHNOS IGNATII SEED, and LYCOPODIUM CLAVATUM SPORE	TABLET	ORAL	20160801	20260831	UNAPPROVED HOMEOPATHIC		MediNatura Inc	CAPSICUM; FUCUS VESICULOSUS; GRAPHITE; IRON; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; STRYCHNOS IGNATII SEED	12; 12; 12; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	
62795-1112_0a6b0e83-5280-4742-b415-a8404c2ec0e5	62795-1112	HUMAN OTC DRUG	Arnica Montana 3X, 6X, 12X, 30X, 200X		ARNICA MONTANA ROOT	TABLET	ORAL	20160801	20270228	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA ROOT	3	[hp_X]/1			N	
62795-1113_d4c7bbe2-b7d4-4a0c-b9e8-ef2ca6486521	62795-1113	HUMAN OTC DRUG	Dr. Hendel Arthritis Pain Relief		BRYONIA ALBA ROOT, ARNICA MONTANA, COLCHICUM AUTUMNALE BULB, SOLANUM DULCAMARA TOP, HARPAGOPHYTUM PROCUMBENS ROOT, LEDUM PALUSTRE TWIG, RHODODENDRON AUREUM LEAF,COMFREY ROOT, TOXICODENDRON PUBESCENS LEAF, OYSTER SHELL CALCIUM CARBONATE, CRUDE, TRIBASIC CALCIUM PHOSPHATE, and SILICON DIOXIDE	TABLET	ORAL	20160801		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; HARPAGOPHYTUM PROCUMBENS ROOT; LEDUM PALUSTRE TWIG; OYSTER SHELL CALCIUM CARBONATE, CRUDE; RHODODENDRON AUREUM LEAF; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	6; 4; 6; 6; 6; 6; 12; 6; 3; 6; 8; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
62795-1114_a0d1f708-8647-44fa-839c-44f8fa9a6db3	62795-1114	HUMAN OTC DRUG	Dr. Hendel Back Pain Relief		HORSE CHESTNUT, BRYONIA ALBA ROOT, CITRULLUS COLOCYNTHIS FRUIT PULP, SOLANUM DULCAMARA TOP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, HYPERICUM PERFORATUM, STRYCHNOS NUX-VOMICA SEED, and TOXICODENDRON PUBESCENS LEAF	TABLET	ORAL	20160801	20270331	UNAPPROVED HOMEOPATHIC		MediNatura Inc	BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; HORSE CHESTNUT; HYPERICUM PERFORATUM; PSEUDOGNAPHALIUM OBTUSIFOLIUM; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
62795-1115_c0eeb7b9-388c-410e-a8d0-00e2860b16e0	62795-1115	HUMAN OTC DRUG	Calm Plus		AVENA SATIVA FLOWERING TOP, MATRICARIA RECUTITA, PASSIFLORA INCARNATA FLOWERING, TRIBASIC CALCIUM PHOSPHATE, DIBASIC POTASSIUM PHOSPHATE, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC, SODIUM CHLORIDE, SODIUM SULFATE, ZINC VALERATE DIHYDRATE, ARABICA COFFEE BEAN, STRYCHNOS NUX-VOMICA SEED, and SULFUR	TABLET	ORAL	20160901	20260430	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; DIBASIC POTASSIUM PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM SULFATE; SODIUM CHLORIDE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SULFUR; TRIBASIC CALCIUM PHOSPHATE; ZINC VALERATE DIHYDRATE	12; 2; 6; 6; 2; 2; 6; 6; 6; 12; 12; 2; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	
62795-1116_9a7ae59e-27b4-484d-a41d-c77ef51c5d69	62795-1116	HUMAN OTC DRUG	Dr. Hendel Cold and Sore Throat Relief		APIS ELLIFERA, ONION, ATROPA BELLADONNA, GELSEMIUM SEMPERVIRENS ROOT, CAPSICUM, EUPATORIUM PERFOLIATUM FLOWERING TOP, ANEMONE PULSATILLA, and POTASSIUM DICHROMATE	TABLET	ORAL	20160801	20250731	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ANEMONE PULSATILLA; APIS MELLIFERA; ATROPA BELLADONNA; CAPSICUM; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; ONION; POTASSIUM DICHROMATE	6; 4; 4; 6; 6; 4; 4; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	
62795-1117_463d05a0-6e23-4edc-aa8b-07228b9711c6	62795-1117	HUMAN OTC DRUG	Hendel Fibromyalgia Symptom Relief		VALERIAN, ARNICA MONTANA ROOT, ACONITUM NAPELLUS, BRYONIA ALBA ROOT,TOXICODENDRON PUBESCENS LEAF, BERBERIS VULGARIS ROOT BARK, COLCHICUM AUTUMNALE BULB, SOLANUM DULCAMARA TOP, HARPAGOPHYTUM PROCUMBENS WHOLE, RHODODENDRON TOMENTOSUM LEAFY TWIG, and RHODODENDRON AUREUM LEAF	TABLET	ORAL	20160801		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACONITUM NAPELLUS; ARNICA MONTANA ROOT; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; HARPAGOPHYTUM PROCUMBENS WHOLE; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF; VALERIAN	4; 3; 6; 4; 6; 6; 6; 6; 6; 4; 2	[hp_X]/1; [hp_X]/1; 1/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1118_e1c0ca8c-7465-4e50-bf67-ea9b15560ce2	62795-1118	HUMAN OTC DRUG	Hendel Homeopathic Calm		AVENA SATIVA FLOWERING TOP, MATRICARIA CHAMOMILLA, HOPS, PASSIFLORA INCARNATA FLOWERING TOP, ZINC VALERATE DIHYDRATE, ARABICA COFFEE BEAN, STRYCHNOS NUX-VOMICA SEED, and SULFUR	TABLET	ORAL	20160801	20260930	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; HOPS; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR; ZINC VALERATE DIHYDRATE	12; 2; 2; 2; 2; 12; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	
62795-1120_c5912419-63fa-417f-acd2-8b9b49ff5e29	62795-1120	HUMAN OTC DRUG	Hendel Insomnia Relief		PASSIFLORA INCARNATA FLOWERING TOP, AMBERGRIS, SCUTELLARIA LATERIFLORA, ZINC VALERATE DIHYDRATE, ANAMIRTA COCCULUS SEED, and ARABICA COFFEE BEAN	TABLET	ORAL	20160531		UNAPPROVED HOMEOPATHIC		MediNatura Inc	AMBERGRIS; ANAMIRTA COCCULUS SEED; ARABICA COFFEE BEAN; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA; ZINC VALERATE DIHYDRATE	6; 12; 12; 2; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62795-1122_de6ac1da-25f6-4da2-a971-cb6b5665245b	62795-1122	HUMAN OTC DRUG	Hendel Liver Support		BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA ROOT, VERONICASTRUM VIRGINICUM ROOT, MANDRAGORA OFFICINARUM ROOT, TARAXACUM OFFICINALE, ACTIVATED CHARCOAL, CHELIDONIUM MAJUS, and LYCOPODIUM CLAVATUM SPORE	TABLET	ORAL	20160901	20260228	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACTIVATED CHARCOAL; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; LYCOPODIUM CLAVATUM SPORE; MANDRAGORA OFFICINARUM ROOT; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT	12; 6; 6; 12; 12; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1124_e9a3d195-fb5a-44b6-aef4-a8c117eec356	62795-1124	HUMAN OTC DRUG	Hendel Pain and Injury Relief		ACONITUM NAPELLUS, ARNICA MONTANA ROOT, BELLIS PERENNIS, CALENDULA OFFICINALIS FLOWERING TOP, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, HYPERICUM PERFORATUM, RHODODENDRON TOMENTOSUM LEAFY TWIG, RUTA GRAVEOLENS FLOWERING TOP, and COMFREY ROOT	TABLET	ORAL	20160801	20260228	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACONITUM NAPELLUS; ARNICA MONTANA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP	4; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1126_19d60e31-a1d2-4724-a2da-9045fd58284e	62795-1126	HUMAN OTC DRUG	Hendel Psoriasis, Eczema, Seborrhea		KEROSENE,GRAPHITE, CALCIUM SULFIDE, SEPIA OFFICINALIS JUICE, SULFUR, and THUJA OCCIDENTALIS LEAFY TWIG	TABLET	ORAL	20160707	20260430	UNAPPROVED HOMEOPATHIC		MediNatura Inc	CALCIUM SULFIDE; GRAPHITE; KEROSENE; SEPIA OFFICINALIS JUICE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 6; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1127_1d395e50-5530-43f8-b384-c3081051bfd2	62795-1127	HUMAN OTC DRUG	Hendel Rhus Tox		TOXICODENDRON PUBESCENS LEAF	TABLET	ORAL	20160712	20270131	UNAPPROVED HOMEOPATHIC		MediNatura Inc	TOXICODENDRON PUBESCENS LEAF	6	[hp_X]/1			N	
62795-1128_7c5afe85-db35-46e1-ab1b-0e6aa995134e	62795-1128	HUMAN OTC DRUG	Hendel Schuessler Cell Salts		CALCIUM FLUORIDE, TRIBASIC CALCIUM PHOSPHATE, CALCIUM SULFATE ANHYDROUS,FERROUS PHOSPHATE,POTASSIUM CHLORIDE,POTASSIUM SULFATE,MAGNESIUM PHOSPHATE, DIBASIC,SODIUM PHOSPHATE, DIBASIC,SODIUM SULFATE and SILICON DIOXIDE	TABLET	ORAL	20160816	20260930	UNAPPROVED HOMEOPATHIC		MediNatura Inc	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERRUM PHOSPHORICUM; MAGNESIUM PHOSPHATE, DIBASIC; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	
62795-1130_01db75f0-7f65-4883-920f-ea01f607424f	62795-1130	HUMAN OTC DRUG	Hendel Stress, Burnout and Exhaustion Symptoms		BRYONIA ALBA ROOT,MATRICARIA CHAMOMILLA, CITRULLUS COLOCYNTHIS FRUIT PULP, STRYCHNOS NUX-VOMICA SEED and SEPIA OFFICINALIS JUICE	TABLET	ORAL	20160531		UNAPPROVED HOMEOPATHIC		MediNatura Inc	BRYONIA ALBA ROOT; CITRULLUS COLOCYNTHIS FRUIT PULP; MATRICARIA CHAMOMILLA; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
62795-1131_5bae4a44-9a44-478e-8d22-9b6009afa768	62795-1131	HUMAN OTC DRUG	Hendel Indigestion and Bloating		ACTIVATED CHARCOAL, STRYCHNOS NUX-VOMICA SEED, SILVER NITRATE, ARSENIC TRIOXIDE, and IPECAC	TABLET	ORAL	20180903	20260930	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; IPECAC; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED	3; 12; 6; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
62795-1132_acec53a2-5fcb-46aa-9a68-45bdb26a1e06	62795-1132	HUMAN OTC DRUG	Hendel Nerve Pain Relief		DAPHNE MEZEREUM BARK, ARNICA MONTANA, ARSENIC TRIOXIDE, ATROPA BELLADONNA, CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, HYPERICUM PERFORATUM, RUTA GRAVEOLENS FLOWERING TOP, and TOXICODENDRON PUBESCENS LEAF	TABLET	ORAL	20180802		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CITRULLUS COLOCYNTHIS FRUIT PULP; DAPHNE MEZEREUM BARK; HYPERICUM PERFORATUM; PSEUDOGNAPHALIUM OBTUSIFOLIUM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	6; 12; 6; 6; 3; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-1133_236170c9-286a-4ec1-901f-b9eb77d24e59	62795-1133	HUMAN OTC DRUG	Hendel Periodontal and Tooth Pain Relief		SODIUM BORATE, TRIBASIC CALCIUM PHOSPHATE, MERCURIUS SOLUBILIS, and SILICON DIOXIDE	TABLET	ORAL	20180801	20270131	UNAPPROVED HOMEOPATHIC		MediNatura Inc	MERCURIUS SOLUBILIS; SILICON DIOXIDE; SODIUM BORATE; TRIBASIC CALCIUM PHOSPHATE	12; 12; 8; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
62795-1134_e9e1ff34-9e67-47ae-a2f9-335160791be2	62795-1134	HUMAN OTC DRUG	Hendel Sinus Relief		ECHINACEA PURPUREA, ANEMONE PULSATILLA, EUPATORIUM PERFOLIATUM FLOWERING, GOLDENSEAL, POTASSDICHROMATE, LUFFA OPERCULATA FRUIT, POTASSIUM IODIDE, CALCIUM SULFIDE and MERCURIC SULFIDE	TABLET	ORAL	20160622	20270430	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ANEMONE PULSATILLA; CALCIUM SULFIDE; ECHINACEA PURPUREA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GOLDENSEAL; LUFFA OPERCULATA FRUIT; MERCURIC SULFIDE; POTASSIUM DICHROMATE; POTASSIUM IODIDE	4; 10; 3; 6; 6; 6; 12; 6; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-1135_b83b1cb3-37c3-4aaa-9b87-ef31cc89b13a	62795-1135	HUMAN OTC DRUG	Hendel Leg Cramp		CINCHONA OFFICINALIS BARK,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,COPPER,PSEUDOGNAPHALIUM OBTUSIFOLIUM,Veratrum album Root,HYOSCYAMUS NIGER,PLATINUM and ZINC VALERATE DIHYDRATE	TABLET	ORAL	20190507		UNAPPROVED HOMEOPATHIC		MediNatura Inc	CINCHONA OFFICINALIS BARK; COPPER; HYOSCYAMUS NIGER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PLATINUM; PSEUDOGNAPHALIUM OBTUSIFOLIUM; VERATRUM ALBUM ROOT; ZINC VALERATE DIHYDRATE	3; 6; 12; 4; 12; 6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62795-1221_a4334f92-51ed-4731-8af8-ce7848c89c52	62795-1221	HUMAN OTC DRUG	WellMind Mental Focus		WellMind	TABLET	ORAL	20161101	20270430	UNAPPROVED HOMEOPATHIC		MediNatura Inc.	ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; KEROSENE; SELENIUM; SEMECARPUS ANACARDIUM JUICE	4; 3; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
62795-2004_4333393f-9b1f-4773-8be2-05f6bde98e6c	62795-2004	HUMAN OTC DRUG	BodyAnew		BodyAnew	KIT		20180101		UNAPPROVED HOMEOPATHIC		MediNatura Inc						N	20241231
62795-2010_b7adba46-235d-4d94-9184-fe03eaf54102	62795-2010	HUMAN OTC DRUG	T-Relief Extra Strength		CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA RECUTITA, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, ACHILLEA MILLEFOLIUM, RUTA GRAVEOLENS FLOWERING TOP, COMFREY ROOT, ACONITUM NAPELLUS, ECHINACEA, UNSPECIFIED, BAPTISIA TINCTORIA ROOT, ATROPA BELLADONNA, ARNICA MONTANA, BELLIS PERENNIS and HYPERICUM PERFORATUM	SOLUTION/ DROPS	ORAL	20191105		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP	2; 3; 3; 3; 2; 2; 2; 8; 2; 3; 3; 2; 3	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
62795-2302_b8047305-bf5e-40a9-98b7-cc113890003b	62795-2302	HUMAN OTC DRUG	Traumex		ARNICA MONTANA WHOLE, CALENDULA OFFICINALIS FLOWERING TOP, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK,BAPTISIA TINCTORIA ROOT, BELLIS PERENNIS WHOLE, ECHINACEA ANGUSTIFOLIA WHOLE,ACONITUM NAPELLUS WHOLE,MATRICARIA CHAMOMILLA WHOLE,ACHILLEA MILLEFOLIUM WHOLE,ATROPA BELLADONNA,HYPERICUM PERFORATUM WHOLE,RUTA GRAVEOLENS FLOWERING TOP and COMFREY ROOT	TABLET, CHEWABLE	ORAL	20230320		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM WHOLE; ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM WHOLE; MATRICARIA CHAMOMILLA WHOLE; RUTA GRAVEOLENS FLOWERING TOP	2; 3; 3; 3; 2; 2; 2; 8; 2; 2; 3; 2; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-2303_1ebf8c33-ca9a-439f-8e66-7b44667c2280	62795-2303	HUMAN OTC DRUG	Traumed		ARNICA MONTANA WHOLE, CALENDULA OFFICINALIS FLOWERING TOP, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK,BAPTISIA TINCTORIA ROOT, BELLIS PERENNIS WHOLE, ECHINACEA ANGUSTIFOLIA WHOLE,ACONITUM NAPELLUS WHOLE,MATRICARIA CHAMOMILLA WHOLE,ACHILLEA MILLEFOLIUM WHOLE,ATROPA BELLADONNA,HYPERICUM PERFORATUM WHOLE,RUTA GRAVEOLENS FLOWERING TOP and COMFREY ROOT	TABLET, CHEWABLE	ORAL	20230321		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM WHOLE; ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM WHOLE; MATRICARIA CHAMOMILLA WHOLE; RUTA GRAVEOLENS FLOWERING TOP	2; 3; 3; 3; 2; 2; 2; 8; 2; 2; 3; 2; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-4004_8a18d95c-9b99-4421-ba4b-a9ce7026d331	62795-4004	HUMAN OTC DRUG	ReBoost		APIS MELLIFERA, ATROPA BELLADONNA, ZINC GLUCONATE, BAPTISIA TINCTORIA ROOT, ULMUS RUBRA BARK, SULFUR, ZINC ACETATE ANHYDROUS,VINCETOXICUM HIRUNDINARIA ROOT and CAIRINA MOSCHATA HEART/LIVER	SPRAY	ORAL	20200205		UNAPPROVED HOMEOPATHIC		MediNatura	APIS MELLIFERA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA PURPUREA; GOLDENSEAL; PHYTOLACCA AMERICANA ROOT; PLANTAGO MAJOR; SAGE; SULFUR; ULMUS RUBRA BARK; VINCETOXICUM HIRUNDINARIA ROOT; ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	6; 5; 1; 20; 4; 4; 5; 4; 3; 3; 4; 1; 6; 4; 1	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
62795-4005_dc9cb3f4-8286-48c3-bfa0-0ed53a3840b1	62795-4005	HUMAN OTC DRUG	ReBoost		SILVER NITRATE,EUPHORBIA RESINIFERA RESIN, CALCIUM SULFIDE, GOLDENSEAL, POTASSIUM DICHROMATE,LUFFA OPERCULATA FRUIT, SODIUM CARBONATE, ECHINACEA UNSPECIFIED, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE and PULSATILLA VULGARIS	SPRAY	NASAL	20200204		UNAPPROVED HOMEOPATHIC		MediNatura	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CALCIUM SULFIDE; ECHINACEA, UNSPECIFIED; EUPHORBIA RESINIFERA RESIN; GOLDENSEAL; LUFFA OPERCULATA FRUIT; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SILVER NITRATE; SODIUM CARBONATE	20; 10; 3; 4; 5; 2; 6; 2; 10; 6	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL			N	20241231
62795-4006_c5d30dbc-f317-4ff1-86b6-8d57bfb0da75	62795-4006	HUMAN OTC DRUG	Clearlife Extra Strength		ONION, GALPHIMIA GLAUCA FLOWERING TOP, HISTAMINE DIHYDROCHLORIDE, LUFFA OPERCULATA FRUIT, SULFUR, AMBROSIA ARTEMISIIFOLIA WHOLE, EUPHRASIA STRICTA and SCHOENOCAULON OFFICINALE SEED	SPRAY	NASAL	20210106		UNAPPROVED HOMEOPATHIC		MediNatura Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; ONION; SCHOENOCAULON OFFICINALE SEED; SULFUR	4; 4; 4; 8; 3; 4; 4; 4	[hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
62795-6006_9e682242-8885-4822-9d88-8284891f524e	62795-6006	HUMAN OTC DRUG	T-Relief Arthritis		ARNICA MONTANA ROOT, BRYONIA ALBA WHOLE, SUS SCROFA UMBILICAL CORD, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO, SUS SCROFA UMBILICAL CORD, LEDUM PALUSTRE TWIG, SUS SCROFA PLACENTA, RHODODENDRON AUREUM LEAF, TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SULFUR, and COMFREY ROOT	CREAM	TOPICAL	20170131	20260531	UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARNICA MONTANA ROOT; BRYONIA ALBA WHOLE; COMFREY ROOT; LEDUM PALUSTRE TWIG; RHODODENDRON AUREUM LEAF; SANGUINARIA CANADENSIS ROOT; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	2; 2; 7; 6; 8; 3; 2; 6; 4; 4; 4; 4; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	
62795-7004_5efc2aef-833a-4b2c-a651-6a014bd450d2	62795-7004	HUMAN OTC DRUG	T-Relief		ACHILLEA MILLEFOLIUM, HYPERICUM PERFORATUM, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, ECHINACEA, UNSPECIFIED, MATRICARIA RECUTITA, ATROPA BELLADONNA,COMFREY ROOT, ACONITUM NAPELLUS, BELLIS PERENNIS,ARNICA MONTANA, and RUTA GRAVEOLENS FLOWERING TOP	OINTMENT	TOPICAL	20151201		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP	2; 1; 1; 2; 4; 2; 1; 4; 1; 2; 6; 2; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
62795-7005_d2d95f05-1490-4ae6-9a9e-7f75a289cdf1	62795-7005	HUMAN OTC DRUG	T-Relief		ACONITUM NAPELLUS, ARNICA MONTANA, BAPTISIA TINCTORIA ROOT, ATROPA BELLADONNA, BELLIS PERENNIS, CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA RECUTITA, ECHINACEA UNSPECIFIED, HAMAMELIS VIRGINIANA ROOT BARK STEM BARK, HYPERICUM PERFORATUM, ACHILLEA MILLEFOLIUM, RUTA GRAVEOLENS FLOWERING TOP and COMFREY ROOT	GEL	TOPICAL	20160731		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP	2; 1; 1; 2; 4; 2; 1; 4; 1; 2; 6; 2; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
62795-7006_0747964b-b515-47b6-87ac-542b263a54a4	62795-7006	HUMAN OTC DRUG	T-Relief Extra Strength Gel		ACONITUM NAPELLUS, ARNICA MONTANA, BAPTISIA TINCTORIA ROOT, ATROPA BELLADONNA, BELLIS PERENNIS, CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA RECUTITA, ECHINACEA UNSPECIFIED, HAMAMELIS VIRGINIANA ROOT BARK STEM BARK, HYPERICUM PERFORATUM, ACHILLEA MILLEFOLIUM, RUTA GRAVEOLENS FLOWERING TOP and COMFREY ROOT	GEL	TOPICAL	20200414		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP	2; 1; 1; 2; 4; 2; 1; 4; 1; 2; 6; 2; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
62795-7007_677f014e-daf5-40b4-8b5f-fbcb7db0f0ae	62795-7007	HUMAN OTC DRUG	T-Relief Extra Strength Cream		ARNICA MONTANA, CALENDULA OFFICINALIS FLOWERING TOP, ECHINACEA UNSPECIFIED, ACONITUM NAPELLUS, ACHILLEA MILLEFOLIUM, HAMAMELIS VIRGINIANA ROOT BARK STEM BARK, MATRICARIA CHAMOMILLA, ATROPA BELLADONNA, BELLIS PERENNIS, RUTA GRAVEOLENS FLOWERING TOP, BAPTISIA TINCTORIA ROOT, COMFREY ROOT and HYPERICUM PERFORATUM	CREAM	TOPICAL	20171019		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; RUTA GRAVEOLENS FLOWERING TOP	2; 1; 1; 2; 4; 2; 1; 4; 1; 2; 6; 2; 4	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
62795-9003_6fca3c42-3180-4925-be6d-0e60b30abb30	62795-9003	HUMAN OTC DRUG	WellMind Vertigo		SEMECARPUS ANACARDIUM JUICE, ANAMIRTA COCCULUS SEED, CONIUM MACULATUM FLOWERING TOP, KEROSENE, and SELENIUM	TABLET	ORAL	20220310		UNAPPROVED HOMEOPATHIC		MediNatura Inc.	ANAMIRTA COCCULUS SEED; CONIUM MACULATUM FLOWERING TOP; PETROLEUM ALKYLATE; SELENIUM; SEMECARPUS ANACARDIUM JUICE	4; 3; 8; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-9004_a9bfb09f-0839-4421-ad84-dc6ccc211a12	62795-9004	HUMAN OTC DRUG	BHI Uri-Control		APIS MELLIFERA, SILVER NITRATE, ATROPA BELLADONNA, LYTTA VESICATORIA, CAUSTICUM, EQUISETUM HYEMALE, PETROSELINUM CRISPUM, PULSATILLA VULGARIS, SMILAX REGELII ROOT, and TURPENTINE OIL	TABLET	ORAL	20220221		UNAPPROVED HOMEOPATHIC		MediNatura Inc	APIS MELLIFERA; ATROPA BELLADONNA; CAUSTICUM; EQUISETUM HYEMALE; LYTTA VESICATORIA; PETROSELINUM CRISPUM; PULSATILLA VULGARIS; SILVER NITRATE; SMILAX ORNATA ROOT; TURPENTINE OIL	6; 4; 8; 6; 6; 8; 6; 6; 6; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
62795-9487_f3bcc288-eae8-4ad0-b3f2-b0d170d3cf21	62795-9487	HUMAN OTC DRUG	Traumeel		ACONITUM NAPELLUS, ARNICA MONTANA ROOT, ATROPA BELLADONNA, BELLIS PERENNIS, CALENDULA OFFICINALIS FLOWERING TOP, MATRICARIA RECUTITA, ECHINACEA, UNSPECIFIED, ECHINACEA PURPUREA, HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK, CALCIUM SULFIDE, HYPERICUM PERFORATUM, MERCURIUS SOLUBILIS, ACHILLEA MILLEFOLIUM and COMFREY ROOT	OINTMENT	TOPICAL	20211214		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	1; 1; 3; 1; 1; 6; 1; 4; 1; 1; 1; 6; 1; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
62795-9488_fffc7bd4-a533-4c7a-aec5-3eb0b15a0eb9	62795-9488	HUMAN OTC DRUG	Traumeel		ATROPA BELLADONNA,ECHINACEA, UNSPECIFIED,ARNICA MONTANA ROOT,ACONITUM NAPELLUS,BELLIS PERENNIS,CALENDULA OFFICINALIS FLOWERING TOP,CALCIUM SULFIDE,HYPERICUM PERFORATUM,COMFREY ROOT,MATRICARIA RECUTITA,HAMAMELIS VIRGINIANA LEAF,ECHINACEA PURPUREA,MERCURIUS SOLUBILIS,ACHILLEA MILLEFOLIUM	TABLET	ORAL	20220124		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA LEAF; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	3; 3; 2; 4; 2; 8; 2; 8; 2; 2; 2; 2; 3; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62795-9489_f2ca4a93-cc2e-425c-bda1-caf5f201d492	62795-9489	HUMAN OTC DRUG	Zeel		ALPHA LIPOIC ACID, ARNICA MONTANA WHOLE,SUS SCROFA CARTILAGE, COENZYME A,SOLANUM DULCAMARA TOP,SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD, NADIDE, SODIUM DIETHYL OXALACETATE,SUS SCROFA PLACENTA,TOXICODENDRON PUBESCENS LEAF, SANGUINARIA CANADENSIS ROOT, SILICON DIOXIDE,SULFUR,CORIANDER	OINTMENT	TOPICAL	20220308		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ALPHA LIPOIC ACID; ARNICA MONTANA WHOLE; COENZYME A; CORIANDER; NADIDE; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SODIUM DIETHYL OXALACETATE; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	6; 2; 6; 8; 6; 2; 6; 6; 2; 6; 2; 2; 2; 2; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
62795-9490_6f211ff7-c47f-476a-a968-0c17e4d2f18f	62795-9490	HUMAN OTC DRUG	Engystol		VINCETOXICUM HIRUNDINARIA ROOT, SULFUR	TABLET	ORAL	20220112		UNAPPROVED HOMEOPATHIC		Medinatura Inc	SULFUR; VINCETOXICUM HIRUNDINARIA ROOT	10; 30	[hp_X]/1; [hp_X]/1			N	20241231
62795-9491_e9f45548-f449-42ab-92e5-3ab8149f839d	62795-9491	HUMAN OTC DRUG	Lymphomyosot		ARANEUS DIADEMATUS, TRIBASIC CALCIUM PHOSPHATE,EQUISETUM HYEMALE WHOLE, FERROUS IODIDE,FUMARIA OFFICINALIS FLOWERING TOP, GENTIANA LUTEA ROOT, JUGLANS REGIA LEAF, LEVOTHYROXINE SODIUM ANHYDROUS, MYOSOTIS ARVENSIS WHOLE,NASTURTIUM OFFICINALE,SODIUM SULFATE, PINUS SYLVESTRIS LEAFY TWIG,SMILAX ORNATA ROOT,SCROPHULARIA NODOSA WHOLE, TEUCRIUM SCORODONIA FLOWERING, VERONICA OFFICINALIS FLOWERING TOP	TABLET	ORAL	20220216		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ARANEUS DIADEMATUS; EQUISETUM HYEMALE WHOLE; FERROUS IODIDE; FUMARIA OFFICINALIS FLOWERING TOP; GENTIANA LUTEA ROOT; GERANIUM ROBERTIANUM; JUGLANS REGIA LEAF; LEVOTHYROXINE SODIUM ANHYDROUS; MYOSOTIS ARVENSIS WHOLE; NASTURTIUM OFFICINALE; PINUS SYLVESTRIS LEAFY TWIG; SCROPHULARIA NODOSA WHOLE; SMILAX ORNATA ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; VERONICA OFFICINALIS FLOWERING TOP	6; 4; 12; 4; 5; 4; 3; 12; 3; 4; 4; 3; 6; 4; 3; 12; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
62795-9493_cae3666b-3400-45b1-ac08-4e1c40e7eb1d	62795-9493	HUMAN OTC DRUG	Spascupreel		ACONITUM NAPELLUS WHOLE, AMANITA MUSCARIA FRUITING BODY, AMMONIUM BROMIDE, ATROPINE SULFATE, ATROPINE SULFATE, MATRICARIA CHAMOMILLA WHOLE, CITRULLUS COLOCYNTHIS FRUIT PULP, CUPRIC SULFATE,GELSEMIUM SEMPERVIRENS ROOT,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,PASSIFLORA INCARNATA FLOWERING TOP,VERATRUM ALBUM ROOT	TABLET	ORAL	20220217		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ACONITUM NAPELLUS WHOLE; AMANITA MUSCARIA FRUITING BODY; AMMONIUM BROMIDE; ATROPINE SULFATE; CITRULLUS COLOCYNTHIS FRUIT PULP; CUPRIC SULFATE; GELSEMIUM SEMPERVIRENS ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; VERATRUM ALBUM ROOT	6; 4; 4; 6; 4; 6; 6; 6; 3; 2; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
62795-9494_00923ff7-9639-44eb-829a-92f238ec9eb4	62795-9494	HUMAN OTC DRUG	Zeel		ALPHA LIPOIC ACID, ARNICA MONTANAROOT,SUS SCROFA CARTILAGE,COENZYME A, SOLANUM DULCAMARA TOP, SUS SCROFA EMBRYO,SUS SCROFA UMBILICAL CORD,NADIDE,SODIUM DIETHYL OXALACETATE, SUS SCROFA PLACENTA,TOXICODENDRON PUBESCENS LEAF,SANGUINARIA CANADENSIS ROOT,SILICON DIOXIDE,SULFUR,COMFREY ROOT	TABLET	ORAL	20220112		UNAPPROVED HOMEOPATHIC		MediNatura Inc	ALPHA LIPOIC ACID; ARNICA MONTANA ROOT; COENZYME A; COMFREY ROOT; NADIDE; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; SODIUM DIETHYL OXALACETATE; SOLANUM DULCAMARA TOP; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA EMBRYO; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; TOXICODENDRON PUBESCENS LEAF	6; 1; 6; 8; 6; 3; 6; 6; 2; 6; 4; 4; 4; 4; 2	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
62800-015_ed22f3b0-9208-0595-e053-2a95a90a37ee	62800-015	HUMAN OTC DRUG	Pure Skin Naked All Natural Sunscreen SPF 35		ZINC OXIDE	CREAM	TOPICAL	20220601	20241231	OTC MONOGRAPH NOT FINAL	part352	HNC Products Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
62818-102_61c0af32-1b3f-4d55-baf3-b709a9d3dc66	62818-102	HUMAN OTC DRUG	AtoQ30 Solution		Colloidal Oatmeal	SOLUTION	TOPICAL	20140501	20240501	OTC MONOGRAPH FINAL	part347	Biometics Co.,Ltd.	OATMEAL	.8	g/40g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
62819-268_d685553c-a151-1efe-e053-2a95a90a4512	62819-268	HUMAN OTC DRUG	Total Solutions Hygien Hand		Benzalkonium	SOAP	TOPICAL	20130118		OTC MONOGRAPH NOT FINAL	part333E	Athea Laboratories, Inc.	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
62830-265_a3bcd8e3-2e5c-4098-a5d2-88ac644dd18c	62830-265	HUMAN OTC DRUG	One Step Antiseptic Hand Wash		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20171227		OTC MONOGRAPH NOT FINAL	part333E	RECO Research Chemical Specialties Company, Inc.	BENZALKONIUM CHLORIDE	25	mg/mL			N	20241231
62832-080_cb98e3b1-fbd4-43c4-8ee5-89b2ea2fd06d	62832-080	HUMAN OTC DRUG	GENUINE JOE Cleaning Supplies Antibacterial Foam So ap Refill		Chloroxylenol	LIQUID	TOPICAL	20080930		OTC MONOGRAPH NOT FINAL	part333E	S.P. Richards Company	CHLOROXYLENOL	.003	mg/mL			N	20241231
62832-118_4990c344-ce78-4095-b49a-96546e33a02c	62832-118	HUMAN OTC DRUG	Benzalkonium Chloride		Benzalkonium Chloride	LIQUID	TOPICAL	20171103		OTC MONOGRAPH NOT FINAL	part333A	S.P. Richards Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62832-370_d3499e1d-06b8-4f8d-81ab-03bf6bb0b72b	62832-370	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20150202		OTC MONOGRAPH NOT FINAL	part333A	S. P. Richards Company	ALCOHOL	70	mL/100mL			N	20241231
62832-437_e64e37a6-0a6c-4b19-a01f-a9a63400797c	62832-437	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20171103		OTC MONOGRAPH NOT FINAL	part333A	S.P. Richards Company	ALCOHOL	63	mg/mL			N	20241231
62832-447_6effe52b-4478-49e6-9da9-7ed5aa3248f3	62832-447	HUMAN OTC DRUG	Ethyl alcohol		Ethyl Alcohol	LOTION	TOPICAL	20171103		OTC MONOGRAPH NOT FINAL	part333A	S.P. Richards Company	ALCOHOL	.62	mL/mL			N	20241231
62832-628_382fd5d1-f20b-4804-a0c6-bbef204cf148	62832-628	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride	LIQUID	TOPICAL	20211123		OTC MONOGRAPH NOT FINAL	part333A	S. P. Richards Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62832-701_09d2c038-8d8c-7f30-e063-6394a90a72a2	62832-701	HUMAN OTC DRUG	Genuine Joe Antibacterial		PCMX	SOAP	TOPICAL	20210709		OTC MONOGRAPH DRUG	505G(a)(3)	S.P. Richards Company	CHLOROXYLENOL	1	g/L			N	20241231
62839-0138_12c003ba-3584-4e53-bd37-0112842d4d3f	62839-0138	HUMAN OTC DRUG	Nu Skin Clear Action	Acne Medication Toner	Salicylic Acid	LIQUID	TOPICAL	20020125		OTC MONOGRAPH FINAL	part333D	NSE Products, Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
62839-0272_7faff83d-3a00-4651-b418-42cb30f26b26	62839-0272	HUMAN OTC DRUG	Moisture Restore Day Protective Mattefying Broad Spectrum SPF15 Combination to Oily		Octinoxate, Octisalate, and Titanium Dioxide	LOTION	TOPICAL	20010610		OTC MONOGRAPH NOT FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	75; 30; 28	mg/mL; mg/mL; mg/mL			N	20241231
62839-0273_0f66735b-c897-4fde-917a-e8adfba4121f	62839-0273	HUMAN OTC DRUG	Nu Skin Tri-Phasic White Day Milk Broad Spectrum SPF 15		Avobenzone, Octinoxate, and Octisalate	LOTION	TOPICAL	20130401		OTC MONOGRAPH NOT FINAL	part352	NSE Products, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	24; 74; 30	mg/mL; mg/mL; mg/mL			N	20241231
62839-0853_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0853	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Neutral Beige		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0854_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0854	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Soft Beige		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0855_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0855	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Delicate Ivory		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0856_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0856	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Sunny Beige		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0857_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0857	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Almond		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0858_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0858	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Sunset Beige		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0859_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0859	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Tawny		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0860_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0860	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Mocha		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0861_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0861	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Honey Beige		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0862_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0862	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Beige		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20160801		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0863_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0863	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Ochre		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0864_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0864	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Pink		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0865_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0865	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Pink Ochre		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0866_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0866	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Medium Ochre		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-0867_3d367207-83b6-41bf-b07c-41516aa8b0ff	62839-0867	HUMAN OTC DRUG	Nu Skin Nu Colour advanced finish broad spectrum SPF 15 - Medium Beige		Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	75; 20; 40	mg/mL; mg/mL; mg/mL			N	20241231
62839-1038_d2cf983a-61aa-4305-83fb-1a2f3c90ef17	62839-1038	HUMAN OTC DRUG	Nu Skin	Clear Action Acne Medication Day Treatment	Salicylic Acid	GEL	TOPICAL	20020125		OTC MONOGRAPH FINAL	part333D	NSE Products, Inc.	SALICYLIC ACID	5	g/1000mL			N	20241231
62839-1083_32d5783f-c3d9-4bf0-898b-4c6d766dd908	62839-1083	HUMAN OTC DRUG	Epoch		Alcohol	GEL	TOPICAL	20090601		OTC MONOGRAPH NOT FINAL	part333E	NSE Products, Inc.	ALCOHOL	61.9937	mL/100mL			N	20241231
62839-1113_cba6a8e6-1628-422e-a409-c3987a3035fc	62839-1113	HUMAN OTC DRUG	Nu Skin Nu Colour advanced tinted moisturizer broad spectrum SPF 15 - Fair		Octinoxate and Octisalate	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE	50; 28	mg/mL; mg/mL			N	20241231
62839-1114_cba6a8e6-1628-422e-a409-c3987a3035fc	62839-1114	HUMAN OTC DRUG	Nu Skin Nu Colour advanced tinted moisturizer broad spectrum SPF 15 - Sand		Octinoxate and Octisalate	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE	50; 28	mg/mL; mg/mL			N	20241231
62839-1115_cba6a8e6-1628-422e-a409-c3987a3035fc	62839-1115	HUMAN OTC DRUG	Nu Skin Nu Colour advanced tinted moisturizer broad spectrum SPF 15 - Honey		Octinoxate and Octisalate	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE	50; 28	mg/mL; mg/mL			N	20241231
62839-1116_cba6a8e6-1628-422e-a409-c3987a3035fc	62839-1116	HUMAN OTC DRUG	Nu Skin Nu Colour advanced tinted moisturizer broad spectrum SPF 15 - Beige		Octinoxate and Octisalate	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE	50; 28	mg/mL; mg/mL			N	20241231
62839-1136_cba6a8e6-1628-422e-a409-c3987a3035fc	62839-1136	HUMAN OTC DRUG	Nu Skin Nu Colour advanced tinted moisturizer broad spectrum SPF 15 - Pink Ochre		Octinoxate and Octisalate	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE	50; 28	mg/mL; mg/mL			N	20241231
62839-1139_cba6a8e6-1628-422e-a409-c3987a3035fc	62839-1139	HUMAN OTC DRUG	Nu Skin Nu Colour advanced tinted moisturizer broad spectrum SPF 15 - Natural Beige		Octinoxate and Octisalate	LOTION	TOPICAL	20141027		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; OCTISALATE	50; 28	mg/mL; mg/mL			N	20241231
62839-1151_0b506952-b76a-4687-b597-2ba48bed56ff	62839-1151	HUMAN OTC DRUG	AP-24 Fluoride		SODIUM MONOFLUOROPHOSPHATE	PASTE	DENTAL	20170508		OTC MONOGRAPH FINAL	part355	NSE Products, Inc.	SODIUM MONOFLUOROPHOSPHATE	8.6	mg/g			N	20241231
62839-1152_84e1d4d6-745e-4bf1-b196-1bdf9f07a3ca	62839-1152	HUMAN OTC DRUG	AP-24		Sodium Fluoride	MOUTHWASH	ORAL	20170508		OTC MONOGRAPH FINAL	part355	NSE Products, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
62839-1155_e2651a88-0bd4-475b-bf7e-79d267c75ea0	62839-1155	HUMAN OTC DRUG	AP-24 Whitening		Sodium Monofluorophosphate	PASTE	DENTAL	20170508		OTC MONOGRAPH FINAL	part355	NSE Products, Inc.	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
62839-1254_7de36c3b-55e3-450f-92de-8df56d0a2ec0	62839-1254	HUMAN OTC DRUG	Nu Skin 180 Degree UV Defense Hydrator SPF 18		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20130801		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	OCTINOXATE; ZINC OXIDE	75; 54	mg/mL; mg/mL			N	20241231
62839-1339_eff3be56-18fd-4cef-9aa7-3dd15607187c	62839-1339	HUMAN OTC DRUG	Nutricentials Here You Glow Exfoliating Toner		salicylic acid	LIQUID	TOPICAL	20200910		OTC MONOGRAPH FINAL	part333D	NSE Products, Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
62839-1344_64b34bac-87cc-4849-aa41-f6c400f96ff9	62839-1344	HUMAN OTC DRUG	Nu Skin Sunright 35 Broad Spectrum SPF 35		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20140423		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	42; 45	mg/mL; mg/mL			N	20241231
62839-1345_380e7a36-6e20-4b11-a2b8-af3ce2776377	62839-1345	HUMAN OTC DRUG	Nu Skin Sunright 50 Broad Spectrum SPF 50		Avobenzone, Homosalate, Octinoxate, Octisalate, and Octocrylene	LOTION	TOPICAL	20140602		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 100; 75; 50; 65	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1495_c4557b1d-f655-499f-9e98-c9a068347c80	62839-1495	HUMAN OTC DRUG	ageLOC LumiSpa Treatment Cleanser Acne		Salicylic Acid	LOTION	TOPICAL	20171001		OTC MONOGRAPH FINAL	part333D	NSE Products, Inc	SALICYLIC ACID	5	mg/mL			N	20241231
62839-1554_9cb294e9-11f6-45a5-a46b-cad289221b41	62839-1554	HUMAN OTC DRUG	Nutricentials Day Dream Protective		homosalate, octisalate, avobenzone, and octocrylene	CREAM	TOPICAL	20200910		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 40; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1555_e8ed6a3d-b3e6-4d4a-b9cb-dbf6d912860c	62839-1555	HUMAN OTC DRUG	Nutricentials Day Dream Protective		Homosalate, Octisalate, Avobenzone, and Octocrylene	LOTION	TOPICAL	20200910		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 40; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1616_a1774936-7bbb-4ea1-b3f0-310eac79676a	62839-1616	HUMAN OTC DRUG	Nu Skin ageLOC Me Day T1 Broad Spectrum SPF 25		Homosalate, Octinoxate, Avobenzone, and Octocrylene	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	30; 40; 35; 27.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1617_632ad7d6-ef8d-41fe-add6-463d066812b1	62839-1617	HUMAN OTC DRUG	Nu Skin ageLOC Me Day S1 Broad Spectrum SPF 25		Homosalate, Octinoxate, Avobenzone, and Octocrylene	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	30; 40; 35; 27.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1618_b8650b15-8cb8-4c49-824f-c78b286a1bf7	62839-1618	HUMAN OTC DRUG	Nu Skin ageLOC Me Day T2 Broad Spectrum SPF 20		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	34; 33.9	mg/mL; mg/mL			N	20241231
62839-1619_ac68f401-b93c-4090-a0ce-a1a379d9587f	62839-1619	HUMAN OTC DRUG	Nu Skin ageLOC Me Day S2 Broad Spectrum SPF 20		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	34; 33.9	mg/mL; mg/mL			N	20241231
62839-1629_8128f294-ae36-4cd5-a003-092e1fe96396	62839-1629	HUMAN OTC DRUG	Nu Skin ageLOC Me Day T3 Broad Spectrum SPF 25		Homosalate, Octisalate, Avobenzone, and Octocrylene	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1630_5cbe8a59-d452-42f2-b807-5a528fbb6518	62839-1630	HUMAN OTC DRUG	Nu Skin ageLOC Me Day S3 Broad Spectrum SPF 25		Homosalate, Octisalate, Avobenzone, and Octocrylene	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1637_0df94c30-5145-4a68-9d7a-76febb5290ae	62839-1637	HUMAN OTC DRUG	Nu Skin ageLOC Me Day T9 Broad Spectrum SPF 25		Octinoxate, Avobenzone, Octocrylene, and Homosalate	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	23; 20; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-1638_b0152ed8-345e-42fd-94e0-fc164bf8283f	62839-1638	HUMAN OTC DRUG	Nu Skin ageLOC Me Day S9 Broad Spectrum SPF 25		Octinoxate, Avobenzone, Octocrylene, and Homosalate	LOTION	TOPICAL	20160501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	23; 20; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-2728_56720d5d-aa1b-4675-82d8-222e48233949	62839-2728	HUMAN OTC DRUG	Nu Skin	Moisture Restore Day Protective SPF 15 Normal to Dry Skin	Octinoxate and Titanium Dioxide	LOTION	TOPICAL	20010610		OTC MONOGRAPH NOT FINAL	part352	NSE Products, Inc.	OCTINOXATE; TITANIUM DIOXIDE	75; 38	g/1000mL; g/1000mL			N	20241231
62839-2734_eb7d981f-075d-4601-9c14-cd5baf4ffaad	62839-2734	HUMAN OTC DRUG	Nu Skin Tri-Phasic White System		Avobenzone, Octinoxate, and Octisalate	KIT		20130401		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.						N	20241231
62839-3360_0a2cdcac-ad53-41ae-a20a-86170d6fa805	62839-3360	HUMAN OTC DRUG	Nu Colour Bioadaptive BB plus Foundation - Beige		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	130	mg/mL			N	20241231
62839-3361_273b9f76-265a-4890-ad4d-47269694dcc8	62839-3361	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Light Golden		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	120	mg/mL			N	20241231
62839-3362_273b9f76-265a-4890-ad4d-47269694dcc8	62839-3362	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Natural Beige		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	120	mg/mL			N	20241231
62839-3363_273b9f76-265a-4890-ad4d-47269694dcc8	62839-3363	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Ochre		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	120	mg/mL			N	20241231
62839-3364_273b9f76-265a-4890-ad4d-47269694dcc8	62839-3364	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Linen		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	120	mg/mL			N	20241231
62839-3365_273b9f76-265a-4890-ad4d-47269694dcc8	62839-3365	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Ivory		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	120	mg/mL			N	20241231
62839-3904_3cc7123b-dc30-47d9-97a4-96eb30f8cda7	62839-3904	HUMAN OTC DRUG	Nu Skin ageLOC Radiant Day Broad Spectrum SPF 22		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20130501		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
62839-3950_0a2cdcac-ad53-41ae-a20a-86170d6fa805	62839-3950	HUMAN OTC DRUG	Nu Colour Bioadaptive BB plus Foundation - Medium Beige		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	130	mg/mL			N	20241231
62839-3951_f3a7eb66-94c7-4bc8-9019-e8966a3c625d	62839-3951	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Almond		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	110	mg/mL			N	20241231
62839-3952_e1a14f98-e39f-4372-91c3-d14503927792	62839-3952	HUMAN OTC DRUG	Nu Colour Bioadaptive BB plus Foundation - Mocha		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	90	mg/mL			N	20241231
62839-3953_8af5ea9b-1bee-4e7a-a265-1479b3da200f	62839-3953	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Espresso		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	50	mg/mL			N	20241231
62839-3954_8af5ea9b-1bee-4e7a-a265-1479b3da200f	62839-3954	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Java		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	50	mg/mL			N	20241231
62839-3955_59773b2f-d732-4a50-a163-50d1d43522d7	62839-3955	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Chestnut		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	80	mg/mL			N	20241231
62839-3956_e1a14f98-e39f-4372-91c3-d14503927792	62839-3956	HUMAN OTC DRUG	Nu Colour Bioadaptive BB plus Foundation - Tan		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	90	mg/mL			N	20241231
62839-3957_f3a7eb66-94c7-4bc8-9019-e8966a3c625d	62839-3957	HUMAN OTC DRUG	Nu Colour Bioadaptive BB Plus Foundation - Shell Beige		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	110	mg/mL			N	20241231
62839-3958_0a2cdcac-ad53-41ae-a20a-86170d6fa805	62839-3958	HUMAN OTC DRUG	Nu Colour Bioadaptive BB plus Foundation - cream		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	130	mg/mL			N	20241231
62839-3959_0a2cdcac-ad53-41ae-a20a-86170d6fa805	62839-3959	HUMAN OTC DRUG	Nu Colour Bioadaptive BB plus Foundation - Medium Ochre		Titanium Dioxide	LOTION	TOPICAL	20220203		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	TITANIUM DIOXIDE	130	mg/mL			N	20241231
62839-4731_5be59167-5c14-46f1-9ea3-c181ed0f8b5d	62839-4731	HUMAN OTC DRUG	Nu Skin Clear Action Acne Medication Night Treatment		Salicylic Acid	GEL	TOPICAL	20130201		OTC MONOGRAPH FINAL	part333D	NSE Products, Inc	SALICYLIC ACID	5.5	g/1000mL			N	20241231
62839-6201_33131cdb-3a5c-4814-97e4-0e66d142fe85	62839-6201	HUMAN OTC DRUG	Nu Skin Sunright Lip Balm Broad Spectrum SPF 15		Octinoxate, Avobenzone, and Octocrylene	STICK	TOPICAL	20140701		OTC MONOGRAPH FINAL	part352	NSE Products, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	30; 75; 27.9	mg/mL; mg/mL; mg/mL			N	20241231
62839-6745_faf5eb3a-7c3e-4a6c-b5c9-887883d341f5	62839-6745	HUMAN OTC DRUG	Epoch Ava Puhi Moni Anti-Dandruff		PYRITHIONE ZINC	SHAMPOO	TOPICAL	20170208		OTC MONOGRAPH FINAL	part358H	NSE Products, Inc.	PYRITHIONE ZINC	65.7	g/1000mL			N	20241231
62856-212_f440b027-4ced-429a-970a-4ab7600c617d	62856-212	HUMAN PRESCRIPTION DRUG	LEQEMBI		lecanemab	INJECTION, SOLUTION	INTRAVENOUS	20230106		BLA	BLA761269	Eisai Inc.	LECANEMAB	100	mg/mL	Amyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]		N	20241231
62856-215_f440b027-4ced-429a-970a-4ab7600c617d	62856-215	HUMAN PRESCRIPTION DRUG	LEQEMBI		lecanemab	INJECTION, SOLUTION	INTRAVENOUS	20230106		BLA	BLA761269	Eisai Inc.	LECANEMAB	100	mg/mL	Amyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]		N	20241231
62856-245_4bc1cba0-8ebe-4b11-b4a4-19148d4249c0	62856-245	HUMAN PRESCRIPTION DRUG	Aricept		donepezil hydrochloride	TABLET, FILM COATED	ORAL	19961125		NDA	NDA020690	Eisai Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62856-246_4bc1cba0-8ebe-4b11-b4a4-19148d4249c0	62856-246	HUMAN PRESCRIPTION DRUG	Aricept		donepezil hydrochloride	TABLET, FILM COATED	ORAL	19961125		NDA	NDA020690	Eisai Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62856-247_4bc1cba0-8ebe-4b11-b4a4-19148d4249c0	62856-247	HUMAN PRESCRIPTION DRUG	Aricept		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20100723		NDA	NDA022568	Eisai Inc.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
62856-272_9e5b8627-60ec-426b-92e5-fa459bc73484	62856-272	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20121022		NDA	NDA202834	Eisai Inc.	PERAMPANEL	2	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20241231
62856-274_9e5b8627-60ec-426b-92e5-fa459bc73484	62856-274	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20121022		NDA	NDA202834	Eisai Inc.	PERAMPANEL	4	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20241231
62856-276_9e5b8627-60ec-426b-92e5-fa459bc73484	62856-276	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20121022		NDA	NDA202834	Eisai Inc.	PERAMPANEL	6	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20241231
62856-278_9e5b8627-60ec-426b-92e5-fa459bc73484	62856-278	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20121022		NDA	NDA202834	Eisai Inc.	PERAMPANEL	8	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20241231
62856-280_9e5b8627-60ec-426b-92e5-fa459bc73484	62856-280	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20121022		NDA	NDA202834	Eisai Inc.	PERAMPANEL	10	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20241231
62856-282_9e5b8627-60ec-426b-92e5-fa459bc73484	62856-282	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20121022		NDA	NDA202834	Eisai Inc.	PERAMPANEL	12	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20241231
62856-290_9e5b8627-60ec-426b-92e5-fa459bc73484	62856-290	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	SUSPENSION	ORAL	20160430		NDA	NDA208277	Eisai Inc.	PERAMPANEL	.5	mg/mL	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20241231
62856-389_e3f88313-4de7-40ce-94b3-a848e4367037	62856-389	HUMAN PRESCRIPTION DRUG	Halaven		eribulin mesylate	INJECTION	INTRAVENOUS	20101115		NDA	NDA201532	Eisai Inc.	ERIBULIN MESYLATE	.5	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
62856-405_e183487a-05cb-44e3-ba3d-858b29efb563	62856-405	HUMAN PRESCRIPTION DRUG	DAYVIGO		lemborexant	TABLET, FILM COATED	ORAL	20200407		NDA	NDA212028	Eisai Inc.	LEMBOREXANT	5	mg/1	Cytochrome P450 2B6 Inducers [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA]	CIV	N	20241231
62856-410_e183487a-05cb-44e3-ba3d-858b29efb563	62856-410	HUMAN PRESCRIPTION DRUG	DAYVIGO		lemborexant	TABLET, FILM COATED	ORAL	20200407		NDA	NDA212028	Eisai Inc.	LEMBOREXANT	10	mg/1	Cytochrome P450 2B6 Inducers [MoA], Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA]	CIV	N	20241231
62856-582_e2b636a9-79ad-4804-b5f9-c9be2713e84b	62856-582	HUMAN PRESCRIPTION DRUG	Banzel		rufinamide	TABLET, FILM COATED	ORAL	20081114		NDA	NDA021911	Eisai Inc.	RUFINAMIDE	200	mg/1			N	20241231
62856-583_e2b636a9-79ad-4804-b5f9-c9be2713e84b	62856-583	HUMAN PRESCRIPTION DRUG	Banzel		rufinamide	TABLET, FILM COATED	ORAL	20081114		NDA	NDA021911	Eisai Inc.	RUFINAMIDE	400	mg/1			N	20241231
62856-584_e2b636a9-79ad-4804-b5f9-c9be2713e84b	62856-584	HUMAN PRESCRIPTION DRUG	Banzel		rufinamide	SUSPENSION	ORAL	20110303		NDA	NDA201367	Eisai Inc.	RUFINAMIDE	40	mg/mL			N	20241231
62856-704_81790f87-5788-495a-b299-68e56840a700	62856-704	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	CAPSULE	ORAL	20180815		NDA	NDA206947	Eisai Inc.	LENVATINIB	4	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
62856-708_81790f87-5788-495a-b299-68e56840a700	62856-708	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	CAPSULE	ORAL	20160513		NDA	NDA206947	Eisai Inc.	LENVATINIB	4	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
62856-710_81790f87-5788-495a-b299-68e56840a700	62856-710	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	CAPSULE	ORAL	20150213		NDA	NDA206947	Eisai Inc.	LENVATINIB	10	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
62856-712_81790f87-5788-495a-b299-68e56840a700	62856-712	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	CAPSULE	ORAL	20180815		NDA	NDA206947	Eisai Inc.	LENVATINIB	4	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
62856-714_81790f87-5788-495a-b299-68e56840a700	62856-714	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	KIT		20150213		NDA	NDA206947	Eisai Inc.						N	20241231
62856-718_81790f87-5788-495a-b299-68e56840a700	62856-718	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	KIT		20160513		NDA	NDA206947	Eisai Inc.						N	20241231
62856-720_81790f87-5788-495a-b299-68e56840a700	62856-720	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	CAPSULE	ORAL	20150213		NDA	NDA206947	Eisai Inc.	LENVATINIB	10	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
62856-724_81790f87-5788-495a-b299-68e56840a700	62856-724	HUMAN PRESCRIPTION DRUG	Lenvima		Lenvatinib	KIT		20150213		NDA	NDA206947	Eisai Inc.						N	20241231
62858-101_fcef5593-6ba7-3602-e053-6294a90a5e08	62858-101	HUMAN OTC DRUG	NAIL RENEW		TOLNAFTATE	LIQUID	TOPICAL	20140322		OTC MONOGRAPH DRUG	M005	Nailrenew Corp	TOLNAFTATE	1	g/100mL			N	20251231
62914-1000_06d6db9b-bdcd-f15f-e063-6294a90a7e2a	62914-1000	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140506		UNAPPROVED MEDICAL GAS		Medassure Inc	OXYGEN	99	L/100L			N	20241231
62935-153_eeda0531-099b-4b55-b287-8c534c3bb5f0	62935-153	HUMAN PRESCRIPTION DRUG	Fensolvi		Leuprolide Acetate	KIT		20200603		NDA	NDA213150	TOLMAR Inc.						N	20241231
62935-163_5a1152b9-ec72-43e3-87ee-3f3940c763ca	62935-163	HUMAN PRESCRIPTION DRUG	Fensolvi		Leuprolide Acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230306		NDA	NDA213150	TOLMAR Inc.	LEUPROLIDE ACETATE	45	mg/.375mL	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
62935-223_a40ab9f3-7c77-4d3c-ba7d-5b3ec57ca778	62935-223	HUMAN PRESCRIPTION DRUG	ELIGARD		Leuprolide Acetate	KIT	SUBCUTANEOUS	20020826		NDA	NDA021379	TOLMAR Inc.						N	20241231
62935-227_002c974b-7403-4975-9168-a495c7b4fd36	62935-227	HUMAN PRESCRIPTION DRUG	Eligard		Leuprolide acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20231218		NDA	NDA021379	TOLMAR Inc.	LEUPROLIDE ACETATE	22.5	mg/.375mL	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
62935-303_a40ab9f3-7c77-4d3c-ba7d-5b3ec57ca778	62935-303	HUMAN PRESCRIPTION DRUG	ELIGARD		Leuprolide Acetate	KIT	SUBCUTANEOUS	20030226		NDA	NDA021488	TOLMAR Inc.						N	20241231
62935-306_002c974b-7403-4975-9168-a495c7b4fd36	62935-306	HUMAN PRESCRIPTION DRUG	Eligard		Leuprolide acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20231127		NDA	NDA021488	TOLMAR Inc.	LEUPROLIDE ACETATE	30	mg/.5mL	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
62935-453_a40ab9f3-7c77-4d3c-ba7d-5b3ec57ca778	62935-453	HUMAN PRESCRIPTION DRUG	ELIGARD		Leuprolide Acetate	KIT	SUBCUTANEOUS	20050107		NDA	NDA021731	TOLMAR Inc.						N	20241231
62935-461_bc1570f9-f7f2-4210-b893-10e2ca7bf094	62935-461	HUMAN PRESCRIPTION DRUG	Eligard		Leuprolide acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20230306		NDA	NDA021731	TOLMAR Inc.	LEUPROLIDE ACETATE	45	mg/.375mL	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
62935-753_a40ab9f3-7c77-4d3c-ba7d-5b3ec57ca778	62935-753	HUMAN PRESCRIPTION DRUG	ELIGARD		Leuprolide Acetate	KIT	SUBCUTANEOUS	20020515		NDA	NDA021343	TOLMAR Inc.						N	20241231
62935-756_002c974b-7403-4975-9168-a495c7b4fd36	62935-756	HUMAN PRESCRIPTION DRUG	Eligard		Leuprolide acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	SUBCUTANEOUS	20231030		NDA	NDA021343	TOLMAR Inc.	LEUPROLIDE ACETATE	7.5	mg/.25mL	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
62936-0102_07eec991-a4f9-cf6c-e063-6294a90af703	62936-0102	HUMAN OTC DRUG	Regular Strength Pain Reliever		Acetaminophen	TABLET	ORAL	20190601		OTC MONOGRAPH DRUG	M013	INGLES MARKETS, INC.	ACETAMINOPHEN	325	mg/1			N	20241231
62936-0279_1c1ffbf8-2580-4627-8b25-25206d8151d7	62936-0279	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20160226		OTC MONOGRAPH NOT FINAL	part333A	Ingles Markets, Inc	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
62936-0370_1237d779-0801-4124-9052-3038cac0d693	62936-0370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20150610		OTC MONOGRAPH NOT FINAL	part333A	Ingles Markets, Inc.	ALCOHOL	70	mL/100mL			N	20241231
62936-0403_bf61431a-8884-452a-b147-83eb9b75ed4d	62936-0403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20160226		OTC MONOGRAPH NOT FINAL	part333A	Ingles Markets, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
62936-0575_0fafb0e1-e242-4ca3-b360-aa584ae8df62	62936-0575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20151228		OTC MONOGRAPH NOT FINAL	part333A	Ingles Markets, Inc	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
62936-0941_efa5fff1-3a7a-202e-e053-2a95a90add3a	62936-0941	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20040101		ANDA	ANDA075010	INGLES MARKETS, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63002-002_ef6a1c09-8491-4a08-bedc-a67ce00d9e23	63002-002	HUMAN OTC DRUG	Byotrol Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140502		OTC MONOGRAPH NOT FINAL	part333A	Advanced Hygienics LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63002-004_bfc689ba-d7f8-4c16-9a13-4bd7b859bbf5	63002-004	HUMAN OTC DRUG	Hand Sanitizer		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20170518		OTC MONOGRAPH NOT FINAL	part333A	Advanced Hygienics LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
63004-8710_b6e6b427-7b6e-4bdc-b792-31b19d0dffeb	63004-8710	HUMAN PRESCRIPTION DRUG	Acthar		Repository Corticotropin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20130107		NDA	NDA008372	Mallinckrodt ARD LLC	CORTICOTROPIN	80	[USP'U]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
63010-010_60117224-186f-4684-8bcb-bf1f58431637	63010-010	HUMAN PRESCRIPTION DRUG	VIRACEPT		nelfinavir mesylate	TABLET, FILM COATED	ORAL	19970314		NDA	NDA020779	AGOURON	NELFINAVIR MESYLATE	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
63010-027_60117224-186f-4684-8bcb-bf1f58431637	63010-027	HUMAN PRESCRIPTION DRUG	VIRACEPT		nelfinavir mesylate	TABLET, FILM COATED	ORAL	20030430		NDA	NDA021503	AGOURON	NELFINAVIR MESYLATE	625	mg/1	Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
63020-040_4dcaf5b7-a31c-4b99-b55a-0c179ee4ae32	63020-040	HUMAN PRESCRIPTION DRUG	EXKIVITY		Mobocertinib	CAPSULE	ORAL	20210915		NDA	NDA215310	Takeda Pharmaceuticals America, Inc.	MOBOCERTINIB	40	mg/1	Cytochrome P450 3A Inducers [MoA], HER1 Antagonists [MoA], Kinase Inhibitor [EPC]		N	20241231
63020-049_0fcf0fc1-377b-4dca-a935-52d3048c837e	63020-049	HUMAN PRESCRIPTION DRUG	VELCADE		bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20030513		NDA	NDA021602	Takeda Pharmaceuticals America, Inc.	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
63020-090_046cf609-69fd-47b9-9e48-dd2ceec3be64	63020-090	HUMAN PRESCRIPTION DRUG	Alunbrig		brigatinib	TABLET, FILM COATED	ORAL	20170428		NDA	NDA208772	Takeda Pharmaceuticals America, Inc.	BRIGATINIB	90	mg/1	Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
63020-113_046cf609-69fd-47b9-9e48-dd2ceec3be64	63020-113	HUMAN PRESCRIPTION DRUG	Alunbrig		brigatinib	TABLET, FILM COATED	ORAL	20170428		NDA	NDA208772	Takeda Pharmaceuticals America, Inc.	BRIGATINIB	30	mg/1	Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
63020-180_046cf609-69fd-47b9-9e48-dd2ceec3be64	63020-180	HUMAN PRESCRIPTION DRUG	Alunbrig		brigatinib	TABLET, FILM COATED	ORAL	20170428		NDA	NDA208772	Takeda Pharmaceuticals America, Inc.	BRIGATINIB	180	mg/1	Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]		N	20241231
63020-198_046cf609-69fd-47b9-9e48-dd2ceec3be64	63020-198	HUMAN PRESCRIPTION DRUG	Alunbrig		brigatinib	KIT		20170428		NDA	NDA208772	Takeda Pharmaceuticals America, Inc.						N	20241231
63020-210_2045e0e5-618b-4bea-8d20-555d9be2d880	63020-210	HUMAN PRESCRIPTION DRUG	Fruzaqla		fruquintinib	CAPSULE	ORAL	20231108		NDA	NDA217564	Takeda Pharmaceuticals America, Inc.	FRUQUINTINIB	1	mg/1			N	20241231
63020-225_2045e0e5-618b-4bea-8d20-555d9be2d880	63020-225	HUMAN PRESCRIPTION DRUG	Fruzaqla		fruquintinib	CAPSULE	ORAL	20231108		NDA	NDA217564	Takeda Pharmaceuticals America, Inc.	FRUQUINTINIB	5	mg/1			N	20241231
63020-230_10af58f2-554b-4d89-9edc-29a68a9f831f	63020-230	HUMAN PRESCRIPTION DRUG	NINLARO		ixazomib	CAPSULE	ORAL	20151120		NDA	NDA208462	Takeda Pharmaceuticals America, Inc.	IXAZOMIB CITRATE	2.3	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
63020-390_10af58f2-554b-4d89-9edc-29a68a9f831f	63020-390	HUMAN PRESCRIPTION DRUG	NINLARO		ixazomib	CAPSULE	ORAL	20151120		NDA	NDA208462	Takeda Pharmaceuticals America, Inc.	IXAZOMIB CITRATE	3	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
63020-400_10af58f2-554b-4d89-9edc-29a68a9f831f	63020-400	HUMAN PRESCRIPTION DRUG	NINLARO		ixazomib	CAPSULE	ORAL	20151120		NDA	NDA208462	Takeda Pharmaceuticals America, Inc.	IXAZOMIB CITRATE	4	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
63020-533_f4a4d73c-5ece-4881-802d-a9a2638a12d8	63020-533	HUMAN PRESCRIPTION DRUG	Iclusig		ponatinib hydrochloride	TABLET, FILM COATED	ORAL	20150422		NDA	NDA203469	Takeda Pharmaceuticals America, Inc.	PONATINIB HYDROCHLORIDE	30	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63020-534_f4a4d73c-5ece-4881-802d-a9a2638a12d8	63020-534	HUMAN PRESCRIPTION DRUG	Iclusig		ponatinib hydrochloride	TABLET, FILM COATED	ORAL	20121214		NDA	NDA203469	Takeda Pharmaceuticals America, Inc.	PONATINIB HYDROCHLORIDE	45	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63020-535_f4a4d73c-5ece-4881-802d-a9a2638a12d8	63020-535	HUMAN PRESCRIPTION DRUG	Iclusig		ponatinib hydrochloride	TABLET, FILM COATED	ORAL	20121214		NDA	NDA203469	Takeda Pharmaceuticals America, Inc.	PONATINIB HYDROCHLORIDE	15	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63020-536_f4a4d73c-5ece-4881-802d-a9a2638a12d8	63020-536	HUMAN PRESCRIPTION DRUG	Iclusig		ponatinib hydrochloride	TABLET, FILM COATED	ORAL	20210111		NDA	NDA203469	Takeda Pharmaceuticals America, Inc.	PONATINIB HYDROCHLORIDE	10	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63029-049_97122b17-0ff8-4fcd-b5ea-8f6becc692bd	63029-049	HUMAN OTC DRUG	Percogesic Extra Strength		Acetaminophen and Diphenhydramine	CAPSULE, COATED	ORAL	20100707		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE	500; 12.5	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63029-050_d89d64f1-0b97-46d8-96f1-516792498a32	63029-050	HUMAN OTC DRUG	Percogesic Original Strength		Acetaminophen and Diphenhydramine	TABLET, COATED	ORAL	20100319		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE	325; 12.5	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63029-051_cb2e155f-d778-42a3-a54c-30079721e397	63029-051	HUMAN OTC DRUG	Percogesic		Magnesium Salicylate	TABLET, COATED	ORAL	20100105		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	MAGNESIUM SALICYLATE	467	mg/1			N	20241231
63029-103_3c38b8dd-59d0-484a-980d-bb9c27bad873	63029-103	HUMAN OTC DRUG	Little Remedies	Gas Relief Drops	simthicone	LIQUID	ORAL	20100104		OTC MONOGRAPH FINAL	part332	Medtech Products Inc.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
63029-105_3a9d3614-0903-46af-8b81-a411ef852100	63029-105	HUMAN OTC DRUG	Uristat Ultra		Phenazopyridine Hydrochloride	TABLET	ORAL	20180215		UNAPPROVED DRUG OTHER		Medtech Products Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
63029-200_533b882a-1059-4fa7-a025-54881fb3e430	63029-200	HUMAN OTC DRUG	BC CHERRY		Aspirin and Caffeine	POWDER	ORAL	20121001		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-203_dd4aac51-c499-49fe-b59d-20cdb882e126	63029-203	HUMAN OTC DRUG	BC MAX		Aspirin, Acetaminophen, Caffeine	POWDER	ORAL	20200315		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	500; 500; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-211_73997599-2800-4dea-96a2-7197d0b35506	63029-211	HUMAN OTC DRUG	Nytol		Diphenhydramine HCl	TABLET	ORAL	20120601		OTC MONOGRAPH FINAL	part338	Medtech Products Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63029-215_f7e5b2ad-68d8-45a6-8ee0-c8c29e590f57	63029-215	HUMAN OTC DRUG	BC	Daytime Multi-Symptom	acetaminophen, dextromethorphan hydrobromide, and phenylephrine hydrochloride	POWDER	ORAL	20180507		OTC MONOGRAPH FINAL	part341	Medtech Products Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63029-221_194e6e26-372f-4523-b570-f42949731523	63029-221	HUMAN OTC DRUG	BC	Sinus Congestion and Pain	acetaminophen, chlorpheniramine maleate, phenylephrine hydrochloride	POWDER	ORAL	20160301		OTC MONOGRAPH FINAL	part341	Medtech Products Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	650; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63029-222_c5356523-8bc6-4b10-8bf9-0d4347d0b95f	63029-222	HUMAN OTC DRUG	Tagamet		Cimetidine	TABLET	ORAL	20120601		NDA	NDA020238	Medtech Products Inc.	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63029-223_c5356523-8bc6-4b10-8bf9-0d4347d0b95f	63029-223	HUMAN OTC DRUG	Tagamet		Cimetidine	TABLET	ORAL	20230201		NDA	NDA020238	Medtech Products Inc.	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63029-302_7fb8514a-a2b0-4952-b4d3-44ec943c9ad6	63029-302	HUMAN OTC DRUG	Ecotrin Regular Strength		Aspirin	TABLET, COATED	ORAL	20120601		OTC MONOGRAPH FINAL	part343	Medtech Products Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63029-310_f6a3c62a-b5d2-48cb-a2f9-9ef63c35617b	63029-310	HUMAN OTC DRUG	MOSCO		Salicylic Acid	PLASTER	TOPICAL	20100108		OTC MONOGRAPH FINAL	part358F	Medtech Products Inc.	SALICYLIC ACID	4	mg/1			N	20241231
63029-311_c3389033-0d23-46d0-954c-d3f167dfd5f6	63029-311	HUMAN OTC DRUG	Ecotrin		Aspirin	TABLET, COATED	ORAL	20120601		OTC MONOGRAPH DRUG	M013	Medtech Products Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20251231
63029-321_14e26db0-7a5e-4f95-8ee3-9c7174410f96	63029-321	HUMAN OTC DRUG	DEBROX		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20120801		OTC MONOGRAPH FINAL	part344	Medtech Products Inc.	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
63029-322_9f119279-3d63-4f93-8080-7f8efdb5e9ab	63029-322	HUMAN OTC DRUG	DEBROX		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20120601		OTC MONOGRAPH FINAL	part344	Medtech Products Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
63029-323_d79bbec9-337d-4d9c-91a9-65202e016d25	63029-323	HUMAN OTC DRUG	Debrox Swimmers Ear		isopropyl alcohol	LIQUID	AURICULAR (OTIC)	20190401		OTC MONOGRAPH FINAL	part344	Medtech Products Inc.	ISOPROPYL ALCOHOL	95	mL/100mL			N	20241231
63029-324_c551b9d5-38e5-4582-af5d-34b9d223ee44	63029-324	HUMAN OTC DRUG	Stye		polyvinyl alcohol and povidone	SOLUTION/ DROPS	OPHTHALMIC	20211201		OTC MONOGRAPH FINAL	part349	Medtech Products Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	5; 6	mg/mL; mg/mL			N	20241231
63029-403_f6c98986-25f6-4a8c-af11-1a80331adbe9	63029-403	HUMAN OTC DRUG	Little Remedies Decongestant Nasal Drops		Phenylephrine Hydrochloride	LIQUID	NASAL	20170101		OTC MONOGRAPH FINAL	part341	Medtech Products Inc.	PHENYLEPHRINE HYDROCHLORIDE	1.25	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63029-406_71dfaa00-169d-4c56-953c-935792c1f3f0	63029-406	HUMAN OTC DRUG	Little Remedies	Sore Throat Pops	pectin	LOZENGE	ORAL	20150601		OTC MONOGRAPH NOT FINAL	part356	Medtech Products Inc.	PECTIN	5.4	mg/1			N	20241231
63029-500_b03e7dd0-f18c-42a3-929f-8c69974f4c24	63029-500	HUMAN OTC DRUG	Gly-Oxide		Carbamide Peroxide	LIQUID	ORAL	20120601		OTC MONOGRAPH NOT FINAL	part356	Medtech Products Inc.	CARBAMIDE PEROXIDE	100	mg/mL			N	20241231
63029-501_34c96c0f-ffd9-4487-ae38-6a50774ded32	63029-501	HUMAN OTC DRUG	Stanback		Aspirin and Caffeine	POWDER	ORAL	20120601		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-505_573b4f2e-a546-4e00-9b16-dc2439b5445b	63029-505	HUMAN OTC DRUG	Sominex Max		Diphenhydramine HCl	TABLET	ORAL	20120601		OTC MONOGRAPH FINAL	part338	Medtech Products Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63029-531_9eda3ff1-260d-4242-a5a2-bdee8a7e98bf	63029-531	HUMAN OTC DRUG	Outgro		Benzocaine	LIQUID	TOPICAL	20130101		OTC MONOGRAPH NOT FINAL	part348	Medtech Products Inc.	BENZOCAINE	18.6	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63029-554_8e28a028-79cd-4f6f-93bb-220c993ed35f	63029-554	HUMAN OTC DRUG	Sominex		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120601		OTC MONOGRAPH FINAL	part338	Medtech Products Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63029-592_f7ded7cb-b3a2-4d58-8aed-59db142d6cee	63029-592	HUMAN OTC DRUG	Compound W	Maximum Strength Fast Acting Liquid	salicylic acid	LIQUID	TOPICAL	20140301		OTC MONOGRAPH FINAL	part358B	Medtech Products Inc.	SALICYLIC ACID	.17	g/9g			N	20241231
63029-593_d7b1cdd7-9fb5-4cac-b633-5b844912d1ca	63029-593	HUMAN OTC DRUG	Compound W One Step Plantar Foot Pads		salicylic acid	PLASTER	TOPICAL	20140315		OTC MONOGRAPH FINAL	part358B	Medtech Products Inc.	SALICYLIC ACID	.4	g/1			N	20241231
63029-594_00ba66c5-2cab-40c4-ac33-b2fc8b4239cf	63029-594	HUMAN OTC DRUG	Compound W One Step Pads		salicylic acid	PLASTER	TOPICAL	20140315		OTC MONOGRAPH FINAL	part358B	Medtech Products Inc.	SALICYLIC ACID	.4	g/1			N	20241231
63029-595_b6ddc1ef-0869-47de-b8e5-0f1253d8a805	63029-595	HUMAN OTC DRUG	Compound W		salicylic acid	GEL	TOPICAL	20140315		OTC MONOGRAPH DRUG	M028	Medtech Products Inc.	SALICYLIC ACID	170	mg/g			N	20251231
63029-596_48d9d4c0-ad79-4478-b891-dd09e0c59754	63029-596	HUMAN OTC DRUG	Compound W	Maximum Strength One Step Invisible	salicylic acid	PLASTER	TOPICAL	20140315		OTC MONOGRAPH FINAL	part358B	Medtech Products Inc.	SALICYLIC ACID	4	mg/1			N	20241231
63029-597_a50124b4-c714-4e5e-ab9e-f28d091946c5	63029-597	HUMAN OTC DRUG	Compound W	Liquid - First Aid	salicylic acid	LIQUID	TOPICAL	20140301		OTC MONOGRAPH FINAL	part358B	Medtech Products Inc.	SALICYLIC ACID	150	mg/mL			N	20241231
63029-598_69ef3c82-55e1-464f-8711-627cd8a45afb	63029-598	HUMAN OTC DRUG	Compound W for Kids One Step Strips		salicylic acid	PLASTER	TOPICAL	20180118		OTC MONOGRAPH FINAL	part358B	Medtech Products Inc.	SALICYLIC ACID	.4	g/1			N	20241231
63029-600_931afc70-6e7c-468f-9058-0333b7506f43	63029-600	HUMAN OTC DRUG	Goodys Back and Body Pain		Acetaminophen and Asprin	POWDER	ORAL	20120601		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; ASPIRIN	325; 500	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63029-602_c0a8a233-d8f6-4a39-ae56-3bc8cc747d16	63029-602	HUMAN OTC DRUG	Little Remedies Childrens Fever Pain Reliever		Acetaminophen	LIQUID	ORAL	20100901		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
63029-603_c0a8a233-d8f6-4a39-ae56-3bc8cc747d16	63029-603	HUMAN OTC DRUG	Little Remedies Childrens Fever Pain Reliever		Acetaminophen	LIQUID	ORAL	20100901		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
63029-610_f4529240-a615-4d1a-a07f-f27f87d3334f	63029-610	HUMAN OTC DRUG	Little Remedies Infant Fever/Pain Reliever		Acetaminophen	LIQUID	ORAL	20110701		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
63029-615_0a57e76e-63e0-4cae-98b2-3b36622c51d0	63029-615	HUMAN OTC DRUG	LITTLE REMEDIES NEW BABY ESSENTIALS		ACETAMINOPHEN, SIMETHICONE, ZINC OXIDE	KIT		20170215		UNAPPROVED DRUG OTHER		Medtech Products Inc.						N	20241231
63029-620_251a0d87-470a-45b4-a38e-6fe87b9ead57	63029-620	HUMAN OTC DRUG	GOODYS	Back and Body	acetaminophen	LIQUID	ORAL	20150801		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN	1000	mg/60mL			N	20241231
63029-625_254d3096-1655-41b5-ba4f-5d38ff7dfe2a	63029-625	HUMAN OTC DRUG	Goodys Extra Strength		Acetaminophen, Aspirin, and Caffeine	POWDER	ORAL	20131101		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	260; 520; 32.5	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-629_c8b3641f-16a5-4677-b625-fef096440ffd	63029-629	HUMAN OTC DRUG	Goodys Headache Relief Shot		Acetaminophen and Caffeine	LIQUID	ORAL	20130211		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; CAFFEINE	1000; 65	mg/60mL; mg/60mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63029-644_a04a69da-506e-415a-9fff-eb75f3002fc6	63029-644	HUMAN OTC DRUG	Goodys Extra Strength		Acetaminophen, Aspirin, and Caffeine	POWDER	ORAL	20131101		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	260; 520; 32.5	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-656_6ce73cc3-08a0-41b2-9a9f-24a040ce2ef5	63029-656	HUMAN OTC DRUG	GOODYS PM		Acetaminophen and Diphenhydramine Citrate	POWDER	ORAL	20130901		OTC MONOGRAPH FINAL	part341	Medtech Products Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE CITRATE	500; 38	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63029-663_9aaee80c-3923-453e-b0d3-c0b8825f6675	63029-663	HUMAN OTC DRUG	Goodys	Cool Orange Headache	Acetaminophen and Aspirin and Caffeine	POWDER	ORAL	20120601		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	325; 500; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-664_061df2d8-dea3-4024-8546-6bbdbf37c81a	63029-664	HUMAN OTC DRUG	GOODYS	Extra Strength Headache Mixed Fruit Blast	acetaminophen, aspirin, and caffeine	POWDER	ORAL	20150801		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	325; 500; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-665_fc29ca4e-e9fe-4a00-94c6-d77a3f090f5b	63029-665	HUMAN OTC DRUG	GOODYS	Hangover	aspirin and caffeine	POWDER	ORAL	20191115		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ASPIRIN; CAFFEINE	1000; 150	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-901_76ecbdd3-b960-4892-86b9-01a07390b2c7	63029-901	HUMAN OTC DRUG	Dramamine Original Formula		Dimenhydrinate	TABLET	ORAL	20120115		OTC MONOGRAPH DRUG	M009	Medtech Products Inc.	DIMENHYDRINATE	50	mg/1			N	20251231
63029-902_7d7edc5c-4edc-4e91-9cb4-dfb5f60f99ea	63029-902	HUMAN OTC DRUG	Dramamine Orange		Dimenhydrinate	TABLET, CHEWABLE	ORAL	20120115		OTC MONOGRAPH FINAL	part336	Medtech Products Inc.	DIMENHYDRINATE	50	mg/1			N	20241231
63029-903_e31a5cb0-8d09-4910-899b-6bc69fc9e94a	63029-903	HUMAN OTC DRUG	Dramamine Less Drowsy		Meclizine Hydrochloride	TABLET	ORAL	20110901		OTC MONOGRAPH DRUG	M009	Medtech Products Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20251231
63029-905_1b472f88-a518-4643-b4d8-e94e7f748149	63029-905	HUMAN OTC DRUG	DRAMAMINE - N		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20180115		OTC MONOGRAPH FINAL	part336	Medtech Products Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63029-906_bcb68239-0f5f-43b5-bc92-6e9056463006	63029-906	HUMAN OTC DRUG	DRAMAMINE		MECLIZINE HYDROCHLORIDE	TABLET, CHEWABLE	ORAL	20190215		OTC MONOGRAPH FINAL	part336	Medtech Products Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63029-910_78047ff1-4c78-4f49-adc4-ecd4c3b4d46b	63029-910	HUMAN OTC DRUG	Dramamine for Kids		Dimenhydrinate	TABLET, CHEWABLE	ORAL	20120215		OTC MONOGRAPH FINAL	part336	Medtech Products Inc.	DIMENHYDRINATE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63029-990_99f9dd8d-5e19-4069-8fc0-341b07a631b6	63029-990	HUMAN OTC DRUG	BC Arthritis		Aspirin and Caffeine	POWDER	ORAL	20120601		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ASPIRIN; CAFFEINE	1000; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63029-992_1b3a6f84-ae93-48fc-b1be-c465b807f232	63029-992	HUMAN OTC DRUG	BC		Aspirin and Caffeine	POWDER	ORAL	20120601		OTC MONOGRAPH NOT FINAL	part343	Medtech Products Inc.	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63039-1002_ed7244f3-6c01-4ff1-e053-2a95a90a1277	63039-1002	HUMAN OTC DRUG	E-2 Food Processing Foam Hand Wash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20140331		OTC MONOGRAPH NOT FINAL	part333A	Chemco Products Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63039-1005_ed727afa-181d-5ac4-e053-2a95a90a3d58	63039-1005	HUMAN OTC DRUG	Antibacterial Foam Hand Wash		CHLOROXYLENOL	LIQUID	TOPICAL	20140411		OTC MONOGRAPH NOT FINAL	part333A	Chemco Products Company	CHLOROXYLENOL	2.5	mg/mL			N	20241231
63039-1006_207c3766-e050-42b6-95d4-95a98e261533	63039-1006	HUMAN OTC DRUG	AB 3000		Benzalkonium Chloride	LIQUID	TOPICAL	20201229		UNAPPROVED DRUG OTHER		Chemco	BENZALKONIUM CHLORIDE	.13	kg/100kg			N	20241231
63044-030_3ac43576-7ac4-480a-8202-8512441284ee	63044-030	HUMAN OTC DRUG	ZIKS ARTHRITIS PAIN RELIEF		ZIKS ARTHRITIS PAIN RELIEF	CREAM	TOPICAL	19991110		OTC MONOGRAPH DRUG	M017	Nnodum Pharmaceuticals	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.014; .566; 6.79	mg/g; mg/g; mg/g			N	20241231
63044-631_71b35326-f83e-4b5e-8565-9acb25f73e41	63044-631	HUMAN PRESCRIPTION DRUG	HEMATOGEN		FERROUS FUMARATE, ASCORBIC ACID, INTRINSIC FACTOR , CYANOCOBALAMIN	CAPSULE	ORAL	20070510		UNAPPROVED DRUG OTHER		Nnodum Pharmaceuticals	ASCORBIC ACID; CYANOCOBALAMIN; FERROUS FUMARATE; INTRINSIC FACTOR	250; 10; 66; 100	mg/1; ug/1; mg/1; mg/1	Ascorbic Acid [CS], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC]		N	20241231
63044-632_e0546189-efb1-4efe-bf84-66bff956218e	63044-632	HUMAN PRESCRIPTION DRUG	Hematogen FA		FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN	CAPSULE	ORAL	20050101		UNAPPROVED DRUG OTHER		Nnodum Pharmaceuticals	ASCORBIC ACID; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID	250; 10; 66; 1	mg/1; ug/1; mg/1; mg/1	Ascorbic Acid [CS], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC]		N	20241231
63044-633_644dd4ff-ca82-4c4f-961d-25ab60e6e1a2	63044-633	HUMAN PRESCRIPTION DRUG	HEMATOGEN FORTE		FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN	CAPSULE, GELATIN COATED	ORAL	20070510		UNAPPROVED DRUG OTHER		Nnodum Pharmaceuticals	ASCORBIC ACID; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID	1; 10; 151; 10	mg/1; mg/1; mg/1; mg/1	Ascorbic Acid [CS], Vitamin B 12 [CS], Vitamin B12 [EPC], Vitamin C [EPC]		N	20241231
63090-100_02c10e00-7f20-41ea-ad45-b239c8b7098a	63090-100	HUMAN PRESCRIPTION DRUG	NUPLAZID		pimavanserin tartrate	TABLET, COATED	ORAL	20180628		NDA	NDA207318	Acadia Pharmaceuticals Inc.	PIMAVANSERIN TARTRATE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63090-340_02c10e00-7f20-41ea-ad45-b239c8b7098a	63090-340	HUMAN PRESCRIPTION DRUG	NUPLAZID		pimavanserin tartrate	CAPSULE	ORAL	20180628		NDA	NDA210793	Acadia Pharmaceuticals Inc.	PIMAVANSERIN TARTRATE	34	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63090-660_0b4ea8eb-a476-488c-ad2a-14d25926e467	63090-660	HUMAN PRESCRIPTION DRUG	Daybue		trofinetide	SOLUTION	ORAL	20221231		NDA	NDA217026	Acadia Pharmaceuticals Inc.	TROFINETIDE	200	mg/mL			N	20241231
63102-101_7ffd904d-64c8-4328-bd53-7a99f3c535b4	63102-101	HUMAN OTC DRUG	ACTINEL		Dextromethorphan HBr,Guaifenesin,Pseudoephedrine HCl	SOLUTION	ORAL	20140924		OTC MONOGRAPH DRUG	M012	Actipharma, Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	15; 200; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63102-102_a07da938-ce8b-49ff-9fb5-82c4be6d0ee4	63102-102	HUMAN OTC DRUG	ACTINEL PEDIATRIC		Dextromethorphan HBr,Guaifenesin,Pseudoephedrine HCl	SOLUTION	ORAL	20140924		OTC MONOGRAPH DRUG	M012	Actipharma, Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 50; 15	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63102-104_7ee7ae4e-b359-4c71-8cd6-d12ed54e5158	63102-104	HUMAN OTC DRUG	ACTINEL DM		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20190520		OTC MONOGRAPH FINAL	part341	Actipharma, Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63102-106_6547c2a3-e3e9-4284-811a-a04956d7dcbd	63102-106	HUMAN OTC DRUG	ACTISEP		BENZOCAINE, MENTHOL, CETYLPYRIDINIUM CHLORIDE	SOLUTION	TOPICAL	20151228		OTC MONOGRAPH NOT FINAL	part356	Actipharma, Inc	BENZOCAINE; CETYLPYRIDINIUM CHLORIDE; MENTHOL, UNSPECIFIED FORM	2; .1; .5	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63102-107_c3b0081c-16a9-48ab-b91f-d1d1eb8d6f5d	63102-107	HUMAN OTC DRUG	ACTISEP		BENZOCAINE, MENTHOL, CETYLPYRIDINIUM CHLORIDE	SPRAY	TOPICAL	20151228		OTC MONOGRAPH NOT FINAL	part356	Actipharma, Inc	BENZOCAINE; CETYLPYRIDINIUM CHLORIDE; MENTHOL, UNSPECIFIED FORM	2; .1; .5	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63102-108_1e3396fc-76ce-400e-84c8-ee47ceda84c9	63102-108	HUMAN OTC DRUG	ACTICON		Dexbrompheniramine Maleate, Pseudoephedrine Hydrochloride	SOLUTION	ORAL	20220215		OTC MONOGRAPH FINAL	part341	ACTIPHARMA, INC	DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 60	mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63102-110_f83ff5c6-e0d5-46b1-b714-0559fca5d034	63102-110	HUMAN OTC DRUG	ACTIDOM DMX		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20150813		OTC MONOGRAPH FINAL	part341	Actipharma, Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	30; 200; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63102-115_42ab8014-a853-4d7a-a56d-5f4b96bbd9a5	63102-115	HUMAN OTC DRUG	ACTIDOM DA		Chlorpheniramine maleate, Phenylephrine hydrochloride	SOLUTION	ORAL	20220120		OTC MONOGRAPH FINAL	part341	Actipharma, Inc	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	1; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63102-401_46d93bc7-2741-4f41-8cb9-3b31ee8b5804	63102-401	HUMAN OTC DRUG	ACTICON		DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE	TABLET	ORAL	20150813		OTC MONOGRAPH DRUG	M012	Actipharma, Inc	DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63102-403_c0ebbc55-5d12-4d55-a715-939f1e5d0321	63102-403	HUMAN OTC DRUG	ACTIDOGESIC DF		Acetaminophen, Dexbrompheniramine Maleate	TABLET	ORAL	20200710		OTC MONOGRAPH DRUG	M012	Actipharma, Inc	ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE	500; 1	mg/1; mg/1			N	20241231
63121-123_06bf3be2-de55-abfc-e063-6294a90aaaf5	63121-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19960801		UNAPPROVED MEDICAL GAS		First Community Care	OXYGEN	99	L/100L			N	20241231
63126-101_296df15a-92f7-4bec-916b-441fc1c71b3c	63126-101	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20220430		ANDA	ANDA208195	YUNG SHIN PHARM. IND. CO., LTD.	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
63126-102_296df15a-92f7-4bec-916b-441fc1c71b3c	63126-102	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20220430		ANDA	ANDA208195	YUNG SHIN PHARM. IND. CO., LTD.	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
63127-101_32384173-e9d9-4f6e-af92-57f89ea3de61	63127-101	HUMAN OTC DRUG	La Defense Broad Spectrum SPF 30 Mineral Sunscreen		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210510		OTC MONOGRAPH DRUG	M020	Luzern Laboratories, Inc	TITANIUM DIOXIDE; ZINC OXIDE	3.57; 15	g/100mL; g/100mL			N	20241231
63135-581_008977e2-cdc2-9f04-e063-6394a90a1dbf	63135-581	HUMAN OTC DRUG	TOPICAINE 5		LIDOCAINE 5%	GEL	TOPICAL	20030420	20251231	OTC MONOGRAPH FINAL	part346	ESBA LABORATORIES INC.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
63138-120_082bf765-c943-3716-e063-6294a90a34dc	63138-120	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100105		UNAPPROVED MEDICAL GAS		Parkmor Drug Inc. dba Goshen Home Medical	OXYGEN	99	L/100L			N	20241231
63144-001_06beb2c9-31df-e46c-e063-6394a90a66d0	63144-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		TransOx, Inc.	OXYGEN	99	L/100L			N	20241231
63146-102_c363ff99-ff66-4e36-a454-fc9db7c71802	63146-102	HUMAN OTC DRUG	Kay McD		Chloroxylenol	SOLUTION	TOPICAL	20051013		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	CHLOROXYLENOL	.5	mg/100mL			N	20241231
63146-105_535d840e-ac85-4a48-b489-462982efba1d	63146-105	HUMAN OTC DRUG	Fortress		Chloroxylenol	SOLUTION	TOPICAL	20050516		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Co.	CHLOROXYLENOL	5	mg/mL			N	20241231
63146-108_64922822-2db3-4f7f-864a-80f33752b346	63146-108	HUMAN OTC DRUG	McD		Chloroxylenol	SOLUTION	TOPICAL	20070817		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	CHLOROXYLENOL	.5	mg/100mL			N	20241231
63146-109_844adc1a-aec3-42c8-b62e-3adcced16870	63146-109	HUMAN OTC DRUG	Kay		Benzalkonium Chloride	SOLUTION	TOPICAL	20080222		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
63146-110_4cf546dc-9fca-49f8-a557-46a319a3bbff	63146-110	HUMAN OTC DRUG	QSR		Chloroxylenol	SOLUTION	TOPICAL	20091215		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	CHLOROXYLENOL	5	mg/mL			N	20241231
63146-111_b6339f4f-bea3-4bb5-bb64-5bf75e18da55	63146-111	HUMAN OTC DRUG	QSR		Chloroxyenol	SOLUTION	TOPICAL	20100222		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	CHLOROXYLENOL	5	mg/mL			N	20241231
63146-112_118bf109-e99a-4386-866d-8edd2bafb5a4	63146-112	HUMAN OTC DRUG	QSR Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20100223		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	ALCOHOL	534	mg/mL			N	20241231
63146-117_0b70efdc-498a-49e5-83b1-7f538efd1ec5	63146-117	HUMAN OTC DRUG	Mystic Foaming Hand Sanitizer		Benzalkonium chloride	SOLUTION	TOPICAL	20101129		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
63146-121_8fb3a9ea-3d48-4afa-864d-7122f841d118	63146-121	HUMAN OTC DRUG	Lagarde		Chloroxylenol	SOLUTION	TOPICAL	20160531		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Co.	CHLOROXYLENOL	.5	mg/100mL			N	20241231
63146-122_ea772fad-366e-4820-975e-bcac5c166509	63146-122	HUMAN OTC DRUG	Ecolab		Benzalkonium chloride	SOLUTION	TOPICAL	20160218		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	BENZALKONIUM CHLORIDE	19.8	mg/mL			N	20241231
63146-123_3dc400f6-fc3d-4265-ad48-5d6dcba67dc3	63146-123	HUMAN OTC DRUG	Ecolab		Benzalkonium Chloride	SOLUTION	TOPICAL	20160201		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
63146-124_ddd01b5f-9d24-495e-b5ca-5a84a81ca1d2	63146-124	HUMAN OTC DRUG	Ecolab		Chloroxylenol	SOLUTION	TOPICAL	20151230		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	CHLOROXYLENOL	5	mg/mL			N	20241231
63146-301_fc4a2f71-a78d-4b1a-a021-fcd5d8692ba7	63146-301	HUMAN OTC DRUG	Kay Actigel		Ethanol	SOLUTION	TOPICAL	20100526		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	ALCOHOL	60	mL/100mL			N	20241231
63146-303_eb689064-871e-43f2-a9f6-d4c224a7cc75	63146-303	HUMAN OTC DRUG	Kay	Alphasan Hand Sanitizer	Alcohol	SOLUTION	TOPICAL	20051013		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Co	ALCOHOL	60	mL/100mL			N	20241231
63146-304_ebda98e9-1923-4edb-9159-2205fedea240	63146-304	HUMAN OTC DRUG	Mystic		Benzalkonium Chloride	SOLUTION	TOPICAL	20160211		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	BENZALKONIUM CHLORIDE	5	mg/mL			N	20241231
63146-308_8e1e886f-1b86-4459-8f87-81ed819420d2	63146-308	HUMAN OTC DRUG	Rushing FAHS		Chloroxylenol	SOLUTION	TOPICAL	20190109		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Co.	CHLOROXYLENOL	5	mg/mL			N	20241231
63146-309_725a8b11-6046-4fd5-88b6-731a2599734a	63146-309	HUMAN OTC DRUG	Kay Chemical Hand Sanitizer Foam		Ethyl Alcohol	SOLUTION	TOPICAL	20200423		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical	ALCOHOL	54.7	g/100g			N	20241231
63146-310_d39faf54-6ec7-4bc9-840d-0013b333e533	63146-310	HUMAN OTC DRUG	QSR Foaming Alcohol Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	ALCOHOL	76.9	mL/100mL			N	20241231
63146-311_09d1eae5-25cc-4e71-af58-b0709f37f524	63146-311	HUMAN OTC DRUG	Retail Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200910		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	ALCOHOL	60	mL/100mL			N	20241231
63146-312_5a60fab5-71f9-43f3-ae2a-f04bd4419fbe	63146-312	HUMAN OTC DRUG	Retail Foaming Alcohol Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20201202		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	ALCOHOL	70	mL/100mL			N	20241231
63146-313_fd06b1a0-32f2-4d23-8e4c-f5b197d8c7ac	63146-313	HUMAN OTC DRUG	Kay Alcohol Foam Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20201202		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	ALCOHOL	70	mL/100mL			N	20241231
63146-314_d0408239-ea20-4ce9-bf31-20d3d91fd242	63146-314	HUMAN OTC DRUG	CHEMSTAR RETAIL HAND SANITIZER		Alcohol	LIQUID	TOPICAL	20210527		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	ALCOHOL	60	mL/100mL			N	20241231
63146-315_dbdfd463-816b-49e2-9868-16e2067bc576	63146-315	HUMAN OTC DRUG	CHEMSTAR		Chloroxylenol	SOLUTION	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Co.	CHLOROXYLENOL	.5	mg/100mL			N	20241231
63146-316_98b8efe8-0356-443e-8975-d4969b1d22b5	63146-316	HUMAN OTC DRUG	CHEMSTAR Foaming Hand Sanitizer		Benzalkonium chloride	SOLUTION	TOPICAL	20101208		OTC MONOGRAPH NOT FINAL	part333E	Kay Chemical Company	BENZALKONIUM CHLORIDE	.1	mg/100mL			N	20241231
63148-028_e8744d84-8d37-6b55-e053-2a95a90af4d0	63148-028	HUMAN OTC DRUG	Life is healed	Daily Moisturizing	Dimethicone	LOTION	TOPICAL	20210720		OTC MONOGRAPH FINAL	part347	Apollo Health and Beauty Care	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
63148-350_e648a772-ffdb-df55-e053-2995a90af20a	63148-350	HUMAN OTC DRUG	berkley jensen		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20220815		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
63148-400_e648bb79-3384-c4ae-e053-2a95a90aac12	63148-400	HUMAN OTC DRUG	berkley jensen		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20220815		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
63148-401_fee36856-3d65-f875-e053-6394a90ac5ab	63148-401	HUMAN OTC DRUG	HIMark		Benzalkonium Chloride	LIQUID	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
63148-402_fee18259-ad2e-a361-e053-6394a90ae4e5	63148-402	HUMAN OTC DRUG	HiGHMARK		Alcohol	LIQUID	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	ALCOHOL	70	mL/100mL			N	20241231
63148-403_fee30fb8-76f7-331c-e053-6394a90a1ca7	63148-403	HUMAN OTC DRUG	HIMARK		Alcohol	LIQUID	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	ALCOHOL	70	mL/100mL			N	20241231
63148-417_0b2d5fb1-64b1-2e70-e063-6294a90a2fcd	63148-417	HUMAN OTC DRUG	Everyday Clean		Pyrithione Zinc	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M032	Apollo Health and Beauty Care	PYRITHIONE ZINC	10	mg/mL			N	20241231
63148-500_909829fe-28f8-49b2-91e8-104cae8cb15a	63148-500	HUMAN OTC DRUG	Life is Simple Hand Sanitizer		Non-Alcohol Foaming Hand Sanitizer	AEROSOL, FOAM	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
63148-502_fe3f5807-cd79-52d2-e053-6294a90a21c6	63148-502	HUMAN OTC DRUG	Guard		Alcohol	GEL	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	Apollo Health and Beauty Care	ALCOHOL	70	mL/100mL			N	20241231
63148-512_18dc6f8b-a807-4396-8598-73c5f84d0477	63148-512	HUMAN OTC DRUG	Natural Concepts Alcohol-Free Hand Sanitizer		Benzalkonium chloride	GEL	TOPICAL	20200414		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63148-512_726c0455-56ff-4179-8b49-79761bd5c7a0	63148-512	HUMAN OTC DRUG	Natural Concepts Alcohol-Free Hand Sanitizer		Benzalkonium chloride	GEL	TOPICAL	20200414		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63148-512_7a1ab7e4-8e15-4e29-85c0-84d72a299e41	63148-512	HUMAN OTC DRUG	Natural Concepts Alcohol-Free Hand Sanitizer		Benzalkonium chloride	GEL	TOPICAL	20200414		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63148-512_efe575ac-5c02-4ff5-8477-fa809af856ce	63148-512	HUMAN OTC DRUG	Natural Concepts Alcohol-Free Hand Sanitizer		Benzalkonium Chloride	GEL	TOPICAL	20200716		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63148-516_2cd31efd-e548-49a2-a133-adb93566bcbc	63148-516	HUMAN OTC DRUG	Natural Concepts Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200511		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	ALCOHOL	650	mg/mL			N	20241231
63148-516_b16d1cea-d307-4a11-b78e-cb63faa9235f	63148-516	HUMAN OTC DRUG	Natural Concepts Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200511		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	ALCOHOL	650	mg/mL			N	20241231
63148-516_d385d974-49fb-4c3f-ac81-79a0d017c0fa	63148-516	HUMAN OTC DRUG	Natural Concepts Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200508		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	ALCOHOL	650	mg/mL			N	20241231
63148-516_ed07aa16-5340-4639-80b5-d224f89e7d83	63148-516	HUMAN OTC DRUG	Natural Concepts Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200623		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	ALCOHOL	650	mg/mL			N	20241231
63148-518_2dc518d5-5aec-4050-a5ef-61c5365d41a2	63148-518	HUMAN OTC DRUG	Natural Concepts Hand Sanitizer		Isopropyl Alcohol	GEL	TOPICAL	20200609		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
63148-519_4c03db90-9cbb-4c45-87ec-ceecbb818357	63148-519	HUMAN OTC DRUG	Guard Hand Sanitizer		Isopropyl Alcohol	GEL	TOPICAL	20200609		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
63148-522_83f94d4a-5f60-4452-a242-a2c81874f811	63148-522	HUMAN OTC DRUG	Natural Concepts		Ethyl Alcohol	GEL	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc	ALCOHOL	700	mg/mL			N	20241231
63148-524_583225d1-e6ae-4741-a59d-c7630449e261	63148-524	HUMAN OTC DRUG	Natural Concepts		Ethyl Alcohol	GEL	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc	ALCOHOL	750	mg/mL			N	20241231
63148-526_9218c284-45e8-4ec1-9d32-ab1bca98deb5	63148-526	HUMAN OTC DRUG	Natural Concepts		Ethyl Alcohol	GEL	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc	ALCOHOL	800	mg/mL			N	20241231
63148-530_37346874-ac6a-450b-8c57-53c99cb2d62c	63148-530	HUMAN OTC DRUG	Natural Concepts		Ethyl Alcohol	GEL	TOPICAL	20210203		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc	ALCOHOL	650	mg/mL			N	20241231
63148-540_daa34d6d-2e1d-43ba-a477-a5f8101af138	63148-540	HUMAN OTC DRUG	Natural Concepts		Ethyl Alcohol	GEL	TOPICAL	20210203		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc	ALCOHOL	700	mg/mL			N	20241231
63148-580_fbc02e5e-a079-02c6-e053-6394a90a6ca7	63148-580	HUMAN OTC DRUG	Classic Clean		Shampoo	SHAMPOO	TOPICAL	20230428		OTC MONOGRAPH FINAL	M032	Apollo Health and Beauty Care	PYRITHIONE ZINC	1000	mg/100mL			N	20241231
63148-626_80cdeebf-4b97-44e7-b001-54a588f9ea10	63148-626	HUMAN OTC DRUG	Guard		Ethyl Alcohol	GEL	TOPICAL	20201123		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care Inc	ALCOHOL	800	mg/mL			N	20241231
63148-632_dbec98dc-5774-1797-e053-2a95a90aa0ad	63148-632	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part333A	Apollo Health and Beauty Care	ALCOHOL	70	mL/100mL			N	20241231
63148-660_169d1181-bb78-400b-aa10-a3fb89f3c7ad	63148-660	HUMAN OTC DRUG	Moxie		Ethyl Alcohol	GEL	TOPICAL	20210302		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	ALCOHOL	700	mg/mL			N	20241231
63148-725_07e40822-666a-4ab7-846f-54ff78d0a21e	63148-725	HUMAN OTC DRUG	Autumn Bliss Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	ALCOHOL	700	mg/mL			N	20241231
63148-726_80b148bd-e93a-480d-9b4b-07cf11fdfd99	63148-726	HUMAN OTC DRUG	Sweet Cinnamon Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	ALCOHOL	700	mg/mL			N	20241231
63148-727_89397c02-30f0-498f-a85e-7b684c8758f2	63148-727	HUMAN OTC DRUG	Winter Frost Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20210708		OTC MONOGRAPH NOT FINAL	part333E	Apollo Health and Beauty Care	ALCOHOL	700	mg/mL			N	20241231
63173-001_08b44ac9-9a36-c392-e063-6294a90ac3fe	63173-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020130		UNAPPROVED MEDICAL GAS		Med-Caire Inc.	OXYGEN	99	L/100L			N	20241231
63187-001_e293f6c0-d64b-401a-81a3-25785fc66998	63187-001	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	SOLUTION/ DROPS	OPHTHALMIC; TOPICAL	20040809		ANDA	ANDA076673	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-002_19d4f41e-82d5-4eb2-94f7-de85f787725d	63187-002	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070831		ANDA	ANDA078050	Proficient Rx LP	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-003_d3c398d7-5370-40dc-bbe2-8621026bec3e	63187-003	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA077438	Proficient Rx	LEVOFLOXACIN	500	mg/1			N	20241231
63187-004_d3c398d7-5370-40dc-bbe2-8621026bec3e	63187-004	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA077438	Proficient Rx	LEVOFLOXACIN	750	mg/1			N	20241231
63187-006_be2722d9-bb72-41c4-b2ec-5c58a5410ec9	63187-006	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20040214		ANDA	ANDA075694	Proficient Rx	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-007_d6250595-3500-4c6f-8175-25a8a92e2d5e	63187-007	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065225	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63187-008_2dd0e8d4-6ac3-433f-a41f-1e55d2b3f5ca	63187-008	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20060822		ANDA	ANDA076817	Proficient Rx LP	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
63187-009_d6f544bc-d13f-4db7-b168-9f48ffba211d	63187-009	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	Proficient Rx LP	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63187-010_34b3a9d3-242c-449b-ba6a-ebb2ecf4f37b	63187-010	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401		ANDA	ANDA077662	Proficient Rx LP	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-011_3beeac9d-07fb-4616-8e2c-898f496c9c3d	63187-011	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	19890503		ANDA	ANDA071611	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-012_4cdae2ee-c739-48aa-96e9-9ce517e10149	63187-012	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	Proficient Rx LP	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-013_7f4ab0f1-5f3f-422a-a945-f4f664ceb12d	63187-013	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		amoxicillin	TABLET, FILM COATED	ORAL	19780710		NDA	NDA050754	Proficient Rx LP	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-014_49e8b27c-0f31-4bba-adce-5c5cb9478494	63187-014	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-015_141d8892-7f38-43d4-8bc4-5a0bf6198717	63187-015	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20110608		ANDA	ANDA090480	Proficient Rx LP	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
63187-016_b81d0eb4-1112-4371-aa8b-afa80ff03ab5	63187-016	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20070725		ANDA	ANDA040627	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63187-017_91f426fc-3fc4-4c2f-a56d-10862e54d745	63187-017	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-018_98c69d2c-3898-4400-aae0-cc8d17587384	63187-018	HUMAN PRESCRIPTION DRUG	Ketoprofen		Ketoprofen	CAPSULE	ORAL	19930101		ANDA	ANDA073517	Proficient Rx LP	KETOPROFEN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-019_87a7950f-b987-4ee0-901e-49b19054707b	63187-019	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Proficient Rx LP	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-020_df3fb8ca-6e08-4e2b-8e27-db94366273ab	63187-020	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Proficient Rx LP	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-021_82b45510-bf4d-4f1a-bba7-8caeedd68d84	63187-021	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20080116		ANDA	ANDA077570	Proficient Rx LP	FLUTICASONE PROPIONATE	50	ug/.1g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-022_7db62aa5-dd71-4f62-b656-c4df75686f02	63187-022	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Proficient Rx LP	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-023_4da76d1e-eb8f-4fa1-8bdf-45e435d40e72	63187-023	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Proficient Rx LP	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63187-024_6458f461-e408-4dcc-b7c3-f8fb9fbcb31d	63187-024	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19931129		ANDA	ANDA064052	Proficient Rx LP	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63187-025_a14464f9-ffde-4cb0-aa0a-baedbeb298a0	63187-025	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-026_8dc382b1-3801-4d0c-a3e6-a564b612e68c	63187-026	HUMAN PRESCRIPTION DRUG	VENTOLIN	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20060609		NDA	NDA020983	Proficient Rx LP	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
63187-027_7f4ab0f1-5f3f-422a-a945-f4f664ceb12d	63187-027	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		amoxicillin	POWDER, FOR SUSPENSION	ORAL	19990415		NDA	NDA050760	Proficient Rx LP	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-028_e1ba35a9-7bc6-4597-965a-7e9fbd602a9b	63187-028	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Proficient Rx LP	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-029_e61645ee-b492-46b5-bb37-8df0e39e20d8	63187-029	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	Proficient Rx LP	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-031_75599dc3-b3a3-440f-b052-6e980c297c93	63187-031	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20100517		ANDA	ANDA090705	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-032_a554e1ac-fea6-4b57-94be-5d517ed49d3d	63187-032	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065101	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-033_ae695028-14a8-458d-a282-77089439a0ad	63187-033	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	19840626		NDA	NDA019117	Proficient Rx LP	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-035_62667034-bf5e-4582-a510-b46b4b3725d0	63187-035	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	19900930		ANDA	ANDA070033	Proficient Rx LP	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
63187-036_cf41df26-cc0b-4e51-a3dc-f3c8ea186150	63187-036	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20001222		ANDA	ANDA065062	Proficient Rx LP	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-037_c1b5fac9-ec3d-491f-8e58-bba1d0f9d861	63187-037	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Proficient Rx LP	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-038_52266eb3-3fb1-4838-b2e1-bbe553ff7cf2	63187-038	HUMAN PRESCRIPTION DRUG	promethazine hydrochloride		promethazine hydrochloride	TABLET	ORAL	20090127		ANDA	ANDA040863	Proficient Rx LP	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63187-039_7af7836c-27c0-4fbf-82dc-3ccfafae12c4	63187-039	HUMAN OTC DRUG	TRIPLE ANTIBIOTIC		bacitracin zinc neomycin sulfate polymyxin b sulfate	OINTMENT	TOPICAL	20030101		OTC MONOGRAPH FINAL	part333B	Proficient Rx LP	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-040_550c050b-4295-488a-a482-7105dacbca5d	63187-040	HUMAN OTC DRUG	Q Tussin DM		Dextromethorphan HBr and Guaifenesin	SYRUP	ORAL	19950401		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63187-042_c7ece449-f294-4adc-9a34-460138bb6e07	63187-042	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110208		ANDA	ANDA090797	Proficient Rx LP	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-043_37ca9099-4aa7-4e1d-b914-40351c7b155b	63187-043	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19880225		ANDA	ANDA062884	Proficient Rx LP	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-044_46acdbce-70d1-462a-b60c-cd242b654e3c	63187-044	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20120112		ANDA	ANDA062058	Proficient Rx LP	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-046_8202b9f1-6f03-4f64-a300-062d1679d0e8	63187-046	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	Proficient Rx LP	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63187-049_bcf1b59f-5656-4913-882c-95ffe205273b	63187-049	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Proficient Rx LP	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-050_f91a5b3e-4e83-45ec-a1a0-b815de7e1876	63187-050	HUMAN PRESCRIPTION DRUG	Lisinopril and hydrochlorothiazide		Lisinopril and hydrochlorothiazide	TABLET	ORAL	20030301		ANDA	ANDA076194	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-051_f91a5b3e-4e83-45ec-a1a0-b815de7e1876	63187-051	HUMAN PRESCRIPTION DRUG	Lisinopril and hydrochlorothiazide		Lisinopril and hydrochlorothiazide	TABLET	ORAL	20030301		ANDA	ANDA076194	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-052_73572f20-b22c-4c8c-b99e-5eb8e70f9be0	63187-052	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100408		ANDA	ANDA078866	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-053_2d6c64fd-0cc8-42ed-9918-2b98b026271b	63187-053	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	19780309		ANDA	ANDA085692	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-055_820641b5-c569-4a24-b0a4-5d17d3cff8ee	63187-055	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-056_75599dc3-b3a3-440f-b052-6e980c297c93	63187-056	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20100517		ANDA	ANDA090705	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-057_34b3a9d3-242c-449b-ba6a-ebb2ecf4f37b	63187-057	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401		ANDA	ANDA077662	Proficient Rx LP	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-058_dfeba17c-c430-4fdc-b18a-1f30c366e07e	63187-058	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL; SUBLINGUAL	20090921		UNAPPROVED DRUG OTHER		Proficient Rx LP	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
63187-059_f68b2272-7a9d-4838-89ff-a10064e49015	63187-059	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA090278	Proficient Rx LP	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-060_f68b2272-7a9d-4838-89ff-a10064e49015	63187-060	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA090278	Proficient Rx LP	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-061_fdcc8bea-bf2b-42e3-8b2e-a59ac27426fc	63187-061	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20031111		ANDA	ANDA076048	Proficient Rx LP	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-063_59d339c1-6ad2-4407-ac41-74e5f4dda6e8	63187-063	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20101115		ANDA	ANDA076003	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63187-064_823432a4-72e2-4584-9c7c-afe1abfaf7e5	63187-064	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20100723		ANDA	ANDA091004	Proficient Rx LP	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
63187-065_dcd5d6d3-2419-467f-91c2-50586e9ca5cb	63187-065	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Proficient Rx LP	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-066_c1b5fac9-ec3d-491f-8e58-bba1d0f9d861	63187-066	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Proficient Rx LP	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-067_190ec4f5-eac7-45b0-b70a-d8d64a146264	63187-067	HUMAN OTC DRUG	MEDI-SULTING TOPICAL PAIN RELIEF		METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE	PATCH	TOPICAL	20120818		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	CAPSAICIN; LIDOCAINE; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.035; .5; 5; 20	g/100g; g/100g; g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63187-069_27cdbe64-490e-4b1d-85da-f4a72a883098	63187-069	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-070_fdcc8bea-bf2b-42e3-8b2e-a59ac27426fc	63187-070	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20031111		ANDA	ANDA076048	Proficient Rx LP	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-071_317c5935-98fa-4bf4-9a07-c19b6daab2ea	63187-071	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Proficient Rx LP	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-072_317c5935-98fa-4bf4-9a07-c19b6daab2ea	63187-072	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Proficient Rx LP	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-073_cada6f46-f67d-41d9-8dbe-53740c3dac62	63187-073	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	Proficient Rx LP	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-074_2d8c4763-f719-46ce-8fb8-04e82fbacf05	63187-074	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20100820		ANDA	ANDA040807	Proficient Rx LP	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-075_f5e53eb7-8199-4ca7-9cd0-8dc140c79376	63187-075	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Proficient Rx LP	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-076_1e43585a-8e75-4a75-a011-56b5f80cb7cd	63187-076	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE, LIQUID FILLED	ORAL	20100604		ANDA	ANDA040682	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63187-077_f68b2272-7a9d-4838-89ff-a10064e49015	63187-077	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		TOPIRAMATE	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA090278	Proficient Rx LP	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-079_df47793e-33f4-4823-b58f-ad991b48b22f	63187-079	HUMAN PRESCRIPTION DRUG	CELEBREX		CELECOXIB	CAPSULE	ORAL	19981002		NDA	NDA020998	Proficient Rx LP	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-080_67be1aec-dfea-48ba-927a-162e4c2e9107	63187-080	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100628		ANDA	ANDA090568	Proficient Rx LP	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
63187-081_27cdbe64-490e-4b1d-85da-f4a72a883098	63187-081	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-082_edcba6c4-01a9-4408-ac46-1b0f3267fc20	63187-082	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Proficient Rx LP	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-083_edcba6c4-01a9-4408-ac46-1b0f3267fc20	63187-083	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Proficient Rx LP	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-084_07437d1c-92eb-437a-8740-24a126006667	63187-084	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET	ORAL	20091217		ANDA	ANDA090485	Proficient Rx LP	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63187-085_17eee13e-d667-4813-94f2-b0b8f9067c38	63187-085	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20090803		ANDA	ANDA083677	Proficient Rx LP	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-086_739358e1-cc8b-4b5c-be06-4eeb8183cf8f	63187-086	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA071523	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
63187-087_87a7950f-b987-4ee0-901e-49b19054707b	63187-087	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Proficient Rx LP	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-089_0fd31fbf-d316-41d3-8a7a-7a69f291c399	63187-089	HUMAN PRESCRIPTION DRUG	Fluoxetine		fluoxetine	CAPSULE	ORAL	20050720		ANDA	ANDA076990	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-090_f353adaf-db4a-45c3-b20c-7078ae0af61a	63187-090	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Proficient Rx LP	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-092_d07f3951-beb5-4943-a972-0813a5ccda60	63187-092	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071204		ANDA	ANDA077877	Proficient Rx LP	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-093_fff76d33-5d1d-4014-910f-d8ae89b04e67	63187-093	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20101217		ANDA	ANDA065246	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63187-094_6d258146-9e61-40a6-b433-d5fb21aecc5e	63187-094	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-095_de8b4d67-65d0-4290-b680-b9b1373033c6	63187-095	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20070103		ANDA	ANDA076002	Proficient Rx LP	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-096_5b625e97-73b5-4920-82e6-c80b864ecf4c	63187-096	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	Proficient Rx LP	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63187-097_fed449e4-9657-4ca1-a8bc-7e14535d854b	63187-097	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20090129		ANDA	ANDA078010	Proficient Rx LP	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63187-098_f0c279c5-1f67-4d03-ba2d-6202d619299c	63187-098	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Proficient Rx LP	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-099_93195b6e-f044-4c65-9828-b45d47a99da2	63187-099	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA075743	Proficient Rx LP	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-100_171ce022-2573-4dc9-b5fd-359a4d16d94d	63187-100	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20030828		ANDA	ANDA076134	Proficient Rx LP	LORATADINE	10	mg/1			N	20241231
63187-101_53e55e82-ac19-4e6e-8b45-21f10ee63b5f	63187-101	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20100422		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63187-102_53e55e82-ac19-4e6e-8b45-21f10ee63b5f	63187-102	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20100422		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63187-103_4c68ec23-f360-4b94-8bd5-c5f46e2fc2eb	63187-103	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol tartrate	TABLET	ORAL	20040115		ANDA	ANDA076670	Proficient Rx LP	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-105_b0100eac-f51f-4aa9-88e1-f628aeea2412	63187-105	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Proficient Rx LP	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-106_51818467-e07a-4aae-b34f-4f106dd9a584	63187-106	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20110706		ANDA	ANDA040419	Proficient Rx LP	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63187-107_0196168a-424a-4836-bdb6-3fff389837f6	63187-107	HUMAN OTC DRUG	Flexall Pain Relieving		Menthol	GEL	TOPICAL	19970101		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	MENTHOL, UNSPECIFIED FORM	.16	g/g			N	20241231
63187-108_12381014-c129-45f9-b594-44c8d1d3cd11	63187-108	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Proficient Rx LP	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-109_12381014-c129-45f9-b594-44c8d1d3cd11	63187-109	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Proficient Rx LP	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-110_c091c3f5-1961-49ad-b4d5-b82062d31e88	63187-110	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-111_96ea8a54-d84e-4ac6-9ce1-2624f20a4992	63187-111	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Proficient Rx LP	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
63187-112_160e7aae-4a67-4845-9fa1-9d13afb5285d	63187-112	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20100118		ANDA	ANDA040736	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63187-114_8cc5ab2b-822e-4d2b-b325-43842fdb685b	63187-114	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090107	Proficient Rx LP	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-117_39d4687f-8ea5-455a-a254-4de982237b96	63187-117	HUMAN OTC DRUG	Guaifenesin and Codeine Phosphate		Guaifenesin and Codeine Phosphate	SOLUTION	ORAL	20061001		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
63187-118_383715b0-118d-4561-a46a-dd23bb680352	63187-118	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	Proficient Rx LP	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-120_69fa9403-88e0-4a4f-aa02-b7bcab633549	63187-120	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20100218		ANDA	ANDA040746	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63187-121_dc4f3c12-86c1-4697-bfe0-b63b7cdd159c	63187-121	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20070426		ANDA	ANDA078432	Proficient Rx LP	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-122_6733ab80-4fe3-4bdb-8e81-3beb50b5db0c	63187-122	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	Proficient Rx LP	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-124_c10e09c6-2958-4fdd-beba-53c388d3f2e1	63187-124	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140127		ANDA	ANDA077284	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-125_68285586-9186-4ffb-9142-924001aed536	63187-125	HUMAN OTC DRUG	Promolaxin		Docusate sodium	TABLET	ORAL	20110415		OTC MONOGRAPH NOT FINAL	part334	Proficient Rx LP	DOCUSATE SODIUM	100	mg/1			N	20241231
63187-127_146abd0d-3e2b-480f-a2f0-925e9c36cec4	63187-127	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20090826		ANDA	ANDA065442	Proficient Rx LP	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63187-128_dd66f622-8f11-4a86-a70c-9a9a8300fda5	63187-128	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	Proficient Rx LP	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-129_b1d75704-ce21-4209-8bc7-636c952587b2	63187-129	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Proficient Rx LP	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63187-130_948f25be-b1ae-4bc9-9272-9f0af5bb3196	63187-130	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130115		ANDA	ANDA086988	Proficient Rx LP	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-131_66dda826-2d3f-466b-ab05-42b7cf892410	63187-131	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Proficient Rx LP	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63187-132_297f2ef3-a614-4992-b087-fe26108471f4	63187-132	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Proficient Rx LP	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-133_739358e1-cc8b-4b5c-be06-4eeb8183cf8f	63187-133	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA071524	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
63187-135_305c2440-855c-4b18-b542-75ae99e2deee	63187-135	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20001201		ANDA	ANDA065055	Proficient Rx LP	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-136_30e14e19-9ab2-44d6-8aa5-297aa3aecf1a	63187-136	HUMAN OTC DRUG	Dendracin Neurodendraxcin		Methyl Salicylate, Menthol and Capsaicin	LOTION	TOPICAL	20110722		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	CAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.015; 6; 18	g/60mL; g/60mL; g/60mL			N	20241231
63187-137_fdc89bd3-7537-4426-a5c2-b53794f6b20b	63187-137	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate And Acetaminophen		Hydrocodone Bitartrate And Acetaminophen	TABLET	ORAL	20060119		ANDA	ANDA040656	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63187-140_288c3af7-acd9-4c1d-a4b5-8ae7aee4549f	63187-140	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	Proficient Rx LP	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-141_2dfd4382-3405-48c3-b7e1-7c19d82901d8	63187-141	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	Proficient Rx LP	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63187-142_91f426fc-3fc4-4c2f-a56d-10862e54d745	63187-142	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-145_fa1c80fd-e646-4850-8f31-04c5417978c0	63187-145	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20040116		ANDA	ANDA076533	Proficient Rx LP	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63187-146_e9f3d596-be8b-47ed-9982-5c26878e3def	63187-146	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20110101		ANDA	ANDA077836	Proficient Rx LP	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
63187-147_388af522-63eb-4a38-9f85-ffb34320fd11	63187-147	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	19880721		ANDA	ANDA072234	Proficient Rx LP	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63187-148_f55b43a8-4ccf-4b28-be7d-8850f5a17222	63187-148	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Proficient Rx LP	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-149_6988fc48-a2e8-4be5-861d-13c3be7b0826	63187-149	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20121029		ANDA	ANDA202764	Proficient Rx LP	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-150_bfe6279f-0cb0-45c6-90f0-a6571cbaa608	63187-150	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		CIPROFLOXACIN HYDROCHLORIDE	SOLUTION/ DROPS	TOPICAL	20080320		ANDA	ANDA077689	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	3.5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-151_a22d9ce1-ccc1-4955-939c-b74e110cffa5	63187-151	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20050923		ANDA	ANDA065170	Proficient Rx LP	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
63187-152_0ca90194-0255-4661-896a-e066e593bf8a	63187-152	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20091111		ANDA	ANDA077255	Proficient Rx LP	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-154_064a64eb-36f7-401b-86f6-10281d7afd84	63187-154	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	19970423		ANDA	ANDA074578	Proficient Rx LP	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-155_4a1af411-3907-475c-9047-4cbe295dc1b7	63187-155	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19970911		ANDA	ANDA040218	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-156_8de781ff-8ad8-48c4-aa07-4714a2be1854	63187-156	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19970911		ANDA	ANDA040218	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-157_008d1180-1d6e-4ed2-950d-c494700dd7a1	63187-157	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20100218		ANDA	ANDA078218	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-160_d1e24bea-ccf4-453d-b5b6-7a44e78c7069	63187-160	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	Proficient Rx LP	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-163_9bc97257-3fe5-45aa-a544-78d044982cd4	63187-163	HUMAN PRESCRIPTION DRUG	GENTAMICIN SULFATE		gentamicin sulfate	SOLUTION/ DROPS	OPHTHALMIC	19980105		ANDA	ANDA062452	Proficient Rx LP	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63187-164_04d6f65a-5603-432e-a92a-91dff27781c6	63187-164	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		SUMATRIPTAN	TABLET	ORAL	20090813		ANDA	ANDA076554	Proficient Rx LP	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-167_74a6154b-2994-4aa2-880b-61427e6797ad	63187-167	HUMAN OTC DRUG	Good Sense Allergy Relief		diphenhydramine hydrochloride	CAPSULE	ORAL	19890915		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-168_67b8d9a0-2da1-4a8d-8775-ecbe065870d4	63187-168	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20130213		ANDA	ANDA077562	Proficient Rx LP	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-169_9471b50f-3435-48b2-a04b-d18e4bca88dc	63187-169	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065211	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63187-170_4536c14e-6d05-451e-8b34-0c022c34d654	63187-170	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA076048	Proficient Rx LP	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-172_58a38000-a494-41ed-9491-a39e589f59b5	63187-172	HUMAN PRESCRIPTION DRUG	Duloxetine Hydrochloride		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20140613		ANDA	ANDA202045	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-173_0471cce6-7ddc-4530-a794-3da0d7fd94d4	63187-173	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	Proficient Rx LP	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-174_4c68ec23-f360-4b94-8bd5-c5f46e2fc2eb	63187-174	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol tartrate	TABLET	ORAL	20040115		ANDA	ANDA076670	Proficient Rx LP	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-176_73572f20-b22c-4c8c-b99e-5eb8e70f9be0	63187-176	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100408		ANDA	ANDA078866	Proficient Rx LP	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-177_cf9e50d9-63c5-42a3-b8e0-774f1dc8df71	63187-177	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-178_73572f20-b22c-4c8c-b99e-5eb8e70f9be0	63187-178	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100408		ANDA	ANDA078866	Proficient Rx LP	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-181_58a38000-a494-41ed-9491-a39e589f59b5	63187-181	HUMAN PRESCRIPTION DRUG	Duloxetine Hydrochloride		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20140613		ANDA	ANDA202045	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-182_347e3045-6810-4821-ab70-0ba268a4cc2e	63187-182	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20091022		ANDA	ANDA075090	Proficient Rx LP	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-184_494bc1d0-100f-46c4-b35f-8248fc20b727	63187-184	HUMAN PRESCRIPTION DRUG	Ofloxacin Otic		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20040514		ANDA	ANDA076527	Proficient Rx LP	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-185_b81d0eb4-1112-4371-aa8b-afa80ff03ab5	63187-185	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20070725		ANDA	ANDA040627	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63187-186_336edd44-77fc-48f7-987c-3432ae79ffa1	63187-186	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	Proficient Rx LP	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-187_de495ce2-88c6-4c15-8fb6-8ed1f81452c9	63187-187	HUMAN OTC DRUG	Ear Wax Remover		CARBAMIDE PEROXIDE	LIQUID	AURICULAR (OTIC)	20090527		OTC MONOGRAPH FINAL	part344	Proficient Rx LP	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
63187-188_c9fb97e3-6748-4b7f-a562-6e4950ec3e4f	63187-188	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20110301		ANDA	ANDA075693	Proficient Rx LP	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63187-189_d6250595-3500-4c6f-8175-25a8a92e2d5e	63187-189	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065223	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63187-190_b0100eac-f51f-4aa9-88e1-f628aeea2412	63187-190	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Proficient Rx LP	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-191_f5e53eb7-8199-4ca7-9cd0-8dc140c79376	63187-191	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Proficient Rx LP	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-192_9c66b198-9eb5-4e9d-89f9-c765eaeb9c69	63187-192	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20060313		ANDA	ANDA077309	Proficient Rx LP	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-193_a0deddd4-f2c7-4594-ac0d-1ed4ce48b891	63187-193	HUMAN PRESCRIPTION DRUG	Trimethoprim sulfate and Polymyxin B sulfate		Trimethoprim sulfate and Polymyxin B sulfate	SOLUTION	OPHTHALMIC	19981217		ANDA	ANDA065006	Proficient Rx LP	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-194_ca1866cb-6cfc-40f3-8bf7-9b2d7ef1219a	63187-194	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Proficient Rx LP	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-196_ad87e769-f109-4e2c-9281-0ae4e9730c64	63187-196	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Proficient Rx LP	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63187-197_34741ce8-e1e1-484c-8c6c-6ff373b02bd0	63187-197	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20110101		ANDA	ANDA077955	Proficient Rx LP	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63187-198_34741ce8-e1e1-484c-8c6c-6ff373b02bd0	63187-198	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20110101		ANDA	ANDA077955	Proficient Rx LP	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63187-199_1aef35f7-75e6-415f-869f-59d184acdae1	63187-199	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	Proficient Rx LP	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-200_21a6e3d2-041b-489e-9c24-8482e77ac51a	63187-200	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	Proficient Rx LP	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-201_93d667f2-a0fd-4def-85ad-f89ae36b78e5	63187-201	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19910917		ANDA	ANDA073025	Proficient Rx LP	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-203_2cb8403d-3262-43c8-ad72-482948223d11	63187-203	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Proficient Rx LP	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-204_621471a7-e06e-4d18-be4b-aca66c225a39	63187-204	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	19970917		ANDA	ANDA074880	Proficient Rx LP	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
63187-205_379fbc28-1afd-4114-8d06-207a0a33783a	63187-205	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA062703	Proficient Rx LP	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63187-206_fb4bf3e5-f62b-489a-ba75-8e94513f29ca	63187-206	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Proficient Rx LP	MIRTAZAPINE	15	mg/1			N	20241231
63187-212_820641b5-c569-4a24-b0a4-5d17d3cff8ee	63187-212	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-213_c77565cf-daac-4bd2-98e8-569c96c0f4e5	63187-213	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine	TABLET	ORAL	20110101		ANDA	ANDA077533	Proficient Rx LP	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
63187-214_2d6c64fd-0cc8-42ed-9918-2b98b026271b	63187-214	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	19780309		ANDA	ANDA085692	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-215_10b381fc-624f-485b-a31f-15d46600232d	63187-215	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20050425		ANDA	ANDA076913	Proficient Rx LP	PREDNISOLONE SODIUM PHOSPHATE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-216_3cdcc4b9-fdcb-4407-b803-689f83aeba91	63187-216	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA201522	Proficient Rx LP	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-217_4b1e6e75-c6ed-4a2c-be35-2a4deaea7def	63187-217	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120314		ANDA	ANDA076765	Proficient Rx LP	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-218_cc4cd573-87f8-452f-98c5-7d46362f9080	63187-218	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	TABLET, FILM COATED	ORAL	20020130		ANDA	ANDA075872	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-219_2fb97f0d-ad18-445a-b9a5-f128ae90cfc0	63187-219	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120326		ANDA	ANDA202152	Proficient Rx LP	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-220_2cb8403d-3262-43c8-ad72-482948223d11	63187-220	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Proficient Rx LP	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-221_d90744a9-2c15-44dc-80b8-82513843cd16	63187-221	HUMAN PRESCRIPTION DRUG	Buspirone HCl		Buspirone hydrochloride	TABLET	ORAL	20010328		ANDA	ANDA074253	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
63187-222_108a4ddb-0e11-472d-989a-5617e8823008	63187-222	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Proficient Rx LP	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-225_525278ca-7947-41ac-92cf-b5a4e90dc56c	63187-225	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Proficient Rx LP	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-226_fe8abfbc-e750-4c0b-ae2d-a66355c86624	63187-226	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960918		ANDA	ANDA074569	Proficient Rx LP	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-228_2fc556b9-f5e3-412e-a250-72dd83490ad6	63187-228	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20110101		ANDA	ANDA079162	Proficient Rx LP	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-229_4a1af411-3907-475c-9047-4cbe295dc1b7	63187-229	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19970911		ANDA	ANDA040218	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-231_b5b3b2b0-9279-4b16-b1ae-b9388fcdf736	63187-231	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20121029		ANDA	ANDA202764	Proficient Rx LP	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-233_d9421a5a-f55b-4d03-b9b4-a5ac4df6d894	63187-233	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-235_99c5f2dc-5112-4a12-9d4e-cdd0f4936ec1	63187-235	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	Proficient Rx LP	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
63187-236_dcd5d6d3-2419-467f-91c2-50586e9ca5cb	63187-236	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Proficient Rx LP	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-237_f0c279c5-1f67-4d03-ba2d-6202d619299c	63187-237	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Proficient Rx LP	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-238_0564a4b6-70c2-4cf5-a0ec-c98e9e0eac61	63187-238	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63187-239_0564a4b6-70c2-4cf5-a0ec-c98e9e0eac61	63187-239	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63187-240_dc8eb4a8-0fb0-4964-9d48-b299f99744f6	63187-240	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20090406		NDA	NDA018877	Proficient Rx LP	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
63187-243_1763b844-f261-4cdc-9a93-43d13a64da0c	63187-243	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20030314		ANDA	ANDA084283	Proficient Rx LP	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-245_63156793-74b0-444c-bb12-dbe7be60ec91	63187-245	HUMAN PRESCRIPTION DRUG	Nitrofurantion Macrocrystals		Nitrofurantion Macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Proficient Rx LP	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
63187-247_2dfd4382-3405-48c3-b7e1-7c19d82901d8	63187-247	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	Proficient Rx LP	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63187-248_75599dc3-b3a3-440f-b052-6e980c297c93	63187-248	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20100517		ANDA	ANDA090705	Proficient Rx LP	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-249_7d51448b-bb0d-40f3-a360-e15a2d5631fc	63187-249	HUMAN PRESCRIPTION DRUG	Nizatidine		Nizatidine	CAPSULE	ORAL	20110715		ANDA	ANDA090618	Proficient Rx LP	NIZATIDINE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63187-251_ba21a8c5-5ab9-4c89-921c-347a068240bc	63187-251	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	Proficient Rx LP	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63187-252_a6d74273-2a8c-4848-ad02-1beed5de35b2	63187-252	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol tartrate	TABLET	ORAL	19970701		ANDA	ANDA074644	Proficient Rx LP	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-253_9f75bb4a-0416-403f-92bc-a3d0e50457c6	63187-253	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	Proficient Rx LP	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-254_948fb463-1798-4f1c-880e-15a62ca86fa8	63187-254	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	19771117		ANDA	ANDA085762	Proficient Rx LP	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
63187-255_aaf7b64f-f795-40ea-85be-d0eb6feb4f78	63187-255	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20110301		ANDA	ANDA074550	Proficient Rx LP	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-256_1aef35f7-75e6-415f-869f-59d184acdae1	63187-256	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	Proficient Rx LP	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-257_f0c279c5-1f67-4d03-ba2d-6202d619299c	63187-257	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Proficient Rx LP	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-258_9a01be91-ff05-4f46-92d4-68b2d1db251c	63187-258	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20120430		ANDA	ANDA200294	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63187-259_2f05553f-474f-46d9-9091-4e276cd557a8	63187-259	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA090678	Proficient Rx LP	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-260_4a1af411-3907-475c-9047-4cbe295dc1b7	63187-260	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19970911		ANDA	ANDA040218	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-261_a0ee6d21-0deb-4308-9af0-314574a04072	63187-261	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20091030		ANDA	ANDA065123	Proficient Rx LP	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
63187-262_e6603270-d47e-47fc-bea9-0c1cea9f70aa	63187-262	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	Proficient Rx LP	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
63187-263_46ff38b8-3cbb-4e18-b66f-703b572a37f6	63187-263	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	Proficient Rx LP	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
63187-264_ce66e2ff-3454-4ec4-8caa-a261ab8c283c	63187-264	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140423		ANDA	ANDA201003	Proficient Rx LP	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-265_8438d683-b2a2-476b-8511-e2b74829e90b	63187-265	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20100528		ANDA	ANDA090121	Proficient Rx LP	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
63187-266_f02e87c2-4b3e-46d7-8afd-c321c83f90ec	63187-266	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Proficient Rx LP	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-267_4d6257b3-af7e-4c8a-bd1a-3b7906dbd981	63187-267	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19960718		ANDA	ANDA064030	Proficient Rx LP	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
63187-268_331a9c17-9946-48a6-bc37-af84ecdea26a	63187-268	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20040514		ANDA	ANDA076622	Proficient Rx LP	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-269_2fb97f0d-ad18-445a-b9a5-f128ae90cfc0	63187-269	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120326		ANDA	ANDA202152	Proficient Rx LP	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-270_b775e7f3-60ea-4b65-a4a7-d196d391036f	63187-270	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone	SOLUTION/ DROPS	AURICULAR (OTIC)	19951229		ANDA	ANDA064053	Proficient Rx LP	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-271_45749004-2d5a-40b8-9e27-a8c0ec5962ba	63187-271	HUMAN PRESCRIPTION DRUG	Promethazine with Codeine		Promethazine Hydrochloride and Codeine Phosphate	SOLUTION	ORAL	20060131		ANDA	ANDA040650	Proficient Rx LP	CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE	10; 6.25	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]	CV	N	20241231
63187-272_0d8718f0-8fa5-413b-bf23-5ffc1b190f85	63187-272	HUMAN PRESCRIPTION DRUG	PROMETHAZINE DM		Dextromethorphan Hydrobromide and Promethazine Hydrochloride	SOLUTION	ORAL	20060214		ANDA	ANDA040649	Proficient Rx LP	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63187-274_a6951185-a20e-424c-8bd5-149a14025c8e	63187-274	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	19880721		ANDA	ANDA072235	Proficient Rx LP	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63187-276_b9c2e610-451a-4237-8cf3-094ab55323d3	63187-276	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	OINTMENT	TOPICAL	20020901		ANDA	ANDA070051	Proficient Rx LP	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-277_cada6f46-f67d-41d9-8dbe-53740c3dac62	63187-277	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	Proficient Rx LP	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-280_83a0b967-118f-4459-ad38-1ec6a769dcc4	63187-280	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051201		ANDA	ANDA077241	Proficient Rx LP	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63187-281_4b1e6e75-c6ed-4a2c-be35-2a4deaea7def	63187-281	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120314		ANDA	ANDA076765	Proficient Rx LP	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-282_21bbc489-2478-48dc-b70b-16bc5f8779c7	63187-282	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20111101		ANDA	ANDA091240	Proficient Rx LP	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-283_827436d3-2e3e-4a88-ab20-190eba38810a	63187-283	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	Proficient Rx LP	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-286_a48885f3-e216-4e67-8701-c1fa25e4ca4c	63187-286	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone dipropionate	CREAM, AUGMENTED	TOPICAL	20031209		ANDA	ANDA076215	Proficient Rx LP	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-288_5f2a9649-6863-4c68-bca8-49fd49cd04a7	63187-288	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20041221		ANDA	ANDA076679	Proficient Rx LP	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-289_f4f92f5f-7bae-4b32-91c0-a0394ac8502b	63187-289	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA078605	Proficient Rx LP	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-291_4a2943a5-d06e-489a-9d56-682712ca8a7e	63187-291	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		ACETAMINOPHEN and CODEINE PHOSPHATE	SOLUTION	ORAL	19810821		ANDA	ANDA087508	Proficient Rx LP	ACETAMINOPHEN; CODEINE PHOSPHATE	120; 12	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
63187-292_db4b884e-dd04-4097-83fe-a42f171bf9a5	63187-292	HUMAN PRESCRIPTION DRUG	Colcrys		Colchicine	TABLET, FILM COATED	ORAL	20090901		NDA	NDA022352	Proficient Rx LP	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
63187-293_aa1ff859-2ff4-43e8-be4f-e0f4f369c20a	63187-293	HUMAN OTC DRUG	PlusPharma Extra Strength	PAIN RELIEVER,FEVER REDUCER 500 mg	Acetaminophen	TABLET	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	500	mg/1			N	20241231
63187-294_c8f2d022-c0bf-4cf5-b0bf-e5b95ad93228	63187-294	HUMAN OTC DRUG	Childrens Silapap		Acetaminophen	LIQUID	ORAL	19940905		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	160	mg/5mL			N	20241231
63187-295_3fdd6b1d-1abd-443d-a772-e9bc549eafd4	63187-295	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	Proficient Rx LP	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-296_982ec015-818a-43ab-b067-a217dcd82a78	63187-296	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Proficient Rx LP	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-298_4f3493eb-ade0-46ca-aef7-92c8afeaa20b	63187-298	HUMAN OTC DRUG	GOODSENSE ARTIFICIAL TEARS		POLYVINYL ALCOHOL	SOLUTION	OPHTHALMIC	20100722		OTC MONOGRAPH FINAL	part349	Proficient Rx LP	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE, UNSPECIFIED	5; 6	mg/mL; mg/mL			N	20241231
63187-299_bdce10e2-9374-480a-bd44-cb7f7a49148e	63187-299	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20091201		OTC MONOGRAPH FINAL	part333B	Proficient Rx LP	BACITRACIN	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
63187-300_7a33b3c9-ca90-4d15-aacf-5a8f91b804a4	63187-300	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Proficient Rx LP	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-301_2680eafe-f0cd-481e-830f-51b249135bdd	63187-301	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20150923		ANDA	ANDA207446	Proficient Rx LP	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-302_daf5900d-9fea-4afd-9cbb-88e9702a7fa7	63187-302	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20131202		ANDA	ANDA074673	Proficient Rx LP	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63187-304_6f7fdb5a-c752-4386-b3d5-39fca7830707	63187-304	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20091215		ANDA	ANDA090702	Proficient Rx LP	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
63187-305_4b42b2f4-a013-4b16-bc3e-d9c3b503beed	63187-305	HUMAN OTC DRUG	Loratadine and Pseudoephedrine		loratadine and pseudoephedrine	TABLET, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Proficient Rx LP	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-306_492007d3-4983-4dc6-a186-bcddc1abea4f	63187-306	HUMAN OTC DRUG	Rugby Travel Sickness	Meclizine HCl, 25 mg Each (ANTIEMETIC)	Meclizine HCl	TABLET, CHEWABLE	ORAL	20140819		OTC MONOGRAPH FINAL	part336	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63187-307_9f61b1e1-ce31-45de-ab89-7ab579ee5878	63187-307	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20110613		ANDA	ANDA091083	Proficient Rx LP	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-308_302d5baa-e97c-46cf-a72c-2c77b5a29b7e	63187-308	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19960828		ANDA	ANDA064065	Proficient Rx LP	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-312_9773ffda-a126-4f03-868f-ca5e0d71feee	63187-312	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-313_83a0b967-118f-4459-ad38-1ec6a769dcc4	63187-313	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051201		ANDA	ANDA077241	Proficient Rx LP	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63187-314_a6d74273-2a8c-4848-ad02-1beed5de35b2	63187-314	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol tartrate	TABLET	ORAL	19970701		ANDA	ANDA074644	Proficient Rx LP	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-315_f9bb27b4-86c0-4924-a820-a2794b84f2d3	63187-315	HUMAN OTC DRUG	banophen		Diphenhydramine HCl	LIQUID	ORAL	20061120		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-317_bc23cc53-f9d5-4890-920e-c2f86250fbd6	63187-317	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	Proficient Rx LP	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-319_41af6e44-37f8-4322-8101-9064edb4b8c1	63187-319	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20061004		ANDA	ANDA077912	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-320_8c98b649-b901-4213-9713-757845f5997a	63187-320	HUMAN PRESCRIPTION DRUG	amoxicillin and clavulanate potassium		amoxicillin and clavulanate potassium	POWDER, FOR SUSPENSION	ORAL	19901022		NDA	NDA050725	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-323_0cdfb1de-15e5-4697-b443-ec4c7db9d432	63187-323	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		SUMATRIPTAN	TABLET	ORAL	20090210		ANDA	ANDA076572	Proficient Rx LP	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-325_ee0246be-6005-448d-a230-42a1ea44fe2e	63187-325	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	Proficient Rx LP	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-326_8edfbfb9-1c06-4032-a861-01a4d9ad7a2c	63187-326	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20140303		ANDA	ANDA203245	Proficient Rx LP	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63187-327_a554e1ac-fea6-4b57-94be-5d517ed49d3d	63187-327	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065101	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-332_1b6ac895-7c0d-4464-8a42-a9a16fafcf45	63187-332	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20140201		ANDA	ANDA203769	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63187-333_6744267c-0b8d-479e-81ee-a21f40e0086b	63187-333	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20040202		ANDA	ANDA074151	Proficient Rx LP	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63187-335_ec3a6992-a66b-4fd9-8e43-eb1b616c673e	63187-335	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	Proficient Rx LP	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-336_794a3f94-d134-4a99-9c1a-4fe4e0b6103a	63187-336	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-340_c6e1cbe2-4d81-4b7c-b948-d64d9b3527a7	63187-340	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Proficient Rx LP	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-341_85b911a5-a0d9-4749-abd5-965a9aa03d06	63187-341	HUMAN OTC DRUG	Siltussin SA		Guaifenesin	LIQUID	ORAL	19981005		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	GUAIFENESIN	100	mg/5mL			N	20241231
63187-342_27151a8c-fa4a-40ea-aa84-99a220bdc51f	63187-342	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET	ORAL	20120402		ANDA	ANDA090478	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-343_71f06d3f-9faf-41ec-8c04-ece870cec3ad	63187-343	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, CHEWABLE	ORAL	19930101		ANDA	ANDA064013	Proficient Rx LP	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-344_b408c71a-3bfa-44aa-ad01-9c4b6e6ff291	63187-344	HUMAN OTC DRUG	Nasal Decongestant		Pseudoephedrine HCl	TABLET	ORAL	20121029		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-345_384e2d89-9064-43b1-a014-4d2ec62d5b22	63187-345	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Proficient Rx LP	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-346_794a3f94-d134-4a99-9c1a-4fe4e0b6103a	63187-346	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-347_6bff4e15-4418-45b5-8c30-2ff825249f9c	63187-347	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100406		ANDA	ANDA077157	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-354_10a1ea3e-48ca-4dd5-8808-a4be16048c3e	63187-354	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63187-357_6d496790-edf8-4309-bc31-2700e9a8c84d	63187-357	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Proficient Rx LP	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-358_a9fd0947-15a1-45d0-94f7-1c08933122a6	63187-358	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Proficient Rx LP	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63187-359_07f01398-8a32-431a-8aa2-9e8a6f2c251a	63187-359	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-360_c98538ac-3907-471d-b8a8-14672be3d429	63187-360	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090101		ANDA	ANDA078154	Proficient Rx LP	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-361_6b493581-ed1a-4346-9eab-0fce11fdb8ad	63187-361	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-362_34f7e985-f275-4c4b-ab35-ffa37e49052b	63187-362	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076999	Proficient Rx LP	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
63187-363_b9d14bcb-219d-406c-85c5-405c9e8b8508	63187-363	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20120117		ANDA	ANDA202677	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63187-364_7af11d56-ef6d-47b7-8119-c30c31ef9cf4	63187-364	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Proficient Rx LP	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-366_0f60482e-7e09-458c-9854-ea4578a08c4a	63187-366	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20140910		ANDA	ANDA204314	Proficient Rx LP	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-367_4efb5b48-aa05-4377-a3af-d2bb6530ab32	63187-367	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	Proficient Rx LP	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-368_f28b44fb-7018-43ee-9d1b-c8d6bdcb7894	63187-368	HUMAN OTC DRUG	GAVILAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA091077	Proficient Rx LP	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63187-371_148ad490-41a3-4be3-b33e-e5c7c551e561	63187-371	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Proficient Rx LP	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63187-372_67071be5-22c8-4d97-95d5-49a9b18cbfe7	63187-372	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160629		ANDA	ANDA090705	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-373_a4458cf8-9a74-4beb-858c-611588e6b6b0	63187-373	HUMAN OTC DRUG	acetaminophen	for children	Acetaminophen	SUPPOSITORY	RECTAL	20101214		ANDA	ANDA070607	Proficient Rx LP	ACETAMINOPHEN	120	mg/1			N	20241231
63187-374_dd9d2003-9288-4d96-8910-705710883378	63187-374	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Proficient Rx LP	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-375_6124893c-8e7a-4f34-a81c-8fd9fb1c3ba8	63187-375	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20120412		ANDA	ANDA201013	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63187-376_03a2435e-288c-440a-8395-7ebf9192519f	63187-376	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20151204		ANDA	ANDA203584	Proficient Rx LP	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
63187-377_e105235b-f15a-4154-a420-0bb77657d781	63187-377	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	20100530		ANDA	ANDA072193	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
63187-378_01dcf18d-4211-409a-a0b1-bfa2856ba8b4	63187-378	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20080301		ANDA	ANDA078671	Proficient Rx LP	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-379_0259eb8a-602d-42c0-a4ea-ad936de76410	63187-379	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Proficient Rx LP	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-380_53d5b830-11da-4445-b431-c04a4bb6b016	63187-380	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20060203		ANDA	ANDA071611	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-381_b2a38220-ee12-47b9-941e-c6f12545bb68	63187-381	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20160314		ANDA	ANDA063029	Proficient Rx LP	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
63187-382_867e0dca-0472-415c-97f5-340123e86116	63187-382	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	Proficient Rx LP	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
63187-383_2c918fc8-1110-4bc5-b0a8-230a2b91e67e	63187-383	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19820826		ANDA	ANDA087916	Proficient Rx LP	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-384_e24dfa3c-b7ac-42ef-ab4f-448c062dbe18	63187-384	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET	ORAL	20120330		ANDA	ANDA076890	Proficient Rx LP	LEVOFLOXACIN	750	mg/1			N	20241231
63187-391_a9de2bb4-1409-4daf-acd1-e3a54b03d41b	63187-391	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA090467	Proficient Rx LP	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-392_01f464f2-61fd-4f72-b718-337159695d38	63187-392	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160629		ANDA	ANDA090705	Proficient Rx LP	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-393_5bab4933-24e6-4d3c-9dbc-886bbc048479	63187-393	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Proficient Rx LP	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63187-394_b2dfdcdc-96ec-4e67-8125-a35d40c42bfb	63187-394	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-395_806ace25-3288-4a8f-8b6b-bac24cea03ce	63187-395	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin, Polymyxin B Sulfates, Dexamethasone	OINTMENT	OPHTHALMIC	20140703		ANDA	ANDA062938	Proficient Rx LP	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-396_18775e95-6eef-4cec-bf3f-3a9d5e8550d1	63187-396	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Proficient Rx LP	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-397_89fd15a7-f9c2-42bb-bb45-c151f3a3ba2d	63187-397	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Proficient Rx LP	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63187-398_0d66603d-b111-4b2e-a841-c47935b8c41a	63187-398	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20101006		ANDA	ANDA090528	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-399_42add858-a128-4b54-9f2e-53644865200d	63187-399	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Proficient Rx LP	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-400_7f00edf4-7b75-4ba8-9685-5f7c6326d0ac	63187-400	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and DextromethorphanHydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	SYRUP	ORAL	20100615		ANDA	ANDA088811	Proficient Rx LP	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-401_531ec397-a99e-44f3-8c1f-52929a70359a	63187-401	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20110529		ANDA	ANDA090768	Proficient Rx LP	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63187-402_d11d3ea2-d309-470d-828f-2ba6220a7e9b	63187-402	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020301		ANDA	ANDA075022	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
63187-403_1b0a2717-1fd5-46a0-9e7c-8368f21575cc	63187-403	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Proficient Rx LP	MIRTAZAPINE	30	mg/1			N	20241231
63187-404_99c5f2dc-5112-4a12-9d4e-cdd0f4936ec1	63187-404	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	Proficient Rx LP	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
63187-405_0d66603d-b111-4b2e-a841-c47935b8c41a	63187-405	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20100406		ANDA	ANDA090528	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-406_464a3727-6b9f-46f3-8749-40928cbc4c97	63187-406	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone hydrochloride and Acetaminophen	TABLET	ORAL	19960730		ANDA	ANDA040105	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63187-408_692f0996-d431-4fcd-b03b-f1413f00d958	63187-408	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-409_c48346c2-771d-4929-800c-1066f2def5dd	63187-409	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Proficient Rx LP	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63187-410_ad87e769-f109-4e2c-9281-0ae4e9730c64	63187-410	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	Proficient Rx LP	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63187-411_55654498-bca4-4d7e-8f9c-6a9ee867ed80	63187-411	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20091105		UNAPPROVED DRUG OTHER		Proficient Rx LP	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
63187-413_2fd93eac-64e3-4d40-b8d5-68034e16e717	63187-413	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Proficient Rx LP	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-414_36330e72-68ba-4393-b1f2-fd064d4e25cf	63187-414	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-415_2fd93eac-64e3-4d40-b8d5-68034e16e717	63187-415	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Proficient Rx LP	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-418_71435439-971d-4db3-89d2-71b74b10f57c	63187-418	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Proficient Rx LP	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-419_f2f79854-3160-43e7-8676-9d1b7d2970c8	63187-419	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	Proficient Rx LP	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63187-420_404f3769-6ab8-4dcb-80dc-4e561d4a7a7d	63187-420	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-422_cc949ee7-fc09-4b2f-a26d-bb6a435f75c4	63187-422	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20100721		ANDA	ANDA062949	Proficient Rx LP	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63187-423_003e7a1f-9035-4e05-a945-df6303cc17a3	63187-423	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021121		ANDA	ANDA065093	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-424_bbd76675-575b-4110-9c2e-e197d750bb54	63187-424	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Proficient Rx LP	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63187-425_b91e5277-f38e-47fd-9733-bab3dfdfb3d1	63187-425	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20120120		ANDA	ANDA078457	Proficient Rx LP	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-426_32166c61-51dc-436c-8d05-08265dc33276	63187-426	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20031107		ANDA	ANDA075563	Proficient Rx LP	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
63187-427_7c22aa60-186e-4ff5-b375-e3022bca2706	63187-427	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-428_3aa14bc0-eb0c-4860-abd0-4bd3203e5ec0	63187-428	HUMAN PRESCRIPTION DRUG	Valsartan and hydrochlorothiazide		Valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA091519	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-429_46cd719f-a6bc-4b3b-8ef5-860896fb787d	63187-429	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Proficient Rx LP	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-430_3987b125-2cd5-4cae-9009-4e839599a38e	63187-430	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET	ORAL	20120803		ANDA	ANDA201515	Proficient Rx LP	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-431_a5b55c92-dad3-4edd-a80b-becf1c4acc9f	63187-431	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120514		ANDA	ANDA077561	Proficient Rx LP	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-432_19190e62-634d-45bb-9f9b-e0f0a4608e98	63187-432	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20080528		ANDA	ANDA078541	Proficient Rx LP	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-434_b0100eac-f51f-4aa9-88e1-f628aeea2412	63187-434	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Proficient Rx LP	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-436_94b97b2e-11b6-42ad-96f5-3d4030347dd7	63187-436	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20131203		ANDA	ANDA078488	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-437_fed449e4-9657-4ca1-a8bc-7e14535d854b	63187-437	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20090129		ANDA	ANDA078010	Proficient Rx LP	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63187-438_42b9c689-6cdb-4667-ae4e-98cef35d1f8c	63187-438	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Proficient Rx LP	LEVOFLOXACIN	500	mg/1			N	20241231
63187-439_9a567a24-6d70-46fd-b24a-2c1a1c2fe5e0	63187-439	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140423		ANDA	ANDA201003	Proficient Rx LP	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-440_115d864c-11d8-4f8c-a00d-d0fc8ba38ee3	63187-440	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070601		ANDA	ANDA040702	Proficient Rx LP	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-441_115d864c-11d8-4f8c-a00d-d0fc8ba38ee3	63187-441	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070601		ANDA	ANDA040702	Proficient Rx LP	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-442_74611f00-d9a2-44c0-952f-5ca7cbc39a34	63187-442	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Proficient Rx LP	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-443_525278ca-7947-41ac-92cf-b5a4e90dc56c	63187-443	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Proficient Rx LP	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-444_525278ca-7947-41ac-92cf-b5a4e90dc56c	63187-444	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19980325		ANDA	ANDA074909	Proficient Rx LP	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-445_7522bce9-9d0b-4cf7-a57b-86301bbef471	63187-445	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Proficient Rx LP	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-447_c48346c2-771d-4929-800c-1066f2def5dd	63187-447	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Proficient Rx LP	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63187-448_a5b55c92-dad3-4edd-a80b-becf1c4acc9f	63187-448	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120514		ANDA	ANDA077561	Proficient Rx LP	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-449_f5e53eb7-8199-4ca7-9cd0-8dc140c79376	63187-449	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Proficient Rx LP	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-450_cf41df26-cc0b-4e51-a3dc-f3c8ea186150	63187-450	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20001222		ANDA	ANDA065062	Proficient Rx LP	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-451_7107b884-4316-43e5-a443-f7501949bdb0	63187-451	HUMAN PRESCRIPTION DRUG	ibuprofen		ibuprofen	TABLET	ORAL	20120222		ANDA	ANDA090796	Proficient Rx LP	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-452_72502e4b-1ebb-4a61-aecf-f319be11ce9b	63187-452	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120326		ANDA	ANDA202152	Proficient Rx LP	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-453_46cd719f-a6bc-4b3b-8ef5-860896fb787d	63187-453	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Proficient Rx LP	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-455_bb54c7fc-15f8-4e1c-8095-aacab4b8f68d	63187-455	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Proficient Rx LP	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-456_ac54475d-30d6-4146-88e5-e073a08467c9	63187-456	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Proficient Rx LP	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63187-457_6a8c9e37-5317-4fa9-ab2c-495d0d326c5e	63187-457	HUMAN PRESCRIPTION DRUG	Duloxetine hydrochloride		Duloxetin hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090774	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-458_5248afaf-9c38-4cc2-a25b-53d93491f698	63187-458	HUMAN PRESCRIPTION DRUG	Tri-Sprintec		norgestimate and ethinyl estradiol	KIT		20031229		ANDA	ANDA075808	Proficient Rx LP						N	20241231
63187-459_fe384c18-1296-43a9-a99c-9b0cc8bdf29e	63187-459	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-460_fe384c18-1296-43a9-a99c-9b0cc8bdf29e	63187-460	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-461_9af6ee64-084d-4ad4-9cb4-e4812c4104c0	63187-461	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Proficient Rx LP	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-462_4b48b484-e780-4b66-a6ca-35c5d61bcf41	63187-462	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Proficient Rx LP	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63187-463_dc8eb4a8-0fb0-4964-9d48-b299f99744f6	63187-463	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20090406		NDA	NDA018832	Proficient Rx LP	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
63187-464_2aeb648a-b45f-4dd7-93f0-610d7490b464	63187-464	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20020903		ANDA	ANDA062840	Proficient Rx LP	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63187-465_11589775-58be-49a6-befb-6d24fa830899	63187-465	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	19970605		ANDA	ANDA074821	Proficient Rx LP	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-466_387169e5-fdc7-4bd8-94f5-ce71571dd90e	63187-466	HUMAN PRESCRIPTION DRUG	Prednisolone		Prednisolone	SOLUTION	ORAL	20030227		ANDA	ANDA040401	Proficient Rx LP	PREDNISOLONE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-467_41af6e44-37f8-4322-8101-9064edb4b8c1	63187-467	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20060410		ANDA	ANDA077912	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-469_3e498751-4077-47d5-803e-564ffb541dbd	63187-469	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100715		ANDA	ANDA090931	Proficient Rx LP	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63187-470_ac3ed05f-f7e2-4340-8c6a-5d026e318e29	63187-470	HUMAN PRESCRIPTION DRUG	Acetaminophen And Codeine		acetaminophen and codeine phosphate	TABLET	ORAL	19880930		ANDA	ANDA089805	Proficient Rx LP	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63187-471_fb4bf3e5-f62b-489a-ba75-8e94513f29ca	63187-471	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Proficient Rx LP	MIRTAZAPINE	45	mg/1			N	20241231
63187-472_adddd480-d3b1-4497-8bad-b5c55c2bb8bb	63187-472	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20080317		ANDA	ANDA076128	Proficient Rx LP	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-474_c2966446-a03f-4cd9-812e-a9861fc22b3a	63187-474	HUMAN PRESCRIPTION DRUG	Methylprednisolone Acetate		Methylprednisolone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20050308		ANDA	ANDA040557	Proficient Rx LP	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-476_5346c4b6-824a-4b08-84de-b4f29101f3e9	63187-476	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20100915		OTC MONOGRAPH NOT FINAL	part334	Proficient Rx LP	DOCUSATE SODIUM	100	mg/1			N	20241231
63187-477_50adabf0-b6ab-4517-a9f0-74f4220896f0	63187-477	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20110301		ANDA	ANDA074550	Proficient Rx LP	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-478_820641b5-c569-4a24-b0a4-5d17d3cff8ee	63187-478	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-479_827436d3-2e3e-4a88-ab20-190eba38810a	63187-479	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	Proficient Rx LP	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-480_8335b16b-0981-4efd-88f7-c3999bbaef04	63187-480	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20020930		ANDA	ANDA089682	Proficient Rx LP	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-481_818c99b0-6f60-4a1b-9ed0-c6953c3921ab	63187-481	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20100701		ANDA	ANDA076565	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-483_19d4f41e-82d5-4eb2-94f7-de85f787725d	63187-483	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070813		ANDA	ANDA078050	Proficient Rx LP	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-484_51b7f2a3-4f74-4074-b871-dc1479083282	63187-484	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20080301		ANDA	ANDA078671	Proficient Rx LP	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-486_d49136d3-d03e-4ed6-88ab-05cce831e7fe	63187-486	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Proficient Rx LP	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-487_18af9e56-f14e-4e59-b3cc-ad6e40d4bd57	63187-487	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Proficient Rx LP	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
63187-488_aad9c785-d8dd-4b2a-8d48-82cd342e3c16	63187-488	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020314		ANDA	ANDA065063	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-489_7db62aa5-dd71-4f62-b656-c4df75686f02	63187-489	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Proficient Rx LP	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-490_37b601ca-6b00-44c1-8b4c-f9e007190df0	63187-490	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20130531		ANDA	ANDA203399	Proficient Rx LP	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
63187-491_a4e384a6-1887-4053-8263-54fc51823174	63187-491	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine		Acetaminophen and Codeine	TABLET	ORAL	20080529		ANDA	ANDA040779	Proficient Rx LP	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63187-493_2e899ff7-4e71-4341-81af-9f4ae60d35da	63187-493	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	Proficient Rx LP	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63187-494_ee6acff5-b3af-457d-bc54-b822635405a3	63187-494	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	SYRUP	ORAL	19950309		ANDA	ANDA087294	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	10	mg/5mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63187-495_51c4bdf0-43a4-4007-b86c-85eb22ad017e	63187-495	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20061110		ANDA	ANDA087385	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-496_fe384c18-1296-43a9-a99c-9b0cc8bdf29e	63187-496	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-497_f2a9b002-a1ee-49e1-8477-0eb89fdbf1de	63187-497	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Proficient Rx LP	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-498_fe6c9c95-3714-4bc9-8de6-52e327ae3bbd	63187-498	HUMAN PRESCRIPTION DRUG	Neomycin Polymyxin B Sulfates and Dexamethasone		Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19950913		ANDA	ANDA064135	Proficient Rx LP	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-499_8b462d0b-fe6e-4240-abd2-2eafbf58a98d	63187-499	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Proficient Rx LP	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
63187-500_8b462d0b-fe6e-4240-abd2-2eafbf58a98d	63187-500	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Proficient Rx LP	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
63187-501_37898929-2314-46ad-b6d2-30e411f9e8d1	63187-501	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH FINAL	part333C	Proficient Rx LP	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63187-502_ba21a8c5-5ab9-4c89-921c-347a068240bc	63187-502	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine Maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	Proficient Rx LP	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63187-504_eee35a5a-6580-4f2c-9b9f-1c5f1cfca7c0	63187-504	HUMAN OTC DRUG	Hydrocortisone	with Aloe	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-505_77d64101-bf12-4578-a441-5ec1202e6ab3	63187-505	HUMAN OTC DRUG	Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20131101		OTC MONOGRAPH FINAL	part346	Proficient Rx LP	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63187-506_2a96ac85-a5c3-48f0-8ab9-7c57ff793502	63187-506	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Proficient Rx LP	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63187-508_40149712-4747-4aec-8c7d-3033321c4ebe	63187-508	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20140303		ANDA	ANDA203245	Proficient Rx LP	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63187-510_06664186-1f92-44f3-b25e-97f1f6a539ea	63187-510	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	Proficient Rx LP	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-511_38b36dca-b8a7-4ade-8307-15ce185b643e	63187-511	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	19900930		ANDA	ANDA070027	Proficient Rx LP	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
63187-512_06a2ca7c-6074-40d3-a5de-b26c64a8990a	63187-512	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63187-513_48ce80a1-5af3-465e-96d9-ef192cafafe3	63187-513	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Proficient Rx LP	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-514_2fb76e4a-2c83-4764-a399-ff7811f179c1	63187-514	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20121110		ANDA	ANDA077652	Proficient Rx LP	LEVOFLOXACIN	750	mg/1			N	20241231
63187-515_8c15a2ef-5730-43fc-82c5-840b8afe8422	63187-515	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20050415		ANDA	ANDA040555	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63187-516_cf994666-c728-4a3b-a73e-f3709cbb141b	63187-516	HUMAN OTC DRUG	PlusPHARMA		Simethicone	TABLET, CHEWABLE	ORAL	20060327		OTC MONOGRAPH FINAL	part347	Proficient Rx LP	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
63187-517_2a96ac85-a5c3-48f0-8ab9-7c57ff793502	63187-517	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Proficient Rx LP	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63187-518_b2f8ddeb-2879-48e7-a026-1de3bc87610d	63187-518	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Proficient Rx LP	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-519_a7b1d449-215a-4356-b1f9-bc04f39c9b60	63187-519	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20140516		ANDA	ANDA090455	Proficient Rx LP	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
63187-520_42b76389-6fa2-49a5-b435-672d3862c6f3	63187-520	HUMAN PRESCRIPTION DRUG	butalbital, acetaminophen and caffeine		butalbital, acetaminophen and caffeine	TABLET	ORAL	19870121		ANDA	ANDA089175	Proficient Rx LP	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
63187-521_001c902a-af30-40fb-bb22-cc18bd8fc94c	63187-521	HUMAN PRESCRIPTION DRUG	bupropion		bupropion	TABLET, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA201567	Proficient Rx LP	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-522_96fcd1c6-8d3f-4bcf-8d27-8b53887906d6	63187-522	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	Proficient Rx LP	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-524_f8276d7a-a8bb-4371-bcc5-fb1ce6c4fa0a	63187-524	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	19960507		ANDA	ANDA074356	Proficient Rx LP	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
63187-525_75ec5f25-865b-455a-b8d6-c942abce985a	63187-525	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20031107		ANDA	ANDA065085	Proficient Rx LP	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
63187-526_0507d498-219e-4f9d-b92e-f6fd15657b5a	63187-526	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Proficient Rx LP	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-527_7db62aa5-dd71-4f62-b656-c4df75686f02	63187-527	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Proficient Rx LP	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-529_e1f6098c-fe98-44bd-9b99-6ea090fa8e75	63187-529	HUMAN PRESCRIPTION DRUG	ipratropium bromide and albuterol sulfate		ipratropium bromide and albuterol sulfate	SOLUTION	RESPIRATORY (INHALATION)	20130513		ANDA	ANDA202496	Proficient Rx LP	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
63187-530_7eb67426-706c-4d6e-b93b-1ffe200c58c0	63187-530	HUMAN OTC DRUG	Regular Strength Aspirin EC		Aspirin	TABLET, DELAYED RELEASE	ORAL	20110909		OTC MONOGRAPH FINAL	part343	Proficient Rx LP	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63187-532_7fdd60d2-87b1-4ad7-9981-a6e26806c974	63187-532	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Proficient Rx LP	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-533_d9fdfb61-581b-4082-ac22-60dc2970ffa2	63187-533	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	19900930		ANDA	ANDA060456	Proficient Rx LP	PENICILLIN V POTASSIUM	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-534_fbdbc52b-3eb9-4ec8-98d1-ab04e553fdc1	63187-534	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Proficient Rx LP	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-535_bd0691c5-aaa9-472e-9b05-926d93defd0c	63187-535	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Proficient Rx LP	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-536_4250a0d9-3e57-4c09-aecb-e464bf7d97d1	63187-536	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20070104		ANDA	ANDA071404	Proficient Rx LP	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-537_68da0b58-ba04-4184-bb85-52c3d9137f5d	63187-537	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20041116		ANDA	ANDA074056	Proficient Rx LP	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-538_0ac3f14c-c375-408e-a1d7-8412e3420a40	63187-538	HUMAN PRESCRIPTION DRUG	valacyclovir hydrochloride		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	20120405		ANDA	ANDA201506	Proficient Rx LP	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-541_2b08189d-4bcb-475e-aa28-a8f693cffd76	63187-541	HUMAN OTC DRUG	SudoGest		Pseudoephedrine Hydrochloride	TABLET, FILM COATED	ORAL	19941001		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	PSEUDOEPHEDRINE HYDROCHLORIDE	60	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-542_51ae03ae-99b0-47e9-ae80-0e8e7b1fc7bc	63187-542	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	POWDER, FOR SUSPENSION	ORAL	20040813		ANDA	ANDA065098	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-543_f8e2a7ad-bc62-438a-8824-2b8615d81c72	63187-543	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-544_aeef8cde-a187-453e-b7fb-e179493ff427	63187-544	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071322	Proficient Rx LP	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-545_de8da502-e219-420e-b886-1d8125c8bb12	63187-545	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090804		ANDA	ANDA077118	Proficient Rx LP	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-546_de8da502-e219-420e-b886-1d8125c8bb12	63187-546	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090804		ANDA	ANDA076862	Proficient Rx LP	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-547_de8da502-e219-420e-b886-1d8125c8bb12	63187-547	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100415		ANDA	ANDA077298	Proficient Rx LP	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-548_75e914c5-6085-4f47-808b-f708657aa375	63187-548	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE, GELATIN COATED	ORAL	19961227		NDA AUTHORIZED GENERIC	NDA020504	Proficient Rx LP	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-549_026c3076-9228-4120-a626-4721d7040931	63187-549	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-550_37777419-2952-40eb-a2a1-c5f50b20b1dd	63187-550	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA090984	Proficient Rx LP	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-552_fb8e542d-442d-40f6-b9f6-2d616f048b02	63187-552	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100406		ANDA	ANDA077157	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-553_a26fd531-4ba9-4a91-89a9-0e4e2a95a3ef	63187-553	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130115		ANDA	ANDA202556	Proficient Rx LP	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-554_98bb70ff-3255-40e9-907b-1ef725068c85	63187-554	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Proficient Rx LP	MIRTAZAPINE	30	mg/1			N	20241231
63187-555_45879472-a15c-4577-8df5-a2fbd9c5173d	63187-555	HUMAN PRESCRIPTION DRUG	Rabeprazole sodium		Rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA202376	Proficient Rx LP	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-556_7b78e74c-e7c3-4450-8b78-bc25fcc76b8c	63187-556	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20030318		ANDA	ANDA063083	Proficient Rx LP	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
63187-557_43dd42fb-22ef-4d43-8793-d15100f5c4dc	63187-557	HUMAN OTC DRUG	good sense lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20071208		OTC MONOGRAPH FINAL	part358G	Proficient Rx LP	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
63187-558_abcdf937-6cde-4adf-97fe-599ac82e20f1	63187-558	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Proficient Rx LP	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-559_23ecdf5e-6b0c-4408-a07b-3c33f092816a	63187-559	HUMAN OTC DRUG	clotrimazole		Clotrimazole	CREAM	TOPICAL	20110603		OTC MONOGRAPH FINAL	part333C	Proficient Rx LP	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63187-560_d0354f86-c43a-4166-8fe2-710442ff548e	63187-560	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19940511		ANDA	ANDA064048	Proficient Rx LP	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63187-561_64c0e623-ed7a-4168-83e4-8cd3905d06aa	63187-561	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	Proficient Rx LP	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-562_94327867-b615-4077-85a8-b7647355169b	63187-562	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150603		ANDA	ANDA204197	Proficient Rx LP	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-563_38c06a76-2497-40d5-bc3c-ec231becc9c8	63187-563	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN Benzoate		RIZATRIPTAN Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203478	Proficient Rx LP	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-564_4637d56c-fd38-47ea-b814-4d87a7d36f1f	63187-564	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	Proficient Rx LP	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-565_ae552b3d-c4e7-4abb-9132-0ffc2b477567	63187-565	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Proficient Rx LP	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-566_c925c162-1843-4844-81d6-781b8f6d5d30	63187-566	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	Proficient Rx LP	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-567_aa75144e-e1b4-4a63-ae25-d3d3a18513de	63187-567	HUMAN OTC DRUG	Hydrocortisone Maximum Strength with Aloe		Hydrocortisone	CREAM	TOPICAL	20090421		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-568_211667a9-4988-4c45-8678-c6ff4c1d4320	63187-568	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SOLUTION	AURICULAR (OTIC)	20030318		ANDA	ANDA062423	Proficient Rx LP	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [iU]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-569_8cba07f6-cfa2-4006-abc4-8c9ca4e2d386	63187-569	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-570_7b868c28-775c-419d-af3f-46580228a4bb	63187-570	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Proficient Rx LP	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63187-571_a543bb07-d767-4b72-afe8-72fb969b13b9	63187-571	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-572_8cba07f6-cfa2-4006-abc4-8c9ca4e2d386	63187-572	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-573_8cba07f6-cfa2-4006-abc4-8c9ca4e2d386	63187-573	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-574_4a7f6547-dac8-4cf9-9834-ae6815f154b5	63187-574	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	Proficient Rx LP	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-575_4b3ad633-5de0-445f-bbe1-452ca2c1c006	63187-575	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20010913		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	HYDROCORTISONE	.5	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-576_72ca02e3-e300-4d40-83db-a3112081eb94	63187-576	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20070103		ANDA	ANDA071403	Proficient Rx LP	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-577_8e820fa5-876f-4db4-9c80-d03a96cace58	63187-577	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		lidocaine and prilocaine	CREAM	TOPICAL	20121112		NDA AUTHORIZED GENERIC	NDA019941	Proficient Rx LP	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
63187-578_df562b71-4edb-4e13-bf1e-23031eaf0975	63187-578	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20120514		ANDA	ANDA077561	Proficient Rx LP	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-579_a923089b-eeab-4a61-876f-9e77b896e719	63187-579	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140925		ANDA	ANDA091113	Proficient Rx LP	ESZOPICLONE	1	mg/1		CIV	N	20241231
63187-581_dadeb4dd-3cee-4d5e-84af-6d7729fa68c0	63187-581	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-582_c57cc18e-48b1-4979-99f2-e66722aca356	63187-582	HUMAN PRESCRIPTION DRUG	Voltaren		diclofenac sodium	GEL	TOPICAL	20071017		NDA	NDA022122	Proficient Rx LP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-583_81a1a2d9-e7d9-4738-9d4d-fd70c9e4618f	63187-583	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060130		ANDA	ANDA077651	Proficient Rx LP	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
63187-584_017ad17c-87b9-dc4e-e063-6294a90ac5e0	63187-584	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Proficient Rx LP	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63187-585_4c1c58ee-da74-4e38-b052-7c6d3eee47e9	63187-585	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20121015		ANDA	ANDA090460	Proficient Rx LP	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63187-587_a4a873d0-68ca-476c-9286-b8b99c81da9c	63187-587	HUMAN OTC DRUG	Mucus Relief Sinus		Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20060415		OTC MONOGRAPH DRUG	M012	Proficient Rx LP	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63187-588_8500f34d-562e-4dec-aac9-834096181385	63187-588	HUMAN OTC DRUG	Childrens MAPAP Acetaminophen		Acetaminophen	LIQUID	ORAL	20120820		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	160	mg/5mL			N	20241231
63187-590_075ad1d6-9018-41c4-b6b8-a3a77f0b738a	63187-590	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20150325		ANDA	ANDA078722	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-591_a694d973-bbd9-4bdf-82ee-fc4688c101d4	63187-591	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	Proficient Rx LP	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-594_1b1d0591-dd31-435d-801a-6e7c98c86e51	63187-594	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20080211		ANDA	ANDA065405	Proficient Rx LP	AZITHROMYCIN ANHYDROUS	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63187-596_056f2617-2de4-4296-bd4d-714f34f7a15c	63187-596	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140411		ANDA	ANDA074661	Proficient Rx LP	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-597_9cd8b7ee-83bb-46fd-b5a2-2a38e55c577f	63187-597	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63187-598_72a68ee9-c480-4fce-be2f-8bb614cd0d52	63187-598	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-599_c925be88-1cf9-4631-9d10-d6cca5e94765	63187-599	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-600_805212e8-b34d-4583-a03b-e1bc695212f2	63187-600	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Proficient Rx LP	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-601_d36424c7-b438-4c23-884d-d4bfdac81fcf	63187-601	HUMAN OTC DRUG	Loratadine	antihistamine	Loratadine	TABLET	ORAL	20081015		ANDA	ANDA076301	Proficient Rx LP	LORATADINE	10	mg/1			N	20241231
63187-602_c925be88-1cf9-4631-9d10-d6cca5e94765	63187-602	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-603_0bfb873c-326d-4383-8a64-c6ffe16f0fbe	63187-603	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Proficient Rx LP	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-604_abb13010-cce0-4ca8-8078-134ebf73c49a	63187-604	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20080211		ANDA	ANDA065404	Proficient Rx LP	AZITHROMYCIN ANHYDROUS	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63187-606_ab1812ff-a83c-466e-944b-c81630d1c8fd	63187-606	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20150810		ANDA	ANDA202765	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63187-607_11962982-e9c2-4dca-a018-1573c6b43ad8	63187-607	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Proficient Rx LP	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-608_bb8e6b6b-70fd-48b7-b43d-23180531dc9f	63187-608	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19940729		ANDA	ANDA064067	Proficient Rx LP	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
63187-609_a5cdde79-e69c-49ab-bdf6-31224a110e38	63187-609	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Proficient Rx LP	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-610_38cd9d83-0fd6-47bb-82bc-629d7c974501	63187-610	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110222		NDA AUTHORIZED GENERIC	NDA018279	Proficient Rx LP	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63187-611_dadeb4dd-3cee-4d5e-84af-6d7729fa68c0	63187-611	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20071001		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-612_9e0aea8e-e493-432d-a390-5f6d7944ba69	63187-612	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-613_4a5d7cd0-63f5-4f16-b335-ad27a3c0b519	63187-613	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20040729		ANDA	ANDA076077	Proficient Rx LP	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63187-614_886c2c63-ff0a-46d0-a429-2a39bcfdcde0	63187-614	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Proficient Rx LP	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-615_e42cf782-73d9-4cb9-9d74-9ca0535fc2ce	63187-615	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20150701		NDA	NDA022370	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	150	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63187-616_aec22cad-186d-4dac-9fe3-c3b4d6075b2c	63187-616	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070508		ANDA	ANDA065332	Proficient Rx LP	CEFDINIR MONOHYDRATE	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63187-617_0018d900-f86c-4c3d-8977-8bf0c76e2d55	63187-617	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Proficient Rx LP	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-618_1da9a839-db61-41e9-a214-d007b8f59820	63187-618	HUMAN PRESCRIPTION DRUG	CHANTIX		varenicline tartrate	KIT		20060510		NDA	NDA021928	Proficient Rx LP						N	20241231
63187-619_71f30593-dbe4-4344-a576-6b6432ce3c64	63187-619	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	Proficient Rx LP	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
63187-620_4b095509-2a35-488c-a8d5-f5834be0d31f	63187-620	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041221		ANDA	ANDA075317	Proficient Rx LP	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63187-621_0f274741-0b4d-4575-a149-515e241e954b	63187-621	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride	ER	Diethylpropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111024		ANDA	ANDA091680	Proficient Rx LP	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63187-622_788b4191-969a-4aa1-b043-2db763575d22	63187-622	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065212	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63187-623_02709ca8-e71e-4003-b038-7c1440fe392f	63187-623	HUMAN OTC DRUG	Triple Antibiotic		Polymyxin B Sulfate, Bacitracin Zinc and Neomycin Sulfate	OINTMENT	TOPICAL	19950111		OTC MONOGRAPH DRUG	M004	Proficient Rx LP	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-625_5e3f6cab-81be-4dd4-adb7-02dc14c3ca53	63187-625	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	Proficient Rx LP	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
63187-626_b54fe609-9c8c-4ca3-bd5c-8f3ab197f969	63187-626	HUMAN PRESCRIPTION DRUG	MONTELUKAST		MONTELUKAST	TABLET, CHEWABLE	ORAL	20141201		ANDA	ANDA203037	Proficient Rx LP	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-627_55ec9138-f8f7-4222-ad3b-2cf85db6ac28	63187-627	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077135	Proficient Rx LP	VALACYCLOVIR HYDROCHLORIDE	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-628_ff9f9a3f-028e-49bd-8283-ad948d93a27f	63187-628	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	SOLUTION	OPHTHALMIC	20091105		ANDA	ANDA078434	Proficient Rx LP	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-629_27b7f24b-f6c5-46d8-a0b1-d554a1655ac4	63187-629	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20110808		ANDA	ANDA076447	Proficient Rx LP	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-631_38978a23-dfcb-4930-96a7-15f42fe54e56	63187-631	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19970214		ANDA	ANDA064120	Proficient Rx LP	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-632_77186922-128f-4ed4-8caa-b45fce773345	63187-632	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	20000215		ANDA	ANDA040327	Proficient Rx LP	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-633_a97c2b4d-4a9b-4343-be08-aff7778679dd	63187-633	HUMAN PRESCRIPTION DRUG	Celecoxib 200 mg		CELECOXIB	CAPSULE	ORAL	20151124		ANDA	ANDA204519	Proficient Rx LP	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-634_e20358fa-96f3-4f29-92eb-3323969d7f4e	63187-634	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20060829		ANDA	ANDA040750	Proficient Rx LP	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63187-635_267cb769-1f48-4ea2-a39d-e29f5cb51c5e	63187-635	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-636_2996955e-2b6c-4702-8c4a-6ab17c9e6e87	63187-636	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Proficient Rx LP	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-637_503fd66a-220b-410b-b82f-2c449dbb8dab	63187-637	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-638_f4fbc8dd-9893-4600-8bcf-2504bd669a0d	63187-638	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20070919		ANDA	ANDA077538	Proficient Rx LP	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-639_39837b40-4b4c-4030-8a8a-7176c9f543e4	63187-639	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA204165	Proficient Rx LP	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
63187-640_d757df65-74c8-41b1-8dd3-1797928dd285	63187-640	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20060510		ANDA	ANDA076635	Proficient Rx LP	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63187-641_539f397e-9afb-444a-ac5b-c26f4bd791ba	63187-641	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Proficient Rx LP	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-642_e3793e49-cf4b-4bf3-a89a-bd9deaf2be61	63187-642	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20150909		ANDA	ANDA201003	Proficient Rx LP	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-643_87d8cb44-f135-4660-8988-ad81480a9308	63187-643	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20150312		ANDA	ANDA200562	Proficient Rx LP	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-644_6a76eb3c-8d19-4d97-b3a7-b08f330b0666	63187-644	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20150212		ANDA	ANDA202392	Proficient Rx LP	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-645_17bf8148-e593-4cf3-948a-4a3bed8266f8	63187-645	HUMAN PRESCRIPTION DRUG	Buspirone HCl		Buspirone hydrochloride	TABLET	ORAL	20010328		ANDA	ANDA074253	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
63187-646_4c6cb7aa-0384-4ff9-b9c8-60d24754d7af	63187-646	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20061024		ANDA	ANDA076510	Proficient Rx LP	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-647_a4292cb2-a47f-4e14-a8e0-641c3ae72bac	63187-647	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION	INTRAMUSCULAR	20120501		ANDA	ANDA091244	Proficient Rx LP	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63187-648_a0c2530c-4783-482e-9630-10eba7412c01	63187-648	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SUSPENSION	AURICULAR (OTIC)	20030317		ANDA	ANDA062488	Proficient Rx LP	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-650_81b530d1-1156-4106-a003-0caadb83839f	63187-650	HUMAN OTC DRUG	Bismatrol		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20030103		OTC MONOGRAPH FINAL	part335	Proficient Rx LP	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63187-651_1f21f520-fee9-4006-a20f-45128152a2b7	63187-651	HUMAN OTC DRUG	Bismatrol		Bismuth Subsalicylate	LIQUID	ORAL	20080530		OTC MONOGRAPH FINAL	part335	Proficient Rx LP	BISMUTH SUBSALICYLATE	262	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63187-652_395371e2-4598-4520-9bef-d46de93ff75a	63187-652	HUMAN OTC DRUG	Multi-Symptom Mapap Cold Formula		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050715		OTC MONOGRAPH DRUG	M012	Proficient Rx LP	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63187-653_2c82bb30-406c-4b3e-9834-ed32ea065bf0	63187-653	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20120927		ANDA	ANDA202414	Proficient Rx LP	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-654_1692b267-9d4a-4145-8f92-7c5d4ddfc51e	63187-654	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Proficient Rx LP	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-655_0e31e187-683b-437f-91b6-d14cd11882bf	63187-655	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Proficient Rx LP	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-656_112b28f5-270a-4fce-9bbb-796e0deedd9f	63187-656	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Proficient Rx LP	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-658_53d10ccb-24f8-4d73-89ee-22bd08590f0a	63187-658	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20120412		ANDA	ANDA201013	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63187-659_cd9ac2ca-699f-44bb-89e6-3fe08f6c8b73	63187-659	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20101005		ANDA	ANDA090937	Proficient Rx LP	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-660_f63da686-124f-424d-a2af-8a88b36f7523	63187-660	HUMAN OTC DRUG	Rugby Capsaicin	External Analgesic	Capsaicin	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	CAPSAICIN	.25	mg/g			N	20241231
63187-661_6ea8b135-ac8a-4a01-9b3e-0440562af45c	63187-661	HUMAN PRESCRIPTION DRUG	KENALOG-40		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20090601		NDA	NDA014901	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-662_78fd4254-2047-414b-ab00-68d3427a3261	63187-662	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20080701		ANDA	ANDA076407	Proficient Rx LP	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-663_9dd81e5d-5ec6-41c5-b76a-c0c3488c6d7f	63187-663	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20141027		ANDA	ANDA203646	Proficient Rx LP	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-664_052ce621-5b6e-4246-a510-2673f8fc1503	63187-664	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide	SYRUP	ORAL	20150206		ANDA	ANDA205292	Proficient Rx LP	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-665_bbd1d1c9-8b2d-4b42-b7b3-b82bebfbf578	63187-665	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20140925		ANDA	ANDA091113	Proficient Rx LP	ESZOPICLONE	3	mg/1		CIV	N	20241231
63187-666_516a73f5-d543-4c59-9281-cf7b5a6dd2bf	63187-666	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-667_d19e8583-285d-471e-a205-0c340584231b	63187-667	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20101005		ANDA	ANDA090937	Proficient Rx LP	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-668_32e8bd9b-effa-4d86-864a-6d9b2aa8457f	63187-668	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20040818		ANDA	ANDA076368	Proficient Rx LP	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63187-669_84f8a211-aaba-4d86-b71c-9a0632217c9e	63187-669	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin Sulfate, Polymyxin B Sulfate, and Dexamethasone	OINTMENT	OPHTHALMIC	19940725		ANDA	ANDA064063	Proficient Rx LP	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-670_f302f985-2fc7-4ba8-bcc5-4ff5e4e127dd	63187-670	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	Proficient Rx LP	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-671_00a71bbf-ee21-419d-a85b-bb54aad76026	63187-671	HUMAN OTC DRUG	PlusPharma Extra Strength	PAIN RELIEVER,FEVER REDUCER 500 mg	ACETAMINOPHEN	TABLET	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	500	mg/1			N	20241231
63187-672_4e403a62-3004-40e4-8bee-ed3b2b37b589	63187-672	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20140414		ANDA	ANDA204234	Proficient Rx LP	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-673_2b2e33aa-55ad-4969-85d1-9cbfb62cabbb	63187-673	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Proficient Rx LP	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63187-674_55160086-9335-4d4b-bfc9-bb77270e0bb5	63187-674	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	Proficient Rx LP	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
63187-676_813e25e8-145f-40be-a7f1-fb8e0f2b0553	63187-676	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Proficient Rx LP	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-679_4b2a9a90-3ac3-4386-8772-64b4b9a86b28	63187-679	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	Proficient Rx LP	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-680_38e647c7-29f7-40dd-ad45-ca895ce38ff3	63187-680	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	20100530		ANDA	ANDA072192	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
63187-681_cee81634-9e3d-46e7-a42b-a17562bafa59	63187-681	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20151123		ANDA	ANDA204019	Proficient Rx LP	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63187-682_1d5b9b11-cb94-486d-9780-aca61a75c076	63187-682	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070423		ANDA	ANDA076410	Proficient Rx LP	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-683_4e48ba59-9b47-4427-9369-43edfe8024f2	63187-683	HUMAN OTC DRUG	Plus Pharma Senna	Standardized Senna Concentrate 8.6 mg Sennosides Each	SENNOSIDES	TABLET, FILM COATED	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part334	Proficient Rx LP	SENNOSIDES	8.6	mg/1			N	20241231
63187-685_e88cbdb3-efc2-4e45-af5e-a125eaf02dc8	63187-685	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20090801		ANDA	ANDA077789	Proficient Rx LP	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
63187-687_ab4967ce-4b33-43f1-838d-23695e04f9a9	63187-687	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	20020901		ANDA	ANDA070050	Proficient Rx LP	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-690_3f8065e2-9b67-478b-83a3-c4e6eed0fe32	63187-690	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20070423		ANDA	ANDA077322	Proficient Rx LP	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-691_3f8065e2-9b67-478b-83a3-c4e6eed0fe32	63187-691	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20070423		ANDA	ANDA077322	Proficient Rx LP	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-692_51ba5811-a7f6-4c07-abde-873a75ba5554	63187-692	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, COATED	ORAL	20151110		ANDA	ANDA203432	Proficient Rx LP	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-693_e9c75381-ef2c-49ec-8a2f-cc445aa5527b	63187-693	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	Proficient Rx LP	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-694_e97313e9-cc69-42ae-8eea-de13af3af4ce	63187-694	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-695_04942785-402c-49ca-a03d-6b69609673a7	63187-695	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Proficient Rx LP	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
63187-696_227a1197-689d-4d71-897f-928144027b02	63187-696	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Proficient Rx LP	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-698_b1330ae8-15e5-4aca-a5fe-6fb906740eeb	63187-698	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Proficient Rx LP	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-700_b2212d27-a0f7-48a6-ac0c-6e1ae378cb18	63187-700	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20100811		ANDA	ANDA090598	Proficient Rx LP	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
63187-701_e73a6f7b-fcab-44f8-941d-2f65ec95a571	63187-701	HUMAN OTC DRUG	Nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20090317		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	OXYMETAZOLINE HYDROCHLORIDE	5	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63187-702_4037464d-72bd-4d25-b1e8-0f6a4e694414	63187-702	HUMAN PRESCRIPTION DRUG	DULOXETINE	DELAYED-RELEASE	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-703_bbcffae3-b609-478f-9702-6ae78847cdba	63187-703	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	19930128		ANDA	ANDA064022	Proficient Rx LP	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63187-705_cf14c5ce-0aa3-4511-9db0-7d5aa995f04d	63187-705	HUMAN PRESCRIPTION DRUG	Trezix		acetaminophen, caffeine, dihydrocodeine bitartrate	CAPSULE	ORAL	20141201		ANDA	ANDA204785	Proficient Rx LP	ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE	320.5; 30; 16	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
63187-706_9c9550f3-e050-4978-be2f-b66c6d13cbca	63187-706	HUMAN PRESCRIPTION DRUG	Nalfon		fenoprofen calcium	CAPSULE	ORAL	20120827		NDA	NDA017604	Proficient Rx LP	FENOPROFEN CALCIUM	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-707_f8dfb619-9219-4973-9362-f6a32ecac185	63187-707	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070423		ANDA	ANDA076410	Proficient Rx LP	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-708_e7f9bccb-bb82-49fd-b59b-92670ee46f9e	63187-708	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Proficient Rx LP	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-709_f4c58aa3-ca42-4627-b267-35e3894f69bb	63187-709	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Proficient Rx LP	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63187-710_6144c77d-0600-4b23-9a4a-4f93332871e5	63187-710	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19950222		ANDA	ANDA074056	Proficient Rx LP	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-712_3aba6b55-812d-44e3-95e2-7be62d33db53	63187-712	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Proficient Rx LP	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-713_b5525d33-534c-440c-8a04-df329fc85056	63187-713	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		BUPROPION HYDROCHLORIDE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090501		ANDA	ANDA077415	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-714_81a18f97-01cd-4939-ab69-beb3a2a6e3b3	63187-714	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20101231		ANDA	ANDA090066	Proficient Rx LP	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-715_ab58250b-3975-4411-96c5-870e0de04c5c	63187-715	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Proficient Rx LP	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-716_6f8cd8f8-8650-4080-a488-ed1c497c5f5f	63187-716	HUMAN PRESCRIPTION DRUG	Duloxetine Hydrochloride		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20140613		ANDA	ANDA202045	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-717_bdd843d5-53be-4062-9922-45a507f276c4	63187-717	HUMAN OTC DRUG	aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20071212		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63187-718_0bc8ce8c-54f4-4f4a-b2b0-2c58d52f4e5a	63187-718	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20090909		ANDA	ANDA078581	Proficient Rx LP	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-719_b9d14bcb-219d-406c-85c5-405c9e8b8508	63187-719	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20160309		ANDA	ANDA202677	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63187-720_1f36294a-3092-46a3-9d23-9d0c1a3e6254	63187-720	HUMAN PRESCRIPTION DRUG	DULOXETINE	DELAYED-RELEASE	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-721_b6da114d-fc88-4f72-9055-a963b4625f25	63187-721	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20071127		ANDA	ANDA040778	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63187-722_f2b34441-3099-4719-8436-aad63219b9bd	63187-722	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20150523		ANDA	ANDA075994	Proficient Rx LP	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-723_c34993a0-b4e0-4443-a5b7-1fc9e2b019f7	63187-723	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Proficient Rx LP	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63187-726_d2ba7af1-c874-47ab-b638-be94dfe1b1dd	63187-726	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090702		ANDA	ANDA079095	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-727_8ca8b7a2-72ef-4029-9b87-42afd298bb97	63187-727	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-729_8407c6b1-788b-479e-8c41-3d6fe2b7b8ec	63187-729	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	Proficient Rx LP	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-731_34dcede0-61f8-4aaa-b409-0e7d5c9e6f02	63187-731	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20061023		ANDA	ANDA076939	Proficient Rx LP	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-732_34dcede0-61f8-4aaa-b409-0e7d5c9e6f02	63187-732	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20061023		ANDA	ANDA076939	Proficient Rx LP	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-733_edabc25f-0f5d-42c1-8edc-b3e5bcc4dd45	63187-733	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20120324		ANDA	ANDA204279	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63187-734_6fdf3036-94ca-4ad4-ae32-395156115512	63187-734	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	OPHTHALMIC	20141215		ANDA	ANDA078559	Proficient Rx LP	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-735_c40e425f-a9b7-4ab5-93ea-6e14ae0b77f9	63187-735	HUMAN PRESCRIPTION DRUG	DULOXETINE	DELAYED-RELEASE	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-736_1df6a536-d2d9-4d3b-bc5b-91e7a26beed2	63187-736	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	Proficient Rx LP	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-737_0adbcb7c-cbd5-49b6-99a4-cdd876ac278a	63187-737	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202254	Proficient Rx LP	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-738_eaf2cd92-bdea-475c-bca7-b685c2138c4c	63187-738	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	19910731		ANDA	ANDA063083	Proficient Rx LP	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
63187-739_7a15b0c4-de78-4bdc-85f3-fa25c7f7c429	63187-739	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Proficient Rx LP	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63187-740_29702d54-0228-4f90-9360-4d1c4189754b	63187-740	HUMAN PRESCRIPTION DRUG	DIGOX		Digoxin	TABLET	ORAL	20020726		ANDA	ANDA076268	Proficient Rx LP	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
63187-741_0af96348-1258-4d44-8985-0cd7c8e5b95d	63187-741	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	Proficient Rx LP	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
63187-742_ea6ad932-2a45-4117-9f1d-b21d2b0a1905	63187-742	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	Proficient Rx LP	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63187-743_ea6ad932-2a45-4117-9f1d-b21d2b0a1905	63187-743	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	Proficient Rx LP	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63187-744_41997610-4969-48ab-bc60-ae2bfdffc3ca	63187-744	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		Lamotrigine	TABLET	ORAL	20101101		ANDA	ANDA077783	Proficient Rx LP	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63187-745_76d63714-ef9b-4fc0-8fc4-a220ebbee413	63187-745	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	Proficient Rx LP	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
63187-746_d2e911b2-5c28-45a9-b11b-3546725481d2	63187-746	HUMAN PRESCRIPTION DRUG	PIOGLITAZONEHYDROCHLORIDE		PIOGLITAZONEHYDROCHLORIDE	TABLET	ORAL	20130213		ANDA	ANDA091298	Proficient Rx LP	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
63187-747_bfd7348c-fd58-4c1d-ba8a-110a7e01f56e	63187-747	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20130801		NDA AUTHORIZED GENERIC	NDA019048	Proficient Rx LP	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-748_a55952ea-18c3-4e7b-bb29-16518eae5ff2	63187-748	HUMAN PRESCRIPTION DRUG	Norethindrone		Norethindrone	TABLET	ORAL	20101103		ANDA	ANDA091209	Proficient Rx LP	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
63187-749_086f1e11-bff2-4f7b-9591-2ba9e1fdf217	63187-749	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	19900930		ANDA	ANDA071655	Proficient Rx LP	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63187-750_76d63714-ef9b-4fc0-8fc4-a220ebbee413	63187-750	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150512		ANDA	ANDA040616	Proficient Rx LP	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
63187-751_8bfb3767-f8fe-4bc4-8f45-1e84914d51f0	63187-751	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, CHEWABLE	ORAL	20151110		ANDA	ANDA203328	Proficient Rx LP	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-752_0a1e4108-e2a9-4c22-ab48-900d3bc20c1d	63187-752	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-753_b7cca998-edc7-40b5-bc62-b789921ad6c8	63187-753	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		diclofenac sodium	GEL	TOPICAL	20160701		NDA AUTHORIZED GENERIC	NDA022122	Proficient Rx LP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-754_3ef2edb0-29cc-45da-a3ef-c82f015b7ecb	63187-754	HUMAN PRESCRIPTION DRUG	TRI-LO-MARZIA		norgestimate and ethinyl estradiol	KIT		20160118		ANDA	ANDA200541	Proficient Rx LP						N	20241231
63187-756_f537d5d2-a239-49e0-9811-3b5e6526f728	63187-756	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Proficient Rx LP	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-757_2203d183-4cf9-42a4-94b3-44651a4cbeeb	63187-757	HUMAN PRESCRIPTION DRUG	Irbesartan		IRBESARTAN	TABLET	ORAL	20120927		ANDA	ANDA203071	Proficient Rx LP	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-758_f4311c55-f736-4e0d-a743-0b6fdd1395b2	63187-758	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Proficient Rx LP	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-759_6ed93a5b-338f-42c2-bf47-403abb5d2922	63187-759	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950405		ANDA	ANDA074132	Proficient Rx LP	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-760_ce938712-eb6a-4c1b-b917-9dd150f4c416	63187-760	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20060510		ANDA	ANDA076635	Proficient Rx LP	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63187-761_e6961030-ff60-458f-9576-387b97ff2a48	63187-761	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19960326		ANDA	ANDA074514	Proficient Rx LP	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-762_490d4045-f6a8-4c92-8b02-28d9942ddec0	63187-762	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac	GEL	TOPICAL	20160321		ANDA	ANDA208077	Proficient Rx LP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-763_1a480466-6b36-42d0-b95f-c783acff1d90	63187-763	HUMAN PRESCRIPTION DRUG	HYDROXYZINE PAMOATE		HYDROXYZINE PAMOATE	CAPSULE	ORAL	20101117		ANDA	ANDA201507	Proficient Rx LP	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63187-764_a119d390-b228-4fce-b5a6-26a13833ace0	63187-764	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20061213		ANDA	ANDA064163	Proficient Rx LP	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63187-765_045f5277-63a9-43c3-ae26-126a3ad3c16e	63187-765	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Proficient Rx LP	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-766_42428c55-bb9b-44be-a82f-478f6d22500d	63187-766	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081126		ANDA	ANDA077715	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-767_bf653681-ada4-416d-83f8-9a69044da4c0	63187-767	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-768_f2c9155c-5610-4c36-aa1d-7c2e64629bf9	63187-768	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Proficient Rx LP	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-769_8cfc7ee8-ec1c-478b-bd90-6778f9c3fb98	63187-769	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	19951226		ANDA	ANDA074185	Proficient Rx LP	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63187-770_3e44326f-096a-4565-a82e-bd39ff0db60b	63187-770	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20050113		ANDA	ANDA065089	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-771_880a5683-eb5b-4576-8218-9da10cbd1789	63187-771	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20090102		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-772_e7d02874-58bd-44fb-afdf-41b8f82a93e3	63187-772	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20160708		ANDA	ANDA077836	Proficient Rx LP	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
63187-773_a3b868e4-d9b8-4e48-a11e-8bf67f9f4b52	63187-773	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Proficient Rx LP	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-774_b8de64ec-7114-42c5-a6c6-ee1122b05bf9	63187-774	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20021218		ANDA	ANDA075638	Proficient Rx LP	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63187-775_b2961dbf-a83c-4c4b-a3bf-5c9e3158f12c	63187-775	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Proficient Rx LP	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-776_e5dca408-5050-47da-a6c8-fb75a79cc86e	63187-776	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Proficient Rx LP	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-777_df37d0b1-1981-4c46-a3a6-60712c06370c	63187-777	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20091207		ANDA	ANDA076109	Proficient Rx LP	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-778_156868e3-86ea-4689-90b4-734d29634b29	63187-778	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20120412		ANDA	ANDA201013	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63187-779_32990ec3-e5a3-4680-bd47-314f9766659e	63187-779	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20130301		ANDA	ANDA201991	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63187-780_1adce89f-748a-4ef9-9820-af7a52301560	63187-780	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Proficient Rx LP	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-781_e36b33e0-a969-46fc-8a6a-c62f4ae61607	63187-781	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20130411		ANDA	ANDA202717	Proficient Rx LP	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-782_5a945d95-78e5-470a-8567-5021043a3db6	63187-782	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	Proficient Rx LP	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
63187-783_52c3f53e-0feb-4946-82b6-ad9db9258503	63187-783	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Proficient Rx LP	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63187-784_2bab7712-de3d-45a1-a21c-b6273721bb28	63187-784	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19860730		ANDA	ANDA085223	Proficient Rx LP	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63187-785_1f31e7f3-c013-4492-90ac-481c23448403	63187-785	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160722		ANDA	ANDA202764	Proficient Rx LP	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-786_430f0bd3-56f3-4293-a83b-4854b9ee5e0d	63187-786	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20150601		ANDA	ANDA205085	Proficient Rx LP	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
63187-787_83ca8d89-bbd6-4a72-aeb3-ac1b4f93cc88	63187-787	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Proficient Rx LP	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-788_937ace02-fbbc-411d-9369-2b6eb02e1388	63187-788	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		RABEPRAZOLE SODIUM	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA078964	Proficient Rx LP	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-789_ab4d1c94-4535-4233-8521-6ec8059b7a05	63187-789	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20121108		ANDA	ANDA202025	Proficient Rx LP	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
63187-790_466aeaf2-3c90-4d18-b231-bf2bef44e0cf	63187-790	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Proficient Rx LP	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63187-791_7dee7971-4694-409c-b8fa-847074a41234	63187-791	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION/ DROPS	TRANSDERMAL	20150820		ANDA	ANDA204132	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-792_1d3fd7ce-1ee9-413f-9c5d-73e9864327f3	63187-792	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20140813		ANDA	ANDA077137	Proficient Rx LP	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
63187-793_e29663ca-306c-4e25-a233-fe701cee7071	63187-793	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Proficient Rx LP	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-794_f63d2be5-56a8-4c70-b684-c210f67058ba	63187-794	HUMAN OTC DRUG	Good Sense Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140331		ANDA	ANDA074661	Proficient Rx LP	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-795_46242389-2faa-4900-a43a-643cf388a6d7	63187-795	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-797_1e55d596-ee9b-4181-82de-f45312af3c72	63187-797	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Proficient Rx LP	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-798_4aa4c04f-3f5f-49a4-b1a6-eba6e09a588b	63187-798	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Proficient Rx LP	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-799_f4c90607-02fd-4956-809c-6045cb48720c	63187-799	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070409		ANDA	ANDA040597	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63187-800_4e1cdc95-3d6c-4a43-8aec-194daf2abd12	63187-800	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110610		ANDA	ANDA203068	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63187-801_c2a2f49e-24ed-42dc-b52c-a473e8a39930	63187-801	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Proficient Rx LP	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-802_5b5f70c9-c6e5-4f54-86e2-b659d3c7e616	63187-802	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20160526		ANDA	ANDA040232	Proficient Rx LP	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-803_c7442c05-30ea-427d-b832-611e0d1c392f	63187-803	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020315		ANDA	ANDA065064	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-804_77e00163-ec11-4bba-b1f9-08313bf22310	63187-804	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Proficient Rx LP	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
63187-805_fb7aa017-a443-47c0-8544-fb91c421a144	63187-805	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	Proficient Rx LP	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-806_d5292939-9818-40ba-86a1-267f8f24a092	63187-806	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20060222		ANDA	ANDA076504	Proficient Rx LP	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-807_69508b79-c086-493a-a46f-b9ab7c60a519	63187-807	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Proficient Rx LP	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-808_5b4c73ba-f4ed-4630-9729-e5642dc54bb8	63187-808	HUMAN PRESCRIPTION DRUG	Losartan Potassium		losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Proficient Rx LP	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-809_18679a71-2bb7-46cc-bebe-83b2ccb3fb14	63187-809	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950405		ANDA	ANDA074132	Proficient Rx LP	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63187-810_bd1a42c2-a627-4f3b-ba8c-bb1877f99ca0	63187-810	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-811_f4346952-5801-4df2-a6cb-97c35bfe5651	63187-811	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	Proficient Rx LP	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-812_3afe19fb-b693-47f7-a08e-a46cc756ffda	63187-812	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA090478	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-813_46ab16a5-1f10-4772-97c6-272c4d28164e	63187-813	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103		ANDA	ANDA203814	Proficient Rx LP	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
63187-814_66349a08-4c69-40f3-a639-fab5f068c910	63187-814	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Proficient Rx LP	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-815_5dde8fb0-3744-4a96-89c4-5b891681ccd9	63187-815	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20170105		ANDA	ANDA202800	Proficient Rx LP	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63187-816_cd41f0ae-d2bb-4ffc-9a5e-7ca6345cbe89	63187-816	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Proficient Rx LP	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-817_db1ef475-ac5d-4e80-aac1-d7fc42696157	63187-817	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	Proficient Rx LP	ESZOPICLONE	1	mg/1		CIV	N	20241231
63187-818_2d19d14a-d1c7-4467-8c6d-e98d59accb03	63187-818	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE, GELATIN COATED	ORAL	19840507		ANDA	ANDA062396	Proficient Rx LP	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-819_a35c75a3-e0fd-4031-8f4c-b350cac13875	63187-819	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20150217		ANDA	ANDA077285	Proficient Rx LP	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-820_8d62caf4-32be-4a2c-be08-c70a967ef307	63187-820	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Proficient Rx LP	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-821_628ae6d3-36b1-4702-8040-04ba2f4694de	63187-821	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Proficient Rx LP	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-822_2e24c976-daee-435d-8e1a-ae8297b26ad5	63187-822	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19951130		ANDA	ANDA074394	Proficient Rx LP	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-823_bd442a36-9c53-4088-bc80-749efcfa0bc5	63187-823	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20161201		ANDA	ANDA201972	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63187-824_9f711da8-c5d3-42ae-a8bc-bfdc75b1baf3	63187-824	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63187-825_17ff0808-5d64-412e-9e99-8a401dfc5aeb	63187-825	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Proficient Rx LP	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-826_2797b8b4-eac7-419e-b7da-a6e7493661c7	63187-826	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20071201		ANDA	ANDA065191	Proficient Rx LP	AMOXICILLIN; CLAVULANIC ACID	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-827_f9212f42-e8ca-4afe-8989-42b284681c13	63187-827	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	Proficient Rx LP	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
63187-828_0ceb9ab7-6082-414c-93a2-329c4accb306	63187-828	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Proficient Rx LP	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-829_a31e8f85-d588-4653-abf6-efe03da4149c	63187-829	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	19730919		ANDA	ANDA083426	Proficient Rx LP	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63187-830_2385274a-12e4-415b-b2fe-d7c7040d00aa	63187-830	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Proficient Rx LP	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-831_15e6f1c7-bbe1-4b4c-a32e-260bfca5e9b5	63187-831	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Proficient Rx LP	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-832_2c2ca723-20ca-4aed-8579-528163d0505c	63187-832	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Proficient Rx LP	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-833_e5c99469-b1e5-4f86-b4fa-7fcb4eac8f46	63187-833	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Proficient Rx LP	LEVOFLOXACIN	750	mg/1			N	20241231
63187-834_0ccbd919-79d8-4159-9b3e-c31230c157db	63187-834	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim	SOLUTION	OPHTHALMIC	19980416		ANDA	ANDA064211	Proficient Rx LP	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63187-835_5fcd955c-b46e-4949-b804-f81abe9d37b6	63187-835	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	Proficient Rx LP	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63187-836_d85acb60-6118-4b25-b1b3-d3decfca222e	63187-836	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20150813		ANDA	ANDA086724	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63187-837_06cc0229-6d8c-4b43-9936-391dd39975d5	63187-837	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20160620		ANDA	ANDA205119	Proficient Rx LP	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-838_4960f0db-c0f1-4d9c-bca7-8e62861fbfc3	63187-838	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA040148	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 2.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63187-839_a48795f5-fbef-445d-a633-8163755d6765	63187-839	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20081013		ANDA	ANDA078955	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-840_6d5cf36c-417b-4b36-b570-2a757b516246	63187-840	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20121128		ANDA	ANDA090168	Proficient Rx LP	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
63187-841_2ddce055-13bf-4f0b-9435-635d6118e631	63187-841	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Proficient Rx LP	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63187-842_2274db0b-42a3-484e-941c-990bad99df65	63187-842	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	19861117		ANDA	ANDA071209	Proficient Rx LP	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
63187-843_fe135c0b-c9e3-4078-958d-bd4ef956033b	63187-843	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	Proficient Rx LP	ESZOPICLONE	3	mg/1		CIV	N	20241231
63187-844_e818889d-6a4e-473d-90cc-f817ffece059	63187-844	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Proficient Rx LP	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-845_a9543772-1142-4aa5-a386-e1e77251b16e	63187-845	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		DOXYCYCLINE HYCLATE	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Proficient Rx LP	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-846_aa9a7386-f4d6-43b3-b92c-6698cafb446c	63187-846	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20160803		ANDA	ANDA071136	Proficient Rx LP	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-847_d13c0ace-65a3-4d56-bfce-c4aa234af26b	63187-847	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20060921		ANDA	ANDA062225	Proficient Rx LP	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63187-848_031d5759-e2a4-43f4-b944-7fd30030a13a	63187-848	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19950830		ANDA	ANDA074388	Proficient Rx LP	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-849_0e9c3eb8-1ae1-45b3-8304-10dc0a3c9b4d	63187-849	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110805		ANDA	ANDA090700	Proficient Rx LP	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63187-850_6606118e-4e3d-4559-9cd9-3894c3147260	63187-850	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Proficient Rx LP	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-851_36c46b33-7e01-49b7-b139-5148a6cf761c	63187-851	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20020301		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-852_03ae31de-621b-4ccc-8c25-17a53f124176	63187-852	HUMAN PRESCRIPTION DRUG	indomethacin		indomethacin	CAPSULE	ORAL	20160721		ANDA	ANDA090403	Proficient Rx LP	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-853_d216e267-eb95-41dd-9bc3-5ae4d99383f9	63187-853	HUMAN OTC DRUG	good sense tussin dm		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	19910918		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63187-854_45fcab03-1ec7-4695-b4b7-e4866de4a8c1	63187-854	HUMAN PRESCRIPTION DRUG	Ramipril		ramipril	CAPSULE	ORAL	20071226		ANDA	ANDA076549	Proficient Rx LP	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-856_0d824e6b-0a50-4b44-a9ac-44a6e9854eee	63187-856	HUMAN OTC DRUG	Good Sense ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20041109		ANDA	ANDA076359	Proficient Rx LP	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-857_665eb028-198a-4309-97c8-e4f97f1b7bba	63187-857	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20040923		ANDA	ANDA065162	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-858_4db2af05-d01e-4ccc-8d4b-84651835db6e	63187-858	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	SOLUTION	ORAL	20090313		ANDA	ANDA040891	Proficient Rx LP	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63187-859_7731d02d-7220-4f43-b230-9d38875f4192	63187-859	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-860_c6db2f0a-9e4c-4886-a377-b376f756de9a	63187-860	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Proficient Rx LP	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-861_d5bfc979-a820-4d06-ab41-9ccbaf28a914	63187-861	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Proficient Rx LP	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63187-862_16ffd293-15a1-4014-9b06-6772decd7651	63187-862	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		zolpidem tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101206		NDA AUTHORIZED GENERIC	NDA021774	Proficient Rx LP	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63187-863_fdd2ba1f-49ae-46cb-8c9c-47d2b0d659ab	63187-863	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20131108		ANDA	ANDA091643	Proficient Rx LP	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
63187-864_c6db2f0a-9e4c-4886-a377-b376f756de9a	63187-864	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Proficient Rx LP	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-865_c6db2f0a-9e4c-4886-a377-b376f756de9a	63187-865	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Proficient Rx LP	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-866_02f87529-6ca5-4107-a6d1-af756b9b8a59	63187-866	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-867_8ef03e37-1e76-4b72-b5ce-05eb0280ec99	63187-867	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20160803		ANDA	ANDA071135	Proficient Rx LP	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-869_a54f604f-fa5f-4403-ab1a-b58a05a9da45	63187-869	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160818		ANDA	ANDA079166	Proficient Rx LP	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-870_bac15676-050f-4656-9a21-69342aa8c408	63187-870	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20060928		ANDA	ANDA086414	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-871_ea42fd4b-fc18-451c-9550-706abfbe7513	63187-871	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol fumarate	TABLET	ORAL	20090921		ANDA	ANDA078635	Proficient Rx LP	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63187-873_57dbd129-b76f-49e6-b76a-eb86ad22273b	63187-873	HUMAN PRESCRIPTION DRUG	Gentak		Gentamicin Sulfate	OINTMENT	OPHTHALMIC	20060508		ANDA	ANDA064093	Proficient Rx LP	GENTAMICIN SULFATE	3	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63187-874_47f95e90-75fb-4294-b861-9a2349a48e91	63187-874	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril Hydrochloride	TABLET, FILM COATED	ORAL	20130429		ANDA	ANDA202725	Proficient Rx LP	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-875_19b531f9-27f9-42e5-8c1e-7015c256bb22	63187-875	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Proficient Rx LP	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63187-876_a790bb9c-91e9-4231-a093-4d3edbaf94fc	63187-876	HUMAN PRESCRIPTION DRUG	Levalbuterol tartrate HFA inhalation		levalbuterol tartrate	AEROSOL, METERED	ORAL	20161001		NDA AUTHORIZED GENERIC	NDA021730	Proficient Rx LP	LEVALBUTEROL TARTRATE	45	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
63187-878_05e11a44-c072-4969-9175-1caa92458ad7	63187-878	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	Proficient Rx LP	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63187-879_7c413f9c-e8c1-4359-8a68-4cac49331b85	63187-879	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		Atovaquone and Proguanil Hydrochloride	TABLET, FILM COATED	ORAL	20110818		ANDA	ANDA091211	Proficient Rx LP	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
63187-880_31883dd0-bd99-4cde-9ded-a4c2fc3be8cc	63187-880	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065387	Proficient Rx LP	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-881_8f80fceb-9bda-4d9a-aac2-4aedee437f16	63187-881	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021127		ANDA	ANDA065117	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63187-882_2e9ea82b-2131-46ed-9054-df45307882a1	63187-882	HUMAN OTC DRUG	Aspirin	Low Dose Safety Coated	Aspirin	TABLET, COATED	ORAL	20130315		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63187-883_da08672f-6155-4026-b283-a7738f7eb678	63187-883	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	Proficient Rx LP	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63187-884_3195d486-86b4-4ee4-b049-a1ad55e9ab06	63187-884	HUMAN PRESCRIPTION DRUG	Nitrostat		nitroglycerin	TABLET	SUBLINGUAL	20000501		NDA	NDA021134	Proficient Rx LP	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
63187-885_bb56f31c-5b87-409e-b5ec-bc410c4607e0	63187-885	HUMAN OTC DRUG	Antifungal		miconazole nitrate	CREAM	TOPICAL	20070501		OTC MONOGRAPH FINAL	part333C	Proficient Rx LP	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63187-888_ae298067-50ce-4e37-9740-c18372854d8d	63187-888	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Proficient Rx LP	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-889_3064bb68-9847-4293-9638-bf031ba7e420	63187-889	HUMAN PRESCRIPTION DRUG	Aviane		Levonorgestrel and Ethinyl Estradiol	KIT		20010402		ANDA	ANDA075796	Proficient Rx LP						N	20241231
63187-890_d73ad261-b388-48ac-ad8f-133af829dfbc	63187-890	HUMAN PRESCRIPTION DRUG	Junel Fe 1.5/30		norethindrone acetate and ethinyl estradiol, and ferrous fumarate	KIT		20030918		ANDA	ANDA076064	Proficient Rx LP						N	20241231
63187-891_29553798-cdb4-4f5a-99d5-be83f704559b	63187-891	HUMAN PRESCRIPTION DRUG	PHENYTOIN SODIUM		PHENYTOIN SODIUM	CAPSULE, EXTENDED RELEASE	ORAL	20061212		ANDA	ANDA040621	Proficient Rx LP	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-892_de5d688d-8c71-4bf5-999c-17a3f323f854	63187-892	HUMAN OTC DRUG	Lidozen		LIDOCAINE HYDROCHLORIDE, MENTHOL	GEL	TOPICAL	20170722		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63187-893_6b3e5c9c-4415-4f20-9071-ef6451896123	63187-893	HUMAN OTC DRUG	GoodSense Artifical Tears		Polyvinyl alcohol, and Povidone	SOLUTION/ DROPS	OPHTHALMIC	20160404		OTC MONOGRAPH FINAL	part349	Proficient Rx LP	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE, UNSPECIFIED	.05; .06	g/mL; g/mL			N	20241231
63187-895_581223b4-bbec-4e9b-9e86-4749c0b28c42	63187-895	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20030201		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
63187-896_c1e8f3ed-105b-4abd-a99e-6a8ebfd6edaf	63187-896	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA200405	Proficient Rx LP	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
63187-897_07dda324-2d2e-489f-ab71-004579ac5ece	63187-897	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060317		ANDA	ANDA077634	Proficient Rx LP	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
63187-898_96fa8857-d124-474b-aadd-ca9b9a08ba66	63187-898	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	19970819		ANDA	ANDA085588	Proficient Rx LP	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
63187-900_44ed966d-bf75-4379-84f4-b5270e2bb700	63187-900	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET	ORAL	19930630		NDA AUTHORIZED GENERIC	NDA020215	Proficient Rx LP	ISOSORBIDE MONONITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
63187-901_8abc5903-cbd2-436d-b229-4e76d3726e09	63187-901	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20070406		ANDA	ANDA086242	Proficient Rx LP	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63187-902_f1b5aa19-119f-4d5a-aa8d-8f3778a48753	63187-902	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	19960131		ANDA	ANDA064096	Proficient Rx LP	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63187-904_09702e4f-a98d-4284-a95d-1d560ee4dce9	63187-904	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
63187-905_bfe1a860-0657-4f48-9b82-31f9483838c4	63187-905	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20111212		ANDA	ANDA201407	Proficient Rx LP	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-906_9eeaae93-ac71-4721-98ad-8c7a9231f822	63187-906	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Proficient Rx LP	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63187-907_6fe42517-aec2-4203-9574-2576c6472a94	63187-907	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA205519	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63187-908_819e32bc-5944-4f22-b80b-03c547a95dbf	63187-908	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Proficient Rx LP	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63187-909_563dace5-c1ab-46ff-b3f9-774fe2a62ca5	63187-909	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160629		ANDA	ANDA090705	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-910_fdcb382b-4753-45e8-ab3c-28d929c764b7	63187-910	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	Proficient Rx LP	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63187-911_cf674be7-f206-4b82-ab29-e9658b7f70a6	63187-911	HUMAN PRESCRIPTION DRUG	Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20020926		ANDA	ANDA075804	Proficient Rx LP						N	20241231
63187-913_e984b0c0-21c6-46b5-a2da-c03d01db97e1	63187-913	HUMAN OTC DRUG	Aspir Low		Aspirin	TABLET	ORAL	20110524		OTC MONOGRAPH FINAL	part343	Proficient Rx LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63187-914_b9f0a743-12ea-403f-bf32-d2e003d8815b	63187-914	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	Proficient Rx LP	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63187-915_c8c3c559-7a98-49c0-a386-a3b74b0ac4b2	63187-915	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Proficient Rx LP	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63187-916_513bc814-d2ed-4444-89f3-e18f907e0952	63187-916	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Proficient Rx LP	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-918_038d5ca0-71f9-4135-9921-2e1889a9cf23	63187-918	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-919_fe188ea7-a1f6-4139-9679-3c07130cfc4f	63187-919	HUMAN PRESCRIPTION DRUG	FAMCICLOVIR		Famciclovir	TABLET	ORAL	20110321		ANDA	ANDA078278	Proficient Rx LP	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-920_fe188ea7-a1f6-4139-9679-3c07130cfc4f	63187-920	HUMAN PRESCRIPTION DRUG	FAMCICLOVIR		Famciclovir	TABLET	ORAL	20110321		ANDA	ANDA078278	Proficient Rx LP	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-921_9d96cb6a-14e9-4dcb-84e4-63d98a716070	63187-921	HUMAN OTC DRUG	Fexofenadine HCl		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA204507	Proficient Rx LP	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-922_93640180-fa14-4cca-b133-ca82177287c9	63187-922	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20150213		ANDA	ANDA203027	Proficient Rx LP	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-923_7e7dea0f-3605-4fe0-b204-d46938a16a6a	63187-923	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20170801		ANDA	ANDA078722	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63187-924_abfc4554-8993-455e-8c6c-62b3f7d9ec06	63187-924	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20020301		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-925_ff66dce0-d440-4e94-8f0c-88b911db6dff	63187-925	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET	ORAL	20120330		ANDA	ANDA076890	Proficient Rx LP	LEVOFLOXACIN	250	mg/1			N	20241231
63187-926_651d3bac-e755-40ea-9ded-3dab23e0ffba	63187-926	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Proficient Rx LP	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63187-927_b4618a70-5719-43c4-9010-ef790f7495cb	63187-927	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Proficient Rx LP	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63187-928_5b03582e-fcc5-4cbb-8a72-0c53fcc32900	63187-928	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040627	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63187-929_3088635b-b4fc-484d-b979-2a8d3ed37d7f	63187-929	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63187-930_57b91c11-72cf-43cb-8e47-eb6345d95653	63187-930	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	SYRUP	ORAL	20160921		ANDA	ANDA203375	Proficient Rx LP	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-931_798485b6-b33b-4192-b87e-b411643f75b6	63187-931	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Proficient Rx LP	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-932_78af6245-731f-4845-b844-6ad94bacfea5	63187-932	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20071227		ANDA	ANDA078317	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63187-933_7dab4e36-bc51-4ee3-ac6e-ec651dcfc508	63187-933	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20120913		ANDA	ANDA200243	Proficient Rx LP	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
63187-934_271f4ae3-b09c-42b9-a9ae-92f1ed965b57	63187-934	HUMAN PRESCRIPTION DRUG	Lidocaine		LIDOCAINE	OINTMENT	TOPICAL	20161115		ANDA	ANDA086724	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63187-936_8c93d33f-1500-4f79-8841-caec0bcf121a	63187-936	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20160429		ANDA	ANDA204446	Proficient Rx LP	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-937_71114f1d-474e-46e1-9bcd-cdf746046b9a	63187-937	HUMAN PRESCRIPTION DRUG	Flurbiprofen Sodium		Flurbiprofen Sodium	SOLUTION/ DROPS	OPHTHALMIC	19950104		ANDA	ANDA074447	Proficient Rx LP	FLURBIPROFEN SODIUM	.3	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-938_96e2029a-2614-4862-b7de-dbbdbf10006b	63187-938	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Proficient Rx LP	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-939_397aa3b9-b2ba-44d0-92a4-b63cedc333cf	63187-939	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170707		ANDA	ANDA086727	Proficient Rx LP	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
63187-940_09fb6f73-a2b3-4258-9642-cadabc64f827	63187-940	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20160209		NDA AUTHORIZED GENERIC	NDA021656	Proficient Rx LP	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63187-941_f83cec53-93fb-4fa6-81e8-5e8801c99e62	63187-941	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Proficient Rx LP	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63187-942_9fea1ae3-2eb3-452d-a3bf-caee9f6f0ccc	63187-942	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		DOXYCYCLINE HYCLATE	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Proficient Rx LP	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63187-943_2d51bede-441e-4d75-ab5f-22736967d958	63187-943	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-946_d327c98b-8ef9-4355-b49d-664413f4158e	63187-946	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Proficient Rx LP	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63187-947_0ca25f66-ddce-4617-be6e-69e3d8ad7844	63187-947	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride		Diethylpropion Hydrochloride	TABLET	ORAL	20110718		ANDA	ANDA200177	Proficient Rx LP	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63187-948_7998043a-b571-4151-8a93-6aa76884807c	63187-948	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	Proficient Rx LP	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-950_441151ec-31f4-413c-8764-11fc16fb2ada	63187-950	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	Proficient Rx LP	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-951_8de923a7-5488-4e04-8c58-37a3d5355d00	63187-951	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	Proficient Rx LP	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63187-952_9c9203c1-38dd-49de-a79d-cf0404ef3f72	63187-952	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090324		ANDA	ANDA079095	Proficient Rx LP	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63187-953_efb4df4c-19c2-4c42-bf10-d1613186db7b	63187-953	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20130429		ANDA	ANDA090297	Proficient Rx LP	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
63187-954_d8381687-e02a-45ea-8a85-8c84874cf919	63187-954	HUMAN OTC DRUG	Mucinex		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120703		NDA	NDA021282	Proficient Rx LP	GUAIFENESIN	600	mg/1			N	20241231
63187-955_0a08231c-188b-4c9a-8680-d43152d71983	63187-955	HUMAN OTC DRUG	Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride		Cetirizine HCl, Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20080410		ANDA	ANDA077170	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-957_cda6757e-ba20-4c5c-8171-632dd1a875aa	63187-957	HUMAN PRESCRIPTION DRUG	FLOVENT	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20081013		NDA	NDA020833	Proficient Rx LP	FLUTICASONE PROPIONATE	100	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-959_1c522e4f-54b7-48b1-899e-5b4290f330b4	63187-959	HUMAN PRESCRIPTION DRUG	FLUTICASONE PROPIONATE		fluticasone propionate	CREAM	TOPICAL	20040514		ANDA	ANDA076451	Proficient Rx LP	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-960_474280cc-828d-4cfc-96ae-08a47e64d320	63187-960	HUMAN OTC DRUG	Guaifenesin and pseudoephedrine hydrochloride Extended Release		Guaifenesin, pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160129		ANDA	ANDA091071	Proficient Rx LP	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63187-962_042c021e-4cc7-47ea-8395-845c01d13f0e	63187-962	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Proficient Rx LP	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-963_fb9e5c2c-85f7-4c5f-b27b-02b0ddfe7bc2	63187-963	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Proficient Rx LP	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-964_5d8ef640-33d7-451f-af54-2413337b92ee	63187-964	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20151210		ANDA	ANDA078279	Proficient Rx LP	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-965_3f575cc4-f92e-4e55-aeb2-c634fe3411d3	63187-965	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Proficient Rx LP	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63187-966_9d0608bc-8754-4cd9-b2a9-1b0108755f7e	63187-966	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20151001		ANDA	ANDA200739	Proficient Rx LP	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-967_f858d715-a62b-429c-9c38-9a06e7f3716b	63187-967	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Proficient Rx LP	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-968_f2d98e1e-740a-4411-af91-1f5e9b4766ea	63187-968	HUMAN OTC DRUG	Childrens Chewable Mapap		Acetaminophen	TABLET, CHEWABLE	ORAL	20110504		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	80	mg/1			N	20241231
63187-969_1fb984b9-ebc3-45a8-a33b-11416194e83c	63187-969	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Proficient Rx LP	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63187-970_c07cfea0-a9fa-4ed5-928f-5aab69e12793	63187-970	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	Proficient Rx LP	ESZOPICLONE	2	mg/1		CIV	N	20241231
63187-971_8d04300a-7984-48c4-9c26-e214bff97de7	63187-971	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Proficient Rx LP	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63187-972_f937de38-3c64-4b91-bef4-59ba68dcaa05	63187-972	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20161219		ANDA	ANDA207938	Proficient Rx LP	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-973_3439b089-5661-47e1-87e9-7b18c7d61540	63187-973	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19950109		ANDA	ANDA062535	Proficient Rx LP	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63187-974_ed77dc17-564e-44a4-810b-44952cda19e3	63187-974	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20160620		ANDA	ANDA205119	Proficient Rx LP	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63187-975_b946749b-7e55-4ad8-bd21-ba2a094bef04	63187-975	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20160506		ANDA	ANDA086724	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63187-976_d25ae08b-7a5f-4b97-b0b6-c5228e6018d5	63187-976	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20110815		ANDA	ANDA070929	Proficient Rx LP	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
63187-977_386e877f-e67d-4f4a-964d-ca85afc1ba32	63187-977	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Proficient Rx LP	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63187-978_5c1e5064-9311-4161-a11f-1e006dd97bfb	63187-978	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080937	Proficient Rx LP	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
63187-979_2e3dc23e-8c5d-4c9c-878d-decc75c85677	63187-979	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	19860417		NDA	NDA019123	Proficient Rx LP	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63187-980_35ff4860-111c-48cb-94c3-6601d892901a	63187-980	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Proficient Rx LP	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-981_ae512032-f396-4e77-bce4-409b8844ce3e	63187-981	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130124		ANDA	ANDA077369	Proficient Rx LP	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63187-982_88d4aee7-1761-481c-9f75-ce065e44d6b7	63187-982	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20020301		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63187-983_3c461af6-3b02-4fd6-b1e4-4f0f24046353	63187-983	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160930		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-984_09fe7043-1a50-4d4a-89ff-e0acc2850023	63187-984	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20130715		ANDA	ANDA201972	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63187-985_6d644d3b-aaa3-489f-b2e7-5a9a5e2ac903	63187-985	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-986_444d8db1-15f7-4338-86bf-93fb162d470c	63187-986	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20120501		ANDA	ANDA090545	Proficient Rx LP	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-987_f8e58aea-898e-441f-a256-2bfb18e7fc4d	63187-987	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63187-988_9d1108db-da27-4c84-9a27-2993343c1694	63187-988	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63187-989_a1a1f2d7-b989-41f7-a770-ae1b4b6231ce	63187-989	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20070406		ANDA	ANDA065330	Proficient Rx LP	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63187-990_d0f31dff-c2dd-487d-a329-342765d135e3	63187-990	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63187-991_8251b1f4-6da1-461e-9512-fed77a1f402b	63187-991	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	Proficient Rx LP	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63187-992_ad45dc23-f2b0-4de6-aaab-07549fc226f2	63187-992	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Proficient Rx LP	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-993_6da40333-09b9-4e21-8223-35cb0f9087e9	63187-993	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Proficient Rx LP	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63187-994_c8c5fa0d-9b0d-48dc-bdfb-7727a050e888	63187-994	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000228		ANDA	ANDA075492	Proficient Rx LP	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63187-995_ae7e968c-c9fd-48ec-b93b-72ff585d6e65	63187-995	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	Proficient Rx LP	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
63187-996_6d44d894-810c-4608-a503-0cc6ff1f965d	63187-996	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63187-997_1d113b1d-8a37-4f10-89af-66b4dd8697b2	63187-997	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA080356	Proficient Rx LP	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63187-998_f77d4f79-bf54-40dd-84c8-8b2cd1c2ebe4	63187-998	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202438	Proficient Rx LP	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63187-999_6df77a1c-accd-4559-9a9a-00a030f6ba64	63187-999	HUMAN OTC DRUG	heartburn relief	original strength	Famotidine	TABLET	ORAL	20090909		ANDA	ANDA075400	Proficient Rx LP	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63255-111_7bbfe7b1-fa74-4c58-82af-7623fe3c691c	63255-111	HUMAN OTC DRUG	HYSAN PAIN RELIEVER		METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	OIL	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part348	HYSAN PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); METHYL SALICYLATE	10; 37	g/100mL; g/100mL			N	20241231
63255-122_222b9897-9420-4196-b479-7e59c42886b3	63255-122	HUMAN OTC DRUG	HYSAN HUO LU MEDICATED		METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	OIL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part348	HYSAN PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); METHYL SALICYLATE	10; 37	g/100mL; g/100mL			N	20241231
63255-123_51a196db-1fab-4f66-9b61-ee07b16ca92b	63255-123	HUMAN OTC DRUG	HYSAN HUA TUO HUO LU		METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	OIL	TOPICAL	20210218		OTC MONOGRAPH NOT FINAL	part348	HYSAN PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); METHYL SALICYLATE	10; 37	g/100mL; g/100mL			N	20241231
63255-210_ec071fb0-aca8-4fc1-b904-e158ce770153	63255-210	HUMAN OTC DRUG	HYSAN HUA TUO MEDICATED		Methyl Salicylate	PLASTER	TOPICAL	20210428		OTC MONOGRAPH NOT FINAL	part348	HYSAN PHARMACEUTICAL CO LTD	METHYL SALICYLATE	1	g/1			N	20241231
63255-330_51883374-552a-4802-a206-987fb86173e0	63255-330	HUMAN OTC DRUG	HYSAN ANALGESIC		METHYL SALICYLATE, CAMPHOR (SYNTHETIC)	OINTMENT	TOPICAL	20210802		OTC MONOGRAPH NOT FINAL	part348	HYSAN PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); METHYL SALICYLATE	2; 22	g/100g; g/100g			N	20241231
63287-419_e3da5cc2-c71d-3a22-e053-2995a90adfeb	63287-419	HUMAN OTC DRUG	RELEEV Cold Sore Treatment		Benzalkonium Chloride	LIQUID	TOPICAL	20060601		OTC MONOGRAPH NOT FINAL	part333A	Merix Pharmaceutical Corp.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63299-001_310f812b-cd56-45f6-b022-26baff9f0cd0	63299-001	HUMAN OTC DRUG	MENTHOL AND METHYL SALICYLATE		ELECTRIC MEDICATED BALM ULTRA STRENGTH	OINTMENT	TOPICAL	20180328		OTC MONOGRAPH NOT FINAL	part348	FEI FAH MEDICAL MANUFACTURING PTE LTD	MENTHOL; METHYL SALICYLATE	16; 32	g/100g; g/100g			N	20241231
63299-046_fc697735-bfdd-4113-ad1a-be8b4ecfc887	63299-046	HUMAN OTC DRUG	ELECTRIC MEDICATED BALM		Menthol and Methyl Salicylate	OINTMENT	TOPICAL	20080213		OTC MONOGRAPH NOT FINAL	part348	FEI FAH MEDICAL MANUFACTURING PTE LTD	MENTHOL; METHYL SALICYLATE	11; 22	g/100g; g/100g			N	20241231
63301-001_09c4efc8-aa8d-7fad-e063-6294a90acd22	63301-001	HUMAN OTC DRUG	McD Foaming Antibacterial Hand		CHLOROXYLENOL	LIQUID	TOPICAL	20160321		OTC MONOGRAPH DRUG	505G(a)(3)	Kath Khemicals LLC	CHLOROXYLENOL	5	mg/mL			N	20241231
63304-008_32a6b020-3673-469f-8757-741297fb458b	63304-008	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180207		NDA	NDA210428	Sun Pharmaceutical Industries Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63304-009_32a6b020-3673-469f-8757-741297fb458b	63304-009	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180207		NDA	NDA210428	Sun Pharmaceutical Industries Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63304-010_32a6b020-3673-469f-8757-741297fb458b	63304-010	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180207		NDA	NDA210428	Sun Pharmaceutical Industries Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63304-011_32a6b020-3673-469f-8757-741297fb458b	63304-011	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	CAPSULE, EXTENDED RELEASE	ORAL	20180207		NDA	NDA210428	Sun Pharmaceutical Industries Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63304-017_9d320810-99dc-4276-ab06-688b60cc957d	63304-017	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190528		ANDA	ANDA211707	Sun Pharmaceutical Industries, Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63304-018_9d320810-99dc-4276-ab06-688b60cc957d	63304-018	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190528		ANDA	ANDA211707	Sun Pharmaceutical Industries, Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63304-041_3b4a2db3-5368-400c-81f6-ffa0b7a34653	63304-041	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230312		ANDA	ANDA211846	Sun Pharmaceutical Industries, Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
63304-042_3b4a2db3-5368-400c-81f6-ffa0b7a34653	63304-042	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230304		ANDA	ANDA211846	Sun Pharmaceutical Industries, Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
63304-043_3b4a2db3-5368-400c-81f6-ffa0b7a34653	63304-043	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230304		ANDA	ANDA211846	Sun Pharmaceutical Industries, Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
63304-044_3b4a2db3-5368-400c-81f6-ffa0b7a34653	63304-044	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230304		ANDA	ANDA211846	Sun Pharmaceutical Industries, Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
63304-045_3b4a2db3-5368-400c-81f6-ffa0b7a34653	63304-045	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230312		ANDA	ANDA211846	Sun Pharmaceutical Industries, Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
63304-046_3b4a2db3-5368-400c-81f6-ffa0b7a34653	63304-046	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230304		ANDA	ANDA211846	Sun Pharmaceutical Industries, Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
63304-047_50c7518b-349e-4284-ac0c-1ac2c332c3e4	63304-047	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	TABLET, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA211889	Sun Pharmaceutical Industries, Inc.	PREGABALIN	82.5	mg/1		CV	N	20241231
63304-048_50c7518b-349e-4284-ac0c-1ac2c332c3e4	63304-048	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	TABLET, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA211889	Sun Pharmaceutical Industries, Inc.	PREGABALIN	165	mg/1		CV	N	20241231
63304-049_50c7518b-349e-4284-ac0c-1ac2c332c3e4	63304-049	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	TABLET, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA211889	Sun Pharmaceutical Industries, Inc.	PREGABALIN	330	mg/1		CV	N	20241231
63304-076_0e924cf6-53b8-28c4-e063-6294a90a4ac4	63304-076	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20191120		ANDA	ANDA076368	Sun Pharmaceutical Industries, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63304-078_0e920885-4086-c99c-e063-6294a90aaa67	63304-078	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200102		ANDA	ANDA208864	Sun Pharmaceutical Industries, Inc.	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63304-083_c2d3824b-8e6f-414d-aa16-de9e2d448645	63304-083	HUMAN PRESCRIPTION DRUG	ChlorproMAZINE Hydrochloride		ChlorproMAZINE	TABLET, SUGAR COATED	ORAL	20201118		ANDA	ANDA214256	Sun Pharmaceutical Industries Inc	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63304-086_ca97f06d-5449-4f4f-a362-47f65448bf8c	63304-086	HUMAN PRESCRIPTION DRUG	droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214384	Sun Pharmaceutical Industries, Inc.	DROXIDOPA	100	ug/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
63304-089_1b905f15-0048-41f5-9e39-6bf4d29bce2c	63304-089	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20220513		ANDA	ANDA214585	Sun Pharmaceutical Industries Inc.	MESALAMINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
63304-090_0e920885-4086-c99c-e063-6294a90aaa67	63304-090	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200102		ANDA	ANDA208864	Sun Pharmaceutical Industries, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63304-091_da5ee265-23ee-47c1-bbe5-5eff4a46c5a3	63304-091	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20191225		ANDA	ANDA213914	Sun Pharmaceutical Industries Inc.	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-092_da5ee265-23ee-47c1-bbe5-5eff4a46c5a3	63304-092	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20191225		ANDA	ANDA213914	Sun Pharmaceutical Industries Inc.	SUNITINIB MALATE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-093_da5ee265-23ee-47c1-bbe5-5eff4a46c5a3	63304-093	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20191225		ANDA	ANDA213914	Sun Pharmaceutical Industries Inc.	SUNITINIB MALATE	37.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-094_da5ee265-23ee-47c1-bbe5-5eff4a46c5a3	63304-094	HUMAN PRESCRIPTION DRUG	Sunitinib malate		Sunitinib malate	CAPSULE	ORAL	20191225		ANDA	ANDA213914	Sun Pharmaceutical Industries Inc.	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-095_c160713b-c06f-49b4-80ea-fc1afb030b81	63304-095	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20191105		ANDA	ANDA210300	Sun Pharmaceutical Industries, Inc.	ERLOTINIB	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-096_c160713b-c06f-49b4-80ea-fc1afb030b81	63304-096	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20191105		ANDA	ANDA210300	Sun Pharmaceutical Industries, Inc.	ERLOTINIB	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-097_9bc4f2da-41f0-42e2-98b2-b689c02d0a3e	63304-097	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET	ORAL	20090813		ANDA	ANDA076554	SUN PHARMACEUTICAL INDUSTRIES, INC.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63304-098_9bc4f2da-41f0-42e2-98b2-b689c02d0a3e	63304-098	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET	ORAL	20090813		ANDA	ANDA076554	SUN PHARMACEUTICAL INDUSTRIES, INC.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63304-099_9bc4f2da-41f0-42e2-98b2-b689c02d0a3e	63304-099	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET	ORAL	20090210		ANDA	ANDA076572	SUN PHARMACEUTICAL INDUSTRIES, INC.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63304-104_ca97f06d-5449-4f4f-a362-47f65448bf8c	63304-104	HUMAN PRESCRIPTION DRUG	droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214384	Sun Pharmaceutical Industries, Inc.	DROXIDOPA	200	ug/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
63304-106_801949ca-1baf-4a19-8466-91b4269a2c63	63304-106	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20210701		ANDA	ANDA214781	SUN PHARMACEUTICAL INDUSTRIES, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63304-110_801949ca-1baf-4a19-8466-91b4269a2c63	63304-110	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20210701		ANDA	ANDA214781	SUN PHARMACEUTICAL INDUSTRIES, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63304-112_ca97f06d-5449-4f4f-a362-47f65448bf8c	63304-112	HUMAN PRESCRIPTION DRUG	droxidopa		droxidopa	CAPSULE	ORAL	20210218		ANDA	ANDA214384	Sun Pharmaceutical Industries, Inc.	DROXIDOPA	300	ug/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
63304-114_c2d3824b-8e6f-414d-aa16-de9e2d448645	63304-114	HUMAN PRESCRIPTION DRUG	ChlorproMAZINE Hydrochloride		ChlorproMAZINE	TABLET, SUGAR COATED	ORAL	20201118		ANDA	ANDA214256	Sun Pharmaceutical Industries Inc	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63304-116_3aa752ae-7fad-4728-bded-7a3e1a4b3589	63304-116	HUMAN PRESCRIPTION DRUG	Pazopanib		Pazopanib	TABLET, FILM COATED	ORAL	20231020		ANDA	ANDA215837	SUN PHARMACEUTICAL INDUSTRIES, INC.	PAZOPANIB HYDROCHLORIDE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-122_c2d3824b-8e6f-414d-aa16-de9e2d448645	63304-122	HUMAN PRESCRIPTION DRUG	ChlorproMAZINE Hydrochloride		ChlorproMAZINE	TABLET, SUGAR COATED	ORAL	20201118		ANDA	ANDA214256	Sun Pharmaceutical Industries Inc	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63304-130_fd417a50-69b5-40b4-89fd-58aea77ab547	63304-130	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA065356	Sun Pharmaceutical Industries Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63304-131_fd417a50-69b5-40b4-89fd-58aea77ab547	63304-131	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA065356	Sun Pharmaceutical Industries Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63304-132_fd417a50-69b5-40b4-89fd-58aea77ab547	63304-132	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA065356	Sun Pharmaceutical Industries Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63304-135_c160713b-c06f-49b4-80ea-fc1afb030b81	63304-135	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20191105		ANDA	ANDA210300	Sun Pharmaceutical Industries, Inc.	ERLOTINIB	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63304-143_c2d3824b-8e6f-414d-aa16-de9e2d448645	63304-143	HUMAN PRESCRIPTION DRUG	ChlorproMAZINE Hydrochloride		ChlorproMAZINE	TABLET, SUGAR COATED	ORAL	20201118		ANDA	ANDA214256	Sun Pharmaceutical Industries Inc	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63304-173_fd417a50-69b5-40b4-89fd-58aea77ab547	63304-173	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA065356	Sun Pharmaceutical Industries Inc.	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63304-175_3f29d761-eab5-4f6b-a4f4-ffcc072648e3	63304-175	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	TABLET, DELAYED RELEASE	ORAL	20190201		ANDA	ANDA211858	Sun Pharmaceutical Industries, Inc.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
63304-185_c2d3824b-8e6f-414d-aa16-de9e2d448645	63304-185	HUMAN PRESCRIPTION DRUG	ChlorproMAZINE Hydrochloride		ChlorproMAZINE	TABLET, SUGAR COATED	ORAL	20201118		ANDA	ANDA214256	Sun Pharmaceutical Industries Inc	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63304-191_cd04a0b2-a7f2-4629-997f-af2a8e65f15b	63304-191	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20130305		NDA	NDA204150	Sun Pharmaceutical Industries, Inc.	DESVENLAFAXINE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63304-192_cd04a0b2-a7f2-4629-997f-af2a8e65f15b	63304-192	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20130305		NDA	NDA204150	Sun Pharmaceutical Industries, Inc.	DESVENLAFAXINE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63304-239_ccc0e02b-bd1e-45f2-9256-6933ac193518	63304-239	HUMAN PRESCRIPTION DRUG	CALCITRIOL		CALCITRIOL	CAPSULE	ORAL	20090826		NDA AUTHORIZED GENERIC	NDA018044	Sun Pharmaceutical Industries, Inc.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
63304-240_ccc0e02b-bd1e-45f2-9256-6933ac193518	63304-240	HUMAN PRESCRIPTION DRUG	CALCITRIOL		CALCITRIOL	CAPSULE	ORAL	20090826		NDA AUTHORIZED GENERIC	NDA018044	Sun Pharmaceutical Industries, Inc.	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
63304-241_ccc0e02b-bd1e-45f2-9256-6933ac193518	63304-241	HUMAN PRESCRIPTION DRUG	CALCITRIOL		CALCITRIOL	SOLUTION	ORAL	20090826		NDA AUTHORIZED GENERIC	NDA021068	Sun Pharmaceutical Industries, Inc.	CALCITRIOL	1	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
63304-351_f41dcc9c-49a0-4849-e053-2995a90ab9f4	63304-351	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Sun Pharmaceutical Industries, Inc.	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
63304-352_f41dcc9c-49a0-4849-e053-2995a90ab9f4	63304-352	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Sun Pharmaceutical Industries, Inc.	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
63304-440_d97c9e6a-01e9-46ae-9088-0ca86b4eb842	63304-440	HUMAN PRESCRIPTION DRUG	RISEDRONATE SODIUM		RISEDRONATE SODIUM	TABLET, DELAYED RELEASE	ORAL	20190710		ANDA	ANDA203925	Sun Pharmaceutical Industires Inc.	RISEDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
63304-443_08eb7fa6-bece-43e2-bed8-ef3d06a785a6	63304-443	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20150302		ANDA	ANDA201748	Sun Pharmaceutical Industries, Inc.	FENOFIBRATE	43	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63304-444_08eb7fa6-bece-43e2-bed8-ef3d06a785a6	63304-444	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20150302		ANDA	ANDA201748	Sun Pharmaceutical Industries, Inc.	FENOFIBRATE	130	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63304-448_5f5e6f81-fe5a-4ad6-be4e-0cf5f28a0f00	63304-448	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20180601		ANDA	ANDA200884	Sun Pharmaceutical Industries, Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63304-449_5f5e6f81-fe5a-4ad6-be4e-0cf5f28a0f00	63304-449	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20180601		ANDA	ANDA200884	Sun Pharmaceutical Industries, Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63304-450_39a0166a-c2ca-47bf-8654-85e0a431b9a0	63304-450	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Sun Pharmaceutical Industries, Inc.	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63304-451_39a0166a-c2ca-47bf-8654-85e0a431b9a0	63304-451	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Sun Pharmaceutical Industries, Inc.	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63304-452_39a0166a-c2ca-47bf-8654-85e0a431b9a0	63304-452	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Sun Pharmaceutical Industries, Inc.	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63304-453_39a0166a-c2ca-47bf-8654-85e0a431b9a0	63304-453	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Sun Pharmaceutical Industries, Inc.	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63304-458_ad113c32-f57c-4548-9882-c46b9a990bd8	63304-458	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Sun Pharmaceutical Industries, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63304-459_ad113c32-f57c-4548-9882-c46b9a990bd8	63304-459	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Sun Pharmaceutical Industries, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63304-479_558c3230-3788-4ef0-a5b5-3c06870317a9	63304-479	HUMAN PRESCRIPTION DRUG	Cevimeline		Cevimeline	CAPSULE	ORAL	20160310	20270430	NDA	NDA020989	Sun Pharmaceutical Industries, Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	
63304-497_4f875c7a-4454-45a2-bf55-fcc2932c51db	63304-497	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180731		ANDA	ANDA040826	Sun Pharmaceutical Industries, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63304-506_48ee2bd7-f7c9-4bf8-8932-ba9065c64cf3	63304-506	HUMAN PRESCRIPTION DRUG	pentazocine and naloxone		pentazocine and naloxone	TABLET	ORAL	20180731		ANDA	ANDA075523	Sun Pharmaceutical Industries, Inc.	NALOXONE HYDROCHLORIDE; PENTAZOCINE	.5; 50	mg/1; mg/1	Competitive Opioid Antagonists [MoA], Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
63304-561_fdf3553d-5ed3-4a78-bf8b-a908e33699fe	63304-561	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	19800123		ANDA	ANDA087083	Sun Pharmaceutical Industries, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63304-562_fdf3553d-5ed3-4a78-bf8b-a908e33699fe	63304-562	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	19781116		ANDA	ANDA085868	Sun Pharmaceutical Industries, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63304-583_5d53a971-671a-4ca6-87f8-2a629099eca7	63304-583	HUMAN PRESCRIPTION DRUG	Fosamprenavir Calcium		Fosamprenavir Calcium	TABLET, COATED	ORAL	20191128		ANDA	ANDA204024	Sun Pharmaceutical Industries, Inc.	FOSAMPRENAVIR CALCIUM	700	mg/1	Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inducers [MoA], Protease Inhibitor [EPC]		N	20241231
63304-614_d87fed49-4d26-4c1e-a097-7922f0f4d967	63304-614	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	Sun Pharmaceutical Industries, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63304-615_d87fed49-4d26-4c1e-a097-7922f0f4d967	63304-615	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	Sun Pharmaceutical Industries, Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63304-616_d87fed49-4d26-4c1e-a097-7922f0f4d967	63304-616	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	Sun Pharmaceutical Industries, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63304-632_db910c53-3c87-40cb-b799-53bbb95a983c	63304-632	HUMAN PRESCRIPTION DRUG	Fluoxetine		fluoxetine	CAPSULE	ORAL	20180816		ANDA	ANDA076990	Sun Pharmaceutical Industries, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63304-643_8c155c45-e5c8-4358-90da-8f6d193ad88b	63304-643	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100806		ANDA	ANDA078474	Sun Pharmaceutical Industries, Inc.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63304-644_8c155c45-e5c8-4358-90da-8f6d193ad88b	63304-644	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100806		ANDA	ANDA078474	Sun Pharmaceutical Industries, Inc.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63304-692_d418323e-f235-443e-81b1-ce60d8c0b4b9	63304-692	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	Sun Pharmaceutical Industries, Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63304-693_d418323e-f235-443e-81b1-ce60d8c0b4b9	63304-693	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	Sun Pharmaceutical Industries, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63304-718_e419f648-fd63-4a90-be3c-0de9e4a0a147	63304-718	HUMAN PRESCRIPTION DRUG	Diltiazem hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181031		ANDA	ANDA203023	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63304-719_e419f648-fd63-4a90-be3c-0de9e4a0a147	63304-719	HUMAN PRESCRIPTION DRUG	Diltiazem hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181031		ANDA	ANDA203023	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63304-720_e419f648-fd63-4a90-be3c-0de9e4a0a147	63304-720	HUMAN PRESCRIPTION DRUG	Diltiazem hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181031		ANDA	ANDA203023	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63304-721_e419f648-fd63-4a90-be3c-0de9e4a0a147	63304-721	HUMAN PRESCRIPTION DRUG	Diltiazem hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181031		ANDA	ANDA203023	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63304-722_e419f648-fd63-4a90-be3c-0de9e4a0a147	63304-722	HUMAN PRESCRIPTION DRUG	Diltiazem hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181031		ANDA	ANDA203023	Sun Pharmaceutical Industries, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63304-723_b77986dd-a843-40a4-bd08-563cde4e289b	63304-723	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201209		ANDA	ANDA200216	Sun Pharmaceutical Industries, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63304-724_87fade5a-b4db-44c8-811a-2924b7341386	63304-724	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210101		ANDA	ANDA203650	Sun Pharmaceutical Industries, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63304-734_3b641a6e-5f36-4db9-b1bf-777a2a4c1894	63304-734	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180531		ANDA	ANDA209735	Sun Pharmaceutical Industries, Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63304-735_3b641a6e-5f36-4db9-b1bf-777a2a4c1894	63304-735	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180531		ANDA	ANDA209735	Sun Pharmaceutical Industries, Inc	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63304-740_6ac3f3a4-98df-4eb3-9b9e-c85253811b85	63304-740	HUMAN OTC DRUG	Esomeprazole		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191130		ANDA	ANDA212866	Sun Pharmaceutical Industries, Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63304-758_39a0166a-c2ca-47bf-8654-85e0a431b9a0	63304-758	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Sun Pharmaceutical Industries, Inc.	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63304-772_b8fbb599-96d9-4866-908d-d8be424e5ee3	63304-772	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230625		ANDA	ANDA076045	SUN PHARMACEUTICAL INDUSTRIES INC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63304-773_b8fbb599-96d9-4866-908d-d8be424e5ee3	63304-773	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230625		ANDA	ANDA076045	SUN PHARMACEUTICAL INDUSTRIES INC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63304-774_b8fbb599-96d9-4866-908d-d8be424e5ee3	63304-774	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230625		ANDA	ANDA076045	SUN PHARMACEUTICAL INDUSTRIES INC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63304-827_36c3fd4e-9aa1-4be1-93d9-a130be6c1f34	63304-827	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Sun Pharmaceutical Industries Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63304-828_36c3fd4e-9aa1-4be1-93d9-a130be6c1f34	63304-828	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Sun Pharmaceutical Industries Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63304-829_36c3fd4e-9aa1-4be1-93d9-a130be6c1f34	63304-829	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Sun Pharmaceutical Industries Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63304-830_36c3fd4e-9aa1-4be1-93d9-a130be6c1f34	63304-830	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Sun Pharmaceutical Industries Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63304-900_dff94094-9aa3-4233-90ff-816d0d249d59	63304-900	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200918		ANDA	ANDA076635	Sun Pharmaceutical Industries, Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63304-901_dff94094-9aa3-4233-90ff-816d0d249d59	63304-901	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200918		ANDA	ANDA076635	Sun Pharmaceutical Industries, Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63304-904_9421473a-6648-4b38-af49-6d6dd7011846	63304-904	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20201219		ANDA	ANDA076588	SUN PHARMACEUTICAL INDUSTRIES, INC.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63304-905_9421473a-6648-4b38-af49-6d6dd7011846	63304-905	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20201219		ANDA	ANDA076588	SUN PHARMACEUTICAL INDUSTRIES, INC.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63304-924_ccff8408-b71e-434b-96ce-42827aa6c362	63304-924	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Sun Pharmaceutical Industries, Inc	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63304-925_ccff8408-b71e-434b-96ce-42827aa6c362	63304-925	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Sun Pharmaceutical Industries, Inc	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63304-926_ccff8408-b71e-434b-96ce-42827aa6c362	63304-926	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Sun Pharmaceutical Industries, Inc	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63304-927_ccff8408-b71e-434b-96ce-42827aa6c362	63304-927	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Sun Pharmaceutical Industries, Inc	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63304-949_8c155c45-e5c8-4358-90da-8f6d193ad88b	63304-949	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100806		ANDA	ANDA077542	Sun Pharmaceutical Industries, Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63304-950_8c155c45-e5c8-4358-90da-8f6d193ad88b	63304-950	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100806		ANDA	ANDA077542	Sun Pharmaceutical Industries, Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63304-951_8c155c45-e5c8-4358-90da-8f6d193ad88b	63304-951	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100806		ANDA	ANDA077542	Sun Pharmaceutical Industries, Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63304-987_0a1f3d5d-13ce-97b3-e063-6394a90aa250	63304-987	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20231114		ANDA	ANDA076368	Sun Pharmaceutical Industries, Inc.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-010_48a57ed5-3809-49cc-a7ec-715e7e2c1720	63323-010	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000810		ANDA	ANDA062366	Fresenius Kabi USA, LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-010_9490c585-3fbd-34c9-e053-2995a90a0413	63323-010	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000810		ANDA	ANDA062366	Fresenius Kabi USA, LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-010_cf4327d0-9155-4a07-9c54-51592b66b817	63323-010	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000810		ANDA	ANDA062366	Fresenius Kabi USA, LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-011_9b005f1e-1e26-3cb7-e053-2995a90a1056	63323-011	HUMAN PRESCRIPTION DRUG	Chloramphenicol Sodium Succinate		CHLORAMPHENICOL SODIUM SUCCINATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010112		ANDA	ANDA062365	Fresenius Kabi USA, LLC	CHLORAMPHENICOL SODIUM SUCCINATE	1	g/10mL	Amphenicol-class Antibacterial [EPC], Amphenicols [EXT]		N	20241231
63323-012_1ea6fccc-d789-4560-a50e-a89f2126d7e5	63323-012	HUMAN PRESCRIPTION DRUG	Oxytocin		OXYTOCIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000810		NDA	NDA018248	Fresenius Kabi USA, LLC	OXYTOCIN	10	[USP'U]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
63323-012_94dce3c2-f6d5-45a3-bec9-81e54be4bd1e	63323-012	HUMAN PRESCRIPTION DRUG	Oxytocin		OXYTOCIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000810		NDA	NDA018248	Fresenius Kabi USA, LLC	OXYTOCIN	10	[USP'U]/mL	Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
63323-013_4739cdd2-8a24-4f67-9a9f-902e9c0f3457	63323-013	HUMAN PRESCRIPTION DRUG	Thiamine		THIAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000901		ANDA	ANDA080556	Fresenius Kabi USA, LLC	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
63323-013_963a1196-c752-d5d9-e053-2a95a90a5c50	63323-013	HUMAN PRESCRIPTION DRUG	Thiamine		THIAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000901		ANDA	ANDA080556	Fresenius Kabi USA, LLC	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
63323-013_ac61fd3b-9461-4bb1-b7eb-565128215109	63323-013	HUMAN PRESCRIPTION DRUG	Thiamine		THIAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000901		ANDA	ANDA080556	Fresenius Kabi USA, LLC	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
63323-024_fe8beed4-a8db-400e-834e-b5efe2f5af1c	63323-024	HUMAN PRESCRIPTION DRUG	Mannitol		MANNITOL	INJECTION, SOLUTION	INTRAVENOUS	20000319		ANDA	ANDA080677	Fresenius Kabi USA, LLC	MANNITOL	250	mg/mL	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
63323-030_efba422f-ed18-484b-a141-1ba2c3ec8175	63323-030	HUMAN PRESCRIPTION DRUG	Chorionic Gonadotropin		Chorionic Gonadotropin	KIT		20110421		BLA	BLA017067	Fresenius Kabi USA, LLC						N	20241231
63323-032_9b00cb54-42d1-c928-e053-2995a90abda6	63323-032	HUMAN PRESCRIPTION DRUG	SODIUM ACETATE		SODIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20171030		ANDA	ANDA206687	Fresenius Kabi USA, LLC	SODIUM ACETATE	4	meq/100mL			N	20241231
63323-044_2eb2a5f1-82c8-40bc-8f08-16fc124c6ad9	63323-044	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		CYANOCOBALAMIN	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20001018		ANDA	ANDA080557	Fresenius Kabi USA, LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
63323-044_30e9dd95-6543-49ab-ad1f-6714026ba156	63323-044	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		CYANOCOBALAMIN	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20001018		ANDA	ANDA080557	Fresenius Kabi USA, LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
63323-047_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-047	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19780210		NDA	NDA017651	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-064_331fa756-1a83-4b07-a373-486fbd0ca27a	63323-064	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000808		NDA	NDA019316	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-064_707416f2-9001-47fc-93f6-3c975cfa6b61	63323-064	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000808		NDA	NDA019316	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-064_ab836aa7-3157-415c-90e2-b144d586c37b	63323-064	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000808		NDA	NDA019316	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-083_fd39636a-d22c-4470-abbc-fe7c5db67679	63323-083	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20170728		UNAPPROVED DRUG OTHER		Fresensius Kabi USA, LLC	SODIUM BICARBONATE	42	mg/mL			N	20241231
63323-088_946c1f93-fea7-ed2b-e053-2995a90a42ec	63323-088	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20010112		UNAPPROVED DRUG OTHER		Fresenius Kabi USA, LLC	SODIUM CHLORIDE	234	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-089_fd39636a-d22c-4470-abbc-fe7c5db67679	63323-089	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20170728		UNAPPROVED DRUG OTHER		Fresensius Kabi USA, LLC	SODIUM BICARBONATE	84	mg/mL			N	20241231
63323-090_eb8f5fdb-b8da-4d67-a5e0-b2479bf38170	63323-090	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210428		ANDA	ANDA212070	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	2.5	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-093_570d0b0e-2f05-4b8b-af0f-ad8e7588aad9	63323-093	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210428		ANDA	ANDA212248	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	4	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-095_5db02ff9-4936-46b0-8fb5-3fc491895ae1	63323-095	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220214		ANDA	ANDA212070	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	4	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-099_f5197532-af45-42c9-919b-30d00276650e	63323-099	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230711		ANDA	ANDA217796	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	4	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-101_9b008181-ab33-db2f-e053-2995a90aad57	63323-101	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		DOXORUBICIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20000614		ANDA	ANDA063277	Fresenius Kabi USA, LLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
63323-102_239ba766-de5b-4268-8583-2d7e033849f2	63323-102	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110726		ANDA	ANDA090799	Fresenius Kabi USA, LLC	GEMCITABINE HYDROCHLORIDE	200	mg/5mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-102_4c447f74-d06c-459b-ba63-6b72aaf4fd2e	63323-102	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110726		ANDA	ANDA090799	Fresenius Kabi USA, LLC	GEMCITABINE HYDROCHLORIDE	200	mg/5mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-103_9b008181-ab66-db2f-e053-2995a90aad57	63323-103	HUMAN PRESCRIPTION DRUG	Cisplatin		CISPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20000905		ANDA	ANDA074735	Fresenius Kabi USA, LLC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
63323-104_d672a555-bb0e-4a82-ac5e-5c9393b59c28	63323-104	HUMAN PRESCRIPTION DRUG	Etoposide		ETOPOSIDE	INJECTION, SOLUTION	INTRAVENOUS	20010718		ANDA	ANDA074983	Fresenius Kabi USA, LLC	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
63323-106_5880dd4c-744d-4599-8d59-3ed8bfc467b0	63323-106	HUMAN PRESCRIPTION DRUG	magnesium sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20160315		ANDA	ANDA206485	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-106_cc5a330c-b7cd-4e07-9cab-311c51fd1d6f	63323-106	HUMAN PRESCRIPTION DRUG	magnesium sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20160315		ANDA	ANDA206485	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-107_5880dd4c-744d-4599-8d59-3ed8bfc467b0	63323-107	HUMAN PRESCRIPTION DRUG	magnesium sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20160315		ANDA	ANDA206485	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	80	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-108_43f17ef2-91b1-407a-9ede-a02796477d5c	63323-108	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in 5% Dextrose		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20160307		ANDA	ANDA206486	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-108_c81db490-9894-491f-a6c5-a127f252587b	63323-108	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in 5% Dextrose		Magnesium Sulfate Heptahydrate	INJECTION, SOLUTION	INTRAVENOUS	20160307		ANDA	ANDA206486	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-113_5fe83fb0-2b64-40a2-a996-aaa6292e661e	63323-113	HUMAN PRESCRIPTION DRUG	Pentam 300		PENTAMIDINE ISETHIONATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010116		NDA	NDA019264	Fresenius Kabi USA, LLC	PENTAMIDINE ISETHIONATE	300	mg/3mL	Antiprotozoal [EPC]		N	20241231
63323-117_35070b81-d97b-46c3-8649-083cbfbc1ad1	63323-117	HUMAN PRESCRIPTION DRUG	Fluorouracil		FLUOROURACIL	INJECTION, SOLUTION	INTRAVENOUS	20000712		ANDA	ANDA040278	Fresenius Kabi USA, LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-117_3951b642-04cc-4936-9547-7c3d2a5951b0	63323-117	HUMAN PRESCRIPTION DRUG	Fluorouracil		FLUOROURACIL	INJECTION, SOLUTION	INTRAVENOUS	20000712		ANDA	ANDA040279	Fresenius Kabi USA, LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-117_aae047b8-627c-4d29-b4da-85dd4f6d4ea1	63323-117	HUMAN PRESCRIPTION DRUG	Fluorouracil		FLUOROURACIL	INJECTION, SOLUTION	INTRAVENOUS	20000712		ANDA	ANDA040279	Fresenius Kabi USA, LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-117_bb530f92-6ccf-443a-a5d3-64f28cc14956	63323-117	HUMAN PRESCRIPTION DRUG	Fluorouracil		FLUOROURACIL	INJECTION, SOLUTION	INTRAVENOUS	20000712		ANDA	ANDA040278	Fresenius Kabi USA, LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-117_c9948b3e-6a20-46a8-b8af-bd4a15e728f7	63323-117	HUMAN PRESCRIPTION DRUG	Fluorouracil		FLUOROURACIL	INJECTION, SOLUTION	INTRAVENOUS	20170102		ANDA	ANDA040279	Fresenius Kabi USA, LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-117_f33f3a7f-29f9-4b9f-b97d-58fb1fc92145	63323-117	HUMAN PRESCRIPTION DRUG	Fluorouracil		FLUOROURACIL	INJECTION, SOLUTION	INTRAVENOUS	20000712		ANDA	ANDA040278	Fresenius Kabi USA, LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-118_8ecd0ddb-06a5-46b9-954d-d66c0935105a	63323-118	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20181116		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/.5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-120_88adbc49-b19d-44af-8f0b-a563bbb02aec	63323-120	HUMAN PRESCRIPTION DRUG	Cytarabine		CYTARABINE	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20041129		ANDA	ANDA076512	Fresenius Kabi USA, LLC	CYTARABINE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-122_10ac151e-e0da-4686-b2a1-c706982e777a	63323-122	HUMAN PRESCRIPTION DRUG	Methotrexate		METHOTREXATE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20000122		ANDA	ANDA040266	Fresenius Kabi USA, LLC	METHOTREXATE SODIUM	1	g/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
63323-123_880c2caa-1b11-45ce-a54e-a3733da367f0	63323-123	HUMAN PRESCRIPTION DRUG	Methotrexate		METHOTREXATE SODIUM	INJECTION, SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS	20010910		ANDA	ANDA040263	Fresenius Kabi USA, LLC	METHOTREXATE SODIUM	25	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
63323-125_239ba766-de5b-4268-8583-2d7e033849f2	63323-125	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110726		ANDA	ANDA090799	Fresenius Kabi USA, LLC	GEMCITABINE HYDROCHLORIDE	1	g/25mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-125_4c447f74-d06c-459b-ba63-6b72aaf4fd2e	63323-125	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110726		ANDA	ANDA090799	Fresenius Kabi USA, LLC	GEMCITABINE HYDROCHLORIDE	1	g/25mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-126_239ba766-de5b-4268-8583-2d7e033849f2	63323-126	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110726		ANDA	ANDA090799	Fresenius Kabi USA, LLC	GEMCITABINE HYDROCHLORIDE	2	g/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-126_a71908f7-538a-4ed0-ad61-f91899e5e5bc	63323-126	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110517		ANDA	ANDA090242	Fresenius Kabi USA, LLC	GEMCITABINE HYDROCHLORIDE	2	g/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-127_04644165-06c9-4a55-a026-a529d824cc90	63323-127	HUMAN PRESCRIPTION DRUG	Dacarbazine		DACARBAZINE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20010907		ANDA	ANDA075371	Fresenius Kabi USA, LLC	DACARBAZINE	10	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
63323-128_04644165-06c9-4a55-a026-a529d824cc90	63323-128	HUMAN PRESCRIPTION DRUG	Dacarbazine		DACARBAZINE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20010907		ANDA	ANDA075371	Fresenius Kabi USA, LLC	DACARBAZINE	10	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
63323-130_22ec807c-14e3-4b73-baa8-931ade7d3203	63323-130	HUMAN PRESCRIPTION DRUG	Doxy 100		DOXYCYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20001017		ANDA	ANDA062475	Fresenius Kabi USA, LLC	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63323-130_3a246ad7-ff63-4e8c-9030-32074a78dc78	63323-130	HUMAN PRESCRIPTION DRUG	Doxy 100		DOXYCYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20001017		ANDA	ANDA062475	Fresenius Kabi USA, LLC	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63323-130_b4654993-19ce-4911-a0d0-4836f357223d	63323-130	HUMAN PRESCRIPTION DRUG	Doxy 100		DOXYCYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20001017		ANDA	ANDA062475	Fresenius Kabi USA, LLC	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63323-132_9b009bb2-02c2-d844-e053-2a95a90a242c	63323-132	HUMAN PRESCRIPTION DRUG	Mitoxantrone		MITOXANTRONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20060411		ANDA	ANDA077496	Fresenius Kabi USA, LLC	MITOXANTRONE HYDROCHLORIDE	2	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
63323-134_d2e3def4-a49f-4810-ab4e-f7edebefa210	63323-134	HUMAN PRESCRIPTION DRUG	Pemetrexed		PEMETREXED DISODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA090384	Fresenius Kabi USA, LLC	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
63323-136_9b00b242-432b-502e-e053-2a95a90a1155	63323-136	HUMAN PRESCRIPTION DRUG	Bleomycin		BLEOMYCIN SULFATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20090213		ANDA	ANDA065185	Fresenius Kabi USA, LLC	BLEOMYCIN SULFATE	15	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
63323-137_9b00b242-432b-502e-e053-2a95a90a1155	63323-137	HUMAN PRESCRIPTION DRUG	Bleomycin		BLEOMYCIN SULFATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20090213		ANDA	ANDA065185	Fresenius Kabi USA, LLC	BLEOMYCIN SULFATE	30	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
63323-139_946c3735-c530-46c5-e053-2a95a90ae5af	63323-139	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20000906		UNAPPROVED DRUG OTHER		Fresenius Kabi USA, LLC	SODIUM CHLORIDE	146	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-140_9b00e23f-d8e3-87f7-e053-2995a90a038f	63323-140	HUMAN PRESCRIPTION DRUG	Cladribine		CLADRIBINE	INJECTION	INTRAVENOUS	20041201		ANDA	ANDA076571	Fresenius Kabi USA, LLC	CLADRIBINE	1	mg/mL	Purine Antimetabolite [EPC]		N	20241231
63323-142_94929aec-97bb-7741-e053-2995a90ac45d	63323-142	HUMAN PRESCRIPTION DRUG	Ifosfamide		IFOSFAMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20030128		ANDA	ANDA076078	Fresenius Kabi USA, LLC	IFOSFAMIDE	1	g/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
63323-142_bd16ccc0-ad9d-4e40-987e-3228181a5ae5	63323-142	HUMAN PRESCRIPTION DRUG	Ifosfamide		IFOSFAMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20030128		ANDA	ANDA076078	Fresenius Kabi USA, LLC	IFOSFAMIDE	1	g/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
63323-145_9b00ef55-2f80-a983-e053-2995a90a45ab	63323-145	HUMAN PRESCRIPTION DRUG	Floxuridine		FLOXURIDINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRA-ARTERIAL	20010315		ANDA	ANDA075837	Fresenius Kabi USA, LLC	FLOXURIDINE	500	mg/5mL	Antimetabolite [EPC], Deoxyuridine [CS]		N	20241231
63323-161_187f0b93-0e0a-4259-a5aa-01fb7eb6ab2e	63323-161	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA075784	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-161_2b1c6066-d9e0-40a0-ade5-776fc35a3626	63323-161	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA075784	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-161_55ed7afb-db66-4b28-939b-db45b55bf058	63323-161	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA075784	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-162_187f0b93-0e0a-4259-a5aa-01fb7eb6ab2e	63323-162	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20001018		ANDA	ANDA075784	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-162_2b1c6066-d9e0-40a0-ade5-776fc35a3626	63323-162	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20001018		ANDA	ANDA075784	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-162_55ed7afb-db66-4b28-939b-db45b55bf058	63323-162	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20001018		ANDA	ANDA075784	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-164_4cb18985-3412-411e-8501-450512d84b72	63323-164	HUMAN PRESCRIPTION DRUG	LACTATED RINGERS		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190128		ANDA	ANDA209338	Fresenius Kabi USA, LLC	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-165_959909f1-5258-9792-e053-2995a90ae799	63323-165	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000907		ANDA	ANDA084916	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-165_db7f0736-ea5b-4b8c-92bb-a8353b033480	63323-165	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000907		ANDA	ANDA084916	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-170_38669b97-6c71-410e-bccc-a991a25ff64f	63323-170	HUMAN PRESCRIPTION DRUG	Sodium Phosphates		SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20000906		UNAPPROVED DRUG OTHER		Fresenius Kabi USA, LLC	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	142; 276	mg/mL; mg/mL			N	20241231
63323-172_3a1dd588-13b0-4d58-8d46-3a25a4fc6b40	63323-172	HUMAN PRESCRIPTION DRUG	Carboplatin		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20091211		ANDA	ANDA077266	Fresenius Kabi USA, LLC	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
63323-173_9496154c-0fb5-f0b6-e053-2a95a90a3f56	63323-173	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041129		ANDA	ANDA062366	Fresenius Kabi USA, LLC	GENTAMICIN SULFATE	10	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-173_aa0e7e88-2ae5-4527-888b-983fb4580ac2	63323-173	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041129		ANDA	ANDA062366	Fresenius Kabi USA, LLC	GENTAMICIN SULFATE	10	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
63323-173_b5dcfd7a-3a61-404f-80b4-0876ba1076db	63323-173	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041129		ANDA	ANDA062366	Fresenius Kabi USA, LLC	GENTAMICIN SULFATE	10	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-178_d40f0ff2-4abf-4030-b4e1-2b85ad7448a0	63323-178	HUMAN PRESCRIPTION DRUG	Sterile Water		Water	INJECTION, SOLUTION	INTRAVENOUS	20171124		ANDA	ANDA209689	Fresenius Kabi USA, LLC	WATER	1000	mL/1000mL			N	20241231
63323-180_969dd6dd-de7a-9b65-e053-2a95a90aaa5e	63323-180	HUMAN PRESCRIPTION DRUG	Pyridoxine Hydrochloride		PYRIDOXINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19720814		ANDA	ANDA080618	Fresenius Kabi USA, LLC	PYRIDOXINE HYDROCHLORIDE	100	mg/mL	Analogs/Derivatives [Chemical/Ingredient], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
63323-184_9b00ff97-07fb-0b68-e053-2a95a90a6bcc	63323-184	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20000905		ANDA	ANDA089202	Fresenius Kabi USA, LLC	FOLIC ACID	5	mg/mL			N	20241231
63323-185_42c6c812-706a-425b-b8cb-931006e40484	63323-185	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20000905		ANDA	ANDA088400	Fresenius Kabi USA, LLC	WATER	1	mL/mL			N	20241231
63323-186_75c567e3-582b-4fff-9a72-f326f1d13c8f	63323-186	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION	INTRAVENOUS	20000810		ANDA	ANDA088912	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-186_946c72c9-cdec-f185-e053-2995a90ad1bf	63323-186	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20000810		UNAPPROVED DRUG OTHER		Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-187_946d321a-eccd-5144-e053-2995a90afa2e	63323-187	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20000905		UNAPPROVED DRUG OTHER		Fresenius Kabi USA, LLC	SODIUM CHLORIDE	234	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-192_9b00feb3-d0d2-12ab-e053-2a95a90ad9f3	63323-192	HUMAN PRESCRIPTION DRUG	Fludarabine		FLUDARABINE PHOSPHATE	INJECTION, SOLUTION	INTRAVENOUS	20071116		ANDA	ANDA078393	Fresenius Kabi USA, LLC	FLUDARABINE PHOSPHATE	25	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-193_4e0a18c8-35aa-447c-bd91-b81d7d494d8e	63323-193	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		IRINOTECAN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20090401		ANDA	ANDA077776	Fresenius Kabi USA, LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
63323-201_161e4a7d-3a57-4474-88aa-cc669a019f0d	63323-201	HUMAN PRESCRIPTION DRUG	Lidocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100527		ANDA	ANDA080404	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-201_dd2f27a5-ff6d-4363-b5a7-0020f17fb695	63323-201	HUMAN PRESCRIPTION DRUG	Lidocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100527		ANDA	ANDA088586	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-202_161e4a7d-3a57-4474-88aa-cc669a019f0d	63323-202	HUMAN PRESCRIPTION DRUG	Lidocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100527		ANDA	ANDA080404	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-203_2e1e9deb-9c6d-4751-922f-28f53b70d0c0	63323-203	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160817		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	750	mg/15mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-203_db804e44-1a81-43d5-b6ba-abe6ea15ac99	63323-203	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160817		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	750	mg/15mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-205_10a23baf-3b3c-4dad-96c9-804804b3f70b	63323-205	HUMAN PRESCRIPTION DRUG	Omegaven		Fish oil	INJECTION, EMULSION	INTRAVENOUS	20180727		NDA	NDA210589	Fresenius Kabi USA, LLC	FISH OIL	.1	g/mL			N	20241231
63323-208_b53e13a1-a61f-46ab-b8ba-40871a833535	63323-208	HUMAN PRESCRIPTION DRUG	Lidocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20000905		NDA	NDA017584	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-221_0ab54d7b-de6b-412f-b2b5-a8522f78f3c4	63323-221	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171101		ANDA	ANDA204107	Fresenius Kabi, LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-221_23a89459-d331-4975-84fe-4bfa6ed2c24e	63323-221	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171026		ANDA	ANDA204107	Fresenius Kabi, LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-221_c96ea8a6-2a89-4819-9193-8eefae67e244	63323-221	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210503		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-221_db804e44-1a81-43d5-b6ba-abe6ea15ac99	63323-221	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20000901		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-229_083a416a-ff54-43a2-b621-c4cf7a30b464	63323-229	HUMAN PRESCRIPTION DRUG	Protamine Sulfate		PROTAMINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20001018		ANDA	ANDA089454	Fresenius Kabi USA, LLC	PROTAMINE SULFATE	10	mg/mL	Heparin Binding Activity [MoA], Heparin Reversal Agent [EPC], Reversed Anticoagulation Activity [PE]		N	20241231
63323-229_6405e200-c2e3-4200-b58a-6d235efd9dba	63323-229	HUMAN PRESCRIPTION DRUG	Protamine Sulfate		PROTAMINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20001018		ANDA	ANDA089454	Fresenius Kabi USA, LLC	PROTAMINE SULFATE	10	mg/mL	Heparin Binding Activity [MoA], Heparin Reversal Agent [EPC], Reversed Anticoagulation Activity [PE]		N	20241231
63323-229_9b01b466-fba5-f255-e053-2995a90ac92d	63323-229	HUMAN PRESCRIPTION DRUG	Protamine Sulfate		PROTAMINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20001018		ANDA	ANDA089454	Fresenius Kabi USA, LLC	PROTAMINE SULFATE	10	mg/mL	Heparin Binding Activity [MoA], Heparin Reversal Agent [EPC], Reversed Anticoagulation Activity [PE]		N	20241231
63323-236_321ffc80-ee94-4a86-8c33-e966438d9fbb	63323-236	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		CEFAZOLIN SODIUM	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110715		ANDA	ANDA065303	Fresenius Kabi USA, LLC	CEFAZOLIN SODIUM	500	mg/2.2mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-237_321ffc80-ee94-4a86-8c33-e966438d9fbb	63323-237	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		CEFAZOLIN SODIUM	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110715		ANDA	ANDA065303	Fresenius Kabi USA, LLC	CEFAZOLIN SODIUM	1	g/3mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-238_9684b8e0-7438-41d9-89e1-b217b5568360	63323-238	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin Sodium	POWDER, FOR SOLUTION	INTRAVENOUS	20110614		ANDA	ANDA065306	Fresenius Kabi USA, LLC	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-241_aeed61b6-c0c3-416d-be37-991dd58a4950	63323-241	HUMAN PRESCRIPTION DRUG	Glycophos		SODIUM GLYCOLATE	INJECTION, SOLUTION	INTRAVENOUS	20130513		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Fresenius Kabi USA, LLC	SODIUM GLYCEROPHOSPHATE ANHYDROUS	216	mg/mL			N	20241231
63323-255_dc369096-3042-4942-9aeb-bbdf98f35bb8	63323-255	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		METHYLPREDNISOLONE SODIUM SUCCINATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041130		ANDA	ANDA040583	Fresenius Kabi USA, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-258_dc369096-3042-4942-9aeb-bbdf98f35bb8	63323-258	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		METHYLPREDNISOLONE SODIUM SUCCINATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041130		ANDA	ANDA040583	Fresenius Kabi USA, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-260_b3d50315-0f09-4294-a788-990036dfc45c	63323-260	HUMAN PRESCRIPTION DRUG	Polocaine-MPF		MEPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20090720		ANDA	ANDA089406	Fresenius Kabi USA, LLC	MEPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-261_9b01a2e5-5aea-2dbe-e053-2995a90a9b54	63323-261	HUMAN PRESCRIPTION DRUG	Progesterone		PROGESTERONE	INJECTION, SOLUTION	INTRAMUSCULAR	20010719		ANDA	ANDA075906	Fresenius Kabi USA, LLC	PROGESTERONE	50	mg/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
63323-262_2f22758f-1fa9-450c-bee9-568f12a1997f	63323-262	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200325		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-262_348567ec-3cce-4ba2-b1ef-49f50eac863a	63323-262	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200302		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-262_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-262	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-262_bf214cba-c4af-402f-b265-fe4d26d778f7	63323-262	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-265_dc369096-3042-4942-9aeb-bbdf98f35bb8	63323-265	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		METHYLPREDNISOLONE SODIUM SUCCINATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041130		ANDA	ANDA040612	Fresenius Kabi USA, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	1	g/16mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-269_1ff4b98f-58e4-4d0b-bede-0754c436f10f	63323-269	HUMAN PRESCRIPTION DRUG	Diprivan		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20091113		NDA	NDA019627	Fresenius Kabi USA, LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
63323-269_cc87948e-1a93-4c4b-ab1d-3b450a27f92d	63323-269	HUMAN PRESCRIPTION DRUG	Diprivan		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20091113		NDA	NDA019627	Fresenius Kabi USA, LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
63323-269_ec65aaa3-0cec-4fcf-b935-6d2c8db7da6b	63323-269	HUMAN PRESCRIPTION DRUG	Diprivan		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20091117		NDA	NDA019627	Fresenius Kabi USA, LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
63323-269_f4e2c0a2-0e30-4235-861b-9cd149ad5570	63323-269	HUMAN PRESCRIPTION DRUG	Diprivan		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20091113		NDA	NDA019627	Fresenius Kabi USA, LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
63323-272_9b00feb3-d0fb-12ab-e053-2a95a90ad9f3	63323-272	HUMAN PRESCRIPTION DRUG	Fluphenazine Decanoate		FLUPHENAZINE DECANOATE	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20101215		ANDA	ANDA071413	Fresenius Kabi USA, LLC	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63323-273_3e2e024a-7495-4a67-8969-df26411eaee8	63323-273	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20110412		ANDA	ANDA079242	Fresenius Kabi USA, LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63323-276_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-276	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-278_9b01b466-fbca-f255-e053-2995a90ac92d	63323-278	HUMAN PRESCRIPTION DRUG	Vinblastine Sulfate		VINBLASTINE SULFATE	INJECTION	INTRAVENOUS	20000712		ANDA	ANDA089515	Fresenius Kabi USA, LLC	VINBLASTINE SULFATE	1	mg/mL	Vinca Alkaloid [EPC], Vinca Alkaloids [CS]		N	20241231
63323-280_b76097ac-8d65-4a26-8656-d19870240f1f	63323-280	HUMAN PRESCRIPTION DRUG	Furosemide		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000712		NDA	NDA018902	Fresenius Kabi USA, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
63323-280_f174b84c-3a81-40f0-b445-63d14e525bbb	63323-280	HUMAN PRESCRIPTION DRUG	Furosemide		FUROSEMIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000712		NDA	NDA018902	Fresenius Kabi USA, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63323-281_9b015c66-e960-0b6c-e053-2a95a90a2071	63323-281	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		FLUPHENAZINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR	20101228		ANDA	ANDA089556	Fresenius Kabi USA, LLC	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63323-282_0303c92f-8410-4f12-b31f-f98ef869ecb4	63323-282	HUMAN PRESCRIPTION DRUG	Clindamycin		CLINDAMYCIN PHOSPHATE	INJECTION, SOLUTION	INTRAVENOUS	20091122		ANDA	ANDA065346	Fresenius Kabi USA, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
63323-282_96b5fe3f-ff7c-cefa-e053-2995a90aec4c	63323-282	HUMAN PRESCRIPTION DRUG	Clindamycin		CLINDAMYCIN PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091122		ANDA	ANDA065347	Fresenius Kabi USA, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
63323-283_b3d50315-0f09-4294-a788-990036dfc45c	63323-283	HUMAN PRESCRIPTION DRUG	Polocaine		MEPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20090720		ANDA	ANDA089407	Fresenius Kabi USA, LLC	MEPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-284_23a89459-d331-4975-84fe-4bfa6ed2c24e	63323-284	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171026		ANDA	ANDA204107	Fresenius Kabi, LLC	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-284_94a2bef0-c803-5ce1-e053-2995a90a1c11	63323-284	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20000920		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-284_c96ea8a6-2a89-4819-9193-8eefae67e244	63323-284	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210503		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-284_db804e44-1a81-43d5-b6ba-abe6ea15ac99	63323-284	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20000920		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-285_0a867cf6-2e82-42c5-9cfc-a481cec305c9	63323-285	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20090804		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-285_5e96a969-4311-40c8-a7fc-7859426b9ae2	63323-285	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	19960924		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-285_acccb950-aad9-4602-8d4d-ac546ebee07a	63323-285	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20090804		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-286_0a867cf6-2e82-42c5-9cfc-a481cec305c9	63323-286	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20090804		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-286_5e96a969-4311-40c8-a7fc-7859426b9ae2	63323-286	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	19960924		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-286_acccb950-aad9-4602-8d4d-ac546ebee07a	63323-286	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; PERINEURAL	20090804		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-287_5e96a969-4311-40c8-a7fc-7859426b9ae2	63323-287	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; PERINEURAL	19960924		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-288_1f70dfce-5103-465e-b276-1cb838c70637	63323-288	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL	19960924		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-288_5e96a969-4311-40c8-a7fc-7859426b9ae2	63323-288	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL	19960924		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-288_acccb950-aad9-4602-8d4d-ac546ebee07a	63323-288	HUMAN PRESCRIPTION DRUG	Naropin		ROPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL	20090804		NDA	NDA020533	Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-293_b3d50315-0f09-4294-a788-990036dfc45c	63323-293	HUMAN PRESCRIPTION DRUG	Polocaine-MPF		MEPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20090721		ANDA	ANDA089408	Fresenius Kabi USA, LLC	MEPIVACAINE HYDROCHLORIDE	15	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-294_b3d50315-0f09-4294-a788-990036dfc45c	63323-294	HUMAN PRESCRIPTION DRUG	Polocaine-MPF		MEPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20090721		ANDA	ANDA089409	Fresenius Kabi USA, LLC	MEPIVACAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-295_020618ad-8f1f-4189-a95c-254f05a077cc	63323-295	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010717		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-295_61ca1076-563b-48b2-9632-4f9a88f7639a	63323-295	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20010717		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-296_b3d50315-0f09-4294-a788-990036dfc45c	63323-296	HUMAN PRESCRIPTION DRUG	Polocaine		MEPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20090720		ANDA	ANDA089410	Fresenius Kabi USA, LLC	MEPIVACAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-300_9b0228ed-82ac-724a-e053-2995a90a9932	63323-300	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-300_9b0228ed-82e8-724a-e053-2995a90a9932	63323-300	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-303_94a2dea5-ef2b-7f8f-e053-2995a90abecb	63323-303	HUMAN PRESCRIPTION DRUG	Tobramycin		TOBRAMYCIN SULFATE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20051123		NDA	NDA050789	Fresenius Kabi USA, LLC	TOBRAMYCIN SULFATE	1200	mg/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-303_eac796f4-8d7d-4afe-a633-2f4d37eff738	63323-303	HUMAN PRESCRIPTION DRUG	Tobramycin		TOBRAMYCIN SULFATE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20051123		NDA	NDA050789	Fresenius Kabi USA, LLC	TOBRAMYCIN SULFATE	1200	mg/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-304_3818dc40-bb84-4f61-a461-a572125fce30	63323-304	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20110531		ANDA	ANDA090498	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-304_69f5d2eb-3621-4ae9-bf66-b2f14d0275f9	63323-304	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20110531		ANDA	ANDA090498	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-304_97b27b0f-1296-4912-84eb-576679be97d1	63323-304	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20110531		ANDA	ANDA090498	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-305_b4f95f7c-c96d-4314-801b-2bb56dde25e4	63323-305	HUMAN PRESCRIPTION DRUG	Tobramycin		TOBRAMYCIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041130		ANDA	ANDA065122	Fresenius Kabi USA, LLC	TOBRAMYCIN SULFATE	10	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-306_99498141-70fe-c243-e053-2a95a90ab23a	63323-306	HUMAN PRESCRIPTION DRUG	Tobramycin		TOBRAMYCIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051123		ANDA	ANDA065122	Fresenius Kabi USA, LLC	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-306_b4f95f7c-c96d-4314-801b-2bb56dde25e4	63323-306	HUMAN PRESCRIPTION DRUG	Tobramycin		TOBRAMYCIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051123		ANDA	ANDA065122	Fresenius Kabi USA, LLC	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-307_f600dca6-dba3-4c03-8d55-15f8dbd467fa	63323-307	HUMAN PRESCRIPTION DRUG	Tobramycin		TOBRAMYCIN SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20041130		ANDA	ANDA065120	Fresenius Kabi USA, LLC	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-309_9b0228ed-82ac-724a-e053-2995a90a9932	63323-309	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-309_9b0228ed-82e8-724a-e053-2995a90a9932	63323-309	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-314_020618ad-8f1f-4189-a95c-254f05a077cc	63323-314	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20041130		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	10	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-314_61ca1076-563b-48b2-9632-4f9a88f7639a	63323-314	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20041130		ANDA	ANDA062663	Fresenius Kabi USA, LLC	VANCOMYCIN HYDROCHLORIDE	10	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-314_d11a86ee-15b0-49cf-880a-f4b3b70e22cf	63323-314	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170901		ANDA	ANDA204125	Fresenius Kabi, LLC	VANCOMYCIN HYDROCHLORIDE	10	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63323-315_5f2d460e-f4cc-41fe-869a-43422caad85f	63323-315	HUMAN PRESCRIPTION DRUG	Ganciclovir		GANCICLOVIR SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100628		ANDA	ANDA090658	Fresenius Kabi USA, LLC	GANCICLOVIR SODIUM	500	mg/10mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
63323-315_6a576726-9413-47b3-aa25-145102205642	63323-315	HUMAN PRESCRIPTION DRUG	Ganciclovir		GANCICLOVIR SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100628		ANDA	ANDA090658	Fresenius Kabi USA, LLC	GANCICLOVIR SODIUM	500	mg/10mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
63323-318_fd73c3f4-aa7d-4c2f-ab74-1883910ea086	63323-318	HUMAN PRESCRIPTION DRUG	Granisetron		GRANISETRON HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20091120		ANDA	ANDA078096	Fresenius Kabi USA, LLC	GRANISETRON HYDROCHLORIDE	1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63323-319_fd73c3f4-aa7d-4c2f-ab74-1883910ea086	63323-319	HUMAN PRESCRIPTION DRUG	Granisetron		GRANISETRON HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20091120	20240531	ANDA	ANDA078090	Fresenius Kabi USA, LLC	GRANISETRON HYDROCHLORIDE	1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
63323-320_9b0228ed-82ac-724a-e053-2995a90a9932	63323-320	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-320_9b0228ed-82e8-724a-e053-2995a90a9932	63323-320	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN SODIUM,TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20091013		ANDA	ANDA065523	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-321_545b3d1d-6c8f-44aa-b81e-b24fc99f9c82	63323-321	HUMAN PRESCRIPTION DRUG	POLYMYXIN B		POLYMYXIN B SULFATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	20091117		ANDA	ANDA065372	Fresenius Kabi USA, LLC	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63323-321_b473292e-e7ce-4ce2-aec7-91604b82bb11	63323-321	HUMAN PRESCRIPTION DRUG	POLYMYXIN B		POLYMYXIN B SULFATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	20091117		ANDA	ANDA065372	Fresenius Kabi USA, LLC	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63323-322_2bb9b6ad-8e8d-4667-b108-b57a8c16318f	63323-322	HUMAN PRESCRIPTION DRUG	Imipenem and Cilastatin		Imipenem and Cilastatin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120103		ANDA	ANDA090577	Fresenius Kabi USA, LLC	CILASTATIN SODIUM; IMIPENEM	500; 500	mg/20mL; mg/20mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
63323-322_68d30458-8cd9-4fbe-9215-f36dec6c733b	63323-322	HUMAN PRESCRIPTION DRUG	Imipenem and Cilastatin		Imipenem and Cilastatin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120103		ANDA	ANDA090577	Fresenius Kabi USA, LLC	CILASTATIN SODIUM; IMIPENEM	500; 500	mg/20mL; mg/20mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
63323-322_fb64108d-9be7-4eef-9395-74c782e3a3c0	63323-322	HUMAN PRESCRIPTION DRUG	Imipenem and Cilastatin		Imipenem and Cilastatin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120103		ANDA	ANDA090577	Fresenius Kabi USA, LLC	CILASTATIN SODIUM; IMIPENEM	500; 500	mg/20mL; mg/20mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
63323-325_8a5d3c2f-956a-4030-a37e-f0407a853d65	63323-325	HUMAN PRESCRIPTION DRUG	Acyclovir		ACYCLOVIR SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20001017		ANDA	ANDA074930	Fresenius Kabi USA, LLC	ACYCLOVIR SODIUM	50	mg/mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63323-325_de8b8fa7-d773-4983-a881-55f3a73d8442	63323-325	HUMAN PRESCRIPTION DRUG	Acyclovir		ACYCLOVIR SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20001017		ANDA	ANDA074930	Fresenius Kabi USA, LLC	ACYCLOVIR SODIUM	50	mg/mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63323-326_8c2fbf43-34bd-49d1-bda8-a2191c8bc54b	63323-326	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100830		ANDA	ANDA065441	Fresenius Kabi USA, LLC	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-327_89168d2d-2dc0-3f50-e053-2a95a90a31be	63323-327	HUMAN PRESCRIPTION DRUG	Nafcillin		NAFCILLIN SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110630		ANDA	ANDA090002	Fresenius Kabi USA, LLC	NAFCILLIN SODIUM	1	g/4mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63323-328_89168d2d-2dc0-3f50-e053-2a95a90a31be	63323-328	HUMAN PRESCRIPTION DRUG	Nafcillin		NAFCILLIN SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110630		ANDA	ANDA090002	Fresenius Kabi USA, LLC	NAFCILLIN SODIUM	2	g/8mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63323-328_89a714ea-e764-6aeb-e053-2995a90a8a89	63323-328	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110630		ANDA	ANDA090002	Fresenius Kabi USA, LLC	NAFCILLIN SODIUM	2	g/8mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63323-330_8b27ca5e-a933-7606-e053-2a95a90a0a33	63323-330	HUMAN PRESCRIPTION DRUG	Nafcillin		NAFCILLIN	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20110427		ANDA	ANDA090005	Fresenius Kabi USA, LLC	NAFCILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63323-340_8c2fbf43-34bd-49d1-bda8-a2191c8bc54b	63323-340	HUMAN PRESCRIPTION DRUG	Cefepime		Cefepime	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20100830		ANDA	ANDA065441	Fresenius Kabi USA, LLC	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-341_0fffe10d-e5bc-4a0c-ae5b-bbf4095990ba	63323-341	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin Sodium	POWDER, FOR SOLUTION	INTRAVENOUS	20110706		ANDA	ANDA065414	Fresenius Kabi USA, LLC	CEFOXITIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-341_9f457501-b963-49c0-89a3-4228eb493895	63323-341	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin Sodium	POWDER, FOR SOLUTION	INTRAVENOUS	20110706		ANDA	ANDA065414	Fresenius Kabi USA, LLC	CEFOXITIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-342_0fffe10d-e5bc-4a0c-ae5b-bbf4095990ba	63323-342	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin Sodium	POWDER, FOR SOLUTION	INTRAVENOUS	20110706		ANDA	ANDA065414	Fresenius Kabi USA, LLC	CEFOXITIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-342_9f457501-b963-49c0-89a3-4228eb493895	63323-342	HUMAN PRESCRIPTION DRUG	Cefoxitin		Cefoxitin Sodium	POWDER, FOR SOLUTION	INTRAVENOUS	20110706		ANDA	ANDA065414	Fresenius Kabi USA, LLC	CEFOXITIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-346_27777645-c5ae-4c89-abaf-ddb62dc7b859	63323-346	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110620		ANDA	ANDA065329	Fresenius Kabi USA, LLC	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-349_2bb9b6ad-8e8d-4667-b108-b57a8c16318f	63323-349	HUMAN PRESCRIPTION DRUG	Imipenem and Cilastatin		Imipenem and Cilastatin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120103		ANDA	ANDA090577	Fresenius Kabi USA, LLC	CILASTATIN SODIUM; IMIPENEM	250; 250	mg/20mL; mg/20mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
63323-349_68d30458-8cd9-4fbe-9215-f36dec6c733b	63323-349	HUMAN PRESCRIPTION DRUG	Imipenem and Cilastatin		Imipenem and Cilastatin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120103		ANDA	ANDA090577	Fresenius Kabi USA, LLC	CILASTATIN SODIUM; IMIPENEM	250; 250	mg/20mL; mg/20mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
63323-349_fb64108d-9be7-4eef-9395-74c782e3a3c0	63323-349	HUMAN PRESCRIPTION DRUG	Imipenem and Cilastatin		Imipenem and Cilastatin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120103		ANDA	ANDA090577	Fresenius Kabi USA, LLC	CILASTATIN SODIUM; IMIPENEM	250; 250	mg/20mL; mg/20mL	Carbapenems [CS], Dipeptidase Inhibitors [MoA], Penem Antibacterial [EPC], Renal Dehydropeptidase Inhibitor [EPC]		N	20241231
63323-351_60eb9c46-3c34-455b-a740-c03884565072	63323-351	HUMAN PRESCRIPTION DRUG	Rifampin		RIFAMPIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140821		ANDA	ANDA091181	Fresenius Kabi USA, LLC	RIFAMPIN	600	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
63323-355_7e3e7975-82d6-4394-847b-10deb1f97992	63323-355	HUMAN PRESCRIPTION DRUG	Levofloxacin		LEVOFLOXACIN	INJECTION	INTRAVENOUS	20130620		ANDA	ANDA200674	Fresenius Kabi USA, LLC	LEVOFLOXACIN	5	mg/mL			N	20241231
63323-356_effb4d5b-582a-4b93-a15a-aaeb773018ce	63323-356	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161230		NDA	NDA206110	Fresenius Kabi USA, LLC	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
63323-358_effb4d5b-582a-4b93-a15a-aaeb773018ce	63323-358	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161230		NDA	NDA206110	Fresenius Kabi USA, LLC	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
63323-360_3e4a7e0e-c7f4-4aa0-8c9c-0aa3fd7dc729	63323-360	HUMAN PRESCRIPTION DRUG	Calcium Gluconate		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20170615		NDA	NDA208418	Fresenius Kabi USA, LLC	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
63323-366_9b02a83b-c248-aabb-e053-2a95a90ad0ff	63323-366	HUMAN PRESCRIPTION DRUG	Dimenhydrinate		Dimenhydrinate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20041129		ANDA	ANDA040519	Fresenius Kabi USA, LLC	DIMENHYDRINATE	50	mg/mL			N	20241231
63323-367_5cf9b65b-6df4-42f8-b395-d0cf0a1003d3	63323-367	HUMAN PRESCRIPTION DRUG	Polymyxin B		Polymyxin B Sulfate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS	20150909		ANDA	ANDA202766	Fresenius Kabi USA, LLC	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63323-371_7b38aacb-d9c9-47db-a6fe-7e7d938fcd69	63323-371	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180411		ANDA	ANDA206077	Fresenius Kabi USA, LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
63323-371_b1854217-71fa-48a4-9279-928e663eb5ec	63323-371	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180411		ANDA	ANDA206077	Fresenius Kabi USA, LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
63323-373_83824969-e116-40d6-8940-ff134a4f16c0	63323-373	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20091118		ANDA	ANDA076972	Fresenius Kabi USA, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63323-374_83824969-e116-40d6-8940-ff134a4f16c0	63323-374	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20091118		ANDA	ANDA076974	Fresenius Kabi USA, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63323-376_8fc8e3fe-5ae9-4507-afde-7bc48969749d	63323-376	HUMAN PRESCRIPTION DRUG	Octreotide		OCTREOTIDE ACETATE	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060314		ANDA	ANDA077457	Fresenius Kabi USA, LLC	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
63323-376_c76a096b-f38c-4a9a-bd24-a1533a900e32	63323-376	HUMAN PRESCRIPTION DRUG	Octreotide		OCTREOTIDE ACETATE	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060314		ANDA	ANDA077457	Fresenius Kabi USA, LLC	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
63323-377_8fc8e3fe-5ae9-4507-afde-7bc48969749d	63323-377	HUMAN PRESCRIPTION DRUG	Octreotide		OCTREOTIDE ACETATE	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060314		ANDA	ANDA077457	Fresenius Kabi USA, LLC	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
63323-377_c76a096b-f38c-4a9a-bd24-a1533a900e32	63323-377	HUMAN PRESCRIPTION DRUG	Octreotide		OCTREOTIDE ACETATE	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060314		ANDA	ANDA077457	Fresenius Kabi USA, LLC	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
63323-378_c76a096b-f38c-4a9a-bd24-a1533a900e32	63323-378	HUMAN PRESCRIPTION DRUG	Octreotide		OCTREOTIDE ACETATE	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060314		ANDA	ANDA077450	Fresenius Kabi USA, LLC	OCTREOTIDE ACETATE	200	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
63323-379_c76a096b-f38c-4a9a-bd24-a1533a900e32	63323-379	HUMAN PRESCRIPTION DRUG	Octreotide		OCTREOTIDE ACETATE	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20060314		ANDA	ANDA077450	Fresenius Kabi USA, LLC	OCTREOTIDE ACETATE	1000	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
63323-385_7970302d-0f36-4eb4-9a30-0b029a92977c	63323-385	HUMAN PRESCRIPTION DRUG	Cefotetan		CEFOTETAN DISODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091118		ANDA	ANDA065374	Fresenius Kabi USA, LLC	CEFOTETAN DISODIUM	1	g/10mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-386_7970302d-0f36-4eb4-9a30-0b029a92977c	63323-386	HUMAN PRESCRIPTION DRUG	Cefotetan		CEFOTETAN DISODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091118		ANDA	ANDA065374	Fresenius Kabi USA, LLC	CEFOTETAN DISODIUM	2	g/20mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63323-393_4637a207-5042-4af6-a7a7-e63cd472b0d3	63323-393	HUMAN PRESCRIPTION DRUG	Colistimethate		COLISTIMETHATE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091204		ANDA	ANDA065364	Fresenius Kabi USA, LLC	COLISTIMETHATE SODIUM	150	mg/2mL	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63323-398_93f29c3d-b3ae-7ed2-e053-2a95a90af017	63323-398	HUMAN PRESCRIPTION DRUG	Azithromycin		AZITHROMYCIN MONOHYDRATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060320		ANDA	ANDA065179	Fresenius Kabi USA, LLC	AZITHROMYCIN MONOHYDRATE	500	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63323-398_94a38ec5-e40e-dd25-e053-2995a90a2525	63323-398	HUMAN PRESCRIPTION DRUG	Azithromycin		AZITHROMYCIN MONOHYDRATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060320		ANDA	ANDA065179	Fresenius Kabi USA, LLC	AZITHROMYCIN MONOHYDRATE	500	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63323-398_97b61d78-ed96-24cf-e053-2995a90a76ed	63323-398	HUMAN PRESCRIPTION DRUG	Azithromycin		AZITHROMYCIN MONOHYDRATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20060320		ANDA	ANDA065179	Fresenius Kabi USA, LLC	AZITHROMYCIN MONOHYDRATE	500	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
63323-400_799d949b-b1db-4e10-ab5c-89bf7c1bd308	63323-400	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	INJECTION, SOLUTION	INTRAVENOUS	20150813		ANDA	ANDA090876	Fresenius Kabi USA, LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63323-400_87d6e0ef-ffd5-49d6-b9df-ef216576d3e8	63323-400	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	INJECTION, SOLUTION	INTRAVENOUS	20150813		ANDA	ANDA090876	Fresenius Kabi USA, LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63323-401_6cd42e51-1a5d-4c6a-8881-0cbde3ca8d70	63323-401	HUMAN PRESCRIPTION DRUG	Aztreonam		AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	1	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
63323-401_8fe750bd-6416-428f-9184-7b15c7fe9d45	63323-401	HUMAN PRESCRIPTION DRUG	Aztreonam		AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	1	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
63323-401_b6926b10-085f-4255-b4f1-24572a7ef57a	63323-401	HUMAN PRESCRIPTION DRUG	Aztreonam		AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	1	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
63323-402_6cd42e51-1a5d-4c6a-8881-0cbde3ca8d70	63323-402	HUMAN PRESCRIPTION DRUG	Aztreonam		AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	2	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
63323-402_8fe750bd-6416-428f-9184-7b15c7fe9d45	63323-402	HUMAN PRESCRIPTION DRUG	Aztreonam		AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	2	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
63323-402_b6926b10-085f-4255-b4f1-24572a7ef57a	63323-402	HUMAN PRESCRIPTION DRUG	Aztreonam		AZTREONAM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091105		ANDA	ANDA065439	Fresenius Kabi USA, LLC	AZTREONAM	2	g/1	Monobactam Antibacterial [EPC], Monobactams [CS]		N	20241231
63323-403_84385df0-4793-47d2-8e49-5c84668a0ba3	63323-403	HUMAN PRESCRIPTION DRUG	Fosphenytoin		FOSPHENYTOIN SODIUM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20091214		ANDA	ANDA078052	Fresenius Kabi USA, LLC	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63323-406_8d47943c-b6f3-4742-90fe-4667e19c8605	63323-406	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		CAFFEINE CITRATE	SOLUTION	ORAL	20091119		ANDA	ANDA078002	Fresenius Kabi USA, LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63323-407_2c3a55e5-1b61-4ed2-adca-c3beb44baf14	63323-407	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		CAFFEINE CITRATE	INJECTION, SOLUTION	INTRAVENOUS	20091119		ANDA	ANDA077997	Fresenius Kabi USA, LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63323-407_6e710851-4ae5-46ba-811e-64d19f3e2ca6	63323-407	HUMAN PRESCRIPTION DRUG	Caffeine Citrate		CAFFEINE CITRATE	INJECTION, SOLUTION	INTRAVENOUS	20091119		ANDA	ANDA077997	Fresenius Kabi USA, LLC	CAFFEINE CITRATE	20	mg/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63323-411_87b0e4cc-f3b0-4d47-aaf2-f6748959095f	63323-411	HUMAN PRESCRIPTION DRUG	Midazolam		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000714		ANDA	ANDA075154	Fresenius Kabi USA, LLC	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63323-412_87b0e4cc-f3b0-4d47-aaf2-f6748959095f	63323-412	HUMAN PRESCRIPTION DRUG	Midazolam		MIDAZOLAM HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000710		ANDA	ANDA075154	Fresenius Kabi USA, LLC	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63323-412_d1596b9b-8c13-4876-8191-0a0c60ea6792	63323-412	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170328		ANDA	ANDA208878	Fresenius Kabi USA, LLC	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63323-413_3abc0611-0e8c-49f9-9678-e4b2fda3d8ed	63323-413	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20150108		NDA	NDA203629	Fresenius Kabi USA, LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63323-413_94a4c8ae-3c25-1ccf-e053-2a95a90a6a5f	63323-413	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20150108		NDA	NDA203629	Fresenius Kabi USA, LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63323-415_3abc0611-0e8c-49f9-9678-e4b2fda3d8ed	63323-415	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20150108		NDA	NDA203629	Fresenius Kabi USA, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63323-415_94a4c8ae-3c25-1ccf-e053-2a95a90a6a5f	63323-415	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20150108		NDA	NDA203629	Fresenius Kabi USA, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63323-416_0d662c1d-2eef-4e5f-8610-fe606716c810	63323-416	HUMAN PRESCRIPTION DRUG	Cisatracurium		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20150226		ANDA	ANDA203182	Fresenius Kabi USA, LLC	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-417_0d662c1d-2eef-4e5f-8610-fe606716c810	63323-417	HUMAN PRESCRIPTION DRUG	Cisatracurium		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20150226		ANDA	ANDA203183	Fresenius Kabi USA, LLC	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-418_0d662c1d-2eef-4e5f-8610-fe606716c810	63323-418	HUMAN PRESCRIPTION DRUG	Cisatracurium		CISATRACURIUM BESYLATE	INJECTION, SOLUTION	INTRAVENOUS	20150226		ANDA	ANDA203182	Fresenius Kabi USA, LLC	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-421_19087b96-58fb-400b-b5c6-689e5e33c5c8	63323-421	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		dexmedetomidine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20150918		ANDA	ANDA201072	Fresenius Kabi USA, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
63323-424_73f4da51-e292-4603-b5e1-056fcd34ec9c	63323-424	HUMAN PRESCRIPTION DRUG	Flumazenil		FLUMAZENIL	INJECTION, SOLUTION	INTRAVENOUS	20050405		ANDA	ANDA076955	Fresenius Kabi USA, LLC	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
63323-426_3f4d5e11-2c14-4406-8954-04dba2fc65ff	63323-426	HUMAN PRESCRIPTION DRUG	Rocuronium		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20091213		ANDA	ANDA078651	Fresenius Kabi USA, LLC	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-426_d6e2ff8d-838d-4c27-8e73-230548b09d63	63323-426	HUMAN PRESCRIPTION DRUG	Rocuronium		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20091213		ANDA	ANDA078651	Fresenius Kabi USA, LLC	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-434_5bca931d-076c-44f8-8b61-a067692c5f3f	63323-434	HUMAN PRESCRIPTION DRUG	Acetaminophen		ACETAMINOPHEN	INJECTION	INTRAVENOUS	20201206		NDA	NDA204767	Fresenius Kabi USA, LLC	ACETAMINOPHEN	10	mg/mL			N	20241231
63323-450_d2e3def4-a49f-4810-ab4e-f7edebefa210	63323-450	HUMAN PRESCRIPTION DRUG	Pemetrexed		PEMETREXED DISODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA090384	Fresenius Kabi USA, LLC	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
63323-451_4347699d-d9de-4f59-a3de-7af661e2e6c9	63323-451	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180410		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-452_4347699d-d9de-4f59-a3de-7af661e2e6c9	63323-452	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180410		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-454_4347699d-d9de-4f59-a3de-7af661e2e6c9	63323-454	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180410		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-455_4347699d-d9de-4f59-a3de-7af661e2e6c9	63323-455	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180410		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-458_4347699d-d9de-4f59-a3de-7af661e2e6c9	63323-458	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180410		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	8	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-459_2f22758f-1fa9-450c-bee9-568f12a1997f	63323-459	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191104		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-459_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-459	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-460_8d81a6bc-6ffc-7091-e053-2995a90aa153	63323-460	HUMAN PRESCRIPTION DRUG	SENSORCAINE	MPF	BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20101119		NDA	NDA018304	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	7.5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-461_cc1f6507-eb3e-4398-a1d3-0c56a2099e6b	63323-461	HUMAN PRESCRIPTION DRUG	SENSORCAINE		BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20101119		ANDA	ANDA070967	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-462_8d81a6bc-6ffc-7091-e053-2995a90aa153	63323-462	HUMAN PRESCRIPTION DRUG	SENSORCAINE	MPF	BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20101119		NDA	NDA018304	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-463_cc1f6507-eb3e-4398-a1d3-0c56a2099e6b	63323-463	HUMAN PRESCRIPTION DRUG	SENSORCAINE		BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	PERINEURAL	20101119		ANDA	ANDA070968	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-464_8d81a6bc-6ffc-7091-e053-2995a90aa153	63323-464	HUMAN PRESCRIPTION DRUG	SENSORCAINE	MPF	BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20101119		NDA	NDA018304	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-464_b41b5dbd-7aff-4d97-ac97-f4355393ee4e	63323-464	HUMAN PRESCRIPTION DRUG	Sensorcaine	MPF	BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20101119		ANDA	ANDA070552	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-465_8d81a6bc-6ffc-7091-e053-2995a90aa153	63323-465	HUMAN PRESCRIPTION DRUG	SENSORCAINE		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20101119		NDA	NDA018304	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-466_8d81a6bc-6ffc-7091-e053-2995a90aa153	63323-466	HUMAN PRESCRIPTION DRUG	SENSORCAINE	MPF	BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20101119		NDA	NDA018304	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-466_b41b5dbd-7aff-4d97-ac97-f4355393ee4e	63323-466	HUMAN PRESCRIPTION DRUG	Sensorcaine	MPF	BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20101119		ANDA	ANDA070553	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-467_8d81a6bc-6ffc-7091-e053-2995a90aa153	63323-467	HUMAN PRESCRIPTION DRUG	SENSORCAINE		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	PERINEURAL	20101119		NDA	NDA018304	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-468_cc1f6507-eb3e-4398-a1d3-0c56a2099e6b	63323-468	HUMAN PRESCRIPTION DRUG	SENSORCAINE	MPF	BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20101119		ANDA	ANDA070966	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	2.5; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-469_86dff2aa-2ab3-42fc-989e-619b13ace573	63323-469	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20000216		ANDA	ANDA074893	Fresenius Kabi USA, LLC	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
63323-471_86dff2aa-2ab3-42fc-989e-619b13ace573	63323-471	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20000712		ANDA	ANDA074893	Fresenius Kabi USA, LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
63323-471_ffe1197b-99e4-4dee-922e-d1b528d84052	63323-471	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20000712		ANDA	ANDA074893	Fresenius Kabi USA, LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
63323-472_cc1f6507-eb3e-4398-a1d3-0c56a2099e6b	63323-472	HUMAN PRESCRIPTION DRUG	SENSORCAINE	MPF	BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20101119		ANDA	ANDA070554	Fresenius Kabi USA, LLC	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
63323-474_f3409439-088d-49ec-9e10-c6c3b1a07eef	63323-474	HUMAN PRESCRIPTION DRUG	Haloperidol		HALOPERIDOL LACTATE	INJECTION, SOLUTION	INTRAMUSCULAR	20001020		ANDA	ANDA075689	Fresenius Kabi USA, LLC	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
63323-475_46570679-3557-4250-bb21-b406097e106d	63323-475	HUMAN PRESCRIPTION DRUG	Nesacaine		CHLOROPROCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20101014		NDA	NDA009435	Fresenius Kabi USA, LLC	CHLOROPROCAINE HYDROCHLORIDE	10	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
63323-476_46570679-3557-4250-bb21-b406097e106d	63323-476	HUMAN PRESCRIPTION DRUG	Nesacaine		CHLOROPROCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20101014		NDA	NDA009435	Fresenius Kabi USA, LLC	CHLOROPROCAINE HYDROCHLORIDE	20	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
63323-477_46570679-3557-4250-bb21-b406097e106d	63323-477	HUMAN PRESCRIPTION DRUG	Nesacaine	MPF	CHLOROPROCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20101014		NDA	NDA009435	Fresenius Kabi USA, LLC	CHLOROPROCAINE HYDROCHLORIDE	20	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
63323-478_46570679-3557-4250-bb21-b406097e106d	63323-478	HUMAN PRESCRIPTION DRUG	Nesacaine	MPF	CHLOROPROCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20101014		NDA	NDA009435	Fresenius Kabi USA, LLC	CHLOROPROCAINE HYDROCHLORIDE	30	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
63323-481_ea480a68-5927-4278-9deb-2956961da428	63323-481	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-482_0d3254f2-b6cf-477f-aae8-6d7857c07acc	63323-482	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 10	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-482_ea480a68-5927-4278-9deb-2956961da428	63323-482	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 10	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-483_ea480a68-5927-4278-9deb-2956961da428	63323-483	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-484_ea480a68-5927-4278-9deb-2956961da428	63323-484	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-485_0d3254f2-b6cf-477f-aae8-6d7857c07acc	63323-485	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-485_ea480a68-5927-4278-9deb-2956961da428	63323-485	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-486_0d3254f2-b6cf-477f-aae8-6d7857c07acc	63323-486	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-486_ea480a68-5927-4278-9deb-2956961da428	63323-486	HUMAN PRESCRIPTION DRUG	Xylocaine		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-487_ea480a68-5927-4278-9deb-2956961da428	63323-487	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 10	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-488_ea480a68-5927-4278-9deb-2956961da428	63323-488	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 15	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-489_ea480a68-5927-4278-9deb-2956961da428	63323-489	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	.005; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
63323-491_ea480a68-5927-4278-9deb-2956961da428	63323-491	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-492_0d3254f2-b6cf-477f-aae8-6d7857c07acc	63323-492	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-492_bf0e6f28-00fc-4b40-a5b2-3ddaa5048dda	63323-492	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20110718		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-492_ea480a68-5927-4278-9deb-2956961da428	63323-492	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-493_bf0e6f28-00fc-4b40-a5b2-3ddaa5048dda	63323-493	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20110718		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	15	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-494_d495c020-63d7-4637-9f4d-a0d9cafe1912	63323-494	HUMAN PRESCRIPTION DRUG	Valproate Sodium		VALPROATE SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20030818		ANDA	ANDA076539	Fresenius Kabi USA, LLC	VALPROATE SODIUM	100	mg/mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63323-494_f1d60764-b8c1-4b58-9f32-c35fe621d402	63323-494	HUMAN PRESCRIPTION DRUG	Valproate Sodium		VALPROATE SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20030818		ANDA	ANDA076539	Fresenius Kabi USA, LLC	VALPROATE SODIUM	100	mg/mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63323-495_0d3254f2-b6cf-477f-aae8-6d7857c07acc	63323-495	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-495_ea480a68-5927-4278-9deb-2956961da428	63323-495	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20100812		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-496_bf0e6f28-00fc-4b40-a5b2-3ddaa5048dda	63323-496	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20110718		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63323-506_5284d2ce-44c2-4731-bf19-0cfc760265c8	63323-506	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20030529		ANDA	ANDA040491	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-506_7e4e829e-9dd4-48f1-9034-4d006a194cbf	63323-506	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20030529		ANDA	ANDA040491	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-507_6e7f961a-7766-4426-8aa4-096bfba99e56	63323-507	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20111014		ANDA	ANDA091404	Fresenius Kabi USA, LLC	MEROPENEM	500	mg/10mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
63323-507_8fe3d813-4656-49d6-ad91-6a075f3d3a82	63323-507	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20111014		ANDA	ANDA091404	Fresenius Kabi USA, LLC	MEROPENEM	500	mg/10mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
63323-507_f5b64ff4-85ce-416b-865a-c35ff4cfda42	63323-507	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20111014		ANDA	ANDA091404	Fresenius Kabi USA, LLC	MEROPENEM	500	mg/10mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
63323-508_6e7f961a-7766-4426-8aa4-096bfba99e56	63323-508	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20111026		ANDA	ANDA091404	Fresenius Kabi USA, LLC	MEROPENEM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
63323-508_8fe3d813-4656-49d6-ad91-6a075f3d3a82	63323-508	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20111026		ANDA	ANDA091404	Fresenius Kabi USA, LLC	MEROPENEM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
63323-508_f5b64ff4-85ce-416b-865a-c35ff4cfda42	63323-508	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20111026		ANDA	ANDA091404	Fresenius Kabi USA, LLC	MEROPENEM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
63323-516_7e4e829e-9dd4-48f1-9034-4d006a194cbf	63323-516	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050405		ANDA	ANDA040572	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63323-517_7c4482a5-9eea-4123-a702-f0da0a02ce44	63323-517	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20170824		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	10000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-518_7c4482a5-9eea-4123-a702-f0da0a02ce44	63323-518	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20170824		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-519_6077fbfb-7b91-4cba-aee9-b2e5831b5033	63323-519	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS	20200724		ANDA	ANDA212441	Fresenius Kabi USA, LLC	HEPARIN SODIUM	200	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-522_7c4482a5-9eea-4123-a702-f0da0a02ce44	63323-522	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20170824		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-523_7c4482a5-9eea-4123-a702-f0da0a02ce44	63323-523	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20170824		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	10000	[USP'U]/100mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-526_38530ce5-b666-4502-83f1-63e553bd86b4	63323-526	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION, SOLUTION	INTRAVENOUS	20150323		NDA	NDA201811	Fresenius Kabi USA, LLC	ARGATROBAN	100	mg/mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
63323-530_613e9aef-5e01-4d00-8407-488872b9902f	63323-530	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20200320		ANDA	ANDA209476	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	3	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-531_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-531	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-531_f1604264-1625-131c-e053-2a95a90a897c	63323-531	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-533_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-533	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-533_f1604264-1625-131c-e053-2a95a90a897c	63323-533	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-535_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-535	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-535_f1604264-1625-131c-e053-2a95a90a897c	63323-535	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-537_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-537	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-537_f1604264-1625-131c-e053-2a95a90a897c	63323-537	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-539_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-539	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-539_f1604264-1625-131c-e053-2a95a90a897c	63323-539	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-540_2f22758f-1fa9-450c-bee9-568f12a1997f	63323-540	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191104		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-540_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-540	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-540_bf214cba-c4af-402f-b265-fe4d26d778f7	63323-540	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-542_2f22758f-1fa9-450c-bee9-568f12a1997f	63323-542	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191104		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-542_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-542	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-543_2f22758f-1fa9-450c-bee9-568f12a1997f	63323-543	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191104		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/.5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-543_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-543	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/.5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-559_762bb928-f81d-4392-b755-0c930248653c	63323-559	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-559_d70d8613-9a3c-432c-bc3a-4a75edaae8d6	63323-559	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-562_aaf5d1e9-5dea-4b71-a1e0-144695be0c87	63323-562	HUMAN PRESCRIPTION DRUG	Bivalirudin		Bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171030		ANDA	ANDA090189	Fresenius Kabi USA, LLC	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
63323-562_b4a901fc-eecf-435c-8ce7-f1c5ee9fe3fa	63323-562	HUMAN PRESCRIPTION DRUG	Bivalirudin		Bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161028		ANDA	ANDA090189	Fresenius Kabi USA, LLC	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
63323-563_ddb5d068-9d9e-45da-92d7-516dd792af1b	63323-563	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20120524		ANDA	ANDA091596	Fresenius Kabi USA, LLC	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
63323-564_762bb928-f81d-4392-b755-0c930248653c	63323-564	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-564_d70d8613-9a3c-432c-bc3a-4a75edaae8d6	63323-564	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-566_762bb928-f81d-4392-b755-0c930248653c	63323-566	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-566_d70d8613-9a3c-432c-bc3a-4a75edaae8d6	63323-566	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-572_5d0113e4-7027-4908-a76d-46eac772e404	63323-572	HUMAN PRESCRIPTION DRUG	CLOFARABINE		clofarabine	INJECTION	INTRAVENOUS	20170510		ANDA	ANDA204029	Fresenius Kabi USA, LLC	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-574_d1c9afa7-c4ac-4739-85f1-2ae82440210c	63323-574	HUMAN PRESCRIPTION DRUG	Icatibant		Icatibant	INJECTION, SOLUTION	SUBCUTANEOUS	20201115		ANDA	ANDA208317	Fresenius Kabi USA, LLC	ICATIBANT ACETATE	10	mg/mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20251231
63323-578_779dc924-ecc3-41cc-8cf9-a7354db4f763	63323-578	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20171027		ANDA	ANDA209328	Fresenius Kabi USA, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63323-578_df53e166-accc-41a1-bed2-d207f075d21d	63323-578	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20171027		ANDA	ANDA209328	Fresenius Kabi USA, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63323-579_efc423ee-f932-45d4-9fd2-d4b4c350f5db	63323-579	HUMAN PRESCRIPTION DRUG	SINCALIDE		sincalide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230401		NDA	NDA017697	Fresenius Kabi USA, LLC	SINCALIDE	5	ug/5mL	Cholecystokinin Analog [EPC], Cholecystokinin [CS]		N	20241231
63323-580_38bc10ab-df7f-48f4-8b16-0b8838eff694	63323-580	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170123		NDA	NDA209260	Fresenius Kabi USA, LLC	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63323-582_fd7651ff-06a1-4644-8355-8b330f5c1120	63323-582	HUMAN PRESCRIPTION DRUG	Glucagon		Glucagon	KIT		20190909		NDA	NDA201849	Fresenius Kabi USA, LLC						N	20241231
63323-584_762bb928-f81d-4392-b755-0c930248653c	63323-584	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-584_d70d8613-9a3c-432c-bc3a-4a75edaae8d6	63323-584	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-586_762bb928-f81d-4392-b755-0c930248653c	63323-586	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-586_d70d8613-9a3c-432c-bc3a-4a75edaae8d6	63323-586	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-589_d70d8613-9a3c-432c-bc3a-4a75edaae8d6	63323-589	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190423		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-593_eb37fc8a-a264-4ce9-a130-466e9b5f3a38	63323-593	HUMAN PRESCRIPTION DRUG	Glucagon		Glucagon	KIT		20150508		NDA	NDA201849	Fresenius Kabi USA, LLC						N	20241231
63323-594_9e17207f-b348-4be8-8416-2f0aa1392390	63323-594	HUMAN PRESCRIPTION DRUG	Glucagon		Glucagon	KIT		20151201		NDA	NDA201849	Fresenius Kabi USA, LLC						N	20241231
63323-596_9e17207f-b348-4be8-8416-2f0aa1392390	63323-596	HUMAN PRESCRIPTION DRUG	Glucagon		Glucagon	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150508		NDA	NDA201849	Fresenius Kabi USA, LLC	GLUCAGON HYDROCHLORIDE	1	mg/mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20241231
63323-596_eb37fc8a-a264-4ce9-a130-466e9b5f3a38	63323-596	HUMAN PRESCRIPTION DRUG	Glucagon		Glucagon	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150508		NDA	NDA201849	Fresenius Kabi USA, LLC	GLUCAGON HYDROCHLORIDE	1	mg/mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20241231
63323-597_e9db4d63-aeb3-4ea1-907e-2af11e0bbd3c	63323-597	HUMAN PRESCRIPTION DRUG	Deferoxamine		DEFEROXAMINE MESYLATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20091215		ANDA	ANDA078718	Fresenius Kabi USA, LLC	DEFEROXAMINE MESYLATE	95	mg/mL	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
63323-599_e9db4d63-aeb3-4ea1-907e-2af11e0bbd3c	63323-599	HUMAN PRESCRIPTION DRUG	Deferoxamine		DEFEROXAMINE MESYLATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20091215		ANDA	ANDA078718	Fresenius Kabi USA, LLC	DEFEROXAMINE MESYLATE	95	mg/mL	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
63323-604_505851c4-b18c-4cd7-805c-4e923cc1fa7e	63323-604	HUMAN PRESCRIPTION DRUG	Propranolol		PROPRANOLOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20010907		ANDA	ANDA075826	Fresenius Kabi USA, LLC	PROPRANOLOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63323-605_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-605	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-605_f1604264-1625-131c-e053-2a95a90a897c	63323-605	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-607_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-607	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-607_f1604264-1625-131c-e053-2a95a90a897c	63323-607	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-609_e6469c97-a1b5-4cd0-966e-19e3f9944e1a	63323-609	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-609_f1604264-1625-131c-e053-2a95a90a897c	63323-609	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20190618		NDA AUTHORIZED GENERIC	NDA020164	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-614_2f8362b3-0a39-40b0-95bf-4a786cb15a74	63323-614	HUMAN PRESCRIPTION DRUG	hydrALAZINE Hydrochloride		hydrALAZINE Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110131		ANDA	ANDA040388	Fresenius Kabi USA, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63323-614_4b641472-3abc-4954-b4bd-37191da10012	63323-614	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA040388	Fresenius Kabi USA, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63323-614_5e30cfd3-9310-41a0-966e-dd22ff88379e	63323-614	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA040388	Fresenius Kabi USA, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63323-616_faf36761-7b49-425a-b941-5aba638df545	63323-616	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		AMIODARONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20030128		ANDA	ANDA075761	Fresenius Kabi USA, LLC	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63323-617_7ada1876-c47a-4e3e-bd48-a6a1f486b517	63323-617	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		MILRINONE LACTATE	INJECTION, SOLUTION	INTRAVENOUS	20020801		ANDA	ANDA075936	Fresenius Kabi USA, LLC	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
63323-621_d2e3def4-a49f-4810-ab4e-f7edebefa210	63323-621	HUMAN PRESCRIPTION DRUG	Pemetrexed		PEMETREXED DISODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA090384	Fresenius Kabi USA, LLC	PEMETREXED DISODIUM	750	mg/30mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
63323-622_d2e3def4-a49f-4810-ab4e-f7edebefa210	63323-622	HUMAN PRESCRIPTION DRUG	Pemetrexed		PEMETREXED DISODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA090384	Fresenius Kabi USA, LLC	PEMETREXED DISODIUM	1	g/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
63323-623_15b78fed-793b-4320-8c3f-f0df0d9f4cda	63323-623	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-624_4cfbe8ac-5e60-4fa2-b96c-4206a098d555	63323-624	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20161021		ANDA	ANDA207449	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE	50	mg/mL			N	20241231
63323-626_0294c782-9333-4ea7-ba32-53bb2de0bd82	63323-626	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180723		ANDA	ANDA208122	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-631_1184b650-292c-4c45-9325-a4c5980f0226	63323-631	HUMAN PRESCRIPTION DRUG	Leucovorin calcium		Leucovorin calcium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180727		ANDA	ANDA207226	Fresenius Kabi USA, LLC	LEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
63323-631_8cabb9ac-eee3-459b-bc7c-d7d4a45632c2	63323-631	HUMAN PRESCRIPTION DRUG	Leucovorin calcium		Leucovorin calcium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170131		ANDA	ANDA207241	Fresenius Kabi USA, LLC	LEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
63323-632_b1de166c-c503-4d64-980e-f7177970f9ed	63323-632	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-637_e5b5eeed-c654-40bf-b32b-fec1f8710995	63323-637	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION, SOLUTION	INTRAVENOUS	20180831		ANDA	ANDA208231	Fresenius Kabi USA, LLC	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
63323-642_89d02988-a12e-4224-88f0-3f05f7ee324f	63323-642	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160129		NDA	NDA019316	Fresenius Kabi USA, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-647_9b01d8ae-450a-72e1-e053-2a95a90a9808	63323-647	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM ANHYDROUS	200	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-648_9b01d5bb-4310-4768-e053-2995a90a9fad	63323-648	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM ANHYDROUS	500	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-648_9b01d8ae-450a-72e1-e053-2a95a90a9808	63323-648	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM ANHYDROUS	500	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-649_9b01d5bb-4310-4768-e053-2995a90a9fad	63323-649	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM ANHYDROUS	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-649_9b01d8ae-450a-72e1-e053-2a95a90a9808	63323-649	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM ANHYDROUS	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-649_9b01dfdf-ee8e-51e3-e053-2a95a90ad676	63323-649	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110624		NDA	NDA202231	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM ANHYDROUS	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-651_2a538eee-679f-4606-b36f-5fc0fb1c885d	63323-651	HUMAN PRESCRIPTION DRUG	Adenosine		ADENOSINE	INJECTION, SOLUTION	INTRAVENOUS	20171127		ANDA	ANDA077897	Fresenius Kabi USA, LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
63323-651_5af5d3b5-1a03-4717-b828-97589f278992	63323-651	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20180416		ANDA	ANDA205568	Fresenius Kabi USA, LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
63323-651_82a5c8e7-05d6-4f65-8677-af4426952dd7	63323-651	HUMAN PRESCRIPTION DRUG	Adenosine		ADENOSINE	INJECTION, SOLUTION	INTRAVENOUS	20051123		ANDA	ANDA077133	Fresenius Kabi USA, LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
63323-652_bd3b0e69-6fd6-4d0f-8bc8-7fb3c81acdb3	63323-652	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		ESMOLOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20041130		ANDA	ANDA076573	Fresenius Kabi USA, LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63323-655_d70d8613-9a3c-432c-bc3a-4a75edaae8d6	63323-655	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20190501		ANDA	ANDA078990	Fresenius Kabi USA, LLC	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
63323-658_0bcdc25b-6e14-4c48-8f4b-ea1aa5cf7b4a	63323-658	HUMAN PRESCRIPTION DRUG	Chlorothiazide		CHLOROTHIAZIDE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20091021		ANDA	ANDA090896	Fresenius Kabi USA, LLC	CHLOROTHIAZIDE SODIUM	500	mg/18mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63323-658_85e1af90-9f5e-44a1-8bc3-5868be35812b	63323-658	HUMAN PRESCRIPTION DRUG	Chlorothiazide		CHLOROTHIAZIDE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20091021		ANDA	ANDA090896	Fresenius Kabi USA, LLC	CHLOROTHIAZIDE SODIUM	500	mg/18mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63323-658_caa7f828-1628-46e2-8ee5-e90e9da681bf	63323-658	HUMAN PRESCRIPTION DRUG	Chlorothiazide		CHLOROTHIAZIDE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20091021		ANDA	ANDA090896	Fresenius Kabi USA, LLC	CHLOROTHIAZIDE SODIUM	500	mg/18mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63323-659_4ada9870-cf14-4c61-892f-6ad9349c31de	63323-659	HUMAN PRESCRIPTION DRUG	Indomethacin		INDOMETHACIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100319		NDA	NDA022536	Fresenius Kabi USA, LLC	INDOMETHACIN	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-659_8669be4e-809a-470d-a081-837834bd9eb8	63323-659	HUMAN PRESCRIPTION DRUG	Indomethacin		INDOMETHACIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100319		NDA	NDA022536	Fresenius Kabi USA, LLC	INDOMETHACIN	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-659_f77a01f1-d5ef-4894-aba1-cd23e3ee4e7b	63323-659	HUMAN PRESCRIPTION DRUG	Indomethacin		INDOMETHACIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100319		NDA	NDA022536	Fresenius Kabi USA, LLC	INDOMETHACIN	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63323-660_3ba610b3-f5fa-41af-a5ee-cb7bac207c77	63323-660	HUMAN PRESCRIPTION DRUG	Metoprolol		METOPROLOL TARTRATE	INJECTION, SOLUTION	INTRAVENOUS	20101028		ANDA	ANDA091045	Fresenius Kabi USA, LLC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63323-664_94042cc8-870d-20ba-e053-2995a90a2be8	63323-664	HUMAN PRESCRIPTION DRUG	Diphenhydramine		DIPHENHYDRAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20020801		ANDA	ANDA040466	Fresenius Kabi USA, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63323-664_971612e7-9b94-1822-e053-2a95a90afdf9	63323-664	HUMAN PRESCRIPTION DRUG	Diphenhydramine		DIPHENHYDRAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20020801		ANDA	ANDA040466	Fresenius Kabi USA, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63323-665_15846c75-dc60-4339-b97b-5c9d78d66cf1	63323-665	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		TERBUTALINE SULFATE	INJECTION, SOLUTION	SUBCUTANEOUS	20110310		ANDA	ANDA076887	Fresenius Kabi USA, LLC	TERBUTALINE SULFATE	1	mg/mL			N	20241231
63323-667_3357d0fc-b646-4150-a5e5-b829f5e05c23	63323-667	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride, Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20210423		ANDA	ANDA212346	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE	5; 75	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-669_3357d0fc-b646-4150-a5e5-b829f5e05c23	63323-669	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride, Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20210423		ANDA	ANDA212346	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE	5; 150	g/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-671_a94d19bc-e8ff-440a-ac11-8a6e4b5667bf	63323-671	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20190513		ANDA	ANDA208129	Fresenius Kabi USA, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
63323-673_a118bce3-a56b-4c7a-bb02-2c32abea5b0d	63323-673	HUMAN PRESCRIPTION DRUG	PALONOSETRON		Palonosetron	INJECTION, SOLUTION	INTRAVENOUS	20180919		ANDA	ANDA206802	Fresenius Kabi USA, LLC	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63323-673_c1aa6a23-e1b5-441a-a947-55b35d33509b	63323-673	HUMAN PRESCRIPTION DRUG	Palonosetron		Palonosetron	INJECTION, SOLUTION	INTRAVENOUS	20180919		ANDA	ANDA206801	Fresenius Kabi USA, LLC	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63323-683_541dac53-c4f6-49bc-8f69-3ff418c98c40	63323-683	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		Sodium Chloride and Potassium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20210602		ANDA	ANDA212347	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE; SODIUM CHLORIDE	150; 450	mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-685_3ed81dc8-a1e0-4513-be2a-7a16aea62198	63323-685	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	INJECTION, SOLUTION	INTRAVENOUS	20231226		ANDA	ANDA209983	Fresensius Kabi USA, LLC	POSACONAZOLE	18	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20251231
63323-686_541dac53-c4f6-49bc-8f69-3ff418c98c40	63323-686	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		Sodium Chloride and Potassium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20210602		ANDA	ANDA212347	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE; SODIUM CHLORIDE	150; 900	mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-688_541dac53-c4f6-49bc-8f69-3ff418c98c40	63323-688	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Sodium Chloride		Sodium Chloride and Potassium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20210602		ANDA	ANDA212347	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE; SODIUM CHLORIDE	300; 900	mg/100mL; mg/100mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-690_05c9a4dd-4070-4725-8ee8-3c9484faf96e	63323-690	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20120901		ANDA	ANDA203853	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-690_eeea4928-a68a-4552-836f-d819de9de1d4	63323-690	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20120901		ANDA	ANDA203853	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-691_05c9a4dd-4070-4725-8ee8-3c9484faf96e	63323-691	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20140331		ANDA	ANDA204674	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	100	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-692_05c9a4dd-4070-4725-8ee8-3c9484faf96e	63323-692	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20120901		ANDA	ANDA203853	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-693_05c9a4dd-4070-4725-8ee8-3c9484faf96e	63323-693	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20140331		ANDA	ANDA204674	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	100	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-694_05c9a4dd-4070-4725-8ee8-3c9484faf96e	63323-694	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20120901		ANDA	ANDA203853	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-694_eeea4928-a68a-4552-836f-d819de9de1d4	63323-694	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20120901		ANDA	ANDA203853	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-695_05c9a4dd-4070-4725-8ee8-3c9484faf96e	63323-695	HUMAN PRESCRIPTION DRUG	Acetylcysteine		ACETYLCYSTEINE	SOLUTION	ORAL; RESPIRATORY (INHALATION)	20140331		ANDA	ANDA204674	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	100	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-710_2375d4bc-97fb-42cb-b548-403515d9c243	63323-710	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		LEUCOVORIN CALCIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100918		ANDA	ANDA040258	Fresenius Kabi USA, LLC	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
63323-710_2497bd71-0f85-48ec-9353-d591e1c728f8	63323-710	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		LEUCOVORIN CALCIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100918		ANDA	ANDA040258	Fresenius Kabi USA, LLC	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
63323-711_2497bd71-0f85-48ec-9353-d591e1c728f8	63323-711	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		LEUCOVORIN CALCIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20100918		ANDA	ANDA040286	Fresenius Kabi USA, LLC	LEUCOVORIN CALCIUM	500	mg/50mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
63323-712_35adedd7-934f-4be9-8802-05c5993fce92	63323-712	HUMAN PRESCRIPTION DRUG	Kabiven		Dextrose, Soybean oil, Electrolytes, Lysine, Phenylalanine, Leucine, Valine, Threonine, Methionine, Isoleucine, Tryptophan, Alanine, Arginine, Glycine, Proline, Histidine, Glutamic Acid, Serine, Aspartic Acid and Tyrosine	INJECTION, EMULSION	INTRAVENOUS	20140825		NDA	NDA200656	Fresenius Kabi USA, LLC	ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; METHIONINE; PHENYLALANINE; POTASSIUM CHLORIDE; PROLINE; SERINE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE ANHYDROUS; SOYBEAN OIL; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	467; 330; 99; 29; 10.8; 164; 231; 199; 164; 231; 263; 96; 164; 231; 174; 199; 131; 239; 147; 3.9; 164; 55; 6.7; 213	mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Lipid Emulsion [EPC], Lipids [CS], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-713_44d4fd62-64cd-4e72-b5ed-1f82207dbdb0	63323-713	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	INJECTION, SOLUTION	INTRAVENOUS	20150622		ANDA	ANDA204764	Fresenius Kabi USA, LLC	LINEZOLID	2	mg/mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
63323-714_19ddcce5-fefc-428d-a57a-7df023363e25	63323-714	HUMAN PRESCRIPTION DRUG	Perikabiven		Dextrose, Soybean oil, Electrolytes, Lysine, Phenylalanine, Leucine, Valine, Threonine, Methionine, Isoleucine, Tryptophan, Alanine, Arginine, Glycine, Proline, Histidine, Glutamic Acid, Serine, Aspartic Acid and Tyrosine	INJECTION, EMULSION	INTRAVENOUS	20140825		NDA	NDA200656	Fresenius Kabi USA, LLC	ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; METHIONINE; PHENYLALANINE; POTASSIUM CHLORIDE; PROLINE; SERINE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE ANHYDROUS; SOYBEAN OIL; THREONINE; TRYPTOPHAN; TYROSINE; VALINE	333; 235; 71; 20; 7.5; 116; 164; 141; 116; 164; 187; 68; 116; 164; 124; 141; 94; 170; 105; 3.5; 116; 40; 4.8; 152	mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Lipid Emulsion [EPC], Lipids [CS], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63323-715_8aba3cf6-8f6c-45f9-aaa5-6e13319208a8	63323-715	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20190520		NDA	NDA210326	Fresenius Kabi USA, LLC	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
63323-721_81e8728c-5928-4029-8aa0-0e7f761af75a	63323-721	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171106		NDA	NDA205004	Fresenius Kabi USA, LLC	BORTEZOMIB	1	mg/mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
63323-723_1976a804-bfb7-4ea7-b89a-1d7b521b37ec	63323-723	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-723_e5018c8a-1bfa-4972-a8fe-8e7972a6b172	63323-723	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-724_1976a804-bfb7-4ea7-b89a-1d7b521b37ec	63323-724	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-725_1976a804-bfb7-4ea7-b89a-1d7b521b37ec	63323-725	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119		ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-728_e4cf72d0-27fe-42ec-9f09-a22733fc5803	63323-728	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200508		ANDA	ANDA207344	Fresenius Kabi USA, LLC	MICAFUNGIN SODIUM	50	mg/1	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
63323-729_374215cc-01ce-4255-b523-041713394cb6	63323-729	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200508		ANDA	ANDA207344	Fresenius Kabi USA, LLC	MICAFUNGIN SODIUM	100	mg/1	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
63323-729_e4cf72d0-27fe-42ec-9f09-a22733fc5803	63323-729	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200508		ANDA	ANDA207344	Fresenius Kabi USA, LLC	MICAFUNGIN SODIUM	100	mg/1	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
63323-733_6d252f0f-310a-4b86-9bc8-326813c65d9d	63323-733	HUMAN PRESCRIPTION DRUG	Mesna		MESNA	INJECTION, SOLUTION	INTRAVENOUS	20010905		ANDA	ANDA075811	Fresenius Kabi USA, LLC	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
63323-738_14c82153-53c9-4457-8cd3-fbb045885412	63323-738	HUMAN PRESCRIPTION DRUG	Famotidine		FAMOTIDINE	INJECTION, SOLUTION	INTRAVENOUS	20010719		ANDA	ANDA075709	Fresenius Kabi USA, LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63323-739_241710d5-bcef-4852-a09c-0e681250e6aa	63323-739	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION, SOLUTION	INTRAVENOUS	20010315		ANDA	ANDA075813	Fresenius Kabi USA, LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63323-739_7411dc23-e297-42cb-b491-b90d70c841a3	63323-739	HUMAN PRESCRIPTION DRUG	Famotidine		FAMOTIDINE	INJECTION, SOLUTION	INTRAVENOUS	20010315		ANDA	ANDA075813	Fresenius Kabi USA, LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63323-750_4e575573-2338-4d73-a095-32275c4f691d	63323-750	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20100611		ANDA	ANDA078811	Fresenius Kabi USA, LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
63323-751_34ab57b5-98e6-4284-8f0a-96334a07a915	63323-751	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20190525		ANDA	ANDA210665	Fresenius Kabi USA, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
63323-751_592b1907-7c11-4ac5-9098-ff17013c8a2b	63323-751	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20190525		ANDA	ANDA210666	Fresenius Kabi USA, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63323-751_f7ea538e-7b2e-4951-967b-27bc594566e9	63323-751	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20190525		ANDA	ANDA210665	Fresenius Kabi USA, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63323-760_cb1e42cf-02b9-47d3-922c-0dbc251f878d	63323-760	HUMAN PRESCRIPTION DRUG	Melphalan		Melphalan Hydrochloride	KIT		20171222		ANDA	ANDA203393	Fresenius Kabi USA, LLC						N	20241231
63323-762_11dbb5b9-c1ad-410b-aea7-cd05239a3645	63323-762	HUMAN PRESCRIPTION DRUG	Topotecan Hydrochloride		TOPOTECAN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20101130		ANDA	ANDA091089	Fresenius Kabi USA, LLC	TOPOTECAN HYDROCHLORIDE	4	mg/4mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
63323-762_d05566f6-72f2-4b91-993f-b8ed6adee90c	63323-762	HUMAN PRESCRIPTION DRUG	Topotecan Hydrochloride		TOPOTECAN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20101130		ANDA	ANDA091089	Fresenius Kabi USA, LLC	TOPOTECAN HYDROCHLORIDE	4	mg/4mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
63323-763_f09b1d2c-e18f-43c7-90c3-473f923594d3	63323-763	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20090320		ANDA	ANDA077574	Fresenius Kabi USA, LLC	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
63323-771_c8e569b9-aac0-47ef-8891-3bbdc620a359	63323-771	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20170316		ANDA	ANDA207518	Fresenius Kabi USA, LLC	AZACITIDINE	100	mg/30mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-778_48b93f8f-93d5-4ca0-befe-b4dab9781d28	63323-778	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180417		ANDA	ANDA209331	Fresenius Kabi USA, LLC	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63323-781_19b712c5-7fb2-435c-aa19-6e63fd1ced39	63323-781	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160630		ANDA	ANDA205390	Fresenius Kabi USA, LLC	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-781_ef0a4c9f-a65e-48dd-b625-eb76a18905f2	63323-781	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160630		ANDA	ANDA205390	Fresenius Kabi USA, LLC	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-782_ef0a4c9f-a65e-48dd-b625-eb76a18905f2	63323-782	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160630		ANDA	ANDA205390	Fresenius Kabi USA, LLC	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
63323-806_a3532e70-055b-479d-9b5a-bc56b7eb3101	63323-806	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190503		ANDA	ANDA210762	Fresenius Kabi USA, LLC	FENTANYL CITRATE	.05	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-808_2fd7132a-0a1d-4b7c-8f38-d163ce092fd0	63323-808	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200930		ANDA	ANDA212086	Fresenius Kabi USA, LLC	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-810_2fd7132a-0a1d-4b7c-8f38-d163ce092fd0	63323-810	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210115		ANDA	ANDA212086	Fresenius Kabi USA, LLC	FENTANYL CITRATE	100	ug/2mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-811_f28ac591-52e8-4c3f-93a8-8b5174b97d97	63323-811	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20201101		ANDA	ANDA206199	Fresenius Kabi USA, LLC	OXACILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63323-812_c7907a70-1efa-46eb-b046-fcf043fdb413	63323-812	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201101		ANDA	ANDA206198	Fresenius Kabi USA, LLC	OXACILLIN SODIUM	2	g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63323-813_c7907a70-1efa-46eb-b046-fcf043fdb413	63323-813	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201101		ANDA	ANDA206198	Fresenius Kabi USA, LLC	OXACILLIN SODIUM	1	g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63323-815_04612f35-e6fb-4937-bdfe-32105876c5b6	63323-815	HUMAN PRESCRIPTION DRUG	Amikacin Sulfate		Amikacin Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151209		ANDA	ANDA205604	Fresenius Kabi USA, LLC	AMIKACIN SULFATE	250	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
63323-820_7b8a6525-3481-465a-86b9-e92ef38cec75	63323-820	HUMAN PRESCRIPTION DRUG	Smoflipid		Smoflipid	INJECTION, EMULSION	INTRAVENOUS	20160713		NDA	NDA207648	Fresenius Kabi USA, LLC	FISH OIL; MEDIUM-CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL	3; 6; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL	Lipid Emulsion [EPC], Lipid Emulsion [EPC], Lipids [CS], Lipids [CS]		N	20241231
63323-821_d5673806-0259-4f59-9c87-e973fa00f8e1	63323-821	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502		ANDA	ANDA209659	Fresenius Kabi USA, LLC	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
63323-823_8a08dc4b-9129-4b04-b586-19ca10abeafb	63323-823	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191010		ANDA	ANDA208790	Fresenius Kabi USA, LLC	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
63323-824_d4eda8d8-e374-469e-8ac0-9c9fb7a58aaf	63323-824	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20190329		ANDA	ANDA209448	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE	100	mg/mL			N	20241231
63323-825_9597df32-1230-63c3-e053-2995a90a3acf	63323-825	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191202		ANDA	ANDA210756	Fresenius Kabi USA, LLC	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
63323-842_d6d9c538-e365-4e27-9371-531342f93897	63323-842	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	20190912		ANDA	ANDA210257	Fresenius Kabi USA, LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63323-850_78ddbe5e-f994-4167-8e9f-ecc3108a284b	63323-850	HUMAN PRESCRIPTION DRUG	Moxifloxacin		MOXIFLOXACIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20150318		NDA	NDA205572	Fresenius Kabi USA, LLC	MOXIFLOXACIN HYDROCHLORIDE	400	mg/250mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63323-851_b6b97afc-bc81-4cef-a031-08c68bd02c8f	63323-851	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171215		NDA	NDA019034	Fresenius Kabi USA, LLC	HYDROMORPHONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-852_b6b97afc-bc81-4cef-a031-08c68bd02c8f	63323-852	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171215		NDA	NDA019034	Fresenius Kabi USA, LLC	HYDROMORPHONE HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-853_b6b97afc-bc81-4cef-a031-08c68bd02c8f	63323-853	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171215		NDA	NDA019034	Fresenius Kabi USA, LLC	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-854_b6b97afc-bc81-4cef-a031-08c68bd02c8f	63323-854	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171215		NDA	NDA019034	Fresenius Kabi USA, LLC	HYDROMORPHONE HYDROCHLORIDE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63323-867_81d84124-ccfc-423f-8f6f-bc816f82b2b5	63323-867	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201026		ANDA	ANDA211194	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .3	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-869_9ad292e3-6730-40b8-bdfc-3ff3f93af841	63323-869	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201026		ANDA	ANDA211276	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .45	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-870_cf512680-be23-415a-852b-5806668e61d0	63323-870	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201026		ANDA	ANDA211211	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .9	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-871_54a51227-ae83-4fec-a18b-ebadbc72fcf8	63323-871	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160628		ANDA	ANDA206005	Fresenius Kabi USA, LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
63323-873_e7cba27a-cf18-40d9-986d-29f552d413ff	63323-873	HUMAN PRESCRIPTION DRUG	Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE and SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201026		ANDA	ANDA211221	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	5; .225	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-874_246065b3-688f-43b6-b847-9ba16ac639d4	63323-874	HUMAN PRESCRIPTION DRUG	DEXTROSE AND SODIUM CHLORIDE		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA211190	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; SODIUM CHLORIDE	2.5; .45	g/100mL; g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-875_773fcafd-38ca-4aeb-9ecd-e7d436560ddb	63323-875	HUMAN PRESCRIPTION DRUG	Foscarnet		foscarnet sodium	INJECTION, SOLUTION	INTRAVENOUS	20210129		ANDA	ANDA212483	Fresenius Kabi USA, LLC	FOSCARNET SODIUM	24	mg/mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
63323-877_cd129b1e-4b12-443e-a3de-6cc056830fa1	63323-877	HUMAN PRESCRIPTION DRUG	NebuPent		PENTAMIDINE ISETHIONATE	INHALANT	RESPIRATORY (INHALATION)	20110215		NDA	NDA019887	Fresenius Kabi USA, LLC	PENTAMIDINE ISETHIONATE	300	mg/6mL	Antiprotozoal [EPC]		N	20241231
63323-881_3ae3c9a3-3503-4264-8c77-00089f50cc74	63323-881	HUMAN PRESCRIPTION DRUG	Sodium Phosphates		sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous	INJECTION, SOLUTION	INTRAVENOUS	20220330		ANDA	ANDA209997	Fresenius Kabi USA, LLC	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	142; 276	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-883_9b008181-ab33-db2f-e053-2995a90aad57	63323-883	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		DOXORUBICIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20000414		ANDA	ANDA063277	Fresenius Kabi USA, LLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
63323-884_3ae3c9a3-3503-4264-8c77-00089f50cc74	63323-884	HUMAN PRESCRIPTION DRUG	Sodium Phosphates		sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous	INJECTION, SOLUTION	INTRAVENOUS	20220330		ANDA	ANDA209997	Fresenius Kabi USA, LLC	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	142; 276	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-885_6514086f-834b-4c0c-82a1-c95338ef42a0	63323-885	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	INJECTION, SOLUTION	INTRAVENOUS	20180529		NDA	NDA210632	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM	20	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-885_a943dd1f-16c4-442c-b7a8-b2d6ba105004	63323-885	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	INJECTION, SOLUTION	INTRAVENOUS	20180529		NDA	NDA210632	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM	20	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-885_b76cd786-4b5c-4f96-bbbf-a7399d50fb27	63323-885	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	INJECTION, SOLUTION	INTRAVENOUS	20180529		NDA	NDA210632	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM	20	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-886_3ae3c9a3-3503-4264-8c77-00089f50cc74	63323-886	HUMAN PRESCRIPTION DRUG	Sodium Phosphates		sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous	INJECTION, SOLUTION	INTRAVENOUS	20220330		ANDA	ANDA209997	Fresenius Kabi USA, LLC	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	142; 276	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-890_a943dd1f-16c4-442c-b7a8-b2d6ba105004	63323-890	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	INJECTION, SOLUTION	INTRAVENOUS	20180529		NDA	NDA210632	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM	40	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-895_a943dd1f-16c4-442c-b7a8-b2d6ba105004	63323-895	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	INJECTION, SOLUTION	INTRAVENOUS	20180529		NDA	NDA210632	Fresenius Kabi USA, LLC	LEVOTHYROXINE SODIUM	100	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63323-915_2f22758f-1fa9-450c-bee9-568f12a1997f	63323-915	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20191104		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	20000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-915_56eabaa1-9620-4250-924d-df9ad695fdc2	63323-915	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19720222		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	20000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63323-924_0a452260-751d-4bec-9888-4306894fa93c	63323-924	HUMAN PRESCRIPTION DRUG	Bacteriostatic Sodium Chloride		SODIUM CHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20000808		ANDA	ANDA088911	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
63323-926_89d989ef-6d9f-4b93-a271-5a9664b0f328	63323-926	HUMAN PRESCRIPTION DRUG	Romidepsin		Romidepsin	KIT		20211012		ANDA	ANDA206254	Fresenius Kabi USA, LLC						N	20241231
63323-930_d353404e-766d-43f2-9ce6-305ed87722cc	63323-930	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION, SOLUTION	INTRAVENOUS	20230526		ANDA	ANDA213206	Fresenius Kabi USA, LLC	VASOPRESSIN	20	[USP'U]/mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
63323-940_c7fb762a-d42e-44a1-9c3a-af503aa96fb5	63323-940	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		NOREPINEPHRINE BITARTRATE	SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA211382	Fresenius Kabi USA, LLC	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
63323-943_63babf60-dc94-4478-bfec-f293cd333e1f	63323-943	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		SUCCINYLCHOLINE CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210125		ANDA	ANDA211346	Fresenius Kabi USA, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
63323-960_be02ec53-e514-4779-841b-22c6af4771af	63323-960	HUMAN PRESCRIPTION DRUG	Tigecycline		Tigecycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161201		NDA	NDA205645	Fresenius Kabi USA, LLC	TIGECYCLINE	50	mg/5mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
63323-961_fd2c8ca9-52d9-4df8-bcd8-8569a4989cd0	63323-961	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION	INTRAVENOUS	20140904		ANDA	ANDA202923	Fresenius Kabi USA, LLC	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
63323-963_2d292664-30db-4cb4-8e38-21b5d684c635	63323-963	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20121109		ANDA	ANDA200644	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-963_c37a989c-c130-4837-ba1e-5789bfd5f3a4	63323-963	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20121109		ANDA	ANDA200644	Fresenius Kabi USA, LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
63323-965_a1b31b46-2bb4-457e-a30b-e7dab47a2c54	63323-965	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	19990927		ANDA	ANDA088901	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE	2	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-966_9fb5ae91-44b4-4b48-aaeb-0a2ba676aa16	63323-966	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20170217		ANDA	ANDA204217	Fresenius Kabi USA, LLC	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
63323-967_a1b31b46-2bb4-457e-a30b-e7dab47a2c54	63323-967	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20000905		ANDA	ANDA088908	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE	2	meq/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63323-970_a57917b5-0d73-40ce-9cec-1f66b0684139	63323-970	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110531		ANDA	ANDA090233	Fresenius Kabi USA, LLC	BENZTROPINE MESYLATE	1	mg/mL	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
63323-972_4481c0e3-2678-4361-8d31-3f9fe2e6665e	63323-972	HUMAN PRESCRIPTION DRUG	Fosaprepitant		FOSAPREPITANT	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190905		ANDA	ANDA206197	Fresenius Kabi USA, LLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
63323-981_0802b499-4d2a-43ad-8fea-ad80b6738a46	63323-981	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180518		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-981_6487ad37-921c-4994-bef4-38854cdecec9	63323-981	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180518		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-982_0802b499-4d2a-43ad-8fea-ad80b6738a46	63323-982	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180518		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-982_6487ad37-921c-4994-bef4-38854cdecec9	63323-982	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180518		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-983_0802b499-4d2a-43ad-8fea-ad80b6738a46	63323-983	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180518		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63323-983_6487ad37-921c-4994-bef4-38854cdecec9	63323-983	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180518		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
63347-112_52aacff7-6265-4446-9dd0-dfef99dd4785	63347-112	HUMAN OTC DRUG	RevitaDERM PSORIASIS		COAL TAR	OINTMENT	TOPICAL	20111101		OTC MONOGRAPH DRUG	M032	Blaine Labs Inc.	COAL TAR	2	mg/100mL			N	20241231
63347-120_69b73949-a7e7-4e85-911e-ae688d658bbf	63347-120	HUMAN OTC DRUG	RevitaDERM Wound Care		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20120524		OTC MONOGRAPH DRUG	M003	Blaine Labs Inc.	BENZALKONIUM CHLORIDE	170	mg/89mL			N	20241231
63347-130_665e9976-dd83-4b80-8f56-18140f5a1868	63347-130	HUMAN OTC DRUG	All Acne Treatment		SALICYLIC ACID	GEL	TOPICAL	20220517		OTC MONOGRAPH DRUG	M006	Blaine Labs Inc.	SALICYLIC ACID	.5	g/100g			N	20241231
63347-223_421ca685-190c-41ab-a718-52be851b2bdb	63347-223	HUMAN OTC DRUG	HempNesic		Menthol, Camphor	GEL	TOPICAL	20180401		OTC MONOGRAPH DRUG	M012	Blaine Labs Inc.	CAMPHOR (SYNTHETIC); MENTHOL	.2; 3.5	g/100mL; g/100mL			N	20241231
63347-223_c16a7bdb-02fe-45e7-b103-de8ec4b8be7b	63347-223	HUMAN OTC DRUG	HempNesic		Menthol, Camphor	GEL	TOPICAL	20180401		OTC MONOGRAPH DRUG	M012	Blaine Labs Inc.	CAMPHOR (SYNTHETIC); MENTHOL	.2; 3.5	g/100mL; g/100mL			N	20241231
63347-401_dd198e83-da7d-4242-9107-743c3ca699c8	63347-401	HUMAN OTC DRUG	Ortho-Nesic With Capsaicin		Menthol	GEL	TOPICAL	19950101		OTC MONOGRAPH DRUG	M012	Blaine Labs Inc.	CAMPHOR (SYNTHETIC); MENTHOL	.2; 3.5	g/100g; g/100g			N	20241231
63347-502_f1fed33a-86fb-436f-a6f6-c0d5b0ace649	63347-502	HUMAN OTC DRUG	TINEACIDE	Antifungal	MICONAZOLE NITRATE	CREAM	TOPICAL	20130601		OTC MONOGRAPH DRUG	M005	Blaine Labs Inc.	MICONAZOLE NITRATE	.7	g/35g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63347-511_7929e269-caee-4126-a9ba-14cbc2dd73d1	63347-511	HUMAN OTC DRUG	TINEACIDE		TOLNAFTATE	LIQUID	TOPICAL	20120919		OTC MONOGRAPH DRUG	M005	Blaine Labs Inc.	TOLNAFTATE	140	mg/15mL			N	20241231
63347-600_92f83cae-7224-46f8-a9ac-550118c21f29	63347-600	HUMAN OTC DRUG	TERPENICOL	ANTIFUNGAL	UNDECYLENIC ACID	LIQUID	TOPICAL	20140401		OTC MONOGRAPH DRUG	M005	Blaine Labs Inc.	UNDECYLENIC ACID	25	g/100mL			N	20241231
63347-601_f6a16024-2fa1-44ff-a718-af2dc7ae822e	63347-601	HUMAN OTC DRUG	TERPENICOL		UNDECYLENIC ACID	CREAM	TOPICAL	20170619		OTC MONOGRAPH DRUG	M005	Blaine Labs Inc.	UNDECYLENIC ACID	4.55	g/37.5mL			N	20241231
63347-720_772f74a2-46cc-44aa-99d3-2189d512d53f	63347-720	HUMAN OTC DRUG	VERUCIDE WART REMOVER Kit		Wart Remover	KIT		20230929		OTC MONOGRAPH DRUG	M028	Blaine Labs Inc.						N	20241231
63347-800_b2789482-7ddf-4185-abd9-26e1f57c15c6	63347-800	HUMAN OTC DRUG	Vite20		UNDECYLENIC ACID	CREAM	TOPICAL	20120201		OTC MONOGRAPH DRUG	M005	Blaine Labs Inc.	UNDECYLENIC ACID	2	mg/20mL			N	20241231
63347-810_e5f572fd-5c6e-4454-81a2-2cc33bf73f64	63347-810	HUMAN OTC DRUG	Vite20		MICONAZOLE NITRATE	LIQUID	TOPICAL	20160401		OTC MONOGRAPH DRUG	M005	Blaine Labs Inc.	MICONAZOLE NITRATE	.3	mg/15mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63354-039_edfed70d-507d-e2e1-e053-2995a90a238b	63354-039	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20181015		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-043_0b283930-4500-cc99-e063-6294a90af431	63354-043	HUMAN OTC DRUG	Banana Boat Sport Mineral SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20220412		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 6.5	g/100g; g/100g			N	20241231
63354-046_09bd46fc-4198-af92-e063-6394a90a9a59	63354-046	HUMAN OTC DRUG	Banana Boat Sport Ultra Face SPF30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20220412		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 6; 4.5; 4.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-054_0b6532c1-7eba-b65f-e063-6294a90a4949	63354-054	HUMAN OTC DRUG	Hawaiian Tropic Everyday Active SPF30		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	LOTION	TOPICAL	20220413		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.2; 7; 4.2	g/100g; g/100g; g/100g			N	20241231
63354-073_0a3701dc-e31c-6d38-e063-6294a90aac74	63354-073	HUMAN OTC DRUG	Banana Boat Kids Sport Sunscreen Roll-On UVA/UVB Broad Spectrum SPF 60 Plus		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-078_0ad976fd-2ef4-7d53-e063-6394a90aff3a	63354-078	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20181015		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-081_0c6aeadb-f61e-29e3-e063-6294a90a7473	63354-081	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	LOTION	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 9; 7.5	g/100g; g/100g; g/100g			N	20241231
63354-083_0890dd2a-4b03-bd95-e063-6394a90a5be2	63354-083	HUMAN OTC DRUG	HAWAIIAN TROPIC SUNSCREEN CLEAR WEIGHTLESS HYDRATION SPF70		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.8; 9.5; 4.7; 7.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-099_069afc12-0eeb-5b8a-e063-6394a90a7699	63354-099	HUMAN OTC DRUG	Wet Ones Hand Sanitizing Wipes Plus		ETHYL ALCOHOL	SWAB	TOPICAL	20220726		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	ALCOHOL	70	mL/100mL			N	20241231
63354-102_06d74dbd-d847-5580-e063-6394a90aa72e	63354-102	HUMAN OTC DRUG	BANANA BOAT		ZINC OXIDE	AEROSOL, SPRAY	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	ZINC OXIDE	16.8	g/100g			N	20241231
63354-103_06d74dbd-d848-5580-e063-6394a90aa72e	63354-103	HUMAN OTC DRUG	BANANA BOAT		ZINC OXIDE	AEROSOL, SPRAY	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	ZINC OXIDE	16.8	g/100g			N	20241231
63354-115_0ac1f742-681b-f508-e063-6294a90a964b	63354-115	HUMAN OTC DRUG	BANANA BOAT KIDS FREE 50		BANANA BOAT KIDS FREE 50	SPRAY	TOPICAL	20150108		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-129_099835ad-890e-7fde-e063-6394a90a24ee	63354-129	HUMAN OTC DRUG	Banana Boat		Avobenzone Homosalate Octisalate Octocrylene Oxybenzone	SPRAY	TOPICAL	20141015		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
63354-140_d578f0b0-5e63-1ef2-e053-2995a90ae7c1	63354-140	HUMAN OTC DRUG	BANANA BOAT		avobenzone, octocrylene, oxybenzone	STICK	TOPICAL	20110826		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	2; 10; 6	g/100g; g/100g; g/100g			N	20241231
63354-159_e53509bf-6bb8-2db7-e053-2a95a90aae18	63354-159	HUMAN OTC DRUG	BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BORAD SPECTRUM SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-164_06d73d47-c91d-b3a3-e063-6294a90aa135	63354-164	HUMAN OTC DRUG	BANANA BOAT		ZINC OXIDE	STICK	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	ZINC OXIDE	23.8	g/100g			N	20241231
63354-166_06d74dbd-d846-5580-e063-6394a90aa72e	63354-166	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-179_0cdff8a8-db86-4bc6-e063-6394a90a3824	63354-179	HUMAN OTC DRUG	Hawaiian Tropic Everyday Active SPF50		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20220413		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-181_06d73d47-c91a-b3a3-e063-6294a90aa135	63354-181	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-190_5cf23262-9b34-66fc-e053-2a91aa0ae062	63354-190	HUMAN OTC DRUG	Banana Boat		AVOBENZONE HOMOSALATE OCTOCRYLENE	SPRAY	TOPICAL	20150407		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1.5; 5; 3.5	g/100g; g/100g; g/100g			N	20241231
63354-195_087cc01e-0a95-0625-e063-6294a90a741c	63354-195	HUMAN OTC DRUG	HAWAIIAN TROPIC INVISIBLE SUNSCREEN SHEER TOUCH SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LIQUID	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 6; 4.5; 4.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-196_087cd69b-30e3-26a7-e063-6394a90a3922	63354-196	HUMAN OTC DRUG	HAWAIIAN TROPIC INVISIBLE SUNSCREEN SHEER TOUCH SPF 50		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LIQUID	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-197_eb41b1ad-d3fc-bd78-e053-2995a90a925b	63354-197	HUMAN OTC DRUG	HAWAIIAN TROPIC SUNSCREEN SHEER TOUCH FACE SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LIQUID	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 6; 4.5; 4.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-201_098345af-981a-77dd-e063-6294a90aa11e	63354-201	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140101		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
63354-204_0a33e170-e8ac-25a8-e063-6394a90addf5	63354-204	HUMAN OTC DRUG	Banana Boat Ultra Sport Sunscreen Broad Spectrum SPF 15		Avobenzone,Homosalate,Octisalate,Octocrylene	LOTION	TOPICAL	20191114		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3; 4.5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-207_0a372502-348f-aa74-e063-6394a90a4c54	63354-207	HUMAN OTC DRUG	Banana Boat Sport Ultra Sunscreen Roll-On UVA/UVB Broad Spectrum SPF 60 Plus		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-211_0aafef6f-a3f1-776b-e063-6294a90ac086	63354-211	HUMAN OTC DRUG	Banana Boat Sport coolzone Clear Sunscreen Broad Spectrum SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	SPRAY	TOPICAL	20200728		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 6; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-219_098254ea-eab3-06f9-e063-6294a90a2e27	63354-219	HUMAN OTC DRUG	BANANA BOAT		avobenzone, octocrylene, oxybenzone	LOTION	TOPICAL	20121119		OTC MONOGRAPH DRUG	M020	EdgewellPersonal Care Brands LLC	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	2.5; 8; 3.5	g/100g; g/100g; g/100g			N	20241231
63354-220_7c4a172a-4beb-56ca-e053-2a91aa0a87ea	63354-220	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OXYBENZONE	OIL	TOPICAL	20121119		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE; OXYBENZONE	3; 5; 4; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-232_090904d1-c04d-3fca-e063-6294a90a7cc7	63354-232	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-241_0829a76c-6c90-4a9b-e063-6294a90a22d6	63354-241	HUMAN OTC DRUG	HAWAIIAN TROPIC		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181005		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-261_0a38b184-ec56-4fcb-e063-6294a90a8c58	63354-261	HUMAN OTC DRUG	Banana Boat simply protect sensitive MINERAL ENRICHED SUNSCREEN UVA/UVB BROAD SPECTRUM SPF 50		HOMOSALATE,OCTISALATE,OCTOCRYLENE,ZINC OXIDE	SPRAY	TOPICAL	20190923		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	9; 3; 6; 7.3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-264_0ad8187d-43a4-933b-e063-6294a90a20c4	63354-264	HUMAN OTC DRUG	Banana Boat		HOMOSALATE,OCTISALATE,OCTOCRYLENE,ZINC OXIDE	SPRAY	TOPICAL	20200430		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	9; 3; 6; 7.3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-270_dae52e15-9162-c8d2-e053-2a95a90adb98	63354-270	HUMAN OTC DRUG	Wet Ones Hand Sanitizer Mist Lavender Blossom		ETHYL ALCOHOL	AEROSOL, SPRAY	TOPICAL	20220620		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	ALCOHOL	63.2	mL/100mL			N	20241231
63354-271_0a373f1c-2e1e-80b7-e063-6294a90af9bc	63354-271	HUMAN OTC DRUG	Banana Boat Sport Ultra Sunscreen Broad Spectrum SPF 65		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20211115		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 13.5; 4.5; 6.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-278_0c6a7d4c-c1bd-feeb-e063-6394a90a0e5b	63354-278	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20181015		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-299_0905f71b-0a6a-877c-e063-6294a90a3bfe	63354-299	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2; 7; 5	g/100g; g/100g; g/100g			N	20241231
63354-311_0878d9b0-a59f-01a2-e063-6294a90ade85	63354-311	HUMAN OTC DRUG	Hawaiian Tropic Silk Hydration Broad Spectrum SPF 15		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	OIL	TOPICAL	20200921		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1.5; 5; 3.5	g/100g; g/100g; g/100g			N	20241231
63354-319_0b625d48-9633-0464-e063-6394a90a9adc	63354-319	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE OCTISALATE OCTOCRYLENE	OIL	TOPICAL	20231130		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2; 2.5; 3	g/100g; g/100g; g/100g			N	20241231
63354-323_0afaece8-be85-9ed5-e063-6394a90ae69c	63354-323	HUMAN OTC DRUG	BANANA BOAT		HOMOSALATE OCTOCRYLENE	SPRAY	TOPICAL	20150224		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	HOMOSALATE; OCTOCRYLENE	3; 1	g/100g; g/100g			N	20241231
63354-324_06e8dfa4-360c-bda1-e063-6394a90a3bf8	63354-324	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.7; 8; 6	g/100g; g/100g; g/100g			N	20241231
63354-332_0ac12ced-70b5-7bbe-e063-6394a90aad52	63354-332	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE HOMOSALATE OCTOCRYLENE	SPRAY	TOPICAL	20150224		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1; 3; 2	g/100g; g/100g; g/100g			N	20241231
63354-340_097f836c-0683-f1b0-e063-6394a90ac9c3	63354-340	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE HOMOSALATE OCTOCRYLENE	SPRAY	TOPICAL	20150224		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1.5; 5; 3.5	g/100g; g/100g; g/100g			N	20241231
63354-341_0a9ceb73-b41e-867b-e063-6294a90a5056	63354-341	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20181015		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2; 6; 6	g/100g; g/100g; g/100g			N	20241231
63354-353_0a4a3484-d5c3-d476-e063-6394a90a1736	63354-353	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE HOMOSALATE OCTOCRYLENE	SPRAY	TOPICAL	20150223		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2; 7; 5	g/100g; g/100g; g/100g			N	20241231
63354-361_0ad6e962-ab09-245f-e063-6394a90a1a08	63354-361	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20181031		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1.6; 4; 4.5	g/100g; g/100g; g/100g			N	20241231
63354-364_0a9940f4-934e-c726-e063-6394a90ad1ce	63354-364	HUMAN OTC DRUG	Banana Boat Mineral Sensitive Face SPF50		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20220412		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 6.5	g/100g; g/100g			N	20241231
63354-379_8b889b75-07ad-4276-e053-2a95a90a69c6	63354-379	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20190617		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2; 6; 6	g/100g; g/100g; g/100g			N	20241231
63354-383_0a36aba0-d573-46ba-e063-6294a90a238f	63354-383	HUMAN OTC DRUG	Banana Boat Kids Mineral 100% Sunscreen UVA/UVB Broad Spectrum SPF 30		ZINC OXIDE	SPRAY	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	ZINC OXIDE	15	g/100g			N	20241231
63354-384_0a36aba0-d57d-46ba-e063-6294a90a238f	63354-384	HUMAN OTC DRUG	Banana Boat Sport Mineral 100% Sunscreen UVA/UVB Broad Spectrum SPF 30		ZINC OXIDE	SPRAY	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	ZINC OXIDE	15	g/100g			N	20241231
63354-386_087c8864-70d9-59db-e063-6294a90ab210	63354-386	HUMAN OTC DRUG	HAWAIIAN TROPIC SUNSCREEN SHEER TOUCH SPF 70		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.8; 9.5; 4.7; 8.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-387_0a385568-db69-1e78-e063-6294a90ad947	63354-387	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20180102		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-388_0a466db9-64b5-00b1-e063-6294a90adef3	63354-388	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20180102		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-389_0a4c0818-6055-7e1e-e063-6394a90a6322	63354-389	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20180102		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-410_edfeda0a-34c4-11e4-e053-2a95a90adf20	63354-410	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20130101		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4.5; 3.2; 2.4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-420_0829dfb9-a4e1-c9f8-e063-6394a90ac679	63354-420	HUMAN OTC DRUG	Hawaiian Tropic		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181029		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 8; 4.5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-421_087bb2a9-63c4-9667-e063-6394a90a7b48	63354-421	HUMAN OTC DRUG	Hawaiian Tropic Mineral Skin Nourishing Milk Sunscreen Broad Spectrum SPF 30		ZINC OXIDE	LOTION	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	ZINC OXIDE	15	g/100g			N	20241231
63354-436_09a51e8e-627d-1be8-e063-6394a90a3e11	63354-436	HUMAN OTC DRUG	Banana Boat Mineral Sensitive SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20220412		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 6.5	g/100g; g/100g			N	20241231
63354-453_06e8fff9-be6d-f44d-e063-6394a90a72d7	63354-453	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3.5; 2; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-454_06e8fdb7-42c5-e4e7-e063-6394a90a3c7b	63354-454	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3.5; 2; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-470_09bb2be5-eeba-5b5a-e063-6294a90ae931	63354-470	HUMAN OTC DRUG	Banana Boat Ultra Sport Sunscreen Broad Spectrum SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20200626		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 6; 4.5; 4.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-481_0bc57113-b8f4-a560-e063-6294a90a558d	63354-481	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190530		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-483_0a35f15c-c1c8-e9d4-e063-6294a90a333d	63354-483	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190306		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-493_06e8f4b5-17eb-1980-e063-6294a90a1bf1	63354-493	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-494_0918fdd3-cffc-78e9-e063-6394a90ad5c7	63354-494	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3; 2; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-500_06d73d47-c91e-b3a3-e063-6294a90aa135	63354-500	HUMAN OTC DRUG	BANANA BOAT PROTECTION PLUS VITAMINS FACE SUNSCREEN UVA/UVB BROAD SPECTRUM SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-502_08f1d9ea-888b-df3f-e063-6394a90aadfa	63354-502	HUMAN OTC DRUG	Hawaiian Tropic Matte Effect Mineral Enriched Sunscreen SPF 30		Homosalate, Octisalate, Octocrylene, Zinc Oxide	LOTION	TOPICAL	20190906		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	6; 4.5; 4.5; 5.6695	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-512_06e902ac-e32c-43f1-e063-6294a90a4328	63354-512	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.7; 4.5; 5.2	g/100g; g/100g; g/100g			N	20241231
63354-520_087be9c3-6893-bf98-e063-6294a90af4b5	63354-520	HUMAN OTC DRUG	Hawaiian Tropic Lip Balm Sunscreen SPF 30		AVOBENZONE,OCTISALATE,OCTOCRYLENE	STICK	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100g; g/100g; g/100g			N	20241231
63354-521_0867da12-c430-d353-e063-6294a90ae2af	63354-521	HUMAN OTC DRUG	Hawaiian Tropic Island Tanning Broad Spectrum SPF 25		Avobenzone,Homosalate,Octisalate,Octocrylene	OIL	TOPICAL	20191118		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 7; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-523_0909824b-772c-185a-e063-6394a90a59de	63354-523	HUMAN OTC DRUG	Hawaiian Tropic Silk Hydration Clear Sunscreen Broad Spectrum SPF50		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	SPRAY	TOPICAL	20200728		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-527_dc67bb11-e77d-4dc3-e053-2a95a90af4e4	63354-527	HUMAN OTC DRUG	Wet Ones Hand Sanitizer		ETHYL ALCOHOL	LIQUID	TOPICAL	20220411		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	DEHYDRATED ALCOHOL	63.2	mL/100mL			N	20241231
63354-536_0649dece-7e1f-f1c5-e063-6294a90a15c3	63354-536	HUMAN OTC DRUG	Wet Ones Antibacterial Hand Wipes Lavender Scent		Benzalkonium Chloride	SWAB	TOPICAL	20221201		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
63354-542_0868c03c-702e-738d-e063-6394a90a9933	63354-542	HUMAN OTC DRUG	Hawaiian Tropic Matte Effect Mineral Enriched Sunscreen SPF 50		HOMOSALATE,OCTISALATE,OCTOCRYLENE,ZINC OXIDE	LOTION	TOPICAL	20190814		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	8; 4.5; 5.75; 7.395	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-543_f05b3c40-fe61-3b17-e053-2995a90a046b	63354-543	HUMAN OTC DRUG	Schick Hydro Silk Post-Dermaplaning Moisturizer Broad Spectrum SPF 50		Avobenzone,Homosalate,Octisalate,Octocrylene	LOTION	TOPICAL	20221221		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-547_efb832d3-cc64-4d58-e053-2a95a90a642b	63354-547	HUMAN OTC DRUG	Wet Ones Antibacterial Hand Wipes - Eucalyptus and Mint		Benzalkonium Chloride	SWAB	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	BENZALKONIUM CHLORIDE	.11	g/100g			N	20241231
63354-548_8a1f4906-8fd6-1408-e053-2a95a90a771f	63354-548	HUMAN OTC DRUG	Banana Boat Light as air face SUNSCREEN UVA UVB Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190530		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-549_0b3c5d39-439f-9073-e063-6294a90a2e45	63354-549	HUMAN OTC DRUG	Hawaiian Tropic Everyday Active SPF15		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20220413		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3; 2; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-571_08f13eda-989d-8a2a-e063-6394a90a6003	63354-571	HUMAN OTC DRUG	BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BROAD SPECTRUM SPF 50		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-581_053e273b-56f8-ee07-e063-6394a90abbaa	63354-581	HUMAN OTC DRUG	Hawaiian Tropic Silk Hydration Sunscreen Face Broad Spectrum SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	LOTION	TOPICAL	20201023		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-593_08f34b31-6338-ef7c-e063-6294a90a1c4c	63354-593	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,OCTOCRYLENE	SPRAY	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTOCRYLENE	1; 3	g/100g; g/100g			N	20241231
63354-597_0b29886a-a18e-eca7-e063-6294a90a2883	63354-597	HUMAN OTC DRUG	Banana Boat Sport Ultra Broad Spectrum SPF 50 Plus Sunscreen Lip Balm		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	STICK	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-613_08f3b27f-b234-d406-e063-6394a90ada76	63354-613	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 6; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-625_091d8fa7-911d-dbd7-e063-6294a90a02fc	63354-625	HUMAN OTC DRUG	HAWAIIAN TROPIC		avobenzone, octocrylene	LOTION	TOPICAL	20120101		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; OCTOCRYLENE	.5; 1	g/100g; g/100g			N	20241231
63354-631_08a030af-1aed-0100-e063-6294a90a9b88	63354-631	HUMAN OTC DRUG	BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BORAD SPECTRUM SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-632_0878f17e-545f-089f-e063-6394a90ab81f	63354-632	HUMAN OTC DRUG	Hawaiin Tropic Silk Hydration Dry Broad Spectrum SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	OIL	TOPICAL	20200925		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 6; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-634_0a371d76-2ba2-ae1a-e063-6394a90af615	63354-634	HUMAN OTC DRUG	Banana Boat Sport Ultra Clear Sunscreen Broad Spectrum SPF 65		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20211015		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-640_0a4b3245-0a33-2420-e063-6394a90a46fa	63354-640	HUMAN OTC DRUG	Banana Boat Kids Mineral Protection SPF50		TITANIUM DIOXIDE,ZINC OXIDE	LOTION	TOPICAL	20220412		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 6.5	g/100g; g/100g			N	20241231
63354-641_08a069fb-2ce7-eb9f-e063-6294a90a609d	63354-641	HUMAN OTC DRUG	BANANA BOAT PROTECTION PLUS VITAMINS SUNSCREEN UVA/UVB BORAD SPECTRUM SPF 30		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 6; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-643_0869ac56-9014-a42c-e063-6394a90a4c9d	63354-643	HUMAN OTC DRUG	Hawaiian Tropic Mineral Face Skin Nourishing Tinted Milk Coconut Oil SPF30		Titanium Dioxide, Zinc Oxide	OIL	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.3; 6	g/100g; g/100g			N	20241231
63354-649_09ba859c-087e-4ca0-e063-6394a90a14f4	63354-649	HUMAN OTC DRUG	Banana Boat Deep Tanning Sunscreen SPF 4		AVOBENZONE,OCTISALATE	OIL	TOPICAL	20200729		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTISALATE	.5; 4	g/100g; g/100g			N	20241231
63354-660_0a395cf1-bdee-96d1-e063-6394a90aa325	63354-660	HUMAN OTC DRUG	Banana Boat Sport coolzone Clear Sunscreen Broad Spectrum SPF 50 Plus		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	SPRAY	TOPICAL	20200729		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-682_0a367b49-adb7-4974-e063-6394a90a66c3	63354-682	HUMAN OTC DRUG	Banana Boat Baby Mineral Enriched Sunscreen UVA/UVB Protection Broad Spectrum SPF 50PLUS		HOMOSALATE,OCTISALATE,OCTOCRYLENE,ZINC OXIDE	LOTION	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	9; 3; 6; 7.3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-688_0c7e839d-b41c-5bd7-e063-6294a90ab15e	63354-688	HUMAN OTC DRUG	Hawaiian Tropic Silk Hydration Weightless Clear Sunscreen SPF 15		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL	TOPICAL	20220413	20240831	OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.5; 3; 1; 3	g/100g; g/100g; g/100g; g/100g			N	
63354-689_09913322-688e-5633-e063-6394a90abbb9	63354-689	HUMAN OTC DRUG	Banana Boat Ultra Sport Sunscreen Broad Spectrum SPF 50		Avobenzone,Homosalate,Octisalate,Octocrylene	LOTION	TOPICAL	20191119		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 6.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-703_0c7ea2af-2d79-5b66-e063-6394a90a2bc8	63354-703	HUMAN OTC DRUG	Hawaiian Tropic Mineral Skin Nourishing Milk Coconut Oil SPF 50		Titanium Dioxide, Zinc Oxide	OIL	TOPICAL	20221001	20250831	OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.9; 6.7	g/100g; g/100g			N	
63354-712_06e8fdb7-42c7-e4e7-e063-6394a90a3c7b	63354-712	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.7; 8; 6	g/100g; g/100g; g/100g			N	20241231
63354-724_e42ad040-e6ca-e5e5-e053-2995a90a37f5	63354-724	HUMAN OTC DRUG	Banana Boat		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
63354-751_0b386972-f106-f9a4-e063-6294a90a66a7	63354-751	HUMAN OTC DRUG	Banana Boat Ultra Defense Clear Sunscreen Broad Spectrum SPF 100		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,OXYBENZONE	SPRAY	TOPICAL	20200925		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
63354-755_0c6b7ce7-8bcc-78cb-e063-6294a90aa3a3	63354-755	HUMAN OTC DRUG	Banana Boat		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20170102	20240201	OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 6.5	g/100g; g/100g			N	
63354-771_091e27a0-ca4b-1f59-e063-6394a90a6b63	63354-771	HUMAN OTC DRUG	Hawaiian Tropic Island Tanning Sunscreen Cocoa Butter SPF 4		Avobenzone,Octocrylene	LOTION	TOPICAL	20191113		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; OCTOCRYLENE	1; 2	g/100g; g/100g			N	20241231
63354-786_5cf258d5-bc64-a8a1-e053-2991aa0aeb42	63354-786	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170102		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE; OXYBENZONE	2; 7; 1.5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-787_5cf258d5-bc55-a8a1-e053-2991aa0aeb42	63354-787	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170102		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 3; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
63354-788_ee11bc36-8fb2-22bf-e053-2995a90a218a	63354-788	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20170102		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-801_0d0b2cd4-f01a-a1b9-e063-6294a90a4f23	63354-801	HUMAN OTC DRUG	Hawaiian Tropic everyday Active Sport Sunscreen SPF50		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20220412		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-803_08a5761f-2ecc-a00f-e063-6394a90a9b8f	63354-803	HUMAN OTC DRUG	Hawaiian Tropic Sport Sunscreen Everyday Active		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20211001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1.5; 5; 3.5	g/100g; g/100g; g/100g			N	20241231
63354-805_08efc731-104c-12a6-e063-6394a90aca55	63354-805	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,OCTOCRYLENE	SPRAY	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTOCRYLENE	3; 5	g/100g; g/100g			N	20241231
63354-820_087c3d5e-c534-92e9-e063-6394a90aa406	63354-820	HUMAN OTC DRUG	Hawaiian Tropic Mineral Translucent Sunscreen Powder SPF 30		Zinc Oxide	POWDER	TOPICAL	20211115		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	ZINC OXIDE	24.5	g/100g			N	20241231
63354-821_08a07131-f32a-2019-e063-6294a90a220e	63354-821	HUMAN OTC DRUG	BANANA BOAT KIDS SPF 65 CLEAR SUNSCREEN		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20220412		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-832_08294851-db1e-8f95-e063-6294a90a14c8	63354-832	HUMAN OTC DRUG	Hawaiian Tropic		Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20181019		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.7; 6; 6	g/100g; g/100g; g/100g			N	20241231
63354-832_0b65d5e6-4fda-3999-e063-6294a90a5c26	63354-832	HUMAN OTC DRUG	Hawaiian Tropic		Avobenzone, Homosalate, Octocrylene	SPRAY	TOPICAL	20190306		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.7; 6; 6	g/100g; g/100g; g/100g			N	20241231
63354-841_0c7b7571-7318-98bc-e063-6294a90aa29f	63354-841	HUMAN OTC DRUG	BANANA BOAT		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-860_0b37bfd0-4266-16e7-e063-6394a90aeb68	63354-860	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20140101		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4.5; 3.2; 2.4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-894_088fa3cd-b9b9-d10b-e063-6394a90a7fd6	63354-894	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20231026		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-902_087b5a9e-3158-abc7-e063-6394a90a554b	63354-902	HUMAN OTC DRUG	Hawaiian Tropic Lip Balm Sunscreen SPF 25		AVOBENZONE,OCTISALATE,OCTOCRYLENE	STICK	TOPICAL	20201215		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100g; g/100g; g/100g			N	20241231
63354-909_e9abef25-773f-b67f-e053-2995a90a3640	63354-909	HUMAN OTC DRUG	Wet Ones Antibacterial Non Plastic Hand Wipes		Benzalkonium Chloride	SWAB	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
63354-911_09be69fc-6428-1ef8-e063-6394a90af449	63354-911	HUMAN OTC DRUG	Banana Boat		AVOBENZONE OCTOCRYLENE OXYBENZONE	LOTION	TOPICAL	20150219		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	2.5; 8; 3.5	g/100g; g/100g; g/100g			N	20241231
63354-912_090a705d-8cd1-6711-e063-6394a90a9297	63354-912	HUMAN OTC DRUG	HAWAIIAN TROPIC		AVOBENZONE,HOMOSALATE,OCTOCRYLENE	LOTION	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.2; 7; 4.2	g/100g; g/100g; g/100g			N	20241231
63354-918_ee11cc0e-a836-3082-e053-2a95a90ab7eb	63354-918	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20180102		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-922_0afa5c21-c371-8533-e063-6394a90a0035	63354-922	HUMAN OTC DRUG	Banana Boat		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20180102		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 6.5	g/100g; g/100g			N	20241231
63354-923_ee11cc0e-a837-3082-e053-2a95a90ab7eb	63354-923	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20180102		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-925_ee11cc0e-a838-3082-e053-2a95a90ab7eb	63354-925	HUMAN OTC DRUG	Banana Boat		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20180102		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-926_06bc804e-f583-c4bd-e063-6294a90a1481	63354-926	HUMAN OTC DRUG	WET ONES		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20231001		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	BENZALKONIUM CHLORIDE	.13	g/1			N	20241231
63354-927_082ac877-9269-3f10-e063-6294a90a3db5	63354-927	HUMAN OTC DRUG	Hawaiian Tropic		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181015		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 6; 4.5; 4.5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-929_082b36e3-771d-bc16-e063-6394a90ad66d	63354-929	HUMAN OTC DRUG	Hawaiian Tropic		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181011		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-932_7c4a172a-4bb9-56ca-e053-2a91aa0a87ea	63354-932	HUMAN OTC DRUG	BANANA BOAT		avobenzone, octocrylene, oxybenzone	SPRAY	TOPICAL	20111229		OTC MONOGRAPH NOT FINAL	part352	Edgewell Personal Care Brands LLC	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	1; 7.7; 3	g/100g; g/100g; g/100g			N	20241231
63354-939_082a2a14-2c58-bf64-e063-6294a90a4cd9	63354-939	HUMAN OTC DRUG	Hawaiian Tropic Silk Hydration Clear Sunscreen Broad Spectrum SPF 50		Avobenzone,Homosalate,Octisalate,Octocrylene,Oxybenzone	SPRAY	TOPICAL	20191120		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 3; 4	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
63354-971_0b2953bf-dd25-c837-e063-6294a90af125	63354-971	HUMAN OTC DRUG	Banana Boat Sunscreen Lip Balm UVA/UVB Broad Spectrum SPF 45		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	STICK	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Edgewell Personal Care Brands LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
63354-988_e42ae9bd-ffed-6684-e053-2a95a90ade2a	63354-988	HUMAN OTC DRUG	Wet Ones Hand Sanitizer Fresh Scent		ETHYL ALCOHOL	GEL	TOPICAL	20200918		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	ALCOHOL	62.044	mL/100mL			N	20241231
63354-989_d579f41e-bf00-240b-e053-2995a90a8ef8	63354-989	HUMAN OTC DRUG	Wet Ones Antibacterial Hand Wipes Tropical Splash		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20190926		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	BENZALKONIUM CHLORIDE	.13	1/1			N	20241231
63354-995_d579f3a1-7333-27f6-e053-2995a90a84cd	63354-995	HUMAN OTC DRUG	Wet Ones Antibacterial Hand Wipes Fresh Scent		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part333A	Edgewell Personal Care Brands LLC	BENZALKONIUM CHLORIDE	.13	1/1			N	20241231
63361-243_153fb25e-6b96-481d-9de1-ed4573a43aec	63361-243	VACCINE	VAXELIS		diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20181221		BLA	BLA125563	MSP Vaccine Company	BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN; BORDETELLA PERTUSSIS PERTACTIN ANTIGEN; BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN; HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)	20; 5; 3; 20; 5; 15; 3; 10; 29; 7; 26	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; [Lf]/.5mL; [Lf]/.5mL; ug/.5mL; ug/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL	Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Haemophilus Vaccines [CS], Hepatitis B Vaccines [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Inactivated Haemophilus Influenzae B Vaccine [EPC], Inactivated Hepatitis B Virus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Inactivated Poliovirus Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Poliovirus Vaccines [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]		N	20241231
63388-910_09445992-8332-4bc7-e063-6394a90a4701	63388-910	HUMAN OTC DRUG	Kids Relief		Asafoetida, Ignatia amara, Valeriana officinalis, Avena sativa, Argentum nitricum, Hyoscyamus niger, Paeonia officinalis, Stramonium, Cocculus indicus	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Laboratoire Atlas Inc	ANAMIRTA COCCULUS WHOLE; ASAFETIDA; DATURA STRAMONIUM; HYOSCYAMUS NIGER; OAT BRAN; PAEONIA OFFICINALIS ROOT; SILVER NITRATE; STRYCHNOS IGNATII SEED; VALERIANA OFFICINALIS WHOLE	8; 8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
63388-912_09445992-8349-4bc7-e063-6394a90a4701	63388-912	HUMAN OTC DRUG	Kids Relief		DROSERA, ARNICA MONTANA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Laboratoire Atlas Inc	ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; COCHINEAL; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; TIN	3; 3; 1; 3; 3; 1; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL			N	20241231
63388-915_09449601-ffab-2d21-e063-6294a90a1119	63388-915	HUMAN OTC DRUG	Kids Relief		DROSERA, ARNICA MONTANA, BRYONIA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CHAMOMILLA, COFFEE CRUDEA	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Laboratoire Atlas Inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63388-918_0d1dfe51-f02f-f1fe-e063-6394a90ae5c6	63388-918	HUMAN OTC DRUG	Real Relief		DROSERA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Laboratoire Atlas Inc	ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PROTORTONIA CACTI; TIN	3; 3; 1; 3; 1; 3; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL			N	20241231
63388-920_0d1dfe51-f03d-f1fe-e063-6394a90ae5c6	63388-920	HUMAN OTC DRUG	Real Relief		DROSERA, ARNICA MONTANA, BRYONIA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CAMOMILLA, COFFEA CRUDEA	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Laboratoire Atlas Inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63388-989_0d1e5498-02af-5ce0-e063-6294a90a36f7	63388-989	HUMAN OTC DRUG	Real Relief		DROSERA, ARNICA MONTANA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CAMOMILLA, COFFEA CRUDEA	LIQUID	ORAL	20180503		UNAPPROVED HOMEOPATHIC		Laboratoire Atlas Inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63388-999_09457338-a48b-bdd1-e063-6394a90ab545	63388-999	HUMAN OTC DRUG	Kids Relief		DROSERA, ARNICA MONTANA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CAMOMILLA, COFFEA CRUDEA	LIQUID	ORAL	20180503		UNAPPROVED HOMEOPATHIC		Laboratoire Atlas Inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63395-201_24b744ff-3334-424d-9500-76dbfca5979a	63395-201	HUMAN PRESCRIPTION DRUG	Evoxac		cevimeline hydrochloride	CAPSULE	ORAL	20000112	20250831	NDA	NDA020989	Daiichi Sankyo, Inc.	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	
63402-190_090b28a9-9f1b-4082-9414-6dea6e722cd0	63402-190	HUMAN PRESCRIPTION DRUG	Lunesta		ESZOPICLONE	TABLET, COATED	ORAL	20050404	20250731	NDA	NDA021476	Sumitomo Pharma America, Inc.	ESZOPICLONE	1	mg/1		CIV	N	
63402-191_090b28a9-9f1b-4082-9414-6dea6e722cd0	63402-191	HUMAN PRESCRIPTION DRUG	Lunesta		ESZOPICLONE	TABLET, COATED	ORAL	20050404	20250131	NDA	NDA021476	Sumitomo Pharma America, Inc.	ESZOPICLONE	2	mg/1		CIV	N	
63402-193_090b28a9-9f1b-4082-9414-6dea6e722cd0	63402-193	HUMAN PRESCRIPTION DRUG	Lunesta		ESZOPICLONE	TABLET, COATED	ORAL	20050404	20250731	NDA	NDA021476	Sumitomo Pharma America, Inc.	ESZOPICLONE	3	mg/1		CIV	N	
63402-202_3af99c5d-50e2-4336-8a5e-e93b6cf3618a	63402-202	HUMAN PRESCRIPTION DRUG	Aptiom		ESLICARBAZEPINE ACETATE	TABLET	ORAL	20140407		NDA	NDA022416	Sumitomo Pharma America, Inc.	ESLICARBAZEPINE ACETATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63402-204_3af99c5d-50e2-4336-8a5e-e93b6cf3618a	63402-204	HUMAN PRESCRIPTION DRUG	Aptiom		ESLICARBAZEPINE ACETATE	TABLET	ORAL	20140407		NDA	NDA022416	Sumitomo Pharma America, Inc.	ESLICARBAZEPINE ACETATE	400	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63402-206_3af99c5d-50e2-4336-8a5e-e93b6cf3618a	63402-206	HUMAN PRESCRIPTION DRUG	Aptiom		ESLICARBAZEPINE ACETATE	TABLET	ORAL	20140407		NDA	NDA022416	Sumitomo Pharma America, Inc.	ESLICARBAZEPINE ACETATE	600	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63402-208_3af99c5d-50e2-4336-8a5e-e93b6cf3618a	63402-208	HUMAN PRESCRIPTION DRUG	Aptiom		ESLICARBAZEPINE ACETATE	TABLET	ORAL	20140407		NDA	NDA022416	Sumitomo Pharma America, Inc.	ESLICARBAZEPINE ACETATE	800	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63402-248_3af99c5d-50e2-4336-8a5e-e93b6cf3618a	63402-248	HUMAN PRESCRIPTION DRUG	Aptiom		ESLICARBAZEPINE ACETATE	KIT	ORAL	20140407		NDA	NDA022416	Sumitomo Pharma America, Inc.						N	20241231
63402-302_538d29c8-d0fe-4a2d-99ad-f16a9a4aa4d2	63402-302	HUMAN PRESCRIPTION DRUG	Latuda		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20111207		NDA	NDA200603	Sumitomo Pharma America, Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63402-304_538d29c8-d0fe-4a2d-99ad-f16a9a4aa4d2	63402-304	HUMAN PRESCRIPTION DRUG	Latuda		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20101028		NDA	NDA200603	Sumitomo Pharma America, Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63402-306_538d29c8-d0fe-4a2d-99ad-f16a9a4aa4d2	63402-306	HUMAN PRESCRIPTION DRUG	Latuda		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20130712		NDA	NDA200603	Sumitomo Pharma America, Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63402-308_538d29c8-d0fe-4a2d-99ad-f16a9a4aa4d2	63402-308	HUMAN PRESCRIPTION DRUG	Latuda		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20101028		NDA	NDA200603	Sumitomo Pharma America, Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63402-312_538d29c8-d0fe-4a2d-99ad-f16a9a4aa4d2	63402-312	HUMAN PRESCRIPTION DRUG	Latuda		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20120426		NDA	NDA200603	Sumitomo Pharma America, Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63404-0910_0c99f36a-9b4e-47e7-a22d-e7245c26eae0	63404-0910	HUMAN OTC DRUG	SprinJene	Fresh Boost	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20141010		OTC MONOGRAPH FINAL	part355	Health and Natural Beauty USA Corp	SODIUM FLUORIDE	1.5	mg/g			N	20241231
63404-1108_ffb7f805-b6df-43fa-a817-f1d00780be24	63404-1108	HUMAN OTC DRUG	SprinJene	Health Boost	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20160701		OTC MONOGRAPH FINAL	part355	Health and Natural Beauty USA Corp	SODIUM MONOFLUOROPHOSPHATE	1.5	mg/g			N	20241231
63418-0001_06d6c9cd-b66b-fa5f-e063-6294a90a9d24	63418-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091030		UNAPPROVED MEDICAL GAS		Rogers Pharmacy	OXYGEN	99	L/100L			N	20241231
63433-383_da98f1be-9181-47c7-8066-dd1e48e27e3d	63433-383	HUMAN OTC DRUG	DHC Salicylic Acne Wash		Salicylic Acid	LOTION	TOPICAL	20181101		OTC MONOGRAPH FINAL	part333D	DHC USA Incorporated	SALICYLIC ACID	30	mg/1.5mL			N	20241231
63433-389_b63c89b8-6c47-414f-92e7-7d91207e9a14	63433-389	HUMAN OTC DRUG	DHC Acne Spot Therapy		Sulfur	CREAM	TOPICAL	20180101		OTC MONOGRAPH FINAL	part333D	DHC USA Incorporated	SULFUR	6	mg/.2g			N	20241231
63433-452_688c7024-ed92-4db3-8147-06f1fabd38da	63433-452	HUMAN OTC DRUG	DHC Brightening Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20200301		OTC MONOGRAPH FINAL	part352	DHC USA Incorporated	TITANIUM DIOXIDE; ZINC OXIDE	80; 130	mg/mL; mg/mL			N	20241231
63443-5057_f1773a09-cd15-bc3b-e053-2995a90a683b	63443-5057	HUMAN OTC DRUG	Nicotine Polacrilex Gum		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20221221		ANDA	ANDA214354	Fertin Pharma A/S	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63459-101_c3aa4adc-5366-42b9-9898-71047f28fa20	63459-101	HUMAN PRESCRIPTION DRUG	Provigil		Modafinil	TABLET	ORAL	19990215		NDA	NDA020717	Cephalon, LLC	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
63459-103_7b8afe53-a095-4dca-ae40-c4dc350be592	63459-103	HUMAN PRESCRIPTION DRUG	Truxima		rituximab-abbs	INJECTION, SOLUTION	INTRAVENOUS	20200504		BLA	BLA761088	Cephalon, Inc.	RITUXIMAB	10	mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
63459-104_7b8afe53-a095-4dca-ae40-c4dc350be592	63459-104	HUMAN PRESCRIPTION DRUG	Truxima		rituximab-abbs	INJECTION, SOLUTION	INTRAVENOUS	20200504		BLA	BLA761088	Cephalon, Inc.	RITUXIMAB	10	mg/mL	CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]		N	20241231
63459-177_f68bb131-b4bd-4141-8f45-ff929ac7c225	63459-177	HUMAN PRESCRIPTION DRUG	SYNRIBO		Omacetaxine Mepesuccinate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20121119	20240430	NDA	NDA203585	Cephalon, LLC	OMACETAXINE MEPESUCCINATE	3.5	mg/mL			N	
63459-201_c3aa4adc-5366-42b9-9898-71047f28fa20	63459-201	HUMAN PRESCRIPTION DRUG	Provigil		Modafinil	TABLET	ORAL	19990215		NDA	NDA020717	Cephalon, LLC	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
63459-205_e2c236ad-5a5a-46fa-a62e-2d0ac8e443c2	63459-205	HUMAN PRESCRIPTION DRUG	Nuvigil		Armodafinil	TABLET	ORAL	20090526		NDA	NDA021875	Cephalon, LLC	ARMODAFINIL	50	mg/1		CIV	N	20241231
63459-215_e2c236ad-5a5a-46fa-a62e-2d0ac8e443c2	63459-215	HUMAN PRESCRIPTION DRUG	Nuvigil		Armodafinil	TABLET	ORAL	20090526		NDA	NDA021875	Cephalon, LLC	ARMODAFINIL	150	mg/1		CIV	N	20241231
63459-220_e2c236ad-5a5a-46fa-a62e-2d0ac8e443c2	63459-220	HUMAN PRESCRIPTION DRUG	Nuvigil		Armodafinil	TABLET	ORAL	20140220		NDA	NDA021875	Cephalon, LLC	ARMODAFINIL	200	mg/1		CIV	N	20241231
63459-225_e2c236ad-5a5a-46fa-a62e-2d0ac8e443c2	63459-225	HUMAN PRESCRIPTION DRUG	Nuvigil		Armodafinil	TABLET	ORAL	20090526		NDA	NDA021875	Cephalon, LLC	ARMODAFINIL	250	mg/1		CIV	N	20241231
63459-303_9f5e71fd-0a0d-4eb3-bb36-b87c1818542f	63459-303	HUMAN PRESCRIPTION DRUG	HERZUMA		TRASTUZUMAB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200316		BLA	BLA761091	Cephalon, Inc.	TRASTUZUMAB	150	mg/7.15mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
63459-305_9f5e71fd-0a0d-4eb3-bb36-b87c1818542f	63459-305	HUMAN PRESCRIPTION DRUG	HERZUMA		TRASTUZUMAB	KIT		20200316		BLA	BLA761091	Cephalon, Inc.						N	20241231
63459-348_990c33df-99fd-4570-8e6e-de0d6a76baf8	63459-348	HUMAN PRESCRIPTION DRUG	Bendeka		bendamustine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20151208		NDA	NDA208194	Teva Pharmaceuticals USA, Inc.	BENDAMUSTINE HYDROCHLORIDE	25	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
63459-390_77ae475d-2d59-4fe2-8de7-833b6fc9d51a	63459-390	HUMAN PRESCRIPTION DRUG	TREANDA		Bendamustine Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100105		NDA	NDA022249	Cephalon, LLC	BENDAMUSTINE HYDROCHLORIDE	25	mg/5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
63459-391_77ae475d-2d59-4fe2-8de7-833b6fc9d51a	63459-391	HUMAN PRESCRIPTION DRUG	TREANDA		Bendamustine Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20080331		NDA	NDA022249	Cephalon, LLC	BENDAMUSTINE HYDROCHLORIDE	100	mg/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
63459-402_d7af694a-3367-452e-aeaa-5a529d1dd364	63459-402	HUMAN PRESCRIPTION DRUG	GABITRIL		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20010401	20240430	NDA	NDA020646	Cephalon, LLC	TIAGABINE HYDROCHLORIDE	2	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
63459-404_d7af694a-3367-452e-aeaa-5a529d1dd364	63459-404	HUMAN PRESCRIPTION DRUG	GABITRIL		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20010401	20240430	NDA	NDA020646	Cephalon, LLC	TIAGABINE HYDROCHLORIDE	4	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
63459-412_d7af694a-3367-452e-aeaa-5a529d1dd364	63459-412	HUMAN PRESCRIPTION DRUG	GABITRIL		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20010401	20240430	NDA	NDA020646	Cephalon, LLC	TIAGABINE HYDROCHLORIDE	12	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
63459-416_d7af694a-3367-452e-aeaa-5a529d1dd364	63459-416	HUMAN PRESCRIPTION DRUG	GABITRIL		Tiagabine Hydrochloride	TABLET, FILM COATED	ORAL	20010401	20240331	NDA	NDA020646	Cephalon, LLC	TIAGABINE HYDROCHLORIDE	16	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
63459-502_8a94b3ea-e58d-4f86-ab93-7a84918e8e55	63459-502	HUMAN PRESCRIPTION DRUG	ACTIQ		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	19990120	20240531	NDA	NDA020747	Cephalon, LLC	FENTANYL CITRATE	200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63459-504_8a94b3ea-e58d-4f86-ab93-7a84918e8e55	63459-504	HUMAN PRESCRIPTION DRUG	ACTIQ		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	19990120	20250531	NDA	NDA020747	Cephalon, LLC	FENTANYL CITRATE	400	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63459-506_8a94b3ea-e58d-4f86-ab93-7a84918e8e55	63459-506	HUMAN PRESCRIPTION DRUG	ACTIQ		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	19990120	20240531	NDA	NDA020747	Cephalon, LLC	FENTANYL CITRATE	600	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63459-508_8a94b3ea-e58d-4f86-ab93-7a84918e8e55	63459-508	HUMAN PRESCRIPTION DRUG	ACTIQ		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	19990120	20240630	NDA	NDA020747	Cephalon, LLC	FENTANYL CITRATE	800	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63459-512_8a94b3ea-e58d-4f86-ab93-7a84918e8e55	63459-512	HUMAN PRESCRIPTION DRUG	ACTIQ		Fentanyl Citrate	LOZENGE	ORAL; TRANSMUCOSAL	19990120	20240531	NDA	NDA020747	Cephalon, LLC	FENTANYL CITRATE	1200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63459-541_0241b137-cfa8-4101-b05b-da1938a22963	63459-541	HUMAN PRESCRIPTION DRUG	FENTORA		Fentanyl	TABLET	BUCCAL; SUBLINGUAL	20061002		NDA	NDA021947	Cephalon, LLC	FENTANYL CITRATE	100	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63459-542_0241b137-cfa8-4101-b05b-da1938a22963	63459-542	HUMAN PRESCRIPTION DRUG	FENTORA		Fentanyl	TABLET	BUCCAL; SUBLINGUAL	20061002		NDA	NDA021947	Cephalon, LLC	FENTANYL CITRATE	200	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63459-544_0241b137-cfa8-4101-b05b-da1938a22963	63459-544	HUMAN PRESCRIPTION DRUG	FENTORA		Fentanyl	TABLET	BUCCAL; SUBLINGUAL	20061002		NDA	NDA021947	Cephalon, LLC	FENTANYL CITRATE	400	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63459-546_0241b137-cfa8-4101-b05b-da1938a22963	63459-546	HUMAN PRESCRIPTION DRUG	FENTORA		Fentanyl	TABLET	BUCCAL; SUBLINGUAL	20061002		NDA	NDA021947	Cephalon, LLC	FENTANYL CITRATE	600	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63459-548_0241b137-cfa8-4101-b05b-da1938a22963	63459-548	HUMAN PRESCRIPTION DRUG	FENTORA		Fentanyl	TABLET	BUCCAL; SUBLINGUAL	20061002		NDA	NDA021947	Cephalon, LLC	FENTANYL CITRATE	800	ug/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63459-601_c6f1760b-1b0a-4e85-bdb5-b5554ba302d3	63459-601	HUMAN PRESCRIPTION DRUG	Trisenox		Arsenic Trioxide	INJECTION, SOLUTION	INTRAVENOUS	20171222		NDA	NDA021248	Cephalon, LLC	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
63459-700_396e049e-2cf9-4dec-b295-a563d917407d	63459-700	HUMAN PRESCRIPTION DRUG	AMRIX		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20071002		NDA	NDA021777	Cephalon, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63459-701_396e049e-2cf9-4dec-b295-a563d917407d	63459-701	HUMAN PRESCRIPTION DRUG	AMRIX		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20071001		NDA	NDA021777	Cephalon, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	30	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63459-910_6c844d2a-1b12-4434-a915-dad9ad4b094f	63459-910	HUMAN PRESCRIPTION DRUG	GRANIX		tbo-filgrastim	INJECTION, SOLUTION	SUBCUTANEOUS	20131111		BLA	BLA125294	Cephalon, LLC	FILGRASTIM	300	ug/.5mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
63459-912_6c844d2a-1b12-4434-a915-dad9ad4b094f	63459-912	HUMAN PRESCRIPTION DRUG	GRANIX		tbo-filgrastim	INJECTION, SOLUTION	SUBCUTANEOUS	20131111		BLA	BLA125294	Cephalon, LLC	FILGRASTIM	480	ug/.8mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
63459-918_6c844d2a-1b12-4434-a915-dad9ad4b094f	63459-918	HUMAN PRESCRIPTION DRUG	GRANIX		tbo-filgrastim	INJECTION, SOLUTION	SUBCUTANEOUS	20181107		BLA	BLA125294	Cephalon, LLC	FILGRASTIM	300	ug/mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
63459-920_6c844d2a-1b12-4434-a915-dad9ad4b094f	63459-920	HUMAN PRESCRIPTION DRUG	GRANIX		tbo-filgrastim	INJECTION, SOLUTION	SUBCUTANEOUS	20181107		BLA	BLA125294	Cephalon, LLC	FILGRASTIM	480	ug/1.6mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
63471-3000_09d6ad4d-5f98-559a-e063-6394a90a7f59	63471-3000	HUMAN OTC DRUG	Boudreauxs Rash Kicking		ZINC OXIDE	KIT		20180525		OTC MONOGRAPH DRUG	M016	Geodis Logistics LLC						N	20241231
63471-3001_09d6b1f9-0ea2-e6ed-e063-6294a90a4d92	63471-3001	HUMAN OTC DRUG	Boudreauxs Butt Diaper Rash Max Strength		ZINC OXIDE	CREAM	TOPICAL	20191202		OTC MONOGRAPH DRUG	M016	Geodis Logistics LLC	ZINC OXIDE	40	g/113g			N	20241231
63471-3002_09d6b62c-3b5c-5c0b-e063-6394a90aaacc	63471-3002	HUMAN OTC DRUG	Boudreauxs Butt Diaper Rash Original		ZINC OXIDE	CREAM	TOPICAL	20191202		OTC MONOGRAPH DRUG	M016	Geodis Logistics LLC	ZINC OXIDE	16	g/113g			N	20241231
63471-3005_09d6b845-ce49-6bac-e063-6394a90a1369	63471-3005	HUMAN OTC DRUG	Clear Eyes Redness Relief Eye Drops Sterile		GLYCERIN, NAPHAZOLINE HYDROCHLORIDE	LIQUID	OPHTHALMIC	20110427		OTC MONOGRAPH DRUG	M018	Geodis Logistics LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	2.5; .12	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
63471-3006_d76bfee7-60f8-fd41-e053-2995a90a5edc	63471-3006	HUMAN OTC DRUG	Nix Lice Killing Creme Rinse		PERMETHRIN	RINSE	TOPICAL	20131115		NDA	NDA019918	Geodis Logistics LLC	PERMETHRIN	1	g/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
63471-3010_d76d4779-5871-c676-e053-2a95a90ada97	63471-3010	HUMAN OTC DRUG	Nix FAMILY PACK Lice Killing Creme Rinse Kit		PERMETHRIN	KIT		20131115		NDA	NDA019918	Geodis Logistics LLC						N	20241231
63471-3020_d76d72b9-cd2d-116a-e053-2995a90a32cb	63471-3020	HUMAN OTC DRUG	Nix COMPLETE Lice Treatment		PERMETHRIN	KIT		20131115		NDA	NDA019918	Geodis Logistics LLC						N	20241231
63479-0101_0e7630cb-8c84-6d0e-e063-6394a90ace15	63479-0101	HUMAN OTC DRUG	A01	CELLULAR RECHARGE	ACETICUM ACIDUM, ARNICA MONTANA, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CEANOTHUS AMERICANUS, CERATOSTIGMA ILLMOTTIANUM, CHININUM ARSENICOSUM, CITRICUM ACIDUM, ENGLISH ELM, EUROPEAN HORNBEAM, EUROPEAN OLIVE, GENTIANELLA AMARELLA, HYDROFLUORICUM ACIDUM, JUGLANS REGIA, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SILICOFLUORICUM, NATRUM SULPHURICUM, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACETIC ACID; ANHYDROUS CITRIC ACID; ARNICA MONTANA; AVENA SATIVA FLOWERING TOP; CALCIUM SULFATE ANHYDROUS; CARPINUS BETULUS FLOWER; CEANOTHUS AMERICANUS LEAF; CERATOSTIGMA WILLMOTTIANUM FLOWER; GENTIANELLA AMARELLA FLOWER; HYDROFLUORIC ACID; JUGLANS REGIA FLOWERING TOP; LACTIC ACID, DL-; LACTIC ACID, L-; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OLEA EUROPAEA FLOWER; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORIC ACID; QUININE ARSENITE; SODIUM CHLORIDE; SODIUM HEXAFLUOROSILICATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE; ULMUS PROCERA FLOWERING TWIG	30; 30; 12; 1; 12; 9; 4; 12; 12; 30; 9; 15; 15; 15; 12; 15; 1; 30; 15; 30; 8; 12; 10; 1; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Antimalarial [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Decreased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
63479-0102_0e7645b5-71a8-72fb-e063-6394a90ae398	63479-0102	HUMAN OTC DRUG	A02	GENTLE DRAINAGE	ALFALFA, ALLIUM SATIVUM, AMERICAN GINSENG, ASPARAGUS OFFICINALIS, AVENA SATIVA, BERBERIS VULGARIS, BOS TAURUS ADRENAL GLAND, COLON, KIDNEY, LIVER, LYMPH VESSEL, PANCREAS, CALCAREA PHOSPHORICA, CARBO VEGETABILIS, CRAB APPLE FLOWER, EUROPEAN HORNBEAM FLOWER, GENTIANA LUTEA, HISTAMINUM HYDROCHLORICUM, JUNIPERUS COMMUNIS STEM, LACTICUM ACIDUM, PASSIFLORA INCARNATA, PHOSPHORUS, RIBES NIGRUM FLOWER BUD, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACTIVATED CHARCOAL; ALFALFA; AMERICAN GINSENG; ASPARAGUS; AVENA SATIVA FLOWERING TOP; BEEF KIDNEY; BEEF LIVER; BERBERIS VULGARIS ROOT BARK; BOS TAURUS ADRENAL GLAND; BOS TAURUS COLON; BOS TAURUS LYMPH VESSEL; BOS TAURUS PANCREAS; CARPINUS BETULUS FLOWER; GARLIC; GENTIANA LUTEA ROOT; HISTAMINE DIHYDROCHLORIDE; JUNIPERUS COMMUNIS STEM; LACTIC ACID, DL-; MALUS SYLVESTRIS FLOWER; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; RIBES NIGRUM FLOWER BUD; SCROPHULARIA NODOSA; SOLIDAGO VIRGAUREA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE	15; 6; 9; 9; 6; 7; 7; 12; 7; 7; 7; 7; 12; 9; 6; 6; 8; 12; 12; 9; 12; 6; 10; 9; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
63479-0103_0e765c65-dfc5-b0fa-e063-6294a90a4b51	63479-0103	HUMAN OTC DRUG	A03	ULTRA ANTITOX	ALFALFA, AMERICAN GINSENG, APIS MELLIFICA, ASPARAGUS OFFICINALIS, AVENA SATIVA, BARYTA IODATA, BERBERIS VULGARIS, BRYONIA, CARDUUS MARIANUS, CHAMOMILLA, CHELIDONIUM MAJUS, CONIUM MACULATUM, FERRUM IODATUM, LAPIS ALBUS, LYCOPODIUM CLAVATUM, NATRUM CARBONICUM, PASSIFLORA INCARNATA, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, UVA URSI	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALFALFA; AMERICAN GINSENG; APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; ASPARAGUS; AVENA SATIVA FLOWERING TOP; BARIUM IODIDE; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALCIUM HEXAFLUOROSILICATE; CHELIDONIUM MAJUS; CONIUM MACULATUM FLOWERING TOP; FERROUS IODIDE; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; MILK THISTLE; PASSIFLORA INCARNATA FLOWERING TOP; SCROPHULARIA NODOSA; SODIUM CARBONATE; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE	1; 2; 6; 1; 2; 1; 12; 1; 15; 15; 1; 12; 12; 6; 1; 1; 1; 3; 6; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20251231
63479-0104_0e765c65-dfe7-b0fa-e063-6294a90a4b51	63479-0104	HUMAN OTC DRUG	A04	DEEP ANTITOX	ALLIUM CEPA, ALLIUM SATIVUM, ALOE SOCOTRINA, ARSENICUM IODATUM, ASTERIAS RUBENS, BAPTISIA TINCTORIA, CALCAREA IODATA, CANDIDA ALBICANS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, CINA, CINCHONA OFFICINALIS, COLCHICUM AUTUMNALE, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, INDOLUM, LAC VACCINUM, LACTICUM ACIDUM, MILLEFOLIUM, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SCROPHULARIA NODOSA, SKATOLUM, SOLIDAGO VIRGAUREA, SULPHUR, URICUM ACIDUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ALOE; ARSENIC TRIIODIDE; ARTEMISIA CINA PRE-FLOWERING TOP; ASTERIAS RUBENS; BAPTISIA TINCTORIA ROOT; CALCIUM IODIDE; CANDIDA ALBICANS; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; COW MILK; ECHINACEA ANGUSTIFOLIA WHOLE; ECHINACEA PURPUREA; GARLIC; INDOLE; LACTIC ACID, DL-; LACTIC ACID, L-; ONION; SCROPHULARIA NODOSA; SKATOLE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUCROSE; SULFUR; URIC ACID	1; 12; 15; 15; 3; 8; 15; 30; 200; 30; 3; 30; 200; 1; 1; 1; 30; 200; 200; 1; 30; 30; 1; 200; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
63479-0105_0e766448-875a-76db-e063-6394a90a0ab1	63479-0105	HUMAN OTC DRUG	A05	HEAVY ANTITOX	ALLIUM CEPA, ALLIUM SATIVUM, ALUMINIUM METALLICUM, APIS MELLIFICA, ARGENTUM METALLICUM, AURUM METALLICUM, BELLADONNA, BERBERIS VULGARIS, CADMIUM METALLICUM, CHELIDONIUM MAJUS, CUPRUM METALLICUM, FAGUS SYLVATICA, FORMALINUM, FORMICUM ACIDUM, HYPERICUM PERFORATUM, ICHTHYOLUM, MERCURIUS CORROSIVUS, MERCURIUS SOLUBILIS, NICCOLUM METALLICUM, PLUMBUM METALLICUM, SELENIUM METALLICUM, SILICEA, SOLIDAGO VIRGAUREA, STANNUM METALLICUM, THIOSINAMINUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALLYLTHIOUREA; ALUMINUM; APIS MELLIFERA; ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; CADMIUM; CHELIDONIUM MAJUS; COPPER; FAGUS SYLVATICA NUT; FORMALDEHYDE; FORMIC ACID; GARLIC; GOLD; HYPERICUM PERFORATUM; ICHTHAMMOL; LEAD; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; NICKEL; ONION; SELENIUM; SILICON DIOXIDE; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; TIN	12; 30; 4; 4; 1; 60; 1; 60; 2; 30; 12; 1; 30; 3; 10; 60; 200; 60; 15; 1; 15; 30; 60; 1; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20251231
63479-0106_0e766448-875c-76db-e063-6394a90a0ab1	63479-0106	HUMAN OTC DRUG	A06	REVITALIZATION	AVENA SATIVA, BONE MARROW SUIS, BOS TAURUS ADRENAL GLAND, BOS TAURUS ARTERY, BOS TAURUS COLON, BOS TAURUS KIDNEY, BOS TAURUS LIVER, BOS TAURUS LYMPH VESSEL, BOS TAURUS PANCREAS, BOS TAURUS PITUITARUM POSTERIUM, BOS TAURUS PLACENTA, BOS TAURUS SKIN, BOS TAURUS THYMUS, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, HAMAMELIS VIRGINIANA, HYDROFLUORICUM ACIDUM, KALI PHOSPHORICUM, PROCAINE, SUS SCROFA SPLEEN	SOLUTION/ DROPS	SUBLINGUAL	19881215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AVENA SATIVA FLOWERING TOP; BEEF KIDNEY; BEEF LIVER; BOS TAURUS ADRENAL GLAND; BOS TAURUS ARTERY; BOS TAURUS COLON; BOS TAURUS LYMPH VESSEL; BOS TAURUS PANCREAS; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS PLACENTA; BOS TAURUS SKIN; BOS TAURUS THYMUS; GENTIANA LUTEA ROOT; GLYCYRRHIZA GLABRA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYDROFLUORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; PROCAINE; SUS SCROFA BONE MARROW; SUS SCROFA SPLEEN	4; 7; 7; 7; 7; 7; 7; 7; 7; 15; 7; 7; 6; 6; 9; 30; 10; 8; 7; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63479-0109_0e767659-f963-7c88-e063-6294a90a0f64	63479-0109	HUMAN OTC DRUG	A09	FEMALE BALANCE	ARGENTUM NITRICUM, ATROPINUM SULPHURICUM, AURUM MURIATICUM NATRONATUM, BOS TAURUS OVARY, BOS TAURUS PANCREAS, BOS TAURUS PITUITARUM POSTERIUM, BOS TAURUS UTERUS, CIMICIFUGA RACEMOSA, ESTRONE, HELONIAS DIOICA, PROGESTERONE, PULSATILLA VULGARIS, SABINA, SEPIA, SEQUOIADENDRON GIGANTEUM WHOLE, SUS SCROFA PINEAL GLAND, SUS SCROFA SPLEEN, THIOSINAMINUM, THYROIDINUM, VIBURNUM OPULUS	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALLYLTHIOUREA; ATROPINE SULFATE; BLACK COHOSH; BOS TAURUS OVARY; BOS TAURUS PANCREAS; BOS TAURUS PITUITARY GLAND; BOS TAURUS UTERUS; CHAMAELIRIUM LUTEUM ROOT; ESTRONE; JUNIPERUS SABINA LEAFY TWIG; PROGESTERONE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SEQUOIADENDRON GIGANTEUM WHOLE; SILVER NITRATE; SODIUM TETRACHLOROAURATE; SUS SCROFA PINEAL GLAND; SUS SCROFA SPLEEN; THYROID, UNSPECIFIED; VIBURNUM OPULUS BARK	8; 10; 10; 7; 7; 9; 7; 8; 9; 12; 9; 10; 30; 9; 9; 12; 9; 7; 7; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Progesterone [CS], Progesterone [EPC]		N	20251231
63479-0111_0e7645b5-71aa-72fb-e063-6394a90ae398	63479-0111	HUMAN OTC DRUG	A11	ENVIRO-PROTECT	ALLIUM SATIVUM, ALTERNARIA ALTERNATA, ASCORBICUM ACIDUM, ASPERGILLUS NIGER, AUREOBASIDIUM PULLULANS, BERBERIS VULGARIS, CADMIUM METALLICUM, CARBONEUM OXYGENISATUM, CHELIDONIUM MAJUS, CHLORINUM, CLADOSPORIUM PHAEROSPERMUM, COCHLIOBOLUS SATIVUS, COCHLIOBOLUS SPICIFER, GIBBERELLA FUJIKUROI, HOUSE DUST, LEAD, LYCOPODIUM CLAVATUM, MALUS SYLVESTRIS, MUCOR PLUMBEUS, NIACIN, PENICILLIUM NOTATUM, PETROLATUM, PHENOL, QUERCUS ROBUR, RHIZOPUS STOLONIFER, SOLIDAGO VIRGAUREA, TABACUM, VITAMIN A, VITAMIN E	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	.ALPHA.-TOCOPHEROL ACETATE; ALTERNARIA ALTERNATA; ASCORBIC ACID; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BERBERIS VULGARIS ROOT BARK; CADMIUM; CARBON MONOXIDE; CHELIDONIUM MAJUS; CHLORINE; CLADOSPORIUM SPHAEROSPERMUM; COCHLIOBOLUS SATIVUS; COCHLIOBOLUS SPICIFER; GARLIC; GIBBERELLA FUJIKUROI; HOUSE DUST; LEAD; LYCOPODIUM CLAVATUM SPORE; MALUS SYLVESTRIS FLOWER; MINERAL OIL; MUCOR PLUMBEUS; NIACIN; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PHENOL; QUERCUS ROBUR FLOWER BUD; RHIZOPUS STOLONIFER; SOLIDAGO VIRGAUREA FLOWERING TOP; TOBACCO LEAF; VITAMIN A ACETATE	15; 30; 12; 30; 30; 10; 15; 30; 8; 30; 30; 30; 30; 10; 30; 100; 30; 12; 15; 30; 30; 12; 30; 30; 9; 30; 9; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin C [EPC]		N	20251231
63479-0112_0e764c29-02d9-6485-e063-6394a90a6a45	63479-0112	HUMAN OTC DRUG	A12	DTX-KIDNEY	APIS MELLIFICA, BERBERIS VULGARIS, BETULA PUBESCENS BARK, BETULA VERRUCOSA LEAF, BOS TAURUS KIDNEY, BOS TAURUS URINARY BLADDER, CITRICUM ACIDUM, CITRUS LIMONUM, FAGUS SYLVESTRIS FLOWER BUD, NATRUM MURIATICUM, PETROSELINUM SATIVUM, QUERCUS ROBUR FLOWER BUD, SINUSITISINUM, SOLIDAGO VIRGAUREA	SOLUTION/ DROPS	SUBLINGUAL	19981015		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ANHYDROUS CITRIC ACID; APIS MELLIFERA; BEEF KIDNEY; BERBERIS VULGARIS ROOT BARK; BETULA PENDULA LEAF; BETULA PUBESCENS BARK; BOS TAURUS URINARY BLADDER; FAGUS SYLVATICA FLOWER BUD; LEMON JUICE; PETROSELINUM CRISPUM; QUERCUS ROBUR FLOWER BUD; SINUSITISINUM; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 6; 7; 9; 1; 3; 7; 1; 3; 2; 1; 7; 15; 1	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Bee Venoms [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0113_0e767659-f964-7c88-e063-6294a90a0f64	63479-0113	HUMAN OTC DRUG	A13	DTX-LIVER	BOS TAURUS GALLBLADDER, BRYONIA, CHELIDONIUM MAJUS, CHOLESTERINUM, HEPAR SULPHURIS CALCAREUM , JUNIPERUS COMMUNIS STEM, LYCOPODIUM CLAVATUM, NATRUM SULPHURICUM, PHOSPHORUS, RHAMNUS PURSHIANA, ROSMARINUS OFFICINALIS, SECALE CEREALE WHOLE	SOLUTION/ DROPS	SUBLINGUAL	19981015		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BOS TAURUS GALLBLADDER; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; CHOLESTEROL; FRANGULA PURSHIANA BARK; JUNIPERUS COMMUNIS STEM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; ROSMARINUS OFFICINALIS FLOWERING TOP; SECALE CEREALE WHOLE; SODIUM SULFATE	7; 6; 7; 12; 12; 3; 1; 30; 30; 1; 1; 6	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
63479-0114_0e76684e-8d52-ba16-e063-6294a90a5409	63479-0114	HUMAN OTC DRUG	A14	DTX-LYMPH	ARANEA DIADEMA, BARIUM IODATE, BOS TAURUS LIVER, BOS TAURUS LYMPH VESSEL, BOS TAURUS THYMUS, EQUISETUM HYEMALE, FERRUM IODATUM, MERCURIUS IODATUS FLAVUS, MYOSOTIS ARVENSIS, PHYTOLACCA DECANDRA, SCROPHULARIA NODOSA, TEUCRIUM SCORODONIA	SOLUTION/ DROPS	SUBLINGUAL	19981015		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARANEUS DIADEMATUS; BARIUM IODATE; BEEF LIVER; BOS TAURUS LYMPH VESSEL; BOS TAURUS THYMUS; EQUISETUM HYEMALE; FERROUS IODIDE; MERCUROUS IODIDE; MYOSOTIS ARVENSIS; PHYTOLACCA AMERICANA ROOT; SCROPHULARIA NODOSA; TEUCRIUM SCORODONIA FLOWERING TOP	6; 30; 7; 4; 4; 4; 9; 12; 4; 12; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20251231
63479-0201_0e76a879-b2c6-dcc6-e063-6294a90ac60e	63479-0201	HUMAN OTC DRUG	B01	ACUTE RESCUE	ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA ALBA, CALENDULA OFFICINALIS, CHAMOMILLA, CHERRY PLUM, CLEMATIS, COLOCYNTHIS, DULCAMARA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS, MILLEFOLIUM, RHUS TOXICODENDRON, ROCK ROSE, STAR OF BETHLEHEM, SULPHUR, SYMPHYTUM OFFICINALE, VERATRUM ALBUM	SOLUTION	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CITRULLUS COLOCYNTHIS FRUIT PULP; CLEMATIS VITALBA FLOWER; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HELIANTHEMUM NUMMULARIUM FLOWER; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA CHAMOMILLA; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER; SOLANUM DULCAMARA WHOLE; SULFUR; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	3; 30; 12; 30; 15; 30; 12; 12; 9; 8; 30; 3; 6; 6; 8; 15; 3; 30; 12; 6; 30; 8; 30; 30; 8; 9; 12; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0202_0e769d13-23f1-f61f-e063-6294a90a8cd1	63479-0202	HUMAN OTC DRUG	B02	ADRENAL PEP	ACETICUM ACIDUM, ADRENALINUM, AMERICAN GINSENG, ARNICA MONTANA, BALSAMUM PERUVIANUM, BOS TAURUS PITUITARUM POSTERIUM, CHERRY PLUM FLOWER, CHININUM ARSENICOSUM, CINCHONA OFFICINALIS, CLEMATIS VITALBA FLOWER, DAMIANA, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE FLOWER, GLYCYRRHIZA GLABRA, IMPATIENS GLANDULIFERA FLOWER, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYRENEES STAR OF BETHLEHEM, ROCKROSE FLOWER, SELENIUM METALLICUM, THYROIDINUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACETIC ACID; AMERICAN GINSENG; ARNICA MONTANA; BALSAM PERU; BOS TAURUS PITUITARY GLAND, POSTERIOR; CARPINUS BETULUS FLOWER; CINCHONA OFFICINALIS BARK; CLEMATIS VITALBA FLOWER; DIBASIC POTASSIUM PHOSPHATE; EPINEPHRINE; GLYCYRRHIZA GLABRA; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OLEA EUROPAEA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PHOSPHORIC ACID; PHOSPHORUS; PRUNUS CERASIFERA FLOWER; QUININE ARSENITE; SELENIUM; THYROID, UNSPECIFIED; TURNERA DIFFUSA LEAFY TWIG	30; 2; 12; 9; 15; 8; 12; 8; 12; 6; 1; 8; 8; 12; 12; 8; 8; 30; 30; 8; 12; 15; 6; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Antimalarial [EPC], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
63479-0203_0e769d13-23f2-f61f-e063-6294a90a8cd1	63479-0203	HUMAN OTC DRUG	B03	Sinus Relief	ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS	SOLUTION/ DROPS	SUBLINGUAL	19950215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	CALCIUM IODIDE; CALCIUM SULFATE ANHYDROUS; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EUPHORBIA RESINIFERA RESIN; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; LACTOSE, UNSPECIFIED FORM; LUFFA OPERCULATA FRUIT; MERCURIC SULFIDE; ONION; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; POTASSIUM SULFATE; PULSATILLA VULGARIS; SKIM MILK; THUJA OCCIDENTALIS LEAFY TWIG	12; 12; 15; 1; 1; 6; 1; 30; 12; 12; 12; 12; 8; 10; 15; 12; 12; 30; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Vegetable Proteins [CS]		N	20251231
63479-0204_0e76a879-b2c8-dcc6-e063-6294a90ac60e	63479-0204	HUMAN OTC DRUG	B04	DIGESTION	ALFALFA, ANTIMONIUM CRUDUM, AVENA SATIVA, BERBERIS VULGARIS, CAJUPUTUM, CARBO ANIMALIS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, FEL TAURI, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, ILLICIUM ANISATUM, INDOLUM, KALI CARBONICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PANCREATINUM, PEPSINUM, RAPHANUS SATIVUS, RHAMNUS PURSHIANA, SKATOLUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACTIVATED CHARCOAL; ALFALFA; ANTIMONY TRISULFIDE; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; BOS TAURUS BILE; CAJUPUT OIL; CARBO ANIMALIS; CHELIDONIUM MAJUS; FRANGULA PURSHIANA BARK; GENTIANA LUTEA ROOT; GLYCYRRHIZA GLABRA; INDOLE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PANCRELIPASE; PEPSIN; POTASSIUM CARBONATE; RADISH; SKATOLE; STAR ANISE; STRYCHNOS NUX-VOMICA SEED	20; 1; 15; 1; 4; 4; 3; 15; 1; 1; 1; 2; 12; 9; 8; 10; 4; 10; 8; 12; 1; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20251231
63479-0205_0e769c02-e362-91a1-e063-6394a90a42b9	63479-0205	HUMAN OTC DRUG	B05	GLUCO BALANCE	ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BOS TAURUS PITUITARY GLAND, POSTERIOR; EPINEPHRINE; GLYCERIN; GLYCYRRHIZA GLABRA; LACTIC ACID, DL-; LACTIC ACID, L-; LACTOSE, UNSPECIFIED FORM; MAGNESIUM SULFATE HEPTAHYDRATE; NICKEL; PANCRELIPASE; PHOSPHORIC ACID; POTASSIUM CARBONATE; SACCHARIN; SELENIUM; SILVER NITRATE; SUCROSE; SYZYGIUM CUMINI SEED; THYROID, UNSPECIFIED; ZINC	30; 12; 12; 1; 15; 15; 15; 12; 12; 30; 8; 15; 15; 30; 15; 30; 3; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
63479-0206_0e769c02-e363-91a1-e063-6394a90a42b9	63479-0206	HUMAN OTC DRUG	B06	Stress Resistance	AVENA SATIVA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COFFEA CRUDA, ENGLISH OAK, ESCHSCHOLTZIA CALIFORNICA, EUROPEAN HORNBEAM, FICUS CARICA, HUMULUS LUPULUS, IGNATIA AMARA, IMPATIENS GLANDULIFERA, KALI PHOSPHORICUM, KALI SILICATUM, MELISSA OFFICINALIS, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, PYRENEES STAR OF BETHLEHEM, ROCKROSE, SUS SCROFA PARASYMPATHETIC NERVE, PINEAL GLAND, SYMPATHETIC NERVE, VALERIANA OFFICINALIS, VERBENA OFFICINALIS, ZINCUM VALERIANICUM	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; CARPINUS BETULUS FLOWER; CLEMATIS VITALBA FLOWER; DIBASIC POTASSIUM PHOSPHATE; ESCHSCHOLZIA CALIFORNICA; FICUS CARICA FLOWER BUD; HELIANTHEMUM NUMMULARIUM FLOWER; HOPS; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA CHAMOMILLA; MELISSA OFFICINALIS; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORIC ACID; POTASSIUM SILICATE; PRUNUS CERASIFERA FLOWER; QUERCUS ROBUR FLOWER; STRYCHNOS IGNATII SEED; SUS SCROFA PARASYMPATHETIC NERVE; SUS SCROFA PINEAL GLAND; SUS SCROFA SYMPATHETIC NERVE; VALERIAN; VERBENA OFFICINALIS FLOWERING TOP; ZINC VALERATE DIHYDRATE	12; 1; 15; 15; 15; 6; 9; 15; 4; 15; 30; 6; 15; 4; 30; 15; 15; 15; 30; 7; 7; 7; 6; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Seed Storage Proteins [CS]		N	20251231
63479-0207_0e768a0e-1c4f-7a5b-e063-6394a90a8097	63479-0207	HUMAN OTC DRUG	B07	DPRSN ANTITOX	ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER	SOLUTION/ DROPS	SUBLINGUAL	19970715		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AETHUSA CYNAPIUM; ALFALFA; AVENA SATIVA FLOWERING TOP; CARPINUS BETULUS FLOWER; CASTANEA SATIVA FLOWER; CERATOSTIGMA WILLMOTTIANUM FLOWER; CHASTE TREE; EPINEPHRINE; GOLD; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; MANDRAGORA OFFICINARUM ROOT; PASSIFLORA INCARNATA FLOWERING TOP; POPULUS TREMULA FLOWERING TOP; POTASSIUM PHOSPHATE, DIBASIC; PRUNUS CERASIFERA FLOWER; ROSA CANINA FLOWER; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; THYROID, UNSPECIFIED; TURNERA DIFFUSA LEAFY TWIG; ULEX EUROPAEUS FLOWER	30; 1; 1; 15; 15; 30; 2; 6; 30; 3; 60; 30; 1; 30; 30; 15; 15; 30; 30; 15; 30; 6; 1; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
63479-0208_0e765edc-2644-533a-e063-6394a90a7c53	63479-0208	HUMAN OTC DRUG	B08	MUCOUS MEMBRANES	BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BALSAM PERU; BRYONIA ALBA ROOT; CALCIUM ACETATE; CALOMEL; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EUCALYPTUS GLOBULUS LEAF; EUPHORBIA RESINIFERA RESIN; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; IPECAC; LUFFA OPERCULATA FRUIT; MERCURIC CYANIDE; MERCURIC SULFIDE; PANCRELIPASE; POTASSIUM DICHROMATE; PROTORTONIA CACTI; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARINE NITRATE; SAPONARIA OFFICINALIS ROOT; SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE; SODIUM BORATE	6; 6; 12; 12; 1; 1; 8; 6; 1; 30; 10; 12; 12; 15; 4; 12; 10; 12; 6; 8; 9; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC]		N	20251231
63479-0209_0e765edc-2645-533a-e063-6394a90a7c53	63479-0209	HUMAN OTC DRUG	B09	ACUTE VIROTOX	ACONITUM NAPELLUS, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BRYONIA, CHERRY PLUM, CLEMATIS VITALBA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, EUROPEAN OLIVE, FERRUM PHOSPHORICUM, GENTIANA LUTEA, IMPATIENS GLANDULIFERA, INFLUENZA A VIRUS, LACHESIS MUTUS, LUFFA OPERCULATA, ORNITHOGALUM UMBELLATUM, PHOSPHORUS, ROCKROSE, SARCOLACTICUM ACIDUM, VERATRUM ALBUM, YELLOW JASMINE	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CLEMATIS VITALBA FLOWER; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GENTIANA LUTEA ROOT; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; INFLUENZA A VIRUS WHOLE; LACHESIS MUTA VENOM; LACTIC ACID, L-; LUFFA OPERCULATA FRUIT; OLEA EUROPAEA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PHOSPHORUS; PRUNUS CERASIFERA FLOWER; VERATRUM ALBUM ROOT	200; 200; 200; 9; 200; 9; 1; 1; 12; 3; 200; 30; 6; 9; 9; 30; 30; 12; 12; 9; 9; 30; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-0211_0e768a0e-1c52-7a5b-e063-6394a90a8097	63479-0211	HUMAN OTC DRUG	B11	INJUROTOX	ARISTOLOCHIA MILHOMENS, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA OFFICINALIS, CARBO VEGETABILIS, CHAMOMILLA, CHERRY PLUM FLOWER, CLEMATIS VITALBA FLOWER, ECHINACEA ANGUSTIFOLIA, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA FLOWER, LACHESIS MUTUS, MILLEFOLIUM, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE FLOWER, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SULPHUR IODATUM, SYMPHYTUM OFFICINALE, VERATRUM ALBUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARISTOLOCHIA CYMBIFERA FLOWER; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CLEMATIS VITALBA FLOWER; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HELIANTHEMUM NUMMULARIUM FLOWER; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; LACHESIS MUTA VENOM; LACTIC ACID, L-; MATRICARIA CHAMOMILLA; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER; RUTA GRAVEOLENS FLOWERING TOP; SULFUR IODIDE; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	1; 12; 9; 100; 30; 8; 1; 30; 30; 1; 9; 2; 1; 1; 9; 3; 9; 30; 30; 30; 9; 9; 3; 12; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-0213_0e768a0e-1c63-7a5b-e063-6394a90a8097	63479-0213	HUMAN OTC DRUG	B13	CELL SALT COMPLEX	ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS	SOLUTION/ DROPS	SUBLINGUAL	19941101		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACTIVATED CHARCOAL; AVENA SATIVA FLOWERING TOP; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROUS IODIDE; GARLIC; HYPERICUM PERFORATUM; LACTIC ACID, DL-; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TRIBASIC CALCIUM PHOSPHATE; URTICA URENS	30; 1; 30; 20; 30; 10; 1; 30; 30; 20; 30; 30; 200; 30; 20; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
63479-0214_0e765edc-2648-533a-e063-6394a90a7c53	63479-0214	HUMAN OTC DRUG	B14	BRONCHOTOX	BELLADONNA, BLATTA ORIENTALIS, COCCUS CACTI, CORALLIUM RUBRUM, CUPRUM METALLICUM, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, HEDERA HELIX, HYDRASTIS CANADENSIS, IPECACUANHA, KALI NITRICUM, LAC VACCINUM, LOBELIA INFLATA, PASSIFLORA INCARNATA, PERTUSSINUM, SAMBUCUS NIGRA, THYMUS SERPYLLUM, VALERIANA OFFICINALIS	SOLUTION/ DROPS	SUBLINGUAL	19941101		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ATROPA BELLADONNA; BLATTA ORIENTALIS; COPPER; CORALLIUM RUBRUM EXOSKELETON; COW MILK; DROSERA ROTUNDIFOLIA; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; HEDERA HELIX FLOWERING TWIG; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; IPECAC; LOBELIA INFLATA; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM NITRATE; PROTORTONIA CACTI; SAMBUCUS NIGRA FLOWERING TOP; THYMUS SERPYLLUM; VALERIAN	4; 3; 10; 10; 30; 2; 1; 2; 3; 30; 30; 3; 1; 8; 4; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Insect Proteins [CS], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20251231
63479-0219_0e765edc-264c-533a-e063-6394a90a7c53	63479-0219	HUMAN OTC DRUG	B19	ACUTE RESCUE	ACONITUM NAPELLUS,APIS MELLIFICA,ARNICA MONTANA,ARSENICUM ALBUM,BELLADONNA,BELLIS PERENNIS,BRYONIA,CALENDULA OFFICINALIS,CHAMOMILLA,CHERRY PLUM,CLEMATIS VITALBA,COLOCYNTHIS,COMFREY,DULCAMARA LIGNOSA,ECHINACEA ANGUSTIFOLIA,ECHINACEA PURPUREA,EUPATORIUM PERFOLIATUM,FERRUM PHOSPHORICUM,HAMAMELIS VIRGINIANA,HISTAMINUM,HYPERICUM PERFORATUM,IMPATIENS GLANDULIFERA,LEDUM PALUSTRE,MENTHA PIPERITA,MILLEFOLIUM,ORNITHOGALUM UMBELLATUM,PLANTAGO MAJOR,RHUS TOXICODENDRON,ROCKROSE,SULPHUR,VERATRUM ALBUM,VERBASCUM THAPSUS	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CITRULLUS COLOCYNTHIS FRUIT PULP; CLEMATIS VITALBA FLOWER; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HELIANTHEMUM NUMMULARIUM FLOWER; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; LEDUM PALUSTRE TWIG; MATRICARIA CHAMOMILLA WHOLE; MENTHA PIPERITA; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PLANTAGO MAJOR; PRUNUS CERASIFERA FLOWER; SOLANUM DULCAMARA WHOLE; SULFUR; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT; VERBASCUM THAPSUS	3; 30; 12; 30; 15; 30; 12; 12; 9; 8; 30; 6; 6; 6; 8; 15; 3; 30; 12; 6; 30; 1; 8; 1; 30; 1; 30; 8; 9; 12; 30; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0220_0e8b3606-7e0b-af78-e063-6294a90afbd2	63479-0220	HUMAN OTC DRUG	B20	ACUTE RESCUE	ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COLOCYNTHIS, DULCAMARA LIGNOSA, ECHINACEA, EUPATORIUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA, LEDUM PALUSTRE, MENTHA PIPERITA, MILLEFOLIUM, PLANTAGO MAJOR, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE, SULFUR, COMFREY, VERATRUM ALBUM, VERBASCUM THAPSUS	CREAM	TOPICAL	19940830		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS WHOLE; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BELLIS PERENNIS; BRYONIA ALBA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; CITRULLUS COLOCYNTHIS FRUIT PULP; CLEMATIS VITALBA FLOWER; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HELIANTHEMUM NUMMULARIUM FLOWER; HISTAMINE DIHYDROCHLORIDE; HYPERICUM PERFORATUM; IMPATIENS GLANDULIFERA FLOWER; MATRICARIA CHAMOMILLA; MENTHA PIPERITA; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PLANTAGO MAJOR; PRUNUS CERASIFERA FLOWER; RHODODENDRON TOMENTOSUM LEAFY TWIG; SOLANUM DULCAMARA WHOLE; SULFUR; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT; VERBASCUM THAPSUS	3; 30; 12; 30; 15; 30; 12; 12; 9; 8; 30; 6; 6; 6; 8; 15; 3; 30; 12; 6; 30; 8; 1; 30; 1; 30; 1; 8; 9; 12; 30; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0302_0e76df45-c99f-7085-e063-6294a90a6423	63479-0302	HUMAN OTC DRUG	C02	FIBROZOLVE	APIS MELLIFICA, AURUM MURIATICUM NATRONATUM, BERBERIS VULGARIS, BOS TAURUS PITUITARUM POSTERIUM, CALCAREA FLUORICA, CALCAREA IODATA, CONIUM MACULATUM, FRAXINUS AMERICANA, HYDRASTIS CANADENSIS, HYDROFLUORICUM ACIDUM, LAPIS ALBUS, PANCREATINUM, SARCOLACTICUM ACIDUM, SEPIA, SULPHUR IODATUM, THIOSINAMINUM, THUJA OCCIDENTALIS, THYROIDINUM	SOLUTION/ DROPS	SUBLINGUAL	19950215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALLYLTHIOUREA; APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; BOS TAURUS PITUITARY GLAND, POSTERIOR; CALCIUM FLUORIDE; CALCIUM HEXAFLUOROSILICATE; CALCIUM IODIDE; CONIUM MACULATUM FLOWERING TOP; FRAXINUS AMERICANA BARK; GOLDENSEAL; HYDROFLUORIC ACID; LACTIC ACID, L-; PANCRELIPASE; SEPIA OFFICINALIS JUICE; SODIUM TETRACHLOROAURATE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED	30; 30; 30; 7; 15; 30; 12; 15; 2; 1; 15; 200; 7; 15; 30; 12; 30; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Bee Venoms [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0304_0e76cd12-9f3e-c98f-e063-6394a90ad9fb	63479-0304	HUMAN OTC DRUG	C04	ARTHRO MUSCOTOX	ACTAEA SPICATA, AMMONIUM BENZOICUM, ARNICA MONTANA, BELLIS PERENNIS, BERBERIS VULGARIS, BRYONIA, CHELIDONIUM MAJUS, CHININUM SULPHURICUM, DULCAMARA LIGNOSA WHOLE, ECHINACEA PURPUREA, FORMICA RUFA, FRAXINUS EXCELSIOR LEAF, LACTICUM ACIDUM, LEDUM PALUSTRE, PULSATILLA VULGARIS, RHODODENDRON CHRYSANTHUM, RHUS TOXICODENDRON, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SYMPHYTUM OFFICINALE, URICUM ACIDUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACTAEA SPICATA ROOT; AMMONIUM BENZOATE; ARNICA MONTANA; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; COMFREY ROOT; ECHINACEA PURPUREA; FORMICA RUFA; FRAXINUS EXCELSIOR LEAF; LACTIC ACID, DL-; LACTIC ACID, L-; PULSATILLA VULGARIS WHOLE; QUININE SULFATE; RHODODENDRON AUREUM LEAF; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SOLANUM DULCAMARA WHOLE; TOXICODENDRON PUBESCENS LEAF; URIC ACID	12; 9; 30; 12; 1; 30; 1; 9; 1; 30; 1; 30; 15; 30; 9; 12; 6; 9; 30; 30; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC]		N	20251231
63479-0307_0e76d80a-2d12-e4c4-e063-6294a90aeac2	63479-0307	HUMAN OTC DRUG	C07	STRONG LIGAMENTS AND JOINTS	ARNICA MONTANA, ASCORBICUM ACIDUM, BOS TAURUS LYMPH VESSEL, INTERVERTEBRAL FIBROCARTILAGE, BOS TAURUS MESENCHYME, CALCAREA PHOSPHORICA, CARTILAGO SUIS, FORMICUM ACIDUM, LAPIS ALBUS, PINUS MONTANA LEAFY TWIG, RHAMNUS CALIFORNICA, RHUS TOXICODENDRON, RUTA GRAVEOLENS, SILICEA, SUS SCROFA JOINT ENVELOPE, SUS SCROFA LIGAMENT, SUS SCROFA MENISCUS, SUS SCROFA PARATHYROID GLAND, SUS SCROFA VEIN, SYMPHYTUM OFFICINALE	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARNICA MONTANA; ASCORBIC ACID; BOS TAURUS INTERVERTEBRAL DISC; BOS TAURUS LYMPH VESSEL; BOS TAURUS MESENCHYME; CALCIUM HEXAFLUOROSILICATE; COMFREY ROOT; FORMIC ACID; FRANGULA CALIFORNICA BARK; PINUS MUGO LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; SUS SCROFA CARTILAGE; SUS SCROFA JOINT CAPSULE; SUS SCROFA LIGAMENT; SUS SCROFA MENISCUS; SUS SCROFA PARATHYROID GLAND; SUS SCROFA VEIN; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	12; 8; 8; 7; 8; 12; 9; 12; 8; 7; 12; 12; 7; 8; 8; 7; 8; 7; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Vitamin C [EPC]		N	20251231
63479-0308_0e76d80a-2d15-e4c4-e063-6294a90aeac2	63479-0308	HUMAN OTC DRUG	C08	CALCIUM METABOLISM	ABIES ALBA LEAFY TWIG, CALCAREA ACETICA, CALCAREA ARSENICICA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA HYPOPHOSPHOROSA, CALCAREA IODATA, CALCAREA MURIATICA, CALCAREA OXALICA, CALCAREA PHOSPHORICA, CALCAREA PICRATA, CALCAREA SULPHURICA, CALCULUS BOVIS, CALENDULA OFFICINALIS, CHOLESTERINUM, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, LAPIS ALBUS, SILICEA, SULPHUR IODATUM, SUS SCROFA PARATHYROID GLAND, SYMPHYTUM OFFICINALE, URTICA URENS, VITAMIN D	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ABIES ALBA LEAFY TWIG; BOS TAURUS GALLSTONE; CALCIUM ACETATE; CALCIUM ARSENATE; CALCIUM CHLORIDE; CALCIUM FLUORIDE; CALCIUM HEXAFLUOROSILICATE; CALCIUM HYPOPHOSPHITE; CALCIUM IODIDE; CALCIUM OXALATE MONOHYDRATE; CALCIUM PICRATE; CALCIUM SULFATE ANHYDROUS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CHOLESTEROL; COMFREY ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; SULFUR IODIDE; SUS SCROFA PARATHYROID GLAND; TRIBASIC CALCIUM PHOSPHATE; URTICA URENS; VITAMIN D	8; 15; 12; 8; 12; 15; 12; 12; 12; 12; 12; 12; 15; 6; 15; 6; 6; 15; 12; 12; 9; 15; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calcium [CS], Calcium [CS], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA]		N	20251231
63479-0401_0e76e634-d93f-70ac-e063-6294a90a6ad3	63479-0401	HUMAN OTC DRUG	D01	DRAINAGE COMPLEX	ALFALFA, ALLIUM SATIVUM, ASPARAGUS OFFICINALIS, AVENA SATIVA, BELLADONNA, BERBERIS VULGARIS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, HYDRASTIS CANADENSIS, JUNIPERUS VIRGINIANA, NICCOLUM METALLICUM, PASSIFLORA INCARNATA, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALFALFA; ASPARAGUS; ATROPA BELLADONNA; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; GARLIC; GLYCYRRHIZA GLABRA; GOLDENSEAL; JUNIPERUS VIRGINIANA TWIG; LACTIC ACID, L-; NICKEL; PASSIFLORA INCARNATA FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE	1; 8; 15; 1; 6; 10; 8; 1; 12; 6; 30; 12; 1; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20251231
63479-0402_0e76df45-c9e7-7085-e063-6294a90a6423	63479-0402	HUMAN OTC DRUG	D02	DIGESTIVE DRAINAGE	ALOE, ACTIVATED CHARCOAL, COLCHICUM AUTUMNALE BULB, COLLINSONIA CANADENSIS ROOT, CUCURBITA PEPO FLOWER, DRYOPTERIS FILIX-MAS ROOT, INDOLE, SKIM MILK, LYCOPODIUM CLAVATUM SPORE, ACHILLEA MILLEFOLIUM, SODIUM SULFATE, FRANGULA PURSHIANA BARK, SCROPHULARIA NODOSA, SKATOLE, TARAXACUM OFFICINALE, TARTARIC ACID	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ALOE; COLCHICUM AUTUMNALE BULB; COLLINSONIA CANADENSIS ROOT; CUCURBITA PEPO FLOWER; DRYOPTERIS FILIX-MAS ROOT; FRANGULA PURSHIANA BARK; INDOLE; LYCOPODIUM CLAVATUM SPORE; SCROPHULARIA NODOSA; SKATOLE; SKIM MILK; SODIUM SULFATE; TARAXACUM OFFICINALE; TARTARIC ACID	1; 30; 2; 12; 4; 2; 8; 1; 15; 12; 9; 30; 10; 30; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-0403_0e76ea05-c3d0-8465-e063-6294a90a747f	63479-0403	HUMAN OTC DRUG	D03	LVR-DRN	berberis vulgaris root bark, bryonia alba root, phenol, milk thistle, chelidonium majus, juniper berry, lycopodium clavatum spore, sodium phosphate, dibasic, heptahydrate, sodium sulfate, strychnos nux-vomica seed, phosphorus, lactic acid, l-, taraxacum officinale, viscum album fruiting top, and yucca filamentosa	SOLUTION	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS; JUNIPER BERRY; LACTIC ACID, L-; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHENOL; PHOSPHORUS; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; VISCUM ALBUM FRUITING TOP; YUCCA FILAMENTOSA	1; 12; 2; 1; 12; 30; 1; 12; 12; 15; 10; 30; 12; 2; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-0405_0e76e858-e00d-c0d8-e063-6394a90a946b	63479-0405	HUMAN OTC DRUG	D05	KDNY-DRN	apis mellifera, asparagus, berberis vulgaris root bark, lytta vesicatoria, chelidonium majus, juniper berry, magnesium chloride, sodium chloride, populus tremuloides bark, rhus aromatica root bark, rubia tinctorum root, saw palmetto, solidago virgaurea flowering top, taraxacum officinale, and arctostaphylos uva-ursi leaf	SOLUTION	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; ASPARAGUS; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; JUNIPER BERRY; LYTTA VESICATORIA; MAGNESIUM CHLORIDE; POPULUS TREMULOIDES BARK; RHUS AROMATICA ROOT BARK; RUBIA TINCTORUM ROOT; SAW PALMETTO; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE	15; 1; 1; 6; 3; 6; 15; 30; 9; 2; 6; 2; 30; 1; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20251231
63479-0406_0e76cbc6-8ceb-7dc8-e063-6294a90a815a	63479-0406	HUMAN OTC DRUG	D06	BLDR-DRN	APIS MELLIFICA, ARGENTUM NITRICUM, BADIAGA, BELLADONNA, CANTHARIS, CAUSTICUM, CHIMAPHILA UMBELLATA, COLOCYNTHIS, CUBEBA OFFICINALIS, CUCURBITA CITRULLUS, CUCURBITA PEPO FLOWER, ECHINACEA ANGUSTIFOLIA, EQUISETUM HYEMALE, ERYNGIUM AQUATICUM, FERRUM PHOSPHORICUM, MITCHELLA REPENS, OLEUM SANTALI, PETROSELINUM SATIVUM, PIPER METHYSTICUM, POPULUS TREMULOIDES BARK, SARSAPARILLA, TEREBINTHINA, UVA URSI	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; ATROPA BELLADONNA; CAUSTICUM; CHIMAPHILA UMBELLATA; CITRULLUS COLOCYNTHIS FRUIT PULP; CUCURBITA PEPO FLOWER; ECHINACEA ANGUSTIFOLIA; EQUISETUM HYEMALE; ERYNGIUM YUCCIFOLIUM ROOT; FERROSOFERRIC PHOSPHATE; LYTTA VESICATORIA; MACROPIPER METHYSTICUM ROOT; MITCHELLA REPENS; PETROSELINUM CRISPUM; PIPER CUBEBA FRUIT; POPULUS TREMULOIDES BARK; SANDALWOOD OIL; SILVER NITRATE; SMILAX ORNATA ROOT; SPONGILLA LACUSTRIS; TURPENTINE OIL; WATERMELON SEED	6; 1; 10; 8; 2; 8; 3; 1; 6; 2; 10; 12; 2; 1; 3; 3; 2; 6; 6; 6; 8; 8; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0407_0e76df45-c9e8-7085-e063-6294a90a6423	63479-0407	HUMAN OTC DRUG	D07	LMPH-DRN	araneus diadematus, arisaema triphyllum root, asterias rubens, baptisia tinctoria, barium iodide, echinacea angustifolia, ferrous iodide, goldenseal, lachesis muta venom, phytolacca americana root, pinus sylvestris flowering top, scrophularia nodosa, spongia officinalis skeleton, roasted, and teucrium scorodonia flowering top	SOLUTION	SUBLINGUAL	19880801		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARANEUS DIADEMATUS; ARISAEMA TRIPHYLLUM ROOT; ASTERIAS RUBENS; BAPTISIA TINCTORIA ROOT; BARIUM IODIDE; ECHINACEA ANGUSTIFOLIA; FERROUS IODIDE; GOLDENSEAL; LACHESIS MUTA VENOM; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS FLOWERING TOP; SCROPHULARIA NODOSA; SPONGIA OFFICINALIS SKELETON, ROASTED; TEUCRIUM SCORODONIA FLOWERING TOP	18; 2; 6; 2; 6; 1; 12; 6; 30; 30; 15; 2; 30; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-0408_0e76e858-e00f-c0d8-e063-6394a90a946b	63479-0408	HUMAN OTC DRUG	D08	LNG-DRN	ACONITUM NAPELLUS, AMERICAN GINSENG, ARSENICUM IODATUM, BLATTA ORIENTALIS, CALCAREA SULPHURICA, CARPINUS BETULUS FLOWER, CUPRUM METALLICUM, GRINDELIA, HEPAR SULPHURIS CALCAREUM, IPECACUANHA, JUSTICIA ADHATODA, KALI IODATUM, LOBELIA INFLATA, NAPHTHALINUM, NARCISSUS PSEUDONARCISSUS, PINE TAR, POPULUS CANDICANS, TABACUM, THUJA OCCIDENTALIS, THYMUS SERPYLLUM	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ARSENIC TRIIODIDE; BLATTA ORIENTALIS; CALCIUM SULFATE ANHYDROUS; CALCIUM SULFIDE; CARPINUS BETULUS FLOWERING TOP; COPPER; GRINDELIA HIRSUTULA FLOWERING TOP; IPECAC; JUSTICIA ADHATODA LEAF; LOBELIA INFLATA; NAPHTHALENE; NARCISSUS PSEUDONARCISSUS; PINE TAR; POPULUS BALSAMIFERA LEAF BUD; POTASSIUM IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; THYMUS SERPYLLUM; TOBACCO LEAF	4; 3; 10; 6; 10; 8; 2; 9; 3; 4; 3; 4; 5; 3; 12; 2; 3; 3; 1; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS]		N	20251231
63479-0409_0e76db01-1825-6a4e-e063-6294a90a6e32	63479-0409	HUMAN OTC DRUG	D09	SNS-DRN	AMBROSIA ARTEMISIAEFOLIA, ARALIA RACEMOSA, ARNICA MONTANA, CALENDULA OFFICINALIS, CHROMICUM ACIDUM, ECHINACEA PURPUREA, EUCALYPTOL, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC VACCINUM, MERCURIUS IODATUS FLAVUS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, ROSA DAMASCENA, SABADILLA, SANGUINARINUM NITRICUM, SYMPHYTUM OFFICINALE	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AMBROSIA ARTEMISIIFOLIA; ARALIA RACEMOSA ROOT; ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; CHROMIUM TRIOXIDE; COMFREY ROOT; COW MILK; ECHINACEA PURPUREA; EUCALYPTOL; MERCURIC SULFIDE; MERCUROUS IODIDE; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; POTASSIUM SULFATE; ROSA DAMASCENA FLOWERING TOP; SANGUINARINE NITRATE; SCHOENOCAULON OFFICINALE SEED; SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE	3; 3; 9; 2; 8; 8; 15; 1; 4; 8; 8; 8; 8; 8; 3; 8; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20251231
63479-0410_0e76e858-e011-c0d8-e063-6394a90a946b	63479-0410	HUMAN OTC DRUG	D10	SKN-DRN	ALNUS GLUTINOSA, APIS MELLIFICA, BERBERIS VULGARIS, CALCIUM SULFIDE, CROTON TIGLIUM, ECHINACEA ANGUSTIFOLIA, GRAPHITE, GRINDELIA HIRSUTULA, HYDROFLUORIC ACID, JUGLANS REGIA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MYRISTICA SEBIFERA, NITRICUM ACIDUM, PHOSPHORUS, RHUS TOXICODENDRON, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, SULPHUR, VINCA MINOR	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALNUS GLUTINOSA BARK; APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CROTON TIGLIUM SEED; ECHINACEA ANGUSTIFOLIA; GRAPHITE; GRINDELIA HIRSUTULA WHOLE; HYDROFLUORIC ACID; JUGLANS REGIA FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NITRIC ACID; PHOSPHORUS; SCROPHULARIA NODOSA; SOLIDAGO VIRGAUREA FLOWERING TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF; VINCA MINOR; VIROLA SEBIFERA RESIN	3; 12; 3; 10; 12; 3; 10; 1; 10; 1; 6; 12; 8; 12; 3; 3; 8; 12; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0507_0e892003-98dd-bbc6-e063-6294a90a5233	63479-0507	HUMAN OTC DRUG	E07	TYPE A BALANCE	ACONITUM NAPELLUS, ARALIA QUINQUEFOLIA, CHININUM ARSENICOSUM, COFFEA CRUDA, COLCHICUM AUTUMNALE, CRATAEGUS OXYACANTHA FRUIT, ECHINACEA PURPUREA, ESCHSCHOLTZIA CALIFORNICA, HUMULUS LUPULUS, IGNATIA AMARA, LYCOPUS VIRGINICUS, NUX VOMICA, PASSIFLORA INCARNATA, SCUTELLARIA LATERIFLORA, STRYCHNINUM PHOSPHORICUM, THYROIDINUM, VISCUM ALBUM FRUITING TOP, YELLOW JASMINE ROOT	SOLUTION/ DROPS	SUBLINGUAL	20231016		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACONITUM NAPELLUS; AMERICAN GINSENG; ARABICA COFFEE BEAN; COLCHICUM AUTUMNALE BULB; CRATAEGUS LAEVIGATA FRUIT; ECHINACEA PURPUREA; ESCHSCHOLZIA CALIFORNICA; GELSEMIUM SEMPERVIRENS ROOT; HOPS; LYCOPUS VIRGINICUS; PASSIFLORA INCARNATA TOP; QUININE ARSENITE; SCUTELLARIA LATERIFLORA WHOLE; STRYCHNINE PHOSPHATE DIHYDRATE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; VISCUM ALBUM FRUITING TOP	8; 15; 12; 12; 4; 3; 1; 12; 1; 1; 1; 6; 1; 12; 8; 12; 9; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-0508_0e76f0d9-0ac3-e097-e063-6394a90adba2	63479-0508	HUMAN OTC DRUG	E08	BIOCLOCK REGULATOR	BETULA VERRUCOSA, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARUM POSTERIUM, CALCAREA IODATA, COCCULUS INDICUS, COLCHICUM AUTUMNALE, ELEUTHERO, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE, HYPOTHALAMUS, JUNIPERUS COMMUNIS STEM, KALI CARBONICUM, KALI PHOSPHORICUM, LAC CANINUM, NUX VOMICA, PASSIFLORA INCARNATA, ORNITHOGALUM UMBELLATUM, PHOSPHORICUM ACIDUM, RHAMNUS PURSHIANA, RIBES NIGRUM, SARCOLACTICUM ACIDUM, SEPIA, SOLIDAGO VIRGAUREA, SUS SCROFA PINEAL GLAND, TRYPTOPHAN, TYROSINE, YELLOW JASMINE	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ANAMIRTA COCCULUS SEED; BETULA PENDULA LEAF; BOS TAURUS ADRENAL GLAND; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND; CALCIUM IODIDE; CANIS LUPUS FAMILIARIS MILK; CARPINUS BETULUS FLOWER; COLCHICUM AUTUMNALE BULB; ELEUTHERO; FRANGULA PURSHIANA BARK; GELSEMIUM SEMPERVIRENS ROOT; JUNIPERUS COMMUNIS STEM; LACTIC ACID, L-; OLEA EUROPAEA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PASSIFLORA INCARNATA TOP; PHOSPHORIC ACID; POTASSIUM CARBONATE; POTASSIUM PHOSPHATE, DIBASIC; RIBES NIGRUM FLOWER BUD; SEPIA OFFICINALIS JUICE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PINEAL GLAND; TRYPTOPHAN; TYROSINE	12; 6; 4; 7; 7; 12; 15; 30; 12; 9; 6; 15; 9; 30; 30; 30; 12; 12; 12; 30; 8; 30; 9; 30; 4; 7; 7	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS]		N	20251231
63479-0601_0e76cbc6-8ced-7dc8-e063-6294a90a815a	63479-0601	HUMAN OTC DRUG	F01	ANGR-RLS	BIG SAGEBRUSH, BOS TAURUS LIVER, GALLBLADDER, BRIZA MAXIMA, CALENDULA OFFICINALIS, CHAMOMILE FLOWER, CHICORY FLOWER, GARLIC, ENGLISH HOLLY FLOWER, EUROPEAN BEECH FLOWER, FORKING LARKSPUR FLOWER, GERMAN CHAMOMILE FLOWER, IMPATIENS GLANDULIFERA FLOWER, LILIUM TIGRINUM, MOUNTAIN DOGWOOD, NATRUM MURIATICUM, NUX VOMICA, RUBBER RABBITBRUSH, VITIS VINIFERA FLOWER, WATERMELON, WHITE WILLOW FLOWER, YELLOW STAR THISTLE	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALLIUM SATIVUM WHOLE; ARTEMISIA TRIDENTATA WHOLE; BEEF LIVER; BOS TAURUS GALLBLADDER; BRIZA MAXIMA WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; CENTAUREA SOLSTITIALIS WHOLE; CHAMOMILE; CICHORIUM INTYBUS FLOWER; CONSOLIDA REGALIS FLOWER; CORNUS NUTTALLII WHOLE; ERICAMERIA NAUSEOSA WHOLE; FAGUS SYLVATICA FLOWERING TOP; ILEX AQUIFOLIUM FLOWERING TOP; IMPATIENS GLANDULIFERA FLOWER; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA RECUTITA FLOWERING TOP; SALIX ALBA FLOWERING TOP; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VITIS VINIFERA FLOWERING TOP; WATERMELON	12; 12; 60; 60; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 20; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-0602_0e76f0d9-0ac5-e097-e063-6394a90adba2	63479-0602	HUMAN OTC DRUG	F02	ANGR-FLX	ADELHEID AQUA, ARSENICUM ALBUM, BIG SAGEBRUSH, BOS TAURUS LIVER, GALLBLADDER, BRIZA MAXIMA, CALENDULA OFFICINALIS, CAYENNE, CHAMOMILE , CHICORY , GARLIC, ENGLISH HOLLY , EUROPEAN BEECH , FORKING LARKSPUR , GERMAN CHAMOMILE , IMPATIENS GLANDULIFERA , JUGLANS REGIA , LILIUM TIGRINUM, MORNING GLORY, MOUNTAIN DOGWOOD, NATRUM MURIATICUM, NUX VOMICA, PINUS SYLVESTRIS , REDWOOD, RUBBER RABBITBRUSH, SEPIA, TOLMIE STAR TULIP, VERBENA OFFICINALIS , VITIS VINIFERA , WATERMELON, WHITE WILLOW , YELLOW STAR THISTLE	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALLIUM SATIVUM WHOLE; ARSENIC TRIOXIDE; ARTEMISIA TRIDENTATA WHOLE; BEEF LIVER; BOS TAURUS GALLBLADDER; BRIZA MAXIMA WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; CALOCHORTUS TOLMIEI WHOLE; CAPSICUM; CENTAUREA SOLSTITIALIS WHOLE; CHAMOMILE; CICHORIUM INTYBUS FLOWER; CONSOLIDA REGALIS FLOWER; CORNUS NUTTALLII WHOLE; ERICAMERIA NAUSEOSA WHOLE; FAGUS SYLVATICA FLOWERING TOP; ILEX AQUIFOLIUM FLOWERING TOP; IMPATIENS GLANDULIFERA FLOWER; IPOMOEA PURPUREA TOP; JUGLANS REGIA FLOWERING TOP; LILIUM LANCIFOLIUM WHOLE FLOWERING; MATRICARIA CHAMOMILLA FLOWERING TOP; PINUS SYLVESTRIS FLOWERING TOP; SALIX ALBA FLOWERING TOP; SEPIA OFFICINALIS JUICE; SEQUOIA SEMPERVIRENS WHOLE; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; VERBENA OFFICINALIS FLOWERING TOP; VITIS VINIFERA FLOWERING TOP; WATER; WATERMELON	12; 15; 12; 60; 60; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 15; 12; 12; 20; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20251231
63479-0603_0e76e634-d944-70ac-e063-6294a90a6ad3	63479-0603	HUMAN OTC DRUG	F03	FR-RLS	ASPEN, ARSENICUM ALBUM, DIPLACUS AURANTIACUS, GARLIC, LILIUM TIGRINUM, LOQUAT, LUFFA OPERCULATA, MIMULUS GUTTATUS, PENSTEMON DAVIDSONII, PRUNUS CERASIFERA, RED HORSE CHESTNUT, RUBUS URSINUS, ROCKROSE, TOXICODENDRON DIVERSILOBUM, VIOLA ODORATA, WATERMELON, YELLOW JASMINE	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AESCULUS CARNEA FLOWER; ALLIUM SATIVUM WHOLE; ARSENIC TRIOXIDE; DIPLACUS AURANTIACUS WHOLE; ERIOBOTRYA JAPONICA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; HELIANTHEMUM NUMMULARIUM FLOWER; LILIUM LANCIFOLIUM WHOLE FLOWERING; LUFFA OPERCULATA FRUIT; MIMULUS GUTTATUS FLOWERING TOP; PENSTEMON DAVIDSONII WHOLE; POPULUS TREMULA FLOWERING TOP; PRUNUS CERASIFERA FLOWER; RUBUS URSINUS WHOLE; TOXICODENDRON DIVERSILOBUM WHOLE; VIOLA ODORATA FLOWER; WATERMELON	12; 12; 20; 12; 12; 20; 12; 20; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20251231
63479-0604_0e76e634-d946-70ac-e063-6294a90a6ad3	63479-0604	HUMAN OTC DRUG	F04	FR-TRST	ARSENICUM ALBUM, CALOCHORTUS GUNNISONII, CERATOSTIGMA WILLMOTTIANUM, CHERRY PLUM, CHIRAKABHEDA WHOLE, COMMON VIOLET, GARLIC, DEERBRUSH, ENGLISH HOLLY, EUROPEAN ASPEN, HYOSCYAMUS NIGER, LILIUM TIGRINUM, LOQUAT, MIMULUS GUTTATUS, MOSCHUS, MULLEIN, ORANGE BUSH MONKEY, OREGON GRAPEHOLLY, PACIFIC POISONOAK, PENSTEMON DAVIDSONII, RED HORSECHESTNUT, ROCKROSE, RUBUS URSINUS, SACRED LOTUS, SELF HEAL, HYPERICUM PERFORATUM, WATERMELON, YELLOW JASMINE	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AESCULUS X CARNEA FLOWER; ALLIUM SATIVUM WHOLE; ANGELICA ARCHANGELICA WHOLE; ARSENIC TRIOXIDE; CALOCHORTUS GUNNISONII WHOLE; CEANOTHUS INTEGERRIMUS WHOLE; CERATOSTIGMA WILLMOTTIANUM FLOWER; DIPLACUS AURANTIACUS WHOLE; ERIOBOTRYA JAPONICA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; HELIANTHEMUM NUMMULARIUM FLOWER; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM FLOWER; ILEX AQUIFOLIUM FLOWERING TOP; LILIUM LANCIFOLIUM WHOLE FLOWERING; MAHONIA AQUIFOLIUM WHOLE; MIMULUS GUTTATUS FLOWERING TOP; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; NELUMBO NUCIFERA FLOWER; PENSTEMON DAVIDSONII WHOLE; POPULUS TREMULA FLOWERING TOP; PRUNELLA VULGARIS FLOWER; PRUNUS CERASIFERA FLOWER; RUBUS URSINUS WHOLE; TOXICODENDRON DIVERSILOBUM WHOLE; VERBASCUM DENSIFLORUM FLOWER; VIOLA ODORATA FLOWER; WATERMELON	12; 12; 12; 20; 12; 12; 12; 12; 12; 20; 12; 15; 12; 12; 20; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [kp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20251231
63479-0605_0e76f50e-2560-d499-e063-6394a90aa92e	63479-0605	HUMAN OTC DRUG	F05	SLFSTM	BULBOUS BUTTERCUP, CENTAURY, CERATOSTIGMA WILLMOTTIANUM, JASMINUM OFFICINALE, LAC CANINUM, LARIX DECIDUA, LYCOPODIUM CLAVATUM, ASIMINA TRILOBA, PRICKLY PEAR, PULSATILLA VULGARIS, ROUNDLEAF MALLOW, SAGUARO, SUNFLOWER, TRUMPET VINE, YELLOW JASMINE	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ASIMINA TRILOBA WHOLE; CAMPSIS RADICANS FLOWER; CANIS LUPUS FAMILIARIS MILK; CARNEGIEA GIGANTEA FLOWER; CENTAURIUM ERYTHRAEA FLOWER; CERATOSTIGMA WILLMOTTIANUM FLOWER; GELSEMIUM SEMPERVIRENS ROOT; HELIANTHUS ANNUUS FLOWERING TOP; JASMINUM OFFICINALE FLOWER; LARIX DECIDUA FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; MALVA NEGLECTA WHOLE; OPUNTIA FICUS-INDICA FLOWER; PULSATILLA VULGARIS WHOLE; RANUNCULUS BULBOSUS	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20251231
63479-0607_0e76f0d9-0ac6-e097-e063-6394a90adba2	63479-0607	HUMAN OTC DRUG	F07	LVJY	aloe vera, big sagebrush, borage, california wildrose, calochortus gunnisonii, causticum, chicory, coffea cruda, crocus sativus, dicentra formosa, diplacus aurantiacus, english hawthron, english holly, european aspen, flowering quince, forking larkspur, mimulus guttatus, nasturtium, phosphoricum acidum, strophanthus hispidus, wild mustard, yellow star thistle, yerba santa, zinnia elegans	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALOE VERA FLOWER; ARABICA COFFEE BEAN; ARTEMISIA TRIDENTATA WHOLE; BORAGO OFFICINALIS FLOWER; CALOCHORTUS GUNNISONII WHOLE; CAUSTICUM; CENTAUREA SOLSTITIALIS WHOLE; CHAENOMELES LAGENARIA WHOLE; CICHORIUM INTYBUS FLOWER; CONSOLIDA REGALIS FLOWER; CRATAEGUS MONOGYNA FLOWER; DICENTRA FORMOSA WHOLE; DIPLACUS AURANTIACUS WHOLE; ERIODICTYON CALIFORNICUM FLOWERING TOP; ILEX AQUIFOLIUM FLOWERING TOP; MIMULUS GUTTATUS FLOWERING TOP; PHOSPHORIC ACID; POPULUS TREMULA FLOWERING TOP; ROSA CALIFORNICA WHOLE; SAFFRON; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; STROPHANTHUS HISPIDUS SEED; TROPAEOLUM MAJUS FLOWER; ZINNIA ELEGANS WHOLE	12; 9; 12; 12; 12; 9; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 9; 12; 12; 9; 12; 9; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-0608_0e76f50e-2564-d499-e063-6394a90aa92e	63479-0608	HUMAN OTC DRUG	F08	FRGV	ALLEGHENY MONKEYFLOWER, ARNICA MONTANA, ARNICA MONTANA FLOWER, CEANOTHUS INTEGERRIMUS, EHRENDORFERIA CHRYSANTHA, FAGUS SYLVATICA FLOWER, IGNATIA AMARA, ILEX AQUIFOLIUM FLOWER, MALUS SYLVESTRIS FLOWER, MULLEIN FLOWER, NETTLELEAF GIANT HYSSOP, PINUS SYLVESTRIS FLOWER, SALIX ALBA FLOWER	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AGASTACHE URTICIFOLIA WHOLE; ARNICA MONTANA; ARNICA MONTANA FLOWER; CEANOTHUS INTEGERRIMUS WHOLE; EHRENDORFERIA CHRYSANTHA WHOLE; FAGUS SYLVATICA FLOWERING TOP; ILEX AQUIFOLIUM FLOWERING TOP; MALUS SYLVESTRIS FLOWER; MIMULUS RINGENS WHOLE; PINUS SYLVESTRIS FLOWERING TOP; SALIX ALBA FLOWERING TOP; STRYCHNOS IGNATII SEED; VERBASCUM DENSIFLORUM FLOWER	12; 15; 12; 12; 12; 12; 12; 12; 12; 12; 12; 15; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20251231
63479-0609_0e76f50e-2565-d499-e063-6394a90aa92e	63479-0609	HUMAN OTC DRUG	F09	LTGO	ADELHEID AQUA, AGRIMONY, MALUS SYLVESTRIS, ARSENICUM ALBUM, FILAREE, HEATHER, HORSE CHESTNUT, LACHESIS MUTUS, NASTURTIUM, RED HORSE CHESTNUT, SEPIA, SILICEA, STRAMONIUM, VERBENA OFFICINALIS	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AESCULUS HIPPOCASTANUM FLOWER; AESCULUS X CARNEA FLOWER; AGRIMONIA EUPATORIA FLOWER; ARSENIC TRIOXIDE; CALLUNA VULGARIS FLOWERING TOP; DATURA STRAMONIUM; ERODIUM CICUTARIUM; LACHESIS MUTA VENOM; MALUS SYLVESTRIS FLOWER; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; TROPAEOLUM MAJUS FLOWER; VERBENA OFFICINALIS FLOWERING TOP; WATER	12; 12; 12; 12; 12; 9; 12; 9; 12; 12; 9; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20251231
63479-0610_0e76f0d9-0ac8-e097-e063-6394a90adba2	63479-0610	HUMAN OTC DRUG	F10	WRMLV	AGRIMONY, ALOE VERA, AURUM METALLICUM, AZURITE, BASIL, CALENDULA OFFICINALIS, CARICA PAPAYA, CAYENNE, DAFFODIL, DICENTRA FORMOSA, DIPLACUS AURANTIACUS, HIBISCUS CHINENSIS, HORSE CHESTNUT, HYLOTELEPHIUM TELEPHIUM, LAVANDULA STOECHAS, LILIUM TIGRINUM, MALVA NEGLECTA, MELILOTUS ALBA, NELUMBO NUCIFERA, PHOSPHORUS, PRUNELLA VULGARIS, ROSA LUCIAE, ROSEMARY, SCUTELLARIA LATERIFLORA, SEPIA, SILICEA, THUJA OCCIDENTALIS, TOXICODENDRON DIVERSILOBUM, VIOLA ODORATA, YELLOW JASMINE	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ABELMOSCHUS MOSCHATUS FLOWER; AESCULUS HIPPOCASTANUM FLOWER; AGRIMONIA EUPATORIA FLOWER; ALOE VERA FLOWER; AZURITE; CALENDULA OFFICINALIS FLOWERING TOP; CAPSICUM; CARICA PAPAYA WHOLE; DICENTRA FORMOSA WHOLE; DIPLACUS AURANTIACUS WHOLE; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HYLOTELEPHIUM TELEPHIUM WHOLE; LAVANDULA STOECHAS FLOWERING TOP; LILIUM LANCIFOLIUM WHOLE FLOWERING; MALVA NEGLECTA WHOLE; MELILOTUS ALBUS TOP; NARCISSUS PSEUDONARCISSUS FLOWER; NELUMBO NUCIFERA FLOWER; OCIMUM BASILICUM FLOWERING TOP; PHOSPHORUS; PRUNELLA VULGARIS FLOWER; ROSA LUCIAE FLOWERING TOP; ROSMARINUS OFFICINALIS FLOWER; SCUTELLARIA LATERIFLORA TOP; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON DIVERSILOBUM WHOLE; VIOLA ODORATA FLOWER	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20251231
63479-0612_0e76cbc6-8d01-7dc8-e063-6294a90a815a	63479-0612	HUMAN OTC DRUG	F12	PSTVTY	ALOE VERA, AVOCADO, BERBERIS AQUIFOLIUM, CALOCHORTUS TOLMIE, CAROBA, CHAMOMILE, CORNSILK, DILL, FAGUS SYLVATICA, GOLD, HYPERICUM PERFORATUM, ILEX AQUIFOLIUM, JUGLANS REGIA, LAVENDER, LYCOPODIUM CLAVATUM, MADIA ELEGANS, MEADIA HENDERSONII, MONARDELLA, MORNING GLORY, NAJA TRIPUDIANS, PENSTEMON DAVIDSONII, PHOSPHORUS, PRUNUS PERSICA, PSORINUM, PULSATILLA VULGARIS, RED CLOVER, ROSA CALIFORNICA, SACRED LOTUS, SARSAPARILLA, SILENE LACINIATA, SILVER, SOLIDAGO CALIFORNICA, SPIDERWORT, WHITE WILLOW	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALOE VERA FLOWER; ANETHUM GRAVEOLENS WHOLE; BERBERIS AQUIFOLIUM WHOLE; CALOCHORTUS TOLMIEI WHOLE; CHAMOMILE; CORN SILK; FAGUS SYLVATICA FLOWERING TOP; GOLD; HYPERICUM PERFORATUM FLOWER; ILEX AQUIFOLIUM FLOWERING TOP; IPOMOEA PURPUREA TOP; JACARANDA CAROBA FLOWER; JUGLANS REGIA FLOWERING TOP; LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWER; LYCOPODIUM CLAVATUM SPORE; MADIA ELEGANS WHOLE; MONARDELLA ODORATISSIMA WHOLE; NAJA NAJA VENOM; NELUMBO NUCIFERA FLOWER; PENSTEMON DAVIDSONII WHOLE; PERSEA AMERICANA WHOLE; PHOSPHORUS; PRIMULA HENDERSONII WHOLE; PRUNUS PERSICA VAR. NUCIPERSICA WHOLE; PULSATILLA VULGARIS WHOLE; ROSA CALIFORNICA WHOLE; SALIX ALBA FLOWERING TOP; SARSAPARILLA; SCABIES LESION LYSATE (HUMAN); SILENE LACINIATA WHOLE; SILVER; SOLIDAGO CALIFORNICA WHOLE; TRADESCANTIA OCCIDENTALIS WHOLE; TRIFOLIUM PRATENSE FLOWER	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 15; 12; 12; 15; 12; 12; 15; 12; 12; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
63479-0614_0e76cbc6-8d03-7dc8-e063-6294a90a815a	63479-0614	HUMAN OTC DRUG	F14	INCDNT-RLS	ARNICA MONTANA, ARNICA MONTANA, CALOCHORTUS GUNNISONII, CHERRY PLUM, CLEMATIS VITALBA, DICENTRA FORMOSA, EHRENDORFERIA CHRYSANTHA, ENGLISH HAWTHRON, HYPERICUM PERFORATUM, IGNATIA AMARA, IMPATIENS GLANDULIFERA, ORNITHOGALUM UMBELLATUM, PRUNELLA VULGARIS, ROCKROSE, RUTA GRAVEOLENS, STAPHYSAGRIA	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARNICA MONTANA; ARNICA MONTANA FLOWER; CALOCHORTUS GUNNISONII WHOLE; CLEMATIS VITALBA FLOWER; CRATAEGUS MONOGYNA FLOWER; DELPHINIUM STAPHISAGRIA SEED; DICENTRA FORMOSA WHOLE; EHRENDORFERIA CHRYSANTHA WHOLE; HELIANTHEMUM NUMMULARIUM FLOWER; HYPERICUM PERFORATUM; HYPERICUM PERFORATUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNELLA VULGARIS FLOWER; PRUNUS CERASIFERA FLOWER; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS IGNATII SEED	30; 12; 12; 12; 12; 12; 12; 12; 12; 20; 12; 12; 12; 12; 12; 15; 15	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL			N	20251231
63479-0615_0e76f0d9-0aca-e097-e063-6394a90adba2	63479-0615	HUMAN OTC DRUG	F15	MND-MMRY	AGNUS CASTUS, ALLEGHENY MONKEYFLOWER, ANACARDIUM ORIENTALE, ARNICA MONTANA, ARNICA MONTANA FLOWER, BANANA, COMFREY, CALOCHORTUS GUNNISONII, CITRUS PARADISI, CORNUS NUTTALLII, EHRENDORFERIA CHRYSANTHA, MELILOTUS OFFICINALIS, MYOSOTIS SYLVATICA, IGNATIA AMARA, KALI BROMATUM, LAC CANINUM, ORNITHOGALUM UMBELLATUM, PEPPERMINT, PHOSPHORICUM ACIDUM, PHOSPHORUS, PINUS SYLVESTRIS, RANUNCULUS BULBOSUS, RUDBECKIA HIRTA, SAGUARO, TOXICODENDRON DIVERSILOBUM, YARROW, YERBA SANTA, ZINNIA ELEGANS	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM FLOWER; ARNICA MONTANA; ARNICA MONTANA FLOWER; CALOCHORTUS GUNNISONII WHOLE; CANIS LUPUS FAMILIARIS MILK; CARNEGIEA GIGANTEA FLOWER; CHASTE TREE; CITRUS PARADISI WHOLE; CORNUS NUTTALLII WHOLE; EHRENDORFERIA CHRYSANTHA WHOLE; ERIODICTYON CALIFORNICUM FLOWERING TOP; MELILOTUS OFFICINALIS TOP; MIMULUS RINGENS WHOLE; MUSA X PARADISIACA FLOWER; MYOSOTIS SYLVATICA FLOWERING TOP; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PEPPERMINT; PHOSPHORIC ACID; PHOSPHORUS; PINUS SYLVESTRIS FLOWERING TOP; POTASSIUM BROMIDE; RANUNCULUS BULBOSUS WHOLE; RUDBECKIA HIRTA WHOLE; SEMECARPUS ANACARDIUM JUICE; STRYCHNOS IGNATII SEED; SYMPHYTUM OFFICINALE WHOLE; TOXICODENDRON DIVERSILOBUM WHOLE; ZINNIA ELEGANS WHOLE	30; 120; 30; 30; 10; 30; 6; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 10; 12; 30; 10; 30; 30; 12; 60; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
63479-0618_0e77063c-fc3a-cee6-e063-6394a90a0d54	63479-0618	HUMAN OTC DRUG	F18	RLXTN	APRICOT, CHAMOMILE, COFFEA ARABICA, COFFEA CRUDA, COMFREY, CRIMSON MONKEY, DATE PALM, DILL, ENGLISH ELM ING TWIG, EUROPEAN ASPEN, FILAREE, GOLDEN EARDROPS, HORSE CHESTNUT, HUMULUS LUPULUS, HYPERICUM PERFORATUM, HYPERICUM PERFORATUM FLOWER, IMPATIENS GLANDULIFERA, MAGNESIA PHOSPHORICA, MEXICAN PINK, MIMULUS GUTTATUS, NUX VOMICA, OREGON GRAPEHOLLY, PASSIFLORA INCARNATA, SCUTELLARIA LATERIFLORA, SWEET CHESTNUT, VERBENA OFFICINALIS, WATERMELON, YERBA SANTA, ZINCUM VALERIANICUM	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AESCULUS HIPPOCASTANUM FLOWER; ANETHUM GRAVEOLENS WHOLE; ARABICA COFFEE BEAN; BERBERIS AQUIFOLIUM WHOLE; CALOCHORTUS GUNNISONII WHOLE; CASTANEA SATIVA FLOWER; COFFEA ARABICA WHOLE; EHRENDORFERIA CHRYSANTHA WHOLE; ERIODICTYON CALIFORNICUM FLOWERING TOP; ERODIUM CICUTARIUM; ERYTHRANTHE CARDINALIS WHOLE; HOPS; HYPERICUM PERFORATUM; HYPERICUM PERFORATUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA FLOWERING TOP; MIMULUS GUTTATUS FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; PHOENIX DACTYLIFERA WHOLE; POPULUS TREMULA FLOWERING TOP; PRUNUS ARMENIACA WHOLE; SCUTELLARIA LATERIFLORA WHOLE; SILENE LACINIATA WHOLE; STRYCHNOS NUX-VOMICA SEED; SYMPHYTUM OFFICINALE WHOLE; ULMUS PROCERA FLOWERING TWIG; VERBENA OFFICINALIS FLOWERING TOP; WATERMELON; ZINC VALERATE DIHYDRATE	12; 12; 15; 12; 12; 12; 12; 12; 12; 12; 12; 4; 4; 12; 12; 10; 12; 12; 4; 12; 12; 12; 6; 12; 10; 12; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
63479-0619_0e7707c6-b7c8-adf7-e063-6294a90a60bc	63479-0619	HUMAN OTC DRUG	F19	STRNG-MND	ANACARDIUM ORIENTALE, ARNICA MONTANA, AURUM METALLICUM, CASTANEA SATIVA, CITRUS SINENSIS, CRATAEGUS MONOGYNA, CYTISUS SCOPARIUS, DANDELION, FAGUS SYLVATICA, FUCHSIA, GORSE, HYDRASTIS CANADENSIS, IGNATIA AMARA, IRON, KALI PHOSPHORICUM, MALUS SYLVESTRIS, NATRUM MURIATICUM, PAEONIA CALIFORNICA, POMEGRANATE, PRUNELLA VULGARIS, ROSA CALIFORNICA, SINAPIS ARVENSIS, YARROW, YERBA SANTA	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM FLOWER; ARNICA MONTANA; ARNICA MONTANA FLOWER; CASTANEA SATIVA FLOWER; CITRUS SINENSIS FLOWER; CRATAEGUS MONOGYNA FLOWER; CYTISUS SCOPARIUS FLOWER; ERIODICTYON CALIFORNICUM FLOWERING TOP; FAGUS SYLVATICA FLOWERING TOP; FUCHSIA MAGELLANICA WHOLE; GOLD; HYDRASTIS CANADENSIS WHOLE; IRON; MALUS SYLVESTRIS FLOWER; PAEONIA CALIFORNICA WHOLE; POTASSIUM PHOSPHATE, DIBASIC; PRUNELLA VULGARIS FLOWER; PUNICA GRANATUM FLOWER; ROSA CALIFORNICA WHOLE; SEMECARPUS ANACARDIUM JUICE; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; TARAXACUM OFFICINALE FLOWERING TOP; ULEX EUROPAEUS FLOWER	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 20; 12; 12	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC]		N	20251231
63479-0620_0e7707c6-b7c9-adf7-e063-6294a90a60bc	63479-0620	HUMAN OTC DRUG	F20	VTLTY	ACER NIGRUM, AESCULUS HIPPOCASTANUM, AGNUS CASTUS, ALFALFA, ALOE VERA, AMERICAN GINSENG, ARNICA MONTANA, BORAGE FLOWER, CAYENNE, CHININUM ARSENICOSUM, CORNUS NUTTALLII, ENGLISH ELM, EUROPEAN HORNBEAM, EUROPEAN HORSE CHESTNUT, EUROPEAN OLIVE, FUCHSIA, IRIS MISSOURIENSIS, LILAC, NASTURTIUM, NELUMBO NUCIFERA, NUX VOMICA, PEACH FLOWER, PHOSPHORICUM ACIDUM, PRUNELLA VULGARIS, RUDBECKIA HIRTA, SCARLET PIMPERNEL, SPICEBUSH, VERBENA OFFICINALIS, ZINNIA ELEGANS	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACER NIGRUM WHOLE; AESCULUS HIPPOCASTANUM FLOWER; ALFALFA; ALOE VERA FLOWER; AMERICAN GINSENG; ANAGALLIS ARVENSIS EXTRACT; ARNICA MONTANA FLOWER; BORAGO OFFICINALIS FLOWER; CAPSICUM; CARPINUS BETULUS FLOWER; CHASTE TREE; CORNUS NUTTALLII WHOLE; FUCHSIA MAGELLANICA WHOLE; IRIS MISSOURIENSIS WHOLE; NELUMBO NUCIFERA FLOWER; OLEA EUROPAEA FLOWER; PHOSPHORIC ACID; PRUNELLA VULGARIS FLOWER; PRUNUS PERSICA FLOWER; QUININE ARSENITE; RUDBECKIA HIRTA WHOLE; STRYCHNOS NUX-VOMICA SEED; SYRINGA VULGARIS FLOWER; TROPAEOLUM MAJUS FLOWER; ULMUS PROCERA FLOWERING TWIG; UMBELLULARIA CALIFORNICA WHOLE; VERBENA OFFICINALIS FLOWERING TOP; ZINNIA ELEGANS WHOLE	12; 12; 4; 12; 4; 12; 12; 12; 12; 12; 4; 12; 12; 12; 12; 12; 12; 12; 12; 9; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20251231
63479-0622_0e7707c6-b7ca-adf7-e063-6294a90a60bc	63479-0622	HUMAN OTC DRUG	F22	SOMATICA	AGRIMONY, CALOCHORTUS TOLMIEI, CIMICIFUGA RACEMOSA, CLEMATIS VITALBA, DANDELION, DIPLACUS AURANTIACUS, ECHINACEA ANGUSTIFOLIA, EHRENDORFERIA CHRYSANTHA, FUCHSIA, HYDRASTIS CANADENSIS, KALI PHOSPHORICUM, LARIX DECIDUA, LATHYRUS ODORATUS, LONICERA CAPRIFOLIUM, NATRUM MURIATICUM, ROSA CALIFORNICA, ROSMARINUS OFFICINALIS, STIGMATA MAIDIS, SULPHUR, YARROW, YERBA SANTA	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM FLOWER; AGRIMONIA EUPATORIA FLOWER; BLACK COHOSH; CALOCHORTUS TOLMIEI WHOLE; CLEMATIS VITALBA FLOWER; CORN SILK; DIPLACUS AURANTIACUS WHOLE; ECHINACEA ANGUSTIFOLIA; EHRENDORFERIA CHRYSANTHA WHOLE; ERIODICTYON CALIFORNICUM FLOWERING TOP; FUCHSIA MAGELLANICA WHOLE; GOLDENSEAL; LARIX DECIDUA FLOWERING TOP; LATHYRUS ODORATUS FLOWER; LONICERA CAPRIFOLIUM FLOWER; POTASSIUM PHOSPHATE, DIBASIC; ROSA CALIFORNICA WHOLE; SALVIA ROSMARINUS FLOWER; SODIUM CHLORIDE; SULFUR; TARAXACUM OFFICINALE FLOWERING TOP	12; 12; 15; 12; 12; 12; 12; 9; 12; 12; 12; 9; 12; 12; 12; 15; 12; 12; 12; 1; 9	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63479-0625_0e771c1f-597e-e177-e063-6394a90a0b89	63479-0625	HUMAN OTC DRUG	F25	LF-CHNGS	AGRIMONY FLOWER	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AESCULUS HIPPOCASTANUM FLOWER; AGRIMONIA EUPATORIA FLOWER; ARNICA MONTANA FLOWER; ARSENIC TRIOXIDE; ARTEMISIA TRIDENTATA WHOLE; CALLUNA VULGARIS FLOWERING TOP; CALOCHORTUS TOLMIEI WHOLE; CAPSICUM; DIEFFENBACHIA SEGUINE; ESCHSCHOLZIA CALIFORNICA FLOWER; FAGUS SYLVATICA FLOWERING TOP; GOSSYPIUM HERBACEUM FLOWER; HELIANTHUS ANNUUS FLOWERING TOP; HYLOTELEPHIUM TELEPHIUM WHOLE; IPOMOEA PURPUREA TOP; JUGLANS REGIA FLOWERING TOP; LACHESIS MUTA VENOM; LARREA TRIDENTATA WHOLE; LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWER; LAWSONIA INERMIS FLOWERING TOP; LONICERA CAPRIFOLIUM FLOWER; MALVA NEGLECTA WHOLE; MATRICARIA CHAMOMILLA FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; PENSTEMON DAVIDSONII WHOLE; PETUNIA AXILLARIS WHOLE; PLANTAGO MAJOR; PRUNELLA VULGARIS FLOWER; RANUNCULUS BULBOSUS WHOLE; ROSA CALIFORNICA WHOLE; SALIX ALBA FLOWERING TOP; SALVIA OFFICINALIS FLOWERING TOP; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 30; 12; 12; 12; 12; 4; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 12; 12; 12; 12; 4; 12; 12; 4; 12; 12; 12; 12; 12; 30; 12; 15	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20251231
63479-0626_0e772402-6cf5-8c75-e063-6294a90a5c45	63479-0626	HUMAN OTC DRUG	F26	PRSVR	ALLIUM CEPA WHOLE, APIS MELLIFICA, AURUM METALLICUM, BORAGE, BROMUS RAMOSUS, CALIFORNIA WILDROSE WHOLE, ENGLISH ELM ING TWIG, ENGLISH HAWTHRON, ENGLISH OAK, EUROPEAN HORNBEAM, EUROPEAN OLIVE, GENTIANELLA AMARELLA, GORSE, LARIX DECIDUA, LUFFA OPERCULATA, MERCURIUS SOLUBILIS, MULLEIN, NATRUM MURIATICUM, PENSTEMON DAVIDSONII WHOLE, PLATINUM METALLICUM, PULSATILLA VULGARIS, PURPLE LOOSESTRIFE WHOLE, ROSA CHINENSIS, SCOTCH BROOM, SEPIA, WILD MUSTARD, YERBA SANTA, ZINCUM METALLICUM	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALLIUM CEPA WHOLE; APIS MELLIFERA; BORAGO OFFICINALIS FLOWER; BROMUS RAMOSUS FLOWER; CARPINUS BETULUS FLOWER; CRATAEGUS MONOGYNA FLOWER; CYTISUS SCOPARIUS FLOWER; ERIODICTYON CALIFORNICUM FLOWERING TOP; GENTIANELLA AMARELLA FLOWER; GOLD; LARIX DECIDUA FLOWERING TOP; LUFFA OPERCULATA FRUIT; LYTHRUM SALICARIA WHOLE; MERCURIUS SOLUBILIS; OLEA EUROPAEA FLOWER; PENSTEMON DAVIDSONII WHOLE; PLATINUM; PULSATILLA VULGARIS; QUERCUS ROBUR FLOWER; ROSA CALIFORNICA WHOLE; ROSA CHINENSIS FLOWER; SEPIA OFFICINALIS JUICE; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; ULEX EUROPAEUS FLOWER; ULMUS PROCERA FLOWERING TWIG; VERBASCUM DENSIFLORUM FLOWER; ZINC	12; 15; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 15; 12; 12; 15; 15; 12; 12; 12; 12; 12; 15; 12; 12; 12; 12	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-0627_0e77166a-8fb0-eb67-e063-6394a90a1f12	63479-0627	HUMAN OTC DRUG	F27	MVON	AGRIMONY, ARNICA MONTANA, ARSENICUM ALBUM, ARTEMISIA TRIDENTATA, ASPEN, CHAMOMILE, CHICORY, DICENTRA FORMOSA, EHRENDORFERIA CHRYSANTHA, EUCALYPTUS GLOBULUS, HARDY FUCHSIA, HORSE CHESTNUT, IGNATIA AMARA, JUGLANS REGIA, LACHESIS MUTUS, LARIX DECIDUA, MIMULUS GUTTATUS, MOUNTAIN DOGWOOD, NATRUM MURIATICUM, PALLADIUM, PERFOLIATE HONEYSUCKLE, PETUNIA AXILLARIS, PULSATILLA VULGARIS, PYRENEES STAR OF BETHLEHEM, SCOTCH BROOM, TRILLIUM CHLOROPETALUM, YELLOW JASMINE, YERBA SANTA, ZINNIA ELEGANS	SOLUTION/ DROPS	SUBLINGUAL	19960312		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AESCULUS CARNEA FLOWER; AESCULUS HIPPOCASTANUM FLOWER; AGRIMONIA EUPATORIA FLOWER; ARNICA MONTANA; ARNICA MONTANA FLOWER; ARSENIC TRIOXIDE; ARTEMISIA TRIDENTATA WHOLE; CICHORIUM INTYBUS FLOWER; CORNUS NUTTALLII WHOLE; CYTISUS SCOPARIUS FLOWER; DICENTRA FORMOSA WHOLE; EHRENDORFERIA CHRYSANTHA WHOLE; ERIODICTYON CALIFORNICUM FLOWERING TOP; EUCALYPTUS GLOBULUS LEAF; FUCHSIA MAGELLANICA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; JUGLANS REGIA FLOWERING TOP; LACHESIS MUTA VENOM; LARIX DECIDUA FLOWERING TOP; LONICERA CAPRIFOLIUM FLOWER; MATRICARIA CHAMOMILLA FLOWERING TOP; MIMULUS GUTTATUS FLOWERING TOP; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PALLADIUM; PETUNIA AXILLARIS WHOLE; POPULUS TREMULA FLOWERING TOP; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; TRILLIUM CHLOROPETALUM WHOLE; ZINNIA ELEGANS WHOLE	12; 12; 12; 15; 12; 7; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 20; 12; 12; 15; 12; 12; 15; 12; 12; 15; 20; 20; 12; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
63479-0703_0e77166a-8fb3-eb67-e063-6394a90a1f12	63479-0703	HUMAN OTC DRUG	G03	TEST-MET	ADENOSINE TRIPHOSPHATE, AMMONIUM CHLORIDE, APIS MELLIFERA, BAPTISIA TINCTORIA ROOT, CALCIUM FLUORIDE, CAMPHOR (NATURAL), CITRULLUS COLOCYNTHIS FRUIT PULP, SEQUOIA SEMPERVIRENS BARK, SPONGIA OFFICINALIS SKELETON, ROASTED, TESTOSTERONE	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CHLORIDE; APIS MELLIFERA; BAPTISIA TINCTORIA ROOT; CALCIUM FLUORIDE; CAMPHOR (NATURAL); CITRULLUS COLOCYNTHIS FRUIT PULP; SEQUOIA SEMPERVIRENS BARK; SPONGIA OFFICINALIS SKELETON, ROASTED; TESTOSTERONE	5; 6; 7; 6; 1; 2; 12; 1; 7; 3	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_Q]/mL	Allergens [CS], Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]	CIII	N	20251231
63479-0705_0e772402-6cf6-8c75-e063-6294a90a5c45	63479-0705	HUMAN OTC DRUG	G05	OXI-MET	ADENOSINE TRIPHOSPHATE, IGNATIA AMARA, KALI PHOSPHORICUM, NATRUM MURIATICUM, NUX VOMICA, SULPHUR	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; DIBASIC POTASSIUM PHOSPHATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR	5; 1; 2; 2; 1; 7	[hp_X]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS]		N	20251231
63479-0706_0e77063c-fc3d-cee6-e063-6394a90a0d54	63479-0706	HUMAN OTC DRUG	G06	ENZY-MET	CINCHONA OFFICINALIS	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	CINCHONA OFFICINALIS BARK; JUNIPERUS COMMUNIS STEM; ROSA CANINA LEAF; VITIS VINIFERA FLOWERING TOP	7; 1; 1; 1	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-0709_0e771d35-a49e-ef2e-e063-6394a90ae759	63479-0709	HUMAN OTC DRUG	G09	CARDI-MET	ADENOSINE TRIPHOSPHATE, CALCAREA FLUORICA, CRATAEGUS OXYACANTHOIDES, FERRUM PHOSPHORICUM, LIPASE, NATRUM SULPHURICUM, STROPHANTHUS HISPIDUS, YELLOW JASMINE	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; CALCIUM FLUORIDE; CRATAEGUS LAEVIGATA FRUIT; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; PANCRELIPASE LIPASE; SODIUM SULFATE; STROPHANTHUS HISPIDUS SEED	5; 7; 7; 1; 1; 7; 1; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_C]/mL			N	20251231
63479-0710_0e772402-6cfb-8c75-e063-6294a90a5c45	63479-0710	HUMAN OTC DRUG	G10	CEREBRAL-MET	ADENOSINE TRIPHOSPHATE, AMMONIUM CARBONICUM, CROCUS SATIVUS, HYPERICUM PERFORATUM, RHUS TOXICODENDRON, SABAL SERRULATA, SEPIA	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CARBONATE; HYPERICUM PERFORATUM; SAFFRON; SAW PALMETTO; SEPIA OFFICINALIS JUICE; TOXICODENDRON PUBESCENS LEAF	5; 6; 7; 2; 1; 2; 1	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL			N	20251231
63479-0711_0e771c1f-5980-e177-e063-6394a90a0b89	63479-0711	HUMAN OTC DRUG	G11	PINEAL-MET	ADENOSINE TRIPHOSPHATE, AMMONIUM CHLORIDE, GOLD, SAFFRON, FERROSOFERRIC PHOSPHATE, PULSATILLA VULGARIS WHOLE	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CHLORIDE; FERROSOFERRIC PHOSPHATE; GOLD; PULSATILLA VULGARIS; SAFFRON	5; 6; 200; 7; 7; 2	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
63479-0712_0e77063c-fc3e-cee6-e063-6394a90a0d54	63479-0712	HUMAN OTC DRUG	G12	HEPAR MET	ADENOSINE TRIPHOSPHATE, AMMONIUM MURIATICUM, CALCAREA CARBONICA, CICHORIUM INTYBUS, LYCOPODIUM CLAVATUM, PETROLEUM, PHOSPHORUS, SPONGIA TOSTA, TESTOSTERONE	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CHLORIDE; CHICORY ROOT; KEROSENE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SPONGIA OFFICINALIS SKELETON, ROASTED; TESTOSTERONE	5; 6; 3; 1; 1; 7; 2; 7; 4	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
63479-0714_0e7705bd-1604-d906-e063-6394a90a2ee4	63479-0714	HUMAN OTC DRUG	G14	PARASYMP-MET	ADENOSINE TRIPHOSPHATE, AURUM METALLICUM, CAMPHORA, GRAPHITE, IGNATIA AMARA, RUTA GRAVEOLENS, STRAMONIUM	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; CAMPHOR (NATURAL); DATURA STRAMONIUM; GOLD; GRAPHITE; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS IGNATII SEED	7; 1; 2; 1; 1; 7; 7	[hp_X]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
63479-0716_0e77063c-fc3f-cee6-e063-6394a90a0d54	63479-0716	HUMAN OTC DRUG	G16	ELECTRO-MET	ADENOSINE TRIPHOSPHATE, ANTIMONY POTASSIUM TARTRATE, CINCHONA OFFICINALIS BARK, STRYCHNOS NUX-VOMICA SEED, PHOSPHORIC ACID, SULFUR	SOLUTION/ DROPS	SUBLINGUAL	19960515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; ANTIMONY POTASSIUM TARTRATE; CINCHONA OFFICINALIS BARK; PHOSPHORIC ACID; STRYCHNOS NUX-VOMICA SEED; SULFUR	6; 1; 7; 3; 1; 2	[hp_X]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-1142_0e773c6a-016e-fae5-e063-6294a90af595	63479-1142	HUMAN OTC DRUG	KH42	NEUROTRANS ACTIVE	ACETYLCHOLINE CHLORIDE, ADRENALINUM, DOPAMINE, GABA, NOREPINEPHRINE, SEROTONIN	SPRAY	SUBLINGUAL	20080818		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; DOPAMINE; EPINEPHRINE; NOREPINEPHRINE; SEROTONIN	30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
63479-1312_0e773c6a-016f-fae5-e063-6294a90af595	63479-1312	HUMAN OTC DRUG	M12	BRAIN	ARGENTUM METALLICUM, ARTEMISIA VULGARIS, CICUTA VIROSA, COBALTUM METALLICUM, COCCULUS INDICUS, CONIUM MACULATUM, GINKGO BILOBA, KALI BROMATUM, LATHYRUS SATIVUS, MERCURIUS SOLUBILIS, NUX VOMICA, PLUMBUM METALLICUM, SALIX ALBA, SCOPOLAMINUM HYDROBROMIDUM, SEQUOIADENDRON GIGANTEUM, SUS SCROFA CEREBRUM	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc	ANAMIRTA COCCULUS SEED; ARTEMISIA VULGARIS ROOT; CICUTA VIROSA ROOT; COBALT; CONIUM MACULATUM FLOWERING TOP; GINKGO; LATHYRUS SATIVAS SEED; LEAD; MERCURIUS SOLUBILIS; POTASSIUM BROMIDE; SALIX ALBA BARK; SCOPOLAMINE HYDROBROMIDE; SEQUOIADENDRON GIGANTEUM WHOLE; SILVER; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM	4; 2; 6; 20; 10; 2; 2; 20; 10; 8; 2; 10; 2; 15; 10; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Anticholinergic [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20251231
63479-1401_0e77063c-fc41-cee6-e063-6394a90a0d54	63479-1401	HUMAN OTC DRUG	N01	PROTOMER	ADRENALINUM, ARGENTUM NITRICUM, ARNICA MONTANA, AURUM METALLICUM, AVENA SATIVA, BERBERIS VULGARIS, CHELIDONIUM MAJUS, CHININUM ARSENICOSUM, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, NATRUM FLUORATUM, NICCOLUM METALLICUM, PASSIFLORA INCARNATA, SARSAPARILLA, SILICEA, SOLIDAGO VIRGAUREA, THUJA OCCIDENTALIS, ZINCUM VALERIANICUM	SOLUTION/ DROPS	SUBLINGUAL	19970715		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARNICA MONTANA; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; CHELIDONIUM MAJUS; EPINEPHRINE; GOLD; HYPERICUM PERFORATUM; NICKEL; PASSIFLORA INCARNATA TOP; QUININE ARSENITE; SARSAPARILLA; SILICON DIOXIDE; SILVER NITRATE; SODIUM FLUORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; ZINC VALERATE DIHYDRATE	12; 1; 1; 12; 1; 4; 30; 3; 15; 1; 12; 2; 20; 15; 12; 1; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20251231
63479-1402_0e771c1f-5981-e177-e063-6394a90a0b89	63479-1402	HUMAN OTC DRUG	N02	PETROCHEM	ACETONE, ANILINUM, BENZINUM, BENZOPYRENE, CARBO VEGETABILIS, CARBOLICUM ACIDUM, CARBON TETRACHLORIDE, ETHER, MAGNESIA SULPHURICA, METHYL ALCOHOL, PETROLEUM, PHENOLPHTHALEIN, PHOSPHORUS, PICRICUM ACIDUM, PINE TAR, PLUMBOUS CHLORIDE, PLUMBUM METALLICUM, SULPHONALUM, SULPHURICUM ACIDUM, TEREBINTHINA, TRICHLOROETHYLENE, VANADIUM METALLICUM	SOLUTION/ DROPS	SUBLINGUAL	19970715		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACETONE; ACTIVATED CHARCOAL; ANILINE; BENZENE; BENZO(A)PYRENE; CARBON TETRACHLORIDE; ETHER; KEROSENE; LEAD; LEAD CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; METHYL ALCOHOL; PHENOL; PHENOLPHTHALEIN; PHOSPHORUS; PICRIC ACID; PINE TAR; SULFONMETHANE; SULFURIC ACID; TRICHLOROETHYLENE; TURPENTINE OIL; VANADIUM	15; 12; 30; 15; 30; 15; 12; 30; 15; 15; 15; 12; 30; 15; 30; 15; 12; 15; 15; 30; 12; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]	CIII	N	20251231
63479-1403_0e77340b-340c-fe13-e063-6294a90a0301	63479-1403	HUMAN OTC DRUG	N03	EXCHEM	ALLIUM SATIVUM, ARSENICUM ALBUM, BENZOICUM ACIDUM, BERBERIS VULGARIS, BETULA VERRUCOSA, CALCAREA CARBONICA, CARBOLICUM ACIDUM, CHELIDONIUM MAJUS, CHLORINUM, CITRICUM ACIDUM, HISTAMINUM, ICHTHYOLUM, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM BICARBONICUM, SODIUM HYPOCHLORITE, SOLIDAGO VIRGAUREA, SULPHUR	SOLUTION/ DROPS	SUBLINGUAL	19880815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ANHYDROUS CITRIC ACID; ARSENIC TRIOXIDE; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BETULA PENDULA LEAF; CHELIDONIUM MAJUS; CHLORINE; GARLIC; HISTAMINE DIHYDROCHLORIDE; ICHTHAMMOL; JUNIPERUS COMMUNIS STEM; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHENOL; SODIUM BICARBONATE; SODIUM HYPOCHLORITE; SOLIDAGO VIRGAUREA FLOWERING TOP; SULFUR	30; 30; 30; 12; 9; 9; 30; 15; 30; 15; 9; 30; 30; 30; 30; 30; 30; 9; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
63479-1404_0e77340b-340e-fe13-e063-6294a90a0301	63479-1404	HUMAN OTC DRUG	N04	RAD-TOX	ALOE SOCOTRINA, BONE MARROW SUIS, BOS TAURUS PLACENTA, BOS TAURUS SKIN, DNA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, FERRUM METALLICUM, FUCUS VESICULOSUS, IODIUM, KALI PHOSPHORICUM, PHOSPHORUS, RIBES NIGRUM FLOWER BUD, SOY LECITHIN, VITAMIN A ACETATE, VITAMIN E ACETATE	SOLUTION/ DROPS	SUBLINGUAL	19970715		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	.ALPHA.-TOCOPHEROL ACETATE; ALOE; BOS TAURUS PLACENTA; BOS TAURUS SKIN; DIBASIC POTASSIUM PHOSPHATE; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; FUCUS VESICULOSUS; HERRING SPERM DNA; IODINE; IRON; LECITHIN, SOYBEAN; PHOSPHORUS; RIBES NIGRUM FLOWER BUD; SUS SCROFA BONE MARROW; VITAMIN A ACETATE	9; 12; 7; 7; 30; 6; 6; 9; 12; 30; 30; 9; 30; 8; 7; 9	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Animal Skin Allergenic Extract [EPC], Vitamin A [CS], Vitamin A [EPC]		N	20251231
63479-1405_0e7729de-104c-e578-e063-6394a90a7de6	63479-1405	HUMAN OTC DRUG	N05	LYMPHOTOX	ARANEA DIADEMA, ARNICA MONTANA, ASTERIAS RUBENS, BARYTA IODATA, CARBO VEGETABILIS, CEANOTHUS AMERICANUS, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EQUISETUM HYEMALE, FERRUM IODATUM, GLYCYRRHIZA GLABRA, HYDRASTIS CANADENSIS, LACHESIS MUTUS, MERCUROUS IODIDE, MILLEFOLIUM, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, PINUS SYLVESTRIS FLOWER, SCROPHULARIA NODOSA, SULPHUR IODATUM, TEUCRIUM SCORODONIA, VERONICA BECCABUNGA	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACHILLEA MILLEFOLIUM; ACTIVATED CHARCOAL; ARANEUS DIADEMATUS; ARNICA MONTANA; ASTERIAS RUBENS; BARIUM IODIDE; CEANOTHUS AMERICANUS LEAF; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; EQUISETUM HYEMALE; FERROUS IODIDE; GLYCYRRHIZA GLABRA; GOLDENSEAL; LACHESIS MUTA VENOM; MERCUROUS IODIDE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS FLOWERING TOP; SCROPHULARIA NODOSA; SODIUM SULFATE; SULFUR IODIDE; TEUCRIUM SCORODONIA FLOWERING TOP; VERONICA BECCABUNGA	1; 30; 12; 3; 10; 20; 1; 1; 1; 12; 15; 1; 9; 15; 9; 12; 12; 15; 12; 30; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
63479-1409_0e773c6a-0172-fae5-e063-6294a90af595	63479-1409	HUMAN OTC DRUG	N09	BACTEROTOX	ACONITUM NAPELLUS, ALLIUM CEPA, ALLIUM SATIVUM, BELLADONNA, CALCAREA SULPHURICA, CALENDULA OFFICINALIS, ECHINACEA ANGUSTIFOLIA, FERRUM PHOSPHORICUM, CALCIUM SULFIDE, HYDRASTIS CANADENSIS, LACHESIS MUTUS, MYRISTICA SEBIFERA, SILICEA, THUJA OCCIDENTALIS	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; CALCIUM SULFATE ANHYDROUS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; GARLIC; GOLDENSEAL; LACHESIS MUTA VENOM; ONION; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; VIROLA SEBIFERA RESIN	200; 200; 60; 200; 1; 1; 60; 30; 1; 90; 30; 12; 90; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
63479-1410_0e7729de-104d-e578-e063-6394a90a7de6	63479-1410	HUMAN OTC DRUG	N10	PARAKLENZ	ALLIUM CEPA, ALLIUM SATIVUM, BARYTA IODATA, BERBERIS VULGARIS, CARDUUS MARIANUS, CHENOPODIUM ANTHELMINTICUM, CHININUM ARSENICOSUM, CINA, CINCHONA OFFICINALIS, CROTON TIGLIUM, ECHINACEA ANGUSTIFOLIA, HYDRASTIS CANADENSIS, ILLICIUM ANISATUM, LYCOPODIUM CLAVATUM, NATRUM PHOSPHORICUM, RHAMNUS PURSHIANA, SANTONINUM, SCROPHULARIA NODOSA, SENNA, SULPHUR, TANACETUM VULGARE, TEUCRIUM MARUM	SOLUTION/ DROPS	SUBLINGUAL	19941215		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARTEMISIA CINA FLOWER; BARIUM IODIDE; BERBERIS VULGARIS ROOT BARK; CHENOPODIUM AMBROSIOIDES; CINCHONA OFFICINALIS BARK; CROTON TIGLIUM SEED; ECHINACEA ANGUSTIFOLIA; FRANGULA PURSHIANA BARK; GARLIC; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; ONION; QUININE ARSENITE; SANTONIN; SCROPHULARIA NODOSA; SENNA LEAF; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STAR ANISE; SULFUR; TANACETUM VULGARE TOP; TEUCRIUM MARUM	6; 10; 1; 1; 9; 3; 1; 1; 1; 1; 12; 1; 1; 9; 8; 3; 1; 12; 2; 9; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
63479-1412_0e77455b-8a04-91de-e063-6394a90ad7b0	63479-1412	HUMAN OTC DRUG	N12	IMMUNOSODE	ARSENIC TRIOXIDE, BAPTISIA TINCTORIA ROOT, SUS SCROFA BONE MARROW, BRYONIA ALBA ROOT, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, OLEA EUROPAEA FLOWER, ULEX EUROPAEUS, FLOWER, LACHESIS MUTA VENOM, LEVISTICUM OFFICINALE, TREPONEMIC SKIN CANKER HUMAN	SOLUTION/ DROPS	SUBLINGUAL	19971204		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BILBERRY; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; GONORRHEAL URETHRAL SECRETION HUMAN; LACHESIS MUTA VENOM; LEVISTICUM OFFICINALE; OLEA EUROPAEA FLOWER; RANCID BEEF; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS PYOGENES; SULFUR; SUS SCROFA BONE MARROW; SUS SCROFA SPLEEN; THUJA OCCIDENTALIS LEAFY TWIG; TREPONEMIC SKIN CANKER HUMAN; TUBERCULIN PURIFIED PROTEIN DERIVATIVE; ULEX EUROPAEUS FLOWER; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN; VISCUM ALBUM FRUITING TOP	30; 15; 30; 30; 9; 9; 30; 30; 12; 30; 30; 60; 30; 30; 30; 30; 30; 7; 7; 30; 30; 30; 30; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Antigens, Bacterial [CS], Cell-mediated Immunity [PE], Live Vaccinia Virus Vaccine [EPC], Skin Test Antigen [EPC], Smallpox Vaccine [CS], Tuberculosis Skin Test [EPC], Vaccines, Live, Unattenuated [CS]		N	20251231
63479-1801_0e77340b-3413-fe13-e063-6294a90a0301	63479-1801	HUMAN OTC DRUG	R01	LIVER	ADENOSINE TRIPHOSPHATE, MATRICARIA CHAMOMILLA, LYCOPODIUM CLAVATUM SPORE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORUS	SOLUTION/ DROPS	SUBLINGUAL	19860315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; PHOSPHORUS; STRYCHNOS NUX-VOMICA SEED	5; 7; 7; 7; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-1802_0e77340b-3415-fe13-e063-6294a90a0301	63479-1802	HUMAN OTC DRUG	R02	BILE DUCTS	FERROSOFERRIC PHOSPHATE, JUNIPERUS COMMUNIS STEM, RIBES NIGRUM FLOWER BUD, VISCUM ALBUM STEM	SOLUTION/ DROPS	SUBLINGUAL	19860315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	FERROSOFERRIC PHOSPHATE; JUNIPERUS COMMUNIS STEM; RIBES NIGRUM FLOWER BUD; VISCUM ALBUM STEM	7; 1; 1; 1	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-1803_0e76ea05-c3d2-8465-e063-6294a90a747f	63479-1803	HUMAN OTC DRUG	R03	PANCREAS	ADENOSINE TRIPHOSPHATE, TRIBASIC CALCIUM PHOSPHATE, CINCHONA OFFICINALIS BARK, SAFFRON, PHOSPHORUS, VISCUM ALBUM FRUITING TOP	SOLUTION/ DROPS	SUBLINGUAL	19860315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; CINCHONA OFFICINALIS BARK; PHOSPHORUS; SAFFRON; TRIBASIC CALCIUM PHOSPHATE; VISCUM ALBUM FRUITING TOP	5; 7; 30; 2; 1; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL			N	20251231
63479-1804_0e7729de-104f-e578-e063-6394a90a7de6	63479-1804	HUMAN OTC DRUG	R04	KIDNEY	ADENOSINE TRIPHOSPHATE, SILVER, CAMPHOR (NATURAL), BLACK CURRANT, TESTOSTERONE	SOLUTION/ DROPS	SUBLINGUAL	19860315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; BLACK CURRANT; CAMPHOR (NATURAL); SILVER; TESTOSTERONE	5; 7; 1; 1; 4	[hp_X]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
63479-1806_0e77224c-d67c-ad31-e063-6294a90a9032	63479-1806	HUMAN OTC DRUG	R06	THYROID	adenosine triphosphate, ammonium carbonicum, camphora, crotalus cascavella, fucus vesiculosus, iodium, kali phosphoricum, levothyroxine, triiodothyronine	SOLUTION/ DROPS	SUBLINGUAL	19860315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CARBONATE; CAMPHOR (NATURAL); CROTALUS DURISSUS TERRIFICUS VENOM; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; IODINE; LEVOTHYROXINE; LIOTHYRONINE	5; 6; 1; 1; 3; 4; 1; 3; 3	[hp_X]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20251231
63479-1807_0e76ea05-c3d3-8465-e063-6294a90a747f	63479-1807	HUMAN OTC DRUG	R07	PITUITARY	ADENOSINE TRIPHOSPHATE DISODIUM, AMMONIUM CARBONATE, SAFFRON, STRYCHNOS IGNATII SEED, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, STRYCHNOS NUX-VOMICA SEED, and VERATRUM ALBUM ROOT	SOLUTION	SUBLINGUAL	19931115		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; AMMONIUM CARBONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SAFFRON; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	5; 6; 7; 1; 7; 7; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
63479-1808_0e772402-6d02-8c75-e063-6294a90a5c45	63479-1808	HUMAN OTC DRUG	R08	LYMPHATICS	ADENOSINE TRIPHOSPHATE, AMMONIUM MURIATICUM, BAPTISIA TINCTORIA, COLCHICUM AUTUMNALE, JUNIPERUS COMMUNIS, LEVOTHYROXINE, PODOPHYLLINUM, RHUS TOXICODENDRON	SOLUTION/ DROPS	SUBLINGUAL	19860315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CHLORIDE; BAPTISIA TINCTORIA ROOT; COLCHICUM AUTUMNALE BULB; JUNIPER BERRY; LEVOTHYROXINE; PODOPHYLLUM RESIN; TOXICODENDRON PUBESCENS LEAF	5; 5; 4; 7; 7; 4; 5; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
63479-1809_0e76ea05-c3d4-8465-e063-6294a90a747f	63479-1809	HUMAN OTC DRUG	R09	SPLEEN	ADENOSINE TRIPHOSPHATE, BAPTISIA TINCTORIA ROOT, CEANOTHUS AMERICANUS LEAF, FUCUS VESICULOSUS, PODOPHYLLUM RESIN, SEPIA OFFICINALIS JUICE, TESTOSTERONE	SOLUTION/ DROPS	SUBLINGUAL	19860315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; BAPTISIA TINCTORIA ROOT; CEANOTHUS AMERICANUS LEAF; FUCUS VESICULOSUS; PODOPHYLLUM RESIN; SEPIA OFFICINALIS JUICE; TESTOSTERONE	5; 4; 7; 4; 6; 1; 4	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_C]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
63479-1811_0e772402-6d03-8c75-e063-6294a90a5c45	63479-1811	HUMAN OTC DRUG	R11	NEUTROVIR	ADENOSINE TRIPHOSPHATE, ANTIMONIUM CRUDUM, CROTALUS HORRIDUS, ELAPS CORALLINUS, LYCOPODIUM CLAVATUM, NAJA TRIPUDIANS, VISCUM ALBUM FRUITING TOP	SOLUTION/ DROPS	SUBLINGUAL	19941201		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; ANTIMONY TRISULFIDE; CROTALUS HORRIDUS HORRIDUS VENOM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; VISCUM ALBUM FRUITING TOP	5; 1; 7; 7; 6; 6; 7	[hp_X]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20251231
63479-1813_0e77566d-437a-c560-e063-6294a90ae164	63479-1813	HUMAN OTC DRUG	R13	ADRENAL	ACTIVATED CHARCOAL, CAUSTICUM, ARABICA COFFEE BEAN, PRASTERONE, GLYCYRRHIZA GLABRA, RIBES NIGRUM FLOWER BUD, ELEUTHERO, and VERATRUM ALBUM ROOT	SOLUTION	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACTIVATED CHARCOAL; ARABICA COFFEE BEAN; CAUSTICUM; ELEUTHERO; GLYCYRRHIZA GLABRA; PRASTERONE; RIBES NIGRUM FLOWER BUD; VERATRUM ALBUM ROOT	7; 7; 1; 1; 6; 3; 1; 7	[hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-1816_0e7729de-1050-e578-e063-6394a90a7de6	63479-1816	HUMAN OTC DRUG	R16	BRONCHI	ADENOSINE TRIPHOSPHATE, CALCAREA IODATA, CUPRUM METALLICUM, IGNATIA AMARA, PLATINUM METALLICUM, SILICEA, THUJA OCCIDENTALIS	SOLUTION/ DROPS	SUBLINGUAL	19941201		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; CALCIUM IODIDE; COPPER; PLATINUM; SILICON DIOXIDE; STRYCHNOS IGNATII SEED; THUJA OCCIDENTALIS LEAFY TWIG	5; 2; 2; 2; 1; 2; 1	[hp_X]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Inhibit Ovum Fertilization [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20251231
63479-1818_0e772402-6d04-8c75-e063-6294a90a5c45	63479-1818	HUMAN OTC DRUG	R18	OVAGEN	ADENOSINE TRIPHOSPHATE, AGNUS CASTUS, AMMONIUM CARBONICUM, AMMONIUM MURIATICUM, APIS MELLIFICA, LYCOPODIUM CLAVATUM, PLATINUM METALLICUM, PROGESTERONE	SOLUTION/ DROPS	SUBLINGUAL	19941201		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CARBONATE; AMMONIUM CHLORIDE; APIS MELLIFERA; CHASTE TREE; LYCOPODIUM CLAVATUM SPORE; PLATINUM; PROGESTERONE	5; 6; 6; 7; 7; 7; 1; 3	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Progesterone [CS], Progesterone [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20251231
63479-1820_0e77455b-8a07-91de-e063-6394a90ad7b0	63479-1820	HUMAN OTC DRUG	R20	TESTOGEN	ADENOSINE TRIPHOSPHATE, ARSENICUM ALBUM, LEVOTHYROXINE, NATRUM SULPHURICUM, PHOSPHORUS, RUTA GRAVEOLENS	SOLUTION/ DROPS	SUBLINGUAL	19941201		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; ARSENIC TRIOXIDE; LEVOTHYROXINE; PHOSPHORUS; RUTA GRAVEOLENS FLOWERING TOP; SODIUM SULFATE	5; 1; 4; 2; 7; 1	[hp_X]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_Q]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
63479-1823_0e775ae0-57d5-e614-e063-6394a90ad193	63479-1823	HUMAN OTC DRUG	R23	INTESTINAL MUCOSA	ADENOSINE TRIPHOSPHATE, ARNICA MONTANA, CALENDULA OFFICINALIS, CANTHARIS, CROCUS SATIVUS, NITRICUM ACIDUM, PLATINUM METALLICUM	SOLUTION/ DROPS	SUBLINGUAL	19980515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; LYTTA VESICATORIA; NITRIC ACID; PLATINUM; SAFFRON	5; 7; 2; 7; 1; 2; 2	[hp_X]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL			N	20251231
63479-1827_0e7729de-1051-e578-e063-6394a90a7de6	63479-1827	HUMAN OTC DRUG	R27	EYE	ADENOSINE TRIPHOSPHATE, ARSENIC TRIOXIDE, ARABICA COFFEE BEAN, LYCOPODIUM CLAVATUM SPORE, PULSATILLA VULGARIS WHOLE, DATURA STRAMONIUM, BILBERRY	SOLUTION/ DROPS	SUBLINGUAL	19980515		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; BILBERRY; DATURA STRAMONIUM; LYCOPODIUM CLAVATUM SPORE; PULSATILLA VULGARIS	5; 7; 7; 3; 2; 2; 2	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-1832_0e7729de-1052-e578-e063-6394a90a7de6	63479-1832	HUMAN OTC DRUG	R32	IMMUNO-CLR	BETULA PENDULA, FOLIA, BOS TAURUS THYMUS, CASTANEA VESCA, POPLAR BUD, RIBES NIGRUM FLOWER BUD, RNA, VISCUM ALBUM STEM	SOLUTION/ DROPS	SUBLINGUAL	20210616		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BETULA PENDULA LEAF; BOS TAURUS THYMUS; CASTANEA SATIVA LEAF; POPULUS BALSAMIFERA LEAF BUD; RIBES NIGRUM FLOWER BUD; SACCHAROMYCES CEREVISIAE RNA; VISCUM ALBUM STEM	2; 7; 2; 2; 1; 4; 1	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-1901_0e775a95-3ba3-f934-e063-6394a90a314f	63479-1901	HUMAN OTC DRUG	S01	ALLERDRAIN	aloe socotrina, berberis vulgaris, betula verrucosa, bryonia, carduus marianus, echinacea angustifolia, ginkgo biloba, histaminum hydrochloricum, juniperus communis, lycopodium clavatum, melaleuca alternifolia oil, quercus robur, rhamnus purshiana, ribes nigrum, rosa canina, rosmarinus officinalis, scrophularia nodosa, senna, solidago virgaurea, taraxacum officinale, vaccinium vitus idaea	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ALOE; BERBERIS VULGARIS ROOT BARK; BETULA PENDULA LEAF; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA; FRANGULA PURSHIANA BARK; GINKGO; HISTAMINE DIHYDROCHLORIDE; JUNIPERUS COMMUNIS STEM; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; QUERCUS ROBUR FLOWER BUD; RIBES NIGRUM FLOWER BUD; ROSA CANINA LEAF; ROSMARINUS OFFICINALIS FLOWERING TOP; SCROPHULARIA NODOSA; SENNA LEAF; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE; TEA TREE OIL; VACCINIUM VITIS-IDAEA LEAF	3; 1; 2; 1; 2; 1; 2; 200; 2; 4; 2; 2; 2; 2; 2; 2; 2; 1; 2; 12; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-1902_0e775ae0-57da-e614-e063-6394a90ad193	63479-1902	HUMAN OTC DRUG	S02	ALLER-TOTAL	APIS MELLIFICA, BERBERIS VULGARIS, BOS TAURUS SKIN, CANIS FAMILIARIS SKIN, CAPRA HIRCUS HAIR, CHELIDONIUM MAJUS, EQUUS CABALLUS SKIN, FAGUS SYLVESTRIS, FELIS CATUS HAIR, FORMICUM ACIDUM, HISTAMINUM, HOUSE DUST, JUNIPERUS COMMUNIS, LAC VACCINUM, LUFFA OPERCULATA, MONOSODIUM GLUTAMATE, OVIS ARIES SKIN, PEANUTS, POLLEN MIX, RIBES NIGRUM, SABADILLA, SHEEP HAIR, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, URTICA URENS, WHEAT	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ACANTHICARPA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; BOS TAURUS SKIN; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS HAIR; CHELIDONIUM MAJUS; CHENOPODIUM ALBUM POLLEN; COW MILK; CYNODON DACTYLON POLLEN; EQUUS CABALLUS SKIN; FAGUS SYLVATICA FLOWER BUD; FELIS CATUS HAIR; FORMIC ACID; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; JUNIPERUS COMMUNIS STEM; LUFFA OPERCULATA FRUIT; MONOSODIUM GLUTAMATE; OVIS ARIES SKIN; PEANUT; RIBES NIGRUM FLOWER BUD; SCHOENOCAULON OFFICINALE SEED; SHEEP WOOL; SOLIDAGO VIRGAUREA FLOWERING TOP; SORGHUM HALEPENSE POLLEN; TARAXACUM OFFICINALE; URTICA URENS; WHEAT; XANTHIUM STRUMARIUM POLLEN	200; 200; 200; 200; 200; 200; 4; 1; 200; 200; 200; 1; 200; 200; 200; 200; 2; 200; 200; 200; 200; 2; 6; 90; 200; 30; 2; 200; 200; 1; 200; 2; 2; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Milk Proteins [CS], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Nut Proteins [EXT], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Salivary Proteins and Peptides [CS], Standardized Animal Hair Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20251231
63479-1912_0e775a95-3ba4-f934-e063-6394a90a314f	63479-1912	HUMAN OTC DRUG	S12	AIRBORNE	ALFALFA, ALLIUM SATIVUM, ARSENICUM IODATUM, BARLEY, BETULA PUBESCENS, BROWN RICE, CORN GRAIN, EUPHRASIA OFFICINALIS, FEATHER MIX, HAIR MIX, HISTAMINUM, HOUSE DUST MITE, LOLIUM PERENNE, OAT, PERFOLIATE HONEYSUCKLE, PHLEUM PRATENSE, POLLEN MIX, RYE, SABADILLA, SILICEA, SKIN MIX, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, TEREBINTHINA, WHEAT	SOLUTION/ DROPS	SUBLINGUAL	19930315		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AGROSTIS GIGANTEA POLLEN; ALFALFA TOP; AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN; ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; ANTHOXANTHUM ODORATUM POLLEN; ARSENIC TRIIODIDE; ARTEMISIA VULGARIS POLLEN; BARLEY; BETULA LENTA POLLEN; BETULA OCCIDENTALIS POLLEN; BETULA PUBESCENS FLOWER BUD; BOS TAURUS SKIN; BROWN RICE; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS HAIR; CAPRA HIRCUS SKIN; CHENOPODIUM ALBUM POLLEN; CORN GRAIN; DACTYLIS GLOMERATA POLLEN; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DYSPHANIA AMBROSIOIDES POLLEN; EQUUS CABALLUS SKIN; EUPHRASIA STRICTA; FELIS CATUS HAIR; FESTUCA PRATENSIS POLLEN; GALLUS GALLUS FEATHER; GARLIC; HISTAMINE DIHYDROCHLORIDE; IVA ANNUA POLLEN; LEUCANTHEMUM VULGARE POLLEN; LOLIUM PERENNE POLLEN; LOLIUM PERENNE TOP; LONICERA CAPRIFOLIUM FLOWER; OAT; PHLEUM PRATENSE POLLEN; PHLEUM PRATENSE TOP; POA PRATENSIS POLLEN; RYE; SCHOENOCAULON OFFICINALE SEED; SHEEP WOOL; SILICON DIOXIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE; TARAXACUM OFFICINALE POLLEN; TURPENTINE OIL; WHEAT; XANTHIUM STRUMARIUM POLLEN	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Feathers [CS], Feathers [CS], Feathers [CS], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE]		N	20251231
63479-2304_0e7729de-1053-e578-e063-6394a90a7de6	63479-2304	HUMAN OTC DRUG	W04	NEUROCALM	AMERICAN GINSENG, AVENA SATIVA, CHAMOMILLA, COFFEA TOSTA, ESCHSCHOLTZIA CALIFORNICA, GLYCYRRHIZA GLABRA, HUMULUS LUPULUS, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, PASSIFLORA INCARNATA, PHOSPHORUS, PULSATILLA VULGARIS, VALERIANA OFFICINALIS, ZINCUM VALERIANICUM	SOLUTION/ DROPS	SUBLINGUAL	19940815		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	AMERICAN GINSENG; AVENA SATIVA FLOWERING TOP; COFFEA ARABICA SEED, ROASTED; ESCHSCHOLZIA CALIFORNICA; GLYCYRRHIZA GLABRA; HOPS; HYPERICUM PERFORATUM; MATRICARIA CHAMOMILLA; PASSIFLORA INCARNATA TOP; PHOSPHORUS; POTASSIUM PHOSPHATE, DIBASIC; PULSATILLA VULGARIS; VALERIAN; ZINC VALERATE DIHYDRATE	1; 1; 12; 1; 1; 1; 3; 3; 1; 10; 9; 12; 1; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63479-2501_0e775ae0-57db-e614-e063-6394a90ad193	63479-2501	HUMAN OTC DRUG	HAIR Formula		BETULA PUBESCENS FLOWER BUD, CASTANEA VESCA, HUMAN HAIR, PHOSPHORUS, POPULUS NIGRA LEAF BUD, RNA	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BETULA PUBESCENS FLOWER BUD; CASTANEA SATIVA LEAF; HUMAN HAIR; PHOSPHORUS; POPULUS NIGRA LEAF BUD; SACCHAROMYCES CEREVISIAE RNA	2; 2; 7; 7; 2; 4	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-2502_0e775ae0-57de-e614-e063-6394a90ad193	63479-2502	HUMAN OTC DRUG	ADRENAL STIM Formula		BETULA PENDULA FOLIA BOS TAURUS ADRENAL GLAND, CASTANEA VESCA, POPLAR BUD, RNA	SOLUTION/ DROPS	SUBLINGUAL	20220801		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BETULA PENDULA LEAF; BOS TAURUS ADRENAL GLAND; CASTANEA SATIVA LEAF; POPULUS BALSAMIFERA LEAF BUD; SACCHAROMYCES CEREVISIAE RNA	2; 7; 2; 2; 4	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-2503_0e77224c-d67f-ad31-e063-6294a90a9032	63479-2503	HUMAN OTC DRUG	PANCREAS Formula		ADENOSINE TRIPHOSPHATE, TRIBASIC CALCIUM PHOSPHATE, CINCHONA OFFICINALIS BARK, SAFFRON, PHOSPHORUS, VISCUM ALBUM FRUITING TOP	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; CINCHONA OFFICINALIS BARK; PHOSPHORUS; SAFFRON; TRIBASIC CALCIUM PHOSPHATE; VISCUM ALBUM FRUITING TOP	5; 7; 30; 2; 1; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL			N	20251231
63479-2504_0e775b4a-84e0-ff58-e063-6394a90a64f7	63479-2504	HUMAN OTC DRUG	THYMUS Formula		BETULA PENDULA FOLIA BOS TAURUS THYMUS, CASTANEA VESCA, POPLAR BUD, RNA	SOLUTION/ DROPS	SUBLINGUAL	20220725		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BETULA PENDULA LEAF; BOS TAURUS THYMUS; CASTANEA SATIVA LEAF; POPULUS BALSAMIFERA LEAF BUD; SACCHAROMYCES CEREVISIAE RNA	2; 7; 2; 2; 4	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-2505_0e7735ff-acf6-c569-e063-6294a90a29c0	63479-2505	HUMAN OTC DRUG	LIVER PLUS Formula		ADENOSINE TRIPHOSPHATE, IGNATIA AMARA, KALI PHOSPHORICUM, NATRUM MURIATICUM, NUX VOMICA, SULPHUR	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; DIBASIC POTASSIUM PHOSPHATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFUR	5; 1; 2; 2; 1; 7	[hp_X]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS]		N	20251231
63479-2506_0e775ae0-57e0-e614-e063-6394a90ad193	63479-2506	HUMAN OTC DRUG	THYROID Formula		adenosine triphosphate, ammonium carbonicum, camphora, crotalus cascavella, fucus vesiculosus, iodium, kali phosphoricum, levothyroxine, triiodothyronine	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CARBONATE; CAMPHOR (NATURAL); CROTALUS DURISSUS TERRIFICUS VENOM; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; IODINE; LEVOTHYROXINE; LIOTHYRONINE	5; 6; 1; 1; 3; 4; 1; 3; 3	[hp_X]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL; [hp_Q]/mL	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20251231
63479-2507_0e775b4a-84f2-ff58-e063-6394a90a64f7	63479-2507	HUMAN OTC DRUG	PINEAL Formula		BETULA PENDULA FOLIA, CASTANEA VESCA, POPLAR BUD, RNA, SUS SCROFA PINEAL GLAND	SOLUTION/ DROPS	SUBLINGUAL	20221017		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BETULA PENDULA LEAF; CASTANEA SATIVA LEAF; POPULUS BALSAMIFERA LEAF BUD; SACCHAROMYCES CEREVISIAE RNA; SUS SCROFA PINEAL GLAND	2; 2; 2; 4; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	20251231
63479-2508_0e775b4a-84f3-ff58-e063-6394a90a64f7	63479-2508	HUMAN OTC DRUG	INTESTINE Formula		ADENOSINE TRIPHOSPHATE, AMMONIUM MURIATICUM, BAPTISIA TINCTORIA, COLCHICUM AUTUMNALE, JUNIPERUS COMMUNIS, LEVOTHYROXINE, PODOPHYLLINUM, RHUS TOXICODENDRON	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; AMMONIUM CHLORIDE; BAPTISIA TINCTORIA ROOT; COLCHICUM AUTUMNALE BULB; JUNIPER BERRY; LEVOTHYROXINE; PODOPHYLLUM RESIN; TOXICODENDRON PUBESCENS LEAF	5; 5; 4; 7; 7; 4; 5; 7	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
63479-2509_0e775ae0-57e1-e614-e063-6394a90ad193	63479-2509	HUMAN OTC DRUG	IMMUNE PLUS Formula		ADENOSINE TRIPHOSPHATE, BAPTISIA TINCTORIA ROOT, CEANOTHUS AMERICANUS LEAF, FUCUS VESICULOSUS, PODOPHYLLUM RESIN, SEPIA OFFICINALIS JUICE, TESTOSTERONE	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; BAPTISIA TINCTORIA ROOT; CEANOTHUS AMERICANUS LEAF; FUCUS VESICULOSUS; PODOPHYLLUM RESIN; SEPIA OFFICINALIS JUICE; TESTOSTERONE	5; 4; 7; 4; 6; 1; 4	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_C]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
63479-2511_0e775ae0-57e2-e614-e063-6394a90ad193	63479-2511	HUMAN OTC DRUG	IMMUNE Formula		ADENOSINE TRIPHOSPHATE, ANTIMONIUM CRUDUM, CROTALUS HORRIDUS, ELAPS CORALLINUS, LYCOPODIUM CLAVATUM, NAJA TRIPUDIANS, VISCUM ALBUM FRUITING TOP	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; ANTIMONY TRISULFIDE; CROTALUS HORRIDUS HORRIDUS VENOM; LYCOPODIUM CLAVATUM SPORE; MICRURUS CORALLINUS VENOM; NAJA NAJA VENOM; VISCUM ALBUM FRUITING TOP	5; 1; 7; 7; 6; 6; 7	[hp_X]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20251231
63479-2513_0e774462-818c-9c5d-e063-6294a90affac	63479-2513	HUMAN OTC DRUG	ADRENAL Formula		ACTIVATED CHARCOAL, CAUSTICUM, ARABICA COFFEE BEAN, PRASTERONE, GLYCYRRHIZA GLABRA, RIBES NIGRUM FLOWER BUD, ELEUTHERO, and VERATRUM ALBUM ROOT	SOLUTION	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ACTIVATED CHARCOAL; ARABICA COFFEE BEAN; CAUSTICUM; ELEUTHERO; GLYCYRRHIZA GLABRA; PRASTERONE; RIBES NIGRUM FLOWER BUD; VERATRUM ALBUM ROOT	7; 7; 1; 1; 6; 3; 1; 7	[hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-2516_0e774462-818d-9c5d-e063-6294a90affac	63479-2516	HUMAN OTC DRUG	ENERGY Formula		ADENOSINE TRIPHOSPHATE, ANTIMONY POTASSIUM TARTRATE, CINCHONA OFFICINALIS BARK, STRYCHNOS NUX-VOMICA SEED, PHOSPHORIC ACID, SULFUR	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	ADENOSINE TRIPHOSPHATE; ANTIMONY POTASSIUM TARTRATE; CINCHONA OFFICINALIS BARK; PHOSPHORIC ACID; STRYCHNOS NUX-VOMICA SEED; SULFUR	6; 1; 7; 3; 1; 2	[hp_X]/mL; [hp_Q]/mL; [hp_C]/mL; [hp_C]/mL; [hp_Q]/mL; [hp_Q]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20251231
63479-2532_0e7735ff-acf7-c569-e063-6294a90a29c0	63479-2532	HUMAN OTC DRUG	IMMUNO-REG Formula		BETULA PENDULA, FOLIA, BOS TAURUS THYMUS, CASTANEA VESCA, POPLAR BUD, RIBES NIGRUM FLOWER BUD, RNA, VISCUM ALBUM STEM	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	BETULA PENDULA LEAF; BOS TAURUS THYMUS; CASTANEA SATIVA LEAF; POPULUS BALSAMIFERA LEAF BUD; RIBES NIGRUM FLOWER BUD; SACCHAROMYCES CEREVISIAE RNA; VISCUM ALBUM STEM	2; 7; 2; 2; 1; 4; 1	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63479-2556_0e7735ff-acf8-c569-e063-6294a90a29c0	63479-2556	HUMAN OTC DRUG	DIGESTION Formula		CINCHONA OFFICINALIS	SOLUTION/ DROPS	SUBLINGUAL	20220322		UNAPPROVED HOMEOPATHIC		Apex Energetics Inc.	CINCHONA OFFICINALIS BARK; JUNIPERUS COMMUNIS STEM; ROSA CANINA LEAF; VITIS VINIFERA FLOWERING TOP	7; 1; 1; 1	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
63481-025_492b9727-53ae-47e2-a832-08bb7930b5bb	63481-025	HUMAN PRESCRIPTION DRUG	FROVA		frovatriptan succinate	TABLET, FILM COATED	ORAL	20011108		NDA	NDA021006	Endo Pharmaceuticals, Inc.	FROVATRIPTAN SUCCINATE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63481-183_0892bc7c-3157-43dd-a8f3-4758b23bf571	63481-183	HUMAN PRESCRIPTION DRUG	FORTESTA		testosterone	GEL, METERED	TOPICAL	20101229		NDA	NDA021463	Endo Pharmaceuticals Inc.	TESTOSTERONE	10	mg/.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63481-529_7d79882e-12eb-4b51-88f8-6d0089fa5122	63481-529	HUMAN PRESCRIPTION DRUG	Cortisporin TC		colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetate	SUSPENSION	AURICULAR (OTIC)	20190603		NDA	NDA050356	Endo Pharmaceuticals, Inc.	COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE	3; 10; 3.3; .5	mg/mL; mg/mL; mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63481-623_eca56a4f-6c3d-45db-9996-b4fd78f7ef55	63481-623	HUMAN PRESCRIPTION DRUG	PERCOCET		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	19990630		ANDA	ANDA040330	Endo Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63481-627_eca56a4f-6c3d-45db-9996-b4fd78f7ef55	63481-627	HUMAN PRESCRIPTION DRUG	PERCOCET		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	19990630		ANDA	ANDA040330	Endo Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63481-628_eca56a4f-6c3d-45db-9996-b4fd78f7ef55	63481-628	HUMAN PRESCRIPTION DRUG	PERCOCET		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	20011130		ANDA	ANDA040330	Endo Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63481-629_eca56a4f-6c3d-45db-9996-b4fd78f7ef55	63481-629	HUMAN PRESCRIPTION DRUG	PERCOCET		oxycodone hydrochloride and acetaminophen	TABLET	ORAL	20011130		ANDA	ANDA040330	Endo Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63481-687_e3bb80f5-e881-4c0f-87bd-21cac3e07281	63481-687	HUMAN PRESCRIPTION DRUG	LIDODERM		lidocaine	PATCH	CUTANEOUS	19990320	20250331	NDA	NDA020612	Endo Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
63505-771_081cc8b7-daba-f6fa-e063-6394a90a248d	63505-771	HUMAN OTC DRUG	Solaire peau Parfaite Mineral Screen SPF 30		ZINC OXIDE	CREAM	TOPICAL	20220901		OTC MONOGRAPH DRUG	M020	Yves Rocher North America Inc.	ZINC OXIDE	190	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63517-070_0a0d9ae0-6785-3114-e063-6294a90aa085	63517-070	HUMAN OTC DRUG	Cardinal Health		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20210104		OTC MONOGRAPH DRUG	M021	Cardinal Health 200, LLC	SODIUM FLUORIDE	.15	g/100g			N	20241231
63517-125_0805151c-6890-af17-e063-6394a90a62c3	63517-125	HUMAN OTC DRUG	Personal Cleansing with Dimethicone		DIMETHICONE	CLOTH	TOPICAL	20190515		OTC MONOGRAPH DRUG	M022	Cardinal Health 200, Inc.	DIMETHICONE	32	mg/mL	Skin Barrier Activity [PE]		N	20241231
63517-126_08051305-a3dc-d5c5-e063-6394a90a4602	63517-126	HUMAN OTC DRUG	Personal Cleansing with Dimethicone		DIMETHICONE	CLOTH	TOPICAL	20190515		OTC MONOGRAPH DRUG	M022	Cardinal Health 200, Inc	DIMETHICONE	32	mg/mL	Skin Barrier Activity [PE]		N	20241231
63517-131_08145204-358b-5251-e063-6394a90af75e	63517-131	HUMAN OTC DRUG	INCONTINENCE CARE WIPE		DIMETHICONE	SWAB	TOPICAL	20190515		OTC MONOGRAPH DRUG	M022	Cardinal Health 200, Inc.	DIMETHICONE	32	mg/g	Skin Barrier Activity [PE]		N	20241231
63517-210_08632219-c5f3-6c06-e063-6294a90a4dbe	63517-210	HUMAN OTC DRUG	Antibacterial Bathing		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20190515		OTC MONOGRAPH DRUG	M003	Cardinal Health, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63517-242_09c713b2-ce40-7359-e063-6394a90a0257	63517-242	HUMAN OTC DRUG	Alcohol sterile		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20150429		OTC MONOGRAPH DRUG	M003	Cardinal Health, Inc	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
63517-244_09c712f0-9417-428b-e063-6394a90ad096	63517-244	HUMAN OTC DRUG	Alcohol sterile		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20150430		OTC MONOGRAPH DRUG	M003	Cardinal Health 200 LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
63517-251_09c732f6-0be8-b95e-e063-6394a90aa53b	63517-251	HUMAN OTC DRUG	Povidone-Iodine Prep Sterile		POVIDONE-IODINE	SWAB	TOPICAL	20150429		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200, Inc	POVIDONE-IODINE	100	mg/g			N	20241231
63517-252_09d693d5-ec0a-5c7c-e063-6394a90a6d74	63517-252	HUMAN OTC DRUG	Povidone-Iodine Scrub Sterile		POVIDONE-IODINE	SWAB	TOPICAL	20150429		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200, Inc	POVIDONE-IODINE	75	mg/g			N	20241231
63517-254_09c732f6-0bf8-b95e-e063-6394a90aa53b	63517-254	HUMAN OTC DRUG	Povidone-Iodine Prep Sterile		POVIDONE-IODINE	SWAB	TOPICAL	20150429		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200 LLC	POVIDONE-IODINE	100	mg/g			N	20241231
63517-255_09c727e0-017f-4b43-e063-6394a90abe69	63517-255	HUMAN OTC DRUG	Povidone-Iodine Scrub Sterile		POVIDONE-IODINE	SWAB	TOPICAL	20150429		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200, Inc	POVIDONE-IODINE	75	mg/g			N	20241231
63517-400_085ebaa7-2663-90e3-e063-6294a90a8a56	63517-400	HUMAN OTC DRUG	Povidone-Iodine Prep Pad		POVIDONE-IODINE	SOLUTION	TOPICAL	20160805		OTC MONOGRAPH DRUG	M003	Cardinal Health 200, Inc.	POVIDONE-IODINE	10	g/100g			N	20241231
63517-450_464609ac-5ddf-459e-8b01-a89b17945dba	63517-450	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20150601		OTC MONOGRAPH NOT FINAL	part333A	Cardinal Health	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
63517-452_2e735517-b2af-40e2-8340-673b1b5e1f4a	63517-452	HUMAN OTC DRUG	Isopropyl Alcohol 70%		Isopropyl alcohol	LIQUID	TOPICAL	20150601		OTC MONOGRAPH NOT FINAL	part333A	Cardinal Health	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
63517-500_0a533dba-d9ba-22dd-e063-6294a90aa5aa	63517-500	HUMAN OTC DRUG	Alcohol Prep Pads		isopropyl alcohol	SWAB	TOPICAL	20160202		OTC MONOGRAPH DRUG	M003	Cardinal Health	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
63517-501_085ec0ff-b5e0-2628-e063-6294a90ade13	63517-501	HUMAN OTC DRUG	Antiseptic BZK Towelette		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20160601		OTC MONOGRAPH DRUG	M003	Cardinal Health 200, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
63517-600_0a532499-a600-a333-e063-6394a90a19fd	63517-600	HUMAN OTC DRUG	Alcohol Prep Pads		isopropyl alcohol	SWAB	TOPICAL	20160208		OTC MONOGRAPH DRUG	M003	Cardinal Health 200, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
63517-657_09c713eb-f416-4842-e063-6294a90a1760	63517-657	HUMAN OTC DRUG	Povidone-Iodine Scrub Sterile		POVIDONE-IODINE	SPONGE	TOPICAL	20150430		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200 LLC	POVIDONE-IODINE	75	mg/g			N	20241231
63517-658_09c7249c-7a80-51b1-e063-6394a90a7073	63517-658	HUMAN OTC DRUG	Povidone-Iodine Prep Sterile		POVIDONE-IODINE	SPONGE	TOPICAL	20150430		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200 LLC	POVIDONE-IODINE	100	mg/g			N	20241231
63517-751_09c737af-be94-00b0-e063-6394a90adfb1	63517-751	HUMAN OTC DRUG	Povidone-Iodine Prep Winged Sterile Small		POVIDONE-IODINE	SPONGE	TOPICAL	20150430		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200 LLC	POVIDONE-IODINE	100	mg/g			N	20241231
63517-759_09c7249c-7a91-51b1-e063-6394a90a7073	63517-759	HUMAN OTC DRUG	Povidone-Iodine Prep Winged Sterile Large		POVIDONE-IODINE	SPONGE	TOPICAL	20150430		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 200, Inc	POVIDONE-IODINE	100	mg/g			N	20241231
63517-803_08b5eaa4-d381-d73f-e063-6294a90a8bde	63517-803	HUMAN OTC DRUG	Roll On Anti-Perspirant (Alcohol Free)		ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20130904		OTC MONOGRAPH DRUG	M019	Cardinal Health	ALUMINUM CHLOROHYDRATE	10	g/100mL			N	20241231
63533-007_397a46f0-911b-4026-ba9d-e2b969d89022	63533-007	HUMAN OTC DRUG	Han I Foam		ALCOHOL	LIQUID	TOPICAL	20200810		OTC MONOGRAPH NOT FINAL	part333E	Momar Incorporated	ALCOHOL	.62	mL/mL			N	20241231
63533-221_2d0de76a-fd02-4900-8f0c-335e1d9af17b	63533-221	HUMAN OTC DRUG	Han-I-Size		ALCOHOL	GEL	TOPICAL	20051201		OTC MONOGRAPH NOT FINAL	part333E	Momar Incorporated	ALCOHOL	.7	mL/mL			N	20241231
63533-457_27d744a0-8691-4ef8-926f-a52e1f05b1cd	63533-457	HUMAN OTC DRUG	99 Plus Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20190628		OTC MONOGRAPH NOT FINAL	part333E	Momar Incorporated	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63533-693_0c415ba1-4681-ce55-e063-6394a90a392c	63533-693	HUMAN OTC DRUG	HAN-I-SIZE		HAN-I-SIZE	LIQUID	TOPICAL	20200323		OTC MONOGRAPH DRUG	505G(a)(3)	Momar, Inc.	ALCOHOL	67	mL/100mL			N	20241231
63533-855_032b0f35-b441-434a-817c-6185a8b82158	63533-855	HUMAN OTC DRUG	Han-I-Foam		ALCOHOL	LIQUID	TOPICAL	20200810		OTC MONOGRAPH NOT FINAL	part333E	Momar Incorporated	ALCOHOL	.62	mL/mL			N	20241231
63533-876_3128d029-61e6-44b3-92a2-82351ad2ab7d	63533-876	HUMAN OTC DRUG	Handtastic Foamy Mango Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170120		OTC MONOGRAPH NOT FINAL	part333E	Momar Incorporated	CHLOROXYLENOL	3	mg/mL			N	20241231
63539-012_0d583822-093c-4174-ba96-b31ae3f43e58	63539-012	HUMAN PRESCRIPTION DRUG	XELJANZ		tofacitinib	TABLET, FILM COATED	ORAL	20121108		NDA	NDA203214	U.S. Pharmaceuticals	TOFACITINIB CITRATE	5	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
63539-016_0d583822-093c-4174-ba96-b31ae3f43e58	63539-016	HUMAN PRESCRIPTION DRUG	XELJANZ		tofacitinib	TABLET, FILM COATED	ORAL	20180702		NDA	NDA203214	U.S. Pharmaceuticals	TOFACITINIB CITRATE	10	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
63539-017_789efe1c-a895-4b2d-a6eb-3854e3636f7f	63539-017	HUMAN PRESCRIPTION DRUG	SUTENT		Sunitinib malate	CAPSULE	ORAL	20060126		NDA	NDA021938	U.S. Pharmaceuticals	SUNITINIB MALATE	12.5	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63539-019_789efe1c-a895-4b2d-a6eb-3854e3636f7f	63539-019	HUMAN PRESCRIPTION DRUG	SUTENT		Sunitinib malate	CAPSULE	ORAL	20060126		NDA	NDA021938	U.S. Pharmaceuticals	SUNITINIB MALATE	50	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
63539-026_474bf7b0-403b-4603-ba0c-cccd94333b42	63539-026	HUMAN PRESCRIPTION DRUG	INLYTA		axitinib	TABLET, FILM COATED	ORAL	20120127		NDA	NDA202324	U.S. Pharmaceuticals	AXITINIB	1	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
63539-044_474bf7b0-403b-4603-ba0c-cccd94333b42	63539-044	HUMAN PRESCRIPTION DRUG	INLYTA		axitinib	TABLET, FILM COATED	ORAL	20120127		NDA	NDA202324	U.S. Pharmaceuticals	AXITINIB	5	mg/1	Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]		N	20241231
63539-051_8b30c92a-7971-4701-9810-82e53466f18f	63539-051	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20230621		NDA	NDA211651	U.S. Pharmaceuticals	TALAZOPARIB TOSYLATE	.5	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
63539-117_36db594d-78c5-4535-8b8f-0ee0ec2e010f	63539-117	HUMAN PRESCRIPTION DRUG	BOSULIF		Bosutinib	TABLET, FILM COATED	ORAL	20120904		NDA	NDA203341	U.S. Pharmaceuticals	BOSUTINIB MONOHYDRATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
63539-121_0dcd3231-552e-4243-bbc9-b8ed733d3ff4	63539-121	HUMAN PRESCRIPTION DRUG	Caverject Impulse		Alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	20140504		NDA	NDA021212	U.S. Pharmaceuticals	ALPROSTADIL	10	ug/.5mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
63539-122_8617f185-4d2c-4574-a611-caee518fd5b6	63539-122	HUMAN PRESCRIPTION DRUG	Duavee		conjugated estrogens/bazedoxifene	TABLET, FILM COATED	ORAL	20131115		NDA	NDA022247	U.S. Pharmaceuticals	BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED	20; .45	mg/1; mg/1	Estrogen Agonist/Antagonist [EPC], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Selective Estrogen Receptor Modulators [MoA]		N	20241231
63539-135_1191475f-e999-49f4-a805-93ad08596b1b	63539-135	HUMAN PRESCRIPTION DRUG	ZAVZPRET		zavegepant	SPRAY	NASAL	20230601		NDA	NDA216386	U.S. Pharmaceuticals	ZAVEGEPANT HYDROCHLORIDE	10	mg/.1mL	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
63539-183_8c840c97-1ef1-40bc-bd5c-8734856e91f3	63539-183	HUMAN PRESCRIPTION DRUG	Toviaz		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081031		NDA	NDA022030	U.S. Pharmaceuticals	FESOTERODINE FUMARATE	8	mg/1			N	20241231
63539-187_88309e0f-1792-4959-94e2-01a6a05dfc5f	63539-187	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	CAPSULE	ORAL	20170508		NDA	NDA207103	U.S. Pharmaceuticals	PALBOCICLIB	75	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
63539-188_88309e0f-1792-4959-94e2-01a6a05dfc5f	63539-188	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	CAPSULE	ORAL	20170508		NDA	NDA207103	U.S. Pharmaceuticals	PALBOCICLIB	100	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
63539-189_88309e0f-1792-4959-94e2-01a6a05dfc5f	63539-189	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	CAPSULE	ORAL	20150203		NDA	NDA207103	U.S. Pharmaceuticals	PALBOCICLIB	125	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
63539-193_36db594d-78c5-4535-8b8f-0ee0ec2e010f	63539-193	HUMAN PRESCRIPTION DRUG	BOSULIF		Bosutinib	TABLET, FILM COATED	ORAL	20120904		NDA	NDA203341	U.S. Pharmaceuticals	BOSUTINIB MONOHYDRATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
63539-197_afc03569-5f90-4301-9b76-f651c5ffbc35	63539-197	HUMAN PRESCRIPTION DRUG	Vizimpro		dacomitinib	TABLET, FILM COATED	ORAL	20190201		NDA	NDA211288	U.S. Pharmaceuticals	DACOMITINIB	15	mg/1			N	20241231
63539-221_0dcd3231-552e-4243-bbc9-b8ed733d3ff4	63539-221	HUMAN PRESCRIPTION DRUG	Caverject Impulse		Alprostadil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVERNOUS	20140504		NDA	NDA021212	U.S. Pharmaceuticals	ALPROSTADIL	20	ug/.5mL	Genitourinary Arterial Vasodilation [PE], Prostaglandin Analog [EPC], Prostaglandin E1 Agonist [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS], Venous Vasodilation [PE]		N	20241231
63539-236_39348c48-a987-4d47-b44a-6a32266f6d8b	63539-236	HUMAN PRESCRIPTION DRUG	CIBINQO		abrocitinib	TABLET, FILM COATED	ORAL	20220224		NDA	NDA213871	U.S. Pharmaceuticals	ABROCITINIB	50	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
63539-242_8c840c97-1ef1-40bc-bd5c-8734856e91f3	63539-242	HUMAN PRESCRIPTION DRUG	Toviaz		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20081031		NDA	NDA022030	U.S. Pharmaceuticals	FESOTERODINE FUMARATE	4	mg/1			N	20241231
63539-252_aa044060-5b4b-4692-bf0f-9a50e140b10e	63539-252	HUMAN PRESCRIPTION DRUG	Elrexfio		elranatamab-bcmm	INJECTION, SOLUTION	SUBCUTANEOUS	20230815		BLA	BLA761345	U.S. Pharmaceuticals	ELRANATAMAB	44	mg/1.1mL			N	20241231
63539-274_d5b2a717-1b5c-4aed-a69c-64a0c4561c40	63539-274	HUMAN PRESCRIPTION DRUG	Velsipity		etrasimod	TABLET, FILM COATED	ORAL	20231109		NDA	NDA216956	U.S. Pharmaceuticals	ETRASIMOD ARGININE	2	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
63539-284_96b5bbb5-940a-4a15-a699-583921564d53	63539-284	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	TABLET, FILM COATED	ORAL	20200330		NDA	NDA212436	U.S. Pharmaceuticals	PALBOCICLIB	75	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
63539-295_8b30c92a-7971-4701-9810-82e53466f18f	63539-295	HUMAN PRESCRIPTION DRUG	Talzenna		talazoparib	CAPSULE	ORAL	20181210		NDA	NDA211651	U.S. Pharmaceuticals	TALAZOPARIB TOSYLATE	1	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
63539-334_1882f799-61b0-4813-965a-4910c4ae419c	63539-334	HUMAN PRESCRIPTION DRUG	Litfulo		ritlecitinib	CAPSULE	ORAL	20230706		NDA	NDA215830	U.S. Pharmaceuticals	RITLECITINIB TOSYLATE	50	mg/1			N	20241231
63539-336_39348c48-a987-4d47-b44a-6a32266f6d8b	63539-336	HUMAN PRESCRIPTION DRUG	CIBINQO		abrocitinib	TABLET, FILM COATED	ORAL	20220224		NDA	NDA213871	U.S. Pharmaceuticals	ABROCITINIB	100	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
63539-436_39348c48-a987-4d47-b44a-6a32266f6d8b	63539-436	HUMAN PRESCRIPTION DRUG	CIBINQO		abrocitinib	TABLET, FILM COATED	ORAL	20220224		NDA	NDA213871	U.S. Pharmaceuticals	ABROCITINIB	200	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
63539-486_96b5bbb5-940a-4a15-a699-583921564d53	63539-486	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	TABLET, FILM COATED	ORAL	20200330		NDA	NDA212436	U.S. Pharmaceuticals	PALBOCICLIB	100	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
63539-501_0d583822-093c-4174-ba96-b31ae3f43e58	63539-501	HUMAN PRESCRIPTION DRUG	XELJANZ	XR	tofacitinib	TABLET, EXTENDED RELEASE	ORAL	20160307		NDA	NDA208246	U.S. Pharmaceuticals	TOFACITINIB CITRATE	11	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
63539-502_0d583822-093c-4174-ba96-b31ae3f43e58	63539-502	HUMAN PRESCRIPTION DRUG	XELJANZ	XR	tofacitinib	TABLET, EXTENDED RELEASE	ORAL	20200121		NDA	NDA208246	U.S. Pharmaceuticals	TOFACITINIB CITRATE	22	mg/1	Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]		N	20241231
63539-688_96b5bbb5-940a-4a15-a699-583921564d53	63539-688	HUMAN PRESCRIPTION DRUG	Ibrance		palbociclib	TABLET, FILM COATED	ORAL	20200330		NDA	NDA212436	U.S. Pharmaceuticals	PALBOCICLIB	125	mg/1	Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]		N	20241231
63539-927_5fc88709-ec95-48d9-9e9f-e6c1790f6778	63539-927	HUMAN PRESCRIPTION DRUG	Lorbrena		lorlatinib	TABLET, FILM COATED	ORAL	20230103		NDA	NDA210868	U.S. Pharmaceuticals	LORLATINIB	25	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA], Organic Cation Transporter 1 Inhibitors [MoA], P-Glycoprotein Inducers [MoA]		N	20241231
63545-001_e4bde4e4-d363-9556-e053-2a95a90a5655	63545-001	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	6	[hp_C]/1			N	20241231
63545-001_e4bde4e4-d364-9556-e053-2a95a90a5655	63545-001	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	6	[hp_C]/1			N	20241231
63545-001_e4be62ac-8909-0cb5-e053-2a95a90a6dc3	63545-001	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	6	[hp_C]/1			N	20241231
63545-003_efa3b455-2592-4cf8-e053-2995a90a225f	63545-003	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20201021		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM CHLORIDE	6	[hp_C]/1			N	20241231
63545-004_efa3a8ae-c69e-08f7-e053-2995a90a4f27	63545-004	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20201023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM PHOSPHATE, DIBASIC	6	[hp_C]/1			N	20241231
63545-005_ef6a6e71-d65a-9c58-e053-2a95a90a4b6d	63545-005	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANGOSTURA BARK	200	[hp_C]/1			N	20241231
63545-006_ef6a6e71-d65a-9c58-e053-2a95a90a4b6d	63545-006	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANGOSTURA BARK	500	[hp_C]/1			N	20241231
63545-007_ef6a6e71-d65a-9c58-e053-2a95a90a4b6d	63545-007	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANGOSTURA BARK	1	[hp_M]/1			N	20241231
63545-008_ef6a6e71-d65a-9c58-e053-2a95a90a4b6d	63545-008	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANGOSTURA BARK	30	[hp_C]/1			N	20241231
63545-009_ef6a6e71-d65a-9c58-e053-2a95a90a4b6d	63545-009	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANGOSTURA BARK	100	[hp_C]/1			N	20241231
63545-040_bb642f37-0156-3973-e053-2995a90a9597	63545-040	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	6	[hp_C]/1			N	20241231
63545-041_bb642f37-0156-3973-e053-2995a90a9597	63545-041	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	12	[hp_C]/1			N	20241231
63545-042_bb642f37-0156-3973-e053-2995a90a9597	63545-042	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	30	[hp_C]/1			N	20241231
63545-043_bb642f37-0156-3973-e053-2995a90a9597	63545-043	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	100	[hp_C]/1			N	20241231
63545-044_bb642f37-0156-3973-e053-2995a90a9597	63545-044	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	200	[hp_C]/1			N	20241231
63545-045_bb642f37-0156-3973-e053-2995a90a9597	63545-045	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	500	[hp_C]/1			N	20241231
63545-046_bb642f37-0156-3973-e053-2995a90a9597	63545-046	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	1	[hp_M]/1			N	20241231
63545-047_bb642f37-0156-3973-e053-2995a90a9597	63545-047	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	10	[hp_M]/1			N	20241231
63545-048_bb642f37-0156-3973-e053-2995a90a9597	63545-048	HUMAN OTC DRUG	Antimonium Tartaricum		Antimonium Tartaricum	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	ANTIMONY POTASSIUM TARTRATE	1	[hp_Q]/1			N	20241231
63545-049_bb67bcff-2991-c926-e053-2995a90a20b5	63545-049	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	6	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-050_bb67bcff-2991-c926-e053-2995a90a20b5	63545-050	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	12	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-051_bb67bcff-2991-c926-e053-2995a90a20b5	63545-051	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	30	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-052_bb67bcff-2991-c926-e053-2995a90a20b5	63545-052	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	100	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-053_bb67bcff-2991-c926-e053-2995a90a20b5	63545-053	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	200	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-054_bb67bcff-2991-c926-e053-2995a90a20b5	63545-054	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	500	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-055_bb67bcff-2991-c926-e053-2995a90a20b5	63545-055	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	1	[hp_M]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-056_bb67bcff-2991-c926-e053-2995a90a20b5	63545-056	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	10	[hp_M]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-057_bb67bcff-2991-c926-e053-2995a90a20b5	63545-057	HUMAN OTC DRUG	Apis Mellifica		Apis Mellifica	PELLET	ORAL	20210215		UNAPPROVED HOMEOPATHIC		HAHNEMANN LABORATORIES, INC	APIS MELLIFERA	1	[hp_Q]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
63545-058_bc09b625-bfad-9955-e053-2a95a90a512c	63545-058	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	6	[hp_C]/1			N	20241231
63545-059_bc09b625-bfad-9955-e053-2a95a90a512c	63545-059	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	12	[hp_C]/1			N	20241231
63545-060_bc09b625-bfad-9955-e053-2a95a90a512c	63545-060	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	30	[hp_C]/1			N	20241231
63545-061_bc09b625-bfad-9955-e053-2a95a90a512c	63545-061	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	100	[hp_C]/1			N	20241231
63545-062_bc09b625-bfad-9955-e053-2a95a90a512c	63545-062	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	200	[hp_C]/1			N	20241231
63545-063_bc09b625-bfad-9955-e053-2a95a90a512c	63545-063	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	500	[hp_C]/1			N	20241231
63545-064_bc09b625-bfad-9955-e053-2a95a90a512c	63545-064	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	1	[hp_M]/1			N	20241231
63545-065_bc09b625-bfad-9955-e053-2a95a90a512c	63545-065	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	10	[hp_M]/1			N	20241231
63545-066_bc09b625-bfad-9955-e053-2a95a90a512c	63545-066	HUMAN OTC DRUG	Apocynum Cannabinum		Apocynum Cannabinum	PELLET	ORAL	20210223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	APOCYNUM CANNABINUM ROOT	1	[hp_Q]/1			N	20241231
63545-067_e4bc675e-a9f0-5ccf-e053-2a95a90a4d82	63545-067	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	6	[hp_C]/1			N	20241231
63545-067_e4bce54d-d36b-4084-e053-2995a90a0069	63545-067	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	6	[hp_C]/1			N	20241231
63545-067_e4bce665-f139-32d9-e053-2995a90aa6da	63545-067	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	6	[hp_C]/1			N	20241231
63545-068_e4bbc487-0969-cbba-e053-2995a90a67cf	63545-068	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	6	[hp_C]/1			N	20241231
63545-068_e4bbe97b-c966-153c-e053-2a95a90aec5f	63545-068	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	6	[hp_C]/1			N	20241231
63545-068_e4bbeded-eeac-6ff3-e053-2995a90ac8d3	63545-068	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	6	[hp_C]/1			N	20241231
63545-069_dbd8d132-c77d-6bd9-e053-2a95a90a7e0c	63545-069	HUMAN OTC DRUG	Baryta Iodata		Baryta Iodata	PELLET	ORAL	20220404		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM IODIDE	6	[hp_C]/1			N	20241231
63545-071_dbd8d132-c77d-6bd9-e053-2a95a90a7e0c	63545-071	HUMAN OTC DRUG	Baryta Iodata		Baryta Iodata	PELLET	ORAL	20220404		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM IODIDE	12	[hp_C]/1			N	20241231
63545-072_dbd8d132-c77d-6bd9-e053-2a95a90a7e0c	63545-072	HUMAN OTC DRUG	Baryta Iodata		Baryta Iodata	PELLET	ORAL	20220404		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM IODIDE	30	[hp_C]/1			N	20241231
63545-073_bc1a103b-b700-15f3-e053-2a95a90acfb0	63545-073	HUMAN OTC DRUG	Aralia Quinquefolia		Aralia Quinquefolia	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMERICAN GINSENG	6	[hp_C]/1			N	20241231
63545-074_bc1a103b-b700-15f3-e053-2a95a90acfb0	63545-074	HUMAN OTC DRUG	Aralia Quinquefolia		Aralia Quinquefolia	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMERICAN GINSENG	12	[hp_C]/1			N	20241231
63545-075_bc1a103b-b700-15f3-e053-2a95a90acfb0	63545-075	HUMAN OTC DRUG	Aralia Quinquefolia		Aralia Quinquefolia	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMERICAN GINSENG	30	[hp_C]/1			N	20241231
63545-076_bc1a103b-b700-15f3-e053-2a95a90acfb0	63545-076	HUMAN OTC DRUG	Aralia Quinquefolia		Aralia Quinquefolia	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMERICAN GINSENG	100	[hp_C]/1			N	20241231
63545-077_bc1a103b-b700-15f3-e053-2a95a90acfb0	63545-077	HUMAN OTC DRUG	Aralia Quinquefolia		Aralia Quinquefolia	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMERICAN GINSENG	200	[hp_C]/1			N	20241231
63545-078_bc1a103b-b700-15f3-e053-2a95a90acfb0	63545-078	HUMAN OTC DRUG	Aralia Quinquefolia		Aralia Quinquefolia	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMERICAN GINSENG	500	[hp_C]/1			N	20241231
63545-079_bc1a103b-b700-15f3-e053-2a95a90acfb0	63545-079	HUMAN OTC DRUG	Aralia Quinquefolia		Aralia Quinquefolia	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMERICAN GINSENG	1	[hp_M]/1			N	20241231
63545-080_bc1c6150-aa63-f9b1-e053-2995a90a07d0	63545-080	HUMAN OTC DRUG	Aralia Racemosa		Aralia Racemosa	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARALIA RACEMOSA ROOT	6	[hp_C]/1			N	20241231
63545-081_bc1c6150-aa63-f9b1-e053-2995a90a07d0	63545-081	HUMAN OTC DRUG	Aralia Racemosa		Aralia Racemosa	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARALIA RACEMOSA ROOT	12	[hp_C]/1			N	20241231
63545-082_bc1c6150-aa63-f9b1-e053-2995a90a07d0	63545-082	HUMAN OTC DRUG	Aralia Racemosa		Aralia Racemosa	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARALIA RACEMOSA ROOT	30	[hp_C]/1			N	20241231
63545-083_bc1c6150-aa63-f9b1-e053-2995a90a07d0	63545-083	HUMAN OTC DRUG	Aralia Racemosa		Aralia Racemosa	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARALIA RACEMOSA ROOT	100	[hp_C]/1			N	20241231
63545-084_bc1c6150-aa63-f9b1-e053-2995a90a07d0	63545-084	HUMAN OTC DRUG	Aralia Racemosa		Aralia Racemosa	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARALIA RACEMOSA ROOT	200	[hp_C]/1			N	20241231
63545-085_bc1c6150-aa63-f9b1-e053-2995a90a07d0	63545-085	HUMAN OTC DRUG	Aralia Racemosa		Aralia Racemosa	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARALIA RACEMOSA ROOT	500	[hp_C]/1			N	20241231
63545-086_bc1c6150-aa63-f9b1-e053-2995a90a07d0	63545-086	HUMAN OTC DRUG	Aralia Racemosa		Aralia Racemosa	PELLET	ORAL	20210224		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARALIA RACEMOSA ROOT	1	[hp_M]/1			N	20241231
63545-087_bc2ff6a4-3519-5617-e053-2995a90adc50	63545-087	HUMAN OTC DRUG	Araneus Diadematus		Araneus Diadematus	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARANEUS DIADEMATUS	6	[hp_C]/1			N	20241231
63545-088_bc2ff6a4-3519-5617-e053-2995a90adc50	63545-088	HUMAN OTC DRUG	Araneus Diadematus		Araneus Diadematus	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARANEUS DIADEMATUS	12	[hp_C]/1			N	20241231
63545-089_bc2ff6a4-3519-5617-e053-2995a90adc50	63545-089	HUMAN OTC DRUG	Araneus Diadematus		Araneus Diadematus	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARANEUS DIADEMATUS	30	[hp_C]/1			N	20241231
63545-090_bc2ff6a4-3519-5617-e053-2995a90adc50	63545-090	HUMAN OTC DRUG	Araneus Diadematus		Araneus Diadematus	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARANEUS DIADEMATUS	100	[hp_C]/1			N	20241231
63545-091_bc2ff6a4-3519-5617-e053-2995a90adc50	63545-091	HUMAN OTC DRUG	Araneus Diadematus		Araneus Diadematus	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARANEUS DIADEMATUS	200	[hp_C]/1			N	20241231
63545-092_bc2ff6a4-3519-5617-e053-2995a90adc50	63545-092	HUMAN OTC DRUG	Araneus Diadematus		Araneus Diadematus	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARANEUS DIADEMATUS	500	[hp_C]/1			N	20241231
63545-093_bc2ff6a4-3519-5617-e053-2995a90adc50	63545-093	HUMAN OTC DRUG	Araneus Diadematus		Araneus Diadematus	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARANEUS DIADEMATUS	1	[hp_M]/1			N	20241231
63545-094_bc32799a-0578-5b10-e053-2a95a90a2483	63545-094	HUMAN OTC DRUG	Aratinga Arythrogenys		Aratinga Arythrogenys	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARATINGA ERYTHROGENYS FEATHER	6	[hp_C]/1			N	20241231
63545-095_bc32799a-0578-5b10-e053-2a95a90a2483	63545-095	HUMAN OTC DRUG	Aratinga Arythrogenys		Aratinga Arythrogenys	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARATINGA ERYTHROGENYS FEATHER	12	[hp_C]/1			N	20241231
63545-096_bc32799a-0578-5b10-e053-2a95a90a2483	63545-096	HUMAN OTC DRUG	Aratinga Arythrogenys		Aratinga Arythrogenys	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARATINGA ERYTHROGENYS FEATHER	30	[hp_C]/1			N	20241231
63545-097_bc32799a-0578-5b10-e053-2a95a90a2483	63545-097	HUMAN OTC DRUG	Aratinga Arythrogenys		Aratinga Arythrogenys	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARATINGA ERYTHROGENYS FEATHER	100	[hp_C]/1			N	20241231
63545-098_bc32799a-0578-5b10-e053-2a95a90a2483	63545-098	HUMAN OTC DRUG	Aratinga Arythrogenys		Aratinga Arythrogenys	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARATINGA ERYTHROGENYS FEATHER	200	[hp_C]/1			N	20241231
63545-099_bc32799a-0578-5b10-e053-2a95a90a2483	63545-099	HUMAN OTC DRUG	Aratinga Arythrogenys		Aratinga Arythrogenys	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARATINGA ERYTHROGENYS FEATHER	500	[hp_C]/1			N	20241231
63545-100_bc32799a-0578-5b10-e053-2a95a90a2483	63545-100	HUMAN OTC DRUG	Aratinga Arythrogenys		Aratinga Arythrogenys	PELLET	ORAL	20210225		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARATINGA ERYTHROGENYS FEATHER	1	[hp_M]/1			N	20241231
63545-101_bc92fa39-2e8a-8434-e053-2995a90a6150	63545-101	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER IODIDE	6	[hp_C]/1			N	20241231
63545-102_bc92fa39-2e8a-8434-e053-2995a90a6150	63545-102	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER IODIDE	12	[hp_C]/1			N	20241231
63545-103_bc92fa39-2e8a-8434-e053-2995a90a6150	63545-103	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER IODIDE	30	[hp_C]/1			N	20241231
63545-104_bc92fa39-2e8a-8434-e053-2995a90a6150	63545-104	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER IODIDE	100	[hp_C]/1			N	20241231
63545-105_bc92fa39-2e8a-8434-e053-2995a90a6150	63545-105	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER IODIDE	200	[hp_C]/1			N	20241231
63545-106_bc92fa39-2e8a-8434-e053-2995a90a6150	63545-106	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER IODIDE	500	[hp_C]/1			N	20241231
63545-107_bc92fa39-2e8a-8434-e053-2995a90a6150	63545-107	HUMAN OTC DRUG	Argentum Iodatum		Argentum Iodatum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER IODIDE	1	[hp_M]/1			N	20241231
63545-108_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-108	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	6	[hp_C]/1			N	20241231
63545-109_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-109	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	12	[hp_C]/1			N	20241231
63545-110_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-110	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	30	[hp_C]/1			N	20241231
63545-111_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-111	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	100	[hp_C]/1			N	20241231
63545-112_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-112	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	200	[hp_C]/1			N	20241231
63545-113_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-113	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	500	[hp_C]/1			N	20241231
63545-114_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-114	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	1	[hp_M]/1			N	20241231
63545-115_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-115	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	10	[hp_M]/1			N	20241231
63545-116_bc96ecec-0974-4b62-e053-2995a90a7e3c	63545-116	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210302		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER	1	[hp_Q]/1			N	20241231
63545-117_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-117	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	6	[hp_C]/1			N	20241231
63545-118_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-118	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	12	[hp_C]/1			N	20241231
63545-119_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-119	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	30	[hp_C]/1			N	20241231
63545-120_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-120	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	100	[hp_C]/1			N	20241231
63545-121_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-121	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	200	[hp_C]/1			N	20241231
63545-122_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-122	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	500	[hp_C]/1			N	20241231
63545-123_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-123	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	1	[hp_M]/1			N	20241231
63545-124_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-124	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	10	[hp_M]/1			N	20241231
63545-125_bca8589c-c3e2-2ebd-e053-2995a90ad46a	63545-125	HUMAN OTC DRUG	Argentum Muriaticum		Argentum Muriaticum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER CHLORIDE	1	[hp_Q]/1			N	20241231
63545-126_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-126	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	6	[hp_C]/1			N	20241231
63545-127_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-127	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	12	[hp_C]/1			N	20241231
63545-128_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-128	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	30	[hp_C]/1			N	20241231
63545-129_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-129	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	100	[hp_C]/1			N	20241231
63545-130_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-130	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	200	[hp_C]/1			N	20241231
63545-131_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-131	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	500	[hp_C]/1			N	20241231
63545-132_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-132	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	1	[hp_M]/1			N	20241231
63545-133_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-133	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	10	[hp_M]/1			N	20241231
63545-134_bcaab86c-e57c-8287-e053-2a95a90a83a9	63545-134	HUMAN OTC DRUG	Argentum Nitricum		Argentum Nitricum	PELLET	ORAL	20210303		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER NITRATE	1	[hp_X]/1			N	20241231
63545-135_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-135	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	6	[hp_C]/1			N	20241231
63545-136_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-136	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	12	[hp_C]/1			N	20241231
63545-137_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-137	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	30	[hp_C]/1			N	20241231
63545-138_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-138	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	100	[hp_C]/1			N	20241231
63545-139_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-139	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	200	[hp_C]/1			N	20241231
63545-140_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-140	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	500	[hp_C]/1			N	20241231
63545-141_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-141	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	1	[hp_M]/1			N	20241231
63545-143_e4cf219e-0871-81bc-e053-2a95a90a7cda	63545-143	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	6	[hp_C]/1			N	20241231
63545-143_e4cf2621-27ab-106e-e053-2995a90a7bb7	63545-143	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	6	[hp_C]/1			N	20241231
63545-143_e4cf6a72-15ea-63cd-e053-2995a90a7133	63545-143	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	6	[hp_C]/1			N	20241231
63545-144_e4c1202e-5897-34f6-e053-2a95a90aa6b3	63545-144	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	6	[hp_C]/1			N	20241231
63545-144_e4c14fde-12d8-80e9-e053-2a95a90a472a	63545-144	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	6	[hp_C]/1			N	20241231
63545-144_e4c17878-6f7b-5694-e053-2a95a90ab3ed	63545-144	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	6	[hp_C]/1			N	20241231
63545-146_e4a9cd6d-b2b4-447f-e053-2995a90a6471	63545-146	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	6	[hp_C]/1			N	20241231
63545-146_e4aacf5b-095c-5ce2-e053-2995a90ab00a	63545-146	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	6	[hp_C]/1			N	20241231
63545-146_e4aad0a5-1d56-2da4-e053-2a95a90a2e9b	63545-146	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	6	[hp_C]/1			N	20241231
63545-148_dbd8d132-c77d-6bd9-e053-2a95a90a7e0c	63545-148	HUMAN OTC DRUG	Baryta Iodata		Baryta Iodata	PELLET	ORAL	20220404		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM IODIDE	100	[hp_C]/1			N	20241231
63545-150_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-150	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	10	[hp_M]/1			N	20241231
63545-151_bcbbacc5-aadc-58a5-e053-2a95a90a60f0	63545-151	HUMAN OTC DRUG	Argentum Phosphoricum		Argentum Phosphoricum	PELLET	ORAL	20210304		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SILVER PHOSPHATE	1	[hp_Q]/1			N	20241231
63545-152_bccdb6a4-075e-b576-e053-2a95a90aa9dc	63545-152	HUMAN OTC DRUG	Armadillidium Vulgare		Armadillidium Vulgare	PELLET	ORAL	20210305		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARMADILLIDIUM VULGARE WHOLE	6	[hp_C]/1			N	20241231
63545-153_bccdb6a4-075e-b576-e053-2a95a90aa9dc	63545-153	HUMAN OTC DRUG	Armadillidium Vulgare		Armadillidium Vulgare	PELLET	ORAL	20210305		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARMADILLIDIUM VULGARE WHOLE	12	[hp_C]/1			N	20241231
63545-154_bccdb6a4-075e-b576-e053-2a95a90aa9dc	63545-154	HUMAN OTC DRUG	Armadillidium Vulgare		Armadillidium Vulgare	PELLET	ORAL	20210305		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARMADILLIDIUM VULGARE WHOLE	30	[hp_C]/1			N	20241231
63545-155_bccdb6a4-075e-b576-e053-2a95a90aa9dc	63545-155	HUMAN OTC DRUG	Armadillidium Vulgare		Armadillidium Vulgare	PELLET	ORAL	20210305		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARMADILLIDIUM VULGARE WHOLE	100	[hp_C]/1			N	20241231
63545-156_bccdb6a4-075e-b576-e053-2a95a90aa9dc	63545-156	HUMAN OTC DRUG	Armadillidium Vulgare		Armadillidium Vulgare	PELLET	ORAL	20210305		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARMADILLIDIUM VULGARE WHOLE	200	[hp_C]/1			N	20241231
63545-157_bccdb6a4-075e-b576-e053-2a95a90aa9dc	63545-157	HUMAN OTC DRUG	Armadillidium Vulgare		Armadillidium Vulgare	PELLET	ORAL	20210305		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARMADILLIDIUM VULGARE WHOLE	500	[hp_C]/1			N	20241231
63545-158_bccdb6a4-075e-b576-e053-2a95a90aa9dc	63545-158	HUMAN OTC DRUG	Armadillidium Vulgare		Armadillidium Vulgare	PELLET	ORAL	20210305		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARMADILLIDIUM VULGARE WHOLE	1	[hp_M]/1			N	20241231
63545-159_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-159	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	6	[hp_C]/1			N	20241231
63545-160_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-160	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	12	[hp_C]/1			N	20241231
63545-161_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-161	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	30	[hp_C]/1			N	20241231
63545-162_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-162	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	100	[hp_C]/1			N	20241231
63545-163_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-163	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	200	[hp_C]/1			N	20241231
63545-164_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-164	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	500	[hp_C]/1			N	20241231
63545-165_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-165	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	1	[hp_M]/1			N	20241231
63545-166_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-166	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	10	[hp_M]/1			N	20241231
63545-167_bd5fb73e-d129-1b1e-e053-2a95a90a4dea	63545-167	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	PELLET	ORAL	20210312		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARNICA MONTANA	1	[hp_Q]/1			N	20241231
63545-168_be399781-afff-1cb0-e053-2995a90ad25e	63545-168	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	6	[hp_C]/1			N	20241231
63545-169_be399781-afff-1cb0-e053-2995a90ad25e	63545-169	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	12	[hp_C]/1			N	20241231
63545-170_be399781-afff-1cb0-e053-2995a90ad25e	63545-170	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	30	[hp_C]/1			N	20241231
63545-171_be399781-afff-1cb0-e053-2995a90ad25e	63545-171	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	100	[hp_C]/1			N	20241231
63545-172_be399781-afff-1cb0-e053-2995a90ad25e	63545-172	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	200	[hp_C]/1			N	20241231
63545-173_be399781-afff-1cb0-e053-2995a90ad25e	63545-173	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	500	[hp_C]/1			N	20241231
63545-174_be399781-afff-1cb0-e053-2995a90ad25e	63545-174	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	1	[hp_M]/1			N	20241231
63545-175_be399781-afff-1cb0-e053-2995a90ad25e	63545-175	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	10	[hp_M]/1			N	20241231
63545-176_be399781-afff-1cb0-e053-2995a90ad25e	63545-176	HUMAN OTC DRUG	Arsenicum Album		Arsenicum Album	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	10	[hp_Q]/1			N	20241231
63545-177_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-177	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	6	[hp_C]/1			N	20241231
63545-178_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-178	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	12	[hp_C]/1			N	20241231
63545-179_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-179	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	30	[hp_C]/1			N	20241231
63545-180_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-180	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	100	[hp_C]/1			N	20241231
63545-181_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-181	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	200	[hp_C]/1			N	20241231
63545-182_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-182	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	500	[hp_C]/1			N	20241231
63545-183_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-183	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	1	[hp_M]/1			N	20241231
63545-184_be3cd6a2-08fe-c2b5-e053-2995a90aab35	63545-184	HUMAN OTC DRUG	Arsenicum Bromatum		Arsenicum Bromatum	PELLET	ORAL	20210323		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIBROMIDE	10	[hp_M]/1			N	20241231
63545-185_be4d9c00-ccc3-2fe3-e053-2a95a90a99a5	63545-185	HUMAN OTC DRUG	Arsenicum Iodatum		Arsenicum Iodatum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	6	[hp_C]/1			N	20241231
63545-186_be4d9c00-ccc3-2fe3-e053-2a95a90a99a5	63545-186	HUMAN OTC DRUG	Arsenicum Iodatum		Arsenicum Iodatum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	12	[hp_C]/1			N	20241231
63545-187_be4d9c00-ccc3-2fe3-e053-2a95a90a99a5	63545-187	HUMAN OTC DRUG	Arsenicum Iodatum		Arsenicum Iodatum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	30	[hp_C]/1			N	20241231
63545-188_be4d9c00-ccc3-2fe3-e053-2a95a90a99a5	63545-188	HUMAN OTC DRUG	Arsenicum Iodatum		Arsenicum Iodatum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	100	[hp_C]/1			N	20241231
63545-189_be4d9c00-ccc3-2fe3-e053-2a95a90a99a5	63545-189	HUMAN OTC DRUG	Arsenicum Iodatum		Arsenicum Iodatum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	200	[hp_C]/1			N	20241231
63545-190_be4d9c00-ccc3-2fe3-e053-2a95a90a99a5	63545-190	HUMAN OTC DRUG	Arsenicum Iodatum		Arsenicum Iodatum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	500	[hp_C]/1			N	20241231
63545-191_be4d9c00-ccc3-2fe3-e053-2a95a90a99a5	63545-191	HUMAN OTC DRUG	Arsenicum Iodatum		Arsenicum Iodatum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	1	[hp_M]/1			N	20241231
63545-192_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-192	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	6	[hp_C]/1			N	20241231
63545-193_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-193	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	12	[hp_C]/1			N	20241231
63545-194_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-194	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	30	[hp_C]/1			N	20241231
63545-195_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-195	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	100	[hp_C]/1			N	20241231
63545-196_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-196	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	200	[hp_C]/1			N	20241231
63545-197_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-197	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	500	[hp_C]/1			N	20241231
63545-198_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-198	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	1	[hp_M]/1			N	20241231
63545-199_be4fa1bc-fd10-5d9e-e053-2a95a90a3c42	63545-199	HUMAN OTC DRUG	Argentum Metallicum		Argentum Metallicum	PELLET	ORAL	20210324		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIIODIDE	1	[hp_Q]/1			N	20241231
63545-200_be73897a-daf1-313a-e053-2995a90a7aee	63545-200	HUMAN OTC DRUG	Arsenicum Muriaticum		Arsenicum Muriaticum	PELLET	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRICHLORIDE	6	[hp_C]/1			N	20241231
63545-201_be73897a-daf1-313a-e053-2995a90a7aee	63545-201	HUMAN OTC DRUG	Arsenicum Muriaticum		Arsenicum Muriaticum	PELLET	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRICHLORIDE	12	[hp_C]/1			N	20241231
63545-202_be73897a-daf1-313a-e053-2995a90a7aee	63545-202	HUMAN OTC DRUG	Arsenicum Muriaticum		Arsenicum Muriaticum	PELLET	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRICHLORIDE	30	[hp_C]/1			N	20241231
63545-203_be73897a-daf1-313a-e053-2995a90a7aee	63545-203	HUMAN OTC DRUG	Arsenicum Muriaticum		Arsenicum Muriaticum	PELLET	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRICHLORIDE	100	[hp_C]/1			N	20241231
63545-204_be73897a-daf1-313a-e053-2995a90a7aee	63545-204	HUMAN OTC DRUG	Arsenicum Muriaticum		Arsenicum Muriaticum	PELLET	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRICHLORIDE	200	[hp_C]/1			N	20241231
63545-205_be73897a-daf1-313a-e053-2995a90a7aee	63545-205	HUMAN OTC DRUG	Arsenicum Muriaticum		Arsenicum Muriaticum	PELLET	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRICHLORIDE	500	[hp_C]/1			N	20241231
63545-206_be73897a-daf1-313a-e053-2995a90a7aee	63545-206	HUMAN OTC DRUG	Arsenicum Muriaticum		Arsenicum Muriaticum	PELLET	ORAL	20210326		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRICHLORIDE	1	[hp_M]/1			N	20241231
63545-207_be792c50-2d63-45ca-e053-2a95a90abd1b	63545-207	HUMAN OTC DRUG	Arsenicum Oxydatum		Arsenicum Oxydatum	PELLET	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	6	[hp_C]/1			N	20241231
63545-208_be792c50-2d63-45ca-e053-2a95a90abd1b	63545-208	HUMAN OTC DRUG	Arsenicum Oxydatum		Arsenicum Oxydatum	PELLET	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	12	[hp_C]/1			N	20241231
63545-209_be792c50-2d63-45ca-e053-2a95a90abd1b	63545-209	HUMAN OTC DRUG	Arsenicum Oxydatum		Arsenicum Oxydatum	PELLET	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	30	[hp_C]/1			N	20241231
63545-210_be792c50-2d63-45ca-e053-2a95a90abd1b	63545-210	HUMAN OTC DRUG	Arsenicum Oxydatum		Arsenicum Oxydatum	PELLET	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	100	[hp_C]/1			N	20241231
63545-211_be792c50-2d63-45ca-e053-2a95a90abd1b	63545-211	HUMAN OTC DRUG	Arsenicum Oxydatum		Arsenicum Oxydatum	PELLET	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	200	[hp_C]/1			N	20241231
63545-212_be792c50-2d63-45ca-e053-2a95a90abd1b	63545-212	HUMAN OTC DRUG	Arsenicum Oxydatum		Arsenicum Oxydatum	PELLET	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	500	[hp_C]/1			N	20241231
63545-213_be792c50-2d63-45ca-e053-2a95a90abd1b	63545-213	HUMAN OTC DRUG	Arsenicum Oxydatum		Arsenicum Oxydatum	PELLET	ORAL	20210329		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRIOXIDE	1	[hp_M]/1			N	20241231
63545-214_beb36c22-2021-eba1-e053-2a95a90aef7e	63545-214	HUMAN OTC DRUG	Arsenicum Sulphuratum Flavum		Arsenicum Sulphuratum Flavum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRISULFIDE	6	[hp_C]/1			N	20241231
63545-215_beb36c22-2021-eba1-e053-2a95a90aef7e	63545-215	HUMAN OTC DRUG	Arsenicum Sulphuratum Flavum		Arsenicum Sulphuratum Flavum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRISULFIDE	12	[hp_C]/1			N	20241231
63545-216_beb36c22-2021-eba1-e053-2a95a90aef7e	63545-216	HUMAN OTC DRUG	Arsenicum Sulphuratum Flavum		Arsenicum Sulphuratum Flavum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRISULFIDE	30	[hp_C]/1			N	20241231
63545-217_beb36c22-2021-eba1-e053-2a95a90aef7e	63545-217	HUMAN OTC DRUG	Arsenicum Sulphuratum Flavum		Arsenicum Sulphuratum Flavum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRISULFIDE	100	[hp_C]/1			N	20241231
63545-218_beb36c22-2021-eba1-e053-2a95a90aef7e	63545-218	HUMAN OTC DRUG	Arsenicum Sulphuratum Flavum		Arsenicum Sulphuratum Flavum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRISULFIDE	200	[hp_C]/1			N	20241231
63545-219_beb36c22-2021-eba1-e053-2a95a90aef7e	63545-219	HUMAN OTC DRUG	Arsenicum Sulphuratum Flavum		Arsenicum Sulphuratum Flavum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRISULFIDE	500	[hp_C]/1			N	20241231
63545-220_beb36c22-2021-eba1-e053-2a95a90aef7e	63545-220	HUMAN OTC DRUG	Arsenicum Sulphuratum Flavum		Arsenicum Sulphuratum Flavum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC TRISULFIDE	1	[hp_M]/1			N	20241231
63545-221_be617141-751d-fdef-e053-2995a90a81a9	63545-221	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	6	[hp_C]/1			N	20241231
63545-222_be617141-751d-fdef-e053-2995a90a81a9	63545-222	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	12	[hp_C]/1			N	20241231
63545-223_be617141-751d-fdef-e053-2995a90a81a9	63545-223	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	30	[hp_C]/1			N	20241231
63545-224_be617141-751d-fdef-e053-2995a90a81a9	63545-224	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	100	[hp_C]/1			N	20241231
63545-226_be617141-751d-fdef-e053-2995a90a81a9	63545-226	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	200	[hp_C]/1			N	20241231
63545-227_be617141-751d-fdef-e053-2995a90a81a9	63545-227	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	500	[hp_C]/1			N	20241231
63545-228_be617141-751d-fdef-e053-2995a90a81a9	63545-228	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	1	[hp_M]/1			N	20241231
63545-229_be617141-751d-fdef-e053-2995a90a81a9	63545-229	HUMAN OTC DRUG	Arsenicum Metallicum		Arsenicum Metallicum	PELLET	ORAL	20210325		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARSENIC	1	[hp_Q]/1			N	20241231
63545-230_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-230	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	12	[hp_C]/1			N	20241231
63545-231_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-231	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	30	[hp_C]/1			N	20241231
63545-232_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-232	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	100	[hp_C]/1			N	20241231
63545-233_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-233	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	200	[hp_C]/1			N	20241231
63545-234_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-234	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	500	[hp_C]/1			N	20241231
63545-235_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-235	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	1	[hp_M]/1			N	20241231
63545-236_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-236	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	10	[hp_M]/1			N	20241231
63545-237_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-237	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	1	[hp_Q]/1			N	20241231
63545-238_bec7439c-1a48-2acf-e053-2995a90a5a51	63545-238	HUMAN OTC DRUG	Artemisia Vulgaris		Artemisia Vulgaris	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA VULGARIS ROOT	6	[hp_C]/1			N	20241231
63545-239_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-239	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	6	[hp_C]/1			N	20241231
63545-240_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-240	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	12	[hp_C]/1			N	20241231
63545-241_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-241	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	30	[hp_C]/1			N	20241231
63545-242_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-242	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	100	[hp_C]/1			N	20241231
63545-243_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-243	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	200	[hp_C]/1			N	20241231
63545-244_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-244	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	500	[hp_C]/1			N	20241231
63545-245_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-245	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	1	[hp_M]/1			N	20241231
63545-246_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-246	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	10	[hp_M]/1			N	20241231
63545-247_bec94aeb-6dd8-404d-e053-2995a90a8d5c	63545-247	HUMAN OTC DRUG	Arum Triphyllum		Arum Triphyllum	PELLET	ORAL	20210330		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARISAEMA TRIPHYLLUM ROOT	1	[hp_Q]/1			N	20241231
63545-248_bed9a389-db59-1301-e053-2995a90a3577	63545-248	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	6	[hp_C]/1			N	20241231
63545-249_bed9a389-db59-1301-e053-2995a90a3577	63545-249	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	12	[hp_C]/1			N	20241231
63545-250_bed9a389-db59-1301-e053-2995a90a3577	63545-250	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	30	[hp_C]/1			N	20241231
63545-251_bed9a389-db59-1301-e053-2995a90a3577	63545-251	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	100	[hp_C]/1			N	20241231
63545-252_bed9a389-db59-1301-e053-2995a90a3577	63545-252	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	200	[hp_C]/1			N	20241231
63545-253_bed9a389-db59-1301-e053-2995a90a3577	63545-253	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	500	[hp_C]/1			N	20241231
63545-254_bed9a389-db59-1301-e053-2995a90a3577	63545-254	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	1	[hp_M]/1			N	20241231
63545-255_bed9a389-db59-1301-e053-2995a90a3577	63545-255	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	10	[hp_M]/1			N	20241231
63545-256_bed9a389-db59-1301-e053-2995a90a3577	63545-256	HUMAN OTC DRUG	Arundo Mauritanica		Arundo Mauritanica	PELLET	ORAL	20210331		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARUNDO PLINIANA ROOT	1	[hp_Q]/1			N	20241231
63545-257_beee19c9-1487-d594-e053-2a95a90abc4d	63545-257	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	6	[hp_C]/1			N	20241231
63545-258_e4c18848-de84-fc71-e053-2a95a90acb51	63545-258	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	7	[hp_C]/1			N	20241231
63545-258_e4c18f7b-72b5-5b9c-e053-2995a90ad22c	63545-258	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	7	[hp_C]/1			N	20241231
63545-258_e4c1906b-76b6-4a88-e053-2995a90aa344	63545-258	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	7	[hp_C]/1			N	20241231
63545-259_e4a8aee6-ff83-9dd1-e053-2a95a90a5fbc	63545-259	HUMAN OTC DRUG	Agraphis nutans		Agraphis nutans	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	HYACINTHOIDES NON-SCRIPTA	6	[hp_C]/1			N	20241231
63545-259_e4a8aff3-72f2-837e-e053-2a95a90a9a5f	63545-259	HUMAN OTC DRUG	Agraphis nutans		Agraphis nutans	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	HYACINTHOIDES NON-SCRIPTA	6	[hp_C]/1			N	20241231
63545-259_e4a8b194-caee-1ce6-e053-2995a90abdcb	63545-259	HUMAN OTC DRUG	Agraphis nutans		Agraphis nutans	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	HYACINTHOIDES NON-SCRIPTA	6	[hp_C]/1			N	20241231
63545-260_beee19c9-1487-d594-e053-2a95a90abc4d	63545-260	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	30	[hp_C]/1			N	20241231
63545-261_beee19c9-1487-d594-e053-2a95a90abc4d	63545-261	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	100	[hp_C]/1			N	20241231
63545-262_beee19c9-1487-d594-e053-2a95a90abc4d	63545-262	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	200	[hp_C]/1			N	20241231
63545-263_beee19c9-1487-d594-e053-2a95a90abc4d	63545-263	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	500	[hp_C]/1			N	20241231
63545-264_beee19c9-1487-d594-e053-2a95a90abc4d	63545-264	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	1	[hp_M]/1			N	20241231
63545-265_beee19c9-1487-d594-e053-2a95a90abc4d	63545-265	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	10	[hp_M]/1			N	20241231
63545-266_beee19c9-1487-d594-e053-2a95a90abc4d	63545-266	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	1	[hp_Q]/1			N	20241231
63545-267_beee19c9-1487-d594-e053-2a95a90abc4d	63545-267	HUMAN OTC DRUG	Asafortida		Asafortida	PELLET	ORAL	20210401		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASAFETIDA	12	[hp_C]/1			N	20241231
63545-268_bef18dfa-8756-48eb-e053-2995a90af8da	63545-268	HUMAN OTC DRUG	Asarum Europaeum		Asarum Europaeum	PELLET	ORAL	20210402		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASARUM EUROPAEUM	6	[hp_C]/1			N	20241231
63545-269_bef18dfa-8756-48eb-e053-2995a90af8da	63545-269	HUMAN OTC DRUG	Asarum Europaeum		Asarum Europaeum	PELLET	ORAL	20210402		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASARUM EUROPAEUM	12	[hp_C]/1			N	20241231
63545-270_bef18dfa-8756-48eb-e053-2995a90af8da	63545-270	HUMAN OTC DRUG	Asarum Europaeum		Asarum Europaeum	PELLET	ORAL	20210402		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASARUM EUROPAEUM	30	[hp_C]/1			N	20241231
63545-271_bef18dfa-8756-48eb-e053-2995a90af8da	63545-271	HUMAN OTC DRUG	Asarum Europaeum		Asarum Europaeum	PELLET	ORAL	20210402		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASARUM EUROPAEUM	100	[hp_C]/1			N	20241231
63545-272_bef18dfa-8756-48eb-e053-2995a90af8da	63545-272	HUMAN OTC DRUG	Asarum Europaeum		Asarum Europaeum	PELLET	ORAL	20210402		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASARUM EUROPAEUM	200	[hp_C]/1			N	20241231
63545-273_bef18dfa-8756-48eb-e053-2995a90af8da	63545-273	HUMAN OTC DRUG	Asarum Europaeum		Asarum Europaeum	PELLET	ORAL	20210402		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASARUM EUROPAEUM	500	[hp_C]/1			N	20241231
63545-274_bef18dfa-8756-48eb-e053-2995a90af8da	63545-274	HUMAN OTC DRUG	Asarum Europaeum		Asarum Europaeum	PELLET	ORAL	20210402		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASARUM EUROPAEUM	1	[hp_M]/1			N	20241231
63545-275_bf7a265b-63b9-4289-e053-2995a90af970	63545-275	HUMAN OTC DRUG	Asparagus Officinalis		Asparagus Officinalis	PELLET	ORAL	20210408		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASPARAGUS	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
63545-276_bf7a265b-63b9-4289-e053-2995a90af970	63545-276	HUMAN OTC DRUG	Asparagus Officinalis		Asparagus Officinalis	PELLET	ORAL	20210408		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASPARAGUS	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
63545-277_bf7a265b-63b9-4289-e053-2995a90af970	63545-277	HUMAN OTC DRUG	Asparagus Officinalis		Asparagus Officinalis	PELLET	ORAL	20210408		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASPARAGUS	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
63545-278_bf7a265b-63b9-4289-e053-2995a90af970	63545-278	HUMAN OTC DRUG	Asparagus Officinalis		Asparagus Officinalis	PELLET	ORAL	20210408		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASPARAGUS	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
63545-279_bf7a265b-63b9-4289-e053-2995a90af970	63545-279	HUMAN OTC DRUG	Asparagus Officinalis		Asparagus Officinalis	PELLET	ORAL	20210408		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASPARAGUS	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
63545-280_bf7a265b-63b9-4289-e053-2995a90af970	63545-280	HUMAN OTC DRUG	Asparagus Officinalis		Asparagus Officinalis	PELLET	ORAL	20210408		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASPARAGUS	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
63545-281_bf7a265b-63b9-4289-e053-2995a90af970	63545-281	HUMAN OTC DRUG	Asparagus Officinalis		Asparagus Officinalis	PELLET	ORAL	20210408		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASPARAGUS	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
63545-282_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-282	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	6	[hp_C]/1			N	20241231
63545-283_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-283	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	12	[hp_C]/1			N	20241231
63545-284_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-284	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	30	[hp_C]/1			N	20241231
63545-285_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-285	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	100	[hp_C]/1			N	20241231
63545-287_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-287	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	200	[hp_C]/1			N	20241231
63545-288_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-288	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	500	[hp_C]/1			N	20241231
63545-289_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-289	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	1	[hp_M]/1			N	20241231
63545-290_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-290	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	10	[hp_M]/1			N	20241231
63545-291_bf8eac85-9e9a-8ba8-e053-2995a90aa69e	63545-291	HUMAN OTC DRUG	Asterias Rubens		Asterias Rubens	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ASTERIAS RUBENS	1	[hp_Q]/1			N	20241231
63545-292_bf8faf69-43c8-86c2-e053-2a95a90ad29a	63545-292	HUMAN OTC DRUG	Aurum Bromatum		Aurum Bromatum	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRIBROMIDE	6	[hp_C]/1			N	20241231
63545-293_bf8faf69-43c8-86c2-e053-2a95a90ad29a	63545-293	HUMAN OTC DRUG	Aurum Bromatum		Aurum Bromatum	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRIBROMIDE	12	[hp_C]/1			N	20241231
63545-294_bf8faf69-43c8-86c2-e053-2a95a90ad29a	63545-294	HUMAN OTC DRUG	Aurum Bromatum		Aurum Bromatum	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRIBROMIDE	30	[hp_C]/1			N	20241231
63545-295_bf8faf69-43c8-86c2-e053-2a95a90ad29a	63545-295	HUMAN OTC DRUG	Aurum Bromatum		Aurum Bromatum	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRIBROMIDE	100	[hp_C]/1			N	20241231
63545-296_bf8faf69-43c8-86c2-e053-2a95a90ad29a	63545-296	HUMAN OTC DRUG	Aurum Bromatum		Aurum Bromatum	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRIBROMIDE	200	[hp_C]/1			N	20241231
63545-297_bf8faf69-43c8-86c2-e053-2a95a90ad29a	63545-297	HUMAN OTC DRUG	Aurum Bromatum		Aurum Bromatum	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRIBROMIDE	500	[hp_C]/1			N	20241231
63545-298_bf8faf69-43c8-86c2-e053-2a95a90ad29a	63545-298	HUMAN OTC DRUG	Aurum Bromatum		Aurum Bromatum	PELLET	ORAL	20210409		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRIBROMIDE	1	[hp_M]/1			N	20241231
63545-299_bfdefc20-4949-6156-e053-2995a90a77cb	63545-299	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-300_bfdefc20-4949-6156-e053-2995a90a77cb	63545-300	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-301_bfdefc20-4949-6156-e053-2995a90a77cb	63545-301	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-302_bfdefc20-4949-6156-e053-2995a90a77cb	63545-302	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-303_bfdefc20-4949-6156-e053-2995a90a77cb	63545-303	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-304_bfdefc20-4949-6156-e053-2995a90a77cb	63545-304	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-305_bfdefc20-4949-6156-e053-2995a90a77cb	63545-305	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-306_bfdefc20-4949-6156-e053-2995a90a77cb	63545-306	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	10	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-307_bfdefc20-4949-6156-e053-2995a90a77cb	63545-307	HUMAN OTC DRUG	Aurum Metallicum		Aurum Metallicum	PELLET	ORAL	20210413		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD	1	[hp_Q]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63545-308_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-308	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	6	[hp_C]/1			N	20241231
63545-309_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-309	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	12	[hp_C]/1			N	20241231
63545-310_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-310	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	30	[hp_C]/1			N	20241231
63545-311_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-311	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	100	[hp_C]/1			N	20241231
63545-312_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-312	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	200	[hp_C]/1			N	20241231
63545-313_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-313	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	500	[hp_C]/1			N	20241231
63545-314_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-314	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	1	[hp_M]/1			N	20241231
63545-315_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-315	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	10	[hp_M]/1			N	20241231
63545-316_c006e0d7-db41-aac7-e053-2995a90ab0e4	63545-316	HUMAN OTC DRUG	Aurum Muriaticum		Aurum Muriaticum	PELLET	ORAL	20210415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	GOLD TRICHLORIDE	1	[hp_Q]/1			N	20241231
63545-317_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-317	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	6	[hp_C]/1			N	20241231
63545-318_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-318	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	12	[hp_C]/1			N	20241231
63545-319_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-319	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	30	[hp_C]/1			N	20241231
63545-320_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-320	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	100	[hp_C]/1			N	20241231
63545-321_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-321	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	200	[hp_C]/1			N	20241231
63545-322_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-322	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	500	[hp_C]/1			N	20241231
63545-323_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-323	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	1	[hp_M]/1			N	20241231
63545-324_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-324	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	10	[hp_M]/1			N	20241231
63545-325_c00b6a08-8838-83ab-e053-2a95a90a6213	63545-325	HUMAN OTC DRUG	Aurum Muriaticum Natronatum		Aurum Muriaticum Natronatum	PELLET	ORAL	20210416		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SODIUM TETRACHLOROAURATE	1	[hp_Q]/1			N	20241231
63545-326_deabf506-f746-eec0-e053-2a95a90a0f62	63545-326	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	6	[hp_C]/1			N	20241231
63545-327_deabf506-f746-eec0-e053-2a95a90a0f62	63545-327	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	12	[hp_C]/1			N	20241231
63545-328_deabf506-f746-eec0-e053-2a95a90a0f62	63545-328	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	30	[hp_C]/1			N	20241231
63545-329_deabf506-f746-eec0-e053-2a95a90a0f62	63545-329	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	100	[hp_C]/1			N	20241231
63545-330_deabf506-f746-eec0-e053-2a95a90a0f62	63545-330	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	200	[hp_C]/1			N	20241231
63545-331_deabf506-f746-eec0-e053-2a95a90a0f62	63545-331	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	500	[hp_C]/1			N	20241231
63545-332_deabf506-f746-eec0-e053-2a95a90a0f62	63545-332	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	1	[hp_M]/1			N	20241231
63545-333_deabf506-f746-eec0-e053-2a95a90a0f62	63545-333	HUMAN OTC DRUG	Bromoethanum		Bromoethanum	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMOETHANE	1	[hp_Q]/1			N	20241231
63545-334_e4c24865-1ae0-1fee-e053-2a95a90aeca4	63545-334	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	6	[hp_C]/1			N	20241231
63545-334_e4ce4e72-e163-2629-e053-2995a90ab010	63545-334	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	6	[hp_C]/1			N	20241231
63545-334_e4ce4f86-e3b6-f7df-e053-2a95a90a0cdd	63545-334	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	6	[hp_C]/1			N	20241231
63545-345_c50e45f6-6d8c-7582-e053-2a95a90a951d	63545-345	HUMAN OTC DRUG	Badiaga		Badiaga	PELLET	ORAL	20210618		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SPONGILLA LACUSTRIS	6	[hp_C]/1			N	20241231
63545-346_c50e45f6-6d8c-7582-e053-2a95a90a951d	63545-346	HUMAN OTC DRUG	Badiaga		Badiaga	PELLET	ORAL	20210618		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SPONGILLA LACUSTRIS	12	[hp_C]/1			N	20241231
63545-347_c50e45f6-6d8c-7582-e053-2a95a90a951d	63545-347	HUMAN OTC DRUG	Badiaga		Badiaga	PELLET	ORAL	20210618		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SPONGILLA LACUSTRIS	30	[hp_C]/1			N	20241231
63545-348_c50e45f6-6d8c-7582-e053-2a95a90a951d	63545-348	HUMAN OTC DRUG	Badiaga		Badiaga	PELLET	ORAL	20210618		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SPONGILLA LACUSTRIS	100	[hp_C]/1			N	20241231
63545-349_c50e45f6-6d8c-7582-e053-2a95a90a951d	63545-349	HUMAN OTC DRUG	Badiaga		Badiaga	PELLET	ORAL	20210618		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SPONGILLA LACUSTRIS	200	[hp_C]/1			N	20241231
63545-350_c50e45f6-6d8c-7582-e053-2a95a90a951d	63545-350	HUMAN OTC DRUG	Badiaga		Badiaga	PELLET	ORAL	20210618		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SPONGILLA LACUSTRIS	500	[hp_C]/1			N	20241231
63545-351_c50e45f6-6d8c-7582-e053-2a95a90a951d	63545-351	HUMAN OTC DRUG	Badiaga		Badiaga	PELLET	ORAL	20210618		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SPONGILLA LACUSTRIS	1	[hp_M]/1			N	20241231
63545-352_c562c423-70e5-0953-e053-2a95a90a6681	63545-352	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	6	[hp_C]/1			N	20241231
63545-353_c562c423-70e5-0953-e053-2a95a90a6681	63545-353	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	12	[hp_C]/1			N	20241231
63545-354_c562c423-70e5-0953-e053-2a95a90a6681	63545-354	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	30	[hp_C]/1			N	20241231
63545-355_c562c423-70e5-0953-e053-2a95a90a6681	63545-355	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	100	[hp_C]/1			N	20241231
63545-356_c562c423-70e5-0953-e053-2a95a90a6681	63545-356	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	200	[hp_C]/1			N	20241231
63545-357_c562c423-70e5-0953-e053-2a95a90a6681	63545-357	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	500	[hp_C]/1			N	20241231
63545-358_c562c423-70e5-0953-e053-2a95a90a6681	63545-358	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	1	[hp_M]/1			N	20241231
63545-359_c562c423-70e5-0953-e053-2a95a90a6681	63545-359	HUMAN OTC DRUG	Baptisia Tinctoria		Baptisia Tinctoria	PELLET	ORAL	20210622		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BAPTISIA TINCTORIA ROOT	10	[hp_M]/1			N	20241231
63545-360_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-360	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	6	[hp_C]/1			N	20241231
63545-361_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-361	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	12	[hp_C]/1			N	20241231
63545-362_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-362	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	30	[hp_C]/1			N	20241231
63545-363_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-363	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	100	[hp_C]/1			N	20241231
63545-364_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-364	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	200	[hp_C]/1			N	20241231
63545-365_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-365	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	500	[hp_C]/1			N	20241231
63545-366_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-366	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	10	[hp_M]/1			N	20241231
63545-367_c5ed8d49-50e3-3c97-e053-2995a90a151e	63545-367	HUMAN OTC DRUG	Baryta Acetica		Baryta Acetica	PELLET	ORAL	20210629		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM ACETATE	1	[hp_M]/1			N	20241231
63545-368_c678646e-8b07-4af4-e053-2a95a90a028e	63545-368	HUMAN OTC DRUG	Baryta Bromata		Baryta Bromata	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM BROMIDE	6	[hp_C]/1			N	20241231
63545-369_c678646e-8b07-4af4-e053-2a95a90a028e	63545-369	HUMAN OTC DRUG	Baryta Bromata		Baryta Bromata	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM BROMIDE	12	[hp_C]/1			N	20241231
63545-370_c678646e-8b07-4af4-e053-2a95a90a028e	63545-370	HUMAN OTC DRUG	Baryta Bromata		Baryta Bromata	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM BROMIDE	30	[hp_C]/1			N	20241231
63545-371_c678646e-8b07-4af4-e053-2a95a90a028e	63545-371	HUMAN OTC DRUG	Baryta Bromata		Baryta Bromata	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM BROMIDE	100	[hp_C]/1			N	20241231
63545-372_c678646e-8b07-4af4-e053-2a95a90a028e	63545-372	HUMAN OTC DRUG	Baryta Bromata		Baryta Bromata	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM BROMIDE	200	[hp_C]/1			N	20241231
63545-373_c678646e-8b07-4af4-e053-2a95a90a028e	63545-373	HUMAN OTC DRUG	Baryta Bromata		Baryta Bromata	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM BROMIDE	500	[hp_C]/1			N	20241231
63545-374_c678646e-8b07-4af4-e053-2a95a90a028e	63545-374	HUMAN OTC DRUG	Baryta Bromata		Baryta Bromata	PELLET	ORAL	20210706		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	BARIUM BROMIDE	1	[hp_M]/1			N	20241231
63545-375_db4ade79-da96-19d8-e053-2995a90aabfa	63545-375	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	6	[hp_C]/1			N	20241231
63545-376_db4ade79-da96-19d8-e053-2995a90aabfa	63545-376	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	12	[hp_C]/1			N	20241231
63545-377_db4ade79-da96-19d8-e053-2995a90aabfa	63545-377	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	30	[hp_C]/1			N	20241231
63545-378_db4ade79-da96-19d8-e053-2995a90aabfa	63545-378	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	100	[hp_C]/1			N	20241231
63545-379_db4ade79-da96-19d8-e053-2995a90aabfa	63545-379	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	200	[hp_C]/1			N	20241231
63545-380_db4ade79-da96-19d8-e053-2995a90aabfa	63545-380	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	500	[hp_C]/1			N	20241231
63545-381_db4ade79-da96-19d8-e053-2995a90aabfa	63545-381	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	1	[hp_M]/1			N	20241231
63545-382_e4be7f54-173c-68c0-e053-2a95a90af40c	63545-382	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	6	[hp_C]/1			N	20241231
63545-382_e4be8399-5694-ab0e-e053-2a95a90a99cc	63545-382	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	6	[hp_C]/1			N	20241231
63545-382_e4be8399-5695-ab0e-e053-2a95a90a99cc	63545-382	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	6	[hp_C]/1			N	20241231
63545-384_db4ade79-da96-19d8-e053-2995a90aabfa	63545-384	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	10	[hp_M]/1			N	20241231
63545-392_db4ade79-da96-19d8-e053-2995a90aabfa	63545-392	HUMAN OTC DRUG	Baryta Carbonica		Baryta Carbonica	PELLET	ORAL	20220328		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc	BARIUM CARBONATE	1	[hp_Q]/1			N	20241231
63545-393_dbd8d132-c77d-6bd9-e053-2a95a90a7e0c	63545-393	HUMAN OTC DRUG	Baryta Iodata		Baryta Iodata	PELLET	ORAL	20220404		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM IODIDE	500	[hp_C]/1			N	20241231
63545-394_dbd8d132-c77d-6bd9-e053-2a95a90a7e0c	63545-394	HUMAN OTC DRUG	Baryta Iodata		Baryta Iodata	PELLET	ORAL	20220404		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM IODIDE	1	[hp_M]/1			N	20241231
63545-395_dbd8d132-c77d-6bd9-e053-2a95a90a7e0c	63545-395	HUMAN OTC DRUG	Baryta Iodata		Baryta Iodata	PELLET	ORAL	20220404		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM IODIDE	10	[hp_M]/1			N	20241231
63545-396_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-396	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	6	[hp_C]/1			N	20241231
63545-397_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-397	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	12	[hp_C]/1			N	20241231
63545-398_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-398	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	30	[hp_C]/1			N	20241231
63545-399_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-399	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	100	[hp_C]/1			N	20241231
63545-400_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-400	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	200	[hp_C]/1			N	20241231
63545-401_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-401	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	500	[hp_C]/1			N	20241231
63545-402_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-402	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	1	[hp_M]/1			N	20241231
63545-403_dc008fe6-c862-5a7f-e053-2995a90ac709	63545-403	HUMAN OTC DRUG	Baryta Muriatica		Baryta Muriatica	PELLET	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC	BARIUM CHLORIDE DIHYDRATE	1	[hp_M]/1			N	20241231
63545-404_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-404	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	6	[hp_C]/1			N	20241231
63545-405_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-405	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	12	[hp_C]/1			N	20241231
63545-406_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-406	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	30	[hp_C]/1			N	20241231
63545-407_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-407	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	100	[hp_C]/1			N	20241231
63545-408_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-408	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	200	[hp_C]/1			N	20241231
63545-409_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-409	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	500	[hp_C]/1			N	20241231
63545-410_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-410	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	1	[hp_M]/1			N	20241231
63545-411_dcb6b2b7-9d3d-b74b-e053-2995a90a3196	63545-411	HUMAN OTC DRUG	Baryta Phosphorica		Baryta Phosphorica	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BARIUM PHOSPHATE, DIBASIC	1	[hp_Q]/1			N	20241231
63545-412_dc15962b-4af0-f049-e053-2995a90ab195	63545-412	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	6	[hp_C]/1			N	20241231
63545-413_dc15962b-4af0-f049-e053-2995a90ab195	63545-413	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	12	[hp_C]/1			N	20241231
63545-414_dc15962b-4af0-f049-e053-2995a90ab195	63545-414	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	30	[hp_C]/1			N	20241231
63545-415_dc15962b-4af0-f049-e053-2995a90ab195	63545-415	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	100	[hp_C]/1			N	20241231
63545-416_dc15962b-4af0-f049-e053-2995a90ab195	63545-416	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	200	[hp_C]/1			N	20241231
63545-417_dc15962b-4af0-f049-e053-2995a90ab195	63545-417	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	500	[hp_C]/1			N	20241231
63545-418_dc15962b-4af0-f049-e053-2995a90ab195	63545-418	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	1	[hp_M]/1			N	20241231
63545-419_dc15962b-4af0-f049-e053-2995a90ab195	63545-419	HUMAN OTC DRUG	Belladonna		Belladonna	PELLET	ORAL	20220407		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	ATROPA BELLADONNA	1	[hp_Q]/1			N	20241231
63545-420_dc676835-31dc-5131-e053-2995a90ae26d	63545-420	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	6	[hp_C]/1			N	20241231
63545-421_dc676835-31dc-5131-e053-2995a90ae26d	63545-421	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	12	[hp_C]/1			N	20241231
63545-422_dc676835-31dc-5131-e053-2995a90ae26d	63545-422	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	30	[hp_C]/1			N	20241231
63545-423_dc676835-31dc-5131-e053-2995a90ae26d	63545-423	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	100	[hp_C]/1			N	20241231
63545-424_dc676835-31dc-5131-e053-2995a90ae26d	63545-424	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	200	[hp_C]/1			N	20241231
63545-425_dc676835-31dc-5131-e053-2995a90ae26d	63545-425	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	500	[hp_C]/1			N	20241231
63545-426_dc676835-31dc-5131-e053-2995a90ae26d	63545-426	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	1	[hp_M]/1			N	20241231
63545-427_dc676835-31dc-5131-e053-2995a90ae26d	63545-427	HUMAN OTC DRUG	Bellis Perennis		Bellis Perennis	PELLET	ORAL	20220411		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BELLIS PERENNIS	1	[hp_Q]/1			N	20241231
63545-428_dca1f84c-4440-61ba-e053-2995a90a618a	63545-428	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	6	[hp_C]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-429_dca1f84c-4440-61ba-e053-2995a90a618a	63545-429	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	12	[hp_C]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-430_dca1f84c-4440-61ba-e053-2995a90a618a	63545-430	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	30	[hp_C]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-431_dca1f84c-4440-61ba-e053-2995a90a618a	63545-431	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	100	[hp_C]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-432_dca1f84c-4440-61ba-e053-2995a90a618a	63545-432	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	200	[hp_C]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-433_dca1f84c-4440-61ba-e053-2995a90a618a	63545-433	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	500	[hp_C]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-434_dca1f84c-4440-61ba-e053-2995a90a618a	63545-434	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	1	[hp_M]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-435_dca1f84c-4440-61ba-e053-2995a90a618a	63545-435	HUMAN OTC DRUG	Acidum Benzoicum		Acidum Benzoicum	PELLET	ORAL	20220414		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BENZOIC ACID	10	[hp_M]/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
63545-436_dcb4954f-b634-890e-e053-2a95a90a304f	63545-436	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	6	[hp_C]/1			N	20241231
63545-437_dcb4954f-b634-890e-e053-2a95a90a304f	63545-437	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	12	[hp_C]/1			N	20241231
63545-438_dcb4954f-b634-890e-e053-2a95a90a304f	63545-438	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	30	[hp_C]/1			N	20241231
63545-439_dcb4954f-b634-890e-e053-2a95a90a304f	63545-439	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	100	[hp_C]/1			N	20241231
63545-440_dcb4954f-b634-890e-e053-2a95a90a304f	63545-440	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	200	[hp_C]/1			N	20241231
63545-441_dcb4954f-b634-890e-e053-2a95a90a304f	63545-441	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	500	[hp_C]/1			N	20241231
63545-442_dcb4954f-b634-890e-e053-2a95a90a304f	63545-442	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	1	[hp_M]/1			N	20241231
63545-443_dcb4954f-b634-890e-e053-2a95a90a304f	63545-443	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	10	[hp_M]/1			N	20241231
63545-444_dcb4954f-b634-890e-e053-2a95a90a304f	63545-444	HUMAN OTC DRUG	Berberis Vulgaris		Berberis Vulgaris	PELLET	ORAL	20220415		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERBERIS VULGARIS ROOT BARK	1	[hp_Q]/1			N	20241231
63545-445_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-445	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	6	[hp_C]/1			N	20241231
63545-446_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-446	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	12	[hp_C]/1			N	20241231
63545-447_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-447	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	30	[hp_C]/1			N	20241231
63545-448_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-448	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	100	[hp_C]/1			N	20241231
63545-449_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-449	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	200	[hp_C]/1			N	20241231
63545-450_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-450	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	500	[hp_C]/1			N	20241231
63545-451_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-451	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	1	[hp_M]/1			N	20241231
63545-452_dd1b5fdf-b6a5-4040-e053-2a95a90aa761	63545-452	HUMAN OTC DRUG	Beryllium Fluoratum		Beryllium Fluoratum	PELLET	ORAL	20220420		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM FLUORIDE	1	[hp_Q]/1			N	20241231
63545-453_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-453	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	6	[hp_C]/1			N	20241231
63545-454_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-454	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	12	[hp_C]/1			N	20241231
63545-455_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-455	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	30	[hp_C]/1			N	20241231
63545-456_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-456	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	100	[hp_C]/1			N	20241231
63545-457_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-457	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	200	[hp_C]/1			N	20241231
63545-458_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-458	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	500	[hp_C]/1			N	20241231
63545-459_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-459	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	1	[hp_M]/1			N	20241231
63545-460_dd7f3a93-e549-0b64-e053-2a95a90a5495	63545-460	HUMAN OTC DRUG	Beryllium Metallicum		Beryllium Metallicum	PELLET	ORAL	20220425		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM	1	[hp_Q]/1			N	20241231
63545-461_dec096db-f7bd-4b77-e053-2995a90a06a5	63545-461	HUMAN OTC DRUG	Carum Carvi		Carum Carvi	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARAWAY SEED	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63545-462_dec096db-f7bd-4b77-e053-2995a90a06a5	63545-462	HUMAN OTC DRUG	Carum Carvi		Carum Carvi	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARAWAY SEED	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63545-463_dec096db-f7bd-4b77-e053-2995a90a06a5	63545-463	HUMAN OTC DRUG	Carum Carvi		Carum Carvi	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARAWAY SEED	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63545-464_dec096db-f7bd-4b77-e053-2995a90a06a5	63545-464	HUMAN OTC DRUG	Carum Carvi		Carum Carvi	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARAWAY SEED	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63545-465_dec096db-f7bd-4b77-e053-2995a90a06a5	63545-465	HUMAN OTC DRUG	Carum Carvi		Carum Carvi	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARAWAY SEED	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63545-466_dec096db-f7bd-4b77-e053-2995a90a06a5	63545-466	HUMAN OTC DRUG	Carum Carvi		Carum Carvi	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARAWAY SEED	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63545-467_dec096db-f7bd-4b77-e053-2995a90a06a5	63545-467	HUMAN OTC DRUG	Carum Carvi		Carum Carvi	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CARAWAY SEED	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
63545-468_dda77625-f9bb-d8dc-e053-2995a90a41a0	63545-468	HUMAN OTC DRUG	Beryllium Oxydatum		Beryllium Oxydatum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM OXYACETATE	6	[hp_C]/1			N	20241231
63545-469_dda77625-f9bb-d8dc-e053-2995a90a41a0	63545-469	HUMAN OTC DRUG	Beryllium Oxydatum		Beryllium Oxydatum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM OXYACETATE	12	[hp_C]/1			N	20241231
63545-470_dda77625-f9bb-d8dc-e053-2995a90a41a0	63545-470	HUMAN OTC DRUG	Beryllium Oxydatum		Beryllium Oxydatum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM OXYACETATE	30	[hp_C]/1			N	20241231
63545-471_dda77625-f9bb-d8dc-e053-2995a90a41a0	63545-471	HUMAN OTC DRUG	Beryllium Oxydatum		Beryllium Oxydatum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM OXYACETATE	100	[hp_C]/1			N	20241231
63545-472_dda77625-f9bb-d8dc-e053-2995a90a41a0	63545-472	HUMAN OTC DRUG	Beryllium Oxydatum		Beryllium Oxydatum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM OXYACETATE	200	[hp_C]/1			N	20241231
63545-473_dda77625-f9bb-d8dc-e053-2995a90a41a0	63545-473	HUMAN OTC DRUG	Beryllium Oxydatum		Beryllium Oxydatum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM OXYACETATE	500	[hp_C]/1			N	20241231
63545-474_dda77625-f9bb-d8dc-e053-2995a90a41a0	63545-474	HUMAN OTC DRUG	Beryllium Oxydatum		Beryllium Oxydatum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BERYLLIUM OXYACETATE	1	[hp_M]/1			N	20241231
63545-475_dec35ba0-f612-0fa9-e053-2a95a90a0898	63545-475	HUMAN OTC DRUG	Chenopodium Anthelminticum		Chenopodium Anthelminticum	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPHANIA AMBROSIOIDES WHOLE	6	[hp_C]/1			N	20241231
63545-476_dec35ba0-f612-0fa9-e053-2a95a90a0898	63545-476	HUMAN OTC DRUG	Chenopodium Anthelminticum		Chenopodium Anthelminticum	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPHANIA AMBROSIOIDES WHOLE	12	[hp_C]/1			N	20241231
63545-477_dec35ba0-f612-0fa9-e053-2a95a90a0898	63545-477	HUMAN OTC DRUG	Chenopodium Anthelminticum		Chenopodium Anthelminticum	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPHANIA AMBROSIOIDES WHOLE	30	[hp_C]/1			N	20241231
63545-478_dec35ba0-f612-0fa9-e053-2a95a90a0898	63545-478	HUMAN OTC DRUG	Chenopodium Anthelminticum		Chenopodium Anthelminticum	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPHANIA AMBROSIOIDES WHOLE	100	[hp_C]/1			N	20241231
63545-479_dec35ba0-f612-0fa9-e053-2a95a90a0898	63545-479	HUMAN OTC DRUG	Chenopodium Anthelminticum		Chenopodium Anthelminticum	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPHANIA AMBROSIOIDES WHOLE	200	[hp_C]/1			N	20241231
63545-480_dec35ba0-f612-0fa9-e053-2a95a90a0898	63545-480	HUMAN OTC DRUG	Chenopodium Anthelminticum		Chenopodium Anthelminticum	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPHANIA AMBROSIOIDES WHOLE	500	[hp_C]/1			N	20241231
63545-481_dec35ba0-f612-0fa9-e053-2a95a90a0898	63545-481	HUMAN OTC DRUG	Chenopodium Anthelminticum		Chenopodium Anthelminticum	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DYSPHANIA AMBROSIOIDES WHOLE	1	[hp_M]/1			N	20241231
63545-482_dec454e3-7621-04bc-e053-2995a90af264	63545-482	HUMAN OTC DRUG	Chimaphila Umbellata		Chimaphila Umbellata	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHIMAPHILA UMBELLATA	6	[hp_C]/1			N	20241231
63545-483_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-483	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	6	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-484_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-484	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	12	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-485_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-485	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	30	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-486_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-486	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	100	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-487_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-487	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	200	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-488_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-488	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	500	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-489_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-489	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	1	[hp_M]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-490_de0d2bf6-962a-7c7a-e053-2a95a90a1616	63545-490	HUMAN OTC DRUG	Bismuthum Oxydatum		Bismuthum Oxydatum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH OXIDE	1	[hp_Q]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-491_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-491	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	6	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-492_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-492	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	12	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-493_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-493	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	30	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-494_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-494	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	100	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-495_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-495	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	200	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-496_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-496	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	500	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-497_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-497	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	1	[hp_M]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-498_de0f84f3-5f8a-2ac2-e053-2995a90a8caa	63545-498	HUMAN OTC DRUG	Bismuthum Subnitricum		Bismuthum Subnitricum	PELLET	ORAL	20220502		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH SUBNITRATE	1	[hp_Q]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-499_de1fdc80-735f-9faa-e053-2995a90a59e2	63545-499	HUMAN OTC DRUG	Blatta Orientalis		Blatta Orientalis	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLATTA ORIENTALIS	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
63545-500_de1fdc80-735f-9faa-e053-2995a90a59e2	63545-500	HUMAN OTC DRUG	Blatta Orientalis		Blatta Orientalis	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLATTA ORIENTALIS	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
63545-501_de1fdc80-735f-9faa-e053-2995a90a59e2	63545-501	HUMAN OTC DRUG	Blatta Orientalis		Blatta Orientalis	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLATTA ORIENTALIS	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
63545-502_de1fdc80-735f-9faa-e053-2995a90a59e2	63545-502	HUMAN OTC DRUG	Blatta Orientalis		Blatta Orientalis	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLATTA ORIENTALIS	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
63545-503_de1fdc80-735f-9faa-e053-2995a90a59e2	63545-503	HUMAN OTC DRUG	Blatta Orientalis		Blatta Orientalis	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLATTA ORIENTALIS	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
63545-504_de1fdc80-735f-9faa-e053-2995a90a59e2	63545-504	HUMAN OTC DRUG	Blatta Orientalis		Blatta Orientalis	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLATTA ORIENTALIS	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
63545-505_de1fdc80-735f-9faa-e053-2995a90a59e2	63545-505	HUMAN OTC DRUG	Blatta Orientalis		Blatta Orientalis	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BLATTA ORIENTALIS	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
63545-506_de2165c5-02d4-77a6-e053-2995a90a46ef	63545-506	HUMAN OTC DRUG	Borax		Borax	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BORATE	6	[hp_C]/1			N	20241231
63545-507_de2165c5-02d4-77a6-e053-2995a90a46ef	63545-507	HUMAN OTC DRUG	Borax		Borax	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BORATE	12	[hp_C]/1			N	20241231
63545-508_de2165c5-02d4-77a6-e053-2995a90a46ef	63545-508	HUMAN OTC DRUG	Borax		Borax	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BORATE	30	[hp_C]/1			N	20241231
63545-509_de2165c5-02d4-77a6-e053-2995a90a46ef	63545-509	HUMAN OTC DRUG	Borax		Borax	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BORATE	100	[hp_C]/1			N	20241231
63545-510_de2165c5-02d4-77a6-e053-2995a90a46ef	63545-510	HUMAN OTC DRUG	Borax		Borax	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BORATE	200	[hp_C]/1			N	20241231
63545-511_de2165c5-02d4-77a6-e053-2995a90a46ef	63545-511	HUMAN OTC DRUG	Borax		Borax	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BORATE	500	[hp_C]/1			N	20241231
63545-512_de2165c5-02d4-77a6-e053-2995a90a46ef	63545-512	HUMAN OTC DRUG	Borax		Borax	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SODIUM BORATE	1	[hp_M]/1			N	20241231
63545-513_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-513	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	6	[hp_C]/1			N	20241231
63545-514_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-514	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	12	[hp_C]/1			N	20241231
63545-515_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-515	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	30	[hp_C]/1			N	20241231
63545-516_04b6f675-5955-c4e0-e063-6394a90aed68	63545-516	HUMAN OTC DRUG	SINECCHi		Arnica montana	CAPSULE	ORAL	20200221		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories Inc. dba Alpine Pharmaceuticals	ARNICA MONTANA	1	[hp_M]/1			N	20241231
63545-518_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-518	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	100	[hp_C]/1			N	20241231
63545-521_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-521	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	200	[hp_C]/1			N	20241231
63545-522_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-522	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	500	[hp_C]/1			N	20241231
63545-523_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-523	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	1	[hp_M]/1			N	20241231
63545-524_de22d1dc-f04f-10dd-e053-2a95a90afbef	63545-524	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON	1	[hp_Q]/1			N	20241231
63545-525_de342425-7b22-96a4-e053-2a95a90a4d96	63545-525	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	6	[hp_C]/1			N	20241231
63545-526_de342425-7b22-96a4-e053-2a95a90a4d96	63545-526	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	12	[hp_C]/1			N	20241231
63545-527_de342425-7b22-96a4-e053-2a95a90a4d96	63545-527	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	30	[hp_C]/1			N	20241231
63545-528_de342425-7b22-96a4-e053-2a95a90a4d96	63545-528	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	100	[hp_C]/1			N	20241231
63545-529_de342425-7b22-96a4-e053-2a95a90a4d96	63545-529	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	200	[hp_C]/1			N	20241231
63545-530_de342425-7b22-96a4-e053-2a95a90a4d96	63545-530	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	500	[hp_C]/1			N	20241231
63545-531_de342425-7b22-96a4-e053-2a95a90a4d96	63545-531	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	1	[hp_M]/1			N	20241231
63545-532_de342425-7b22-96a4-e053-2a95a90a4d96	63545-532	HUMAN OTC DRUG	Boron Oxydatum		Boron Oxydatum	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BORON OXIDE	1	[hp_Q]/1			N	20241231
63545-533_de36ae16-8f43-0a37-e053-2a95a90ab0d1	63545-533	HUMAN OTC DRUG	Bovista		Bovista	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPERDON UTRIFORME FRUITING BODY	6	[hp_C]/1			N	20241231
63545-534_de36ae16-8f43-0a37-e053-2a95a90ab0d1	63545-534	HUMAN OTC DRUG	Bovista		Bovista	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPERDON UTRIFORME FRUITING BODY	12	[hp_C]/1			N	20241231
63545-535_de36ae16-8f43-0a37-e053-2a95a90ab0d1	63545-535	HUMAN OTC DRUG	Bovista		Bovista	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPERDON UTRIFORME FRUITING BODY	30	[hp_C]/1			N	20241231
63545-536_de36ae16-8f43-0a37-e053-2a95a90ab0d1	63545-536	HUMAN OTC DRUG	Bovista		Bovista	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPERDON UTRIFORME FRUITING BODY	100	[hp_C]/1			N	20241231
63545-537_de36ae16-8f43-0a37-e053-2a95a90ab0d1	63545-537	HUMAN OTC DRUG	Bovista		Bovista	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPERDON UTRIFORME FRUITING BODY	200	[hp_C]/1			N	20241231
63545-538_de36ae16-8f43-0a37-e053-2a95a90ab0d1	63545-538	HUMAN OTC DRUG	Bovista		Bovista	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPERDON UTRIFORME FRUITING BODY	500	[hp_C]/1			N	20241231
63545-539_de36ae16-8f43-0a37-e053-2a95a90ab0d1	63545-539	HUMAN OTC DRUG	Bovista		Bovista	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	LYCOPERDON UTRIFORME FRUITING BODY	1	[hp_M]/1			N	20241231
63545-540_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-540	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	6	[hp_C]/1			N	20241231
63545-541_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-541	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	12	[hp_C]/1			N	20241231
63545-542_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-542	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	30	[hp_C]/1			N	20241231
63545-543_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-543	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	100	[hp_C]/1			N	20241231
63545-544_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-544	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	200	[hp_C]/1			N	20241231
63545-545_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-545	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	500	[hp_C]/1			N	20241231
63545-546_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-546	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	1	[hp_M]/1			N	20241231
63545-547_de3826bd-0078-0c6a-e053-2a95a90ab02d	63545-547	HUMAN OTC DRUG	Bromium		Bromium	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BROMINE	1	[hp_Q]/1			N	20241231
63545-548_de47da97-3d03-afad-e053-2995a90aaaa3	63545-548	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	6	[hp_C]/1			N	20241231
63545-549_de47da97-3d03-afad-e053-2995a90aaaa3	63545-549	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	12	[hp_C]/1			N	20241231
63545-551_de47da97-3d03-afad-e053-2995a90aaaa3	63545-551	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	30	[hp_C]/1			N	20241231
63545-552_de47da97-3d03-afad-e053-2995a90aaaa3	63545-552	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	100	[hp_C]/1			N	20241231
63545-553_de47da97-3d03-afad-e053-2995a90aaaa3	63545-553	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	200	[hp_C]/1			N	20241231
63545-554_de47da97-3d03-afad-e053-2995a90aaaa3	63545-554	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	500	[hp_C]/1			N	20241231
63545-555_de47da97-3d03-afad-e053-2995a90aaaa3	63545-555	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	1	[hp_M]/1			N	20241231
63545-556_de47da97-3d03-afad-e053-2995a90aaaa3	63545-556	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	10	[hp_M]/1			N	20241231
63545-557_de47da97-3d03-afad-e053-2995a90aaaa3	63545-557	HUMAN OTC DRUG	Bryonia Alba		Bryonia Alba	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BRYONIA ALBA ROOT	1	[hp_Q]/1			N	20241231
63545-558_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-558	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	6	[hp_C]/1			N	20241231
63545-559_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-559	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	12	[hp_C]/1			N	20241231
63545-560_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-560	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	30	[hp_C]/1			N	20241231
63545-561_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-561	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	100	[hp_C]/1			N	20241231
63545-562_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-562	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	200	[hp_C]/1			N	20241231
63545-563_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-563	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	500	[hp_C]/1			N	20241231
63545-564_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-564	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	1	[hp_M]/1			N	20241231
63545-565_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-565	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	10	[hp_M]/1			N	20241231
63545-566_de4925b2-3aa2-10c6-e053-2995a90ae3d7	63545-566	HUMAN OTC DRUG	Cactus Grandiflorus		Cactus Grandiflorus	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	SELENICEREUS GRANDIFLORUS STEM	1	[hp_Q]/1			N	20241231
63545-567_de4bb651-5330-ce7d-e053-2a95a90a38e6	63545-567	HUMAN OTC DRUG	Cadmium Bromatum		Cadmium Bromatum	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM BROMIDE	6	[hp_C]/1			N	20241231
63545-568_de4bb651-5330-ce7d-e053-2a95a90a38e6	63545-568	HUMAN OTC DRUG	Cadmium Bromatum		Cadmium Bromatum	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM BROMIDE	12	[hp_C]/1			N	20241231
63545-569_de4bb651-5330-ce7d-e053-2a95a90a38e6	63545-569	HUMAN OTC DRUG	Cadmium Bromatum		Cadmium Bromatum	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM BROMIDE	30	[hp_C]/1			N	20241231
63545-570_de4bb651-5330-ce7d-e053-2a95a90a38e6	63545-570	HUMAN OTC DRUG	Cadmium Bromatum		Cadmium Bromatum	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM BROMIDE	100	[hp_C]/1			N	20241231
63545-571_de4bb651-5330-ce7d-e053-2a95a90a38e6	63545-571	HUMAN OTC DRUG	Cadmium Bromatum		Cadmium Bromatum	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM BROMIDE	200	[hp_C]/1			N	20241231
63545-572_de4bb651-5330-ce7d-e053-2a95a90a38e6	63545-572	HUMAN OTC DRUG	Cadmium Bromatum		Cadmium Bromatum	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM BROMIDE	500	[hp_C]/1			N	20241231
63545-573_de4bb651-5330-ce7d-e053-2a95a90a38e6	63545-573	HUMAN OTC DRUG	Cadmium Bromatum		Cadmium Bromatum	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM BROMIDE	1	[hp_M]/1			N	20241231
63545-574_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-574	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	6	[hp_C]/1			N	20241231
63545-575_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-575	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	12	[hp_C]/1			N	20241231
63545-576_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-576	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	30	[hp_C]/1			N	20241231
63545-577_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-577	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	100	[hp_C]/1			N	20241231
63545-578_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-578	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	200	[hp_C]/1			N	20241231
63545-579_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-579	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	500	[hp_C]/1			N	20241231
63545-580_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-580	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	1	[hp_M]/1			N	20241231
63545-581_de5ca1c1-cb5a-8836-e053-2995a90adf34	63545-581	HUMAN OTC DRUG	Cadmium Fluoratum		Cadmium Fluoratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM FLUORIDE	1	[hp_Q]/1			N	20241231
63545-582_de5dcee0-5697-d833-e053-2995a90ab345	63545-582	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	6	[hp_C]/1			N	20241231
63545-584_de5dcee0-5697-d833-e053-2995a90ab345	63545-584	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	12	[hp_C]/1			N	20241231
63545-585_de5dcee0-5697-d833-e053-2995a90ab345	63545-585	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	30	[hp_C]/1			N	20241231
63545-586_de5dcee0-5697-d833-e053-2995a90ab345	63545-586	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	100	[hp_C]/1			N	20241231
63545-587_de5dcee0-5697-d833-e053-2995a90ab345	63545-587	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	200	[hp_C]/1			N	20241231
63545-588_de5dcee0-5697-d833-e053-2995a90ab345	63545-588	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	500	[hp_C]/1			N	20241231
63545-589_de5dcee0-5697-d833-e053-2995a90ab345	63545-589	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	1	[hp_M]/1			N	20241231
63545-590_de5dcee0-5697-d833-e053-2995a90ab345	63545-590	HUMAN OTC DRUG	Cadmium Metallicum		Cadmium Metallicum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM	1	[hp_Q]/1			N	20241231
63545-591_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-591	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	6	[hp_C]/1			N	20241231
63545-592_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-592	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	12	[hp_C]/1			N	20241231
63545-593_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-593	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	30	[hp_C]/1			N	20241231
63545-594_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-594	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	100	[hp_C]/1			N	20241231
63545-595_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-595	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	200	[hp_C]/1			N	20241231
63545-596_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-596	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	500	[hp_C]/1			N	20241231
63545-597_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-597	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	1	[hp_M]/1			N	20241231
63545-598_de60dd76-9495-79a3-e053-2a95a90a62d9	63545-598	HUMAN OTC DRUG	Cadmium Muriaticum		Cadmium Muriaticum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM CHLORIDE	1	[hp_Q]/1			N	20241231
63545-599_de625369-3994-a8fa-e053-2995a90adf88	63545-599	HUMAN OTC DRUG	Cadmium Sulphuratum		Cadmium Sulphuratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM SULFIDE	6	[hp_C]/1			N	20241231
63545-600_de625369-3994-a8fa-e053-2995a90adf88	63545-600	HUMAN OTC DRUG	Cadmium Sulphuratum		Cadmium Sulphuratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM SULFIDE	12	[hp_C]/1			N	20241231
63545-601_de625369-3994-a8fa-e053-2995a90adf88	63545-601	HUMAN OTC DRUG	Cadmium Sulphuratum		Cadmium Sulphuratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM SULFIDE	30	[hp_C]/1			N	20241231
63545-602_de625369-3994-a8fa-e053-2995a90adf88	63545-602	HUMAN OTC DRUG	Cadmium Sulphuratum		Cadmium Sulphuratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM SULFIDE	100	[hp_C]/1			N	20241231
63545-603_de625369-3994-a8fa-e053-2995a90adf88	63545-603	HUMAN OTC DRUG	Cadmium Sulphuratum		Cadmium Sulphuratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM SULFIDE	200	[hp_C]/1			N	20241231
63545-604_de625369-3994-a8fa-e053-2995a90adf88	63545-604	HUMAN OTC DRUG	Cadmium Sulphuratum		Cadmium Sulphuratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM SULFIDE	500	[hp_C]/1			N	20241231
63545-605_de625369-3994-a8fa-e053-2995a90adf88	63545-605	HUMAN OTC DRUG	Cadmium Sulphuratum		Cadmium Sulphuratum	PELLET	ORAL	20220506		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CADMIUM SULFIDE	1	[hp_M]/1			N	20241231
63545-606_de985010-5c3f-7e18-e053-2995a90a50d5	63545-606	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	6	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-607_de985010-5c3f-7e18-e053-2995a90a50d5	63545-607	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	12	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-608_de985010-5c3f-7e18-e053-2995a90a50d5	63545-608	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	30	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-609_de985010-5c3f-7e18-e053-2995a90a50d5	63545-609	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	100	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-610_de985010-5c3f-7e18-e053-2995a90a50d5	63545-610	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	200	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-611_de985010-5c3f-7e18-e053-2995a90a50d5	63545-611	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	500	[hp_C]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-612_de985010-5c3f-7e18-e053-2995a90a50d5	63545-612	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	1	[hp_M]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-613_de985010-5c3f-7e18-e053-2995a90a50d5	63545-613	HUMAN OTC DRUG	Bismuthum Phosphoricum		Bismuthum Phosphoricum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BISMUTH PHOSPHATE	1	[hp_Q]/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63545-614_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-614	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	6	[hp_C]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-615_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-615	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	12	[hp_C]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-616_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-616	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	30	[hp_C]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-617_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-617	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	100	[hp_C]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-618_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-618	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	200	[hp_C]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-619_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-619	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	500	[hp_C]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-620_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-620	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	1	[hp_M]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-621_de99f74d-6f68-2ed3-e053-2995a90a9875	63545-621	HUMAN OTC DRUG	Caffeinum		Caffeinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CAFFEINE	1	[hp_Q]/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63545-622_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-622	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	6	[hp_C]/1			N	20241231
63545-623_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-623	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	12	[hp_C]/1			N	20241231
63545-624_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-624	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	30	[hp_C]/1			N	20241231
63545-625_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-625	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	100	[hp_C]/1			N	20241231
63545-626_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-626	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	200	[hp_C]/1			N	20241231
63545-627_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-627	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	500	[hp_C]/1			N	20241231
63545-628_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-628	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	1	[hp_M]/1			N	20241231
63545-629_de9b1a67-910c-08c4-e053-2995a90af7ce	63545-629	HUMAN OTC DRUG	Caladium Seguinum		Caladium Seguinum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	DIEFFENBACHIA SEGUINE	1	[hp_Q]/1			N	20241231
63545-630_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-630	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	6	[hp_C]/1			N	20241231
63545-631_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-631	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	12	[hp_C]/1			N	20241231
63545-632_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-632	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	30	[hp_C]/1			N	20241231
63545-633_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-633	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	100	[hp_C]/1			N	20241231
63545-634_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-634	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	200	[hp_C]/1			N	20241231
63545-635_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-635	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	500	[hp_C]/1			N	20241231
63545-636_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-636	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	1	[hp_M]/1			N	20241231
63545-638_de9c9f85-221b-18d2-e053-2a95a90a3c69	63545-638	HUMAN OTC DRUG	Biotitum		Biotitum	PELLET	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	BIOTIN	1	[hp_Q]/1			N	20241231
63545-641_dec454e3-7621-04bc-e053-2995a90af264	63545-641	HUMAN OTC DRUG	Chimaphila Umbellata		Chimaphila Umbellata	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHIMAPHILA UMBELLATA	12	[hp_C]/1			N	20241231
63545-642_dec454e3-7621-04bc-e053-2995a90af264	63545-642	HUMAN OTC DRUG	Chimaphila Umbellata		Chimaphila Umbellata	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHIMAPHILA UMBELLATA	30	[hp_C]/1			N	20241231
63545-643_dec454e3-7621-04bc-e053-2995a90af264	63545-643	HUMAN OTC DRUG	Chimaphila Umbellata		Chimaphila Umbellata	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHIMAPHILA UMBELLATA	100	[hp_C]/1			N	20241231
63545-647_dec454e3-7621-04bc-e053-2995a90af264	63545-647	HUMAN OTC DRUG	Chimaphila Umbellata		Chimaphila Umbellata	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHIMAPHILA UMBELLATA	200	[hp_C]/1			N	20241231
63545-648_dec454e3-7621-04bc-e053-2995a90af264	63545-648	HUMAN OTC DRUG	Chimaphila Umbellata		Chimaphila Umbellata	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHIMAPHILA UMBELLATA	500	[hp_C]/1			N	20241231
63545-649_dec454e3-7621-04bc-e053-2995a90af264	63545-649	HUMAN OTC DRUG	Chimaphila Umbellata		Chimaphila Umbellata	PELLET	ORAL	20220511		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, INC.	CHIMAPHILA UMBELLATA	1	[hp_M]/1			N	20241231
63545-699_e4cf721c-f249-1e51-e053-2a95a90ab668	63545-699	HUMAN OTC DRUG	Erbium sulphuricum		Erbium sulphuricum	PELLET	BUCCAL; ORAL; SUBLINGUAL	20180709		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ERBIUM SULFATE OCTAHYDRATE	1	[hp_M]/[hp_M]			N	20241231
63545-700_04b7422d-cc42-d90d-e063-6394a90a7409	63545-700	HUMAN OTC DRUG	SinEcch		Arnica montana	CAPSULE	ORAL	20190507		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals	ARNICA MONTANA	1	[hp_M]/[hp_M]			N	20241231
63545-701_e4cf1def-7439-8baa-e053-2a95a90a23d4	63545-701	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	12	[hp_C]/1			N	20241231
63545-701_e4cf219e-0872-81bc-e053-2a95a90a7cda	63545-701	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	12	[hp_C]/1			N	20241231
63545-701_e4cf219e-0873-81bc-e053-2a95a90a7cda	63545-701	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	12	[hp_C]/1			N	20241231
63545-702_e4cf1def-7438-8baa-e053-2a95a90a23d4	63545-702	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	30	[hp_C]/1			N	20241231
63545-702_e4cf219e-0870-81bc-e053-2a95a90a7cda	63545-702	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	30	[hp_C]/1			N	20241231
63545-702_e4cf2415-336a-8feb-e053-2a95a90a3ec6	63545-702	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	30	[hp_C]/1			N	20241231
63545-703_e4ceed74-38e8-4986-e053-2a95a90a1096	63545-703	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	100	[hp_C]/1			N	20241231
63545-703_e4cef4c6-92a6-68d3-e053-2a95a90ab4b0	63545-703	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	100	[hp_C]/1			N	20241231
63545-703_e4cf1def-7436-8baa-e053-2a95a90a23d4	63545-703	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	100	[hp_C]/1			N	20241231
63545-703_e4cf1def-7437-8baa-e053-2a95a90a23d4	63545-703	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	100	[hp_C]/1			N	20241231
63545-704_e4ced92f-3a1c-e2f7-e053-2995a90ab80c	63545-704	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	200	[hp_C]/1			N	20241231
63545-704_e4cedea3-b60f-da63-e053-2995a90a6df3	63545-704	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	200	[hp_C]/1			N	20241231
63545-704_e4ceed74-38e7-4986-e053-2a95a90a1096	63545-704	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	200	[hp_C]/1			N	20241231
63545-704_e4cef18b-c915-8007-e053-2995a90a0d53	63545-704	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	200	[hp_C]/1			N	20241231
63545-706_e4ce53fa-bdeb-2da1-e053-2a95a90aabe4	63545-706	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	1	[hp_M]/1			N	20241231
63545-706_e4ce53fa-bdec-2da1-e053-2a95a90aabe4	63545-706	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	1	[hp_M]/1			N	20241231
63545-706_e4ce5a6c-b35e-aaac-e053-2995a90aee9e	63545-706	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	1	[hp_M]/1			N	20241231
63545-706_e4ced425-4829-e2f5-e053-2995a90a7c24	63545-706	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	1	[hp_M]/1			N	20241231
63545-707_e4ce3db8-ae26-4628-e053-2995a90a4aec	63545-707	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	10	[hp_M]/1			N	20241231
63545-707_e4ce3db8-ae27-4628-e053-2995a90a4aec	63545-707	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	10	[hp_M]/1			N	20241231
63545-707_e4ce53fa-bde9-2da1-e053-2a95a90aabe4	63545-707	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	10	[hp_M]/1			N	20241231
63545-707_e4ce53fa-bdea-2da1-e053-2a95a90aabe4	63545-707	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	10	[hp_M]/1			N	20241231
63545-708_e4ce487c-d3d3-a5ba-e053-2a95a90ae4a3	63545-708	HUMAN OTC DRUG	Abies nigra		Abies nigra	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	PICEA MARIANA RESIN	1	[hp_Q]/1			N	20241231
63545-709_e4c23efd-2150-c830-e053-2995a90ad190	63545-709	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	12	[hp_C]/1			N	20241231
63545-709_e4c24175-e110-dc4b-e053-2a95a90afaf4	63545-709	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	12	[hp_C]/1			N	20241231
63545-709_e4c24175-e112-dc4b-e053-2a95a90afaf4	63545-709	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	12	[hp_C]/1			N	20241231
63545-710_e4c23efd-214e-c830-e053-2995a90ad190	63545-710	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	30	[hp_C]/1			N	20241231
63545-710_e4c23efd-214f-c830-e053-2995a90ad190	63545-710	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	30	[hp_C]/1			N	20241231
63545-710_e4c24175-e10f-dc4b-e053-2a95a90afaf4	63545-710	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	30	[hp_C]/1			N	20241231
63545-710_e4c24175-e111-dc4b-e053-2a95a90afaf4	63545-710	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191210		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	30	[hp_C]/1			N	20241231
63545-711_e4c1906b-76b7-4a88-e053-2995a90aa344	63545-711	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	100	[hp_C]/1			N	20241231
63545-711_e4c1906b-76b9-4a88-e053-2995a90aa344	63545-711	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	100	[hp_C]/1			N	20241231
63545-711_e4c23efd-214c-c830-e053-2995a90ad190	63545-711	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	100	[hp_C]/1			N	20241231
63545-711_e4c23efd-214d-c830-e053-2995a90ad190	63545-711	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	100	[hp_C]/1			N	20241231
63545-712_e4c18848-de86-fc71-e053-2a95a90acb51	63545-712	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	200	[hp_C]/1			N	20241231
63545-712_e4c1906b-76b8-4a88-e053-2995a90aa344	63545-712	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	200	[hp_C]/1			N	20241231
63545-712_e4c197ca-27b5-1211-e053-2995a90a65e8	63545-712	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	200	[hp_C]/1			N	20241231
63545-712_e4c197ca-27b6-1211-e053-2995a90a65e8	63545-712	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	200	[hp_C]/1			N	20241231
63545-713_e4c183b3-ae5c-3060-e053-2995a90a4616	63545-713	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	500	[hp_C]/1			N	20241231
63545-713_e4c183b3-ae5d-3060-e053-2995a90a4616	63545-713	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	500	[hp_C]/1			N	20241231
63545-713_e4c183b3-ae5e-3060-e053-2995a90a4616	63545-713	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	500	[hp_C]/1			N	20241231
63545-713_e4c18848-de85-fc71-e053-2a95a90acb51	63545-713	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	500	[hp_C]/1			N	20241231
63545-714_e4c183b3-ae5b-3060-e053-2995a90a4616	63545-714	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	1	[hp_M]/1			N	20241231
63545-714_e4c18848-de81-fc71-e053-2a95a90acb51	63545-714	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	1	[hp_M]/1			N	20241231
63545-714_e4c18848-de82-fc71-e053-2a95a90acb51	63545-714	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	1	[hp_M]/1			N	20241231
63545-714_e4c18848-de83-fc71-e053-2a95a90acb51	63545-714	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	1	[hp_M]/1			N	20241231
63545-716_e4c183b3-ae59-3060-e053-2995a90a4616	63545-716	HUMAN OTC DRUG	Abrotanum		Abrotanum	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP	1	[hp_Q]/1			N	20241231
63545-717_e4c14fde-12db-80e9-e053-2a95a90a472a	63545-717	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	12	[hp_C]/1			N	20241231
63545-717_e4c14fde-12dc-80e9-e053-2a95a90a472a	63545-717	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	12	[hp_C]/1			N	20241231
63545-717_e4c183b3-ae58-3060-e053-2995a90a4616	63545-717	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191217		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	12	[hp_C]/1			N	20241231
63545-718_e4c114be-cbd5-3cd2-e053-2a95a90a880a	63545-718	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	30	[hp_C]/1			N	20241231
63545-718_e4c1202e-5899-34f6-e053-2a95a90aa6b3	63545-718	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	30	[hp_C]/1			N	20241231
63545-718_e4c14fde-12d9-80e9-e053-2a95a90a472a	63545-718	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	30	[hp_C]/1			N	20241231
63545-718_e4c14fde-12da-80e9-e053-2a95a90a472a	63545-718	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	30	[hp_C]/1			N	20241231
63545-719_e4c110b0-6bea-93d0-e053-2995a90afe92	63545-719	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	100	[hp_C]/1			N	20241231
63545-719_e4c114be-cbcc-3cd2-e053-2a95a90a880a	63545-719	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	100	[hp_C]/1			N	20241231
63545-719_e4c114be-cbcd-3cd2-e053-2a95a90a880a	63545-719	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	100	[hp_C]/1			N	20241231
63545-719_e4c1202e-5898-34f6-e053-2a95a90aa6b3	63545-719	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	100	[hp_C]/1			N	20241231
63545-720_e4c03d8b-c5e0-3214-e053-2a95a90a68a1	63545-720	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	200	[hp_C]/1			N	20241231
63545-720_e4c082a9-447d-2848-e053-2995a90ae59e	63545-720	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	200	[hp_C]/1			N	20241231
63545-720_e4c10b65-64b7-20d0-e053-2a95a90a4f97	63545-720	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	200	[hp_C]/1			N	20241231
63545-720_e4c110b0-6be8-93d0-e053-2995a90afe92	63545-720	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	200	[hp_C]/1			N	20241231
63545-721_e4c03420-62de-74f8-e053-2995a90aefdd	63545-721	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	500	[hp_C]/1			N	20241231
63545-721_e4c03420-62df-74f8-e053-2995a90aefdd	63545-721	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	500	[hp_C]/1			N	20241231
63545-721_e4c03d8b-c5de-3214-e053-2a95a90a68a1	63545-721	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	500	[hp_C]/1			N	20241231
63545-721_e4c04015-6345-45d0-e053-2995a90adcee	63545-721	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	500	[hp_C]/1			N	20241231
63545-722_e4c03420-62db-74f8-e053-2995a90aefdd	63545-722	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	1000	[hp_C]/1			N	20241231
63545-722_e4c03420-62dc-74f8-e053-2995a90aefdd	63545-722	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	1000	[hp_C]/1			N	20241231
63545-722_e4c03420-62dd-74f8-e053-2995a90aefdd	63545-722	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	1000	[hp_C]/1			N	20241231
63545-722_e4c03d8b-c5df-3214-e053-2a95a90a68a1	63545-722	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	1000	[hp_C]/1			N	20241231
63545-723_e4c03420-62d9-74f8-e053-2995a90aefdd	63545-723	HUMAN OTC DRUG	Absinthium		Absinthium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	WORMWOOD	1	[hp_Q]/1			N	20241231
63545-725_e4bde4e4-d35f-9556-e053-2a95a90a5655	63545-725	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	30	[hp_C]/1			N	20241231
63545-725_e4bde4e4-d360-9556-e053-2a95a90a5655	63545-725	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	30	[hp_C]/1			N	20241231
63545-725_e4bde8f1-024e-9339-e053-2995a90afd52	63545-725	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	30	[hp_C]/1			N	20241231
63545-725_e4bdeba4-b193-0f9f-e053-2995a90a6bd6	63545-725	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	30	[hp_C]/1			N	20241231
63545-726_e4bd5644-f7ff-44f4-e053-2a95a90a7132	63545-726	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	100	[hp_C]/1			N	20241231
63545-726_e4bde4e4-d35e-9556-e053-2a95a90a5655	63545-726	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	100	[hp_C]/1			N	20241231
63545-726_e4bde805-eef1-a8dd-e053-2995a90a88f2	63545-726	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	100	[hp_C]/1			N	20241231
63545-727_e4bd52da-39d2-c808-e053-2a95a90af258	63545-727	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	200	[hp_C]/1			N	20241231
63545-727_e4bd52da-39d3-c808-e053-2a95a90af258	63545-727	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	200	[hp_C]/1			N	20241231
63545-727_e4bd52da-39d4-c808-e053-2a95a90af258	63545-727	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	200	[hp_C]/1			N	20241231
63545-727_e4bd5644-f7fe-44f4-e053-2a95a90a7132	63545-727	HUMAN OTC DRUG	Acidum Aceticum		Acidum Aceticum	PELLET	ORAL	20191223		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACETIC ACID	200	[hp_C]/1			N	20241231
63545-732_e4c114be-cbd3-3cd2-e053-2a95a90a880a	63545-732	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	12	[hp_C]/1			N	20241231
63545-732_e4c114be-cbd4-3cd2-e053-2a95a90a880a	63545-732	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	12	[hp_C]/1			N	20241231
63545-732_e4c1202e-5896-34f6-e053-2a95a90aa6b3	63545-732	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	12	[hp_C]/1			N	20241231
63545-733_e4c114be-cbcf-3cd2-e053-2a95a90a880a	63545-733	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	30	[hp_C]/1			N	20241231
63545-733_e4c114be-cbd0-3cd2-e053-2a95a90a880a	63545-733	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	30	[hp_C]/1			N	20241231
63545-733_e4c114be-cbd1-3cd2-e053-2a95a90a880a	63545-733	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	30	[hp_C]/1			N	20241231
63545-733_e4c114be-cbd2-3cd2-e053-2a95a90a880a	63545-733	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	30	[hp_C]/1			N	20241231
63545-734_e4c110b0-6beb-93d0-e053-2995a90afe92	63545-734	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	100	[hp_C]/1			N	20241231
63545-734_e4c110b0-6bec-93d0-e053-2995a90afe92	63545-734	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	100	[hp_C]/1			N	20241231
63545-734_e4c114be-cbce-3cd2-e053-2a95a90a880a	63545-734	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	100	[hp_C]/1			N	20241231
63545-735_e4c0fd87-0012-d5f5-e053-2995a90abe52	63545-735	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	200	[hp_C]/1			N	20241231
63545-735_e4c10b65-64b8-20d0-e053-2a95a90a4f97	63545-735	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	200	[hp_C]/1			N	20241231
63545-735_e4c10b65-64b9-20d0-e053-2a95a90a4f97	63545-735	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	200	[hp_C]/1			N	20241231
63545-735_e4c110b0-6be9-93d0-e053-2995a90afe92	63545-735	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	200	[hp_C]/1			N	20241231
63545-736_e4c082a9-447e-2848-e053-2995a90ae59e	63545-736	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	500	[hp_C]/1			N	20241231
63545-736_e4c082a9-447f-2848-e053-2995a90ae59e	63545-736	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	500	[hp_C]/1			N	20241231
63545-736_e4c0885b-204e-60ce-e053-2995a90aa165	63545-736	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	500	[hp_C]/1			N	20241231
63545-736_e4c0885b-204f-60ce-e053-2995a90aa165	63545-736	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	500	[hp_C]/1			N	20241231
63545-737_e4c082a9-447c-2848-e053-2995a90ae59e	63545-737	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	1	[hp_M]/1			N	20241231
63545-737_e4c08397-652f-3973-e053-2a95a90afb07	63545-737	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	1	[hp_M]/1			N	20241231
63545-737_e4c08397-6530-3973-e053-2a95a90afb07	63545-737	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	1	[hp_M]/1			N	20241231
63545-737_e4c08397-6531-3973-e053-2a95a90afb07	63545-737	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	1	[hp_M]/1			N	20241231
63545-738_e4c03420-62d8-74f8-e053-2995a90aefdd	63545-738	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	10	[hp_M]/1			N	20241231
63545-738_e4c03420-62da-74f8-e053-2995a90aefdd	63545-738	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	10	[hp_M]/1			N	20241231
63545-738_e4c03734-0bc8-afc2-e053-2a95a90ac3b4	63545-738	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	10	[hp_M]/1			N	20241231
63545-738_e4c082a9-447b-2848-e053-2995a90ae59e	63545-738	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	10	[hp_M]/1			N	20241231
63545-739_e4bfd9f5-ca32-a5da-e053-2995a90a5609	63545-739	HUMAN OTC DRUG	Aconitum napellus		Aconitum napellus	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACONITUM NAPELLUS	1	[hp_Q]/1			N	20241231
63545-741_e4a89577-cd5b-6bbc-e053-2995a90afc5d	63545-741	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	30	[hp_C]/1			N	20241231
63545-741_e4a89577-cd5c-6bbc-e053-2995a90afc5d	63545-741	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	30	[hp_C]/1			N	20241231
63545-741_e4be7f54-173d-68c0-e053-2a95a90af40c	63545-741	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	30	[hp_C]/1			N	20241231
63545-741_e4beac8e-4ced-d6cb-e053-2a95a90a9d67	63545-741	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	30	[hp_C]/1			N	20241231
63545-742_e4a79f2f-fe81-2c1f-e053-2a95a90acebf	63545-742	HUMAN OTC DRUG	Actaea Spicita		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	100	[hp_C]/1			N	20241231
63545-742_e4a85f2b-a92b-59c5-e053-2995a90aa81b	63545-742	HUMAN OTC DRUG	Actaea Spicita		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	100	[hp_C]/1			N	20241231
63545-742_e4a862c4-3303-961d-e053-2a95a90aa446	63545-742	HUMAN OTC DRUG	Actaea Spicita		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	100	[hp_C]/1			N	20241231
63545-742_e4beab04-f036-31b4-e053-2995a90a9b94	63545-742	HUMAN OTC DRUG	Actaea Spicita		Actaea Spicata	PELLET	ORAL	20191219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	100	[hp_C]/1			N	20241231
63545-743_e4a79f2f-fe82-2c1f-e053-2a95a90acebf	63545-743	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	200	[hp_C]/1			N	20241231
63545-743_e4a79f2f-fe83-2c1f-e053-2a95a90acebf	63545-743	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	200	[hp_C]/1			N	20241231
63545-743_e4a89577-cd5a-6bbc-e053-2995a90afc5d	63545-743	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	200	[hp_C]/1			N	20241231
63545-743_e4bfd9f5-ca31-a5da-e053-2995a90a5609	63545-743	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	200	[hp_C]/1			N	20241231
63545-745_e4a84cbe-b89f-7504-e053-2a95a90a8df3	63545-745	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	1000	[hp_C]/1			N	20241231
63545-745_e4a85f2b-a929-59c5-e053-2995a90aa81b	63545-745	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	1000	[hp_C]/1			N	20241231
63545-745_e4a85f2b-a92a-59c5-e053-2995a90aa81b	63545-745	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191230		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	1000	[hp_C]/1			N	20241231
63545-745_e4be7c1c-4ada-75ab-e053-2995a90ad7c1	63545-745	HUMAN OTC DRUG	Actaea Spicata		Actaea Spicata	PELLET	ORAL	20191219		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ACTAEA SPICATA ROOT	1000	[hp_C]/1			N	20241231
63545-747_e4bde805-eef3-a8dd-e053-2995a90a88f2	63545-747	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	12	[hp_C]/1			N	20241231
63545-747_e4be7f54-173a-68c0-e053-2a95a90af40c	63545-747	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	12	[hp_C]/1			N	20241231
63545-747_e4be7f54-173b-68c0-e053-2a95a90af40c	63545-747	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	12	[hp_C]/1			N	20241231
63545-749_e4bd4e55-1c2d-693f-e053-2a95a90aafcb	63545-749	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	100	[hp_C]/1			N	20241231
63545-749_e4bd4e55-1c2e-693f-e053-2a95a90aafcb	63545-749	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	100	[hp_C]/1			N	20241231
63545-749_e4bd4e55-1c2f-693f-e053-2a95a90aafcb	63545-749	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	100	[hp_C]/1			N	20241231
63545-750_e4bce665-f13a-32d9-e053-2995a90aa6da	63545-750	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	200	[hp_C]/1			N	20241231
63545-750_e4bd0170-1064-9ef5-e053-2a95a90a338d	63545-750	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	200	[hp_C]/1			N	20241231
63545-750_e4bd040b-aed2-e792-e053-2995a90a1480	63545-750	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	200	[hp_C]/1			N	20241231
63545-751_e4bd00d5-7ed2-5404-e053-2a95a90afc70	63545-751	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	500	[hp_C]/1			N	20241231
63545-751_e4bd00d5-7ed3-5404-e053-2a95a90afc70	63545-751	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	500	[hp_C]/1			N	20241231
63545-751_e4bd00d5-7ed4-5404-e053-2a95a90afc70	63545-751	HUMAN OTC DRUG	Adamas		Adamas	PELLET	ORAL	20191220		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DIAMOND	500	[hp_C]/1			N	20241231
63545-761_e4bc65a2-a7e7-fa8e-e053-2995a90a6bad	63545-761	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	12	[hp_C]/1			N	20241231
63545-761_e4bc675e-a9ef-5ccf-e053-2a95a90a4d82	63545-761	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	12	[hp_C]/1			N	20241231
63545-762_e4bc6362-72ba-2905-e053-2a95a90a58b7	63545-762	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	30	[hp_C]/1			N	20241231
63545-762_e4bc6d31-e508-b321-e053-2995a90a831c	63545-762	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	30	[hp_C]/1			N	20241231
63545-763_e4bc26e2-1514-20fc-e053-2a95a90a9f71	63545-763	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	100	[hp_C]/1			N	20241231
63545-763_e4bc2bd2-57ef-51e3-e053-2995a90a246a	63545-763	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	100	[hp_C]/1			N	20241231
63545-763_e4bc675e-a9ed-5ccf-e053-2a95a90a4d82	63545-763	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	100	[hp_C]/1			N	20241231
63545-764_e4bc26e2-1512-20fc-e053-2a95a90a9f71	63545-764	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	200	[hp_C]/1			N	20241231
63545-764_e4bc26e2-1513-20fc-e053-2a95a90a9f71	63545-764	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	200	[hp_C]/1			N	20241231
63545-764_e4bc2bd2-57ee-51e3-e053-2995a90a246a	63545-764	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	200	[hp_C]/1			N	20241231
63545-765_e4bc095a-aa1c-ffbe-e053-2995a90aee3c	63545-765	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	500	[hp_C]/1			N	20241231
63545-765_e4bc095a-aa1d-ffbe-e053-2995a90aee3c	63545-765	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	500	[hp_C]/1			N	20241231
63545-765_e4bc26e2-1511-20fc-e053-2a95a90a9f71	63545-765	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	500	[hp_C]/1			N	20241231
63545-766_e4bbea8b-6b9a-328e-e053-2995a90ad187	63545-766	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	1	[hp_M]/1			N	20241231
63545-766_e4bc24df-f8d1-f467-e053-2995a90a26b7	63545-766	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	1	[hp_M]/1			N	20241231
63545-766_e4bc24df-f8d2-f467-e053-2995a90a26b7	63545-766	HUMAN OTC DRUG	Aethusa cynapium		Aethusa cynapium	PELLET	ORAL	20191218		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AETHUSA CYNAPIUM	1	[hp_M]/1			N	20241231
63545-767_e4bbd94b-3a11-f7c0-e053-2a95a90abb4b	63545-767	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	12	[hp_C]/1			N	20241231
63545-767_e4bbea8b-6b98-328e-e053-2995a90ad187	63545-767	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	12	[hp_C]/1			N	20241231
63545-767_e4bbea8b-6b99-328e-e053-2995a90ad187	63545-767	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	12	[hp_C]/1			N	20241231
63545-768_e4bbc2ad-e566-3958-e053-2995a90a7478	63545-768	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	30	[hp_C]/1			N	20241231
63545-768_e4bbc487-0968-cbba-e053-2995a90a67cf	63545-768	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	30	[hp_C]/1			N	20241231
63545-768_e4bbd94b-3a10-f7c0-e053-2a95a90abb4b	63545-768	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	30	[hp_C]/1			N	20241231
63545-769_e4bb9d18-2d90-d776-e053-2a95a90a4b15	63545-769	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	100	[hp_C]/1			N	20241231
63545-769_e4bb9d18-2d91-d776-e053-2a95a90a4b15	63545-769	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	100	[hp_C]/1			N	20241231
63545-769_e4bbc2ad-e565-3958-e053-2995a90a7478	63545-769	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	100	[hp_C]/1			N	20241231
63545-770_e4bbae98-09b1-f028-e053-2a95a90a169a	63545-770	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	200	[hp_C]/1			N	20241231
63545-770_e4bbae98-09b3-f028-e053-2a95a90a169a	63545-770	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	200	[hp_C]/1			N	20241231
63545-770_e4bbbf88-0846-29b1-e053-2a95a90a4e07	63545-770	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	200	[hp_C]/1			N	20241231
63545-771_e4ab70c1-495a-d51b-e053-2995a90adb29	63545-771	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	500	[hp_C]/1			N	20241231
63545-771_e4ab8e34-a656-f110-e053-2995a90a4b7c	63545-771	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	500	[hp_C]/1			N	20241231
63545-771_e4ab9723-828c-1f64-e053-2995a90aaf1c	63545-771	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	500	[hp_C]/1			N	20241231
63545-772_e4ab70c1-4959-d51b-e053-2995a90adb29	63545-772	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	1	[hp_M]/1			N	20241231
63545-772_e4ab8bee-27a9-e482-e053-2995a90a8626	63545-772	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	1	[hp_M]/1			N	20241231
63545-772_e4ab8bee-27aa-e482-e053-2995a90a8626	63545-772	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	1	[hp_M]/1			N	20241231
63545-773_e4ab391f-9565-0cff-e053-2995a90a45d2	63545-773	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	10	[hp_M]/1			N	20241231
63545-773_e4ab6aea-148e-2de8-e053-2995a90af82d	63545-773	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	10	[hp_M]/1			N	20241231
63545-773_e4ab6f59-2167-7760-e053-2995a90a05b9	63545-773	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	10	[hp_M]/1			N	20241231
63545-774_e4ab377f-5b44-7734-e053-2995a90afb8c	63545-774	HUMAN OTC DRUG	Agaricus muscarius		Agaricus muscarius	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMANITA MUSCARIA FRUITING BODY	1	[hp_Q]/1			N	20241231
63545-776_e4a9afde-6f72-0dea-e053-2995a90a04f4	63545-776	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	30	[hp_C]/1			N	20241231
63545-776_e4a9ca27-9622-2cf9-e053-2a95a90a20b2	63545-776	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	30	[hp_C]/1			N	20241231
63545-776_e4a9ca27-9623-2cf9-e053-2a95a90a20b2	63545-776	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	30	[hp_C]/1			N	20241231
63545-777_e4a9ca27-9620-2cf9-e053-2a95a90a20b2	63545-777	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	100	[hp_C]/1			N	20241231
63545-777_e4a9ca27-9621-2cf9-e053-2a95a90a20b2	63545-777	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	100	[hp_C]/1			N	20241231
63545-777_e4a9cd6d-b2b3-447f-e053-2995a90a6471	63545-777	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	100	[hp_C]/1			N	20241231
63545-778_e4a8e5c2-1fee-e65a-e053-2995a90a2045	63545-778	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	200	[hp_C]/1			N	20241231
63545-778_e4a9ca27-961f-2cf9-e053-2a95a90a20b2	63545-778	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	200	[hp_C]/1			N	20241231
63545-778_e4a9cbd2-d162-0f95-e053-2a95a90a07f1	63545-778	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	200	[hp_C]/1			N	20241231
63545-779_e4a8e2fe-c8de-f933-e053-2a95a90aace2	63545-779	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	500	[hp_C]/1			N	20241231
63545-779_e4a8e3a8-6d44-19f8-e053-2995a90a7b2f	63545-779	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	500	[hp_C]/1			N	20241231
63545-779_e4a9c1c3-4186-2d2f-e053-2995a90af63c	63545-779	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	500	[hp_C]/1			N	20241231
63545-780_e4a8b313-78a8-08a5-e053-2a95a90a60ff	63545-780	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	1	[hp_M]/1			N	20241231
63545-780_e4a8e2fe-c8dd-f933-e053-2a95a90aace2	63545-780	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	1	[hp_M]/1			N	20241231
63545-780_e4a8e3a8-6d43-19f8-e053-2995a90a7b2f	63545-780	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	1	[hp_M]/1			N	20241231
63545-781_e4a8b194-caef-1ce6-e053-2995a90abdcb	63545-781	HUMAN OTC DRUG	Agnus castus		Agnus castus	PELLET	ORAL	20191227		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	CHASTE TREE	1	[hp_Q]/1			N	20241231
63545-782_eecc8713-2edd-577d-e053-2995a90a2923	63545-782	HUMAN OTC DRUG	Agraphis nutans		Agraphis nutans	PELLET	ORAL	20200106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	HYACINTHOIDES NON-SCRIPTA	12	[hp_C]/1			N	20241231
63545-782_eecc89e4-24b1-e27d-e053-2995a90aae1d	63545-782	HUMAN OTC DRUG	Agraphis nutans		Agraphis nutans	PELLET	ORAL	20200106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	HYACINTHOIDES NON-SCRIPTA	12	[hp_C]/1			N	20241231
63545-782_eecc941b-97a3-fd6f-e053-2995a90a4196	63545-782	HUMAN OTC DRUG	Agraphis nutans		Agraphis nutans	PELLET	ORAL	20200106		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	HYACINTHOIDES NON-SCRIPTA	12	[hp_C]/1			N	20241231
63545-900_ef6a71d3-6d2b-57e3-e053-2995a90ae4f3	63545-900	HUMAN OTC DRUG	Aluminium sulphuricum		Aluminium sulphuricum	PELLET	ORAL	20200429		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ALUMINUM SULFATE	100	[hp_C]/1			N	20241231
63545-950_efa3b455-2592-4cf8-e053-2995a90a225f	63545-950	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20201021		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM CHLORIDE	12	[hp_C]/1			N	20241231
63545-951_efa3b455-2592-4cf8-e053-2995a90a225f	63545-951	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20201021		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM CHLORIDE	30	[hp_C]/1			N	20241231
63545-952_efa3b455-2592-4cf8-e053-2995a90a225f	63545-952	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20201021		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM CHLORIDE	100	[hp_C]/1			N	20241231
63545-953_efa3b455-2592-4cf8-e053-2995a90a225f	63545-953	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20201021		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM CHLORIDE	200	[hp_C]/1			N	20241231
63545-954_efa3b455-2592-4cf8-e053-2995a90a225f	63545-954	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20201021		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM CHLORIDE	500	[hp_C]/1			N	20241231
63545-955_efa3b455-2592-4cf8-e053-2995a90a225f	63545-955	HUMAN OTC DRUG	Ammonium Muriaticum		Ammonium Muriaticum	PELLET	ORAL	20201021		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM CHLORIDE	1	[hp_M]/1			N	20241231
63545-956_efa3a8ae-c69e-08f7-e053-2995a90a4f27	63545-956	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20201023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM PHOSPHATE, DIBASIC	12	[hp_C]/1			N	20241231
63545-957_efa3a8ae-c69e-08f7-e053-2995a90a4f27	63545-957	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20201023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM PHOSPHATE, DIBASIC	30	[hp_C]/1			N	20241231
63545-958_efa3a8ae-c69e-08f7-e053-2995a90a4f27	63545-958	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20201023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM PHOSPHATE, DIBASIC	100	[hp_C]/1			N	20241231
63545-959_efa3a8ae-c69e-08f7-e053-2995a90a4f27	63545-959	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20201023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM PHOSPHATE, DIBASIC	200	[hp_C]/1			N	20241231
63545-960_efa3a8ae-c69e-08f7-e053-2995a90a4f27	63545-960	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20201023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM PHOSPHATE, DIBASIC	500	[hp_C]/1			N	20241231
63545-961_efa3a8ae-c69e-08f7-e053-2995a90a4f27	63545-961	HUMAN OTC DRUG	Ammonium Phosphoricum		Ammonium Phosphoricum	PELLET	ORAL	20201023		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	AMMONIUM PHOSPHATE, DIBASIC	1	[hp_M]/1			N	20241231
63545-962_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-962	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	6	[hp_C]/1			N	20241231
63545-963_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-963	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	12	[hp_C]/1			N	20241231
63545-964_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-964	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	30	[hp_C]/1			N	20241231
63545-965_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-965	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	100	[hp_C]/1			N	20241231
63545-966_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-966	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	200	[hp_C]/1			N	20241231
63545-967_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-967	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	500	[hp_C]/1			N	20241231
63545-968_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-968	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	1	[hp_M]/1			N	20241231
63545-969_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-969	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	10	[hp_M]/1			N	20241231
63545-970_efa3a8ae-c69d-08f7-e053-2995a90a4f27	63545-970	HUMAN OTC DRUG	Anacardium Occidentale		Anacardium Occidentale	PELLET	ORAL	20201102		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANACARDIUM OCCIDENTALE FRUIT	1	[hp_Q]/1			N	20241231
63545-971_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-971	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	6	[hp_C]/1			N	20241231
63545-972_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-972	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	12	[hp_C]/1			N	20241231
63545-973_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-973	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	30	[hp_C]/1			N	20241231
63545-974_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-974	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	100	[hp_C]/1			N	20241231
63545-975_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-975	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	200	[hp_C]/1			N	20241231
63545-976_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-976	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	500	[hp_C]/1			N	20241231
63545-977_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-977	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	1	[hp_M]/1			N	20241231
63545-978_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-978	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	10	[hp_M]/1			N	20241231
63545-979_ef6aa8f8-7d21-780b-e053-2995a90a222f	63545-979	HUMAN OTC DRUG	Anacardium Orientale		Anacardium Orientale	PELLET	ORAL	20201110		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	SEMECARPUS ANACARDIUM JUICE	1	[hp_Q]/1			N	20241231
63545-980_ef6a86f1-40b6-ea77-e053-2a95a90a4f74	63545-980	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvernsis	PELLET	ORAL	20201116		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANAGALLIS ARVENSIS WHOLE	12	[hp_C]/1			N	20241231
63545-981_ef6a86f1-40b6-ea77-e053-2a95a90a4f74	63545-981	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvernsis	PELLET	ORAL	20201116		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANAGALLIS ARVENSIS WHOLE	30	[hp_C]/1			N	20241231
63545-982_ef6a86f1-40b6-ea77-e053-2a95a90a4f74	63545-982	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvernsis	PELLET	ORAL	20201116		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANAGALLIS ARVENSIS WHOLE	100	[hp_C]/1			N	20241231
63545-983_ef6a86f1-40b6-ea77-e053-2a95a90a4f74	63545-983	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvernsis	PELLET	ORAL	20201116		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANAGALLIS ARVENSIS WHOLE	200	[hp_C]/1			N	20241231
63545-984_ef6a86f1-40b6-ea77-e053-2a95a90a4f74	63545-984	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvernsis	PELLET	ORAL	20201116		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANAGALLIS ARVENSIS WHOLE	500	[hp_C]/1			N	20241231
63545-985_ef6a86f1-40b6-ea77-e053-2a95a90a4f74	63545-985	HUMAN OTC DRUG	Anagallis Arvensis		Anagallis Arvernsis	PELLET	ORAL	20201116		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANAGALLIS ARVENSIS WHOLE	1	[hp_M]/1			N	20241231
63545-991_ef6a784b-3d0c-da51-e053-2a95a90ad05d	63545-991	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20201216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DILL	6	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63545-992_ef6a784b-3d0c-da51-e053-2a95a90ad05d	63545-992	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20201216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DILL	12	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63545-993_ef6a784b-3d0c-da51-e053-2a95a90ad05d	63545-993	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20201216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DILL	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63545-994_ef6a784b-3d0c-da51-e053-2a95a90ad05d	63545-994	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20201216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DILL	100	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63545-995_ef6a784b-3d0c-da51-e053-2a95a90ad05d	63545-995	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20201216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DILL	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63545-996_ef6a784b-3d0c-da51-e053-2a95a90ad05d	63545-996	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20201216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DILL	500	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63545-997_ef6a784b-3d0c-da51-e053-2a95a90ad05d	63545-997	HUMAN OTC DRUG	Anethum Graveolens		Anethum Graveolens	PELLET	ORAL	20201216		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	DILL	1	[hp_M]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63545-998_ef6a6e71-d65a-9c58-e053-2a95a90a4b6d	63545-998	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANGOSTURA BARK	6	[hp_C]/1			N	20241231
63545-999_ef6a6e71-d65a-9c58-e053-2a95a90a4b6d	63545-999	HUMAN OTC DRUG	Angustura Vera		Angustura Vera	PELLET	ORAL	20201222		UNAPPROVED HOMEOPATHIC		Hahnemann Laboratories, Inc.	ANGOSTURA BARK	12	[hp_C]/1			N	20241231
63548-0101_bf9467df-5c81-4b04-8ca3-e3f9104132e9	63548-0101	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20170227		ANDA	ANDA207867	PLD Acquisitions LLC DBA Avma Pharma Solutions	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63548-0102_bf9467df-5c81-4b04-8ca3-e3f9104132e9	63548-0102	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20170227		ANDA	ANDA207867	PLD Acquisitions LLC DBA Avma Pharma Solutions	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63548-0185_eced939d-605e-48f9-a547-4f9cb71300f7	63548-0185	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20130801	20250202	ANDA	ANDA076460	PLD Acquisitions LLC DBA Avma Pharma Solutions	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63548-0234_616902bc-ffd6-41d3-ae4d-6e30519147c0	63548-0234	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20130801		ANDA	ANDA076460	PLD Acquisitions LLC DBA Avma Pharma Solutions	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63548-0262_d03276cf-e4bf-42d9-9897-4e00d49d6106	63548-0262	HUMAN OTC DRUG	Nicotine	Mini	nicotine polacrilex	LOZENGE	ORAL	20190401		ANDA	ANDA207868	PLD Acquisitions LLC DBA Avma Pharma Solutions	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63548-0264_d03276cf-e4bf-42d9-9897-4e00d49d6106	63548-0264	HUMAN OTC DRUG	Nicotine	Mini	nicotine polacrilex	LOZENGE	ORAL	20190401		ANDA	ANDA207868	PLD Acquisitions LLC DBA Avma Pharma Solutions	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63548-0662_ad1479f7-87d7-489b-aff5-e547de25edfe	63548-0662	HUMAN OTC DRUG	Childrens Allergy Relief		Fexofenadine HCL	TABLET	ORAL	20191001		ANDA	ANDA204097	PLD Acquisitions LLC DBA Avma Pharma Solutions	FEXOFENADINE HYDROCHLORIDE	30	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63548-0663_12832954-b355-49a3-9f33-7cc163d16298	63548-0663	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20191001		ANDA	ANDA204097	PLD Acquisitions LLC DBA Avma Pharma Solutions	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63548-0664_df845ee9-b17a-484f-be90-1918450c6b75	63548-0664	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20191001		ANDA	ANDA204097	PLD Acquisitions LLC DBA Avma Pharma Solutions	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63548-0739_a06103f0-b1c2-42e5-9089-7d1cd3f694e3	63548-0739	HUMAN OTC DRUG	Indoor outdoor allergies		Cetirizine HCl	TABLET	ORAL	20190701		ANDA	ANDA077946	PLD Acquisitions LLC DBA Avma Pharma Solutions	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63548-0753_c24222bc-72ef-4c15-b7c2-9401fe5f40a6	63548-0753	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20181030		ANDA	ANDA075209	PLD Acquisitions LLC DBA Avma Pharma Solutions	LORATADINE	10	mg/1			N	20241231
63550-108_eecaf2b7-a8fc-0219-e053-2a95a90a387a	63550-108	HUMAN OTC DRUG	Moisturizer Maple day SPF15		Moisturizer Maple day SPF15	CREAM	TOPICAL	20011101		OTC MONOGRAPH FINAL	part352	Kamins Dermatologics Inc.	AVOBENZONE; OCTINOXATE; OXYBENZONE	20; 75; 45	mg/g; mg/g; mg/g			N	20241231
63550-114_eeca812d-b153-1e04-e053-2a95a90a274f	63550-114	HUMAN OTC DRUG	LIP BALM		OCTINOXATE OXYBENZONE ZINC OXIDE	OINTMENT	TOPICAL	20040201		OTC MONOGRAPH FINAL	part352	Kamins Dermatologics Inc.	OCTINOXATE; OXYBENZONE; ZINC OXIDE	75; 50; 40	mg/g; mg/g; mg/g			N	20241231
63550-119_eec867d8-7e58-db8a-e053-2995a90a7c93	63550-119	HUMAN OTC DRUG	Acne Wash		Salicylic acid	SOLUTION	TOPICAL	20041001		OTC MONOGRAPH FINAL	part358B	Kamins Dermatologics	SALICYLIC ACID	20	mg/mL			N	20241231
63550-120_eec9b264-b0f8-0549-e053-2995a90a8858	63550-120	HUMAN OTC DRUG	DAY C		AVOBENZONE OCTINOXATE OXYBENZONE	CREAM	TOPICAL	20031001		OTC MONOGRAPH FINAL	part352	Kamins Dermatologics Inc.	AVOBENZONE; OCTINOXATE; OXYBENZONE	20; 70; 50	mg/g; mg/g; mg/g			N	20241231
63550-122_eeca4350-d0b9-5f00-e053-2995a90a2751	63550-122	HUMAN OTC DRUG	DAY L		AVOBENZONE OCTISALATE OCTINOXATE	LOTION	TOPICAL	20040301		OTC MONOGRAPH FINAL	part352	Kamins Dermatologics Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	25; 75; 40	mg/mL; mg/mL; mg/mL			N	20241231
63550-154_eec8b847-a3ed-4514-e053-2995a90a2f13	63550-154	HUMAN OTC DRUG	Anti-Blemish		Salicylic Acid	DISC	TOPICAL	20100801		OTC MONOGRAPH FINAL	part333D	Kamins Dermatologics Inc.	SALICYLIC ACID	20	mg/1			N	20241231
63550-191_eecacfc5-8bae-635c-e053-2a95a90ad670	63550-191	HUMAN OTC DRUG	Matte Moisturizer SPF 15		OCTINOXATE OCTISALATE AVOBENZONE	CREAM	TOPICAL	20101001		OTC MONOGRAPH FINAL	part352	Kamins Dermatologics Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	25; 75; 40	mg/mL; mg/mL; mg/mL			N	20241231
63550-192_eecb2903-8256-a4e6-e053-2995a90aba16	63550-192	HUMAN OTC DRUG	Soothing Day SPF 15		AVOBENZONE OCTINOXATE OXYBENZONE	CREAM	TOPICAL	20101001		OTC MONOGRAPH FINAL	part352	Kamins Dermatologics Inc.	AVOBENZONE; OCTINOXATE; OXYBENZONE	20; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
63550-193_eec955b1-676d-7ddc-e053-2995a90ad4b5	63550-193	HUMAN OTC DRUG	Blemish		Benzoyl peroxide	GEL	TOPICAL	20101001		OTC MONOGRAPH FINAL	part333D	Kamins Dermatologics Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
63553-001_07614d66-6c5f-57df-e063-6294a90a5bb1	63553-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190130		NDA	NDA205767	Life Supply Corp	OXYGEN	99	L/100L			N	20241231
63560-001_0762982e-5619-4595-e063-6394a90a58b3	63560-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19980501		UNAPPROVED MEDICAL GAS		Memorial Home Services of Central Illinois, Inc.	OXYGEN	992	mL/L			N	20241231
63561-0173_0d956873-02ee-650b-e063-6294a90ae305	63561-0173	HUMAN PRESCRIPTION DRUG	Methocarbamol Tablets, USP, 500 mg		Methocarbamol	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA212623	Granulation Technology, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63561-0174_0d956873-02ee-650b-e063-6294a90ae305	63561-0174	HUMAN PRESCRIPTION DRUG	Methocarbamol Tablets, USP, 750 mg		Methocarbamol	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA212623	Granulation Technology, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63561-0178_06e6abb2-42ec-5536-e063-6394a90a8a79	63561-0178	HUMAN OTC DRUG	Astringent		Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate	POWDER, FOR SOLUTION	TOPICAL	20231005		OTC MONOGRAPH NOT FINAL	part347	Granulation Technology, Inc.	ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE	1347; 952	mg/2299mg; mg/2299mg	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
63580-269_0da8eb7f-2e13-a7d5-e063-6294a90a88e7	63580-269	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Coastal Med-Tech Corp.	OXYGEN	99	L/100L			N	20241231
63615-000_0888b5f3-0425-f641-e063-6394a90a89c2	63615-000	HUMAN OTC DRUG	Cavity Protection Fresh Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20140523		OTC MONOGRAPH DRUG	M021	Oxyfresh Worldwide Inc	SODIUM FLUORIDE	2.35	mg/g			N	20241231
63615-001_088872f1-196c-a108-e063-6394a90adbfb	63615-001	HUMAN OTC DRUG	Cavity Protection Fresh Mint Anticavity Mouthwash		SODIUM FLUORIDE	MOUTHWASH	ORAL	20140523		OTC MONOGRAPH DRUG	M021	Oxyfresh Worldwide Inc	SODIUM FLUORIDE	.5	mg/mL			N	20241231
63621-335_0a5f32b4-43e5-7b27-e063-6394a90a4732	63621-335	HUMAN OTC DRUG	Prestige		Chloroxylenol	SOAP	TOPICAL	20200403		OTC MONOGRAPH DRUG	505G(a)(3)	Sunburst Chemicals, Inc.	CHLOROXYLENOL	10	mg/mL			N	20241231
63621-353_0a498306-4cc0-0a9c-e063-6394a90aa024	63621-353	HUMAN OTC DRUG	SunDrops 67		Chloroxylenol	SOAP	TOPICAL	20080214	20240630	OTC MONOGRAPH DRUG	505G(a)(3)	Sunburst Chemicals, Inc.	CHLOROXYLENOL	7.5	mg/mL			N	
63621-354_0a5d10a5-d5e1-c4b5-e063-6294a90a3283	63621-354	HUMAN OTC DRUG	SunDrops 77		Benzalkonium Chloride	SOAP	TOPICAL	20080505		OTC MONOGRAPH DRUG	505G(a)(3)	Sunburst Chemicals, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
63621-356_0a5b9639-4ef8-a652-e063-6394a90ac181	63621-356	HUMAN OTC DRUG	SunDrops 75		Alcohol	GEL	TOPICAL	20091014		OTC MONOGRAPH DRUG	505G(a)(3)	Sunburst Chemicals, Inc.	ALCOHOL	.6	mL/mL			N	20241231
63621-387_0a5dc604-737b-d8c3-e063-6294a90a3251	63621-387	HUMAN OTC DRUG	SunDrops 87		Benzalkonium Chloride	SOAP	TOPICAL	20200608		OTC MONOGRAPH DRUG	505G(a)(3)	Sunburst Chemicals, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
63629-1010_fc632cb9-a546-07a9-e053-6394a90a63b9	63629-1010	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
63629-1011_9a391820-15b4-4c0b-a02d-4c0f76845bbc	63629-1011	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-1012_9a391820-15b4-4c0b-a02d-4c0f76845bbc	63629-1012	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-1013_9e2e08e6-20e8-4c9e-ab57-8400529b0408	63629-1013	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Bryant Ranch Prepack	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
63629-1014_9e2e08e6-20e8-4c9e-ab57-8400529b0408	63629-1014	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
63629-1018_fbd3ec3b-2a09-a318-e053-6294a90a33e8	63629-1018	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Bryant Ranch Prepack	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1023_0c230256-e475-41f3-94d9-05217d383eeb	63629-1023	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20071102		ANDA	ANDA077955	Bryant Ranch Prepack	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
63629-1024_ff242576-5fe6-4693-933a-ae9721e7c3a3	63629-1024	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20071102		ANDA	ANDA077955	Bryant Ranch Prepack	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
63629-1027_c513c20b-ef58-4df1-8cce-ab397ef8e67c	63629-1027	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20120116		ANDA	ANDA090635	Bryant Ranch Prepack	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1028_a89b4b31-56c2-4244-9fde-243c28217873	63629-1028	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
63629-1030_3d13e4a7-637c-473a-97bf-5ad155676c60	63629-1030	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
63629-1031_05ce0a40-2603-45c7-a4f4-d8d26c7e7362	63629-1031	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
63629-1032_0d0e6eac-4998-4f1b-bd51-f9e4dae549c7	63629-1032	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
63629-1033_27b391a3-b031-4b8a-9164-aee436aeac1f	63629-1033	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
63629-1034_171760f9-9534-46ce-aba8-47b93d10e521	63629-1034	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
63629-1035_5f85d98e-af91-4bd4-82e8-adc7589ed8f1	63629-1035	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
63629-1036_290d0d8c-5d7d-4c0d-b47b-a75ab6838532	63629-1036	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
63629-1037_94cba410-6885-4da4-9e03-6b7184e0bf0c	63629-1037	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
63629-1038_8f5b8410-b4f5-4615-b958-2dd941218b4b	63629-1038	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
63629-1039_b5197fe1-bf14-4aef-aeb1-9bd0d02e1c92	63629-1039	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
63629-1040_fbd454af-3520-3311-e053-6394a90a7e66	63629-1040	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1041_fbd5beb1-15ce-92df-e053-6394a90ac626	63629-1041	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1042_fbd5beb1-15ce-92df-e053-6394a90ac626	63629-1042	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1043_f477c0f7-1bd7-4c12-877a-ba8d77554c92	63629-1043	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
63629-1044_fbec1189-5c39-a0e8-e053-6394a90aa02f	63629-1044	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1045_fbfb282f-1918-1b18-e053-6294a90a1d2d	63629-1045	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1046_98bc3962-2a5f-4014-abf8-22e415bbcb21	63629-1046	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20130923		ANDA	ANDA075274	Bryant Ranch Prepack	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
63629-1047_080161d0-f74b-8701-e063-6294a90a8be9	63629-1047	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20130923		ANDA	ANDA075274	Bryant Ranch Prepack	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
63629-1048_fbfb4a5e-fbe0-947a-e053-6294a90a1606	63629-1048	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20110415		ANDA	ANDA075517	Bryant Ranch Prepack	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
63629-1057_a11a6ac3-61ee-4104-b037-e4b854fe38cf	63629-1057	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
63629-1061_66e6330a-83b8-4e65-909b-20bc2c562a5f	63629-1061	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1062_ed0df415-6189-4615-a330-c54e0eb7eb8c	63629-1062	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1063_83f05fc3-fe2a-4866-b224-53f7ef67e5e9	63629-1063	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20200605		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1064_4d06ef13-3833-4324-85d6-c0c93cf163e0	63629-1064	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1065_019271f9-48b7-4be8-a4f6-5245c10e7372	63629-1065	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1066_5ba1a568-266f-4dfe-94b1-0264778324a0	63629-1066	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1067_df634fb8-5504-487a-8bae-b17dd0c82d16	63629-1067	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1068_8f649a95-4bcb-4c23-bbc3-640639e6d5fe	63629-1068	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		Spironolactone and Hydrochlorothiazide	TABLET	ORAL	19870702		ANDA	ANDA089534	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-1069_78b56756-a377-4166-8fb1-8f859e708ca4	63629-1069	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		Spironolactone and Hydrochlorothiazide	TABLET	ORAL	19870702		ANDA	ANDA089534	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-1071_fbfcc5e3-bce7-3305-e053-6394a90a7c2e	63629-1071	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		Spironolactone and Hydrochlorothiazide	TABLET	ORAL	19870702		ANDA	ANDA089534	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-1072_a29598e5-59c6-4c6e-a817-739d5413094d	63629-1072	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA076368	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1073_723036bc-d678-4d3f-b25d-e59ee24e30be	63629-1073	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20191120		ANDA	ANDA076368	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1074_ec94a868-2c46-491d-8b1d-39f2de2e5400	63629-1074	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA076368	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1075_6771a977-16a2-4503-a1e0-9a24ca6967fa	63629-1075	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA076368	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1076_fbfe27f5-bff9-fc52-e053-6294a90ac742	63629-1076	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA208864	Bryant Ranch Prepack	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1077_fbfe6b64-139c-5280-e053-6294a90ac220	63629-1077	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA208864	Bryant Ranch Prepack	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1078_72118355-8372-4491-9a71-416125e6634d	63629-1078	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA208864	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1079_fbfeb214-d81c-af9a-e053-6394a90a1ba7	63629-1079	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200102		ANDA	ANDA208864	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1080_fbfed17b-7698-9b44-e053-6394a90a76a6	63629-1080	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA208864	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63629-1085_61c96bf8-91ef-4e2c-a0e4-ab451aa8d632	63629-1085	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	20200705		ANDA	ANDA072709	Bryant Ranch Prepack	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-1086_236dceaa-cec4-48ef-91b5-3371e3d92d87	63629-1086	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	19951214		ANDA	ANDA072709	Bryant Ranch Prepack	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-1087_b064d348-3af3-40a1-8320-de5f40ad5b40	63629-1087	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1088_674599fb-b61f-4da9-b39b-f1f5620caacd	63629-1088	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1089_1e3029f7-2b1f-4143-9cca-f86567886f44	63629-1089	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1090_fbff63e2-90ec-190c-e053-6394a90a73d4	63629-1090	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1091_9de19424-d647-4f96-8f0e-46daf079e555	63629-1091	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1092_155990c5-1e73-446b-b66e-3751eeb31abc	63629-1092	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1093_10281c7c-612d-4f99-9588-21a77f1fc5b4	63629-1093	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1094_892c042f-da95-47f7-a47c-ce27b5882710	63629-1094	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1095_5ed3a7af-4bd9-4d2c-aee8-efcd27c54d26	63629-1095	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1099_fc00265d-3e23-e09a-e053-6394a90a7f61	63629-1099	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200918		ANDA	ANDA076635	Bryant Ranch Prepack	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63629-1100_0801dc92-96c8-8279-e063-6294a90a4f9c	63629-1100	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200918		ANDA	ANDA076635	Bryant Ranch Prepack	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63629-1101_fc007faa-c843-e727-e053-6394a90a929b	63629-1101	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200918		ANDA	ANDA076635	Bryant Ranch Prepack	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
63629-1102_935934c2-8b94-42fb-8360-5bf08eab0522	63629-1102	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-1103_963f6fe1-d577-48de-9d5b-981b5c1af797	63629-1103	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-1104_8cdf525e-5d05-4d53-8111-84490f61fc47	63629-1104	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
63629-1105_22ccf17e-a341-444f-8b24-47e684744b81	63629-1105	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
63629-1106_ef1bd683-477c-41c3-a624-04690d707fad	63629-1106	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20200617		ANDA	ANDA040526	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1107_f14ba46c-5d83-425c-a495-b2fd98a788c0	63629-1107	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20200617		ANDA	ANDA040526	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1108_b92a2a34-1236-4f4b-a6fe-c7e01ae223e5	63629-1108	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20200617		ANDA	ANDA040526	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-1111_428d259f-6ef6-4086-b6d3-c32dac048044	63629-1111	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200301		ANDA	ANDA211767	Bryant Ranch Prepack	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63629-1114_4d1b4976-f17c-402e-bd3a-c49e320572b2	63629-1114	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200730		ANDA	ANDA211861	Bryant Ranch Prepack	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1115_4d1b4976-f17c-402e-bd3a-c49e320572b2	63629-1115	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200730		ANDA	ANDA211861	Bryant Ranch Prepack	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1116_fc64e9c4-8718-8492-e053-6394a90a7fd2	63629-1116	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20200730		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1117_e3cb1ae5-2201-4bd9-9219-bd980c1584a5	63629-1117	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20161205		ANDA	ANDA203713	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
63629-1118_bfa44376-0f36-4803-add3-5304205fc5f2	63629-1118	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20200730		ANDA	ANDA203713	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-1119_cdc473a0-6e31-425f-adc9-b7921bb1d3f6	63629-1119	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20200730		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-1120_620c9a96-bc8b-4966-ab6d-3a77ecb29747	63629-1120	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20200730		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-1121_ee3f914a-a497-405a-8117-4dfdf8a24ab9	63629-1121	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
63629-1123_48c14203-9c72-4ca5-abb1-8e20921b9c4f	63629-1123	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20171215		ANDA	ANDA086989	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1124_583bb782-f1cf-4d0d-b836-a07760de451d	63629-1124	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130115		ANDA	ANDA086988	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1126_5b405dbe-2ad9-421a-b13d-e12727960f5e	63629-1126	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20180725		OTC MONOGRAPH FINAL	part331	Bryant Ranch Prepack	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63629-1130_19092ede-4ab2-4066-861b-42eb7a7b116d	63629-1130	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	.25	mg/1			N	20241231
63629-1131_00a110ab-9f58-4596-9748-aa7f1f83f612	63629-1131	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	.5	mg/1			N	20241231
63629-1132_d093ffd0-ecb2-4de1-b96c-d93576286cea	63629-1132	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	.5	mg/1			N	20241231
63629-1133_f2114eaf-a1f2-4229-95a5-f7917fb92422	63629-1133	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	1	mg/1			N	20241231
63629-1134_43427c83-fe19-44fb-b5c8-ac73365c064d	63629-1134	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; .25; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
63629-1135_7a10df22-2df3-4380-ba65-c67c78e67aa6	63629-1135	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; .25; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
63629-1136_871bbf2a-9922-46f3-8568-4958adb60245	63629-1136	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; .5; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
63629-1137_66cc3d5e-7001-405b-9189-eff07dc74675	63629-1137	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; .5; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
63629-1138_63a77183-16bd-49e9-9773-3d04ac77f931	63629-1138	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; 1; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
63629-1139_8ab02edb-3f85-4a82-bc7c-ea3cd1acb684	63629-1139	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		.ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A and VITAMIN D	TABLET, CHEWABLE	ORAL	20180720		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	.ALPHA.-TOCOPHEROL ACETATE, DL-; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; NIACIN; PYRIDOXINE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A; VITAMIN D	15; 60; 4.5; 300; 13.5; 1.05; 1.2; 1; 1.05; 2500; 400	[iU]/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
63629-1140_d0a3976a-dc8f-4a4c-a35b-30de5afc4ba1	63629-1140	HUMAN PRESCRIPTION DRUG	M-Natal Plus		Vitamin A, Vitamin C, Vitamin D, Vitamin E, Thiamine, Riboflavin, Niacin, Vitamin B6, Folic Acid, Vitamin B12, Calcium, Iron, Zinc, Copper	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; CALCIUM; COPPER; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE; VITAMIN A; VITAMIN D; ZINC	22; 120; 200; 2; 12; 27; 1; 20; 10; 3; 1.84; 4000; 400; 25	[iU]/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calcium [CS], Calcium [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
63629-1141_dfdd87a3-ce7a-41ba-9a8e-894a4946f5eb	63629-1141	HUMAN PRESCRIPTION DRUG	Tri-Vite Drops with Fluoride		ASCORBIC ACID, SODIUM FLUORIDE, VITAMIN A and VITAMIN D	SOLUTION	ORAL	20180725		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ASCORBIC ACID; SODIUM FLUORIDE; VITAMIN A; VITAMIN D	35; .5; 1500; 400	mg/mL; mg/mL; [iU]/mL; [iU]/mL	Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin C [EPC]		N	20241231
63629-1145_42be2a74-078c-4c13-8e76-a2410dcc4ace	63629-1145	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCl 100mg		Phenazopyridine Hydrochloride	TABLET	ORAL	20141231		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
63629-1146_ea7abc32-10ae-49be-831f-01e32b0db598	63629-1146	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCl 200mg		Phenazopyridine Hydrochloride	TABLET	ORAL	20141231		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
63629-1148_4cc83307-06e4-4fa1-bd1d-6422c1b25dbf	63629-1148	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		selenium sulfide	SHAMPOO	TOPICAL	20150601		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SELENIUM SULFIDE	22.5	mg/mL			N	20241231
63629-1149_331e28d1-eb5e-4749-ad8f-6880c91fd5b3	63629-1149	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		selenium sulfide	SHAMPOO	TOPICAL	20180405		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SELENIUM SULFIDE	23	mg/mL			N	20241231
63629-1151_38e30708-ba29-4652-bd85-490d31901968	63629-1151	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 Plus		Sodium Fluoride	CREAM	DENTAL	20190528		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	5	mg/g			N	20241231
63629-1155_0c2b9671-522d-4f84-8a97-373bb98df41f	63629-1155	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan Hydrobromide		Guaifenesin and Dextromethorphan Hydrobromide	SYRUP	ORAL	20160614		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63629-1156_863892f2-737f-409d-8cc1-2a8727757d4c	63629-1156	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	LIQUID	ORAL	20160209		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63629-1157_e1f5e79c-8017-4447-940d-58763ff613a3	63629-1157	HUMAN OTC DRUG	M-PAP		Acetaminophen	LIQUID	ORAL	20190801		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ACETAMINOPHEN	160	mg/5mL			N	20241231
63629-1158_0ec78413-7153-4587-8748-aee18c243fe1	63629-1158	HUMAN OTC DRUG	M-PAP		Acetaminophen	LIQUID	ORAL	20190801		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ACETAMINOPHEN	160	mg/5mL			N	20241231
63629-1159_2dd88110-f1cd-4854-936a-b25f72f930db	63629-1159	HUMAN OTC DRUG	M-Dryl		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20190801		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63629-1160_dc9d8aa9-c473-4060-947b-01d4feb459c0	63629-1160	HUMAN OTC DRUG	M-Dryl		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20190801		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63629-1161_4e37812e-e342-4a46-9e27-83b382bbdc60	63629-1161	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-1162_732934a4-b3bb-40ee-9f43-d252dfeeea67	63629-1162	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-1163_e6e7bfab-a95b-45af-9f7e-8fc9b6f742ab	63629-1163	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-1164_301684cb-acc3-4d17-8b1d-bbe289c54f04	63629-1164	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-1165_093140c1-5e0a-4c4d-bca8-7b7e39a83b86	63629-1165	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-1166_78b19f7e-fa91-49de-bdd5-b97fb812c676	63629-1166	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-1168_bbe69d4e-6f10-4777-a49b-301a1c34f844	63629-1168	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190808		ANDA	ANDA040245	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
63629-1169_344cb2c0-3024-4343-a08e-f18dc5f864a8	63629-1169	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190808		ANDA	ANDA040245	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
63629-1170_cf5a4ae5-726e-4cae-87a2-70c15cf87784	63629-1170	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-1171_08025a83-212f-c949-e063-6394a90a52bc	63629-1171	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-1172_2634682b-e010-4224-8cba-7995fdd52907	63629-1172	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20130816		ANDA	ANDA090710	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1173_fc10f120-2898-1379-e053-6294a90a5d79	63629-1173	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20200914		ANDA	ANDA212452	Bryant Ranch Prepack	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
63629-1174_fc65434f-8e1f-ecde-e053-6394a90ab918	63629-1174	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20190301		ANDA	ANDA207511	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1175_fc12c2bd-2293-9b42-e053-6294a90a42cc	63629-1175	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20190329		ANDA	ANDA210139	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-1176_766addd2-4d8e-4ce0-b09b-746632c16ac6	63629-1176	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20190329		ANDA	ANDA210139	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1177_fc12f03d-145a-f3cf-e053-6294a90aa85b	63629-1177	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20190617		ANDA	ANDA207509	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-1178_fc13ca4e-554f-0320-e053-6394a90ac234	63629-1178	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Bryant Ranch Prepack	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1179_bd61638a-dd44-4d11-a4b1-c8434230b701	63629-1179	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20200901		ANDA	ANDA207509	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-1180_ffdf8868-26d5-4dea-9e78-fa8055715c74	63629-1180	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20190617		ANDA	ANDA207509	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-1181_bd61638a-dd44-4d11-a4b1-c8434230b701	63629-1181	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20200901		ANDA	ANDA207509	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-1183_42849223-11eb-4d4e-837f-df3baf8a2b38	63629-1183	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20190617		ANDA	ANDA207509	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-1184_bd61638a-dd44-4d11-a4b1-c8434230b701	63629-1184	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20200901		ANDA	ANDA207509	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-1185_fc13ff80-ac59-50fb-e053-6294a90a0d57	63629-1185	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 15	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63629-1186_913726ca-0f6a-4dc8-9b34-599663456014	63629-1186	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63629-1188_d8bcdf3a-4873-42e5-bc50-b07b47d6d82e	63629-1188	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
63629-1190_44718767-e131-4f39-879e-8628abe64d87	63629-1190	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
63629-1191_d6309100-2407-4823-bab7-facf5353b7bd	63629-1191	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Bryant Ranch Prepack	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1194_fc14349f-a6b9-8c57-e053-6294a90af1cb	63629-1194	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20201113		ANDA	ANDA214282	Bryant Ranch Prepack	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
63629-1195_08031467-57cf-f232-e063-6394a90a4092	63629-1195	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20201113		ANDA	ANDA214282	Bryant Ranch Prepack	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
63629-1196_fc14b711-12dc-0bdf-e053-6294a90a0fc0	63629-1196	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Bryant Ranch Prepack	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1197_fc4d9915-f24a-0107-e053-6294a90a6d97	63629-1197	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Bryant Ranch Prepack	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1198_fc4dacfb-f491-b343-e053-6394a90aade4	63629-1198	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Bryant Ranch Prepack	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1199_fc896f3b-f9e6-cc1a-e053-6294a90a7d25	63629-1199	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Bryant Ranch Prepack	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1200_b43db187-7872-4e34-bf69-30fc92debc34	63629-1200	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Bryant Ranch Prepack	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-1201_fc896ba0-b37c-aefa-e053-6294a90a9d47	63629-1201	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1202_fc896ba0-b3e2-aefa-e053-6294a90a9d47	63629-1202	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1203_c9e62575-14bb-4406-87bb-f72dcb70a7a2	63629-1203	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
63629-1204_fc896f70-8c4d-f17d-e053-6294a90a7b8b	63629-1204	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1205_080357d4-69ee-e795-e063-6394a90af25a	63629-1205	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1206_080372ff-2a68-0b9e-e063-6394a90adf9f	63629-1206	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1207_0803b64a-da7a-c660-e063-6394a90a822d	63629-1207	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1208_fc4d8ff1-ac47-d1eb-e053-6294a90a0f18	63629-1208	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180215		ANDA	ANDA209757	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-1209_32a1c44f-c38a-4dda-921f-cb5dec0571c0	63629-1209	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1210_d4fa4121-d9d3-4eb7-b53b-2861f8ea6590	63629-1210	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
63629-1211_24ced74c-3ea6-4629-97e2-486919a57174	63629-1211	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
63629-1212_c000dfb8-781e-41aa-84eb-2fe5dad1bc77	63629-1212	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1213_fc117ad1-470d-c16e-e053-6394a90a0461	63629-1213	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1214_ddf690b2-6661-4f06-af84-322d335fa74b	63629-1214	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-1215_a493543f-9bf5-449c-905a-376f1032f149	63629-1215	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-1216_afccb7bb-de77-4366-be8d-cf6d37972259	63629-1216	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-1217_7ea5b95f-2b13-4fff-b66f-bd6119743de2	63629-1217	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-1218_b15d313b-f602-47e9-91cc-fd655cf568ba	63629-1218	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
63629-1219_fc1159f2-aafe-9846-e053-6294a90a5aec	63629-1219	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-1220_0803d298-8a74-ebee-e063-6394a90aecc7	63629-1220	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-1221_b822c9bb-7354-46ba-8bc6-2dd4255b0513	63629-1221	HUMAN PRESCRIPTION DRUG	Albendazole	200 mg	Albendazole	TABLET, FILM COATED	ORAL	20181215		ANDA	ANDA210011	Bryant Ranch Prepack	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
63629-1222_fc112178-fac3-83f5-e053-6294a90aa17a	63629-1222	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161024		ANDA	ANDA206574	Bryant Ranch Prepack	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
63629-1223_12d08843-f1b1-4851-8a69-e65760816902	63629-1223	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161024		ANDA	ANDA206574	Bryant Ranch Prepack	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
63629-1224_fc110c78-67fc-c8ec-e053-6394a90a0a2b	63629-1224	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-1225_0803f426-8460-3651-e063-6294a90a4c71	63629-1225	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-1226_fc11109e-263c-af39-e053-6394a90acd59	63629-1226	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201014		ANDA	ANDA212378	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-1227_dba58e1a-a617-4be7-ac45-030b76fd8d43	63629-1227	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201014		ANDA	ANDA212378	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
63629-1228_fc110c78-67eb-c8ec-e053-6394a90a0a2b	63629-1228	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201014		ANDA	ANDA212378	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-1229_fc109f3d-9f42-4ee1-e053-6294a90a30ac	63629-1229	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63629-1231_0804ce61-db7a-ae28-e063-6294a90a88b2	63629-1231	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-1254_9909be5d-e56f-4883-a8bb-c1ed03863d90	63629-1254	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Bryant Ranch Prepack	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63629-1307_fc785200-389b-e031-e053-6294a90a88f1	63629-1307	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	19961111		ANDA	ANDA070848	Bryant Ranch Prepack	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
63629-1326_c5eb3888-b860-4599-8e3d-2b99b594a345	63629-1326	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
63629-1346_fc630aac-990b-e3c1-e053-6394a90af178	63629-1346	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	Bryant Ranch Prepack	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-1388_1ea92c65-513b-42f0-b427-cab173c2e02f	63629-1388	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	Bryant Ranch Prepack	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
63629-1398_50be0203-624d-411b-9b86-edf7b868adad	63629-1398	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	Bryant Ranch Prepack	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63629-1424_bd7e7d87-af1f-44cb-acda-babc1752ff9f	63629-1424	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET, EXTENDED RELEASE	ORAL	19981030	20240331	ANDA	ANDA075155	Bryant Ranch Prepack	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
63629-1464_fc78db5a-57fb-cd04-e053-6294a90aca53	63629-1464	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Bryant Ranch Prepack	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-1467_8445f638-124d-40e8-82ea-39dfa70f8a6b	63629-1467	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20040101		ANDA	ANDA075010	Bryant Ranch Prepack	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-1468_a6be478d-cb2f-40e7-a5fe-c778da5ed2af	63629-1468	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Bryant Ranch Prepack	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-1516_67394f1c-45d1-4f3d-9586-7c9a202d0db4	63629-1516	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET	ORAL	19890101		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ACETAMINOPHEN	500	mg/1			N	20241231
63629-1522_fc87d456-51bf-76c8-e053-6394a90a7509	63629-1522	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Bryant Ranch Prepack	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63629-1523_fc880f7a-112b-b93e-e053-6294a90aaff1	63629-1523	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	Bryant Ranch Prepack	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1525_fc888abe-fc15-6bda-e053-6294a90af9ed	63629-1525	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Bryant Ranch Prepack	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63629-1526_fc88f6f7-f1a6-629f-e053-6294a90aa677	63629-1526	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Bryant Ranch Prepack	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63629-1564_fc896ba0-b3c3-aefa-e053-6294a90a9d47	63629-1564	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	Bryant Ranch Prepack	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1579_8013818c-9995-4c90-8ef3-8fa071b9c398	63629-1579	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-1586_ce997ae3-b09e-4429-892c-79a42900ceb9	63629-1586	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20110822		ANDA	ANDA089859	Bryant Ranch Prepack	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1591_4675b99e-fcc4-4b16-985f-6313918b9c0b	63629-1591	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Bryant Ranch Prepack	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-1605_02965df0-7401-f8bd-e063-6394a90a0bc1	63629-1605	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-1610_fc8cb10c-49a8-c0bd-e053-6394a90a6fdb	63629-1610	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-1619_400c170a-f4dc-4806-803d-e2f633dd2a86	63629-1619	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Bryant Ranch Prepack	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1621_fc9c7b08-e251-aa25-e053-6294a90aca75	63629-1621	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-1622_fc9b6f6a-b308-9fa6-e053-6294a90a15bd	63629-1622	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-1673_8da6cb70-04ca-4c80-9496-ca0be3f83ba5	63629-1673	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-1678_972f853e-72ae-4a4e-a33b-8528017ae16f	63629-1678	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Bryant Ranch Prepack	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63629-1724_7c505578-50ed-433b-be79-862777662c79	63629-1724	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
63629-1748_2b80e248-f12d-44f1-aa6d-c4548efda3d8	63629-1748	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	Bryant Ranch Prepack	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
63629-1761_c943affc-665e-48ba-bae7-9072aeace785	63629-1761	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Bryant Ranch Prepack	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63629-1765_09bf4ebb-d069-4036-a16a-2c22b9dd592d	63629-1765	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	Bryant Ranch Prepack	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
63629-1774_b29184d3-ee60-40b4-ae4c-67ec4312328f	63629-1774	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20030827	20240331	ANDA	ANDA040511	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	
63629-1823_cd1f9754-4bec-4b57-96f5-e2f948ca14aa	63629-1823	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET, EXTENDED RELEASE	ORAL	19981030	20240331	ANDA	ANDA075155	Bryant Ranch Prepack	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
63629-1830_74fa5e30-cd13-4f78-aef6-df20bbc41565	63629-1830	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-1840_8e54f559-c713-4a0a-a929-631d2c94bd3f	63629-1840	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Bryant Ranch Prepack	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-1856_1d93ba7e-d1a0-49e7-a434-bdda927b30b2	63629-1856	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20140820		ANDA	ANDA204279	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63629-1902_e69d3d8c-f015-404e-ac3c-870ed32783e7	63629-1902	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1903_d8230c44-1d9c-4de4-941b-f55bee53a259	63629-1903	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1904_c1ff9a7e-6041-4ea5-bc22-b701ff4c5b1d	63629-1904	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA211009	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1905_dd3c69bc-d9af-4b23-8fb4-38f8e0edc3c9	63629-1905	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20190103		ANDA	ANDA211228	Bryant Ranch Prepack	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-1906_f632728a-8b89-4aeb-8e77-ae3342f6fa1e	63629-1906	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20190103		ANDA	ANDA211228	Bryant Ranch Prepack	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-1907_cee73ea0-dadd-49da-99c7-9b3c4f2362d8	63629-1907	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1908_32db9f58-6620-4948-80d3-649222d038bb	63629-1908	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1909_acf83fcb-3cde-4744-a8cf-59f3ae4d0379	63629-1909	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411	20240229	ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63629-1911_2c9d0a6a-2fa8-40f9-aeb8-1910dcae23c5	63629-1911	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1912_9e75a4ab-c340-43f1-af11-cfc1a0a2b658	63629-1912	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1913_b3ce5c92-e35b-4402-adbb-cadc36e8b2e8	63629-1913	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-1914_e21b46ae-e083-4f41-917e-ad56f594fbaa	63629-1914	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-1915_b7e6aae2-0d38-4924-a9d3-32d15b997dda	63629-1915	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20150724		ANDA	ANDA201807	Bryant Ranch Prepack	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-1916_ffcbd84c-69a2-49d5-921b-075c229a9a0c	63629-1916	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20091215	20240531	ANDA	ANDA090702	Bryant Ranch Prepack	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	
63629-1917_6391a7eb-907d-418b-aa66-b39dc038f60e	63629-1917	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20091215		ANDA	ANDA090702	Bryant Ranch Prepack	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
63629-1918_45790a72-5ca9-487b-a96b-786f191355e0	63629-1918	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20190225		ANDA	ANDA207420	Bryant Ranch Prepack	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
63629-1919_6c388226-4bf4-4a6c-b432-97b9ac3b43e8	63629-1919	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1920_22693349-895f-4d4c-88e8-eef43f6aef5f	63629-1920	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1921_6c139623-fa63-4d58-8e4b-b7538e09b3c0	63629-1921	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1922_b1eb5cc6-4fed-4402-8b0e-edbaffb77890	63629-1922	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1923_6cab249d-299d-4d0a-ae18-2af1128f701e	63629-1923	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1924_e1d48c0b-9199-4163-9dc1-45ce7d71639e	63629-1924	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1925_b59cdbd6-7a3b-4773-a2b2-bf8f4c199e54	63629-1925	HUMAN PRESCRIPTION DRUG	OXYMORPHONE HYDROCHLORIDE		OXYMORPHONE HYDROCHLORIDE	TABLET	ORAL	20180301		ANDA	ANDA210175	Bryant Ranch Prepack	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-1926_c58a9e13-1792-4569-a677-28d9aaf0c9f0	63629-1926	HUMAN PRESCRIPTION DRUG	OXYMORPHONE HYDROCHLORIDE		OXYMORPHONE HYDROCHLORIDE	TABLET	ORAL	20180301		ANDA	ANDA210175	Bryant Ranch Prepack	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-1927_6acfe83e-3d42-48fd-a903-486c431c7397	63629-1927	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-1928_baf6e4df-2985-4fb1-8550-92cbf9d74a7c	63629-1928	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-1929_92c50862-68ee-4dcc-b2d9-7922aec8c47b	63629-1929	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1930_06c695ae-e538-4c96-8f41-f988c38b1c0a	63629-1930	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1931_faf2be70-0dbd-439d-b3fb-976fed246ef2	63629-1931	HUMAN PRESCRIPTION DRUG	Drospirenone and ethinyl estradiol		Drospirenone and ethinyl estradiol	KIT		20190322		ANDA	ANDA211944	Bryant Ranch Prepack						N	20241231
63629-1933_990d9101-159f-4cbb-ae2b-8c37661d34bf	63629-1933	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170707		ANDA	ANDA086727	Bryant Ranch Prepack	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
63629-1934_cc317f7f-7dc9-4c1d-b4ad-a073e62bfe4b	63629-1934	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170707		ANDA	ANDA086727	Bryant Ranch Prepack	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20251231
63629-1935_5abdbf36-d1f1-4ca9-ae5e-a64aa132efe7	63629-1935	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150309		ANDA	ANDA075126	Bryant Ranch Prepack	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-1936_77e7bf81-1ccc-46ef-9f61-6ee031dafe38	63629-1936	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150201		ANDA	ANDA075126	Bryant Ranch Prepack	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-1937_fbc8ce60-5546-4635-8bf9-e5b37e488b82	63629-1937	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20180904		ANDA	ANDA202284	Bryant Ranch Prepack	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-1938_95463a6b-430e-404d-98a5-7089a4a995e3	63629-1938	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-1939_800c257e-7642-422d-a083-e618470c51fd	63629-1939	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-1940_1729dbfc-8b09-47e2-a1ea-90398c265638	63629-1940	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-1942_b4d007b2-cd0b-4e69-be92-565c4ceac7c5	63629-1942	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1943_236ed778-21dd-4e6f-825f-9b4d74e831e7	63629-1943	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-1944_5904822f-6aa8-4b75-b99f-be5e253ce42a	63629-1944	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20180904		ANDA	ANDA202284	Bryant Ranch Prepack	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-1945_09ae5f12-e34e-40f4-83cc-65c703030b77	63629-1945	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	Bryant Ranch Prepack	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-1946_bc359069-e7b1-43ce-b3c3-9932530274b6	63629-1946	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	Bryant Ranch Prepack	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-1951_0bd85689-6c7c-4117-9616-52c03c539de8	63629-1951	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160401		ANDA	ANDA080706	Bryant Ranch Prepack	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-1952_9afc67f5-e8a8-46eb-ab16-3442bdd9a089	63629-1952	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160401		ANDA	ANDA080706	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-1953_d2e7d4c9-bb04-4aae-a803-6388a9da4575	63629-1953	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA074299	Bryant Ranch Prepack	INDAPAMIDE	1.25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
63629-1954_252eae4a-b6fc-43f1-a779-95629b1763ad	63629-1954	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA074299	Bryant Ranch Prepack	INDAPAMIDE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
63629-1961_b2e9a4d4-a2f8-4a6c-96a4-87a4c14a4e12	63629-1961	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	SOLUTION	ORAL	20150518		ANDA	ANDA071402	Bryant Ranch Prepack	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20251231
63629-1963_03621bfd-3245-4fab-a7b5-0cc32f554485	63629-1963	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200622		ANDA	ANDA074450	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20251231
63629-1964_0ad7c228-ac0e-4374-bfcd-990e053dafcb	63629-1964	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200622		ANDA	ANDA074450	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20251231
63629-1965_0e23cbfa-6cae-4001-85ae-0c4f4eb80349	63629-1965	HUMAN PRESCRIPTION DRUG	Opium Tincture Deodorized		morphine tincture	SOLUTION	ORAL	20110225		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	MORPHINE	10	g/1000mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-1966_318292a1-d121-49e6-a842-26bd061d4a1b	63629-1966	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA212779	Bryant Ranch Prepack	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
63629-1967_690d4350-ea26-40c9-87ae-d8552f542f8a	63629-1967	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA212779	Bryant Ranch Prepack	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20251231
63629-1970_4c47f33a-d207-4eab-a67a-a1d99c1e9502	63629-1970	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	POWDER, FOR SOLUTION	ORAL	20190909		ANDA	ANDA061667	Bryant Ranch Prepack	VANCOMYCIN HYDROCHLORIDE	250	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63629-1971_293a528f-1edf-49aa-9107-c92fa94882ea	63629-1971	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	POWDER, FOR SOLUTION	ORAL	20190909		ANDA	ANDA061667	Bryant Ranch Prepack	VANCOMYCIN HYDROCHLORIDE	250	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63629-1972_231a8c57-21bc-4719-9b50-d3e4e24dd978	63629-1972	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	POWDER, FOR SOLUTION	ORAL	20190909		ANDA	ANDA061667	Bryant Ranch Prepack	VANCOMYCIN HYDROCHLORIDE	250	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
63629-1973_9191a3fa-7304-4588-b065-5e0851df2c86	63629-1973	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1974_89588c7e-7bc6-4cae-abf1-349446465278	63629-1974	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1975_5d0090ce-5984-422c-b3e2-360639e25855	63629-1975	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1976_bb370bcf-4a54-4f34-93e4-ce55064ec3a3	63629-1976	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1977_3d4e6bc6-138f-4972-8d59-5e2fc874968f	63629-1977	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1978_dd504b42-8d7e-4806-9fe0-6029c206ba3e	63629-1978	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA205401	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-1979_07b99e24-0765-494a-b656-e6ddf8fd75f4	63629-1979	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20101222		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	1.25; 2.5	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-1980_d205c7cd-a393-4698-baaa-a9fe3aeca7c2	63629-1980	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20101222		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	.625; 1.25	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-1981_eccea262-3f2e-47bd-b99a-41fc30c117fc	63629-1981	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	Bryant Ranch Prepack	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-1986_5aa6379f-6d80-43b0-b25d-02cf641dcb84	63629-1986	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20141106		ANDA	ANDA040001	Bryant Ranch Prepack	METHAZOLAMIDE	25	mg/1			N	20251231
63629-1987_05e68527-1d25-4faa-97b6-85fe9fb9372a	63629-1987	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20141106		ANDA	ANDA040001	Bryant Ranch Prepack	METHAZOLAMIDE	50	mg/1			N	20251231
63629-1988_867f3571-bc0f-41b8-a25a-109144dd9725	63629-1988	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-1989_3449de07-24c8-45e2-ad26-af5cd31c03aa	63629-1989	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-1990_077a1fb9-e38f-4620-911d-51117ec501c5	63629-1990	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
63629-1991_084714a1-7742-4aeb-9115-d3f3c652b8f8	63629-1991	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
63629-1992_f4fe78bd-4339-4878-b4a1-05d857a755ee	63629-1992	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
63629-1993_2b858a61-405a-4352-9da9-978bb1f5a29a	63629-1993	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20101227		ANDA	ANDA077714	Bryant Ranch Prepack	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20251231
63629-1994_99366532-d4d4-436c-b150-7ac0291e9b73	63629-1994	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	20170501		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-1997_dc3954e4-2255-4b15-822e-e3195a8a0fa6	63629-1997	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
63629-1998_908337ab-d6f7-4b1e-a80d-7bc76f4d9216	63629-1998	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
63629-2001_ee022e23-245a-4d4a-862b-b5f9590abbd8	63629-2001	HUMAN PRESCRIPTION DRUG	Amiodarone HCl		Amiodarone Hydrochloride	TABLET	ORAL	20130101		ANDA	ANDA077069	Bryant Ranch Prepack	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63629-2007_6bf73cca-6190-48d2-b91b-cb0ec78f46d5	63629-2007	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
63629-2008_d0df774c-8418-4e3f-b3e7-b622939ca44d	63629-2008	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
63629-2009_c873c84f-6751-453f-913b-94063e73d6a2	63629-2009	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20170817		ANDA	ANDA206261	Bryant Ranch Prepack	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63629-2010_499c3a69-5616-4a32-8b99-02c35a8baa3d	63629-2010	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-2011_73da3e69-1e8e-45e0-8f69-16d8b094a727	63629-2011	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-2012_9f005ea7-9f4a-4c7f-8e21-74de2dc49ece	63629-2012	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-2013_ae287719-9402-4581-86ca-b017a1ad99c3	63629-2013	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-2014_ef80b1f6-6bf9-4e88-8389-2389bf8f6f05	63629-2014	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63629-2015_29fb0962-660b-433a-87ca-fcab8e29b125	63629-2015	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63629-2016_62cbe8e3-aa4e-4e12-9081-cf70bea73556	63629-2016	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Bryant Ranch Prepack	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
63629-2017_3460484f-1f4a-4eb2-9773-d3ce3ea99e22	63629-2017	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Bryant Ranch Prepack	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
63629-2018_cdbb82d9-6dc3-42e7-8a52-2c760f88cd9d	63629-2018	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-2019_053fd3a4-8d2a-40dd-8095-1bc33456ba00	63629-2019	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Bryant Ranch Prepack	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-2022_377c4f60-a1d7-45b7-ac6d-08431db4b76c	63629-2022	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20200215		ANDA	ANDA040728	Bryant Ranch Prepack	BETHANECHOL CHLORIDE	5	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
63629-2023_b08717c2-1c00-439a-affa-6f2dfff94d08	63629-2023	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20200215		ANDA	ANDA040728	Bryant Ranch Prepack	BETHANECHOL CHLORIDE	10	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
63629-2024_9605ed99-a6c9-4a3d-a9b7-067925f5ffb3	63629-2024	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20200215		ANDA	ANDA040728	Bryant Ranch Prepack	BETHANECHOL CHLORIDE	25	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
63629-2025_4071fbc6-bb2c-4758-b2e8-284c4626cb56	63629-2025	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20200215		ANDA	ANDA040728	Bryant Ranch Prepack	BETHANECHOL CHLORIDE	50	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
63629-2029_a9af9231-2465-4bab-9a7d-ad178a1c57dd	63629-2029	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20251231
63629-2031_3f5420a2-834a-4fac-8124-21855b2f4483	63629-2031	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate		Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170207		ANDA	ANDA090313	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
63629-2036_d9802356-9353-48bf-94c3-27dbc8eda1c3	63629-2036	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20131202		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	39	g/100g			N	20251231
63629-2038_c8c8f690-b00e-45ee-b40d-503e17814c19	63629-2038	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20140901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	40	g/100g			N	20251231
63629-2040_c29ab67d-12b6-4558-a5f7-d9f7c53c234f	63629-2040	HUMAN PRESCRIPTION DRUG	UREA		UREA	LOTION	TOPICAL	20140919		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	40	g/100g			N	20241231
63629-2041_9ba1a1fa-8044-4368-9484-add03a144dac	63629-2041	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	15	mg/1		CIV	N	20241231
63629-2042_35247cf0-f986-48fb-9a29-a06b4a5513ed	63629-2042	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	15	mg/1		CIV	N	20251231
63629-2043_2c3ce038-2b60-4617-8d53-260267bb6369	63629-2043	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	30	mg/1		CIV	N	20241231
63629-2044_6f577147-d9ce-4cda-82ff-e2545761153b	63629-2044	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	30	mg/1		CIV	N	20241231
63629-2045_2bb16ec6-d2dd-4f03-984e-3c4a3a62b81c	63629-2045	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	60	mg/1		CIV	N	20241231
63629-2046_53e6f8d0-42ef-4d1a-839f-8cc3e956650c	63629-2046	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	60	mg/1		CIV	N	20251231
63629-2047_ba053ddc-a52a-4fde-9f8e-37cf67b4bca4	63629-2047	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	100	mg/1		CIV	N	20241231
63629-2048_7329a5d6-7995-4460-8160-160a6c97e7b0	63629-2048	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	100	mg/1		CIV	N	20251231
63629-2049_3f5b5f07-05b1-4a68-bf73-90d4a57cbb3d	63629-2049	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	LIQUID	ORAL	20190329		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	20	mg/5mL		CIV	N	20251231
63629-2053_887d805b-d3d6-4b36-aa21-992df0c0201d	63629-2053	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA207863	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2054_a42669d6-2662-4689-bfe7-d8e1034005ad	63629-2054	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA207863	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2055_ce9867c2-ca9e-4b28-a31f-8b75854ff231	63629-2055	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA207863	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2056_b281a648-3f02-4068-9f6b-08afb861f7d9	63629-2056	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET, FILM COATED	ORAL	20191219		ANDA	ANDA211031	Bryant Ranch Prepack	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
63629-2062_f923623b-0be1-456c-b273-29cb1197a80d	63629-2062	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20131021	20240131	ANDA	ANDA040644	Bryant Ranch Prepack	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	
63629-2063_856f5b7e-11f1-406a-ab7a-5f26b3d54507	63629-2063	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20180521		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63629-2064_5058c8de-7a73-41c7-beb9-56c2e366e04f	63629-2064	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Bryant Ranch Prepack	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-2065_3e34c7dc-3cae-4c3f-b353-f7a2bc980b4a	63629-2065	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Bryant Ranch Prepack	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-2066_0441f8ee-e737-4388-ab6e-4faf89153192	63629-2066	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Bryant Ranch Prepack	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-2069_fce3e580-2b55-4339-9aa6-4a61fcaaf6fd	63629-2069	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2070_acb42e20-f083-4b51-aeb8-5ee141fa77b3	63629-2070	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-2071_c593a0c6-6622-4315-a228-06d8d9a2a999	63629-2071	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2072_13ce9188-274e-445d-aade-caabfabbe22f	63629-2072	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-2074_850f5612-6134-46af-bd3f-fed2511cca63	63629-2074	HUMAN PRESCRIPTION DRUG	METHYLERGONOVINE MALEATE		Methylergonovine Maleate	INJECTION	INTRAVENOUS	20161107		ANDA	ANDA040889	Bryant Ranch Prepack	METHYLERGONOVINE MALEATE	.2	mg/mL	Ergolines [CS], Ergot Derivative [EPC]		N	20251231
63629-2075_db7de82f-c40f-4e41-83f5-1edee684fb59	63629-2075	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Bryant Ranch Prepack	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-2076_1622827c-1552-4988-b85b-09eec3008b2a	63629-2076	HUMAN PRESCRIPTION DRUG	Amiodarone HCl		Amiodarone Hydrochloride	TABLET	ORAL	20170101		ANDA	ANDA077069	Bryant Ranch Prepack	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63629-2077_c051be09-bfe5-42eb-90b4-987dc8db47eb	63629-2077	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-2078_acf94676-f866-4b57-92fa-9d9c1944305f	63629-2078	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200525		ANDA	ANDA212901	Bryant Ranch Prepack	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2079_6d0b98de-f6f1-4b60-ab55-819932c2b780	63629-2079	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200525		ANDA	ANDA212901	Bryant Ranch Prepack	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2080_bcc56968-6d35-4bc3-8ccb-ba772dba23e2	63629-2080	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
63629-2081_8a1480d9-122f-4064-a751-0f29f0b72c47	63629-2081	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
63629-2082_6c56945c-1294-40b9-9864-dd9b357f5433	63629-2082	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
63629-2083_502e3dff-580a-4aa3-8679-a61e6dacb500	63629-2083	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
63629-2084_e8875fbb-0e8e-43ea-b904-f15d00931b9c	63629-2084	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-2087_c2b01c51-d83c-4083-a237-16a3c7bc1707	63629-2087	HUMAN PRESCRIPTION DRUG	butalbital, acetaminophen and caffeine		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20191217		ANDA	ANDA212083	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
63629-2088_cfdd48a5-d756-4339-9927-85b669a3e25f	63629-2088	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
63629-2089_10b4374f-a62e-474b-88b9-d3189ff763a9	63629-2089	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63629-2090_e453c4de-a2d3-4336-a533-0ad01314417f	63629-2090	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63629-2091_f3c2a2c0-0a45-4967-b24d-df28bb692526	63629-2091	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63629-2092_86a66180-52db-4d78-968b-be45ce9a2c2a	63629-2092	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
63629-2093_3df49492-17e6-4454-8603-8c130b0d42ad	63629-2093	HUMAN PRESCRIPTION DRUG	Levorphanol Tartrate		Levorphanol Tartrate	TABLET	ORAL	20190520		ANDA	ANDA213479	Bryant Ranch Prepack	LEVORPHANOL TARTRATE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-2094_15329fa8-6ddb-4efc-85d8-01bdde1f665a	63629-2094	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
63629-2095_7d61ded6-c512-43d6-8b7a-db81f7b58066	63629-2095	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	OROPHARYNGEAL	20070227		ANDA	ANDA040708	Bryant Ranch Prepack	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-2096_e925fd12-5716-4260-8f35-67a4d4597347	63629-2096	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL	20070227		ANDA	ANDA040710	Bryant Ranch Prepack	LIDOCAINE HYDROCHLORIDE ANHYDROUS	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-2097_5ff83a2f-cc31-4acc-a6d5-0f9fcbf85c36	63629-2097	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Bryant Ranch Prepack	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-2098_5cf43f76-4c90-44ff-aae3-930c29cb73cb	63629-2098	HUMAN PRESCRIPTION DRUG	Methadone Hydrocloride	dye-free, sugar-free, unflavored	methadone hydrochloride	CONCENTRATE	ORAL	20201102		ANDA	ANDA212093	Bryant Ranch Prepack	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2099_ff71fc42-4d66-45f6-9c6d-31ea11861e00	63629-2099	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20051014		ANDA	ANDA077220	Bryant Ranch Prepack	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
63629-2100_c03a4815-4a12-4abb-aa11-0b1b078929da	63629-2100	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA209193	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63629-2102_c1dff050-0b83-4576-a7fb-45b2e86904e7	63629-2102	HUMAN PRESCRIPTION DRUG	Zafirlukast		zafirlukast	TABLET, COATED	ORAL	20101119	20240430	NDA	NDA020547	Bryant Ranch Prepack	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	
63629-2104_67f0c0e9-15f3-49a9-bdf0-1982eeb8e44d	63629-2104	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20151013		ANDA	ANDA204979	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2105_7fcd6fb8-268f-4cc5-bc4b-cec6f74764f7	63629-2105	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-2111_7a882d70-737d-47bc-8c09-2e5ce3d53f1c	63629-2111	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Bryant Ranch Prepack	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
63629-2112_a437f264-f29c-4ffd-b410-9a0211a3292b	63629-2112	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Bryant Ranch Prepack	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
63629-2113_78dccc25-d609-432c-be7c-2af38a5014ca	63629-2113	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Bryant Ranch Prepack	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
63629-2114_84adc61b-3ed3-452d-a1b8-d062869b263d	63629-2114	HUMAN PRESCRIPTION DRUG	Amiloride Hydrochloride		Amiloride Hydrochloride	TABLET	ORAL	19860122		ANDA	ANDA070346	Bryant Ranch Prepack	AMILORIDE HYDROCHLORIDE ANHYDROUS	5	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
63629-2124_fb529b14-fbe7-4e50-9e3c-38250ca568ea	63629-2124	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20150902	20240228	ANDA	ANDA076744	Bryant Ranch Prepack	TESTOSTERONE	25	mg/2.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	
63629-2125_1435d5db-c4ea-4ce7-a9a3-b82a622eb300	63629-2125	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20150902		ANDA	ANDA076744	Bryant Ranch Prepack	TESTOSTERONE	50	mg/5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
63629-2126_0cb183f4-98a5-45a6-9feb-b8abd66a96e2	63629-2126	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Bryant Ranch Prepack	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63629-2127_150687e2-5e5a-412b-a2e5-7e17f8d2f621	63629-2127	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Bryant Ranch Prepack	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63629-2128_d61f4f25-d41c-4447-bec8-1f31322a62f3	63629-2128	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077156	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-2129_7af8d664-891e-4df6-b79b-e39c7919fb1f	63629-2129	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077156	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
63629-2130_dc58c202-9131-446d-9a15-89691afaab38	63629-2130	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077068	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-2131_bb4eca63-071a-4ca8-9b61-fc222b61a7cc	63629-2131	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077068	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63629-2132_09811220-849d-4033-a88f-b148e968e2a8	63629-2132	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515	20240531	ANDA	ANDA204713	Bryant Ranch Prepack	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
63629-2133_5057b7a1-fad0-4203-94d5-c6010da16072	63629-2133	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515		ANDA	ANDA204713	Bryant Ranch Prepack	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
63629-2134_6e0b5490-63c2-49a8-a76f-59adb0d03a3d	63629-2134	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515	20240630	ANDA	ANDA204713	Bryant Ranch Prepack	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
63629-2135_f2c20c9f-939e-4907-b812-c1c631447665	63629-2135	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515	20240630	ANDA	ANDA204713	Bryant Ranch Prepack	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
63629-2136_1ebe578a-6953-4cbb-9bd6-5a073a1b1139	63629-2136	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612	20250531	ANDA	ANDA077284	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
63629-2137_ca1ac63b-404b-47e7-a699-d79963c3f6cc	63629-2137	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612	20250531	ANDA	ANDA077284	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
63629-2138_7e67f0e9-c8f1-40fd-b9cd-c08ca8f3f718	63629-2138	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612		ANDA	ANDA077284	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63629-2139_caea72c8-d730-4762-b129-aaf597c0fd09	63629-2139	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612		ANDA	ANDA077284	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63629-2140_376cfc3d-2e5e-4dff-9a52-86d100afe086	63629-2140	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20030827	20240331	ANDA	ANDA040511	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	
63629-2142_521d8c17-240e-489a-ba75-f7aac0478d59	63629-2142	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200519		ANDA	ANDA205365	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
63629-2144_73e26351-ec4d-4d73-96f0-95d4fad37a60	63629-2144	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	SOLUTION	ORAL	20150518		ANDA	ANDA071402	Bryant Ranch Prepack	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
63629-2145_3410eae8-3459-4a3d-a0c5-04f159c6d140	63629-2145	HUMAN PRESCRIPTION DRUG	Mexiletine Hydrochloride		Mexiletine Hydrochloride	CAPSULE	ORAL	20200622		ANDA	ANDA074450	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20251231
63629-2147_862f80df-ebb7-419d-a726-73de31905dfc	63629-2147	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Bryant Ranch Prepack	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
63629-2148_039931b0-6e1a-4795-be74-33877739f9a3	63629-2148	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Bryant Ranch Prepack	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
63629-2149_719ef642-2ed4-44fc-9a24-f1e2d16cde24	63629-2149	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	POWDER, FOR SOLUTION	RESPIRATORY (INHALATION)	20200415		NDA	NDA018859	Bryant Ranch Prepack	RIBAVIRIN	6	g/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20251231
63629-2150_e5f546a3-9fbd-4f3f-8722-57878a9c51b5	63629-2150	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20141001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SALSALATE	750	mg/1			N	20241231
63629-2151_f10c1d71-3afd-4705-8214-1b342691a157	63629-2151	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20030827	20240331	ANDA	ANDA040511	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	
63629-2153_2c5654aa-2c8b-4581-8605-bef46ad3f7c5	63629-2153	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2154_321ec15d-757f-491f-a5b9-742e68c5c6d5	63629-2154	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2155_b92824d2-5149-4419-8df0-fcf643e3a1ba	63629-2155	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2156_be1d4978-1286-402f-b73b-91db106046b8	63629-2156	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2157_8730bee3-3dd7-4a0c-9964-82ae857b1195	63629-2157	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2158_8549aafa-d9c8-4bbe-ad27-6eeb4d2c366d	63629-2158	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2159_7c51b805-577a-41a2-bf6f-b2058872b249	63629-2159	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2160_905e0eff-cafa-497b-a322-951323abb055	63629-2160	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
63629-2161_7e49f9ae-f1ef-4ca7-921d-b9897fae6415	63629-2161	HUMAN PRESCRIPTION DRUG	Cholestyramine		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077203	Bryant Ranch Prepack	CHOLESTYRAMINE	4	g/5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20251231
63629-2162_058a1e41-eec4-4899-8767-8a5504c6d0b9	63629-2162	HUMAN PRESCRIPTION DRUG	Cholestyramine		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077203	Bryant Ranch Prepack	CHOLESTYRAMINE	4	g/5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
63629-2163_7d6f19f0-744c-445c-89b0-d9374e95d3d4	63629-2163	HUMAN PRESCRIPTION DRUG	Cholestyramine		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077204	Bryant Ranch Prepack	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20251231
63629-2164_273b2c4d-bae2-4fd0-8387-25ed9de84b1a	63629-2164	HUMAN PRESCRIPTION DRUG	Cholestyramine		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077204	Bryant Ranch Prepack	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
63629-2165_71566f7b-d451-4f31-a935-181015962c63	63629-2165	HUMAN PRESCRIPTION DRUG	Clomiphene Citrate		Clomiphene Citrate	TABLET	ORAL	19990830	20250228	ANDA	ANDA075528	Bryant Ranch Prepack	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	
63629-2166_294d20bb-a2cb-4175-9a2c-fb0aaa59264d	63629-2166	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20180701		NDA AUTHORIZED GENERIC	NDA022352	Bryant Ranch Prepack	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20251231
63629-2167_23989303-4ab9-4731-b0a5-3542de654b95	63629-2167	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20180701		NDA AUTHORIZED GENERIC	NDA022352	Bryant Ranch Prepack	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20251231
63629-2168_f1824ce6-39ab-45f0-aa1f-ddbf12c59c66	63629-2168	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Bryant Ranch Prepack	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
63629-2169_fad369a3-e2e1-4b11-9ac4-282f18621ed2	63629-2169	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Bryant Ranch Prepack	DANTROLENE SODIUM	50	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
63629-2170_4d9619ea-d238-466b-ab8e-4da53f08ef3e	63629-2170	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Bryant Ranch Prepack	DANTROLENE SODIUM	100	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20251231
63629-2171_ae07820d-b4ca-4b9a-9d07-b822e27a79af	63629-2171	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2172_373e9236-4c86-42c6-ad32-02944e163ad9	63629-2172	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20131119		ANDA	ANDA078992	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2173_48db1c1c-f7d7-4c64-89bd-aed472012758	63629-2173	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2174_63592970-f979-48a7-aa65-c9c99c1278f3	63629-2174	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2175_32c02118-b3eb-4b5c-83a4-fe29fb96c526	63629-2175	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20131119		ANDA	ANDA078992	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2176_dfe38cf0-b882-4aee-bf30-ab86b94b5e1f	63629-2176	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2177_b8fbc843-1d9b-4be4-ab49-ee8e882f7ebd	63629-2177	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2178_927f6044-70f9-4cf0-b1aa-294112b95165	63629-2178	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2179_17dcbf5e-5f01-498e-abac-264a8df4ca80	63629-2179	HUMAN PRESCRIPTION DRUG	dicyclomine hydrochloride		dicyclomine hydrochloride	SOLUTION	ORAL	20050623		ANDA	ANDA040169	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	10	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
63629-2180_76ca6856-e514-4d3c-86e9-351e9ff3d592	63629-2180	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	19871109		ANDA	ANDA071422	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63629-2181_0adfb479-6c92-4186-80b0-1af639936f69	63629-2181	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	19871109		ANDA	ANDA071422	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63629-2182_d3f37d39-70ce-4acb-8fae-a0ec6e663e9b	63629-2182	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	19871109		ANDA	ANDA071422	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63629-2184_aaf58415-1e55-4d24-ae46-d16708f4c0b7	63629-2184	HUMAN PRESCRIPTION DRUG	Doxylamine Succinate and Pyridoxine Hydrochloride		Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg	TABLET, DELAYED RELEASE	ORAL	20191219		ANDA	ANDA208518	Bryant Ranch Prepack	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
63629-2187_aa8d9468-9235-4e77-b96b-901b9cfa5886	63629-2187	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20030306		ANDA	ANDA040330	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2188_3c68a9ce-0680-4cd6-8835-0618305b508a	63629-2188	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20000526		ANDA	ANDA040330	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2189_356b99df-3247-4b4a-b55c-8ef26f4d89ee	63629-2189	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20000526		ANDA	ANDA040330	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2190_8b2a6f3d-cc80-4345-b662-cc3b84bdf4b6	63629-2190	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20030306		ANDA	ANDA040330	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2191_9c62cad4-fd97-431e-bf81-aeec5fdf3e89	63629-2191	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-2192_e07a009b-d956-4119-9c84-005463b98d22	63629-2192	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-2193_dcee7345-4712-4b21-91bd-44e7f28b8c07	63629-2193	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20090331		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-2194_cd2c7b5f-4351-4c7e-b288-463b4d6e19d5	63629-2194	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20090331		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-2195_a8053f21-9a75-4f6f-a915-13307438cbfb	63629-2195	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-2196_369b87bc-4877-4a39-b230-ef518e592856	63629-2196	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-2197_02a9b206-9ae1-051e-e063-6294a90afc5c	63629-2197	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-2198_02a9cb50-47a0-2ade-e063-6294a90a1e16	63629-2198	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-2199_02aa0449-2860-36a0-e063-6394a90a5bda	63629-2199	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-2200_acccc0a2-e2d4-43da-ab03-14c45887df8a	63629-2200	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
63629-2201_02aa40b2-a13b-4e08-e063-6394a90a28bc	63629-2201	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA209419	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-2206_02aa8008-94e9-4180-e063-6294a90a0e06	63629-2206	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Bryant Ranch Prepack	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63629-2207_02aab1d3-9b78-90df-e063-6294a90ac23b	63629-2207	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Bryant Ranch Prepack	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63629-2208_fb64cf8d-9dd9-497b-8221-8e1cbb46a374	63629-2208	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021	20240131	ANDA	ANDA088292	Bryant Ranch Prepack	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	
63629-2211_02ab1b28-719e-446d-e063-6294a90a7f2e	63629-2211	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2212_02ab23b0-333a-8ced-e063-6394a90a7530	63629-2212	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2213_02ab470e-19ff-9157-e063-6294a90ab9bb	63629-2213	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2214_02ac415e-b497-e09f-e063-6394a90a2ca6	63629-2214	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2215_02ac6586-8edb-5b91-e063-6394a90ad988	63629-2215	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2216_02ac6586-8ef3-5b91-e063-6394a90ad988	63629-2216	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2218_02acbe46-6959-edb6-e063-6394a90ae19e	63629-2218	HUMAN PRESCRIPTION DRUG	MethylPREDNISolone		methylprednisolone	TABLET	ORAL	19981222		ANDA	ANDA040183	Bryant Ranch Prepack	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2224_02ad2580-a7fb-c641-e063-6294a90a8fc2	63629-2224	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20000329	20241031	ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
63629-2225_78b6defd-2b1e-4219-81d7-ffdbfbef01ed	63629-2225	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20000329	20241031	ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
63629-2226_02af0e7c-422a-fd56-e063-6394a90a9659	63629-2226	HUMAN PRESCRIPTION DRUG	MethylPREDNISolone		methylprednisolone	TABLET	ORAL	19981222		ANDA	ANDA040183	Bryant Ranch Prepack	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2227_eeb7ab44-53b0-47d6-b23f-badbebb8b231	63629-2227	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20181029		ANDA	ANDA207169	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63629-2230_8b33a48e-b7d3-4646-990a-8de49e8bffa0	63629-2230	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071839	Bryant Ranch Prepack	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63629-2231_d95cc642-c815-4b68-8d3c-a36e2eaf2ed8	63629-2231	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071839	Bryant Ranch Prepack	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-2232_7dbbdab3-6b77-4660-a31d-6a19ac43909f	63629-2232	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071826	Bryant Ranch Prepack	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63629-2233_8af3d1e1-0cc0-409f-b665-f0d126ebc82b	63629-2233	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20191004		ANDA	ANDA211041	Bryant Ranch Prepack	NITISINONE	10	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20251231
63629-2234_a6f7c9c3-8dbd-4e67-bed6-6a1c1ca122db	63629-2234	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20191004		ANDA	ANDA211041	Bryant Ranch Prepack	NITISINONE	2	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20251231
63629-2235_8daf42bc-595c-48fd-aa3b-cbabbadde0c8	63629-2235	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20191004		ANDA	ANDA211041	Bryant Ranch Prepack	NITISINONE	5	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20251231
63629-2236_c2a747bb-3085-472c-bbc4-f1043f984a4c	63629-2236	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		posaconazole	TABLET, COATED	ORAL	20190830		NDA AUTHORIZED GENERIC	NDA205053	Bryant Ranch Prepack	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63629-2238_8def81ed-0ec3-4756-a999-962107b62ef5	63629-2238	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Bryant Ranch Prepack	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
63629-2239_3ef478b0-f313-4c20-a3f4-0181023d9d90	63629-2239	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Bryant Ranch Prepack	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-2240_9bab7c1c-a2cb-4234-a1a4-6f6eb28cd23d	63629-2240	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Bryant Ranch Prepack	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-2241_117202dc-b8e2-4e6b-9340-f54b0a48e47d	63629-2241	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Bryant Ranch Prepack	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-2248_2d0ae5e9-f547-404a-b177-a099fc6004e7	63629-2248	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-2249_53a48c94-fb0b-4619-86b8-6c13fb856e46	63629-2249	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-2250_fb2c7a2d-9ec7-402d-80cb-5cf0ed835676	63629-2250	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-2251_91ba4d24-907f-40b0-b5a2-1e3d5ebee04e	63629-2251	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-2252_f39ba894-56f9-4986-9887-1a38c4a38d3a	63629-2252	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-2253_d59f511c-61d4-49e0-a3a8-b99b18d457b0	63629-2253	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-2254_e4781946-c2b4-4c96-8d2f-2470174a80c2	63629-2254	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20041221		ANDA	ANDA040584	Bryant Ranch Prepack	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2255_dec8f536-73e5-4e43-a87b-61a4651edfc9	63629-2255	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20041221		ANDA	ANDA040584	Bryant Ranch Prepack	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2256_4fc2fcb4-f4d0-4473-81a9-54380dd314e5	63629-2256	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2257_d737002c-b0bf-4396-80e0-05c903dcea10	63629-2257	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2258_82367ec2-9646-4b96-a40f-84a2d4ea9d13	63629-2258	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2259_371d11f4-c13d-4c3e-912a-09acc8b2a507	63629-2259	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2260_637e9094-b2c7-43ae-8b7c-2b1c8bfab2ef	63629-2260	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20041221		ANDA	ANDA040581	Bryant Ranch Prepack	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2261_e2e240c1-d398-4113-b0ee-41f77f7a3679	63629-2261	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2262_06a9df22-e49f-4215-8d9c-1af17ca52955	63629-2262	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2263_6a146e85-ce63-4c42-9474-e473ef68f5f2	63629-2263	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2264_c35f118f-74d7-4d2e-a4c1-ce3ebc9e5ed5	63629-2264	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2266_1ecbef8c-0c23-49c0-9ec3-beec10b6f04e	63629-2266	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, FILM COATED	ORAL	20021017	20240430	ANDA	ANDA075938	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	
63629-2268_75234239-d6c3-494b-a83a-778787e62c12	63629-2268	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, FILM COATED	ORAL	20021017	20240331	ANDA	ANDA075938	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	
63629-2269_d91a0347-7a84-4451-a04d-99e423654c6a	63629-2269	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110103	20240930	ANDA	ANDA078540	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	
63629-2274_750b8c8c-3aae-4b24-9cd0-bd12217b1957	63629-2274	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2275_dbc3567c-113c-4971-b199-2966fe11dee2	63629-2275	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2276_d08b6ad0-14f0-48cf-a5d1-a5771fe54ad9	63629-2276	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2277_fd16d7cc-7c95-41b0-908a-e3b711221c8d	63629-2277	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2278_6282af0c-cf01-4d4f-af3b-c5f6baf5d369	63629-2278	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2279_02e4fcb7-ad4d-47ba-e063-6294a90a8666	63629-2279	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2280_02e4f270-e98e-0bef-e063-6294a90a09ff	63629-2280	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2281_b6623fa8-de18-41f1-b461-792f6857f00e	63629-2281	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2282_5eed9d6c-a058-4df0-b869-735bab61bbe2	63629-2282	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-2283_df7b3f79-dd96-4808-bf6c-9e18fb9613f6	63629-2283	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20090601		ANDA	ANDA077494	Bryant Ranch Prepack	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63629-2284_c4abf32d-7702-4ddc-920c-5f190463091a	63629-2284	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20090601		ANDA	ANDA077494	Bryant Ranch Prepack	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63629-2285_2294c670-ded9-47b9-ae22-9807039077a9	63629-2285	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE	ORAL	20121024		ANDA	ANDA201687	Bryant Ranch Prepack	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
63629-2286_15aa5fa7-2054-473e-bd59-b6f228f01cc7	63629-2286	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Bryant Ranch Prepack	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
63629-2287_d83fe954-7354-4feb-b117-d53942d04979	63629-2287	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Bryant Ranch Prepack	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
63629-2288_03931256-0341-4876-b140-d0a09e7c04cc	63629-2288	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir hydrochloride	TABLET, FILM COATED	ORAL	20141104		ANDA	ANDA200790	Bryant Ranch Prepack	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20251231
63629-2289_0860c858-709f-4c42-a9d7-0b1f0109b793	63629-2289	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20020301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20251231
63629-2290_a534044d-b099-443d-b543-03ebe853ec3e	63629-2290	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20011201		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	64.8	mg/1		CIV	N	20251231
63629-2291_989ebe28-5515-4cae-84a0-73a0d69acf60	63629-2291	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20011201		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	97.2	mg/1		CIV	N	20251231
63629-2292_768e29bf-667c-4258-a4d2-ee049f5d3ffc	63629-2292	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-2293_fd64152c-8243-4caa-8d78-ceac65796ebc	63629-2293	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2294_87e61b83-13c4-4972-8bad-e5f015aaf115	63629-2294	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2295_d250801a-1c60-4c5e-ad9f-ab09de272e10	63629-2295	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2296_73f41c8a-fe75-4815-af65-c3bb8c2faeb4	63629-2296	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2297_db3d8080-3294-4e8a-9934-cb6b402deb27	63629-2297	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2298_bfc009bc-76eb-47ec-8f9e-acdf9bb6f6e0	63629-2298	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2299_268517fd-a2a4-4bcb-82de-e44a118845c8	63629-2299	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2300_75f3d26d-52d1-49fd-a1aa-0f20ca700fb9	63629-2300	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2301_e8a2848b-8666-4c21-b5c1-9659e58ed6df	63629-2301	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20150921		ANDA	ANDA203518	Bryant Ranch Prepack	MORPHINE SULFATE	20	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2302_9e0944d6-c816-4d0e-97bd-31b3eaf011f6	63629-2302	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20150921		ANDA	ANDA203518	Bryant Ranch Prepack	MORPHINE SULFATE	20	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-2303_694c3f95-5146-4b22-b28a-d2d6596451e8	63629-2303	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	extended-release	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150306		ANDA	ANDA091632	Bryant Ranch Prepack	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE	8; 10	mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-2304_06d725a6-f0b9-499e-a95b-b2cee637ca59	63629-2304	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	extended-release	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150306		ANDA	ANDA091632	Bryant Ranch Prepack	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE	8; 10	mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-2305_a94ee633-3b2f-4f07-b250-f061c7d890e4	63629-2305	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		ANDA	ANDA207901	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2306_522e02a9-e5dd-42dd-8ede-ac9badb47660	63629-2306	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		ANDA	ANDA207901	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2307_e3e20e09-b76f-487f-802e-dd26ccdd753d	63629-2307	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		dexmethylphenidate hydrochloride	TABLET	ORAL	20011130		ANDA	ANDA207901	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2308_81b0a855-813a-48d3-8277-79f3aaa626d3	63629-2308	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160407		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-2309_f46bb116-06cb-4f54-8efb-e24a7bdbfaea	63629-2309	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160407		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2310_a9e7ccdf-bb7d-435d-9c76-d440c2c699d6	63629-2310	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160407		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2314_d581412d-ccc6-4cf0-8c63-89f5715fb18d	63629-2314	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2315_31a3ebe3-c16a-40b3-99fa-6b491d690c7e	63629-2315	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2316_a09a07e6-0a04-462c-8b82-f3ac0a519483	63629-2316	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2317_a47f3a3e-7115-4e33-9c2a-647346e8824a	63629-2317	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2318_3b4e2ddd-7758-4073-92ee-acc54bdcd0cf	63629-2318	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2319_e321865f-70c6-41c0-bbcd-778808d4b9d1	63629-2319	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2326_2b84f6af-65af-4d5c-b8f1-4e35916c5b97	63629-2326	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
63629-2327_ecd1aaae-ac08-4e8b-b43c-fbee2c7da05d	63629-2327	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	TOPICAL	20200130		ANDA	ANDA201501	Bryant Ranch Prepack	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
63629-2328_ab4273c9-fceb-44f0-856c-eae25b50088b	63629-2328	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	TOPICAL	20200130		ANDA	ANDA201501	Bryant Ranch Prepack	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
63629-2329_39f4806f-dd49-4537-92ee-58c7c38e020a	63629-2329	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180619		ANDA	ANDA210034	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2330_ae46f34c-656d-46f6-b810-5211a34fc6fe	63629-2330	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180619		ANDA	ANDA210034	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2331_18ce192e-a24d-4da6-8605-33956c597deb	63629-2331	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180619		ANDA	ANDA210034	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2332_a06814d5-1f90-4a9c-9248-fbd282bc0809	63629-2332	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180619		ANDA	ANDA210034	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2333_ee917122-9502-46bb-a453-25b1a36ac068	63629-2333	HUMAN PRESCRIPTION DRUG	Isibloom		desogestrel and ethinyl estradiol	KIT		20180201		ANDA	ANDA202789	Bryant Ranch Prepack						N	20251231
63629-2335_65492141-f6d8-4c3d-900a-e98fdd9fe27c	63629-2335	HUMAN PRESCRIPTION DRUG	Syeda		Drospirenone and Ethinyl Estradiol	KIT		20171201		ANDA	ANDA090114	Bryant Ranch Prepack						N	20251231
63629-2336_8abd054d-ac7b-442a-9b09-01e349d336df	63629-2336	HUMAN PRESCRIPTION DRUG	LORYNA		Drospirenone and Ethinyl Estradiol Tablets	KIT		20181009		ANDA	ANDA079221	Bryant Ranch Prepack						N	20251231
63629-2337_813a433f-8108-434b-a275-f59fe7164752	63629-2337	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20191209		ANDA	ANDA212976	Bryant Ranch Prepack	FLUOCINONIDE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2338_f1589a17-9a5d-4202-ab38-1833a8273a2e	63629-2338	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20191209		ANDA	ANDA212976	Bryant Ranch Prepack	FLUOCINONIDE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2339_54bb848f-3583-4555-9760-21d6e300127c	63629-2339	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20191209		ANDA	ANDA212976	Bryant Ranch Prepack	FLUOCINONIDE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2340_52387734-e8a5-4d06-9b2b-5c91290e49e4	63629-2340	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180824		ANDA	ANDA203203	Bryant Ranch Prepack	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
63629-2341_220a6897-1676-4ca5-843d-1b9574636ffd	63629-2341	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180824		ANDA	ANDA203203	Bryant Ranch Prepack	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
63629-2342_fab94e66-27b4-46f8-aa60-8e541e0f088e	63629-2342	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180824		ANDA	ANDA203203	Bryant Ranch Prepack	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
63629-2343_bea980c0-6724-4cc5-8018-26e87a565dd0	63629-2343	HUMAN PRESCRIPTION DRUG	ALTAVERA		Levonorgestrel and Ethinyl Estradiol	KIT		20180101		ANDA	ANDA079102	Bryant Ranch Prepack						N	20241231
63629-2344_6da231a9-5daf-4894-822e-da364768463d	63629-2344	HUMAN PRESCRIPTION DRUG	Vienva TM		Levonorgestrel and Ethinyl Estradiol	KIT		20180315		ANDA	ANDA201088	Bryant Ranch Prepack						N	20251231
63629-2345_671c669b-22e7-439e-b6d5-80d90ddf9f97	63629-2345	HUMAN PRESCRIPTION DRUG	JAIMIESS		levonorgestrel / ethinyl estradiol and ethinyl estradiol	KIT		20180101		ANDA	ANDA203770	Bryant Ranch Prepack						N	20251231
63629-2346_8bfa3b96-7a9d-411c-b193-be6de1269691	63629-2346	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
63629-2347_bd172555-525c-49af-ad32-6335428b5ccc	63629-2347	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
63629-2348_04857555-d592-4a19-b2a0-55ca6fa43cb1	63629-2348	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
63629-2349_ede791d7-97ab-4779-8f04-7640cdc2f314	63629-2349	HUMAN PRESCRIPTION DRUG	Estarylla		Norgestimate and ethinyl estradiol	KIT		20180101		ANDA	ANDA090794	Bryant Ranch Prepack						N	20251231
63629-2350_d0415120-5b87-48d6-9742-9e7b07b45ba7	63629-2350	HUMAN PRESCRIPTION DRUG	Tri-Estarylla		norgestimate and ethinyl estradiol	KIT		20180101		ANDA	ANDA090793	Bryant Ranch Prepack						N	20241231
63629-2351_b3ca1725-bf1b-4ab3-8cdf-89ed69fbd700	63629-2351	HUMAN PRESCRIPTION DRUG	Tri-Lo- Estarylla		norgestimate and ethinyl estradiol	KIT		20180101		ANDA	ANDA091232	Bryant Ranch Prepack						N	20241231
63629-2352_d8c473ed-b5b2-439f-923d-5f953f9b24db	63629-2352	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL, METERED	TRANSDERMAL	20200508		ANDA	ANDA210835	Bryant Ranch Prepack	TESTOSTERONE	20.25	mg/1.25g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
63629-2353_5d9c0fad-ffc3-4b32-b024-2826e2843909	63629-2353	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111122	20240831	ANDA	ANDA079057	Bryant Ranch Prepack	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
63629-2354_2a401452-5c2d-4dd0-b662-910cd0903467	63629-2354	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111122	20240831	ANDA	ANDA079057	Bryant Ranch Prepack	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
63629-2355_bd43ed4c-b7ef-4ef3-935e-ad3fc380011e	63629-2355	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20081028		ANDA	ANDA078536	Bryant Ranch Prepack	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20251231
63629-2356_dbdb4c44-6050-467c-97f4-892fbf3f869d	63629-2356	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20081028		ANDA	ANDA078536	Bryant Ranch Prepack	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
63629-2357_d7637462-7c7a-4a69-96fd-1261994c7b1f	63629-2357	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20081028		ANDA	ANDA078536	Bryant Ranch Prepack	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
63629-2359_d128e1da-ffcd-40b9-b79b-3ecd91650c5a	63629-2359	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20021115		ANDA	ANDA075713	Bryant Ranch Prepack	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63629-2360_28868003-d213-4282-8e4d-896d7e0e3308	63629-2360	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20021115		ANDA	ANDA075713	Bryant Ranch Prepack	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-2361_976ecf99-dc83-4107-abd4-11d5a8ac3595	63629-2361	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20050819		ANDA	ANDA075713	Bryant Ranch Prepack	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-2362_e65e3533-4a1e-4c10-a567-5316e6cec237	63629-2362	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20171108		ANDA	ANDA075713	Bryant Ranch Prepack	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-2363_0f8d384b-167b-48e8-a502-0d0f3cf5f624	63629-2363	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Bryant Ranch Prepack	GALANTAMINE HYDROBROMIDE	24	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-2364_085cf387-f51c-4b34-ba76-3de840496b54	63629-2364	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Bryant Ranch Prepack	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-2365_7c7987ea-bd3d-4f1f-85d4-d6dce7c37800	63629-2365	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Bryant Ranch Prepack	GALANTAMINE HYDROBROMIDE	16	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-2366_1eb1c932-34e1-4587-9f9e-3976e8b257b0	63629-2366	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Bryant Ranch Prepack	MIRTAZAPINE	15	mg/1			N	20241231
63629-2367_cbbd5e0a-2653-492a-89bd-a10de2fe64b3	63629-2367	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Bryant Ranch Prepack	MIRTAZAPINE	15	mg/1			N	20241231
63629-2368_8c9cb37b-9cfd-4322-b5c1-34a9a87432f8	63629-2368	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Bryant Ranch Prepack	MIRTAZAPINE	30	mg/1			N	20241231
63629-2369_be2d0cd2-9765-488c-a701-46cfbb85d83f	63629-2369	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20170724		ANDA	ANDA040684	Bryant Ranch Prepack	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-2370_eb889e86-5171-4cdf-9f43-a68e321905cd	63629-2370	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2371_0ba74039-177c-4ad5-b6ea-0c6855b31a2a	63629-2371	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-2372_bedb8e02-a1fc-4803-97ce-b06f8db0fa86	63629-2372	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20170110		ANDA	ANDA207118	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
63629-2373_63c2bb31-d823-4b66-9967-cdc0ecfb556c	63629-2373	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20200709		ANDA	ANDA211421	Bryant Ranch Prepack	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
63629-2374_c533cb2e-5551-40a4-9f98-d2900aa84ebe	63629-2374	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA210059	Bryant Ranch Prepack	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2375_67cb8430-4a86-41a4-9d2b-5a46c8e1fc17	63629-2375	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA210059	Bryant Ranch Prepack	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2376_496452ce-d0e6-48f0-8103-19496c907369	63629-2376	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2377_776e9693-1307-47e2-88dd-0a395910e178	63629-2377	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2378_a6e6f467-e7f9-4b1f-8a8e-215530841178	63629-2378	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2379_81147103-0d78-4e5a-bbd4-9c30b7e46127	63629-2379	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2380_01b755c0-e17e-4c0f-a62d-12eb858bc888	63629-2380	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2381_08d0ed01-c58d-4c45-ba3c-941284ebdf2b	63629-2381	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2382_16582e3b-de53-4b06-b34a-d1bb8357acbc	63629-2382	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE		dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA209799	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2383_c02a7029-e1b3-4425-be3f-a363b1cf7607	63629-2383	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2384_4857806b-f348-4c59-9f8f-13a74fe13f51	63629-2384	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2385_1c8076b1-e555-41b7-9013-9835d4f02e27	63629-2385	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2386_5ffb39d8-f169-493e-b3ff-0fdd980b2db9	63629-2386	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205017	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2387_7b7f1710-e39a-4014-8ec3-6cb48a52f1dc	63629-2387	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205017	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2388_41d9cebb-2343-42bf-b337-ec37f3bda1fc	63629-2388	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20170124		ANDA	ANDA205008	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2389_c76614b8-e938-4172-97e1-f7158722d3d6	63629-2389	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20170124		ANDA	ANDA205008	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2390_31a29f5f-2ac7-4005-8c8c-a4be5d4b5b99	63629-2390	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE		sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124		ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
63629-2391_e3d78197-4881-4f88-a608-9eda612807cb	63629-2391	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PALMITATE HYDROCHLORIDE	(Pediatric)	CLINDAMYCIN PALMITATE HYDROCHLORIDE	GRANULE, FOR SOLUTION	ORAL	20120911		ANDA	ANDA201821	Bryant Ranch Prepack	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-2392_b46235f2-1805-4a4b-b1e2-af4e44081b33	63629-2392	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		Clobetasol Propionate	CREAM	TOPICAL	20190131		ANDA	ANDA211401	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2393_db3babf9-ca25-4038-b664-c4f9e640b523	63629-2393	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		Clobetasol Propionate	CREAM	TOPICAL	20190131		ANDA	ANDA211401	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2394_6d4bd3c6-fba9-4be7-91a6-3e3d8e37cadc	63629-2394	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		Clobetasol Propionate	CREAM	TOPICAL	20190131		ANDA	ANDA211401	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2395_854036f2-b5f9-4e53-a2fe-a647aa1c5913	63629-2395	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		Clobetasol Propionate	CREAM	TOPICAL	20190131		ANDA	ANDA211401	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2396_3283b7d0-17da-43fb-9795-01c22e6ba47e	63629-2396	HUMAN PRESCRIPTION DRUG	PROCTOZONE-HC		hydrocortisone 2.5%	CREAM	TOPICAL	20150803		ANDA	ANDA040879	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2397_4b660c77-a50b-4a0e-8264-d8569cdc82d9	63629-2397	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUPPOSITORY	RECTAL	20190605		ANDA	ANDA207448	Bryant Ranch Prepack	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
63629-2398_79f37f03-6872-4690-a49d-e0c6bd98021c	63629-2398	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	Bryant Ranch Prepack	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-2399_9289f5ca-ba11-4ff7-b7cc-d1fff99a45ad	63629-2399	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	LIQUID	ORAL	20200901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
63629-2400_b0b54e62-3b4a-4728-9ae2-198cfdc818ac	63629-2400	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20251231
63629-2401_5500b038-6256-4d72-9ca3-a94d2a9dd664	63629-2401	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20251231
63629-2402_936356e4-0739-41da-9f19-1e7dd4087147	63629-2402	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
63629-2403_1d6e3b64-afb2-4c4a-b8dc-1f48ed9c235a	63629-2403	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
63629-2404_a448d660-e7c5-4d2d-993b-3b407b176ac9	63629-2404	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	97.2	mg/1		CIV	N	20251231
63629-2406_5d152117-aab7-47f5-a0a6-7e939d95a405	63629-2406	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	AEROSOL, SPRAY	TOPICAL	20170908		ANDA	ANDA206786	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.147	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2407_573f7c04-aa93-4c7d-8d9a-1bcc0757d578	63629-2407	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	AEROSOL, SPRAY	TOPICAL	20170908		ANDA	ANDA206786	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.147	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2408_cba7234a-88f1-446f-950b-1d07c010b7df	63629-2408	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
63629-2409_11109d24-0181-4dbf-88d9-fd7da6286511	63629-2409	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20251231
63629-2410_8eb0a004-3158-4624-aa95-6d98034a9758	63629-2410	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
63629-2411_c99edf48-c3bc-4379-87e1-38572dabfe3d	63629-2411	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
63629-2412_3edb94e3-8fcb-4de2-9cac-14d90a4e819e	63629-2412	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
63629-2413_8ac80283-3216-4f42-beb9-3a0b97ae1956	63629-2413	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
63629-2414_4c627d71-0c62-4177-9a89-ec2b75492d4e	63629-2414	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200501		ANDA	ANDA078302	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
63629-2415_f1998bc4-937e-4152-bb20-9e30b5f9a175	63629-2415	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200501		ANDA	ANDA078302	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
63629-2416_8e93e70d-92ca-4b45-8842-ca89a7a16c77	63629-2416	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
63629-2417_1f749808-7361-4565-b7f2-525005026703	63629-2417	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-2418_10f997f4-1b96-476c-9305-add489f5253a	63629-2418	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-2419_6895c7ca-8d18-45f0-81e7-d1dbc9ec66ac	63629-2419	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
63629-2420_c36ffef6-1957-403b-8664-bc28791605cd	63629-2420	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-2421_c5599033-9596-4bc3-adb9-d2131d8aad60	63629-2421	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20251231
63629-2422_0eb1ab92-4b97-4ff8-8524-1ac13d0c47c9	63629-2422	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
63629-2423_83bf1c37-e5b7-47a9-9e04-cf3324048fc3	63629-2423	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
63629-2424_0ddfd35e-1bd9-403f-9bcd-9034a55c4ef0	63629-2424	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20060404		ANDA	ANDA077563	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
63629-2426_dbbf1cf1-e8ab-4350-a947-ccbb35f6030b	63629-2426	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 25 mg		losartan potassium	TABLET	ORAL	20120918		ANDA	ANDA201170	Bryant Ranch Prepack	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
63629-2427_98ceabda-8af5-419a-bd17-3bb82eb89d64	63629-2427	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 50 mg		losartan potassium	TABLET	ORAL	20120918		ANDA	ANDA201170	Bryant Ranch Prepack	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63629-2428_ee10aa80-bfb3-40fc-9bdc-03e2fa39b617	63629-2428	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 100 mg		losartan potassium	TABLET	ORAL	20120918		ANDA	ANDA201170	Bryant Ranch Prepack	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
63629-2429_4fb2612a-fab8-43cb-beb0-c5cb64072a07	63629-2429	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
63629-2430_26c3fcbc-6fff-4d37-844a-a4d4fac71639	63629-2430	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
63629-2431_48ef0dd4-cd2b-457a-8861-6b26b66c035c	63629-2431	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-2432_09070485-0913-47b5-8204-c960757d34df	63629-2432	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63629-2433_77e7f56b-1611-4bbc-bb2a-4548b153810f	63629-2433	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	Bryant Ranch Prepack	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2434_b7050b2c-b3d9-4efb-b784-0fbbe377b10f	63629-2434	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20050606		ANDA	ANDA040611	Bryant Ranch Prepack	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2435_b9c980ab-2909-4256-90f3-bb093c7b1514	63629-2435	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Bryant Ranch Prepack	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2436_f9d63265-f685-4f8e-a6db-e46440464c21	63629-2436	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
63629-2437_3a9797ea-bc9b-427f-b988-64ab2db19d5c	63629-2437	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
63629-2438_bad76aae-061a-435b-ab09-08f675935176	63629-2438	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20130201		ANDA	ANDA203253	Bryant Ranch Prepack	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
63629-2439_2a9f9b2d-c64d-4d4c-bd66-5f0deea8ecc9	63629-2439	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Bryant Ranch Prepack	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
63629-2443_1ea9dc6b-b444-4f21-a087-6098d932b7e3	63629-2443	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20251231
63629-2444_96c29367-412f-460b-86d8-945bf42596ff	63629-2444	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20251231
63629-2445_a110631a-5292-4e76-b1c3-3730fda219ee	63629-2445	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20180612		ANDA	ANDA091174	Bryant Ranch Prepack	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
63629-2447_8085df8d-e065-432b-a0ee-59c61d807b64	63629-2447	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	Bryant Ranch Prepack	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
63629-2448_1f7ec163-5055-457e-b725-1c1af6aa7d9d	63629-2448	HUMAN PRESCRIPTION DRUG	Omega-3-Acid Ethyl Ester		omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20170115		ANDA	ANDA206455	Bryant Ranch Prepack	OMEGA-3-ACID ETHYL ESTERS	900	mg/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
63629-2449_50ece9ce-fedb-4a45-9ac6-e4253fcab02c	63629-2449	HUMAN PRESCRIPTION DRUG	Volnea		Desogestrel and Ethinyl Estradiol	KIT		20171201		ANDA	ANDA202689	Bryant Ranch Prepack						N	20251231
63629-2451_33d6f908-904e-4e05-9958-baae9adc3e97	63629-2451	HUMAN PRESCRIPTION DRUG	Omega-3-Acid Ethyl Ester		omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20170115		ANDA	ANDA206455	Bryant Ranch Prepack	OMEGA-3-ACID ETHYL ESTERS	900	mg/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20251231
63629-2452_ebdb6003-c042-471d-a563-92d5da613858	63629-2452	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160816		ANDA	ANDA202539	Bryant Ranch Prepack	PARICALCITOL	1	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
63629-2453_546a8c78-2549-4a7e-999a-33a784d23c51	63629-2453	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160816		ANDA	ANDA202539	Bryant Ranch Prepack	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
63629-2454_9d2d3642-78f6-4718-a9d8-323ef416cc81	63629-2454	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20160715		ANDA	ANDA073484	Bryant Ranch Prepack	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
63629-2455_05e1e910-41c4-4199-99a7-62d8e693bd27	63629-2455	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2456_869eeb86-ae57-42d3-a2bd-763407bee030	63629-2456	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2457_36cb28c9-707d-4c44-8f24-c1475f438519	63629-2457	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2458_c21c536e-2da2-4612-a254-162e8351d2ad	63629-2458	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2459_500d061d-7196-4bc1-be33-25c41ebf3da1	63629-2459	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2460_1acca51f-1028-462b-9240-f17e320c34f6	63629-2460	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2461_3c289569-ca78-48eb-8776-0bc321e0c3ee	63629-2461	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
63629-2462_922a7488-c6b1-4b60-bc0b-7bf11d5e3d87	63629-2462	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170814		ANDA	ANDA205327	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2463_2bd51f87-9098-4bbc-9f29-d8e2f52647ab	63629-2463	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171229		ANDA	ANDA205327	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	72	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2464_7dd8498b-dcb0-410e-a7bd-ae531100c6be	63629-2464	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Bryant Ranch Prepack	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
63629-2465_6f6d7557-7f1f-4035-a5a3-3f6b014f318e	63629-2465	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20180528		ANDA	ANDA207222	Bryant Ranch Prepack	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
63629-2466_d132d914-4d09-4556-9219-e8fa914464f6	63629-2466	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		TIZANIDINE HYDROCHLORIDE	CAPSULE	ORAL	20190926		ANDA	ANDA210021	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
63629-2467_855a73b7-66af-4e5f-b166-68a55aa462fc	63629-2467	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		TIZANIDINE HYDROCHLORIDE	CAPSULE	ORAL	20190926		ANDA	ANDA210021	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
63629-2468_463bd426-9124-4feb-9b61-ba82266b3f5d	63629-2468	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-2469_f229b730-8562-4de2-9c34-48a6b8fc641e	63629-2469	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2470_4b6fd4d2-0f26-44d3-bc0a-5c06028391eb	63629-2470	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2471_8ca8d6dc-0fbe-419c-adf1-b8b7b5be1a6e	63629-2471	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-2473_7550b4fe-6aa1-4e9e-a18a-c436420be775	63629-2473	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170907		ANDA	ANDA202765	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63629-2474_dc26a277-8af3-481f-a1c0-2b10bcc70c61	63629-2474	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170907		ANDA	ANDA202765	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63629-2475_373cc1d7-1f22-4851-bb40-bb5d4b0138fb	63629-2475	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20150810		ANDA	ANDA202765	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63629-2476_6ad351a4-5f72-43d5-bc22-6eea86c0896e	63629-2476	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20150810		ANDA	ANDA202765	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20251231
63629-2477_8e20148c-7992-4efa-81a0-867934c216ff	63629-2477	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-2478_d1a15f66-46cf-4d6f-8784-7912c713fe44	63629-2478	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Bryant Ranch Prepack	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63629-2479_5a927c85-2212-4854-b363-ad6c3bb53712	63629-2479	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Bryant Ranch Prepack	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-2480_f069ecb7-bf1c-4beb-a79b-eac9dd420712	63629-2480	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Bryant Ranch Prepack	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63629-2481_a173fc0a-b908-40ca-9629-9dcc83c1d9fd	63629-2481	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Bryant Ranch Prepack	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63629-2482_120e8cef-46f2-4b62-910b-310166b92f5e	63629-2482	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	Bryant Ranch Prepack	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63629-2483_5c169efd-ffa0-4202-9e01-e3bd14b024d4	63629-2483	HUMAN PRESCRIPTION DRUG	CROMOLYN SODIUM		CROMOLYN SODIUM	SOLUTION, CONCENTRATE	ORAL	20171016		ANDA	ANDA209264	Bryant Ranch Prepack	CROMOLYN SODIUM	100	mg/5mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20251231
63629-2484_d7c244a0-f2ca-4972-ad58-f77fa3de9b62	63629-2484	HUMAN PRESCRIPTION DRUG	EC-NAPROXEN		naproxen	TABLET, DELAYED RELEASE	ORAL	20181015		NDA	NDA020067	Bryant Ranch Prepack	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-2485_baa08bb6-f101-4a9f-b135-31387c5c89b8	63629-2485	HUMAN PRESCRIPTION DRUG	CROMOLYN SODIUM		CROMOLYN SODIUM	SOLUTION, CONCENTRATE	ORAL	20171016		ANDA	ANDA209264	Bryant Ranch Prepack	CROMOLYN SODIUM	100	mg/5mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
63629-2488_ab2d5195-eec8-4405-94f5-2287defb682d	63629-2488	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20181011	20240930	ANDA	ANDA210616	Bryant Ranch Prepack	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63629-2489_b379329e-5d14-44ba-964f-d5828fe80553	63629-2489	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	TABLET	ORAL	20180701		ANDA	ANDA085588	Bryant Ranch Prepack	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
63629-2490_6c500c77-4351-4a77-9362-7d088b020511	63629-2490	HUMAN PRESCRIPTION DRUG	Omeprazole, Sodium bicarbonate		Omeprazole, Sodium bicarbonate	CAPSULE	ORAL	20210511		ANDA	ANDA212587	Bryant Ranch Prepack	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
63629-2491_859fb23d-e8fd-4f0e-ba2b-a52ce839fb94	63629-2491	HUMAN PRESCRIPTION DRUG	Omeprazole, Sodium bicarbonate		Omeprazole, Sodium bicarbonate	CAPSULE	ORAL	20210511		ANDA	ANDA212587	Bryant Ranch Prepack	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63629-2492_4088ceaa-ab64-4593-bd4a-6d3c31c52e0b	63629-2492	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	SUSPENSION	ORAL	20200814		ANDA	ANDA062832	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
63629-2493_e40f904c-b4b1-4e59-8581-6dc7ede1c4fc	63629-2493	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	SUSPENSION	ORAL	20200814		ANDA	ANDA062832	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
63629-2494_e89a6025-8fc0-4cca-bb73-144ebdf6039d	63629-2494	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		TIZANIDINE HYDROCHLORIDE	CAPSULE	ORAL	20190926		ANDA	ANDA210021	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
63629-2495_121be817-d058-4353-9be9-eefd1396a5c6	63629-2495	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20190928		ANDA	ANDA207741	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-2496_7d2fdf4d-560c-48b2-ac5f-829d8628b8d5	63629-2496	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20190928		ANDA	ANDA207741	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-2497_3579cfd8-bb6c-4829-8291-6c44fd6312dd	63629-2497	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20190928		ANDA	ANDA207741	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-2498_b89a98db-5f78-49bb-8116-ba74ef82e2d7	63629-2498	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20180329		ANDA	ANDA200166	Bryant Ranch Prepack	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2499_4617dc5d-bf31-4b74-bfb9-f8c61531129b	63629-2499	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20180329		ANDA	ANDA200166	Bryant Ranch Prepack	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
63629-2500_9391d94d-e22c-47d4-a1c4-7240a9adaacf	63629-2500	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	GRANULE, FOR SUSPENSION	ORAL	20160928		NDA	NDA050207	Bryant Ranch Prepack	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20251231
63629-2503_deab1a2e-f0b1-44a5-af91-41639c81fc1f	63629-2503	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20170310		ANDA	ANDA207810	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-2504_2811ddc3-8d09-469e-922f-c9cebeaa31af	63629-2504	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20170310		ANDA	ANDA207810	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-2505_76cf0ee3-d8e2-4f96-99d7-a8ffc739fcd8	63629-2505	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200918		ANDA	ANDA076635	Bryant Ranch Prepack	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
63629-2506_4da26304-4818-4dc8-b4eb-24131ecc6663	63629-2506	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20200617		ANDA	ANDA210198	Bryant Ranch Prepack	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2507_469f4846-2365-49be-a93d-a9ba13b162fd	63629-2507	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20200617		ANDA	ANDA210198	Bryant Ranch Prepack	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2508_044103f1-8aa3-4d79-b0ee-acf105a841e9	63629-2508	HUMAN PRESCRIPTION DRUG	FLUOCINONIDE		FLUOCINONIDE	CREAM	TOPICAL	20200430		ANDA	ANDA208989	Bryant Ranch Prepack	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2509_dd63c231-aeb3-4703-8680-a81d68c5fb65	63629-2509	HUMAN PRESCRIPTION DRUG	FLUOCINONIDE		FLUOCINONIDE	CREAM	TOPICAL	20200430		ANDA	ANDA208989	Bryant Ranch Prepack	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2510_566bc9f8-66a9-467e-b7e3-49b5dc4ede40	63629-2510	HUMAN PRESCRIPTION DRUG	FLUOCINONIDE		FLUOCINONIDE	CREAM	TOPICAL	20200430		ANDA	ANDA208989	Bryant Ranch Prepack	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2511_14b17a3c-b3e8-41e3-b0e0-664225c6373f	63629-2511	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
63629-2512_f05f0498-106d-45f5-9509-dcbd3a25d062	63629-2512	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
63629-2513_0259deac-9c4d-47b5-a33f-3f4ca4348efe	63629-2513	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
63629-2514_16652984-6db6-4780-9fa8-8faf436c404c	63629-2514	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
63629-2515_93338b75-a637-411f-ba9a-fc9fe6dbf913	63629-2515	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20200624		ANDA	ANDA207767	Bryant Ranch Prepack	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-2516_76c4c131-29b4-4e9a-af1b-ca97c467e221	63629-2516	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20200624		ANDA	ANDA207767	Bryant Ranch Prepack	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-2518_3fa815bf-1312-4537-9a35-5c70242ea85d	63629-2518	HUMAN PRESCRIPTION DRUG	Alosetron		Alosetron	TABLET	ORAL	20200914		ANDA	ANDA213614	Bryant Ranch Prepack	ALOSETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
63629-2519_3a2aa576-e82c-4cde-b74f-dcfa30d0a923	63629-2519	HUMAN PRESCRIPTION DRUG	azelastine hcl nasal		Azelastine HCl	SPRAY	NASAL	20140509		ANDA	ANDA202743	Bryant Ranch Prepack	AZELASTINE HYDROCHLORIDE	205.5	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63629-2520_ea65f651-7e10-4b2e-af33-fd75351b3b8c	63629-2520	HUMAN PRESCRIPTION DRUG	Calcipotriene and Betamethasone Dipropionate		Calcipotriene, Betamethasone Dipropionate	OINTMENT	TOPICAL	20200130		ANDA	ANDA200174	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	.643; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
63629-2521_29c10bbd-dcd5-4231-80c1-061d50b51c7b	63629-2521	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine hydrochloride	SOLUTION	ORAL	20080724	20240430	ANDA	ANDA078398	Bryant Ranch Prepack	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63629-2522_9f8eb703-f4e2-4ec3-80e1-e8f9f6503403	63629-2522	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	SUSPENSION	TOPICAL	20061229		ANDA	ANDA077676	Bryant Ranch Prepack	CICLOPIROX OLAMINE	7.7	mg/100mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-2523_d82ab990-9080-4bad-b24c-1db12b799dc6	63629-2523	HUMAN PRESCRIPTION DRUG	Clindamycin Palmitate Hydrochloride		Clindamycin Palmitate Hydrochloride	GRANULE, FOR SOLUTION	ORAL	20100121		ANDA	ANDA090902	Bryant Ranch Prepack	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-2526_81555a10-095e-4fc2-8029-c30bcb863607	63629-2526	HUMAN PRESCRIPTION DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20181127		ANDA	ANDA210893	Bryant Ranch Prepack	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-2527_84ed19dc-6d20-4496-9103-1f09ba74104e	63629-2527	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20060613		ANDA	ANDA085027	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2528_4714e86e-aa94-4f2b-aff5-9537955995ff	63629-2528	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20060613		ANDA	ANDA085027	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2529_90b4a72b-78bf-4770-b44f-99171d8c118a	63629-2529	HUMAN PRESCRIPTION DRUG	hydrocortisone		hydrocortisone	LOTION	TOPICAL	20080523		ANDA	ANDA089074	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-2530_b2fe39a6-f48e-46d9-ab00-d8865d7e06e9	63629-2530	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	19900701		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2531_4bf2e2cf-1490-495d-a5c2-2a6f9f807741	63629-2531	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	19900701		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-2532_971f9f4c-1e16-40fb-b08f-e5dc1424e2d2	63629-2532	HUMAN PRESCRIPTION DRUG	HYDROMORPHONE HYDROCHLORIDE		HYDROMORPHONE HYDROCHLORIDE	SUPPOSITORY	RECTAL	19960131		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	3	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-2533_79c47b03-c025-4536-b09b-4f57cd5f961e	63629-2533	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		Levocetirizine dihydrochloride	SOLUTION	ORAL	20111107		ANDA	ANDA091263	Bryant Ranch Prepack	LEVOCETIRIZINE DIHYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63629-2534_b909160c-b71d-4bca-9658-6c7bb31573af	63629-2534	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20050502		ANDA	ANDA076379	Bryant Ranch Prepack	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-2535_a82085ee-29f7-4036-9636-22256c3b28e7	63629-2535	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	MORPHINE SULFATE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-2536_10a7ac6b-3d48-414b-84fc-12d7d61ad04d	63629-2536	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	MORPHINE SULFATE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-2537_8b2dcb83-86f4-40c1-8c71-3572b45abee6	63629-2537	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	MORPHINE SULFATE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-2538_cff101d7-1d35-4210-b1db-40b159bee3bf	63629-2538	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		MORPHINE SULFATE	SUPPOSITORY	RECTAL	19900901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-2611_84e98191-dd61-4b65-b5de-37ee1ff6f9e7	63629-2611	HUMAN PRESCRIPTION DRUG	Albuterol		albuterol	TABLET	ORAL	20180629		ANDA	ANDA207046	Bryant Ranch Prepack	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
63629-2612_fd2ac764-98e6-7e78-e053-6294a90a6ad8	63629-2612	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	Bryant Ranch Prepack	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
63629-2782_a008ae16-1e16-455b-9fc6-0ac3bcc813c2	63629-2782	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63629-2910_0263b16b-7de7-4641-bb59-bb1e17d2051b	63629-2910	HUMAN PRESCRIPTION DRUG	PENTOXIFYLLINE		PENTOXIFYLLINE	TABLET, EXTENDED RELEASE	ORAL	19990610		ANDA	ANDA075191	Bryant Ranch Prepack	PENTOXIFYLLINE	400	mg/1	Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]		N	20241231
63629-2948_7646f730-f1d5-4d3f-a622-9bbc90b144fa	63629-2948	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071307	Bryant Ranch Prepack	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-2952_dd1fa3f8-4ef8-42c9-9bc0-e4c91bfa8ca9	63629-2952	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE		Butalbital, Aspirin, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20090501		ANDA	ANDA075231	Bryant Ranch Prepack	ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	20241231
63629-2974_1d9caf46-330d-433f-962e-8da0468be79e	63629-2974	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	Bryant Ranch Prepack	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-3031_7f0f50c7-22e4-45f2-86ec-60ad1ec04c99	63629-3031	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
63629-3043_d877f389-167f-42c4-a9c2-adc90a7cad20	63629-3043	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	Bryant Ranch Prepack	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63629-3209_82084f4e-00d0-c298-c13a-88a6c0860b02	63629-3209	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-3248_27f7f1b9-55bb-46ec-a1e0-430251cfa702	63629-3248	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Bryant Ranch Prepack	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-3292_9a2be6ab-1838-4d22-9c1e-ca4206e8b5c8	63629-3292	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride		Pioglitazone Hydrochloride	TABLET	ORAL	20130213	20250930	ANDA	ANDA200044	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	
63629-3293_39303fe6-8d9f-4fa1-91fa-4b012e71d6cc	63629-3293	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060317		ANDA	ANDA077634	Bryant Ranch Prepack	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
63629-3299_9a2be6ab-1838-4d22-9c1e-ca4206e8b5c8	63629-3299	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride		pioglitazone hydrochloride	TABLET	ORAL	20130213	20250731	ANDA	ANDA200044	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	
63629-3324_75d643dd-8904-4a11-8aab-b52c0b651cb2	63629-3324	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63629-3328_a46e8c28-fbba-4a6f-9e96-65dce377ec58	63629-3328	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Bryant Ranch Prepack	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-3330_b440a762-34a9-486a-928c-318b44c02d98	63629-3330	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		PIOGLITAZONE HYDROCHLORIDE	TABLET	ORAL	20130213	20250831	ANDA	ANDA200044	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	
63629-3331_3e3f03f9-e3d1-493d-b3d7-1f8215d6a9ee	63629-3331	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	Bryant Ranch Prepack	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-3349_aeb84101-0f28-4dbe-af26-09fed4111d87	63629-3349	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Bryant Ranch Prepack	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-3385_e1fa3736-6681-4a6c-8953-cc6b02468212	63629-3385	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Bryant Ranch Prepack	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-3392_56e5c0f7-c8b3-4c32-908e-d0988cbc121d	63629-3392	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Bryant Ranch Prepack	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-3393_e3a4dbf3-2066-4aa9-9701-da180ca546c7	63629-3393	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Bryant Ranch Prepack	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-3405_b59bfb24-a009-4400-9ba3-c3d8fd08b36a	63629-3405	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20090505		ANDA	ANDA078989	Bryant Ranch Prepack	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
63629-3408_e142a127-bdff-4745-a8cb-07658d62cc00	63629-3408	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Bryant Ranch Prepack	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-3549_e21c142f-b0af-43cc-bc26-b3f8f7066b15	63629-3549	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-3685_fabc51a7-4a20-42f3-8e59-3b0c228c6646	63629-3685	HUMAN PRESCRIPTION DRUG	Trimethobenzamide Hydrochloride		Trimethobenzamide Hydrochloride	CAPSULE	ORAL	20030828		ANDA	ANDA076570	Bryant Ranch Prepack	TRIMETHOBENZAMIDE HYDROCHLORIDE	300	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63629-3739_1009900e-6a3d-4e8d-a533-334e0bfca2c2	63629-3739	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-3742_ce3eeaa7-3b4f-455a-ae01-f592db862382	63629-3742	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	Bryant Ranch Prepack	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-3798_5c286414-d233-4f43-8aad-8b3b9ae3d6bb	63629-3798	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091123		NDA AUTHORIZED GENERIC	NDA019892	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-3816_6a526e44-d586-42b3-93d2-ea77f448bca9	63629-3816	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Bryant Ranch Prepack	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-3868_ecdea0b5-1d03-4e03-a83f-b42a57b918a1	63629-3868	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63629-4042_839d0e00-074c-43fc-b1b2-59c696c7a505	63629-4042	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	19970528	20250630	ANDA	ANDA064150	Bryant Ranch Prepack	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	
63629-4060_102e4280-8dc0-4609-8973-99190d1908f5	63629-4060	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Bryant Ranch Prepack	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63629-4093_a63e904d-7fac-4b56-9c0d-4642ffe347cf	63629-4093	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077050	Bryant Ranch Prepack	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63629-4094_3e57d997-8fd3-4c96-b8cc-848d0812f989	63629-4094	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-4108_37d9b7c1-4bf8-44ed-8d48-bd1ee6efd72c	63629-4108	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	TABLET, FILM COATED	ORAL	19980811		ANDA	ANDA075219	Bryant Ranch Prepack	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-4129_4a25abaa-862a-43f7-a3cc-4cfb056e6743	63629-4129	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19750603		ANDA	ANDA084613	Bryant Ranch Prepack	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-4137_f621e61c-af8f-4ece-bad3-2dd8302bb2e4	63629-4137	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078154	Bryant Ranch Prepack	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-4284_3bb1aed1-a206-4375-b7f0-f1cbb4c7dba8	63629-4284	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091123		NDA AUTHORIZED GENERIC	NDA019892	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-4306_fe74b19e-e8b6-4cdf-a4c6-3e879ba5fd2f	63629-4306	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	Bryant Ranch Prepack	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63629-4331_7259a3c0-e67f-468c-b0d4-12f01f0dc173	63629-4331	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20000329	20241031	ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
63629-4385_1116eef4-ae25-4dba-ba60-5d2b8a2622ad	63629-4385	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20120815		ANDA	ANDA040876	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-4470_ec8665ac-3953-4159-bb23-252103e6cc4d	63629-4470	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-4556_9ee70b03-0aa3-4422-96c7-3f7af63ec442	63629-4556	HUMAN PRESCRIPTION DRUG	NP Thyroid 30		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20110114		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	LEVOTHYROXINE; LIOTHYRONINE	19; 4.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
63629-4675_373da7ba-65f7-4790-905f-b0dd8c218aa1	63629-4675	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078154	Bryant Ranch Prepack	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-4708_fd7aaf1a-b0f0-9c18-e053-6294a90a94a5	63629-4708	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET, EXTENDED RELEASE	ORAL	20111031		ANDA	ANDA090107	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-4776_b90dde00-3e96-4937-a4bb-a3ff6a865342	63629-4776	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Bryant Ranch Prepack	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-4813_006090ad-5072-c319-e063-6394a90ade1e	63629-4813	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260131	ANDA	ANDA077449	Bryant Ranch Prepack	FENTANYL	100	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63629-4841_c8984cbc-784c-4dca-ad4e-79264d387108	63629-4841	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Bryant Ranch Prepack	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-4929_1d93ba7e-d1a0-49e7-a434-bdda927b30b2	63629-4929	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20140820		ANDA	ANDA204279	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63629-4964_62d0b548-5ede-478e-ae58-bfe0f893f9ea	63629-4964	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Bryant Ranch Prepack	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-4968_8044acc4-51ec-4f3b-a9a6-0289087f4b3c	63629-4968	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Bryant Ranch Prepack	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
63629-4974_005ffedc-9d49-b5cb-e063-6394a90af21c	63629-4974	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20251231	ANDA	ANDA077449	Bryant Ranch Prepack	FENTANYL	25	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63629-4976_00605cdd-b923-77f2-e063-6394a90a3992	63629-4976	HUMAN PRESCRIPTION DRUG	FENTANYL		FENTANYL	PATCH, EXTENDED RELEASE	TRANSDERMAL	20130404	20260131	ANDA	ANDA077449	Bryant Ranch Prepack	FENTANYL	75	ug/h	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
63629-5042_010833ff-5170-43df-825b-ccfd14713339	63629-5042	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Bryant Ranch Prepack	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
63629-5094_c6770218-eb44-4dc9-8d8d-b206e584ed93	63629-5094	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20130915		ANDA	ANDA200675	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-5173_e5b82db7-5871-48fa-8d1d-26be3d9698cc	63629-5173	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol fumarate	TABLET	ORAL	20090921		ANDA	ANDA078635	Bryant Ranch Prepack	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-5237_f3839cb6-7753-4cbc-a645-4d5fae4c9806	63629-5237	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Bryant Ranch Prepack	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63629-5246_c023ef6b-cdd6-4655-9d56-ce0cc14d7597	63629-5246	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63629-5247_3f2a6266-4f76-427d-9228-1749e4af59f5	63629-5247	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Bryant Ranch Prepack	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63629-5269_6d1d9aef-5f64-41f2-b6f8-db82e67c8a12	63629-5269	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	Bryant Ranch Prepack	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
63629-5284_0ea714a1-b05e-bc87-e063-6294a90a28e7	63629-5284	HUMAN PRESCRIPTION DRUG	Ibuprofen and Pseudoephedrine hydrochloride		ibuprofen and pseudoephedrine hydrochloride	TABLET, SUGAR COATED	ORAL	20011013		ANDA	ANDA074567	Bryant Ranch Prepack	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20251231
63629-5302_1d943296-508e-48f4-907d-277474c827e1	63629-5302	HUMAN PRESCRIPTION DRUG	Clomiphene Citrate		Clomiphene Citrate	TABLET	ORAL	19990830	20250228	ANDA	ANDA075528	Bryant Ranch Prepack	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	
63629-5341_ed6e23ec-657b-4b09-a3a7-84174eb223e9	63629-5341	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-5650_b20e1048-ff33-4c70-a12c-debd612144b4	63629-5650	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Bryant Ranch Prepack	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
63629-5682_d1bb9bdb-dc51-4702-ad12-50b216489fba	63629-5682	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	Bryant Ranch Prepack	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63629-5698_8af70082-d192-4446-8afc-186dc6aa3efb	63629-5698	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20161210		ANDA	ANDA090912	Bryant Ranch Prepack	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
63629-6408_7a1cc4ef-5488-49fa-a7a7-9402c7b413c8	63629-6408	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20000329	20241031	ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
63629-6907_8686dc5b-71bf-4078-a436-f88fdd2af2f6	63629-6907	HUMAN PRESCRIPTION DRUG	Bisoprolol		Bisoprolol fumarate	TABLET, FILM COATED	ORAL	20190620		ANDA	ANDA075474	Bryant Ranch Prepack	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-7059_6fdac38a-5989-4505-a6bf-d44209306b20	63629-7059	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	CUTANEOUS	20160229		ANDA	ANDA200675	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-7108_27d4bff0-86f7-4ff1-a7e3-0d8e0438f801	63629-7108	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA201519	Bryant Ranch Prepack	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-7116_24c57159-0dd3-43ec-b89e-54ed5d2f218c	63629-7116	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Bryant Ranch Prepack	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-7157_ed581629-1edf-472e-a10d-f1d2b0c29fa0	63629-7157	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-7158_37b4962e-ee7d-49aa-b891-cf76017be3f8	63629-7158	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20161031		ANDA	ANDA201619	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-7207_3b7c9ae7-4770-4903-98f6-307737bc53d3	63629-7207	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20130415		ANDA	ANDA202675	Bryant Ranch Prepack	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-7282_5cc6eb0a-e2be-4260-ba6d-63149e41eeb2	63629-7282	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-7306_9f71f477-2474-4b7c-9971-2014a2d54950	63629-7306	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-7413_c89ce235-1211-4857-a2a9-a5098b7bfbe4	63629-7413	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA203931	Bryant Ranch Prepack	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
63629-7421_1b2f36d9-7620-43a7-8071-7c057711bf61	63629-7421	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20140912		ANDA	ANDA078155	Bryant Ranch Prepack	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-7422_8b23e0ce-968c-4f7e-8992-734d95033e29	63629-7422	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	CAPSULE	ORAL	20141001		NDA	NDA204820	Bryant Ranch Prepack	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20241231
63629-7475_9d59c07f-5b16-4a33-9080-db0587988d7e	63629-7475	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20160713		NDA	NDA019781	Bryant Ranch Prepack	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
63629-7508_a8344420-764c-4648-bab6-546ebb6ef3a0	63629-7508	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-7515_c0e41a74-3508-4e93-89cd-6ae176075eb3	63629-7515	HUMAN PRESCRIPTION DRUG	Nalfon		fenoprofen calcium	CAPSULE	ORAL	20120827		NDA	NDA017604	Bryant Ranch Prepack	FENOPROFEN CALCIUM	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-7525_1f281cc6-bd8f-48d0-8e46-48ae5392e700	63629-7525	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	Bryant Ranch Prepack	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63629-7559_440cfc9d-4cca-4368-86d9-4c2f303a7f51	63629-7559	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	Bryant Ranch Prepack	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63629-7631_bc77caf7-031e-41af-a7a7-85068b121e5e	63629-7631	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	19880808	20241231	ANDA	ANDA072423	Bryant Ranch Prepack	MEGESTROL ACETATE	40	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	
63629-7747_0feaa740-7f73-4e1e-92e5-33e95b9f1224	63629-7747	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	Bryant Ranch Prepack	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
63629-7782_1a8f13a1-f72a-46d2-ac42-6276c429b610	63629-7782	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130418		ANDA	ANDA202556	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-7801_936dc5c3-adb0-476e-b9a3-c6de10c8885f	63629-7801	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	Bryant Ranch Prepack	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63629-7803_2c5a8f50-44ce-43bb-a60a-bae2c75aedc2	63629-7803	HUMAN PRESCRIPTION DRUG	Fexmid		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20180430		ANDA	ANDA071611	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-7806_4a25abaa-862a-43f7-a3cc-4cfb056e6743	63629-7806	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19830915		ANDA	ANDA088316	Bryant Ranch Prepack	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-7811_fd91b633-a614-2b4f-e053-6394a90ab767	63629-7811	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20091224		ANDA	ANDA040866	Bryant Ranch Prepack	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-7819_5643d810-e5a0-4774-8907-71281122346b	63629-7819	HUMAN PRESCRIPTION DRUG	Letrozole		letrozole	TABLET, FILM COATED	ORAL	20110602		ANDA	ANDA090934	Bryant Ranch Prepack	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
63629-7850_4a25abaa-862a-43f7-a3cc-4cfb056e6743	63629-7850	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19830915		ANDA	ANDA088306	Bryant Ranch Prepack	DEXAMETHASONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-7895_ec0435d9-ffc3-4574-a86e-f5926a8a7931	63629-7895	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Bryant Ranch Prepack	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
63629-7917_273ae2ea-b345-4560-accc-274857e86d70	63629-7917	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Bryant Ranch Prepack	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-7928_bbf259eb-a267-4610-8764-187249e79a95	63629-7928	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Bryant Ranch Prepack	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63629-7979_b56a83a2-c698-4384-93a5-887bbb6a384a	63629-7979	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150708		ANDA	ANDA202821	Bryant Ranch Prepack	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-7982_ff6e4a0d-65a7-40c7-a60a-5764c51db141	63629-7982	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20150708		ANDA	ANDA202821	Bryant Ranch Prepack	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-7987_f9163911-a22e-4690-826a-0233c8499810	63629-7987	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	Bryant Ranch Prepack	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-7988_6323aa8a-8bca-40ed-94c2-989bcacfc01c	63629-7988	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	Bryant Ranch Prepack	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-8014_07ccff59-e335-40be-9e40-fd2d08197617	63629-8014	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170619		ANDA	ANDA203695	Bryant Ranch Prepack	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
63629-8042_9827e5c7-80bf-405f-81b1-2e5c06544444	63629-8042	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-8149_2f7f107f-7f80-479e-b914-b36c617792cf	63629-8149	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021		ANDA	ANDA088292	Bryant Ranch Prepack	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63629-8152_fbd454af-3520-3311-e053-6394a90a7e66	63629-8152	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-8195_96a4862e-10d9-49ba-8764-89eae3a1add1	63629-8195	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	50	mg/1		CV	N	20241231
63629-8196_f40b4787-d9ec-465c-b4d0-f9a163b66850	63629-8196	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	75	mg/1		CV	N	20241231
63629-8197_f7c6e1b0-ca90-4695-bd7a-a7e65d1ceca9	63629-8197	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	100	mg/1		CV	N	20241231
63629-8198_13658fe5-a9da-4235-9f8c-02c8d2acb74d	63629-8198	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	150	mg/1		CV	N	20241231
63629-8199_c1996bca-ceed-4f99-9c56-e4e6560fcaa5	63629-8199	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	25	mg/1		CV	N	20241231
63629-8207_32a859eb-81da-4a95-9605-8156f75b5e36	63629-8207	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161024		ANDA	ANDA206574	Bryant Ranch Prepack	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
63629-8208_1e597e8e-775a-45a8-a048-099681943821	63629-8208	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	200	mg/1		CV	N	20241231
63629-8212_2eeba957-6763-4cc8-84fe-d24d66d21660	63629-8212	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20001201	20241130	ANDA	ANDA065055	Bryant Ranch Prepack	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
63629-8239_7cef837f-951f-4496-a5b8-95985f79c53b	63629-8239	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	225	mg/1		CV	N	20241231
63629-8240_302b4f3b-6f8a-410d-8e3d-19c72be2276b	63629-8240	HUMAN OTC DRUG	Feverall	Jr. Strength	Acetaminophen	SUPPOSITORY	RECTAL	20131212		NDA	NDA018337	Bryant Ranch Prepack	ACETAMINOPHEN	325	mg/1			N	20241231
63629-8247_83232e7d-ec2c-4dfe-a259-83d40cb9c724	63629-8247	HUMAN PRESCRIPTION DRUG	Vascepa		icosapent ethyl	CAPSULE	ORAL	20121001		NDA	NDA202057	Bryant Ranch Prepack	ICOSAPENT ETHYL	1000	mg/1			N	20241231
63629-8248_de8339aa-1bc3-4435-b97a-3e96573f5f31	63629-8248	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	300	mg/1		CV	N	20241231
63629-8253_342de96e-45a9-49af-9a85-efeaae182a53	63629-8253	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	Bryant Ranch Prepack	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-8265_a78a7a02-3720-469f-a600-a89ea587589f	63629-8265	HUMAN PRESCRIPTION DRUG	NP Thyroid 15		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20161116		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	LEVOTHYROXINE; LIOTHYRONINE	9.5; 2.25	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
63629-8288_8ef25342-8c24-4bd2-a503-1d6072b4985c	63629-8288	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Bryant Ranch Prepack	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
63629-8315_d12a6c9d-b478-460f-b832-5355d594588f	63629-8315	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Bryant Ranch Prepack	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8319_34b199b9-6db9-4f7b-8aca-677cbe0fa528	63629-8319	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63629-8323_d9fd1f31-a35f-4b72-8928-bd6e1f8f4524	63629-8323	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63629-8324_01db3fdf-3f2b-4e87-b529-2b39b95ad8e0	63629-8324	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
63629-8338_b018b566-3288-430e-b430-2a2d37f8da9d	63629-8338	HUMAN PRESCRIPTION DRUG	Flurbiprofen		Flurbiprofen	TABLET, FILM COATED	ORAL	19950602		ANDA	ANDA074431	Bryant Ranch Prepack	FLURBIPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8344_361f92c1-054a-4661-b3b9-fdd0782f5c01	63629-8344	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63629-8347_ab0124b1-3769-400f-8544-398aaa689615	63629-8347	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20120115		ANDA	ANDA040734	Bryant Ranch Prepack	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
63629-8351_8352c533-bd35-453c-91ac-8397277f944d	63629-8351	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20051014		ANDA	ANDA077220	Bryant Ranch Prepack	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
63629-8353_8b2c5225-0b03-4789-b253-bdef17cb67ae	63629-8353	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Bryant Ranch Prepack	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
63629-8357_27864513-a113-4ec1-9e78-41bc762172bc	63629-8357	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA076938	Bryant Ranch Prepack	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
63629-8362_fe8febe0-17b1-4929-bedd-cb39b62558a7	63629-8362	HUMAN PRESCRIPTION DRUG	colchicine		colchicine	TABLET	ORAL	20190210		ANDA	ANDA211250	Bryant Ranch Prepack	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
63629-8392_d6694aa0-dcef-45c6-a12f-369bfb551861	63629-8392	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20120913		ANDA	ANDA200243	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
63629-8418_1d47272d-979e-46fe-814f-7b835a0f23d4	63629-8418	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Bryant Ranch Prepack	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
63629-8432_3f23a80a-9ff8-4569-9e83-6731a78a7328	63629-8432	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	Bryant Ranch Prepack	APIXABAN	2.5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
63629-8434_0ffa0440-211c-4a7f-9493-2368ab4cfb82	63629-8434	HUMAN PRESCRIPTION DRUG	olopatadine hydrochloride		Olopatadine Hydrochloride	SPRAY	NASAL	20170614		ANDA	ANDA202853	Bryant Ranch Prepack	OLOPATADINE HYDROCHLORIDE	665	ug/1	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
63629-8435_decf4364-61e3-451f-a6ec-45388af6a3f5	63629-8435	HUMAN PRESCRIPTION DRUG	Belladonna and Opium		ATROPA BELLADONNA and OPIUM	SUPPOSITORY	RECTAL	19940501		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ATROPA BELLADONNA; OPIUM	16.2; 30	mg/1; mg/1		CII	N	20251231
63629-8436_580cd487-06dc-4c1b-a312-0042f4e792e8	63629-8436	HUMAN PRESCRIPTION DRUG	Belladonna and Opium		ATROPA BELLADONNA and OPIUM	SUPPOSITORY	RECTAL	19940501		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ATROPA BELLADONNA; OPIUM	16.2; 30	mg/1; mg/1		CII	N	20251231
63629-8439_d8c32cdb-28d2-4f6b-9482-5e190659ec49	63629-8439	HUMAN PRESCRIPTION DRUG	pilocarpine hydrchloride		pilocarpine hydrchloride	TABLET, FILM COATED	ORAL	20200824		ANDA	ANDA076746	Bryant Ranch Prepack	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
63629-8442_e26d6cbc-1dbc-4d6b-b60a-24d62e6d0958	63629-8442	HUMAN PRESCRIPTION DRUG	Potassium chloride extended release		Potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20151211		ANDA	ANDA205993	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63629-8443_03d59ab7-4548-480f-81ce-906c21a8b2c8	63629-8443	HUMAN PRESCRIPTION DRUG	Potassium chloride extended release		Potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20151211		ANDA	ANDA205993	Bryant Ranch Prepack	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
63629-8445_6432d3ac-a988-4461-be93-b496b3e8d36f	63629-8445	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SUPPOSITORY	RECTAL	20060517		ANDA	ANDA040500	Bryant Ranch Prepack	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
63629-8447_65709363-1d5e-491a-bfe1-f5ab23e8208c	63629-8447	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20130809		ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	.5	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
63629-8448_2d056b97-b8b9-4ade-b5ae-5a249f2fcb22	63629-8448	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20140122		ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
63629-8449_a1bf815b-3b45-4467-830d-4449cfe36dd9	63629-8449	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20140122		ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	2	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
63629-8450_49126b9a-496e-4a77-b43d-2ea7bf2d43a7	63629-8450	HUMAN PRESCRIPTION DRUG	Scopolamine Trandermal System		scolopamine transdermal system	PATCH, EXTENDED RELEASE	TRANSDERMAL	20170613		ANDA	ANDA078830	Bryant Ranch Prepack	SCOPOLAMINE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63629-8451_b2d03045-48f7-4681-99e1-d46525ff6cf4	63629-8451	HUMAN PRESCRIPTION DRUG	Scopolamine Trandermal System		scolopamine transdermal system	PATCH, EXTENDED RELEASE	TRANSDERMAL	20170613		ANDA	ANDA078830	Bryant Ranch Prepack	SCOPOLAMINE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
63629-8452_122f20c5-c039-478f-8425-8b85c48acfb9	63629-8452	HUMAN PRESCRIPTION DRUG	Scopolamine Trandermal System		scolopamine transdermal system	PATCH, EXTENDED RELEASE	TRANSDERMAL	20170613		ANDA	ANDA078830	Bryant Ranch Prepack	SCOPOLAMINE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63629-8455_1e0fbc7c-1dd6-4a73-9d02-f5075066ce21	63629-8455	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20181012		ANDA	ANDA204268	Bryant Ranch Prepack	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-8457_33088c98-8ffc-410a-9135-7cc6b3d4843b	63629-8457	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	TABLET, FILM COATED	ORAL	20101117		ANDA	ANDA091573	Bryant Ranch Prepack	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-8458_bd2b4f17-c800-4b6c-80be-4fbf1e1a9b64	63629-8458	HUMAN PRESCRIPTION DRUG	Trospium Chloride	ER	Trospium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20130607		ANDA	ANDA201291	Bryant Ranch Prepack	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-8459_0957406b-b170-4c70-b370-4077042a8dab	63629-8459	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET	ORAL	20210211		ANDA	ANDA212451	Bryant Ranch Prepack	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-8460_e98af13a-971d-46a9-b46b-b55d06ee2e04	63629-8460	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET	ORAL	20210211		ANDA	ANDA212451	Bryant Ranch Prepack	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-8469_16689553-4704-4ca8-b354-74e3e0f50ed1	63629-8469	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-8470_3ecf02a6-953e-4b9b-9a9e-8b2c93b48f49	63629-8470	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-8471_3ca3816b-65dc-42db-a654-4c0c595734f4	63629-8471	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-8472_4cd44e1f-a96e-4938-9867-7af5fe795a03	63629-8472	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-8473_5a1127a4-963e-4014-aac1-0e92b8879b23	63629-8473	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
63629-8474_3440beb7-5896-4c57-a5e3-c9b1782355d2	63629-8474	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
63629-8475_5819a1cd-4a62-465e-a4d4-356e843b31ec	63629-8475	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
63629-8476_b97be7e2-6a57-44ab-9f1b-d4c478fa34cb	63629-8476	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
63629-8477_c4c9c869-6c0b-40ff-8934-f99197ded50d	63629-8477	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
63629-8478_84528e75-3663-4277-8168-b9adec26475e	63629-8478	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
63629-8479_bc17cf72-d498-4d3d-894e-afc741aee128	63629-8479	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
63629-8481_fcda0b95-aba5-47be-b9b6-8f7bde0425ce	63629-8481	HUMAN PRESCRIPTION DRUG	Desonide Ointment, 0.05%		Desonide Ointment, 0.05%	OINTMENT	TOPICAL	20190320		ANDA	ANDA210998	Bryant Ranch Prepack	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-8482_2e2495e4-8c18-457f-97af-8d4242ce8d59	63629-8482	HUMAN PRESCRIPTION DRUG	Desonide Ointment, 0.05%		Desonide Ointment, 0.05%	OINTMENT	TOPICAL	20190320		ANDA	ANDA210998	Bryant Ranch Prepack	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-8483_6f78fe1c-7057-41ef-bea2-4f932a842178	63629-8483	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20150301		ANDA	ANDA203104	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
63629-8484_35f114d8-dbcd-4fd4-95f4-1e007657412e	63629-8484	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8485_eb39211f-b090-4b6b-8404-3c7574a933bc	63629-8485	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8486_221be94d-0f48-4957-9bf9-ceb1b0295078	63629-8486	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8487_afe33952-5ca1-4bd0-82cc-1c1b67801580	63629-8487	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8488_dce866c7-788a-404e-8b96-4a20721a8faf	63629-8488	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Bryant Ranch Prepack	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8489_f7cb99dc-ee6e-4e40-b828-89926f6637d6	63629-8489	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8490_903ffd28-b8bd-4c95-ab84-ce884030bfcf	63629-8490	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8491_ac56cfa8-a69d-45e2-b15e-e3358a64eda2	63629-8491	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8492_f97ffac1-cbaf-4415-a94f-ea9d601ce54a	63629-8492	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-8493_6cbee232-1810-4489-b081-362d0e41399b	63629-8493	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-8494_2ebf4c15-b4cc-4577-8cfa-da203b61c959	63629-8494	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-8495_f3870673-f5e1-4cde-90c9-62b80f6a5050	63629-8495	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-8496_550be954-fd4f-4ba8-bed1-dcc919cf2b5a	63629-8496	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-8497_0a3f1261-d3e3-4f67-9a28-01edbf99635e	63629-8497	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63629-8498_fd16f2db-1ff9-4c03-a852-4ab7522f694c	63629-8498	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
63629-8499_3bd9b7ab-5ab8-4e82-90da-7d9572bcba04	63629-8499	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20251231
63629-8500_cd6cb7eb-9e20-414c-98ff-cc7472d29dcb	63629-8500	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20140909		ANDA	ANDA203646	Bryant Ranch Prepack	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
63629-8501_57029a4d-1846-4811-8cd2-e6017905e8d6	63629-8501	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63629-8502_4ee2f78b-9e0a-48e5-8306-814d9678c3d5	63629-8502	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63629-8503_df9541d1-769e-4b35-9da7-59fdad1632bf	63629-8503	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63629-8504_5c1f7ec4-ea5a-4745-b159-3113906e0611	63629-8504	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63629-8505_81259c8e-a210-4024-bc64-3ce97542681f	63629-8505	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110114		ANDA	ANDA074769	Bryant Ranch Prepack	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-8506_df5fae6b-0918-478e-9c56-d52763017852	63629-8506	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8508_159d0df1-d905-4877-8eb8-04215b316b60	63629-8508	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8509_f14b1045-d9ea-4a05-9588-ad73af5afb23	63629-8509	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8510_3b777c02-9d2c-44b4-9e1a-c31910045018	63629-8510	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8511_4f8060d8-0cff-4ed2-b14e-1b01e2b28093	63629-8511	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Bryant Ranch Prepack	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8512_57e86ab1-1525-4108-8f41-dbb3c8e27b1b	63629-8512	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Bryant Ranch Prepack	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8513_c3e5a0bb-0dd8-4fc0-afaa-189d8d91a551	63629-8513	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Bryant Ranch Prepack	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8514_c941253e-7994-4e68-a715-c3c8c9ff93dc	63629-8514	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Bryant Ranch Prepack	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8515_fb146d22-0dbb-48e6-8d41-5b6e75631747	63629-8515	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Bryant Ranch Prepack	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8516_92a76ca5-8c83-4a3a-94e4-c0d9d26c366b	63629-8516	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	Bryant Ranch Prepack	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8517_68a3d73c-c396-4c4a-a8fd-bcb8bcc51911	63629-8517	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	Bryant Ranch Prepack	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8519_6e92da54-e4e7-4bf5-975c-267972f90dcf	63629-8519	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20120501		ANDA	ANDA064142	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8520_e505ff47-c84a-4e72-a249-5232d13f216d	63629-8520	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	SUSPENSION	ORAL	20200814		ANDA	ANDA062832	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8521_c6b8c132-c241-4768-99a3-fec1c71f1fdd	63629-8521	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20120501		ANDA	ANDA065422	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
63629-8522_63fab6d4-0622-40d9-ace7-3c125cd5dbe0	63629-8522	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
63629-8523_65b8d431-6acc-4496-bf5d-2d9a9f5cab06	63629-8523	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
63629-8524_9302872e-250a-43fe-b302-8839a9bcd8e6	63629-8524	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
63629-8525_1334412a-53f4-4cf7-b858-7e8cb05e2d44	63629-8525	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
63629-8526_0c66df97-9246-4857-a6aa-ebe9567b7c69	63629-8526	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-8527_d72b03fa-f81e-4eab-95aa-00c6c48ebf37	63629-8527	HUMAN PRESCRIPTION DRUG	Paroxetine Hydrochloride		Paroxetine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20141031		ANDA	ANDA204744	Bryant Ranch Prepack	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
63629-8528_c4ce519c-b16f-42d9-b6f0-e724d0e8cda0	63629-8528	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
63629-8529_f16a94f8-6d0b-45a0-9e5a-40ba9bef08f5	63629-8529	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20170724		ANDA	ANDA040684	Bryant Ranch Prepack	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
63629-8530_cb3961f6-f6e3-4ca7-81f4-242d69f7f462	63629-8530	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20160713		NDA	NDA019781	Bryant Ranch Prepack	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
63629-8531_a9d96aef-96e9-4688-bc03-72f71fa90576	63629-8531	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20201001		ANDA	ANDA213186	Bryant Ranch Prepack	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
63629-8532_f1a70279-30d4-4c00-a28e-4434b85d5ced	63629-8532	HUMAN PRESCRIPTION DRUG	SOLIFENACIN SUCCINATE		SOLIFENACIN SUCCINATE	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA211657	Bryant Ranch Prepack	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
63629-8533_ec9df1e6-a223-4854-9511-02933eda29a8	63629-8533	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
63629-8537_e915d936-3c0f-40b8-bdd9-73d488405ed0	63629-8537	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
63629-8539_922833d9-6835-41af-9672-deafda3fd4e7	63629-8539	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63629-8541_8e86050e-255b-4962-9200-17cf644eb38c	63629-8541	HUMAN OTC DRUG	Polyethylene Glycol 3350		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20190327	20240930	ANDA	ANDA090812	Bryant Ranch Prepack	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63629-8576_3d6283c8-ab0b-497b-9965-afd9886d5847	63629-8576	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA204239	Bryant Ranch Prepack	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
63629-8598_46b8a4c3-5475-4edf-9be5-12cbeaf94597	63629-8598	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Bryant Ranch Prepack	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8599_8d9c163d-5a47-4c45-98bf-b9a59813542a	63629-8599	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET, FILM COATED	ORAL	20130103		ANDA	ANDA202093	Bryant Ranch Prepack	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
63629-8601_9a1a8d1a-2a0a-4260-83be-eb96a9fb893e	63629-8601	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20120628		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-8602_ad63b198-9c80-47d6-a755-dffdbd149c96	63629-8602	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Bryant Ranch Prepack	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-8603_966db1da-18d8-4caa-b4f2-1400b8082735	63629-8603	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Bryant Ranch Prepack	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-8604_bb2354c0-ae61-4be3-bec7-fa29df33a100	63629-8604	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20120628		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
63629-8605_757434ab-3b3a-4597-96b2-a455f6873793	63629-8605	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-8606_0e9f1e0d-d1ac-4895-a5ce-51decea8846c	63629-8606	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-8607_00b266d9-ac2c-e931-e063-6294a90a6a0b	63629-8607	HUMAN PRESCRIPTION DRUG	adapalene and benzoyl peroxide		Adapalene and Benzoyl Peroxide	GEL	TOPICAL	20180124		ANDA	ANDA205033	Bryant Ranch Prepack	ADAPALENE; BENZOYL PEROXIDE	.1; 2.5	g/100g; g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
63629-8608_00b29e25-a82f-6c6b-e063-6294a90aeaad	63629-8608	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	CREAM	TOPICAL	20060816		ANDA	ANDA075774	Bryant Ranch Prepack	AMMONIUM LACTATE	12	g/100g	Acidifying Activity [MoA]		N	20241231
63629-8609_00b2bf41-a961-6394-e063-6394a90ac8fc	63629-8609	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	CREAM	TOPICAL	20060816		ANDA	ANDA075774	Bryant Ranch Prepack	AMMONIUM LACTATE	12	g/100g	Acidifying Activity [MoA]		N	20241231
63629-8610_00b2a93c-92de-90c6-e063-6294a90a6d33	63629-8610	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	LOTION	TOPICAL	20060620		ANDA	ANDA075570	Bryant Ranch Prepack	AMMONIUM LACTATE	12	g/100g	Acidifying Activity [MoA]		N	20241231
63629-8611_00b2ef34-42c0-523c-e063-6294a90a753d	63629-8611	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	LOTION	TOPICAL	20060620		ANDA	ANDA075570	Bryant Ranch Prepack	AMMONIUM LACTATE	12	g/100g	Acidifying Activity [MoA]		N	20241231
63629-8612_76bb89b3-4f39-4bc0-9a6e-27d4385a0980	63629-8612	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE		azelastine hydrochloride, fluticasone propionate	SPRAY, METERED	NASAL	20210301		ANDA	ANDA208111	Bryant Ranch Prepack	AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE	137; 50	ug/1; ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63629-8613_00b37a7c-f078-ef70-e063-6394a90a23d2	63629-8613	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20060928		ANDA	ANDA076592	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8614_8cf308aa-053b-44d9-b294-c33f70c03524	63629-8614	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20060928		ANDA	ANDA076592	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-8615_00b3b488-8b98-0fee-e063-6294a90a4d26	63629-8615	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide	SYRUP	ORAL	20150206		ANDA	ANDA205292	Bryant Ranch Prepack	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63629-8616_00b3b7f5-3e29-836e-e063-6394a90ac915	63629-8616	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide	SYRUP	ORAL	20150206		ANDA	ANDA205292	Bryant Ranch Prepack	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63629-8617_00b3f040-c085-db52-e063-6394a90aa60e	63629-8617	HUMAN PRESCRIPTION DRUG	Calcipotriene and Betamethasone Dipropionate		Calcipotriene, Betamethasone Dipropionate	OINTMENT	TOPICAL	20200130		ANDA	ANDA200174	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	.643; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
63629-8618_00b3fcbd-3047-967e-e063-6294a90a1c3b	63629-8618	HUMAN PRESCRIPTION DRUG	calcipotriene and betamethasone dipropionate		calcipotriene and betamethasone dipropionate	SUSPENSION	TOPICAL	20201009		ANDA	ANDA212367	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
63629-8619_00b59586-8836-c5ba-e063-6294a90af650	63629-8619	HUMAN PRESCRIPTION DRUG	calcipotriene and betamethasone dipropionate		calcipotriene and betamethasone dipropionate	SUSPENSION	TOPICAL	20201009		ANDA	ANDA212367	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
63629-8620_00b5909d-494f-86cc-e063-6394a90ab2fa	63629-8620	HUMAN PRESCRIPTION DRUG	CICLOPIROX		CICLOPIROX	GEL	TOPICAL	20090107		ANDA	ANDA078266	Bryant Ranch Prepack	CICLOPIROX	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8621_1b3a1cf8-6673-4fe7-92cb-eb2bb3a36537	63629-8621	HUMAN PRESCRIPTION DRUG	CICLOPIROX		CICLOPIROX	GEL	TOPICAL	20090107		ANDA	ANDA078266	Bryant Ranch Prepack	CICLOPIROX	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8622_52d76980-71dc-4e9d-aeea-1a101eef6b3c	63629-8622	HUMAN PRESCRIPTION DRUG	CICLOPIROX		CICLOPIROX	GEL	TOPICAL	20090107		ANDA	ANDA078266	Bryant Ranch Prepack	CICLOPIROX	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8623_00b59586-8858-c5ba-e063-6294a90af650	63629-8623	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SOLUTION	TOPICAL	20070919		ANDA	ANDA077623	Bryant Ranch Prepack	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8624_00b5c559-4564-f5cb-e063-6394a90ad0b1	63629-8624	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	CREAM	TOPICAL	20060719		ANDA	ANDA077364	Bryant Ranch Prepack	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8625_00b5c559-4579-f5cb-e063-6394a90ad0b1	63629-8625	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	CREAM	TOPICAL	20060719		ANDA	ANDA077364	Bryant Ranch Prepack	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8626_00b60a84-542f-63f7-e063-6394a90a6c66	63629-8626	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	CREAM	TOPICAL	20060719		ANDA	ANDA077364	Bryant Ranch Prepack	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8627_00b5dd85-24e0-1c81-e063-6394a90a24d3	63629-8627	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	SUSPENSION	TOPICAL	20061229		ANDA	ANDA077676	Bryant Ranch Prepack	CICLOPIROX OLAMINE	7.7	mg/100mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8628_00b610fd-f5aa-6140-e063-6394a90a13d8	63629-8628	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	AEROSOL, FOAM	TOPICAL	20100331		ANDA	ANDA090785	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8629_00b63f17-6efe-ac54-e063-6394a90a4832	63629-8629	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	AEROSOL, FOAM	TOPICAL	20100331		ANDA	ANDA090785	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8630_85465c9f-0f22-48e7-9d9c-ea9d41a4bcb7	63629-8630	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PHOSPHATE		clindamycin phosphate	GEL	TOPICAL	20210120		ANDA	ANDA212104	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8631_00b610eb-ba17-de05-e063-6294a90aa7ca	63629-8631	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PHOSPHATE		clindamycin phosphate	GEL	TOPICAL	20210120		ANDA	ANDA212104	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8632_ed3c042d-0836-43c5-b2c4-09e467423cba	63629-8632	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	LOTION	TOPICAL	20210331		ANDA	ANDA214604	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8633_742caea5-01c0-4269-a956-99362b88ae77	63629-8633	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20130917		ANDA	ANDA064050	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8634_f0ee41ac-f4cb-4b6f-8dc9-f7b4e1695f45	63629-8634	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20130917		ANDA	ANDA064050	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8635_00b68cb4-a998-8fe9-e063-6294a90abd17	63629-8635	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate, Benzoyl Peroxide	GEL	TOPICAL	20190912		ANDA	ANDA205397	Bryant Ranch Prepack	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	25; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-8637_00b6a0cd-61fa-68c3-e063-6394a90a1c2e	63629-8637	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol propionate	GEL	TOPICAL	20080730		ANDA	ANDA075027	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8638_00b6a816-9e41-c731-e063-6394a90acb99	63629-8638	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol propionate	GEL	TOPICAL	20080730		ANDA	ANDA075027	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8639_00b6a816-9e5a-c731-e063-6394a90acb99	63629-8639	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol propionate	GEL	TOPICAL	20080730		ANDA	ANDA075027	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8640_00b6b704-9aa7-68bc-e063-6394a90a117b	63629-8640	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	INJECTION, SOLUTION	INTRAVENOUS	20031007		ANDA	ANDA065151	Bryant Ranch Prepack	CYCLOSPORINE	50	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63629-8641_00b6c089-dcbd-9278-e063-6394a90ab774	63629-8641	HUMAN PRESCRIPTION DRUG	desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20150514		ANDA	ANDA077770	Bryant Ranch Prepack	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8642_00b6c15e-88bb-52ea-e063-6294a90a02cf	63629-8642	HUMAN PRESCRIPTION DRUG	desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20150514		ANDA	ANDA077770	Bryant Ranch Prepack	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8644_dff3a87a-4cac-48f5-8bca-2196382828c1	63629-8644	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20190520	20250501	ANDA	ANDA211253	Bryant Ranch Prepack	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63629-8645_00b6e254-328f-330d-e063-6394a90af1e3	63629-8645	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20060808		ANDA	ANDA076479	Bryant Ranch Prepack	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63629-8646_b78a35df-0bbf-4378-916f-b82e13dc4be8	63629-8646	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20060808		ANDA	ANDA076479	Bryant Ranch Prepack	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20251231
63629-8647_00b6eb5e-c182-5942-e063-6394a90a404f	63629-8647	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20060808		ANDA	ANDA076479	Bryant Ranch Prepack	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63629-8648_00b80232-6c14-5ed0-e063-6394a90a2704	63629-8648	HUMAN PRESCRIPTION DRUG	Ery		Erythromycin	SWAB	TOPICAL	20080707		ANDA	ANDA064126	Bryant Ranch Prepack	ERYTHROMYCIN	20	mg/mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
63629-8652_e614ce96-5d35-40b6-894b-4640aa76a077	63629-8652	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	GEL	TOPICAL	20080612		ANDA	ANDA063211	Bryant Ranch Prepack	ERYTHROMYCIN	20	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
63629-8653_00b8281a-2996-a715-e063-6394a90a85fc	63629-8653	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	GEL	TOPICAL	20080612		ANDA	ANDA063211	Bryant Ranch Prepack	ERYTHROMYCIN	20	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
63629-8654_00b829af-5b11-d843-e063-6394a90a0183	63629-8654	HUMAN PRESCRIPTION DRUG	Estradiol Vaginal		Estradiol	CREAM	VAGINAL	20210106		ANDA	ANDA210194	Bryant Ranch Prepack	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
63629-8655_00b82ca7-a375-f359-e063-6394a90a82a8	63629-8655	HUMAN PRESCRIPTION DRUG	fluocinolone acetonide		fluocinolone acetonide	OIL	TOPICAL	20170614		ANDA	ANDA202847	Bryant Ranch Prepack	FLUOCINOLONE ACETONIDE	.01	mg/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8656_00b82ca7-a39a-f359-e063-6394a90a82a8	63629-8656	HUMAN PRESCRIPTION DRUG	Fluocinolone acetonide		Fluocinolone acetonide	OIL	TOPICAL	20170614		ANDA	ANDA202848	Bryant Ranch Prepack	FLUOCINOLONE ACETONIDE	.01	mg/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8657_00b804f5-7685-0b1d-e063-6294a90a5753	63629-8657	HUMAN PRESCRIPTION DRUG	Flurandrenolide		Flurandrenolide	LOTION	TOPICAL	20161006		ANDA	ANDA207133	Bryant Ranch Prepack	FLURANDRENOLIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8658_00b83209-a959-f376-e063-6394a90a5e8a	63629-8658	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	CREAM	TOPICAL	20060913		ANDA	ANDA076793	Bryant Ranch Prepack	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8659_00b804f5-769a-0b1d-e063-6294a90a5753	63629-8659	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	CREAM	TOPICAL	20060913		ANDA	ANDA076793	Bryant Ranch Prepack	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8660_00b804f5-76c0-0b1d-e063-6294a90a5753	63629-8660	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	CREAM	TOPICAL	20060913		ANDA	ANDA076793	Bryant Ranch Prepack	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8661_00b84e94-88a3-f12b-e063-6294a90a3927	63629-8661	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	OINTMENT	TOPICAL	20070709		ANDA	ANDA076668	Bryant Ranch Prepack	FLUTICASONE PROPIONATE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8662_00b83209-a97f-f376-e063-6394a90a5e8a	63629-8662	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	OINTMENT	TOPICAL	20070709		ANDA	ANDA076668	Bryant Ranch Prepack	FLUTICASONE PROPIONATE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8663_00c546a4-42ef-0ec3-e063-6294a90a55a3	63629-8663	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	OINTMENT	TOPICAL	20070709		ANDA	ANDA076668	Bryant Ranch Prepack	FLUTICASONE PROPIONATE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8664_00c560e2-465a-2004-e063-6294a90aa717	63629-8664	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	OINTMENT	TOPICAL	20090205		ANDA	ANDA076872	Bryant Ranch Prepack	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8665_00c546a4-430f-0ec3-e063-6294a90a55a3	63629-8665	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	OINTMENT	TOPICAL	20090205		ANDA	ANDA076872	Bryant Ranch Prepack	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8666_00c57157-26e4-cd85-e063-6394a90a39d2	63629-8666	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8667_00c57157-26fd-cd85-e063-6394a90a39d2	63629-8667	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8668_00c58273-1f28-fa59-e063-6394a90a50b2	63629-8668	HUMAN PRESCRIPTION DRUG	hydrocortisone		hydrocortisone	LOTION	TOPICAL	20080523		ANDA	ANDA089074	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8669_00c57157-2716-cd85-e063-6394a90a39d2	63629-8669	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate pramoxine hcl		hydrocortisone acetate pramoxine hcl	CREAM	TOPICAL	20100413		ANDA	ANDA085368	Bryant Ranch Prepack	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	1; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8670_00c593be-d522-db41-e063-6294a90a8863	63629-8670	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate Pramoxine Hcl		Hydrocortisone Acetate Pramoxine Hcl	CREAM	TOPICAL	19960927		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8671_00c5ba9b-ebd4-4920-e063-6394a90aface	63629-8671	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate Pramoxine Hcl		Hydrocortisone Acetate Pramoxine Hcl	CREAM	TOPICAL	19960927		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8672_00c5ba9b-ebed-4920-e063-6394a90aface	63629-8672	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate Pramoxine Hcl		Hydrocortisone Acetate Pramoxine Hcl	CREAM	TOPICAL	19960927		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8673_00c5ba9b-ec08-4920-e063-6394a90aface	63629-8673	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate pramoxine HCl		Hydrocortisone Acetate, Pramoxine HCl	CREAM	TOPICAL	20110329		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8674_00c5cbe7-c0c5-9145-e063-6394a90af411	63629-8674	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate pramoxine HCl		Hydrocortisone Acetate, Pramoxine HCl	CREAM	TOPICAL	20110329		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	2.5; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8675_00c5f013-5979-a3d5-e063-6294a90a43d3	63629-8675	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	SHAMPOO, SUSPENSION	TOPICAL	20100119		ANDA	ANDA076419	Bryant Ranch Prepack	KETOCONAZOLE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63629-8676_00c5e67e-046e-7a37-e063-6294a90a307b	63629-8676	HUMAN PRESCRIPTION DRUG	ketoconazole		ketoconazole	AEROSOL, FOAM	TOPICAL	20110830		ANDA	ANDA091550	Bryant Ranch Prepack	KETOCONAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63629-8677_e1fde1b5-0f48-41ef-a8c4-f95252d63b97	63629-8677	HUMAN PRESCRIPTION DRUG	ketoconazole		ketoconazole	AEROSOL, FOAM	TOPICAL	20110830		ANDA	ANDA091550	Bryant Ranch Prepack	KETOCONAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63629-8678_00c5e7f9-d395-4e82-e063-6294a90af3d7	63629-8678	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	KIT		20090901		ANDA	ANDA076751	Bryant Ranch Prepack						N	20241231
63629-8679_00c5cbe7-c0e5-9145-e063-6394a90af411	63629-8679	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	KIT		20180802		ANDA	ANDA076751	Bryant Ranch Prepack						N	20241231
63629-8680_825e9bc6-05d7-4318-aad4-baf0c198f6e5	63629-8680	HUMAN PRESCRIPTION DRUG	metronidazole vaginal		metronidazole	GEL	VAGINAL	20190708		ANDA	ANDA211786	Bryant Ranch Prepack	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
63629-8681_00c5f381-ce79-ad56-e063-6294a90ad9f3	63629-8681	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20041221		ANDA	ANDA076679	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8682_858d791f-64a6-4f43-afcc-edc83198b089	63629-8682	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20041221		ANDA	ANDA076679	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-8683_a1ea11d1-756f-4afd-a0dd-c920f847c17c	63629-8683	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20080718		ANDA	ANDA076067	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8684_614a1289-9a79-43e6-a1da-def902da6d11	63629-8684	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20080718		ANDA	ANDA076067	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8685_0835016a-d3ed-425a-a392-70698da69f5b	63629-8685	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	SOLUTION	TOPICAL	20081211		ANDA	ANDA077180	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8686_3df9f663-2e10-438f-ac50-02c5b276af08	63629-8686	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	SOLUTION	TOPICAL	20081211		ANDA	ANDA077180	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8687_e6ce6efb-d5db-4765-aa5d-a7a8bbb4faf8	63629-8687	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20091030		ANDA	ANDA065123	Bryant Ranch Prepack	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
63629-8688_93d132bf-d36c-40c2-9998-6485b75856ea	63629-8688	HUMAN PRESCRIPTION DRUG	NYSTATIN AND TRIAMCINOLONE ACETONIDE		nystatin, triamcinolone acetonide	CREAM	TOPICAL	20171127		ANDA	ANDA208479	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8689_8c1dea0a-3c39-4794-8442-dc87d9230431	63629-8689	HUMAN PRESCRIPTION DRUG	NYSTATIN AND TRIAMCINOLONE ACETONIDE		nystatin, triamcinolone acetonide	CREAM	TOPICAL	20171127		ANDA	ANDA208479	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8690_23bed418-faf6-4f62-9f79-d6482f7c6f5f	63629-8690	HUMAN PRESCRIPTION DRUG	NYSTATIN AND TRIAMCINOLONE ACETONIDE		nystatin, triamcinolone acetonide	CREAM	TOPICAL	20171127		ANDA	ANDA208479	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8691_18ad73c3-7cbc-4c05-81e8-9d83776f6582	63629-8691	HUMAN PRESCRIPTION DRUG	nystatin and triamcinolone acetonide		nystatin and triamcinolone acetonide	OINTMENT	TOPICAL	20171018		ANDA	ANDA207380	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8692_4faa75c3-a6e6-40ff-9e46-83251c4b21c1	63629-8692	HUMAN PRESCRIPTION DRUG	nystatin and triamcinolone acetonide		nystatin and triamcinolone acetonide	OINTMENT	TOPICAL	20171018		ANDA	ANDA207380	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8693_7e155f00-ba32-4daa-a131-97d00bd67741	63629-8693	HUMAN PRESCRIPTION DRUG	nystatin and triamcinolone acetonide		nystatin and triamcinolone acetonide	OINTMENT	TOPICAL	20171018		ANDA	ANDA207380	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8694_2a544df0-6f32-4846-a239-5ec4cd798522	63629-8694	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20060921		ANDA	ANDA062225	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8695_b4562e84-3289-492e-896a-038cb35972d0	63629-8695	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20060921		ANDA	ANDA062225	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8696_d89912ea-5323-4894-97bb-a1df8c986dfd	63629-8696	HUMAN PRESCRIPTION DRUG	Nystop		Nystatin	POWDER	TOPICAL	19960816		ANDA	ANDA064118	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
63629-8697_57ff4804-95a7-4422-96ce-bc04d206480e	63629-8697	HUMAN PRESCRIPTION DRUG	Nystop		Nystatin	POWDER	TOPICAL	19960816		ANDA	ANDA064118	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8698_e2eefaea-d61c-408d-b67a-e3128545316c	63629-8698	HUMAN PRESCRIPTION DRUG	Nystop		Nystatin	POWDER	TOPICAL	19960816		ANDA	ANDA064118	Bryant Ranch Prepack	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63629-8699_01196278-c8ea-4b89-8e71-eed68e8be55a	63629-8699	HUMAN PRESCRIPTION DRUG	Podocon 25		Podophyllum resin	TINCTURE	TOPICAL	19900901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PODOPHYLLUM RESIN	1	mg/4mL			N	20241231
63629-8701_08918eab-05d3-4d11-b013-4c6ee1835fe7	63629-8701	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	SPRAY	NASAL	20201004		ANDA	ANDA213650	Bryant Ranch Prepack	SUMATRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63629-8702_00b6d33b-2c22-03a2-e063-6394a90a5d5e	63629-8702	HUMAN PRESCRIPTION DRUG	desoximetasone		desoximetasone	SPRAY	TOPICAL	20181206		ANDA	ANDA206441	Bryant Ranch Prepack	DESOXIMETASONE	2.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8703_dcd644c1-1de0-4752-836c-a4cb0f1925ca	63629-8703	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	SPRAY	NASAL	20201004		ANDA	ANDA213465	Bryant Ranch Prepack	SUMATRIPTAN	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63629-8704_01b126cc-20d0-44b6-b6db-f69b3fbcb7ab	63629-8704	HUMAN PRESCRIPTION DRUG	Tavaborole		Tavaborole	SOLUTION	TOPICAL	20210110		ANDA	ANDA211848	Bryant Ranch Prepack	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
63629-8705_00b20a8c-dec0-e930-e063-6394a90a7ed0	63629-8705	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20140501		ANDA	ANDA091244	Bryant Ranch Prepack	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-8706_17554a6c-99b5-4e6c-a981-4629973d4da1	63629-8706	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20140501		ANDA	ANDA091244	Bryant Ranch Prepack	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-8707_0b646820-3ccb-464b-a236-2ad393bfd979	63629-8707	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20060517		ANDA	ANDA086413	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8708_d52453a4-f868-41eb-aec3-09a7f7ec0418	63629-8708	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	20210301		ANDA	ANDA212460	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8710_78872c13-1caa-4a0f-9f5e-995fcfb35e73	63629-8710	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20171110		ANDA	ANDA205823	Bryant Ranch Prepack	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
63629-8711_550dd465-39a2-48ba-ac4b-7842acfe28ae	63629-8711	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63629-8712_58a1426c-0110-49de-af8a-8a0a88a8da88	63629-8712	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
63629-8713_ad4ed7c0-a2a3-41cc-b380-57616f5bf6f7	63629-8713	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	CREAM	VAGINAL	20180305		ANDA	ANDA209767	Bryant Ranch Prepack	ESTRADIOL HEMIHYDRATE	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
63629-8714_da67b3b1-b150-4c7d-a5d8-4f318faa51c2	63629-8714	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Bryant Ranch Prepack	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-8715_a0d88759-a721-42f0-b4dd-dddadf92e3c4	63629-8715	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20020901		ANDA	ANDA075948	Bryant Ranch Prepack	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63629-8716_7dcf4ee7-c1d6-4608-b182-d408e8c4bfef	63629-8716	HUMAN PRESCRIPTION DRUG	Ofloxacin Otic		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20040514		ANDA	ANDA076527	Bryant Ranch Prepack	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63629-8717_f9c2f658-49c6-4d45-a38d-01642859171c	63629-8717	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Bryant Ranch Prepack	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-8718_ab70f62c-8197-47d8-ba14-2063ba6660c6	63629-8718	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Bryant Ranch Prepack	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-8719_5fbb8273-6a7d-44fc-921e-bbcb3b87fba8	63629-8719	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	Bryant Ranch Prepack	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63629-8720_b989cc42-caa5-4aa2-957c-dd2410210c3a	63629-8720	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20120323		ANDA	ANDA078986	Bryant Ranch Prepack	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63629-8721_e9fa543d-3b06-43df-b396-b5cbb29839c5	63629-8721	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20120323		ANDA	ANDA078986	Bryant Ranch Prepack	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63629-8722_1c9bb8dd-aaa5-401f-bde3-122a543a5fd7	63629-8722	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20031219		ANDA	ANDA076732	Bryant Ranch Prepack	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
63629-8723_4e9fb45c-1a34-4f95-8d11-3d5abe1950d0	63629-8723	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Bryant Ranch Prepack	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
63629-8724_1dc2d61f-6958-4e0c-b4b4-ae659eb86e83	63629-8724	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20010131		ANDA	ANDA075845	Bryant Ranch Prepack	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8725_5c5d5050-d161-4643-a566-68262d9f550b	63629-8725	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Bryant Ranch Prepack	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
63629-8726_32174eeb-f4dd-4dba-823a-08ebc80d6e81	63629-8726	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Bryant Ranch Prepack	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
63629-8727_4662d7f2-f7fd-4ead-9a7d-8cd1e4f16575	63629-8727	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Bryant Ranch Prepack	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
63629-8728_b32e6166-86dc-4d5e-aad8-7d47f09a76b2	63629-8728	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Bryant Ranch Prepack	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
63629-8729_35e62e03-4ca6-400e-adfd-28e8b641ea3f	63629-8729	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Bryant Ranch Prepack	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
63629-8730_6463ee6e-c3eb-4ede-83ed-64c321705bca	63629-8730	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20160701		ANDA	ANDA074477	Bryant Ranch Prepack	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
63629-8731_71a96e10-e85b-4f6a-bc0a-2af109d1e3f3	63629-8731	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	VAGINAL	20061031	20241031	ANDA	ANDA077264	Bryant Ranch Prepack	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	
63629-8732_f7749e64-7337-4230-a199-b362474df5b3	63629-8732	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	19970605		ANDA	ANDA074821	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
63629-8733_2f2662c0-714a-4ab4-84b8-2121ad74ed52	63629-8733	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20031219		ANDA	ANDA076466	Bryant Ranch Prepack	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
63629-8734_e3c3f642-1d35-4933-8b27-e92f6c446e99	63629-8734	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20111212		ANDA	ANDA200265	Bryant Ranch Prepack	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63629-8735_0cb6281f-67d0-4b62-8873-09c7d418bffe	63629-8735	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		halobetasol propionate	CREAM	TOPICAL	20041216		ANDA	ANDA077001	Bryant Ranch Prepack	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-8736_dfbbb798-0f35-42fd-b9f5-d3a7b69a4e3e	63629-8736	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Bryant Ranch Prepack	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
63629-8737_32424983-c47c-4dd9-9c70-81a24edcff5d	63629-8737	HUMAN PRESCRIPTION DRUG	Fluvastatin		Fluvastatin	CAPSULE	ORAL	20120705		ANDA	ANDA078407	Bryant Ranch Prepack	FLUVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8738_6f049b45-8122-415e-b276-04ba95eb9a3d	63629-8738	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20130219		ANDA	ANDA088617	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
63629-8739_9c860612-547f-4e8b-8500-aacbda73569a	63629-8739	HUMAN PRESCRIPTION DRUG	Desonide		desonide	LOTION	TOPICAL	20090528		ANDA	ANDA072354	Bryant Ranch Prepack	DESONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8740_74123c1b-4d34-47c8-b092-05b4f5af8019	63629-8740	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121009		ANDA	ANDA088618	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
63629-8741_05d0696c-9c9f-4af5-afac-2b7ac11f4593	63629-8741	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20160825		ANDA	ANDA075765	Bryant Ranch Prepack	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
63629-8742_dadb2771-531a-4afd-9633-b8297bedfa4b	63629-8742	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20160701		ANDA	ANDA075765	Bryant Ranch Prepack	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
63629-8743_24ac4904-1ace-47db-9d37-840531de454c	63629-8743	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	19950918		ANDA	ANDA073524	Bryant Ranch Prepack	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63629-8744_bc689d47-fb46-4f47-a8a8-e6ac75947006	63629-8744	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20040914		ANDA	ANDA076553	Bryant Ranch Prepack	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
63629-8745_740620d5-b637-48ba-b703-98dcd70e127c	63629-8745	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	Bryant Ranch Prepack	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20251231
63629-8746_67232cb9-090f-4da2-aad0-d4e318b2701b	63629-8746	HUMAN PRESCRIPTION DRUG	Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20020926		ANDA	ANDA075804	Bryant Ranch Prepack						N	20251231
63629-8747_22d0e3d6-e354-4f28-84b1-0863a97d305f	63629-8747	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA073192	Bryant Ranch Prepack	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63629-8748_9ef55d5b-b2c0-409a-87f6-307d5a282648	63629-8748	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
63629-8750_5780feee-f1ad-4426-b29c-80cc0a03c639	63629-8750	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20070222		ANDA	ANDA071745	Bryant Ranch Prepack	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
63629-8751_535ca8b8-e695-418e-8fea-2c2bae700b22	63629-8751	HUMAN PRESCRIPTION DRUG	Tri-Sprintec		norgestimate and ethinyl estradiol	KIT		20031229		ANDA	ANDA075808	Bryant Ranch Prepack						N	20251231
63629-8752_3df5a324-a7be-4167-be49-b29843a8780e	63629-8752	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE, LIQUID FILLED	ORAL	20070626		ANDA	ANDA077684	Bryant Ranch Prepack	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20251231
63629-8753_d2db4ce8-9f3b-4f18-94ae-b906b4b6ff8a	63629-8753	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19900930		ANDA	ANDA070541	Bryant Ranch Prepack	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63629-8754_341828c2-badd-4af4-9077-f0a5a3be130d	63629-8754	HUMAN PRESCRIPTION DRUG	Ivermectin		Ivermectin	CREAM	TOPICAL	20191014		ANDA	ANDA210019	Bryant Ranch Prepack	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
63629-8755_baaf46f2-4eae-444f-8a32-55b0c45c5d20	63629-8755	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20130915		ANDA	ANDA200675	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-8756_31764d63-40c5-46f3-908f-c6d917cb8005	63629-8756	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20070222		ANDA	ANDA071745	Bryant Ranch Prepack	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
63629-8757_8ff68366-6c0d-4e6e-9b2b-aa429fc42f7a	63629-8757	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA088467	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63629-8758_135c623c-7c37-45e9-b9c7-13a3c1a57a78	63629-8758	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20031216		ANDA	ANDA076002	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8759_3af62a61-a384-4f52-aa75-6419fea90b54	63629-8759	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20180530		ANDA	ANDA209758	Bryant Ranch Prepack	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20251231
63629-8761_a7f7f7d2-4915-4a44-9033-c9b2ce9f22b6	63629-8761	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20200213		ANDA	ANDA213412	Bryant Ranch Prepack	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20251231
63629-8762_9c48d444-00d6-4ec7-af5c-f205dd4d1870	63629-8762	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20200213		ANDA	ANDA213412	Bryant Ranch Prepack	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20251231
63629-8763_a82f740d-3aef-442d-ab53-8acd1bdba53d	63629-8763	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Bryant Ranch Prepack	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
63629-8764_2750d293-5089-4267-9e36-9e95a3b85c59	63629-8764	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Bryant Ranch Prepack	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
63629-8765_8cdea7f1-29c7-44ae-9044-a6e0f657ddfa	63629-8765	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Bryant Ranch Prepack	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
63629-8766_e7dca6fd-c120-41fe-8741-e875d0601580	63629-8766	HUMAN PRESCRIPTION DRUG	colchicine		colchicine	TABLET	ORAL	20190210		ANDA	ANDA211250	Bryant Ranch Prepack	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
63629-8767_6908d556-384b-450c-ae30-102a8f98d3dd	63629-8767	HUMAN PRESCRIPTION DRUG	Colesevelam HCL		Colesevelam HCL	TABLET, FILM COATED	ORAL	20181006		ANDA	ANDA209038	Bryant Ranch Prepack	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
63629-8768_c6c821a4-fe19-404b-bcbb-0d68d51bdd2a	63629-8768	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Bryant Ranch Prepack	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-8769_fe203867-9125-4a19-989b-6ffc4d2f288b	63629-8769	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Bryant Ranch Prepack	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-8770_01d47147-61ce-430c-b319-7e7dfac473b5	63629-8770	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Bryant Ranch Prepack	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-8771_eb23a15b-0419-482b-9f9f-ff9d6cf52fdb	63629-8771	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Bryant Ranch Prepack	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-8772_93268aeb-624b-49fb-b155-a61a970bb635	63629-8772	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Bryant Ranch Prepack	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-8773_a05eba8f-6414-41e3-af43-6459f5604378	63629-8773	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Bryant Ranch Prepack	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-8774_ebc4e3cd-ad73-49ea-becf-134eb2375846	63629-8774	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	SOLUTION	ORAL	20060630		ANDA	ANDA076934	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-8775_130fb7a3-6ee9-48e7-ad64-d059eb3969e0	63629-8775	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	TABLET	ORAL	20200720		OTC MONOGRAPH FINAL	part331	Bryant Ranch Prepack	SODIUM BICARBONATE	650	mg/1	Alkalinizing Activity [MoA]		N	20241231
63629-8778_ea792186-6a62-40a1-88bb-02d9186a0523	63629-8778	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8779_76bced7b-6fff-4166-85d0-4829f9ad59b1	63629-8779	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8780_9e78c40e-c77c-4945-bc73-ed0ab359448a	63629-8780	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8781_0826447d-8143-4ef1-9c84-9024455bc930	63629-8781	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8782_530698e8-f83e-483c-941b-ea4d764201bf	63629-8782	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8783_9409360a-4c63-404c-832e-f97a7148b112	63629-8783	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-8784_42954eb7-44bd-4a99-a16c-070d605d5c7e	63629-8784	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8785_236363e4-5f5b-4428-a107-b1e186fec2cf	63629-8785	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8791_c32bad44-9711-4ca6-9040-c08e2302bb94	63629-8791	HUMAN PRESCRIPTION DRUG	Adapalene		adapalene	CREAM	TOPICAL	20100630		ANDA	ANDA090824	Bryant Ranch Prepack	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20251231
63629-8792_25664779-2f5f-4f89-ace5-8091ec31d00c	63629-8792	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION	OPHTHALMIC	20101002		NDA	NDA021764	Bryant Ranch Prepack	BRIMONIDINE TARTRATE	1.5	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20251231
63629-8793_1ee01126-586c-4852-977c-c3a145d6f511	63629-8793	HUMAN PRESCRIPTION DRUG	Brinzolamide		Brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	20210308		NDA AUTHORIZED GENERIC	NDA020816	Bryant Ranch Prepack	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20251231
63629-8794_abc25601-e82a-4faf-929e-05cc2ecedf7c	63629-8794	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		carvedilol phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20191101		NDA AUTHORIZED GENERIC	NDA022012	Bryant Ranch Prepack	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
63629-8795_9480a145-30c0-4142-9633-1e5182ab04c9	63629-8795	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20121024		ANDA	ANDA077027	Bryant Ranch Prepack	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20251231
63629-8796_95356724-d48e-4adf-a367-40075289b1c9	63629-8796	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20120424		ANDA	ANDA077027	Bryant Ranch Prepack	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
63629-8797_1fdea66b-522b-440f-acbf-3c33727a7506	63629-8797	HUMAN PRESCRIPTION DRUG	Ciprofloxacin and Dexamethasone		ciprofloxacin and dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20200810		NDA AUTHORIZED GENERIC	NDA021537	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
63629-8798_458b61fd-b815-415c-bdd4-960277516b22	63629-8798	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20160825		ANDA	ANDA203688	Bryant Ranch Prepack	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 12	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
63629-8800_e5c83c41-c67d-4b3b-82ed-0c9fd7416f40	63629-8800	HUMAN PRESCRIPTION DRUG	Enulose		Lactulose	SOLUTION	ORAL; RECTAL	20110228		ANDA	ANDA090502	Bryant Ranch Prepack	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63629-8802_63fef87a-29dd-4bb7-9295-a7e48e3ecdec	63629-8802	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	Bryant Ranch Prepack	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
63629-8803_77bfa766-1e62-4b42-807f-cd7c08a650d6	63629-8803	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	INSERT	VAGINAL	20170724		ANDA	ANDA206388	Bryant Ranch Prepack	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
63629-8804_67a0d3b2-1d98-4f79-bf8d-4fcceece8d29	63629-8804	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	INSERT	VAGINAL	20170724		ANDA	ANDA206388	Bryant Ranch Prepack	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
63629-8805_7a626976-7842-4ff8-bd5a-3b28b0440d93	63629-8805	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	Bryant Ranch Prepack	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8806_ef0f8def-a10b-41ad-a965-a8ba02dc485a	63629-8806	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		Fludrocortisone Acetate	TABLET	ORAL	20030214		ANDA	ANDA040425	Bryant Ranch Prepack	FLUDROCORTISONE ACETATE	.1	mg/1			N	20251231
63629-8807_c0bca202-8121-4b6a-998f-25c23439b3e0	63629-8807	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Bryant Ranch Prepack	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-8808_a91f60d1-facf-428e-8c1a-d57008beada4	63629-8808	HUMAN PRESCRIPTION DRUG	Flurbiprofen		Flurbiprofen	TABLET, FILM COATED	ORAL	19950602		ANDA	ANDA074431	Bryant Ranch Prepack	FLURBIPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-8809_3e4fb614-2598-4616-b4e9-b53079df47e4	63629-8809	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	Bryant Ranch Prepack	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	113; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
63629-8810_3c72f1f1-5dff-48c3-8fdc-0a2cfde898af	63629-8810	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	Bryant Ranch Prepack	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	232; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
63629-8811_cded5144-7a06-4ed6-9aa7-ce2a256d0068	63629-8811	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol		Fluticasone Propionate and Salmeterol	POWDER, METERED	RESPIRATORY (INHALATION)	20170428		NDA AUTHORIZED GENERIC	NDA208799	Bryant Ranch Prepack	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	55; 14	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
63629-8812_a94b896f-6170-4ada-970d-9e1e130c7eab	63629-8812	HUMAN PRESCRIPTION DRUG	Fluvastatin		Fluvastatin	CAPSULE	ORAL	20120705		ANDA	ANDA078407	Bryant Ranch Prepack	FLUVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-8813_37f67ff0-5292-47b4-849e-25cf51d1d61b	63629-8813	HUMAN PRESCRIPTION DRUG	Formoterol fumarate		Formoterol fumarate	SOLUTION	RESPIRATORY (INHALATION)	20210622		ANDA	ANDA091141	Bryant Ranch Prepack	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
63629-8814_20678b2e-fc63-4809-a890-b2382014c7f3	63629-8814	HUMAN PRESCRIPTION DRUG	Formoterol fumarate		Formoterol fumarate	SOLUTION	RESPIRATORY (INHALATION)	20210622		ANDA	ANDA091141	Bryant Ranch Prepack	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
63629-8815_270eae66-f225-48f9-abc6-e6fe183566d1	63629-8815	HUMAN PRESCRIPTION DRUG	Glatopa		Glatiramer Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20150618		ANDA	ANDA090218	Bryant Ranch Prepack	GLATIRAMER ACETATE	20	mg/mL			N	20251231
63629-8816_cbfb6068-6f58-46a6-9a57-aed5b9bb241a	63629-8816	HUMAN PRESCRIPTION DRUG	Glatopa		Glatiramer Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20180212		ANDA	ANDA206921	Bryant Ranch Prepack	GLATIRAMER ACETATE	40	mg/mL			N	20251231
63629-8817_51c786a9-6130-44e1-891f-dc16ac377606	63629-8817	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	19930528		ANDA	ANDA081203	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-8818_ef077240-9aaf-424f-bf69-6258589d0589	63629-8818	HUMAN PRESCRIPTION DRUG	Imiquimod		imiquimod	CREAM	TOPICAL	20200730		NDA AUTHORIZED GENERIC	NDA022483	Bryant Ranch Prepack	IMIQUIMOD	37.5	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20251231
63629-8819_d29922c6-7e4f-493c-97a7-182e7f415deb	63629-8819	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20190208		ANDA	ANDA075581	Bryant Ranch Prepack	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
63629-8820_21bd4467-5a52-41b8-b583-6bff890cf499	63629-8820	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20190208		ANDA	ANDA075581	Bryant Ranch Prepack	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
63629-8827_e54103fe-1264-4e91-9be0-4037964ee81a	63629-8827	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20210105		NDA AUTHORIZED GENERIC	NDA022301	Bryant Ranch Prepack	MESALAMINE	375	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
63629-8829_cd62b134-af7d-4220-a08b-69b8d6f2d1ec	63629-8829	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430	20240601	ANDA	ANDA211604	Bryant Ranch Prepack	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
63629-8832_5fb31d16-e35d-437c-ab7c-2b57a40fc63e	63629-8832	HUMAN PRESCRIPTION DRUG	Podofilox		Podofilox	SOLUTION	TOPICAL	19901213		NDA AUTHORIZED GENERIC	NDA019795	Bryant Ranch Prepack	PODOFILOX	5	mg/mL	Decreased Mitosis [PE]		N	20241231
63629-8833_0a0ec6af-f406-44b8-8d59-1b8b482e2e31	63629-8833	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8834_e3c1f46b-51a5-413e-a8c6-8a809bf13d5b	63629-8834	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-8835_01c60740-f135-4774-af01-b98cdce4aee5	63629-8835	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8836_5d2ce5b4-fee4-4218-b9fa-1b97d8625d02	63629-8836	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8842_80e6e379-5037-422d-9e33-b59c74bd71c9	63629-8842	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		verapamil hydrochloride	CAPSULE, DELAYED RELEASE PELLETS	ORAL	19900529		NDA	NDA019614	Bryant Ranch Prepack	VERAPAMIL HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63629-8846_22bd4169-f99f-48e5-9f5f-15ec98ac6264	63629-8846	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Bryant Ranch Prepack	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63629-8847_e80a3750-c4a6-47ad-ad2d-b5b48bc31061	63629-8847	HUMAN PRESCRIPTION DRUG	PROCTOZONE-HC		hydrocortisone 2.5%	CREAM	TOPICAL	20150803		ANDA	ANDA040879	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-8848_61a47f6a-97e8-4ee6-ba7e-72f9dc83df8c	63629-8848	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20170310		ANDA	ANDA207810	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63629-8849_beecdb86-1fa6-4739-b976-b4227eb671da	63629-8849	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE		sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124		ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
63629-8850_68dd17af-8dcd-48f2-8af2-4ad02200bd19	63629-8850	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE		sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124		ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
63629-8854_63d26596-027a-4138-9fe0-cae5a7d01717	63629-8854	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-8855_95b9cd22-e378-4929-83f6-5b9e7f26fa48	63629-8855	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-8856_d0b3f824-eebe-4ebb-b774-ee7efd8e7e26	63629-8856	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-8858_f988aceb-7649-47a1-9d98-9976de0c279b	63629-8858	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	Bryant Ranch Prepack	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-8859_3e2b9565-bcdd-4063-9be4-4ade21a843f0	63629-8859	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20210427		ANDA	ANDA214065	Bryant Ranch Prepack	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
63629-8860_f2535310-8b5a-4d3e-9596-ce572695124a	63629-8860	HUMAN PRESCRIPTION DRUG	Colesevelam hydrochloride		Colesevelam hydrochloride	POWDER, FOR SUSPENSION	ORAL	20190509		ANDA	ANDA210316	Bryant Ranch Prepack	COLESEVELAM HYDROCHLORIDE	3.75	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
63629-8861_d5f00b13-9525-408c-9a98-358072b1ca3f	63629-8861	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	Bryant Ranch Prepack	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
63629-8862_c7d992f8-2027-48f2-a46a-b88af1e17a16	63629-8862	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	Bryant Ranch Prepack	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
63629-8864_06cf3940-70ce-451c-94b4-f2885fde1e5a	63629-8864	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Bryant Ranch Prepack	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-8865_108c7f8c-5f53-4413-b69b-cbdf51aaa975	63629-8865	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Bryant Ranch Prepack	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-8866_af2a9534-03bd-414a-b61d-9d7a0e9145f6	63629-8866	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Bryant Ranch Prepack	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-8867_e91490bc-2f94-4db9-b246-f6d6c36340b1	63629-8867	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Bryant Ranch Prepack	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-8868_d0d8221e-6baf-4918-8bd6-2706e1b33d52	63629-8868	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Bryant Ranch Prepack	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-8869_421b5d0a-e4d9-44ac-a769-b2362c5a51b7	63629-8869	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Bryant Ranch Prepack	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-8870_f191f142-d5de-47e1-8c04-cac9651a6f30	63629-8870	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Bryant Ranch Prepack	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-8871_380fd4e2-5a5b-4c73-bbd5-425634b2192f	63629-8871	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-8872_5b204ea7-c358-4736-af58-a89185fa2c54	63629-8872	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-8873_16995ac3-897f-4a4d-bb4d-ebe1ce2db9ee	63629-8873	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-8874_daa09dc3-0e2b-4d4c-a847-aaf196016293	63629-8874	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63629-8876_c0c86baa-9a26-4561-9712-50cd6511bd12	63629-8876	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-8879_483776e4-c531-4c67-92b6-e513195b84dc	63629-8879	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
63629-8885_9b5c8b30-a78b-40c6-ba73-b8171e4a33ba	63629-8885	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-8886_14eea1c6-9a16-4045-b6f7-10feba5f9fa4	63629-8886	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
63629-8888_aa7aa6aa-9298-4800-bbfc-3b9e71d08414	63629-8888	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-8889_a1c4b9cd-2eb0-4e78-a5e1-e3e10f7a56bd	63629-8889	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-8890_b3b46d94-05f5-4c5f-bd3c-ffb632e62e10	63629-8890	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
63629-8891_0f58f940-1966-434e-ba90-c222797c8198	63629-8891	HUMAN PRESCRIPTION DRUG	Ibuprofen and famotidine		Ibuprofen and famotidine	TABLET, FILM COATED	ORAL	20210804		ANDA	ANDA211890	Bryant Ranch Prepack	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8893_9cf74867-2739-45b6-b58d-9ed3aab293ca	63629-8893	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin Enteric Coated Tablets 81 mg	TABLET, DELAYED RELEASE	ORAL	20210503		OTC MONOGRAPH FINAL	part343	Bryant Ranch Prepack	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63629-8894_2dfda64a-3d68-41dc-9b80-b2b462991bbc	63629-8894	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin Enteric Coated Tablets 81 mg	TABLET, DELAYED RELEASE	ORAL	20210503		OTC MONOGRAPH FINAL	part343	Bryant Ranch Prepack	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63629-8895_f44f94da-0c0f-4573-b0ee-dfbc3e3915d0	63629-8895	HUMAN OTC DRUG	Senna		Sennosides 8.6 mg Tablets	TABLET	ORAL	20190830		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	SENNOSIDES	8.6	mg/1			N	20241231
63629-8896_6531a1a9-b793-4463-aecb-607fefe1b099	63629-8896	HUMAN OTC DRUG	Senna		Sennosides 8.6 mg Tablets	TABLET	ORAL	20190830		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	SENNOSIDES	8.6	mg/1			N	20241231
63629-8897_417413e8-1ef3-4d7c-933b-54b0bd4273d5	63629-8897	HUMAN OTC DRUG	Lubricant PM		Mineral Oil, White Petrolatum Lubricant Eye Ointment	OINTMENT	OPHTHALMIC	20200319		OTC MONOGRAPH FINAL	part349	Bryant Ranch Prepack	MINERAL OIL; PETROLATUM	425; 573	mg/g; mg/g			N	20241231
63629-8898_634bd3ea-9ea4-42b3-921e-38b9f5cbcf46	63629-8898	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-8899_efe9a3ea-48bb-4c90-b6b6-958a1aa630b3	63629-8899	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-8900_1530bd66-262e-4279-af63-651f3a1c99e2	63629-8900	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-8901_93c81455-29f4-41ba-ab10-4194d8959787	63629-8901	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-8902_3fbf6531-99ff-4054-9dbf-aef00fabd440	63629-8902	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-8903_c251a536-aef5-4da9-acec-dc5270e871a3	63629-8903	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
63629-8904_a8b6e6a3-4608-4620-a300-f60dee8d7fb4	63629-8904	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8905_6760b40b-44ed-4a25-9952-b40c0dfe0a00	63629-8905	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8906_fdb19997-282e-42aa-b290-b7d13663ca93	63629-8906	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8907_ccfecae4-32bc-4f44-ad56-6b1e8fdded0a	63629-8907	HUMAN OTC DRUG	Senna-S		Docusate Sodium 50 mg Sennosides 8.6 mg	TABLET, FILM COATED	ORAL	20190830		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63629-8908_82f3fb52-12b3-4230-8a52-5934918d17e7	63629-8908	HUMAN OTC DRUG	Senna-S		Docusate Sodium 50 mg Sennosides 8.6 mg	TABLET, FILM COATED	ORAL	20190830		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63629-8909_0700b2c1-5783-4276-a5bf-66684fa304c0	63629-8909	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-8910_5f62b771-3f3e-47d6-b8f7-7cf93681ea9a	63629-8910	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
63629-8911_79c2f20b-ea91-4717-937c-1c158dce9920	63629-8911	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8912_846ca966-404e-4664-a6dc-e0c40e851e4b	63629-8912	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8913_d09362a0-fe8c-4da2-9ede-525e1190637b	63629-8913	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-8968_9dee21a5-d21f-4454-a856-c5f3b2db8ea6	63629-8968	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	Bryant Ranch Prepack	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
63629-8970_7339f32c-d8fc-4b31-a8ef-672bb9405117	63629-8970	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Bryant Ranch Prepack	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63629-8979_05ba0ee6-a504-4054-9c43-1baffca03afd	63629-8979	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin Enteric Coated Tablets 81 mg	TABLET, DELAYED RELEASE	ORAL	20210503		OTC MONOGRAPH FINAL	part343	Bryant Ranch Prepack	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63629-8983_043fff25-ff13-4bcc-8483-baf71e78c298	63629-8983	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-8985_23c12a1f-6d23-4bbd-b029-3a8f489e2de6	63629-8985	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
63629-8986_adb78c3f-3b58-49c3-8940-87172eb06f53	63629-8986	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
63629-8987_08ec7034-241e-482e-973f-29d3e255b7da	63629-8987	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19970911		ANDA	ANDA040218	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
63629-8988_19701835-1635-4608-a87e-8124d95d6be2	63629-8988	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63629-8989_a168e3e4-6451-4439-913d-c88181932786	63629-8989	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-8990_dd12db56-8fc2-4a97-bc73-a00d0c5ec245	63629-8990	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63629-8991_677b6fad-d4b9-4111-9a69-0720a10863c1	63629-8991	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-8992_61f76c85-a81f-44a7-bbd5-96b8a952f356	63629-8992	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
63629-8993_4aeb6076-6374-4c4f-89e0-6ad79568e7ca	63629-8993	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8994_42a39dd4-4aed-40fa-8257-7e6799b9a94d	63629-8994	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-8995_35f3d171-c6d5-482f-942a-fa5f42304ef2	63629-8995	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130115		ANDA	ANDA086988	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63629-8997_1a3bc83e-3c55-4596-9f47-ed4dc754fcfb	63629-8997	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20141001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SALSALATE	750	mg/1			N	20241231
63629-8998_758cefee-9515-46d9-9971-76bf15941524	63629-8998	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-8999_57a80123-3653-4753-a3a7-688b79dba8cb	63629-8999	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-9057_d9ac5388-b850-462d-aabb-c1158f145e88	63629-9057	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20060613		ANDA	ANDA085027	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
63629-9091_929b6430-c873-4d5c-9e2b-6e03ac833bab	63629-9091	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Bryant Ranch Prepack	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63629-9093_39ccbea8-f559-4a14-be4c-0a2d22d40800	63629-9093	HUMAN PRESCRIPTION DRUG	budesonide		budesonide	TABLET, EXTENDED RELEASE	ORAL	20180710		NDA AUTHORIZED GENERIC	NDA203634	Bryant Ranch Prepack	BUDESONIDE	9	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-9099_2de42a58-0218-4e70-a1cc-00c3cb2e6944	63629-9099	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63629-9102_566e9501-ad5a-4c14-92e5-e884e8f060be	63629-9102	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63629-9104_1bf3d0d1-da67-4547-88e9-370c55ed05cb	63629-9104	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
63629-9109_21d4cbf3-f217-40ba-89e0-77e9539ceb02	63629-9109	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20121018		ANDA	ANDA075269	Bryant Ranch Prepack	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63629-9110_b6bb14f3-c916-4abd-b967-862eb4f858eb	63629-9110	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Bryant Ranch Prepack	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
63629-9123_2c7c581f-d557-4542-a2a5-1b95eae35a04	63629-9123	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20190812		NDA AUTHORIZED GENERIC	NDA017955	Bryant Ranch Prepack	TRETINOIN	.1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
63629-9124_f591b3f8-a69b-462d-b5c6-70f3d84f9020	63629-9124	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20190712		NDA AUTHORIZED GENERIC	NDA017579	Bryant Ranch Prepack	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
63629-9127_0119ad75-e096-4b04-820d-1350a1ec18f9	63629-9127	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
63629-9134_b71982d3-ff53-4b75-8eb4-acd281ee0fb6	63629-9134	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Bryant Ranch Prepack	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63629-9137_df2fc49b-b22f-437b-b65f-827d2f950bf6	63629-9137	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20000329	20241031	ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	
63629-9144_7347207f-3788-468a-8476-bbb007ea1bc0	63629-9144	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20170512		ANDA	ANDA207237	Bryant Ranch Prepack	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
63629-9145_f2d378f8-2564-43e3-8056-7f002a9e7665	63629-9145	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20211001		ANDA	ANDA207237	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
63629-9146_f897ba61-4d5a-4099-8460-6d994cda6b08	63629-9146	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200806		ANDA	ANDA076756	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63629-9147_f70200e9-9e16-40ee-a09f-04a418ae1d36	63629-9147	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200806		ANDA	ANDA076756	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
63629-9148_7b72edab-b564-41b9-9157-4c26def12a13	63629-9148	HUMAN PRESCRIPTION DRUG	Piroxicam		piroxicam	CAPSULE	ORAL	20200220		ANDA	ANDA074116	Bryant Ranch Prepack	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
63629-9149_c01d936b-e840-482d-8954-104426086fb8	63629-9149	HUMAN PRESCRIPTION DRUG	Piroxicam		piroxicam	CAPSULE	ORAL	20200220		ANDA	ANDA074118	Bryant Ranch Prepack	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-9150_6b80eea2-0926-4319-92ef-8f46f4cc22de	63629-9150	HUMAN PRESCRIPTION DRUG	Piroxicam		piroxicam	CAPSULE	ORAL	20200220		ANDA	ANDA074118	Bryant Ranch Prepack	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63629-9151_0c4b71b7-0aaa-4aa0-9c8d-a0b0ad85e1ff	63629-9151	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	SOLUTION	ORAL	20090313		ANDA	ANDA040891	Bryant Ranch Prepack	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
63629-9152_68eb54fd-5a5e-4803-a43e-1c3134416377	63629-9152	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	Bryant Ranch Prepack	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20251231
63629-9153_b0edecc4-682e-4bfe-8d0e-25234fef06c0	63629-9153	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	Bryant Ranch Prepack	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20251231
63629-9154_e0924b5a-26ad-49ca-98e6-46f6451b1901	63629-9154	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20210812		ANDA	ANDA078536	Bryant Ranch Prepack	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20251231
63629-9156_67b52766-0b1d-4a46-b141-f9687b9f3929	63629-9156	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Bryant Ranch Prepack	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
63629-9157_0d3aa2f3-8a31-4c36-a7c6-795161e0192f	63629-9157	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Bryant Ranch Prepack	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
63629-9162_4639b9ac-8df6-4429-8bb5-e26af2529df9	63629-9162	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-9163_43588a29-5068-46a7-8497-9e42678255db	63629-9163	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-9164_3b9e30c6-0799-4c72-a086-0f4cc5ee7799	63629-9164	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-9165_619af8b9-380a-48f6-aec6-10b4a37c25df	63629-9165	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63629-9166_bde4bb3f-c105-444a-87a7-24979f0c9ba4	63629-9166	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA	NDA018651	Bryant Ranch Prepack	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
63629-9168_d7fcf10d-fc24-4227-9f14-b14f35e428ae	63629-9168	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Bryant Ranch Prepack	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9170_942afc84-5f0b-4820-a76a-2e4acf13672f	63629-9170	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Bryant Ranch Prepack	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9171_20f31932-5f49-472b-90ae-509a807ae377	63629-9171	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Bryant Ranch Prepack	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9177_873d72c2-5287-492d-a5a3-b28e0b0a3ef3	63629-9177	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20201215		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	1.25; 2.5	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-9178_c4d310e4-6753-4559-a06c-eb2f127fa1f5	63629-9178	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20201215		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	.625; 1.25	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-9179_a308a2bc-1e1d-4133-a9e6-0de4a5ab3a08	63629-9179	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-9180_8783d6c1-d71c-49ea-b1be-4181f9ab06aa	63629-9180	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-9181_e4e4a99f-c012-4701-9df1-dbf824017a41	63629-9181	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
63629-9196_e768c7f5-387d-4c3f-adc6-bc8ff15480b4	63629-9196	HUMAN PRESCRIPTION DRUG	cholestyramine powder for suspension		cholestyramine powder for suspension	POWDER, FOR SUSPENSION	ORAL	20211020		ANDA	ANDA211856	Bryant Ranch Prepack	CHOLESTYRAMINE	4	g/8.78g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
63629-9198_6951efe8-b23b-41b9-8a17-0790e35f2d65	63629-9198	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9199_420b7cbe-675c-4a39-923f-31f43883ae8a	63629-9199	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9200_77da8cd2-f9e5-42f0-8549-ad8b20606554	63629-9200	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9201_322f43e9-0830-4c40-b64d-69a5474cd26d	63629-9201	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9202_f060d65e-8ed0-43a8-85c4-eafc8d7e2a22	63629-9202	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20120604		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9203_89d108cc-0d9f-4e14-94a6-81fdc11c2479	63629-9203	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20120604		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9204_23562d64-2100-4a78-9b05-a98d0b540c2d	63629-9204	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	Bryant Ranch Prepack	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9208_88c5a571-a33a-42e7-9076-d1cf601100f1	63629-9208	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9209_7695cc17-f5bb-4684-b9d1-2809344d83fd	63629-9209	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	115	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9210_53fcb9b5-3a49-4ea1-8244-49aa055fbc58	63629-9210	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9211_8a466779-0115-40d3-a155-59eb6db82004	63629-9211	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9212_dc22b01b-82b3-4e27-a765-c87cbcca0ce7	63629-9212	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191223		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	55	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9213_a2d53642-a412-4139-9942-369e0d78e659	63629-9213	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	65	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9214_42357d96-74ef-4de3-a647-bdcb52aaa29e	63629-9214	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	80	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9215_8e84906e-7b68-4a3b-9019-49c999f67f7d	63629-9215	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63629-9244_a522d2fd-1839-4c5c-bbd8-43e95d8913d1	63629-9244	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19840701		ANDA	ANDA088488	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	100	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63629-9247_3def3917-28f7-46ca-bd6a-78d910994705	63629-9247	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20141001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SALSALATE	500	mg/1			N	20241231
63629-9248_5ad1ce4a-38e3-457d-80cb-b1fc1c8494c2	63629-9248	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20141001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SALSALATE	500	mg/1			N	20241231
63629-9249_3ce5e193-26c3-4045-bb57-74b2086fb94b	63629-9249	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220228		ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
63629-9250_ec8b9cdd-da45-4afe-bbc2-7d10cc8c3e50	63629-9250	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220228		ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
63629-9251_4b26eda0-85c8-4478-84da-e75750eee6c2	63629-9251	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220228		ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
63629-9255_7589696a-5977-4e07-89a9-f6265d135aef	63629-9255	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Bryant Ranch Prepack	MIRTAZAPINE	7.5	mg/1			N	20241231
63629-9257_c6362cfe-dcae-4dd0-bcb4-77917ca68d5b	63629-9257	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20180209		ANDA	ANDA211064	Bryant Ranch Prepack	FOLIC ACID	1	mg/1			N	20241231
63629-9258_b7448bf8-ce9b-4316-8f85-fffadecfa627	63629-9258	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20180209		ANDA	ANDA211064	Bryant Ranch Prepack	FOLIC ACID	1	mg/1			N	20241231
63629-9259_29156a28-e69c-4e49-9b6d-6239d79c85a8	63629-9259	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide and Sulfur		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-9260_ffb41cff-c922-453c-8238-67f276516065	63629-9260	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide and Sulfur		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-9261_8b245c80-a03d-4769-be25-8821e06ae0d7	63629-9261	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide and Sulfur		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-9262_14abb894-91af-46a2-923d-2599eda0e026	63629-9262	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide		Sodium Sulfacetamide	LIQUID	TOPICAL	20220115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-9263_0a12d634-bb10-43b0-bbb5-fef943927dbb	63629-9263	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide		Sodium Sulfacetamide	LIQUID	TOPICAL	20220115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-9264_9c20a2c1-41e9-4190-a413-01363a9cd5da	63629-9264	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide		Sodium Sulfacetamide	LIQUID	TOPICAL	20220115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
63629-9265_f7f33804-16ec-49e9-9b63-8333d44c8de6	63629-9265	HUMAN PRESCRIPTION DRUG	Urea 40 Percent		Urea	CREAM	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	400	mg/g			N	20241231
63629-9266_b33a8945-5ef7-4236-b5a0-a65d327d9d27	63629-9266	HUMAN PRESCRIPTION DRUG	Urea 40 Percent		Urea	CREAM	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	400	mg/g			N	20241231
63629-9267_1aa37069-9984-4b0a-af4f-6234f6c02fe0	63629-9267	HUMAN PRESCRIPTION DRUG	Urea 40 Percent		Urea	CREAM	TOPICAL	20211115		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	400	mg/g			N	20241231
63629-9268_0df4b3a0-1999-43f5-9d48-73838a4b639c	63629-9268	HUMAN OTC DRUG	Senna Syrup		Natural Vegetable Laxative	LIQUID	ORAL	20210928		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	SENNOSIDES	8.8	mg/5mL			N	20241231
63629-9269_bbbeb2b0-e1e5-4775-ace0-5b334a6642e7	63629-9269	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
63629-9270_e8cbb1ba-e7f3-404f-9910-2c190d1f830b	63629-9270	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
63629-9271_0fabebfd-22c6-4be1-bff1-0e1bc1a65689	63629-9271	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
63629-9272_0471c856-e08e-4e61-9927-0c8a3beff4df	63629-9272	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
63629-9273_a9e9e4e1-ae72-4a52-abf3-81e4e6a7ad9b	63629-9273	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
63629-9274_6cbd5f19-b9c3-47c0-b3a1-ab83895b1d8c	63629-9274	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
63629-9275_83a1deb3-3f99-4cf9-a910-7bb01351f637	63629-9275	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
63629-9276_038ba4d1-5db7-4785-81df-52eb5aa97e84	63629-9276	HUMAN PRESCRIPTION DRUG	Clomiphene Citrate		Clomiphene Citrate	TABLET	ORAL	19990830	20250228	ANDA	ANDA075528	Bryant Ranch Prepack	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	
63629-9278_b0ca1b60-e9e3-4bd9-b376-0b0217881872	63629-9278	HUMAN PRESCRIPTION DRUG	Albendazole	200 mg	Albendazole	TABLET, FILM COATED	ORAL	20181215		ANDA	ANDA210011	Bryant Ranch Prepack	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
63629-9279_ccc4b7c7-f584-485a-958c-cc4b3db7fd6b	63629-9279	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	TABLET, FILM COATED	ORAL	20101117		ANDA	ANDA091573	Bryant Ranch Prepack	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-9285_eb46d59d-9559-42f7-a94b-2320b7e5bd72	63629-9285	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20181011	20240930	ANDA	ANDA210616	Bryant Ranch Prepack	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63629-9287_c9984558-4a99-4f2d-add8-6b8c6b64c930	63629-9287	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Bryant Ranch Prepack	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
63629-9295_1441ed4b-c0df-446a-af84-23d050e0cfc4	63629-9295	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111122		ANDA	ANDA079057	Bryant Ranch Prepack	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63629-9298_4efabeca-190f-4cd4-a112-a219334bf5f6	63629-9298	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20180528		ANDA	ANDA207222	Bryant Ranch Prepack	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
63629-9305_fae7db70-ecfc-4f93-bc0d-34a4c4cc3b18	63629-9305	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20080718		ANDA	ANDA076067	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-9309_c76b1a14-ca9e-40a7-a7f2-f8855c8cc80d	63629-9309	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PHOSPHATE		clindamycin phosphate	GEL	TOPICAL	20210120		ANDA	ANDA212104	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
63629-9310_881f062f-f4f1-4b59-a8c0-884b0e2338d8	63629-9310	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	SOLUTION	TOPICAL	20170628		ANDA	ANDA204255	Bryant Ranch Prepack	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
63629-9325_c625158f-fcc0-456b-a03e-b42f596890b3	63629-9325	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20110930		ANDA	ANDA091195	Bryant Ranch Prepack	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
63629-9413_3f1122f9-5aa5-4ee8-94d0-e22e25fd62c6	63629-9413	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Bryant Ranch Prepack	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9420_945f34e6-993b-4a7d-b457-66f96b676c3f	63629-9420	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20180725		OTC MONOGRAPH FINAL	part331	Bryant Ranch Prepack	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63629-9423_7e177dfd-dc3a-4ec5-9fab-31e0a4b12606	63629-9423	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20211217		ANDA	ANDA211053	Bryant Ranch Prepack	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9424_63db2895-6015-401a-9cc2-3a2f5688acc9	63629-9424	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20211217		ANDA	ANDA211053	Bryant Ranch Prepack	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9427_42ef39aa-5c53-44e0-b9c9-4426104749f7	63629-9427	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Bryant Ranch Prepack	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63629-9428_b91d2f70-9d03-4d24-9efc-cd921643075f	63629-9428	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20180223		ANDA	ANDA090609	Bryant Ranch Prepack	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63629-9433_fd92a931-11bf-3a73-e053-6294a90a8cca	63629-9433	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071826	Bryant Ranch Prepack	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63629-9446_98c257e2-f4e7-4786-bad3-fabbd0081ada	63629-9446	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	Bryant Ranch Prepack	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9447_165e0286-8087-41a5-861e-2776adc42fc4	63629-9447	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	Bryant Ranch Prepack	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9448_df6291c0-dfdd-4cd4-9e9c-e1c355cf1cd0	63629-9448	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	Bryant Ranch Prepack	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9449_492ed4c5-b3b8-4974-9aad-f4ef48c7c44f	63629-9449	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	Bryant Ranch Prepack	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
63629-9450_54a7930d-8690-451e-b3f6-3f27e11ad03e	63629-9450	HUMAN PRESCRIPTION DRUG	Dalfampridine		Dalfampridine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180731		ANDA	ANDA206765	Bryant Ranch Prepack	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
63629-9575_328e8b18-f64f-4bcd-99ed-e6e69778f46b	63629-9575	HUMAN PRESCRIPTION DRUG	zolmitriptan		zolmitriptan	SPRAY	NASAL	20211116		ANDA	ANDA212469	Bryant Ranch Prepack	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
63629-9581_a60a5a2e-1622-4288-bf27-e27140a2bc57	63629-9581	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Bryant Ranch Prepack	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
63629-9582_d9a9ef7d-7eda-4385-896b-5641a2464771	63629-9582	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	TABLET	ORAL	20090504		ANDA	ANDA065416	Bryant Ranch Prepack	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
63629-9583_0f463173-6fc7-4944-b73b-759088cced99	63629-9583	HUMAN PRESCRIPTION DRUG	Fluocinonide		fluocinonide topical solution usp, 0.05%	SOLUTION	TOPICAL	20190419		ANDA	ANDA209699	Bryant Ranch Prepack	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-9584_624ed4a6-7fb3-4d70-9023-eaf39bb5284e	63629-9584	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide Topical Solution USP, 0.01%		Fluocinolone Acetonide Topical Solution USP, 0.01%	SOLUTION	TOPICAL	20190320		ANDA	ANDA209913	Bryant Ranch Prepack	FLUOCINOLONE ACETONIDE	.1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63629-9604_f84523b9-d927-4d7f-af4f-95b73be5a9a2	63629-9604	HUMAN PRESCRIPTION DRUG	LIDOCAINE AND PRILOCAINE		Lidocaine and Prilocaine	CREAM	TOPICAL	20221205		ANDA	ANDA212482	Bryant Ranch Prepack	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
63629-9606_237566ff-2000-4d03-8309-84b75324d5ce	63629-9606	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Bryant Ranch Prepack	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
63629-9607_314d702f-8b34-4a57-8583-822427ae2435	63629-9607	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Bryant Ranch Prepack	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
63629-9608_25c91803-536e-44ca-86e7-d24145ddddd0	63629-9608	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Bryant Ranch Prepack	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
63629-9612_71d7407a-eb9e-4f0d-9740-39447ed356f8	63629-9612	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63629-9613_757af499-f124-4727-8fa2-83a729d86a86	63629-9613	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-9614_0a99ab89-5163-495b-aea6-15388b852deb	63629-9614	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63629-9615_b6ec2fd8-cfd6-49c8-9bc0-de01cb1abf78	63629-9615	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20090115		ANDA	ANDA078582	Bryant Ranch Prepack	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-9616_ee63f0f9-fb9a-4151-9e1b-3e8f2e8c2ee4	63629-9616	HUMAN PRESCRIPTION DRUG	BRIMONIDINE		brimonidine	GEL	TOPICAL	20230101		ANDA	ANDA209158	Bryant Ranch Prepack	BRIMONIDINE TARTRATE	5	mg/g	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63629-9620_c9add9d6-4983-408b-a56b-94bff8ee45a8	63629-9620	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071839	Bryant Ranch Prepack	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63629-9632_d5247a34-7953-4ea0-8da9-2dedbe1150a8	63629-9632	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022012	Bryant Ranch Prepack	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9633_edd9f64a-9e5d-40c6-aa87-168241f297f3	63629-9633	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022012	Bryant Ranch Prepack	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9634_1d71e2bc-2725-43b8-b5c0-3ad66bd41931	63629-9634	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Bryant Ranch Prepack	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9635_2904e9a1-fe79-4d23-818f-a7d9a8908f7a	63629-9635	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Bryant Ranch Prepack	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
63629-9689_6ded93e5-c572-4267-bc64-433ac64f2973	63629-9689	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161214		ANDA	ANDA207138	Bryant Ranch Prepack	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63629-9715_7820c8c5-b02b-402e-aa42-0e27856f2d8e	63629-9715	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20221215		ANDA	ANDA085828	Bryant Ranch Prepack	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
63629-9728_f078cf37-e24e-4a1a-b29c-92e343555e45	63629-9728	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET, FILM COATED	ORAL	20210329		ANDA	ANDA213652	Bryant Ranch Prepack	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
63629-9729_d16dde3e-a659-4acf-8f85-b18b0f0dbc9a	63629-9729	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA090636	Bryant Ranch Prepack	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
63629-9842_fa56d3f2-c4d2-4bc1-998d-82d0e6a56e98	63629-9842	HUMAN PRESCRIPTION DRUG	CANDESARTAN CILEXETIL		CANDESARTAN CILEXETIL	TABLET	ORAL	20181205		ANDA	ANDA210302	Bryant Ranch Prepack	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63629-9847_1f9171e8-3a2d-434e-9c18-4311de698654	63629-9847	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140501		ANDA	ANDA203468	Bryant Ranch Prepack	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63629-9863_671bdcca-bd56-4802-8b20-53eb0b01e789	63629-9863	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride		Cevimeline Hydrochloride	CAPSULE	ORAL	20140617		ANDA	ANDA203775	Bryant Ranch Prepack	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
63645-130_c4765775-122e-47a5-b712-0011a0b171e9	63645-130	HUMAN OTC DRUG	ChapIce Original SPF 4 Lip Balm		Padimate O, Petrolatum	STICK	TOPICAL	20130315		OTC MONOGRAPH NOT FINAL	part352	OraLabs	PADIMATE O; PETROLATUM	1.5; 44	mg/g; mg/g			N	20241231
63645-140_fa1fce17-67f9-46cb-b562-f3e35c69e7e1	63645-140	HUMAN OTC DRUG	ChapIce Moisture SPF 15 Lip Balm		Oxybenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20130315		OTC MONOGRAPH NOT FINAL	part352	OraLabs	OCTINOXATE; OXYBENZONE; PETROLATUM	7.5; 3.5; 40.7	mg/g; mg/g; mg/g			N	20241231
63645-163_c84fba33-6301-49cc-ae74-54759e4ac373	63645-163	HUMAN OTC DRUG	ChapIce SPF 30 Lip Balm		Octinoxate, Octocrylene, Oxybenzone, Octisalate	STICK	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part352	OraLabs	OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	7.5; 5; 10; 5	mg/g; mg/g; mg/g; mg/g			N	20241231
63645-164_2b9b275e-c1c4-4ec9-a217-270601a4b745	63645-164	HUMAN OTC DRUG	ChapIce SPF 30 Lip Balm		Octinoxate, Octocrylene, Oxybenzone, Octisalate	STICK	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part352	OraLabs	OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	7.5; 5; 10; 5	mg/g; mg/g; mg/g; mg/g			N	20241231
63645-165_ec2f0978-7ec8-49a3-8954-5475cbb581a3	63645-165	HUMAN OTC DRUG	Sunfrog Ultra SPF 30 Lip Balm		Octinoxate, Octocrylene, Oxybenzone, Octisalate, Petroleum Jelly	STICK	TOPICAL	20171129		OTC MONOGRAPH NOT FINAL	part352	OraLabs	OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; PETROLATUM	7.5; 5; 7; 5; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
63645-166_1123e0c4-ab0b-4079-aa5e-06d01e6d7cf4	63645-166	HUMAN OTC DRUG	Sanell Hand Sanitizer		Alcohol	GEL	TOPICAL	20180307		OTC MONOGRAPH NOT FINAL	part333A	OraLabs	ALCOHOL	58.1	mg/g			N	20241231
63645-169_733a76a9-2460-472e-8b5c-93008351509f	63645-169	HUMAN OTC DRUG	OraLabs ChapIce Original Petrolatum		Petrolatum	STICK	TOPICAL	20200309		OTC MONOGRAPH FINAL	part347	OraLabs	PETROLATUM	45	mg/g			N	20241231
63645-170_5d87de38-3bf8-4da6-b291-82f74bd1a537	63645-170	HUMAN OTC DRUG	OraLabs ChapIce Cherry Petrolatum		Petrolatum	STICK	TOPICAL	20200309		OTC MONOGRAPH FINAL	part347	OraLabs	PETROLATUM	45	mg/g			N	20241231
63645-174_e5314981-da30-4353-a4ad-3b1c5a96054e	63645-174	HUMAN OTC DRUG	Sanell Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20190812		OTC MONOGRAPH NOT FINAL	part333A	OraLabs	ALCOHOL	6.3	mL/10mL			N	20241231
63645-176_d5d54a65-99b5-4f3d-9e3b-93d543f7c057	63645-176	HUMAN OTC DRUG	Tea Tree Lip Balm, SPF 15		Octinoxate, Oxybenzone	STICK	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part352	OraLabs	OCTINOXATE; OXYBENZONE	20; 45	mg/g; mg/g			N	20241231
63645-177_cb39aa7a-443b-4a4f-8e64-ecf90e08b3e3	63645-177	HUMAN OTC DRUG	Sanell Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20180307		OTC MONOGRAPH NOT FINAL	part333A	OraLabs	ALCOHOL	4.275	mL/7.5mL			N	20241231
63645-178_91bd6dbc-064a-4636-b334-0fc6431e3ec4	63645-178	HUMAN OTC DRUG	SPF 50 Sunscreen Stick		Zinc Oxide	STICK	TOPICAL	20200224		OTC MONOGRAPH NOT FINAL	part352	OraLabs	ZINC OXIDE	200	mg/g			N	20241231
63645-179_c421c473-d1b7-4ba5-a562-1c29f64e9b43	63645-179	HUMAN OTC DRUG	CPH Anti-bacterial Breath Mist		Cetylpyridinium chloride	SPRAY	TOPICAL	20220415		OTC MONOGRAPH NOT FINAL	part356	OraLabs	CETYLPYRIDINIUM CHLORIDE	1.11	g/13mL			N	20241231
63645-180_c7094485-a19f-41b7-88b8-d6d472adbff1	63645-180	HUMAN OTC DRUG	ChapIce SPF 30 Lip Balm		Avobenzone, Octisalate, Homosalate, Petrolatum	STICK	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part352	OraLabs	AVOBENZONE; HOMOSALATE; OCTISALATE; PETROLATUM	30; 80; 50; 396	mg/g; mg/g; mg/g; mg/g			N	20241231
63645-181_3ac8569f-4b11-4536-8919-234f79bbd7fc	63645-181	HUMAN OTC DRUG	OraLabs SPF 15 Lip Balm		Avobenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20220620		OTC MONOGRAPH NOT FINAL	part352	OraLabs	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 423	mg/g; mg/g; mg/g			N	20241231
63645-182_8c293e38-83de-404a-b667-01c2e4b99072	63645-182	HUMAN OTC DRUG	SPF 15 - Zinc Oxide Lip Balm		Zinc Oxide	STICK	TOPICAL	20230606		OTC MONOGRAPH NOT FINAL	part352	OraLabs	ZINC OXIDE	100	mg/g			N	20241231
63645-183_afd10abe-1e8b-4df8-9d8c-ef15266c510c	63645-183	HUMAN OTC DRUG	SPF 45 - Lip Balm		Avobenzone, Homosalate, Octinoxate, Octisalate, Petrolatum	STICK	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part352	OraLabs	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; PETROLATUM	30; 30; 75; 50; 400	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
63646-010_eea5b1d8-7b6e-4783-afb5-3049efb9e5b1	63646-010	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	SHAMPOO, SUSPENSION	TOPICAL	20050411		ANDA	ANDA076942	TOLMAR Inc.	KETOCONAZOLE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63646-040_b4d1b2b3-8962-409c-95cc-b0917b0b1980	63646-040	HUMAN PRESCRIPTION DRUG	calcipotriene and betamethasone dipropionate		calcipotriene and betamethasone dipropionate	SUSPENSION	TOPICAL	20200511	20241130	ANDA	ANDA210765	TOLMAR Inc.	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	
63646-500_a9ec52b5-161b-4d9f-b5d7-7271039bab9d	63646-500	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SOLUTION	TOPICAL	20170208		ANDA	ANDA076977	TOLMAR Inc.	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63647-001_e99b4b38-5abf-3ccd-e053-2a95a90a1bc0	63647-001	HUMAN OTC DRUG	Aloesept HS		Ethanol	LIQUID	TOPICAL	20210412	20240713	OTC MONOGRAPH NOT FINAL	part333E	Walter G. Legge Company, Inc.	ALCOHOL	70	mL/100mL			N	
63654-275_f7300376-dd92-4f5e-b68d-175e8023ca44	63654-275	HUMAN OTC DRUG	Cold Medicine		Acetaminophen, Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20111115		OTC MONOGRAPH DRUG	M012	Selder, S.A. de C.V.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63654-309_39201d37-e750-420b-8035-feb97bc77c21	63654-309	HUMAN OTC DRUG	Allergy		Loratadine	TABLET	ORAL	20141216		ANDA	ANDA076471	Selder, S.A. de C.V.	LORATADINE	10	mg/1			N	20241231
63654-342_eb00ca6b-b29c-7513-e053-2995a90a77cf	63654-342	HUMAN OTC DRUG	Mucus Relief Xpect		Guaifensin, Dextromethorphan	TABLET	ORAL	20210517		OTC MONOGRAPH FINAL	M012	Selder, S.A. de C.V.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63654-363_82a1d588-5ad1-4ab9-8bdb-bfa044823dee	63654-363	HUMAN OTC DRUG	Ibuprofen	Softgels	Ibuprofen 200 mg	CAPSULE, LIQUID FILLED	ORAL	20141222		ANDA	ANDA079205	Selder, S.A. de C.V.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63654-380_9519d5f7-acd5-4700-9738-08cef7e54083	63654-380	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20170517		ANDA	ANDA208150	Selder, S.A. de C.V.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63654-601_eb00ebf2-5c46-3ab9-e053-2995a90a6c76	63654-601	HUMAN OTC DRUG	Cold Medicine	XL3 FORTE	Acetaminophen Chlorpheniramine Maleate Phenylepherine Hydrochloride	TABLET	ORAL	20170801		OTC MONOGRAPH FINAL	M012	Selder, S.A. de C.V.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63654-605_e2c35f3a-1d7b-bc51-e053-2a95a90a4159	63654-605	HUMAN OTC DRUG	Cold Medicine	XL3	Acetaminophen Chlorpheniramine Maleate Phenylepherine Hydrochloride	TABLET	ORAL	20220627		OTC MONOGRAPH FINAL	part341	Selder, S.A. de C.V.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63667-010_5e6c680a-6cb7-4186-9a1f-b9b51e7896d9	63667-010	HUMAN OTC DRUG	ORGANIC PEPPERMINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	20191202		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	1.9	mg/1			N	20241231
63667-153_f1a34136-e5c3-46c4-9832-30ba809a8cc6	63667-153	HUMAN OTC DRUG	COOL RELIEF ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20180601		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	15.3	mg/1			N	20241231
63667-156_30062e60-92a9-45b7-a3ed-e5ec796a6902	63667-156	HUMAN OTC DRUG	COOL RELIEF LEMON FROST ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20190401		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	16	mg/1			N	20241231
63667-185_f2b6fb1a-b77d-4361-8665-ccc87b19a55c	63667-185	HUMAN OTC DRUG	MOUNTAIN HERB SUGAR FREE WITH STEVIA COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20150901		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	4.8	mg/1			N	20241231
63667-201_8d25375e-5fde-4da6-9a2b-5bba1061e2b2	63667-201	HUMAN OTC DRUG	RICOLA MAX THROAT CARE SWISS CHERRY		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.3	mg/1			N	20241231
63667-202_2b7d1167-f5f3-4e8f-a6dd-3bf7e238ad46	63667-202	HUMAN OTC DRUG	RICOLA MAX THROAT CARE COOL PEPPERMINT		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.3	mg/1			N	20241231
63667-203_99f148ba-a1e1-42cf-abf6-504c81776155	63667-203	HUMAN OTC DRUG	RICOLA MAX THROAT CARE HONEY LEMON		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.3	mg/1			N	20241231
63667-206_41d57295-21c9-43bc-9ad9-f4d84aa0ec6f	63667-206	HUMAN OTC DRUG	RICOLA MAX NASAL CARE COOL MENTHOL		MENTHOL	LOZENGE	ORAL	20220301		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	15.3	mg/1			N	20241231
63667-224_87f1bea1-b132-4f19-95bb-766f0c8f6978	63667-224	HUMAN OTC DRUG	DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20110403		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.3	mg/1			N	20241231
63667-234_2a17a439-d078-4362-8715-4f037939261d	63667-234	HUMAN OTC DRUG	DUAL ACTION HONEY LEMON COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20150501		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.3	mg/1			N	20241231
63667-242_3cddbe88-3fac-45c6-a434-acf2024d72a6	63667-242	HUMAN OTC DRUG	DUAL ACTION CHERRY COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20110403		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.5	mg/1			N	20241231
63667-301_9ab2f166-3fc9-484a-9961-05a01fafe0e6	63667-301	HUMAN OTC DRUG	Throat Balm Caramel Pectin		Pectin	LOZENGE	ORAL	20221101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	PECTIN	3.8	mg/1			N	20241231
63667-436_12214716-3db9-4bd9-b3eb-86c9b81a93be	63667-436	HUMAN OTC DRUG	BERRY MEDLEY THROAT DROPS		MENTHOL	LOZENGE	ORAL	20210517		OTC MONOGRAPH DRUG	M022	Ricola USA Inc.	MENTHOL	1.7	mg/1			N	20241231
63667-503_d2d0732a-0f0b-4ec0-b636-3f829287b8d8	63667-503	HUMAN OTC DRUG	EXTRA STRENGTH WITH NATURAL MENTHOL GLACIER MINT COUGH SUPPRESSANT		MENTHOL	LOZENGE	ORAL	20130527		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.3	mg/1			N	20241231
63667-507_e4eebf12-668c-4627-adba-e9d7edab5c12	63667-507	HUMAN OTC DRUG	Natural Cherry Honey Herb Throat Drops		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	1.8	mg/1			N	20241231
63667-513_7a2582e6-f1ee-4813-9211-9d60fa89ce9e	63667-513	HUMAN OTC DRUG	COOL RELIEF ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20200201		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	13.2	mg/1			N	20241231
63667-517_5f69c3fc-0a22-45e7-b694-c22d02862c5c	63667-517	HUMAN OTC DRUG	Natural Cherry Honey Herb Throat Drops		MENTHOL	LOZENGE	ORAL	20220101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	2.1	mg/1			N	20241231
63667-518_f58b85d7-52f8-458b-8ecc-516c5e7cebff	63667-518	HUMAN OTC DRUG	Cherry Throat Drops		MENTHOL	LOZENGE	ORAL	20230401		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	1.3	mg/1			N	20241231
63667-603_7f6ea0c9-31e7-4e18-bb07-8ff943bf5936	63667-603	HUMAN OTC DRUG	DUAL ACTION GLACIER MINT COUGH SUPPRESSANT ORAL ANESTHETIC		MENTHOL	LOZENGE	ORAL	20160101		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	8.3	mg/1			N	20241231
63667-676_c390bc7c-6841-4825-a4cd-04a7b15e07bb	63667-676	HUMAN OTC DRUG	NATURAL LEMON MINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	1.6	mg/1			N	20241231
63667-923_15e6f938-04fc-4b4e-92b8-1a0be629d64c	63667-923	HUMAN OTC DRUG	THE ORIGINAL NATURAL HERB COUGH DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	5.3	mg/1			N	20241231
63667-933_7674e1f8-697b-476a-8c69-334199035f19	63667-933	HUMAN OTC DRUG	Original Herb Cough Drops		MENTHOL	LOZENGE	ORAL	20220101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	5.5	mg/1			N	20241231
63667-952_afbb84ee-d14f-4cf4-9772-53d185617c44	63667-952	HUMAN OTC DRUG	Cherry Throat Drops		MENTHOL	LOZENGE	ORAL	20230401		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	1.4	mg/1			N	20241231
63667-953_22a1572f-7739-4409-9e5a-1960b2d69865	63667-953	HUMAN OTC DRUG	Natural Cherry Honey Herb Throat Drops		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	2	mg/1			N	20241231
63667-954_76c0a4dc-522b-4072-acaa-4dbdce4227e3	63667-954	HUMAN OTC DRUG	NATURAL HONEY HERB COUGH SUPPRESSANT THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	2	mg/1			N	20241231
63667-955_285f13a4-8de2-4ad2-8a19-032790018440	63667-955	HUMAN OTC DRUG	THE ORIGINAL NATURAL HERB COUGH DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	4.8	mg/1			N	20241231
63667-956_3b4f8034-105d-46bc-8f31-fbdef20f8ef5	63667-956	HUMAN OTC DRUG	SUGAR FREE LEMON MINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	1.1	mg/1			N	20241231
63667-957_cdd5c7fd-e851-4704-ba96-a02c87a07808	63667-957	HUMAN OTC DRUG	NATURAL LEMON MINT HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	1.5	mg/1			N	20241231
63667-958_9c2b706c-5b89-4715-aa54-2aca14786aad	63667-958	HUMAN OTC DRUG	Sugar Free Mountain Herb Cough Suppressant Throat Drops		MENTHOL	LOZENGE	ORAL	19420412		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	4.8	mg/1			N	20241231
63667-960_dd81d817-a857-4ce4-97ae-0cff571f079e	63667-960	HUMAN OTC DRUG	Natural Honey Lemon with Echinacea Cough Suppressant Throat Drops		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	3.5	mg/1			N	20241231
63667-971_a27ade36-80fd-45de-be88-dd55db72183e	63667-971	HUMAN OTC DRUG	SUGAR FREE GREEN TEA WITH ECHINACEA COUGH SUPPRESSANT THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH FINAL	part341	Ricola USA Inc.	MENTHOL	4.1	mg/1			N	20241231
63667-976_706637af-dd36-4f4b-b76e-b209e320f8c2	63667-976	HUMAN OTC DRUG	SUGAR FREE SWISS CHERRY HERB THROAT DROPS		MENTHOL	LOZENGE	ORAL	19420101		OTC MONOGRAPH NOT FINAL	part356	Ricola USA Inc.	MENTHOL	2.2	mg/1			N	20241231
63672-0021_0c7b3f33-ef83-690b-e063-6294a90a4d6e	63672-0021	HUMAN PRESCRIPTION DRUG	Tamsulosin hydrochloride		tamsulosin hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078801	Synthon Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63674-001_f10c710f-5fc5-6d21-e053-2a95a90a8d86	63674-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Uintah Basin Medical Center dba Home Health Equipment and Supply	OXYGEN	99	L/100L			N	20241231
63704-004_22f71b67-46c9-4c72-a89a-00f6f9104e10	63704-004	HUMAN PRESCRIPTION DRUG	METHYLERGONOVINE MALEATE		methylergonovine maleate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20101101		ANDA	ANDA040889	Pharmacist Pharmaceutical, LLC	METHYLERGONOVINE MALEATE	.2	mg/mL	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
63704-008_bfad3255-81e7-4716-bf48-f20d897b16a2	63704-008	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20130412		ANDA	ANDA091667	Pharmacist Pharmaceutical, LLC	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
63710-001_08a1742d-29e0-c31d-e063-6294a90a7ea3	63710-001	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200302		OTC MONOGRAPH DRUG	505G(a)(3)	Laboratorios Zeyco, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
63710-002_08a16eed-b9f2-b1fa-e063-6294a90a6615	63710-002	HUMAN OTC DRUG	Zeyco Antiseptic Hand Sanitizer Gel		ALCOHOL	GEL	TOPICAL	20200302		OTC MONOGRAPH DRUG	505G(a)(3)	Laboratorios Zeyco, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
63710-003_08a17e39-fe91-3976-e063-6294a90ae8ca	63710-003	HUMAN OTC DRUG	Zeyco Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200302		OTC MONOGRAPH DRUG	505G(a)(3)	Laboratorios Zeyco, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
63710-004_08a16eed-ba0f-b1fa-e063-6294a90a6615	63710-004	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200302		OTC MONOGRAPH DRUG	505G(a)(3)	Laboratorios Zeyco, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
63710-005_08a17e39-fe9f-3976-e063-6294a90ae8ca	63710-005	HUMAN OTC DRUG	Monarch Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200924		OTC MONOGRAPH DRUG	505G(a)(3)	Laboratorios Zeyco, S.A. de C.V.	ALCOHOL	.7	L/L			N	20241231
63712-001_fc0c3aad-acc2-bdcf-e053-6294a90a7b43	63712-001	HUMAN OTC DRUG	Zelens Daily Defence Mineral Sunscreen SPF 30		Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH FINAL	M020	Zelens Limited	ZINC OXIDE	200	mg/mL			N	20241231
63713-050_9fe06de6-8108-11eb-869b-71fefb2ca371	63713-050	PLASMA DERIVATIVE	EVARREST		Fibrinogen Human and Human Thrombin	PATCH	TOPICAL	20130301		BLA	BLA125392	Ethicon, Inc.	FIBRINOGEN HUMAN; HUMAN THROMBIN	8.6; 37.5	mg/cm2; [iU]/cm2	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
63713-461_ad2e2962-8e07-11ed-9fa2-85d20153d3da	63713-461	PLASMA DERIVATIVE	thrombin human		thrombin human	POWDER, FOR SOLUTION	TOPICAL	20090919		BLA	BLA125247	Ethicon, Inc	HUMAN THROMBIN	2000	[iU]/2mL	Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Increased Coagulation Factor Activity [PE]		N	20241231
63730-001_08aaf4ce-9b1b-5491-e063-6294a90a8a4e	63730-001	HUMAN OTC DRUG	Diamond Luminous UV Defense Light Tinted Fluid Sunscreen Broad Spectrum SPF 40		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210601		OTC MONOGRAPH DRUG	M020	NATURA BISSE INTERNATIONAL SA	TITANIUM DIOXIDE; ZINC OXIDE	78; 250	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63736-010_311a8a93-b525-4f05-a16a-6f29eb40303d	63736-010	HUMAN OTC DRUG	Monistat 3 Combination Pack		Miconazole Nitrate	KIT		20091210		NDA	NDA020670	Insight Pharmaceuticals LLC						N	20241231
63736-013_0863c829-5c28-4720-a91f-77a6388a2a74	63736-013	HUMAN OTC DRUG	Monistat 1 Combination Pack		Miconazole Nitrate	KIT		20010629		NDA	NDA021308	Insight Pharmaceuticals LLC						N	20241231
63736-015_9202303b-e2d0-4d9a-afb3-93f2a8396f56	63736-015	HUMAN OTC DRUG	Monistat 3	3 Day	Miconazole Nitrate	CREAM	VAGINAL	19980330		NDA	NDA020827	Insight Pharmaceuticals LLC	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63736-017_d9b1a3bc-e34b-4f32-b76f-5870ef345bfc	63736-017	HUMAN OTC DRUG	MONISTAT 3		Miconazole Nitrate	KIT		19960416		NDA	NDA020670	Insight Pharmaceuticals LLC						N	20241231
63736-019_4233bca3-1637-4e7c-8af2-2ed6e98730e3	63736-019	HUMAN OTC DRUG	Monistat 3 Combination Pack	3 Ovule Inserts	Miconazole Nitrate	KIT		19960416		NDA	NDA020670	Insight Pharmaceuticals LLC						N	20241231
63736-023_80c7d48e-c1df-4d61-a801-50f4aee2ee63	63736-023	HUMAN OTC DRUG	Monistat 7 Combination Pack	7-Day Pre-Filled Applicators	Miconazole Nitrate	KIT		20200423		NDA	NDA017450	Insight Pharmaceuticals LLC						N	20241231
63736-025_1cac7cc9-d11d-4e79-8174-d4c13b96bca7	63736-025	HUMAN OTC DRUG	Monistat 7	with Reusable Applicator	Miconazole Nitrate	CREAM	VAGINAL	19930426		NDA	NDA017450	Insight Pharmaceuticals LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63736-026_bb13a4d5-c68c-4b4d-b651-1cf67bd864a7	63736-026	HUMAN OTC DRUG	MONISTAT 7	7-DAY DISPOSABLE APPLICATORS	Miconazole Nitrate	CREAM	VAGINAL	19930426		NDA	NDA017450	Insight Pharmaceuticals LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63736-029_5dfa37c9-ffd8-4506-ade3-da6ecac2044f	63736-029	HUMAN OTC DRUG	Monistat Complete Care Instant Itch Relief		hydrocortisone	CREAM	TOPICAL	20131115		OTC MONOGRAPH NOT FINAL	part348	Insight Pharmaceuticals LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63736-030_39ca1326-92bb-400b-b227-d20c22b9db34	63736-030	HUMAN OTC DRUG	Nix		Permethrin	RINSE	TOPICAL	20131115		NDA	NDA019918	Insight Pharmaceuticals LLC	PERMETHRIN	1	g/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
63736-031_98d5051d-ad9c-4e5d-9a33-d92674b0523e	63736-031	HUMAN OTC DRUG	Monistat Complete Care Chafing Relief		dimethicone	GEL	TOPICAL	20131115		OTC MONOGRAPH FINAL	part347	Insight Pharmaceuticals LLC	DIMETHICONE	1.2	g/100g	Skin Barrier Activity [PE]		N	20241231
63736-035_f369cf99-ff7c-402a-b4a1-ca06bd5788e7	63736-035	HUMAN OTC DRUG	Nix Complete Lice Treatment		Permethrin	KIT		20131115		NDA	NDA019918	Insight Pharmaceuticals LLC						N	20241231
63736-040_0f95503e-df37-4ac8-aff2-9fe7642bed60	63736-040	HUMAN OTC DRUG	Boil Ease		Benzocaine	OINTMENT	TOPICAL	20100621		OTC MONOGRAPH NOT FINAL	part348	Insight Pharmaceuticals LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63736-050_9b8a641e-489e-497f-a3f0-154d8d836c59	63736-050	HUMAN OTC DRUG	Monistat Care Instant Itch Relief		Benzocaine	SPRAY	TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part348	Insight Pharmaceuticals LLC	BENZOCAINE	11.4	g/57g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63736-051_588715b9-e752-4e8f-a0a5-4f157ad160a3	63736-051	HUMAN OTC DRUG	Ting		Tolnaftate	CREAM	TOPICAL	20090608		OTC MONOGRAPH FINAL	part333C	Insight Pharmaceuticals LLC	TOLNAFTATE	10	mg/g			N	20241231
63736-200_11bd624d-b3d5-4ea4-ae24-705364eb2603	63736-200	HUMAN OTC DRUG	Anacin		Asprin and Caffeine	TABLET	ORAL	20090625		OTC MONOGRAPH NOT FINAL	part343	Insight Pharmaceuticals LLC	ASPIRIN; CAFFEINE	400; 32	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63736-205_c763b32e-91b7-4c97-baf5-f523f385a96e	63736-205	HUMAN OTC DRUG	CEPASTAT	Sore throat and Cough	Benzocaine, Dextromethorphan HBr, Menthol	LOZENGE	ORAL	20161001		OTC MONOGRAPH NOT FINAL	part356	Insight Pharmaceuticals LLC	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL	6; 5; 10	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63736-238_01f42a38-4d7e-4f37-9646-93f4bdb5d3b9	63736-238	HUMAN OTC DRUG	Stye		Mineral Oil and Petrolatum	GEL	OPHTHALMIC	20100615		OTC MONOGRAPH DRUG	M018	Insight Pharmaceuticals LLC	MINERAL OIL; PETROLATUM	319; 577	mg/g; mg/g			N	20251231
63736-302_f3cbbb8e-5906-4086-ad8e-1a5e2afcce4a	63736-302	HUMAN OTC DRUG	Dermarest	Psoriasis Medicated	Salicylic Acid	LIQUID	TOPICAL	20100723		OTC MONOGRAPH FINAL	part358H	Insight Pharmaceuticals LLC	SALICYLIC ACID	3	g/100mL			N	20241231
63736-305_500ecd32-b339-4f00-b3a4-e8ed149f1eca	63736-305	HUMAN OTC DRUG	Caldesene Baby		Starch, Corn and Zinc Oxide	POWDER	TOPICAL	20090707		OTC MONOGRAPH DRUG	M016	Insight Pharmaceuticals LLC	STARCH, CORN; ZINC OXIDE	115; 21	g/142g; g/142g			N	20251231
63736-306_0a3ddc61-dbbe-4ca9-be57-88240de87658	63736-306	HUMAN OTC DRUG	Caldesene Medicated Protecting		Cornstarch and Zinc Oxide	POWDER	TOPICAL	20170715		OTC MONOGRAPH DRUG	M016	Insight Pharmaceuticals LLC	STARCH, CORN; ZINC OXIDE	115; 21	g/142g; g/142g			N	20251231
63736-312_2ac6b87c-0101-4ec7-8f54-d334656b3bd1	63736-312	HUMAN OTC DRUG	Dermarest	Psoriasis Medicated Scalp Treatment	Salicylic Acid	GEL	TOPICAL	20101220		OTC MONOGRAPH FINAL	part358H	Insight Pharmaceuticals LLC	SALICYLIC ACID	3	g/100mL			N	20241231
63736-327_c540e5e0-8ba7-4c0f-b333-290fde2cef65	63736-327	HUMAN OTC DRUG	Auro Dri		Isopropyl alcohol	LIQUID	AURICULAR (OTIC)	20100614		OTC MONOGRAPH FINAL	part344	Insight Pharmaceuticals LLC	ISOPROPYL ALCOHOL	95	mL/100mL			N	20241231
63736-339_ca45ab8f-7078-4d91-be07-e3f7b244fcb8	63736-339	HUMAN OTC DRUG	Dermarest	Eczema Medicated	Hydrocortisone	LOTION	TOPICAL	20100920		OTC MONOGRAPH NOT FINAL	part348	Insight Pharmaceuticals LLC	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63736-375_272a1b21-943a-4bbc-acfd-2a5e3433ef05	63736-375	HUMAN OTC DRUG	Americaine		Benzocaine	OINTMENT	TOPICAL	20090710		OTC MONOGRAPH FINAL	part346	Insight Pharmaceuticals LLC	BENZOCAINE	5.6	g/28g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63736-378_a964404f-73c4-4fd2-abb3-c78ac8273255	63736-378	HUMAN OTC DRUG	Americaine		Benzocaine	AEROSOL, SPRAY	TOPICAL	20090714		OTC MONOGRAPH NOT FINAL	part348	Insight Pharmaceuticals LLC	BENZOCAINE	11.4	g/57g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63736-413_c7b11d34-bd8a-4c84-aa4c-2cc6cf9037df	63736-413	HUMAN OTC DRUG	MONISTAT TIOCONAZOLE 1		TIOCONAZOLE	OINTMENT	TOPICAL	20011121		ANDA	ANDA075915	Insight Pharmaceuticals LLC	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63736-532_fa7416b7-3135-49e1-b924-3358b15b7ac4	63736-532	HUMAN OTC DRUG	Ting		Miconazole Nitrate	AEROSOL, POWDER	TOPICAL	20090716	20250502	OTC MONOGRAPH FINAL	part333C	Insight Pharmaceuticals LLC	MICONAZOLE NITRATE	2.56	g/128g	Azole Antifungal [EPC], Azoles [CS]		N	
63736-560_ac3470a9-3bfc-43d8-81e3-a63112616907	63736-560	HUMAN OTC DRUG	Sucrets Sore Throat Wild Cherry		Dyclonine Hydrochloride	LOZENGE	ORAL	20090728		OTC MONOGRAPH NOT FINAL	part356	Insight Pharmaceuticals LLC	DYCLONINE HYDROCHLORIDE	2	mg/1			N	20241231
63736-567_80263450-45ca-4950-8d76-c9a37c450fff	63736-567	HUMAN OTC DRUG	Sucrets		Dyclonine HCl, Menthol, and Pectin	LOZENGE	ORAL	20141104		OTC MONOGRAPH NOT FINAL	part356	Insight Pharmaceuticals LLC	DYCLONINE HYDROCHLORIDE; MENTHOL; PECTIN	2; 5; 6	mg/1; mg/1; 1/1			N	20241231
63736-730_73e21c3c-bbd6-4f12-beb4-262a31eacdd3	63736-730	HUMAN OTC DRUG	Nostrilla		Oxymetazoline Hydrochloride	SPRAY, METERED	NASAL	20090608		OTC MONOGRAPH FINAL	part341	Insight Pharmaceuticals LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63736-819_430d9675-78f1-45e2-a68b-771c00fece21	63736-819	HUMAN OTC DRUG	Ting		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20090727	20250502	OTC MONOGRAPH FINAL	part333C	Insight Pharmaceuticals LLC	TOLNAFTATE	1.28	g/128g			N	
63736-921_26d04041-0776-4349-8f7f-917ae2cd74c6	63736-921	HUMAN OTC DRUG	SUCRETS VAPOR CHERRY		dyclonine hydrochloride and menthol	LOZENGE	ORAL	20090728		OTC MONOGRAPH NOT FINAL	part356	Insight Pharmaceuticals LLC	DYCLONINE HYDROCHLORIDE; MENTHOL	2; 6	mg/1; mg/1			N	20241231
63739-003_0c7a7c19-3dbc-e237-e063-6394a90a19d0	63739-003	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20120628		ANDA	ANDA071457	McKesson Corporation dba SKY Packaging	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
63739-005_f7aa095f-5910-98e3-e053-6394a90ad972	63739-005	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	McKesson Corporation dba SKY Packaging	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-008_f49a4cb2-d023-2cbf-e053-2995a90a902d	63739-008	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET	ORAL	20160531		ANDA	ANDA206181	Mckesson Corporation DBA SKY Packaginng	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63739-014_0c6b7451-01fe-58b7-e063-6394a90ac460	63739-014	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	McKesson Corporation dba SKY Packaging	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63739-015_0c6b7451-01fe-58b7-e063-6394a90ac460	63739-015	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	McKesson Corporation dba SKY Packaging	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63739-016_0c6b7451-01fe-58b7-e063-6394a90ac460	63739-016	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	McKesson Corporation dba SKY Packaging	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63739-029_0c6b4600-671e-44f1-e063-6294a90a5065	63739-029	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040627	McKesson Corporation dba SKY Packaging	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
63739-051_0c6b1899-7c42-1921-e063-6394a90a04eb	63739-051	HUMAN PRESCRIPTION DRUG	Amiodarone hydrochloride		Amiodarone hydrochloride	TABLET	ORAL	20090810		ANDA	ANDA079029	McKesson Corporation dba SKY Packaging	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
63739-052_e99683de-d0a4-373b-e053-2a95a90ac808	63739-052	HUMAN PRESCRIPTION DRUG	Sky Oral Rinse		Chlorhexidine Gluconate	RINSE	ORAL	20201201		ANDA	ANDA077789	McKesson	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
63739-067_b8593c77-a6de-4ace-b373-565df95f158d	63739-067	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20211020		ANDA	ANDA209215	McKesson Corporation dba SKY Packaging	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63739-069_f1d7e020-1723-6a0e-e053-2a95a90a0de2	63739-069	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20211109		ANDA	ANDA205064	McKesson Corporation dba SKY Packaging	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-070_f1d7e020-1723-6a0e-e053-2a95a90a0de2	63739-070	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20211109		ANDA	ANDA205064	McKesson Corporation dba SKY Packaging	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-072_0c7a60e7-0bd9-9aa2-e063-6294a90a3209	63739-072	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20220329		ANDA	ANDA203623	McKesson Corporation dba SKY Packaging	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
63739-074_f1d7e020-1723-6a0e-e053-2a95a90a0de2	63739-074	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20211109		ANDA	ANDA205064	McKesson Corporation dba SKY Packaging	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-076_04df57b7-a76c-feee-e063-6294a90ab888	63739-076	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET, FILM COATED	ORAL	20220307		ANDA	ANDA205166	McKesson Corporation DBA SKY Packaging	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
63739-077_0c7a9fff-9391-da12-e063-6394a90ae0a1	63739-077	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20220317		ANDA	ANDA203047	McKesson Corporation dba SKY Packaging	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
63739-078_f1d7e020-1723-6a0e-e053-2a95a90a0de2	63739-078	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20211109		ANDA	ANDA205064	McKesson Corporation dba SKY Packaging	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-086_0c7ac394-3013-310d-e063-6394a90a2b3a	63739-086	HUMAN PRESCRIPTION DRUG	valproic acid		valproic acid	CAPSULE	ORAL	20210713		ANDA	ANDA073229	McKesson Corporation dba SKY Packaging	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63739-097_0b63bede-5f32-d4c3-e063-6394a90a9891	63739-097	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180827		ANDA	ANDA203894	McKesson Corporation DBA SKY Packaging	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
63739-098_0c6cab2c-a68f-e1bb-e063-6394a90a9498	63739-098	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	McKesson Corporation dba SKY Packaging	MIRTAZAPINE	15	mg/1			N	20241231
63739-099_0c6cab2c-a68f-e1bb-e063-6394a90a9498	63739-099	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	McKesson Corporation dba SKY Packaging	MIRTAZAPINE	30	mg/1			N	20241231
63739-108_0c6b5ba7-2a0e-39ff-e063-6394a90abe17	63739-108	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20180716		ANDA	ANDA073589	McKesson Corporation dba SKY Packaging	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
63739-115_05b98783-b724-141a-e063-6394a90a2d08	63739-115	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20230919		ANDA	ANDA077731	McKesson Corporation DBA SKY Packaging	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
63739-132_053026ee-501f-2654-e063-6294a90a0852	63739-132	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230912		ANDA	ANDA210081	McKesson Corporation DBA SKY Packaging	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
63739-143_07740fcc-9b18-770f-e063-6394a90aa947	63739-143	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20211214		ANDA	ANDA075797	McKesson Corporation dba SKY Packaging	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
63739-145_0c6cab2c-a68d-e1bb-e063-6394a90a9498	63739-145	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	McKesson Corporation DBA SKY Packaging	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63739-158_8d54b349-71cc-42ee-81cc-5dda2ad14647	63739-158	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20220701		ANDA	ANDA201157	McKesson Corporation dba SKY Packaging	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-160_e26d507e-f7ba-2c85-e053-2995a90a5482	63739-160	HUMAN PRESCRIPTION DRUG	Nystatin		NYSTATIN	SUSPENSION	ORAL	20200717		ANDA	ANDA203621	McKesson Corporation dba as SKY Packaging	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
63739-168_0c6bb239-04c2-9cc3-e063-6394a90a65ff	63739-168	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	19900101		ANDA	ANDA062421	McKesson Corporation dba SKY Packaging	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
63739-170_0cbe8fea-59a6-8a86-e063-6294a90a6e11	63739-170	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	INTRAVENOUS	20220622		ANDA	ANDA212821	McKesson Corporation dba SKY Packaging	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63739-178_46c30fc8-7591-a7fb-a93e-34e807b32c4b	63739-178	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20220818		ANDA	ANDA091023	McKesson Corporation dba SKY Packaging	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
63739-193_3f14108b-f3f2-48e9-b111-d0614def78cf	63739-193	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20220315		ANDA	ANDA211884	McKesson Corporation dba SKY Packaging	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
63739-196_0ce166a6-2800-443a-812b-cf9e514aae2c	63739-196	HUMAN OTC DRUG	Milk of Magnesia		Magnesium Hydroxide	SUSPENSION	ORAL	20240101		OTC MONOGRAPH DRUG	M007	McKesson Corporation dba SKY Packaging	MAGNESIUM HYDROXIDE	400	mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
63739-198_79c20e03-f175-4502-81b1-58d833ca4ec9	63739-198	HUMAN OTC DRUG	SKY PEG3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20200608		ANDA	ANDA090685	McKesson Corporation dba SKY Packaging	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63739-213_0c7a2932-b2b1-b0f3-e063-6394a90a62c8	63739-213	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	19751219	20240930	ANDA	ANDA084176	McKesson Corporation dba SKY Packaging	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	
63739-225_619f1270-59bb-4214-896c-230bd7f6d6d7	63739-225	HUMAN OTC DRUG	Gas relief		Simethicone	TABLET, CHEWABLE	ORAL	20211019		OTC MONOGRAPH FINAL	part332	McKesson Corporation dba SKY Packaging	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
63739-236_0c6bb744-7c7b-fb85-e063-6294a90a8b76	63739-236	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Mckesson Corporation DBA SKY Packaginng	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-253_6e5ca6ac-75ca-4a53-92ab-995dff1f6672	63739-253	HUMAN PRESCRIPTION DRUG	Valproic acid		Valproic acid	CAPSULE	ORAL	20200221		ANDA	ANDA207611	McKesson Corporation dba SKY Packaging	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63739-327_0c6bf0ae-1c5e-5ecd-e063-6394a90af9bc	63739-327	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20130630		ANDA	ANDA200770	McKesson Corporation dba SKY Packaging	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63739-328_0e0d1ae8-2ce1-1951-e063-6294a90a8556	63739-328	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20130630		ANDA	ANDA200770	McKesson Corporation dba SKY Packaging	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
63739-333_0c6cf012-57c5-f2a6-e063-6394a90a1461	63739-333	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20180711		ANDA	ANDA077851	McKesson Corporation dba SKY Packaging	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63739-357_0c7ab201-daf4-2ae8-e063-6394a90a32b3	63739-357	HUMAN PRESCRIPTION DRUG	VALGANCICLOVIR HYDROCHLORIDE		VALGANCICLOVIR HYDROCHLORIDE	TABLET	ORAL	20160331		ANDA	ANDA204750	Mckesson Corporation DBA SKY Packaginng	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
63739-367_0c6c9b0d-57e3-89db-e063-6294a90ac1fe	63739-367	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	19811215		ANDA	ANDA087537	McKesson Corporation dba SKY Packaging	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
63739-368_a234250a-9bc8-4a21-a13f-021658e1573a	63739-368	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200427		ANDA	ANDA079038	McKesson Corporation dba SKY Packaging	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63739-369_9e108ef3-26bf-4452-b08e-2825d3b9d666	63739-369	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200427		ANDA	ANDA079219	McKesson Corporation dba SKY Packaging	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63739-370_ae260e0f-2fda-4d9e-b086-a4f95f57f907	63739-370	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200427		ANDA	ANDA079216	McKesson Corporation dba SKY Packaging	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63739-371_7320d8e4-6736-4993-88f3-b7ca61ca981a	63739-371	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20200427		ANDA	ANDA074507	McKesson Corporation dba SKY Packaging	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63739-403_07737712-83d0-fd68-e063-6294a90a4b5c	63739-403	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	McKesson Corporation dba SKY Packaging	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63739-410_0c6aeadb-f61f-29e3-e063-6294a90a7473	63739-410	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091116		ANDA	ANDA078253	McKesson Corporation dba SKY Packaging	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
63739-411_fbea051d-79bc-b7ee-e053-6394a90ac4c5	63739-411	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Mckesson Corporation DBA SKY Packaginng	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-413_0e0d7ba6-58bf-e2c2-e063-6394a90abd10	63739-413	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	McKesson Corporation dba SKY Packaging	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
63739-478_0eb04b61-8831-9394-e063-6394a90a2293	63739-478	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20101109		OTC MONOGRAPH DRUG	505G(a)(3)	McKesson Corporation	DOCUSATE SODIUM	100	mg/1			N	20251231
63739-479_f460796e-ed84-5937-e053-2995a90a4c80	63739-479	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20110101		ANDA	ANDA078504	Mckesson Corporation DBA SKY Packaginng	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63739-480_f460796e-ed84-5937-e053-2995a90a4c80	63739-480	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20110101		ANDA	ANDA078401	Mckesson Corporation DBA SKY Packaginng	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
63739-483_f76bec18-e209-6d9c-e053-6394a90a01cb	63739-483	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	McKesson Corporation dba SKY Packaging	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63739-486_f76bec18-e209-6d9c-e053-6394a90a01cb	63739-486	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	McKesson Corporation dba SKY Packaging	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63739-505_357e51c7-84d4-40c9-8a69-db81f3ebc697	63739-505	HUMAN OTC DRUG	GUAIFENESIN DM		GUAIFENESIN and DEXTROMETHORPHAN	SYRUP	ORAL	20240110		OTC MONOGRAPH DRUG	M012	McKesson Corporation dba SKY Packaging	DEXTROMETHORPHAN; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
63739-506_357e51c7-84d4-40c9-8a69-db81f3ebc697	63739-506	HUMAN OTC DRUG	GUAIFENESIN DM		GUAIFENESIN and DEXTROMETHORPHAN	SYRUP	ORAL	20240110		OTC MONOGRAPH DRUG	M012	McKesson Corporation dba SKY Packaging	DEXTROMETHORPHAN; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
63739-508_f7aa095f-5910-98e3-e053-6394a90ad972	63739-508	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	McKesson Corporation dba SKY Packaging	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-525_b4cb3101-d20d-c2a6-e053-2995a90aa806	63739-525	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Mckesson Corporation DBA SKY Packaginng	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
63739-526_0c7a8ee5-a82e-a1d4-e063-6294a90af0f4	63739-526	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	McKesson Corporation dba SKY Packaging	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
63739-544_f41f9d5d-a62e-3086-e053-2995a90a4bf4	63739-544	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	McKesson Corporation dba SKY Packaging	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63739-545_f41f9d5d-a62e-3086-e053-2995a90a4bf4	63739-545	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20110601		ANDA	ANDA091426	McKesson Corporation dba SKY Packaging	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
63739-548_0c6d0351-2a04-f775-e063-6394a90a9604	63739-548	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20090301		ANDA	ANDA078503	McKesson Corporation dba SKY Packaging	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
63739-549_39a5e454-c347-48d6-824c-69077fc2b177	63739-549	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20231218		ANDA	ANDA075671	McKesson Corporation dba SKY Packaging	MEGESTROL ACETATE	400	mg/10mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
63739-555_0c6c860a-4110-6633-e063-6294a90a2c31	63739-555	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	McKesson Corporation dba SKY Packaging	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63739-559_f214c893-efde-b30b-e053-2a95a90a4fb4	63739-559	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	McKesson Corporation dba SKY Packaging	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63739-560_fbc35222-b031-ec4b-e053-6394a90a18d4	63739-560	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	McKesson Corporation dba SKY Packaging	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-564_f66a8ec0-0174-73e0-e053-2a95a90ac419	63739-564	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	McKesson Corporation dba SKY Packaging	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63739-567_fc9af3d1-0559-2b23-e053-6294a90af39c	63739-567	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078225	McKesson Corporation dba SKY Packaging	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
63739-569_0c6c9b0d-57e3-89db-e063-6294a90ac1fe	63739-569	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	19791222		ANDA	ANDA086925	McKesson Corporation dba SKY Packaging	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
63739-570_0c7a4aca-d43a-d6b4-e063-6394a90ab3c5	63739-570	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	McKesson Corporation dba SKY Packaging	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63739-571_0c7a4aca-d43a-d6b4-e063-6394a90ab3c5	63739-571	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	McKesson Corporation dba SKY Packaging	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63739-572_0c7a4aca-d43a-d6b4-e063-6394a90ab3c5	63739-572	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	McKesson Corporation dba SKY Packaging	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63739-573_0c7a4aca-d43a-d6b4-e063-6394a90ab3c5	63739-573	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	McKesson Corporation dba SKY Packaging	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
63739-588_0c79f8ea-d882-669b-e063-6294a90af284	63739-588	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085161	McKesson Corporation dba SKY Packaging	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63739-591_0c6bb744-7c7b-fb85-e063-6294a90a8b76	63739-591	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Mckesson Corporation DBA SKY Packaginng	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-645_f6e205ed-dc50-1804-e053-6394a90ae1b0	63739-645	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Mckesson Corporation DBA SKY Packaginng	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63739-666_f7aa095f-5910-98e3-e053-6394a90ad972	63739-666	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	McKesson Corporation dba SKY Packaging	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-673_03adcf54-192a-012d-e063-6394a90adafb	63739-673	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Mckesson Corporation DBA SKY Packaginng	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63739-686_03adcf54-192a-012d-e063-6394a90adafb	63739-686	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Mckesson Corporation DBA SKY Packaginng	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63739-698_03ae3c99-f48d-c019-e063-6394a90a2edc	63739-698	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	McKesson Corporation dba SKY Packaging	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
63739-700_f201ef0f-6208-33d2-e053-2a95a90a8a95	63739-700	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Mckesson Corporation DBA SKY Packaginng	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
63739-724_210b675f-bc71-4cfb-8a5c-4c6717145470	63739-724	HUMAN PRESCRIPTION DRUG	Potassium Chloride		POTASSIUM CHLORIDE	SOLUTION	ORAL	20230825		ANDA	ANDA210766	McKesson Corporation dba SKY Packaging	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63739-777_0c6c10ed-299d-ae02-e063-6394a90a1351	63739-777	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	McKesson Corporation dba SKY Packaging	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
63739-787_fbea051d-79bc-b7ee-e053-6394a90ac4c5	63739-787	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Mckesson Corporation DBA SKY Packaginng	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-795_fbea051d-79bc-b7ee-e053-6394a90ac4c5	63739-795	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Mckesson Corporation DBA SKY Packaginng	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-796_0c6aeadb-f61f-29e3-e063-6294a90a7473	63739-796	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091116		ANDA	ANDA078253	McKesson Corporation dba SKY Packaging	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
63739-797_0c6cdd67-7463-bb44-e063-6294a90afa17	63739-797	HUMAN PRESCRIPTION DRUG	Nimodipine		Nimodipine	CAPSULE, LIQUID FILLED	ORAL	20150101		ANDA	ANDA090103	McKesson Corporation dba SKY Packaging	NIMODIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
63739-888_0773b8e2-dc36-e2ba-e063-6394a90ac4eb	63739-888	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	McKesson Corporation dba SKY Packaging	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63739-900_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-900	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202732	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-901_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-901	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202733	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-902_addbc2c3-3a6a-469e-bb1f-5363f2e02094	63739-902	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210715		ANDA	ANDA090858	McKesson Corporation dba Sky Packaging	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-903_addbc2c3-3a6a-469e-bb1f-5363f2e02094	63739-903	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210715		ANDA	ANDA090858	McKesson Corporation dba Sky Packaging	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-904_addbc2c3-3a6a-469e-bb1f-5363f2e02094	63739-904	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210715		ANDA	ANDA090858	McKesson Corporation dba Sky Packaging	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-920_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-920	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-931_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-931	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-942_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-942	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-943_0c7a8230-ef24-a02d-e063-6294a90a541f	63739-943	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	19961111		ANDA	ANDA070848	McKesson Corporation dba SKY Packaging	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
63739-953_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-953	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-963_0773b8e2-dc36-e2ba-e063-6394a90ac4eb	63739-963	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	McKesson Corporation dba SKY Packaging	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
63739-964_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-964	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA203198	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-969_576ba7d7-c8f6-4be9-9e6d-222ee80e54e5	63739-969	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		Pyridostigmine Bromide	TABLET	ORAL	20190417		ANDA	ANDA211181	McKesson Corporation dba SKY Packaging	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
63739-972_fc74288c-93de-6ae3-e053-6394a90a8312	63739-972	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	19981120		ANDA	ANDA074726	Mckesson Corporation DBA SKY Packaginng	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63739-973_fc74288c-93de-6ae3-e053-6394a90a8312	63739-973	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	19981120		ANDA	ANDA074726	Mckesson Corporation DBA SKY Packaginng	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63739-975_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-975	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA203198	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-976_e1e541e5-2ddf-4a76-bd6a-d329bd291a2c	63739-976	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	LIQUID	ORAL	20210816		OTC MONOGRAPH NOT FINAL	part334	McKesson Corporation dba SKY Packaging	DOCUSATE SODIUM	100	mg/10mL			N	20241231
63739-984_0c6bb744-7c7b-fb85-e063-6294a90a8b76	63739-984	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Mckesson Corporation DBA SKY Packaginng	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
63739-986_041f4c70-eb0b-e76e-e063-6394a90aaeb4	63739-986	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA203198	McKesson Corporation dba SKY Packaging	HEPARIN SODIUM	20000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
63739-988_f7aa095f-5910-98e3-e053-6394a90ad972	63739-988	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	McKesson Corporation dba SKY Packaging	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
63739-991_fc749882-2e22-cad3-e053-6294a90a33ca	63739-991	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20210722		ANDA	ANDA209312	McKesson Corporation dba SKY Packaging	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63739-992_fc749882-2e22-cad3-e053-6294a90a33ca	63739-992	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20210722		ANDA	ANDA209312	McKesson Corporation dba SKY Packaging	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
63739-995_0c6b73b6-392b-46fc-e063-6394a90a043a	63739-995	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	CAPSULE	ORAL	20090123		ANDA	ANDA078979	McKesson Corporation dba SKY Packaging	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
63739-997_f7a46797-7046-d785-e053-6394a90a011e	63739-997	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	LOTION	TOPICAL	20200312	20240131	ANDA	ANDA204494	McKesson Corporation	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
63742-001_0d766155-d1a0-7bf3-e063-6394a90a17b6	63742-001	HUMAN OTC DRUG	Numb Master		LIDOCAINE	CREAM	TOPICAL	20140424		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63742-002_0d762cea-b5e1-6ff1-e063-6394a90aee03	63742-002	HUMAN OTC DRUG	Numb 520		LIDOCAINE	CREAM	TOPICAL	20151218		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63742-003_0d762cea-b5e2-6ff1-e063-6394a90aee03	63742-003	HUMAN OTC DRUG	Numb 100		LIDOCAINE	CREAM	TOPICAL	20160618		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63742-006_0d762cea-b5e3-6ff1-e063-6394a90aee03	63742-006	HUMAN OTC DRUG	Numb520		LIDOCAINE	LIQUID	TOPICAL	20180515		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63742-007_0d766155-d1a2-7bf3-e063-6394a90a17b6	63742-007	HUMAN OTC DRUG	ARNICOOL		MENTHOL	CREAM	TOPICAL	20180515		OTC MONOGRAPH DRUG	M017	Clinical Resolution Laboratory, Inc.	MENTHOL	40	mg/g			N	20241231
63742-012_0d76f485-b7e3-50a6-e063-6294a90a56aa	63742-012	HUMAN OTC DRUG	Numb520		LIDOCAINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE	SPRAY	TOPICAL	20190501		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	50; 2.5	mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63742-013_0dba40ce-4e15-821f-e063-6394a90a9838	63742-013	HUMAN OTC DRUG	Lightning Pain Relief		MENTHOL	CREAM	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	Clinical Resolution Laboratory, Inc.	MENTHOL	40	mg/g			N	20251231
63742-020_0d76f485-b7e5-50a6-e063-6294a90a56aa	63742-020	HUMAN OTC DRUG	Dr Acne Wash Facial Cleanser		BENZOYL PEROXIDE	CREAM	TOPICAL	20190215		OTC MONOGRAPH DRUG	M006	Clinical Resolution Laboratory, Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
63742-022_0a452583-5f67-6741-e063-6294a90ab17a	63742-022	HUMAN OTC DRUG	Liposomal Hemorrhoid Master		Lidocaine , Phenylephrine Hcl	OINTMENT	TOPICAL	20240101		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	5; .25	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63742-030_0d7707a4-3459-c7ef-e063-6394a90a7b88	63742-030	HUMAN OTC DRUG	Numb520		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20190912		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE HYDROCHLORIDE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63742-031_0d7718f6-3857-c916-e063-6394a90aad2a	63742-031	HUMAN OTC DRUG	Numb Master		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20190912		OTC MONOGRAPH DRUG	M015	Clinical Resolution Laboratory, Inc.	LIDOCAINE HYDROCHLORIDE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63742-040_0d77230e-fbef-c95e-e063-6394a90ab484	63742-040	HUMAN OTC DRUG	Hand Sanitizer Plus		ALCOHOL	GEL	TOPICAL	20200301		OTC MONOGRAPH DRUG	505G(a)(3)	Clinical Resolution Laboratory, Inc.	ALCOHOL	.7	mL/mL			N	20241231
63759-3048_8e36994a-0455-44ab-9ccc-02eaa0ec5699	63759-3048	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION	INTRAVENOUS	20230603		NDA	NDA215179	SHILPA MEDICARE LIMITED	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/10mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
63759-3049_8e36994a-0455-44ab-9ccc-02eaa0ec5699	63759-3049	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION	INTRAVENOUS	20230603		NDA	NDA215179	SHILPA MEDICARE LIMITED	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/50mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
63759-3050_8e36994a-0455-44ab-9ccc-02eaa0ec5699	63759-3050	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION	INTRAVENOUS	20230603		NDA	NDA215179	SHILPA MEDICARE LIMITED	PEMETREXED DISODIUM HEMIPENTAHYDRATE	1000	mg/100mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
63776-035_f1ec2358-18b0-cfeb-e053-2995a90abe7f	63776-035	HUMAN OTC DRUG	Arthros		anti-interleukin-1.alpha. immunoglobulin g rabbit, .alpha.-ketoglutaric acid, .alpha.-lipoic acid, apomorphine, bos taurus joint capsule, sus scrofa joint capsule, ascorbic acid, bos taurus adrenal gland, sus scrofa adrenal gland, brain-derived neurotrophic factor human, metenkefalin, ersofermin, bos taurus solar plexus, sus scrofa solar plexus, calcitonin, bos taurus cartilage, sus scrofa cartilage, colchicum autumnale bulb, pork collagen, bos taurus red blood cell, sus scrofa red blood cell	SPRAY	ORAL	20120724		UNAPPROVED HOMEOPATHIC		VIATREXX BIO INCORPORATED	.ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; APOMORPHINE; ASCORBIC ACID; BEEF LIVER; BOS TAURUS ADRENAL GLAND; BOS TAURUS CARTILAGE; BOS TAURUS JOINT CAPSULE; BOS TAURUS LYMPH; BOS TAURUS MESENCHYME; BOS TAURUS PARATHYROID GLAND; BOS TAURUS PLACENTA; BOS TAURUS RED BLOOD CELL; BOS TAURUS SOLAR PLEXUS; BOS TAURUS VEIN; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; CALCITONIN; COLCHICUM AUTUMNALE BULB; EDODEKIN ALFA; ERSOFERMIN; INTERFERON GAMMA-1A; METENKEFALIN; NADIDE; PORK COLLAGEN; PORK LIVER; QUINHYDRONE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA CARTILAGE; SUS SCROFA JOINT CAPSULE; SUS SCROFA LYMPH; SUS SCROFA MESENCHYME; SUS SCROFA PARATHYROID GLAND; SUS SCROFA RED BLOOD CELL; SUS SCROFA SOLAR PLEXUS; SUS SCROFA VEIN	30; 30; 200; 30; 30; 200; 200; 200; 200; 200; 200; 200; 30; 200; 200; 30; 200; 200; 200; 200; 200; 200; 200; 30; 200; 200; 30; 30; 200; 200; 200; 200; 200; 200; 200; 200; 30	[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [hp_Q]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [hp_Q]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL	Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Depigmenting Activity [PE], Dietary Proteins [CS], Dopamine Agonists [MoA], Dopaminergic Agonist [EPC], Increased Histamine Release [PE], Meat Proteins [EXT], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Non-Standardized Food Allergenic Extract [EPC], Vitamin C [EPC]		N	20241231
63776-095_f1ec5ef2-3ea6-fc36-e053-2a95a90af653	63776-095	HUMAN OTC DRUG	Collagen		Pork Collagen	SPRAY	ORAL	20120724		UNAPPROVED HOMEOPATHIC		VIATREXX BIO INCORPORATED	PORK COLLAGEN	200	[kp_C]/mL			N	20241231
63776-165_f1ec571c-8edf-19d8-e053-2995a90a9833	63776-165	HUMAN OTC DRUG	Foods		activated charcoal, ageratina aromatica root, ferrous iodide, gelsemium sempervirens root, calcium sulfide, histamine, interleukin-12 human, interferon gamma-1a, iodine, potassium gluconate, lycopodium clavatum spore, cajuput oil, black currant, rosa canina fruit, serotonin, xanthine, almond, apple, banana, barley, bean, beef, cashew, casein, emmental cultured, casein, lactococcus lactis cultured, casein, lactococcus lactis cultured aged, casein, lactococcus lactis cultured	SPRAY	ORAL	20120724		UNAPPROVED HOMEOPATHIC		VIATREXX BIO INCORPORATED	ACTIVATED CHARCOAL; AGERATINA AROMATICA ROOT; ALMOND; APPLE; ARCHED SWIMMING CRAB, COOKED; BANANA; BARLEY; BEAN; BEEF; BLACK CURRANT; BLUE CRAB; BROWN RICE; CAJUPUT OIL; CALCIUM SULFIDE; CASEIN, EMMENTAL CULTURED; CASEIN, LACTOCOCCUS LACTIS CULTURED; CASEIN, LACTOCOCCUS LACTIS CULTURED, AGED; CASEIN, LACTOCOCCUS LACTIS CULTURED, PENICILLIUM CAMEMBERTI CULTURED, AGED; CASHEW; CHICKEN; COCOA; COCONUT; COD, UNSPECIFIED; COFFEE BEAN; COTTON FIBER; COTTON SEED; COW MILK; DUNGENESS CRAB, COOKED; EGG; EGGPLANT; ENGLISH WALNUT; FERROUS IODIDE; FLAX SEED; GELSEMIUM SEMPERVIRENS ROOT; GREEN BELL PEPPER; HAZELNUT, UNSPECIFIED; HISTAMINE; INTERFERON GAMMA-1A; INTERLEUKIN-12 HUMAN; IODINE; LAMB; LYCOPODIUM CLAVATUM SPORE; ONION; ORANGE; OYSTER, UNSPECIFIED; PEANUT; PECAN; PORK; POTASSIUM GLUCONATE; POTATO; ROSA CANINA FRUIT; SALMON, UNSPECIFIED; SEROTONIN; SERRATED SWIMMING CRAB, COOKED; SHRIMP, UNSPECIFIED; SNOW CRAB, UNSPECIFIED; SOYBEAN; STARCH, RICE; STRAWBERRY; TEA LEAF; TOMATO; TUNA, UNSPECIFIED; WHEAT; WHEAT GLUTEN; WHITE RICE; XANTHINE	30; 30; 30; 30; 30; 30; 30; 30; 30; 1; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 200; 200; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 1; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [hp_X]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [hp_X]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fish Proteins, Dietary [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Fruit Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE]		N	20241231
63776-373_f1ec339b-9183-999d-e053-2995a90ac45a	63776-373	HUMAN OTC DRUG	Neuro 3		oxitriptan, acetylcholinesterase human, choline chloride, dopamine, glutamic acid, glycine, histidine, levodopa, malvin, melanin synthetic (tyrosine, peroxide), nitric oxide, norepinephrine, octopamine, o-methyl serotonin, phenylalanine, serotonin, taurine, tryptophan, tyrosine	SPRAY	ORAL	20120724		UNAPPROVED HOMEOPATHIC		VIATREXX BIO INCORPORATED	5-METHOXYTRYPTAMINE; ACETYLCHOLINESTERASE HUMAN; CHOLINE CHLORIDE; DOPAMINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; LEVODOPA; MALVIN; MELANIN SYNTHETIC (TYROSINE, PEROXIDE); MELATONIN; NITRIC OXIDE; NOREPINEPHRINE; OCTOPAMINE; OXITRIPTAN; PHENYLALANINE; SEROTONIN; TAURINE; TRYPTOPHAN; TYROSINE	200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200; 200	[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Vasodilation [PE], Vasodilator [EPC]		N	20241231
63776-449_f1ec2ae6-64a8-5495-e053-2a95a90af6b2	63776-449	HUMAN OTC DRUG	Radiation		cadmium iodide, fucus vesiculosus, iodine, chondrus crispus, radium bromide, strontium, thyroid, bovine and thyroid, porcine	SPRAY	ORAL	20120724		UNAPPROVED HOMEOPATHIC		VIATREXX BIO INCORPORATED	CADMIUM IODIDE; CHONDRUS CRISPUS; FUCUS VESICULOSUS; IODINE; RADIUM BROMIDE; STRONTIUM; THYROID, BOVINE; THYROID, PORCINE	12; 3; 3; 12; 12; 12; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [kp_C]/mL; [kp_C]/mL			N	20241231
63776-628_f1ec2358-18a0-cfeb-e053-2995a90abe7f	63776-628	HUMAN OTC DRUG	BDNF		Brain-derived Neurotrophic Factor Human	SPRAY	ORAL	20120724		UNAPPROVED HOMEOPATHIC		VIATREXX BIO INCORPORATED	BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN	30	[kp_C]/mL			N	20241231
63783-005_1f7e8380-bc4a-484e-ad19-8400d5c7f369	63783-005	HUMAN PRESCRIPTION DRUG	KIDS CHOICE		STANNOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-006_1f7e8380-bc4a-484e-ad19-8400d5c7f369	63783-006	HUMAN PRESCRIPTION DRUG	KIDS CHOICE		STANNOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-007_1f7e8380-bc4a-484e-ad19-8400d5c7f369	63783-007	HUMAN PRESCRIPTION DRUG	KIDS CHOICE		STANNOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-008_1f7e8380-bc4a-484e-ad19-8400d5c7f369	63783-008	HUMAN PRESCRIPTION DRUG	KIDS CHOICE		STANNOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-009_1f7e8380-bc4a-484e-ad19-8400d5c7f369	63783-009	HUMAN PRESCRIPTION DRUG	KIDS CHOICE		STANNOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-011_71664b66-2cf6-457f-98cb-4ed083a8dba5	63783-011	HUMAN PRESCRIPTION DRUG	DOCTORS CHOICE		STANOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-012_71664b66-2cf6-457f-98cb-4ed083a8dba5	63783-012	HUMAN PRESCRIPTION DRUG	DOCTORS CHOICE		STANNOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-015_1f7e8380-bc4a-484e-ad19-8400d5c7f369	63783-015	HUMAN PRESCRIPTION DRUG	KIDS CHOICE		STANNOUS FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	STANNOUS FLUORIDE	.12	g/120g			N	20241231
63783-210_f4f43eb5-6526-4d1d-864b-f31e6af1e56e	63783-210	HUMAN PRESCRIPTION DRUG	GINGIMED		STANNOUS FLUORIDE	LIQUID	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental	STANNOUS FLUORIDE	.19	g/100g			N	20241231
63783-211_f4f43eb5-6526-4d1d-864b-f31e6af1e56e	63783-211	HUMAN PRESCRIPTION DRUG	GINGIMED		STANNOUS FLUORIDE	LIQUID	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental	STANNOUS FLUORIDE	.19	g/100g			N	20241231
63783-212_f4f43eb5-6526-4d1d-864b-f31e6af1e56e	63783-212	HUMAN PRESCRIPTION DRUG	GINGIMED		STANNOUS FLUORIDE	LIQUID	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental	STANNOUS FLUORIDE	.19	g/100g			N	20241231
63783-400_2a1d770f-d9a7-4980-a1f2-cf4df96d0f40	63783-400	HUMAN OTC DRUG	ORTHO GUARD		SODIUM FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		OTC MONOGRAPH DRUG	M021	Massco Dental A Division of Dunagin Pharmaceuticals	SODIUM FLUORIDE	4.4	mg/10mL			N	20241231
63783-401_2a1d770f-d9a7-4980-a1f2-cf4df96d0f40	63783-401	HUMAN OTC DRUG	ORTHO GUARD		SODIUM FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		OTC MONOGRAPH DRUG	M021	Massco Dental A Division of Dunagin Pharmaceuticals	SODIUM FLUORIDE	4.4	mg/10mL			N	20241231
63783-403_2a1d770f-d9a7-4980-a1f2-cf4df96d0f40	63783-403	HUMAN OTC DRUG	ORTHO GUARD		SODIUM FLUORIDE	GEL, DENTIFRICE	ORAL	19890101		OTC MONOGRAPH DRUG	M021	Massco Dental A Division of Dunagin Pharmaceuticals	SODIUM FLUORIDE	4.4	mg/10mL			N	20241231
63783-500_5e2c9003-948d-4b08-8bdd-fdf3c751cb4c	63783-500	HUMAN PRESCRIPTION DRUG	NEUTRAMAXX 5000 PLUS TURBO		SODIUM FLUORIDE	PASTE	ORAL	20110901		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	SODIUM FLUORIDE	1.1	g/112g			N	20241231
63783-501_22fb5942-a2d6-4f0e-8064-a6012e05f43b	63783-501	HUMAN PRESCRIPTION DRUG	NEUTRAMAXX 5000 TCP		SODIUM FLUORIDE	PASTE, DENTIFRICE	ORAL	20110801		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	SODIUM FLUORIDE	1.1	g/112g			N	20241231
63783-502_75b41669-7d9c-4257-ae94-9e48604b6a48	63783-502	HUMAN PRESCRIPTION DRUG	NEUTRAMAXX 5000	Tri-Calcium Phosphate	SODIUM FLUORIDE	PASTE, DENTIFRICE	ORAL	20110801		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	SODIUM FLUORIDE	1.1	g/112g			N	20241231
63783-504_cb8064d7-2d0f-4860-b794-d90a121761ad	63783-504	HUMAN PRESCRIPTION DRUG	NEUTRA MAXX 5000		SODIUM FLUORIDE	GEL	ORAL	19890101		UNAPPROVED DRUG OTHER		Massco Dental A Division of Dunagin Pharmaceuticals	SODIUM FLUORIDE	1.428	g/120g			N	20241231
63801-107_3ec5aa4b-f1f8-432a-abb1-62cc1f449817	63801-107	HUMAN PRESCRIPTION DRUG	Bensal HP		Salicylic Acid	OINTMENT	TOPICAL	19981001		UNAPPROVED DRUG OTHER		SMG Pharmaceuticals, LLC	SALICYLIC ACID	30	mg/g			N	20241231
63817-123_06d27e26-9804-24e3-e063-6394a90a4260	63817-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130531		UNAPPROVED MEDICAL GAS		Therap-ease Inc.	OXYGEN	99	L/100L			N	20241231
63824-008_04ca59b8-2af1-70bf-e063-6394a90a01e5	63824-008	HUMAN OTC DRUG	Mucinex		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120703		NDA	NDA021282	RB Health (US) LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63824-015_776f2bad-f869-4274-ab93-21850fbbcd1d	63824-015	HUMAN OTC DRUG	Mucinex Fast-Max	Cold, Flu and Sore Throat	acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	SOLUTION	ORAL	20120207		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-017_d2c2b3df-2b3d-4f10-ba77-4299acc23a79	63824-017	HUMAN OTC DRUG	Childrens Mucinex	Multi-Symptom Cold and Fever	acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	SOLUTION	ORAL	20110404	20240215	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63824-019_03afbc5a-a9ca-e823-e063-6394a90a0cb2	63824-019	HUMAN OTC DRUG	Mucinex Fast-Max	DM Max	dextromethorphan hydrobromide and guaifenesin	SOLUTION	ORAL	20120718		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-023_3749160e-0e3b-4c6c-8f36-d9fc7311f78f	63824-023	HUMAN OTC DRUG	Mucinex	Maximum Strength	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021282	RB Health (US) LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63824-041_8d9f4400-2441-44d9-9777-3a62d6dfab92	63824-041	HUMAN OTC DRUG	Mucinex D	Maximum Strength	Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021585	RB Health (US) LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
63824-056_f3a9bb41-e44b-4d87-9133-19841cdfec5e	63824-056	HUMAN OTC DRUG	Mucinex DM		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021620	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-057_a528a930-5a3c-4f9d-85ce-2d560f04b5ca	63824-057	HUMAN OTC DRUG	Mucinex D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021585	RB Health (US) LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
63824-072_03b01536-c65a-83ab-e063-6394a90aaf41	63824-072	HUMAN OTC DRUG	Mucinex DM	Maximum Strength	Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20120626		NDA	NDA021620	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-115_fda3b8df-18c7-c874-e053-6394a90a9e39	63824-115	HUMAN OTC DRUG	Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain and Mucinex Nightshift Sinus		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20220530		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-116_03b03099-3138-db34-e063-6394a90a285c	63824-116	HUMAN OTC DRUG	Mucinex-Sinus Max Severe Congestion and Pain Clear and Cool and Mucinex Nightshift Sinus Clear and Cool		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Triprolidine Hydrochloride	KIT		20190101	20240129	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	
63824-117_fda3bd7d-76b0-ca9b-e053-6394a90a4ec9	63824-117	HUMAN OTC DRUG	Mucinex Fast-Max Severe Congestion and Cough and Mucinex Nightshift Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE	KIT		20190624		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-118_fda3d836-0038-ee77-e053-6394a90ac66b	63824-118	HUMAN OTC DRUG	Mucinex Fast-Max DM Max and Mucinex Nightshift Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Triprolidine Hydrochloride	KIT		20190620		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-119_0a39d28e-d257-cf4b-e063-6294a90a7126	63824-119	HUMAN OTC DRUG	Mucinex Fast-Max Cold, Flu and Sore Throat and Mucinex NightShift Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20190717	20250401	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC						N	
63824-120_e4536185-8c38-45d7-85a5-e6c81656533e	63824-120	HUMAN OTC DRUG	MUCINEX SINUS-MAX	SEVERE CONGESTION RELIEF SINUS and ALLERGY	Oxymetazoline Hydrochloride	SOLUTION	NASAL	20181101		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63824-129_70e6a279-f96d-4d2f-8937-d35269083af4	63824-129	HUMAN OTC DRUG	MUCINEX SINUS-MAX	SEVERE NASAL CONGESTION RELIEF CLEAR and COOL NASAL	Oxymetazoline Hydrochloride	SOLUTION	NASAL	20181001		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63824-137_03b02ba2-b4a3-8fae-e063-6394a90a0355	63824-137	HUMAN OTC DRUG	Mucinex Fast-Max Cold and Flu and Mucinex NightShift Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20190805	20240901	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	
63824-171_04a74259-fbbd-4df7-bcc4-b595eadf2851	63824-171	HUMAN OTC DRUG	Delsym		Dextromethorphan	SUSPENSION, EXTENDED RELEASE	ORAL	20100504		NDA	NDA018658	RB Health (US) LLC	DEXTROMETHORPHAN	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-173_df6b0971-5c43-43cc-8d0b-6d37d964ef87	63824-173	HUMAN OTC DRUG	Delsym (Dextromethorphan)		Dextromethorphan	SUSPENSION, EXTENDED RELEASE	ORAL	20110819		NDA	NDA018658	RB Health (US) LLC	DEXTROMETHORPHAN	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-175_6636ee1b-6c5c-4a0f-8c96-d0f94b0e84fa	63824-175	HUMAN OTC DRUG	Delsym		Dextromethorphan	SUSPENSION, EXTENDED RELEASE	ORAL	20100504		NDA	NDA018658	RB Health (US) LLC	DEXTROMETHORPHAN	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-177_a29b05cd-affb-4ca6-a1d4-aa7fe61df4b7	63824-177	HUMAN OTC DRUG	Delsym (Dextromethorphan)		Dextromethorphan	SUSPENSION, EXTENDED RELEASE	ORAL	20110819		NDA	NDA018658	RB Health (US) LLC	DEXTROMETHORPHAN	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-193_03b06183-12f1-70c5-e063-6294a90a55ac	63824-193	HUMAN OTC DRUG	Mucinex Fast-Max	Severe Congestion and Cough	Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20130315		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-201_0b529799-dc16-0fb8-e063-6294a90aa61f	63824-201	HUMAN OTC DRUG	Mucinex Sinus-Max	Severe Congestion Relief	Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20120723		OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-204_03b0fec4-7077-07c3-e063-6394a90adb9d	63824-204	HUMAN OTC DRUG	Mucinex Sinus-Max	Day Night	Acetaminophen, Diphenhydramine Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride	KIT		20150825	20250619	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	
63824-204_07ee631e-2d9e-eae9-e063-6294a90a20d4	63824-204	HUMAN OTC DRUG	Mucinex Sinus-Max	Day Night	Acetaminophen, Diphenhydramine Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride	KIT		20200601	20240315	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC						N	
63824-212_03b112b6-9e24-31e7-e063-6394a90a662b	63824-212	HUMAN OTC DRUG	Childrens Delsym	Cough Plus Cold Night Time	Acetaminophen, Diphenhydramine Hydrochloride, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20130318		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-213_f5b682aa-a182-09ff-e053-2a95a90ade73	63824-213	HUMAN OTC DRUG	Delsym	Cough Plus Chest Congestion DM	Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20130331		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-214_f5770e3a-85d9-c525-e053-2a95a90a936c	63824-214	HUMAN OTC DRUG	Childrens Delsym	Cough Plus Chest Congestion DM	Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20130331		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-218_f5b5b2d7-230a-a0f0-e053-2995a90aa287	63824-218	HUMAN OTC DRUG	Childrens Delsym Cough Plus Chest Congestion DM and Delsym Cough Plus Cold Night Time		Acetaminophen, Dextromethorphan Hydrobromide, Diphenhydramine Hydrochloride, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20170701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-221_f5b614c0-8eac-a57d-e053-2995a90a6db9	63824-221	HUMAN OTC DRUG	Delsym	Cough Plus Sore Throat	Acetaminophen and Dextromethorphan Hydrobromide	SOLUTION	ORAL	20190701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-223_f5b6422f-53ff-60e0-e053-2995a90a6981	63824-223	HUMAN OTC DRUG	Delsym Nighttime Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and TRIPROLIDINE HYDROCHLORIDE	SOLUTION	ORAL	20200630		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-236_00dd6ee1-ef7d-1e26-e063-6294a90a541f	63824-236	HUMAN OTC DRUG	Mucinex Fast-Max	Congestion and Headache	ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20161001	20240127	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63824-237_ddb95cd7-2d12-3bd6-e053-2995a90a18c7	63824-237	HUMAN OTC DRUG	Mucinex Fast-Max	Cold, Flu and Sore Throat	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20171001		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-241_de2173fc-8879-fa3d-e053-2a95a90adb73	63824-241	HUMAN OTC DRUG	Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20180301		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-242_bd6c8625-1b52-4727-b01f-df46ee8d8870	63824-242	HUMAN OTC DRUG	Maximum Strength Mucinex Sinus-Max Pressure, Pain and Cough		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20180501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-243_ad2405a2-9f9a-4aa8-aa09-7014eff15158	63824-243	HUMAN OTC DRUG	Mucinex Sinus-Max	Severe Congestion and Pain, Maximum Strength	Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20180331		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-250_64100c05-db8f-4750-96df-92bb3fe496d9	63824-250	HUMAN OTC DRUG	Mucinex Sinus-Max	Pressure, Pain and Cough	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20181115		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; ug/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-251_00dd9ad3-cc0a-8588-e063-6294a90aaf14	63824-251	HUMAN OTC DRUG	Mucinex Sinus-Max Day Night		Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride, and Diphenhydramine Hydrochloride	KIT		20181120	20240315	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	
63824-254_fbd15264-3bd6-015a-e053-6294a90abc6a	63824-254	HUMAN OTC DRUG	Childrens Mucinex	Mini-Melts Chest Congestion	Guaifenesin	GRANULE	ORAL	20090324	20240225	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	GUAIFENESIN	100	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
63824-261_043ea5d8-085e-3a4a-e063-6394a90add46	63824-261	HUMAN OTC DRUG	Mucinex Sinus-Max	Severe Congestion Relief	ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20140326	20240901	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63824-266_deab804f-feff-c95c-e053-2995a90af4f6	63824-266	HUMAN OTC DRUG	Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20180301		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-267_043ee8bb-6a96-2040-e063-6294a90ab758	63824-267	HUMAN OTC DRUG	Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain Clear and Cool		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20160701	20240304	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63824-269_f18a9b5d-0d02-54a6-e053-2995a90ade4d	63824-269	HUMAN OTC DRUG	Mucinex Nightshift	Sinus	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	SOLUTION	ORAL	20190615		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-270_cba7424f-1c95-45b2-84ee-997cd89c6449	63824-270	HUMAN OTC DRUG	Mucinex Nightshift	Sinus Clear and Cool	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	SOLUTION	ORAL	20190615		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-278_44e1cdca-d88a-40e1-b788-105ab4746237	63824-278	HUMAN OTC DRUG	Childrens Mucinex	Cold, Cough and Sore Throat	acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	SOLUTION	ORAL	20110419	20240215	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63824-282_07eecd86-52b9-514c-e063-6294a90ab79b	63824-282	HUMAN OTC DRUG	Childrens Mucinex Multi-Symptom Cold		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20120717		OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-284_61dc7407-eefc-41a3-8c90-75a864a67626	63824-284	HUMAN OTC DRUG	Childrens Mucinex Stuffy Nose and Cold		Guaifenesin and Phenylephrine Hydrochloride	SOLUTION	ORAL	20120713	20240215	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	100; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63824-286_24ec5cc3-2b8b-455e-b3ad-63717519166c	63824-286	HUMAN OTC DRUG	Childrens Mucinex	Cough	Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20120713	20240215	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
63824-287_f4c3ad36-72b4-16e8-e053-2a95a90a8702	63824-287	HUMAN OTC DRUG	Childrens Mucinex Multi Symptom Cold and Childrens Mucinex Night Time Multi Symptom Cold		Acetaminophen, Dextromethorphan Hydrobromide, Diphenhydramine Hydrochloride, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20140401		OTC MONOGRAPH FINAL	part341	RB Health (US)						N	20241231
63824-315_00de23e8-4a68-df96-e063-6394a90a34fc	63824-315	HUMAN OTC DRUG	Clearasil Ultra	Daily Face Wash	Salicylic Acid	SOLUTION	TOPICAL	20090820	20240901	OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-318_00de6498-6753-765a-e063-6394a90aea20	63824-318	HUMAN OTC DRUG	Clearasil Ultra	Acne Clearing Scrub	Salicylic Acid	SOLUTION	TOPICAL	20090818	20240901	OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-334_00de7384-6f02-4a12-e063-6294a90ac17a	63824-334	HUMAN OTC DRUG	Clearasil Daily Clear	Daily Pore Cleansing Pads	Salicylic Acid	SWAB	TOPICAL	20110824	20240901	OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-339_00de7ec5-1bbc-d1b6-e063-6394a90a555a	63824-339	HUMAN OTC DRUG	Clearasil Ultra	Overnight Face	Salicylic Acid	LOTION	TOPICAL	20110818	20240901	OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-347_06fd3608-5f62-dbcc-e063-6394a90a38a6	63824-347	HUMAN OTC DRUG	Clearasil Ultra	Acne Plus Marks Spot	Salicylic Acid	LOTION	TOPICAL	20110801	20240901	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-350_04c9489c-bbd7-6f21-e063-6394a90ad393	63824-350	HUMAN OTC DRUG	Clearasil	Daily Clear Oil-Free Daily Face Wash	Salicylic Acid	LOTION	TOPICAL	20120624	20240901	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-351_06fd451b-ef60-137f-e063-6394a90a8a2c	63824-351	HUMAN OTC DRUG	Clearasil	Daily Clear Oil-Free Daily Face Wash Sensitive Formula	Salicylic Acid	LOTION	TOPICAL	20120715	20240901	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-353_06fd3608-5f79-dbcc-e063-6394a90a38a6	63824-353	HUMAN OTC DRUG	Clearasil Ultra	Rapid Action Seal-to-Clear	Salicylic Acid	GEL	TOPICAL	20110721	20240901	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-395_06fd70ae-8e12-90b7-e063-6294a90a0622	63824-395	HUMAN OTC DRUG	Clearasil Ultra	Acne Plus Marks Daily Scrub	Salicylic Acid	LOTION	TOPICAL	20120504	20240901	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC	SALICYLIC ACID	20	mg/mL			N	
63824-415_070e5fa9-2773-5980-e063-6394a90ab320	63824-415	HUMAN OTC DRUG	Clearasil Ultra Rapid Action	Face Wash	Salicylic Acid	LOTION	TOPICAL	20131201	20240901	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-416_070e5f23-ccaf-54f7-e063-6394a90ab027	63824-416	HUMAN OTC DRUG	Clearasil Ultra Rapid Action	Scrub	Salicylic Acid	LOTION	TOPICAL	20131201	20240901	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	
63824-431_e79ef1cf-e0f0-5028-e053-2a95a90a9445	63824-431	HUMAN OTC DRUG	Clearasil Rapid Rescue Deep Treatment Pads		Salicylic Acid	CLOTH	TOPICAL	20171205		OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	.02	g/1			N	20241231
63824-432_f54d43b9-a58b-1f18-e053-2995a90a078d	63824-432	HUMAN OTC DRUG	Clearasil Rapid Rescue Deep Treatment Wash		Salicylic Acid	LOTION	TOPICAL	20171201		OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	20241231
63824-433_d0c9b892-caf7-4982-b692-8353f1a00514	63824-433	HUMAN OTC DRUG	Clearasil Rapid Rescue Spot Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20171206		OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	BENZOYL PEROXIDE	10	g/100g			N	20241231
63824-436_f214c7ce-fa1a-b6e1-e053-2a95a90a24a7	63824-436	HUMAN OTC DRUG	Clearasil Stubborn Acne Control 5in1 Exfoliating Wash		Salicylic Acid	LOTION	TOPICAL	20171205		OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	2	g/100mL			N	20241231
63824-438_7ea592e7-4a0d-4a2a-8ac5-036a5ba14ac8	63824-438	HUMAN OTC DRUG	Clearasil Stubborn Acne Control 5in1 Spot Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20171206		OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	BENZOYL PEROXIDE	10	g/100g			N	20241231
63824-439_e8a50451-c26b-429d-e053-2995a90ade5d	63824-439	HUMAN OTC DRUG	Clearasil Stubborn Acne Control 5in1 Daily Pads		Salicylic Acid	CLOTH	TOPICAL	20171205		OTC MONOGRAPH FINAL	part333D	RB Health (US) LLC	SALICYLIC ACID	.03	g/1			N	20241231
63824-449_07ef001a-c65f-5639-e063-6294a90ab4d3	63824-449	HUMAN OTC DRUG	Clearasil Rapidly Clear Acne Solutions		Salicylic Acid	KIT		20200901	20241231	OTC MONOGRAPH DRUG	M006	RB Health (US) LLC						N	
63824-500_06c23317-c6c2-811e-e063-6294a90af9b1	63824-500	HUMAN OTC DRUG	Maximum Strength Mucinex Fast-Max Night Time Cold and Flu		Acetaminophen, Diphenhydramine Hydrochloride, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20130315	20240901	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
63824-503_e9071387-8850-436c-badc-a087a899e0ac	63824-503	HUMAN OTC DRUG	Mucinex Nightshift	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Triprolidine Hydrochloride	SOLUTION	ORAL	20190615		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-504_e2338cd2-7b44-036c-e053-2a95a90a3517	63824-504	HUMAN OTC DRUG	Mucinex Nightshift Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE	SOLUTION	ORAL	20200601		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-505_fda382f5-4831-2531-e053-6294a90a696b	63824-505	HUMAN OTC DRUG	Maximum Strength Mucinex Fast-Max Cold and Flu and Mucinex NightShift Severe Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20200619		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-509_06c28c1d-f41f-5e16-e063-6294a90a54a0	63824-509	HUMAN OTC DRUG	Mucinex Sinus-Max Pressure, Pain and Cough and Mucinex Sinus-Max Severe Congestion Relief Clear and Cool		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride and Oxymetazoline Hydrochloride	KIT		20200801	20240415	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC						N	
63824-514_b54617d7-fe0f-4128-b016-f902421d33e4	63824-514	HUMAN OTC DRUG	Mucinex Fast-Max	Cold and Flu	Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide	TABLET, FILM COATED	ORAL	20180801		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-515_0b76e5ce-b8a8-f2d5-e063-6394a90a1aa5	63824-515	HUMAN OTC DRUG	Mucinex Fast-Max	Severe Congestion and Cough	Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide	TABLET, FILM COATED	ORAL	20180801		OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-516_06c28dcc-bec2-ebdd-e063-6394a90a6c91	63824-516	HUMAN OTC DRUG	Mucinex Fast-Max	Day Time Cold and Flu and Night Time Cold and Flu	Acetaminophen, Dextromethrophan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Diphenhydramine Hydrochloride	KIT		20181201	20250216	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC						N	
63824-517_06c28dcc-bea8-ebdd-e063-6394a90a6c91	63824-517	HUMAN OTC DRUG	Mucinex Fast-Max	Cold, Flu and Sore Throat	Acetaminophen, Guaifenesin, Phenylephrine Hydrochloride, and Dextromethorphan Hydrobromide	TABLET, COATED	ORAL	20180801	20250901	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63824-518_4c2ebd25-3a82-4589-81c2-2777501db216	63824-518	HUMAN OTC DRUG	Maximum Strength Mucinex Fast-Max Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180728		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-519_deab8320-be58-ae3c-e053-2a95a90a253e	63824-519	HUMAN OTC DRUG	Maximum Strength Mucinex Fast-Max Day Cold and Flu and Night Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20180728		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-527_ecfb5bd2-a4ff-d278-e053-2a95a90a636a	63824-527	HUMAN OTC DRUG	Maximum Strength Mucinex Fast-Max Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20180728		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-535_fd4431ed-6ef9-4a83-b1df-02ba8afb774c	63824-535	HUMAN OTC DRUG	Mucinex Fast-Max DM Max Honey and Berry Flavor		Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20200601		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-536_06c24116-71c1-9803-e063-6294a90ac79d	63824-536	HUMAN OTC DRUG	Mucinex Fast-Max	Congestion and Headache	ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20161001	20250401	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63824-537_8ef9555c-76f8-4392-9c70-5e0336952a0d	63824-537	HUMAN OTC DRUG	Mucinex Fast-Max Chest Congestion Honey and Berry Flavor		Guaifenesin	SOLUTION	ORAL	20200601		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	GUAIFENESIN	400	mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63824-540_06c2459c-fefa-6f53-e063-6394a90a518a	63824-540	HUMAN OTC DRUG	Mucinex Fast-Max	Severe Congestion and Cough	dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	SOLUTION	ORAL	20171101		OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-541_06c24f77-e1ae-4c70-e063-6394a90a23bb	63824-541	HUMAN OTC DRUG	Mucinex Fast-Max	Severe Congestion and Cough Clear and Cool	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20160701	20240907	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63824-548_7a5b190e-5375-4364-8c1d-0c85a70ef776	63824-548	HUMAN OTC DRUG	Maximum Strength Mucinex Fast-Max Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20180728		OTC MONOGRAPH FINAL	part341	RB Health (US)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-558_06c1eb9b-2ed7-1bc3-e063-6394a90a00c2	63824-558	HUMAN OTC DRUG	Mucinex Fast-Max Day Time Severe Congestion and Cough - Mucinex Fast-Max Night Time Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Diphenhydramine Hydrochloride, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20200601	20251214	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC						N	
63824-575_0b52fe45-ebac-2345-e063-6394a90ae873	63824-575	HUMAN OTC DRUG	Maximum Strength Mucinex Fast-Max Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20180728		OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-591_e41aa137-fd0f-fc03-e053-2a95a90a9c4e	63824-591	HUMAN OTC DRUG	Mucinex Fast-Max	Cold, Flu and Sore Throat	Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20150715		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-600_769b4612-265d-433c-8e7b-4703ece1c77f	63824-600	HUMAN OTC DRUG	Childrens Mucinex	Night Time Multi-Symptom Cold	Acetaminophen, Diphenhydramine Hydrochloride, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20130325	20240215	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
63824-670_dfc384cc-8250-4c0b-946a-75c0f9fa0e74	63824-670	HUMAN OTC DRUG	Mucinex Junior	Cold and Flu	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20190401	20240225	OTC MONOGRAPH FINAL	part341	RB Health (US)LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	162.5; 5; 100; 2.5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63824-671_1d3f7456-7311-4f85-b811-2d60c604063a	63824-671	HUMAN OTC DRUG	Mucinex Childrens	Cough and Congestion	dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	TABLET, COATED	ORAL	20190401	20240225	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63824-692_c891b126-ce9e-451d-99ee-03ceb1067289	63824-692	HUMAN OTC DRUG	Mucinex Sinus-Max	Severe Congestion and Pain	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20170701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-693_8df2da2d-294c-45df-9f95-f44817e80275	63824-693	HUMAN OTC DRUG	Mucinex Sinus-Max	Pressure, Pain and Cough	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20170701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-713_065149c7-3edf-b6ee-e063-6394a90a93a7	63824-713	HUMAN OTC DRUG	Cepacol	Extra Strength Sore Throat cherry	Benzocaine and Menthol	LOZENGE	ORAL	20130715		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63824-722_06513e4c-1274-83da-e063-6294a90a62b2	63824-722	HUMAN OTC DRUG	Cepacol	Extra Strength Sore Throat sugar free cherry	Benzocaine and Menthol	LOZENGE	ORAL	20130715	20240901	OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
63824-732_a0c37e76-ac1c-427c-9fbf-3c619c2af98f	63824-732	HUMAN OTC DRUG	Cepacol	Extra Strength Sore Throat honey lemon	Benzocaine and Menthol	LOZENGE	ORAL	20130715		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	15; 2.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63824-744_0650e5e8-1241-6c92-e063-6394a90ac9c0	63824-744	HUMAN OTC DRUG	Cepacol	Extra Strength Sore Throat and Cough	BENZOCAINE and DEXTROMETHORPHAN HYDROBROMIDE	LOZENGE	ORAL	20140505		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-781_0650e5e8-122a-6c92-e063-6394a90ac9c0	63824-781	HUMAN OTC DRUG	Cepacol	Sore Throat	Dyclonine Hydrochloride and Glycerin	LIQUID	ORAL	20110520	20240901	OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	DYCLONINE HYDROCHLORIDE; GLYCERIN	.1; 33	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	
63824-790_eb04d546-a26e-4a25-8b51-a58e3c605a20	63824-790	HUMAN OTC DRUG	Cepacol	Antibacterial	Cetylpyridinium chloride	LIQUID	ORAL	20110622		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	CETYLPYRIDINIUM CHLORIDE	.05	g/100mL			N	20241231
63824-791_0650daef-27a2-391a-e063-6294a90a56d8	63824-791	HUMAN OTC DRUG	Mucinex Fast-Max	Congestion and Headache	ACETAMINOPHEN, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20180801	20250901	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63824-792_0650cf9b-46e8-a375-e063-6294a90a0274	63824-792	HUMAN OTC DRUG	Mucinex Fast Max	Day Time Severe Congestion and Cough and Night Time Cold and Flu	Guaifenesin, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, Acetaminophen, and Diphenhydrmaine Hydrochloride	KIT		20181215	20250216	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	
63824-793_deabbe4b-ef9e-4368-e053-2a95a90a2d24	63824-793	HUMAN OTC DRUG	Mucinex Fast-Max	Night Time Cold and Flu	ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180910		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-810_0b531eba-2bb5-8bae-e063-6294a90a8dca	63824-810	HUMAN OTC DRUG	Lanacane	Maximum Strength Anti-Itch	Benzethonium chloride and Benzocaine	CREAM	TOPICAL	20120928	20250825	OTC MONOGRAPH DRUG	M003	RB Health (US) LLC	BENZETHONIUM CHLORIDE; BENZOCAINE	2; 200	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
63824-851_f214b48d-aaad-415e-e053-2995a90a06c4	63824-851	HUMAN OTC DRUG	Scalpicin	Anti-Itch Maximum Strength	Hydrocortisone	LIQUID	TOPICAL	20121015		OTC MONOGRAPH NOT FINAL	part348	RB Health (US) LLC	HYDROCORTISONE	1	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63824-938_0650be9e-7a4d-a3bf-e063-6294a90a0dd3	63824-938	HUMAN OTC DRUG	Mucinex FreeFrom Cold and Flu Nighttime		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	SOLUTION	ORAL	20200608	20240121	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63824-940_06509e7d-dd51-a2c2-e063-6294a90a3254	63824-940	HUMAN OTC DRUG	Mucinex FreeFrom Cold and Flu Daytime and Mucinex FreeFrom Cold and Flu Nighttime		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20200619	20240215	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	
63824-941_b7b9e9d5-5109-4299-bdf0-7d3d902cc296	63824-941	HUMAN OTC DRUG	Mucinex Childrens	Chest Congestion Mini-Melts Bubble Gum	Guaifenesin	GRANULE	ORAL	20190331	20240225	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	GUAIFENESIN	100	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
63824-942_45ab0502-ae94-434f-a8ef-cbcd47732f6b	63824-942	HUMAN OTC DRUG	Mucinex Childrens	Cough Mini-Melts Orange Creme	Dextromethorphan Hydrobromide and Guaifenesin	GRANULE	ORAL	20190331	20240225	OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
63824-943_a3080d71-61a2-4814-a63e-3fe61121ab26	63824-943	HUMAN OTC DRUG	Mucinex Childrens	Cough and Chest Congestion Mini-Melts Orange Creme	Dextromethorphan Hydrobromide and Guaifenesin	GRANULE	ORAL	20220127		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-944_37958be4-8974-4d55-986b-e525756a1a91	63824-944	HUMAN OTC DRUG	Mucinex Childrens Day Time Multi-Symptom Cold and Mucinex Childrens Night Time Multi-Symptom Cold Triple Pack		Acetaminophen, Diphenylhydramine Hydrochloride, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, and Guaifenesin	KIT		20220525		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-945_f22b1329-53e4-2e11-e053-2a95a90aaffb	63824-945	HUMAN OTC DRUG	Mucinex Childrens FreeFrom Multi-Symptom Cold, Flu and Sore Throat and Mucinex Childrens FreeFrom Multi-Symptom Cold and Flu Nighttime		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20200801		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-946_d12a44d5-0b5b-48ee-93c5-592c4e3112d2	63824-946	HUMAN OTC DRUG	Mucinex Childrens	Cough	Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20180501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63824-947_8125113d-bf37-4d47-9864-304ee2b587a0	63824-947	HUMAN OTC DRUG	Mucinex Childrens Cough and Congestion		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SUSPENSION	ORAL	20180330		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-949_06509e7d-dd28-a2c2-e063-6294a90a3254	63824-949	HUMAN OTC DRUG	Mucinex Childrens Multi-Symptom Cold		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SUSPENSION	ORAL	20180330		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-950_deabee02-d3dd-3165-e053-2995a90abc23	63824-950	HUMAN OTC DRUG	Mucinex Childrens	Night Time Multi-Symptom Cold	ACETAMINOPHEN, Diphenhydramine Hydrochloride, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20180501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-951_00ebb7e4-8722-474b-b66b-fd9e2d58ca0e	63824-951	HUMAN OTC DRUG	Mucinex Childrens	Stuffy Nose and Chest Congestion	Guaifenesin and Phenylephrine Hydrochloride	SOLUTION	ORAL	20180501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	100; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-952_d2cf33a1-0337-4f5f-b0d9-5b516360e5b6	63824-952	HUMAN OTC DRUG	Mucinex Childrens	Multi-Symptom Cold and Sore Throat	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20180501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-954_b5236e71-cf22-4d28-a009-6704633795ee	63824-954	HUMAN OTC DRUG	Mucinex Childrens	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20190401		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-955_deabbc76-0d2a-72db-e053-2995a90a4345	63824-955	HUMAN OTC DRUG	Mucinex Childrens	Day Time Multi-Symptom Cold and Night Time Multi-Symptom Cold	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Acetaminophen, and Diphenhydramine Hydrochloride	KIT		20190121		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-956_1f64f023-32c3-43dd-88d7-f259966fef11	63824-956	HUMAN OTC DRUG	Mucinex Childrens FreeFrom Multi-Symptom Cold and Stuffy Nose		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20200601		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-957_0b534bb5-858c-5ff3-e063-6394a90a0117	63824-957	HUMAN OTC DRUG	Mucinex Childrens FreeFrom Cough and Mucus		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	SOLUTION	ORAL	20200601	20241001	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
63824-958_24e23ded-3bb5-4268-b092-d60f686eba32	63824-958	HUMAN OTC DRUG	Mucinex Childrens FreeFrom Multi-Symptom Cold, Flu and Sore Throat		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SOLUTION	ORAL	20200601		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-959_e7ec13b8-bdf3-49b4-ad45-ddc211e653ab	63824-959	HUMAN OTC DRUG	Mucinex Childrens FreeFrom Multi-Symptom Cold and Flu Nighttime		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	SOLUTION	ORAL	20200601		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	325; 10; 5; 1.25	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63824-960_e0671fd7-2a6e-7916-e053-2995a90abdf0	63824-960	HUMAN OTC DRUG	Mucinex Childrens FreeFrom Multi-Symptom Cold, Flu and Sore Throat and Mucinex Childrens FreeFrom Multi-Symptom Cold and Flu Nighttime		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20200615		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
63824-961_18b24923-8613-451f-b62c-0bdeae626a4d	63824-961	HUMAN OTC DRUG	MUCINEX Childrens Stuffy Nose		Oxymetazoline Hydrochloride	SOLUTION	NASAL	20180330		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63830-221_785f1a4b-8d07-4446-8e9e-ca93535e046a	63830-221	HUMAN OTC DRUG	Sani-Care		ALCOHOL	GEL	TOPICAL	20200716		OTC MONOGRAPH NOT FINAL	part333E	Pro Chem, Inc.	ALCOHOL	.7	mL/mL			N	20241231
63830-457_f210a3ee-1ad5-4832-ae44-b74d14a26a07	63830-457	HUMAN OTC DRUG	SUDS Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20190812		OTC MONOGRAPH NOT FINAL	part333E	Pro Chem, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63830-544_98a93b39-5a0d-490b-8a18-97e4117cf9ea	63830-544	HUMAN OTC DRUG	Ban-Aid		CHLOROXYLENOL	SOAP	TOPICAL	20070201		OTC MONOGRAPH NOT FINAL	part333E	Pro Chem, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
63830-855_04592bcf-e266-4259-b798-ab97c0228414	63830-855	HUMAN OTC DRUG	Prevent		ALCOHOL	LIQUID	TOPICAL	20090901		OTC MONOGRAPH NOT FINAL	part333E	Pro Chem, Incorporated	ALCOHOL	.62	mL/mL			N	20241231
63830-876_f0faa719-7892-40cc-963f-27a971407c55	63830-876	HUMAN OTC DRUG	Suds High Foaming Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170110		OTC MONOGRAPH NOT FINAL	part333E	Pro chem, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
63830-950_dd170cc7-1ff1-70e1-e053-2a95a90ae157	63830-950	HUMAN OTC DRUG	Fresh Start		CHLOROXYLENOL	SOAP	TOPICAL	20220420		OTC MONOGRAPH NOT FINAL	part333E	Pro Chem, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
63833-386_bf67ad30-c0b2-456a-beda-f65ee1830c3f	63833-386	PLASMA DERIVATIVE	Kcentra		PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, Protein C, Protein S Human, and Water	KIT		20130429		BLA	BLA125421	CSL Behring GmbH						N	20241231
63833-387_bf67ad30-c0b2-456a-beda-f65ee1830c3f	63833-387	PLASMA DERIVATIVE	Kcentra		PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, Protein C, Protein S Human, and Water	KIT		20131213		BLA	BLA125421	CSL Behring GmbH						N	20241231
63833-518_5834bcd0-b7c1-4591-8ec7-f0c847c5e428	63833-518	PLASMA DERIVATIVE	Corifact		Factor XIII Concentrate (Human)	KIT		20110217		BLA	BLA125385	CSL Behring GmbH						N	20241231
63833-615_3fefdbbb-c86f-4ed6-b4f0-73bcad062e01	63833-615	PLASMA DERIVATIVE	Humate-P		antihemophilic factor/von willebrand factor complex (human)	KIT		19860501		BLA	BLA103960	CSL Behring GmbH						N	20241231
63833-616_3fefdbbb-c86f-4ed6-b4f0-73bcad062e01	63833-616	PLASMA DERIVATIVE	Humate-P		antihemophilic factor/von willebrand factor complex (human)	KIT		19860501		BLA	BLA103960	CSL Behring GmbH						N	20241231
63833-617_3fefdbbb-c86f-4ed6-b4f0-73bcad062e01	63833-617	PLASMA DERIVATIVE	Humate-P		antihemophilic factor/von willebrand factor complex (human)	KIT		19860501		BLA	BLA103960	CSL Behring GmbH						N	20241231
63833-825_6f3826cd-77fd-4ae0-909c-66a91dbe5f72	63833-825	PLASMA DERIVATIVE	Berinert		HUMAN C1-ESTERASE INHIBITOR	KIT		20111222		BLA	BLA125287	CSL Behring GmbH						N	20241231
63833-828_c53fd34d-f366-4ee5-bbea-88201bf6b7c8	63833-828	PLASMA DERIVATIVE	HAEGARDA	C1 Esterase Inhibitor Subcutaneous (Human)	HUMAN C1-ESTERASE INHIBITOR	KIT		20170622		BLA	BLA125606	CSL Behring GmbH						N	20241231
63833-829_c53fd34d-f366-4ee5-bbea-88201bf6b7c8	63833-829	PLASMA DERIVATIVE	HAEGARDA	C1 Esterase Inhibitor Subcutaneous (Human)	HUMAN C1-ESTERASE INHIBITOR	KIT		20170622		BLA	BLA125606	CSL Behring GmbH						N	20241231
63833-891_c325b4a3-416a-4d83-8839-db48ca304816	63833-891	PLASMA DERIVATIVE	RiaSTAP		FIBRINOGEN HUMAN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20090116		BLA	BLA125317	CSL Behring GmbH	FIBRINOGEN HUMAN	1300	mg/50mL	Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE]		N	20241231
63850-0003_04819dac-e9c5-4d65-b8e4-15a1fd5a93c8	63850-0003	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Tablets	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Natco Pharma Limited	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63850-0004_04819dac-e9c5-4d65-b8e4-15a1fd5a93c8	63850-0004	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Tablets	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Natco Pharma Limited	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63850-0005_67953305-4eb0-4b00-abae-716ac25c5bf9	63850-0005	HUMAN PRESCRIPTION DRUG	Granisetron hydrochloride		Granisetron hydrochloride	TABLET, FILM COATED	ORAL	20090622		ANDA	ANDA078969	Natco Pharma Limited	GRANISETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
63850-0010_605b2a4c-1f1d-473d-a911-133ca46f0538	63850-0010	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100628		ANDA	ANDA079220	Natco Pharma Limited	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
63850-0021_2b77cfd6-ad8a-4cbf-a22c-eb69e7a8548c	63850-0021	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20101017		ANDA	ANDA091630	Natco Pharma Limited	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
63850-0022_2b77cfd6-ad8a-4cbf-a22c-eb69e7a8548c	63850-0022	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20101007		ANDA	ANDA091630	Natco Pharma Limited	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
63850-0025_7917d6e0-df93-4c10-97c9-3d90b00b7bd4	63850-0025	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole	TABLET	ORAL	20110603		ANDA	ANDA200161	Natco Pharma Limited	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
63850-0058_6df3819e-2d45-4030-a4af-6caeccb8a471	63850-0058	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210305		ANDA	ANDA205426	Natco Pharma Limited	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
63850-0059_6df3819e-2d45-4030-a4af-6caeccb8a471	63850-0059	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210305		ANDA	ANDA205426	Natco Pharma Limited	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
63850-0060_6df3819e-2d45-4030-a4af-6caeccb8a471	63850-0060	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210305		ANDA	ANDA205426	Natco Pharma Limited	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
63850-0061_6df3819e-2d45-4030-a4af-6caeccb8a471	63850-0061	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20211001		ANDA	ANDA205426	Natco Pharma Limited	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
63850-0062_ab421697-aaf4-48ac-97b0-1a63cfd71942	63850-0062	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210520		ANDA	ANDA205432	Natco Pharma Limited	EVEROLIMUS	.25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
63850-0063_ab421697-aaf4-48ac-97b0-1a63cfd71942	63850-0063	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210520		ANDA	ANDA205432	Natco Pharma Limited	EVEROLIMUS	.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
63850-0064_ab421697-aaf4-48ac-97b0-1a63cfd71942	63850-0064	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20210520		ANDA	ANDA205432	Natco Pharma Limited	EVEROLIMUS	.75	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
63862-003_eb3c6328-da4d-0ca1-e053-2995a90a7cf3	63862-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19971107		NDA	NDA205866	J & M CYLINDER GASES, INC.	NITROGEN	990	mL/L			N	20241231
63862-004_07dbded4-e1be-ea85-e063-6394a90a8457	63862-004	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19971107		NDA	NDA205865	J & M CYLINDER GASES, INC.	OXYGEN	990	mL/L			N	20241231
63868-002_ee3b0446-97a6-1d86-e053-2995a90a239d	63868-002	HUMAN OTC DRUG	NATURA-LAX		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20140501		ANDA	ANDA090812	Chain Drug Marketing Association	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-003_7e48b8df-7be1-79a5-e053-2991aa0ada8e	63868-003	HUMAN OTC DRUG	Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120724		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-007_b3efb6bb-bf3b-89f6-e053-2995a90a76c7	63868-007	HUMAN OTC DRUG	Quality Choice Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101028		OTC MONOGRAPH FINAL	part358G	Quality Choice	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
63868-015_efcec8ae-9f4c-19b7-e053-2a95a90a39ff	63868-015	HUMAN OTC DRUG	Cold Multi Symptom Daytime Nighttime		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	KIT		20130306		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association						N	20241231
63868-018_2fcf544b-976a-42e1-adda-375a0d7dc452	63868-018	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20191215		OTC MONOGRAPH NOT FINAL	part334	CDMA	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-019_a12b9032-7b40-4868-8fc1-563e0c050e1f	63868-019	HUMAN OTC DRUG	Quality Choice Maximum Strength Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20220802		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-020_a680e425-3049-4a40-8c5a-ca120183ceed	63868-020	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-022_83c6dfc1-0683-4c82-b726-64c1741ef236	63868-022	HUMAN OTC DRUG	Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20151031	20240223	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
63868-025_b1eeea1a-04f8-d205-fe4a-13699ea6bb47	63868-025	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20140401		ANDA	ANDA076502	Chain Drug Marketing Associate	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-026_0c868adb-9999-5c7a-e063-6394a90a6638	63868-026	HUMAN OTC DRUG	Quality Choice Earwax Removal Kit		CARBAMIDE PEROXIDE	LIQUID	TOPICAL	20141127		OTC MONOGRAPH DRUG	M014	Chain Drug Marketing Association, Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
63868-027_0c868adb-99ab-5c7a-e063-6394a90a6638	63868-027	HUMAN OTC DRUG	Quality Choice Earwax Removal Drops		CARBAMIDE PEROXIDE	LIQUID	TOPICAL	20141127		OTC MONOGRAPH DRUG	M014	Chain Drug Marketing Association, Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
63868-029_ccecbdf4-d3ae-49ee-ac6e-49728411f252	63868-029	HUMAN OTC DRUG	Chewable Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	20010904		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-032_0d2318b6-c08f-4f2b-9f1b-903e0f524df3	63868-032	HUMAN OTC DRUG	Menstrual Complete	Maximum Strength	Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63868-034_b73c42e8-358f-47d3-a549-279bc856732b	63868-034	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	CHAIN DRUG MARKETING ASSOCIATION INC	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-035_418c99c7-8fb2-4dac-ba03-08996b97e2e7	63868-035	HUMAN OTC DRUG	Quality Choice Regular Strength Antacid Peppermint	Regular strength Antacid Peppermint	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220718		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
63868-037_af22b6cf-4afb-4a30-9a7b-00c66f3fdce9	63868-037	HUMAN OTC DRUG	Daytime	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20151031	20240223	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-039_5b8753f4-517d-4789-9f38-d2b03bfae583	63868-039	HUMAN OTC DRUG	Adult Tussin Expectorant		GUAIFENESIN	LIQUID	ORAL	20120907		OTC MONOGRAPH DRUG	M012	Chain Drug Marketing Association, Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63868-040_f31cce26-8155-448f-e053-2a95a90ad84b	63868-040	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Remover	PATCH	TOPICAL	20171218		OTC MONOGRAPH FINAL	part358F	Chain Drug Marketing Association	SALICYLIC ACID	40	mg/91			N	20241231
63868-041_f31ccd6a-7802-41ec-e053-2a95a90a2ec0	63868-041	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358F	Chain Drug Marketing Association	SALICYLIC ACID	40	mg/41			N	20241231
63868-042_f31ccd6a-77ff-41ec-e053-2a95a90a2ec0	63868-042	HUMAN OTC DRUG	Salicylic Acid		Medicated Plantar Wart Remover	PATCH	TOPICAL	20171218		OTC MONOGRAPH FINAL	part358B	Chain Drug Marketing Association	SALICYLIC ACID	40	mg/241			N	20241231
63868-045_f31cd6b2-47ef-0cd4-e053-2995a90a1256	63868-045	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171219		OTC MONOGRAPH NOT FINAL	part333A	Chain Drug Marketing Association	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
63868-047_8b8790b9-5e2c-4836-8b4c-cfc46eceb1fb	63868-047	HUMAN OTC DRUG	Quality Choice Chewable Antacid	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH DRUG	M001	Chain Drug Marketing Association	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
63868-048_50be20f9-7d12-4c60-acad-d5ba318102f1	63868-048	HUMAN OTC DRUG	Quality Choice Ultra Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION	CALCIUM CARBONATE	1000	mg/1			N	20241231
63868-049_00f70c02-5cdb-4921-b122-059a7e803096	63868-049	HUMAN OTC DRUG	QC Antacid Calcium	Assorted Berry	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190416		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION INC.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
63868-057_08190d53-3335-9d79-e063-6294a90a48d2	63868-057	HUMAN OTC DRUG	Cherry Antacid Soft Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20150610		OTC MONOGRAPH DRUG	M001	Quality Choice	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
63868-059_0818aeca-40ce-a0a1-e063-6294a90afca5	63868-059	HUMAN OTC DRUG	menthol cough drop		Menthol	LOZENGE	ORAL	20171012		OTC MONOGRAPH DRUG	M012	Chain Drug Marketing Association	MENTHOL	5.4	mg/1			N	20241231
63868-060_0cf4b1c3-dc91-db2f-e063-6394a90ab347	63868-060	HUMAN OTC DRUG	Instant Antiseptic Pain Relief		Camphor 10.8% and Phenol 4.7%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Chain Drug Market Association	CAMPHOR (NATURAL); PHENOL	108; 47	mg/mL; mg/mL			N	20241231
63868-061_0818c2f3-e346-6871-e063-6394a90ad9e1	63868-061	HUMAN OTC DRUG	cherry cough drops		Menthol	LOZENGE	ORAL	20171012		OTC MONOGRAPH DRUG	M012	Chain Drug Marketing Accociation	MENTHOL	5.8	mg/1			N	20241231
63868-062_0818d574-dd83-1943-e063-6394a90a690c	63868-062	HUMAN OTC DRUG	honey lemon cough drops		Menthol	LOZENGE	ORAL	20171012		OTC MONOGRAPH DRUG	M012	Chain Drug Marketing Association	MENTHOL	7.5	mg/1			N	20241231
63868-071_7e48d3d0-248e-c83f-e053-2a91aa0ad6b6	63868-071	HUMAN OTC DRUG	Severe Sinus Congestion and Pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20091113		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-078_4448e633-8341-44aa-8958-fcc87c617648	63868-078	HUMAN OTC DRUG	Quality Choice Fiber Therapy		Methylcellulose	TABLET	ORAL	20220728		OTC MONOGRAPH NOT FINAL	part334	Chain Drug Marketing Association Inc.	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
63868-081_efb701e1-d929-fc03-e053-2995a90ace4f	63868-081	HUMAN OTC DRUG	Severe Cold Head Congestion		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20150930		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-082_7e490b7b-e77c-5917-e053-2991aa0a3d17	63868-082	HUMAN OTC DRUG	Pain Relief	Regular Strength	Acetaminophen	TABLET	ORAL	20140613		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ACETAMINOPHEN	325	mg/1			N	20241231
63868-083_7e490b7b-e78e-5917-e053-2991aa0a3d17	63868-083	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET	ORAL	20140613		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ACETAMINOPHEN	500	mg/1			N	20241231
63868-084_94592969-5251-a13e-e053-2995a90ab182	63868-084	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20140613		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ACETAMINOPHEN	500	mg/1			N	20241231
63868-087_94200b9f-83c6-2484-e053-2995a90af234	63868-087	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20081110		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-088_94599912-bcf5-4193-e053-2995a90a290d	63868-088	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20120827		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ACETAMINOPHEN	500	mg/1			N	20241231
63868-089_5e31330b-4b84-469f-a933-059e77358c79	63868-089	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Chain Drug Marketing Association Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
63868-091_76aae029-5743-4cb2-b497-136c941443ea	63868-091	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Chain Drug Marketing Association Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
63868-095_f1d7ed0a-7c63-5091-e053-2a95a90ab7c3	63868-095	HUMAN OTC DRUG	QC Burn Relief Aloe		Lidocaine HCl	GEL	TOPICAL	20201204		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association Inc	LIDOCAINE HYDROCHLORIDE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63868-097_0d9a5cf8-de3a-bacf-e063-6394a90a761a	63868-097	HUMAN OTC DRUG	Quality Choice Anti-Itch Clear		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Chain Drug Market Association	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63868-098_825a9598-82c0-40d9-85ec-689708dbd7c8	63868-098	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160728		OTC MONOGRAPH FINAL	part332	Chain Drug Marketing Association Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
63868-102_e557a9dd-0160-67f8-e053-2995a90ae7d0	63868-102	HUMAN OTC DRUG	Head Congestion Flu Severe PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220803		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-103_e557b805-ff77-6ac4-e053-2995a90acd99	63868-103	HUMAN OTC DRUG	Head Congestion Mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220803		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-108_09747d73-2810-429b-93fd-1d3fe50ba848	63868-108	HUMAN OTC DRUG	QC Gas Relief	Mint Flavor	Simethicone	TABLET, CHEWABLE	ORAL	20190415		OTC MONOGRAPH DRUG	M002	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
63868-111_0c19d7f4-1e48-51bb-e063-6294a90a8aca	63868-111	HUMAN OTC DRUG	Quality Choice Vapor Steam		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20111102		OTC MONOGRAPH DRUG	M012	Chain Drug Marketing Association, Inc.	CAMPHOR (SYNTHETIC)	.623	g/10mL			N	20241231
63868-112_f956aff6-1d65-4639-81c7-3116c37b777a	63868-112	HUMAN OTC DRUG	Quality Choice Infants Non-staining Gas relief		Simethicone	SOLUTION/ DROPS	ORAL	20220729		OTC MONOGRAPH FINAL	part332	Chain Drug Marketing Association Inc.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
63868-114_11be0aa2-b392-476d-890f-3f891dc8382a	63868-114	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	CHAIN DRUG MARKETING ASSOCIATION INC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63868-117_4a2f71dd-ebb1-4e2d-bb90-99805966335e	63868-117	HUMAN OTC DRUG	Quality Choice Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Chain Drug Marketing Association	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
63868-119_b0a50c3e-f66a-417d-a5eb-cbf89ba470d3	63868-119	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20150531	20250530	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63868-120_f31ccb09-7a98-60af-e053-2995a90a6e97	63868-120	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Pen	LIQUID	TOPICAL	20150901		OTC MONOGRAPH FINAL	part333C	Chain Drug Marketing Association	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
63868-122_923c8ec2-83a7-4978-b27c-3391dade6f09	63868-122	HUMAN OTC DRUG	Quality Choice Extra Strength Antacid Assorted Fruit	Extra Strength Antacid Assorted Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220719		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
63868-124_1289a099-6246-435f-8545-7084a73600e0	63868-124	HUMAN OTC DRUG	Medicated Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20170901		OTC MONOGRAPH NOT FINAL	part348	QUALITY CHOICE (Chain Drug Marketing Association)	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
63868-127_1d56e827-3be8-4191-bf42-f57aa8090a8f	63868-127	HUMAN OTC DRUG	Quality Choice Ultra Strength Antacid assorted Berry	Ultra strength Antacid Assorted berry	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220719		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
63868-128_dc59c25d-3849-4987-9f18-5886f20c3c3b	63868-128	HUMAN OTC DRUG	Dye Free Allergy	childrens	Diphenhydramine Hydrochloride	LIQUID	ORAL	20160229		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-129_0c998343-20d9-44a6-b2cd-dd1a688e54f6	63868-129	HUMAN OTC DRUG	Dye Free Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20160229	20250228	OTC MONOGRAPH NOT FINAL	part343	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN	160	mg/5mL			N	
63868-130_029e8f2c-ffe5-48ba-8969-a2d69abebd60	63868-130	HUMAN OTC DRUG	QC Regular Strength		Antacid	TABLET, CHEWABLE	ORAL	20220715		OTC MONOGRAPH DRUG	M001	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	CALCIUM CARBONATE	500	mg/1			N	20241231
63868-132_2f9f8dc0-8034-445c-b7b0-bf680a6be979	63868-132	HUMAN OTC DRUG	Quality Choice Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	Chain Drug Marketing Association Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-134_2b8e38c4-06f1-438f-80c1-30265a85f9c3	63868-134	HUMAN OTC DRUG	Regular Strength Antacid Antigas		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20220728		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-135_3db1b4d4-0073-41d6-a1ca-577a323da0d3	63868-135	HUMAN OTC DRUG	Stool Softener	Stimulant laxative	docusate sodium and sennosides	TABLET	ORAL	20151130	20240531	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
63868-136_e0359274-3327-46b0-a46c-1f2999a111bf	63868-136	HUMAN OTC DRUG	Quality Choice Regular Strength Antacid	Regular strength Antacid	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220817		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
63868-139_d357d8bf-bd25-49d7-8b06-b20f2738914c	63868-139	HUMAN OTC DRUG	All Day Allergy		Cetirizine HCl	CAPSULE	ORAL	20160430	20240531	NDA	NDA022429	QUALITY CHOICE (Chain Drug Marketing Association)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63868-140_d8f12543-2d14-4b78-84dc-18cc2ac61485	63868-140	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20160331		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-141_fb214245-0f46-4fab-a24e-5261d6b07252	63868-141	HUMAN OTC DRUG	Fexofenadine HCl		Fexofenadine HCl	TABLET	ORAL	20160331	20250331	ANDA	ANDA079112	QUALITY CHOICE (Chain Drug Marketing Association)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63868-143_4cc7999a-1c1f-49a9-af68-4ad045f3496a	63868-143	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	Chain Drug Marketing Association Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63868-144_fda3ac00-9a38-4bcf-b884-70e9da753637	63868-144	HUMAN OTC DRUG	Nasal Decongestant PE	Non-Drowsy Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION INC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
63868-147_d10cf67e-c8f2-4b89-be48-753073339543	63868-147	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	19930111		OTC MONOGRAPH NOT FINAL	part333A	C.D.M.A.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
63868-148_d0718695-5405-db6a-e053-2995a90ac591	63868-148	HUMAN OTC DRUG	Maximum Strength Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210917		ANDA	ANDA213420	CHAIN DRUG MARKETING ASSOCIATION INC	GUAIFENESIN	1200	mg/1			N	20241231
63868-149_d07197cb-9b4f-82f5-e053-2995a90a1e3b	63868-149	HUMAN OTC DRUG	12 Hour Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210917		ANDA	ANDA213420	CHAIN DRUG MARKETING ASSOCIATION INC	GUAIFENESIN	600	mg/1			N	20241231
63868-151_08f2bf78-eba5-41ce-bcb0-733e2760d44b	63868-151	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20030819		ANDA	ANDA076134	Chain Drug Marketing Association Inc.	LORATADINE	10	mg/1			N	20241231
63868-153_db4e6f97-06c6-49f0-b882-aae6602d785b	63868-153	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH FINAL	part344	CDMA	ISOPROPYL ALCOHOL	924	mg/mL			N	20241231
63868-155_ec729051-72d3-4d1a-8e39-d4495d5c1cf3	63868-155	HUMAN OTC DRUG	Quality Choice Extra Strength Assorted Berry Antacid	Extra strength Assorted Berry Antacid	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220815		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
63868-161_8b251abf-b836-4d9e-9db3-f2729b83427e	63868-161	HUMAN OTC DRUG	Quality Choice Ultra Strength Antacid Assorted Fruit	Ultra strength Assorted Fruit Antacid	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220816		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
63868-162_eb902b4c-1470-4313-b9de-ece16aec5496	63868-162	HUMAN OTC DRUG	Quality Choice Extra Strength Gas Relief Cherry		Simethicone	TABLET, CHEWABLE	ORAL	20220815		OTC MONOGRAPH FINAL	part332	Chain Drug Marketing Association Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
63868-163_4a8bf560-81f6-4a53-ab35-60571ada2a39	63868-163	HUMAN OTC DRUG	Travel Ease		Meclizine HCl	TABLET, CHEWABLE	ORAL	20020529		OTC MONOGRAPH DRUG	M009	CHAIN DRUG MARKETING ASSOCIATION INC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
63868-166_1471c8af-297d-40ec-bea5-a710fb4191d5	63868-166	HUMAN OTC DRUG	CDMA Fiber Therapy		Methylcellulose	TABLET	ORAL	20190419		OTC MONOGRAPH DRUG	M007	CHAIN DRUG MARKETING ASSOCIATION	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
63868-167_217f0271-e0e9-4cb0-a1d0-c5298788bd82	63868-167	HUMAN OTC DRUG	Nicotine Polacrilex		Nicoitne Polacrilex	GUM, CHEWING	BUCCAL	20160701	20250701	ANDA	ANDA078697	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-168_217f0271-e0e9-4cb0-a1d0-c5298788bd82	63868-168	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20160701	20250701	ANDA	ANDA078699	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-169_b42321dd-efe7-4309-8f94-4a467c3253c2	63868-169	HUMAN OTC DRUG	Fiber Therapy		Calcium polycarbophil	TABLET	ORAL	20220815		OTC MONOGRAPH NOT FINAL	part334	Chain Drug Marketing Association Inc.	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
63868-171_c4e80aee-4c38-434d-90d8-7f4bfa891d49	63868-171	HUMAN OTC DRUG	QC Pink Bismuth		Bismuth Subsalicylate	TABLET, FILM COATED	ORAL	20190415		OTC MONOGRAPH DRUG	M008	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
63868-172_fbc0ca4e-3eb7-9806-e053-6294a90a5b97	63868-172	HUMAN OTC DRUG	Quality Choice	Natural White	Fluoride	PASTE, DENTIFRICE	DENTAL	20110120		OTC MONOGRAPH NOT FINAL	part356	CHAIN DRUG MARKETING ASSOCIATION INC	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
63868-173_d7e6ece9-559a-4090-ac17-d6c936e3bf3f	63868-173	HUMAN OTC DRUG	Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20220815		OTC MONOGRAPH FINAL	part331	Chain Drug Marketing Association Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-174_79704be8-4c3c-4ad7-9ccb-1890edc4e4cf	63868-174	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	SUSPENSION	ORAL	20141031		OTC MONOGRAPH NOT FINAL	part343	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN	160	mg/5mL			N	20241231
63868-176_0e1f7541-f4fc-4e24-8ed1-574916225606	63868-176	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	SUSPENSION	ORAL	20150430	20240430	OTC MONOGRAPH NOT FINAL	part343	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN	160	mg/5mL			N	
63868-177_463e67c9-c716-f8d1-ce2a-367abdb1c9d6	63868-177	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160101		ANDA	ANDA078878	Chain Drug Marketing Association	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63868-179_af8be832-764a-4dcd-8b38-199a02b9352a	63868-179	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine Maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170331		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION INC	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-180_f31cc455-e1fb-57c1-e053-2a95a90af845	63868-180	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Powder Spray Talc Free	AEROSOL, POWDER	TOPICAL	20171219		OTC MONOGRAPH FINAL	part333C	Chain Drug Marketing Association	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63868-181_f31c781e-3c34-491c-e053-2a95a90a0bbd	63868-181	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20171219		OTC MONOGRAPH FINAL	part333C	Chain Drug Marketing Association	TOLNAFTATE	1.3	g/130g			N	20241231
63868-184_09c4ced0-3a79-926e-e063-6294a90af6c1	63868-184	HUMAN OTC DRUG	Quality Choice Hydrogen Peroxide Wipes		HYDROGEN PEROXIDE	CLOTH	TOPICAL	20200901		OTC MONOGRAPH DRUG	M003	Chain Drug Marketing Association, Inc.	HYDROGEN PEROXIDE	.03	mL/mL			N	20241231
63868-185_09c4ced0-3a88-926e-e063-6294a90af6c1	63868-185	HUMAN OTC DRUG	Quality Choice Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20190315		OTC MONOGRAPH DRUG	M003	Chain Drug Marketing Association, Inc.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
63868-186_fe0cd756-807c-4812-8c23-06f5636b8a53	63868-186	HUMAN OTC DRUG	Non-Aspirin	childrens	acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN	160	mg/1			N	20241231
63868-187_943ba4da-4ac2-4c34-ba79-8a37d980c7b8	63868-187	HUMAN OTC DRUG	Quality Choice Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		Chain Drug Marketing Association	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
63868-198_d353be3c-4a6d-4c33-b443-1a5fe60a7531	63868-198	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20100701		ANDA	ANDA074164	QUALITY CHOICE (Chain Drug Marketing Association)	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63868-209_a62103eb-0105-4269-a250-0c26892fa2c6	63868-209	HUMAN OTC DRUG	Womens Laxative		Bisacodyl	TABLET	ORAL	20140831	20240531	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63868-210_e1dcac61-3ba0-454c-8b2d-f2565a88eb70	63868-210	HUMAN OTC DRUG	Acetaminophen PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-213_caa210bd-4cb4-4a00-9322-7bb19d674084	63868-213	HUMAN OTC DRUG	Severe sinus Congestion Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170713		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-214_43d7d0aa-f0e9-46c0-8b0a-a90c8c6841b9	63868-214	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20101228		OTC MONOGRAPH NOT FINAL	part356	Chain Drug Manufacturing Assn	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63868-217_c4101390-7cac-4e6d-898c-a2a7c72b9be0	63868-217	HUMAN OTC DRUG	Regular Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20170713		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
63868-219_2f636d9f-b674-48c8-9903-89fc51187397	63868-219	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170713		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-220_4bd4ebf5-521b-4fd1-b614-137d8aa5b5c9	63868-220	HUMAN OTC DRUG	COLD FLU and SORE THROAT RELIEF		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170713		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-222_52e5aec2-ebdb-4096-bb67-b96772571fd1	63868-222	HUMAN OTC DRUG	Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20170713		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-223_0d2a90b7-c121-a9a4-e063-6294a90a15ef	63868-223	HUMAN OTC DRUG	Quality Choice Artificial Tears		polyvinyl alcohol, povidone	SOLUTION/ DROPS	OPHTHALMIC	20190726		OTC MONOGRAPH DRUG	M018	Chain Drug Marketing Association, Inc.	POLYVINYL ALCOHOL; POVIDONE	500; 600	mg/100mL; mg/100mL			N	20241231
63868-227_00c43c28-853e-49ec-9694-f293cca36c2d	63868-227	HUMAN OTC DRUG	Severe Sinus Congestion Allergy and Cough Formula		Acetaminophen, Dextromethorphan hydrobromide , Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170713		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-228_c1bd1d54-3887-7ca5-e053-2995a90a3f42	63868-228	HUMAN OTC DRUG	Quality Choice Effervescent Cold Relief Plus		Aspirin, Chlorpheniramine maleate, and Phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20140101		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-229_f03090fa-f7e8-f53a-e053-2a95a90aa819	63868-229	HUMAN OTC DRUG	Quality Choice Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20140305		OTC MONOGRAPH FINAL	part343	Chain Drug Marketing Association	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-230_0cf49768-1bb7-199c-e063-6294a90a2fc3	63868-230	HUMAN OTC DRUG	Quality Choice Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Chain Drug Market Association	POVIDONE-IODINE	100	mg/mL			N	20241231
63868-234_e067e06d-4a52-4ae5-8c6e-26b8e4a1c9dd	63868-234	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20160831		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-235_600dbf7e-2378-4357-b0a8-d6928a66695a	63868-235	HUMAN OTC DRUG	Mucus Relief DM Max	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20160331		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-236_a66895f1-4686-4b32-aac2-cb940cdf19f7	63868-236	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20160331	20250131	OTC MONOGRAPH DRUG	M016	QUALITY CHOICE (Chain Drug Marketing Association)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
63868-238_7e957631-97ae-a38f-e053-2a91aa0ad7a7	63868-238	HUMAN OTC DRUG	Cold and Flu Severe Daytime and Nighttime		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20170901		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC.						N	20241231
63868-239_d3d7df4b-98d5-4d99-bb6c-b7a30f6b3929	63868-239	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170823		ANDA	ANDA206568	Chain Drug Marketing Association Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-241_0b0ffff7-e11b-43c8-a610-5e4aca9d7511	63868-241	HUMAN OTC DRUG	Dibromm Cold and Allergy	Childrens	Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20150731		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-242_fe7d12e1-ecd5-401f-ad58-1edf6d9b3e9b	63868-242	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20171001	20241001	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM	100	mg/1			N	
63868-244_20c45152-af6b-486d-b082-119c5d350769	63868-244	HUMAN OTC DRUG	Tussin CF	Non Drowsy	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20140630	20241231	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-259_77ae462c-38b6-4b2f-b0cf-3b6a168d0c4a	63868-259	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20141015		ANDA	ANDA074165	QUALITY CHOICE (Chain Drug Marketing Association)	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63868-260_b4e1fe4a-b0d9-ba31-e053-2a95a90a3692	63868-260	HUMAN OTC DRUG	Itch Stopping		Diphenhydramine HCl	GEL	TOPICAL	20140514		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association	DIPHENHYDRAMINE HYDROCHLORIDE	2	g/100g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-266_66aef678-3c76-4bfd-8f43-16016337d5e1	63868-266	HUMAN OTC DRUG	Chocolated Laxative		Sennosides Stimulant Laxative	TABLET, CHEWABLE	ORAL	20140101		OTC MONOGRAPH NOT FINAL	part334	C.D.M.A., Inc.	SENNOSIDES	15	mg/1			N	20241231
63868-267_ac200f17-cfbd-4bd6-a2cc-a64d8040887c	63868-267	HUMAN OTC DRUG	Vapor Inhaler		Levmetamfetamine Nasal Decongestant	INHALANT	NASAL	20140101		OTC MONOGRAPH FINAL	part341	C.D.M.A., Inc.	LEVMETAMFETAMINE	50	mg/1			N	20241231
63868-268_d07197cb-9b39-82f5-e053-2995a90a1e3b	63868-268	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20210531		ANDA	ANDA079174	CHAIN DRUG MARKETING ASSOCIATION INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-271_f7e3d751-a47b-2bca-e053-6394a90a6541	63868-271	HUMAN OTC DRUG	QC Scar		Allantoin 0.5%	GEL	TOPICAL	20210816		OTC MONOGRAPH FINAL	part347	CDMA	ALLANTOIN	.5	g/100g			N	20241231
63868-280_b09d4aeb-0644-4001-e053-2995a90a52fc	63868-280	HUMAN OTC DRUG	Antiseptic Skin Cleanser	Exidine-2 CHG	CHLORHEXIDINE GLUCONATE	SOLUTION	TOPICAL	20160701		NDA	NDA019422	Quality Choice	CHLORHEXIDINE GLUCONATE	2	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
63868-281_2365a842-2673-4a8c-91bc-aa12445fb1af	63868-281	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170713		ANDA	ANDA206568	Chain Drug Marketing Association Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-282_0c00ce56-67e2-c716-e063-6294a90a52eb	63868-282	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20120320		OTC MONOGRAPH DRUG	M007	Chain Drug Marketing Association Inc.	GLYCERIN	1.2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
63868-283_0c006801-5c15-68ae-e063-6294a90aa1b5	63868-283	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20120315		OTC MONOGRAPH DRUG	M007	Chain Drug Marketing Association Inc.	GLYCERIN	2.1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
63868-287_44606e24-f5fa-4a10-be7f-89d5b7d03e13	63868-287	HUMAN OTC DRUG	Zinc Cold Therapy		ZINC GLUCONATE	TABLET	ORAL	20180501		UNAPPROVED HOMEOPATHIC		Chain Drug Manufacturing Assn	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63868-291_f726f3c9-de7d-4e51-a6a9-8e8050fd7727	63868-291	HUMAN OTC DRUG	Quality Choice Severe Cold and Cough Nighttime		ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20180716		OTC MONOGRAPH DRUG	M012	Chain Drug Manufacturing Assn	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-292_92d4b62c-baef-4972-bb92-e64e599a43ff	63868-292	HUMAN OTC DRUG	Cough Relief	Nighttime	Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20180731		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-296_e931042a-1be2-4c87-9fa6-65a629addd4d	63868-296	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20180831		OTC MONOGRAPH DRUG	M007	QUALITY CHOICE (Chain Drug Marketing Association)	SENNOSIDES	25	mg/1			N	20241231
63868-297_fc68f269-9196-4d40-844c-959733d9d7df	63868-297	HUMAN OTC DRUG	Quality Choice Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190815		UNAPPROVED DRUG OTHER		Chain Drug Marketing Association	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
63868-298_f31cbcb8-43ca-b5a6-e053-2995a90a9fca	63868-298	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20151001		OTC MONOGRAPH FINAL	part358B	Chain Drug Marketing Association Inc.	SALICYLIC ACID	.17	g/9.8mL			N	20241231
63868-299_f31cce26-8151-448f-e053-2a95a90ad84b	63868-299	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20151001		OTC MONOGRAPH FINAL	part358B	Chain Drug Marketing Association Inc.	SALICYLIC ACID	.17	g/9mL			N	20241231
63868-300_d7504e12-51c8-403c-90d6-31d45ee3ad6a	63868-300	HUMAN OTC DRUG	Gas Relief	Extra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190930	20250930	OTC MONOGRAPH FINAL	part347	QUALITY CHOICE (Chain Drug Marketing Association)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
63868-304_36ebec55-11ab-466e-ab52-e5089343eb4d	63868-304	HUMAN OTC DRUG	QC Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20190416		OTC MONOGRAPH DRUG	M008	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63868-305_9096c168-da67-4559-a31a-f61809c68e42	63868-305	HUMAN OTC DRUG	QC Stomach Relief	Cherry Flavor	Bismuth Subsalicylate	SUSPENSION	ORAL	20190415		OTC MONOGRAPH DRUG	M008	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63868-306_dafeb1ee-93a3-476d-aa30-6cc86a71d9c8	63868-306	HUMAN OTC DRUG	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE		CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	PELLET	ORAL	20210801		UNAPPROVED HOMEOPATHIC		CHAIN DRUG MARKETING ASSOCIATION INC.	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
63868-308_c9351a5f-6cc8-4b47-9aa3-5e0cab0b67a0	63868-308	HUMAN OTC DRUG	2-Count HEAT PATCHES		CAPSAICIN	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	QUALITY CHOICE (Chain Drug Marketing Association)	CAPSAICIN	.025	g/100g			N	20241231
63868-309_c961b5cd-dbd9-da07-e053-2995a90af70a	63868-309	HUMAN OTC DRUG	QUALITY CHOICE PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part348	QUALITY CHOICE (Chain Drug Marketing Association)	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63868-310_097f89f6-ab89-7014-e063-6294a90a6799	63868-310	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20140401		OTC MONOGRAPH DRUG	M007	Chain Drug Marketing Association	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-316_ee299f62-f505-5e30-e053-2995a90a3c41	63868-316	HUMAN OTC DRUG	Migraine Relief		ACETAMINOPHEN, ASPIRIN and CAFFEINE	TABLET	ORAL	20220505		ANDA	ANDA214039	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63868-317_0cf4bfe6-384e-e836-e063-6394a90ab8c3	63868-317	HUMAN OTC DRUG	Quality Choice Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Chain Drug Market Association	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63868-318_05b3b03d-631c-4ce3-be9a-acafdce4a09f	63868-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20190825		OTC MONOGRAPH NOT FINAL	part356	CDMA	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63868-322_0cf4bcc4-fa02-3d44-e063-6294a90ad7ff	63868-322	HUMAN OTC DRUG	Quality Choice Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Chain Drug Market Asociation	CASTOR OIL	1	mg/mL			N	20241231
63868-325_0918f6d4-ae31-6f3b-e063-6394a90a1f2f	63868-325	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20071108		OTC MONOGRAPH DRUG	M013	Chain Drug Marketing Association	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-330_0cf49a57-812c-2985-e063-6294a90aa887	63868-330	HUMAN OTC DRUG	Quality Choice Iodine Tincture Mild		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	19790101		OTC MONOGRAPH DRUG	M003	Chain Drug Market Association	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
63868-331_0cf4bfe6-384f-e836-e063-6394a90ab8c3	63868-331	HUMAN OTC DRUG	Quality Choice Iodides Tincture		Ethyl Alcohol	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Chain Drug Market Association	ALCOHOL	.45	mL/mL			N	20241231
63868-332_b6d8d6a4-ce85-4f42-967a-5fe3c1fc9341	63868-332	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20210702		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-333_c4c83e77-b9d8-47ac-8813-ba4412f02a92	63868-333	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	20210708		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION INC	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-334_cb698988-2d8c-e15d-e053-2a95a90a5ec4	63868-334	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210706		ANDA	ANDA211075	CHAIN DRUG MARKETING ASSOCIATION INC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-338_0ea72333-af5b-8141-e063-6294a90afe55	63868-338	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Chain Drug Marketing Association Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
63868-339_9f3723f1-cec3-4fc8-a8fc-10fc29b7f2a5	63868-339	HUMAN OTC DRUG	QC Anti Diarrheal	Vanilla Regular Flavor	Bismuth subsalicylate	SUSPENSION	ORAL	20190416		OTC MONOGRAPH DRUG	M008	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	BISMUTH SUBSALICYLATE	262	mg/15mL			N	20241231
63868-348_0551f7f6-c973-4882-bcb8-e9b1971057e8	63868-348	HUMAN OTC DRUG	Quality Choice	Fiber Laxative	Psyllium Husk	CAPSULE	ORAL	20190418		OTC MONOGRAPH DRUG	M007	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	PSYLLIUM HUSK	.52	g/1			N	20241231
63868-352_5a422ee0-d6b0-48df-b864-ec59bf22bcc7	63868-352	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-354_d0adac1f-d537-4785-8d59-169c59d597f8	63868-354	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, COATED	ORAL	20140731	20240223	OTC MONOGRAPH NOT FINAL	part343	QUALITY CHOICE (Chain Drug Marketing Association)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
63868-363_240edb3a-dd24-429f-b113-b702dd66ee3a	63868-363	HUMAN OTC DRUG	Aspirin	Enteric Coated	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-369_732a7a25-b7a9-43f3-acb1-e6ff4dc68e6e	63868-369	HUMAN OTC DRUG	Triacting Daytime Cold Cough	Childrens	Dextromethorphan HBr, Phenylephrine HCl	SYRUP	ORAL	20140530	20240530	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	5; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-370_d17e7722-ba3b-480f-982e-bbf7127122f8	63868-370	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine Hydrochloride	LIQUID	ORAL	20140530		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-373_941f9db2-1b56-a2bc-e053-2995a90a18b0	63868-373	HUMAN OTC DRUG	Aspirin 81 mg		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20140613		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-376_0d2a8ad3-bddc-ab01-e063-6294a90aeb6c	63868-376	HUMAN OTC DRUG	Quality Choice Eye Drops Moisturizing Relief		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline HCl	SOLUTION	OPHTHALMIC	20200105		OTC MONOGRAPH DRUG	M018	Chain Drug Marketing Association, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
63868-380_6afc2d36-2280-4596-b2ac-adda2d44f2f5	63868-380	HUMAN OTC DRUG	QUALITY CHOICE SINGLE SALINE	LAXATIVE	SODIUM PHOSPHATE, DIBASIC and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20100601		OTC MONOGRAPH NOT FINAL	part334	CDMA	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
63868-393_66ff5875-a8f9-4dd9-83d1-5fc166c02788	63868-393	HUMAN OTC DRUG	Unisom SleepMelts Nighttime Sleep-Aid		Diphenhydramine Hydrochloride	TABLET, CHEWABLE	ORAL	20190107		OTC MONOGRAPH DRUG	M010	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-394_e0f7d67d-8b00-43ee-b8d8-c093f905d9dd	63868-394	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20180831	20241227	OTC MONOGRAPH FINAL	part338	QUALITY CHOICE (Chain Drug Marketing Association)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63868-395_3af215a1-c16f-4753-8f4c-480f026fab43	63868-395	HUMAN OTC DRUG	Quality Choice Medicated Pads		Witch Hazel	CLOTH	TOPICAL	20210512		OTC MONOGRAPH FINAL	part346	QUALITY CHOICE (Chain Drug Marketing Association)	WITCH HAZEL	.0086	g/1			N	20241231
63868-396_3ec7e573-e787-45fc-882c-ddc8d9a107cc	63868-396	HUMAN OTC DRUG	QUALITY CHOICE Medicated Wipes		Witch Hazel	CLOTH	TOPICAL	20210728		OTC MONOGRAPH FINAL	part346	QUALITY CHOICE (Chain Drug Marketing Association)	WITCH HAZEL	50	g/100mL			N	20241231
63868-400_78034a7d-a32f-f004-3225-5e05fbfb9ad8	63868-400	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20171213	20240430	ANDA	ANDA208150	Chain Drug Marketing Association	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
63868-407_a0d31e7e-9380-4515-bb05-54410d27f3e2	63868-407	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20180831	20241227	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-408_0cf4bd66-6c92-b631-e063-6294a90af55c	63868-408	HUMAN OTC DRUG	Quality Choice Instant Ear Dry		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20200128		OTC MONOGRAPH DRUG	M014	Chain Drug Manufacturing Association	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
63868-409_e02555b9-57db-41bd-9da1-d0a4c601bd5d	63868-409	HUMAN OTC DRUG	Cold and Flu Relief	Daytime	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-411_cda83d4d-e630-4708-aafd-495681a3f2b7	63868-411	HUMAN OTC DRUG	Naproxen PM		Naproxen Sodium	TABLET	ORAL	20190131	20250601	ANDA	ANDA209726	QUALITY CHOICE (Chain Drug Marketing Association)	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63868-414_67979878-1de4-4f50-b2cb-0bfed40faa89	63868-414	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20210415		ANDA	ANDA075209	QUALITY CHOICE (Chain Drug Marketing Association)	LORATADINE	10	mg/1			N	20241231
63868-415_08584e96-a2ef-4f1c-b6df-71b700b27d42	63868-415	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCL	CAPSULE	ORAL	20191227		OTC MONOGRAPH FINAL	part338	QUALITY CHOICE (Chain Drug Marketing Association)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-417_88896529-1fc7-4c36-ad96-ce99949a4188	63868-417	HUMAN OTC DRUG	Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20180831	20241227	OTC MONOGRAPH DRUG	M012	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
63868-418_39f5091a-d7ed-43f6-b631-ca410cbf29ad	63868-418	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190830		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-420_01f80cbb-3c3f-738f-e063-6394a90a5ed4	63868-420	HUMAN OTC DRUG	Quality Choice Anti-itch Medicated		Calamine and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	CHAIN DRUG MARKETING ASSOCIATION INC	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63868-425_e4c110bb-f074-7ed2-e941-8bf681a2a30d	63868-425	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180706		ANDA	ANDA207673	CHAIN DRUG MARKETING ASSOCIATION INC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63868-427_f05f2b96-79d6-6c12-e053-2a95a90a80c9	63868-427	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200716		ANDA	ANDA078682	CHAIN DRUG MARKETING ASSOCIATION INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-428_b837984a-f112-4a43-bdc7-bc3374baad61	63868-428	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190716		ANDA	ANDA078682	CHAIN DRUG MARKETING ASSOCIATION INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-429_236ccaaa-8eea-b6c0-575c-d3de258b751a	63868-429	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190913		ANDA	ANDA202194	Chain Drug Marketing Association	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63868-430_16b17be2-f5bc-48bd-a5a0-91e22a6de261	63868-430	HUMAN OTC DRUG	Childrens Allergy		Cetirizine HCl	LIQUID	ORAL	20141231	20240531	ANDA	ANDA090474	QUALITY CHOICE (Chain Drug Marketing Association)	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63868-432_cee35bd7-dd9c-42b0-81ab-00fbc479f884	63868-432	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180630	20240223	ANDA	ANDA207235	QUALITY CHOICE (Chain Drug Marketing Association)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63868-433_f0fec7d5-f90e-753c-e053-2a95a90a3aeb	63868-433	HUMAN OTC DRUG	All Day Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20190125		NDA	NDA022429	CHAIN DRUG MARKETING ASSOCIATION INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-439_8e08a0dc-d9d0-462e-81bf-e9dd8d821541	63868-439	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20211005		OTC MONOGRAPH NOT FINAL	part333A	CDMA	ALCOHOL	.7	mL/mL			N	20241231
63868-451_dc792777-d8b5-3ebc-e053-2a95a90abc3f	63868-451	HUMAN OTC DRUG	Lidocaine HCl 4%		Lidocaine HCl 4%	OINTMENT	TOPICAL	20201028		OTC MONOGRAPH NOT FINAL	part348	CHAIN DRUG MARKETING ASSOCIATION INC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63868-458_fc61822a-3fbb-343c-e053-6294a90af72c	63868-458	HUMAN OTC DRUG	Ichthammol 20%		Ichthammol	OINTMENT	TOPICAL	20190319		UNAPPROVED HOMEOPATHIC		Chain Drug Marketing Association, Inc.	ICHTHAMMOL	20	g/100g			N	20241231
63868-459_fc8792f6-199f-d6e3-e053-6394a90a2ccb	63868-459	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate.	OINTMENT	TOPICAL	20190326		OTC MONOGRAPH FINAL	part333B	Chain Drug Marketing Association	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63868-460_bd454517-7b3f-404e-9b13-1b2f99a1fa1d	63868-460	HUMAN OTC DRUG	NightTime Maximum Strength Cold and Flu		Acetaminophen, Phenylephrine hydrochloride, Doxylamine succinate, Dextromethorphan hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20160803		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-461_0d748c2e-202b-4bfa-8108-eabb1717e772	63868-461	HUMAN OTC DRUG	DayTime Maximum Strength Cold and Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20160803		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-462_847b0a98-4af6-45a3-aead-f499125080a8	63868-462	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20190228	20250228	ANDA	ANDA075209	QUALITY CHOICE (Chain Drug Marketing Association)	LORATADINE	10	mg/1			N	
63868-463_f26a4f1f-ba77-4701-9a51-dc928c1c2cfd	63868-463	HUMAN OTC DRUG	DayTime Sinus		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170412		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-464_6f600ad5-ad1f-479f-9754-1dc6746a60aa	63868-464	HUMAN OTC DRUG	Daytime Sinus Relief and Nighttime Sinus Relief		acetaminophen, doxylamine succinate, phenylephrine hydrochloride	KIT		20170412		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.						N	20241231
63868-465_94202ade-aee5-8c94-e053-2a95a90ac749	63868-465	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20090903		ANDA	ANDA079096	Chain Drug Marketing Association	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-466_94206088-a6ec-8bdb-e053-2a95a90af579	63868-466	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20090619		ANDA	ANDA079096	Chain Drug Marketing Association	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-467_a31db29c-85f4-4b48-a5ad-66d4bd1e99ea	63868-467	HUMAN OTC DRUG	Daytime Severe Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220503		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-468_90f42b4e-a242-43d1-a647-c94f51ed513f	63868-468	HUMAN OTC DRUG	Nighttime Severe Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220503		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-469_945908ea-d18e-3eb1-e053-2995a90ab2c9	63868-469	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20180926		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-470_f0d3a221-4870-abc3-e053-2995a90aa4be	63868-470	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20191009		ANDA	ANDA078682	Chain Drug Marketing Association, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-471_d4b70e8e-22dc-6574-67e0-e1ebf789716d	63868-471	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200201		ANDA	ANDA207740	Chain Drug Marketing Association INC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63868-473_3c8bb96b-e283-d8dc-b1ec-6590a3feb121	63868-473	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20200624		ANDA	ANDA210375	Chain Drug Marketing Association INC	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-474_7e4f2b47-6a1d-48f0-b231-f979a82e0abe	63868-474	HUMAN OTC DRUG	Allergy Relief Antihistamine		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210501		OTC MONOGRAPH FINAL	part341	CDMA Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-480_28939ea0-3aaa-0f2b-3adf-fdef8f40fd54	63868-480	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET, COATED	ORAL	20180701		ANDA	ANDA078192	Chain Drug Marketing Association	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63868-482_d5a0c763-85d7-7813-a6a7-fbec0176b522	63868-482	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20180701		ANDA	ANDA075294	Chain Drug Marketing Association	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63868-483_fc61847b-cb67-97b1-e053-6394a90ae1b9	63868-483	HUMAN OTC DRUG	Hemorroidal Cooling gel		Phenylephrine, Witch Hazel	GEL	TOPICAL	20190715		OTC MONOGRAPH FINAL	part346	Chain Drug Marketing Association	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	.25; .5	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-485_7eee713e-7971-4c60-a606-6c7b00e07bcf	63868-485	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin and caffeine	TABLET, FILM COATED	ORAL	19921117		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63868-490_0cf4a4b6-9e6c-dc85-e063-6394a90a2762	63868-490	HUMAN OTC DRUG	Quality Choice Camphor Spirit		Camphor 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Chain Drug Market Association	CAMPHOR (NATURAL)	100	mg/mL			N	20241231
63868-492_fc49c595-a252-cd5e-e053-6294a90ac7c7	63868-492	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140613		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-493_0cf4bfe6-3853-e836-e063-6394a90ab8c3	63868-493	HUMAN OTC DRUG	Quality Choice Merthiolate		Benzalkonium Chloride	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Chain Drug Market Association	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63868-500_effabd46-34f7-16e7-e053-2995a90a6654	63868-500	HUMAN OTC DRUG	Quality Choice Maximum Strength Zinc Oxide		Zinc Oxide	OINTMENT	TOPICAL	20191111		OTC MONOGRAPH FINAL	part347	Chain Drug Marketing Association Inc	ZINC OXIDE	40	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63868-503_7e49996b-5180-a0a9-e053-2a91aa0a3b87	63868-503	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20070315		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ACETAMINOPHEN	500	mg/1			N	20241231
63868-505_0d2a970e-f4d4-9d62-e063-6394a90ae8b9	63868-505	HUMAN OTC DRUG	Quality Choice Eye Drops Irritation Relief		tetrahydroxoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20200105		OTC MONOGRAPH DRUG	M018	Quality Choice	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63868-507_7e49996b-519a-a0a9-e053-2a91aa0a3b87	63868-507	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20070814		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ACETAMINOPHEN	500	mg/1			N	20241231
63868-511_f1d7e57e-4322-3ec8-e053-2995a90a7865	63868-511	HUMAN OTC DRUG	QC Cool and Heat Roll-On		Menthol 16%	LIQUID	TOPICAL	20211216		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association Inc	MENTHOL	16	g/100g			N	20241231
63868-525_0c1ad894-fb84-90bb-e063-6394a90a932a	63868-525	HUMAN OTC DRUG	Quality Choice Lice Treatment		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20101028		OTC MONOGRAPH DRUG	M031	Chain Drug Marketing Association						N	20241231
63868-530_bc5aed92-9134-488e-b136-d17f535b196a	63868-530	HUMAN OTC DRUG	Quality Choice		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20190416		OTC MONOGRAPH DRUG	M007	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
63868-531_f82080b1-ef91-a027-e053-6294a90a19f2	63868-531	HUMAN OTC DRUG	QC SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20211222		OTC MONOGRAPH NOT FINAL	part352	CDMA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
63868-559_5b0ffa2c-08e5-4499-9d71-3cc367668c8b	63868-559	HUMAN OTC DRUG	Anti Diarrheal		Loperamide HCl	TABLET	ORAL	20050503		ANDA	ANDA076497	CHAIN DRUG MARKETING ASSOCIATION INC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63868-560_e430beca-f5d9-4ee8-aac9-5776ba79b583	63868-560	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831	20240831	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM	100	mg/1			N	
63868-561_fc6152a2-7161-250f-e053-6394a90a951a	63868-561	HUMAN OTC DRUG	Hemorrhoidal Cream with Aloe		Glycerol, Phenylephine, Pramoxine, Petrolatum	CREAM	TOPICAL	20190707		OTC MONOGRAPH FINAL	part346	Chain Drug Marketing Association	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-565_097f7264-6848-61fb-e063-6294a90a3f2f	63868-565	HUMAN OTC DRUG	HEARTBURN RELIEF		aluminum hydroxide and magnesium carbonate	SUSPENSION	ORAL	20191101		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
63868-567_08a2d361-f109-47b6-aad0-0ec0cc9b3468	63868-567	HUMAN OTC DRUG	Flu HBP	Maximum Strength	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20200325		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-568_b595318a-0bef-ac72-e053-2995a90a78db	63868-568	HUMAN OTC DRUG	Quality Choice Effervescent Cold Relief - Orange		Aspirin, Chlorpheniramine maleate, Phenylephrine bitartrate	TABLET, EFFERVESCENT	ORAL	20200615		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-569_c0a988b7-c67d-deb6-e053-2995a90a0214	63868-569	HUMAN OTC DRUG	Quality Choice Extra Strength Effervescent Antacid and Pain Relief		Aspirin, Anhydrous Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20201104		OTC MONOGRAPH FINAL	part343	Chain Drug Marketing Association	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 500; 1985	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-570_ae064a9e-dad7-fa86-e053-2a95a90a16a7	63868-570	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200325		ANDA	ANDA202312	CHAIN DRUG MARKETING ASSOCIATION INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-571_ae065210-91af-f773-e053-2995a90afa66	63868-571	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200325		ANDA	ANDA202312	CHAIN DRUG MARKETING ASSOCIATION INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-572_f027311a-b9f5-43d0-a4ac-fdba5584f36d	63868-572	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20200214		OTC MONOGRAPH DRUG	505G(a)(3)	CHAIN DRUG MARKETING ASSOCIATION INC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-573_77e15dd9-782e-44d0-93c2-90242640188a	63868-573	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20200217		OTC MONOGRAPH DRUG	505G(a)(3)	CHAIN DRUG MARKETING ASSOCIATION INC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-574_f5edb048-977e-0a82-e053-2995a90af50d	63868-574	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20200611		OTC MONOGRAPH FINAL	part333B	Chain Drug Marketing Association Inc.	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
63868-576_fc5f0913-8738-35cb-e053-6294a90accad	63868-576	HUMAN OTC DRUG	Triple Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20200615		OTC MONOGRAPH FINAL	part333B	Chain Drug Marketing Association Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63868-577_3e5012c7-1ad4-4ba9-84f2-ffa7b7ae0af0	63868-577	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	QUALITY CHOICE (Chain Drug Marketing Association)	LORATADINE	10	mg/1			N	20241231
63868-578_bccb3894-65e3-0c3d-e053-2a95a90a8d82	63868-578	HUMAN OTC DRUG	Allergy Multisymptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200615		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-579_551ed2bf-2c94-42fa-961b-6be2ce32a289	63868-579	HUMAN OTC DRUG	Vegetable Laxative		Sennosides	TABLET, FILM COATED	ORAL	20201208		OTC MONOGRAPH DRUG	505G(a)(3)	CHAIN DRUG MARKETING ASSOCIATION INC	SENNOSIDES	8.6	mg/1			N	20241231
63868-581_efb7307f-0560-5347-e053-2a95a90a16cd	63868-581	HUMAN OTC DRUG	Sinus Pressure plus Pain		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200615		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-582_efb74694-1737-6f83-e053-2995a90a7631	63868-582	HUMAN OTC DRUG	Sinus plus Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200615		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-583_e1ff5801-aa77-4f65-374e-ffef88179d6e	63868-583	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20201201		ANDA	ANDA077367	Chain Drug Marketing Association INC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63868-584_e1ff5801-aa77-4f65-374e-ffef88179d6e	63868-584	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20201201		ANDA	ANDA077367	Chain Drug Marketing Association INC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63868-585_18d8ee5c-6c94-402a-8e57-98d8d951acb3	63868-585	HUMAN OTC DRUG	Quality Choice Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20201111		OTC MONOGRAPH NOT FINAL	part334	Chain Drug Marketing Association	DOCUSATE SODIUM	100	mg/1			N	20241231
63868-586_f7047966-d474-47b7-b3b1-f69ee50b4706	63868-586	HUMAN OTC DRUG	Quality Choice Gas Relief	Extra Strength Softgels	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20201202		OTC MONOGRAPH FINAL	part332	Chain Drug Marketing Association	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
63868-587_efb744ed-a2fb-f1d5-e053-2a95a90a6353	63868-587	HUMAN OTC DRUG	Mucus Relief Sinus Pressure Pain and Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-588_efb74986-02b4-d9c2-e053-2995a90adc12	63868-588	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-589_efb74b8a-8db1-dc1b-e053-2995a90a9bf2	63868-589	HUMAN OTC DRUG	Mucus Relief Cold and Flu All in One		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-592_0da71200-e680-41d6-bc66-6a62186c2f46	63868-592	HUMAN OTC DRUG	WITCH HAZEL		WITCH HAZEL	SOLUTION	TOPICAL	20210201		OTC MONOGRAPH FINAL	part347	CHAIN DRUG MARKETING ASSOCIATION INC	WITCH HAZEL	85	mg/mL			N	20241231
63868-599_841e0057-93fe-4633-932b-2396ba03fd99	63868-599	HUMAN OTC DRUG	Petroleum with Cocoa		White Petrolatum	JELLY	TOPICAL	20200101		OTC MONOGRAPH FINAL	part347	QUALITY CHOICE (Chain Drug Marketing Association)	PETROLATUM	100	g/100g			N	20241231
63868-601_4bce9234-1c7f-4766-b247-2174ea69b6cc	63868-601	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20200101		OTC MONOGRAPH FINAL	part347	QUALITY CHOICE (Chain Drug Marketing Association)	PETROLATUM	100	g/100g			N	20241231
63868-602_a3a2adf7-a6a6-452c-b0dc-71c12f4607aa	63868-602	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20191202		OTC MONOGRAPH NOT FINAL	part334	C.D.M.A.	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-604_a0a6acdd-6aac-613b-e053-2995a90aa86f	63868-604	HUMAN OTC DRUG	Quality Choice Ear Relief Drops		MATRICARIA CHAMOMILLA WHOLE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20131001		UNAPPROVED HOMEOPATHIC		Chain Drug Marketing Association	MATRICARIA CHAMOMILLA WHOLE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
63868-605_7abfe9c8-a55e-4b62-84a3-fa5f14aae007	63868-605	HUMAN OTC DRUG	OXYMETAZOLINE HYDROCHLORIDE		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20210201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63868-607_c9bf3ee3-c20c-4103-acc9-c9b53b18e7ea	63868-607	HUMAN OTC DRUG	OXYMETAZOLINE HYDROCHLORIDE		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20210201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63868-608_3421a196-7c1a-41a6-8e10-8532c58629ef	63868-608	HUMAN OTC DRUG	OXYMETAZOLINE HYDROCHLORIDE		OXYMETAZOLINE HYDROCHLORIDE	SOLUTION	NASAL	20210315		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63868-611_941f59df-2832-37c8-e053-2995a90a7734	63868-611	HUMAN OTC DRUG	Nighttime Sleep Aid		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20070625		OTC MONOGRAPH FINAL	part338	Chain Drug Marketing Association	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-616_00c76d23-c8fb-e176-e063-6394a90a7b90	63868-616	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Honey Lemon Sugar Free	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	MENTHOL	7.6	mg/1			N	20241231
63868-617_00c79d2d-03f7-7bc6-e063-6294a90a9aaa	63868-617	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Honey Lemon	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	MENTHOL	7.5	mg/1			N	20241231
63868-618_0d2a9bb6-dea2-a1cb-e063-6394a90a9fc7	63868-618	HUMAN OTC DRUG	Quality Choice Lubricant Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20200313		OTC MONOGRAPH DRUG	M018	Chain Drug Marketing Assoc., Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
63868-622_25788bd2-f666-4c2f-9977-b343388c0c08	63868-622	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M008	CDMA- QC	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
63868-638_b5d1e1f7-8faa-4ac9-af6a-71a667e56a91	63868-638	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20211230		OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM	100	mg/1			N	20241231
63868-656_b8738aa6-8ca7-9245-8b8f-2ae6807081e5	63868-656	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20220225		ANDA	ANDA208150	Chain Drug Marketing Association	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63868-660_efa81391-18c8-2b65-e053-2a95a90a75fa	63868-660	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200801		ANDA	ANDA211544	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN	650	mg/1			N	20241231
63868-661_9a89550e-e550-4c96-bda4-9e590786558e	63868-661	HUMAN OTC DRUG	Quality Choice Pain Relief Powder		Aspirin and Caffeine	POWDER	ORAL	20210325		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63868-662_c0f46f10-3530-471c-988a-db33766bdf23	63868-662	HUMAN OTC DRUG	Quality Choice Stool Softener	laxative	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20220119		OTC MONOGRAPH NOT FINAL	part334	Chain Drug Marketing Association	DOCUSATE SODIUM	250	mg/1			N	20241231
63868-664_37984c07-d374-4217-bfb9-d6465f2da0c6	63868-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19950111		OTC MONOGRAPH NOT FINAL	part356	C.D.M.A., Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63868-665_945908ea-d1a3-3eb1-e053-2995a90ab2c9	63868-665	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20180901		ANDA	ANDA209274	CHAIN DRUG MARKETING ASSOCIATION INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-669_7e9542d0-f6b9-7156-e053-2a91aa0a9a16	63868-669	HUMAN OTC DRUG	Allergy Relief		loratadine	CAPSULE, LIQUID FILLED	ORAL	20180901		ANDA	ANDA206214	CHAIN DRUG MARKETING ASSOCIATION INC.	LORATADINE	10	mg/1			N	20241231
63868-670_1250db11-5cba-42e3-9afd-6f621d175073	63868-670	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Sinus		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL	CAPSULE	ORAL	20190630	20250630	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-671_b29c2dd2-f827-411e-9c47-64317dc6f919	63868-671	HUMAN OTC DRUG	Mucus Relief Cold Flu Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20190630	20250630	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-672_21207b77-2b6a-44e2-af88-400253308c7a	63868-672	HUMAN OTC DRUG	Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate,Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20180731	20250731	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-673_00b7d939-06fa-3651-e063-6394a90a93b2	63868-673	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Vitamin C	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	MENTHOL	2.7	mg/1			N	20241231
63868-674_00b700b8-a6b6-7b58-e063-6394a90a2062	63868-674	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Cherry	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	MENTHOL	5.8	mg/1			N	20241231
63868-675_00b78df5-f479-a028-e063-6394a90a8d6a	63868-675	HUMAN OTC DRUG	QUALITY CHOICE		Cough Drops Menthol	LOZENGE	ORAL	20230715		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	MENTHOL	5.4	mg/1			N	20241231
63868-676_7abfe9c8-a55e-4b62-84a3-fa5f14aae007	63868-676	HUMAN OTC DRUG	OXYMETAZOLINE HYDROCHLORIDE		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20210201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG MARKETING ASSOCIATION INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63868-677_5f506966-d192-4374-a455-d10e3e1cb518	63868-677	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	SUSPENSION	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN	160	mg/5mL			N	20241231
63868-678_b1b052c8-0b66-43c8-9551-e265b618022a	63868-678	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	SUSPENSION	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN	160	mg/5mL			N	20241231
63868-679_ae065210-9198-f773-e053-2995a90afa66	63868-679	HUMAN OTC DRUG	8 Hour Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200801		ANDA	ANDA211544	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN	650	mg/1			N	20241231
63868-683_fc87a6a0-8a7a-acce-e053-6294a90a667e	63868-683	HUMAN OTC DRUG	Anti-Itch Cream		Diphenhydramine hydrochloride 2%, zinc acetate 0.1%	CREAM	TOPICAL	20200814		OTC MONOGRAPH FINAL	part347	Chain Drug Marketing Association Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-684_fc5f831c-169e-de28-e053-6394a90a8f1f	63868-684	HUMAN OTC DRUG	Hemorrhoidal		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20200814		OTC MONOGRAPH FINAL	part346	Chain Drug Marketing Association Inc.	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-685_fc5f2212-8ecb-e4c8-e053-6394a90a7483	63868-685	HUMAN OTC DRUG	Antifungal		Tolnaftate 1%	CREAM	TOPICAL	20200814		OTC MONOGRAPH FINAL	part333C	Chain Drug Marketing Association Inc.	TOLNAFTATE	1	g/100g			N	20241231
63868-686_fc61822a-3fbd-343c-e053-6294a90af72c	63868-686	HUMAN OTC DRUG	Zinc Oxide 20%		Zinc Oxide	OINTMENT	TOPICAL	20200814		OTC MONOGRAPH FINAL	part347	Chain Drug Marketing Association Inc.	ZINC OXIDE	.2	g/g			N	20241231
63868-688_fc5f2212-8ecc-e4c8-e053-6394a90a7483	63868-688	HUMAN OTC DRUG	Anti-Itch with Aloe		Hydrocortisone 1%	CREAM	TOPICAL	20200813		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63868-689_f5edc427-d8ee-5954-e053-2995a90a8b5e	63868-689	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20191212		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63868-690_fc8797f1-908b-accb-e053-6294a90a1649	63868-690	HUMAN OTC DRUG	Clotrimazole 1%		Clotrimazole	CREAM	TOPICAL	20200813		OTC MONOGRAPH FINAL	part333C	Chain Drug Marketing Association Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63868-691_ded1f690-eb66-4651-825a-971d63fe6f1b	63868-691	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	TABLET	ORAL	20210331		OTC MONOGRAPH DRUG	M008	CHAIN DRUG MARKETING ASSOCIATION INC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
63868-692_be62bd1e-5a06-f775-e053-2995a90aba63	63868-692	HUMAN OTC DRUG	Quality Choice Ultra Strength Pain Relieving Cream	Ultra Strength	camphor, menthol, methyl salicylate	CREAM	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	QUALITY CHOICE (Chain Drug Marketing Association)	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
63868-694_097f8a95-e858-70c1-e063-6294a90a9d22	63868-694	HUMAN OTC DRUG	ANTACID MINT		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20140301		OTC MONOGRAPH DRUG	M001	Chain Drug Marketing Association	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-696_3dde11b9-c3b8-4c2f-8dc6-e812f7be7fcd	63868-696	HUMAN OTC DRUG	Quality Choice Infants Dye Free Gas Relief		Simethicone	EMULSION	ORAL	20181217		OTC MONOGRAPH DRUG	M002	CHAIN DRUG MARKETING ASSOCIATION	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
63868-697_e07f11ed-16d7-452f-a712-d5740074091b	63868-697	HUMAN OTC DRUG	Quality Choice		Phenylephrine Hydrochloride	SOLUTION/ DROPS	NASAL	20181218		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-698_35dffb18-36cc-485e-bd74-f10a0e602f2b	63868-698	HUMAN OTC DRUG	Quality Choice	Maximum Strength	oxymetazoline hydrochloride	SPRAY	NASAL	20181217		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63868-699_6b728c2c-329c-45dd-8ebf-87d3cc677559	63868-699	HUMAN OTC DRUG	Quality Choice		Oxymetazoline Hydrochloride	SPRAY	NASAL	20181217		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63868-700_b547fc76-bd21-463d-996b-695f1429d669	63868-700	HUMAN OTC DRUG	Quality Choice Regular Strength	Peppermint Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION	CALCIUM CARBONATE	500	mg/1			N	20241231
63868-701_190a3159-508d-4724-bf73-64d58f8439c0	63868-701	HUMAN OTC DRUG	Quality Choice Antacid	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION	CALCIUM CARBONATE	500	mg/1			N	20241231
63868-702_0787c106-29df-4968-a659-ef17f49a305b	63868-702	HUMAN OTC DRUG	Quality Choice Extra Strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION	CALCIUM CARBONATE	750	mg/1			N	20241231
63868-703_3caa0fce-70a2-4499-82a7-d1b8bf07a3f4	63868-703	HUMAN OTC DRUG	Quality Choice Assorted Berries	Extra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181215		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION	CALCIUM CARBONATE	750	mg/1			N	20241231
63868-704_6fe3cdae-f43f-4541-a9f8-e97f4a072452	63868-704	HUMAN OTC DRUG	Anti Nausea Liquid	Cherry Flavor	dextrose(glucose),Levulose(fructose),Phosphoric acid	SOLUTION	ORAL	20190416		UNAPPROVED DRUG OTHER		QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
63868-709_b178a437-25f7-4737-8b81-2e0e2ff6417e	63868-709	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20200302	20240131	ANDA	ANDA074916	QUALITY CHOICE (Chain Drug Marketing Association)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63868-712_097f861d-60dc-700d-e063-6294a90afc78	63868-712	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20140301		OTC MONOGRAPH DRUG	M001	Chain Drug Marketing Association	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-715_097f861d-60dd-700d-e063-6294a90afc78	63868-715	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20140301		OTC MONOGRAPH DRUG	M001	Chain Drug Marketing Association	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-721_e8b85171-dc31-3b61-e053-2a95a90a6bb2	63868-721	HUMAN OTC DRUG	Pressure Pain Cold PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140521	20240630	OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-722_efb7586a-0c08-99c3-e053-2a95a90af420	63868-722	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20150610		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-724_b178a437-25f7-4737-8b81-2e0e2ff6417e	63868-724	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20200309	20240131	ANDA	ANDA074916	QUALITY CHOICE (Chain Drug Marketing Association)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63868-730_58780bd4-1647-8277-175e-b3ad270e0e0e	63868-730	HUMAN OTC DRUG	DICLOFENAC SODIUM		Diclofenac Sodium topical gel, 1%	GEL	TOPICAL	20200926		ANDA	ANDA210986	Chain Drug Marketing Association INC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-732_5e6ca332-6ba4-cafd-82ed-f7208381d9bf	63868-732	HUMAN OTC DRUG	Nicotine Polacrilex Lozenge Mint		Nicotine Polacrilex Lozenge 4 mg	LOZENGE	ORAL	20210401		ANDA	ANDA212796	Chain Drug Marketing Association INC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63868-733_5e6ca332-6ba4-cafd-82ed-f7208381d9bf	63868-733	HUMAN OTC DRUG	Nicotine Polacrilex Lozenge Mint		Nicotine Polacrilex Lozenge 2 mg	LOZENGE	ORAL	20210401		ANDA	ANDA212796	Chain Drug Marketing Association INC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63868-734_aab5e767-8339-5ddd-ae36-a174f2070fd4	63868-734	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20201031		NDA	NDA020076	Chain Drug Marketing Association INC	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63868-735_aab5e767-8339-5ddd-ae36-a174f2070fd4	63868-735	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20201031		NDA	NDA020076	Chain Drug Marketing Association INC	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63868-736_b5f0e71e-0fd1-47d4-9b02-3623c5f8f86a	63868-736	HUMAN OTC DRUG	Cold and Flu	Daytime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-737_cbbee44a-f448-4c1b-9d3e-d6cf647b1dfe	63868-737	HUMAN OTC DRUG	Night Time Cold and Flu	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-745_214af049-b1d9-4170-9be0-4d0178565c27	63868-745	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20150131		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-746_107167aa-f327-49da-bb6d-88d33bdc3eab	63868-746	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20150131		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-747_7e555b65-5cdd-2eb5-e053-2991aa0a8dce	63868-747	HUMAN OTC DRUG	Pressure Pain Mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140521		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-753_3104215b-f439-4a5e-951e-a85e97b97a3f	63868-753	HUMAN OTC DRUG	Quality Choice Mucus Relief DM	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-759_212cb5bf-aa66-489d-8b45-5c7061aa4b3c	63868-759	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20130311	20250311	ANDA	ANDA078682	QUALITY CHOICE (Chain Drug Marketing Association)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63868-770_a77bce38-2711-4067-8e51-c557f1a5f94c	63868-770	HUMAN OTC DRUG	Childrens Mucus Relief	Chest Congestion	Guaifenesin	SOLUTION	ORAL	20151019		OTC MONOGRAPH DRUG	M012	Chain Drug Manufacturing Assn	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63868-771_5807d840-01ce-4c52-9884-3286958530ce	63868-771	HUMAN OTC DRUG	Childrens Mucus and Cough Relief		GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE	LIQUID	ORAL	20151019		OTC MONOGRAPH DRUG	M012	Chain Drug Manufacturing Assn	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-772_7e5574b6-c71d-7ada-e053-2991aa0a4cd5	63868-772	HUMAN OTC DRUG	Rest Simply		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140613		OTC MONOGRAPH FINAL	part338	Chain Drug Marketing Association	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-773_ccd5c344-fee8-41ba-9619-111f0ca9f89e	63868-773	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	CHAIN DRUG MARKETING ASSOCIATION INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-775_d276f157-ef5c-4589-b100-9f8f75dca311	63868-775	HUMAN OTC DRUG	Cold and Cough	Childrens	Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20150930	20250930	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63868-776_b178a437-25f7-4737-8b81-2e0e2ff6417e	63868-776	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20180322		ANDA	ANDA074916	QUALITY CHOICE (Chain Drug Marketing Association)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-779_b178a437-25f7-4737-8b81-2e0e2ff6417e	63868-779	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20180322	20240131	ANDA	ANDA074916	QUALITY CHOICE (Chain Drug Marketing Association)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63868-787_097f836c-0684-f1b0-e063-6394a90ac9c3	63868-787	HUMAN OTC DRUG	MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	LIQUID	ORAL	20140401		OTC MONOGRAPH DRUG	M007	Chain Drug Marketing Association	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-788_097f7264-6849-61fb-e063-6294a90a3f2f	63868-788	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	LIQUID	ORAL	20140401		OTC MONOGRAPH DRUG	M007	Chain Drug Marketing Association	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-795_28940dbe-2b8d-466d-a1c0-af9377be11f1	63868-795	HUMAN OTC DRUG	Childrens Ibuprofen		IBUPROFEN	SUSPENSION	ORAL	20201215		ANDA	ANDA210602	Chain Drug Marketing Association, Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-798_f31cce26-8153-448f-e053-2a95a90ad84b	63868-798	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20141201		OTC MONOGRAPH FINAL	part333C	Chain Drug Marketing Association	TOLNAFTATE	1.5	g/150g			N	20241231
63868-800_c0e3f50a-d5ea-77bd-e053-2995a90ae9ef	63868-800	HUMAN OTC DRUG	Quality Choice Medicated Chest Rub		camphor, menthol, eucalyptus oil	OINTMENT	TOPICAL	20210401		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
63868-801_6942d03c-6188-4f6e-bd39-392a47e26a66	63868-801	HUMAN OTC DRUG	Mucus Relief D Sinus Congestion		Guaifenesin, Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20200423		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION INC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	400; 40	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
63868-802_17d700a4-f98e-487b-91d7-5ab3d89a2c97	63868-802	HUMAN OTC DRUG	Nasal Decongestant	Maximum Strength	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	CHAIN DRUG MARKETING ASSOCIATION INC	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63868-804_be6cd5ec-53ae-4131-a6f2-bdc5b994097c	63868-804	HUMAN OTC DRUG	91% Isopropyl Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230207		OTC MONOGRAPH NOT FINAL	part333A	C.D.M.A. Inc	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
63868-805_f0d274bd-b6b5-74c9-e053-2995a90a6f72	63868-805	HUMAN OTC DRUG	Dye-Free Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20211116		ANDA	ANDA078682	CHAIN DRUG MARKETING ASSOCIATION INC.	IBUPROFEN	200	mg/1201	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-809_c7469728-7e7b-48f0-9909-ac6f3943c38f	63868-809	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SYRUP	ORAL	20230701		OTC MONOGRAPH NOT FINAL	part343	CHAIN DRUG MARKETING ASSOCIATION INC.	ACETAMINOPHEN	500	mg/15mL			N	20241231
63868-810_0892fd7e-2bc5-40d6-b6b9-25725e91620c	63868-810	HUMAN OTC DRUG	70% Isopropyl Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part333A	C.D.M.A. Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
63868-811_3ca5bdea-5ee3-49c3-adb5-c02cf22bb099	63868-811	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140831		OTC MONOGRAPH NOT FINAL	part356	QUALITY CHOICE (Chain Drug Marketing Association)	PHENOL	1.4	g/100mL			N	20241231
63868-813_bf7651c9-d11b-4769-8332-9bd8673650d0	63868-813	HUMAN OTC DRUG	Stomach Relief	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20210625		OTC MONOGRAPH DRUG	M008	QUALITY CHOICE (Chain Drug Marketing Association)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63868-814_2d018914-4f6d-4040-a77e-94879f6f4a25	63868-814	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20210326		OTC MONOGRAPH FINAL	part335	QUALITY CHOICE (Chain Drug Marketing Association)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63868-819_760d5216-fc21-4fea-1a05-9f0710eacbe9	63868-819	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride 60 mg	TABLET	ORAL	20210517		ANDA	ANDA076502	Chain Drug Marketing Association INC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-821_d0cb9874-aa6c-c077-b6b7-54d152ad9938	63868-821	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210101		ANDA	ANDA209752	Chain Drug Marketing Association INC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
63868-822_9b331d48-e5c5-de94-0359-afcfd50724e3	63868-822	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20210101		ANDA	ANDA209619	Chain Drug Marketing Association INC	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
63868-823_08870722-b154-443f-996c-6b00a5be3d32	63868-823	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine HCl	LIQUID	ORAL	20140630		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-824_38683c55-9eda-4219-8d4f-f1689892b518	63868-824	HUMAN OTC DRUG	Long Acting Cough Softgels		Dextromethorphan Hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20220503		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association, Inc.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-829_f0d1d4c1-7214-b8c2-e053-2995a90a650f	63868-829	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20210611		ANDA	ANDA090397	CHAIN DRUG MARKETING ASSOCIATION INC.	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-830_f060cee9-5392-7126-e053-2995a90afbf1	63868-830	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20210603		NDA	NDA021920	CHAIN DRUG MARKETING ASSOCIATION INC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-831_802ec761-8264-4c13-953d-841a863a6d48	63868-831	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20191222		OTC MONOGRAPH NOT FINAL	part334	C.D.M.A.	MINERAL OIL	99.9	mg/mL			N	20241231
63868-832_bea32beb-ac5c-461a-a5cb-92f057568e29	63868-832	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20210326		OTC MONOGRAPH DRUG	M008	QUALITY CHOICE (Chain Drug Marketing Association)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63868-836_42528c30-cfec-46e2-a6d4-4b553bead55b	63868-836	HUMAN OTC DRUG	Pain Relief	Infants	Acetaminophen	SUSPENSION	ORAL	20150531	20240223	OTC MONOGRAPH NOT FINAL	part343	QUALITY CHOICE (Chain Drug Marketing Association)	ACETAMINOPHEN	160	mg/5mL			N	
63868-841_0d2aa191-5005-9d65-e063-6394a90ad8ab	63868-841	HUMAN OTC DRUG	Quality Choice Eye Wash		water	SOLUTION/ DROPS	OPHTHALMIC	20200421		OTC MONOGRAPH DRUG	M018	Chain Drug Marketing Assoc., Inc.	WATER	99.05	g/100mL			N	20241231
63868-842_868b80c9-fa6f-435f-a54b-4541d6b144e8	63868-842	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200427	20251231	ANDA	ANDA079038	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-843_a74b4cd2-faec-4b32-86b3-2a2cca2c34d9	63868-843	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210129	20251231	ANDA	ANDA204833	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-844_7aea1c5b-2d47-4fdc-b3b7-6fa49d9cf55e	63868-844	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20201231	20251231	ANDA	ANDA079044	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-845_2f71dfc0-c459-4486-93e8-a86e22e920c5	63868-845	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20201231	20251231	ANDA	ANDA204794	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-848_f3785cd5-9bb1-4b0c-8152-8c33d57a1b59	63868-848	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20201231	20251231	ANDA	ANDA074707	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-849_db634c21-6cb3-4cf8-bfb5-24ad48ea59d0	63868-849	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20210129	20250131	ANDA	ANDA074507	QUALITY CHOICE (Chain Drug Marketing Association)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
63868-859_0e18c005-6df2-459d-88cb-2f4b93063b7a	63868-859	HUMAN OTC DRUG	Tussin Mucus and Chest Congestion	Adult	Guaifenesin	LIQUID	ORAL	20150531	20241231	OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
63868-863_7ea5e3ae-a250-49d0-9fc8-b78e25b3114c	63868-863	HUMAN OTC DRUG	Extra Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20160722		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Marketing Association Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
63868-864_20a71d90-e509-4a22-a497-e05f265ac6ad	63868-864	HUMAN OTC DRUG	DayTime Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20170308		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63868-865_434f1b5b-1e26-406a-a5e2-df310b74e993	63868-865	HUMAN OTC DRUG	CHILDRENS ALLERGY RELIEF		Cetirizine Hydrochloride	SOLUTION	ORAL	20141120		ANDA	ANDA090750	C.D.M.A., Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-868_e8c7a8a0-7e07-44bd-b2db-b24e580b3939	63868-868	HUMAN OTC DRUG	Tussin DM Cough and Chest Congestion	Non Drowsy	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20140930		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-869_e8766b0f-702f-4f47-8ca7-91810491f8e8	63868-869	HUMAN OTC DRUG	Tussin Cough DM	Sugar Free	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20180831		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-870_63708ea4-8e73-41a7-9bb7-184d112f86be	63868-870	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20181231		ANDA	ANDA209692	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-871_17f873f9-cb25-412e-95f2-5a83cbf085ac	63868-871	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20181231	20251231	ANDA	ANDA207342	QUALITY CHOICE (Chain Drug Marketing Association)	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
63868-872_81f9d318-0a15-4733-b926-6a507b5958d5	63868-872	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20181231	20251231	ANDA	ANDA207342	QUALITY CHOICE (Chain Drug Marketing Association)	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
63868-874_c539cb1c-64cf-4106-a89c-9555f2a76a8a	63868-874	HUMAN OTC DRUG	Stool Softener plus Laxative		Docusate Sodium Sennosides	TABLET	ORAL	20190131	20250430	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
63868-875_795c67b4-3afa-47d1-ba3d-d31d80034abe	63868-875	HUMAN OTC DRUG	Stool Softener	Stimulant laxative	docusate sodium and sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63868-876_f05dd9d9-e5a3-61ab-e053-2a95a90acbe0	63868-876	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190125		NDA	NDA021855	CHAIN DRUG MARKETING ASSOCIATION INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63868-877_0cf4cb65-adda-e3ca-e063-6294a90a3e30	63868-877	HUMAN OTC DRUG	Poison Ivy Wash		Pramoxine HCl	LOTION	TOPICAL	20190424		OTC MONOGRAPH DRUG	M017	Chain Drug Market Association	PRAMOXINE HYDROCHLORIDE	10	mg/mL			N	20241231
63868-878_995ad26d-f69b-4398-a072-b9035b9fa1a3	63868-878	HUMAN OTC DRUG	Stool Softener plus Laxative		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20191030		OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63868-882_e539cbae-4bc9-48e3-94f5-d5be15400693	63868-882	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20211005		OTC MONOGRAPH NOT FINAL	part333A	CDMA	ALCOHOL	70	mL/100mL			N	20241231
63868-884_d8b075d7-c70b-4444-893d-418bf76084fa	63868-884	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200630		OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63868-898_7e4ff876-b450-4cc5-a8b5-f63611b66ff6	63868-898	HUMAN OTC DRUG	Enteric Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	19921214		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63868-900_52445956-f8bf-4bbd-9e14-035a690161a0	63868-900	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20191227		OTC MONOGRAPH FINAL	part338	QUALITY CHOICE (Chain Drug Marketing Association)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-903_113f8438-b42f-4e8a-8e6d-17b2ebe60a52	63868-903	HUMAN OTC DRUG	QUALITY CHOICE ORIGINAL EYE DROPS		TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20120930		OTC MONOGRAPH FINAL	part349	CHAIN DRUG MARKETING ASSOCIATION INC	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
63868-907_8ddf9643-2ef3-449b-b110-5fa060847080	63868-907	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20220128		OTC MONOGRAPH FINAL	part335	QUALITY CHOICE (Chain Drug Marketing Association)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63868-908_8773bb82-9b82-45e4-9931-d9cf32e55235	63868-908	HUMAN OTC DRUG	Gentle Laxative	Stimulant Laxative	Bisacodyl	TABLET, COATED	ORAL	20190419		OTC MONOGRAPH DRUG	M007	QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-911_fc61847b-cb64-97b1-e053-6394a90ae1b9	63868-911	HUMAN OTC DRUG	Dibucaine		Dibucaine 1%	OINTMENT	TOPICAL	20220914		OTC MONOGRAPH FINAL	part346	Chain Drug Marketing Association Inc.	DIBUCAINE	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63868-912_fc61822a-3fba-343c-e053-6294a90af72c	63868-912	HUMAN OTC DRUG	Multi Action		Bacitracinzinc,NeomycinSulfate,PolymyxinBSulfate,PramoxineHCL	OINTMENT	TOPICAL	20220830		OTC MONOGRAPH FINAL	part333B	Chain Drug Marketing Association Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63868-913_f80ceb05-0bd5-1355-e053-6294a90afb19	63868-913	HUMAN OTC DRUG	QC SPF 30 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 6%	LOTION	TOPICAL	20211222		OTC MONOGRAPH NOT FINAL	part352	CDMA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
63868-929_848be13d-6ae3-4cc1-ad7b-6b42cd58e551	63868-929	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20200218		OTC MONOGRAPH NOT FINAL	part334	C.D.M.A., Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63868-934_4483878c-425a-41db-ae2f-96b18ddc2e9a	63868-934	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20140630	20250228	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63868-935_f69f9485-2dc8-4fe9-b776-1f6e70677c19	63868-935	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20140630	20250228	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63868-937_6b46f08f-1856-4354-976f-bd9362279a87	63868-937	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20171231	20251231	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63868-938_ca3086e8-2446-49e4-9816-997ef2e4f9fe	63868-938	HUMAN OTC DRUG	Mineral oil		Mineral oil	OIL	ORAL	20140731	20250530	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	MINERAL OIL	100	mg/100mL			N	
63868-940_0b390371-8d11-ac69-e063-6294a90ab76b	63868-940	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20140501		NDA	NDA019125	Chain Drug Marketing Association Inc.	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
63868-942_9adedce7-c479-424a-9a70-112afca2ef41	63868-942	HUMAN OTC DRUG	Magnesium Citrate	Saline Laxative	Magnesium citrate	LIQUID	ORAL	20160831	20240531	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63868-944_f5de8087-0594-45d4-8a53-1dc3248dcf8b	63868-944	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20180430	20240430	OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63868-946_6188d4a7-f16b-4a6f-86f2-961fd8081352	63868-946	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20210331		OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63868-948_fc619907-ae29-d730-e053-6394a90a072e	63868-948	HUMAN OTC DRUG	Quality Choice Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	20191219		OTC MONOGRAPH FINAL	part347	Chain Drug Marketing Association Inc.	ZINC OXIDE	40	g/100g			N	20241231
63868-949_f5391ab7-dcf9-a88d-e053-2a95a90a5fa6	63868-949	HUMAN OTC DRUG	Feminine Anti-Itch Creme		BENZOCAINE, RESORCINOL	CREAM	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part348	Quality Choice (CHAIN DRUG MARKETING ASSOCIATION)	BENZOCAINE; RESORCINOL	5.67; .85	g/28g; g/28g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
63868-952_8735c96c-f943-49fd-e053-2a91aa0a17db	63868-952	HUMAN OTC DRUG	Quality Choice Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20140414		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-955_e936ddab-48d4-81b3-e053-2a95a90a54cd	63868-955	HUMAN OTC DRUG	Quality Choice Anti Itch		Hydrocortisone	CREAM	TOPICAL	20191107		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63868-956_b5e427ee-3b6a-04ef-e053-2a95a90ad8c7	63868-956	HUMAN OTC DRUG	QC Lidocaine	Maximum Strength	Lidocaine HCl	CREAM	TOPICAL	20201207		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63868-957_4f700504-77b8-49a0-93db-fd8badfdfac0	63868-957	HUMAN OTC DRUG	Cough Relief	Cough Suppressant	Dextromethorphan HBr	LIQUID	ORAL	20150731		OTC MONOGRAPH FINAL	part341	QUALITY CHOICE (Chain Drug Marketing Association)	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63868-959_b5e41e3a-81e0-3a63-e053-2a95a90a5839	63868-959	HUMAN OTC DRUG	QC Medicated anti itch		Pramoxine hydrochloride, menthol	CREAM	TOPICAL	20201207		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Marketing Association	MENTHOL; PRAMOXINE HYDROCHLORIDE	1; 1	g/100g; g/100g			N	20241231
63868-961_39d95a78-8c13-4b5a-8177-2fc121c42ba5	63868-961	HUMAN OTC DRUG	Menstrual Pain Relief	Maximum Strength	Acetaminophen, Pamabrom, Pyrilamine Maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
63868-970_c23f3f85-e203-4453-8f93-43d7c7c3c3f6	63868-970	HUMAN OTC DRUG	Quality Choice Nighttime Sleep-Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20230328		OTC MONOGRAPH FINAL	part338	Chain Drug Marketing Association, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63868-975_0d0a5240-b4e7-4911-8868-a159e15fd568	63868-975	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230328		OTC MONOGRAPH FINAL	part332	Chain Drug Marketing Association, Inc.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
63868-979_08ee1693-c347-42be-add1-0fdb235ce9e3	63868-979	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	CHAIN DRUG MARKETING ASSOCIATION INC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63868-987_d0664f25-d61d-47db-bba1-178b00f0c529	63868-987	HUMAN OTC DRUG	Pain Relief	Extra Strength, Non-Aspirin	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	CHAIN DRUG MARKETING ASSOCIATION INC	ACETAMINOPHEN	500	mg/1			N	20241231
63868-996_f4ef737c-a4db-43b0-83ae-5b1c28852bdc	63868-996	HUMAN OTC DRUG	Extra Strength Antacid	Original Flavor	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20190419		OTC MONOGRAPH DRUG	M001	CHAIN DRUG MARKETING ASSOCIATION INC.	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
63868-998_68b450ff-ce50-4210-a983-c61ab5e975c7	63868-998	HUMAN OTC DRUG	Quality Choice Mucus Relief		Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Chain Drug Marketing Association	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63900-002_08bfee10-3530-f20e-e063-6394a90a635b	63900-002	HUMAN OTC DRUG	Foaming Alcohol Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200807		OTC MONOGRAPH DRUG	505G(a)(3)	Simoniz USA, Inc	ALCOHOL	.62	mL/mL			N	20241231
63923-100_08f61dea-b023-87b1-e063-6294a90ac835	63923-100	HUMAN OTC DRUG	Jet Zone Jet Lag Prevention		Arnica montana, Anamirta cocculus, Potassium phosphate, Gelsemium sempervirens, Strychnos nux vomica, Silver nitrate	TABLET, CHEWABLE	ORAL	20080101		UNAPPROVED HOMEOPATHIC		Belclare Corporation	ANAMIRTA COCCULUS SEED; ARNICA MONTANA; GELSEMIUM SEMPERVIRENS ROOT; POTASSIUM PHOSPHATE, DIBASIC; SILVER NITRATE; STRYCHNOS NUX-VOMICA WHOLE	12; 12; 12; 6; 12; 12	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
63931-0391_f4be3e92-fbf5-1581-e053-2a95a90ab164	63931-0391	HUMAN OTC DRUG	WL-AAE-ZT-O-391		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20181016		OTC MONOGRAPH FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-1158_fc4d9915-f294-0107-e053-6294a90a6d97	63931-1158	HUMAN OTC DRUG	WL-AAB-Z-W-1158		Zinc Oxide	LOTION	TOPICAL	20230522		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	154	mg/mL			N	20241231
63931-1513_0155d2a5-3bb2-bafc-e063-6394a90ad6c8	63931-1513	HUMAN OTC DRUG	WL-AAB-Z-W-1513		Zinc Oxide	LOTION	TOPICAL	20230623		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	73.6	mg/mL			N	20241231
63931-1657_fe7d587f-19ef-5e74-e053-6394a90ace14	63931-1657	HUMAN OTC DRUG	WL-AAD-Z-W-1657		Zinc Oxide	LOTION	TOPICAL	20230125		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-1803_00d72196-d25f-94de-e063-6394a90ac02b	63931-1803	HUMAN OTC DRUG	WL-AAB-Z-W-1803		Zinc Oxide	LOTION	TOPICAL	20230320		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	107	mg/mL			N	20241231
63931-1819_0154d998-2095-2cb5-e063-6294a90ad13f	63931-1819	HUMAN OTC DRUG	WL-AAB-Z-W-1819		Zinc Oxide	LOTION	TOPICAL	20230602		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-1910_0152f564-9290-784b-e063-6294a90afc84	63931-1910	HUMAN OTC DRUG	WL-AAI-ZT-P-1910		Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20230725		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	.125; .225	g/g; g/g			N	20241231
63931-2063_042268d3-747a-3cbb-e063-6294a90a5452	63931-2063	HUMAN OTC DRUG	WL-AAD-Z-W-2063		Zinc Oxide	LOTION	TOPICAL	20230830		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4300_d5c86986-91aa-2d04-e053-2a95a90a5c44	63931-4300	HUMAN OTC DRUG	WL-AAE-ZT-O-400		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20181016		OTC MONOGRAPH FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	1; 1	g/g; g/g			N	20241231
63931-4301_d5c83068-bb7f-47fe-e053-2a95a90aed2e	63931-4301	HUMAN OTC DRUG	WL-AAE-ZT-O-391		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20181016		OTC MONOGRAPH FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	1; 1	g/g; g/g			N	20241231
63931-4302_f1ece2bc-b4a1-f6cd-e053-2995a90a4f0a	63931-4302	HUMAN OTC DRUG	WL-AAS-Z-A-348		Zinc Oxide	LOTION	TOPICAL	20190724		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	95	mg/mL			N	20241231
63931-4309_f1ecf9ba-1c04-7fb7-e053-2a95a90a875a	63931-4309	HUMAN OTC DRUG	WL-AAB-Z-W-471		Zinc Oxide	LOTION	TOPICAL	20190313		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4312_826a1017-f8b3-cc0b-e053-2a91aa0a9553	63931-4312	HUMAN OTC DRUG	WL-AAJ-Z-W-508 (Kopari 50ml)		Zinc Oxide	LOTION	TOPICAL	20190208		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4314_f1ecfcdd-62fc-67ce-e053-2995a90a0eb8	63931-4314	HUMAN OTC DRUG	WL-AAE-ZT-O-492		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20190403		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	22; 11	mg/mL; mg/mL			N	20241231
63931-4317_f1ed1265-5452-6735-e053-2a95a90a83a7	63931-4317	HUMAN OTC DRUG	WL-AAI-ZT-P-522		Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20190715		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	.125; .225	g/g; g/g			N	20241231
63931-4318_f1ecfcdd-62ff-67ce-e053-2995a90a0eb8	63931-4318	HUMAN OTC DRUG	WL-AAI-ZT-P-523		Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20190715		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	.125; .225	g/g; g/g			N	20241231
63931-4319_f1ed183a-2492-74f1-e053-2a95a90a0799	63931-4319	HUMAN OTC DRUG	WL-AAI-ZT-P-524		Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20190715		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	.125; .225	g/g; g/g			N	20241231
63931-4322_f1ed1824-ffcd-83b5-e053-2a95a90ad743	63931-4322	HUMAN OTC DRUG	WL-AAB-Z-W-330		Zinc Oxide	LOTION	TOPICAL	20190509		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4325_f1ed1d9c-8d87-a288-e053-2995a90af3fa	63931-4325	HUMAN OTC DRUG	WL-AAB-Z-W-401		Zinc Oxide	LOTION	TOPICAL	20190530		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4337_f1ed1d03-2d87-90da-e053-2a95a90a8c4d	63931-4337	HUMAN OTC DRUG	WL-AAC-Z-A-567		Zinc Oxide	STICK	TOPICAL	20190516		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	150	mg/g			N	20241231
63931-4338_f1ed1d9c-8d8a-a288-e053-2995a90af3fa	63931-4338	HUMAN OTC DRUG	WL-AAC-Z-A-568		Zinc Oxide	STICK	TOPICAL	20190516		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	150	mg/g			N	20241231
63931-4348_d5c82eaf-9d7d-e63c-e053-2995a90a33d6	63931-4348	HUMAN OTC DRUG	WL-AAD-Z-W-691		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4349_bb9dae8f-31d4-e6ef-e053-2995a90a6baf	63931-4349	HUMAN OTC DRUG	WL-AAJ-Z-W-633		Zinc Oxide	LOTION	TOPICAL	20210315		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4354_d5c83068-bb79-47fe-e053-2a95a90aed2e	63931-4354	HUMAN OTC DRUG	WL-AAC-Z-A-809		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	125	mg/g			N	20241231
63931-4355_d5c82eaf-9d78-e63c-e053-2995a90a33d6	63931-4355	HUMAN OTC DRUG	WL-AAB-Z-W-780		Zinc Oxide	LOTION	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	134.4	mg/mL			N	20241231
63931-4360_d5c842ad-c063-ec05-e053-2a95a90ab5f3	63931-4360	HUMAN OTC DRUG	WL-AAD-Z-W-750		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4361_d5c842ad-c062-ec05-e053-2a95a90ab5f3	63931-4361	HUMAN OTC DRUG	WL-AAD-Z-W-751		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4362_d5c842ad-c061-ec05-e053-2a95a90ab5f3	63931-4362	HUMAN OTC DRUG	WL-AAD-Z-W-752		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4363_d5c842ad-c060-ec05-e053-2a95a90ab5f3	63931-4363	HUMAN OTC DRUG	WL-AAD-Z-W-753		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4364_d5c842ad-c05f-ec05-e053-2a95a90ab5f3	63931-4364	HUMAN OTC DRUG	WL-AAD-Z-W-754		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4365_d5c84084-2d4f-2072-e053-2995a90a38db	63931-4365	HUMAN OTC DRUG	WL-AAD-Z-W-755		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4366_d5c84084-2d4d-2072-e053-2995a90a38db	63931-4366	HUMAN OTC DRUG	WL-AAD-Z-W-756		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4367_d5c84084-2d4e-2072-e053-2995a90a38db	63931-4367	HUMAN OTC DRUG	WL-AAD-Z-W-757		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4368_d5c82eaf-9d7c-e63c-e053-2995a90a33d6	63931-4368	HUMAN OTC DRUG	WL-AAD-Z-W-758		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4369_d5c83068-bb7a-47fe-e053-2a95a90aed2e	63931-4369	HUMAN OTC DRUG	WL-AAD-Z-W-759		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4371_d5c82eaf-9d7b-e63c-e053-2995a90a33d6	63931-4371	HUMAN OTC DRUG	WL-AAD-Z-W-760		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4372_d5c82eaf-9d7a-e63c-e053-2995a90a33d6	63931-4372	HUMAN OTC DRUG	WL-AAD-Z-W-761		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4373_d5c8349e-92d1-76a6-e053-2a95a90a54de	63931-4373	HUMAN OTC DRUG	WL-AAD-Z-W-762		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4374_d5c82eaf-9d79-e63c-e053-2995a90a33d6	63931-4374	HUMAN OTC DRUG	WL-AAD-Z-W-763		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4375_d5c8349e-92d0-76a6-e053-2a95a90a54de	63931-4375	HUMAN OTC DRUG	WL-AAD-Z-W-764		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4376_d5c8349e-92cf-76a6-e053-2a95a90a54de	63931-4376	HUMAN OTC DRUG	WL-AAD-Z-W-765		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4377_d5c8349e-92ce-76a6-e053-2a95a90a54de	63931-4377	HUMAN OTC DRUG	WL-AAD-Z-W-766		Zinc Oxide	LOTION	TOPICAL	20200115		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4378_d5c8349e-92d3-76a6-e053-2a95a90a54de	63931-4378	HUMAN OTC DRUG	WL-AAC-Z-A-790		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	125	mg/g			N	20241231
63931-4379_d5c82eaf-9d77-e63c-e053-2995a90a33d6	63931-4379	HUMAN OTC DRUG	WL-AAC-Z-A-792		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	125	mg/g			N	20241231
63931-4380_d5c83068-bb7e-47fe-e053-2a95a90aed2e	63931-4380	HUMAN OTC DRUG	WL-AAB-Z-W-807		Zinc Oxide	LOTION	TOPICAL	20200110		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	127	mg/mL			N	20241231
63931-4384_d3c1aae3-0ac7-1700-e053-2995a90ad286	63931-4384	HUMAN OTC DRUG	WL-AAN-Z-A-822		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135	mg/g			N	20241231
63931-4385_d5c80f2e-692c-ca2c-e053-2995a90a4de1	63931-4385	HUMAN OTC DRUG	WL-AAJ-Z-W-832		Zinc Oxide	LOTION	TOPICAL	20200325		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4386_d5c80f2e-692b-ca2c-e053-2995a90a4de1	63931-4386	HUMAN OTC DRUG	WL-AAJ-Z-W-838		Zinc Oxide	LOTION	TOPICAL	20200325		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4408_d5c80f2e-692a-ca2c-e053-2995a90a4de1	63931-4408	HUMAN OTC DRUG	WL-AAB-Z-W-850		Zinc Oxide	LOTION	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4413_cc35c9d3-47e9-2d9a-e053-2995a90a187d	63931-4413	HUMAN OTC DRUG	WL-AAD-Z-W-772		Zinc Oxide	LOTION	TOPICAL	20210526		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4414_cc359ae0-ba30-6def-e053-2a95a90a70f7	63931-4414	HUMAN OTC DRUG	WL-AAJ-Z-W-796		Zinc Oxide	LOTION	TOPICAL	20210628		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	128	mg/mL			N	20241231
63931-4416_cc31bea3-76ce-00e4-e053-2995a90ad4e4	63931-4416	HUMAN OTC DRUG	WL-AAJ-Z-W-818		Zinc Oxide	LOTION	TOPICAL	20210610		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4420_bd982f11-9fff-56b7-e053-2995a90a6997	63931-4420	HUMAN OTC DRUG	WL-AAJ-Z-W-870		Zinc Oxide	LOTION	TOPICAL	20210315		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4421_bd98d47b-0bd5-4d4c-e053-2a95a90a815c	63931-4421	HUMAN OTC DRUG	WL-AAJ-Z-W-914		Zinc Oxide	LOTION	TOPICAL	20210330		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4424_d5c805f8-cd66-70fe-e053-2995a90a706b	63931-4424	HUMAN OTC DRUG	WL-AAJ-Z-W-942		Zinc Oxide	LOTION	TOPICAL	20201026		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4431_cc0958ad-882f-7622-e053-2a95a90a907d	63931-4431	HUMAN OTC DRUG	WL-AAD-Z-W-971		Zinc Oxide	LOTION	TOPICAL	20210511		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4432_dcedb866-43b4-05bc-e053-2a95a90ab09f	63931-4432	HUMAN OTC DRUG	WL-AAD-Z-W-987		Zinc Oxide	LOTION	TOPICAL	20210504		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4437_c9ad92ea-ecc3-235f-e053-2a95a90a648f	63931-4437	HUMAN OTC DRUG	WL-AAB-Z-W-1026		Zinc Oxide	LOTION	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4438_cba6b8b4-f524-9c5f-e053-2995a90a15b0	63931-4438	HUMAN OTC DRUG	WL-AAB-Z-W-1001		Zinc Oxide	LOTION	TOPICAL	20210506		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4439_cba849ff-6c5f-8bf1-e053-2995a90ae3e4	63931-4439	HUMAN OTC DRUG	WL-AAB-Z-W-1003		Zinc Oxide	LOTION	TOPICAL	20210506		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4440_cba85b44-faff-9103-e053-2995a90a3b41	63931-4440	HUMAN OTC DRUG	WL-AAB-Z-W-988		Zinc Oxide	LOTION	TOPICAL	20210506		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4441_cba85b44-fb01-9103-e053-2995a90a3b41	63931-4441	HUMAN OTC DRUG	WL-AAB-Z-W-1018		Zinc Oxide	LOTION	TOPICAL	20210506		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4442_cc090f7e-6c1b-ef14-e053-2995a90a7f4f	63931-4442	HUMAN OTC DRUG	WL-AAB-Z-W-980		Zinc Oxide	LOTION	TOPICAL	20210809		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4443_cbe14598-e593-6b9b-e053-2a95a90a0af8	63931-4443	HUMAN OTC DRUG	WL-AAB-Z-W-982		Zinc Oxide	LOTION	TOPICAL	20210602		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4446_cba8cf3e-c2b9-7343-e053-2995a90a05a8	63931-4446	HUMAN OTC DRUG	WL-AAB-Z-W-1019		Zinc Oxide	LOTION	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4447_cbe84653-c4c1-3628-e053-2995a90a0011	63931-4447	HUMAN OTC DRUG	WL-AAE-ZT-O-414		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20210527		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-4448_cbe86a95-dcbd-5d6c-e053-2995a90aa939	63931-4448	HUMAN OTC DRUG	WL-AAE-ZT-O-416		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20210527		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-4449_b945c5d4-de72-ca68-e053-2995a90a12bc	63931-4449	HUMAN OTC DRUG	WL-AAD-Z-W-1049		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4450_b9464597-93cf-7260-e053-2a95a90a8f4c	63931-4450	HUMAN OTC DRUG	WL-AAD-Z-W-1050		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4451_b9465651-722f-e06b-e053-2995a90a777b	63931-4451	HUMAN OTC DRUG	WL-AAD-Z-W-1051		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4452_b9464cf4-007b-5cf9-e053-2a95a90a1b72	63931-4452	HUMAN OTC DRUG	WL-AAD-Z-W-1052		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4453_b94661c6-e00c-091b-e053-2a95a90ada43	63931-4453	HUMAN OTC DRUG	WL-AAD-Z-W-1053		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4454_b94661c6-e00f-091b-e053-2a95a90ada43	63931-4454	HUMAN OTC DRUG	WL-AAD-Z-W-1054		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4455_b9469aff-c7fb-3b18-e053-2a95a90a6279	63931-4455	HUMAN OTC DRUG	WL-AAD-Z-W-1055		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4456_b946a11a-f37a-706f-e053-2a95a90aa4be	63931-4456	HUMAN OTC DRUG	WL-AAD-Z-W-1056		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4457_b946a896-ed1f-9bd1-e053-2a95a90aef9a	63931-4457	HUMAN OTC DRUG	WL-AAD-Z-W-1057		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4458_b9469dad-395b-2e41-e053-2a95a90abd26	63931-4458	HUMAN OTC DRUG	WL-AAD-Z-W-1058		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4459_b946c0f3-b634-e9c2-e053-2995a90a909f	63931-4459	HUMAN OTC DRUG	WL-AAD-Z-W-1059		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4460_b946c56d-9f5c-646e-e053-2a95a90a9f7f	63931-4460	HUMAN OTC DRUG	WL-AAD-Z-W-1060		Zinc Oxide	LOTION	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4462_cbe71da5-4a29-a7b4-e053-2995a90a2e56	63931-4462	HUMAN OTC DRUG	WL-AAE-ZT-O-413		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20210527		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-4463_cbdfc922-6ec7-4dda-e053-2995a90aaa71	63931-4463	HUMAN OTC DRUG	WL-AAB-Z-W-1117		Zinc Oxide	LOTION	TOPICAL	20210524		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4464_cbe081fc-3ede-189b-e053-2a95a90ac74c	63931-4464	HUMAN OTC DRUG	WL-AAB-Z-W-1118		Zinc Oxide	LOTION	TOPICAL	20210627		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
63931-4465_deecf27a-a2db-d9a8-e053-2a95a90a9926	63931-4465	HUMAN OTC DRUG	WL-AAE-Z-O-1039		Zinc Oxide	LOTION	TOPICAL	20211004		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4466_dcedebee-6baa-0c8e-e053-2a95a90afb41	63931-4466	HUMAN OTC DRUG	WL-AAD-Z-W-1020		Zinc Oxide	LOTION	TOPICAL	20220418		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4468_e2259dc4-37b5-a9cb-e053-2a95a90ab91b	63931-4468	HUMAN OTC DRUG	WL-AAB-Z-W-1095		Zinc Oxide	LOTION	TOPICAL	20210515		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4469_da5b2a1d-d711-4456-e053-2995a90a704e	63931-4469	HUMAN OTC DRUG	WL-AAE-Z-O-1032		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4470_da588145-28c9-e48f-e053-2a95a90a7666	63931-4470	HUMAN OTC DRUG	WL-AAJ-Z-W-1138		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4473_d7ff41b0-1128-b4d7-e053-2995a90af849	63931-4473	HUMAN OTC DRUG	WL-AAD-Z-W-1038		Zinc Oxide	LOTION	TOPICAL	20220214		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4475_dc7ccbd0-4417-0bcb-e053-2995a90a06ce	63931-4475	HUMAN OTC DRUG	WL-AAD-Z-W-1062		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4476_dc88da28-9c39-ba09-e053-2995a90addc5	63931-4476	HUMAN OTC DRUG	WL-AAD-Z-W-1063		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4477_dc88ec6f-8480-26c1-e053-2a95a90a8b43	63931-4477	HUMAN OTC DRUG	WL-AAD-Z-W-1064		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4478_dc88f8e4-1d30-f204-e053-2a95a90ad6b3	63931-4478	HUMAN OTC DRUG	WL-AAD-Z-W-1065		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4479_da577c26-1652-08f5-e053-2995a90a247d	63931-4479	HUMAN OTC DRUG	WL-AAB-Z-W-1190		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4480_cb03faae-ef45-7f4b-e053-2995a90acc20	63931-4480	HUMAN OTC DRUG	WL-AAB-Z-W-1173		Zinc Oxide	LOTION	TOPICAL	20210826		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4482_ceb46cbb-bcb1-7de1-e053-2995a90a2767	63931-4482	HUMAN OTC DRUG	WL-AAD-Z-W-1189		Zinc Oxide	LOTION	TOPICAL	20211022		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	12	mg/mL			N	20241231
63931-4486_f4b16616-5ed7-65db-e053-2995a90a7efe	63931-4486	HUMAN OTC DRUG	WL-AAB-Z-W-403		Zinc Oxide	LOTION	TOPICAL	20220323		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4492_dcf1eeb8-6a49-81fb-e053-2a95a90a9511	63931-4492	HUMAN OTC DRUG	WL-AAD-Z-W-1226		Zinc Oxide	LOTION	TOPICAL	20220214		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4494_da6b1893-1871-09fd-e053-2995a90a4a0d	63931-4494	HUMAN OTC DRUG	WL-AAC-Z-A-1312		Zinc Oxide	STICK	TOPICAL	20220317		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	125	mg/g			N	20241231
63931-4495_da6c0af1-f93b-0abb-e053-2a95a90a9fd8	63931-4495	HUMAN OTC DRUG	WL-AAC-Z-A-1313		Zinc Oxide	STICK	TOPICAL	20220317		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	125	mg/g			N	20241231
63931-4496_da6c0ad8-f220-578e-e053-2995a90a441e	63931-4496	HUMAN OTC DRUG	WL-AAC-Z-A-1314		Zinc Oxide	STICK	TOPICAL	20220317		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	125	mg/g			N	20241231
63931-4497_dcee6328-1415-7f21-e053-2995a90a98f7	63931-4497	HUMAN OTC DRUG	WL-AAD-Z-W-1311		Zinc Oxide	LOTION	TOPICAL	20220418		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4505_da5e0bcf-ac57-40ab-e053-2995a90af60d	63931-4505	HUMAN OTC DRUG	WL-ACA-Z-A-1405		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	107	mg/mL			N	20241231
63931-4506_da5f0685-a4da-1ec6-e053-2a95a90a1bd2	63931-4506	HUMAN OTC DRUG	WL-ACA-Z-A-1428		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	107	mg/mL			N	20241231
63931-4507_da5f0685-a4dd-1ec6-e053-2a95a90a1bd2	63931-4507	HUMAN OTC DRUG	WL-ACA-Z-A-1444		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	107	mg/mL			N	20241231
63931-4508_da5c7713-d877-6863-e053-2995a90aaacb	63931-4508	HUMAN OTC DRUG	WL-AAE-ZT-O-1258		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-4511_da5722cb-9e87-be1d-e053-2995a90a2376	63931-4511	HUMAN OTC DRUG	WL-AAE-Z-O-1307		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4512_da55e0ee-3aaa-4ba5-e053-2995a90adbf4	63931-4512	HUMAN OTC DRUG	WL-AAE-Z-O-1342		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4516_d8afc9fa-1392-46da-e053-2a95a90a96c4	63931-4516	HUMAN OTC DRUG	WL-AAB-Z-W-1350		Zinc Oxide	LOTION	TOPICAL	20220223		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4517_d8afcf67-8560-dbac-e053-2a95a90aeee1	63931-4517	HUMAN OTC DRUG	WL-AAB-Z-W-1351		Zinc Oxide	LOTION	TOPICAL	20210826		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4518_d8afb8b5-8a76-07c8-e053-2a95a90a51b4	63931-4518	HUMAN OTC DRUG	WL-AAE-ZT-O-1337		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20220223		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-4520_f4abf64d-5042-3182-e053-2a95a90ae2ae	63931-4520	HUMAN OTC DRUG	WL-AAD-Z-W-1371 (Master Alleyoop)		Zinc Oxide	LOTION	TOPICAL	20221205		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4523_f4ae77cc-fe9b-75cf-e053-2a95a90a79b1	63931-4523	HUMAN OTC DRUG	WL-AAD-Z-W-1374 (Alleyoop Shade 3)		Zinc Oxide	LOTION	TOPICAL	20221205		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4527_f4ae9ed6-293c-f2f0-e053-2a95a90a14ee	63931-4527	HUMAN OTC DRUG	WL-AAD-Z-W-1399		Zinc Oxide	LOTION	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	110	mg/mL			N	20241231
63931-4528_dd2bbdd9-9c64-7cda-e053-2a95a90adbd2	63931-4528	HUMAN OTC DRUG	WL-AAD-Z-W-1347		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	110	mg/mL			N	20241231
63931-4529_dd9527f5-c1f5-5cec-e053-2a95a90ab6b0	63931-4529	HUMAN OTC DRUG	WL-AAD-Z-W-1386		Zinc Oxide	LOTION	TOPICAL	20220426		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	110	mg/mL			N	20241231
63931-4530_d7ff8a2b-01c8-4e5d-e053-2995a90a4bb7	63931-4530	HUMAN OTC DRUG	WL-AAD-Z-W-1367		Zinc Oxide	LOTION	TOPICAL	20220214		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4532_e54775c9-66d5-60e2-e053-2a95a90a8541	63931-4532	HUMAN OTC DRUG	WL-AAB-Z-W-404		Zinc Oxide	LOTION	TOPICAL	20220802		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4537_f4b2f6b9-d1f8-5ea9-e053-2a95a90a4d60	63931-4537	HUMAN OTC DRUG	WL-AAE-ZT-O-1151		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20220501		OTC MONOGRAPH FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-4540_f4b27385-f6d8-1c5c-e053-2a95a90a6a0c	63931-4540	HUMAN OTC DRUG	WL-AAB-Z-W-1321		Zinc Oxide	LOTION	TOPICAL	20220502		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4543_da5d8bfd-d706-6e47-e053-2995a90ad59d	63931-4543	HUMAN OTC DRUG	WL-ACA-Z-A-1473		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	107	mg/mL			N	20241231
63931-4547_f4b260d9-34b6-479e-e053-2a95a90ab01f	63931-4547	HUMAN OTC DRUG	WL-AAD-Z-W-1502		Zinc Oxide	LOTION	TOPICAL	20220418		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63931-4557_ed2069ac-155d-9129-e053-2995a90a44b0	63931-4557	HUMAN OTC DRUG	WL-AAE-ZT-O-408		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20220617		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
63931-4569_f8fca5a6-5fee-cdc4-e053-6394a90ac45d	63931-4569	HUMAN OTC DRUG	WL-AAE-Z-O-1720		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	174	mg/mL			N	20241231
63931-4572_f4ea502e-0e69-e532-e053-2a95a90a6c18	63931-4572	HUMAN OTC DRUG	WL-AAS-Z-A-1761		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	100	mg/mL			N	20241231
63931-4573_f4e85233-4523-f36d-e053-2a95a90aa7d3	63931-4573	HUMAN OTC DRUG	WL-AAS-Z-A-1762		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	100	mg/mL			N	20241231
63931-4574_f4eb2719-4f58-14e9-e053-2a95a90a9af8	63931-4574	HUMAN OTC DRUG	WL-AAS-Z-A-1763		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	100	mg/mL			N	20241231
63931-4580_f938dfaa-58b0-e20e-e053-6394a90a3912	63931-4580	HUMAN OTC DRUG	WL-AAD-Z-W-1676		Zinc Oxide	LOTION	TOPICAL	20230329		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	132	mg/mL			N	20241231
63936-0975_08846c1b-91f8-aadf-e063-6294a90accfa	63936-0975	HUMAN OTC DRUG	Stopain Clinical		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20170119		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL, UNSPECIFIED FORM	100	mg/g			N	20241231
63936-4850_0884f72a-a1fa-5ed2-e063-6294a90ae225	63936-4850	HUMAN OTC DRUG	Stopain Extra Strength Continuous		MENTHOL	SPRAY	TOPICAL	20180401		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	80	mg/mL			N	20241231
63936-8508_06e9dc12-acb9-3d79-e063-6294a90ad7a6	63936-8508	HUMAN OTC DRUG	ULTRA STRENGTH STOPAIN PAIN RELIEVING		MENTHOL	SPRAY	TOPICAL	20101129	20240131	OTC MONOGRAPH DRUG	M017	TROY MANUFACTURING	MENTHOL	80	mg/mL			N	
63936-8523_0885415f-b00d-4dd2-e063-6294a90ac5ac	63936-8523	HUMAN OTC DRUG	EXTRA STRENGTH STOPAIN COLD PAIN RELIEVING ROLL ON		MENTHOL	LIQUID	TOPICAL	20101013		OTC MONOGRAPH DRUG	M017	TROY MANUFACTURING, INC	MENTHOL	80	mg/mL			N	20241231
63936-8558_06ea3b0d-2e5d-d536-e063-6294a90a460c	63936-8558	HUMAN OTC DRUG	STOPAIN COLD PAIN RELIEVING		MENTHOL	SPRAY	TOPICAL	20101013	20240131	OTC MONOGRAPH DRUG	M017	TROY MANUFACTURING, INC	MENTHOL	60	mg/mL			N	
63936-8700_f318d14a-9f86-4238-e053-2995a90abc15	63936-8700	HUMAN OTC DRUG	Stopain Migraine Pain Relieving		MENTHOLUM, BELLADONNA, IRIS VERSICOLOR, SANGUINARIA CANADENSIS	GEL	TOPICAL	20150320		UNAPPROVED HOMEOPATHIC		TROY MANUFACTURING, INC	ATROPA BELLADONNA; IRIS VERSICOLOR ROOT; MENTHOL, UNSPECIFIED FORM; SANGUINARIA CANADENSIS ROOT	3; 6; 1; 6	[hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
63936-8800_0943e773-5f0e-91f1-e063-6294a90a17f4	63936-8800	HUMAN OTC DRUG	Stopain Extra Strength Gel		MENTHOL	GEL	TOPICAL	20221010		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	80	mg/mL			N	20241231
63936-8801_08854bfe-b2b2-e134-e063-6394a90a773f	63936-8801	HUMAN OTC DRUG	Stopain Extra Strength		MENTHOL	GEL	TOPICAL	20230131		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	80	mg/g			N	20241231
63936-9500_06ea3d35-67db-d0b8-e063-6294a90a5b0c	63936-9500	HUMAN OTC DRUG	Stopain Clinical		MENTHOL, UNSPECIFIED FORM	SPRAY	TOPICAL	20170118	20240131	OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL, UNSPECIFIED FORM	100	mg/mL			N	
63936-9504_0884f72a-a1eb-5ed2-e063-6294a90ae225	63936-9504	HUMAN OTC DRUG	Stopain Clinical Continuous		MENTHOL	LIQUID	TOPICAL	20200101		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	100	mg/mL			N	20241231
63936-9505_0884e870-1c24-0062-e063-6294a90a1b89	63936-9505	HUMAN OTC DRUG	Stopain Clinical		MENTHOL	GEL	TOPICAL	20210809		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	100	mg/mL			N	20241231
63936-9506_0885356c-11ff-ff76-e063-6294a90a44a3	63936-9506	HUMAN OTC DRUG	Stopain Extra Strength Gel		MENTHOL	GEL	TOPICAL	20220124		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	80	mg/mL			N	20241231
63936-9520_08846c1b-91e9-aadf-e063-6294a90accfa	63936-9520	HUMAN OTC DRUG	Stopain Clinical Roll-On		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20170118		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL, UNSPECIFIED FORM	100	mg/mL			N	20241231
63936-9700_f318667c-c615-79fc-e053-2995a90ae7cb	63936-9700	HUMAN OTC DRUG	STOPAIN CLINICAL Migraine and Headache		MENTHOL, UNSPECIFIED FORM, ATROPA BELLADONNA, IRIS VERSICOLOR ROOT, SANGUINARIA CANADENSIS ROOT	GEL	TOPICAL	20180701		UNAPPROVED HOMEOPATHIC		Troy Manufacturing, Inc.	ATROPA BELLADONNA; IRIS VERSICOLOR ROOT; MENTHOL, UNSPECIFIED FORM; SANGUINARIA CANADENSIS ROOT	3; 6; 1; 6	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
63936-9750_0884f72a-a20b-5ed2-e063-6294a90ae225	63936-9750	HUMAN OTC DRUG	Stopain Clinical		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20170118		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL, UNSPECIFIED FORM	100	mg/mL			N	20241231
63936-9751_0885415f-b01d-4dd2-e063-6294a90ac5ac	63936-9751	HUMAN OTC DRUG	Stopain Clinical		MENTHOL	GEL	TOPICAL	20230131		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	100	mg/g			N	20241231
63936-9758_0884e870-1c34-0062-e063-6294a90a1b89	63936-9758	HUMAN OTC DRUG	Stopain Clinical		MENTHOL	GEL	TOPICAL	20221130		OTC MONOGRAPH DRUG	M017	Troy Manufacturing, Inc.	MENTHOL	100	mg/g			N	20241231
63940-003_f2a30cca-7ee4-6d2d-e053-2a95a90ad511	63940-003	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Pen	LIQUID	TOPICAL	20140218		OTC MONOGRAPH FINAL	part333C	Harmon Store Inc.	UNDECYLENIC ACID	25	mg/1.7mL			N	20241231
63940-004_6b8e01e7-2a95-4452-b7b7-938ecc9be2f1	63940-004	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20150224		OTC MONOGRAPH FINAL	part355	Liberty Procurement, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
63940-006_f2a3046d-2beb-5629-e053-2a95a90a8687	63940-006	HUMAN OTC DRUG	Tolnaftate		Athletes Foot Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20120214		OTC MONOGRAPH FINAL	part333C	Harmon Store Inc.	TOLNAFTATE	1.5	g/150g			N	20241231
63940-008_f2a2f8df-741a-2124-e053-2995a90a7ca5	63940-008	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20120117		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc.	SALICYLIC ACID	40	mg/91			N	20241231
63940-009_f2a2e754-7a92-ba33-e053-2995a90a85f6	63940-009	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover	LIQUID	TOPICAL	20120124		OTC MONOGRAPH FINAL	part358B	Harmon Store Inc.	SALICYLIC ACID	.17	mg/15mL			N	20241231
63940-010_f2a2fd19-570c-ba31-e053-2995a90a6b75	63940-010	HUMAN OTC DRUG	Salicylic Acid		Extra Thick Callus Remover	PATCH	TOPICAL	20140218		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc.	SALICYLIC ACID	40	mg/41			N	20241231
63940-011_f2a2cb4f-c5b5-61b1-e053-2995a90a441f	63940-011	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Powder Spray	AEROSOL, SPRAY	TOPICAL	20120127		OTC MONOGRAPH FINAL	part333C	Harmon Store Inc.	TOLNAFTATE	1.3	g/113g			N	20241231
63940-012_f2a2e754-7a94-ba33-e053-2995a90a85f6	63940-012	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20120214		OTC MONOGRAPH NOT FINAL	part333A	Harmon Store Inc.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/10mL; mg/10mL			N	20241231
63940-014_f2a2e754-7a93-ba33-e053-2995a90a85f6	63940-014	HUMAN OTC DRUG	Menthol		Maximum Strength Medicated Foot Powder	POWDER	TOPICAL	20120101		OTC MONOGRAPH NOT FINAL	part348	Harmon Store Inc.	MENTHOL	2.8	g/283g			N	20241231
63940-016_f2a2d8f1-699a-140d-e053-2a95a90a9178	63940-016	HUMAN OTC DRUG	Salicylic Acid		One Step Corn Remover	PATCH	TOPICAL	20120328		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc.	SALICYLIC ACID	40	mg/61			N	20241231
63940-018_f28f1c00-09d7-4d58-e053-2995a90a8b79	63940-018	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20120105		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc.	SALICYLIC ACID	40	mg/91			N	20241231
63940-019_f28f25f8-721a-701e-e053-2995a90ae7ee	63940-019	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20150924		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc	SALICYLIC ACID	.17	g/9mL			N	20241231
63940-021_f2a2eddf-2fdf-5625-e053-2a95a90aaf80	63940-021	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover Liquid	LIQUID	TOPICAL	20150924		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc.	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
63940-022_f2a2ee93-3e6f-5627-e053-2a95a90af847	63940-022	HUMAN OTC DRUG	Allantoin		Advanced Derma Therapy	SPRAY	TOPICAL	20150904		OTC MONOGRAPH FINAL	part347	Harmon Store Inc.	ALLANTOIN	.425	g/85g			N	20241231
63940-023_f28f5c34-891f-185e-e053-2a95a90a58fa	63940-023	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel Pen	GEL	TOPICAL	20150901		OTC MONOGRAPH FINAL	part358B	Harmon Store Inc.	SALICYLIC ACID	.17	g/g			N	20241231
63940-024_f2a2eddf-2fe1-5625-e053-2a95a90aaf80	63940-024	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief	SPRAY	TOPICAL	20120403		OTC MONOGRAPH NOT FINAL	part348	Harmon Store Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63940-025_f2a33a58-8017-2e6a-e053-2a95a90a999f	63940-025	HUMAN OTC DRUG	Miconazole Nitrate		Antifungal Liquid Continuous Spray	AEROSOL, SPRAY	TOPICAL	20120117		OTC MONOGRAPH FINAL	part333C	Harmon Store Inc.	MICONAZOLE NITRATE	3	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63940-026_f2a2ee93-3e70-5627-e053-2a95a90af847	63940-026	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20120117		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc.	SALICYLIC ACID	40	mg/41			N	20241231
63940-027_f2a2f8df-741b-2124-e053-2995a90a7ca5	63940-027	HUMAN OTC DRUG	Undecylenic Acid		Antifungal Solution	LIQUID	TOPICAL	20131120		OTC MONOGRAPH FINAL	part333C	Harmon Store Inc.	UNDECYLENIC ACID	7.5	g/30g			N	20241231
63940-028_f28ef69d-3981-38a3-e053-2995a90a6950	63940-028	HUMAN OTC DRUG	Maximum Strength Antifungal Liquid		Tolnaftate	LIQUID	TOPICAL	20220921		OTC MONOGRAPH FINAL	part333C	Harmon Store Inc.	TOLNAFTATE	.3	g/30mL			N	20241231
63940-032_d7aab78e-fd33-484e-8597-7eefd1c73427	63940-032	HUMAN OTC DRUG	core values minoxidil		minoxidil	SOLUTION	TOPICAL	20210706		ANDA	ANDA075598	Harmon Stores Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63940-035_0d2aaa83-e833-cccd-e063-6294a90acf53	63940-035	HUMAN OTC DRUG	Core Values Eye Drops Dry Eye Relief		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20230330		OTC MONOGRAPH DRUG	M018	Liberty Procurement Co. Inc.	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
63940-043_6ccf23ae-8475-40b3-b383-49afb4d46ffb	63940-043	HUMAN OTC DRUG	Core Values Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20161122		ANDA	ANDA078336	Harmon Stores Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63940-050_b86bad7e-9b26-71f0-e053-2995a90a1f1e	63940-050	HUMAN OTC DRUG	ECZEMA MOISTURIZING		COLLOIDAL OATMEAL	LOTION	TOPICAL	20150210		OTC MONOGRAPH FINAL	part347	Harmon Stores Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
63940-051_d4dea11b-2af1-c70e-e053-2a95a90af86b	63940-051	HUMAN OTC DRUG	HARMON FACE VALUES BREAK-OUT FREE SPF 55 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20151207		OTC MONOGRAPH NOT FINAL	part352	Harmon Stores Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 40; 45; 60; 45	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-052_c71a9661-2618-f65c-e053-2995a90a62a5	63940-052	HUMAN OTC DRUG	ACNE WASH		SALICYLIC ACID	LIQUID	TOPICAL	20151002		OTC MONOGRAPH FINAL	part358H	Harmon Stores Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
63940-053_91b68342-9e60-4a38-a1db-ab408fea2c8a	63940-053	HUMAN OTC DRUG	ACNE WASH		SALICYLIC ACID	LIQUID	TOPICAL	20160205		OTC MONOGRAPH FINAL	part358H	Harmon Stores Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
63940-054_87543d43-c64f-4cce-bb8a-74e84654cc2a	63940-054	HUMAN OTC DRUG	ACNE WASH		SALICYLIC ACID	LIQUID	TOPICAL	20100729		OTC MONOGRAPH FINAL	part358H	Harmon Stores Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
63940-056_c71ad08a-a6db-db30-e053-2995a90a4cef	63940-056	HUMAN OTC DRUG	FACE VALUES ULTRA LIGHT BODY MIST SUNSCREEN SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20110725		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 23.5	mg/g; mg/g; mg/g; mg/g			N	20241231
63940-059_a5e4dc4a-6f67-4420-a62e-fc55db38c612	63940-059	HUMAN OTC DRUG	FACE VALUES WET N DRY WET SKIN SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20140606		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 40; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
63940-062_742c39de-76ab-47c4-8f93-e74eb5a84000	63940-062	HUMAN OTC DRUG	FACE VALUES DAILY FACIAL MOISTURIZING SPF 30 SUNSCREEN		HOMOSALATE, OCTINOXATE, ZINC OXIDE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20171027		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	HOMOSALATE; OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	120; 75; 20; 35	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63940-063_0d3d3ebc-22fa-433d-9aea-19605279985f	63940-063	HUMAN OTC DRUG	FACE VALUES ACNE MEDICATION		BENZOYL PEROXIDE	GEL	TOPICAL	20101115		OTC MONOGRAPH FINAL	part333D	HARMON STORES, INC.	BENZOYL PEROXIDE	100	mg/g			N	20241231
63940-065_d51f311d-52db-451a-9303-aa0560ced942	63940-065	HUMAN OTC DRUG	HARMON FACE VALUES ULTRA LIGHT DRY TO THE TOUCH SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OXYBENZONE	LOTION	TOPICAL	20110705		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 70; 75; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-066_a9ac126e-960a-49a6-baee-1811c01ba7a8	63940-066	HUMAN OTC DRUG	FACE VALUES RADIANT FACIAL DAILY MOISTURIZER SPF 15 SUNSCREEN		AVOBENZONE, OCTINOXATE, OCTISALATE	LOTION	TOPICAL	20101027		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
63940-067_f119e412-c34c-7b9a-e053-2a95a90ac57b	63940-067	HUMAN OTC DRUG	FACE VALUES ULTRA SPORT ACTIVE SPF 30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20080229		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 45; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-068_c54dd017-805d-3756-e053-2a95a90a733e	63940-068	HUMAN OTC DRUG	FACE VALUES ULTRA SPORT ACTIVE SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170406		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-069_0c029296-b269-4a99-89b8-083ad8fe2597	63940-069	HUMAN OTC DRUG	Petrolatum		White Petrolatum	JELLY	TOPICAL	19930316		OTC MONOGRAPH FINAL	part347	Liberty Procurement, Inc	PETROLATUM	1	g/g			N	20241231
63940-070_c706c85b-26ab-4fef-e053-2a95a90a79d7	63940-070	HUMAN OTC DRUG	FACE VALUES ULTRA SPORT ACTIVE SPF 15 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE	AEROSOL, SPRAY	TOPICAL	20080227		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE	20; 100; 50	mg/g; mg/g; mg/g			N	20241231
63940-071_c54e50ec-9967-94cb-e053-2a95a90a815d	63940-071	HUMAN OTC DRUG	FACE VALUES ULTRA SPORT ACTIVE SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20140211		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-072_ec34faf2-a577-46f3-869f-37c657d98226	63940-072	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19951009		OTC MONOGRAPH NOT FINAL	part356	Liberty Chemical CO.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-073_cee3e430-4905-2772-e053-2a95a90a1dd1	63940-073	HUMAN OTC DRUG	FACE VALUES SPF 15 FACIAL MOISTURIZER		OCTINOXATE, OCTISALATE, OXYBENZONE	LOTION	TOPICAL	20130308		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	OCTINOXATE; OCTISALATE; OXYBENZONE	30; 50; 30	mg/mL; mg/mL; mg/mL			N	20241231
63940-074_cee4887a-839f-f762-e053-2995a90a0bf8	63940-074	HUMAN OTC DRUG	HARMON DAILY MOISTURZIER		DIMETHICONE	LOTION	TOPICAL	20120505		OTC MONOGRAPH FINAL	part347	HARMON STORES, INC.	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
63940-075_c510b5f1-edf1-5095-e053-2a95a90a463f	63940-075	HUMAN OTC DRUG	Harmon Face Values Ultra Light Dry to the Touch Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20190829		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-076_c52b3490-9985-1077-e053-2a95a90a1ca5	63940-076	HUMAN OTC DRUG	Harmon Face Values Ultra Light Dry to the Touch SPF 100 Sunscreen		avobenzone, homosalate, octisalate, octocrylene, oxybenzone	LOTION	TOPICAL	20191203		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-077_c5eb5027-84be-cddb-e053-2a95a90a5367	63940-077	HUMAN OTC DRUG	Harmon Face Values Ultra Light Dry to the Touch Sunscreen Broad Spectrum SPF 45		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 28	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-078_c6171104-6f0c-0491-e053-2a95a90a7496	63940-078	HUMAN OTC DRUG	Harmon Face Values Ultra Light Dry to the Touch Suncreen SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20120323		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-079_c62832d1-11e2-822a-e053-2995a90a0d9f	63940-079	HUMAN OTC DRUG	Face Values Ultra Light Dry to the Touch Sunscreen Broad Spectrum SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190829		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-080_bb0331c9-1560-3972-e053-2a95a90ab803	63940-080	HUMAN OTC DRUG	Harmon Core Values Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20190115		OTC MONOGRAPH NOT FINAL	part334	HARMON STORES, INC.	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63940-081_d4deca05-bc87-d760-e053-2a95a90a17f8	63940-081	HUMAN OTC DRUG	HARMON FACE VALUES BREAK-OUT FREE SPF 55 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20210111		OTC MONOGRAPH NOT FINAL	part352	Harmon Stores Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 40; 45; 60; 45	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-082_d5542717-0457-6350-e053-2a95a90aee62	63940-082	HUMAN OTC DRUG	Harmon Face Values Oil-Free Body Wash Salicylic Acid Acne Treatment Pink Grapefruit		SALICYLIC ACID	LIQUID	TOPICAL	20140306		OTC MONOGRAPH FINAL	part358B	HARMON STORES, INC.	SALICYLIC ACID	20	mg/mL			N	20241231
63940-083_e068aeed-b04c-9ff1-e053-2a95a90ab050	63940-083	HUMAN OTC DRUG	Harmon Face Values Blemishes and Blackheads Apricot Scrub		SALICYLIC ACID	EMULSION	TOPICAL	20100619		OTC MONOGRAPH FINAL	part333D	HARMON STORES, INC.	SALICYLIC ACID	20	mg/g			N	20241231
63940-084_e4bc9df7-b09e-01fb-e053-2995a90a295d	63940-084	HUMAN OTC DRUG	HARMON FACE VALUES ULTRA SPORT ACTIVE SUNSCREEN SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	AEROSOL, SPRAY	TOPICAL	20080313		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
63940-085_f071a44f-c122-3afc-e053-2995a90adf5b	63940-085	HUMAN OTC DRUG	FACE VALUES WET N DRY WET SKIN SUNSCREEN SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210702		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
63940-086_f0f0ebb0-132f-8517-e053-2a95a90a89d5	63940-086	HUMAN OTC DRUG	HARMON FACE VALUES REFRESHING COOLING BODY MIST SUNSCREEN SPF 45		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 23.5	mg/g; mg/g; mg/g; mg/g			N	20241231
63940-087_24cf3e7e-8e33-4507-b513-489433572b15	63940-087	HUMAN OTC DRUG	Core Values Tussin DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20161122		OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63940-088_f13e5aa7-f109-5874-e053-2995a90ac718	63940-088	HUMAN OTC DRUG	HARMON FACE VALUES ULTRA SPORT ACTIVE SUNSCREEN SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20090522		OTC MONOGRAPH NOT FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
63940-089_f31f17c7-b922-48a5-e053-2a95a90a5058	63940-089	HUMAN OTC DRUG	Harmon Face Values All-Day Skin Relief Moisturizing		DIMETHICONE	LOTION	TOPICAL	20170116		OTC MONOGRAPH FINAL	part347	HARMON STORES, INC.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
63940-096_f3329241-2268-3420-e053-2995a90a915f	63940-096	HUMAN OTC DRUG	Harmon Face Values Ultra Light Dry to the Touch Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190829		OTC MONOGRAPH FINAL	part352	HARMON STORES, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-097_f71b4c43-e9b2-b8f5-e053-6294a90ace73	63940-097	HUMAN OTC DRUG	Harmon Face Values Daily Facial Moisturizing with Sunscreen SPF 15 For All Skin Types		AVOBENZONE, OCTOCRYLENE	LOTION	TOPICAL	20191206		OTC MONOGRAPH FINAL	M020	HARMON STORES, INC.	AVOBENZONE; OCTOCRYLENE	30; 100	mg/mL; mg/mL			N	20241231
63940-119_fff00fd0-0dae-4abd-8581-cabbd6b28fe8	63940-119	HUMAN OTC DRUG	core values anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20170728		ANDA	ANDA075232	Harmon Stores Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63940-131_3e9c345d-e1d8-4f55-97f6-1d206d369880	63940-131	HUMAN OTC DRUG	Core Values Tussin CF		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20161122		OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63940-162_f28f177f-d751-2e56-e053-2a95a90abc8c	63940-162	HUMAN OTC DRUG	Medicated Plantar Wart Remover		Salicylic acid	PATCH	TOPICAL	20220819		OTC MONOGRAPH FINAL	part358B	Harmon Store Inc.	SALICYLIC ACID	40	mg/241			N	20241231
63940-163_c803c998-f7d3-4212-a70b-5ce67bc1692c	63940-163	HUMAN OTC DRUG	Anticavity		SODIUM FLUORIDE	MOUTHWASH	ORAL	20160706		OTC MONOGRAPH FINAL	part355	Liberty Procurement, Inc	SODIUM FLUORIDE	.1	mg/mL			N	20241231
63940-165_f28f177f-d752-2e56-e053-2a95a90abc8c	63940-165	HUMAN OTC DRUG	Clear Gel Corn Remover		Salicylic Acid	PATCH	TOPICAL	20180101		OTC MONOGRAPH FINAL	part358F	Harmon Store Inc.	SALICYLIC ACID	40	mg/61			N	20241231
63940-202_6b496d24-7536-4841-a277-08fbca2b6683	63940-202	HUMAN OTC DRUG	harmon face values minoxidil		minoxidil	SOLUTION	TOPICAL	20111218		ANDA	ANDA075357	Harmon Stores Inc.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63940-213_643c998b-57b8-429a-a939-23cf9abcb289	63940-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20160706		OTC MONOGRAPH FINAL	part355	Liberty Procurement, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
63940-219_1f499d0d-9d7c-4814-a8ae-69f58db6bd46	63940-219	HUMAN OTC DRUG	core values childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20171114		ANDA	ANDA074937	Harmon Stores Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63940-224_820e1386-ac98-45d2-b6d0-af7beaf454cd	63940-224	HUMAN OTC DRUG	harmon face values anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20111218		ANDA	ANDA075232	Harmon Stores Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63940-242_94027fba-a071-44ab-89fa-14f2f4a171b9	63940-242	HUMAN OTC DRUG	Core Values Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20161122		NDA	NDA022032	Harmon Stores Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63940-299_82b7b57c-df52-431c-bce5-6cda3eec044a	63940-299	HUMAN OTC DRUG	Antiseptic		Cetylpyridinium chloride	MOUTHWASH	ORAL	20160711		OTC MONOGRAPH NOT FINAL	part356	Liberty Procurement, Inc	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
63940-309_a0749b77-e8bf-4e25-b7ff-5064bde8ee94	63940-309	HUMAN OTC DRUG	core values pain and fever		Acetaminophen	SUSPENSION	ORAL	20171106		OTC MONOGRAPH NOT FINAL	part343	Harmon Stores Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
63940-318_9ae5dd94-2236-412f-b94c-cbee17c9a59f	63940-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20160620		OTC MONOGRAPH NOT FINAL	part356	Liberty Procurement, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-320_ee2b0242-9a60-c26d-e053-2a95a90a7b6f	63940-320	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, COATED	ORAL	20091109	20250531	OTC MONOGRAPH NOT FINAL	part343	Harmon Stores Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
63940-330_e52e7685-35e3-c0b2-e053-2a95a90abb25	63940-330	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20240831	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63940-332_e52e8216-a362-7897-e053-2a95a90adb42	63940-332	HUMAN OTC DRUG	Cold Max		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20240630	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63940-333_ee2b0242-9a62-c26d-e053-2a95a90a7b6f	63940-333	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20180911	20241231	OTC MONOGRAPH NOT FINAL	part343	Harmon Stores Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
63940-336_1b4288c2-1d06-4799-b3fa-9919a5f0982a	63940-336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxind HCl	LOTION	TOPICAL	20160908		OTC MONOGRAPH FINAL	part347	Liberty Procurement, Inc	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	8.6; 10; 20	mg/mL; mg/mL; mg/mL			N	20241231
63940-337_ee2afa52-0cb9-ac41-e053-2995a90a79c1	63940-337	HUMAN OTC DRUG	Severe Congestion		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20241231	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63940-339_e52e8746-218d-4151-e053-2995a90ae7ad	63940-339	HUMAN OTC DRUG	Pressure Pain Mucus		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20240831	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63940-340_e52e95b9-15b6-0aa4-e053-2995a90afbd5	63940-340	HUMAN OTC DRUG	Pressure Pain Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20240630	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63940-341_e52e95b9-15b7-0aa4-e053-2995a90afbd5	63940-341	HUMAN OTC DRUG	Cold Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20240831	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
63940-342_ee2affbc-63ca-96b0-e053-2995a90a94b6	63940-342	HUMAN OTC DRUG	Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20240731	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63940-344_0d2a55f9-19c8-74eb-e063-6294a90a700e	63940-344	HUMAN OTC DRUG	Core Values Eye Drops Advanced Relief		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	Liberty Procurement Co., Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
63940-363_ee2af522-0230-1e8f-e053-2995a90a4d3d	63940-363	HUMAN OTC DRUG	Cold Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180911	20241130	OTC MONOGRAPH FINAL	part341	Harmon Stores Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63940-370_53121c39-90ea-4763-b27a-b09fd2e50a43	63940-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20140218		OTC MONOGRAPH NOT FINAL	part333A	Harmon Store Inc.	ALCOHOL	70	mL/100mL			N	20241231
63940-374_42aa76f1-aadf-4d23-bfbf-9db683053248	63940-374	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191219		OTC MONOGRAPH NOT FINAL	part333A	Liberty Procurement, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63940-385_12146a69-9bc7-4d13-91d6-63fe1010a177	63940-385	HUMAN OTC DRUG	Core Values Minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20170517		ANDA	ANDA091344	Harmon Stores Inc.	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63940-434_f0e76a80-74da-47f7-aae7-d2cd963c5e25	63940-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20160610		OTC MONOGRAPH NOT FINAL	part356	Liberty Procurement, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-435_259f34a8-c237-4a02-9b7a-6dd0d8a63732	63940-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150915		OTC MONOGRAPH FINAL	part355	Libertu Procurement, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
63940-436_e94383b2-344e-42ac-a1b2-6505ad737b36	63940-436	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20160908		OTC MONOGRAPH FINAL	part347	Liberty Procurement, Inc	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
63940-439_17e8c910-607f-401d-b531-de113550086c	63940-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Alcohol	GEL	TOPICAL	20140218		OTC MONOGRAPH NOT FINAL	part333A	Harmon Stores, Inc	ALCOHOL	616	mL/mL			N	20241231
63940-466_733fb419-6760-4067-9f5b-e2da56e06ed5	63940-466	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20160217		OTC MONOGRAPH NOT FINAL	part333A	Harmon Stores, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63940-482_44e1e31c-7a57-42d4-8152-d0be1ef7fbd9	63940-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20161128		OTC MONOGRAPH FINAL	part355	Liberty Procurement, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
63940-484_7c5e4c95-80ac-4134-a3ac-fefa155abd4b	63940-484	HUMAN OTC DRUG	core values pain reliever		Acetaminophen	TABLET	ORAL	20181126		OTC MONOGRAPH NOT FINAL	part343	Harmon Stores Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
63940-491_13b15a42-1833-48c1-85d5-ca3d7a66d319	63940-491	HUMAN OTC DRUG	Core Values Minoxidil		minoxidil	SOLUTION	TOPICAL	20170517		ANDA	ANDA075357	Harmon Stores Inc.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63940-500_f28f5c34-88e6-185e-e053-2a95a90a58fa	63940-500	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20170415		OTC MONOGRAPH FINAL	part333C	Harmon Store Inc.	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
63940-509_c092bffc-9784-4c33-a74a-4cceb047b734	63940-509	HUMAN OTC DRUG	core values minoxidil		Minoxidil	SOLUTION	TOPICAL	20211215		ANDA	ANDA075357	Harmon Stores Inc.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63940-532_8f99a6c0-478d-401d-b055-1de35693147d	63940-532	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, FILM COATED	ORAL	20051222	20240322	OTC MONOGRAPH FINAL	part341	Harmon Store Inc.	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
63940-575_abf4a3ae-21be-408b-8401-86cbe8368b15	63940-575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160304		OTC MONOGRAPH NOT FINAL	part333A	Harmon Stores, Inc	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
63940-582_f578202c-9f8a-4bf7-a21c-7ffb8f3f9b8f	63940-582	HUMAN OTC DRUG	Core Values Minoxidil		Minoxidil	SOLUTION	TOPICAL	20170517		ANDA	ANDA075598	Harmon Stores Inc.	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63940-602_53fdc03d-5cb7-4955-a960-536fb5ee9f4d	63940-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20160711		OTC MONOGRAPH NOT FINAL	part334	Liberty Procurement, Inc	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63940-619_3c5d6704-493a-464d-b308-90e4ecb97620	63940-619	HUMAN OTC DRUG	Harmon Core Values Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20161114		OTC MONOGRAPH NOT FINAL	part343	Harmon Stores Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
63940-628_c847a79e-8e88-4390-83b3-3cffc0f880d1	63940-628	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20161220		OTC MONOGRAPH NOT FINAL	part333A	Liberty Procurement, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63940-664_0e759736-344e-4058-8ab2-fa9ba84cf7d7	63940-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19930521		OTC MONOGRAPH NOT FINAL	part356	Liberty Procurement, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-804_209ee56e-84e3-4827-b1a3-28de7161a2b3	63940-804	HUMAN OTC DRUG	91%		Isopropyl alcohol	LIQUID	TOPICAL	20090518		OTC MONOGRAPH NOT FINAL	part333A	Liberty Procurement, Inc	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
63940-810_04881037-6bbe-4db9-90d5-080ed7ab3843	63940-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20090518		OTC MONOGRAPH NOT FINAL	part333A	Liberty Procurement, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
63940-822_52e40588-6fc2-4bab-a855-567e094cc207	63940-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20110408		OTC MONOGRAPH FINAL	part347	Liberty Procurement, Inc	WITCH HAZEL	841	mg/mL			N	20241231
63940-855_ea22af8b-bfdf-4ac7-858b-b54289391bf4	63940-855	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part356	Liberty Procurement, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63940-871_bdc92f4b-0167-4939-b788-16d9e2d0118a	63940-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20090612		OTC MONOGRAPH NOT FINAL	part333A	Liberty Procurement, Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
63940-876_360378b4-fb73-4460-b72f-885b94da08e4	63940-876	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20110420		OTC MONOGRAPH NOT FINAL	part333A	Liberty Procurement, Inc	ALCOHOL	70	mL/100mL			N	20241231
63940-904_f38c02a9-4bea-4932-a6e5-b7c1d4a2e94e	63940-904	HUMAN OTC DRUG	Core Values Allergy Relief		Loratadine	TABLET	ORAL	20111218		ANDA	ANDA076301	Harmon Stores Inc.	LORATADINE	10	mg/1			N	20241231
63940-911_cb0fbb21-ddb0-48fc-935a-9fcc367af890	63940-911	HUMAN OTC DRUG	PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20180301		OTC MONOGRAPH NOT FINAL	part348	Liberty Procurement, In	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63940-971_4b9118c8-4080-4e75-8163-d080ca401455	63940-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20221103		OTC MONOGRAPH FINAL	part355	Liberty Procurement, Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
63941-001_c60f4840-9591-43da-bcdd-44a5215f3033	63941-001	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19950609		OTC MONOGRAPH NOT FINAL	part356	Valu Merchandisers Co.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63941-003_f5e0e658-6757-43ff-81aa-2dc598c0ad5f	63941-003	HUMAN OTC DRUG	Antiseptic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19950609		OTC MONOGRAPH NOT FINAL	part356	Valu Merchandisers Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63941-005_a076b99a-9908-4a39-b3e1-6b2bc94053e2	63941-005	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl	GEL	TOPICAL	20170814		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers, CO.	LIDOCAINE HYDROCHLORIDE	2.5	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
63941-006_3a3a6029-3c1c-4c22-863d-1bf12733c39f	63941-006	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Best Choice	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63941-008_72636226-0268-47d0-9222-2c3c8a7c3b0d	63941-008	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20141016		OTC MONOGRAPH NOT FINAL	part333A	Valu Merchandisers,CO	ALCOHOL	70	mL/100mL			N	20241231
63941-009_e026c84e-c0f7-446f-9c01-b8729da63eb2	63941-009	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230926		ANDA	ANDA206531	Best Choice	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63941-010_11686e86-4bc8-40e6-b016-20fdd736a4ee	63941-010	HUMAN OTC DRUG	Best Choice	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH FINAL	part331	BEST CHOICE (VALU MERCHANDISERS COMPANY)	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
63941-011_bede6a02-ef20-478e-bb49-09c6c39d7c9a	63941-011	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230926		ANDA	ANDA206531	Best Choice	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63941-015_0d2aa191-5006-9d65-e063-6394a90ad8ab	63941-015	HUMAN OTC DRUG	Best Choice Artificial Tears		polyvinyl alcohol, povidone	SOLUTION/ DROPS	OPHTHALMIC	20230321		OTC MONOGRAPH DRUG	M018	Best Choice	POLYVINYL ALCOHOL; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
63941-020_d11b084f-9dec-db89-e053-2995a90afe4d	63941-020	HUMAN OTC DRUG	Stay Awake		CAFFEINE	TABLET	ORAL	20170119		OTC MONOGRAPH FINAL	part340	VALU MERCHANDISERS COMPANY	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
63941-021_b47ae3c9-ea79-4c13-a038-3563409c5475	63941-021	HUMAN OTC DRUG	Best Choice Extra Strength	Assorted Berry	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190423		OTC MONOGRAPH FINAL	part331	BEST CHOICE (VALU MERCHANDISERS COMPANY)	CALCIUM CARBONATE	750	mg/1			N	20241231
63941-022_3e0ca0fc-df73-46b0-8ccd-90c2d66e07da	63941-022	HUMAN OTC DRUG	Best Choice Extra Strength	Tropical Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20190426		OTC MONOGRAPH FINAL	part331	BEST CHOICE (VALU MERCHANDISERS COMPANY)	CALCIUM CARBONATE	750	mg/1			N	20241231
63941-023_af2d6537-5d8a-49c2-b8b5-fa3291f9ab4e	63941-023	HUMAN OTC DRUG	Best Choice		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20190416		OTC MONOGRAPH NOT FINAL	part334	BEST CHOICE (VALU MERCHANDISERS COMPANY)	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
63941-026_aeb486bc-8e6f-4982-a17a-980837414876	63941-026	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20150630	20240630	OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63941-047_0e8855e7-13a3-59ca-e063-6294a90a9f4e	63941-047	HUMAN OTC DRUG	Cherry Sore Throat Relief Lozenge		Benzocaine	LOZENGE	ORAL	20130828		OTC MONOGRAPH DRUG	M012	Valu Merchandisers Company	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
63941-048_0e87be72-564d-c80f-e063-6294a90a58be	63941-048	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	LOZENGE	ORAL	20171109		OTC MONOGRAPH DRUG	M012	Valu Merchandisers	MENTHOL	5.4	mg/1			N	20251231
63941-049_0e8801d7-3d76-0116-e063-6394a90ad589	63941-049	HUMAN OTC DRUG	Cherry Cough Drops		Menthol	LOZENGE	ORAL	20171109		OTC MONOGRAPH DRUG	M012	Valu Merchandisers	MENTHOL	5.8	mg/1			N	20251231
63941-050_0e880bfb-73cb-fbd8-e063-6294a90af778	63941-050	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20171109		OTC MONOGRAPH DRUG	M012	Valu Merchandisers	MENTHOL	7.5	mg/1			N	20251231
63941-064_574d2b1e-0c87-4e0a-8258-97eea6386666	63941-064	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCL	TABLET, COATED	ORAL	20191001		ANDA	ANDA204097	Best Choice (Valu Merchandisers Company)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-069_6c92c597-3d93-461f-a6bf-a33b0497eab5	63941-069	HUMAN OTC DRUG	Pure petroleum		White Petrolatum	JELLY	TOPICAL	20201015		OTC MONOGRAPH FINAL	part347	Valu Merchandisers	PETROLATUM	1	g/g			N	20241231
63941-071_16e408d6-afea-4249-9517-f44fb763ec5a	63941-071	HUMAN OTC DRUG	Best Choice	Extra Strength	Calcium Carbonate ,Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH FINAL	part331	BEST CHOICE (VALU MERCHANDISERS COMPANY)	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	675; 135	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-081_af0a1633-d4aa-c72b-e053-2995a90a0dc1	63941-081	HUMAN OTC DRUG	Low Dose Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20200401		OTC MONOGRAPH NOT FINAL	part343	VALU MERCHANDISERS COMPANY	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-090_d11b084f-9dc7-db89-e053-2995a90afe4d	63941-090	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170227		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-091_d11b084f-9db5-db89-e053-2995a90afe4d	63941-091	HUMAN OTC DRUG	Nighttime Sleep Aid		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20100225		OTC MONOGRAPH FINAL	part338	VALU MERCHANDISERS COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-095_d11aa3a3-1ef9-1d4e-e053-2995a90ad173	63941-095	HUMAN OTC DRUG	Extra Strength Pain Relief PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20100201		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-101_dda46ab7-a8dc-4818-9b06-c1e82973bff3	63941-101	HUMAN OTC DRUG	Best Choice	Regular Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190425		OTC MONOGRAPH FINAL	part331	BEST CHOICE (VALU MERCHANDISERS COMPANY)	CALCIUM CARBONATE	500	mg/1			N	20241231
63941-104_08f44528-66bc-21ff-e063-6394a90a1972	63941-104	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20091204		OTC MONOGRAPH DRUG	M013	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
63941-105_d11a0e8a-bd05-f434-e053-2a95a90a0861	63941-105	HUMAN OTC DRUG	Low Dose Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20211015		OTC MONOGRAPH NOT FINAL	part343	VALU MERCHANDISERS COMPANY	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-107_d06afd6b-9b95-4932-9770-505774b47136	63941-107	HUMAN OTC DRUG	Best Choice Extra Strength	Berry Flavor	Calcium carbonate ,Magnesium hydroxide,Simethicone	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH FINAL	part331	BEST CHOICE (VALU MERCHANDISERS COMPANY)	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	675; 60; 135	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-109_08f44883-d54d-232b-e063-6394a90a2924	63941-109	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170501		ANDA	ANDA079174	VALU MERCHANDISERS COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-110_28b27aec-4108-4f90-9ff5-c3a4489078d2	63941-110	HUMAN OTC DRUG	Best Choice	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH FINAL	part332	BEST CHOICE (VALU MERCHANDISERS COMPANY)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
63941-111_af0a1633-d4bf-c72b-e053-2995a90a0dc1	63941-111	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200401		ANDA	ANDA202312	VALU MERCHANDISERS COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-119_8ab623c3-2132-405e-8644-5cd6c2ad1576	63941-119	HUMAN OTC DRUG	Best Choice	Fiber Laxative	Psyllium Husk	CAPSULE	ORAL	20190516		OTC MONOGRAPH NOT FINAL	part334	BEST CHOICE (VALU MERCHANDISERS COMPANY)	PSYLLIUM HUSK	.52	g/1			N	20241231
63941-122_397d6e2a-9432-4289-a49b-3e637357e8b6	63941-122	HUMAN OTC DRUG	Best Choice	Fiber Therapy	Methylcellulose	TABLET	ORAL	20190419		OTC MONOGRAPH NOT FINAL	part334	BEST CHOICE (VALU MERCHANDISERS COMPANY)	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
63941-123_0ea71b09-2bb9-8966-e063-6294a90a813e	63941-123	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Valu Merchandisers Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
63941-131_476994be-00fa-4b6a-9542-26fac250e2d2	63941-131	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Valu Merchandisers Company	LORATADINE	5	mg/5mL			N	20241231
63941-137_8ae25688-1ed0-4140-93ab-a429059faeab	63941-137	HUMAN OTC DRUG	BEST CHOICE	No Drip	Allergy Sinus	SPRAY	NASAL	20220411		OTC MONOGRAPH FINAL	part341	BEST CHOICE (VALU MERCHANDISERS COMPANY)	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63941-144_d11aa11d-fd27-0466-e053-2a95a90a87f9	63941-144	HUMAN OTC DRUG	All Day Pain Relief		NAPROXEN SODIUM	TABLET, COATED	ORAL	20100610		ANDA	ANDA079096	VALU MERCHANDISERS COMPANY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-149_36a6930c-540d-47d4-8169-af0c8afe71d0	63941-149	HUMAN OTC DRUG	Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231107		OTC MONOGRAPH DRUG	M020	Valu Merchandisers, CO.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
63941-152_73aa21a1-ec80-4f4c-b05e-f54add489904	63941-152	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20231231		OTC MONOGRAPH DRUG	M002	Best Choice (Valu Merchandisers Company)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
63941-153_1b30d2ce-023d-444c-a591-9f4c27b8bd94	63941-153	HUMAN OTC DRUG	Everyday Clean Dandruff		pyrithione zinc	SHAMPOO	TOPICAL	19990314		OTC MONOGRAPH DRUG	M032	Value Merchandisers	PYRITHIONE ZINC	10	mg/mL			N	20241231
63941-157_e0faca68-2e07-49a7-b9f0-254bb84fb772	63941-157	HUMAN OTC DRUG	Aspirin NSAID		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-159_f20c84e6-d272-4591-8645-76eb44725ef2	63941-159	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin and caffeine	TABLET, FILM COATED	ORAL	19921117		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63941-162_032fcb37-cc80-4d21-a787-eb5ec6767503	63941-162	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20200924		OTC MONOGRAPH DRUG	M007	Value Merchandisers	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-163_052a7888-e4c7-bdaf-e063-6394a90ae859	63941-163	HUMAN OTC DRUG	Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120309	20251231	OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63941-167_d11a13c1-e910-3713-e053-2a95a90a64d2	63941-167	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141113		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-170_c4932c53-465c-4d57-9e8a-982c9281c2dc	63941-170	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20210825		OTC MONOGRAPH FINAL	part355	Value Merchandiser, CO	SODIUM FLUORIDE	.2	mg/mL			N	20241231
63941-173_d11a0e8a-bd31-f434-e053-2a95a90a0861	63941-173	HUMAN OTC DRUG	Pressure and Pain Plus Mucus PE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20141113		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-174_052a7888-e4c8-bdaf-e063-6394a90ae859	63941-174	HUMAN OTC DRUG	Pressure and Pain Plus Cold PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140514	20251130	OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63941-192_08efc996-55fc-254c-e063-6294a90ae8cd	63941-192	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20070619		OTC MONOGRAPH DRUG	M013	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
63941-193_af0a1633-d4eb-c72b-e053-2995a90a0dc1	63941-193	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20200701		ANDA	ANDA210722	Valu Merchandisers Company	LORATADINE	10	mg/1			N	20241231
63941-194_af0a19ab-6bbb-7a70-e053-2a95a90a2d0b	63941-194	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20200401		ANDA	ANDA209274	VALU MERCHANDISERS COMPANY	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-198_d0cbb513-ee81-43ac-bfc1-56de5dd995f2	63941-198	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	20190215		OTC MONOGRAPH DRUG	M009	Valu Merchandisers Company	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-202_f43630ef-eb3f-076f-e053-2995a90a79ed	63941-202	HUMAN OTC DRUG	Hemorrhoidal		petrolatum, mineral oil, phenylephrine HCl	OINTMENT	TOPICAL	20120206		OTC MONOGRAPH FINAL	part346	Valu Merchandisers, Co.	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-209_090604b0-2c87-8f1c-e063-6294a90a2fe7	63941-209	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20231029		ANDA	ANDA079174	VALU MERCHANDISERS COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-210_d11aab10-a236-bb0f-e053-2995a90aeb5c	63941-210	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170601		ANDA	ANDA079174	VALU MERCHANDISERS COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-212_680293ef-453c-4b8b-8012-38021889dedb	63941-212	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Best Choice (Valu Merchandisers Company)	DOCOSANOL	100	mg/g			N	20251231
63941-219_d11b0708-ec87-e582-e053-2a95a90ac297	63941-219	HUMAN OTC DRUG	Nighttime Sleep Aid		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20170119		OTC MONOGRAPH FINAL	part338	VALU MERCHANDISERS COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-220_d11aa3a3-1ece-1d4e-e053-2995a90ad173	63941-220	HUMAN OTC DRUG	Sinus Pressure plus Pain PE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201001		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-226_cba34789-84bf-4843-bcd1-dfa00161a030	63941-226	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	CREAM	TOPICAL	20201230		OTC MONOGRAPH FINAL	part347	Valu Merchandisers	ZINC OXIDE	130	mg/g			N	20241231
63941-229_f463355c-08cc-7591-e053-2a95a90a0e16	63941-229	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20120130		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers, Co.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63941-231_c504ff53-9639-41a1-bcb9-760a3b474fbc	63941-231	HUMAN OTC DRUG	PAIN RELIEVER PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	CAPSULE, GELATIN COATED	ORAL	20130308		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-245_d11a2a53-a6e4-40af-e053-2995a90a497b	63941-245	HUMAN OTC DRUG	All Day Pain Relief		NAPROXEN SODIUM	TABLET, COATED	ORAL	20100519		ANDA	ANDA079096	VALU MERCHANDISERS COMPANY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-248_0ddbd801-d453-4cc7-967b-d84c259e09cd	63941-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	CREAM	TOPICAL	20090112		OTC MONOGRAPH FINAL	part341	Valu Merchandisers, co	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
63941-249_eae7e940-f118-4229-a6ab-5457074f3859	63941-249	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19930804		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-253_488061ad-1a60-57d3-e054-00144ff88e88	63941-253	HUMAN OTC DRUG	Best Choice Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101028		OTC MONOGRAPH FINAL	part358G	Valu Merchandisers, CO.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
63941-256_86bb9b70-d39d-3ba3-e053-2a91aa0a25c0	63941-256	HUMAN OTC DRUG	Best Choice Vapor Steam		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20111102		OTC MONOGRAPH FINAL	part341	Valu merchandiser	CAMPHOR (SYNTHETIC)	.623	g/10mL			N	20241231
63941-259_8735213f-9d9d-6300-e053-2991aa0afb81	63941-259	HUMAN OTC DRUG	Best Choice Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20140414		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-260_884ca701-6685-347d-e053-2995a90a02ab	63941-260	HUMAN OTC DRUG	Best Choice Itch Stopping		Diphenhydramine HCl	GEL	TOPICAL	20140514		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers	DIPHENHYDRAMINE HYDROCHLORIDE	2	g/100g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-263_f951aca6-dda1-405e-e053-6394a90a0fc2	63941-263	HUMAN OTC DRUG	Cold plus Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230414		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-265_0c5321c3-8028-779d-e063-6394a90a9183	63941-265	HUMAN OTC DRUG	Best Choice Medicated anti itch		Pramoxine hydrochloride, menthol	CREAM	TOPICAL	20140413		OTC MONOGRAPH DRUG	M017	value merchandisers	MENTHOL; PRAMOXINE HYDROCHLORIDE	1; 1	g/100g; g/100g			N	20241231
63941-274_f9519812-a5e3-1a19-e053-6294a90a471d	63941-274	HUMAN OTC DRUG	Head Congestion plus Flu Severe PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230414		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-275_d1e16e4c-8892-4757-b407-5c554fe646ab	63941-275	HUMAN OTC DRUG	Sinus Severe		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20230808		OTC MONOGRAPH DRUG	M012	Valu Merchandisers Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-279_e9a91dc8-1f0c-401c-ac96-fe4f262a68d7	63941-279	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20160202		OTC MONOGRAPH DRUG	505G(a)(c)	Valu Merchandisers, CO	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63941-282_b29d82a6-6d06-4522-bdba-2b24c906eb18	63941-282	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20151031		OTC MONOGRAPH NOT FINAL	part343	Best Choice (Valu Merchandisers Company)	ACETAMINOPHEN	160	mg/5mL			N	20241231
63941-288_3455adbc-3163-4133-81f2-3be13ca36e9b	63941-288	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20150228		OTC MONOGRAPH NOT FINAL	part343	Best Choice (Valu Merchandisers Company)	ACETAMINOPHEN	160	mg/5mL			N	20241231
63941-296_ebeddbfc-7f56-4a58-8d82-add5bb998a67	63941-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20231002		OTC MONOGRAPH FINAL	part358H	Valu Merchandisers, CO.	PYRITHIONE ZINC	10	mg/mL			N	20241231
63941-299_f19c344f-176e-452f-851f-751da3daf0de	63941-299	HUMAN OTC DRUG	ANTISEPTIC		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20070731		OTC MONOGRAPH NOT FINAL	part356	Valu Merchandisers.Co	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
63941-300_af0a19ab-6bce-7a70-e053-2a95a90a2d0b	63941-300	HUMAN OTC DRUG	8 Hour Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200101		ANDA	ANDA211544	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN	650	mg/1			N	20241231
63941-301_af0a1633-d4d5-c72b-e053-2995a90a0dc1	63941-301	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200601		ANDA	ANDA202312	VALU MERCHANDISERS COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-303_08f0140d-d083-19fa-e063-6394a90a0e61	63941-303	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET	ORAL	20091125		OTC MONOGRAPH DRUG	M013	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
63941-304_c7f60199-591e-4862-a5b3-a0c5fb10e67a	63941-304	HUMAN OTC DRUG	Childrens Plus Multi Symptom Cold		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	SUSPENSION	ORAL	20150531		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	160; 1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-309_d265dd05-c173-446a-848d-5415b09a5cc2	63941-309	HUMAN OTC DRUG	Cough Relief		Dextromethorphan HBr	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-311_8eed938e-e0da-4142-9ca6-d831a81d341c	63941-311	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20090106		OTC MONOGRAPH DRUG	M032	Valu Merchandisers Co	PYRITHIONE ZINC	10	mg/mL			N	20241231
63941-312_f3449a7c-6813-4cd1-e053-2995a90a05c8	63941-312	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20120229		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers, Co.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63941-313_f43630ef-eb3d-076f-e053-2995a90a79ed	63941-313	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20120130		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers, Co.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63941-315_f4362d2e-d30e-1b17-e053-2a95a90aadb9	63941-315	HUMAN OTC DRUG	Triple Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20120905		OTC MONOGRAPH FINAL	part333B	Valu Merchandisers, Co.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63941-316_f43630ef-eb2a-076f-e053-2995a90a79ed	63941-316	HUMAN OTC DRUG	Allergic Itch Relief		Diphenhydramine HCl, Zinc acetate	CREAM	TOPICAL	20111201		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers, Co.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-317_f43630ef-eb2b-076f-e053-2995a90a79ed	63941-317	HUMAN OTC DRUG	Muscle and Joint Pain Relief		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20120130		OTC MONOGRAPH NOT FINAL	part348	Valu Merchandisers, Co.	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
63941-318_f43630ef-eb29-076f-e053-2995a90a79ed	63941-318	HUMAN OTC DRUG	Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20120130		OTC MONOGRAPH FINAL	part347	Valu Merchandisers, Co.	ZINC OXIDE	400	mg/g			N	20241231
63941-326_a0526551-87a4-4319-ba4c-62687310b9c9	63941-326	HUMAN OTC DRUG	Tartar Control Plus		eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19991025		OTC MONOGRAPH NOT FINAL	part356	Valu Merchandisers, Co.,	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63941-329_e51213f0-d651-4277-8857-7b2c9a5d4180	63941-329	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20150630	20240630	OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
63941-331_d11aa11d-fd3b-0466-e053-2a95a90a87f9	63941-331	HUMAN OTC DRUG	Nasal Decongestant PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170307		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-333_aba193c0-bf0c-45b2-a9f7-dec119b1f1d7	63941-333	HUMAN OTC DRUG	Acetaminophen - APAP Arthritis		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Valu Merchandisers Company	ACETAMINOPHEN	650	mg/1			N	20241231
63941-334_51ec20bb-176e-4931-bfb9-e6eba102facd	63941-334	HUMAN OTC DRUG	Mineral oil		Mineral oil	OIL	ORAL	20161031	20251031	OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	MINERAL OIL	100	mg/100mL			N	
63941-336_69d1cc24-301c-41dc-8e64-b00468c01942	63941-336	HUMAN OTC DRUG	Acetaminophen - APAP 8 Hour		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Valu Merchandisers Company	ACETAMINOPHEN	650	mg/1			N	20241231
63941-340_2e283800-b158-4e4a-953b-c991866a1f63	63941-340	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20200821		OTC MONOGRAPH FINAL	part347	Valu Merchandisers	PETROLATUM	100	g/100g			N	20241231
63941-343_9f3cf2ad-4fa2-4366-a98e-1cf066f84924	63941-343	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20161031		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-344_388ab49b-63fc-416e-9a51-c4d3fdc4110a	63941-344	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20161031		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-348_7f31e96c-c887-4480-a194-8b417312402f	63941-348	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, SUGAR COATED	ORAL	20210724	20240523	OTC MONOGRAPH DRUG	505G(a)(3)	Valu Merchandisers Company	SENNOSIDES	25	mg/1			N	
63941-354_f43630ef-eb28-076f-e053-2995a90a79ed	63941-354	HUMAN OTC DRUG	Tolnaftate		Tolnaftate	CREAM	TOPICAL	20120301		OTC MONOGRAPH FINAL	part333C	Valu Merchandisers, Co.	TOLNAFTATE	1	g/100g			N	20241231
63941-372_3d3419ca-7ee3-46c5-bab9-633815058b8d	63941-372	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20150331	20241231	OTC MONOGRAPH FINAL	part335	Best Choice (Valu Merchandisers Company)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
63941-375_a7d42290-e60d-4396-b0a2-93394217bd33	63941-375	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20200505		ANDA	ANDA076497	Valu Merchandisers Company	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63941-376_dd8a48af-edc2-4da3-84a2-4c9f01804fb2	63941-376	HUMAN OTC DRUG	Sore Throat Relief	Cherry	Phenol	SPRAY	ORAL	20140829		OTC MONOGRAPH DRUG	M022	Best Choice (Valu Merchandisers Company)	PHENOL	1.4	g/100mL			N	20241231
63941-385_a04aa66e-462e-489e-817b-2f04d1157464	63941-385	HUMAN OTC DRUG	Tussin Cough and Chest Congestion DM		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20150331		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-390_f85a53c2-ff99-40a1-bde7-8529bd9e8f7c	63941-390	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20140829	20241227	OTC MONOGRAPH FINAL	part347	Best Choice (Valu Merchandisers Company)	WITCH HAZEL	842	mg/mL			N	
63941-397_eb158851-0d06-4549-b856-4512ceef152a	63941-397	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	20010904		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-399_d11bb14e-46ed-f5e9-e053-2a95a90a2f89	63941-399	HUMAN OTC DRUG	Sinus Relief Pressure, Pain and Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210301		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-400_0cf4d771-f6b0-ec8c-e063-6394a90a3551	63941-400	HUMAN OTC DRUG	Best Choice Anti-Itch Clear		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Valu Merchandisers, CO	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63941-401_d11a13c1-e8fb-3713-e053-2a95a90a64d2	63941-401	HUMAN OTC DRUG	8 Hour Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20191212		ANDA	ANDA211544	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN	650	mg/1			N	20241231
63941-402_d2a34d50-ab4d-4d86-b1ae-24e2eb3c0a24	63941-402	HUMAN OTC DRUG	Best Choice Pain Relief Powder		Aspirin and Caffeine	POWDER	ORAL	20220617		OTC MONOGRAPH NOT FINAL	part343	Value Merch	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63941-403_29ad521f-c098-4422-9463-65eb46507d22	63941-403	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	LIQUID	TOPICAL	20141009		OTC MONOGRAPH NOT FINAL	part333A	Valu Merchandisers, CO	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
63941-404_0905c1fd-7a76-654d-e063-6294a90ac552	63941-404	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20231029		OTC MONOGRAPH DRUG	M013	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN	500	mg/1			N	20241231
63941-413_d11aa11d-fd61-0466-e053-2a95a90a87f9	63941-413	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20170428		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-420_0cf4d6ef-ff4e-ecf0-e063-6394a90a9802	63941-420	HUMAN OTC DRUG	Best Choice Medicated Calamine		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Valu Merchandisers, CO.	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63941-421_f0e62c4c-3587-1c9c-e053-2995a90a8830	63941-421	HUMAN OTC DRUG	Best Choice Effervescent Antacid Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20201029		OTC MONOGRAPH FINAL	part343	Valu Merchandisers Company	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-421_f0e6420c-b1f7-d520-e053-2995a90a4ef0	63941-421	HUMAN OTC DRUG	Best Choice Effervescent Antacid Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20130830		OTC MONOGRAPH FINAL	part343	Valu Merchandisers Company	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-433_cfbf3f52-61ba-4c38-8b1d-4e7d36e20c36	63941-433	HUMAN OTC DRUG	Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210405		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63941-439_d9f1b180-ba0f-463f-b8bb-0fe29ae071c7	63941-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20141015		OTC MONOGRAPH DRUG	505G(a)(3)	Valu Merchandisers,CO	ALCOHOL	70	mL/100mL			N	20241231
63941-456_d11b084f-9dfd-db89-e053-2995a90afe4d	63941-456	HUMAN OTC DRUG	Regular Strength Pain Relief		Acetaminophen	TABLET	ORAL	20100205		OTC MONOGRAPH NOT FINAL	part343	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN	325	mg/1			N	20241231
63941-466_ce5dd2b3-2e47-49da-b107-2649afc35189	63941-466	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20150630		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-470_abdf03b4-80a2-426a-ae38-7aee97722017	63941-470	HUMAN OTC DRUG	Multi-Symptom Cold	Daytime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050715		OTC MONOGRAPH DRUG	M012	Valu Merchandisers Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-473_34b4d642-2f7d-4e6f-ae7d-32b9cc652d6f	63941-473	HUMAN OTC DRUG	Multi-Symptom Cold		Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050721		OTC MONOGRAPH DRUG	M012	Valu Merchandisers Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-489_ee3b42b7-8e12-7af5-e053-2a95a90a3bed	63941-489	HUMAN OTC DRUG	EasyLAX		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20180101		ANDA	ANDA090812	VALU MERCHANDISERS COMPANY	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-497_f9519812-a5b5-1a19-e053-6294a90a471d	63941-497	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210326		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-498_f951904d-9097-2720-e053-6394a90aca3a	63941-498	HUMAN OTC DRUG	Mucus Relief Cold and Flu All in One		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210312		OTC MONOGRAPH FINAL	part341	VALU MERCHANDISERS COMPANY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-499_03030445-da6d-41e2-bfeb-ed479d0dcf75	63941-499	HUMAN OTC DRUG	Cough Relief	Nighttime	Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20180131		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-503_54d929d7-4283-4bad-be54-b4159ecf1ae0	63941-503	HUMAN OTC DRUG	Multi-Symptom Cold	Severe, Non-Drowsy, Daytime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804	20250804	OTC MONOGRAPH DRUG	M012	Valu Merchandisers Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
63941-504_d7cc376d-f8d3-427f-8737-12305c829d54	63941-504	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20170531		ANDA	ANDA079112	Best Choice (Valu Merchandisers Company)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-509_1c96d1d5-b63e-433f-8947-01793083b034	63941-509	HUMAN OTC DRUG	Cold Multi-Symptom	Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804		OTC MONOGRAPH DRUG	M012	Valu Merchandisers Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-511_6703482b-9b15-40f3-849c-e689cb87a5a1	63941-511	HUMAN OTC DRUG	Best Choice Fiber Therapy	original coarse	Psyllium Husk	POWDER	ORAL	20190514		OTC MONOGRAPH NOT FINAL	part334	BEST CHOICE (VALU MERCHANDISERS COMPANY)	PSYLLIUM HUSK	3.4	g/7g			N	20241231
63941-513_e2d58516-8e84-4694-9c22-a7bfe29892b8	63941-513	HUMAN OTC DRUG	Best Choice Fiber Therapy	Orange Flavor	Psyllium Husk	POWDER	ORAL	20190515		OTC MONOGRAPH NOT FINAL	part334	BEST CHOICE (VALU MERCHANDISERS COMPANY)	PSYLLIUM HUSK	3.4	g/12g			N	20241231
63941-516_9a7a777c-5464-4b01-96a3-23756e0fe405	63941-516	HUMAN OTC DRUG	citroma		Magesium Citrate	LIQUID	ORAL	20200924		OTC MONOGRAPH DRUG	M007	Value Merchandisers	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-519_32c39abb-4437-45cc-9fb8-4b20baa7c245	63941-519	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ACETAMINOPHEN	500	mg/1			N	20241231
63941-522_0c181dc9-a05b-7b4f-e063-6294a90a5eee	63941-522	HUMAN OTC DRUG	Best Choice Lice Treatment		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20101028		OTC MONOGRAPH DRUG	M031	Associated Wholesale Grocers, Inc.						N	20241231
63941-526_bc05aca7-4224-4b42-93b7-d28fbf18c0b1	63941-526	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20030819		ANDA	ANDA076134	Valu Merchandisers Company	LORATADINE	10	mg/1			N	20241231
63941-527_bbb72736-b09f-4d18-bc5f-c26e87ce9fee	63941-527	HUMAN OTC DRUG	Severe Sinus Congestion and Pain	Non-Drowsy, Daytime	Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	Valu Merchandisers Company	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-533_1e89a03d-0321-41ba-afa4-c28325d20833	63941-533	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20200924		OTC MONOGRAPH DRUG	M007	Valu Merchandisers	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-540_f2289e19-6a2d-ef5c-e053-2995a90aa1d2	63941-540	HUMAN OTC DRUG	Tolnafate		Tolnaftate Jock Itch Powder Spray - Talc Free	AEROSOL, SPRAY	TOPICAL	20171031		OTC MONOGRAPH FINAL	part333C	VALU MERCHANDISERS, CO.	TOLNAFTATE	1.3	g/130g			N	20241231
63941-541_f2289061-97d3-2073-e053-2a95a90a9876	63941-541	HUMAN OTC DRUG	Tolnafate		Tolnaftate Athletes Foot Powder Spray Talc Free	AEROSOL, SPRAY	TOPICAL	20171031		OTC MONOGRAPH FINAL	part333C	VALU MERCHANDISERS, CO	TOLNAFTATE	1.3	g/130g			N	20241231
63941-542_f228a2c4-b7af-fa91-e053-2995a90a988b	63941-542	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171208		OTC MONOGRAPH FINAL	part358F	VALU MERCHANDISERS, CO	SALICYLIC ACID	40	mg/91			N	20241231
63941-543_f228a758-6188-1c73-e053-2a95a90a7aaa	63941-543	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20171208		OTC MONOGRAPH FINAL	part358F	VALU MERCHANDISERS, CO	SALICYLIC ACID	40	mg/41			N	20241231
63941-544_f228a2c4-b77d-fa91-e053-2995a90a988b	63941-544	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover Kit	LIQUID	TOPICAL	20171211		OTC MONOGRAPH FINAL	part358F	VALU MERCHANDISERS, CO	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
63941-545_f22881cb-1892-fe6e-e053-2a95a90a5e84	63941-545	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20171211		OTC MONOGRAPH FINAL	part358F	VALU MERCHANDISERS, CO	SALICYLIC ACID	.17	g/9mL			N	20241231
63941-546_f2288787-4c4f-169b-e053-2995a90a6948	63941-546	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20171211		OTC MONOGRAPH NOT FINAL	part333A	VALU MERCHANDISERS, CO	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
63941-549_f2288009-5733-5716-e053-2a95a90ab61f	63941-549	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Extra Strength Itch Relief	SPRAY	TOPICAL	20171211		OTC MONOGRAPH NOT FINAL	part348	VALU MERCHANDISERS, CO	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/88mL; g/88mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-551_f22881cb-1891-fe6e-e053-2a95a90a5e84	63941-551	HUMAN OTC DRUG	Salicylic acid		Medicated Callus Removers Extra Thick	PATCH	TOPICAL	20140101		OTC MONOGRAPH FINAL	part358F	VALU MERCHANDISERS, CO	SALICYLIC ACID	40	mg/41			N	20241231
63941-553_f2285eaa-39b6-86ae-e053-2a95a90ab7a0	63941-553	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel Tube	GEL	TOPICAL	20171212		OTC MONOGRAPH FINAL	part358B	VALU MERCHANDISERS, CO	SALICYLIC ACID	.17	g/7g			N	20241231
63941-555_f2286dfc-c5fb-1c8b-e053-2995a90a235f	63941-555	HUMAN OTC DRUG	Tolnaftate		Tolnaftate Athletes Foot Powder Spray	SPRAY	TOPICAL	20171212		OTC MONOGRAPH FINAL	part333C	VALU MERCHANDISERS, CO	TOLNAFTATE	1.3	g/130g			N	20241231
63941-556_71eabc97-72fc-4bce-870c-588a84d62a28	63941-556	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine HCl	TABLET	ORAL	20071217	20250412	OTC MONOGRAPH NOT FINAL	part343	Valu Merchandisers Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63941-564_f4abb4a4-255c-a8bb-e053-2995a90a4023	63941-564	HUMAN OTC DRUG	Antifungal Liquid		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20210320		OTC MONOGRAPH FINAL	part333C	VALU MERCHANDISERS, CO	TOLNAFTATE	1.5	g/150g			N	20241231
63941-600_ecf95338-08c2-4251-ace1-594c0f6bfb76	63941-600	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20210405		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-602_1b612861-676d-4867-8e1d-4c00fe944f40	63941-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20141015		OTC MONOGRAPH NOT FINAL	part334	Valu Merchandisers, Co.	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-616_f43630ef-eb2c-076f-e053-2995a90a79ed	63941-616	HUMAN OTC DRUG	Best Choice Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20120724		OTC MONOGRAPH FINAL	part333B	Valu Merchandisers, Co.	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
63941-619_09074f63-4ba9-3ad1-e063-6294a90a289a	63941-619	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID AND ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20170801		OTC MONOGRAPH DRUG	M001	VALU MERCHANDISERS COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-620_0ccc9f3d-51ea-201c-e063-6394a90a75d9	63941-620	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20231218		OTC MONOGRAPH DRUG	M016	VALU MERCHANDISERS, CO	DIMETHICONE	13	mg/100mL	Skin Barrier Activity [PE]		N	20241231
63941-624_0919ee48-b0ac-e368-e063-6394a90a6a14	63941-624	HUMAN OTC DRUG	SUPREME ANTACID		calcium carbonate, magnesium hydroxide	SUSPENSION	ORAL	20170801		OTC MONOGRAPH DRUG	M001	VALU MERCHANDISERS COMPANY	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	400; 135	mg/5mL; mg/5mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-629_0919f0ef-9137-b605-e063-6294a90af582	63941-629	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20170701		OTC MONOGRAPH DRUG	M001	VALU MERCHANDISERS COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-631_83c029b1-cb8e-4796-b98d-01b40920b37f	63941-631	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20181231	20241227	OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	SENNOSIDES	8.6	mg/1			N	
63941-638_09084178-5f92-e514-e063-6294a90a669d	63941-638	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID AND ANTIGAS CHERRY		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20170801		OTC MONOGRAPH DRUG	M001	VALU MERCHANDISERS COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-639_09195805-d837-6585-e063-6294a90a7798	63941-639	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20170801		OTC MONOGRAPH DRUG	M001	VALU MERCHANDISERS COMPANY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-647_09074f63-4ba4-3ad1-e063-6294a90a289a	63941-647	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20170701		OTC MONOGRAPH DRUG	M007	VALU MERCHANDISERS COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-648_0907322c-b5c4-2c3b-e063-6294a90a7531	63941-648	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20170701		OTC MONOGRAPH DRUG	M007	VALU MERCHANDISERS COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-649_09074cf3-f89d-db31-e063-6394a90a96b6	63941-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20170701		OTC MONOGRAPH DRUG	M007	VALU MERCHANDISERS COMPANY	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63941-664_009026f6-34d0-48ee-aa05-dccc7f2fab5f	63941-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19980315		OTC MONOGRAPH NOT FINAL	part356	Valu Merchandisers, Co	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63941-674_960cb297-5161-48c4-9559-dc4b16e7fb93	63941-674	HUMAN OTC DRUG	Headache Relief PM		Acetaminophen, Aspirin, Diphenhydramine citrate	TABLET, FILM COATED	ORAL	20160831		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE	250; 250; 38	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63941-680_06d34c06-f0eb-0825-e063-6394a90ae0c9	63941-680	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20231005		ANDA	ANDA078682	VALU MERCHANDISERS COMPANY	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-681_06d2daf1-3067-95e9-e063-6294a90aa789	63941-681	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20231003		NDA	NDA021920	VALU MERCHANDISERS COMPANY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-682_06d3d2fc-a073-863f-e063-6394a90a2374	63941-682	HUMAN OTC DRUG	Ibuprofen and Diphenhydramine HCl		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20231003		ANDA	ANDA090397	VALU MERCHANDISERS COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-683_0788c3b6-d878-b337-e063-6294a90acd3a	63941-683	HUMAN OTC DRUG	Nighttime Sleep-Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20231012		OTC MONOGRAPH DRUG	M010	VALU MERCHANDISERS COMPANY	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-684_06fe77f7-a20c-f066-e063-6294a90a7653	63941-684	HUMAN OTC DRUG	anti-diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20231010		NDA	NDA021855	VALU MERCHANDISERS COMPANY	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
63941-689_569644bf-3f02-4adc-a041-5d49555af0fd	63941-689	HUMAN OTC DRUG	Cold and Cough		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170331	20240202	OTC MONOGRAPH FINAL	part341	Valu Merchandisers Company	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
63941-704_a2171762-655d-48af-805d-9cc7e006d994	63941-704	HUMAN OTC DRUG	Saline		Nasal	SPRAY	NASAL	20201019		OTC MONOGRAPH FINAL	part349	BEST CHOICE (VALU MERCHANDISERS COMPANY)	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
63941-708_44c42256-cdcd-448f-890e-fb57f2864e17	63941-708	HUMAN OTC DRUG	Best Choice Anti Nausea	Cherry Flavor	dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20190416		UNAPPROVED DRUG OTHER		BEST CHOICE (VALU MERCHANDISERS COMPANY)	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
63941-709_cf89ed05-22cb-4561-ac1b-698ca8c4ea16	63941-709	HUMAN OTC DRUG	Best Choice		Simethicone	SUSPENSION/ DROPS	ORAL	20190410		OTC MONOGRAPH FINAL	part332	BEST CHOICE (VALU MERCHANDISERS COMPANY)	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
63941-710_391d7425-a162-4a4b-bff5-2b26962a51d0	63941-710	HUMAN OTC DRUG	Best Choice Childrens Allergy Relief	Bubblegum flavor	Diphenhydramine HCl	LIQUID	ORAL	20210607		OTC MONOGRAPH FINAL	part341	BEST CHOICE (VALU MERCHANDISERS COMPANY)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-715_b141b78a-1280-446b-b331-720aef0c2e45	63941-715	HUMAN OTC DRUG	Best Choice	Maximum Strength	oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH FINAL	part341	BEST CHOICE (VALU MERCHANDISERS COMPANY)	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63941-716_0febde1b-5b2f-4c5c-9632-2a571ee781aa	63941-716	HUMAN OTC DRUG	Best Choice		oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH FINAL	part341	BEST CHOICE (VALU MERCHANDISERS COMPANY)	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63941-718_004f00ff-d453-444d-89ee-1928cd4b96ad	63941-718	HUMAN OTC DRUG	Best Choice	Maximum Strength	Oxymetazoline hydrochloride	SPRAY	NASAL	20190522		OTC MONOGRAPH FINAL	part341	BEST CHOICE (VALU MERCHANDISERS COMPANY)	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63941-720_5f203d61-a0d7-4788-8df4-a4945c55613b	63941-720	HUMAN OTC DRUG	Best Choice		Oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH FINAL	part341	BEST CHOICE (VALU MERCHANDISERS COMPANY)	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63941-724_189e4b91-ba71-4c00-8073-5063ae350e58	63941-724	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part335	Best Choice (Valu Merchandisers Company)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63941-726_c8427270-7548-4d9d-96f0-f4c057daaf87	63941-726	HUMAN OTC DRUG	Best Choice	Ultra Fine Mist	Oxymetazoline Hydrochloride	SPRAY	NASAL	20190521		OTC MONOGRAPH FINAL	part341	BEST CHOICE (VALU MERCHANDISERS COMPANY)	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
63941-727_f57dbd29-bcb7-4ab7-ae46-8f91c07ca378	63941-727	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20171121		OTC MONOGRAPH FINAL	part352	Valu Merchandisers	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	26.49; 132.45; 44.15; 52.98	mg/g; mg/g; mg/g; mg/g			N	20241231
63941-730_9b73f9fc-4f31-4b29-a658-6817b2f19d12	63941-730	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20171213		OTC MONOGRAPH FINAL	part352	Valu Merchandiser, Co	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 150; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
63941-731_99323ac0-390b-4dd2-a958-566224b6e2ba	63941-731	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20220114		ANDA	ANDA207342	Best Choice (Valu Merchandisers Company)	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63941-733_fc9eb2c6-4d21-461f-8867-99cde20c9305	63941-733	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20220114		ANDA	ANDA209692	Best Choice (Valu Merchandisers Company)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-734_684f47d9-d65a-447d-817a-59d13dd13f0d	63941-734	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20220114		ANDA	ANDA209692	Best Choice (Valu Merchandisers Company)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-735_9f4ce414-9614-4430-9333-f0e07397918e	63941-735	HUMAN OTC DRUG	Nighttime sleep aid	Maximum Strength	DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180930	20241227	OTC MONOGRAPH FINAL	part338	Best Choice (Valu Merchandisers Company)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63941-736_9b88cdb4-65d3-4ffb-b075-97950469c638	63941-736	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part335	Best Choice (Valu Merchandisers Company)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63941-737_6a8dc265-d831-47b4-b18d-1ca0ddd3393f	63941-737	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part335	Best Choice (Valu Merchandisers Company)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
63941-745_a9bf36df-1290-4d1e-af46-6fda4e60262d	63941-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	Best Choice (Valu Merchandisers Company)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-760_a8f30ae8-d4ee-4ebb-b0dc-81bcc3e5bfdb	63941-760	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20190125		ANDA	ANDA074916	Best Choice (Valu Merchandisers Company)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-761_a8f30ae8-d4ee-4ebb-b0dc-81bcc3e5bfdb	63941-761	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20190213		ANDA	ANDA074916	Best Choice (Valu Merchandisers Company)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-762_a8f30ae8-d4ee-4ebb-b0dc-81bcc3e5bfdb	63941-762	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20171226		ANDA	ANDA074916	Best Choice (Valu Merchandisers Company)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-773_c6da7894-5f62-4f15-ae9e-1d4bf7d64a72	63941-773	HUMAN OTC DRUG	Anti-Gas	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200430		OTC MONOGRAPH FINAL	part332	Best Choice (Valu Merchandisers Company)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
63941-788_60735e77-a0ee-4aa1-b840-95e2018716e6	63941-788	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20171215		OTC MONOGRAPH FINAL	part352	VALU MERCHANDISERS, CO	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27.03; 135.15; 45.05; 90.1; 54.06	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
63941-801_5a880ff7-e417-4017-aeb9-8f214b1099dd	63941-801	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20220429		ANDA	ANDA211075	Best Choice (Valu Merchandisers Company)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-804_275f8dc4-977f-421b-b016-7c246d5bb698	63941-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20141022		OTC MONOGRAPH NOT FINAL	part333A	Valu Merchandisers, CO	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
63941-810_448742c7-6b65-417a-8557-dfc211ac2ed7	63941-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20031124		OTC MONOGRAPH NOT FINAL	part333A	Valu Merchandisers, CO.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
63941-812_08724065-bfb7-4138-96a9-46e3e9c22915	63941-812	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20200730		ANDA	ANDA208077	Best Choice (Valu Merchandisers Company)	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63941-815_44f19208-ff57-4ab9-9978-f6e92e3d9a11	63941-815	HUMAN OTC DRUG	Laxative Pills	maximum strength	Sennosides	TABLET	ORAL	20181231	20241227	OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	SENNOSIDES	25	mg/1			N	
63941-817_67659f78-8fd9-461c-a331-a892324db61e	63941-817	HUMAN OTC DRUG	Cough and Congestion DM	Sugar Free	Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20180930		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-822_e5a6f8ec-0268-4b88-9945-58c46ebbcd5a	63941-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20211221		OTC MONOGRAPH FINAL	part347	Value Merchandisers, CO	WITCH HAZEL	860	mg/mL			N	20241231
63941-829_a579b337-5ccc-47a4-899f-c30700d53370	63941-829	HUMAN OTC DRUG	Stool Softener	With Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20181231	20241227	OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
63941-831_f463355c-08cb-7591-e053-2a95a90a0e16	63941-831	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B	OINTMENT	TOPICAL	20120716		OTC MONOGRAPH FINAL	part333B	Valu Merchandisers, Co.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
63941-832_7f6af704-0dc4-44ec-8799-37867d2facaa	63941-832	HUMAN OTC DRUG	Antigas	ultra strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20181231	20241227	OTC MONOGRAPH FINAL	part332	Best Choice (Valu Merchandisers Company)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
63941-835_0c868857-d577-9413-e063-6294a90a0bab	63941-835	HUMAN OTC DRUG	Best Choice Earwax Removal Kit		Carbamide peroxide	LIQUID	TOPICAL	20141127		OTC MONOGRAPH DRUG	M014	Valu Merchandisers, Co.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
63941-836_0c7ff686-65f9-a7f4-e063-6294a90a25e0	63941-836	HUMAN OTC DRUG	Best Choice Earwax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20141127		OTC MONOGRAPH DRUG	M014	Valu Merchandisers Company	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
63941-838_0d2aaa83-e834-cccd-e063-6294a90acf53	63941-838	HUMAN OTC DRUG	Best Choice Eye Drops A.C.		tetrahydrozoline HCl, zinc sulfate	SOLUTION	OPHTHALMIC	20230320		OTC MONOGRAPH DRUG	M018	Best Choice (Valu Merchandisers Company)	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
63941-842_27614cfa-0c02-4321-9ace-2f0907fe84bb	63941-842	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20190430	20241227	OTC MONOGRAPH FINAL	part335	Best Choice (Valu Merchandisers Company)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
63941-845_ee67f7ac-2a71-4cef-aed1-36eb7e6473f4	63941-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20141024		OTC MONOGRAPH FINAL	part344	Valu Merchandisers, Co	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
63941-853_b8dfd18f-8e57-496c-b95c-181f79910971	63941-853	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	DOCUSATE SODIUM	100	mg/1			N	20241231
63941-855_d32917c0-9734-47ba-9578-14bd11b446ab	63941-855	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200801		OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63941-860_d7afff67-6e1f-432d-9773-afa435bf7d56	63941-860	HUMAN OTC DRUG	Nighttime sleep aid	Maximum Strength	DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part338	Best Choice (Valu Merchandisers Company)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-871_0274ab38-de4b-4d28-ae9e-210581a5c04e	63941-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20030715		OTC MONOGRAPH NOT FINAL	part333A	Valu Merchandisers, co	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
63941-873_76df52ed-e906-4075-e053-2991aa0a2618	63941-873	HUMAN OTC DRUG	Best Choice Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20131210		OTC MONOGRAPH FINAL	part341	Valu Merchandiser Company	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-878_de1e145d-9a32-400a-99a1-a715884130c4	63941-878	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200802		OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
63941-882_9d412bf5-4f91-4cdc-9002-81924a3c1f6d	63941-882	HUMAN OTC DRUG	Senna laxative		Sennosides	TABLET	ORAL	20211231		OTC MONOGRAPH NOT FINAL	part334	Best Choice (Valu Merchandisers Company)	SENNOSIDES	8.6	mg/1			N	20241231
63941-897_1f27fee8-f4e4-4fa3-8fcc-f34834f14b8e	63941-897	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part347	Best Choice (Valu Merchandisers Company)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
63941-904_fca0e771-f2f1-4d37-9b98-6319cfa41fb3	63941-904	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20220729		OTC MONOGRAPH FINAL	part355	Value Merchandisers, CO	SODIUM FLUORIDE	.2	mg/mL			N	20241231
63941-916_3e1069bc-fda1-4e89-97f2-45637e12ac4b	63941-916	HUMAN OTC DRUG	Nighttime sleep aid	Maximum Strength	DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH FINAL	part338	Best Choice (Valu Merchandisers Company)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-922_3613fc7e-1a73-462c-be00-ea938425083e	63941-922	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20230901		ANDA	ANDA208754	Best Choice (Valu Merchandisers Company)	DOCOSANOL	100	mg/g			N	20241231
63941-923_9b823fef-4aa0-413c-9306-aff6038788e9	63941-923	HUMAN OTC DRUG	Childrens Allergy		Fexofenadine HCL	SUSPENSION	ORAL	20221007		ANDA	ANDA203330	Best Choice (Valu Merchandisers Company)	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-926_8b978321-d832-4d11-8456-f2372c7cb174	63941-926	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201028		OTC MONOGRAPH FINAL	part352	Valu Merchandisers	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
63941-929_e10740c3-25ca-4292-9ef7-9b1e55395c69	63941-929	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201028		OTC MONOGRAPH FINAL	part352	Valu Merchandisers	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
63941-939_2d78941a-3bfd-4c92-aa00-2a4f99db44c8	63941-939	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	Valu Merchandisers Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-941_439bea0d-a098-4d8d-bf70-8e122dcf1062	63941-941	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160119		OTC MONOGRAPH NOT FINAL	part333A	Valu Merchandisers, Co	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
63941-942_0d2ab928-4082-e9dc-e063-6294a90a5e47	63941-942	HUMAN OTC DRUG	Best Choice Eye Drops Advanced Relief		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	Valu Merchandisers, Co.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
63941-944_cc45cc28-5d9d-46bf-b99e-729e021208c1	63941-944	HUMAN OTC DRUG	childrens pain reliever		acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ACETAMINOPHEN	160	mg/1			N	20241231
63941-946_0ff6938b-23a9-4d8f-8d45-246ab761dbf1	63941-946	HUMAN OTC DRUG	Sport Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M020	Valu Merchandisers, CO.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
63941-952_b3cebc83-4a15-4f20-8f6a-7e757e713272	63941-952	HUMAN OTC DRUG	Dry Scalp		Pyrithione zinc	SHAMPOO	TOPICAL	20090106		OTC MONOGRAPH DRUG	M032	Valu Merchandisers Co.	PYRITHIONE ZINC	10	mg/mL			N	20241231
63941-956_c9bac6fd-9cb9-441c-abe9-ba0f53fe58dd	63941-956	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20230412		OTC MONOGRAPH DRUG	M013	Valu Merchandisers Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63941-958_4c2cc06d-2b12-4cb6-9096-5b9a49e4985c	63941-958	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate,Otisalate, Octocrylene	SPRAY	TOPICAL	20201028		OTC MONOGRAPH FINAL	part352	Valu Merchandisers	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
63941-962_5cdbcde9-7460-4af5-9d8d-071e32940631	63941-962	HUMAN OTC DRUG	Sunscreen for Kids SPF 50		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M020	Valu Merchandisers, CO.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
63941-971_c53c7b26-7b7e-4438-8536-b259d4843ea9	63941-971	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016		ANDA	ANDA209339	Best Choice	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63941-980_e38e48f5-2860-4ba8-9d4b-423a45017269	63941-980	HUMAN OTC DRUG	Chocolated Laxative	Regular Strength Sennosides Stimulant Laxative, Best Choice	Sennosides	TABLET, CHEWABLE	ORAL	20210224		OTC MONOGRAPH NOT FINAL	part334	Valu Merchandisers Company	SENNOSIDES	15	mg/1			N	20241231
63941-981_e8b4799b-a445-4017-9765-9ca1aa030f81	63941-981	HUMAN OTC DRUG	Vapor Inhaler	levmetamfetamine nasal decongestant, Best Choice	Levmetamfetamine	INHALANT	NASAL	20210224		OTC MONOGRAPH FINAL	part341	Valu Merchandisers Company	LEVMETAMFETAMINE	50	mg/1			N	20241231
63941-984_ca9c022f-6988-4d2f-baf3-dc0f7da5293b	63941-984	HUMAN OTC DRUG	Nighttime Cold and Cough	childrens	Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20220610		OTC MONOGRAPH FINAL	part341	Best Choice (Valu Merchandisers Company)	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-985_30b6801b-027e-44ce-8268-e383f1c146f6	63941-985	HUMAN OTC DRUG	Always Save Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20220822		OTC MONOGRAPH FINAL	part341	Valu Merch	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-986_375f37c3-2c47-4b0d-9829-3ba6e5e7cba6	63941-986	HUMAN OTC DRUG	Always Save Mucus Relief	PE	Guaifenesin/phenylephrine	TABLET	ORAL	20210818		OTC MONOGRAPH FINAL	part341	Valu Merch	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
63941-987_92ab021e-4264-44b2-9d45-312c37cf24bf	63941-987	HUMAN OTC DRUG	Always Save Chest Congestion Relief	GUAF	Guaifenesin	TABLET	ORAL	20220822		OTC MONOGRAPH FINAL	part341	Valu Merch	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63941-989_19becd16-90c4-493b-94f3-0e8ac959f3c4	63941-989	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20220202		OTC MONOGRAPH FINAL	part341	Valu Merchandisers Company	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63941-997_9c033207-ae1c-4212-aeef-3bb5bfef6fca	63941-997	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180720		ANDA	ANDA207891	VALU MERCHANDISERS COMPANY	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63941-999_2bac9451-0cc9-49a4-ad53-5ca6648a64ce	63941-999	HUMAN OTC DRUG	Esomeprazole		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200814		ANDA	ANDA212866	VALU MERCHANDISERS COMPANY	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63956-002_3684f8bc-d7f9-4c96-8c9b-e50a55cfdcd1	63956-002	HUMAN OTC DRUG	Emmi-dent Kids		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190715		OTC MONOGRAPH FINAL	part355	EMAG AG	SODIUM FLUORIDE	110	mg/75mL			N	20241231
63956-003_21527bb7-b2ba-4c58-998e-7a6a22120feb	63956-003	HUMAN OTC DRUG	Emmi-dent Whitening		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190730		OTC MONOGRAPH FINAL	part355	EMAG AG	SODIUM FLUORIDE	320	mg/75mL			N	20241231
63956-004_44d1ed60-1de5-49e0-bfe4-45208180a4e9	63956-004	HUMAN OTC DRUG	Emmi-dent Fresh		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20190715		OTC MONOGRAPH FINAL	part355	EMAG AG	SODIUM FLUORIDE	199	mg/75mL			N	20241231
63961-010_076194c3-5671-c83c-e063-6294a90aa582	63961-010	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20220110		NDA	NDA216614	Middlesex Gases & Technologies, Inc.	CARBON DIOXIDE	998	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
63961-100_0761944c-ed9e-0ca3-e063-6394a90acad9	63961-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19970728		NDA	NDA205849	Middlesex Gases and Technologies, Inc.	OXYGEN	990	mL/L			N	20241231
63961-200_0761944c-ed9d-0ca3-e063-6394a90acad9	63961-200	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19970728		NDA	NDA205850	Middlesex Gases and Technologies, Inc.	NITROGEN	990	mL/L			N	20241231
63970-001_06d6564a-73d6-a78a-e063-6294a90a82ab	63970-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19930701		UNAPPROVED MEDICAL GAS		Texoma Medical Services, Inc. dba Western Medical Equipment	OXYGEN	99	L/100L			N	20241231
63978-001_0802d996-8a51-ce42-e063-6394a90a91ea	63978-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19800101		NDA	NDA205712	QUALITY AIR PRODUCTS INC	OXYGEN	990	mL/L			N	20241231
63978-201_0802c587-c0d7-4fc9-e063-6294a90a3d6c	63978-201	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20090101		NDA	NDA206009	Air Supply of North Texas	NITROUS OXIDE	990	mL/L			N	20241231
63981-001_69001f99-ed08-4224-82b9-d5bbdcde6676	63981-001	HUMAN OTC DRUG	Kirkland Signature Aller Flo		Fluticasone propionate	SPRAY, METERED	NASAL	20160529		ANDA	ANDA207957	Costco Wholesale Company	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63981-002_1af3d2c2-fdb2-45a2-a0ee-d56bd5f5fe8b	63981-002	HUMAN OTC DRUG	moisture eyes lubricant eye drops		moisture eyes lubricant eye drops	SOLUTION	OPHTHALMIC	20200626		OTC MONOGRAPH FINAL	part349	Costco Wholesale Company	POVIDONE, UNSPECIFIED	20	mg/mL			N	20241231
63981-012_84385d6d-ff50-4746-a664-838b53dc01c2	63981-012	HUMAN OTC DRUG	Kirkland Signature Quit 2		Nicotine polacrilex	GUM, CHEWING	ORAL	20170321		ANDA	ANDA206394	Costco Wholesale Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-019_86e06cea-1030-478d-a45b-778a0ce22f3a	63981-019	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20221012		OTC MONOGRAPH DRUG	M013	COSTCO WHOLESALE CORPORATION	ACETAMINOPHEN	500	mg/1			N	20241231
63981-029_81fd3658-8397-4a2b-ada2-378d7b996a00	63981-029	HUMAN OTC DRUG	kirkland signature quit 2		Nicotine Polacrilex	GUM, CHEWING	ORAL	20120515		ANDA	ANDA076775	Costco Wholesale Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-032_dc7eeb91-1dec-41b8-bb81-a860712a75c7	63981-032	HUMAN OTC DRUG	kirkland signature minoxidil		minoxidil	SOLUTION	TOPICAL	20210513		ANDA	ANDA075598	Costco Wholesale Company	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63981-056_7240afe6-6516-4aaf-b11b-42bebf64746f	63981-056	HUMAN OTC DRUG	Acetaminophen PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20221004		OTC MONOGRAPH DRUG	M013	COSTCO WHOLESALE CORPORATION	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63981-112_d4efe5e9-891f-43e7-ab11-50524c677e98	63981-112	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20201030		ANDA	ANDA208077	Costco Wholesale	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-117_77b33ee9-2912-4bcf-96e1-e6e53538ae18	63981-117	HUMAN OTC DRUG	Kirkland Signature Lansoprazole Delayed Release		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20131217		ANDA	ANDA202319	Costco Wholesale Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63981-121_ca84058e-b93a-474a-bfc6-3007f0b21b0f	63981-121	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131	20251231	ANDA	ANDA202300	Costco Wholesale	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
63981-124_f67f9328-6575-4c79-ab5c-ee1e9b46eb96	63981-124	HUMAN OTC DRUG	Kirkland Signature Nicotine		nicotine	LOZENGE	ORAL	20200508		ANDA	ANDA090711	Costco Wholesale Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-147_e15a63cb-fca8-4111-804b-c510bf33d8ff	63981-147	HUMAN OTC DRUG	kirkland signature aller tec d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200330		ANDA	ANDA210719	Costco Wholesale Company	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
63981-170_d6109803-e570-49b7-8831-b70702a4fe5e	63981-170	HUMAN OTC DRUG	kirkland signature quit 4		Nicotine Polacrilex	GUM, CHEWING	ORAL	20120507		ANDA	ANDA076789	Costco Wholesale Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-190_b864361c-f31a-4bdf-b033-828f7f204f1e	63981-190	HUMAN OTC DRUG	Kirkland Signature Nicotine		nicotine	LOZENGE	ORAL	20200508		ANDA	ANDA090711	Costco Wholesale Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-194_d6a8617a-10f8-4800-ba5d-b8721a49ad76	63981-194	HUMAN OTC DRUG	kirkland signature acid controller		Famotidine	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA077351	Costco Wholesale Company	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
63981-211_9954b340-4783-4387-a9da-2f36b4cf8089	63981-211	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20221231		ANDA	ANDA208077	Costco Wholesale	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-291_8fcc8ef5-bc8c-4f1a-a695-023faf8f8cb6	63981-291	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	COSTCO WHOLESALE CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-294_7fde9baa-d3cb-45ef-9a07-bf48b8d28aec	63981-294	HUMAN OTC DRUG	kirkland signature Minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20120417		ANDA	ANDA091344	Costco Wholesale Company	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63981-306_5c0cc01e-d67d-427f-bdac-756b70af223a	63981-306	HUMAN OTC DRUG	kirkland signature laxaclear	original prescription strength	Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091107		ANDA	ANDA090685	Costco Wholesale Company	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
63981-309_42533b24-e8d1-41ae-addd-8c3bfc9336b3	63981-309	HUMAN OTC DRUG	kirkland signature quit 4		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170321		ANDA	ANDA206393	Costco Wholesale Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-329_9220d62a-2f4c-47d5-aa86-d2d7971b8c1d	63981-329	HUMAN OTC DRUG	Allergy Medicine		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	COSTCO WHOLESALE CORPORATION	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63981-344_d3e32857-a3d2-42b7-a288-f395687f7f28	63981-344	HUMAN OTC DRUG	kirkland signature quit 2		Nicotine Polacrilex	LOZENGE	ORAL	20140912		ANDA	ANDA077007	Costco Wholesale Company	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-368_307a6f37-dc9d-4ea8-b664-6e888fc1f681	63981-368	HUMAN OTC DRUG	kirkland signature naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20070604		ANDA	ANDA074661	Costco Wholesale Company	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-380_4368eea4-afbd-4fb3-96d6-7a3ca92abb97	63981-380	HUMAN OTC DRUG	Kirkland Signature Minoxidil		Minoxidil	SOLUTION	TOPICAL	20130825		ANDA	ANDA075598	Costco Wholesale Company	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63981-393_fe2125ff-ae50-4e7b-ba32-aa0736c45f13	63981-393	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	COSTCO WHOLESALE CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-458_95ef3756-9cfe-4340-8bf2-958eebfc9d4f	63981-458	HUMAN OTC DRUG	kirkland signature aller tec	allergy	Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080325		ANDA	ANDA078336	Costco Wholesale Company	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63981-475_fcdbe753-6a33-4c46-acfe-3ead668364ec	63981-475	HUMAN OTC DRUG	Kirkland Signature Childrens Aller Tec		Cetirizine HCl	SOLUTION	ORAL	20160708		ANDA	ANDA204226	Costco Wholesale Company	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63981-517_65e4db7f-45f6-4540-b265-7ca72b6c86ea	63981-517	HUMAN OTC DRUG	kirkland signature ibuprofen ib		Ibuprofen	TABLET, FILM COATED	ORAL	20070622		ANDA	ANDA077349	Costco Wholesale Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-519_8a1be2b6-98fe-41ea-87fd-46d65e7269f1	63981-519	HUMAN OTC DRUG	RAPID RELEASE ACETAMINOPHEN	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	COSTCO WHOLESALE CORPORATION	ACETAMINOPHEN	500	mg/1			N	20241231
63981-532_1b8a7cda-1436-45f1-8418-8b6dd178254a	63981-532	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, FILM COATED	ORAL	20051222		OTC MONOGRAPH DRUG	M012	COSTCO WHOLESALE CORPORATION	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
63981-556_4368fb2a-a593-48a0-9a5f-3b8ea053225b	63981-556	HUMAN OTC DRUG	Rapid Release Acetaminophen PM	Extra Strength	Acetaminophen and Diphenhydramine HCl	TABLET, COATED	ORAL	20071217	20241027	OTC MONOGRAPH NOT FINAL	part343	COSTCO WHOLESALE CORPORATION	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
63981-563_e2723935-9863-4001-8e3a-a4912e45d503	63981-563	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	COSTCO WHOLESALE CORPORATION	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
63981-582_c590b228-0fed-420f-b20a-dedb99f99b1b	63981-582	HUMAN OTC DRUG	Kirkland Signature Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20211122		ANDA	ANDA202319	Costco Wholesale Company	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63981-598_91870a35-5a48-479c-b394-11e57ebb7ca4	63981-598	HUMAN OTC DRUG	Ibuprofen		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20180206		ANDA	ANDA078682	Costco Wholesale	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-599_c768068b-cfd3-4a15-b26a-c8b126c88fa0	63981-599	HUMAN OTC DRUG	kirkland signature arthritis pain relief		diclofenac sodium	GEL	TOPICAL	20230303		ANDA	ANDA211253	Costco Wholesale Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-604_0460453b-dc93-4251-a164-a97b3578f586	63981-604	HUMAN OTC DRUG	kirkland signature ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20030625		ANDA	ANDA072096	Costco Wholesale Company	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-664_74e282a9-3168-44ff-a815-5ba19cd05d48	63981-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20110614		OTC MONOGRAPH NOT FINAL	part356	Costco Wholesale Corporation	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
63981-699_55fa8174-61c9-43ec-bc65-b39a687974c4	63981-699	HUMAN OTC DRUG	kirkland signature migraine headache relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20220609		ANDA	ANDA075794	Costco Wholesale Company	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
63981-700_39c0346d-6c85-4332-9f92-141bfbe2dcf5	63981-700	HUMAN OTC DRUG	kirkland signature acetaminophen	adult extra strength	Acetaminophen	TABLET	ORAL	20090603		OTC MONOGRAPH NOT FINAL	part343	Costco Wholesale Company	ACETAMINOPHEN	500	mg/1			N	20241231
63981-702_f76607b4-8ba5-4b60-9261-54f19aad9a39	63981-702	HUMAN OTC DRUG	Cold and Flu Multi-Symptom	Daytime/Nighttime Severe	Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Guaifenesin and Phenylephrine HCl	KIT		20200409	20250418	OTC MONOGRAPH FINAL	part341	COSTCO WHOLESALE CORPORATION						N	
63981-723_24d75860-d636-416a-b89f-4b503c526802	63981-723	HUMAN OTC DRUG	kirkland signature allerclear d 12 hr		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180507		ANDA	ANDA076050	Costco Wholesale Company	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63981-724_ebc90414-74b9-4186-99af-b1e655f177eb	63981-724	HUMAN OTC DRUG	KIRKLAND SIGNATURE ALLERCLEAR D 24 HR	Extended Release	loratadine and pseudoephedrine sulfate	TABLET, EXTENDED RELEASE	ORAL	20170825		ANDA	ANDA076557	Kirkland-COSTCO WHOLESALE COMPANY	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
63981-750_878e4453-ed55-4eac-8f20-3ca61f85f05d	63981-750	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180731		ANDA	ANDA206999	Costco Wholesale	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-795_995cfc37-9e55-4662-974b-0aff194be711	63981-795	HUMAN OTC DRUG	Severe Cold and Flu Plus Congestion		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Guaifenesin, Phenylephrine HCl	KIT		20230630		OTC MONOGRAPH DRUG	M012	COSTCO WHOLESALE CORPORATION						N	20241231
63981-798_91ab74cc-0690-4777-a4ac-0170abdfba7b	63981-798	HUMAN OTC DRUG	kirkland signature minoxidil		Minoxidil	SOLUTION	TOPICAL	20120522		ANDA	ANDA075598	Costco Wholesale Company	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
63981-812_f13504ed-1296-47ec-b8e9-147ce56a7129	63981-812	HUMAN OTC DRUG	kirkland signature mucus dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230519		ANDA	ANDA207602	Costco Wholesale Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
63981-847_9d7724ba-f3b3-4ac8-9558-42753f6fe838	63981-847	HUMAN OTC DRUG	kirkland signature aller fex		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20210819		ANDA	ANDA212971	Costco Wholesale Company	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
63981-853_0fd87eb3-5d1d-43fa-8be4-f4452f0375c9	63981-853	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20220318		OTC MONOGRAPH NOT FINAL	part334	Costco Wholesale	DOCUSATE SODIUM	100	mg/1			N	20241231
63981-870_f78a8607-b53c-4c5e-82d3-e1cd9686703a	63981-870	HUMAN OTC DRUG	kirkland signature diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20210913		ANDA	ANDA211253	Costco Wholesale Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
63981-873_e2cd5ccc-3e88-49e7-9fd7-29ac2b9b8089	63981-873	HUMAN OTC DRUG	kirkland signature quit 4		Nicotine Polacrilex	LOZENGE	ORAL	20140912		ANDA	ANDA077007	Costco Wholesale Company	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
63981-898_d48237c8-d52a-4125-bfbe-f9d748d34086	63981-898	HUMAN OTC DRUG	kirkland signature esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170922		ANDA	ANDA207193	Costco Wholesale Company	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63981-915_e69b629d-855f-4755-91a5-e914be952189	63981-915	HUMAN OTC DRUG	kirkland signature omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080227		NDA	NDA022032	Costco Wholesale Company	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
63981-933_49a1fbb6-dca3-494b-b874-bcaba9e08cb4	63981-933	HUMAN OTC DRUG	dishwashing		chloroxylenol	LIQUID	TOPICAL	20191214		OTC MONOGRAPH NOT FINAL	part333A	Costco Wholesale Corporation	CHLOROXYLENOL	3	mg/mL			N	20241231
63981-973_39a50893-1150-437d-b43f-ea364282930a	63981-973	HUMAN OTC DRUG	kirkland signature hydrocortisone plus	maximum strength	hydrocortisone	CREAM	TOPICAL	20091002		OTC MONOGRAPH NOT FINAL	part348	Costco Wholesale Company	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
63981-986_3e3f215e-23ff-496e-86c3-817645dc8f64	63981-986	HUMAN OTC DRUG	Sleep Aid		Doxylamine succinate	TABLET	ORAL	20190503		ANDA	ANDA040564	COSTCO WHOLESALE CORPORATION	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
63998-364_91e54780-0948-4b73-86dc-573b02d4b78d	63998-364	HUMAN OTC DRUG	Instant Antiseptic Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part333A	United Laboratories Inc.	ALCOHOL	70	mL/100mL			N	20241231
63998-693_eedb2bd4-f037-acf4-e053-2995a90a6520	63998-693	HUMAN OTC DRUG	Contact Instant Antiseptic Hand Sanitizer		Contact Instant Antiseptic Hand Sanitizer	LIQUID	TOPICAL	20220908		OTC MONOGRAPH NOT FINAL	part333A	United Laboratories, Inc.	ALCOHOL	67	mL/100mL			N	20241231
63998-758_f06ae791-df6a-4dbf-e053-2995a90a997b	63998-758	HUMAN OTC DRUG	Meringue Foaming Dye Free Antibacterial		Choroxylenol	LIQUID	TOPICAL	20221222		OTC MONOGRAPH NOT FINAL	part333A	United Laboratories Inc.	CHLOROXYLENOL	2.5	mg/mL			N	20241231
63998-764_63f98a4a-af4d-4deb-a37e-6b3aad06c3bc	63998-764	HUMAN OTC DRUG	Alcohol-Free Hand Sanitizing Foam		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part333E	United Laboratories Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
64004-001_06d69cac-507a-c781-e063-6294a90a2a8a	64004-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141001		UNAPPROVED MEDICAL GAS		Williams Bros Health Care Pharmacy, Inc.	OXYGEN	99	L/100L			N	20241231
64009-200_0ce31895-e42b-46b8-e063-6394a90a63ab	64009-200	HUMAN OTC DRUG	FoamyIQ E2 Sanitizing Handwash		Benzalkonium Chloride	SOAP	TOPICAL	20191203		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	BENZALKONIUM CHLORIDE	1.3	g/L			N	20241231
64009-201_0ce31a3c-976c-66ce-e063-6294a90ad6d6	64009-201	HUMAN OTC DRUG	FoamyIQ Eucalyptus Mint Sanitizing Handwash		Benzalkonium Chloride	SOAP	TOPICAL	20191209		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	BENZALKONIUM CHLORIDE	1.3	g/L			N	20241231
64009-203_0ce33d15-46f7-a846-e063-6294a90ac4b4	64009-203	HUMAN OTC DRUG	FoamyIQ Healthcare Personnel Handwash		Chloroxyenol	SOAP	TOPICAL	20191209		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	CHLOROXYLENOL	10.11	g/L			N	20241231
64009-221_0ce28f17-7e6b-25df-e063-6294a90ab529	64009-221	HUMAN OTC DRUG	FoamyiQ Non-Alcohol Hand Sanitizer		FoamyiQ Non-Alcohol Hand Sanitizer	SOAP	TOPICAL	20221231		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	BENZALKONIUM CHLORIDE	1	g/1000g			N	20241231
64009-222_0ce2595f-c940-021d-e063-6394a90ac4ad	64009-222	HUMAN OTC DRUG	Lite n Foamy Non-Alcohol Hand Sanitizer		Lite n Foamy Non-Alcohol Hand Sanitizer	SOAP	TOPICAL	20221231		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	BENZALKONIUM CHLORIDE	1	g/1000g			N	20241231
64009-332_0ce2d547-7ccc-65ec-e063-6294a90a184f	64009-332	HUMAN OTC DRUG	Lite nFoamy Eucalyptus Mint Sanitizing Handwash		Benzalkonium Chloride	SOAP	TOPICAL	20140414		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	BENZALKONIUM CHLORIDE	1.3	g/L			N	20241231
64009-333_0ce2f142-2284-7c37-e063-6294a90a63f8	64009-333	HUMAN OTC DRUG	Lite nFoamy E2 Sanitizing Handwash		Benzalkonium Chloride	SOAP	TOPICAL	20140401		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	BENZALKONIUM CHLORIDE	1.3	g/L			N	20241231
64009-334_0ce28410-686c-2791-e063-6294a90ac0f5	64009-334	HUMAN OTC DRUG	Lite nFoamy E3 Hand Sanitizer		Benzalkonium Chloride	SOAP	TOPICAL	20140401		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	BENZALKONIUM CHLORIDE	1	g/L			N	20241231
64009-335_0ce31aaf-3cb2-8676-e063-6294a90aa54e	64009-335	HUMAN OTC DRUG	Lite nFoamy Healthcare Personnel Handwash		Chloroxylenol	SOAP	TOPICAL	20150105		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	CHLOROXYLENOL	10.11	g/L			N	20241231
64009-336_0ce32f27-fdd4-9f33-e063-6294a90ab85c	64009-336	HUMAN OTC DRUG	Antiseptic Hand Cleaner		Chloroxylenol	SOAP	TOPICAL	20150105		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company	CHLOROXYLENOL	10.11	g/L			N	20241231
64009-338_0ce340eb-9176-4dbf-e063-6394a90ae5b8	64009-338	HUMAN OTC DRUG	Clean Xpress Antiseptic Hand Cleaner		Chloroxylenol	SOAP	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Spartan Chemical Company, Inc.	CHLOROXYLENOL	10	mg/mL			N	20241231
64009-660_06bd825d-9150-5ca7-e063-6394a90aec49	64009-660	HUMAN OTC DRUG	Purforma Advanced Hand Sanitizer 70% Alcohol		Hand Sanitizer 70% Alcohol	SOAP	TOPICAL	20231002		OTC MONOGRAPH DRUG	M016	Spartan Chemical Company, Inc.	ALCOHOL	70	mL/100mL			N	20241231
64024-002_02abd52b-e144-4ac8-8356-267f91950abd	64024-002	HUMAN OTC DRUG	welby ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160107		ANDA	ANDA072096	Aldi, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64024-003_49d5d2a0-e309-4b07-83aa-a3d180877475	64024-003	HUMAN OTC DRUG	Welby Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20210920		ANDA	ANDA074937	Aldi, Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64024-007_441e9ff4-4e1e-4fb6-89b0-96f998a4f854	64024-007	HUMAN OTC DRUG	Welby Fluticasone		Fluticasone propionate	SPRAY, METERED	NASAL	20190710		ANDA	ANDA207957	Aldi Inc	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64024-008_dafa52fe-42e5-2c21-e053-2995a90a413f	64024-008	HUMAN OTC DRUG	Lacura Moisturizing Hand Sanitizer		Ethyl Alcohol 62%	LIQUID	TOPICAL	20220404		OTC MONOGRAPH NOT FINAL	part333E	Aldi	ALCOHOL	62	g/100mL			N	20241231
64024-020_0f42bbe8-c90a-4678-b738-fbd3b80ae79f	64024-020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	PASTE	TOPICAL	20160927		OTC MONOGRAPH FINAL	part347	ALDI Inc	ZINC OXIDE	400	mg/g			N	20241231
64024-023_402c635d-4116-4767-baa9-e956fed02884	64024-023	HUMAN OTC DRUG	welby childrens allergy relief		Loratadine	SOLUTION	ORAL	20220302		ANDA	ANDA075728	Aldi Inc	LORATADINE	5	mg/5mL			N	20241231
64024-153_25e30fcf-516c-49bc-a410-3aa503c4d20b	64024-153	HUMAN OTC DRUG	Simply Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20210122		OTC MONOGRAPH FINAL	part358H	Aldi, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
64024-180_8f4fdba5-794f-4281-9d5f-8da225f9dc2b	64024-180	HUMAN OTC DRUG	Healing		petrolatum	OINTMENT	TOPICAL	20160922		OTC MONOGRAPH FINAL	part347	ALDI Inc.	PETROLATUM	340	mg/g			N	20241231
64024-222_8554fa25-2ba5-4031-b090-2c482b4d8e45	64024-222	HUMAN OTC DRUG	welby mucus relief		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210930		ANDA	ANDA078912	Aldi Inc	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
64024-226_f279e17c-94fd-4101-9085-3e004b5a7315	64024-226	HUMAN OTC DRUG	Zinc oxide		Zinc oxide	CREAM	TOPICAL	20201230		OTC MONOGRAPH FINAL	part347	Aldi, Inc	ZINC OXIDE	130	mg/g			N	20241231
64024-279_3880fdc1-5cc3-4d7e-a8ab-fd0e2f6b595c	64024-279	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20221116		OTC MONOGRAPH NOT FINAL	part333A	Aldi, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64024-306_19c4902f-1ee3-4d65-980b-68a0a344b749	64024-306	HUMAN OTC DRUG	Welby ClearLax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20170821		ANDA	ANDA090685	Aldi, Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64024-311_b224b25f-b6f9-4216-a7a0-2f724bde75b2	64024-311	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20210121		OTC MONOGRAPH FINAL	part358H	Aldi, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
64024-370_c7720e91-51b8-4026-accf-bd0af11837e7	64024-370	HUMAN OTC DRUG	Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20140602		OTC MONOGRAPH NOT FINAL	part333A	Aldi Inc.	ALCOHOL	70	mL/100mL			N	20241231
64024-466_e9178257-ae4f-47ee-bcf4-0ec17f539769	64024-466	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160217		OTC MONOGRAPH NOT FINAL	part333A	Aldi, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64024-475_a8fd50c6-1a27-4ed2-8a63-f9b9918ffb4a	64024-475	HUMAN OTC DRUG	Welby Childrens Allergy Relief		Cetirizine Hydrochloride	SOLUTION	ORAL	20220302		ANDA	ANDA204226	Aldi Inc	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
64024-479_5a13068c-01c7-416e-adab-660bdebf4527	64024-479	HUMAN OTC DRUG	welby allergy relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20170714		OTC MONOGRAPH FINAL	part341	Aldi Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
64024-499_6aa94106-de52-47c4-a6f9-48e47991dae0	64024-499	HUMAN OTC DRUG	welby allergy relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20170714		ANDA	ANDA078336	Aldi Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
64024-576_f0546e3f-26bc-4f51-b7bf-ac1d172bf221	64024-576	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20220919		OTC MONOGRAPH NOT FINAL	part356	ALDI, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
64024-619_1d5b07e3-8023-4ca2-94ae-05de85253aac	64024-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20210405		OTC MONOGRAPH FINAL	part347	Aldi, Inc	DIMETHICONE	13.13	mg/mL	Skin Barrier Activity [PE]		N	20241231
64024-703_efe2fa11-8115-4d33-bb32-8e2509839ef4	64024-703	HUMAN OTC DRUG	welby all day allergy relief		Loratadine	TABLET	ORAL	20210622		ANDA	ANDA076301	Aldi, Inc	LORATADINE	10	mg/1			N	20241231
64024-849_50a01bc3-589d-410d-89c3-79acf5e82c37	64024-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201220		OTC MONOGRAPH NOT FINAL	part333A	ALDI INC.	ALCOHOL	62	mg/100mL			N	20241231
64024-915_e20b6b4f-33d2-4f3f-b8f1-2fad3ef62b23	64024-915	HUMAN OTC DRUG	welby omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20171004		NDA	NDA022032	Aldi Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64024-935_8121c125-e7ad-4e47-9e9e-12e6d38b853f	64024-935	HUMAN OTC DRUG	Sheer Touch Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231116		OTC MONOGRAPH DRUG	MM020	Aldi, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
64024-938_4e994a61-d244-4df3-8995-2b91ea849a02	64024-938	HUMAN OTC DRUG	Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231121		OTC MONOGRAPH DRUG	M	Aldi, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
64024-943_bc407efb-1cbf-f7cf-e053-2995a90acb05	64024-943	HUMAN OTC DRUG	Aldi Lacura Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	ALDI INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
64024-944_e3de5a1c-3855-6c54-e053-2995a90ad6d4	64024-944	HUMAN OTC DRUG	ALDI LACURA KIDS SPF 50 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20190131		OTC MONOGRAPH NOT FINAL	part352	ALDI INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
64024-945_f7abecc9-d827-278d-e053-6394a90a487e	64024-945	HUMAN OTC DRUG	Aldi Lacura Ultra Light Body SPF 100		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20220124		OTC MONOGRAPH FINAL	M020	ALDI INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
64024-946_f7ad0172-88a7-3de1-e053-6394a90aa06e	64024-946	HUMAN OTC DRUG	ALDI LACURA KIDS SUNSCREEN MINERAL BASED SPF 50		OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20190125		OTC MONOGRAPH FINAL	M020	ALDI INC	OCTISALATE; ZINC OXIDE	50; 145	mg/mL; mg/mL			N	20241231
64024-947_f7b1e78e-c0c4-3ed6-e053-6294a90a827f	64024-947	HUMAN OTC DRUG	Aldi LACURA SPORT Sunscreen 30 Broad Spectrum SPF 30		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20190315		OTC MONOGRAPH FINAL	M020	ALDI INC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
64024-948_f7b24dc7-59df-5086-e053-6394a90aa9e3	64024-948	HUMAN OTC DRUG	Aldi LACURA SPORT Sunscreen 50 Broad Spectrum SPF 50		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20190129		OTC MONOGRAPH FINAL	M020	ALDI INC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
64024-949_f7b2cf4e-468d-3406-e053-6394a90a2139	64024-949	HUMAN OTC DRUG	Aldi LACURA Ultra Light Dry-Touch 100 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20220126		OTC MONOGRAPH FINAL	M020	ALDI INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
64024-950_f7b32a63-df97-3116-e053-6294a90a1bb6	64024-950	HUMAN OTC DRUG	Aldi LACURA Sport Sunscreen 50 Broad Spectrum SPF 50 Continuous		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190129		OTC MONOGRAPH FINAL	M020	ALDI INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
64024-951_f7bdc269-10a0-4b70-e053-6394a90ac8a0	64024-951	HUMAN OTC DRUG	Aldi LACURA Sport Sunscreen 30 Broad Spectrum SPF 30 Continuous		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190131		OTC MONOGRAPH FINAL	M020	ALDI INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
64024-956_2561d42c-c7f7-41f5-a7f9-f68bb6f079b4	64024-956	HUMAN OTC DRUG	Ultra		Chloroxylenol 0.3%	LIQUID	TOPICAL	20190117		OTC MONOGRAPH NOT FINAL	part333A	Aldi	CHLOROXYLENOL	3.09	g/mL			N	20241231
64067-216_694eeb15-a5af-4adf-97c0-ec6314fb5d5f	64067-216	HUMAN PRESCRIPTION DRUG	UVADEX		Methoxsalen	INJECTION, SOLUTION	EXTRACORPOREAL	19990225		NDA	NDA020969	Therakos, Inc.	METHOXSALEN	20	ug/mL	Photoabsorption [MoA], Photoactivated Radical Generator [EPC], Photosensitizing Activity [PE], Psoralen [EPC], Psoralens [CS]		N	20241231
64068-402_0c868857-d58b-9413-e063-6294a90a0bab	64068-402	HUMAN OTC DRUG	Endit Zinc Oxide Skin Protectant		ZINC OXIDE	OINTMENT	TOPICAL	20170531		OTC MONOGRAPH DRUG	M016	Endit Laboratories, Inc.	ZINC OXIDE	20	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
64068-500_0c863def-7337-49f7-e063-6294a90a5d41	64068-500	HUMAN OTC DRUG	Endit zinc oxide skin protection		ZINC OXIDE	OINTMENT	TOPICAL	20220809		OTC MONOGRAPH DRUG	M016	EndIt Laboratories, Inc.	ZINC OXIDE	200	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
64069-4111_08031883-3737-3037-e063-6294a90a8f42	64069-4111	HUMAN PRESCRIPTION DRUG	Oxygen, Compressed U.S.P.		Oxygen, Compressed U.S.P.	GAS	RESPIRATORY (INHALATION)	20100610		NDA	NDA205865	Techgas Inc.	OXYGEN	1	L/L			N	20241231
64075-123_08b45bf3-0d81-f07b-e063-6394a90acfe5	64075-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070917		UNAPPROVED MEDICAL GAS		Alick's Home Medical Equipment, Inc.	OXYGEN	99	L/100L			N	20241231
64092-012_a5d79b6e-2df7-4b5a-ae95-0cdd7e9ddc71	64092-012	HUMAN OTC DRUG	Rest Simply		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610	20240916	OTC MONOGRAPH FINAL	part338	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
64092-105_cba2b071-f064-497f-ac54-e45f2ea7abf3	64092-105	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20050503	20241014	ANDA	ANDA076497	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	
64092-110_91a64408-6737-44fb-8aea-96523d1540bf	64092-110	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	19930804	20240204	OTC MONOGRAPH NOT FINAL	part343	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
64092-112_b37db3b9-eb50-447a-a3ca-174b056e67a1	64092-112	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin and caffeine	TABLET, FILM COATED	ORAL	19921117	20241024	OTC MONOGRAPH NOT FINAL	part343	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
64092-119_9e2c1bc2-d807-4a7d-9e77-0b4ff67ac9a9	64092-119	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501	20240125	OTC MONOGRAPH NOT FINAL	part343	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
64092-150_e2dedbae-a56b-45c0-b6c2-767be13917ef	64092-150	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19900912	20240920	OTC MONOGRAPH NOT FINAL	part343	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
64092-200_aaf3fab3-57f5-4f46-a410-bf433794c2ce	64092-200	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524	20241031	ANDA	ANDA075010	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
64092-413_0cf4d771-f6b1-ec8c-e063-6394a90a3551	64092-413	HUMAN OTC DRUG	Health Care Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	Great Lakes Wholesale, Marketing and Sales Inc	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
64092-820_fe720d7f-fd91-4dc9-befe-c09022f6eecb	64092-820	HUMAN OTC DRUG	Chlor-Allergy 4-Hour		Chlorpheniramine Maleate	TABLET	ORAL	19921219	20241019	OTC MONOGRAPH FINAL	part341	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
64092-830_f76a5b51-cc4c-4d59-bdcc-6d28b1a0ed13	64092-830	HUMAN OTC DRUG	Complete Allergy		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302	20240506	OTC MONOGRAPH FINAL	part341	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
64092-845_71b27ea2-f159-401d-a950-8e3acdf2083d	64092-845	HUMAN OTC DRUG	Non-Drowsy Sinus Daytime		Acetaminophen and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726	20241021	OTC MONOGRAPH FINAL	part341	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
64092-865_544a935a-2be3-4ace-88fe-a7977f34934b	64092-865	HUMAN OTC DRUG	Complete Allergy and Sinus	Multi Symptom	Acetaminophen, Chlorpheniramine Maleate and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050628	20240725	OTC MONOGRAPH FINAL	part341	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
64092-870_bbd7bde8-cbf0-4559-90c3-d2863490e0ee	64092-870	HUMAN OTC DRUG	Multi-Symptom Cold Daytime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050715	20240302	OTC MONOGRAPH FINAL	part341	GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
64097-0001_a750692f-9e05-4540-8f92-8cbf171625eb	64097-0001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19960101		UNAPPROVED MEDICAL GAS		Alternacare Home Health Services	OXYGEN	99.5	L/100L			N	20241231
64108-212_dbc3f516-cb64-4ca9-971e-677816181bd0	64108-212	HUMAN OTC DRUG	MINIDROPS		Lubricant eye drops	LIQUID	OPHTHALMIC	19910401		OTC MONOGRAPH DRUG	M018	Optics Laboratory, Inc	POLYVINYL ALCOHOL; POVIDONE, UNSPECIFIED	14; 6	mg/mL; mg/mL			N	20241231
64108-313_f6f1c2eb-2c5e-4986-8d92-e32f0124f464	64108-313	HUMAN OTC DRUG	OCUFRESH		Water	LIQUID	OPHTHALMIC	20140115		OTC MONOGRAPH DRUG	M018	Optics Laboratory Inc.	WATER	.988	mL/mL			N	20241231
64121-693_d9a83530-24cb-023b-e053-2995a90abde4	64121-693	HUMAN OTC DRUG	Instant Hand Sanitizer KE-53SAN		Instant Hand Sanitizer KE-53SAN	LIQUID	TOPICAL	20220223		OTC MONOGRAPH NOT FINAL	part333A	Kinzua Environmental	ALCOHOL	67	mL/100mL			N	20241231
64122-605_5a3e561c-c210-41d8-a576-a197951306ab	64122-605	HUMAN OTC DRUG	AfterPill		levonorgestrel	TABLET	ORAL	20170914		ANDA	ANDA201446	Syzygy Healthcare Solutions, LLC PO Box 588, Westport, CT 06880	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
64127-195_06d3c11c-9e58-3fcb-e063-6394a90a7639	64127-195	HUMAN OTC DRUG	GM COLLIN PURACNE		Salicylic Acid	GEL	TOPICAL	20181126		OTC MONOGRAPH DRUG	M006	Laboratoires Dermo-Cosmetik Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
64127-205_06d39c27-649f-4de5-e063-6394a90abb72	64127-205	HUMAN OTC DRUG	GMC MEDICAL Acne		Salicylic Acid	GEL	TOPICAL	20181126	20240731	OTC MONOGRAPH DRUG	M006	Laboratoires Dermo Cosmetik	SALICYLIC ACID	20	mg/mL			N	
64127-234_07d92a69-05da-5394-e063-6294a90a4229	64127-234	HUMAN OTC DRUG	GM Collin	SPF 25 UVA - UVB Urban Protection Veil Sunscreen	zinc oxide and titanium dioxide	CREAM	TOPICAL	20210115		OTC MONOGRAPH DRUG	M020	Laboratoires Dermo-Cosmetik Inc.	TITANIUM DIOXIDE; ZINC OXIDE	4.2; 14.6	mg/100mL; mg/100mL			N	20241231
64127-244_01dcfd14-7a1e-98fa-e063-6294a90a0336	64127-244	HUMAN OTC DRUG	G.M. Collin FPS-SPF 45 UVA-UVB TINTED SUNSCREEN		zinc oxide, titanium dioxide	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	LABORATOIRES DERMO-COSMETIK INC.	TITANIUM DIOXIDE; ZINC OXIDE	11.2; 8.4	g/100g; g/100g			N	20241231
64140-101_4fe3fee1-7d0d-491c-b81e-e8334a055bcd	64140-101	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19910101		NDA	NDA205840	Greene Respiratory Services, Inc	OXYGEN	99	L/100L			N	20241231
64141-013_017abe9e-16e6-538e-e063-6294a90accc2	64141-013	HUMAN OTC DRUG	BOBBI BROWN SKIN FOUNDATION	BROAD SPECTRUM SPF 15	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20120901		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	OCTINOXATE; TITANIUM DIOXIDE	75; 10	mg/mL; mg/mL			N	20241231
64141-019_fd282216-5d12-b15f-e053-6294a90a2407	64141-019	HUMAN OTC DRUG	BOBBI BROWN LIP BALM BROAD SPECTRUM SPF 15		AVOBENZONE, OCTINOXATE, and OCTISALATE	LIPSTICK	TOPICAL	20020201		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	3; 7.5; 3.5	g/100g; g/100g; g/100g			N	20241231
64141-025_f0708711-a932-563f-e053-2995a90a276c	64141-025	HUMAN OTC DRUG	SKIN LONG-WEAR WEIGHTLESS FOUNDATION BROAD SPECTRUM SPF 15		OCTINOXATE and TITANIUM DIOXIDE	LOTION	TOPICAL	20170721		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	OCTINOXATE; TITANIUM DIOXIDE	30; 16	mg/mL; mg/mL			N	20241231
64141-027_fa58da35-2e26-99e7-e053-6394a90a6643	64141-027	HUMAN OTC DRUG	BOBBI BROWN TINTED MOISTURIZER BROAD SPECTRUM SPF 15		OCTINOXATE and TITANIUM DIOXIDE	LOTION	TOPICAL	20010101		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	OCTINOXATE; TITANIUM DIOXIDE	75; 30	mg/mL; mg/mL			N	20241231
64141-030_0077c4d5-af23-66b3-e063-6294a90a0831	64141-030	HUMAN OTC DRUG	SKIN LONG-WEAR FLUID powder FOUNDATION BROAD SPECTRUM SPF 20		ENSULIZOLE, TITANIUM DIOXIDE, and ZINC OXIDE	LIQUID	TOPICAL	20191016		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	ENSULIZOLE; TITANIUM DIOXIDE; ZINC OXIDE	20; 37; 18	mg/mL; mg/mL; mg/mL			N	20241231
64141-031_0077b6b1-d7ed-3939-e063-6394a90ad7a2	64141-031	HUMAN OTC DRUG	BOBBI BROWN INTENSIVE SERUM FOUNDATION BROAD SPECTRUM SPF 40		octinoxate, titanium dioxide, and zinc oxide	LIQUID	TOPICAL	20210127		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	40; 62; 39	mg/mL; mg/mL; mg/mL			N	20241231
64141-032_0077c4d5-af26-66b3-e063-6294a90a0831	64141-032	HUMAN OTC DRUG	BOBBI BROWN INTENSIVE SERUM FOUNDATION BROAD SPECTRUM SPF 30		OCTINOXATE, TITANIUM DIOXIDE and ZINC OXIDE	LIQUID	TOPICAL	20210412		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	67; 21; 13	mg/mL; mg/mL; mg/mL			N	20241231
64141-033_0077b6b1-d7f1-3939-e063-6394a90ad7a2	64141-033	HUMAN OTC DRUG	VITAMIN ENRICHED SKIN TINT BROAD SPECTRUM SPF 15		VITAMIN ENRICHED SKIN TINT BROAD SPECTRUM SPF 15	LIQUID	TOPICAL	20230501		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 29	mg/mL; mg/mL; mg/mL			N	20241231
64141-034_fbd04b66-738c-2762-e053-6394a90a8b72	64141-034	HUMAN OTC DRUG	WEIGHTLESS SKIN FOUNDATION BROAD SPECTRUM SPF 15		OCTINOXATE, TITANIUM DIOXIDE	EMULSION	TOPICAL	20230516		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	OCTINOXATE; TITANIUM DIOXIDE	67; 17	mg/mL; mg/mL			N	20241231
64141-035_03372376-ef04-943d-e063-6394a90a52ee	64141-035	HUMAN OTC DRUG	BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,AND OXYBENZONE	CREAM	TOPICAL	20230818		OTC MONOGRAPH FINAL	M020	Bobbi Brown Professional Cosmetics Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 50; 27; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
64169-001_0761147f-1339-606e-e063-6394a90abd5d	64169-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19971001		NDA	NDA205767	EUGENE WELDERS SUPPLY CO	OXYGEN	990	mL/L			N	20241231
64169-002_076103a1-a40f-4bd1-e063-6394a90aab28	64169-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20140101		NDA	NDA205766	801576526	NITROGEN	995	mL/L			N	20241231
64169-003_07612f65-6235-5254-e063-6294a90ae02f	64169-003	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20160801		NDA	NDA205767	EUGENE WELDERS SUPPLY CO	OXYGEN	210	mL/L			N	20241231
64169-004_0c69e4ce-6fbf-cd62-e063-6394a90a9e43	64169-004	HUMAN PRESCRIPTION DRUG	Carbogen		Carbogen	GAS	RESPIRATORY (INHALATION)	20231212		NDA	NDA205767	EUGENE WELDERS SUPPLY CO	OXYGEN	950	mL/L			N	20241231
64175-991_0cc9f504-80ab-437d-e063-6294a90a6a08	64175-991	HUMAN OTC DRUG	Relax AM-PM		Valerian Root, Passiflora, Magnesium Carbonate	TABLET	ORAL	20111116		UNAPPROVED HOMEOPATHIC		Foster Regal Laboratories	MAGNESIUM CARBONATE; PASSIFLORA INCARNATA FLOWER; VALERIAN	1; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
64193-424_ab7450a4-3888-42dd-b0fe-12155b41cb0c	64193-424	HUMAN PRESCRIPTION DRUG	FEIBA		anti-inhibitor coagulant complex	KIT		19860131		BLA	BLA101447	Takeda Pharmaceuticals America, Inc.						N	20241231
64193-425_ab7450a4-3888-42dd-b0fe-12155b41cb0c	64193-425	HUMAN PRESCRIPTION DRUG	FEIBA		anti-inhibitor coagulant complex	KIT		19860131		BLA	BLA101447	Takeda Pharmaceuticals America, Inc.						N	20241231
64193-426_ab7450a4-3888-42dd-b0fe-12155b41cb0c	64193-426	HUMAN PRESCRIPTION DRUG	FEIBA		anti-inhibitor coagulant complex	KIT		19860131		BLA	BLA101447	Takeda Pharmaceuticals America, Inc.						N	20241231
64203-020_203f5299-f743-4057-89a6-7287499a9975	64203-020	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19930101		UNAPPROVED MEDICAL GAS		New Schryver LLC	OXYGEN	99	L/100L			N	20241231
64208-2510_448a5a5b-6701-43bc-9a95-218269a39c19	64208-2510	HUMAN PRESCRIPTION DRUG	ALBUMINEX		Albumin Human	SOLUTION	INTRAVENOUS	20200527		BLA	BLA125644	BPL	ALBUMIN HUMAN	.05	g/mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
64208-2512_7ce4eaeb-75b9-4a97-ac4c-88c7584fad40	64208-2512	HUMAN PRESCRIPTION DRUG	ALBUMINEX		Albumin Human	SOLUTION	INTRAVENOUS	20200527		BLA	BLA125644	BPL	ALBUMIN HUMAN	.25	g/mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
64208-7752_25a8061d-34ba-48a8-a467-1c6eb49b5642	64208-7752	HUMAN PRESCRIPTION DRUG	Coagadex		Coagulation Factor X Human	KIT		20151021		BLA	BLA125506	Bio Products Laboratory Limited						N	20241231
64208-7753_25a8061d-34ba-48a8-a467-1c6eb49b5642	64208-7753	HUMAN PRESCRIPTION DRUG	Coagadex		Coagulation Factor X Human	KIT		20151021		BLA	BLA125506	Bio Products Laboratory Limited						N	20241231
64208-8234_39944116-60f1-4516-a416-d91077d2f25c	64208-8234	PLASMA DERIVATIVE	Gammaplex		HUMAN IMMUNOGLOBULIN G	SOLUTION	INTRAVENOUS	20101101		BLA	BLA125329	Bio Products Laboratory Limited	HUMAN IMMUNOGLOBULIN G	5	g/100mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
64208-8235_e01123dc-3fdc-41ae-bb13-fd50b51de663	64208-8235	PLASMA DERIVATIVE	Gammaplex		HUMAN IMMUNOGLOBULIN G	SOLUTION	INTRAVENOUS	20170407		BLA	BLA125329	Bio Products Laboratory Limited	HUMAN IMMUNOGLOBULIN G	5	g/50mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
64233-221_61966a58-1550-4227-956b-b1f0c63d3ccf	64233-221	HUMAN OTC DRUG	Alco San		ALCOHOL	GEL	TOPICAL	20150701		OTC MONOGRAPH NOT FINAL	part333E	Mid American Research Chemical Corp	ALCOHOL	.7	mL/mL			N	20241231
64233-693_bd44312b-2e48-29ec-e053-2a95a90ac803	64233-693	HUMAN OTC DRUG	Alco-San		Alco-San	LIQUID	TOPICAL	20200724		OTC MONOGRAPH NOT FINAL	part333A	Mid-American Research Chemical Corp.	ALCOHOL	67	mL/100mL			N	20241231
64253-020_f3953452-2bb4-9c96-e053-2a95a90aed50	64253-020	HUMAN PRESCRIPTION DRUG	Sterile Water		Sterile Water for Injection	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20200127		ANDA	ANDA211188	Medefil, Inc.	WATER	100	mL/100mL			N	20241231
64253-400_fbfdf718-beff-ad22-e053-6294a90a3715	64253-400	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate Injection	INJECTION, SOLUTION	INTRAVENOUS	20230511		ANDA	ANDA214970	Medefil, Inc.	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
64253-900_fd8f5c27-f125-4390-e053-6394a90a39c4	64253-900	HUMAN PRESCRIPTION DRUG	Calcium Chloride		Calcium Chloride Injection	INJECTION, SOLUTION	INTRAVENOUS	20190822		ANDA	ANDA211553	Medefil, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
64281-100_04804d80-7a96-41dc-a7db-1cfa4a42a740	64281-100	HUMAN PRESCRIPTION DRUG	Provocholine		methacholine chloride	POWDER, FOR SOLUTION	RESPIRATORY (INHALATION)	20130327		NDA	NDA019193	Methapharm Inc.	METHACHOLINE CHLORIDE	100	mg/100mg	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
64281-110_04804d80-7a96-41dc-a7db-1cfa4a42a740	64281-110	HUMAN PRESCRIPTION DRUG	Provocholine Inhalation Solution		Methacholine Chloride Inhalation Solution	KIT		20220303		NDA	NDA019193	Methapharm Inc.						N	20241231
64304-4304_eb60756f-aca5-7a92-e053-2a95a90a5181	64304-4304	HUMAN PRESCRIPTION DRUG	Medical Gasseous Oxygen Cylinders		OXYGEN	GAS	RESPIRATORY (INHALATION)	19980607		UNAPPROVED MEDICAL GAS		McKinley Medical Supply, Inc.	OXYGEN	1	L/L			N	20241231
64307-001_07ca66ec-a987-7d19-e063-6294a90ae868	64307-001	HUMAN OTC DRUG	Decon Hand Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	19990601		OTC MONOGRAPH DRUG	505G(a)(3)	Veltek Associates, Inc.	ALCOHOL	64.5	mL/100mL			N	20241231
64319-001_0bddaa1e-0d98-13d2-e063-6394a90a7932	64319-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Diversified Medical Supply Corporation dba Medigas Distribution and Supply	OXYGEN	99	L/100L			N	20241231
64321-123_f4fac964-4a26-335d-e053-2a95a90ac4eb	64321-123	HUMAN OTC DRUG	Little Buddy in a Little Tubby		Hand Sanitizing Towelettes	CLOTH	TOPICAL	20230218		OTC MONOGRAPH NOT FINAL	part333A	Continental Research Corp	BENZALKONIUM CHLORIDE	.12	mg/100mL			N	20241231
64330-630_0a294e70-735e-4226-b52d-9127a1080aa2	64330-630	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20220606		ANDA	ANDA216243	Centaur Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64330-631_0a294e70-735e-4226-b52d-9127a1080aa2	64330-631	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20220606		ANDA	ANDA216243	Centaur Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64330-632_0a294e70-735e-4226-b52d-9127a1080aa2	64330-632	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20220606		ANDA	ANDA216243	Centaur Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64330-633_0a294e70-735e-4226-b52d-9127a1080aa2	64330-633	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20220606		ANDA	ANDA216243	Centaur Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64330-634_0a294e70-735e-4226-b52d-9127a1080aa2	64330-634	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20220606		ANDA	ANDA216243	Centaur Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64330-635_0a294e70-735e-4226-b52d-9127a1080aa2	64330-635	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20220606		ANDA	ANDA216243	Centaur Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64336-001_07d62d02-39a2-4d81-e063-6294a90abc41	64336-001	HUMAN OTC DRUG	Vicks VapoRub ADVANCED PLUS		Camphor, Eucalyptus oil, Menthol	OINTMENT	TOPICAL	20230706		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing GmbH	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	.048; .012; .026	g/g; g/g; g/g			N	20241231
64336-015_07de694d-d16a-9c2f-e063-6394a90aefd1	64336-015	HUMAN OTC DRUG	Vicks Sinex SEVERE	MOISTURIZING ULTRA FINE MIST	Oxymetazoline Hydrochloride	SPRAY	NASAL	20180710		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing GmbH	OXYMETAZOLINE HYDROCHLORIDE	.05	g/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
64336-170_07de98ba-0839-e8d7-e063-6294a90a1556	64336-170	HUMAN OTC DRUG	Vicks Sinex	Severe Original	Oxymetazoline Hydrochloride	SPRAY	NASAL	20181220		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing GmbH	OXYMETAZOLINE HYDROCHLORIDE	.0005095	g/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
64336-171_07de3e34-75cf-bf7e-e063-6394a90a72f3	64336-171	HUMAN OTC DRUG	Vicks Sinex	12 Hour Decongestant Ultra Fine Mist	Oxymetazoline Hydrochloride	SPRAY	NASAL	20150427		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing GmbH,	OXYMETAZOLINE HYDROCHLORIDE	.0005095	g/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
64336-173_07de2b7e-96f6-162d-e063-6394a90a4488	64336-173	HUMAN OTC DRUG	Vicks Sinex	12 Hour Decongestant Ultra Fine Mist	Oxymetazoline Hydrochloride	SPRAY	NASAL	20200501		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing GmbH	OXYMETAZOLINE HYDROCHLORIDE	.0005095	g/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
64363-0025_0a83b038-fd9c-b119-e063-6294a90a4ac8	64363-0025	HUMAN OTC DRUG	Stiff n Sore		Arnica Montana, Bellis Perennis, Ruta Graveolens,Rhus Toxicondendron gel	GEL	TOPICAL	20150301		UNAPPROVED HOMEOPATHIC		Suco Inc	ARNICA MONTANA; BELLIS PERENNIS; RUTA GRAVEOLENS WHOLE; TOXICODENDRON PUBESCENS WHOLE	4; 4; 4; 4	[hp_X]/480g; [hp_X]/480g; [hp_X]/480g; [hp_X]/480g			N	20241231
64363-0045_0a83b038-fd9c-b119-e063-6294a90a4ac8	64363-0045	HUMAN OTC DRUG	Stiff n Sore		Arnica Montana, Bellis Perennis, Ruta Graveolens,Rhus Toxicondendron	CREAM	TOPICAL	20150201		UNAPPROVED HOMEOPATHIC		Suco Inc	ARNICA MONTANA; BELLIS PERENNIS; RUTA GRAVEOLENS WHOLE; TOXICODENDRON PUBESCENS WHOLE	4; 4; 4; 4	[hp_X]/480g; [hp_X]/480g; [hp_X]/480g; [hp_X]/480g			N	20241231
64370-375_f80d1fd4-6040-93b1-e053-6294a90a786a	64370-375	HUMAN PRESCRIPTION DRUG	HEMANGEOL		propranolol hydrochloride	SOLUTION	ORAL	20140414		NDA	NDA205410	Pierre Fabre Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	4.28	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
64380-127_2fe2da71-4def-41c2-8be5-0fa1a13ca2bb	64380-127	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20220816		ANDA	ANDA216046	Strides Pharma Science Limited	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
64380-128_2fe2da71-4def-41c2-8be5-0fa1a13ca2bb	64380-128	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20220816		ANDA	ANDA216046	Strides Pharma Science Limited	CYCLOSPORINE	50	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
64380-129_2fe2da71-4def-41c2-8be5-0fa1a13ca2bb	64380-129	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, LIQUID FILLED	ORAL	20220816		ANDA	ANDA216046	Strides Pharma Science Limited	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
64380-151_0381ae33-1948-43c3-b7ce-1c24e11190c3	64380-151	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20220627		ANDA	ANDA076744	Strides Pharma Science Limited	TESTOSTERONE	25	mg/2.5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
64380-152_0381ae33-1948-43c3-b7ce-1c24e11190c3	64380-152	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20220627		ANDA	ANDA076744	Strides Pharma Science Limited	TESTOSTERONE	50	mg/5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
64380-153_65b7d0a6-97c0-43f8-a39d-8f29a9d154af	64380-153	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir hydrochloride	TABLET, FILM COATED	ORAL	20220912		ANDA	ANDA200790	Strides Pharma Science Limited	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
64380-154_73a30dc4-352b-4307-b902-07ffefc99a99	64380-154	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET	ORAL	20220411		ANDA	ANDA065131	Strides Pharma Science Limited	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
64380-155_73a30dc4-352b-4307-b902-07ffefc99a99	64380-155	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET	ORAL	20220411		ANDA	ANDA065131	Strides Pharma Science Limited	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
64380-156_73a30dc4-352b-4307-b902-07ffefc99a99	64380-156	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET	ORAL	20220411		ANDA	ANDA065131	Strides Pharma Science Limited	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
64380-158_59a75075-268a-494c-b895-cd1c0dffc535	64380-158	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	20220411		ANDA	ANDA072422	Strides Pharma Science Limited	MEGESTROL ACETATE	20	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
64380-159_59a75075-268a-494c-b895-cd1c0dffc535	64380-159	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	20220404		ANDA	ANDA072423	Strides Pharma Science Limited	MEGESTROL ACETATE	40	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
64380-160_d842f1ed-8df5-4fe9-a694-5da7a042134e	64380-160	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20220321		ANDA	ANDA075671	Strides Pharma Science Limited	MEGESTROL ACETATE	40	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
64380-162_e97579c0-7ea8-4392-b1ed-b94bc096996d	64380-162	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		oxybutynin chloride	TABLET	ORAL	20220404		ANDA	ANDA075079	Strides Pharma Science Limited	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
64380-163_21b4b8c0-17fe-4ad6-8531-486accffa2ad	64380-163	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA075938	Strides Pharma Science Limited	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	20241231
64380-164_21b4b8c0-17fe-4ad6-8531-486accffa2ad	64380-164	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA075938	Strides Pharma Science Limited	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
64380-165_21b4b8c0-17fe-4ad6-8531-486accffa2ad	64380-165	HUMAN PRESCRIPTION DRUG	PROPAFENONE HYDROCHLORIDE		PROPAFENONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA075938	Strides Pharma Science Limited	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
64380-166_fac9083b-0b86-4d8d-b843-25f74f217e15	64380-166	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	ELIXIR	ORAL	20220404		UNAPPROVED DRUG OTHER		Strides Pharma Science Limited	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
64380-167_8793aaba-40bc-40c6-ba89-f32aa7c3d43c	64380-167	HUMAN PRESCRIPTION DRUG	Nateglinide		nateglinide	TABLET	ORAL	20220509		ANDA	ANDA077463	Strides Pharma Science Limited	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
64380-168_8793aaba-40bc-40c6-ba89-f32aa7c3d43c	64380-168	HUMAN PRESCRIPTION DRUG	Nateglinide		nateglinide	TABLET	ORAL	20220509		ANDA	ANDA077463	Strides Pharma Science Limited	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
64380-169_cac4d77c-e9e9-448a-b786-7d65367fba43	64380-169	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20220411		ANDA	ANDA088292	Strides Pharma Science Limited	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64380-170_cac4d77c-e9e9-448a-b786-7d65367fba43	64380-170	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20220509		ANDA	ANDA088262	Strides Pharma Science Limited	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64380-171_cac4d77c-e9e9-448a-b786-7d65367fba43	64380-171	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20220411		ANDA	ANDA088276	Strides Pharma Science Limited	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64380-172_e6e9ffca-5d4a-45d2-bc94-82285dcea2f0	64380-172	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20220411		ANDA	ANDA078109	Strides Pharma Science Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
64380-173_e6e9ffca-5d4a-45d2-bc94-82285dcea2f0	64380-173	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20220411		ANDA	ANDA078109	Strides Pharma Science Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
64380-174_e6e9ffca-5d4a-45d2-bc94-82285dcea2f0	64380-174	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20220411		ANDA	ANDA078109	Strides Pharma Science Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
64380-175_e6e9ffca-5d4a-45d2-bc94-82285dcea2f0	64380-175	HUMAN PRESCRIPTION DRUG	Olanzapine		olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20220411		ANDA	ANDA078109	Strides Pharma Science Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
64380-176_8f68f947-b896-4164-87bf-1bddc7afb6b2	64380-176	HUMAN PRESCRIPTION DRUG	TRANYLCYPROMINE SULFATE		tranylcypromine sulfate	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA040640	Strides Pharma Science Limited	TRANYLCYPROMINE SULFATE	10	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
64380-179_f11624cc-00b4-4bde-ab06-f1b40a2a0b0b	64380-179	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20220801		ANDA	ANDA065055	Strides Pharma Science Limited	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
64380-180_f11624cc-00b4-4bde-ab06-f1b40a2a0b0b	64380-180	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20220801		ANDA	ANDA065055	Strides Pharma Science Limited	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
64380-181_f11624cc-00b4-4bde-ab06-f1b40a2a0b0b	64380-181	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20220801		ANDA	ANDA065055	Strides Pharma Science Limited	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
64380-182_2ac68a93-2f3b-46aa-a874-c109ad1bfefe	64380-182	HUMAN PRESCRIPTION DRUG	Omeprazole/Sodium Bicarbonate		omeprazole	POWDER, FOR SUSPENSION	ORAL	20221001		ANDA	ANDA079182	Strides Pharma Science Limited	OMEPRAZOLE; SODIUM BICARBONATE	20; 1680	mg/1700mg; mg/1700mg	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64380-183_2ac68a93-2f3b-46aa-a874-c109ad1bfefe	64380-183	HUMAN PRESCRIPTION DRUG	Omeprazole/Sodium Bicarbonate		omeprazole	POWDER, FOR SUSPENSION	ORAL	20221001		ANDA	ANDA079182	Strides Pharma Science Limited	OMEPRAZOLE; SODIUM BICARBONATE	40; 1680	mg/1720mg; mg/1720mg	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64380-184_7a0fcf65-360e-4164-aeed-3cbd3c3af845	64380-184	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220404		ANDA	ANDA078540	Strides Pharma Science Limited	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
64380-185_7a0fcf65-360e-4164-aeed-3cbd3c3af845	64380-185	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220404		ANDA	ANDA078540	Strides Pharma Science Limited	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
64380-186_7a0fcf65-360e-4164-aeed-3cbd3c3af845	64380-186	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220404		ANDA	ANDA078540	Strides Pharma Science Limited	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
64380-187_40dd2c6b-9585-41ea-a50d-74b3a8faf248	64380-187	HUMAN PRESCRIPTION DRUG	Zafirlukast		zafirlukast	TABLET, COATED	ORAL	20220915		NDA	NDA020547	Strides Pharma Science Limited	ZAFIRLUKAST	10	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
64380-188_40dd2c6b-9585-41ea-a50d-74b3a8faf248	64380-188	HUMAN PRESCRIPTION DRUG	Zafirlukast		zafirlukast	TABLET, COATED	ORAL	20220801		NDA	NDA020547	Strides Pharma Science Limited	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
64380-189_4bb0aa92-80d2-4cbc-9261-012f3b5eb1c1	64380-189	HUMAN PRESCRIPTION DRUG	Zileuton		zileuton	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20221015		ANDA	ANDA212670	Strides Pharma Science Limited	ZILEUTON	600	mg/1	5-Lipoxygenase Inhibitor [EPC], 5-Lipoxygenase Inhibitors [MoA], Decreased Leukotriene Production [PE]		N	20241231
64380-203_bac2d7a8-110c-4eb6-bc41-105f38713254	64380-203	HUMAN PRESCRIPTION DRUG	Doxepin		doxepin hydrochloride	TABLET	ORAL	20220912		ANDA	ANDA202510	Strides Pharma Science Limited	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64380-204_bac2d7a8-110c-4eb6-bc41-105f38713254	64380-204	HUMAN PRESCRIPTION DRUG	Doxepin		doxepin hydrochloride	TABLET	ORAL	20220912		ANDA	ANDA202510	Strides Pharma Science Limited	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64380-212_e355c721-78d1-4a61-96db-77df6c5b41ed	64380-212	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220314		ANDA	ANDA040350	Strides Pharma Science Limited	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
64380-213_e355c721-78d1-4a61-96db-77df6c5b41ed	64380-213	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220314		ANDA	ANDA040350	Strides Pharma Science Limited	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
64380-214_283c45af-f4e8-4a1b-885b-ccee2f73d4ef	64380-214	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20221024		ANDA	ANDA090011	Strides Pharma Science Limited	AMLODIPINE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
64380-215_283c45af-f4e8-4a1b-885b-ccee2f73d4ef	64380-215	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20221024		ANDA	ANDA090011	Strides Pharma Science Limited	AMLODIPINE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
64380-216_283c45af-f4e8-4a1b-885b-ccee2f73d4ef	64380-216	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20221024		ANDA	ANDA090011	Strides Pharma Science Limited	AMLODIPINE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
64380-217_283c45af-f4e8-4a1b-885b-ccee2f73d4ef	64380-217	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		amlodipine and valsartan	TABLET	ORAL	20221024		ANDA	ANDA090011	Strides Pharma Science Limited	AMLODIPINE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
64380-707_0f7e315b-472d-49ae-81e2-f224a080fcfe	64380-707	HUMAN PRESCRIPTION DRUG	Lamivudine and Zidovudine		Lamivudine and Zidovudine	TABLET	ORAL	20161210		ANDA	ANDA079128	Strides Pharma Science Limited	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
64380-709_e81597ed-063a-40df-8366-cf25357311c7	64380-709	HUMAN PRESCRIPTION DRUG	Nevirapine		Nevirapine	TABLET	ORAL	20120522		ANDA	ANDA078195	Strides Pharma Science Limited	NEVIRAPINE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
64380-710_31d3229a-eb77-4ca7-b4ac-8d5aeb235650	64380-710	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20181019		ANDA	ANDA090457	Strides Pharma Science Limited	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
64380-711_31d3229a-eb77-4ca7-b4ac-8d5aeb235650	64380-711	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20181019		ANDA	ANDA090457	Strides Pharma Science Limited	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
64380-714_a9a707a3-fe7d-439a-9e28-a30545dbff60	64380-714	HUMAN PRESCRIPTION DRUG	TENOFOVIR DISOPROXIL FUMARATE		tenofovir disoproxil fumarate	TABLET	ORAL	20180126		ANDA	ANDA090742	Strides Pharma Science Limited	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
64380-715_267a3598-712e-4f02-a78f-78cff4ac4ab7	64380-715	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20090514		ANDA	ANDA077928	Strides Pharma Science Limited	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-716_267a3598-712e-4f02-a78f-78cff4ac4ab7	64380-716	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20090514		ANDA	ANDA077928	Strides Pharma Science Limited	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-717_4e07d70d-94b6-4fe2-bbf1-d1084e88cb87	64380-717	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET	ORAL	20161028		ANDA	ANDA091050	Strides Pharma Science Limited	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
64380-719_e96f0f25-b46d-4f5f-8268-2ef426403a77	64380-719	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		EMTRICITABINE and TENOFOVIR Disoproxil Fumarate	TABLET	ORAL	20210330		ANDA	ANDA091055	Strides Pharma Science Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
64380-720_48cd3633-d3c0-4197-aa6b-033887913404	64380-720	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201005		ANDA	ANDA090687	Strides Pharma Science Limited	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
64380-721_48cd3633-d3c0-4197-aa6b-033887913404	64380-721	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20140813		ANDA	ANDA090687	Strides Pharma Science Limited	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
64380-722_48cd3633-d3c0-4197-aa6b-033887913404	64380-722	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201005		ANDA	ANDA090687	Strides Pharma Science Limited	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
64380-723_1619b821-bfbe-4d50-b333-5e71caa25693	64380-723	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol Capsules 0.25 mcg	CAPSULE	ORAL	20161210		ANDA	ANDA091356	Strides Pharma Science Limited	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
64380-724_1619b821-bfbe-4d50-b333-5e71caa25693	64380-724	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol Capsules 0.5 mcg	CAPSULE	ORAL	20161227		ANDA	ANDA091356	Strides Pharma Science Limited	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
64380-725_f5c5753e-639c-4e68-a1aa-74486067d330	64380-725	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	TABLET, FILM COATED	ORAL	20101106		ANDA	ANDA090456	Strides Pharma Science Limited	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
64380-726_f5c5753e-639c-4e68-a1aa-74486067d330	64380-726	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	CAPSULE	ORAL	20101106		ANDA	ANDA090055	Strides Pharma Science Limited	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
64380-732_2c462426-b635-44dd-b4cb-54f67afb37d9	64380-732	HUMAN OTC DRUG	IBUPROFEN AND DIPHENHYDRAMINE HCL		IBUPROFEN AND DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20120305		ANDA	ANDA200888	Strides Pharma Science Limited	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-733_4ca5f9d2-a4ec-4be1-865f-96a4615087b9	64380-733	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20220630		ANDA	ANDA200770	Strides Pharma Science Limited	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
64380-734_4ca5f9d2-a4ec-4be1-865f-96a4615087b9	64380-734	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20130630		ANDA	ANDA200770	Strides Pharma Science Limited	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
64380-735_4ca5f9d2-a4ec-4be1-865f-96a4615087b9	64380-735	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20130630		ANDA	ANDA200770	Strides Pharma Science Limited	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
64380-736_4ca5f9d2-a4ec-4be1-865f-96a4615087b9	64380-736	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20130630		ANDA	ANDA200770	Strides Pharma Science Limited	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
64380-737_08a99dff-5765-49b0-b289-4e854d3c6725	64380-737	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20140516		ANDA	ANDA090455	Strides Pharma Science Limited	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
64380-741_d705dfed-371a-48e5-a8c3-54d514f65549	64380-741	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	Strides Pharma Science Limited	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
64380-742_d705dfed-371a-48e5-a8c3-54d514f65549	64380-742	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	Strides Pharma Science Limited	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
64380-743_d705dfed-371a-48e5-a8c3-54d514f65549	64380-743	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	Strides Pharma Science Limited	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
64380-744_d705dfed-371a-48e5-a8c3-54d514f65549	64380-744	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	Strides Pharma Science Limited	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
64380-745_db43c81e-0277-47ca-ab97-0cba3240bc37	64380-745	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20170523		ANDA	ANDA202350	Strides Pharma Science Limited	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
64380-746_94664b38-edd0-4181-8eb2-8bbd9aa3a451	64380-746	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20210215		ANDA	ANDA202702	Strides Pharma Science Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
64380-747_94664b38-edd0-4181-8eb2-8bbd9aa3a451	64380-747	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20210215		ANDA	ANDA202702	Strides Pharma Science Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
64380-748_94664b38-edd0-4181-8eb2-8bbd9aa3a451	64380-748	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20210215		ANDA	ANDA202702	Strides Pharma Science Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
64380-749_94664b38-edd0-4181-8eb2-8bbd9aa3a451	64380-749	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20210215		ANDA	ANDA202702	Strides Pharma Science Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
64380-750_94664b38-edd0-4181-8eb2-8bbd9aa3a451	64380-750	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20210215		ANDA	ANDA202702	Strides Pharma Science Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
64380-751_94664b38-edd0-4181-8eb2-8bbd9aa3a451	64380-751	HUMAN PRESCRIPTION DRUG	pramipexole dihydrochloride		pramipexole dihydrochloride	TABLET	ORAL	20210215		ANDA	ANDA202702	Strides Pharma Science Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
64380-752_cd3d6653-dd87-443d-8a97-0377d5dc09c9	64380-752	HUMAN PRESCRIPTION DRUG	Methoxsalen		Methoxsalen	CAPSULE, LIQUID FILLED	ORAL	20161208		ANDA	ANDA202687	Strides Pharma Science Limited	METHOXSALEN	10	mg/1	Photoabsorption [MoA], Photoactivated Radical Generator [EPC], Photosensitizing Activity [PE], Psoralen [EPC], Psoralens [CS]		N	20241231
64380-758_590cf6ae-d307-481a-9f94-2039fb2774c5	64380-758	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20161208		ANDA	ANDA090912	Strides Pharma Science Limited	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
64380-759_590cf6ae-d307-481a-9f94-2039fb2774c5	64380-759	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20161210		ANDA	ANDA090912	Strides Pharma Science Limited	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
64380-760_590cf6ae-d307-481a-9f94-2039fb2774c5	64380-760	HUMAN PRESCRIPTION DRUG	Acarbose		acarbose	TABLET	ORAL	20161210		ANDA	ANDA090912	Strides Pharma Science Limited	ACARBOSE	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
64380-761_8d39d714-db8f-4d90-90c7-ee249eb17de9	64380-761	HUMAN PRESCRIPTION DRUG	omega-3-acid ethyl esters		omega-3-acid ethyl esters	CAPSULE	ORAL	20190118		ANDA	ANDA203893	Strides Pharma Science Limited	OMEGA-3-ACID ETHYL ESTERS	900	mg/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
64380-763_44b80a39-9206-4f6f-82c5-12bb8ef0530e	64380-763	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161209		ANDA	ANDA204262	Strides Pharma Science Limited	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
64380-765_4dbd0eea-61da-4339-98c9-54e4122e7c7e	64380-765	HUMAN PRESCRIPTION DRUG	Polyethylene Glycol 3350 and electrolytes - Unflavored		Polyethylene Glycol 3350 and electrolytes - Unflavored	POWDER, FOR SOLUTION	ORAL	20190110		ANDA	ANDA204558	Strides Pharma Science Limited	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORATE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/4L; g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64380-766_4dbd0eea-61da-4339-98c9-54e4122e7c7e	64380-766	HUMAN PRESCRIPTION DRUG	Polyethylene Glycol 3350 and electrolytes with Lemon Flavor		Polyethylene Glycol 3350 and electrolytes with Lemon Flavor	POWDER, FOR SOLUTION	ORAL	20190110		ANDA	ANDA204558	Strides Pharma Science Limited	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/4L; g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64380-767_4dbd0eea-61da-4339-98c9-54e4122e7c7e	64380-767	HUMAN PRESCRIPTION DRUG	Polyethylene Glycol 3350 and electrolyteswith Orange Flavor		Polyethylene Glycol 3350 and electrolytes with Orange Flavor	POWDER, FOR SOLUTION	ORAL	20190110		ANDA	ANDA204558	Strides Pharma Science Limited	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS	236; 2.97; 6.74; 5.86; 22.74	g/4L; g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64380-768_5ecacfb6-b0c7-4460-820c-9a4453dd16f5	64380-768	HUMAN PRESCRIPTION DRUG	Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored		Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored	POWDER, FOR SOLUTION	ORAL	20150414		ANDA	ANDA204559	Strides Pharma Science Limited	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	420; 1.48; 5.72; 11.2	g/4L; g/4L; g/4L; g/4L	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64380-769_5ecacfb6-b0c7-4460-820c-9a4453dd16f5	64380-769	HUMAN PRESCRIPTION DRUG	Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride with Lemon Flavor		Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride with Lemon Flavor	POWDER, FOR SOLUTION	ORAL	20150414		ANDA	ANDA204559	Strides Pharma Science Limited	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	420; 1.48; 5.72; 11.2	g/4L; g/4L; g/4L; g/4L	Alkalinizing Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64380-770_5ecacfb6-b0c7-4460-820c-9a4453dd16f5	64380-770	HUMAN PRESCRIPTION DRUG	Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride with Orange Flavor		Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride with Orange Flavor	POWDER, FOR SOLUTION	ORAL	20150414		ANDA	ANDA204559	Strides Pharma Science Limited	POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE	420; 1.48; 5.72; 11.2	g/4L; g/4L; g/4L; g/4L	Alkalinizing Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64380-774_db43c81e-0277-47ca-ab97-0cba3240bc37	64380-774	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20170523		ANDA	ANDA202350	Strides Pharma Science Limited	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
64380-779_e8f0d8df-c61e-4192-b64d-6af1ba2fbba6	64380-779	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20160525		ANDA	ANDA208162	Strides Pharma Science Limited	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
64380-780_e8f0d8df-c61e-4192-b64d-6af1ba2fbba6	64380-780	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20160525		ANDA	ANDA208162	Strides Pharma Science Limited	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
64380-782_644272ea-ee37-445f-a09e-b1b0453deb64	64380-782	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA210785	Strides Pharma Science Limited	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-783_e21813f7-e735-4d6c-803f-edd4bdd20736	64380-783	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA209727	Strides Pharma Science Limited	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-784_b0517ba5-d086-4c92-ae91-cd9c4c2f9faf	64380-784	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Strides Pharma Science Limited	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-785_b0517ba5-d086-4c92-ae91-cd9c4c2f9faf	64380-785	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Strides Pharma Science Limited	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-786_3f5bf140-40c1-4555-9ca1-7c74a444424a	64380-786	HUMAN PRESCRIPTION DRUG	roflumilast		ROFLUMILAST	TABLET	ORAL	20221013		ANDA	ANDA208247	Strides Pharma Science Limited	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
64380-787_d705dfed-371a-48e5-a8c3-54d514f65549	64380-787	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170217		ANDA	ANDA202330	Strides Pharma Science Limited	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
64380-789_e6c9429c-13b9-4932-abad-e605c4c7fb68	64380-789	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	OINTMENT	TOPICAL	20190101		ANDA	ANDA210958	Strides Pharma Science Limited	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
64380-792_1daddbc8-6391-463d-b3d9-cbdca28285db	64380-792	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20170630		ANDA	ANDA209177	Strides Pharma Science Limited	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64380-793_1daddbc8-6391-463d-b3d9-cbdca28285db	64380-793	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20170630		ANDA	ANDA209177	Strides Pharma Science Limited	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64380-794_1daddbc8-6391-463d-b3d9-cbdca28285db	64380-794	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20170630		ANDA	ANDA209177	Strides Pharma Science Limited	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64380-795_54787424-10c7-40b3-b1ca-5a796572ad34	64380-795	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20180411		ANDA	ANDA209172	Strides Pharma Science Limited	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
64380-796_bfaa8c59-a07f-4671-9244-74bca76c72b7	64380-796	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20220919		ANDA	ANDA209173	Strides Pharma Science Limited	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
64380-797_aa0e2642-b771-4a8d-b790-cac43f40f956	64380-797	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181008		ANDA	ANDA209421	Strides Pharma Science Limited	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
64380-798_aa0e2642-b771-4a8d-b790-cac43f40f956	64380-798	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	Strides Pharma Science Limited	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
64380-799_aa0e2642-b771-4a8d-b790-cac43f40f956	64380-799	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	Strides Pharma Science Limited	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
64380-807_0381d5f5-aef9-40bf-8e84-8150568d4dc3	64380-807	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	Strides Pharma Science Limited	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-808_0381d5f5-aef9-40bf-8e84-8150568d4dc3	64380-808	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	Strides Pharma Science Limited	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-809_0381d5f5-aef9-40bf-8e84-8150568d4dc3	64380-809	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	Strides Pharma Science Limited	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-827_bf07547c-c86d-404d-90ef-9aaf3636783b	64380-827	HUMAN PRESCRIPTION DRUG	KETOCONAZOLE		KETOCONAZOLE	TABLET	ORAL	20180626		ANDA	ANDA210457	Strides Pharma Science Limited	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
64380-835_e21813f7-e735-4d6c-803f-edd4bdd20736	64380-835	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA209727	Strides Pharma Science Limited	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-836_99342793-1dda-45c5-9a39-b9e5ae8137ca	64380-836	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20190515		ANDA	ANDA210077	Strides Pharma Science Limited	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
64380-841_2c516279-8c26-44be-82f9-4a3024295d7c	64380-841	HUMAN PRESCRIPTION DRUG	diclofenac potassium		diclofenac potassium	CAPSULE, LIQUID FILLED	ORAL	20220920		ANDA	ANDA210078	Strides Pharma Science Limited	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-842_a5f97393-9508-44c8-8510-d8889a98e0f1	64380-842	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20180507		ANDA	ANDA210347	Strides Pharma Science Limited	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-843_a5f97393-9508-44c8-8510-d8889a98e0f1	64380-843	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20180507		ANDA	ANDA210347	Strides Pharma Science Limited	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64380-844_46e8718f-fb37-4590-ad7e-7a55913fddf4	64380-844	HUMAN PRESCRIPTION DRUG	URSODIOL		ursodiol	CAPSULE	ORAL	20210913		ANDA	ANDA210344	Strides Pharma Science Limited	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
64380-860_853af0b0-dc2a-46ce-9ca2-89dc07cae63d	64380-860	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20181119		ANDA	ANDA210733	Strides Pharma Science Limited	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
64380-861_853af0b0-dc2a-46ce-9ca2-89dc07cae63d	64380-861	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20181127		ANDA	ANDA210733	Strides Pharma Science Limited	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
64380-862_cd49441d-853e-4400-90bb-8e9e81d96b9f	64380-862	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20221201		ANDA	ANDA211354	Strides Pharma Science Limited	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
64380-867_c1e6ed47-8fbf-4351-801f-45d4391505f1	64380-867	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20181017		ANDA	ANDA211314	Strides Pharma Science Limited	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
64380-868_c1e6ed47-8fbf-4351-801f-45d4391505f1	64380-868	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20181017		ANDA	ANDA211314	Strides Pharma Science Limited	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
64380-869_c1e6ed47-8fbf-4351-801f-45d4391505f1	64380-869	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20181017		ANDA	ANDA211314	Strides Pharma Science Limited	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
64380-870_a16f57bb-ad68-4ff7-9911-11c792563b20	64380-870	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20210630		ANDA	ANDA211315	Strides Pharma Science Limited	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-871_a16f57bb-ad68-4ff7-9911-11c792563b20	64380-871	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20210630		ANDA	ANDA211315	Strides Pharma Science Limited	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-874_8e2b7f2a-5247-497d-a9cc-1356a2c0872c	64380-874	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20230224		ANDA	ANDA211665	Strides Pharma Science Limited	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
64380-875_1ea30ea8-e08e-44cd-b160-5ba998588a1a	64380-875	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20221024		ANDA	ANDA211667	Strides Pharma Science Limited	POTASSIUM CHLORIDE	1.5	g/1.58g			N	20241231
64380-878_6f135052-6c5c-4aa1-9449-aab2d197627b	64380-878	HUMAN PRESCRIPTION DRUG	ETHOSUXIMIDE		ETHOSUXIMIDE	CAPSULE	ORAL	20190515		ANDA	ANDA211928	Strides Pharma Science Limited	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
64380-879_77e8e587-76ff-4587-862a-a700565c0bc6	64380-879	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20221024		ANDA	ANDA211894	Strides Pharma Science Limited	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
64380-883_61399d7c-ee88-4df1-b3b3-b4995e787a53	64380-883	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190716		ANDA	ANDA209226	Strides Pharma Science Limited	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
64380-884_61399d7c-ee88-4df1-b3b3-b4995e787a53	64380-884	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190822		ANDA	ANDA209226	Strides Pharma Science Limited	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
64380-885_61399d7c-ee88-4df1-b3b3-b4995e787a53	64380-885	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190822		ANDA	ANDA209226	Strides Pharma Science Limited	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
64380-889_649b23a8-264b-4a0d-a698-d692f306ea6e	64380-889	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	TABLET	ORAL	20180329		ANDA	ANDA204869	Strides Pharma Science Limited	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
64380-890_b5e6a784-df46-4fc9-93ff-701541b7cc38	64380-890	HUMAN PRESCRIPTION DRUG	TETRACYCLINE HYDROCHLORIDE		TETRACYCLINE HYDROCHLORIDE	CAPSULE	ORAL	20230421		ANDA	ANDA212635	Strides Pharma Science Limited	TETRACYCLINE HYDROCHLORIDE	250	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
64380-891_b5e6a784-df46-4fc9-93ff-701541b7cc38	64380-891	HUMAN PRESCRIPTION DRUG	TETRACYCLINE HYDROCHLORIDE		TETRACYCLINE HYDROCHLORIDE	CAPSULE	ORAL	20230421		ANDA	ANDA212635	Strides Pharma Science Limited	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
64380-901_31dbccd0-450b-43be-b32a-ddef632c85ec	64380-901	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20200605		ANDA	ANDA212356	Strides Pharma Science Limited	TRIAMCINOLONE ACETONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-905_b94a1850-8c15-4812-8d55-6f959c85218d	64380-905	HUMAN PRESCRIPTION DRUG	CLARITHROMYCIN		CLARITHROMYCIN	TABLET, FILM COATED	ORAL	20190318		ANDA	ANDA202710	Strides Pharma Science Limited	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
64380-906_b94a1850-8c15-4812-8d55-6f959c85218d	64380-906	HUMAN PRESCRIPTION DRUG	CLARITHROMYCIN		CLARITHROMYCIN	TABLET, FILM COATED	ORAL	20190318		ANDA	ANDA202710	Strides Pharma Science Limited	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
64380-907_6aca1bec-4bf9-485a-bbba-5e518d8bb1af	64380-907	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191105		ANDA	ANDA090551	Strides Pharma Science Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
64380-908_6aca1bec-4bf9-485a-bbba-5e518d8bb1af	64380-908	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191105		ANDA	ANDA090551	Strides Pharma Science Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
64380-918_98ef38f7-20f0-4e3d-9407-6f99df7b9e21	64380-918	HUMAN PRESCRIPTION DRUG	URSODIOL		ursodiol	TABLET	ORAL	20210208		ANDA	ANDA213504	Strides Pharma Science Limited	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
64380-919_98ef38f7-20f0-4e3d-9407-6f99df7b9e21	64380-919	HUMAN PRESCRIPTION DRUG	URSODIOL		ursodiol	TABLET	ORAL	20210208		ANDA	ANDA213504	Strides Pharma Science Limited	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
64380-933_9bbc4a81-d023-4e75-a771-52af48b21cac	64380-933	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	25 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	Strides Pharma Science Limited	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
64380-934_9bbc4a81-d023-4e75-a771-52af48b21cac	64380-934	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	50 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	Strides Pharma Science Limited	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
64380-935_9bbc4a81-d023-4e75-a771-52af48b21cac	64380-935	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	100 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	Strides Pharma Science Limited	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
64380-949_b0517ba5-d086-4c92-ae91-cd9c4c2f9faf	64380-949	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220524		ANDA	ANDA208412	Strides Pharma Science Limited	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64380-997_e6705907-f479-4472-b966-ba97929f927b	64380-997	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20230919		ANDA	ANDA215311	Strides Pharma Science Limited	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
64395-0001_0763875c-1208-4cfc-e063-6294a90a19e6	64395-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091223		UNAPPROVED MEDICAL GAS		Pacific Island Medical, Inc.	OXYGEN	99	L/100L			N	20241231
64406-005_c6ac2a37-5a71-4428-b793-6e43a7cbf9df	64406-005	HUMAN PRESCRIPTION DRUG	TECFIDERA		dimethyl fumarate	CAPSULE	ORAL	20130327		NDA	NDA204063	Biogen Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
64406-006_c6ac2a37-5a71-4428-b793-6e43a7cbf9df	64406-006	HUMAN PRESCRIPTION DRUG	TECFIDERA		dimethyl fumarate	CAPSULE	ORAL	20130327		NDA	NDA204063	Biogen Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
64406-007_c6ac2a37-5a71-4428-b793-6e43a7cbf9df	64406-007	HUMAN PRESCRIPTION DRUG	Tecfidera		dimethyl fumarate	KIT		20130327		NDA	NDA204063	Biogen Inc.						N	20241231
64406-008_c7e88fc5-9622-4d43-9af9-42f4e77c3c4f	64406-008	HUMAN PRESCRIPTION DRUG	TYSABRI		natalizumab	INJECTION	INTRAVENOUS	20041123		BLA	BLA125104	Biogen Inc.	NATALIZUMAB	300	mg/15mL	Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]		N	20241231
64406-011_488569c2-1737-414d-9d48-0ad5567a38f6	64406-011	HUMAN PRESCRIPTION DRUG	Plegridy	Pen	peginterferon beta-1a	INJECTION, SOLUTION	SUBCUTANEOUS	20140815		BLA	BLA125499	Biogen Inc.	PEGINTERFERON BETA-1A	125	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
64406-012_488569c2-1737-414d-9d48-0ad5567a38f6	64406-012	HUMAN PRESCRIPTION DRUG	Plegridy	Pen	peginterferon beta-1a	KIT		20140815		BLA	BLA125499	Biogen Inc.						N	20241231
64406-015_488569c2-1737-414d-9d48-0ad5567a38f6	64406-015	HUMAN PRESCRIPTION DRUG	Plegridy		peginterferon beta-1a	INJECTION, SOLUTION	SUBCUTANEOUS	20140815		BLA	BLA125499	Biogen Inc.	PEGINTERFERON BETA-1A	125	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
64406-016_488569c2-1737-414d-9d48-0ad5567a38f6	64406-016	HUMAN PRESCRIPTION DRUG	Plegridy		peginterferon beta-1a	KIT		20140815		BLA	BLA125499	Biogen Inc.						N	20241231
64406-017_488569c2-1737-414d-9d48-0ad5567a38f6	64406-017	HUMAN PRESCRIPTION DRUG	Plegridy		peginterferon beta-1a	INJECTION, SOLUTION	INTRAMUSCULAR	20210129		BLA	BLA125499	Biogen Inc.	PEGINTERFERON BETA-1A	125	ug/.5mL	Interferon beta [EPC], Interferon-beta [CS]		N	20241231
64406-019_bc93c0a1-2d15-47c6-aadb-29244dfcc202	64406-019	HUMAN PRESCRIPTION DRUG	Byooviz		ranibizumab-nuna	INJECTION, SOLUTION	INTRAVITREAL	20220601		BLA	BLA761202	BIOGEN INC.	RANIBIZUMAB	10	mg/mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
64406-020_c77c2a1a-cfb5-4c6e-ac79-4cfa8f3109e2	64406-020	HUMAN PRESCRIPTION DRUG	Vumerity		diroximel fumarate	CAPSULE	ORAL	20191029		NDA	NDA211855	Biogen Inc.	DIROXIMEL FUMARATE	231	mg/1			N	20251231
64406-029_caba3764-d440-4999-846d-7b7b3b9f1dd5	64406-029	HUMAN PRESCRIPTION DRUG	ZURZUVAE		zuranolone	CAPSULE	ORAL	20231031		NDA	NDA217369	Biogen MA Inc.	ZURANOLONE	20	mg/1	GABA A Receptor Positive Modulators [MoA], Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]	CIV	N	20241231
64406-030_caba3764-d440-4999-846d-7b7b3b9f1dd5	64406-030	HUMAN PRESCRIPTION DRUG	ZURZUVAE		zuranolone	CAPSULE	ORAL	20231031		NDA	NDA217369	Biogen MA Inc.	ZURANOLONE	25	mg/1	GABA A Receptor Positive Modulators [MoA], Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]	CIV	N	20241231
64406-031_caba3764-d440-4999-846d-7b7b3b9f1dd5	64406-031	HUMAN PRESCRIPTION DRUG	ZURZUVAE		zuranolone	CAPSULE	ORAL	20231031		NDA	NDA217369	Biogen MA Inc.	ZURANOLONE	30	mg/1	GABA A Receptor Positive Modulators [MoA], Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]	CIV	N	20241231
64406-058_8e6001bb-26f5-4725-acae-7af5e10edf34	64406-058	HUMAN PRESCRIPTION DRUG	Spinraza		Nusinersen	INJECTION, SOLUTION	INTRATHECAL	20161223		NDA	NDA209531	Biogen	NUSINERSEN	2.4	mg/mL	Antisense Oligonucleotide [EPC], Increased Protein Synthesis [PE], Oligonucleotides, Antisense [CS], Survival Motor Neuron-2-directed RNA Interaction [EPC]		N	20241231
64406-101_bdbcb712-6e43-45e4-9404-452239d0daa0	64406-101	HUMAN PRESCRIPTION DRUG	Aduhelm		Aducanumab	INJECTION, SOLUTION	INTRAVENOUS	20210607		BLA	BLA761178	Biogen Inc.	ADUCANUMAB	100	mg/mL	Amyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]		N	20241231
64406-102_bdbcb712-6e43-45e4-9404-452239d0daa0	64406-102	HUMAN PRESCRIPTION DRUG	Aduhelm		Aducanumab	INJECTION, SOLUTION	INTRAVENOUS	20210607		BLA	BLA761178	Biogen Inc.	ADUCANUMAB	100	mg/mL	Amyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]		N	20241231
64406-109_49746560-541f-415a-9ac6-bf214fce0793	64406-109	HUMAN PRESCRIPTION DRUG	QALSODY		tofersen	INJECTION	INTRATHECAL	20230425		NDA	NDA215887	Biogen Inc.	TOFERSEN	100	mg/15mL			N	20241231
64464-001_8d739e92-3c6f-4e1c-ad59-a8769ba6fa74	64464-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19960101		UNAPPROVED MEDICAL GAS		O2 Plus, Inc	OXYGEN	99	L/100L			N	20241231
64471-348_96ab85cf-2539-4c2e-844d-fbb7f0da8e05	64471-348	HUMAN OTC DRUG	Wellguard		Aconitum Napellus, Arsenicum Iodatum, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Helix Tosta, Hydrogen, Influenzinum 2019-2020, Kreosotum, Phosphorus, Teucrium Scorodonia, Thuja Occidentalis, Veratrum Viride, Anas Barbariae.	PELLET	ORAL	20210412		UNAPPROVED HOMEOPATHIC		Source Naturals, Inc.	ACONITUM NAPELLUS WHOLE; ARSENIC TRIIODIDE; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; ESCARGOT SHELL, COOKED; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; HYDROGEN; INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); PHOSPHORUS; TEUCRIUM SCORODONIA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM VIRIDE ROOT; WOOD CREOSOTE	30; 30; 30; 200; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g			N	20241231
64477-001_0ac537ac-d044-f76e-e063-6394a90a29a1	64477-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19980305		UNAPPROVED MEDICAL GAS		S & S Drug Inc.	OXYGEN	99	L/100L			N	20241231
64522-001_d658d3bc-d090-202a-e053-2995a90a4e79	64522-001	HUMAN OTC DRUG	VistaCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20180201		OTC MONOGRAPH NOT FINAL	part356	Inter-Med, INC.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
64522-002_d658b63c-d2bc-1438-e053-2a95a90a9f87	64522-002	HUMAN OTC DRUG	VistaCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20180201		OTC MONOGRAPH NOT FINAL	part356	Inter-Med, INC.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
64522-003_d658b63c-d2c8-1438-e053-2a95a90a9f87	64522-003	HUMAN OTC DRUG	VistaCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20180201		OTC MONOGRAPH NOT FINAL	part356	Inter-Med, INC.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
64522-004_d658d6c6-e004-5083-e053-2a95a90a1a1f	64522-004	HUMAN OTC DRUG	VistaCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20180201		OTC MONOGRAPH NOT FINAL	part356	Inter-Med, INC.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
64525-6560_961d82d2-f06e-faec-3349-051531d6642c	64525-6560	HUMAN OTC DRUG	Allergy Relief		Fluticasone Propionate	SPRAY, METERED	NASAL	20220323		ANDA	ANDA208150	Quality Home Products	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64525-8000_74d8f26a-a4ea-5ff2-e013-34bc4f404626	64525-8000	HUMAN OTC DRUG	Allergy Relief		Fluticasone Propionate	SPRAY, METERED	NASAL	20180417	20240406	ANDA	ANDA208150	Quality Home Products	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
64536-0114_9a151b4c-ee2f-b95f-e053-2a95a90a8aa4	64536-0114	HUMAN OTC DRUG	Soft Care Instant Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20140822		OTC MONOGRAPH NOT FINAL	part333E	Diversey, Inc.	ALCOHOL	67.6	L/100L			N	20241231
64536-1406_37e277d7-d617-49d0-86b6-b12927d0a03d	64536-1406	HUMAN OTC DRUG	Soft Care Hand Sanitizing Wipe Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20150416		OTC MONOGRAPH NOT FINAL	part333A	Diversey, Inc.	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
64536-1565_99e95986-5ef8-5127-e053-2995a90a5a51	64536-1565	HUMAN OTC DRUG	Soft Care Impact Mini Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20160629		OTC MONOGRAPH NOT FINAL	part333E	Diversey. Inc.	ALCOHOL	70	mL/100mL			N	20241231
64536-1726_0d81e82f-3fc8-cdee-e063-6394a90ad3fe	64536-1726	HUMAN OTC DRUG	Soft Care Hand Sanitizing Wipes		Alcohol	CLOTH	TOPICAL	20191120		OTC MONOGRAPH DRUG	505G(a)(3)	Diversey, Inc.	ALCOHOL	70	g/100g			N	20241231
64536-1948_b113e4a1-fdba-4f2a-9800-994b7aa6a924	64536-1948	HUMAN OTC DRUG	Soft Care Sentry		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20180219		OTC MONOGRAPH NOT FINAL	part333A	Diversey, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
64536-3628_99e9a79f-3197-b14e-e053-2a95a90a294d	64536-3628	HUMAN OTC DRUG	Soft Care Instant Hand Sanitizer AF		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20170414		OTC MONOGRAPH NOT FINAL	part333A	Diversey, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
64536-6618_99e8f4c7-8b55-068a-e053-2a95a90a98e2	64536-6618	HUMAN OTC DRUG	Soft Care Impact Alcohol Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20160812		OTC MONOGRAPH NOT FINAL	part333E	Diversey, Inc.	ALCOHOL	76	L/100L			N	20241231
64536-7295_99d785d4-bbf0-7a1e-e053-2995a90a930e	64536-7295	HUMAN OTC DRUG	Soft Care Foam Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20160803		OTC MONOGRAPH NOT FINAL	part333E	Diversey, Inc.	ALCOHOL	62	mL/100mL			N	20241231
64536-8068_a3cdf888-c4c9-67a5-e053-2a95a90a5cd2	64536-8068	HUMAN OTC DRUG	Soft Care Impact Foam Alcohol Foam Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20160815		OTC MONOGRAPH NOT FINAL	part333E	Diversey, Inc.	ALCOHOL	76	L/100L			N	20241231
64536-8308_0c6c860a-410f-6633-e063-6294a90a2c31	64536-8308	HUMAN OTC DRUG	Soft Care Defend Foam Antibacterial Handwash		Chloroxylenol	SOLUTION	TOPICAL	20160701		OTC MONOGRAPH DRUG	505G(a)(3)	Diversey, Inc.	CHLOROXYLENOL	1	g/100mL			N	20241231
64536-8692_fd152b7d-ff11-b65a-e053-6294a90af993	64536-8692	HUMAN OTC DRUG	Soft Care Defend Antibacterial Handwash		Chloroxylenol	SOLUTION	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	Diversey, Inc.	CHLOROXYLENOL	10	g/L			N	20241231
64536-8748_fd8bd60f-74a8-03fb-e053-6394a90a201e	64536-8748	HUMAN OTC DRUG	Soft Care Defend Antibacterial Handwash		Choroxylenol	SOLUTION	TOPICAL	20160606		OTC MONOGRAPH NOT FINAL	part333A	Diversey, Inc.	CHLOROXYLENOL	1	g/100mL			N	20241231
64536-8760_fd8c1ce4-0668-47ba-e053-6394a90a3fdd	64536-8760	HUMAN OTC DRUG	Soft Care Defend Antibacterial Handwash		Chloroxylenol	SOLUTION	TOPICAL	20160718		OTC MONOGRAPH NOT FINAL	part333A	Diversey, Inc.	CHLOROXYLENOL	10	g/L			N	20241231
64542-017_03a8fa2d-97a6-9f63-e063-6394a90afe68	64542-017	HUMAN OTC DRUG	E2 Hand Sanitizer		E2 Hand Sanitizer	SOLUTION	TOPICAL	20180207		OTC MONOGRAPH NOT FINAL	part333A	State Industrial Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
64542-056_03a8fa2d-97a8-9f63-e063-6394a90afe68	64542-056	HUMAN OTC DRUG	Hand Sanitizer		Gel Hand Sanitizer	GEL	TOPICAL	20200309		OTC MONOGRAPH NOT FINAL	part333A	State Industrial Products	ALCOHOL	62	mL/100mL			N	20241231
64542-207_03a8d6f3-00f7-5ae3-e063-6294a90a91c2	64542-207	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	SOLUTION	TOPICAL	20190214		OTC MONOGRAPH NOT FINAL	part333A	State Industrial Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
64542-213_03a8d733-d4d3-c48f-e063-6294a90a8621	64542-213	HUMAN OTC DRUG	Foaming Hand Wash		Antibacterial Hand Wash	SOAP	TOPICAL	20190214		OTC MONOGRAPH NOT FINAL	part333A	State Industrial Products	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
64542-300_03a9050a-991a-e852-e063-6394a90af2d2	64542-300	HUMAN OTC DRUG	Clean Skin Sanitizer		Hand Sanitizer	SOLUTION	TOPICAL	20140114		OTC MONOGRAPH NOT FINAL	part333A	State Industrial Products	ALCOHOL	62	mL/100mL			N	20241231
64542-683_03a8bd37-d221-2a2d-e063-6294a90a0406	64542-683	HUMAN OTC DRUG	Foaming Antiseptic		Foaming Antiseptic	SOLUTION	TOPICAL	20160609		OTC MONOGRAPH NOT FINAL	part333A	State Industrial Products	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
64542-688_03a904f5-0640-f1e2-e063-6294a90af80e	64542-688	HUMAN OTC DRUG	Hand Sanitizer		Foaming Alcohol Hand Sanitizer	SOLUTION	TOPICAL	20171121		OTC MONOGRAPH NOT FINAL	part333A	State Industrial Product	ALCOHOL	62	mL/100mL			N	20241231
64543-112_0384814e-33f6-f4a9-e063-6394a90a57bb	64543-112	HUMAN PRESCRIPTION DRUG	Symax SR		Hyoscyamine Sulfate	TABLET, EXTENDED RELEASE	ORAL	20091107	20240802	UNAPPROVED DRUG OTHER		Capellon Pharmaceuticals, LLC	HYOSCYAMINE SULFATE	.375	mg/1			N	
64543-118_0373aa7d-3538-2cb3-e063-6394a90a5330	64543-118	HUMAN PRESCRIPTION DRUG	Symax Duotab		Hyoscyamine Sulfate	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20091107	20241216	UNAPPROVED DRUG OTHER		Capellon Pharmaceuticals, LLC	HYOSCYAMINE SULFATE	.375	mg/1			N	
64543-600_0373f989-69af-0332-e063-6394a90a8240	64543-600	HUMAN PRESCRIPTION DRUG	POLMON		Dexchlorpheniramine Maleate	SOLUTION	ORAL	20180716	20241005	ANDA	ANDA202520	Capellon Pharmaceuticals, LLC	DEXCHLORPHENIRAMINE MALEATE	2	mg/5mL			N	
64578-0057_bbfcc3a8-caf3-493f-95fd-a3557179d815	64578-0057	HUMAN OTC DRUG	Aller-Chord A		Alfalfa, Allium Cepa, Ambrosia Artemisiaefolia, Bryonia (Alba), Citricum Acidum, Coumarinum, Euphrasia Officinalis, Glandula Suprarenalis Suis, Hepar Suis, Histaminum Hydrochloricum, Hydrastis Canadensis, Juniperus Communis, Mucosa Nasalis Suis, Natrum Sulphuricum, Phosphorus, Pothos Foetidus, Pulsatilla (Vulgaris), Solidago Virgaurea, Sulphur, Tanacetum Vulgare, Taraxacum Officinale, Trifolium Pratense	LIQUID	ORAL	20140929		UNAPPROVED HOMEOPATHIC		Energetix Corp	ALFALFA; AMBROSIA ARTEMISIIFOLIA; ANHYDROUS CITRIC ACID; BRYONIA ALBA ROOT; COUMARIN; EUPHRASIA STRICTA; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; JUNIPER BERRY; ONION; PHOSPHORUS; PORK LIVER; PULSATILLA VULGARIS; SODIUM SULFATE; SOLIDAGO VIRGAUREA FLOWERING TOP; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA NASAL MUCOSA; SYMPLOCARPUS FOETIDUS ROOT; TANACETUM VULGARE TOP; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER	9; 6; 12; 6; 12; 6; 9; 12; 9; 6; 12; 9; 12; 12; 9; 12; 9; 9; 9; 9; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
64578-0058_a7629513-2e91-4b40-8604-cab0b1827088	64578-0058	HUMAN OTC DRUG	Amoeba-Chord		Absinthium, Baptisia Tinctoria, Cajuputum, Capsicum Annuum, Cinchona Officinalis, Fragaria Vesca, Gentiana Lutea, Glandula Suprarenalis Suis, Hepar Suis, Lycopodium Clavatum, Mucosa Nasalis Suis, Nux Vomica, Pancreas Suis, Pulsatilla, Pyrogenium, Quassia, Senna, Triticum Repens	LIQUID	ORAL	20141022		UNAPPROVED HOMEOPATHIC		Energetix Corp	ALPINE STRAWBERRY; BAPTISIA TINCTORIA ROOT; CAJUPUT OIL; CAPSICUM; CINCHONA OFFICINALIS BARK; ELYMUS REPENS ROOT; GENTIANA LUTEA ROOT; LYCOPODIUM CLAVATUM SPORE; PORK LIVER; PULSATILLA VULGARIS; QUASSIA AMARA WOOD; RANCID BEEF; SENNA LEAF; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA NASAL MUCOSA; SUS SCROFA PANCREAS; WORMWOOD	4; 4; 6; 5; 12; 4; 6; 12; 9; 12; 4; 30; 4; 12; 9; 9; 9; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
64578-0060_25cd2dac-dd55-4b29-aaa8-25c33358ee40	64578-0060	HUMAN OTC DRUG	Medi-Chord		Homeopathic Liquid	LIQUID	ORAL	20170921		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ACETIC ACID; ALUMINUM; ARCTIUM LAPPA ROOT; ASPIRIN; ATROPA BELLADONNA; BENZENE; CHLORAMPHENICOL; CHLORPROMAZINE; CORTICOTROPIN HUMAN; CORTISONE ACETATE; ELYMUS REPENS ROOT; ESTRONE; FRANGULA PURSHIANA BARK; GLYCYRRHIZA GLABRA; KEROSENE; LEAD; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PHENACETIN; PHENYL SALICYLATE; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; PORK LIVER; POTASSIUM IODIDE; SARSAPARILLA; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER	18; 18; 4; 18; 12; 12; 18; 18; 18; 18; 4; 18; 4; 4; 18; 15; 12; 12; 18; 18; 12; 4; 9; 12; 4; 12; 9; 9; 4	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Amphenicol-class Antibacterial [EPC], Amphenicols [EXT], Anti-Inflammatory Agents, Non-Steroidal [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Phenothiazine [EPC], Phenothiazines [CS], Plant Proteins [CS], Plant Proteins [CS], Platelet Aggregation Inhibitor [EPC], Seed Storage Proteins [CS]		N	20241231
64578-0061_69a2d620-7b95-477f-927d-6f277ac889b5	64578-0061	HUMAN OTC DRUG	Colo-Chord		Homeopathic Liquid	LIQUID	ORAL	20141008		UNAPPROVED HOMEOPATHIC		Energetix Corp	ABELMOSCHUS MOSCHATUS SEED; ACTIVATED CHARCOAL; ARANEUS DIADEMATUS; ASAFETIDA; BAPTISIA TINCTORIA ROOT; BERBERIS VULGARIS ROOT BARK; BOS TAURUS BILE; BOS TAURUS COLOSTRUM; CANDIDA ALBICANS; COW MILK; ESCHERICHIA COLI; FRANGULA PURSHIANA BARK; LYCOPODIUM CLAVATUM SPORE; MANDRAGORA OFFICINARUM ROOT; MARSDENIA CONDURANGO BARK; MERCURIUS SOLUBILIS; PORK LIVER; RHEUM OFFICINALE ROOT; SELENIUM; SUS SCROFA NASAL MUCOSA; VERATRUM ALBUM ROOT	12; 15; 12; 12; 30; 4; 8; 8; 18; 12; 24; 4; 12; 12; 12; 12; 9; 4; 15; 9; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
64578-0062_4142c03b-6fac-47a0-8e5c-518145d8d574	64578-0062	HUMAN OTC DRUG	Dental-Chord		Homeopathic Liquid	LIQUID	ORAL	20140904		UNAPPROVED HOMEOPATHIC		Energetix Corp	ACETIC ACID; AMMONIUM CHLORIDE; ARCTIUM LAPPA ROOT; CALCIUM FLUORIDE; COPPER; DELPHINIUM STAPHISAGRIA SEED; GLYCYRRHIZA GLABRA; GOLD; IRON; LACTOSE, X-RAY EXPOSED (1000 RAD); LEMON JUICE; MERCURIUS SOLUBILIS; MYRRH; PALLADIUM; PHENOL; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; SELENIUM; SILICON DIOXIDE; SILVER; SODIUM FLUORIDE; STILLINGIA SYLVATICA ROOT; SUS SCROFA BONE MARROW; TIN; TRIBASIC CALCIUM PHOSPHATE; TRIFOLIUM PRATENSE FLOWER; ZINC OXIDE	15; 15; 4; 12; 15; 6; 4; 15; 12; 30; 12; 12; 6; 15; 15; 15; 4; 15; 12; 15; 12; 4; 9; 15; 12; 4; 15	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
64578-0063_28a62ea6-043a-4887-a62f-856c259299dd	64578-0063	HUMAN OTC DRUG	Gyne-Chord		Homeopathic Liquid	LIQUID	ORAL	20170719		UNAPPROVED HOMEOPATHIC		Energetix Corp	ANGELICA SINENSIS ROOT; BLACK COHOSH; BORIC ACID; CANDIDA ALBICANS; CHAMAELIRIUM LUTEUM ROOT; DELPHINIUM STAPHISAGRIA SEED; ESTRONE; GOLD TRICHLORIDE; GOLDENSEAL; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SODIUM SULFATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; WOOD CREOSOTE; ZINC GLUCONATE	8; 6; 12; 12; 12; 12; 7; 15; 12; 12; 15; 12; 12; 12; 9; 9; 12; 9; 15; 8	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
64578-0064_d3e9ead9-1324-4fb1-b978-7684fb5ee453	64578-0064	HUMAN OTC DRUG	Hepata-Chord		Homeopathic Liquid	LIQUID	ORAL	20141117		UNAPPROVED HOMEOPATHIC		Energetix Corp	ACETIC ACID; ALUMINUM OXIDE; ARCTIUM LAPPA ROOT; ASPIRIN; BENZENE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; CENTELLA ASIATICA; CHELIDONIUM MAJUS; CHELONE GLABRA; CHLORAMPHENICOL; CHLORPROMAZINE; CHOLESTEROL; CORTISONE ACETATE; ESTRONE; GAMBOGE; KEROSENE; MILK THISTLE; PARAFFIN; PHENACETIN; PHOSPHORUS; PORK LIVER; SILICON DIOXIDE; SODIUM SULFATE; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED	18; 18; 4; 18; 12; 4; 12; 5; 4; 12; 18; 18; 12; 18; 18; 12; 18; 4; 18; 18; 12; 9; 12; 12; 4; 9	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Amphenicol-class Antibacterial [EPC], Amphenicols [EXT], Anti-Inflammatory Agents, Non-Steroidal [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Phenothiazine [EPC], Phenothiazines [CS], Platelet Aggregation Inhibitor [EPC]		N	20241231
64578-0065_df344739-6d99-4c4c-b88f-b59814a5f656	64578-0065	HUMAN OTC DRUG	HZ-Chord		Baptisia Tinctoria, Ceanothus Americanus, Citricum Acidum, Echinacea (Angustifolia), Gelsemium Sempervirens, Hydrocotyle Asiatica, Lycopodium Clavatum, Mercurius Solubilis, Mezereum, Morbillinum, Nux Vomica, Paloondo, Phytolacca Decandra, Sepia, Thuja Occidentalis, Thyroidinum (Bovine)	LIQUID	ORAL	20140905		UNAPPROVED HOMEOPATHIC		Energetix Corp	ANHYDROUS CITRIC ACID; BAPTISIA TINCTORIA ROOT; CEANOTHUS AMERICANUS LEAF; CENTELLA ASIATICA; DAPHNE MEZEREUM BARK; ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; LARREA TRIDENTATA TOP; LYCOPODIUM CLAVATUM SPORE; MEASLES VIRUS; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, BOVINE	12; 4; 6; 12; 12; 4; 12; 5; 12; 30; 12; 4; 12; 12; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64578-0068_66af7d02-2cdb-4afe-ba0f-88a01099edd1	64578-0068	HUMAN OTC DRUG	Metal-Chord		Allium Cepa, Allium Sativum, Alpha-Lipoicum Acidum, Alumina, Arsenicum Metallicum, Berberis Vulgaris, Cadmium Metallicum, Carduus Marianus, Cetraria Islandica, Cuprum Metallicum, Cysteinum, Glycyrrhiza Glabra, Hepar Suis, Lappa Major, Lycopodium Clavatum, Mercurius Solubilis, Nux Vomica, Plantago Major, Plumbum Metallicum, Pyridoxinum Hydrochloricum, Selenium Metallicum, Stillingia Sylvatica, Thyroidinum, Trifolium Pratense, Zingiber Officinale	LIQUID	ORAL	20140620		UNAPPROVED HOMEOPATHIC		Energetix Corp	.ALPHA.-LIPOIC ACID; ALUMINUM OXIDE; ARCTIUM LAPPA ROOT; ARSENIC; BERBERIS VULGARIS ROOT BARK; CADMIUM; CETRARIA ISLANDICA SUBSP. ISLANDICA; COPPER; CYSTEINE; GARLIC; GINGER; GLYCYRRHIZA GLABRA; LEAD; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; MILK THISTLE; ONION; PLANTAGO MAJOR; PORK LIVER; PYRIDOXINE HYDROCHLORIDE; SELENIUM; STILLINGIA SYLVATICA ROOT; STRYCHNOS NUX-VOMICA SEED; THYROID, BOVINE; TRIFOLIUM PRATENSE FLOWER	12; 15; 4; 15; 4; 15; 12; 15; 12; 6; 6; 4; 15; 4; 15; 4; 6; 4; 9; 12; 15; 4; 12; 9; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
64578-0073_036ff6e8-7cd0-4ba8-a248-3fb673d3d505	64578-0073	HUMAN OTC DRUG	Para-Chord		Homeopathic Liquid	LIQUID	ORAL	20150707		UNAPPROVED HOMEOPATHIC		Energetix Corp	ARTEMISIA ABROTANUM FLOWERING TOP; ARTEMISIA CINA PRE-FLOWERING TOP; ARTEMISIA VULGARIS ROOT; DRYOPTERIS FILIX-MAS ROOT; DYSPHANIA AMBROSIOIDES; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PEUMUS BOLDUS LEAF; PUNICA GRANATUM ROOT BARK; SILICON DIOXIDE; SODIUM PHOSPHATE, DIBASIC; SPIGELIA ANTHELMIA; TANACETUM VULGARE TOP; TEUCRIUM MARUM; WHITE MUSTARD SEED	12; 5; 12; 4; 12; 12; 15; 4; 12; 12; 12; 6; 12; 5; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL			N	20241231
64578-0075_ae88f359-3faf-4703-8f70-82af72025f07	64578-0075	HUMAN OTC DRUG	Rena-Chord		Homeopathic Liquid	LIQUID	ORAL	20160428		UNAPPROVED HOMEOPATHIC		Energetix Corp	AGATHOSMA BETULINA LEAF; ALUMINUM OXIDE; ANTIMONY; APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CADMIUM; COBALT; COPPER; ECHINACEA ANGUSTIFOLIA; ELYMUS REPENS ROOT; EUTROCHIUM PURPUREUM ROOT; IRON; KEROSENE; LEAD; LITHIUM CARBONATE; LYTTA VESICATORIA; MERCURIC CHLORIDE; PLATINUM; PULSATILLA VULGARIS; SARSAPARILLA; SAW PALMETTO; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; TITANIUM; VANADIUM; ZINC	6; 15; 15; 12; 5; 15; 4; 12; 15; 15; 15; 4; 4; 6; 15; 15; 15; 15; 8; 15; 15; 12; 5; 8; 6; 4; 12; 15; 15; 15	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
64578-0076_1e959fb9-10da-43ad-b75b-51cbd1d7f7c2	64578-0076	HUMAN OTC DRUG	Thyro-Chord		Homeopathic Liquid	LIQUID	ORAL	20170908		UNAPPROVED HOMEOPATHIC		Energetix Corporation	.ALPHA.-KETOGLUTARIC ACID; ACETIC ACID; AMMONIUM CHLORIDE; ASPARAGUS; CHELIDONIUM MAJUS; COENZYME A; COPPER; ECHINACEA ANGUSTIFOLIA; FERROUS IODIDE; FUCUS VESICULOSUS; FUMARIC ACID; GENTIANA LUTEA ROOT; GLYCYRRHIZA GLABRA; GOLD; IODINE; MERCURIUS SOLUBILIS; NADIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PALLADIUM; PERSICARIA PUNCTATA; PHOSPHORIC ACID; POTASSIUM IODIDE; PULSATILLA VULGARIS; RANCID BEEF; SAGE; SILICON DIOXIDE; SILVER; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; THYROID, UNSPECIFIED; TIN; VANADIUM; ZINC OXIDE	12; 15; 15; 12; 4; 12; 15; 4; 12; 6; 12; 4; 4; 15; 8; 15; 12; 12; 15; 12; 12; 12; 12; 12; 8; 12; 15; 12; 12; 12; 9; 15; 15; 15	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
64578-0083_c1d36ba0-f05a-4498-ae6c-f33aa437484d	64578-0083	HUMAN OTC DRUG	Inflamma-Tone		Aconitum Napellus, Belladonna, Bryonia (Alba), Chamomilla	LIQUID	ORAL	20131003		UNAPPROVED HOMEOPATHIC		Energetix Corp	ACONITUM NAPELLUS; ATROPA BELLADONNA; BRYONIA ALBA ROOT; MATRICARIA RECUTITA	8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64578-0085_46277a0f-b491-49a8-86bd-a960c01407eb	64578-0085	HUMAN OTC DRUG	Hepatic-Tone		Carduus Marianus, Ceanothus Americanus, Chelidonium Majus, Chionanthus Virginica, Citricum Acidum, Cysteinum, Hepar Suis, Leptandra Virginica, Magnesia Muriatica, Natrum Sulphuricum, Nux Vomica, Phosphorus, Quassia (Amara), Taraxacum Officinale	LIQUID	ORAL	20140529		UNAPPROVED HOMEOPATHIC		Energetix Corp	ANHYDROUS CITRIC ACID; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CYSTEINE; MAGNESIUM CHLORIDE; MILK THISTLE; PHOSPHORUS; PORK LIVER; QUASSIA AMARA WOOD; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT	8; 12; 4; 8; 8; 8; 4; 12; 9; 4; 12; 12; 4; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64578-0086_0b117105-0bcf-49f3-ada9-f012fd0c3fb9	64578-0086	HUMAN OTC DRUG	Lymph-Tone	I	Adenosinum Cyclophosphoricum, Apis Mellifica, Aranea Diadema, Belladonna, Boldo, Calcarea Carbonica, Echinacea (Angustifolia),Galium Aparine, Glandula Suprarenalis Suis, Hypothalamus (Bovine), Kali Iodatum, Phosphorus, Phytolacca Decandra, Pinus Sylvestris, Pituitarum Posterium (Bovine), Pulsatilla (Vulgaris), Rhus Tox, Scrophularia Nodosa, Sulphur, Thyroidinum (Bovine)	LIQUID	ORAL	20150702		UNAPPROVED HOMEOPATHIC		Energetix Corp	ADENOSINE CYCLIC PHOSPHATE; APIS MELLIFERA; ARANEUS DIADEMATUS; ATROPA BELLADONNA; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND; ECHINACEA ANGUSTIFOLIA; GALIUM APARINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PEUMUS BOLDUS LEAF; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM IODIDE; PULSATILLA VULGARIS; SCROPHULARIA NODOSA; SULFUR; SUS SCROFA ADRENAL GLAND; THYROID, BOVINE; THYROID, PORCINE; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 12; 4; 12; 12; 4; 12; 4; 9; 4; 12; 12; 12; 9; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
64578-0090_8f74c592-87fa-42b0-968b-fd0260e4c9b0	64578-0090	HUMAN OTC DRUG	ReHydration		Adenosinum Cyclophosphoricum, Coffea Cruda, Glandula Suprarenalis Suis, Hypothalamus (Bovine), Kali Phosphoricum, Natrum Muriaticum, Sarsaparilla, Silicea, Taraxacum Officinale, Thyroidinum (Bovine)	LIQUID	ORAL	20141117		UNAPPROVED HOMEOPATHIC		Energetix Corp	ADENOSINE CYCLIC PHOSPHATE; ARABICA COFFEE BEAN; BOS TAURUS HYPOTHALAMUS; POTASSIUM PHOSPHATE, DIBASIC; SARSAPARILLA; SILICON DIOXIDE; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; TARAXACUM OFFICINALE; THYROID, BOVINE	12; 9; 12; 6; 4; 12; 8; 9; 4; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64578-0091_298721d0-267d-4f4b-b77f-ab412abfffa9	64578-0091	HUMAN OTC DRUG	Relax-Tone		Calcarea Carbonica, Coffea Cruda, Humulus Lupulus, Ignatia Amara, Kali Phosphoricum, Moschus, Nux Vomica, Passiflora Incarnate, Phosphorus, Pulsatilla Vulgaris, Staphysagria, Valeriana Officinalis	LIQUID	ORAL	20131001		UNAPPROVED HOMEOPATHIC		Energetix Corp	ARABICA COFFEE BEAN; DELPHINIUM STAPHISAGRIA SEED; HOPS; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; POTASSIUM PHOSPHATE, DIBASIC; PULSATILLA VULGARIS; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VALERIAN	12; 12; 10; 12; 12; 4; 12; 12; 12; 12; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64578-0092_9d09cb5d-24af-4f94-9484-7afeae7badc2	64578-0092	HUMAN OTC DRUG	Relief-Tone		Arnica Montana, Belladonna, Cortisone Aceticum, Hypericum Perforatum, Symphytum Officinale	LIQUID	ORAL	20131204		UNAPPROVED HOMEOPATHIC		Energetix Corp	ARNICA MONTANA; ATROPA BELLADONNA; COMFREY ROOT; CORTISONE ACETATE; HYPERICUM PERFORATUM	12; 6; 12; 24; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64578-0095_28cb18c4-f078-4772-a305-743f14726bea	64578-0095	HUMAN OTC DRUG	Adaptopath		Adenosinum Cyclophosphoricum, Alpha-Lipoicum Acidum, Argentum Metallicum, Avena Sativa, Capsicum Annuum, Citricum Acidum, Coenzyme A, Cuprum Metallicum, Ginkgo Biloba, Glandula Suprarenalis Suis, Glycyrrhiza Glabra, Hypothalamus (Bovine), Iodium, Ledum Palustre, Manganum Aceticum, Nadidum, Natrum Carbonicum, Oleum Morrhuae, Phosphoricum Acidum, Picricum Acidum, Riboflavinum, Selenium Metallicum Sepia, Silicea, Thiaminum Hydrochloricum, Thyroidinum (Bovine), Vanadium Metallicum	LIQUID	ORAL	20141022		UNAPPROVED HOMEOPATHIC		Energetix Corp	.ALPHA.-LIPOIC ACID; ADENOSINE CYCLIC PHOSPHATE; ANHYDROUS CITRIC ACID; AVENA SATIVA FLOWERING TOP; BOS TAURUS HYPOTHALAMUS; CAPSICUM; COD LIVER OIL; COENZYME A; COPPER; GINKGO; GLYCYRRHIZA GLABRA; IODINE; LEDUM PALUSTRE TWIG; MANGANESE ACETATE TETRAHYDRATE; NADIDE; PHOSPHORIC ACID; PICRIC ACID; RIBOFLAVIN; SELENIUM; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SILVER; SODIUM CARBONATE; SUS SCROFA ADRENAL GLAND; THIAMINE HYDROCHLORIDE; THYROID, BOVINE; VANADIUM	12; 8; 4; 4; 12; 4; 6; 8; 12; 4; 4; 12; 6; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 9; 8; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
64578-0096_256663fd-0bb5-4489-8c3e-b5111e220a07	64578-0096	HUMAN OTC DRUG	Adrenapath		Carduus Marianus, Chelidonium Majus, Echinacea (Angustifolia), Glandula Suprarenalis Suis, Natrum Muriaticum, Phosphoricum Acidum, Pituitarum Posterium (Bovine), Thyroidinum (Bovine)	LIQUID	ORAL	20170313		UNAPPROVED HOMEOPATHIC		Energetix Corporation	BOS TAURUS PITUITARY GLAND; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; MILK THISTLE; PHOSPHORIC ACID; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; THYROID, BOVINE	12; 4; 4; 12; 12; 12; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64578-0099_9496e924-079b-4af1-858a-3cc3b636db22	64578-0099	HUMAN OTC DRUG	Endopath-M		Adenosinum Cyclophosphoricum, Agnus Castus, Asparagus Officinalis, Avena Sativa, Cadmium Metallicum, Damiana, Glandula Suprarenalis Suis, Juniperus Communis, Lycopodium Clavatum, Orchitinum (Bovine), Petroselinum Sativum, Pituitarum Posterium (Bovine), Pulsatilla (Vulgaris), Sabal Serrulata, Sarsaparilla (Smilax Regelii)	LIQUID	ORAL	20141008		UNAPPROVED HOMEOPATHIC		Energetix Corp	ADENOSINE CYCLIC PHOSPHATE; ASPARAGUS; AVENA SATIVA FLOWERING TOP; BOS TAURUS TESTICLE; CADMIUM; CHASTE TREE; JUNIPER BERRY; LYCOPODIUM CLAVATUM SPORE; PETROSELINUM CRISPUM; PULSATILLA VULGARIS; SAW PALMETTO; SMILAX ORNATA ROOT; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; TURNERA DIFFUSA LEAFY TWIG	10; 6; 4; 9; 15; 4; 4; 4; 4; 6; 4; 4; 9; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
64578-0101_6b5787ea-0c16-4bfc-8e95-a2731814f6e8	64578-0101	HUMAN OTC DRUG	Endocrinpath		Alfalfa, Borago Officinalis, Calcarea Carbonica, Ceanothus Americanus, Citricum Acidum, Fucus Vesiculosus, Ginkgo Biloba, Glandula Suprarenalis Suis, Glycyrrhiza Glabra, Hydrocotyle Asiatica, Hypothalamus (Bovine), Kali Phosphoricum, Pancreas Suis, Phytolacca Decandra, Pituitarum Posterium (Bovine), Sarsaparilla (Smilax Regelii), Silicea, Syzygium Jambolanum, Taraxacum Officinale, Thyroidinum (Bovine)	LIQUID	ORAL	20141120		UNAPPROVED HOMEOPATHIC		Energetix Corp	ALFALFA; ANHYDROUS CITRIC ACID; BORAGE; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND; CEANOTHUS AMERICANUS LEAF; CENTELLA ASIATICA; FUCUS VESICULOSUS; GINKGO; GLYCYRRHIZA GLABRA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM PHOSPHATE, DIBASIC; SILICON DIOXIDE; SMILAX ORNATA ROOT; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SYZYGIUM CUMINI SEED; TARAXACUM OFFICINALE; THYROID, BOVINE	15; 15; 15; 12; 12; 4; 15; 15; 15; 15; 15; 4; 15; 12; 15; 9; 9; 4; 15; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64578-0102_4e352ba3-a23c-4411-b75a-73cb6ca99a34	64578-0102	HUMAN OTC DRUG	Metabopath		Adenosinum Cyclophosphoricum, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Berberis Vulgaris, Citricum Acidum, Coenzyme A, DNA, Fumaricum Acidum, Glycyrrhiza Glabra, Hepar Sulphuris Calcareum, Lappa Major, Magnesia Phosphorica, Manganum Aceticum, Nadidum, Natrum Muriaticum, Natrum Oxalaceticum, Natrum Pyruvicum, Nicotinamidum, Pulsatilla, Pyridoxinum Hydrochloricum, Rhamnus Purshiana, Riboflavinum, RNA, Silicea, Succinicum Acidum, Sulphur, Thiaminum Hydrochloricum,	LIQUID	ORAL	20140808		UNAPPROVED HOMEOPATHIC		Energetix Corp	.ALPHA.-KETOGLUTARIC ACID; ADENOSINE CYCLIC PHOSPHATE; ADENOSINE TRIPHOSPHATE DISODIUM; ANHYDROUS CITRIC ACID; ARCTIUM LAPPA ROOT; BERBERIS VULGARIS ROOT BARK; CALCIUM SULFIDE; COENZYME A; FRANGULA PURSHIANA BARK; FUMARIC ACID; GLYCYRRHIZA GLABRA; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, DIBASIC; MANGANESE ACETATE TETRAHYDRATE; NADIDE; NIACINAMIDE; PULSATILLA VULGARIS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SULFUR; THIAMINE HYDROCHLORIDE; THYROID, BOVINE; TRIFOLIUM PRATENSE FLOWER; ZANTHOXYLUM AMERICANUM BARK; ZINC GLUCONATE	12; 8; 12; 8; 4; 4; 30; 12; 4; 12; 4; 30; 12; 10; 12; 6; 12; 6; 10; 30; 12; 12; 12; 12; 12; 12; 6; 9; 4; 4; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
64578-0103_04c69a6d-b302-46e7-90e5-69999d1b58ce	64578-0103	HUMAN OTC DRUG	Renapath		Benzoicum Acidum, Berberis Vulgaris, Bryonia, DNA, Eupatorium Purpureum, Glandula Suprarenalis Suis, Hydrangea Arborescens, Hypothalamus, Mercurius Corrosivus, Pancreas Suis, Pareira Brava, Petroselinum Sativum, Pituitarum Posterium, Rubia Tinctorum, Sarsaparilla, Solidago Virgaurea, Thyroidinum (Bovine), Uva-Ursi	LIQUID	ORAL	20140606		UNAPPROVED HOMEOPATHIC		Energetix Corp	ARCTOSTAPHYLOS UVA-URSI LEAF; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; BRYONIA ALBA ROOT; CHONDRODENDRON TOMENTOSUM ROOT; EUTROCHIUM PURPUREUM ROOT; HERRING SPERM DNA; HYDRANGEA ARBORESCENS ROOT; MERCURIC CHLORIDE; PETROSELINUM CRISPUM; RUBIA TINCTORUM ROOT; SARSAPARILLA; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	4; 10; 4; 12; 12; 10; 12; 12; 4; 12; 4; 6; 4; 4; 9; 9; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
64578-0105_76382d0d-0508-4f50-8eba-1ec85ed23192	64578-0105	HUMAN OTC DRUG	Fields of Flowers		Homeopathic Liquid	LIQUID	ORAL	20170901		UNAPPROVED HOMEOPATHIC		Energetix Corporation	AESCULUS CARNEA FLOWER; AESCULUS HIPPOCASTANUM FLOWER; AGRIMONIA EUPATORIA FLOWER; BROMUS RAMOSUS FLOWER; CALLUNA VULGARIS FLOWERING TOP; CARPINUS BETULUS FLOWERING TOP; CASTANEA SATIVA FLOWER; CENTAURIUM ERYTHRAEA FLOWER; CERATOSTIGMA WILLMOTTIANUM FLOWER; CICHORIUM INTYBUS FLOWER; CLEMATIS VITALBA FLOWER; FAGUS SYLVATICA FLOWERING TOP; GENTIANELLA AMARELLA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; HORSE CHESTNUT; HOTTONIA PALUSTRIS FLOWER; ILEX AQUIFOLIUM FLOWERING TOP; IMPATIENS GLANDULIFERA FLOWER; JUGLANS REGIA FLOWERING TOP; LARIX DECIDUA FLOWERING TOP; LONICERA CAPRIFOLIUM FLOWERING TOP; MALUS DOMESTICA FLOWER; MIMULUS GUTTATUS FLOWERING TOP; OLEA EUROPAEA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PINUS SYLVESTRIS FLOWERING TOP; POPULUS TREMULA FLOWERING TOP; PRUNUS CERASIFERA FLOWER; QUERCUS ROBUR FLOWER; ROSA CANINA FLOWER; SALIX ALBA FLOWERING TOP; SCLERANTHUS ANNUUS FLOWERING TOP; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; ULEX EUROPAEUS FLOWER; ULMUS PROCERA FLOWERING TWIG; VERBENA OFFICINALIS FLOWERING TOP; VITIS VINIFERA FLOWERING TOP	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL; [hp_C]/59.1mL			N	20241231
64578-0109_034293ce-f932-4521-aa24-2caca19035e0	64578-0109	HUMAN OTC DRUG	Isopathic Phenolic Rings		Homeopathic Liquid	LIQUID	ORAL	20171103		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ACETALDEHYDE; ANHYDROUS CITRIC ACID; ARABICA COFFEE BEAN; BENZENE; BOS TAURUS HYPOTHALAMUS; BOS TAURUS TESTICLE; CAFFEINE; CANDIDA ALBICANS; CHOLINE; CINNAMON; COCOA; COUMARIN; ESTRONE; GALLIC ACID; GREEN PEPPERCORN; HISTAMINE; INDOLE; KEROSENE; ONION; PETROSELINUM CRISPUM; PHENOL; PHLORIZIN; PHOSPHORUS; SUCROSE; SUS SCROFA ADRENAL GLAND; TURPENTINE OIL; VALERIAN	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 9; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS], Xanthines [CS]		N	20241231
64578-0127_02298c8e-a131-4f99-be1e-b52fb3cdaf1c	64578-0127	HUMAN OTC DRUG	Phytogel		Arnica Montana, Calendula Officinalis, Hypericum Perforatum, Bellis Perennis, Calcarea Fluorica, Ferrum Phosphoricum, Ledum Palustre, Natrum Sulphuricum, Rhus Tox, Sulphuricum Acidum, Symphytum Officinale	GEL	TOPICAL	20160615		UNAPPROVED HOMEOPATHIC		Energetix Corp	ARNICA MONTANA; BELLIS PERENNIS; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; FERRUM PHOSPHORICUM; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; SODIUM SULFATE; SULFURIC ACID; TOXICODENDRON PUBESCENS LEAF	1; 12; 30; 1; 6; 30; 1; 12; 30; 12; 30	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_C]/g; [hp_X]/g; [hp_X]/g			N	20241231
64578-0128_d45ef850-6f87-468a-e053-2995a90a1864	64578-0128	HUMAN OTC DRUG	Viru-Chord		Belladonna, Cinchona Officinalis, Echinacea (Angustifolia), Gelsemium Sempervirens, Glandula Suprarenalis Suis, Glycyrrhiza Glabra, Hepar Suis, Hydrastis Canadensis, Illicium Anisatum, Influenzinum, Lachesis Mutus, Lappa Major, Magnesia Phosphorica, Morbillinum, Myrrha, Nasturtium Aquaticum, Nux Vomica, Paloondo, Pyridoxinum Hydrochloricum, Riboflavinum, Sambucus Nigra, Scutellaria Lateriflora, Thiaminum Hydrochloricum, Thyroidinum (Bovine)	LIQUID	ORAL	20160601		UNAPPROVED HOMEOPATHIC		Energetix Corp	ARCTIUM LAPPA ROOT; ATROPA BELLADONNA; CINCHONA OFFICINALIS BARK; ECHINACEA ANGUSTIFOLIA; GELSEMIUM SEMPERVIRENS ROOT; GLYCYRRHIZA GLABRA; GOLDENSEAL; INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); LACHESIS MUTA VENOM; LARREA TRIDENTATA LEAF; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MEASLES VIRUS; MYRRH; NASTURTIUM OFFICINALE; PORK LIVER; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SAMBUCUS NIGRA FLOWERING TOP; SCUTELLARIA LATERIFLORA; STAR ANISE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; THIAMINE HYDROCHLORIDE; THYROID, BOVINE	4; 12; 12; 4; 6; 4; 5; 30; 30; 30; 30; 30; 30; 12; 12; 12; 30; 4; 6; 9; 12; 12; 4; 6; 12; 12; 9; 12; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
64578-0130_69332262-99a6-400f-9c7d-12cc674df851	64578-0130	HUMAN OTC DRUG	GB-Tone		Ammi Visnaga, Atropinum Sulphuricum, Boldo, Carduus Marianus, Chelidonium Majus, Echinacea, Fel Tauri, Hepar Suis, Hydrastis Canadensis, Leptandra Virginica, Magnesia Phosphorica, Natrum Phosphoricum, Podophyllum Peltatum, Taraxacum Officinale	LIQUID	ORAL	20160714		UNAPPROVED HOMEOPATHIC		Energetix Corp	AMMI VISNAGA FRUIT; ATROPINE SULFATE; BOS TAURUS BILE; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MILK THISTLE; PEUMUS BOLDUS LEAF; PODOPHYLLUM; PORK LIVER; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT	12; 12; 8; 12; 4; 5; 12; 4; 4; 12; 9; 6; 4; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64578-0131_b7cdd19d-c517-46d5-895b-e75164f1a429	64578-0131	HUMAN OTC DRUG	Bacteria Chord		Azadirachta Indica, Belladonna, Berberis Vulgaris, Boldo, Candida Albicans, Ceanothus Americanus, Cetraria Islandica, Crotalus Horridus, Echinacea (Angustifolia), Glandula Suprarenalis Suis, Glycyrrhiza Glabra, Hamamelis Virginiana, Hepar Suis, Hydrastis Canadensis, Hydrocotyle Asiatica, Hypericum Perforatum, Lappa Major, Ledum Palustre, Millefolium, Morbillinum, Myrrha, Pancreas Suis, Pertussinum, Phosphorus, Plantago Major, Pyrogenium, Solidago Virgaurea, Zingiber Officinale	LIQUID	ORAL	20161111		UNAPPROVED HOMEOPATHIC		Energetix Corp	ACHILLEA MILLEFOLIUM; ARCTIUM LAPPA ROOT; ATROPA BELLADONNA; AZADIRACHTA INDICA BARK; BERBERIS VULGARIS ROOT BARK; CANDIDA ALBICANS; CEANOTHUS AMERICANUS LEAF; CENTELLA ASIATICA; CETRARIA ISLANDICA SUBSP. ISLANDICA; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; MEASLES VIRUS; MYRRH; PEUMUS BOLDUS LEAF; PHOSPHORUS; PLANTAGO MAJOR; PORK LIVER; RANCID BEEF; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS	12; 4; 8; 8; 9; 30; 4; 6; 12; 12; 4; 6; 4; 5; 6; 30; 12; 9; 30; 4; 4; 12; 4; 9; 30; 4; 9; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS]		N	20241231
64578-0132_2ad25885-0d81-414b-8f73-dc19ec339d94	64578-0132	HUMAN OTC DRUG	Tox-Chord		Alfalfa, Alumina, Benzoicum Acidum, Carboneum, Cetraria Islandica, Folliculinum, Fucus Vesiculosus, Fumaricum Acidum, Hepar Suis, Kali Carbonicum, Kreosotum, Natrum Muriaticum, Paraffinum, Petroleum, Phosphoricum Acidum, Phosphorus, Pix Liquida, Plantago Major, Plumbum Metallicum, Pulsatilla (Vulgaris), Radium Bromatum, Resorcinum, Salol, Silicea, Symphytum Officinale, Tabacum, Terebinthina, Thyroidinum (Bovine), Triticum Repens, Zincum Oxydatum	LIQUID	ORAL	20161111		UNAPPROVED HOMEOPATHIC		Energetix Corp	ALFALFA; ALUMINUM OXIDE; BENZOIC ACID; CETRARIA ISLANDICA SUBSP. ISLANDICA; COMFREY ROOT; D&C BLACK NO. 2; ELYMUS REPENS ROOT; ESTRONE; FUCUS VESICULOSUS; FUMARIC ACID; KEROSENE; LEAD; PARAFFIN; PHENYL SALICYLATE; PHOSPHORIC ACID; PHOSPHORUS; PINE TAR; PLANTAGO MAJOR; PORK LIVER; POTASSIUM CARBONATE; PULSATILLA VULGARIS; RADIUM BROMIDE; RESORCINOL; SILICON DIOXIDE; SODIUM CHLORIDE; THYROID, BOVINE; TOBACCO LEAF; TURPENTINE OIL; WOOD CREOSOTE; ZINC OXIDE	4; 18; 18; 9; 6; 18; 4; 18; 5; 18; 18; 15; 18; 18; 12; 12; 18; 4; 9; 12; 12; 15; 18; 12; 12; 9; 30; 18; 18; 18	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64578-0133_c868542f-da94-4187-905d-ea5e3a634163	64578-0133	HUMAN OTC DRUG	Thyropath		Avena Sativa, Borago Officinalis, Calcarea Carbonica, Chelidonium Majus, Ferrum Iodatum, Fucus Vesiculosus, Glandula Suprarenalis Suis, Hepar Suis, Iodium, Kali Iodatum, Phosphoricum Acidum, Pituitarum Posterium (Bovine), Pyridoxinum Hydrochloricum, Thyroidinum (Bovine), Zincum Metallicum	LIQUID	ORAL	20161115		UNAPPROVED HOMEOPATHIC		Energetix Corp	AVENA SATIVA FLOWERING TOP; BORAGE; BOS TAURUS PITUITARY GLAND, POSTERIOR; CHELIDONIUM MAJUS; FERROUS IODIDE; FUCUS VESICULOSUS; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PORK LIVER; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; SUS SCROFA ADRENAL GLAND; THYROID, BOVINE; ZINC	4; 6; 12; 4; 12; 4; 12; 12; 12; 9; 12; 10; 9; 9; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
64578-0136_181b5d68-442e-498b-bffd-4978e1e56834	64578-0136	HUMAN OTC DRUG	Flu-Tone		Anas Barbariae, Hepatis Et Cordis Extractum, Azadirachta Indica, Baptisia Tinctoria, Bryonia (Alba), Crotalus Horridus, Echinacea (Angustifolia), Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens, Ginkgo Biloba, Influenzinum, Mucosa Nasalis Suis, Phytolacca Decandra, Pinus Sylvestris, Pyrogenium, Selenium Metallicum, Stillingia Sylvatica	LIQUID	ORAL	20181101		UNAPPROVED HOMEOPATHIC		Energetix Corp	AZADIRACHTA INDICA BARK; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERRUM PHOSPHORICUM; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; RANCID BEEF; SELENIUM; STILLINGIA SYLVATICA ROOT; SUS SCROFA NASAL MUCOSA	12; 4; 12; 15; 15; 4; 30; 12; 6; 4; 30; 30; 30; 30; 4; 9; 30; 12; 4; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64578-0141_19b2de9f-90da-495c-b6f5-11485ef2a2ee	64578-0141	HUMAN OTC DRUG	Throat Spray- Tone		Apis mellifica, Baptisia tinctoria, Belladonna, Calendula officinalis, Hepar sulphuris calcareum, Hydrastis canadensis, Lachesis mutus, Mercurius solubilis, Myrrha, Phytolacca decandra, Spilanthes oleracea.	LIQUID	ORAL	20171103		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ACMELLA OLERACEA FLOWERING TOP; APIS MELLIFERA; ATROPA BELLADONNA; BAPTISIA TINCTORIA; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; GOLDENSEAL; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS; MYRRH; PHYTOLACCA AMERICANA ROOT	5; 12; 12; 4; 15; 4; 5; 12; 12; 5; 4	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
64578-0142_bd8521ca-228c-4a76-b0b4-d39b34569c56	64578-0142	HUMAN OTC DRUG	Drainage-Tone		Calcarea iodata, Capsicum annuum, Coenzyme A, Echinacea angustifolia, Equisetum arvense, Hydrastis canadensis, Nadidum, Nitricum acidum, Oleum morrhuae, Petroselinum sativum, Phytolacca decandra, Scrophularia nodosa, Silicea, Sinapis alba, Thuja occidentalis.	LIQUID	ORAL	20170731		UNAPPROVED HOMEOPATHIC		Energetix Corporation	CALCIUM IODIDE; CAPSICUM; COD LIVER OIL; COENZYME A; ECHINACEA ANGUSTIFOLIA; EQUISETUM ARVENSE TOP; GOLDENSEAL; NADIDE; NITRIC ACID; PETROSELINUM CRISPUM; PHYTOLACCA AMERICANA ROOT; SCROPHULARIA NODOSA; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; WHITE MUSTARD SEED	12; 6; 15; 8; 4; 6; 5; 8; 12; 4; 4; 4; 12; 4; 4	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
64578-0143_bbfbf77a-4d71-4bb3-96e5-aeccc9e97d51	64578-0143	HUMAN OTC DRUG	Vac-Chord		Alumina, Arsenicum album, Baptisia tinctoria, Belladonna, Boldo, Calcarea carbonica, Carduus marianus, Chamomilla, Chelidonium majus, Echinacea, Hydrastis canadensis, Lecithin, Ledum palustre, Lycopodium clavatum, Mercurius solubilis, Morbillinum, Pertussinum, Phytolacca decandra, Pyrogenium, Rhus tox, Silicea, Sulphur, Taraxacum officinale, Thuja occidentalis, Thyroidinum.	LIQUID	ORAL	20170922		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ALUMINUM OXIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; EGG PHOSPHOLIPIDS; GOLDENSEAL; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; MEASLES VIRUS; MERCURIUS SOLUBILIS; MILK THISTLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PEUMUS BOLDUS LEAF; PHYTOLACCA AMERICANA ROOT; RANCID BEEF; SILICON DIOXIDE; SULFUR; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF	15; 12; 12; 4; 4; 4; 12; 5; 30; 16; 12; 12; 30; 15; 4; 12; 4; 4; 30; 12; 15; 4; 6; 9; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL			N	20241231
64578-0144_3fe30d36-8ace-4307-a148-7e8e8514974e	64578-0144	HUMAN OTC DRUG	MycoCan-Chord		Alumina, Avena Sativa, Borax, Candida Albicans, Carbolicum Acidum, Ceanothus Americanus, Echinacea, Gaultheria Procumbens, Glandula Suprarenalis Suis, Hydrastis Canadensis, Linum Usitatissimum, Lithium Carbonicum, Medulla Ossis Suis, Natrum Muriaticum, Phosphoricum Acidum, Phytolacca Decandra, Sarcolacticum Acidum, Sepia, Silicea, Solidago Virgaurea, Tellurium Metallicum, Teucrium Marum, Zincum Metallicum	LIQUID	ORAL	20160610		UNAPPROVED HOMEOPATHIC		Energetix Corp	ALUMINUM OXIDE; AVENA SATIVA FLOWERING TOP; CANDIDA ALBICANS; CEANOTHUS AMERICANUS LEAF; ECHINACEA ANGUSTIFOLIA; FLAX SEED; GAULTHERIA PROCUMBENS TOP; GOLDENSEAL; LACTIC ACID, L-; LITHIUM CARBONATE; PHENOL; PHOSPHORIC ACID; PHYTOLACCA AMERICANA ROOT; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM BORATE; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; TELLURIUM; TEUCRIUM MARUM; ZINC	15; 4; 16; 4; 4; 6; 6; 5; 12; 12; 8; 12; 12; 15; 12; 8; 12; 4; 9; 9; 15; 6; 15	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64578-0145_5a757af8-c72d-4808-b771-81f5fa63ddfa	64578-0145	HUMAN OTC DRUG	Lipo-Chord		Aceticum ac, Acetylsal ac, Adrenocorticotrophin, Alumina, Arsenicum alb, Borago, Ceanothus, Chelidonium maj, Chionanthus, Chloramphenicolum, Chlorpromazinum, Cholesterinum, Cortisone aceticum, Damiana, Folliculinum, Fumaricum ac, Kali iod, Lycopodium, Nat sulphuricum, Nux vom, Oleum morrhuae, Petroleum, Phenacetinum, Phosphoricum ac, Phosphorus, Plumb met, Saccharum off, Silicea, Taraxacum, Thyroidinum.	LIQUID	ORAL	20170818		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ACETIC ACID; ALUMINUM OXIDE; ARSENIC TRIOXIDE; ASPIRIN; BORAGE; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CHLORAMPHENICOL; CHLORPROMAZINE; CHOLESTEROL; COD LIVER OIL; CORTICOTROPIN HUMAN; CORTISONE ACETATE; ESTRONE; FUMARIC ACID; KEROSENE; LEAD; LYCOPODIUM CLAVATUM SPORE; PHENACETIN; PHOSPHORIC ACID; PHOSPHORUS; POTASSIUM IODIDE; SILICON DIOXIDE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SUCROSE; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED; TURNERA DIFFUSA LEAFY TWIG	18; 18; 30; 18; 6; 6; 12; 6; 18; 18; 12; 12; 18; 18; 18; 30; 18; 30; 30; 18; 30; 30; 30; 30; 30; 30; 30; 4; 9; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Amphenicol-class Antibacterial [EPC], Amphenicols [EXT], Anti-Inflammatory Agents, Non-Steroidal [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Phenothiazine [EPC], Phenothiazines [CS], Plant Proteins [CS], Platelet Aggregation Inhibitor [EPC], Seed Storage Proteins [CS]		N	20241231
64578-0146_a24445ea-958a-442a-93b7-48e28993ac45	64578-0146	HUMAN OTC DRUG	Circulopath		Adenosinum cyclophosphoricum, Arnica montana, Aurum muriaticum, Baryta muriatica, Borago officinalis, Cholesterinum, Citrus limonum, Hypothalamus (Bovine), Kali iodatum, Laurocerasus, Magnesia muriatica, Nadidum, Phaseolus, Phosphorus, Thyroidinum (Bovine)	LIQUID	ORAL	20160620		UNAPPROVED HOMEOPATHIC		Energetix Corp	ADENOSINE CYCLIC PHOSPHATE; ARNICA MONTANA; BARIUM CHLORIDE DIHYDRATE; BORAGE; BOS TAURUS HYPOTHALAMUS; CHOLESTEROL; COENZYME A; CONIUM MACULATUM FLOWERING TOP; DIGITALIS; GINKGO; GOLD TRICHLORIDE; KIDNEY BEAN; LEMON JUICE; MAGNESIUM CHLORIDE; NADIDE; PHOSPHORUS; POTASSIUM IODIDE; PRUNUS LAUROCERASUS LEAF; THYROID, BOVINE	10; 30; 12; 6; 12; 12; 10; 12; 6; 4; 12; 5; 4; 8; 9; 30; 12; 10; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
64578-0148_fdb59c29-bdc7-4d66-a54e-94392c36e77e	64578-0148	HUMAN OTC DRUG	Aller-Chord F		Acetaldehyde, Aceticum ac, Arg nit, Caffeinum, Calc sulph, Citricum ac, Cortisone aceticum, Echinacea purp, Folliculinum, Fragaria, Fumaricum ac, Gallicum ac, Glandula suprarenalis suis, Hepar suis, Histaminum hydrochloricum, Hydrangea, Lac vac, Lecithin, Limulus, Lycopersicum, Lycopodium, Nat bicarb, Nat mur, Nux vom, Paraffinum, Phosphoricum ac, Saccharum off, Silicea, Tartaricum ac, Torula cerevisiae.	LIQUID	ORAL	20140808		UNAPPROVED HOMEOPATHIC		Energetix Corp	ACETALDEHYDE; ACETIC ACID; ALPINE STRAWBERRY; ANHYDROUS CITRIC ACID; CAFFEINE; CALCIUM SULFATE ANHYDROUS; CORTISONE ACETATE; COW MILK; ECHINACEA PURPUREA; EGG PHOSPHOLIPIDS; ESTRONE; FUMARIC ACID; GALLIC ACID MONOHYDRATE; HISTAMINE DIHYDROCHLORIDE; HYDRANGEA ARBORESCENS ROOT; LIMULUS POLYPHEMUS; LYCOPODIUM CLAVATUM SPORE; PARAFFIN; PHOSPHORIC ACID; PORK LIVER; SACCHAROMYCES CEREVISIAE; SILICON DIOXIDE; SILVER NITRATE; SODIUM BICARBONATE; SODIUM CHLORIDE; SOLANUM LYCOPERSICUM; STRYCHNOS NUX-VOMICA SEED; SUCROSE; SUS SCROFA ADRENAL GLAND; TARTARIC ACID	12; 15; 15; 15; 15; 15; 20; 15; 6; 15; 15; 15; 12; 12; 6; 15; 12; 15; 15; 9; 15; 15; 10; 15; 12; 15; 12; 15; 9; 15	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylxanthine [EPC], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Xanthines [CS]		N	20241231
64578-0149_ea75facb-5e67-4b2b-997f-776aca3a465f	64578-0149	HUMAN OTC DRUG	Kidney-Tone		Agrimonia eupatoria, Berberis vulgaris, Calcarea oxalica, Calcarea phosphorica, Cantharis, Echinacea, Equisetum arvense, Ferrum phosphoricum, Lycopodium clavatum, Pareira brava, Petroselinum sativum, Rubia tinctorum, Sarsaparilla, Solidago virgaurea, Uva-ursi.	LIQUID	ORAL	20170401		UNAPPROVED HOMEOPATHIC		Energetix Corporation	AGRIMONIA EUPATORIA; ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; CALCIUM OXALATE MONOHYDRATE; CHONDRODENDRON TOMENTOSUM ROOT; ECHINACEA, UNSPECIFIED; EQUISETUM ARVENSE TOP; FERROSOFERRIC PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; PETROSELINUM CRISPUM; RUBIA TINCTORUM ROOT; SARSAPARILLA; SOLIDAGO VIRGAUREA FLOWERING TOP; TRIBASIC CALCIUM PHOSPHATE	12; 5; 4; 12; 4; 4; 12; 12; 12; 12; 4; 12; 5; 5; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calcium [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
64578-0150_cc7c955e-98a6-4019-ba64-da72d6db87bc	64578-0150	HUMAN OTC DRUG	Adrenal-Tone		Adrenalinum, Avena, Ginkgo, Glycyrrhiza, Kali phos, Nat mur, Nux vomica, Phosphoricum ac, Pituitarum posterium, Sarsaparilla, Thyroidinum, Veratrum alb, Zinc met.	LIQUID	ORAL	20171103		UNAPPROVED HOMEOPATHIC		Energetix Corporation	AVENA SATIVA FLOWERING TOP; EPINEPHRINE; GINKGO; GLYCYRRHIZA GLABRA; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SARSAPARILLA; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIED; VERATRUM ALBUM ROOT; ZINC	4; 12; 4; 4; 12; 12; 4; 12; 12; 12; 6; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
64578-0151_b0503f08-5c74-4356-8299-d2b449f3607c	64578-0151	HUMAN OTC DRUG	Tox-Chord		Alfalfa, Alumina, Benzoicum ac, Carboneum, Cetraria, Folliculinum, Fucus, Fumaricum ac, Hepar suis, Kali carb, Kreosotum, Nat mur, Paraffinum, Petroleum, Phosphoricum ac, Phos, Pix liquida, Plantago, Plumb met, Pulsatilla, Radium brom, Resorcinum, Salol, Silicea, Symphytum, Tabacum, Terebinthina, Thyroidinum, Triticum, Zinc oxyd.	LIQUID	ORAL	20170401		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ALFALFA; ALUMINUM OXIDE; BENZOIC ACID; CETRARIA ISLANDICA SUBSP. ISLANDICA; COMFREY ROOT; D&C BLACK NO. 2; ELYMUS REPENS ROOT; ESTRONE; FUCUS VESICULOSUS; FUMARIC ACID; KEROSENE; LEAD; PARAFFIN; PHENYL SALICYLATE; PHOSPHORIC ACID; PHOSPHORUS; PINE TAR; PLANTAGO MAJOR; PORK LIVER; POTASSIUM CARBONATE; PULSATILLA VULGARIS; RADIUM BROMIDE; RESORCINOL; SILICON DIOXIDE; SODIUM CHLORIDE; THYROID, UNSPECIFIED; TOBACCO LEAF; TURPENTINE OIL; WOOD CREOSOTE; ZINC OXIDE	4; 18; 18; 9; 6; 18; 4; 18; 5; 18; 18; 15; 18; 18; 12; 12; 18; 4; 9; 12; 12; 15; 18; 12; 12; 9; 30; 18; 18; 18	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64578-0153_ab5e68a2-7007-449d-a216-dadd64ca4b65	64578-0153	HUMAN OTC DRUG	Lymph-Tone II		Aesculus hipp, Azadirachta, Baryta carb, Berber vulg, Boldo, Bufo, Calc carb, Calc phos, Coenzyme A, Collinsonia, Echinacea, Ferrum phos, Glandula suprarenalis suis, Hypothalamus, Kreosotum, Nadidum, Nat mur, Phos, Phytolacca, Pinus syl, Pituitarum posterium, Pix liquida, Pulsatilla, Silicea, Stillingia, Thuja occ.	LIQUID	ORAL	20171103		UNAPPROVED HOMEOPATHIC		Energetix Corporation	AZADIRACHTA INDICA BARK; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND; BUFO BUFO CUTANEOUS GLAND; COENZYME A; COLLINSONIA CANADENSIS ROOT; ECHINACEA ANGUSTIFOLIA; FERRUM PHOSPHORICUM; HORSE CHESTNUT; NADIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PEUMUS BOLDUS LEAF; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PINE TAR; PINUS SYLVESTRIS LEAFY TWIG; PULSATILLA VULGARIS; SILICON DIOXIDE; SODIUM CHLORIDE; STILLINGIA SYLVATICA ROOT; SUS SCROFA ADRENAL GLAND; THUJA OCCIDENTALIS LEAFY TWIG; TRIBASIC CALCIUM PHOSPHATE; WOOD CREOSOTE	8; 12; 12; 12; 12; 12; 12; 10; 6; 12; 12; 12; 12; 4; 30; 4; 6; 9; 12; 12; 12; 4; 9; 12; 12; 15	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
64578-0154_711caa20-c158-40c1-bcd1-f64dbf07f64f	64578-0154	HUMAN OTC DRUG	Sinus-Tone		Allium cepa, Echinacea, Hydrastis canadensis, Kali bichromicum, Mercurius solubilis, Mercurius sulphuratus ruber, Mucosa nasalis suis, Natrum sulphuricum, Nux moschata, Pulsatilla.	LIQUID	ORAL	20171019		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ECHINACEA, UNSPECIFIED; GOLDENSEAL; MERCURIC SULFIDE; MERCURIUS SOLUBILIS; NUTMEG; ONION; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SODIUM SULFATE; SUS SCROFA NASAL MUCOSA	4; 5; 12; 30; 6; 12; 12; 12; 12; 9	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
64578-0155_b16a472f-65bc-4699-b752-66c1d7f17d4a	64578-0155	HUMAN OTC DRUG	ReHydration		Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum	LIQUID	ORAL	20180405		UNAPPROVED HOMEOPATHIC		Energetix	ADENOSINE CYCLIC PHOSPHATE; ARABICA COFFEE BEAN; BOS TAURUS HYPOTHALAMUS; DIBASIC POTASSIUM PHOSPHATE; SARSAPARILLA; SILICON DIOXIDE; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; TARAXACUM OFFICINALE ROOT; THYROID, UNSPECIFIED	12; 9; 12; 6; 4; 12; 8; 9; 4; 12	[hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64578-0156_c830f8ab-6356-45b0-8ad5-b8a17cc2ee81	64578-0156	HUMAN OTC DRUG	Agri-Chord		Arsenicum alb, Belladonna, Calc carb, Ceanothus, Chelidonium maj, Cuprum sulph, Fumaricum ac, Galium, Glandula suprarenalis suis, Hepar suis, Kali iod, Lycopodium, Pancreas suis, Petroleum, Phosphoricum ac, Phosphorus, Phytolacca, Sarsaparilla, Silicea, Sulphur, Thyroidinum, Trifolium prat, Xanthoxylum, Zinc phos	LIQUID	ORAL	20180405		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ARSENIC TRIOXIDE; ATROPA BELLADONNA; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS; CUPRIC SULFATE; FUMARIC ACID; GALIUM APARINE; KEROSENE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PORK LIVER; POTASSIUM IODIDE; SARSAPARILLA; SILICON DIOXIDE; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER; ZANTHOXYLUM AMERICANUM BARK; ZINC PHOSPHIDE	12; 12; 6; 12; 30; 30; 6; 30; 12; 30; 12; 30; 4; 9; 30; 12; 30; 30; 9; 9; 9; 4; 4; 30	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL			N	20241231
64578-0157_74d6e1c6-e98c-41f4-b8a0-53674acf951a	64578-0157	HUMAN OTC DRUG	Calm Five		Clematis vitalba flos, Helianthemum nummularium flos, Impatiens glandulifera flos, Ornithogalum umbellatum flos, Prunus cerasifera flos	LIQUID	ORAL	20190401		UNAPPROVED HOMEOPATHIC		Energetix Corp	CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM; PRUNUS CERASIFERA FLOWER	30; 30; 30; 30; 30	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
64578-0158_e6a6c457-d505-4e4c-bc05-f76c6d4b85f8	64578-0158	HUMAN OTC DRUG	Bacteria-Chord		Azadirachta, Belladonna, Berber vulg, Boldo, Candida alb, Ceanothus, Cetraria, Crotalus hor , Echinacea, Glandula suprarenalis suis, Glycyrrhiza, Hamamelis, Hepar suis, Hydrastis, Hydrocotyle, Hypericum, Lappa, Ledum, Millefolium, Morbillinum, Myrrha, Pancreas, Pertussinum, Phos, Plantago, Pyrogenium, Solidago, Zingiber	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ACHILLEA MILLEFOLIUM WHOLE; ARCTIUM LAPPA ROOT; ATROPA BELLADONNA; AZADIRACHTA INDICA BARK; BERBERIS VULGARIS ROOT BARK; CANDIDA ALBICANS; CEANOTHUS AMERICANUS LEAF; CENTELLA ASIATICA; CETRARIA ISLANDICA WHOLE; CROTALUS HORRIDUS HORRIDUS VENOM; ECHINACEA, UNSPECIFIED; GINGER; GLYCYRRHIZA GLABRA; GOLDENSEAL; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYPERICUM PERFORATUM WHOLE; MEASLES VIRUS; MYRRH; PEUMUS BOLDUS LEAF; PHOSPHORUS; PLANTAGO MAJOR; PORK LIVER; RANCID BEEF; RHODODENDRON TOMENTOSUM LEAFY TWIG; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS	12; 4; 8; 8; 9; 30; 4; 6; 12; 12; 4; 6; 4; 5; 6; 30; 12; 30; 4; 4; 12; 4; 9; 30; 9; 4; 9; 9	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS]		N	20241231
64578-0159_f7573745-c54d-49e5-a1dd-2d90f1cd51d2	64578-0159	HUMAN OTC DRUG	GB-Tone		Ammi vis, Atropinum sulphuricum, Boldo, Carduus mar, Chelidonium maj, Echinacea, Fel tauri, Hepar suis, Hydrastis, Leptandra, Mag phos, Nat phos, Podoph pelt, Taraxacum	LIQUID	ORAL	20190101		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ATROPINE SULFATE; BOS TAURUS BILE; CHELIDONIUM MAJUS; ECHINACEA, UNSPECIFIED; GOLDENSEAL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MILK THISTLE; PEUMUS BOLDUS LEAF; PODOPHYLLUM; PORK LIVER; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT; VISNAGA DAUCOIDES FRUIT	12; 8; 12; 4; 5; 12; 4; 4; 12; 9; 6; 4; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64578-0170_4683d919-b9bb-4c0e-8b10-906bfbcaa0b9	64578-0170	HUMAN OTC DRUG	Endopath-F		Agnus, Angelica sin, Cimicifuga, Fucus, Glandula suprarenalis suis, Glycyrrhiza, Hypothalamus, Oophorinum, Pituitarum posterium, Pulsatilla, Sepia, Thyroidinum, Xanthoxylum	LIQUID	ORAL	20150910		UNAPPROVED HOMEOPATHIC		Energetix Corp	ANGELICA SINENSIS ROOT; BLACK COHOSH; BOS TAURUS HYPOTHALAMUS; CHASTE TREE FRUIT; FUCUS VESICULOSUS; LICORICE; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIED; ZANTHOXYLUM AMERICANUM BARK	8; 4; 12; 4; 4; 4; 12; 12; 9; 9; 12; 9; 4	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL			N	20241231
64578-0171_5901dee4-ba17-446d-9921-337569fa4630	64578-0171	HUMAN OTC DRUG	Hypothalmapath		Gelsemium, Ginkgo, Glycyrrhiza, Hydrocotyle, Hypothalamus, Petroselinum, Pituitarum posterium, Pyridoxinum hydrochloricum, Senna, Silicea	LIQUID	ORAL	20171103		UNAPPROVED HOMEOPATHIC		Energetix Corporation	BOS TAURUS HYPOTHALAMUS; CENTELLA ASIATICA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; LICORICE; PETROSELINUM CRISPUM WHOLE; PYRIDOXINE HYDROCHLORIDE; SENNA LEAF; SILICON DIOXIDE; SUS SCROFA PITUITARY GLAND, POSTERIOR	12; 4; 12; 6; 4; 4; 12; 8; 12; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Analogs/Derivatives [Chemical/Ingredient], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
64578-0172_38a4df13-57e3-4651-a133-fcc3895d857e	64578-0172	HUMAN OTC DRUG	Lymph-Tone III		Adenosinum cyclophosphoricum, Arnica, Boldo, Calc iod, Calendula, Cartilago suis, Ceanothus, Coenzyme A, Echinacea, Hamamelis, Hepar sulph calc, Hypothalamus, Nadidum, Naja, Nat sulphuricum, Phaseolus, Phos, Phytolacca, Pinus syl, Pituitarum posterium, Pyrogenium, Silicea, Sulphur, Thuja occ, Thyroidinum, Viscum	LIQUID	ORAL	20170901		UNAPPROVED HOMEOPATHIC		Energetix Corporation	ADENOSINE CYCLIC PHOSPHATE; ARNICA MONTANA WHOLE; BOS TAURUS HYPOTHALAMUS; CALCIUM IODIDE; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; CEANOTHUS AMERICANUS LEAF; COENZYME A; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HERRING SPERM DNA; KIDNEY BEAN; NADIDE; NAJA NAJA VENOM; PEUMUS BOLDUS LEAF; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; RANCID BEEF; SILICON DIOXIDE; SODIUM SULFATE; SULFUR; SUS SCROFA CARTILAGE; SUS SCROFA PITUITARY GLAND, POSTERIOR; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, UNSPECIFIED; VISCUM ALBUM FRUITING TOP	12; 12; 12; 12; 12; 30; 9; 12; 4; 12; 12; 4; 12; 15; 4; 15; 4; 9; 12; 12; 30; 15; 6; 12; 15; 9; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
64578-0173_75b6d721-57c3-45c4-aff8-dac529bc8428	64578-0173	HUMAN OTC DRUG	ReHydration		Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum	LIQUID	ORAL	20151015		UNAPPROVED HOMEOPATHIC		Energetix Corp	ADENOSINE CYCLIC PHOSPHATE; ARABICA COFFEE BEAN; BOS TAURUS HYPOTHALAMUS; DIBASIC POTASSIUM PHOSPHATE; SMILAX ORNATA ROOT; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED	12; 9; 12; 6; 4; 8; 9; 4; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64578-0174_d0c5d3c4-d1e6-437a-a001-48f8be1c8f04	64578-0174	HUMAN OTC DRUG	Neuro-Chord		Agaricus musc, Alumina, Arsenicum met, Cadmium met, Coenzyme A, Conium, Cuprum met, Gelsemium, Glandula suprarenalis suis, Latrodectus mac, Naja, Phos, Plumb met, Pyridoxinum hydrochloricum, Rhus tox, Riboflavinum, Sarsaparilla, Thiaminum hydrochloricum, Zinc met	LIQUID	ORAL	20210825		UNAPPROVED HOMEOPATHIC		Energetix Corp	ALUMINUM OXIDE; AMANITA MUSCARIA FRUITING BODY; ARSENIC; CADMIUM; COENZYME A; CONIUM MACULATUM FLOWERING TOP; COPPER; GELSEMIUM SEMPERVIRENS ROOT; LATRODECTUS MACTANS; LEAD; NAJA NAJA VENOM; PHOSPHORUS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SMILAX ORNATA ROOT; SUS SCROFA ADRENAL GLAND; THIAMINE HYDROCHLORIDE; TOXICODENDRON PUBESCENS LEAF; ZINC	15; 12; 15; 15; 12; 12; 15; 30; 30; 15; 30; 12; 12; 12; 6; 9; 12; 12; 15	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Analogs/Derivatives [Chemical/Ingredient], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
64578-0175_6e244b47-b9c6-427e-a38d-85b3e552874a	64578-0175	HUMAN OTC DRUG	ReHydration		Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum	LIQUID	ORAL	20230324		UNAPPROVED HOMEOPATHIC		Energetix	ADENOSINE CYCLIC PHOSPHATE; ARABICA COFFEE BEAN; BOS TAURUS HYPOTHALAMUS; DIBASIC POTASSIUM PHOSPHATE; SARSAPARILLA; SILICON DIOXIDE; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; TARAXACUM OFFICINALE ROOT; THYROID, UNSPECIFIED	12; 9; 12; 6; 4; 12; 8; 9; 4; 12	[hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL; [hp_X]/118.2mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64578-0176_a49a5d64-5930-44c9-81a1-8489b528ac4e	64578-0176	HUMAN OTC DRUG	Hepata-Chord		Homeopathic Liquid	LIQUID	ORAL	20230324		UNAPPROVED HOMEOPATHIC		Energetix Corp	ACETIC ACID; ALUMINUM OXIDE; ARCTIUM LAPPA ROOT; ASPIRIN; BENZENE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; CENTELLA ASIATICA; CHELIDONIUM MAJUS; CHELONE GLABRA; CHLORAMPHENICOL; CHLORPROMAZINE; CHOLESTEROL; CORTISONE ACETATE; ESTRONE; GAMBOGE; KEROSENE; MILK THISTLE; PHENACETIN; PHOSPHORUS; PORK LIVER; SILICON DIOXIDE; SODIUM SULFATE; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED	18; 18; 4; 18; 12; 4; 12; 5; 4; 12; 18; 18; 12; 18; 18; 12; 18; 4; 18; 12; 9; 12; 12; 4; 9	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Amphenicol-class Antibacterial [EPC], Amphenicols [EXT], Anti-Inflammatory Agents, Non-Steroidal [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Phenothiazine [EPC], Phenothiazines [CS], Platelet Aggregation Inhibitor [EPC]		N	20241231
64578-0177_1249df32-59fd-40dd-ad3a-e40c4b99d4d2	64578-0177	HUMAN OTC DRUG	ReHydration		Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum	LIQUID	ORAL	20230412		UNAPPROVED HOMEOPATHIC		Energetix Corp	ADENOSINE CYCLIC PHOSPHATE; ARABICA COFFEE BEAN; BOS TAURUS HYPOTHALAMUS; DIBASIC POTASSIUM PHOSPHATE; SILICON DIOXIDE; SMILAX ORNATA ROOT; SODIUM CHLORIDE; SUS SCROFA ADRENAL GLAND; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED	12; 9; 12; 6; 12; 4; 8; 9; 4; 12	[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64597-301_0f916cea-0d2b-4d75-8b68-25be67cbcd99	64597-301	HUMAN PRESCRIPTION DRUG	NUEDEXTA		dextromethorphan hydrobromide and quinidine sulfate	CAPSULE, GELATIN COATED	ORAL	20101201		NDA	NDA021879	Avanir Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE	20; 10	mg/1; mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
64616-038_0d9b6c09-d165-0f31-e063-6394a90a7431	64616-038	HUMAN OTC DRUG	Olive Leaf Throat	Flavored	Throat Spray	SPRAY	ORAL	20030227		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	BAPTISIA TINCTORIA	4	[hp_X]/mL			N	20241231
64616-039_0d9b6c09-d166-0f31-e063-6394a90a7431	64616-039	HUMAN OTC DRUG	Olive Leaf Nasal		Nasal Spray	SPRAY	NASAL	20030107		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	BAPTISIA TINCTORIA	4	[hp_X]/mL			N	20241231
64616-042_0d9b5d8d-8da8-fc84-e063-6294a90a2693	64616-042	HUMAN OTC DRUG	Olive-Viate		Topical Skin Relief	LIQUID	TOPICAL	20040302		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	CALCIUM SULFIDE; GRAPHITE; SULFUR; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-045_0d9b7b88-2800-003d-e063-6394a90a47c9	64616-045	HUMAN OTC DRUG	Earache Remedy		Ear Drops	LIQUID	AURICULAR (OTIC)	20040823		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACONITUM NAPELLUS; ATROPA BELLADONNA; MATRICARIA RECUTITA; PLANTAGO MAJOR; POTASSIUM CHLORIDE; VERBASCUM THAPSUS	6; 3; 6; 3; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
64616-048_0d9b5b87-bff5-0cd1-e063-6394a90a8b21	64616-048	HUMAN OTC DRUG	Stop Rash		Adult Skin Relief	LIQUID	TOPICAL	20060506		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	CALCIUM SULFIDE; LYTTA VESICATORIA; SULFUR; TOXICODENDRON PUBESCENS LEAF	12; 6; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-050_0d9b5d8d-8da9-fc84-e063-6294a90a2693	64616-050	HUMAN OTC DRUG	Pediatric Earache Remedy		Ear Drops	LIQUID	AURICULAR (OTIC)	20061023		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	ACONITUM NAPELLUS; ATROPA BELLADONNA; MATRICARIA RECUTITA; PLANTAGO MAJOR; POTASSIUM CHLORIDE; VERBASCUM THAPSUS	6; 3; 6; 3; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
64616-055_0d9b2e53-9c1e-fcd7-e063-6294a90a276a	64616-055	HUMAN OTC DRUG	Olive Vaginal Formula		Olive Leaf Vaginal Spray	SPRAY	VAGINAL	20100210		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	CHAMAELIRIUM LUTEUM ROOT; PLATINUM; SODIUM BORATE; WOOD CREOSOTE	8; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-069_0d9b2e53-9c20-fcd7-e063-6294a90a276a	64616-069	HUMAN OTC DRUG	Olive Leaf Acne Remedy		Topical Skin Relief	LIQUID	TOPICAL	20110420		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	ANTIMONY TRISULFIDE; CALCIUM SULFATE ANHYDROUS; JUGLANS REGIA FLOWERING TOP; SULFUR IODIDE	12; 12; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
64616-072_0d9b8bfc-62d9-3e8f-e063-6294a90a373b	64616-072	HUMAN OTC DRUG	Formula 3 Cough Syrup		Cough Syrup	LIQUID	ORAL	20100707		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	PELARGONIUM SIDOIDES ROOT; PRUNUS SEROTINA BARK; SAMBUCUS NIGRA FLOWER	1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-077_0dab8150-45ac-0b88-e063-6294a90a5976	64616-077	HUMAN OTC DRUG	Slenderiix		Weight Management Formula	LIQUID	ORAL	20120516		UNAPPROVED HOMEOPATHIC		Vitality Works	AMMONIUM BROMIDE; AVENA SATIVA FLOWERING TOP; FUCUS VESICULOSUS; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; THYROID, UNSPECIFIED	12; 6; 6; 12; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64616-079_0d9ba1fe-019d-4c6a-e063-6294a90a641a	64616-079	HUMAN OTC DRUG	ADR-Bal		Adrenal Support	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ALETRIS FARINOSA ROOT; FENNEL SEED; SALIX NIGRA BARK; WOOD TAR HYDROCARBON DISTILLATE; WYETHIA HELENIOIDES ROOT	7; 15; 15; 15; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-080_0d9b708d-7033-1072-e063-6394a90a7f2c	64616-080	HUMAN OTC DRUG	Al-Inflam		Joint Support	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ANAGALLIS ARVENSIS; CROTALUS HORRIDUS HORRIDUS VENOM; HAWTHORN LEAF WITH FLOWER; PASSIFLORA INCARNATA FLOWERING TOP; PLATINUM; SILVER NITRATE; URTICA URENS	10; 20; 20; 15; 12; 15; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-081_0d9b6838-98ad-0f20-e063-6394a90a8caf	64616-081	HUMAN OTC DRUG	Brain Supp		Brain Support	LIQUID	ORAL	20130404		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ARISAEMA TRIPHYLLUM ROOT; CHOLESTEROL; CINCHONA OFFICINALIS BARK; EGG PHOSPHOLIPIDS; GARLIC; GOLDENSEAL; IRON; LATHYRUS SATIVAS SEED; PHOSPHORUS; SANTONIN; SUS SCROFA PITUITARY GLAND; VALERIAN	6; 10; 30; 8; 6; 6; 10; 10; 12; 10; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64616-082_0d9b708d-7035-1072-e063-6394a90a7f2c	64616-082	HUMAN OTC DRUG	Category I		Immune System Booster	LIQUID	ORAL	20130320		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	ACTAEA SPICATA ROOT; ANAGALLIS ARVENSIS; ARGEMONE MEXICANA; CANDIDA ALBICANS; HELODERMA HORRIDUM VENOM; HYOSCYAMUS NIGER; POTASSIUM DICHROMATE; POTASSIUM IODIDE; POTASSIUM NITRATE; POTASSIUM PHOSPHATE, DIBASIC; SENNA LEAF; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 6; 15; 17; 14; 5; 10; 10; 10; 10; 7; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
64616-083_0d9ba38c-c286-0c9f-e063-6394a90a3a17	64616-083	HUMAN OTC DRUG	Category II		Immune System Booster	LIQUID	ORAL	20130320		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	ARALIA RACEMOSA ROOT; ARUNDO PLINIANA ROOT; CHASTE TREE; ERIODICTYON CALIFORNICUM LEAF; EUPHORBIA RESINIFERA RESIN; GAMBOGE; LEAD; LYCOSA TARANTULA; MERCURIC CHLORIDE; MERCURIC CYANIDE; MERCURIC IODIDE; MERCURY; PAEONIA OFFICINALIS ROOT; PINE TAR; SELENIUM; THYROID, UNSPECIFIED; TRILLIUM ERECTUM ROOT	6; 6; 3; 3; 14; 7; 10; 15; 10; 15; 10; 10; 15; 10; 15; 6; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
64616-084_0d9b6c09-d168-0f31-e063-6394a90a7431	64616-084	HUMAN OTC DRUG	Category III		Immune System Booster	LIQUID	ORAL	20130313		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIIODIDE; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; CHIONANTHUS VIRGINICUS BARK; CORALLIUM RUBRUM EXOSKELETON; EGG PHOSPHOLIPIDS; GOLD; MORELLA CERIFERA ROOT BARK; ORNITHOGALUM UMBELLATUM; PETROSELINUM CRISPUM; SANGUINARIA CANADENSIS ROOT	12; 10; 10; 9; 7; 15; 15; 10; 7; 10; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
64616-085_0d9ba1fe-019b-4c6a-e063-6294a90a641a	64616-085	HUMAN OTC DRUG	Category IV		Immune System Booster	LIQUID	ORAL	20130320		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACTAEA SPICATA ROOT; ALOE; COPPER; CUPRIC ARSENITE; FRAXINUS AMERICANA BARK; LYTTA VESICATORIA; SKIM MILK; SOLANUM DULCAMARA TOP; URTICA URENS; ZINC	6; 7; 10; 15; 8; 7; 20; 5; 5; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
64616-086_0d9b6838-98ac-0f20-e063-6394a90a8caf	64616-086	HUMAN OTC DRUG	Category V		Immune System Booster	LIQUID	ORAL	20130320		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc,	ANAGALLIS ARVENSIS; ANHYDROUS CITRIC ACID; AQUA REGIA; ARSENIC TRIIODIDE; CALCIUM LACTATE; CHAMAEMELUM NOBILE; COPPER; DELPHINIUM STAPHISAGRIA SEED; EPINEPHRINE; FRAXINUS AMERICANA BARK; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; LACTIC ACID; PETROSELINUM CRISPUM; PICRIC ACID; POTASSIUM CARBONATE; SALICYLIC ACID; SALIX NIGRA BARK; STRYCHNOS IGNATII SEED; URANYL NITRATE HEXAHYDRATE	3; 15; 15; 10; 50; 20; 25; 5; 15; 4; 14; 15; 20; 12; 8; 12; 20; 4; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Inhibit Ovum Fertilization [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
64616-087_0d9b8ed6-9761-1813-e063-6394a90ac926	64616-087	HUMAN OTC DRUG	CL-N		Emotional Health Booster	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACONITUM NAPELLUS; AMBERGRIS; AMMI VISNAGA FRUIT; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BLACK MUSTARD SEED; CAUSTICUM; CHELIDONIUM MAJUS; CLEMATIS RECTA FLOWERING TOP; EUPATORIUM PERFOLIATUM FLOWERING TOP; FENNEL SEED; FERRUM PHOSPHORICUM; FRAXINUS AMERICANA BARK; LILIUM LANCIFOLIUM WHOLE FLOWERING; MARSDENIA CONDURANGO BARK; MATRICARIA RECUTITA; MERCURIC CHLORIDE; ORNITHOGALUM UMBELLATUM; PASSIFLORA INCARNATA FLOWERING TOP; SCROPHULARIA NODOSA; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	6; 12; 10; 15; 6; 12; 12; 15; 10; 10; 7; 5; 3; 30; 12; 12; 10; 10; 5; 17; 7; 15; 7; 10; 15; 7; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
64616-088_0d9b8ed6-9764-1813-e063-6394a90ac926	64616-088	HUMAN OTC DRUG	ENC		Emotional Health Booster	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ANGUILLA ROSTRATA BLOOD SERUM; CHASTE TREE; HORSE CHESTNUT; IRIS VERSICOLOR ROOT; MANGANESE ACETATE TETRAHYDRATE; MERCURIC CYANIDE; ORNITHOGALUM UMBELLATUM; SELENIUM; THYROID, UNSPECIFIED; ZINC	8; 10; 10; 10; 14; 14; 20; 30; 6; 20	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
64616-089_0d9b8ed6-9765-1813-e063-6394a90ac926	64616-089	HUMAN OTC DRUG	Epl-Cell Repair		Cell Repair Aid	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ARTEMISIA VULGARIS ROOT; ASAFETIDA; BENZENE; CALCIUM CHLORIDE; CALCIUM PICRATE; CHAMAELIRIUM LUTEUM ROOT; FUCUS VESICULOSUS; FUMARIA OFFICINALIS FLOWERING TOP; JACOBAEA MARITIMA; NITROGLYCERIN; PROTORTONIA CACTI; SEMECARPUS ANACARDIUM JUICE; STRYCHNOS NUX-VOMICA SEED; TEUCRIUM MARUM; VIBURNUM OPULUS BARK	7; 7; 20; 10; 10; 7; 7; 8; 7; 15; 10; 7; 6; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
64616-090_0d9b8bfc-62d7-3e8f-e063-6294a90a373b	64616-090	HUMAN PRESCRIPTION DRUG	Fem Repair Non-Preg		Fem Glandular and Tissue Aid	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ANTIMONY ARSENATE; CENTELLA ASIATICA; CHIONANTHUS VIRGINICUS BARK; CHRYSOPOGON ZIZANIOIDES ROOT; CLAVICEPS PURPUREA SCLEROTIUM; DAPHNE MEZEREUM BARK; GENTIANA LUTEA ROOT; MERCURIUS SOLUBILIS; OXALIC ACID DIHYDRATE; POTASSIUM PHOSPHATE, DIBASIC; RUTA GRAVEOLENS FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA PITUITARY GLAND; VALERIANA OFFICINALIS WHOLE; ZINC OXIDE	14; 6; 6; 6; 7; 15; 6; 12; 10; 20; 6; 20; 6; 6; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
64616-091_0d9b6838-98ae-0f20-e063-6394a90a8caf	64616-091	HUMAN OTC DRUG	Fem Response		Female Reproductive Booster	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	APOCYNUM CANNABINUM ROOT; ARALIA RACEMOSA ROOT; BELLIS PERENNIS; CUPRIC ARSENITE; JUNIPERUS SABINA LEAFY TWIG; LACTIC ACID, DL-; PAPAYA SEED; WYETHIA HELENIOIDES ROOT	7; 30; 20; 10; 20; 10; 8; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
64616-092_0d9b8bfc-62d3-3e8f-e063-6294a90a373b	64616-092	HUMAN OTC DRUG	GDS-Calm		Digestive Balance	LIQUID	ORAL	20130417		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ASPIDOSPERMA QUEBRACHO-BLANCO BARK; CANDIDA ALBICANS; CHAMAEMELUM NOBILE; CHRYSOPOGON ZIZANIOIDES ROOT; HELIANTHEMUM CANADENSE; HORSE CHESTNUT; LILIUM LANCIFOLIUM WHOLE FLOWERING; ROBINIA PSEUDOACACIA BARK; SYZYGIUM JAMBOS SEED; VIROLA SEBIFERA RESIN	6; 14; 14; 7; 8; 7; 15; 7; 7; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
64616-093_0d9b708d-7034-1072-e063-6394a90a7f2c	64616-093	HUMAN OTC DRUG	HCB-Res		Heart,Circulatory System and Blood Booster	LIQUID	ORAL	20130404		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	GALIUM APARINE; HELODERMA HORRIDUM VENOM; KALMIA LATIFOLIA LEAF; KEROSENE; MARSDENIA CONDURANGO BARK; MILK THISTLE; SALIX NIGRA BARK; SEMECARPUS ANACARDIUM JUICE; VERATRUM VIRIDE ROOT; VERBENA OFFICINALIS	7; 15; 10; 15; 3; 7; 10; 5; 10; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-094_0d9ba38c-c284-0c9f-e063-6394a90a3a17	64616-094	HUMAN OTC DRUG	HCB-Tone		Heart Muscle Aid	LIQUID	ORAL	20130404		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	CAMPHOR (NATURAL); GALIUM APARINE; HELODERMA HORRIDUM VENOM; KEROSENE; MARSDENIA CONDURANGO BARK; PAPAYA SEED; SALIX NIGRA BARK; SEMECARPUS ANACARDIUM JUICE; VERATRUM VIRIDE ROOT; VERBENA OFFICINALIS	9; 10; 15; 15; 4; 8; 10; 6; 10; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-095_0d9b6838-98af-0f20-e063-6394a90a8caf	64616-095	HUMAN OTC DRUG	L-Trans		Lymph System Booster	LIQUID	ORAL	20130320		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ARNICA MONTANA; ARSENIC TRIIODIDE; BAPTISIA TINCTORIA; BENZENE; CAPSELLA BURSA-PASTORIS; COBALT; CRATAEGUS FRUIT; EUPATORIUM PERFOLIATUM FLOWERING TOP; FRAXINUS AMERICANA BARK; HYOSCYAMUS NIGER; LEDUM PALUSTRE TWIG; NICOTINE; SARSAPARILLA; SILVER; SYZYGIUM JAMBOS SEED; TEUCRIUM MARUM; TURPENTINE OIL; VERONICASTRUM VIRGINICUM ROOT; VIBURNUM OPULUS BARK	8; 14; 10; 12; 10; 14; 10; 10; 7; 7; 10; 12; 10; 14; 7; 6; 20; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Cholinergic Nicotinic Agonist [EPC], Increased Histamine Release [PE], Nicotine [CS], Standardized Chemical Allergen [EPC]		N	20241231
64616-096_0d9b8bfc-62d2-3e8f-e063-6294a90a373b	64616-096	HUMAN OTC DRUG	Lung-Resp		Cough Relief	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	ARSENIC TRIOXIDE; BROMINE; GERANIUM MACULATUM ROOT; IPECAC; LACTUCA VIROSA; LYCOPERDON UTRIFORME FRUITING BODY; MYRTUS COMMUNIS TOP; SALIX NIGRA BARK; WYETHIA HELENIOIDES ROOT	15; 10; 12; 15; 20; 10; 20; 10; 20	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-097_0d9b6c09-d169-0f31-e063-6394a90a7431	64616-097	HUMAN OTC DRUG	LV-FX		Liver Assit	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc	ANACARDIUM OCCIDENTALE FRUIT; ARALIA RACEMOSA ROOT; ARSENIC TRIIODIDE; ARSENIC TRIOXIDE; BELLIS PERENNIS; CALCIUM FLUORIDE; CHAMAELIRIUM LUTEUM ROOT; FERULA SUMBUL ROOT; HORSE CHESTNUT; LEDUM PALUSTRE TWIG; MANGANESE ACETATE TETRAHYDRATE; MILK THISTLE; MYRTUS COMMUNIS TOP; PHYSALIS ALKEKENGI FRUIT; RUTA GRAVEOLENS FLOWERING TOP; SELENIUM; SIMABA CEDRON SEED; THYROID, UNSPECIFIED; VERATRUM VIRIDE ROOT	14; 10; 15; 15; 7; 20; 10; 14; 10; 20; 20; 15; 6; 7; 10; 30; 9; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL			N	20241231
64616-098_0d9b6838-98ab-0f20-e063-6394a90a8caf	64616-098	HUMAN OTC DRUG	MALE-PROS		Prostrate Booster	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACTAEA SPICATA ROOT; ANTIMONY TRISULFIDE; ARNICA MONTANA; CHELIDONIUM MAJUS; CLEMATIS RECTA FLOWERING TOP; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; KEROSENE; LEDUM PALUSTRE TWIG; MERCURIC CYANIDE; MERCURIUS SOLUBILIS; OCIMUM AMERICANUM LEAF; PSEUDOGNAPHALIUM OBTUSIFOLIUM; SILVER NITRATE; VERATRUM ALBUM ROOT; ZINC OXIDE	10; 9; 7; 6; 15; 14; 20; 10; 7; 14; 12; 15; 70; 15; 6; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
64616-099_0d9ba1fe-019a-4c6a-e063-6294a90a641a	64616-099	HUMAN OTC DRUG	NRV-Systemic		Nervouse System Aid	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ATROPINE; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLLINSONIA CANADENSIS ROOT; EPINEPHRINE; KRAMERIA LAPPACEA ROOT; ORNITHOGALUM UMBELLATUM; PILOCARPUS JABORANDI LEAF; POTASSIUM ARSENITE ANHYDROUS; SEMPERVIVUM TECTORUM LEAF; SILVER; SILVER IODIDE; SILVER NITRATE; THUJA OCCIDENTALIS LEAFY TWIG; ZINC	14; 6; 8; 7; 20; 10; 10; 7; 18; 10; 10; 14; 10; 3; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Anticholinergic [EPC], Catecholamine [EPC], Catecholamines [CS], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
64616-100_0d9b8ed6-9760-1813-e063-6394a90ac926	64616-100	HUMAN OTC DRUG	OP-P		Emotional Health Booster	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACONITUM LYCOCTONUM; ALOE; ALUMINUM OXIDE; ARSENIC TRIIODIDE; ARSENIC TRIOXIDE; BLACK COHOSH; BRYONIA ALBA ROOT; CALCIUM OXALATE MONOHYDRATE; DROSERA ROTUNDIFOLIA; ECHINACEA PURPUREA; GAMBOGE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; LOBELIA INFLATA; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PARAFFIN; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; PULSATILLA PRATENSIS; SCUTELLARIA LATERIFLORA; SEMECARPUS ANACARDIUM JUICE; SENNA LEAF; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; USTILAGO MAYDIS	5; 10; 10; 8; 15; 6; 12; 15; 12; 6; 12; 10; 5; 15; 6; 10; 15; 30; 12; 27; 5; 14; 10; 6; 2; 7; 10; 10; 30; 30; 10; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64616-101_0d9b8bfc-62d0-3e8f-e063-6294a90a373b	64616-101	HUMAN OTC DRUG	Pan-Zyme-S		Pancreas Balance	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ARNICA MONTANA ROOT; CRATAEGUS FRUIT; ETHER; LILIUM LANCIFOLIUM WHOLE FLOWERING; MANGANESE ACETATE TETRAHYDRATE; PARAFFIN; PLANTAGO MAJOR; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE; THYROID, UNSPECIFIED; VALERIAN; WOOD CREOSOTE	5; 10; 10; 10; 15; 14; 10; 10; 45; 6; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
64616-102_0d9b8bfc-62d1-3e8f-e063-6294a90a373b	64616-102	HUMAN OTC DRUG	Para-BN		Parathyroid Booster	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ALFALFA; ARSENIC TRIOXIDE; CALCIUM FLUORIDE; CALCIUM HYDROXIDE; CALCIUM IODIDE; CALCIUM OXALATE MONOHYDRATE; CROTON TIGLIUM SEED; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PODOPHYLLUM; POTASSIUM CARBONATE; SODIUM TETRACHLOROAURATE; TEUCRIUM MARUM; URANYL NITRATE HEXAHYDRATE	7; 30; 12; 20; 12; 20; 6; 10; 7; 10; 20; 10; 17	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64616-104_0d9ba38c-c287-0c9f-e063-6394a90a3a17	64616-104	HUMAN OTC DRUG	RPT-Sys		Emotional Rebalance	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	APOCYNUM CANNABINUM ROOT; ASAFETIDA; EGG PHOSPHOLIPIDS; EUCALYPTUS GLOBULUS LEAF; GENTIANA LUTEA ROOT; LATHYRUS SATIVAS SEED; LYCOPODIUM CLAVATUM SPORE; NUTMEG; OXALIC ACID DIHYDRATE; PHOSPHORIC ACID; PLATINUM; SILICON DIOXIDE; SODIUM BORATE; STRYCHNOS IGNATII SEED; SUS SCROFA PITUITARY GLAND; THYROID, UNSPECIFIED; TOXICODENDRON PUBESCENS LEAF; TRILLIUM ERECTUM ROOT; WOOD CREOSOTE	10; 6; 20; 7; 7; 20; 7; 7; 10; 8; 10; 10; 7; 10; 6; 6; 10; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64616-105_0d9b5d8d-8dad-fc84-e063-6294a90a2693	64616-105	HUMAN OTC DRUG	Sweep		Detoxifying	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACTIVATED CHARCOAL; AMMI VISNAGA FRUIT; CARBO ANIMALIS; CITRULLUS COLOCYNTHIS FRUIT PULP; DAPHNE MEZEREUM BARK; NITRIC ACID; PALLADIUM; PLATINUM; POTASSIUM ARSENITE ANHYDROUS; QUININE ARSENATE; SARSAPARILLA; SELENIUM	10; 10; 20; 7; 10; 20; 14; 15; 20; 14; 15; 20	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-106_0d9b5b87-bff7-0cd1-e063-6394a90a8b21	64616-106	HUMAN OTC DRUG	THY-Plex		Thyroid Support	LIQUID	ORAL	20130408		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	AQUA REGIA; BARIUM IODIDE; CALCIUM ACETATE; CALENDULA OFFICINALIS FLOWERING TOP; CHRYSOPOGON ZIZANIOIDES ROOT; GALLIC ACID MONOHYDRATE; GAMBOGE; HYOSCYAMUS NIGER; PHYSOSTIGMA VENENOSUM SEED; POTASSIUM IODIDE; SCHOENOCAULON OFFICINALE SEED; THYROID, UNSPECIFIED; URTICA URENS; ZINC OXIDE	15; 18; 10; 3; 10; 12; 5; 12; 10; 12; 10; 6; 5; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
64616-107_0d9b2e53-9c1f-fcd7-e063-6294a90a276a	64616-107	HUMAN OTC DRUG	TLB-Matrix		Joint Booster	LIQUID	ORAL	20130320		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ATROPA BELLADONNA; FERRIC PICRATE; GOLD; LAMIUM ALBUM; PICEA MARIANA RESIN; PULSATILLA VULGARIS; PUNICA GRANATUM ROOT BARK; THYROID, UNSPECIFIED; URTICA URENS; VIBURNUM OPULUS BARK; ZINC OXIDE	15; 15; 15; 7; 15; 15; 10; 6; 7; 14; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC]		N	20241231
64616-108_0d9b8bfc-62d8-3e8f-e063-6294a90a373b	64616-108	HUMAN OTC DRUG	Vital-FL		Body Fluid Balance	LIQUID	ORAL	20130404		UNAPPROVED HOMEOPATHIC		Vitaltiy Works, Inc.	ARISAEMA TRIPHYLLUM ROOT; CALCIUM FLUORIDE; CANIS LUPUS FAMILIARIS MILK; CAPSELLA BURSA-PASTORIS; FERRIC PICRATE; GENTIANA LUTEA ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYOSCYAMUS NIGER; LACTUCA VIROSA; SODIUM CHLORIDE; SULFUR IODIDE; TEUCRIUM MARUM; VALERIAN; WOOD CREOSOTE	7; 10; 20; 7; 15; 7; 60; 5; 5; 15; 15; 7; 7; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
64616-109_0d9b5b87-bff8-0cd1-e063-6394a90a8b21	64616-109	HUMAN OTC DRUG	Cal-5-Revive		Calcium Balance	LIQUID	ORAL	20130320		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ACONITUM NAPELLUS; BISMUTH SUBNITRATE; CALCIUM ARSENATE; CALCIUM FLUORIDE; CALCIUM HYDROXIDE; CALCIUM IODIDE; CALCIUM OXALATE MONOHYDRATE; ELAEIS GUINEENSIS FRUIT; HELIANTHUS ANNUUS FLOWERING TOP; HYDRANGEA ARBORESCENS ROOT; IPECAC; IRIS GERMANICA VAR. FLORENTINA ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE ACETATE TETRAHYDRATE; MERCURIUS SOLUBILIS; OSMIUM; PHOSPHORIC ACID; POTASSIUM ARSENITE ANHYDROUS; POTASSIUM CHLORATE; SANGUINARINE NITRATE; TELLURIUM; ZINC GLUCONATE	20; 15; 12; 25; 27; 10; 30; 20; 22; 14; 24; 23; 22; 22; 30; 22; 36; 20; 30; 17; 27; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bismuth [CS], Bismuth [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64616-111_0d9b8ed6-9766-1813-e063-6394a90ac926	64616-111	HUMAN OTC DRUG	Sore Muscle and Joint Relief		Muscle and Joint Remedy	LIQUID	ORAL	20130404		UNAPPROVED HOMEOPATHIC		Vitaltiy Works, Inc.	ARNICA MONTANA; BRYONIA ALBA ROOT; LACTIC ACID, L-; MATRICARIA RECUTITA; POTASSIUM IODIDE; PULSATILLA VULGARIS; TOXICODENDRON PUBESCENS LEAF; ZINC OXIDE	30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
64616-113_0d9bdcde-c239-2fac-e063-6394a90a6ef3	64616-113	HUMAN OTC DRUG	CalmEase Rescue Remedy		CalmEase Rescue Remedy	LIQUID	ORAL	20100122		UNAPPROVED HOMEOPATHIC		vitality Works	CLEMATIS VITALBA WHOLE; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM; PRUNUS CERASIFERA FLOWER	7; 7; 7; 7; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
64616-115_0d9b7b88-2801-003d-e063-6394a90a47c9	64616-115	HUMAN OTC DRUG	Comfort for Teething		Comfort for Teething	LIQUID	ORAL	20130705		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	ARNICA MONTANA; CHAMOMILE; MAGNESIUM PHOSPHATE, MONOBASIC, UNSPECIFIED; RHEUM OFFICINALE ROOT; TRIBASIC CALCIUM PHOSPHATE; WOOD CREOSOTE	6; 3; 6; 6; 6; 6	[hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
64616-116_0d9be4da-5e7f-3043-e063-6394a90a5fd2	64616-116	HUMAN OTC DRUG	Comfort for Colic		Comfort for Kids	LIQUID	ORAL	20130705		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	AETHUSA CYNAPIUM; CHAMOMILE; CITRULLUS COLOCYNTHIS FRUIT; DIOSCOREA VILLOSA TUBER; MAGNESIUM PHOSPHATE, DIBASIC; PULSATILLA PRATENSIS	4; 4; 4; 6; 6; 4	[hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL; [hp_X]/.05mL			N	20241231
64616-117_0d9ba1fe-019f-4c6a-e063-6294a90a641a	64616-117	HUMAN OTC DRUG	RadDefense 2		RadDefense2	LIQUID	ORAL	20160224		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	CALIFORNIUM CF-249; EUPATORIUM PERFOLIATUM FLOWERING TOP; RHEUM PALMATUM ROOT	30; 30; 30	[hp_C]/.03mL; [hp_C]/.03mL; [hp_C]/.03mL			N	20241231
64616-118_0d9ba1fe-019e-4c6a-e063-6294a90a641a	64616-118	HUMAN OTC DRUG	RadDefense1		RadDefense1	LIQUID	ORAL	20160302		UNAPPROVED HOMEOPATHIC		Vitality Works, Inc.	STRYCHNOS NUX-VOMICA SEED; URANYL NITRATE HEXAHYDRATE; VISCUM ALBUM WHOLE	30; 30; 30	[hp_C]/29.6mL; [hp_C]/29.6mL; [hp_C]/29.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
64616-119_0d9bdcde-c23a-2fac-e063-6394a90a6ef3	64616-119	HUMAN OTC DRUG	Gripe Water		Gripe Water	LIQUID	ORAL	20170131		UNAPPROVED HOMEOPATHIC		Vitality Works	FOENICULUM VULGARE VAR. VULGARE WHOLE; MATRICARIA CHAMOMILLA WHOLE; MENTHA PIPERITA; ZINGIBER OFFICINALE WHOLE	1; 1; 1; 1	[hp_X]/.0025mL; [hp_X]/.0025mL; [hp_X]/.0025mL; [hp_X]/.0025mL			N	20241231
64646-043_fa542159-1278-3385-e053-6294a90a13be	64646-043	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333A	Charlotte Products Ltd.	ALCOHOL	71	mL/100mL			N	20241231
64646-420_0336e3f0-0a2e-90ef-e063-6294a90a2a98	64646-420	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333A	Charlotte Products Ltd.	ALCOHOL	75	mL/100mL			N	20241231
64650-345_8f3f423b-34f5-47a2-affd-53c2c1aac4ad	64650-345	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19710101		NDA	NDA205767	Airweld, Inc.	OXYGEN	99	L/100L			N	20241231
64661-650_a5369c78-1e2f-4a51-b3df-6ed5b5478986	64661-650	HUMAN PRESCRIPTION DRUG	EnBrace HR		LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, and PHOSPHATIDYL SERINE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20110812		UNAPPROVED DRUG OTHER		Jaymac Pharma	1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; BETAINE; COBAMAMIDE; COCARBOXYLASE; FERROUS CYSTEINE GLYCINATE; FLAVIN ADENINE DINUCLEOTIDE; FOLIC ACID; LEUCOVORIN; LEVOMEFOLATE MAGNESIUM; MAGNESIUM ASCORBATE; MAGNESIUM L-THREONATE; NADH; PHOSPHATIDYL SERINE; PYRIDOXAL PHOSPHATE ANHYDROUS; ZINC ASCORBATE	6.4; 800; 500; 50; 25; 13.6; 25; 1; 2.5; 5.23; 24; 1; 25; 12; 25; 1	mg/1; ug/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Ascorbic Acid [CS], Ascorbic Acid [CS], Folate Analog [EPC], Folate Analog [EPC], Folic Acid [CS], Folic Acid [CS], Methylating Activity [MoA], Methylating Agent [EPC], Vitamin C [EPC], Vitamin C [EPC]		N	20241231
64673-001_e6d75eef-b41d-0896-e053-2995a90a97a3	64673-001	HUMAN PRESCRIPTION DRUG	Oxygen, Compressed Gas		OXYGEN	GAS	RESPIRATORY (INHALATION)	20220801		UNAPPROVED MEDICAL GAS		MedCyl Services, Ltd.	OXYGEN	1	L/L			N	20241231
64673-002_e6d7677f-3589-fc7f-e053-2a95a90aaff7	64673-002	HUMAN PRESCRIPTION DRUG	Oxygen Compressed Gas		OXYGEN	GAS	RESPIRATORY (INHALATION)	20220801		UNAPPROVED MEDICAL GAS		MedCyl Services, Ltd.	OXYGEN	1	L/L			N	20241231
64673-003_e6d77e8e-9051-fa2a-e053-2995a90af579	64673-003	HUMAN PRESCRIPTION DRUG	Oxygen Compressed Gas		OXYGEN	GAS	RESPIRATORY (INHALATION)	20220801		UNAPPROVED MEDICAL GAS		MedCyl Services, Ltd.	OXYGEN	1	L/L			N	20241231
64673-004_e6d79132-3903-52da-e053-2a95a90a2fa7	64673-004	HUMAN PRESCRIPTION DRUG	Oxygen Compressed Gas		OXYGEN	GAS	RESPIRATORY (INHALATION)	20220801		UNAPPROVED MEDICAL GAS		MedCyl Services, Ltd.	OXYGEN	1	L/L			N	20241231
64673-005_e6d79132-3905-52da-e053-2a95a90a2fa7	64673-005	HUMAN PRESCRIPTION DRUG	Oxygen Compressed Gas		OXYGEN	GAS	RESPIRATORY (INHALATION)	20220801		UNAPPROVED MEDICAL GAS		MedCyl Services, Ltd.	OXYGEN	1	L/L			N	20241231
64673-006_e6d75eef-b41e-0896-e053-2995a90a97a3	64673-006	HUMAN PRESCRIPTION DRUG	Oxygen Compressed Gas		OXYGEN	GAS	RESPIRATORY (INHALATION)	20220801		UNAPPROVED MEDICAL GAS		MedCyl Services, Ltd.	OXYGEN	1	L/L			N	20241231
64673-007_e6d7b468-49fb-9e80-e053-2995a90a8284	64673-007	HUMAN PRESCRIPTION DRUG	Oxygen Compressed Gas		OXYGEN	GAS	RESPIRATORY (INHALATION)	20220801		UNAPPROVED MEDICAL GAS		MedCyl Services, Ltd.	OXYGEN	1	L/L			N	20241231
64678-010_435a3bf1-7e9a-434c-916a-cf43c1e5c23b	64678-010	HUMAN PRESCRIPTION DRUG	Tembexa		Brincidofovir	TABLET, FILM COATED	ORAL	20220420		NDA	NDA214461	Emergent BioDefense Operations Lansing LLC	BRINCIDOFOVIR	100	mg/1			N	20241231
64678-012_b6b279f9-20d2-4a54-a57f-ecbfd9c2a1c3	64678-012	HUMAN PRESCRIPTION DRUG	Tembexa		Brincidofovir	SUSPENSION	ORAL	20220420		NDA	NDA214460	Emergent BioDefense Operations Lansing LLC	BRINCIDOFOVIR	10	mg/mL			N	20241231
64678-211_12832647-b320-4bb4-8697-6679c2613030	64678-211	VACCINE	BioThrax		BACILLUS ANTHRACIS	INJECTION, SUSPENSION	INTRAMUSCULAR; SUBCUTANEOUS	19701104		BLA	BLA103821	Emergent BioDefense Operations Lansing, LLC	BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS	100	ug/mL	Actively Acquired Immunity [PE], Anthrax Vaccines [Chemical/Ingredient], Live Attenuated Bacillus Anthracis Vaccine [EPC], Vaccines, Attenuated [Chemical/Ingredient]		N	20241231
64679-012_d3d0790b-5af3-10da-e053-2995a90ae1c4	64679-012	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		piperacillin sodium and tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170322		ANDA	ANDA206996	Wockhardt USA LLC.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
64679-021_0b49129a-568d-fb05-e063-6394a90a4f5e	64679-021	HUMAN PRESCRIPTION DRUG	Abiraterone acetate		Abiraterone acetate	TABLET	ORAL	20190227		ANDA	ANDA208380	Wockhardt USA LLC.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
64679-034_d3d0790b-5af3-10da-e053-2995a90ae1c4	64679-034	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		piperacillin sodium and tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170322		ANDA	ANDA206996	Wockhardt USA LLC.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
64679-056_d3d0790b-5af3-10da-e053-2995a90ae1c4	64679-056	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		piperacillin sodium and tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170322		ANDA	ANDA206996	Wockhardt USA LLC.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
64679-067_0203d7b9-3d86-4a8c-b7e2-11d31d803c71	64679-067	HUMAN PRESCRIPTION DRUG	Decitabine		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201214		ANDA	ANDA209056	Wockhardt USA LLC.	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
64679-096_ff17cbb9-0fae-40ed-9f4f-04ef8b3e9f31	64679-096	HUMAN PRESCRIPTION DRUG	AZACITIDINE		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20160929		ANDA	ANDA207518	Wockhardt USA LLC.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
64679-102_f0f5ceaa-d325-5948-e053-2a95a90a94e2	64679-102	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20121121		ANDA	ANDA202189	Wockhardt USA LLC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64679-103_f0f5ceaa-d325-5948-e053-2a95a90a94e2	64679-103	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220128		ANDA	ANDA202189	Wockhardt USA LLC.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64679-465_f802be0c-ca6b-a01f-e053-6294a90a4a67	64679-465	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		lidocaine hydrochloride	SOLUTION	TOPICAL	19821118		ANDA	ANDA087881	Wockhardt USA LLC.	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
64679-516_f5b0ae80-f386-4dbf-a01f-8f5b98e5a248	64679-516	HUMAN PRESCRIPTION DRUG	TAMSULOSIN HYDROCHLORIDE		TAMSULOSIN HYDROCHLORIDE	CAPSULE	ORAL	20100427		ANDA	ANDA078938	Wockhardt USA LLC.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
64679-600_fb2a0694-d7f9-1469-e053-6294a90a36f4	64679-600	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20230418		ANDA	ANDA205746	Wockhardt USA LLC.	ACETAMINOPHEN	10	mg/mL			N	20241231
64679-604_f761c04e-acaf-8742-e053-6294a90a0148	64679-604	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide		promethazine hydrochloride and dextromethorphan hydrobromide	SYRUP	ORAL	19850104		ANDA	ANDA088864	Wockhardt USA LLC.	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
64679-608_f7764a28-fb92-f1b7-e053-6294a90a312f	64679-608	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	SYRUP	ORAL	19821115		ANDA	ANDA087953	Wockhardt USA LLC.	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64679-631_f69df5dd-4984-6d75-e053-6294a90ad4ff	64679-631	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	INJECTION	INTRAVENOUS	20091117		ANDA	ANDA090671	Wockhardt USA LLC.	NICARDIPINE HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
64679-679_d18749f8-9e4d-84e1-e053-2a95a90a416a	64679-679	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		piperacillin sodium and tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170320		ANDA	ANDA207146	Wockhardt USA LLC.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
64679-698_0acabc7b-fd52-fd74-e063-6294a90aa8cc	64679-698	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170731		ANDA	ANDA207147	Wockhardt USA LLC.	OXACILLIN SODIUM	1	g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
64679-699_0acabc7b-fd52-fd74-e063-6294a90aa8cc	64679-699	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170731		ANDA	ANDA207147	Wockhardt USA LLC.	OXACILLIN SODIUM	2	g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
64679-700_0aa37a7b-8534-d9d5-e063-6294a90a23be	64679-700	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20171124		ANDA	ANDA207148	Wockhardt USA LLC.	OXACILLIN SODIUM	10	g/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
64679-728_0d67500d-2810-f567-e063-6294a90a3031	64679-728	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20090206		ANDA	ANDA078593	Wockhardt USA LLC.	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
64679-729_f0f36bc4-c2d6-f525-e053-2995a90adfac	64679-729	HUMAN PRESCRIPTION DRUG	FOSPHENYTOIN SODIUM		fosphenytoin sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20070806		ANDA	ANDA078137	Wockhardt USA LLC.	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
64679-730_f0f36bc4-c2d6-f525-e053-2995a90adfac	64679-730	HUMAN PRESCRIPTION DRUG	FOSPHENYTOIN SODIUM		fosphenytoin sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20070806		ANDA	ANDA078137	Wockhardt USA LLC.	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
64679-759_f0f59714-f0b6-766f-e053-2995a90a26ae	64679-759	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20070322		ANDA	ANDA077941	Wockhardt USA LLC.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
64679-781_b6bfa61c-117f-497c-acc4-98b926fbdac1	64679-781	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET, FILM COATED	ORAL	20120930		NDA	NDA020796	Wockhardt USA LLC.	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
64679-782_337712b0-f220-4f72-ba81-7ffdcb9643b4	64679-782	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		carbidopa, levodopa and entacapone	TABLET, FILM COATED	ORAL	20120229		NDA AUTHORIZED GENERIC	NDA021485	Wockhardt USA LLC.	CARBIDOPA; ENTACAPONE; LEVODOPA	12.5; 200; 50	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
64679-783_337712b0-f220-4f72-ba81-7ffdcb9643b4	64679-783	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		carbidopa, levodopa and entacapone	TABLET, FILM COATED	ORAL	20120229		NDA AUTHORIZED GENERIC	NDA021485	Wockhardt USA LLC.	CARBIDOPA; ENTACAPONE; LEVODOPA	18.75; 200; 75	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
64679-784_337712b0-f220-4f72-ba81-7ffdcb9643b4	64679-784	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		carbidopa, levodopa and entacapone	TABLET, FILM COATED	ORAL	20120229		NDA AUTHORIZED GENERIC	NDA021485	Wockhardt USA LLC.	CARBIDOPA; ENTACAPONE; LEVODOPA	25; 200; 100	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
64679-785_337712b0-f220-4f72-ba81-7ffdcb9643b4	64679-785	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		carbidopa, levodopa and entacapone	TABLET, FILM COATED	ORAL	20120229		NDA AUTHORIZED GENERIC	NDA021485	Wockhardt USA LLC.	CARBIDOPA; ENTACAPONE; LEVODOPA	31.25; 200; 125	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
64679-786_337712b0-f220-4f72-ba81-7ffdcb9643b4	64679-786	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		carbidopa, levodopa and entacapone	TABLET, FILM COATED	ORAL	20120229		NDA AUTHORIZED GENERIC	NDA021485	Wockhardt USA LLC.	CARBIDOPA; ENTACAPONE; LEVODOPA	37.5; 200; 150	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
64679-787_337712b0-f220-4f72-ba81-7ffdcb9643b4	64679-787	HUMAN PRESCRIPTION DRUG	CARBIDOPA, LEVODOPA AND ENTACAPONE		carbidopa, levodopa and entacapone	TABLET, FILM COATED	ORAL	20120229		NDA AUTHORIZED GENERIC	NDA021485	Wockhardt USA LLC.	CARBIDOPA; ENTACAPONE; LEVODOPA	50; 200; 200	mg/1; mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
64679-830_a73acc01-a46f-4bd9-93bc-a0651059014e	64679-830	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180809		NDA AUTHORIZED GENERIC	NDA022497	Wockhardt USA LLC.	BUPROPION HYDROCHLORIDE	450	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64693-002_4c30b3e4-dd3d-4784-8469-77bd134d41fb	64693-002	HUMAN PRESCRIPTION DRUG	INOMAX		nitric oxide	GAS	RESPIRATORY (INHALATION)	19991223		NDA	NDA020845	INO THERAPEUTICS LLC	NITRIC OXIDE	.98	mg/L	Vasodilation [PE], Vasodilator [EPC]		N	20241231
64693-003_4c30b3e4-dd3d-4784-8469-77bd134d41fb	64693-003	HUMAN PRESCRIPTION DRUG	INOMAX		nitric oxide	GAS	RESPIRATORY (INHALATION)	19991223		NDA	NDA020845	INO THERAPEUTICS LLC	NITRIC OXIDE	6	mg/L	Vasodilation [PE], Vasodilator [EPC]		N	20241231
64709-100_643dfe7e-dea5-46b1-b0c5-4c7ab089d30a	64709-100	HUMAN OTC DRUG	Benzalkonium Chloride		Antibacterial Wet Wipes	SWAB	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part333A	Diamond Wipes International	BENZALKONIUM CHLORIDE	.13	mg/mL			N	20241231
64709-105_0b64fb56-6068-860a-e063-6294a90a879b	64709-105	HUMAN OTC DRUG	ANTISEPTIC WIPE		BENZALKONIUM CHLORIDE WIPE	CLOTH	TOPICAL	20201105		OTC MONOGRAPH DRUG	505G(a)(3)	Diamond Wipes International	BENZALKONIUM CHLORIDE	13	g/100g			N	20241231
64709-107_0b768565-56af-d4d3-e063-6394a90a1d60	64709-107	HUMAN OTC DRUG	Travel lite Hand Sanitizing Wipes		Non-drying alcohol-free	CLOTH	TOPICAL	20201110		OTC MONOGRAPH DRUG	505G(a)(3)	Diamond Wipes International, Inc	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
64709-108_0a49c713-56db-af45-e063-6394a90a8fce	64709-108	HUMAN OTC DRUG	ANTISEPTIC WIPE		BENZALKONIUM CHLORIDE WIPE	CLOTH	TOPICAL	20231123		OTC MONOGRAPH DRUG	505G(a)(3)	Diamond Wipes International	BENZALKONIUM CHLORIDE	13	g/100g			N	20241231
64709-157_0b743ae2-a20f-01fd-e063-6394a90a6618	64709-157	HUMAN OTC DRUG	Travel lite Hand Sanitizing Wipes		Alcohol hand sanitizing wipes	CLOTH	TOPICAL	20180801		OTC MONOGRAPH DRUG	505G(a)(3)	Diamond Wipes International, Inc	ALCOHOL	65	mL/100mL			N	20241231
64709-158_0bef2d6f-3368-e653-e063-6394a90a5aef	64709-158	HUMAN OTC DRUG	Anti-Itch Wipes		Anti-Itch Wipe	CLOTH	TOPICAL	20220706		OTC MONOGRAPH DRUG	M017	Diamond Wipes International	PRAMOXINE HYDROCHLORIDE	1	g/100g			N	20241231
64709-160_0b78b820-a502-c222-e063-6294a90a2259	64709-160	HUMAN OTC DRUG	LA FRESH Antiperspirant Wipe		Aluminum Chlorohydrate 15%	CLOTH	TOPICAL	20190101		OTC MONOGRAPH DRUG	M019	Diamond Wipes International, Inc	ALUMINUM CHLOROHYDRATE	.15	g/g			N	20241231
64709-177_0bb5120b-7f2e-8dee-e063-6394a90a6394	64709-177	HUMAN OTC DRUG	Travel Lite Hand Sanitizing Gel		Travel Lite Hand Sanitizing Gel	GEL	TOPICAL	20201019		OTC MONOGRAPH DRUG	505G(a)(3)	Diamond Wipes International, Inc	ALCOHOL	70	mL/100mL			N	20241231
64709-185_0b628d7f-c779-74fb-e063-6294a90ac4ed	64709-185	HUMAN OTC DRUG	INSTANT HAND SANITIZER WIPES		Alcohol Hand Sanitizer Wipes	CLOTH	TOPICAL	20170101		OTC MONOGRAPH DRUG	505G(a)(3)	Diamond Wipes International, Inc.	ALCOHOL	70	mL/100mL			N	20241231
64709-256_0bb52e03-d655-ab38-e063-6394a90a72ba	64709-256	HUMAN OTC DRUG	Hero Wipes EMS		Alcohol Hand Sanitizer Wipes	CLOTH	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Diamond Wipes International, Inc	ALCOHOL	65	mL/100mL			N	20241231
64724-1016_ee8afa19-f806-5bc9-e053-2a95a90a196d	64724-1016	HUMAN OTC DRUG	NATURALTECH PURIFYING ANTI-DANDRUFF		SELENIUM SULFIDE	SHAMPOO	TOPICAL	20120229		OTC MONOGRAPH FINAL	M032	Davines S.p.A.	SELENIUM SULFIDE	.6	g/100mL			N	20241231
64724-1017_ee8b1e5d-07f2-f1c4-e053-2a95a90afd06	64724-1017	HUMAN OTC DRUG	NATURALTECH PURIFYING ANTI-DANDRUFF		PYRITHIONE ZINC	GEL	TOPICAL	20120229		OTC MONOGRAPH FINAL	M032	Davines S.p.A.	PYRITHIONE ZINC	.48	g/100mL			N	20241231
64760-705_f80d325d-d00d-bd3a-e053-6294a90a690d	64760-705	HUMAN OTC DRUG	Glytone Acne Clearing Cleanser		salicylic acid	LIQUID	TOPICAL	20171003		OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA	SALICYLIC ACID	2	g/100mL			N	20241231
64760-706_f80d325d-d020-bd3a-e053-6294a90a690d	64760-706	HUMAN OTC DRUG	Glytone Acne Clearing Toner		salicylic acid	SOLUTION	TOPICAL	20161021		OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
64760-708_f80d3a9b-da4d-e7c9-e053-6294a90a01db	64760-708	HUMAN OTC DRUG	Glytone Acne Spot Treatment		sulfur, resorcinol	LOTION	TOPICAL	20171011		OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA	RESORCINOL; SULFUR	20; 80	mg/mL; mg/mL			N	20241231
64760-709_f80d3a9b-da4f-e7c9-e053-6294a90a01db	64760-709	HUMAN OTC DRUG	Glytone Acne Treatment		salicylic acid	LOTION	TOPICAL	20171020		OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA Inc.	SALICYLIC ACID	1	g/100g			N	20241231
64760-710_f9c93aac-cc29-6ced-e053-6294a90a9449	64760-710	HUMAN OTC DRUG	Glytone Acne Treatment Mask		sulfur	CREAM	TOPICAL	20180314	20240605	OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA Inc.	SULFUR	64	mg/g			N	
64760-713_f80d57b1-a23f-262b-e053-6294a90a4414	64760-713	HUMAN OTC DRUG	Glytone Daily Body		avobenzone, octinoxate, octocrylene, oxybenzone	LOTION	TOPICAL	20171003		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	2; 7.5; 1.86; 3	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64760-714_f9c93aac-cc29-6ced-e053-6294a90a9449	64760-714	HUMAN OTC DRUG	Glytone Acne Clarifying Treatment Mask		SULFUR	CREAM	TOPICAL	20230623		OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA Inc.	SULFUR	64	mg/g			N	20241231
64760-716_f80d66bb-6d0e-8e0f-e053-6394a90a7ada	64760-716	HUMAN OTC DRUG	Glytone Sunscreen SPF 40		Octinoxate, Octisalate, Zinc oxide	LOTION	TOPICAL	20180306		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 20; 76.5	mg/mL; mg/mL; mg/mL			N	20241231
64760-719_f80d3a9b-da4c-e7c9-e053-6294a90a01db	64760-719	HUMAN OTC DRUG	Glytone Acne Self-Foaming Cleanser		salicylic acid	GEL	TOPICAL	20201109		OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
64760-720_f8ae5f26-cc28-8c20-e053-6294a90a7fe0	64760-720	HUMAN OTC DRUG	Glytone Hydra Lipid UV Mineral Sunscreen	SPF 40 PLUS	zinc oxide, titanium dioxide	LOTION	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2; 1	mg/50mL; mg/50mL			N	20241231
64760-724_f8ae62be-3a64-be6b-e053-6394a90ab627	64760-724	HUMAN OTC DRUG	Avene Solaire UV Mineral Sunscreen	SPF 50 PLUS	Zinc Oxide	LOTION	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	ZINC OXIDE	120	mg/mL			N	20241231
64760-725_f80d1fd4-6041-93b1-e053-6294a90a786a	64760-725	HUMAN OTC DRUG	Avene Solaire UV Tinted Mineral Sunscreen	SPF 50 PLUS	Zinc Oxide	LOTION	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	ZINC OXIDE	120	mg/mL			N	20241231
64760-730_f8ae651b-f3f8-e648-e053-6394a90a4e5b	64760-730	HUMAN OTC DRUG	Glytone Age Defense UV Mineral Sunscreen Serum Broad Spectrum SPF 50 PLUS		Zinc Oxide	LOTION	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	ZINC OXIDE	120	mg/mL			N	20241231
64760-731_f80d3a9b-da50-e7c9-e053-6294a90a01db	64760-731	HUMAN OTC DRUG	GLYTONE Acne Treatment		Salicylic Acid	LOTION	TOPICAL	20210901		OTC MONOGRAPH FINAL	part358H	Pierre Fabre USA Inc.	SALICYLIC ACID	10	mg/1			N	20241231
64760-732_f80d3396-3a44-1d95-e053-6394a90ac5ba	64760-732	HUMAN OTC DRUG	GLYTONE Acne BPO Treatment Gel		Benzoyl Peroxide	GEL	TOPICAL	20210901		OTC MONOGRAPH FINAL	part333D	Pierre Fabre USA Inc.	BENZOYL PEROXIDE	50	mg/1			N	20241231
64760-733_f80d325d-d00e-bd3a-e053-6294a90a690d	64760-733	HUMAN OTC DRUG	GLYTONE Acne Clearing Toner		Salicylic Acid	LIQUID	TOPICAL	20211001		OTC MONOGRAPH FINAL	part358H	Pierre Fabre USA Inc.	SALICYLIC ACID	20	mg/1			N	20241231
64760-735_f80d2bb5-cb7c-9695-e053-6294a90a9541	64760-735	HUMAN OTC DRUG	Glytone Acne Back and Chest Treatment		Salicylic acid	SPRAY	TOPICAL	20210901		OTC MONOGRAPH FINAL	part358H	Pierre Fabre USA Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
64760-775_faa8e2b6-5205-5f1a-e053-6294a90a65f7	64760-775	HUMAN OTC DRUG	Avene Cleanance Acne Medicated Clearing Gel Cleanser		SALICYLIC ACID	LIQUID	TOPICAL	20230530		OTC MONOGRAPH FINAL	M006	Pierre Fabre USA Inc.	SALICYLIC ACID	2	mg/200mL			N	20241231
64760-776_facb99a0-f67f-80bf-e053-6294a90a2332	64760-776	HUMAN OTC DRUG	Avene Cleanance Acne Medicated Clearing Treatment		BENZOYL PEROXIDE	LIQUID	TOPICAL	20230530		OTC MONOGRAPH FINAL	M006	Pierre Fabre USA Inc.	BENZOYL PEROXIDE	5.5	mg/40mL			N	20241231
64760-780_fb5b1e94-bed4-8486-e053-6294a90a3a84	64760-780	HUMAN OTC DRUG	Avene Mineral Sunscreen Face and Body		ZINC OXIDE	LOTION	TOPICAL	20230517		OTC MONOGRAPH FINAL	M020	Pierre Fabre USA Inc.	ZINC OXIDE	120	mg/120mg			N	20241231
64763-099_7e9316c0-6033-4127-91d2-25b5849d728a	64763-099	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20020101		NDA	NDA205767	Johnson Drug Company, Inc	OXYGEN	99	L/100L			N	20241231
64764-046_60f9d1bd-9e6f-4c09-86e7-f9e066ea439a	64764-046	HUMAN PRESCRIPTION DRUG	Prevacid		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	19950510		NDA	NDA020406	Takeda Pharmaceuticals America, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64764-080_7a1ad838-dfa0-4cfa-bca0-d04b1a383102	64764-080	HUMAN PRESCRIPTION DRUG	Amitiza		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20060131		NDA	NDA021908	Takeda Pharmaceuticals America, Inc.	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
64764-107_a01aa894-bc6e-4f36-be45-dd025df6a4d6	64764-107	HUMAN PRESCRIPTION DRUG	ENTYVIO		vedolizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230927		BLA	BLA761133	Takeda Pharmaceuticals America, Inc.	VEDOLIZUMAB	108	mg/.68mL	Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]		N	20241231
64764-108_a01aa894-bc6e-4f36-be45-dd025df6a4d6	64764-108	HUMAN PRESCRIPTION DRUG	ENTYVIO Pen		vedolizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230927		BLA	BLA761133	Takeda Pharmaceuticals America, Inc.	VEDOLIZUMAB	108	mg/.68mL	Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]		N	20241231
64764-119_1465d75f-f2f7-4d78-9760-65e5d8e1d822	64764-119	HUMAN PRESCRIPTION DRUG	Colcrys		Colchicine	TABLET, FILM COATED	ORAL	20090901		NDA	NDA022352	Takeda Pharmaceuticals America, Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS]		N	20241231
64764-123_2132de34-57ee-4ffa-8c28-a085d533f8aa	64764-123	HUMAN PRESCRIPTION DRUG	OSENI		alogliptin and pioglitazone	TABLET, FILM COATED	ORAL	20130125		NDA	NDA022426	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	12.5; 30	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-125_c5487e88-84e3-41df-ab12-fd2140cc6ef2	64764-125	HUMAN PRESCRIPTION DRUG	Nesina		alogliptin	TABLET, FILM COATED	ORAL	20130125		NDA	NDA022271	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE	12.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
64764-140_325b9c3f-c547-44ed-b8c1-c5abe8b3da53	64764-140	HUMAN PRESCRIPTION DRUG	ADZYNMA		Apadamtase Alfa	KIT		20231109		BLA	BLA125795	TAKEDA PHARMACEUTICALS AMERICA, INC.						N	20241231
64764-145_325b9c3f-c547-44ed-b8c1-c5abe8b3da53	64764-145	HUMAN PRESCRIPTION DRUG	ADZYNMA		Apadamtase Alfa	KIT		20231109		BLA	BLA125795	TAKEDA PHARMACEUTICALS AMERICA, INC.						N	20241231
64764-151_be0fe13d-3a31-4eec-ade0-e0785fc7b3c1	64764-151	HUMAN PRESCRIPTION DRUG	Actos		pioglitazone	TABLET	ORAL	19990715		NDA	NDA021073	Takeda Pharmaceuticals America, Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-158_25c4af08-5c25-4c94-9d98-7cc0e603a099	64764-158	HUMAN PRESCRIPTION DRUG	Actoplus Met		pioglitazone and metformin hydrochloride	TABLET, FILM COATED	ORAL	20050829		NDA	NDA021842	Takeda Pharmaceuticals America, Inc.	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	850; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-171_c34971cf-0a79-428a-a456-20c48ee627e8	64764-171	HUMAN PRESCRIPTION DRUG	Dexilant		dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20100412		NDA	NDA022287	Takeda Pharmaceuticals America, Inc.	DEXLANSOPRAZOLE	30	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64764-175_c34971cf-0a79-428a-a456-20c48ee627e8	64764-175	HUMAN PRESCRIPTION DRUG	Dexilant		dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20100412		NDA	NDA022287	Takeda Pharmaceuticals America, Inc.	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64764-240_7a1ad838-dfa0-4cfa-bca0-d04b1a383102	64764-240	HUMAN PRESCRIPTION DRUG	Amitiza		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20060131		NDA	NDA021908	Takeda Pharmaceuticals America, Inc.	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
64764-250_c5487e88-84e3-41df-ab12-fd2140cc6ef2	64764-250	HUMAN PRESCRIPTION DRUG	Nesina		alogliptin	TABLET, FILM COATED	ORAL	20130125		NDA	NDA022271	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
64764-251_2132de34-57ee-4ffa-8c28-a085d533f8aa	64764-251	HUMAN PRESCRIPTION DRUG	OSENI		alogliptin and pioglitazone	TABLET, FILM COATED	ORAL	20130125		NDA	NDA022426	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	25; 15	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-253_2132de34-57ee-4ffa-8c28-a085d533f8aa	64764-253	HUMAN PRESCRIPTION DRUG	OSENI		alogliptin and pioglitazone	TABLET, FILM COATED	ORAL	20130125		NDA	NDA022426	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	25; 30	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-254_2132de34-57ee-4ffa-8c28-a085d533f8aa	64764-254	HUMAN PRESCRIPTION DRUG	OSENI		alogliptin and pioglitazone	TABLET, FILM COATED	ORAL	20130125		NDA	NDA022426	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE	25; 45	mg/1; mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-300_a01aa894-bc6e-4f36-be45-dd025df6a4d6	64764-300	HUMAN PRESCRIPTION DRUG	Entyvio		vedolizumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140520		BLA	BLA125476	Takeda Pharmaceuticals America, Inc.	VEDOLIZUMAB	300	mg/5mL	Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]		N	20241231
64764-301_be0fe13d-3a31-4eec-ade0-e0785fc7b3c1	64764-301	HUMAN PRESCRIPTION DRUG	Actos		pioglitazone	TABLET	ORAL	19990715		NDA	NDA021073	Takeda Pharmaceuticals America, Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-302_053856e0-af50-49c3-94f4-b214ed766bd1	64764-302	HUMAN PRESCRIPTION DRUG	Duetact		pioglitazone and glimepiride	TABLET	ORAL	20060728		NDA	NDA021925	Takeda Pharmaceuticals America, Inc.	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	2; 30	mg/1; mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-304_053856e0-af50-49c3-94f4-b214ed766bd1	64764-304	HUMAN PRESCRIPTION DRUG	Duetact		pioglitazone and glimepiride	TABLET	ORAL	20060728		NDA	NDA021925	Takeda Pharmaceuticals America, Inc.	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	4; 30	mg/1; mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-335_7e03a27c-c802-48a0-801c-785f55f1df36	64764-335	HUMAN PRESCRIPTION DRUG	KAZANO		alogliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20130125		NDA	NDA203414	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE	12.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
64764-337_7e03a27c-c802-48a0-801c-785f55f1df36	64764-337	HUMAN PRESCRIPTION DRUG	KAZANO		alogliptin and metformin hydrochloride	TABLET, FILM COATED	ORAL	20130125		NDA	NDA203414	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE	12.5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
64764-451_be0fe13d-3a31-4eec-ade0-e0785fc7b3c1	64764-451	HUMAN PRESCRIPTION DRUG	Actos		pioglitazone	TABLET	ORAL	19990715		NDA	NDA021073	Takeda Pharmaceuticals America, Inc.	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
64764-543_60f9d1bd-9e6f-4c09-86e7-f9e066ea439a	64764-543	HUMAN PRESCRIPTION DRUG	Prevacid SoluTab		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20020830		NDA	NDA021428	Takeda Pharmaceuticals America, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64764-544_60f9d1bd-9e6f-4c09-86e7-f9e066ea439a	64764-544	HUMAN PRESCRIPTION DRUG	Prevacid SoluTab		lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20020830		NDA	NDA021428	Takeda Pharmaceuticals America, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
64764-625_c5487e88-84e3-41df-ab12-fd2140cc6ef2	64764-625	HUMAN PRESCRIPTION DRUG	Nesina		alogliptin	TABLET, FILM COATED	ORAL	20130125		NDA	NDA022271	Takeda Pharmaceuticals America, Inc.	ALOGLIPTIN BENZOATE	6.25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
64764-677_fecf6101-9a35-4781-bea4-e7b92b4afb81	64764-677	HUMAN PRESCRIPTION DRUG	ULORIC		febuxostat	TABLET	ORAL	20090213		NDA	NDA021856	Takeda Pharmaceuticals America, Inc.	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
64764-720_9a2e06ef-8cc7-4f2a-ae57-fb965b37550b	64764-720	HUMAN PRESCRIPTION DRUG	Trintellix		vortioxetine	TABLET, FILM COATED	ORAL	20131002		NDA	NDA204447	Takeda Pharmaceuticals America, Inc.	VORTIOXETINE HYDROBROMIDE	5	mg/1			N	20241231
64764-730_9a2e06ef-8cc7-4f2a-ae57-fb965b37550b	64764-730	HUMAN PRESCRIPTION DRUG	Trintellix		vortioxetine	TABLET, FILM COATED	ORAL	20131002		NDA	NDA204447	Takeda Pharmaceuticals America, Inc.	VORTIOXETINE HYDROBROMIDE	10	mg/1			N	20241231
64764-750_9a2e06ef-8cc7-4f2a-ae57-fb965b37550b	64764-750	HUMAN PRESCRIPTION DRUG	Trintellix		vortioxetine	TABLET, FILM COATED	ORAL	20131002		NDA	NDA204447	Takeda Pharmaceuticals America, Inc.	VORTIOXETINE HYDROBROMIDE	20	mg/1			N	20241231
64764-800_b15552d2-7462-4043-ab27-1e53128fcc93	64764-800	HUMAN PRESCRIPTION DRUG	Livtencity		MARIBAVIR	TABLET, COATED	ORAL	20211123		NDA	NDA215596	Takeda Pharmaceuticals America, Inc.	MARIBAVIR	200	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytomegalovirus pUL97 Kinase Inhibitor [EPC], Cytomegalovirus pUL97 Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
64764-805_2dd3b589-791d-4151-8d80-357f6144d565	64764-805	HUMAN PRESCRIPTION DRUG	Rozerem		ramelteon	TABLET, FILM COATED	ORAL	20050722		NDA	NDA021782	Takeda Pharmaceuticals America, Inc.	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
64764-918_fecf6101-9a35-4781-bea4-e7b92b4afb81	64764-918	HUMAN PRESCRIPTION DRUG	ULORIC		febuxostat	TABLET	ORAL	20090213		NDA	NDA021856	Takeda Pharmaceuticals America, Inc.	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
64768-2922_08a564d1-833e-a056-e063-6394a90a7d1d	64768-2922	HUMAN OTC DRUG	MUSTELA Diaper Rash 1 2 3		ZINC OXIDE	CREAM	TOPICAL	20170109		OTC MONOGRAPH DRUG	M016	Expanscience Laboratories d/b/a Mustela	ZINC OXIDE	9.9	g/100g			N	20241231
64768-2924_08624c71-e6ef-11a5-e063-6394a90a043d	64768-2924	HUMAN OTC DRUG	MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 50		ZINC OXIDE	LOTION	TOPICAL	20191101		OTC MONOGRAPH DRUG	M020	Expanscience Laboratories d/b/a Mustela	ZINC OXIDE	240	mg/mL			N	20241231
64768-2925_0862a0ff-ebca-04f6-e063-6394a90a6c3b	64768-2925	HUMAN OTC DRUG	MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 30		ZINC OXIDE	SPRAY	TOPICAL	20200709		OTC MONOGRAPH DRUG	M020	Expanscience Laboratories d/b/a Mustela	ZINC OXIDE	120	mg/mL			N	20241231
64768-2926_086299e1-e485-5e65-e063-6394a90a29fb	64768-2926	HUMAN OTC DRUG	MUSTELA MINERAL SUNSCREEN SPF 50		ZINC OXIDE	STICK	TOPICAL	20210125		OTC MONOGRAPH DRUG	M020	Expanscience Laboratories d/b/a Mustela	ZINC OXIDE	197	mg/g			N	20241231
64768-2927_0862a0ff-ebcb-04f6-e063-6394a90a6c3b	64768-2927	HUMAN OTC DRUG	MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 50		ZINC OXIDE, TITANIUM DIOXIDE	SPRAY	TOPICAL	20210501		OTC MONOGRAPH DRUG	M020	Expanscience Laboratories d/b/a Mustela	TITANIUM DIOXIDE; ZINC OXIDE	43; 147	mg/g; mg/g			N	20241231
64768-2928_0862b13e-4fb5-2bdf-e063-6394a90a44eb	64768-2928	HUMAN OTC DRUG	Mustela Diaper Rash Sprayable		ZINC OXIDE	CREAM	TOPICAL	20220307		OTC MONOGRAPH DRUG	M016	Expanscience Laboratories d/b/a Mustela	ZINC OXIDE	149	mg/mL			N	20241231
64768-7024_0862ada6-4b71-b042-e063-6394a90a5d34	64768-7024	HUMAN OTC DRUG	Mustela Stelatopia Intense Eczema Relief Skin Protectant		Colloidal Oatmeal	LOTION	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	Expanscience Laboratories d/b/a Mustela	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64778-0373_0d1b2e11-008b-0fb9-e063-6294a90a8525	64778-0373	HUMAN PRESCRIPTION DRUG	Denti-Care Denti-Foam	Topical Sodium Fluoride Bubble Gum	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20030501	20240531	UNAPPROVED DRUG OTHER		AMD Medicom Inc.	SODIUM FLUORIDE	.0272	g/g			N	
64778-0376_0d1b1caa-ec21-0fab-e063-6294a90a086e	64778-0376	HUMAN PRESCRIPTION DRUG	Denti-Care Denti-Foam	Topical Sodium Fluoride Mint	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20030501	20240531	UNAPPROVED DRUG OTHER		AMD Medicom Inc.	SODIUM FLUORIDE	.0272	g/g			N	
64778-0379_0d1b475e-5784-2bd1-e063-6294a90a7311	64778-0379	HUMAN PRESCRIPTION DRUG	Denti-Care Denti-Foam	Topical Sodium Fluoride Strawberry	Sodium Fluoride	AEROSOL, FOAM	DENTAL	20030501	20240531	UNAPPROVED DRUG OTHER		AMD Medicom Inc	SODIUM FLUORIDE	.0272	g/g			N	
64778-0446_b9e46fe1-724a-e9ce-e053-2995a90a44e1	64778-0446	HUMAN PRESCRIPTION DRUG	Denti-Care Denti-Rinse	Neutral Sodium Fluoride Oral Rinse	Sodium Fluoride	LIQUID	DENTAL	20010301		UNAPPROVED DRUG OTHER		AMD Medicom	SODIUM FLUORIDE	.02	g/mL			N	20241231
64796-311_f1784e5b-b572-4953-e053-2a95a90aa37b	64796-311	HUMAN OTC DRUG	Kindfill		Mint Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	Identipak, Inc	SODIUM FLUORIDE	.62	mg/312mg			N	20241231
64796-312_f178accb-07f8-19eb-e053-2a95a90a671f	64796-312	HUMAN OTC DRUG	Kindfill		Cinnamon Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	Identipak, Inc	SODIUM FLUORIDE	.62	mg/312mg			N	20241231
64796-321_029560a6-5d7b-c0be-e063-6394a90a81d4	64796-321	HUMAN OTC DRUG	Kindfill		Mint Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	Identipak, Inc	SODIUM FLUORIDE	.62	mg/1			N	20241231
64796-322_02953481-629c-6af9-e063-6394a90a1422	64796-322	HUMAN OTC DRUG	Kindfill		Cinnamon Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	Identipak, Inc	SODIUM FLUORIDE	.62	mg/1			N	20241231
64842-0120_2511dda0-f005-41bf-82c8-86a9434bb1e0	64842-0120	HUMAN PRESCRIPTION DRUG	LYTGOBI		FUTIBATINIB	TABLET	ORAL	20230203		NDA	NDA214801	TAIHO PHARMACEUTICAL CO., LTD.	FUTIBATINIB	4	mg/1			N	20241231
64842-0727_8a42c130-411f-4614-a0ce-bba065e85210	64842-0727	HUMAN PRESCRIPTION DRUG	INQOVI		CEDAZURIDINE and DECITABINE	TABLET, FILM COATED	ORAL	20200707		NDA	NDA212576	Taiho Pharmaceutical Co., Ltd.	CEDAZURIDINE; DECITABINE	100; 35	mg/1; mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
64842-1020_1376bc92-67d0-403d-b9d3-602d58df9d8c	64842-1020	HUMAN PRESCRIPTION DRUG	LONSURF		trifluridine and tipiracil	TABLET, FILM COATED	ORAL	20150922		NDA	NDA207981	Taiho Pharmaceutical Co., Ltd.	TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE	8.19; 20	mg/1; mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT], Nucleoside Metabolic Inhibitor [EPC], Thymidine Phosphorylase Inhibitor [EPC], Thymidine Phosphorylase Inhibitors [MoA]		N	20241231
64842-1025_1376bc92-67d0-403d-b9d3-602d58df9d8c	64842-1025	HUMAN PRESCRIPTION DRUG	LONSURF		trifluridine and tipiracil	TABLET, FILM COATED	ORAL	20150922		NDA	NDA207981	Taiho Pharmaceutical Co., Ltd.	TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE	6.14; 15	mg/1; mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT], Nucleoside Metabolic Inhibitor [EPC], Thymidine Phosphorylase Inhibitor [EPC], Thymidine Phosphorylase Inhibitors [MoA]		N	20241231
64850-440_97b69c02-a69e-46fe-8686-4b4d8ceb5dca	64850-440	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		Phendimetrazine Tartrate	TABLET	ORAL	20121120		ANDA	ANDA040762	Elite Laboratories, Inc	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
64850-500_b65e0266-7172-4730-8f93-eb42e08fb7b8	64850-500	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-501_b65e0266-7172-4730-8f93-eb42e08fb7b8	64850-501	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-502_b65e0266-7172-4730-8f93-eb42e08fb7b8	64850-502	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-503_b65e0266-7172-4730-8f93-eb42e08fb7b8	64850-503	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-504_b65e0266-7172-4730-8f93-eb42e08fb7b8	64850-504	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-505_b65e0266-7172-4730-8f93-eb42e08fb7b8	64850-505	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-506_b65e0266-7172-4730-8f93-eb42e08fb7b8	64850-506	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-510_3eeb957d-1f63-4cdf-877c-c7da1b0084e9	64850-510	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-511_3eeb957d-1f63-4cdf-877c-c7da1b0084e9	64850-511	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-512_3eeb957d-1f63-4cdf-877c-c7da1b0084e9	64850-512	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-513_3eeb957d-1f63-4cdf-877c-c7da1b0084e9	64850-513	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-514_3eeb957d-1f63-4cdf-877c-c7da1b0084e9	64850-514	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-515_3eeb957d-1f63-4cdf-877c-c7da1b0084e9	64850-515	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Elite Laboratories, Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
64850-641_0f1f2b09-bbdb-448c-8a7a-73dc3eefaf3d	64850-641	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20190910		ANDA	ANDA212418	Elite Laboratories, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 15	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
64850-642_0f1f2b09-bbdb-448c-8a7a-73dc3eefaf3d	64850-642	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20190910		ANDA	ANDA212418	Elite Laboratories, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
64850-643_0f1f2b09-bbdb-448c-8a7a-73dc3eefaf3d	64850-643	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20190910		ANDA	ANDA212418	Elite Laboratories, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
64850-810_b5ae8929-1e47-452c-b48c-13145b43a9a5	64850-810	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20140501		ANDA	ANDA040190	Elite Laboratories, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
64850-840_e3fc6ec6-cdde-456a-81bd-8ebd07065afc	64850-840	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Elite Laboratories, Inc.	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
64850-841_e3fc6ec6-cdde-456a-81bd-8ebd07065afc	64850-841	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Elite Laboratories, Inc.	DANTROLENE SODIUM	50	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
64850-842_e3fc6ec6-cdde-456a-81bd-8ebd07065afc	64850-842	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Elite Laboratories, Inc.	DANTROLENE SODIUM	100	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
64850-850_5aa33d8f-3fbf-4109-8335-c9e8e150e5bc	64850-850	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20111121		ANDA	ANDA077361	Elite Laboratories, Inc.	TRIMIPRAMINE MALEATE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64850-851_5aa33d8f-3fbf-4109-8335-c9e8e150e5bc	64850-851	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20111121		ANDA	ANDA077361	Elite Laboratories, Inc.	TRIMIPRAMINE MALEATE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64850-852_5aa33d8f-3fbf-4109-8335-c9e8e150e5bc	64850-852	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20111021		ANDA	ANDA077361	Elite Laboratories, Inc.	TRIMIPRAMINE MALEATE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64850-890_1ae345d7-3740-4f9f-9046-16c9dddcc543	64850-890	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20200127		ANDA	ANDA076868	Elite Laboratories, Inc.	LOXAPINE SUCCINATE	5	mg/1			N	20241231
64850-891_1ae345d7-3740-4f9f-9046-16c9dddcc543	64850-891	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20200127		ANDA	ANDA076868	Elite Laboratories, Inc.	LOXAPINE SUCCINATE	10	mg/1			N	20241231
64850-892_1ae345d7-3740-4f9f-9046-16c9dddcc543	64850-892	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20200127		ANDA	ANDA076868	Elite Laboratories, Inc.	LOXAPINE SUCCINATE	25	mg/1			N	20241231
64850-893_1ae345d7-3740-4f9f-9046-16c9dddcc543	64850-893	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20200127		ANDA	ANDA076868	Elite Laboratories, Inc.	LOXAPINE SUCCINATE	50	mg/1			N	20241231
64850-910_194819ab-8bf2-4f80-b9bb-a1209af1ba21	64850-910	HUMAN PRESCRIPTION DRUG	Isradipine		Isradipine	CAPSULE	ORAL	20221228		ANDA	ANDA077169	Elite Laboratories, Inc.	ISRADIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
64850-911_194819ab-8bf2-4f80-b9bb-a1209af1ba21	64850-911	HUMAN PRESCRIPTION DRUG	Isradipine		Isradipine	CAPSULE	ORAL	20221228		ANDA	ANDA077169	Elite Laboratories, Inc.	ISRADIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
64866-123_07fe5f81-c0a3-7640-e063-6394a90a0a88	64866-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170509		UNAPPROVED MEDICAL GAS		Billings Clinic Home Oxygen & Medical Equipment Inc	OXYGEN	99	L/100L			N	20241231
64889-0001_06d5833d-ee9b-4c23-e063-6394a90a54e4	64889-0001	HUMAN PRESCRIPTION DRUG	Oxygen	64889-0001	Oxygen	GAS	RESPIRATORY (INHALATION)	20130325		UNAPPROVED MEDICAL GAS		Advanced Oxy-Med Services Inc	OXYGEN	99	L/100L			N	20241231
64896-076_c74519bf-2f00-4790-a3aa-80aecadbca94	64896-076	HUMAN PRESCRIPTION DRUG	LYVISPAH		baclofen	GRANULE	ORAL	20230601		NDA	NDA215422	Amneal Pharmaceuticals LLC	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
64896-077_c74519bf-2f00-4790-a3aa-80aecadbca94	64896-077	HUMAN PRESCRIPTION DRUG	LYVISPAH		baclofen	GRANULE	ORAL	20230601		NDA	NDA215422	Amneal Pharmaceuticals LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
64896-078_c74519bf-2f00-4790-a3aa-80aecadbca94	64896-078	HUMAN PRESCRIPTION DRUG	LYVISPAH		baclofen	GRANULE	ORAL	20230601		NDA	NDA215422	Amneal Pharmaceuticals LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
64896-661_1dc7ba21-9494-4b7f-9786-0a7390c12e3a	64896-661	HUMAN PRESCRIPTION DRUG	RYTARY		Carbidopa and Levodopa	CAPSULE, EXTENDED RELEASE	ORAL	20150112		NDA	NDA203312	Amneal Pharmaceuticals LLC	CARBIDOPA; LEVODOPA	23.75; 95	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
64896-662_1dc7ba21-9494-4b7f-9786-0a7390c12e3a	64896-662	HUMAN PRESCRIPTION DRUG	RYTARY		Carbidopa and Levodopa	CAPSULE, EXTENDED RELEASE	ORAL	20150112		NDA	NDA203312	Amneal Pharmaceuticals LLC	CARBIDOPA; LEVODOPA	36.25; 145	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
64896-663_1dc7ba21-9494-4b7f-9786-0a7390c12e3a	64896-663	HUMAN PRESCRIPTION DRUG	RYTARY		Carbidopa and Levodopa	CAPSULE, EXTENDED RELEASE	ORAL	20150112		NDA	NDA203312	Amneal Pharmaceuticals LLC	CARBIDOPA; LEVODOPA	48.75; 195	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
64896-664_1dc7ba21-9494-4b7f-9786-0a7390c12e3a	64896-664	HUMAN PRESCRIPTION DRUG	RYTARY		Carbidopa and Levodopa	CAPSULE, EXTENDED RELEASE	ORAL	20150112		NDA	NDA203312	Amneal Pharmaceuticals LLC	CARBIDOPA; LEVODOPA	61.25; 245	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
64896-669_7f1e08e7-417f-4466-892b-ee637ac6bc0d	64896-669	HUMAN PRESCRIPTION DRUG	Emverm		mebendazole	TABLET, CHEWABLE	ORAL	20160215		ANDA	ANDA073580	Amneal Pharmaceuticals LLC	MEBENDAZOLE	100	mg/1	Anthelmintic [EPC]		N	20241231
64896-671_f5787ecd-e8c4-49b3-9b47-710c31010965	64896-671	HUMAN PRESCRIPTION DRUG	ZOMIG		Zolmitriptan	TABLET	ORAL	20120402		NDA	NDA020768	Amneal Pharmaceuticals	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
64896-672_f5787ecd-e8c4-49b3-9b47-710c31010965	64896-672	HUMAN PRESCRIPTION DRUG	ZOMIG		Zolmitriptan	TABLET	ORAL	20120402		NDA	NDA020768	Amneal Pharmaceuticals	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
64896-673_d1d97919-842b-492d-b743-edd052f3b60b	64896-673	HUMAN PRESCRIPTION DRUG	DEXEDRINE	SPANSULE	dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	19760802		NDA	NDA017078	Amneal Pharmaceuticals LLC	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
64896-674_d1d97919-842b-492d-b743-edd052f3b60b	64896-674	HUMAN PRESCRIPTION DRUG	DEXEDRINE	SPANSULE	dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	19760802		NDA	NDA017078	Amneal Pharmaceuticals LLC	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
64896-675_d1d97919-842b-492d-b743-edd052f3b60b	64896-675	HUMAN PRESCRIPTION DRUG	DEXEDRINE	SPANSULE	dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	19760802		NDA	NDA017078	Amneal Pharmaceuticals LLC	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
64896-681_b023615a-7793-41a1-abbc-b89bd120b0d3	64896-681	HUMAN PRESCRIPTION DRUG	ZOMIG		Zolmitriptan	SPRAY, METERED	NASAL	20120702		NDA	NDA021450	Amneal Pharmaceuticals	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
64896-682_b023615a-7793-41a1-abbc-b89bd120b0d3	64896-682	HUMAN PRESCRIPTION DRUG	ZOMIG		Zolmitriptan	SPRAY, METERED	NASAL	20131206		NDA	NDA021450	Amneal Pharmaceuticals	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
64896-691_f5787ecd-e8c4-49b3-9b47-710c31010965	64896-691	HUMAN PRESCRIPTION DRUG	ZOMIG ZMT		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20120702		NDA	NDA021231	Amneal Pharmaceuticals	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
64896-692_f5787ecd-e8c4-49b3-9b47-710c31010965	64896-692	HUMAN PRESCRIPTION DRUG	ZOMIG ZMT		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20120702		NDA	NDA021231	Amneal Pharmaceuticals	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
64896-693_e65aab4e-279f-4cf2-b37e-07179b9d54c0	64896-693	HUMAN PRESCRIPTION DRUG	ALBENZA		albendazole	TABLET, FILM COATED	ORAL	19960611		NDA	NDA020666	Amneal Pharmaceuticals LLC	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
64896-695_61a770cc-7bae-4c2f-8db8-b8219c64e681	64896-695	HUMAN PRESCRIPTION DRUG	Oxymorphone hydrochloride		Oxymorphone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130102		ANDA	ANDA079087	Amneal Pharmaceuticals LLC	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64896-696_61a770cc-7bae-4c2f-8db8-b8219c64e681	64896-696	HUMAN PRESCRIPTION DRUG	Oxymorphone hydrochloride		Oxymorphone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130102		ANDA	ANDA079087	Amneal Pharmaceuticals LLC	OXYMORPHONE HYDROCHLORIDE	7.5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64896-697_61a770cc-7bae-4c2f-8db8-b8219c64e681	64896-697	HUMAN PRESCRIPTION DRUG	Oxymorphone hydrochloride		Oxymorphone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130102		ANDA	ANDA079087	Amneal Pharmaceuticals LLC	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64896-698_61a770cc-7bae-4c2f-8db8-b8219c64e681	64896-698	HUMAN PRESCRIPTION DRUG	Oxymorphone hydrochloride		Oxymorphone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130102		ANDA	ANDA079087	Amneal Pharmaceuticals LLC	OXYMORPHONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64896-699_61a770cc-7bae-4c2f-8db8-b8219c64e681	64896-699	HUMAN PRESCRIPTION DRUG	Oxymorphone hydrochloride		Oxymorphone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130102		ANDA	ANDA079087	Amneal Pharmaceuticals LLC	OXYMORPHONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64896-700_61a770cc-7bae-4c2f-8db8-b8219c64e681	64896-700	HUMAN PRESCRIPTION DRUG	Oxymorphone hydrochloride		Oxymorphone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130102		ANDA	ANDA079087	Amneal Pharmaceuticals LLC	OXYMORPHONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64896-701_61a770cc-7bae-4c2f-8db8-b8219c64e681	64896-701	HUMAN PRESCRIPTION DRUG	Oxymorphone hydrochloride		Oxymorphone hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130102		ANDA	ANDA079087	Amneal Pharmaceuticals LLC	OXYMORPHONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64922-233_5bf3d897-ccee-4c09-850b-ece71fabc61a	64922-233	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205767	ADF Welding & Medical, Inc.	OXYGEN	99	L/100L			N	20241231
64922-240_20b9a8f1-6d7c-4745-8421-1846325990c7	64922-240	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	19900101		NDA	NDA205766	ADF Welding & Medical, Inc.	NITROGEN	99	L/100L			N	20241231
64942-1141_f7e5474d-0d70-cb42-e053-6294a90a5216	64942-1141	HUMAN OTC DRUG	Dove	Clinical Protection Revive Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1163_ef17c871-6af9-53c0-e053-2a95a90acb4b	64942-1163	HUMAN OTC DRUG	Dove Men Clinical Protection Clean Comfort	Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1201_ef17704c-0d78-34a6-e053-2995a90a087a	64942-1201	HUMAN OTC DRUG	Degree	Clinical Men Clean Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1202_ef17d3a8-8471-e628-e053-2995a90af32c	64942-1202	HUMAN OTC DRUG	Degree	Clinical Men Sport Strength Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1203_ef1965c7-382a-0ddc-e053-2995a90a5968	64942-1203	HUMAN OTC DRUG	Degree	Clinical Men Extreme Fresh Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1218_ef19aba5-e7a5-ba0d-e053-2995a90a85bb	64942-1218	HUMAN OTC DRUG	Dove	Clean Comfort Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20111110		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1222_ef19af74-b383-33e9-e053-2995a90ac026	64942-1222	HUMAN OTC DRUG	Dove	Clinical Protection Soothing Chamomile Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1228_d2187cf3-78b9-3a0b-e053-2a95a90af47e	64942-1228	HUMAN OTC DRUG	Dove	Go Fresh Burst Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20120120		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1229_c9751bce-f88c-2ef9-e053-2a95a90ae776	64942-1229	HUMAN OTC DRUG	Dove	Go Fresh Energizing Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20120120		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1241_c9751817-1603-7fa9-e053-2a95a90a9d0b	64942-1241	HUMAN OTC DRUG	Dove	Original Clean Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20120214		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1257_b2e7823a-42d5-5b91-e053-2a95a90a6b9d	64942-1257	HUMAN OTC DRUG	Degree	Clinical Men Thermo Dry Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1258_f771da79-60c4-989c-e053-6394a90a2e30	64942-1258	HUMAN OTC DRUG	Degree	Clinical Protection Motion Sense Summer Strength Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1265_ef1a02c5-554b-8207-e053-2a95a90aa506	64942-1265	HUMAN OTC DRUG	Noxzema	AntiBlemish Daily Scrub	Salicyclic Acid	SOAP	TOPICAL	20121001		OTC MONOGRAPH FINAL	part333D	CONOPCO Inc. d/b/a Unilever	SALICYLIC ACID	.01	g/g			N	20241231
64942-1301_f7719cd9-fc69-911e-e053-6394a90a51b0	64942-1301	HUMAN OTC DRUG	Degree	Clinical Protection Motion Sense Stress Control Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1303_ef19e9ed-654b-1f8a-e053-2a95a90a315a	64942-1303	HUMAN OTC DRUG	Degree	Clinical Sheer Powder Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1304_ef1972bc-7e60-0dda-e053-2995a90a7b28	64942-1304	HUMAN OTC DRUG	Degree	Clinical Shower Clean Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20151215		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1305_ef19e9ed-654d-1f8a-e053-2a95a90a315a	64942-1305	HUMAN OTC DRUG	Dove DermaSeries	Rough Patch Treatment	Dimethicone	LOTION	TOPICAL	20131010		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	DIMETHICONE	1.1	g/100mL	Skin Barrier Activity [PE]		N	20241231
64942-1306_ef195fee-89c8-6c8f-e053-2995a90a8b29	64942-1306	HUMAN OTC DRUG	Dove DermaSeries	Eczema Therapy Cream	Oatmeal	CREAM	TOPICAL	20131015		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64942-1307_ee244c09-7653-173d-e053-2a95a90a16b1	64942-1307	HUMAN OTC DRUG	Dove DermaSeries	Intense Repairing Body Cream	Dimethicone	CREAM	TOPICAL	20131015		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	DIMETHICONE	6	g/100mL	Skin Barrier Activity [PE]		N	20241231
64942-1318_ef1a175c-df35-8206-e053-2995a90a6223	64942-1318	HUMAN OTC DRUG	Degree	Cool Rush Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20131201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1334_ef1a1afe-123e-dc27-e053-2a95a90aa80b	64942-1334	HUMAN OTC DRUG	Dove	Men plus Care Hydrate Face	AVOBENZONE, ENSULIZOLE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20160122		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE	2; 1.5; 5; 1.3	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64942-1337_ef1a175c-df38-8206-e053-2995a90a6223	64942-1337	HUMAN OTC DRUG	Dove Men plus Care	Clean Comfort Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20131215		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1355_ef1a2d0b-0372-bdbf-e053-2995a90a53cb	64942-1355	HUMAN OTC DRUG	Simple	Light Moisturizer SPF 15	AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE	LOTION	TOPICAL	20160122		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE	2; 1.5; 5; 1.3	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64942-1358_b087bac7-8677-62b9-e053-2995a90a4533	64942-1358	HUMAN OTC DRUG	Dove	Cool Essentials Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1359_b0880f39-a6fd-23ab-e053-2995a90a7eb2	64942-1359	HUMAN OTC DRUG	Dove	Beauty Finish Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1360_b0880e33-ddfd-42ee-e053-2995a90a3f59	64942-1360	HUMAN OTC DRUG	Dove	Sensitive Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1361_b0880e33-de08-42ee-e053-2995a90a3f59	64942-1361	HUMAN OTC DRUG	Dove	Clear Tone Skin Renew Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1362_b088273d-d6dc-42f0-e053-2995a90ac681	64942-1362	HUMAN OTC DRUG	Dove	Revive Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1363_b0882dd7-fb64-7989-e053-2a95a90a520e	64942-1363	HUMAN OTC DRUG	Dove	Nourished Beauty Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1365_b08f3bf1-f553-5c68-e053-2a95a90ac3ac	64942-1365	HUMAN OTC DRUG	Dove	Men plus Care Cool Silver Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1366_b08f4c6c-bd2a-598b-e053-2a95a90a7aee	64942-1366	HUMAN OTC DRUG	Dove	Men plus Care Clean Comfort Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1367_b08f54a3-afb9-5a2d-e053-2a95a90a3a1b	64942-1367	HUMAN OTC DRUG	Dove	Men plus Care Unscented Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1372_b0918f01-1de0-e684-e053-2995a90a7c9d	64942-1372	HUMAN OTC DRUG	Axe	Air Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1373_b091b61a-757f-efed-e053-2a95a90ac0c6	64942-1373	HUMAN OTC DRUG	Axe	Night Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1374_b091b073-d942-6e92-e053-2995a90a43c8	64942-1374	HUMAN OTC DRUG	Axe	Forest Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1375_b091d362-c62f-c485-e053-2995a90a2a92	64942-1375	HUMAN OTC DRUG	Axe	Island Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1376_b05f96ab-ed0c-529d-e053-2995a90a24a1	64942-1376	HUMAN OTC DRUG	Degree	Shower Clean Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1377_ee244f55-1e48-7de5-e053-2995a90a90de	64942-1377	HUMAN OTC DRUG	Degree	Fresh Energy Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1378_b05f9b1f-b3cf-6b86-e053-2a95a90abc00	64942-1378	HUMAN OTC DRUG	Degree	Sheer Powder Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1379_b05f9b1f-b3e5-6b86-e053-2a95a90abc00	64942-1379	HUMAN OTC DRUG	Degree	Peach Burst Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1380_b061d3e7-51cc-048c-e053-2995a90af53f	64942-1380	HUMAN OTC DRUG	Degree	Everest Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1381_b0622d19-8aae-f6f6-e053-2a95a90a3d65	64942-1381	HUMAN OTC DRUG	Degree	Extreme Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1382_b0622d19-8ab9-f6f6-e053-2a95a90a3d65	64942-1382	HUMAN OTC DRUG	Degree	Adventure Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1383_b0623540-50cf-8102-e053-2995a90a9a61	64942-1383	HUMAN OTC DRUG	Degree	Sport Defense Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1385_b0622ed7-1041-96fd-e053-2a95a90a5add	64942-1385	HUMAN OTC DRUG	Degree	Overtime Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1393_ef28847d-86cb-491b-e053-2a95a90a9579	64942-1393	HUMAN OTC DRUG	Dove	Clinical Protection Powder Soft Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1394_f771aa19-295b-9f4e-e053-6294a90a1674	64942-1394	HUMAN OTC DRUG	Degree	5 In 1 Clinical Protection Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1396_ef31eadc-0419-4a11-e053-2a95a90adc5f	64942-1396	HUMAN OTC DRUG	Dove	Advanced Care Original Clean Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20141215		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1397_ef3225d4-7f5b-265c-e053-2a95a90a4ddf	64942-1397	HUMAN OTC DRUG	Dove Men plus Care	Sensitive Shield Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20141215		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1398_b05f9b1f-b3da-6b86-e053-2a95a90abc00	64942-1398	HUMAN OTC DRUG	Degree	Sexy Intrigue Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20141101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1400_ef2fd192-964b-d99d-e053-2a95a90a974d	64942-1400	HUMAN OTC DRUG	Vaseline	Lip Therapy Advanced Healing	Petrolatum	OINTMENT	TOPICAL	20040120		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	PETROLATUM	100	g/100g			N	20241231
64942-1401_ef2fd192-964c-d99d-e053-2a95a90a974d	64942-1401	HUMAN OTC DRUG	Vaseline	Intensive Care Deep Moisture	Petroleum	CREAM	TOPICAL	20151001		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	PETROLATUM	30	g/100g			N	20241231
64942-1402_b091d362-c63b-c485-e053-2995a90a2a92	64942-1402	HUMAN OTC DRUG	Axe	Signature Air Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1403_b091d362-c64b-c485-e053-2995a90a2a92	64942-1403	HUMAN OTC DRUG	Axe	Signature Night Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1404_b091e535-6ee1-a45c-e053-2995a90a130f	64942-1404	HUMAN OTC DRUG	Axe	Signature Forest Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1405_b091e9f4-8a49-3aca-e053-2a95a90a2614	64942-1405	HUMAN OTC DRUG	Axe	Signature Island Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1408_b05f9b1f-b3f0-6b86-e053-2a95a90abc00	64942-1408	HUMAN OTC DRUG	Degree	for Women Motionsense Active Shield Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1409_b05f96ab-ed1a-529d-e053-2995a90a24a1	64942-1409	HUMAN OTC DRUG	Degree	Motionsense Daisy Fresh Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1410_d21707f7-2f93-1c1e-e053-2995a90a3399	64942-1410	HUMAN OTC DRUG	Degree	For Men Motionsense Cool Rush Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1411_d21711f1-ce9a-f8ca-e053-2a95a90a720a	64942-1411	HUMAN OTC DRUG	Degree	For Men Motionsense Active Shield Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1412_b08844a5-9064-2d95-e053-2a95a90a8eff	64942-1412	HUMAN OTC DRUG	Dove	Original Clean Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1413_b0884158-20e8-e1d3-e053-2995a90a5369	64942-1413	HUMAN OTC DRUG	Dove	Soothing Chamomile Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1414_b08f65f6-8165-5a33-e053-2a95a90ab8f6	64942-1414	HUMAN OTC DRUG	Dove	Men plus Care Cool Fresh Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1415_b08f54a3-afc9-5a2d-e053-2a95a90a3a1b	64942-1415	HUMAN OTC DRUG	Dove	Men plus Care Sensitive Shield Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1429_ef3ca403-2326-4775-e053-2a95a90ac88c	64942-1429	HUMAN OTC DRUG	Degree	Clinical Protection Active Shield Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1439_ef3ca403-2327-4775-e053-2a95a90ac88c	64942-1439	HUMAN OTC DRUG	Dove	Clinical Protection Skin Renew Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1440_ef3ca403-2328-4775-e053-2a95a90ac88c	64942-1440	HUMAN OTC DRUG	Dove	Clinical Protection Original Clean Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1441_ef3c9dbe-ddfd-9384-e053-2995a90af83e	64942-1441	HUMAN OTC DRUG	Dove	Clinical Protection Cool Essentials Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1442_b0b79a50-67fc-76d6-e053-2a95a90afb66	64942-1442	HUMAN OTC DRUG	Degree Men	Black and White Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160720		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1443_b05ffc2e-4878-6810-e053-2a95a90a7318	64942-1443	HUMAN OTC DRUG	Degree	MotionSense Ultraclear Black and White Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160902		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1444_ee244c09-7652-173d-e053-2a95a90a16b1	64942-1444	HUMAN OTC DRUG	Degree Men	MotionSense Ultraclear Black and White Fresh Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160914		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1446_b0626451-1056-fb1a-e053-2a95a90aee70	64942-1446	HUMAN OTC DRUG	Degree Men	MotionSense Stress Control Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160914		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1447_b05fcebb-d01b-c117-e053-2995a90a1064	64942-1447	HUMAN OTC DRUG	Degree	MotionSense Stress Control Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160919		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1450_b08f62b0-98e0-5aac-e053-2a95a90a6d8a	64942-1450	HUMAN OTC DRUG	Dove Men plus Care	Invisible Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1452_b0884158-20f9-e1d3-e053-2995a90a5369	64942-1452	HUMAN OTC DRUG	Dove	Invisible Sheer Fresh Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1453_b08f65f6-8170-5a33-e053-2a95a90ab8f6	64942-1453	HUMAN OTC DRUG	Dove Men plus Care	Invisible Fresh Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160919		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1454_b08f6f48-795b-3b40-e053-2a95a90a75f6	64942-1454	HUMAN OTC DRUG	Dove Men plus Care	Minerals and Sage Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160903		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1455_d217ab68-30fe-902e-e053-2995a90ae0d0	64942-1455	HUMAN OTC DRUG	Dove Men plus Care	Mineral Powder and Sandalwood Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160914		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1456_b091e9f4-8a56-3aca-e053-2a95a90a2614	64942-1456	HUMAN OTC DRUG	Axe	Signature Gold Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1461_0cf98e48-245f-98a4-e063-6394a90ab86e	64942-1461	HUMAN OTC DRUG	Dove	Advanced Care Invisible Clear Finish 48h Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20161003		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1466_ef3c9dbe-de00-9384-e053-2995a90af83e	64942-1466	HUMAN OTC DRUG	Degree Men	Motionsense UltraClear Black and White 48H Antiperspirant	Aluminum zirconium tetrachlorohydrex GLY	STICK	TOPICAL	20161008		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1467_ef3cb591-4b6f-3684-e053-2995a90a7791	64942-1467	HUMAN OTC DRUG	Degree	Motionsense UltraClear Black and White Invisible Solid 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20161008		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1474_ef3cb6d4-2e60-4672-e053-2995a90a7074	64942-1474	HUMAN OTC DRUG	Axe	Signature Night Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20161019		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1483_ef3cb591-4b71-3684-e053-2995a90a7791	64942-1483	HUMAN OTC DRUG	Axe	Signature Daily Dandruff Defense Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20161110		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1484_ef3cb6d4-2e61-4672-e053-2995a90a7074	64942-1484	HUMAN OTC DRUG	Dove	Dermacare Scalp Pure Daily Care Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20161106		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1485_ef3cb591-4b72-3684-e053-2995a90a7791	64942-1485	HUMAN OTC DRUG	Dove	Dermacare Scalp Pure Daily Care 2 In 1 Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20161110		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1486_ef3cb6d4-2e62-4672-e053-2995a90a7074	64942-1486	HUMAN OTC DRUG	Dove	Dermacare Scalp Dryness and Itch Relief Anti-Dandruff Conditioner	Pyrithione Zinc	LIQUID	TOPICAL	20161110		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	.5	g/100mL			N	20241231
64942-1487_bd35f98d-742e-0b65-e053-2a95a90a49f3	64942-1487	HUMAN OTC DRUG	Dove	Dermacare Scalp Dryness and Itch Relief Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20161110		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1488_bd35c88f-c639-4136-e053-2a95a90a0cc1	64942-1488	HUMAN OTC DRUG	Dove	Dermacare Scalp Invigorating Mint Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20161110		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1489_bd3584c3-5dd3-3f91-e053-2995a90a45a1	64942-1489	HUMAN OTC DRUG	Dove	Dermacare Scalp Invigorating Mint 2 In 1 Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20161110		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1492_d2171989-351e-0599-e053-2995a90a3bff	64942-1492	HUMAN OTC DRUG	Degree Men	MotionSense Ultraclear Black and White Driftwood 48H Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20170707		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1493_b06267cd-677b-f0da-e053-2995a90af30c	64942-1493	HUMAN OTC DRUG	Degree Men	MotionSense Ultraclear Black and White Ocean Air 48H Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20170707		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1494_b05fc277-2259-3e27-e053-2995a90a4dd8	64942-1494	HUMAN OTC DRUG	Degree	MotionSense Ultraclear Black and White Tropical Touch 48H Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20170707		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1495_b05fc277-2266-3e27-e053-2995a90a4dd8	64942-1495	HUMAN OTC DRUG	Degree	MotionSense Ultraclear Black and White Pure Rain 48H Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20170707		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1496_d2174748-0c7c-acd7-e053-2995a90a768c	64942-1496	HUMAN OTC DRUG	Degree Men		MotionSense Ultraclear Black and White Driftwood 48H Antiperspirant	STICK	TOPICAL	20170731		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1497_d21cc6ac-d706-e7a1-e053-2995a90a228c	64942-1497	HUMAN OTC DRUG	Degree Men		MotionSense Ultraclear Black and White Ocean Air 48H Antiperspirant	STICK	TOPICAL	20170731		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1498_d21cbfda-17e0-b17c-e053-2995a90a3399	64942-1498	HUMAN OTC DRUG	Degree		MotionSense Ultraclear Black and White Pure Rain Invisible Solid 48H Antiperspirant	STICK	TOPICAL	20170731		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1499_d21cbfda-17e4-b17c-e053-2995a90a3399	64942-1499	HUMAN OTC DRUG	Degree		MotionSense Ultraclear Black and White Tropical Touch Invisible Solid 48H Antiperspirant	STICK	TOPICAL	20170731		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1500_d21ccdab-2f8d-520d-e053-2a95a90aa5ec	64942-1500	HUMAN OTC DRUG	Degree Men		MotionSense Advanced Protection Extreme Blast 48H Antiperspirant	STICK	TOPICAL	20170731		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1501_d21ccdab-2f8f-520d-e053-2a95a90aa5ec	64942-1501	HUMAN OTC DRUG	Degree Men		MotionSense Advanced Protection Clean 48H Antiperspirant	STICK	TOPICAL	20170731		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1502_ef3db226-c9c1-47d9-e053-2995a90ad420	64942-1502	HUMAN OTC DRUG	Dove	DermaSeries Dry Skin Relief Replenishing Face Cream SPF 15	Avobenzone,Ensulizole, Octisalate, Octocrylene	CREAM	TOPICAL	20170712		OTC MONOGRAPH NOT FINAL	part352	Conopco, Inc. d/b/a Unilever	AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE	2; 1.5; 5; 1.3	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64942-1503_ef3db7b9-abe1-6b2e-e053-2995a90a69ea	64942-1503	HUMAN OTC DRUG	Dove	DermaSeries Eczema Relief Soothing Body	Colloidal Oatmeal	LOTION	TOPICAL	20170713		OTC MONOGRAPH FINAL	part347	Conopco, Inc. d/b/a/ Unilever	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64942-1504_b0885bf9-a1f3-010b-e053-2995a90a45bc	64942-1504	HUMAN OTC DRUG	Dove		Invisible Crystal Touch Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170822		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1505_b08864ed-b233-7d8a-e053-2a95a90afc58	64942-1505	HUMAN OTC DRUG	Dove		Lavender Fresh Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170822		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1506_b08864ed-b23f-7d8a-e053-2a95a90afc58	64942-1506	HUMAN OTC DRUG	Dove		Invisible Sheer Cool Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170822		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1507_b090a798-9ec1-05f8-e053-2a95a90aa87f	64942-1507	HUMAN OTC DRUG	Axe		Gold Original Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1508_b090a798-9ec0-05f8-e053-2a95a90aa87f	64942-1508	HUMAN OTC DRUG	Dove		Go Fresh Rejuvenate 48H Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1509_b08ee0cc-6265-7bfc-e053-2995a90a59db	64942-1509	HUMAN OTC DRUG	Dove		GClear Tone Pink Rosa Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1510_b08f6f48-796d-3b40-e053-2a95a90a75f6	64942-1510	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Cool 48H Dry Sray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1514_b0908876-277c-7ba8-e053-2a95a90af248	64942-1514	HUMAN OTC DRUG	Axe		Axe Charge Up Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170911		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1515_b08f84d8-f092-25b6-e053-2995a90a2094	64942-1515	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Clean 48H Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170912		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1516_b09068f2-5b74-6997-e053-2995a90a85c2	64942-1516	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Fresh 48H Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170912		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1517_b0908876-277d-7ba8-e053-2a95a90af248	64942-1517	HUMAN OTC DRUG	Axe		Gold Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170911		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1518_b0920fd8-5405-c7a6-e053-2a95a90a28ba	64942-1518	HUMAN OTC DRUG	Axe		Forest Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170911		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1519_b0909bb3-7c0b-7080-e053-2995a90abdd1	64942-1519	HUMAN OTC DRUG	Axe		Night Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20170911		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1522_d21908fc-5dbd-4cb6-e053-2995a90a7590	64942-1522	HUMAN OTC DRUG	Axe		Gold Original Antiperspirant	STICK	TOPICAL	20170914		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1523_d218cbaf-c27f-30d1-e053-2995a90a64fd	64942-1523	HUMAN OTC DRUG	Dove		Advanced Care Invisible Crystal Touch 48H Antiperspirant	STICK	TOPICAL	20170914		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1524_d218d00e-5024-7236-e053-2a95a90a9cd8	64942-1524	HUMAN OTC DRUG	Dove		Dove Advanced Care Invisible Sheer Cool 48H Antiperspirant	STICK	TOPICAL	20170918		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1525_d218d00e-5021-7236-e053-2a95a90a9cd8	64942-1525	HUMAN OTC DRUG	Dove		Advanced Care Go Fresh Rejuvenate 48H Antiperspirant	STICK	TOPICAL	20170918		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1526_d2187307-632e-6484-e053-2a95a90a8b1b	64942-1526	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Cool 48H Antiperspirant	STICK	TOPICAL	20170918		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1527_d218be8a-2792-2104-e053-2995a90a2692	64942-1527	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Clean 48H Antiperspirant	STICK	TOPICAL	20170919		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1528_d218af4c-4110-9d41-e053-2a95a90a33fb	64942-1528	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Fresh 48H Antiperspirant	STICK	TOPICAL	20170919		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1529_d2190186-7b17-fb1b-e053-2995a90a55a7	64942-1529	HUMAN OTC DRUG	Axe		Men plus Care Stain Defense Fresh 48H Antiperspirant	STICK	TOPICAL	20170919		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1530_d21914e1-9f32-06c5-e053-2a95a90a7fe9	64942-1530	HUMAN OTC DRUG	Axe		Anarchy Antiperspirant and Deodorant	STICK	TOPICAL	20170920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1531_d21914e1-9f33-06c5-e053-2a95a90a7fe9	64942-1531	HUMAN OTC DRUG	Axe	Dark Temptation Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1532_d2191165-7f49-687c-e053-2a95a90a37b3	64942-1532	HUMAN OTC DRUG	Axe	Apollo Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1533_d21914e1-9f34-06c5-e053-2a95a90a7fe9	64942-1533	HUMAN OTC DRUG	Axe	Black Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170926		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1534_d2191165-7f4e-687c-e053-2a95a90a37b3	64942-1534	HUMAN OTC DRUG	Axe	Black Chill Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170926		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1535_d21914e1-9f38-06c5-e053-2a95a90a7fe9	64942-1535	HUMAN OTC DRUG	Axe	Black Eclipse Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170926		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1536_d21904df-9469-d4d0-e053-2995a90a1f67	64942-1536	HUMAN OTC DRUG	Axe	Gold Temptation Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170926		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1537_d21926ae-fa4a-60e4-e053-2a95a90a14d9	64942-1537	HUMAN OTC DRUG	Axe	You Got Something Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170926		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1538_d21925bb-0932-97ec-e053-2a95a90ab078	64942-1538	HUMAN OTC DRUG	Axe	Essence Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170926		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1539_d2187307-632f-6484-e053-2a95a90a8b1b	64942-1539	HUMAN OTC DRUG	Axe	Phoenix Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1540_d21925bb-0936-97ec-e053-2a95a90ab078	64942-1540	HUMAN OTC DRUG	Axe	Kilo Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1541_d21925bb-0937-97ec-e053-2a95a90ab078	64942-1541	HUMAN OTC DRUG	Axe	Advanced Protection Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1542_d2193225-491e-4b3e-e053-2a95a90ad91b	64942-1542	HUMAN OTC DRUG	Axe	Night Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1543_d2193410-ea28-2898-e053-2a95a90a83bc	64942-1543	HUMAN OTC DRUG	Axe	Forest Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1544_d21a13db-6606-b9fd-e053-2a95a90a0ebf	64942-1544	HUMAN OTC DRUG	Axe	Island Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1545_d21a1529-c452-2e7c-e053-2995a90ae993	64942-1545	HUMAN OTC DRUG	Axe	Gold Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1546_d219fc9e-19f2-86b9-e053-2995a90a5f1b	64942-1546	HUMAN OTC DRUG	Axe	Charge Up Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170927		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1547_d21cd28b-3eba-46ef-e053-2995a90aa47e	64942-1547	HUMAN OTC DRUG	Degree	Men MotionSense Extreme Blast 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170929		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1548_d21cc6ac-d70b-e7a1-e053-2995a90a228c	64942-1548	HUMAN OTC DRUG	Degree	Men MotionSense Cool Rush 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170929		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1549_d21ccdab-2f90-520d-e053-2a95a90aa5ec	64942-1549	HUMAN OTC DRUG	Degree	Men MotionSense Sport Defense 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20170929		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1550_d21ccdab-2f91-520d-e053-2a95a90aa5ec	64942-1550	HUMAN OTC DRUG	Degree	Men MotionSense Everest 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171013		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1551_ef3dfed7-3bd9-3906-e053-2995a90a0f5b	64942-1551	HUMAN OTC DRUG	Degree	Men Cool Rush 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171016		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1552_d2184eb9-be53-5913-e053-2a95a90abf3e	64942-1552	HUMAN OTC DRUG	Degree	Men Cool Comfort 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171016		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1553_d21820b5-4869-6635-e053-2a95a90af6ed	64942-1553	HUMAN OTC DRUG	Degree	Men Sport 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171016		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1554_d218475e-e2cc-f7c3-e053-2a95a90a0f9a	64942-1554	HUMAN OTC DRUG	Degree	Men MotionSense Adventure 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171018		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1555_d2184497-3c59-eb01-e053-2a95a90a9797	64942-1555	HUMAN OTC DRUG	Degree	Men MotionSense Extreme 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171020		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1556_d2183ea0-0bde-08eb-e053-2995a90ac71c	64942-1556	HUMAN OTC DRUG	Degree	Men MotionSense Overtime 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171020		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1557_d21743d0-4057-09b6-e053-2a95a90a84e5	64942-1557	HUMAN OTC DRUG	Degree	Men MotionSense Active Shield 48H Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20171020		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1559_ef3e1c88-4876-2299-e053-2995a90a2946	64942-1559	HUMAN OTC DRUG	Dove	Powder 24h Invisible Solid AntiPerspirant Deodorant	ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20171121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	22	g/100mL			N	20241231
64942-1561_b09079ea-1260-7a3e-e053-2a95a90acc69	64942-1561	HUMAN OTC DRUG	Axe		Apollo Dry Spray Antiperspirant 48HR Protection Dry	AEROSOL, SPRAY	TOPICAL	20171129		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1562_b0906cf9-f2ea-7b81-e053-2a95a90ad7f4	64942-1562	HUMAN OTC DRUG	Axe		Black Dry Spray Antiperspirant 48HR Protection Dry 48HR Protection Dry	AEROSOL, SPRAY	TOPICAL	20171129		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1563_b0905891-b058-5007-e053-2a95a90a3cab	64942-1563	HUMAN OTC DRUG	Axe		Dark Temptation Dry Spray Antiperspirant 48HR Protection Dry	AEROSOL, SPRAY	TOPICAL	20171129		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1564_b3a0c3d2-da5b-876f-e053-2a95a90abd87	64942-1564	HUMAN OTC DRUG	Axe	Black Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1565_b09089ac-5237-65bb-e053-2995a90aabd0	64942-1565	HUMAN OTC DRUG	Axe		Apollo Dry Spray Antiperspirant 48HR Protection Dry	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1566_b08efa04-5d24-61c7-e053-2a95a90a017e	64942-1566	HUMAN OTC DRUG	Dove		Cool Essentials Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1567_b0906cf9-f2e7-7b81-e053-2a95a90ad7f4	64942-1567	HUMAN OTC DRUG	Dove		Men plus Care Clean Comfort Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1568_b05fcebb-d028-c117-e053-2995a90a1064	64942-1568	HUMAN OTC DRUG	Degree		MotionSense Ultraclear Black and White Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1569_b06267cd-678a-f0da-e053-2995a90af30c	64942-1569	HUMAN OTC DRUG	Degree		Men MotionSense Ultraclear Black and White Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1570_d217575b-5e6b-00c8-e053-2a95a90a4cae	64942-1570	HUMAN OTC DRUG	Axe		Phoenix Dry Spray Antiperspirant 48HR Protection Dry	AEROSOL, SPRAY	TOPICAL	20180203		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1571_b3a32670-6cc9-22d3-e053-2995a90a7ccf	64942-1571	HUMAN OTC DRUG	Degree		MotionSense Grapefruit and Verbena Scent Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1572_b3a333de-e3ec-e043-e053-2a95a90afb29	64942-1572	HUMAN OTC DRUG	Degree	MotionSense Grapefruit and Verbena Scent Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1573_b05fcebb-d036-c117-e053-2995a90a1064	64942-1573	HUMAN OTC DRUG	Degree		MotionSense Daisy Fresh and Aloe Vera Scent Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180219		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1574_b3a32670-6cca-22d3-e053-2995a90a7ccf	64942-1574	HUMAN OTC DRUG	Degree	MotionSense Daisy Fresh and Aloe Vera Scent Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1575_d21caf3f-3a02-2c7b-e053-2995a90a0372	64942-1575	HUMAN OTC DRUG	Axe		Powder 48 Hour Protection Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1576_d21ca5da-9563-3ecf-e053-2a95a90a0f35	64942-1576	HUMAN OTC DRUG	Axe		Coconut Kiss 48 Hour Protection Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1577_d21cab38-6bbd-e7cf-e053-2a95a90a4237	64942-1577	HUMAN OTC DRUG	Axe		Wild Cherry Blossom 48 Hour Protection Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1578_ef3e387e-19cc-117a-e053-2a95a90a8954	64942-1578	HUMAN OTC DRUG	Dove		Powder Roll-On AntiPerspirant Deodorant	LIQUID	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	22	g/100mL			N	20241231
64942-1579_b3a2b41e-a9f7-538e-e053-2995a90aafdd	64942-1579	HUMAN OTC DRUG	Axe		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1580_b3a2b41e-aa04-538e-e053-2995a90aafdd	64942-1580	HUMAN OTC DRUG	Axe		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1581_b3a333de-e3ed-e043-e053-2a95a90afb29	64942-1581	HUMAN OTC DRUG	Degree	MotionSense White Flowers and Lychee Scent Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1584_ef3e36d7-d34b-d7cb-e053-2995a90a74f7	64942-1584	HUMAN OTC DRUG	Ponds		Rejuveness Anti-Wrinkle Daily Moisturizer with Sunscreen SPF 30	CREAM	TOPICAL	20180814		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	OCTINOXATE; ZINC OXIDE	7; 6	g/100g; g/100g			N	20241231
64942-1585_ef3ddd58-7030-73de-e053-2a95a90aef82	64942-1585	HUMAN OTC DRUG	Ponds		Clarant B3 Even Skin Tone Daily Moisturizer with Sunscreen SPF 30	CREAM	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	OCTINOXATE; ZINC OXIDE	7; 6	g/100g; g/100g			N	20241231
64942-1587_b3a208c8-e491-4431-e053-2a95a90ab1ff	64942-1587	HUMAN OTC DRUG	Axe		Anarchy Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1588_a3b95303-48c9-f559-e053-2a95a90a4a20	64942-1588	HUMAN OTC DRUG	Axe		Apollo Antiperspirant and Deodorant	STICK	TOPICAL	20180806		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1589_b3a2f215-c294-85c9-e053-2995a90a6944	64942-1589	HUMAN OTC DRUG	Axe		Black Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1590_b3a2f215-c295-85c9-e053-2995a90a6944	64942-1590	HUMAN OTC DRUG	Axe		Black Chill Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1591_b3a3044d-a175-4731-e053-2995a90a99ef	64942-1591	HUMAN OTC DRUG	Axe		Black Eclipse Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1592_b3a3044d-a176-4731-e053-2995a90a99ef	64942-1592	HUMAN OTC DRUG	Axe		Dark Temptation Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1594_b3a3044d-a179-4731-e053-2995a90a99ef	64942-1594	HUMAN OTC DRUG	Axe		Gold Fresh Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1595_b3a3044d-a17d-4731-e053-2995a90a99ef	64942-1595	HUMAN OTC DRUG	Axe		Kilo 48H Dry Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1596_b3a30cef-251e-099e-e053-2995a90ad2a5	64942-1596	HUMAN OTC DRUG	Axe		Phoenix Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1597_b3a32670-6cbf-22d3-e053-2995a90a7ccf	64942-1597	HUMAN OTC DRUG	Axe		You Got Something 48H Dry Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1598_b3a32670-6cc3-22d3-e053-2995a90a7ccf	64942-1598	HUMAN OTC DRUG	Axe		Essence Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1599_b3a333de-e3eb-e043-e053-2a95a90afb29	64942-1599	HUMAN OTC DRUG	Axe		Gold Oud Wood and Dark Vanilla 48H Dry Antiperspirant and Deodorant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1601_ef3efb34-c39b-5a2b-e053-2995a90a0b46	64942-1601	HUMAN OTC DRUG	Degree		MotionSense Citrus and Bergamot Scent Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20180808		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1602_b3a32670-6ccd-22d3-e053-2995a90a7ccf	64942-1602	HUMAN OTC DRUG	Degree		MotionSense Citrus and Bergamot Scent Antiperspirant	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1603_ef3f0f2c-96b0-682d-e053-2a95a90a16a0	64942-1603	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1604_b3a36780-2f21-251d-e053-2995a90a5dc2	64942-1604	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1605_ef3efc36-52e4-67d2-e053-2995a90a1dd7	64942-1605	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20181002		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1606_b3a16aa6-a5c4-8fbc-e053-2a95a90a1412	64942-1606	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1607_b3a36de0-6052-58c1-e053-2a95a90aa0fa	64942-1607	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1608_ef3f198c-1e31-5bfb-e053-2995a90aa605	64942-1608	HUMAN OTC DRUG	Dove		Rose Petals Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20181203		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1609_ef3f1c0f-da43-98e5-e053-2a95a90a427c	64942-1609	HUMAN OTC DRUG	Dove		Powder Finish Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20181203		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1610_b3a36de0-6053-58c1-e053-2a95a90aa0fa	64942-1610	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1611_b3a36780-2f23-251d-e053-2995a90a5dc2	64942-1611	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1612_ef3f1edb-3494-b151-e053-2a95a90a3cf3	64942-1612	HUMAN OTC DRUG	Dove	Powder Finish Dry Serum Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	CONOPCO Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	12.9	g/100g			N	20241231
64942-1617_ef3f5d8a-441e-28ac-e053-2995a90ab198	64942-1617	HUMAN OTC DRUG	Dove	Dermacare Scalp Coconut Hydration Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1618_ef3f5d8a-441f-28ac-e053-2995a90ab198	64942-1618	HUMAN OTC DRUG	Dove	Dermacare Scalp Coconut Hydration Anti-Dandruff Conditioner	Pyrithione Zinc	LIQUID	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	.5	g/100mL			N	20241231
64942-1619_ef3f5d8a-4420-28ac-e053-2995a90ab198	64942-1619	HUMAN OTC DRUG	Dove		Pyrithione Zinc	SHAMPOO	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1620_ef3f5d8a-4421-28ac-e053-2995a90ab198	64942-1620	HUMAN OTC DRUG	Dove		Pyrithione Zinc	LIQUID	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	.5	g/100mL			N	20241231
64942-1621_ef3f66a5-11c1-4856-e053-2a95a90a0a00	64942-1621	HUMAN OTC DRUG	Dove		Pyrithione Zinc	LIQUID	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1622_ef3f6fa4-9006-a009-e053-2a95a90a9806	64942-1622	HUMAN OTC DRUG	Dove		Pyrithione Zinc	LIQUID	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1623_d2189c43-ec31-0a9a-e053-2a95a90a7e9b	64942-1623	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1624_d2187e4f-0461-fef0-e053-2a95a90ad95e	64942-1624	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1625_ef3f6fa4-9007-a009-e053-2a95a90a9806	64942-1625	HUMAN OTC DRUG	Dove		Pyrithione Zinc	SHAMPOO	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1626_ef3f6fa4-9008-a009-e053-2a95a90a9806	64942-1626	HUMAN OTC DRUG	Dove		Pyrithione Zinc	SHAMPOO	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-1627_ef3f6fa4-9009-a009-e053-2a95a90a9806	64942-1627	HUMAN OTC DRUG	ApotheCare		Salicylic Acid	LIQUID	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1628_ef3f6eab-0df6-6426-e053-2995a90a311b	64942-1628	HUMAN OTC DRUG	ApotheCare		Salicylic Acid	LIQUID	TOPICAL	20200101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1632_ef3f81fe-7c4b-9ef7-e053-2995a90a6361	64942-1632	HUMAN OTC DRUG	Dove	Rose Finish Dry Serum Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	CONOPCO Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	12.9	g/100g			N	20241231
64942-1633_ef3f84ad-9d66-b242-e053-2a95a90ac876	64942-1633	HUMAN OTC DRUG	Dr Sweat		Aluminum Chloride	LIQUID	TOPICAL	20190329		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLORIDE	15	g/100g			N	20241231
64942-1634_ef3f81fe-7c4d-9ef7-e053-2995a90a6361	64942-1634	HUMAN OTC DRUG	Dove	Jasmine Finish Dry Serum Antiperspirant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201030		OTC MONOGRAPH FINAL	part350	CONOPCO Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	12.9	g/100g			N	20241231
64942-1643_ef3fdd30-e093-fd54-e053-2995a90a880c	64942-1643	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20190415		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1644_ef3fdd30-e090-fd54-e053-2995a90a880c	64942-1644	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20190415		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1645_ef3fc9c5-9015-aef9-e053-2995a90ad42d	64942-1645	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20190517		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1647_ef3fc9c5-9013-aef9-e053-2995a90ad42d	64942-1647	HUMAN OTC DRUG	Degree		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1648_ee16cd06-82fd-5e43-e053-2a95a90a038e	64942-1648	HUMAN OTC DRUG	Degree		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1649_ee16bdaf-5f20-4374-e053-2a95a90abaa4	64942-1649	HUMAN OTC DRUG	Degree		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1650_ee1684a4-466a-450e-e053-2995a90a2af6	64942-1650	HUMAN OTC DRUG	Degree		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1651_ef3fd208-d532-7ae2-e053-2a95a90a56d3	64942-1651	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1652_ef3fd1e7-6f47-7bbe-e053-2a95a90ab95d	64942-1652	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1653_ef3fd1e7-6f46-7bbe-e053-2a95a90ab95d	64942-1653	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1654_ef3fc59c-d2b4-aefb-e053-2995a90a745f	64942-1654	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1657_ee16bdaf-5f1f-4374-e053-2a95a90abaa4	64942-1657	HUMAN OTC DRUG	Degree		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1658_ef3fc59c-d2b3-aefb-e053-2995a90a745f	64942-1658	HUMAN OTC DRUG	Degree		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20190801		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1659_ee16c042-8f87-447d-e053-2995a90aae9a	64942-1659	HUMAN OTC DRUG	Degree		Aluminum Sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20190901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1660_ee16b702-8567-37d5-e053-2995a90aae3f	64942-1660	HUMAN OTC DRUG	Degree		Aluminum Sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20190901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1661_ee16bb3d-c254-45bd-e053-2995a90abef4	64942-1661	HUMAN OTC DRUG	Degree		Aluminum Sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20190901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1662_ee16b702-8562-37d5-e053-2995a90aae3f	64942-1662	HUMAN OTC DRUG	Degree		Aluminum Sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20190901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1663_ef3fba45-6a80-8bb9-e053-2995a90a8bdb	64942-1663	HUMAN OTC DRUG	Degree		Aluminum Sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20190901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1664_ee16b5ea-8703-f491-e053-2995a90adadc	64942-1664	HUMAN OTC DRUG	Degree		Aluminum Sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20190901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1665_ef3fba45-6a7f-8bb9-e053-2995a90a8bdb	64942-1665	HUMAN OTC DRUG	Axe		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1666_ef3fba45-6a7e-8bb9-e053-2995a90a8bdb	64942-1666	HUMAN OTC DRUG	Axe		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1667_ef3fb088-efe2-44f3-e053-2995a90a11fd	64942-1667	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1668_ef3fa3dc-127a-4854-e053-2a95a90a5c0c	64942-1668	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1669_ee16ad8b-c06a-0eef-e053-2a95a90a753a	64942-1669	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1673_ee16a19d-6c6f-0ef5-e053-2a95a90ac1bc	64942-1673	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1674_ee16ad8b-c068-0eef-e053-2a95a90a753a	64942-1674	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1675_ef3fb22f-9458-3dd6-e053-2995a90a0747	64942-1675	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1676_ef3fb088-efe0-44f3-e053-2995a90a11fd	64942-1676	HUMAN OTC DRUG	Axe		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1677_ee16a459-be08-eb50-e053-2a95a90a4fd7	64942-1677	HUMAN OTC DRUG	Axe		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1678_ee15fc92-822b-1ae5-e053-2995a90a08de	64942-1678	HUMAN OTC DRUG	Axe		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20191001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1679_ee169b21-4fe2-f934-e053-2a95a90a0ea6	64942-1679	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1680_ee16a38b-ec8a-0ef3-e053-2a95a90ade29	64942-1680	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1681_ee16a0ba-73a8-0b4b-e053-2a95a90a2d64	64942-1681	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1682_ee16976e-ac13-e61c-e053-2a95a90aa92b	64942-1682	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1683_ee169b21-4fdf-f934-e053-2a95a90a0ea6	64942-1683	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1684_ee16976e-ac10-e61c-e053-2a95a90aa92b	64942-1684	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1685_ee1694e1-ed4a-b0a1-e053-2a95a90adf60	64942-1685	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1686_ee166349-cb21-cac4-e053-2995a90afdbc	64942-1686	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1687_ee166c78-530b-4692-e053-2a95a90a0109	64942-1687	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1688_ee1666bd-ee3e-34b0-e053-2995a90ae4b6	64942-1688	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1689_ee166651-b5de-081f-e053-2a95a90a0239	64942-1689	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1690_ee166349-cb1f-cac4-e053-2995a90afdbc	64942-1690	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1691_ee1659ee-c88b-0d59-e053-2995a90a5a64	64942-1691	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1692_ee164e33-29aa-935b-e053-2995a90a9b0d	64942-1692	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1693_ee165adc-664e-16d7-e053-2995a90afdbd	64942-1693	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1694_ee1650d1-d8fc-43eb-e053-2a95a90abc12	64942-1694	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1695_ee1650d1-d8f9-43eb-e053-2a95a90abc12	64942-1695	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1696_ee1650d1-d8f8-43eb-e053-2a95a90abc12	64942-1696	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1697_ef3fe251-92ea-bafe-e053-2a95a90a7dad	64942-1697	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1698_ee161afd-67ba-7668-e053-2a95a90acde4	64942-1698	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1699_ef3fe251-92ed-bafe-e053-2a95a90a7dad	64942-1699	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1700_ee1618b6-4dcd-85f0-e053-2a95a90a31f3	64942-1700	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1701_d53df155-7805-ae99-e053-2a95a90a7fa4	64942-1701	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1702_ee160181-3d04-c9fe-e053-2995a90a1b61	64942-1702	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1703_ee160f2c-78bc-10a3-e053-2a95a90a3842	64942-1703	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1704_ef3fb5cc-6d4a-d1b7-e053-2995a90a3de0	64942-1704	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200601		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1705_ee160f2c-78bb-10a3-e053-2a95a90a3842	64942-1705	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1706_ee160181-3d03-c9fe-e053-2995a90a1b61	64942-1706	HUMAN OTC DRUG	Dove		ALUMINUM CHLOROHYDRATE	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1707_ee1606b7-a432-3d18-e053-2a95a90a085f	64942-1707	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1708_ee160423-b273-aa1c-e053-2995a90a6d1f	64942-1708	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1709_ee160181-3d02-c9fe-e053-2995a90a1b61	64942-1709	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1710_ee15f54e-b16a-0c4e-e053-2a95a90a41b5	64942-1710	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1711_ee15fc92-8229-1ae5-e053-2995a90a08de	64942-1711	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1712_ee157f73-0d53-2c92-e053-2a95a90a9b23	64942-1712	HUMAN OTC DRUG	Dove		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200320		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1713_ee15709f-0fec-4015-e053-2995a90a7680	64942-1713	HUMAN OTC DRUG	Degree		Aluminum Sesquichlorohydrate	STICK	TOPICAL	20200620		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1714_ee157f73-0d52-2c92-e053-2a95a90a9b23	64942-1714	HUMAN OTC DRUG	Degree		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20200620		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1715_ee156f9f-3ad2-3ffb-e053-2995a90aba7d	64942-1715	HUMAN OTC DRUG	Degree		ALUMINUM SESQUICHLOROHYDRATE	STICK	TOPICAL	20200620		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1716_ee23e492-8d3e-08f9-e053-2995a90ae9ab	64942-1716	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Clear Minerals 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200420		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1717_ee1552d4-493b-8982-e053-2995a90adea9	64942-1717	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Original Clean 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200420		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1718_ee1551b3-b33d-91bd-e053-2995a90af487	64942-1718	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Skin Renew 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200420		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1719_ee1551b3-b33c-91bd-e053-2995a90af487	64942-1719	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Soothing Chamomile 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200420		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1720_ef3ffb85-bbe4-2cfc-e053-2995a90a3acb	64942-1720	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1721_ef3ff5de-4a2d-f4e7-e053-2a95a90ac555	64942-1721	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1722_ee15f54e-b168-0c4e-e053-2a95a90a41b5	64942-1722	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1723_ee153b72-799c-28ba-e053-2995a90ada24	64942-1723	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1724_ee153b72-799b-28ba-e053-2995a90ada24	64942-1724	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1725_ee152d0b-f100-064a-e053-2a95a90ac394	64942-1725	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1726_ee151267-d7a1-1abd-e053-2a95a90a4720	64942-1726	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1727_ee151ede-d760-4760-e053-2a95a90a0055	64942-1727	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1728_ee150c3f-441d-120f-e053-2995a90a220b	64942-1728	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1729_ee150c3f-441c-120f-e053-2995a90a220b	64942-1729	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1730_ee14f649-d36b-8131-e053-2a95a90ac0b6	64942-1730	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200520		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1731_ef40607f-fee3-828b-e053-2995a90afd70	64942-1731	HUMAN OTC DRUG	Dove		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20200924		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1741_a61464e3-f17b-6df2-e053-2a95a90ad164	64942-1741	HUMAN OTC DRUG	SHEA MOISTURE SPF 35 MINERAL SUNSCREEN		ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20190418		OTC MONOGRAPH NOT FINAL	part352	CONOPCO INC. D/B/A/ UNILEVER	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/mL; mg/mL			N	20241231
64942-1743_8d836750-90fb-4b78-ba9b-4de8ce14e158	64942-1743	HUMAN OTC DRUG	HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200522		OTC MONOGRAPH NOT FINAL	part333A	Conopco, Inc. d/b/a/ Unilever	ALCOHOL	72	mL/100mL			N	20241231
64942-1745_ddcab34c-2cd6-a76b-e053-2a95a90a235a	64942-1745	HUMAN OTC DRUG	Dove		Hand Sanitizer Deep Moisture	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-1746_ddcae318-986a-b9a4-e053-2a95a90a1e6d	64942-1746	HUMAN OTC DRUG	Dove		Hand Sanitizer Shea Butter	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-1747_ddcb15c2-4b75-55e3-e053-2995a90a2142	64942-1747	HUMAN OTC DRUG	Dove		Hand Sanitizer Lavender	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-1748_ef408398-7a82-5561-e053-2995a90a4667	64942-1748	HUMAN OTC DRUG	Dove		Nourishing Secrets Calming Ritual Waterlily Antiperspirant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1749_ef407d9e-b833-24e2-e053-2a95a90a4a9e	64942-1749	HUMAN OTC DRUG	Dove		Nourishing Secrets Soothing Ritual Lavender 48h Antiperspirant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1750_ef40850e-ad6e-41fb-e053-2a95a90a4c1a	64942-1750	HUMAN OTC DRUG	Dove		Nourishing Secrets Indulging Ritual Vanilla Antiperspirant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1751_ef40850e-ad71-41fb-e053-2a95a90a4c1a	64942-1751	HUMAN OTC DRUG	Dove		Nourishing Secrets Soothing Ritual Dry Spray Lavender Jasmine 48h Antiperspirant	AEROSOL, SPRAY	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1752_ef40850e-ad73-41fb-e053-2a95a90a4c1a	64942-1752	HUMAN OTC DRUG	Dove		Nourishing Secrets Calming Ritual Dry Spray Waterlily Sakura Blossoms 48h Antiperspirant	AEROSOL, SPRAY	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1753_ef408398-7a86-5561-e053-2995a90a4667	64942-1753	HUMAN OTC DRUG	Dove		Nourishing Secrets Indulging Ritual Dry Spray Vanilla Cocoa Butter 48h Antiperspirant	AEROSOL, SPRAY	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1756_ecf847d1-d6c7-47df-b115-8f240cc643c8	64942-1756	HUMAN OTC DRUG	NUMIAN HERATAGE HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200810		OTC MONOGRAPH NOT FINAL	part333A	Conopco, Inc. d/b/a/ Unilever	ALCOHOL	72	mL/100mL			N	20241231
64942-1760_ef40a853-db85-58df-e053-2a95a90a5c8f	64942-1760	HUMAN OTC DRUG	Dove		Men Clinical Protection Clean Comfort Antiperspirant	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1761_ef40a853-db86-58df-e053-2a95a90a5c8f	64942-1761	HUMAN OTC DRUG	Dove		Clinical Protection Original Clean Antiperspirant Deodorant	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1762_ef40b19d-fb39-f95e-e053-2a95a90a3dc6	64942-1762	HUMAN OTC DRUG	Dove		MotionSense Clinical Protection Shower Clean Antiperspirant Deodorant	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1763_ef40b478-99e4-859f-e053-2995a90ab915	64942-1763	HUMAN OTC DRUG	Dove		Men MotionSense Clinical Protection Sport Strength Antiperspirant Deodorant	STICK	TOPICAL	20210201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-1764_ef40aaeb-0478-65c2-e053-2995a90aab5b	64942-1764	HUMAN OTC DRUG	Degree		Motionsense Dry Spray Apple and Gardenia 48H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20201015		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1765_ef40b879-7aec-0d38-e053-2a95a90a8da2	64942-1765	HUMAN OTC DRUG	Degree		Motionsense Dry Spray Coconut and Hibiscus 48H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20201015		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1766_ef40ba93-95c3-4bc7-e053-2995a90add44	64942-1766	HUMAN OTC DRUG	Degree		Motionsense Dry Spray Mango and Jasmine 48H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20201015		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1767_ef40b19d-fb3a-f95e-e053-2a95a90a3dc6	64942-1767	HUMAN OTC DRUG	Degree		Motionsense Dry Spray Coconut and Mint 48H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20201019		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1768_ef40b879-7aed-0d38-e053-2a95a90a8da2	64942-1768	HUMAN OTC DRUG	Degree		Motionsense Dry Spray Mandarin and Vetiver 48H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20201019		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1769_ef40b478-99e5-859f-e053-2995a90ab915	64942-1769	HUMAN OTC DRUG	Degree		Motionsense Dry Spray Basil and Lavender 48H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20201015		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1778_ef40ce70-a8e2-9966-e053-2995a90aeb24	64942-1778	HUMAN OTC DRUG	Dove		Men plus Care Dry Spray Eucalyptus and Birch 24H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20201001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1779_ef40d2a5-e16c-2ca8-e053-2995a90a6658	64942-1779	HUMAN OTC DRUG	Dove		Men plus Care Dry Spray Sandalwood and Orange 24H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20201001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1780_ef40d2a5-e16d-2ca8-e053-2995a90a6658	64942-1780	HUMAN OTC DRUG	Dove		Men plus Care Dry Spray Lime and Sage 24H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20201001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1781_ef40d783-686d-3e06-e053-2995a90aa565	64942-1781	HUMAN OTC DRUG	Dove		Men plus Care Sportcare Renew 48HR plus Comfort Antiperspirant	STICK	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1782_ef40d783-686e-3e06-e053-2995a90aa565	64942-1782	HUMAN OTC DRUG	Dove		Men plus Care Refreshing Eucalyptus Birch 24H Antiperspirant	STICK	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1783_ef40d974-7fb0-7ddf-e053-2a95a90ad654	64942-1783	HUMAN OTC DRUG	Dove		Men plus Care Purifying Charcoal 24H Antiperspirant	STICK	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1784_ef42b688-8a36-1508-e053-2995a90a2d27	64942-1784	HUMAN OTC DRUG	Dove		Men plus Care Soothing Sandalwood Orange 24H Antiperspirant	STICK	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1785_ef42b90e-1d07-1bbe-e053-2a95a90aae93	64942-1785	HUMAN OTC DRUG	Dove		Men plus Care Invigorating Lime Sage 24H Antiperspirant	STICK	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1786_ef42a9e3-986a-e5e4-e053-2a95a90ac8c8	64942-1786	HUMAN OTC DRUG	Degree		Motionsense Apple Gardenia Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1787_ef42bd62-0e4f-240c-e053-2a95a90add92	64942-1787	HUMAN OTC DRUG	Degree		Motionsense Coconut Hibiscus Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1788_ef42bf24-6030-65ff-e053-2995a90aee14	64942-1788	HUMAN OTC DRUG	Degree		Degree Motionsense Mango Jasmine Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1789_ef42bf24-6031-65ff-e053-2995a90aee14	64942-1789	HUMAN OTC DRUG	Degree		Motionsense Coconut Mango Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1790_ef42c371-bea5-07e6-e053-2995a90a4988	64942-1790	HUMAN OTC DRUG	Degree		Motionsense Mandarin Vetiver Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19.2	g/100g			N	20241231
64942-1791_ef42bc9c-a880-c6b8-e053-2a95a90a372a	64942-1791	HUMAN OTC DRUG	Degree		Degree Motionsense Pure Clean Ultraclear Black White 48H Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1794_ef42c96e-a499-50f0-e053-2a95a90a1811	64942-1794	HUMAN OTC DRUG	Degree		Men Wild Woods 48H Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1795_ef42c96e-a49a-50f0-e053-2a95a90a1811	64942-1795	HUMAN OTC DRUG	Degree		Men Fresh Ultraclear Black White 48H Antiperspirant Deodorant	STICK	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1796_ef42bc9c-a882-c6b8-e053-2a95a90a372a	64942-1796	HUMAN OTC DRUG	Degree	MotionSense Ultraclear Black and White Pure Clean Dry Antiperspirant	MotionSense Ultraclear Black and White Pure Clean Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1797_ef42bf24-6073-65ff-e053-2995a90aee14	64942-1797	HUMAN OTC DRUG	Degree		Men MotionSense Ultraclear Black and White Dry 48H Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1798_ef42be77-f2e9-6e0b-e053-2995a90a5738	64942-1798	HUMAN OTC DRUG	Degree	Men Motionsense Sport Defense 48H Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1799_ef42bf24-6074-65ff-e053-2995a90aee14	64942-1799	HUMAN OTC DRUG	Degree	Men Motionsense Overtime 48H Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20200901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
64942-1800_ef42dba8-b05f-7391-e053-2995a90a5321	64942-1800	HUMAN OTC DRUG	Axe		Dark Temptation 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20201012		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1801_ef42dba8-b060-7391-e053-2995a90a5321	64942-1801	HUMAN OTC DRUG	Axe		Essence 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20201012		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1802_ef42dcb3-c845-7393-e053-2995a90ae27e	64942-1802	HUMAN OTC DRUG	Axe		Phoenix 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20201012		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1803_ef42e232-aab4-5b9b-e053-2a95a90afec8	64942-1803	HUMAN OTC DRUG	Axe		Ice Chill 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20201012		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1804_ef42be77-f2eb-6e0b-e053-2995a90a5738	64942-1804	HUMAN OTC DRUG	Axe		Anarchy 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20201012		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1805_ef42e598-59e7-a7e2-e053-2a95a90a33e9	64942-1805	HUMAN OTC DRUG	Axe		Apollo 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20201012		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1806_ef42e759-b0e9-b301-e053-2a95a90ac87f	64942-1806	HUMAN OTC DRUG	Axe		Black 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20201012		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1807_ef42e759-b0ea-b301-e053-2a95a90ac87f	64942-1807	HUMAN OTC DRUG	Dove	Soothing Chamomile Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20151201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1808_ef42ea9f-f6b6-7396-e053-2995a90a04f5	64942-1808	HUMAN OTC DRUG	Dove	Invisible Sheer Fresh Dry Antiperspirant	Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20160907		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1809_ef42e8c9-175a-b1dc-e053-2995a90a189a	64942-1809	HUMAN OTC DRUG	Dove	Men plus Care Hydrate Face	AVOBENZONE, ENSULIZOLE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20160122		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE	2; 1.5; 5; 1.3	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64942-1811_ef42f056-d6fc-d9d9-e053-2a95a90a548f	64942-1811	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Sheer Fresh 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1812_ef42f056-d6ff-d9d9-e053-2a95a90a548f	64942-1812	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Clear Finish 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1813_ef42f056-d700-d9d9-e053-2a95a90a548f	64942-1813	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Crystal Touch 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1814_ef42f056-d702-d9d9-e053-2a95a90a548f	64942-1814	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Sheer Cool 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200920		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1815_ef42ea9f-f6b8-7396-e053-2995a90a04f5	64942-1815	HUMAN OTC DRUG	Dove		Sheer Fresh 48h Antiperspirant Deodorant	STICK	TOPICAL	20201013		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1816_ef42f9a5-7281-f6c8-e053-2a95a90a3da1	64942-1816	HUMAN OTC DRUG	Dove		Sheer Cool 48h Antiperspirant Deodorant	STICK	TOPICAL	20201014		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1817_ef42e8c9-175e-b1dc-e053-2995a90a189a	64942-1817	HUMAN OTC DRUG	Dove		Advanced Care Invisible Clear Finish 48h Antiperspirant Deodorant	STICK	TOPICAL	20201014		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-1818_ef42f9a5-7283-f6c8-e053-2a95a90a3da1	64942-1818	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Clear Minerals 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20200420		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1819_ef42fef9-4842-0874-e053-2a95a90a4e80	64942-1819	HUMAN OTC DRUG	Dove Men plus Care	Clean Comfort Antiperspirant and Deodorant	Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20201113		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1821_02f8251f-1d38-1898-e063-6294a90a98b9	64942-1821	HUMAN OTC DRUG	Suave		24 Hour Protection Fresh Aerosol Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20201113		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	19.1	g/100g			N	20241231
64942-1826_ef42f213-a71f-e413-e053-2995a90a3a87	64942-1826	HUMAN OTC DRUG	Baby Dove		8h Moisturization Hand Sanitizer	GEL	TOPICAL	20210115		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-1827_ef430d70-5a87-1315-e053-2995a90aa59c	64942-1827	HUMAN OTC DRUG	Find Your Happy Place		Catching the Sunrise Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1828_ef42f213-a720-e413-e053-2995a90a3a87	64942-1828	HUMAN OTC DRUG	Find Your Happy Place		Girls Night Out Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1829_ef430eee-9f08-3d8e-e053-2a95a90abcc6	64942-1829	HUMAN OTC DRUG	Find Your Happy Place		After the Rain Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1830_ef432678-afc8-22df-e053-2a95a90a4d65	64942-1830	HUMAN OTC DRUG	Find Your Happy Place		Sunkissed Ocean Waves Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1831_ef433298-2f1d-8c07-e053-2995a90a9566	64942-1831	HUMAN OTC DRUG	Find Your Happy Place		Under the Starlit Sky Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1832_ef433e3b-131d-f37a-e053-2995a90a7a30	64942-1832	HUMAN OTC DRUG	Find Your Happy Place		Summertime Sprinklers Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1833_ef433e3b-131e-f37a-e053-2995a90a7a30	64942-1833	HUMAN OTC DRUG	Find Your Happy Place		Wrapped In Your Arms Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1834_ef432e0a-9823-88a6-e053-2995a90aeb3c	64942-1834	HUMAN OTC DRUG	Find Your Happy Place		Lazy Weekends Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1835_ef432e0a-9824-88a6-e053-2995a90aeb3c	64942-1835	HUMAN OTC DRUG	Find Your Happy Place		Sweet Treats Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1836_ef433a1b-8445-e389-e053-2995a90a3e1b	64942-1836	HUMAN OTC DRUG	Dove		Dove Men plus Care Skin Defense Body Wash	LIQUID	TOPICAL	20210115		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-1837_ef43430a-c821-7183-e053-2a95a90a3c4f	64942-1837	HUMAN OTC DRUG	Love Beauty and Planet		Beloved Coconut and Warm Vanilla Hand Sanitizer	GEL	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1838_ef433a1b-8447-e389-e053-2995a90a3e1b	64942-1838	HUMAN OTC DRUG	Love Beauty and Planet		Beloved Catcus Flower and Basil Hand Sanitizer	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1839_ef433e3b-1321-f37a-e053-2995a90a7a30	64942-1839	HUMAN OTC DRUG	Love Beauty and Planet		Beloved Lavender and Hyssop Hand Sanitizer	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1840_ef43430a-c822-7183-e053-2a95a90a3c4f	64942-1840	HUMAN OTC DRUG	Love Beauty and Planet		Beloved Green Clay and Eucalyptus Hand Sanitizer	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1841_ef434edf-6811-b3a5-e053-2a95a90a19f7	64942-1841	HUMAN OTC DRUG	Love Beauty and Planet		Beloved Cherry Blossom and Tea Rose Hand Sanitizer	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1842_ef43430a-c823-7183-e053-2a95a90a3c4f	64942-1842	HUMAN OTC DRUG	Love Beauty and Planet		Beloved Patchouli and Orange Flower Hand Sanitizer	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1843_ded01d2c-168e-99e2-e053-2a95a90a5ee9	64942-1843	HUMAN OTC DRUG	Dove		Care and Protect Moisture Renew Antibacterial Body Wash	LIQUID	TOPICAL	20210115		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-1844_ef434edf-6812-b3a5-e053-2a95a90a19f7	64942-1844	HUMAN OTC DRUG	Love Beauty and Planet		Beloved Grapefruit and Red Ginger Hand Sanitizer	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	ALCOHOL	700	mg/mL			N	20241231
64942-1845_ef434edf-6813-b3a5-e053-2a95a90a19f7	64942-1845	HUMAN OTC DRUG	Dove		Care and Protect Antibacterial Beauty Bar	SOAP	TOPICAL	20210115		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
64942-1846_ef4356f8-6a56-d872-e053-2a95a90abd80	64942-1846	HUMAN OTC DRUG	Dove		Men Skin Defense Antibacterial 3N1 Hand Body Shave Bar	SOAP	TOPICAL	20210115		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
64942-1847_ef4356f8-6a57-d872-e053-2a95a90abd80	64942-1847	HUMAN OTC DRUG	Dove		Care and Protect Antibacterial Hand Wash	LIQUID	TOPICAL	20210115		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-1849_df279564-5173-7119-e053-2a95a90a4d09	64942-1849	HUMAN OTC DRUG	Vaseline		Clinical Care Hand Sanitizer Lotion	LOTION	TOPICAL	20210129		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-1851_ef4359fa-db70-4ba7-e053-2995a90aec45	64942-1851	HUMAN OTC DRUG	Love Beauty and Planet		Eucalyptus and Vetiver Hand Sanitizer Lotion	LOTION	TOPICAL	20210701		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-1853_ef436273-32d9-f1e3-e053-2a95a90aab0b	64942-1853	HUMAN OTC DRUG	Dove		Fresh Antiperspirant Deodorant	STICK	TOPICAL	20210421		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	19.6	g/100g			N	20241231
64942-1854_ef4356f8-6a5a-d872-e053-2a95a90abd80	64942-1854	HUMAN OTC DRUG	Dove		Original Clean Antiperspirant Deodorant	STICK	TOPICAL	20210421		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	19.6	g/100g			N	20241231
64942-1855_ef43668c-3a8a-d870-e053-2a95a90a734f	64942-1855	HUMAN OTC DRUG	Dove		Powder Antiperspirant Deodorant	STICK	TOPICAL	20210421		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	19.6	g/100g			N	20241231
64942-1856_ef43668c-3a8b-d870-e053-2a95a90a734f	64942-1856	HUMAN OTC DRUG	Dove		Sensitive Antiperspirant Deodorant	STICK	TOPICAL	20210421		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM CHLOROHYDRATE	19.6	g/100g			N	20241231
64942-1857_ef436396-09e5-ac6b-e053-2995a90a87f0	64942-1857	HUMAN OTC DRUG	Mele	Men plus Care Hydrate Face	Dew The Most Sheer Moisturizer Sunscreen	LOTION	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; OCTINOXATE	2; 3.99	g/100mL; g/100mL			N	20241231
64942-1858_ef436dd1-4c2d-d874-e053-2a95a90af06f	64942-1858	HUMAN OTC DRUG	Mele	Men plus Care Hydrate Face	No Shade Sunscreen Oil	OIL	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; OCTINOXATE	2; 7.49	g/100mL; g/100mL			N	20241231
64942-1859_ef437287-176b-5e21-e053-2995a90adc98	64942-1859	HUMAN OTC DRUG	St. Ives	Blemish and Blackhead Control Apricot Scrub	Acne Control Apricot Scrub	EMULSION	TOPICAL	20210215		OTC MONOGRAPH FINAL	part333D	CONOPCO Inc. d/b/a Unilever	SALICYLIC ACID	.02	g/g			N	20241231
64942-1860_ef437405-2482-2946-e053-2a95a90a1357	64942-1860	HUMAN OTC DRUG	St. Ives	Blemish and Blackhead Control Apricot Scrub	Green Tea and Bamboo Blackhead Cleansing Scrub	EMULSION	TOPICAL	20210215		OTC MONOGRAPH FINAL	part333D	CONOPCO Inc. d/b/a Unilever	SALICYLIC ACID	.01	g/g			N	20241231
64942-1861_ef437287-176c-5e21-e053-2995a90adc98	64942-1861	HUMAN OTC DRUG	St. Ives	Blemish and Blackhead Control Apricot Scrub	Solutions Acne Control Spot Treatment	LOTION	TOPICAL	20210701		OTC MONOGRAPH FINAL	part333D	CONOPCO Inc. d/b/a Unilever	SALICYLIC ACID	.02	g/g			N	20241231
64942-1862_ef436dd1-4c2e-d874-e053-2a95a90af06f	64942-1862	HUMAN OTC DRUG	St. Ives	Men plus Care Hydrate Face	Solutions Clear Skin Moisturizer Sunscreen	LOTION	TOPICAL	20210701		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; OCTINOXATE	2; 7.49	g/100mL; g/100mL			N	20241231
64942-1863_ef437979-e7c5-4a3e-e053-2a95a90a44c6	64942-1863	HUMAN OTC DRUG	Simple	Men plus Care Hydrate Face	Kind To Skin Protecting Light Moisturizer Sunscreen	LOTION	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 3; 2	g/100mL; g/100mL; g/100mL			N	20241231
64942-1865_ef436619-f9a6-0366-e053-2a95a90a5b8c	64942-1865	HUMAN OTC DRUG	St. Ives	Blemish and Blackhead Control Apricot Scrub	Solutions Acne Control Tea Tree Cleanser	LOTION	TOPICAL	20210215		OTC MONOGRAPH FINAL	part333D	CONOPCO Inc. d/b/a Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1866_ef437d20-6384-638b-e053-2995a90abd77	64942-1866	HUMAN OTC DRUG	Vaseline		Baby Healing Jelly	JELLY	TOPICAL	20210303		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	PETROLATUM	99.96	g/100g			N	20241231
64942-1867_ef437979-e7c9-4a3e-e053-2a95a90a44c6	64942-1867	HUMAN OTC DRUG	Vaseline		Clinical Care Eczema Calming Therapy Cream	LOTION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part347	Conopco, Inc. d/b/a/ Unilever	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64942-1868_ef437bed-902a-52d8-e053-2a95a90a68c8	64942-1868	HUMAN OTC DRUG	Dove	Men plus Care Hydrate Face	DermaSeries Dry Skin Relief Replenishing Face Cream Sunscreen	LOTION	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE	2; 1.5; 5; 1.3	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64942-1869_ef438099-18a5-70cd-e053-2a95a90ae31b	64942-1869	HUMAN OTC DRUG	Vaseline		Baby Healing Jelly	JELLY	TOPICAL	20210303		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	PETROLATUM	99.96	g/100g			N	20241231
64942-1870_ef438099-18ab-70cd-e053-2a95a90ae31b	64942-1870	HUMAN OTC DRUG	Dove		DermaSeries Eczema Relief Soothing Body Lotion	LOTION	TOPICAL	20210305		OTC MONOGRAPH FINAL	part347	Conopco, Inc. d/b/a/ Unilever	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64942-1871_ef437405-2483-2946-e053-2a95a90a1357	64942-1871	HUMAN OTC DRUG	Vaseline	Men plus Care Hydrate Face	Aging Chest and Neck Rescue Treatment Cream	CREAM	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64942-1872_ef437bed-902b-52d8-e053-2a95a90a68c8	64942-1872	HUMAN OTC DRUG	Vaseline		Clinical Care Eczema Flare-Up Rescue Therapy Cream	CREAM	TOPICAL	20210305		OTC MONOGRAPH FINAL	part347	Conopco, Inc. d/b/a/ Unilever	OATMEAL	1.25	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64942-1873_ef4388ae-a819-7578-e053-2a95a90ab804	64942-1873	HUMAN OTC DRUG	Baby Dove		Eczema Care Soothing Cream	CREAM	TOPICAL	20210305		OTC MONOGRAPH FINAL	part347	Conopco, Inc. d/b/a/ Unilever	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
64942-1874_ef4389e1-05e0-d5a3-e053-2995a90ad53a	64942-1874	HUMAN OTC DRUG	Vaseline		Healing Jelly	JELLY	TOPICAL	20210303		OTC MONOGRAPH FINAL	part347	Conopco Inc. d/b/a Unilever	PETROLATUM	99.96	g/100g			N	20241231
64942-1876_bd95ff53-9e61-2e17-e053-2a95a90a32b9	64942-1876	HUMAN OTC DRUG	Simple		Kind To Skin Protecting Light Moisturizer Sunscreen	LOTION	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; OCTISALATE; OCTOCRYLENE	1.5; 3; 2	g/100mL; g/100mL; g/100mL			N	20241231
64942-1877_ef436396-09e8-ac6b-e053-2995a90a87f0	64942-1877	HUMAN OTC DRUG	Vaseline		Aging Chest and Neck Rescue Treatment Cream	CREAM	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 3; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
64942-1878_ef438738-2dc5-0773-e053-2a95a90a8e90	64942-1878	HUMAN OTC DRUG	Mele		No Shade Sunscreen Oil	OIL	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part352	CONOPCO Inc. d/b/a Unilever	AVOBENZONE; OCTINOXATE	2; 7.49	g/100mL; g/100mL			N	20241231
64942-1879_ef439b68-ba58-2465-e053-2995a90a9cf1	64942-1879	HUMAN OTC DRUG	Degree		Ultraclear Black and White Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210706		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-1880_ef439a61-b991-246b-e053-2995a90a2764	64942-1880	HUMAN OTC DRUG	Degree		Advanced White Flowers and Lychee Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210706		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1881_ef438d5e-213c-60c6-e053-2a95a90a954f	64942-1881	HUMAN OTC DRUG	Degree		Advanced Apple and Gardenia Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210706		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1882_ef438d5e-213d-60c6-e053-2a95a90a954f	64942-1882	HUMAN OTC DRUG	Degree		Advanced Coconut and Hibiscus Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210706		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1883_ef438d5e-213e-60c6-e053-2a95a90a954f	64942-1883	HUMAN OTC DRUG	Degree		Ultraclear Black and White Dry Spray 72H Pure Clean Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210706		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-1884_ef43a3d7-4257-2467-e053-2995a90a4584	64942-1884	HUMAN OTC DRUG	Degree		Ultraclear Black and White Dry Spray 72H Pure Rain Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210706		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-1885_ef43a56a-e4c6-a2ba-e053-2a95a90ae8d4	64942-1885	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Acai Berry and Lotus Flower 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210715		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1886_ef43a75a-2e11-650a-e053-2995a90a6d3d	64942-1886	HUMAN OTC DRUG	Dove		Nourishing Secrets Dry Spray Honeysuckle and Mint 48h Antiperspirant	AEROSOL, SPRAY	TOPICAL	20210715		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1888_ef43ab11-d9fb-b8ad-e053-2a95a90a1309	64942-1888	HUMAN OTC DRUG	Degree		Advanced Sexy Intrigue Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210716		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1889_ef43e6a2-c27f-2a8d-e053-2a95a90a2c7a	64942-1889	HUMAN OTC DRUG	Degree		Advanced Shower Clean Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210716		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1890_ef43f307-fae5-3560-e053-2995a90aa8de	64942-1890	HUMAN OTC DRUG	Degree		Advanced Stress Control Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210716		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1891_ef43ef08-82ce-1e49-e053-2995a90a65a2	64942-1891	HUMAN OTC DRUG	Degree		Advanced Fresh Energy Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210719		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1892_ef43a75a-2e13-650a-e053-2995a90a6d3d	64942-1892	HUMAN OTC DRUG	Degree		Advanced Sheer Powder Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210719		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1893_ef439b68-ba59-2465-e053-2995a90a9cf1	64942-1893	HUMAN OTC DRUG	Degree		Advanced Sage and Ocean Mist Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210719		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1894_ef43fe17-10a3-1bea-e053-2995a90a7410	64942-1894	HUMAN OTC DRUG	Degree		Advanced Amber and Pine Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210721		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1895_ef43fa90-6bd2-2469-e053-2995a90a2b31	64942-1895	HUMAN OTC DRUG	Degree		Advanced Cedarwood and Menthol Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210721		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1896_ef43fe17-10a4-1bea-e053-2995a90a7410	64942-1896	HUMAN OTC DRUG	Degree		Advanced Nonstop Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210721		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1897_ef439b68-ba5a-2465-e053-2995a90a9cf1	64942-1897	HUMAN OTC DRUG	Degree		Advanced Extreme Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210721		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1898_ef4405f1-0af5-3ec4-e053-2995a90a6efa	64942-1898	HUMAN OTC DRUG	Degree		Advanced Coconut and Mint Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210721		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1899_ef4405f1-0af6-3ec4-e053-2995a90a6efa	64942-1899	HUMAN OTC DRUG	Degree		Advanced Mandarin and Vetiver Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210721		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1900_c81ff396-65db-af01-e053-2a95a90aec09	64942-1900	HUMAN OTC DRUG	Degree		Advanced Cool Rush Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210722		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1901_ef4405f1-0af7-3ec4-e053-2995a90a6efa	64942-1901	HUMAN OTC DRUG	Degree		Advanced Adventure Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210722		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1902_ef440d7c-b181-6c97-e053-2995a90a2049	64942-1902	HUMAN OTC DRUG	Degree		Advanced Overtime Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210722		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1903_ef43f183-1beb-4c7e-e053-2a95a90a4b06	64942-1903	HUMAN OTC DRUG	Degree		Advanced Sport Defense Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210722		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1904_ef43e637-e450-dfb6-e053-2a95a90ad6a2	64942-1904	HUMAN OTC DRUG	Degree		Advanced Fresh Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210723		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1905_ef43e637-e452-dfb6-e053-2a95a90ad6a2	64942-1905	HUMAN OTC DRUG	Degree		Advanced Ultraclear Black and White Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210723		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1906_ef440d2d-4b74-230b-e053-2995a90a0559	64942-1906	HUMAN OTC DRUG	Degree		Advanced Ultraclear Black and White Driftwood Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20210723		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1907_ef44181a-cd26-3c22-e053-2a95a90a7e49	64942-1907	HUMAN OTC DRUG	Degree		Advanced Ultraclear Black and White Driftwood Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20211201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1908_ef4419f4-7378-8235-e053-2995a90a9c72	64942-1908	HUMAN OTC DRUG	Degree		Advanced Vanilla and Jasmine Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20211201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1909_ef4419f4-7379-8235-e053-2995a90a9c72	64942-1909	HUMAN OTC DRUG	Degree		Advanced Mint and Wild Flowers Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20211201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1910_ef441dc0-91e5-2aa1-e053-2a95a90aba59	64942-1910	HUMAN OTC DRUG	Degree		Advanced Unscented Balance Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20211201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1911_ef44181a-cd27-3c22-e053-2a95a90a7e49	64942-1911	HUMAN OTC DRUG	Degree		Advanced Nonstop Fresh Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20211201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1912_ef44181a-cd29-3c22-e053-2a95a90a7e49	64942-1912	HUMAN OTC DRUG	Degree		Advanced Lavender and Waterlily Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20211201		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-1913_ef44236c-b3b8-6068-e053-2995a90a649c	64942-1913	HUMAN OTC DRUG	Dove		Advanced Care Go Fresh Cool Essentials 48h Antiperspirant Deodorant	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1914_ef4424f7-dae6-bc9b-e053-2a95a90a2775	64942-1914	HUMAN OTC DRUG	Dove		Advanced Care Go Fresh Acai Berry and Lotus Flower 48h Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1915_ef44236c-b3be-6068-e053-2995a90a649c	64942-1915	HUMAN OTC DRUG	Dove		Nourishing Secrets Honeysuckle and Mint 48h Antiperspirant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1916_ef442f36-a45a-70ef-e053-2995a90aa0ed	64942-1916	HUMAN OTC DRUG	Dove		Ultimate Coconut and Sandalwood 48h Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1917_ef442f36-a45c-70ef-e053-2995a90aa0ed	64942-1917	HUMAN OTC DRUG	Dove		Ultimate Gardenia and Aloe 48h Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1919_ef44371a-aa40-b386-e053-2995a90a065f	64942-1919	HUMAN OTC DRUG	Dove		Ultimate Cucumber Water and Mint 48h Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1920_ef443960-de1a-b393-e053-2995a90a682b	64942-1920	HUMAN OTC DRUG	Dove		Ultimate Jasmine and Vanilla 48h Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1921_ef444427-2dac-24f0-e053-2995a90ab996	64942-1921	HUMAN OTC DRUG	Dove		Ultimate Orchid and Blackberry 48h Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1923_ef4471f4-edc6-cefb-e053-2a95a90a123f	64942-1923	HUMAN OTC DRUG	Dove		Ultimate Peony and Rose Water 48h Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1924_ef446fee-a9b4-d61d-e053-2a95a90af2ea	64942-1924	HUMAN OTC DRUG	Dove		Men plus Care Ultimate Juniper Woods 48H Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1925_ef447608-d4db-d82c-e053-2a95a90ab72f	64942-1925	HUMAN OTC DRUG	Dove		Men plus Care Ultimate Coastal Cedar 48H Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1926_ef447608-d4dc-d82c-e053-2a95a90ab72f	64942-1926	HUMAN OTC DRUG	Dove		Men plus Care Ultimate Ocean Breeze 48H Antiperspirant Deodorant	STICK	TOPICAL	20210823		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.15	g/100g			N	20241231
64942-1930_ef4471f4-edc7-cefb-e053-2a95a90a123f	64942-1930	HUMAN OTC DRUG	Degree		Advanced Mint and Wild Flowers 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1931_ef4477d3-f203-7c0a-e053-2a95a90a793d	64942-1931	HUMAN OTC DRUG	Degree		Advanced Unscented Balance 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1932_ef44856b-3beb-cb5a-e053-2a95a90a01cf	64942-1932	HUMAN OTC DRUG	Degree		Advanced Sexy Intrigue 72H Antiperspirant Deodorant	STICK	TOPICAL	20210901		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1933_ef448b48-1001-93f1-e053-2a95a90a1314	64942-1933	HUMAN OTC DRUG	Degree		Advanced Cool Rush 72H Antiperspirant Deodorant	STICK	TOPICAL	20210719		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1934_ef44872c-ba5f-d69b-e053-2a95a90adb55	64942-1934	HUMAN OTC DRUG	Degree		Advanced Sage and Ocean Breeze 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1935_ef448ee7-f3a0-0b2c-e053-2995a90a2dd6	64942-1935	HUMAN OTC DRUG	Degree		Advanced Amber and Pine 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1936_ef448ee7-f3a1-0b2c-e053-2995a90a2dd6	64942-1936	HUMAN OTC DRUG	Degree		Advanced Cedarwood and Menthol 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1937_ef448ee7-f3a2-0b2c-e053-2995a90a2dd6	64942-1937	HUMAN OTC DRUG	Degree		Advanced Nonstop 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1938_ef44872c-ba60-d69b-e053-2a95a90adb55	64942-1938	HUMAN OTC DRUG	Degree		Advanced Extreme Blast 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1939_ef4491f9-89c3-cd6a-e053-2a95a90ac861	64942-1939	HUMAN OTC DRUG	Degree		Advanced Adventure 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1940_ef4491f9-89c4-cd6a-e053-2a95a90ac861	64942-1940	HUMAN OTC DRUG	Degree		Advanced Sport Defense 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1941_ef448b48-1002-93f1-e053-2a95a90a1314	64942-1941	HUMAN OTC DRUG	Degree		Advanced Clean 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1942_ef448b48-1004-93f1-e053-2a95a90a1314	64942-1942	HUMAN OTC DRUG	Degree		Advanced Extreme 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1943_ef44a059-bf8c-7a23-e053-2a95a90a2662	64942-1943	HUMAN OTC DRUG	Degree		Advanced Everest 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1944_ef448ee7-f3a4-0b2c-e053-2995a90a2dd6	64942-1944	HUMAN OTC DRUG	Degree		Advanced Apple and Gardenia 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1945_ef4489b1-69ad-9b2c-e053-2995a90ac7d0	64942-1945	HUMAN OTC DRUG	Degree		Advanced Berry and Peony 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1946_ef44d8aa-cc2a-1931-e053-2995a90acb21	64942-1946	HUMAN OTC DRUG	Degree		Advanced Shower Clean 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1947_ef44dae6-358d-04bb-e053-2a95a90ae32b	64942-1947	HUMAN OTC DRUG	Degree		Advanced Stress Control 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1948_ef44dc5d-91a9-0c1e-e053-2995a90a14d2	64942-1948	HUMAN OTC DRUG	Degree		Advanced Fresh Energy 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1949_ef44dae6-358e-04bb-e053-2a95a90ae32b	64942-1949	HUMAN OTC DRUG	Degree		Advanced Sheer Powder 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1950_ef44dc5d-91ac-0c1e-e053-2995a90a14d2	64942-1950	HUMAN OTC DRUG	Degree		Advanced White Flowers and Lychee 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1951_ef44e1dd-8422-0827-e053-2a95a90af750	64942-1951	HUMAN OTC DRUG	Degree		Advanced Coconut and Hibiscus 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1952_ef44d076-226a-e3c6-e053-2995a90a4ca1	64942-1952	HUMAN OTC DRUG	Degree		Advanced Active Shield 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1953_ef44d076-226b-e3c6-e053-2995a90a4ca1	64942-1953	HUMAN OTC DRUG	Degree		Ultraclear Black plus White Fresh Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-1954_ef44e293-a297-0381-e053-2a95a90af11b	64942-1954	HUMAN OTC DRUG	Degree		Advanced Lavender and Waterlily 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1955_ef44e1dd-8424-0827-e053-2a95a90af750	64942-1955	HUMAN OTC DRUG	Degree		Advanced Vanilla and Jasmine 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1956_ef44e9e0-379f-0b86-e053-2995a90a3bcf	64942-1956	HUMAN OTC DRUG	Degree		Ultraclear Black plus White Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-1957_ef44d8aa-cc2b-1931-e053-2995a90acb21	64942-1957	HUMAN OTC DRUG	Degree		Ultraclear Black plus White Ocean Air Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-1958_ef44ed30-e556-1de6-e053-2995a90abff5	64942-1958	HUMAN OTC DRUG	Degree		Ultraclear Black plus White Driftwood Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-1959_ef44e9e0-37a0-0b86-e053-2995a90a3bcf	64942-1959	HUMAN OTC DRUG	Degree		Ultraclear Black plus White Pure Clean Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-1960_ef44e293-a299-0381-e053-2a95a90af11b	64942-1960	HUMAN OTC DRUG	Degree		Ultraclear Black plus White Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-1961_ef44ebfd-30ec-3ee1-e053-2a95a90a17b0	64942-1961	HUMAN OTC DRUG	Degree		Ultraclear Black plus White Pure Rain Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-1962_ef44ed30-e55b-1de6-e053-2995a90abff5	64942-1962	HUMAN OTC DRUG	Axe		Cool Ocean 48H Anti Sweat Antiperspirant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-1963_ef44ebfd-30ee-3ee1-e053-2a95a90a17b0	64942-1963	HUMAN OTC DRUG	bhs beautiful hair and scalp		Vibrant Color with Rose Essence Anti-dandruff Shampoo	SHAMPOO	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	3	g/100mL			N	20241231
64942-1964_ef44f94d-4214-4f8f-e053-2995a90a8475	64942-1964	HUMAN OTC DRUG	bhs beautiful hair and scalp		Vibrant Color with Rose Essence Anti-dandruff Conditioner	LIQUID	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1965_ef44f94d-4216-4f8f-e053-2995a90a8475	64942-1965	HUMAN OTC DRUG	bhs beautiful hair and scalp		Curl Moisture Anti-dandruff Shampoo	SHAMPOO	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	3	g/100mL			N	20241231
64942-1966_ee268cec-aabe-06c8-e053-2a95a90a8459	64942-1966	HUMAN OTC DRUG	bhs beautiful hair and scalp		Curl Moisture Anti-dandruff Conditioner	LIQUID	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1967_ef44f8a4-b5b3-b29e-e053-2995a90a3637	64942-1967	HUMAN OTC DRUG	bhs beautiful hair and scalp		Full and Strong Anti-dandruff Shampoo	SHAMPOO	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	3	g/100mL			N	20241231
64942-1968_ee2696e7-b288-ee50-e053-2995a90abfa9	64942-1968	HUMAN OTC DRUG	bhs beautiful hair and scalp		Full and Strong Anti-dandruff Conditioner	LIQUID	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1969_ef4504e7-4c46-23f4-e053-2a95a90a7db8	64942-1969	HUMAN OTC DRUG	bhs beautiful hair and scalp		Damage Repair Anti-dandruff Shampoo	SHAMPOO	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	3	g/100mL			N	20241231
64942-1970_ee2699f4-d1cf-4ca2-e053-2995a90a0918	64942-1970	HUMAN OTC DRUG	bhs beautiful hair and scalp		Damage Repair Anti-dandruff Conditioner	LIQUID	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1971_ef44f8a4-b5b4-b29e-e053-2995a90a3637	64942-1971	HUMAN OTC DRUG	bhs beautiful hair and scalp		Smooth Frizz Anti-dandruff Shampoo	SHAMPOO	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	3	g/100mL			N	20241231
64942-1972_ee2699f4-d1d0-4ca2-e053-2995a90a0918	64942-1972	HUMAN OTC DRUG	bhs beautiful hair and scalp		Smooth Frizz Anti-dandruff Conditioner	LIQUID	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-1973_ee268cec-aabf-06c8-e053-2a95a90a8459	64942-1973	HUMAN OTC DRUG	bhs beautiful hair and scalp		Fresh Detox 2 IN 1 Anti-dandruff Shampoo	SHAMPOO	TOPICAL	20211101		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	3	g/100mL			N	20241231
64942-1974_ef44f8a4-b5b5-b29e-e053-2995a90a3637	64942-1974	HUMAN OTC DRUG	Degree		Ultraclear Black plus White 72H Antiperspirant Deodorant	STICK	TOPICAL	20211221		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-1975_ef450844-0759-3454-e053-2a95a90a75f0	64942-1975	HUMAN OTC DRUG	Dove		Men plus Care Dry Spray Energizing Tumeric and Fresh Mandarin 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20211001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1976_ef450844-075c-3454-e053-2a95a90a75f0	64942-1976	HUMAN OTC DRUG	Dove		Men plus Care Dry Spray Relaxing Sea Salt and Wild Lavender 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20211001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1977_ef450e0e-da6e-b5db-e053-2995a90a3d96	64942-1977	HUMAN OTC DRUG	Dove		Men plus Care Energizing Tumeric Fresh Mandarin 48H Antiperspirant	STICK	TOPICAL	20211121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1978_ef450844-075f-3454-e053-2a95a90a75f0	64942-1978	HUMAN OTC DRUG	Dove		Men plus Care Relaxing Sea Salt Wild Lavender 48H Antiperspirant	STICK	TOPICAL	20211121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1979_ef4504e7-4c47-23f4-e053-2a95a90a7db8	64942-1979	HUMAN OTC DRUG	Degree		Shower Clean Antiperspirant Deodorant	STICK	TOPICAL	20211025		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1980_ef4511da-8bdd-3639-e053-2a95a90a12b5	64942-1980	HUMAN OTC DRUG	Degree		Sheer Powder Antiperspirant Deodorant	STICK	TOPICAL	20211025		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1981_ef4504e7-4c48-23f4-e053-2a95a90a7db8	64942-1981	HUMAN OTC DRUG	Degree		Fresh Antiperspirant Deodorant	STICK	TOPICAL	20211025		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1982_ef4519f5-0a60-0f2a-e053-2995a90af73a	64942-1982	HUMAN OTC DRUG	Dove		Teens Blue Raspberry 48h Antiperspirant	STICK	TOPICAL	20211121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1983_ef4519fa-1629-f379-e053-2995a90afdfd	64942-1983	HUMAN OTC DRUG	Dove		Teens Mango Sunshine 48h Antiperspirant	STICK	TOPICAL	20211121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-1984_ef451995-32fc-b1fd-e053-2995a90a9207	64942-1984	HUMAN OTC DRUG	Dove		Teens Blue Raspberry 48h Antiperspirant	AEROSOL, SPRAY	TOPICAL	20211116		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1985_ef451009-57f7-7c2a-e053-2a95a90ac871	64942-1985	HUMAN OTC DRUG	Dove		Teens Mango Sunshine 48h Antiperspirant	AEROSOL, SPRAY	TOPICAL	20211116		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-1995_ef452efb-1599-6911-e053-2995a90a4299	64942-1995	HUMAN OTC DRUG	Degree		Shower Clean Antiperspirant Deodorant	STICK	TOPICAL	20110810		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1996_ddcbbd51-c255-e1fd-e053-2995a90aafbe	64942-1996	HUMAN OTC DRUG	Dove		Nourishing Hand Sanitizer Sensitive Skin 8hr Moisturization	GEL	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-1997_ef4537c2-a940-ac1a-e053-2a95a90a13cf	64942-1997	HUMAN OTC DRUG	Degree		Cool Rush 48H Antiperspirant Deodorant	STICK	TOPICAL	20220121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1998_ef453952-06cf-1cf6-e053-2995a90a4194	64942-1998	HUMAN OTC DRUG	Degree		Extreme Blast 48H Antiperspirant Deodorant	STICK	TOPICAL	20220121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-1999_ef452c7d-bb81-b441-e053-2a95a90a10d7	64942-1999	HUMAN OTC DRUG	Degree		Sport 48H Antiperspirant Deodorant	STICK	TOPICAL	20220121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2001_ef45212f-031b-4a38-e053-2995a90ada61	64942-2001	HUMAN OTC DRUG	Degree		Wild Woods 48H Antiperspirant Deodorant	STICK	TOPICAL	20220121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2002_ef453952-06d2-1cf6-e053-2995a90a4194	64942-2002	HUMAN OTC DRUG	Degree		Cool Comfort 48H Antiperspirant Deodorant	STICK	TOPICAL	20220121		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2003_d9a555e5-5e3c-13d9-e053-2a95a90a62ed	64942-2003	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Passion Fruit and Lemongrass 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220505		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2004_d9a4022c-129d-0d66-e053-2995a90a620d	64942-2004	HUMAN OTC DRUG	Dove		Advanced Care Passion Fruit and Lemongrass 48h Antiperspirant Deodorant	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2005_e1699f5e-8346-dae8-e053-2995a90a0c0b	64942-2005	HUMAN OTC DRUG	Unlimited by Degree		Clean Dry Spray Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	18	g/100g			N	20241231
64942-2006_db5c075a-d0a9-d090-e053-2995a90ad9f6	64942-2006	HUMAN OTC DRUG	Unlimited by Degree		Clean Invisible Solid Antiperspirant Deodorant	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	17	g/100g			N	20241231
64942-2007_db5cf4b9-435d-40f6-e053-2995a90a6b42	64942-2007	HUMAN OTC DRUG	Unlimited by Degree		Fresh Invisible Solid Antiperspirant Deodorant	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	17	g/100g			N	20241231
64942-2008_db61323a-cd67-1d86-e053-2995a90af275	64942-2008	HUMAN OTC DRUG	Unlimited by Degree		Marine Invisible Solid Antiperspirant Deodorant	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	17	g/100g			N	20241231
64942-2009_db847489-9085-348e-e053-2995a90a63d2	64942-2009	HUMAN OTC DRUG	Unlimited by Degree		Neutral Invisible Solid Antiperspirant Deodorant	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	17	g/100g			N	20241231
64942-2010_db876d3a-1d36-95f0-e053-2995a90a116e	64942-2010	HUMAN OTC DRUG	Unlimited by Degree		Bold Invisible Solid Antiperspirant Deodorant	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	17	g/100g			N	20241231
64942-2011_db9c7ac3-8ec3-4d3a-e053-2a95a90aa799	64942-2011	HUMAN OTC DRUG	Unlimited by Degree		Energy Invisible Solid Antiperspirant Deodorant	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	17	g/100g			N	20241231
64942-2012_ec553c9f-5ba5-52f0-e053-2a95a90ae03c	64942-2012	HUMAN OTC DRUG	Dove Men plus Care		Clean Comfort 72H Antiperspirant	STICK	TOPICAL	20220622		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2013_dbd6fdca-8356-e051-e053-2a95a90afee6	64942-2013	HUMAN OTC DRUG	Dove Men plus Care		Stain Defense 72H Antiperspirant	STICK	TOPICAL	20220622		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2014_e168cf9d-8c23-43ea-e053-2995a90af075	64942-2014	HUMAN OTC DRUG	Dove Men plus Care		Dry Spray Extra Fresh 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2015_e169d908-7987-f0c3-e053-2995a90ada3c	64942-2015	HUMAN OTC DRUG	Unlimited by Degree		Fresh Dry Spray Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	18	g/100g			N	20241231
64942-2016_e169ddc2-27e8-0805-e053-2995a90ae7b3	64942-2016	HUMAN OTC DRUG	Unlimited by Degree		Neutral Dry Spray Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	18	g/100g			N	20241231
64942-2017_e169d908-798b-f0c3-e053-2995a90ada3c	64942-2017	HUMAN OTC DRUG	Unlimited by Degree		Marinel Dry Spray Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	18	g/100g			N	20241231
64942-2018_e169c4a6-3e9e-ac81-e053-2a95a90a7cbf	64942-2018	HUMAN OTC DRUG	Unlimited by Degree		Energy Dry Spray Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	18	g/100g			N	20241231
64942-2019_e169e5e5-0d14-70a4-e053-2a95a90a0d49	64942-2019	HUMAN OTC DRUG	Unlimited by Degree		Bold Dry Spray Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	18	g/100g			N	20241231
64942-2030_debc5983-e8bd-c6d5-e053-2995a90af774	64942-2030	HUMAN OTC DRUG	Dove		Moisturizing Hand Sanitizer Wipes Shea Butter and Warm Vanilla Scent	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	760	mg/mL			N	20241231
64942-2032_ddca7c55-0a7d-cea6-e053-2995a90ace5a	64942-2032	HUMAN OTC DRUG	Dove		Hand Sanitizer Deep Moisture	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-2033_ddcad36b-1908-3bbb-e053-2995a90a295a	64942-2033	HUMAN OTC DRUG	Dove		Hand Sanitizer Shea Butter	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-2034_ddcb0871-9904-125f-e053-2a95a90a75de	64942-2034	HUMAN OTC DRUG	Dove		Hand Sanitizer Lavender	GEL	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-2035_ddcbab1c-7afa-2656-e053-2995a90ad07a	64942-2035	HUMAN OTC DRUG	Dove		Nourishing Hand Sanitizer Sensitive Skin 8hr Moisturization	GEL	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-2036_df734b51-33af-d6b7-e053-2995a90a08cc	64942-2036	HUMAN OTC DRUG	Baby Dove		8h Moisturization Hand Sanitizer Fragrance Free	GEL	TOPICAL	20220715		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	610	mg/mL			N	20241231
64942-2037_e168c9c4-6f0b-42ef-e053-2a95a90a3190	64942-2037	HUMAN OTC DRUG	Dove Men plus Care		Dry Spray Clean Comfort 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2038_e169bf76-1db6-4e2d-e053-2995a90a3a90	64942-2038	HUMAN OTC DRUG	Dove Men plus Care		Dry Spray Cool Fresh 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2039_e169a942-2599-a101-e053-2a95a90a8382	64942-2039	HUMAN OTC DRUG	Dove Men plus Care		Dry Spray Stain Defense Cool 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2040_e169ad73-c6bd-0ce9-e053-2995a90aaa9f	64942-2040	HUMAN OTC DRUG	Dove Men plus Care		Dry Spray Stain Defense Clean 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2041_df73e518-caeb-a73b-e053-2995a90a69f5	64942-2041	HUMAN OTC DRUG	Dove		Hand Sanitizer Wipes Shea Butter and Warm Vanilla Scent	CLOTH	TOPICAL	20220520		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	760	mg/mL			N	20241231
64942-2042_df74d901-c86b-ed71-e053-2995a90a39c2	64942-2042	HUMAN OTC DRUG	Dove		Hand Sanitizer Wipes Aloe and Eucalyptus Scent	CLOTH	TOPICAL	20220520		OTC MONOGRAPH NOT FINAL	part333E	Conopco Inc. d/b/a/ Unilever	ALCOHOL	760	mg/mL			N	20241231
64942-2044_e169e5e5-0d16-70a4-e053-2a95a90a0d49	64942-2044	HUMAN OTC DRUG	Degree		Advanced Cucumber Burst Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2045_e169f626-00db-4e1c-e053-2995a90a6dfe	64942-2045	HUMAN OTC DRUG	Degree		Advanced Light and Fresh Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2046_e169f626-00dc-4e1c-e053-2995a90a6dfe	64942-2046	HUMAN OTC DRUG	Degree		Advanced Sensitive Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2047_e169f626-00de-4e1c-e053-2995a90a6dfe	64942-2047	HUMAN OTC DRUG	Degree		Advanced Ultraclear Black White Pure Fresh Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2048_e169f8c6-9e97-72a2-e053-2a95a90a94c5	64942-2048	HUMAN OTC DRUG	Degree		Advanced Coconut Rush Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2049_e1698cc8-76de-e8b1-e053-2995a90ad242	64942-2049	HUMAN OTC DRUG	Degree		Advanced Icy Mint Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2050_e1698cc8-76df-e8b1-e053-2995a90ad242	64942-2050	HUMAN OTC DRUG	Degree		Advanced Light and Fresh Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2051_e169a014-8c9b-487b-e053-2995a90aaf7b	64942-2051	HUMAN OTC DRUG	Dove		Black White Alpine Woods Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220614		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2052_e17bb6f6-00ab-2850-e053-2995a90ae48f	64942-2052	HUMAN OTC DRUG	Dove		Advanced Care Invisble Cucumber Cactus Water 48h Antiperspirant Deodorant	STICK	TOPICAL	20220922		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-2053_ec554b17-4c92-b53d-e053-2a95a90a7bdc	64942-2053	HUMAN OTC DRUG	Dove		Men Care Extra Fresh 72H Antiperspirant	STICK	TOPICAL	20220922		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2054_e909a42e-ca00-6878-e053-2a95a90a9b76	64942-2054	HUMAN OTC DRUG	Dove		Men Care Clean Comfort 72H Antiperspirant	STICK	TOPICAL	20220922		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2055_e20dfb39-da5f-21d7-e053-2a95a90a71ed	64942-2055	HUMAN OTC DRUG	Dove		Men Care Sensitive Shield 72H Antiperspirant	STICK	TOPICAL	20220922		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2056_e21e41fd-0de4-aab4-e053-2995a90adf61	64942-2056	HUMAN OTC DRUG	Dove		Men Care Stain Defense Clean 72H Antiperspirant	STICK	TOPICAL	20220922		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-2057_e2207580-7222-8f26-e053-2995a90a5d7c	64942-2057	HUMAN OTC DRUG	Dove		Men Care Stain Defense Cool 72H Antiperspirant	STICK	TOPICAL	20220922		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-2064_e34d45d9-ee1f-175b-e053-2a95a90ad592	64942-2064	HUMAN OTC DRUG	Dove		Men plus Care Cedarwood Tonka Beans 48H Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2065_e34e7b3d-9b36-9311-e053-2a95a90a8bf0	64942-2065	HUMAN OTC DRUG	Dove		Men plus Care Cedarwood Tonka Beans Dry Spray 48H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2066_e35057e0-ec7b-d705-e053-2995a90afbe9	64942-2066	HUMAN OTC DRUG	Axe		Dark Temptation 48H Fresh Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2067_e387e2bf-09c0-2340-e053-2995a90a3623	64942-2067	HUMAN OTC DRUG	Axe		Anarchy 48H Fresh Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2068_e38b6061-313a-0bc2-e053-2a95a90ab15b	64942-2068	HUMAN OTC DRUG	Axe		Apollo 48H Fresh Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2069_e38bc99c-9ae3-6dbd-e053-2995a90aa10b	64942-2069	HUMAN OTC DRUG	Axe		Phoenix 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2070_e38e3d5e-4da0-7e94-e053-2995a90a8d1a	64942-2070	HUMAN OTC DRUG	Axe		Black 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2071_e39ef5e7-22db-4e9d-e053-2995a90a4a1f	64942-2071	HUMAN OTC DRUG	Axe		Cool Ocean 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2072_e39f41ed-090b-9f0e-e053-2995a90ab36a	64942-2072	HUMAN OTC DRUG	Axe		Essence 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2073_e3a0491a-d83d-f7d7-e053-2995a90acc8c	64942-2073	HUMAN OTC DRUG	Axe		Ice Chill 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20221022		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2075_e4cbd1e4-4fcb-8eb3-e053-2a95a90a6d41	64942-2075	HUMAN OTC DRUG	Dove		Men plus Care Ultimate Coconut Scent 48H Antiperspirant	STICK	TOPICAL	20220822		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2076_e4cbd1e4-4fcd-8eb3-e053-2a95a90a6d41	64942-2076	HUMAN OTC DRUG	Dove		Men plus Care Ultimate Shea Butter Scent 48H Antiperspirant	STICK	TOPICAL	20220822		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2077_e4cba654-4729-46c7-e053-2995a90a8dfd	64942-2077	HUMAN OTC DRUG	Dove		Men plus Care Ultimate Aloe Vera Scent 48H Antiperspirant	STICK	TOPICAL	20220822		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2078_e4cc1a69-efdf-1eb8-e053-2995a90aa322	64942-2078	HUMAN OTC DRUG	Dove		Men plus Care Ultimate Hemp Scent 48H Antiperspirant	STICK	TOPICAL	20220822		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2081_e56edc13-9225-84f3-e053-2a95a90a2c51	64942-2081	HUMAN OTC DRUG	St. Ives		Acne Control Apricot Scrub	LOTION	TOPICAL	20220804		OTC MONOGRAPH FINAL	part333D	CONOPCO Inc. d/b/a Unilever	SALICYLIC ACID	.02	g/g			N	20241231
64942-2082_e5e6400a-abf5-c457-e053-2a95a90ae29b	64942-2082	HUMAN OTC DRUG	Shea Moisture		Apple Cider Vinegar Anti-dandruff Shampoo	LIQUID	TOPICAL	20221201		OTC MONOGRAPH FINAL	M032	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	3	g/100mL			N	20241231
64942-2083_e5e720f7-4a23-8f34-e053-2a95a90acd8c	64942-2083	HUMAN OTC DRUG	Shea Moisture		Apple Cider Vinegar Anti-dandruff Conditioner	LIQUID	TOPICAL	20221201		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	2	g/100mL			N	20241231
64942-2084_e5e84ecf-a9c6-920e-e053-2a95a90aabe7	64942-2084	HUMAN OTC DRUG	Shea Moisture		Apple Cider Vinegar Anti-dandruff Pre-Wash	LIQUID	TOPICAL	20221201		OTC MONOGRAPH FINAL	M032	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	1.8	g/100mL			N	20241231
64942-2085_e5e7ca6d-8d38-626b-e053-2a95a90ab91b	64942-2085	HUMAN OTC DRUG	Shea Moisture		Apple Cider Vinegar Anti-dandruff Leave-In	LIQUID	TOPICAL	20221201		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	SALICYLIC ACID	1.8	g/100mL			N	20241231
64942-2086_e685c09e-6496-f933-e053-2995a90ad741	64942-2086	HUMAN OTC DRUG	Dove		Ultimate Cucumber Water plus Mint Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220905		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2087_e68520c4-3d9d-9c7b-e053-2a95a90a4ec6	64942-2087	HUMAN OTC DRUG	Dove		Ultimate Coconut plus Sandalwood Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220905		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2088_e689681e-4086-d026-e053-2995a90a0a01	64942-2088	HUMAN OTC DRUG	Dove		Ultimate Peony plus Rose Water Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220905		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2089_e689c5fd-d4da-139e-e053-2a95a90ad394	64942-2089	HUMAN OTC DRUG	Dove		Ultimate Jasmine plus Vanilla Water Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20220905		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2090_e7746d53-982f-1c0c-e053-2a95a90a0318	64942-2090	HUMAN OTC DRUG	Dove Men plus Care		Active Recharge Enduring Woody Scent Dry Spray 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2091_e774ee79-d23b-ebaa-e053-2a95a90a4c56	64942-2091	HUMAN OTC DRUG	Dove Men plus Care		Active Revive Enduring Zesty Scent Dry Spray 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2092_e77556e5-d3cf-5311-e053-2995a90a1402	64942-2092	HUMAN OTC DRUG	Dove Men plus Care		Stain Defense Clean Dry Spray 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2094_eaaffa3a-22e5-9f36-e053-2995a90a302a	64942-2094	HUMAN OTC DRUG	Dove		Advanced Care Dry Spray Mango and Almond Butter 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221010		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2095_eb3ed3c9-e125-ef82-e053-2995a90a33a8	64942-2095	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Clean 72H Antiperspirant	STICK	TOPICAL	20221017		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-2096_f07139c4-c2cf-b001-e053-2995a90a952b	64942-2096	HUMAN OTC DRUG	Dove Men plus Care		Clean Comfort Dry Spray 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20221018		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2097_ec6ebb0b-f955-6fe2-e053-2a95a90aebc1	64942-2097	HUMAN OTC DRUG	Dove		Advanced Care Beauty Finish Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2098_ec6d9d04-bd9a-d089-e053-2a95a90a994c	64942-2098	HUMAN OTC DRUG	Dove		Advanced Care Cool Essentials Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2099_ec6d76b2-ce07-34cf-e053-2a95a90acafa	64942-2099	HUMAN OTC DRUG	Dove Men plus Care		Clean Comfort Dry Spray 72H Antiperspirant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2100_ec698b75-2345-41ef-e053-2995a90afa37	64942-2100	HUMAN OTC DRUG	Degree		Ultraclear Black and White Pure Rain Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2101_ec6befdb-a6a0-0e84-e053-2a95a90a5051	64942-2101	HUMAN OTC DRUG	Degree		Advanced Shower Clean Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2102_ec6c6021-a630-68cb-e053-2995a90aab02	64942-2102	HUMAN OTC DRUG	Degree		Ultraclear Black and White Fresh Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2103_ec6c72b0-8e8c-1785-e053-2a95a90a6d85	64942-2103	HUMAN OTC DRUG	Degree		Advanced Cool Rush Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2104_ec6d398b-7af5-2a42-e053-2a95a90ae2b1	64942-2104	HUMAN OTC DRUG	Degree		Advanced Shower Clean Dry Spray 72H Motionsense Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2105_ed234413-7779-9c82-e053-2a95a90a6f98	64942-2105	HUMAN OTC DRUG	Dove		Care and Protect Antibacterial Hand Wash	LIQUID	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-2107_ed32025f-89d2-b921-e053-2995a90a06b2	64942-2107	HUMAN OTC DRUG	Dove		Men plus Care Antibactercial Skin Defense Body and Face Wash	LIQUID	TOPICAL	20230116		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-2108_edad357c-0105-418d-e053-2995a90a8860	64942-2108	HUMAN OTC DRUG	Dove		Men plus Care Stain Defense Clean 72H Antiperspirant	STICK	TOPICAL	20221122		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	9.6	g/100g			N	20241231
64942-2110_2044253c-bd77-452d-a57c-51152dc8040e	64942-2110	HUMAN OTC DRUG	Michiru hair regrowth treatment for women		Minoxidil	SOLUTION	TOPICAL	20221214		ANDA	ANDA075357	Conopco Inc. d/b/a Unilever	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
64942-2111_f8307521-8a87-462a-ad47-76a983911967	64942-2111	HUMAN OTC DRUG	nexxus hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20230419		ANDA	ANDA075357	Conopco Inc. d/b/a Unilever	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
64942-2115_af9b4981-1cea-4808-9797-c802a5b27569	64942-2115	HUMAN OTC DRUG	shea moisture hair regrowth treatment for women		Minoxidil	SOLUTION	TOPICAL	20231016		ANDA	ANDA075357	Conopco Inc. d/b/a Unilever	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
64942-2117_062f87d5-d20d-2a74-e063-6394a90a13ce	64942-2117	HUMAN OTC DRUG	Dove		Men plus Care Clean Comfort 72H Antiperspirant	STICK	TOPICAL	20230315		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2118_f695b237-2ef6-4b34-e053-2a95a90ac90e	64942-2118	HUMAN OTC DRUG	Dove		Advanced Care Caring Coconut 48h Antiperspirant Deodorant	STICK	TOPICAL	20221017		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2119_f7f7ac15-8549-e93f-e053-6394a90aadf7	64942-2119	HUMAN OTC DRUG	Dove		Advanced Care Go Fresh Revive 48h Antiperspirant Deodorant	STICK	TOPICAL	20200201		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2120_f99e5056-a28d-6004-e053-6394a90a63ac	64942-2120	HUMAN OTC DRUG	Dove		Men plus Care 96H Clinical Protection Clean Comfort Antiperspirant	STICK	TOPICAL	20230414		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
64942-2121_fc723d3e-7488-34fb-e053-6394a90a09ec	64942-2121	HUMAN OTC DRUG	Dove		Care and Protect Antibactercial Body Wash	LIQUID	TOPICAL	20230524		OTC MONOGRAPH NOT FINAL	part333A	Conopco Inc. d/b/a/ Unilever	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
64942-2122_00d5b4a7-90bb-7a7c-e063-6294a90a52b0	64942-2122	HUMAN OTC DRUG	Axe		Essence Black Pepper and Cedarwood Scent 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20230703		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2123_00d63f96-10eb-668b-e063-6394a90a72c8	64942-2123	HUMAN OTC DRUG	Axe		Black Frozen Pear and Cedarwood Scent 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20230719		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2124_00d68a75-6c5d-1b7a-e063-6394a90ab78e	64942-2124	HUMAN OTC DRUG	Axe		Dark Temptation Dark Chocolate Scent 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20230703		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2125_00d7203d-fdc4-951c-e063-6394a90ae46b	64942-2125	HUMAN OTC DRUG	Axe		Phoenix Crushed Mint and Rosemary 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20230719		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2126_fe1830cc-42ad-8122-e053-6394a90a905c	64942-2126	HUMAN OTC DRUG	Dove		Advanced Care Coconut Water and Lime Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2127_fe193935-9630-8fa9-e053-6294a90a6697	64942-2127	HUMAN OTC DRUG	Dove		Advanced Care Peach and Chamomile Tea Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2128_feb7484e-e2c5-9ee1-e053-6394a90ad4d7	64942-2128	HUMAN OTC DRUG	Dove		Advanced Care Beauty Finish Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2129_feb8692a-9c05-0d5c-e053-6394a90a904b	64942-2129	HUMAN OTC DRUG	Dove		Advanced Care Lavender Fresh Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2130_feb8cebe-c223-7616-e053-6394a90a3067	64942-2130	HUMAN OTC DRUG	Dove		Advanced Care Original Clean Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2131_004a8c7c-920d-f17d-e063-6394a90a3b4e	64942-2131	HUMAN OTC DRUG	Dove		Advanced Coconut Water and Lime Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20230901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2132_ffbd246d-7dbf-08b9-e053-6294a90a2d95	64942-2132	HUMAN OTC DRUG	Dove		Advanced Care Invisible plus Cucumber and Cactus water Antiperspirant Deodorant	STICK	TOPICAL	20230705		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-2133_004a06c1-0408-b41b-e063-6294a90a698f	64942-2133	HUMAN OTC DRUG	Dove		Teens Strawberry Sparkle 48h Antiperspirant	AEROSOL, SPRAY	TOPICAL	20230901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2134_0035395a-85a4-0223-e063-6394a90abfbc	64942-2134	HUMAN OTC DRUG	Dove		Even Tone plus Niacinamide Apple Blossom and Mango Butter Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-2135_0034fbaf-129b-bb29-e063-6394a90a6d0a	64942-2135	HUMAN OTC DRUG	Dove		Even Tone plus Niacinamide Peach Blossom and Rice Milk Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-2136_0035ae96-13de-9cac-e063-6394a90addea	64942-2136	HUMAN OTC DRUG	Dove		Even Tone plus Niacinamide Rosewood and Powder Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-2137_0035a027-54d3-6de3-e063-6294a90a1266	64942-2137	HUMAN OTC DRUG	Dove		Even Tone plus Niacinamide Shea Butter and Vanilla Antiperspirant Deodorant	STICK	TOPICAL	20230711		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-2138_0024658a-0b43-790f-e063-6294a90aefe8	64942-2138	HUMAN OTC DRUG	Dove		Even Tone plus Niacinamide Apple Blossom and Mango Butter Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20230710		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2139_00257c38-d51f-21a0-e063-6294a90a684e	64942-2139	HUMAN OTC DRUG	Dove		Even Tone plus Niacinamide Peach Blossom and Rice Milk Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20230710		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2140_002679c3-39e4-75aa-e063-6294a90a0290	64942-2140	HUMAN OTC DRUG	Dove		Even Tone plus Niacinamide Shea Butter and Vanilla Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20230710		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2141_00eef191-4eab-5b06-e063-6294a90ad5bd	64942-2141	HUMAN OTC DRUG	Dove		Advanced Peach and Chamomile Tea Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20230901		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2142_00ff649b-4075-aa70-e063-6394a90a7879	64942-2142	HUMAN OTC DRUG	Axe		Apollo Sage and Cedarwood Scent 48H Fresh and Dry Antiperspirant	STICK	TOPICAL	20230721		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2144_0218b0ce-4ad6-1611-e063-6294a90a7d33	64942-2144	HUMAN OTC DRUG	Suave		Essentials Scalp Control Anti-Dandruff 2 IN 1 Shampoo plus Conditioner	SHAMPOO	TOPICAL	20230804		OTC MONOGRAPH FINAL	part358H	Conopco, Inc. d/b/a/ Unilever	PYRITHIONE ZINC	1	g/100mL			N	20241231
64942-2145_021b8ff5-9a4e-7db6-e063-6294a90a1cf3	64942-2145	HUMAN OTC DRUG	Suave		Aloe and Rose Water Anti-Staining Antiperspirant Deodorant	STICK	TOPICAL	20230804		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2146_036dcdd1-d9a1-fe29-e063-6294a90ab113	64942-2146	HUMAN OTC DRUG	Suave		Cocoa Shea Anti-Staining Antiperspirant Deodorant	STICK	TOPICAL	20230807		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2147_03882c90-f469-47b4-e063-6394a90a99e4	64942-2147	HUMAN OTC DRUG	Dove		Raw Shea Butter and Hyaluronic Acid Moisturizing 48h Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2148_03890907-8f64-e6e6-e063-6394a90aa291	64942-2148	HUMAN OTC DRUG	Dove		Coconut and Hibiscus Fresh 48h Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2149_038979e2-bc59-2e3c-e063-6294a90aa573	64942-2149	HUMAN OTC DRUG	Dove		Manuka Honey and Retinol Smoothing 48h Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2150_0395ebb0-8d03-bdc9-e063-6394a90a0a53	64942-2150	HUMAN OTC DRUG	Dove		Aloe Vera and Ceramide Sensitive 48h Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2151_02e2fb37-5911-1e3d-e063-6394a90adecd	64942-2151	HUMAN OTC DRUG	Suave		Men Energizing Sport Bergamot plus Wood Antiperspirant Deodorant	STICK	TOPICAL	20230814		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2152_031deebd-3cd8-1267-e063-6394a90ae6af	64942-2152	HUMAN OTC DRUG	Dove		Advanced Care Caring Coconut Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2153_031eef9d-14e1-6727-e063-6294a90a19df	64942-2153	HUMAN OTC DRUG	Dove		Advanced Care Cool Essentials Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2154_031f6392-1d9c-8e4f-e063-6294a90a7863	64942-2154	HUMAN OTC DRUG	Dove		Advanced Care Restore Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2155_031fca69-a52c-9347-e063-6294a90a4e9c	64942-2155	HUMAN OTC DRUG	Dove		Advanced Care Rose Petals Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2156_03205444-c74e-7d46-e063-6394a90ac53c	64942-2156	HUMAN OTC DRUG	Dove		Advanced Care Revive Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2157_05f1a7b6-8a35-34a1-e063-6294a90a2f0e	64942-2157	HUMAN OTC DRUG	Dove		Advanced Care Caring Coconut Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20230922		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2158_0a997b94-a07d-79d5-e063-6394a90a99cb	64942-2158	HUMAN OTC DRUG	Dove		Advanced Care Cool Essentials Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2159_037193b9-6eee-6840-e063-6394a90ac9ca	64942-2159	HUMAN OTC DRUG	Dove		Advanced Care Lavender Fresh Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2160_03720ac6-741c-e717-e063-6394a90a4040	64942-2160	HUMAN OTC DRUG	Dove		Advanced Care Clear Minerals Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2161_075ea13f-0439-2816-e063-6394a90a8e6c	64942-2161	HUMAN OTC DRUG	Suave		Mango and Citrus Anti-Staining Antiperspirant Deodorant	STICK	TOPICAL	20230807		OTC MONOGRAPH DRUG	M026	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2162_0372616a-6c19-c014-e063-6294a90a8b64	64942-2162	HUMAN OTC DRUG	Dove		Advanced Care Pink Rosa Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2163_03731c08-375e-bd94-e063-6394a90a7545	64942-2163	HUMAN OTC DRUG	Dove		Advanced Care Shea Butter Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2164_0382269f-bfbe-206f-e063-6394a90a2e09	64942-2164	HUMAN OTC DRUG	Dove		Advanced Care Rose Petals Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2165_038264d4-38e1-10e3-e063-6294a90aa798	64942-2165	HUMAN OTC DRUG	Dove		Advanced Care Powder Soft Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2166_03827ccb-c6a9-349c-e063-6394a90a0f31	64942-2166	HUMAN OTC DRUG	Dove		Advanced Care Nourished Beauty Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2167_03833cd9-6fc8-7d69-e063-6294a90a9bf8	64942-2167	HUMAN OTC DRUG	Dove		Advanced Care Original Clean Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2168_03839c1e-7bd6-5dcf-e063-6394a90a62c6	64942-2168	HUMAN OTC DRUG	Dove		Advanced Care Sheer Cool Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2169_039b83ec-e62d-e1f9-e063-6394a90ae83a	64942-2169	HUMAN OTC DRUG	Dove		Advanced Care Sheer Fresh Dry Spray 48h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
64942-2170_03963e9b-f7b5-f947-e063-6394a90ad004	64942-2170	HUMAN OTC DRUG	Dove		Vitamin E and Kukui Nut Oil Soothing Post-Shave 48h Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2171_03969c4b-0fc7-4729-e063-6394a90aad2c	64942-2171	HUMAN OTC DRUG	Dove		Vitamin C and Niacinamide Even Tone 48h Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2172_039d06a1-9bfb-2385-e063-6394a90a45c2	64942-2172	HUMAN OTC DRUG	Dove		Advanced Care Unscented Sensitive Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2173_03aab1a1-6e82-e249-e063-6294a90ab995	64942-2173	HUMAN OTC DRUG	Dove		Advanced Care Shea Butter Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2174_03ab7712-dc20-3b6a-e063-6294a90a1e34	64942-2174	HUMAN OTC DRUG	Dove		Advanced Care Apple and White Tea Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2175_03ac4d1b-e82e-4e5f-e063-6294a90a3d44	64942-2175	HUMAN OTC DRUG	Dove		Advanced Care Rejuvenate Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2176_03ae9375-df37-0ea4-e063-6394a90a3b95	64942-2176	HUMAN OTC DRUG	Dove		Advanced Care Vanilla and Cocoa Butter Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2177_03af1c34-8651-70a4-e063-6294a90a4322	64942-2177	HUMAN OTC DRUG	Dove		Advanced Care Waterlily and Sakura Blossom Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2178_03c04e37-88d2-3a57-e063-6394a90a4613	64942-2178	HUMAN OTC DRUG	Degree		Advanced Cool Rush Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231107		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2179_03fdac16-38b3-bd44-e063-6294a90a0a07	64942-2179	HUMAN OTC DRUG	Degree		Advanced Move Fresh Coconut Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231107		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2180_03feaaef-73ff-d464-e063-6294a90a2b2d	64942-2180	HUMAN OTC DRUG	Degree		Advanced Sheer Powder Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231107		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2181_03ff1eeb-7e3e-fbb1-e063-6294a90a9ce9	64942-2181	HUMAN OTC DRUG	Degree		Advanced Shower Clean Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231107		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2182_040ecf3a-b4b1-4e7a-e063-6394a90a0d86	64942-2182	HUMAN OTC DRUG	Degree		Cool Rush 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2184_06e6c8fd-84d3-7878-e063-6294a90a75cf	64942-2184	HUMAN OTC DRUG	Axe		Anarchy Dark Pomegrante and Sandalwood 48H Sweat and Odor Protection Antiperspirant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M026	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2185_04b0de72-20d7-7807-e063-6294a90ab845	64942-2185	HUMAN OTC DRUG	Axe		Apollo Sage and Cedarwood 48H Sweat and Odor Protection Antiperspirant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2186_04b1a890-736b-5850-e063-6394a90a6f7e	64942-2186	HUMAN OTC DRUG	Axe		Phoenix Crushed Mint and Rosemary 48H Sweat and Odor Protection Antiperspirant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2187_04b24a69-0363-376a-e063-6394a90ac67b	64942-2187	HUMAN OTC DRUG	Axe		Black Frozen Pear and Cedarwood 48H Sweat and Odor Protection Antiperspirant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2188_04b4194f-4a6a-8a8a-e063-6394a90adef1	64942-2188	HUMAN OTC DRUG	Axe		Cool Ocean Sea Mist and Grapefruit 48H Sweat and Odor Protection Antiperspirant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2189_04b49599-eb48-22d0-e063-6294a90a4966	64942-2189	HUMAN OTC DRUG	Axe		Essence Black Pepper and Cedarwood 48H Sweat and Odor Protection Antiperspirant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2190_04b5039e-e528-930a-e063-6394a90a2219	64942-2190	HUMAN OTC DRUG	Axe		Ice Chill Iced Mint and Lemon 48H Sweat and Odor Protection Antiperspirant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
64942-2191_0d30a5ae-3717-f58c-e063-6394a90a0848	64942-2191	HUMAN OTC DRUG	Dove		Dove Men plus Care Midnigth Classic 72H Antiperspirant	STICK	TOPICAL	20221122		OTC MONOGRAPH DRUG	M026	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2192_0d3179c1-a98d-f0bc-e063-6294a90a493b	64942-2192	HUMAN OTC DRUG	Dove		Dove Men plus Care Cool Fresh 72H Antiperspirant	STICK	TOPICAL	20221122		OTC MONOGRAPH DRUG	M026	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.8	g/100g			N	20241231
64942-2193_0d5709de-9205-e932-e063-6394a90a3817	64942-2193	HUMAN OTC DRUG	Dove		Men plus Care Moon Oasis 72H Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2194_0d2f1ddf-bd64-58e9-e063-6394a90af909	64942-2194	HUMAN OTC DRUG	Dove		Men plus Care Midnight Classico 72H Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2195_0d2f69be-e232-6405-e063-6394a90aad95	64942-2195	HUMAN OTC DRUG	Dove		Men plus Care Morning Fresco 72H Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2196_062f732d-ba38-17ed-e063-6294a90afcfa	64942-2196	HUMAN OTC DRUG	Degree		Advanced Shower Clean 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2197_04cbb5bf-96ca-df57-e063-6394a90a5d15	64942-2197	HUMAN OTC DRUG	Degree		Advanced Move Fresh Coconut 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2198_070bbc81-b38b-527e-e063-6394a90a775d	64942-2198	HUMAN OTC DRUG	Degree		Advanced Cool Rush 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M026	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2199_04d81361-8860-cd25-e063-6394a90aa78b	64942-2199	HUMAN OTC DRUG	Degree		Advanced Deep Cedar and Lavender Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2200_04d9bf46-56e7-79ba-e063-6394a90a7547	64942-2200	HUMAN OTC DRUG	Degree		Advanced Iced Eucalyptus Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2201_04dac9dd-ef43-9675-e063-6294a90ad263	64942-2201	HUMAN OTC DRUG	Degree		Advanced Icy Mint Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2202_05166e8a-5bea-7850-e063-6394a90af5db	64942-2202	HUMAN OTC DRUG	Degree		Advanced Coconut Rush Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2203_0517d403-9aa1-5b07-e063-6394a90a5fac	64942-2203	HUMAN OTC DRUG	Degree		Advanced Sage and Ocean Mist Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2204_05189f85-cc89-6af6-e063-6394a90acdba	64942-2204	HUMAN OTC DRUG	Degree		Advanced Extreme Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2205_0519ecdf-5db5-49f0-e063-6394a90aebe5	64942-2205	HUMAN OTC DRUG	Degree		Advanced Deep Cedar and Lavender 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2206_051acbc2-7bf9-4059-e063-6394a90a115b	64942-2206	HUMAN OTC DRUG	Degree		Advanced Fresh Bergamot aand Sandalwood 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2207_0528e877-c030-ba57-e063-6394a90a3077	64942-2207	HUMAN OTC DRUG	Degree		Advanced Nonstop Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2208_06578611-1f4d-6fd0-e063-6294a90a8df3	64942-2208	HUMAN OTC DRUG	Degree		Advanced Adventure 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2209_052ccdd7-46dd-d12d-e063-6294a90a50f0	64942-2209	HUMAN OTC DRUG	Degree		Advanced Iced Eucalyptus 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2210_052e4ac6-553e-18c8-e063-6394a90adc4d	64942-2210	HUMAN OTC DRUG	Degree		Advanced Fresh English Rose 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2211_054053dd-c37f-1c77-e063-6394a90a848c	64942-2211	HUMAN OTC DRUG	Degree		Advanced Lavender and Waterlily Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2212_05418133-95c6-ea56-e063-6394a90a2a6e	64942-2212	HUMAN OTC DRUG	Degree		Sport 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2213_05513822-4673-cdf6-e063-6294a90a113a	64942-2213	HUMAN OTC DRUG	Degree		Extreme Blast 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2214_05524ff8-23ba-9fd0-e063-6394a90a6de5	64942-2214	HUMAN OTC DRUG	Degree		Wild Woods 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2215_05b9c4d9-abff-cace-e063-6294a90aa0b7	64942-2215	HUMAN OTC DRUG	Degree		Advanced Advanture 72H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2216_05cd94e7-1809-3bb3-e063-6294a90a4140	64942-2216	HUMAN OTC DRUG	Degree		Advanced Sage and Ocean Mist 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2217_05cedb37-61de-f2c1-e063-6394a90a4492	64942-2217	HUMAN OTC DRUG	Degree		Cool Comfort 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	18.2	g/100g			N	20241231
64942-2218_05deca74-7639-5769-e063-6394a90a8b1a	64942-2218	HUMAN OTC DRUG	Degree		Advanced Nonstop 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2219_05df284a-71b5-58bb-e063-6394a90a66f0	64942-2219	HUMAN OTC DRUG	Degree		Advanced Extreme 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2220_05e04fc6-e487-6158-e063-6294a90ad30c	64942-2220	HUMAN OTC DRUG	Degree		Advanced Vanilla and Jasmine Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2221_05e2b5ea-5569-9e3a-e063-6294a90a7b2f	64942-2221	HUMAN OTC DRUG	Degree		Advanced Sensitive Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2222_05f24576-ca8e-fb7d-e063-6294a90a946b	64942-2222	HUMAN OTC DRUG	Degree		Advanced Stress Control Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2223_05f3357c-86a8-11ed-e063-6294a90af628	64942-2223	HUMAN OTC DRUG	Degree		Advanced Lavender and Waterlily 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2224_06343ab5-e5f2-dd22-e063-6294a90a27d8	64942-2224	HUMAN OTC DRUG	Dove		Advanced Care Revive Antiperspirant Deodorant	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	part350	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
64942-2225_06427c8d-d5d0-ab71-e063-6394a90a00d9	64942-2225	HUMAN OTC DRUG	Degree		Advanced Cucumber Burst Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH FINAL	part350	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2226_0d303907-1b2b-f416-e063-6394a90aa4af	64942-2226	HUMAN OTC DRUG	Dove		Men plus Care Citrus Zest plus Sage 72H Dry Spray Antiperspirant	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2228_06cf9954-2a14-d2b7-e063-6394a90a7610	64942-2228	HUMAN OTC DRUG	Degree		Advanced Vanilla and Jasmine 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2229_06d0cd28-a4fa-8fdd-e063-6294a90ad4da	64942-2229	HUMAN OTC DRUG	Degree		Advanced Stress Control 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2230_06d236c0-a53a-c9f7-e063-6294a90a5ac9	64942-2230	HUMAN OTC DRUG	Degree		Advanced Sheer Powder 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2231_06e7c206-0cca-8a8d-e063-6394a90ac6ff	64942-2231	HUMAN OTC DRUG	Degree		Advanced Move Fresh Coconut 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2232_06e8fff9-be6e-f44d-e063-6394a90a72d7	64942-2232	HUMAN OTC DRUG	Degree		Advanced White Flower and Lycee Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2233_079a6add-30f7-6f70-e063-6394a90aa076	64942-2233	HUMAN OTC DRUG	Degree		Advanced Extreme Blast 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2234_0a990d46-124e-7142-e063-6394a90a466a	64942-2234	HUMAN OTC DRUG	Dove		Advanced Care Beauty Finish Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231101		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2235_091c2001-e62e-e3d7-e063-6294a90ab9c0	64942-2235	HUMAN OTC DRUG	Suave		24 Hour Powder Invisible Solid Antiperspirant Deodorant	STICK	TOPICAL	20090407		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a Unilever	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
64942-2236_091ff4b4-5a0c-de8c-e063-6394a90aa2a0	64942-2236	HUMAN OTC DRUG	Dove		Advanced Care Cucumber and Cactus Water Antiperspirant Deodorant	STICK	TOPICAL	20231115		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	11.4	g/100g			N	20241231
64942-2237_09420bbd-9de6-195d-e063-6394a90a1372	64942-2237	HUMAN OTC DRUG	Degree		Advanced Everest 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2238_09ba4db2-3e5a-1367-e063-6394a90abb06	64942-2238	HUMAN OTC DRUG	Degree		Advanced Sport Defense Dry Spray 72H Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M019	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	17.6	g/100g			N	20241231
64942-2239_0a95d9d3-937c-e190-e063-6294a90a732b	64942-2239	HUMAN OTC DRUG	Dove		Advanced Care Rejevenate Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231201		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2240_0a967ff4-c275-b506-e063-6394a90a1d97	64942-2240	HUMAN OTC DRUG	Dove		Advanced Care Apple and White Tea Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231201		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2241_0bb078f7-dcf4-d010-e063-6294a90a3338	64942-2241	HUMAN OTC DRUG	Dove		Advanced Care Invisible Clear Finish Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231201		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	12.2	g/100g			N	20241231
64942-2242_0a979691-2826-5dff-e063-6394a90aa9ed	64942-2242	HUMAN OTC DRUG	Dove		Advanced Care Acai Berry and Lotus Flower Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231201		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2243_0a984938-98ba-b96f-e063-6394a90aaa0b	64942-2243	HUMAN OTC DRUG	Dove		Advanced Care Waterlily and Sakura Blossom Dry Spray 72h Antiperspirant Deodorant	AEROSOL, SPRAY	TOPICAL	20231201		OTC MONOGRAPH DRUG	M026	Conopco, Inc. d/b/a Unilever	ALUMINUM SESQUICHLOROHYDRATE	15.2	g/100g			N	20241231
64942-2244_0a9a29d9-a5e0-ab3b-e063-6394a90aa943	64942-2244	HUMAN OTC DRUG	Degree		Advanced Sport Defense 72H Antiperspirant Deodorant	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
64942-2252_0e73ba69-22cd-ad0f-e063-6394a90aede6	64942-2252	HUMAN OTC DRUG	Degree		Shower Clean 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20251231
64942-2253_0eb1be5a-99b0-d5f8-e063-6294a90aeea5	64942-2253	HUMAN OTC DRUG	Degree		Sheer Powder 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20251231
64942-2254_0e9b8215-cc6c-062b-e063-6394a90a3910	64942-2254	HUMAN OTC DRUG	Degree		Fresh 48H Antiperspirant Deodorant	STICK	TOPICAL	20231108		OTC MONOGRAPH DRUG	M019	Conopco Inc. d/b/a/ Unilever	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20251231
64944-0001_07eae6ea-e671-df0e-e063-6294a90a13fb	64944-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091012		UNAPPROVED MEDICAL GAS		Seventh Street Medical Supply, Inc	OXYGEN	99	L/100L			N	20241231
64950-205_c1633e0f-dae2-4bd4-ac4d-de8498ee9398	64950-205	HUMAN PRESCRIPTION DRUG	Hycodan		Hydrocodone Bitartrate and Homatropine Methylbromide	TABLET	ORAL	20211101		NDA	NDA005213	Genus Lifesciences Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
64950-206_36258c4f-6e18-4fe0-8c35-e77e4d215d94	64950-206	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		Hydrocodone Bitartrate and Homatropine Methylbromide	TABLET	ORAL	20220810		NDA AUTHORIZED GENERIC	NDA005213	Genus Lifesciences Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
64950-211_c3f91320-8143-47fc-9d0e-ed5e2800c852	64950-211	HUMAN PRESCRIPTION DRUG	Carbinoxamine Maleate		Carbinoxamine Maleate	TABLET	ORAL	20230802		ANDA	ANDA040458	Genus Lifesciences Inc.	CARBINOXAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
64950-243_c3f91320-8143-47fc-9d0e-ed5e2800c852	64950-243	HUMAN PRESCRIPTION DRUG	CARBINOXZAMINE MALEATE		Carbinoxamine Maleate	SOLUTION	ORAL	20230609		ANDA	ANDA040458	Genus Lifesciences Inc.	CARBINOXAMINE MALEATE	4	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
64950-320_cb36c0c7-0f89-4241-a5d3-a3895d29ae14	64950-320	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20150215		NDA	NDA206814	Genus Lifesciences Inc.	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
64950-321_015c512b-8162-47af-9181-69065eef98fa	64950-321	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20150907		NDA	NDA208019	Genus Lifesciences Inc.	POTASSIUM CHLORIDE	1.5	g/1.58g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
64950-342_c1633e0f-dae2-4bd4-ac4d-de8498ee9398	64950-342	HUMAN PRESCRIPTION DRUG	Hycodan		Hydrocodone Bitartrate and Homatropine Methylbromide	SOLUTION	ORAL	20190610		NDA	NDA005213	Genus Lifesciences Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
64950-343_ff61229c-3028-4ac8-8aa3-5f09f05cb10e	64950-343	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		hydrocodone bitartrate and acetaminophen	SOLUTION	ORAL	20201120		ANDA	ANDA040894	Genus Lifesciences Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
64950-353_f8eb605b-c62d-491b-85e8-08a57b3397b9	64950-353	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20101020		NDA	NDA200535	Genus Lifesciences Inc.	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64950-354_f8eb605b-c62d-491b-85e8-08a57b3397b9	64950-354	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20130909		NDA	NDA200535	Genus Lifesciences Inc.	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64950-359_67539cd8-fe3c-4c30-af97-2b3451654f71	64950-359	HUMAN PRESCRIPTION DRUG	GOPRELTO		cocaine hydrochloride	SOLUTION	NASAL	20180108		NDA	NDA209963	Genus Lifesciences Inc.	COCAINE HYDROCHLORIDE	40	mg/mL		CII	N	20241231
64950-362_eeae9de6-c422-4d6e-a5f9-46b07a55a8ab	64950-362	HUMAN PRESCRIPTION DRUG	cocaine hydrochloride		cocaine hydrochloride	SOLUTION	NASAL	20180604		NDA AUTHORIZED GENERIC	NDA209963	Genus Lifesciences Inc.	COCAINE HYDROCHLORIDE	40	mg/mL		CII	N	20241231
64950-371_36258c4f-6e18-4fe0-8c35-e77e4d215d94	64950-371	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Homatropine Methylbromide		Hydrocodone Bitartrate and Homatropine Methylbromide	SOLUTION	ORAL	20220810		NDA AUTHORIZED GENERIC	NDA005213	Genus Lifesciences Inc.	HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE	1.5; 5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
64950-373_4ccf1893-2c40-455c-901e-2f6dbfe15c33	64950-373	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		hydrocodone bitartrate and acetaminophen	SOLUTION	ORAL	20231015		ANDA	ANDA040838	Genus Lifesciences Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
64950-374_2b649ef9-bd17-4c7f-9535-fd00007ec812	64950-374	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	SOLUTION	ORAL	20230810		ANDA	ANDA087508	Genus Lifesciences Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	120; 12	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
64950-901_a1132aeb-1a6a-439b-9a33-812b901a511c	64950-901	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	CAPSULE	ORAL	20101020		NDA	NDA200534	Genus Lifesciences Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
64952-002_080308f6-2f77-4f66-e063-6394a90a7b9d	64952-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19861124		NDA	NDA205889	T J Nowak Supply Co Inc	OXYGEN	990	mL/L			N	20241231
64973-001_08f4a4b6-88b9-db56-e063-6294a90a25e5	64973-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110121		UNAPPROVED MEDICAL GAS		Carolina Home Medical, Inc.	OXYGEN	99	L/100L			N	20241231
64980-104_1456e202-86a7-41f3-98ba-5535a285e3f4	64980-104	HUMAN PRESCRIPTION DRUG	Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate		Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate	TABLET	ORAL	20120628		UNAPPROVED DRUG OTHER		Rising Pharmaceuticals, Inc.	POTASSIUM PHOSPHATE, MONOBASIC; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	155; 852; 130	mg/1; mg/1; mg/1			N	20241231
64980-124_0cc31fd1-b6fb-44d0-a911-b4c11ce12c4b	64980-124	HUMAN PRESCRIPTION DRUG	Diflorasone Diacetate		diflorasone diacetate	OINTMENT	TOPICAL	20170227		ANDA	ANDA207440	Rising Pharma Holdings, Inc.	DIFLORASONE DIACETATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-133_f0e7ea64-b873-0fc4-e053-2a95a90ae18d	64980-133	HUMAN PRESCRIPTION DRUG	DIPYRIDAMOLE		DIPYRIDAMOLE	TABLET, FILM COATED	ORAL	20070805		ANDA	ANDA040733	Rising Pharmaceuticals, Inc.	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
64980-134_f0e7ea64-b873-0fc4-e053-2a95a90ae18d	64980-134	HUMAN PRESCRIPTION DRUG	DIPYRIDAMOLE		DIPYRIDAMOLE	TABLET, FILM COATED	ORAL	20070213		ANDA	ANDA040733	Rising Pharmaceuticals, Inc.	DIPYRIDAMOLE	50	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
64980-135_f0e7ea64-b873-0fc4-e053-2a95a90ae18d	64980-135	HUMAN PRESCRIPTION DRUG	DIPYRIDAMOLE		DIPYRIDAMOLE	TABLET, FILM COATED	ORAL	20070213		ANDA	ANDA040733	Rising Pharmaceuticals, Inc.	DIPYRIDAMOLE	75	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
64980-177_8afebbdc-6f28-45f0-911b-55d6df41095a	64980-177	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		Chloroquine Phosphate	TABLET	ORAL	20110701		ANDA	ANDA091621	Rising Pharmaceuticals, Inc.	CHLOROQUINE PHOSPHATE	250	mg/1	Antimalarial [EPC]		N	20241231
64980-178_4b7864e7-cecf-45ad-a002-45cafc2d3c7a	64980-178	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		Chloroquine Phosphate	TABLET	ORAL	20110701		ANDA	ANDA090612	Rising Pharmaceuticals, Inc.	CHLOROQUINE PHOSPHATE	500	mg/1	Antimalarial [EPC]		N	20241231
64980-205_7f02cf47-2286-4513-9d0f-00c70897ea2c	64980-205	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20160323		ANDA	ANDA204779	Rising Pharmaceuticals, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
64980-206_593fedfc-4dc8-496d-b44c-d8febcc025ef	64980-206	HUMAN PRESCRIPTION DRUG	Zileuton		Zileuton	TABLET, EXTENDED RELEASE	ORAL	20170321		ANDA	ANDA204929	Rising Pharmaceuticals, Inc.	ZILEUTON	600	mg/1	5-Lipoxygenase Inhibitor [EPC], 5-Lipoxygenase Inhibitors [MoA], Decreased Leukotriene Production [PE]		N	20241231
64980-209_7c38d5c8-61d0-4cd0-b5a1-86dddc390faf	64980-209	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160927		ANDA	ANDA206121	Rising Pharma Holdings, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
64980-210_7c38d5c8-61d0-4cd0-b5a1-86dddc390faf	64980-210	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160927		ANDA	ANDA206121	Rising Pharma Holdings, Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
64980-211_7c38d5c8-61d0-4cd0-b5a1-86dddc390faf	64980-211	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20160927		ANDA	ANDA206121	Rising Pharma Holdings, Inc.	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
64980-220_d2d61026-246c-48d4-bdcf-f2906402a27d	64980-220	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		Pyridostigmine Bromide	TABLET	ORAL	20170815		ANDA	ANDA205464	Rising Pharmaceuticals, Inc.	PYRIDOSTIGMINE BROMIDE	180	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
64980-221_63d34dff-95c9-4e93-944c-2027a5c8d46d	64980-221	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20181218		ANDA	ANDA205756	Rising Pharma Holdings, Inc.	METHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
64980-222_63d34dff-95c9-4e93-944c-2027a5c8d46d	64980-222	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20181218		ANDA	ANDA205756	Rising Pharma Holdings, Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
64980-223_63d34dff-95c9-4e93-944c-2027a5c8d46d	64980-223	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20181218		ANDA	ANDA205756	Rising Pharma Holdings, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
64980-235_0e31a067-d128-4d12-8e76-84cb2519ca3a	64980-235	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20160222		ANDA	ANDA205245	Rising Pharmaceuticals, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
64980-236_0e31a067-d128-4d12-8e76-84cb2519ca3a	64980-236	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20160222		ANDA	ANDA205245	Rising Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
64980-255_bdd1994f-fecc-41e9-ad6b-bd6bfcf049e7	64980-255	HUMAN PRESCRIPTION DRUG	Budesonide		budesonide	CAPSULE	ORAL	20170830		ANDA	ANDA207367	Rising Pharmaceuticals, Inc.	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-264_98bde501-aab7-4277-a20a-da6846ba883f	64980-264	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20210422		ANDA	ANDA202068	Rising Pharmaceuticals, Inc.	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
64980-265_98bde501-aab7-4277-a20a-da6846ba883f	64980-265	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20210422		ANDA	ANDA202068	Rising Pharmaceuticals, Inc.	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
64980-278_c69159c3-fc9b-4a42-b0c4-8e2657f5148d	64980-278	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA205663	Rising Pharmaceuticals, Inc.	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20241231
64980-279_b4c5f0d8-206d-4415-a182-a8f378bbc32a	64980-279	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	Rising Pharmaceuticals, Inc.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
64980-280_b4c5f0d8-206d-4415-a182-a8f378bbc32a	64980-280	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	Rising Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
64980-281_b4c5f0d8-206d-4415-a182-a8f378bbc32a	64980-281	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	Rising Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
64980-282_de981df1-747a-480d-a866-e72332a1544d	64980-282	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUPPOSITORY	RECTAL	20190605		ANDA	ANDA207448	Rising Pharmaceuticals, Inc.	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
64980-290_86446d3b-3e83-4bf5-b1ce-a22d2d4f6c81	64980-290	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Rising Pharmaceuticals, Inc.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64980-291_86446d3b-3e83-4bf5-b1ce-a22d2d4f6c81	64980-291	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Rising Pharmaceuticals, Inc.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64980-292_86446d3b-3e83-4bf5-b1ce-a22d2d4f6c81	64980-292	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Rising Pharmaceuticals, Inc.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64980-293_86446d3b-3e83-4bf5-b1ce-a22d2d4f6c81	64980-293	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Rising Pharmaceuticals, Inc.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
64980-294_6cc368d3-c202-43f3-954f-0a83697f69f1	64980-294	HUMAN OTC DRUG	Sodium Bicarbonate		sodium bicarbonate	TABLET	ORAL	20170201		OTC MONOGRAPH FINAL	part331	Rising Pharmaceuticals, Inc.	SODIUM BICARBONATE	650	mg/1	Alkalinizing Activity [MoA]		N	20241231
64980-301_0c61d2ad-0795-455a-a720-a81df1a0b0e4	64980-301	HUMAN PRESCRIPTION DRUG	Proctozone	HC	hydrocortisone	CREAM	TOPICAL	20120501		ANDA	ANDA089682	Rising Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-303_848cd8a6-7989-4fb7-ad8c-4ed7cfeda37e	64980-303	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20170517		ANDA	ANDA206904	Rising Pharmaceuticals, Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
64980-304_848cd8a6-7989-4fb7-ad8c-4ed7cfeda37e	64980-304	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20170517		ANDA	ANDA206904	Rising Pharmaceuticals, Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
64980-305_a011fc01-64fc-4340-ab2a-21dd884c2ec0	64980-305	HUMAN PRESCRIPTION DRUG	Denta 5000 Plus		Sodium fluoride	GEL, DENTIFRICE	ORAL	20120713		UNAPPROVED DRUG OTHER		Rising Pharmaceuticals, Inc.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
64980-306_a011fc01-64fc-4340-ab2a-21dd884c2ec0	64980-306	HUMAN PRESCRIPTION DRUG	Denta 5000 Plus		Sodium fluoride	GEL, DENTIFRICE	ORAL	20120713		UNAPPROVED DRUG OTHER		Rising Pharmaceuticals, Inc.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
64980-307_d4b7e0f1-72ec-4b12-8d75-4b55656390e1	64980-307	HUMAN PRESCRIPTION DRUG	DentaGel		Sodium fluoride	GEL	ORAL	20120501		UNAPPROVED DRUG OTHER		Rising Pharmaceuticals, Inc.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
64980-320_c2ec30c4-475d-4204-b88b-eb2bdb6cc444	64980-320	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	PASTE	TOPICAL	20100707		ANDA	ANDA040771	Rising Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-324_d929629c-8c27-4e73-a1ae-4e121ad267de	64980-324	HUMAN PRESCRIPTION DRUG	PROCTOZONE-HC		hydrocortisone 2.5%	CREAM	TOPICAL	20150803		ANDA	ANDA040879	Rising Pharma Holdings, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-325_bdfb700f-8946-4551-aaf5-e6051c458333	64980-325	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20180215		ANDA	ANDA206785	Rising Pharmaceuticals, Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
64980-328_3c460c4e-2017-4ef1-aa57-58ff6a166ed9	64980-328	HUMAN PRESCRIPTION DRUG	Erythromycin and Benzoyl Peroxide		Erythromycin and Benzoyl Peroxide	GEL	TOPICAL	20161018		ANDA	ANDA065385	Rising Pharmaceuticals, Inc.	BENZOYL PEROXIDE; ERYTHROMYCIN	50; 30	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
64980-329_f2189f6f-a314-4316-9e64-8ca8e847f0c2	64980-329	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide	Oil	Fluocinolone Acetonide Oil	OIL	AURICULAR (OTIC)	20160914		ANDA	ANDA203378	Rising Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-330_c2280baa-34ef-4b6c-8059-401de0ddba7f	64980-330	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide	Oil	Fluocinolone Acetonide	OIL	TOPICAL	20160718		ANDA	ANDA090982	Rising Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-331_e74fcd7c-2027-43c1-8bcf-7341100646c6	64980-331	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide	Oil	Fluocinolone Acetonide	OIL	TOPICAL	20160718		ANDA	ANDA203377	Rising Pharmaceuticals, Inc.	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-340_3c9273d9-dc20-4287-b8e6-813ef15a10dd	64980-340	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	Rising Pharmaceuticals, Inc.	ALENDRONATE SODIUM	10	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
64980-341_3c9273d9-dc20-4287-b8e6-813ef15a10dd	64980-341	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	Rising Pharmaceuticals, Inc.	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
64980-342_3c9273d9-dc20-4287-b8e6-813ef15a10dd	64980-342	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	Rising Pharmaceuticals, Inc.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
64980-343_35102b70-c689-4975-a3cc-5ae7b5a54810	64980-343	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	Rising Pharma Holdings, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
64980-349_f5ead090-8124-4e94-bcbd-9b4525ccdaf7	64980-349	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20110321		ANDA	ANDA091114	Rising Pharmaceuticals, Inc.	FAMCICLOVIR	125	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
64980-350_f5ead090-8124-4e94-bcbd-9b4525ccdaf7	64980-350	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20110321		ANDA	ANDA091114	Rising Pharmaceuticals, Inc.	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
64980-351_f5ead090-8124-4e94-bcbd-9b4525ccdaf7	64980-351	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20110321		ANDA	ANDA091114	Rising Pharmaceuticals, Inc.	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
64980-373_fe7035f0-29cf-477c-80d1-e82adbd69b94	64980-373	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Rising Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64980-374_fe7035f0-29cf-477c-80d1-e82adbd69b94	64980-374	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Rising Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64980-375_fe7035f0-29cf-477c-80d1-e82adbd69b94	64980-375	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Rising Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64980-376_fe7035f0-29cf-477c-80d1-e82adbd69b94	64980-376	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Rising Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64980-377_fe7035f0-29cf-477c-80d1-e82adbd69b94	64980-377	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Rising Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64980-378_fe7035f0-29cf-477c-80d1-e82adbd69b94	64980-378	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Rising Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64980-379_fe7035f0-29cf-477c-80d1-e82adbd69b94	64980-379	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Rising Pharmaceuticals, Inc.	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
64980-402_ab5e3ba3-8547-481f-b31b-02e87ed4c9f5	64980-402	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	GRANULE, FOR SUSPENSION	ORAL	20070608		ANDA	ANDA065409	Rising Pharma Holdings, Inc.	CEFPODOXIME PROXETIL	50	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
64980-403_ab5e3ba3-8547-481f-b31b-02e87ed4c9f5	64980-403	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	GRANULE, FOR SUSPENSION	ORAL	20070608		ANDA	ANDA065409	Rising Pharma Holdings, Inc.	CEFPODOXIME PROXETIL	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
64980-404_f21f679b-c137-472c-b8ef-7410b1021b97	64980-404	HUMAN PRESCRIPTION DRUG	Toremifene Citrate		Toremifene Citrate	TABLET	ORAL	20190118		ANDA	ANDA208813	Rising Pharmaceuticals, Inc.	TOREMIFENE CITRATE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
64980-405_b8611a41-39f7-47d1-98ff-e895dbbb18a9	64980-405	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir Sulfate	SOLUTION	ORAL	20180314		ANDA	ANDA077950	Rising Pharmaceuticals, Inc.	ABACAVIR SULFATE	20	mg/mL	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
64980-406_ef5feaa1-6aff-47fc-9a9b-6ead5518b699	64980-406	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	CAPSULE	ORAL	20171215		ANDA	ANDA078064	Rising Pharma Holdings, Inc.	EFAVIRENZ	50	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
64980-407_ef5feaa1-6aff-47fc-9a9b-6ead5518b699	64980-407	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	CAPSULE	ORAL	20171215		ANDA	ANDA078064	Rising Pharma Holdings, Inc.	EFAVIRENZ	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
64980-409_9c03a597-12b5-4855-8e64-3ba50acd6ac1	64980-409	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	SOLUTION, CONCENTRATE	ORAL	20081031		ANDA	ANDA078861	Rising Pharma Holdings, Inc.	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
64980-410_c8949f3b-abd9-4552-b296-624c689795a3	64980-410	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
64980-411_c8949f3b-abd9-4552-b296-624c689795a3	64980-411	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
64980-412_c8949f3b-abd9-4552-b296-624c689795a3	64980-412	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
64980-413_c8949f3b-abd9-4552-b296-624c689795a3	64980-413	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
64980-414_c8949f3b-abd9-4552-b296-624c689795a3	64980-414	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
64980-415_c8949f3b-abd9-4552-b296-624c689795a3	64980-415	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
64980-416_c8949f3b-abd9-4552-b296-624c689795a3	64980-416	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	225	mg/1		CV	N	20241231
64980-417_c8949f3b-abd9-4552-b296-624c689795a3	64980-417	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Rising Pharma Holdings, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
64980-418_aba84da7-197d-4268-9f0e-b8b28213ddcd	64980-418	HUMAN PRESCRIPTION DRUG	Abiraterone acetate		Abiraterone acetate	TABLET	ORAL	20190225		ANDA	ANDA208371	Rising Pharmaceuticals, Inc.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
64980-426_37044541-dbe9-4d1b-b052-ddf0559f39aa	64980-426	HUMAN PRESCRIPTION DRUG	Tindazole		Tinidazole	TABLET, FILM COATED	ORAL	20131009		ANDA	ANDA202489	Rising Pharma Holdings, Inc.	TINIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
64980-427_37044541-dbe9-4d1b-b052-ddf0559f39aa	64980-427	HUMAN PRESCRIPTION DRUG	Tindazole		Tinidazole	TABLET, FILM COATED	ORAL	20131009		ANDA	ANDA202489	Rising Pharma Holdings, Inc.	TINIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
64980-431_49aaa5a4-e367-4ef9-873a-86ff026380fc	64980-431	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20180201		ANDA	ANDA209025	Rising Pharmaceuticals, Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
64980-432_65b9716e-beec-4e03-8007-c769e7b9450d	64980-432	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	AURICULAR (OTIC)	20220701		ANDA	ANDA215038	Rising Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
64980-433_ffd4dfb9-a6d8-4c81-8b8c-8228d9e2f93e	64980-433	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190401		ANDA	ANDA207613	Rising Pharmaceuticals, Inc.	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
64980-434_ffd4dfb9-a6d8-4c81-8b8c-8228d9e2f93e	64980-434	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190401		ANDA	ANDA207613	Rising Pharmaceuticals, Inc.	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
64980-435_ffd4dfb9-a6d8-4c81-8b8c-8228d9e2f93e	64980-435	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190401		ANDA	ANDA207613	Rising Pharmaceuticals, Inc.	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
64980-437_6e0cbb82-3be8-4b45-abe7-b2f542d81bec	64980-437	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Rising Pharmaceuticals, Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
64980-438_6e0cbb82-3be8-4b45-abe7-b2f542d81bec	64980-438	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Rising Pharmaceuticals, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
64980-439_6e0cbb82-3be8-4b45-abe7-b2f542d81bec	64980-439	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Rising Pharmaceuticals, Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
64980-441_c8147912-7ee1-4348-8d78-2d2bfa17fefc	64980-441	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		Clobetasol Propionate	CREAM	TOPICAL	20190131		ANDA	ANDA211401	Rising Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-442_72389d34-8e40-4409-8f0a-a9c0f44e8b80	64980-442	HUMAN PRESCRIPTION DRUG	Albuterol		albuterol	TABLET	ORAL	20180629		ANDA	ANDA207046	Rising Pharmaceuticals, Inc.	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
64980-443_72389d34-8e40-4409-8f0a-a9c0f44e8b80	64980-443	HUMAN PRESCRIPTION DRUG	Albuterol		albuterol	TABLET	ORAL	20180629		ANDA	ANDA207046	Rising Pharmaceuticals, Inc.	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
64980-447_7ea7469b-6ac0-1b1b-e053-2991aa0a1e07	64980-447	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	SOLUTION	ORAL	20170321		ANDA	ANDA209798	Rising Pharmaceuticals, Inc.	CALCITRIOL	1	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
64980-448_6b84e25b-6c8c-4361-b58a-4cca241d30bf	64980-448	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension		neomycin and polymyxin B sulfates and hydrocortisone otic	SUSPENSION	AURICULAR (OTIC)	20190315		NDA AUTHORIZED GENERIC	NDA060613	Rising Pharma Holdings, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
64980-449_edbad756-2ade-b95f-e053-2a95a90ae698	64980-449	HUMAN PRESCRIPTION DRUG	fingolimod		Fingolimod hcl	CAPSULE	ORAL	20211110		ANDA	ANDA207939	Rising Pharmaceuticals, Inc.	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
64980-450_db938579-9a95-4fc6-98e2-46caf77b7c7b	64980-450	HUMAN PRESCRIPTION DRUG	Trientine hydrochloride		Trientine hydrochloride	CAPSULE	ORAL	20200220		ANDA	ANDA212238	Rising Pharmaceuticals, Inc.	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
64980-452_052ed7ac-2715-4aeb-8351-77f19a38e4f4	64980-452	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide Topical Solution USP, 0.05%	SOLUTION	TOPICAL	20181201		ANDA	ANDA209699	Rising Pharmaceuticals, Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-453_485cb247-48d8-4bc3-b16b-a0abadea856b	64980-453	HUMAN PRESCRIPTION DRUG	alosetron hydrochloride		alosetron hydrochloride	TABLET	ORAL	20190114		ANDA	ANDA209180	Rising Pharmaceuticals, Inc.	ALOSETRON HYDROCHLORIDE	.5	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
64980-454_485cb247-48d8-4bc3-b16b-a0abadea856b	64980-454	HUMAN PRESCRIPTION DRUG	alosetron hydrochloride		alosetron hydrochloride	TABLET	ORAL	20190114		ANDA	ANDA209180	Rising Pharmaceuticals, Inc.	ALOSETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
64980-472_f256e874-703a-48a8-bae8-77c0b46a2968	64980-472	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	Rising Pharmaceuticals, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
64980-483_49b564cd-6948-4df1-a7d6-0ce87f8a0a61	64980-483	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20200212		ANDA	ANDA213200	Rising Pharma Holdings, Inc.	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
64980-503_f1d658ef-51d9-4524-b32b-a1395ef7fabc	64980-503	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine	SOLUTION	ORAL	20040920		ANDA	ANDA076851	Rising Pharmaceuticals, Inc.	LEVOCARNITINE	1	g/10mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
64980-504_ac71bb72-472f-4bd2-8dd0-f65238c9a9ee	64980-504	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	SYRUP	ORAL	20060710		ANDA	ANDA040668	Rising Pharmaceuticals, Inc.	CYPROHEPTADINE HYDROCHLORIDE	2	mg/5mL			N	20241231
64980-509_44e01bb2-d449-48ec-9ddf-a4399e502d93	64980-509	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	ELIXIR	ORAL	20110801		ANDA	ANDA090891	Rising Pharma Holdings, Inc.	DEXAMETHASONE	.5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
64980-511_cf8dd9a0-9dcd-4845-aa61-dea67cb19b03	64980-511	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PALMITATE HYDROCHLORIDE	(Pediatric)	CLINDAMYCIN PALMITATE HYDROCHLORIDE	GRANULE, FOR SOLUTION	ORAL	20120911		ANDA	ANDA201821	Rising Pharma Holdings, Inc.	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
64980-513_8eaa2d62-25cf-4b14-bd14-40bf2c2458e0	64980-513	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20141215		ANDA	ANDA077259	Rising Pharma Holdings, Inc.	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
64980-514_8eaa2d62-25cf-4b14-bd14-40bf2c2458e0	64980-514	HUMAN PRESCRIPTION DRUG	TIMOLOL MALEATE		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20141215		ANDA	ANDA077259	Rising Pharma Holdings, Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
64980-515_7d8aa6b9-4490-49c4-93ff-5a0a053fa783	64980-515	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	OPHTHALMIC	20141215		ANDA	ANDA078559	Rising Pharma Holdings, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
64980-516_a41e9a09-7416-4f66-ad9b-db0d38ff6963	64980-516	HUMAN PRESCRIPTION DRUG	LATANOPROST		latanoprost	SOLUTION	OPHTHALMIC	20160901		ANDA	ANDA202442	Rising Pharma Holdings, Inc.	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
64980-526_50ed7394-0fee-4977-b617-07acc2025e52	64980-526	HUMAN PRESCRIPTION DRUG	Nitazoxanide		Nitazoxanide	TABLET, FILM COATED	ORAL	20201127		ANDA	ANDA213820	Rising Pharmaceuticals, Inc.	NITAZOXANIDE	500	mg/1	Antiprotozoal [EPC]		N	20241231
64980-528_91abe1e7-db44-4572-a7f6-a55edac11049	64980-528	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	TABLET	ORAL	20200720		OTC MONOGRAPH FINAL	part331	Rising Pharmaceuticals, Inc.	SODIUM BICARBONATE	650	mg/1	Alkalinizing Activity [MoA]		N	20241231
64980-531_49aaa5a4-e367-4ef9-873a-86ff026380fc	64980-531	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20230401		ANDA	ANDA209025	Rising Pharmaceuticals, Inc.	OXYBUTYNIN CHLORIDE	2.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
64980-561_bf4fa35d-93c9-41c3-a2ae-0298014b8a9f	64980-561	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET	ORAL	20231120		ANDA	ANDA078845	Rising Pharma Holdings, Inc.	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
64980-562_23cca193-329a-4d99-b861-84f230c6fec0	64980-562	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	Rising Pharma Holdings, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
64980-563_23cca193-329a-4d99-b861-84f230c6fec0	64980-563	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	Rising Pharma Holdings, Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
64980-564_23cca193-329a-4d99-b861-84f230c6fec0	64980-564	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	Rising Pharma Holdings, Inc.	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
64980-566_83cde033-5aa0-4c97-b307-ef334dcf2acf	64980-566	HUMAN PRESCRIPTION DRUG	Dapsone		dapsone	TABLET	ORAL	20221211		ANDA	ANDA207165	Rising Pharma Holdings, Inc.	DAPSONE	100	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
64980-567_83cde033-5aa0-4c97-b307-ef334dcf2acf	64980-567	HUMAN PRESCRIPTION DRUG	Dapsone		dapsone	TABLET	ORAL	20230720		ANDA	ANDA207165	Rising Pharma Holdings, Inc.	DAPSONE	25	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
64980-578_8e36e9dc-c3e3-43a3-b4a5-f235fe1d3466	64980-578	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20221128		ANDA	ANDA216044	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
64980-579_8e36e9dc-c3e3-43a3-b4a5-f235fe1d3466	64980-579	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20221128		ANDA	ANDA216044	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
64980-580_8e36e9dc-c3e3-43a3-b4a5-f235fe1d3466	64980-580	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20221128		ANDA	ANDA216044	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
64980-581_8e36e9dc-c3e3-43a3-b4a5-f235fe1d3466	64980-581	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20221128		ANDA	ANDA216044	Rising Pharma Holdings, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
64980-582_62dd7376-e5b5-43a6-8c2e-e2f40666ada1	64980-582	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20230809		ANDA	ANDA216925	Rising Pharma Holdings, Inc.	CHLORZOXAZONE	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
64980-588_710a2c8c-3620-4f6f-b8fc-fb19ab9e9f22	64980-588	HUMAN PRESCRIPTION DRUG	Edetate Calcium Disodium		Edetate Calcium Disodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230503		ANDA	ANDA216435	Rising Pharmaceuticals, Inc.	EDETATE CALCIUM DISODIUM	200	mg/mL	Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Decreased Coagulation Factor Activity [PE], Lead Chelating Activity [MoA], Lead Chelator [EPC]		N	20241231
64980-592_66234d3f-40a4-489e-8596-bf6feba295c1	64980-592	HUMAN PRESCRIPTION DRUG	Lactulose Solution		Lactulose Solution USP, 10 g/15 mL	SOLUTION	ORAL; RECTAL	20211014		ANDA	ANDA076645	Rising Pharmaceuticals, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
64980-593_bc288cd3-2bc1-4a1b-a0da-26c56401bd21	64980-593	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20230511		ANDA	ANDA212607	Rising Pharma Holdings, Inc.	NITROFURANTOIN MONOHYDRATE	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
64980-594_b2cf92df-72cb-48b5-bc84-ada9215cd87b	64980-594	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20231225		ANDA	ANDA217975	Rising Pharma Holdings, Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64980-595_b2cf92df-72cb-48b5-bc84-ada9215cd87b	64980-595	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20231225		ANDA	ANDA217975	Rising Pharma Holdings, Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64980-596_b2cf92df-72cb-48b5-bc84-ada9215cd87b	64980-596	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20231225		ANDA	ANDA217975	Rising Pharma Holdings, Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64980-597_b2cf92df-72cb-48b5-bc84-ada9215cd87b	64980-597	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20231225		ANDA	ANDA217975	Rising Pharma Holdings, Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64980-598_b2cf92df-72cb-48b5-bc84-ada9215cd87b	64980-598	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20231225		ANDA	ANDA217975	Rising Pharma Holdings, Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
64987-0266_0d6c286b-9b82-59b6-e063-6294a90a1dd0	64987-0266	HUMAN OTC DRUG	Antibacterial Skin Rain Forest Extract From Entiere		CHLOROXYLENOL	SOAP	TOPICAL	20170927		OTC MONOGRAPH DRUG	505G(a)(3)	World Club Supply Corp	CHLOROXYLENOL	2.5	mg/mL			N	20241231
64987-0321_0d6bde62-e2cf-7e3c-e063-6394a90ac00d	64987-0321	HUMAN OTC DRUG	Entiere Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200715		OTC MONOGRAPH DRUG	505G(a)(3)	World Club Supply Corp	ALCOHOL	.7	mL/mL			N	20241231
64987-0322_0d6c2b51-e84b-5e77-e063-6294a90afb66	64987-0322	HUMAN OTC DRUG	Entiere Hand Sanitizer, Fragrance Free		ALCOHOL	GEL	TOPICAL	20200724		OTC MONOGRAPH DRUG	505G(a)(3)	World Club Supply Corp	ALCOHOL	.7	mL/mL			N	20241231
64987-0323_0d6c286b-9b84-59b6-e063-6294a90a1dd0	64987-0323	HUMAN OTC DRUG	Entiere Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20221128		OTC MONOGRAPH DRUG	505G(a)(3)	World Club Supply Corp	ALCOHOL	70	L/100L			N	20241231
64987-2661_0d6c3b91-d2d7-e673-e063-6394a90a8fa7	64987-2661	HUMAN OTC DRUG	Entiere Antibacterial Skin		CHLOROXYLENOL	LIQUID	TOPICAL	20171017		OTC MONOGRAPH DRUG	505G(a)(3)	World Club Supply Corp	CHLOROXYLENOL	2.5	mg/mL			N	20241231
64987-6322_0d6c6d3e-726c-f281-e063-6294a90a9908	64987-6322	HUMAN OTC DRUG	Roots Hand Sanitizer Gel, Fragrance Free		ALCOHOL	GEL	TOPICAL	20200724		OTC MONOGRAPH DRUG	505G(a)(3)	World Club Supply Corp	ALCOHOL	.7	mL/mL			N	20241231
64987-6323_0d6c6d3e-726d-f281-e063-6294a90a9908	64987-6323	HUMAN OTC DRUG	Roots Hand Sanitizer Gel, Fragranced		ALCOHOL	GEL	TOPICAL	20200724		OTC MONOGRAPH DRUG	505G(a)(3)	World Club Supply Corp	ALCOHOL	.7	mL/mL			N	20241231
65008-005_2ea877b9-5363-4e2f-9d2d-0f669094f099	65008-005	HUMAN OTC DRUG	Comfortcaine		Lidocaine HCL	GEL	TOPICAL	20041112		OTC MONOGRAPH NOT FINAL	part348	QS Key West Aloe, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65008-006_7d1ca0fb-5f3a-457f-ac23-7b872c48be3a	65008-006	HUMAN OTC DRUG	Sunsorb Reef Safe SPF30		Homosalate, Octocrylene, Avobenzone	LOTION	TOPICAL	20191018		OTC MONOGRAPH DRUG	M020	QS Key West Aloe, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/g; mg/g; mg/g			N	20241231
65008-007_81333c58-956e-4789-9be3-149f24960557	65008-007	HUMAN OTC DRUG	Sunsorb Reef Safe SPF50		Homosalate, Zinc Oxide, Octocrylene	LOTION	TOPICAL	20190715		OTC MONOGRAPH DRUG	M020	QS Key West Aloe, LLC	HOMOSALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 57	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65008-008_14fbd5b8-a6c7-45f9-9bd3-078d5a4c85c3	65008-008	HUMAN OTC DRUG	Sunsorb Reef Safe SPF15		Homosalate, Octocrylene, Avobenzone	LOTION	TOPICAL	20190709		OTC MONOGRAPH DRUG	M020	QS Key West Aloe, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 50; 30	mg/g; mg/g; mg/g			N	20241231
65010-002_0761d577-ec32-6627-e063-6394a90a40f0	65010-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19930101		NDA	NDA206023	Technical Gas Products, Inc.	OXYGEN	992	mL/L			N	20241231
65038-055_08372123-23e0-458d-b297-61eb97047223	65038-055	HUMAN PRESCRIPTION DRUG	Adlarity		Donepezil Hydrochloride	PATCH	TRANSDERMAL	20220311		NDA	NDA212304	Corium, LLC.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65038-056_08372123-23e0-458d-b297-61eb97047223	65038-056	HUMAN PRESCRIPTION DRUG	Adlarity		Donepezil Hydrochloride	PATCH	TRANSDERMAL	20220311		NDA	NDA212304	Corium, LLC.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65038-286_bb5e8b93-0bd6-48fa-b9c5-80b76a200cbe	65038-286	HUMAN PRESCRIPTION DRUG	AZSTARYS		Serdexmethylphenidate and Dexmethylphenidate	CAPSULE	ORAL	20210716		NDA	NDA212994	Corium, LLC.	DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE	5.2; 26.1	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
65038-429_bb5e8b93-0bd6-48fa-b9c5-80b76a200cbe	65038-429	HUMAN PRESCRIPTION DRUG	AZSTARYS		Serdexmethylphenidate and Dexmethylphenidate	CAPSULE	ORAL	20210716		NDA	NDA212994	Corium, LLC.	DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE	7.8; 39.2	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
65038-561_bb5e8b93-0bd6-48fa-b9c5-80b76a200cbe	65038-561	HUMAN PRESCRIPTION DRUG	AZSTARYS		Serdexmethylphenidate and Dexmethylphenidate	CAPSULE	ORAL	20210716		NDA	NDA212994	Corium, LLC.	DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE	10.4; 52.3	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
65044-0537_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0537	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Bermuda Grass		Standardized Grass Pollen, Bermuda Grass	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103872	Jubilant HollisterStier LLC	CYNODON DACTYLON POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0545_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0545	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Bluegrass, Kentucky June		Standardized Grass Pollen, Bluegrass, Kentucky June	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103873	Jubilant HollisterStier LLC	POA PRATENSIS POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0546_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0546	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Bluegrass, Kentucky June		Standardized Grass Pollen, Bluegrass, Kentucky June	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103873	Jubilant HollisterStier LLC	POA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0611_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0611	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Fescue, Meadow		Standardized Grass Pollen, Fescue, Meadow	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103874	Jubilant HollisterStier LLC	FESTUCA PRATENSIS POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0612_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0612	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Fescue, Meadow		Standardized Grass Pollen, Fescue, Meadow	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103874	Jubilant HollisterStier LLC	FESTUCA PRATENSIS POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0718_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0718	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Orchard Grass		Standardized Grass Pollen, Orchard Grass	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103875	Jubilant HollisterStier LLC	DACTYLIS GLOMERATA POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0719_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0719	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Orchard Grass		Standardized Grass Pollen, Orchard Grass	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103875	Jubilant HollisterStier LLC	DACTYLIS GLOMERATA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0777_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0777	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Redtop		Standardized Grass Pollen, Redtop	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103876	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0778_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0778	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Redtop		Standardized Grass Pollen, Redtop	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103876	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0787_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0787	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Ryegrass		Standardized Grass Pollen, Ryegrass	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103877	Jubilant HollisterStier LLC	LOLIUM PERENNE POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0788_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0788	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Ryegrass		Standardized Grass Pollen, Ryegrass	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103877	Jubilant HollisterStier LLC	LOLIUM PERENNE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0825_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0825	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Sweet Vernal Grass		Standardized Grass Pollen, Sweet Vernal Grass	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103878	Jubilant HollisterStier LLC	ANTHOXANTHUM ODORATUM POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0826_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0826	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Sweet Vernal Grass		Standardized Grass Pollen, Sweet Vernal Grass	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103878	Jubilant HollisterStier LLC	ANTHOXANTHUM ODORATUM POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0831_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0831	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Timothy		Standardized Grass Pollen, Timothy	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103879	Jubilant HollisterStier LLC	PHLEUM PRATENSE POLLEN	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0832_4c7b2f5d-44b9-4e8a-b826-9815530df04d	65044-0832	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Timothy		Standardized Grass Pollen, Timothy	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103879	Jubilant HollisterStier LLC	PHLEUM PRATENSE POLLEN	100000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0842_2ed394a8-5fd0-4d64-958c-312b5f866bc4	65044-0842	STANDARDIZED ALLERGENIC	Standardized Grass Pollen, Grass Mix 4		Standardized Grass Pollen, Grass Mix 4	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19980115		BLA	BLA103873	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	25000; 25000; 25000; 25000	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0854_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-0854	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Southern Grass Mix		Pollens - Grasses, Southern Grass Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN	100000; 100000; 10000; 100000; 100000; 100000; .05	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0855_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-0855	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Southern Grass Mix		Pollens - Grasses, Southern Grass Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN	100000; 100000; 10000; 100000; 100000; 100000; .05	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0856_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-0856	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Southern Grass Mix		Pollens - Grasses, Southern Grass Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN	10000; 10000; 1000; 10000; 10000; 10000; .005	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0857_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-0857	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Southern Grass Mix		Pollens - Grasses, Southern Grass Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; DACTYLIS GLOMERATA POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN	10000; 10000; 1000; 10000; 10000; 10000; .005	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-0879_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-0879	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Grass Mix 8		Grass Mix 8	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AGROSTIS GIGANTEA POLLEN; CYNODON DACTYLON POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN	100000; 10000; 100000; 100000; .05	[BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-1006_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1006	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Acacia Acacia longifolia		Acacia longifolia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACACIA LONGIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1007_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1007	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Acacia Acacia longifolia		Acacia longifolia	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACACIA LONGIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1018_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1018	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Alder, Red Alnus rubra		Alder, Red Alnus rubra	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALNUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1019_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1019	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Alder, Red Alnus rubra		Alder, Red Alnus rubra	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALNUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1021_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1021	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Alder, Red Alnus rubra		Alder, Red Alnus rubra	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALNUS RUBRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1060_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1060	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Ash, White Fraxinus americana		Ash, White Fraxinus americana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	FRAXINUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1061_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1061	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Ash, White Fraxinus americana		Ash, White Fraxinus americana	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	FRAXINUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1081_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1081	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Bahia Grass Paspalum notatum		Bahia Grass Paspalum notatum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PASPALUM NOTATUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1082_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1082	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Bahia Grass Paspalum notatum		Bahia Grass Paspalum notatum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PASPALUM NOTATUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1084_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1084	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Bahia Grass Paspalum notatum		Bahia Grass Paspalum notatum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PASPALUM NOTATUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1120_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1120	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Beech, American Fagus grandifolia		Beech, American Fagus grandifolia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	FAGUS GRANDIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1121_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1121	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Beech, American Fagus grandifolia		Beech, American Fagus grandifolia	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	FAGUS GRANDIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1168_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1168	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Birch Mix		Birch Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1169_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1169	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Birch Mix		Birch Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1171_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1171	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Birch Mix		Birch Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1172_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1172	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Birch Mix		Birch Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN	40000; 20000; 40000	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1207_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1207	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Bottle Brush Callistemon spp.		Bottle Brush Callistemon spp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MELALEUCA CITRINA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1208_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1208	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Bottlebrush, Callistemon spp.		Bottlebrush, Callistemon citrinus	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MELALEUCA CITRINA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1213_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1213	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Boxelder/Maple Mix		Boxelder/Maple Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1214_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1214	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Boxelder/Maple Mix		Boxelder/Maple Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1216_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1216	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Boxelder/Maple Mix		Boxelder/Maple Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1217_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1217	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Boxelder/Maple Mix		Boxelder/Maple Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN	40000; 40000; 40000	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1237_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1237	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Brome, Smooth Bromus inermis		Brome, Smooth Bromus inermis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BROMUS INERMIS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1238_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1238	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Brome, Smooth Bromus inermis		Brome, Smooth Bromus inermis	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BROMUS INERMIS POLLEN	.05	g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1297_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1297	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Careless Weed Amaranthus palmeri		Careless Weed Amaranthus palmeri	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS PALMERI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1298_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1298	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Careless Weed Amaranthus palmeri		Careless Weed Amaranthus palmeri	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS PALMERI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1300_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1300	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Careless/Pigweed Mix		Careless/Pigweed Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1301_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1301	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Careless/Pigweed Mix		Careless/Pigweed Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1303_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1303	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Careless/Pigweed Mix		Careless/Pigweed Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS PALMERI POLLEN; AMARANTHUS RETROFLEXUS POLLEN	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1336_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1336	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cedar, Mountain Juniperus ashei		Cedar, Mountain Juniperus ashei	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUNIPERUS ASHEI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1337_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1337	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cedar, Mountain Juniperus ashei		Cedar, Mountain Juniperus ashei	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUNIPERUS ASHEI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1339_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1339	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cedar, Mountain Juniperus ashei		Cedar, Mountain Juniperus ashei	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUNIPERUS ASHEI POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1340_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1340	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cedar, Red Juniperus virginiana		Cedar, Red Juniperus virginiana	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUNIPERUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1342_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1342	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cedar, Red Juniperus virginiana		Cedar, Red Juniperus virginiana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUNIPERUS VIRGINIANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1343_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1343	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cedar, Red Juniperus virginiana		Cedar, Red Juniperus virginiana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUNIPERUS VIRGINIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1405_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1405	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Cocklebur Xanthium strumarium		Cocklebur Xanthium strumarium	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	XANTHIUM STRUMARIUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1406_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1406	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Cocklebur Xanthium strumarium		Cocklebur Xanthium strumarium	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	XANTHIUM STRUMARIUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1408_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1408	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Cocklebur Xanthium strumarium		Cocklebur Xanthium strumarium	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	XANTHIUM STRUMARIUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1409_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1409	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Cocklebur Xanthium strumarium		Cocklebur Xanthium strumarium	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	XANTHIUM STRUMARIUM POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1414_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1414	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Corn, Cultivated Zea mays		Corn, Cultivated Zea mays	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ZEA MAYS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1415_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1415	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Corn, Cultivated Zea mays		Corn, Cultivated Zea mays	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ZEA MAYS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1435_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1435	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cottonwood, Common Populus deltoides		Cottonwood, Common Populus deltoides	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	POPULUS DELTOIDES POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1436_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1436	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cottonwood, Common Populus deltoides		Cottonwood, Common Populus deltoides	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	POPULUS DELTOIDES POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1438_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1438	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cottonwood, Common Populus deltoides		Cottonwood, Common Populus deltoides	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	POPULUS DELTOIDES POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1450_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1450	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cypress, Arizona Cupressus arizonica		Cypress, Arizona Cupressus arizonica	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CUPRESSUS ARIZONICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1451_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1451	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cypress, Arizona Cupressus arizonica		Cypress, Arizona Cupressus arizonica	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CUPRESSUS ARIZONICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1453_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1453	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cypress, Bald Taxodium distichum		Cypress, Bald Taxodium distichum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	TAXODIUM DISTICHUM POLLEN	.02	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1454_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1454	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Cypress, Bald Taxodium distichum		Cypress, Bald Taxodium distichum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	TAXODIUM DISTICHUM POLLEN	.02	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1516_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1516	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Dock/Sorrel Mix		Pollens - Weeds, Dock/Sorrel Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1517_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1517	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Dock/Sorrel Mix		Pollens - Weeds, Dock/Sorrel Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1519_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1519	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Dock/Sorrel Mix		Pollens - Weeds, Dock/Sorrel Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1520_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1520	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Dock/Sorrel Mix		Pollens - Weeds, Dock/Sorrel Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1540_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1540	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Elm, American Ulmus americana		Elm, American Ulmus americana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ULMUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1541_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1541	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Elm, American Ulmus americana		Elm, American Ulmus americana	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ULMUS AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1543_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1543	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Elm, American Ulmus americana		Elm, American Ulmus americana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ULMUS AMERICANA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1544_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1544	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Elm, American Ulmus americana		Elm, American Ulmus americana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ULMUS AMERICANA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1546_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1546	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Elm, Chinese Ulmus parvifolia		Elm, Chinese Ulmus parvifolia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ULMUS PARVIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1547_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1547	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Elm, Chinese Ulmus parvifolia		Elm, Chinese Ulmus parvifolia	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ULMUS PARVIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1564_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1564	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Eucalyptus, Eucalyptus globulus		Eucalyptus, Eucalyptus globulus	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EUCALYPTUS GLOBULUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1565_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1565	NON-STANDARDIZED ALLERGENIC	POLLENS - TREES, EUCALYPTUS, EUCALYPTUS GLOBULUS		Eucalyptus globulus	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EUCALYPTUS GLOBULUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1630_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1630	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Goldenrod Solidago canadensis		Goldenrod Solidago canadensis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOLIDAGO CANADENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1631_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1631	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Goldenrod Solidago canadensis		Goldenrod Solidago canadensis	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOLIDAGO CANADENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1660_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1660	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Gum, Sweet Liquidambar styraciflua		Gum, Sweet Liquidambar styraciflua	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	LIQUIDAMBAR STYRACIFLUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1661_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1661	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Gum, Sweet Liquidambar styraciflua		Gum, Sweet Liquidambar styraciflua	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	LIQUIDAMBAR STYRACIFLUA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1662_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1662	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Gum, Sweet Liquidambar styraciflua		Gum, Sweet Liquidambar styraciflua	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	LIQUIDAMBAR STYRACIFLUA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1663_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1663	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Hackberry Celtis occidentalis		Hackberry Celtis occidentalis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CELTIS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1664_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1664	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Hackberry Celtis occidentalis		Hackberry Celtis occidentalis	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CELTIS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1702_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1702	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Hickory, Shagbark Carya ovata		Hickory, Shagbark Carya ovata	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CARYA OVATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1703_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1703	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Hickory, Shagbark Carya ovata		Hickory, Shagbark Carya ovata	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CARYA OVATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1744_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1744	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Johnson Grass Sorghum halepense		Johnson Grass Sorghum halepense	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SORGHUM HALEPENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1745_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1745	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Johnson Grass Sorghum halepense		Johnson Grass Sorghum halepense	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SORGHUM HALEPENSE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1747_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1747	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Johnson Grass Sorghum halepense		Johnson Grass Sorghum halepense	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SORGHUM HALEPENSE POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1780_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1780	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Kochia scoparia		Kochia scoparia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BASSIA SCOPARIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1781_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1781	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Kochia scoparia		Kochia scoparia	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BASSIA SCOPARIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1783_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1783	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Kochia scoparia		Kochia scoparia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BASSIA SCOPARIA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1786_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1786	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Lambs Quarters Chenopodium album		Lambs Quarters Chenopodium album	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CHENOPODIUM ALBUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1787_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1787	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Lambs Quarters Chenopodium album		Lambs Quarters Chenopodium album	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CHENOPODIUM ALBUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1789_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1789	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Lambs Quarters Chenopodium album		Lambs Quarters Chenopodium album	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CHENOPODIUM ALBUM POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1790_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1790	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Lambs Quarters Chenopodium album		Lambs Quarters Chenopodium album	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CHENOPODIUM ALBUM POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1791_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1791	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Lambs Quarters Chenopodium album		Lambs Quarters Chenopodium album	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CHENOPODIUM ALBUM POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1801_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1801	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Linden Basswood Tilia americana		Linden Basswood Tilia americana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	TILIA AMERICANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1831_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1831	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Maple, Hard Acer saccharum		Maple, Hard Acer saccharum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER SACCHARUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1832_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1832	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Maple, Hard Acer saccharum		Maple, Hard Acer saccharum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER SACCHARUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1858_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1858	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Marshelder/Poverty Mix		Pollens - Weeds, Marshelder/Poverty Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CYCLACHAENA XANTHIFOLIA POLLEN; IVA ANNUA POLLEN; IVA AXILLARIS POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1859_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1859	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Marshelder/Poverty Mix		Pollens - Weeds, Marshelder/Poverty Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CYCLACHAENA XANTHIFOLIA POLLEN; IVA ANNUA POLLEN; IVA AXILLARIS POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1861_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1861	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Marshelder/Poverty Mix		Pollens - Weeds, Marshelder/Poverty Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CYCLACHAENA XANTHIFOLIA POLLEN; IVA ANNUA POLLEN; IVA AXILLARIS POLLEN	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-1873_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1873	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Melaleuca Punk Tree Melaleuca quinquenervia		Melaleuca Punk Tree Melaleuca quinquenervia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MELALEUCA QUINQUENERVIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1874_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1874	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Melaleuca Punk Tree Melaleuca quinquenervia		Melaleuca, Melaleuca quinquenervia	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MELALEUCA QUINQUENERVIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1876_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1876	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Mesquite, Prosopis juliflora		Mesquite, Prosopis juliflora	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PROSOPIS JULIFLORA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1877_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1877	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Mesquite, Prosopis juliflora		Mesquite, Prosopis juliflora	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PROSOPIS JULIFLORA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1909_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1909	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Mulberry Mix		Mulberry Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MORUS ALBA POLLEN; MORUS RUBRA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1910_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1910	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Mulberry Mix		Mulberry Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MORUS ALBA POLLEN; MORUS RUBRA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1912_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1912	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Mulberry Mix		Mulberry Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MORUS ALBA POLLEN; MORUS RUBRA POLLEN	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS]		N	20241231
65044-1945_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1945	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Nettle Urtica dioica		Nettle Urtica dioica	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	URTICA DIOICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1946_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-1946	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Nettle Urtica dioica		Nettle Urtica dioica	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	URTICA DIOICA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-1947_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-1947	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Nettle Urtica dioica		Nettle Urtica dioica	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	URTICA DIOICA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2014_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2014	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Oak, Red Quercus rubra		Oak, Red Quercus rubra	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	QUERCUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2015_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2015	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Oak, Red Quercus rubra		Oak, Red Quercus rubra	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	QUERCUS RUBRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2017_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2017	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Palo Verde Cercidium floridum		Palo Verde Cercidium floridum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PARKINSONIA FLORIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2018_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2018	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Palo Verde Cercidium floridum		Palo Verde Cercidium floridum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PARKINSONIA FLORIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2035_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2035	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Oak Mix		Oak Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2036_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2036	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Oak Mix		Oak Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2038_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2038	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Oak Mix		Oak Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2039_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2039	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Oak Mix		Oak Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN	20000; 20000; 20000	[PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2041_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2041	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Oats, Common, Cultivated Avena sativa		Oats, Common, Cultivated Avena sativa	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AVENA SATIVA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2042_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2042	NON-STANDARDIZED ALLERGENIC	Pollens - Grasses, Oats, Common, Cultivated Avena sativa		Oats, Common, Cultivated Avena sativa	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AVENA SATIVA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2050_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2050	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Olive Olea europaea		Olive Olea europaea	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	OLEA EUROPAEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2051_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2051	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Olive Olea europaea		Olive Olea europaea	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	OLEA EUROPAEA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2053_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2053	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Olive Olea europaea		Olive Olea europaea	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	OLEA EUROPAEA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2057_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2057	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Dog Fennel, Eastern Eupatorium capillifolium		Dog Fennel, Eastern Eupatorium capillifolium	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EUPATORIUM CAPILLIFOLIUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2058_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2058	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Dog Fennel Eupatorium capillifolium		Dog Fennel Eupatorium capillifolium	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EUPATORIUM CAPILLIFOLIUM POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2074_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2074	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Palm, Queen Cocos plumosa		Palm, Queen Cocos plumosa	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SYAGRUS ROMANZOFFIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2075_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2075	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Palm, Queen Cocos plumosa		Palm, Queen Cocos plumosa	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SYAGRUS ROMANZOFFIANA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2098_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2098	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Pecan Carya Carya illinoensis		Pecan Carya Carya illinoensis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CARYA ILLINOINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2099_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2099	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Pecan Carya Carya illinoensis		Pecan Carya Carya illinoensis	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CARYA ILLINOINENSIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2101_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2101	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Pecan Carya Carya illinoensis		Pecan Carya Carya illinoensis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CARYA ILLINOINENSIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2107_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2107	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Pepper Tree, California Schinus molle		Pepper Tree, California Schinus molle	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SCHINUS MOLLE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2108_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2108	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Pepper Tree, California Schinus molle		Pepper Tree, California Schinus molle	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SCHINUS MOLLE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2125_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2125	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Pigweed, Rough Redroot Amaranthus retroflexus		Pigweed, Rough Redroot Amaranthus retroflexus	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS RETROFLEXUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2126_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2126	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Pigweed, Rough Redroot Amaranthus retroflexus		Pigweed, Rough Redroot Amaranthus retroflexus	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS RETROFLEXUS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2203_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2203	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Pine Mix		Pine Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PINUS CONTORTA POLLEN; PINUS PONDEROSA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2204_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2204	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Pine Mix		Pine Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PINUS CONTORTA POLLEN; PINUS PONDEROSA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2212_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2212	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Plantain, English Plantago lanceolata		Plantain, English Plantago lanceolata	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLANTAGO LANCEOLATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2213_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2213	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Plantain, English Plantago lanceolata		Plantain, English Plantago lanceolata	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLANTAGO LANCEOLATA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2215_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2215	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Plantain, English Plantago lanceolata		Plantain, English Plantago lanceolata	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLANTAGO LANCEOLATA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2216_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2216	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Plantain, English Plantago lanceolata		Plantain, English Plantago lanceolata	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLANTAGO LANCEOLATA POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2217_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2217	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Plantain, English Plantago lanceolata		Plantain, English Plantago lanceolata	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLANTAGO LANCEOLATA POLLEN	20000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2251_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2251	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Privet Ligustrum vulgare		Privet Ligustrum vulgare	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	LIGUSTRUM VULGARE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2252_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2252	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Privet Ligustrum vulgare		Privet Ligustrum vulgare	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	LIGUSTRUM VULGARE POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2293_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2293	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Ragweed, Giant Ambrosia trifida		Ragweed, Giant Ambrosia trifida	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA TRIFIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2294_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2294	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Ragweed, Giant Ambrosia trifida		Ragweed, Giant Ambrosia trifida	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA TRIFIDA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2296_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2296	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Ragweed, Giant Ambrosia trifida		Ragweed, Giant Ambrosia trifida	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA TRIFIDA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2297_be670d57-df5e-40fd-97b8-49a3b7337160	65044-2297	STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Short Ragweed, Ambrosia artemisiifolia		Short Ragweed, Ambrosia artemisiifolia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19771018		BLA	BLA103880	Jubilant HollisterStier LLC	AMBROSIA ARTEMISIIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-2308_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2308	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Ragweed. Western Ambrosia psilostachya		Ragweed. Western Ambrosia psilostachya	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA PSILOSTACHYA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2309_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2309	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Ragweed. Western Ambrosia psilostachya		Ragweed. Western Ambrosia psilostachya	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA PSILOSTACHYA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2311_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2311	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Ragweed. Western Ambrosia psilostachya		Ragweed. Western Ambrosia psilostachya	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA PSILOSTACHYA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2315_be670d57-df5e-40fd-97b8-49a3b7337160	65044-2315	STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Ragweed, Mixed Ambrosia		Ragweed, Mixed Ambrosia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19771018		BLA	BLA103880	Jubilant HollisterStier LLC	AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA TRIFIDA POLLEN	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-2318_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2318	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Giant, Short, Western Ragweed Mix		Giant, Short, Western Ragweed Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-2320_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2320	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Giant, Short, Western Ragweed Mix		Giant, Short, Western Ragweed Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMBROSIA ARTEMISIIFOLIA POLLEN; AMBROSIA PSILOSTACHYA POLLEN; AMBROSIA TRIFIDA POLLEN	.05; .05; .05	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
65044-2359_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2359	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Russian Olive Elaeagnus angustifolia		Russian Olive Elaeagnus angustifolia	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ELAEAGNUS ANGUSTIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2360_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2360	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Olive, Russian Elaeagnus angustifolia		Russian Olive Elaeagnus angustifolia	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ELAEAGNUS ANGUSTIFOLIA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2362_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2362	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Russian Thistle Salsola kali		Russian Thistle Salsola kali	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SALSOLA KALI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2363_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2363	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Russian Thistle Salsola kali		Russian Thistle Salsola kali	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SALSOLA KALI POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2413_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2413	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Sagebrush, Mugwort Artemisia vulgaris		Sagebrush, Mugwort Artemisia vulgaris	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ARTEMISIA VULGARIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2414_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2414	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Sagebrush, Mugwort Artemisia vulgaris		Sagebrush, Mugwort Artemisia vulgaris	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ARTEMISIA VULGARIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2416_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2416	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Sagebrush, Mugwort Artemisia vulgaris		Sagebrush, Mugwort Artemisia vulgaris	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ARTEMISIA VULGARIS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2417_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2417	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Sagebrush, Mugwort Artemisia vulgaris		Sagebrush, Mugwort Artemisia vulgaris	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ARTEMISIA VULGARIS POLLEN	40000	[PNU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2482_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2482	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Scale, Wing Shad Atriplex canescens		Scale, Wing Shad Atriplex canescens	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ATRIPLEX CANESCENS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2483_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2483	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Scale, Wing Shad Atriplex canescens		Scale, Wing Shad Atriplex canescens	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ATRIPLEX CANESCENS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2485_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2485	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Scale, Wing Shad Atriplex canescens		Scale, Wing Shad Atriplex canescens	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ATRIPLEX CANESCENS POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2486_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2486	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Scotch Broom Cytisus scoparius		Scotch Broom Cytisus scoparius	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CYTISUS SCOPARIUS FLOWERING TOP	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
65044-2487_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2487	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Scotch Broom Cytisus scoparius		Scotch Broom Cytisus scoparius	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CYTISUS SCOPARIUS FLOWERING TOP	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
65044-2506_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2506	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Sorrel, Sheep Rumex acetosella		Sorrel, Sheep Rumex acetosella	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RUMEX ACETOSELLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2507_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2507	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Sorrel, Sheep Rumex acetosella		Sorrel, Sheep Rumex acetosella	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RUMEX ACETOSELLA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2508_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2508	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds and Garden Plants, Sorrel, Sheep Rumex acetosella		Sorrel, Sheep Rumex acetosella	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RUMEX ACETOSELLA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2563_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2563	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Sycamore, American Eastern Platanus occidentallis		Sycamore, American Eastern Platanus occidentallis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLATANUS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2564_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2564	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Sycamore, American Eastern Platanus occidentallis		Sycamore, American Eastern Platanus occidentallis	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLATANUS OCCIDENTALIS POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2599_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2599	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree of Heaven Ailanthus altissima		Tree of Heaven Ailanthus altissima	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AILANTHUS ALTISSIMA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2600_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2600	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree of Heaven Ailanthus altissima		Tree of Heaven Ailanthus altissima	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AILANTHUS ALTISSIMA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2619_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2619	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 11		Tree Mix 11	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.05; .05; .05; .05; .05; .05; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2620_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2620	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 11		Tree Mix 11	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.05; .05; .05; .05; .05; .05; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2622_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2622	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 11		Tree Mix 11	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	.1; .1; .1; .1; .1; .1; .1; .1; .1; .1	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2623_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2623	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 11		Tree Mix 11	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	40000; 40000; 40000; 40000; 40000; 40000; 40000; 40000; 40000; 40000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2624_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2624	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 11		Tree Mix 11	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER SACCHARUM POLLEN; BETULA NIGRA POLLEN; CARYA OVATA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLEN	20000; 20000; 20000; 20000; 20000; 20000; 20000; 20000; 20000; 20000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2626_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2626	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Walnut, Black Juglans nigra		Walnut, Black Juglans nigra	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUGLANS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2627_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2627	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Walnut, Black Juglans nigra		Walnut, Black Juglans nigra	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUGLANS NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2629_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2629	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Walnut, Black Juglans nigra		Walnut, Black Juglans nigra	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	JUGLANS NIGRA POLLEN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2630_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2630	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Weed mix 2630		Weed mix 2630	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; XANTHIUM STRUMARIUM POLLEN	.05; .05; .025; .025; .05	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2632_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2632	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Weed mix 2630		Weed mix 2630	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; XANTHIUM STRUMARIUM POLLEN	.1; .1; .05; .05; .1	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2633_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2633	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Weed mix 2630		Weed mix 2630	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; XANTHIUM STRUMARIUM POLLEN	40000; 40000; 40000; 40000; 40000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2634_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2634	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Weed mix 2630		Weed mix 2630	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; XANTHIUM STRUMARIUM POLLEN	.05; .05; .025; .025; .05	g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2635_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2635	NON-STANDARDIZED ALLERGENIC	Pollens - Weeds, Weed mix 2630		Weed mix 2630	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AMARANTHUS RETROFLEXUS POLLEN; CHENOPODIUM ALBUM POLLEN; RUMEX ACETOSELLA POLLEN; RUMEX CRISPUS POLLEN; XANTHIUM STRUMARIUM POLLEN	20000; 20000; 20000; 20000; 20000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2677_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2677	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Willow, Black Salix nigra		Willow, Black Salix nigra	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SALIX NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2678_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2678	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Willow, Black Salix nigra		Willow, Black Salix nigra	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SALIX NIGRA POLLEN	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]		N	20241231
65044-2854_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2854	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 5		Tree Mix 5	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; CARYA ILLINOINENSIS POLLEN; PLATANUS OCCIDENTALIS POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; SALIX NIGRA POLLEN	.017; .017; .017; .05; .05; .017; .017; .017; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2855_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2855	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 5		Tree Mix 5	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; CARYA ILLINOINENSIS POLLEN; PLATANUS OCCIDENTALIS POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; SALIX NIGRA POLLEN	20000; 20000; 20000; 20000; 20000; 20000; 20000; 20000; 20000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2856_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2856	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 5		Tree Mix 5	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; CARYA ILLINOINENSIS POLLEN; PLATANUS OCCIDENTALIS POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; SALIX NIGRA POLLEN	.033; .033; .033; .1; .1; .033; .033; .033; .1	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2858_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2858	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 5		Tree Mix 5	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ACER SACCHARUM POLLEN; CARYA ILLINOINENSIS POLLEN; PLATANUS OCCIDENTALIS POLLEN; QUERCUS ALBA POLLEN; QUERCUS RUBRA POLLEN; QUERCUS VIRGINIANA POLLEN; SALIX NIGRA POLLEN	.017; .017; .017; .05; .05; .017; .017; .017; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2859_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-2859	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 6		Tree Mix 6	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; POPULUS DELTOIDES POLLEN; ULMUS AMERICANA POLLEN	.017; .017; .017; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2861_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2861	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 6		Tree Mix 6	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; POPULUS DELTOIDES POLLEN; ULMUS AMERICANA POLLEN	.033; .033; .033; .1; .1; .1; .1	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2862_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2862	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 6		Tree Mix 6	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; POPULUS DELTOIDES POLLEN; ULMUS AMERICANA POLLEN	20000; 20000; 20000; 20000; 20000; 20000; 20000	[PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-2863_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-2863	NON-STANDARDIZED ALLERGENIC	Pollens - Trees, Tree Mix 6		Tree Mix 6	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BETULA NIGRA POLLEN; BETULA PAPYRIFERA POLLEN; BETULA PENDULA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; POPULUS DELTOIDES POLLEN; ULMUS AMERICANA POLLEN	.017; .017; .017; .05; .05; .05; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
65044-3014_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3014	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Almond Prunus amygdalus		Almond Prunus amygdalus	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALMOND	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
65044-3020_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3020	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Apple Malus sp.		Apple Malus sp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	APPLE	.1	g/mL	Allergens [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3041_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3041	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Banana Musa sapientum		Banana Musa sapientum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BANANA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3074_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3074	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, String Bean Mix		String Bean Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	STRING BEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
65044-3077_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3077	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Beef Bovine spp.		Beef Bovine spp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BEEF	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3078_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3078	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Beef Bovine spp.		Beef Bovine spp.	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BEEF	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3107_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3107	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Brazil Nut Bertholletia excelsa		Brazil Nut Bertholletia excelsa	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BRAZIL NUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
65044-3116_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3116	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Melon, Cantaloupe Cucumis melo		Cantaloupe Cucumis melo	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CANTALOUPE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3125_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3125	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Carrot Daucus carota		Carrot Daucus carota	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CARROT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
65044-3134_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3134	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Cashew Nut Anacardium occidentalie		Cashew Nut Anacardium occidentalie	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CASHEW	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
65044-3140_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3140	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Celery Apium graveolens		Celery Apium graveolens	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CELERY	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
65044-3173_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3173	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Chicken Meat Gallus sp.		Chicken Meat Gallus sp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	POULTRY, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
65044-3174_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3174	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Chicken Meat Gallus sp.		Chicken Meat Gallus sp.	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	POULTRY, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
65044-3191_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3191	NON-STANDARDIZED ALLERGENIC	Food - Fish and Shellfish, Clam		Clam	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	QUAHOG, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
65044-3203_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3203	NON-STANDARDIZED ALLERGENIC	Food - Fish and Shellfish, Codfish Gadus callarias		Codfish Gadus callarias	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	COD, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3212_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3212	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Corn Zea mays		Corn Zea mays	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CORN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3215_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3215	NON-STANDARDIZED ALLERGENIC	Food - Fish and Shellfish, Crab Xiphosurus sowerbyi		Crab Xiphosurus sowerbyi	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CRAB LEG, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
65044-3248_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3248	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Egg, White Gallus sp.		Egg, White Gallus sp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EGG WHITE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3249_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3249	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Egg, White Gallus sp.		Egg, White Gallus sp.	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EGG WHITE	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3254_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3254	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Egg, Yolk Gallus sp.		Egg, Yolk Gallus sp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EGG YOLK	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3255_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3255	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Egg, Yolk Gallus sp.		Egg, Yolk Gallus sp.	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EGG YOLK	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3305_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3305	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Hazelnut Filbert Corylus spp.		Hazelnut Filbert Corylus spp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	HAZELNUT, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
65044-3362_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3362	NON-STANDARDIZED ALLERGENIC	Food - Fish and Shellfish, Lobster Homarus americanus		Lobster Homarus americanus	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	LOBSTER, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
65044-3380_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3380	NON-STANDARDIZED ALLERGENIC	Food - Dairy Products, Casein, Cow Milk		Casein, Cow Milk	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CASEIN	.1	g/mL	Allergens [CS], Caseins [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3381_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3381	NON-STANDARDIZED ALLERGENIC	Food - Dairy Products, Casein, Cow Milk		Casein, Cow Milk	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CASEIN	.1	g/mL	Allergens [CS], Caseins [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3389_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3389	NON-STANDARDIZED ALLERGENIC	Food - Dairy Products, Milk, Whole Cow		Milk, Whole Cow	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	COW MILK	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3390_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3390	NON-STANDARDIZED ALLERGENIC	Food - Dairy Products, Milk, Whole Cow		Milk, Whole Cow	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	COW MILK	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3428_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3428	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Orange Citrus sinensis		Orange Citrus sinensis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ORANGE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3449_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3449	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Pea, Green or English Pisum sativum		Pea, Green or English Pisum sativum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PEA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
65044-3452_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3452	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Peach Prunus persica		Peach Prunus persica	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PEACH	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3455_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3455	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Peanut Arachis hypogaea		Peanut Arachis hypogaea	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PEANUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
65044-3461_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3461	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Pecan Carya illinoensis		Pecan Carya illinoensis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PECAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
65044-3509_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3509	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Pork Sus sp.		Pork Sus sp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PORK	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3510_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3510	NON-STANDARDIZED ALLERGENIC	Food - Animal Products and Poultry Products, Pork Sus sp.		Pork Sus sp.	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PORK	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3518_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3518	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Potato, White Solanum tuberosum		Potato, White Solanum tuberosum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	POTATO	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
65044-3548_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3548	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Rice, Whole Grain		Rice, Whole Grain	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BROWN RICE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3554_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3554	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Rye Grain		Rye Grain	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RYE	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3565_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3565	NON-STANDARDIZED ALLERGENIC	Food - Fish and Shellfish, Salmon Salmo salar		Salmon Salmo salar	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SALMON, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3584_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3584	NON-STANDARDIZED ALLERGENIC	Food - Fish and Shellfish, Shrimp Crago sp.		Shrimp Crago sp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SHRIMP, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]		N	20241231
65044-3596_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3596	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Soybean Glycine soja		Soybean Glycine soja	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOYBEAN	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
65044-3626_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3626	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Strawberry Fragaria chiloensis		Strawberry Fragaria chiloensis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	STRAWBERRY	.05	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3656_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3656	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Tomato Nicotiana spp.		Tomato Nicotiana spp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	TOMATO	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
65044-3674_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3674	NON-STANDARDIZED ALLERGENIC	Food - Fish and Shellfish, Tuna Thunnus sp.		Tuna Thunnus sp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	TUNA, UNSPECIFIED	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
65044-3695_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3695	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Walnut, Black Juglans nigra		Walnut, Black Juglans nigra	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLACK WALNUT	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
65044-3713_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3713	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Yeast, Baker Saccharomyces cerevisiae		Yeast, Baker Saccharomyces cerevisiae	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	YEAST	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-3714_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3714	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Yeast, Baker Saccharomyces cerevisiae		Yeast, Baker Saccharomyces cerevisiae	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	YEAST	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-3716_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-3716	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Yeast, Brewer Saccharomyces cerevisiae		Yeast, Brewer Saccharomyces cerevisiae	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	YEAST	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-3717_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-3717	NON-STANDARDIZED ALLERGENIC	Food - Plant Source, Yeast, Brewer Saccharomyces cerevisiae		Yeast, Brewer Saccharomyces cerevisiae	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	YEAST	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-4083_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4083	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Dog Hair and Dander Canis spp.		Dog Hair Canis spp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CANIS LUPUS FAMILIARIS DANDER; CANIS LUPUS FAMILIARIS HAIR	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4084_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-4084	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Dog Hair and Dander Canis spp.		Dog Hair Canis spp.	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CANIS LUPUS FAMILIARIS DANDER; CANIS LUPUS FAMILIARIS HAIR	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4085_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4085	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Dog Hair and Dander Canis spp.		Dog Hair Canis spp.	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CANIS LUPUS FAMILIARIS DANDER; CANIS LUPUS FAMILIARIS HAIR	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4349_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4349	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Feather Mix		Feather Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
65044-4350_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-4350	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Feather Mix		Feather Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
65044-4352_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4352	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Feather Mix		Feather Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; GALLUS GALLUS FEATHER	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC]		N	20241231
65044-4401_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4401	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Guinea Pig Hair and Dander		Guinea Pig Hair and Dander	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CAVIA PORCELLUS DANDER; CAVIA PORCELLUS HAIR	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4402_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-4402	NON-STANDARDIZED ALLERGENIC	Animal Allergens, Guinea Pig Hair and Dander		Guinea Pig Hair and Dander	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CAVIA PORCELLUS DANDER; CAVIA PORCELLUS HAIR	.05; .05	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4810_a962d0fd-a14a-4add-90a5-e727948ff12c	65044-4810	STANDARDIZED ALLERGENIC	Standardized Cat Pelt		Standardized Cat Pelt	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19921020		BLA	BLA103890	Jubilant HollisterStier LLC	FELIS CATUS DANDER	10000	[BAU]/mL			N	20241231
65044-4811_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4811	NON-STANDARDIZED ALLERGENIC	Animal Allergens, AP Cattle Hair and Dander		Cattle Hair and Dander	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19780130		BLA	BLA103888	Jubilant HollisterStier LLC	BOS TAURUS DANDER; BOS TAURUS HAIR	.01; .01	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4812_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-4812	NON-STANDARDIZED ALLERGENIC	Animal Allergens, AP Cattle Hair and Dander		Cattle Hair and Dander	INJECTION, SOLUTION	PERCUTANEOUS	19780130		BLA	BLA103888	Jubilant HollisterStier LLC	BOS TAURUS DANDER; BOS TAURUS HAIR	.01; .01	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4815_1b35bf06-06b0-4666-8862-c9dbbf206788	65044-4815	STANDARDIZED ALLERGENIC	Standardized Cat Hair		Standardized Cat Hair	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19920924		BLA	BLA103889	Jubilant HollisterStier LLC	FELIS CATUS HAIR	10000	[BAU]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dander [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Salivary Proteins and Peptides [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4824_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4824	NON-STANDARDIZED ALLERGENIC	Animal Allergens, AP Dog Hair and Dander Canis spp		Animal Allergens, Dog Dander Canis spp	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19760824		BLA	BLA103888	Jubilant HollisterStier LLC	CANIS LUPUS FAMILIARIS DANDER; CANIS LUPUS FAMILIARIS HAIR	.005; .005	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4825_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-4825	NON-STANDARDIZED ALLERGENIC	Animal Allergens, AP Dog Hair and Dander Canis spp		Animal Allergens, Dog Dander Canis spp	INJECTION, SOLUTION	PERCUTANEOUS	19760824		BLA	BLA103888	Jubilant HollisterStier LLC	CANIS LUPUS FAMILIARIS DANDER; CANIS LUPUS FAMILIARIS HAIR	.005; .005	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4850_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-4850	NON-STANDARDIZED ALLERGENIC	Animal Allergens, UF Dog Hair-Dander Canis spp		Animal Allergens, Dog Dander Canis spp	INJECTION, SOLUTION	PERCUTANEOUS	20220701		BLA	BLA103888	Jubilant HollisterStier LLC	CANIS LUPUS FAMILIARIS DANDER; CANIS LUPUS FAMILIARIS HAIR	.0008; .0008	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4850_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4850	NON-STANDARDIZED ALLERGENIC	Animal Allergens, UF Dog Hair-Dander Canis spp		Animal Allergens, Dog Dander Canis spp	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	20220701		BLA	BLA103888	Jubilant HollisterStier LLC	CANIS LUPUS FAMILIARIS DANDER; CANIS LUPUS FAMILIARIS HAIR	.0008; .0008	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4855_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-4855	NON-STANDARDIZED ALLERGENIC	Animal Allergens, AP Horse Hair and Dander		AP Horse Hair and Dander	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19780130		BLA	BLA103888	Jubilant HollisterStier LLC	EQUUS CABALLUS DANDER; EQUUS CABALLUS HAIR	.01; .01	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-4856_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-4856	NON-STANDARDIZED ALLERGENIC	Animal Allergens, AP Horse Hair and Dander		AP Horse Hair and Dander	INJECTION, SOLUTION	PERCUTANEOUS	19780130		BLA	BLA103888	Jubilant HollisterStier LLC	EQUUS CABALLUS DANDER; EQUUS CABALLUS HAIR	.01; .01	g/mL; g/mL	Allergens [CS], Allergens [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
65044-5000_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5000	NON-STANDARDIZED ALLERGENIC	Molds - Mold Mix 4		Molds - Mold Mix 4	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; ASPERGILLUS TERREUS; CLADOSPORIUM CLADOSPORIOIDES; CLONOSTACHYS ROSEA F. ROSEA; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM EXPANSUM	.1; .025; .025; .025; .025; .1; .025; .025; .025; .025	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5002_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5002	NON-STANDARDIZED ALLERGENIC	Molds - Mold Mix 4		Molds - Mold Mix 4	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; ASPERGILLUS TERREUS; CLADOSPORIUM CLADOSPORIOIDES; CLONOSTACHYS ROSEA F. ROSEA; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM EXPANSUM	.1; .025; .025; .025; .025; .1; .025; .025; .025; .05	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5003_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5003	NON-STANDARDIZED ALLERGENIC	Molds - Alternaria/Hormodendrum Mix		Molds - Alternaria/Hormodendrum Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA; CLADOSPORIUM CLADOSPORIOIDES	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5004_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5004	NON-STANDARDIZED ALLERGENIC	Molds - Alternaria/Hormodendrum Mix		Molds - Alternaria/Hormodendrum Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA; CLADOSPORIUM CLADOSPORIOIDES	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5008_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5008	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Alternaria tenuis		Alternaria tenuis	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5009_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5009	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Alternaria tenuis		Alternaria tenuis	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5020_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5020	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Aspergillus fumigatus		Aspergillus fumigatus	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ASPERGILLUS FUMIGATUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5021_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5021	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Aspergillus fumigatus		Aspergillus fumigatus	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ASPERGILLUS FUMIGATUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5032_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5032	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Aspergillus niger		Aspergillus niger	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ASPERGILLUS NIGER VAR. NIGER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5033_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5033	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Aspergillus niger		Aspergillus niger	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ASPERGILLUS NIGER VAR. NIGER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5048_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5048	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Botrytis cinerea		Botrytis cinerea	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BOTRYTIS CINEREA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5049_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5049	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Botrytis cinerea		Botrytis cinerea	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BOTRYTIS CINEREA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5052_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5052	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Candida albicans		Candida albicans	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CANDIDA ALBICANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5053_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5053	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Candida albicans		Candida albicans	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CANDIDA ALBICANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5055_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5055	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Candida albicans		Candida albicans	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CANDIDA ALBICANS	.001	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5056_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5056	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Cephalosporium acremonium		Cephalosporium acremonium	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SAROCLADIUM STRICTUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5057_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5057	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Cephalosporium acremonium		Cephalosporium acremonium	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SAROCLADIUM STRICTUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5076_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5076	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Curvularia spicifera		Curvularia spicifera	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	COCHLIOBOLUS SPICIFER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5077_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5077	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Curvularia spicifera		Curvularia spicifera	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	COCHLIOBOLUS SPICIFER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5100_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5100	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Epicoccum nigrum		Epicoccum nigrum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EPICOCCUM NIGRUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5101_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5101	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Epicoccum nigrum		Epicoccum nigrum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EPICOCCUM NIGRUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5104_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5104	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Epidermophyton floccosum		Epidermophyton floccosum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EPIDERMOPHYTON FLOCCOSUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5105_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5105	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Epidermophyton floccosum		Epidermophyton floccosum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	EPIDERMOPHYTON FLOCCOSUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5112_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5112	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Fusarium vasinfectum		Fusarium vasinfectum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	FUSARIUM OXYSPORUM VASINFECTUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5113_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5113	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Fusarium vasinfectum		Fusarium vasinfectum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	FUSARIUM OXYSPORUM VASINFECTUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5124_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5124	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Helminthosporium interseminatum		Helminthosporium interseminatum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	DENDRYPHIELLA VINOSA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5125_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5125	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Helminthosporium interseminatum		Helminthosporium interseminatum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	DENDRYPHIELLA VINOSA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5128_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5128	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Hormodendrum cladosporioides		Hormodendrum cladosporioides	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CLADOSPORIUM CLADOSPORIOIDES	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5129_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5129	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Hormodendrum cladosporioides		Hormodendrum cladosporioides	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CLADOSPORIUM CLADOSPORIOIDES	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5136_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5136	NON-STANDARDIZED ALLERGENIC	Molds - Mold Mix 10		Molds - Mold Mix 10	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; ASPERGILLUS TERREUS; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CLADOSPORIUM CLADOSPORIOIDES; CLONOSTACHYS ROSEA F. ROSEA; DENDRYPHIELLA VINOSA; FUSARIUM OXYSPORUM VASINFECTUM; MUCOR RACEMOSUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM EXPANSUM; PHOMA EXIGUA VAR. EXIGUA; RHIZOPUS STOLONIFER	.1; .025; .025; .025; .025; .1; .1; .02; .1; .1; .1; .02; .02; .02; .1; .1	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5137_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5137	NON-STANDARDIZED ALLERGENIC	Molds - Mold Mix 10		Molds - Mold Mix 10	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER VAR. NIGER; ASPERGILLUS TERREUS; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CLADOSPORIUM CLADOSPORIOIDES; CLONOSTACHYS ROSEA F. ROSEA; DENDRYPHIELLA VINOSA; FUSARIUM OXYSPORUM VASINFECTUM; MUCOR RACEMOSUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM EXPANSUM; PHOMA EXIGUA VAR. EXIGUA; RHIZOPUS STOLONIFER	.1; .025; .025; .025; .025; .1; .1; .02; .1; .1; .1; .02; .02; .04; .1; .1	g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5144_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5144	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Mucor racemosus		Mucor racemosus	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MUCOR RACEMOSUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5145_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5145	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Mucor racemosus		Mucor racemosus	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	MUCOR RACEMOSUS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5168_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5168	NON-STANDARDIZED ALLERGENIC	Molds, Penicillium Mix		Molds, Penicillium Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CLONOSTACHYS ROSEA F. ROSEA; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM EXPANSUM	.1; .1; .1; .1	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5169_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5169	NON-STANDARDIZED ALLERGENIC	Molds, Penicillium Mix		Molds, Penicillium Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	CLONOSTACHYS ROSEA F. ROSEA; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM DIGITATUM; PENICILLIUM EXPANSUM	.1; .1; .1; .2	g/mL; g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5208_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5208	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Penicillium notatum		Penicillium notatum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5209_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5209	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Penicillium notatum		Penicillium notatum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5220_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5220	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Phoma herbarum		Phoma herbarum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PHOMA EXIGUA VAR. EXIGUA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5221_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5221	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Phoma herbarum		Phoma herbarum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PHOMA EXIGUA VAR. EXIGUA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5230_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5230	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Rhizopus nigricans		Rhizopus nigricans	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RHIZOPUS STOLONIFER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5232_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5232	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Rhizopus nigricans		Rhizopus nigricans	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	RHIZOPUS STOLONIFER	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5233_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5233	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Pullularia pullulans		Pullularia pullulans	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AUREOBASIDIUM PULLULANS VAR. PULLUTANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5235_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5235	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Pullularia pullulans		Pullularia pullulans	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	AUREOBASIDIUM PULLULANS VAR. PULLUTANS	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5264_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5264	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Stemphylium botryosum		Stemphylium botryosum	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLEOSPORA TARDA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5265_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5265	NON-STANDARDIZED ALLERGENIC	Molds, Rusts and Smuts, Stemphylium botryosum		Stemphylium botryosum	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PLEOSPORA TARDA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5284_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-5284	NON-STANDARDIZED ALLERGENIC	Molds - Trichophyton Mix		Molds - Trichophyton Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-5285_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-5285	NON-STANDARDIZED ALLERGENIC	Molds - Trichophyton Mix		Molds - Trichophyton Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS	.1; .1; .1	g/mL; g/mL; g/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
65044-6513_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-6513	NON-STANDARDIZED ALLERGENIC	Insects Whole Body, Ant, Fire Solenopsis Invicta		Ant, Fire Solenopsis Invicta	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOLENOPSIS INVICTA	.1	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
65044-6513_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6513	NON-STANDARDIZED ALLERGENIC	Insects Whole Body, Ant, Fire Solenopsis Invicta		Ant, Fire Solenopsis Invicta	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOLENOPSIS INVICTA	.1	g/mL	Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
65044-6515_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-6515	NON-STANDARDIZED ALLERGENIC	Insects whole body, Fire Ant Mix		Insects whole body, Fire Ant Mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOLENOPSIS INVICTA; SOLENOPSIS RICHTERI	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Ant Venoms [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
65044-6517_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6517	NON-STANDARDIZED ALLERGENIC	Insects whole body, Fire Ant Mix		Insects whole body, Fire Ant Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOLENOPSIS INVICTA; SOLENOPSIS RICHTERI	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Ant Venoms [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
65044-6518_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6518	NON-STANDARDIZED ALLERGENIC	Insects whole body, Fire Ant Mix		Insects whole body, Fire Ant Mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	SOLENOPSIS INVICTA; SOLENOPSIS RICHTERI	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [CS], Ant Venoms [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Insect Venom Allergenic Extract [EPC], Non-Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
65044-6580_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6580	NON-STANDARDIZED ALLERGENIC	Insects whole body cockroach, American Periplaneta americana		Insects whole body cockroach, American Periplaneta americana	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	PERIPLANETA AMERICANA	.1	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6581_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6581	NON-STANDARDIZED ALLERGENIC	Insects whole body Cockroach, German Blatella germanica		Insects whole body Cockroach, German Blatella germanica	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLATTELLA GERMANICA	.1	g/mL	Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6584_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6584	NON-STANDARDIZED ALLERGENIC	Insects whole body cockroach mix		Insects whole body cockroach mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6585_232acffb-aaa8-4ad5-81c5-afaebe3f5c09	65044-6585	NON-STANDARDIZED ALLERGENIC	Insects whole body cockroach mix		Insects whole body cockroach mix	INJECTION, SOLUTION	PERCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6587_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6587	NON-STANDARDIZED ALLERGENIC	Insects whole body cockroach mix		Insects whole body cockroach mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	.1; .1	g/mL; g/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6588_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6588	NON-STANDARDIZED ALLERGENIC	Insects whole body cockroach mix		Insects whole body cockroach mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6589_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6589	NON-STANDARDIZED ALLERGENIC	Insects whole body cockroach mix		Insects whole body cockroach mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	20000; 20000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6590_57c4d84e-b073-4dc8-a0ce-58343fff140a	65044-6590	NON-STANDARDIZED ALLERGENIC	Insects whole body cockroach mix		Insects whole body cockroach mix	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19410419		BLA	BLA103888	Jubilant HollisterStier LLC	BLATTELLA GERMANICA; PERIPLANETA AMERICANA	5000; 5000	[PNU]/mL; [PNU]/mL	Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [Chemical/Ingredient], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6690_2624a67a-4df4-4ee3-9e7d-b8a7e947736a	65044-6690	STANDARDIZED ALLERGENIC	Standardized Mite Mix, Dermatophagoides pteronyssinus and Dermatophagoides farinae, 30000 AU per mL		Standardized Mite Mix, Dermatophagoides pteronyssinus and Dermatophagoides farinae, 30000 AU per mL	INJECTION, SOLUTION	SUBCUTANEOUS	19880526		BLA	BLA103870	Jubilant HollisterStier LLC	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	15000; 15000	[AU]/mL; [AU]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6691_2624a67a-4df4-4ee3-9e7d-b8a7e947736a	65044-6691	STANDARDIZED ALLERGENIC	Standardized Mite Mix, Dermatophagoides pteronyssinus and Dermatophagoides farinae, 10000 AU per mL		Standardized Mite Mix, Dermatophagoides pteronyssinus and Dermatophagoides farinae, 10000 AU per mL	INJECTION, SOLUTION	SUBCUTANEOUS	19880526		BLA	BLA103870	Jubilant HollisterStier LLC	DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS	5000; 5000	[AU]/mL; [AU]/mL	Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6692_2624a67a-4df4-4ee3-9e7d-b8a7e947736a	65044-6692	STANDARDIZED ALLERGENIC	Standardized Mite, Dermatophagoides pteronyssinus, Scratch or Bulk, 30000 AU per mL		Standardized Mite, Dermatophagoides pteronyssinus, Scratch or Bulk, 30000 AU per mL	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19880526		BLA	BLA103871	Jubilant HollisterStier LLC	DERMATOPHAGOIDES PTERONYSSINUS	30000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6695_2624a67a-4df4-4ee3-9e7d-b8a7e947736a	65044-6695	STANDARDIZED ALLERGENIC	Standardized Mite, Dermatophagoides pteronyssinus, Bulk, 10000 AU per mL		Standardized Mite, Dermatophagoides pteronyssinus, Bulk, 10000 AU per mL	INJECTION, SOLUTION	SUBCUTANEOUS	19880526		BLA	BLA103871	Jubilant HollisterStier LLC	DERMATOPHAGOIDES PTERONYSSINUS	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6720_2624a67a-4df4-4ee3-9e7d-b8a7e947736a	65044-6720	STANDARDIZED ALLERGENIC	Standardized Mite, Dermatophagoides farinae, Scratch or Bulk, 30000 AU per mL		Standardized Mite, Dermatophagoides farinae, Scratch or Bulk, 30000 AU per mL	INJECTION, SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19880526		BLA	BLA103870	Jubilant HollisterStier LLC	DERMATOPHAGOIDES FARINAE	30000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-6723_2624a67a-4df4-4ee3-9e7d-b8a7e947736a	65044-6723	STANDARDIZED ALLERGENIC	Standardized Mite, Dermatophagoides farinae, Bulk, 10000 AU per mL		Standardized Mite, Dermatophagoides farinae, Bulk, 10000 AU per mL	INJECTION, SOLUTION	SUBCUTANEOUS	19880526		BLA	BLA103870	Jubilant HollisterStier LLC	DERMATOPHAGOIDES FARINAE	10000	[AU]/mL	Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Standardized Insect Allergenic Extract [EPC]		N	20241231
65044-9940_157ac9be-cb54-411f-9933-61de439b89f6	65044-9940	STANDARDIZED ALLERGENIC	Honey Bee Hymenoptera Venom Multidose		Honey Bee Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19791016		BLA	BLA103882	Jubilant HollisterStier LLC	APIS MELLIFERA VENOM	100	ug/mL			N	20241231
65044-9941_157ac9be-cb54-411f-9933-61de439b89f6	65044-9941	STANDARDIZED ALLERGENIC	White Faced Hornet Hymenoptera Venom Multidose		White Faced Hornet Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19791016		BLA	BLA103885	Jubilant HollisterStier LLC	DOLICHOVESPULA MACULATA VENOM PROTEIN	100	ug/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], Wasp Venoms [CS]		N	20241231
65044-9942_157ac9be-cb54-411f-9933-61de439b89f6	65044-9942	STANDARDIZED ALLERGENIC	Yellow Hornet Hymenoptera Venom Multidose		Yellow Hornet Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19791016		BLA	BLA103886	Jubilant HollisterStier LLC	DOLICHOVESPULA ARENARIA VENOM PROTEIN	100	ug/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], Wasp Venoms [CS]		N	20241231
65044-9943_157ac9be-cb54-411f-9933-61de439b89f6	65044-9943	STANDARDIZED ALLERGENIC	Wasp Hymenoptera Venom Multidose		Wasp Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19791016		BLA	BLA103884	Jubilant HollisterStier LLC	POLISTES SPP. VENOM PROTEIN	100	ug/mL			N	20241231
65044-9944_157ac9be-cb54-411f-9933-61de439b89f6	65044-9944	STANDARDIZED ALLERGENIC	Yellow Jacket Hymenoptera Venom Multidose		Yellow Jacket Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19791016		BLA	BLA103887	Jubilant HollisterStier LLC	VESPULA GERMANICA VENOM PROTEIN; VESPULA MACULIFRONS VENOM PROTEIN; VESPULA PENSYLVANICA VENOM PROTEIN; VESPULA SQUAMOSA VENOM PROTEIN; VESPULA VULGARIS VENOM PROTEIN	20; 20; 20; 20; 20	ug/mL; ug/mL; ug/mL; ug/mL; ug/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS]		N	20241231
65044-9945_157ac9be-cb54-411f-9933-61de439b89f6	65044-9945	STANDARDIZED ALLERGENIC	Mixed Vespid Hymenoptera Venom Multidose		Mixed Vespid Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	19801211		BLA	BLA103883	Jubilant HollisterStier LLC	DOLICHOVESPULA ARENARIA VENOM PROTEIN; DOLICHOVESPULA MACULATA VENOM PROTEIN; VESPULA GERMANICA VENOM PROTEIN; VESPULA MACULIFRONS VENOM PROTEIN; VESPULA PENSYLVANICA VENOM PROTEIN; VESPULA SQUAMOSA VENOM PROTEIN; VESPULA VULGARIS VENOM PROTEIN	100; 100; 20; 20; 20; 20; 20	ug/mL; ug/mL; ug/mL; ug/mL; ug/mL; ug/mL; ug/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS]		N	20241231
65044-9950_2e7a6fe0-1030-44bd-8381-7f67b321f585	65044-9950	STANDARDIZED ALLERGENIC	Honey Bee Hymenoptera Venom	Multidose	Honey Bee Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19950411		BLA	BLA103882	Jubilant HollisterStier LLC	APIS MELLIFERA VENOM	100	ug/mL			N	20241231
65044-9953_2e7a6fe0-1030-44bd-8381-7f67b321f585	65044-9953	STANDARDIZED ALLERGENIC	Wasp Hymenoptera Venom	Multidose	Wasp Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19950411		BLA	BLA103884	Jubilant HollisterStier LLC	POLISTES SPP. VENOM PROTEIN	100	ug/mL			N	20241231
65044-9954_2e7a6fe0-1030-44bd-8381-7f67b321f585	65044-9954	STANDARDIZED ALLERGENIC	Yellow Jacket Hymenoptera Venom	Multidose	Yellow Jacket Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS; SUBCUTANEOUS	19950411		BLA	BLA103887	Jubilant HollisterStier LLC	VESPULA GERMANICA VENOM PROTEIN; VESPULA MACULIFRONS VENOM PROTEIN; VESPULA PENSYLVANICA VENOM PROTEIN; VESPULA SQUAMOSA VENOM PROTEIN; VESPULA VULGARIS VENOM PROTEIN	20; 20; 20; 20; 20	ug/mL; ug/mL; ug/mL; ug/mL; ug/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS]		N	20241231
65044-9955_2e7a6fe0-1030-44bd-8381-7f67b321f585	65044-9955	STANDARDIZED ALLERGENIC	Mixed Vespid Hymenoptera Venom	Multidose	Mixed Vespid Hymenoptera Venom Multidose	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	19950411		BLA	BLA103883	Jubilant HollisterStier LLC	DOLICHOVESPULA ARENARIA VENOM PROTEIN; DOLICHOVESPULA MACULATA VENOM PROTEIN; VESPULA GERMANICA VENOM PROTEIN; VESPULA MACULIFRONS VENOM PROTEIN; VESPULA PENSYLVANICA VENOM PROTEIN; VESPULA SQUAMOSA VENOM PROTEIN; VESPULA VULGARIS VENOM PROTEIN	100; 100; 20; 20; 20; 20; 20	ug/mL; ug/mL; ug/mL; ug/mL; ug/mL; ug/mL; ug/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS], Wasp Venoms [CS]		N	20241231
65044-9960_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9960	STANDARDIZED ALLERGENIC	Honey Bee Hymenoptera Venom Venomil Diagnostic		Honey Bee Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103882	Jubilant HollisterStier LLC						N	20241231
65044-9961_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9961	STANDARDIZED ALLERGENIC	White Faced Hornet Hymenoptera Venom Venomil Diagnostic		White Faced Hornet Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103885	Jubilant HollisterStier LLC						N	20241231
65044-9962_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9962	STANDARDIZED ALLERGENIC	Yellow Hornet Hymenoptera Venom Venomil Diagnostic		Yellow Hornet Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103886	Jubilant HollisterStier LLC						N	20241231
65044-9963_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9963	STANDARDIZED ALLERGENIC	Wasp Hymenoptera Venom Venomil Diagnostic		Wasp Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103884	Jubilant HollisterStier LLC						N	20241231
65044-9964_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9964	STANDARDIZED ALLERGENIC	Yellow Jacket Hymenoptera Venom Venomil Diagnostic		Yellow Jacket Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103887	Jubilant HollisterStier LLC						N	20241231
65044-9970_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9970	STANDARDIZED ALLERGENIC	Honey Bee Hymenoptera Venom Venomil Maintenance		Honey Bee Hymenoptera Venom Venomil Maintenance	KIT	SUBCUTANEOUS	19820222		BLA	BLA103882	Jubilant HollisterStier LLC						N	20241231
65044-9971_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9971	STANDARDIZED ALLERGENIC	White Faced Hornet Hymenoptera Venom Venomil Maintenance		White Faced Hornet Hymenoptera Venom Venomil Maintenance	KIT	SUBCUTANEOUS	19820222		BLA	BLA103885	Jubilant HollisterStier LLC						N	20241231
65044-9972_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9972	STANDARDIZED ALLERGENIC	Yellow Hornet Hymenoptera Venom Venomil Maintenance		Yellow Hornet Hymenoptera Venom Venomil Maintenance	KIT	SUBCUTANEOUS	19820222		BLA	BLA103886	Jubilant HollisterStier LLC						N	20241231
65044-9973_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9973	STANDARDIZED ALLERGENIC	Wasp Hymenoptera Venom Venomil Maintenance		Wasp Hymenoptera Venom Venomil Maintenance	KIT	SUBCUTANEOUS	19820222		BLA	BLA103884	Jubilant HollisterStier LLC						N	20241231
65044-9974_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9974	STANDARDIZED ALLERGENIC	Yellow Jacket Hymenoptera Venom Venomil Maintenance		Yellow Jacket Hymenoptera Venom Venomil Maintenance	KIT	SUBCUTANEOUS	19820222		BLA	BLA103887	Jubilant HollisterStier LLC						N	20241231
65044-9975_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9975	STANDARDIZED ALLERGENIC	Mixed Vespid Hymenoptera Venom Venomil Maintenance		Mixed Vespid Hymenoptera Venom Venomil Maintenance	KIT	SUBCUTANEOUS	19820222		BLA	BLA103883	Jubilant HollisterStier LLC						N	20241231
65044-9986_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9986	STANDARDIZED ALLERGENIC	Honey Bee Hymenoptera Venom Venomil Diagnostic		Honey Bee Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103882	Jubilant HollisterStier LLC						N	20241231
65044-9987_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9987	STANDARDIZED ALLERGENIC	White Faced Hornet Hymenoptera Venom Venomil Diagnostic		White Faced Hornet Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103885	Jubilant HollisterStier LLC						N	20241231
65044-9988_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9988	STANDARDIZED ALLERGENIC	Yellow Hornet Hymenoptera Venom Venomil Diagnostic		Yellow Hornet Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103886	Jubilant HollisterStier LLC						N	20241231
65044-9989_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9989	STANDARDIZED ALLERGENIC	Wasp Hymenoptera Venom Venomil Diagnostic		Wasp Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103884	Jubilant HollisterStier LLC						N	20241231
65044-9994_b9289dcf-445f-4a93-89f7-f513569254fd	65044-9994	STANDARDIZED ALLERGENIC	Yellow Jacket Hymenoptera Venom Venomil Diagnostic		Yellow Jacket Hymenoptera Venom Venomil Diagnostic	KIT	INTRADERMAL; PERCUTANEOUS	19820222		BLA	BLA103887	Jubilant HollisterStier LLC						N	20241231
65044-9998_e823ed8a-d7e1-4f85-9cd7-508ba38e08ce	65044-9998	HUMAN PRESCRIPTION DRUG	Positive Skin Test Control - Histamine		Histamine	INJECTION	PERCUTANEOUS	19950615		BLA	BLA103891	Jubilant HollisterStier LLC	HISTAMINE	6	mg/mL			N	20241231
65055-101_09c28c59-b8a4-195c-e063-6394a90abbac	65055-101	HUMAN OTC DRUG	Iodine Tincture		Iodine Tincture	TINCTURE	TOPICAL	20160824		OTC MONOGRAPH DRUG	M003	Laboratorios Jaloma, S.A. de C.V.	IODINE; SODIUM IODIDE	2; 2.4	g/100mL; g/100mL			N	20241231
65055-201_09c28e4c-cea4-8f33-e063-6294a90a580e	65055-201	HUMAN OTC DRUG	Mertodol Solution		Benzalkonium Chloride	LIQUID	TOPICAL	20160824		OTC MONOGRAPH DRUG	M003	Laboratorios Jaloma, S.A. de C.V.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
65055-501_09c291d4-531a-0346-e063-6394a90a9169	65055-501	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20130918		OTC MONOGRAPH DRUG	M003	Laboratorios Jaloma, S.A. de C.V.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
65076-101_05be37e9-e1c0-424a-a95c-2d207114878f	65076-101	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19990101		NDA	NDA206023	Bickett Machine and Supply, Inc	OXYGEN	99	L/100L			N	20241231
65077-001_09a68d04-a105-a901-e063-6394a90a9e15	65077-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Kaup Pharmacy, Inc.	OXYGEN	99	L/100L			N	20241231
65086-001_0789796b-2f2d-f754-e063-6294a90a5663	65086-001	HUMAN PRESCRIPTION DRUG	Verkazia		cyclosporine	EMULSION	OPHTHALMIC; TOPICAL	20220201		NDA	NDA214965	Santen Incorporated	CYCLOSPORINE	1	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65086-002_074cf154-7476-e203-e063-6294a90ab60e	65086-002	HUMAN PRESCRIPTION DRUG	Omlonti		omidenepag isopropyl	SOLUTION/ DROPS	OPHTHALMIC	20220923		NDA	NDA215092	Santen Incorporated	OMIDENEPAG ISOPROPYL	.02	mg/mL	Prostaglandin E2 Receptor Agonist [EPC], Prostaglandin E2 Receptor Agonists [MoA]		N	20241231
65111-005_2d4e33f9-a89d-4305-9599-4c921226c21a	65111-005	HUMAN OTC DRUG	ARNICA MONTANA		ARNICA MONTANA	TABLET	ORAL	20141117	20260908	UNAPPROVED HOMEOPATHIC		VITAMEDICA INC	ARNICA MONTANA	30	[hp_X]/1			N	
65111-005_b3fc45c7-c208-4194-82a2-ad311dce494e	65111-005	HUMAN OTC DRUG	Arnica Montana		Arnica Montana	TABLET	ORAL	20210812	20260922	UNAPPROVED HOMEOPATHIC		Vitamedica Corporation	ARNICA MONTANA	30	[hp_X]/1			N	
65113-1001_d8f5d967-901c-447f-9436-54ef4b29b317	65113-1001	HUMAN OTC DRUG	f(x)l Skin Care Hand Sanitizer		Alcohol	GEL	TOPICAL	20200515		OTC MONOGRAPH NOT FINAL	part333A	G.S. COSMECEUTICAL USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
65113-1201_08f5ab40-82c9-441a-9fea-70b10c989128	65113-1201	HUMAN OTC DRUG	Rush Salicylc Acid Complexion Pads		Salicylic Acid	LIQUID	TOPICAL	20190415		OTC MONOGRAPH FINAL	part333D	G.S. COSMECEUTICAL USA, INC.	SALICYLIC ACID	2	g/100g			N	20241231
65113-2372_b1b03316-c3c8-4f19-861b-bd4dc8138ef3	65113-2372	HUMAN OTC DRUG	AGE INTERVENTION DUALITY		BENZOYL PEROXIDE	CREAM	TOPICAL	20110501		OTC MONOGRAPH FINAL	part333D	G.S. COSMECEUTICAL USA, INC.	BENZOYL PEROXIDE	10	g/100g			N	20241231
65113-2373_89fed0ba-a212-4fbb-b4de-48d2a29ea37b	65113-2373	HUMAN OTC DRUG	AGE INTERVENTION DUALITY MD		BENZOYL PEROXIDE	CREAM	TOPICAL	20110501		OTC MONOGRAPH FINAL	part333D	G.S. COSMECEUTICAL USA, INC.	BENZOYL PEROXIDE	10	g/100g			N	20241231
65119-345_ef07ea3f-3b23-4b6e-ac87-2135770ef2e5	65119-345	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	19710101		NDA	NDA205767	Bronx Welding Supply Inc	OXYGEN	99	L/100L			N	20241231
65121-032_0973e425-f377-5656-e063-6394a90acb15	65121-032	HUMAN OTC DRUG	Phoenix KinetiCream Anti-inflammatory and Pain Relief		MENTHOL	CREAM	TOPICAL	20130522		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	MENTHOL	20	mg/mL			N	20241231
65121-054_09d72d1b-d33d-923b-e063-6394a90a0cfc	65121-054	HUMAN OTC DRUG	PURE SOURCE Hand Sanitizer		Alcohol	GEL	TOPICAL	20200401		OTC MONOGRAPH DRUG	505G(a)(3)	Pure Source, LLC	ALCOHOL	.7	mL/mL			N	20241231
65121-069_0973c689-82e4-6348-e063-6394a90accb4	65121-069	HUMAN OTC DRUG	PURE SOURCE Hand Sanitizer		Alcohol	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Pure Source, LLC	ALCOHOL	.7	mL/mL			N	20241231
65121-071_0973e425-f384-5656-e063-6394a90acb15	65121-071	HUMAN OTC DRUG	EmoniNail Antifungal		UNDECYLENIC ACID	LIQUID	TOPICAL	20200501		OTC MONOGRAPH DRUG	M005	Pure Source, LLC	UNDECYLENIC ACID	100	mg/mL			N	20241231
65121-100_09d74877-2b43-391f-e063-6294a90a331d	65121-100	HUMAN OTC DRUG	Soulus Rp Rash and Pain		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20110323		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	LIDOCAINE HYDROCHLORIDE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65121-101_482e2384-ef37-01c7-e054-00144ff88e88	65121-101	HUMAN OTC DRUG	BOSLEY PROFESSIONAL STRENGTH HAIR REGROWTH TREATMENT Regular Strength For Women		MINOXIDIL	LIQUID	TOPICAL	20130815		ANDA	ANDA076239	Pure Source, LLC	MINOXIDIL	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
65121-102_482e2384-efa5-01c7-e054-00144ff88e88	65121-102	HUMAN OTC DRUG	BOSLEY PROFESSIONAL STRENGTH HAIR REGROWTH TREATMENT Regular Strength For Men		MINOXIDIL	LIQUID	TOPICAL	20130815		ANDA	ANDA076239	Pure Source, LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
65121-113_0973e425-f394-5656-e063-6394a90acb15	65121-113	HUMAN OTC DRUG	OxyRub Pain Relief		MENTHOL	CREAM	TOPICAL	20130501		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	MENTHOL	1.25	g/100g			N	20241231
65121-208_097401f8-6ba0-3d15-e063-6294a90af1a3	65121-208	HUMAN OTC DRUG	Senophile Dermal		PETROLATUM, COD LIVER	OINTMENT	TOPICAL	20141224		OTC MONOGRAPH DRUG	M016	Pure Source, LLC	COD LIVER OIL; PETROLATUM	10; 40	g/100g; g/100g			N	20241231
65121-209_09d74b93-96ed-917f-e063-6394a90a830e	65121-209	HUMAN OTC DRUG	biochemistry PAIN RELIEF FOOT ACTIVE		BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20140206		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	190; 40	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
65121-300_0abe02e9-6e6e-9463-e063-6394a90a8c74	65121-300	HUMAN OTC DRUG	AvaDerm		lidocaine hcl, menthol	CREAM	TOPICAL	20150610		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65121-301_0abe5f3b-4b5a-8b18-e063-6394a90a9934	65121-301	HUMAN PRESCRIPTION DRUG	Vita-Rx Diabetic Vitamin		Vitamin C, Vitamin D, Vitamin E, Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Biotin, Pantothenic Acid, Chromium	CAPSULE, GELATIN COATED	ORAL	20150811		UNAPPROVED DRUG OTHER		Pure Source, LLC	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; CHOLECALCIFEROL; CHROMIUM PICOLINATE; FOLIC ACID; METHYLCOBALAMIN; NIACIN; PYRIDOXAL PHOSPHATE ANHYDROUS; RIBOFLAVIN; THIAMINE MONONITRATE; THIOCTIC ACID; UBIDECARENONE	10; 120; 2.5; 10; .0625; .465; .8; .0025; 20; 12.5; 1.7; 1.5; 150; 50	mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Ascorbic Acid [CS], Nicotinic Acid [EPC], Nicotinic Acids [CS], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
65121-302_0abe5f3b-4b5b-8b18-e063-6394a90a9934	65121-302	HUMAN OTC DRUG	VitaCin		methyl salicylate, menthol, capsaicin	CREAM	TOPICAL	20150610		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.0375; 5; 20	g/100g; g/100g; g/100g			N	20241231
65121-397_0973aae6-55d2-5f1a-e063-6394a90a9848	65121-397	HUMAN OTC DRUG	VIRCIN Advanced wart treatment		SALICYLIC ACID	CREAM	TOPICAL	20140612		OTC MONOGRAPH DRUG	M028	Pure Source, LLC	SALICYLIC ACID	17	g/100g			N	20241231
65121-403_0973aae6-55dc-5f1a-e063-6394a90a9848	65121-403	HUMAN OTC DRUG	Dr. Freds MIRACLE RUB		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20130606		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	HISTAMINE DIHYDROCHLORIDE	.25	mg/mL			N	20241231
65121-494_09d70e71-d1d2-2749-e063-6294a90abd05	65121-494	HUMAN OTC DRUG	Jungle Screen SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20140421		OTC MONOGRAPH DRUG	M020	Pure Source, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL			N	20241231
65121-498_0974579b-6f3a-6b47-e063-6294a90a0217	65121-498	HUMAN OTC DRUG	CORISIN ARTHRITIS PAIN RELIEF		CAPSAICIN, MENTHOL	GEL	TOPICAL	20140421		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	CAPSAICIN; MENTHOL	.025; 10	g/100g; g/100g			N	20241231
65121-562_48309692-0dbf-5e6b-e054-00144ff88e88	65121-562	HUMAN OTC DRUG	KERANIQUE For Women Hair Regrowth Treatment		MINOXIDIL	LIQUID	TOPICAL	20140206		ANDA	ANDA078176	Pure Source, LLC	MINOXIDIL	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
65121-644_097456a7-ad1b-551a-e063-6294a90a5e07	65121-644	HUMAN OTC DRUG	Reliaderm		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20140625		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.035; 10; 25	g/100g; g/100g; g/100g			N	20241231
65121-682_09745352-6fd4-50e6-e063-6294a90a5989	65121-682	HUMAN OTC DRUG	PHACE BIOACTIVE SOOTHING DAY Plus PRIMER BROAD-SPECTRUM SPF 46		OCTINOXATE, ZINC OXIDE	LOTION	TOPICAL	20140319		OTC MONOGRAPH DRUG	M020	Pure Source, LLC	OCTINOXATE; ZINC OXIDE	75; 90	mg/mL; mg/mL			N	20241231
65121-683_09745352-6fe4-50e6-e063-6294a90a5989	65121-683	HUMAN OTC DRUG	PHACE BIOACTIVE CLARIFYING SERUM		SALICYLIC ACID	CREAM	TOPICAL	20160913		OTC MONOGRAPH DRUG	M006	Pure Source, LLC	SALICYLIC ACID	15	mg/mL			N	20241231
65121-711_482e2384-ef7a-01c7-e054-00144ff88e88	65121-711	HUMAN OTC DRUG	Tag Away		THUJA OCCIDENTALIS LEAFY TWIG	LIQUID	TOPICAL	20130522		UNAPPROVED HOMEOPATHIC		Pure Source, LLC	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/mL			N	20241231
65121-712_0974736c-8d06-767b-e063-6294a90a5abe	65121-712	HUMAN OTC DRUG	Curefini		petrolatum, cod liver	OINTMENT	TOPICAL	20130117		OTC MONOGRAPH DRUG	M016	Pure Source, LLC	COD LIVER OIL; PETROLATUM	100; 300	mg/mL; mg/mL			N	20241231
65121-715_0974579b-6f47-6b47-e063-6294a90a0217	65121-715	HUMAN OTC DRUG	ecolyptus pain relieving muscle rub		MENTHOL	CREAM	TOPICAL	20140206		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	MENTHOL	60	mg/mL			N	20241231
65121-789_09d70e71-d1e2-2749-e063-6294a90abd05	65121-789	HUMAN OTC DRUG	Zeta Clear Antifungal		UNDECYLENIC ACID	SOLUTION	TOPICAL	20170217		OTC MONOGRAPH DRUG	M005	Pure Source, LLC	UNDECYLENIC ACID	100	mg/mL			N	20241231
65121-828_09d70e71-d1f1-2749-e063-6294a90abd05	65121-828	HUMAN OTC DRUG	PainKoolers		MENTHOL, CAPSAICIN	PATCH	TOPICAL	20141230		OTC MONOGRAPH DRUG	M017	Pure Source, LLC	CAPSAICIN; MENTHOL	.0375; 5	g/100g; g/100g			N	20241231
65121-883_09d6fabb-0d49-222e-e063-6294a90a95b6	65121-883	HUMAN OTC DRUG	DR. MERCOLA Sunscreen Broad Spectrum SPF-30		ZINC OXIDE	CREAM	TOPICAL	20140428		OTC MONOGRAPH DRUG	M020	Pure Source, LLC	ZINC OXIDE	200	mg/mL			N	20241231
65121-884_097478f1-9b1a-b749-e063-6394a90a9977	65121-884	HUMAN OTC DRUG	DR. MERCOLA Sunscreen Broad Spectrum SPF-15		ZINC OXIDE	CREAM	TOPICAL	20140428		OTC MONOGRAPH DRUG	M020	Pure Source, LLC	ZINC OXIDE	95	mg/mL			N	20241231
65121-885_09d7554e-9396-9886-e063-6394a90a1a85	65121-885	HUMAN OTC DRUG	GranuLotion		MENTHOL, ZINC OXIDE	LOTION	TOPICAL	20140326		OTC MONOGRAPH DRUG	M015	Pure Source, LLC	MENTHOL; ZINC OXIDE	.11; 5.1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65121-886_09d72589-141d-349f-e063-6294a90a4d95	65121-886	HUMAN OTC DRUG	DR. MERCOLA Sunscreen SPF-50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20140428		OTC MONOGRAPH DRUG	M020	Pure Source, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 225	mg/mL; mg/mL			N	20241231
65121-887_579b1f76-1298-684f-e053-2a91aa0a83d7	65121-887	HUMAN OTC DRUG	Pain Away Solution		Aconitum Nepellus Hypericum Peforatum Lycopodium Clavatum Phosphorus Rhus Toxicodendron Secale Cornutum	SPRAY	TOPICAL	20170825		UNAPPROVED HOMEOPATHIC		Pure Source, LLC	ACONITUM NAPELLUS; CLAVICEPS PURPUREA SCLEROTIUM; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF	24; 24; 24; 24; 24; 24	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
65131-054_7ec85034-cc70-4465-bc25-9c700731eb02	65131-054	HUMAN OTC DRUG	BRONCOCHEM	KIDS COLD AND FLU	ACETAMINOPHEN-PHENYLEPHRINE HCl-GUAIFENESIN	SYRUP	ORAL	20170501		OTC MONOGRAPH FINAL	part341	LABORATORIO MAGNACHEM INTERNATIONAL SRL	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65131-091_b4e75d5f-2f1c-4ea0-84f2-705fd4631199	65131-091	HUMAN OTC DRUG	BRONCOCHEM	MAXIMUM COUGH	DEXTROMETHORPHAN HBr-GYAIFENESIN	SYRUP	ORAL	20161230		OTC MONOGRAPH FINAL	part341	LABORATORIO MAGNACHEM INTERNATIONAL SRL	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65131-097_6634cf8a-9769-40ea-9da6-b56f00d1013d	65131-097	HUMAN OTC DRUG	BRONCOCHEM	COLD AND FLU TEA	ACETAMINOPHEN-PHENYLEPHRINE HYDROCHLORIDE-CHLORPHENIRAMINE MALEATE	GRANULE, FOR SOLUTION	ORAL	20130901		OTC MONOGRAPH NOT FINAL	part343	LABORATORIO MAGNACHEM INTERNATIONAL SRL	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	500; 4	mg/13g; mg/13g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65131-098_8ddc705a-c6b4-4b03-8492-d2b00eaa4b88	65131-098	HUMAN OTC DRUG	BRONCOCHEM	ALLERGY CONTROL	Cholpheniramine maleate-Phenylephrine HCl	SYRUP	ORAL	20170401		OTC MONOGRAPH FINAL	part341	LABORATORIO MAGNACHEM INTERNATIONAL SRL	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65131-102_ae64d780-0c9d-4239-8f47-757c75981f27	65131-102	HUMAN OTC DRUG	HANDRUB	Hand Sanitizer	Alcohol	SOLUTION	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	LABORATORIO MAGNACHEM INTERNATIONAL SRL	ALCOHOL	80	L/1000mL			N	20241231
65131-111_ade271a2-acb3-481c-98f6-4d6861d0737a	65131-111	HUMAN OTC DRUG	BRONCOCHEM	COLD AND FLU CAPLETS	Acetaminophen-Dextromethorphan HBr-Phenylephrine HCl-Chlorpheniramine Maleate	TABLET, COATED	ORAL	20100101		OTC MONOGRAPH FINAL	part341	LABOTORIO MAGNACHEM INTERNATIONAL SRL	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 3; 30; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65131-116_383c518a-2d0c-4346-894c-9e089094d612	65131-116	HUMAN OTC DRUG	BRONCOCHEM	EXPECTORANT II	ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBr-GUAIFENESIN-PHENYLEPHRINE HCl	SYRUP	ORAL	20161230		OTC MONOGRAPH NOT FINAL	part343	LABORATORIO MAGNACHEM INTERNATIONAL SRL	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	250; 4; 13.33; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65131-180_a0bd3860-b58b-4e71-846c-354c603d1500	65131-180	HUMAN OTC DRUG	BRONCOCHEM	MAXIMUM COUGH KIDS	DEXTROMETHORPHAN HBr-GUAIFENESIN	SYRUP	ORAL	20170501		OTC MONOGRAPH FINAL	part341	LABORATORIO MAGNACHEM INTERNATIONAL SRL	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/15mL; mg/15mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65131-418_d42910c8-7859-41af-ae13-a7e442b6924f	65131-418	HUMAN OTC DRUG	BRONCOCHEM	KIDS ALLERGY CONTROL	Chlorpheniramine maleate-Dextromethrophan HBr	SYRUP	ORAL	20170501		OTC MONOGRAPH FINAL	part341	LABORATORIO MAGANCEHM INTERNATIONAL SRL	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 10	mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65133-110_e4af61e5-a9d6-4c70-e053-2995a90a7a1f	65133-110	HUMAN OTC DRUG	Aire-Master		Alcohol	GEL	TOPICAL	19980101	20250531	OTC MONOGRAPH NOT FINAL	part333E	Aire-Master of America, Inc.	ALCOHOL	60	mL/100mL			N	
65133-120_e4af9dfa-fd5f-cf4e-e053-2a95a90a71b0	65133-120	HUMAN OTC DRUG	Aire-Master		Alcohol	GEL	TOPICAL	20071212	20250531	OTC MONOGRAPH NOT FINAL	part333E	Aire-Master of America, Inc.	ALCOHOL	62	mL/100mL			N	
65133-150_e4c2c9f9-aa14-efa3-e053-2a95a90a29cb	65133-150	HUMAN OTC DRUG	Aire-Master		Alcohol	LIQUID	TOPICAL	20060101	20240531	OTC MONOGRAPH NOT FINAL	part333E	Aire-Master of America, Inc.	ALCOHOL	60	mL/100mL			N	
65133-160_e4cdbea4-d94d-3af4-e053-2995a90ad5a6	65133-160	HUMAN OTC DRUG	Aire-Master		Liquid spray handsanitizer	LIQUID	TOPICAL	20120507	20240228	OTC MONOGRAPH NOT FINAL	part333E	Aire-Master of America, Inc.	ALCOHOL	62	mL/100mL			N	
65133-190_e4c39027-98eb-d67f-e053-2a95a90aed9d	65133-190	HUMAN OTC DRUG	Aire-Master	Foaming AB Triclosan Free	BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20160101	20250531	OTC MONOGRAPH NOT FINAL	part333A	Aire-Master of America, Inc.	BENZALKONIUM CHLORIDE	.13	g/10mL			N	
65133-200_e4cdf27e-f6ac-b0a3-e053-2a95a90a58ae	65133-200	HUMAN OTC DRUG	Aire-Master	Alcohol Free Foaming Sanitizer	BENZALKONIUM CHLORIDE	AEROSOL, FOAM	TOPICAL	20160201	20240831	OTC MONOGRAPH NOT FINAL	part333A	Aire-Master of America, Inc.	BENZALKONIUM CHLORIDE	.1	g/10mL			N	
65145-101_0e3cad9f-e8ac-455a-8f6d-a5568c9da55f	65145-101	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION	INTRAVENOUS	20191205		ANDA	ANDA211016	Caplin Steriles Limited	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
65145-102_b2b9f56a-a1d6-4dce-a4ca-9bf155e97967	65145-102	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190501		ANDA	ANDA211705	Caplin Steriles Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
65145-103_b2b9f56a-a1d6-4dce-a4ca-9bf155e97967	65145-103	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190501		ANDA	ANDA211705	Caplin Steriles Limited	GLYCOPYRROLATE	.4	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
65145-104_b2b9f56a-a1d6-4dce-a4ca-9bf155e97967	65145-104	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190501		ANDA	ANDA211705	Caplin Steriles Limited	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
65145-105_b2b9f56a-a1d6-4dce-a4ca-9bf155e97967	65145-105	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190501		ANDA	ANDA211705	Caplin Steriles Limited	GLYCOPYRROLATE	4	mg/20mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
65145-106_3967832f-4438-4b01-b66e-969de08e7e0c	65145-106	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION	INTRAVENOUS	20210908		ANDA	ANDA212360	Caplin Steriles Limited	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
65145-107_4869fcee-2113-4fd1-b1ce-f389993caeb8	65145-107	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20240104		ANDA	ANDA212808	Caplin Steriles Limited	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
65145-108_4869fcee-2113-4fd1-b1ce-f389993caeb8	65145-108	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20240104		ANDA	ANDA212808	Caplin Steriles Limited	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
65145-109_4869fcee-2113-4fd1-b1ce-f389993caeb8	65145-109	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20240104		ANDA	ANDA212808	Caplin Steriles Limited	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
65145-110_4869fcee-2113-4fd1-b1ce-f389993caeb8	65145-110	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL	20240104		ANDA	ANDA212808	Caplin Steriles Limited	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20251231
65145-111_de2f2948-6e31-43d4-9c59-816ec936f5f2	65145-111	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20210430		ANDA	ANDA213074	Caplin Steriles Limited	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65145-112_de2f2948-6e31-43d4-9c59-816ec936f5f2	65145-112	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20210430		ANDA	ANDA213074	Caplin Steriles Limited	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65145-113_65c2beec-a224-4492-85d2-466f9ba282d2	65145-113	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200501		ANDA	ANDA213232	Caplin Steriles Limited	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65145-114_65c2beec-a224-4492-85d2-466f9ba282d2	65145-114	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200501		ANDA	ANDA213232	Caplin Steriles Limited	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65145-115_bce68fbe-1f6e-4648-a3f9-3fc6ece5cb23	65145-115	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20200630		ANDA	ANDA213318	Caplin Steriles Limited	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65145-116_bce68fbe-1f6e-4648-a3f9-3fc6ece5cb23	65145-116	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20200630		ANDA	ANDA213318	Caplin Steriles Limited	PHENYLEPHRINE HYDROCHLORIDE	50	mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65145-117_bce68fbe-1f6e-4648-a3f9-3fc6ece5cb23	65145-117	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20200630		ANDA	ANDA213318	Caplin Steriles Limited	PHENYLEPHRINE HYDROCHLORIDE	100	mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65145-118_d2af7c80-7e67-4ba4-866f-01504f1dc7de	65145-118	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	INJECTION, SOLUTION	SUBCUTANEOUS	20210730		ANDA	ANDA213998	Caplin Steriles Limited	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65145-119_27f87467-4ff3-4102-b3da-cddb5cf62abb	65145-119	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210503		ANDA	ANDA214379	Caplin Steriles Limited	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
65145-120_9b0040e3-4332-4865-ac29-a40a07df59e1	65145-120	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20210426		ANDA	ANDA214380	Caplin Steriles Limited	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
65145-121_9b0040e3-4332-4865-ac29-a40a07df59e1	65145-121	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20210426		ANDA	ANDA214380	Caplin Steriles Limited	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
65145-122_9b0040e3-4332-4865-ac29-a40a07df59e1	65145-122	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20210426		ANDA	ANDA214380	Caplin Steriles Limited	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
65145-124_bfa71aa8-ccb9-4a8f-a7e1-fa9c53406e35	65145-124	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210922		ANDA	ANDA214533	Caplin Steriles Limited	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65145-125_bfa71aa8-ccb9-4a8f-a7e1-fa9c53406e35	65145-125	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210922		ANDA	ANDA214533	Caplin Steriles Limited	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65145-126_d39944dc-98a0-43ad-980a-15921c7cdd4b	65145-126	HUMAN PRESCRIPTION DRUG	ARGATROBAN		Argatroban	INJECTION	INTRAVENOUS	20210204		ANDA	ANDA214235	Caplin Steriles Limited	ARGATROBAN	50	mg/50mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
65145-127_5b8d90b5-cc3e-45aa-a82a-6ff0bc088a03	65145-127	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20210315		ANDA	ANDA215028	Caplin Steriles Limited	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
65145-128_5b8d90b5-cc3e-45aa-a82a-6ff0bc088a03	65145-128	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20210315		ANDA	ANDA215028	Caplin Steriles Limited	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
65145-129_8909424c-9d5b-4e35-b2d3-da9d3316a4cc	65145-129	HUMAN PRESCRIPTION DRUG	Thiamine		Thiamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230315		ANDA	ANDA215692	Caplin Steriles Limited	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
65145-130_8a5dbb63-22bd-4bb5-9b7e-3a95792c89a9	65145-130	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20230315		ANDA	ANDA216234	Caplin Steriles Limited	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
65145-131_8a5dbb63-22bd-4bb5-9b7e-3a95792c89a9	65145-131	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20230315		ANDA	ANDA216234	Caplin Steriles Limited	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
65145-132_4517c881-5b46-4a8c-98ec-7a65ae628877	65145-132	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230401		ANDA	ANDA216882	Caplin Steriles Limited	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
65145-133_2ffda6e7-d45d-4af3-a3b1-250a4c95e736	65145-133	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		norepinephrine bitartrate	INJECTION	INTRAVENOUS	20230920		ANDA	ANDA217575	Caplin Steriles Limited	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
65145-135_93101770-10a1-4bad-a762-289c793d8ace	65145-135	HUMAN PRESCRIPTION DRUG	Cisatracurium besylate		Cisatracurium besylate	INJECTION	INTRAVENOUS	20230613		ANDA	ANDA217725	Caplin Steriles Limited	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
65145-136_93101770-10a1-4bad-a762-289c793d8ace	65145-136	HUMAN PRESCRIPTION DRUG	Cisatracurium besylate		Cisatracurium besylate	INJECTION	INTRAVENOUS	20230613		ANDA	ANDA217725	Caplin Steriles Limited	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
65145-137_93101770-10a1-4bad-a762-289c793d8ace	65145-137	HUMAN PRESCRIPTION DRUG	Cisatracurium besylate		Cisatracurium besylate	INJECTION	INTRAVENOUS	20230613		ANDA	ANDA217725	Caplin Steriles Limited	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
65145-143_2bb61a24-87a6-4e74-a319-fc5e7c483bbb	65145-143	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin Otic	SOLUTION/ DROPS	AURICULAR (OTIC)	20240109		ANDA	ANDA217903	Caplin Steriles Limited	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20251231
65145-144_2bb61a24-87a6-4e74-a319-fc5e7c483bbb	65145-144	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin Otic solution	SOLUTION/ DROPS	AURICULAR (OTIC)	20240109		ANDA	ANDA217903	Caplin Steriles Limited	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20251231
65145-145_588b4804-4ac5-4b96-947e-354029ea4df9	65145-145	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230524		ANDA	ANDA217789	Caplin Steriles Limited	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65145-146_588b4804-4ac5-4b96-947e-354029ea4df9	65145-146	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230524		ANDA	ANDA217789	Caplin Steriles Limited	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-001_7ee71d0e-0b63-4f0a-8918-06d94a7b5ffe	65162-001	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20180622		ANDA	ANDA205913	Amneal Pharmaceuticals LLC	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
65162-002_7ee71d0e-0b63-4f0a-8918-06d94a7b5ffe	65162-002	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20180622		ANDA	ANDA205913	Amneal Pharmaceuticals LLC	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
65162-003_69a2ba0d-9604-4d33-9620-493207ebbb1d	65162-003	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine	SOLUTION	ORAL	20091007		ANDA	ANDA090765	Amneal Pharmaceuticals LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65162-005_fa346360-b8c7-4238-ab67-f9ad56c9212f	65162-005	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine	SOLUTION	ORAL	20091007		ANDA	ANDA090765	Amneal Pharmaceuticals LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65162-006_bcb74b52-6b4a-4d42-a313-7ad8f81dcfa3	65162-006	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20100621		ANDA	ANDA078477	Amneal Pharmaceuticals LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65162-007_bcb74b52-6b4a-4d42-a313-7ad8f81dcfa3	65162-007	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20100621		ANDA	ANDA078477	Amneal Pharmaceuticals LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65162-008_bcb74b52-6b4a-4d42-a313-7ad8f81dcfa3	65162-008	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20100621		ANDA	ANDA078477	Amneal Pharmaceuticals LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65162-015_afd7fdfa-e858-4385-8750-1dd07091b71a	65162-015	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20100623		ANDA	ANDA078826	Amneal Pharmaceuticals LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-017_afd7fdfa-e858-4385-8750-1dd07091b71a	65162-017	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20100623		ANDA	ANDA078826	Amneal Pharmaceuticals LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-018_afd7fdfa-e858-4385-8750-1dd07091b71a	65162-018	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20100623		ANDA	ANDA078826	Amneal Pharmaceuticals LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-019_c88e0081-6db8-468c-90cb-205a3c2e7eea	65162-019	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20170517		ANDA	ANDA205619	Amneal Pharmaceuticals LLC	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65162-020_c88e0081-6db8-468c-90cb-205a3c2e7eea	65162-020	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20170517		ANDA	ANDA205619	Amneal Pharmaceuticals LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65162-021_c88e0081-6db8-468c-90cb-205a3c2e7eea	65162-021	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20170517		ANDA	ANDA205619	Amneal Pharmaceuticals LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65162-023_50798664-15e7-48d2-9f25-353db5e7fb47	65162-023	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine	CAPSULE	ORAL	20230828		ANDA	ANDA202830	Amneal Pharmaceuticals LLC	LISDEXAMFETAMINE DIMESYLATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-024_50798664-15e7-48d2-9f25-353db5e7fb47	65162-024	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine	CAPSULE	ORAL	20230828		ANDA	ANDA202830	Amneal Pharmaceuticals LLC	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-025_50798664-15e7-48d2-9f25-353db5e7fb47	65162-025	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine	CAPSULE	ORAL	20230828		ANDA	ANDA202830	Amneal Pharmaceuticals LLC	LISDEXAMFETAMINE DIMESYLATE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-026_50798664-15e7-48d2-9f25-353db5e7fb47	65162-026	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine	CAPSULE	ORAL	20230828		ANDA	ANDA202830	Amneal Pharmaceuticals LLC	LISDEXAMFETAMINE DIMESYLATE	50	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-027_50798664-15e7-48d2-9f25-353db5e7fb47	65162-027	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine	CAPSULE	ORAL	20230828		ANDA	ANDA202830	Amneal Pharmaceuticals LLC	LISDEXAMFETAMINE DIMESYLATE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-028_50798664-15e7-48d2-9f25-353db5e7fb47	65162-028	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate		Lisdexamfetamine	CAPSULE	ORAL	20230828		ANDA	ANDA202830	Amneal Pharmaceuticals LLC	LISDEXAMFETAMINE DIMESYLATE	70	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-033_a37e5b33-eb88-4ad2-bedc-c29ac46a16f1	65162-033	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine		Acetaminophen and Codeine	TABLET	ORAL	20080529		ANDA	ANDA040779	Amneal Pharmaceuticals LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
65162-034_37a1442a-5885-498b-b970-e3b1773c8e8b	65162-034	HUMAN PRESCRIPTION DRUG	Omega-3-Acid Ethyl Esters		Omega-3-Acid Ethyl Esters	CAPSULE, LIQUID FILLED	ORAL	20151130		ANDA	ANDA204940	Amneal Pharmaceuticals LLC	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
65162-036_b58f3f20-7c61-4825-bd4a-99f142fde719	65162-036	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180727		ANDA	ANDA207342	Amneal Pharmaceuticals LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
65162-037_b58f3f20-7c61-4825-bd4a-99f142fde719	65162-037	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180727		ANDA	ANDA207342	Amneal Pharmaceuticals LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
65162-038_bd665cf4-3a05-4f94-8161-2a4eb98e9c89	65162-038	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20181101		ANDA	ANDA209692	Amneal Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65162-039_f7ff437e-0f41-4659-82d1-fdebb9ee68b2	65162-039	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20181101		ANDA	ANDA209692	Amneal Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65162-042_a52e5add-18c4-4319-8fbc-3ad504d61057	65162-042	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		Eletriptan Hydrobromide	TABLET, FILM COATED	ORAL	20180530		ANDA	ANDA206787	Amneal Pharmaceuticals LLC	ELETRIPTAN HYDROBROMIDE MONOHYDRATE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65162-043_a52e5add-18c4-4319-8fbc-3ad504d61057	65162-043	HUMAN PRESCRIPTION DRUG	Eletriptan Hydrobromide		Eletriptan Hydrobromide	TABLET, FILM COATED	ORAL	20180530		ANDA	ANDA206787	Amneal Pharmaceuticals LLC	ELETRIPTAN HYDROBROMIDE MONOHYDRATE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65162-045_785feb22-255b-47c0-91eb-2915f55cac9e	65162-045	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine	TABLET	ORAL	20100121		ANDA	ANDA078780	Amneal Pharmaceuticals LLC	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65162-047_435dfeb0-e81a-444d-9efc-1c70417dca06	65162-047	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Amneal Pharmaceuticals LLC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
65162-048_435dfeb0-e81a-444d-9efc-1c70417dca06	65162-048	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Amneal Pharmaceuticals LLC	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
65162-049_435dfeb0-e81a-444d-9efc-1c70417dca06	65162-049	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Amneal Pharmaceuticals LLC	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
65162-050_435dfeb0-e81a-444d-9efc-1c70417dca06	65162-050	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Amneal Pharmaceuticals LLC	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
65162-051_435dfeb0-e81a-444d-9efc-1c70417dca06	65162-051	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Amneal Pharmaceuticals LLC	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
65162-052_c3016e4e-4200-4efd-9735-e53e2f50060f	65162-052	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20100406		ANDA	ANDA077289	Amneal Pharmaceuticals LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
65162-053_c3016e4e-4200-4efd-9735-e53e2f50060f	65162-053	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20100406		ANDA	ANDA077289	Amneal Pharmaceuticals LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
65162-054_c3016e4e-4200-4efd-9735-e53e2f50060f	65162-054	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20100406		ANDA	ANDA077289	Amneal Pharmaceuticals LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
65162-057_7913189a-ed3c-410d-b290-d78ced778ea5	65162-057	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20160120		ANDA	ANDA208206	Amneal Pharmaceuticals LLC	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
65162-058_9ac0ab22-bdaa-4978-8741-f811b16fca6f	65162-058	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20171128		ANDA	ANDA207288	Amneal Pharmaceuticals LLC	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
65162-059_1bcb5eef-e494-460d-84e9-b4a421fc650d	65162-059	HUMAN PRESCRIPTION DRUG	Saxagliptin		Saxagliptin	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA205941	Amneal Pharmaceuticals LLC	SAXAGLIPTIN HYDROCHLORIDE	2.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
65162-060_1bcb5eef-e494-460d-84e9-b4a421fc650d	65162-060	HUMAN PRESCRIPTION DRUG	Saxagliptin		Saxagliptin	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA205941	Amneal Pharmaceuticals LLC	SAXAGLIPTIN HYDROCHLORIDE	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
65162-061_857f06ed-b004-4216-a2ff-5fb74366aa6a	65162-061	HUMAN PRESCRIPTION DRUG	Ritonavir		Ritonavir	TABLET	ORAL	20180921		ANDA	ANDA208890	Amneal Pharmaceuticals LLC	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
65162-062_3ac84cf7-0e8e-4b3a-8254-b2d8bd5e9722	65162-062	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate Oral	SUSPENSION	ORAL	20191202		ANDA	ANDA209356	Amneal Pharmaceuticals LLC	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
65162-079_abbb434d-c44d-44b9-80f1-d897ff1f4e6f	65162-079	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA207480	Amneal Pharmaceuticals LLC	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-080_abbb434d-c44d-44b9-80f1-d897ff1f4e6f	65162-080	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA207480	Amneal Pharmaceuticals LLC	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-081_abbb434d-c44d-44b9-80f1-d897ff1f4e6f	65162-081	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA207480	Amneal Pharmaceuticals LLC	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-082_64d6dcbf-0861-4838-8776-694498da6d6d	65162-082	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, COATED	ORAL	20230102		ANDA	ANDA208002	Amneal Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-087_6166e314-4a3d-4574-a7e1-ddb94c91f473	65162-087	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	SOLUTION	ORAL	20140430		ANDA	ANDA205573	Amneal Pharmaceuticals LLC	ITRACONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
65162-091_5dd080c7-7abf-479a-9c33-d9bd6a099f04	65162-091	HUMAN PRESCRIPTION DRUG	Milnacipran HCl		Milnacipran HCl	TABLET	ORAL	20140131		ANDA	ANDA205081	Amneal Pharmaceuticals LLC	MILNACIPRAN HYDROCHLORIDE	12.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-092_5dd080c7-7abf-479a-9c33-d9bd6a099f04	65162-092	HUMAN PRESCRIPTION DRUG	Milnacipran HCl		Milnacipran HCl	TABLET	ORAL	20140131		ANDA	ANDA205081	Amneal Pharmaceuticals LLC	MILNACIPRAN HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-093_5dd080c7-7abf-479a-9c33-d9bd6a099f04	65162-093	HUMAN PRESCRIPTION DRUG	Milnacipran HCl		Milnacipran HCl	TABLET	ORAL	20140131		ANDA	ANDA205081	Amneal Pharmaceuticals LLC	MILNACIPRAN HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-094_5dd080c7-7abf-479a-9c33-d9bd6a099f04	65162-094	HUMAN PRESCRIPTION DRUG	Milnacipran HCl		Milnacipran HCl	TABLET	ORAL	20140131		ANDA	ANDA205081	Amneal Pharmaceuticals LLC	MILNACIPRAN HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-101_2a6a40c3-2d75-46b7-bc78-d9a386fc5e8d	65162-101	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Amneal Pharmaceuticals LLC	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-102_2a6a40c3-2d75-46b7-bc78-d9a386fc5e8d	65162-102	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Amneal Pharmaceuticals LLC	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-103_2a6a40c3-2d75-46b7-bc78-d9a386fc5e8d	65162-103	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Amneal Pharmaceuticals LLC	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-126_1770ca40-6917-4e19-b1c6-e73a69536544	65162-126	HUMAN PRESCRIPTION DRUG	LYLLANA		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals LLC	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-145_577bbdcd-1819-408b-9d08-40da69977583	65162-145	HUMAN OTC DRUG	Cetirizine Hydrochloride	Hives Relief	Cetirizine	TABLET	ORAL	20100121		ANDA	ANDA078780	Amneal Pharmaceuticals LLC	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65162-148_1770ca40-6917-4e19-b1c6-e73a69536544	65162-148	HUMAN PRESCRIPTION DRUG	LYLLANA		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals LLC	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-149_1770ca40-6917-4e19-b1c6-e73a69536544	65162-149	HUMAN PRESCRIPTION DRUG	LYLLANA		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals LLC	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-150_1770ca40-6917-4e19-b1c6-e73a69536544	65162-150	HUMAN PRESCRIPTION DRUG	LYLLANA		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals LLC	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-155_55a7f91b-2744-4df1-bbce-20d955f67dd2	65162-155	HUMAN PRESCRIPTION DRUG	Cinacalcet Hydrochloride		Cinacalcet	TABLET	ORAL	20211206		ANDA	ANDA204364	Amneal Pharmaceuticals LLC	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
65162-157_55a7f91b-2744-4df1-bbce-20d955f67dd2	65162-157	HUMAN PRESCRIPTION DRUG	Cinacalcet Hydrochloride		Cinacalcet	TABLET	ORAL	20211206		ANDA	ANDA204364	Amneal Pharmaceuticals LLC	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
65162-169_44fe94e6-b157-4621-9760-e19eaa5e2660	65162-169	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine	TABLET, FILM COATED	ORAL	20220324		ANDA	ANDA090041	Amneal Pharmaceuticals LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65162-173_44fe94e6-b157-4621-9760-e19eaa5e2660	65162-173	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine	TABLET, FILM COATED	ORAL	20220324		ANDA	ANDA090041	Amneal Pharmaceuticals LLC	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65162-178_ac48eaa6-dd9d-4e5a-93b6-a63a0e11fdf0	65162-178	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20091202		ANDA	ANDA078596	Amneal Pharmaceuticals LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65162-179_ac48eaa6-dd9d-4e5a-93b6-a63a0e11fdf0	65162-179	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100226		ANDA	ANDA078596	Amneal Pharmaceuticals LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65162-188_0658e62b-42e9-4e6a-a8ee-4043207f7755	65162-188	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Amneal Pharmaceuticals LLC	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-189_0658e62b-42e9-4e6a-a8ee-4043207f7755	65162-189	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Amneal Pharmaceuticals LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-190_0658e62b-42e9-4e6a-a8ee-4043207f7755	65162-190	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Amneal Pharmaceuticals LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-209_30a63cf7-b95d-4fc2-8342-ad2251270ff1	65162-209	HUMAN PRESCRIPTION DRUG	Nevirapine		Nevirapine	TABLET	ORAL	20140430		ANDA	ANDA078195	Amneal Pharmaceuticals LLC	NEVIRAPINE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65162-212_f629af5d-faef-4416-9b98-55a3a5ec8271	65162-212	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20091216		ANDA	ANDA040765	Amneal Pharmaceuticals LLC	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-213_55a7f91b-2744-4df1-bbce-20d955f67dd2	65162-213	HUMAN PRESCRIPTION DRUG	Cinacalcet Hydrochloride		Cinacalcet	TABLET	ORAL	20211206		ANDA	ANDA204364	Amneal Pharmaceuticals LLC	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
65162-218_7b29cff0-8b9b-4e45-98a3-dd16ea7d9446	65162-218	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	Amneal Pharmaceuticals LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65162-219_7b29cff0-8b9b-4e45-98a3-dd16ea7d9446	65162-219	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	Amneal Pharmaceuticals LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65162-220_7b29cff0-8b9b-4e45-98a3-dd16ea7d9446	65162-220	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20121217		ANDA	ANDA077880	Amneal Pharmaceuticals LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65162-226_d909c2a0-0d49-4fd6-ae59-d8f00b1a9572	65162-226	HUMAN PRESCRIPTION DRUG	YUVAFEM		Estradiol	TABLET	VAGINAL	20161017		ANDA	ANDA205256	Amneal Pharmaceuticals LLC	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-228_1770ca40-6917-4e19-b1c6-e73a69536544	65162-228	HUMAN PRESCRIPTION DRUG	LYLLANA		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals LLC	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-231_23381e3e-a9c6-4156-92f9-149bbb43ac1b	65162-231	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA207515	Amneal Pharmaceuticals LLC	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-233_23381e3e-a9c6-4156-92f9-149bbb43ac1b	65162-233	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA207515	Amneal Pharmaceuticals LLC	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-235_23381e3e-a9c6-4156-92f9-149bbb43ac1b	65162-235	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA207515	Amneal Pharmaceuticals LLC	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-237_23381e3e-a9c6-4156-92f9-149bbb43ac1b	65162-237	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA207515	Amneal Pharmaceuticals LLC	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
65162-240_238703c3-9c6b-4d37-ac30-2afbc383ca74	65162-240	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET, FILM COATED	ORAL	20181229		ANDA	ANDA206421	Amneal Pharmaceuticals LLC	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
65162-247_d5ac0b1f-19bc-4a8c-a3dd-a71407c12f28	65162-247	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190701		ANDA	ANDA207204	Amneal Pharmaceuticals LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
65162-248_bda445ca-01a9-40ee-aaf7-f8d6a321c01d	65162-248	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride		Alosetron Hydrochloride	TABLET, FILM COATED	ORAL	20170102		ANDA	ANDA206647	Amneal Pharmaceuticals LLC	ALOSETRON HYDROCHLORIDE	.5	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65162-249_bda445ca-01a9-40ee-aaf7-f8d6a321c01d	65162-249	HUMAN PRESCRIPTION DRUG	Alosetron Hydrochloride		Alosetron Hydrochloride	TABLET, FILM COATED	ORAL	20170102		ANDA	ANDA206647	Amneal Pharmaceuticals LLC	ALOSETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65162-250_d5ac0b1f-19bc-4a8c-a3dd-a71407c12f28	65162-250	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190701		ANDA	ANDA207204	Amneal Pharmaceuticals LLC	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
65162-253_3f730b87-2405-485e-a562-ff56320cac69	65162-253	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20091216		ANDA	ANDA077824	Amneal Pharmaceuticals LLC	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
65162-254_3f730b87-2405-485e-a562-ff56320cac69	65162-254	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20091216		ANDA	ANDA077824	Amneal Pharmaceuticals LLC	RANITIDINE HYDROCHLORIDE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
65162-280_ca26f93a-2ccd-4fe7-9537-fd2233bd59ad	65162-280	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20190924		ANDA	ANDA204707	Amneal Pharmaceuticals LLC	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-281_ca26f93a-2ccd-4fe7-9537-fd2233bd59ad	65162-281	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20190924		ANDA	ANDA204707	Amneal Pharmaceuticals LLC	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-282_ca26f93a-2ccd-4fe7-9537-fd2233bd59ad	65162-282	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20190924		ANDA	ANDA204707	Amneal Pharmaceuticals LLC	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-283_ca26f93a-2ccd-4fe7-9537-fd2233bd59ad	65162-283	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20190924		ANDA	ANDA204707	Amneal Pharmaceuticals LLC	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-284_53be538c-d2c6-47e4-9661-c61027970b8e	65162-284	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20180417		ANDA	ANDA204740	Amneal Pharmaceuticals LLC	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-285_53be538c-d2c6-47e4-9661-c61027970b8e	65162-285	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20180417		ANDA	ANDA204740	Amneal Pharmaceuticals LLC	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-286_53be538c-d2c6-47e4-9661-c61027970b8e	65162-286	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20180417		ANDA	ANDA204740	Amneal Pharmaceuticals LLC	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-291_af20755d-cc55-4cc2-a7fc-441f5337ff7a	65162-291	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20130531		ANDA	ANDA204415	Amneal Pharmaceuticals LLC	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-292_af20755d-cc55-4cc2-a7fc-441f5337ff7a	65162-292	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20130531		ANDA	ANDA204415	Amneal Pharmaceuticals LLC	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-293_af20755d-cc55-4cc2-a7fc-441f5337ff7a	65162-293	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20130531		ANDA	ANDA204415	Amneal Pharmaceuticals LLC	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-300_ff2aaeb0-788a-4f17-9d54-085c0dfd0348	65162-300	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET	ORAL	20100511		ANDA	ANDA079098	Amneal Pharmaceuticals LLC	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-302_ff2aaeb0-788a-4f17-9d54-085c0dfd0348	65162-302	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET	ORAL	20100511		ANDA	ANDA079098	Amneal Pharmaceuticals LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-305_ff2aaeb0-788a-4f17-9d54-085c0dfd0348	65162-305	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET	ORAL	20100511		ANDA	ANDA079098	Amneal Pharmaceuticals LLC	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-306_ff2aaeb0-788a-4f17-9d54-085c0dfd0348	65162-306	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET	ORAL	20100511		ANDA	ANDA079098	Amneal Pharmaceuticals LLC	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-307_ff2aaeb0-788a-4f17-9d54-085c0dfd0348	65162-307	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET	ORAL	20100511		ANDA	ANDA079098	Amneal Pharmaceuticals LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-321_b50aeac6-ecb7-4948-bd1b-fa3a3e19ebd8	65162-321	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20150727		ANDA	ANDA203578	Amneal Pharmaceuticals LLC	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
65162-322_5f753958-58ea-4d23-bb9e-5455c519df92	65162-322	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151211		ANDA	ANDA204178	Amneal Pharmaceuticals LLC	NIACIN	750	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
65162-323_b50aeac6-ecb7-4948-bd1b-fa3a3e19ebd8	65162-323	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET, EXTENDED RELEASE	ORAL	20150727		ANDA	ANDA203578	Amneal Pharmaceuticals LLC	NIACIN	1000	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
65162-339_664ba234-0325-42ff-b33a-c507f63b70d5	65162-339	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20231024		ANDA	ANDA209890	Amneal Pharmaceuticals LLC	DAPSONE	50	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
65162-351_85f43612-24c8-431e-bed3-e1b3cc67811e	65162-351	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20121108		ANDA	ANDA202025	Amneal Pharmaceuticals LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65162-356_3daa8006-448e-416c-a255-95b625faf1b4	65162-356	HUMAN OTC DRUG	Ibuprofen	Pain Reliever/Fever Reducer	Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20130329		ANDA	ANDA202300	Amneal Pharmaceuticals LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-358_ef9569cc-946a-467d-835c-3a7602d6eabc	65162-358	HUMAN PRESCRIPTION DRUG	ZAFEMY		Norelgestromin and Ethinyl Estradiol	PATCH	TRANSDERMAL	20200628		ANDA	ANDA213950	Amneal Pharmaceuticals LLC	ETHINYL ESTRADIOL; NORELGESTROMIN	35; 150	ug/d; ug/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
65162-361_51a533bf-0287-4d82-9e59-63e2591f7f83	65162-361	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20091202		ANDA	ANDA040625	Amneal Pharmaceuticals LLC	FOLIC ACID	1	mg/1			N	20241231
65162-369_9da83697-4ecd-4da8-804a-d0c229ec3d20	65162-369	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106		ANDA	ANDA205002	Amneal Pharmaceuticals LLC	FESOTERODINE FUMARATE	4	mg/1			N	20241231
65162-370_9da83697-4ecd-4da8-804a-d0c229ec3d20	65162-370	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20230106		ANDA	ANDA205002	Amneal Pharmaceuticals LLC	FESOTERODINE FUMARATE	8	mg/1			N	20241231
65162-371_18ebf19f-1c32-41b3-86d8-f089d5d22b89	65162-371	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20151102		ANDA	ANDA204010	Amneal Pharmaceuticals LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
65162-372_18ebf19f-1c32-41b3-86d8-f089d5d22b89	65162-372	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20151102		ANDA	ANDA204010	Amneal Pharmaceuticals LLC	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
65162-373_18ebf19f-1c32-41b3-86d8-f089d5d22b89	65162-373	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20151102		ANDA	ANDA204010	Amneal Pharmaceuticals LLC	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
65162-376_2f7b8e70-ed0c-4d1f-ad46-6f29ab86a7fc	65162-376	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210312		ANDA	ANDA207690	Amneal Pharmaceuticals LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65162-379_2f7b8e70-ed0c-4d1f-ad46-6f29ab86a7fc	65162-379	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210312		ANDA	ANDA207690	Amneal Pharmaceuticals LLC	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65162-411_7149e393-2535-4c4b-96c6-dddecfe03493	65162-411	HUMAN PRESCRIPTION DRUG	Levomilnacipran		Levomilnacipran	CAPSULE, EXTENDED RELEASE	ORAL	20190204		ANDA	ANDA210790	Amneal Pharmaceuticals LLC	LEVOMILNACIPRAN HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-414_26d6bbc2-fc1e-45c3-953d-dbecde03220b	65162-414	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20130930		ANDA	ANDA203751	Amneal Pharmaceuticals LLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
65162-415_7629ab89-6e1c-44f1-934b-db0a57a3a396	65162-415	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl and Naloxone HCl		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20130222		ANDA	ANDA203136	Amneal Pharmaceuticals LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
65162-416_7629ab89-6e1c-44f1-934b-db0a57a3a396	65162-416	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl and Naloxone HCl		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20130222		ANDA	ANDA203136	Amneal Pharmaceuticals LLC	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
65162-431_dd7d4819-fb1b-4b49-85fc-2f1e71ee7e11	65162-431	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine Extended-release	TABLET, FILM COATED	ORAL	20181026		ANDA	ANDA211405	Amneal Pharmaceuticals LLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-436_563b0390-b986-4b4d-a46a-8ea894d4d1be	65162-436	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20161201		ANDA	ANDA203995	Amneal Pharmaceuticals LLC	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
65162-437_7149e393-2535-4c4b-96c6-dddecfe03493	65162-437	HUMAN PRESCRIPTION DRUG	Levomilnacipran		Levomilnacipran	CAPSULE, EXTENDED RELEASE	ORAL	20190204		ANDA	ANDA210790	Amneal Pharmaceuticals LLC	LEVOMILNACIPRAN HYDROCHLORIDE	80	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-438_563b0390-b986-4b4d-a46a-8ea894d4d1be	65162-438	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20161201		ANDA	ANDA203995	Amneal Pharmaceuticals LLC	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
65162-441_f36cd043-3266-48c7-8eb5-c4eaf937f1aa	65162-441	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine	TABLET	ORAL	20100212		ANDA	ANDA201451	Amneal Pharmaceuticals LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
65162-442_f36cd043-3266-48c7-8eb5-c4eaf937f1aa	65162-442	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20100212		ANDA	ANDA201451	Amneal Pharmaceuticals LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
65162-444_f36cd043-3266-48c7-8eb5-c4eaf937f1aa	65162-444	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20100212		ANDA	ANDA201451	Amneal Pharmaceuticals LLC	MECLIZINE HYDROCHLORIDE	50	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
65162-446_9604a518-c25b-457e-a88c-b7d315fbd80d	65162-446	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20141128		ANDA	ANDA206652	Amneal Pharmaceuticals LLC	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65162-449_9604a518-c25b-457e-a88c-b7d315fbd80d	65162-449	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20141128		ANDA	ANDA206652	Amneal Pharmaceuticals LLC	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65162-455_7149e393-2535-4c4b-96c6-dddecfe03493	65162-455	HUMAN PRESCRIPTION DRUG	Levomilnacipran		Levomilnacipran	CAPSULE, EXTENDED RELEASE	ORAL	20190204		ANDA	ANDA210790	Amneal Pharmaceuticals LLC	LEVOMILNACIPRAN HYDROCHLORIDE	120	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-464_256e7116-8560-4255-860c-346bfa95ecd2	65162-464	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Amneal Pharmaceuticals LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-465_256e7116-8560-4255-860c-346bfa95ecd2	65162-465	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Amneal Pharmaceuticals LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-466_256e7116-8560-4255-860c-346bfa95ecd2	65162-466	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Amneal Pharmaceuticals LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-469_66f4c3ec-c27d-4d7c-9973-5beaf932cd72	65162-469	HUMAN PRESCRIPTION DRUG	EluRyng		Etonogestrel and Ethinyl Estradiol	RING	VAGINAL	20191216		ANDA	ANDA210830	Amneal Pharmaceuticals LLC	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
65162-475_24aef00c-bbdf-4c6b-b260-ade5a3f8cc82	65162-475	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate		Norethindrone	TABLET	ORAL	20090701		ANDA	ANDA200275	Amneal Pharmaceuticals LLC	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
65162-478_7fcd9f92-a667-4330-ad8b-6ebe4768434c	65162-478	HUMAN PRESCRIPTION DRUG	Nitrofurantoin	(monohydrate/macrocrystals)	Nitrofurantoin monohydrate/macrocrystals	CAPSULE	ORAL	20170525		ANDA	ANDA207372	Amneal Pharmaceuticals LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
65162-506_c159c603-0fae-480a-9344-6364def07c80	65162-506	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20101206		ANDA	ANDA091549	Amneal Pharmaceuticals LLC	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-511_5ad15078-05de-4f62-b840-c1d476be2795	65162-511	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	Amneal Pharmaceuticals LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
65162-512_65a26d26-9be4-4961-8e2a-c9e90a28a5c9	65162-512	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20100924		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals LLC	SALSALATE	500	mg/1			N	20241231
65162-513_65a26d26-9be4-4961-8e2a-c9e90a28a5c9	65162-513	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20100924		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals LLC	SALSALATE	750	mg/1			N	20241231
65162-514_5ad15078-05de-4f62-b840-c1d476be2795	65162-514	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	Amneal Pharmaceuticals LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
65162-515_5ad15078-05de-4f62-b840-c1d476be2795	65162-515	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	Amneal Pharmaceuticals LLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
65162-519_38295301-0c5f-45da-aedd-ebe0d71ae647	65162-519	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE	ORAL	20170618		ANDA	ANDA203289	Amneal Pharmaceuticals LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
65162-521_267539d3-4822-4653-8814-78562619594a	65162-521	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20110303		ANDA	ANDA091179	Amneal Pharmaceuticals LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
65162-522_267539d3-4822-4653-8814-78562619594a	65162-522	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20110303		ANDA	ANDA091179	Amneal Pharmaceuticals LLC	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
65162-528_fa9c045e-8dbd-49d9-a7f4-7c648c3d2de1	65162-528	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20130228		ANDA	ANDA090767	Amneal Pharmaceuticals LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-529_fa9c045e-8dbd-49d9-a7f4-7c648c3d2de1	65162-529	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20130228		ANDA	ANDA090767	Amneal Pharmaceuticals LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-536_17ad79fd-b959-458a-bca6-f36645f31bd0	65162-536	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE, LIQUID FILLED	ORAL	20100604		ANDA	ANDA040682	Amneal Pharmaceuticals LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
65162-537_17ad79fd-b959-458a-bca6-f36645f31bd0	65162-537	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE, LIQUID FILLED	ORAL	20100604		ANDA	ANDA040682	Amneal Pharmaceuticals LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
65162-538_fa9c045e-8dbd-49d9-a7f4-7c648c3d2de1	65162-538	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20130228		ANDA	ANDA090767	Amneal Pharmaceuticals LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-539_fa9c045e-8dbd-49d9-a7f4-7c648c3d2de1	65162-539	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20130228		ANDA	ANDA090767	Amneal Pharmaceuticals LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-540_cb149fdb-eac2-4e98-9f7a-b06020dfac45	65162-540	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20100218		ANDA	ANDA078218	Amneal Pharmaceuticals LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
65162-541_cb149fdb-eac2-4e98-9f7a-b06020dfac45	65162-541	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20100218		ANDA	ANDA078218	Amneal Pharmaceuticals LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
65162-544_8e3d05bf-88ed-441c-8917-884a262ce040	65162-544	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20091224		ANDA	ANDA040866	Amneal Pharmaceuticals LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-545_8e3d05bf-88ed-441c-8917-884a262ce040	65162-545	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20091224		ANDA	ANDA040866	Amneal Pharmaceuticals LLC	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-553_ede742ea-baad-4981-a912-230fa3c86d4f	65162-553	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20130531		ANDA	ANDA203399	Amneal Pharmaceuticals LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
65162-554_42b7fc68-ccc6-4e2f-897c-2125e07bb724	65162-554	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline	TABLET	ORAL	20080227		ANDA	ANDA065425	Amneal Pharmaceuticals LLC	DEMECLOCYCLINE HYDROCHLORIDE	150	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
65162-555_42b7fc68-ccc6-4e2f-897c-2125e07bb724	65162-555	HUMAN PRESCRIPTION DRUG	Demeclocycline Hydrochloride		Demeclocycline	TABLET	ORAL	20080227		ANDA	ANDA065425	Amneal Pharmaceuticals LLC	DEMECLOCYCLINE HYDROCHLORIDE	300	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
65162-556_a2863e69-bf07-4c96-807f-f33bb38a4ecc	65162-556	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20160523		ANDA	ANDA203482	Amneal Pharmaceuticals LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-557_a2863e69-bf07-4c96-807f-f33bb38a4ecc	65162-557	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20160523		ANDA	ANDA203482	Amneal Pharmaceuticals LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-558_52445d3b-d3ff-4401-a536-392f3649d82c	65162-558	HUMAN PRESCRIPTION DRUG	TAYSOFY		Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate	KIT	ORAL	20210728		ANDA	ANDA214292	Amneal Pharmaceuticals LLC						N	20241231
65162-571_7af0006b-2e1e-499f-89d3-fb56474deabb	65162-571	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20071121		ANDA	ANDA040855	Amneal Pharmaceuticals LLC	BETHANECHOL CHLORIDE	5	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
65162-572_7af0006b-2e1e-499f-89d3-fb56474deabb	65162-572	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20071121		ANDA	ANDA040855	Amneal Pharmaceuticals LLC	BETHANECHOL CHLORIDE	10	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
65162-573_7af0006b-2e1e-499f-89d3-fb56474deabb	65162-573	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20071121		ANDA	ANDA040855	Amneal Pharmaceuticals LLC	BETHANECHOL CHLORIDE	25	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
65162-574_7af0006b-2e1e-499f-89d3-fb56474deabb	65162-574	HUMAN PRESCRIPTION DRUG	Bethanechol Chloride		Bethanechol Chloride	TABLET	ORAL	20071121		ANDA	ANDA040855	Amneal Pharmaceuticals LLC	BETHANECHOL CHLORIDE	50	mg/1	Cholinergic Muscarinic Agonist [EPC], Cholinergic Muscarinic Agonists [MoA]		N	20241231
65162-575_e0717641-d08b-447a-8c78-2efde4809b22	65162-575	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine	TABLET, FILM COATED	ORAL	20080924		ANDA	ANDA040808	Amneal Pharmaceuticals LLC	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
65162-576_38295301-0c5f-45da-aedd-ebe0d71ae647	65162-576	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE	ORAL	20170618		ANDA	ANDA203289	Amneal Pharmaceuticals LLC	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
65162-577_e0717641-d08b-447a-8c78-2efde4809b22	65162-577	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine	TABLET, FILM COATED	ORAL	20080924		ANDA	ANDA040808	Amneal Pharmaceuticals LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
65162-583_a2863e69-bf07-4c96-807f-f33bb38a4ecc	65162-583	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20160523		ANDA	ANDA203482	Amneal Pharmaceuticals LLC	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-584_a2863e69-bf07-4c96-807f-f33bb38a4ecc	65162-584	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20160523		ANDA	ANDA203482	Amneal Pharmaceuticals LLC	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-590_f2c59635-97a7-4016-a443-0054d9e69225	65162-590	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20141008		ANDA	ANDA201658	Amneal Pharmaceuticals LLC	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
65162-596_5f2cdfc0-1031-41fe-8929-0a4ef2ea3ec6	65162-596	HUMAN PRESCRIPTION DRUG	Aspirin and Extended-Release Dipyridamole		Aspirin and Extended-Release Dipyridamole	CAPSULE	ORAL	20160328		ANDA	ANDA206392	Amneal Pharmaceuticals LLC	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
65162-627_98398ec1-f852-4c60-9158-6fb63bf66d68	65162-627	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20101115		ANDA	ANDA076003	Amneal Pharmaceuticals LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
65162-630_53ff1b1d-7b2b-4ecf-a809-b7afea610b81	65162-630	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE	ORAL	20160927		ANDA	ANDA205080	Amneal Pharmaceuticals LLC	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65162-636_45650bad-556c-45b0-9ae5-bd265ef00dd8	65162-636	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20160620		ANDA	ANDA205119	Amneal Pharmaceuticals LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65162-637_45650bad-556c-45b0-9ae5-bd265ef00dd8	65162-637	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20160620		ANDA	ANDA205119	Amneal Pharmaceuticals LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65162-641_e21a5fa0-2fc7-4d77-bd07-4255abdc2516	65162-641	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20091201		ANDA	ANDA075442	Amneal Pharmaceuticals LLC	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
65162-642_e21a5fa0-2fc7-4d77-bd07-4255abdc2516	65162-642	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20091201		ANDA	ANDA075442	Amneal Pharmaceuticals LLC	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
65162-643_e21a5fa0-2fc7-4d77-bd07-4255abdc2516	65162-643	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20091201		ANDA	ANDA075442	Amneal Pharmaceuticals LLC	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
65162-644_93959bc8-20a5-4cc2-b76a-f3e98056d1ae	65162-644	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190410		ANDA	ANDA209647	Amneal Pharmaceuticals LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
65162-645_93959bc8-20a5-4cc2-b76a-f3e98056d1ae	65162-645	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190410		ANDA	ANDA209647	Amneal Pharmaceuticals LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
65162-649_eb6369e3-0722-4d90-995c-87b6e33012dc	65162-649	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	SUSPENSION	ORAL	20120604		ANDA	ANDA202961	Amneal Pharmaceuticals LLC	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-669_1d5acb47-1406-4d03-b1cb-b5c0b6a464b8	65162-669	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20091201		ANDA	ANDA075047	Amneal Pharmaceuticals LLC	ACEBUTOLOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65162-670_1d5acb47-1406-4d03-b1cb-b5c0b6a464b8	65162-670	HUMAN PRESCRIPTION DRUG	Acebutolol Hydrochloride		Acebutolol Hydrochloride	CAPSULE	ORAL	20091201		ANDA	ANDA075047	Amneal Pharmaceuticals LLC	ACEBUTOLOL HYDROCHLORIDE	400	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65162-671_e0717641-d08b-447a-8c78-2efde4809b22	65162-671	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine	TABLET, FILM COATED	ORAL	20080924		ANDA	ANDA040808	Amneal Pharmaceuticals LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
65162-673_95d6c6e6-b12e-4e02-a038-f38244fab420	65162-673	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	SOLUTION	ORAL	20110531		ANDA	ANDA091384	Amneal Pharmaceuticals LLC	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
65162-675_180dff18-252f-4edd-9609-0574a8c299e2	65162-675	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20150130		ANDA	ANDA206869	Amneal Pharmaceuticals LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
65162-679_1af3eeac-303f-4e30-91ac-0c53e7278f31	65162-679	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Phenylephrine Hydrochloride		Promethazine and Phenylephrine	SOLUTION	ORAL	20090825		ANDA	ANDA040902	Amneal Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE	5; 6.25	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65162-680_3236c3e4-8625-4dc0-bdbd-ee6c91aab6aa	65162-680	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide		Promethazine Hydrochloride and Dextromethorphan Hydrobromide	SOLUTION	ORAL	20110304		ANDA	ANDA090575	Amneal Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65162-681_c6ba973f-b7d6-40d7-aef3-26b0415454c6	65162-681	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
65162-682_c6ba973f-b7d6-40d7-aef3-26b0415454c6	65162-682	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		Amneal Pharmaceuticals LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
65162-683_ea33e9f2-1d99-4f45-9874-d2491f08d926	65162-683	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20220823		ANDA	ANDA208198	Amneal Pharmaceuticals LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-684_ac2671b5-3704-44dc-9b6e-6a190aed6b37	65162-684	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine	SOLUTION	ORAL	20091007		ANDA	ANDA090766	Amneal Pharmaceuticals LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65162-685_543ad665-43be-41d8-a190-3fa1a61abd39	65162-685	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20091027		ANDA	ANDA090992	Amneal Pharmaceuticals LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
65162-687_70a83823-45d7-4e15-b948-9f5b345214e6	65162-687	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	CONCENTRATE	ORAL	20100201		ANDA	ANDA091383	Amneal Pharmaceuticals LLC	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-689_bf73704c-93ce-472e-b17c-4b2f68ade39a	65162-689	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20110324		ANDA	ANDA201679	Amneal Pharmaceuticals LLC	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
65162-691_bf32c962-3bd9-49ed-a1d8-c8876c219939	65162-691	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	SOLUTION	ORAL	20101217		ANDA	ANDA091483	Amneal Pharmaceuticals LLC	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
65162-693_92ffcac5-e284-4bd9-b612-aa59b0279afb	65162-693	HUMAN PRESCRIPTION DRUG	ATOVAQUONE		ATOVAQUONE	SUSPENSION	ORAL	20110209		ANDA	ANDA202960	Amneal Pharmaceuticals LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
65162-694_8a7ce8a7-d7ca-4e9f-b5ba-bcbfb6dfe09d	65162-694	HUMAN PRESCRIPTION DRUG	Promethazine HCl, Phenylephrine HCl, Codeine Phosphate		Promethazine, Phenylephrine, Codeine	SYRUP	ORAL	20131101		ANDA	ANDA200963	Amneal Pharmaceuticals LLC	CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE	10; 5; 6.25	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS], alpha-1 Adrenergic Agonist [EPC]	CV	N	20241231
65162-696_243dff2e-a5eb-47d6-97e8-2f766985729b	65162-696	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20150227		ANDA	ANDA207137	Amneal Pharmaceuticals LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
65162-700_5fb00cff-beb5-4df6-b9d4-f697310f4508	65162-700	HUMAN OTC DRUG	Dextromethorphan Polistirex Extended-Release		Dextromethorphan Polistirex	SUSPENSION	ORAL	20170801		ANDA	ANDA203133	Amneal Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65162-702_96b3079f-74e9-49bf-8c0a-76fa4dbe6e88	65162-702	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	OIL	AURICULAR (OTIC)	20150922		ANDA	ANDA091306	Amneal Pharmaceuticals LLC	FLUOCINOLONE ACETONIDE	.11	mg/20mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-703_fac90e44-8703-4ab7-aa7a-361ad6eecaf4	65162-703	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	OIL	TOPICAL	20150922		ANDA	ANDA201759	Amneal Pharmaceuticals LLC	FLUOCINOLONE ACETONIDE	.11	mg/118.28mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-704_deabcae2-66db-4abc-a4ec-274ced4da509	65162-704	HUMAN PRESCRIPTION DRUG	FLUOCINOLONE ACETONIDE		FLUOCINOLONE ACETONIDE	OIL	TOPICAL	20150922		ANDA	ANDA201764	Amneal Pharmaceuticals LLC	FLUOCINOLONE ACETONIDE	.11	mg/118.28mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-705_f83642b1-06dd-46e0-bb15-d2fbb9294ce8	65162-705	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram	SOLUTION	ORAL	20110903		ANDA	ANDA202227	Amneal Pharmaceuticals LLC	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
65162-708_4500d2b6-2bce-4897-b879-663b4ec70102	65162-708	HUMAN PRESCRIPTION DRUG	Azithromycin Monohydrate		Azithromycin Monohydrate	POWDER, FOR SUSPENSION	ORAL	20180723		ANDA	ANDA205666	Amneal Pharmaceuticals LLC	AZITHROMYCIN MONOHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
65162-710_99d594cc-39d4-4fd8-8d40-ba591ba8b0e8	65162-710	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20160930		ANDA	ANDA204711	Amneal Pharmaceuticals LLC	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
65162-711_ec19a9c6-47e6-4153-b548-942ff374da5f	65162-711	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	19981125		ANDA	ANDA075109	Amneal Pharmaceuticals LLC	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
65162-713_ec19a9c6-47e6-4153-b548-942ff374da5f	65162-713	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	19981125		ANDA	ANDA075109	Amneal Pharmaceuticals LLC	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
65162-724_ab534bdf-68e6-460f-809c-38a47a53a925	65162-724	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole	TABLET, DELAYED RELEASE	ORAL	20151001		ANDA	ANDA204179	Amneal Pharmaceuticals LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65162-732_649fda43-d027-467b-8177-77a54ae4d416	65162-732	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast	TABLET	ORAL	20130731		ANDA	ANDA204604	Amneal Pharmaceuticals LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
65162-734_6650d6ff-cc06-4bea-a3fe-135b9b07e881	65162-734	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20110916		ANDA	ANDA201680	Amneal Pharmaceuticals LLC	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-735_6650d6ff-cc06-4bea-a3fe-135b9b07e881	65162-735	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20110916		ANDA	ANDA201680	Amneal Pharmaceuticals LLC	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-745_267539d3-4822-4653-8814-78562619594a	65162-745	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20110303		ANDA	ANDA091179	Amneal Pharmaceuticals LLC	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
65162-749_758e7e2b-8afb-4869-8fa9-c53a6c62e174	65162-749	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH	TRANSDERMAL	20150630		ANDA	ANDA207308	Amneal Pharmaceuticals LLC	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65162-750_a5783288-788b-4108-bc37-29c20b64883c	65162-750	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE	ORAL	20151102		ANDA	ANDA203118	Amneal Pharmaceuticals LLC	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
65162-751_b699605d-1aa0-4144-871f-fd0f75a93518	65162-751	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Amneal Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
65162-752_b699605d-1aa0-4144-871f-fd0f75a93518	65162-752	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Amneal Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
65162-753_b699605d-1aa0-4144-871f-fd0f75a93518	65162-753	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Amneal Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
65162-754_b699605d-1aa0-4144-871f-fd0f75a93518	65162-754	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Amneal Pharmaceuticals LLC	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
65162-755_8a23e4a2-c4b7-415f-9fd8-c6ab500a7fac	65162-755	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20150601		ANDA	ANDA203730	Amneal Pharmaceuticals LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65162-757_8a23e4a2-c4b7-415f-9fd8-c6ab500a7fac	65162-757	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20150601		ANDA	ANDA203730	Amneal Pharmaceuticals LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65162-758_4500d2b6-2bce-4897-b879-663b4ec70102	65162-758	HUMAN PRESCRIPTION DRUG	Azithromycin Monohydrate		Azithromycin Monohydrate	POWDER, FOR SUSPENSION	ORAL	20180723		ANDA	ANDA205666	Amneal Pharmaceuticals LLC	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
65162-759_4500d2b6-2bce-4897-b879-663b4ec70102	65162-759	HUMAN PRESCRIPTION DRUG	Azithromycin Monohydrate		Azithromycin Monohydrate	POWDER, FOR SUSPENSION	ORAL	20180723		ANDA	ANDA205666	Amneal Pharmaceuticals LLC	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
65162-760_4500d2b6-2bce-4897-b879-663b4ec70102	65162-760	HUMAN PRESCRIPTION DRUG	Azithromycin Monohydrate		Azithromycin Monohydrate	POWDER, FOR SUSPENSION	ORAL	20180723		ANDA	ANDA205666	Amneal Pharmaceuticals LLC	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
65162-761_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-761	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-762_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-762	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-763_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-763	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-764_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-764	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-765_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-765	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-766_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-766	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-767_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-767	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-768_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-768	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-769_3370ee38-9ec0-4b6e-a6db-07d22efb0f81	65162-769	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Amneal Pharmaceuticals LLC	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65162-770_78419e75-265c-43f9-9206-088213ff0115	65162-770	HUMAN OTC DRUG	Ibuprofen Pain Reliever/Fever Reducer		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20111223		ANDA	ANDA202300	Amneal Pharmaceuticals LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-771_707806f1-4084-4925-8f30-d132826adc48	65162-771	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast	TABLET, CHEWABLE	ORAL	20200904		ANDA	ANDA205107	Amneal Pharmaceuticals LLC	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
65162-772_707806f1-4084-4925-8f30-d132826adc48	65162-772	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast	TABLET, CHEWABLE	ORAL	20200904		ANDA	ANDA205107	Amneal Pharmaceuticals LLC	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
65162-777_c16a0877-6ad7-4421-a359-ce63d6ee9d49	65162-777	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET	ORAL	20150519		ANDA	ANDA204536	Amneal Pharmaceuticals LLC	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
65162-778_fba76108-353d-4a7d-8aa2-b05be8f476cb	65162-778	HUMAN PRESCRIPTION DRUG	Budesonide		Budesonide	CAPSULE, DELAYED RELEASE	ORAL	20170915		ANDA	ANDA206200	Amneal Pharmaceuticals LLC	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-782_503233b9-e486-4228-85d9-9ea8fc74b80d	65162-782	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171222		ANDA	ANDA205825	Amneal Pharmaceuticals LLC	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65162-783_503233b9-e486-4228-85d9-9ea8fc74b80d	65162-783	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171222		ANDA	ANDA205825	Amneal Pharmaceuticals LLC	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65162-784_503233b9-e486-4228-85d9-9ea8fc74b80d	65162-784	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171222		ANDA	ANDA205825	Amneal Pharmaceuticals LLC	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65162-785_503233b9-e486-4228-85d9-9ea8fc74b80d	65162-785	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171222		ANDA	ANDA205825	Amneal Pharmaceuticals LLC	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65162-791_903266f7-1fdc-4093-a61a-740a8e8ed95d	65162-791	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20200825		ANDA	ANDA206463	Amneal Pharmaceuticals LLC	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65162-794_0dc6ad28-b576-4578-90f8-e7cc85bf7542	65162-794	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA207495	Amneal Pharmaceuticals LLC	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
65162-795_0dc6ad28-b576-4578-90f8-e7cc85bf7542	65162-795	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA207495	Amneal Pharmaceuticals LLC	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
65162-799_8c21a3ac-3202-4a1c-b7b5-42d3c1c7aa8b	65162-799	HUMAN OTC DRUG	Dextromethorphan Polistirex Extended-Release		Dextromethorphan Polistirex	SUSPENSION	ORAL	20170801		ANDA	ANDA203133	Amneal Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
65162-801_95fed2aa-ef49-4e41-a2a9-8fea625698d0	65162-801	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20150403		ANDA	ANDA203691	Amneal Pharmaceuticals LLC	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65162-802_95fed2aa-ef49-4e41-a2a9-8fea625698d0	65162-802	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20150403		ANDA	ANDA203691	Amneal Pharmaceuticals LLC	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65162-803_95fed2aa-ef49-4e41-a2a9-8fea625698d0	65162-803	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20150403		ANDA	ANDA203691	Amneal Pharmaceuticals LLC	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65162-804_95fed2aa-ef49-4e41-a2a9-8fea625698d0	65162-804	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20150403		ANDA	ANDA203691	Amneal Pharmaceuticals LLC	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65162-805_95fed2aa-ef49-4e41-a2a9-8fea625698d0	65162-805	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20150403		ANDA	ANDA203691	Amneal Pharmaceuticals LLC	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65162-806_95fed2aa-ef49-4e41-a2a9-8fea625698d0	65162-806	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20150403		ANDA	ANDA203691	Amneal Pharmaceuticals LLC	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65162-807_bffb6ed6-c9ab-46e4-8ac4-3ca463796a5b	65162-807	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20170911		ANDA	ANDA207724	Amneal Pharmaceuticals LLC	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
65162-808_bffb6ed6-c9ab-46e4-8ac4-3ca463796a5b	65162-808	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20170911		ANDA	ANDA207724	Amneal Pharmaceuticals LLC	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
65162-809_373bad8f-2110-4877-9289-45f35454a797	65162-809	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20091203		ANDA	ANDA078387	Amneal Pharmaceuticals LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-810_373bad8f-2110-4877-9289-45f35454a797	65162-810	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20091203		ANDA	ANDA078387	Amneal Pharmaceuticals LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-811_46c71539-79d6-4a85-866f-f2ca1e6b99be	65162-811	HUMAN PRESCRIPTION DRUG	Quinine Sulfate		Quinine	CAPSULE	ORAL	20160729		ANDA	ANDA203729	Amneal Pharmaceuticals LLC	QUININE SULFATE	324	mg/1	Antimalarial [EPC]		N	20241231
65162-812_373bad8f-2110-4877-9289-45f35454a797	65162-812	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20091203		ANDA	ANDA078387	Amneal Pharmaceuticals LLC	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-813_373bad8f-2110-4877-9289-45f35454a797	65162-813	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20091203		ANDA	ANDA078387	Amneal Pharmaceuticals LLC	ALPRAZOLAM	3	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65162-817_7a012dd9-b932-4cde-8a34-9545b9bf37bf	65162-817	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20180625		ANDA	ANDA208833	Amneal Pharmaceuticals LLC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-818_7a012dd9-b932-4cde-8a34-9545b9bf37bf	65162-818	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20180625		ANDA	ANDA208833	Amneal Pharmaceuticals LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-819_7a012dd9-b932-4cde-8a34-9545b9bf37bf	65162-819	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20180625		ANDA	ANDA208833	Amneal Pharmaceuticals LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-820_7a012dd9-b932-4cde-8a34-9545b9bf37bf	65162-820	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20180625		ANDA	ANDA208833	Amneal Pharmaceuticals LLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-822_a15cc965-1571-462f-9c12-f3238ae5ff75	65162-822	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160115		ANDA	ANDA204327	Amneal Pharmaceuticals LLC	PARICALCITOL	1	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
65162-823_a15cc965-1571-462f-9c12-f3238ae5ff75	65162-823	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160115		ANDA	ANDA204327	Amneal Pharmaceuticals LLC	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
65162-824_a15cc965-1571-462f-9c12-f3238ae5ff75	65162-824	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160115		ANDA	ANDA204327	Amneal Pharmaceuticals LLC	PARICALCITOL	4	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
65162-825_758e7e2b-8afb-4869-8fa9-c53a6c62e174	65162-825	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH	TRANSDERMAL	20150630		ANDA	ANDA207308	Amneal Pharmaceuticals LLC	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65162-826_758e7e2b-8afb-4869-8fa9-c53a6c62e174	65162-826	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH	TRANSDERMAL	20150630		ANDA	ANDA207308	Amneal Pharmaceuticals LLC	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65162-833_b42ef4ac-f143-46a9-bf92-4ec5a186f40b	65162-833	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac	GEL	TOPICAL	20160321		ANDA	ANDA208077	Amneal Pharmaceuticals LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-835_1b7b701a-04a2-4366-b437-83c229513e3d	65162-835	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	TOPICAL	20140103		ANDA	ANDA204605	Amneal Pharmaceuticals LLC	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65162-836_e165bb16-6235-4435-983a-09b92a6aeadc	65162-836	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CREAM	TOPICAL	20201111		ANDA	ANDA208766	Amneal Pharmaceuticals LLC	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65162-837_c2288356-08bd-477e-9bba-acf3a6a49669	65162-837	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160127		ANDA	ANDA204011	Amneal Pharmaceuticals LLC	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-838_c2288356-08bd-477e-9bba-acf3a6a49669	65162-838	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160127		ANDA	ANDA204011	Amneal Pharmaceuticals LLC	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-839_c2288356-08bd-477e-9bba-acf3a6a49669	65162-839	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160127		ANDA	ANDA204011	Amneal Pharmaceuticals LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-840_c2288356-08bd-477e-9bba-acf3a6a49669	65162-840	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20160127		ANDA	ANDA204011	Amneal Pharmaceuticals LLC	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65162-841_9cef8f4d-28c7-4cc7-97a1-b58f8e4adee9	65162-841	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20211203		ANDA	ANDA209450	Amneal Pharmaceuticals LLC	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
65162-842_9cef8f4d-28c7-4cc7-97a1-b58f8e4adee9	65162-842	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20211203		ANDA	ANDA209450	Amneal Pharmaceuticals LLC	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
65162-843_1a486e69-519c-4bd1-b777-013a1b5b2793	65162-843	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET	ORAL	20170310	20240201	ANDA	ANDA204741	Amneal Pharmaceuticals LLC	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	
65162-844_1a486e69-519c-4bd1-b777-013a1b5b2793	65162-844	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET	ORAL	20170310	20240201	ANDA	ANDA204741	Amneal Pharmaceuticals LLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	
65162-845_de757841-d823-4c62-926a-81916c22d199	65162-845	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65162-846_de757841-d823-4c62-926a-81916c22d199	65162-846	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65162-847_de757841-d823-4c62-926a-81916c22d199	65162-847	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65162-848_de757841-d823-4c62-926a-81916c22d199	65162-848	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65162-849_de757841-d823-4c62-926a-81916c22d199	65162-849	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA204382	Amneal Pharmaceuticals LLC	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65162-871_f7f28c54-b0ef-4cfc-93c3-aeeaab4c951d	65162-871	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20150529		ANDA	ANDA207481	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-873_0337d7ff-94a9-4fba-901b-9ef9313164b8	65162-873	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA209742	Amneal Pharmaceuticals LLC	BOSENTAN ANHYDROUS	62.5	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
65162-874_0337d7ff-94a9-4fba-901b-9ef9313164b8	65162-874	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA209742	Amneal Pharmaceuticals LLC	BOSENTAN ANHYDROUS	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
65162-879_64d6dcbf-0861-4838-8776-694498da6d6d	65162-879	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, COATED	ORAL	20230102		ANDA	ANDA208002	Amneal Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-880_64d6dcbf-0861-4838-8776-694498da6d6d	65162-880	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, COATED	ORAL	20230102		ANDA	ANDA208002	Amneal Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-881_64d6dcbf-0861-4838-8776-694498da6d6d	65162-881	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, COATED	ORAL	20230102		ANDA	ANDA208002	Amneal Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-882_64d6dcbf-0861-4838-8776-694498da6d6d	65162-882	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, COATED	ORAL	20230102		ANDA	ANDA208002	Amneal Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-890_359c7188-43da-41e3-9201-436f9568d454	65162-890	HUMAN PRESCRIPTION DRUG	Olopatadine Hydrochloride		Olopatadine Hydrochloride	SPRAY, METERED	NASAL	20200203		ANDA	ANDA210901	Amneal Pharmaceuticals LLC	OLOPATADINE HYDROCHLORIDE	665	ug/1	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
65162-891_7d479170-bfc0-45a4-b723-68c21fb15d31	65162-891	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone	SPRAY, METERED	NASAL	20170404		ANDA	ANDA207989	Amneal Pharmaceuticals LLC	MOMETASONE FUROATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-893_ea79234e-41fd-4210-b225-a98568ab7a51	65162-893	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	SOLUTION	ORAL	20150817		ANDA	ANDA203906	Amneal Pharmaceuticals LLC	ARIPIPRAZOLE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
65162-896_5e8d3056-3d3f-4a55-9d5d-d8bfc2bcdaa2	65162-896	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Amneal Pharmaceuticals LLC	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-897_5e8d3056-3d3f-4a55-9d5d-d8bfc2bcdaa2	65162-897	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Amneal Pharmaceuticals LLC	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-898_5e8d3056-3d3f-4a55-9d5d-d8bfc2bcdaa2	65162-898	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Amneal Pharmaceuticals LLC	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-899_5e8d3056-3d3f-4a55-9d5d-d8bfc2bcdaa2	65162-899	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Amneal Pharmaceuticals LLC	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-901_5e8d3056-3d3f-4a55-9d5d-d8bfc2bcdaa2	65162-901	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Amneal Pharmaceuticals LLC	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-902_5e8d3056-3d3f-4a55-9d5d-d8bfc2bcdaa2	65162-902	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20160620		ANDA	ANDA204838	Amneal Pharmaceuticals LLC	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65162-911_68408966-20e1-461b-b60c-4cd442b59115	65162-911	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20160902		ANDA	ANDA206116	Amneal Pharmaceuticals LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65162-913_5d0796f8-7ba9-4212-a72f-26c209049562	65162-913	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	POWDER, FOR SUSPENSION	ORAL	20131129		ANDA	ANDA205034	Amneal Pharmaceuticals LLC	VORICONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65162-914_3a3ef4b7-6b70-453d-be8c-dd921d46d4c6	65162-914	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20140713		ANDA	ANDA205501	Amneal Pharmaceuticals LLC	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
65162-918_0a416141-de5a-4e9e-879d-023903408aa0	65162-918	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20150810		ANDA	ANDA206297	Amneal Pharmaceuticals LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65162-918_b5ba9dd7-501d-4fca-99ce-67abdd615659	65162-918	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20150810		ANDA	ANDA206297	Amneal Pharmaceuticals LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65162-923_4bc450e0-da81-432e-aef3-9e7c8fee8be0	65162-923	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220321		ANDA	ANDA204857	Amneal Pharmaceuticals LLC	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65162-924_4bc450e0-da81-432e-aef3-9e7c8fee8be0	65162-924	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220321		ANDA	ANDA204857	Amneal Pharmaceuticals LLC	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65162-925_4bc450e0-da81-432e-aef3-9e7c8fee8be0	65162-925	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220321		ANDA	ANDA204857	Amneal Pharmaceuticals LLC	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65162-926_4bc450e0-da81-432e-aef3-9e7c8fee8be0	65162-926	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20220321		ANDA	ANDA204857	Amneal Pharmaceuticals LLC	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65162-960_7149e393-2535-4c4b-96c6-dddecfe03493	65162-960	HUMAN PRESCRIPTION DRUG	Levomilnacipran		Levomilnacipran	CAPSULE, EXTENDED RELEASE	ORAL	20190204		ANDA	ANDA210790	Amneal Pharmaceuticals LLC	LEVOMILNACIPRAN HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65162-980_f7f28c54-b0ef-4cfc-93c3-aeeaab4c951d	65162-980	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20150529		ANDA	ANDA207481	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE	8	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-982_f7f28c54-b0ef-4cfc-93c3-aeeaab4c951d	65162-982	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20150529		ANDA	ANDA207481	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE	16	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-984_f7f28c54-b0ef-4cfc-93c3-aeeaab4c951d	65162-984	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20150529		ANDA	ANDA207481	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE	32	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65162-989_ec0dbf61-6eab-43e6-88be-1da16b53a664	65162-989	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals LLC	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-992_ec0dbf61-6eab-43e6-88be-1da16b53a664	65162-992	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals LLC	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-993_ec0dbf61-6eab-43e6-88be-1da16b53a664	65162-993	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals LLC	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-995_ec0dbf61-6eab-43e6-88be-1da16b53a664	65162-995	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals LLC	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-997_ec0dbf61-6eab-43e6-88be-1da16b53a664	65162-997	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals LLC	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
65162-998_01c00064-26f7-4ebc-95bf-cff4daaef4bd	65162-998	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130517		ANDA	ANDA078476	Amneal Pharmaceuticals LLC	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65162-999_01c00064-26f7-4ebc-95bf-cff4daaef4bd	65162-999	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130517		ANDA	ANDA078476	Amneal Pharmaceuticals LLC	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65174-021_efb00947-c7d1-4fc8-8ca0-24d80952b7ef	65174-021	HUMAN PRESCRIPTION DRUG	RUBY-FILL		Rubidium Rb 82	INJECTION, SOLUTION	INTRAVENOUS	20160930		NDA	NDA202153	Jubilant DraxImage Inc., dba Jubilant Radiopharma	RUBIDIUM CHLORIDE RB-82	100	mCi/1	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65174-179_92a1bc37-cc23-4498-ad61-29347c3876dc	65174-179	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc 99m Sulfur Colloid		Technetium Tc 99m Sulfur Colloid Kit	KIT		20231204		ANDA	ANDA213516	Jubilant DraxImage Inc., dba Jubilant Radiopharma						N	20241231
65174-200_b6ac3371-435a-46bc-90de-556e32446b9f	65174-200	HUMAN PRESCRIPTION DRUG	Drax Exametazime		Kit for the Preparation of Technetium Tc 99m Exametazime for Leukocyte Labeling	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170817		NDA	NDA208870	Jubilant DraxImage Inc., dba Jubilant Radiopharma	TECHNETIUM TC-99M EXAMETAZIME	.5	mg/1	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65174-261_c7627788-6211-4255-82a9-ec12343149f8	65174-261	HUMAN PRESCRIPTION DRUG	TECHNETIUM Tc 99m MERTIATIDE		Technetium Tc 99m Mertiatide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230331		NDA	NDA216820	Jubilant DraxImage Inc., dba Jubilant Radiopharma	BETIATIDE	1	mg/1			N	20241231
65174-270_c3ca92d8-e308-47f1-b66b-8ba914dd9128	65174-270	HUMAN PRESCRIPTION DRUG	DRAXIMAGE MAA		Kit for the preparation of Technetium Tc 99m Albumin aggregated	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20231214		BLA	BLA017881	Jubilant DraxImage Inc., dba Jubilant Radiopharma	ALBUMIN AGGREGATED	2.5	mg/1			N	20241231
65174-288_ea90e623-af26-4014-a0c3-3fe5d753a5e6	65174-288	HUMAN PRESCRIPTION DRUG	DRAXIMAGE DTPA		Kit for the preparation of Technetium Tc 99m Pentetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; RESPIRATORY (INHALATION)	19891229		NDA	NDA018511	Jubilant DraxImage Inc., dba Jubilant Radiopharma	PENTETIC ACID	20	mg/1	Lead Chelating Activity [MoA], Lead Chelator [EPC]		N	20241231
65174-461_6dfea844-f0a4-4485-b898-399267cccc2d	65174-461	HUMAN PRESCRIPTION DRUG	Sodium Iodide I 131 Diagnostic		Sodium Iodide I 131	CAPSULE	ORAL	20060501		NDA	NDA021305	Jubilant DraxImage Inc., dba Jubilant Radiopharma	SODIUM IODIDE I-131	100	mCi/1	Radioactive Therapeutic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65174-660_52f116e3-2edf-47b4-a5f7-3bae26afb6da	65174-660	HUMAN PRESCRIPTION DRUG	Technetium Tc 99m Medronate		Technetium Tc 99m Medronate	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20040227		NDA	NDA018035	Jubilant DraxImage Inc., dba Jubilant Radiopharma	MEDRONIC ACID	25	mg/1			N	20241231
65174-880_1ecec1ca-304e-4bb1-9812-9323af036390	65174-880	HUMAN PRESCRIPTION DRUG	HICON		Sodium Iodide I 131	SOLUTION	ORAL	20030407		NDA	NDA021305	Jubilant DraxImage Inc., dba Jubilant Radiopharma	SODIUM IODIDE I-131	1000	mCi/mL	Radioactive Therapeutic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65197-103_89b3a546-fbdc-4c1d-96af-c4f83be1f6d2	65197-103	HUMAN OTC DRUG	Micatin		Miconazole nitrate	CREAM	TOPICAL	20090624		OTC MONOGRAPH FINAL	part333C	WellSpring Pharmaceutical Corporation	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
65197-201_2100f5ec-8b0e-42ed-b481-7ef1f4d79afb	65197-201	HUMAN OTC DRUG	Emetrol Cherry		phosphorated carbohydrate	SOLUTION	ORAL	20090624		UNAPPROVED DRUG OTHER		WellSpring Pharmaceutical Corporation	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
65197-202_56c6eb63-c3a1-4344-afae-f2b70ff0eab7	65197-202	HUMAN OTC DRUG	Emetrol Children Mixed Berry		phosphorated carbohydrate	SOLUTION	ORAL	20230601		UNAPPROVED DRUG OTHER		WellSpring Pharmaceutical Corporation	DEXTROSE; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
65197-203_9d8d2ee7-9db7-4be7-8c73-511eb2e32459	65197-203	HUMAN OTC DRUG	Emetrol Powder	Non-Drowsy	Sodium Citrate Dihydrate	POWDER, FOR SOLUTION	ORAL	20231201		UNAPPROVED DRUG OTHER		WellSpring Pharmaceutical Corporation	TRISODIUM CITRATE DIHYDRATE	460	mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
65197-204_052c21bb-93f9-4404-bb23-124a320cb364	65197-204	HUMAN OTC DRUG	Emetrol Chewables		Sodium citrate dihydrate	TABLET, CHEWABLE	ORAL	20220315		UNAPPROVED DRUG OTHER		WellSpring Pharmaceutical Corporation	TRISODIUM CITRATE DIHYDRATE	230	mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
65197-275_a460d336-d339-42c9-a4a3-8d2da438f420	65197-275	HUMAN OTC DRUG	BONINE		meclizine hydrochloride	TABLET, CHEWABLE	ORAL	20141215		OTC MONOGRAPH FINAL	part336	WellSpring Pharmaceutical Corporation	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
65197-296_a460d336-d339-42c9-a4a3-8d2da438f420	65197-296	HUMAN OTC DRUG	BONINE		meclizine hydrochloride	TABLET, CHEWABLE	ORAL	20230215		OTC MONOGRAPH FINAL	part336	WellSpring Pharmaceutical Corporation	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
65197-300_775a4dcb-fa27-405a-8470-ccc5b2972a9f	65197-300	HUMAN OTC DRUG	Gelusil		Alumina, Magnesia, Simethicone	TABLET, CHEWABLE	ORAL	20080924		OTC MONOGRAPH DRUG	M001	WellSpring Pharmaceutical Corporation	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE; SILICON DIOXIDE	200; 24; 200; 1	mg/1; mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
65197-400_373942cf-6ae4-44b3-925f-99ad5b10903a	65197-400	HUMAN OTC DRUG	AD First Aid Multipurpose		AD First Aid Multipurpose	OINTMENT	TOPICAL	20230930		OTC MONOGRAPH FINAL	part347	WellSpring Pharmaceutical Corporation	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
65197-401_2b49e65d-f4c9-4705-8eb7-7297c8316d11	65197-401	HUMAN OTC DRUG	AD PREVENT Original		AD PREVENT Original	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH FINAL	part347	WellSpring Pharmaceutical Corporation	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
65197-402_f81c2a81-b21f-4186-ad88-c7a0b0f1c422	65197-402	HUMAN OTC DRUG	AD Treat Diaper Rash Cream with Dimethicone and Zinc Oxide		AD Treat Diaper Rash Cream with Dimethicone and Zinc Oxide	CREAM	TOPICAL	20230919		OTC MONOGRAPH FINAL	part347	WellSpring Pharmaceutical Corporation	DIMETHICONE; ZINC OXIDE	1; 10	g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
65197-410_c1da2b20-e125-494f-b704-1a4a1d2eade5	65197-410	HUMAN OTC DRUG	Emetrol Chewables Orange		Sodium citrate dihydrate	TABLET, CHEWABLE	ORAL	20230701		UNAPPROVED DRUG OTHER		WellSpring Pharmaceutical Corporation	TRISODIUM CITRATE DIHYDRATE	230	mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
65197-420_9b0e4c82-36af-43f9-84e2-98a58aee0319	65197-420	HUMAN OTC DRUG	Emetrol Chewables Mixed Berry		Sodium citrate dihydrate	TABLET, CHEWABLE	ORAL	20230701		UNAPPROVED DRUG OTHER		WellSpring Pharmaceutical Corporation	TRISODIUM CITRATE DIHYDRATE	230	mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
65197-502_f2714193-c06a-441f-9660-fd84ca305786	65197-502	HUMAN OTC DRUG	Solarcaine Burn Pain Relief 4oz		Solarcaine Burn Pain Relief 4oz	SPRAY	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	WellSpring Pharmaceutical Corporation	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65197-520_2b84f935-afef-4caa-a93b-fd42cdc6375b	65197-520	HUMAN OTC DRUG	BONINE MAX		meclizine hydrochloride	TABLET, CHEWABLE	ORAL	20230324		OTC MONOGRAPH FINAL	part336	WellSpring Pharmaceutical Corporation	MECLIZINE HYDROCHLORIDE	50	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
65197-616_ac542c3b-c73b-4782-9fca-a5fc05836f1a	65197-616	HUMAN OTC DRUG	BONINE	Faster-Acting	Diphenhydramine HCl	TABLET	ORAL	20230501		OTC MONOGRAPH FINAL	part336	WellSpring Pharmaceutical Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65197-811_9cf6ce6f-7cdb-4dbc-9994-6c314c5f7575	65197-811	HUMAN OTC DRUG	Bactine Max		benzalkonium chloride and lidocaine hydrochloride	LIQUID	TOPICAL	20180622		OTC MONOGRAPH NOT FINAL	part333A	WellSpring Pharmaceutical Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65197-815_a3f5d68c-431b-47c1-90ca-952862ed4641	65197-815	HUMAN OTC DRUG	Bactine Max Dry		lidocaine hydrochloride	SPRAY	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part348	WellSpring Pharmaceutical Corporation	LIDOCAINE HYDROCHLORIDE	5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65197-820_e2e9f1c5-2a16-483d-8a7c-336be8c246c4	65197-820	HUMAN OTC DRUG	BACTINE	MAX	Bactine Max Wound Wash	LIQUID	CUTANEOUS	20230415		OTC MONOGRAPH NOT FINAL	part333A	WellSpring Pharmaceutical Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
65197-832_153e170a-e4eb-421c-b19b-41b0fc5d7f4d	65197-832	HUMAN OTC DRUG	Bactine Max		Lidocaine	LIQUID	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part348	WellSpring Pharmaceutical Corporation	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65208-123_0cdefed6-6440-c34c-e063-6394a90a4099	65208-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Loving Care and More Home Medical	OXYGEN	99	L/100L			N	20241231
65217-0001_07fed70b-2ec6-0704-e063-6394a90a1f79	65217-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091029		UNAPPROVED MEDICAL GAS		Frances Mahon Deaconess Hospital Home Oxygen	OXYGEN	99	L/100L			N	20241231
65219-004_01f8ade1-6721-4a84-85f6-70da95db049e	65219-004	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	20210625		ANDA	ANDA211087	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE	10	meq/50mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
65219-006_01f8ade1-6721-4a84-85f6-70da95db049e	65219-006	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	20210625		ANDA	ANDA211087	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE	20	meq/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
65219-008_01f8ade1-6721-4a84-85f6-70da95db049e	65219-008	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	20210625		ANDA	ANDA211087	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE	20	meq/50mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
65219-010_01f8ade1-6721-4a84-85f6-70da95db049e	65219-010	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	20210625		ANDA	ANDA211087	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE	40	meq/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
65219-012_01f8ade1-6721-4a84-85f6-70da95db049e	65219-012	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	INJECTION	INTRAVENOUS	20210625		ANDA	ANDA211087	Fresenius Kabi USA, LLC	POTASSIUM CHLORIDE	10	meq/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
65219-014_38c6c088-e4ab-4859-b4d9-89e846cf9d5f	65219-014	HUMAN PRESCRIPTION DRUG	Ampicillin		ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191030		ANDA	ANDA062719	Fresenius Kabi USA, LLC	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65219-016_38c6c088-e4ab-4859-b4d9-89e846cf9d5f	65219-016	HUMAN PRESCRIPTION DRUG	Ampicillin		ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200803		ANDA	ANDA062719	Fresenius Kabi USA, LLC	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65219-018_38c6c088-e4ab-4859-b4d9-89e846cf9d5f	65219-018	HUMAN PRESCRIPTION DRUG	Ampicillin		ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200113		ANDA	ANDA062719	Fresenius Kabi USA, LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65219-020_38c6c088-e4ab-4859-b4d9-89e846cf9d5f	65219-020	HUMAN PRESCRIPTION DRUG	Ampicillin		ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191031		ANDA	ANDA062797	Fresenius Kabi USA, LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65219-028_6de9994e-e95e-4cc5-8c50-5c12c23a07b7	65219-028	HUMAN PRESCRIPTION DRUG	Ganirelix Acetate		Ganirelix Acetate	INJECTION	SUBCUTANEOUS	20230324		ANDA	ANDA215658	Fresenius Kabi USA, LLC	GANIRELIX ACETATE	250	ug/.5mL	Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]		N	20241231
65219-029_a1ce70f8-1f22-4771-b51a-2e9b12876558	65219-029	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20220411		ANDA	ANDA214222	Fresenius Kabi USA, LLC	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65219-039_e689b16d-980f-4afe-82fd-1e56ee447c4e	65219-039	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION, SOLUTION	INTRAVENOUS	20230526		ANDA	ANDA213206	Fresenius Kabi USA, LLC	VASOPRESSIN	20	[USP'U]/mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
65219-052_e95e8654-1edf-40f7-8f42-38aacf3dcd08	65219-052	HUMAN PRESCRIPTION DRUG	Potassium Phosphates		Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200210		NDA	NDA212832	Fresenius Kabi USA, LLC	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
65219-054_e95e8654-1edf-40f7-8f42-38aacf3dcd08	65219-054	HUMAN PRESCRIPTION DRUG	Potassium Phosphates		Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200210		NDA	NDA212832	Fresenius Kabi USA, LLC	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
65219-056_e95e8654-1edf-40f7-8f42-38aacf3dcd08	65219-056	HUMAN PRESCRIPTION DRUG	Potassium Phosphates		Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20200210		NDA	NDA212832	Fresenius Kabi USA, LLC	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
65219-065_68f8f5e7-46a8-47f9-a622-6339df1a3d1b	65219-065	HUMAN PRESCRIPTION DRUG	Rocuronium		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20220307		ANDA	ANDA078651	Fresenius Kabi USA, LLC	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
65219-066_575a039f-c873-4cef-9dd5-b5617a14616a	65219-066	HUMAN PRESCRIPTION DRUG	Heparin Sodium		HEPARIN SODIUM	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220322		NDA	NDA017029	Fresenius Kabi USA, LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
65219-080_afd3cf46-3d9c-4d0e-a02a-42cf846ba1e7	65219-080	HUMAN PRESCRIPTION DRUG	Gadoterate Meglumine		gadoterate meglumine	INJECTION	INTRAVENOUS	20220620		ANDA	ANDA215304	Fresenius Kabi USA, LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-082_afd3cf46-3d9c-4d0e-a02a-42cf846ba1e7	65219-082	HUMAN PRESCRIPTION DRUG	Gadoterate Meglumine		gadoterate meglumine	INJECTION	INTRAVENOUS	20220620		ANDA	ANDA215304	Fresenius Kabi USA, LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-084_afd3cf46-3d9c-4d0e-a02a-42cf846ba1e7	65219-084	HUMAN PRESCRIPTION DRUG	Gadoterate Meglumine		gadoterate meglumine	INJECTION	INTRAVENOUS	20220620		ANDA	ANDA215304	Fresenius Kabi USA, LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-086_afd3cf46-3d9c-4d0e-a02a-42cf846ba1e7	65219-086	HUMAN PRESCRIPTION DRUG	Gadoterate Meglumine		gadoterate meglumine	INJECTION	INTRAVENOUS	20220620		ANDA	ANDA215304	Fresenius Kabi USA, LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-088_cda69da3-21e3-477f-b545-ef199e810055	65219-088	HUMAN PRESCRIPTION DRUG	Gadoterate Meglumine		gadoterate meglumine	INJECTION	INTRAVENOUS	20220620		ANDA	ANDA215982	Fresenius Kabi USA, LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-118_2f14d6d6-0d11-4e8d-a4ed-ca2b14344abf	65219-118	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220831		ANDA	ANDA213445	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 1.49; 9	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-119_2f14d6d6-0d11-4e8d-a4ed-ca2b14344abf	65219-119	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220831		ANDA	ANDA213445	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 2.98; 9	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-131_b11946ea-c5bc-4cc0-9f2c-2198dbc62ddd	65219-131	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20231117		ANDA	ANDA204555	Fresenius Kabi USA, LLC	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65219-133_b11946ea-c5bc-4cc0-9f2c-2198dbc62ddd	65219-133	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20231117		ANDA	ANDA204555	Fresenius Kabi USA, LLC	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65219-135_b11946ea-c5bc-4cc0-9f2c-2198dbc62ddd	65219-135	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20231117		ANDA	ANDA204555	Fresenius Kabi USA, LLC	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65219-140_6ccb3099-bd2e-44f5-9585-031ab620e640	65219-140	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		NOREPINEPHRINE BITARTRATE	SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA211382	Fresenius Kabi USA, LLC	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
65219-142_cc9b5527-878f-4c16-bcdd-2a3564f1bb49	65219-142	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220826		ANDA	ANDA213523	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; .745; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-144_cc9b5527-878f-4c16-bcdd-2a3564f1bb49	65219-144	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220826		ANDA	ANDA213523	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 1.49; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-146_cc9b5527-878f-4c16-bcdd-2a3564f1bb49	65219-146	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220826		ANDA	ANDA213523	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 2.24; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-148_cc9b5527-878f-4c16-bcdd-2a3564f1bb49	65219-148	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220826		ANDA	ANDA213523	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 2.98; 4.5	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-150_cc9b5527-878f-4c16-bcdd-2a3564f1bb49	65219-150	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220826		ANDA	ANDA213523	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	25; .745; 2.25	g/500mL; g/500mL; g/500mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-151_ea83d257-7a4e-4870-b9a8-c6c09b3a925d	65219-151	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220902		ANDA	ANDA212348	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 1.49; 2.25	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-153_ea83d257-7a4e-4870-b9a8-c6c09b3a925d	65219-153	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Dextrose and Sodium Chloride		DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20220902		ANDA	ANDA212348	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	50; 1.49; 2.25	g/1000mL; g/1000mL; g/1000mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-162_8c1018aa-9049-4a9c-a553-a76a7630f17a	65219-162	HUMAN PRESCRIPTION DRUG	Calcium Gluconate		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20210617		NDA	NDA208418	Fresenius Kabi USA, LLC	CALCIUM GLUCONATE MONOHYDRATE	20	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
65219-164_8c1018aa-9049-4a9c-a553-a76a7630f17a	65219-164	HUMAN PRESCRIPTION DRUG	Calcium Gluconate		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20210617		NDA	NDA208418	Fresenius Kabi USA, LLC	CALCIUM GLUCONATE MONOHYDRATE	20	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
65219-184_fca3eb6b-16e4-403e-9d65-71f15d9b2c45	65219-184	HUMAN PRESCRIPTION DRUG	ketamine hydrochloride		ketamine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230710		ANDA	ANDA215808	Fresenius Kabi USA, LLC	KETAMINE HYDROCHLORIDE	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
65219-187_0a672bdf-163d-4af5-a791-f815de5b309c	65219-187	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220429		ANDA	ANDA088400	Fresenius Kabi USA, LLC	WATER	1	mL/mL			N	20241231
65219-188_fca3eb6b-16e4-403e-9d65-71f15d9b2c45	65219-188	HUMAN PRESCRIPTION DRUG	ketamine hydrochloride		ketamine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230710		ANDA	ANDA215808	Fresenius Kabi USA, LLC	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
65219-190_c21cb931-a928-4486-b016-f5342843b5a3	65219-190	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201201		ANDA	ANDA211099	Fresenius Kabi USA, LLC	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65219-200_2b33d5f1-198e-41ef-ac78-ccfd27fc137a	65219-200	HUMAN PRESCRIPTION DRUG	Temsirolimus		Temsirolimus	KIT	INTRAVENOUS	20201120		ANDA	ANDA207383	Fresenius Kabi USA, LLC						N	20241231
65219-204_4aa7ce0c-5a30-4a80-8b8a-ce83bb126c5d	65219-204	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	INJECTION	INTRAVENOUS	20220725		ANDA	ANDA214677	Fresenius Kabi USA, LLC	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65219-218_76682a17-2190-4cde-a9b4-614f0c9ad5f5	65219-218	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-220_76682a17-2190-4cde-a9b4-614f0c9ad5f5	65219-220	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-222_76682a17-2190-4cde-a9b4-614f0c9ad5f5	65219-222	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-224_76682a17-2190-4cde-a9b4-614f0c9ad5f5	65219-224	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-226_10dee8c4-1d38-4078-8bda-739795dc3e09	65219-226	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180723		ANDA	ANDA208122	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	225	mg/50mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-228_10dee8c4-1d38-4078-8bda-739795dc3e09	65219-228	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180723		ANDA	ANDA208122	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	450	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-230_10dee8c4-1d38-4078-8bda-739795dc3e09	65219-230	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180723		ANDA	ANDA208122	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	1125	mg/250mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-232_10dee8c4-1d38-4078-8bda-739795dc3e09	65219-232	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180723		ANDA	ANDA208122	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	2250	mg/500mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-234_10ab34d3-0b88-4f72-872a-06367f87115d	65219-234	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20161021		ANDA	ANDA207449	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE	2500	mg/50mL			N	20241231
65219-236_10ab34d3-0b88-4f72-872a-06367f87115d	65219-236	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20161021		ANDA	ANDA207449	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE	5000	mg/100mL			N	20241231
65219-238_10ab34d3-0b88-4f72-872a-06367f87115d	65219-238	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20161021		ANDA	ANDA207449	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE	12500	mg/250mL			N	20241231
65219-240_10ab34d3-0b88-4f72-872a-06367f87115d	65219-240	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20161021		ANDA	ANDA207449	Fresenius Kabi USA, LLC	DEXTROSE MONOHYDRATE	25000	mg/500mL			N	20241231
65219-241_a8463bc6-b9b6-431c-a1a3-eddcc4e95bde	65219-241	HUMAN PRESCRIPTION DRUG	Lactated Ringers and Dextrose		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20220328		ANDA	ANDA210332	Fresenius Kabi USA, LLC	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 5; 30; 600; 310	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-243_a8463bc6-b9b6-431c-a1a3-eddcc4e95bde	65219-243	HUMAN PRESCRIPTION DRUG	Lactated Ringers and Dextrose		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20220328		ANDA	ANDA210332	Fresenius Kabi USA, LLC	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 5; 30; 600; 310	mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-246_2866b223-bb9c-4b84-be2c-3dce21c4b3b1	65219-246	HUMAN PRESCRIPTION DRUG	Potassium Chloride in Lactated Ringers and Dextrose		POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, and DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20200403		ANDA	ANDA211428	Fresenius Kabi USA, LLC	CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	.2; 50; 1.79; 6; 3.1	g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-256_6ccd9aa6-c500-4d66-a2a2-53fb3be54f00	65219-256	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20171116		ANDA	ANDA203720	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65219-256_896cd6ee-e09c-42eb-a459-95ef145ae3ec	65219-256	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20171116		ANDA	ANDA203720	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65219-256_b494fd3b-25f9-4dce-a827-cea1a7b4d14d	65219-256	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20171116		ANDA	ANDA203720	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65219-257_453036d8-bcc1-45a2-a905-edb03a8b743a	65219-257	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20201031		ANDA	ANDA209646	Fresenius Kabi USA, LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
65219-258_9c1af4dc-3653-49cb-baa5-e916369a4e0a	65219-258	HUMAN PRESCRIPTION DRUG	Cardioplegic Solution		POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, and MAGNESIUM CHLORIDE	INJECTION, SOLUTION	INTRA-ARTERIAL	20220606		ANDA	ANDA214623	Fresenius Kabi, USA, LLC	CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE	17.6; 325.3; 119.3; 643	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
65219-259_35f3281c-1865-4958-ae33-acdfbf8b1b28	65219-259	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210524		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65219-259_fc5fb491-5c91-4c60-a6a0-218d3da38d38	65219-259	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180518		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65219-281_8a028b97-4cd8-4dcc-b370-3a7a0d4b07d1	65219-281	HUMAN PRESCRIPTION DRUG	Gadobutrol		Gadobutrol	INJECTION	INTRAVENOUS	20230414		ANDA	ANDA215061	Fresenius Kabi USA, LLC	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-282_abd97425-4a84-4688-aaf1-4a7999584c05	65219-282	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20230630		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-284_81af2b8d-eab9-4411-b6be-6ec22192402b	65219-284	HUMAN PRESCRIPTION DRUG	Plerixafor		PLERIXAFOR	INJECTION, SOLUTION	SUBCUTANEOUS	20230622		NDA AUTHORIZED GENERIC	NDA022311	Fresenius Kabi Usa, LLC	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
65219-287_54027cd5-9739-4e3a-8485-ff2928426ebc	65219-287	HUMAN PRESCRIPTION DRUG	Gadobutrol		Gadobutrol	INJECTION	INTRAVENOUS	20231001		ANDA	ANDA216081	Fresenius Kabi USA, LLC	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-289_54027cd5-9739-4e3a-8485-ff2928426ebc	65219-289	HUMAN PRESCRIPTION DRUG	Gadobutrol		Gadobutrol	INJECTION	INTRAVENOUS	20231001		ANDA	ANDA216081	Fresenius Kabi USA, LLC	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
65219-293_8c4f989c-e7b2-428d-8b5f-3a77c0583bd5	65219-293	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230911		ANDA	ANDA216922	Fresenius Kabi USA, LLC	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
65219-295_499d7fa7-43ab-47f0-ae4b-0f9791745f14	65219-295	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230911		ANDA	ANDA216904	Fresenius Kabi USA, LLC	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
65219-323_0b0b9b52-bc7d-4c4e-8df5-6c9ab0b268d5	65219-323	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20091118		ANDA	ANDA076972	Fresenius Kabi USA, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65219-328_904e72e0-2558-4548-8ddd-8c6877c23b98	65219-328	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-335_804a9b58-4495-403f-9a45-8430a5f44dee	65219-335	HUMAN PRESCRIPTION DRUG	Vitalipid N		VITAMIN A PALMITATE, Ergocalciferol, .ALPHA.-TOCOPHEROL, DL-, PHYTONADIONE	EMULSION	INTRAVENOUS	20230818		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Fresenius Kabi USA, LLC	.ALPHA.-TOCOPHEROL, DL-; ERGOCALCIFEROL; PHYTONADIONE; VITAMIN A PALMITATE	1; 20; 15; 330	[iU]/mL; [iU]/mL; ug/mL; [iU]/mL	Ergocalciferols [CS], Increased Prothrombin Activity [PE], Provitamin D2 Compound [EPC], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
65219-337_804a9b58-4495-403f-9a45-8430a5f44dee	65219-337	HUMAN PRESCRIPTION DRUG	Vitalipid N		VITAMIN A PALMITATE, Ergocalciferol, .ALPHA.-TOCOPHEROL, DL-, PHYTONADIONE	EMULSION	INTRAVENOUS	20230818		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Fresenius Kabi USA, LLC	.ALPHA.-TOCOPHEROL, DL-; ERGOCALCIFEROL; PHYTONADIONE; VITAMIN A PALMITATE	.7; 40; 20; 230	[iU]/mL; [iU]/mL; ug/mL; [iU]/mL	Ergocalciferols [CS], Increased Prothrombin Activity [PE], Provitamin D2 Compound [EPC], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
65219-339_804a9b58-4495-403f-9a45-8430a5f44dee	65219-339	HUMAN PRESCRIPTION DRUG	Vitalipid N		VITAMIN A PALMITATE, Ergocalciferol, .ALPHA.-TOCOPHEROL, DL-, PHYTONADIONE	EMULSION	INTRAVENOUS	20230818		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Fresenius Kabi USA, LLC	.ALPHA.-TOCOPHEROL, DL-; ERGOCALCIFEROL; PHYTONADIONE; VITAMIN A PALMITATE	.7; 40; 20; 230	[iU]/mL; [iU]/mL; ug/mL; [iU]/mL	Ergocalciferols [CS], Increased Prothrombin Activity [PE], Provitamin D2 Compound [EPC], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
65219-359_b2415a53-f5dd-431e-857f-cf65639ce019	65219-359	HUMAN PRESCRIPTION DRUG	Cisplatin		CISPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20230901		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Fresenius Kabi USA, LLC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
65219-371_90fa8a88-1bd6-49cf-a482-ccbc0d315b3d	65219-371	HUMAN PRESCRIPTION DRUG	STIMUFEND		pegflilgrastim-fpgk	INJECTION, SOLUTION	SUBCUTANEOUS	20221006		BLA	BLA761173	Fresenius Kabi USA, LLC	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
65219-380_2d2f4a09-b8bd-47ff-87db-a615efc34c4c	65219-380	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220314		ANDA	ANDA212363	Fresenius Kabi USA, LLC	ALLOPURINOL SODIUM	500	mg/25mL	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
65219-381_1980ecbd-58c9-4176-af7f-af955bb0ad2e	65219-381	HUMAN PRESCRIPTION DRUG	Iodixanol		Iodixanol	INJECTION, SOLUTION	INTRAVASCULAR	20220621		ANDA	ANDA214271	FRESENIUS KABI USA, LLC	IODIXANOL	270	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
65219-383_1980ecbd-58c9-4176-af7f-af955bb0ad2e	65219-383	HUMAN PRESCRIPTION DRUG	Iodixanol		Iodixanol	INJECTION, SOLUTION	INTRAVASCULAR	20220621		ANDA	ANDA214271	FRESENIUS KABI USA, LLC	IODIXANOL	320	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
65219-387_847f9b87-ebe4-4ff7-89b7-bcee26ef1f49	65219-387	HUMAN PRESCRIPTION DRUG	Multiple Electrolytes pH 5.5		sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride	INJECTION, SOLUTION	INTRAVENOUS	20210701		ANDA	ANDA215370	Fresenius Kabi USA, LLC	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE	30; 37; 368; 526; 502	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
65219-389_6edcf60f-df7d-438a-85a4-3efca083e0e1	65219-389	HUMAN PRESCRIPTION DRUG	Multiple Electrolytes pH 7.4		sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride	INJECTION, SOLUTION	INTRAVENOUS	20210617		ANDA	ANDA215371	Fresenius Kabi USA, LLC	MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE	30; 37; 368; 526; 502	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
65219-401_af258d83-398d-4601-ab09-14c9fe383cc2	65219-401	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20221227		ANDA	ANDA216145	Fresenius Kabi USA, LLC	ZINC SULFATE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65219-403_af258d83-398d-4601-ab09-14c9fe383cc2	65219-403	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20221227		ANDA	ANDA216145	Fresenius Kabi USA, LLC	ZINC SULFATE	3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65219-405_af258d83-398d-4601-ab09-14c9fe383cc2	65219-405	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20221227		ANDA	ANDA216145	Fresenius Kabi USA, LLC	ZINC SULFATE	5	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65219-429_f97531bc-3cbb-462f-838a-658caf95ccde	65219-429	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION	INTRAVENOUS	20210524		ANDA	ANDA214235	Fresenius Kabi USA, LLC	ARGATROBAN	50	mg/50mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
65219-432_904e72e0-2558-4548-8ddd-8c6877c23b98	65219-432	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
65219-433_5945c78e-4682-417b-85e9-efdfe8b087d7	65219-433	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210827		ANDA	ANDA090296	Fresenius Kabi USA, LLC	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65219-434_fc5fb491-5c91-4c60-a6a0-218d3da38d38	65219-434	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230320		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65219-436_fc5fb491-5c91-4c60-a6a0-218d3da38d38	65219-436	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230320		ANDA	ANDA203719	Fresenius Kabi USA, LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65219-445_30488a7e-ea9e-4a27-95a9-a07149c50282	65219-445	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20210801		ANDA	ANDA215028	Fresenius Kabi USA, LLC	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
65219-445_446487f1-002e-41d3-846a-67570e797171	65219-445	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20231001		ANDA	ANDA215028	Fresenius Kabi USA, LLC	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
65219-447_30488a7e-ea9e-4a27-95a9-a07149c50282	65219-447	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20210801		ANDA	ANDA215028	Fresenius Kabi USA, LLC	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
65219-466_4110390b-2806-4c92-b283-a90115f89114	65219-466	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
65219-468_4110390b-2806-4c92-b283-a90115f89114	65219-468	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
65219-470_4110390b-2806-4c92-b283-a90115f89114	65219-470	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
65219-472_4110390b-2806-4c92-b283-a90115f89114	65219-472	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
65219-474_4110390b-2806-4c92-b283-a90115f89114	65219-474	HUMAN PRESCRIPTION DRUG	Sodium chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170919		ANDA	ANDA207310	Fresenius Kabi USA, LLC	SODIUM CHLORIDE	9	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
65219-479_1050d171-31f0-431d-94ec-059c36f742e3	65219-479	HUMAN PRESCRIPTION DRUG	LACTATED RINGERS		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190128		ANDA	ANDA209338	Fresenius Kabi USA, LLC	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65219-531_b4c1ed6d-ed81-446a-9b55-5787f68dc79f	65219-531	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA018449	Fresenius Kabi USA, LLC	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
65219-533_b4c1ed6d-ed81-446a-9b55-5787f68dc79f	65219-533	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA018449	Fresenius Kabi USA, LLC	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
65219-535_b4c1ed6d-ed81-446a-9b55-5787f68dc79f	65219-535	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA018449	Fresenius Kabi USA, LLC	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
65219-537_77adad0f-4c90-4ef4-9b37-32c348414f87	65219-537	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA019942	Fresenius Kabi USA, LLC	SOYBEAN OIL	30	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
65219-539_a0b82d42-d59e-4823-a783-efd7be7e5950	65219-539	HUMAN PRESCRIPTION DRUG	Intralipid		I.V. Fat Emulsion	EMULSION	INTRAVENOUS	20040401		NDA	NDA020248	Fresenius Kabi USA, LLC	SOYBEAN OIL	20	g/100mL	Lipid Emulsion [EPC], Lipids [CS]		N	20241231
65219-550_510bc71b-20e4-428a-8fc2-29c9fc20f2f3	65219-550	HUMAN PRESCRIPTION DRUG	Pralatrexate		Pralatrexate	INJECTION	INTRAVENOUS	20221115		NDA AUTHORIZED GENERIC	NDA022468	Fresenius Kabi USA, LLC	PRALATREXATE	20	mg/mL	Folate Analog Metabolic Inhibitor [EPC]		N	20241231
65219-552_510bc71b-20e4-428a-8fc2-29c9fc20f2f3	65219-552	HUMAN PRESCRIPTION DRUG	Pralatrexate		Pralatrexate	INJECTION	INTRAVENOUS	20221115		NDA AUTHORIZED GENERIC	NDA022468	Fresenius Kabi USA, LLC	PRALATREXATE	40	mg/2mL	Folate Analog Metabolic Inhibitor [EPC]		N	20241231
65219-554_b2bd7097-fca7-473f-a7a4-a216eff496f2	65219-554	HUMAN PRESCRIPTION DRUG	Idacio		adalimumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761255	Fresenius Kabi USA, LLC	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
65219-556_b2bd7097-fca7-473f-a7a4-a216eff496f2	65219-556	HUMAN PRESCRIPTION DRUG	Idacio		adalimumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761255	Fresenius Kabi USA, LLC	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
65219-564_204bc630-60a8-46e7-8dc7-aa781b46ff2b	65219-564	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230115		ANDA	ANDA215687	Fresenius Kabi USA, LLC	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65219-566_204bc630-60a8-46e7-8dc7-aa781b46ff2b	65219-566	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230115		ANDA	ANDA215687	Fresenius Kabi USA, LLC	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65219-568_c8893d3b-e9e0-4ab1-8c6d-376a7f1037bc	65219-568	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230115		ANDA	ANDA216648	Fresenius Kabi USA, LLC	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
65219-570_aaff61c4-203b-4905-9138-0f98959ad013	65219-570	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220926		ANDA	ANDA216434	Fresenius Kabi USA, LLC	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
65219-572_aaff61c4-203b-4905-9138-0f98959ad013	65219-572	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220926		ANDA	ANDA216434	Fresenius Kabi USA, LLC	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
65219-579_9388ae75-3bda-41ee-93b5-f99313a16391	65219-579	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230612		ANDA	ANDA216882	Fresenius Kabi USA, LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
65219-612_21e88b45-9451-4f5a-85d2-0510433a5b98	65219-612	HUMAN PRESCRIPTION DRUG	Adalimumab-aacf		adalimumab	KIT	SUBCUTANEOUS	20231206		BLA	BLA761255	Fresenius Kabi USA, LLC						N	20241231
65219-800_1e37a234-bcf4-4280-9429-b9ff025aca2d	65219-800	HUMAN PRESCRIPTION DRUG	Diprivan		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20200113		NDA	NDA019627	Fresenius Kabi USA, LLC	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
65219-801_516b2ac1-7eab-4d63-a0d0-97245858a1d0	65219-801	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231231		ANDA	ANDA209328	Fresenius Kabi USA, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
65219-810_60e93fcf-f8f3-4ee0-85d0-4c0161f7822d	65219-810	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20201030		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65219-811_a88bdda2-25e6-4c10-bbf7-e3ff9a24bf4a	65219-811	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20150108		NDA	NDA203629	Fresenius Kabi USA, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65219-812_60e93fcf-f8f3-4ee0-85d0-4c0161f7822d	65219-812	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20201030		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65219-814_60e93fcf-f8f3-4ee0-85d0-4c0161f7822d	65219-814	HUMAN PRESCRIPTION DRUG	Xylocaine	MPF	LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20201030		NDA	NDA006488	Fresenius Kabi USA, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65222-401_b42b2479-5edc-4ccb-b59d-96cd153dfe71	65222-401	HUMAN PRESCRIPTION DRUG	Nupro Fluorides NaF Oral Solution	Mint	Sodium Fluoride	GEL	DENTAL	19740101		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "DENTSPLY Professional"	SODIUM FLUORIDE	20	mg/g			N	20241231
65222-411_b42b2479-5edc-4ccb-b59d-96cd153dfe71	65222-411	HUMAN PRESCRIPTION DRUG	Nupro Fluorides NaF Oral Solution	Mandarin Orange	Sodium Fluoride	GEL	DENTAL	19740101		UNAPPROVED DRUG OTHER		Dentsply LLC. Professional Division Trading as "DENTSPLY Professional"	SODIUM FLUORIDE	20	mg/g			N	20241231
65222-800_0b09cc7f-0c8f-4722-ba5e-da524a524f0f	65222-800	HUMAN PRESCRIPTION DRUG	NUPRO Chlorhexidine Gluconate		CHLORHEXIDINE GLUCONATE	RINSE	ORAL	20170117		ANDA	ANDA077789	Dentsply LLC. Professional Division Trading as "DENTSPLY Professional"	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
65250-003_61b0ba20-8899-406a-99be-daef39df8f89	65250-003	HUMAN PRESCRIPTION DRUG	Zilretta		triamcinolone acetonide extended-release injectable suspension	KIT	INTRA-ARTICULAR	20171006		NDA	NDA208845	Pacira Pharmaceuticals, Inc.						N	20241231
65250-133_c2bf3953-14e5-4c57-b33d-004134a49aaa	65250-133	HUMAN PRESCRIPTION DRUG	EXPAREL		bupivacaine	INJECTION, SUSPENSION, LIPOSOMAL	INFILTRATION	20160101		NDA	NDA022496	Pacira Pharmaceuticals, Inc.	BUPIVACAINE	13.3	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
65250-266_c2bf3953-14e5-4c57-b33d-004134a49aaa	65250-266	HUMAN PRESCRIPTION DRUG	EXPAREL		bupivacaine	INJECTION, SUSPENSION, LIPOSOMAL	INFILTRATION	20120101		NDA	NDA022496	Pacira Pharmaceuticals, Inc.	BUPIVACAINE	13.3	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
65257-001_07da7e0c-6d8d-7c2f-e063-6294a90a04bf	65257-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100831		UNAPPROVED MEDICAL GAS		AlpinAire Healthcare	OXYGEN	99	L/100L			N	20241231
65282-1505_0e649488-3951-382e-e063-6294a90a55c1	65282-1505	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170721		ANDA	ANDA206171	Spectra Medical Deviecs, LLC	SODIUM CHLORIDE	9	mg/mL			N	20251231
65282-1510_0e649488-3951-382e-e063-6294a90a55c1	65282-1510	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170721		ANDA	ANDA206171	Spectra Medical Deviecs, LLC	SODIUM CHLORIDE	9	mg/mL			N	20251231
65282-1605_0e8f7cf3-12eb-12f6-e063-6294a90a5da6	65282-1605	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE ANHYDROUS	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20180418		ANDA	ANDA208017	Spectra Medical Devices, LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
65282-1815_0ceeef4e-90fe-d542-e063-6394a90abc8d	65282-1815	HUMAN OTC DRUG	NUMSTAT Antiseptic and Pain Relieving Prep Pad		alcohol, menthol, and benzocaine prep pad	SWAB	TOPICAL	20230101		OTC MONOGRAPH DRUG	M003	Spectra Medical Devices, LLC	BENZOCAINE; ISOPROPYL ALCOHOL; MENTHOL	15; 71; 1	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
65297-001_0a9d6f57-9657-e06d-e063-6294a90a7f1b	65297-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Eagle Home Medical Corp.	OXYGEN	99	L/100L			N	20241231
65321-011_36cfa533-9a85-4330-be49-e1eff0345758	65321-011	HUMAN OTC DRUG	Moisturizing Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20100225		OTC MONOGRAPH DRUG	M003	Rubbermaid Commercial Products LLC	ALCOHOL	63	mL/100mL			N	20241231
65321-024_8630b469-12f7-452c-83cd-1767a55e369d	65321-024	HUMAN OTC DRUG	Foam Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20100501		OTC MONOGRAPH DRUG	M003	Rubbermaid Commercial Products LLC	ALCOHOL	75	mL/100mL			N	20241231
65321-031_6c81d310-d365-4ea3-ae82-cc1048fcfc94	65321-031	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	SOAP	TOPICAL	20170724		OTC MONOGRAPH NOT FINAL	part333E	Rubbermaid Commercial Products LLC	BENZALKONIUM CHLORIDE	13	mg/10mL			N	20241231
65321-032_5bdd2a03-350a-474e-b630-9b0c108ab973	65321-032	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium Chloride	SOAP	TOPICAL	20170724		OTC MONOGRAPH DRUG	M003	Rubbermaid Commercial Products LLC	BENZALKONIUM CHLORIDE	13	mg/10mL			N	20241231
65321-034_6e93033b-22b7-4d5e-8123-8671d4a24029	65321-034	HUMAN OTC DRUG	TC Alcohol-Free Hand Sanitizer		Benzethonium Chloride	LIQUID	TOPICAL	20191028		OTC MONOGRAPH DRUG	M004	Rubbermaid Commercial Products LLC	BENZETHONIUM CHLORIDE	.1	mg/100mL			N	20241231
65321-036_3f8fdda2-9a6f-4b4b-b306-a1391a1d1450	65321-036	HUMAN OTC DRUG	TC Enriched Foam Alcohol Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20191104		OTC MONOGRAPH DRUG	M004	Rubbermaid Commercial Products LLC	ALCOHOL	70	mg/100mL			N	20241231
65321-039_77b30a39-eff8-4c58-9bd7-8ff0238b3b24	65321-039	HUMAN OTC DRUG	Enriched Foam Alcohol-Free Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20210621		OTC MONOGRAPH DRUG	M004	Rubbermaid Commercial Products LLC	BENZALKONIUM CHLORIDE	13	mg/100mL			N	20241231
65321-040_f8ac0bff-371f-43ec-9787-205de40ea9f9	65321-040	HUMAN OTC DRUG	CrackleClean Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20210715		OTC MONOGRAPH NOT FINAL	part333A	Rubbermaid Commercial Products LLC	BENZALKONIUM CHLORIDE	13	mg/100g			N	20241231
65321-041_59e5749f-ef18-4341-a4c2-568883ff995e	65321-041	HUMAN OTC DRUG	Alcohol Foam Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333A	Rubbermaid Commercial Products LLC	ALCOHOL	70	mg/100mL			N	20241231
65342-1230_f4e7082c-c495-2a38-e053-2995a90ac589	65342-1230	HUMAN OTC DRUG	ReVive Fermitif Neck Renewal SPF 15		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20110506		OTC MONOGRAPH FINAL	part352	Gurwitch Products, LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	20; 60; 27; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
65342-2340_f4e6ff3c-81f4-7b80-e053-2995a90a04c0	65342-2340	HUMAN OTC DRUG	Laura Mercier Flawless Skin Daily Face Shield SPF 40		OCTINOXATE, TITANIUM DIOXIDE	LIQUID	TOPICAL	20110421		OTC MONOGRAPH FINAL	part352	Gurwitch Products, LLC	OCTINOXATE; TITANIUM DIOXIDE	75; 50	mg/mL; mg/mL			N	20241231
65353-8442_06309db0-da3a-b4ca-e063-6394a90a2c46	65353-8442	HUMAN OTC DRUG	New Wave Hand Sanitizer Gel		ALCOHOL	GEL	TOPICAL	20201019	20250131	OTC MONOGRAPH NOT FINAL	part333A	BRENNTAG MID-SOUTH, INC.	ALCOHOL	70	L/100L			N	
65386-0001_0762ca47-6bea-e332-e063-6294a90a6868	65386-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091028		UNAPPROVED MEDICAL GAS		Advacare Home Services	OXYGEN	99	L/100L			N	20241231
65435-0100_09c282c0-4e51-8772-e063-6294a90ae4dd	65435-0100	HUMAN OTC DRUG	Safe Sea SPF 50		Homosalate, Octocrylene, Octisalate, Avobenzone	LOTION	TOPICAL	20210430		OTC MONOGRAPH DRUG	M020	NIDARIA TECHNOLOGY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
65435-0200_09c282c0-4e5c-8772-e063-6294a90ae4dd	65435-0200	HUMAN OTC DRUG	Safe Sea SPF 50 kids		Homosalate, Octocrylene, Octisalate, Avobenzone	LOTION	TOPICAL	20210430		OTC MONOGRAPH DRUG	M020	NIDARIA TECHNOLOGY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
65435-0300_09c2a084-c6c7-04eb-e063-6394a90adbcf	65435-0300	HUMAN OTC DRUG	Safe Sea SPF 40		Octocrylene, Homosalate, Ethylhexyl Salicylate, Butyl Methoxydibenzoylmethane	LIQUID	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	NIDARIA TECHNOLOGY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
65435-0400_fda1e66f-8a41-8034-e053-6394a90a783e	65435-0400	HUMAN OTC DRUG	Safe Sea SPF 50 Mineral		Zinc Oxide	LOTION	TOPICAL	20230620		OTC MONOGRAPH FINAL	part352	Nidaria Technology Ltd.	ZINC OXIDE	210	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65453-123_075e9aaf-4058-025d-e063-6294a90ad03b	65453-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070522		UNAPPROVED MEDICAL GAS		Larry's Home Oxygen, Inc.	OXYGEN	99	L/100L			N	20241231
65464-001_0bb798b1-4a2e-6a0d-e063-6394a90a4db0	65464-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20160916		UNAPPROVED MEDICAL GAS		A PLUS HOME MEDICAL, INC.	OXYGEN	99	L/99L			N	20241231
65465-0001_0983a9b0-57d7-b42c-e063-6294a90ae81a	65465-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		St. Peter's Hospital	OXYGEN	99	L/100L			N	20241231
65517-0001_07a00162-0149-455d-e063-6294a90a4cef	65517-0001	HUMAN OTC DRUG	Dukal Alcohol Prep Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20100501		OTC MONOGRAPH DRUG	M003	Dukal LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
65517-0002_079fe784-f7a6-e027-e063-6394a90ab4f5	65517-0002	HUMAN OTC DRUG	Dukal Sterile Alcohol Prep Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20000101		OTC MONOGRAPH DRUG	M003	Dukal LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
65517-0002_82fa90c6-8f97-484b-e053-2a91aa0a3bdd	65517-0002	HUMAN OTC DRUG	Dukal Sterile Alcohol Prep Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20000101		OTC MONOGRAPH NOT FINAL	part333A	Dukal Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
65517-0004_079feab5-a3f1-8896-e063-6294a90a8838	65517-0004	HUMAN OTC DRUG	BZK Towelette		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20060101		OTC MONOGRAPH DRUG	M003	Dukal LLC	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
65517-0005_07a095bb-40f2-8aed-e063-6394a90aba2f	65517-0005	HUMAN OTC DRUG	DUKAL STING RELIEF PAD		BENZOCAINE	SWAB	TOPICAL	20100601		OTC MONOGRAPH DRUG	M003	Dukal LLC	BENZOCAINE; ISOPROPYL ALCOHOL	60; .6	mg/mL; mL/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
65517-0006_07a07f48-fcb0-29b4-e063-6294a90a4de7	65517-0006	HUMAN OTC DRUG	Dukal Sterile Alcohol Prep Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20000101		OTC MONOGRAPH DRUG	M003	Dukal LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
65517-0033_079fe784-f7a5-e027-e063-6394a90ab4f5	65517-0033	HUMAN OTC DRUG	PVP-Iodine Swabstick Threes		Povidone-iodine	SWAB	TOPICAL	20180131		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
65517-0034_079fe952-bca8-728b-e063-6294a90a67c2	65517-0034	HUMAN OTC DRUG	PVP-I Prep Pads foil-foil		Povidone-iodine	SWAB	TOPICAL	20180131		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
65517-0035_079feab5-a3f2-8896-e063-6294a90a8838	65517-0035	HUMAN OTC DRUG	PVP-I Pouch foil-foil		Povidone-iodine	SOLUTION	TOPICAL	20180131		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
65517-0036_079fe952-bca7-728b-e063-6294a90a67c2	65517-0036	HUMAN OTC DRUG	Povidone-Iodine Gel Swabstick		Povidone Iodine	GEL	TOPICAL	20191202		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	10	mg/g			N	20241231
65517-0037_079f8754-babe-2257-e063-6394a90ae966	65517-0037	HUMAN OTC DRUG	Dukal Povidone-Iodine Scrub Winged Sponges		Povidone-Iodine Scrub Winged Sponges	SPONGE	TOPICAL	20220915		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	1.1	g/100mL			N	20241231
65517-0038_079f89fa-85e1-3c77-e063-6294a90addb4	65517-0038	HUMAN OTC DRUG	Dukal Povidone-Iodine Paint Sponge Stick		Povidone-Iodine Paint Sponge Stick	SPONGE	TOPICAL	20230111		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	1.1	g/100mL			N	20241231
65517-0039_079fcd1e-cc1b-5d52-e063-6394a90a9966	65517-0039	HUMAN OTC DRUG	PVP-I Prep Pads paper-foil		Povidone-iodine	SWAB	TOPICAL	20230215		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
65517-0040_079fb589-1a8d-2417-e063-6394a90a7ac4	65517-0040	HUMAN OTC DRUG	Dukal Povidone-Iodine Scrub Sponge Sticks		Povidone-Iodine Scrub Sponge Sticks	SPONGE	TOPICAL	20230315		OTC MONOGRAPH DRUG	M003	Dukal LLC	POVIDONE-IODINE	1.1	g/100mL			N	20241231
65517-1005_07a089d0-8b41-6f2c-e063-6394a90a4b6b	65517-1005	HUMAN OTC DRUG	DawnMist Antiperspirant Deodorant		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20130110		OTC MONOGRAPH DRUG	M019	Dukal LLC	ALUMINUM CHLOROHYDRATE	45	mg/mL			N	20241231
65517-1007_079fb083-a9c8-5e20-e063-6394a90ab7bd	65517-1007	HUMAN OTC DRUG	DawnMist Alcohol Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20130114		OTC MONOGRAPH DRUG	M003	Dukal LLC	ALCOHOL	700	mg/mL			N	20241231
65517-1008_07a09684-f835-ac98-e063-6294a90a3767	65517-1008	HUMAN OTC DRUG	DawnMist Antiperspirant Deodorant		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20130110		OTC MONOGRAPH DRUG	M019	Dukal LLC	ALUMINUM CHLOROHYDRATE	45	mg/mL			N	20241231
65517-1009_07a07f48-fcb1-29b4-e063-6294a90a4de7	65517-1009	HUMAN OTC DRUG	DawnMist Antiperspirant Deodorant		ALUMINUM CHLOROHYDRATE	LIQUID	TOPICAL	20130110		OTC MONOGRAPH DRUG	M019	Dukal LLC	ALUMINUM CHLOROHYDRATE	45	mg/mL			N	20241231
65517-1014_07a07f48-fcb5-29b4-e063-6294a90a4de7	65517-1014	HUMAN OTC DRUG	DawnMist Antiperspirant Deodorant		ALUMINUM CHLOROHYDRATE	GEL	TOPICAL	20130502		OTC MONOGRAPH DRUG	M019	Dukal LLC	ALUMINUM CHLOROHYDRATE	45	mg/mL			N	20241231
65517-1020_079ffae7-3218-f822-e063-6394a90a8d75	65517-1020	HUMAN OTC DRUG	DawnMist Alcohol Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20130114		OTC MONOGRAPH DRUG	M003	Dukal LLC	ALCOHOL	.63	mL/mL			N	20241231
65517-1021_07a085aa-adc9-4648-e063-6294a90a6cb7	65517-1021	HUMAN OTC DRUG	DawnMist Antiperspirant Deodorant		ALUMINUM CHLOROHYDRATE	LOTION	TOPICAL	20181012		OTC MONOGRAPH DRUG	M019	Dukal LLC	ALUMINUM CHLOROHYDRATE	78	mg/mL			N	20241231
65517-1023_07a03ddc-9f84-25e3-e063-6294a90adae9	65517-1023	HUMAN OTC DRUG	DawnMist Alcohol Hand Sanitizer		Alcohol	GEL	TOPICAL	20200409		OTC MONOGRAPH DRUG	M003	Dukal LLC	ALCOHOL	.62	mL/mL			N	20241231
65517-2000_07a09684-f836-ac98-e063-6294a90a3767	65517-2000	HUMAN OTC DRUG	Sodium fluoride		Toothpaste	CREAM	ORAL	20131113		OTC MONOGRAPH DRUG	M022	DUKAL LLC	SODIUM FLUORIDE	.22	g/100g			N	20241231
65517-2017_07a0a500-d4a9-db78-e063-6394a90a401c	65517-2017	HUMAN OTC DRUG	DAWNMIST FLUORIDE		SODIUM FLUORIDE	PASTE	DENTAL	20140117		OTC MONOGRAPH DRUG	M022	Dukal LLC	SODIUM FLUORIDE	.22	g/100g			N	20241231
65517-2018_07a085aa-add0-4648-e063-6294a90a6cb7	65517-2018	HUMAN OTC DRUG	DawnMist Fluoride		Sodium Fluoride	PASTE	DENTAL	20140130		OTC MONOGRAPH DRUG	M022	Dukal LLC	SODIUM FLUORIDE	.76	g/100g			N	20241231
65517-2020_079fde79-61a1-45f0-e063-6394a90a5e54	65517-2020	HUMAN OTC DRUG	Dawnmist Petroleum		Petrolatum	JELLY	TOPICAL	20141024		OTC MONOGRAPH DRUG	M016	Dukal LLC	PETROLATUM	100	g/100g			N	20241231
65517-2022_079fb589-1a8e-2417-e063-6394a90a7ac4	65517-2022	HUMAN OTC DRUG	Dukal Sterile Alcohol Swabstick		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20000101		OTC MONOGRAPH DRUG	M003	Dukal LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
65517-2023_0e35836c-a2bd-c9ed-e063-6394a90a2481	65517-2023	HUMAN OTC DRUG	DUKAL WHITE PETROLATUM		PETROLATUM	JELLY	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Dukal LLC	PETROLATUM	1	g/g			N	20251231
65551-001_0da89e69-31ed-4daf-e063-6294a90a0eec	65551-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20150312		UNAPPROVED MEDICAL GAS		AeroCare Holdings, LLC	OXYGEN	99	L/100L			N	20241231
65585-365_0b756336-e229-c53b-e063-6294a90a6fec	65585-365	HUMAN OTC DRUG	WhiskCare 365		Chloroxylenol	SOAP	TOPICAL	20000331		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	CHLOROXYLENOL	10	mg/mL			N	20241231
65585-372_0568e4b0-6472-ed56-e063-6394a90a0916	65585-372	HUMAN OTC DRUG	WhiskCare 371		Alcohol	SPRAY	TOPICAL	20080115		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-373_6c6708ae-4a1a-4921-be1d-ab480eddf533	65585-373	HUMAN OTC DRUG	WhiskCare 373		Alcohol	SOAP	TOPICAL	20080117	20240214	OTC MONOGRAPH NOT FINAL	part333E	Whisk Products, Inc.	ALCOHOL	650	mL/L			N	
65585-374_0b75e970-d8ec-aa54-e063-6394a90a2cdb	65585-374	HUMAN OTC DRUG	WhiskCare 373		Alcohol	SOAP	TOPICAL	20220617		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	620	mL/L			N	20241231
65585-375_0b782b71-11a1-56d4-e063-6394a90a7676	65585-375	HUMAN OTC DRUG	WhiskCare 375		Alcohol	GEL	TOPICAL	20050601		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-376_0befd80c-dadb-240f-e063-6294a90a2850	65585-376	HUMAN OTC DRUG	WhiskCare 375 Fragrance Free		Alcohol	GEL	TOPICAL	20091001	20251231	OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	
65585-378_0b794d05-0c98-bab7-e063-6394a90a46af	65585-378	HUMAN OTC DRUG	WhiskCare 375	Fragrance Free	Alcohol	GEL	TOPICAL	20220712		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-379_ff089a1b-b4c6-53e1-e053-6394a90a8875	65585-379	HUMAN OTC DRUG	WhiskCare 375	Fragrance Free	Alcohol	GEL	TOPICAL	20230622	20250430	OTC MONOGRAPH NOT FINAL	part333E	Whisk Products, Inc.	ALCOHOL	70	mL/100mL			N	
65585-380_0c054670-1e49-d10b-e063-6294a90a7014	65585-380	HUMAN OTC DRUG	Pacific Breeze Instant Hand Sanitizer Gel		Alcohol	GEL	TOPICAL	20230303		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-489_0c054670-1e52-d10b-e063-6294a90a7014	65585-489	HUMAN OTC DRUG	Pretty Pump Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20071009		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-498_0c052697-8b05-596c-e063-6394a90a94a9	65585-498	HUMAN OTC DRUG	D-Germ		Alcohol	GEL	TOPICAL	20230613		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-513_0bf1ccd3-27c3-04bb-e063-6294a90a5197	65585-513	HUMAN OTC DRUG	WhiskCare 387		Benzalkonium Chloride	SOAP	TOPICAL	20200415		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-514_0c04ef09-1093-4c9f-e063-6394a90a3bbf	65585-514	HUMAN OTC DRUG	Alpha Foaming E-2		Benzalkonium Chloride	SOAP	TOPICAL	20200423		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-520_0c02b069-61aa-8331-e063-6294a90a1951	65585-520	HUMAN OTC DRUG	Algonquin HanClean Foam		Benzalkonium Chloride	SOAP	TOPICAL	20200429		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-521_0c030243-4802-be45-e063-6394a90accb2	65585-521	HUMAN OTC DRUG	FOAM-BAC Antibacterial Hand		Benzalkonium Chloride	SOAP	TOPICAL	20210426		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-522_0c027c1e-a96a-53b1-e063-6294a90a82d9	65585-522	HUMAN OTC DRUG	Algonquin HanSan		Alcohol	GEL	TOPICAL	20220923		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-523_0bf1cb26-06a6-b05c-e063-6394a90acab2	65585-523	HUMAN OTC DRUG	Aire-Master Antibacterial Foam		Benzalkonium Chloride	SOLUTION	TOPICAL	20220919		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-524_0bf203ee-fd91-552b-e063-6294a90a9000	65585-524	HUMAN OTC DRUG	Aire-Master Foaming Hand Sanitizer Fragrance Free		Alcohol	SOLUTION	TOPICAL	20220919		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	620	mL/L			N	20241231
65585-525_0bf21b7e-fb60-ce8e-e063-6394a90a555e	65585-525	HUMAN OTC DRUG	Aire-Master Waterless Hand Sanitizer		Alcohol	GEL	TOPICAL	20220919		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-526_b148247d-4b7e-42ba-8ac1-b274acdc5ed3	65585-526	HUMAN OTC DRUG	Foamy Blue		Benzalkonium Chloride	SOLUTION	TOPICAL	20230118	20250131	OTC MONOGRAPH NOT FINAL	part333E	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	
65585-527_0bf12bf6-737d-87c1-e063-6394a90aa1dd	65585-527	HUMAN OTC DRUG	WhiskCare 377	Free	Benzalkonium Chloride	SOLUTION	TOPICAL	20231005		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-557_0d1b4d01-3ba2-eb09-e063-6394a90a43d2	65585-557	HUMAN OTC DRUG	WhiskCare 357		Benzalkonium Chloride	SOAP	TOPICAL	20200325		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-562_0b750715-f199-3f7b-e063-6394a90a876e	65585-562	HUMAN OTC DRUG	WhiskCare 362		Chloroxylenol	SOAP	TOPICAL	20060123		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	CHLOROXYLENOL	7.5	mg/mL			N	20241231
65585-568_0b75a68a-1b93-2191-e063-6294a90ab9e8	65585-568	HUMAN OTC DRUG	WhiskCare 367		Chloroxylenol	SOAP	TOPICAL	20071206		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	CHLOROXYLENOL	7.5	mg/mL			N	20241231
65585-577_0bf1202d-1d58-7707-e063-6394a90a8ce4	65585-577	HUMAN OTC DRUG	WhiskCare 377		Benzalkonium Chloride	SOAP	TOPICAL	20051012		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65585-578_0bf17178-c341-d6fb-e063-6294a90a884a	65585-578	HUMAN OTC DRUG	WhiskCare 377 Free		Benzalkonium Chloride	SOAP	TOPICAL	20160406	20251231	OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	
65585-580_0bf2073f-50d0-529d-e063-6294a90abfd4	65585-580	HUMAN OTC DRUG	AP HanSan		Alcohol	SPRAY	TOPICAL	20161024		OTC MONOGRAPH DRUG	505G(a)(3)	WhiskProducts, Inc.	ALCOHOL	600	mL/L			N	20241231
65585-586_0c05a4f3-1bb3-f41c-e063-6294a90ac64b	65585-586	HUMAN OTC DRUG	Jade Antibacterial Hand		Benzalkonium Chloride	SOAP	TOPICAL	20210419		OTC MONOGRAPH DRUG	505G(a)(3)	Whisk Products, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65597-101_9a1acd82-0655-4e72-9177-12ddf31c4b1b	65597-101	HUMAN PRESCRIPTION DRUG	Benicar		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20020425	20240131	NDA	NDA021286	Daiichi Sankyo, Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
65597-103_9a1acd82-0655-4e72-9177-12ddf31c4b1b	65597-103	HUMAN PRESCRIPTION DRUG	Benicar		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20020425	20240331	NDA	NDA021286	Daiichi Sankyo, Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
65597-104_9a1acd82-0655-4e72-9177-12ddf31c4b1b	65597-104	HUMAN PRESCRIPTION DRUG	Benicar		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20020425	20240331	NDA	NDA021286	Daiichi Sankyo, Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
65597-107_95b56527-9a72-45dd-a7a5-378d72a1aba7	65597-107	HUMAN PRESCRIPTION DRUG	Benicar HCT		olmesartan medoxomil-hydrochlorothiazide	TABLET, FILM COATED	ORAL	20030605	20240229	NDA	NDA021532	Daiichi Sankyo, Inc.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
65597-111_d5485e0f-7c18-4073-91f6-0890243d9bd6	65597-111	HUMAN PRESCRIPTION DRUG	Azor		amlodipine besylate and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20070926	20240831	NDA	NDA022100	Daiichi Sankyo Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
65597-113_d5485e0f-7c18-4073-91f6-0890243d9bd6	65597-113	HUMAN PRESCRIPTION DRUG	Azor		amlodipine besylate and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20070926	20250228	NDA	NDA022100	Daiichi Sankyo Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
65597-114_d38366c2-56f0-47d2-add1-f87c9f5d6f30	65597-114	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100731	20240831	NDA	NDA200175	Daiichi Sankyo, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
65597-116_d38366c2-56f0-47d2-add1-f87c9f5d6f30	65597-116	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100731	20240630	NDA	NDA200175	Daiichi Sankyo, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
65597-117_d38366c2-56f0-47d2-add1-f87c9f5d6f30	65597-117	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100731	20240531	NDA	NDA200175	Daiichi Sankyo, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
65597-118_d38366c2-56f0-47d2-add1-f87c9f5d6f30	65597-118	HUMAN PRESCRIPTION DRUG	Tribenzor		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100731	20240229	NDA	NDA200175	Daiichi Sankyo, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
65597-201_ecdf9b93-99ef-4356-a6cc-15d04a4b28c4	65597-201	HUMAN PRESCRIPTION DRUG	SAVAYSA		EDOXABAN TOSYLATE	TABLET, FILM COATED	ORAL	20150112		NDA	NDA206316	Daiichi Sankyo	EDOXABAN TOSYLATE	15	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
65597-202_ecdf9b93-99ef-4356-a6cc-15d04a4b28c4	65597-202	HUMAN PRESCRIPTION DRUG	SAVAYSA		EDOXABAN TOSYLATE	TABLET, FILM COATED	ORAL	20150112		NDA	NDA206316	Daiichi Sankyo	EDOXABAN TOSYLATE	30	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
65597-203_ecdf9b93-99ef-4356-a6cc-15d04a4b28c4	65597-203	HUMAN PRESCRIPTION DRUG	SAVAYSA		EDOXABAN TOSYLATE	TABLET, FILM COATED	ORAL	20150112		NDA	NDA206316	Daiichi Sankyo	EDOXABAN TOSYLATE	60	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
65597-402_291804c0-9187-43fc-aaf5-b897ecebb52b	65597-402	HUMAN PRESCRIPTION DRUG	Turalio		pexidartinib	CAPSULE	ORAL	20190802	20240131	NDA	NDA211810	Daiichi Sankyo Inc.	PEXIDARTINIB HYDROCHLORIDE	200	mg/1	Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	
65597-406_b07983c7-f76f-490c-8a07-622b95044abd	65597-406	HUMAN PRESCRIPTION DRUG	Enhertu		fam-trastuzumab deruxtecan-nxki	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191220		BLA	BLA761139	Daiichi Sankyo, Inc.	TRASTUZUMAB DERUXTECAN	100	mg/5mL			N	20241231
65597-407_be11f339-6416-44a9-a12f-2b3d8f84b227	65597-407	HUMAN PRESCRIPTION DRUG	Turalio		pexidartinib hydrochloride	CAPSULE	ORAL	20230201		NDA	NDA211810	Daiichi Sankyo, Inc.	PEXIDARTINIB HYDROCHLORIDE	125	mg/1	Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
65597-504_024f78d0-3892-4d1c-9ec8-6a595a4fe2bb	65597-504	HUMAN PRESCRIPTION DRUG	VANFLYTA		QUIZARTINIB	TABLET, FILM COATED	ORAL	20230720		NDA	NDA216993	Daiichi Sankyo Inc.	QUIZARTINIB DIHYDROCHLORIDE	17.7	mg/1			N	20241231
65597-511_024f78d0-3892-4d1c-9ec8-6a595a4fe2bb	65597-511	HUMAN PRESCRIPTION DRUG	VANFLYTA		QUIZARTINIB	TABLET, FILM COATED	ORAL	20230720		NDA	NDA216993	Daiichi Sankyo Inc.	QUIZARTINIB DIHYDROCHLORIDE	26.5	mg/1			N	20241231
65597-701_3e806127-4a87-41cc-9b17-a77e20bb2452	65597-701	HUMAN PRESCRIPTION DRUG	Welchol		colesevelam hydrochloride	TABLET, FILM COATED	ORAL	20000901	20250930	NDA	NDA021176	Daiichi Sankyo Inc.	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	
65597-902_3e806127-4a87-41cc-9b17-a77e20bb2452	65597-902	HUMAN PRESCRIPTION DRUG	Welchol		colesevelam hydrochloride	FOR SUSPENSION	ORAL	20100101	20260228	NDA	NDA022362	Daiichi Sankyo Inc.	COLESEVELAM HYDROCHLORIDE	3.75	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	
65601-700_af0b7728-2cb3-d5d7-e053-2995a90ab29e	65601-700	HUMAN OTC DRUG	Alcohol Free Foaming Hand Sanitizer		Benzalkonium Chloride	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333A	Betco Corporation, Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
65601-708_af09755e-42d7-2e45-e053-2a95a90a9c15	65601-708	HUMAN OTC DRUG	Antibacterial Skin Cleanser		Chloroxylenol	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333A	Betco Corporation, Ltd.	CHLOROXYLENOL	3.75	mg/mL			N	20241231
65601-709_af0b3d41-492b-51b4-e053-2995a90adc90	65601-709	HUMAN OTC DRUG	Antibacterial Foaming Skin Cleanser		Benzalkonium Chloride	SOAP	TOPICAL	20170719		OTC MONOGRAPH NOT FINAL	part333E	Betco Corporation, Ltd.	BENZALKONIUM CHLORIDE	.13	mg/mL			N	20241231
65601-754_23d7d61c-26cb-44ba-91a3-76d50efcce8e	65601-754	HUMAN OTC DRUG	Winning Hands Foaming Antibacterial		Benzalkonium Chloride	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333E	Betco Corporation, Ltd.	BENZALKONIUM CHLORIDE	13	mg/mL			N	20241231
65601-759_ad512df9-baeb-bd6f-e053-2a95a90a96df	65601-759	HUMAN OTC DRUG	Ultra Blue Antibacterial Foaming Skin Cleanser		benzalkonium chloride	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333E	Betco Corporation, Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
65601-779_af0c37c2-31d3-7583-e053-2a95a90a3306	65601-779	HUMAN OTC DRUG	E3 Alcohol Free Foaming Sanitizer		Benzalkonium Chloride	SOAP	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part333A	Betco Corporation, Ltd.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
65601-796_8f62fa63-2270-ecf6-e053-2995a90ac7d8	65601-796	HUMAN OTC DRUG	Advanced Alcohol Gel Sanitizer		Alcohol	GEL	TOPICAL	20190801		OTC MONOGRAPH NOT FINAL	part333E	Betco Corporation, Ltd	ALCOHOL	1	mL/.7mL			N	20241231
65601-801_e077d195-ea35-06f6-e053-2995a90a8b6b	65601-801	HUMAN OTC DRUG	Advanced Alcohol Gel Sanitizer		Alcohol	GEL	TOPICAL	20190801		OTC MONOGRAPH NOT FINAL	part333E	Betco Corporation, Ltd	ALCOHOL	.7	mL/mL			N	20241231
65601-802_0da8eb7f-2e15-a7d5-e063-6294a90a88e7	65601-802	HUMAN OTC DRUG	Advanced Alcohol Foaming Hand Sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	20231229		OTC MONOGRAPH DRUG	505G(a)(3)	Betco Corporation LLC	ALCOHOL	.6787	mL/mL			N	20251231
65601-817_af0b0908-310a-2cce-e053-2995a90a007d	65601-817	HUMAN OTC DRUG	E2 Antibacterial Foaming Skin Cleanser		Benzalkonium Chloride	SOAP	TOPICAL	20140117		OTC MONOGRAPH NOT FINAL	part333A	Betco Corporation, Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
65601-865_aa91475b-ea85-afe9-e053-2a95a90ad0aa	65601-865	HUMAN OTC DRUG	Skin Cleanser		Chloroxylenol	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333A	Betco Corporation, Ltd.	CHLOROXYLENOL	5	mg/mL			N	20241231
65603-100_0710ef8e-683f-585b-e063-6294a90a5ac8	65603-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20011020		NDA	NDA205840	Arkansas Welding Supply, Inc.	OXYGEN	992	mL/L			N	20241231
65603-200_0710ef8e-6840-585b-e063-6294a90a5ac8	65603-200	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20221206		NDA	NDA205766	Arkansas Welding Supply, Inc.	NITROGEN	990	mL/L			N	20241231
65616-006_0878f24d-a24e-5033-e063-6294a90ab258	65616-006	HUMAN OTC DRUG	Sterillium Foam		Alcohol	LIQUID	TOPICAL	20190925		OTC MONOGRAPH DRUG	505G(a)(3)	BODE Chemie GmbH	ALCOHOL	85	mL/100mL			N	20241231
65616-007_0bf2d427-0ed1-ff82-e063-6394a90a0fd3	65616-007	HUMAN OTC DRUG	Sterillium Med		Alcohol	LIQUID	TOPICAL	20190731		OTC MONOGRAPH DRUG	505G(a)(3)	BODE Chemie GmbH	ALCOHOL	89.5	mL/100mL			N	20241231
65616-008_026defbf-df60-918a-e063-6294a90a9421	65616-008	HUMAN OTC DRUG	Sterillium Rub Fragrance Free		ALCOHOL	LIQUID	TOPICAL	20190731		OTC MONOGRAPH NOT FINAL	part333E	BODE Chemie GmbH	ALCOHOL	89.5	mL/100mL			N	20241231
65616-009_0befd548-9577-2363-e063-6394a90a0ab4	65616-009	HUMAN OTC DRUG	Sterillium Comfort		Alcohol	GEL	TOPICAL	20190731		OTC MONOGRAPH DRUG	505G(a)(3)	BODE Chemie GmbH	ALCOHOL	85	mL/100mL			N	20241231
65626-206_08b8a3a8-e3e5-9403-e063-6394a90aee97	65626-206	HUMAN OTC DRUG	Hand Essentials Instant Hand Antiseptic		ethyl alcohol	GEL	TOPICAL	20101001		OTC MONOGRAPH DRUG	505G(a)(3)	Hu-Friedy Mfg. Co., Inc.	ALCOHOL	70	mL/100mL			N	20241231
65626-470_08b8ad2e-41d5-a493-e063-6294a90a16bc	65626-470	HUMAN OTC DRUG	Instant Hand Sanitizer Unscented		Alcohol	GEL	TOPICAL	20210126		OTC MONOGRAPH DRUG	505G(a)(3)	Hu-Friedy Mfg. Co., Inc.	ALCOHOL	70	mL/100mL			N	20241231
65628-015_0c025ef1-006d-f5b6-e063-6294a90a087b	65628-015	HUMAN PRESCRIPTION DRUG	FIRVANQ		vancomycin hydrochloride	KIT		20200214		NDA	NDA208910	Azurity Pharmaceuticals, Inc						N	20241231
65628-016_0c025ef1-006d-f5b6-e063-6294a90a087b	65628-016	HUMAN PRESCRIPTION DRUG	FIRVANQ		vancomycin hydrochloride	KIT		20200214		NDA	NDA208910	Azurity Pharmaceuticals, Inc						N	20241231
65628-204_0c018d41-1802-4500-e063-6394a90a2ef2	65628-204	HUMAN PRESCRIPTION DRUG	FIRVANQ		vancomycin hydrochloride	KIT		20180126		NDA	NDA208910	Azurity Pharmaceuticals, Inc						N	20241231
65628-205_0c018d41-1802-4500-e063-6394a90a2ef2	65628-205	HUMAN PRESCRIPTION DRUG	FIRVANQ		vancomycin hydrochloride	KIT		20180126		NDA	NDA208910	Azurity Pharmaceuticals, Inc						N	20241231
65628-206_0c018d41-1802-4500-e063-6394a90a2ef2	65628-206	HUMAN PRESCRIPTION DRUG	FIRVANQ		vancomycin hydrochloride	KIT		20180126		NDA	NDA208910	Azurity Pharmaceuticals, Inc						N	20241231
65628-208_0c018d41-1802-4500-e063-6394a90a2ef2	65628-208	HUMAN PRESCRIPTION DRUG	FIRVANQ		vancomycin hydrochloride	KIT		20180126		NDA	NDA208910	Azurity Pharmaceuticals, Inc						N	20241231
65628-272_6fc0a7c7-babb-4ab2-8e18-8a212803ce2d	65628-272	HUMAN PRESCRIPTION DRUG	Konvomep		omeprazole and sodium bicarbonate	KIT		20230215		NDA	NDA213593	Azurity Pharmaceuticals, Inc.						N	20241231
65649-003_e757981c-c4fc-4702-83ee-0d90382fb959	65649-003	HUMAN PRESCRIPTION DRUG	Trulance	Immediate release	Plecanatide	TABLET	ORAL	20170221		NDA	NDA208745	Salix Pharmaceuticals Inc.	PLECANATIDE	3	mg/1	Guanylate Cyclase Activators [MoA], Guanylate Cyclase-C Agonist [EPC]		N	20241231
65649-101_092f61af-2996-0c58-e063-6394a90a3753	65649-101	HUMAN PRESCRIPTION DRUG	Colazal		balsalazide disodium	CAPSULE	ORAL	20000718		NDA	NDA020610	Salix Pharmaceuticals, Inc	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
65649-103_0e88852d-72fc-3002-e063-6394a90a0369	65649-103	HUMAN PRESCRIPTION DRUG	APRISO		mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20081031		NDA	NDA022301	Salix Pharmaceuticals, Inc.	MESALAMINE	375	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20251231
65649-150_0c52697c-202f-6baa-e063-6294a90a2591	65649-150	HUMAN PRESCRIPTION DRUG	Relistor		Methylnaltrexone bromide	TABLET	ORAL	20080801		NDA	NDA208271	Salix Pharmaceuticals, Inc.	METHYLNALTREXONE BROMIDE	150	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Quaternary Ammonium Compounds [CS]		N	20241231
65649-201_aeede670-8fd9-4e9b-a694-143fc5044f83	65649-201	HUMAN PRESCRIPTION DRUG	MoviPrep		POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE	KIT		20061001		NDA	NDA021881	Salix Pharmaceuticals, Inc.						N	20241231
65649-231_0cceeb5c-3f54-cca0-e063-6394a90a3b95	65649-231	HUMAN PRESCRIPTION DRUG	Azasan		Azathioprine	TABLET	ORAL	20030401		ANDA	ANDA075252	Salix Pharmaceuticals	AZATHIOPRINE	75	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
65649-241_0cceeb5c-3f54-cca0-e063-6394a90a3b95	65649-241	HUMAN PRESCRIPTION DRUG	Azasan		Azathioprine	TABLET	ORAL	20030401		ANDA	ANDA075252	Salix Pharmaceuticals	AZATHIOPRINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
65649-301_0a33f9a9-1faa-7cdf-e063-6294a90adca1	65649-301	HUMAN PRESCRIPTION DRUG	XIFAXAN		rifaximin	TABLET	ORAL	20040725		NDA	NDA021361	Salix Pharmaceuticals, Inc.	RIFAXIMIN	200	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
65649-303_0a33f9a9-1faa-7cdf-e063-6294a90adca1	65649-303	HUMAN PRESCRIPTION DRUG	XIFAXAN		rifaximin	TABLET	ORAL	20100501		NDA	NDA021361	Salix Pharmaceuticals, Inc.	RIFAXIMIN	550	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
65649-311_7875229f-e08f-4443-9980-d2ca6fab68f7	65649-311	HUMAN PRESCRIPTION DRUG	DIURIL		CHLOROTHIAZIDE	SUSPENSION	ORAL	19620215		NDA	NDA011870	Salix Pharmaceuticals, Inc	CHLOROTHIAZIDE	250	mg/5mL	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65649-400_c23688c3-a0ff-40bd-aa0c-9ebee4f69119	65649-400	HUMAN PRESCRIPTION DRUG	Plenvu		POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE	KIT		20180504		NDA	NDA209381	Salix Pharmaceuticals, Inc						N	20241231
65649-401_1103c6ea-1e5c-465c-bae8-9d56dfa9a7cd	65649-401	HUMAN PRESCRIPTION DRUG	Anusol	HC	hydrocortisone	CREAM	TOPICAL	19840606		ANDA	ANDA088250	Salix Pharmaceuticals, Inc	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65649-411_40875941-02f0-44de-a3b9-c03248645f7b	65649-411	HUMAN PRESCRIPTION DRUG	Anusol HC		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	20040601		UNAPPROVED DRUG OTHER		Salix Pharmaceuticals, Inc	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65649-501_62bfc47a-1d14-4dd2-8020-56e01f4e89a7	65649-501	HUMAN PRESCRIPTION DRUG	Proctocort		HYDROCORTISONE	CREAM	TOPICAL	20040601		ANDA	ANDA080706	Salix Pharmaceuticals, Inc	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65649-511_c09b0ff0-c9cd-4850-b071-9a6bc5098d04	65649-511	HUMAN PRESCRIPTION DRUG	Proctocort		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	20040601		UNAPPROVED DRUG OTHER		Salix Pharmaceuticals, Inc	HYDROCORTISONE ACETATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65649-551_0c52697c-202f-6baa-e063-6294a90a2591	65649-551	HUMAN PRESCRIPTION DRUG	Relistor		Methylnaltrexone bromide	INJECTION, SOLUTION	SUBCUTANEOUS	20080424		NDA	NDA021964	Salix Pharmaceuticals, Inc.	METHYLNALTREXONE BROMIDE	12	mg/.6mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Quaternary Ammonium Compounds [CS]		N	20241231
65649-552_0c52697c-202f-6baa-e063-6294a90a2591	65649-552	HUMAN PRESCRIPTION DRUG	Relistor		Methylnaltrexone bromide	INJECTION, SOLUTION	SUBCUTANEOUS	20080424		NDA	NDA021964	Salix Pharmaceuticals, Inc.	METHYLNALTREXONE BROMIDE	8	mg/.4mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Quaternary Ammonium Compounds [CS]		N	20241231
65649-651_be09d39b-5ddd-4763-97b4-760fcd93392d	65649-651	HUMAN PRESCRIPTION DRUG	Uceris		budesonide	AEROSOL, FOAM	RECTAL	20141201		NDA	NDA205613	Salix Pharmaceuticals, Inc.	BUDESONIDE	28	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65692-0307_0decf6f7-de38-4584-8bfe-83596fb81e25	65692-0307	HUMAN OTC DRUG	Broad Spectrum SPF 15 Coconut Lip Balm		ZINC OXIDE	STICK	TOPICAL	20210427		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc.	ZINC OXIDE	35	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65692-0308_edb8a385-0a59-42d0-a127-2c6f2c582f08	65692-0308	HUMAN OTC DRUG	Puriya Antifungal Balm		ZINC UNDECYLENATE	CREAM	TOPICAL	20210604		OTC MONOGRAPH DRUG	M005	Raining Rose, Inc.	ZINC UNDECYLENATE	5.7	g/57g			N	20241231
65692-0309_31e65ac9-28f7-42a2-b757-3663ce8be477	65692-0309	HUMAN OTC DRUG	OKeeffes Medicated Lip Repair Seal and Heal		Medicated Lip Repair	STICK	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc.	PETROLATUM	1.26	g/4.2g			N	20241231
65692-0310_31e65ac9-28f7-42a2-b757-3663ce8be477	65692-0310	HUMAN OTC DRUG	OKeeffes Medicated Lip Repair Seal and Heal		Medicated Lip Repair	STICK	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc.	PETROLATUM	1.26	g/4.2g			N	20241231
65692-0311_3812fdbc-b730-4e10-83ab-4b83931ba020	65692-0311	HUMAN OTC DRUG	OKeeffes Healthy Feet Pain Relief Cream		Pain Relief Cream	LOTION	TOPICAL	20220301		OTC MONOGRAPH DRUG	M017	Raining Rose, Inc.	ALLANTOIN; LIDOCAINE HYDROCHLORIDE	.5; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65692-0313_1998d509-e5c1-4148-a84e-8eec4e9e79d5	65692-0313	HUMAN OTC DRUG	All Good Broad Spectrum SPF 15 Spearmint Lip Balm		Broad Spectrum SPF 15 Spearmint Lip Balm	STICK	TOPICAL	20230724		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc.	ZINC OXIDE	35	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
65692-0508_08a14d4e-8a9f-9712-e063-6394a90a0bad	65692-0508	HUMAN OTC DRUG	Grape Soda SPF 15 Broad Spectrum Lip Balm		Grape Soda SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0509_08a17627-41bc-f17e-e063-6394a90aff5a	65692-0509	HUMAN OTC DRUG	Juice Box SPF 15 Broad Spectrum Lip Balm		Juice Box SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0512_07637d90-0ab5-5267-e063-6294a90affc9	65692-0512	HUMAN OTC DRUG	Orange Soda SPF 15 Broad Spectrum Lip Balm		Orange Soda SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0515_080489ba-9d55-80cd-e063-6394a90ac0a0	65692-0515	HUMAN OTC DRUG	Mineral SPF 15 Broad Spectrum Lip Balm		Mineral SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	ZINC OXIDE	.34	g/4.25g			N	20241231
65692-0516_0863a4d3-32aa-730f-e063-6394a90a43f2	65692-0516	HUMAN OTC DRUG	Breath Fresh SPF 15 Broad Spectrum Lip Balm		Breath Fresh SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0517_08655ac6-b74b-15c9-e063-6394a90a3665	65692-0517	HUMAN OTC DRUG	Broad Spectrum SPF 30 Tropical Sunscreen		Broad Spectrum SPF 30 Tropical Sunscreen	LOTION	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.9; 2.25; 1.5; .75; 1.8	g/30mL; g/30mL; g/30mL; g/30mL; g/30mL			N	20241231
65692-0518_0863e133-c2e5-c44d-e063-6394a90aa783	65692-0518	HUMAN OTC DRUG	Broad Spectrum SPF 30 Sun Stick		Broad Spectrum SPF 30 Sun Stick	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.51; 1.28; .09; .43; 1.02	g/17g; g/17g; g/17g; g/17g; g/17g			N	20241231
65692-0519_08653319-1a87-3e26-e063-6394a90a97aa	65692-0519	HUMAN OTC DRUG	Broad Spectrum SPF 30 Tropical Sunscreen		Broad Spectrum SPF 30 Tropical Sunscreen	LOTION	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	1.32; 3.3; 2.2; 1.1; 2.64	g/44mL; g/44mL; g/44mL; g/44mL; g/44mL			N	20241231
65692-0520_0863632c-c1d3-aab8-e063-6394a90adc89	65692-0520	HUMAN OTC DRUG	Beeswax SPF 15 Broad Spectrum Lip Balm		Beeswax SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0521_0863a4d3-32a9-730f-e063-6394a90a43f2	65692-0521	HUMAN OTC DRUG	Blackberry Smoothie SPF 15 Broad Spectrum Lip Balm		Blackberry Smoothie SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0522_0863945d-2b5a-7bbe-e063-6294a90ae6a4	65692-0522	HUMAN OTC DRUG	Bubblegum SPF 15 Broad Spectrum Lip Balm		Bubblegum SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0523_0867b727-7fde-0080-e063-6394a90ad172	65692-0523	HUMAN OTC DRUG	Caribbean Breeze SPF 15 Broad Spectrum Lip Balm		Caribbean Breeze SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0524_080423a5-9564-828e-e063-6394a90aa422	65692-0524	HUMAN OTC DRUG	Cherry SPF 15 Broad Spectrum Lip Balm		Cherry SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0525_086580f8-6300-c786-e063-6294a90a2cc3	65692-0525	HUMAN OTC DRUG	Citrus SPF 15 Broad Spectrum Lip Balm		Citrus SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0526_08637d4a-db4a-02f8-e063-6394a90acbfb	65692-0526	HUMAN OTC DRUG	Coconut SPF 15 Broad Spectrum Lip Balm		Coconut SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0527_0863f67a-814c-401c-e063-6394a90ac9d4	65692-0527	HUMAN OTC DRUG	Cranberry Orange SPF 15 Broad Spectrum Lip Balm		Cranberry Orange SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0528_0867da12-c42e-d353-e063-6294a90ae2af	65692-0528	HUMAN OTC DRUG	Iced Pear SPF 15 Broad Spectrum Lip Balm		Iced Pear SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0529_086810e8-468b-f9d2-e063-6394a90a583b	65692-0529	HUMAN OTC DRUG	Lemonade SPF 15 Broad Spectrum Lip Balm		Lemonade SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0530_08688808-a73a-f955-e063-6394a90a4f42	65692-0530	HUMAN OTC DRUG	Orange Creamsicle SPF 15 Broad Spectrum Lip Balm		Orange Creamsicle SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0531_080471ff-075a-bac1-e063-6294a90a33e2	65692-0531	HUMAN OTC DRUG	Peppermint SPF 15 Broad Spectrum Lip Balm		Peppermint SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0532_0804658c-3a0e-4213-e063-6394a90ab25c	65692-0532	HUMAN OTC DRUG	Pomegranate SPF 15 Broad Spectrum Lip Balm		Pomegranate SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0533_080468d8-d76b-42a9-e063-6394a90a5353	65692-0533	HUMAN OTC DRUG	Raspberry SPF 15 Broad Spectrum Lip Balm		Raspberry SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0534_080400f1-4cdc-30ff-e063-6294a90aa19a	65692-0534	HUMAN OTC DRUG	Spearmint SPF 15 Broad Spectrum Lip Balm		Spearmint SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0535_08682393-4d74-fd5e-e063-6294a90a5bae	65692-0535	HUMAN OTC DRUG	Strawberry SPF 15 Broad Spectrum Lip Balm		Strawberry SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0536_0804636f-d98d-8566-e063-6294a90a1a4e	65692-0536	HUMAN OTC DRUG	Tropical SPF 15 Broad Spectrum Lip Balm		Tropical SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0537_0804236d-9497-cb3d-e063-6294a90ae431	65692-0537	HUMAN OTC DRUG	Vanilla Mint SPF 15 Broad Spectrum Lip Balm		Vanilla Mint SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0538_080468d8-d769-42a9-e063-6394a90a5353	65692-0538	HUMAN OTC DRUG	Vanilla SPF 15 Broad Spectrum Lip Balm		Vanilla SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0539_08041bb3-a007-a234-e063-6294a90a5e48	65692-0539	HUMAN OTC DRUG	Watermelon Twist SPF 15 Broad Spectrum Lip Balm		Watermelon Twist SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0540_0804377a-ee45-a589-e063-6394a90a1044	65692-0540	HUMAN OTC DRUG	Wildberry SPF 15 Broad Spectrum Lip Balm		Wildberry SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0542_0864fad7-3c06-8e7a-e063-6294a90a4c05	65692-0542	HUMAN OTC DRUG	Super Mint SPF 15 Broad Spectrum Lip Balm		Super Mint SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0543_08a17e39-feb0-3976-e063-6294a90ae8ca	65692-0543	HUMAN OTC DRUG	Beeswax SPF 30 Broad Spectrum Lip Balm		Beeswax SPF 30 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.13; .32; .21; .11; .26	g/4.25g; g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0552_08037ad4-2b4a-2824-e063-6294a90ac6da	65692-0552	HUMAN OTC DRUG	Tropical Mint Broad Spectrum SPF 15 Lip Moisturizer		Tropical Mint SPF 15 Broad Spectrum Lip Moisturizer	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE	.09; .32	g/4.25g; g/4.25g			N	20241231
65692-0553_08037c8d-ab26-5308-e063-6394a90abd8d	65692-0553	HUMAN OTC DRUG	Vanilla Mint Broad Spectrum SPF 15 Lip Moisturizer		Vanilla Mint SPF 15 Broad Spectrum Lip Moisturizer	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE	.09; .32	g/4.25g; g/4.25g			N	20241231
65692-0554_08038c96-0e8d-3c3a-e063-6294a90a96c7	65692-0554	HUMAN OTC DRUG	Mint Broad Spectrum SPF 15 Lip Moisturizer		Mint SPF 15 Broad Spectrum Lip Moisturizer	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE	.09; .32	g/4.25g; g/4.25g			N	20241231
65692-0556_08654a71-51cd-1591-e063-6394a90ab5e4	65692-0556	HUMAN OTC DRUG	Spearmint SPF 30 Broad Spectrum Lip Balm		Spearmint SPF 30 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.13; .32; .21; .11; .26	g/4.25g; g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0557_08659a5c-2d11-2f98-e063-6394a90a7760	65692-0557	HUMAN OTC DRUG	Vanilla SPF 30 Broad Spectrum Lip Balm		Vanilla SPF 30 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.13; .32; .21; .11; .26	g/4.25g; g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0558_0865929f-e8c8-3f68-e063-6294a90ac71c	65692-0558	HUMAN OTC DRUG	Coconut Mineral SPF 15 Broad Spectrum Lip Balm		Coconut Mineral SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	ZINC OXIDE	.34	g/4.25g			N	20241231
65692-0559_0865be75-8588-825b-e063-6394a90a5d6b	65692-0559	HUMAN OTC DRUG	Pineapple Mineral SPF 15 Broad Spectrum Lip Balm		Pineapple Mineral SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	ZINC OXIDE	.34	g/4.25g			N	20241231
65692-0560_08658f86-fcf1-ebea-e063-6294a90ac8ef	65692-0560	HUMAN OTC DRUG	Broad Spectrum SPF 15 Vanilla Mint Lip Balm		Broad Spectrum SPF 15 Vanilla Mint Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0561_080131f9-1466-4156-e063-6394a90a734a	65692-0561	HUMAN OTC DRUG	Key Lime Pie Shake SPF 15 Broad Spectrum Lip Balm		Key Lime Pie Shake SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0562_080111cc-feba-e557-e063-6294a90a73cf	65692-0562	HUMAN OTC DRUG	Raspberry Lime Margarita SPF 15 Broad Spectrum Lip Balm		Raspberry Lime Margarita SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0563_08010b5e-854e-096b-e063-6294a90ad443	65692-0563	HUMAN OTC DRUG	Strawberry Limoncello SPF 15 Broad Spectrum Lip Balm		Strawberry Limoncello SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0564_080135a9-99a3-6681-e063-6394a90acf2b	65692-0564	HUMAN OTC DRUG	Summer Sangria SPF 15 Broad Spectrum Lip Balm		Summer Sangria SPF 15 Broad Spectrum Lip Balm	STICK	TOPICAL	20200217		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0565_08014998-0793-5edd-e063-6294a90af738	65692-0565	HUMAN OTC DRUG	Broad Spectrum SPF 30 Mineral Sun Stick		Broad Spectrum SPF 30 Mineral Sun Stick	STICK	TOPICAL	20210512		OTC MONOGRAPH DRUG	M020	Raining Rose	ZINC OXIDE	3.06	g/17g			N	20241231
65692-0566_08037ad4-2b3e-2824-e063-6294a90ac6da	65692-0566	HUMAN OTC DRUG	Broad Spectrum SPF 30 Sunscreen		Broad Spectrum SPF 30 Sunscreen	LOTION	TOPICAL	20210513		OTC MONOGRAPH DRUG	M020	Raining Rose	ZINC OXIDE	8.25	g/44mL			N	20241231
65692-0567_08015c8a-a20e-b088-e063-6394a90a48dc	65692-0567	HUMAN OTC DRUG	Broad Spectrum SPF 30 Sunscreen		Broad Spectrum SPF 30 Sunscreen	LOTION	TOPICAL	20210513		OTC MONOGRAPH DRUG	M020	Raining Rose	ZINC OXIDE	5.625	g/30mL			N	20241231
65692-0568_08037c4e-4e9a-315b-e063-6394a90aaba8	65692-0568	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Cherry Lip Balm		Broad Spectrum SPF 15 Sunscreen Cherry Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0569_08a4a74e-6f19-de1c-e063-6394a90a56a2	65692-0569	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Citrus Lip Balm		Broad Spectrum SPF 15 Sunscreen Citrus Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0570_08a4bd0b-2c70-9b15-e063-6294a90a1552	65692-0570	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Iced Pear Lip Balm		Broad Spectrum SPF 15 Sunscreen Iced Pear Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0571_08a48426-8790-5d99-e063-6394a90a505c	65692-0571	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Mint Lip Balm		Broad Spectrum SPF 15 Sunscreen Mint Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0572_08a496a0-120a-10e2-e063-6294a90a6ea3	65692-0572	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Tropical Smoothie Lip Balm		Broad Spectrum SPF 15 Sunscreen Tropical Smoothie Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0573_08a48083-e5fa-5bd7-e063-6394a90a0daa	65692-0573	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Unflavored Lip Balm		Broad Spectrum SPF 15 Sunscreen Unflavored Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0574_0800aacb-0983-b266-e063-6294a90a9ab2	65692-0574	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Vanilla Mint Lip Balm		Broad Spectrum SPF 15 Sunscreen Vanilla Mint Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-0575_07f09e4d-42e8-0e3a-e063-6294a90a9723	65692-0575	HUMAN OTC DRUG	Broad Spectrum SPF 15 Sunscreen Vanilla Lip Balm		Broad Spectrum SPF 15 Sunscreen Vanilla Lip Balm	STICK	TOPICAL	20221213		OTC MONOGRAPH DRUG	M020	Raining Rose	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.13; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
65692-1002_788f7d8a-9d03-4919-bb43-2bec3b875b44	65692-1002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161116		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc.	ALCOHOL	65	mL/100mL			N	20241231
65692-1003_43aaebc2-c295-4689-e054-00144ff88e88	65692-1003	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161215		OTC MONOGRAPH NOT FINAL	part333E	Raining Rose, Inc.	ALCOHOL	62	mL/100mL			N	20241231
65692-1006_cf03a049-0945-478c-95cb-da1f2c878807	65692-1006	HUMAN OTC DRUG	Bullet Line		Lip Balm SPF 15	STICK	TOPICAL	20200218		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	mg/g; mg/g; mg/g; mg/g			N	20241231
65692-1007_cf03a049-0945-478c-95cb-da1f2c878807	65692-1007	HUMAN OTC DRUG	Bullet Line		Lip Balm SPF 15	STICK	TOPICAL	20200218		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	mg/g; mg/g; mg/g; mg/g			N	20241231
65692-1008_cf03a049-0945-478c-95cb-da1f2c878807	65692-1008	HUMAN OTC DRUG	Bullet Line		Lip Balm SPF 15	STICK	TOPICAL	20200218		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	mg/g; mg/g; mg/g; mg/g			N	20241231
65692-1009_cf03a049-0945-478c-95cb-da1f2c878807	65692-1009	HUMAN OTC DRUG	Bullet Line		Lip Balm SPF 15	STICK	TOPICAL	20200218		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	mg/g; mg/g; mg/g; mg/g			N	20241231
65692-1010_cf03a049-0945-478c-95cb-da1f2c878807	65692-1010	HUMAN OTC DRUG	Bullet Line		Lip Balm SPF 15	STICK	TOPICAL	20200218		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	mg/g; mg/g; mg/g; mg/g			N	20241231
65692-1011_cf03a049-0945-478c-95cb-da1f2c878807	65692-1011	HUMAN OTC DRUG	Bullet Line		Lip Balm SPF 15	STICK	TOPICAL	20200218		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	mg/g; mg/g; mg/g; mg/g			N	20241231
65692-1012_cf03a049-0945-478c-95cb-da1f2c878807	65692-1012	HUMAN OTC DRUG	Bullet Line		Lip Balm SPF 15	STICK	TOPICAL	20200218		OTC MONOGRAPH DRUG	M020	Raining Rose, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	mg/g; mg/g; mg/g; mg/g			N	20241231
65692-2053_09949ed0-a66e-d2a8-e063-6294a90ad86a	65692-2053	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	62	mL/100mL			N	20241231
65692-2054_09949b46-d0a0-b7b8-e063-6394a90a2b54	65692-2054	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	62	mL/100mL			N	20241231
65692-2055_0993e833-a142-7485-e063-6394a90a73ac	65692-2055	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	65	mL/100mL			N	20241231
65692-2056_099496f1-4e2c-8d21-e063-6294a90af695	65692-2056	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	65	mL/100mL			N	20241231
65692-2058_09a75e2f-139d-0e63-e063-6394a90a8a1d	65692-2058	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	64	mL/100mL			N	20241231
65692-2060_09a75e2f-139e-0e63-e063-6394a90a8a1d	65692-2060	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	64	mL/100mL			N	20241231
65692-2061_09a769d2-ccda-a476-e063-6294a90a647a	65692-2061	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	62	mL/100mL			N	20241231
65692-2062_09a7738c-4c95-11cc-e063-6394a90ae25e	65692-2062	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Raining Rose, Inc	ALCOHOL	64	mL/100mL			N	20241231
65692-2073_09a78453-8621-afed-e063-6294a90add8f	65692-2073	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20220310		OTC MONOGRAPH DRUG	M003	Raining Rose	ALCOHOL	64	mL/100mL			N	20241231
65692-2074_0b6406fc-0029-0897-e063-6394a90adfb8	65692-2074	HUMAN OTC DRUG	Unscented Hand Sanitizer		Alcohol	GEL	TOPICAL	20230301		OTC MONOGRAPH DRUG	505G(a)(3)	Raining Rose	ALCOHOL	60	mL/100mL			N	20241231
65692-2075_0b642bd3-ef1f-c69d-e063-6294a90a1dd2	65692-2075	HUMAN OTC DRUG	Unscented Hand Sanitizer		Alcohol	GEL	TOPICAL	20230301		OTC MONOGRAPH DRUG	505G(a)(3)	Raining Rose	ALCOHOL	60	mL/100mL			N	20241231
65692-2076_0b643cdb-a4f0-1f9b-e063-6394a90acf70	65692-2076	HUMAN OTC DRUG	Unscented Hand Sanitizer		Alcohol	GEL	TOPICAL	20230301		OTC MONOGRAPH DRUG	505G(a)(3)	Raining Rose	ALCOHOL	60	mL/100mL			N	20241231
65692-2077_0b644f83-9f73-d48d-e063-6294a90a3868	65692-2077	HUMAN OTC DRUG	Unscented Hand Sanitizer		Alcohol	GEL	TOPICAL	20230301		OTC MONOGRAPH DRUG	505G(a)(3)	Raining Rose	ALCOHOL	70	mL/100mL			N	20241231
65692-2078_0b64683c-2ba3-f4ef-e063-6294a90a40cd	65692-2078	HUMAN OTC DRUG	Unscented Hand Sanitizer		Alcohol	GEL	TOPICAL	20230301		OTC MONOGRAPH DRUG	505G(a)(3)	Raining Rose	ALCOHOL	70	mL/100mL			N	20241231
65707-002_0cf3bc88-3e83-84fe-e063-6294a90a085e	65707-002	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20180614		NDA	NDA207166	Reliant Holdings, Ltd	CARBON DIOXIDE	990	mL/L	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
65734-504_f1f09ca2-53e6-60e7-e053-2995a90aa2e3	65734-504	HUMAN OTC DRUG	Dr. Piercing Aftercare		Benzalkonium Chloride	SWAB	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Swabplus, L.P.	BENZALKONIUM CHLORIDE	1.1	mg/mL			N	20241231
65753-101_0847f22b-ece4-e4c1-e063-6394a90a4d62	65753-101	HUMAN OTC DRUG	CoreTex Sun X SPF 30 Thin		Avobenzone, Homosalate, Octinoxate, Octisalate, Oxybenzone	LIQUID	TOPICAL	20181122		OTC MONOGRAPH DRUG	M020	CoreTex Products Inc	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1; 5; 7.5; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
65753-108_0a949f6f-d5f5-8eb2-e063-6394a90aa6a5	65753-108	HUMAN OTC DRUG	Sun X SPF 50 Broad Spectrum Sunscreen Lip Balm		Avobenzone, Homosalate, Octinoxate, Octisalate, Petrolatum	LIPSTICK	TOPICAL	20170101		OTC MONOGRAPH DRUG	M020	CoreTex Products, INC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; PETROLATUM	3; 3; 7.5; 5; 40	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
65753-109_084870bb-b526-c6af-e063-6394a90a1609	65753-109	HUMAN OTC DRUG	CoreTex Sun X SPF 30 Multipack New		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230108		OTC MONOGRAPH DRUG	M020	CoreTex Products	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
65753-110_08fb1bbf-f361-29da-e063-6394a90aa397	65753-110	HUMAN OTC DRUG	CoreTex Sun X SPF 30 New		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210107		OTC MONOGRAPH DRUG	M020	CoreTex Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
65753-350_0847d369-49c2-6807-e063-6294a90afc84	65753-350	HUMAN OTC DRUG	StingX		benzocaine	SWAB	TOPICAL	20191125		OTC MONOGRAPH DRUG	M017	CoreTex Products Inc	BENZOCAINE	6	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
65753-400_0a949b94-bdc0-ba2c-e063-6294a90aa930	65753-400	HUMAN OTC DRUG	CoreTex Anti-Itch Gel		camphor, diphenhydramine, zinc acetate	GEL	TOPICAL	20191125		OTC MONOGRAPH DRUG	M017	CoreTex Products Inc	CAMPHOR (SYNTHETIC); DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	.1; 2; 1	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
65753-504_ee065ea3-580a-2105-e053-2a95a90a700f	65753-504	HUMAN OTC DRUG	CoreTex Professional Outdoor Skin Protection Wallet		CoreTex Professional Outdoor Skin Protection Wallet	KIT		20191127		UNAPPROVED DRUG OTHER		CoreTex Products Inc						N	20241231
65753-510_0846ac97-10d9-cc56-e063-6394a90aa6f3	65753-510	HUMAN OTC DRUG	SunX SPF 30/BugX Wallmount		SunX SPF 30/BugX Wallmount	KIT		20231011		UNAPPROVED DRUG OTHER		CoreTex Products Inc						N	20241231
65753-511_0847d369-49f0-6807-e063-6294a90afc84	65753-511	HUMAN OTC DRUG	SunX SPF 30/BugX Wallmount		SunX SPF 30/BugX Wallmount	KIT		20231011		UNAPPROVED DRUG OTHER		CoreTex Products Inc						N	20241231
65753-513_0a95175a-369d-bd37-e063-6394a90a2ca7	65753-513	HUMAN OTC DRUG	CoreTex Professional Outdoor Skin Protection Wallet Refill		CoreTex Professional Outdoor Skin Protection Wallet Refill	KIT		20230224		OTC MONOGRAPH DRUG	M020	CoreTex Products Inc						N	20241231
65753-514_f57bc055-4f01-783b-e053-2a95a90a07b9	65753-514	HUMAN OTC DRUG	CoreTex Professional Outdoor Skin Protection Wallet		CoreTex Professional Outdoor Skin Protection Wallet	KIT		20230224		OTC MONOGRAPH DRUG	M020	CoreTex Products Inc						N	20241231
65753-515_0958059a-66de-da55-e063-6294a90ad449	65753-515	HUMAN OTC DRUG	CoreTex Professional Outdoor Skin Protection Wallet Refill		CoreTex Professional Outdoor Skin Protection Wallet Refill	KIT		20230224		OTC MONOGRAPH DRUG	M020	CoreTex Products Inc						N	20241231
65753-602_071317c9-19a3-71a7-e063-6394a90a58f2	65753-602	HUMAN OTC DRUG	CorTex SunX 50 Thick		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230309		OTC MONOGRAPH DRUG	M020	CoreTex Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
65753-603_0a949f6f-d5f8-8eb2-e063-6394a90aa6a5	65753-603	HUMAN OTC DRUG	CoreTex Sun X 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230103		OTC MONOGRAPH DRUG	M020	CoreTex Products Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
65757-300_7e88c2c9-c3a9-4d25-b780-2b8aa1c66a00	65757-300	HUMAN PRESCRIPTION DRUG	VIVITROL		naltrexone	KIT		20060613		NDA	NDA021897	Alkermes, Inc.						N	20241231
65757-301_7e88c2c9-c3a9-4d25-b780-2b8aa1c66a00	65757-301	HUMAN PRESCRIPTION DRUG	VIVITROL		naltrexone	KIT		20060613		NDA	NDA021897	Alkermes, Inc.						N	20241231
65757-401_d7e63a3f-06f0-41fd-a4db-8c0646fda89a	65757-401	HUMAN PRESCRIPTION DRUG	ARISTADA		aripiprazole lauroxil	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20151005		NDA	NDA207533	Alkermes, Inc.	ARIPIPRAZOLE LAUROXIL	441	mg/1.6mL			N	20241231
65757-402_d7e63a3f-06f0-41fd-a4db-8c0646fda89a	65757-402	HUMAN PRESCRIPTION DRUG	ARISTADA		aripiprazole lauroxil	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20151005		NDA	NDA207533	Alkermes, Inc.	ARIPIPRAZOLE LAUROXIL	662	mg/2.4mL			N	20241231
65757-403_d7e63a3f-06f0-41fd-a4db-8c0646fda89a	65757-403	HUMAN PRESCRIPTION DRUG	ARISTADA		aripiprazole lauroxil	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20151005		NDA	NDA207533	Alkermes, Inc.	ARIPIPRAZOLE LAUROXIL	882	mg/3.2mL			N	20241231
65757-404_d7e63a3f-06f0-41fd-a4db-8c0646fda89a	65757-404	HUMAN PRESCRIPTION DRUG	ARISTADA		aripiprazole lauroxil	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20170605		NDA	NDA207533	Alkermes, Inc.	ARIPIPRAZOLE LAUROXIL	1064	mg/3.9mL			N	20241231
65757-500_64c04e28-0c78-42d4-af87-6c45ab6fbb46	65757-500	HUMAN PRESCRIPTION DRUG	ARISTADA INITIO		aripiprazole lauroxil	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20180629		NDA	NDA209830	Alkermes, Inc.	ARIPIPRAZOLE LAUROXIL	675	mg/2.4mL			N	20241231
65757-651_f4ad4266-1f28-451a-bfb0-a31e7d746f6b	65757-651	HUMAN PRESCRIPTION DRUG	LYBALVI		olanzapine and samidorphan L-malate	TABLET, FILM COATED	ORAL	20210920		NDA	NDA213378	Alkermes, Inc.	OLANZAPINE; SAMIDORPHAN L-MALATE	5; 10	mg/1; mg/1	Atypical Antipsychotic [EPC], Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
65757-652_f4ad4266-1f28-451a-bfb0-a31e7d746f6b	65757-652	HUMAN PRESCRIPTION DRUG	LYBALVI		olanzapine and samidorphan L-malate	TABLET, FILM COATED	ORAL	20210920		NDA	NDA213378	Alkermes, Inc.	OLANZAPINE; SAMIDORPHAN L-MALATE	10; 10	mg/1; mg/1	Atypical Antipsychotic [EPC], Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
65757-653_f4ad4266-1f28-451a-bfb0-a31e7d746f6b	65757-653	HUMAN PRESCRIPTION DRUG	LYBALVI		olanzapine and samidorphan L-malate	TABLET, FILM COATED	ORAL	20210920		NDA	NDA213378	Alkermes, Inc.	OLANZAPINE; SAMIDORPHAN L-MALATE	15; 10	mg/1; mg/1	Atypical Antipsychotic [EPC], Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
65757-654_f4ad4266-1f28-451a-bfb0-a31e7d746f6b	65757-654	HUMAN PRESCRIPTION DRUG	LYBALVI		olanzapine and samidorphan L-malate	TABLET, FILM COATED	ORAL	20210920		NDA	NDA213378	Alkermes, Inc.	OLANZAPINE; SAMIDORPHAN L-MALATE	20; 10	mg/1; mg/1	Atypical Antipsychotic [EPC], Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
65785-034_06a7aecc-d271-40f4-e063-6294a90a702e	65785-034	HUMAN OTC DRUG	Eyewash Station Additive Concentrate		Chlorhexidine gluconate and Propylene Glycol	LIQUID	OPHTHALMIC	20111115		OTC MONOGRAPH DRUG	M018	Niagara Pharmaceuticals Inc.	CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL	145.6; 280	kg/2800L; kg/2800L	Decreased Cell Wall Integrity [PE]		N	20241231
65785-160_777d386d-df5a-9369-e053-2a91aa0a0ea9	65785-160	HUMAN OTC DRUG	PUR-WASH		Water	SOLUTION	OPHTHALMIC	20110912		NDA	NDA022305	Niagara Pharmaceuticals Inc.	WATER	929	g/946mL			N	20241231
65785-162_777e1559-7870-8d54-e053-2991aa0aa98d	65785-162	HUMAN OTC DRUG	PUR-WASH		Water	SOLUTION	OPHTHALMIC	20110912		NDA	NDA022305	Niagara Pharmaceuticals Inc.	WATER	929	g/946mL			N	20241231
65785-164_777cde52-c3f4-4140-e053-2991aa0ac858	65785-164	HUMAN OTC DRUG	PUR-WASH		Water	SOLUTION	OPHTHALMIC	20110912		NDA	NDA022305	Niagara Pharmaceuticals Inc.	WATER	929	g/946mL			N	20241231
65785-166_777d4aa0-8bc7-7786-e053-2a91aa0a66cf	65785-166	HUMAN OTC DRUG	PUR-WASH		Water	SOLUTION	OPHTHALMIC	20130524		NDA	NDA022305	Niagara Pharmaceuticals Inc.	WATER	929	g/946mL			N	20241231
65785-168_f68dfd2b-34e9-ad12-e053-2a95a90a54f4	65785-168	HUMAN OTC DRUG	Pur-Wash		Eyewash	SOLUTION	OPHTHALMIC	20150130		NDA	NDA022305	Niagara Pharmaceuticals, Inc.	WATER	465	mL/473mL			N	20241231
65785-169_bed9635f-79f8-9503-e053-2a95a90a013e	65785-169	HUMAN OTC DRUG	PUR-WASH		Water	SOLUTION	OPHTHALMIC	20110912		NDA	NDA022305	Niagara Pharmaceuticals Inc.	WATER	929	g/946mL			N	20241231
65808-318_b79d513b-e854-799c-e053-2995a90aa022	65808-318	HUMAN OTC DRUG	Real Relief		Allium cepa, Aralia racemosa, Arsenicum album, Cuprum metallicum, Euphrasia officinalis, Nux vomica, Sabadilla, Sticta pulmonaria	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		GMP Laboratories of America, Inc.	ARALIA RACEMOSA ROOT; ARSENIC TRIOXIDE; COPPER; EUPHRASIA STRICTA; LOBARIA PULMONARIA; ONION; SCHOENOCAULON OFFICINALE SEED; STRYCHNOS NUX-VOMICA SEED	8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
65808-320_b79f7319-1ec2-77f5-e053-2a95a90a5a81	65808-320	HUMAN OTC DRUG	Real Relief		Eriodictyon californicum, Histaminum, Ipecacuanha, Lobelia inflata, Sambucus nigra, Solidago virgaurea	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		GMP Laboratories of America, Inc.	ERIODICTYON CALIFORNICUM LEAF; HISTAMINE DIHYDROCHLORIDE; IPECAC; LOBELIA INFLATA; SAMBUCUS NIGRA FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP	8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
65808-322_b7a03493-0510-2bd7-e053-2a95a90a16e8	65808-322	HUMAN OTC DRUG	Real Relief		Chamomila, Coffea Cruda, Eriodictyon californicum, Histaminum, Ipecacuanha, Lobelia inflata, Sambucus nigra, Solidago virgaurea	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		GMP Laboratories of America, Inc.	ARABICA COFFEE BEAN; ERIODICTYON CALIFORNICUM LEAF; HISTAMINE DIHYDROCHLORIDE; IPECAC; LOBELIA INFLATA; MATRICARIA CHAMOMILLA; SAMBUCUS NIGRA FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP	8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
65808-324_b7a1ce34-a98c-22cf-e053-2a95a90afa45	65808-324	HUMAN OTC DRUG	Real Relief		Apis Mellifica, Arnica Montana, Benzoicum Acidum, Causticum, Colchicum Autumnale, Natrum Carbonicum	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		GMP Laboratories of America, Inc.	APIS MELLIFERA; ARNICA MONTANA; BENZOIC ACID; CAUSTICUM; COLCHICUM AUTUMNALE BULB; SODIUM CARBONATE	8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
65808-326_b7a21773-caf1-2960-e053-2995a90ada31	65808-326	HUMAN OTC DRUG	Real Relief		Arnica montana, Bryonia, Causticum, Cinchona officinalis, Dulcamara, Hydrastis canadensis, Kali bromatum, Sulphur	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		GMP Laboratories of America, Inc.	ARNICA MONTANA; BRYONIA ALBA ROOT; CAUSTICUM; CINCHONA OFFICINALIS BARK; GOLDENSEAL; POTASSIUM BROMIDE; SOLANUM DULCAMARA TOP; SULFUR	8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
65841-022_dcaaa30b-389f-4409-8c25-8e1b9a1e76cc	65841-022	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	Zydus Lifesciences Limited	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65841-023_dcaaa30b-389f-4409-8c25-8e1b9a1e76cc	65841-023	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	Zydus Lifesciences Limited	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65841-024_dcaaa30b-389f-4409-8c25-8e1b9a1e76cc	65841-024	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	Zydus Lifesciences Limited	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65841-027_98157d0e-cac3-45cb-9726-e8d005a48126	65841-027	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20050928		ANDA	ANDA077060	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-028_e88724a2-0bd6-435c-bc66-f7d05d85d667	65841-028	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20050928		ANDA	ANDA077064	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-029_e88724a2-0bd6-435c-bc66-f7d05d85d667	65841-029	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20050928		ANDA	ANDA077064	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-030_e88724a2-0bd6-435c-bc66-f7d05d85d667	65841-030	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20050928		ANDA	ANDA077064	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-039_98157d0e-cac3-45cb-9726-e8d005a48126	65841-039	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20050928		ANDA	ANDA077078	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-040_2c372214-b5cc-4ca3-8074-ee205ff0f7f5	65841-040	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Zydus Lifesciences Limited	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
65841-041_2c372214-b5cc-4ca3-8074-ee205ff0f7f5	65841-041	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Zydus Lifesciences Limited	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
65841-042_2c372214-b5cc-4ca3-8074-ee205ff0f7f5	65841-042	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Zydus Lifesciences Limited	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
65841-043_30bf47f5-36c5-4518-bcff-6087f6126363	65841-043	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20171202		ANDA	ANDA077106	Zydus Lifesciences Limited	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65841-044_30bf47f5-36c5-4518-bcff-6087f6126363	65841-044	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20171202		ANDA	ANDA077106	Zydus Lifesciences Limited	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65841-045_30bf47f5-36c5-4518-bcff-6087f6126363	65841-045	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20171202		ANDA	ANDA077106	Zydus Lifesciences Limited	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65841-046_79cb2dd5-bbd1-413f-b61a-9bfff2a3baeb	65841-046	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Lifesciences Limited	RIBAVIRIN	200	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65841-050_e2e7eb0f-7da0-45cd-93d8-d49ea6756d73	65841-050	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Zydus Lifesciences Limited	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-051_e2e7eb0f-7da0-45cd-93d8-d49ea6756d73	65841-051	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Zydus Lifesciences Limited	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-052_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-052	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-053_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-053	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-054_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-054	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-055_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-055	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-056_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-056	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-057_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-057	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-058_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-058	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-059_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-059	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-064_754f4ec0-142a-4c10-87f8-595a73996d3d	65841-064	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Lifesciences Limited	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
65841-065_f6a1f948-fffb-40ff-a5fc-e6767c93957d	65841-065	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Lifesciences Limited	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-066_f6a1f948-fffb-40ff-a5fc-e6767c93957d	65841-066	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Lifesciences Limited	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-067_f6a1f948-fffb-40ff-a5fc-e6767c93957d	65841-067	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Lifesciences Limited	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-068_f6a1f948-fffb-40ff-a5fc-e6767c93957d	65841-068	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Lifesciences Limited	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-069_f6a1f948-fffb-40ff-a5fc-e6767c93957d	65841-069	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Lifesciences Limited	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-097_50512e7e-5a95-42a1-acf9-9db1328739b6	65841-097	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Lifesciences Limited	PAROXETINE HYDROCHLORIDE ANHYDROUS	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65841-098_50512e7e-5a95-42a1-acf9-9db1328739b6	65841-098	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Lifesciences Limited	PAROXETINE HYDROCHLORIDE ANHYDROUS	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65841-099_50512e7e-5a95-42a1-acf9-9db1328739b6	65841-099	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Lifesciences Limited	PAROXETINE HYDROCHLORIDE ANHYDROUS	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65841-129_79cb2dd5-bbd1-413f-b61a-9bfff2a3baeb	65841-129	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Lifesciences Limited	RIBAVIRIN	600	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65841-260_81e414f0-8bbc-4bfa-98a6-067f2bd0c1ab	65841-260	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	CAPSULE	ORAL	20060125		ANDA	ANDA077224	Zydus Lifesciences Limited	RIBAVIRIN	200	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65841-536_042721ed-7f5d-47f1-beff-b54ba88bcd27	65841-536	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140812		ANDA	ANDA203546	Zydus Lifesciences Limited	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
65841-537_042721ed-7f5d-47f1-beff-b54ba88bcd27	65841-537	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140812		ANDA	ANDA203546	Zydus Lifesciences Limited	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
65841-538_042721ed-7f5d-47f1-beff-b54ba88bcd27	65841-538	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140812		ANDA	ANDA203546	Zydus Lifesciences Limited	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
65841-601_50512e7e-5a95-42a1-acf9-9db1328739b6	65841-601	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Lifesciences Limited	PAROXETINE HYDROCHLORIDE ANHYDROUS	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65841-602_f730402e-7d5f-4694-8172-1c45ae0b9a6e	65841-602	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20070711		ANDA	ANDA077621	Zydus Lifesciences Limited	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
65841-603_79cb2dd5-bbd1-413f-b61a-9bfff2a3baeb	65841-603	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Lifesciences Limited	RIBAVIRIN	400	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65841-605_6a2901c3-b5aa-4276-ac1c-e60251d01028	65841-605	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20230405		ANDA	ANDA079017	Zydus Lifesciences Limited	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-606_6a2901c3-b5aa-4276-ac1c-e60251d01028	65841-606	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20171206		ANDA	ANDA079017	Zydus Lifesciences Limited	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-607_6a2901c3-b5aa-4276-ac1c-e60251d01028	65841-607	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20171206		ANDA	ANDA079017	Zydus Lifesciences Limited	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-608_6a2901c3-b5aa-4276-ac1c-e60251d01028	65841-608	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20171206		ANDA	ANDA079017	Zydus Lifesciences Limited	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-609_6a2901c3-b5aa-4276-ac1c-e60251d01028	65841-609	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20171206		ANDA	ANDA079017	Zydus Lifesciences Limited	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-610_6a2901c3-b5aa-4276-ac1c-e60251d01028	65841-610	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20171206		ANDA	ANDA079017	Zydus Lifesciences Limited	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-611_6a2901c3-b5aa-4276-ac1c-e60251d01028	65841-611	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20171206		ANDA	ANDA079017	Zydus Lifesciences Limited	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-614_ae2b2fa5-2b6d-4f86-97a0-28ff5d22e73c	65841-614	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070904		ANDA	ANDA040597	Zydus Lifesciences Limited	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
65841-616_638b3163-8c52-41aa-a28a-5db01a98fe7c	65841-616	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Lifesciences Limited	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65841-617_638b3163-8c52-41aa-a28a-5db01a98fe7c	65841-617	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Lifesciences Limited	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65841-618_638b3163-8c52-41aa-a28a-5db01a98fe7c	65841-618	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Lifesciences Limited	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65841-619_638b3163-8c52-41aa-a28a-5db01a98fe7c	65841-619	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Lifesciences Limited	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65841-620_65386722-5517-413e-9b56-63463a0f2980	65841-620	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070921		ANDA	ANDA078226	Zydus Lifesciences Limited	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65841-621_65386722-5517-413e-9b56-63463a0f2980	65841-621	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070921		ANDA	ANDA078226	Zydus Lifesciences Limited	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65841-622_65386722-5517-413e-9b56-63463a0f2980	65841-622	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070921		ANDA	ANDA078226	Zydus Lifesciences Limited	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65841-626_da9a9ec9-21e2-4633-873a-19e4b5c25ccc	65841-626	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Zydus Lifesciences Limited	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
65841-627_da9a9ec9-21e2-4633-873a-19e4b5c25ccc	65841-627	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Zydus Lifesciences Limited	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
65841-628_da9a9ec9-21e2-4633-873a-19e4b5c25ccc	65841-628	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Zydus Lifesciences Limited	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
65841-629_aa80b623-2abf-418e-bded-79666b225353	65841-629	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20180405		ANDA	ANDA079137	Zydus Lifesciences Limited	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65841-630_aa80b623-2abf-418e-bded-79666b225353	65841-630	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20180405		ANDA	ANDA079137	Zydus Lifesciences Limited	VALACYCLOVIR HYDROCHLORIDE	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65841-631_9efa81cc-3f65-4cb9-8fe0-cafbb1bf7fb6	65841-631	HUMAN PRESCRIPTION DRUG	Amiodarone hydrochloride		Amiodarone hydrochloride	TABLET	ORAL	20090810		ANDA	ANDA079029	Zydus Lifesciences Limited	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65841-632_79cb2dd5-bbd1-413f-b61a-9bfff2a3baeb	65841-632	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Lifesciences Limited	RIBAVIRIN	500	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65841-633_7b597988-ff58-4dde-94bd-53ecd0d9eec0	65841-633	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	Zydus Lifesciences Limited	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
65841-634_002bd53e-88c1-441b-acfb-09128b26adc8	65841-634	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20100306		ANDA	ANDA077100	Zydus Lifesciences Limited	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65841-635_002bd53e-88c1-441b-acfb-09128b26adc8	65841-635	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20100306		ANDA	ANDA077100	Zydus Lifesciences Limited	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65841-636_002bd53e-88c1-441b-acfb-09128b26adc8	65841-636	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20100306		ANDA	ANDA077100	Zydus Lifesciences Limited	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65841-637_d0431c44-92e9-4479-b41f-809ec0b171bf	65841-637	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130107		ANDA	ANDA078239	Zydus Lifesciences Limited	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65841-638_d0431c44-92e9-4479-b41f-809ec0b171bf	65841-638	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130107		ANDA	ANDA078239	Zydus Lifesciences Limited	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65841-639_4b6824bc-0244-4add-9e76-e8ae780c9cf2	65841-639	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	CAPSULE, COATED PELLETS	ORAL	20090127		ANDA	ANDA078919	Zydus Lifesciences Limited	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65841-640_43c2c43f-bcf8-446f-befe-fd01d1916f48	65841-640	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100629		ANDA	ANDA078516	Zydus Lifesciences Limited	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-641_43c2c43f-bcf8-446f-befe-fd01d1916f48	65841-641	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100629		ANDA	ANDA078516	Zydus Lifesciences Limited	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-642_43c2c43f-bcf8-446f-befe-fd01d1916f48	65841-642	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100629		ANDA	ANDA078516	Zydus Lifesciences Limited	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-647_8a989029-e6a6-4b52-a927-8007642f32e4	65841-647	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Lifesciences Limited	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-648_8a989029-e6a6-4b52-a927-8007642f32e4	65841-648	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Lifesciences Limited	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-649_8a989029-e6a6-4b52-a927-8007642f32e4	65841-649	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Lifesciences Limited	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-650_8a989029-e6a6-4b52-a927-8007642f32e4	65841-650	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Lifesciences Limited	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-651_8e90e7b9-efed-46d5-925b-4123ac9d6b37	65841-651	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	CAPSULE, COATED PELLETS	ORAL	20091014		ANDA	ANDA078877	Zydus Lifesciences Limited	TOPIRAMATE	15	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-652_8e90e7b9-efed-46d5-925b-4123ac9d6b37	65841-652	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	CAPSULE, COATED PELLETS	ORAL	20091014		ANDA	ANDA078877	Zydus Lifesciences Limited	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-654_7e314671-fe6e-4ad9-b25a-f6fe1ca2109f	65841-654	HUMAN PRESCRIPTION DRUG	Bromocriptine mesylate		Bromocriptine mesylate	CAPSULE	ORAL	20090123		ANDA	ANDA078899	Zydus Lifesciences Limited	BROMOCRIPTINE MESYLATE	5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
65841-655_e34be86c-b48f-480a-bb96-2ceb2824bdcb	65841-655	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Lifesciences Limited	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-656_e34be86c-b48f-480a-bb96-2ceb2824bdcb	65841-656	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Lifesciences Limited	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-657_e34be86c-b48f-480a-bb96-2ceb2824bdcb	65841-657	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Lifesciences Limited	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-658_e34be86c-b48f-480a-bb96-2ceb2824bdcb	65841-658	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Lifesciences Limited	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-659_d182433b-e6d4-4939-9905-b0960cfe0691	65841-659	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	Zydus Lifesciences Limited	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-660_d182433b-e6d4-4939-9905-b0960cfe0691	65841-660	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	Zydus Lifesciences Limited	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-661_d182433b-e6d4-4939-9905-b0960cfe0691	65841-661	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	Zydus Lifesciences Limited	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-662_11a26f51-90ef-479a-9c8f-7d9b429982c4	65841-662	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA040874	Zydus Lifesciences Limited	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
65841-663_11a26f51-90ef-479a-9c8f-7d9b429982c4	65841-663	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA040874	Zydus Lifesciences Limited	DIPYRIDAMOLE	50	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
65841-664_11a26f51-90ef-479a-9c8f-7d9b429982c4	65841-664	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA040874	Zydus Lifesciences Limited	DIPYRIDAMOLE	75	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
65841-665_d3434be8-0c2b-4d53-91de-5abbe0f4b009	65841-665	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Lifesciences Limited	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-666_d3434be8-0c2b-4d53-91de-5abbe0f4b009	65841-666	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Lifesciences Limited	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-667_d3434be8-0c2b-4d53-91de-5abbe0f4b009	65841-667	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Lifesciences Limited	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-668_d3434be8-0c2b-4d53-91de-5abbe0f4b009	65841-668	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Lifesciences Limited	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-669_d3434be8-0c2b-4d53-91de-5abbe0f4b009	65841-669	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081112		ANDA	ANDA078040	Zydus Lifesciences Limited	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-670_d3434be8-0c2b-4d53-91de-5abbe0f4b009	65841-670	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Lifesciences Limited	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65841-671_637bdb70-ec58-4ef7-9bf3-b9977f4f0ccc	65841-671	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-672_637bdb70-ec58-4ef7-9bf3-b9977f4f0ccc	65841-672	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-673_637bdb70-ec58-4ef7-9bf3-b9977f4f0ccc	65841-673	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-674_637bdb70-ec58-4ef7-9bf3-b9977f4f0ccc	65841-674	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-675_637bdb70-ec58-4ef7-9bf3-b9977f4f0ccc	65841-675	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-676_aa74b720-15e7-489d-a00e-7ac6f49bb745	65841-676	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20171109		ANDA	ANDA078620	Zydus Lifesciences Limited	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-677_aa74b720-15e7-489d-a00e-7ac6f49bb745	65841-677	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20171109		ANDA	ANDA078620	Zydus Lifesciences Limited	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-678_aa74b720-15e7-489d-a00e-7ac6f49bb745	65841-678	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20171109		ANDA	ANDA078620	Zydus Lifesciences Limited	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-682_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-682	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Lifesciences Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-683_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-683	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Lifesciences Limited	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-684_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-684	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Lifesciences Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-685_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-685	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Lifesciences Limited	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-686_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-686	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Lifesciences Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-687_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-687	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Lifesciences Limited	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-689_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-689	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090123		ANDA	ANDA078009	Zydus Lifesciences Limited	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-690_470c8a7a-67d9-412a-a890-4e7e59f319e8	65841-690	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090123		ANDA	ANDA078009	Zydus Lifesciences Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65841-691_15d11e92-6f8b-4c8a-b2b1-90eac26f8e3b	65841-691	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20121110		ANDA	ANDA077652	Zydus Lifesciences Limited	LEVOFLOXACIN	250	mg/1			N	20241231
65841-692_15d11e92-6f8b-4c8a-b2b1-90eac26f8e3b	65841-692	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20101110		ANDA	ANDA077652	Zydus Lifesciences Limited	LEVOFLOXACIN	500	mg/1			N	20241231
65841-693_15d11e92-6f8b-4c8a-b2b1-90eac26f8e3b	65841-693	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20121110		ANDA	ANDA077652	Zydus Lifesciences Limited	LEVOFLOXACIN	750	mg/1			N	20241231
65841-695_5878fa0c-ddc2-4783-9a3b-1b2a8f56fb92	65841-695	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078225	Zydus Lifesciences Limited	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
65841-699_3c272717-5c87-4f26-ad63-6034e5c40b41	65841-699	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Lifesciences Limited	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-700_3c272717-5c87-4f26-ad63-6034e5c40b41	65841-700	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Lifesciences Limited	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-701_3c272717-5c87-4f26-ad63-6034e5c40b41	65841-701	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Lifesciences Limited	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-702_3c272717-5c87-4f26-ad63-6034e5c40b41	65841-702	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Lifesciences Limited	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65841-703_8f5c6dfd-ef46-4370-8ef7-50b1cef88dfc	65841-703	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA078918	Zydus Lifesciences Limited	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-704_8f5c6dfd-ef46-4370-8ef7-50b1cef88dfc	65841-704	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA078918	Zydus Lifesciences Limited	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-705_597b8231-e3b2-4058-ad8a-2208af0b16bb	65841-705	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	Zydus Lifesciences Limited	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-706_597b8231-e3b2-4058-ad8a-2208af0b16bb	65841-706	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	Zydus Lifesciences Limited	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65841-712_82436c19-cab1-4857-9a7d-9e32e4ba0f72	65841-712	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20090923		ANDA	ANDA090411	Zydus Lifesciences Limited	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-713_82436c19-cab1-4857-9a7d-9e32e4ba0f72	65841-713	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20090923		ANDA	ANDA090411	Zydus Lifesciences Limited	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-714_82436c19-cab1-4857-9a7d-9e32e4ba0f72	65841-714	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20090923		ANDA	ANDA090411	Zydus Lifesciences Limited	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-715_82436c19-cab1-4857-9a7d-9e32e4ba0f72	65841-715	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20090923		ANDA	ANDA090411	Zydus Lifesciences Limited	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-716_82436c19-cab1-4857-9a7d-9e32e4ba0f72	65841-716	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20090923		ANDA	ANDA090411	Zydus Lifesciences Limited	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-717_82436c19-cab1-4857-9a7d-9e32e4ba0f72	65841-717	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20090923		ANDA	ANDA090411	Zydus Lifesciences Limited	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-718_82436c19-cab1-4857-9a7d-9e32e4ba0f72	65841-718	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20090923		ANDA	ANDA090411	Zydus Lifesciences Limited	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-721_df951447-f07e-448f-83ea-5b3e873c6174	65841-721	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20110511		ANDA	ANDA090175	Zydus Lifesciences Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-722_df951447-f07e-448f-83ea-5b3e873c6174	65841-722	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20110511		ANDA	ANDA090175	Zydus Lifesciences Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-729_699213a2-8233-4c3b-826e-6980ccc018b6	65841-729	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Zydus Lifesciences Limited	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65841-730_699213a2-8233-4c3b-826e-6980ccc018b6	65841-730	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Zydus Lifesciences Limited	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65841-731_699213a2-8233-4c3b-826e-6980ccc018b6	65841-731	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Zydus Lifesciences Limited	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65841-732_de170f72-0f59-4ed3-9715-8bdff49fc5da	65841-732	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20100410		ANDA	ANDA078385	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65841-733_de170f72-0f59-4ed3-9715-8bdff49fc5da	65841-733	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20100410		ANDA	ANDA078385	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65841-734_45a8b1f5-90da-46df-9f01-2f174331f3e8	65841-734	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE DIHYDROCHLORIDE		PRAMIPEXOLE DIHYDROCHLORIDE	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-735_45a8b1f5-90da-46df-9f01-2f174331f3e8	65841-735	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE DIHYDROCHLORIDE		PRAMIPEXOLE DIHYDROCHLORIDE	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-736_45a8b1f5-90da-46df-9f01-2f174331f3e8	65841-736	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE DIHYDROCHLORIDE		PRAMIPEXOLE DIHYDROCHLORIDE	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-737_45a8b1f5-90da-46df-9f01-2f174331f3e8	65841-737	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE DIHYDROCHLORIDE		PRAMIPEXOLE DIHYDROCHLORIDE	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-738_45a8b1f5-90da-46df-9f01-2f174331f3e8	65841-738	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE DIHYDROCHLORIDE		PRAMIPEXOLE DIHYDROCHLORIDE	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65841-739_06a7213c-2672-47ba-86ec-58754a44504d	65841-739	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Lifesciences Limited	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-740_06a7213c-2672-47ba-86ec-58754a44504d	65841-740	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Lifesciences Limited	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-741_06a7213c-2672-47ba-86ec-58754a44504d	65841-741	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Lifesciences Limited	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-742_06a7213c-2672-47ba-86ec-58754a44504d	65841-742	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Lifesciences Limited	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65841-743_fb283e71-450a-412a-bf0c-da9796729e29	65841-743	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, COATED	ORAL	20100627		ANDA	ANDA078921	Zydus Lifesciences Limited	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
65841-745_aa9c5856-379d-49b0-90b7-a16dc636d6d7	65841-745	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Lifesciences Limited	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65841-746_aa9c5856-379d-49b0-90b7-a16dc636d6d7	65841-746	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Lifesciences Limited	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65841-747_aa9c5856-379d-49b0-90b7-a16dc636d6d7	65841-747	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Lifesciences Limited	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65841-748_aa9c5856-379d-49b0-90b7-a16dc636d6d7	65841-748	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Lifesciences Limited	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65841-749_3ca60c78-2542-4158-ab90-ad32d5271bd1	65841-749	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20110525		ANDA	ANDA090100	Zydus Lifesciences Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-750_3ca60c78-2542-4158-ab90-ad32d5271bd1	65841-750	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20110525		ANDA	ANDA090100	Zydus Lifesciences Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-751_f20749dc-d1f6-4860-b583-82b82d3a2242	65841-751	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-752_f20749dc-d1f6-4860-b583-82b82d3a2242	65841-752	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-753_f20749dc-d1f6-4860-b583-82b82d3a2242	65841-753	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-754_0ced2b00-2184-4cc5-8247-a87f3a08115d	65841-754	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA090404	Zydus Lifesciences Limited	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
65841-755_6ef0e163-f218-4693-b490-a4e863220942	65841-755	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20111010		ANDA	ANDA078898	Zydus Lifesciences Limited	GALANTAMINE HYDROBROMIDE	4	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-756_6ef0e163-f218-4693-b490-a4e863220942	65841-756	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20111010		ANDA	ANDA078898	Zydus Lifesciences Limited	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-757_6ef0e163-f218-4693-b490-a4e863220942	65841-757	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20111010		ANDA	ANDA078898	Zydus Lifesciences Limited	GALANTAMINE HYDROBROMIDE	12	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-758_0ba70e83-9193-4b54-833f-01fe76575960	65841-758	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20121015		ANDA	ANDA090460	Zydus Lifesciences Limited	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
65841-759_02875cb7-9b8a-4452-901d-96ba7004b74d	65841-759	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Zydus Lifesciences Limited	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65841-760_02875cb7-9b8a-4452-901d-96ba7004b74d	65841-760	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Zydus Lifesciences Limited	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65841-761_02875cb7-9b8a-4452-901d-96ba7004b74d	65841-761	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Zydus Lifesciences Limited	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65841-762_d132a559-d8db-49bd-b007-c3b4b2c8eeea	65841-762	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	CAPSULE	ORAL	20190410		ANDA	ANDA205301	Zydus Lifesciences Limited	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
65841-763_2a443b8b-1ae9-40d9-a38d-36a6e7eb1bdf	65841-763	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130301		ANDA	ANDA091534	Zydus Lifesciences Limited	RANITIDINE HYDROCHLORIDE	25	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
65841-764_2a443b8b-1ae9-40d9-a38d-36a6e7eb1bdf	65841-764	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130301		ANDA	ANDA091534	Zydus Lifesciences Limited	RANITIDINE HYDROCHLORIDE	25	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
65841-765_5dab8979-c3a9-4317-8144-17eb77713742	65841-765	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20181112		ANDA	ANDA203019	Zydus Lifesciences Limited	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65841-766_5dab8979-c3a9-4317-8144-17eb77713742	65841-766	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20181112		ANDA	ANDA203019	Zydus Lifesciences Limited	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65841-767_5b9e0e70-4136-44d2-b9e2-c57b8a8f79f3	65841-767	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20130516		ANDA	ANDA202890	Zydus Lifesciences Limited	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65841-768_5b9e0e70-4136-44d2-b9e2-c57b8a8f79f3	65841-768	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20130516		ANDA	ANDA202890	Zydus Lifesciences Limited	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65841-769_9bd89c11-ec8f-4467-b8e6-9fab5037fbbc	65841-769	HUMAN PRESCRIPTION DRUG	lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130823		ANDA	ANDA202366	Zydus Lifesciences Limited	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65841-770_9bd89c11-ec8f-4467-b8e6-9fab5037fbbc	65841-770	HUMAN PRESCRIPTION DRUG	lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130823		ANDA	ANDA202366	Zydus Lifesciences Limited	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65841-771_7e6e294d-cf29-40e2-91e1-9693fdcd6b6c	65841-771	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20140115		ANDA	ANDA201676	Zydus Lifesciences Limited	SIROLIMUS	.5	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
65841-772_7e6e294d-cf29-40e2-91e1-9693fdcd6b6c	65841-772	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20230216		ANDA	ANDA201676	Zydus Lifesciences Limited	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
65841-773_7e6e294d-cf29-40e2-91e1-9693fdcd6b6c	65841-773	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20230216		ANDA	ANDA201676	Zydus Lifesciences Limited	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
65841-777_4553e909-a4e2-4d42-b5b1-2c029d8cc817	65841-777	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Zydus Lifesciences Limited	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-778_4553e909-a4e2-4d42-b5b1-2c029d8cc817	65841-778	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Zydus Lifesciences Limited	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-779_4553e909-a4e2-4d42-b5b1-2c029d8cc817	65841-779	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Zydus Lifesciences Limited	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65841-780_30b6520d-ee87-4a71-83eb-87448080151b	65841-780	HUMAN PRESCRIPTION DRUG	bupropion		bupropion	TABLET, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA201567	Zydus Lifesciences Limited	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-781_adb696ac-f216-4bbf-8201-67f4794630a2	65841-781	HUMAN PRESCRIPTION DRUG	buspirone hydrochloride		buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Lifesciences Limited	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
65841-782_adb696ac-f216-4bbf-8201-67f4794630a2	65841-782	HUMAN PRESCRIPTION DRUG	buspirone hydrochloride		buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Lifesciences Limited	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
65841-783_adb696ac-f216-4bbf-8201-67f4794630a2	65841-783	HUMAN PRESCRIPTION DRUG	buspirone hydrochloride		buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Lifesciences Limited	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
65841-784_adb696ac-f216-4bbf-8201-67f4794630a2	65841-784	HUMAN PRESCRIPTION DRUG	buspirone hydrochloride		buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Lifesciences Limited	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
65841-799_55d15483-b1dd-4901-ae80-e8892bd25e3a	65841-799	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090739	Zydus Lifesciences Limited	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-800_55d15483-b1dd-4901-ae80-e8892bd25e3a	65841-800	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090739	Zydus Lifesciences Limited	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-801_55d15483-b1dd-4901-ae80-e8892bd25e3a	65841-801	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090739	Zydus Lifesciences Limited	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65841-802_13b4b28f-13c7-4a10-bb31-d2174e5f7bde	65841-802	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20140910		ANDA	ANDA204314	Zydus Lifesciences Limited	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65841-803_13b4b28f-13c7-4a10-bb31-d2174e5f7bde	65841-803	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20140910		ANDA	ANDA204314	Zydus Lifesciences Limited	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65841-804_47ebee63-1674-419b-a349-7070a0bcd2c7	65841-804	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20140827		ANDA	ANDA203325	Zydus Lifesciences Limited	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65841-805_47ebee63-1674-419b-a349-7070a0bcd2c7	65841-805	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20140827		ANDA	ANDA203325	Zydus Lifesciences Limited	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65841-806_47ebee63-1674-419b-a349-7070a0bcd2c7	65841-806	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20140827		ANDA	ANDA203325	Zydus Lifesciences Limited	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65841-809_e88724a2-0bd6-435c-bc66-f7d05d85d667	65841-809	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA203686	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-810_e88724a2-0bd6-435c-bc66-f7d05d85d667	65841-810	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA203686	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-811_e88724a2-0bd6-435c-bc66-f7d05d85d667	65841-811	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA203686	Zydus Lifesciences Limited	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65841-818_069985f2-a43c-4b79-a5d8-fb7583e9ef91	65841-818	HUMAN PRESCRIPTION DRUG	etomidate		etomidate	INJECTION, SOLUTION	INTRAVENOUS	20150403		ANDA	ANDA202360	Zydus Lifesciences Limited	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
65841-819_4f18b45a-d2c9-49d8-ad9e-245c8011615d	65841-819	HUMAN PRESCRIPTION DRUG	pyridostigmine bromide		pyridostigmine bromide	TABLET	ORAL	20150807		ANDA	ANDA205650	Zydus Lifesciences Limited	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65841-821_c54701fe-04d7-40ac-bfe3-7f6f72fa5dc4	65841-821	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Zydus Lifesciences Limited	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65841-822_c54701fe-04d7-40ac-bfe3-7f6f72fa5dc4	65841-822	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Zydus Lifesciences Limited	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65841-823_c54701fe-04d7-40ac-bfe3-7f6f72fa5dc4	65841-823	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Zydus Lifesciences Limited	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65841-824_74ad710f-2587-4697-a053-bf02d23fadcb	65841-824	HUMAN PRESCRIPTION DRUG	glyburide and metformin hydrochloride		glyburide and metformin hydrochloride	TABLET	ORAL	20160407		ANDA	ANDA206748	Zydus Lifesciences Limited	GLYBURIDE; METFORMIN HYDROCHLORIDE	1.25; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-825_74ad710f-2587-4697-a053-bf02d23fadcb	65841-825	HUMAN PRESCRIPTION DRUG	glyburide and metformin hydrochloride		glyburide and metformin hydrochloride	TABLET	ORAL	20160407		ANDA	ANDA206748	Zydus Lifesciences Limited	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-826_74ad710f-2587-4697-a053-bf02d23fadcb	65841-826	HUMAN PRESCRIPTION DRUG	glyburide and metformin hydrochloride		glyburide and metformin hydrochloride	TABLET	ORAL	20160407		ANDA	ANDA206748	Zydus Lifesciences Limited	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-829_698388ff-9664-4781-a1f5-3b67095a9f9a	65841-829	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20160503		ANDA	ANDA204313	Zydus Lifesciences Limited	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65841-830_5c08315c-1394-4924-9e0e-d8b17d517891	65841-830	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET	ORAL	20160525		ANDA	ANDA206747	Zydus Lifesciences Limited	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65841-831_5c08315c-1394-4924-9e0e-d8b17d517891	65841-831	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET	ORAL	20160525		ANDA	ANDA206747	Zydus Lifesciences Limited	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65841-832_0450d056-3523-44c3-a4cf-f4557e520ce5	65841-832	HUMAN PRESCRIPTION DRUG	glyburide		glyburide	TABLET	ORAL	20160602		ANDA	ANDA206749	Zydus Lifesciences Limited	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-833_0450d056-3523-44c3-a4cf-f4557e520ce5	65841-833	HUMAN PRESCRIPTION DRUG	glyburide		glyburide	TABLET	ORAL	20160602		ANDA	ANDA206749	Zydus Lifesciences Limited	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-834_0450d056-3523-44c3-a4cf-f4557e520ce5	65841-834	HUMAN PRESCRIPTION DRUG	glyburide		glyburide	TABLET	ORAL	20160602		ANDA	ANDA206749	Zydus Lifesciences Limited	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65841-835_dd50959a-9924-4988-b09f-c27322a53752	65841-835	HUMAN PRESCRIPTION DRUG	amantadine hydrochloride		amantadine hydrochloride	CAPSULE	ORAL	20160804		ANDA	ANDA208278	Zydus Lifesciences Limited	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
65841-836_30b6520d-ee87-4a71-83eb-87448080151b	65841-836	HUMAN PRESCRIPTION DRUG	bupropion		bupropion	TABLET, EXTENDED RELEASE	ORAL	20180802		ANDA	ANDA201567	Zydus Lifesciences Limited	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65841-837_da9a9ec9-21e2-4633-873a-19e4b5c25ccc	65841-837	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230201		ANDA	ANDA077580	Zydus Lifesciences Limited	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
65841-838_da9a9ec9-21e2-4633-873a-19e4b5c25ccc	65841-838	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230201		ANDA	ANDA077580	Zydus Lifesciences Limited	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
65841-839_da9a9ec9-21e2-4633-873a-19e4b5c25ccc	65841-839	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230201		ANDA	ANDA077580	Zydus Lifesciences Limited	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
65841-840_9efa81cc-3f65-4cb9-8fe0-cafbb1bf7fb6	65841-840	HUMAN PRESCRIPTION DRUG	Amiodarone hydrochloride		Amiodarone hydrochloride	TABLET	ORAL	20230209		ANDA	ANDA079029	Zydus Lifesciences Limited	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65841-841_9efa81cc-3f65-4cb9-8fe0-cafbb1bf7fb6	65841-841	HUMAN PRESCRIPTION DRUG	Amiodarone hydrochloride		Amiodarone hydrochloride	TABLET	ORAL	20230209		ANDA	ANDA079029	Zydus Lifesciences Limited	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65841-842_adb696ac-f216-4bbf-8201-67f4794630a2	65841-842	HUMAN PRESCRIPTION DRUG	buspirone hydrochloride		buspirone hydrochloride	TABLET	ORAL	20230321		ANDA	ANDA078888	Zydus Lifesciences Limited	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
65841-843_ae2b2fa5-2b6d-4f86-97a0-28ff5d22e73c	65841-843	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070904		ANDA	ANDA040597	Zydus Lifesciences Limited	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
65841-844_45a8b1f5-90da-46df-9f01-2f174331f3e8	65841-844	HUMAN PRESCRIPTION DRUG	PRAMIPEXOLE DIHYDROCHLORIDE		PRAMIPEXOLE DIHYDROCHLORIDE	TABLET	ORAL	20221123		ANDA	ANDA078920	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65857-150_41abd652-7741-45e9-89a8-535a91d57f51	65857-150	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F-18		Fludeoxyglucose F-18	INJECTION	INTRAVENOUS	20190102		ANDA	ANDA203603	Cardinal Health 414, LLC	FLUDEOXYGLUCOSE F-18	500	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65857-200_886dbcba-5cf9-4d8b-95c0-d4fc574e8e02	65857-200	HUMAN PRESCRIPTION DRUG	Ammonia	N-13	Ammonia N-13	INJECTION	INTRAVENOUS	20130225		ANDA	ANDA203700	Cardinal Health 414, LLC	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65857-300_56810233-d952-4904-a3e9-c3dc3aa480e6	65857-300	HUMAN PRESCRIPTION DRUG	Sodium Fluoride	F18	Sodium Fluoride F18	INJECTION	INTRAVENOUS	20150730		ANDA	ANDA203780	Cardinal Health 414, LLC	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65857-425_b31e5f30-d4e4-44ea-918b-630247709747	65857-425	HUMAN PRESCRIPTION DRUG	Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept)		tilmanocept	KIT		20170920		NDA	NDA202207	Cardinal Health 414, LLC						N	20241231
65857-450_b31e5f30-d4e4-44ea-918b-630247709747	65857-450	HUMAN PRESCRIPTION DRUG	Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept)		tilmanocept	KIT		20170920		NDA	NDA202207	Cardinal Health 414, LLC						N	20241231
65857-500_876005d6-8642-4356-934c-838bd9d3a952	65857-500	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc99m Sestamibi		Kit for the Preparation of Technetium Tc99m Sestamibi	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PARENTERAL	20100601		ANDA	ANDA078809	Cardinal Health 414, LLC	TECHNETIUM TC-99M SESTAMIBI	1	mg/5mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65857-505_46ba888d-5102-40c6-b550-4c18e55f1f85	65857-505	HUMAN PRESCRIPTION DRUG	Kit for the Preparation of Technetium Tc 99m Medronate		technetium tc 99m medronate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201201		NDA	NDA018107	Cardinal Health 414, LLC	TECHNETIUM TC-99M MEDRONATE	20	mg/1	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
65862-001_fbb7592b-2145-49b3-80af-f4710c07c9ff	65862-001	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Aurobindo Pharma Limited	MIRTAZAPINE	7.5	mg/1			N	20241231
65862-003_fbb7592b-2145-49b3-80af-f4710c07c9ff	65862-003	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Aurobindo Pharma Limited	MIRTAZAPINE	30	mg/1			N	20241231
65862-005_6fc7097b-a847-4d83-a839-b41b566cf9ed	65862-005	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	Aurobindo Pharma Limited	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-006_6fc7097b-a847-4d83-a839-b41b566cf9ed	65862-006	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	Aurobindo Pharma Limited	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-007_6fc7097b-a847-4d83-a839-b41b566cf9ed	65862-007	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	Aurobindo Pharma Limited	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-008_c535450c-12fd-478d-ad45-743c5badfc28	65862-008	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	Aurobindo Pharma Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
65862-009_c535450c-12fd-478d-ad45-743c5badfc28	65862-009	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	Aurobindo Pharma Limited	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
65862-010_c535450c-12fd-478d-ad45-743c5badfc28	65862-010	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20050114		ANDA	ANDA077095	Aurobindo Pharma Limited	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
65862-011_4680748c-467b-4a7c-9387-848919a206bc	65862-011	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Aurobindo Pharma Limited	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-012_4680748c-467b-4a7c-9387-848919a206bc	65862-012	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Aurobindo Pharma Limited	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-013_4680748c-467b-4a7c-9387-848919a206bc	65862-013	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Aurobindo Pharma Limited	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-014_3638d0b7-4a46-4fa8-b366-4764f57829ee	65862-014	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	Aurobindo Pharma Limited	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-015_3638d0b7-4a46-4fa8-b366-4764f57829ee	65862-015	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	Aurobindo Pharma Limited	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-016_59e72563-2ad1-4b2a-a58d-b08d8ba7ed92	65862-016	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Aurobindo Pharma Limited	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-017_59e72563-2ad1-4b2a-a58d-b08d8ba7ed92	65862-017	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Aurobindo Pharma Limited	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-018_423d8291-e732-4828-982d-b9d382c3ebe3	65862-018	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	Aurobindo Pharma Limited	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-019_423d8291-e732-4828-982d-b9d382c3ebe3	65862-019	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	Aurobindo Pharma Limited	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-021_361ad2eb-23ce-42af-a036-4646cc2e39d6	65862-021	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20051208		ANDA	ANDA077376	Aurobindo Pharma Limited	MIRTAZAPINE	15	mg/1			N	20241231
65862-022_361ad2eb-23ce-42af-a036-4646cc2e39d6	65862-022	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20051208		ANDA	ANDA077376	Aurobindo Pharma Limited	MIRTAZAPINE	30	mg/1			N	20241231
65862-023_361ad2eb-23ce-42af-a036-4646cc2e39d6	65862-023	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20060228		ANDA	ANDA077376	Aurobindo Pharma Limited	MIRTAZAPINE	45	mg/1			N	20241231
65862-024_48608dfb-1e25-4444-8df5-d7093cbe0d4c	65862-024	HUMAN PRESCRIPTION DRUG	Zidovudine		Zidovudine	TABLET, FILM COATED	ORAL	20050919		ANDA	ANDA077267	Aurobindo Pharma Limited	ZIDOVUDINE	300	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-025_c9405700-5496-4863-9714-4bb0008515b7	65862-025	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20161121		ANDA	ANDA077464	Aurobindo Pharma Limited	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-026_c9405700-5496-4863-9714-4bb0008515b7	65862-026	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20161121		ANDA	ANDA077464	Aurobindo Pharma Limited	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-027_c93f5572-eb8f-4839-b4d0-530ec282dfb6	65862-027	HUMAN PRESCRIPTION DRUG	Nevirapine		Nevirapine	TABLET	ORAL	20120522		ANDA	ANDA077521	Aurobindo Pharma Limited	NEVIRAPINE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-031_fbb7592b-2145-49b3-80af-f4710c07c9ff	65862-031	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Aurobindo Pharma Limited	MIRTAZAPINE	15	mg/1			N	20241231
65862-032_fbb7592b-2145-49b3-80af-f4710c07c9ff	65862-032	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Aurobindo Pharma Limited	MIRTAZAPINE	45	mg/1			N	20241231
65862-036_51fefbd4-c285-426c-93d8-afd448bd6efb	65862-036	HUMAN PRESCRIPTION DRUG	Lamivudine and Zidovudine		Lamivudine and Zidovudine	TABLET, FILM COATED	ORAL	20170505		ANDA	ANDA077558	Aurobindo Pharma Limited	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-037_02e12641-9edf-4791-8684-5f148f3ed574	65862-037	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Aurobindo Pharma Limited	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-038_02e12641-9edf-4791-8684-5f148f3ed574	65862-038	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Aurobindo Pharma Limited	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-039_02e12641-9edf-4791-8684-5f148f3ed574	65862-039	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Aurobindo Pharma Limited	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-040_02e12641-9edf-4791-8684-5f148f3ed574	65862-040	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Aurobindo Pharma Limited	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-041_02e12641-9edf-4791-8684-5f148f3ed574	65862-041	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Aurobindo Pharma Limited	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-042_02e12641-9edf-4791-8684-5f148f3ed574	65862-042	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060222		ANDA	ANDA077622	Aurobindo Pharma Limited	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-043_932626de-56a2-4d28-bd74-688cc9cdfe95	65862-043	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060314		ANDA	ANDA077606	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-044_932626de-56a2-4d28-bd74-688cc9cdfe95	65862-044	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060314		ANDA	ANDA077606	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-045_932626de-56a2-4d28-bd74-688cc9cdfe95	65862-045	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060314		ANDA	ANDA077606	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-048_b386d167-ddd7-4163-b965-19a3bfaf01d4	65862-048	HUMAN PRESCRIPTION DRUG	Zidovudine		Zidovudine	SYRUP	ORAL	20050919		ANDA	ANDA077268	Aurobindo Pharma Limited	ZIDOVUDINE	10	mg/mL	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-049_f9982eb1-1e15-4fad-99f9-0f9da04fd058	65862-049	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	TABLET, FILM COATED	ORAL	20180921		ANDA	ANDA077673	Aurobindo Pharma Limited	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
65862-050_7aa9abed-6d40-4370-aeac-4d34e2cf0416	65862-050	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	Aurobindo Pharma Limited	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
65862-051_7aa9abed-6d40-4370-aeac-4d34e2cf0416	65862-051	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	Aurobindo Pharma Limited	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
65862-052_7aa9abed-6d40-4370-aeac-4d34e2cf0416	65862-052	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	Aurobindo Pharma Limited	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
65862-053_7aa9abed-6d40-4370-aeac-4d34e2cf0416	65862-053	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	Aurobindo Pharma Limited	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
65862-054_7aa9abed-6d40-4370-aeac-4d34e2cf0416	65862-054	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	Aurobindo Pharma Limited	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
65862-055_24850b2e-46f9-42ac-a806-a1e489c88993	65862-055	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	SOLUTION	ORAL	20161121		ANDA	ANDA077695	Aurobindo Pharma Limited	LAMIVUDINE	10	mg/mL	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-057_a504611b-43ca-4d37-934f-a4b1f46d8d5b	65862-057	HUMAN PRESCRIPTION DRUG	Nevirapine		Nevirapine	SUSPENSION	ORAL	20120522		ANDA	ANDA077702	Aurobindo Pharma Limited	NEVIRAPINE HEMIHYDRATE	50	mg/5mL	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-058_f74d59c1-583e-450d-8eb9-456f5e95c4f0	65862-058	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Aurobindo Pharma Limited	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-059_f74d59c1-583e-450d-8eb9-456f5e95c4f0	65862-059	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Aurobindo Pharma Limited	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-060_f74d59c1-583e-450d-8eb9-456f5e95c4f0	65862-060	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Aurobindo Pharma Limited	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-061_f74d59c1-583e-450d-8eb9-456f5e95c4f0	65862-061	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Aurobindo Pharma Limited	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-062_24ee2b52-1506-4e4d-91a6-611017ac2bb3	65862-062	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aurobindo Pharma Limited	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-063_24ee2b52-1506-4e4d-91a6-611017ac2bb3	65862-063	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aurobindo Pharma Limited	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-064_24ee2b52-1506-4e4d-91a6-611017ac2bb3	65862-064	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aurobindo Pharma Limited	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-068_1ae93dfb-003c-4b94-b5b9-ff0de04c513a	65862-068	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA065340	Aurobindo Pharma Limited	CEFPROZIL	250	mg/1			N	20241231
65862-069_1ae93dfb-003c-4b94-b5b9-ff0de04c513a	65862-069	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	TABLET, FILM COATED	ORAL	20070524		ANDA	ANDA065340	Aurobindo Pharma Limited	CEFPROZIL	500	mg/1			N	20241231
65862-070_d69fb5eb-e9f4-461e-a70b-975805dc2e4b	65862-070	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	Aurobindo Pharma Limited	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-071_d69fb5eb-e9f4-461e-a70b-975805dc2e4b	65862-071	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	Aurobindo Pharma Limited	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-073_02e8e657-b23d-4d10-8d1e-a3e57777eae7	65862-073	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET, FILM COATED	ORAL	20121217		ANDA	ANDA077844	Aurobindo Pharma Limited	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-074_0e716ceb-10b9-4ac2-b4d0-a75efd7ea25a	65862-074	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	SOLUTION	ORAL	20060828		ANDA	ANDA077812	Aurobindo Pharma Limited	CITALOPRAM HYDROBROMIDE	10	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-076_de35888f-a8ef-4ada-9ca1-9ac37c854337	65862-076	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Aurobindo Pharma Limited	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
65862-077_de35888f-a8ef-4ada-9ca1-9ac37c854337	65862-077	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Aurobindo Pharma Limited	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
65862-078_de35888f-a8ef-4ada-9ca1-9ac37c854337	65862-078	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Aurobindo Pharma Limited	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
65862-079_f3325eac-c4b6-419f-b10f-b4633b554226	65862-079	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	Aurobindo Pharma Limited	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
65862-080_fdedb669-6be4-4c45-8a09-62b767855894	65862-080	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	Aurobindo Pharma Limited	GLYBURIDE; METFORMIN HYDROCHLORIDE	1.25; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65862-081_fdedb669-6be4-4c45-8a09-62b767855894	65862-081	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	Aurobindo Pharma Limited	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65862-082_fdedb669-6be4-4c45-8a09-62b767855894	65862-082	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	Aurobindo Pharma Limited	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65862-083_d19121dd-8836-4e95-bbe8-0980ce5cac2f	65862-083	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20130425		ANDA	ANDA065349	Aurobindo Pharma Limited	CEFADROXIL	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-084_d19121dd-8836-4e95-bbe8-0980ce5cac2f	65862-084	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20130425		ANDA	ANDA065349	Aurobindo Pharma Limited	CEFADROXIL	500	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-085_b3a0ee13-5e63-4d3c-9a6d-5dd74a8152f8	65862-085	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	Aurobindo Pharma Limited	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-086_5e608b34-7b6d-470e-bd6d-576b6e4eda5f	65862-086	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20061227		ANDA	ANDA077910	Aurobindo Pharma Limited	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-087_5e608b34-7b6d-470e-bd6d-576b6e4eda5f	65862-087	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20061227		ANDA	ANDA077910	Aurobindo Pharma Limited	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-089_6b5189d5-5955-46ad-88cf-73f56f26194a	65862-089	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir Sulfate	SOLUTION	ORAL	20180314		ANDA	ANDA077950	Aurobindo Pharma Limited	ABACAVIR SULFATE	20	mg/mL	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-095_12ee6554-adfc-4c3b-b87e-3568576359a6	65862-095	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	Aurobindo Pharma Limited	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
65862-096_12ee6554-adfc-4c3b-b87e-3568576359a6	65862-096	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	Aurobindo Pharma Limited	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
65862-097_d6ea4c95-689f-457c-bf27-434d322e5707	65862-097	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20061002		ANDA	ANDA078008	Aurobindo Pharma Limited	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-098_d6ea4c95-689f-457c-bf27-434d322e5707	65862-098	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20061002		ANDA	ANDA078008	Aurobindo Pharma Limited	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-099_4bb8393f-0d0f-4435-9cfd-a56b3785e8a6	65862-099	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130		ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	125	mg/5mL			N	20241231
65862-100_4bb8393f-0d0f-4435-9cfd-a56b3785e8a6	65862-100	HUMAN PRESCRIPTION DRUG	Cefprozil		Cefprozil	POWDER, FOR SUSPENSION	ORAL	20070130		ANDA	ANDA065381	Aurobindo Pharma Limited	CEFPROZIL	250	mg/5mL			N	20241231
65862-101_ed50c0b6-3827-450a-84a7-da6f79c712bc	65862-101	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070717		ANDA	ANDA078021	Aurobindo Pharma Limited	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-102_ed50c0b6-3827-450a-84a7-da6f79c712bc	65862-102	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070717		ANDA	ANDA078021	Aurobindo Pharma Limited	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-103_ed50c0b6-3827-450a-84a7-da6f79c712bc	65862-103	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070717		ANDA	ANDA078021	Aurobindo Pharma Limited	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-104_a02dd4c8-6159-48b0-a79c-c362f1f4daf9	65862-104	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	CAPSULE	ORAL	20171215		ANDA	ANDA078064	Aurobindo Pharma Limited	EFAVIRENZ	50	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
65862-105_a02dd4c8-6159-48b0-a79c-c362f1f4daf9	65862-105	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	CAPSULE	ORAL	20171215		ANDA	ANDA078064	Aurobindo Pharma Limited	EFAVIRENZ	100	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
65862-106_a02dd4c8-6159-48b0-a79c-c362f1f4daf9	65862-106	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	CAPSULE	ORAL	20171215		ANDA	ANDA078064	Aurobindo Pharma Limited	EFAVIRENZ	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
65862-107_4b4bd620-4095-4719-8285-4a15760f3d8c	65862-107	HUMAN PRESCRIPTION DRUG	Zidovudine		Zidovudine	CAPSULE	ORAL	20060327		ANDA	ANDA078128	Aurobindo Pharma Limited	ZIDOVUDINE	100	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-113_392abd0f-3897-4b56-acfe-6775bc175075	65862-113	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20070919		ANDA	ANDA078164	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-116_6c4a4520-30af-4362-a40d-124510bd9ed2	65862-116	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	Aurobindo Pharma Limited	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
65862-117_6c4a4520-30af-4362-a40d-124510bd9ed2	65862-117	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	Aurobindo Pharma Limited	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
65862-118_6c4a4520-30af-4362-a40d-124510bd9ed2	65862-118	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	Aurobindo Pharma Limited	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
65862-125_b727a62d-8066-49b7-801f-7418c5777556	65862-125	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Aurobindo Pharma Limited	TORSEMIDE	5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
65862-126_b727a62d-8066-49b7-801f-7418c5777556	65862-126	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Aurobindo Pharma Limited	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
65862-127_b727a62d-8066-49b7-801f-7418c5777556	65862-127	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Aurobindo Pharma Limited	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
65862-128_b727a62d-8066-49b7-801f-7418c5777556	65862-128	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Aurobindo Pharma Limited	TORSEMIDE	100	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
65862-133_857dd673-6ba8-485c-b96b-14291666b852	65862-133	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070720		ANDA	ANDA040780	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-134_857dd673-6ba8-485c-b96b-14291666b852	65862-134	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070720		ANDA	ANDA040780	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-140_95331369-8343-4244-8d82-03a1bc4af0c0	65862-140	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	GRANULE, FOR SUSPENSION	ORAL	20070608		ANDA	ANDA065409	Aurobindo Pharma Limited	CEFPODOXIME PROXETIL	50	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
65862-141_95331369-8343-4244-8d82-03a1bc4af0c0	65862-141	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	GRANULE, FOR SUSPENSION	ORAL	20070608		ANDA	ANDA065409	Aurobindo Pharma Limited	CEFPODOXIME PROXETIL	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
65862-142_152f2d41-2c2f-4feb-8c4b-1a22a94e2ca9	65862-142	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aurobindo Pharma Limited	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65862-143_152f2d41-2c2f-4feb-8c4b-1a22a94e2ca9	65862-143	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aurobindo Pharma Limited	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65862-144_152f2d41-2c2f-4feb-8c4b-1a22a94e2ca9	65862-144	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aurobindo Pharma Limited	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65862-145_152f2d41-2c2f-4feb-8c4b-1a22a94e2ca9	65862-145	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aurobindo Pharma Limited	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
65862-146_bf37e6d8-53c1-45a9-93c8-06c0a49cd509	65862-146	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Aurobindo Pharma Limited	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-147_bf37e6d8-53c1-45a9-93c8-06c0a49cd509	65862-147	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Aurobindo Pharma Limited	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-148_bf37e6d8-53c1-45a9-93c8-06c0a49cd509	65862-148	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Aurobindo Pharma Limited	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-149_de2db704-6e94-422d-b3ef-8da5862cb91e	65862-149	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	Aurobindo Pharma Limited	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
65862-154_905f7b97-d2fb-4414-a571-1629a86d52e9	65862-154	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	Aurobindo Pharma Limited	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-155_905f7b97-d2fb-4414-a571-1629a86d52e9	65862-155	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	Aurobindo Pharma Limited	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-156_905f7b97-d2fb-4414-a571-1629a86d52e9	65862-156	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	Aurobindo Pharma Limited	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-157_905f7b97-d2fb-4414-a571-1629a86d52e9	65862-157	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070725		ANDA	ANDA078406	Aurobindo Pharma Limited	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-158_75754a95-33cf-4bfb-bee1-7d308a227250	65862-158	HUMAN PRESCRIPTION DRUG	carisoprodol		carisoprodol	TABLET	ORAL	20090806		ANDA	ANDA040792	Aurobindo Pharma Limited	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
65862-159_74c16acb-ed05-4b1b-934b-faf9d5bc8c70	65862-159	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Aurobindo Pharma Limited	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
65862-160_74c16acb-ed05-4b1b-934b-faf9d5bc8c70	65862-160	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Aurobindo Pharma Limited	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
65862-161_9d4a5632-70f4-4942-b956-abce786592e5	65862-161	HUMAN PRESCRIPTION DRUG	QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE		QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20070824		ANDA	ANDA078450	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-162_9d4a5632-70f4-4942-b956-abce786592e5	65862-162	HUMAN PRESCRIPTION DRUG	QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE		QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20070824		ANDA	ANDA078450	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-163_9d4a5632-70f4-4942-b956-abce786592e5	65862-163	HUMAN PRESCRIPTION DRUG	QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE		QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20070824		ANDA	ANDA078450	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-164_72ada027-49dd-4904-b969-e06aa5fb5cb8	65862-164	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070612		ANDA	ANDA078438	Aurobindo Pharma Limited	TRANDOLAPRIL	1	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-165_72ada027-49dd-4904-b969-e06aa5fb5cb8	65862-165	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070612		ANDA	ANDA078438	Aurobindo Pharma Limited	TRANDOLAPRIL	2	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-166_72ada027-49dd-4904-b969-e06aa5fb5cb8	65862-166	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070612		ANDA	ANDA078438	Aurobindo Pharma Limited	TRANDOLAPRIL	4	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-167_787f2282-0a3a-4d01-8c94-4a318f960e1c	65862-167	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	SOLUTION	ORAL	20190325		ANDA	ANDA078452	Aurobindo Pharma Limited	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
65862-168_a8c7e2b7-ff51-4a47-850b-c71260b8e289	65862-168	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071031		ANDA	ANDA078512	Aurobindo Pharma Limited	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-169_a8c7e2b7-ff51-4a47-850b-c71260b8e289	65862-169	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071031		ANDA	ANDA078512	Aurobindo Pharma Limited	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-170_a8c7e2b7-ff51-4a47-850b-c71260b8e289	65862-170	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20071031		ANDA	ANDA078512	Aurobindo Pharma Limited	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-171_cd9dad01-5c9f-40df-a4e6-7893e79119f3	65862-171	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Aurobindo Pharma Limited	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-172_cd9dad01-5c9f-40df-a4e6-7893e79119f3	65862-172	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Aurobindo Pharma Limited	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-173_cd9dad01-5c9f-40df-a4e6-7893e79119f3	65862-173	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Aurobindo Pharma Limited	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-174_cd9dad01-5c9f-40df-a4e6-7893e79119f3	65862-174	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Aurobindo Pharma Limited	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-175_7b3fb934-771d-4f76-9abe-8002861dd633	65862-175	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Aurobindo Pharma Limited	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-176_7b3fb934-771d-4f76-9abe-8002861dd633	65862-176	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	Aurobindo Pharma Limited	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-177_8c33c71e-e798-4fdd-88bc-12e6d0a1afbd	65862-177	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	Aurobindo Pharma Limited	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-185_63b91cc0-5a49-4f9b-bfb2-088f0bc0fa20	65862-185	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20090826		ANDA	ANDA065442	Aurobindo Pharma Limited	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
65862-186_63b91cc0-5a49-4f9b-bfb2-088f0bc0fa20	65862-186	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20090826		ANDA	ANDA065442	Aurobindo Pharma Limited	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
65862-187_23292a95-b91b-426f-aeb9-bfea73f156f2	65862-187	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Aurobindo Pharma Limited	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65862-188_23292a95-b91b-426f-aeb9-bfea73f156f2	65862-188	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Aurobindo Pharma Limited	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65862-189_23292a95-b91b-426f-aeb9-bfea73f156f2	65862-189	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Aurobindo Pharma Limited	ONDANSETRON HYDROCHLORIDE	24	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65862-190_13f9bb96-7677-4506-befe-d7afa9b13cab	65862-190	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Aurobindo Pharma Limited	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
65862-191_13f9bb96-7677-4506-befe-d7afa9b13cab	65862-191	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Aurobindo Pharma Limited	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
65862-192_0d4f11cd-3cc6-4865-a63b-9f68228fb182	65862-192	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Aurobindo Pharma Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-193_0d4f11cd-3cc6-4865-a63b-9f68228fb182	65862-193	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Aurobindo Pharma Limited	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-194_0d4f11cd-3cc6-4865-a63b-9f68228fb182	65862-194	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Aurobindo Pharma Limited	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-198_768d6029-4c6d-401e-b9ec-87ea2b9cc987	65862-198	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aurobindo Pharma Limited	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
65862-199_768d6029-4c6d-401e-b9ec-87ea2b9cc987	65862-199	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aurobindo Pharma Limited	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
65862-200_768d6029-4c6d-401e-b9ec-87ea2b9cc987	65862-200	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aurobindo Pharma Limited	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
65862-201_bd478210-8b15-4f1d-877b-2c1016b3cb1d	65862-201	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Aurobindo Pharma Limited	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-202_bd478210-8b15-4f1d-877b-2c1016b3cb1d	65862-202	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Aurobindo Pharma Limited	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-203_bd478210-8b15-4f1d-877b-2c1016b3cb1d	65862-203	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Aurobindo Pharma Limited	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-207_1df6353a-6bb8-4b76-8c41-c9d97b05b4c3	65862-207	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20090917		ANDA	ANDA079111	Aurobindo Pharma Limited	RIBAVIRIN	200	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65862-208_380686e7-c045-42ef-86c6-0f20b80202b1	65862-208	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	SOLUTION	ORAL	20071128		ANDA	ANDA078776	Aurobindo Pharma Limited	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65862-209_22ef1e7d-49a8-44e4-81b8-26597f6f7e5e	65862-209	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20080311		ANDA	ANDA065470	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-210_22ef1e7d-49a8-44e4-81b8-26597f6f7e5e	65862-210	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20080311		ANDA	ANDA065470	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-211_22ef1e7d-49a8-44e4-81b8-26597f6f7e5e	65862-211	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20080311		ANDA	ANDA065470	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-214_3026ab42-03c1-48a3-aee4-172a08aa2c8a	65862-214	HUMAN PRESCRIPTION DRUG	ZALEPLON		ZALEPLON	CAPSULE	ORAL	20080606		ANDA	ANDA078829	Aurobindo Pharma Limited	ZALEPLON	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
65862-215_3026ab42-03c1-48a3-aee4-172a08aa2c8a	65862-215	HUMAN PRESCRIPTION DRUG	ZALEPLON		ZALEPLON	CAPSULE	ORAL	20080606		ANDA	ANDA078829	Aurobindo Pharma Limited	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
65862-218_949142e8-2221-46ea-8d60-ae98a1e49a38	65862-218	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	Aurobindo Pharma Limited	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-219_949142e8-2221-46ea-8d60-ae98a1e49a38	65862-219	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	Aurobindo Pharma Limited	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-224_a3f4154d-37e0-419b-b1df-589ff015982f	65862-224	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	SOLUTION, CONCENTRATE	ORAL	20081031		ANDA	ANDA078861	Aurobindo Pharma Limited	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-225_4bb3048c-0a75-4818-9be5-4c81cfe9649c	65862-225	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	Aurobindo Pharma Limited	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
65862-226_4bb3048c-0a75-4818-9be5-4c81cfe9649c	65862-226	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	Aurobindo Pharma Limited	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
65862-227_6edad751-f66f-4827-b42e-ea13476d0104	65862-227	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	Aurobindo Pharma Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65862-228_6edad751-f66f-4827-b42e-ea13476d0104	65862-228	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	Aurobindo Pharma Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65862-229_6edad751-f66f-4827-b42e-ea13476d0104	65862-229	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	Aurobindo Pharma Limited	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65862-230_6edad751-f66f-4827-b42e-ea13476d0104	65862-230	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078956	Aurobindo Pharma Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65862-237_5810b0cf-d1a0-456b-aaf0-220dc720335a	65862-237	HUMAN PRESCRIPTION DRUG	Ibandronate Sodium		Ibandronate Sodium	TABLET, FILM COATED	ORAL	20160311		ANDA	ANDA204502	Aurobindo Pharma Limited	IBANDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-238_4675a097-a29b-4d3a-bc77-8e41cd5925d1	65862-238	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Aurobindo Pharma Limited	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65862-239_4675a097-a29b-4d3a-bc77-8e41cd5925d1	65862-239	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Aurobindo Pharma Limited	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65862-240_4675a097-a29b-4d3a-bc77-8e41cd5925d1	65862-240	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Aurobindo Pharma Limited	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65862-241_4675a097-a29b-4d3a-bc77-8e41cd5925d1	65862-241	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Aurobindo Pharma Limited	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65862-242_4675a097-a29b-4d3a-bc77-8e41cd5925d1	65862-242	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Aurobindo Pharma Limited	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65862-243_4675a097-a29b-4d3a-bc77-8e41cd5925d1	65862-243	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Aurobindo Pharma Limited	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65862-244_4675a097-a29b-4d3a-bc77-8e41cd5925d1	65862-244	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Aurobindo Pharma Limited	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
65862-245_49f7d231-f076-4298-9413-04e3607bf0fe	65862-245	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Aurobindo Pharma Limited	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-246_49f7d231-f076-4298-9413-04e3607bf0fe	65862-246	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Aurobindo Pharma Limited	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-247_49f7d231-f076-4298-9413-04e3607bf0fe	65862-247	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Aurobindo Pharma Limited	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-248_dcda80b2-f321-42a4-a13f-2094d513ffeb	65862-248	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	SOLUTION	ORAL	20120403		ANDA	ANDA079062	Aurobindo Pharma Limited	ESCITALOPRAM OXALATE	5	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-249_d8c832c1-9455-4647-822a-ee4f35ba0560	65862-249	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120830		ANDA	ANDA079060	Aurobindo Pharma Limited	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
65862-250_36f79c67-6ec5-4644-a951-c35ef5ec9a9a	65862-250	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20090115		ANDA	ANDA079063	Aurobindo Pharma Limited	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-286_00bc1834-9626-49a2-8727-7c976679635e	65862-286	HUMAN PRESCRIPTION DRUG	Perindopril Erbumine		Perindopril Erbumine	TABLET	ORAL	20091110		ANDA	ANDA079070	Aurobindo Pharma Limited	PERINDOPRIL ERBUMINE	2	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-287_00bc1834-9626-49a2-8727-7c976679635e	65862-287	HUMAN PRESCRIPTION DRUG	Perindopril Erbumine		Perindopril Erbumine	TABLET	ORAL	20091110		ANDA	ANDA079070	Aurobindo Pharma Limited	PERINDOPRIL ERBUMINE	4	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-288_00bc1834-9626-49a2-8727-7c976679635e	65862-288	HUMAN PRESCRIPTION DRUG	Perindopril Erbumine		Perindopril Erbumine	TABLET	ORAL	20091110		ANDA	ANDA079070	Aurobindo Pharma Limited	PERINDOPRIL ERBUMINE	8	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-290_5e22126a-e450-455a-b237-0d0ef4c8f40b	65862-290	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	CAPSULE	ORAL	20090917		ANDA	ANDA079117	Aurobindo Pharma Limited	RIBAVIRIN	200	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65862-291_f2bf47e5-b110-4574-95ea-21fda63777ee	65862-291	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120720		ANDA	ANDA079118	Aurobindo Pharma Limited	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65862-292_f2bf47e5-b110-4574-95ea-21fda63777ee	65862-292	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120720		ANDA	ANDA079118	Aurobindo Pharma Limited	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
65862-293_d15371cd-5d55-424f-97d4-295d994f1fae	65862-293	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Aurobindo Pharma Limited	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-294_d15371cd-5d55-424f-97d4-295d994f1fae	65862-294	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Aurobindo Pharma Limited	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-295_d15371cd-5d55-424f-97d4-295d994f1fae	65862-295	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Aurobindo Pharma Limited	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-296_d15371cd-5d55-424f-97d4-295d994f1fae	65862-296	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Aurobindo Pharma Limited	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-299_e5dde38e-1ec2-4091-8585-9c55be4e1d5d	65862-299	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	POWDER, FOR SUSPENSION	ORAL	20090918		ANDA	ANDA079150	Aurobindo Pharma Limited	FLUCONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-300_e5dde38e-1ec2-4091-8585-9c55be4e1d5d	65862-300	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	POWDER, FOR SUSPENSION	ORAL	20090918		ANDA	ANDA079150	Aurobindo Pharma Limited	FLUCONAZOLE	40	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-301_2bb2b403-2397-4c4d-a23f-666a58998bc3	65862-301	HUMAN PRESCRIPTION DRUG	Emtricitabine		Emtricitabine	CAPSULE	ORAL	20230315		ANDA	ANDA079188	Aurobindo Pharma Limited	EMTRICITABINE	200	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
65862-306_5be21f45-21bd-492b-9d14-e6911ce05fcd	65862-306	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	SOLUTION	ORAL	20090319		ANDA	ANDA079209	Aurobindo Pharma Limited	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-308_634070c9-e12d-4b5b-90fa-67cbeb9b2fea	65862-308	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium and Hydrochlorothiazide		Fosinopril Sodium and Hydrochlorothiazide	TABLET	ORAL	20090709		ANDA	ANDA079245	Aurobindo Pharma Limited	FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-309_634070c9-e12d-4b5b-90fa-67cbeb9b2fea	65862-309	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium and Hydrochlorothiazide		Fosinopril Sodium and Hydrochlorothiazide	TABLET	ORAL	20090709		ANDA	ANDA079245	Aurobindo Pharma Limited	FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-315_49f7d231-f076-4298-9413-04e3607bf0fe	65862-315	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078993	Aurobindo Pharma Limited	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-325_3c956648-d46c-41e2-a2d9-8560846a7a32	65862-325	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA090056	Aurobindo Pharma Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
65862-326_3c956648-d46c-41e2-a2d9-8560846a7a32	65862-326	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA090056	Aurobindo Pharma Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
65862-327_7dec2f20-f5ae-4a0b-a703-9b148d2b70ec	65862-327	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	Aurobindo Pharma Limited	ALENDRONATE SODIUM	10	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-328_7dec2f20-f5ae-4a0b-a703-9b148d2b70ec	65862-328	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	Aurobindo Pharma Limited	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-329_7dec2f20-f5ae-4a0b-a703-9b148d2b70ec	65862-329	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	Aurobindo Pharma Limited	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-335_b46161be-360f-4d6d-95ff-780c3a2e1930	65862-335	HUMAN PRESCRIPTION DRUG	Abacavir and Lamivudine		Abacavir and Lamivudine	TABLET, FILM COATED	ORAL	20181115		ANDA	ANDA090159	Aurobindo Pharma Limited	ABACAVIR SULFATE; LAMIVUDINE	600; 300	mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-354_7f7713c5-7a99-4dd3-a6c0-28cb60c6ef09	65862-354	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA090513	Aurobindo Pharma Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
65862-357_736f1792-59f3-4ea4-8bad-2ee06923b9c1	65862-357	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	Aurobindo Pharma Limited	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
65862-361_c280a9e2-877e-42b3-bc86-f8eb582f296d	65862-361	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20091104		ANDA	ANDA090401	Aurobindo Pharma Limited	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65862-362_c280a9e2-877e-42b3-bc86-f8eb582f296d	65862-362	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20091104		ANDA	ANDA090401	Aurobindo Pharma Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
65862-373_ae929ea5-dbd7-4530-b28c-c4fa196a6c62	65862-373	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	Aurobindo Pharma Limited	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-374_ae929ea5-dbd7-4530-b28c-c4fa196a6c62	65862-374	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	Aurobindo Pharma Limited	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-375_ae929ea5-dbd7-4530-b28c-c4fa196a6c62	65862-375	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	Aurobindo Pharma Limited	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
65862-390_77ae0eb0-b1ce-441d-8cfa-1d3113f2d79e	65862-390	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Aurobindo Pharma Limited	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65862-391_77ae0eb0-b1ce-441d-8cfa-1d3113f2d79e	65862-391	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Aurobindo Pharma Limited	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
65862-402_8e9bfd31-9e95-4357-8fe9-44e441c2a53d	65862-402	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	Aurobindo Pharma Limited	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65862-403_8e9bfd31-9e95-4357-8fe9-44e441c2a53d	65862-403	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	Aurobindo Pharma Limited	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65862-404_426d12db-50e2-4915-999f-84645fb387d9	65862-404	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine Hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-405_426d12db-50e2-4915-999f-84645fb387d9	65862-405	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine Hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-406_426d12db-50e2-4915-999f-84645fb387d9	65862-406	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine Hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-407_426d12db-50e2-4915-999f-84645fb387d9	65862-407	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine Hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-408_426d12db-50e2-4915-999f-84645fb387d9	65862-408	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine Hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-419_6f73d0f2-c537-4b1e-9fba-067a4f9e6a41	65862-419	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Aurobindo Pharma Limited	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
65862-420_6f73d0f2-c537-4b1e-9fba-067a4f9e6a41	65862-420	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Aurobindo Pharma Limited	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
65862-421_3d50ad7c-efa4-4efc-a827-701517c076df	65862-421	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA090647	Aurobindo Pharma Limited	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
65862-448_7b3f41c2-d3f9-4915-958d-dc45d50309f0	65862-448	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Aurobindo Pharma Limited	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
65862-449_7b3f41c2-d3f9-4915-958d-dc45d50309f0	65862-449	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Aurobindo Pharma Limited	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
65862-454_770e31e7-2444-4748-b0aa-f0b1981664e3	65862-454	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Aurobindo Pharma Limited	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-455_770e31e7-2444-4748-b0aa-f0b1981664e3	65862-455	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Aurobindo Pharma Limited	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-456_770e31e7-2444-4748-b0aa-f0b1981664e3	65862-456	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Aurobindo Pharma Limited	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-457_770e31e7-2444-4748-b0aa-f0b1981664e3	65862-457	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Aurobindo Pharma Limited	ALPRAZOLAM	3	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-458_ffab7644-6656-488f-b898-681a9ce0cd12	65862-458	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20110329		ANDA	ANDA090957	Aurobindo Pharma Limited	GALANTAMINE HYDROBROMIDE	4	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-459_ffab7644-6656-488f-b898-681a9ce0cd12	65862-459	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20110329		ANDA	ANDA090957	Aurobindo Pharma Limited	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-460_ffab7644-6656-488f-b898-681a9ce0cd12	65862-460	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20110329		ANDA	ANDA090957	Aurobindo Pharma Limited	GALANTAMINE HYDROBROMIDE	12	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-465_fd2358a3-99d0-4c40-8a56-beaf2b806e4b	65862-465	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20110321		ANDA	ANDA091114	Aurobindo Pharma Limited	FAMCICLOVIR	125	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65862-466_fd2358a3-99d0-4c40-8a56-beaf2b806e4b	65862-466	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20110321		ANDA	ANDA091114	Aurobindo Pharma Limited	FAMCICLOVIR	250	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65862-467_fd2358a3-99d0-4c40-8a56-beaf2b806e4b	65862-467	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20110321		ANDA	ANDA091114	Aurobindo Pharma Limited	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
65862-468_740ddd9c-172d-4f0f-a8db-f5e1a2add664	65862-468	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-469_740ddd9c-172d-4f0f-a8db-f5e1a2add664	65862-469	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-470_740ddd9c-172d-4f0f-a8db-f5e1a2add664	65862-470	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-471_62d91ed6-500a-489e-b35c-0592cfecb54d	65862-471	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20110330		ANDA	ANDA091163	Aurobindo Pharma Limited	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-472_62d91ed6-500a-489e-b35c-0592cfecb54d	65862-472	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20110330		ANDA	ANDA091163	Aurobindo Pharma Limited	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-473_62d91ed6-500a-489e-b35c-0592cfecb54d	65862-473	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril Sodium	TABLET	ORAL	20110330		ANDA	ANDA091163	Aurobindo Pharma Limited	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-474_3875ae34-1cd2-4d70-a690-31f065c07aa8	65862-474	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Aurobindo Pharma Limited	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-475_3875ae34-1cd2-4d70-a690-31f065c07aa8	65862-475	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Aurobindo Pharma Limited	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-476_3875ae34-1cd2-4d70-a690-31f065c07aa8	65862-476	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Aurobindo Pharma Limited	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-477_3875ae34-1cd2-4d70-a690-31f065c07aa8	65862-477	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Aurobindo Pharma Limited	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-489_938808b2-1a53-4c6d-8305-255696197062	65862-489	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-490_938808b2-1a53-4c6d-8305-255696197062	65862-490	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-491_938808b2-1a53-4c6d-8305-255696197062	65862-491	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-492_938808b2-1a53-4c6d-8305-255696197062	65862-492	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-493_938808b2-1a53-4c6d-8305-255696197062	65862-493	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-494_938808b2-1a53-4c6d-8305-255696197062	65862-494	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-495_938808b2-1a53-4c6d-8305-255696197062	65862-495	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-496_c63f89c9-967e-4f4f-97dd-f34b6b4ffed0	65862-496	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20100608		ANDA	ANDA091348	Aurobindo Pharma Limited	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
65862-497_e45a9953-97a0-4885-acbd-5af0f22c4f74	65862-497	HUMAN PRESCRIPTION DRUG	Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate		Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA203041	Aurobindo Pharma Limited	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
65862-501_7ce23740-96b4-48d1-86f0-1e116767e1fe	65862-501	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091569	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65862-502_7ce23740-96b4-48d1-86f0-1e116767e1fe	65862-502	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091569	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65862-503_7ce23740-96b4-48d1-86f0-1e116767e1fe	65862-503	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65862-512_aeaf401b-bb3c-422a-8590-d8149fbd9fe2	65862-512	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	Aurobindo Pharma Limited	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
65862-513_aeaf401b-bb3c-422a-8590-d8149fbd9fe2	65862-513	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	Aurobindo Pharma Limited	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
65862-514_aeaf401b-bb3c-422a-8590-d8149fbd9fe2	65862-514	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	Aurobindo Pharma Limited	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
65862-515_9ba1dabb-298d-478f-b7a8-82e8ad0b1896	65862-515	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20111031		ANDA	ANDA200629	Aurobindo Pharma Limited	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-516_9ba1dabb-298d-478f-b7a8-82e8ad0b1896	65862-516	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20111031		ANDA	ANDA200629	Aurobindo Pharma Limited	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-517_0ea9763a-4db4-4fe0-a954-ab8e278c74db	65862-517	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA200296	Aurobindo Pharma Limited	RISEDRONATE SODIUM	5	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-518_0ea9763a-4db4-4fe0-a954-ab8e278c74db	65862-518	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA200296	Aurobindo Pharma Limited	RISEDRONATE SODIUM	30	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-519_0ea9763a-4db4-4fe0-a954-ab8e278c74db	65862-519	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA200296	Aurobindo Pharma Limited	RISEDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-520_fff8f484-c574-4e56-9ff5-f56968cdca59	65862-520	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	Aurobindo Pharma Limited	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
65862-521_fff8f484-c574-4e56-9ff5-f56968cdca59	65862-521	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	Aurobindo Pharma Limited	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
65862-522_fff8f484-c574-4e56-9ff5-f56968cdca59	65862-522	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	Aurobindo Pharma Limited	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
65862-523_b413e137-5b59-47cf-ad47-f144008867ec	65862-523	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Aurobindo Pharma Limited	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
65862-524_b413e137-5b59-47cf-ad47-f144008867ec	65862-524	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Aurobindo Pharma Limited	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
65862-525_6f32d553-fc2e-41e4-af54-ffe1d445db51	65862-525	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride and Metformin Hydrochloride		Pioglitazone Hydrochloride and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20130213		ANDA	ANDA200823	Aurobindo Pharma Limited	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	500; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
65862-526_6f32d553-fc2e-41e4-af54-ffe1d445db51	65862-526	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride and Metformin Hydrochloride		Pioglitazone Hydrochloride and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20130213		ANDA	ANDA200823	Aurobindo Pharma Limited	METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE	850; 15	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
65862-527_90b993cd-e9aa-4b60-8824-dc08bbb7154b	65862-527	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-528_90b993cd-e9aa-4b60-8824-dc08bbb7154b	65862-528	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-533_b8c128bc-86fe-445a-88f9-81883574cfa9	65862-533	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65862-534_b8c128bc-86fe-445a-88f9-81883574cfa9	65862-534	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65862-535_931d3641-af31-475b-ad17-431fb2f3dd80	65862-535	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	Aurobindo Pharma Limited	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
65862-536_27593c1a-6420-4b64-ae35-50a1487f7f46	65862-536	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	Aurobindo Pharma Limited	LEVOFLOXACIN	250	mg/1			N	20241231
65862-537_27593c1a-6420-4b64-ae35-50a1487f7f46	65862-537	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	Aurobindo Pharma Limited	LEVOFLOXACIN	500	mg/1			N	20241231
65862-538_27593c1a-6420-4b64-ae35-50a1487f7f46	65862-538	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	Aurobindo Pharma Limited	LEVOFLOXACIN	750	mg/1			N	20241231
65862-547_ebf62261-34b0-434c-9672-a717da9ddd9f	65862-547	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-548_ebf62261-34b0-434c-9672-a717da9ddd9f	65862-548	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-549_ebf62261-34b0-434c-9672-a717da9ddd9f	65862-549	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-550_ebf62261-34b0-434c-9672-a717da9ddd9f	65862-550	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-551_ebf62261-34b0-434c-9672-a717da9ddd9f	65862-551	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202519	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-554_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-554	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20121119		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-555_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-555	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180928		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	65	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-556_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-556	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20121119		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-557_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-557	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180928		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	115	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-558_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-558	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20121119		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-559_4f55b3b5-70cb-4168-bf64-3db08a685e68	65862-559	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	Aurobindo Pharma Limited	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65862-560_4f55b3b5-70cb-4168-bf64-3db08a685e68	65862-560	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	Aurobindo Pharma Limited	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65862-561_ed955156-766b-4bdb-a4f8-a56550c7f263	65862-561	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Aurobindo Pharma Limited	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-562_ed955156-766b-4bdb-a4f8-a56550c7f263	65862-562	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Aurobindo Pharma Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-563_ed955156-766b-4bdb-a4f8-a56550c7f263	65862-563	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Aurobindo Pharma Limited	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-564_ed955156-766b-4bdb-a4f8-a56550c7f263	65862-564	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Aurobindo Pharma Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-565_ed955156-766b-4bdb-a4f8-a56550c7f263	65862-565	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Aurobindo Pharma Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-566_ed955156-766b-4bdb-a4f8-a56550c7f263	65862-566	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Aurobindo Pharma Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-567_05310d45-6b7e-478d-8412-82f1714cc317	65862-567	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA202096	Aurobindo Pharma Limited	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
65862-568_05310d45-6b7e-478d-8412-82f1714cc317	65862-568	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA202096	Aurobindo Pharma Limited	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
65862-570_d373063c-9dc0-4788-b09a-9754d97038ad	65862-570	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA202223	Aurobindo Pharma Limited	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-571_d373063c-9dc0-4788-b09a-9754d97038ad	65862-571	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA202223	Aurobindo Pharma Limited	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-572_d373063c-9dc0-4788-b09a-9754d97038ad	65862-572	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA202223	Aurobindo Pharma Limited	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-573_d373063c-9dc0-4788-b09a-9754d97038ad	65862-573	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20150105		ANDA	ANDA202223	Aurobindo Pharma Limited	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-574_05310d45-6b7e-478d-8412-82f1714cc317	65862-574	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA202468	Aurobindo Pharma Limited	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
65862-579_05f3d676-3274-41d0-b262-b3151c0b00f5	65862-579	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Aurobindo Pharma Limited	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65862-580_05f3d676-3274-41d0-b262-b3151c0b00f5	65862-580	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Aurobindo Pharma Limited	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65862-581_05f3d676-3274-41d0-b262-b3151c0b00f5	65862-581	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Aurobindo Pharma Limited	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
65862-582_a89779b7-cfc4-473c-a3ec-448ba957a2f2	65862-582	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	2.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-583_a89779b7-cfc4-473c-a3ec-448ba957a2f2	65862-583	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-584_a89779b7-cfc4-473c-a3ec-448ba957a2f2	65862-584	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-585_a89779b7-cfc4-473c-a3ec-448ba957a2f2	65862-585	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-586_a89779b7-cfc4-473c-a3ec-448ba957a2f2	65862-586	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-587_a89779b7-cfc4-473c-a3ec-448ba957a2f2	65862-587	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-594_40d1a12b-b033-4b50-85fd-03c2a0c083e6	65862-594	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	Aurobindo Pharma Limited	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65862-595_40d1a12b-b033-4b50-85fd-03c2a0c083e6	65862-595	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	Aurobindo Pharma Limited	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65862-596_78e0ae1e-9c06-4831-b962-e1aa65546110	65862-596	HUMAN PRESCRIPTION DRUG	Clindamycin Palmitate Hydrochloride (Pediatric)		Clindamycin Palmitate Hydrochloride (Pediatric)	SOLUTION	ORAL	20130430		ANDA	ANDA202409	Aurobindo Pharma Limited	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
65862-598_94771a21-3051-46cc-8deb-200bc9f3dcb3	65862-598	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Aurobindo Pharma Limited	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
65862-599_579c01bf-3d78-4a2a-be54-80195730eeb1	65862-599	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Aurobindo Pharma Limited	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-600_579c01bf-3d78-4a2a-be54-80195730eeb1	65862-600	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Aurobindo Pharma Limited	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-601_9979e4fe-ca3d-47c2-9010-85c913efe2cc	65862-601	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Aurobindo Pharma Limited	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
65862-602_9979e4fe-ca3d-47c2-9010-85c913efe2cc	65862-602	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Aurobindo Pharma Limited	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
65862-603_a8a590fd-c803-406c-9972-ba012954059c	65862-603	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN HYDROCHLORIDE		moxifloxacin hydrochloride	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA202632	Aurobindo Pharma Limited	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
65862-604_6a54f410-0fc1-4e7d-a7d4-0f3c71d5fb79	65862-604	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Aurobindo Pharma Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65862-605_6a54f410-0fc1-4e7d-a7d4-0f3c71d5fb79	65862-605	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Aurobindo Pharma Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65862-606_6a54f410-0fc1-4e7d-a7d4-0f3c71d5fb79	65862-606	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Aurobindo Pharma Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65862-607_6a54f410-0fc1-4e7d-a7d4-0f3c71d5fb79	65862-607	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Aurobindo Pharma Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65862-608_6a54f410-0fc1-4e7d-a7d4-0f3c71d5fb79	65862-608	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Aurobindo Pharma Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65862-609_6a54f410-0fc1-4e7d-a7d4-0f3c71d5fb79	65862-609	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20121026		ANDA	ANDA202633	Aurobindo Pharma Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
65862-617_9e66076b-c857-482e-a1d3-ddc40c5171e9	65862-617	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril Hydrochloride	TABLET, FILM COATED	ORAL	20130429		ANDA	ANDA202725	Aurobindo Pharma Limited	QUINAPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-618_9e66076b-c857-482e-a1d3-ddc40c5171e9	65862-618	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril Hydrochloride	TABLET, FILM COATED	ORAL	20130429		ANDA	ANDA202725	Aurobindo Pharma Limited	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-619_9e66076b-c857-482e-a1d3-ddc40c5171e9	65862-619	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril Hydrochloride	TABLET, FILM COATED	ORAL	20130429		ANDA	ANDA202725	Aurobindo Pharma Limited	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-620_9e66076b-c857-482e-a1d3-ddc40c5171e9	65862-620	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril Hydrochloride	TABLET, FILM COATED	ORAL	20130429		ANDA	ANDA202725	Aurobindo Pharma Limited	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
65862-621_c100187f-d40e-4ffe-aab7-068a9f3bd7b9	65862-621	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20171103		ANDA	ANDA202821	Aurobindo Pharma Limited	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20251231
65862-622_c100187f-d40e-4ffe-aab7-068a9f3bd7b9	65862-622	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20171103		ANDA	ANDA202821	Aurobindo Pharma Limited	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20251231
65862-623_c100187f-d40e-4ffe-aab7-068a9f3bd7b9	65862-623	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate	TABLET	ORAL	20171103		ANDA	ANDA202821	Aurobindo Pharma Limited	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20251231
65862-624_b263300a-dc89-4ad0-b84d-715cd5bf0aec	65862-624	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	Aurobindo Pharma Limited	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
65862-625_a145439e-ef26-4622-a164-d9ca7148eaf9	65862-625	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203062	Aurobindo Pharma Limited	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-626_a145439e-ef26-4622-a164-d9ca7148eaf9	65862-626	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203062	Aurobindo Pharma Limited	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-629_6619f999-a4a4-4162-a2cc-09ec957320ed	65862-629	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130222		ANDA	ANDA203630	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-630_6619f999-a4a4-4162-a2cc-09ec957320ed	65862-630	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130222		ANDA	ANDA203630	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-631_6619f999-a4a4-4162-a2cc-09ec957320ed	65862-631	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160331		ANDA	ANDA203630	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; IRBESARTAN	25; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-632_12a923a8-378d-47ae-ba43-5c01ff3b45c2	65862-632	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Aurobindo Pharma Limited	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-633_12a923a8-378d-47ae-ba43-5c01ff3b45c2	65862-633	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Aurobindo Pharma Limited	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-634_12a923a8-378d-47ae-ba43-5c01ff3b45c2	65862-634	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Aurobindo Pharma Limited	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-635_12a923a8-378d-47ae-ba43-5c01ff3b45c2	65862-635	HUMAN PRESCRIPTION DRUG	Pravastatin sodium		Pravastatin sodium	TABLET	ORAL	20170202		ANDA	ANDA203367	Aurobindo Pharma Limited	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-637_388aa520-efb3-4265-b43b-eeaec16b952b	65862-637	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA203081	Aurobindo Pharma Limited	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-638_388aa520-efb3-4265-b43b-eeaec16b952b	65862-638	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA203081	Aurobindo Pharma Limited	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-639_388aa520-efb3-4265-b43b-eeaec16b952b	65862-639	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA203081	Aurobindo Pharma Limited	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-641_1c0e75bf-c2ba-4924-bb9a-92746d754802	65862-641	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	Aurobindo Pharma Limited	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
65862-642_1c0e75bf-c2ba-4924-bb9a-92746d754802	65862-642	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207398	Aurobindo Pharma Limited	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
65862-648_ceea2ee5-be20-4059-b3cc-530172c9aac4	65862-648	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20160325		ANDA	ANDA204572	Aurobindo Pharma Limited	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-649_ceea2ee5-be20-4059-b3cc-530172c9aac4	65862-649	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20160325		ANDA	ANDA204572	Aurobindo Pharma Limited	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-650_ceea2ee5-be20-4059-b3cc-530172c9aac4	65862-650	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20160325		ANDA	ANDA204572	Aurobindo Pharma Limited	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-651_ceea2ee5-be20-4059-b3cc-530172c9aac4	65862-651	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20160325		ANDA	ANDA204572	Aurobindo Pharma Limited	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-652_12f3b127-625b-4c19-99f5-54f0ddc5cdc0	65862-652	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20151013		ANDA	ANDA203175	Aurobindo Pharma Limited	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65862-653_12f3b127-625b-4c19-99f5-54f0ddc5cdc0	65862-653	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20151013		ANDA	ANDA203175	Aurobindo Pharma Limited	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
65862-654_990534c8-16b2-451d-bf61-7ec91ceac88d	65862-654	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET, FILM COATED	ORAL	20150619		ANDA	ANDA203437	Aurobindo Pharma Limited	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
65862-656_dccf8a2c-5978-4749-a545-1de1bbb44320	65862-656	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140515		ANDA	ANDA203708	Aurobindo Pharma Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-657_dccf8a2c-5978-4749-a545-1de1bbb44320	65862-657	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140515		ANDA	ANDA203708	Aurobindo Pharma Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-658_dccf8a2c-5978-4749-a545-1de1bbb44320	65862-658	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140515		ANDA	ANDA203708	Aurobindo Pharma Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-659_dccf8a2c-5978-4749-a545-1de1bbb44320	65862-659	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20140515		ANDA	ANDA203708	Aurobindo Pharma Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-661_c947551d-69ef-4524-8c3d-d3d0d49057aa	65862-661	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Aurobindo Pharma Limited	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-662_c947551d-69ef-4524-8c3d-d3d0d49057aa	65862-662	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Aurobindo Pharma Limited	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-663_c947551d-69ef-4524-8c3d-d3d0d49057aa	65862-663	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Aurobindo Pharma Limited	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-664_c947551d-69ef-4524-8c3d-d3d0d49057aa	65862-664	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Aurobindo Pharma Limited	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-665_c947551d-69ef-4524-8c3d-d3d0d49057aa	65862-665	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Aurobindo Pharma Limited	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-666_c947551d-69ef-4524-8c3d-d3d0d49057aa	65862-666	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Aurobindo Pharma Limited	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-670_7a7b883a-ccb0-4037-87a9-d64e5ab5d4c5	65862-670	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20140122		ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	.5	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
65862-671_7a7b883a-ccb0-4037-87a9-d64e5ab5d4c5	65862-671	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20140122		ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
65862-672_7a7b883a-ccb0-4037-87a9-d64e5ab5d4c5	65862-672	HUMAN PRESCRIPTION DRUG	Repaglinide		Repaglinide	TABLET	ORAL	20140122		ANDA	ANDA203820	Aurobindo Pharma Limited	REPAGLINIDE	2	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
65862-673_c6a84860-329c-4566-8ca2-784e43933ae7	65862-673	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	Aurobindo Pharma Limited	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-674_c6a84860-329c-4566-8ca2-784e43933ae7	65862-674	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	Aurobindo Pharma Limited	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-675_c6a84860-329c-4566-8ca2-784e43933ae7	65862-675	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	Aurobindo Pharma Limited	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-676_8067d9b3-80d3-4435-a8f1-2c45ee8a2622	65862-676	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Aurobindo Pharma Limited	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-677_8067d9b3-80d3-4435-a8f1-2c45ee8a2622	65862-677	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Aurobindo Pharma Limited	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-678_8067d9b3-80d3-4435-a8f1-2c45ee8a2622	65862-678	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Aurobindo Pharma Limited	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-679_8067d9b3-80d3-4435-a8f1-2c45ee8a2622	65862-679	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Aurobindo Pharma Limited	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
65862-687_dca8eddf-c54f-4b6e-b56c-19d6dd3e7e90	65862-687	HUMAN PRESCRIPTION DRUG	Ritonavir		Ritonavir	TABLET, FILM COATED	ORAL	20180917		ANDA	ANDA206614	Aurobindo Pharma Limited	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
65862-688_62f6d2b8-48aa-4904-a8ed-35d0c1f2b62e	65862-688	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20151118		ANDA	ANDA203963	Aurobindo Pharma Limited	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-689_f3ce5e4b-0b8b-4db0-b3b9-761691f32729	65862-689	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA203962	Aurobindo Pharma Limited	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-690_f3ce5e4b-0b8b-4db0-b3b9-761691f32729	65862-690	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA203962	Aurobindo Pharma Limited	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-691_f3ce5e4b-0b8b-4db0-b3b9-761691f32729	65862-691	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA203962	Aurobindo Pharma Limited	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-692_8b54186e-7485-40f0-8fe0-58b417dfcb7e	65862-692	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20150610		ANDA	ANDA204309	Aurobindo Pharma Limited	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
65862-693_75754a95-33cf-4bfb-bee1-7d308a227250	65862-693	HUMAN PRESCRIPTION DRUG	carisoprodol		carisoprodol	TABLET	ORAL	20161108		ANDA	ANDA040792	Aurobindo Pharma Limited	CARISOPRODOL	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
65862-694_4c2ba8f4-ea90-4eb9-a9f1-6ecfc5545f9f	65862-694	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	Aurobindo Pharma Limited	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
65862-695_4c2ba8f4-ea90-4eb9-a9f1-6ecfc5545f9f	65862-695	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	Aurobindo Pharma Limited	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
65862-697_90b993cd-e9aa-4b60-8824-dc08bbb7154b	65862-697	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111123		ANDA	ANDA200834	Aurobindo Pharma Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
65862-698_91b4f74c-a7f6-43dc-8106-145a5267caa0	65862-698	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	Aurobindo Pharma Limited	CEFUROXIME AXETIL	125	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-699_91b4f74c-a7f6-43dc-8106-145a5267caa0	65862-699	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	Aurobindo Pharma Limited	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-700_91b4f74c-a7f6-43dc-8106-145a5267caa0	65862-700	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	Aurobindo Pharma Limited	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-702_5f5b84de-9675-4d87-81dd-f22e7d257d0f	65862-702	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20161227		ANDA	ANDA204117	Aurobindo Pharma Limited	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-703_5f5b84de-9675-4d87-81dd-f22e7d257d0f	65862-703	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20161227		ANDA	ANDA204117	Aurobindo Pharma Limited	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-704_5f5b84de-9675-4d87-81dd-f22e7d257d0f	65862-704	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20161227		ANDA	ANDA204117	Aurobindo Pharma Limited	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-705_5f5b84de-9675-4d87-81dd-f22e7d257d0f	65862-705	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20161227		ANDA	ANDA204117	Aurobindo Pharma Limited	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-706_80614a03-31a5-4bd2-8f74-9bec1c9a4866	65862-706	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	Aurobindo Pharma Limited	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-707_80614a03-31a5-4bd2-8f74-9bec1c9a4866	65862-707	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	Aurobindo Pharma Limited	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
65862-709_b6e82e91-76f7-4bca-b95d-37b84e60580a	65862-709	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20150828		ANDA	ANDA204310	Aurobindo Pharma Limited	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
65862-710_01c2659d-b61e-4d7e-97b8-beb77f3be95c	65862-710	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir	CAPSULE	ORAL	20180625		ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	100	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20251231
65862-711_01c2659d-b61e-4d7e-97b8-beb77f3be95c	65862-711	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir	CAPSULE	ORAL	20180625		ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20251231
65862-712_01c2659d-b61e-4d7e-97b8-beb77f3be95c	65862-712	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir	CAPSULE	ORAL	20180625		ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20251231
65862-713_01c2659d-b61e-4d7e-97b8-beb77f3be95c	65862-713	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate		Atazanavir	CAPSULE	ORAL	20180625		ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20251231
65862-721_006b8ca7-4583-4e32-bb3a-47c04d0820f8	65862-721	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20170217		ANDA	ANDA205761	Aurobindo Pharma Limited	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65862-732_1437ec00-c400-401d-91fc-917cf5654396	65862-732	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20160603		ANDA	ANDA204742	Aurobindo Pharma Limited	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
65862-737_7b573bca-a494-4c6f-b7e5-d2b35f7c71e0	65862-737	HUMAN PRESCRIPTION DRUG	Amlodipine and valsartan		Amlodipine and valsartan	TABLET, FILM COATED	ORAL	20160422		ANDA	ANDA206512	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-738_7b573bca-a494-4c6f-b7e5-d2b35f7c71e0	65862-738	HUMAN PRESCRIPTION DRUG	Amlodipine and valsartan		Amlodipine and valsartan	TABLET, FILM COATED	ORAL	20160422		ANDA	ANDA206512	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-739_7b573bca-a494-4c6f-b7e5-d2b35f7c71e0	65862-739	HUMAN PRESCRIPTION DRUG	Amlodipine and valsartan		Amlodipine and valsartan	TABLET, FILM COATED	ORAL	20160422		ANDA	ANDA206512	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-740_7b573bca-a494-4c6f-b7e5-d2b35f7c71e0	65862-740	HUMAN PRESCRIPTION DRUG	Amlodipine and valsartan		Amlodipine and valsartan	TABLET, FILM COATED	ORAL	20160422		ANDA	ANDA206512	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-741_91e6ff5a-5235-495f-90aa-0b64008be831	65862-741	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA204798	Aurobindo Pharma Limited	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-742_91e6ff5a-5235-495f-90aa-0b64008be831	65862-742	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA204798	Aurobindo Pharma Limited	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-743_91e6ff5a-5235-495f-90aa-0b64008be831	65862-743	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA204798	Aurobindo Pharma Limited	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-744_ffaf42a9-5cec-406d-92d3-cd21075507a0	65862-744	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	CAPSULE, EXTENDED RELEASE	ORAL	20160805		ANDA	ANDA204895	Aurobindo Pharma Limited	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-745_ffaf42a9-5cec-406d-92d3-cd21075507a0	65862-745	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	CAPSULE, EXTENDED RELEASE	ORAL	20160805		ANDA	ANDA204895	Aurobindo Pharma Limited	GALANTAMINE HYDROBROMIDE	16	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-746_ffaf42a9-5cec-406d-92d3-cd21075507a0	65862-746	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	CAPSULE, EXTENDED RELEASE	ORAL	20160805		ANDA	ANDA204895	Aurobindo Pharma Limited	GALANTAMINE HYDROBROMIDE	24	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
65862-747_e27e1510-6ca9-4607-bc25-6bb4b9d262af	65862-747	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230105		ANDA	ANDA204994	Aurobindo Pharma Limited	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65862-748_e27e1510-6ca9-4607-bc25-6bb4b9d262af	65862-748	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230105		ANDA	ANDA204994	Aurobindo Pharma Limited	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65862-749_e27e1510-6ca9-4607-bc25-6bb4b9d262af	65862-749	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230105		ANDA	ANDA204994	Aurobindo Pharma Limited	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65862-750_e27e1510-6ca9-4607-bc25-6bb4b9d262af	65862-750	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230105		ANDA	ANDA204994	Aurobindo Pharma Limited	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
65862-751_8bb5971c-e916-4ee1-b3a7-b5db39d45d02	65862-751	HUMAN PRESCRIPTION DRUG	Cefixime		cefixime	POWDER, FOR SUSPENSION	ORAL	20150414		ANDA	ANDA204835	Aurobindo Pharma Limited	CEFIXIME	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-752_8bb5971c-e916-4ee1-b3a7-b5db39d45d02	65862-752	HUMAN PRESCRIPTION DRUG	Cefixime		cefixime	POWDER, FOR SUSPENSION	ORAL	20150414		ANDA	ANDA204835	Aurobindo Pharma Limited	CEFIXIME	200	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
65862-753_11d7eae2-53f4-4f8c-b5aa-4e99f3e747e5	65862-753	HUMAN PRESCRIPTION DRUG	VALGANCICLOVIR HYDROCHLORIDE		VALGANCICLOVIR HYDROCHLORIDE	TABLET	ORAL	20160331		ANDA	ANDA204750	Aurobindo Pharma Limited	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
65862-758_11034861-eef2-4996-8082-afc3c1769171	65862-758	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	25	mg/1		CV	N	20241231
65862-759_11034861-eef2-4996-8082-afc3c1769171	65862-759	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	50	mg/1		CV	N	20241231
65862-760_11034861-eef2-4996-8082-afc3c1769171	65862-760	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	75	mg/1		CV	N	20241231
65862-761_11034861-eef2-4996-8082-afc3c1769171	65862-761	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	100	mg/1		CV	N	20241231
65862-762_11034861-eef2-4996-8082-afc3c1769171	65862-762	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	150	mg/1		CV	N	20241231
65862-763_11034861-eef2-4996-8082-afc3c1769171	65862-763	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	200	mg/1		CV	N	20241231
65862-764_11034861-eef2-4996-8082-afc3c1769171	65862-764	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	225	mg/1		CV	N	20241231
65862-765_11034861-eef2-4996-8082-afc3c1769171	65862-765	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230329		ANDA	ANDA205321	Aurobindo Pharma Limited	PREGABALIN	300	mg/1		CV	N	20241231
65862-766_dee1c3bd-eb06-435a-9526-36be48a85056	65862-766	HUMAN PRESCRIPTION DRUG	FESOTERODINE FUMARATE		FESOTERODINE FUMARATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220617		ANDA	ANDA205007	Aurobindo Pharma Limited	FESOTERODINE FUMARATE	4	mg/1			N	20241231
65862-767_dee1c3bd-eb06-435a-9526-36be48a85056	65862-767	HUMAN PRESCRIPTION DRUG	FESOTERODINE FUMARATE		FESOTERODINE FUMARATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220617		ANDA	ANDA205007	Aurobindo Pharma Limited	FESOTERODINE FUMARATE	8	mg/1			N	20241231
65862-768_947eef5f-49a8-4e9a-9b70-fb27f9beed9d	65862-768	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, COATED	ORAL	20160505		ANDA	ANDA205118	Aurobindo Pharma Limited	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
65862-769_947eef5f-49a8-4e9a-9b70-fb27f9beed9d	65862-769	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, COATED	ORAL	20160505		ANDA	ANDA205118	Aurobindo Pharma Limited	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
65862-770_1c79d44d-8f10-4a8f-a0b5-21c2ba258777	65862-770	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20201203		ANDA	ANDA205190	Aurobindo Pharma Limited	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-775_77065a5e-614f-41f5-a1df-2ad2204c8e38	65862-775	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20181115		ANDA	ANDA205191	Aurobindo Pharma Limited	KETOROLAC TROMETHAMINE	4	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-776_b53425ca-66f3-4ca6-9c76-fdde179170ba	65862-776	HUMAN PRESCRIPTION DRUG	Mili		norgestimate and ethinyl estradiol	KIT		20160707		ANDA	ANDA205449	Aurobindo Pharma Limited						N	20241231
65862-777_4f010d17-76f4-4320-a0e3-1f03c594422d	65862-777	HUMAN PRESCRIPTION DRUG	Tri-Mili		Norgestimate and Ethinyl Estradiol	KIT		20160706		ANDA	ANDA205441	Aurobindo Pharma Limited						N	20251231
65862-778_cfe665cd-2ff9-42bd-a0c1-571df7fc0509	65862-778	HUMAN PRESCRIPTION DRUG	Tri-Lo-Mili		Norgestimate and Ethinyl Estradiol	KIT		20161104		ANDA	ANDA205762	Aurobindo Pharma Limited						N	20241231
65862-779_3c0b6b43-7df3-4fc4-998d-e533c1f26d7f	65862-779	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205391	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-780_3c0b6b43-7df3-4fc4-998d-e533c1f26d7f	65862-780	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205391	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-781_3c0b6b43-7df3-4fc4-998d-e533c1f26d7f	65862-781	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205391	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-782_1e44e1a2-5f6b-45af-b5fa-7a91f9ef1cef	65862-782	HUMAN PRESCRIPTION DRUG	Methenamine Hippurate		Methenamine Hippurate	TABLET	ORAL	20160705		ANDA	ANDA205661	Aurobindo Pharma Limited	METHENAMINE HIPPURATE	1	g/1			N	20241231
65862-783_46c33c0d-4062-40e0-a599-997488a20240	65862-783	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160421		ANDA	ANDA205606	Aurobindo Pharma Limited	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65862-784_46c33c0d-4062-40e0-a599-997488a20240	65862-784	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160421		ANDA	ANDA205606	Aurobindo Pharma Limited	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65862-789_fa40fc6b-1bd0-4496-b53a-8b3e1c122a50	65862-789	HUMAN PRESCRIPTION DRUG	Bromfenac		Bromfenac	SOLUTION/ DROPS	OPHTHALMIC	20220318		ANDA	ANDA204813	Aurobindo Pharma Limited	BROMFENAC SODIUM	.9	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-802_3ba5f1e6-a8f2-4205-bb03-b968326dbc08	65862-802	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20221006		ANDA	ANDA205537	Aurobindo Pharma Limited	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
65862-805_e05b6e91-7f79-41ee-ada6-cc52a92f9dac	65862-805	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20180306		ANDA	ANDA206069	Aurobindo Pharma Limited	ARMODAFINIL	50	mg/1		CIV	N	20241231
65862-806_e05b6e91-7f79-41ee-ada6-cc52a92f9dac	65862-806	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20180306		ANDA	ANDA206069	Aurobindo Pharma Limited	ARMODAFINIL	150	mg/1		CIV	N	20241231
65862-807_e05b6e91-7f79-41ee-ada6-cc52a92f9dac	65862-807	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20180306		ANDA	ANDA206069	Aurobindo Pharma Limited	ARMODAFINIL	250	mg/1		CIV	N	20241231
65862-812_f00c8695-8e03-4b40-a80b-97b49b091882	65862-812	HUMAN PRESCRIPTION DRUG	Pitavastatin		Pitavastatin	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA206015	Aurobindo Pharma Limited	PITAVASTATIN CALCIUM	1	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-813_f00c8695-8e03-4b40-a80b-97b49b091882	65862-813	HUMAN PRESCRIPTION DRUG	Pitavastatin		Pitavastatin	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA206015	Aurobindo Pharma Limited	PITAVASTATIN CALCIUM	2	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-814_f00c8695-8e03-4b40-a80b-97b49b091882	65862-814	HUMAN PRESCRIPTION DRUG	Pitavastatin		Pitavastatin	TABLET, FILM COATED	ORAL	20231102		ANDA	ANDA206015	Aurobindo Pharma Limited	PITAVASTATIN CALCIUM	4	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
65862-818_3d50ad7c-efa4-4efc-a827-701517c076df	65862-818	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA090647	Aurobindo Pharma Limited	TENOFOVIR DISOPROXIL FUMARATE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
65862-819_3d50ad7c-efa4-4efc-a827-701517c076df	65862-819	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA090647	Aurobindo Pharma Limited	TENOFOVIR DISOPROXIL FUMARATE	200	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
65862-820_3d50ad7c-efa4-4efc-a827-701517c076df	65862-820	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA090647	Aurobindo Pharma Limited	TENOFOVIR DISOPROXIL FUMARATE	250	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
65862-825_03c6454b-2a0f-4436-9d27-09db8b16a4b6	65862-825	HUMAN PRESCRIPTION DRUG	Saxagliptin		Saxagliptin	TABLET, FILM COATED	ORAL	20230731		ANDA	ANDA205972	Aurobindo Pharma Limited	SAXAGLIPTIN HYDROCHLORIDE	2.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20251231
65862-826_03c6454b-2a0f-4436-9d27-09db8b16a4b6	65862-826	HUMAN PRESCRIPTION DRUG	Saxagliptin		Saxagliptin	TABLET, FILM COATED	ORAL	20230731		ANDA	ANDA205972	Aurobindo Pharma Limited	SAXAGLIPTIN HYDROCHLORIDE	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20251231
65862-829_53fa7950-5de8-45bd-afff-ab2975214624	65862-829	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20171016		ANDA	ANDA205888	Aurobindo Pharma Limited	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
65862-830_53fa7950-5de8-45bd-afff-ab2975214624	65862-830	HUMAN PRESCRIPTION DRUG	Prasugrel		Prasugrel	TABLET, FILM COATED	ORAL	20171016		ANDA	ANDA205888	Aurobindo Pharma Limited	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
65862-831_ef7be4a9-df4c-4790-aafd-14a3111e747e	65862-831	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190625		ANDA	ANDA206125	Aurobindo Pharma Limited	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
65862-832_ef7be4a9-df4c-4790-aafd-14a3111e747e	65862-832	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190625		ANDA	ANDA206125	Aurobindo Pharma Limited	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
65862-833_ef7be4a9-df4c-4790-aafd-14a3111e747e	65862-833	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190625		ANDA	ANDA206125	Aurobindo Pharma Limited	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
65862-834_2427a2ec-4baf-41c6-a39a-070bf61083e2	65862-834	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20171219		ANDA	ANDA206180	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-835_2427a2ec-4baf-41c6-a39a-070bf61083e2	65862-835	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20171219		ANDA	ANDA206180	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-836_2427a2ec-4baf-41c6-a39a-070bf61083e2	65862-836	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20171219		ANDA	ANDA206180	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-837_2427a2ec-4baf-41c6-a39a-070bf61083e2	65862-837	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20171219		ANDA	ANDA206180	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-838_2427a2ec-4baf-41c6-a39a-070bf61083e2	65862-838	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20171219		ANDA	ANDA206180	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 320	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-840_0eb2c29c-73cb-44de-be8c-604fe8c3083f	65862-840	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN		MOXIFLOXACIN	SOLUTION/ DROPS	OPHTHALMIC	20171004		ANDA	ANDA206242	Aurobindo Pharma Limited	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
65862-841_81e4395b-8a3e-466e-b039-0a804f171b43	65862-841	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20150826		ANDA	ANDA206217	Aurobindo Pharma Limited	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-842_81e4395b-8a3e-466e-b039-0a804f171b43	65862-842	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20150826		ANDA	ANDA206217	Aurobindo Pharma Limited	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
65862-844_b2666ba9-e113-4156-86b8-7bde5b9ce216	65862-844	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Aurobindo Pharma Limited	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-845_b2666ba9-e113-4156-86b8-7bde5b9ce216	65862-845	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Aurobindo Pharma Limited	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-846_b2666ba9-e113-4156-86b8-7bde5b9ce216	65862-846	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Aurobindo Pharma Limited	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-847_b2666ba9-e113-4156-86b8-7bde5b9ce216	65862-847	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20161129		ANDA	ANDA206433	Aurobindo Pharma Limited	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-848_845e7f52-785e-4529-a173-1f481842e905	65862-848	HUMAN PRESCRIPTION DRUG	Ayuna		Levonorgestrel and Ethinyl Estradiol	KIT		20160923		ANDA	ANDA206866	Aurobindo Pharma Limited						N	20241231
65862-849_6ecdc7bb-e521-4c64-8f5c-b2e713c66026	65862-849	HUMAN PRESCRIPTION DRUG	Afirmelle		Levonorgestrel and Ethinyl Estradiol	KIT		20161114		ANDA	ANDA206886	Aurobindo Pharma Limited						N	20241231
65862-850_59f56021-1999-4ea3-ad91-5fee857692d3	65862-850	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Aurobindo Pharma Limited	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-851_59f56021-1999-4ea3-ad91-5fee857692d3	65862-851	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Aurobindo Pharma Limited	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-852_59f56021-1999-4ea3-ad91-5fee857692d3	65862-852	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Aurobindo Pharma Limited	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-853_59f56021-1999-4ea3-ad91-5fee857692d3	65862-853	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA206285	Aurobindo Pharma Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-854_6b2e8055-d50a-4d7a-80b0-b649c7486222	65862-854	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170515		ANDA	ANDA206906	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-855_6b2e8055-d50a-4d7a-80b0-b649c7486222	65862-855	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170515		ANDA	ANDA206906	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-856_6b2e8055-d50a-4d7a-80b0-b649c7486222	65862-856	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170515		ANDA	ANDA206906	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-857_6b2e8055-d50a-4d7a-80b0-b649c7486222	65862-857	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170515		ANDA	ANDA206906	Aurobindo Pharma Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
65862-858_edf711ed-63ca-f6f9-e053-2a95a90acf1b	65862-858	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	SOLUTION	RESPIRATORY (INHALATION)	20171017		ANDA	ANDA206224	Aurobindo Pharma Limited	ALBUTEROL SULFATE	.83	mg/mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
65862-859_57e42022-b04f-4275-a9b0-06e4c2c4884b	65862-859	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	Aurobindo Pharma Limited	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
65862-860_57e42022-b04f-4275-a9b0-06e4c2c4884b	65862-860	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	Aurobindo Pharma Limited	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
65862-861_4d8a3ddd-817b-407d-a7a7-e3ad69111ce1	65862-861	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160919		ANDA	ANDA206743	Aurobindo Pharma Limited	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
65862-862_4d8a3ddd-817b-407d-a7a7-e3ad69111ce1	65862-862	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160919		ANDA	ANDA206743	Aurobindo Pharma Limited	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
65862-863_96930264-0fff-4542-afdb-00f21bdfdf0a	65862-863	HUMAN PRESCRIPTION DRUG	DALFAMPRIDINE		DALFAMPRIDINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180625		ANDA	ANDA206811	Aurobindo Pharma Limited	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
65862-864_5fdeb154-0e74-44b6-a493-ed377dd838e3	65862-864	HUMAN PRESCRIPTION DRUG	Simpesse		Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol	KIT		20170407		ANDA	ANDA206851	Aurobindo Pharma Limited						N	20241231
65862-865_87a9906c-12a7-41a3-9fe8-b69afa78d61a	65862-865	HUMAN PRESCRIPTION DRUG	Iclevia		Levonorgestrel and Ethinyl Estradiol	KIT		20180629		ANDA	ANDA206850	Aurobindo Pharma Limited						N	20241231
65862-866_482c2fa6-991f-4987-b343-36652f5b7c3f	65862-866	HUMAN PRESCRIPTION DRUG	Lo Simpesse		Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol	KIT		20170428		ANDA	ANDA206852	Aurobindo Pharma Limited						N	20241231
65862-867_1ea6baf8-f05e-484f-94ec-e1edb6d1ebc8	65862-867	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150903		ANDA	ANDA206511	Aurobindo Pharma Limited	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-868_1ea6baf8-f05e-484f-94ec-e1edb6d1ebc8	65862-868	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150903		ANDA	ANDA206511	Aurobindo Pharma Limited	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-869_1ea6baf8-f05e-484f-94ec-e1edb6d1ebc8	65862-869	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150903		ANDA	ANDA206511	Aurobindo Pharma Limited	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
65862-870_66d33450-ae15-4c55-88e3-d2dcd8351ab1	65862-870	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20161021		ANDA	ANDA206768	Aurobindo Pharma Limited	RISEDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
65862-872_54d2f142-0d56-44f0-9997-72dcc00bfcb0	65862-872	HUMAN PRESCRIPTION DRUG	Latanoprost		Latanoprost	SOLUTION/ DROPS	OPHTHALMIC	20190903		ANDA	ANDA206519	Aurobindo Pharma Limited	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
65862-873_3c1b7401-ac14-45f3-bd5b-658097d1a1c6	65862-873	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA207655	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-874_3c1b7401-ac14-45f3-bd5b-658097d1a1c6	65862-874	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA207655	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-875_3c1b7401-ac14-45f3-bd5b-658097d1a1c6	65862-875	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA207655	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-876_3c1b7401-ac14-45f3-bd5b-658097d1a1c6	65862-876	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA207655	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-877_3c1b7401-ac14-45f3-bd5b-658097d1a1c6	65862-877	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA207655	Aurobindo Pharma Limited	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-878_23e11677-e5e3-44a1-9de8-5e40a2c92200	65862-878	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20221227		ANDA	ANDA206817	Aurobindo Pharma Limited	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
65862-879_23e11677-e5e3-44a1-9de8-5e40a2c92200	65862-879	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20221227		ANDA	ANDA206817	Aurobindo Pharma Limited	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
65862-880_6c79117e-7a36-4c9d-9bf3-77723b2d7323	65862-880	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190205		ANDA	ANDA206286	Aurobindo Pharma Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
65862-883_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-883	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190821		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	55	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-884_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-884	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160613		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	80	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-885_0cce7db3-c380-4ffc-89b5-53bd6b46bf59	65862-885	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160613		ANDA	ANDA202261	Aurobindo Pharma Limited	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
65862-886_0b3a1c59-d16d-41c1-a291-9a9333025f6c	65862-886	HUMAN PRESCRIPTION DRUG	SIMLIYA		Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol	KIT		20170322		ANDA	ANDA206853	Aurobindo Pharma Limited						N	20241231
65862-887_dfff8013-d2b0-41e5-909e-ee162dfbdd8f	65862-887	HUMAN PRESCRIPTION DRUG	Kalliga		Desogestrel and Ethinyl Estradiol	KIT		20170517		ANDA	ANDA207081	Aurobindo Pharma Limited						N	20241231
65862-891_aa0c1770-e92f-453b-b07f-f28d28fc092b	65862-891	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20160122		ANDA	ANDA206837	Aurobindo Pharma Limited	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-892_aa0c1770-e92f-453b-b07f-f28d28fc092b	65862-892	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	TABLET, FILM COATED	ORAL	20160122		ANDA	ANDA206837	Aurobindo Pharma Limited	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
65862-895_1f2883d8-12db-40b7-9104-22a6690a22a7	65862-895	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20230328		ANDA	ANDA207167	Aurobindo Pharma Limited	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65862-896_1f2883d8-12db-40b7-9104-22a6690a22a7	65862-896	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20230328		ANDA	ANDA207167	Aurobindo Pharma Limited	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
65862-897_bc9e730c-8402-43e3-9a17-5b4ccf717a4c	65862-897	HUMAN PRESCRIPTION DRUG	Nylia 7/7/7		Norethindrone and Ethinyl Estradiol	KIT		20161021		ANDA	ANDA207054	Aurobindo Pharma Limited						N	20241231
65862-898_ea0b61da-d6b9-4ad7-85b4-5c3afd6e32b0	65862-898	HUMAN PRESCRIPTION DRUG	Nylia 1/35		Norethindrone and Ethinyl Estradiol	KIT		20161021		ANDA	ANDA207056	Aurobindo Pharma Limited						N	20241231
65862-899_e128a04a-71a7-402c-9afd-375104504b92	65862-899	HUMAN PRESCRIPTION DRUG	Cyonanz		Norethindrone and Ethinyl Estradiol	KIT		20161021		ANDA	ANDA207055	Aurobindo Pharma Limited						N	20241231
65862-905_08eada61-404a-b5f8-e063-6294a90a74e7	65862-905	HUMAN PRESCRIPTION DRUG	Ipratropium bromide		Ipratropium bromide	SOLUTION	RESPIRATORY (INHALATION)	20161027		ANDA	ANDA206543	Aurobindo Pharma Limited	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
65862-906_08febdad-3a3d-f105-e063-6294a90a0b3b	65862-906	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20200709		ANDA	ANDA206532	Aurobindo Pharma Limited	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
65862-907_1992870d-994a-4db4-97b6-be46e6f68182	65862-907	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20160201		ANDA	ANDA206827	Aurobindo Pharma Limited	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-908_1992870d-994a-4db4-97b6-be46e6f68182	65862-908	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20160201		ANDA	ANDA206827	Aurobindo Pharma Limited	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-909_1992870d-994a-4db4-97b6-be46e6f68182	65862-909	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20160201		ANDA	ANDA206827	Aurobindo Pharma Limited	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-910_1992870d-994a-4db4-97b6-be46e6f68182	65862-910	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20160201		ANDA	ANDA206827	Aurobindo Pharma Limited	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
65862-914_23f45a0d-e537-43d2-8e6f-e5b6dfd3e028	65862-914	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160511		ANDA	ANDA207021	Aurobindo Pharma Limited	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-915_23f45a0d-e537-43d2-8e6f-e5b6dfd3e028	65862-915	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160511		ANDA	ANDA207021	Aurobindo Pharma Limited	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-921_0ef3a3e0-266f-4842-903e-2a0cb653af38	65862-921	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20170717		ANDA	ANDA207179	Aurobindo Pharma Limited	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
65862-922_596e47f5-cbb0-46be-a6e9-37fe7e187ff9	65862-922	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20170322		ANDA	ANDA207152	Aurobindo Pharma Limited	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
65862-925_0caa1c4e-9536-49b0-a523-b6a6676434ba	65862-925	HUMAN PRESCRIPTION DRUG	Incassia		NORETHINDRONE	TABLET	ORAL	20160923		ANDA	ANDA207304	Aurobindo Pharma Limited	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
65862-926_c442d603-f61f-4f9e-8776-15d764842c27	65862-926	HUMAN PRESCRIPTION DRUG	Nexesta Fe		norethindrone and ethinyl estradiol and ferrous fumarate	KIT		20170202		ANDA	ANDA207535	Aurobindo Pharma Limited						N	20241231
65862-927_381422a1-3810-40c2-bc67-d5eaf72b6a62	65862-927	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20140920		ANDA	ANDA203687	Aurobindo Pharma Limited	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
65862-928_76a50761-0bcc-4561-8dc2-ec9acf969d16	65862-928	HUMAN PRESCRIPTION DRUG	Sumatriptan and Naproxen Sodium		Sumatriptan and Naproxen Sodium	TABLET, FILM COATED	ORAL	20180215		ANDA	ANDA207457	Aurobindo Pharma Limited	NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE	500; 85	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
65862-929_788f1fe3-d8a1-42cc-9280-07f842da34ea	65862-929	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		Nitrofurantoin (Monohydrate/Macrocrystals)	CAPSULE	ORAL	20230330		ANDA	ANDA209225	Aurobindo Pharma Limited	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
65862-930_e8c6db3c-3509-4033-8161-555236328bed	65862-930	HUMAN PRESCRIPTION DRUG	SEVELAMER CARBONATE		SEVELAMER CARBONATE	POWDER, FOR SUSPENSION	ORAL	20170613		ANDA	ANDA207624	Aurobindo Pharma Limited	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
65862-931_e8c6db3c-3509-4033-8161-555236328bed	65862-931	HUMAN PRESCRIPTION DRUG	SEVELAMER CARBONATE		SEVELAMER CARBONATE	POWDER, FOR SUSPENSION	ORAL	20170613		ANDA	ANDA207624	Aurobindo Pharma Limited	SEVELAMER CARBONATE	2400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
65862-934_8b98eb73-94c9-43f2-bc65-de59a5ed1aed	65862-934	HUMAN PRESCRIPTION DRUG	Aurovela 24 Fe		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170615		ANDA	ANDA207504	Aurobindo Pharma Limited						N	20241231
65862-935_07926174-446c-43dc-9db1-db8b78432645	65862-935	HUMAN PRESCRIPTION DRUG	Aurovela 1.5/30		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20170626		ANDA	ANDA207581	Aurobindo Pharma Limited	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	30; 1.5	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
65862-936_162204c0-4791-44bc-9c2e-45f354987013	65862-936	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20160114		ANDA	ANDA207672	Aurobindo Pharma Limited	PARICALCITOL	1	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
65862-937_162204c0-4791-44bc-9c2e-45f354987013	65862-937	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20160114		ANDA	ANDA207672	Aurobindo Pharma Limited	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
65862-938_162204c0-4791-44bc-9c2e-45f354987013	65862-938	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20160114		ANDA	ANDA207672	Aurobindo Pharma Limited	PARICALCITOL	4	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
65862-939_e42c0b14-e08a-4e77-8ead-8b44fb472f5f	65862-939	HUMAN PRESCRIPTION DRUG	Aurovela 1/20		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20170616		ANDA	ANDA207506	Aurobindo Pharma Limited	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	20; 1	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
65862-940_2fb192cb-1d17-41ce-8fbb-04f188f6079b	65862-940	HUMAN PRESCRIPTION DRUG	Aurovela Fe 1/20		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170616		ANDA	ANDA207505	Aurobindo Pharma Limited						N	20241231
65862-941_837c477f-da74-4754-90a5-a33af31a6fea	65862-941	HUMAN PRESCRIPTION DRUG	AUROVELA Fe		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170615		ANDA	ANDA207580	Aurobindo Pharma Limited						N	20241231
65862-942_08fe55b3-a3cd-d8cf-e063-6394a90a1a95	65862-942	HUMAN PRESCRIPTION DRUG	LEVALBUTEROL		LEVALBUTEROL	SOLUTION, CONCENTRATE	RESPIRATORY (INHALATION)	20170131		ANDA	ANDA207628	Aurobindo Pharma Limited	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/.5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
65862-943_08fb4748-d22b-35af-e063-6394a90a0827	65862-943	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20161230		ANDA	ANDA207625	Aurobindo Pharma Limited	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
65862-944_08fb4748-d22b-35af-e063-6394a90a0827	65862-944	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20161230		ANDA	ANDA207625	Aurobindo Pharma Limited	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
65862-945_08fb4748-d22b-35af-e063-6394a90a0827	65862-945	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol	SOLUTION	RESPIRATORY (INHALATION)	20161230		ANDA	ANDA207625	Aurobindo Pharma Limited	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
65862-946_2db40040-9747-4af8-9666-d09daa6238c4	65862-946	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20210514		ANDA	ANDA207629	Aurobindo Pharma Limited	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-947_fd6c28a4-40df-487d-abe5-e71744941af1	65862-947	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate Preservative Free		Dorzolamide Hydrochloride and Timolol Maleate Preservative Free	SOLUTION/ DROPS	OPHTHALMIC	20180724		ANDA	ANDA207630	Aurobindo Pharma Limited	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
65862-953_6ab7b492-d568-4fae-a993-f52921691c6a	65862-953	HUMAN PRESCRIPTION DRUG	LURASIDONE HYDROCHLORIDE		LURASIDONE HYDROCHLORIDE	TABLET	ORAL	20230310		ANDA	ANDA208045	Aurobindo Pharma Limited	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-954_6ab7b492-d568-4fae-a993-f52921691c6a	65862-954	HUMAN PRESCRIPTION DRUG	LURASIDONE HYDROCHLORIDE		LURASIDONE HYDROCHLORIDE	TABLET	ORAL	20230310		ANDA	ANDA208045	Aurobindo Pharma Limited	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-955_6ab7b492-d568-4fae-a993-f52921691c6a	65862-955	HUMAN PRESCRIPTION DRUG	LURASIDONE HYDROCHLORIDE		LURASIDONE HYDROCHLORIDE	TABLET	ORAL	20230310		ANDA	ANDA208045	Aurobindo Pharma Limited	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-956_6ab7b492-d568-4fae-a993-f52921691c6a	65862-956	HUMAN PRESCRIPTION DRUG	LURASIDONE HYDROCHLORIDE		LURASIDONE HYDROCHLORIDE	TABLET	ORAL	20230310		ANDA	ANDA208045	Aurobindo Pharma Limited	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-957_6ab7b492-d568-4fae-a993-f52921691c6a	65862-957	HUMAN PRESCRIPTION DRUG	LURASIDONE HYDROCHLORIDE		LURASIDONE HYDROCHLORIDE	TABLET	ORAL	20230310		ANDA	ANDA208045	Aurobindo Pharma Limited	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
65862-959_8e9bfd31-9e95-4357-8fe9-44e441c2a53d	65862-959	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	Aurobindo Pharma Limited	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
65862-967_a39aa520-c8ad-4f39-ad71-04a839474b5b	65862-967	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Aurobindo Pharma Limited	ESZOPICLONE	1	mg/1		CIV	N	20241231
65862-968_a39aa520-c8ad-4f39-ad71-04a839474b5b	65862-968	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Aurobindo Pharma Limited	ESZOPICLONE	2	mg/1		CIV	N	20241231
65862-969_a39aa520-c8ad-4f39-ad71-04a839474b5b	65862-969	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Aurobindo Pharma Limited	ESZOPICLONE	3	mg/1		CIV	N	20241231
65862-976_f9fd6909-1527-4096-bbd8-b4f60a16026c	65862-976	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20161215		ANDA	ANDA208727	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-977_f9fd6909-1527-4096-bbd8-b4f60a16026c	65862-977	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20161215		ANDA	ANDA208727	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-978_f9fd6909-1527-4096-bbd8-b4f60a16026c	65862-978	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20161215		ANDA	ANDA208727	Aurobindo Pharma Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
65862-986_43cc6b36-fcf7-4e43-b66a-00eecc48d0a7	65862-986	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181219		ANDA	ANDA210921	Aurobindo Pharma Limited	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65862-987_43cc6b36-fcf7-4e43-b66a-00eecc48d0a7	65862-987	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181219		ANDA	ANDA210921	Aurobindo Pharma Limited	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
65862-998_e05b6e91-7f79-41ee-ada6-cc52a92f9dac	65862-998	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20181207		ANDA	ANDA206069	Aurobindo Pharma Limited	ARMODAFINIL	200	mg/1		CIV	N	20241231
65868-001_0762048c-6f59-bff3-e063-6294a90abb66	65868-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20120125		UNAPPROVED MEDICAL GAS		Mercy Home Medical Equipment Inc dba MercyOne Clinton Home Medical Equipment	OXYGEN	99	L/100L			N	20251231
65875-101_ed7cb2f8-8ab8-497f-b09b-f5ceeef96e5b	65875-101	HUMAN PRESCRIPTION DRUG	Avoca Flexible Caustic Applicator		Silver Nitrate Applicator	STICK	TOPICAL	19250401		UNAPPROVED DRUG OTHER		Bray Group Limited	SILVER NITRATE	30	mg/40mg			N	20241231
65912-001_0c66f460-5083-e7c2-e063-6294a90a549c	65912-001	HUMAN OTC DRUG	Pro-Collagen Marine	Broad Spectrum SPF 30	AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	CREAM	TOPICAL	20180119		OTC MONOGRAPH DRUG	M020	ELEMIS Limited	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	10; 10; 5	mg/g; mg/g; mg/g			N	20241231
65912-002_0c6746b7-c401-05e3-e063-6394a90a9d80	65912-002	HUMAN OTC DRUG	Dynamic Resurfacing	SPF 30	AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	CREAM	TOPICAL	20180305		OTC MONOGRAPH DRUG	M020	ELEMIS Limited	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	10; 10; 5	mg/g; mg/g; mg/g			N	20241231
65912-003_0c67ff19-b790-377f-e063-6294a90a5de9	65912-003	HUMAN OTC DRUG	Daily Defence Shield	SPF 30	AVOBENZONE, OCTINOXATE, and OCTOCRYLENE	CREAM	TOPICAL	20180604		OTC MONOGRAPH DRUG	M020	ELEMIS Limited	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	14; 14; 7	mg/g; mg/g; mg/g			N	20241231
65912-010_fa5428f3-1517-d51e-e053-6294a90ad3f8	65912-010	HUMAN OTC DRUG	PRO-COLLAGEN PERFECT DUO		Avobenzone, Octinoxate, and Octocrylene	KIT		20230901		OTC MONOGRAPH FINAL	part352	Elemis Ltd.						N	20241231
65912-011_fd7ae529-30c8-f5c5-e053-6294a90ab3a8	65912-011	HUMAN OTC DRUG	GIFT OF PRO-COLLAGEN ICONS		Avobenzone, Octinoxate, and Octocrylene	KIT		20230901		OTC MONOGRAPH FINAL	part352	Elemis Ltd.						N	20241231
65915-123_0762c090-4866-e6fb-e063-6294a90a60c2	65915-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20180901		UNAPPROVED MEDICAL GAS		St. Luke Community Hospital and Nursing Home dba Saint Luke Community Oxygen & Medical Equipment	OXYGEN	99	L/100L			N	20241231
65919-002_0801db1a-6a29-c572-e063-6394a90a00a1	65919-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20000601		NDA	NDA205839	Clinical 1 Home Medical, Inc.	NITROGEN	99	L/100L			N	20241231
65919-004_0801c23b-f704-a04b-e063-6394a90a2f19	65919-004	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000601		NDA	NDA205840	Clinical 1 Home Medical, Inc.	OXYGEN	990	mL/L			N	20241231
65923-003_db8b0d8a-b2e3-4e28-e053-2a95a90a46f0	65923-003	HUMAN OTC DRUG	Family Care Hemorrhoidal		Mineral oil	OINTMENT	TOPICAL	20141124		OTC MONOGRAPH FINAL	part346	United Exchange Corp	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/100g; mg/100g; mg/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
65923-021_db8b8bb2-c726-e832-e053-2995a90a005d	65923-021	HUMAN OTC DRUG	Family Care Antifungal		Tolnaftate	CREAM	TOPICAL	20170102		OTC MONOGRAPH FINAL	part333C	United Exchange Corp.	TOLNAFTATE	10	mg/g			N	20241231
65923-035_deaf6080-d274-9ed5-e053-2995a90aeab6	65923-035	HUMAN OTC DRUG	Gelmicin Hydrocortisone with Aloe		Hydrocortisone	CREAM	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65923-046_de20833b-e6f5-35f9-e053-2995a90a46cd	65923-046	HUMAN OTC DRUG	Family Care Triple Antibiotic		Neomycin, Bacitracin, Polymyxin B	OINTMENT	TOPICAL	20140619		OTC MONOGRAPH FINAL	part333B	United Exchange Corp.	BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
65923-052_db8b8cb9-32c7-ec97-e053-2a95a90a02b1	65923-052	HUMAN OTC DRUG	Family Care Antifungal		Clotrimazole	CREAM	TOPICAL	20180101		OTC MONOGRAPH FINAL	part333C	United Exchange Corp.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
65923-094_db8bc2f1-c050-30ae-e053-2995a90ac857	65923-094	HUMAN OTC DRUG	Iodent Oral Analgesic		Benzocaine	GEL	TOPICAL	20180102		OTC MONOGRAPH NOT FINAL	part356	United Exchange Corp.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
65923-104_db8bc5f9-c3ef-607f-e053-2995a90aa8df	65923-104	HUMAN OTC DRUG	Family Care Maximum Strength Medicated Anti Itch		Menthol	CREAM	TOPICAL	20141124		OTC MONOGRAPH FINAL	part346	United Exchange Corp.	MENTHOL; PRAMOXINE HYDROCHLORIDE	10; 10	mg/g; mg/g			N	20241231
65923-121_db8bc5f9-c3f0-607f-e053-2995a90aa8df	65923-121	HUMAN OTC DRUG	Coralite Extra Strength Pain Relief Sleeve Knee		Menthol	PATCH	TOPICAL	20160210		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	MENTHOL	336	mg/1			N	20241231
65923-122_db8bc889-3c32-c281-e053-2a95a90aaf03	65923-122	HUMAN OTC DRUG	Coralite Extra Strength Pain Relief Sleeve Wrist		Menthol	PATCH	TOPICAL	20160210		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	MENTHOL	336	mg/1			N	20241231
65923-123_db8bc5f9-c3f2-607f-e053-2995a90aa8df	65923-123	HUMAN OTC DRUG	Coralite Medicated Heat		Capsaicin	PATCH	TOPICAL	20160210		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	CAPSAICIN	249	mg/1			N	20241231
65923-144_db8bc5f9-c3f3-607f-e053-2995a90aa8df	65923-144	HUMAN OTC DRUG	Family Care Muscle and Joint		Menthol	GEL	TOPICAL	20191023		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	MENTHOL, UNSPECIFIED FORM	25	mg/g			N	20241231
65923-146_c3f985f3-b797-c03a-e053-2a95a90a9e98	65923-146	HUMAN OTC DRUG	Coralite Pain Relief Hot		Menthol and Capsaicin	PATCH	TOPICAL	20181023		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corporation	CAPSAICIN; MENTHOL	.83; 30	mg/g; mg/g			N	20241231
65923-147_d5cce261-81d7-650a-e053-2a95a90a783d	65923-147	HUMAN OTC DRUG	Coralite Cold and Hot Medicated		Menthol	PATCH	TOPICAL	20181023		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corporation	MENTHOL	50	mg/g			N	20241231
65923-148_fda5459f-9f62-1a9f-e053-6394a90a1747	65923-148	HUMAN OTC DRUG	Coralite Muscle and Joint Pain Relief		Camphor, Menthol, and Mehtyl salicylate	PATCH	TOPICAL	20181023		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corporation	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	12; 57; 63	mg/g; mg/g; mg/g			N	20241231
65923-149_0bb360bc-6151-7396-e063-6294a90a78c8	65923-149	HUMAN OTC DRUG	Coralite Odor Free Pain Relief		Lidocaine	PATCH	TOPICAL	20181029		OTC MONOGRAPH DRUG	M017	United Exchange Corporation	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
65923-154_d5d1487a-4470-7275-e053-2a95a90a2e7d	65923-154	HUMAN OTC DRUG	Coralite Cold and Hot Medicated		MENTHOL	PATCH	TOPICAL	20181022		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corporation	MENTHOL	5	mg/g			N	20241231
65923-161_db8bc5f9-c3f4-607f-e053-2995a90aa8df	65923-161	HUMAN OTC DRUG	Coralite Muscle and Joint Pain Relief		Capsacin	LIQUID	TOPICAL	20150508		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	CAPSAICIN	.0015	g/mL			N	20241231
65923-163_f22d1431-569c-6b25-e053-2a95a90a2866	65923-163	HUMAN OTC DRUG	Coralite Muscle and Joint Pain Relief		Camphor, Menthol, and Mehtyl salicylate	PATCH	TOPICAL	20230113		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corporation	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	12; 57; 63	mg/g; mg/g; mg/g			N	20241231
65923-205_fb344343-9c5f-9e81-e053-6394a90ada74	65923-205	HUMAN OTC DRUG	Coralite Cold and Hot		Menthol	PATCH	TOPICAL	20190404		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	MENTHOL	5	mg/1			N	20241231
65923-214_064a6149-a0e3-8a73-e063-6394a90a7953	65923-214	HUMAN OTC DRUG	Coralite Cold and Hot		Menthol	PATCH	TOPICAL	20230926		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	MENTHOL	210	mg/1			N	20241231
65923-491_df27620e-7313-8082-e053-2995a90aaca6	65923-491	HUMAN OTC DRUG	Family Care First Aid		Bacitracin Zinc	OINTMENT	TOPICAL	20220517		OTC MONOGRAPH FINAL	part333B	United Exchange Corp.	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
65923-493_06737393-d4af-3e7b-e063-6394a90ac19f	65923-493	HUMAN OTC DRUG	Family Care Saline		Sodium Chloride	SPRAY	NASAL	20230928		OTC MONOGRAPH DRUG	M012	United Exchange Corp.	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
65923-494_deb09e89-9795-89a7-e053-2a95a90abdf8	65923-494	HUMAN OTC DRUG	Family Care Anti-Itch		Hydrocortisone	CREAM	TOPICAL	20220510		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65923-510_06492ef7-9a57-dbec-e063-6294a90ab988	65923-510	HUMAN OTC DRUG	Family Care Original Eye		TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20141125		OTC MONOGRAPH FINAL	part349	United Exchange Corp	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
65923-511_9ee3113e-3f1c-50dc-e053-2a95a90a2eb6	65923-511	HUMAN OTC DRUG	Family Care Advanced Formula Eye		Tetrahydrozoline hydrochloride, dextran 70, polyethylene glycol 400, povidone	SOLUTION/ DROPS	OPHTHALMIC	20141125		OTC MONOGRAPH FINAL	part349	United Exchange Corp	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
65923-532_db8bc889-3c35-c281-e053-2a95a90aaf03	65923-532	HUMAN OTC DRUG	Coralite Ultra Strength Pain Relief		Camphor Menthol	OINTMENT	TOPICAL	20141015		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	CAMPHOR (SYNTHETIC); MENTHOL	110; 110	mg/g; mg/g			N	20241231
65923-555_d0654d68-0479-e92c-e053-2a95a90ae2dc	65923-555	HUMAN OTC DRUG	FAMILY CARE LUBRICANT SINGLE USE EYE		CARBOXYMETHYLCELLULOSE SODIUM	SOLUTION/ DROPS	OPHTHALMIC	20130228		OTC MONOGRAPH FINAL	part349	UNITED EXCHANGE CORP	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
65923-564_ded9721b-b136-82a3-e053-2995a90adba7	65923-564	HUMAN OTC DRUG	Coralite Pain Relief		Camphor, Menthol, Methyl Salicylate	PATCH	TOPICAL	20160412		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	1.2; 5.7; 6.3	g/100g; g/100g; g/100g			N	20241231
65923-570_00268556-0741-8ac9-e063-6394a90a96e3	65923-570	HUMAN OTC DRUG	Family Care Nasal Relief		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20130630		OTC MONOGRAPH FINAL	part341	United Exchange Corp	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
65923-571_db8bc889-3c36-c281-e053-2a95a90aaf03	65923-571	HUMAN OTC DRUG	Family Care Nasal Relief		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20130531		OTC MONOGRAPH FINAL	part341	United Exchange Corp	OXYMETAZOLINE HYDROCHLORIDE	5	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
65923-639_db8bc889-3c37-c281-e053-2a95a90aaf03	65923-639	HUMAN OTC DRUG	Family Care Earwax Removal		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20191022		OTC MONOGRAPH FINAL	part344	United Exchange Corp.	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
65923-645_9c223c8a-bfeb-4ba2-e053-2995a90ade49	65923-645	HUMAN OTC DRUG	Family Care Redness Relief		Glycerin and Naphazoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20191212		OTC MONOGRAPH FINAL	part349	United Exchange Corp.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	5; .3	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
65923-657_d0796e76-bb55-8b56-e053-2a95a90a53b2	65923-657	HUMAN OTC DRUG	Restore Plus Single Vial		Carboxmethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20160101		OTC MONOGRAPH FINAL	part349	United Exchange Corp.	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
65923-831_fae29043-efde-429a-e053-6294a90acb24	65923-831	HUMAN OTC DRUG	Coralite Antibacterial Moist		Benzalkonium Chloride	SOLUTION	TOPICAL	20130926		OTC MONOGRAPH NOT FINAL	part333A	United Exchange Corp.	BENZALKONIUM CHLORIDE	.115	g/1			N	20241231
65923-925_db8bc2f1-c051-30ae-e053-2995a90ac857	65923-925	HUMAN OTC DRUG	Family Care Anti-Itch		Hydrocortisone	CREAM	TOPICAL	20190722		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
65923-987_db8bd5dc-75f0-f411-e053-2a95a90ad955	65923-987	HUMAN OTC DRUG	Family Care Muscle Rub		Camphor, Menthol, and Methyl Salicylate	CREAM	TOPICAL	20180117		OTC MONOGRAPH NOT FINAL	part348	United Exchange Corp.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
65954-041_30ef40b9-e0d4-49e7-9f38-a3d59e81e80f	65954-041	HUMAN OTC DRUG	COLGATE	MAX WHITE WITH MINI BRIGHT STRIPS Crystal MINT	SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20110726		OTC MONOGRAPH FINAL	part355	Mission Hills S.A de C.V	SODIUM FLUORIDE	1.1	mg/g			N	20241231
65954-064_c4601d86-19e8-4359-ad69-a85b8ceff8f6	65954-064	HUMAN OTC DRUG	COLGATE ULTRA BRITE ADVANCED WHITENING ALL IN ONE CLEAN MINT		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20051116		OTC MONOGRAPH FINAL	part355	Mission Hills S.A de C.V	SODIUM FLUORIDE	1.1	mg/g			N	20241231
65954-592_22e8c088-1ea0-4b90-8dc5-62c0e833d193	65954-592	HUMAN OTC DRUG	Colgate Fluoride - Trolls - Mild Bubble Fruit		SODIUM FLUORIDE	GEL, DENTIFRICE	DENTAL	20160630		OTC MONOGRAPH FINAL	part355	Mission Hills S.A de C.V	SODIUM FLUORIDE	1.1	mg/g			N	20241231
65954-814_89670403-b8af-4dd6-9148-220f2ba8bfcd	65954-814	HUMAN OTC DRUG	Colgate Optic White Stain Fighter Clean Mint		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220601		OTC MONOGRAPH FINAL	part355	Mission Hills, S.A. de C.V.	SODIUM FLUORIDE	1	mg/g			N	20241231
65954-820_96d1fa0d-2666-4bdc-8a9b-fcec1fbc7d78	65954-820	HUMAN OTC DRUG	Colgate Total SF Clean Mint		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20220725		OTC MONOGRAPH FINAL	part355	Mission Hills S.A de C.V	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
65966-016_fa294774-49e8-9438-e053-6294a90ad988	65966-016	HUMAN OTC DRUG	LA MER THE BROAD SPECTRUM SPF 50 UV PROTECTING FLUID		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE	LOTION	TOPICAL	20130505		OTC MONOGRAPH FINAL	M020	MAX HUBER RESEARCH LAB INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 50; 50; 27; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
65966-018_08ef79c0-b6e7-f12c-e063-6394a90a56d1	65966-018	HUMAN OTC DRUG	THE SOF FLUID LONG WEAR FOUNDATION BROAD SPECTRUM SPF 20		OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20160301		OTC MONOGRAPH DRUG	M020	MAX HUBER RESEARCH LAB INC	OCTINOXATE; TITANIUM DIOXIDE	75; 19	mg/mL; mg/mL			N	20241231
65966-019_0370a06e-c2fe-d298-e063-6294a90af074	65966-019	HUMAN OTC DRUG	LA MER THE LUMINOUS LIFTING CUSHION FOUNDATION BROAD SPECTRUM SPF 20		Titanium Dioxide	LOTION	TOPICAL	20180701		OTC MONOGRAPH FINAL	M020	MAX HUBER RESEARCH LAB INC	TITANIUM DIOXIDE	6.5	g/100g			N	20241231
65966-020_0370ad4c-c402-5ec7-e063-6394a90a9d2d	65966-020	HUMAN OTC DRUG	LA MER THE SOFT MOISTURE FOUNDATION BROAD SPECTRUM SPF 30		octinoxate and titanium dioxide	POWDER	TOPICAL	20190617		OTC MONOGRAPH FINAL	M020	MAX HUBER RESEARCH LAB INC	OCTINOXATE; TITANIUM DIOXIDE	5.1; 6	g/100g; g/100g			N	20241231
65966-021_08f02263-911e-16e5-e063-6394a90a63f6	65966-021	HUMAN OTC DRUG	LA MER THE RADIANT SKINTINT BROAD SPECTRUM SPF 30		OCTINOXATE, OCTISALATE, and TITANIUM DIOXIDE	CREAM	TOPICAL	20200226		OTC MONOGRAPH DRUG	M020	MAX HUBER RESEARCH LAB INC	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	75; 20; 53	mg/mL; mg/mL; mg/mL			N	20241231
65976-100_ad8f433c-5b37-4c11-a8af-d6bbd27539eb	65976-100	HUMAN PRESCRIPTION DRUG	Arestin		Minocycline Hydrochloride	POWDER	ORAL	20110321		NDA	NDA050781	OraPharma, Inc.	MINOCYCLINE HYDROCHLORIDE	1	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
66019-310_3a37f4d1-1fda-4982-adb6-a2fb9204b7c8	66019-310	VACCINE	FluMist Quadrivalent		Influenza Vaccine Live Intranasal	SPRAY	NASAL	20230814		BLA	BLA125020	MedImmune, LLC	INFLUENZA A VIRUS A/NORWAY/16606/2021 (H3N2) LIVE (ATTENUATED) ANTIGEN; INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 LIVE (ATTENUATED) ANTIGEN	10000000; 10000000; 10000000; 10000000	[FFU]/.2mL; [FFU]/.2mL; [FFU]/.2mL; [FFU]/.2mL			N	20241231
66051-236_08fd26de-c3a9-1502-e063-6394a90a8900	66051-236	HUMAN OTC DRUG	Eyewash Additive Concentrate		Water and Propylene Glycol	LIQUID	OPHTHALMIC	20190702		OTC MONOGRAPH DRUG	M018	Haws Corporation	PROPYLENE GLYCOL; WATER	280; 2374.4	kg/2800L; L/2800L			N	20241231
66059-0003_0c0071e9-7efb-dfdb-e063-6394a90af616	66059-0003	HUMAN OTC DRUG	Ramedica Roll On		Camphor,Eucalyptus Oil,Menthol,Wintergreen (Methyl Salicylate)	OIL	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	Ramedicare Sdn. Bhd.	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	10.8; 7; 11; .2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
66059-0004_0c0042fb-3797-581e-e063-6294a90ae342	66059-0004	HUMAN OTC DRUG	Ramedica Herbal Wonder Balm		Camphor,Eucalyptus Oil,Menthol,Wintergreen (Methyl Salicylate)	OINTMENT	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	Ramedicare Sdn. Bhd.	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	10.8; 7; 11; .2	g/100g; g/100g; g/100g; g/100g			N	20241231
66077-693_0c42240b-580d-eb4f-e063-6394a90a24ee	66077-693	HUMAN OTC DRUG	INSTANT		INSTANT	LIQUID	TOPICAL	20101018		OTC MONOGRAPH DRUG	505G(a)(3)	Ultra-Chem, Inc.	ALCOHOL	67	mL/100mL			N	20241231
66077-708_ab973869-205d-7943-e053-2a95a90a7700	66077-708	HUMAN OTC DRUG	Prevent		Chloroxylenol	SOAP	TOPICAL	20121112		OTC MONOGRAPH NOT FINAL	part333A	Ultra-Chem Inc.	CHLOROXYLENOL	3.75	mg/mL			N	20241231
66083-741_06fd4714-92fc-1947-e063-6294a90a55db	66083-741	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110214		UNAPPROVED MEDICAL GAS		Boone Drugs, Inc	OXYGEN	99	L/100L			N	20241231
66096-114_d44b7dc6-41ea-5d79-e053-2995a90a5919	66096-114	HUMAN OTC DRUG	Cold		Aconitum Napellus, Bryonia Alba, Eupatorium Perfoliatum, Ferrum Phosphoricum, Gelsemium Sempervirens, Kali Bichromicum, Kali lodatum, Zincum Gluconicum.	LIQUID	ORAL	20170109		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; POTASSIUM DICHROMATE; POTASSIUM IODIDE; ZINC GLUCONATE	4; 6; 4; 4; 6; 6; 6; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66096-115_d44af2b7-f773-3d27-e053-2a95a90abc46	66096-115	HUMAN OTC DRUG	Cough Relief		Aconitum Nap, Antimon Crud, Antimon Sulph, Antimon Tart, Aralia Rac, Bryonia, Chelidonium Maj, Cuprum Met, Drosera, Hepar Sulph Calc, Kali Carb, Spongia.	LIQUID	ORAL	20150521		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; ANTIMONY PENTASULFIDE; ANTIMONY POTASSIUM TARTRATE; ANTIMONY TRISULFIDE; ARALIA RACEMOSA ROOT; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CHELIDONIUM MAJUS; COPPER; DROSERA ROTUNDIFOLIA; POTASSIUM CARBONATE; SPONGIA OFFICINALIS SKELETON, ROASTED	6; 8; 8; 8; 4; 6; 12; 6; 12; 6; 12; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66096-119_d44b0ecf-2af2-26e4-e053-2a95a90ad19a	66096-119	HUMAN OTC DRUG	OHM Immune Complex		Adrenal Gland, Echinacea Angustifolia, Ferrum Phosphoricum, Kali Muriaticum, Liver Extractum, Pituitarum Posterium, Placenta Totalis Suis, Viscum Album.	LIQUID	ORAL	20160301		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BOS TAURUS ADRENAL GLAND; ECHINACEA ANGUSTIFOLIA; FERROSOFERRIC PHOSPHATE; MAMMAL LIVER; POTASSIUM CHLORIDE; SUS SCROFA PITUITARY GLAND, POSTERIOR; SUS SCROFA PLACENTA; VISCUM ALBUM FRUITING TOP	8; 3; 6; 8; 4; 8; 8; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66096-120_d44b1652-5b98-2927-e053-2a95a90a48f9	66096-120	HUMAN OTC DRUG	OHM Fatigue Relief		Aceticum Ac, Adrenal Gland, Arnica, Benzoicum Ac, Ferrum Phos, Fluoricum Ac, Ginseng, Kali Carb, Kali lod, Kali Mur, Kali Phos, Lacticum Ac, Phosphoricum Ac, Picricum Ac.	LIQUID	ORAL	20150521		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACETIC ACID; ARNICA MONTANA; ASIAN GINSENG; BENZOIC ACID; BOS TAURUS ADRENAL GLAND; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; HYDROFLUORIC ACID; LACTIC ACID, DL-; PHOSPHORIC ACID; PICRIC ACID; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; POTASSIUM IODIDE	30; 12; 3; 30; 10; 3; 6; 30; 30; 30; 30; 4; 3; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Ammonium Ion Binding Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nitrogen Binding Agent [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66096-121_d44b1a1c-ee1d-a783-e053-2995a90ac824	66096-121	HUMAN OTC DRUG	OHM Fever Relief		Aconitum Nap, Baptisia, Belladonna, Bryonia, Chamomilla, Eupatorium Perf, Gelsemium, Rhus Tox.	SPRAY	ORAL	20120607		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA; TOXICODENDRON PUBESCENS LEAF	6; 6; 24; 6; 6; 5; 4; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
66096-122_d44b89d7-02a4-4840-e053-2995a90ac721	66096-122	HUMAN PRESCRIPTION DRUG	OHM Pituitarum Complex		Adrenal Gland, Adrenocorticotrophin, Cerebrum, Liver Gland, Pituitarum Posterium Gland, Placenta, Thyroidinum.	LIQUID	ORAL	20170410		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CORTICOTROPIN; EPINEPHRINE; SUS SCROFA ADRENAL GLAND; SUS SCROFA CEREBRUM; SUS SCROFA PITUITARY GLAND, POSTERIOR; SUS SCROFA PLACENTA; THYROID, UNSPECIFIED	10; 10; 10; 14; 10; 8; 8	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66096-125_d44beeee-4d22-68c3-e053-2a95a90a79ec	66096-125	HUMAN OTC DRUG	Weight Control		Aceticum Ac, Anacard Or, Baryta Iod, Calc Carb, Capsicum, Fucus, Graphites,, Nat Sulphuricum, Phytolacca, Stannum Met, Thyroidinum, Zinc Met.	SPRAY	ORAL	20130930		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACETIC ACID; BARIUM IODIDE; CAPSICUM; FUCUS VESICULOSUS; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SEMECARPUS ANACARDIUM JUICE; SODIUM SULFATE; THYROID, UNSPECIFIED; TIN; ZINC	10; 12; 14; 5; 14; 14; 7; 14; 14; 12; 16; 14	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
66096-139_d44bc6dd-32bc-59c7-e053-2995a90a7d11	66096-139	HUMAN OTC DRUG	OHM Skin Healing Gel		Calendula Officinalis, Stellaria Media, Calcarea Sulphurica, Chamomilla, Echinacea Angustfolia, Silicea, Symphytum Officinale, Thiosinamium, Hamamelis Virginiana.	GEL	TOPICAL	20161116		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ALLYLTHIOUREA; CALCIUM SULFATE ANHYDROUS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MATRICARIA RECUTITA; SILICON DIOXIDE; STELLARIA MEDIA	3; 3; 1; 6; 1; 1; 1; 3; 1	[hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
66096-143_d44bf70c-0a67-0c03-e053-2a95a90a6b53	66096-143	HUMAN OTC DRUG	Anti Fungal		Baptisia Tinctoria, Calendula Officinalis, Thuja Occidentalis.	LIQUID	ORAL	20160210		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BAPTISIA TINCTORIA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	1; 1; 1	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-144_d44b40e1-a61d-4469-e053-2a95a90aa702	66096-144	HUMAN OTC DRUG	OHM Mucosa Cleanser		Calendula Officinalis, Hydrastis Canadensis, Thuja Occidentalis.	LIQUID	NASAL	20110110		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CALENDULA OFFICINALIS FLOWERING TOP; GOLDENSEAL; THUJA OCCIDENTALIS LEAFY TWIG	1; 5; 1	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-153_d44b79dd-a8fb-d27e-e053-2995a90a5a10	66096-153	HUMAN OTC DRUG	OHM Pancreas Aid		Helonias Dioica, Lacticum Acidum, Pancreas Suis, Pancreatinum, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum, Thyroidinum, Uranium Nitricum.	LIQUID	ORAL	20150803		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CHAMAELIRIUM LUTEUM ROOT; LACTIC ACID, DL-; PANCRELIPASE; PHOSPHORIC ACID; PHOSPHORUS; SUS SCROFA PANCREAS; SYZYGIUM CUMINI SEED; THYROID, UNSPECIFIED; URANYL NITRATE HEXAHYDRATE	30; 4; 14; 10; 10; 8; 3; 8; 12	[hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
66096-154_d44bc6dd-32c9-59c7-e053-2995a90a7d11	66096-154	HUMAN OTC DRUG	OHM Sore Throat		Aconitum Nap, Ailanthus, Baptisia, Belladonna, Ferrum Phos, Hepar Sulph Calc, Hydrastis, Merc Cyan, Merc Iod Rub, Phytolacca.	SPRAY	SUBLINGUAL	20170410		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; AILANTHUS ALTISSIMA FLOWERING TWIG; ATROPA BELLADONNA; BAPTISIA TINCTORIA; CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; MERCURIC CYANIDE; MERCURIC IODIDE; PHYTOLACCA AMERICANA ROOT	7; 16; 7; 3; 12; 6; 3; 16; 8; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
66096-156_d44b458a-61ff-755e-e053-2995a90aebc0	66096-156	HUMAN OTC DRUG	OHM Menopause		Ammonium Carbonicum, Amyl Nitrosum, Cimicifuga Racemosa, Glonoinum, Lachesis Mutus, Sanguinaria, Canadensis.	LIQUID	ORAL	20150819		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AMMONIUM CARBONATE; AMYL NITRITE; BLACK COHOSH; LACHESIS MUTA VENOM; NITROGLYCERIN; SANGUINARIA CANADENSIS ROOT	12; 6; 3; 12; 12; 4	[hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
66096-157_d44b89d7-0297-4840-e053-2995a90ac721	66096-157	HUMAN PRESCRIPTION DRUG	OHM Parasites		Chenopodium Anthelminticum, Cina, Cucurbita, Pepo, Cuprum Oxydatum Nigrum, Filix Mas, Granatum, Kousso, Ratanhia, Santoninum, Sabadilla, Spigelia, Teucrium Marum.	LIQUID	ORAL	20150819		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARTEMISIA CINA PRE-FLOWERING TOP; CUPRIC OXIDE; DRYOPTERIS FILIX-MAS ROOT; DYSPHANIA AMBROSIOIDES; HAGENIA ABYSSINICA FLOWER; KRAMERIA LAPPACEA ROOT; PUMPKIN SEED; PUNICA GRANATUM ROOT BARK; SANTONIN; SCHOENOCAULON OFFICINALE SEED; SPIGELIA MARILANDICA ROOT; TEUCRIUM MARUM	6; 12; 4; 6; 7; 4; 3; 4; 10; 4; 4; 4	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
66096-159_d44b4ca0-1534-446b-e053-2a95a90a32e6	66096-159	HUMAN PRESCRIPTION DRUG	OHM Mouthwash		Arnica Montana, Borax, Calendula Officinalis, Hypericum Perforatum, Myrrha, Plantago Major, Ratanhia, Salvia Officinalis, Symphytum Officinale.	LIQUID	ORAL	20150915		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; HYPERICUM PERFORATUM; KRAMERIA LAPPACEA ROOT; MYRRH; PLANTAGO MAJOR; SAGE; SODIUM BORATE	3; 1; 6; 3; 3; 3; 1; 1; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
66096-166_d44b323b-080a-b3d4-e053-2995a90aafb7	66096-166	HUMAN OTC DRUG	Kali Iodatum 1X		Kali Iodatum.	LIQUID	ORAL	20160210		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	POTASSIUM IODIDE	1	[hp_X]/30mL			N	20241231
66096-168_d44ad1d9-cfa1-62c1-e053-2a95a90a323e	66096-168	HUMAN OTC DRUG	Acne Relief		Antimonium Crud, Arsenicum Brom, Bovista, Eugenia Jamb, Fluoricum Acidum, Hepar Sulph Calc, Kali Brom, Kali Iod, Kali Mur, Nat Brom, Niccolum Sulph, Phosphoricum AC, Sulphur Iod.	LIQUID	ORAL	20150521		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ANTIMONY TRISULFIDE; ARSENIC TRIBROMIDE; CALCIUM SULFIDE; HYDROFLUORIC ACID; LYCOPERDON UTRIFORME FRUITING BODY; NICKEL SULFATE HEXAHYDRATE; PHOSPHORIC ACID; POTASSIUM BROMIDE; POTASSIUM CHLORIDE; POTASSIUM IODIDE; SODIUM BROMIDE; SULFUR IODIDE; SYZYGIUM JAMBOS SEED	6; 30; 30; 30; 30; 4; 30; 3; 6; 3; 4; 14; 14	[hp_X]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66096-170_d44b1652-5ba4-2927-e053-2a95a90a48f9	66096-170	HUMAN OTC DRUG	OHM FLU		Anas barbariae, hepatis et cordis extractum, Influenzinum	LIQUID	ORAL	20150423		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; INFLUENZA A VIRUS; INFLUENZA B VIRUS	200; 9; 9	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
66096-176_b8a65a1d-83c1-187d-e053-2a95a90a0609	66096-176	HUMAN OTC DRUG	OHM HEPATIC TERRAIN		Berberis Vulgaris, Carduus Marianus, Chelidonium Majus, China Officinalis, Cynara Scolymus, Taraxacum Officinale, Veratrum Album	LIQUID	ORAL	20150423		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; MILK THISTLE; TARAXACUM OFFICINALE; VERATRUM ALBUM ROOT	12; 12; 7; 9; 6; 7; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
66096-191_d44ad1d9-cfb0-62c1-e053-2a95a90a323e	66096-191	HUMAN OTC DRUG	Ohm Cholesterol Aid		Cholesterinum, Fel Tauri, Guatteria Guameri.	LIQUID	ORAL	20170110		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BOS TAURUS BILE; CHOLESTEROL; MALMEA DEPRESSA BARK	3; 13; 5	[hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL			N	20241231
66096-192_d44acb83-411f-5445-e053-2995a90a6760	66096-192	HUMAN OTC DRUG	Eczema Relief		Arsenicum Iodatum, Kali Bromatum, Kali Muriaticum, Natrum Bromatum, Niccolum Sulphuricum, Sulphur Iodatum, Viola Tricolor, Zincum Bromatum.	LIQUID	ORAL	20150522		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARSENIC TRIIODIDE; NICKEL SULFATE HEXAHYDRATE; POTASSIUM BROMIDE; POTASSIUM CHLORIDE; SODIUM BROMIDE; SULFUR IODIDE; VIOLA TRICOLOR; ZINC BROMIDE	8; 5; 4; 4; 4; 14; 12; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66096-341_d44be798-00d5-311b-e053-2a95a90aaf88	66096-341	HUMAN PRESCRIPTION DRUG	OHM Venous Aid		Aesculus Hippocastanum, Arnica Montana, Calendula Officinalis, Echinacea Purpurea, Hamamelis Virginiana, Paeonia Officinalis, Ratanhia.	CREAM	TOPICAL	20150624		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA PURPUREA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; KRAMERIA LAPPACEA ROOT; PAEONIA OFFICINALIS ROOT	1; 1; 1; 3; 1; 3; 1	[hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g			N	20241231
66096-527_d44bbba5-9d68-096a-e053-2a95a90a3fe4	66096-527	HUMAN OTC DRUG	OHM Sinus Nasal		Aralia Rac, Euphorbium, Galphimia, Hepar Sulph Calc, Histaminum, Hydrastis, Kali Bic, Kali Iod, Luffa, Pulsatilla, Teucrium Mar.	SPRAY	NASAL	20170123		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ANEMONE PULSATILLA; ARALIA RACEMOSA ROOT; CALCIUM SULFIDE; EUPHORBIA RESINIFERA RESIN; GALPHIMIA GLAUCA FLOWERING TOP; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; POTASSIUM DICHROMATE; POTASSIUM IODIDE; TEUCRIUM MARUM	6; 6; 12; 6; 6; 12; 12; 6; 12; 4; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-636_eedfeb86-91fd-3304-e053-2a95a90a2b98	66096-636	HUMAN OTC DRUG	Miranda Castros healing cell salts for bones, hair, nails and teeth	Homeopathic Combination	Calcarea Fluorica, Calcarea Phosphorica, Silicea	PELLET	ORAL	20151021		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CALCIUM FLUORIDE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
66096-669_d44bf234-8627-c121-e053-2a95a90ad3f7	66096-669	HUMAN OTC DRUG	OHM Allergy Animal Mix		Cat Hair, Cattle, Dog, Guinea Pig, Hamster, Hog, Mouse, Rabbit Hair and Epithelia, Chicken, Duck, Goose Feathers, Horse Hair and Dander, Histaminum.	SPRAY	ORAL	20130313		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; BOS TAURUS HAIR; CANIS LUPUS FAMILIARIS HAIR; CAVIA PORCELLUS HAIR; EQUUS CABALLUS DANDER; EQUUS CABALLUS HAIR; FELIS CATUS HAIR; GALLUS GALLUS FEATHER; HISTAMINE DIHYDROCHLORIDE; MESOCRICETUS AURATUS SKIN; MUS MUSCULUS HAIR; ORYCTOLAGUS CUNICULUS HAIR; ORYCTOLAGUS CUNICULUS SKIN; SUS SCROFA HAIR	12; 12; 12; 12; 12; 12; 12; 12; 12; 60; 12; 12; 12; 12; 12	[hp_X]/59mL; 1/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Dander [CS], Dander [CS], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Salivary Proteins and Peptides [CS], Salivary Proteins and Peptides [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
66096-670_d44c0054-2c44-4c2f-e053-2a95a90aef76	66096-670	HUMAN OTC DRUG	OHM Allergy Mold Mix		Alternaria Alt, Aspergillus Fum, Aspergillus Nig, Boletus Sat, Botrytis Cin, Candida Alb, Cladosporium Met, Fusarium Oxy, Helminthosporium, Murcor Mue, Pullularia Pul, Rhizopus Nig, Ustaligo, Histaminum.	LIQUID	ORAL	20151029		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ALTERNARIA ALTERNATA; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOLETUS SATANAS FRUITING BODY; BOTRYTIS CINEREA; CANDIDA ALBICANS; COCHLIOBOLUS SATIVUS; FUSARIUM OXYSPORUM; HISTAMINE DIHYDROCHLORIDE; PASSALORA FULVA; RHIZOPUS STOLONIFER; USTILAGO MAYDIS	14; 14; 14; 14; 14; 14; 14; 14; 14; 60; 14; 14; 14	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
66096-681_eee0015a-6f6e-b75e-e053-2a95a90a80e7	66096-681	HUMAN OTC DRUG	Miranda Castros Healing Gel for Bites and Stings		Calendula Officinalis, Caladium Seguinum, Ledum Palustre, Natrum Muriaticum, Plantago Major, Staphysagria, Urtica Urens.	GEL	TOPICAL	20150521		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CALENDULA OFFICINALIS FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; PLANTAGO MAJOR; RHODODENDRON TOMENTOSUM LEAFY TWIG; SODIUM CHLORIDE; URTICA URENS	1; 6; 12; 1; 6; 3; 1	[hp_X]/28.3g; [hp_X]/28.3g; [hp_X]/28.3g; [hp_X]/28.3g; [hp_X]/28.3g; [hp_X]/28.3g; [hp_X]/28.3g			N	20241231
66096-692_d44b6e78-2531-2edc-e053-2995a90a4b4d	66096-692	HUMAN OTC DRUG	OHM Muscle and Joint Pain Relief		Arnica, Aconitum Nap, Arnica, Belladonna, Bellis, Calc Fluor, Calc Phos, Calendula, Echinacea, Hamamelis, Hypericum, Kali Mur, Ledum, Mag Phos, Rhus Tox, Ruta, Symphytum.	CREAM	TOPICAL	20110222		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; ARNICA MONTANA FLOWER; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; RHODODENDRON TOMENTOSUM LEAFY TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	3; 1; 3; 3; 4; 1; 6; 1; 200; 1; 3; 3; 2; 1; 3; 4	[hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_C]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66096-693_d44ba5cf-a958-2072-e053-2995a90aa710	66096-693	HUMAN OTC DRUG	OHM Skin Healing Cream		Calendula Officinalis, Stellaria Media, Calcarea Sulphurica, Chamomilla, Echinacea Angustifolia, Silicea, Symphytum Officinale, Thiosinamium, Hamamelis Virginiana.	CREAM	TOPICAL	20161115		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ALLYLTHIOUREA; CALCIUM SULFATE ANHYDROUS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MATRICARIA RECUTITA; SILICON DIOXIDE; STELLARIA MEDIA	3; 3; 1; 6; 1; 1; 1; 3; 1	[hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
66096-695_d44b0fad-c077-e84a-e053-2995a90a68d9	66096-695	HUMAN OTC DRUG	OHM Drainage Lymphatic		Aesculus Hipp, Apis Mel, Aranea, Baryta Carb, Equisetum Hyem, Fucus, Fumaria, Juglans Cin, Kali Iod, Kali Mur, Myosotis, Nasturtium, Nat Sulphuricum, Phytolacca, Sarsaparilla, Scrophulara, Secale, Teucrium Scor, Thyroidinum, Vipera.	GEL	TOPICAL	20141216		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	APIS MELLIFERA; ARANEUS DIADEMATUS; BARIUM CARBONATE; CLAVICEPS PURPUREA SCLEROTIUM; EQUISETUM HYEMALE; FUCUS VESICULOSUS; FUMARIA OFFICINALIS FLOWERING TOP; HORSE CHESTNUT; JUGLANS CINEREA BRANCH BARK/ROOT BARK; MYOSOTIS ARVENSIS; NASTURTIUM OFFICINALE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; POTASSIUM IODIDE; SCROPHULARIA NODOSA; SMILAX ORNATA ROOT; SODIUM SULFATE; TEUCRIUM SCORODONIA FLOWERING TOP; THYROID, UNSPECIFIED; VIPERA BERUS VENOM	4; 14; 14; 6; 3; 3; 2; 4; 2; 2; 2; 2; 2; 2; 3; 2; 2; 2; 10; 6	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66096-699_d44bbea7-073b-14e0-e053-2995a90abb41	66096-699	HUMAN OTC DRUG	OHM Skin Growths		Thuja Occ., Baptisia Tinctoria, Calendula Officinalis, Hydrastis Canadensis.	GEL	TOPICAL	20170823		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BAPTISIA TINCTORIA ROOT; CALENDULA OFFICINALIS FLOWERING TOP; GOLDENSEAL; THUJA OCCIDENTALIS LEAFY TWIG	1; 1; 5; 1	[hp_X]/56.7g; [hp_X]/56.7g; [hp_X]/56.7g; [hp_X]/56.7g			N	20241231
66096-701_d44b6e78-253d-2edc-e053-2995a90a4b4d	66096-701	HUMAN OTC DRUG	OHM Muscle and Joint Pain Relief Gel		Arnica, Aconitum Nap, Arnica, Belladonna, Bellis, Calc Fluor, Calc Phos, Calendula, Echinacea Purp, Hamamelis, Hypericum, Kali Mur, Ledum, Mag Phos, Rhus Tox, Ruta, Symphytum.	GEL	TOPICAL	20170913		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM FLUORIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	3; 1; 3; 3; 4; 1; 6; 1; 200; 1; 2; 3; 3; 1; 3; 4	[hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_C]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g; [hp_X]/96.5g	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66096-706_b8a719c7-3b71-773b-e053-2995a90af29b	66096-706	HUMAN OTC DRUG	OHM Mucus Relief		Antimonium Crudum, Antimonium Tartaricum, Chelidonium Majus, Ferrum Phosphoricum, Kali Carboonicum, Kali muriaticum, Kali Sulphuricum, Marrubium Vulgare.	TABLET, CHEWABLE	ORAL	20150514		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ANTIMONY POTASSIUM TARTRATE; ANTIMONY TRISULFIDE; CHELIDONIUM MAJUS; FERROSOFERRIC PHOSPHATE; MARRUBIUM VULGARE; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; POTASSIUM SULFATE	6; 6; 6; 6; 9; 30; 6; 12; 6	[hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
66096-707_d44bd013-78ec-0cd5-e053-2a95a90a016f	66096-707	HUMAN OTC DRUG	OHM Sting Relief and Insect Repellent		Apis Mel, Arnica, Belladonna, Caladium, Calendula, Graphites, Ledum, Pulsatilla, Rhus Tox, Staphysagria.	SPRAY	TOPICAL	20150623		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ANEMONE PULSATILLA; APIS MELLIFERA; ARNICA MONTANA; ATROPA BELLADONNA; CALENDULA ARVENSIS WHOLE; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; GRAPHITE; RHODODENDRON TOMENTOSUM LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	6; 6; 1; 6; 2; 6; 14; 6; 6; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66096-708_d44b323b-0816-b3d4-e053-2995a90aafb7	66096-708	HUMAN OTC DRUG	Kids Cough Relief Syrup		Antimonium Sulphuratum Aureum, Antimonium Tartaricum, Bryonia Alba, Drosera Rotundifolia, Ipecacuanha, Kali Muriaticum, Rumex Crispus, Senega Officinalis, Spongia Tosta.	LIQUID	ORAL	20150820		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ANTIMONY PENTASULFIDE; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC; POLYGALA SENEGA ROOT; POTASSIUM CHLORIDE; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	12; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66096-709_d44af2b7-f77f-3d27-e053-2a95a90abc46	66096-709	HUMAN OTC DRUG	Cough Relief Syrup		Althaea, Antimon Sulph, Antimon Tart, Bryonia, Cetraria, Chamomilla, Drosera, Echinacea Ang, Ipecac, Kali Mur, Plantago, Rumex Crisp, Senega, Spongia, Thymus, Trifolium Prat, Urtica Di, Verbascum.	LIQUID	ORAL	20150818		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ALTHAEA OFFICINALIS ROOT; ANTIMONY PENTASULFIDE; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CETRARIA ISLANDICA SUBSP. ISLANDICA; DROSERA ROTUNDIFOLIA; ECHINACEA ANGUSTIFOLIA; IPECAC; MATRICARIA RECUTITA; PLANTAGO LANCEOLATA POLLEN; POLYGALA SENEGA ROOT; POTASSIUM CHLORIDE; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA THYMUS; TRIFOLIUM PRATENSE FLOWER; URTICA DIOICA; VERBASCUM THAPSUS	1; 12; 6; 6; 1; 6; 1; 6; 1; 1; 6; 6; 6; 6; 1; 1; 1; 1	[hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Pollen Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Pollen [CS], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66096-710_d44bf234-8633-c121-e053-2a95a90ad3f7	66096-710	HUMAN OTC DRUG	Allergy Relief		Allium Cepa, Apis Mellifica, Aralia Racemosa, Blatta Orientalis, Bovista, Carduus Marianus, Chelidonium Majus, Euphrasia Officinalas, Galphimia Glauca, Hedera Helix, Hydrastis Canadensis, Luffa Operculata, Nasturtium Aquaticum, Okoubaka, Sabadilla, Scrophularia Nodosa, Solidago Virgaurea, Taraxacum Officinale.	LIQUID	ORAL	20170602		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	APIS MELLIFERA; ARALIA RACEMOSA ROOT; BLATTA ORIENTALIS; CHELIDONIUM MAJUS; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; GOLDENSEAL; HEDERA HELIX FLOWERING TWIG; LUFFA OPERCULATA FRUIT; LYCOPERDON UTRIFORME FRUITING BODY; MILK THISTLE; NASTURTIUM OFFICINALE; OKOUBAKA AUBREVILLEI BARK; ONION; SCHOENOCAULON OFFICINALE SEED; SCROPHULARIA NODOSA; SOLIDAGO VIRGAUREA FLOWERING TOP; TARAXACUM OFFICINALE	5; 5; 12; 3; 8; 5; 5; 5; 5; 12; 3; 3; 5; 5; 5; 3; 5; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
66096-711_d44be050-5169-91d3-e053-2a95a90a12ef	66096-711	HUMAN PRESCRIPTION DRUG	OHM Tonic Syrup		Alfalfa, Aralia Quin (Ginseng), Avena, Calc Phos, Cinchona, Ferrum Phos, Hydrastis, Kali Iod, Kali Mur, Kali Phos, Mag Phos, Nat Phos, Nux Vom, Phosphoricum Ac.	LIQUID	ORAL	20150915		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ALFALFA; AMERICAN GINSENG; AVENA SATIVA FLOWERING TOP; CINCHONA BARK; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; POTASSIUM IODIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; TRIBASIC CALCIUM PHOSPHATE	1; 1; 1; 2; 6; 6; 5; 6; 14; 6; 6; 6; 6; 6	[hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL; [hp_X]/148mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66096-712_d44ac4d7-4c0a-f937-e053-2995a90ac3dc	66096-712	HUMAN OTC DRUG	Joette Calabrese Survivalist Kit		Abrot Acon Agn Ail Ambr Ambro Am-C Ant-C Apis Arn Ars Aur-A Aur Bapt Bar-C Bell BB Both Bov Brom Cadm-S Calad Calc Camph Carb-Ac Card-M Cean Chel Chinin-A Cina Chin Cic Cob Colch Con Crot-H Crot-T Cupr Dulc Elaps Eup-Per Fl-Ac Galph Graph Gunp Ham Hekla Hell Hep Hydr-Ac Hyos Hyper Kali-Br Kali-C Kali-I Lath Laur Led Lob Merc-Cy Merc Mez Mosch Mur-Ac Naja Nat-C Nit-Ac Nux-M Pyrog Ph-Ac Pic-Ac Plb Rhus-T Ruta Samb Sang Sarr Sep Stram Sul-Ac Tab Terent Ter Teucr Verat Verat-V Vip	PELLET	ORAL	20151026		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; AETHUSA CYNAPIUM; AILANTHUS ALTISSIMA FLOWERING TWIG; AMBERGRIS; AMBROSIA ARTEMISIIFOLIA POLLEN; AMMONIUM CARBONATE; ANTIMONY TRISULFIDE; APIS MELLIFERA; ARNICA MONTANA; ARSENIC TRIOXIDE; ARTEMISIA ABROTANUM FLOWERING TOP; ARTEMISIA CINA PRE-FLOWERING TOP; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; BARIUM CARBONATE; BORRELIA BURGDORFERI; BOTHROPS ATROX VENOM; BROMINE; CADMIUM SULFATE; CALCIUM SULFIDE; CAMPHOR (NATURAL); CEANOTHUS AMERICANUS LEAF; CHASTE TREE; CHELIDONIUM MAJUS; CICUTA VIROSA ROOT; CINCHONA OFFICINALIS BARK; CLAVICEPS PURPUREA SCLEROTIUM; COBALT; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; COPPER; CROTALUS HORRIDUS HORRIDUS VENOM; CROTON TIGLIUM SEED; DAPHNE MEZEREUM BARK; DATURA STRAMONIUM; DIEFFENBACHIA SEGUINE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; GOLD; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HEKLA LAVA; HELLEBORUS NIGER ROOT; HYDROCHLORIC ACID; HYDROFLUORIC ACID; HYDROGEN CYANIDE; HYOSCYAMUS NIGER; HYPERICUM PERFORATUM; LATHYRUS SATIVAS SEED; LEAD; LEDUM PALUSTRE TWIG; LOBELIA INFLATA; LYCOPERDON UTRIFORME FRUITING BODY; LYCOSA TARANTULA; MERCURIC CYANIDE; MERCURIUS SOLUBILIS; MICRURUS CORALLINUS VENOM; MILK THISTLE; MOSCHUS MOSCHIFERUS WHOLE; NAJA NAJA VENOM; NITRIC ACID; NUTMEG; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHENOL; PHOSPHORIC ACID; PICRIC ACID; POTASSIUM BROMIDE; POTASSIUM CARBONATE; POTASSIUM IODIDE; PRUNUS LAUROCERASUS LEAF; QUININE SULFATE; RANCID BEEF; RUTA GRAVEOLENS FLOWERING TOP; SAMBUCUS NIGRA FLOWERING TOP; SANGUINARIA CANADENSIS ROOT; SARRACENIA PURPUREA; SEPIA OFFICINALIS JUICE; SODIUM CARBONATE; SOLANUM DULCAMARA TOP; SULFURIC ACID; TEUCRIUM MARUM; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; TURPENTINE OIL; VERATRUM ALBUM ROOT; VERATRUM VIRIDE ROOT; VIPERA BERUS VENOM	1; 200; 30; 30; 30; 30; 6; 1; 3; 3; 6; 3; 3; 200; 30; 200; 30; 30; 30; 6; 200; 30; 200; 6; 30; 3; 6; 30; 30; 3; 6; 6; 30; 200; 30; 30; 200; 30; 200; 200; 200; 30; 30; 30; 30; 30; 6; 1; 30; 30; 1; 30; 30; 30; 200; 6; 30; 30; 30; 30; 30; 30; 1; 6; 6; 200; 30; 200; 6; 30; 3; 200; 6; 30; 200; 30; 6; 30; 30; 30; 200; 30; 1; 6; 200; 30; 30	[hp_M]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_M]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_M]/1; [hp_C]/1; [hp_C]/1; [hp_M]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_M]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_M]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antimalarial [EPC], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Pollen [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Insect Venom Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
66096-713_d44bc82e-6205-7f35-e053-2995a90addb4	66096-713	HUMAN OTC DRUG	Anxiety Stress Relief		Arg Nit, Aur Met, Avena, Gelsemium, Hyoscyamus, Ignatia, Moschus, Nat Mur, Passiflora, Stannum Met, Valeriana.	LIQUID	ORAL	20160301		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AVENA SATIVA FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HYOSCYAMUS NIGER; MOSCHUS MOSCHIFERUS WHOLE; PASSIFLORA INCARNATA TOP; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; TIN; VALERIAN	2; 13; 13; 13; 13; 2; 8; 13; 13; 13; 2	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66096-717_5ba1e4a9-baf1-4b73-8ff0-555089a9a4fd	66096-717	HUMAN OTC DRUG	OHM-ANX		Argentum Nitricum, Aurum Metallicum, Avena Sativa, Gelsemium Sempervirens, Hyoscyamus Niger, Ignatia Amara, Moschus, Natrum Muriaticum, Passiflora Incarnata, Stannum Metallicum, Valeriana Officinalis	SPRAY	ORAL	20200207		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AVENA SATIVA FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HYOSCYAMUS NIGER; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; PASSIFLORA INCARNATA FLOWERING TOP; SILVER NITRATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; TIN; VALERIAN	5; 14; 14; 14; 14; 5; 14; 14; 14; 16; 5	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66096-718_f6871cf3-c4b8-458f-ad66-a342957787d7	66096-718	HUMAN OTC DRUG	OHM-DETK		Apis Mellifica, Berberis Vulgaris, Chimaphila Umbellata, Cuprum Metallicum, Equisetum Hyemale, Formica Rufa, Sabal Serrulata, Solidago	SPRAY	ORAL	20200210		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	APIS MELLIFERA; BERBERIS VULGARIS ROOT BARK; CHIMAPHILA UMBELLATA WHOLE; COPPER; EQUISETUM HYEMALE WHOLE; FORMICA RUFA; SAW PALMETTO; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP	5; 5; 5; 14; 7; 5; 5; 5; 5	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66096-719_9eea2b36-8dec-4bbc-8054-20008a44462d	66096-719	HUMAN OTC DRUG	OHM-DETL		Boldo, Carduus Marianus, Chelidonium Majus, China Officinalis, Cynara Scolymus, Hydrastis Canadensis, Nux Vomica, Stannum Metallicum, Taraxacum Officinale	SPRAY	ORAL	20200210		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CHELIDONIUM MAJUS WHOLE; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; GOLDENSEAL; MILK THISTLE; PEUMUS BOLDUS LEAF; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TIN	5; 7; 5; 5; 5; 5; 7; 5; 16	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
66096-720_b7112736-0845-441d-b934-88b067e82b1b	66096-720	HUMAN OTC DRUG	OHM-INS		Avena Sativa, Coffea Cruda, Ignatia Amara, Passiflora Incarnata, Valeriana Officinalis	SPRAY	ORAL	20200207		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; VALERIAN	30; 5; 5; 14; 5	[hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
66096-721_3b867f11-713e-4b7a-b8b6-b23c3186a35a	66096-721	HUMAN OTC DRUG	OHM-DAM		Agnus Castus, Avena Sativa, Damiana, Gelsemium Sempervirens, Ignatia Amara, Lycopodium Clavatum, Orchitinum, Phosphoricum Acidum, Sabal Serrulata, Selenium Metallicum, Tribulus Terrestris, Yohimbinum	SPRAY	ORAL	20200207		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AVENA SATIVA FLOWERING TOP; BOS TAURUS TESTICLE; CHASTE TREE FRUIT; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; SAW PALMETTO; SELENIUM; STRYCHNOS IGNATII SEED; TRIBULUS TERRESTRIS WHOLE; TURNERA DIFFUSA LEAFY TWIG; YOHIMBINE	5; 12; 5; 14; 14; 14; 5; 12; 14; 7; 5; 10	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-722_d44b40e1-a611-4469-e053-2a95a90aa702	66096-722	HUMAN OTC DRUG	Lyme Disease Support 1		Alumen, Calcarea carbonica, DNA, Ferrum phosphoricum, Hepar sulphuris calcareum, Kali carbonicum, Kali muriaticum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, RNA, Silicea.	LIQUID	ORAL	20171120		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM ALUM; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6; 6; 4; 6; 6; 12; 6; 6; 6; 4; 12; 6; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66096-723_d44b323b-0822-b3d4-e053-2995a90aafb7	66096-723	HUMAN OTC DRUG	Lyme Disease Support 2		Argentum nitricum, Astragalus menziesii, Calcarea sulphurica, Cuprum arsenicosum, DNA, Ferrum phosphoricum, Kali muriaticum, Kali sulphuricum, Ledum palustre, Magnesia phosphorica, RNA, Silicea.	LIQUID	ORAL	20171120		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ASTRAGALUS NUTTALLII LEAF; CALCIUM SULFATE ANHYDROUS; CUPRIC ARSENITE; FERROSOFERRIC PHOSPHATE; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SILVER NITRATE	3; 6; 12; 6; 4; 6; 6; 6; 1; 4; 6; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_M]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66096-724_d44b0421-de20-ac5a-e053-2995a90a5e70	66096-724	HUMAN OTC DRUG	Detox Drainage Kidney		Apis Mel, Berber Vulg, Chimaphila Umb, Cuprum Met, Equisetum Hyem, Formica, Nat Sulphuricum, Sabal, Sarsaparilla, Solidago, Uva Ursi.	LIQUID	ORAL	20170321		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; BERBERIS VULGARIS ROOT BARK; CHIMAPHILA UMBELLATA; COPPER; EQUISETUM HYEMALE; FORMICA RUFA; SARSAPARILLA; SAW PALMETTO; SODIUM SULFIDE NONAHYDRATE; SOLIDAGO VIRGAUREA FLOWERING TOP	5; 3; 3; 3; 14; 6; 6; 3; 3; 4; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66096-725_d44b0421-de2c-ac5a-e053-2995a90a5e70	66096-725	HUMAN OTC DRUG	Detox Drainage Liver		Boldo, Carduus Mar, Chelidonium Maj, Cinchona, Cynara, Fel Tauri, Hydrastis, Myrica, Nux Vomica, Stannum Met, Taraxacum.	LIQUID	ORAL	20170315		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BOS TAURUS BILE; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; GOLDENSEAL; MILK THISTLE; MORELLA CERIFERA ROOT BARK; PEUMUS BOLDUS LEAF; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; TIN	4; 6; 3; 3; 5; 3; 3; 3; 6; 3; 8	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
66096-726_d44ad692-3331-29f3-e053-2a95a90acbf8	66096-726	HUMAN OTC DRUG	Damiana Complex		Agnes Castus, Avena Sativa, Damiana, Gelsemium Sempervirens, Ignatia Amara, Lycopodium Clavatum, Orchitinum, Phosphoricum Acidum, Sabal Serrulata, Selenium Metallicum.	LIQUID	ORAL	20150819		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AVENA SATIVA FLOWERING TOP; CHASTE TREE; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; SAW PALMETTO; SELENIUM; STRYCHNOS IGNATII SEED; SUS SCROFA TESTICLE; TURNERA DIFFUSA LEAFY TWIG	3; 3; 12; 12; 12; 3; 12; 12; 12; 3	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
66096-727_d44bb081-9f15-afc7-e053-2995a90a7245	66096-727	HUMAN OTC DRUG	OHM Sleep Well		Avena Sativa, Coffea Cruda, Ignatia Amara, Nux Vomica, Passiflora, Incarnata, Stramonium, Valeriana Officinalis.	LIQUID	ORAL	20170421		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; DATURA STRAMONIUM; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; VALERIAN	30; 4; 30; 4; 12; 30; 4	[hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
66096-747_d44ae412-0004-a536-e053-2a95a90af73f	66096-747	HUMAN OTC DRUG	Acne Relief Gel		Calendula Officinalis, Chamomilla, Berberis Aquafolium, Hamamelis, Hepar Sulph. Calc. , Sulphur	GEL	TOPICAL	20181129		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BERBERIS AQUIFOLIUM ROOT BARK; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MATRICARIA CHAMOMILLA; SULFUR	2; 6; 1; 2; 1; 6	[hp_X]/50g; [hp_X]/50g; [hp_X]/50g; [hp_X]/50g; [hp_X]/50g; [hp_X]/50g			N	20241231
66096-749_d449d3d9-49bd-2a4b-e053-2995a90a5a95	66096-749	HUMAN PRESCRIPTION DRUG	Spongilla lacustris MT		Spongilla lacustris	TINCTURE	ORAL	20190301		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	SPONGILLA LACUSTRIS	1	[hp_X]/.25L			N	20241231
66096-750_d449c11e-7703-9da3-e053-2995a90a4371	66096-750	HUMAN OTC DRUG	Psychotria Ipecacuanha MT		Psychotria Ipecacuanha	TINCTURE	ORAL	20190301		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CARAPICHEA IPECACUANHA WHOLE	1	[hp_X]/.25L			N	20241231
66096-751_d43abd50-5ff6-883c-e053-2995a90a5f05	66096-751	HUMAN PRESCRIPTION DRUG	Aralia Racemosa MT		Aralia Racemosa	LIQUID	ORAL	20190301		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARALIA RACEMOSA ROOT	.25	1/.25L			N	20241231
66096-752_d449d164-e338-cfb6-e053-2a95a90a6b8e	66096-752	HUMAN OTC DRUG	Rhus Toxicodendron MT		Rhus Toxicodendron	TINCTURE	ORAL	20190301		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	TOXICODENDRON PUBESCENS LEAF	1	[hp_X]/.25L			N	20241231
66096-753_1d673f91-8b0a-4844-a15a-c75d5456f610	66096-753	HUMAN PRESCRIPTION DRUG	OHM-CIR		Baryta Iodata, Cactus Grandiflorus, Carbo Vegetabilis, Crataegus Oxyacantha, Curare, Kali Carbonicum, Kalmia Latifolia, Melilotus Officinale, Naja Tripudians, Secale Cornutum, Solanum Nigrum, Spigelia Anthelmia	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACTIVATED CHARCOAL; BARIUM IODIDE; CLAVICEPS PURPUREA SCLEROTIUM; HAWTHORN LEAF WITH FLOWER; KALMIA LATIFOLIA LEAF; MELILOTUS OFFICINALIS TOP; NAJA NAJA VENOM; POTASSIUM CARBONATE; SELENICEREUS GRANDIFLORUS STEM; SOLANUM NIGRUM TOP; SPIGELIA ANTHELMIA; TUBOCURARINE CHLORIDE	12; 12; 12; 6; 6; 6; 12; 7; 6; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-754_b8a7d171-ccd8-16ea-e053-2a95a90a1100	66096-754	HUMAN PRESCRIPTION DRUG	OHM-DREN LFT		Apis Mellifica, Aranea Diadema, Berberis Vulgaris, Equisetum Hyemale, Galium Aparine, Juglans Regia, Manganum Phosphoricum, Nicotinamidum, Nitricum Acidum, Sarsaparilla, Thuja Occidentalis, Urtica Urens	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	APIS MELLIFERA; ARANEUS DIADEMATUS; BERBERIS VULGARIS ROOT BARK; EQUISETUM HYEMALE; GALIUM APARINE; JUGLANS REGIA WHOLE; MANGANESE PHOSPHATE, DIBASIC; NIACINAMIDE; NITRIC ACID; SARSAPARILLA; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS	12; 9; 12; 7; 6; 6; 9; 9; 12; 9; 6; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66096-755_b8a7d31b-81a8-174e-e053-2a95a90a9ed5	66096-755	HUMAN PRESCRIPTION DRUG	OHM-FLU		Anas barbariae, hepatis et cordis extractum, Influenzinum	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; INFLUENZA A VIRUS; INFLUENZA B VIRUS	200; 9; 9	[hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL			N	20241231
66096-756_b8a7e698-353d-6841-e053-2a95a90ada82	66096-756	HUMAN OTC DRUG	OHM-HEP		Berberis Vulgaris, Carduus Marianus, Chelidonium Majus, China Officinalis, Cynara Scolymus, Taraxacum Officinale, Veratrum Album	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; MILK THISTLE; TARAXACUM OFFICINALE; VERATRUM ALBUM ROOT	12; 12; 7; 9; 6; 7; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-757_132d6703-451f-4dca-b1bc-997c667354d1	66096-757	HUMAN PRESCRIPTION DRUG	OHM-INMA		Aconitum Napellus, Aranea Diadema, Arnica Montana, Asclepias Vincetoxicum, Baptisia Tinctoria, Bryonia Alba, Echinacea Angustifolia, Equisetum Hyemale, Eupatorium Perforliatum, Gelsemium Sempervirens, Hepar Sulphuris Calcareum, Juglans Regia, Phytolacca Decandra, Sanguinaria Canadensis, Sarsaparilla, Sulphur, Zincum Metallicum	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; ARANEUS DIADEMATUS; ARNICA MONTANA; BAPTISIA TINCTORIA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; EQUISETUM HYEMALE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; JUGLANS REGIA LEAF; PHYTOLACCA AMERICANA ROOT; SANGUINARIA CANADENSIS ROOT; SARSAPARILLA; SULFUR; ZINC	7; 9; 6; 8; 10; 12; 12; 6; 7; 10; 8; 6; 10; 8; 9; 10; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-758_765be013-8d34-47c0-a69d-416ee4325857	66096-758	HUMAN PRESCRIPTION DRUG	OHM-OST		Arnica Montana, Calcarea Phosphorica, Causticum, China Officinalis, Colchicum Autumnale, Dulcamara, Ledum Palustre, Rhus Toxicodendron, Symphytum Officinale	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARNICA MONTANA; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; LEDUM PALUSTRE TWIG; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF; TRIBASIC CALCIUM PHOSPHATE	4; 12; 12; 12; 8; 7; 6; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
66096-759_5491857a-a4bd-4186-8275-00b32e157495	66096-759	HUMAN PRESCRIPTION DRUG	OHM-PAN		Carbo Vegetabilis, Ceanothus Americanus, Gallium Aparine, Leptandra Virginica, Mandragora Officinarum, Momordica Balsamina, Quassia Amara	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACTIVATED CHARCOAL; CEANOTHUS AMERICANUS LEAF; GALIUM APARINE; MANDRAGORA OFFICINARUM ROOT; MOMORDICA BALSAMINA IMMATURE FRUIT; QUASSIA AMARA WOOD; VERONICASTRUM VIRGINICUM ROOT	12; 10; 5; 10; 8; 5; 5	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-760_2d05ab33-1ea3-459b-9c21-e34dadedfcc7	66096-760	HUMAN PRESCRIPTION DRUG	OHM-REN		Apis Mellifica, Aranea Diadema, Berberis Vulgaris, Cantharis, Equisetum Hyemale, Hydrastis Canadensis, Juglans Regia, Kali Bichromicum, Mercurius Solubilis, Sarsaparilla, Solidago Virgaurea	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	APIS MELLIFERA; ARANEUS DIADEMATUS; BERBERIS VULGARIS ROOT BARK; EQUISETUM HYEMALE; GOLDENSEAL; JUGLANS REGIA LEAF; LYTTA VESICATORIA; MERCURIUS SOLUBILIS; POTASSIUM DICHROMATE; SARSAPARILLA; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 8; 12; 7; 6; 7; 7; 12; 10; 8; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66096-761_49761d43-a4ff-4e4b-91a6-3a8694e3d96f	66096-761	HUMAN PRESCRIPTION DRUG	OHM-RESB		Aconitum, Aranea, Bryonia, Equisetum, Eupatorium Perf, Hydrastis, Juglans Reg, Kali Bic, Phosphorus, Sarsaparrilla, Sulphur	SPRAY	ORAL	20181219		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS; ARANEUS DIADEMATUS; BRYONIA ALBA ROOT; EQUISETUM HYEMALE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GOLDENSEAL; JUGLANS REGIA LEAF; PHOSPHORUS; POTASSIUM DICHROMATE; SARSAPARILLA	6; 9; 6; 7; 5; 7; 6; 7; 12; 9	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
66096-762_d449c11e-76f8-9da3-e053-2995a90a4371	66096-762	HUMAN OTC DRUG	Convallaria Majalis MT		Convallaria Majalis	LIQUID	ORAL	20190301		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CONVALLARIA MAJALIS	1	[hp_X]/.5L			N	20241231
66096-777_d4506c55-eb4a-298d-e053-2995a90a90a5	66096-777	HUMAN OTC DRUG	Aconitum Napellus		ACONITUM NAPELLUS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACONITUM NAPELLUS	6	[hp_C]/6[hp_C]			N	20241231
66096-778_d450922f-3861-3f22-e053-2995a90a9c7d	66096-778	HUMAN OTC DRUG	Adrenalinum		ADRENALINUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	EPINEPHRINE	6	[hp_C]/6[hp_C]	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66096-779_d450946e-4249-8164-e053-2995a90a76c1	66096-779	HUMAN OTC DRUG	Aesculus Hippocastanum		AESCULUS HIPPOCASTANUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	HORSE CHESTNUT	6	[hp_C]/6[hp_C]			N	20241231
66096-780_d450946e-4255-8164-e053-2995a90a76c1	66096-780	HUMAN OTC DRUG	Aethusa Cynapium		AETHUSA CYNAPIUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AETHUSA CYNAPIUM	6	[hp_C]/6[hp_C]			N	20241231
66096-781_d450946e-4261-8164-e053-2995a90a76c1	66096-781	HUMAN PRESCRIPTION DRUG	Agaricus Muscarius		AGARICUS MUSCARIUS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AMANITA MUSCARIA FRUITING BODY	6	[hp_C]/6[hp_C]			N	20241231
66096-782_d450927c-8435-efd6-e053-2a95a90a4f4e	66096-782	HUMAN OTC DRUG	Allium Cepa		ALLIUM CEPA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ONION	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
66096-783_d450927c-8441-efd6-e053-2a95a90a4f4e	66096-783	HUMAN OTC DRUG	Anacardium Orientale		ANACARDIUM ORIENTALE	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	SEMECARPUS ANACARDIUM JUICE	6	[hp_C]/6[hp_C]			N	20241231
66096-784_d450adc7-289b-63b2-e053-2a95a90afca1	66096-784	HUMAN OTC DRUG	Anas Barbariae		ANAS BARBARIAE	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	6	[hp_C]/6[hp_C]			N	20241231
66096-785_d450927c-8450-efd6-e053-2a95a90a4f4e	66096-785	HUMAN OTC DRUG	Antimonium Tartaricum		ANTIMONIUM TARTARICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ANTIMONY POTASSIUM TARTRATE	6	[hp_C]/6[hp_C]			N	20241231
66096-786_d450b424-2d5a-86e0-e053-2995a90ab15e	66096-786	HUMAN OTC DRUG	Apis Mellifica		APIS MELLIFICA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	APIS MELLIFERA	6	[hp_C]/6[hp_C]	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66096-787_d450b732-cb2c-7416-e053-2995a90a2c2e	66096-787	HUMAN OTC DRUG	Argentum Metallicum		ARGENTUM METALLICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	SILVER	6	[hp_C]/6[hp_C]			N	20241231
66096-788_b8e2b08d-51d1-8ddb-e053-2a95a90a4357	66096-788	HUMAN OTC DRUG	Argentum Muriaticum		ARGENTUM MURIATICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	SILVER CHLORIDE	6	[hp_C]/6[hp_C]			N	20241231
66096-789_d450b732-cb3b-7416-e053-2995a90a2c2e	66096-789	HUMAN OTC DRUG	Arnica Montana		ARNICA MONTANA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARNICA MONTANA	6	[hp_C]/6[hp_C]			N	20241231
66096-790_d450c339-baeb-0434-e053-2995a90a2717	66096-790	HUMAN OTC DRUG	Arsenicum Album		ARSENICUM ALBUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARSENIC TRIOXIDE	6	[hp_C]/6[hp_C]			N	20241231
66096-791_d450caaf-c867-7167-e053-2995a90a8e7b	66096-791	HUMAN OTC DRUG	Arsenicum Iodatum		ARSENICUM IODATUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARSENIC TRIIODIDE	6	[hp_C]/6[hp_C]			N	20241231
66096-792_d450d37f-3ae5-8648-e053-2995a90a4194	66096-792	HUMAN OTC DRUG	Aurum Metallicum		AURUM METALLICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	GOLD	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66096-793_d450d900-84fc-b8ed-e053-2995a90ae48a	66096-793	HUMAN OTC DRUG	Avena Sativa		AVENA SATIVA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	AVENA SATIVA FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
66096-794_d450d478-256b-86e2-e053-2995a90a06ab	66096-794	HUMAN OTC DRUG	Baptisia Tinctoria		BAPTISIA TINCTORIA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BAPTISIA TINCTORIA ROOT	6	[hp_C]/6[hp_C]			N	20241231
66096-795_d450d37f-3af6-8648-e053-2995a90a4194	66096-795	HUMAN OTC DRUG	Baryta Carbonica		BARYTA CARBONICA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BARIUM CARBONATE	6	[hp_C]/6[hp_C]			N	20241231
66096-796_d450d9d2-55fe-494b-e053-2995a90ae369	66096-796	HUMAN OTC DRUG	Baryta Iodata		BARYTA IODATA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BARIUM IODIDE	6	[hp_C]/6[hp_C]			N	20241231
66096-797_d450edda-bf82-13b8-e053-2a95a90a3b6b	66096-797	HUMAN OTC DRUG	Belladonna		BELLADONNA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ATROPA BELLADONNA	6	[hp_C]/6[hp_C]			N	20241231
66096-798_d450edda-bf91-13b8-e053-2a95a90a3b6b	66096-798	HUMAN OTC DRUG	Bellis Perennis		BELLIS PERENNIS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BELLIS PERENNIS	6	[hp_C]/6[hp_C]			N	20241231
66096-799_d450ed21-5dae-2b14-e053-2995a90adee1	66096-799	HUMAN OTC DRUG	Benzoicum Acidum		BENZOICUM ACIDUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BENZOIC ACID	6	[hp_C]/6[hp_C]	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
66096-800_d450f5ab-364d-46cd-e053-2995a90addd1	66096-800	HUMAN OTC DRUG	Borax		BORAX	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	SODIUM BORATE	6	[hp_C]/6[hp_C]			N	20241231
66096-801_d450ef42-89d6-29b7-e053-2a95a90ab4bb	66096-801	HUMAN OTC DRUG	Bovista		BOVISTA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	LYCOPERDON UTRIFORME FRUITING BODY	6	[hp_C]/6[hp_C]			N	20241231
66096-802_d45105c6-84dd-2154-e053-2995a90a0821	66096-802	HUMAN OTC DRUG	Bryonia Alba		BRYONIA ALBA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BRYONIA ALBA ROOT	6	[hp_C]/6[hp_C]			N	20241231
66096-803_d4510a44-3d60-4553-e053-2995a90a61ad	66096-803	HUMAN OTC DRUG	Cadmium Metallicum		CADMIUM METALLICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CADMIUM	6	[hp_C]/6[hp_C]			N	20241231
66096-804_d45105c6-852f-2154-e053-2995a90a0821	66096-804	HUMAN OTC DRUG	Calcarea Carbonica		CALCAREA CARBONICA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	OYSTER SHELL CALCIUM CARBONATE, CRUDE	6	[hp_C]/6[hp_C]			N	20241231
66096-805_d4511290-ad4f-094a-e053-2a95a90aa70b	66096-805	HUMAN OTC DRUG	Calcarea Fluorica		CALCAREA FLUORICA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CALCIUM FLUORIDE	6	[hp_C]/6[hp_C]			N	20241231
66096-806_d45e20fc-0dbf-4321-e053-2a95a90a08f6	66096-806	HUMAN OTC DRUG	Calcarea Phosphorica		CALCAREA PHOSPHORICA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	TRIBASIC CALCIUM PHOSPHATE	6	[hp_C]/6[hp_C]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
66096-807_d45e20fc-0dcb-4321-e053-2a95a90a08f6	66096-807	HUMAN OTC DRUG	Calendula Officinalis		CALENDULA OFFICINALIS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CALENDULA OFFICINALIS FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
66096-808_d45e319c-030b-7f13-e053-2a95a90af67e	66096-808	HUMAN OTC DRUG	Camphora		CAMPHORA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CAMPHOR (NATURAL)	6	[hp_C]/6[hp_C]			N	20241231
66096-809_d45e319c-0317-7f13-e053-2a95a90af67e	66096-809	HUMAN OTC DRUG	Camphoricum Acidum		CAMPHORICUM ACIDUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CAMPHORIC ACID, (+)-	6	[hp_C]/6[hp_C]			N	20241231
66096-810_d45e3f07-f87b-0c10-e053-2995a90a0c18	66096-810	HUMAN OTC DRUG	Carbo Animalis		CARBO ANIMALIS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CARBO ANIMALIS	6	[hp_C]/6[hp_C]			N	20241231
66096-811_d45e3db7-e461-11af-e053-2a95a90ab07b	66096-811	HUMAN OTC DRUG	Carbo Vegetabilis		CARBO VEGETABILIS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ACTIVATED CHARCOAL	6	[hp_C]/6[hp_C]			N	20241231
66096-812_d45e48c4-d9e0-26f9-e053-2995a90a76f2	66096-812	HUMAN OTC DRUG	Carduus Marianus		CARDUUS MARIANUS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	MILK THISTLE	6	[hp_C]/6[hp_C]			N	20241231
66096-813_d45e3db7-e46d-11af-e053-2a95a90ab07b	66096-813	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CAUSTICUM	6	[hp_C]/6[hp_C]			N	20241231
66096-814_d45e50d8-8521-5309-e053-2a95a90acd40	66096-814	HUMAN OTC DRUG	Chamomilla		CHAMOMILLA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	MATRICARIA CHAMOMILLA	6	[hp_C]/6[hp_C]			N	20241231
66096-815_d45e57e7-33b9-54da-e053-2a95a90aa8ec	66096-815	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CHELIDONIUM MAJUS	6	[hp_C]/6[hp_C]			N	20241231
66096-816_d45e5e2a-0ab6-61de-e053-2995a90a6ba5	66096-816	HUMAN OTC DRUG	Chenopodium		CHENOPODIUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CHENOPODIUM AMBROSIOIDES	6	[hp_C]/6[hp_C]			N	20241231
66096-817_d45e62d3-b510-530d-e053-2a95a90ac447	66096-817	HUMAN OTC DRUG	Chininum Sulphuricum		CHININUM SULPHURICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	QUININE SULFATE	6	[hp_C]/6[hp_C]	Antimalarial [EPC]		N	20241231
66096-818_d45e62d3-b51d-530d-e053-2a95a90ac447	66096-818	HUMAN OTC DRUG	Cimicifuga Racemosa		CIMICIFUGA RACEMOSA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	BLACK COHOSH	6	[hp_C]/6[hp_C]			N	20241231
66096-819_d45e62d3-b529-530d-e053-2a95a90ac447	66096-819	HUMAN OTC DRUG	Cina		CINA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARTEMISIA CINA PRE-FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
66096-820_d45e6dec-24ee-530f-e053-2a95a90a11c3	66096-820	HUMAN OTC DRUG	Cinchona Officinalis		CINCHONA OFFICINALIS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CINCHONA OFFICINALIS BARK	6	[hp_C]/6[hp_C]			N	20241231
66096-821_d45e6dec-24fa-530f-e053-2a95a90a11c3	66096-821	HUMAN OTC DRUG	Coccus Cacti		COCCUS CACTI	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	PROTORTONIA CACTI	6	[hp_C]/6[hp_C]			N	20241231
66096-822_d45e6d38-9c04-62bb-e053-2a95a90a507e	66096-822	HUMAN OTC DRUG	Coffea Cruda		COFFEA CRUDA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	ARABICA COFFEE BEAN	6	[hp_C]/6[hp_C]	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
66096-823_d45e9648-2449-40a0-e053-2a95a90af927	66096-823	HUMAN OTC DRUG	Colocynthis		COLOCYNTHIS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CITRULLUS COLOCYNTHIS FRUIT PULP	6	[hp_C]/6[hp_C]			N	20241231
66096-824_d45ea19a-a748-8964-e053-2a95a90aeb16	66096-824	HUMAN OTC DRUG	Conium Maculatum		CONIUM MACULATUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CONIUM MACULATUM FLOWERING TOP	6	[hp_C]/6[hp_C]			N	20241231
66096-825_d45ea19a-a755-8964-e053-2a95a90aeb16	66096-825	HUMAN OTC DRUG	Crotalus Horridus		CROTALUS HORRIDUS	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CROTALUS HORRIDUS HORRIDUS VENOM	6	[hp_C]/6[hp_C]			N	20241231
66096-826_d45eadc3-f555-3693-e053-2a95a90aab34	66096-826	HUMAN OTC DRUG	Cuprum Metallicum		CUPRUM METALLICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	COPPER	6	[hp_C]/6[hp_C]	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66096-827_d45eadc3-f561-3693-e053-2a95a90aab34	66096-827	HUMAN OTC DRUG	Cuprum Sulphuricum		CUPRUM SULPHURICUM	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	CUPRIC SULFATE	6	[hp_C]/6[hp_C]			N	20241231
66096-828_d45eb4dc-0b14-36cd-e053-2a95a90a6139	66096-828	HUMAN OTC DRUG	Damiana		DAMIANA	PELLET	ORAL	20191101		UNAPPROVED HOMEOPATHIC		OHM PHARMA INC.	TURNERA DIFFUSA LEAFY TWIG	6	[hp_C]/6[hp_C]			N	20241231
66097-001_0b588ccf-e4d6-9784-e063-6394a90ababd	66097-001	HUMAN OTC DRUG	SISLEYA Global Anti-Age Hand care	SPF 15	AVOBENZONE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20130120		OTC MONOGRAPH DRUG	M020	C.F.E.B. Sisley	AVOBENZONE; OCTINOXATE; OCTISALATE	20; 50; 30	mg/g; mg/g; mg/g			N	20241231
66097-002_0b58acbb-89a5-08f5-e063-6294a90a3b2a	66097-002	HUMAN OTC DRUG	SUNLEYA Age minimizing sun care	SPF 15	AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20130121		OTC MONOGRAPH DRUG	M020	C.F.E.B. Sisley	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	30; 50; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
66097-003_0b589989-6b8d-063c-e063-6294a90a0a1a	66097-003	HUMAN OTC DRUG	SUNLEYA Age minimizing sun care	SPF 50 plus	AVOBENZONE, HOMOSALTE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20130121		OTC MONOGRAPH DRUG	M020	C.F.E.B. Sisley	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
66097-004_0b58a685-e634-934f-e063-6394a90aeeb7	66097-004	HUMAN OTC DRUG	SUPER CREME SOLAIRE CORPS Body sun care	SPF 15	AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20130121		OTC MONOGRAPH DRUG	M020	C.F.E.B. Sisley	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	30; 50; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
66097-007_0b58a9e4-04b2-ff54-e063-6294a90a231a	66097-007	HUMAN OTC DRUG	Tinted Sunscreen SPF 30 1-Natural		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20151222		OTC MONOGRAPH DRUG	M020	C.F.E.B. - Sisley	TITANIUM DIOXIDE; ZINC OXIDE	154.3; 108.9	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66097-008_0b589014-59c0-916d-e063-6394a90ae72d	66097-008	HUMAN OTC DRUG	Tinted Sunscreen SPF 30 2-Golden		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20151223		OTC MONOGRAPH DRUG	M020	C.F.E.B. - Sisley	TITANIUM DIOXIDE; ZINC OXIDE	147.4; 108.9	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66097-009_0b589014-59cf-916d-e063-6394a90ae72d	66097-009	HUMAN OTC DRUG	Tinted Sunscreen Cream SPF 30 4-Deep Amber		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170315		OTC MONOGRAPH DRUG	M020	C.F.E.B. - Sisley	TITANIUM DIOXIDE; ZINC OXIDE	129.3; 108.9	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66130-001_0787f5d5-42b4-575b-e063-6394a90ad4ce	66130-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19930703		UNAPPROVED MEDICAL GAS		Lubbock Oxygen & Medical Gases, Inc.	OXYGEN	99	L/100L			N	20241231
66155-544_36e7ee81-dfe3-40bf-95ea-d215ccdf413a	66155-544	HUMAN OTC DRUG	Surgent Antiseptic		CHLOROXYLENOL	SOAP	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part333E	SunCoast Paper Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
66163-0300_274bc8d6-b17d-406b-93a3-da7f94d3ef5f	66163-0300	HUMAN OTC DRUG	Professional Solutions - Botanical Day Cream Broad Spectrum SPF 30 Sunscreen		Octinoxate and Zinc Oxide	CREAM	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part352	Cosmetic Solutions LLC	OCTINOXATE; ZINC OXIDE	7.5; 10	g/100g; g/100g			N	20241231
66163-0301_5b120e76-0b6c-4bc6-85e6-4abfa0a1baa5	66163-0301	HUMAN OTC DRUG	Mimi Luzon - Face Defence Age Defying Cream Broad Spectrum SPF 30 Sunscreen		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part352	Cosmetic Solutions LLC	OCTINOXATE; ZINC OXIDE	7.5; 10	g/100mL; g/100mL			N	20241231
66163-1000_a63ebeff-416a-4ca1-9209-6c0a48651910	66163-1000	HUMAN OTC DRUG	Norwex Natural Sunscreen Broad Spectrum SPF 30		Zinc Oxide	OINTMENT	TOPICAL	20190701		OTC MONOGRAPH NOT FINAL	part352	Cosmetic Solutions LLC	ZINC OXIDE	20	g/100g			N	20241231
66163-1001_86517050-3aa0-4ee7-b0d7-fca037544433	66163-1001	HUMAN OTC DRUG	Norwex Natural Sunscreen Lip Balm Broad Spectrum SPF 15		Zinc Oxide	STICK	TOPICAL	20190301		OTC MONOGRAPH NOT FINAL	part352	Cosmetic Solutions LLC	ZINC OXIDE	10.5	g/100g			N	20241231
66163-1006_c3e45cd6-4cd1-4794-aca1-c64b0aaf610e	66163-1006	HUMAN OTC DRUG	hello bello Kids Soothing Itch Skin Protectant		OATMEAL	STICK	TOPICAL	20230101		OTC MONOGRAPH FINAL	part347	Cosmetic Solutions LLC	OATMEAL	10	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
66163-4272_5313aba4-617b-4f61-9eba-1c8c06a3934b	66163-4272	HUMAN OTC DRUG	Dr. Dennis Gross Skincare - Lightweight Wrinkle Defense Broad Spectrum SPF 30		Zinc Oxide	LIQUID	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Cosmetic Solutions LLC	ZINC OXIDE	16	g/100mL			N	20241231
66163-4708_03b24da1-a4f6-43d1-a754-967781dac6d4	66163-4708	HUMAN OTC DRUG	Josie Maran - Argan Apothecary Daily Response Calming Treatment		SULFUR	LOTION	TOPICAL	20230515		OTC MONOGRAPH FINAL	part333D	Cosmetic Solutions LLC	SULFUR	30	mg/mL			N	20241231
66171-123_0c5b74ab-a033-2667-e063-6294a90a757e	66171-123	HUMAN OTC DRUG	Dr.Denese SPF 30 Defense Day		ZINC OXIDE, OCTINOXATE	CREAM	TOPICAL	20110521		OTC MONOGRAPH DRUG	M020	SkinScience Labs, Inc	OCTINOXATE; ZINC OXIDE	7.5; 7.5	g/100g; g/100g			N	20241231
66184-153_0bd9b74a-021e-bb21-e063-6394a90a4d52	66184-153	HUMAN OTC DRUG	Sally Hansen Ouch-Relief	Wax Kit	Benzocaine	KIT	TOPICAL	20120101		OTC MONOGRAPH DRUG	M017	Coty US LLC						N	20241231
66184-155_fc8a2605-d82c-5cf8-e053-6394a90ab9d2	66184-155	HUMAN OTC DRUG	Sally Hansen Microwavable Eybrow, Face and Lip Wax Kit		Benzocaine	KIT	TOPICAL	20120101		OTC MONOGRAPH FINAL	part333B	Coty US LLC						N	20241231
66184-161_ffc2e9b4-1f15-220c-e053-6294a90a6d75	66184-161	HUMAN OTC DRUG	Sally Hansen Ouch-Relief Stripless Hard Wax Kit		benzocaine	KIT	TOPICAL	20181018		OTC MONOGRAPH FINAL	part348	Coty US LLC						N	20241231
66215-101_04025128-2bb0-207c-e063-6394a90a7603	66215-101	HUMAN PRESCRIPTION DRUG	Tracleer		bosentan	TABLET, FILM COATED	ORAL	20011120		NDA	NDA021290	Actelion Pharmaceuticals US, Inc.	BOSENTAN	62.5	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
66215-102_04025128-2bb0-207c-e063-6394a90a7603	66215-102	HUMAN PRESCRIPTION DRUG	Tracleer		bosentan	TABLET, FILM COATED	ORAL	20011120		NDA	NDA021290	Actelion Pharmaceuticals US, Inc.	BOSENTAN	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
66215-103_04025128-2bb0-207c-e063-6394a90a7603	66215-103	HUMAN PRESCRIPTION DRUG	Tracleer		bosentan	TABLET, FOR SUSPENSION	ORAL	20171113		NDA	NDA209279	Actelion Pharmaceuticals US, Inc.	BOSENTAN	32	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
66215-201_f9cb16ee-d325-b331-e053-6394a90ab08c	66215-201	HUMAN PRESCRIPTION DRUG	Zavesca		miglustat	CAPSULE	ORAL	20030731		NDA	NDA021348	Actelion Pharmaceuticals US, Inc.	MIGLUSTAT	100	mg/1	Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA]		N	20241231
66215-232_04025128-2bb0-207c-e063-6394a90a7603	66215-232	HUMAN PRESCRIPTION DRUG	Tracleer		bosentan	TABLET, FOR SUSPENSION	ORAL	20210729		NDA	NDA209279	Actelion Pharmaceuticals US, Inc.	BOSENTAN	32	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
66215-302_431e95f6-7248-48e7-a836-3e43c7295229	66215-302	HUMAN PRESCRIPTION DRUG	VENTAVIS		iloprost	SOLUTION	RESPIRATORY (INHALATION)	20050507		NDA	NDA021779	Actelion Pharmaceuticals US, Inc.	ILOPROST	10	ug/mL	Prostacycline [EPC], Prostaglandins I [CS]		N	20241231
66215-303_431e95f6-7248-48e7-a836-3e43c7295229	66215-303	HUMAN PRESCRIPTION DRUG	VENTAVIS		iloprost	SOLUTION	RESPIRATORY (INHALATION)	20090824		NDA	NDA021779	Actelion Pharmaceuticals US, Inc.	ILOPROST	20	ug/mL	Prostacycline [EPC], Prostaglandins I [CS]		N	20241231
66215-402_39e8b7f8-f82a-4083-a284-ce571a87ce97	66215-402	HUMAN PRESCRIPTION DRUG	Veletri		epoprostenol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100422		NDA	NDA022260	Actelion Pharmaceuticals US, Inc.	EPOPROSTENOL	1.5	mg/10mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66215-403_39e8b7f8-f82a-4083-a284-ce571a87ce97	66215-403	HUMAN PRESCRIPTION DRUG	Veletri		epoprostenol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20100422		NDA	NDA022260	Actelion Pharmaceuticals US, Inc.	EPOPROSTENOL	.5	mg/10mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66215-501_fe1c280f-5053-ee0f-e053-6294a90a1489	66215-501	HUMAN PRESCRIPTION DRUG	OPSUMIT		macitentan	TABLET, FILM COATED	ORAL	20131104		NDA	NDA204410	Actelion Pharmaceuticals US, Inc.	MACITENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
66215-602_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-602	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	200	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-604_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-604	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	400	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-606_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-606	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	600	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-608_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-608	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	800	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-610_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-610	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	1000	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-612_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-612	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	1200	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-614_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-614	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	1400	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-616_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-616	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	TABLET, COATED	ORAL	20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	1600	ug/1	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66215-628_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-628	HUMAN PRESCRIPTION DRUG	UPTRAVI Titration Pack		Selexipag	KIT		20151221		NDA	NDA207947	Actelion Pharmaceuticals US, Inc.						N	20241231
66215-718_f9b62ce2-37c1-2e5c-e053-6394a90a657b	66215-718	HUMAN PRESCRIPTION DRUG	UPTRAVI		Selexipag	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210729		NDA	NDA214275	Actelion Pharmaceuticals US, Inc.	SELEXIPAG	1800	ug/10mL	Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]		N	20241231
66220-207_25a2135a-ff86-4f54-87ae-22f2020c4bbb	66220-207	HUMAN PRESCRIPTION DRUG	ACETADOTE		Acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20040123		NDA	NDA021539	Cumberland Pharmaceuticals Inc.	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
66220-284_049f2c46-6b00-429e-a4fa-d2f288e3cc48	66220-284	HUMAN PRESCRIPTION DRUG	Caldolor		ibuprofen	INJECTION	INTRAVENOUS	20200101		NDA	NDA022348	Cumberland Pharmaceuticals Inc.	IBUPROFEN	800	mg/200mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66220-287_049f2c46-6b00-429e-a4fa-d2f288e3cc48	66220-287	HUMAN PRESCRIPTION DRUG	Caldolor		ibuprofen	INJECTION	INTRAVENOUS	20090611		NDA	NDA022348	Cumberland Pharmaceuticals Inc.	IBUPROFEN	800	mg/8mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66220-315_4d14335c-e22a-4113-a112-fcbde33b727d	66220-315	HUMAN PRESCRIPTION DRUG	VIBATIV		telavancin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210101		NDA	NDA022110	Cumberland Pharmaceuticals Inc.	TELAVANCIN HYDROCHLORIDE	15	mg/mL	Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [EXT]		N	20241231
66220-422_6d6034ac-47ef-4a5d-b99f-1548898b017e	66220-422	HUMAN PRESCRIPTION DRUG	Omeclamox-Pak		omeprazole, clarithromycin, amoxicillin	KIT		20120427		NDA	NDA050824	Cumberland Pharmaceuticals Inc.						N	20241231
66220-719_85528d56-e38f-4565-9136-c7639b479634	66220-719	HUMAN PRESCRIPTION DRUG	KRISTALOSE		lactulose	POWDER, FOR SOLUTION	ORAL	20120120		ANDA	ANDA074712	Cumberland Pharmaceuticals Inc.	LACTULOSE	10	g/10g	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66220-729_85528d56-e38f-4565-9136-c7639b479634	66220-729	HUMAN PRESCRIPTION DRUG	KRISTALOSE		lactulose	POWDER, FOR SOLUTION	ORAL	20120120		ANDA	ANDA074712	Cumberland Pharmaceuticals Inc.	LACTULOSE	20	g/20g	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66228-002_0801e096-6b73-deaa-e063-6294a90acfe7	66228-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19910401		NDA	NDA206023	CLAY COUNTY HOSPITAL DME	OXYGEN	990	mL/L			N	20241231
66259-037_fb625515-a4a0-4d3b-8f4a-5de7705be9aa	66259-037	HUMAN PRESCRIPTION DRUG	PINPOINT Lymphatics Kit		indocyanine green	KIT	INTRAVASCULAR; INTRAVENOUS	20181121		NDA	NDA211580	Novadaq Technologies Inc						N	20241231
66259-306_fb625515-a4a0-4d3b-8f4a-5de7705be9aa	66259-306	HUMAN PRESCRIPTION DRUG	SPY Elite Kit		indocyanine green	KIT	INTRADERMAL; INTRAVASCULAR; INTRAVENOUS	20181121		NDA	NDA211580	Novadaq Technologies Inc						N	20241231
66259-903_fb625515-a4a0-4d3b-8f4a-5de7705be9aa	66259-903	HUMAN PRESCRIPTION DRUG	SPY-PHI Kit		indocyanine green	KIT	INTRADERMAL; INTRAVASCULAR; INTRAVENOUS	20190910		NDA	NDA211580	Novadaq Technologies Inc						N	20241231
66259-936_fb625515-a4a0-4d3b-8f4a-5de7705be9aa	66259-936	HUMAN PRESCRIPTION DRUG	SPY-MIS Kit		indocyanine green	KIT	INTRADERMAL; INTRAVASCULAR; INTRAVENOUS	20190910		NDA	NDA211580	Novadaq Technologies Inc						N	20241231
66259-937_fb625515-a4a0-4d3b-8f4a-5de7705be9aa	66259-937	HUMAN PRESCRIPTION DRUG	SPY Lymphatics Kit		indocyanine green	KIT	INTRADERMAL; INTRAVASCULAR; INTRAVENOUS	20181121		NDA	NDA211580	Novadaq Technologies Inc						N	20241231
66267-045_f6936ce4-f2c9-ab0a-e053-2a95a90ab350	66267-045	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	NuCare Pharmaceuticals, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
66267-071_fc9ff1d6-3c1f-8a1e-e053-6294a90a7d5a	66267-071	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66267-073_d57979c0-6d4b-5e32-e053-2995a90ab8ee	66267-073	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	NuCare Pharmaceticals, Inc.	DICLOXACILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
66267-080_e767c105-d9e1-7162-e053-2a95a90afc9d	66267-080	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66267-166_de470e33-3061-4178-e053-2995a90a6325	66267-166	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	NuCare Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
66267-172_0bdf5586-3eeb-97ef-e063-6394a90a163d	66267-172	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	NuCare Pharmaceuticals,Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66267-259_d579d39f-a238-258a-e053-2a95a90abef4	66267-259	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110222		NDA AUTHORIZED GENERIC	NDA018279	NuCare Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66267-291_d579db86-b5cc-a3b4-e053-2995a90ad23b	66267-291	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	NuCare Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
66267-321_e1fd954f-843e-eac0-e053-2995a90a9932	66267-321	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	NuCare Pharmaceuticals,Inc.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
66267-325_d579f41e-beee-240b-e053-2995a90a8ef8	66267-325	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	NuCare Pharmaceuticals, Inc.	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
66267-377_f19ac465-fa90-b049-e053-2a95a90a4cf3	66267-377	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150422		ANDA	ANDA202824	NuCare Pharmaceuticals, Inc.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
66267-394_d57ac1f7-eca3-720c-e053-2995a90a568f	66267-394	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	NuCare Pharmaceuticals, Inc,	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
66267-400_da727156-1daf-5694-e053-2a95a90acbd0	66267-400	HUMAN PRESCRIPTION DRUG	KETOCONAZOLE		KETOCONAZOLE	TABLET	ORAL	20180626		ANDA	ANDA210457	NuCare Pharmaceuticals,Inc.	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
66267-506_d57bbe99-4931-7541-e053-2a95a90acc7d	66267-506	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	NuCare Pharmaceuticals, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66267-665_e3169e46-0210-680e-e053-2a95a90abe5e	66267-665	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20150429		ANDA	ANDA203154	NuCare Pharmaceuticals, Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
66267-803_d57e5182-4ae8-964c-e053-2a95a90aa2a7	66267-803	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	NuCare Pharmaceuticals,Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
66267-816_d57e616e-813d-5109-e053-2995a90a45ab	66267-816	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	NuCare Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
66267-832_ee8be683-f937-b32b-e053-2995a90aa51f	66267-832	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	NuCare Pharmaceuticals, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66267-860_fd196032-c29f-af0b-e053-6294a90a3be5	66267-860	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	NuCare Pharmaceuticals,Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66267-919_d57e7398-0f30-bcb0-e053-2a95a90acf07	66267-919	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	NuCare Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
66267-936_e39ea058-4882-329f-e053-2995a90ab307	66267-936	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	19931129		ANDA	ANDA064052	NuCare Pharmaceuticals,Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
66267-943_d57e7781-dc6d-1274-e053-2995a90aad77	66267-943	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	NuCare Pharmaceuticals,Inc.	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
66267-963_d57e8058-bb76-3aa6-e053-2a95a90a1520	66267-963	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66267-964_d57e9a7c-3c1d-abff-e053-2a95a90aefbd	66267-964	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	NuCare Pharmaceuticals Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66267-967_ef1853e1-b7e8-e428-e053-2995a90a3388	66267-967	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66267-971_d57e7cf4-3879-51c7-e053-2a95a90abb7a	66267-971	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20061213		ANDA	ANDA064163	NuCare Pharmaceuticals, Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
66267-975_d57ea847-dfa0-56a4-e053-2a95a90a3c44	66267-975	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19940729		ANDA	ANDA064067	NuCare Pharmaceuticals,Inc.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
66267-977_d57eb311-e883-597b-e053-2a95a90a6cce	66267-977	HUMAN OTC DRUG	Siladryl Allergy Medicine		diphenhydramine hydrochloride	LIQUID	ORAL	19970101		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66267-980_d57eb311-e884-597b-e053-2a95a90a6cce	66267-980	HUMAN OTC DRUG	Major Clotrimazole		CLOTRIMAZOLE	CREAM	TOPICAL	20041004		OTC MONOGRAPH FINAL	part333C	NuCare Pharmaceuticals,Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
66267-994_d57e9ffb-8736-4bf9-e053-2995a90a80ff	66267-994	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
66288-1100_1e43f706-81c4-4c84-9bfc-cab0a420cd92	66288-1100	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		CEFAZOLIN SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20070101		ANDA	ANDA065141	Samson Medical Technologies, L.L.C.	CEFAZOLIN SODIUM	100	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
66288-1300_1e43f706-81c4-4c84-9bfc-cab0a420cd92	66288-1300	HUMAN PRESCRIPTION DRUG	CEFAZOLIN		CEFAZOLIN SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20070101		ANDA	ANDA065141	Samson Medical Technologies, L.L.C.	CEFAZOLIN SODIUM	300	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
66288-4100_b137208d-8dfd-4133-94c2-7287866a5525	66288-4100	HUMAN PRESCRIPTION DRUG	Cefoxitin		cefoxitin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160301		ANDA	ANDA200938	SAMSON MEDICAL TECHNOLOGIES LLC	CEFOXITIN SODIUM	100	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
66288-6100_6aff16e3-f491-4175-a3f2-842bed6ebecb	66288-6100	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20140630		ANDA	ANDA090057	Samson Medical Technologies, LLC	CEFTRIAXONE SODIUM	100	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
66288-7100_d607785f-563a-4816-83c4-dfc38bbc29bd	66288-7100	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160601		ANDA	ANDA091532	SAMSON MEDICAL TECHNOLOGIES LLC	VANCOMYCIN HYDROCHLORIDE	100	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
66294-051_a317f585-13d0-46bf-849a-fe0f362881f8	66294-051	HUMAN OTC DRUG	PRIME SOURCE Antibacterial Ltion So ap		Chloroxylenol	LIQUID	TOPICAL	20010815		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	CHLOROXYLENOL	.003	mg/mL			N	20241231
66294-060_cf71a95e-4a9a-4e9c-8a11-1e557349b9a2	66294-060	HUMAN OTC DRUG	PRIME SOURCE Antimicrobial Hand So ap		CHLOROXYLENOL	LIQUID	TOPICAL	20081015		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	CHLOROXYLENOL	.003	mg/mL			N	20241231
66294-080_4f101014-04e3-4151-b4ae-72e7ebf54b24	66294-080	HUMAN OTC DRUG	PRIME SOURCE Antimicrobial Foaming Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20021115		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	CHLOROXYLENOL	.003	mg/mL			N	20241231
66294-082_92098749-1fea-43df-b6d6-e26de30c1e2f	66294-082	HUMAN OTC DRUG	PRIME SOURCE Antimicrobial Foam So ap		Chloroxylenol	LIQUID	TOPICAL	20071215		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	CHLOROXYLENOL	.003	mg/mL			N	20241231
66294-114_d40a25f5-5e63-4e50-b2c8-8760fb97d6c8	66294-114	HUMAN OTC DRUG	Hawthorn Hygiene Solutions ENERGY ANTIBACTERIAL FOAM FRAGRANCE FREE 1200 mL		Benzalkonium Chloride	LIQUID	TOPICAL	20231205		OTC MONOGRAPH DRUG	505G(a)(3)	BUNZL Distribution	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
66294-400_e9a342d0-f583-47be-855d-bd758732141d	66294-400	HUMAN OTC DRUG	PRIME SOURCE Antibacterial Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66294-401_9bba83cc-08f0-4a95-9cce-cc547994eb7f	66294-401	HUMAN OTC DRUG	PRIME SOURCE ULTRA Energy Plum Antibacterial Foam Hand So ap		Benzalkonium Chloride	LIQUID	TOPICAL	20171130		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66294-402_c1a5fa51-2b95-400e-a7b5-c8fe78b8b508	66294-402	HUMAN OTC DRUG	PRIME SOURCE SELECT Plum Antibacterial Foam Hand So ap		Benzalkonium Chloride	LIQUID	TOPICAL	20171130		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66294-432_edf0475b-44b9-441d-bc87-d054a6a73435	66294-432	HUMAN OTC DRUG	Prime Source SELECT Plum Antibacterial Dye Free Foam Hand So ap		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20171130		OTC MONOGRAPH NOT FINAL	part333E	BUNZL Distribution	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66294-521_f867e114-c71e-45b5-b007-b0b6889f6c46	66294-521	HUMAN OTC DRUG	ProPower Originals Antimicrobial Foaming So ap		CHLOROXYLENOL	LIQUID	TOPICAL	20150515		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	CHLOROXYLENOL	.005	mg/mL			N	20241231
66294-523_fc2b9039-9df2-4adb-9ec1-cf2249b68316	66294-523	HUMAN OTC DRUG	PRIME SOURCE E2 Foam So ap		CHLOROXYLENOL	LIQUID	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	CHLOROXYLENOL	.5	mg/100mL			N	20241231
66294-965_d2ce6586-4eb4-403f-924c-666e703f0412	66294-965	HUMAN OTC DRUG	PRIME SOURCE Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20020930		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	ALCOHOL	.62	mL/mL			N	20241231
66294-966_a54a016e-cc1b-45d0-9217-727bf3f9744b	66294-966	HUMAN OTC DRUG	Osceola Skin Care Sani-Gel Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20030730		OTC MONOGRAPH NOT FINAL	part333E	BUNZL	ALCOHOL	.62	mL/mL			N	20241231
66298-1060_55c630dc-955a-0ce4-e054-00144ff88e88	66298-1060	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20170802		ANDA	ANDA206485	Fresenius Kabi Norge AS	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66298-1070_55c630dc-955a-0ce4-e054-00144ff88e88	66298-1070	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20170801		ANDA	ANDA206485	Fresenius Kabi Norge AS	MAGNESIUM SULFATE HEPTAHYDRATE	80	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66298-5137_74f6ba39-459c-c32b-e053-2991aa0a665c	66298-5137	HUMAN PRESCRIPTION DRUG	Zyvox		LINEZOLID	INJECTION, SOLUTION	INTRAVENOUS	20180604		NDA	NDA021131	Fresenius Kabi Norge As	LINEZOLID	200	mg/100mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
66298-5140_74f6ba39-4604-c32b-e053-2991aa0a665c	66298-5140	HUMAN PRESCRIPTION DRUG	Zyvox		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20180605		NDA	NDA021131	Fresenius Kabi Norge As	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
66298-7131_55c6e7c5-2f72-267c-e054-00144ff88e88	66298-7131	HUMAN PRESCRIPTION DRUG	Linezolid		LINEZOLID	INJECTION, SOLUTION	INTRAVENOUS	20170727		ANDA	ANDA204764	Fresenius Kabi Norge AS	LINEZOLID	2	mg/mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
66298-7807_74f6ba39-46d0-c32b-e053-2991aa0a665c	66298-7807	HUMAN PRESCRIPTION DRUG	Zyvox		LINEZOLID	INJECTION	INTRAVENOUS	20180605		NDA	NDA021131	Fresenius Kabi Norge As	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
66298-8507_616cf61b-abdb-30d7-e053-2a91aa0a3c7d	66298-8507	HUMAN PRESCRIPTION DRUG	Moxifloxacin		MOXIFLOXACIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170802		NDA	NDA205572	Fresenius Kabi Norge AS	MOXIFLOXACIN HYDROCHLORIDE	400	mg/250mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
66302-014_292edc42-e0de-40b2-be38-aadc411b1c88	66302-014	HUMAN PRESCRIPTION DRUG	Unituxin		DINUTUXIMAB	INJECTION	INTRAVENOUS	20150310		BLA	BLA125516	United Therapeutics Corporation	DINUTUXIMAB	3.5	mg/mL	Glycolipid Disialoganglioside-directed Antibody Interactions [MoA], Glycolipid Disialoganglioside-directed Antibody [EPC]		N	20241231
66302-101_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-101	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20020522		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	20	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-102_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-102	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20020522		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	50	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-105_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-105	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20020522		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	100	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-110_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-110	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20020522		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	200	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-111_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-111	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230928		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	2	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-112_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-112	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230928		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	4	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-114_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-114	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230928		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	8	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-120_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-120	HUMAN PRESCRIPTION DRUG	Remodulin		treprostinil	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220125		NDA	NDA021272	United Therapeutics Corporation	TREPROSTINIL	400	mg/20mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-150_a8994b40-f2ce-4a6d-bc58-8b5214231d5a	66302-150	HUMAN PRESCRIPTION DRUG	Sterile Diluent for Remodulin		water	INJECTION, SOLUTION	INTRAVENOUS	20020522		NDA	NDA021272	United Therapeutics Corporation	WATER	1	mL/mL			N	20241231
66302-206_793c8b90-98ca-4d44-9c88-d4df538f97e5	66302-206	HUMAN PRESCRIPTION DRUG	TYVASO		treprostinil	INHALANT	ORAL	20090814		NDA	NDA022387	United Therapeutics Corporation	TREPROSTINIL	1.74	mg/2.9mL	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-300_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-300	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	TABLET, EXTENDED RELEASE	ORAL	20131220		NDA	NDA203496	United Therapeutics Corporation	TREPROSTINIL	.125	mg/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-302_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-302	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	TABLET, EXTENDED RELEASE	ORAL	20131220		NDA	NDA203496	United Therapeutics Corporation	TREPROSTINIL	.25	mg/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-310_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-310	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	TABLET, EXTENDED RELEASE	ORAL	20131220		NDA	NDA203496	United Therapeutics Corporation	TREPROSTINIL	1	mg/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-325_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-325	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	TABLET, EXTENDED RELEASE	ORAL	20131220		NDA	NDA203496	United Therapeutics Corporation	TREPROSTINIL	2.5	mg/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-350_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-350	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	TABLET, EXTENDED RELEASE	ORAL	20131220		NDA	NDA203496	United Therapeutics Corporation	TREPROSTINIL	5	mg/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-361_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-361	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	KIT		20230214		NDA	NDA203496	United Therapeutics Corporation						N	20241231
66302-362_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-362	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	KIT		20230214		NDA	NDA203496	United Therapeutics Corporation						N	20241231
66302-363_e9babc9a-fe4f-4da1-9110-4425b17f2381	66302-363	HUMAN PRESCRIPTION DRUG	Orenitram		treprostinil	KIT		20230214		NDA	NDA203496	United Therapeutics Corporation						N	20241231
66302-467_9ff3a32f-da21-41bd-a8ec-7b0fa70dc1bd	66302-467	HUMAN PRESCRIPTION DRUG	ADCIRCA		Tadalafil	TABLET	ORAL	20090522		NDA	NDA022332	United Therapeutics Corporation	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
66302-600_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-600	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	KIT		20220523		NDA	NDA214324	United Therapeutics Corporation						N	20241231
66302-610_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-610	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	KIT		20220523		NDA	NDA214324	United Therapeutics Corporation						N	20241231
66302-616_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-616	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	16	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-620_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-620	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	KIT		20220523		NDA	NDA214324	United Therapeutics Corporation						N	20241231
66302-630_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-630	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	KIT		20230627		NDA	NDA214324	United Therapeutics Corporation						N	20241231
66302-632_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-632	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	32	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-640_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-640	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	KIT		20230627		NDA	NDA214324	United Therapeutics Corporation						N	20241231
66302-648_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-648	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	48	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-650_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-650	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	KIT		20230627		NDA	NDA214324	United Therapeutics Corporation						N	20241231
66302-664_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-664	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	64	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-716_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-716	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	16	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-720_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-720	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	KIT		20220523		NDA	NDA214324	United Therapeutics Corporation						N	20241231
66302-732_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-732	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	32	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-748_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-748	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	48	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66302-764_194fcd42-22c2-4f1b-a45a-02e2bbeeba6a	66302-764	HUMAN PRESCRIPTION DRUG	Tyvaso DPI		treprostinil	INHALANT	ORAL	20220523		NDA	NDA214324	United Therapeutics Corporation	TREPROSTINIL	64	ug/1	Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]		N	20241231
66312-176_83eae922-075a-4138-a036-08428f53bd14	66312-176	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	19850122		ANDA	ANDA088390	Dentsply Pharmaceutical	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	10; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66312-181_83eae922-075a-4138-a036-08428f53bd14	66312-181	HUMAN PRESCRIPTION DRUG	Xylocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	19850122		ANDA	ANDA088389	Dentsply Pharmaceutical	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	20; 20	ug/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66312-441_ed74d7bf-db66-4fc2-bbf5-d85e91fc5569	66312-441	HUMAN PRESCRIPTION DRUG	Polocaine		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	19841010		ANDA	ANDA088387	Dentsply Pharmaceutical	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
66312-580_fc5f9ba7-22e9-4bd9-9a44-26b8704021c5	66312-580	HUMAN PRESCRIPTION DRUG	Citanest Forte DENTAL		prilocaine hcl and epinephrine	INJECTION, SOLUTION	PARENTERAL	20171204		ANDA	ANDA078959	Dentsply Pharmaceutical Inc.	EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE	.005; 40	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66312-601_cd2469eb-3771-4470-84e5-1b79c0e47d92	66312-601	HUMAN PRESCRIPTION DRUG	Articadent		Articaine hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20090901		NDA AUTHORIZED GENERIC	NDA020971	Dentsply Pharmaceutical	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .01	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66312-602_cd2469eb-3771-4470-84e5-1b79c0e47d92	66312-602	HUMAN PRESCRIPTION DRUG	Articadent		Articaine hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20090901		NDA AUTHORIZED GENERIC	NDA020971	Dentsply Pharmaceutical	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66312-630_14eaeca2-d602-48eb-a384-eee02a9a1b04	66312-630	HUMAN PRESCRIPTION DRUG	Citanest Plain		prilocaine hydrochloride	INJECTION, SOLUTION	SUBMUCOSAL	19651118		ANDA	ANDA079235	Dentsply Pharmaceutical Inc.	PRILOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
66314-001_075f071c-f118-95b3-e063-6394a90a425c	66314-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20101001		UNAPPROVED MEDICAL GAS		Med Resources, Inc.	OXYGEN	99	L/100L			N	20241231
66343-056_b96efd18-f3fb-1ddb-e053-2a95a90a3e71	66343-056	HUMAN PRESCRIPTION DRUG	Emvita 7		Anacard occ, Lachesis mutus, Phosphorus, Glandula sup, Lycopodium	LIQUID	ORAL	20190603		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ANACARDIUM OCCIDENTALE FRUIT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; SUS SCROFA ADRENAL GLAND	18; 800; 16; 21; 21	[hp_M]/50mL; [hp_C]/50mL; [hp_M]/50mL; [hp_X]/50mL; [hp_X]/50mL			N	20241231
66343-082_02733946-3c2f-4152-a4dc-677c2b4dcb15	66343-082	HUMAN OTC DRUG	Anxiovita		Aconitum napellus, Anacardium orientale, Cerebrum, Hypericum perforatum	LIQUID	ORAL	20221128		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ACONITUM NAPELLUS; HYPERICUM PERFORATUM; SEMECARPUS ANACARDIUM JUICE; SUS SCROFA CEREBRUM	18; 21; 12; 200	[hp_M]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL			N	20241231
66343-083_20a89ac3-5105-4150-96ea-9fbdee8d85bd	66343-083	HUMAN OTC DRUG	Chavita 1		Carbo veg, Oophorinum, Silicea, Olibanum, Orchitinum, Urtica urens	LIQUID	ORAL	20221210		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ACTIVATED CHARCOAL; BOS TAURUS TESTICLE; FRANKINCENSE; SILICON DIOXIDE; SUS SCROFA OVARY; URTICA URENS	50; 21; 21; 21; 21; 21	[hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-084_c910a413-7682-450b-aa21-f5dea51f0fc0	66343-084	HUMAN OTC DRUG	Chavita 2		ARGENTUM METALLICUM, CAUSTICUM, GLANDULA SUPRARENALIS, JUNIPERUS COMMUNIS, LAVANDULA ANGUSTIFOLIA, PLATINUM METALLICUM, THUJA OCCIDENTALIS	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		RUBIMED AG	CAUSTICUM; JUNIPER BERRY; LAVANDULA ANGUSTIFOLIA WHOLE; PLATINUM; SILVER; SUS SCROFA ADRENAL GLAND; THUJA OCCIDENTALIS LEAFY TWIG	200; 21; 21; 50; 21; 21; 21	[hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
66343-085_27f628d4-099a-4a9e-9eb1-f7cfd630102b	66343-085	HUMAN OTC DRUG	Chavita 4		Aur met, Crataegus, Cetraria, Eucalyptus globulus, Ferrum met, Thymus gland, Zinc val	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		RUBIMED AG	BOS TAURUS THYMUS; CETRARIA ISLANDICA WHOLE; EUCALYPTUS GLOBULUS LEAF; GOLD; HAWTHORN LEAF WITH FLOWER; IRON; ZINC VALERATE DIHYDRATE	21; 21; 21; 21; 21; 50; 200	[hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_C]/60mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66343-086_b9cf86e2-8ed9-4f90-8172-f989d7e2f6a7	66343-086	HUMAN OTC DRUG	Chavita 5		Phosphorus, Thuja occidentalis, Thyroidinum, Viola tric	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		RUBIMED AG	PHOSPHORUS; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, PORCINE; VIOLA TRICOLOR WHOLE	21; 50; 21; 21	[hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-087_2b6739a6-20af-4a70-a648-8865f8611ea8	66343-087	HUMAN OTC DRUG	Chavita 6		Cerebrum, Plumb met, Staphysagria, Viscum album	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		RUBIMED AG	DELPHINIUM STAPHISAGRIA SEED; LEAD; SUS SCROFA CEREBRUM; VISCUM ALBUM FRUITING TOP	50; 21; 21; 21	[hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-088_450f86b5-dfdc-474a-9971-b207edd0f2f1	66343-088	HUMAN OTC DRUG	Chavita 7		Aur met, Calc sulf, Cerebrum, Hypericum perforatum, Lachesis mutus, Millefolium, Valeriana	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ACHILLEA MILLEFOLIUM WHOLE; CALCIUM SULFATE ANHYDROUS; GOLD; HYPERICUM PERFORATUM WHOLE; LACHESIS MUTA VENOM; SUS SCROFA CEREBRUM; VALERIAN	21; 200; 200; 21; 21; 21; 21	[hp_X]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66343-089_6feeae09-8490-4bb6-8ae6-80599e7bb3bb	66343-089	HUMAN OTC DRUG	Emvita 1		Calcarea carbonica, Kali carbonicum, Lachesis mutus, Naja tripudians, Pulsatilla, Oophorinum, Orchitinum	LIQUID	ORAL	20221220		UNAPPROVED HOMEOPATHIC		RUBIMED AG	BOS TAURUS TESTICLE; LACHESIS MUTA VENOM; NAJA NAJA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; PULSATILLA VULGARIS WHOLE; SUS SCROFA OVARY	21; 18; 21; 16; 800; 21; 21	[hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-090_0b77b032-7558-413e-ac95-2fcc17f96bd6	66343-090	HUMAN OTC DRUG	Emvita 2		Calcarea phosphorica, Cuprum metallicum, Oophorinum, Orchitinum, Veratrum album, Vipera berus	LIQUID	ORAL	20221220		UNAPPROVED HOMEOPATHIC		RUBIMED AG	BOS TAURUS TESTICLE; COPPER; SUS SCROFA OVARY; TRIBASIC CALCIUM PHOSPHATE; VERATRUM ALBUM ROOT; VIPERA BERUS VENOM	21; 18; 21; 800; 16; 21	[hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_M]/60mL; [hp_X]/60mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66343-091_09184dbb-c21f-4562-9810-7400a81a3769	66343-091	HUMAN OTC DRUG	Emvita 4		Apis mellifica, Orchitinum, Oophorinum, Petroleum, Platinum met, Stramonium	LIQUID	ORAL	20221220		UNAPPROVED HOMEOPATHIC		RUBIMED AG	APIS MELLIFERA; BOS TAURUS TESTICLE; DATURA STRAMONIUM; LIQUID PETROLEUM; PLATINUM; SUS SCROFA OVARY	21; 21; 18; 16; 800; 21	[hp_X]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_M]/60mL; [hp_C]/60mL; [hp_X]/60mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66343-092_9217d45c-3780-4ab1-8190-21031e24d257	66343-092	HUMAN OTC DRUG	Emvita 5		Bufo rana, Cuprum metallicum, Glandula suprarenalis, Phosphorus, Pulsatilla, Zincum metallicum	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	BUFO BUFO CUTANEOUS GLAND; COPPER; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; SUS SCROFA ADRENAL GLAND; ZINC	800; 18; 21; 16; 21; 21	[hp_C]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66343-093_a6dbbbc3-6f8a-4a5f-85f8-5be896c7d1ab	66343-093	HUMAN OTC DRUG	Emvita 6		Arsenicum album, Glandula sup, Lachesis mutus, Phosphorus, Secale cornutum	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ARSENIC TRIOXIDE; CLAVICEPS PURPUREA SCLEROTIUM; LACHESIS MUTA VENOM; PHOSPHORUS; SUS SCROFA ADRENAL GLAND	18; 16; 21; 800; 21	[hp_M]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL			N	20241231
66343-094_e7eed71e-38de-4051-8af8-60916c02e462	66343-094	HUMAN OTC DRUG	Emvita 7		Anacard occ, Glandula sup, Lachesis mutus, Lycopodium, Phosphorus	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ANACARDIUM OCCIDENTALE FRUIT; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; SUS SCROFA ADRENAL GLAND	18; 800; 16; 21; 21	[hp_M]/60mL; [hp_C]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-095_f6626713-66e2-406f-b44a-862ee92b196b	66343-095	HUMAN OTC DRUG	Emvita 8		Ammon carb, Calcarea carbonica, Chininum ars, Eschscholtzia, Graphites, Pancreas	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	AMMONIUM CARBONATE; ESCHSCHOLZIA CALIFORNICA WHOLE; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; QUININE ARSENITE; SUS SCROFA PANCREAS	800; 21; 16; 21; 18; 21	[hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL	Antimalarial [EPC]		N	20241231
66343-096_b09aad53-e81d-42c3-ba10-f2b5b80d33cc	66343-096	HUMAN OTC DRUG	Emvita 9		Hepar sulph calc, Lycopodium, Pancreas, Sulphur, Tarentula hispana	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	CALCIUM SULFIDE; LYCOPODIUM CLAVATUM SPORE; LYCOSA TARANTULA; SULFUR; SUS SCROFA PANCREAS	21; 800; 16; 18; 21	[hp_X]/60mL; [hp_C]/60mL; [hp_M]/60mL; [hp_M]/60mL; [hp_X]/60mL			N	20241231
66343-097_702f73e7-b7ed-4f0c-8371-e843d114f3dc	66343-097	HUMAN OTC DRUG	Emvita 10		Agnus castus, Arum triph, Hepar Sulph calc, Lachesis, Pancreas, Petroleum	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ARISAEMA TRIPHYLLUM ROOT; CALCIUM SULFIDE; CHASTE TREE FRUIT; KEROSENE; LACHESIS MUTA VENOM; SUS SCROFA PANCREAS	18; 800; 21; 21; 16; 21	[hp_M]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL			N	20241231
66343-098_d97c02fe-7f8c-49ae-bd41-740d95a492f2	66343-098	HUMAN OTC DRUG	Emvita 11		Cuprum met, Ferrum met, Ignatia amara, Pancreas, Secale	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	CLAVICEPS PURPUREA SCLEROTIUM; COPPER; IRON; STRYCHNOS IGNATII SEED; SUS SCROFA PANCREAS	21; 21; 800; 18; 21	[hp_X]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_M]/60mL; [hp_X]/60mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66343-099_da4b6300-8a07-4144-9026-e4eaef212c53	66343-099	HUMAN OTC DRUG	Emvita 12		Apis mellifica, Baryta carb, Eschscholtzia, Graphites, Ignatia, Naja, Thymus gland	LIQUID	ORAL	20221221		UNAPPROVED HOMEOPATHIC		RUBIMED AG	APIS MELLIFERA; BARIUM CARBONATE; BOS TAURUS THYMUS; ESCHSCHOLZIA CALIFORNICA WHOLE; GRAPHITE; NAJA NAJA VENOM; STRYCHNOS IGNATII SEED	800; 18; 21; 21; 21; 800; 16	[hp_C]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_M]/60mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66343-100_dea01567-eab8-4eba-8cbf-a4f150e37955	66343-100	HUMAN OTC DRUG	Emvita 13		Anacard occ, Bothrops, Calc carb, Graphites, Thymus gland	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ANACARDIUM OCCIDENTALE FRUIT; BOS TAURUS THYMUS; BOTHROPS ATROX VENOM; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE	21; 21; 800; 18; 16	[hp_X]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_M]/60mL; [hp_M]/60mL			N	20241231
66343-101_f52597cb-39e9-4b7a-9fd4-2b4b4cc03068	66343-101	HUMAN OTC DRUG	Emvita 14		Calc carb, Hyoscyamus niger, Moschus, Plumb met, Stramonium, Sulphur, Thymus gland	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	BOS TAURUS THYMUS; DATURA STRAMONIUM; HYOSCYAMUS NIGER; LEAD; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SULFUR	21; 800; 21; 21; 16; 21; 18	[hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_M]/60mL			N	20241231
66343-102_7f5a3c12-2ab1-4576-889c-34ce2a8b596d	66343-102	HUMAN OTC DRUG	Emvita 15		Apis mellifica, Lachesis mutus, Phosphorus, Thymus gland, Zinc met	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	APIS MELLIFERA; BOS TAURUS THYMUS; LACHESIS MUTA VENOM; PHOSPHORUS; ZINC	800; 21; 18; 21; 16	[hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_M]/60mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66343-103_0665b3ec-6a4b-4e19-b00f-100367a0cef5	66343-103	HUMAN OTC DRUG	Emvita 16		Aconitum napellus, Ambra grisea, Eschscholtzia, Secale, Thymus gland, Zinc met	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ACONITUM NAPELLUS WHOLE; AMBERGRIS; BOS TAURUS THYMUS; CLAVICEPS PURPUREA SCLEROTIUM; ESCHSCHOLZIA CALIFORNICA WHOLE; ZINC	800; 18; 21; 21; 16; 21	[hp_C]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL			N	20241231
66343-104_8b29b9b0-c9e8-423d-b870-98553eed43d9	66343-104	HUMAN OTC DRUG	Emvita 17		Baryta carb, Chininum ars, Graphites, Pulsatilla, Thyroidinum	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	BARIUM CARBONATE; GRAPHITE; PULSATILLA VULGARIS WHOLE; QUININE ARSENITE; THYROID, PORCINE	21; 18; 21; 800; 21	[hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL	Antimalarial [EPC]		N	20241231
66343-105_ab223e2a-f251-4bda-9d64-0f911b211f43	66343-105	HUMAN OTC DRUG	Emvita 18		Agaricus muscarius, Bufo rana, Cuprum met, Thyroidinum, Iodium	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	AMANITA MUSCARIA FRUITING BODY; BUFO BUFO CUTANEOUS GLAND; COPPER; IODINE; THYROID, PORCINE	800; 21; 18; 21; 21	[hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66343-106_9e4e1ac6-3af2-46e5-9fa3-5d802177dac7	66343-106	HUMAN OTC DRUG	Emvita 19		Calcarea carbonica, Hypophysis, Mag carb, Zinc met	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	MAGNESIUM CARBONATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SUS SCROFA PITUITARY GLAND; ZINC	800; 21; 21; 18	[hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_M]/60mL			N	20241231
66343-107_6b1f01d6-11a6-4542-b404-3dc170c0dd19	66343-107	HUMAN OTC DRUG	Emvita 20		Apis mellifica, Belladonna, Cantharis, Hypophysis, Ignatia amara, Mag carb, Phosphorus, Pulsatilla	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	APIS MELLIFERA; ATROPA BELLADONNA; LYTTA VESICATORIA; MAGNESIUM CARBONATE; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; STRYCHNOS IGNATII SEED; SUS SCROFA PITUITARY GLAND	18; 800; 21; 21; 21; 21; 16; 21	[hp_M]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66343-108_ca1d6e98-bc86-4352-b496-e6943310d902	66343-108	HUMAN OTC DRUG	Emvita 21		Arsenicum alb, Chamomilla, Hypophysis, Lachesis mutus, Mag carb	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ARSENIC TRIOXIDE; LACHESIS MUTA VENOM; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA WHOLE; SUS SCROFA PITUITARY GLAND	21; 800; 21; 18; 21	[hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL			N	20241231
66343-109_b2ff7a96-2a2a-4b74-9ae9-fd22890e763a	66343-109	HUMAN OTC DRUG	Emvita 22		Ambra grisea, Anacard occ, Chamomilla, Crotalus horridus, Hypophysis, Iodium, Phosphorus	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	AMBERGRIS; ANACARDIUM OCCIDENTALE FRUIT; CROTALUS HORRIDUS HORRIDUS VENOM; IODINE; MATRICARIA CHAMOMILLA WHOLE; PHOSPHORUS; SUS SCROFA PITUITARY GLAND	21; 18; 21; 16; 800; 21; 21	[hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-110_db8d222e-04de-4b30-8fde-5c6eaab2fb27	66343-110	HUMAN OTC DRUG	Emvita 23		Agaricus muscarius, Cuprum met, Hypophysis, Rhus tox	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	AMANITA MUSCARIA FRUITING BODY; COPPER; SUS SCROFA PITUITARY GLAND; TOXICODENDRON PUBESCENS LEAF	21; 800; 21; 18	[hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66343-111_db8b3bd0-0f94-4767-9f3c-887c17951526	66343-111	HUMAN OTC DRUG	Emvita 24		Chamomilla, Crotalus horridus, Hypophysis, Ignatia amara, Phosphorus	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	CROTALUS HORRIDUS HORRIDUS VENOM; MATRICARIA CHAMOMILLA WHOLE; PHOSPHORUS; STRYCHNOS IGNATII SEED; SUS SCROFA PITUITARY GLAND	800; 18; 16; 21; 21	[hp_C]/60mL; [hp_M]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-112_080cf852-8fef-4655-96ae-f1e897452f8f	66343-112	HUMAN OTC DRUG	Emvita 25		Cerebrum, Conium, Lobelia inflata, Lycopodium, Mag carb, Plumb met	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	CONIUM MACULATUM FLOWERING TOP; LEAD; LOBELIA INFLATA WHOLE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; SUS SCROFA CEREBRUM	800; 21; 18; 21; 16; 21	[hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL			N	20241231
66343-113_a3aae731-75bb-4734-ad96-15b3e43d7320	66343-113	HUMAN OTC DRUG	Emvita 26		Arsenicum alb, Cerebrum, Lycopodium, Millefolium, Plumb met	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ACHILLEA MILLEFOLIUM WHOLE; ARSENIC TRIOXIDE; LEAD; LYCOPODIUM CLAVATUM SPORE; SUS SCROFA CEREBRUM	21; 800; 18; 16; 21	[hp_X]/60mL; [hp_C]/60mL; [hp_M]/60mL; [hp_M]/60mL; [hp_X]/60mL			N	20241231
66343-114_82fb1339-db73-4be0-a27a-163bdb45e9ac	66343-114	HUMAN OTC DRUG	Emvita 27		Anacard occ, Calcarea carbonica, Cerebrum, Helleborus niger, Mandragora	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	ANACARDIUM OCCIDENTALE FRUIT; HELLEBORUS NIGER ROOT; MANDRAGORA OFFICINARUM ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SUS SCROFA CEREBRUM	18; 800; 16; 21; 21	[hp_M]/60mL; [hp_C]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-115_8a918524-606e-46bf-a63b-6d58213f3228	66343-115	HUMAN OTC DRUG	Emvita 28		Cerebrum, Helleborus niger, Hyoscyamus niger, Mandragora	LIQUID	ORAL	20221223		UNAPPROVED HOMEOPATHIC		RUBIMED AG	HELLEBORUS NIGER ROOT; MANDRAGORA OFFICINARUM ROOT; SUS SCROFA CEREBRUM; SUS SCROFA PITUITARY GLAND	18; 800; 21; 21	[hp_M]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-116_0b83461d-2d60-497b-b9b8-4d9c67450d06	66343-116	HUMAN OTC DRUG	Geovita		Cerebrum, Cuprum met, Ferrum met, Formicum acidum, Silicea	LIQUID	ORAL	20221227		UNAPPROVED HOMEOPATHIC		RUBIMED AG	COPPER; FORMIC ACID; IRON; SILICON DIOXIDE; SUS SCROFA CEREBRUM	21; 21; 6; 12; 21	[hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL; [hp_X]/60mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
66343-117_26d8342c-ef7b-4696-8303-b70bb2a72dde	66343-117	HUMAN OTC DRUG	Geovita		Ambra grisea, Cerebrum, Cinchona, Cuprum acet, Melissa, Phosphorus	LIQUID	ORAL	20221227		UNAPPROVED HOMEOPATHIC		RUBIMED AG	AMBERGRIS; CINCHONA OFFICINALIS BARK; CUPRIC ACETATE; MELISSA OFFICINALIS WHOLE; PHOSPHORUS; SUS SCROFA CEREBRUM	21; 50; 200; 4; 12; 21	[hp_X]/60mL; [hp_C]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_X]/60mL			N	20241231
66343-118_00fc5618-297f-411d-9e20-a7a30261ab19	66343-118	HUMAN OTC DRUG	Paravita		Cerebrum, Formica rufa, Sulphur, Vespa crabro	LIQUID	ORAL	20221227		UNAPPROVED HOMEOPATHIC		RUBIMED AG	FORMICA RUFA; SULFUR; SUS SCROFA CEREBRUM; VESPA CRABRO	12; 200; 21; 30	[hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL			N	20241231
66343-119_5ee365c8-d49c-416c-93ac-a399c365aefb	66343-119	HUMAN OTC DRUG	Simvita		Cerebrum, Chamomilla, Ephedra vulgaris, Secale	LIQUID	ORAL	20221227		UNAPPROVED HOMEOPATHIC		RUBIMED AG	CLAVICEPS PURPUREA SCLEROTIUM; EPHEDRA DISTACHYA FLOWERING TWIG; MATRICARIA CHAMOMILLA WHOLE; SUS SCROFA CEREBRUM	12; 30; 200; 21	[hp_X]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL			N	20241231
66343-120_67836b59-0869-49e2-940a-361c520a430a	66343-120	HUMAN OTC DRUG	Chavita 3		Argentum met, Chamomilla, Chelidonium majus, Nux vomica, Pancreas suis, Lycopodium, Zingiber	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		RUBIMED AG	CHELIDONIUM MAJUS WHOLE; GINGER; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA WHOLE; SILVER; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS	21; 21; 200; 21; 21; 50; 21	[hp_X]/60mL; [hp_X]/60mL; [hp_C]/60mL; [hp_X]/60mL; [hp_X]/60mL; [kp_C]/60mL; [hp_X]/60mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
66343-121_a04be5c7-aec0-421e-81dc-2681393911b2	66343-121	HUMAN OTC DRUG	Emvita 3		Apis mellifica, Bovista, Conium, Hepar sulph calc, Oophorinum, Orchitinum	LIQUID	ORAL	20221220		UNAPPROVED HOMEOPATHIC		RUBIMED AG	APIS MELLIFERA; BOS TAURUS TESTICLE; CALCIUM SULFIDE; CONIUM MACULATUM FLOWERING TOP; LYCOPERDON UTRIFORME FRUITING BODY; SUS SCROFA OVARY	800; 21; 16; 18; 21; 21	[hp_C]/60mL; [hp_X]/60mL; [hp_M]/60mL; [hp_M]/60mL; [hp_X]/60mL; [hp_X]/60mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
66345-001_0e72d982-98ed-9a71-e063-6294a90aabd8	66345-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100719		UNAPPROVED MEDICAL GAS		Medi-Fair, Inc	OXYGEN	99	L/100L			N	20251231
66353-117_a6076639-5dac-4cb1-e053-2995a90ae26f	66353-117	HUMAN OTC DRUG	ProGel Max Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333A	Delta Pharma Inc.	ALCOHOL	80	mL/100mL			N	20241231
66365-001_0761944c-ed9c-0ca3-e063-6394a90acad9	66365-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20010601		NDA	NDA205849	Medical Comfort Systems Inc	OXYGEN	998	mL/L			N	20241231
66391-1603_f21981f8-2b21-361a-e053-2a95a90a1856	66391-1603	HUMAN OTC DRUG	Miracle Rub		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20161031		OTC MONOGRAPH NOT FINAL	part348	Winning Solutions	MENTHOL; METHYL SALICYLATE	2.5; 10	g/106g; g/106g			N	20241231
66391-3001_f33361a7-e049-4681-e053-2a95a90ab909	66391-3001	HUMAN OTC DRUG	SUN SHIELD SUNSCREEN	SPF 30	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20230126		OTC MONOGRAPH FINAL	M020	Winning Solutions	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 10; 5; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
66403-308_6a2ab4cb-4105-4739-8c54-21a226ac8577	66403-308	HUMAN OTC DRUG	Tiger Balm Red	Extra Strength	Camphor (Synthetic) and Menthol	OINTMENT	TOPICAL	20020125		OTC MONOGRAPH NOT FINAL	part348	Tiger Balm (Malaysia) Sdn. Bhd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 100	mg/g; mg/g			N	20241231
66403-309_11aba9f1-e4c4-4fb5-8315-1ff30e9b8d84	66403-309	HUMAN OTC DRUG	Tiger Balm White	Regular Strength	Camphor (Synthetic) and Menthol	OINTMENT	TOPICAL	20020125		OTC MONOGRAPH NOT FINAL	part348	Tiger Balm (Malaysia) Sdn. Bhd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 80	mg/g; mg/g			N	20241231
66424-020_dd0db02e-dffe-4db8-ab43-8b8b249b1250	66424-020	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	SDA Laboratories, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66424-021_ffa28582-bd9e-4243-88c2-f7f9606e1cd0	66424-021	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	SDA Laboratories, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66424-562_bc8996b0-7c33-4c05-8fc3-f061ccd434e5	66424-562	HUMAN OTC DRUG	SENNA Syrup		Sennosides A and B	SYRUP	ORAL	20150101		OTC MONOGRAPH NOT FINAL	part334	SDA Laboratories, Inc.	SENNOSIDES A AND B	8.8	mg/5mL			N	20241231
66424-564_0eb0b074-9f48-a3ad-e063-6394a90a9ded	66424-564	HUMAN OTC DRUG	CETIRIZINE HYDROCHLORIDE	10 MG	CETIRIZINE HYDROCHLORIDE	TABLET	ORAL	20210427		ANDA	ANDA209274	SDA Laboratories, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
66467-2210_d65b1aed-c93b-46df-e053-2a95a90ad44d	66467-2210	HUMAN PRESCRIPTION DRUG	60 Second Fluoride Gel		Sodium Fluoride	GEL	DENTAL	20190801		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66467-2220_d65acddb-541b-18c7-e053-2995a90a7a8c	66467-2220	HUMAN PRESCRIPTION DRUG	60 Second Fluoride Gel		Sodium Fluoride	GEL	DENTAL	20190801		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66467-2230_d65a579d-8604-e5db-e053-2995a90a2a0e	66467-2230	HUMAN PRESCRIPTION DRUG	60 Second Fluoride Gel		Sodium Fluoride	GEL	DENTAL	20190801		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66467-2240_d65aad1d-4d75-4baa-e053-2995a90a3671	66467-2240	HUMAN PRESCRIPTION DRUG	60 Second Fluoride Gel		Sodium Fluoride	GEL	DENTAL	20190801		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66467-2250_d65aceb5-1d36-2b6d-e053-2995a90a7321	66467-2250	HUMAN PRESCRIPTION DRUG	60 Second Fluoride Gel		Sodium Fluoride	GEL	DENTAL	20190801		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66467-2260_d65adc81-ac53-de4b-e053-2a95a90a0609	66467-2260	HUMAN PRESCRIPTION DRUG	60 Second Fluoride Gel		Sodium Fluoride	GEL	DENTAL	20190801		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66467-2270_d65adeeb-2c40-bba4-e053-2995a90a0b0a	66467-2270	HUMAN PRESCRIPTION DRUG	60 Second Fluoride Gel		Sodium Fluoride	GEL	DENTAL	20190801		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66467-2560_3182472a-0f04-4cdb-8ed4-31a939ab1a1a	66467-2560	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20060702		ANDA	ANDA077789	Darby Dental Supply, LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
66467-4000_ff97c871-ae2f-2c2a-e053-6394a90aecba	66467-4000	HUMAN OTC DRUG	BENZOCAINE	Raspberry	Benzocaine	GEL	DENTAL	19630219		OTC MONOGRAPH NOT FINAL	part356	Darby Dental Supply, LLC	BENZOCAINE	220	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66467-8003_41a2c0a1-baac-4a89-b8f7-b980c2a2f63f	66467-8003	HUMAN PRESCRIPTION DRUG	DARBY APF STRAWBERRY		SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20191029		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
66467-8004_41a2c0a1-baac-4a89-b8f7-b980c2a2f63f	66467-8004	HUMAN PRESCRIPTION DRUG	DARBY APF MINT		SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20191029		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
66467-8005_41a2c0a1-baac-4a89-b8f7-b980c2a2f63f	66467-8005	HUMAN PRESCRIPTION DRUG	DARBY APF BUBBLE GUM		SODIUM FLUORIDE	AEROSOL, FOAM	DENTAL	20191029		UNAPPROVED DRUG OTHER		Darby Dental Supply, LLC	SODIUM FLUORIDE	2.72	g/100g			N	20241231
66467-9710_0462dc9e-64b8-4d7f-aeb9-9465258f14e0	66467-9710	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20110114		ANDA	ANDA088389	Darby Dental Supply, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.02; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66467-9730_149889a8-ec69-4510-85be-268a59fab8c1	66467-9730	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111215		ANDA	ANDA088390	Darby Dental Supply, LLC	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66467-9760_8d8d9385-b82c-4107-82ab-b8788327bfcc	66467-9760	HUMAN PRESCRIPTION DRUG	Mepivacaine		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20110114		ANDA	ANDA088387	Darby Dental Supply, LLC	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
66487-001_0761b2dd-1b7e-2aa8-e063-6394a90a7784	66487-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19990109		NDA	NDA205840	ROBINSON`S INDUSTRIAL GAS & EQUIPMENT CORP.	OXYGEN	997	mL/L			N	20241231
66487-002_0761d315-1208-41d4-e063-6394a90ae68e	66487-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	LIQUID	RESPIRATORY (INHALATION)	20100901		NDA	NDA205839	ROBINSON`S INDUSTRIAL GAS & EQUIPMENT CORP.	NITROGEN	997	mL/L			N	20241231
66490-690_9d9f03b1-4eb4-4ba5-a357-600e368802c6	66490-690	HUMAN PRESCRIPTION DRUG	Mysoline		Primidone	TABLET	ORAL	20090624		NDA	NDA009170	Bausch Health US, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
66490-691_9d9f03b1-4eb4-4ba5-a357-600e368802c6	66490-691	HUMAN PRESCRIPTION DRUG	Mysoline		Primidone	TABLET	ORAL	20090624		NDA	NDA009170	Bausch Health US, LLC	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
66492-001_d449048d-9c0e-8815-e053-2a95a90a6d20	66492-001	HUMAN OTC DRUG	FLU TERMINATOR DROPS		Gelsemium, Zincum gluconicum, Zincum metallicum, Aconitum napellus, Eupatorium perfoliatum, Sulphur, Phosphorus, Asclepias vincetoxicum, Influenzinum, Anas barbariae.	LIQUID	ORAL	20000101		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	ACONITUM NAPELLUS; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CYNANCHUM VINCETOXICUM ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS; INFLUENZA B VIRUS; PHOSPHORUS; SULFUR; ZINC; ZINC GLUCONATE	4; 200; 6; 4; 3; 12; 12; 5; 4; 3; 3	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66492-004_d44a03c4-5a56-bf16-e053-2995a90aca66	66492-004	HUMAN OTC DRUG	SINUS		Pulsatilla, Euphorbium, Allium Cepa, Histaminum, Luffa Operculata, Sabadilla, Hepar Sulfur.	LIQUID	NASAL	20170901		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	CALCIUM SULFIDE; EUPHORBIA RESINIFERA RESIN; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; ONION; PULSATILLA VULGARIS; SCHOENOCAULON OFFICINALE SEED	12; 4; 6; 6; 6; 2; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
66492-005_d44a0c64-2298-9c8f-e053-2a95a90a2bbf	66492-005	HUMAN OTC DRUG	Headek Nasal		Belladonna, Glonoinum, Coffea, Natrum Carb, Natrum Mur.	SPRAY	NASAL	20110222		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	ARABICA COFFEE BEAN; ATROPA BELLADONNA; NITROGLYCERIN; SODIUM CARBONATE; SODIUM CHLORIDE	6; 3; 6; 6; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
66492-006_d449d3d9-49c8-2a4b-e053-2995a90a5a95	66492-006	HUMAN OTC DRUG	ALLERGY DROPS		Apis mellifica, Apisinum, Allium cepa, Euphrasia, Sabadilla, Euphorbium, Pulsatilla, Hedera helix, Histaminum.	LIQUID	ORAL	20000101		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	APIS MELLIFERA; APIS MELLIFERA VENOM; EUPHORBIA RESINIFERA RESIN; EUPHRASIA STRICTA; HEDERA HELIX FLOWERING TWIG; HISTAMINE DIHYDROCHLORIDE; ONION; PULSATILLA VULGARIS; SCHOENOCAULON OFFICINALE SEED	2; 12; 6; 3; 4; 6; 3; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
66492-008_d449e97e-9f8b-23aa-e053-2a95a90af6c6	66492-008	HUMAN OTC DRUG	Stress Drops		Cimicifuga racemosa, Gelsemium, Hypericum, Staphysagria, Ignatia amara, Kali bromatum, Kali phosphoricum, Moschus, Lachesis mutus, Pulsatilla.	LIQUID	SUBLINGUAL	20130716		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	ANEMONE PULSATILLA; BLACK COHOSH; DELPHINIUM STAPHISAGRIA SEED; DIBASIC POTASSIUM PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; HYPERICUM PERFORATUM; LACHESIS MUTA VENOM; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; POTASSIUM BROMIDE; STRYCHNOS IGNATII SEED	12; 3; 3; 6; 3; 3; 12; 6; 6; 4	[hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL; [hp_X]/58.5mL			N	20241231
66492-038_d449fe22-23ef-f43c-e053-2995a90a39ae	66492-038	HUMAN OTC DRUG	Lung Drops		Belladonna, Ipecacuanha, Lobelia Inflata, Quebracho, Antimonium Tartaricum, Blatta Orientalis, Naphthalinum, Natrum Sulphuricum, Pulsatilla, Rumex Crispus, Mercurius Solubilis, Adrenalinum.	LIQUID	SUBLINGUAL	20141125		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ASPIDOSPERMA QUEBRACHO-BLANCO BARK; ATROPA BELLADONNA; BLATTA ORIENTALIS; EPINEPHRINE; IPECAC; LOBELIA INFLATA; MERCURIUS SOLUBILIS; NAPHTHALENE; RUMEX CRISPUS ROOT; SODIUM SULFATE	6; 6; 5; 4; 6; 5; 4; 4; 8; 6; 6; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66492-069_d44a0c64-228a-9c8f-e053-2a95a90a2bbf	66492-069	HUMAN OTC DRUG	Arnica Well		Bellis Perennis, Calendula Officinalis, Hamamelis Virginiana, Millefollium MT, Chamomilla, Ferrum Phosphoricum, Ledum Palustre, Magnesia Phosphorica, Apis Mellifica, Arnica Montana, Belladonna, Symphytum Officinale, Hypericum Perforatum.	GEL	TOPICAL	20130818		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics 052584997	ACHILLEA MILLEFOLIUM; APIS MELLIFERA; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; RHODODENDRON TOMENTOSUM LEAFY TWIG	1; 3; 3; 3; 1; 1; 4; 2; 1; 6; 2; 1; 2	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66492-245_d449bc17-6367-d085-e053-2995a90a2548	66492-245	HUMAN OTC DRUG	Arnica Plus DROPS		Aconitum napellus, Arnica montana, Chamomilla, Hypericum perforatum, Ruta graveolens, Symphytum officinale, Belladonna, Colocynthis, Rhus tox, Ferrum phos, Magnesium phos.	LIQUID	ORAL	20000101		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; CITRULLUS COLOCYNTHIS FRUIT PULP; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC; MATRICARIA RECUTITA; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	3; 3; 4; 4; 3; 8; 3; 8; 3; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66492-260_d44a03c4-5a62-bf16-e053-2995a90aca66	66492-260	HUMAN OTC DRUG	Phase 6 Drops		Taraxacum Off, Galium Aparine, Thuja, Aloe, Phytolacca, Euphorbium Officinarum, Zincum Metallicum, Arsenicum Album, Viscum Album, Conium Maculatum, Histaminum Hydrochloricum, Formicum Acidum	LIQUID	ORAL	20170901		UNAPPROVED HOMEOPATHIC		Be Well Medical dba Richard Clement Nutrition y Be Well Homeopathics	ALOE; ARSENIC TRIOXIDE; CONIUM MACULATUM FLOWERING TOP; EUPHORBIA RESINIFERA RESIN; FORMIC ACID; GALIUM APARINE; HISTAMINE DIHYDROCHLORIDE; PHYTOLACCA AMERICANA ROOT; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG; VISCUM ALBUM FRUITING TOP; ZINC	3; 6; 30; 6; 200; 1; 200; 3; 1; 3; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
66503-001_078bd3e2-5702-d418-e063-6394a90afe9f	66503-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110422		UNAPPROVED MEDICAL GAS		Johnson Medical Consulting, Inc	OXYGEN	99	L/100L			N	20241231
66506-183_05d4d229-bb90-9ea4-e063-6394a90a4b9b	66506-183	HUMAN OTC DRUG	CheeZheng Pain Relieveing Plaster		camphor	PLASTER	TOPICAL	20191129		OTC MONOGRAPH NOT FINAL	part348	Tibet Cheezheng Tibetan Medicine Co. Ltd.	CAMPHOR (NATURAL)	1	g/100g			N	20241231
66506-186_07e4f3bc-4af0-48a2-e063-6394a90a6649	66506-186	HUMAN OTC DRUG	Tibetree Pain Relieveing Medicated Plaster		camphor	PLASTER	TOPICAL	20191205		OTC MONOGRAPH DRUG	M017	Tibet Cheezheng Tibetan Medicine Co. Ltd	CAMPHOR (NATURAL)	1	g/100g			N	20241231
66513-220_eb017336-7b4d-7039-e053-2995a90a6a2c	66513-220	HUMAN OTC DRUG	Bronco Rub		Camphor Eucalyptus Menthol	OINTMENT	TOPICAL	20140815		OTC MONOGRAPH FINAL	M012	Distribuidora de Alimentos Naturales y Nutricionales, S.A. de C.V	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
66525-056_08674efa-99b1-4f65-9a69-3cda3a12a856	66525-056	HUMAN OTC DRUG	BEE BRAND MEDICATED		MENTHOL AND CAMPHOR	OIL	TOPICAL	20210603		OTC MONOGRAPH NOT FINAL	part348	PT. TAWON JAYA MAKASSAR	CAMPHOR (SYNTHETIC); MENTHOL	4; 2.2	mg/100mL; mg/100mL			N	20241231
66586-1073_0e72ca90-47b4-962b-e063-6294a90a42ff	66586-1073	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091012		UNAPPROVED MEDICAL GAS		Robin Drug Corporation dba Corner Home Medical	OXYGEN	99	L/100L			N	20251231
66608-056_03a8c5b9-b080-8b10-e063-6294a90ac578	66608-056	HUMAN OTC DRUG	Hand Sanitizer		62% Ethyl Alcohol	GEL	TOPICAL	20190904		OTC MONOGRAPH NOT FINAL	part333E	Kimball Midwest	ALCOHOL	62.5	mL/100mL			N	20241231
66608-207_d24760bb-8461-49f6-b2a9-155f9c7c55cc	66608-207	HUMAN OTC DRUG	Instant Foaming Hand Sanitizer		Benzalkonium chloride	SOAP	TOPICAL	20170404	20240118	OTC MONOGRAPH DRUG	505G(a)(3)	Kimball Midwest	BENZALKONIUM CHLORIDE	.0026	mg/100mL			N	
66608-215_03a8d6f3-00f9-5ae3-e063-6294a90a91c2	66608-215	HUMAN OTC DRUG	Antibacterial Hand Cleanser		Benzalkonium Chloride	SOAP	TOPICAL	20170628		OTC MONOGRAPH NOT FINAL	part333E	Kimball Midwest	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
66608-693_cc1f98fb-9f92-4e67-9eba-6a073f9bf489	66608-693	HUMAN OTC DRUG	Vindicator - E		Vindicator - E	LIQUID	TOPICAL	20200513	20240901	OTC MONOGRAPH NOT FINAL	part333A	Kimball Midwest	ALCOHOL	67	mL/100mL			N	
66621-0150_036723fb-cef3-4705-b9c5-ad61049acef5	66621-0150	PLASMA DERIVATIVE	ANASCORP		centruroides (scorpion) immune F(ab)2 (equine)	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20110803		BLA	BLA125335	Rare Disease Therapeutics, Inc	CENTRUROIDES FAB2 ANTIVENIN (EQUINE)	7	mg/mL	Antivenin [EPC], Antivenins [CS], Passively Acquired Immunity [PE], Venom Neutralization [MoA]		N	20241231
66621-0790_3bf4212b-aa74-4e6f-94ee-3b1ac77f0ca1	66621-0790	PLASMA DERIVATIVE	ANAVIP		crotalidae immune F(ab)2(equine)	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150506		BLA	BLA125488	Rare Disease Therapeutics, Inc	PIT VIPER (CROTALINAE) IMMUNE GLOBULIN ANTIVENIN (EQUINE)	12	mg/mL			N	20241231
66658-102_f9c6cef5-fb71-4cb0-9793-5c23ac04572e	66658-102	HUMAN PRESCRIPTION DRUG	Orfadin		Nitisinone	CAPSULE	ORAL	20160701		NDA	NDA021232	SWEDISH ORPHAN BIOVITRUM AB (PUBL)	NITISINONE	2	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
66658-105_f9c6cef5-fb71-4cb0-9793-5c23ac04572e	66658-105	HUMAN PRESCRIPTION DRUG	Orfadin		Nitisinone	CAPSULE	ORAL	20160701		NDA	NDA021232	SWEDISH ORPHAN BIOVITRUM AB (PUBL)	NITISINONE	5	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
66658-110_f9c6cef5-fb71-4cb0-9793-5c23ac04572e	66658-110	HUMAN PRESCRIPTION DRUG	Orfadin		Nitisinone	CAPSULE	ORAL	20160701		NDA	NDA021232	SWEDISH ORPHAN BIOVITRUM AB (PUBL)	NITISINONE	10	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
66658-113_f8f8dc56-48c3-464d-bbe9-c3a7d2b3dcd8	66658-113	HUMAN PRESCRIPTION DRUG	KEPIVANCE		palifermin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230804		BLA	BLA125103	Swedish Orphan Biovitrum AB (publ)	PALIFERMIN	5.16	mg/1.2mL	Fibroblast Growth Factor 7 [CS], Increased Epithelial Proliferation [PE], Mucocutaneous Epithelial Cell Growth Factor [EPC]		N	20241231
66658-120_f9c6cef5-fb71-4cb0-9793-5c23ac04572e	66658-120	HUMAN PRESCRIPTION DRUG	Orfadin		Nitisinone	CAPSULE	ORAL	20160701		NDA	NDA021232	SWEDISH ORPHAN BIOVITRUM AB (PUBL)	NITISINONE	20	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
66658-204_e1dfb1a3-372e-bd6b-e053-2995a90a5da7	66658-204	HUMAN PRESCRIPTION DRUG	ORFADIN		nitisinone	SUSPENSION	ORAL	20160601		NDA	NDA206356	Swedish Orphan Biovitrum AB (publ)	NITISINONE	4	mg/mL	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
66658-230_2f379d7b-dcfd-4629-b14c-2f1d37891f7e	66658-230	HUMAN PRESCRIPTION DRUG	Synagis		palivizumab	INJECTION, SOLUTION	INTRAMUSCULAR	19991209		BLA	BLA103770	Swedish Orphan Biovitrum AB (publ)	PALIVIZUMAB	50	mg/.5mL	Antibodies, Monoclonal [CS], Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]		N	20241231
66658-231_2f379d7b-dcfd-4629-b14c-2f1d37891f7e	66658-231	HUMAN PRESCRIPTION DRUG	Synagis		palivizumab	INJECTION, SOLUTION	INTRAMUSCULAR	19980619		BLA	BLA103770	Swedish Orphan Biovitrum AB (publ)	PALIVIZUMAB	100	mg/mL	Antibodies, Monoclonal [CS], Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]		N	20241231
66658-234_7c3433fa-6e70-4740-9d58-b2cae670e639	66658-234	HUMAN PRESCRIPTION DRUG	Kineret		anakinra	INJECTION, SOLUTION	SUBCUTANEOUS	20091215		BLA	BLA103950	Swedish Orphan Biovitrum AB (publ)	ANAKINRA	100	mg/.67mL	Interleukin 1 Receptor Antagonists [MoA], Interleukin-1 Receptor Antagonist [EPC]		N	20241231
66658-501_924766fc-c878-4a8e-b1f5-3fc40136be17	66658-501	HUMAN PRESCRIPTION DRUG	GAMIFANT		emapalumab-lzsg	INJECTION	INTRAVENOUS	20190517		BLA	BLA761107	Swedish Orphan Biovitrum AB (publ)	EMAPALUMAB	10	mg/2mL	Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]		N	20241231
66658-505_924766fc-c878-4a8e-b1f5-3fc40136be17	66658-505	HUMAN PRESCRIPTION DRUG	GAMIFANT		emapalumab-lzsg	INJECTION	INTRAVENOUS	20190517		BLA	BLA761107	Swedish Orphan Biovitrum AB (publ)	EMAPALUMAB	50	mg/10mL	Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]		N	20241231
66658-510_924766fc-c878-4a8e-b1f5-3fc40136be17	66658-510	HUMAN PRESCRIPTION DRUG	GAMIFANT		emapalumab-lzsg	INJECTION	INTRAVENOUS	20200626		BLA	BLA761107	Swedish Orphan Biovitrum AB (publ)	EMAPALUMAB	100	mg/20mL	Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]		N	20241231
66658-522_924766fc-c878-4a8e-b1f5-3fc40136be17	66658-522	HUMAN PRESCRIPTION DRUG	GAMIFANT		emapalumab-lzsg	INJECTION	INTRAVENOUS	20230607		BLA	BLA761107	Swedish Orphan Biovitrum AB (publ)	EMAPALUMAB	50	mg/2mL	Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]		N	20241231
66658-523_924766fc-c878-4a8e-b1f5-3fc40136be17	66658-523	HUMAN PRESCRIPTION DRUG	GAMIFANT		emapalumab-lzsg	INJECTION	INTRAVENOUS	20230607		BLA	BLA761107	Swedish Orphan Biovitrum AB (publ)	EMAPALUMAB	100	mg/4mL	Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]		N	20241231
66658-524_924766fc-c878-4a8e-b1f5-3fc40136be17	66658-524	HUMAN PRESCRIPTION DRUG	GAMIFANT		emapalumab-lzsg	INJECTION	INTRAVENOUS	20230607		BLA	BLA761107	Swedish Orphan Biovitrum AB (publ)	EMAPALUMAB	250	mg/10mL	Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]		N	20241231
66658-525_924766fc-c878-4a8e-b1f5-3fc40136be17	66658-525	HUMAN PRESCRIPTION DRUG	GAMIFANT		emapalumab-lzsg	INJECTION	INTRAVENOUS	20230607		BLA	BLA761107	Swedish Orphan Biovitrum AB (publ)	EMAPALUMAB	500	mg/20mL	Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]		N	20241231
66685-1001_340ac3f0-df7f-4aa1-9b69-311b88118aba	66685-1001	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021121		ANDA	ANDA065093	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
66685-1002_340ac3f0-df7f-4aa1-9b69-311b88118aba	66685-1002	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021127		ANDA	ANDA065117	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
66685-1011_340ac3f0-df7f-4aa1-9b69-311b88118aba	66685-1011	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	POWDER, FOR SUSPENSION	ORAL	20040813		ANDA	ANDA065098	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
66685-1012_340ac3f0-df7f-4aa1-9b69-311b88118aba	66685-1012	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	POWDER, FOR SUSPENSION	ORAL	20040813		ANDA	ANDA065098	Sandoz Inc	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
66689-004_e297e7d7-cf6b-4bbd-9f87-5dfcfebe36e1	66689-004	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	SOLUTION	ORAL	20190624		ANDA	ANDA200343	VistaPharm, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	108; 2.5	mg/5mL; mg/5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
66689-005_e297e7d7-cf6b-4bbd-9f87-5dfcfebe36e1	66689-005	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	SOLUTION	ORAL	20190624		ANDA	ANDA200343	VistaPharm, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	217; 5	mg/10mL; mg/10mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
66689-008_beaf5815-9659-4ba3-ac23-6e734f4afc05	66689-008	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20120501		ANDA	ANDA064142	VistaPharm, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
66689-020_5824a840-d3bb-4543-82d3-926b2903465f	66689-020	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20120822		ANDA	ANDA075671	VistaPharm, Inc.	MEGESTROL ACETATE	40	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
66689-023_e297e7d7-cf6b-4bbd-9f87-5dfcfebe36e1	66689-023	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	SOLUTION	ORAL	20170105		ANDA	ANDA200343	VistaPharm, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
66689-025_505b4182-e9b4-42de-8d24-df2389aa966c	66689-025	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20120815		ANDA	ANDA202537	VistaPharm, Inc.	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-031_d878f7b4-d7b5-4db0-9e97-dde119731159	66689-031	HUMAN PRESCRIPTION DRUG	Metoclopramide Hydrochloride		Metoclopramide Hydrochloride	SOLUTION	ORAL	20100212		ANDA	ANDA075051	VistaPharm, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
66689-036_c24a0d96-5333-4123-b595-44136ad7bc43	66689-036	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20100510		ANDA	ANDA040342	VistaPharm, Inc.	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
66689-037_beaf5815-9659-4ba3-ac23-6e734f4afc05	66689-037	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20100510		ANDA	ANDA064142	VistaPharm, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
66689-038_4bead912-29de-4a1b-a6e5-049990053554	66689-038	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	20100510		ANDA	ANDA074138	VistaPharm, Inc.	LACTULOSE	20	g/30mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66689-039_4bead912-29de-4a1b-a6e5-049990053554	66689-039	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	20100510		ANDA	ANDA074138	VistaPharm, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66689-047_2d1d7b4e-5ac0-46a0-ba85-0470b0935693	66689-047	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20150215		NDA	NDA206814	VistaPharm, Inc.	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66689-048_2d1d7b4e-5ac0-46a0-ba85-0470b0935693	66689-048	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20150215		NDA	NDA206814	VistaPharm, Inc.	POTASSIUM CHLORIDE	40	meq/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
66689-053_774c9bcf-e112-42d3-a5e0-2f23173cf6ed	66689-053	HUMAN OTC DRUG	Milk of Magnesia		Magnesium Hydroxide	SUSPENSION	ORAL	20180419		OTC MONOGRAPH FINAL	part331	VistaPharm, Inc.	MAGNESIUM HYDROXIDE	400	mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
66689-058_734227f2-617d-442b-a33d-cf76d7c49733	66689-058	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20190830		ANDA	ANDA210746	VistaPharm, LLC	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
66689-062_59c420ca-d2ea-4f83-a8c0-b0875ed95d75	66689-062	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20180914		ANDA	ANDA202960	VistaPharm, LLC	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
66689-063_f3712751-164d-433f-b2eb-733669f119a5	66689-063	HUMAN PRESCRIPTION DRUG	Donnatal		phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide	ELIXIR	ORAL	20171026		UNAPPROVED DRUG OTHER		VistaPharm, Inc.	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
66689-105_24ae0fe1-3627-4fb9-a5b7-d186aa3e01cb	66689-105	HUMAN PRESCRIPTION DRUG	THYQUIDITY		Levothyroxine Sodium	SOLUTION	ORAL	20210215	20240731	NDA	NDA214047	VistaPharm, Inc.	LEVOTHYROXINE SODIUM	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	
66689-106_48c0ed8c-dffa-4ddf-8fc6-c33517298d3a	66689-106	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	BUCCAL	20220124		ANDA	ANDA203212	VistaPharm, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
66689-107_8164ec13-4fbf-410d-8238-b73beb3034cd	66689-107	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20211115		NDA	NDA022255	VistaPharm, Inc.	LACOSAMIDE	50	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
66689-108_8164ec13-4fbf-410d-8238-b73beb3034cd	66689-108	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20211115		NDA	NDA022255	VistaPharm, Inc.	LACOSAMIDE	100	mg/10mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
66689-109_8164ec13-4fbf-410d-8238-b73beb3034cd	66689-109	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20211115		NDA	NDA022255	VistaPharm, Inc.	LACOSAMIDE	150	mg/15mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
66689-110_8164ec13-4fbf-410d-8238-b73beb3034cd	66689-110	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20211115		NDA	NDA022255	VistaPharm, Inc.	LACOSAMIDE	200	mg/20mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
66689-201_6a715993-8902-4244-9bfb-d20aaa7b303e	66689-201	HUMAN OTC DRUG	INSTA-CHAR AQUEOUS		POISON TREATMENT ADSORBENT	SUSPENSION	ORAL	20061003		OTC MONOGRAPH DRUG	505G(a)(3)	VistaPharm, LLC	ACTIVATED CHARCOAL	50	g/240mL			N	20241231
66689-202_950e0932-1734-417c-8cf5-13b02d0dabc0	66689-202	HUMAN OTC DRUG	INSTA-CHAR AQUEOUS CHERRY		POISON ADSORBENT	SUSPENSION	ORAL	20071211		OTC MONOGRAPH DRUG	505G(a)(3)	VistaPharm, LLC	ACTIVATED CHARCOAL	50	g/240mL			N	20241231
66689-203_c7865307-6162-4210-9385-3dbc80ec3575	66689-203	HUMAN OTC DRUG	INSTA-CHAR SORBITOL		POISON ADSORBENT	SUSPENSION	ORAL	20080328		OTC MONOGRAPH DRUG	505G(a)(3)	VistaPharm, LLC	ACTIVATED CHARCOAL	50	g/240mL			N	20241231
66689-305_f133ac10-0969-47cb-932a-7b100b05105c	66689-305	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20220315		ANDA	ANDA211884	VistaPharm, LLC	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
66689-307_5cd07ba1-653b-48cc-9761-337112ec05e9	66689-307	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	POWDER, FOR SUSPENSION	ORAL	20190215		ANDA	ANDA210370	VistaPharm, LLC	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
66689-318_157c2f43-d3d5-4bf2-a8fa-1409ed56937a	66689-318	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	SOLUTION	ORAL	20221219		ANDA	ANDA212677	VistaPharm, LLC	METFORMIN HYDROCHLORIDE	500	mg/5mL	Biguanide [EPC], Biguanides [CS]		N	20241231
66689-327_8a42aa30-77b8-4009-909b-fb5502341790	66689-327	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	SOLUTION	ORAL	20191004		ANDA	ANDA213000	VistaPharm, LLC	DIGOXIN	.05	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
66689-330_9011a1eb-4025-421c-908e-02a5a00d636b	66689-330	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	SOLUTION	ORAL	20200304		ANDA	ANDA212814	VistaPharm, LLC	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
66689-333_13701068-9041-4e3e-a2f9-e650140bea7d	66689-333	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	SOLUTION	ORAL	20190729		ANDA	ANDA209108	VistaPharm, LLC	CYPROHEPTADINE	2	mg/5mL			N	20241231
66689-342_28968b08-f4ff-4076-bc3e-d9529976a9b0	66689-342	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	SUSPENSION	ORAL	20210927		ANDA	ANDA213951	VistaPharm, Inc.	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
66689-347_108c73a1-2e24-46c8-b52c-07d0e253dbe3	66689-347	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	SOLUTION	ORAL	20190128		ANDA	ANDA211040	VistaPharm, Inc.	SIROLIMUS	1	mg/mL	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
66689-401_6f0d315a-4d02-4548-b993-ba648c596bc3	66689-401	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20120315		NDA	NDA201194	VistaPharm, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-403_6f0d315a-4d02-4548-b993-ba648c596bc3	66689-403	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20120315		NDA	NDA201194	VistaPharm, Inc.	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-406_2a1d661a-1b7d-4f86-8830-21acfddde6dd	66689-406	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		Pyridostigmine Bromide	SOLUTION	ORAL	20200106		ANDA	ANDA211694	VistaPharm, LLC	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
66689-694_f61f3c63-1f73-4429-ac9b-e1c1c1a1d551	66689-694	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	CONCENTRATE	ORAL	20091030		ANDA	ANDA040088	VistaPharm, Inc.	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-695_f61f3c63-1f73-4429-ac9b-e1c1c1a1d551	66689-695	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	CONCENTRATE	ORAL	20170329		ANDA	ANDA040088	VistaPharm, Inc.	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-710_597d8a12-db33-4b5f-96cb-be6da8d3cd65	66689-710	HUMAN OTC DRUG	Kerr 100 Triple Dye Dispos-A		proflavine hemisulfate, Brilliant Green, and Gentian Violet	SWAB	TOPICAL	20040501		OTC MONOGRAPH DRUG	505G(a)(3)	VistaPharm, LLC	BRILLIANT GREEN; GENTIAN VIOLET; PROFLAVINE HEMISULFATE	2.29; 2.2; 1.14	mg/mL; mg/mL; mg/mL			N	20241231
66689-711_ea0de6af-8e1d-4d04-acc4-10177280badf	66689-711	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	20100801		ANDA	ANDA090707	VistaPharm, Inc.	METHADONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-712_ea0de6af-8e1d-4d04-acc4-10177280badf	66689-712	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	20100801		ANDA	ANDA090707	VistaPharm, Inc.	METHADONE HYDROCHLORIDE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-735_e9d3f448-7d70-4c68-85b5-16cea3afc682	66689-735	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	SOLUTION	ORAL	20200619		ANDA	ANDA212870	VistaPharm, Inc.	ARIPIPRAZOLE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
66689-775_c24a0d96-5333-4123-b595-44136ad7bc43	66689-775	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20170329		ANDA	ANDA040342	VistaPharm, Inc.	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
66689-820_8aa408d2-8e74-4ffa-b401-f0fec1abb44e	66689-820	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20181122		ANDA	ANDA040241	VistaPharm, LLC	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-825_c5c995bf-8fbe-415d-94f5-22c875f086c2	66689-825	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	SUSPENSION	ORAL	20190624	20240131	ANDA	ANDA211333	VistaPharm, Inc.	FELBAMATE	600	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
66689-836_7261486f-57ac-402e-a693-4d0288ee40b5	66689-836	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone	TABLET	ORAL	20200911		ANDA	ANDA204166	VistaPharm, Inc.	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66689-898_f9f8d5f5-62fd-42a7-ae1e-8440a3072f82	66689-898	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	19980325		ANDA	ANDA075082	VistaPharm, Inc.	METHADONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66694-001_0cdf46ff-530a-08f1-e063-6294a90a59d3	66694-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110214		UNAPPROVED MEDICAL GAS		ProCaire, LLC	OXYGEN	99	L/100L			N	20241231
66698-001_08b6d880-8d84-033b-e063-6294a90a6707	66698-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141001		UNAPPROVED MEDICAL GAS		UnityPoint at Home	OXYGEN	99	L/100L			N	20241231
66715-0370_411624ea-e67b-4da3-9c82-45d833067847	66715-0370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20151122		OTC MONOGRAPH NOT FINAL	part333A	Lil' Drug Store Products, Inc	ALCOHOL	70	mL/100mL			N	20241231
66715-5103_ef307cfd-6227-37cc-e053-2995a90aeba8	66715-5103	HUMAN OTC DRUG	Aleve		naproxen sodium tablet	TABLET	ORAL	20061116		NDA	NDA020204	Lil' Drug Store Products, Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-5106_0c7b4dd5-e270-60da-e063-6394a90ad029	66715-5106	HUMAN OTC DRUG	Alka-Seltzer		Aspirin, Citric Acid, Sodium Bicarbonate effervescent tablet	TABLET, EFFERVESCENT	ORAL	20080117	20260601	OTC MONOGRAPH DRUG	M001	Lil' Drug Store Products, Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
66715-5154_0c7b8b84-3a6a-7cb1-e063-6294a90a42a4	66715-5154	HUMAN OTC DRUG	Allergy, Circle K		Diphenhydramine HCl 25mg tablet	TABLET, COATED	ORAL	20210712		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-5206_0c7a60e7-0bdf-9aa2-e063-6294a90a3209	66715-5206	HUMAN OTC DRUG	Alka-Seltzer		buffered aspirin	TABLET, EFFERVESCENT	ORAL	20230601		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-5254_d19031f6-e1ea-34f7-e053-2a95a90a3bc9	66715-5254	HUMAN OTC DRUG	Allergy	Circle K	Diphenhydramine Hydrochloride	TABLET	ORAL	20150110	20241104	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
66715-5405_0d98477b-aa34-ebb7-e063-6294a90a597f	66715-5405	HUMAN OTC DRUG	Triple Antibiotic Ointment, Circle K		Triple Antibiotic	OINTMENT	TOPICAL	20231228		OTC MONOGRAPH DRUG	M004	Lil' Drug Store products, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
66715-5438_0c7b9b74-df63-7154-e063-6394a90ab2ef	66715-5438	HUMAN OTC DRUG	Headache, Circle K		Acetaminophen, Caffeine, Aspirin tablet	TABLET	ORAL	20210917		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-5503_0c7ba1ad-f58d-aae5-e063-6294a90a1ed2	66715-5503	HUMAN OTC DRUG	Sleep-Aid, Circle K		Diphenhydramine HCl caplet, 25mg	TABLET, FILM COATED	ORAL	20211220		OTC MONOGRAPH DRUG	M010	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-5504_0c7e1aa2-7052-435d-e063-6394a90a2d08	66715-5504	HUMAN OTC DRUG	Circle K Aspirin 325		Aspirin	TABLET	ORAL	20211110		OTC MONOGRAPH DRUG	M013	Lil Drug Store Products, Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-5505_0c7e49e0-7156-440d-e063-6294a90ae363	66715-5505	HUMAN OTC DRUG	Circle K Triple Antibiotic		bacitracin zinc, polymyxin b sulfate, and neomycin sulfate ointment	OINTMENT	TOPICAL	20210526	20260425	OTC MONOGRAPH DRUG	M004	Lil Drug Store Products, Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/1; mg/1; [iU]/1	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
66715-5506_0c7e49e0-715a-440d-e063-6294a90ae363	66715-5506	HUMAN OTC DRUG	Extra Strength Headache, Circle K		acetaminophen/aspirin/caffeine tablet	TABLET	ORAL	20210924		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-5507_eac91c67-55e0-1476-e053-2a95a90af587	66715-5507	HUMAN OTC DRUG	Circle K Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20210817		ANDA	ANDA079174	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-5508_ead7db0d-4963-5e3b-e053-2a95a90a5b98	66715-5508	HUMAN OTC DRUG	Circle K Pain Reliever		Acetaminophen Caplets, 500 mg	TABLET, FILM COATED	ORAL	20210907	20250131	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-5528_f6011faf-20fe-ec31-e053-2a95a90a838c	66715-5528	HUMAN OTC DRUG	Circle K Cold		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20210326	20260303	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 15; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
66715-5529_ead7ce67-572c-242f-e053-2a95a90a1b9b	66715-5529	HUMAN OTC DRUG	Anti-Diarrheal, Circle K		Loperamide HCl tablet	TABLET	ORAL	20210326		ANDA	ANDA074091	Lil' Drug Store Products, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
66715-5530_e7119e49-e807-ad8b-e053-2995a90ab134	66715-5530	HUMAN OTC DRUG	NoSnooze	Circle K	Caffeine	TABLET	ORAL	20110208	20250203	OTC MONOGRAPH FINAL	part340	Lil' Drug Store Products, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
66715-5531_0c7eae8c-129f-35ee-e063-6294a90a2173	66715-5531	HUMAN OTC DRUG	Circle K Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	LIQUID	ORAL	20210807		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-5533_0c7ed4df-8e3b-7b4f-e063-6294a90a494c	66715-5533	HUMAN OTC DRUG	Circle K Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20210301		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-5534_0c7eceaf-ae6c-7003-e063-6294a90ab81a	66715-5534	HUMAN OTC DRUG	Circle K Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	LIQUID	ORAL	20210803		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-5539_e9366dd9-28c9-c2c7-e053-2a95a90ad199	66715-5539	HUMAN OTC DRUG	Circle K Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20210301		ANDA	ANDA075010	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-5544_0c7f0538-050c-81f2-e063-6394a90adf57	66715-5544	HUMAN OTC DRUG	Non-Drowsy Sinus Severe, Circle K		Acetaminophen, Guaifenesin, Phenylephrine HCl caplet, film-coated	TABLET, FILM COATED	ORAL	20220801		OTC MONOGRAPH DRUG	M012	Lil' Drug Store products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-5554_0c7ef8d3-7163-679e-e063-6394a90a7990	66715-5554	HUMAN OTC DRUG	Circle K Allergy	Antihistamine	Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20141101		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-5560_0c7f2e9e-363e-c91f-e063-6294a90a2b99	66715-5560	HUMAN OTC DRUG	Circle K	Congestion Relief	Oxymetazoline Hydrochloride	SPRAY	NASAL	20210624		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
66715-5571_0c7f4514-dfe4-9a66-e063-6294a90a10fd	66715-5571	HUMAN OTC DRUG	Circle K Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210825		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-5572_0c7f4514-dfe5-9a66-e063-6294a90a10fd	66715-5572	HUMAN OTC DRUG	Circle K Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20210616		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-5628_0c7f4514-dfe6-9a66-e063-6294a90a10fd	66715-5628	HUMAN OTC DRUG	Non-Drowsy Max Cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCI tablet, film-coated	TABLET, FILM COATED	ORAL	20221201		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-5632_0c7f0538-050c-81f2-e063-6394a90adf57	66715-5632	HUMAN OTC DRUG	Non-Drowsy Sinus Severe, Circle K		Acetaminophen, Guaifenesin, Phenylephrine HCl caplet, film-coated	TABLET, FILM COATED	ORAL	20220801		OTC MONOGRAPH DRUG	M012	Lil' Drug Store products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-5633_0c7ed4df-8e3b-7b4f-e063-6294a90a494c	66715-5633	HUMAN OTC DRUG	Circle K Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20110127	20240520	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-5644_0c51c36a-f956-e176-e063-6394a90a4f8b	66715-5644	HUMAN OTC DRUG	Anti-Diarrheal 24/7 for Life by 7-Eleven		loperamide hcl tablet	TABLET	ORAL	20220419		ANDA	ANDA076497	Lil' Drug Store Products, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
66715-5654_0c7ef8d3-7163-679e-e063-6394a90a7990	66715-5654	HUMAN OTC DRUG	Circle K Allergy	Antihistamine	Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20141101	20240414	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
66715-5671_d18a84e9-eebd-18f2-e053-2a95a90aa73a	66715-5671	HUMAN OTC DRUG	Circle K Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20140905	20240713	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
66715-5672_d3c25f86-3202-7c20-e053-2a95a90a0d59	66715-5672	HUMAN OTC DRUG	Circle K Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20140905	20240810	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
66715-5680_0c7f2e9e-3645-c91f-e063-6294a90a2b99	66715-5680	HUMAN OTC DRUG	Extra Strength Pain Reliever		Acetaminophen 500 mg, film-coated caplet	TABLET, FILM COATED	ORAL	20220509		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-5728_f6011faf-20fe-ec31-e053-2a95a90a838c	66715-5728	HUMAN OTC DRUG	Circle K Cold		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20141101	20240909	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 15; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
66715-5729_0c8e1e6b-f90e-29f1-e063-6394a90a3219	66715-5729	HUMAN OTC DRUG	Circle K Eye Drops	Redness Reliever	Tetrahydrozoline Hydrochloride	SOLUTION/ DROPS	TOPICAL	20160504	20241116	OTC MONOGRAPH DRUG	M018	Lil Drug Store Products, Inc	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	
66715-5733_0c7ed4df-8e3b-7b4f-e063-6294a90a494c	66715-5733	HUMAN OTC DRUG	Circle K Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20110127	20240520	OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-5738_d3c435f2-1eb9-1fb0-e053-2a95a90ac196	66715-5738	HUMAN OTC DRUG	Circle K Headache Relief		Acetaminophen, Aspirin, and Caffeine	TABLET	ORAL	20141101	20240413	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
66715-5744_c78fbc6b-f7bd-9824-e053-2995a90ad0ad	66715-5744	HUMAN OTC DRUG	Circle K Multi-Symptom Sinus Relief		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20151207	20240430	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
66715-5755_d1f2856a-7887-8e05-e053-2995a90a1be4	66715-5755	HUMAN OTC DRUG	Circle K Stomach		Bismuth Subsalicylate	LIQUID	ORAL	20151016	20240726	OTC MONOGRAPH FINAL	part335	Lil' Drug Store Products, Inc	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
66715-5756_0c8e2893-bcee-2903-e063-6394a90a7d02	66715-5756	HUMAN OTC DRUG	Hand Sanitizer	Circle K	Alcohol	GEL	TOPICAL	20200313	20250309	OTC MONOGRAPH DRUG	505G(a)(3)	Lil' Drug Store Products, Inc.	ALCOHOL	62	mL/100mL			N	
66715-5760_0c7f2e9e-363e-c91f-e063-6294a90a2b99	66715-5760	HUMAN OTC DRUG	Circle K	Congestion Relief	Oxymetazoline Hydrochloride	SPRAY	NASAL	20141101	20240818	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	
66715-5771_0c7f4514-dfe4-9a66-e063-6294a90a10fd	66715-5771	HUMAN OTC DRUG	Circle K Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20140905	20240713	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
66715-5772_0c7f4514-dfe5-9a66-e063-6294a90a10fd	66715-5772	HUMAN OTC DRUG	Circle K Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20140905	20240810	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
66715-5803_dd302e18-39ea-7e1a-e053-2a95a90a5f7c	66715-5803	HUMAN OTC DRUG	Advil		Ibuprofen Tablets, coated	TABLET, COATED	ORAL	20061116		NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-5822_d18d2f36-75ad-2b01-e053-2a95a90aff05	66715-5822	HUMAN OTC DRUG	Lil Drug Store Headache Relief	Extra Strength	Acetaminophen, Aspirin, and Caffeine	TABLET	ORAL	20171127	20240924	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
66715-5830_e7119e49-e807-ad8b-e053-2995a90ab134	66715-5830	HUMAN OTC DRUG	NoSnooze	Circle K	Caffeine	TABLET	ORAL	20110208	20240714	OTC MONOGRAPH FINAL	part340	Lil' Drug Store Products, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
66715-5834_0c7eceaf-ae6c-7003-e063-6294a90ab81a	66715-5834	HUMAN OTC DRUG	Circle K Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	LIQUID	ORAL	20141101	20240915	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
66715-5839_e9366dd9-28c9-c2c7-e053-2a95a90ad199	66715-5839	HUMAN OTC DRUG	Circle K Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20160621	20240512	ANDA	ANDA075010	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
66715-5863_e78bd59c-6e73-75cc-e053-2995a90ae030	66715-5863	HUMAN OTC DRUG	Circle K Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170606	20250128	OTC MONOGRAPH NOT FINAL	part333E	Lil' Drug Store Products, Inc.	ALCOHOL	62	mg/100mL			N	
66715-5880_f71da5d6-1740-a598-e053-6294a90a6e74	66715-5880	HUMAN OTC DRUG	Afrin Original		Oxymetazoline Hydrochloride	SPRAY	NASAL	20180213		OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
66715-5930_e7119e49-e807-ad8b-e053-2995a90ab134	66715-5930	HUMAN OTC DRUG	NoSnooze	Circle K	Caffeine	TABLET	ORAL	20110208	20240714	OTC MONOGRAPH FINAL	part340	Lil' Drug Store Products, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
66715-5931_0c7eae8c-129f-35ee-e063-6294a90a2173	66715-5931	HUMAN OTC DRUG	Circle K Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	LIQUID	ORAL	20141101	20241014	OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
66715-5932_d6dd6dda-5636-286d-e053-2a95a90a4c5d	66715-5932	HUMAN OTC DRUG	Circle K Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate and Polymyxin B Sulfate	OINTMENT	TOPICAL	20190212		OTC MONOGRAPH FINAL	part333B	Lil Drug Store Products, Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
66715-6300_eac6e05f-6551-367a-e053-2995a90a001f	66715-6300	HUMAN OTC DRUG	Hand Sanitizer with Moisturizing Aloe		Ethyl Alcohol Gel	GEL	TOPICAL	20200702	20250320	OTC MONOGRAPH NOT FINAL	part333E	Lil' Drug Store Products, Inc.	ALCOHOL	70	mL/100mL			N	
66715-6304_0a2329f9-fb21-71b2-e063-6394a90a5442	66715-6304	HUMAN OTC DRUG	Daytime Cold and Flu Severe, Caseys 4goog		Acetaminophen, Phenylephrine, Dextromethorphan HBr, Guaifenesin tablet, film coated	TABLET, FILM COATED	ORAL	20230801		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6307_04b3ad8b-bdfa-47f3-e063-6294a90ac350	66715-6307	HUMAN OTC DRUG	Ibuprofen, Caseys 4good		Ibuprofen tablets	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA079174	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6314_04b78b23-424e-9762-e063-6394a90a52e3	66715-6314	HUMAN OTC DRUG	Allergy 36ct, Caseys 4good		Diphenhydramine HCl 25mg	TABLET, COATED	ORAL	20230801		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-6315_0a2329f9-fb21-71b2-e063-6394a90a5442	66715-6315	HUMAN OTC DRUG	Daytime Cold and Flu Severe, Caseys 4good		Acetaminophen, Phenylephrine, Dextromethorphan HBr, Guaifenesin tablet, film coated	TABLET, FILM COATED	ORAL	20230508		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6321_02e6f826-b54b-0d9c-e063-6394a90a1bbd	66715-6321	HUMAN OTC DRUG	Extra Strength Pain Reliever, Caseys 4good		Acetaminophen 500mg, film-coated caplet	TABLET, FILM COATED	ORAL	20230801		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-6332_033837c0-fa69-a38d-e063-6394a90a9832	66715-6332	HUMAN OTC DRUG	Sinus Relief, Caseys 4good		acetaminophen, guaifenesin, phenylephrine hcl caplet, film-coated	TABLET, FILM COATED	ORAL	20230801		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6337_039d2cf1-57f7-4d9d-e063-6394a90a5492	66715-6337	HUMAN OTC DRUG	Pain Reliever, Caseys 4good		acetaminophen 500 mg, tablet	TABLET	ORAL	20230801		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-6338_0425c6a8-a3eb-24ad-e063-6294a90ae15a	66715-6338	HUMAN OTC DRUG	Extra Strength Headache, Caseys 4good		acetaminophen, aspirin, caffeine tablet	TABLET	ORAL	20230801		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-6339_0402556a-25f9-7afc-e063-6294a90a77ce	66715-6339	HUMAN OTC DRUG	Ibuprofen, Caseys 4good		Ibuprofen tablet, film-coated	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA075010	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6355_030d29b5-26d0-4bff-e063-6394a90a8fe3	66715-6355	HUMAN OTC DRUG	Extra Strength Antacid Tablets, Caseys 4good		Calcium Carbonate 750 mg	TABLET, CHEWABLE	ORAL	20230801		OTC MONOGRAPH FINAL	M001	Lil' Drug Store Prodsucts, Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
66715-6359_043b0ab4-8fbb-37d1-e063-6394a90a4cd4	66715-6359	HUMAN OTC DRUG	Anti-Diarrheal, Caseys 4good		loperamide hcl	TABLET	ORAL	20230801		ANDA	ANDA074091	Lil' Drug Store Products, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
66715-6400_eac7c543-dc38-9847-e053-2995a90af01d	66715-6400	HUMAN OTC DRUG	Hand Sanitizer with Moisturizing Aloe		Ethyl Alcohol Gel	GEL	TOPICAL	20200702	20250320	OTC MONOGRAPH NOT FINAL	part333E	Lil' Drug Store Products, Inc.	ALCOHOL	70	mL/100mL			N	
66715-6403_0bd9a2db-1735-a097-e063-6294a90a3274	66715-6403	HUMAN OTC DRUG	Alka-Seltzer Original Flavor		Buffered aspirin, effervescent tablet	TABLET, EFFERVESCENT	ORAL	20220419		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-6404_065cdc43-bf9c-9976-e063-6294a90a10cb	66715-6404	HUMAN OTC DRUG	DayQuil Severe plus VapoCOOL Cold and Flu, Travel BASIX		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20221128		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6405_06be9e28-b6c3-a4e4-e063-6294a90a3400	66715-6405	HUMAN OTC DRUG	NyQuil Severe Plus VapoCOOL Cold and Flu, TRAVEL BASIX		Acetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide	TABLET, COATED	ORAL	20221129		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6406_0645dc23-8c74-629d-e063-6294a90ad3f6	66715-6406	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20221128		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-6409_06e4f0c4-48a3-cf27-e063-6294a90a0fe9	66715-6409	HUMAN OTC DRUG	Dramamine, TRAVEL BASIX		Dimenhydrinate	TABLET, CHEWABLE	ORAL	20221128		OTC MONOGRAPH DRUG	M009	Lil' Drug Store Products, Inc.	DIMENHYDRINATE	50	mg/1			N	20241231
66715-6410_06c1ac52-474d-db5c-e063-6294a90afb5f	66715-6410	HUMAN OTC DRUG	Excedrin Extra Strength, TRAVEL BASIX		Acetaminophen, Aspirin, and Caffeine	TABLET, FILM COATED	ORAL	20221128		OTC MONOGRAPH DRUG	M013	Lil Drug Store Products, Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-6411_06d4fa39-3b4e-4894-e063-6294a90a6fa0	66715-6411	HUMAN OTC DRUG	Aleve, TRAVEL BASIX		Naproxen Sodium	TABLET	ORAL	20221115		NDA	NDA020204	Lil' Drug Store Products, Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6412_06d5de1c-31ec-ab46-e063-6294a90a006c	66715-6412	HUMAN OTC DRUG	Motrin IB, TRAVEL BASIX		Ibuprofen	TABLET, FILM COATED	ORAL	20221129		ANDA	ANDA077349	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6423_06d6de24-fbde-ec5d-e063-6394a90a4fff	66715-6423	HUMAN OTC DRUG	Pepto-Bismol Chewable, TRAVEL BASIX		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20221129		OTC MONOGRAPH DRUG	M008	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
66715-6424_075d4215-dba2-3d49-e063-6394a90a1e25	66715-6424	HUMAN OTC DRUG	Mucinex DM, TRAVEL BASIX		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20221129		NDA	NDA021620	Lil' Drug Store Products, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-6426_06fe648d-7a5a-9165-e063-6294a90a5f68	66715-6426	HUMAN OTC DRUG	BAYER Aspirin Original, TRAVEL BASIX		ASPIRIN	TABLET	ORAL	20221129		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-6432_f71dd792-11e7-0bfd-e053-6294a90ab948	66715-6432	HUMAN OTC DRUG	Claritin, BSX	Non-Drowsy, 24 Hour	Loratadine	TABLET	ORAL	20201103		NDA	NDA019658	Lil' Drug Store Products, Inc	LORATADINE	10	mg/1			N	20241231
66715-6433_074eb399-93ac-3e4e-e063-6294a90a3a7b	66715-6433	HUMAN OTC DRUG	Advil PM, TRAVEL BASIX		Ibuprofen and Diphenhydramine citrate	TABLET, COATED	ORAL	20221115		NDA	NDA021394	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6434_05e3b293-4b6c-f6f8-e063-6394a90af653	66715-6434	HUMAN OTC DRUG	Advil		Ibuprofen	TABLET, COATED	ORAL	20221129		NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6438_0c41deda-490c-f5d2-e063-6394a90a5047	66715-6438	HUMAN OTC DRUG	Extra Strength Headache, Lil Drug Store		EXTRA STRENGHT HEADACHE RELIEF- acetaminophen, aspirin, caffeine tablet	TABLET	ORAL	20220419		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-6445_074f1dca-9050-0035-e063-6394a90ae0b9	66715-6445	HUMAN OTC DRUG	Midol Complete, TRAVEL BASIX		Acetaminophen, Caffeine, and Pyrilamine Maleate	TABLET	ORAL	20221129		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
66715-6447_07d85e4c-86a7-a62e-e063-6394a90ae377	66715-6447	HUMAN OTC DRUG	TYLENOL EXTRA STRENGTH, TRAVEL BASIX		Acetaminophen	TABLET, COATED	ORAL	20221122		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-6449_07daff8e-5934-4bfe-e063-6294a90a5958	66715-6449	HUMAN OTC DRUG	Excedrin Migraine, TRAVEL BASIX		acetaminophen, aspirin, and caffeine	TABLET, FILM COATED	ORAL	20221129		NDA	NDA020802	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-6452_05e08a97-afb0-a32d-e063-6294a90af4bb	66715-6452	HUMAN OTC DRUG	Advil Liqui-Gels		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20171023		NDA	NDA020402	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6500_05e3b293-4b6c-f6f8-e063-6394a90af653	66715-6500	HUMAN OTC DRUG	Advil		Ibuprofen	TABLET, COATED	ORAL	20220506		NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6502_06d4fa39-3b4e-4894-e063-6294a90a6fa0	66715-6502	HUMAN OTC DRUG	Aleve		Naproxen Sodium	TABLET	ORAL	20220506		NDA	NDA020204	Lil' Drug Store Products, Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6503_0bd9a2db-1735-a097-e063-6294a90a3274	66715-6503	HUMAN OTC DRUG	Alka-Seltzer Original Flavor		Buffered aspirin, effervescent tablet	TABLET, EFFERVESCENT	ORAL	20220506		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-6506_0645dc23-8c74-629d-e063-6294a90ad3f6	66715-6506	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20220506		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-6510_06c1ac52-474d-db5c-e063-6294a90afb5f	66715-6510	HUMAN OTC DRUG	Excedrin Extra Strength, CVP HEALTH		Acetaminophen, Aspirin, and Caffeine	TABLET, FILM COATED	ORAL	20220506		OTC MONOGRAPH DRUG	M013	Lil Drug Store Products, Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-6512_06d5de1c-31ec-ab46-e063-6294a90a006c	66715-6512	HUMAN OTC DRUG	Motrin IB, CVP HEALTH		Ibuprofen	TABLET, FILM COATED	ORAL	20220506		ANDA	ANDA077349	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6514_04c9db9a-95f0-3a48-e063-6294a90a4e8e	66715-6514	HUMAN OTC DRUG	Allergy Relief, 24-7 Lift by 7-Eleven		Diphenhydramine HCl 25mg	TABLET, COATED	ORAL	20220419		OTC MONOGRAPH FINAL	M012	Lil' Drug Store products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-6515_05cc7185-d49e-82a3-e063-6294a90a568e	66715-6515	HUMAN OTC DRUG	Cold and Flu Daytime Severe, 24/7 Life		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl tablet	TABLET, FILM COATED	ORAL	20220419		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6516_05d0410f-164f-e7ee-e063-6394a90a2aaa	66715-6516	HUMAN OTC DRUG	Cold and Flu Nighttime Severe, 24-7 Life		acetaminophen, dextromethorphan hbr, doxylamine succinate, phenylephrine hcl	TABLET, FILM COATED	ORAL	20220419		OTC MONOGRAPH FINAL	M012	Lil' Drug Store products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6517_0a239a57-45a9-9944-e063-6394a90a32a1	66715-6517	HUMAN OTC DRUG	Tylenol PM Extra Strength, CVP HEALTH		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20220506		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-6522_07db539f-ac55-7227-e063-6294a90afbaa	66715-6522	HUMAN OTC DRUG	Pepcid Complete, TRAVEL BASIX		Famotidine, Calcium Carbonate, Magnesium Hydroxide Chewable Tablet	TABLET, CHEWABLE	ORAL	20220506		NDA	NDA020958	Lil' Drug Store Products, Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
66715-6523_06d6de24-fbde-ec5d-e063-6394a90a4fff	66715-6523	HUMAN OTC DRUG	Pepto-Bismol Chewable, CVP HEALTH		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20220506		OTC MONOGRAPH DRUG	M008	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
66715-6524_075d4215-dba2-3d49-e063-6394a90a1e25	66715-6524	HUMAN OTC DRUG	Mucinex DM, CVP HEALTH		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20220506		NDA	NDA021620	Lil' Drug Store Products, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-6526_06fe648d-7a5a-9165-e063-6294a90a5f68	66715-6526	HUMAN OTC DRUG	BAYER Aspirin Original, CVP HEALTH		ASPIRIN	TABLET	ORAL	20220506		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-6531_f92582f5-c810-a976-e053-6394a90a0f3f	66715-6531	HUMAN OTC DRUG	Alka-Seltzer Plus Cold and Flu, CVP		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide tablet	TABLET, EFFERVESCENT	ORAL	20220425		OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6532_f71dd792-11e7-0bfd-e053-6294a90ab948	66715-6532	HUMAN OTC DRUG	Claritin, CVP	Non-Drowsy, 24 Hour	Loratadine	TABLET	ORAL	20170825		NDA	NDA019658	Lil' Drug Store Products, Inc	LORATADINE	10	mg/1			N	20241231
66715-6533_074eb399-93ac-3e4e-e063-6294a90a3a7b	66715-6533	HUMAN OTC DRUG	Advil PM, CVP HEALTH		Ibuprofen and Diphenhydramine citrate	TABLET, COATED	ORAL	20220506		NDA	NDA021394	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6547_07d85e4c-86a7-a62e-e063-6394a90ae377	66715-6547	HUMAN OTC DRUG	TYLENOL EXTRA STRENGTH, CVP HEALTH		Acetaminophen	TABLET, COATED	ORAL	20220506		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-6549_07daff8e-5934-4bfe-e063-6294a90a5958	66715-6549	HUMAN OTC DRUG	Excedrin Migraine, CVP HEALTH		acetaminophen, aspirin, and caffeine	TABLET, FILM COATED	ORAL	20220506		NDA	NDA020802	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-6551_031ecc85-8325-4505-e063-6294a90a580b	66715-6551	HUMAN OTC DRUG	Non-Drowsy Allergy Relief, 24-7 Life		loratadine tablet	TABLET	ORAL	20220630		ANDA	ANDA210722	Lil' Drug Store Products, Inc.	LORATADINE	10	mg/1			N	20241231
66715-6556_0a1f29ea-f6ed-68a4-e063-6294a90adc40	66715-6556	HUMAN OTC DRUG	Tylenol Cold plus Flu Severe, CVP HEALTH		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20220506		OTC MONOGRAPH DRUG	M012	Lil Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6557_0a207445-d6b3-1add-e063-6394a90ae9ba	66715-6557	HUMAN OTC DRUG	Tylenol Sinus Severe, CVP HEALTH		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20220506		OTC MONOGRAPH DRUG	M012	Lil Drug Store Products, Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6559_043b0ab4-8fbb-37d1-e063-6394a90a4cd4	66715-6559	HUMAN OTC DRUG	Anti-Diarrheal, CVP HEALTH		loperamide hcl	TABLET	ORAL	20220506		ANDA	ANDA074091	Lil' Drug Store Products, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
66715-6580_065cdc43-bf9c-9976-e063-6294a90a10cb	66715-6580	HUMAN OTC DRUG	DayQuil Severe plus VapoCOOL Cold and Flu, CVP HEALTH		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20220801		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6581_06be9e28-b6c3-a4e4-e063-6294a90a3400	66715-6581	HUMAN OTC DRUG	NyQuil Severe Plus VapoCOOL Cold and Flu, CVP HEALTH		Acetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide	TABLET, COATED	ORAL	20220801		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6643_0c7ba1ad-f58d-aae5-e063-6294a90a1ed2	66715-6643	HUMAN OTC DRUG	Sleep-Aid, Lil Drug Store		Diphenhydramine HCl caplet, 25mg	TABLET, FILM COATED	ORAL	20211220		OTC MONOGRAPH DRUG	M010	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-6704_0c7e1aa2-7052-435d-e063-6394a90a2d08	66715-6704	HUMAN OTC DRUG	Circle K Aspirin 325		Aspirin	TABLET	ORAL	20171010	20240903	OTC MONOGRAPH DRUG	M013	Lil Drug Store Products, Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
66715-6705_0c7e49e0-7156-440d-e063-6294a90ae363	66715-6705	HUMAN OTC DRUG	Circle K Triple Antibiotic		Bacitracin zinc, Polymyxin B sulfate, and Neomycin sulfate	OINTMENT	TOPICAL	20171010		OTC MONOGRAPH DRUG	M004	Lil Drug Store Products, Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
66715-6706_d2809b4b-994e-3b8d-e053-2995a90ab332	66715-6706	HUMAN OTC DRUG	Circle K Headache Relief	Extra Strength	acetaminophen, aspirin, caffeine	TABLET	ORAL	20171010	20240903	OTC MONOGRAPH NOT FINAL	part343	Lil Drug Store Products, Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
66715-6707_eac91c67-55e0-1476-e053-2a95a90af587	66715-6707	HUMAN OTC DRUG	Circle K Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20150110	20240802	ANDA	ANDA079174	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
66715-6708_d2800765-6116-63a1-e053-2995a90a3b8e	66715-6708	HUMAN OTC DRUG	Circle K Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20141101	20240817	OTC MONOGRAPH NOT FINAL	part343	Lil Drug Store Products, Inc	ACETAMINOPHEN	500	mg/1			N	
66715-6715_ead8fc39-5bf7-b9be-e053-2995a90a1c71	66715-6715	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20140905		OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 15; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6716_ead9184b-6071-4903-e053-2a95a90a893a	66715-6716	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20140905		OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-6743_dd1d4399-2f2a-e348-e053-2995a90a0319	66715-6743	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20190715	20250107	OTC MONOGRAPH FINAL	part338	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
66715-6744_0c8e6ff3-c03e-4de8-e063-6394a90a127d	66715-6744	HUMAN OTC DRUG	Daytime Sinus Severe		Acetaminophen, Guaifenesin, Phenylephrine HCl tablet, film-coated	TABLET, FILM COATED	ORAL	20220802		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6803_ea500c69-6eb8-818b-e053-2a95a90a1ef1	66715-6803	HUMAN OTC DRUG	Circle K Nighttime Sleep-Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20171010	20250429	OTC MONOGRAPH FINAL	part338	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
66715-6814_ead9641b-4d1e-da10-e053-2995a90a60e7	66715-6814	HUMAN OTC DRUG	Allergy	Lil Drug Store Products	Diphenhydramine Hydrochloride	TABLET	ORAL	20150110	20250131	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
66715-6815_0c8e76bc-9d95-4fe5-e063-6394a90a746d	66715-6815	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20140905		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6816_0c8e6fd3-f06a-69cb-e063-6294a90aebcd	66715-6816	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20140905		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-6817_d3c27d2d-2878-2065-e053-2995a90a28ae	66715-6817	HUMAN OTC DRUG	Lil Drug Store Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20150110	20240812	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-6821_d3c272ee-c321-1678-e053-2995a90aff5b	66715-6821	HUMAN OTC DRUG	Lil Drug Store Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20170117	20240819	OTC MONOGRAPH NOT FINAL	part343	Lil Drug Store Products, Inc	ACETAMINOPHEN	500	mg/1			N	
66715-6822_d18d2f36-75ad-2b01-e053-2a95a90aff05	66715-6822	HUMAN OTC DRUG	Lil Drug Store Headache Relief	Extra Strength	Acetaminophen, Aspirin, and Caffeine	TABLET	ORAL	20171127	20240924	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
66715-6827_d3c27d2d-2878-2065-e053-2995a90a28ae	66715-6827	HUMAN OTC DRUG	Lil Drug Store Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20150110	20240812	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-6832_0c8e9634-be64-5a02-e063-6394a90af2c4	66715-6832	HUMAN OTC DRUG	Lil Drug Store Eye Drops	Redness Reliever	Tetrahydrozoline Hydrochloride	LIQUID	TOPICAL	20160504		OTC MONOGRAPH DRUG	M018	Lil Drug Store Products, Inc	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
66715-6835_e3b68307-0396-0d49-e053-2a95a90a9655	66715-6835	HUMAN OTC DRUG	Lil Drug Store Petroleum Jelly		Petrolatum	JELLY	TOPICAL	20160504		OTC MONOGRAPH FINAL	part347	Lil Drug Store Products, Inc	PETROLATUM	1	g/g			N	20241231
66715-6837_d3c27d2d-2878-2065-e053-2995a90a28ae	66715-6837	HUMAN OTC DRUG	Lil Drug Store Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	20150110	20240812	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-6839_eaeca82e-4832-1f17-e053-2a95a90a6804	66715-6839	HUMAN OTC DRUG	Lil Drug Store Ibuprofen		Ibuprofen	TABLET	ORAL	20150110		ANDA	ANDA079174	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6840_0c8e9f7e-598f-5957-e063-6394a90a3412	66715-6840	HUMAN OTC DRUG	Lil Drug Store Aspirin 325		Aspirin	TABLET	ORAL	20160504		OTC MONOGRAPH DRUG	M013	Lil Drug Store Products, Inc	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-6841_eaecf5aa-6673-33fc-e053-2a95a90a9b5d	66715-6841	HUMAN OTC DRUG	Anti-Diarrheal		Bismuth Subsalicylate	TABLET	ORAL	20190221		OTC MONOGRAPH FINAL	part335	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
66715-6844_ea50a317-6726-8bdc-e053-2a95a90ada14	66715-6844	HUMAN OTC DRUG	Lil Drug Store Multi-Symptom Sinus	Severe Congestion	Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20141215	20250610	OTC MONOGRAPH FINAL	part341	Lil Drug Store Products, Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
66715-6845_0c8e9634-be66-5a02-e063-6394a90af2c4	66715-6845	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol	Lil Drug Store Products	Isopropyl alcohol	LIQUID	TOPICAL	20141201		OTC MONOGRAPH DRUG	505G(a)(3)	Lil' Drug Store Products, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
66715-6846_0c8ecc47-6441-6193-e063-6394a90afecc	66715-6846	HUMAN OTC DRUG	Hydrogen Peroxide	Lil Drug Store Products	Hydrogen Peroxide	LIQUID	TOPICAL	20141201		OTC MONOGRAPH DRUG	505G(a)(3)	Lil' Drug Store Products, Inc	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
66715-6855_0c8ecc47-6446-6193-e063-6394a90afecc	66715-6855	HUMAN OTC DRUG	Stomach	Lil Drug Store Products	Bismuth Subsalicylate	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M001	Lil' Drug Store Products, Inc	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
66715-6858_0c8ecc47-6447-6193-e063-6394a90afecc	66715-6858	HUMAN OTC DRUG	Adult Tussin DM	Lil Drug Store Products	Dextromethorphan Hydrobromide and Guaifenesin	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-6860_0c8efe9d-2f5b-a5f3-e063-6394a90ad973	66715-6860	HUMAN OTC DRUG	Congestion Relief	Lil Drug Store Products	Oxymetazoline Hydrochloride	SPRAY	NASAL	20141201		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
66715-6861_0c8ef7db-5368-9f5e-e063-6394a90a408e	66715-6861	HUMAN OTC DRUG	Antiseptic	Lil Drug Store Products	Eucalyptol, Menthol, Unspecified Form, Methyl salicylate, and Thymol	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M022	Lil' Drug Store Products, Inc	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
66715-6863_0c8f2edd-e154-3709-e063-6294a90a3b7b	66715-6863	HUMAN OTC DRUG	Antibacterial Hand Wipes	Lil Drug Store	Benzalkonium chloride	CLOTH	TOPICAL	20200609		OTC MONOGRAPH DRUG	505G(a)(3)	Lil' Drug Store Products, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
66715-6867_0c8f4454-051f-b87a-e063-6394a90aa9b7	66715-6867	HUMAN OTC DRUG	Pain Reliever		Acetaminophen 500 mg, film-coated tablet	TABLET, FILM COATED	ORAL	20220304		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-6871_02e6f826-b54b-0d9c-e063-6394a90a1bbd	66715-6871	HUMAN OTC DRUG	Pain Reliever		Acetaminophen 500mg, film-coated caplet	TABLET, FILM COATED	ORAL	20220304		OTC MONOGRAPH FINAL	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-6914_0c7b8b84-3a6a-7cb1-e063-6294a90a42a4	66715-6914	HUMAN OTC DRUG	Allergy, Lil Drug Store		Diphenhydramine HCl 25mg tablet	TABLET, COATED	ORAL	20210712		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-6920_eaf09ec6-8837-25de-e053-2a95a90a7b02	66715-6920	HUMAN OTC DRUG	Lil Drug Store Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170223		ANDA	ANDA079174	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-6922_0c7e49e0-715a-440d-e063-6294a90ae363	66715-6922	HUMAN OTC DRUG	Extra Strength Headache		acetaminophen/aspirin/caffeine tablet	TABLET	ORAL	20210924		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-6931_0c8f4c74-4b04-32c0-e063-6294a90a36a7	66715-6931	HUMAN OTC DRUG	Daytime Cold and Flu	Lil Drug Store Products	Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-6934_0c8f22fa-65e9-2c97-e063-6294a90ae68c	66715-6934	HUMAN OTC DRUG	Nighttime Cold and Flu	Lil Drug Store Products	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	LIQUID	ORAL	20141201		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-6950_ec9584f8-5b92-4b39-e053-2a95a90a1527	66715-6950	HUMAN OTC DRUG	24 Hour Allergy	Lil Drug Store Products	Cetirizine hydrochloride	TABLET	ORAL	20180601	20241217	ANDA	ANDA209274	Lil' Drug Store Products, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
66715-6956_f0d2435c-090f-416d-e053-2995a90acd56	66715-6956	HUMAN OTC DRUG	Lil Drug Store Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20141201		OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
66715-6967_ed243841-0307-24fd-e053-2a95a90a7bdf	66715-6967	HUMAN OTC DRUG	Extra Strength Pain Reliever		Acetaminophen Caplet, 500 mg	TABLET, FILM COATED	ORAL	20210907	20250331	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-6971_ed243841-0307-24fd-e053-2a95a90a7bdf	66715-6971	HUMAN OTC DRUG	Extra Strength Pain Reliever		Acetaminophen Caplets, 500 mg	TABLET, FILM COATED	ORAL	20210920	20250331	OTC MONOGRAPH NOT FINAL	part343	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	
66715-7010_0c8f4454-0523-b87a-e063-6394a90aa9b7	66715-7010	HUMAN OTC DRUG	Cleareyes Redness Relief		Naphazoline Hydrochloride and Glycerin	LIQUID	OPHTHALMIC	20001102		OTC MONOGRAPH DRUG	M018	Lil' Drug Store Products, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.0025; .00012	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
66715-7012_0c8f623a-affb-54ea-e063-6294a90a07af	66715-7012	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20091001		OTC MONOGRAPH DRUG	505G(a)(3)	Lil' Drug Store Products, Inc	ALCOHOL	.62	mL/mL			N	20241231
66715-7016_f71da5d6-1740-a598-e053-6294a90a6e74	66715-7016	HUMAN OTC DRUG	Afrin Original		Oxymetazoline Hydrochloride	SPRAY	NASAL	20080101		OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
66715-7172_0c8f623a-b000-54ea-e063-6294a90a07af	66715-7172	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20190601		OTC MONOGRAPH DRUG	505G(a)(3)	Lil' Drug Store Products, Inc.	ALCOHOL	62	mg/100mL			N	20241231
66715-7822_07db539f-ac55-7227-e063-6294a90afbaa	66715-7822	HUMAN OTC DRUG	Pepcid Complete, TRAVEL BASIX		Famotidine, Calcium Carbonate, Magnesium Hydroxide Chewable Tablet	TABLET, CHEWABLE	ORAL	20221129		NDA	NDA020958	Lil' Drug Store Products, Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
66715-7831_f92582f5-c810-a976-e053-6394a90a0f3f	66715-7831	HUMAN OTC DRUG	Alka-Seltzer Plus Cold and Flu, BASIX		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide tablet	TABLET, EFFERVESCENT	ORAL	20221130		OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-7856_0a1f29ea-f6ed-68a4-e063-6294a90adc40	66715-7856	HUMAN OTC DRUG	Tylenol Cold plus Flu Severe, TRAVEL BASIX		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20221130		OTC MONOGRAPH DRUG	M012	Lil Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-7857_0a207445-d6b3-1add-e063-6394a90ae9ba	66715-7857	HUMAN OTC DRUG	Tylenol Sinus Severe, TRAVEL BASIX		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20221130		OTC MONOGRAPH DRUG	M012	Lil Drug Store Products, Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-8123_0e74e9fd-f79b-ffea-e063-6394a90a721e	66715-8123	HUMAN OTC DRUG	Nicorette 4mg Cinnamon Surge		nicotine polacrilex	GUM, CHEWING	BUCCAL	20220506		NDA	NDA020066	Lil' Drug Store products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20251231
66715-8124_0e85dcfa-d9e2-5fbb-e063-6394a90aeae6	66715-8124	HUMAN OTC DRUG	Nicorette 4mg Fruit Chill Gum, Lil Drug Store		nicotine polacrilex	GUM, CHEWING	BUCCAL	20220506		NDA	NDA020066	Lil' Drug Store Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20251231
66715-8125_0e894f4f-2d42-24c2-e063-6294a90ae26c	66715-8125	HUMAN OTC DRUG	Nicorette 4mg White Ice Mint Gum, Lil Drug Store		nicotine polacrilex	GUM, CHEWING	BUCCAL	20220506		NDA	NDA020066	Lil' Drug Store Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20251231
66715-8151_0a47e228-67b2-984b-e063-6394a90a652c	66715-8151	HUMAN OTC DRUG	Tums Antacid Chewy Bites		Calcium Carbonate 750 mg	TABLET, CHEWABLE	ORAL	20220419		OTC MONOGRAPH DRUG	M001	Lil' Drug Store products, Inc.	CALCIUM CARBONATE	750	mg/1			N	20241231
66715-8355_031fb012-702e-0b02-e063-6394a90a0394	66715-8355	HUMAN OTC DRUG	Stomach Relief, Caseys 4good		Bismuth Subsalicylate suspension	LIQUID	ORAL	20230801		OTC MONOGRAPH FINAL	M008	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
66715-8553_030d29b5-26d0-4bff-e063-6394a90a8fe3	66715-8553	HUMAN OTC DRUG	Extra Strength Antacid Tablets, 24/7 Life		Calcium Carbonate 750 mg	TABLET, CHEWABLE	ORAL	20220419		OTC MONOGRAPH FINAL	M001	Lil' Drug Store Prodsucts, Inc.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
66715-8554_031fb012-702e-0b02-e063-6394a90a0394	66715-8554	HUMAN OTC DRUG	Stomach Relief, 24-7 Life		Bismuth Subsalicylate suspension	LIQUID	ORAL	20220419		OTC MONOGRAPH FINAL	M008	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
66715-8815_031fc3e5-b5ec-447c-e063-6294a90a13b5	66715-8815	HUMAN OTC DRUG	Non-Drowsy Allergy Relief		loratadine tablet	TABLET	ORAL	20220506		ANDA	ANDA076471	Lil' Drug Store Products, Inc.	LORATADINE	10	mg/1			N	20241231
66715-9601_030d9bca-a935-6ef9-e063-6394a90a8277	66715-9601	HUMAN OTC DRUG	Advil Dual Action with Acetaminophen		ibuprofen, acetaminophen tablet, film coated	TABLET, FILM COATED	ORAL	20230517		NDA	NDA211733	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9603_0bd9a2db-1735-a097-e063-6294a90a3274	66715-9603	HUMAN OTC DRUG	Alka-Seltzer Original Flavor		Buffered aspirin, effervescent tablet	TABLET, EFFERVESCENT	ORAL	20221201		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-9631_0d98477b-aa34-ebb7-e063-6294a90a597f	66715-9631	HUMAN OTC DRUG	Triple Antibiotic Ointment, Lil Drug Store		Triple Antibiotic	OINTMENT	TOPICAL	20231228		OTC MONOGRAPH DRUG	M004	Lil' Drug Store products, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
66715-9637_0c8f99ae-73a5-7ac4-e063-6294a90a0f36	66715-9637	HUMAN OTC DRUG	Pain Reliever		acetaminophen tablet, extra strength	TABLET, FILM COATED	ORAL	20220930		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-9700_05e3b293-4b6c-f6f8-e063-6394a90af653	66715-9700	HUMAN OTC DRUG	Advil		Ibuprofen	TABLET, COATED	ORAL	20100222		NDA	NDA018989	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9702_06d4fa39-3b4e-4894-e063-6294a90a6fa0	66715-9702	HUMAN OTC DRUG	Aleve		Naproxen Sodium	TABLET	ORAL	20000101		NDA	NDA020204	Lil' Drug Store Products, Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9703_0c8f899a-43bf-c969-e063-6394a90a4c1f	66715-9703	HUMAN OTC DRUG	Alka-Seltzer		Anhydrous Citric Acid, Aspirin, and Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20000101	20250419	OTC MONOGRAPH DRUG	M001	Lil' Drug Store Products, Inc	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
66715-9706_0645dc23-8c74-629d-e063-6294a90ad3f6	66715-9706	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20100916		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-9707_f04630fb-8ea0-25e5-e053-2995a90aa8f2	66715-9707	HUMAN OTC DRUG	Allegra Allergy		Fexofenadine Hydrochloride	TABLET, FILM COATED	ORAL	20140901		NDA	NDA020872	Lil' Drug Store Products, Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-9711_0c91d1ee-b12a-7c38-e063-6394a90ad835	66715-9711	HUMAN OTC DRUG	Allergy		Diphenhydramine HCl Tablet	TABLET	ORAL	20140912		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-9721_eac34b9e-c756-a572-e053-2a95a90a7ea2	66715-9721	HUMAN OTC DRUG	Multi-Symptom Sinus	Severe Congestion	Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20140912	20250809	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
66715-9723_06d6de24-fbde-ec5d-e063-6394a90a4fff	66715-9723	HUMAN OTC DRUG	Pepto-Bismol		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20100916		OTC MONOGRAPH DRUG	M008	Lil' Drug Store Products, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
66715-9724_075d4215-dba2-3d49-e063-6394a90a1e25	66715-9724	HUMAN OTC DRUG	Mucinex DM		Guaifenesin and Dextromethorphan Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20100510		NDA	NDA021620	Lil' Drug Store Products, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
66715-9726_06fe648d-7a5a-9165-e063-6294a90a5f68	66715-9726	HUMAN OTC DRUG	BAYER		ASPIRIN	TABLET	ORAL	20090701		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
66715-9731_0c922b65-c084-ef59-e063-6294a90ad7f5	66715-9731	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, POLYMYXIN B SULFATE, and Neomycin Sulfate	OINTMENT	TOPICAL	20181015	20260425	OTC MONOGRAPH DRUG	M004	Lil' Drug Store Products, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
66715-9732_f71dd792-11e7-0bfd-e053-6294a90ab948	66715-9732	HUMAN OTC DRUG	Lil Drug Store Claritin	Non-Drowsy, 24 Hour	Loratadine	TABLET	ORAL	20110421		NDA	NDA019658	Lil' Drug Store Products, Inc	LORATADINE	10	mg/1			N	20241231
66715-9733_074eb399-93ac-3e4e-e063-6294a90a3a7b	66715-9733	HUMAN OTC DRUG	Advil PM		Ibuprofen and Diphenhydramine citrate	TABLET, COATED	ORAL	20100511		NDA	NDA021394	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9735_e7a207e4-797f-08b4-e053-2a95a90af329	66715-9735	HUMAN OTC DRUG	Alka-Seltzer Plus		Aspirin, Chlorpheniramine Maleate, and Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20000101	20250609	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
66715-9738_c7a8d2d7-f4de-0b46-e053-2a95a90a82e0	66715-9738	HUMAN OTC DRUG	Lil Drug Store Headache Relief	Extra Strength	Acetaminophen, Aspirin, and Caffeine	TABLET	ORAL	20110127	20240715	ANDA	ANDA075794	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
66715-9739_eedf9669-d93c-37d4-e053-2a95a90ad9f5	66715-9739	HUMAN OTC DRUG	Lil Drug Store Ibuprofen		Ibuprofen	TABLET	ORAL	20110127		ANDA	ANDA075010	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9740_eedfeb86-91f9-3304-e053-2a95a90a2b98	66715-9740	HUMAN OTC DRUG	Lil Drug Store Pain Relief	All Day	Naproxen Sodium	TABLET	ORAL	20110127		ANDA	ANDA079096	Lil' Drug Store Products, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9742_f0e77162-c602-1a0f-e053-2a95a90ab714	66715-9742	HUMAN OTC DRUG	Claritin		loratadine tablet	TABLET	ORAL	20220601		ANDA	ANDA075209	Lil' Drug Store Products, Inc.	LORATADINE	10	mg/1			N	20241231
66715-9744_d3ae0396-2a76-39e4-e053-2a95a90ae5c4	66715-9744	HUMAN OTC DRUG	Lil Drug Store Multi-Symptom Sinus Relief		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20110601	20240519	OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
66715-9745_074f1dca-9050-0035-e063-6394a90ae0b9	66715-9745	HUMAN OTC DRUG	Midol Complete		Acetaminophen, Caffeine, and Pyrilamine Maleate	TABLET	ORAL	20111201		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
66715-9746_0c92579b-5d46-ac10-e063-6394a90aa854	66715-9746	HUMAN OTC DRUG	ZzzQuil		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20151223		OTC MONOGRAPH DRUG	M010	Lil' Drug Store Products, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/21	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-9747_07d85e4c-86a7-a62e-e063-6394a90ae377	66715-9747	HUMAN OTC DRUG	TYLENOL EXTRA STRENGTH		Acetaminophen	TABLET, COATED	ORAL	20110809		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
66715-9748_0e8487fc-3e0e-bbfc-e063-6394a90a3073	66715-9748	HUMAN OTC DRUG	Pepcid AC		Famotidine	TABLET, FILM COATED	ORAL	20200401		NDA	NDA020325	Lil' Drug Store Products, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
66715-9749_07daff8e-5934-4bfe-e063-6294a90a5958	66715-9749	HUMAN OTC DRUG	Excedrin Migraine		acetaminophen, aspirin, and caffeine	TABLET, FILM COATED	ORAL	20190815		NDA	NDA020802	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-9752_05e08a97-afb0-a32d-e063-6294a90af4bb	66715-9752	HUMAN OTC DRUG	Advil Liqui-Gels		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20171023		NDA	NDA020402	Lil Drug Store Products, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9756_0a1f29ea-f6ed-68a4-e063-6294a90adc40	66715-9756	HUMAN OTC DRUG	Lil Drug Store Tylenol Cold plus Flu Severe		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20171023		OTC MONOGRAPH DRUG	M012	Lil Drug Store Products, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-9757_0a207445-d6b3-1add-e063-6394a90ae9ba	66715-9757	HUMAN OTC DRUG	Lil Drug Store Tylenol Sinus Severe		Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20171023		OTC MONOGRAPH DRUG	M012	Lil Drug Store Products, Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-9758_ea38535a-c9dc-d03f-e053-2a95a90adf2d	66715-9758	HUMAN OTC DRUG	Zantac 360		Famotidine tablet, film-coated	TABLET, FILM COATED	ORAL	20210920		ANDA	ANDA206531	Lil' Drug Store Products, Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
66715-9801_d35f391d-62db-da44-e053-2995a90ab429	66715-9801	HUMAN OTC DRUG	Nicotac Nicotine Polacrilex	Coated Cinnamon	Nicotine	GUM, CHEWING	BUCCAL	20180403	20241212	ANDA	ANDA079219	Lil' Drug Store Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
66715-9802_d35f326a-be9e-0895-e053-2995a90ac139	66715-9802	HUMAN OTC DRUG	Nicotac Nicotine Polacrilex	Coated Fruit	Nicotine	GUM, CHEWING	BUCCAL	20180403	20241212	ANDA	ANDA079038	Lil' Drug Store Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
66715-9803_d35f391d-62dc-da44-e053-2995a90ab429	66715-9803	HUMAN OTC DRUG	Nicotac Nicotine Polacrilex	Coated Mint	Nicotine	GUM, CHEWING	BUCCAL	20180403	20241212	ANDA	ANDA078697	Lil' Drug Store Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
66715-9804_d35f391d-62db-da44-e053-2995a90ab429	66715-9804	HUMAN OTC DRUG	Nicotac Nicotine Polacrilex	Coated Cinnamon	Nicotine	GUM, CHEWING	BUCCAL	20180403	20240402	ANDA	ANDA079216	Lil' Drug Store Products, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
66715-9805_d0760ad2-b5c9-371e-e053-2995a90a79ea	66715-9805	HUMAN OTC DRUG	Nicotac Nicotine Polacrilex	Coated Fruit	Nicotine	GUM, CHEWING	BUCCAL	20180403	20240402	ANDA	ANDA079044	Lil' Drug Store Products, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
66715-9806_d18b3788-7f57-3f88-e053-2995a90adb59	66715-9806	HUMAN OTC DRUG	Nicotac Nicotine Polacrilex	Coated Mint	Nicotine	GUM, CHEWING	BUCCAL	20180403	20240726	ANDA	ANDA078699	Lil' Drug Store Products, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	
66715-9809_06e4f0c4-48a3-cf27-e063-6294a90a0fe9	66715-9809	HUMAN OTC DRUG	Dramamine		Dimenhydrinate	TABLET, CHEWABLE	ORAL	20100510		OTC MONOGRAPH DRUG	M009	Lil' Drug Store Products, Inc.	DIMENHYDRINATE	50	mg/1			N	20241231
66715-9810_06c1ac52-474d-db5c-e063-6294a90afb5f	66715-9810	HUMAN OTC DRUG	Excedrin Extra Strength		Acetaminophen, Aspirin, and Caffeine	TABLET, FILM COATED	ORAL	20100510		OTC MONOGRAPH DRUG	M013	Lil Drug Store Products, Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-9812_06d5de1c-31ec-ab46-e063-6294a90a006c	66715-9812	HUMAN OTC DRUG	Motrin IB		Ibuprofen	TABLET, FILM COATED	ORAL	20120103		ANDA	ANDA077349	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9815_0c922809-81de-fc2f-e063-6294a90a4203	66715-9815	HUMAN OTC DRUG	BC Cherry		Aspirin and Caffeine	POWDER	ORAL	20140301		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
66715-9817_0a239a57-45a9-9944-e063-6394a90a32a1	66715-9817	HUMAN OTC DRUG	Lil Drug Store Tylenol PM Extra Strength		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20171020		OTC MONOGRAPH DRUG	M013	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
66715-9819_e5bf5e09-7d43-6314-e053-2a95a90a2325	66715-9819	HUMAN OTC DRUG	Ibuprofen		Ibuprofen tablet, film-coated	TABLET, FILM COATED	ORAL	20140912		ANDA	ANDA075010	Lil' Drug Store Products, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66715-9822_07db539f-ac55-7227-e063-6294a90afbaa	66715-9822	HUMAN OTC DRUG	Pepcid Complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide Chewable Tablet	TABLET, CHEWABLE	ORAL	20200717		NDA	NDA020958	Lil' Drug Store Products, Inc.	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
66715-9831_f92582f5-c810-a976-e053-6394a90a0f3f	66715-9831	HUMAN OTC DRUG	Alka-Seltzer Plus Cold and Flu		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide tablet	TABLET, EFFERVESCENT	ORAL	20220425		OTC MONOGRAPH FINAL	part341	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-9859_ef2f9f8f-6292-ae09-e053-2995a90a1a30	66715-9859	HUMAN OTC DRUG	Lil Drug Store Anti-Diarrheal		Loperamide Hydrochloride	TABLET	ORAL	20120914		ANDA	ANDA074091	Lil' Drug Store Products, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
66715-9899_0c92744b-a2ac-3402-e063-6294a90aa674	66715-9899	HUMAN OTC DRUG	NoDoz Alertness Aid		Caffeine tablet, film-coated	TABLET, FILM COATED	ORAL	20220102		OTC MONOGRAPH DRUG	M011	Lil' Drug Store Products, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
66715-9904_065cdc43-bf9c-9976-e063-6294a90a10cb	66715-9904	HUMAN OTC DRUG	DayQuil Severe Plus VapoCOOL Cold And Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20190501		OTC MONOGRAPH FINAL	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66715-9905_06be9e28-b6c3-a4e4-e063-6294a90a3400	66715-9905	HUMAN OTC DRUG	NyQuil Severe Plus VapoCOOL Cold and Flu		Acetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide	TABLET, COATED	ORAL	20190501		OTC MONOGRAPH DRUG	M012	Lil' Drug Store Products, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
66733-948_998a1220-14b4-413f-8d3f-51bfeec3cd73	66733-948	HUMAN PRESCRIPTION DRUG	ERBITUX		cetuximab	SOLUTION	INTRAVENOUS	20040212		BLA	BLA125084	ImClone LLC	CETUXIMAB	2	mg/mL	Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]		N	20241231
66733-958_998a1220-14b4-413f-8d3f-51bfeec3cd73	66733-958	HUMAN PRESCRIPTION DRUG	ERBITUX		cetuximab	SOLUTION	INTRAVENOUS	20071002		BLA	BLA125084	ImClone LLC	CETUXIMAB	2	mg/mL	Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]		N	20241231
66738-020_c8bff895-108f-46af-b106-f70ec4509533	66738-020	HUMAN OTC DRUG	Double-Duty Face Moisturizer		mositurizing sunscreen	LOTION	TOPICAL	20090529		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE	2.2; 7.5	g/1000g; g/1000g			N	20241231
66738-022_9c12d420-aecb-43b3-af54-3c8a7af5fc94	66738-022	HUMAN OTC DRUG	Jack Black Bump Fix		Salicylic Acid	LIQUID	TOPICAL	20200909		OTC MONOGRAPH DRUG	M006	Jack Black, L.L.C.	SALICYLIC ACID	20	g/1000g			N	20241231
66738-029_cf05b2c8-5985-4834-a1e3-b339c0ae5793	66738-029	HUMAN OTC DRUG	Intense Therapy Lip Balm Asian Pear		sunscreen skin protectant lip balm	OINTMENT	TOPICAL	20130730		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-030_75af8be3-1e72-4c1f-b10c-8d1facfb6628	66738-030	HUMAN OTC DRUG	Intense Therapy Lip Balm SPF25, Shea Butter and Vitamin E		Lip Balm SPF25	OINTMENT	TOPICAL	20110810		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	3; 7.5; 40.2	g/1000g; g/1000g; g/1000g			N	20241231
66738-031_75c7c213-d8c8-4f49-a042-5cdea941d0b4	66738-031	HUMAN OTC DRUG	Intense Therapy Lip Balm Black Cherry		sunscreen skin protectant lip balm	OINTMENT	TOPICAL	20130730		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-034_bb568b1c-deca-4141-ad02-45a8a256d6a9	66738-034	HUMAN OTC DRUG	Intense Therapy Lip Balm Mango and Mandarin		Sunscreen Skin Protectant Lip Balm	OINTMENT	TOPICAL	20110803		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-045_63d27098-2ac8-4f7b-9df2-b8a5f7a68b81	66738-045	HUMAN OTC DRUG	Intense Therapy Lip Balm Basil Lemon		sunscreen skin protectant lip balm	OINTMENT	TOPICAL	20180608		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-046_ea521310-870c-41c1-bbd7-650a0096bfc2	66738-046	HUMAN OTC DRUG	Intense Therapy Lip Balm Pineapple Mint		sunscreen skin protectant lip balm	OINTMENT	TOPICAL	20180621		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-047_8f58cbf0-d584-4ee2-adc2-688a250a5cb4	66738-047	HUMAN OTC DRUG	Intense Therapy Lip Balm Cucumber Lime		sunscreen skin protectant lip balm	OINTMENT	TOPICAL	20180605		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-048_9c5ac490-977d-432f-be3b-7d71038e649c	66738-048	HUMAN OTC DRUG	Intense Therapy Lip Balm Winter Melon		sunscreen skin protectant lip balm	OINTMENT	TOPICAL	20180627		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-051_eb3fa6f7-d149-260a-e053-2995a90a9084	66738-051	HUMAN OTC DRUG	Fieldtrip - Whatever the Weather Daily Moisturizer Zinc Oxide Sunscreen - SPF 30		Zinc Oxide	LOTION	TOPICAL	20230102		OTC MONOGRAPH FINAL	M020	Jack Black L.L.C	ZINC OXIDE	17.8	g/100mL			N	20241231
66738-063_602059ee-d695-4ff8-a592-3d25ae7900b3	66738-063	HUMAN OTC DRUG	Jack Black Intensive Therapy Lip Balm Mango Chili Lime		avobenzone, octinoxate lip balm sunscreen	OINTMENT	TOPICAL	20200803		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-064_1d232f71-afd7-462e-9bcf-f459c6f5b014	66738-064	HUMAN OTC DRUG	Jack Black Intense Therapy Lip Balm Vanilla Bourbon		avobenzone, octinoxate lip balm sunscreen	OINTMENT	TOPICAL	20200803		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-065_dccb6bb6-4b3a-444c-8d47-c04dcfb6765a	66738-065	HUMAN OTC DRUG	Jack Black Intense Therapy Lip Balm Passion Fruit		avobenzone, octinoxate lip balm sunscreen	OINTMENT	TOPICAL	20200803		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/100g; g/100g; g/100g			N	20241231
66738-101_d4b682c6-7465-3990-e053-2995a90aeb3f	66738-101	HUMAN OTC DRUG	JACK BLACK PERFORMANCE REMEDY DRAGON ICE		MENTHOL	CREAM	TOPICAL	20190713		OTC MONOGRAPH NOT FINAL	part348	JACK BLACK LLC	MENTHOL	2.2	g/100g			N	20241231
66738-300_fae13c3b-c2a9-474d-861f-71135f60de46	66738-300	HUMAN OTC DRUG	Jack Black Intense Lip Therapy SPF25, Natural Mint and Shea Butter		Lip Balm Sunscreen	OINTMENT	TOPICAL	20090609		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	3; 7.5; 40.2	g/1000g; g/1000g; g/1000g			N	20241231
66738-301_bd30ef84-bae1-4a49-ab71-9315f0a41777	66738-301	HUMAN OTC DRUG	Jack Black Intense Therapy Lip Balm SPF25, Grapefruit and Ginger		Lip Balm Sunscreen	OINTMENT	TOPICAL	20110318		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	3; 7.5; 40.2	g/1000g; g/1000g; g/1000g			N	20241231
66738-302_50120a9a-c51f-4c33-9784-e0c0852c9c69	66738-302	HUMAN OTC DRUG	Jack Black Lavender Lip Balm 0.25oz		Lip Balm Sunscreen	OINTMENT	TOPICAL	20210303		OTC MONOGRAPH DRUG	M020	Jack Black, L.L.C.	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 402	g/1000g; g/1000g; g/1000g			N	20241231
66738-304_9f37269f-7312-4ff5-afe6-29ef07eb23e0	66738-304	HUMAN OTC DRUG	Jack Black Sun Guard Sunscreen SPF45		Sunscreen	LOTION	TOPICAL	20100209		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	OCTINOXATE; OCTISALATE; ZINC OXIDE	7.5; 3; 8	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66738-309_bd90d095-a1ac-4e2d-8f19-41aeb8d7e114	66738-309	HUMAN OTC DRUG	Jack Black Intense Lip Therapy SPF25, Black Tea and Blackberry		Lip Balm Sunscreen	OINTMENT	TOPICAL	20100827		OTC MONOGRAPH DRUG	M20	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	3; 7.5; 40.2	g/1000g; g/1000g; g/1000g			N	20241231
66738-310_14f6b6ad-22a5-471a-b5dd-5eda8b32c820	66738-310	HUMAN OTC DRUG	Jack Black Intense Thearpy Lip Balm SPF25, Lemon and Shea Butter		Lip Balm Sunscreen	OINTMENT	TOPICAL	20090924		OTC MONOGRAPH DRUG	M020	Jack Black, LLC	AVOBENZONE; OCTINOXATE; PETROLATUM	3; 7.5; 40.2	g/1000g; g/1000g; g/1000g			N	20241231
66738-434_ec94be9c-4ee2-8854-e053-2995a90aeee8	66738-434	HUMAN OTC DRUG	Jack Black Balancing Foam Cleanser		Salicylic Acid	GEL	TOPICAL	20210212		OTC MONOGRAPH FINAL	part358H	Jack Black LLC	SALICYLIC ACID	.5	g/100mL			N	20241231
66738-436_ec94bb45-f4fd-4c50-e053-2a95a90ac467	66738-436	HUMAN OTC DRUG	Jack Black Clearing Spot Treatment		Sulfur	GEL	TOPICAL	20210212		OTC MONOGRAPH FINAL	M006	Jack Black LLC	SULFUR	.5	g/100g			N	20241231
66738-701_c9b32a26-aa8d-769e-e053-2a95a90a4694	66738-701	HUMAN OTC DRUG	Pit Boss Antiperspirant and Deodorant		Antiperspirant/Deodorant	STICK	TOPICAL	20121206		OTC MONOGRAPH FINAL	part350	Jack Black L.L.C.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	25	g/100g			N	20241231
66754-001_0760b982-d73e-f9f2-e063-6394a90a3ac8	66754-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19800101		NDA	NDA205712	Eureka Oxygen Company	OXYGEN	990	mL/L			N	20241231
66758-050_5e285ddf-60dd-40b1-be0d-9ada43c3fe51	66758-050	HUMAN PRESCRIPTION DRUG	Docetaxel		docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20110629		NDA	NDA201525	Sandoz Inc.	DOCETAXEL	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
66758-145_5ccb77f9-d47b-4381-ad5c-5b92524e1c4a	66758-145	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Sandoz Inc	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
66758-146_5ccb77f9-d47b-4381-ad5c-5b92524e1c4a	66758-146	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Sandoz Inc	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
66758-147_5ccb77f9-d47b-4381-ad5c-5b92524e1c4a	66758-147	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Sandoz Inc	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
66758-148_5ccb77f9-d47b-4381-ad5c-5b92524e1c4a	66758-148	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Sandoz Inc	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
66758-149_5ccb77f9-d47b-4381-ad5c-5b92524e1c4a	66758-149	HUMAN PRESCRIPTION DRUG	Vivelle-Dot		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	19990108		NDA	NDA020538	Sandoz Inc	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
66758-950_c223f766-c25c-45b2-b1ba-4bd5bac0da70	66758-950	HUMAN PRESCRIPTION DRUG	Docetaxel		docetaxel	INJECTION, SOLUTION	INTRAVENOUS	20150722		NDA	NDA201525	Sandoz Inc.	DOCETAXEL	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
66758-959_fe18be99-bc4e-0390-e053-6294a90a6896	66758-959	HUMAN PRESCRIPTION DRUG	Proventil HFA		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20210504	20240930	NDA	NDA020503	Sandoz	ALBUTEROL SULFATE	108	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	
66761-128_381afe0e-22be-4d57-a35d-d7147cdd2c10	66761-128	HUMAN OTC DRUG	Tiger Balm	Active Muscle	Methyl Salicylate and Menthol, Unspecified Form	GEL	TOPICAL	20180501		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	80; 160	mg/g; mg/g			N	20251231
66761-129_9dc8253b-ef0f-4a14-82e9-f36b8e82abe1	66761-129	HUMAN OTC DRUG	Tiger Balm	Active Muscle Rub	METHYL SALICYLATE, MENTHOL, UNSPECIFIED FORM, and CAMPHOR (SYNTHETIC)	CREAM	TOPICAL	20180501		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	30; 50; 150	mg/g; mg/g; mg/g			N	20251231
66761-308_5c452eee-2d2a-4233-9186-f3cf67abd6d4	66761-308	HUMAN OTC DRUG	Tiger Balm Red	Extra Strength	Camphor (Synthetic) and Menthol	OINTMENT	TOPICAL	20050817		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 100	mg/g; mg/g			N	20251231
66761-309_018784e5-355a-4f31-b6fb-af796de4e1a3	66761-309	HUMAN OTC DRUG	Tiger Balm White	Regular Strength	Camphor (Synthetic) and Menthol	OINTMENT	TOPICAL	20070201		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 80	mg/g; mg/g			N	20251231
66761-311_adfa0f7f-740e-485a-a820-677439811477	66761-311	HUMAN OTC DRUG	Kwan Loong		Methyl salicylate and Menthol	OIL	TOPICAL	20050901		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	160; 350	mg/mL; mg/mL			N	20251231
66761-315_86618273-736c-45d5-bfc0-c79f77277550	66761-315	HUMAN OTC DRUG	Tiger Balm	Ultra Strength	Camphor (Synthetic) and Menthol	OINTMENT	TOPICAL	20050817		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 110	mg/g; mg/g			N	20241231
66761-321_aa40eb12-23b0-4c7f-8491-7d34d3eae5fa	66761-321	HUMAN OTC DRUG	Tiger Balm		Camphor (Synthetic) and Menthol	PATCH	TOPICAL	20070115		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	230; 70	mg/1; mg/1			N	20251231
66761-322_7e558ff2-0dac-45f3-b898-05b302232043	66761-322	HUMAN OTC DRUG	Tiger Balm		Camphor (Synthetic), Menthol, and Capsicum	PATCH	TOPICAL	20011115		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); CAPSICUM; MENTHOL, UNSPECIFIED FORM	80; 16; 24	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
66761-323_5d44e6c9-fc6a-437b-a4e1-ff31401d3494	66761-323	HUMAN OTC DRUG	TIGER BALM	PAIN RELIEVING HYDROGEL	Camphor (Synthetic), Levomenthol, and Capsicum	PATCH	TOPICAL	20180101		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); CAPSICUM; LEVOMENTHOL	110; 22; 33	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
66761-324_f30f4362-a2d3-4b0c-a7b1-f338a86212cc	66761-324	HUMAN OTC DRUG	Tiger Balm Pain Relieving Hydrogel	Large	CAMPHOR (SYNTHETIC), LEVOMENTHOL, and CAPSICUM	PATCH	TOPICAL	20170101		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); CAPSICUM; LEVOMENTHOL	230; 46; 70	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
66761-327_a6dbac5d-d5bb-4182-a047-2798e105166f	66761-327	HUMAN OTC DRUG	Tiger Balm	Pain Relieving Muscle	Methyl Salicylate, Menthol, Unspecified Form, and Camphor (Synthetic)	SPRAY	TOPICAL	20180501		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	70; 160; 250	mg/mL; mg/mL; mg/mL			N	20251231
66761-329_833fd716-e346-4ae0-8b30-4a75ad46a927	66761-329	HUMAN OTC DRUG	TIGER BALM	PAIN RELIEVING	Camphor (Synthetic), Levomenthol, and Capsicum	PATCH	TOPICAL	20231201		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); CAPSICUM; LEVOMENTHOL	110; 22; 33	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
66761-333_631f7712-7c92-4944-b01a-66314fd7463a	66761-333	HUMAN OTC DRUG	Tiger Balm		Methyl Salicylate and Menthol	LINIMENT	TOPICAL	20051208		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	148.8; 260.4	mg/mL; mg/mL			N	20251231
66761-341_77314b74-a8cb-47cb-962d-90d5b4f971d2	66761-341	HUMAN OTC DRUG	Tiger Balm	Neck and Shoulder Rub	Camphor (Synthetic) and Menthol	CREAM	TOPICAL	20081024		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	11; 10	mg/g; mg/g			N	20251231
66761-354_f7e195a0-bf3e-403d-9bf1-c3a9c0cfd143	66761-354	HUMAN OTC DRUG	TIGER Balm	PAIN RELIEVING HYDROGEL	Camphor (Synthetic), Levomenthol, and Capsicum	PATCH	TOPICAL	20210301		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); CAPSICUM; LEVOMENTHOL	160; 32; 48	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20251231
66761-422_7cc74c6b-31f1-4951-8d09-3662089c2ddf	66761-422	HUMAN OTC DRUG	Tiger Balm	Arthritis Rub	Camphor (Synthetic) and Menthol, Unspecified Form	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M017	Haw Par Healthcare Ltd.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 110	mg/mL; mg/mL			N	20251231
66794-011_f3a5781c-8f04-2acb-e053-2995a90ad0a0	66794-011	HUMAN PRESCRIPTION DRUG	Terrell		Isoflurane	LIQUID	RESPIRATORY (INHALATION)	20100228		ANDA	ANDA074416	Piramal Critical Care Inc	ISOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-012_ef1386ae-152b-95cc-e053-2995a90a3053	66794-012	HUMAN PRESCRIPTION DRUG	Sojourn		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20100413		ANDA	ANDA077867	Piramal Critical Care Inc	SEVOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-015_0d19abbe-502a-6b5a-e063-6394a90a02c6	66794-015	HUMAN PRESCRIPTION DRUG	Sevoflurane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20110715		ANDA	ANDA077867	Piramal Critical Care Inc	SEVOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-017_f0791593-45bd-c1ef-e053-2a95a90a046e	66794-017	HUMAN PRESCRIPTION DRUG	Isoflurane		Isoflurane	LIQUID	RESPIRATORY (INHALATION)	20111007		ANDA	ANDA074502	Piramal Critical Care, Inc.	ISOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-019_f079e401-ed43-237a-e053-2995a90a1869	66794-019	HUMAN PRESCRIPTION DRUG	Terrell		Isoflurane	LIQUID	RESPIRATORY (INHALATION)	20120321		ANDA	ANDA074502	Piramal Critical Care Inc	ISOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-020_f4cf92df-3e7d-a47c-e053-2a95a90a38d7	66794-020	HUMAN PRESCRIPTION DRUG	Isoflurane		Isoflurane	LIQUID	RESPIRATORY (INHALATION)	20131113		ANDA	ANDA074416	Piramal Critical Care Inc	ISOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-021_f5bd88e1-5b8b-2924-e053-2a95a90a36de	66794-021	HUMAN PRESCRIPTION DRUG	Desflurane		Desflurane	LIQUID	RESPIRATORY (INHALATION)	20230214		UNAPPROVED DRUG OTHER		Piramal Critical Care Inc	DESFLURANE	250	mL/250mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-022_f0f5ef09-86e5-bc8d-e053-2a95a90a4559	66794-022	HUMAN PRESCRIPTION DRUG	Sevoflurane		Sevoflurane	LIQUID	RESPIRATORY (INHALATION)	20201001		ANDA	ANDA077867	Piramal Critical Care Inc	SEVOFLURANE	1	mL/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
66794-151_f0943592-c2ad-4493-e053-2a95a90ac654	66794-151	HUMAN PRESCRIPTION DRUG	Gablofen		Baclofen Injection	INJECTION, SOLUTION	INTRATHECAL	20170401		NDA	NDA022462	Piramal Critical Care Inc	BACLOFEN	50	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
66794-155_f0943592-c2ad-4493-e053-2a95a90ac654	66794-155	HUMAN PRESCRIPTION DRUG	Gablofen		Baclofen Injection	INJECTION, SOLUTION	INTRATHECAL	20170401		NDA	NDA022462	Piramal Critical Care Inc	BACLOFEN	500	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
66794-156_f0943592-c2ad-4493-e053-2a95a90ac654	66794-156	HUMAN PRESCRIPTION DRUG	Gablofen		Baclofen Injection	INJECTION, SOLUTION	INTRATHECAL	20170401		NDA	NDA022462	Piramal Critical Care Inc	BACLOFEN	1000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
66794-157_f0943592-c2ad-4493-e053-2a95a90ac654	66794-157	HUMAN PRESCRIPTION DRUG	Gablofen		Baclofen Injection	INJECTION, SOLUTION	INTRATHECAL	20170401		NDA	NDA022462	Piramal Critical Care Inc	BACLOFEN	2000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
66794-160_0d7e38ea-9993-52b5-e063-6394a90a7a95	66794-160	HUMAN PRESCRIPTION DRUG	MITIGO		Morphine Sulfate	INJECTION	EPIDURAL; INTRATHECAL	20190225		ANDA	ANDA204393	Piramal Critical Care, Inc.	MORPHINE SULFATE	200	mg/20mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66794-162_0d7e38ea-9993-52b5-e063-6394a90a7a95	66794-162	HUMAN PRESCRIPTION DRUG	MITIGO		Morphine Sulfate	INJECTION	EPIDURAL; INTRATHECAL	20181015		ANDA	ANDA204393	Piramal Critical Care, Inc.	MORPHINE SULFATE	500	mg/20mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
66794-200_0d19777c-1645-1abb-e063-6294a90acab8	66794-200	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	INJECTION	INTRAVENOUS	20221001		ANDA	ANDA206163	Piramal Critical Care, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
66794-201_0d19777c-1645-1abb-e063-6294a90acab8	66794-201	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	INJECTION	INTRAVENOUS	20221001		ANDA	ANDA206163	Piramal Critical Care, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	500	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
66794-202_0d08c1e8-2cc3-33a5-e063-6394a90aa286	66794-202	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190711		ANDA	ANDA210842	Piramal Critical Care Inc	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
66794-203_0d08c1e8-2cc3-33a5-e063-6394a90aa286	66794-203	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190711		ANDA	ANDA210842	Piramal Critical Care Inc	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
66794-204_0d08c1e8-2cc3-33a5-e063-6394a90aa286	66794-204	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190711		ANDA	ANDA210842	Piramal Critical Care Inc	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
66794-205_0d08c1e8-2cc3-33a5-e063-6394a90aa286	66794-205	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190711		ANDA	ANDA210842	Piramal Critical Care Inc	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
66794-215_f6fe7ec1-1a60-3b3d-e053-6394a90ab674	66794-215	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190808		ANDA	ANDA091117	Piramal Critical Care Inc	CEFTRIAXONE SODIUM	10	g/100mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
66794-219_f0cdd5f3-2b03-e30c-e053-2a95a90ab2de	66794-219	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	INJECTION, SOLUTION	INTRAVENOUS	20191218		ANDA	ANDA207001	Piramal Critical Care Inc	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
66794-228_0d11684c-b55e-2ff5-e063-6394a90aec7b	66794-228	HUMAN PRESCRIPTION DRUG	Rocuronium		Rocuronium	INJECTION, SOLUTION	INTRAVENOUS	20200720		ANDA	ANDA210437	Piramal Critical Care Inc	ROCURONIUM BROMIDE	50	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
66794-229_0d11684c-b55e-2ff5-e063-6394a90aec7b	66794-229	HUMAN PRESCRIPTION DRUG	Rocuronium		Rocuronium	INJECTION, SOLUTION	INTRAVENOUS	20200720		ANDA	ANDA210437	Piramal Critical Care Inc	ROCURONIUM BROMIDE	100	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
66794-230_0d077391-30ee-4497-e063-6294a90a5ad9	66794-230	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		Dexmedetomidine	INJECTION, SOLUTION	INTRAVENOUS	20210119		ANDA	ANDA202126	Piramal Critical Care Inc	DEXMEDETOMIDINE HYDROCHLORIDE	200	ug/2mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
66794-232_0d0552a9-e98f-02d4-e063-6294a90aeaf7	66794-232	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210120		ANDA	ANDA214246	Piramal Critical Care Inc	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
66794-233_0d08873b-53a6-29e1-e063-6394a90ac159	66794-233	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		Dexmedetomidine	INJECTION, SOLUTION	INTRAVENOUS	20210501		ANDA	ANDA202126	Piramal Critical Care Inc	DEXMEDETOMIDINE HYDROCHLORIDE	200	ug/2mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
66794-234_0d77f6f4-3371-fcef-e063-6394a90a4a9a	66794-234	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION	INTRAVENOUS	20210401		ANDA	ANDA209307	Piramal Critical Care Inc	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
66794-235_0d77f6f4-3371-fcef-e063-6394a90a4a9a	66794-235	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION	INTRAVENOUS	20210401		ANDA	ANDA209307	Piramal Critical Care Inc	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
66794-236_0d087679-6336-6080-e063-6294a90a806c	66794-236	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	INJECTION	INTRAVENOUS	20211201		ANDA	ANDA207001	Piramal Critical Care Inc.	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
66794-237_fd672959-0150-8300-e053-6394a90a5ec5	66794-237	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230605		ANDA	ANDA215583	Piramal Critical Care Inc	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
66794-238_e26b89c7-8f28-0c94-e053-2a95a90a6113	66794-238	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		Dexmedetomidine	INJECTION, SOLUTION	INTRAVENOUS	20200424		ANDA	ANDA214794	Piramal Critical Care Inc	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
66794-239_0d09c61f-7bf9-1965-e063-6294a90a08c7	66794-239	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20220620		ANDA	ANDA216249	Piramal Critical Care Inc.	ZINC SULFATE	25	mg/5mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66794-240_0d09c61f-7bf9-1965-e063-6294a90a08c7	66794-240	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20220620		ANDA	ANDA216249	Piramal Critical Care Inc.	ZINC SULFATE	30	mg/10mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66794-241_f48ec7a8-42a6-88be-e053-2995a90ac849	66794-241	HUMAN PRESCRIPTION DRUG	ampicillin and sulbactam		ampicillin and sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230101		ANDA	ANDA090579	Piramal Critical Care Inc	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
66794-242_f48ec7a8-42a6-88be-e053-2995a90ac849	66794-242	HUMAN PRESCRIPTION DRUG	ampicillin and sulbactam		ampicillin and sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230101		ANDA	ANDA090579	Piramal Critical Care Inc	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
66794-243_f48ec7a8-42b6-88be-e053-2995a90ac849	66794-243	HUMAN PRESCRIPTION DRUG	ampicillin and sulbactam		ampicillin and sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190520		ANDA	ANDA090578	Piramal Critical Care Inc	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
66794-245_02781af1-0d38-3c49-e063-6294a90a13c4	66794-245	HUMAN PRESCRIPTION DRUG	Cisatracurium besylate		Cisatracurium besylate	INJECTION	INTRAVENOUS	20220801		ANDA	ANDA215516	PIRAMAL CRITICAL CARE INC	CISATRACURIUM BESYLATE	10	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
66794-246_02781af1-0d38-3c49-e063-6294a90a13c4	66794-246	HUMAN PRESCRIPTION DRUG	Cisatracurium besylate		Cisatracurium besylate	INJECTION	INTRAVENOUS	20220801		ANDA	ANDA215516	PIRAMAL CRITICAL CARE INC	CISATRACURIUM BESYLATE	200	mg/20mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
66794-255_0c8cbd54-2530-b0b5-e063-6394a90a4751	66794-255	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20231130		ANDA	ANDA216249	Piramal Critical Care Inc.	ZINC SULFATE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66794-258_0cca9f84-b848-98b8-e063-6294a90af081	66794-258	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM	I.V.	PANTOPRAZOLE SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20231010		ANDA	ANDA214680	Piramal Critical Care	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
66800-0000_f4eb1789-c4c0-0600-e053-2995a90a3568	66800-0000	HUMAN OTC DRUG	Eucerin Advanced Hydration Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-0002_f63d16de-093a-0eb4-e053-2a95a90a5baf	66800-0002	HUMAN OTC DRUG	Coppertone Sport Mineral Sunscreen SPF 50		Zinc oxide	LOTION	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	240.8	mg/mL			N	20241231
66800-0003_0e83192e-0cd9-6cf7-e063-6294a90a38d0	66800-0003	HUMAN OTC DRUG	Coppertone Glow Suncreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20201102		OTC MONOGRAPH DRUG	M020	Beiersdord Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 45; 80	mg/g; mg/g; mg/g; mg/g			N	20251231
66800-0004_0e83b571-b417-b964-e063-6294a90a7abf	66800-0004	HUMAN OTC DRUG	Coppertone Glow Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	AEROSOL, SPRAY	TOPICAL	20201102		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 45; 90	mg/g; mg/g; mg/g; mg/g			N	20251231
66800-0026_f6291552-c4a8-5cee-e053-2995a90a692d	66800-0026	HUMAN OTC DRUG	Coppertone Complete Sunscreen SPF 30		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 8%	LOTION	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-0030_f6290f53-490f-ce93-e053-2a95a90aa1cb	66800-0030	HUMAN OTC DRUG	Coppertone Complete Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	LOTION	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-0079_f4ec4978-117a-7de1-e053-2a95a90a97ac	66800-0079	HUMAN OTC DRUG	Coppertone Protect and Tan Sunscreen SPF 45		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20211103		OTC MONOGRAPH NOT FINAL	part352	Beiersdort Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 100	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-0082_f4ec0853-86ce-b8ef-e053-2a95a90a8625	66800-0082	HUMAN OTC DRUG	Coppertone Protect and Tan SPF 30		Avobenzone 3%, Homosalate 14%, Octisalate 4.5%, Octocrylene 9%	LOTION	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 14; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-0100_f6508560-008d-0edc-e053-2a95a90a2c3e	66800-0100	HUMAN OTC DRUG	Coppertone Complete Sunscreen SPF 30		Avobenzone 2%, Homosalate 8%, Octisalate 4.5%, Octocrylene 7%	AEROSOL, SPRAY	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 8; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-0104_f62896ed-09ab-2a0d-e053-2995a90acdf6	66800-0104	HUMAN OTC DRUG	Coppertone Complete Sunscreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	AEROSOL, SPRAY	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-1000_f60649bc-18f9-515a-e053-2995a90a5c4f	66800-1000	HUMAN OTC DRUG	Eucerin Sensitive Mineral SPF 50 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20211103		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	24	g/100g			N	20241231
66800-1093_f3e3f4c6-2cba-7b17-e053-2a95a90a3854	66800-1093	HUMAN OTC DRUG	Coppertone Every Tone Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-1094_0dbb33de-3148-bbab-e063-6394a90a4c00	66800-1094	HUMAN OTC DRUG	Coppertone EveryTone Face Sunscreen SPF 55		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20231101		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2000_f303c2b7-d80d-8289-e053-2995a90ab7ee	66800-2000	HUMAN OTC DRUG	Eucerin Advanced Hydration SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211103		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2074_f6289307-aadb-54a8-e053-2a95a90a051c	66800-2074	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 15		Avobenzone 2%, Octisalate 4.5%, Octocrylene 7%	AEROSOL, SPRAY	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2; 4.5; 7	g/100g; g/100g; g/100g			N	20241231
66800-2350_f5732d5c-02c3-7bc0-e053-2995a90a969f	66800-2350	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	AEROSOL, SPRAY	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2351_f572c69a-5bb3-0467-e053-2995a90a60fe	66800-2351	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 30		Avobenzone 2%, Homosalate 8%, Octisalate 4.5%, Octocrylene 7%	AEROSOL, SPRAY	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 8; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2391_f4eab506-f9a3-1ace-e053-2995a90a8821	66800-2391	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 70		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%, Oxybenzone 6%	AEROSOL	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 15; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2450_f4d355cb-89b7-3f40-e053-2a95a90a907e	66800-2450	HUMAN OTC DRUG	Coppertone Kids Tear Free Mineral Sunscreen SPF 50		Octinoxate 7.5%, Octisalate 5%, Zinc Oxide 14.5%	LOTION	TOPICAL	20211004		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	OCTINOXATE; OCTISALATE; ZINC OXIDE	7.5; 5; 14.5	g/100g; g/100g; g/100g			N	20241231
66800-2461_f4bf98a3-6853-ea90-e053-2995a90a7510	66800-2461	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 70		Avobenzone 3%, Homosalate 13%, Octisalate 5%, Octocrylene 10%, Oxybenzone 6%	LOTION	TOPICAL	20001102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 13; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2462_f63d681b-b5a1-f709-e053-2a95a90ad120	66800-2462	HUMAN OTC DRUG	Coppertone Kids Sunscreen SPF 70		Avobenzone 3%, Homosalate 13%, Octisalate 5%, Octocrylene 10%, Oxybenzone 6%	LOTION	TOPICAL	20210104		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 13; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2465_f63d24dc-06f5-3a4b-e053-2995a90a5f96	66800-2465	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 100		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%, Oxybenzone 6%	LOTION	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 15; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2495_f4d36c95-82eb-e065-e053-2a95a90a6f0a	66800-2495	HUMAN OTC DRUG	Coppertone Kids Sport Sunscreen SPF 100		Avobenzone 3%, Homosalate 15%, Octinoxate 2% Octisalate 5%, Octocrylene 10%, Oxybenzone 6%	SPRAY	TOPICAL	20210208		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 15; 2; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2496_f651a2ad-f97e-3b99-e053-2a95a90aef20	66800-2496	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 100		Avobenzone 3%, Homosalate 15%, Octinoxate 2% Octisalate 5%, Octocrylene 10%, Oxybenzone 6%	AEROSOL, SPRAY	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 15; 2; 5; 10; 6	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2669_f62960e9-b210-98c2-e053-2995a90a93c3	66800-2669	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 30		Avobenzone 3%, Homosalate 8%, Octisalate 4.5%, Octocrylene 6%	LOTION	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-2744_08147940-0e8c-c894-e063-6394a90af8ac	66800-2744	HUMAN OTC DRUG	Coppertone Pure and Simple Kids Suncreen SPF 50		Zinc oxide 24.08%	LOTION	TOPICAL	20231026		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE	24.08	g/100g			N	20241231
66800-2871_092b50bc-5f9f-80b0-e063-6394a90a4b95	66800-2871	HUMAN OTC DRUG	Coppertone Pure and Simple Baby Sunscreen SPF 50		Zinc oxide 24.08%	LOTION	TOPICAL	20231206		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	ZINC OXIDE	24.08	g/100g			N	20241231
66800-2880_0806bdb9-9620-3146-e063-6294a90a4625	66800-2880	HUMAN OTC DRUG	Coppertone Waterbabies Pure and Simple Sunscreen SPF 50		Zinc Oxide 24.08%	SPRAY	TOPICAL	20231103		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	ZINC OXIDE	24.08	g/100g			N	20241231
66800-2881_088b7152-d3d2-9e74-e063-6394a90a4152	66800-2881	HUMAN OTC DRUG	Coppertone Pure and Simple Baby Sunscreen SPF 50		Zinc Oxide 24.08%	AEROSOL, SPRAY	TOPICAL	20240108		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	ZINC OXIDE	24.08	g/100g			N	20241231
66800-2882_09a97e3f-f6dd-eaa7-e063-6294a90ad274	66800-2882	HUMAN OTC DRUG	Coppertone Pure and Simple Kids Sunscreen SPF 50		Zinc Oxide (24.08%)	SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	ZINC OXIDE	24.08	g/100g			N	20241231
66800-2883_09a88116-463c-2b77-e063-6294a90ae769	66800-2883	HUMAN OTC DRUG	Coppertone Pure and Simple Sunscreen SPF 50		Zinc oxide 24.08%	LOTION	TOPICAL	20231106		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	ZINC OXIDE	24.08	g/100g			N	20241231
66800-3000_0e83d372-e2cb-8bf3-e063-6394a90a885b	66800-3000	HUMAN OTC DRUG	Eucerin Advance Hydration Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211201		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 4.5; 8	g/100g; g/100g; g/100g; g/100g			N	20251231
66800-3026_f41e09bf-407e-65a4-e053-2a95a90a2436	66800-3026	HUMAN OTC DRUG	Coppertone Limited Edition Sunscreen SPF 30		Avobenzone 2%, Homosalate 8%, Octisalate 4.5%, Octocrylene 7%	AEROSOL, SPRAY	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 8; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-3074_f4eab0bd-07c8-093f-e053-2995a90a4a09	66800-3074	HUMAN OTC DRUG	Coppertone Sport SPF 15 Sunscreen		Avobenzone 2%, Octisalate 4.5%, Octocrylene 7%	AEROSOL	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2; 4.5; 7	g/100g; g/100g; g/100g			N	20241231
66800-3091_f63d24dc-06f6-3a4b-e053-2995a90a5f96	66800-3091	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPL 15		Avobenzone 2%, Homosalate 5%, Octisalate 4.5%, Octocrylene 3%	LOTION	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5; 4.5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-3350_0a5a40ff-a015-3995-e063-6394a90a11e6	66800-3350	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 50		(To Deliver) Avobenzone 3%, Homosalate 10%,Octisalate 5%, Octocrylene 5%	SPRAY	TOPICAL	20231117		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-3351_0a5a5370-ec70-42a7-e063-6394a90ac37c	66800-3351	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 30		(To Deliver) Avobenzone 2%, Homosalate 8%, Octisalate 4.5%, Octocrylene 7%	SPRAY	TOPICAL	20231117		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 8; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-3641_f4d2e84b-f7b5-3fbf-e053-2a95a90a04e7	66800-3641	HUMAN OTC DRUG	Coppertone Defend and Clear		Octinoxate, Octisalate, Zinc Oxide	LOTION	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	OCTINOXATE; OCTISALATE; ZINC OXIDE	7.5; 4.5; 9.7	g/100g; g/100g; g/100g			N	20241231
66800-3900_f6515d62-580d-7055-e053-2a95a90aa301	66800-3900	HUMAN OTC DRUG	Coppertone Oil Free Sunscreen SPF 30		Avobenzone 3%, Homosalate 8%, Octisalate 4.5%, Octocrylene 6%	LOTION	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-3993_f6527a03-41ea-5990-e053-2995a90a4973	66800-3993	HUMAN OTC DRUG	Coppertone Pure and Simple Sunscreen SPF 50		Zinc Oxide 24.08%	LOTION	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	24.08	g/100g			N	20241231
66800-4000_f67c3f80-dff4-f18c-e053-2995a90ab6c3	66800-4000	HUMAN OTC DRUG	Eucerin Baby Sensitive Mineral SPF 50 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20211103		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	24	g/100g			N	20241231
66800-4026_f411f6be-3d2e-6873-e053-2a95a90a5929	66800-4026	HUMAN OTC DRUG	Coppertone Kids Roll-On Sunscreen SPF 50		Zinc Oxide 24.08%	LOTION	SUPRACHOROIDAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	24.08	g/100g			N	20241231
66800-4079_f62adce8-ddc8-465f-e053-2a95a90ac209	66800-4079	HUMAN OTC DRUG	Coppertone Limited Edition Sunscreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 4.5%, Octocrylene 8%	LOTION	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 4.5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4080_f62adce8-ddc7-465f-e053-2a95a90ac209	66800-4080	HUMAN OTC DRUG	Coppertone Limited Edition Sunscreen SPF 30		Avobenzone 3%, Homosalate 8%, Octisalate 4.5%, Octocrylene 6%	LOTION	TOPICAL	20201109		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4082_f65135bf-bdca-2abf-e053-2995a90a7116	66800-4082	HUMAN OTC DRUG	Coppertone Tanning Sunscreen SPF 15		Avobenzone 2%, Octisalate 4.5%, Octocrylene 7%	AEROSOL	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2; 4.5; 7	g/100g; g/100g; g/100g			N	20241231
66800-4086_f4eb2f52-17ac-6dc7-e053-2995a90a4c79	66800-4086	HUMAN OTC DRUG	Coppertone Tanning Sunscreen SPF 8		Avobenzone 2%, Homosalate 5%, Octisalate 4.5%, Octocrylene 3%	LOTION	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5; 4.5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4087_f4ebbbad-03e1-0568-e053-2a95a90ab201	66800-4087	HUMAN OTC DRUG	Coppertone Tanning Sunscreen SPF 15		Avobenzone 2%, Homosalate 5%, Octisalate 4.5%, Octocrylene 3%	LOTION	TOPICAL	20211220		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5; 4.5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4094_f63d072b-a41f-cc5a-e053-2995a90a2975	66800-4094	HUMAN OTC DRUG	Coppertone Oil Free SPF 50 Sunscreen		Avobenzone 3%, Homosalate 10%, Octisalate 4.5%, Octocrylene 8%	LOTION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 4.5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4107_f629632b-92cc-03c3-e053-2995a90a0781	66800-4107	HUMAN OTC DRUG	Coppertone Sunscreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 4.5%, Octocrylene 8%	LOTION	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 4.5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4109_f45a525f-af1c-46cb-e053-2a95a90a7c65	66800-4109	HUMAN OTC DRUG	Coppertone Waterbabies Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	LOTION	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4115_0e846398-b2ee-2ab2-e063-6294a90a310c	66800-4115	HUMAN OTC DRUG	Coppertone Sunscreen SPF 50		Zinc Oxide 20%	STICK	TOPICAL	20211101		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	ZINC OXIDE	20	g/100g			N	20251231
66800-4118_0e84b9f8-e0f0-bc06-e063-6394a90a6dad	66800-4118	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 40		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	STICK	TOPICAL	20211102		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20251231
66800-4232_f6295926-40bc-3309-e053-2a95a90a0d6f	66800-4232	HUMAN OTC DRUG	Coppertone Waterbabies Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	AEROSOL, SPRAY	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4350_f4d31fcf-19b0-dc0d-e053-2a95a90a1719	66800-4350	HUMAN OTC DRUG	Coppertone Kids Sport Sunscreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	SPRAY	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4351_f4d4b178-7caf-58f1-e053-2a95a90a9d35	66800-4351	HUMAN OTC DRUG	Coppertone Sport Sunscreen SPF 30		Avobenzone 2%, Homosalate 8%, Octisalate 4.5%, Octocrylene 7%	AEROSOL, SPRAY	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdort Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 8; 4.5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4352_f4d370db-09dc-d8ac-e053-2a95a90a6c47	66800-4352	HUMAN OTC DRUG	Coppertone Kids Sunscreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	SPRAY	TOPICAL	20201102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4353_f6520330-7e64-5768-e053-2a95a90a0a6f	66800-4353	HUMAN OTC DRUG	Coppertone Kids SPF 50 Sunscreen		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	AEROSOL, SPRAY	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4354_f4ead6c1-c174-7720-e053-2a95a90a5283	66800-4354	HUMAN OTC DRUG	Coppertone Limited Edition Sunscreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	AEROSOL, SPRAY	TOPICAL	20201104		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4355_f63d5ed6-21e1-b782-e053-2a95a90a69ff	66800-4355	HUMAN OTC DRUG	Coppertone Sport SPF 50 Sunscreen		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	AEROSOL	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part352	Beiersdort Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4356_f6522330-5921-e2c1-e053-2995a90a8fcd	66800-4356	HUMAN OTC DRUG	Coppertone Sport Suncreen SPF 50		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 5%	AEROSOL, SPRAY	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4473_0e850cbc-ba59-9974-e063-6294a90af222	66800-4473	HUMAN OTC DRUG	Coppertone Glow Hydragel SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	GEL	TOPICAL	20201102		OTC MONOGRAPH DRUG	M020	Beiersdort Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 45; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
66800-4480_0e853d0a-f978-e1b1-e063-6394a90a2389	66800-4480	HUMAN OTC DRUG	Coppertone Glow Hydragel Sunscreen SPF 30		Avobenzone 3%, Homosalate 10%, Octisalate 4.5%, Octocrylene 9%	GEL	TOPICAL	20201102		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20251231
66800-4724_f4eb7b3d-29a2-f361-e053-2995a90ab994	66800-4724	HUMAN OTC DRUG	Coppertone Sport Mineral Sunscreen SPF 50		Zinc Oxide	AEROSOL, SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	240.8	mg/g			N	20241231
66800-4744_f4d2e84b-f7b3-3fbf-e053-2a95a90a04e7	66800-4744	HUMAN OTC DRUG	Coppertone Pure and Simple Sunscreen SPF 50		Zinc Oxide 24.08%	AEROSOL, SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	240.8	mg/g			N	20241231
66800-4839_f5729c84-6a9f-53bc-e053-2995a90af4e2	66800-4839	HUMAN OTC DRUG	Coppertone Waterbabies Pure and Simple Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	LOTION	TOPICAL	20211202		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-4839_ffe5ce50-5676-5e85-e053-6394a90a9f0d	66800-4839	HUMAN OTC DRUG	Coppertone Waterbabies Pure and Simple Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	LOTION	TOPICAL	20211229		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-5000_0993e115-04c1-76fc-e063-6394a90a40bb	66800-5000	HUMAN OTC DRUG	Eucerin Age Defense SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211103		OTC MONOGRAPH DRUG	M020	Beiersdort Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-5049_07eb67e2-2b7e-4fc0-e063-6394a90a09b7	66800-5049	HUMAN OTC DRUG	Coppertone EveryTone Sunscreen SPF 50		Avobenzone 3%, Homosalate 9%, Octisalate 4.5%, Octocrylene 9%	SPRAY	TOPICAL	20231103		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-5082_0a5a35be-9e25-18dd-e063-6394a90a097f	66800-5082	HUMAN OTC DRUG	Coppertone Tanning Sunscreen SPF 15		(To Deliver) Avobenzone 2%, Octisalate 4.5%, Octocrylene 7%	AEROSOL	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2; 4.5; 7	g/100g; g/100g; g/100g			N	20251231
66800-5353_0a5a42a3-6fe5-2980-e063-6394a90a54fe	66800-5353	HUMAN OTC DRUG	Coppertone Kids Sunscreen SPF 50		(To Deliver) Avobenzone 3%, Homosalate 5%, Octisalate 10%, Octocrylene 5%	SPRAY	TOPICAL	20231130		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20251231
66800-6000_f7e282e1-44dc-4c86-e053-6394a90aaa73	66800-6000	HUMAN OTC DRUG	Eucerin Oil-Control SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-7000_f601f0a9-ef4f-2186-e053-2995a90a2d26	66800-7000	HUMAN OTC DRUG	Eucerin Sensitive Mineral Face Sunscreen SPF 35		Zinc Oxide 24%	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	ZINC OXIDE	24	g/100g			N	20241231
66800-8159_f98945b5-b081-7856-e053-6294a90a062d	66800-8159	HUMAN OTC DRUG	Coppertone Complete Sunscreen SPF 45		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-8164_f3d163b4-6775-4c2e-e053-2a95a90afd59	66800-8164	HUMAN OTC DRUG	Coppertone Oil Free and Shine Control Face Sunscreen SPF 45		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
66800-9013_0dbb3029-941c-4043-e063-6294a90a413a	66800-9013	HUMAN OTC DRUG	Coppertone Sport Face SPF 60 Plus Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20231101		OTC MONOGRAPH DRUG	M020	Beiersdorf Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
66820-0200_00efdae6-3753-95c0-e063-6394a90a4a94	66820-0200	HUMAN OTC DRUG	SEKKISEI TREATMENT BB 00		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20190301		OTC MONOGRAPH FINAL	part352	KOSE AMERICA, INC.	OCTINOXATE; ZINC OXIDE	83; 66	mg/mL; mg/mL			N	20241231
66820-0201_00efdae6-3753-95c0-e063-6394a90a4a94	66820-0201	HUMAN OTC DRUG	SEKKISEI TREATMENT BB 01		OCTINOXATE, ZINC OXIDE	CREAM	TOPICAL	20190301		OTC MONOGRAPH FINAL	part352	KOSE AMERICA, INC.	OCTINOXATE; ZINC OXIDE	83; 66	mg/mL; mg/mL			N	20241231
66820-0300_ee3c4a33-e994-da48-e053-2995a90a09cb	66820-0300	HUMAN OTC DRUG	DECORTE AQ UV PROTECTION		titanium dioxide, zinc oxide	CREAM	TOPICAL	20220301		OTC MONOGRAPH FINAL	part352	KOSE AMERICA, INC.	TITANIUM DIOXIDE; ZINC OXIDE	128.452381; 77.5	mg/mL; mg/mL			N	20241231
66824-001_075efd92-162d-d8c8-e063-6294a90a8c1a	66824-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Home Health Medical Equipment, Inc.	OXYGEN	99	L/100L			N	20241231
66843-721_02acffc0-6a55-3109-e063-6394a90a27ee	66843-721	HUMAN OTC DRUG	Scholls Wellness Company LLC	Ingrown Toenail	Sodium Sulfide	GEL	TOPICAL	20210101		OTC MONOGRAPH FINAL	part358D	Scapa Tapes North America, LLC	SODIUM SULFIDE	1	g/10g			N	20241231
66869-104_1783ecd3-0116-4ad8-9a43-25d5b2dc62e6	66869-104	HUMAN PRESCRIPTION DRUG	Livalo		pitavastatin calcium	TABLET, FILM COATED	ORAL	20190516		NDA	NDA022363	Kowa Pharmaceuticals America, Inc.	PITAVASTATIN CALCIUM	1.045	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66869-204_1783ecd3-0116-4ad8-9a43-25d5b2dc62e6	66869-204	HUMAN PRESCRIPTION DRUG	Livalo		pitavastatin calcium	TABLET, FILM COATED	ORAL	20190516		NDA	NDA022363	Kowa Pharmaceuticals America, Inc.	PITAVASTATIN CALCIUM	2.09	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66869-404_1783ecd3-0116-4ad8-9a43-25d5b2dc62e6	66869-404	HUMAN PRESCRIPTION DRUG	Livalo		pitavastatin calcium	TABLET, FILM COATED	ORAL	20190516		NDA	NDA022363	Kowa Pharmaceuticals America, Inc.	PITAVASTATIN CALCIUM	4.18	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66869-564_badd15b0-400a-4f3a-bf2d-e3d4b87b2348	66869-564	HUMAN PRESCRIPTION DRUG	SEGLENTIS		celecoxib and tramadol hydrochloride	TABLET	ORAL	20220101		NDA	NDA213426	Kowa Pharmaceuticals America, Inc.	CELECOXIB; TRAMADOL HYDROCHLORIDE	56; 44	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Full Opioid Agonists [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC]	CIV	N	20241231
66878-001_0762c090-486a-e6fb-e063-6294a90a60c2	66878-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110103		UNAPPROVED MEDICAL GAS		GC Medical Equipment, Inc.	OXYGEN	991	mL/L			N	20241231
66885-080_c2aa2ebb-f725-46ab-9488-df1ede36dc67	66885-080	HUMAN OTC DRUG	BRIGHT SOLUTIONS Foaming Antimicrobial So ap		Chloroxylenol	LIQUID	TOPICAL	20070830		OTC MONOGRAPH NOT FINAL	part333E	Kel-San, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
66885-081_456c698d-4180-40fa-9549-e8dc782283a2	66885-081	HUMAN OTC DRUG	BRIGHT SOLUTIONS Antimicrobial Foam So ap		Chloroxylenol	LIQUID	TOPICAL	20070830		OTC MONOGRAPH NOT FINAL	part333E	Kel-San, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
66885-400_e7dbf32a-2835-4c3f-b7c7-63499d1ecb3b	66885-400	HUMAN OTC DRUG	BRIGHT SOLUTIONS Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Kel-San, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66887-001_47eec3ee-092d-4fe5-bf03-ec17d5f7f8a8	66887-001	HUMAN PRESCRIPTION DRUG	Testim		testosterone	GEL	TRANSDERMAL	20021031		NDA	NDA021454	Endo Pharmaceuticals Inc.	TESTOSTERONE	50	mg/5g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
66887-003_5505cae4-b71d-45f0-ac09-413d47a4324b	66887-003	HUMAN PRESCRIPTION DRUG	XIAFLEX		collagenase clostridium histolyticum	KIT		20100222		BLA	BLA125338	Endo Pharmaceuticals Inc.						N	20241231
66887-004_a4f7de50-dce8-45ca-9be5-46f562cf1853	66887-004	HUMAN PRESCRIPTION DRUG	Testopel		testosterone	PELLET	SUBCUTANEOUS	20141031		ANDA	ANDA080911	Endo Pharmaceuticals Inc.	TESTOSTERONE	75	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
66888-050_0e7b53d3-ba74-4bbd-e063-6294a90a8394	66888-050	HUMAN OTC DRUG	HAUTE PROTECTION HIGH PROTECTION TINTED COMPACT BROAD SPECTRUM SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210316		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A.	TITANIUM DIOXIDE; ZINC OXIDE	1.42; .49	g/10g; g/10g			N	20251231
66888-051_0e7b7508-03b3-2f70-e063-6294a90acdea	66888-051	HUMAN OTC DRUG	HAUTE PROTECTION HIGH PROTECTION TINTED COMPACT BROAD SPECTRUM SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210316		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A.	TITANIUM DIOXIDE; ZINC OXIDE	1.42; .49	g/10g; g/10g			N	20251231
66888-330_0e76c75d-7b73-ab73-e063-6294a90a2876	66888-330	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-332_0e76d80a-2d13-e4c4-e063-6294a90aeac2	66888-332	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-333_0e7706c0-396e-c12a-e063-6294a90af4ea	66888-333	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-334_0e76e917-55c2-d7b3-e063-6394a90afc95	66888-334	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-335_0e7707c5-ca6b-e9fe-e063-6394a90a36e0	66888-335	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-336_0e772402-6cf4-8c75-e063-6294a90a5c45	66888-336	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-337_0e771d35-a497-ef2e-e063-6394a90ae759	66888-337	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-338_0e7705bd-1601-d906-e063-6394a90a2ee4	66888-338	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-339_0e77063c-fc3c-cee6-e063-6394a90a0d54	66888-339	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-340_fe09600f-d03e-c37c-e053-6294a90aab0f	66888-340	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH NOT FINAL	part352	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20241231
66888-341_0e7729de-1046-e578-e063-6394a90a7de6	66888-341	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-342_0e772402-6cf9-8c75-e063-6294a90a5c45	66888-342	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-343_0e772402-6cfa-8c75-e063-6294a90a5c45	66888-343	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-344_0e772402-6cfd-8c75-e063-6294a90a5c45	66888-344	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-345_0e7735ff-acf4-c569-e063-6294a90a29c0	66888-345	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-346_0e7735ff-acf5-c569-e063-6294a90a29c0	66888-346	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-347_0e7956f1-6e43-6add-e063-6394a90a4465	66888-347	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-348_0e7956f1-6e44-6add-e063-6394a90a4465	66888-348	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-349_0e7b15f8-a494-fb08-e063-6294a90aa5ec	66888-349	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-350_0e7b15f8-a495-fb08-e063-6294a90aa5ec	66888-350	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-351_0e7b15f8-a496-fb08-e063-6294a90aa5ec	66888-351	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-352_0e7aeb3b-385e-1ee3-e063-6394a90a9d2f	66888-352	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-353_0e7b2a69-4dd9-1333-e063-6294a90a494f	66888-353	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-354_0e7acbdb-10be-e0c6-e063-6294a90a9c4a	66888-354	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-355_0e7b2fef-20cd-3b11-e063-6394a90a2329	66888-355	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-356_0e7b2fef-20ce-3b11-e063-6394a90a2329	66888-356	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66888-357_0e7aeb3b-3860-1ee3-e063-6394a90a9d2f	66888-357	HUMAN OTC DRUG	Titanium Dioxide		Sunscreen	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Tecnocosmesi S.p.A	TITANIUM DIOXIDE	99	mg/mL			N	20251231
66890-990_0940ec9c-a1c4-9ccc-e063-6394a90a8b98	66890-990	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020115		UNAPPROVED MEDICAL GAS		Stillwater Medical Authority DBA Cimarron Medical Services	OXYGEN	99	L/100L			N	20241231
66897-001_6013ee03-4bc5-6d9d-e053-2a91aa0a8115	66897-001	HUMAN OTC DRUG	Wong To Yick	External Analgesic	Camphor Menthol Methyl Salicylate	OIL	TOPICAL	20111115		OTC MONOGRAPH NOT FINAL	part348	Wicsun Trading Inc	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	1; 1.6; 5	mg/10mL; mg/10mL; mg/10mL			N	20241231
66902-000_155ae528-75a1-40fb-9daf-c8956c37c6f6	66902-000	HUMAN OTC DRUG	Fast Freeze		CAMPHOR (NATURAL), Menthol	GEL	TOPICAL	20100401		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials Inc.	CAMPHOR (NATURAL); MENTHOL	2; 35	mg/g; mg/g			N	20241231
66902-001_e6f590fb-f034-4f08-8ddc-d26d229db4be	66902-001	HUMAN OTC DRUG	Fast Freeze		CAMPHOR (NATURAL), MENTHOL	SPRAY	TOPICAL	20100401		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials Inc.	CAMPHOR (NATURAL); MENTHOL	2; 100	mg/g; mg/g			N	20241231
66902-015_e8ceee3f-2bd2-49d2-8256-ccc95015eb89	66902-015	HUMAN OTC DRUG	Fast Freeze		MENTHOL	SPRAY	TOPICAL	20130101		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials Inc.	MENTHOL	100	mg/g			N	20241231
66902-016_21f872b8-48ec-49f6-a266-793dae613bf1	66902-016	HUMAN OTC DRUG	Fast Freeze		Menthol	GEL	TOPICAL	20130101		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials Inc.	MENTHOL	35	mg/g			N	20241231
66902-057_119d8582-2a1b-4a60-9f39-05cfa64727e9	66902-057	HUMAN OTC DRUG	Lidocaine Pain Relief with Lavender		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20210122		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	LIDOCAINE HYDROCHLORIDE	38	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-114_8a9c8e08-1ae5-479d-a944-0143eca38fe8	66902-114	HUMAN OTC DRUG	COLD LEAF NUTRITION MUSCLE AND JOINT PAIN RELIEF		MENTHOL	GEL	TOPICAL	20180927		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	MENTHOL	37	mg/mL			N	20241231
66902-115_7e5bb176-a1e6-4523-b247-2fd8c3101a0d	66902-115	HUMAN OTC DRUG	Fast Freeze Pain Relieving Continuous		MENTHOL, UNSPECIFIED FORM	SPRAY	TOPICAL	20210319		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	MENTHOL, UNSPECIFIED FORM	89	mg/mL			N	20241231
66902-116_ebde04e9-e83c-4507-8070-8352fe63cf43	66902-116	HUMAN OTC DRUG	Fast Freeze Pain Relieving		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	MENTHOL, UNSPECIFIED FORM	33	mg/mL			N	20241231
66902-140_fffe6659-b0cf-4a60-ba3e-42d3d4244bc5	66902-140	HUMAN OTC DRUG	CVS Health Muscle Balm		MENTHOL, UNSPECIFIED FORM, CAMPHOR (SYNTHETIC)	OINTMENT	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 110	mg/g; mg/g			N	20241231
66902-142_77249d6f-9e7f-44da-b046-8f0fe4641193	66902-142	HUMAN OTC DRUG	Muscle Balm		MENTHOL, UNSPECIFIED FORM, CAMPHOR (SYNTHETIC)	OINTMENT	TOPICAL	20220531		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	110; 110	mg/g; mg/g			N	20241231
66902-156_3d9dc4f6-cfa2-4039-b3ae-97b735a0e4f0	66902-156	HUMAN OTC DRUG	CVS Health Cold and Hot Roll-On		LIDOCAINE, MENTHOL	CREAM	TOPICAL	20180914		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	LIDOCAINE; MENTHOL	41; 9	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-165_a6e37537-90e9-4edd-9a7c-cf0b91deba1c	66902-165	HUMAN OTC DRUG	ICY FREEZE		MENTHOL	GEL	TOPICAL	20171201		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	MENTHOL	35	mg/mL			N	20241231
66902-166_7fdcc070-648f-46b7-ba60-8c3f75b6f955	66902-166	HUMAN OTC DRUG	Game On Xtreme		MENTHOL, UNSPECIFIED FORM	LIQUID	TOPICAL	20230228		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials Inc.	MENTHOL, UNSPECIFIED FORM	3.7	mg/g			N	20241231
66902-167_4f69e04c-9c6f-4364-bc0e-012af7336076	66902-167	HUMAN OTC DRUG	Still Standing		MENTHOL, UNSPECIFIED FORM	LIQUID	TOPICAL	20230228		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials Inc.	MENTHOL, UNSPECIFIED FORM	89	mg/mL			N	20241231
66902-168_b5cfbe07-0d53-4fea-8b00-f597d5f9e76e	66902-168	HUMAN OTC DRUG	ICY FREEZE		Menthol, unspecified form	SPRAY	TOPICAL	20200514		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	MENTHOL, UNSPECIFIED FORM	89	mg/mL			N	20241231
66902-195_f8272e0e-52bc-41dd-9fcb-0a62d0e7b17d	66902-195	HUMAN OTC DRUG	Evel Knievels Natural Choice Pain Relief		Menthol, unspecified form	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	MENTHOL, UNSPECIFIED FORM	100	mg/g			N	20241231
66902-215_d6984623-1cf3-42fe-8aaf-ccb456f96519	66902-215	HUMAN OTC DRUG	CVS Health Lidocaine Pain Relief		Lidocaine	PATCH	TRANSDERMAL	20191218		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	LIDOCAINE	567	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-220_117b3ae3-cc99-44fe-9b43-bbd6a5ee0adb	66902-220	HUMAN OTC DRUG	CVS Health Lidocaine Pain Relief Plus Menthol		Lidocaine, Menthol, unspecified form	PATCH	TRANSDERMAL	20191218		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	240; 60	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-225_5a191089-650b-4bca-97b9-fdc654033f28	66902-225	HUMAN OTC DRUG	Fast Freeze Lidocaine		LIDOCAINE	SPRAY	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	LIDOCAINE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-235_078ec311-0ee4-4e73-a1e9-e1ad2268d151	66902-235	HUMAN OTC DRUG	Fast Freeze Lidocaine Roll-On		Lidocaine Hydrochloride, Benzyl Alcohol	LIQUID	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	10; 40	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
66902-257_3177f89a-af41-45e8-905e-91db6c1ff7b1	66902-257	HUMAN OTC DRUG	CVS Lidocaine Pain Relief Dry		MENTHOL, UNSPECIFIED FORM, LIDOCAINE	SPRAY	TOPICAL	20210121		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-260_e03dd536-45c5-4134-beb4-cdcc8efd3f49	66902-260	HUMAN OTC DRUG	Dr. Hess Pain Relief		MENTHOL, UNSPECIFIED FORM	SPRAY	TOPICAL	20210126		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	MENTHOL, UNSPECIFIED FORM	3.7	mg/g			N	20241231
66902-276_f29bcc0f-4ec3-49bf-854a-ba3133fc2c46	66902-276	HUMAN OTC DRUG	CVS Health Lidocaine Pain-Relieving		Lidocaine	PATCH	TRANSDERMAL	20191218		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	LIDOCAINE	567	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-280_f13cb6b3-c931-41b4-ac8f-a848faaf3c91	66902-280	HUMAN OTC DRUG	CVS Health Pain Relieving		CAMPHOR (SYNTHETIC), MENTHOL (UNSPECIFIED FORM), METHYL SALICYLATE	PATCH	TRANSDERMAL	20201123		OTC MONOGRAPH NOT FINAL	part348	Natural Essentials, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	28; 54; 90	mg/1; mg/1; mg/1			N	20241231
66902-286_2a262fa7-2f28-4396-977b-cf546b031e7d	66902-286	HUMAN OTC DRUG	CVS Health XL Lidocaine Pain Relief		Lidocaine	PATCH	TRANSDERMAL	20191218		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	LIDOCAINE	858	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
66902-292_4d1fc1a8-9a9f-4b29-9792-bd6f4585b450	66902-292	HUMAN OTC DRUG	CVS Health Pain Relief Foot		MENTHOL, UNSPECIFIED FORM	CREAM	TOPICAL	20211022		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	MENTHOL, UNSPECIFIED FORM	100	mg/g			N	20241231
66902-343_b6e0579e-71c6-4705-847a-5f7d3d921474	66902-343	HUMAN OTC DRUG	Germ Attack Hand Sanitizer		Alcohol	GEL	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-386_5591d0df-a43e-49be-9290-1b24a9c41be0	66902-386	HUMAN OTC DRUG	Germ Attack Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	BENZALKONIUM CHLORIDE	.0013	g/g			N	20241231
66902-410_82a28bfd-b285-4f08-a6d2-e6164b80878e	66902-410	HUMAN OTC DRUG	Muscle Freeze Relief		MENTHOL	GEL	TOPICAL	20210715		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	MENTHOL, UNSPECIFIED FORM	37	mg/g			N	20241231
66902-442_fd628023-f577-4c58-ae34-af7390f73b40	66902-442	HUMAN OTC DRUG	Sure-Pure Sanitizing Hand Sanitizer		Alcohol	GEL	TOPICAL	20200513		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-443_6c7a31fd-3c45-42e2-9259-4df5608c39e8	66902-443	HUMAN OTC DRUG	Germ Attack Hand Sanitizer		Alcohol	GEL	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-444_dda2bb75-6f96-4146-b88f-d2cb417f6968	66902-444	HUMAN OTC DRUG	Sure-Pure Sanitizing Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200513		OTC MONOGRAPH NOT FINAL	part333A	NATURAL ESSENTIALS, INC.	ALCOHOL	.7	mL/mL			N	20241231
66902-449_175b2075-273e-4ae0-9186-094cb2605b4d	66902-449	HUMAN OTC DRUG	CVS Health Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20200401		OTC MONOGRAPH FINAL	part347	NATURAL ESSENTIALS, INC.	ZINC OXIDE	14.7	g/113g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
66902-450_01644e01-5db2-43c3-9dd4-cc94f35d45b0	66902-450	HUMAN OTC DRUG	CVS Health Lidocaine Pain-Relieving		Lidocaine	KIT	TRANSDERMAL	20200602		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.						N	20241231
66902-480_52f91dc8-a243-460c-ac68-46f21460bac2	66902-480	HUMAN OTC DRUG	Germ Attack Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	NATURAL ESSENTIALS, INC.	ALCOHOL	.62	mL/mL			N	20241231
66902-482_5b6c06d6-768e-4535-94d7-02373bce7b81	66902-482	HUMAN OTC DRUG	Germ Attack Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-484_a849142d-e923-427c-a494-f042894bd214	66902-484	HUMAN OTC DRUG	Natures Oil Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333A	NATURAL ESSENTIALS, INC.	ALCOHOL	.62	mL/mL			N	20241231
66902-643_a87dd485-a64e-4f92-a2de-87f11087becb	66902-643	HUMAN OTC DRUG	Sparoom Hand Sanitizer		Alcohol	GEL	TOPICAL	20200504		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-645_a5fab514-f67d-4d4f-a6e0-0e3b80295392	66902-645	HUMAN OTC DRUG	Sparoom Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200603		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-710_be578a8e-05bb-4105-ad0d-f0ed993d330d	66902-710	HUMAN OTC DRUG	Aromatique Apricot Mint Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200910		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-712_d6c6797a-7d85-4aea-bdce-1c3265c66ae3	66902-712	HUMAN OTC DRUG	Aromatique Fresh Air Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200910		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-714_2dd2309c-2d9a-4b2d-8756-9461c60a35a4	66902-714	HUMAN OTC DRUG	Aromatique Kiwi Pear Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200910		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-716_7e5fb116-de11-4b56-89ba-129ffe21a1eb	66902-716	HUMAN OTC DRUG	Aromatique Valencia Orange Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-720_93bdd290-7381-40e5-8fb5-64b3e39386b1	66902-720	HUMAN OTC DRUG	Aromatique Apricot Mint Hand Sanitizer		Alcohol	GEL	TOPICAL	20200909		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-722_6038996e-c76a-4ea8-9221-259ae6e3b013	66902-722	HUMAN OTC DRUG	Aromatique Fresh Air Hand Sanitizer		Alcohol	GEL	TOPICAL	20200909		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-724_775fff5a-1f7f-4a3e-a11f-0fbc563a66d6	66902-724	HUMAN OTC DRUG	Aromatique Kiwi Pear Hand Sanitizer		Alcohol	GEL	TOPICAL	20200909		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-726_5e2bda78-c148-48a1-8fd0-209618128f1f	66902-726	HUMAN OTC DRUG	Aromatique Valencia Orange Hand Sanitizer		Alcohol	GEL	TOPICAL	20200923		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-743_53f7b7e1-c86d-48c9-b15f-7b547c3be1e9	66902-743	HUMAN OTC DRUG	Germ Attack Hand Sanitizer		Alcohol	GEL	TOPICAL	20200626		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-750_c2aa9b2a-394c-4fed-b402-30ffbf856c31	66902-750	HUMAN OTC DRUG	Waxman Kleen Freak Hand Sanitizer		Alcohol	GEL	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-758_f96a3df1-5507-4364-92a3-e509919f9fc7	66902-758	HUMAN OTC DRUG	CVS Health Lidocaine Plus	Pain Relieving	Lidocaine Hydrochloride, Benzyl Alcohol	CREAM	TOPICAL	20210423		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	100; 40	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
66902-777_b1b5626b-fdcf-4088-ba27-5e6c0cd13780	66902-777	HUMAN OTC DRUG	CVS Health Arnica Blend Roll-On		Aloe Vera Leaf, Arnica Montana Flower, Calendula Officinalis Flowering Top, Bellis Perennis Whole	GEL	TOPICAL	20190603		UNAPPROVED HOMEOPATHIC		NATURAL ESSENTIALS, INC.	ALOE VERA LEAF; ARNICA MONTANA FLOWER; BELLIS PERENNIS WHOLE; CALENDULA OFFICINALIS FLOWERING TOP	3; 1; 4; 3	[hp_X]/89mL; [hp_X]/89mL; [hp_X]/89mL; [hp_X]/89mL			N	20241231
66902-778_10578563-b55c-48a4-99fd-3d74a40c1336	66902-778	HUMAN OTC DRUG	CVS Arnica		ARNICA MONTANA FLOWER	GEL	TOPICAL	20210127		UNAPPROVED HOMEOPATHIC		Natural Essentials, Inc.	ARNICA MONTANA FLOWER	1	[hp_X]/73g			N	20241231
66902-843_82248cb9-336b-47aa-a17f-2759a397dc7c	66902-843	HUMAN OTC DRUG	Sky Organics Hand Sanitizer		Alcohol	GEL	TOPICAL	20200915		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66902-920_c5519162-0188-4cf7-a7a0-63af7da414f5	66902-920	HUMAN OTC DRUG	CVS Health Pain Relief		Menthol, unspecified form	GEL	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part348	NATURAL ESSENTIALS, INC.	MENTHOL, UNSPECIFIED FORM	36	mg/mL			N	20241231
66902-943_f1ad7c12-7280-4816-af32-b0ed992c825d	66902-943	HUMAN OTC DRUG	Germ Attack Hand Sanitizer		Alcohol	GEL	TOPICAL	20210730		OTC MONOGRAPH NOT FINAL	part333A	Natural Essentials, Inc.	ALCOHOL	.7	mL/mL			N	20241231
66908-051_437192be-1024-44db-8698-b3bc0b0f5810	66908-051	HUMAN OTC DRUG	PRO-LINK Prestige Antibacterial Gold Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20000530		OTC MONOGRAPH NOT FINAL	part333E	Pro-Link, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
66908-080_f09acdbe-c1f2-4a5d-a498-91d76e358db7	66908-080	HUMAN OTC DRUG	PRO-LINK OPTIMUM Foaming Antimicrobial So ap		Chloroxylenol	LIQUID	TOPICAL	20021130		OTC MONOGRAPH NOT FINAL	part333E	Pro-Link, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
66908-081_3c0ca629-6d54-4686-b848-836dcba6e7b8	66908-081	HUMAN OTC DRUG	PRO-LINK Free Hands Antibacterial Foam So ap		Chloroxylenol	LIQUID	TOPICAL	20060530		OTC MONOGRAPH NOT FINAL	part333E	Pro-Link, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
66908-400_b930791d-8033-4615-9ab1-7d9eb52ee8d0	66908-400	HUMAN OTC DRUG	PRO-LINK Antibacterial Plum Perfection Foam So ap		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Pro-Link, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66908-401_8d9fc145-b3ae-4c5f-8b9d-39bc349edec3	66908-401	HUMAN OTC DRUG	Pro Formance Plum Perfection Antibacterial Foam S oap		Benzalkonium Chloride	LIQUID	TOPICAL	20180228		OTC MONOGRAPH NOT FINAL	part333E	Pro-Link, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66908-965_266d0d35-6c68-4ee2-bda1-5a95d3f4d86c	66908-965	HUMAN OTC DRUG	PRO-LINK Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20000530		OTC MONOGRAPH NOT FINAL	part333E	Pro-Link, Inc.	ALCOHOL	.62	mL/mL			N	20241231
66910-400_af382a95-45d7-45f7-a6d1-904c2bcba848	66910-400	HUMAN OTC DRUG	DON Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Edward Don & Company	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
66910-600_588754c7-f635-445f-9b37-e08d2986da5e	66910-600	HUMAN OTC DRUG	DON Luxury Foam Antibacterial Handwash		Chloroxylenol	LIQUID	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part333E	Edward Don & Company	CHLOROXYLENOL	.003	mg/mL			N	20241231
66923-000_30b48a4c-1c64-4ac3-b0d9-d4d53d3009ad	66923-000	HUMAN OTC DRUG	Abridge Cold Sore Treatment		Camphor, Menthol, Phenol, White Petrolatum	CREAM	TOPICAL	20200224		OTC MONOGRAPH NOT FINAL	part333E	Ranir LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
66923-002_5f93be52-72e2-4aa8-b7f9-0ae747c1f1fb	66923-002	HUMAN OTC DRUG	Reach Anti Plaque		cetylpyridinium chloride	RINSE	DENTAL	20210616		OTC MONOGRAPH NOT FINAL	part356	Ranir LLC	CETYLPYRIDINIUM CHLORIDE	.75	mg/mL			N	20241231
66923-003_e91ed8a1-0d45-402c-9c16-1ae72e695a37	66923-003	HUMAN OTC DRUG	Firefly Anticavity Fluoride		sodium fluoride	RINSE	DENTAL	20210616		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
66923-004_861fbd39-a851-4bd3-b939-94c4ed59caa3	66923-004	HUMAN OTC DRUG	Firefly Anticavity Fluoride		sodium fluoride	RINSE	DENTAL	20210218		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
66923-005_bf332854-eaec-4de2-a709-2b0a90bc23e2	66923-005	HUMAN OTC DRUG	Firefly Strawberry Smoothie		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210325		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	2.4	mg/g			N	20241231
66923-006_ad1cbb65-f654-49de-a555-43b8b2047a25	66923-006	HUMAN OTC DRUG	Firefly Bubble Blast		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210408		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	2.2	mg/g			N	20241231
66923-007_9f98913f-6754-4e1c-98cf-b89fe87750f8	66923-007	HUMAN OTC DRUG	Firefly Anticavity Fluoride		sodium fluoride	RINSE	DENTAL	20210616		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
66923-111_abdc7f79-5f87-4307-8ddd-e6281ac67a04	66923-111	HUMAN OTC DRUG	Firefly Anticavity Fluoride		sodium fluoride	RINSE	DENTAL	20210615		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
66923-258_5ed51d87-79d7-4ae0-b14c-197681ea7437	66923-258	HUMAN OTC DRUG	Rembrandt Deeply White		Sodium Monofluorophosphate	PASTE, DENTIFRICE	ORAL	20190301		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM MONOFLUOROPHOSPHATE	88.4	mg/g			N	20241231
66923-300_49978130-5004-476f-9b2b-a095f8906c67	66923-300	HUMAN OTC DRUG	Reach Anti cavity Fluoride		sodium fluoride	RINSE	DENTAL	20210622		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
66923-373_e0428891-ec04-4b79-831a-64df632b1287	66923-373	HUMAN OTC DRUG	Rembrandt Intense Stain		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20160725		OTC MONOGRAPH FINAL	part355	Ranir LLC	SODIUM FLUORIDE	24.3	mg/g			N	20241231
66944-001_f1782116-ed2e-2bf6-e053-2a95a90a98bf	66944-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020130		UNAPPROVED MEDICAL GAS		Halifax Medical Equipment	OXYGEN	99	L/100L			N	20241231
66949-105_07ea82d9-bb1d-1b6d-e063-6394a90a7e3d	66949-105	HUMAN OTC DRUG	Zep FS Antimicrobial Hand Cleaner		Benzalkonium Chloride	LIQUID	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-106_07ea6a8d-4032-0c5e-e063-6294a90a4a6e	66949-106	HUMAN OTC DRUG	Zep Fuzion Antimicrobial Hand Cleaner		Benzalkonium Chloride	LIQUID	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-107_07ea6980-5fe3-1ca3-e063-6394a90ade5e	66949-107	HUMAN OTC DRUG	Zep Non Alcohol Foam Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20110714	20241231	OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
66949-108_07ea5e0d-2626-8aa8-e063-6394a90a0c88	66949-108	HUMAN OTC DRUG	Zep Foam San		Benzalkonium Chloride	LIQUID	TOPICAL	20030318	20241231	OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
66949-110_07ea6ebf-da7e-fbed-e063-6394a90a4205	66949-110	HUMAN OTC DRUG	Zep Antibacterial HS		Benzalkonium Chloride	LIQUID	TOPICAL	20200629		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-111_07ea74ae-b59b-10c3-e063-6294a90aec6c	66949-111	HUMAN OTC DRUG	Fuzion AB Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20170310		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-113_07ea7ac6-f74e-469a-e063-6394a90ad7bd	66949-113	HUMAN OTC DRUG	Zep Mild Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20200323		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-114_07ea6ebf-da7f-fbed-e063-6394a90a4205	66949-114	HUMAN OTC DRUG	Zep Acclaim AB		Benzalkonium Chloride	LIQUID	TOPICAL	20161215		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-116_07ea6a8d-4036-0c5e-e063-6294a90a4a6e	66949-116	HUMAN OTC DRUG	Zep FS Antimicrobial Foaming Hand Cleaner		Benzalkonium Chloride	LIQUID	TOPICAL	20060412		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-117_07ea82d9-bb23-1b6d-e063-6394a90a7e3d	66949-117	HUMAN OTC DRUG	Zep Instant Hand Sanitizer Gel		Alcohol	LIQUID	TOPICAL	20200928		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	70	mL/100mL			N	20241231
66949-118_07ea82d9-bb24-1b6d-e063-6394a90a7e3d	66949-118	HUMAN OTC DRUG	Zep Instant Hand Sanitizer Gel		Alcohol	LIQUID	TOPICAL	20200928		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	70	mL/100mL			N	20241231
66949-119_07ea9a37-7d57-8b08-e063-6394a90a3e21	66949-119	HUMAN OTC DRUG	Zep Fuzion Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20201102		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	70	mL/100mL			N	20241231
66949-123_07ea6ebf-da82-fbed-e063-6394a90a4205	66949-123	HUMAN OTC DRUG	Zep Applaud AB		Chloroxylenol	LIQUID	TOPICAL	20170310		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	CHLOROXYLENOL	.3	g/100mL			N	20241231
66949-124_07ea6a8d-4037-0c5e-e063-6294a90a4a6e	66949-124	HUMAN OTC DRUG	Zep Blue Sky AB		Benzalkonium Chloride	LIQUID	TOPICAL	20170123		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-125_07ee4270-5b56-b2de-e063-6394a90a7e37	66949-125	HUMAN OTC DRUG	Zep E-2 Hand Sanitizing Cleaner		Chloroxylenol	LIQUID	TOPICAL	19880615		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	CHLOROXYLENOL	3	g/100mL			N	20241231
66949-127_07ea82d9-bb26-1b6d-e063-6394a90a7e3d	66949-127	HUMAN OTC DRUG	Zep Handstand Antimicrobial		Benzalkonium Chloride	LIQUID	TOPICAL	20170823		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-128_07ea74ae-b5a6-10c3-e063-6294a90aec6c	66949-128	HUMAN OTC DRUG	Zep Mango AB		Benzalkonium Chloride	LIQUID	TOPICAL	20170302		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-129_07ea82d9-bb27-1b6d-e063-6394a90a7e3d	66949-129	HUMAN OTC DRUG	ZEP ROUND ONE AB		Chloroxylenol	LIQUID	TOPICAL	20170719		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	CHLOROXYLENOL	.4	g/100mL			N	20241231
66949-130_07ea8a3a-35fb-4030-e063-6394a90ac9d0	66949-130	HUMAN OTC DRUG	Zep Professional Mild AB		Benzalkonium Chloride	LIQUID	TOPICAL	20160310		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-131_07ea9a37-7d58-8b08-e063-6394a90a3e21	66949-131	HUMAN OTC DRUG	Zep Acclaim AB		Benzalkonium Chloride	LIQUID	TOPICAL	20161215		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-132_07ea9a37-7d59-8b08-e063-6394a90a3e21	66949-132	HUMAN OTC DRUG	Zep Fuzion FS Antimicrobial Foaming Hand Cleaner		Benzalkonium Chloride	LIQUID	TOPICAL	20060412		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-133_07eaaf1b-1a84-b57d-e063-6294a90a3421	66949-133	HUMAN OTC DRUG	Zep Alcohol Sanitizer		Ethanol	LIQUID	TOPICAL	20000807		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	70	mL/100mL			N	20241231
66949-136_07eab1ff-e331-d278-e063-6394a90a4999	66949-136	HUMAN OTC DRUG	Zep Alcohol Sanitizer		Ethanol	LIQUID	TOPICAL	20210322	20241231	OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	70	mL/100mL			N	
66949-137_07eaabf9-e96c-bb03-e063-6294a90a7f9d	66949-137	HUMAN OTC DRUG	Hand Sanitizer Gel		Ethanol	LIQUID	TOPICAL	20210705		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	70	mL/100mL			N	20241231
66949-246_07eab647-9708-ccc3-e063-6294a90a20b9	66949-246	HUMAN OTC DRUG	Zep Instant Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20040129	20241231	OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	60	mL/100mL			N	
66949-387_07eaaf1b-1a86-b57d-e063-6294a90a3421	66949-387	HUMAN OTC DRUG	Zep Tranq Mdw AB Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20170802		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-393_07eab1ff-e332-d278-e063-6394a90a4999	66949-393	HUMAN OTC DRUG	ZEP PEAR AB HS		Benzalkonium Chloride	LIQUID	TOPICAL	20170303		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
66949-405_07eaa07a-9122-8a4e-e063-6394a90ad547	66949-405	HUMAN OTC DRUG	Zep Hand Sanitizer Wipes		Ethanol	SWAB	TOPICAL	20080812		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	70	mL/1			N	20241231
66949-906_07eaa07a-9123-8a4e-e063-6394a90ad547	66949-906	HUMAN OTC DRUG	Zep Handstand Instant Hand Sanitizer		Ethyl Alcohol	LIQUID	TOPICAL	19970905		OTC MONOGRAPH DRUG	505G(a)(3)	Zep Inc.	ALCOHOL	62	g/100mL			N	20241231
66961-100_0804569f-07d8-252e-e063-6294a90a5405	66961-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020212		NDA	NDA205865	Victor Welding Supply Company	OXYGEN	992	mL/L			N	20241231
66961-120_08046b49-a8bb-a78d-e063-6394a90a80fa	66961-120	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20020212		NDA	NDA205866	Victor Welding Supply Company	NITROGEN	992	mL/L			N	20241231
66975-050_d70c50cf-7e92-15be-e053-2a95a90a0713	66975-050	HUMAN PRESCRIPTION DRUG	Iris 60 Second APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Benco Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66975-051_d70c73cb-2203-59a2-e053-2a95a90a13de	66975-051	HUMAN PRESCRIPTION DRUG	Iris 60 Second APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Benco Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66975-052_d70c8143-4a62-9538-e053-2a95a90a059c	66975-052	HUMAN PRESCRIPTION DRUG	Iris 60 Second APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Benco Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66975-053_d70c7b9f-7d80-51ac-e053-2995a90a4a8f	66975-053	HUMAN PRESCRIPTION DRUG	Iris 60 Second APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Benco Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66975-054_d70c8143-4a70-9538-e053-2a95a90a059c	66975-054	HUMAN PRESCRIPTION DRUG	Iris 60 Second APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Benco Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
66975-101_0b39d4bb-1957-5128-e063-6394a90a4948	66975-101	HUMAN OTC DRUG	Natural Extensions Fragrance- Free Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20100801		OTC MONOGRAPH DRUG	505G(a)(3)	Benco Dental	ALCOHOL	60	mL/100mL			N	20241231
66975-104_0b3a9966-c5a0-1328-e063-6294a90a0cc4	66975-104	HUMAN OTC DRUG	Natural Extensions Antibacterial Foaming Hand		Benzalkonium Chloride	SOAP	TOPICAL	20181115		OTC MONOGRAPH DRUG	505G(a)(3)	Benco Dental	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
66975-340_05cf428c-3bc9-5fcb-e063-6394a90a962a	66975-340	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20201001		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-341_05e300c7-20df-ac3d-e063-6394a90a71af	66975-341	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20201001		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-343_05e2db2d-409b-1690-e063-6294a90a987c	66975-343	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20201001		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-350_d659747e-7861-399e-e053-2995a90a3440	66975-350	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-351_d65976b1-00ce-225f-e053-2995a90a38bf	66975-351	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-352_d6597b1c-8005-74ab-e053-2a95a90a045a	66975-352	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-353_d6598926-5f9b-318a-e053-2a95a90a160a	66975-353	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-354_d65a3bf5-0569-a03e-e053-2a95a90afda5	66975-354	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-355_d6598926-5fa8-318a-e053-2a95a90a160a	66975-355	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-356_d6598926-5fb5-318a-e053-2a95a90a160a	66975-356	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-357_d6598926-5fc1-318a-e053-2a95a90a160a	66975-357	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-358_d6599996-6229-f7a3-e053-2995a90aea36	66975-358	HUMAN OTC DRUG	BencoCaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20140627		OTC MONOGRAPH NOT FINAL	part356	Benco Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
66975-359_d65a5e77-866f-aa21-e053-2a95a90a24bf	66975-359	HUMAN PRESCRIPTION DRUG	Gibson Healthcare Buffered Hemostatic Solution		Aluminum Chloride	SOLUTION	DENTAL	20150101		UNAPPROVED DRUG OTHER		Benco Dental	ALUMINUM CHLORIDE	7500	mg/30mL			N	20241231
66975-406_df843087-5886-410e-8592-bf6703cf0454	66975-406	HUMAN PRESCRIPTION DRUG	Mepivacaine		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20110101		ANDA	ANDA088387	Benco Dental	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
66975-415_6ff1aff8-cffe-40fc-9772-804412cf1f47	66975-415	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111207		ANDA	ANDA088389	Benco Dental	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.02; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66975-417_acf03c2d-24a1-405a-8a04-1281a0ece5ab	66975-417	HUMAN PRESCRIPTION DRUG	ARTICAINE		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20160404		NDA AUTHORIZED GENERIC	NDA020971	Benco Dental	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .01	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66975-418_3c3b2945-0781-4426-ac78-5442983c4f62	66975-418	HUMAN PRESCRIPTION DRUG	ARTICAINE		Articaine Hydrochloride and Epinephrine	INJECTION, SOLUTION	SUBCUTANEOUS	20160404		NDA AUTHORIZED GENERIC	NDA020971	Benco Dental	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; .005	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66975-425_7c9f4bf1-ec76-426f-a242-fba37bd8e913	66975-425	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111207		ANDA	ANDA088390	Benco Dental	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
66975-501_4d1a3bcd-d558-4f5f-b669-ddcc6db32691	66975-501	HUMAN PRESCRIPTION DRUG	ProSys 5000		SODIUM FLUORIDE	PASTE, DENTIFRICE	ORAL	20231013		UNAPPROVED DRUG OTHER		Benco Dental	SODIUM FLUORIDE	1.1	g/100g			N	20241231
66975-600_0cf322fd-1584-d90d-e063-6294a90a2eaa	66975-600	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20120418		ANDA	ANDA077789	Benco Dental	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
66990-1019_fd00efdf-c486-81d1-e053-6394a90aed6e	66990-1019	HUMAN OTC DRUG	Vertra Pearl White Face Stick SPF 50		Padimate O, Titanium Dioxide	STICK	TOPICAL	20201216		OTC MONOGRAPH FINAL	M020	Toshiki Pigment Co., ltd.	PADIMATE O; TITANIUM DIOXIDE	7; 17	g/100g; g/100g			N	20241231
66990-1020_fd00be12-6099-1d4c-e053-6294a90aae87	66990-1020	HUMAN OTC DRUG	Vertra Ehukai Beige Face Stick SPF 38		Titanium Dioxide	STICK	TOPICAL	20201218		OTC MONOGRAPH FINAL	M020	Toshiki Pigment Co., ltd.	TITANIUM DIOXIDE	23	g/100g			N	20241231
66990-1021_fd01043b-7b89-52db-e053-6394a90a6e6e	66990-1021	HUMAN OTC DRUG	Vertra S Dorian Kona Gold Signature Face Stick SPF 38		Titanium Dioxide	STICK	TOPICAL	20201218		OTC MONOGRAPH FINAL	M020	Toshiki Pigment Co., ltd.	TITANIUM DIOXIDE	23	g/100g			N	20241231
66990-1025_fc89e482-cee1-f630-e053-6294a90ab7a8	66990-1025	HUMAN OTC DRUG	Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige		Titanium Dioxide	STICK	TOPICAL	20210127		OTC MONOGRAPH FINAL	M020	Toshiki Pigment Co., Ltd.	TITANIUM DIOXIDE	23	g/100g			N	20241231
66993-002_5b59e53b-ecf2-4704-9a22-7d1dde98a43b	66993-002	HUMAN PRESCRIPTION DRUG	Estradiol Vaginal Cream		estradiol	CREAM	VAGINAL	20211001		ANDA	ANDA212313	Prasco Laboratories	ESTRADIOL	.1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
66993-019_d020dd21-c70e-4b40-8a14-fc2a2b77ca98	66993-019	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20190115		NDA AUTHORIZED GENERIC	NDA020983	Prasco Laboratories	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-060_33e78f69-a092-4573-9380-a1ec94fee498	66993-060	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil HCl		atovaquone and proguanil hydrochloride	TABLET, FILM COATED	ORAL	20120727		NDA AUTHORIZED GENERIC	NDA021078	Prasco Laboratories	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
66993-066_96f23a38-8d24-495a-9e01-1a6e1bedd3c7	66993-066	HUMAN PRESCRIPTION DRUG	Phenoxybenzamine Hydrochloride		Phenoxybenzamine Hydrochloride	CAPSULE	ORAL	20150811		NDA AUTHORIZED GENERIC	NDA008708	Prasco Laboratories	PHENOXYBENZAMINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
66993-078_e1b94748-3344-484f-bcd1-b2fca5408c21	66993-078	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	Prasco Laboratories	FLUTICASONE PROPIONATE	44	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-079_e1b94748-3344-484f-bcd1-b2fca5408c21	66993-079	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	Prasco Laboratories	FLUTICASONE PROPIONATE	110	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-080_e1b94748-3344-484f-bcd1-b2fca5408c21	66993-080	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA021433	Prasco Laboratories	FLUTICASONE PROPIONATE	220	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-081_4a855286-6896-49de-a7a0-1cfb98afaa66	66993-081	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	SPRAY	NASAL	20200701		NDA AUTHORIZED GENERIC	NDA020626	Prasco Laboratories	SUMATRIPTAN	5	mg/100uL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
66993-082_4a855286-6896-49de-a7a0-1cfb98afaa66	66993-082	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	SPRAY	NASAL	20200701		NDA AUTHORIZED GENERIC	NDA020626	Prasco Laboratories	SUMATRIPTAN	20	mg/100uL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
66993-083_8c34ee1b-813e-426b-a426-78f66124385b	66993-083	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	INJECTION, SOLUTION	SUBCUTANEOUS	20200701		NDA AUTHORIZED GENERIC	NDA020080	Prasco Laboratories	SUMATRIPTAN SUCCINATE	4	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
66993-084_8c34ee1b-813e-426b-a426-78f66124385b	66993-084	HUMAN PRESCRIPTION DRUG	SUMATRIPTAN		sumatriptan	INJECTION, SOLUTION	SUBCUTANEOUS	20200701		NDA AUTHORIZED GENERIC	NDA020080	Prasco Laboratories	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
66993-086_1401102c-53a7-4303-9404-1e75f019f238	66993-086	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol HFA		fluticasone propionate and salmeterol xinafoate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20230301		NDA AUTHORIZED GENERIC	NDA021254	Prasco Laboratories	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	45; 21	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-087_1401102c-53a7-4303-9404-1e75f019f238	66993-087	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol HFA		fluticasone propionate and salmeterol xinafoate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20230301		NDA AUTHORIZED GENERIC	NDA021254	Prasco Laboratories	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	115; 21	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-088_1401102c-53a7-4303-9404-1e75f019f238	66993-088	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol HFA		fluticasone propionate and salmeterol xinafoate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20230301		NDA AUTHORIZED GENERIC	NDA021254	Prasco Laboratories	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	230; 21	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-135_2de0f003-da7c-4961-a93b-378de0275993	66993-135	HUMAN PRESCRIPTION DRUG	Fluticasone Furoate and Vilanterol		fluticasone furoate and vilanterol	POWDER	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA204275	Prasco Laboratories	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	100; 25	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-136_2de0f003-da7c-4961-a93b-378de0275993	66993-136	HUMAN PRESCRIPTION DRUG	Fluticasone Furoate and Vilanterol		fluticasone furoate and vilanterol	POWDER	RESPIRATORY (INHALATION)	20220523		NDA AUTHORIZED GENERIC	NDA204275	Prasco Laboratories	FLUTICASONE FUROATE; VILANTEROL TRIFENATATE	200; 25	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-141_ef17e7d9-2ca4-4512-b383-cf91d1aff7b2	66993-141	HUMAN PRESCRIPTION DRUG	Aliskiren		aliskiren hemifumarate	TABLET, FILM COATED	ORAL	20190304		NDA AUTHORIZED GENERIC	NDA021985	Prasco Laboratories	ALISKIREN HEMIFUMARATE	150	mg/1	Renin Inhibitor [EPC], Renin Inhibitors [MoA]		N	20241231
66993-142_ef17e7d9-2ca4-4512-b383-cf91d1aff7b2	66993-142	HUMAN PRESCRIPTION DRUG	Aliskiren		aliskiren hemifumarate	TABLET, FILM COATED	ORAL	20190304		NDA AUTHORIZED GENERIC	NDA021985	Prasco Laboratories	ALISKIREN HEMIFUMARATE	300	mg/1	Renin Inhibitor [EPC], Renin Inhibitors [MoA]		N	20241231
66993-188_038a7fef-e500-457e-9fc6-3dcaea2d66d6	66993-188	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		spironolactone and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211129		NDA AUTHORIZED GENERIC	NDA012616	Prasco Laboratories	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
66993-193_b350b79b-b940-40f3-8476-61576d595066	66993-193	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	SPRAY, METERED	NASAL	20200804		NDA AUTHORIZED GENERIC	NDA022382	Prasco Laboratories	KETOROLAC TROMETHAMINE	15.75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
66993-195_43a62e66-8821-40b6-85dd-0f29fe4adc8c	66993-195	HUMAN PRESCRIPTION DRUG	Tobramycin Inhalation		tobramycin inhalation	SOLUTION	RESPIRATORY (INHALATION)	20200915		NDA AUTHORIZED GENERIC	NDA201820	Prasco, LLC	TOBRAMYCIN	300	mg/4mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
66993-212_c9e38096-18a3-4884-b918-a6b4b438f51e	66993-212	HUMAN PRESCRIPTION DRUG	Nilutamide		Nilutamide	TABLET	ORAL	20191122		NDA AUTHORIZED GENERIC	NDA020169	Prasco Laboratories	NILUTAMIDE	150	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
66993-263_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-263	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-264_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-264	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-265_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-265	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-266_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-266	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-267_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-267	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-268_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-268	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-269_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-269	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-270_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-270	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-271_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-271	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-272_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-272	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-273_ef500e60-46ea-4722-945b-2b4549fd36b8	66993-273	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, COATED	ORAL	20220314		NDA AUTHORIZED GENERIC	NDA021540	Prasco Laboratories	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
66993-343_523d18b8-4a66-4bd8-a6ab-f4dec2564d39	66993-343	HUMAN PRESCRIPTION DRUG	Eplerenone		eplerenone	TABLET, FILM COATED	ORAL	20210601		ANDA	ANDA203896	Prasco Laboratories	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
66993-344_523d18b8-4a66-4bd8-a6ab-f4dec2564d39	66993-344	HUMAN PRESCRIPTION DRUG	Eplerenone		eplerenone	TABLET, FILM COATED	ORAL	20210601		ANDA	ANDA203896	Prasco Laboratories	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
66993-359_749aea08-23ad-4db1-9e0e-f7e33e1e88b4	66993-359	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		dextroamphetamine sulfate	SOLUTION	ORAL	20140515		ANDA	ANDA040776	Prasco Laboratories	DEXTROAMPHETAMINE SULFATE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
66993-361_eaf135b6-e378-4f62-a1e7-db45e23668c7	66993-361	HUMAN PRESCRIPTION DRUG	dapagliflozin and metformin hydrochloride		dapagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20240103		NDA AUTHORIZED GENERIC	NDA205649	PRASCO, LLC	DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE	5; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20251231
66993-362_eaf135b6-e378-4f62-a1e7-db45e23668c7	66993-362	HUMAN PRESCRIPTION DRUG	dapagliflozin and metformin hydrochloride		dapagliflozin and metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20240103		NDA AUTHORIZED GENERIC	NDA205649	PRASCO, LLC	DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE	10; 1000	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20251231
66993-370_156975b8-2333-45e3-9378-9fea25b8e461	66993-370	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20210706		NDA AUTHORIZED GENERIC	NDA020246	Prasco Laboratories	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
66993-371_156975b8-2333-45e3-9378-9fea25b8e461	66993-371	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20211021		NDA AUTHORIZED GENERIC	NDA020246	Prasco Laboratories	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
66993-372_02412e72-f54e-4c75-b45d-1316e5d4b10f	66993-372	HUMAN PRESCRIPTION DRUG	Phenytoin Infatabs		Phenytoin	TABLET, CHEWABLE	ORAL	20211123		ANDA	ANDA084427	Prasco Laboratories	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
66993-407_d90288c6-a8c9-4572-a5cf-221314764adc	66993-407	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20111215		NDA AUTHORIZED GENERIC	NDA020712	Prasco Laboratories	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
66993-408_d90288c6-a8c9-4572-a5cf-221314764adc	66993-408	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20111215		NDA AUTHORIZED GENERIC	NDA020712	Prasco Laboratories	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
66993-409_d90288c6-a8c9-4572-a5cf-221314764adc	66993-409	HUMAN PRESCRIPTION DRUG	Carbamazepine		carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20111215		NDA AUTHORIZED GENERIC	NDA020712	Prasco Laboratories	CARBAMAZEPINE	300	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
66993-422_824f1321-83d4-4f22-a6ee-828e9f713da7	66993-422	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20170830		NDA AUTHORIZED GENERIC	NDA021468	Prasco Laboratories	LANTHANUM CARBONATE	500	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
66993-423_824f1321-83d4-4f22-a6ee-828e9f713da7	66993-423	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20170830		NDA AUTHORIZED GENERIC	NDA021468	Prasco Laboratories	LANTHANUM CARBONATE	750	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
66993-424_824f1321-83d4-4f22-a6ee-828e9f713da7	66993-424	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20170830		NDA AUTHORIZED GENERIC	NDA021468	Prasco Laboratories	LANTHANUM CARBONATE	1000	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
66993-429_c8695339-0d5e-4988-b411-f094676b77bf	66993-429	HUMAN PRESCRIPTION DRUG	Tafluprost Ophthalmic		tafluprost	SOLUTION/ DROPS	OPHTHALMIC	20221118		NDA AUTHORIZED GENERIC	NDA202514	Prasco Laboratories	TAFLUPROST	.0045	mg/.3mL	Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]		N	20241231
66993-431_17bbefb1-40e1-42ea-a432-a40928d0c1e4	66993-431	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20210825		NDA AUTHORIZED GENERIC	NDA017442	Prasco Laboratories	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
66993-432_17bbefb1-40e1-42ea-a432-a40928d0c1e4	66993-432	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20220311		NDA AUTHORIZED GENERIC	NDA017442	Prasco Laboratories	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
66993-433_17bbefb1-40e1-42ea-a432-a40928d0c1e4	66993-433	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20220311		NDA AUTHORIZED GENERIC	NDA017442	Prasco Laboratories	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
66993-456_3aba33aa-f8c6-4b10-85c8-dfa14578d07c	66993-456	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20240103		NDA AUTHORIZED GENERIC	NDA202293	PRASCO, LLC	DAPAGLIFLOZIN PROPANEDIOL	5	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20251231
66993-457_3aba33aa-f8c6-4b10-85c8-dfa14578d07c	66993-457	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN		DAPAGLIFLOZIN	TABLET, FILM COATED	ORAL	20240103		NDA AUTHORIZED GENERIC	NDA202293	PRASCO, LLC	DAPAGLIFLOZIN PROPANEDIOL	10	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20251231
66993-472_d31ce88b-db37-4d0d-95e7-0bd7719384ac	66993-472	HUMAN PRESCRIPTION DRUG	Nisoldipine		Nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120227		NDA AUTHORIZED GENERIC	NDA020356	Prasco Laboratories	NISOLDIPINE	8.5	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
66993-473_d31ce88b-db37-4d0d-95e7-0bd7719384ac	66993-473	HUMAN PRESCRIPTION DRUG	Nisoldipine		Nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120227		NDA AUTHORIZED GENERIC	NDA020356	Prasco Laboratories	NISOLDIPINE	17	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
66993-475_d31ce88b-db37-4d0d-95e7-0bd7719384ac	66993-475	HUMAN PRESCRIPTION DRUG	Nisoldipine		Nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120227		NDA AUTHORIZED GENERIC	NDA020356	Prasco Laboratories	NISOLDIPINE	34	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
66993-478_d498fd29-9d46-4862-a3b3-ae75a30563b0	66993-478	HUMAN PRESCRIPTION DRUG	Lamivudine		lamivudine	TABLET, FILM COATED	ORAL	20140905		NDA AUTHORIZED GENERIC	NDA021003	Prasco Laboratories	LAMIVUDINE	100	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
66993-489_c76d44e7-3869-4e8b-93cf-b031f6f62c0a	66993-489	HUMAN PRESCRIPTION DRUG	Dactinomycin		Dactinomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171204		NDA AUTHORIZED GENERIC	NDA050682	Prasco Laboratories	DACTINOMYCIN	.5	mg/mL	Actinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]		N	20241231
66993-490_76cf5477-6f24-4959-b782-18b0176b2bc5	66993-490	HUMAN PRESCRIPTION DRUG	Ibuprofen Lysine		ibuprofen lysine	SOLUTION	INTRAVENOUS	20160414		NDA AUTHORIZED GENERIC	NDA021903	Prasco Laboratories	IBUPROFEN LYSINE	10	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
66993-495_f97c4351-0bc9-49a7-b558-e92b02827dde	66993-495	HUMAN PRESCRIPTION DRUG	Teriparatide		Teriparatide	INJECTION, SOLUTION	SUBCUTANEOUS	20231117		NDA AUTHORIZED GENERIC	NDA021318	Prasco Laboratories	TERIPARATIDE	250	ug/mL	Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]		N	20241231
66993-584_1b2d7f6c-8299-4826-9a30-758ce5dfbb42	66993-584	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	Prasco Laboratories	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	100; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-585_1b2d7f6c-8299-4826-9a30-758ce5dfbb42	66993-585	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	Prasco Laboratories	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-586_1b2d7f6c-8299-4826-9a30-758ce5dfbb42	66993-586	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	Prasco Laboratories	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	500; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
66993-594_abd9fbe4-5cc8-4b3f-9c74-d4ba2288f330	66993-594	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Prasco Laboratories	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
66993-595_abd9fbe4-5cc8-4b3f-9c74-d4ba2288f330	66993-595	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Prasco Laboratories	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
66993-596_abd9fbe4-5cc8-4b3f-9c74-d4ba2288f330	66993-596	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Prasco Laboratories	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
66993-597_abd9fbe4-5cc8-4b3f-9c74-d4ba2288f330	66993-597	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Prasco Laboratories	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
66993-598_abd9fbe4-5cc8-4b3f-9c74-d4ba2288f330	66993-598	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Prasco Laboratories	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
66993-599_abd9fbe4-5cc8-4b3f-9c74-d4ba2288f330	66993-599	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE	CAPSULE, EXTENDED RELEASE	ORAL	20090402		NDA AUTHORIZED GENERIC	NDA021303	Prasco Laboratories	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
66993-605_169ad168-e8ae-43a7-b203-1625d5c34e6e	66993-605	HUMAN PRESCRIPTION DRUG	Etonogestrel/Ethinyl Estradiol		etonogestrel and ethinyl estradiol	INSERT, EXTENDED RELEASE	VAGINAL	20210601		NDA AUTHORIZED GENERIC	NDA021187	Prasco Laboratories	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
66993-606_e1a19354-1c97-49ed-8ec9-bb895dbe69f3	66993-606	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA216751	Prasco Laboratories	MIRTAZAPINE	7.5	mg/1			N	20241231
66993-607_e1a19354-1c97-49ed-8ec9-bb895dbe69f3	66993-607	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA216751	Prasco Laboratories	MIRTAZAPINE	15	mg/1			N	20241231
66993-608_e1a19354-1c97-49ed-8ec9-bb895dbe69f3	66993-608	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA216751	Prasco Laboratories	MIRTAZAPINE	30	mg/1			N	20241231
66993-609_e1a19354-1c97-49ed-8ec9-bb895dbe69f3	66993-609	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA216751	Prasco Laboratories	MIRTAZAPINE	45	mg/1			N	20241231
66993-680_257af069-b3dd-4a9f-938e-fcff35e4c9cd	66993-680	HUMAN PRESCRIPTION DRUG	OLANZAPINE		olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Prasco Laboratories	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
66993-681_257af069-b3dd-4a9f-938e-fcff35e4c9cd	66993-681	HUMAN PRESCRIPTION DRUG	OLANZAPINE		olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Prasco Laboratories	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
66993-682_257af069-b3dd-4a9f-938e-fcff35e4c9cd	66993-682	HUMAN PRESCRIPTION DRUG	OLANZAPINE		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Prasco Laboratories	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
66993-683_257af069-b3dd-4a9f-938e-fcff35e4c9cd	66993-683	HUMAN PRESCRIPTION DRUG	OLANZAPINE		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Prasco Laboratories	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
66993-684_257af069-b3dd-4a9f-938e-fcff35e4c9cd	66993-684	HUMAN PRESCRIPTION DRUG	OLANZAPINE		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Prasco Laboratories	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
66993-685_257af069-b3dd-4a9f-938e-fcff35e4c9cd	66993-685	HUMAN PRESCRIPTION DRUG	OLANZAPINE		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Prasco Laboratories	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
66993-727_9be87a9b-167c-44f4-9a06-8eb1bf5e00be	66993-727	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		sulfamethoxazole and trimethoprim	SUSPENSION	ORAL	20220705		ANDA	ANDA077612	Prasco Laboratories	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
66993-730_4c2cdb75-c557-4d32-a0fb-d4295e14af0d	66993-730	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220430		ANDA	ANDA080399	Prasco Laboratories	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-790_0b409cec-0094-4e46-a052-661c1d358446	66993-790	HUMAN PRESCRIPTION DRUG	FLUTICASONE PROPIONATE	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20231030		NDA AUTHORIZED GENERIC	NDA020833	Prasco Laboratories	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-791_0b409cec-0094-4e46-a052-661c1d358446	66993-791	HUMAN PRESCRIPTION DRUG	FLUTICASONE PROPIONATE	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20231030		NDA AUTHORIZED GENERIC	NDA020833	Prasco Laboratories	FLUTICASONE PROPIONATE	100	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-792_0b409cec-0094-4e46-a052-661c1d358446	66993-792	HUMAN PRESCRIPTION DRUG	FLUTICASONE PROPIONATE	DISKUS	fluticasone propionate	POWDER, METERED	RESPIRATORY (INHALATION)	20231030		NDA AUTHORIZED GENERIC	NDA020833	Prasco Laboratories	FLUTICASONE PROPIONATE	250	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-815_f5edfbdc-7314-4a03-bd5a-c836e7a7e337	66993-815	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20150401		NDA AUTHORIZED GENERIC	NDA050805	Prasco Laboratories	DOXYCYCLINE	40	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
66993-821_d682ddb2-aeae-456a-b7ea-3e5c2e9b75bd	66993-821	HUMAN PRESCRIPTION DRUG	pioglitazone and glimepiride		pioglitazone and glimepiride	TABLET	ORAL	20150804		NDA AUTHORIZED GENERIC	NDA021925	Prasco Laboratories	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	2; 30	mg/1; mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
66993-822_d682ddb2-aeae-456a-b7ea-3e5c2e9b75bd	66993-822	HUMAN PRESCRIPTION DRUG	pioglitazone and glimepiride		pioglitazone and glimepiride	TABLET	ORAL	20150804		NDA AUTHORIZED GENERIC	NDA021925	Prasco Laboratories	GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE	4; 30	mg/1; mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
66993-831_d7ce0a55-ba61-4995-8141-43c4736d4be9	66993-831	HUMAN PRESCRIPTION DRUG	triamterene		Triamterene	CAPSULE	ORAL	20190813		NDA AUTHORIZED GENERIC	NDA013174	Prasco Laboratories	TRIAMTERENE	50	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
66993-832_d7ce0a55-ba61-4995-8141-43c4736d4be9	66993-832	HUMAN PRESCRIPTION DRUG	Triamterene		Triamterene	CAPSULE	ORAL	20190813		NDA AUTHORIZED GENERIC	NDA013174	Prasco Laboratories	TRIAMTERENE	100	mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC]		N	20241231
66993-844_4995189d-7448-4175-b720-8f1b7c1ff39e	66993-844	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate	ODT	prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING	ORAL	20151021		NDA AUTHORIZED GENERIC	NDA021959	Prasco Laboratories	PREDNISOLONE SODIUM PHOSPHATE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-845_4995189d-7448-4175-b720-8f1b7c1ff39e	66993-845	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate	ODT	prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING	ORAL	20151021		NDA AUTHORIZED GENERIC	NDA021959	Prasco Laboratories	PREDNISOLONE SODIUM PHOSPHATE	15	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-846_4995189d-7448-4175-b720-8f1b7c1ff39e	66993-846	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING	ORAL	20151021		NDA AUTHORIZED GENERIC	NDA021959	Prasco Laboratories	PREDNISOLONE SODIUM PHOSPHATE	30	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-869_0b7e4a98-52af-4f19-9b13-1a9238d9811b	66993-869	HUMAN PRESCRIPTION DRUG	Adapalene and Benzoyl Peroxide		adapalene and benzoyl peroxide	GEL	TOPICAL	20170803		NDA AUTHORIZED GENERIC	NDA022320	Prasco Laboratories	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
66993-877_3682f2c5-9bce-4b4a-a4d6-9af29f08ad63	66993-877	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	CREAM	TOPICAL	19961001		NDA AUTHORIZED GENERIC	NDA020554	Prasco Laboratories	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
66993-878_701245ab-fce0-4a80-90c7-9e3cfa79a9f5	66993-878	HUMAN PRESCRIPTION DRUG	calcipotriene		calcipotriene	OINTMENT	TOPICAL	20130701		NDA AUTHORIZED GENERIC	NDA020273	Prasco Laboratories	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
66993-884_6c51995a-bb3a-4d56-b0bf-ca7d9415765d	66993-884	HUMAN PRESCRIPTION DRUG	ADAPALENE		ADAPALENE	GEL	TOPICAL	20140101		NDA AUTHORIZED GENERIC	NDA021753	Prasco Laboratories	ADAPALENE	3	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
66993-897_1126b8b8-8860-4991-9027-996550c051e5	66993-897	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		betamethasone dipropionate	OINTMENT	TOPICAL	20210601		NDA AUTHORIZED GENERIC	NDA018741	Prasco Laboratories	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-936_ed07a9ce-d72f-4482-bd35-0787602479e3	66993-936	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	GEL	TOPICAL	20050630		NDA AUTHORIZED GENERIC	NDA021789	Prasco Laboratories	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
66993-937_2c5956ce-e443-4441-b48d-0bb4434a7d3b	66993-937	HUMAN PRESCRIPTION DRUG	Calcipotriene and Betamethasone Dipropionate		Calcipotriene and Betamethasone Dipropionate	SUSPENSION	TOPICAL	20200107		NDA AUTHORIZED GENERIC	NDA022185	Prasco Laboratories	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
66993-938_aad74639-2667-44ea-9d2b-32a5dd5ea596	66993-938	HUMAN PRESCRIPTION DRUG	Calcipotriene and Betamethasone Dipropionate		Calcipotriene and Betamethasone Dipropionate	OINTMENT	TOPICAL	20200128		NDA AUTHORIZED GENERIC	NDA021852	Prasco Laboratories	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE	.5; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
66993-939_f125ca94-2aed-410d-b8e0-958d544a6e6b	66993-939	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	SHAMPOO	TOPICAL	20200120		NDA AUTHORIZED GENERIC	NDA021644	Prasco Laboratories	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-947_e6c10808-9788-4654-bf4a-465daeea176f	66993-947	HUMAN PRESCRIPTION DRUG	Clocortolone Pivalate Cream		Clocortolone Pivalate	CREAM	TOPICAL	20190901		NDA AUTHORIZED GENERIC	NDA017765	Prasco Laboratories	CLOCORTOLONE PIVALATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
66993-959_34fe58cb-6bfe-43ed-9e48-4614d4c1a975	66993-959	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Tretinion		clindamycin phosphate and tretinoin	GEL	TOPICAL	20180628		NDA AUTHORIZED GENERIC	NDA050803	Prasco Laboratories	CLINDAMYCIN PHOSPHATE; TRETINOIN	10; .25	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE], Retinoid [EPC], Retinoids [CS]		N	20241231
66993-960_f6a66334-2758-4eda-a6d8-881ecb1d5e37	66993-960	HUMAN PRESCRIPTION DRUG	METRONIDAZOLE		METRONIDAZOLE	CREAM	TOPICAL	20090618		NDA AUTHORIZED GENERIC	NDA020531	Prasco Laboratories	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
66993-961_10c57390-98b0-4a9f-8f8d-8d4eb9d16401	66993-961	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	LOTION	TOPICAL	20090528		NDA AUTHORIZED GENERIC	NDA020901	Prasco Laboratories	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
66993-962_3c2c4df2-5e31-4392-b39c-7aa8fedf84f5	66993-962	HUMAN PRESCRIPTION DRUG	Metronidazole Topical Gel		metronidazole	GEL	TOPICAL	20140301		NDA AUTHORIZED GENERIC	NDA019737	Prasco Laboratories	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
67015-2035_f80d4d61-dc77-e8a0-e053-6394a90a85b6	67015-2035	HUMAN OTC DRUG	HAUTE PROTECTION High Protection Tinted Compact Broad Spectrum SPF 50 Honey		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190603		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	TITANIUM DIOXIDE; ZINC OXIDE	13.7; 4.9	g/100g; g/100g			N	20241231
67015-2036_f80d6d3c-510c-4de9-e053-6294a90a6fcd	67015-2036	HUMAN OTC DRUG	HAUTE PROTECTION High Protection Tinted Compact Broad Spectrum SPF 50 Beige		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20190315		OTC MONOGRAPH NOT FINAL	part352	Pierre Fabre USA Inc.	TITANIUM DIOXIDE; ZINC OXIDE	13.7; 4.9	g/100g; g/100g			N	20241231
67038-203_f262e5a7-3c58-a6d8-e053-2995a90aacbc	67038-203	HUMAN OTC DRUG	Bliss Block Star Sheer Liquid Daily Sunscreen SPF 50	SPF-50	Zinc Oxide	LOTION	TOPICAL	20230131		OTC MONOGRAPH FINAL	M020	Bliss Products Holdings LLC	ZINC OXIDE	20	g/100mL			N	20241231
67060-001_feb250d0-cddb-448d-b08d-00a0fc091055	67060-001	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN 200MG	TABLET, FILM COATED	ORAL	20150409		ANDA	ANDA079174	ADVANCED FIRST AID, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67060-194_f1b2a5df-5742-96d5-e053-2a95a90af523	67060-194	HUMAN OTC DRUG	PAIN AND SINUS RELIEVER		ACETAMINOPHEN AND PHENYLEPHRINE	TABLET	ORAL	20150409	20240801	OTC MONOGRAPH FINAL	part341	ADVANCED FIRST AID, INC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
67060-360_f1b3bb77-b5c5-8f7d-e053-2a95a90a8c19	67060-360	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin, Neomycin, Polymyxin B	OINTMENT	TOPICAL	20150408	20240301	OTC MONOGRAPH FINAL	part333B	ADVANCED FIRST AID, INC.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
67060-370_f1b3aeb8-a1bb-a481-e053-2a95a90a19ad	67060-370	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20150408	20240701	OTC MONOGRAPH NOT FINAL	part348	ADVANCED FIRST AID, INC.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
67066-005_ce52186f-08a7-8c85-e053-2995a90a4e41	67066-005	HUMAN PRESCRIPTION DRUG	ChiRhoStim		Human Secretin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20040801		NDA	NDA021256	ChiRhoClin, Inc.	SECRETIN HUMAN	16	ug/8mL			N	20241231
67066-007_ce52186f-08a7-8c85-e053-2995a90a4e41	67066-007	HUMAN PRESCRIPTION DRUG	ChiRhoStim 40		Human Secretin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20070601		NDA	NDA021256	ChiRhoClin, Inc.	SECRETIN HUMAN	40	ug/10mL			N	20241231
67091-020_5741d3f5-792b-4d08-b9ad-fe67f82f2e07	67091-020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	OINTMENT	TOPICAL	20220801		OTC MONOGRAPH FINAL	part347	WinCo Foods, LLC	ZINC OXIDE	532	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
67091-051_997047cc-8d57-4e29-b633-48d009d84a50	67091-051	HUMAN OTC DRUG	WINCO ANTIFUNGAL		Tolnaftate 1%	CREAM	TOPICAL	20220430		OTC MONOGRAPH FINAL	part333C	WinCo Foods LLC	TOLNAFTATE	10	mg/g			N	20241231
67091-055_bf3e34bb-03cb-457e-adc8-1d9e8440d51b	67091-055	HUMAN OTC DRUG	WINCO Hydrocortisone		Hydrocortisone 1%	CREAM	TOPICAL	20220430		OTC MONOGRAPH NOT FINAL	part348	WinCo Foods LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67091-100_02762f72-de2f-4b9d-9ed0-86ce6b14488a	67091-100	HUMAN OTC DRUG	70% Isopropyl Rubbing Alcohol		Isopropyl Rubbing Alcohol	SOLUTION	TOPICAL	20150828		OTC MONOGRAPH NOT FINAL	part333A	WinCo Foods, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
67091-102_cf47222b-638d-42f7-9432-1cdb9070b995	67091-102	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20141003		OTC MONOGRAPH NOT FINAL	part356	WinCo Foods, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
67091-103_ac0f9476-afd7-40e6-9582-c8996ede8972	67091-103	HUMAN OTC DRUG	Antispetic		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20140819		OTC MONOGRAPH NOT FINAL	part356	WinCo Foods, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
67091-104_bf5e3c24-db3f-4e56-b89c-2edfbc5716a8	67091-104	HUMAN OTC DRUG	Kids Flouride Rinse		Sodium Fluoride	RINSE	ORAL	20110209		OTC MONOGRAPH FINAL	part355	WinCo Foods, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
67091-105_2907b9c1-be34-48e9-9775-b4610d17bbfe	67091-105	HUMAN OTC DRUG	Mint Alcohol Free		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20140926		OTC MONOGRAPH NOT FINAL	part356	WinCo Foods LLC	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
67091-106_ea4801fc-17c3-48e2-876e-9d5f2e44a9a8	67091-106	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20141003		OTC MONOGRAPH NOT FINAL	part356	WinCo Foods, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
67091-107_84d59608-cdef-4307-b130-496acd306ebf	67091-107	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part333A	WinCo Foods, LLC	ALCOHOL	70	mL/100mL			N	20241231
67091-108_f0467784-786d-eddf-e053-2995a90aef61	67091-108	HUMAN OTC DRUG	WinCo Foods Effervescent Antacid and Pain Relief		ASPIRIN, SODIUM BICARBONATE, CITRIC ACID Tablet	TABLET, EFFERVESCENT	ORAL	20150101		OTC MONOGRAPH FINAL	part343	WinCo Foods, LLC	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
67091-109_c1bd2e44-e679-1dee-e053-2995a90a6e02	67091-109	HUMAN OTC DRUG	WinCo Foods Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, and Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20140702		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-110_7880fb73-186b-45bf-8e40-a854572c3641	67091-110	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	WinCo Foods, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
67091-112_c189d1af-264c-4ec0-a13c-fe4642ec47f8	67091-112	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20080313		OTC MONOGRAPH DRUG	M013	WinCo Foods, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
67091-114_9858fe87-9678-4922-8107-6138a7b7562e	67091-114	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20141231	20240223	OTC MONOGRAPH FINAL	part338	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
67091-115_e77143bd-6a5d-4510-b1b4-5ed85d7f88de	67091-115	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-117_659e70de-353e-438a-8bf3-ed9183a362c2	67091-117	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	WinCo Foods, LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
67091-118_3ce6a59e-b07d-471f-9027-bb81d1af6bae	67091-118	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate	TABLET	ORAL	19921201		OTC MONOGRAPH DRUG	M009	WinCo Foods, LLC	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
67091-119_e6cbfab2-7061-4652-a768-d9b41475ad13	67091-119	HUMAN OTC DRUG	Childrens Pain Relief Dye-Free		Acteaminophen	SUSPENSION	ORAL	20141212		OTC MONOGRAPH NOT FINAL	part343	WinCo Foods, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
67091-123_940bb63a-faf2-25d6-e053-2a95a90a9f39	67091-123	HUMAN OTC DRUG	Aspirin	Low Dose	ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20141215		OTC MONOGRAPH NOT FINAL	part343	WinCo Foods, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
67091-132_7e555ba3-c6b6-0808-e053-2991aa0a0b25	67091-132	HUMAN OTC DRUG	Acetaminophen	Regular Strength	Acetaminophen	TABLET	ORAL	20141215		OTC MONOGRAPH NOT FINAL	part343	WinCo Foods, LLC	ACETAMINOPHEN	325	mg/1			N	20241231
67091-133_7e55ceaf-cefe-501d-e053-2991aa0af753	67091-133	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20141215		OTC MONOGRAPH NOT FINAL	part343	WinCo Foods, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
67091-135_7e55a7d7-c998-ecd2-e053-2a91aa0abfe3	67091-135	HUMAN OTC DRUG	Acetaminophen Easy Tabs	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20141215		OTC MONOGRAPH NOT FINAL	part343	WinCo Foods, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
67091-137_7e55a7d7-c9ab-ecd2-e053-2a91aa0abfe3	67091-137	HUMAN OTC DRUG	Acetaminophen PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20141215		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-138_9455625c-6dc4-c5b7-e053-2995a90a22df	67091-138	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20141215		ANDA	ANDA079096	WinCo Foods, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-140_94555f5d-1f2c-e5c1-e053-2a95a90a5ed5	67091-140	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20141215		ANDA	ANDA079096	WinCo Foods, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-141_46dc8da3-6fda-4e1f-8ce7-c7e3621e760b	67091-141	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20141231	20240531	ANDA	ANDA078682	WinCo Foods, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
67091-145_8a508493-b564-495f-babe-cfd155af99cd	67091-145	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20141108		OTC MONOGRAPH FINAL	part347	WinCo Foods, LLC,	PETROLATUM	1	g/g			N	20241231
67091-146_c33cf5e6-8d1d-48cd-b05a-ae11f3fd7ec3	67091-146	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20160831	20240531	OTC MONOGRAPH FINAL	part347	WinCo Foods, LLC	WITCH HAZEL	842	mg/mL			N	
67091-160_e31b93bb-1475-4516-80f0-936d71fd48a8	67091-160	HUMAN OTC DRUG	Therapeutic Anti-Dandruff		Coal Tar	SHAMPOO	TOPICAL	20141117		OTC MONOGRAPH FINAL	part358H	Winco Foods, LLC	COAL TAR	25	mg/mL			N	20241231
67091-161_fefab8e3-6c5b-469e-8641-018051e0f5d9	67091-161	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20141209		OTC MONOGRAPH FINAL	part341	Winco Foods, LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
67091-168_55df46da-af52-46d9-96d2-d74edcb4372d	67091-168	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20150113		OTC MONOGRAPH DRUG	M006	WNCO FOODS LLC	SALICYLIC ACID	19.8	mg/g			N	20241231
67091-175_226ad651-9980-470a-9ce3-80fedb518322	67091-175	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20141120		OTC MONOGRAPH FINAL	part333D	Winco Foods, LLC	SALICYLIC ACID	20.6	mg/mL			N	20241231
67091-178_0e5791ef-23cc-49fe-b8a7-13812cc98695	67091-178	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20141209		OTC MONOGRAPH FINAL	part358H	WinCo Foods, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
67091-185_95101238-524e-904c-e053-2995a90abc3b	67091-185	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180501		ANDA	ANDA079205	Winco Foods, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-190_d5cd6565-27fe-4836-e053-2995a90a785f	67091-190	HUMAN OTC DRUG	Winco Antifungal		Tolnaftate	CREAM	TOPICAL	20210112		OTC MONOGRAPH FINAL	part333C	Winco Foods, LLC	TOLNAFTATE	10	mg/g			N	20241231
67091-196_d5ce5601-46b7-5393-e053-2995a90a1c56	67091-196	HUMAN OTC DRUG	WinCo Foods Antifungal		Clotrimazole	CREAM	TOPICAL	20210520		OTC MONOGRAPH FINAL	part333C	Winco Foods LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67091-197_db8bc2f1-c052-30ae-e053-2995a90ac857	67091-197	HUMAN OTC DRUG	Winco Maximum Strength Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20201012		OTC MONOGRAPH NOT FINAL	part348	WINCO FOODS, LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67091-198_db8bc2f1-c053-30ae-e053-2995a90ac857	67091-198	HUMAN OTC DRUG	WinCo Foods Maximum Strength Oral Analgesic		Benzocaine	GEL	TOPICAL	20141201		OTC MONOGRAPH NOT FINAL	part356	WinCo Foods, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67091-200_c04e6a83-0e63-4eb3-b0ed-a3fb10f308a4	67091-200	HUMAN OTC DRUG	Allergy Relief	Complete	Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-201_76d132ff-914a-426b-9e2c-681deaed9993	67091-201	HUMAN OTC DRUG	Allergy Relief	Complete	Diphenhydramine HCl	CAPSULE	ORAL	19900315		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-203_55ab0815-00cf-4335-a950-224128ea0576	67091-203	HUMAN OTC DRUG	Allergy Relief	4 Hour	Chlorpheniramine maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-207_91c5b9c9-eaa5-46d3-ad19-1c815b136766	67091-207	HUMAN OTC DRUG	Nasal Decongestant PE	Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
67091-209_1ce17de0-7d15-4ffe-b650-4e33e7d4554f	67091-209	HUMAN OTC DRUG	Nasal Decongestant PE and Pain Relief	Maximum Strength	Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20050623		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-212_c6759d0f-7ed8-402d-8858-66bb9150c4ad	67091-212	HUMAN OTC DRUG	Cold and Head Congestion Relief	Severe	Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050806		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-213_34c56072-5020-4989-ac1d-88503fa82c74	67091-213	HUMAN OTC DRUG	Sinus Congestion and Pain Relief	Non-Drowsy	Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-215_0669680f-3e9a-4fbb-a073-b7e0ba32f9e8	67091-215	HUMAN OTC DRUG	Laxative	Gentle	Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	WinCo Foods, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67091-244_70bc7062-ab3c-43eb-b524-0d8c6d1a674d	67091-244	HUMAN OTC DRUG	Acid Reducer		Ranitidine Hydrochloride	TABLET, FILM COATED	ORAL	20120802		ANDA	ANDA201745	WinCo Foods, LLC	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67091-245_53fce6fc-65d0-4fac-b3e0-b54865d8b158	67091-245	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20030828		ANDA	ANDA076134	WinCo Foods, LLC	LORATADINE	10	mg/1			N	20241231
67091-246_53fce6fc-65d0-4fac-b3e0-b54865d8b158	67091-246	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20030828		ANDA	ANDA076134	WinCo Foods, LLC	LORATADINE	10	mg/1			N	20241231
67091-249_b60e52ce-a61c-4d6b-9509-a771a5a53933	67091-249	HUMAN OTC DRUG	Winco Original SPF 4 Lip Balm		Padimate O, Petrolatum	STICK	TOPICAL	20150102		OTC MONOGRAPH NOT FINAL	part352	Winco	PADIMATE O; PETROLATUM	1.5; 44	mg/g; mg/g			N	20241231
67091-250_c8ea7153-a1b1-44ff-8592-d8f3290c2868	67091-250	HUMAN OTC DRUG	Winco Moisture SPF 15 Lip Balm		Oxybenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20150102		OTC MONOGRAPH NOT FINAL	part352	Winco	OCTINOXATE; OXYBENZONE; PETROLATUM	7.5; 3.5; 40.7	mg/g; mg/g; mg/g			N	20241231
67091-251_6dbe0d16-e428-4477-bbe5-58d48a28364f	67091-251	HUMAN OTC DRUG	Winco Medicated Lip Balm		Petrolatum	STICK	TOPICAL	20150102		OTC MONOGRAPH FINAL	part347	Winco	PETROLATUM	30	mg/g			N	20241231
67091-252_a7b39223-db18-44f8-a46f-cb14345d1db1	67091-252	HUMAN OTC DRUG	Winco Cherry SPF 4 Lip Balm		Padimate O, Petrolatum	STICK	TOPICAL	20150102		OTC MONOGRAPH NOT FINAL	part352	Winco	PADIMATE O; PETROLATUM	1.5; 44	mg/g; mg/g			N	20241231
67091-253_2696f632-1138-43a7-a213-839d26d63caf	67091-253	HUMAN OTC DRUG	Winco Original Petrolatum		Petrolatum	STICK	TOPICAL	20230615		OTC MONOGRAPH FINAL	part347	Winco	PETROLATUM	45	mg/g			N	20241231
67091-258_38c99f07-2d7a-42f5-8068-9d4b156900e1	67091-258	HUMAN OTC DRUG	Cold and Flu Relief	Multi Symptom Nighttime	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20141231		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-265_4f0403cc-a70c-458b-8ebc-e0afd84215c3	67091-265	HUMAN OTC DRUG	Tussin DM Cough and Chest	Non Drowsy	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20141231	20240531	OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
67091-266_c596cfb1-2723-4e13-8c1f-ad060462c456	67091-266	HUMAN OTC DRUG	Tussin CF	Non Drowsy Multi Symptom	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20141231		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-267_7de2bf3e-d4c2-49b5-a40d-16ca35ca0554	67091-267	HUMAN OTC DRUG	Sore Throat Relief		Phenol	SPRAY	ORAL	20141231	20241231	OTC MONOGRAPH NOT FINAL	part356	WinCo Foods, LLC	PHENOL	1.4	g/100mL			N	
67091-270_39f87bd7-1ad7-4528-91dc-27be752fd82d	67091-270	HUMAN OTC DRUG	Winco Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20210323		OTC MONOGRAPH FINAL	part333B	WinCo Foods, LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
67091-272_49b4fe68-e97f-45f6-bf9d-c97ef3d2c89c	67091-272	HUMAN OTC DRUG	WinCo Maximum Strength Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Poymyxin B Sulfate, and Pramoxine Hydrochrloride	OINTMENT	TOPICAL	20150210		OTC MONOGRAPH FINAL	part333B	WinCo Foods, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67091-274_37471dc6-90e2-4f3e-aaf2-2bd21708f781	67091-274	HUMAN OTC DRUG	WinCo Original Strength Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, and Polymyxin B sulfate	OINTMENT	TOPICAL	20150212		OTC MONOGRAPH FINAL	part333B	WinCo Foods, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67091-276_04033026-7066-e651-e063-6294a90a6c70	67091-276	HUMAN OTC DRUG	Winco Foods Tolnaftate		Tolnaftate	CREAM	TOPICAL	20150206		OTC MONOGRAPH FINAL	part333C	Winco Foods, LLC	TOLNAFTATE	10	mg/g			N	20241231
67091-277_db8bdada-c8e3-e9fd-e053-2995a90a512b	67091-277	HUMAN OTC DRUG	WinCo Original Strength Anti-Itch		Diphenhydramine hydrochloride, and Zinc acetate	CREAM	TOPICAL	20140209		OTC MONOGRAPH NOT FINAL	part348	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-278_db8bdbdb-cd38-0e05-e053-2a95a90ad7be	67091-278	HUMAN OTC DRUG	Winco Hemorrhoidal		Mineral oil, Petrolatum, and Phenylephrine Hydrochloride	CREAM	TOPICAL	20150129		OTC MONOGRAPH FINAL	part346	Winco Foods, LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	140; 749; 2.5	mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-282_0d2ac186-88d6-0e96-e063-6394a90acfb9	67091-282	HUMAN OTC DRUG	Winco Advanced Relief Eye Drops		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCl	SOLUTION/ DROPS	OPHTHALMIC	20150109		OTC MONOGRAPH DRUG	M018	WinCo Foods, LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	100; 1000; 1000; 50	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
67091-283_0d369b0b-fbc6-1955-e063-6394a90ab3c5	67091-283	HUMAN OTC DRUG	Winco Irritation Relief Eye		Tetrahydrozoline HCl, Zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20150109		OTC MONOGRAPH DRUG	M018	WinCo Foods, LLC	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	50; 250	mg/100mL; mg/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
67091-284_99044b03-0baa-2697-e053-2a95a90a3d38	67091-284	HUMAN OTC DRUG	Artificial Tears Lubricant Eye		polyvinyl alcohol, povidone	SOLUTION/ DROPS	OPHTHALMIC	20150109		OTC MONOGRAPH FINAL	part349	WinCo Foods, LLC	POLYVINYL ALCOHOL; POVIDONE	500; 600	mg/100mL; mg/100mL			N	20241231
67091-285_0d376b0b-0987-5527-e063-6394a90acce9	67091-285	HUMAN OTC DRUG	Winco Maximum Redness Relief Eye Drops		Glycerin, Naphazoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20150109		OTC MONOGRAPH DRUG	M018	WinCo Foods, LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	500; 30	mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67091-286_d237c779-99d6-4145-bdd5-69a0bcc73711	67091-286	HUMAN OTC DRUG	Laxative	Women	Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	WinCo Foods, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67091-287_ee1738bc-8082-45db-accd-d98ade2c5a0a	67091-287	HUMAN OTC DRUG	Cold and Flu Relief	Multi symptom	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20170228		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-288_02ef4aa9-ee15-46de-b5e6-93cf29ade77e	67091-288	HUMAN OTC DRUG	Cold and Flu Relief	Severe	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-289_a1ff3223-3b35-4aae-a2db-8fdab9639570	67091-289	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20151216		OTC MONOGRAPH NOT FINAL	part333A	WinCo Foods, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
67091-290_94af7475-25c3-4291-95c6-c9ff8c8a89f3	67091-290	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCl	LIQUID	ORAL	20160630		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-299_f91594ff-8c20-0385-e053-6394a90a04e7	67091-299	HUMAN OTC DRUG	Mucus Relief Sinus Pressure Pain and Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230411		OTC MONOGRAPH FINAL	part341	WINCO FOODS, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-300_0981e559-d8cb-c87f-e063-6294a90a7af1	67091-300	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20140819		OTC MONOGRAPH DRUG	M012	Winco Foods	MENTHOL	5.4	mg/1			N	20241231
67091-300_09820770-c7ad-3ab1-e063-6394a90ade0d	67091-300	HUMAN OTC DRUG	menthol cough drops		menthol	LOZENGE	ORAL	20160608		OTC MONOGRAPH DRUG	M012	Winco Foods	MENTHOL	5.4	mg/1			N	20241231
67091-301_0981cd1a-ade2-2778-e063-6394a90afeb3	67091-301	HUMAN OTC DRUG	cherry cough drops		menthol	LOZENGE	ORAL	20140819		OTC MONOGRAPH DRUG	M012	Winco Foods	MENTHOL	5.8	mg/1			N	20241231
67091-302_0981e361-dbc1-c872-e063-6294a90af7aa	67091-302	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20160608		OTC MONOGRAPH DRUG	M012	Winco foods	MENTHOL	7.5	mg/1			N	20241231
67091-302_0981fec6-145d-3929-e063-6394a90a0bba	67091-302	HUMAN OTC DRUG	honey lemon cough drops		menthol	LOZENGE	ORAL	20140819		OTC MONOGRAPH DRUG	M012	Winco Foods	MENTHOL	7.5	mg/1			N	20241231
67091-304_0981fb78-d8ec-32b2-e063-6394a90ac2d0	67091-304	HUMAN OTC DRUG	sugar free cherry cough drops		menthol	LOZENGE	ORAL	20140819		OTC MONOGRAPH DRUG	M012	Winco Foods	MENTHOL	5.8	mg/1			N	20241231
67091-307_4b562f3a-5605-424a-b0ec-86a82cd70d6d	67091-307	HUMAN OTC DRUG	Rubbing Alcohol	91 percent isopropyl	Isopropyl alcohol	LIQUID	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	WinCo Foods, LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
67091-308_109e2567-1176-4370-b7bd-2f89d8f23cc0	67091-308	HUMAN OTC DRUG	Cold and Flu Relief	DayTime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCI	CAPSULE, LIQUID FILLED	ORAL	20160930	20240531	OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
67091-309_9fd386c5-d534-4cb5-8ebe-aba3c6fdfc1e	67091-309	HUMAN OTC DRUG	Cold and Flu Relief	Multi symptom	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, Doxylamine succinate	KIT	ORAL	20160930	20241231	OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC						N	
67091-310_0d37718d-85d7-696a-e063-6394a90a291e	67091-310	HUMAN OTC DRUG	Winco Original Formula Eye Drops		Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20180926		OTC MONOGRAPH DRUG	M018	WinCo Foods, LLC	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
67091-311_b60b4483-7dd6-4707-be57-dd667220ec59	67091-311	HUMAN OTC DRUG	childrens acetaminophen		Acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	WinCo Foods, LLC	ACETAMINOPHEN	160	mg/1			N	20241231
67091-314_d794e7e6-3681-4329-9ab8-22de9e94debd	67091-314	HUMAN OTC DRUG	Mucus Relief DM Expectorant and Cough Suppressant		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Winco Foods, LLC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-315_b6b1e266-1ff8-4a43-b9b5-dfe69ac5559b	67091-315	HUMAN OTC DRUG	Mucus Relief DM Expectorant and Cough Suppressant Maximum Strength		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Winco Foods, LLC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-316_78754ca5-c9a9-436c-a941-8c70e0f58df0	67091-316	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Winco Foods, LLC.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67091-320_fafb3c9d-ef28-47b2-b376-226873baa329	67091-320	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20171231	20240531	OTC MONOGRAPH FINAL	part347	WinCo Foods, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
67091-321_7d2b3ded-415a-45f0-86a3-2f3345d185f7	67091-321	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20181102		ANDA	ANDA209207	WinCo Foods, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-322_a4af04d5-ad71-45c6-867f-9f339f9a3d30	67091-322	HUMAN OTC DRUG	Severe Cold and Cough Daytime		ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20180801		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-323_7d422032-23dd-40e9-ad5a-2cff8bff5dff	67091-323	HUMAN OTC DRUG	Severe Cold and Cough Nighttime		ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20180801		OTC MONOGRAPH DRUG	M012	WinCo Foods, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-324_49fb60b7-5c8f-4be3-89a7-ec530fc9fc98	67091-324	HUMAN OTC DRUG	Extra Moisturizing Nasal Pump Mist	Anti Drip	oxymetazoline hydrochloride	SPRAY	NASAL	20180801		OTC MONOGRAPH DRUG	M012	WinCo FOODS, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
67091-325_013cd969-7afe-4af3-b9f5-641aded6dee6	67091-325	HUMAN OTC DRUG	Severe Congestion Nasal Anti-Drip Nasal Decongestant		Oxymetazoline hydrochloride	SPRAY	NASAL	20180802		OTC MONOGRAPH DRUG	M012	WinCo FOODS, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
67091-326_a0624521-ce70-4aaf-89f5-aec5338a462d	67091-326	HUMAN OTC DRUG	ORIGINAL Nasal PUMP MIST	No Drip	oxymetazoline hydrochloride	SPRAY	NASAL	20180801		OTC MONOGRAPH DRUG	M012	WinCo FOODS, LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
67091-327_1280fee4-e763-49ba-8722-8cdb8157f1a4	67091-327	HUMAN OTC DRUG	WinCo Foods Saline Nasal Relief		Sodium Chloride	SPRAY	NASAL	20180801		OTC MONOGRAPH FINAL	part349	WinCo Foods, LLC	SODIUM CHLORIDE	.65	g/100mL			N	20241231
67091-328_11ad7424-cbf0-42c5-b565-1e7d6c6519ca	67091-328	HUMAN OTC DRUG	Stool Softener	with laxative	docusate sodium and sennosides	TABLET	ORAL	20181231		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
67091-330_1bb91129-0764-4dd9-962f-40f07811f214	67091-330	HUMAN OTC DRUG	WinCo Foods Antacid Ultra Strength		Calcium carbonate	TABLET, CHEWABLE	ORAL	20180808		OTC MONOGRAPH FINAL	part331	WinCo Foods, LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
67091-333_5dd586e9-597d-4055-8abb-29efea2a0196	67091-333	HUMAN OTC DRUG	Tussin DM Nighttime Cough	Maximum Strength	Dextromethorphan HBr, Doxylamine succinate	LIQUID	ORAL	20190201	20240531	OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
67091-334_756cafa2-1b09-44ff-b8bb-d15561133b2a	67091-334	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20190201		OTC MONOGRAPH DRUG	M013	WinCo Foods, LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
67091-335_9583ec65-581c-4b42-906f-4d620f62fac9	67091-335	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20190208		ANDA	ANDA076497	WinCo Foods, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
67091-336_ea7daf7a-65cf-4013-b01f-8e3b16e456d1	67091-336	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20190601		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC						N	20241231
67091-337_f28a56fd-249e-446a-9461-d43caa402e45	67091-337	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190601	20241231	OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
67091-338_a13359db-6f7c-44e2-9bb5-c3d929555a93	67091-338	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190601		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-339_580d241a-574d-4a8a-865d-30f01d506de4	67091-339	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20191119		OTC MONOGRAPH DRUG	M010	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-341_b9e48a25-4560-4170-9565-81d0f7cc10ea	67091-341	HUMAN OTC DRUG	Maximum Strength	Cold Flu and Sore Throat	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20190716		OTC MONOGRAPH DRUG	M012	WINCO FOODS, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-342_22e525d2-3ee8-4e7c-994f-9b471cbbb039	67091-342	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr and Guaifenesin	SOLUTION	ORAL	20190716		OTC MONOGRAPH DRUG	M012	WINCO FOODS, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-344_b6be5a72-9aea-4881-ac21-5ace98b16e17	67091-344	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190901		ANDA	ANDA209692	WinCo Foods, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-345_03f9cf53-725a-4289-9402-03c6ac2e0b13	67091-345	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190901		ANDA	ANDA209692	WinCo Foods, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-347_9650e46d-1e86-4479-e053-2a95a90ab8be	67091-347	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170601		ANDA	ANDA079174	Winco Foods, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-348_9650e46d-1e9c-4479-e053-2a95a90ab8be	67091-348	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170724		ANDA	ANDA079174	Winco Foods, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-349_efb76260-892f-c90a-e053-2a95a90aa8b3	67091-349	HUMAN OTC DRUG	Nasal Decongestant PE and Pain Relief Plus Mucus Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20171025		OTC MONOGRAPH FINAL	part341	Winco Foods, LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-350_4c7ef79d-7d85-4209-a25a-afe3c49ff902	67091-350	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20200115		ANDA	ANDA075209	WinCo Foods, LLC	LORATADINE	10	mg/1			N	20241231
67091-351_76ca82fe-8968-4b8f-981a-c9669585d949	67091-351	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20200115		ANDA	ANDA209274	WinCo Foods, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-352_0f19b2fe-152f-418c-89f1-733d97c7ca4b	67091-352	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20180701		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods, LLC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67091-354_5ceedd5d-848f-44ba-9500-afbfd4b0039b	67091-354	HUMAN OTC DRUG	Winco Foods Childrens Allergy Relief	Dye Free	Diphenhydramine hydrochloride	SOLUTION	ORAL	20200309		OTC MONOGRAPH DRUG	M012	WINCO FOODS, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-355_e807e551-1aff-4915-9c9d-378869a15708	67091-355	HUMAN OTC DRUG	Winco Foods Childrens Multi Symptom Cold		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	SUSPENSION	ORAL	20200330		OTC MONOGRAPH DRUG	M012	WINCO FOODS, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-356_a1e25024-f371-4d07-bd0f-0259ac6b20cc	67091-356	HUMAN OTC DRUG	WinCo FOODS Antacid	Regular strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200225		OTC MONOGRAPH DRUG	M001	WINCO FOODS, LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
67091-357_34fdb07c-ed1d-499c-a24a-b32245dc8f72	67091-357	HUMAN OTC DRUG	WinCo FOODS Antacid	Regular Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200225		OTC MONOGRAPH DRUG	M001	WINCO FOODS, LLC	CALCIUM CARBONATE	500	mg/1			N	20241231
67091-358_385adc7a-8a71-4139-a0f9-c3869380cc5c	67091-358	HUMAN OTC DRUG	WinCo FOODS Antacid	Ultra Strength	Calcium carbonate	TABLET, CHEWABLE	ORAL	20200226		OTC MONOGRAPH DRUG	M001	WINCO FOODS, LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
67091-359_35438e91-86c4-4b57-aec4-07a745f5229f	67091-359	HUMAN OTC DRUG	WinCo FOODS Antacid	Extra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200225		OTC MONOGRAPH DRUG	M001	WINCO FOODS, LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
67091-360_86149a3b-f245-411a-9581-1d3ed8dd9d7e	67091-360	HUMAN OTC DRUG	WinCo FOODS Antacid	Extra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200226		OTC MONOGRAPH DRUG	M001	WINCO FOODS, LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
67091-361_ab3a473c-adeb-4347-b38a-8d2522444644	67091-361	HUMAN OTC DRUG	WinCo FOODS Extra Strength	Gas Relief	Simethicone	TABLET, CHEWABLE	ORAL	20200225		OTC MONOGRAPH DRUG	M002	WINCO FOODS, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
67091-362_483506dd-73c2-47eb-8f77-0ad6f8d13030	67091-362	HUMAN OTC DRUG	WinCo FOODS Stomach Relief		Bismuth Subsalicylate	SUSPENSION	ORAL	20200224		OTC MONOGRAPH DRUG	M008	WINCO FOODS	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
67091-363_a3e6e1e7-1e15-4a5d-a3e6-a7efc5cd785c	67091-363	HUMAN OTC DRUG	WinCo FOODS Ultra Strength	Stomach Relief	Bismuth subsalicylate	SUSPENSION	ORAL	20200225		OTC MONOGRAPH DRUG	M008	WINCO FOODS	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
67091-364_41c061fb-bceb-41a2-af9b-71ccaea15bf6	67091-364	HUMAN OTC DRUG	WinCo FOODS Stomach Relief		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20200224		OTC MONOGRAPH DRUG	M008	WINCO FOODS LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
67091-365_79f0b6f3-bc38-47b6-9421-18017986555e	67091-365	HUMAN OTC DRUG	WinCo FOODS Antacid	Ultra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200226		OTC MONOGRAPH DRUG	M001	WINCO FOODS, LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
67091-366_c67a7d88-d4be-401f-9811-6f0c55b19b87	67091-366	HUMAN OTC DRUG	Winco Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200901		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
67091-368_af885c3f-3f05-1a64-e053-2995a90a99fa	67091-368	HUMAN OTC DRUG	Ibuprofen IB		Ibuprofen	TABLET, COATED	ORAL	20200401		ANDA	ANDA202312	WINCO FOODS, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-369_af886d56-0d28-ec1b-e053-2a95a90ae531	67091-369	HUMAN OTC DRUG	Ibuprofen IB		Ibuprofen	TABLET, COATED	ORAL	20200401		ANDA	ANDA202312	WINCO FOODS, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67091-370_e72f1680-be47-42d0-9b49-7c8cc45613bf	67091-370	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20201014		ANDA	ANDA207342	WinCo Foods, LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
67091-371_1d01f518-573d-472d-b55d-b59b5c03cfe4	67091-371	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Phenylephrine HCI DoxylamineSucinate	KIT		20201014		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC						N	20241231
67091-372_5228352d-4ef5-4c28-814f-035e242db629	67091-372	HUMAN OTC DRUG	WinCo Foods Oil Free Acne Wash with Pink Grapefruit	Acne treatment	Salicylic Acid	LOTION	TOPICAL	20201215		OTC MONOGRAPH FINAL	part333D	WINCO FOODS, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
67091-373_7793b2b0-a8f9-450e-ae9c-4e4ead145e75	67091-373	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20201030		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
67091-374_e2eb8777-8bd2-44f4-9cb9-c869b33aa6e1	67091-374	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20201030		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
67091-377_28fd15bf-e609-43d3-b333-4e161fc5b8bf	67091-377	HUMAN OTC DRUG	12 Hour Nasal Decongestant Extra Moisturizing		Nasal Spray	LIQUID	NASAL	20210325		OTC MONOGRAPH FINAL	part341	WinCo Foods LLC	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
67091-378_ebe8406b-2f32-4e99-900d-1269acd10c65	67091-378	HUMAN OTC DRUG	12 Hour Original Nasal Decongestant		Nasal Spray	LIQUID	NASAL	20210219		OTC MONOGRAPH FINAL	part341	WinCo Foods LLC	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
67091-379_6efbc9ea-4aaf-402e-9141-be9a8ebe8523	67091-379	HUMAN OTC DRUG	WinCo Foods Gas Relief	Extra Strength Softgels	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20201202		OTC MONOGRAPH FINAL	part332	WinCo Foods, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
67091-380_69dc607a-9f79-46d8-b7cb-72f11562be97	67091-380	HUMAN OTC DRUG	Winco Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210713		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
67091-381_d4e4b743-40ff-3666-e053-2995a90a4131	67091-381	HUMAN OTC DRUG	Complete Allergy Relief		Diphenhydramine HCl 25mg	TABLET	ORAL	20220115		OTC MONOGRAPH FINAL	part341	WinCo Foods LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-382_dfa9f6d1-8ed1-bb21-e053-2a95a90a9c0c	67091-382	HUMAN OTC DRUG	Aspirin		Aspirin tablet 325mg	TABLET	ORAL	20220118		OTC MONOGRAPH NOT FINAL	part343	WinCo Foods LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
67091-383_d50f6aa7-9f85-7b2f-e053-2a95a90a050b	67091-383	HUMAN OTC DRUG	Maximum Strength Laxative		Sennosides 25 mg	TABLET	ORAL	20220120		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods LLC	SENNOSIDES	25	mg/1			N	20241231
67091-384_d50ce169-0f66-78d1-e053-2a95a90a8691	67091-384	HUMAN OTC DRUG	Regular Strength Laxative		Sennosides 15 mg	TABLET	ORAL	20220114		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods LLC	SENNOSIDES	15	mg/1			N	20241231
67091-385_d4e989df-015f-4ee0-e053-2995a90a34e0	67091-385	HUMAN OTC DRUG	Gentle laxative		Bisacodyl	TABLET	ORAL	20220112		OTC MONOGRAPH NOT FINAL	part334	WinCo Foods LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67091-386_9f8e7b7b-dfd1-42f1-9933-e1f4dcb6539d	67091-386	HUMAN OTC DRUG	Allergy Relief	Non Drowsy	Fexofenadine HCl	CAPSULE	ORAL	20220301		ANDA	ANDA211075	WinCo Foods	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-387_e873f672-d914-3461-e053-2a95a90a90ae	67091-387	HUMAN OTC DRUG	Winco Foods		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20210806		OTC MONOGRAPH NOT FINAL	part333E	WinCo Foods, LLC	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
67091-389_cacc3808-47f8-25b6-e053-2a95a90af6da	67091-389	HUMAN OTC DRUG	Low Dose Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20210830		OTC MONOGRAPH NOT FINAL	part343	WinCo Foods, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
67091-390_f2168f75-2e23-3e40-e053-2995a90ac726	67091-390	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Powder Spray	AEROSOL, SPRAY	TOPICAL	20210929		OTC MONOGRAPH FINAL	part333C	Winco Foods, LLC	TOLNAFTATE	1.3	g/113g			N	20241231
67091-391_f216aefe-fcae-512b-e053-2995a90ad242	67091-391	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20210929		OTC MONOGRAPH FINAL	part333C	Winco Foods, LLC	TOLNAFTATE	1.5	g/150g			N	20241231
67091-392_f216ad85-ecbe-3d70-e053-2a95a90ad772	67091-392	HUMAN OTC DRUG	Miconazole Nitrate		Antifungal Miconazole Powder Spray	AEROSOL, SPRAY	TOPICAL	20210929		OTC MONOGRAPH FINAL	part333C	Winco Foods, LLC	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67091-393_ccd91136-fad4-46b1-b054-a50c773865ec	67091-393	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT	ORAL	20211029		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC						N	20241231
67091-394_5ce1b274-e7ff-4384-8621-800b556af26f	67091-394	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20211029		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67091-395_2c6a24ac-27fd-44f6-ba15-8fcba968b6e9	67091-395	HUMAN OTC DRUG	NightTime Cold and Flu	Multi Symptom	ACETAMINOPHEN DEXTROMETHORPHAN HYDROBROMIDE DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20211029		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67091-401_f9159d83-e662-0576-e053-6394a90a651a	67091-401	HUMAN OTC DRUG	Arthritis Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20230411		ANDA	ANDA211544	WINCO FOODS, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
67091-403_f9159bbb-479b-5605-e053-6294a90ad3fd	67091-403	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230411		ANDA	ANDA213420	WINCO FOODS, LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
67091-404_f9159d83-e679-0576-e053-6394a90a651a	67091-404	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230411		ANDA	ANDA213420	WINCO FOODS, LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
67091-405_1d21dc63-1ef4-4d5b-b7e3-a861b0e0855c	67091-405	HUMAN OTC DRUG	Anti Diarrheal		Loperamide HCL	CAPSULE	ORAL	20220301		ANDA	ANDA076497	WinCo Foods	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
67091-406_4c8b6c4b-51cd-4bae-b2b3-8888ce87be73	67091-406	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20220107		OTC MONOGRAPH NOT FINAL	part333A	WinCo Foods, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
67091-407_bfca3cb9-bf24-4034-b1fd-e8c4305ad3c3	67091-407	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20220107		OTC MONOGRAPH NOT FINAL	part356	WinCo Foods, LLC	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
67091-408_2a6cf697-0084-4522-bc89-b3e0f96a598d	67091-408	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20220824		ANDA	ANDA208314	Winco Foods, LLC.	LORATADINE	10	mg/1			N	20241231
67091-410_f54e5ef7-4a2e-22de-e053-2995a90a0967	67091-410	HUMAN OTC DRUG	Winco Foods Medicated Chest Rub		Camphor (synthetic), Eucalyptus oil, and Menthol	OINTMENT	TOPICAL	20230201		OTC MONOGRAPH FINAL	part341	WinCo Foods, LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
67091-411_f5dca6dd-6a75-1706-e053-2995a90a436c	67091-411	HUMAN OTC DRUG	WinCo FoodsPetroleum Jelly		White Petrolatum	JELLY	TOPICAL	20230201		OTC MONOGRAPH FINAL	M016	WinCo Foods, LLC	PETROLATUM	100	g/100g			N	20241231
67091-412_f5dcf0b2-4fa0-023a-e053-2995a90a183a	67091-412	HUMAN OTC DRUG	WinCo FoodsPetroleum Jelly		White Petrolatum	JELLY	TOPICAL	20230201		OTC MONOGRAPH FINAL	M016	WinCo Foods, LLC	PETROLATUM	100	g/100g			N	20241231
67091-413_49847cc6-469e-428c-a101-e19612801528	67091-413	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCL	CAPSULE	ORAL	20220429		OTC MONOGRAPH FINAL	part338	WinCo Foods, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-419_db8bdada-c8e4-e9fd-e053-2995a90a512b	67091-419	HUMAN OTC DRUG	WinCo Foods Hydrocortisone Cream Intensive Healing		Hydrocortisone	CREAM	TOPICAL	20200807		OTC MONOGRAPH NOT FINAL	part348	WINCO FOODS, LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67091-439_6394cf7c-bb06-485f-a79a-d38ebc4d4094	67091-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20170703		OTC MONOGRAPH NOT FINAL	part333A	Winco Foods	ALCOHOL	700	mg/mL			N	20241231
67091-442_0c1a00a0-30f0-6298-e063-6294a90a4310	67091-442	HUMAN OTC DRUG	Winco Vapor Steam		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20230801		OTC MONOGRAPH DRUG	M012	Winco Foods, LLC	CAMPHOR (SYNTHETIC)	.623	g/10mL			N	20241231
67091-447_b564a638-92b2-464e-843a-dc3f7d0e6ee6	67091-447	HUMAN OTC DRUG	Winco		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230821		NDA	NDA022015	WINCO FOODS	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67091-494_f91594ff-8c0c-0385-e053-6394a90a04e7	67091-494	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20230411		ANDA	ANDA209274	WINCO FOODS, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-630_b500df0f-e752-402a-8a1b-03157b433c2f	67091-630	HUMAN OTC DRUG	Nighttime Sleep Aid	Berry Flavor	DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20230109		OTC MONOGRAPH FINAL	part341	WINCO FOODS, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67091-804_e3dfafb6-4a87-4faf-b5e3-23ff60d2790e	67091-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20050701		OTC MONOGRAPH NOT FINAL	part333A	WinCo Foods, LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
67091-914_db8bdbdb-cd3a-0e05-e053-2a95a90ad7be	67091-914	HUMAN OTC DRUG	Winco Cold and Hot Medicated Patch Large		Menthol	PATCH	TOPICAL	20200911		OTC MONOGRAPH NOT FINAL	part348	WINCO FOODS, LLC	MENTHOL	50	mg/1			N	20241231
67091-952_cbfe4374-2c6f-424a-abd3-971b36daac95	67091-952	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20170703		OTC MONOGRAPH NOT FINAL	part333A	Winco Foods	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
67108-3565_e903089a-6fa7-4dc9-8b59-eb6adfd0e68e	67108-3565	HUMAN PRESCRIPTION DRUG	MESNEX		MESNA	TABLET, FILM COATED	ORAL	20020321		NDA	NDA020855	Baxter Healthcare Corporation	MESNA	400	mg/1	Cytoprotective Agent [EPC]		N	20241231
67133-001_06d591dc-1bd5-36cc-e063-6394a90aabb6	67133-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Fairmeadows Home Health Center	OXYGEN	99	L/100L			N	20241231
67147-544_d9ef8477-b648-4d3c-b4f1-3f767a4aea88	67147-544	HUMAN OTC DRUG	Pro-Care		CHLOROXYLENOL	SOAP	TOPICAL	20100901		OTC MONOGRAPH NOT FINAL	part333E	Apple Products, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
67151-343_f6f86f49-bbe7-4501-e053-6294a90af864	67151-343	HUMAN OTC DRUG	Wipesplus Sanitizing Alcohol Free Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20220713		OTC MONOGRAPH NOT FINAL	part333A	Progressive Products, LLC	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
67151-738_f6c98ef2-91bb-f347-e053-6294a90abaf7	67151-738	HUMAN OTC DRUG	Ethyl Alcohol		Hand Sanitizing Wipes	CLOTH	TOPICAL	20230313		OTC MONOGRAPH NOT FINAL	part333A	Progressive Products, LLC	ALCOHOL	70	mL/100mL			N	20241231
67157-101_0bf56634-8b26-f9ad-e063-6294a90ae970	67157-101	HUMAN PRESCRIPTION DRUG	Ascor		Ascorbic Acid	INJECTION	INTRAVENOUS	20180115		NDA	NDA209112	McGuff Pharmaceuticals, Inc.	ASCORBIC ACID	500	mg/mL	Ascorbic Acid [CS], Vitamin C [EPC]		N	20241231
67172-015_df027ba7-4e38-42e6-931d-c79fd2fd6d34	67172-015	HUMAN OTC DRUG	Chloraseptic Total Sore Throat and Cough, Sugar Free		Menthol and Benzocaine and Dextromethorphan Hydrobromide	LOZENGE	ORAL	20100801		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL	6; 5; 10	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67172-016_c5c358be-2eb3-47c0-a7ec-15a7d26e9ca2	67172-016	HUMAN OTC DRUG	Chloraseptic Total Sore Throat and Cough		Menthol and Benzocaine and Dextromethorphan Hydrobromide	LOZENGE	ORAL	20100801		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE; MENTHOL	6; 5; 10	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67172-017_e5f0c5e3-4e4e-4c09-b22e-6463726a96b1	67172-017	HUMAN OTC DRUG	Chloraseptic Warming Sore Throat		Benzocaine	LOZENGE	ORAL	20120101		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE	15	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67172-018_e5f0c5e3-4e4e-4c09-b22e-6463726a96b1	67172-018	HUMAN OTC DRUG	Chloraseptic Warming Sore Throat		Benzocaine	LOZENGE	ORAL	20120901		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE	15	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67172-021_ffa0e5a7-bdd9-4c1b-91f1-cda80db8251e	67172-021	HUMAN OTC DRUG	CHLORASEPTIC		menthol and benzocaine	LOZENGE	ORAL	20100801		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE; MENTHOL	6; 10	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67172-022_29517308-9668-4012-92c9-dbc61ae923a4	67172-022	HUMAN OTC DRUG	CHLORASEPTIC		menthol and benzocaine	LOZENGE	ORAL	20100801		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE; MENTHOL	6; 10	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67172-023_b7126e6f-a0a0-4ef2-98ec-e6e2d36525fa	67172-023	HUMAN OTC DRUG	Chloraspetic		menthol and benzocaine	LOZENGE	ORAL	20100801		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE; MENTHOL	6; 10	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67172-111_f8688121-fa5d-4a4d-9add-371a73bb6dc4	67172-111	HUMAN OTC DRUG	Chloraseptic Sore Throat Cherry		Phenol	SPRAY	ORAL	20100901		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PHENOL	1.4	g/100mL			N	20241231
67172-112_f8688121-fa5d-4a4d-9add-371a73bb6dc4	67172-112	HUMAN OTC DRUG	Chloraseptic Sore Throat Citrus		Phenol	SPRAY	ORAL	20100901		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PHENOL	1.4	g/100mL			N	20241231
67172-113_f8688121-fa5d-4a4d-9add-371a73bb6dc4	67172-113	HUMAN OTC DRUG	Chloraseptic Sore Throat Menthol		Phenol	SPRAY	ORAL	20100901		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PHENOL	1.4	g/100mL			N	20241231
67172-114_93e3fb68-9f51-411b-a26c-7ac7576a3e5f	67172-114	HUMAN OTC DRUG	CHLORASEPTIC MAX		Menthol and Benzocaine	LOZENGE	ORAL	20100801		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	BENZOCAINE; MENTHOL	15; 10	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67172-181_50110024-641b-407d-a4b8-2e7c8a7d018b	67172-181	HUMAN OTC DRUG	Artificial Tears Lubricant Eye		Polyvinyl Alcohol and Povidone	LIQUID	OPHTHALMIC	20120601		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	5; 6	mg/mL; mg/mL			N	20241231
67172-212_838978be-fbb7-4b2b-9916-20462a04cb8f	67172-212	HUMAN OTC DRUG	Chloraseptic Warming Sore Throat		Phenol	SPRAY	ORAL	20120701		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PHENOL	3.5	mg/.7mL			N	20241231
67172-281_7569e54f-c70f-4394-a7ea-d8cb65d30fc4	67172-281	HUMAN OTC DRUG	Equate Eye Drops		Tetrahyrozoline hydrochloride	LIQUID	OPHTHALMIC	20130211		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
67172-282_7569e54f-c70f-4394-a7ea-d8cb65d30fc4	67172-282	HUMAN OTC DRUG	Equate Eye Drops		Tetrahyrozoline hydrochloride	LIQUID	OPHTHALMIC	20130211		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
67172-292_592ab4e9-160a-4e86-96e5-9900e1ff23d7	67172-292	HUMAN OTC DRUG	Clear Eyes Cooling Itchy Eye Relief		Naphazoline Hydrochloride and Glycerin and Zinc Sulfate	LIQUID	OPHTHALMIC	20110215		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE; ZINC SULFATE	2.5; .12; 2.5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67172-361_e00fee66-d1ad-422d-9548-94a5ff811d0f	67172-361	HUMAN OTC DRUG	Murine Ear	Wax Removal Drops	Carbamide peroxide	LIQUID	AURICULAR (OTIC)	20120601		OTC MONOGRAPH FINAL	part344	Prestige Brands Holdings, Inc.	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
67172-393_59253191-5544-4d71-b117-0cabe3dfa023	67172-393	HUMAN OTC DRUG	Clear Eyes Cooling Redness Relief		Glycerin and Naphazoline Hydrochloride	LIQUID	OPHTHALMIC	20110215		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	5; .3	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67172-502_0cdbb695-2a72-4726-8b98-084b7b04624a	67172-502	HUMAN OTC DRUG	Clear Eyes Advanced Dry and Itchy		Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20190215	20251231	OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN	2.5	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	
67172-503_9b1f47fa-121c-469b-a9f7-3369b2a03903	67172-503	HUMAN OTC DRUG	Clear Eyes Sensitive		Phenylephrine hydrochloride and Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20210501		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN; PHENYLEPHRINE HYDROCHLORIDE	2.5; 2	mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67172-504_d15eef05-2c01-4f41-8c8b-08ab658146a1	67172-504	HUMAN OTC DRUG	Clear Eyes Once Daily Eye Allergy Itch Relief		Olopatadine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20210915		ANDA	ANDA090848	Prestige Brands Holdings, Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
67172-557_2aa7bfd8-e1d2-4e63-9f4e-164a27b147f3	67172-557	HUMAN OTC DRUG	Clear Eyes Natural Tears		polyvinyl alcohol and povidone	LIQUID	OPHTHALMIC	20130515		OTC MONOGRAPH DRUG	M018	Prestige Brands Holdings, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	5; 6	mg/mL; mg/mL			N	20241231
67172-573_5c34fc5b-f953-4c4f-898c-72c5f8120e44	67172-573	HUMAN OTC DRUG	Murine Plus for Dry Eyes Redness Relief		polyvinyl alcohol and povidone and tetrahydrozoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20170307		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	5; 6; .5	mg/mL; mg/mL; mg/mL			N	20241231
67172-585_ec40f1bf-dd6e-440e-98e3-9ed0083b41a1	67172-585	HUMAN OTC DRUG	Clear Eyes Travelers Eye Relief		Polyvinyl Alcohol and Povidone and Tetrahydrozoline Hydrochloride	LIQUID	OPHTHALMIC	20111115		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	5; 6; .5	mg/mL; mg/mL; mg/mL			N	20241231
67172-696_7ec217c7-cf3b-46c3-9049-0cc88245d928	67172-696	HUMAN OTC DRUG	Clear Eyes Maximum Redness Relief		Naphazoline Hydrochloride and Glycerin	LIQUID	OPHTHALMIC	20100901		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	5; .3	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67172-707_2c966a39-6954-47c5-b18d-e8cdaf19c8e6	67172-707	HUMAN OTC DRUG	Clear Eyes Complete 7 Sympton Relief		Hypromellose, Naphazoline Hydrochloride, Polysorbate 80 and Zinc Sulfate	LIQUID	OPHTHALMIC	20130612		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	HYPROMELLOSES; NAPHAZOLINE HYDROCHLORIDE; POLYSORBATE 80; ZINC SULFATE	.5; .0625; 1.25; .625	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
67172-796_e2d206d1-512f-40f4-83ee-b9922f0547c9	67172-796	HUMAN OTC DRUG	Clear Eyes Redness Relief Handy Pocket Pal		Naphazoline Hydrochloride and Glycerin	LIQUID	OPHTHALMIC	20121101		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.0025; .00012	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67172-797_e2d206d1-512f-40f4-83ee-b9922f0547c9	67172-797	HUMAN OTC DRUG	Clear Eyes Redness Relief		Naphazoline Hydrochloride and Glycerin	LIQUID	OPHTHALMIC	20110427		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	2.5; .12	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67172-898_fc9a166d-3a2b-4f06-b64b-e34471d28d5e	67172-898	HUMAN OTC DRUG	Clear Eyes Triple Relief		Polyvinyl Alcohol and Povidone and Tetrahydrozoline Hydrochloride	LIQUID	OPHTHALMIC	20110315		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	5; 6; .5	mg/mL; mg/mL; mg/mL			N	20241231
67172-935_7f01fe2d-6ed3-4db7-aaa6-694afe52f5f2	67172-935	HUMAN OTC DRUG	Chloraseptic Sore Throat		Phenol	SPRAY	ORAL	20100901		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	PHENOL	3.5	mg/.7mL			N	20241231
67172-937_5a1d5a34-d862-4ace-a89d-0af612fe286a	67172-937	HUMAN OTC DRUG	Chloraseptic Sore Throat Max		Phenol and Glycerin	SPRAY	ORAL	20110201		OTC MONOGRAPH NOT FINAL	part356	Prestige Brands Holdings, Inc.	GLYCERIN; PHENOL	330; 15	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67172-999_ddbc63e0-d489-4198-99d7-53fe25b7073a	67172-999	HUMAN OTC DRUG	Clear Eyes Maximum Itchy Eye Relief		Glycerin and Naphazoline Hydrochloride and Zinc Sulfate	LIQUID	OPHTHALMIC	20110315		OTC MONOGRAPH FINAL	part349	Prestige Brands Holdings, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE; ZINC SULFATE	2.5; .12; 2.5	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67184-0501_f9f54aa0-22e3-4958-b368-d89d716ac2fa	67184-0501	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160511		ANDA	ANDA204616	Qilu Pharmaceutical Co., Ltd.	OXALIPLATIN	50	mg/10mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
67184-0502_f9f54aa0-22e3-4958-b368-d89d716ac2fa	67184-0502	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160511		ANDA	ANDA204616	Qilu Pharmaceutical Co., Ltd.	OXALIPLATIN	100	mg/20mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
67184-0503_0dc735ab-c4c9-4e19-bb80-8a439be7208c	67184-0503	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA204890	Qilu Pharmaceutical Co., Ltd.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
67184-0504_0dc735ab-c4c9-4e19-bb80-8a439be7208c	67184-0504	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA204890	Qilu Pharmaceutical Co., Ltd.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
67184-0507_cd294344-e9fc-4b11-811f-0a8843db3227	67184-0507	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140908		ANDA	ANDA203711	Qilu Pharmaceutical Co., Ltd.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67184-0508_823cd135-5e79-4f53-955c-d22f9785d681	67184-0508	HUMAN PRESCRIPTION DRUG	Oxaliplatin		oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20160607		ANDA	ANDA204368	Qilu Pharmaceutical Co., Ltd.	OXALIPLATIN	50	mg/10mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
67184-0509_823cd135-5e79-4f53-955c-d22f9785d681	67184-0509	HUMAN PRESCRIPTION DRUG	Oxaliplatin		oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20160607		ANDA	ANDA204368	Qilu Pharmaceutical Co., Ltd.	OXALIPLATIN	100	mg/20mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
67184-0510_823cd135-5e79-4f53-955c-d22f9785d681	67184-0510	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20160607		ANDA	ANDA204368	Qilu Pharmaceutical Co., Ltd.	OXALIPLATIN	200	mg/40mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
67184-0511_5faaf9ca-ed20-4ebf-9e7f-1d3a0ca60056	67184-0511	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20160503		ANDA	ANDA203380	Qilu Pharmaceutical Co., Ltd.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
67184-0512_5faaf9ca-ed20-4ebf-9e7f-1d3a0ca60056	67184-0512	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20160503		ANDA	ANDA203380	Qilu Pharmaceutical Co., Ltd.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
67184-0513_5faaf9ca-ed20-4ebf-9e7f-1d3a0ca60056	67184-0513	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20160503		ANDA	ANDA203380	Qilu Pharmaceutical Co., Ltd.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
67184-0514_abeff9bd-6829-445c-93b8-3d9217993b9c	67184-0514	HUMAN PRESCRIPTION DRUG	Palonosetron		Palonosetron Hydrochloride	INJECTION	INTRAVENOUS	20180919		ANDA	ANDA205648	Qilu Pharmaceutical Co., Ltd.	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67184-0515_abeff9bd-6829-445c-93b8-3d9217993b9c	67184-0515	HUMAN PRESCRIPTION DRUG	Palonosetron		Palonosetron Hydrochloride	INJECTION	INTRAVENOUS	20180919		ANDA	ANDA205648	Qilu Pharmaceutical Co., Ltd.	PALONOSETRON HYDROCHLORIDE	.075	mg/1.5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67184-0517_4ad0176d-0102-457a-9fcb-472dcedd9709	67184-0517	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate Tablets	TABLET, FILM COATED	ORAL	20200401		ANDA	ANDA209333	Qilu Pharmaceutical Co., Ltd.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
67184-0523_3c59b310-6a02-451b-bc53-a29022509963	67184-0523	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211117		ANDA	ANDA210420	Qilu Pharmaceutical Co., Ltd.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
67184-0524_3c59b310-6a02-451b-bc53-a29022509963	67184-0524	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211117		ANDA	ANDA210420	Qilu Pharmaceutical Co., Ltd.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
67184-0525_3c59b310-6a02-451b-bc53-a29022509963	67184-0525	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211117		ANDA	ANDA210420	Qilu Pharmaceutical Co., Ltd.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
67184-0526_3c59b310-6a02-451b-bc53-a29022509963	67184-0526	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211117		ANDA	ANDA210420	Qilu Pharmaceutical Co., Ltd.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
67184-0530_7f2d7d7b-99b3-4b68-9bbd-89a8249c66a0	67184-0530	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502		ANDA	ANDA210824	Qilu Pharmaceutical Co., Ltd.	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
67184-0531_8aa73f33-2813-4dfa-939f-e4291081449a	67184-0531	HUMAN PRESCRIPTION DRUG	Gefitinib		Gefitinib	TABLET, COATED	ORAL	20230213		ANDA	ANDA211591	Qilu Pharmaceutical Co., Ltd.	GEFITINIB	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
67184-0532_ef862d44-0d4c-952e-e053-2a95a90a7031	67184-0532	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET	ORAL	20220621		ANDA	ANDA212135	Qilu Pharmaceutical Co., Ltd.	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
67184-0533_ef862d44-0d4c-952e-e053-2a95a90a7031	67184-0533	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET	ORAL	20220621		ANDA	ANDA212135	Qilu Pharmaceutical Co., Ltd.	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
67184-0535_0afb3dc7-6072-4a53-acc4-59589fb8491e	67184-0535	HUMAN PRESCRIPTION DRUG	Decitabine		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210412		ANDA	ANDA212826	Qilu Pharmaceutical Co., Ltd.	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67184-0540_8cdf3940-953f-425a-930e-e6a34c2655bc	67184-0540	HUMAN PRESCRIPTION DRUG	FOSAPREPITANT DIMEGLUMINE		FOSAPREPITANT DIMEGLUMINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200908		ANDA	ANDA213106	Qilu Pharmaceutical Co., Ltd.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
67184-0549_b5353d4b-44da-4c86-b8ae-f94345c5c3c8	67184-0549	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210824		ANDA	ANDA215316	Qilu Pharmaceutical Co., Ltd.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
67184-0560_0cc53b72-80e0-4a82-e063-6394a90a7fdf	67184-0560	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220318		ANDA	ANDA203661	Qilu Pharmaceutical Co., Ltd.	CEFAZOLIN SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1001_0cc53b72-80e0-4a82-e063-6394a90a7fdf	67184-1001	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151228		ANDA	ANDA203661	Qilu Pharmaceutical Co., Ltd.	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1002_34afba66-733f-4403-83d1-1b67b8a6633b	67184-1002	HUMAN PRESCRIPTION DRUG	Cefepime		CEFEPIME HYDROCHLORIDE	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160201		ANDA	ANDA203704	Qilu Pharmaceutical Co., Ltd.	CEFEPIME HYDROCHLORIDE	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1003_34afba66-733f-4403-83d1-1b67b8a6633b	67184-1003	HUMAN PRESCRIPTION DRUG	Cefepime		CEFEPIME HYDROCHLORIDE	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160201		ANDA	ANDA203704	Qilu Pharmaceutical Co., Ltd.	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1004_34afba66-733f-4403-83d1-1b67b8a6633b	67184-1004	HUMAN PRESCRIPTION DRUG	Cefepime		CEFEPIME HYDROCHLORIDE	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160201		ANDA	ANDA203704	Qilu Pharmaceutical Co., Ltd.	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1005_ffac7eac-e0b5-4d9f-b2ad-9bc704f82e31	67184-1005	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160629		ANDA	ANDA203702	Qilu Pharmaceutical Co., Ltd.	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1006_ffac7eac-e0b5-4d9f-b2ad-9bc704f82e31	67184-1006	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160629		ANDA	ANDA203702	Qilu Pharmaceutical Co., Ltd.	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1007_ffac7eac-e0b5-4d9f-b2ad-9bc704f82e31	67184-1007	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160629		ANDA	ANDA203702	Qilu Pharmaceutical Co., Ltd.	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67184-1008_ffac7eac-e0b5-4d9f-b2ad-9bc704f82e31	67184-1008	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160629		ANDA	ANDA203702	Qilu Pharmaceutical Co., Ltd.	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67191-123_08280310-3a31-c13e-e063-6294a90ac994	67191-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170509		UNAPPROVED MEDICAL GAS		Clinical Medical Services, Inc.	OXYGEN	99	L/100L			N	20241231
67194-005_0814b5f6-6da8-6220-e063-6394a90ae05e	67194-005	HUMAN OTC DRUG	Numquick Topical Analgesic		EPINEPHRINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20160120		OTC MONOGRAPH DRUG	M015	Unit Dose, Ltd.	EPINEPHRINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE	.1; 50	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
67194-008_0814c949-b73a-deed-e063-6294a90acf83	67194-008	HUMAN OTC DRUG	Numquick Analgesic		EPINEPHRINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE	SPRAY	TOPICAL	20160120		OTC MONOGRAPH DRUG	M015	Unit Dose, Ltd.	EPINEPHRINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE	.1; 50	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
67194-012_0814bb16-a648-d1c9-e063-6294a90a5ad2	67194-012	HUMAN OTC DRUG	Healquick Tattoo Balm		PETROLATUM	STICK	TOPICAL	20160122		OTC MONOGRAPH DRUG	M015	Unit Dose, Ltd.	PETROLATUM	670	mg/g			N	20241231
67194-014_08052e8d-9708-d5b6-e063-6394a90ae8e0	67194-014	HUMAN OTC DRUG	Numstick		PETROLATUM, LIDOCAINE	STICK	TOPICAL	20160122		OTC MONOGRAPH DRUG	M015	Unit Dose, Ltd.	LIDOCAINE; PETROLATUM	50; 600	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67194-017_0814dd5c-455c-739e-e063-6394a90ac8bc	67194-017	HUMAN OTC DRUG	Liprotek		PETROLATUM, LIDOCAINE	OINTMENT	TOPICAL	20160121		OTC MONOGRAPH DRUG	M017	Unit Dose, Ltd.	LIDOCAINE; PETROLATUM	6; 610	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67194-018_0814bc6d-5504-8353-e063-6394a90a0e16	67194-018	HUMAN OTC DRUG	Numpot Topical Anesthetic		LIDOCAINE, PETROLATUM	OINTMENT	TOPICAL	20160120		OTC MONOGRAPH DRUG	M015	Unit Dose, Ltd.	LIDOCAINE; PETROLATUM	50; 710	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67194-020_0814ce6b-2e81-e68b-e063-6294a90a3daf	67194-020	HUMAN OTC DRUG	Numfast Tetracaine Green		TETRACAINE	CREAM	TOPICAL	20160120		OTC MONOGRAPH DRUG	M017	Unit Dose, Ltd.	TETRACAINE	20	mg/g	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
67194-022_0814ce6b-2e90-e68b-e063-6294a90a3daf	67194-022	HUMAN OTC DRUG	Microcaine Topical Analgesic		LIDOCAINE	CREAM	TOPICAL	20160119		OTC MONOGRAPH DRUG	M015	Unit Dose, Ltd.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67224-693_be4c1c52-c039-5bd8-e053-2995a90a4cc7	67224-693	HUMAN OTC DRUG	Bacti-Gone		Bacti-Gone	LIQUID	TOPICAL	20110102		OTC MONOGRAPH NOT FINAL	part333A	Beta Technology,Inc	ALCOHOL	67	mL/100mL			N	20241231
67225-2213_0ce7fe34-2c95-cffd-e063-6294a90a81b7	67225-2213	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT LONG STAY 13 IVORY		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20220523		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.91; .42; .7168	g/14g; g/14g; g/14g			N	20241231
67225-2221_0ce82b1f-a34b-c98e-e063-6294a90a1d36	67225-2221	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT LONG STAY 21 LIGHT BEIGE		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20220908		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.91; .42; .7168	g/14g; g/14g; g/14g			N	20241231
67225-2313_0ce81501-c969-142f-e063-6394a90a9b58	67225-2313	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT MOISTURE 13 IVORY		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20220524		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.98; .56; .581	g/14g; g/14g; g/14g			N	20241231
67225-2321_0d6357ac-ea93-7b74-e063-6394a90a1728	67225-2321	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT MOISTURE 21 LIGHT BEIGE		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20220908		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.98; .56; .581	g/14g; g/14g; g/14g			N	20241231
67225-3020_0cc4c3aa-581b-3222-e063-6294a90a4fe3	67225-3020	HUMAN OTC DRUG	AEKYUNGLUNA LONG LASTING CONCEAL FIXING CUSHION 21C COOL IVORY		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220609		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	.7968; .8196	g/12g; g/12g			N	20241231
67225-3021_0cd6854c-dae7-9cd7-e063-6394a90a8dfe	67225-3021	HUMAN OTC DRUG	AEKYUNGLUNA LONG LASTING CONCEAL FIXING CUSHION 21W WARM BEIGE		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220609		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	.7968; .8196	g/12g; g/12g			N	20241231
67225-3022_0cd66efb-11d3-3680-e063-6294a90a62f7	67225-3022	HUMAN OTC DRUG	AEKYUNGLUNA LONG LASTING CONCEAL FIXING CUSHION 23M MEDIUM BEIGE		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220609		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	.7968; .8196	g/12g; g/12g			N	20241231
67225-5013_0cd6d484-5e94-b324-e063-6394a90a0fef	67225-5013	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 13 IVORY		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20220907		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.91; .42; .7168	g/14g; g/14g; g/14g			N	20241231
67225-5021_0cd75356-2c31-032e-e063-6394a90a13df	67225-5021	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 21 LIGHT BEIGE		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20220907		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.91; .42; .7168	g/14g; g/14g; g/14g			N	20241231
67225-5031_0ce76211-7c32-98d3-e063-6394a90af625	67225-5031	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 31 MEDIUM TAN		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20220907		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.91; .42; .7168	g/14g; g/14g; g/14g			N	20241231
67225-5230_0ce752c2-6e42-7162-e063-6294a90a8975	67225-5230	HUMAN OTC DRUG	AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 23 MEDIUM BEIGE		Octinoxate, Octocrylene, Titanium Dioxide	CREAM	TOPICAL	20221020		OTC MONOGRAPH DRUG	M020	Aekyung Industrial Co., Ltd.	OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE	.91; .42; .7168	g/14g; g/14g; g/14g			N	20241231
67226-1021_0a1fa998-dcdd-c181-e063-6294a90ad098	67226-1021	HUMAN OTC DRUG	Medicated Wash		SALICYLIC ACID	LIQUID	TOPICAL	20171111		OTC MONOGRAPH DRUG	M006	Vivier Pharma, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
67226-2016_ec07aaa1-39db-d98c-e053-2995a90aaaa2	67226-2016	HUMAN OTC DRUG	Daily Moisturizing SPF 15		OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20190501	20240229	OTC MONOGRAPH NOT FINAL	part352	Vivier Pharma, Inc.	OCTINOXATE; OCTISALATE; OXYBENZONE	75; 30; 30	mg/mL; mg/mL; mg/mL			N	
67226-2031_0e72e4f1-001d-a67a-e063-6294a90a5c5d	67226-2031	HUMAN OTC DRUG	Sunscreen	SPF 30	AVOBENZONE , OCTINOXATE , ENSULIZOLE	LOTION	TOPICAL	20180701	20250131	OTC MONOGRAPH DRUG	M020	Vivier Pharma, Inc.	AVOBENZONE; ENSULIZOLE; OCTINOXATE	2.5; 2; 7.5	g/100mL; g/100mL; g/100mL			N	
67226-2050_08bf29ff-1c59-1547-e063-6294a90ac7ee	67226-2050	HUMAN OTC DRUG	Acne Treatment		BENZOYL PEROXIDE	LOTION	TOPICAL	20111101		OTC MONOGRAPH DRUG	M006	Vivier Pharma, Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
67226-2231_08171e41-8db2-67c3-e063-6394a90a0c12	67226-2231	HUMAN OTC DRUG	Triple Protection Sunscreen Broad Spectrum SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171111	20251231	OTC MONOGRAPH DRUG	M020	Vivier Pharma Inc	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
67226-2232_08bf2eb5-b405-0ce8-e063-6294a90af3a0	67226-2232	HUMAN OTC DRUG	Sheet SPF 30 Mineral		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210104		OTC MONOGRAPH DRUG	M020	Vivier Pharma Inc.	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL			N	20241231
67226-2845_08176a75-84e5-6b05-e063-6294a90a40b0	67226-2845	HUMAN OTC DRUG	Sheer Broad Spectrum SPF45		ZINC OXIDE, OCTOCRYLENE, OCTINOXATE, OCTISALATE	LOTION	TOPICAL	20150514		OTC MONOGRAPH DRUG	M020	Vivier Pharma Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	75; 50; 80; 99	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
67226-2850_08bf29ff-1c49-1547-e063-6294a90ac7ee	67226-2850	HUMAN OTC DRUG	Vivier Sheer SPF 30 Mineral		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230105		OTC MONOGRAPH DRUG	M020	Vivier Pharma, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL			N	20241231
67226-2851_08bf3bb5-bbfb-99b5-e063-6394a90a8028	67226-2851	HUMAN OTC DRUG	Vivier Sheer SPF 30 Mineral Tinted		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230105		OTC MONOGRAPH DRUG	M020	Vivier Pharma, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	100; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
67226-2852_08bf32be-a1ca-0c37-e063-6294a90a5c9b	67226-2852	HUMAN OTC DRUG	Vivier Sheer SPF 45		ZINC OXIDE, OCTOCRYLENE, OCTINOXATE, OCTISALATE	LOTION	TOPICAL	20230105		OTC MONOGRAPH DRUG	M020	Vivier Pharma, Inc.	OCTINOXATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	75; 50; 80; 99	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
67226-3026_08bf3bb5-bbeb-99b5-e063-6394a90a8028	67226-3026	HUMAN OTC DRUG	Acne Treatment System		BENZOYL PEROXIDE, SALICYLIC ACID	KIT		20171111		OTC MONOGRAPH DRUG	M006	Vivier Pharma, Inc.						N	20241231
67234-001_aa9ba666-5b61-46ec-bd97-a6e98a9c4a70	67234-001	HUMAN OTC DRUG	Natureplex Diaper Rash		ZINC OXIDE	CREAM	TOPICAL	20050102		OTC MONOGRAPH FINAL	part347	Natureplex LLC	ZINC OXIDE	400	mg/g			N	20241231
67234-002_89f0e6ea-4368-417a-ad0b-9b02e69e588e	67234-002	HUMAN OTC DRUG	Muscle Rub	Ultra Strength	MENTHOL and METHYL SALICYLATE	CREAM	TOPICAL	20070102		OTC MONOGRAPH NOT FINAL	part348	Natureplex LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.01; .15	mg/g; mg/g			N	20241231
67234-007_419c92fa-de15-402c-9b8b-f3ae05f0e19a	67234-007	HUMAN OTC DRUG	Acne Treatment		SALICYLIC ACID	GEL	TOPICAL	20070102		OTC MONOGRAPH FINAL	part333D	Natureplex LLC	SALICYLIC ACID	5	mg/g			N	20241231
67234-008_23ac82ee-44e5-452d-aef5-e50e07febcd6	67234-008	HUMAN OTC DRUG	Anti Itch	Maximum Relief	Pramoxine Hydrochloride and Menthol	CREAM	TOPICAL	20080102		OTC MONOGRAPH NOT FINAL	part347	Natureplex LLC	MENTHOL, UNSPECIFIED FORM; PRAMOXINE HYDROCHLORIDE	10; 10	mg/g; mg/g			N	20241231
67234-009_32f06563-9f82-418a-aced-cddda32dd0be	67234-009	HUMAN OTC DRUG	Athlete s Foot	Afac	Clotrimazole	CREAM	TOPICAL	20080122		OTC MONOGRAPH FINAL	part333C	Natureplex, LLC	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67234-010_da2660d2-8e1a-486d-acb1-043266c9473e	67234-010	HUMAN OTC DRUG	Natureplex Hydrocortisone	Hydro	Hydrocortisone	CREAM	TOPICAL	20080122		OTC MONOGRAPH NOT FINAL	part348	Natureplex, LLC	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67234-014_2af194fd-04d0-4c5b-b387-024a7903c0b1	67234-014	HUMAN OTC DRUG	PRO-EX	Anti Fungal	Clotrimazole	CREAM	TOPICAL	20080122		OTC MONOGRAPH FINAL	part333C	Natureplex, LLC	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67234-019_93c3aa6d-aa45-4a56-84f5-6876db5b2572	67234-019	HUMAN OTC DRUG	Enema Mineral Oil		Mineral Oil	ENEMA	RECTAL	20130105		OTC MONOGRAPH NOT FINAL	part334	Natureplex LLC	MINERAL OIL	118	g/118mL			N	20241231
67234-020_ef59dd61-3db3-4254-bd64-f8d199b7da48	67234-020	HUMAN OTC DRUG	NATUREPLEX	Enema	(saline)	ENEMA	RECTAL	20100601		OTC MONOGRAPH NOT FINAL	part334	Natureplex, LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/133mL; g/133mL			N	20241231
67234-022_4e2414b0-e8f1-4a9e-98dd-cdb190918fab	67234-022	HUMAN OTC DRUG	Bella Flore		POVIDONE-IODINE	KIT		20120102		OTC MONOGRAPH NOT FINAL	part333A	Natureplex LLC						N	20241231
67234-023_8a8a28e4-f72c-41e2-b190-3ca26b7c89c4	67234-023	HUMAN OTC DRUG	Dermamine	Extra Strength Itch Stopping	DIPHENHYDRAMINE and ZINC ACETATE	CREAM	TOPICAL	20140301		OTC MONOGRAPH NOT FINAL	part348	Natureplex LLC	DIPHENHYDRAMINE; ZINC ACETATE	.02; .001	mg/g; U/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67234-024_c69046f5-7564-4cb2-a366-c04cc67a9a13	67234-024	HUMAN OTC DRUG	Natureplex	Hemorrhoidal	WITCH HAZEL and PHENYLEPHRINE HYDROCHLORIDE	GEL	TOPICAL	20140318		OTC MONOGRAPH FINAL	part346	Natureplex LLC	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	.0025; .5	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67234-025_1dbf3440-c1f0-4701-aa08-83717433d396	67234-025	HUMAN OTC DRUG	Natureplex	Hemorrhoidal	GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, and PETROLATUM	CREAM	TOPICAL	20140301		OTC MONOGRAPH FINAL	part346	Natureplex LLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	.144; .15; .0025; .1	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67234-027_eee2cb5c-542f-4d10-bebc-8101221429ec	67234-027	HUMAN OTC DRUG	Scar Gel	Advanced Formula	ALLANTOIN	CREAM	TOPICAL	20131101		OTC MONOGRAPH FINAL	part347	Natureplex LLC	ALLANTOIN	.005	mg/g			N	20241231
67234-030_222004da-172c-4964-89c2-d67e212818bc	67234-030	HUMAN OTC DRUG	A and D	Diaper Rash and Skin Protectant	Lanolin and Petrolatum	CREAM	TOPICAL	20141112		OTC MONOGRAPH FINAL	part347	Natureplex LLC	LANOLIN; PETROLATUM	.15; .53	mg/g; mg/g			N	20241231
67234-031_de5a974f-fc60-4c96-b85d-7a264c8a44a3	67234-031	HUMAN OTC DRUG	TRIPLE ANTIBIOTIC	FIRST AID ANTIBIOTIC	BACITRACIN ZINC, NEOMYCIN SULFATE, and POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20110803		OTC MONOGRAPH FINAL	part333B	Natureplex LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	U/9.4g; mg/9.4g; U/9.4g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67234-032_c2258205-0c1d-4535-a590-8ca5f9cc0da4	67234-032	HUMAN OTC DRUG	NATUREPLEX TOLNAFTATE	ANTIFUNGAL	TOLNAFTATE	CREAM	TOPICAL	19930923		OTC MONOGRAPH FINAL	part333C	Natureplex, LLC	TOLNAFTATE	10	mg/g			N	20241231
67234-035_94b69547-fb1d-4591-9e38-451521fbf64b	67234-035	HUMAN OTC DRUG	ZITFREE	ACNE TREATMENT	BENZOYL PEROXIDE	OINTMENT	TOPICAL	20141201		OTC MONOGRAPH FINAL	part333D	Natureplex LLC	BENZOYL PEROXIDE	100	mg/g			N	20241231
67234-037_da4b3275-2f1b-425a-8d98-d61d3a65b87b	67234-037	HUMAN OTC DRUG	BurnX	Pain Relieving Burn	LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20100410		OTC MONOGRAPH NOT FINAL	part348	Natureplex, LLC	LIDOCAINE HYDROCHLORIDE	.025	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67234-038_191f61b4-be43-4421-bc47-a0990edcba51	67234-038	HUMAN OTC DRUG	Climax Control	Benzocaine	Benzocaine	GEL	TOPICAL	20160125		OTC MONOGRAPH FINAL	part333B	Natureplex LLC	BENZOCAINE	.075	g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67234-041_214096c4-abf7-4d4f-b93b-6a0a2f3b7c15	67234-041	HUMAN OTC DRUG	ORAL SALINE LAXATIVE CHERRY	LAXATIVE	SODIUM PHOSPHATE, DIBASIC and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	LIQUID	ORAL	20120831		OTC MONOGRAPH NOT FINAL	part334	Natureplex, LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	1.4; 6.2	g/14.7868mL; g/14.7868mL			N	20241231
67234-042_c75f4dd4-e4a6-49b4-94df-0979b152fcdb	67234-042	HUMAN OTC DRUG	Pediatric	Saline Laxative	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, DIBASIC	ENEMA	RECTAL	20120831		OTC MONOGRAPH NOT FINAL	part334	Natureplex, LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	9.5; 3.5	g/59mL; g/59mL			N	20241231
67234-043_a70d131c-5f66-4ffd-94b8-6ccb27ee834d	67234-043	HUMAN OTC DRUG	PROPLEX GREASELESS MUSCLE RUB		MENTHOL, UNSPECIFIED FORM and METHYL SALICYLATE	CREAM	TOPICAL	20190318		OTC MONOGRAPH NOT FINAL	part348	Natureplex LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 15	mg/g; mg/g			N	20241231
67234-044_e12c16df-924d-4cca-9370-88a02c2379dd	67234-044	HUMAN OTC DRUG	ORAL SALINE LAXATIVE LEMON GINGER		SODIUM PHOSPHATE, DIBASIC and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	LIQUID	ORAL	20120530		OTC MONOGRAPH NOT FINAL	part334	Natureplex, LLC	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	1.4; 6.2	g/14.7868mL; g/14.7868mL			N	20241231
67234-047_1f92c347-487e-4a33-9014-53ae162a221d	67234-047	HUMAN OTC DRUG	Skullduggery Pain Relief and Skin Protection for Tattoos		Lanolin, Petrolatum and Lidocaine	KIT		20030604		OTC MONOGRAPH FINAL	part347	Natureplex, LLC						N	20241231
67234-048_e248765f-837d-4db7-96a3-7ac5f0795318	67234-048	HUMAN OTC DRUG	Kendra SKIN PROTECTION and PAIN RELIEF FOR HAIR REMOVAL		Lanolin, Petrolatum and Lidocaine	KIT		20030604		OTC MONOGRAPH FINAL	part347	Natureplex, LLC						N	20241231
67234-052_de9e7c69-0842-4eb5-af1d-41f259b39571	67234-052	HUMAN OTC DRUG	PROPLEX LIDOCAINE		LIDOCAINE	CREAM	TOPICAL	20190318		OTC MONOGRAPH NOT FINAL	part348	Natureplex LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67234-059_ba6b8196-89c7-4081-b566-a3edc1b9876b	67234-059	HUMAN OTC DRUG	PROPLEX BACITRACIN		BACITRACIN	CREAM	TOPICAL	20190318		OTC MONOGRAPH FINAL	part333B	Natureplex LLC	BACITRACIN	500	U/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
67234-066_9d172c92-66eb-4878-b8ce-0df110014e85	67234-066	HUMAN OTC DRUG	Tattoo After Care	A and D	Lanolin and Petrolatum	OINTMENT	TOPICAL	20180615		OTC MONOGRAPH FINAL	part347	Natureplex LLC	LANOLIN; PETROLATUM	.15; .53	mg/g; mg/g			N	20241231
67234-067_2046c914-81b4-477d-8e1c-f095d8f42e77	67234-067	HUMAN OTC DRUG	Natureplex Lidocaine 4%		Lidocaine	CREAM	TOPICAL	20170315		OTC MONOGRAPH FINAL	part333B	Natureplex LLC	LIDOCAINE	.04	g/28g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67234-068_5c7bf435-0722-43f9-8d3b-2b0e14d15981	67234-068	HUMAN OTC DRUG	NATUREPLEX ANTIBIOTIC plus PAIN RELIEF		NEOMYCIN SULFATE, POLYMYXIN B SULFATE, and PRAMOXINE HYDROCHLORIDE	CREAM	TOPICAL	20181206		OTC MONOGRAPH FINAL	part333B	Natureplex	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/9.4g; [iU]/9.4g; mg/9.4g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67234-073_81626372-eadb-4544-9222-855eb6dea9df	67234-073	HUMAN OTC DRUG	NATUREPLEX PSORIASIS		SALICYLIC ACID	CREAM	TOPICAL	20190724		OTC MONOGRAPH FINAL	part358H	Natureplex LLC	SALICYLIC ACID	20	mg/g			N	20241231
67234-075_1e3b3ab5-0fda-475f-8d51-8edbdbbcdcbe	67234-075	HUMAN OTC DRUG	ALCOHOL ANTISEPTIC		ALCOHOL	SOLUTION	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333E	Natureplex LLC	ALCOHOL	80	mL/100mL			N	20241231
67234-076_5bf670e9-4a55-4c8a-a203-d969e7e3befb	67234-076	HUMAN OTC DRUG	NATUREPLEX EXTRA STRENGTH MUSCLE RUB		MENTHOL, UNSPECIFIED FORM	CREAM	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part348	Natureplex LLC	MENTHOL, UNSPECIFIED FORM	2.5	g/100g			N	20241231
67234-077_23a91898-4e26-42c4-8f86-c262b54712ea	67234-077	HUMAN OTC DRUG	NATUREPLEX ANTIBIOTIC		BACITRACIN ZINC and POLYMYXIN B SULFATE	CREAM	TOPICAL	20210928		OTC MONOGRAPH FINAL	part333B	Natureplex LLC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	U/14g; U/14g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67239-0201_b4ac4b9c-1ac6-491e-8509-b8362e6f822d	67239-0201	HUMAN PRESCRIPTION DRUG	MEPIVACAINE HYDROCHLORIDE		Mepivacaine Hydrochloride	INJECTION, SOLUTION	SUBCUTANEOUS	20110101		ANDA	ANDA088387	Safco Dental Supply Co.	MEPIVACAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
67239-0209_253a3ea1-c583-49d4-9655-b33ffa1115b0	67239-0209	HUMAN PRESCRIPTION DRUG	Articaine HCl and Epinephrine		articaine hydrochloride and epinephrine bitartrate	INJECTION	SUBMUCOSAL	20160601		NDA AUTHORIZED GENERIC	NDA022466	Safco Dental Supply Co.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; 10	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
67239-0210_253a3ea1-c583-49d4-9655-b33ffa1115b0	67239-0210	HUMAN PRESCRIPTION DRUG	Articaine HCl and Epinephrine		articaine hydrochloride and epinephrine bitartrate	INJECTION	SUBMUCOSAL	20160601		NDA AUTHORIZED GENERIC	NDA022466	Safco Dental Supply Co.	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
67239-0218_d65a5631-9609-8e28-e053-2995a90a43af	67239-0218	HUMAN OTC DRUG	Safco Sensicaine Ultra Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Safco Dental Supply Co.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67239-0219_d65a82dd-1139-5945-e053-2a95a90a69ff	67239-0219	HUMAN OTC DRUG	Safco Sensicaine Ultra Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Safco Dental Supply Co.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67239-0220_d65a7d7f-6f3c-0c1c-e053-2995a90a9790	67239-0220	HUMAN OTC DRUG	Safco Sensicaine Ultra Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Safco Dental Supply Co.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67239-0221_d65a82dd-1145-5945-e053-2a95a90a69ff	67239-0221	HUMAN OTC DRUG	Safco Sensicaine Ultra Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Safco Dental Supply Co.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67239-0222_d65a82dd-1151-5945-e053-2a95a90a69ff	67239-0222	HUMAN OTC DRUG	Safco Sensicaine Ultra Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Safco Dental Supply Co.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67239-0223_d65a4bce-29c8-7d9c-e053-2a95a90a97f7	67239-0223	HUMAN OTC DRUG	Safco Sensicaine Ultra Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20190305		OTC MONOGRAPH NOT FINAL	part356	Safco Dental Supply Co.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67239-0225_0d950be9-9d26-202c-e063-6294a90ada7d	67239-0225	HUMAN PRESCRIPTION DRUG	CleanCare Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate	SOLUTION	DENTAL	20220628		ANDA	ANDA075561	Safco Dental Supply LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
67239-0225_0d9624f6-2a0c-c30f-e063-6294a90ae717	67239-0225	HUMAN PRESCRIPTION DRUG	CleanCare Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate	SOLUTION	DENTAL	20220628		ANDA	ANDA075561	Safco Dental Supply LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
67239-0226_d8f021a5-143a-4ba9-9a2a-f259466aefd3	67239-0226	HUMAN OTC DRUG	Sodium Fluoride		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20230424		OTC MONOGRAPH FINAL	part355	Safco Dental Supply LLC	SODIUM FLUORIDE	2.43	mg/g			N	20241231
67239-0227_4819fdbd-4f57-4dcf-ae8c-24836df1612b	67239-0227	HUMAN OTC DRUG	Sodium Fluoride		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20230424		OTC MONOGRAPH DRUG	M021	Safco Dental Supply LLC	SODIUM FLUORIDE	2.43	mg/g			N	20241231
67239-0240_edc7ea54-5878-48b5-830a-14a9c6e7798b	67239-0240	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20111107		ANDA	ANDA088390	Safco Dental Supply Co	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
67253-651_7b69e6bf-0adb-4f15-985b-b20615d8c61a	67253-651	HUMAN PRESCRIPTION DRUG	Propylthiouracil		Propylthiouracil	TABLET	ORAL	19470728		NDA	NDA006188	Par Pharmaceutical, Inc.	PROPYLTHIOURACIL	50	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
67296-0126_f4c13959-0a8e-2c9c-e053-2995a90a2771	67296-0126	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20120101		ANDA	ANDA085223	RedPharm Drug, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
67296-0222_d6843e29-ff57-5f1a-e053-2a95a90a0f7d	67296-0222	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214	20260531	ANDA	ANDA086183	RedPharm Drug, Inc.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
67296-0237_f3f80946-60e0-605f-e053-2a95a90ac4e0	67296-0237	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20180101		ANDA	ANDA075593	RedPharm Drug, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
67296-0246_f423b94c-096c-9932-e053-2a95a90a5167	67296-0246	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	RedPharm Drug, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67296-0355_0ab006cb-c9cb-929e-e063-6294a90af0e1	67296-0355	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20110308		ANDA	ANDA087463	RedPharm Drug, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67296-0525_f45ed77d-5b52-10c4-e053-2995a90a4a7b	67296-0525	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		ACETAMINOPHEN and CODEINE PHOSPHATE	SOLUTION	ORAL	19810821		ANDA	ANDA087508	Redpharm Drug, Inc	ACETAMINOPHEN; CODEINE PHOSPHATE	120; 12	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
67296-0729_f4c38613-6bd9-f08f-e053-2a95a90a6466	67296-0729	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA076670	Redpharm Drug Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67296-0743_0a0fd541-f6a5-804d-e063-6294a90a2c7d	67296-0743	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Redpharm Drug	LEVOFLOXACIN	500	mg/1			N	20241231
67296-0757_f4c1a5a1-b033-d4d3-e053-2995a90a4560	67296-0757	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	RedPharm Drug Inc	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67296-0823_f4c1f9fd-2d30-71d3-e053-2a95a90a3ba4	67296-0823	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	RedPharm Drug, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-0940_0a0fa33e-5175-237f-e063-6394a90a0cdf	67296-0940	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20090826		ANDA	ANDA065442	Redpharm Drug	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
67296-1039_f67ebc2b-a10c-60e0-e053-2995a90a9986	67296-1039	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	RedPharm Drug, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
67296-1083_f3f80946-60e1-605f-e053-2a95a90ac4e0	67296-1083	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	RedPharm Drug, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1097_f3c304c1-b810-5ae8-e053-2995a90a4bbd	67296-1097	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	RedPharm Drug, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
67296-1137_f4240431-b174-67d7-e053-2a95a90ac44a	67296-1137	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Redpharm Drug, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67296-1156_f3bad5e1-07ea-aad9-e053-2995a90ae72b	67296-1156	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	RedPharm Drug, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67296-1202_09d3016f-d1f4-9e90-e063-6394a90aee4c	67296-1202	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20111101		ANDA	ANDA076164	RedPharm Drug, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
67296-1230_09d22c7f-c294-9800-e063-6294a90a5fb7	67296-1230	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	RedPharm Drug, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67296-1235_f3f81d02-1a3c-a538-e053-2a95a90a17a6	67296-1235	HUMAN PRESCRIPTION DRUG	ISENTRESS		ISENTRESS	TABLET, FILM COATED	ORAL	20071012		NDA	NDA022145	RedPharm Drug, Inc.	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
67296-1319_f3f7ee7c-ea0a-0810-e053-2a95a90a68fd	67296-1319	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	RedPharm Drug, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
67296-1368_f3f83886-083e-561b-e053-2995a90a4537	67296-1368	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20140414		ANDA	ANDA204234	RedPharm Drug, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-1415_f4c2526b-1c21-cf1d-e053-2995a90a9021	67296-1415	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	RedPharm Drug, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
67296-1421_fc619907-ae2b-d730-e053-6394a90a072e	67296-1421	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	RedPharm Drug, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
67296-1432_f3f7e844-c928-7643-e053-2995a90a1a00	67296-1432	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	RedPharm Drug, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
67296-1434_f45f04ea-5bba-e8b6-e053-2a95a90a4d84	67296-1434	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Redpharm Drug, Inc	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67296-1435_09d23043-1b16-83b3-e063-6294a90a5ce6	67296-1435	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Redpharm Drug, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-1435_f40f6c37-33e4-42c6-e053-2995a90a6621	67296-1435	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Redpharm Drug, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-1436_f4c45f89-9e6b-34bc-e053-2a95a90abeb6	67296-1436	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	RedPharm Drug, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67296-1437_f423e168-addf-c2cd-e053-2a95a90a8334	67296-1437	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20160726		ANDA	ANDA203562	Redpharm Drug, Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
67296-1438_f40e8ea1-025c-41ad-e053-2a95a90a994a	67296-1438	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Redpharm Drug, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
67296-1440_f423b555-0373-67cf-e053-2a95a90a7eeb	67296-1440	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA090513	Redpharm Drug, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
67296-1441_09d0eff7-df9f-7419-e063-6394a90a87d8	67296-1441	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Redpharm Drug, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-1441_f3d20bc8-ca03-11f5-e053-2995a90a720a	67296-1441	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Redpharm Drug, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-1442_f40f84ab-81b2-0f56-e053-2995a90a1d3d	67296-1442	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Redpharm Drug, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
67296-1442_f4c2c036-6337-be18-e053-2a95a90a4284	67296-1442	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Redpharm Drug, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
67296-1443_f40fb0db-3dd9-5b0d-e053-2a95a90a5ebd	67296-1443	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20181011	20240930	ANDA	ANDA210616	Redpharm Drug, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
67296-1444_f40e7df1-9cba-9ca7-e053-2a95a90a5524	67296-1444	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200206		ANDA	ANDA083677	Redpharm Drug, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1446_f40e8a45-b96d-5fd6-e053-2a95a90ae2e3	67296-1446	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	Redpharm Drug, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1447_f40ea909-9df4-c90a-e053-2995a90a2987	67296-1447	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		Redpharm Drug, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
67296-1448_f3cdc850-d3c0-1b0e-e053-2a95a90a7a3b	67296-1448	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	Redpharm Drug,	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67296-1448_f3d228c8-bdea-ffcf-e053-2a95a90aa5c4	67296-1448	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	Redpharm Drug, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67296-1449_f40fb07e-718d-3ddf-e053-2a95a90afb0c	67296-1449	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Redpharm Drug, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1450_f3c277cb-1ce8-6818-e053-2a95a90aecf3	67296-1450	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20161210		ANDA	ANDA091133	Redpharm Drug, Inc	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
67296-1452_f4232833-c93f-716e-e053-2995a90aa868	67296-1452	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Redpharm Drug, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
67296-1453_f40f6c37-33e7-42c6-e053-2995a90a6621	67296-1453	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Redpharm Drug, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-1454_f3c2acfc-f599-50ab-e053-2a95a90a11e7	67296-1454	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	RedPharm Drug, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
67296-1455_f40e8ea1-025e-41ad-e053-2a95a90a994a	67296-1455	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220524		ANDA	ANDA208412	Redpharm Drug, Inc.	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1456_09d16c1d-cb98-3d4f-e063-6294a90ae8d1	67296-1456	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Redpharm Drug, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-1456_f42392b1-09a6-14a5-e053-2a95a90ad05e	67296-1456	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Redpharm Drug, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-1457_f40ee97e-a191-eb6f-e053-2a95a90af7d5	67296-1457	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Redpharm Drug, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1458_f3bd98ba-968e-7003-e053-2a95a90a7ecb	67296-1458	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20180504		ANDA	ANDA210401	Redpharm Drug, inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
67296-1459_f423ab8a-3912-5b3f-e053-2a95a90adb7e	67296-1459	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA204131	Redpharm Drug, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
67296-1460_f40f24ce-854e-299c-e053-2995a90aa919	67296-1460	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Redpharm Drug, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1461_f40eb4e3-65c1-bb82-e053-2995a90a9b0c	67296-1461	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		Redpharm Drug, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
67296-1462_f3d2a48f-46e5-3a3c-e053-2a95a90a7012	67296-1462	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Redpharm Drug, Inc.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
67296-1463_f4c26992-c989-e20f-e053-2a95a90afb65	67296-1463	HUMAN OTC DRUG	Good Sense 24 hour allergy nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160803		ANDA	ANDA207957	RedPharm Drug, Inc	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1464_f3c2ad81-90ae-13a4-e053-2a95a90ad91e	67296-1464	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20161210		ANDA	ANDA091133	RedPharm Drug, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
67296-1466_f4c302f0-638d-6e70-e053-2a95a90a25c4	67296-1466	HUMAN PRESCRIPTION DRUG	Ella		ulipristal acetate	TABLET	ORAL	20200511		NDA	NDA022474	RedPharm Drug, Inc	ULIPRISTAL ACETATE	30	mg/1	Progesterone Agonist/Antagonist [EPC], Selective Progesterone Receptor Modulators [MoA]		N	20241231
67296-1467_f4c1e781-f30a-1076-e053-2a95a90a5bcb	67296-1467	HUMAN OTC DRUG	Mucus Relief Extended Release		Guaifenesin	TABLET	ORAL	20180831		ANDA	ANDA207342	Redpharm Drug Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
67296-1469_f3d2b803-1f8f-6a77-e053-2a95a90aaebb	67296-1469	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Redpharm Drug, Inc	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
67296-1470_f40f9d37-7804-f6b3-e053-2a95a90a4c40	67296-1470	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Redpharm Drug, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1471_f3d2eaaf-041d-531c-e053-2a95a90a8772	67296-1471	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20110101		ANDA	ANDA079234	Redpharm Drug, Inc.	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
67296-1472_f4c2cf1a-b261-f7d3-e053-2a95a90af6dc	67296-1472	HUMAN OTC DRUG	anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030224		ANDA	ANDA075232	Redpharm Drug Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
67296-1473_f422d446-f476-6ec9-e053-2a95a90a28e2	67296-1473	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		valacyclovir	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA078518	Redpharm Drug, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
67296-1474_f422c711-fe7e-dfa0-e053-2a95a90a1a51	67296-1474	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Redpharm Drug, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1475_f3c258fd-c8cb-5654-e053-2a95a90a95c9	67296-1475	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170907		ANDA	ANDA202765	Redpharm drug, inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
67296-1476_f45f4759-9f0a-82a4-e053-2a95a90a1a49	67296-1476	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		HYDROCODONE BITARTRATE and ACETAMINOPHEN	SOLUTION	ORAL	20130729		ANDA	ANDA040838	Redpharm Drug, Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
67296-1478_f4c415ae-32f8-182e-e053-2a95a90add65	67296-1478	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211011		ANDA	ANDA072926	RedPharm Drug, Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67296-1479_f67e528a-b823-3f7a-e053-2995a90ae733	67296-1479	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	RedPharm Drug, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
67296-1480_f4237113-d8ae-e3db-e053-2a95a90ae6b0	67296-1480	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20151221		ANDA	ANDA077863	RedPharm Drug, Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1481_f422ade5-8396-40e4-e053-2a95a90a4044	67296-1481	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215579	Redpharm Drug, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
67296-1482_f4c0bb1e-a448-fc12-e053-2995a90aa761	67296-1482	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20150527		ANDA	ANDA204093	Redpharn Drug, Inc	MONTELUKAST	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
67296-1484_f4c245b7-7776-cf1f-e053-2995a90a1cb4	67296-1484	HUMAN OTC DRUG	Zyrtec Allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20080101		NDA	NDA019835	RedPharm Drug Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67296-1485_f4c355e6-585c-24da-e053-2a95a90aa1e8	67296-1485	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	Redpharm Drug Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
67296-1486_f422bb34-12f9-0df2-e053-2a95a90a7421	67296-1486	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Redpharm Drug, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67296-1487_f3d2d4b9-634b-0517-e053-2a95a90a4a56	67296-1487	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Redpharm Drug, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
67296-1488_f4c298e2-4502-75fe-e053-2995a90a639e	67296-1488	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20160801		ANDA	ANDA204883	RedPharm Drug Inc	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
67296-1489_f4c35e9d-3291-b9c4-e053-2995a90a0842	67296-1489	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20220523		ANDA	ANDA215788	RedPharm Drug Inc	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1490_f41ea19e-62e6-297f-e053-2995a90adf91	67296-1490	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20201030		OTC MONOGRAPH FINAL	M009	Redpharm Drug, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
67296-1491_f4c2b4f4-328f-96cc-e053-2a95a90ab26d	67296-1491	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760701		ANDA	ANDA084769	Redpharm Drug Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67296-1492_f423b555-0374-67cf-e053-2a95a90a7eeb	67296-1492	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	Redpharm Drug, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67296-1493_f4c23e7b-afac-7b32-e053-2a95a90a6166	67296-1493	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	Redpharm Drug, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67296-1495_f4c31659-8655-d9d7-e053-2995a90a686b	67296-1495	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20190823		ANDA	ANDA204313	RedPharm Drug, Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
67296-1496_f4c0f2d9-3ea2-5358-e053-2995a90aeb84	67296-1496	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20210901		ANDA	ANDA215106	RedPharm Drug, Inc	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1497_f3c32aaa-bab6-e039-e053-2995a90a6c47	67296-1497	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	RedPharm Drug, Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1498_f3d2c5d6-8706-0dc1-e053-2995a90a2f04	67296-1498	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Redpharm Drug, Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
67296-1500_f4c2b4f4-328e-96cc-e053-2a95a90ab26d	67296-1500	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20080804		ANDA	ANDA076768	RedPharm Drug, Inc	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
67296-1502_f42410a1-d7e2-c68d-e053-2a95a90a77e9	67296-1502	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	19971229		ANDA	ANDA074650	Redpharm Drug, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
67296-1503_f4c215ca-9e5b-ca64-e053-2a95a90a47c5	67296-1503	HUMAN OTC DRUG	Hemorrhoidal Cream		Glycerin, Phenylephrine Hydrochloride, Pramoxine Hydrochloride, White Petrolatum	CREAM	TOPICAL	20190403		OTC MONOGRAPH FINAL	part346	Redpharm Drug Inc.	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	4.032; 4.2; .07; .28	g/28g; g/28g; g/28g; g/28g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67296-1510_f4c1ea84-18c3-9ec5-e053-2995a90a89a8	67296-1510	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065211	RedPharm Drug Inc	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
67296-1513_f4c1ca97-64c6-69d3-e053-2995a90a3ccc	67296-1513	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	RedPharm Drug Inc	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
67296-1518_f4236942-d979-1e87-e053-2995a90a000a	67296-1518	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Redpharm Drug, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1519_f4c298d5-b013-7b56-e053-2a95a90a3d55	67296-1519	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20190724		ANDA	ANDA212557	RedPharm Drug, Inc	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
67296-1523_fa1b16ed-2937-dc98-e053-6294a90acde8	67296-1523	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	Redpharm drug	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67296-1525_f3f811ac-7e8c-1eeb-e053-2995a90a51dc	67296-1525	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20111101		ANDA	ANDA091240	RedPharm Drug, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1526_0b2603b6-0bd5-b418-e063-6294a90abf32	67296-1526	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20070124	20240331	ANDA	ANDA077785	Redpharm Drug	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	
67296-1542_fc4e3a24-4f2a-c138-e053-6294a90a3d94	67296-1542	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20000726		ANDA	ANDA040400	Redpharm Drug	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
67296-1547_f67eb871-0fec-4a50-e053-2a95a90a3aeb	67296-1547	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20180101		ANDA	ANDA077293	RedPharm Drug, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
67296-1550_f4c24ba9-23fb-7b24-e053-2a95a90a9c68	67296-1550	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	RedPharm Drug Inc	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67296-1604_f3f7f1bf-9e3f-c3d1-e053-2995a90adc54	67296-1604	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20180101		ANDA	ANDA090564	RedPharm Drug, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67296-1622_f4c3c37c-1114-39f5-e053-2995a90ac5b3	67296-1622	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	RedPharm Drug, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67296-1650_f3bfffd4-6b5d-05f2-e053-2995a90ad262	67296-1650	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20190101		ANDA	ANDA204755	RedPharm Drug, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
67296-1685_f3f7f1bf-9e40-c3d1-e053-2995a90adc54	67296-1685	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	RedPharm Drug, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1701_fc61a016-442a-d710-e053-6394a90afbd0	67296-1701	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20191101		ANDA	ANDA078321	RedPharm Drug, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67296-1707_f3bb3950-5149-3135-e053-2a95a90ad896	67296-1707	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20070609		ANDA	ANDA077309	RedPharm Drug	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
67296-1715_f3c33495-6603-e3e8-e053-2a95a90ad7dd	67296-1715	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20100601		ANDA	ANDA077789	RedPharm Drug, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
67296-1743_f4c14cbe-0973-0be9-e053-2995a90a23c7	67296-1743	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19840507		ANDA	ANDA062396	RedPharm Drug, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-1747_f3f7f1bf-9e41-c3d1-e053-2995a90adc54	67296-1747	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	RedPharm Drug, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
67296-1757_f67e7416-1048-ad1d-e053-2a95a90aaddb	67296-1757	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	RedPharm Drug, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1805_09d0ea9f-ce96-f80e-e063-6294a90a5008	67296-1805	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	RedPharm Drug, Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1830_f42429c6-ca43-59c7-e053-2995a90a269f	67296-1830	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210324		ANDA	ANDA212689	Redpharm Drug, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
67296-1833_f3c23a47-ac92-d7dd-e053-2995a90ace22	67296-1833	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Redpharm drug, inc	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
67296-1834_f4c134d2-f4af-100d-e053-2a95a90a72cb	67296-1834	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20210422		ANDA	ANDA208708	RedPharm Drug Inc	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
67296-1835_f4236180-d2bd-3a1e-e053-2a95a90a84b9	67296-1835	HUMAN OTC DRUG	Docusate Sodium		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20081028		OTC MONOGRAPH NOT FINAL	part334	Redpharm Drug, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
67296-1836_f4235c80-1406-3ea0-e053-2a95a90a8616	67296-1836	HUMAN PRESCRIPTION DRUG	Tindazole		Tinidazole	TABLET, FILM COATED	ORAL	20131009		ANDA	ANDA202489	Redpharm Drug, Inc.	TINIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
67296-1837_f3d1ed3b-d77c-3fb2-e053-2995a90acc8e	67296-1837	HUMAN PRESCRIPTION DRUG	Dexamethasone		dexamethasone	TABLET	ORAL	20210628		ANDA	ANDA088481	Redpharm Drug, Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1839_f4232833-c942-716e-e053-2995a90aa868	67296-1839	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	Redpharm Drug, Inc	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
67296-1840_f3d1dede-6021-2e6c-e053-2a95a90af73a	67296-1840	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20121016		ANDA	ANDA202928	Redpharm Drug, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
67296-1847_f3d26067-1271-7852-e053-2995a90a434b	67296-1847	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	Redpharm Drug, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1848_f3c3181e-4e53-3070-e053-2a95a90aa92f	67296-1848	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	RedPharm Drug, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
67296-1849_f423e005-c93e-6e51-e053-2995a90a3c2b	67296-1849	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20211227		ANDA	ANDA084657	Redpharm Drug, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
67296-1850_f423f79c-09ca-b071-e053-2995a90aedfd	67296-1850	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100715		ANDA	ANDA090931	Redpharm Drug, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
67296-1855_0b3b94f1-8e6a-789c-e063-6394a90ae709	67296-1855	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Redpharm Drug, Inc	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67296-1855_f67ee20f-36a6-044f-e053-2995a90afe25	67296-1855	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Redpharm Drug, Inc	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67296-1857_f4c09a51-5a2e-78d0-e053-2995a90a2d0b	67296-1857	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20180209		ANDA	ANDA210644	Redpharm drug, inc	ACETAMINOPHEN; OXYCODONE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67296-1858_f4c15777-fff6-96ee-e053-2a95a90a23ad	67296-1858	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Redpharm Drug, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-1859_f3d2952c-9117-982d-e053-2995a90a3f34	67296-1859	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075718	Redpharm Drug, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67296-1860_f4c24ba9-23fc-7b24-e053-2a95a90a9c68	67296-1860	HUMAN PRESCRIPTION DRUG	Nyamyc		Nystatin	POWDER	TOPICAL	20050503		ANDA	ANDA065183	RedPharm Drug, Inc	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
67296-1870_f4c54562-96b9-83a7-e053-2995a90a76a8	67296-1870	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	TABLET, FILM COATED	ORAL	20190513		NDA AUTHORIZED GENERIC	NDA050711	RedPharm Drug, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
67296-1876_fc61fbcc-c6e2-3ffd-e053-6394a90a5cf5	67296-1876	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	Redpharm Drug	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67296-1882_09d0e22b-3566-bf00-e063-6394a90aeddd	67296-1882	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201014		ANDA	ANDA212378	RedPharm Drug, Inc	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
67296-1886_0b25f090-d4db-ee9d-e063-6294a90abbb7	67296-1886	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220524		ANDA	ANDA208412	Redpharm drug	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1886_fc4e0ecb-6c0c-307c-e053-6294a90af2a3	67296-1886	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220524		ANDA	ANDA208412	Redpharm drug	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-1890_0ab04984-12b9-c9f1-e063-6394a90a4e7e	67296-1890	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20001020		ANDA	ANDA040409	RedPharm Drug, Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
67296-1890_fa1b5642-e51d-849c-e053-6394a90abacd	67296-1890	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20001020		ANDA	ANDA040409	Redpharm drug	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
67296-1890_fa1b78e2-b626-f716-e053-6294a90a7a22	67296-1890	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20001020		ANDA	ANDA040409	RedPharm Drug, Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
67296-1891_f6d02efd-ad66-99e9-e053-6394a90aa5d2	67296-1891	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	TABLET	ORAL	20221128		ANDA	ANDA216760	RedPharm Drug, Inc	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
67296-1893_09d36214-ef0e-d59f-e063-6394a90a02c4	67296-1893	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Redpharm Drug	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-1893_fc61a016-442c-d710-e053-6394a90afbd0	67296-1893	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Redpharm Drug	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-1894_fc61c9f5-b0f9-3ff8-e053-6394a90adeb7	67296-1894	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Redpharm Drug	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67296-1895_fc61e4ea-12e1-6e7a-e053-6294a90aa70a	67296-1895	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20190726		ANDA	ANDA212114	Redpharm Drug	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
67296-1897_0a231d6e-2958-bdf4-e063-6294a90a3da8	67296-1897	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20200922		ANDA	ANDA204467	Redpharm Drug	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
67296-1898_0b3dccda-b2a5-c56e-e063-6294a90a5a2c	67296-1898	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Redpharm Drug	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
67296-1899_fcb1d531-5362-4b0f-e053-6294a90a75a5	67296-1899	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	RedPharm Drug, Inc	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1900_fcb1efc1-5adf-85a2-e053-6294a90a15dd	67296-1900	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	RedPharm Drug	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1901_fcb2026a-b5c9-f7ec-e053-6394a90ac24c	67296-1901	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	RedPharm Drug, Inc	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1902_0b25ceac-d4ad-701b-e063-6394a90a6269	67296-1902	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Redpharm Drug	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1903_09d2176e-fccc-4ad9-e063-6394a90a182a	67296-1903	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	RedPharm Drug, Inc	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1903_09d23043-1b0a-83b3-e063-6294a90a5ce6	67296-1903	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	RedPharm Drug, Inc	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1903_fcb2812b-37d3-de88-e053-6394a90ac2b5	67296-1903	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	RedPharm Drug, Inc	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67296-1904_0b262016-5ca3-f725-e063-6394a90a15d5	67296-1904	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	Redpharm Drug	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
67296-1905_0b3bc968-f79d-09f6-e063-6294a90a3d43	67296-1905	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20000908		ANDA	ANDA040405	Redpharm Drug	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
67296-1907_fcb13cd8-b824-7149-e053-6294a90a55c8	67296-1907	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	RedPharm Drug, Inc	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
67296-1908_fcb196a9-c4d0-6b6f-e053-6294a90a43d5	67296-1908	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	RedPharm Drug, Inc	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
67296-1909_fcb13cd8-b823-7149-e053-6294a90a55c8	67296-1909	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	RedPharm Drug, Inc	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
67296-1910_0b251e46-f8dd-211e-e063-6294a90a91a3	67296-1910	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	Redpharm Drug	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1912_0b266934-da62-4dc9-e063-6294a90a5445	67296-1912	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Redpharm Drug	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67296-1914_0a101b9c-a325-6579-e063-6394a90ac030	67296-1914	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		Amoxicillin	CAPSULE	ORAL	20220915		ANDA	ANDA062216	Redpharm Drug	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67296-1916_0b2621ee-e184-d638-e063-6394a90ab31d	67296-1916	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20220208		ANDA	ANDA214330	Redpharm Drug	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
67296-2040_09d086f2-dba0-5e15-e063-6394a90abe18	67296-2040	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	Redpharm drugs	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
67296-2041_fa1695e4-072b-7795-e053-6294a90add62	67296-2041	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077038	Redpharm drug	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
67296-2042_fa1ad8d9-73a9-8ace-e053-6294a90aa97a	67296-2042	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	Redpharm drug	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
67296-2043_fa1c0d90-fcd8-e2b1-e053-6294a90af8a8	67296-2043	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	Redpharm drug	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
67296-2044_fa2acee9-1a38-d81d-e053-6394a90aabb7	67296-2044	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Redpharm drug	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
67296-2045_fc4d07ab-4c9e-1204-e053-6394a90a50c0	67296-2045	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20191101		ANDA	ANDA212798	Redpharm Drug	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
67296-2046_fa1bbb6e-ed16-07c9-e053-6294a90aa4a0	67296-2046	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Redpharm drug	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
67296-2047_fa2b5ad9-7e0d-b16a-e053-6394a90a0822	67296-2047	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		pantoprazole sodium	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA090970	Redpharm drug	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67296-2048_fa2aebcd-3cd9-5128-e053-6294a90ac612	67296-2048	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	Redpharm drug	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
67296-2049_fa1c1ee6-557f-0bd7-e053-6394a90a2a28	67296-2049	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Redpharm drug	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
67296-2066_09d1b93a-2504-61b7-e063-6294a90a7fac	67296-2066	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	Redpharm Drug	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-2067_09d326d0-0077-c55e-e063-6394a90ac4db	67296-2067	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200109		ANDA	ANDA211061	Redpharm Drug	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
67296-2069_0b3bd414-49d2-9e5c-e063-6394a90aaac0	67296-2069	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20180301		ANDA	ANDA202075	Redpharm Drug	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
67296-2075_0b253080-dbe0-45f5-e063-6294a90a0a2c	67296-2075	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20191009		ANDA	ANDA211343	Redpharm Drug	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-2079_0ab07a25-b2f7-ff4c-e063-6294a90aee9b	67296-2079	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET, FILM COATED	ORAL	20060329		ANDA	ANDA065308	Redpharm Drug	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67296-2081_0ab0e3aa-a188-5cc9-e063-6294a90a64f9	67296-2081	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	Redpharm Drug	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67296-2083_0ab119e3-9e2a-21d3-e063-6394a90a9a5a	67296-2083	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20220801		ANDA	ANDA065055	Redpharm Drug	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67296-2084_0ab188f3-f7fe-d665-e063-6294a90a198a	67296-2084	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Redpharm Drug	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
67296-2088_0ab11691-5b2b-55fc-e063-6394a90aa328	67296-2088	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET	ORAL	20060329		ANDA	ANDA065308	Redpharm Drug	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67308-101_ccb063c5-2695-4ed5-a281-c75f6ea28d3a	67308-101	HUMAN PRESCRIPTION DRUG	LEVULAN KERASTICK		aminolevulinic acid hydrochloride	KIT		20000904		NDA	NDA020965	DUSA Pharmaceuticals, Inc.						N	20241231
67326-005_09734a55-efa6-3b22-e063-6394a90ad2d2	67326-005	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200415		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
67326-005_09bc4fa1-161f-e347-e063-6294a90ad9cf	67326-005	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200320		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
67326-006_09734dc8-5102-1bd0-e063-6394a90a90c0	67326-006	HUMAN OTC DRUG	Protec Hand Sani Gel Antibacterial		ALCOHOL	GEL	TOPICAL	20200605		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
67326-010_09734dc8-510f-1bd0-e063-6394a90a90c0	67326-010	HUMAN OTC DRUG	Degasa Hand Sanitizer Lemon Lime Scent		ALCOHOL	GEL	TOPICAL	20200429		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
67326-030_097353b6-41ba-cea1-e063-6294a90aea19	67326-030	HUMAN OTC DRUG	ISOPROPYL ALCOHOL		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20201008		OTC MONOGRAPH DRUG	M003	Degasa, S.A. de C.V.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
67326-035_09732ce9-588a-26f2-e063-6394a90a9144	67326-035	HUMAN OTC DRUG	ISOPROPYL ALCOHOL		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20201020		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa, S.A. de C.V.	ISOPROPYL ALCOHOL	.91	mL/mL			N	20241231
67326-350_097358e0-eaba-c991-e063-6294a90acb81	67326-350	HUMAN OTC DRUG	Prep Solution	Topical Antiseptic Microbicide	POVIDONE-IODINE	SOLUTION	TOPICAL	20070101		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa SA De CV	POVIDONE-IODINE	100	mg/mL			N	20241231
67326-351_097353b6-41cb-cea1-e063-6294a90aea19	67326-351	HUMAN OTC DRUG	Surgical Scrub	Skin Cleanser	POVIDONE-IODINE	SOLUTION	TOPICAL	20070101		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa SA De CV	POVIDONE-IODINE	75	mg/mL			N	20241231
67326-352_09735b00-e29b-ab1f-e063-6294a90a81ea	67326-352	HUMAN OTC DRUG	Antiseptic Patient Preoperative Skin Preparation and Surgical Hand Scrub		POVIDONE-IODINE	SOLUTION	TOPICAL	20150813		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa SA De CV	POVIDONE-IODINE	75	mg/mL			N	20241231
67326-353_09735b00-e2a6-ab1f-e063-6294a90a81ea	67326-353	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20171025		OTC MONOGRAPH DRUG	M022	Degasa, S.A. de C.V.	HYDROGEN PEROXIDE	3	mg/mL			N	20241231
67326-354_09735aeb-7410-4078-e063-6394a90a065d	67326-354	HUMAN OTC DRUG	HYDROGEN PEROXIDE		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20200415		OTC MONOGRAPH DRUG	M003	DEGASA SA DE CV	HYDROGEN PEROXIDE	.3	mL/mL			N	20241231
67326-400_09735b2f-2ad5-ca91-e063-6294a90a210a	67326-400	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	CLOTH	TOPICAL	20200709		OTC MONOGRAPH DRUG	505G(a)(3)	Degasa, S.A. de C.V.	ALCOHOL	.7	g/g			N	20241231
67334-0457_ed38e3cd-74ea-5cf0-e053-2995a90a9f25	67334-0457	STANDARDIZED ALLERGENIC	T.R.U.E. Test	Thin-Layer Rapid Use Patch Test	Standardized Allergenic	KIT	CUTANEOUS	20120301		BLA	BLA103738	SmartPractice Denmark ApS						N	20241231
67345-0001_1c7d7e88-c539-492c-9cce-51b97db3e94a	67345-0001	HUMAN OTC DRUG	Purminerals 4-in-1 Mineral Tinted Moisturizer Broad Spectrum SPF 20 (LIGHT)		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part352	Purminerals	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/100g; g/100g			N	20241231
67345-0002_1c7d7e88-c539-492c-9cce-51b97db3e94a	67345-0002	HUMAN OTC DRUG	Purminerals 4-in-1 Mineral Tinted Moisturizer Broad Spectrum SPF 20 (MEDIUM)		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part352	Purminerals	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/100g; g/100g			N	20241231
67345-0003_1c7d7e88-c539-492c-9cce-51b97db3e94a	67345-0003	HUMAN OTC DRUG	Purminerals 4-in-1 Mineral Tinted Moisturizer Broad Spectrum SPF 20 (TAN)		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part352	Purminerals	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/100g; g/100g			N	20241231
67345-0004_1c7d7e88-c539-492c-9cce-51b97db3e94a	67345-0004	HUMAN OTC DRUG	Purminerals 4-in-1 Mineral Tinted Moisturizer Broad Spectrum SPF 20 (DARK)		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part352	Purminerals	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/100g; g/100g			N	20241231
67345-0005_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0005	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (LIGHT)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0006_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0006	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (BLUSH MEDIUM)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0007_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0007	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (GOLDEN MEDIUM)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0008_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0008	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (LIGHT TAN)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0009_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0009	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (TAN)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0010_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0010	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (MEDIUM DARK)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0011_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0011	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (GOLDEN DARK)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0012_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0012	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (DEEP)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0013_9341bed6-53a9-4d87-803f-ba6431ac74ac	67345-0013	HUMAN OTC DRUG	Purminerals 4-in-1 14-Hour Wear Foundation Broad Spectrum SPF 15 (DEEPER)		Octinoxate	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part352	Purminerals	OCTINOXATE	50	mg/mL			N	20241231
67345-0018_f31fbcd5-8c62-68c6-e053-2a95a90aafe9	67345-0018	HUMAN OTC DRUG	Purminerals 4-in-1 Mineral Tinted Moisturizer Broad Spectrum SPF 20 (TAN)		Purminerals 4-in-1 Mineral Tinted Moisturizer Broad Spectrum SPF 20 (TAN)	CREAM	TOPICAL	20200310		OTC MONOGRAPH FINAL	part352	Purminerals	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/100g; g/100g			N	20241231
67345-0380_ec94bb45-f514-4c50-e053-2a95a90ac467	67345-0380	HUMAN OTC DRUG	PUR 4-in-1 Correcting Primer		Salicylic Acid	EMULSION	TOPICAL	20200101		OTC MONOGRAPH FINAL	M006	Purminerals	SALICYLIC ACID	2	g/100mL			N	20241231
67385-023_f238e445-b435-479e-a2e4-20423205c125	67385-023	HUMAN OTC DRUG	clean n natural Hand Sanitizer	Antimicrobial	Alcohol	GEL	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333E	Garcoa, Inc.	ALCOHOL	700	mg/mL			N	20241231
67385-024_55125d43-5152-496d-a2d0-8f36a8ecfb20	67385-024	HUMAN OTC DRUG	clean n natural Hand Sanitizer	Antimicrobial	ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH NOT FINAL	part333E	Garcoa, Inc.	ALCOHOL	700	mg/mL			N	20241231
67385-025_a149315a-89b8-4c2e-abe7-1cd0a7b186f5	67385-025	HUMAN OTC DRUG	clean n natural Hand Sanitizer	Antimicrobial	ALCOHOL	GEL	TOPICAL	20200630		OTC MONOGRAPH NOT FINAL	part333E	Garcoa, Inc.	ALCOHOL	700	mg/mL			N	20241231
67385-026_583d201f-b655-45bf-8931-0653868dddee	67385-026	HUMAN OTC DRUG	clean n natural Hand Sanitizer	Antimicrobial	Alcohol	GEL	TOPICAL	20200604		OTC MONOGRAPH NOT FINAL	part333E	Garcoa, Inc.	ALCOHOL	700	mg/mL			N	20241231
67386-111_90b0adfa-b718-4197-a437-f0f2994539d7	67386-111	HUMAN PRESCRIPTION DRUG	SABRIL		vigabatrin	TABLET, FILM COATED	ORAL	20090821		NDA	NDA020427	Lundbeck Pharmaceuticals LLC	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20251231
67386-130_d60f6c63-84c4-4b4e-a641-5cab738fc9aa	67386-130	HUMAN PRESCRIPTION DRUG	Vyepti		eptinezumab-jjmr	INJECTION	INTRAVENOUS	20200221		BLA	BLA761119	Lundbeck Pharmaceuticals LLC	EPTINEZUMAB	100	mg/mL	Calcitonin Gene-related Peptide Antagonist [EPC], Calcitonin Gene-related Peptide Antagonists [MoA]		N	20251231
67386-211_d3b37db1-0599-4286-969f-5e83a2ead899	67386-211	HUMAN PRESCRIPTION DRUG	SABRIL		vigabatrin	POWDER, FOR SOLUTION	ORAL	20090821		NDA	NDA022006	Lundbeck Pharmaceuticals LLC	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20251231
67386-313_1548d293-e7fe-4145-9636-41df34e34fa7	67386-313	HUMAN PRESCRIPTION DRUG	Onfi		clobazam	SUSPENSION	ORAL	20121214		NDA	NDA203993	Lundbeck Pharmaceuticals LLC	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20251231
67386-314_1548d293-e7fe-4145-9636-41df34e34fa7	67386-314	HUMAN PRESCRIPTION DRUG	Onfi		clobazam	TABLET	ORAL	20131210		NDA	NDA202067	Lundbeck Pharmaceuticals LLC	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20251231
67386-315_1548d293-e7fe-4145-9636-41df34e34fa7	67386-315	HUMAN PRESCRIPTION DRUG	Onfi		clobazam	TABLET	ORAL	20131210		NDA	NDA202067	Lundbeck Pharmaceuticals LLC	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20251231
67386-421_6f524695-2fc1-4c54-9212-69cff22cdfa7	67386-421	HUMAN PRESCRIPTION DRUG	Xenazine		tetrabenazine	TABLET	ORAL	20081124		NDA	NDA021894	Lundbeck Pharmaceuticals LLC	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
67386-422_6f524695-2fc1-4c54-9212-69cff22cdfa7	67386-422	HUMAN PRESCRIPTION DRUG	Xenazine		tetrabenazine	TABLET	ORAL	20081124		NDA	NDA021894	Lundbeck Pharmaceuticals LLC	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
67386-621_001dfe05-5965-4d26-a432-aa35b8a3039d	67386-621	HUMAN PRESCRIPTION DRUG	CARNEXIV		Carbamazepine	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20141021		NDA	NDA206030	Lundbeck Pharmaceuticals LLC	CARBAMAZEPINE	10	mg/mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
67386-820_f720e062-fafd-49bf-ab8c-ab23b25e0545	67386-820	HUMAN PRESCRIPTION DRUG	Northera		droxidopa	CAPSULE	ORAL	20140901		NDA	NDA203202	Lundbeck Pharmaceuticals LLC	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20251231
67386-821_f720e062-fafd-49bf-ab8c-ab23b25e0545	67386-821	HUMAN PRESCRIPTION DRUG	Northera		droxidopa	CAPSULE	ORAL	20140901		NDA	NDA203202	Lundbeck Pharmaceuticals LLC	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20251231
67386-822_f720e062-fafd-49bf-ab8c-ab23b25e0545	67386-822	HUMAN PRESCRIPTION DRUG	Northera		droxidopa	CAPSULE	ORAL	20140901		NDA	NDA203202	Lundbeck Pharmaceuticals LLC	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20251231
67402-021_827f05fc-94d5-4bde-8c2f-e97d250d9660	67402-021	HUMAN PRESCRIPTION DRUG	NeoBenz Micro Plus Pack		benzoyl peroxide	KIT		20090416		UNAPPROVED DRUG OTHER		SkinMedica Pharmaceuticals, Inc.						N	
67414-226_0975230a-8706-cc07-e063-6294a90a3873	67414-226	HUMAN OTC DRUG	Benadryl Allergy Ultratab		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180124		OTC MONOGRAPH DRUG	M012	Jones Healthcare Group - Packaging Services, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67414-239_0975230a-8718-cc07-e063-6294a90a3873	67414-239	HUMAN OTC DRUG	EXCEDRIN	MIGRAINE	Acetaminophen, Aspirin (NSAID) and Caffeine	TABLET, FILM COATED	ORAL	20180124		OTC MONOGRAPH DRUG	M013	Jones Healthcare Group - Packaging Services, Inc	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
67414-240_ddd2849e-23ea-dd00-e053-2995a90a252f	67414-240	HUMAN OTC DRUG	Motrin IB		IBUPROFEN	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA077349	Jones Healthcare Group - Packaging Services, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67414-402_0975bb48-2459-e8bd-e063-6394a90ae8d9	67414-402	HUMAN OTC DRUG	Tylenol Cold Plus Flu Severe	Severe	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180125		OTC MONOGRAPH DRUG	M012	Jones Healthcare Group - Packaging Services, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67414-449_0975230a-8729-cc07-e063-6294a90a3873	67414-449	HUMAN OTC DRUG	Tylenol Extra Strength	Caplet	ACETAMINOPHEN	TABLET	ORAL	20180124		OTC MONOGRAPH DRUG	M013	Jones Healthcare Group - Packaging Services, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
67414-507_09759b68-4bd0-c41f-e063-6294a90a62a4	67414-507	HUMAN OTC DRUG	Tylenol Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20180125		OTC MONOGRAPH DRUG	M012	Jones Healthcare Group - Packaging Services, Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67414-608_0975c654-f30b-1c35-e063-6394a90a0ba2	67414-608	HUMAN OTC DRUG	Tylenol PM	Extra Strength	ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180125		OTC MONOGRAPH DRUG	M013	Jones Healthcare Group - Packaging Services, Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67457-124_0430e5e0-3024-42f5-9c97-073a5d71fb3f	67457-124	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		diphenhydramine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130509		ANDA	ANDA040498	Mylan Institutional LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67457-134_46f389a6-b16b-44af-b468-973805cc3c49	67457-134	HUMAN PRESCRIPTION DRUG	Magnesium Chloride		magnesium chloride	INJECTION	INTRAVENOUS	20130314		UNAPPROVED DRUG OTHER		Mylan Institutional LLC	MAGNESIUM CHLORIDE	200	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67457-146_a7704aa3-bd3d-479e-8469-767d59636c7e	67457-146	HUMAN PRESCRIPTION DRUG	Vitamin B Complex		thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide	INJECTION	INTRAVENOUS	20130510		UNAPPROVED DRUG OTHER		Mylan Institutional LLC	DEXPANTHENOL; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE	2; 100; 2; 2; 100	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL	Analogs/Derivatives [Chemical/Ingredient], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
67457-153_bd9c578c-322f-41fc-936d-bf9b551a2782	67457-153	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		amiodarone hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20021014		ANDA	ANDA076217	Mylan Institutional LLC	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
67457-162_ddecdc4b-0bd4-4b20-a0ac-3c0fa542c14f	67457-162	HUMAN PRESCRIPTION DRUG	Sotradecol		tetradecyl hydrogen sulfate (ester)	INJECTION, SOLUTION	INTRAVENOUS	20130429		ANDA	ANDA040541	Mylan Institutional LLC	TETRADECYL HYDROGEN SULFATE (ESTER)	10	mg/mL			N	20241231
67457-163_ddecdc4b-0bd4-4b20-a0ac-3c0fa542c14f	67457-163	HUMAN PRESCRIPTION DRUG	Sotradecol		tetradecyl hydrogen sulfate (ester)	INJECTION, SOLUTION	INTRAVENOUS	20130429		ANDA	ANDA040541	Mylan Institutional LLC	TETRADECYL HYDROGEN SULFATE (ESTER)	30	mg/mL			N	20241231
67457-177_ed5bd01d-2175-457e-ae65-7197f40d7342	67457-177	HUMAN PRESCRIPTION DRUG	RIMSO-50		Dimethyl Sulfoxide	IRRIGANT	INTRAVESICAL	19780404		NDA	NDA017788	Mylan Institutional LLC	DIMETHYL SULFOXIDE	.54	g/mL			N	20241231
67457-182_1af173c0-dd9d-4061-995b-96d1f60511aa	67457-182	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		esmolol hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20070529		ANDA	ANDA076474	Mylan Institutional LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67457-187_35f241ea-eeb8-41b3-9596-be40eb9af06d	67457-187	HUMAN PRESCRIPTION DRUG	Aloprim		Allopurinol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20070515		NDA	NDA020298	Mylan Institutional LLC	ALLOPURINOL SODIUM	500	mg/25mL	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
67457-195_14d237c9-0b9f-4101-ae53-c6ffe9928801	67457-195	HUMAN PRESCRIPTION DRUG	Melphalan Hydrochloride		Melphalan Hydrochloride	KIT		20130110		ANDA	ANDA090270	Mylan Institutional LLC						N	20241231
67457-196_cbc5513d-4341-455c-b435-53dd5624efaa	67457-196	HUMAN PRESCRIPTION DRUG	Thiamine Hydrochloride		thiamine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130604		ANDA	ANDA091623	Mylan Institutional LLC	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
67457-197_e98a30b2-7c89-43ab-8391-5fc3f812f11b	67457-197	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20111129		ANDA	ANDA091657	Mylan Institutional LLC	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
67457-198_2fa2e80a-ad02-4813-b595-1074422e01e9	67457-198	HUMAN PRESCRIPTION DRUG	Ultiva		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19961106		NDA	NDA020630	Mylan Institutional LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67457-210_e7774227-c6ba-439d-a32f-01b67d010fc5	67457-210	HUMAN PRESCRIPTION DRUG	CIDOFOVIR		Cidofovir Anhydrous	INJECTION, SOLUTION	INTRAVENOUS	20130603		ANDA	ANDA201276	Mylan Institutional LLC	CIDOFOVIR	75	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog [EXT]		N	20241231
67457-211_ac92fef1-664f-4cfd-aa72-b6507934b28f	67457-211	HUMAN PRESCRIPTION DRUG	Fomepizole		Fomepizole	INJECTION, SOLUTION	INTRAVENOUS	20121009		ANDA	ANDA078639	Mylan Institutional LLC	FOMEPIZOLE	1	g/mL	Antidote [EPC]		N	20241231
67457-212_4be6602b-9e8b-4f3d-ab0e-e7fdd1ad0c03	67457-212	HUMAN PRESCRIPTION DRUG	Argatroban		argatroban	INJECTION, SOLUTION	INTRAVENOUS	20171114		ANDA	ANDA202626	Mylan Institutional LLC	ARGATROBAN	250	mg/2.5mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
67457-215_64081e17-f72f-4e4f-9a4d-7744dade88ca	67457-215	HUMAN PRESCRIPTION DRUG	Melphalan Hydrochloride		Melphalan Hydrochloride	KIT		20130110		ANDA	ANDA090270	Mylan Institutional LLC						N	20241231
67457-217_bb84881d-1f49-44a6-bb83-01f43b47ddab	67457-217	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20121220		NDA	NDA021624	Mylan Institutional LLC	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67457-218_671a0224-c38b-4f2e-a132-fa38aa1a0797	67457-218	HUMAN PRESCRIPTION DRUG	Duraclon		clonidine hydrochloride	INJECTION, SOLUTION	EPIDURAL	19970126		NDA	NDA020615	Mylan Institutional LLC	CLONIDINE HYDROCHLORIDE	.1	mg/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
67457-220_fc7ac1e3-9e29-4de4-9a4d-b83ff68beab5	67457-220	HUMAN PRESCRIPTION DRUG	Isosulfan Blue		Isosulfan Blue	INJECTION, SOLUTION	SUBCUTANEOUS	20130314		ANDA	ANDA090874	Mylan Institutional LLC	ISOSULFAN BLUE	10	mg/mL			N	20241231
67457-228_d1e9f9fd-8720-4a0b-a4c3-3b8c051367ae	67457-228	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		rocuronium bromide	INJECTION	INTRAVENOUS	20120206		ANDA	ANDA079199	Mylan Institutional LLC	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
67457-239_f737eb00-56ef-41b1-81cd-34ffbcaab8b0	67457-239	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20110401		ANDA	ANDA079198	Mylan Institutional LLC	OCTREOTIDE ACETATE	50	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
67457-245_f737eb00-56ef-41b1-81cd-34ffbcaab8b0	67457-245	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20110401		ANDA	ANDA079198	Mylan Institutional LLC	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
67457-246_f737eb00-56ef-41b1-81cd-34ffbcaab8b0	67457-246	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		octreotide acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20110401		ANDA	ANDA079198	Mylan Institutional LLC	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
67457-251_b10e25f7-8d56-4c7c-b8c0-6ed0aba9d260	67457-251	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		dexmedetomidine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140818		ANDA	ANDA202881	Mylan Institutional LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
67457-255_c0b7ac62-1213-49a6-8b9c-1a8c22309e41	67457-255	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20120116		NDA	NDA202543	Mylan Institutional LLC	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67457-256_a2421222-e383-494c-8197-8d7ebac645f0	67457-256	HUMAN PRESCRIPTION DRUG	Bivalirudin		bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180605		ANDA	ANDA202471	Mylan Institutional LLC	BIVALIRUDIN	250	mg/5mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
67457-265_c0b7ac62-1213-49a6-8b9c-1a8c22309e41	67457-265	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20120116		NDA	NDA202543	Mylan Institutional LLC	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67457-266_c0b7ac62-1213-49a6-8b9c-1a8c22309e41	67457-266	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20120116		NDA	NDA202543	Mylan Institutional LLC	LEVETIRACETAM	15	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67457-292_292c264d-927b-43a6-b9eb-00154f5d13de	67457-292	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20140306		ANDA	ANDA204997	Mylan Institutional LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
67457-297_28d901ea-bf1b-4fb8-97f0-1365aec98875	67457-297	HUMAN PRESCRIPTION DRUG	Ethacrynic Sodium		ethacrynic sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160831		ANDA	ANDA204634	Mylan Institutional LLC	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
67457-299_a7b1d4b2-f629-4c43-b81c-456e8a16cfe5	67457-299	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20160914		ANDA	ANDA205014	Mylan Institutional LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
67457-316_b47bee52-7718-749c-e053-2a95a90a0f38	67457-316	HUMAN PRESCRIPTION DRUG	Decitabine		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181010		ANDA	ANDA204607	Mylan Institutional LLC	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67457-317_4fbe587d-ddb7-42fd-aad9-e749689d2276	67457-317	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		Palonosetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180920		ANDA	ANDA206416	Mylan Institutional LLC	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67457-323_5ecd45d9-26e6-4607-88a4-dc0d7f05d052	67457-323	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN HYDROCHLORIDE		MOXIFLOXACIN HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20171003		ANDA	ANDA205833	Mylan Institutional LLC	MOXIFLOXACIN HYDROCHLORIDE	400	mg/250mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
67457-324_80de58a0-901b-42b9-84cf-2c2cbcf3f684	67457-324	HUMAN PRESCRIPTION DRUG	linezolid		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20180731		ANDA	ANDA205154	Mylan Institutional LLC	LINEZOLID	200	mg/100mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
67457-339_df08686a-292b-4b54-b3c8-60e7f53e2e31	67457-339	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20131205		ANDA	ANDA065397	Mylan Institutional LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
67457-340_df08686a-292b-4b54-b3c8-60e7f53e2e31	67457-340	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20131205		ANDA	ANDA065397	Mylan Institutional LLC	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
67457-341_4995368b-7dfc-4bb2-8b34-9da5ef6a9061	67457-341	HUMAN PRESCRIPTION DRUG	vancomycin hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20131205		ANDA	ANDA065432	Mylan Institutional LLC	VANCOMYCIN HYDROCHLORIDE	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
67457-342_6fbaa6f7-b238-49e3-9cf7-c38c1846d2e9	67457-342	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20131205		ANDA	ANDA091554	Mylan Institutional LLC	VANCOMYCIN HYDROCHLORIDE	10	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
67457-349_8ebb4add-3890-49ef-b5c9-b03400c2a3d2	67457-349	HUMAN PRESCRIPTION DRUG	ampicillin sodium and sulbactam sodium		ampicillin sodium and sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140408	20240229	ANDA	ANDA201024	Mylan Institutional LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	
67457-351_d5f1a48b-28c5-4264-b2ca-d21f7d105578	67457-351	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20160912	20240531	ANDA	ANDA201025	Mylan Institutional LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	
67457-352_d5f1a48b-28c5-4264-b2ca-d21f7d105578	67457-352	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20161006	20240131	ANDA	ANDA201025	Mylan Institutional LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	
67457-359_cf242100-3073-4d9c-823c-5430a58e9c0e	67457-359	HUMAN PRESCRIPTION DRUG	Fluphenazine Decanoate		FLUPHENAZINE DECANOATE	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20180928		ANDA	ANDA075918	Mylan Institutional LLC	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
67457-366_da9da185-9768-4032-b29f-064320c1ca81	67457-366	HUMAN PRESCRIPTION DRUG	Ibutilide Fumarate		Ibutilide Fumarate	INJECTION, SOLUTION	INTRAVENOUS	20100111		ANDA	ANDA090643	Mylan Institutional LLC	IBUTILIDE FUMARATE	.1	mg/mL	Antiarrhythmic [EPC]		N	20241231
67457-372_9b49b283-9a4f-4283-a290-c5eb039f72b9	67457-372	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20180525		ANDA	ANDA203851	Mylan Institutional LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-373_77b5838e-e9f5-4fa8-9715-2430596966a9	67457-373	HUMAN PRESCRIPTION DRUG	Heparin sodium		Heparin sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180614		ANDA	ANDA203852	Mylan Institutional LLC	HEPARIN SODIUM	20000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-374_9b49b283-9a4f-4283-a290-c5eb039f72b9	67457-374	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20180316		ANDA	ANDA203851	Mylan Institutional LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-383_9b49b283-9a4f-4283-a290-c5eb039f72b9	67457-383	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20180614		ANDA	ANDA203851	Mylan Institutional LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-384_9b49b283-9a4f-4283-a290-c5eb039f72b9	67457-384	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20180316		ANDA	ANDA203851	Mylan Institutional LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-385_9b49b283-9a4f-4283-a290-c5eb039f72b9	67457-385	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20180316		ANDA	ANDA203851	Mylan Institutional LLC	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-386_88086961-6b69-4a92-a1e5-a392f160f47c	67457-386	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210126		ANDA	ANDA203859	Mylan Institutional LLC	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
67457-390_b1d56b68-c2b4-4f76-b04d-597a6b38ee31	67457-390	HUMAN PRESCRIPTION DRUG	Zoledronic acid		Zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140310		ANDA	ANDA202650	Mylan Institutional LLC	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
67457-399_1c22c8bf-f3f3-4144-9fcc-d1252b8fae4b	67457-399	HUMAN PRESCRIPTION DRUG	cyanocobalamine		cyanocobalamine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20170706		ANDA	ANDA204829	Mylan Institutional LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
67457-400_1c22c8bf-f3f3-4144-9fcc-d1252b8fae4b	67457-400	HUMAN PRESCRIPTION DRUG	cyanocobalamine		cyanocobalamine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20170706		ANDA	ANDA204829	Mylan Institutional LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
67457-409_c0d3dc0a-61bd-40ee-87b1-1d4ae489cd52	67457-409	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20140301		ANDA	ANDA075440	Mylan Institutional LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
67457-410_c0d3dc0a-61bd-40ee-87b1-1d4ae489cd52	67457-410	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20130423		ANDA	ANDA075440	Mylan Institutional LLC	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
67457-418_52935e00-7646-4e02-8f61-1f06bb004944	67457-418	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20200415		ANDA	ANDA040803	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-419_52935e00-7646-4e02-8f61-1f06bb004944	67457-419	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20200415		ANDA	ANDA040803	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-420_b96bf614-aaf4-4a89-8405-7953875520a1	67457-420	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110511		ANDA	ANDA040802	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-421_b96bf614-aaf4-4a89-8405-7953875520a1	67457-421	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-422_b96bf614-aaf4-4a89-8405-7953875520a1	67457-422	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-423_b96bf614-aaf4-4a89-8405-7953875520a1	67457-423	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-426_7d2c008b-e71f-410b-bf5d-cfddc6a2e232	67457-426	HUMAN PRESCRIPTION DRUG	HALOPERIDOL LACTATE		HALOPERIDOL LACTATE	INJECTION, SOLUTION	INTRAMUSCULAR	20141218		ANDA	ANDA078347	Mylan Institutional LLC	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
67457-428_7418acd9-03c9-40ed-bac0-1e0702c8114d	67457-428	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20140219		ANDA	ANDA065407	Mylan Institutional LLC	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
67457-430_550f81d7-a877-43dd-bcd9-f6911d8f1628	67457-430	HUMAN PRESCRIPTION DRUG	Pamidronate Disodium		Pamidronate Disodium	INJECTION	INTRAVENOUS	20081101		ANDA	ANDA078520	Mylan Institutional LLC	PAMIDRONATE DISODIUM	3	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
67457-433_32b0bdfe-6daf-4ec9-94c6-cdd700629263	67457-433	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20080626		ANDA	ANDA078642	Mylan Institutional LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67457-436_c257c5df-9cf4-4e4e-93ea-ba914284b3dd	67457-436	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140227		ANDA	ANDA200170	Mylan Institutional LLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
67457-437_0de100c3-d8dc-40ea-a780-fc2580decc6f	67457-437	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181220		ANDA	ANDA091406	Mylan Institutional LLC	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67457-438_8c9683a0-197a-4291-9dc1-fd7ce5723efe	67457-438	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140320		ANDA	ANDA090243	Mylan Institutional LLC	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
67457-442_e54fedad-8020-4470-af8f-37f113470b6a	67457-442	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20140516		ANDA	ANDA091358	Mylan Institutional LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
67457-445_2ab0de4c-6154-4e5e-986d-a355d3edd4f8	67457-445	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150121		ANDA	ANDA065421	Mylan Institutional LLC	RIFAMPIN	600	mg/10mL	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20251231
67457-446_550f81d7-a877-43dd-bcd9-f6911d8f1628	67457-446	HUMAN PRESCRIPTION DRUG	Pamidronate Disodium		Pamidronate Disodium	INJECTION	INTRAVENOUS	20081101		ANDA	ANDA078520	Mylan Institutional LLC	PAMIDRONATE DISODIUM	9	mg/mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
67457-448_32b0bdfe-6daf-4ec9-94c6-cdd700629263	67457-448	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20080626		ANDA	ANDA078641	Mylan Institutional LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67457-457_32b0bdfe-6daf-4ec9-94c6-cdd700629263	67457-457	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20080626		ANDA	ANDA078641	Mylan Institutional LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67457-469_e54fedad-8020-4470-af8f-37f113470b6a	67457-469	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20140825		ANDA	ANDA091358	Mylan Institutional LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
67457-473_7418acd9-03c9-40ed-bac0-1e0702c8114d	67457-473	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20140819		ANDA	ANDA065407	Mylan Institutional LLC	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
67457-475_8c9683a0-197a-4291-9dc1-fd7ce5723efe	67457-475	HUMAN PRESCRIPTION DRUG	VECURONIUM BROMIDE		VECURONIUM BROMIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20150819		ANDA	ANDA090243	Mylan Institutional LLC	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
67457-483_52935e00-7646-4e02-8f61-1f06bb004944	67457-483	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200415		ANDA	ANDA040802	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-484_52935e00-7646-4e02-8f61-1f06bb004944	67457-484	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20200415		ANDA	ANDA040803	Mylan Institutional LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-524_4b6cecb5-336c-4909-8cba-823a4a62e775	67457-524	HUMAN PRESCRIPTION DRUG	ibandronate sodium		ibandronate sodium	INJECTION, SOLUTION	INTRAVENOUS	20140902		ANDA	ANDA202671	Mylan Institutional LLC	IBANDRONATE SODIUM	3	mg/3mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
67457-528_2890b03c-dbef-4db8-8b07-c042d7765677	67457-528	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAMUSCULAR; INTRAVENOUS	20190723		ANDA	ANDA203800	Mylan Institutional LLC	LEUCOVORIN CALCIUM	100	mg/10mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
67457-529_2890b03c-dbef-4db8-8b07-c042d7765677	67457-529	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAMUSCULAR; INTRAVENOUS	20190723		ANDA	ANDA203800	Mylan Institutional LLC	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
67457-530_2890b03c-dbef-4db8-8b07-c042d7765677	67457-530	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAMUSCULAR; INTRAVENOUS	20190102		ANDA	ANDA203800	Mylan Institutional LLC	LEUCOVORIN CALCIUM	350	mg/17.5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
67457-531_08690c1d-8456-4269-b1f5-3f6f12aeca9f	67457-531	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20180928		ANDA	ANDA210072	Mylan Institutional LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
67457-532_08690c1d-8456-4269-b1f5-3f6f12aeca9f	67457-532	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20180928		ANDA	ANDA210848	Mylan Institutional LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
67457-533_08690c1d-8456-4269-b1f5-3f6f12aeca9f	67457-533	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20180905		ANDA	ANDA208859	Mylan Institutional LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
67457-546_2a7d705c-2339-4515-9679-083f9bc24938	67457-546	HUMAN PRESCRIPTION DRUG	clofarabine		clofarabine	INJECTION	INTRAVENOUS	20171106		ANDA	ANDA208860	Mylan Institutional LLC	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67457-553_9b7bc3cc-7e45-422e-bc80-0add7e82fb4b	67457-553	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20201002		ANDA	ANDA209911	Mylan Institutional LLC	MAGNESIUM SULFATE HEPTAHYDRATE	2	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67457-554_9b7bc3cc-7e45-422e-bc80-0add7e82fb4b	67457-554	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20201002		ANDA	ANDA209911	Mylan Institutional LLC	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67457-562_024758c9-c94b-4ebe-8e7e-a47c39488e74	67457-562	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION, SOLUTION	INTRATHECAL	20181221		ANDA	ANDA209592	Mylan Institutional LLC	BACLOFEN	10	mg/20mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
67457-563_7fad5721-cafc-4f49-a265-b15c057b5c76	67457-563	HUMAN PRESCRIPTION DRUG	baclofen		baclofen	INJECTION, SOLUTION	INTRATHECAL	20181221		ANDA	ANDA209594	Mylan Institutional LLC	BACLOFEN	1000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
67457-564_024758c9-c94b-4ebe-8e7e-a47c39488e74	67457-564	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION, SOLUTION	INTRATHECAL	20181221		ANDA	ANDA209592	Mylan Institutional LLC	BACLOFEN	40	mg/20mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
67457-567_22843cff-0c7a-434f-a725-a45839359ce6	67457-567	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate in Dextrose		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20201013		ANDA	ANDA209932	Mylan Institutional LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67457-582_1c1e4186-6c6b-4d3b-931d-d4eaf567e2de	67457-582	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20150105		NDA AUTHORIZED GENERIC	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-583_1c1e4186-6c6b-4d3b-931d-d4eaf567e2de	67457-583	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20150105		NDA AUTHORIZED GENERIC	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-584_1c1e4186-6c6b-4d3b-931d-d4eaf567e2de	67457-584	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20150105		NDA AUTHORIZED GENERIC	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-585_1c1e4186-6c6b-4d3b-931d-d4eaf567e2de	67457-585	HUMAN PRESCRIPTION DRUG	Fondaparinux Sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20150105		NDA AUTHORIZED GENERIC	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-592_71681d56-23b6-483c-92ae-a73a2a6c1757	67457-592	HUMAN PRESCRIPTION DRUG	Arixtra		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20150506		NDA	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-593_71681d56-23b6-483c-92ae-a73a2a6c1757	67457-593	HUMAN PRESCRIPTION DRUG	Arixtra		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20150807		NDA	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-594_71681d56-23b6-483c-92ae-a73a2a6c1757	67457-594	HUMAN PRESCRIPTION DRUG	Arixtra		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20160211		NDA	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-595_71681d56-23b6-483c-92ae-a73a2a6c1757	67457-595	HUMAN PRESCRIPTION DRUG	Arixtra		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20151113		NDA	NDA021345	Mylan Institutional LLC	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
67457-599_fde9e80c-8167-4812-a1d6-c614f9a98592	67457-599	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20141217		ANDA	ANDA204997	Mylan Institutional LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
67457-602_9b49b283-9a4f-4283-a290-c5eb039f72b9	67457-602	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20180525		ANDA	ANDA203851	Mylan Institutional LLC	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-603_9b49b283-9a4f-4283-a290-c5eb039f72b9	67457-603	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20180614		ANDA	ANDA203851	Mylan Institutional LLC	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
67457-616_9c2e0bd5-bce5-4a6a-8b37-872d5e2adaaf	67457-616	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20180103		ANDA	ANDA205242	Mylan Institutional LLC	GEMCITABINE HYDROCHLORIDE	200	mg/5.26mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67457-617_9c2e0bd5-bce5-4a6a-8b37-872d5e2adaaf	67457-617	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20171218		ANDA	ANDA205242	Mylan Institutional LLC	GEMCITABINE HYDROCHLORIDE	1	g/26.3mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67457-618_9c2e0bd5-bce5-4a6a-8b37-872d5e2adaaf	67457-618	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20171218		ANDA	ANDA205242	Mylan Institutional LLC	GEMCITABINE HYDROCHLORIDE	2	g/52.6mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67457-619_8275ff48-2b45-41dd-9b5d-9ab0e92bfc30	67457-619	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20170519		ANDA	ANDA203841	Mylan Institutional LLC	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
67457-621_4015ad7d-46bf-454e-ac86-91fa5dd6a07b	67457-621	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20230508		ANDA	ANDA212567	Mylan Institutional LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-622_4015ad7d-46bf-454e-ac86-91fa5dd6a07b	67457-622	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20230508		ANDA	ANDA212567	Mylan Institutional LLC	TRIAMCINOLONE ACETONIDE	200	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-623_4015ad7d-46bf-454e-ac86-91fa5dd6a07b	67457-623	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20230508		ANDA	ANDA212567	Mylan Institutional LLC	TRIAMCINOLONE ACETONIDE	400	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67457-629_e966c894-560e-4805-bdd5-16e153bb4687	67457-629	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20181001		ANDA	ANDA203258	Mylan Institutional LLC	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
67457-630_e966c894-560e-4805-bdd5-16e153bb4687	67457-630	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20181001		ANDA	ANDA203258	Mylan Institutional LLC	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
67457-631_e966c894-560e-4805-bdd5-16e153bb4687	67457-631	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20181213		ANDA	ANDA203258	Mylan Institutional LLC	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
67457-640_861832d7-6b20-487e-bcc0-a42cfac43358	67457-640	HUMAN PRESCRIPTION DRUG	prochlorperazine edisylate		prochlorperazine edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190403		ANDA	ANDA210710	Mylan Institutional LLC	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
67457-645_ae19fec7-aac8-4fbe-a2aa-ba18a3fe5c9e	67457-645	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20200124		ANDA	ANDA204997	Mylan Institutional LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
67457-657_08eb56ec-0d17-45a5-a0a9-9741b1d14909	67457-657	HUMAN PRESCRIPTION DRUG	esmolol hydrochloride in sodium chloride		esmolol hydrochloride in sodium chloride	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA206608	Mylan Institutional LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67457-658_08eb56ec-0d17-45a5-a0a9-9741b1d14909	67457-658	HUMAN PRESCRIPTION DRUG	esmolol hydrochloride in sodium chloride		esmolol hydrochloride in sodium chloride	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA206608	Mylan Institutional LLC	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67457-675_4f5435c5-1d9c-4543-b756-195eba8adb13	67457-675	HUMAN PRESCRIPTION DRUG	Miacalcin		calcitonin salmon	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20160916		NDA	NDA017808	Mylan Institutional LLC	CALCITONIN SALMON	200	[USP'U]/mL	Calcitonin [CS], Calcitonin [EPC]		N	20241231
67457-692_4c4b3f7e-e5f4-4a77-9aac-4858e51a6126	67457-692	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION, SOLUTION	INTRAVENOUS	20181221		ANDA	ANDA203897	Mylan Institutional LLC	PARICALCITOL	5	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
67457-705_4f4d52d6-37b3-4b47-9242-69ef4fcf31ba	67457-705	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180831		NDA	NDA209481	Mylan Institutional LLC	VANCOMYCIN HYDROCHLORIDE	750	mg/15mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
67457-778_aa80137a-281f-41cd-b8df-0f08df701854	67457-778	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		sulfamethoxazole and trimethoprim	INJECTION	INTRAVENOUS	20171231		ANDA	ANDA206607	Mylan Institutional LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
67457-779_aa80137a-281f-41cd-b8df-0f08df701854	67457-779	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		sulfamethoxazole and trimethoprim	INJECTION	INTRAVENOUS	20171231		ANDA	ANDA206607	Mylan Institutional LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
67457-781_f33c2ca7-e8a1-4da2-9cce-f097151fddc0	67457-781	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20190618		ANDA	ANDA208137	Mylan Institutional LLC	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
67457-790_06be8cfb-5257-485f-9ce2-3c59f4aa8ea4	67457-790	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170724		ANDA	ANDA203308	Mylan Institutional LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67457-794_56262420-3c78-4c82-af48-d5aad6b5de4a	67457-794	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20180605		ANDA	ANDA205254	Mylan Institutional LLC	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
67457-813_d8aedf45-91a2-49a2-b367-add49c7527f0	67457-813	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180904		ANDA	ANDA205037	Mylan Institutional LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
67457-823_4f4d52d6-37b3-4b47-9242-69ef4fcf31ba	67457-823	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180831		NDA	NDA209481	Mylan Institutional LLC	VANCOMYCIN HYDROCHLORIDE	1.25	g/25mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
67457-824_4f4d52d6-37b3-4b47-9242-69ef4fcf31ba	67457-824	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181206		NDA	NDA209481	Mylan Institutional LLC	VANCOMYCIN HYDROCHLORIDE	1.5	g/30mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
67457-833_85a107b2-3583-48e8-a205-79e4bbd3b2a5	67457-833	HUMAN PRESCRIPTION DRUG	Fulphila		pegfilgrastim	INJECTION	SUBCUTANEOUS	20180709	20260531	BLA	BLA761075	Mylan Institutional LLC	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	
67457-839_e408516c-5b97-450d-a4b4-d1b07b4f029c	67457-839	HUMAN PRESCRIPTION DRUG	Sodium nitroprusside		Sodium nitroprusside	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180810		ANDA	ANDA210763	Mylan Institutional LLC	SODIUM NITROPRUSSIDE	25	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
67457-843_80de58a0-901b-42b9-84cf-2c2cbcf3f684	67457-843	HUMAN PRESCRIPTION DRUG	linezolid		linezolid	INJECTION, SOLUTION	INTRAVENOUS	20180731		ANDA	ANDA205154	Mylan Institutional LLC	LINEZOLID	600	mg/300mL	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
67457-844_80c174b3-5287-4fb5-b4c1-e1d5208c249e	67457-844	HUMAN PRESCRIPTION DRUG	Sodium Phenylacetate and Sodium Benzoate		Sodium Phenylacetate and Sodium Benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170523		ANDA	ANDA208521	Mylan Institutional LLC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
67457-847_b57e61b9-04b7-4d8b-b7c2-be56a060421b	67457-847	HUMAN PRESCRIPTION DRUG	OGIVRI		trastuzumab	KIT		20191129	20270430	BLA	BLA761074	Mylan Institutional LLC						N	
67457-852_af3a6bd3-bbc9-43a9-a277-b55ae59d5097	67457-852	HUMAN PRESCRIPTION DRUG	Norepinephrine bitartrate		Norepinephrine bitartrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20181015		ANDA	ANDA211242	Mylan Institutional LLC	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
67457-853_859bfe52-3f8d-4ff5-a70b-bc19ddb8ef07	67457-853	HUMAN PRESCRIPTION DRUG	Acetazolamide		acetazolamide sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180913		ANDA	ANDA200880	Mylan Institutional LLC	ACETAZOLAMIDE SODIUM	500	mg/5mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
67457-854_7710afdc-4172-4424-b36b-f33b41896aa6	67457-854	HUMAN PRESCRIPTION DRUG	adenosine		adenosine	INJECTION	INTRAVENOUS	20180508		ANDA	ANDA078686	Mylan Institutional LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
67457-855_7710afdc-4172-4424-b36b-f33b41896aa6	67457-855	HUMAN PRESCRIPTION DRUG	adenosine		adenosine	INJECTION	INTRAVENOUS	20180508		ANDA	ANDA078686	Mylan Institutional LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
67457-856_15f8979f-4d90-48c6-bf65-3d1a4064536b	67457-856	HUMAN PRESCRIPTION DRUG	Adenosine		adenosine	INJECTION, SOLUTION	INTRAVENOUS	20140328		ANDA	ANDA090212	Mylan Institutional LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
67457-857_15f8979f-4d90-48c6-bf65-3d1a4064536b	67457-857	HUMAN PRESCRIPTION DRUG	Adenosine		adenosine	INJECTION, SOLUTION	INTRAVENOUS	20140328		ANDA	ANDA090212	Mylan Institutional LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
67457-858_03fde6f2-0ea9-4bd9-b349-df84b216e0f6	67457-858	HUMAN PRESCRIPTION DRUG	Adenosine		adenosine	INJECTION, SOLUTION	INTRAVENOUS	20200415		ANDA	ANDA090212	Mylan Institutional LLC	ADENOSINE	60	mg/20mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
67457-859_03fde6f2-0ea9-4bd9-b349-df84b216e0f6	67457-859	HUMAN PRESCRIPTION DRUG	Adenosine		adenosine	INJECTION, SOLUTION	INTRAVENOUS	20190822		ANDA	ANDA090212	Mylan Institutional LLC	ADENOSINE	90	mg/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
67457-861_745f7893-7d47-4fad-9341-93310622013c	67457-861	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180321		ANDA	ANDA091136	Mylan Institutional LLC	GRANISETRON HYDROCHLORIDE	.1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67457-863_745f7893-7d47-4fad-9341-93310622013c	67457-863	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180321		ANDA	ANDA091136	Mylan Institutional LLC	GRANISETRON HYDROCHLORIDE	1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67457-864_745f7893-7d47-4fad-9341-93310622013c	67457-864	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180321		ANDA	ANDA091137	Mylan Institutional LLC	GRANISETRON HYDROCHLORIDE	1	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
67457-886_5c5b840b-0958-4345-ba07-f27cfdffa595	67457-886	HUMAN PRESCRIPTION DRUG	Hydroxyprogesterone Caproate		Hydroxyprogesterone Caproate	INJECTION	INTRAMUSCULAR	20170922	20240630	ANDA	ANDA200271	Mylan Institutional LLC	HYDROXYPROGESTERONE CAPROATE	250	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	
67457-887_a2ec3589-11de-4855-a71b-8d67ba60af78	67457-887	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20181012		ANDA	ANDA210227	Mylan Institutional LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
67457-889_65e4e7f1-6ca9-4138-ad88-38f530abac3b	67457-889	HUMAN PRESCRIPTION DRUG	fosaprepitant		fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190905		ANDA	ANDA204015	Mylan Institutional LLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
67457-893_bd76d3b4-198e-46d5-8d00-5b66d4c9454c	67457-893	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION	INTRAVENOUS	20171121		ANDA	ANDA208536	Mylan Institutional LLC	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
67457-902_b828ca0d-8014-4f65-a527-8388c73b7264	67457-902	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20190301		ANDA	ANDA201044	Mylan Institutional LLC	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
67457-903_b828ca0d-8014-4f65-a527-8388c73b7264	67457-903	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20190301		ANDA	ANDA201044	Mylan Institutional LLC	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
67457-912_fa6f720d-01ea-4c46-9ff1-1680af34b37f	67457-912	HUMAN PRESCRIPTION DRUG	Ultiva		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200415		NDA	NDA020630	Mylan Institutional LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67457-913_fa6f720d-01ea-4c46-9ff1-1680af34b37f	67457-913	HUMAN PRESCRIPTION DRUG	Ultiva		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200415		NDA	NDA020630	Mylan Institutional LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67457-914_fa6f720d-01ea-4c46-9ff1-1680af34b37f	67457-914	HUMAN PRESCRIPTION DRUG	Ultiva		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200415		NDA	NDA020630	Mylan Institutional LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67457-921_94e8941f-bf94-4365-b5ac-b74b73d62c71	67457-921	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		sulfamethoxazole and trimethoprim	INJECTION	INTRAVENOUS	20201012		ANDA	ANDA206607	Mylan Institutional LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
67457-922_94e8941f-bf94-4365-b5ac-b74b73d62c71	67457-922	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		sulfamethoxazole and trimethoprim	INJECTION	INTRAVENOUS	20201012		ANDA	ANDA206607	Mylan Institutional LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
67457-924_f90516a4-b48a-49fe-a410-104fe484af08	67457-924	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201113		ANDA	ANDA212571	Mylan Institutional LLC	DEXMEDETOMIDINE HYDROCHLORIDE	200	ug/50mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
67457-925_f90516a4-b48a-49fe-a410-104fe484af08	67457-925	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20201113		ANDA	ANDA212571	Mylan Institutional LLC	DEXMEDETOMIDINE HYDROCHLORIDE	400	ug/100mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
67457-940_15515cc7-c3e7-4617-9648-a3c5824c2097	67457-940	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20201207		ANDA	ANDA213255	Mylan Institutional LLC	ACETAMINOPHEN	1000	mg/100mL			N	20241231
67457-941_95909792-972b-4c0c-b2ce-2be4bed36cff	67457-941	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231127		ANDA	ANDA213966	Mylan Institutional LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
67457-978_4045f732-add9-4445-b4c8-a3a7f32bab46	67457-978	HUMAN PRESCRIPTION DRUG	Aloprim		Allopurinol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201118		NDA	NDA020298	Mylan Institutional LLC	ALLOPURINOL SODIUM	500	mg/25mL	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
67457-987_4f711224-09e7-4c4e-8780-e7e76c572f8c	67457-987	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191120		ANDA	ANDA205014	Mylan Institutional LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
67457-991_b57e61b9-04b7-4d8b-b7c2-be56a060421b	67457-991	HUMAN PRESCRIPTION DRUG	OGIVRI		trastuzumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191129	20270228	BLA	BLA761074	Mylan Institutional LLC	TRASTUZUMAB	150	mg/7.4mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	
67457-992_b41431e9-346e-48ef-a24e-908fb9713885	67457-992	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20221202		ANDA	ANDA213843	Mylan Institutional LLC	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
67457-994_e1ab38bf-cfd0-444f-a8a6-bb8588b63228	67457-994	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION	INTRAVENOUS	20230921		ANDA	ANDA213856	Mylan Institutional LLC	REGADENOSON	.4	mg/5mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
67457-999_a8999285-16b1-473d-8e92-684f581534f6	67457-999	HUMAN PRESCRIPTION DRUG	Sodium nitroprusside		Sodium nitroprusside	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20201005		ANDA	ANDA210763	Mylan Institutional LLC	SODIUM NITROPRUSSIDE	25	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
67465-0001_f4982a9c-0f05-8312-e053-2a95a90a1fe4	67465-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091027		UNAPPROVED MEDICAL GAS		Mount Vernon Community Pharmacy, Inc. dba TMS Mobility and Rehab	OXYGEN	99	L/100L			N	20241231
67477-001_08025a83-2167-c949-e063-6394a90a52bc	67477-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190130		NDA	NDA205889	MAVERICK OXYGEN & RESPIRATORY EQUIPMENT, LLC	OXYGEN	99	L/100L			N	20241231
67477-002_08025ff2-44ba-2581-e063-6294a90a2884	67477-002	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20191226		NDA	NDA209989	MAVERICK OXYGEN & RESPIRATORY EQUIPMENT, LLC	NITROUS OXIDE	990	mL/L			N	20241231
67480-001_0c0110a5-2305-079c-e063-6394a90a5219	67480-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20120724		UNAPPROVED MEDICAL GAS		Central Health Services	OXYGEN	99	L/100L			N	20241231
67492-104_0c009eaa-28cc-a619-e063-6294a90afc78	67492-104	HUMAN OTC DRUG	Calmol 4		Zinc Oxide and Cocoa Butter	SUPPOSITORY	RECTAL	20060513		OTC MONOGRAPH DRUG	M015	Resical Inc.	COCOA BUTTER; ZINC OXIDE	2052; 270	mg/1; mg/1			N	20241231
67492-105_a5f1f881-6ef6-4b9e-830e-a722f6e1c72d	67492-105	HUMAN OTC DRUG	Resinol		PETROLATUM and RESORCINOL	OINTMENT	TOPICAL	20020629		OTC MONOGRAPH DRUG	M017	ResiCal, Inc.	PETROLATUM; RESORCINOL	55; 2	g/100g; g/100g			N	20251231
67493-0009_09409e9e-d9cb-d451-e063-6294a90a7614	67493-0009	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020926		UNAPPROVED MEDICAL GAS		Buckeye Home Health Center, Inc.	OXYGEN	99	L/100L			N	20241231
67502-391_9ba0c129-8d75-4069-a21a-13693bddb569	67502-391	HUMAN OTC DRUG	Clearly Better		Foaming Hand Sanitizer	LIQUID	TOPICAL	20170828		OTC MONOGRAPH NOT FINAL	part333A	Intercon Chemical Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
67506-001_094050b5-2cbe-9e9d-e063-6294a90a0fa2	67506-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		The RRT Group	OXYGEN	99	L/100L			N	20241231
67510-0005_aa6b1714-7287-c388-e053-2995a90a9795	67510-0005	HUMAN OTC DRUG	Muscle and Joint		Menthol	GEL	TOPICAL	20110811		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	MENTHOL	2.5	g/100g			N	20241231
67510-0054_02fd9f53-768c-ff0b-e063-6294a90a4d13	67510-0054	HUMAN OTC DRUG	Anti Itch		Diphenhydramine HCl, Zinc acetate	CREAM	TOPICAL	20110811		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67510-0057_f4ee88a8-bf3d-454f-e053-2a95a90ae2a1	67510-0057	HUMAN OTC DRUG	Tolnaftate		Tolnaftate	CREAM	TOPICAL	20110811		OTC MONOGRAPH FINAL	part333C	Kareway Product, Inc.	TOLNAFTATE	1	g/100g			N	20241231
67510-0062_f4eb549f-3dcd-7ab8-e053-2995a90a74c7	67510-0062	HUMAN OTC DRUG	Redness reliever		tetrahydrozoline HCl	LIQUID	OPHTHALMIC	20110811		OTC MONOGRAPH FINAL	part349	Kareway Product, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
67510-0064_e3575286-2db1-d528-e053-2a95a90a19a8	67510-0064	HUMAN OTC DRUG	Advanced Relief		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline HCl	LIQUID	OPHTHALMIC	20180530		OTC MONOGRAPH FINAL	part349	Kareway Product, Inc.	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
67510-0065_f4eb549f-3dce-7ab8-e053-2995a90a74c7	67510-0065	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20110810		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	HYDROCORTISONE	1	h/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67510-0068_f83d0498-6b7a-5b17-e053-6394a90ab3a6	67510-0068	HUMAN OTC DRUG	Nasal Decongestant		Oxymetazoline HCl	SPRAY	NASAL	20110812		OTC MONOGRAPH FINAL	part341	Kareway Product, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
67510-0111_f4ee88a8-bf3c-454f-e053-2a95a90ae2a1	67510-0111	HUMAN OTC DRUG	Mint		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20110815		OTC MONOGRAPH FINAL	part355	Kareway Product, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
67510-0112_f4eeaa89-bfe3-22d4-e053-2a95a90ac259	67510-0112	HUMAN OTC DRUG	Regular		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20110815		OTC MONOGRAPH FINAL	part355	Kareway Product, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
67510-0126_f4eb549f-3dcc-7ab8-e053-2995a90a74c7	67510-0126	HUMAN OTC DRUG	Medicated Pain Relief Hot		Menthol, Capsicum extract	PATCH	TOPICAL	20171201		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	CAPSAICIN; MENTHOL	.12; 24	mg/1; mg/1			N	20241231
67510-0170_f4eebabd-e8bd-632e-e053-2995a90a9a70	67510-0170	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B	OINTMENT	TOPICAL	20110810		OTC MONOGRAPH FINAL	part333B	Kareway Product, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67510-0251_b0f45c78-dc99-6f88-e053-2a95a90acec1	67510-0251	HUMAN OTC DRUG	Alcohol Prep Pads		isopropyl alcohol	SWAB	TOPICAL	20130820		OTC MONOGRAPH NOT FINAL	part333A	Kareway Product, Inc.	ISOPROPYL ALCOHOL	70	1/1			N	20241231
67510-0280_f1160d91-55c1-d473-e053-2995a90abad7	67510-0280	HUMAN OTC DRUG	Pure-Aid		Lidocaine, menthol	PATCH	TOPICAL	20180302		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	LIDOCAINE	240	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67510-0283_f4eb4aa7-a563-8197-e053-2a95a90a6356	67510-0283	HUMAN OTC DRUG	Soundbody		Lidocaine	PATCH	TOPICAL	20180302		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	LIDOCAINE	240	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67510-0284_6679cada-f084-26e8-e053-2a91aa0adcc5	67510-0284	HUMAN OTC DRUG	Pure-Aid		Lidocaine, Menthol	PATCH	TOPICAL	20180302		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	240; 60	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67510-0289_6def9da7-e119-fd5c-e053-2991aa0a65d2	67510-0289	HUMAN OTC DRUG	Pure-Aid		Camphor, Menthol, Methyl salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20180605		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	21.56; 41.73; 69.55	mg/1; mg/1; mg/1			N	20241231
67510-0300_f4ee89f0-25d6-6ffc-e053-2995a90a857b	67510-0300	HUMAN OTC DRUG	Cold and Hot Pain Relief		Menthol	PATCH	TOPICAL	20170221		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	MENTHOL	400	mg/1			N	20241231
67510-0301_f4ef5e2d-27ba-ca48-e053-2a95a90a8ab1	67510-0301	HUMAN OTC DRUG	Medicated Pain Relief		Menthol	PATCH	TOPICAL	20110912		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	MENTHOL	428.5	mg/1			N	20241231
67510-0303_6e120fc6-2435-8dae-e053-2a91aa0a8f89	67510-0303	HUMAN OTC DRUG	Capsaicin Pain Relief		Capsaicin	PATCH	TOPICAL	20120123		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	CAPSAICIN	.702	mg/1			N	20241231
67510-0305_5f9cfed0-1b1e-46a2-e053-2991aa0aca8a	67510-0305	HUMAN OTC DRUG	Pain Relief		DL-Camphor, L-Menthol, Methyl Salicylate patch	PATCH	TOPICAL	20120125		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	.4; 1.8; 2	mg/1; mg/1; mg/1			N	20241231
67510-0547_f4ee6f6e-ffc8-4583-e053-2a95a90aa960	67510-0547	HUMAN OTC DRUG	Soundbody medicated patch		Camphor, Menthol, Methyl salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20020219		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	31; 60; 100	mg/1; mg/1; mg/1			N	20241231
67510-0631_f344a0a6-5099-27b3-e053-2995a90a6c43	67510-0631	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B	OINTMENT	TOPICAL	20131212		OTC MONOGRAPH FINAL	part333B	Kareway Product, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67510-0632_f344a0a6-509a-27b3-e053-2995a90a6c43	67510-0632	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20131212		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67510-0633_f4ee88a8-bf3b-454f-e053-2a95a90ae2a1	67510-0633	HUMAN OTC DRUG	Anti-Itch		Diphenhydramine HCl, Zinc acetate	CREAM	TOPICAL	20131213		OTC MONOGRAPH FINAL	part347	Kareway Product, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67510-0634_eda70b68-5c20-387b-e053-2a95a90ab5b2	67510-0634	HUMAN OTC DRUG	Muscle and Joint		Menthol	GEL	TOPICAL	20131212		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	MENTHOL	2.5	g/100g			N	20241231
67510-0636_6c83ec36-3e3e-07a9-e053-2a91aa0ac54c	67510-0636	HUMAN OTC DRUG	Soundbody		Lidocaine, Menthol	PATCH	TOPICAL	20180302		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	LIDOCAINE; MENTHOL	40; 10	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67510-0638_f4eec334-ed72-ea33-e053-2a95a90a12fd	67510-0638	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20110811		OTC MONOGRAPH FINAL	part333C	Kareway Product, Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67510-0649_e3574bbc-ffcf-6d48-e053-2995a90a7c86	67510-0649	HUMAN OTC DRUG	Soundbody Eye Lubricant		polyethylene gloycol, propylene glycol	LIQUID	OPHTHALMIC	20180530		OTC MONOGRAPH FINAL	part349	Kareway Product, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
67510-0657_f4eec748-8fb1-9b8e-e053-2a95a90a5410	67510-0657	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20110811		OTC MONOGRAPH FINAL	part333C	Kareway Product, Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67510-0659_f4ee6f6e-ffc9-4583-e053-2a95a90aa960	67510-0659	HUMAN OTC DRUG	Muscle Rub Ultra		Camphor,Menthol, methyl salicylate	CREAM	TOPICAL	20110811		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	CAMPHOR (NATURAL); MENTHOL; MENTHYL SALICYLATE, (+/-)-	4; 10; 30	g/100g; g/100g; g/100g			N	20241231
67510-0663_f344f37e-0151-0ef2-e053-2995a90a49a7	67510-0663	HUMAN OTC DRUG	Eye Lubricant		polyethylene gloycol, propylene glycol	LIQUID	OPHTHALMIC	20121001		OTC MONOGRAPH FINAL	part349	Kareway Product, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
67510-0665_f4ee8269-4739-3f06-e053-2995a90ad7cf	67510-0665	HUMAN OTC DRUG	Seasonal itchy and Red eye relief		tetrahydrozoline HCl, Zinc sulfate	LIQUID	OPHTHALMIC	20131112		OTC MONOGRAPH FINAL	part349	Kareway Product, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
67510-0673_f3093a16-5ed9-19eb-e053-2995a90a22bc	67510-0673	HUMAN OTC DRUG	Pain Reliving Roll-on		MENTHOL	GEL	TOPICAL	20230124		OTC MONOGRAPH NOT FINAL	part348	KAREWAY PRODUCT, INC.	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
67510-0679_aa6b440f-afa3-47aa-e053-2a95a90a0b9f	67510-0679	HUMAN OTC DRUG	Lidocaine creme		Lidocaine HCl and Menthol	CREAM	TOPICAL	20200713		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	LIDOCAINE	.4	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67510-0680_f3449a7c-6812-4cd1-e053-2995a90a05c8	67510-0680	HUMAN OTC DRUG	Lidocaine creme		Lidocaine HCl and Menthol	CREAM	TOPICAL	20200217		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	LIDOCAINE	.4	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67510-0681_9ef63992-14f6-0a84-e053-2995a90a5b78	67510-0681	HUMAN OTC DRUG	Lidocaine with Menthol		Lidocaine HCl and Menthol	CREAM	TOPICAL	20200217		OTC MONOGRAPH NOT FINAL	part348	Kareway Product, Inc.	LIDOCAINE; MENTHOL	.4; .1	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67510-0682_f4eb647a-12ca-c5db-e053-2995a90ac625	67510-0682	HUMAN OTC DRUG	Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20200217		OTC MONOGRAPH FINAL	part333B	Kareway Product, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67510-1502_f4ee6f6e-ffc6-4583-e053-2a95a90aa960	67510-1502	HUMAN OTC DRUG	Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20110825		OTC MONOGRAPH FINAL	part347	Kareway Product, Inc.	ZINC OXIDE	.13	g/g			N	20241231
67510-1670_f4ee870c-a1dc-1d42-e053-2a95a90ada2d	67510-1670	HUMAN OTC DRUG	Triple Antibiotic Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20170726		OTC MONOGRAPH FINAL	part333B	Kareway Product, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67525-100_3a116560-d843-47f7-b3d3-b03760d3e672	67525-100	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA206023	Spectrum Gas Products, Inc	OXYGEN	99	L/100L			N	20241231
67525-200_5cc8c6da-371f-4c0b-88a8-69753946aa43	67525-200	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA205845	Spectrum Gas Products, Inc	OXYGEN	210	mL/L			N	20241231
67525-300_21ffb48a-6d6c-45de-bbe4-3e83887e4966	67525-300	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA206024	Spectrum Gas Products, Inc	NITROGEN	99	L/100L			N	20241231
67525-400_bec25263-7f3e-4e0f-a40a-059b69d02eb5	67525-400	HUMAN PRESCRIPTION DRUG	NITROUS OXIDE		NITROUS OXIDE	GAS	RESPIRATORY (INHALATION)	20050101		NDA	NDA206009	Spectrum Gas Products, Inc	NITROUS OXIDE	99	L/100L			N	20241231
67544-002_0a78317d-df30-47af-a27c-04e3324e5d89	67544-002	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20110706		ANDA	ANDA040419	Aphena Pharma Solutions - Tennessee, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
67544-003_0a78317d-df30-47af-a27c-04e3324e5d89	67544-003	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20110706		ANDA	ANDA040419	Aphena Pharma Solutions - Tennessee, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
67544-019_fe566d09-3b52-4def-901e-a14f3589f799	67544-019	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19870203		ANDA	ANDA071135	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-020_9286513a-0020-4199-ab54-c5da4831bb64	67544-020	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19870203		ANDA	ANDA071136	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-085_15da0c7c-bd89-40fe-933c-f28a7e315a8a	67544-085	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19970911		ANDA	ANDA040218	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
67544-097_4458c829-ec73-4861-9ff6-3839cdc60643	67544-097	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950407		ANDA	ANDA074305	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
67544-136_6d75ac66-4a65-487b-a938-7414907c2632	67544-136	HUMAN PRESCRIPTION DRUG	Temazepam		temazepam	CAPSULE	ORAL	19870803		ANDA	ANDA071638	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-142_cb8a79d2-86b3-4746-bd69-40105a3c0451	67544-142	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	19911031		ANDA	ANDA072928	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-149_cc734890-e42c-454a-b771-3ecd169d161a	67544-149	HUMAN OTC DRUG	Mucinex		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20120703		NDA	NDA021282	Aphena Pharma Solutions - Tennessee, LLC	GUAIFENESIN	600	mg/1			N	20241231
67544-161_d38bdacd-b80a-4e86-b588-5a6eede1d075	67544-161	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19920501		ANDA	ANDA074052	Aphena Pharma Solutions - Tennessee, LLC	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67544-191_cb8a79d2-86b3-4746-bd69-40105a3c0451	67544-191	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	19911031		ANDA	ANDA072926	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-240_b683fd4a-0b9c-4100-a6ff-73bc34b8e5d6	67544-240	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19990617		ANDA	ANDA073457	Aphena Pharma Solutions - Tennessee, LLC	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67544-253_15da0c7c-bd89-40fe-933c-f28a7e315a8a	67544-253	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19970911		ANDA	ANDA040218	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
67544-261_cb8a79d2-86b3-4746-bd69-40105a3c0451	67544-261	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	19911031		ANDA	ANDA072927	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-282_c0c40b32-61c4-4f74-a388-b2459593531f	67544-282	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	19920201		NDA	NDA019962	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67544-302_4458c829-ec73-4861-9ff6-3839cdc60643	67544-302	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950407		ANDA	ANDA074305	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
67544-310_3c92f359-98a1-43c4-b639-58ab3a388ab3	67544-310	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	19810203		ANDA	ANDA040424	Aphena Pharma Solutions - Tennessee, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
67544-313_c5d95534-5585-40ff-9d6c-8b4a62c1b101	67544-313	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20090406		NDA	NDA018877	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
67544-317_4569b4c4-1f9a-4dcb-96f7-296bb6ef34e7	67544-317	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE ANHYDROUS	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
67544-332_d38bdacd-b80a-4e86-b588-5a6eede1d075	67544-332	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	19910917		ANDA	ANDA073026	Aphena Pharma Solutions - Tennessee, LLC	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67544-347_51152b89-539c-4c80-bb84-d7f2dc082953	67544-347	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Aphena Pharma Solutions - Tennessee, LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-387_4c117ff1-5215-4b0b-9b2d-449a31092f37	67544-387	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA076670	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67544-399_4e4b9eb1-c341-44b9-a496-590eb2c5c7e6	67544-399	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Aphena Pharma Solutions - Tennessee, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67544-414_51152b89-539c-4c80-bb84-d7f2dc082953	67544-414	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Aphena Pharma Solutions - Tennessee, LLC	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-415_51152b89-539c-4c80-bb84-d7f2dc082953	67544-415	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Aphena Pharma Solutions - Tennessee, LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-491_267b96d9-2920-4d66-8adf-92b6aff7a5eb	67544-491	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	19920201		NDA	NDA019962	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67544-492_1bb37fe5-45ba-4f89-b480-35fa1dedf247	67544-492	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20030908		ANDA	ANDA075356	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE ANHYDROUS	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
67544-529_2458678c-6ce9-4fa4-976a-2c49b489a834	67544-529	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960918		ANDA	ANDA074569	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67544-555_c0c40b32-61c4-4f74-a388-b2459593531f	67544-555	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20010326		NDA	NDA019962	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67544-569_7c8f8413-4c41-4f54-9530-46f64782ced0	67544-569	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	19900930		ANDA	ANDA071655	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
67544-657_b08e0b2c-c3c7-42f4-a43c-5eb32ce5be79	67544-657	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	19900930		ANDA	ANDA088467	Aphena Pharma Solutions - Tennessee, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
67544-671_ba0a7c8f-e018-4e0b-97df-8e5752eb03ad	67544-671	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077156	Aphena Pharma Solutions - Tennessee, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
67544-736_887b4ea6-3af9-4825-b453-176d44169b86	67544-736	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	19861024		ANDA	ANDA018659	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
67544-739_81155b23-9294-4758-80c8-5e33c4024868	67544-739	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE, GELATIN COATED	ORAL	19961227		NDA AUTHORIZED GENERIC	NDA020504	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
67544-767_7fa2db15-e9e9-4e97-b544-208e64f73ba3	67544-767	HUMAN OTC DRUG	Simethicone		Simethicone	TABLET, CHEWABLE	ORAL	19990312		OTC MONOGRAPH FINAL	part332	Aphena Pharma Solutions - Tennessee, LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
67544-989_583ccb68-3d4b-4b3b-b0fa-c84dd33a0753	67544-989	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20160201		ANDA	ANDA204418	Aphena Pharma Solutions - Tennessee, LLC	FOLIC ACID	1	mg/1			N	20241231
67546-111_0bcb3d93-5055-9a30-e063-6294a90a3afe	67546-111	HUMAN PRESCRIPTION DRUG	Alinia		nitazoxanide	TABLET	ORAL	20040721		NDA	NDA021497	Romark Laboratories, L.C.	NITAZOXANIDE	500	mg/1	Antiprotozoal [EPC]		N	20241231
67546-212_0bcb3d93-5055-9a30-e063-6294a90a3afe	67546-212	HUMAN PRESCRIPTION DRUG	Alinia		nitazoxanide	POWDER, FOR SUSPENSION	ORAL	20021122		NDA	NDA021498	Romark Laboratories, L.C.	NITAZOXANIDE	100	mg/5mL	Antiprotozoal [EPC]		N	20241231
67573-0102_07ef2d53-1a2e-7d4c-e063-6294a90a8da6	67573-0102	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205713	B & J Welding Supply, LTD. dba B & J Welding Supply	NITROGEN	990	mL/L			N	20241231
67573-0103_07eef4a6-48c7-0c04-e063-6394a90abb0a	67573-0103	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205712	B & J WELDING SUPPLY, LTD. dba B & J Welding Supply	OXYGEN	995	mL/L			N	20241231
67573-0104_07ef2d53-1a2d-7d4c-e063-6294a90a8da6	67573-0104	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19770101		NDA	NDA205712	B & J Welding Supply, LTD. dba B & J Welding Supply	OXYGEN	995	mL/L			N	20241231
67618-101_6e0bf6e9-7a93-4f26-b1cb-9cc9af3b8945	67618-101	HUMAN OTC DRUG	Colace		Docusate sodium	CAPSULE	ORAL	19970130		OTC MONOGRAPH DRUG	M007	Atlantis Consumer Healthcare, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
67618-110_32f949ee-48ec-4916-83ae-046e4de3a0b7	67618-110	HUMAN OTC DRUG	Colace		Docusate sodium - sennosides	TABLET, FILM COATED	ORAL	19570208		OTC MONOGRAPH DRUG	M007	Atlantis Consumer Healthcare, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
67618-111_e0bb692b-cf7f-4a23-a5e5-01fe0242b294	67618-111	HUMAN OTC DRUG	Colace		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	19000107		OTC MONOGRAPH DRUG	M007	Atlantis Consumer Healthcare, Inc.	DOCUSATE SODIUM	50	mg/1			N	20241231
67618-120_b2a10442-8af0-416a-b6b7-1a836420717e	67618-120	HUMAN OTC DRUG	Senokot		standardized senna concentrate	TABLET, FILM COATED	ORAL	19880901		OTC MONOGRAPH DRUG	M007	Atlantis Consumer Healthcare, Inc.	SENNOSIDES	17.2	mg/1			N	20241231
67618-150_37e362bf-7993-439f-8505-2c700e7d3f6f	67618-150	HUMAN OTC DRUG	Betadine	Solution	POVIDONE-IODINE	SOLUTION	TOPICAL	19800601		OTC MONOGRAPH DRUG	M003	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	10	mg/mL			N	20241231
67618-150_84d0fa20-0c7a-4102-ac72-ca97735ad122	67618-150	HUMAN OTC DRUG	Betadine	Solution	POVIDONE-IODINE	SOLUTION	TOPICAL	19800601		OTC MONOGRAPH DRUG	M003	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	10	mg/mL			N	20241231
67618-151_d2837dd9-1ba2-4a6d-a1a5-06ea00a62a1d	67618-151	HUMAN OTC DRUG	Betadine	Surgical Scrub	POVIDONE-IODINE	SOLUTION	TOPICAL	19960701		OTC MONOGRAPH DRUG	M003	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	.075	mg/mL			N	20241231
67618-153_55eae8e0-7c48-4a1b-9ccf-812c564411d1	67618-153	HUMAN OTC DRUG	Betadine	Solution Swabsticks	POVIDONE-IODINE	SOLUTION	TOPICAL	19720915		OTC MONOGRAPH DRUG	M003	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	10	mg/mL			N	20241231
67618-160_136d25e5-5ccc-4a69-ab9d-35b02cefed5b	67618-160	HUMAN OTC DRUG	Betadine		POVIDONE-IODINE	SPRAY	TOPICAL	19920415		OTC MONOGRAPH DRUG	M003	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	5	mg/mL			N	20241231
67618-165_a3cb4462-d000-4159-bb26-678d8c7280c3	67618-165	HUMAN OTC DRUG	Betadine Dry Powder		POVIDONE-IODINE	AEROSOL, SPRAY	TOPICAL	20200615		OTC MONOGRAPH DRUG	M003	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	.05	mg/mL			N	20241231
67618-181_7b70e574-3038-4b4f-ace5-36ebe3baa070	67618-181	HUMAN OTC DRUG	Betadine Gargle		POVIDONE-IODINE	SOLUTION	ORAL	20200615		OTC MONOGRAPH DRUG	M022	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	.05	mg/mL			N	20241231
67618-182_5990203b-4ee2-dab6-270c-908ac89fb03a	67618-182	HUMAN OTC DRUG	BETADINE Antiseptic Oral Rinse		POVIDONE-IODINE	SOLUTION	ORAL	20210208		OTC MONOGRAPH NOT FINAL	part356	Atlantis Consumer Healthcare, Inc.	POVIDONE-IODINE	.05	mg/mL			N	20241231
67618-183_31b94a76-1536-47c0-ab03-e487c2625c58	67618-183	HUMAN OTC DRUG	Maximum Strength Betadine Clear		Benzalkonium Cl and Pramoxine HCl	SPRAY	TOPICAL	20231222		OTC MONOGRAPH DRUG	M003	Atlantis Consumer Healthcare, Inc.	BENZALKONIUM CHLORIDE; PRAMOXINE HYDROCHLORIDE	.13; 1	mg/mL; mg/mL			N	20251231
67618-200_38dcb5ed-dbcd-42dd-9851-23061fed37b1	67618-200	HUMAN OTC DRUG	BETASEPT		Antiseptic Surgical Scrub	SOLUTION	TOPICAL	19930601		NDA	NDA019125	Atlantis Consumer Healthcare, Inc.	CHLORHEXIDINE GLUCONATE	.04	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
67618-300_ab5d1abb-9c2d-4b56-84f5-d281c284e99f	67618-300	HUMAN OTC DRUG	Senokot		standardized senna concentrate	TABLET	ORAL	19560601		OTC MONOGRAPH DRUG	M007	Atlantis Consumer Healthcare, Inc.	SENNOSIDES	8.6	mg/1			N	20241231
67618-310_efb2f802-6a80-4290-8773-e69726f65346	67618-310	HUMAN OTC DRUG	Senokot-S		standardized senna concentrate and docusate sodium	TABLET	ORAL	19741001		OTC MONOGRAPH DRUG	M007	Atlantis Consumer Healthcare, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
67623-001_f925abbe-496b-00b0-e053-6294a90a6e53	67623-001	HUMAN OTC DRUG	Exel Clarifying Line	SPF 50	Octinoxate, Octocrylene, Oxybenzone, Tatanium Dioxide	CREAM	TOPICAL	20150514		OTC MONOGRAPH FINAL	part352	Biocosmetica Exel Argentina SRL	OCTINOXATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	7.5; 8; 3; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
67623-002_f925a626-42d7-eb59-e053-6294a90ad561	67623-002	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333A	Biocosmetica Excel Argentina	ALCOHOL	70	mL/100mL			N	20241231
67623-610_f9258387-481b-a9e7-e053-6394a90a743b	67623-610	HUMAN OTC DRUG	Silk Line Silk Day Cream SPF 15		Octinoxate, Octocrylene, Octisalate	CREAM	TOPICAL	20201026		OTC MONOGRAPH FINAL	part352	Biocosmetica Exel Argentina SRL	OCTINOXATE; OCTISALATE; OCTOCRYLENE	7.5; 2; 7	g/100mL; g/100mL; g/100mL			N	20241231
67676-002_08b41e64-6a22-9100-e063-6294a90afa46	67676-002	HUMAN OTC DRUG	Joint Formula 88 MAX PLUS		CAMPHOR	CREAM	TOPICAL	20130801		OTC MONOGRAPH DRUG	M017	Sarati International, Inc.	CAMPHOR (SYNTHETIC)	3.18	g/100g			N	20241231
67676-006_08b45a2b-4722-2de0-e063-6294a90a163f	67676-006	HUMAN OTC DRUG	BZK Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210331		OTC MONOGRAPH DRUG	505G(a)(3)	Sarati International, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
67676-101_08b4632c-2421-6046-e063-6294a90a1527	67676-101	HUMAN OTC DRUG	OsmoFlex		MENTHOL	CREAM	TOPICAL	20160516		OTC MONOGRAPH DRUG	M017	Sarati International, Inc.	MENTHOL	1.3	g/100g			N	20241231
67684-1901_0c1873b2-b63c-4e47-b437-15acfaa1b80d	67684-1901	HUMAN PRESCRIPTION DRUG	LIPIODOL		ethiodized oil	INJECTION	INTRA-ARTERIAL; INTRALYMPHATIC; INTRAUTERINE	20140321		NDA	NDA009190	Guerbet LLC	ETHIODIZED OIL	480	mg/mL			N	20241231
67684-2000_5b5d08eb-5ba4-4a75-b027-0a5dd6888f64	67684-2000	HUMAN PRESCRIPTION DRUG	DOTAREM		gadoterate meglumine	INJECTION	INTRAVENOUS	20130320		NDA	NDA204781	Guerbet LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
67684-2000_d7bb0b9d-0f02-4141-a3dd-12ed4d1ebe46	67684-2000	HUMAN PRESCRIPTION DRUG	DOTAREM		gadoterate meglumine	INJECTION	INTRAVENOUS	20130426		NDA	NDA204781	Guerbet LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
67684-2001_5b5d08eb-5ba4-4a75-b027-0a5dd6888f64	67684-2001	HUMAN PRESCRIPTION DRUG	DOTAREM		gadoterate meglumine	INJECTION	INTRAVENOUS	20130320		NDA	NDA204781	Guerbet LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
67684-2001_d7bb0b9d-0f02-4141-a3dd-12ed4d1ebe46	67684-2001	HUMAN PRESCRIPTION DRUG	DOTAREM		gadoterate meglumine	INJECTION	INTRAVENOUS	20130426		NDA	NDA204781	Guerbet LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
67684-3001_5b5d08eb-5ba4-4a75-b027-0a5dd6888f64	67684-3001	HUMAN PRESCRIPTION DRUG	DOTAREM		gadoterate meglumine	INJECTION	INTRAVENOUS	20190918		NDA	NDA204781	Guerbet LLC	GADOTERATE MEGLUMINE	376.9	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
67684-4230_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4230	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67684-4231_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4231	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67684-4232_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4232	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67684-4233_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4233	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67684-4240_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4240	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67684-4241_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4241	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67684-4242_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4242	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67684-4250_c1dba3d4-a0f8-4c97-916d-2d4b3025485b	67684-4250	HUMAN PRESCRIPTION DRUG	ELUCIREM		gadopiclenol	INJECTION	INTRAVENOUS	20220921		NDA	NDA216986	Guerbet LLC	GADOPICLENOL	485.1	mg/mL			N	20241231
67691-770_c1f73e85-7170-4554-abd9-cedb0bd53620	67691-770	HUMAN OTC DRUG	Scienceware Eyewash		Water	SOLUTION	OPHTHALMIC	20170115		OTC MONOGRAPH FINAL	part349	Bel-Art	WATER	98.3	mL/100mL			N	20241231
67711-001_7681f05c-75cf-4ede-96d3-c8da778ebe63	67711-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20030101		UNAPPROVED MEDICAL GAS		AIRSERVE, LLC	OXYGEN	991	mL/L			N	20241231
67751-001_08b8a3a8-e3ff-9403-e063-6394a90aee97	67751-001	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20130424		OTC MONOGRAPH DRUG	M003	Navajo Manufacturing Company Inc.	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
67751-002_08b8ad2e-41e5-a493-e063-6294a90a16bc	67751-002	HUMAN OTC DRUG	Handy Solutions Rubbing Alcohol		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20130815		OTC MONOGRAPH DRUG	M003	Navajo Manufacturing Company Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
67751-033_f6f6bf9d-d49f-094e-e053-6394a90a2a14	67751-033	HUMAN OTC DRUG	Allegra Allergy		FEXOFENADINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20150512		NDA	NDA020872	Navajo Manufacturing Company Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67751-095_f6f64b35-d92f-9ad8-e053-6394a90a32f6	67751-095	HUMAN OTC DRUG	Handy Solutions Crest Complete MULTI-BENEFIT WHITENING plus Scope		SODIUM FLUORIDE	PASTE, DENTIFRICE	ORAL	20130816		OTC MONOGRAPH FINAL	part355	Navajo Manufacturing Company Inc	SODIUM FLUORIDE	1.5	mg/g			N	20241231
67751-118_f89be964-c1ce-4e49-e053-6294a90ae70a	67751-118	HUMAN OTC DRUG	Colgate Great Regular Flavor		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20051105		OTC MONOGRAPH FINAL	part355	Navajo Manufacturing Company Inc.	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
67751-119_f7e5728e-6661-788f-e053-6394a90a784a	67751-119	HUMAN OTC DRUG	Excedrin	Extra Strength Pain Reliever	Acetaminophen, Aspirin (NSAID), and Caffeine	TABLET, FILM COATED	ORAL	20190315		OTC MONOGRAPH NOT FINAL	part343	Navajo Manufacturing Company Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
67751-120_f70c1b68-61c9-b333-e053-6294a90aadaa	67751-120	HUMAN OTC DRUG	Motrin IB		IBUPROFEN	TABLET, FILM COATED	ORAL	20160922		NDA	NDA019012	Navajo Manufacturing Company Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67751-125_f706ab57-bb88-8e63-e053-6394a90a99c0	67751-125	HUMAN OTC DRUG	Flanax Pain Reliever/Fever Reducer		Naproxen Sodium	TABLET	ORAL	20200720		ANDA	ANDA090545	Navajo Manufacturing Company Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67751-129_f6f2ca3a-1c6c-ad5a-e053-6394a90a060f	67751-129	HUMAN OTC DRUG	Bayer Genuine Aspirin		Aspirin	TABLET	ORAL	20160601		OTC MONOGRAPH NOT FINAL	part343	Navajo Manufacturing Company Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
67751-130_f70bab42-8e0e-e9a4-e053-6294a90aab1b	67751-130	HUMAN OTC DRUG	Refresh Tears Lubricant		CARBOXYMETHYLCELLULOSE SODIUM	SOLUTION/ DROPS	OPHTHALMIC	20040901		OTC MONOGRAPH FINAL	part349	Navajo Manufacturing Company Inc.	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
67751-134_f70a0d72-439f-fd4f-e053-6294a90adeb3	67751-134	HUMAN OTC DRUG	HANDY SOLUTIONS DOVE COOL ESSENTIAL CUCUMBER AND GREEN TEA SCENT ANTI-PERSPIRANT		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20130816		OTC MONOGRAPH FINAL	part350	Navajo Manufacturing Company Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	14.8	g/100g			N	20241231
67751-143_f5db5155-47d3-b350-e053-2995a90a1370	67751-143	HUMAN OTC DRUG	Alka Seltzer Original		ANHYDROUS CITRIC ACID, ASPIRIN, SODIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20160916	20250401	OTC MONOGRAPH NOT FINAL	part343	Navajo Manufacturing Company Inc.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Platelet Aggregation Inhibitor [EPC]		N	
67751-144_f5db63e0-e9f5-ec67-e053-2995a90a6f90	67751-144	HUMAN OTC DRUG	Aleve		naproxen sodium	TABLET	ORAL	20171204		NDA	NDA020204	Navajo Manufacturing Company Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67751-146_f70a8d20-570c-1e94-e053-6294a90ab66f	67751-146	HUMAN OTC DRUG	Advil		IBUPROFEN	TABLET, COATED	ORAL	20160920		NDA	NDA018989	Navajo Manufacturing Company Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67751-148_ebe15362-ec80-baba-e053-2995a90a112e	67751-148	HUMAN OTC DRUG	Advil Liquigels		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20160920		NDA	NDA020402	Navajo Manufacturing Company Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67751-149_f6f71bb0-5bac-59f7-e053-6394a90abf8e	67751-149	HUMAN OTC DRUG	Advil Allergy and Congestion Relief		CHLORPHENIRAMINE MALEATE, IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160916		NDA	NDA022113	Navajo Manufacturing Company Inc.	CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	4; 200; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67751-150_f6f7501a-9ba4-82ea-e053-6294a90a298e	67751-150	HUMAN OTC DRUG	Advil Sinus Congestion and Pain Relief		IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160920		NDA	NDA022565	Navajo Manufacturing Company Inc.	IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE	200; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67751-153_f5db87e3-16ba-4e7e-e053-2995a90ab04e	67751-153	HUMAN OTC DRUG	Claritin		loratadine	TABLET	ORAL	20171204		NDA	NDA019658	Navajo Manufacturing Company	LORATADINE	10	mg/1			N	20241231
67751-153_f5db88bd-8ea6-0df0-e053-2995a90a18b4	67751-153	HUMAN OTC DRUG	Claritin		LORATADINE	TABLET	ORAL	20160917		NDA	NDA019658	Navajo Manufacturing Company Inc.	LORATADINE	10	mg/1			N	20241231
67751-156_f70c161d-fe32-7783-e053-6294a90a8c23	67751-156	HUMAN OTC DRUG	ZZZQuil Nightime Sleep-Aid		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20160929		OTC MONOGRAPH FINAL	part338	Navajo Manufacturing Company Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67751-159_f70b87a7-fbd5-8e24-e053-6394a90a031a	67751-159	HUMAN OTC DRUG	NyQuil Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160921	20240301	OTC MONOGRAPH FINAL	part341	Navajo Manufacturing Company Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
67751-162_f6f79fd3-55a5-4d2a-e053-6394a90a4ddd	67751-162	HUMAN OTC DRUG	Handy Solutions Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	TABLET	ORAL	20160921		ANDA	ANDA074091	Navajo Manufacturing Company Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
67751-163_f6f7b483-e260-2138-e053-6394a90ae319	67751-163	HUMAN OTC DRUG	Handy Solutions 24 Hour Allergy		LORATADINE	TABLET, FILM COATED	ORAL	20160922		ANDA	ANDA076134	Navajo Manufacturing Company Inc.	LORATADINE	10	mg/1			N	20241231
67751-166_f6f778ab-03b1-b9de-e053-6294a90a6ab4	67751-166	HUMAN OTC DRUG	Benadryl Ultratabs		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160922		OTC MONOGRAPH FINAL	part341	Navajo Manufacturing Company Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67751-170_f6f79a87-6831-c39d-e053-6394a90ae629	67751-170	HUMAN OTC DRUG	Dramamine		DIMENHYDRINATE	TABLET	ORAL	20160923		OTC MONOGRAPH FINAL	part336	Navajo Manufacturing Company Inc.	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67751-171_f70e0eb0-95aa-645c-e053-6394a90aae83	67751-171	HUMAN OTC DRUG	Mucinex DM		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	TABLET, EXTENDED RELEASE	ORAL	20160923		NDA	NDA021620	Navajo Manufacturing Company Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
67751-174_f70a3a08-1922-3bcb-e053-6294a90ad0b9	67751-174	HUMAN OTC DRUG	Sal De Uvas Picot		CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE	GRANULE, EFFERVESCENT	ORAL	20160923		OTC MONOGRAPH FINAL	part331	Navajo Manufacturing Company Inc.	CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE	1.9485; 2.485	g/1; g/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
67751-179_f6f75dbf-57d5-f769-e053-6394a90ad5b3	67751-179	HUMAN OTC DRUG	Banana Boat		avobenzone, homosalate, octocrylene	LOTION	TOPICAL	20171204		OTC MONOGRAPH NOT FINAL	part352	Navajo Manufacturing Company Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	1.8; 7; 5	g/100g; g/100g; g/100g			N	20241231
67751-180_f6f7734b-58fb-bcb7-e053-6294a90ace29	67751-180	HUMAN OTC DRUG	ChapIce Moisture SPF 15 Lip Balm		Oxybenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20171220		OTC MONOGRAPH NOT FINAL	part352	Navajo Manufacturing Company Inc.	OCTINOXATE; OXYBENZONE; PETROLATUM	7.5; 3.5; 40.7	mg/g; mg/g; mg/g			N	20241231
67751-185_f6f6350f-d891-f988-e053-6394a90a6ec4	67751-185	HUMAN OTC DRUG	Afrin		OXYMETAZOLINE HYDROCHLORIDE	SPRAY	TOPICAL	20171204		OTC MONOGRAPH FINAL	part341	Navajo Manufacturing Company Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
67751-186_f6f78f0b-5545-35ed-e053-6394a90a3250	67751-186	HUMAN OTC DRUG	Crest Pro Health		CETYLPYRIDINIUM CHLORIDE	RINSE	TOPICAL	20171204		OTC MONOGRAPH NOT FINAL	part356	Navajo Manufacturing Company Inc.	CETYLPYRIDINIUM CHLORIDE	.014	g/20mL			N	20241231
67751-187_f70b93ee-f234-a6b0-e053-6394a90a8b9d	67751-187	HUMAN OTC DRUG	Old Spice		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20171204		OTC MONOGRAPH FINAL	part350	Navajo Manufacturing Company Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	17	g/100g			N	20241231
67751-192_f70c23f1-f2a8-8415-e053-6394a90a64dc	67751-192	HUMAN OTC DRUG	Zyrtec Allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20191120		NDA	NDA019835	Navajo Manufacturing Company Incorporated	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67751-200_f6f5e6ab-aae6-726e-e053-6394a90a890d	67751-200	HUMAN OTC DRUG	Good to Go Alcohol Wipes		ethyl alcohol	SWAB	TOPICAL	20200629		OTC MONOGRAPH NOT FINAL	part333A	Navajo Manufacturing Company Inc.	ALCOHOL	75	g/100g			N	20241231
67751-216_f5f252db-7fce-0455-e053-2a95a90ae255	67751-216	HUMAN OTC DRUG	Listerine Cool Mint Antiseptic		Eucalyptol, Menthol, Unspecified Form, Methyl Salicylate, and Thymol	LIQUID	ORAL	20181203		OTC MONOGRAPH NOT FINAL	part356	Navajo Manufacturing Company Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
67751-217_f6068596-2078-6791-e053-2995a90a9c29	67751-217	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold and Flu PowerFast Fizz		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide	TABLET, EFFERVESCENT	ORAL	20220601		OTC MONOGRAPH FINAL	part341	Navajo Manufacturing Company Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
67751-219_f7087158-774b-452a-e053-6294a90a8131	67751-219	HUMAN OTC DRUG	Alka-Seltzer Original Flavor		Alka-Seltzer Original Flavor	TABLET, EFFERVESCENT	ORAL	20230316		OTC MONOGRAPH NOT FINAL	part343	Navajo Manufacturing Company Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
67751-220_f70bd774-b786-13f6-e053-6394a90aaaa8	67751-220	HUMAN OTC DRUG	Secret Outlast Completely Clean Invisible	Completely Clean	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221218		OTC MONOGRAPH FINAL	M019	Navajo Manufacturing Company Inc.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
67751-221_f70ce1d9-205c-94ab-e053-6394a90ad89a	67751-221	HUMAN OTC DRUG	Sominex		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120601		OTC MONOGRAPH FINAL	part338	Navajo Manufacturing Company Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67751-222_f71bf214-00c5-c0cd-e053-6294a90a88ba	67751-222	HUMAN OTC DRUG	Degree		Advanced Shower Clean 72H Antiperspirant Deodorant	STICK	TOPICAL	20210921		OTC MONOGRAPH FINAL	part350	Navajo Manufacturing Company Inc.	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
67751-223_f71c05f1-196f-aec0-e053-6394a90af453	67751-223	HUMAN OTC DRUG	Degree		Advanced Cool Rush 72H Antiperspirant Deodorant	STICK	TOPICAL	20210719		OTC MONOGRAPH FINAL	part350	Navajo Manufacturing Company Inc.	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
67751-224_f71c53e0-e2de-16f9-e053-6394a90accff	67751-224	HUMAN OTC DRUG	Colgate Total SF Clean Mint		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20181101		OTC MONOGRAPH FINAL	part355	Navajo Manufacturing Company Inc.	STANNOUS FLUORIDE	1.1	mg/g			N	20241231
67751-225_f71d4eea-ec9f-d274-e053-6394a90a24e8	67751-225	HUMAN OTC DRUG	Gold Bond Medicated Original Strength Body		Menthol	POWDER	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	Navajo Manufacturing Company Inc.	MENTHOL	.15	g/100g			N	20241231
67773-001_0bb3508e-a99d-5d29-e063-6294a90aa37e	67773-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100719		UNAPPROVED MEDICAL GAS		Oxygen Plus	OXYGEN	99	L/100L			N	20241231
67777-002_eff46569-c4bb-6ca4-e053-2a95a90a210c	67777-002	HUMAN OTC DRUG	Povidone Iodine Prep Pad		Antiseptic	SWAB	TOPICAL	20181217		OTC MONOGRAPH FINAL	part333C	Dynarex Corporation	POVIDONE-IODINE	10	g/100g			N	20241231
67777-003_ef401189-5905-6c38-e053-2995a90a5704	67777-003	HUMAN OTC DRUG	Hydrocortisone		Antipruritic (Anti-itch)	CREAM	TOPICAL	20180503		OTC MONOGRAPH NOT FINAL	part348	Dynarex Corporation	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67777-004_edadf27d-6e9c-1188-e053-2995a90aeba7	67777-004	HUMAN OTC DRUG	Hydrocortisone		Antipruritic (Anti-Itch)	CREAM	TOPICAL	20210325		OTC MONOGRAPH NOT FINAL	part348	Dynarex Corporation	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
67777-005_f342fc19-844d-2e04-e053-2a95a90a092d	67777-005	HUMAN OTC DRUG	White Petrolatum		Petrolatum	OINTMENT	TOPICAL	20181026		OTC MONOGRAPH FINAL	M016	Dynarex Corporation	WHITE PETROLATUM	1	g/g			N	20241231
67777-006_ee14e182-d5bf-7595-e053-2a95a90a9942	67777-006	HUMAN OTC DRUG	Vitamins A and D Without Lanolin		Skin Protectant	OINTMENT	TOPICAL	20170404		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	PETROLATUM	93	g/100g			N	20241231
67777-007_eeb12590-e81f-f00d-e053-2995a90a45c1	67777-007	HUMAN OTC DRUG	Burn First Aid		Burn First Aid	CREAM	TOPICAL	20180917		OTC MONOGRAPH NOT FINAL	part348	Dynarex Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	13; 50	mg/10000mg; mg/10000mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67777-008_eeb4aa2a-930a-2b11-e053-2995a90a3581	67777-008	HUMAN OTC DRUG	Bacitracin Zinc		First Aid Antibiotic	OINTMENT	TOPICAL	20180216		OTC MONOGRAPH FINAL	part333B	Dynarex Corporation	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
67777-009_0b4c5234-e7e0-bf15-e063-6294a90aa297	67777-009	HUMAN OTC DRUG	Lidocaine Pain Relief Gel Patch		Lidocaine Pain Relief	PATCH	TOPICAL	20190827		OTC MONOGRAPH DRUG	M017	Dynarex	LIDOCAINE	4	mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67777-010_efe350ef-2fbd-d6e7-e053-2a95a90a8b31	67777-010	HUMAN OTC DRUG	SannyTize Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	ALCOHOL	70	mL/100mL			N	20241231
67777-014_eec7c048-55f5-52b2-e053-2a95a90a95c5	67777-014	HUMAN OTC DRUG	AQUAGARD		Hydrating Ointment	OINTMENT	TOPICAL	20191220		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	PETROLATUM	41	g/100g			N	20241231
67777-113_ed9adaeb-3745-37f4-e053-2a95a90a0ae0	67777-113	HUMAN OTC DRUG	DynaRub		Pain Relieving Cream	CREAM	TOPICAL	20160912		OTC MONOGRAPH NOT FINAL	part348	Dynarex Corporation	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
67777-116_ee14852d-77f0-7452-e053-2a95a90a121e	67777-116	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20160912		OTC MONOGRAPH FINAL	part333B	Dynarex Corporation	BACITRACIN	500	[USP'U]/1000mg	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
67777-119_ee2777e6-235a-30bd-e053-2a95a90afae4	67777-119	HUMAN OTC DRUG	Dynarex Zinc Oxide		Zinc Oxide Ointment	OINTMENT	TOPICAL	20180327		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	ZINC OXIDE	250	mg/g			N	20241231
67777-121_0a54b585-b6e7-8f04-e063-6394a90a3ebc	67777-121	HUMAN OTC DRUG	Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20100701		OTC MONOGRAPH DRUG	M003	Dynarex Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
67777-129_f2919622-621f-1477-e053-2995a90abd5c	67777-129	HUMAN OTC DRUG	XeroBurn Burn Gel		Lidocaine Hydrochloride	GEL	TOPICAL	20170907		OTC MONOGRAPH NOT FINAL	part348	Dynarex Corporation	LIDOCAINE HYDROCHLORIDE	2	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67777-139_f3cd3b53-fbef-5d96-e053-2995a90ab8a6	67777-139	HUMAN OTC DRUG	WeCare Anti-Dandruff		Antidandruff Shampoo	LIQUID	TOPICAL	20181011		OTC MONOGRAPH FINAL	part358H	Dynarex Corporation	PYRITHIONE ZINC	5	g/1000mL			N	20241231
67777-141_eec63102-2d20-3b6c-e053-2a95a90a0eb2	67777-141	HUMAN OTC DRUG	Dynarex Povidone Iodine Prep Solution		Povidone Iodine Prep Solution	LIQUID	TOPICAL	20180508		OTC MONOGRAPH NOT FINAL	part333E	Dynarex Corporation	POVIDONE-IODINE	10	mg/mL			N	20241231
67777-142_eec65fb1-829d-0841-e053-2995a90a4925	67777-142	HUMAN OTC DRUG	Dynarex Povidone Iodine Surgical Scrub		Povidone Iodine Surgical Scrub Solution	LIQUID	TOPICAL	20180508		OTC MONOGRAPH NOT FINAL	part333E	Dynarex Corporation	POVIDONE-IODINE	100	mg/7.5mL			N	20241231
67777-144_f5f27ed3-3fdc-1c2e-e053-2a95a90a3cae	67777-144	HUMAN OTC DRUG	X-Treme Freeze		Cold Therapy Gel	GEL	TOPICAL	20180817		OTC MONOGRAPH NOT FINAL	part348	Dynarex Corporation	MENTHOL	4	g/100mL			N	20241231
67777-147_f40d8bf9-dc4f-77ab-e053-2995a90abcea	67777-147	HUMAN OTC DRUG	D-Cerin		Moisturizer	CREAM	TOPICAL	20180820		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	PETROLATUM	33	g/100g			N	20241231
67777-161_f2f06081-bf8f-52f2-e053-2995a90af9bc	67777-161	HUMAN OTC DRUG	Lemon Glycerin		Glycerin	SWAB	ORAL	20191218		OTC MONOGRAPH NOT FINAL	part356	Dynarex Corporation	GLYCERIN	.3	g/4g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67777-175_eec81c4c-972d-722f-e053-2995a90aeccd	67777-175	HUMAN OTC DRUG	Morning Fresh		Sodium Fluoride	PASTE	ORAL	20141014		OTC MONOGRAPH FINAL	part355	Dynarex Corporation	SODIUM MONOFLUOROPHOSPHATE	76	mg/g			N	20241231
67777-177_eea3ebe6-4d83-8064-e053-2995a90a31b6	67777-177	HUMAN OTC DRUG	1177, 1178 Sunscreen		1177, 1178 Sunscreen	CREAM	TOPICAL	20210527		OTC MONOGRAPH NOT FINAL	part352	Dynarex	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	6; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
67777-201_0d81c27e-2bbb-2fb2-e063-6294a90abd15	67777-201	HUMAN OTC DRUG	Hot/Cold Medicated Patch		Hot Cold Patch	PATCH	TOPICAL	20191213		OTC MONOGRAPH DRUG	M017	Dynarex	MENTHOL	285	mg/5700mg			N	20241231
67777-214_ee14bb7d-aeb9-0661-e053-2995a90af84f	67777-214	HUMAN OTC DRUG	Vitamin A D		PETROLATUM	OINTMENT	TOPICAL	20100324		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	PETROLATUM	.76	g/g			N	20241231
67777-215_efa748d5-20ba-2101-e053-2a95a90adcf6	67777-215	HUMAN OTC DRUG	Vitamin A D		PETROLATUM	OINTMENT	TOPICAL	20131001		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	PETROLATUM	.93	g/g			N	20241231
67777-215_efba5699-eeb4-05bd-e053-2a95a90a777b	67777-215	HUMAN OTC DRUG	Vitamin A D		PETROLATUM	OINTMENT	TOPICAL	20220328		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	PETROLATUM	93	g/100g			N	20241231
67777-217_f2769d17-818b-866d-e053-2995a90afa2c	67777-217	HUMAN OTC DRUG	bacitracin zinc, neomycin sulfate and polymyxin b sulfate		bacitracin zinc, neomycin sulfate and polymyxin b sulfate	OINTMENT	TOPICAL	20091201		OTC MONOGRAPH FINAL	part333B	Dynarex Corporation	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
67777-231_eea09985-a17f-6468-e053-2a95a90a661b	67777-231	HUMAN OTC DRUG	Dynarex Antifungal		antifungal	CREAM	TOPICAL	20100518		OTC MONOGRAPH FINAL	part333C	Dynarex Corporation	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67777-233_ee9dca78-070e-46bc-e053-2a95a90aa56a	67777-233	HUMAN OTC DRUG	Dynarex Hydrogel		glycerin	GEL	TOPICAL	20100526		OTC MONOGRAPH FINAL	part346	Dynarex Corporation	GLYCERIN	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
67777-234_f07fb2da-e4f7-f009-e053-2995a90ab3de	67777-234	HUMAN OTC DRUG	Menthol and Zinc Oxide		Menthol and Zinc Oxide	OINTMENT	TOPICAL	20100511		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	MENTHOL; ZINC OXIDE	.44; 21	g/100g; g/100g			N	20241231
67777-243_ee9d9d31-55c4-5f56-e053-2995a90a7f8b	67777-243	HUMAN OTC DRUG	BZK Pads		Benzalkonium Chloride	SWAB	TOPICAL	20110405		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
67777-244_ee9d1fcf-3c8c-32c8-e053-2a95a90aed5a	67777-244	HUMAN OTC DRUG	BZK Pads		Benzalkonium Chloride	SWAB	TOPICAL	20110405		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
67777-245_0a469d0e-d782-1574-e063-6394a90ad0bb	67777-245	HUMAN OTC DRUG	BZK Pads		Benzalkonium Chloride	SWAB	TOPICAL	20110405		OTC MONOGRAPH DRUG	M003	Dynarex Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
67777-246_ee8e6030-e015-6884-e053-2995a90a0bed	67777-246	HUMAN OTC DRUG	Benzocaine		Benzocaine	SWAB	TOPICAL	20110720		OTC MONOGRAPH NOT FINAL	part348	Dynarex Corporation	BENZOCAINE; ISOPROPYL ALCOHOL	6; 60	mg/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67777-251_fb4831ed-91ce-c9ed-e053-6394a90a045a	67777-251	HUMAN OTC DRUG	Ammonia Inhalants		Ammonia Inhalants	INHALANT	RESPIRATORY (INHALATION)	19760214		UNAPPROVED DRUG OTHER		Dynarex Corporation	AMMONIA	.05	g/.33mL			N	20241231
67777-300_eea3c837-3df6-944e-e053-2995a90a2fbb	67777-300	HUMAN OTC DRUG	Alcohol		Alcohol	SWAB	TOPICAL	20120607		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
67777-308_ee8ee0ab-fc75-dc57-e053-2a95a90adf2d	67777-308	HUMAN OTC DRUG	Dynarex Green		ALCOHOL	LIQUID	TOPICAL	20140701		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	ALCOHOL	.3	mL/mL			N	20241231
67777-316_eea010c2-1949-029c-e053-2a95a90ad4cf	67777-316	HUMAN OTC DRUG	Dynarex Antifungal Powder		Miconazole	POWDER	TOPICAL	20160519		OTC MONOGRAPH FINAL	part333C	Dynarex Corporation	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
67777-318_d3095f49-93cf-3408-e053-2995a90af6d4	67777-318	HUMAN OTC DRUG	Dynarex Green		Chloroxylenol	LIQUID	TOPICAL	20170313		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	CHLOROXYLENOL	.15	g/100mL			N	20241231
67777-319_eeb7c7cf-3723-d892-e053-2995a90a00c6	67777-319	HUMAN OTC DRUG	1438 DynaSoap		Antibacterial Hand Soap	SOAP	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
67777-320_ee9d5c6b-5956-19f4-e053-2a95a90ad69e	67777-320	HUMAN OTC DRUG	SannyTize Hand Sanitizer Wipe		Alcohol	GEL	TOPICAL	20170425		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	ALCOHOL	.7	mL/mL			N	20241231
67777-330_ee8e4152-c747-68a0-e053-2995a90a10ba	67777-330	HUMAN OTC DRUG	Antimicrobial Sanitizing Hand Wipe		Antimicrobial Sanitizing Hand Wipe	SWAB	TOPICAL	20200816		OTC MONOGRAPH NOT FINAL	part333A	Dynarex	ALCOHOL	70	mL/100mL			N	20241231
67777-340_eeb495e9-7cdc-da48-e053-2995a90afdfe	67777-340	HUMAN OTC DRUG	Hand Sanitizer Wipes Pack with Plastic Dispensing Lid		Hand Sanitizer Wipes Pack with Plastic Dispensing Lid	SWAB	TOPICAL	20201123		OTC MONOGRAPH NOT FINAL	part333A	Dynarex	ALCOHOL	75	mL/100mL			N	20241231
67777-402_ee9fa245-af1a-f31e-e053-2995a90a0f75	67777-402	HUMAN OTC DRUG	Saline Enema		Sodium Phosphate Monobasic, Sodium Phosphate Dibasic	ENEMA	RECTAL	20120829		OTC MONOGRAPH NOT FINAL	part334	Dynarex Corporation	SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC	7; 19	g/118mL; g/118mL			N	20241231
67777-403_f3ccba46-0781-4b2e-e053-2a95a90ac043	67777-403	HUMAN OTC DRUG	Wound Cleanser		Wound cleanser	SPRAY	TOPICAL	20170213		OTC MONOGRAPH NOT FINAL	part333A	Dynarex Corporation	BENZETHONIUM CHLORIDE	.13	g/100mL			N	20241231
67777-405_ee8e4152-c748-68a0-e053-2995a90a10ba	67777-405	HUMAN OTC DRUG	Medicaine Sting and Bite		Benzocaine	SWAB	TOPICAL	19760214		UNAPPROVED DRUG OTHER		Dynarex Corporation	BENZOCAINE	.12	g/.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
67777-407_fb453512-061e-cf41-e053-6294a90a3187	67777-407	HUMAN OTC DRUG	Dynashield		zinc oxide	CREAM	TOPICAL	20141001		OTC MONOGRAPH FINAL	M016	Dynarex Corporation	ZINC OXIDE	1.8	g/100g			N	20241231
67777-408_fb455abc-65ff-1124-e053-6394a90ade03	67777-408	HUMAN OTC DRUG	Dynashield with Dimethicone		zinc oxide	CREAM	TOPICAL	20141001		OTC MONOGRAPH FINAL	M016	Dynarex Corporation	DIMETHICONE; ZINC OXIDE	1.8; 2	g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
67777-410_ee135f91-fc87-3b20-e053-2995a90a3db8	67777-410	HUMAN OTC DRUG	Lanashield		Lanolin	OINTMENT	TOPICAL	20141012		OTC MONOGRAPH FINAL	part347	Dynarex Corporation	LANOLIN	50	g/100g			N	20241231
67777-418_ee8e19df-ab01-cc36-e053-2a95a90a9e6a	67777-418	HUMAN OTC DRUG	Povidone Iodine Gel Swabstick		Povidone Iodine Gel Swabstick	GEL	TOPICAL	20221125		OTC MONOGRAPH FINAL	M005	Dynarex Corporation	POVIDONE-IODINE	10	mg/mL			N	20241231
67777-419_eeb273e1-c58b-20aa-e053-2995a90aecfd	67777-419	HUMAN OTC DRUG	povidine iodine		povidine iodine	SWAB	TOPICAL	20160913		OTC MONOGRAPH FINAL	part333C	Dynarex Corporation	POVIDONE-IODINE	10	mg/mL			N	20241231
67777-420_efa768b3-e75b-25a2-e053-2a95a90a4cb7	67777-420	HUMAN OTC DRUG	povidine iodine		povidine iodine	SWAB	TOPICAL	20160913		OTC MONOGRAPH FINAL	part333C	Dynarex Corporation	POVIDONE-IODINE	10	g/100g			N	20241231
67777-430_ee9f4cee-149d-8c66-e053-2995a90a7917	67777-430	HUMAN OTC DRUG	4718 Enema, Mineral Oil		4718 Enema, Mineral Oil	ENEMA	RECTAL	20210226		OTC MONOGRAPH NOT FINAL	part334	Dynarex	MINERAL OIL	133	g/133mL			N	20241231
67795-033_090476db-534b-c39d-e063-6294a90aabb8	67795-033	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Roadrunner Oxygen Service, Inc.	OXYGEN	99	L/100L			N	20241231
67795-100_09049d2a-6074-bb47-e063-6394a90a7b6a	67795-100	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Roadrunner Oxygen Service, Inc.	NITROGEN	99	L/100L			N	20241231
67850-021_92e7aa77-6c1b-42b9-a246-237656c62999	67850-021	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190306		ANDA	ANDA090354	Methapharm Inc.	AMPICILLIN SODIUM	1	g/g	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67850-022_92e7aa77-6c1b-42b9-a246-237656c62999	67850-022	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190306		ANDA	ANDA090354	Methapharm Inc.	AMPICILLIN SODIUM	2	g/2g	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67850-023_92e7aa77-6c1b-42b9-a246-237656c62999	67850-023	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190306		ANDA	ANDA090354	Methapharm Inc.	AMPICILLIN SODIUM	250	mg/250mg	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67850-024_92e7aa77-6c1b-42b9-a246-237656c62999	67850-024	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190306		ANDA	ANDA090354	Methapharm Inc.	AMPICILLIN SODIUM	500	mg/500mg	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67850-031_655706ae-287b-4da0-9a10-ea0b47c7ac86	67850-031	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAMUSCULAR; INTRAVENOUS	20190305		ANDA	ANDA090560	Methapharm Inc.	NAFCILLIN SODIUM	1	g/g	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67850-032_655706ae-287b-4da0-9a10-ea0b47c7ac86	67850-032	HUMAN PRESCRIPTION DRUG	Nafcillin		Nafcillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAMUSCULAR; INTRAVENOUS	20190305		ANDA	ANDA090560	Methapharm Inc.	NAFCILLIN SODIUM	2	g/2g	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
67850-041_320d34b7-7f29-48ed-82e2-1c8717a03e18	67850-041	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20181011		ANDA	ANDA202436	Methapharm, Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
67850-042_320d34b7-7f29-48ed-82e2-1c8717a03e18	67850-042	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20190311		ANDA	ANDA202436	Methapharm, Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
67850-071_5463c1ac-42b9-4661-bfd3-46ee07900b7a	67850-071	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210203		ANDA	ANDA215829	Methapharm Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
67850-072_5463c1ac-42b9-4661-bfd3-46ee07900b7a	67850-072	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		VERAPAMIL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210203		ANDA	ANDA215829	Methapharm Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
67850-140_9cbbd62a-79be-48ce-b00a-dcfd62219448	67850-140	HUMAN PRESCRIPTION DRUG	Asclera		POLIDOCANOL	INJECTION, SOLUTION	INTRAVENOUS	20100601		NDA	NDA021201	Methapharm, Inc	POLIDOCANOL	.005	g/mL	Sclerosing Activity [MoA], Sclerosing Agent [EPC], Vascular Sclerosing Activity [PE]		N	20241231
67850-141_9cbbd62a-79be-48ce-b00a-dcfd62219448	67850-141	HUMAN PRESCRIPTION DRUG	Asclera		POLIDOCANOL	INJECTION, SOLUTION	INTRAVENOUS	20100601		NDA	NDA021201	Methapharm, Inc	POLIDOCANOL	.01	g/mL	Sclerosing Activity [MoA], Sclerosing Agent [EPC], Vascular Sclerosing Activity [PE]		N	20241231
67850-150_59ef9895-2d64-4c90-b8c8-8fbc3ce9f42b	67850-150	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211201		ANDA	ANDA209524	Methapharm, Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
67850-552_212d2226-56a3-4a0c-9f80-34324b36dde5	67850-552	HUMAN PRESCRIPTION DRUG	Aridol Bronchial Challenge Test Kit		mannitol	KIT		20101005		NDA	NDA022368	Methapharm, Inc.						N	20241231
67858-645_7873b8fc-8f7a-3019-e053-2991aa0a8a6a	67858-645	HUMAN OTC DRUG	Express Wipes Hand Sanitizer		Hand Sanitizer Wipe	LIQUID	TOPICAL	20180604		OTC MONOGRAPH NOT FINAL	part333A	QuestSpecialty Corporation	ALCOHOL	7	g/10g			N	20241231
67858-693_f6e0703f-14d9-b1de-e053-6394a90aef1f	67858-693	HUMAN OTC DRUG	Applause		Instant Hand Sanitizer	GEL	TOPICAL	20181002		OTC MONOGRAPH NOT FINAL	part333A	QuestSpecialty Corporation	ALCOHOL	3	g/5g			N	20241231
67860-072_ae6ba9ce-ebfc-4103-9822-e885b3ed030d	67860-072	HUMAN OTC DRUG	Antiseptic Mouthrinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20161118		OTC MONOGRAPH NOT FINAL	part348	Cariba International	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
67860-166_e5a169db-82c8-4cd9-bda4-24b657d2e35c	67860-166	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Carbia International	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
67860-318_239f937c-dc9e-4d34-9f20-2f244117c27b	67860-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20161107		OTC MONOGRAPH NOT FINAL	part356	Cariba International	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
67860-664_dfc8e554-21fb-4261-b4a1-ff9a123e6f15	67860-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20161108		OTC MONOGRAPH NOT FINAL	part356	Cariba International	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
67860-810_92af0ac2-7128-448b-aac1-f97e2090f8a8	67860-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20161220		OTC MONOGRAPH NOT FINAL	part333A	Cariba International	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
67860-845_1d45e8f0-b55a-4781-aba0-406db8462806	67860-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20161216		OTC MONOGRAPH FINAL	part344	Cariba International	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
67860-871_72d05ce8-fd88-42ef-858a-90d7ef580e1c	67860-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20161028		OTC MONOGRAPH NOT FINAL	part333A	Cariba International	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
67871-111_0c8fe61a-098e-a256-e063-6294a90a0664	67871-111	HUMAN PRESCRIPTION DRUG	Sucraid		sacrosidase	SOLUTION	ORAL	19980409		BLA	BLA020772	QOL Medical, LLC	SACROSIDASE	8500	[iU]/mL	Sucrose-specific Enzyme [EPC]		N	20241231
67871-479_0c9031d6-1491-cd36-e063-6294a90a7396	67871-479	HUMAN PRESCRIPTION DRUG	Ethamolin		Ethanolamine Oleate	INJECTION, SOLUTION	INTRAVENOUS	19981222		NDA	NDA019357	QOL Medical, LLC.	ETHANOLAMINE OLEATE	50	mg/mL	Sclerosing Activity [MoA], Sclerosing Agent [EPC], Vascular Sclerosing Activity [PE]		N	20241231
67877-064_ded7636a-4d3b-4738-8772-4b823c30896d	67877-064	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20220609		ANDA	ANDA204827	Ascend Laboratories, LLC	FESOTERODINE FUMARATE	4	mg/1			N	20241231
67877-068_ded7636a-4d3b-4738-8772-4b823c30896d	67877-068	HUMAN PRESCRIPTION DRUG	Fesoterodine Fumarate		Fesoterodine Fumarate	TABLET, EXTENDED RELEASE	ORAL	20220609		ANDA	ANDA204827	Ascend Laboratories, LLC	FESOTERODINE FUMARATE	8	mg/1			N	20241231
67877-116_20153ff4-9230-4650-88de-f63f1a43b7c0	67877-116	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20120116		ANDA	ANDA090635	Ascend Laboratories, LLC	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67877-124_81dc7fe0-27af-4e7b-a3e0-eeb3164e8f67	67877-124	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	19851223		NDA	NDA018810	Ascend Laboratories, LLC	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
67877-146_45d37c04-846d-4f50-ac42-52b2d051d115	67877-146	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Ascend Laboratories, LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67877-147_45d37c04-846d-4f50-ac42-52b2d051d115	67877-147	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Ascend Laboratories, LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67877-148_45d37c04-846d-4f50-ac42-52b2d051d115	67877-148	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20120628		ANDA	ANDA071457	Ascend Laboratories, LLC	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67877-149_45d37c04-846d-4f50-ac42-52b2d051d115	67877-149	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20120628		ANDA	ANDA071457	Ascend Laboratories, LLC	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
67877-159_b849b1fc-2e6f-91dc-e053-2a95a90a9286	67877-159	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20130301		ANDA	ANDA201991	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-164_976bb1e6-e2b0-4900-9ca9-83eac46ed984	67877-164	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20110622		ANDA	ANDA200694	Ascend Laboratories, LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
67877-165_976bb1e6-e2b0-4900-9ca9-83eac46ed984	67877-165	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20110622		ANDA	ANDA200694	Ascend Laboratories, LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
67877-166_976bb1e6-e2b0-4900-9ca9-83eac46ed984	67877-166	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20110622		ANDA	ANDA200694	Ascend Laboratories, LLC	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
67877-167_976bb1e6-e2b0-4900-9ca9-83eac46ed984	67877-167	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20110622		ANDA	ANDA200694	Ascend Laboratories, LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
67877-172_d39f7e44-89d1-4b24-adb1-fba49b25f578	67877-172	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120101		ANDA	ANDA202295	Ascend Laboratories, LLC	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-173_d39f7e44-89d1-4b24-adb1-fba49b25f578	67877-173	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120101		ANDA	ANDA202295	Ascend Laboratories, LLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-174_d39f7e44-89d1-4b24-adb1-fba49b25f578	67877-174	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120101		ANDA	ANDA202295	Ascend Laboratories, LLC	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-175_d39f7e44-89d1-4b24-adb1-fba49b25f578	67877-175	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120101		ANDA	ANDA202295	Ascend Laboratories, LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-176_d39f7e44-89d1-4b24-adb1-fba49b25f578	67877-176	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120101		ANDA	ANDA202295	Ascend Laboratories, LLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-177_d39f7e44-89d1-4b24-adb1-fba49b25f578	67877-177	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120101		ANDA	ANDA202295	Ascend Laboratories, LLC	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-197_e2555e66-d1b9-4ce3-80ef-9214e159a3aa	67877-197	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Ascend Laboratories, LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-198_e2555e66-d1b9-4ce3-80ef-9214e159a3aa	67877-198	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Ascend Laboratories, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-199_e2555e66-d1b9-4ce3-80ef-9214e159a3aa	67877-199	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Ascend Laboratories, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-215_57165b30-a551-409f-885e-ff7dfc4005a9	67877-215	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	Ascend Laboratories, LLC	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-216_57165b30-a551-409f-885e-ff7dfc4005a9	67877-216	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	Ascend Laboratories, LLC	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-217_fe84bb3e-625a-4eff-8df0-6bbaa6548920	67877-217	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA091184	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-218_fe84bb3e-625a-4eff-8df0-6bbaa6548920	67877-218	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA091184	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-219_3e6d72ab-f4ea-4ca6-984d-e6de1b3e7fdf	67877-219	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Ascend Laboratories, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-220_3e6d72ab-f4ea-4ca6-984d-e6de1b3e7fdf	67877-220	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	Ascend Laboratories, LLC	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-221_fe84bb3e-625a-4eff-8df0-6bbaa6548920	67877-221	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA091184	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-222_3f18a156-0423-4689-9b5c-c642e475f97b	67877-222	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Ascend Laboratories, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-223_3f18a156-0423-4689-9b5c-c642e475f97b	67877-223	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Ascend Laboratories, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-224_3f18a156-0423-4689-9b5c-c642e475f97b	67877-224	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Ascend Laboratories, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-225_4a917297-3060-4442-b9be-448d3f98d43f	67877-225	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	TABLET, FILM COATED	ORAL	20111128		ANDA	ANDA091249	Ascend Laboratories, LLC	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
67877-230_c8c7fb8d-5a31-4153-a1e9-dadf2ab30243	67877-230	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	POWDER, FOR SUSPENSION	ORAL	20141117		ANDA	ANDA203005	Ascend Laboratories, LLC	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
67877-242_3c142a5f-4b76-426e-a59a-00ceaa73be3b	67877-242	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Ascend Laboratories, LLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-245_3c142a5f-4b76-426e-a59a-00ceaa73be3b	67877-245	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Ascend Laboratories, LLC	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-246_3c142a5f-4b76-426e-a59a-00ceaa73be3b	67877-246	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Ascend Laboratories, LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-247_3c142a5f-4b76-426e-a59a-00ceaa73be3b	67877-247	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Ascend Laboratories, LLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-248_3c142a5f-4b76-426e-a59a-00ceaa73be3b	67877-248	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Ascend Laboratories, LLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-249_3c142a5f-4b76-426e-a59a-00ceaa73be3b	67877-249	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Ascend Laboratories, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-250_3c142a5f-4b76-426e-a59a-00ceaa73be3b	67877-250	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Ascend Laboratories, LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-254_3e6d72ab-f4ea-4ca6-984d-e6de1b3e7fdf	67877-254	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20120604		ANDA	ANDA090836	Ascend Laboratories, LLC	CEPHALEXIN	333	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-255_3e6d72ab-f4ea-4ca6-984d-e6de1b3e7fdf	67877-255	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20120604		ANDA	ANDA090836	Ascend Laboratories, LLC	CEPHALEXIN	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-259_f8b285b7-ed55-4260-bbc7-ebfdff15f6c9	67877-259	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20171030		ANDA	ANDA201889	Ascend Laboratories, LLC	RASAGILINE MESYLATE	.5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
67877-260_f8b285b7-ed55-4260-bbc7-ebfdff15f6c9	67877-260	HUMAN PRESCRIPTION DRUG	Rasagiline		Rasagiline	TABLET	ORAL	20171030		ANDA	ANDA201889	Ascend Laboratories, LLC	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
67877-261_9fd3ccaa-ae93-475b-9591-5c4af70f51c5	67877-261	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20120625		ANDA	ANDA203269	Ascend Laboratories, LLC	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
67877-262_9fd3ccaa-ae93-475b-9591-5c4af70f51c5	67877-262	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20120625		ANDA	ANDA203269	Ascend Laboratories, LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
67877-263_8168fe48-f1e2-4267-84d1-10c7b7a96b8b	67877-263	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20120501		ANDA	ANDA203197	Ascend Laboratories, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
67877-264_8168fe48-f1e2-4267-84d1-10c7b7a96b8b	67877-264	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20120501		ANDA	ANDA203197	Ascend Laboratories, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
67877-265_8168fe48-f1e2-4267-84d1-10c7b7a96b8b	67877-265	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20120501		ANDA	ANDA203197	Ascend Laboratories, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
67877-266_4a917297-3060-4442-b9be-448d3f98d43f	67877-266	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	CAPSULE	ORAL	20100101		ANDA	ANDA200197	Ascend Laboratories, LLC	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
67877-274_9d59dfb2-038e-480f-8d9a-84141952f81b	67877-274	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190120		ANDA	ANDA207394	Ascend Laboratories, LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67877-275_9d59dfb2-038e-480f-8d9a-84141952f81b	67877-275	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190120		ANDA	ANDA207394	Ascend Laboratories, LLC	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67877-278_7b8bc9e8-d662-49b6-8d64-dd57ff3f9c7b	67877-278	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201113		ANDA	ANDA203740	Ascend Laboratories, LLC	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
67877-279_7b8bc9e8-d662-49b6-8d64-dd57ff3f9c7b	67877-279	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201113		ANDA	ANDA203740	Ascend Laboratories, LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
67877-280_7b8bc9e8-d662-49b6-8d64-dd57ff3f9c7b	67877-280	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201113		ANDA	ANDA203740	Ascend Laboratories, LLC	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
67877-286_a43110e1-22a2-4774-aca3-690f738a996e	67877-286	HUMAN PRESCRIPTION DRUG	Riluzole		Riluzole	TABLET	ORAL	20160331		ANDA	ANDA204048	Ascend Laboratories, LLC	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20241231
67877-288_7f639f16-692c-431f-a6de-1c8e7aa6681a	67877-288	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20170105		ANDA	ANDA204304	Ascend Laboratories, LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
67877-290_26a904df-7070-489e-b0e0-67167a817944	67877-290	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA200737	Ascend Laboratories, LLC	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
67877-291_26a904df-7070-489e-b0e0-67167a817944	67877-291	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20091124		ANDA	ANDA200737	Ascend Laboratories, LLC	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
67877-292_26a904df-7070-489e-b0e0-67167a817944	67877-292	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA200737	Ascend Laboratories, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
67877-293_26a904df-7070-489e-b0e0-67167a817944	67877-293	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA200737	Ascend Laboratories, LLC	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
67877-298_2871b3b9-3aa9-44b6-99ce-eab69a607bcb	67877-298	HUMAN PRESCRIPTION DRUG	cholestyramine powder for suspension		cholestyramine powder for suspension	POWDER, FOR SUSPENSION	ORAL	20211020		ANDA	ANDA211856	Ascend Laboratories, LLC	CHOLESTYRAMINE	4	g/8.78g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
67877-319_c9772df6-21a8-4bd5-9fdd-b69f4687b449	67877-319	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Ascend Laboratories, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67877-320_c9772df6-21a8-4bd5-9fdd-b69f4687b449	67877-320	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Ascend Laboratories, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67877-321_c9772df6-21a8-4bd5-9fdd-b69f4687b449	67877-321	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Ascend Laboratories, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67877-390_0aa580cf-e4cf-4fbd-b894-5e99cae5dd74	67877-390	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	Ascend Laboratories, LLC	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-391_0aa580cf-e4cf-4fbd-b894-5e99cae5dd74	67877-391	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	Ascend Laboratories, LLC	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-392_0aa580cf-e4cf-4fbd-b894-5e99cae5dd74	67877-392	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	Ascend Laboratories, LLC	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-393_0aa580cf-e4cf-4fbd-b894-5e99cae5dd74	67877-393	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20210916		ANDA	ANDA203828	Ascend Laboratories, LLC	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-413_fe84bb3e-625a-4eff-8df0-6bbaa6548920	67877-413	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-414_fe84bb3e-625a-4eff-8df0-6bbaa6548920	67877-414	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-415_205dbc75-b804-4b40-85ee-3c2d9de93de0	67877-415	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20190314		ANDA	ANDA205536	Ascend Laboratories, LLC	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-416_205dbc75-b804-4b40-85ee-3c2d9de93de0	67877-416	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20190314		ANDA	ANDA205536	Ascend Laboratories, LLC	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-417_205dbc75-b804-4b40-85ee-3c2d9de93de0	67877-417	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20190314		ANDA	ANDA205536	Ascend Laboratories, LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-418_205dbc75-b804-4b40-85ee-3c2d9de93de0	67877-418	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20190314		ANDA	ANDA205536	Ascend Laboratories, LLC	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-419_7669ffcf-5e46-4535-a958-a9ec4bc7d065	67877-419	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA205517	Ascend Laboratories, LLC	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
67877-422_a07c3c73-7408-40a1-9c2d-36d47ade8b0e	67877-422	HUMAN PRESCRIPTION DRUG	Choleystyramine Light		Choleystyramine Light	POWDER, FOR SUSPENSION	ORAL	20211020		ANDA	ANDA211799	Ascend Laboratories, LLC	CHOLESTYRAMINE	4	g/5.718g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
67877-426_3e021c3e-6b9c-41a2-987a-e6c60e3c4cf3	67877-426	HUMAN PRESCRIPTION DRUG	MYCOPHENOLIC ACID		MYCOPHENOLIC ACID	TABLET, DELAYED RELEASE	ORAL	20210924		ANDA	ANDA208315	Ascend Laboratories, LLC	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
67877-427_3e021c3e-6b9c-41a2-987a-e6c60e3c4cf3	67877-427	HUMAN PRESCRIPTION DRUG	MYCOPHENOLIC ACID		MYCOPHENOLIC ACID	TABLET, DELAYED RELEASE	ORAL	20210924		ANDA	ANDA208315	Ascend Laboratories, LLC	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
67877-428_5161a766-ef9f-4bf7-a36a-7034228c35ee	67877-428	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Ascend Laboratories, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-429_5161a766-ef9f-4bf7-a36a-7034228c35ee	67877-429	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Ascend Laboratories, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-430_b9acbf07-6633-4f8c-b2af-a9535626635f	67877-430	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Ascend Laboratories, LLC	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-431_b9acbf07-6633-4f8c-b2af-a9535626635f	67877-431	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Ascend Laboratories, LLC	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-432_b9acbf07-6633-4f8c-b2af-a9535626635f	67877-432	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Ascend Laboratories, LLC	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-433_b9acbf07-6633-4f8c-b2af-a9535626635f	67877-433	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Ascend Laboratories, LLC	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-434_b9acbf07-6633-4f8c-b2af-a9535626635f	67877-434	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Ascend Laboratories, LLC	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-435_b9acbf07-6633-4f8c-b2af-a9535626635f	67877-435	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Ascend Laboratories, LLC	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-436_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-436	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191223		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	55	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-437_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-437	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	80	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-438_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-438	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-439_9b9f026a-f1f3-413c-a6d8-ab8d79a8cfe1	67877-439	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	Ascend Laboratories, LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-440_9b9f026a-f1f3-413c-a6d8-ab8d79a8cfe1	67877-440	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	Ascend Laboratories, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-441_9b9f026a-f1f3-413c-a6d8-ab8d79a8cfe1	67877-441	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	Ascend Laboratories, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-442_9b9f026a-f1f3-413c-a6d8-ab8d79a8cfe1	67877-442	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	Ascend Laboratories, LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-443_f3b11232-76f6-4cfd-84ac-73df3fa0d3a4	67877-443	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	Ascend Laboratories, LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67877-444_4dbba67c-d169-4c7d-a152-b0e603a4b72b	67877-444	HUMAN PRESCRIPTION DRUG	Dalfampridine		Dalfampridine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180731		ANDA	ANDA206765	Ascend Laboratories, LLC	DALFAMPRIDINE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
67877-445_978f0cb1-7913-48a3-8705-651796e64519	67877-445	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, COATED	ORAL	20170424		ANDA	ANDA206763	Ascend Laboratories, LLC	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-446_978f0cb1-7913-48a3-8705-651796e64519	67877-446	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, COATED	ORAL	20170424		ANDA	ANDA206763	Ascend Laboratories, LLC	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-447_978f0cb1-7913-48a3-8705-651796e64519	67877-447	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, COATED	ORAL	20170424		ANDA	ANDA206763	Ascend Laboratories, LLC	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-450_e0f4155d-57ab-4a5d-abc1-5eb49db2e5d5	67877-450	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170811		ANDA	ANDA207405	Ascend Laboratories, LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
67877-454_d7efe68c-ec49-4590-9f20-1c309f14fb8d	67877-454	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE, COATED PELLETS	ORAL	20170612		ANDA	ANDA208591	Ascend Laboratories, LLC	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
67877-455_1c62ec5c-cd32-4478-92e6-03769fe541cc	67877-455	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, COATED	ORAL	20170106		ANDA	ANDA207750	Ascend Laboratories, LLC	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
67877-457_91efccb8-1200-46de-97c7-d3b4f93db172	67877-457	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	SOLUTION	ORAL	20190721		ANDA	ANDA207623	Ascend Laboratories, LLC	PREGABALIN	20	mg/mL		CV	N	20241231
67877-458_f289256e-b3d1-497c-b774-6284c6641c8e	67877-458	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20171125		ANDA	ANDA207652	Ascend Laboratories, LLC	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67877-459_f289256e-b3d1-497c-b774-6284c6641c8e	67877-459	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20171125		ANDA	ANDA207652	Ascend Laboratories, LLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
67877-462_bd55a717-33a8-48d0-b793-e6185a92e391	67877-462	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191002		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	25	mg/1		CV	N	20241231
67877-463_bd55a717-33a8-48d0-b793-e6185a92e391	67877-463	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191002		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	50	mg/1		CV	N	20241231
67877-464_bd55a717-33a8-48d0-b793-e6185a92e391	67877-464	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	75	mg/1		CV	N	20241231
67877-465_bd55a717-33a8-48d0-b793-e6185a92e391	67877-465	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	100	mg/1		CV	N	20241231
67877-466_bd55a717-33a8-48d0-b793-e6185a92e391	67877-466	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	150	mg/1		CV	N	20241231
67877-467_bd55a717-33a8-48d0-b793-e6185a92e391	67877-467	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	200	mg/1		CV	N	20241231
67877-468_bd55a717-33a8-48d0-b793-e6185a92e391	67877-468	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	225	mg/1		CV	N	20241231
67877-469_bd55a717-33a8-48d0-b793-e6185a92e391	67877-469	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Ascend Laboratories, LLC	PREGABALIN	300	mg/1		CV	N	20241231
67877-473_3edb9bb8-2e70-4ee3-bf41-90c53c4d5920	67877-473	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20170310		ANDA	ANDA207810	Ascend Laboratories, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
67877-474_275af0ce-a28d-4da9-889c-2d6c8c3841df	67877-474	HUMAN PRESCRIPTION DRUG	Dabigatran Etexilate		Dabigatran Etexilate	CAPSULE, COATED PELLETS	ORAL	20220620		ANDA	ANDA208040	Ascend Laboratories, LLC	DABIGATRAN ETEXILATE MESYLATE	75	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
67877-475_275af0ce-a28d-4da9-889c-2d6c8c3841df	67877-475	HUMAN PRESCRIPTION DRUG	Dabigatran Etexilate		Dabigatran Etexilate	CAPSULE, COATED PELLETS	ORAL	20220620		ANDA	ANDA208040	Ascend Laboratories, LLC	DABIGATRAN ETEXILATE MESYLATE	150	mg/1	Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
67877-476_1517df0f-8d15-4abc-b49f-e85dbad10cee	67877-476	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod hydrochloride	CAPSULE	ORAL	20220921		ANDA	ANDA208004	Ascend Laboratories, LLC	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
67877-477_66c5c246-98fc-4043-b866-b264cc64f1a2	67877-477	HUMAN PRESCRIPTION DRUG	Azelastine		Azelastine	SPRAY, METERED	NASAL	20170818		ANDA	ANDA208156	Ascend Laboratories, LLC	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
67877-478_6924e838-ba2e-4ab4-b029-d2b2b112fa3f	67877-478	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171020		ANDA	ANDA208333	Ascend Laboratories, LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67877-479_6924e838-ba2e-4ab4-b029-d2b2b112fa3f	67877-479	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171020		ANDA	ANDA208333	Ascend Laboratories, LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67877-482_f10918d7-d964-5c11-e053-2a95a90af1a4	67877-482	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	Ascend Laboratories, LLC	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-483_f10918d7-d964-5c11-e053-2a95a90af1a4	67877-483	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	Ascend Laboratories, LLC	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-484_f10918d7-d964-5c11-e053-2a95a90af1a4	67877-484	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	Ascend Laboratories, LLC	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
67877-490_fcddee47-625b-412a-82c5-8b3b040b53d9	67877-490	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20171223		ANDA	ANDA209234	Ascend Laboratories, LLC	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
67877-492_8bb138b1-3ab0-4123-ba5f-3cee00b3f66f	67877-492	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20200329		ANDA	ANDA208687	Ascend Laboratories, LLC	AZATHIOPRINE	25	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
67877-493_8bb138b1-3ab0-4123-ba5f-3cee00b3f66f	67877-493	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20200329		ANDA	ANDA208687	Ascend Laboratories, LLC	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
67877-494_8bb138b1-3ab0-4123-ba5f-3cee00b3f66f	67877-494	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20200329		ANDA	ANDA208687	Ascend Laboratories, LLC	AZATHIOPRINE	75	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
67877-495_8bb138b1-3ab0-4123-ba5f-3cee00b3f66f	67877-495	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20200329		ANDA	ANDA208687	Ascend Laboratories, LLC	AZATHIOPRINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
67877-499_769ea6a3-3337-4ff2-8674-0b5dc1483f47	67877-499	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan Medoxomil		Amlodipine and olmesartan Medoxomil	TABLET	ORAL	20170814		ANDA	ANDA209042	Ascend Laboratories, LLC	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-500_769ea6a3-3337-4ff2-8674-0b5dc1483f47	67877-500	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan Medoxomil		Amlodipine and olmesartan Medoxomil	TABLET	ORAL	20170814		ANDA	ANDA209042	Ascend Laboratories, LLC	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-501_769ea6a3-3337-4ff2-8674-0b5dc1483f47	67877-501	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan Medoxomil		Amlodipine and olmesartan Medoxomil	TABLET	ORAL	20170814		ANDA	ANDA209042	Ascend Laboratories, LLC	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-502_769ea6a3-3337-4ff2-8674-0b5dc1483f47	67877-502	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan Medoxomil		Amlodipine and olmesartan Medoxomil	TABLET	ORAL	20170814		ANDA	ANDA209042	Ascend Laboratories, LLC	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-503_0d78fdf2-fc83-44b5-bd2c-5b3ff268242c	67877-503	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Ascend Laboratories, LLC	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
67877-504_0d78fdf2-fc83-44b5-bd2c-5b3ff268242c	67877-504	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Ascend Laboratories, LLC	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
67877-505_0d78fdf2-fc83-44b5-bd2c-5b3ff268242c	67877-505	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20190518		ANDA	ANDA210570	Ascend Laboratories, LLC	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
67877-506_1602fa80-44fb-430f-9527-1f91b13a07cc	67877-506	HUMAN PRESCRIPTION DRUG	Colesevelam HCL		Colesevelam HCL	TABLET, FILM COATED	ORAL	20181006		ANDA	ANDA209038	Ascend Laboratories, LLC	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
67877-507_28cf8a44-6766-4ffa-9909-4d848245e921	67877-507	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171224		ANDA	ANDA209222	Ascend Laboratories, LLC	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-508_28cf8a44-6766-4ffa-9909-4d848245e921	67877-508	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171224		ANDA	ANDA209222	Ascend Laboratories, LLC	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-509_28cf8a44-6766-4ffa-9909-4d848245e921	67877-509	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171224		ANDA	ANDA209222	Ascend Laboratories, LLC	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-510_28cf8a44-6766-4ffa-9909-4d848245e921	67877-510	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171224		ANDA	ANDA209222	Ascend Laboratories, LLC	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-511_7e9d671d-5f7e-44e4-8952-cf55609a3d73	67877-511	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	Ascend Laboratories, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-512_7e9d671d-5f7e-44e4-8952-cf55609a3d73	67877-512	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	Ascend Laboratories, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-513_7e9d671d-5f7e-44e4-8952-cf55609a3d73	67877-513	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	Ascend Laboratories, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-514_7e9d671d-5f7e-44e4-8952-cf55609a3d73	67877-514	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	Ascend Laboratories, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
67877-523_28be90eb-5090-4aba-ae6e-8a4332ccfbe2	67877-523	HUMAN PRESCRIPTION DRUG	Colesevelam hydrochloride		Colesevelam hydrochloride	POWDER, FOR SUSPENSION	ORAL	20190509		ANDA	ANDA210316	Ascend Laboratories, LLC	COLESEVELAM HYDROCHLORIDE	3.75	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
67877-525_d8bc7320-2f44-4a85-b725-14f3d3824836	67877-525	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201202		ANDA	ANDA209953	Ascend Laboratories, LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
67877-526_d8bc7320-2f44-4a85-b725-14f3d3824836	67877-526	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201202		ANDA	ANDA209953	Ascend Laboratories, LLC	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
67877-527_7ab62d7b-23ff-4f1a-b90a-c4730437a6d9	67877-527	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Ascend Laboratories, LLC	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
67877-528_7ab62d7b-23ff-4f1a-b90a-c4730437a6d9	67877-528	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Ascend Laboratories, LLC	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
67877-537_2d0558e6-e623-468d-8478-148f89e24c88	67877-537	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170428		ANDA	ANDA207658	Ascend Laboratories, LLC	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
67877-538_2d0558e6-e623-468d-8478-148f89e24c88	67877-538	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170428		ANDA	ANDA207658	Ascend Laboratories, LLC	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
67877-539_2d0558e6-e623-468d-8478-148f89e24c88	67877-539	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170428		ANDA	ANDA207658	Ascend Laboratories, LLC	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
67877-540_2d0558e6-e623-468d-8478-148f89e24c88	67877-540	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170428		ANDA	ANDA207658	Ascend Laboratories, LLC	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
67877-541_2d0558e6-e623-468d-8478-148f89e24c88	67877-541	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170428		ANDA	ANDA207658	Ascend Laboratories, LLC	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
67877-542_2d0558e6-e623-468d-8478-148f89e24c88	67877-542	HUMAN PRESCRIPTION DRUG	Temozolomide		Temozolomide	CAPSULE	ORAL	20170428		ANDA	ANDA207658	Ascend Laboratories, LLC	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
67877-543_254d4dd1-0c63-4cdc-9a4e-98a777372204	67877-543	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	Ascend Laboratories, LLC	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-544_84f07b4a-a15e-41cb-af85-e110c5cf342e	67877-544	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	Ascend Laboratories, LLC	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-545_84f07b4a-a15e-41cb-af85-e110c5cf342e	67877-545	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	Ascend Laboratories, LLC	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-547_662007e2-462e-4513-b5b0-efd5dcdc2421	67877-547	HUMAN PRESCRIPTION DRUG	cefdinir		cefdinir	POWDER, FOR SUSPENSION	ORAL	20210220		ANDA	ANDA210534	Ascend Laboratories, LLC	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-548_662007e2-462e-4513-b5b0-efd5dcdc2421	67877-548	HUMAN PRESCRIPTION DRUG	cefdinir		cefdinir	POWDER, FOR SUSPENSION	ORAL	20210220		ANDA	ANDA210534	Ascend Laboratories, LLC	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-549_c5b96658-e424-41ea-a4d0-c4fb0c73d7b3	67877-549	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191122		ANDA	ANDA210519	Ascend Laboratories, LLC	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-550_c5b96658-e424-41ea-a4d0-c4fb0c73d7b3	67877-550	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191122		ANDA	ANDA210519	Ascend Laboratories, LLC	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-551_c5b96658-e424-41ea-a4d0-c4fb0c73d7b3	67877-551	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191122		ANDA	ANDA210519	Ascend Laboratories, LLC	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-552_f4df0e1f-9234-4ff4-95ba-324b7659286e	67877-552	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20200401		ANDA	ANDA210555	Ascend Laboratories, LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-553_f4df0e1f-9234-4ff4-95ba-324b7659286e	67877-553	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20200704		ANDA	ANDA210555	Ascend Laboratories, LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-554_f4df0e1f-9234-4ff4-95ba-324b7659286e	67877-554	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20200401		ANDA	ANDA210555	Ascend Laboratories, LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-555_a9067e3a-ce17-41ee-9a31-844e838ffc1f	67877-555	HUMAN PRESCRIPTION DRUG	Dimethyl fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200926		ANDA	ANDA210440	Ascend Laboratories, LLC	DIMETHYL FUMARATE	120	mg/1			N	20241231
67877-556_a9067e3a-ce17-41ee-9a31-844e838ffc1f	67877-556	HUMAN PRESCRIPTION DRUG	Dimethyl fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200926		ANDA	ANDA210440	Ascend Laboratories, LLC	DIMETHYL FUMARATE	240	mg/1			N	20241231
67877-557_a9067e3a-ce17-41ee-9a31-844e838ffc1f	67877-557	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	KIT		20200926		ANDA	ANDA210440	Ascend Laboratories, LLC						N	20241231
67877-558_73949516-a9d2-48b0-9c5c-770dbcf19263	67877-558	HUMAN PRESCRIPTION DRUG	Brompheniramine, Pseudoephedrine, Dextromethorphan		Brompheniramine, Pseudoephedrine, Dextromethorphan	SYRUP	ORAL	20200716		ANDA	ANDA210647	Ascend Laboratories, LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
67877-559_553fe90f-8d78-4b49-94d2-8c7f7dde9461	67877-559	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20220519		ANDA	ANDA210568	Ascend Laboratories, LLC	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-560_553fe90f-8d78-4b49-94d2-8c7f7dde9461	67877-560	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20220519		ANDA	ANDA210568	Ascend Laboratories, LLC	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-561_2d98aea3-35ba-447a-b88f-a5a20b612b2f	67877-561	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-562_2d98aea3-35ba-447a-b88f-a5a20b612b2f	67877-562	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-563_2d98aea3-35ba-447a-b88f-a5a20b612b2f	67877-563	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Ascend Laboratories, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
67877-571_e1b7178e-7d16-484a-87f7-d72a26ec6b50	67877-571	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	Ascend Laboratories, LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67877-572_e1b7178e-7d16-484a-87f7-d72a26ec6b50	67877-572	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	Ascend Laboratories, LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
67877-576_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-576	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-577_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-577	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-578_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-578	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-584_30690cba-b831-45c1-b799-a013d6cfc2db	67877-584	HUMAN PRESCRIPTION DRUG	CEFIXIME		CEFIXIME	CAPSULE	ORAL	20181012		ANDA	ANDA210574	Ascend Laboratories, LLC	CEFIXIME	400	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-589_3a77af92-fa94-4bba-adc0-671c3f6a47d1	67877-589	HUMAN PRESCRIPTION DRUG	colchicine		colchicine	TABLET	ORAL	20190210		ANDA	ANDA211250	Ascend Laboratories, LLC	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
67877-590_702d0174-8053-45b2-81bf-ef33162a7184	67877-590	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Ascend Laboratories, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-591_702d0174-8053-45b2-81bf-ef33162a7184	67877-591	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Ascend Laboratories, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-592_702d0174-8053-45b2-81bf-ef33162a7184	67877-592	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Ascend Laboratories, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-593_702d0174-8053-45b2-81bf-ef33162a7184	67877-593	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Ascend Laboratories, LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
67877-602_2a496565-0f45-49a8-b49b-e4a734aee439	67877-602	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20200401		ANDA	ANDA211647	Ascend Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-603_2a496565-0f45-49a8-b49b-e4a734aee439	67877-603	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20200401		ANDA	ANDA211647	Ascend Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-610_06274de3-1c99-412b-b62a-cd3a0caa2db4	67877-610	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Ascend Laboratories, LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
67877-611_06274de3-1c99-412b-b62a-cd3a0caa2db4	67877-611	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Ascend Laboratories, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
67877-612_06274de3-1c99-412b-b62a-cd3a0caa2db4	67877-612	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Ascend Laboratories, LLC	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
67877-613_e9f19258-b62c-471d-82c4-1e2bdc030833	67877-613	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20190127		ANDA	ANDA211798	Ascend Laboratories, LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
67877-614_e9f19258-b62c-471d-82c4-1e2bdc030833	67877-614	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20190127		ANDA	ANDA211798	Ascend Laboratories, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
67877-615_26eb889d-5d19-45e8-80da-1355602cd6e7	67877-615	HUMAN PRESCRIPTION DRUG	Methylphenidate hydrochloride		Methylphenidate hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201008		ANDA	ANDA212288	Ascend Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-616_b81a5afa-a318-45e9-b5a4-03d4a4413d4f	67877-616	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20191006		ANDA	ANDA211779	Ascend Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-617_b81a5afa-a318-45e9-b5a4-03d4a4413d4f	67877-617	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20191006		ANDA	ANDA211779	Ascend Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-618_b81a5afa-a318-45e9-b5a4-03d4a4413d4f	67877-618	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20191006		ANDA	ANDA211779	Ascend Laboratories, LLC	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-623_0f91e433-a264-468a-8600-0a1986e69977	67877-623	HUMAN PRESCRIPTION DRUG	Oxycodone		Oxycodone	SOLUTION	ORAL	20190209		ANDA	ANDA211748	Ascend Laboratories, LLC	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67877-625_e8a3f868-73de-4bf7-b04b-df4ea9c0d533	67877-625	HUMAN PRESCRIPTION DRUG	Oxycodone		Oxycodone	SOLUTION	ORAL	20190206		ANDA	ANDA211749	Ascend Laboratories, LLC	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67877-626_8b92bd8e-c502-4a52-8c02-dfaf944580e0	67877-626	HUMAN PRESCRIPTION DRUG	Ibuprofen and famotidine		Ibuprofen and famotidine	TABLET, FILM COATED	ORAL	20210804		ANDA	ANDA211890	Ascend Laboratories, LLC	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67877-633_7579620e-3748-46fa-8295-f9b47d0aa5b8	67877-633	HUMAN PRESCRIPTION DRUG	Imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20190201		ANDA	ANDA208302	Ascend Laboratories, LLC	IMATINIB MESYLATE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
67877-634_7579620e-3748-46fa-8295-f9b47d0aa5b8	67877-634	HUMAN PRESCRIPTION DRUG	Imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20190201		ANDA	ANDA208302	Ascend Laboratories, LLC	IMATINIB MESYLATE	400	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
67877-635_f75355a8-50ef-4a88-aaa0-c85c0ae5c23d	67877-635	HUMAN PRESCRIPTION DRUG	Tolvaptan		Tolvaptan	TABLET	ORAL	20220907		ANDA	ANDA211891	Ascend Laboratories, LLC	TOLVAPTAN	15	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
67877-636_f75355a8-50ef-4a88-aaa0-c85c0ae5c23d	67877-636	HUMAN PRESCRIPTION DRUG	Tolvaptan		Tolvaptan	TABLET	ORAL	20200521		ANDA	ANDA211891	Ascend Laboratories, LLC	TOLVAPTAN	30	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
67877-637_f75355a8-50ef-4a88-aaa0-c85c0ae5c23d	67877-637	HUMAN PRESCRIPTION DRUG	Tolvaptan		Tolvaptan	TABLET	ORAL	20200521		ANDA	ANDA211891	Ascend Laboratories, LLC	TOLVAPTAN	60	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
67877-638_6e4065a5-2672-4ef4-996d-f9d2f58970d3	67877-638	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Ascend Laboratories, LLC	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-639_6e4065a5-2672-4ef4-996d-f9d2f58970d3	67877-639	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Ascend Laboratories, LLC	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-640_6e4065a5-2672-4ef4-996d-f9d2f58970d3	67877-640	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Ascend Laboratories, LLC	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-641_6e4065a5-2672-4ef4-996d-f9d2f58970d3	67877-641	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Ascend Laboratories, LLC	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-642_6e4065a5-2672-4ef4-996d-f9d2f58970d3	67877-642	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA212244	Ascend Laboratories, LLC	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
67877-643_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-643	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	65	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-644_1a259e4f-fadd-4307-abbd-da3fe3e83a3a	67877-644	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Ascend Laboratories, LLC	MINOCYCLINE HYDROCHLORIDE	115	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
67877-648_a85cb8be-4aea-410c-a921-15d44a6ff48a	67877-648	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil Citrate	POWDER, FOR SUSPENSION	ORAL	20191129		ANDA	ANDA212440	Ascend Laboratories, LLC	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
67877-655_9b987855-a940-4d08-b6f3-8f228feec913	67877-655	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20190721		ANDA	ANDA212631	Ascend Laboratories, LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-656_9b987855-a940-4d08-b6f3-8f228feec913	67877-656	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20190721		ANDA	ANDA212631	Ascend Laboratories, LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-657_9b987855-a940-4d08-b6f3-8f228feec913	67877-657	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	TABLET	ORAL	20190721		ANDA	ANDA212631	Ascend Laboratories, LLC	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-658_51c90a07-0b1c-453b-9b81-82639d7c7925	67877-658	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20210507		ANDA	ANDA213039	Ascend Laboratories, LLC	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
67877-659_f0366917-f745-4b01-a662-a98a7d80b4a0	67877-659	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20220811		ANDA	ANDA090635	Ascend Laboratories, LLC	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67877-660_f0366917-f745-4b01-a662-a98a7d80b4a0	67877-660	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20220811		ANDA	ANDA090635	Ascend Laboratories, LLC	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67877-664_3f0a8e33-f4b5-45b4-bf48-ecfeafc6ec67	67877-664	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20231018		ANDA	ANDA212714	Ascend Laboratories, LLC	CLOBAZAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
67877-665_3f0a8e33-f4b5-45b4-bf48-ecfeafc6ec67	67877-665	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20190907		ANDA	ANDA212714	Ascend Laboratories, LLC	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
67877-666_3f0a8e33-f4b5-45b4-bf48-ecfeafc6ec67	67877-666	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20190907		ANDA	ANDA212714	Ascend Laboratories, LLC	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
67877-668_6bb4d90a-bb0d-4a30-b673-ee8273bda1b9	67877-668	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20211208		ANDA	ANDA212924	Ascend Laboratories, LLC	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
67877-669_6bb4d90a-bb0d-4a30-b673-ee8273bda1b9	67877-669	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20211208		ANDA	ANDA212924	Ascend Laboratories, LLC	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
67877-670_7005989b-c396-4f0a-907f-352503bb9b24	67877-670	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET	ORAL	20210211		ANDA	ANDA212451	Ascend Laboratories, LLC	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67877-671_7005989b-c396-4f0a-907f-352503bb9b24	67877-671	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET	ORAL	20210211		ANDA	ANDA212451	Ascend Laboratories, LLC	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
67877-673_0c3c44a0-15f4-4485-8f0c-7ea57a2c650f	67877-673	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	SUSPENSION	ORAL	20210224		ANDA	ANDA213410	Ascend Laboratories, LLC	RUFINAMIDE	40	mg/mL			N	20241231
67877-674_e55f8225-aa06-4e46-81d2-757233b95585	67877-674	HUMAN PRESCRIPTION DRUG	VIGABATRIN		VIGABATRIN	POWDER, FOR SOLUTION	ORAL	20201203		ANDA	ANDA213375	Ascend Laboratories, LLC	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
67877-675_65865f16-a960-4a42-b0b6-05ab2885bf41	67877-675	HUMAN PRESCRIPTION DRUG	Deferasirox oral		Deferasirox oral	GRANULE	ORAL	20200716		ANDA	ANDA213374	Ascend Laboratories, LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-676_65865f16-a960-4a42-b0b6-05ab2885bf41	67877-676	HUMAN PRESCRIPTION DRUG	Deferasirox oral		Deferasirox oral	GRANULE	ORAL	20200716		ANDA	ANDA213374	Ascend Laboratories, LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-677_65865f16-a960-4a42-b0b6-05ab2885bf41	67877-677	HUMAN PRESCRIPTION DRUG	Deferasirox oral		Deferasirox oral	GRANULE	ORAL	20200716		ANDA	ANDA213374	Ascend Laboratories, LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
67877-678_25c12569-0ae1-4117-a945-edfc5457e525	67877-678	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20210402		ANDA	ANDA212848	Ascend Laboratories, LLC	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
67877-696_1ad27d47-337c-4e56-be73-0b6c0d4d307b	67877-696	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20200213		ANDA	ANDA213412	Ascend Laboratories, LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
67877-697_1ad27d47-337c-4e56-be73-0b6c0d4d307b	67877-697	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20200213		ANDA	ANDA213412	Ascend Laboratories, LLC	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
67877-704_011a7c5b-e423-4e40-b073-0d3d3cdb95de	67877-704	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA213911	Ascend Laboratories, LLC	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
67877-705_011a7c5b-e423-4e40-b073-0d3d3cdb95de	67877-705	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA213911	Ascend Laboratories, LLC	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
67877-706_011a7c5b-e423-4e40-b073-0d3d3cdb95de	67877-706	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA213911	Ascend Laboratories, LLC	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
67877-710_f94f4a45-37fe-468f-a820-8cdff3c097c9	67877-710	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20201029		ANDA	ANDA213720	Ascend Laboratories, LLC	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-711_f94f4a45-37fe-468f-a820-8cdff3c097c9	67877-711	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20201029		ANDA	ANDA213720	Ascend Laboratories, LLC	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
67877-712_2e148a1a-d7b9-4b13-9663-30d4fa2ba476	67877-712	HUMAN PRESCRIPTION DRUG	Enalapril Maleate Oral Solution		Enalapril Maleate Oral Solution	SOLUTION	ORAL	20220905		ANDA	ANDA213714	Ascend Laboratories, LLC	ENALAPRIL MALEATE	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
67877-717_f477e4bf-c750-40b1-9a8b-6af4bbaacfc4	67877-717	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20210716		ANDA	ANDA214242	Ascend Laboratories, LLC	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
67877-718_7aa8eb12-c126-411a-90cd-6c84e33c3bd5	67877-718	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20211127		ANDA	ANDA214138	Ascend Laboratories, LLC	EVEROLIMUS	.25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
67877-719_7aa8eb12-c126-411a-90cd-6c84e33c3bd5	67877-719	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20211127		ANDA	ANDA214138	Ascend Laboratories, LLC	EVEROLIMUS	.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
67877-720_7aa8eb12-c126-411a-90cd-6c84e33c3bd5	67877-720	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20211127		ANDA	ANDA214138	Ascend Laboratories, LLC	EVEROLIMUS	.75	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
67877-721_7aa8eb12-c126-411a-90cd-6c84e33c3bd5	67877-721	HUMAN PRESCRIPTION DRUG	Everolimus		Everolimus	TABLET	ORAL	20211127		ANDA	ANDA214138	Ascend Laboratories, LLC	EVEROLIMUS	1	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
67877-726_44843f8f-a4f3-4035-b927-1c5671335fb1	67877-726	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210611		ANDA	ANDA214127	Ascend Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
67877-727_44843f8f-a4f3-4035-b927-1c5671335fb1	67877-727	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210611		ANDA	ANDA214127	Ascend Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
67877-728_44843f8f-a4f3-4035-b927-1c5671335fb1	67877-728	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210611		ANDA	ANDA214127	Ascend Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
67877-729_44843f8f-a4f3-4035-b927-1c5671335fb1	67877-729	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210611		ANDA	ANDA214127	Ascend Laboratories, LLC	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
67877-731_86f797ac-3e72-46c0-a783-2ee15f37100f	67877-731	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20210427		ANDA	ANDA214065	Ascend Laboratories, LLC	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
67877-732_b4cacbb7-7877-4cfe-9758-b7e9599dce68	67877-732	HUMAN PRESCRIPTION DRUG	Lacosamide Oral Solution		Lacosamide Oral Solution	SOLUTION	ORAL	20220520		ANDA	ANDA214672	Ascend Laboratories, LLC	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
67877-733_da1dfbf0-4933-45e6-add6-e3b402857382	67877-733	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Ascend Laboratories, LLC	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
67877-734_da1dfbf0-4933-45e6-add6-e3b402857382	67877-734	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Ascend Laboratories, LLC	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
67877-735_da1dfbf0-4933-45e6-add6-e3b402857382	67877-735	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Ascend Laboratories, LLC	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
67877-736_da1dfbf0-4933-45e6-add6-e3b402857382	67877-736	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20220401		ANDA	ANDA214695	Ascend Laboratories, LLC	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
67877-743_be62466c-d597-473e-8796-76d3f5bf6885	67877-743	HUMAN PRESCRIPTION DRUG	varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20230825		ANDA	ANDA214557	Ascend Laboratories, LLC	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
67877-744_be62466c-d597-473e-8796-76d3f5bf6885	67877-744	HUMAN PRESCRIPTION DRUG	varenicline		varenicline tartrate	TABLET, FILM COATED	ORAL	20230825		ANDA	ANDA214557	Ascend Laboratories, LLC	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
67877-745_be62466c-d597-473e-8796-76d3f5bf6885	67877-745	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline tartrate	KIT		20230825		ANDA	ANDA214557	Ascend Laboratories, LLC						N	20241231
67877-746_85d4d5fb-70cd-4718-9484-38f643556fcf	67877-746	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20210313		ANDA	ANDA214753	Ascend Laboratories, LLC	SIROLIMUS	.5	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
67877-747_85d4d5fb-70cd-4718-9484-38f643556fcf	67877-747	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20210313		ANDA	ANDA214753	Ascend Laboratories, LLC	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
67877-748_85d4d5fb-70cd-4718-9484-38f643556fcf	67877-748	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20210313		ANDA	ANDA214753	Ascend Laboratories, LLC	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
67877-749_f6a079bc-179c-46e4-9077-96168cdd1cf9	67877-749	HUMAN PRESCRIPTION DRUG	Fosfomycin Tromethamine		Fosfomycin Tromethamine	GRANULE, FOR SOLUTION	ORAL	20211022		ANDA	ANDA214554	Ascend Laboratories, LLC	FOSFOMYCIN TROMETHAMINE	3	g/1			N	20241231
67877-750_fc015767-2010-4750-9eeb-b04fccdc8c7f	67877-750	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	KIT		20230801		ANDA	ANDA214913	Ascend Laboratories, LLC						N	20241231
67877-751_fc015767-2010-4750-9eeb-b04fccdc8c7f	67877-751	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	KIT		20230801		ANDA	ANDA214913	Ascend Laboratories, LLC						N	20241231
67877-753_ef3763f7-d386-4bbb-bda6-264e3a99593b	67877-753	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA AUTHORIZED GENERIC	NDA018651	Ascend Laboratories, LLC	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
67877-754_ef3763f7-d386-4bbb-bda6-264e3a99593b	67877-754	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA AUTHORIZED GENERIC	NDA018651	Ascend Laboratories, LLC	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
67877-755_ef3763f7-d386-4bbb-bda6-264e3a99593b	67877-755	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA AUTHORIZED GENERIC	NDA018651	Ascend Laboratories, LLC	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
67877-756_ea84d4fa-5118-498c-a2cf-deee8f1cc1db	67877-756	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220330		ANDA	ANDA216067	Ascend Laboratories, LLC	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-757_ea84d4fa-5118-498c-a2cf-deee8f1cc1db	67877-757	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220330		ANDA	ANDA216067	Ascend Laboratories, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-758_ea84d4fa-5118-498c-a2cf-deee8f1cc1db	67877-758	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220330		ANDA	ANDA216067	Ascend Laboratories, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
67877-762_5e004c89-c7dd-4c52-856b-ca3c85a95f8a	67877-762	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN		ERYTHROMYCIN	TABLET, FILM COATED	ORAL	20220714		ANDA	ANDA216066	Ascend Laboratories, LLC	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
67877-763_5e004c89-c7dd-4c52-856b-ca3c85a95f8a	67877-763	HUMAN PRESCRIPTION DRUG	ERYTHROMYCIN		ERYTHROMYCIN	TABLET, FILM COATED	ORAL	20220714		ANDA	ANDA216066	Ascend Laboratories, LLC	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
67877-768_1a39d540-e9a5-44a4-a537-06142d1470d7	67877-768	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220528		ANDA	ANDA216375	Ascend Laboratories, LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-769_1a39d540-e9a5-44a4-a537-06142d1470d7	67877-769	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220528		ANDA	ANDA216375	Ascend Laboratories, LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-770_1a39d540-e9a5-44a4-a537-06142d1470d7	67877-770	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220408		ANDA	ANDA216375	Ascend Laboratories, LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-771_1a39d540-e9a5-44a4-a537-06142d1470d7	67877-771	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220528		ANDA	ANDA216375	Ascend Laboratories, LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
67877-772_2b2c8805-3cf1-48f8-9612-8a72a30a7f20	67877-772	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	POWDER, FOR SOLUTION	ORAL	20221024		ANDA	ANDA216635	Ascend Laboratories, LLC	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
67877-775_87b513db-989d-4c31-b597-1af0093d0085	67877-775	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SUSPENSION	ORAL	20230824		ANDA	ANDA216400	Ascend Laboratories, LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67877-842_da29c39b-a1cd-41ba-9db2-82dd970e2c85	67877-842	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	Ascend Laboratories, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67877-843_ea50552f-f9b9-467f-a925-62ff027df607	67877-843	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	Ascend Laboratories, LLC	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67877-878_1a9e47ee-3f6f-4be0-9b06-9430d2a5f1bd	67877-878	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA210568	Ascend Laboratories, LLC	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-879_1a9e47ee-3f6f-4be0-9b06-9430d2a5f1bd	67877-879	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20230213		ANDA	ANDA210568	Ascend Laboratories, LLC	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
67877-889_da29c39b-a1cd-41ba-9db2-82dd970e2c85	67877-889	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20230823		ANDA	ANDA215630	Ascend Laboratories, LLC	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
67879-101_0e5ed6b4-aa8b-d67a-e063-6394a90a0383	67879-101	HUMAN OTC DRUG	PHARMA CLEAR CLEANSER		SALICYLIC ACID	GEL	TOPICAL	20150618		OTC MONOGRAPH DRUG	M006	PHARMAGEL INTERNATIONAL INC	SALICYLIC ACID	2	g/100mL			N	20251231
67879-102_0e5f77f3-1ac5-fdf2-e063-6394a90aabcf	67879-102	HUMAN OTC DRUG	PHARMA CLEAR ACNE TREATMENT		SALICYLIC ACID	CONCENTRATE	TOPICAL	20150618		OTC MONOGRAPH DRUG	M006	PHARMAGEL INTERNATIONAL INC	SALICYLIC ACID	2	g/100mL			N	20251231
67879-103_0e5f77f3-1ac3-fdf2-e063-6394a90aabcf	67879-103	HUMAN OTC DRUG	PHARMA CLEAR MOISTURIZER		SALICYLIC ACID	LOTION	TOPICAL	20150618		OTC MONOGRAPH DRUG	M006	PHARMAGEL INTERNATIONAL INC	SALICYLIC ACID	1	g/100mL			N	20251231
67879-104_0e5f814d-e08d-aa57-e063-6294a90ad915	67879-104	HUMAN OTC DRUG	PHARMA CLEAR SPOT TREATMENT		SALICYLIC ACID	LIQUID	TOPICAL	20160615		OTC MONOGRAPH DRUG	M006	PHARMAGEL INTERNATIONAL INC	SALICYLIC ACID	2	g/100mL			N	20251231
67879-201_0e5f77f3-1ac2-fdf2-e063-6394a90aabcf	67879-201	HUMAN OTC DRUG	HAND THERAPE SANITIZER		BENZETHONIUM CHLORIDE	GEL	TOPICAL	20150618		OTC MONOGRAPH DRUG	M003	PHARMAGEL INTERNATIONAL INC	BENZETHONIUM CHLORIDE	.2	g/100mL			N	20251231
67879-301_0e5fa1ca-f9b7-f8a3-e063-6394a90af93f	67879-301	HUMAN OTC DRUG	DERMA FADE		OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20150618		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	OCTINOXATE; OCTISALATE; OXYBENZONE	7.5; 5; 3	g/100g; g/100g; g/100g			N	20251231
67879-302_0e5f77f3-1abf-fdf2-e063-6394a90aabcf	67879-302	HUMAN OTC DRUG	SUN THERAPE FACE	SPF-35	OCTINOXATE, OCTISALATE, OXYBENZONE, AVOBENZONE	LOTION	TOPICAL	20150618		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	3; 7.5; 5; 3	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
67879-303_0e3c764d-a962-2604-e063-6394a90a066b	67879-303	HUMAN OTC DRUG	SUN THERAPE BODY	SPF-35	HOMOSALATE, OCTINOXATE, OCTISALATE, AVOBENZONE	LOTION	TOPICAL	20150618		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	3; 10; 7.5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
67879-304_0e5f77f3-1ac1-fdf2-e063-6394a90aabcf	67879-304	HUMAN OTC DRUG	SUN THERAPE SPORT	SPF-35	HOMOSALATE, OCTINOXATE, OXYBENZONE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	SPRAY	TOPICAL	20150618		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 15; 7.5; 5; 5.5; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
67879-305_0e5f814d-e08c-aa57-e063-6294a90ad915	67879-305	HUMAN OTC DRUG	SUN THERAPE PRO SPORT FACE AND BODY	SPF-35	OCTINOXATE, OCTISALATE, OXYBENZONE, AVOBENZONE	CREAM	TOPICAL	20160609		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	3; 7.5; 5; 3	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
67879-306_0e5f89fd-1e9f-a410-e063-6294a90a582e	67879-306	HUMAN OTC DRUG	SUN THERAPE PRO SPORT	SPF-35	HOMOSALATE, OCTINOXATE, OXYBENZONE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	SPRAY	TOPICAL	20160610		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 15; 7.5; 5; 5.5; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
67879-307_0e5ed6b4-aa8a-d67a-e063-6394a90a0383	67879-307	HUMAN OTC DRUG	LIP RECOVERY		PETROLATUM	OINTMENT	TOPICAL	20150618		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	PETROLATUM	48	g/100mL			N	20251231
67879-308_0e5f77f3-1ac4-fdf2-e063-6394a90aabcf	67879-308	HUMAN OTC DRUG	DERMA BRITE	SPF 35	OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20150618		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	OCTINOXATE; OCTISALATE; OXYBENZONE	7.5; 5; 3	g/100g; g/100g; g/100g			N	20251231
67879-309_0e5f77f3-1ac0-fdf2-e063-6394a90aabcf	67879-309	HUMAN OTC DRUG	SUN THERAPE FACE AND BODY	SPF-35	AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE	LOTION	TOPICAL	20150618		OTC MONOGRAPH DRUG	M020	PHARMAGEL INTERNATIONAL INC	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	3; 7.5; 5; 3	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
67899-001_06d2ba0c-3ec0-95c5-e063-6294a90a819a	67899-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190130		UNAPPROVED MEDICAL GAS		Nicholas Pharmacy	OXYGEN	99	L/100L			N	20241231
67905-0001_06e703b4-f439-c097-e063-6294a90a4821	67905-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091014		UNAPPROVED MEDICAL GAS		Osborn Drugs Inc	OXYGEN	99	L/100L			N	20241231
67919-011_47751373-842d-4e5b-b83f-d17dd0b7606f	67919-011	HUMAN PRESCRIPTION DRUG	Cubicin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20030912		NDA	NDA021572	Merck Sharp & Dohme LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
67919-012_17a6036b-422f-4c49-b865-1b035802ef60	67919-012	HUMAN PRESCRIPTION DRUG	CUBICIN RF		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160706		NDA	NDA021572	Merck Sharp & Dohme LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
67919-020_157db357-a1d7-43de-a564-095b8ad1735c	67919-020	HUMAN PRESCRIPTION DRUG	Entereg		alvimopan	CAPSULE	ORAL	20120416		NDA	NDA021775	Merck Sharp & Dohme LLC	ALVIMOPAN	12	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
67919-030_192cdfb1-de74-4cc1-96d9-082d728a7092	67919-030	HUMAN PRESCRIPTION DRUG	ZERBAXA		ceftolozane and tazobactam	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20141219		NDA	NDA206829	Merck Sharp & Dohme LLC	CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM	1; .5	g/10mL; g/10mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
67919-040_282ae0c1-e1f3-4045-af1d-bc2f6bd7b4e2	67919-040	HUMAN PRESCRIPTION DRUG	SIVEXTRO		tedizolid phosphate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140620		NDA	NDA205436	Merck Sharp & Dohme LLC	TEDIZOLID PHOSPHATE	200	mg/4mL	Breast Cancer Resistance Protein Inhibitors [MoA], Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
67919-041_282ae0c1-e1f3-4045-af1d-bc2f6bd7b4e2	67919-041	HUMAN PRESCRIPTION DRUG	SIVEXTRO		tedizolid phosphate	TABLET, FILM COATED	ORAL	20140620		NDA	NDA205435	Merck Sharp & Dohme LLC	TEDIZOLID PHOSPHATE	200	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
67932-1313_1b1771a2-7113-4897-bfb0-6c6c5e6bf128	67932-1313	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19880101		UNAPPROVED MEDICAL GAS		Premier Oxygen LLC	OXYGEN	99.5	L/100L			N	20241231
67939-010_d93db56f-430e-5490-e053-2995a90ace22	67939-010	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F 18	INJECTION	INTRAVENOUS	20131101		ANDA	ANDA204498	The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
67939-020_d951aa31-f016-e2da-e053-2995a90a5b2d	67939-020	HUMAN PRESCRIPTION DRUG	Sodium Fluoride F 18		Sodium Fluoride F 18	INJECTION	INTRAVENOUS	20120711		ANDA	ANDA204497	The University of Utah DBA Cyclotron Radiochemistry Lab Huntsman Cancer Institute	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
67979-001_0890026b-e03d-34e2-e063-6294a90a6f22	67979-001	HUMAN PRESCRIPTION DRUG	Valstar		valrubicin	SOLUTION, CONCENTRATE	INTRAVESICAL	19981001		NDA	NDA020892	Endo Pharmaceuticals Solutions Inc.	VALRUBICIN	40	mg/mL			N	20241231
67979-002_f9680ba5-1e4f-4de6-b94f-bfd0f1c54f6d	67979-002	HUMAN PRESCRIPTION DRUG	SUPPRELIN	LA	histrelin acetate	IMPLANT	SUBCUTANEOUS	20070531		NDA	NDA022058	Endo Pharmaceuticals Inc.	HISTRELIN ACETATE	50	mg/1	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
67979-511_6aedd4f1-11f5-465d-a683-67e3f1ee1653	67979-511	HUMAN PRESCRIPTION DRUG	Aveed		testosterone undecanoate	INJECTION	INTRAMUSCULAR	20140305		NDA	NDA022219	Endo Pharmaceuticals Inc.	TESTOSTERONE UNDECANOATE	250	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
67996-457_7d9c58d2-fbf8-4d7a-9b28-3e00accaade2	67996-457	HUMAN OTC DRUG	Kontakt II Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20190702		OTC MONOGRAPH NOT FINAL	part333E	Select Specialty Products	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
67996-876_c6ce2ed3-c9db-45c0-9723-ef83362f4818	67996-876	HUMAN OTC DRUG	Inhibit II High Foaming Antiseptic Hand Cleaner		CHLOROXYLENOL	SOAP	TOPICAL	20170112		OTC MONOGRAPH NOT FINAL	part333E	Select Specialty Products	CHLOROXYLENOL	3	mg/mL			N	20241231
68001-005_f651b076-b79f-67b7-e053-2995a90a8883	68001-005	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20130802		ANDA	ANDA040189	BluePoint Laboratories	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68001-105_00d5b376-0955-1d78-e063-6394a90ad20c	68001-105	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20131008		ANDA	ANDA078239	BluePoint Laboratories	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68001-106_00d5b376-0955-1d78-e063-6394a90ad20c	68001-106	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20131008		ANDA	ANDA078239	BluePoint Laboratories	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68001-111_e1e35404-0cf3-e40d-e053-2995a90a3829	68001-111	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20131201		ANDA	ANDA091269	BluePoint Laboratories	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68001-112_e1e35404-0cf3-e40d-e053-2995a90a3829	68001-112	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20131201		ANDA	ANDA091269	BluePoint Laboratories	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68001-113_07fc68ca-a9c5-db83-e063-6394a90a5f31	68001-113	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20140213		ANDA	ANDA091399	BluePoint Laboratories	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-114_07fc68ca-a9c5-db83-e063-6394a90a5f31	68001-114	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20140213		ANDA	ANDA091399	BluePoint Laboratories	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-119_1aeaf7d4-6a9a-49c8-8e09-6f4411462ee4	68001-119	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20131125		ANDA	ANDA078889	BluePoint Laboratories	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-120_1aeaf7d4-6a9a-49c8-8e09-6f4411462ee4	68001-120	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20131125		ANDA	ANDA078889	BluePoint Laboratories	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-121_98f8056c-5885-e243-e053-2995a90a68d1	68001-121	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20140101		ANDA	ANDA090617	BluePoint Laboratories	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-122_98f8056c-5885-e243-e053-2995a90a68d1	68001-122	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20140101		ANDA	ANDA090617	BluePoint Laboratories	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-130_facbe2e1-8ede-d7e4-e053-6394a90ae44f	68001-130	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20150716		ANDA	ANDA078466	BluePoint Laboratories	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68001-131_facbe2e1-8ede-d7e4-e053-6394a90ae44f	68001-131	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20150716		ANDA	ANDA078466	BluePoint Laboratories	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68001-132_facbe2e1-8ede-d7e4-e053-6394a90ae44f	68001-132	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20150716		ANDA	ANDA078466	BluePoint Laboratories	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	2.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68001-133_facbe2e1-8ede-d7e4-e053-6394a90ae44f	68001-133	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20150716		ANDA	ANDA078466	BluePoint Laboratories	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68001-134_facbe2e1-8ede-d7e4-e053-6394a90ae44f	68001-134	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20150716		ANDA	ANDA078466	BluePoint Laboratories	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68001-135_facbe2e1-8ede-d7e4-e053-6394a90ae44f	68001-135	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20150716		ANDA	ANDA078466	BluePoint Laboratories	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68001-151_0d19eb17-04f9-86e4-e063-6394a90a83e3	68001-151	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20140422		ANDA	ANDA077614	BluePoint Laboratories	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68001-152_0d19eb17-04f9-86e4-e063-6394a90a83e3	68001-152	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20140422		ANDA	ANDA077614	BluePoint Laboratories	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68001-153_0d19eb17-04f9-86e4-e063-6394a90a83e3	68001-153	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20140422		ANDA	ANDA077614	BluePoint Laboratories	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68001-154_0d19eb17-04f9-86e4-e063-6394a90a83e3	68001-154	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20140422		ANDA	ANDA077614	BluePoint Laboratories	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68001-155_00ff4fc4-3672-5da2-e063-6394a90ac6a1	68001-155	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, COATED	ORAL	20140101		ANDA	ANDA078921	BluePoint Laboratories	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
68001-156_04c5d11d-d249-eb93-e063-6294a90a1b46	68001-156	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20131125		ANDA	ANDA077653	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-157_04c5d11d-d249-eb93-e063-6294a90a1b46	68001-157	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20131125		ANDA	ANDA077653	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-158_04c5d11d-d249-eb93-e063-6294a90a1b46	68001-158	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20131125		ANDA	ANDA077653	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-159_04c5d11d-d249-eb93-e063-6294a90a1b46	68001-159	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20131125		ANDA	ANDA077653	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-160_04c5d11d-d249-eb93-e063-6294a90a1b46	68001-160	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20131125		ANDA	ANDA077653	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-161_0486f118-2b7c-ac10-e063-6394a90a6e6b	68001-161	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20140113		ANDA	ANDA040596	BluePoint Laboratories	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68001-162_0486f118-2b7c-ac10-e063-6394a90a6e6b	68001-162	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20140113		ANDA	ANDA040596	BluePoint Laboratories	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68001-163_0486f118-2b7c-ac10-e063-6394a90a6e6b	68001-163	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20140113		ANDA	ANDA040596	BluePoint Laboratories	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68001-171_9d0cb864-53d9-4151-b557-dd5114903d6b	68001-171	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20140122		ANDA	ANDA202323	BluePoint Laboratories	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
68001-172_9d0cb864-53d9-4151-b557-dd5114903d6b	68001-172	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20140122		ANDA	ANDA202323	BluePoint Laboratories	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
68001-176_9b3b81dd-627d-4407-98e0-5c2b9b1d54d7	68001-176	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20130228		ANDA	ANDA202025	BluePoint Laboratories	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68001-177_eff41a95-d73d-ed0a-e053-2995a90acfc9	68001-177	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20140226		ANDA	ANDA078181	BluePoint Laboratories	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68001-178_eff41a95-d73d-ed0a-e053-2995a90acfc9	68001-178	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20140226		ANDA	ANDA078181	BluePoint Laboratories	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68001-179_eff41a95-d73d-ed0a-e053-2995a90acfc9	68001-179	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20140226		ANDA	ANDA078181	BluePoint Laboratories	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68001-180_00d80f31-cf05-a4d5-e063-6394a90ab1b7	68001-180	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine	TABLET	ORAL	20130228		ANDA	ANDA201109	BluePoint Laboratories	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-181_00d80f31-cf05-a4d5-e063-6394a90ab1b7	68001-181	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine	TABLET	ORAL	20130228		ANDA	ANDA201109	BluePoint Laboratories	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-182_00d80f31-cf05-a4d5-e063-6394a90ab1b7	68001-182	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine	TABLET	ORAL	20130228		ANDA	ANDA201109	BluePoint Laboratories	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-183_00d80f31-cf05-a4d5-e063-6394a90ab1b7	68001-183	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine	TABLET	ORAL	20130228		ANDA	ANDA201109	BluePoint Laboratories	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-184_00d80f31-cf05-a4d5-e063-6394a90ab1b7	68001-184	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine	TABLET	ORAL	20130228		ANDA	ANDA201109	BluePoint Laboratories	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-185_00d80f31-cf05-a4d5-e063-6394a90ab1b7	68001-185	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine	TABLET	ORAL	20130228		ANDA	ANDA201109	BluePoint Laboratories	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-187_df08337a-79bd-47c9-858a-8ee32469cfe5	68001-187	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20140225		ANDA	ANDA077690	BluePoint Laboratories	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-188_df08337a-79bd-47c9-858a-8ee32469cfe5	68001-188	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20140225		ANDA	ANDA077690	BluePoint Laboratories	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-189_df08337a-79bd-47c9-858a-8ee32469cfe5	68001-189	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20140225		ANDA	ANDA077690	BluePoint Laboratories	QUINAPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-195_c4f837db-92b5-7684-e053-2a95a90acfe2	68001-195	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20140206	20240131	ANDA	ANDA202280	BluePoint Laboratories	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
68001-196_c4f837db-92b5-7684-e053-2a95a90acfe2	68001-196	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20140206	20240131	ANDA	ANDA202280	BluePoint Laboratories	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
68001-197_c4f837db-92b5-7684-e053-2a95a90acfe2	68001-197	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20140206	20240131	ANDA	ANDA202280	BluePoint Laboratories	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
68001-231_f9d6d774-a103-2ccc-e053-6294a90a0629	68001-231	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20140226		ANDA	ANDA201089	BluePoint Laboratories	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
68001-232_f9d6d774-a103-2ccc-e053-6294a90a0629	68001-232	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20140226		ANDA	ANDA201089	BluePoint Laboratories	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
68001-237_0a578bae-ad1a-d812-e063-6394a90a7c88	68001-237	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070974	BluePoint Laboratories	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68001-238_0a578bae-ad1a-d812-e063-6394a90a7c88	68001-238	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070975	BluePoint Laboratories	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68001-239_0a578bae-ad1a-d812-e063-6394a90a7c88	68001-239	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070976	BluePoint Laboratories	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68001-242_e37d89cb-8e25-4a83-8c4d-aadaf892f677	68001-242	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20140313		ANDA	ANDA077651	BluePoint Laboratories	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68001-243_e37d89cb-8e25-4a83-8c4d-aadaf892f677	68001-243	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20140313		ANDA	ANDA077651	BluePoint Laboratories	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68001-244_e37d89cb-8e25-4a83-8c4d-aadaf892f677	68001-244	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20140313		ANDA	ANDA077651	BluePoint Laboratories	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68001-245_eff0fdfe-695c-4e62-e053-2a95a90ab50f	68001-245	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		Atovaquone and Proguanil Hydrochloride	TABLET, FILM COATED	ORAL	20140313		ANDA	ANDA091211	BluePoint Laboratories	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
68001-246_d76f80e5-8d61-b72b-e053-2995a90a8857	68001-246	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20140313		ANDA	ANDA078152	BluePoint Laboratories	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68001-247_d76f80e5-8d61-b72b-e053-2995a90a8857	68001-247	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20140313		ANDA	ANDA078152	BluePoint Laboratories	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68001-249_975b101e-c5cf-4acf-ac72-541e018527d8	68001-249	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20140313		ANDA	ANDA201779	BluePoint Laboratories	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68001-250_975b101e-c5cf-4acf-ac72-541e018527d8	68001-250	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20140313		ANDA	ANDA201779	BluePoint Laboratories	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68001-251_0903852e-f7d3-4261-e063-6394a90a9d32	68001-251	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140313		ANDA	ANDA077253	BluePoint Laboratories	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68001-252_0903852e-f7d3-4261-e063-6394a90a9d32	68001-252	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140313		ANDA	ANDA077253	BluePoint Laboratories	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68001-253_0903852e-f7d3-4261-e063-6394a90a9d32	68001-253	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140313		ANDA	ANDA077253	BluePoint Laboratories	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68001-254_0903852e-f7d3-4261-e063-6394a90a9d32	68001-254	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140313		ANDA	ANDA077253	BluePoint Laboratories	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68001-260_df08337a-79bd-47c9-858a-8ee32469cfe5	68001-260	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20140718		ANDA	ANDA077690	BluePoint Laboratories	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-265_30d6f51a-8099-4ff9-9be6-fb0559c88e42	68001-265	HUMAN PRESCRIPTION DRUG	Etoposide		Etoposide	INJECTION	INTRAVENOUS	20131114		ANDA	ANDA074513	BluePoint Laboratories	ETOPOSIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
68001-266_926a894d-ae3e-4a83-992a-045c1795c74f	68001-266	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20141216		ANDA	ANDA040798	BluePoint Laboratories	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-266_c7e082d2-96d6-498c-9827-c42c72719d5c	68001-266	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20141215		ANDA	ANDA040743	BluePoint Laboratories	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-279_d4d6a80f-a82d-3a82-e053-2a95a90a739a	68001-279	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20151221		ANDA	ANDA090066	BluePoint Laboratories	DICLOFENAC SODIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68001-280_d4d6a80f-a82d-3a82-e053-2a95a90a739a	68001-280	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20151221		ANDA	ANDA090066	BluePoint Laboratories	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68001-281_d4d6a80f-a82d-3a82-e053-2a95a90a739a	68001-281	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20151221		ANDA	ANDA077863	BluePoint Laboratories	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68001-283_c3ddc4a5-9f1b-a8ee-e053-2a95a90a2265	68001-283	HUMAN PRESCRIPTION DRUG	Cisplatin		Cisplatin	INJECTION	INTRAVENOUS	20160802		ANDA	ANDA206774	BluePoint Laboratories	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68001-308_f94a377f-ee4c-6caa-e053-6294a90ab1d7	68001-308	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	BluePoint Laboratories	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68001-309_f94a377f-ee4c-6caa-e053-6294a90ab1d7	68001-309	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	BluePoint Laboratories	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68001-313_0487449f-83dc-2566-e063-6294a90a9976	68001-313	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20170701		NDA	NDA208216	BluePoint Laboratories	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-314_00ff832a-bce0-29bf-e063-6294a90a3d71	68001-314	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	BluePoint Laboratories	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68001-315_00ff832a-bce0-29bf-e063-6294a90a3d71	68001-315	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	BluePoint Laboratories	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68001-316_00ff832a-bce0-29bf-e063-6294a90a3d71	68001-316	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	BluePoint Laboratories	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68001-317_0070af7f-f572-1bcb-e063-6394a90ad5f4	68001-317	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	BluePoint Laboratories	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-318_0070af7f-f572-1bcb-e063-6394a90ad5f4	68001-318	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	BluePoint Laboratories	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-319_0070af7f-f572-1bcb-e063-6394a90ad5f4	68001-319	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	BluePoint Laboratories	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-323_f28d2a00-0213-4467-91b9-a55164bb0a5f	68001-323	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170430		ANDA	ANDA205883	BluePoint Laboratories	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
68001-324_f28d2a00-0213-4467-91b9-a55164bb0a5f	68001-324	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20170430		ANDA	ANDA205883	BluePoint Laboratories	MEROPENEM	1	g/30mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
68001-325_0c4edd95-d523-f96b-e063-6394a90a419b	68001-325	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20170430	20240131	ANDA	ANDA201831	BluePoint Laboratories	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
68001-326_0c4edd95-d523-f96b-e063-6394a90a419b	68001-326	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20170430	20240131	ANDA	ANDA201831	BluePoint Laboratories	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
68001-327_c6e946bd-b0c1-3c75-e053-2995a90abf9e	68001-327	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20170430		ANDA	ANDA071251	BluePoint Laboratories	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68001-328_c6e946bd-b0c1-3c75-e053-2995a90abf9e	68001-328	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20170430		ANDA	ANDA071251	BluePoint Laboratories	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68001-332_c5fac2c4-de1f-49d3-e053-2a95a90a5285	68001-332	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170801		ANDA	ANDA077321	BluePoint Laboratories	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-333_c5fac2c4-de1f-49d3-e053-2a95a90a5285	68001-333	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170801		ANDA	ANDA077321	BluePoint Laboratories	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-334_c5fac2c4-de1f-49d3-e053-2a95a90a5285	68001-334	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170801		ANDA	ANDA077321	BluePoint Laboratories	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-335_c5fac2c4-de1f-49d3-e053-2a95a90a5285	68001-335	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170801		ANDA	ANDA077321	BluePoint Laboratories	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-336_c5fac2c4-de1f-49d3-e053-2a95a90a5285	68001-336	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170801		ANDA	ANDA077321	BluePoint Laboratories	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-337_c5fac2c4-de1f-49d3-e053-2a95a90a5285	68001-337	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170801	20240531	ANDA	ANDA077321	BluePoint Laboratories	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
68001-342_049982fe-a321-b868-e063-6294a90ae861	68001-342	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20180525		NDA	NDA209604	BluePoint Laboratories	GEMCITABINE HYDROCHLORIDE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-345_e9b9ead5-4033-1599-e053-2a95a90a0d81	68001-345	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20180216		ANDA	ANDA208657	BluePoint Laboratories	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
68001-348_049982fe-a321-b868-e063-6294a90ae861	68001-348	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20180525		NDA	NDA209604	BluePoint Laboratories	GEMCITABINE HYDROCHLORIDE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-355_b82975b4-1974-1bd4-e053-2a95a90a3ea2	68001-355	HUMAN PRESCRIPTION DRUG	Palonosetron		Palonosetron	INJECTION, SOLUTION	INTRAVENOUS	20180530		ANDA	ANDA201533	BluePoint Laboratories	PALONOSETRON HYDROCHLORIDE	.05	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68001-356_074cfb96-6fea-5f8d-e063-6394a90af30b	68001-356	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180629		ANDA	ANDA204106	BluePoint Laboratories	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-357_074cfb96-6fea-5f8d-e063-6394a90af30b	68001-357	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180629		ANDA	ANDA204106	BluePoint Laboratories	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-358_074cfb96-6fea-5f8d-e063-6394a90af30b	68001-358	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180629		ANDA	ANDA204106	BluePoint Laboratories	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-359_049982fe-a321-b868-e063-6294a90ae861	68001-359	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE	INJECTION, SOLUTION	INTRAVENOUS	20180525		NDA	NDA209604	BluePoint Laboratories	GEMCITABINE HYDROCHLORIDE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-360_074cfb96-6fea-5f8d-e063-6394a90af30b	68001-360	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180629		ANDA	ANDA204106	BluePoint Laboratories	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-361_d9dbbe03-bcc4-1af7-e053-2a95a90a8053	68001-361	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET	ORAL	20180629		ANDA	ANDA203366	BluePoint Laboratories	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68001-362_f80ad981-4642-03d3-e053-6394a90ab137	68001-362	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20180801		ANDA	ANDA065434	BluePoint Laboratories	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68001-363_030b1ad6-14e0-b4c7-e063-6394a90a344a	68001-363	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180914	20271031	ANDA	ANDA203814	BluePoint Laboratories	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
68001-364_0ad12b8f-9b4b-2e7b-e063-6294a90a0060	68001-364	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20180801		ANDA	ANDA203458	BluePoint Laboratories	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68001-365_0ad12b8f-9b4b-2e7b-e063-6294a90a0060	68001-365	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20180801		ANDA	ANDA203458	BluePoint Laboratories	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68001-367_83d51a49-303a-40a3-ba48-43c45dc865cb	68001-367	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20180630		ANDA	ANDA203562	BluePoint Laboratories	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68001-368_d94f166d-9bf8-640c-e053-2a95a90ac8b5	68001-368	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20180521		ANDA	ANDA203088	BluePoint Laboratories	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-373_9498fa14-1614-4a8e-b872-41c11745b01e	68001-373	HUMAN PRESCRIPTION DRUG	Isosorbide		Isosorbide Dinitrate	TABLET	ORAL	20181130		ANDA	ANDA086067	BluePoint Laboratories	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68001-374_9498fa14-1614-4a8e-b872-41c11745b01e	68001-374	HUMAN PRESCRIPTION DRUG	Isosorbide		Isosorbide Dinitrate	TABLET	ORAL	20181130		ANDA	ANDA086066	BluePoint Laboratories	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68001-375_9498fa14-1614-4a8e-b872-41c11745b01e	68001-375	HUMAN PRESCRIPTION DRUG	Isosorbide		Isosorbide Dinitrate	TABLET	ORAL	20181130		ANDA	ANDA088088	BluePoint Laboratories	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68001-376_fd7800e8-666c-e036-e053-6394a90af158	68001-376	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190501		ANDA	ANDA208375	BluePoint Laboratories	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
68001-377_faf3de2a-e9da-091a-e053-6394a90ae498	68001-377	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20190226		ANDA	ANDA090801	BluePoint Laboratories	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
68001-378_faf3de2a-e9da-091a-e053-6394a90ae498	68001-378	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20190226		ANDA	ANDA090801	BluePoint Laboratories	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
68001-381_ffac2849-40b6-4e5b-e053-6394a90ae38b	68001-381	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190218		ANDA	ANDA207743	BluePoint Laboratories Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-382_ffac2849-40b6-4e5b-e053-6394a90ae38b	68001-382	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190218		ANDA	ANDA207743	BluePoint Laboratories Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-383_ffac2849-40b6-4e5b-e053-6394a90ae38b	68001-383	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190218		ANDA	ANDA207743	BluePoint Laboratories Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-384_ad020393-1c97-49da-b0f3-d6a9359fb73d	68001-384	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20190514		ANDA	ANDA201722	BluePoint Labortories	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68001-385_ad020393-1c97-49da-b0f3-d6a9359fb73d	68001-385	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20190514		ANDA	ANDA201722	BluePoint Labortories	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68001-386_ad020393-1c97-49da-b0f3-d6a9359fb73d	68001-386	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20190514		ANDA	ANDA201722	BluePoint Labortories	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68001-387_bc911a86-8c91-c2bf-e053-2995a90adc9a	68001-387	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20190618		ANDA	ANDA073449	BluePoint Laboratories	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68001-388_bc911a86-8c91-c2bf-e053-2995a90adc9a	68001-388	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20190618		ANDA	ANDA071851	BluePoint Laboratories	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68001-389_c455e123-6115-d234-e053-2995a90a2e93	68001-389	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190514		ANDA	ANDA064144	BluePoint Laboratories	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-390_c455e123-6115-d234-e053-2995a90a2e93	68001-390	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190514		ANDA	ANDA064144	BluePoint Laboratories	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-391_c455e123-6115-d234-e053-2995a90a2e93	68001-391	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190514		ANDA	ANDA064144	BluePoint Laboratories	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-396_431ff2ef-567c-4b60-af43-f4da61febaad	68001-396	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20190703		ANDA	ANDA202868	BluePoint Laboratories	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68001-397_bfda441a-c4ae-7bf3-e053-2a95a90adfe2	68001-397	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA206530	BluePoint Laboratories	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68001-398_bfda441a-c4ae-7bf3-e053-2a95a90adfe2	68001-398	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA206530	BluePoint Laboratories	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68001-399_0c3d632c-6b3e-4e78-e063-6394a90a7ed2	68001-399	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190619		ANDA	ANDA078619	BluePoint Laboratories	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68001-400_0c3d632c-6b3e-4e78-e063-6394a90a7ed2	68001-400	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190619		ANDA	ANDA078619	BluePoint Laboratories	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68001-401_0c3d632c-6b3e-4e78-e063-6394a90a7ed2	68001-401	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190619		ANDA	ANDA078619	BluePoint Laboratories	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68001-402_0cef3a12-0ac4-84a5-e063-6294a90aa534	68001-402	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA078993	BluePoint Laboratories	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-403_0cef3a12-0ac4-84a5-e063-6294a90aa534	68001-403	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA078993	BluePoint Laboratories	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-404_0cef3a12-0ac4-84a5-e063-6294a90aa534	68001-404	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA078993	BluePoint Laboratories	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-405_0cef3a12-0ac4-84a5-e063-6294a90aa534	68001-405	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190619		ANDA	ANDA078993	BluePoint Laboratories	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-406_e94323bb-8135-b34a-e053-2995a90a7ab8	68001-406	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190823		ANDA	ANDA204125	BluePoint Laboratories	VANCOMYCIN HYDROCHLORIDE	5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68001-407_e94323bb-8135-b34a-e053-2995a90a7ab8	68001-407	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190823		ANDA	ANDA204125	BluePoint Laboratories	VANCOMYCIN HYDROCHLORIDE	10	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68001-408_dee246ba-86a4-14ad-e053-2a95a90a3872	68001-408	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190829		ANDA	ANDA207647	BluePoint Laboratories	ERTAPENEM SODIUM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
68001-411_c065a8d4-58d2-a61d-e053-2995a90a496c	68001-411	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20190930		ANDA	ANDA077662	BluePoint Laboratories	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-412_c065a8d4-58d2-a61d-e053-2995a90a496c	68001-412	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20190930		ANDA	ANDA077662	BluePoint Laboratories	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68001-413_075a8a7e-036d-b980-e063-6294a90a0bd9	68001-413	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20190930		ANDA	ANDA090778	BluePoint	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-414_075a8a7e-036d-b980-e063-6294a90a0bd9	68001-414	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20190930		ANDA	ANDA090778	BluePoint	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-415_075a8a7e-036d-b980-e063-6294a90a0bd9	68001-415	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20190930		ANDA	ANDA090778	BluePoint	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-416_d5ee26ca-d963-687f-e053-2a95a90a2a50	68001-416	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190926		ANDA	ANDA089717	BluePoint Laboratories	LEUCOVORIN CALCIUM	100	mg/10mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
68001-417_d5ee26ca-d963-687f-e053-2a95a90a2a50	68001-417	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190926		ANDA	ANDA040056	BluePoint Laboratories	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
68001-418_d5ee26ca-d963-687f-e053-2a95a90a2a50	68001-418	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		Leucovorin Calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190926		ANDA	ANDA040335	BluePoint Laboratories	LEUCOVORIN CALCIUM	350	mg/17.5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
68001-421_46edae30-d50c-4112-9941-954b13ed5eda	68001-421	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191120		ANDA	ANDA205020	BluePoint Laboratories	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
68001-422_a7794bc8-15c1-420b-9018-08f7da3faf8f	68001-422	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191021		ANDA	ANDA206033	BluePoint Laboratories	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-423_559f763c-db04-47b2-90ff-d820b2070c3c	68001-423	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20191113		ANDA	ANDA208516	BluePoint Laboratories	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68001-427_ed27c30d-c83a-45af-9c47-807da858d696	68001-427	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200710		ANDA	ANDA213185	Bluepoint Laboratories	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68001-428_cc2d4071-5469-2766-e053-2995a90ad84d	68001-428	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200228		ANDA	ANDA091604	BluePoint Laboratories	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-429_cc2d4071-5469-2766-e053-2995a90ad84d	68001-429	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200228		ANDA	ANDA091604	BluePoint Laboratories	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-430_cc2d4071-5469-2766-e053-2995a90ad84d	68001-430	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200228		ANDA	ANDA091604	BluePoint Laboratories	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-431_cc2d4071-5469-2766-e053-2995a90ad84d	68001-431	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20200228		ANDA	ANDA091604	BluePoint Laboratories	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-432_005c2736-055a-e29c-e063-6294a90aa8bb	68001-432	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200622		ANDA	ANDA074612	BluePoint Laboratories	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68001-433_005c2736-055a-e29c-e063-6294a90aa8bb	68001-433	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190111		ANDA	ANDA074612	BluePoint Laboratories	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68001-434_005c2736-055a-e29c-e063-6294a90aa8bb	68001-434	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200622		ANDA	ANDA074612	BluePoint Laboratories	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68001-435_fc5ea996-1c49-8d51-e053-6394a90a406b	68001-435	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20200618	20250331	ANDA	ANDA209179	BluePoint Laboratories	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
68001-436_c8455ce1-5b5b-3b17-e053-2995a90a7116	68001-436	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA090760	BluePoint Laboratories	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68001-437_0179cc91-4a11-1cc0-e063-6294a90a6c1e	68001-437	HUMAN PRESCRIPTION DRUG	Zoledronic acid		zoledronic acid	INJECTION	INTRAVENOUS	20200629		ANDA	ANDA205279	BluePoint Laboratories	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68001-438_e1e021de-1501-2fe3-e053-2a95a90a7be9	68001-438	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20200826		ANDA	ANDA208314	BluePoint Laboratories	LORATADINE	10	mg/1			N	20241231
68001-439_bd31cd71-9281-7667-e053-2995a90a4ac0	68001-439	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA076502	BluePoint Laboratories	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68001-440_bd31cd71-9281-7667-e053-2995a90a4ac0	68001-440	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA076502	BluePoint Laboratories	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68001-441_0486dc89-1bf1-8e37-e063-6394a90a9aa7	68001-441	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200619		ANDA	ANDA207740	BluePoint Laboratories	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68001-442_d7e97b99-83db-42d0-8521-b87fe6467a67	68001-442	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20201019		ANDA	ANDA040745	BluePoint Laboratories	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-443_d7e97b99-83db-42d0-8521-b87fe6467a67	68001-443	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20201019		ANDA	ANDA040745	BluePoint Laboratories	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-444_d7e97b99-83db-42d0-8521-b87fe6467a67	68001-444	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20201019		ANDA	ANDA040745	BluePoint Laboratories	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-445_83d51a49-303a-40a3-ba48-43c45dc865cb	68001-445	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20201002		ANDA	ANDA203562	BluePoint Laboratories	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68001-446_ed0cf790-40f6-54a3-e053-2a95a90a402b	68001-446	HUMAN PRESCRIPTION DRUG	MEROPENEM		MEROPENEM	INJECTION	INTRAVENOUS	20200831		ANDA	ANDA206086	BluePoint Laboratories	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
68001-449_ab820f80-b5fd-7896-e053-2995a90a4b1c	68001-449	HUMAN OTC DRUG	Loratadine		Loratadine Oral	SOLUTION	ORAL	20200731		ANDA	ANDA208931	BluePoint Laboratories	LORATADINE	5	mg/5mL			N	20241231
68001-450_0cf5a688-deb4-25ab-e063-6394a90ae92f	68001-450	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20200831		ANDA	ANDA204117	BluePoint Laboratories	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-451_0cf5a688-deb4-25ab-e063-6394a90ae92f	68001-451	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20200831		ANDA	ANDA204117	BluePoint Laboratories	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-452_0cf5a688-deb4-25ab-e063-6394a90ae92f	68001-452	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20200831		ANDA	ANDA204117	BluePoint Laboratories	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-453_0cf5a688-deb4-25ab-e063-6394a90ae92f	68001-453	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20200831		ANDA	ANDA204117	BluePoint Laboratories	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-454_04859621-7cb6-1883-e063-6294a90aba83	68001-454	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA202389	BluePoint Laboratories	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68001-455_04859621-7cb6-1883-e063-6294a90aba83	68001-455	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA202389	BluePoint Laboratories	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68001-456_04859621-7cb6-1883-e063-6294a90aba83	68001-456	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20201001		ANDA	ANDA202389	BluePoint Laboratories	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68001-457_018c897c-b446-14d9-e063-6294a90a35ce	68001-457	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20201019		ANDA	ANDA076684	BluePoint Laboratories	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-458_018c897c-b446-14d9-e063-6294a90a35ce	68001-458	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20201019		ANDA	ANDA076684	BluePoint Laboratories	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-459_018c897c-b446-14d9-e063-6294a90a35ce	68001-459	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20201019		ANDA	ANDA076684	BluePoint Laboratories	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-460_018c897c-b446-14d9-e063-6294a90a35ce	68001-460	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20201019		ANDA	ANDA076684	BluePoint Laboratories	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-461_018c897c-b446-14d9-e063-6294a90a35ce	68001-461	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20201019		ANDA	ANDA076684	BluePoint Laboratories	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-462_018c897c-b446-14d9-e063-6294a90a35ce	68001-462	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20201019		ANDA	ANDA076684	BluePoint Laboratories	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-463_018c897c-b446-14d9-e063-6294a90a35ce	68001-463	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin sodium	INJECTION	SUBCUTANEOUS	20201019		ANDA	ANDA076684	BluePoint Laboratories	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-464_018c897c-b446-14d9-e063-6294a90a35ce	68001-464	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		enoxaparin sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20201019		ANDA	ANDA208600	BluePoint Laboratories	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68001-465_e9578b64-a477-8510-e053-2a95a90a3677	68001-465	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20201130		ANDA	ANDA204107	BluePoint Laboratories	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68001-466_e9578b64-a477-8510-e053-2a95a90a3677	68001-466	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20201130		ANDA	ANDA204107	BluePoint Laboratories	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68001-467_e9ba265a-7e83-d2d5-e053-2995a90a94be	68001-467	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201007		ANDA	ANDA212667	BluePoint Laboratories	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
68001-468_091ba34a-a181-7f31-e063-6294a90a92b6	68001-468	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20201209		ANDA	ANDA204368	BluePoint Laboratories	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68001-469_026a8092-9638-f54d-e063-6294a90ab055	68001-469	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230804		ANDA	ANDA207465	BluePoint Laboratories	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-470_026a8092-9638-f54d-e063-6294a90ab055	68001-470	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230804		ANDA	ANDA207465	BluePoint Laboratories	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-471_026a8092-9638-f54d-e063-6294a90ab055	68001-471	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230804		ANDA	ANDA207465	BluePoint Laboratories	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-472_092ed157-3a22-edce-e063-6394a90a9347	68001-472	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20210120		ANDA	ANDA079163	BluePoint Laboratories	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68001-473_092ed157-3a22-edce-e063-6394a90a9347	68001-473	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20210120		ANDA	ANDA079163	BluePoint Laboratories	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68001-474_092ed157-3a22-edce-e063-6394a90a9347	68001-474	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20210120		ANDA	ANDA079163	BluePoint Laboratories	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68001-475_097d120f-44a3-3b38-e063-6294a90a8e70	68001-475	HUMAN OTC DRUG	Antifungal Cream		antifungal	CREAM	TOPICAL	20201125		OTC MONOGRAPH DRUG	M005	BluePoint Laboratories	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68001-476_09bb7522-4299-8c71-e063-6294a90a0c24	68001-476	HUMAN OTC DRUG	Hydrocortisone		Antipruritic (Anti-Itch)	CREAM	TOPICAL	20201127		OTC MONOGRAPH DRUG	M017	BluePoint Laboratories	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68001-477_097d4e93-7f8a-53f8-e063-6294a90a4e40	68001-477	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20201124		OTC MONOGRAPH DRUG	M004	BluePoint Laboratories	BACITRACIN	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
68001-480_0904e574-8e86-f26a-e063-6394a90afc0b	68001-480	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloide		Irinotecan hydrochloide	INJECTION	INTRAVENOUS	20201214		ANDA	ANDA212993	BluePoint Laboratories	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
68001-481_097d4e93-7f8b-53f8-e063-6294a90a4e40	68001-481	HUMAN OTC DRUG	Antifungal Cream		antifungal	CREAM	TOPICAL	20201201		OTC MONOGRAPH DRUG	M005	BluePoint Laboratories	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68001-483_cd98812b-017d-2cd2-e053-2a95a90a38ce	68001-483	HUMAN OTC DRUG	Triple Antibiotic		First Aid Antibiotic	OINTMENT	TOPICAL	20210615		OTC MONOGRAPH FINAL	part333B	BluePoint Laboratories	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68001-484_bc7b4ee7-68bf-7d53-e053-2995a90adf7a	68001-484	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20210301		ANDA	ANDA210044	BluePoint Laboratories	FULVESTRANT	250	mg/5mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68001-485_edfec650-2a20-127b-e053-2a95a90a7909	68001-485	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20210531		ANDA	ANDA207466	BluePoint Laboratories	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
68001-486_c5fac2c4-de1f-49d3-e053-2a95a90a5285	68001-486	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210501		ANDA	ANDA077321	BluePoint Laboratories	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68001-487_fcfd1ff2-e3d6-dfff-e053-6394a90ababe	68001-487	HUMAN PRESCRIPTION DRUG	CAPECITABINE		CAPECITABINE	TABLET, FILM COATED	ORAL	20210222		ANDA	ANDA202593	BluePoint Laboratories	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-488_fcfd1ff2-e3d6-dfff-e053-6394a90ababe	68001-488	HUMAN PRESCRIPTION DRUG	CAPECITABINE		CAPECITABINE	TABLET, FILM COATED	ORAL	20210222		ANDA	ANDA202593	BluePoint Laboratories	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-489_eff3dbbc-8671-82f5-e053-2995a90a5650	68001-489	HUMAN PRESCRIPTION DRUG	Abiraterone		Abiraterone acetate	TABLET	ORAL	20190710		ANDA	ANDA210686	BluePoint Laboratories	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
68001-490_05c9d227-d639-916a-e063-6294a90a66a6	68001-490	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20210326		ANDA	ANDA078340	BluePoint Laboratories	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
68001-491_05c9d227-d639-916a-e063-6294a90a66a6	68001-491	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20210326		ANDA	ANDA078340	BluePoint Laboratories	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
68001-492_e4156e36-ac31-100a-e053-2a95a90a3b28	68001-492	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20210531		ANDA	ANDA203263	BluePoint Laboratories	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
68001-493_e4156e36-ac31-100a-e053-2a95a90a3b28	68001-493	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20210531		ANDA	ANDA203263	BluePoint Laboratories	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
68001-494_f79353ac-03fd-35b1-e053-6394a90a86ae	68001-494	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20210407		ANDA	ANDA206531	BluePoint Laboratories	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68001-495_04895d7d-bcce-be52-e063-6294a90a3c13	68001-495	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20210430		ANDA	ANDA207229	BluePoint Laboratories	ACETAMINOPHEN	650	mg/1			N	20241231
68001-496_0abf5ab9-eab6-5399-e063-6394a90afd3d	68001-496	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA214419	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-497_0abf5ab9-eab6-5399-e063-6394a90afd3d	68001-497	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA214419	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-498_0abf5ab9-eab6-5399-e063-6394a90afd3d	68001-498	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA214419	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-499_0abf5ab9-eab6-5399-e063-6394a90afd3d	68001-499	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA214419	BluePoint Laboratories	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-501_041e82dd-5b9b-11e0-e063-6294a90aca1a	68001-501	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210514		ANDA	ANDA211143	BluePoint Laboratories	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-502_041e82dd-5b9b-11e0-e063-6294a90aca1a	68001-502	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210514		ANDA	ANDA211143	BluePoint Laboratories	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-503_041e82dd-5b9b-11e0-e063-6294a90aca1a	68001-503	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210514		ANDA	ANDA211143	BluePoint Laboratories	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68001-504_c32554cb-be86-d0d7-e053-2995a90a63a0	68001-504	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20210611		ANDA	ANDA207234	BluePoint Laboratories	AZACITIDINE	100	mg/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-505_cc6e2865-14e2-1ac7-e053-2a95a90acbc0	68001-505	HUMAN OTC DRUG	Polyethylene Glycol		Polyethylene Glycol	POWDER, FOR SUSPENSION	ORAL	20210618		ANDA	ANDA091077	BluePoint Laboratories	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68001-506_f6f25265-14ee-d127-e053-6294a90aaef9	68001-506	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210811		ANDA	ANDA204959	BluePoint Laboratories	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68001-507_f6f25265-14ee-d127-e053-6294a90aaef9	68001-507	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210811		ANDA	ANDA204959	BluePoint Laboratories	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68001-508_f6f25265-14ee-d127-e053-6294a90aaef9	68001-508	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		PIPERACILLIN and TAZOBACTAM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210811		ANDA	ANDA204959	BluePoint Laboratories	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68001-511_e27efdd5-c194-4d18-e053-2995a90a00ca	68001-511	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20210831		ANDA	ANDA206252	Bluepoint Laboratories	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-512_e17da200-0b22-7fcb-e053-2995a90a6c42	68001-512	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20210831		ANDA	ANDA090681	Bluepoint Laboratories	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-513_e17da200-0b22-7fcb-e053-2995a90a6c42	68001-513	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20210831		ANDA	ANDA090681	Bluepoint Laboratories	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-514_e17da200-0b22-7fcb-e053-2995a90a6c42	68001-514	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20210831		ANDA	ANDA090681	Bluepoint Laboratories	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-515_e17da200-0b22-7fcb-e053-2995a90a6c42	68001-515	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20210831		ANDA	ANDA090681	Bluepoint Laboratories	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-516_cbe23a20-0e83-78c3-e053-2a95a90aadd6	68001-516	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20210914		ANDA	ANDA213434	BluePoint Laboratories	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68001-517_0a0bdefc-0b9e-682e-e063-6394a90abfbb	68001-517	HUMAN PRESCRIPTION DRUG	fosaprepitant		fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210823	20240731	ANDA	ANDA212309	BluePoint Laboratories	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	
68001-518_eb3aa568-41e1-6c36-e053-2a95a90aa33a	68001-518	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210910		ANDA	ANDA210921	BluePoint Laboratories	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68001-519_e1004b2a-885b-6778-e053-2995a90ad809	68001-519	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211213		ANDA	ANDA210497	BluePoint Laboratories	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68001-520_e1004b2a-885b-6778-e053-2995a90ad809	68001-520	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211213		ANDA	ANDA210497	BluePoint Laboratories	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68001-521_fcff74f6-9432-d82c-e053-6394a90a8cfe	68001-521	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20220912		ANDA	ANDA209179	BluePoint Laboratories	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68001-522_e4b34fb8-f651-8d00-e053-2995a90a3d2a	68001-522	HUMAN PRESCRIPTION DRUG	FULVESTRANT		Fulvestrant	INJECTION	INTRAMUSCULAR	20211029		ANDA	ANDA211689	BluePoint Laboratories	FULVESTRANT	250	mg/5mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68001-523_f9242039-4c1c-8cd3-e053-6394a90ad325	68001-523	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant dimeglumine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220202		ANDA	ANDA214616	BluePoint Laboratories	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
68001-524_08b153f7-c264-c73d-e063-6394a90ac32c	68001-524	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20220218		ANDA	ANDA210123	BluePoint Laboratories	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-525_08b17a1c-be31-5176-e063-6294a90afa60	68001-525	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20220218		ANDA	ANDA210124	BluePoint Laboratories	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-526_09bb81fa-759d-b1b7-e063-6394a90aa2c8	68001-526	HUMAN OTC DRUG	Hydrocortisone		Antipruritic (Anti-Itch)	OINTMENT	TOPICAL	20230517		OTC MONOGRAPH DRUG	M017	BluePoint Laboratories	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68001-527_f9d76f6d-c0e1-3242-e053-6394a90aea12	68001-527	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220215		ANDA	ANDA207475	BluePoint Laboratories	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-528_097bfb09-4450-bd70-e063-6294a90a91b7	68001-528	HUMAN OTC DRUG	Meclizine HCl		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20220314		OTC MONOGRAPH DRUG	M009	BluePoint Laboratories	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68001-529_d9cb1c58-4dee-7fe4-e053-2995a90a2dce	68001-529	HUMAN OTC DRUG	Meclizine HCl		MECLIZINE HYDROCHLORIDE CHEWABLE	TABLET, CHEWABLE	ORAL	20220314		OTC MONOGRAPH FINAL	part336	BluePoint Laboratories	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68001-530_dbd299b7-11c8-bf59-e053-2a95a90a2cd4	68001-530	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20220408		ANDA	ANDA209995	BluePoint Laboratories	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
68001-531_097e2efb-9a02-c6e6-e063-6294a90a6d7d	68001-531	HUMAN OTC DRUG	Bacitracin Zinc		First Aid Antibiotic	OINTMENT	TOPICAL	20220304		OTC MONOGRAPH DRUG	M004	BluePoint Laboratories	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
68001-532_097e3a92-864a-aef4-e063-6294a90abcf3	68001-532	HUMAN OTC DRUG	Zinc Oxide		Skin Protectant	OINTMENT	TOPICAL	20220324		OTC MONOGRAPH DRUG	M016	BluePoint Laboratories	ZINC OXIDE	20	g/100g			N	20241231
68001-533_097e3a92-864a-aef4-e063-6294a90abcf3	68001-533	HUMAN OTC DRUG	Zinc Oxide		Skin Protectant	OINTMENT	TOPICAL	20220324		OTC MONOGRAPH DRUG	M016	BluePoint Laboratories	ZINC OXIDE	20	g/100g			N	20241231
68001-534_0c4eaa04-b344-eb58-e063-6394a90a99b9	68001-534	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220731		ANDA	ANDA212958	BluePoint Laboratories	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
68001-535_044d8cd9-3d5c-5c5e-e063-6394a90a3bbf	68001-535	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220704		ANDA	ANDA214632	BluePoint Laboratories	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-536_044d8cd9-3d5c-5c5e-e063-6394a90a3bbf	68001-536	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220704		ANDA	ANDA214632	BluePoint Laboratories	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-538_eed98f1e-acdf-28da-e053-2a95a90a046c	68001-538	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220624		ANDA	ANDA204890	BluePoint Laboratories	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-539_eed98f1e-acdf-28da-e053-2a95a90a046c	68001-539	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220624		ANDA	ANDA204890	BluePoint Laboratories	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-540_df1f04a5-b5bc-73e6-e053-2a95a90aa6d4	68001-540	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220516		ANDA	ANDA210824	BluePoint Laboratories	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
68001-541_e6591c11-be30-dd6f-e053-2995a90a766e	68001-541	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220731		ANDA	ANDA209622	BluePoint Laboratories	BORTEZOMIB	3.5	mg/3.5mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
68001-542_fab6a2d8-d9a0-2f8f-e053-6394a90a22bc	68001-542	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION, SOLUTION	SUBCUTANEOUS	20220624		ANDA	ANDA080737	BluePoint Laboratories	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
68001-543_0759eb55-d7ae-c87a-e063-6394a90abe08	68001-543	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA203774	BluePoint Laboratories	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-544_0759eb55-d7ae-c87a-e063-6394a90abe08	68001-544	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220901		ANDA	ANDA203774	BluePoint Laboratories	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-545_fa3ecbbb-86e6-6fca-e053-6394a90a56d9	68001-545	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230228		ANDA	ANDA209851	BluePoint Laboratories	PEMETREXED DISODIUM	750	mg/30mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-546_fa3ecbbb-86e3-6fca-e053-6394a90a56d9	68001-546	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230228		ANDA	ANDA209085	BluePoint Laboratories	PEMETREXED DISODIUM	1000	mg/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68001-557_f651b076-b79f-67b7-e053-2995a90a8883	68001-557	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230131		ANDA	ANDA040189	BluePoint Laboratories	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68001-558_f651b076-b79f-67b7-e053-2995a90a8883	68001-558	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230131		ANDA	ANDA040189	BluePoint Laboratories	METHYLPREDNISOLONE	8	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68001-559_f651b076-b79f-67b7-e053-2995a90a8883	68001-559	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230131		ANDA	ANDA040189	BluePoint Laboratories	METHYLPREDNISOLONE	16	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68001-560_f651b076-b79f-67b7-e053-2995a90a8883	68001-560	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230131		ANDA	ANDA040189	BluePoint Laboratories	METHYLPREDNISOLONE	32	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68001-561_0c4ee6ca-2596-fbd2-e063-6394a90a0806	68001-561	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230315		ANDA	ANDA210453	BluePoint Laboratories	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68001-562_0486c8f3-a2d5-6f54-e063-6394a90aaf65	68001-562	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20230805		ANDA	ANDA213057	BluePoint Laboratories	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68001-564_ff47bfa2-6c28-88b0-e053-6394a90a390d	68001-564	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20230410		NDA	NDA212501	BluePoint Laboratories	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-565_ff47bfa2-6c28-88b0-e053-6394a90a390d	68001-565	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20230410		NDA	NDA212501	BluePoint Laboratories	CYCLOPHOSPHAMIDE ANHYDROUS	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-566_fa3ed776-4bcf-2292-e053-6394a90acc37	68001-566	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Bluepoint Laboratories	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68001-567_fa3ed776-4bcf-2292-e053-6394a90acc37	68001-567	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Bluepoint Laboratories	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68001-568_044a8f50-14be-fb1d-e063-6294a90a3128	68001-568	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230824		ANDA	ANDA209686	BluePoint Laboratories	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68001-570_0c79f8ea-d825-669b-e063-6294a90af284	68001-570	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20230728		ANDA	ANDA208706	BluePoint Laboratories	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-571_0439dae6-d478-6f5d-e063-6294a90ad082	68001-571	HUMAN PRESCRIPTION DRUG	bendamustine hydrochloride		bendamustine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230915		ANDA	ANDA205574	BluePoint Laboratories	BENDAMUSTINE HYDROCHLORIDE	25	mg/5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-572_0439dae6-d478-6f5d-e063-6294a90ad082	68001-572	HUMAN PRESCRIPTION DRUG	bendamustine hydrochloride		bendamustine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230915		ANDA	ANDA205574	BluePoint Laboratories	BENDAMUSTINE HYDROCHLORIDE	100	mg/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68001-573_fc96fe77-06cc-dc04-e053-6394a90a99da	68001-573	HUMAN PRESCRIPTION DRUG	DECITABINE		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230523		ANDA	ANDA210984	BluePoint Laboratories	DECITABINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68001-574_02150d95-2c55-cd5b-e063-6394a90aafad	68001-574	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20230803		ANDA	ANDA077414	BluePoint Laboratories	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
68001-575_02150d95-2c55-cd5b-e063-6394a90aafad	68001-575	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20230803		ANDA	ANDA077414	BluePoint Laboratories	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
68001-578_048557ea-f859-f0f2-e063-6294a90af5ab	68001-578	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20230915		ANDA	ANDA209101	BluePoint Laboratories	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
68001-579_048557ea-f859-f0f2-e063-6294a90af5ab	68001-579	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20230915		ANDA	ANDA209101	BluePoint Laboratories	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
68001-580_048557ea-f859-f0f2-e063-6294a90af5ab	68001-580	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20230731		ANDA	ANDA209101	BluePoint Laboratories	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
68001-581_048557ea-f859-f0f2-e063-6294a90af5ab	68001-581	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20230729		ANDA	ANDA209101	BluePoint Laboratories	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
68001-582_048557ea-f859-f0f2-e063-6294a90af5ab	68001-582	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20230811		ANDA	ANDA209101	BluePoint Laboratories	HALOPERIDOL DECANOATE	500	mg/5mL	Typical Antipsychotic [EPC]		N	20241231
68001-584_03fee4f3-ec4d-6a59-e063-6294a90af81f	68001-584	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230901		ANDA	ANDA091220	BluePoint Laboratories	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68001-585_03fee4f3-ec4d-6a59-e063-6294a90af81f	68001-585	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230901		ANDA	ANDA091220	BluePoint Laboratories	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68001-586_03fee4f3-ec4d-6a59-e063-6294a90af81f	68001-586	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230901		ANDA	ANDA091220	BluePoint Laboratories	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68001-591_0e0999cb-ab1b-1090-e063-6294a90a4e10	68001-591	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20231218		ANDA	ANDA078032	BluePoint Laboratories	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
68001-592_0e0999cb-ab1b-1090-e063-6294a90a4e10	68001-592	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20231214		ANDA	ANDA078032	BluePoint Laboratories	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
68001-593_0e0999cb-ab1b-1090-e063-6294a90a4e10	68001-593	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20231213		ANDA	ANDA078032	BluePoint Laboratories	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
68001-594_0c79f8ea-d825-669b-e063-6294a90af284	68001-594	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20230728		ANDA	ANDA208706	BluePoint Laboratories	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-595_0c79f8ea-d825-669b-e063-6294a90af284	68001-595	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20230728		ANDA	ANDA208706	BluePoint Laboratories	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-596_0c79f8ea-d825-669b-e063-6294a90af284	68001-596	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20230728		ANDA	ANDA208706	BluePoint Laboratories	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68001-597_030b1ad6-14e0-b4c7-e063-6394a90a344a	68001-597	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20230612		ANDA	ANDA203814	BluePoint Laboratories	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68001-598_0c7b3362-937a-5adb-e063-6394a90a0417	68001-598	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA215478	BluePoint Laboratories	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-599_0c7b3362-937a-5adb-e063-6394a90a0417	68001-599	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA215478	BluePoint Laboratories	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-600_0c7b3362-937a-5adb-e063-6394a90a0417	68001-600	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA215478	BluePoint Laboratories	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-601_0c7b3362-937a-5adb-e063-6394a90a0417	68001-601	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA215478	BluePoint Laboratories	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-602_0c7b3362-937a-5adb-e063-6394a90a0417	68001-602	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA215478	BluePoint Laboratories	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68001-603_097a3e7d-7d8f-7408-e063-6394a90afa2e	68001-603	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20231011		ANDA	ANDA217272	BluePoint Laboratories	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68001-604_097a3e7d-7d8f-7408-e063-6394a90afa2e	68001-604	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20231011		ANDA	ANDA217272	BluePoint Laboratories	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68001-605_097a3e7d-7d8f-7408-e063-6394a90afa2e	68001-605	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20231009		ANDA	ANDA217272	BluePoint Laboratories	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68001-606_066bf698-db0f-ad6a-e063-6394a90aa241	68001-606	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20231015		ANDA	ANDA217357	BluePoint Laboratories	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68001-607_02e390df-256e-ffd8-e063-6394a90a2557	68001-607	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20231001		ANDA	ANDA214990	BluePoint Laboratories	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68001-608_0c3ef530-de61-73f7-e063-6294a90a9973	68001-608	HUMAN PRESCRIPTION DRUG	CISPLATIN		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20240101		ANDA	ANDA207323	BluePoint Laboratories	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68001-609_0c3ef530-de61-73f7-e063-6294a90a9973	68001-609	HUMAN PRESCRIPTION DRUG	CISPLATIN		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20240101		ANDA	ANDA207323	BluePoint Laboratories	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68001-610_0df64ea3-a332-2aae-e063-6294a90ae888	68001-610	HUMAN PRESCRIPTION DRUG	Zoledronic acid		Zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20240105		ANDA	ANDA201783	BluePoint Laboratories	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20251231
68007-300_d834e9cf-710c-4717-ab34-a459b5046f65	68007-300	HUMAN OTC DRUG	GUTONG TIEGAO PAIN RELIEVING		CAMPHOR AND MENTHOL	PATCH	TOPICAL	20160414		OTC MONOGRAPH NOT FINAL	part348	GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); MENTHOL	43.9; 18.8	mg/1; mg/1			N	20241231
68007-301_c2356d8a-03cb-4fa0-96d2-cb39ba9ea9da	68007-301	HUMAN OTC DRUG	GUTONG TIEGAO PAIN RELIEVING		Camphor and Menthol	PATCH	TOPICAL	20160413		OTC MONOGRAPH NOT FINAL	part348	GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD	CAMPHOR (SYNTHETIC); MENTHOL	248; 100	mg/1; mg/1			N	20241231
68007-400_b1abe042-4a8d-4d52-8aed-ccee346e84c2	68007-400	HUMAN OTC DRUG	Gutong Tiegao Pain Relieving		Menthol	PLASTER	TRANSDERMAL	20210510		OTC MONOGRAPH NOT FINAL	part348	GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD	MENTHOL	35	mg/1			N	20241231
68007-402_e67d86e0-712b-4f5b-87a9-d412051658e0	68007-402	HUMAN OTC DRUG	Zhuanggu Gao Pain Relieving		Menthol	PLASTER	TRANSDERMAL	20210510		OTC MONOGRAPH NOT FINAL	part348	GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD	MENTHOL	35	mg/1			N	20241231
68007-403_20abe324-92bc-4614-92b6-78da36a0087b	68007-403	HUMAN OTC DRUG	Zhuifeng Gao Pain Relieving		Menthol	PLASTER	TRANSDERMAL	20210511		OTC MONOGRAPH NOT FINAL	part348	GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD	MENTHOL	35	mg/1			N	20241231
68012-002_039bd4a8-cf35-4946-8079-ca0aef70b829	68012-002	HUMAN PRESCRIPTION DRUG	Glumetza		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060801		NDA	NDA021748	Santarus, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68012-003_039bd4a8-cf35-4946-8079-ca0aef70b829	68012-003	HUMAN PRESCRIPTION DRUG	Glumetza		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080617		NDA	NDA021748	Santarus, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68012-004_039bd4a8-cf35-4946-8079-ca0aef70b829	68012-004	HUMAN PRESCRIPTION DRUG	Glumetza		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180320		NDA	NDA021748	Santarus, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68012-052_bc93408c-bea8-429d-a2f9-d587fd3204c3	68012-052	HUMAN PRESCRIPTION DRUG	ZEGERID		omeprazole and sodium bicarbonate	POWDER, FOR SUSPENSION	ORAL	20040615		NDA	NDA021636	Santarus, Inc..	OMEPRAZOLE; SODIUM BICARBONATE	20; 1680	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68012-054_bc93408c-bea8-429d-a2f9-d587fd3204c3	68012-054	HUMAN PRESCRIPTION DRUG	ZEGERID		omeprazole and sodium bicarbonate	POWDER, FOR SUSPENSION	ORAL	20140615		NDA	NDA021636	Santarus, Inc..	OMEPRAZOLE; SODIUM BICARBONATE	40; 1680	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68012-102_bc93408c-bea8-429d-a2f9-d587fd3204c3	68012-102	HUMAN PRESCRIPTION DRUG	ZEGERID		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20060227		NDA	NDA021849	Santarus, Inc..	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68012-104_bc93408c-bea8-429d-a2f9-d587fd3204c3	68012-104	HUMAN PRESCRIPTION DRUG	ZEGERID		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20060227		NDA	NDA021849	Santarus, Inc..	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68012-258_24cac959-31c4-4313-8824-5fff07d343ba	68012-258	HUMAN PRESCRIPTION DRUG	CYCLOSET		bromocriptine mesylate	TABLET	ORAL	20101115		NDA	NDA020866	Santarus, Inc.	BROMOCRIPTINE MESYLATE	.8	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
68012-309_22da619a-1ffe-4f44-914c-1444be7ce6ef	68012-309	HUMAN PRESCRIPTION DRUG	Uceris		budesonide	TABLET, EXTENDED RELEASE	ORAL	20130114		NDA	NDA203634	Santarus Inc.	BUDESONIDE	9	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68012-490_ae9a87e8-23dd-492c-907e-51ea9d58eb97	68012-490	HUMAN PRESCRIPTION DRUG	Fenoglide		fenofibrate	TABLET	ORAL	20101118		NDA	NDA022118	Santarus, Inc.	FENOFIBRATE	40	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68012-495_ae9a87e8-23dd-492c-907e-51ea9d58eb97	68012-495	HUMAN PRESCRIPTION DRUG	Fenoglide		fenofibrate	TABLET	ORAL	20101118		NDA	NDA022118	Santarus, Inc.	FENOFIBRATE	120	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68016-003_9679ad79-1ba0-4417-9b1b-ee758878b871	68016-003	HUMAN OTC DRUG	Premier Value Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		Chain Drug Consortium, LLC	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
68016-006_45b26231-d780-490d-b50d-fac294807c87	68016-006	HUMAN OTC DRUG	Minoxidil	For Women	Minoxidil	SOLUTION	TOPICAL	20000101		ANDA	ANDA074588	Chain Drug Consortium, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68016-008_7ab337e1-90e1-4233-b854-19aee40ccfbe	68016-008	HUMAN OTC DRUG	Premier Value Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20100723		ANDA	ANDA090283	Premier Value	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68016-009_128ed8a8-8f2d-466a-bc01-86727225dfa7	68016-009	HUMAN OTC DRUG	Hydrocortisone	Maximum Strength	Hydrocortisone	OINTMENT	TOPICAL	20060908		OTC MONOGRAPH DRUG	M017	Chain Drug Consortium, LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68016-010_7ab337e1-90e1-4233-b854-19aee40ccfbe	68016-010	HUMAN OTC DRUG	Premier Value Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20100625		ANDA	ANDA090283	Premier Value	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68016-015_0c000c2f-9bdc-c28c-e063-6394a90a455e	68016-015	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20120315		OTC MONOGRAPH DRUG	M007	Chain Drug Consortium LLC	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
68016-018_e01b17a9-936a-4569-8c2d-764aa35d0477	68016-018	HUMAN OTC DRUG	Tussin DM	COUGH SUPPRESSANT/EXPECTORANT	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	LIQUID	ORAL	20120901		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-020_49d643be-1955-4016-ab3c-e7b2fe3c5d3d	68016-020	HUMAN OTC DRUG	Tussin	EXPECTORANT	GUAIFENESIN	LIQUID	ORAL	20120907		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium, LLC	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68016-023_c067a0f7-cadb-42cb-9bd4-6b901aec98c4	68016-023	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20080422		ANDA	ANDA090182	Chain Drug Consortium, LLC (Premier Value)	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-029_08156ef8-87e0-ec67-e063-6394a90a4f87	68016-029	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20070901		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68016-035_5d6ad412-c7ee-445c-b802-3605a98269f9	68016-035	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20030911		OTC MONOGRAPH FINAL	part333C	Chain Drug Consortium, LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-049_043b336e-b3df-43b6-aa2e-1ecd08661d03	68016-049	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-051_38a3a82d-be91-457e-b65c-9907e383b8c3	68016-051	HUMAN OTC DRUG	Allergy Relief	Childrens	Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20110425		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-052_a5a643cd-3ae4-42e3-88b0-217a97a4f871	68016-052	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20190402	20241231	ANDA	ANDA208754	Chain Drug Consortium, LLC	DOCOSANOL	100	mg/g			N	
68016-053_1bfdac5c-3bc2-47ec-9b56-95b2da1f4ff2	68016-053	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20180401		ANDA	ANDA210088	Premier Value	LORATADINE	5	mg/1			N	20241231
68016-054_fb44e956-e4ff-501a-e053-6294a90a5d70	68016-054	HUMAN OTC DRUG	Hemorroidal Cooling gel		Phenylephrine, Witch Hazel	GEL	TOPICAL	20180802		OTC MONOGRAPH FINAL	part346	Pharmacy Value Alliance, LLC	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	.25; .5	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-055_af0f9bd2-3b77-967a-e053-2995a90a9f6a	68016-055	HUMAN OTC DRUG	Allergy Relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20181201		ANDA	ANDA206214	CHAIN DRUG CONSORTIUM	LORATADINE	10	mg/1			N	20241231
68016-056_803b1569-46f0-4937-842c-0c363fe0ed79	68016-056	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20181025		NDA	NDA021920	Premier Value Alliance LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-057_21afce91-afbe-4b38-a8a5-8775148835e8	68016-057	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20181025		ANDA	ANDA090397	Premier Value Alliance LLC	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-058_f0fe4551-a400-5bec-e053-2a95a90a55df	68016-058	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20181025		NDA	NDA021855	Premier Value Alliance LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68016-063_f4190784-1d3c-4171-9c1c-3ea82d1c096b	68016-063	HUMAN OTC DRUG	Premier Value	Hydrocortisone Plus 12 Moisturizers	Hydrocortisone	CREAM	TOPICAL	19891003		OTC MONOGRAPH NOT FINAL	part348	Pharmacy Value Alliance LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68016-066_eff7fe94-3ca6-3965-e053-2995a90a56a3	68016-066	HUMAN OTC DRUG	PREMIER VALUE PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68016-067_f3f6aae5-e840-444c-89e6-1d3ceaf4799b	68016-067	HUMAN OTC DRUG	2-Count HEAT PATCHES		CAPSAICIN	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	CAPSAICIN	.025	g/100g			N	20241231
68016-069_a66ce0ab-0aec-4a03-bf57-e7771ea50d07	68016-069	HUMAN OTC DRUG	Petroleum Skin Protectant		White Petrolatum	JELLY	TOPICAL	20090112		OTC MONOGRAPH FINAL	part347	Pharmacy Value Alliance LLC	PETROLATUM	1	g/g			N	20241231
68016-070_b4cb8843-8811-4d06-989c-8aceeff009b7	68016-070	HUMAN OTC DRUG	Premier Value	Miconazole 3	Miconazole Nitrate	CREAM	VAGINAL	20050302		ANDA	ANDA076773	Pharmacy Value Alliance LLC	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-071_3251b046-7019-44f4-b84d-d848286bf4c5	68016-071	HUMAN OTC DRUG	Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
68016-073_40fa7a7f-aec8-4b4d-bcbf-2f1ea7e935f0	68016-073	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20030911		ANDA	ANDA074164	Chain Drug Consortium, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-075_e668129e-d90d-472d-86de-862522ed971a	68016-075	HUMAN OTC DRUG	Premier Value	Bacitracin Zinc	Bacitracin Zinc	OINTMENT	TOPICAL	20060511		OTC MONOGRAPH FINAL	part333B	Pharmacy Value Alliance LLC	BACITRACIN ZINC	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
68016-076_d827202d-4e5a-4444-b8dd-fbacfc15d041	68016-076	HUMAN OTC DRUG	Premier Value	Antibiotic Plus Pain Relief	Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	CREAM	TOPICAL	20120321		OTC MONOGRAPH FINAL	part333B	Pharmacy Value Alliance LLC	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68016-080_1cc3144f-5f7f-42cb-92c4-b6d026a0cc20	68016-080	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20070702		ANDA	ANDA077511	Pharmacy Value Alliance LLC	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
68016-084_0c00af03-7be6-94d9-e063-6294a90a3090	68016-084	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	SUPPOSITORY	RECTAL	20190603		OTC MONOGRAPH DRUG	M007	Pharmacy Value Alliance LLC	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-086_01123cd1-8faf-4314-908d-c6398e3ea7db	68016-086	HUMAN OTC DRUG	Mini Nicotine		nicotine polacrilex	LOZENGE	ORAL	20190430		ANDA	ANDA207868	Chain Drug Consortium, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-087_cefa5e40-7e93-40a0-8d9f-7dd3a88234bb	68016-087	HUMAN OTC DRUG	Mini Nicotine		nicotine polacrilex	LOZENGE	ORAL	20190430		ANDA	ANDA207868	Chain Drug Consortium, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-088_38d1e80f-4bba-4acb-bc49-89bd3653c2cd	68016-088	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	Chain Drug Consortium, LLC	LORATADINE	10	mg/1			N	20241231
68016-094_29355692-7b20-4b38-8611-8a8f86e636a7	68016-094	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20180416		ANDA	ANDA208314	Chain Drug Consortium, LLC	LORATADINE	10	mg/1			N	20241231
68016-096_e9e176e3-94f5-482c-b46f-d7e15bf88e5c	68016-096	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20190816	20240430	ANDA	ANDA206531	Chain Drug Consortium, LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	
68016-097_c7c34de1-4ed5-4b49-b002-39135edc951a	68016-097	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20190816	20240430	ANDA	ANDA206531	Chain Drug Consortium, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	
68016-099_934c7f1b-9cb5-44c0-82c4-c2b85b95af46	68016-099	HUMAN OTC DRUG	Premier Value	Hydrocortisone	Hydrocortisone	CREAM	TOPICAL	19950823		OTC MONOGRAPH NOT FINAL	part348	Pharmacy Value Alliance LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68016-102_a2a6ae04-dcb0-4e5f-8b1a-561ef50b0157	68016-102	HUMAN OTC DRUG	Hydrocortisone	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20060908	20241227	OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
68016-105_2f10f6f4-ae79-415e-bfe7-04bc8dcc3cb0	68016-105	HUMAN OTC DRUG	Premier Value Extra Strength	Original Flavor	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20190320		OTC MONOGRAPH DRUG	M001	PHARMACY VALUE ALLIANCE, LLC	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
68016-106_51b02412-ebbd-4045-8af4-4b8b8e90daf4	68016-106	HUMAN OTC DRUG	Childrens	Cetirzine	Cetirizine Hydrochloride	SOLUTION	ORAL	20110520		ANDA	ANDA201546	Pharmacy Value Alliance LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-107_fb450e4e-0b95-9b3a-e053-6294a90ae4d7	68016-107	HUMAN OTC DRUG	Premier Value Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20191216		OTC MONOGRAPH FINAL	part333B	Pharmacy Value Alliance LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
68016-108_01d36f45-f74a-42f3-8a0d-e331dcb44389	68016-108	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20171231	20241227	OTC MONOGRAPH FINAL	part347	Chain Drug Consortium, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
68016-118_d6b3c000-0b49-40af-b290-d4de41363bd4	68016-118	HUMAN OTC DRUG	Premier Value Zinc Cold Therapy	Citrus Flavor	ZINC GLUCONATE	TABLET	ORAL	20190418		UNAPPROVED HOMEOPATHIC		PHARMACY VALUE ALLIANCE, LLC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68016-120_3f7907ca-b762-4f4c-94d5-40612028858e	68016-120	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Pharmacy Value Alliance LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68016-122_bf885e5b-73f8-405e-8943-cebcbf242cfe	68016-122	HUMAN OTC DRUG	Premier Value Fiber Therapy		Methylcellulose	TABLET	ORAL	20190419		OTC MONOGRAPH DRUG	M007	PHARMACY VALUE ALLIANCE, LLC	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
68016-123_0ea714a1-b048-bc87-e063-6294a90a28e7	68016-123	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	19930201		ANDA	ANDA074091	Chain Drug Consortium, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
68016-124_923db678-cc0c-4bbb-bdd7-2941f333be86	68016-124	HUMAN OTC DRUG	Premier Value		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20190522		OTC MONOGRAPH DRUG	M008	CHAIN DRUG CONSORTIUM,LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68016-126_62b415e6-6593-436e-b07d-c00812c80e9a	68016-126	HUMAN OTC DRUG	Tussin CF		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20120515		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-128_fb33a16f-4235-f05c-e053-6394a90a8d81	68016-128	HUMAN OTC DRUG	DiaperRashOintment		Zinc Oxide	OINTMENT	TOPICAL	20160822		OTC MONOGRAPH FINAL	part347	Pharmacy Value Alliance, LLC	ZINC OXIDE	40	g/100g			N	20241231
68016-129_5b07167b-acaf-4084-911f-8302b4744b20	68016-129	HUMAN OTC DRUG	Premier Value Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190731		UNAPPROVED DRUG OTHER		Chain Drug Consortium, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
68016-131_aadedce4-e5e5-4028-8398-612e7a2b5667	68016-131	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Pharmacy Value Alliance LLC	LORATADINE	5	mg/5mL			N	20241231
68016-147_a4c831c6-73bd-4e67-8d9b-0de1aa3ce7d7	68016-147	HUMAN OTC DRUG	COLD FLU and SORE THROAT RELIEF		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170823		OTC MONOGRAPH FINAL	part341	Pharmacy Value Alliance, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-148_b0affeed-94c0-4f57-897e-057066b11d70	68016-148	HUMAN OTC DRUG	Severe sinus Congestion Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170823		OTC MONOGRAPH FINAL	part341	Pharmacy Value Alliance, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-149_fb4547d7-628e-b4b5-e053-6294a90a7507	68016-149	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone 1%	CREAM	TOPICAL	20200109		OTC MONOGRAPH NOT FINAL	part348	Pharmacy Value Alliance LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68016-152_fb451364-d1ff-a7f6-e053-6394a90a5de9	68016-152	HUMAN OTC DRUG	Tolnaftate Cream 1%		Tolnaftate	CREAM	TOPICAL	20160823		OTC MONOGRAPH FINAL	part333C	Pharmacy Value Alliance, LLC.	TOLNAFTATE	10	mg/g			N	20241231
68016-159_fb451364-d1ec-a7f6-e053-6394a90a5de9	68016-159	HUMAN OTC DRUG	Zinc Oxide 20%		Zinc Oxide	OINTMENT	TOPICAL	20160719		OTC MONOGRAPH FINAL	part347	Pharmacy Value Alliance, LLC	ZINC OXIDE	.2	g/g			N	20241231
68016-161_0c002c9f-ad85-6cba-e063-6294a90a5295	68016-161	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20120321		OTC MONOGRAPH DRUG	M007	Chain Drug Consortium LLC	GLYCERIN	1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
68016-163_fb450e4e-0b92-9b3a-e053-6294a90ae4d7	68016-163	HUMAN OTC DRUG	Itch Relief Cream		Zinc Acetate 0.1%, Diphenhydramine hydrochloride 2%	CREAM	TOPICAL	20160719		OTC MONOGRAPH FINAL	part347	Pharmacy Value Alliance LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-165_c385832e-d754-45e5-a9ea-69a0ec6d7afb	68016-165	HUMAN OTC DRUG	Premier Value	Childrens Cetirizine	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Pharmacy Value Alliance LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-167_2c525eda-1b53-4577-ae49-1dd7ad67a450	68016-167	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Pharmacy Value Alliance LLC	LORATADINE	5	mg/5mL			N	20241231
68016-170_69bd08f2-42b5-4abd-b126-ef19b7caaae0	68016-170	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20210430		ANDA	ANDA207342	Chain Drug Consortium, LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68016-171_6b29b26a-a37a-4d4b-a751-7fbf5736cf31	68016-171	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20221231		ANDA	ANDA208077	Chain Drug Consortium, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-173_efb75b29-de2c-0c45-e053-2995a90ad5ee	68016-173	HUMAN OTC DRUG	Sinus Pressure and Pain		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200901		OTC MONOGRAPH FINAL	part341	https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e0ef968-dff3-4446-8412-8085677332f0	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-174_efb7586a-0c0a-99c3-e053-2a95a90af420	68016-174	HUMAN OTC DRUG	Sinus and Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200901		OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-197_5eeaf9b3-12f6-4cfe-b3b6-ebdcb7bf6bbb	68016-197	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20150916		OTC MONOGRAPH DRUG	505G(a)(3)	Chain Drug Consortium	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-198_57b49950-b2c3-46d7-a311-aca3a2097f94	68016-198	HUMAN OTC DRUG	Junior Acetaminophen	Ages 6-11	Acetaminophen	TABLET, ORALLY DISINTEGRATING	ORAL	20150807		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ACETAMINOPHEN	160	mg/1			N	20241231
68016-204_f73d7997-407d-4a93-99f5-0f2be115cc51	68016-204	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20060428		ANDA	ANDA077442	Chain Drug Consortium, LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68016-219_be25a6ab-f708-4dc3-ae06-400a722557dc	68016-219	HUMAN OTC DRUG	Premier Value Nighttime Sleep-Aid Liquid	Sleep-Aid	DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20121210		OTC MONOGRAPH DRUG	M010	Chain Drug Consortium	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-220_dd3eaac0-7559-48d0-bde6-199b584ec883	68016-220	HUMAN OTC DRUG	Premier Value		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20190416		OTC MONOGRAPH DRUG	M007	PHARMACY VALUE ALLIANCE, LLC	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
68016-221_0e49c632-4334-4f65-ab33-56c59d8dc59f	68016-221	HUMAN OTC DRUG	Severe Congestion and Cough MAX	Maxium Strength	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20130101		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-228_7d65ade8-0696-7b74-e053-2a91aa0a580c	68016-228	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate 4%	LIQUID	TOPICAL	20121030		NDA	NDA019125	Chain Drug Consortium, LLC	CHLORHEXIDINE GLUCONATE	4	mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
68016-236_55e1e99e-b162-4a5e-bc87-85e43e6265e0	68016-236	HUMAN OTC DRUG	Cold and Flu Day Time Multi-Symptom Relief		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	LIQUID	ORAL	20181001		OTC MONOGRAPH DRUG	M012	Pharmacy Value Alliance, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-237_b29fb6b7-ff03-41cf-9bb2-a36060bda3f7	68016-237	HUMAN OTC DRUG	Cold and Flu Night-time Multi Symptom Relief	Cherry	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20181001		OTC MONOGRAPH DRUG	M012	Pharmacy Value Alliance, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-238_4292658a-436d-4020-8e9b-7a982bd09ef3	68016-238	HUMAN OTC DRUG	Nighttime Cough Relief	Cherry	DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20181001		OTC MONOGRAPH DRUG	M012	Pharmacy Value Alliance, LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-239_d39beac3-583e-44bb-8c3f-98ecf2c8f013	68016-239	HUMAN OTC DRUG	Cold and Flu Night Time Multi-Symptom Relief	Original	ACETAMINOPHEN, DEXTROMETHORPHAN HBr, DOXYLAMINE SUCCINATE	LIQUID	ORAL	20181001		OTC MONOGRAPH DRUG	M012	Pharmacy Value Alliance, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-240_a1cc1757-96eb-424b-af1a-4fbb57422a59	68016-240	HUMAN OTC DRUG	Childrens Pain Relief Oral Suspension		ACETAMINOPHEN	SUSPENSION	ORAL	20181001		OTC MONOGRAPH DRUG	M013	Pharmacy Value Alliance, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
68016-241_84165b61-370d-45a5-a776-e75d2795b237	68016-241	HUMAN OTC DRUG	Childrens Pain Relief Oral Suspension		ACETAMINOPHEN	SUSPENSION	ORAL	20181001		OTC MONOGRAPH DRUG	M013	Pharmacy Value Alliance, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
68016-248_d42fe495-c314-4496-b120-fba9d94208a0	68016-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20160815		OTC MONOGRAPH FINAL	part341	Pharmacy Value Alliance, LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
68016-249_8dc7e2a1-5010-4758-88e6-5edd0f21fecb	68016-249	HUMAN OTC DRUG	Premier Value Maximum Strength	Assorted Fruit	Calcium Carbonate, Simethicone	TABLET, CHEWABLE	ORAL	20190422		OTC MONOGRAPH DRUG	M001	PHARMACY VALUE ALLIANCE, LLC	CALCIUM CARBONATE; DIMETHICONE	1000; 60	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
68016-251_d513c4c0-a7aa-735c-e053-2995a90ac6a5	68016-251	HUMAN OTC DRUG	Sinus Wash Saline Refills	Premier Value	SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20220108		UNAPPROVED DRUG OTHER		PREMIER VALUE	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
68016-253_b3dc154a-e342-5632-e053-2995a90affb2	68016-253	HUMAN OTC DRUG	Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20201012		OTC MONOGRAPH FINAL	part358G	PHARMACY VALUE ALLIANCE LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
68016-257_08175e5f-e027-25be-e063-6394a90a2a31	68016-257	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20221001		OTC MONOGRAPH DRUG	M007	PHARMACY VALUE ALLIANCE, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
68016-280_dfa0389d-ac3a-4a03-baf1-07dcb96227ab	68016-280	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20130701		ANDA	ANDA078699	Chain Drug Consortium, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-281_dfa0389d-ac3a-4a03-baf1-07dcb96227ab	68016-281	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20130601		ANDA	ANDA078697	Chain Drug Consortium, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-284_dfa0389d-ac3a-4a03-baf1-07dcb96227ab	68016-284	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20130601		ANDA	ANDA078699	Chain Drug Consortium, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-285_dfa0389d-ac3a-4a03-baf1-07dcb96227ab	68016-285	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20130901		ANDA	ANDA078697	Chain Drug Consortium, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-286_9ecc9d1a-6ab6-4484-a9f3-31860d36b28e	68016-286	HUMAN OTC DRUG	Nicotine Polacrilex, Original		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20130701		ANDA	ANDA074507	Chain Drug Consortium, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-287_9ecc9d1a-6ab6-4484-a9f3-31860d36b28e	68016-287	HUMAN OTC DRUG	Nicotine Polacrilex, Original		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20130601		ANDA	ANDA074707	Chain Drug Consortium, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-288_09b310d0-9433-3f97-e063-6294a90ae2b4	68016-288	HUMAN OTC DRUG	Nicotine Transdermal System	Step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	19971020		ANDA	ANDA074612	Chain Drug Consortium, LLC	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-289_09b310d0-9433-3f97-e063-6294a90ae2b4	68016-289	HUMAN OTC DRUG	Nicotine Transdermal System	Step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	19971020		ANDA	ANDA074612	Chain Drug Consortium, LLC	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-290_09b310d0-9433-3f97-e063-6294a90ae2b4	68016-290	HUMAN OTC DRUG	Nicotine Transdermal System	Step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	19971020		ANDA	ANDA074612	Chain Drug Consortium, LLC	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-291_99e74a98-14b2-4487-80aa-6ff6dcee1a4f	68016-291	HUMAN OTC DRUG	Miconazole		Miconazole Nitrate	CREAM	TOPICAL	20090515		OTC MONOGRAPH DRUG	M005	Chain Drug Consortium, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-292_62d1099c-200b-4ac2-8e11-3d6ce46845a5	68016-292	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20171001		ANDA	ANDA204794	Chain Drug Consortium, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-293_62d1099c-200b-4ac2-8e11-3d6ce46845a5	68016-293	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20171001		ANDA	ANDA204833	Chain Drug Consortium, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-294_96221436-ce9e-d264-e053-2a95a90a413b	68016-294	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20191101		ANDA	ANDA209274	CHAIN DRUG CONSORTIUM	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-296_fb458801-6b75-26f7-e053-6294a90a7c6d	68016-296	HUMAN OTC DRUG	Premier Value Max Strength Antibiotic plus pain relief		Premier Value Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine HCL	CREAM	TOPICAL	20190922		OTC MONOGRAPH FINAL	part333B	Pharmacy Value Alliance LLC	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68016-301_0f3d82fe-5ddf-40f8-9a9c-eba903af9556	68016-301	HUMAN OTC DRUG	Anti-diarrheal		Loperamide HCl	TABLET	ORAL	20191206		ANDA	ANDA076497	Chain Drug Consortium	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68016-303_af0c4e30-d36d-6243-e053-2995a90a49d1	68016-303	HUMAN OTC DRUG	Arthritis Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200801		ANDA	ANDA211544	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN	650	mg/1			N	20241231
68016-317_875b6f6b-23ac-460c-a6ab-ad1c5ef1edc9	68016-317	HUMAN OTC DRUG	Premier Value Diarrhea Relief	Vanilla Flavor	Bismuth subsalicylate	SUSPENSION	ORAL	20190423		OTC MONOGRAPH DRUG	M008	PHARMACY VALUE ALLIANCE, LLC	BISMUTH SUBSALICYLATE	262	mg/15mL			N	20241231
68016-318_ecc92307-60d2-4862-bd12-06e9752de39f	68016-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20030819		OTC MONOGRAPH NOT FINAL	part356	Chain Drug Consortium	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68016-319_fb455461-db4e-fcb9-e053-6294a90a1c60	68016-319	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20190110		OTC MONOGRAPH FINAL	part333B	Premier Value Alliance LLC.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68016-320_fb450e4e-0b96-9b3a-e053-6294a90ae4d7	68016-320	HUMAN OTC DRUG	Premier Value Triple Antibiotic		Bacitracin zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20190110		OTC MONOGRAPH FINAL	part333B	Premier Value Alliance LLC.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68016-322_0bffeee0-8292-0e32-e063-6294a90adcb3	68016-322	HUMAN OTC DRUG	Hemorrhoidal		Cocoa Butter, Phenylephrine HCl	SUPPOSITORY	RECTAL	20190816		OTC MONOGRAPH DRUG	M015	Pharmacy Value Alliance LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2.39; 6.75	g/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-333_453d1a3e-e19a-4ef5-86c2-c498aaafbdbc	68016-333	HUMAN OTC DRUG	Premier Value Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Chain Drug Consortium, LLC.	ACETAMINOPHEN	650	mg/1			N	20241231
68016-336_d7965bc5-9443-4041-9279-ae703dc067d7	68016-336	HUMAN OTC DRUG	Premier Value Arthritis 8 Hour		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Premier Value	ACETAMINOPHEN	650	mg/1			N	20241231
68016-342_f2e10161-2256-462a-91e0-b72d3513fb19	68016-342	HUMAN OTC DRUG	Sore Throat Relief	Cherry Flavor	Phenol	SPRAY	ORAL	20141231		OTC MONOGRAPH DRUG	M022	Chain Drug Consortium	PHENOL	1.4	g/100mL			N	20241231
68016-343_7073bde0-2915-4091-8021-a41a3425e4cf	68016-343	HUMAN OTC DRUG	Sore Throat Relief	Menthol	Phenol	SPRAY	ORAL	20141231		OTC MONOGRAPH DRUG	M022	Chain Drug Consortium	PHENOL	1.4	g/100mL			N	20241231
68016-344_cd3b6dbb-22e6-4951-8600-7199e8e287bc	68016-344	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20210601		ANDA	ANDA208754	Chain Drug Consortium, LLC	DOCOSANOL	100	mg/g			N	20241231
68016-345_0a133726-e0d9-4070-b3e0-cdaa4b401970	68016-345	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231130		ANDA	ANDA212385	Chain Drug Consortium, LLC	DOCOSANOL	100	mg/g			N	20241231
68016-370_e14bb0ba-62de-4957-90ba-d6c8303f364c	68016-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20130131		OTC MONOGRAPH NOT FINAL	part333A	Pharmacy Value Alliance LLC	ALCOHOL	70	mL/100mL			N	20241231
68016-377_bbfef157-79e8-7305-e053-2995a90aa962	68016-377	HUMAN OTC DRUG	Premier Value Ear Relief Ear Drops		CHAMOMILE, MERCURIUS SOLUBILIS, SULFUR	SOLUTION/ DROPS	AURICULAR (OTIC)	20051001		UNAPPROVED HOMEOPATHIC		Chain Drug Consortium, LLC	CHAMOMILE; MERCURIUS SOLUBILIS; SULFUR	10; 15; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
68016-382_a983c6de-98de-42ce-883e-7a1a78e86b09	68016-382	HUMAN OTC DRUG	Minoxidil	Extra Strength for Men	Minoxidil	SOLUTION	TOPICAL	20030911		ANDA	ANDA075518	Chain Drug Consortium, LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68016-400_0cf4d3d9-4028-2327-e063-6294a90aaa30	68016-400	HUMAN OTC DRUG	Premier Value Calaclear		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Chain Drug Consortium	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68016-413_0cf4d6ef-ff52-ecf0-e063-6394a90a9802	68016-413	HUMAN OTC DRUG	Premiere Value Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	Chain Drug Consortium	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68016-414_fc9fa4a1-bc20-44bf-aa7c-e549a87c0489	68016-414	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20131009		ANDA	ANDA074165	Chain Drug Consortium, LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-415_0cf4f274-9fc2-f48e-e063-6394a90a9d3f	68016-415	HUMAN OTC DRUG	Premier Value Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Chain Drug Consortium	POVIDONE-IODINE	100	mg/mL			N	20241231
68016-444_f2a132af-d760-2ca0-e053-2a95a90a332e	68016-444	HUMAN OTC DRUG	Clear Gel Corn Remover		Salicylic Acid	PATCH	TOPICAL	20180101		OTC MONOGRAPH FINAL	part358F	Chain Drug Consortium, LLC	SALICYLIC ACID	40	mg/61			N	20241231
68016-451_d8508755-bf70-7582-e053-2995a90ac111	68016-451	HUMAN OTC DRUG	Soft Tip Neti Pot Easy to use Sinus Relief	Premier Value	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		Premier Value						N	20241231
68016-452_dd7437b7-5222-aaed-e053-2995a90a1b65	68016-452	HUMAN OTC DRUG	Soft Tip Squeeze bottle Sinus Wash	Premier Value	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		Premier Value						N	20241231
68016-471_430b3e1d-07e2-4e15-a7a9-a1cfd70cd549	68016-471	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part334	Chain Drug Consortium, LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
68016-473_25df4cf3-d295-493e-ace8-b467d09b6f00	68016-473	HUMAN OTC DRUG	Nasal Decongestant	Maximum Strength	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68016-474_ad8d837b-327e-4a6d-bdae-6a241184d61d	68016-474	HUMAN OTC DRUG	Premier Value Antifungal	Maximum Strength	Undecylenic Acid	LIQUID	TOPICAL	20190410		OTC MONOGRAPH DRUG	M005	PHARMACY VALUE ALLIANCE, LLC	UNDECYLENIC ACID	25	mg/30mL			N	20241231
68016-501_08f31a2b-20e7-5ada-e063-6394a90a2407	68016-501	HUMAN OTC DRUG	Nyt Time Sleep Caps		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20130301	20240430	OTC MONOGRAPH DRUG	M010	CHAIN DRUG CONSORTIUM	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
68016-502_08f368a3-1c77-0bc3-e063-6294a90ad1a9	68016-502	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20080101		OTC MONOGRAPH DRUG	M013	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN	500	mg/1			N	20241231
68016-503_08f37d93-37ff-67f4-e063-6394a90a81d3	68016-503	HUMAN OTC DRUG	Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20110501	20240630	OTC MONOGRAPH DRUG	M013	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN	500	mg/1			N	
68016-504_af0d544d-c462-2dc2-e053-2a95a90a75a4	68016-504	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20091101		OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-508_ee9e34b9-2759-3477-e053-2995a90a0091	68016-508	HUMAN OTC DRUG	Cold Max Multi Symptom Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20091101	20240531	OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
68016-511_86876938-33ec-4b3d-9bbb-a33bb19289f0	68016-511	HUMAN OTC DRUG	Premier Value Fiber Therapy	Original Coarse	Psyllium Husk	POWDER	ORAL	20190520		OTC MONOGRAPH DRUG	M007	PHARMACY VALUE ALLIANCE, LLC	PSYLLIUM HUSK	3.4	g/7g			N	20241231
68016-512_af0cbb19-c0fb-85a0-e053-2995a90afbf7	68016-512	HUMAN OTC DRUG	Cold and Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120801		OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-513_51178390-afdc-4dd6-948c-f954c53e2b49	68016-513	HUMAN OTC DRUG	Premier Value Fiber Therapy	Orange Flavor	Psyllium Husk	POWDER	ORAL	20190418		OTC MONOGRAPH DRUG	M007	PHARMACY VALUE ALLIANCE, LLC	PSYLLIUM HUSK	3.4	g/12g			N	20241231
68016-515_0cf4e97f-18df-5426-e063-6294a90ac4b0	68016-515	HUMAN OTC DRUG	Premiere Value Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Chain Drug Consortium	CASTOR OIL	1	mg/mL			N	20241231
68016-516_f31b0b83-4f40-26cc-e053-2995a90a940b	68016-516	HUMAN OTC DRUG	Miconazole Nitrate		Antifungal Liquid Continuous Spray	AEROSOL, SPRAY	TOPICAL	20100105		OTC MONOGRAPH FINAL	part333C	Chain Drug Consortium, LLC	MICONAZOLE NITRATE	3	g/150g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-526_78c14cff-325e-4106-a9a4-cb5281ceec58	68016-526	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20030819		ANDA	ANDA076134	Premier Value	LORATADINE	10	mg/1			N	20241231
68016-528_f5edb656-4f7f-2386-e053-2995a90a70de	68016-528	HUMAN OTC DRUG	HemorrhoidalOintment		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20160719		OTC MONOGRAPH FINAL	part346	Pharmacy Value Alliance, LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-529_fb45863b-1e64-44e4-e053-6294a90a97d2	68016-529	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone 1%	CREAM	TOPICAL	20200109		OTC MONOGRAPH NOT FINAL	part348	Pharmacy Value Alliance LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68016-531_d2448d3f-a6f0-47c9-bf63-0a4bcdaf0ae4	68016-531	HUMAN OTC DRUG	Allergy relief-D		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160817		ANDA	ANDA090922	CHAIN DRUG CONSORTIUM,LLC	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
68016-540_e06a04fd-5b7b-4420-814c-1167fe8cceaf	68016-540	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20230512		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-541_b5104cf4-c542-4015-b55a-3a7001974628	68016-541	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET	ORAL	20230512		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ACETAMINOPHEN	325	mg/1			N	20241231
68016-543_8f593e3d-1e9d-41f3-8af6-4af500af1a80	68016-543	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20220429		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ACETAMINOPHEN	500	mg/1			N	20241231
68016-545_ebe395f9-75a3-4b72-bab7-6269fc91ff38	68016-545	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, FILM COATED	ORAL	20230109		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68016-549_af0cbb19-c0ca-85a0-e053-2995a90afbf7	68016-549	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20140901		OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-550_fd2e8ca9-054e-4acd-b8a8-bb7d0c8f1b52	68016-550	HUMAN OTC DRUG	Mucus Relief DM		Dextromethorphan HBr and Guaifenesin	TABLET, FILM COATED	ORAL	20230112		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-551_607ca6fa-4744-4937-b5aa-539d6fbb8f67	68016-551	HUMAN OTC DRUG	Premier Value	Orange Flavor	Psyllium Husk	POWDER	ORAL	20190410		OTC MONOGRAPH DRUG	M007	PHARMACY VALUE ALLIANCE, LLC	PSYLLIUM HUSK	3.4	g/5.8g			N	20241231
68016-552_0bdebc01-48e4-61d3-e063-6394a90a022d	68016-552	HUMAN OTC DRUG	Premier Value Lice Treatment Kit		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20201209		OTC MONOGRAPH DRUG	M031	PHARMACY VALUE ALLIANCE LLC						N	20241231
68016-557_67a7bd6a-38d1-4798-83fb-f6e143124bef	68016-557	HUMAN OTC DRUG	STOMACH RELIEF	Regular Strength	BISMUTH SUBSALICYLATE	SUSPENSION	ORAL	20191217		OTC MONOGRAPH DRUG	M008	Pharmacy Value Alliance, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
68016-559_dfa0389d-ac3a-4a03-baf1-07dcb96227ab	68016-559	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20141001		ANDA	ANDA078699	Chain Drug Consortium, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-560_dfa0389d-ac3a-4a03-baf1-07dcb96227ab	68016-560	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20141001		ANDA	ANDA078697	Chain Drug Consortium, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68016-586_f396f90b-5bf0-8980-e053-2a95a90a49f0	68016-586	HUMAN OTC DRUG	Tolnaftate		Foot Odor Control Powder Spray	AEROSOL, SPRAY	TOPICAL	20060601		OTC MONOGRAPH FINAL	part333C	Chain Drug Consortium, LLC	TOLNAFTATE	1.3	g/113g			N	20241231
68016-587_8ba14a7d-3b7d-453a-a3f5-ee39caac88f1	68016-587	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part334	Chain Drug Consortium, LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
68016-606_f31b0b83-4f42-26cc-e053-2995a90a940b	68016-606	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20030523		OTC MONOGRAPH FINAL	part358F	Chain Drug Consortium, LLC	SALICYLIC ACID	40	mg/91			N	20241231
68016-607_f31b11ed-2ff7-5cfc-e053-2a95a90af2ca	68016-607	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20030523		OTC MONOGRAPH FINAL	part358F	Chain Drug Consortium, LLC	SALICYLIC ACID	40	mg/41			N	20241231
68016-609_f31aef65-1275-742a-e053-2a95a90ad06a	68016-609	HUMAN OTC DRUG	Tolnaftate		Antifungal Spray Liquid	AEROSOL, SPRAY	TOPICAL	20030523		OTC MONOGRAPH FINAL	part333C	Chain Drug Consortium, LLC	TOLNAFTATE	.15	g/150g			N	20241231
68016-610_f31c227e-fd0c-32aa-e053-2995a90a6d98	68016-610	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover	LIQUID	TOPICAL	20030523		OTC MONOGRAPH FINAL	part358B	Chain Drug Consortium, LLC	SALICYLIC ACID	.17	mg/15mL			N	20241231
68016-611_f31b2d07-7c8c-059a-e053-2a95a90a7a70	68016-611	HUMAN OTC DRUG	Salicylic Acid		Wart Remover	LIQUID	TOPICAL	20030523		OTC MONOGRAPH FINAL	part358B	Chain Drug Consortium, LLC	SALICYLIC ACID	.17	mg/15mL			N	20241231
68016-614_f31b0b83-4f43-26cc-e053-2995a90a940b	68016-614	HUMAN OTC DRUG	Lidocaine		Burn Relief	AEROSOL, SPRAY	TOPICAL	20051207		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68016-615_f31aef65-1276-742a-e053-2a95a90ad06a	68016-615	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20051207		OTC MONOGRAPH NOT FINAL	part333A	Chain Drug Consortium, LLC	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
68016-618_f31af24b-8bcc-75b6-e053-2a95a90a1ef8	68016-618	HUMAN OTC DRUG	Salicylic Acid		Plantar Wart Remover	PATCH	TOPICAL	20090219		OTC MONOGRAPH FINAL	part358F	Chain Drug Consortium, LLC	SALICYLIC ACID	40	mg/241			N	20241231
68016-623_0bdce6c8-b097-c702-e063-6394a90aa356	68016-623	HUMAN OTC DRUG	Stool Softener with Laxative		Docusate Sodium and Sennosides	TABLET, FILM COATED	ORAL	20191201		OTC MONOGRAPH DRUG	505G(a)(3)	PHARMACY VALUE ALLIANCE, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
68016-625_efb76260-8930-c90a-e053-2a95a90aa8b3	68016-625	HUMAN OTC DRUG	Mucus Relief Cold and Flu all in one		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-628_efb77a52-7f02-2039-e053-2995a90a757c	68016-628	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201201		OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-631_f31aef65-1278-742a-e053-2a95a90ad06a	68016-631	HUMAN OTC DRUG	Diphenhydramine HCl and Zinc Acetate		Allergy Relief Spray	AEROSOL, SPRAY	TOPICAL	20101210		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.52; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-632_f31af24b-8bca-75b6-e053-2a95a90a1ef8	68016-632	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Gel	GEL	TOPICAL	20111020		OTC MONOGRAPH FINAL	part358B	Chain Drug Consortium, LLC	SALICYLIC ACID	.17	g/7g			N	20241231
68016-633_a5933bcb-b883-46a2-8faa-eb4295f0d648	68016-633	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Chain Drug Consortium	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-634_87e0039e-98b0-41f0-bb39-b88adb80e07b	68016-634	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Chain Drug Consortium	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68016-635_89a19763-45da-4569-a21f-16ba88699649	68016-635	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Chain Drug Consortium	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-639_b6bc04fa-c4f0-4d29-bbb7-aacfff4f871e	68016-639	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET	ORAL	19900410		OTC MONOGRAPH DRUG	M010	Chain Drug Consortium	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-640_f7b5790e-d78f-40bd-a1c6-b54431d0ea47	68016-640	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	19900315		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-641_00b946de-1ea4-4af0-92e9-65c95e0f6668	68016-641	HUMAN OTC DRUG	Complete Allergy		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-642_40c78060-aeb4-40cb-84a2-e534ba488f8f	68016-642	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68016-645_406e1867-24ff-4cf6-b622-9c3e55eea52c	68016-645	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Chain Drug Consortium	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-649_04940f85-7410-4a7d-84f4-d70ac6affff4	68016-649	HUMAN OTC DRUG	Premier Value Fiber		Psyllium Husk	CAPSULE	ORAL	20110701		OTC MONOGRAPH DRUG	M007	Chain Drug Consortium, LLC	PSYLLIUM HUSK	.52	g/1			N	20241231
68016-652_9d0fbbd0-5fbc-4feb-b6ef-916b4f271880	68016-652	HUMAN OTC DRUG	Premier Value Chewable Antacid	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH DRUG	M001	Chain Drug Consortium, LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68016-653_f31ae9d0-3f78-5e2b-e053-2a95a90abb1e	68016-653	HUMAN OTC DRUG	Tolnafate		Tolnaftate Jock Itch Powder Spray - Talc Free	AEROSOL, SPRAY	TOPICAL	20171031		OTC MONOGRAPH FINAL	part333C	Chain Drug Consortium, LLC	TOLNAFTATE	1.3	g/130g			N	20241231
68016-654_47f839b9-ac8b-161c-e054-00144ff8d46c	68016-654	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCl		Acetaminophen Diphenhydramine HCl	TABLET	ORAL	20160225		OTC MONOGRAPH NOT FINAL	part343	Chain Drug Consortium,LLC	ACETAMINOPHEN; DIPHENHYDRAMINE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-663_f31aef65-1274-742a-e053-2a95a90ad06a	68016-663	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20171205		OTC MONOGRAPH FINAL	part333C	Chain Drug Consortium, LLC	TOLNAFTATE	1.3	g/130g			N	20241231
68016-664_6849391e-ed6e-4804-83be-df39fed284d5	68016-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20090515		OTC MONOGRAPH NOT FINAL	part356	Pharmacy Value Alliance LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68016-665_a4ae7c6e-60c0-49f7-ab84-7a3c71410625	68016-665	HUMAN OTC DRUG	Premier Value Regular Strength Chewable Antacid Peppermint	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH DRUG	M001	Chain Drug Consortium, LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68016-666_40af3592-7782-45cc-9e14-d80b99def580	68016-666	HUMAN OTC DRUG	Premier Value Chewable Antacid Extra Strength	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH DRUG	M001	Chain Drug Consortium	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68016-668_64a793cc-2cd5-4cd4-909e-83c0e2becab8	68016-668	HUMAN OTC DRUG	Premier Value Chewable Antacid Extra Strength	Tropical Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH DRUG	M001	Chain Drug Consortium	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68016-669_85688c60-f8ee-4d49-9714-5fe69f1f6480	68016-669	HUMAN OTC DRUG	Premier Value Chewable Antacid Ultra Strength	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH DRUG	M001	Chain Drug Consortium	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68016-670_5534c506-4e3a-4be8-95ae-e35bbdd58c9a	68016-670	HUMAN OTC DRUG	premier value infants gas relief		Simethicone	EMULSION	ORAL	20150109		OTC MONOGRAPH DRUG	M002	Chain Drug Consortium	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
68016-673_f31ad0f8-15e0-1d5b-e053-2a95a90ab87b	68016-673	HUMAN OTC DRUG	Miconazole Nitrate		Miconazorb Antifungal Powder Talc Free	POWDER	TOPICAL	20171022		OTC MONOGRAPH FINAL	part333C	Chain Drug Consortium, LLC	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-674_0753919f-1a6b-4d2b-b3a5-69d59aadb899	68016-674	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20191129		ANDA	ANDA209692	Chain Drug Consortium, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-675_17c4d08b-24e8-4797-8669-86a6b5a9a4d3	68016-675	HUMAN OTC DRUG	Premier Value Smooth Antacid Extra Strength	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140207		OTC MONOGRAPH DRUG	M001	Chain Drug Consortium	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68016-676_3c11a260-8954-4731-aa97-9efa6cd8032b	68016-676	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20200319		ANDA	ANDA204872	Chain Drug Consortium	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-678_7a36f93b-9649-4a0c-88bf-1069d086025b	68016-678	HUMAN OTC DRUG	Premier Value Extra Strength	Freshmint Flavor	Calcium Carbonate ,Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH DRUG	M001	CHAIN DRUG CONSORTIUM, LLC	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	675; 135	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-679_eafe2d82-e715-4cbb-beac-a67d547c8036	68016-679	HUMAN OTC DRUG	Premier Value Multi Symptom Antacid	Berry Flavor	Calcium carbonate ,Magnesium hydroxide,Simethicone	TABLET, CHEWABLE	ORAL	20190220		OTC MONOGRAPH DRUG	M001	Pharmacy Value Alliance LLC	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	675; 60; 135	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-680_c9b78456-cc3a-4df9-8b7d-d79be73cf492	68016-680	HUMAN OTC DRUG	Alertness Aid		Caffeine	TABLET	ORAL	19961121		OTC MONOGRAPH DRUG	M011	Chain Drug Consortium	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68016-683_a552e17d-0acb-45b1-856f-5625a685f47a	68016-683	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-687_d2cc4d06-b180-44dc-84ec-8455ed41a356	68016-687	HUMAN OTC DRUG	Sinus and Allergy	Maximum Strength	Chlorpheniramine maleate, Phenylephrine HCl	TABLET	ORAL	20050609		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-688_0d757196-8b09-4b9d-8be9-468afc41eec5	68016-688	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Chain Drug Consortium	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-689_5d9b7431-462d-46ac-b91f-e22b9697889d	68016-689	HUMAN OTC DRUG	Aspirin	Chewable Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	20010904		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68016-690_3359fb90-5225-46e0-9c42-affe311425c5	68016-690	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, CHEWABLE	ORAL	19900912		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68016-691_bc5e7be6-e64b-475b-ab24-c2555cd926c7	68016-691	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET	ORAL	19930121		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ACETAMINOPHEN	500	mg/1			N	20241231
68016-696_a8dec039-71a9-4a6e-8721-2a431b91102e	68016-696	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20210603		OTC MONOGRAPH NOT FINAL	part334	Pharmacy Value Alliance LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-700_1f83871e-00c2-4d0c-be63-058268a4768e	68016-700	HUMAN OTC DRUG	PV Extra Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200120		OTC MONOGRAPH DRUG	M001	PHARMACY VALUE ALLIANCE, LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
68016-701_eb07ef99-325b-4332-b6c1-88b03042cbd0	68016-701	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20210603		OTC MONOGRAPH NOT FINAL	part334	Pharmacy Value Alliance	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-714_088f2831-ad71-d9e0-e063-6394a90a2ee7	68016-714	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20220501		OTC MONOGRAPH DRUG	M009	Pharmacy Value Alliance, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68016-715_870f978c-e0af-4752-a221-c9005816e10f	68016-715	HUMAN OTC DRUG	Triple Antibiotic plus Pain Relief	Maximum Strength	bacitracin zinc, neomycin sulfate, polymyxin b sulfate and pramoxine hydrochloride	OINTMENT	TOPICAL	20150710		OTC MONOGRAPH FINAL	part333B	Chain Drug Consortium, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68016-717_af0ca8ae-19a4-bd25-e053-2a95a90a6cc6	68016-717	HUMAN OTC DRUG	Cold and Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20150601		OTC MONOGRAPH FINAL	part341	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-722_08a3bd64-93ca-09cf-e063-6294a90a3151	68016-722	HUMAN OTC DRUG	Enteric coated aspirin		Aspirin	TABLET, COATED	ORAL	20150401		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68016-723_07ef6aa0-a48f-e4f2-1392-6e5e87f50399	68016-723	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20160229		ANDA	ANDA208150	Chain Drugs Consortium, LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68016-724_1a444c43-b3be-4df7-835d-8c9a61888167	68016-724	HUMAN OTC DRUG	Loratadine and Pseudoephedrine Sulfate		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20041117		ANDA	ANDA076557	Chain Drug Consortium, LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68016-726_ee3a5c35-858a-c36b-e053-2a95a90a0516	68016-726	HUMAN OTC DRUG	Laxative		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20150601		ANDA	ANDA090812	Chain Drug Consortium, LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-731_23e7c6d5-6233-49c8-8bc9-91d629e4e0cc	68016-731	HUMAN OTC DRUG	Miconazole 3 Combination Pack		Miconazole Nitrate	KIT		20030911		ANDA	ANDA074926	Chain Drug Consortium, LLC						N	20241231
68016-732_bae4b872-f87a-4c94-83f4-6bee18a663d7	68016-732	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20170831		OTC MONOGRAPH NOT FINAL	part334	Chain Drug Consortium, LLC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-734_e9476ed3-0043-bd38-e053-2995a90acdc7	68016-734	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, COATED	ORAL	20210329		OTC MONOGRAPH NOT FINAL	part343	CHAIN DRUG CONSORTIUM	ACETAMINOPHEN	500	mg/1			N	20241231
68016-736_e47c07a0-0c3a-40d6-9841-ee208a5e6ae9	68016-736	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength	Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20020429		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68016-739_0890e773-7ab9-4f75-89bc-a6f5444cffa0	68016-739	HUMAN OTC DRUG	Laxative	Maximum Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20030102		OTC MONOGRAPH DRUG	505G(a)(3)	Chain Drug Consortium	SENNOSIDES	25	mg/1			N	20241231
68016-740_a18f208f-eff4-4caa-a488-e47681b81f1b	68016-740	HUMAN OTC DRUG	Premier Value	Maximum Strength	Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20190325		OTC MONOGRAPH DRUG	M012	PHARMACY VALUE ALLIANCE LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-744_4094e3d2-de69-4753-9aab-17f0bb4f0cf5	68016-744	HUMAN OTC DRUG	Premier Value		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20190320		OTC MONOGRAPH DRUG	M012	PHARMACY VALUE ALLIANCE LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-745_0bdd23d0-5a80-eda7-e063-6394a90a37ca	68016-745	HUMAN OTC DRUG	SENNA		Sennosides	TABLET	ORAL	20180201		OTC MONOGRAPH DRUG	505G(a)(3)	CHAIN DRUG CONSORTIUM, LLC	SENNOSIDES	8.6	mg/1			N	20241231
68016-747_308f574f-20fd-48e3-9778-c9a62647b493	68016-747	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Chain Drug Consortium	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68016-757_3e475977-f860-4541-bdb6-d846a1e88ca6	68016-757	HUMAN OTC DRUG	Nasal Decongestant	Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-758_e05d8f29-1055-4aef-ac88-f516e236303d	68016-758	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190930		ANDA	ANDA203187	Chain Drug Consortium, LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68016-759_08f41c38-a7f1-10af-e063-6394a90a27d7	68016-759	HUMAN OTC DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20130401	20240229	ANDA	ANDA078878	Chain Drug Consortium, LLC	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
68016-760_17134474-292b-09a5-3630-9fcf69b68b69	68016-760	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160101		ANDA	ANDA078878	Chain Drug Consortium, LLC	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68016-761_08156ef8-87dd-ec67-e063-6394a90a4f87	68016-761	HUMAN OTC DRUG	HEADACHE PAIN RELIEVER		ACETAMINOPHEN, ASPIRIN AND CAFFEINE	TABLET, FILM COATED	ORAL	20200101		OTC MONOGRAPH DRUG	M013	PHARMACY VALUE ALLIANCE, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68016-762_08153d4b-99e6-3c4b-e063-6294a90afd2f	68016-762	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEVER		ACETAMINOPHEN, ASPIRIN AND CAFFEINE	TABLET, FILM COATED	ORAL	20200101		OTC MONOGRAPH DRUG	M013	PHARMACY VALUE ALLIANCE, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68016-763_0b61e81e-8067-d226-e063-6294a90af45c	68016-763	HUMAN OTC DRUG	SENNA-S		Sennosides and Docusate Sodium	TABLET	ORAL	20201201		OTC MONOGRAPH DRUG	505G(a)(3)	PHARMACY VALUE ALLIANCE LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
68016-793_d25ef05b-81c3-409a-a4f9-2113cff481a1	68016-793	HUMAN OTC DRUG	Ear Wax Removal Aid Drops		Carbamide peroxide	LIQUID	AURICULAR (OTIC)	20190418		OTC MONOGRAPH DRUG	M022	PHARMACY VALUE ALLIANCE, LLC	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
68016-797_277af0cb-f363-4fbf-99a4-e6add49cd3df	68016-797	HUMAN OTC DRUG	Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20220902		OTC MONOGRAPH FINAL	part341	Chain Drug Consortium, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-798_291563ee-6ac1-4e85-b978-d3189947ed7c	68016-798	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20220915		OTC MONOGRAPH FINAL	part341	Chain Drug Consortium, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-799_7b9b8f97-865c-4391-a6de-1ebdc6e5a875	68016-799	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20220915		OTC MONOGRAPH FINAL	part341	Chain Drug Consortium, LLC						N	20241231
68016-800_0bbe353f-552e-f116-0bb7-ca4af066f15c	68016-800	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20211101		ANDA	ANDA077367	Chain Drug Consortium, LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68016-801_0bbe353f-552e-f116-0bb7-ca4af066f15c	68016-801	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET	ORAL	20211101		ANDA	ANDA077367	Chain Drug Consortium, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68016-804_c9b9a146-728b-4048-9610-389747fd656e	68016-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20030815		OTC MONOGRAPH NOT FINAL	part333A	Pharmacy Value Alliance LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
68016-807_40f18a5a-16d2-4a56-a16d-b3fc97b82edc	68016-807	HUMAN OTC DRUG	Premier Value Nausea Control	Cherry Flavor	dextrose(glucose),Levulose(fructose),Phosphoric acid	SOLUTION	ORAL	20190416		UNAPPROVED DRUG OTHER		PHARMACY VALUE ALLIANCE, LLC	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
68016-809_0d71caf6-e352-e5d4-e063-6394a90a5e49	68016-809	HUMAN OTC DRUG	Premier Value		Isopropyl Alcohol	SWAB	TOPICAL	20210101		OTC MONOGRAPH DRUG	M003	Pharmacy Value Alliance, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
68016-810_4bac2a47-a050-4689-9bf5-a39911ca5881	68016-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20090515		OTC MONOGRAPH NOT FINAL	part333A	Pharmacy Value Alliance, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
68016-811_583c0168-0c4b-435d-865f-7471b854e020	68016-811	HUMAN OTC DRUG	Premier Value	Extra Strength	Simethicone	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH DRUG	M002	PHARMACY VALUE ALLIANCE, LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68016-813_693f6728-ce14-4c33-b709-4bc9f245b236	68016-813	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20220826		ANDA	ANDA206568	Chain Drug Consortium, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-820_0cf4f695-fe54-55e5-e063-6294a90abe00	68016-820	HUMAN OTC DRUG	Premiere Value Ear Drops for Swimmers		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20200130		OTC MONOGRAPH DRUG	M014	Pharmacy Value Alliance; LLC	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
68016-821_0cf4e97f-18e0-5426-e063-6294a90ac4b0	68016-821	HUMAN OTC DRUG	Premier Value Instant Antiseptic Pain Relief		Camphor 10.8% and Phenol 4.7%	LIQUID	TOPICAL	20200130		OTC MONOGRAPH DRUG	M017	Pharmacy Value Alliance LLC	CAMPHOR (NATURAL); PHENOL	108; 47	mg/mL; mg/mL			N	20241231
68016-822_6b6037ea-0440-45c1-acf3-d5d56d6c0eea	68016-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20030815		OTC MONOGRAPH FINAL	part347	Pharmacy Vlaue Alliance LLC	WITCH HAZEL	842	mg/mL			N	20241231
68016-823_2c9d4607-6181-4524-87fd-15421729c8e0	68016-823	HUMAN OTC DRUG	Childrens Allergy		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20120911		OTC MONOGRAPH DRUG	M009	Chain Drug Consortium, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-831_81a66df0-7a28-4849-bea9-9624e409fdb5	68016-831	HUMAN OTC DRUG	Premier Value		Mineral	OIL	ORAL	20090519		OTC MONOGRAPH NOT FINAL	part334	Pharmacy Value Alliance LLC	MINERAL OIL	999	mg/mL			N	20241231
68016-832_0bdc20a9-7921-9a06-e063-6394a90a84cc	68016-832	HUMAN OTC DRUG	Senna		SENNOSIDES	TABLET	ORAL	20221201		OTC MONOGRAPH DRUG	505G(a)(3)	PHARMACY VALUE ALLIANCE LLC	SENNOSIDES	8.6	mg/1			N	20241231
68016-845_dbf64e80-5b00-4204-984c-82ed03d42533	68016-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20090514		OTC MONOGRAPH FINAL	part344	Pharmacy Value Alliance, LLC	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
68016-850_0cf50881-4226-fb08-e063-6394a90af12f	68016-850	HUMAN OTC DRUG	Premier Value Milk of Magnesia		Magnesium Hydroxide	SUSPENSION	ORAL	20210602		OTC MONOGRAPH DRUG	M001	Pharmacy Value Alliance, LLC	MAGNESIUM HYDROXIDE	80	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68016-855_e65556e3-0dff-4dfd-bac9-4b38baef28cc	68016-855	HUMAN OTC DRUG	Tussin DM	COUGH SUPPRESSANT/EXPECTORANT	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	LIQUID	ORAL	20120901		OTC MONOGRAPH DRUG	M012	Chain Drug Consortium, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-859_3d8d9791-3fdb-4260-8053-7158099a2784	68016-859	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20210430		OTC MONOGRAPH DRUG	M005	Chain Drug Consortium, LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68016-866_999e9556-47b6-4c07-b3a5-7f6c3d57a4fe	68016-866	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride	LIQUID	TOPICAL	20230629		OTC MONOGRAPH NOT FINAL	part333A	Chain Drug Consortium, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
68016-871_83457126-97ae-4312-ac98-94a7d7362d34	68016-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20030813		OTC MONOGRAPH NOT FINAL	part333A	Pharmacy Value Alliance LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
68016-876_eff82087-75ce-30a3-e053-2a95a90a1bc0	68016-876	HUMAN OTC DRUG	Lidocaine plus Menthol		Lidocaine, Menthol	PATCH	TOPICAL	20190114		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68016-877_9857ee21-8c34-4c0a-9078-f0029314ce16	68016-877	HUMAN OTC DRUG	DAYTIME COLD AND FLU MULTI-SYMPTOM RELIEF		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE	ORAL	20190712		OTC MONOGRAPH FINAL	part341	Chain Drug Consortium, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68016-878_09fd180e-7a64-441e-8862-557916982d0e	68016-878	HUMAN OTC DRUG	NIGHTTIME COLD AND FLU RELIEF		Acetaminophen, Dextromethorphan HBr and Doxylamine Succinate	CAPSULE	ORAL	20190712		OTC MONOGRAPH FINAL	part341	Chain Drug Consortium, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68016-879_204453c2-37db-4576-ac41-950e0642e52c	68016-879	HUMAN OTC DRUG	COLD AND FLU MULTI-SYMPTOM RELIEF/COLD AND FLU NIGHTTIME RELIEF		acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and doxylamine succinate	KIT		20190712		OTC MONOGRAPH FINAL	part341	Chain Drug Consortium, LLC						N	20241231
68016-883_018f476d-eb8d-6bcf-e063-6394a90a8ec4	68016-883	HUMAN OTC DRUG	Premier Value		Cough Drops Cherry	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	Pharmacy Value Alliance LLC	MENTHOL	5.8	mg/1			N	20241231
68016-884_018f27ed-49bb-6d1d-e063-6294a90a8937	68016-884	HUMAN OTC DRUG	Premier Value		Cough Drops Honey Lemon	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	Pharmacy Value Alliance LLC	MENTHOL	7.5	mg/1			N	20241231
68016-885_018f3782-8879-eac5-e063-6394a90ac075	68016-885	HUMAN OTC DRUG	Premier Value		Cough Drops Menthol	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	Pharmacy Value Alliance LLC	MENTHOL	5.4	mg/1			N	20241231
68016-886_018f4c74-9522-6c6c-e063-6394a90ab322	68016-886	HUMAN OTC DRUG	Premier Value		Cough Drops Black Cherry Sugar Free	LOZENGE	ORAL	20230731		OTC MONOGRAPH FINAL	part341	Pharmacy Value Alliance LLC	MENTHOL	5.8	mg/1			N	20241231
68016-887_cb694ba6-936e-f854-e053-2995a90a5a20	68016-887	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210708		ANDA	ANDA211075	CHAIN DRUG CONSORTIUM	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-909_e46315b4-ba46-424c-8e11-9af25ffbe933	68016-909	HUMAN OTC DRUG	Hydrocortisone	Maximum Strength	Hydrocortisone	CREAM	TOPICAL	20210507		OTC MONOGRAPH NOT FINAL	part348	Chain Drug Consortium, LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68016-939_62e359b6-7269-4672-9db1-0e9abc63afb3	68016-939	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA077498	Chain Drug Consortium, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68016-940_56338bc0-adfb-4188-9317-e8e8700faf93	68016-940	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20180508		ANDA	ANDA074916	Chain Drug Consortium, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-941_b6c3e199-311c-4163-8b4b-3dd27b77f190	68016-941	HUMAN OTC DRUG	Anitseptic Mouth Rinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20030819		OTC MONOGRAPH NOT FINAL	part348	Pharmacy Value Alliance LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68016-942_56338bc0-adfb-4188-9317-e8e8700faf93	68016-942	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20180717		ANDA	ANDA074916	Chain Drug Consortium, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-943_56338bc0-adfb-4188-9317-e8e8700faf93	68016-943	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20180927		ANDA	ANDA074916	Chain Drug Consortium, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-944_56338bc0-adfb-4188-9317-e8e8700faf93	68016-944	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20181211		ANDA	ANDA074916	Chain Drug Consortium, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68016-952_dff90d6d-4473-4532-8a7a-02ea92a693ff	68016-952	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	LIQUID	TOPICAL	20140828		OTC MONOGRAPH NOT FINAL	part333A	Chain Drug Consortium	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
68016-995_9cb9fb1e-0d5d-763a-4950-4b0d53a5b9ee	68016-995	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20140401		ANDA	ANDA076502	Chain Drug Consortium, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68022-0001_0e8ff1e4-8a54-ede5-e063-6394a90ad2b3	68022-0001	HUMAN PRESCRIPTION DRUG	Malathion		Malathion	LOTION	TOPICAL	20140220		ANDA	ANDA091559	Suven Pharmaceuticals Limited	MALATHION	.005	g/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
68022-0119_0e8fd624-fbe4-c134-e063-6294a90a01e2	68022-0119	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate Capsules 667 mg	CAPSULE	ORAL	20200110		ANDA	ANDA211038	Suven Pharmaceuticals Limited	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20251231
68022-0264_0e8fd624-fbe1-c134-e063-6294a90a01e2	68022-0264	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		Chloroquine Phosphate	TABLET, COATED	ORAL	20220301		ANDA	ANDA214756	Suven Pharmaceuticals Limited	CHLOROQUINE PHOSPHATE	500	mg/1	Antimalarial [EPC]		N	20251231
68022-0265_0e8fd624-fbe1-c134-e063-6294a90a01e2	68022-0265	HUMAN PRESCRIPTION DRUG	Chloroquine Phosphate		Chloroquine Phosphate	TABLET, COATED	ORAL	20220301		ANDA	ANDA214756	Suven Pharmaceuticals Limited	CHLOROQUINE PHOSPHATE	500	mg/1	Antimalarial [EPC]		N	20251231
68025-046_0684cd50-20cd-772e-e063-6294a90a3ea3	68025-046	HUMAN PRESCRIPTION DRUG	Lorzone		chlorzoxazone	TABLET	ORAL	20111001	20241231	ANDA	ANDA040861	Vertical Pharmaceuticals, Inc.	CHLORZOXAZONE	375	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
68025-047_0684cd50-20cd-772e-e063-6294a90a3ea3	68025-047	HUMAN PRESCRIPTION DRUG	Lorzone		chlorzoxazone	TABLET	ORAL	20111001	20241231	ANDA	ANDA040861	Vertical Pharmaceuticals, Inc.	CHLORZOXAZONE	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
68025-065_a539b34c-0a32-43c8-b5ec-a152a460fa23	68025-065	HUMAN PRESCRIPTION DRUG	DIVIGEL		estradiol	GEL	TOPICAL	20141027		NDA	NDA022038	Vertical Pharmaceuticals, LLC	ESTRADIOL	.25	mg/.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68025-066_a539b34c-0a32-43c8-b5ec-a152a460fa23	68025-066	HUMAN PRESCRIPTION DRUG	DIVIGEL		estradiol	GEL	TOPICAL	20141027		NDA	NDA022038	Vertical Pharmaceuticals, LLC	ESTRADIOL	.5	mg/.5g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68025-067_a539b34c-0a32-43c8-b5ec-a152a460fa23	68025-067	HUMAN PRESCRIPTION DRUG	DIVIGEL		estradiol	GEL	TOPICAL	20141027		NDA	NDA022038	Vertical Pharmaceuticals, LLC	ESTRADIOL	1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68025-071_c8930858-0d54-4d21-935d-95efe4ba3f35	68025-071	HUMAN PRESCRIPTION DRUG	ConZip		tramadol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110920		NDA	NDA022370	Vertical Pharmaceuticals, LLC	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
68025-072_c8930858-0d54-4d21-935d-95efe4ba3f35	68025-072	HUMAN PRESCRIPTION DRUG	ConZip		tramadol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110920		NDA	NDA022370	Vertical Pharmaceuticals, LLC	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
68025-073_c8930858-0d54-4d21-935d-95efe4ba3f35	68025-073	HUMAN PRESCRIPTION DRUG	ConZip		tramadol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110920		NDA	NDA022370	Vertical Pharmaceuticals, LLC	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
68025-079_96ebf6c4-5e13-42b5-a48a-7ea5e41915e3	68025-079	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Vertical Pharmaceuticals, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68025-080_96ebf6c4-5e13-42b5-a48a-7ea5e41915e3	68025-080	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Vertical Pharmaceuticals, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68025-081_96ebf6c4-5e13-42b5-a48a-7ea5e41915e3	68025-081	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Vertical Pharmaceuticals, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68025-082_96ebf6c4-5e13-42b5-a48a-7ea5e41915e3	68025-082	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		venlafaxine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100429		NDA AUTHORIZED GENERIC	NDA022104	Vertical Pharmaceuticals, LLC	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68025-083_a539b34c-0a32-43c8-b5ec-a152a460fa23	68025-083	HUMAN PRESCRIPTION DRUG	DIVIGEL		estradiol	GEL	TOPICAL	20190118		NDA	NDA022038	Vertical Pharmaceuticals, LLC	ESTRADIOL	.75	mg/.75g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68025-086_a539b34c-0a32-43c8-b5ec-a152a460fa23	68025-086	HUMAN PRESCRIPTION DRUG	DIVIGEL		estradiol	GEL	TOPICAL	20191217		NDA	NDA022038	Vertical Pharmaceuticals, LLC	ESTRADIOL	1.25	mg/1.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68025-088_08f3dcf5-5d5e-f4ec-e063-6394a90a1ee8	68025-088	HUMAN PRESCRIPTION DRUG	RELEXXII		methylphyenidate hydrochloride extended-release	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Vertical Pharmaceuticals, LLC	METHYLPHENIDATE HYDROCHLORIDE	45	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68025-089_08f3dcf5-5d5e-f4ec-e063-6394a90a1ee8	68025-089	HUMAN PRESCRIPTION DRUG	RELEXXII		methylphyenidate hydrochloride extended-release	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Vertical Pharmaceuticals, LLC	METHYLPHENIDATE HYDROCHLORIDE	63	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68025-095_08f3dcf5-5d5e-f4ec-e063-6394a90a1ee8	68025-095	HUMAN PRESCRIPTION DRUG	RELEXXII		methylphenidate hydrochloride extended-release	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Vertical Pharmaceuticals, LLC	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68025-096_08f3dcf5-5d5e-f4ec-e063-6394a90a1ee8	68025-096	HUMAN PRESCRIPTION DRUG	RELEXXII		methylphenidate hydrochloride extended-release	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Vertical Pharmaceuticals, LLC	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68025-097_08f3dcf5-5d5e-f4ec-e063-6394a90a1ee8	68025-097	HUMAN PRESCRIPTION DRUG	RELEXXII		methylphenidate hydrochloride extended-release	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Vertical Pharmaceuticals, LLC	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68025-709_08f3dcf5-5d5e-f4ec-e063-6394a90a1ee8	68025-709	HUMAN PRESCRIPTION DRUG	RELEXXII		methylphenidate hydrochloride extended-release	TABLET, EXTENDED RELEASE	ORAL	20220623		NDA	NDA216117	Vertical Pharmaceuticals, LLC	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68026-800_0d6bf546-4d8b-a23b-e063-6394a90ae4cc	68026-800	HUMAN OTC DRUG	La Prairie Skin Caviar Essence In Foundation SPF 25 Pure Ivory		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	EMULSION	TOPICAL	20180515		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-802_0d6c82d4-f42d-e37c-e063-6294a90ab306	68026-802	HUMAN OTC DRUG	La Prairie Skin Caviar Essence In Foundation SPF 25 Golden Beige		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	EMULSION	TOPICAL	20180515		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-803_0d6c8874-aa9c-0fb7-e063-6294a90a7f05	68026-803	HUMAN OTC DRUG	La Prairie Skin Caviar Essence In Foundation SPF 25 Honey Beige		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	EMULSION	TOPICAL	20180515		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-804_0d6c82d4-f42e-e37c-e063-6294a90ab306	68026-804	HUMAN OTC DRUG	La Prairie Skin Caviar Essence-In-Foundation SPF 25 Tender Ivory		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	EMULSION	TOPICAL	20180515		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-805_0d6c9518-8529-01f8-e063-6394a90a73cc	68026-805	HUMAN OTC DRUG	La Prairie Skin Caviar Essence-In-Foundation SPF 25 Porcelaine Blush		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	EMULSION	TOPICAL	20180515		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-806_0d6c9518-852a-01f8-e063-6394a90a73cc	68026-806	HUMAN OTC DRUG	La Prairie Skin Caviar Essence-In-Foundation SPF 25 Peche		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	EMULSION	TOPICAL	20180515		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-807_0d6c7b5b-e94e-041d-e063-6294a90a00a9	68026-807	HUMAN OTC DRUG	La Prairie Skin Caviar Essence-In-Foundation SPF 25 Creme Peche		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	EMULSION	TOPICAL	20180515		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-808_0d6c9518-852b-01f8-e063-6394a90a73cc	68026-808	HUMAN OTC DRUG	Skin Caviar Essence In Foundation Broad Spectrum SPF 25 Sunscreen Mocha		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	LOTION	TOPICAL	20190201		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	20241231
68026-809_0d6c8874-aaa0-0fb7-e063-6294a90a7f05	68026-809	HUMAN OTC DRUG	Cellular Swiss UV Protection Veil SPF30		OCTOCRYLENE, HOMOSALATE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27; 90; 45; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68026-810_0d6c6d3e-7275-f281-e063-6294a90a9908	68026-810	HUMAN OTC DRUG	Skin Caviar Concealer-Foundation Sunscreen SPF 15 PECHE		OCTINOXATE	KIT	TOPICAL	20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-812_0a31e329-3f6f-4d72-e063-6394a90ab694	68026-812	HUMAN OTC DRUG	Skin Caviar Concealer-Foundation Sunscreen SPF 15 PORCELAINE BLUSH		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-814_0a31f2b2-ce7f-6c6e-e063-6294a90ad3fe	68026-814	HUMAN OTC DRUG	Skin Caviar Concealer-Foundation Sunscreen SPF 15 TENDER IVORY		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-816_0d6cd501-d9a2-0357-e063-6394a90a45d3	68026-816	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 - ALMOND BEIGE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-818_066db822-b01d-b944-e063-6294a90a666e	68026-818	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 - HONEY BEIGE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-820_0d6be500-d14b-94f4-e063-6394a90aff05	68026-820	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 PETALE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-822_0d6cb70d-47be-08a3-e063-6294a90a3961	68026-822	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 SATIN NUDE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-824_0d6cd501-d9a5-0357-e063-6394a90a45d3	68026-824	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 CREME PECHE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-826_0d6cf5e9-fb6f-2ea3-e063-6294a90a23b0	68026-826	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 MOCHA		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-828_0d6d0d4e-60bf-74b2-e063-6294a90a2da6	68026-828	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 SOFT IVORY		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-830_0d6cc91d-1da0-25ae-e063-6394a90aa6a0	68026-830	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 WARM BEIGE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-832_0d6d0d4e-60da-74b2-e063-6294a90a2da6	68026-832	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 GOLDEN BEIGE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-834_0a31f2b2-ce80-6c6e-e063-6294a90ad3fe	68026-834	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 PURE IVORY		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-836_0d6d0d4e-60db-74b2-e063-6294a90a2da6	68026-836	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 SUNSET BEIGE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-838_0d6d1e65-bb77-3c05-e063-6394a90a0c49	68026-838	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 WARM LINEN		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-842_0a3232d3-e95b-7bcd-e063-6394a90a674d	68026-842	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 - HONEY BEIGE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-844_0d6d62ce-eebf-7863-e063-6294a90aa9cf	68026-844	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 PETALE		OCTINOXATE	KIT	TOPICAL	20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-846_0d6d62ce-eec0-7863-e063-6294a90aa9cf	68026-846	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 SATIN NUDE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-848_0d6d1e7d-93f8-7860-e063-6294a90a9cf7	68026-848	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 CREME PECHE		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68026-862_0d6d72e1-ce5d-2564-e063-6394a90af4fe	68026-862	HUMAN OTC DRUG	La Prairie Concealer-Foundation Sunscreen SPF 15 WARM LINEN		OCTINOXATE	KIT		20140101		OTC MONOGRAPH DRUG	M020	La Prairie, Inc.						N	20241231
68040-712_8a114f8a-76d8-40e9-bd73-f84c784c4020	68040-712	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20230201		NDA	NDA022503	Primus Pharmaceuticals	METAXALONE	640	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68040-713_fd1055cc-4dcc-4cd9-bfea-38fbaf19c17c	68040-713	HUMAN PRESCRIPTION DRUG	Impoyz		clobetasol propionate	CREAM	TOPICAL	20211201		NDA	NDA209483	Primus Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68040-714_0ad18443-4f91-4789-a549-e6ca1cd4aae7	68040-714	HUMAN PRESCRIPTION DRUG	Sernivo		betamethasone dipropionate	SPRAY	TOPICAL	20210628		NDA	NDA208079	Primus Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68041-001_682ce34c-fbb8-4ce7-b904-f27b839ea701	68041-001	HUMAN OTC DRUG	Crystal Clean Antibacterial HandSoap		Chloroxylenol	LIQUID	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333E	Chemcor Chemical Corporation	CHLOROXYLENOL	.00375	mg/mL			N	20241231
68041-002_b5807543-632d-45fb-ae3e-5370cdb35ed1	68041-002	HUMAN OTC DRUG	Crystal Clean Instant Hand Sanitizer		Ethyl alcohol	LIQUID	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	Chemcor Chemical Corporation	ALCOHOL	70	mL/100mL			N	20241231
68041-003_72df94a9-dbb0-4935-80c1-fd6dfdb04342	68041-003	HUMAN OTC DRUG	Instant Sanitizing		Alcohol	SPRAY	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Chemcor Chemical Corporation	ALCOHOL	75	mL/100mL			N	20241231
68041-504_c811df46-1cbc-401e-b022-9ef586b568f7	68041-504	HUMAN OTC DRUG	Antibacterial Handsoap		Chloroxylenol	LIQUID	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333E	Chemcor Chemical Corporation	CHLOROXYLENOL	.00375	mg/mL			N	20241231
68041-512_74305583-197e-406a-8871-a5f25de6f513	68041-512	HUMAN OTC DRUG	Foaming Antibacterial Handsoap		Benzalkonium chloride	LIQUID	TOPICAL	20200715		UNAPPROVED DRUG OTHER		Chemcor Chemical Corporation	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
68041-519_5d1a6d2d-b64d-4690-9668-d81c887aff29	68041-519	HUMAN OTC DRUG	Chemcor Chemical Foaming Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20200601		UNAPPROVED DRUG OTHER		Chemcor Chemical Corporation	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
68041-604_3a7cf0e6-26d0-4f8a-9fa9-696f1b3de7c2	68041-604	HUMAN OTC DRUG	Antibacterial Handsoap		Benzalkonium Chloride	LIQUID	TOPICAL	20230202		UNAPPROVED DRUG OTHER		Chemcor Chemical Corporation	BENZALKONIUM CHLORIDE	.13	g/.1L			N	20241231
68041-740_385f5a5d-d53d-4606-ad80-5f1e18afac0e	68041-740	HUMAN OTC DRUG	Crystal Clean Antibacterial HandSoap		Benzalkonium Chloride	LIQUID	TOPICAL	20230202		UNAPPROVED DRUG OTHER		Chemcor Chemical Corporation	BENZALKONIUM CHLORIDE	.13	g/mL			N	20241231
68047-120_078c5744-c730-a3ca-e063-6394a90acdbc	68047-120	HUMAN OTC DRUG	LoHist	D	Chlorpheniramine Maleate / Pseudoephedrine HCl	LIQUID	ORAL	20030915		OTC MONOGRAPH DRUG	M012	Larken Laboratories, Inc.	CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 30	mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
68047-129_099353c9-371a-29cc-e063-6394a90a5bf3	68047-129	HUMAN OTC DRUG	LoHist DM		Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride	LIQUID	ORAL	20120601		OTC MONOGRAPH DRUG	M012	Larken Laboratories, Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68047-143_078c3c82-b5fb-267f-e063-6294a90a14db	68047-143	HUMAN OTC DRUG	EndaCof DM		Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride	LIQUID	ORAL	20120330		OTC MONOGRAPH DRUG	M012	Larken Laboratories, Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68047-185_078c8db6-07c8-d252-e063-6294a90a84d6	68047-185	HUMAN OTC DRUG	NoHist LQ		Chlorpheniramine Maleate and Phenylephrine Hydrochloride	LIQUID	ORAL	20110106		OTC MONOGRAPH DRUG	M012	Larken Laboratories, Inc.	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68047-186_078c6cae-4383-bb8d-e063-6294a90a42f9	68047-186	HUMAN OTC DRUG	NoHist DM		Chlorpheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride	LIQUID	ORAL	20110106		OTC MONOGRAPH DRUG	M012	Larken Laboratories, Inc.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	4; 15; 10	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68047-252_0773e4cb-c8c4-49a0-e063-6394a90a5d07	68047-252	HUMAN PRESCRIPTION DRUG	OSCIMIN		Hyoscyamine Sulfate	TABLET	ORAL	20110803		UNAPPROVED DRUG OTHER		Larken Laboratories, Inc.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
68047-253_07740fcc-9b17-770f-e063-6394a90aa947	68047-253	HUMAN PRESCRIPTION DRUG	OSCIMIN		Hyoscyamine Sulfate	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20110803		UNAPPROVED DRUG OTHER		Larken Laboratories, Inc.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
68047-702_0771b449-b6e8-09ff-e063-6294a90a147e	68047-702	HUMAN PRESCRIPTION DRUG	Dexamethasone	1.5 mg	Dexamethasone 1.5 mg	TABLET	ORAL	20170901		ANDA	ANDA201270	Larken Laboratories, Inc.	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68047-702_077220f1-e6e9-9f8b-e063-6394a90ae4cc	68047-702	HUMAN PRESCRIPTION DRUG	Dexamethasone	1.5 mg	Dexamethasone 1.5 mg	TABLET	ORAL	20170901		ANDA	ANDA201270	Larken Laboratories, Inc.	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68047-714_0c93282e-5b0f-f879-e063-6394a90aa5ee	68047-714	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20101115		ANDA	ANDA065287	Larken Laboratories, Inc.	DOXYCYCLINE HYCLATE	20	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68047-721_0771bcff-6b38-c003-e063-6294a90a32a8	68047-721	HUMAN PRESCRIPTION DRUG	Butalbital And Acetaminophen		butalbital and acetaminophen	TABLET	ORAL	20151204		ANDA	ANDA203484	Larken Laboratories, Inc.	ACETAMINOPHEN; BUTALBITAL	325; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
68047-752_0771bcff-6b38-c003-e063-6294a90a32a8	68047-752	HUMAN PRESCRIPTION DRUG	ALLZITAL		butalbital and acetaminophen	TABLET	ORAL	20151204		ANDA	ANDA203484	Larken Laboratories, Inc.	ACETAMINOPHEN; BUTALBITAL	325; 25	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
68047-753_0771bcff-6b38-c003-e063-6294a90a32a8	68047-753	HUMAN PRESCRIPTION DRUG	Butalbital and Acetaminophen		butalbital and acetaminophen	TABLET	ORAL	20151204		ANDA	ANDA203484	Larken Laboratories, Inc.	ACETAMINOPHEN; BUTALBITAL	325; 25	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
68055-641_19b2a809-1a5b-472d-98c5-e5e8ef40bb87	68055-641	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20220919		ANDA	ANDA214267	SINTETICA SA	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68055-642_19b2a809-1a5b-472d-98c5-e5e8ef40bb87	68055-642	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20220919		ANDA	ANDA214267	SINTETICA SA	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68055-643_19b2a809-1a5b-472d-98c5-e5e8ef40bb87	68055-643	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20220919		ANDA	ANDA214267	SINTETICA SA	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68055-645_19b2a809-1a5b-472d-98c5-e5e8ef40bb87	68055-645	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20220919		ANDA	ANDA214267	SINTETICA SA	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68055-646_19b2a809-1a5b-472d-98c5-e5e8ef40bb87	68055-646	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20220919		ANDA	ANDA214267	SINTETICA SA	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68055-647_19b2a809-1a5b-472d-98c5-e5e8ef40bb87	68055-647	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20220919		ANDA	ANDA214267	SINTETICA SA	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68055-649_e39eb612-8ff8-6a6c-e053-2a95a90a0252	68055-649	HUMAN PRESCRIPTION DRUG	NA		Lidocaine Hydrochloride	INJECTION, SOLUTION	RETROBULBAR	20220505		ANDA	ANDA214269	SINTETICA SA	LIDOCAINE HYDROCHLORIDE ANHYDROUS	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68062-2217_a83896d0-d142-b4cf-e053-2a95a90a11b9	68062-2217	HUMAN OTC DRUG	Vita Vie Antibacterial Wash		benzalkonium chloride	SOLUTION	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333E	Spa De Soleil	BENZALKONIUM CHLORIDE	.455	g/350mL			N	20241231
68062-2218_a2b8bf2f-25ee-0e4a-e053-2995a90a56c2	68062-2218	HUMAN OTC DRUG	Vitavie		Chloroxylenol	SOLUTION	TOPICAL	20200407		OTC MONOGRAPH NOT FINAL	part333E	Spa De Soleil	CHLOROXYLENOL	1.2	g/240mL			N	20241231
68062-2219_fd69cceb-aec1-ee89-e053-6294a90affa6	68062-2219	HUMAN OTC DRUG	VitaVie		benzalkonium chloride	SOLUTION	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333E	Spa De Soleil	BENZALKONIUM CHLORIDE	.312	g/240mL			N	20241231
68062-2240_ab9d4f6c-1ade-624b-e053-2995a90a18b5	68062-2240	HUMAN OTC DRUG	Dr Lift Antibacterial Body Scrub		benzalkonium chloride	GEL	TOPICAL	20200729		OTC MONOGRAPH NOT FINAL	part333E	Spa de Soleil	BENZALKONIUM CHLORIDE	.23	mg/180mg			N	20241231
68062-2241_ab9dde33-1bd3-062f-e053-2a95a90a4d18	68062-2241	HUMAN OTC DRUG	Dr Lift Antibacterial Body Wash		benzalkonium chloride	GEL	TOPICAL	20200729		OTC MONOGRAPH NOT FINAL	part333E	Spa de Soleil	BENZALKONIUM CHLORIDE	.46	mg/240mg			N	20241231
68062-2242_ab9e2c3c-d423-255e-e053-2a95a90a7a22	68062-2242	HUMAN OTC DRUG	Dr Lift Antibacterial Hand Wash		benzalkonium chloride	GEL	TOPICAL	20200729		OTC MONOGRAPH NOT FINAL	part333E	Spa de Soleil	BENZALKONIUM CHLORIDE	.46	mg/240mg			N	20241231
68062-2243_af894f94-8b2e-563a-e053-2995a90accea	68062-2243	HUMAN OTC DRUG	Dr Lift Antibacterial		Benzalkonium Chloride	LOTION	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part333A	Spa de Soleil	BENZALKONIUM CHLORIDE	.156	mg/120mg			N	20241231
68062-2244_af89bd25-784f-4828-e053-2995a90a8aaa	68062-2244	HUMAN OTC DRUG	Dr Lift Advanced Antibacterial Wipes		Benzalkonium Chloride	LIQUID	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part333A	Spa de Soleil	BENZALKONIUM CHLORIDE	.156	mg/120mg			N	20241231
68062-2248_da472f3a-6a80-6a81-e053-2a95a90a1206	68062-2248	HUMAN OTC DRUG	Dr Lift Unscented Antibacterial Body Wash		Benzalkonium Chloride	LIQUID	TOPICAL	20220315		OTC MONOGRAPH NOT FINAL	part333A	Spa de Soleil	BENZALKONIUM CHLORIDE	.312	mg/240mL			N	20241231
68062-2255_025d4242-9e7e-9ba1-e063-6294a90af752	68062-2255	HUMAN OTC DRUG	Dermatouch Acnecare Facial Scrub		salicylic acid	LIQUID	TOPICAL	20230807		OTC MONOGRAPH FINAL	part333D	Spa de Soleil	SALICYLIC ACID	1.8	mg/180mL			N	20241231
68062-2256_025d79e9-3aec-40b9-e063-6394a90a48a4	68062-2256	HUMAN OTC DRUG	Dermatouch Acnecare Pads		salicylic acid	LIQUID	TOPICAL	20230807		OTC MONOGRAPH FINAL	M006	Spa de Soleil	SALICYLIC ACID	1	mg/100mL			N	20241231
68062-2257_0a90e85a-2171-27ed-e063-6394a90ad993	68062-2257	HUMAN OTC DRUG	Acne Scrub		salicylic acid	LIQUID	TOPICAL	20231120		OTC MONOGRAPH DRUG	M006	Spa de Soleil	SALICYLIC ACID	1.8	mg/180mL			N	20241231
68062-2263_ff200d6f-f4a3-23f4-e053-6294a90a74e2	68062-2263	HUMAN OTC DRUG	Dr. Lift Acne Cleanser		salicylic acid	LIQUID	TOPICAL	20230627		OTC MONOGRAPH FINAL	part333D	Spa de Soleil	SALICYLIC ACID	1.15	mg/230mL			N	20241231
68062-2264_ff246dfe-a3ef-e50f-e053-6394a90abc82	68062-2264	HUMAN OTC DRUG	Dr Lift Soothing Cream		hydrocortisone	LOTION	TOPICAL	20230627		OTC MONOGRAPH NOT FINAL	part348	Spa de Soleil	HYDROCORTISONE	.45	mg/45mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68062-2265_ff2974d3-39df-0fcc-e053-6294a90a0f3e	68062-2265	HUMAN OTC DRUG	Dr Lift Blemish		salicylic acid	LOTION	TOPICAL	20230627		OTC MONOGRAPH FINAL	M006	Spa de Soleil	SALICYLIC ACID; SULFUR	1; 2	mg/100mL; mg/100mL			N	20241231
68062-2266_0a90b77a-4be3-71c5-e063-6294a90a8e41	68062-2266	HUMAN OTC DRUG	Skin Relief Cream		hydrocortisone	LOTION	TOPICAL	20231119		OTC MONOGRAPH DRUG	M016	Spa de Soleil	HYDROCORTISONE	.45	mg/45mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68062-2267_0a90dd85-06d2-13e0-e063-6394a90af2b6	68062-2267	HUMAN OTC DRUG	Acne Care Lotn		salicylic acid	LOTION	TOPICAL	20231119		OTC MONOGRAPH DRUG	M006	Spa de Soleil	SALICYLIC ACID; SULFUR	1; 2	mg/100mL; mg/100mL			N	20241231
68062-8090_f08401ce-bb51-3e6b-e053-2995a90ad595	68062-8090	HUMAN OTC DRUG	Acnecare Dermacontrol Cream		salicylic acid	LIQUID	TOPICAL	20221223		OTC MONOGRAPH FINAL	M006	Spa de Soleil	BENZOYL PEROXIDE	3	mg/60mL			N	20241231
68062-8304_f0743f09-61e5-4b57-e053-2a95a90ad69a	68062-8304	HUMAN OTC DRUG	Natural SPF 30		titanium dioxide, zinc oxide	LOTION	TOPICAL	20170504		OTC MONOGRAPH FINAL	M020	Spa de Soleil	TITANIUM DIOXIDE	750	mg/118mL			N	20241231
68062-8307_f07445b1-3601-7a8f-e053-2a95a90ac621	68062-8307	HUMAN OTC DRUG	Natural SPF 50		titanium dioxide, zinc oxide	LOTION	TOPICAL	20170504		OTC MONOGRAPH FINAL	M020	Spa de Soleil	TITANIUM DIOXIDE; ZINC OXIDE	780; 900	mg/118mL; mg/118mL			N	20241231
68062-8309_d5f8805e-00db-56fe-e053-2a95a90aed52	68062-8309	HUMAN OTC DRUG	Dermatouch Hydrating Clear Moisutrizer SPF 25		avobenzone, homosalate, octisalate	LOTION	TOPICAL	20220118		OTC MONOGRAPH FINAL	part352	Spa de Soleil	AVOBENZONE; HOMOSALATE; OCTISALATE	1.5; 7.5; 2.5	mg/50mL; mg/50mL; mg/50mL			N	20241231
68062-8801_f725cd5c-999f-2393-e053-6394a90a09dc	68062-8801	HUMAN OTC DRUG	Tru Skin Rituals SPF 25		titanium dioxide, zinc oxide	SPRAY	TOPICAL	20230317		OTC MONOGRAPH FINAL	M020	Spa de Soleil	TITANIUM DIOXIDE; ZINC OXIDE	8.16; 11.56	mg/170mL; mg/170mL			N	20241231
68062-8821_f76e616c-e11a-b509-e053-6294a90a2508	68062-8821	HUMAN OTC DRUG	Dr Lift Sun Care SPF 25		titanium dioxide, zinc oxide	LOTION	TOPICAL	20230321		OTC MONOGRAPH FINAL	M020	Spa de Soleil	AVOBENZONE; HOMOSALATE; OCTISALATE	1.35; 6.75; 2.25	mg/45mL; mg/45mL; mg/45mL			N	20241231
68062-9000_efd53834-7fb7-818b-e053-2995a90a99d3	68062-9000	HUMAN OTC DRUG	MD Glam SPF 50		octinoxate	LOTION	TOPICAL	20221214		OTC MONOGRAPH FINAL	part352	Spa de Soleil	OCTINOXATE; ZINC OXIDE	3.75; 19	mg/50mL; mg/50mL			N	20241231
68062-9005_e3514af1-f9ba-c251-e053-2a95a90ac80e	68062-9005	HUMAN OTC DRUG	Dermatouch Acnecare Cleanser		salicylic acid	LIQUID	TOPICAL	20220708		OTC MONOGRAPH FINAL	part333D	Spa de Soleil	SALICYLIC ACID	1.15	mg/230mL			N	20241231
68062-9006_f81834b7-672e-4411-e053-6394a90aeada	68062-9006	HUMAN OTC DRUG	Dermatouch Acnecare Moisturizer		salicylic acid	CREAM	TOPICAL	20230329		OTC MONOGRAPH FINAL	M006	Spa de Soleil	SALICYLIC ACID	.5	mg/50mL			N	20241231
68062-9007_0402c4ba-ff2b-cf25-e063-6294a90a776c	68062-9007	HUMAN OTC DRUG	Dr Lift SPF 50 Cream		titanium dioxide, zinc oxide	CREAM	TOPICAL	20230824		OTC MONOGRAPH FINAL	M020	Spa de Soleil	OCTINOXATE; ZINC OXIDE	3.75; 4.93	mg/50mL; mg/50mL			N	20241231
68062-9098_5bb40e9e-6103-ade0-e053-2a91aa0a6fd9	68062-9098	HUMAN OTC DRUG	Pharmaskincare Solar-C Moisturizer SPF 50		octinoxate, zinc oxide	LOTION	TOPICAL	20171010		OTC MONOGRAPH FINAL	part352	Spa de Soleil	OCTINOXATE; ZINC OXIDE	.188; .238	mg/2.5mL; mg/2.5mL			N	20241231
68062-9099_7e0d3502-14fd-8390-e053-2a91aa0ace24	68062-9099	HUMAN OTC DRUG	Pharmaskincare Solar-C Moisturizer SPF 30		titanium dioxide	LOTION	TOPICAL	20171010		OTC MONOGRAPH FINAL	part352	Spa de Soleil	TITANIUM DIOXIDE	.2625	mg/2.5mL			N	20241231
68062-9100_5b3d3d9c-b1f9-b4e0-e053-2a91aa0afa20	68062-9100	HUMAN OTC DRUG	Pharmaskincare Solar-C Moisturizer SPF 15		zinc oxide	LOTION	TOPICAL	20171010		OTC MONOGRAPH FINAL	part352	Spa de Soleil	ZINC OXIDE	.13	mg/2.5mL			N	20241231
68062-9103_5b49ffb5-ade8-71bd-e053-2a91aa0a865e	68062-9103	HUMAN OTC DRUG	Pharmaskincare Brightening Dermarelief Cream		hydrocortisone	LOTION	TOPICAL	20171010		OTC MONOGRAPH NOT FINAL	part348	Spa de Soleil	HYDROCORTISONE	.025	mg/2.5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68062-9106_5b4e8ef1-2985-cf1c-e053-2a91aa0aa771	68062-9106	HUMAN OTC DRUG	Pharmaskincare Multi-Gly Skin Relief Cream		hydrocortisone	LOTION	TOPICAL	20171010		OTC MONOGRAPH NOT FINAL	part348	Spa de Soleil	HYDROCORTISONE	.025	mg/2.5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68062-9107_5b4f1318-0d98-7bf2-e053-2991aa0a3408	68062-9107	HUMAN OTC DRUG	Pharmaskincare Acnecare Cleanser		benzoyl peroxide	SOLUTION	TOPICAL	20171010		OTC MONOGRAPH FINAL	part333D	Spa de Soleil	BENZOYL PEROXIDE	.063	mg/2.5mL			N	20241231
68062-9108_5b4eb36d-693c-d327-e053-2a91aa0a5eb3	68062-9108	HUMAN OTC DRUG	Pharmaskincare Acnecare Cream		hydrocortisone	LOTION	TOPICAL	20171010		OTC MONOGRAPH NOT FINAL	part348	Spa de Soleil	HYDROCORTISONE	.025	mg/2.5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68062-9109_5b4fdf3a-2bba-54b7-e053-2991aa0aca8c	68062-9109	HUMAN OTC DRUG	Pharmaskincare Acnecare Dermacontrol Cream		benzoyl peroxide	LOTION	TOPICAL	20171010		OTC MONOGRAPH FINAL	part333D	Spa de Soleil	BENZOYL PEROXIDE	.063	mg/2.5mL			N	20241231
68062-9110_5b501566-02a5-1801-e053-2a91aa0ae5da	68062-9110	HUMAN OTC DRUG	Pharmaskincare Acnecare Exfoliator		salicylic acid	SOLUTION	TOPICAL	20171010		OTC MONOGRAPH FINAL	part333D	Spa de Soleil	SALICYLIC ACID	.013	mg/2.5mL			N	20241231
68062-9111_5b526f80-424e-53fd-e053-2991aa0abf17	68062-9111	HUMAN OTC DRUG	Pharmaskincare Acnecare Toner		salicylic acid	SOLUTION	TOPICAL	20171010		OTC MONOGRAPH FINAL	part333D	Spa de Soleil	SALICYLIC ACID	.013	mg/2.5mL			N	20241231
68062-9905_0a90a5e9-65e6-f885-e063-6394a90a8bf8	68062-9905	HUMAN OTC DRUG	Acne Cleanser		salicylic acid	LIQUID	TOPICAL	20231119		OTC MONOGRAPH DRUG	M006	Spa de Soleil	SALICYLIC ACID	1.15	mg/230mL			N	20241231
68062-9907_0a90dd9a-089a-de47-e063-6394a90a7f9e	68062-9907	HUMAN OTC DRUG	Acne Moisturizer		salicylic acid	CREAM	TOPICAL	20231119		OTC MONOGRAPH DRUG	M006	Spa de Soleil	SALICYLIC ACID	.5	mg/50mL			N	20241231
68062-9910_f0c38bc9-ec69-6afd-e053-2995a90abd3d	68062-9910	HUMAN OTC DRUG	Boom Sun SPF 30		titanium dioxide	LOTION	TOPICAL	20220705		OTC MONOGRAPH FINAL	part352	Spa de Soleil	TITANIUM DIOXIDE	3.75	mg/50mL			N	20241231
68071-1026_dcb81c38-2437-6c8e-e053-2995a90a85c7	68071-1026	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	NuCare Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-1288_0aacfb0a-d1fe-e5d2-e063-6294a90ada1a	68071-1288	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	NuCare Pharmaceuticals, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-1311_f0fb49be-2d1f-319e-e053-2995a90aae39	68071-1311	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA210497	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-1317_d6ac2417-796c-347a-e053-2a95a90a2689	68071-1317	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-1318_d6ac4292-0af0-73d1-e053-2a95a90a5176	68071-1318	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	NuCare pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-1395_0bdef49b-25e4-8335-e063-6394a90abed0	68071-1395	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	NuCare Pharmaceuticals,Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68071-1518_d6065309-8647-e06b-e053-2a95a90abc26	68071-1518	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA090467	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-1523_d5d067d8-3e69-66a9-e053-2995a90a6ece	68071-1523	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20111101		ANDA	ANDA200292	NuCare Pharmaceuticals,Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68071-1527_0075a448-349e-b4f9-e063-6294a90a40a4	68071-1527	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20101228		ANDA	ANDA065246	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN MONOHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-1543_ef6c9f7c-a1b1-3fee-e053-2995a90ab2c4	68071-1543	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	NuCare Pharmaceuticals,Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
68071-1552_d6ac3eab-1724-33f5-e053-2995a90a748c	68071-1552	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
68071-1561_0075b813-93d3-c835-e063-6394a90a884c	68071-1561	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	NuCare Pharmaceuticals,Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68071-1562_d592eb64-38cf-749b-e053-2a95a90a3531	68071-1562	HUMAN PRESCRIPTION DRUG	LACTULOSE		LACTULOSE	SOLUTION	ORAL	19660730		ANDA	ANDA074623	NuCare Pharmaceuticals, Inc.	LACTULOSE	10	g/15mL	Acidifying Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68071-1573_ea3c3c24-7f4c-f517-e053-2995a90ade09	68071-1573	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-1598_f9b349b9-c1d8-230c-e053-6294a90a212c	68071-1598	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20060613		ANDA	ANDA085027	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-1623_d6ac585b-1591-af65-e053-2995a90a15ff	68071-1623	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	PASTE	TOPICAL	20100707		ANDA	ANDA040771	NuCare Pharmaceuticals,Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-1625_d6ac5a79-219d-6091-e053-2a95a90a121e	68071-1625	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		Lidocaine and Prilocaine	CREAM	TOPICAL	20030925		ANDA	ANDA076290	NuCare Pharamceuticals,Inc.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
68071-1627_d6ac5ca6-16fe-ae2b-e053-2a95a90abf2e	68071-1627	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin Cream 5% w/w	CREAM	TOPICAL	20190408		ANDA	ANDA211303	NuCare Pharmaceuticals,Inc.	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
68071-1637_f05be1cf-fc2b-9bf2-e053-2a95a90ac12c	68071-1637	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	NuCare Pharmaceuticals,Inc.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-1640_d6ac7265-746c-4ef8-e053-2995a90ab58b	68071-1640	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20140813		ANDA	ANDA077137	NuCare Pharmaceuticals,Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
68071-1645_d57d9cf4-1a07-3cfa-e053-2a95a90aae6f	68071-1645	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	NuCare Pharmaceuticals,Inc.	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-1648_0078d2cf-2c88-3b74-e063-6394a90ab9b7	68071-1648	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	NuCare Pharmaceuticals, Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-1650_f8ada188-7c9f-0d4d-e053-6394a90ad11b	68071-1650	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium and Prednisolone Sodium Phosphate		Sulfacetamide Sodium and Prednisolone Sodium Phosphate	SOLUTION/ DROPS	OPHTHALMIC	19951229		ANDA	ANDA074449	NuCare Pharmaceuticals,Inc.	PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM	2.3; 100	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
68071-1651_e389cd60-127c-32f3-e053-2a95a90a7773	68071-1651	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19970214		ANDA	ANDA064120	NuCare Pharmaceuticals,Inc.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68071-1653_d6ac754b-27dd-2937-e053-2995a90a2954	68071-1653	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	OPHTHALMIC	20080214		ANDA	ANDA078031	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	1	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-1656_d6ac754b-27de-2937-e053-2995a90a2954	68071-1656	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20180301		OTC MONOGRAPH NOT FINAL	part334	NuCare Pharmaceuticals,Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
68071-1670_f45e4f1d-f666-d87e-e053-2a95a90a7fbb	68071-1670	HUMAN PRESCRIPTION DRUG	VENTOLIN	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20060609		NDA	NDA020983	NuCare Pharmaceuticals,Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68071-1690_d5930cc8-00b7-de99-e053-2a95a90ae51b	68071-1690	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-1703_d6ac754b-27df-2937-e053-2995a90a2954	68071-1703	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	19970401		ANDA	ANDA074164	NuCare Pharmaceuticals,Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-1708_d5925a1e-f752-0964-e053-2995a90abb59	68071-1708	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-1712_f5df1e4c-c39c-709f-e053-2995a90a91f9	68071-1712	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20220718		ANDA	ANDA211122	NuCare Pharmaceuticals,Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68071-1730_e5c24de1-63c1-7f4d-e053-2995a90a9265	68071-1730	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-1740_d6983ab7-e5df-caf7-e053-2995a90a66ac	68071-1740	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	NuCare Pharmaceuticals,Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-1742_f8ada0e4-5c1c-17ab-e053-6294a90a12b8	68071-1742	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	NuCare Pharmaceuticals,Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-1760_d6ac8710-cad8-69af-e053-2a95a90ae476	68071-1760	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065322	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-1770_ecab9def-02fc-a00b-e053-2995a90af2aa	68071-1770	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	NuCare Pharmaceuticals,Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-1779_d59062ee-e444-022f-e053-2a95a90a7d20	68071-1779	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	NuCare Pharmaceuticals,Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-1793_fd0139df-1242-59b3-e053-6394a90a1375	68071-1793	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	NuCare Pharmaceuticals,Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-1809_d5cc3105-8ffa-d6d7-e053-2a95a90ab2b6	68071-1809	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-1821_d58ea783-8ac3-71f0-e053-2995a90a1915	68071-1821	HUMAN PRESCRIPTION DRUG	Tobramycin and Dexamethasone		Tobramycin and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19991027		ANDA	ANDA064134	NuCare Pharmaceuticals,Inc.	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-1826_db73fed1-bad1-1cab-e053-2a95a90a75b2	68071-1826	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065378	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-1872_fd78567b-bcad-c8a5-e053-6294a90a9e6c	68071-1872	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20060804		ANDA	ANDA087385	NuCare Pharmaceuticals,Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-1887_ff9952c9-1da9-82f0-e053-6294a90ae0c8	68071-1887	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	NuCare Pharmaceuticals, Inc	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-1890_f4388581-356e-40dc-e053-2995a90a01f4	68071-1890	HUMAN PRESCRIPTION DRUG	VENTOLIN	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20060609		NDA	NDA020983	NuCare Pharmaceuticals,Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68071-1892_d592fca4-8cd3-7771-e053-2a95a90aff3c	68071-1892	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	NuCare Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-1893_d606239d-e61e-0c39-e053-2995a90acaf5	68071-1893	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	NuCare Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-1895_ff99c57a-e066-69d3-e053-6394a90a6775	68071-1895	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	NuCare Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-1911_f32ea5fd-404b-5768-e053-2a95a90a2f07	68071-1911	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-1916_d6062cf6-808d-60a6-e053-2995a90aac7e	68071-1916	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	NuCare Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-1919_d8510e16-33c8-778a-e053-2995a90a31a5	68071-1919	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	NuCare Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-1934_ed24e789-ff48-0be6-e053-2995a90a4135	68071-1934	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100715		ANDA	ANDA090931	NuCare Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-1943_dec2cba8-3a84-6c79-e053-2a95a90aa088	68071-1943	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078490	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-1947_d60637c5-dee2-8455-e053-2995a90a3c29	68071-1947	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	NuCare Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-1951_00b700d1-4c29-f9c0-e063-6294a90a82c9	68071-1951	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	NuCare Pharmaceuticals, Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
68071-2035_efd18138-aabc-61eb-e053-2a95a90a6921	68071-2035	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130319		ANDA	ANDA202389	NuCare Pharmaceuticals,Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-2053_ea3c2b4a-8419-490a-e053-2995a90a9ff2	68071-2053	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	NuCare Pharmaceuticals,Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2054_f31fbae5-aa1f-4740-e053-2995a90a28b0	68071-2054	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	NuCare Pharmaceuticals,Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68071-2055_05f3dd78-107c-6359-e063-6294a90a8a8a	68071-2055	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	NuCare Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68071-2113_00b29e25-a829-6c6b-e063-6294a90aeaad	68071-2113	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, FILM COATED	ORAL	20071012		NDA	NDA022145	NuCare Pharmaceuticals,Inc.	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
68071-2152_fa1d9f8b-9cfb-35d1-e053-6394a90a293e	68071-2152	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20220801		ANDA	ANDA065055	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2158_f420426c-a3d3-7019-e053-2a95a90a1e2f	68071-2158	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	NuCare Pharmaceuticals,Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2159_d5cbc90c-7ba6-0f87-e053-2995a90afaf4	68071-2159	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130418		ANDA	ANDA202556	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2184_fe8120b1-735a-6983-e053-6394a90a8fc7	68071-2184	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	NuCare Pharmaceuticals, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2189_fe941cd8-b328-4388-e053-6294a90a8cea	68071-2189	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	19950830		ANDA	ANDA074388	NuCare Pharmaceuticals, Inc.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-2199_fa1d8dff-0508-264f-e053-6394a90afd82	68071-2199	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	NuCarePharmaceuticals, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2200_ddbb5240-bf93-bcd7-e053-2995a90a5e36	68071-2200	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20171002		NDA	NDA016909	NuCare Pharmaceuticals,Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2201_d738d60d-9eff-09cd-e053-2995a90a17da	68071-2201	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20181018		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68071-2202_d60c97a9-9919-a16e-e053-2a95a90a986c	68071-2202	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	19920501		ANDA	ANDA073481	NuCare Pharmaceuticals,Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2203_d738dd07-6926-9325-e053-2995a90a026d	68071-2203	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	100 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-2204_d738dd07-6927-9325-e053-2995a90a026d	68071-2204	HUMAN PRESCRIPTION DRUG	Folic acid		Folic Acid	TABLET	ORAL	20190530		ANDA	ANDA090035	NuCare Pharmaceuticals,Inc.	FOLIC ACID	1	mg/1			N	20241231
68071-2205_0075774d-9b16-7e25-e063-6394a90a0fc1	68071-2205	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	25 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-2206_d738d60d-9f00-09cd-e053-2995a90a17da	68071-2206	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	NuCare Pharmaceuticals,Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2207_d738dd07-6929-9325-e053-2995a90a026d	68071-2207	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150921		ANDA	ANDA202784	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2208_0075a448-349f-b4f9-e063-6294a90a40a4	68071-2208	HUMAN OTC DRUG	Loratadine	Non drowsy	Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	NuCare Pharmaceuticals,Inc.	LORATADINE	10	mg/1			N	20241231
68071-2209_dee7d2dd-0ce7-5f42-e053-2a95a90ab8ed	68071-2209	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	NuCare Pharmaceuticals,Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2210_d738eb33-5ae2-66bf-e053-2995a90a5e11	68071-2210	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	NuCare Pharmaceuticals,Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68071-2211_0dfe5faa-4197-6c4b-e063-6294a90a75e7	68071-2211	HUMAN OTC DRUG	Triple Antibiotic		Polymyxin B Sulfate, Bacitracin Zinc and Neomycin Sulfate	OINTMENT	TOPICAL	19950111		OTC MONOGRAPH DRUG	M004	NuCare Pharmaceuticals,Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
68071-2212_d5cc04e9-aa3a-b344-e053-2995a90a336b	68071-2212	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
68071-2213_d5cc1848-c4cb-1642-e053-2995a90a890a	68071-2213	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2214_d5cc04e9-aa3b-b344-e053-2995a90a336b	68071-2214	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	NuCare Pharmaceuticals,Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2215_dd7c4534-ec7f-3e00-e053-2995a90ae7b1	68071-2215	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	NuCare Pharmaceuticals,Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2216_d60bcaaf-94a1-4b38-e053-2a95a90a5158	68071-2216	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-2217_d60baefd-283b-2417-e053-2a95a90a156d	68071-2217	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2218_d60ba55e-d200-351c-e053-2995a90a6cdb	68071-2218	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	NuCare Pharmaceuticals,Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2220_d6084c6b-f3ed-623b-e053-2a95a90a47e2	68071-2220	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2222_d7390738-5278-2100-e053-2995a90ac509	68071-2222	HUMAN PRESCRIPTION DRUG	PREDNISOLONE ACETATE		prednisolone acetate	SUSPENSION/ DROPS	OPHTHALMIC	19970819		NDA AUTHORIZED GENERIC	NDA017011	NuCare Pharmaceuticals,Inc.	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2223_d607c61c-50f0-73ff-e053-2995a90ac624	68071-2223	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000228		ANDA	ANDA075492	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2224_d60874f7-4de9-4ba0-e053-2995a90a8d1a	68071-2224	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	NuCare Pharmaceuticals,Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-2225_d7390738-527a-2100-e053-2995a90ac509	68071-2225	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20080311		ANDA	ANDA065470	NuCare Pharmaceuticals,Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2227_d7391709-64cf-20fb-e053-2995a90a8ae5	68071-2227	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2228_d5cc34a7-f0d6-d2a1-e053-2995a90a4de5	68071-2228	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	NuCare Pharmaceuticals,Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-2229_d7701c5f-e4b4-c444-e053-2995a90a4182	68071-2229	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121009		ANDA	ANDA088618	NuCare Pharmaceuticals,Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-2230_0d08263c-ef13-0ed3-e063-6394a90aca0f	68071-2230	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	NuCare Pharmaceuticals,Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2232_d6079b09-0688-1f1a-e053-2a95a90af45d	68071-2232	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	NuCare Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-2233_d607a6ac-e987-741a-e053-2995a90ac561	68071-2233	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20050428		ANDA	ANDA088799	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2235_d607703e-6f51-e9b0-e053-2a95a90a480a	68071-2235	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20161015		ANDA	ANDA201445	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2236_ee27dfb4-1ede-eb54-e053-2995a90ab1de	68071-2236	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2237_efe3b9a2-7ffa-e662-e053-2a95a90ac618	68071-2237	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	NuCare Pharmaceuticals,Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-2239_d7753518-58d4-9116-e053-2a95a90a13dc	68071-2239	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20200130		ANDA	ANDA210986	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2240_d6074940-23e8-4262-e053-2995a90afab3	68071-2240	HUMAN PRESCRIPTION DRUG	CARBIDOPA AND LEVODOPA		CARBIDOPA AND LEVODOPA	TABLET	ORAL	20081028		ANDA	ANDA078536	NuCare Pharmaceuticals,Inc.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
68071-2241_d7754d2b-da30-34c2-e053-2a95a90ab923	68071-2241	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180531		ANDA	ANDA209735	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2242_d6072267-0a64-4b92-e053-2995a90a5673	68071-2242	HUMAN PRESCRIPTION DRUG	Ivermectin		Ivermectin	TABLET	ORAL	20141115		ANDA	ANDA204154	NuCare Pharmaceuticals,Inc.	IVERMECTIN	3	mg/1	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
68071-2243_d6071791-53cb-6fad-e053-2a95a90a8fc7	68071-2243	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20021104		ANDA	ANDA075410	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2244_d7754d2b-da32-34c2-e053-2a95a90ab923	68071-2244	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET	ORAL	19900930		ANDA	ANDA060711	NuCare Pharmaceuticals,Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2245_d606e02d-4054-01a9-e053-2a95a90a4e2d	68071-2245	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	NuCare Pharmaceuticals,Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2246_d7755758-5081-17da-e053-2995a90a638c	68071-2246	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2247_d606fc1f-f279-813e-e053-2a95a90a97da	68071-2247	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20070609		ANDA	ANDA077309	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2248_d7755ccb-dc29-904c-e053-2a95a90af663	68071-2248	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	NuCare Pharmaceuticals,Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2249_016ae32d-952b-39c7-e063-6394a90a41c2	68071-2249	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2251_d7755ccb-dc2a-904c-e053-2a95a90af663	68071-2251	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20171129		ANDA	ANDA205245	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2252_d606fa34-e155-45d3-e053-2995a90a8638	68071-2252	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	SOLUTION	OPHTHALMIC	20091105		ANDA	ANDA076583	NuCare Pharmaceuticals,Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2254_d606f5bb-d219-cfdd-e053-2995a90aa9cc	68071-2254	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20040514		ANDA	ANDA076622	NuCare Pharmaceuticals,Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2255_df51b2f0-164f-2c7a-e053-2a95a90a9480	68071-2255	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	NuCare Pharmaceuticals,Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-2256_d606e02d-4053-01a9-e053-2a95a90a4e2d	68071-2256	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-2257_d606db04-2fe0-0aae-e053-2995a90a37f0	68071-2257	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA073192	NuCare Pharmaceuticals,Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68071-2258_d606e5ed-42da-2a74-e053-2a95a90a4a6f	68071-2258	HUMAN OTC DRUG	Calcium Carbonate	Assorted Flavors	Antacid Tablets	TABLET, CHEWABLE	ORAL	20140812		OTC MONOGRAPH FINAL	part331	NuCare Pharmaceuticals,Inc.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68071-2259_d7756fb2-a9cb-d63f-e053-2995a90a7978	68071-2259	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20200205		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2260_d606e02d-404e-01a9-e053-2a95a90a4e2d	68071-2260	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430		ANDA	ANDA211604	NuCare Pharmaceuticals,Inc.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68071-2261_d606e02d-4050-01a9-e053-2a95a90a4e2d	68071-2261	HUMAN PRESCRIPTION DRUG	Procto-Med HC		HYDROCORTISONE	CREAM	TOPICAL	20200214		ANDA	ANDA085025	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2262_d606a1a1-73b6-6ab9-e053-2995a90adde9	68071-2262	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9	68071-2263	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2264_d6065309-8649-e06b-e053-2a95a90abc26	68071-2264	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130214		ANDA	ANDA202467	NuCare Pharmaceuticals,Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68071-2265_d6066636-92cb-1dbe-e053-2995a90a8b77	68071-2265	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20040514		ANDA	ANDA076622	NuCare Pharmaceuticals,Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2266_d5d049a3-f3e8-b9df-e053-2995a90a5409	68071-2266	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210000	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2267_d5d049a3-f3e9-b9df-e053-2995a90a5409	68071-2267	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20061101		ANDA	ANDA076794	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2269_d5d034d5-6e29-373f-e053-2995a90ae768	68071-2269	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20061101		ANDA	ANDA076794	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2270_d5d02db3-33f1-fa7d-e053-2995a90ab521	68071-2270	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20140303		ANDA	ANDA203245	NuCare Pharmaceuticals,Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-2272_d5d02160-02cb-72bc-e053-2995a90adfe2	68071-2272	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20170628		ANDA	ANDA207444	NuCare Pharmaceuticals,Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68071-2273_d5cf0980-619a-5831-e053-2995a90a0619	68071-2273	HUMAN OTC DRUG	PHENAZOPYRIDINE HYDROCHLORIDE		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
68071-2274_d5cbba75-9b80-af04-e053-2995a90adbb5	68071-2274	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180604		ANDA	ANDA205868	NuCare Pharmaceuticals,Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2275_d5cbbf1b-6fde-f7cd-e053-2995a90a5e33	68071-2275	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	NuCare Pharmaceuticals,Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-2276_d592f2fc-95db-6753-e053-2995a90afb29	68071-2276	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2278_d592f2fc-95da-6753-e053-2995a90afb29	68071-2278	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-2279_d592eb64-38ce-749b-e053-2a95a90a3531	68071-2279	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20130808		ANDA	ANDA074891	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2280_d59270a1-8c30-f984-e053-2995a90a8dc7	68071-2280	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2281_d7759453-1a75-8fd9-e053-2a95a90ad895	68071-2281	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20151001		ANDA	ANDA091095	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68071-2283_d5926e0e-b2c0-2213-e053-2a95a90a2dd3	68071-2283	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	NuCare Pharmaceuticals,Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68071-2284_d5925a1e-f757-0964-e053-2995a90abb59	68071-2284	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2286_d592623e-5d9d-1215-e053-2995a90af5e7	68071-2286	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	NuCare Pharmaceuticals,Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68071-2287_d592623e-5d9e-1215-e053-2995a90af5e7	68071-2287	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20070609		ANDA	ANDA077309	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2288_d5925a1e-f754-0964-e053-2995a90abb59	68071-2288	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161201		ANDA	ANDA079067	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2289_d5925a1e-f753-0964-e053-2995a90abb59	68071-2289	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20200110		ANDA	ANDA211555	NuCare Pharmaceuticals,Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-2290_dc65dc3f-6fce-d3e7-e053-2995a90a675b	68071-2290	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2291_d5922e83-0462-06ae-e053-2a95a90a368e	68071-2291	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2292_d591f344-8a68-5d18-e053-2a95a90aa77b	68071-2292	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2293_d5922e83-0461-06ae-e053-2a95a90a368e	68071-2293	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200101		ANDA	ANDA205945	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2294_d5921749-18cb-9fa7-e053-2a95a90a6eb6	68071-2294	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	NuCare Pharmaceuticals,Inc.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2295_d77594e5-ac40-2d40-e053-2995a90a38e0	68071-2295	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE	ORAL	20181210		ANDA	ANDA204276	NuCare Pharmaceuticals,Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
68071-2296_d5922f8a-7f51-7e96-e053-2a95a90a70a1	68071-2296	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20170215		ANDA	ANDA203266	NuCare Pharmaceuticals,Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
68071-2297_d59224aa-6cad-2f28-e053-2a95a90a7b34	68071-2297	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210001	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2298_d775ac0e-787a-66fe-e053-2995a90a9286	68071-2298	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20021127		ANDA	ANDA065117	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2299_d59120a9-b914-9ae5-e053-2995a90ada61	68071-2299	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20170817		ANDA	ANDA206261	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2301_d775ac0e-787b-66fe-e053-2995a90a9286	68071-2301	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040194	NuCare Pharmaceuticals,Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2302_d591088f-d011-5de7-e053-2995a90a77e9	68071-2302	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2303_dd7c5364-9f0c-1829-e053-2995a90ae46f	68071-2303	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2304_d5910f0b-2e1f-3d25-e053-2a95a90a88af	68071-2304	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	NuCare Pharmaceuticals,Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2305_e65ec1a2-dfa8-7d89-e053-2a95a90aeebc	68071-2305	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	NuCare Pharmaceuticals,Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-2306_edb2cd35-3279-aef3-e053-2995a90a7134	68071-2306	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-2307_d5907515-1336-20e6-e053-2995a90ad7f3	68071-2307	HUMAN OTC DRUG	Benzoyl Peroxide	Acne Medication	Benzoyl Peroxide	GEL	TOPICAL	20150120		OTC MONOGRAPH FINAL	part333D	NuCare Pharmaceuticals,Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
68071-2308_e194145f-a7e4-4d28-e053-2a95a90aad76	68071-2308	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	NuCare Pharmaceuticals,Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2309_d59062ee-e443-022f-e053-2a95a90a7d20	68071-2309	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20190208		ANDA	ANDA075581	NuCare Pharmaceuticals,Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-2310_d59062ee-e442-022f-e053-2a95a90a7d20	68071-2310	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	NuCare Pharmaceuticals,Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2311_d5904f6c-5b27-1465-e053-2995a90a427e	68071-2311	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20080311		ANDA	ANDA065470	NuCare Pharmaceuticals,Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2312_e81a0d8d-afef-4a3d-e053-2995a90add44	68071-2312	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	NuCare Pharmaceuticals,Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-2313_d775c43c-2c40-586b-e053-2a95a90a0b35	68071-2313	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-2314_d59041e0-10e8-a739-e053-2a95a90aa8e1	68071-2314	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	NuCare Pharmaceuticals,Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-2315_d5902ec4-ca7b-5965-e053-2995a90acd9d	68071-2315	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19930831		ANDA	ANDA072640	NuCare Pharmaceuticals,Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2316_d58ecefc-cc0a-682e-e053-2a95a90a35ed	68071-2316	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20190115		ANDA	ANDA209882	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-2317_d58ed27c-5ff8-3a1f-e053-2a95a90a17e5	68071-2317	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH FINAL	part333C	NuCare Pharmaceuticals,Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2319_d58eec28-21a0-0ef0-e053-2995a90a9cf3	68071-2319	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2320_d58ec287-7c33-4ec5-e053-2a95a90ad91a	68071-2320	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2321_d58ebf68-038a-7433-e053-2995a90a2108	68071-2321	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	NuCare Pharmaceuticals,Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2328_0bdf40ec-f2f2-97df-e063-6394a90a6ca8	68071-2328	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	NuCare Pharmaceuticals,Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
68071-2330_d5cc34a7-f0d4-d2a1-e053-2995a90a4de5	68071-2330	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	NuCare Pharmaceuticals,Inc.	PREGABALIN	50	mg/1		CV	N	20241231
68071-2334_021f29bf-c60b-7b0f-e063-6394a90a5662	68071-2334	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	19830324		NDA	NDA018642	NuCare Pharmaceuticals,Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2339_fd2acde2-3cd2-adc8-e053-6394a90ac85d	68071-2339	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	NuCare Pharmaceuticals,Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2343_05f59510-8574-6889-e063-6294a90ac147	68071-2343	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2348_00edbc64-9d30-5751-e063-6294a90a400b	68071-2348	HUMAN PRESCRIPTION DRUG	Kaletra		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20100618		NDA	NDA021906	NuCare Pharmaceuticals,Inc.	LOPINAVIR; RITONAVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
68071-2351_ea64909a-063d-a08f-e053-2995a90a07c3	68071-2351	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20170322		ANDA	ANDA207152	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-2352_f073c750-50cd-dc2b-e053-2a95a90ab282	68071-2352	HUMAN PRESCRIPTION DRUG	Vitamin D		Ergocalciferol	CAPSULE	ORAL	20181210		ANDA	ANDA204276	NuCare Pharmaceuticals,Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
68071-2359_dd42adfe-7792-5aed-e053-2995a90ac4ee	68071-2359	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150921		ANDA	ANDA202784	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2365_de1f2d42-17ec-34a4-e053-2995a90a3023	68071-2365	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET, COATED	ORAL	20190305		ANDA	ANDA209587	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
68071-2393_d61d279c-8499-b418-e053-2995a90a3cc9	68071-2393	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2396_e830c063-fa58-2549-e053-2a95a90a2dcd	68071-2396	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	NuCare Pharmaceuticals,Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2401_efbb5bca-1793-76d1-e053-2995a90a0bc8	68071-2401	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	NuCare Pharmaceuticals,Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2414_e6607b0c-7d83-22cb-e053-2995a90acc76	68071-2414	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	NuCare Pharmaceuticals,Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-2415_f4204cef-239e-50bc-e053-2995a90ac851	68071-2415	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	NuCare Pharmaceuticals,Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-2417_0c08a33a-0ee6-a694-e063-6294a90a40e0	68071-2417	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	NUCARE PHARMACEUTICALS INC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2419_06fbe45e-8081-9a07-e063-6394a90a00a1	68071-2419	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20210412		ANDA	ANDA074164	NuCare Pharmaceuticals,Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2421_ebcdf21f-b60e-108b-e053-2995a90adb7a	68071-2421	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	NuCare Pharmaceuticals,Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2427_00b29522-2fe0-8043-e063-6394a90aab41	68071-2427	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2432_eeb826c8-ccc6-c5bd-e053-2a95a90ab23f	68071-2432	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2467_fd79da76-753c-13c1-e053-6294a90a2d3d	68071-2467	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	NuCare Pharmaceuticals,Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2472_fd8f156a-ee8a-e3e0-e053-6394a90a87fc	68071-2472	HUMAN OTC DRUG	Codeine-Guaifenesin		Codeine Phosphate and Guaifenesin	SOLUTION	ORAL	20200715		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
68071-2481_05bd9ef2-fe59-08b4-e063-6394a90a58ba	68071-2481	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20200401		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68071-2493_ea643bbd-d8dd-72a8-e053-2a95a90a73ed	68071-2493	HUMAN PRESCRIPTION DRUG	cefdinir		cefdinir	POWDER, FOR SUSPENSION	ORAL	20210220		ANDA	ANDA210534	NuCare Pharmaceuticals,Inc.	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2502_e5448cb5-c0f8-6709-e053-2995a90a5ff5	68071-2502	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065096	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2517_fc12c2bd-2291-9b42-e053-6294a90a42cc	68071-2517	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20070308		ANDA	ANDA073652	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68071-2521_0075bda3-0967-e2d9-e063-6394a90a872f	68071-2521	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	NuCare Pharmaceuticals,Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-2525_0075bda3-0966-e2d9-e063-6394a90a872f	68071-2525	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68071-2526_0075774d-9b24-7e25-e063-6394a90a0fc1	68071-2526	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20190823		ANDA	ANDA204313	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2527_00759261-b401-7e0d-e063-6394a90aea2e	68071-2527	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180920		ANDA	ANDA072096	NuCare Pharmaceuticals,Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2529_0075a448-34a2-b4f9-e063-6294a90a40a4	68071-2529	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	POWDER, FOR SUSPENSION	ORAL	19951019		NDA AUTHORIZED GENERIC	NDA050710	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	1200	mg/30mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2530_00758f9b-ba45-999b-e063-6394a90a3d09	68071-2530	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	NuCare Pharmaceuticals,Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68071-2531_e283d8fe-8abd-19d5-e053-2a95a90aa2f2	68071-2531	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-2532_00757782-0488-668d-e063-6294a90af560	68071-2532	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-2533_0075a448-34a0-b4f9-e063-6294a90a40a4	68071-2533	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20200221		ANDA	ANDA208358	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2534_00757782-048b-668d-e063-6294a90af560	68071-2534	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000101		OTC MONOGRAPH NOT FINAL	part334	NuCare Pharmaceuticals,Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
68071-2536_0075b813-93d4-c835-e063-6394a90a884c	68071-2536	HUMAN PRESCRIPTION DRUG	Oxycodone hydrochloride		Oxycodone hydrochloride	TABLET	ORAL	20111230		ANDA	ANDA202116	NuCare Pharmaceuticals,Inc,	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68071-2537_0075774d-9b22-7e25-e063-6394a90a0fc1	68071-2537	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20180504		ANDA	ANDA210394	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2538_00758f9b-ba4a-999b-e063-6394a90a3d09	68071-2538	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	SOLUTION	TOPICAL	20210604		ANDA	ANDA062687	NuCare Pharmaceuticals,Inc.	ERYTHROMYCIN	20	mg/mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
68071-2539_00755665-e837-49ba-e063-6394a90a9385	68071-2539	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		lidocaine hydrochloride	SOLUTION	TOPICAL	19821118		ANDA	ANDA087872	NuCare Pharmaceuticals,Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68071-2540_00755665-e834-49ba-e063-6394a90a9385	68071-2540	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20200910		ANDA	ANDA213864	NuCare Pharmaceuticals,Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68071-2541_0075774d-9b1f-7e25-e063-6394a90a0fc1	68071-2541	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	20180424		ANDA	ANDA209283	NuCare Pharmaceuticals,Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2543_00b2b43b-a2dc-b9fb-e063-6294a90a35b0	68071-2543	HUMAN PRESCRIPTION DRUG	azithromycin		azithromycin	TABLET, FILM COATED	ORAL	20190513		NDA AUTHORIZED GENERIC	NDA050711	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2544_00b2aa98-dea0-90c3-e063-6294a90a35d6	68071-2544	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20190301		ANDA	ANDA076513	NuCare Pharmaceuticaals,Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2546_00b2aa98-de9e-90c3-e063-6294a90a35d6	68071-2546	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20060331		ANDA	ANDA085025	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2547_00b2aa98-de9f-90c3-e063-6294a90a35d6	68071-2547	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	SOLUTION	ORAL	20110127	20241130	ANDA	ANDA091342	NuCare Pharmaceuticals,Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
68071-2548_00b28bd2-5de5-0d73-e063-6394a90a53cd	68071-2548	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20180813		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc/	ACETAMINOPHEN	160	mg/5mL			N	20241231
68071-2549_00b2a93c-92da-90c6-e063-6294a90a6d33	68071-2549	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2551_00b2aa98-de9d-90c3-e063-6294a90a35d6	68071-2551	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2552_00b2b39d-4d1f-3426-e063-6394a90a3a42	68071-2552	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2553_00b29e25-a82a-6c6b-e063-6294a90aeaad	68071-2553	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	NuCare Pharmaceuticals,Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2554_00b2b43b-a2db-b9fb-e063-6294a90a35b0	68071-2554	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	NuCare Pharmaceuticals,Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2556_00b29e25-a828-6c6b-e063-6294a90aeaad	68071-2556	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	19930128		ANDA	ANDA064022	NuCare Pharmaceuticals,Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-2557_00b29e25-a827-6c6b-e063-6294a90aeaad	68071-2557	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-2558_00b2a93c-92d9-90c6-e063-6294a90a6d33	68071-2558	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2559_00b2aee3-487a-56fb-e063-6394a90acac0	68071-2559	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2560_00b2aa98-de9c-90c3-e063-6294a90a35d6	68071-2560	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2561_00b28bd2-5de2-0d73-e063-6394a90a53cd	68071-2561	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	NuCare Pharmaceuticals,Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-2562_00b2aee3-4879-56fb-e063-6394a90acac0	68071-2562	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	NuCare Pharmaceuticals,Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68071-2563_00b2aa98-de9b-90c3-e063-6294a90a35d6	68071-2563	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	NuCare Pharmaceuticals,Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-2564_00b290fc-12a8-292e-e063-6294a90a02a0	68071-2564	HUMAN PRESCRIPTION DRUG	cefdinir		cefdinir	POWDER, FOR SUSPENSION	ORAL	20210220		ANDA	ANDA210534	NuCare Pharmaceuticals,Inc.	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2565_00b28bd2-5de1-0d73-e063-6394a90a53cd	68071-2565	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	NuCare Pharmaceuticals,Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68071-2566_00b27899-e692-e9d9-e063-6394a90a88cb	68071-2566	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2569_00b27899-e68d-e9d9-e063-6394a90a88cb	68071-2569	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20181011	20240930	ANDA	ANDA210616	NuCare Pharmaceuticals,Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
68071-2570_00b28bd2-5de0-0d73-e063-6394a90a53cd	68071-2570	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20181217		ANDA	ANDA078343	NuCare Pharmaceuticals,Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2572_00b266d9-ac51-e931-e063-6294a90a6a0b	68071-2572	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	NuCare Pharmaceuticals,Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
68071-2573_00b28bd2-5ddf-0d73-e063-6394a90a53cd	68071-2573	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	NuCare Pharmaceuticals,Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-2574_05bdd405-9be3-5da5-e063-6294a90a18db	68071-2574	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20201030		OTC MONOGRAPH FINAL	part336	NuCare Pharmaceuticals,Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68071-2575_00b290fc-12a7-292e-e063-6294a90a02a0	68071-2575	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20110525		NDA	NDA020064	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68071-2577_00b26226-4f41-e9c4-e063-6294a90a7c1e	68071-2577	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-2578_00b26226-4f40-e9c4-e063-6294a90a7c1e	68071-2578	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19720421		ANDA	ANDA080352	NuCare Pharmaceuticals,Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2579_fd911d67-8220-21e8-e053-6294a90a4ff1	68071-2579	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	NuCare Pharmaceuticals,Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
68071-2580_fd911830-de00-dc01-e053-6294a90a920c	68071-2580	HUMAN OTC DRUG	Tussin	cough and chest congestion	Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20030627		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc,	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68071-2581_00b26226-4f3d-e9c4-e063-6294a90a7c1e	68071-2581	HUMAN PRESCRIPTION DRUG	Temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	NuCare Pharmaceuticals,Inc.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2582_fd9106e5-3f36-3819-e053-6394a90a07f7	68071-2582	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20070919		ANDA	ANDA077538	NuCare Pharmaceuticals,Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2583_00b290fc-12a1-292e-e063-6294a90a02a0	68071-2583	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
68071-2584_00b290fc-12a4-292e-e063-6294a90a02a0	68071-2584	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2585_00b29e25-a825-6c6b-e063-6294a90aeaad	68071-2585	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2586_00b29e25-a824-6c6b-e063-6294a90aeaad	68071-2586	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-2587_00b2613f-1eec-804b-e063-6394a90a4ba7	68071-2587	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20160714		ANDA	ANDA204598	NuCare Pharmaceuticals,Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68071-2588_00b28bd2-5ddd-0d73-e063-6394a90a53cd	68071-2588	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2589_dd7c3e5c-bfc2-88f2-e053-2a95a90aeff2	68071-2589	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	NuCare Pharmaceuticals,Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-2590_07dd452b-0e92-cf78-e063-6394a90a3ece	68071-2590	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA211977	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2591_00b28bd2-5ddb-0d73-e063-6394a90a53cd	68071-2591	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	NuCare Pharmaceuticals,Inc.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-2592_00b28bd2-5dda-0d73-e063-6394a90a53cd	68071-2592	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20171025		ANDA	ANDA207276	NuCare Pharmaceuticals,Inc.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
68071-2596_06fb6b81-91c4-06ac-e063-6394a90a883e	68071-2596	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-2597_0208a284-ed80-9be9-e063-6294a90a08b5	68071-2597	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	NuCare Pharmaceuticals,Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-2599_00755665-e830-49ba-e063-6394a90a9385	68071-2599	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	NuCare Pharmaceuticals,Inc.	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2600_06fb6d99-1786-15a1-e063-6394a90a63ba	68071-2600	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	NuCare Pharmaceuticals,Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2601_00755665-e82e-49ba-e063-6394a90a9385	68071-2601	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-2602_0075774d-9b17-7e25-e063-6394a90a0fc1	68071-2602	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20180504		ANDA	ANDA210394	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2604_00759261-b3fd-7e0d-e063-6394a90aea2e	68071-2604	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2605_00755665-e82d-49ba-e063-6394a90a9385	68071-2605	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	TABLET	ORAL	20180701		ANDA	ANDA085588	NuCare Pharmaceuticals,Inc.	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
68071-2606_00755665-e82f-49ba-e063-6394a90a9385	68071-2606	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	NuCare Pharmaceuticals,Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68071-2607_0075774d-9b1a-7e25-e063-6394a90a0fc1	68071-2607	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	NuCare Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2608_0075a448-349d-b4f9-e063-6294a90a40a4	68071-2608	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20180504		ANDA	ANDA210394	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2609_d4b2e102-9b2d-17c9-e053-2995a90a06d1	68071-2609	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-2610_d4c90e01-1c62-6865-e053-2995a90ae6dd	68071-2610	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161024		ANDA	ANDA206574	NuCare Pharmaceuticals,Inc.	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-2611_d4ec6dfd-61af-7153-e053-2995a90ad88f	68071-2611	HUMAN OTC DRUG	Banophen		diphenhydramine hcl	CAPSULE	ORAL	20091102		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2612_d4dd4b16-1f09-f837-e053-2995a90acd30	68071-2612	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20200825		ANDA	ANDA212544	NuCare Pharmaceuticals,Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68071-2613_d501dcd9-2c80-c860-e053-2a95a90a2062	68071-2613	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	NuCare Pharmaceuticals,Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2614_d505c338-ddbf-26eb-e053-2a95a90a0261	68071-2614	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20210629		ANDA	ANDA074165	NuCare Pharmaceuticals,Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2615_d56af305-df94-d9ec-e053-2995a90a22ea	68071-2615	HUMAN OTC DRUG	fexofenadine hcl		fexofenadine hcl	TABLET, FILM COATED	ORAL	20210826		ANDA	ANDA204507	NuCare Pharmaceuticals,Inc.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2616_d5801a33-4d2b-e78c-e053-2a95a90acb13	68071-2616	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091116		ANDA	ANDA078253	NuCare Pharmaceuticals,Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68071-2617_ed9ec6b0-ddd5-2c38-e053-2a95a90ac4ad	68071-2617	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2618_d5de9674-4434-6b57-e053-2995a90ad731	68071-2618	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	NuCare Pharmaceuticals,Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-2619_d5df10bc-16ee-7a97-e053-2a95a90ab15e	68071-2619	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	NuCare Pharmaceuticals,Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-2620_fd0557e6-4aff-f499-e053-6294a90a3db6	68071-2620	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, COATED	ORAL	20170106		ANDA	ANDA207750	NuCare Pharmaceuticals,Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-2621_d5f4c2e1-4831-3aae-e053-2995a90aba47	68071-2621	HUMAN PRESCRIPTION DRUG	NYSTATIN		nystatin	POWDER	TOPICAL	20211006		ANDA	ANDA208581	NuCare Pharmaceuticals,Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-2622_d5f4c2a2-6ffa-345c-e053-2995a90ae414	68071-2622	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065225	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2623_d5f545de-6190-1946-e053-2a95a90a1ee4	68071-2623	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-2625_deada606-8a80-9eeb-e053-2a95a90a9e6d	68071-2625	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20210320		ANDA	ANDA075229	NuCare Pharmaceuticals,Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2627_d66fee2a-01b9-d66a-e053-2a95a90a2dea	68071-2627	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2628_d66fd12b-d0bd-c8f3-e053-2995a90a0b7c	68071-2628	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2629_d6966d70-0f1b-9a57-e053-2995a90ac2b1	68071-2629	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-2630_d6f7619e-9477-91fa-e053-2995a90a8fed	68071-2630	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020315		ANDA	ANDA065064	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2631_d6f7e170-858d-9134-e053-2a95a90aac6b	68071-2631	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	NuCare Pharmaceuticals,Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68071-2632_d6e8c52f-4dc2-5d54-e053-2995a90a9358	68071-2632	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	NuCare Pharmaceuticals,Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2633_d6f8af0e-660f-191c-e053-2995a90a45fc	68071-2633	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	NuCare Pharmaceuticals,Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2634_d6fc0b22-a90e-2d87-e053-2995a90a979d	68071-2634	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2635_d6fbe837-988b-7c75-e053-2995a90a599a	68071-2635	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	NuCare Pharmaceuticals,Inc.	MIRTAZAPINE	30	mg/1			N	20241231
68071-2636_d738a7f3-424a-2b9f-e053-2995a90a4a03	68071-2636	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE	ER	metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20131101		ANDA	ANDA201991	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-2637_d726963d-ba8c-2142-e053-2a95a90ac15b	68071-2637	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2638_d7392d9a-6377-2db2-e053-2995a90a53cd	68071-2638	HUMAN PRESCRIPTION DRUG	Clomiphene Citrate		Clomiphene Citrate	TABLET	ORAL	19990830		ANDA	ANDA075528	NuCare Pharmaceuticals,Inc.	CLOMIPHENE CITRATE	50	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68071-2640_f9160bda-9f4a-1a1a-e053-6294a90ae19f	68071-2640	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	NuCare Pharmaceuticals,Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68071-2641_d79a5d7d-9b45-526b-e053-2a95a90ac9fa	68071-2641	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2642_d889c0f8-f19d-0dfa-e053-2995a90a8243	68071-2642	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	NuCare Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-2643_d89ebe50-03d7-b0f4-e053-2995a90a6119	68071-2643	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH NOT FINAL	part334	NuCare Pharmaceuticals,Inc.	DOCUSATE SODIUM	250	mg/1			N	20241231
68071-2644_d88d142c-5272-3c3c-e053-2995a90a6776	68071-2644	HUMAN PRESCRIPTION DRUG	Nystatin Oral Suspension		Nystatin Oral Suspension	SOLUTION	ORAL	20050628		ANDA	ANDA065148	NuCare Pharmaceuticals,Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-2645_d88e5687-4246-1717-e053-2a95a90ac808	68071-2645	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-2646_d8b56f85-8adc-07c2-e053-2995a90a05b6	68071-2646	HUMAN OTC DRUG	Cough		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180822		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68071-2647_d8c68797-47a8-2956-e053-2a95a90a0149	68071-2647	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20160415		ANDA	ANDA201722	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68071-2648_d8dc3878-c83c-51c5-e053-2995a90a34a7	68071-2648	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-2649_d92c28a9-36b2-1b51-e053-2a95a90ad85d	68071-2649	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA211977	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2651_d96a096a-df7f-1c31-e053-2995a90ad6e8	68071-2651	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	NuCare Pharmaceuticals,Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2652_d9bc4bcd-8467-3b02-e053-2a95a90a635f	68071-2652	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2653_d9e29a11-c0a8-c5a0-e053-2a95a90a5831	68071-2653	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	NuCare Pharmaceuticals,Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2654_d9e27999-4ab9-7463-e053-2995a90a1dc4	68071-2654	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2655_f98c5cfd-3528-3d69-e053-6294a90a9de4	68071-2655	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190701		ANDA	ANDA075757	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2656_da44f13e-99d6-6d7a-e053-2a95a90aae65	68071-2656	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		albuterol sulfate	SOLUTION	RESPIRATORY (INHALATION)	20210611		ANDA	ANDA207857	NuCare Pharmaceuticals,Inc.	ALBUTEROL SULFATE	.83	mg/mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68071-2657_da46fe67-ca70-8f0d-e053-2995a90a2c96	68071-2657	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	19911001		OTC MONOGRAPH FINAL	part333C	NuCare Pharmaceuticals,Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2658_da44d87a-159f-24d4-e053-2a95a90a09d9	68071-2658	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin Cream	CREAM	TOPICAL	20150401		ANDA	ANDA061966	NuCare Pharmaceuticals,Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-2659_e325fc34-52ff-38f1-e053-2995a90afe55	68071-2659	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-2660_db496bce-660a-90dc-e053-2995a90a1efc	68071-2660	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20150429		ANDA	ANDA203154	NuCare Pharmaceuticals,Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68071-2661_db4a1415-6d44-15bb-e053-2a95a90a3c97	68071-2661	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	NuCare Pharmaceuticals,Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2662_db4a3ca5-d499-6f75-e053-2995a90a1f94	68071-2662	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211011		ANDA	ANDA072926	NuCare Pharmaceuticals,Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2663_db4a5925-e865-42ba-e053-2a95a90ad381	68071-2663	HUMAN OTC DRUG	Tussin		Guaifenesin	SOLUTION	ORAL	20140917		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68071-2664_e00260a7-54a8-c99c-e053-2995a90a2a74	68071-2664	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-2666_db635a13-5983-f379-e053-2995a90aaff6	68071-2666	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211011		ANDA	ANDA072926	NuCare Pharmaceuticals,Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2667_db86f8ff-6977-7ce2-e053-2995a90ae128	68071-2667	HUMAN PRESCRIPTION DRUG	Fluocinonide Cream		Fluocinonide	CREAM	TOPICAL	20171001		ANDA	ANDA210554	NuCare Pharmceuticals,Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2668_db87c896-0c82-9477-e053-2a95a90aa1c0	68071-2668	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-2669_dbda873b-4bb6-837e-e053-2a95a90a5e2f	68071-2669	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19940816		ANDA	ANDA072096	NuCare Pharmaceuticals,Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2670_e26fd997-e073-e258-e053-2a95a90a020c	68071-2670	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	NuCare Pharmaceuticals,Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-2671_dbfe7b1d-6794-a6d8-e053-2a95a90a8e53	68071-2671	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate Cream USP, 0.05%	Clobetasol Propionate Cream USP, 0.05%	Clobetasol Propionate Cream USP, 0.05%	CREAM	TOPICAL	20201001		ANDA	ANDA212982	NuCare Pharmaceuticals,Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2672_dc8e486e-619e-4ee1-e053-2a95a90a7940	68071-2672	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2673_e3b4284c-8653-5ee4-e053-2995a90a082e	68071-2673	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-2674_dd7d2d2a-e765-7dfe-e053-2995a90a790a	68071-2674	HUMAN PRESCRIPTION DRUG	Tretinoin		tretinoin	CREAM	TOPICAL	20190125		ANDA	ANDA211644	NuCare Pharmaceuticals,Inc.	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68071-2675_066d162c-0853-f406-e063-6394a90a88e6	68071-2675	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	NuCare Pharmaceuticals,Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68071-2676_007715a8-3903-1d94-e063-6294a90a4f47	68071-2676	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	NuCare Pharmaceuticals,Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2678_dd7f7b98-c284-ba34-e053-2995a90a523e	68071-2678	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075718	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-2679_ddbb0c0d-9090-af1d-e053-2995a90afde0	68071-2679	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		albuterol sulfate	SOLUTION	RESPIRATORY (INHALATION)	20210611		ANDA	ANDA207857	NuCare Pharmaceuticals,Inc.	ALBUTEROL SULFATE	.83	mg/mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68071-2680_ddbaf167-4f0c-301f-e053-2a95a90affa6	68071-2680	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2681_ddba3d1e-282a-be3c-e053-2995a90a7650	68071-2681	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68071-2682_df39b1fc-200f-1720-e053-2a95a90a664e	68071-2682	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20190218		ANDA	ANDA204097	NuCare Pharmaceuticals,Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2683_ddbdb94c-509f-d65b-e053-2a95a90afec7	68071-2683	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20210220		ANDA	ANDA210534	NuCare Pharmaceuticals,Inc.	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2684_ddceeead-2cab-2e5a-e053-2a95a90a2387	68071-2684	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20211109		ANDA	ANDA200675	NuCare Pharmaceuticals,Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68071-2686_de3185bf-448d-15f7-e053-2995a90a9a2e	68071-2686	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20130514		ANDA	ANDA202856	NuCare Pharmaceuticals,Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68071-2687_de45aace-c517-2ecd-e053-2a95a90a9c63	68071-2687	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2688_de384c26-bae1-2adc-e053-2a95a90ad0fd	68071-2688	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2689_de5a11ba-8487-dabc-e053-2a95a90ac0c1	68071-2689	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2690_de5c0c87-e90a-fc14-e053-2a95a90af0c5	68071-2690	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-2691_ded7c18e-8aeb-b5df-e053-2a95a90a28d8	68071-2691	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	NuCare Pharmaceutocals,Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2692_de9a97ed-d578-8b34-e053-2a95a90a3273	68071-2692	HUMAN OTC DRUG	Sunmark Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20210908		OTC MONOGRAPH FINAL	part335	NuCare Pharmaceuticals,Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68071-2693_deaa7b8e-9ce6-4294-e053-2a95a90afc94	68071-2693	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19950601		OTC MONOGRAPH FINAL	part333C	NuCare Pharmaceuticals,Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2694_dead8732-1ef6-0a3e-e053-2a95a90af4ae	68071-2694	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20160803		ANDA	ANDA040197	NuCare Pharmaceuticals,Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68071-2695_dee6b60d-3b6d-35a4-e053-2995a90acf56	68071-2695	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150613		ANDA	ANDA090061	NuCare Pharmaceuticals,Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-2696_df371872-2984-7951-e053-2a95a90ad757	68071-2696	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	NuCare Pharmaceuticals,Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2697_e830952a-a724-2553-e053-2a95a90a7ad5	68071-2697	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20211227		ANDA	ANDA084657	NuCare Pharmaceuticals,Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68071-2698_df3d4892-d4ac-c217-e053-2995a90ab42a	68071-2698	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-2699_df4b0df7-975f-3d10-e053-2995a90a2656	68071-2699	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	19950103		ANDA	ANDA070974	NuCare Pharmaceuticals,Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68071-2700_f072c8e6-bcfb-ee08-e053-2a95a90a81cf	68071-2700	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215579	NuCare Pharmaceuticals,Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68071-2701_df60792e-2cf7-c302-e053-2a95a90a834e	68071-2701	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19961003		ANDA	ANDA074649	NuCare Pharmaceuticals,Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68071-2702_df742f4a-9441-538d-e053-2a95a90a1de6	68071-2702	HUMAN PRESCRIPTION DRUG	Valproic Acid		valproic acid	CAPSULE	ORAL	20111029		ANDA	ANDA073229	NuCare Pharmaceuticals,Inc.	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68071-2703_df741f0d-4237-900f-e053-2995a90aae61	68071-2703	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2704_df60a465-444f-ec26-e053-2995a90a229a	68071-2704	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	NuCare Pharmaceuticals,Inc.	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2705_f0ff8758-edbf-5e5f-e053-2995a90a998c	68071-2705	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	NuCare Pharmaceuticals,Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2706_df6123be-ec99-37bf-e053-2995a90a4344	68071-2706	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	NuCare Pharmaceuticals,Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2707_ef3fa0f5-6695-5eb2-e053-2995a90a08bb	68071-2707	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-2708_df5fc3e2-401a-415d-e053-2995a90ae69c	68071-2708	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	NuCare Pharmaceuticals,Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2709_df60101e-0fc9-3bd2-e053-2995a90a51e8	68071-2709	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20201230		ANDA	ANDA204343	NuCare Pharmaceuticals,Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2710_df61a33a-f1fa-582f-e053-2995a90a5cca	68071-2710	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	NuCare Pharmaceuticals,Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2711_df61b895-c357-827b-e053-2995a90a9b60	68071-2711	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	NuCare Pharmaceuticals,Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2712_efb8cdee-d53a-3f24-e053-2995a90a84db	68071-2712	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	NuCare Pharmaceuticals,Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2713_df7434aa-d4c3-63a1-e053-2a95a90a2751	68071-2713	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	NuCare Pharmaceuticals,Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-2714_df753c73-468b-110d-e053-2a95a90a6b4d	68071-2714	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20090203		ANDA	ANDA079139	NuCare Pharmaceuticals,Inc.	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
68071-2715_df739586-04d3-a949-e053-2a95a90adad8	68071-2715	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20180726		ANDA	ANDA077565	NuCare Pharmaceuticals,Inc.	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2716_df73a68b-3305-1174-e053-2a95a90afebf	68071-2716	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20180726		ANDA	ANDA077565	NuCare Pharmaceuticals,Inc.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2717_df78479a-e481-1fc8-e053-2995a90a1ea6	68071-2717	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	NuCare Pharmceuticals,Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68071-2718_df736abd-9ced-4e90-e053-2995a90aab5e	68071-2718	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2719_df759eba-05c2-1923-e053-2a95a90a6b23	68071-2719	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine Hydrochloride	TABLET	ORAL	20210303		ANDA	ANDA214689	NuCare Pharmaceuticals,Inc.	GUANFACINE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68071-2720_df73d27f-b566-7612-e053-2995a90a167d	68071-2720	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	NuCare Pharmceuticals,Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2721_df73db00-ef4d-4e7c-e053-2a95a90a62fc	68071-2721	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20120118		ANDA	ANDA091205	NuCare Pharmceuticals,Inc.	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
68071-2722_dfaf8a04-7137-8327-e053-2a95a90ad0e1	68071-2722	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20200609		ANDA	ANDA212796	NuCare Pharmaceuticals,Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68071-2723_df786377-7d31-249b-e053-2a95a90aab22	68071-2723	HUMAN OTC DRUG	good sense migraine formula		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020417		ANDA	ANDA075794	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68071-2725_e07ae83c-1b63-9425-e053-2a95a90aab1e	68071-2725	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate (Emmolient)		Clobetasol Propionate	CREAM	TOPICAL	20210312		ANDA	ANDA075733	NuCare Pharmaceuticals,Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2726_01f32c25-da3e-6181-e063-6394a90abdf9	68071-2726	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2728_dfb482e6-a407-c450-e053-2995a90a20b6	68071-2728	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	NuCare Pharmaceuticals,Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2729_dfb46870-2ea4-58f8-e053-2995a90a0d71	68071-2729	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	NuCare Pharmaceuticals,Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68071-2730_dfb479a9-d6da-d36d-e053-2a95a90ae4f3	68071-2730	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	19831021		ANDA	ANDA088276	NuCare Pharmaceuticals,Inc.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-2731_dfd9ffe2-029b-7195-e053-2995a90a9b15	68071-2731	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-2732_dfd9ef7e-d3a0-96a9-e053-2a95a90a4cbe	68071-2732	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-2733_05a89a71-88dc-f4e0-e063-6294a90ae89f	68071-2733	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	NuCare Pharmaceuticals,Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2734_dfdc9aa0-8613-9127-e053-2a95a90ae7c8	68071-2734	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200518		ANDA	ANDA203083	NuCare Pharmaceuticals,Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2735_dff07032-2e3f-7468-e053-2a95a90a4777	68071-2735	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SOLUTION	AURICULAR (OTIC)	20030318		ANDA	ANDA062423	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [iU]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68071-2736_dff04cdf-633c-06c3-e053-2a95a90a8762	68071-2736	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	19971126		ANDA	ANDA040039	NuCare Pharmaceuticals,Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2737_dff06163-aa97-c95e-e053-2995a90a040f	68071-2737	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	NuCare Pharmaceuticals,Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2738_07a0e1e7-d52f-1977-e063-6394a90a0b02	68071-2738	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	NuCare Pharmaceuticals,Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2739_e005ae46-fc42-1150-e053-2a95a90af7a6	68071-2739	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2740_e15b7b22-34b4-6caa-e053-2995a90a8682	68071-2740	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2741_e07af86f-aea6-5a91-e053-2a95a90a3795	68071-2741	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA078490	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2742_e07b3225-cca0-9012-e053-2a95a90a7cab	68071-2742	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	NuCare Pharmaceuticals,Inc.	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2743_e07af8c9-559d-5a93-e053-2a95a90a2c63	68071-2743	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	19940930		ANDA	ANDA040037	NuCare Pharmaceuticals,Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2744_e07bf55c-f24b-0893-e053-2995a90a8da3	68071-2744	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20210901		ANDA	ANDA215106	NuCare Pharmaceuticals,Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2745_e08ff660-d8d7-7a39-e053-2a95a90ac910	68071-2745	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	NuCare Pharmaceuticals,Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2746_e07f58e6-c799-4af7-e053-2995a90a5dea	68071-2746	HUMAN OTC DRUG	SIMETHICONE		Simethicone	TABLET, CHEWABLE	ORAL	20040101		OTC MONOGRAPH FINAL	part332	NuCare Pharmaceuticals,Inc.	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
68071-2747_e07e26c3-00ca-0e73-e053-2995a90aee80	68071-2747	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760701		ANDA	ANDA084769	NuCare Pharmaceuticals,Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2748_e07e3eb8-e883-8aaa-e053-2a95a90ab0f0	68071-2748	HUMAN PRESCRIPTION DRUG	HYDROQUINONE 4%		Hydroquinone	CREAM	TOPICAL	20140910		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
68071-2749_e07f727b-f7b2-09dc-e053-2a95a90a3d0d	68071-2749	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	NuCare Pharmaceuticals,Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2750_02e5fed8-40a7-d3d7-e063-6294a90ac5a3	68071-2750	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2751_e0902485-69f1-7351-e053-2a95a90aa0d0	68071-2751	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	NuCare Pharmaceutials,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2752_e09261c7-1818-3042-e053-2a95a90aef90	68071-2752	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	NuCare Pharmaceuticals,Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2753_e0926ed9-437e-11dc-e053-2995a90a0245	68071-2753	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	NuCare Pharmaceuticals,Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2754_e0ce093d-5021-77bf-e053-2995a90aaf3f	68071-2754	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	NuCare Pharmaceuticals,Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68071-2755_e0e08300-cceb-d1b1-e053-2a95a90ad6c2	68071-2755	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2756_e58375ab-7259-e5c2-e053-2a95a90ad4ae	68071-2756	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2757_e17fc3c2-f038-4255-e053-2995a90a9fd2	68071-2757	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	NuCare Pharmaceuticals,Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2758_e546bbbc-8b79-421b-e053-2a95a90a40c8	68071-2758	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180912		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-2759_e17ef157-3e4d-3af8-e053-2a95a90a7f73	68071-2759	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2760_e17ece58-b0e9-73cf-e053-2a95a90ac8a2	68071-2760	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA079172	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2761_0c81fa69-5855-a37e-e063-6394a90a19c6	68071-2761	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2762_e181c08c-1262-381a-e053-2995a90aa86b	68071-2762	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-2763_e183c5af-92d2-f70e-e053-2a95a90ac726	68071-2763	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20210427		ANDA	ANDA090469	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2764_e1854cc8-fae0-39d6-e053-2a95a90aad4b	68071-2764	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20181228		ANDA	ANDA211256	NuCare Pharmaceuticals,Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2765_e1935247-6277-7c6b-e053-2995a90a6393	68071-2765	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2766_e327ed6a-189c-f510-e053-2a95a90a0e37	68071-2766	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2767_e1ab6b63-27c2-3bfa-e053-2995a90af20a	68071-2767	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-2768_fe2dd0d7-36fc-154e-e053-6394a90a88d4	68071-2768	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210412		ANDA	ANDA205229	NuCare Pharmaceuticals,Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68071-2769_e20d5c15-7941-1c16-e053-2995a90acc2d	68071-2769	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	NuCare Pharmaceuticals,Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2770_e3dab203-488e-af9d-e053-2995a90a3043	68071-2770	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210412		ANDA	ANDA205229	NuCare Pharmaceuticals,Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68071-2771_e456fb69-a686-4fa8-e053-2a95a90ae984	68071-2771	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	NuCare Pharmaceuticals,Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2772_e23743b5-6540-26d1-e053-2a95a90a43aa	68071-2772	HUMAN PRESCRIPTION DRUG	TOBRAMYCIN AND DEXAMETHASONE		tobramycin and dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20220317		ANDA	ANDA212715	NuCare Pharmaceuticasl,Inc.	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2773_e285434f-d832-b6e7-e053-2995a90a1ab2	68071-2773	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	NuCare Pharmaceuticals,Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2774_e2ae50b2-ab07-e920-e053-2a95a90ac144	68071-2774	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	NuCare Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-2775_e845be92-8263-2844-e053-2a95a90aac3a	68071-2775	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	NuCare Pharmceuticals,Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2776_0bdd23d0-5a85-eda7-e063-6394a90a37ca	68071-2776	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	NuCare Pharmaceuticals,Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2777_fa422c81-576b-2699-e053-6394a90a53b5	68071-2777	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20220110		ANDA	ANDA207774	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2778_e2aeebcb-c8a4-660e-e053-2995a90ab603	68071-2778	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	NuCare Pharmaceuticals,Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2779_e2c52a30-3956-a096-e053-2995a90a8184	68071-2779	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20180731		ANDA	ANDA209313	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-2780_0946b129-9120-41a7-e063-6394a90ac963	68071-2780	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	NuCare Pharmaceuticals,Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2781_0bdd08c0-83f1-e84a-e063-6394a90adb77	68071-2781	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	NuCare Pharmaceuticals,Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2782_e327a639-68a5-920a-e053-2995a90aa577	68071-2782	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA211977	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2783_f759f298-22ff-6fbb-e053-6394a90a7b44	68071-2783	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	NuCare Pharmaceuticals,Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2784_e38c91de-a328-500e-e053-2995a90aee7a	68071-2784	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	NuCare Pharmaceuticals,Inc.	MIRTAZAPINE	15	mg/1			N	20241231
68071-2785_e38c5f83-51e8-8fd7-e053-2a95a90a99b0	68071-2785	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20180215		ANDA	ANDA204901	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2786_e389a6d7-085d-2499-e053-2995a90aff0e	68071-2786	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-2787_f79789e2-0e0e-b9d5-e053-6294a90abd86	68071-2787	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20220110		ANDA	ANDA207774	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2788_e38c40c7-f0c6-7143-e053-2a95a90a8519	68071-2788	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2789_e845d870-00c2-69d7-e053-2a95a90ad021	68071-2789	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2790_fe97bb6c-5499-07dc-e053-6394a90acd98	68071-2790	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-2791_0bdd5cf0-abdc-fa85-e063-6394a90a4b83	68071-2791	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	NuCare Pharmaceuticals,Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
68071-2792_e3c896c5-52d6-7771-e053-2995a90a30db	68071-2792	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED	ORAL	19861001		ANDA	ANDA070994	NuCare Pharmaceuticals,Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-2793_e3c896c5-52d8-7771-e053-2995a90a30db	68071-2793	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	NuCare Pharmaceuticals,Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2794_e4164d25-9eb4-72a8-e053-2a95a90a5d85	68071-2794	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2795_e42c5abb-492e-d19b-e053-2995a90a7e3e	68071-2795	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, COATED	ORAL	20210701		OTC MONOGRAPH FINAL	part343	NuCare Pharmaceuticals,Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68071-2796_e42bc80d-47e3-7eeb-e053-2a95a90ac877	68071-2796	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-2797_e42c3275-3b24-06f0-e053-2995a90aa978	68071-2797	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2798_e42c47b1-e6d0-3100-e053-2995a90ae8be	68071-2798	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2799_e42f876d-0467-c4d5-e053-2a95a90ae6d4	68071-2799	HUMAN OTC DRUG	Tussin CF		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20140729		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68071-2800_e42fa1c6-d803-630f-e053-2995a90add6b	68071-2800	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68071-2801_e4b9c21f-ac5b-dc73-e053-2a95a90a1aaa	68071-2801	HUMAN OTC DRUG	Childrens Loratadine Oral		Loratadine	SOLUTION	ORAL	20190212		ANDA	ANDA075728	NuCare Pharmaceuticals,Inc.	LORATADINE	5	mg/5mL			N	20241231
68071-2802_e4d04b46-0463-843b-e053-2a95a90aed2b	68071-2802	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-2804_e5d40983-9ce7-223e-e053-2a95a90ae04b	68071-2804	HUMAN PRESCRIPTION DRUG	SSD Cream		Silver Sulfadiazine	CREAM	TOPICAL	20110504		NDA	NDA018578	NuCare Pharmaceuticals,Inc.	SILVER SULFADIAZINE	10	g/1000g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
68071-2805_e5beb9d7-978e-defd-e053-2995a90ac514	68071-2805	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-2806_e60de4bb-935d-0aba-e053-2995a90a2360	68071-2806	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2807_e582a023-1384-79d3-e053-2995a90aa565	68071-2807	HUMAN PRESCRIPTION DRUG	PROCTOZONE-HC		hydrocortisone 2.5%	CREAM	TOPICAL	20150803		ANDA	ANDA040879	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2808_e5bf0ef1-02a9-0b9d-e053-2995a90a763f	68071-2808	HUMAN PRESCRIPTION DRUG	Fluocinonide Cream		Fluocinonide	CREAM	TOPICAL	20171001		ANDA	ANDA210554	NuCare Pharmaceuticals,Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2809_e8d008d9-4d8b-9db3-e053-2995a90a4e80	68071-2809	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-2810_e5d62463-4073-3851-e053-2995a90aa758	68071-2810	HUMAN OTC DRUG	Oxymetazoline HCl		Oxymetazoline HCl	SPRAY	NASAL	20181012		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
68071-2811_eedee891-040b-484d-e053-2995a90a8766	68071-2811	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2812_e64e1b44-75c5-a839-e053-2995a90a459c	68071-2812	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20180501		ANDA	ANDA209504	NuCare Pharmaceuticals,Inc.	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68071-2813_e64d03ac-4409-3d5a-e053-2995a90a7c5a	68071-2813	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20131121		ANDA	ANDA202925	NuCare Pharmaceuticals,Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
68071-2815_e69c6207-cb1d-7b7c-e053-2a95a90a35fd	68071-2815	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2816_e673e040-593f-f9dd-e053-2995a90a0917	68071-2816	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2817_e6d9439f-17cd-2840-e053-2995a90acb1a	68071-2817	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20211227		ANDA	ANDA084657	NuCare Pharmaceuticals,Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68071-2818_e6ebbf48-7df3-5afa-e053-2a95a90a3526	68071-2818	HUMAN OTC DRUG	HYDROCORTISONE		HYDROCORTISONE	CREAM	TOPICAL	20210629		OTC MONOGRAPH NOT FINAL	part348	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2819_e70108bd-ddd0-04f6-e053-2a95a90a01c0	68071-2819	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20190724		ANDA	ANDA212557	NuCare Pharmaceuticals,Inc.	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-2820_e72bade7-af11-af6d-e053-2a95a90aaebc	68071-2820	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	NuCare Pharmaceuticals,Inc.	PREGABALIN	100	mg/1		CV	N	20241231
68071-2821_e72bf35b-acca-3562-e053-2995a90aeff3	68071-2821	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180701		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-2822_e778b3e9-d193-464f-e053-2995a90a707c	68071-2822	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA071523	NuCare Pharmaceuticals,Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68071-2823_ea3a85aa-e8e8-1b2e-e053-2a95a90aedb7	68071-2823	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-2825_e7b5cc69-25a4-3d5e-e053-2995a90a0b78	68071-2825	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20220218		ANDA	ANDA078284	NuCare Pharmaceuticals,Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68071-2826_e82e7508-a731-1a06-e053-2995a90aa0b0	68071-2826	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071135	NuCare Pharmaceuticals,Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2827_e845a1d5-1d06-8ebe-e053-2a95a90ad26e	68071-2827	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20210311		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68071-2828_fe97c8a5-e095-7fcd-e053-6394a90aad0c	68071-2828	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071135	NuCare Pharmaceuticals,Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2829_ec1ca766-e631-d38d-e053-2995a90ab37c	68071-2829	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-2830_e8a75f4d-daa3-1158-e053-2995a90a3728	68071-2830	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20151101		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-2831_e8a56651-a291-7609-e053-2a95a90a7c36	68071-2831	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN		TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20051216		ANDA	ANDA077184	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-2832_e8cfdbec-ad50-a54d-e053-2995a90a35db	68071-2832	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	NuCare Pharmaceuticals,Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68071-2833_ef42dcb3-c843-7393-e053-2995a90ae27e	68071-2833	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	NuCare Pharmaceuticals,Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68071-2834_ef54fd2a-df63-ba37-e053-2a95a90aafb7	68071-2834	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20080701		ANDA	ANDA076407	NuCare Pharmaceuticals,Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2836_ef55e245-a756-67e2-e053-2995a90a4ef3	68071-2836	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	SOLUTION	ORAL	20190401		ANDA	ANDA210914	NuCare Pharmaceuticals,Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	2.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2839_f1775df0-5272-38ca-e053-2a95a90a73c0	68071-2839	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20211213		ANDA	ANDA074497	NuCare Pharmaceuticals,Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-2840_f045193c-01cc-5c3c-e053-2995a90a10aa	68071-2840	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	NuCare Pharmaceuticals,Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68071-2841_fd79a9e4-09cb-6427-e053-6394a90ad837	68071-2841	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	NuCare Pharmaceuticals,Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-2842_fc8734cc-7f77-07ff-e053-6394a90a0aa3	68071-2842	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-2843_ea3c7866-f531-8bcb-e053-2995a90ac00c	68071-2843	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-2844_ea3e248d-a47f-74d7-e053-2a95a90add6e	68071-2844	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20220228		ANDA	ANDA078963	NuCare Pharmaceuticals,Inc.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
68071-2845_ea5061d6-c80b-c7fd-e053-2a95a90ad186	68071-2845	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA077619	NuCare Pharmaceuticals,Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2846_ea764c40-6648-3f9f-e053-2a95a90a4239	68071-2846	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, FILM COATED	ORAL	20160101		ANDA	ANDA204290	NuCare Pharmceuticals,Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68071-2847_eab50ff0-fccd-5f69-e053-2995a90a7aeb	68071-2847	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole Cream, 2%	CREAM	TOPICAL	20210527		ANDA	ANDA212443	NuCare Pharmaceuticals,Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-2848_eab1d8a7-e4e3-65bf-e053-2995a90a1b40	68071-2848	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2849_eaeedb0c-bc6a-b131-e053-2a95a90a7ddf	68071-2849	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	NuCare Pharmaceuticals,Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
68071-2850_ebca0435-7b86-edcf-e053-2995a90a7374	68071-2850	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20060928		ANDA	ANDA076592	NuCare Pharmaceuticals,Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2851_ebca319a-d2ea-b5bd-e053-2a95a90abeff	68071-2851	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA065093	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2852_ebf49364-6e16-84b8-e053-2a95a90aaa0a	68071-2852	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2853_ebca319a-d330-b5bd-e053-2a95a90abeff	68071-2853	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020314		ANDA	ANDA065063	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2854_ebf419f4-69d1-3c39-e053-2a95a90a54c9	68071-2854	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2855_ebf2b303-6369-a27f-e053-2995a90a5a35	68071-2855	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	NuCare Pharmaceuticals,Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2856_ebc989fb-10f1-1da8-e053-2a95a90a54de	68071-2856	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68071-2857_ebc9f451-7cf8-91b9-e053-2995a90a2046	68071-2857	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-2859_ebf29976-4798-da8b-e053-2995a90a5acf	68071-2859	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100715		ANDA	ANDA090931	NuCare Pharmaceuticals,Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-2860_ebf2d63a-37a4-d1bc-e053-2995a90a4bcd	68071-2860	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2861_ebf2aa18-96c9-085f-e053-2995a90af4ee	68071-2861	HUMAN OTC DRUG	cough and chest congestion DM syrup		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220107		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68071-2862_ebf42e5e-df99-65e5-e053-2a95a90a7ac3	68071-2862	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	SOLUTION	ORAL	20190827		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2863_05a89a71-88e0-f4e0-e063-6294a90ae89f	68071-2863	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215579	NuCare Pharmaceuticals,Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68071-2864_ebf3edb9-898d-1dcc-e053-2995a90a911b	68071-2864	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	NuCare Pharmaceuticals,Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-2865_0b7b7161-7cc8-f87f-e063-6294a90a357d	68071-2865	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2866_ec93ad27-aff6-cbc7-e053-2a95a90adc7e	68071-2866	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	NuCare Pharmaceuticals,Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-2867_ec95cdba-e227-cd07-e053-2995a90ae04d	68071-2867	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	NuCare Pharmaceuticals,Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-2868_ec94d19c-33da-dc02-e053-2995a90a01be	68071-2868	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	NuCare Pharmaceuticals,Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68071-2869_ece58736-ebc6-4588-e053-2a95a90a4f43	68071-2869	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20050825		ANDA	ANDA065136	NuCare Pharmaceuticals,Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-2870_ecf96b50-744b-7a12-e053-2995a90a9286	68071-2870	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	LIQUID	ORAL	20210505		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68071-2871_ed0e31e3-f453-eb81-e053-2995a90aaf61	68071-2871	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2872_ed0f6649-5fe5-be7b-e053-2995a90a149d	68071-2872	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2873_f31fa3a7-5a5d-0be1-e053-2995a90a8a61	68071-2873	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	NuCare Pharmaceuticals,Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68071-2874_ed1fe230-2cf7-3939-e053-2a95a90aa8b8	68071-2874	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000101		OTC MONOGRAPH NOT FINAL	part334	NuCare Pharmaceuticals,Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
68071-2875_ed20f445-e129-2dcc-e053-2995a90aa567	68071-2875	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20140915		ANDA	ANDA204030	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2876_fc649340-1685-64cc-e053-6294a90a4d79	68071-2876	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	NuCare Pharmaceuticals,Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2877_fe97bdeb-f403-b322-e053-6294a90a393c	68071-2877	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	NuCare Pharmaceuticals,Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2878_edb07094-9950-c7cf-e053-2a95a90ab494	68071-2878	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2879_ee8f081f-f787-8f93-e053-2995a90ada0f	68071-2879	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET, FILM COATED	ORAL	20060329		ANDA	ANDA065308	NuCare Pharmaceuticals,Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2880_edb1e8e3-6387-7976-e053-2a95a90a11cd	68071-2880	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-2881_edb256e9-87cf-1fa5-e053-2995a90ac065	68071-2881	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190701		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68071-2882_edfebcb7-3f16-3c47-e053-2a95a90aa962	68071-2882	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	NuCare Pharmaceuticals,Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68071-2883_ee27ea1a-c046-9030-e053-2995a90a131e	68071-2883	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	NuCare Pharmaceuticals,Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2884_edc61150-9890-f0d6-e053-2995a90a0eaa	68071-2884	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	NuCare Pharmaceuticals,Inc.	MIRTAZAPINE	30	mg/1			N	20241231
68071-2885_edfe5da0-ee94-30c2-e053-2995a90ae175	68071-2885	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2886_ee00c2b1-e744-2e85-e053-2995a90aa68c	68071-2886	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	NuCare Pharmaceuticals,Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68071-2887_ee16e538-95bc-e59f-e053-2a95a90afc10	68071-2887	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20190724		ANDA	ANDA212557	NuCare Pharmaceuticals,Inc.	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-2888_079b3675-6159-1aac-e063-6394a90abb95	68071-2888	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	NuCare Pharmaceuticals,Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68071-2889_ee278959-d322-d356-e053-2995a90a32c2	68071-2889	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2890_ef309620-1cfc-d007-e053-2995a90ad46f	68071-2890	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-2891_07ffde27-ce8d-0a6f-e063-6294a90afcaf	68071-2891	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA077619	NuCare Pharmaceuticals,Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2892_07139330-ad53-4683-e063-6394a90a5416	68071-2892	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	20211011		ANDA	ANDA215585	NuCare Pharmaceuticals,Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2893_ef4419f4-737a-8235-e053-2995a90a9c72	68071-2893	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2894_ef17b4bf-f210-4a6d-e053-2a95a90ae494	68071-2894	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin otic	SOLUTION	AURICULAR (OTIC)	20220715		ANDA	ANDA216130	NuCare Pharmaceuticals,Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2895_f072c3b4-9e9d-268a-e053-2995a90a13e0	68071-2895	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20090102		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2896_ef2c6763-aa38-231a-e053-2a95a90a6f9a	68071-2896	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091569	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2897_ef418032-f794-3d37-e053-2a95a90ae171	68071-2897	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	19861216		ANDA	ANDA089414	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2898_ef44375f-9af9-7bfe-e053-2a95a90a2bef	68071-2898	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180628		ANDA	ANDA202023	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2899_ef58edcf-6aa6-b42f-e053-2995a90a32a4	68071-2899	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	NuCare Pharmaceuticals,Inc.	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68071-2901_ef6ce20b-e89c-2c82-e053-2a95a90a9afd	68071-2901	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	NuCare Pharmaceuticals,Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2902_efbb79b8-9616-3ad9-e053-2a95a90afdc8	68071-2902	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	TABLET	ORAL	19990615		ANDA	ANDA075319	NuCare Pharmaceuticals,Inc.	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-2903_fdf13ddd-3545-c650-e053-6394a90aec56	68071-2903	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2904_f05b47da-657f-6cf0-e053-2a95a90a02bb	68071-2904	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220411		ANDA	ANDA076095	NuCare Pharmaceuticals,Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
68071-2905_f05c3c9f-06a5-7efb-e053-2995a90a4a70	68071-2905	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2906_f06ec567-fcb0-2cf8-e053-2a95a90a9cc3	68071-2906	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-2907_f0fca0ef-a8fb-6086-e053-2995a90a4265	68071-2907	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	NuCare Pharmaceuticals,Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2908_f1740cdc-19eb-49bf-e053-2995a90acc70	68071-2908	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2909_f2043a6d-4a19-d883-e053-2995a90a760b	68071-2909	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20210427		ANDA	ANDA090469	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2910_f19d5a21-990c-9fb5-e053-2995a90aa9fc	68071-2910	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin otic	SOLUTION	AURICULAR (OTIC)	20220715		ANDA	ANDA216130	NuCare Pharmceuticals,Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2911_f1eee459-9022-b26e-e053-2995a90a7291	68071-2911	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-2912_0a9d6f57-9655-e06d-e063-6294a90a7f1b	68071-2912	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	NuCare Pharmaceuticals,Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
68071-2913_f2041085-9a2a-de1f-e053-2a95a90a8d63	68071-2913	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-2914_f2041d6b-be6b-7baa-e053-2a95a90a50e7	68071-2914	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20070222		ANDA	ANDA071745	NuCare Pharmaceuticals,Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-2915_f27d6323-64c9-bb30-e053-2995a90a3b8b	68071-2915	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20091008		ANDA	ANDA078633	NuCare Pharmaceuticals,Inc.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
68071-2916_f27ca493-48a8-9e49-e053-2a95a90ad5c2	68071-2916	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2917_f2f6a569-9a1d-c3fa-e053-2a95a90aa1c8	68071-2917	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190917		ANDA	ANDA078279	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2918_f2f68c92-247b-6aa4-e053-2a95a90a72a9	68071-2918	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20151210		ANDA	ANDA078279	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2919_f2f75071-7af0-5f6e-e053-2995a90a0229	68071-2919	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210319		ANDA	ANDA213486	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2920_f2f67abe-f214-a19e-e053-2995a90a6b3f	68071-2920	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2921_f31c5f71-e062-f191-e053-2995a90a8674	68071-2921	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	NuCare Pharmaceuticals,Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-2922_f31e5472-7f8d-0f42-e053-2995a90a19b3	68071-2922	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2923_f32e70e0-53ad-3ea5-e053-2a95a90aa24e	68071-2923	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-2924_ff5bb628-8f13-4540-e053-6394a90a55ed	68071-2924	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-2925_f332a521-225c-20a9-e053-2a95a90adaf1	68071-2925	HUMAN OTC DRUG	LIDOCAINE		LIDOCAINE	PATCH	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part348	NuCare Pharmaceuticals,Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68071-2926_ffe98086-b5bc-4731-e053-6394a90a28dc	68071-2926	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	NuCare Pharmaceuticals,Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68071-2927_f3d2c578-f812-189e-e053-2995a90a3834	68071-2927	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	TABLET	ORAL	20220629		ANDA	ANDA040864	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
68071-2928_082ce9e5-e5cb-f78c-e063-6294a90a2bce	68071-2928	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68071-2929_f40f15a9-c3bd-7040-e053-2995a90a0bab	68071-2929	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	NuCare Pharmaceuticals,Inc.	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-2930_f40d1835-55e0-113b-e053-2995a90ac702	68071-2930	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	NuCare Pharmaceuticals,Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-2931_f4102584-a6b9-b874-e053-2a95a90aaa97	68071-2931	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210825		ANDA	ANDA210086	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-2932_f5c82742-fb28-62a2-e053-2a95a90aa7c4	68071-2932	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68071-2933_f433545c-5274-c162-e053-2a95a90a7e8d	68071-2933	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091569	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2934_f4ae940e-1a71-b2e0-e053-2a95a90aebb8	68071-2934	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190220		ANDA	ANDA076301	NuCare Pharmaceuticals,Inc.	LORATADINE	10	mg/1			N	20241231
68071-2935_f4d5137d-b898-9bee-e053-2a95a90a5f5a	68071-2935	HUMAN OTC DRUG	GUAIFENESIN and CODEINE PHOSPHATE		GUAIFENESIN and CODEINE PHOSPHATE	SOLUTION	ORAL	20220523		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
68071-2936_f4bf98a3-6886-ea90-e053-2995a90a7510	68071-2936	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	NuCare Pharmaceuticals,Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68071-2937_f4d68ea8-f24e-c982-e053-2995a90a4789	68071-2937	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2938_f4ed878d-cfbc-326e-e053-2a95a90aad04	68071-2938	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070131		ANDA	ANDA065282	NuCare Pharmaceuticals,Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2939_f8fe8a91-48b2-b27c-e053-6294a90a73b7	68071-2939	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2940_f4d822bb-8b53-8f74-e053-2a95a90aa4bb	68071-2940	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20170906		ANDA	ANDA065234	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2941_f4ea9cfa-e40f-aa4f-e053-2a95a90ab236	68071-2941	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20221003		ANDA	ANDA211604	NuCare Pharmaceuticals,Inc.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68071-2942_f52708dc-a869-658e-e053-2995a90a188c	68071-2942	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20041208		ANDA	ANDA076925	NuCare Pharmaceuticals,Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2943_f562bb10-d0be-219b-e053-2a95a90afdc1	68071-2943	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	VAGINAL	19970113		ANDA	ANDA074444	NuCare Pharmaceuticals,Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2944_f560ead8-9470-3c79-e053-2995a90a9ea2	68071-2944	HUMAN PRESCRIPTION DRUG	Fluocinonide		fluocinonide topical solution usp, 0.05%	SOLUTION	TOPICAL	20190419		ANDA	ANDA209699	NuCare Pharmaceuticals,Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-2945_02e5eb03-05a2-c55c-e063-6394a90ae076	68071-2945	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA203494	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-2946_f5cb3d01-c1b7-6602-e053-2995a90a3ae2	68071-2946	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2947_fd79a9e4-09cc-6427-e053-6394a90ad837	68071-2947	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2948_f5ca7592-9baa-c620-e053-2a95a90aacb4	68071-2948	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2949_f63db7e1-71ce-325c-e053-2995a90aa071	68071-2949	HUMAN PRESCRIPTION DRUG	Lopinavir and Ritonavir		Lopinavir and Ritonavir	TABLET, FILM COATED	ORAL	20220321		ANDA	ANDA213857	NuCare Pharmaceuticals,Inc.	LOPINAVIR; RITONAVIR	200; 50	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
68071-2950_f7f8ebb9-99ee-8730-e053-6394a90a6225	68071-2950	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, COATED	ORAL	20210701		OTC MONOGRAPH FINAL	part343	NuCare Pharmaceuticals,Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68071-2951_f7e8b3eb-96bb-ffef-e053-6294a90ad6d5	68071-2951	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	NuCare Pharmaceuticals,Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-2952_0bb3a773-16e8-24ac-e063-6394a90af307	68071-2952	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA203494	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-2953_f7f98018-dcd7-1219-e053-6294a90acdf0	68071-2953	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2954_f7f957e0-f821-dbd4-e053-6294a90a535c	68071-2954	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	NuCare Pharmaceuticals,Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2955_f6914a0d-4770-6fcd-e053-2995a90ae076	68071-2955	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-2956_0aae4bf0-5cbb-eaf3-e063-6294a90a8d5c	68071-2956	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68071-2957_f78050f2-52f5-53ea-e053-6394a90a3146	68071-2957	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2958_f75c5f90-9c8b-c63e-e053-6394a90a2692	68071-2958	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET, FILM COATED	ORAL	20060329		ANDA	ANDA065308	NuCare Pharmaceuticals,Inc.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2959_f7e6a78e-7ac2-35b9-e053-6294a90aabd0	68071-2959	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	NuCare Pharmaceuticals,Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68071-2960_f75b6dc9-c88e-1a16-e053-6394a90a5cf9	68071-2960	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	NuCare Pharmaceuticals,Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68071-2961_f75c52ad-6cbf-8f58-e053-6394a90ad2a4	68071-2961	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	CREAM	TOPICAL	20211111		ANDA	ANDA214845	NuCare Pharmaceuticals,Inc.	FLUOROURACIL	50	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68071-2962_fcffb6b1-1d44-aa38-e053-6294a90adaad	68071-2962	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	NuCare Pharmaceuticals,Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68071-2963_f7706a65-7609-765a-e053-6394a90a83dd	68071-2963	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	19951019		NDA AUTHORIZED GENERIC	NDA050710	NuCare Pharmaceuticals,Inc,	AZITHROMYCIN DIHYDRATE	900	mg/22.5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-2964_f7e6d4c4-5eec-29e8-e053-6394a90af125	68071-2964	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20180618		ANDA	ANDA209912	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2965_0d0898e9-7031-710d-e063-6294a90a1b26	68071-2965	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2966_0b4cae4b-26a6-e716-e063-6294a90a7a0f	68071-2966	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2967_f8242375-84c4-210c-e053-6294a90a6b24	68071-2967	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	NuCare Pharmaceuticals,Inc.	ATORVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2968_f826c86a-0958-843d-e053-6394a90a5c7c	68071-2968	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	NuCare Pharmaceuticals,Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68071-2969_f8ade1d8-d0d9-458c-e053-6394a90aad6f	68071-2969	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20210406		ANDA	ANDA078539	NuCare Pharmaceuticals,Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-2970_f8ad6aba-8ecf-d002-e053-6394a90ae655	68071-2970	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-2971_0061f18d-733b-4ad3-e063-6294a90a70fe	68071-2971	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET	ORAL	20220731		ANDA	ANDA210722	NuCare Pharmaceuticals,Inc.	LORATADINE	10	mg/1			N	20241231
68071-2972_f8fd7e1d-471e-f4ae-e053-6294a90a8b41	68071-2972	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	NuCare Pharmaceuticals,Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-2973_fbd19f25-cfe0-5bb2-e053-6294a90aa616	68071-2973	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077802	NuCare Pharmaceuticals,Inc.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-2974_f8ff0493-9842-2158-e053-6394a90a5b1e	68071-2974	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211117		ANDA	ANDA077633	NuCare Pharmaceuticals,Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68071-2975_f98e6469-de7f-9b0c-e053-6294a90a96b5	68071-2975	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	NuCare Pharmaceuticals,Inc.	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-2976_070e16ca-64ad-093b-e063-6394a90aa455	68071-2976	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-2977_f98e9d7a-6954-6a4b-e053-6294a90ac363	68071-2977	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	20200423		ANDA	ANDA089424	NuCare Pharmaceuticals,Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68071-2978_f9905f4e-1b1d-c7e7-e053-6294a90a9545	68071-2978	HUMAN OTC DRUG	Miconazole Nitrate Cream 2%		Miconazole Nitrate	CREAM	TOPICAL	20210819		OTC MONOGRAPH FINAL	part333C	NuCare Pharmaceuticals,Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-2979_fbd2091d-788b-41ae-e053-6394a90a3f39	68071-2979	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	NuCare Pharmaceuticals,Inc.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2980_f9b4b80c-1797-133b-e053-6394a90aeb1e	68071-2980	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	NuCare Pharmaceuticals,Inc.	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-2981_f9c8c5b2-64e1-6ce4-e053-6294a90a36eb	68071-2981	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210201		ANDA	ANDA210420	NuCare Pharmaceuticals,Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2982_f9b4d18b-262f-604f-e053-6394a90a5531	68071-2982	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA065063	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-2983_fe7e8dd7-61e0-70f1-e053-6394a90a2648	68071-2983	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20221110		ANDA	ANDA217038	NuCare Pharmaceuticals,Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2984_f9b4d263-bc59-6065-e053-6394a90a5e35	68071-2984	HUMAN PRESCRIPTION DRUG	Acetic Acid		Acetic Acid	SOLUTION	AURICULAR (OTIC)	20200605		ANDA	ANDA040607	NuCare Pharmaceuticals,Inc.	ACETIC ACID	20.65	mg/mL			N	20241231
68071-2985_f98d514c-05a5-62e0-e053-6294a90a3be5	68071-2985	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180628		ANDA	ANDA202023	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-2987_f98d25a7-6b72-38a9-e053-6394a90a541d	68071-2987	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	NuCare Pharmaceuticals,Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
68071-2988_fa53fbe8-decd-7e98-e053-6394a90a2ed7	68071-2988	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	NuCare Pharmaceuticals,Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68071-2989_05a8d755-a75a-6a75-e063-6394a90a76c3	68071-2989	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	NuCare Pharmaceuticals,Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68071-2990_fa1db27f-7f98-61b3-e053-6394a90a875c	68071-2990	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-2991_fa2d9782-4ce1-76d7-e053-6294a90a553a	68071-2991	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2992_fa43f66c-9ae5-cd36-e053-6394a90a1526	68071-2992	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20221025		ANDA	ANDA211064	NuCare Pharmaceuticals,Inc.	FOLIC ACID	1	mg/1			N	20241231
68071-2993_fa43e7f9-cab2-99ad-e053-6394a90a732f	68071-2993	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	NuCare Pharmaceuticals,Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-2994_faba7fc1-2e09-74ef-e053-6394a90afd04	68071-2994	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-2995_fbd7f407-a9cd-60f8-e053-6394a90ad3eb	68071-2995	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	NuCare Pharmaceuticals,Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
68071-2996_fc9b9876-4c35-eee9-e053-6294a90ad2ad	68071-2996	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	NuCare Pharmaceuticals,Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68071-2997_06868e0f-bb6d-2c2a-e063-6394a90a97dc	68071-2997	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	NuCare Pharmaceuticals,Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68071-2998_fae5506f-aab4-2604-e053-6394a90abdcc	68071-2998	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-2999_fe7e87b7-29c3-fb72-e053-6294a90adffe	68071-2999	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20170105		ANDA	ANDA204304	NuCare Pharmaceuticals,Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-3001_005066b6-19b1-2571-e063-6394a90a1da8	68071-3001	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051201		ANDA	ANDA077241	NuCare Pharmaceuticals, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-3004_e844a4cf-bbac-21a0-e053-2995a90a1f6c	68071-3004	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	NuCare Pharmaceuticals,Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-3007_00506c2b-31da-0d26-e063-6394a90a413d	68071-3007	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	NuCare Pharmaceuticals,Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-3008_0050701f-4391-3f01-e063-6394a90a4e0e	68071-3008	HUMAN PRESCRIPTION DRUG	Lisinopril and hydrochlorothiazide		Lisinopril and hydrochlorothiazide	TABLET	ORAL	20030301		ANDA	ANDA076194	NuCarePharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-3009_0050701f-4392-3f01-e063-6394a90a4e0e	68071-3009	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20110718		ANDA	ANDA074550	NuCare Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-3012_00505b4a-7d50-04ea-e063-6394a90ac3b9	68071-3012	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	NuCare Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-3013_d775d14f-e409-2347-e053-2a95a90a65dc	68071-3013	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	NuCare Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-3030_f691006d-973e-6661-e053-2a95a90afbb2	68071-3030	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	NuCare Pharmaceuticals,Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3034_d5932692-d9c9-606d-e053-2a95a90a8cf3	68071-3034	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20100406		ANDA	ANDA077289	NuCare Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-3037_d7758b3f-13e4-130f-e053-2995a90ad42b	68071-3037	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077135	NuCare Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-3039_f4af2440-3f32-36bc-e053-2995a90ab038	68071-3039	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	NuCare Pharmaceuticals, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-3044_0052dab8-1195-8c0b-e063-6394a90abbde	68071-3044	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20121015		ANDA	ANDA090460	NuCare Pharmaceuticals, Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-3064_e35044bd-98b0-c38d-e053-2995a90a2341	68071-3064	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	NuCare Pharmaceuticals,Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-3092_d592fca4-8cd4-7771-e053-2a95a90aff3c	68071-3092	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	NuCare Pharmaceuticals, Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3096_091a272a-59d7-cf30-e063-6294a90adeeb	68071-3096	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	NuCare Pharmaceuticals, Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-3100_d775d9ad-438c-17ee-e053-2995a90a38f4	68071-3100	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20170105		ANDA	ANDA202800	NuCare Pharmaceuticals, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68071-3107_d5cbb013-7d90-27b4-e053-2995a90a4474	68071-3107	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065101	NuCare Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-3119_faf4821d-e53d-a0fa-e053-6294a90a4d3e	68071-3119	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-3121_ff999514-264e-e411-e053-6394a90a5ebe	68071-3121	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	NuCare Pharmaceuticals, Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-3123_e672908c-4b1d-0c8a-e053-2995a90a99c5	68071-3123	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	NuCare Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-3125_d5930cc8-00b8-de99-e053-2a95a90ae51b	68071-3125	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3127_de1eefb2-2cbd-7c9f-e053-2995a90aef85	68071-3127	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	NuCare Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3138_edc6c466-0b18-fcac-e053-2a95a90a1be6	68071-3138	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	NuCare Pharmaceuticals, Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68071-3143_f306adae-a2fd-5477-e053-2995a90a7838	68071-3143	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	NuCare Pharmaceuticals,Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-3146_d775d9ad-438d-17ee-e053-2995a90a38f4	68071-3146	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	NuCare Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-3156_ed21a75e-1a08-ea65-e053-2a95a90afeee	68071-3156	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070508		ANDA	ANDA065332	NuCare Pharmaceuticals, Inc.	CEFDINIR MONOHYDRATE	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-3172_07868eda-f6f4-24fe-e063-6394a90a288f	68071-3172	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	NuCare Pharmaceuticals,Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3177_d7756fe8-00c9-1404-e053-2995a90a4d3e	68071-3177	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060410		ANDA	ANDA077912	NuCare Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-3181_d775d9ad-438e-17ee-e053-2995a90a38f4	68071-3181	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-3194_039a0f22-520d-ce60-e063-6294a90a83a3	68071-3194	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-3198_d5930cc8-00ba-de99-e053-2a95a90ae51b	68071-3198	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20150202		ANDA	ANDA203034	NuCare Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68071-3211_d590fef1-58b2-db06-e053-2995a90a6770	68071-3211	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	NuCare Pharmaceuticals, Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-3216_e4cddf04-1226-42e1-e053-2a95a90afff4	68071-3216	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	NuCare Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-3220_d7756fe8-00ca-1404-e053-2995a90a4d3e	68071-3220	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	NuCare Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-3222_f690e186-4fa6-27c9-e053-2995a90abe50	68071-3222	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	NuCare Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-3234_f06e8d5d-24c4-80a1-e053-2995a90aa4a9	68071-3234	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	NuCare Pharmaceuticals,Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-3235_e4f49a7e-0696-7928-e053-2995a90a1d15	68071-3235	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-3236_d775f29f-40a1-291f-e053-2a95a90ab16b	68071-3236	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	NuCarePharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
68071-3238_f5c62560-0b60-0fa6-e053-2a95a90a0024	68071-3238	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20090702		ANDA	ANDA040907	NuCare Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-3249_f98cf0cc-78cd-ca72-e053-6394a90a0be6	68071-3249	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20120913		ANDA	ANDA200243	NuCare Pharmaceuticals, Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
68071-3261_e8075a86-42c4-553a-e053-2995a90a55cb	68071-3261	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	NuCare Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3265_e11b27ab-5a2b-76c4-e053-2a95a90a7293	68071-3265	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	NuCare Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-3267_e3531eab-b109-d832-e053-2a95a90af1c5	68071-3267	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA205519	NuCare Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3268_091a3387-1d43-f9e7-e063-6394a90adb14	68071-3268	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	NuCare Pharmaceuticals, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-3273_0ce5d2b3-ddbc-a886-e063-6294a90a1902	68071-3273	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-3298_f80e042f-32fd-dba2-e053-6394a90a4c9b	68071-3298	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	NuCare Pharmaceuticals, Inc.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-3299_ff5c06ee-1646-9a47-e053-6294a90aec34	68071-3299	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	NuCare Pharmaceuticals,Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-3301_d592fca4-8cd7-7771-e053-2a95a90aff3c	68071-3301	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA090467	NuCarePharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-3306_dfaf7e4c-e69e-59c2-e053-2995a90ab7f1	68071-3306	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20100528		ANDA	ANDA090121	NuCare Pharmaceuticals,Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-3332_f37ed6e0-5ccd-4cf0-e053-2995a90af452	68071-3332	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	NuCare Pharmaceuticals,Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-3337_e69c6207-cb1a-7b7c-e053-2a95a90a35fd	68071-3337	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	NuCare Pharmaceuticals, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-3351_ff5a64ca-56b4-6b4f-e053-6394a90aeb7a	68071-3351	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68071-3362_dd42aa43-1587-2c98-e053-2995a90aac40	68071-3362	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3400_0ce65253-8c01-6669-e063-6394a90a3d50	68071-3400	HUMAN PRESCRIPTION DRUG	DIETHYLPROPION HYDROCHLORIDE		DIETHYLPROPION HYDROCHLORIDE	TABLET	ORAL	20101227		ANDA	ANDA201212	NuCare Pharmaceuticals,Inc.	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68071-3401_fbd3ec3b-2a53-a318-e053-6294a90a33e8	68071-3401	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	NuCare Pharmaceuticals,Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-3402_fea9e4ce-3dcc-9404-e053-6294a90af30d	68071-3402	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA204755	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-3403_fbd7827f-0387-0bf3-e053-6294a90a2964	68071-3403	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070507		ANDA	ANDA065259	NuCare Pharmaceuticals,Inc.	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-3404_fbd3a132-a649-2a60-e053-6394a90af39f	68071-3404	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-3406_fbd7739d-71f2-4951-e053-6294a90a8bde	68071-3406	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071136	NuCare Pharmaceuticals,Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-3407_fd00be12-6098-1d4c-e053-6294a90aae87	68071-3407	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	NuCare Pharmaceuticals,Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-3408_fe2d9e90-baab-0ffa-e053-6294a90a8633	68071-3408	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	NuCare Pharmaceuticals,Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-3409_05a8d6e8-9cac-6764-e063-6394a90ab05a	68071-3409	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	NuCare Pharmaceuticals,Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-3410_fbe71308-2960-2467-e053-6394a90aa419	68071-3410	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-3411_ffd51030-f5c5-936e-e053-6394a90a9d9f	68071-3411	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	NuCare Pharmaceuticals,Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-3412_fc1301cf-a0a1-b0d7-e053-6394a90aa13f	68071-3412	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190220		ANDA	ANDA076301	NuCare Pharmaceuticals,Inc.	LORATADINE	10	mg/1			N	20241231
68071-3413_fc603137-6861-6568-e053-6394a90aa4b1	68071-3413	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	NuCare Pharmceuticals,Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-3414_fc638c2d-66e4-a149-e053-6394a90a3f4f	68071-3414	HUMAN OTC DRUG	Loratadine	antihistamine	Loratadine	TABLET	ORAL	20081015		ANDA	ANDA076301	NuCare Pharmaceuticals,Inc.	LORATADINE	10	mg/1			N	20241231
68071-3415_fc873849-3099-09f9-e053-6394a90a561b	68071-3415	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3416_fc8b57eb-11c0-9204-e053-6294a90afced	68071-3416	HUMAN OTC DRUG	Clotrimazole Cream 1%		Clotrimazole	CREAM	TOPICAL	20210819		OTC MONOGRAPH FINAL	part333C	NuCare Pharmaceuticals,Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-3417_fc9c4996-302d-2ad8-e053-6294a90a5f38	68071-3417	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	NuCare Pharmaceuticals,Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68071-3418_fc9ffbce-cc86-37fa-e053-6294a90adf5e	68071-3418	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	NuCare Pharmaceuticals,Inc.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-3419_fe7d9f8d-06f6-fee1-e053-6294a90af007	68071-3419	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210319		ANDA	ANDA213486	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-3420_05a8e521-a4f4-bebf-e063-6294a90a5631	68071-3420	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-3421_fd039c26-dc80-5738-e053-6394a90af879	68071-3421	HUMAN PRESCRIPTION DRUG	carisoprodol		carisoprodol	TABLET	ORAL	20090806		ANDA	ANDA040792	NuCare Pharmaceuticals,Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
68071-3422_fd0557e6-4b11-f499-e053-6294a90a3db6	68071-3422	HUMAN OTC DRUG	oxymetazoline hydrochloride		oxymetazoline hydrochloride	SPRAY	NASAL	20051205		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
68071-3423_fd165c82-ea95-c943-e053-6294a90a6425	68071-3423	HUMAN OTC DRUG	GERI-LANTA MAXIMUM STRENGTH		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20000101		OTC MONOGRAPH FINAL	part331	NuCare Pharmaceuticals,Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68071-3425_ff3232c0-8f22-d00d-e053-6294a90ae743	68071-3425	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68071-3426_066f6a68-d3b6-0fdc-e063-6294a90a951e	68071-3426	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3427_fd78567b-bcbb-c8a5-e053-6294a90a9e6c	68071-3427	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	NuCare Pharmaceuticals,Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-3428_fd7ed0b6-f5da-8cb5-e053-6294a90afcbc	68071-3428	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-3429_fd7dcbb7-33cd-35ec-e053-6294a90a9c12	68071-3429	HUMAN OTC DRUG	MICONAZOLE Nitrate		MICONAZOLE NITRATE	CREAM	TOPICAL	20160322		OTC MONOGRAPH FINAL	part333C	NuCare Pharmaceuticals,Inc.	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-3430_fd90a5e3-2bd8-7bb6-e053-6294a90a82d9	68071-3430	HUMAN OTC DRUG	Capsaicin	External Analgesic	Capsaicin	CREAM	TOPICAL	20120301		OTC MONOGRAPH NOT FINAL	part348	NuCare Pharmaceuticals,Inc.	CAPSAICIN	.25	mg/g			N	20241231
68071-3431_017a914e-3eaa-20a7-e063-6294a90a97e2	68071-3431	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-3432_fe7de51e-8a80-fe68-e053-6294a90a7339	68071-3432	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-3433_fda12c38-2ce8-2d6d-e053-6294a90a13bc	68071-3433	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-3434_fe054b18-c18e-403c-e053-6294a90a7bff	68071-3434	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20110107		ANDA	ANDA071881	NuCare Pharmaceuticals,Inc.	VERAPAMIL HYDROCHLORIDE	80	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-3435_fe0583bf-9997-e01e-e053-6294a90a0b26	68071-3435	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	NuCare Pharmaceuticals,Inc.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-3436_fdb7de91-e611-8d50-e053-6294a90a4986	68071-3436	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	NuCare Pharmaceuticals,Inc.	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-3437_fdb73326-bcdc-66dd-e053-6294a90a9caa	68071-3437	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20180726		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-3438_fdf3bd3a-a77e-9c37-e053-6294a90a4fde	68071-3438	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20221115		OTC MONOGRAPH NOT FINAL	part334	NuCare Pharmaceuticals,Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
68071-3440_fe2f0c26-1b1a-798a-e053-6294a90a9366	68071-3440	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	NuCare Pharmaceuticals,Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68071-3441_fe82699d-fdc4-038e-e053-6294a90a606c	68071-3441	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20230213		ANDA	ANDA210568	NuCare Pharmaceuticals,Inc.	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-3442_00b738d1-96a3-dcaf-e063-6394a90a7565	68071-3442	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3443_fea598a2-0fbe-b2b0-e053-6294a90a3194	68071-3443	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070312		ANDA	ANDA040707	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-3444_fea87de3-116d-4774-e053-6394a90a0aad	68071-3444	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20211223		ANDA	ANDA090455	NuCare Pharmaceuticals,Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
68071-3445_0100d618-d3c2-be5d-e063-6394a90adc20	68071-3445	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	NuCare Pharmaceuticals,Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-3446_febcb0a3-1a9f-e10f-e053-6394a90a6edb	68071-3446	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110805		ANDA	ANDA090700	NuCare Pharmaceuticals,Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-3447_fed200e2-e180-af55-e053-6294a90a5752	68071-3447	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-3448_ff97b682-ab9f-e891-e053-6294a90ac865	68071-3448	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20221207		ANDA	ANDA215886	NuCare Pharmaceuticals,Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-3449_0050bffd-8ef2-83ac-e063-6394a90a4871	68071-3449	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL; TOPICAL	19850426		ANDA	ANDA088802	NuCare Pharmaceuticals,Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68071-3450_ffd35778-de48-f9a7-e053-6294a90a2877	68071-3450	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	NuCare Pharmaceuticals,Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-3451_0156b658-dd6d-512d-e063-6294a90a3c54	68071-3451	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium Tablets	TABLET, FILM COATED	ORAL	20220512		ANDA	ANDA215750	NuCare Pharmaceuticals,Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3452_ffd30dab-72ce-0922-e053-6394a90aca9a	68071-3452	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20211005		ANDA	ANDA203379	NuCare Pharmaceuticals,Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-3453_0100d618-d3c1-be5d-e063-6394a90adc20	68071-3453	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	10 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	NuCare Pharmaceuticals,Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-3454_0672a6f2-23f7-e03d-e063-6394a90ac6dd	68071-3454	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20210311		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68071-3455_0bdf40ec-f2f0-97df-e063-6394a90a6ca8	68071-3455	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	NuCare Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-3456_00529a3e-3bb4-5112-e063-6294a90a077d	68071-3456	HUMAN OTC DRUG	Diclofenac Sodium		diclofenac sodium	GEL	TOPICAL	20200709		ANDA	ANDA211253	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3457_0060ea32-a400-23d5-e063-6394a90ad90b	68071-3457	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	NuCare Pharmaceuticals,Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-3458_079cdb6b-b851-46bd-e063-6394a90a80ff	68071-3458	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220411		ANDA	ANDA076095	NuCare Pharmaceuticals,Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
68071-3459_00d9abda-9a96-52fc-e063-6294a90a6c50	68071-3459	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-3460_0bdee259-a5c2-7554-e063-6394a90a1b1f	68071-3460	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230321		ANDA	ANDA217272	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68071-3461_00dbf2f4-a05c-30a9-e063-6394a90a62ce	68071-3461	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-3462_01cca28b-fbd8-150a-e063-6394a90a76c5	68071-3462	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-3463_00de23e8-4a66-df96-e063-6394a90a34fc	68071-3463	HUMAN PRESCRIPTION DRUG	QUETIAPINE FUMARATE		QUETIAPINE FUMARATE	TABLET, EXTENDED RELEASE	ORAL	20171130		ANDA	ANDA206252	NuCare Pharmaceuticals,Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-3464_028440ec-99de-e795-e063-6294a90ae247	68071-3464	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210503		ANDA	ANDA213603	NuCare Pharmaceuticals,Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-3465_01f38b69-d15c-f703-e063-6294a90a4c87	68071-3465	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH FINAL	part341	NuCare Pharmaceuticals,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-3466_01540ab3-fc16-dc3c-e063-6294a90a283d	68071-3466	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20191009		ANDA	ANDA211343	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-3467_0153f96a-75ee-2b28-e063-6394a90a657d	68071-3467	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	NuCare Pharmaceuticals,Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-3468_013f7fbb-854a-2f03-e063-6294a90a32d8	68071-3468	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20220126		ANDA	ANDA215885	NuCare Pharmaceuticals,Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-3469_0165eec7-eb93-3d54-e063-6394a90a10aa	68071-3469	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	NuCare Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-3470_01682de6-887d-ee3b-e063-6294a90a560c	68071-3470	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3471_016798a8-4276-47d0-e063-6294a90a5aca	68071-3471	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201001		ANDA	ANDA205064	NuCare Pharmaceuticals,Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68071-3472_016b1d06-0c8b-bb4b-e063-6394a90a1e4f	68071-3472	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	NuCare Pharmaceuticals,Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-3473_01cb5249-88ca-0eb5-e063-6294a90ab579	68071-3473	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		Atovaquone and Proguanil Hydrochloride	TABLET, FILM COATED	ORAL	20110915		ANDA	ANDA091211	NuCare Pharmaceuticals,Inc.	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
68071-3474_01df228e-7cd3-32b1-e063-6294a90ab974	68071-3474	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-3475_05a89a71-88de-f4e0-e063-6294a90ae89f	68071-3475	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-3477_079e0819-6b57-f6fd-e063-6294a90ae92e	68071-3477	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-3478_0206fbcf-0ac5-9aea-e063-6294a90ae21b	68071-3478	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	NuCare Pharmaceuticals,Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
68071-3479_02203683-e847-8ff9-e063-6394a90a9353	68071-3479	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20230102		ANDA	ANDA206173	NuCare Pharmaceuticals,Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-3480_0283e237-067e-f8a8-e063-6294a90abb03	68071-3480	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210601		ANDA	ANDA077321	NuCare Pharmaceuticals,Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-3481_02840ea6-e4a1-96a0-e063-6394a90a19ae	68071-3481	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-3482_032032df-3f0a-3057-e063-6394a90a39e4	68071-3482	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	NuCare Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-3483_0326ea65-d6e8-d03e-e063-6294a90ab2ea	68071-3483	HUMAN OTC DRUG	DICLOFENAC SODIUM		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20200914		ANDA	ANDA210986	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3484_079ac9a2-8a01-2910-e063-6394a90ad858	68071-3484	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	CAPSULE	ORAL	20210808		ANDA	ANDA201336	NuCare Pharmaceuticals,Inc.w	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-3485_0339cad5-9187-2b91-e063-6294a90ae4a1	68071-3485	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	NuCare Pharmaceuticals,Inc.	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-3486_037764de-93d9-2857-e063-6294a90a78a1	68071-3486	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		Lidocaine hydrochloride	SOLUTION	ORAL; TOPICAL	20230328		ANDA	ANDA216780	NuCare Pharmaceuticals,Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68071-3488_03b1784c-ff34-9184-e063-6394a90a30b6	68071-3488	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		Atovaquone and Proguanil Hydrochloride	TABLET, FILM COATED	ORAL	20110915		ANDA	ANDA091211	NuCare Pharmaceuticals,Inc.	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
68071-3489_03b13997-fea4-e33a-e063-6294a90a19eb	68071-3489	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	CREAM	TOPICAL	20100305		ANDA	ANDA090368	NuCare Pharmaceuticals,Inc.	FLUOROURACIL	50	mg/g	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68071-3490_03b1cef1-7f5d-0dd7-e063-6394a90aee6b	68071-3490	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3491_03b214aa-447e-61d0-e063-6394a90a83b4	68071-3491	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20070312		ANDA	ANDA040707	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-3492_03c1e0ae-6082-f9a6-e063-6294a90a6d87	68071-3492	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20211005		ANDA	ANDA203379	NuCare Pharmaceuticals,Inc.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-3493_03c39631-fade-8c39-e063-6394a90ad400	68071-3493	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20211005		ANDA	ANDA203379	NuCare Pharmaceuticals,Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-3494_0403919a-8b62-38d8-e063-6294a90aa48d	68071-3494	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20200814		ANDA	ANDA213358	NuCare Pharmaceuticals,Inc.	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68071-3495_0415ee03-316c-e975-e063-6294a90abf3c	68071-3495	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3496_0415ff20-8844-8aab-e063-6294a90aaf75	68071-3496	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170614		ANDA	ANDA090693	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-3497_0428273f-9cd2-c4fa-e063-6294a90ae594	68071-3497	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-3498_0429fcd3-bdf6-921d-e063-6394a90ab304	68071-3498	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210503		ANDA	ANDA213603	NuCare Pharmaceuticals,Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-3499_043e4beb-5dc1-2fdb-e063-6294a90afded	68071-3499	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68071-3500_049fe4fb-3002-c346-e063-6294a90a0dcd	68071-3500	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3501_05a8d6e8-9caa-6764-e063-6394a90ab05a	68071-3501	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3502_049f0ece-5758-45ca-e063-6394a90a80ce	68071-3502	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20211018		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-3503_05ce7ad9-d479-05b2-e063-6394a90aadb7	68071-3503	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	NuCare Pharmaceuticals,Inc.	ATORVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3504_0919deb8-74c1-a04e-e063-6294a90af4ac	68071-3504	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3505_05cce163-93cb-9cf1-e063-6394a90a4145	68071-3505	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3506_05cc932d-b41c-0710-e063-6394a90a87f6	68071-3506	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180628		ANDA	ANDA202023	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-3507_05ce8f51-6e96-48bd-e063-6394a90a7a17	68071-3507	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3508_05cc9c4b-5d83-fb22-e063-6294a90a27e5	68071-3508	HUMAN PRESCRIPTION DRUG	nystatin		nystatin	TABLET, COATED	ORAL	20111031		ANDA	ANDA062474	NuCare Pharmaceuticals,Inc.	NYSTATIN	500000	[USP'U]/1	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-3509_0e13c3dc-e96f-b5d0-e063-6294a90a6c04	68071-3509	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		Phendimetrazine Tartrate	TABLET	ORAL	20121120		ANDA	ANDA040762	NuCare Pharmaceuticals,Inc.	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20251231
68071-3510_05bd8165-c89e-09a2-e063-6394a90a7b92	68071-3510	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	19871222		ANDA	ANDA062364	NuCare Pharmaceuticals,Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-3511_05d1bf49-c5b4-8a3f-e063-6294a90a01f7	68071-3511	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	NuCare Pharmaceuticals,Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
68071-3512_05f99647-e772-abfe-e063-6294a90a0bc2	68071-3512	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole Cream, 2%	CREAM	TOPICAL	20210527		ANDA	ANDA212443	NuCare Pharmaceuticals,Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-3513_065e7b29-05de-f2f0-e063-6394a90af94a	68071-3513	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20220307		ANDA	ANDA040625	NuCare Pharmaceuticals,Inc.	FOLIC ACID	1	mg/1			N	20241231
68071-3514_065eaeaf-904c-137c-e063-6394a90a018b	68071-3514	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211117		ANDA	ANDA077633	NuCare Pharmaceuticals,Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68071-3515_06862daa-dae9-2225-e063-6394a90ab87c	68071-3515	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-3516_06867a4c-7bf5-81c1-e063-6394a90acf18	68071-3516	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20160913		ANDA	ANDA208301	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3517_0e13c3dc-e970-b5d0-e063-6294a90a6c04	68071-3517	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
68071-3518_079a8cf6-e560-e062-e063-6394a90adb21	68071-3518	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3519_075fe5f7-e09a-169b-e063-6294a90aac43	68071-3519	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	NuCare Pharmaceuticals,Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-3520_0772fd73-3e46-3e56-e063-6294a90a68f0	68071-3520	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070175	NuCare Pharmaceuticals,Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-3521_094429d2-6991-ed16-e063-6294a90ab68b	68071-3521	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-3522_09441cd1-b382-cc1d-e063-6294a90a2a32	68071-3522	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230201		ANDA	ANDA217054	NuCare Pharmaceutials,Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68071-3523_0786f8cb-fba6-0851-e063-6394a90a2334	68071-3523	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20211101		ANDA	ANDA207057	NuCare Pharmaceuticals,Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-3524_07ff6359-257b-8074-e063-6294a90ad811	68071-3524	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA077619	NuCare Pharmaceuticals,Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-3525_082d0336-a21f-d768-e063-6394a90a09ba	68071-3525	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20220218		ANDA	ANDA078284	NuCare Pharmaceuticals,Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68071-3526_0865f83f-0f35-0690-e063-6294a90abf04	68071-3526	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3527_0ab0d108-a22e-50c2-e063-6294a90a6ab9	68071-3527	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20211101		ANDA	ANDA075477	NuCare Pharmaceuticals,Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-3529_0d96ba1d-39d1-186f-e063-6294a90a7af9	68071-3529	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	NuCare Pharmaceuticals,Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68071-3530_0a1fbd9b-10e1-ce12-e063-6394a90a9cca	68071-3530	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3531_0b3d3ca7-3cfc-6571-e063-6294a90ab1b3	68071-3531	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3532_0d0e08b5-1d55-f62b-e063-6294a90ace87	68071-3532	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-3533_0d6f9891-8fb0-d9fa-e063-6294a90ae140	68071-3533	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
68071-3534_0a1f97b8-394a-bdf0-e063-6394a90aafe0	68071-3534	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-3535_0b4dada4-49db-0a1a-e063-6294a90a1bca	68071-3535	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	NuCare Pharmaceuticals,Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68071-3536_0b3d803d-610f-b229-e063-6394a90aaf37	68071-3536	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-3537_0b3dbe11-ff76-cb98-e063-6294a90ad2e9	68071-3537	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	NuCare Pharmaceuticals,Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-3538_0aae4bf0-5cb7-eaf3-e063-6294a90a8d5c	68071-3538	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-3540_0a9cfec2-5343-99f8-e063-6394a90a8323	68071-3540	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	NuCare Pharmaceuticals,Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-3541_0c81f4cf-a123-cab1-e063-6294a90aec28	68071-3541	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	NuCare Pharmaceuticals,Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68071-3542_0b4e9e72-4ae0-538a-e063-6394a90ad3ca	68071-3542	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20220927		ANDA	ANDA216798	NuCare Pharmaceuticals,Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68071-3543_0b4dfd5e-641f-40e9-e063-6294a90a3fda	68071-3543	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	SUSPENSION	ORAL	20221205		ANDA	ANDA214346	NuCare Pharmaceuticals,Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68071-3544_0c053b1c-eaa5-5f5d-e063-6394a90ac613	68071-3544	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20210315		ANDA	ANDA074164	NuCare Pharmaceuticals,Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-3545_0b75f74f-b7cc-9e9c-e063-6394a90a88f2	68071-3545	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20220118		ANDA	ANDA210609	NuCare Pharmaceuticals,Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-3546_0a9ca463-4a7a-37c8-e063-6394a90a9d22	68071-3546	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-3547_0aac93f7-d392-8f9d-e063-6294a90a4ea2	68071-3547	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-3548_0b296fc3-cbad-09b9-e063-6394a90a1082	68071-3548	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20220531		ANDA	ANDA074497	NuCare Pharmaceuticals,Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-3549_0bb3df93-cf5c-fecd-e063-6294a90a2b51	68071-3549	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-3550_0b76bd6d-3291-e438-e063-6394a90a5b23	68071-3550	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20210819		ANDA	ANDA215101	NuCare Pharmaceuticals,Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68071-3551_0b7bfbb3-f612-8aa8-e063-6394a90a9a71	68071-3551	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution		Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution	SOLUTION	ORAL	20201005		ANDA	ANDA040649	NuCare Pharmaceuticals,Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68071-3552_0bee42b9-1aaf-a979-e063-6394a90a08ad	68071-3552	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3553_0bee7d82-bc9b-a81a-e063-6394a90af332	68071-3553	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	NuCare Pharmaceuticals,Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68071-3554_0bef2944-7aaf-e6bf-e063-6394a90af56a	68071-3554	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19940511		ANDA	ANDA064048	NuCare Pharmaceuticals,Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68071-3555_0d07b053-39cb-ec89-e063-6394a90a23f5	68071-3555	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20230425		ANDA	ANDA040317	NuCare Pharmaceuticals,Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68071-3556_0d1cfe14-52eb-8975-e063-6294a90afbb7	68071-3556	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, EXTENDED RELEASE	ORAL	20021106		ANDA	ANDA076201	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-3557_0d976b65-bf3a-6cdf-e063-6294a90a57ba	68071-3557	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	NuCare Pharmaceuticals,Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68071-3558_0dfb11d9-f48e-56ee-e063-6294a90ad256	68071-3558	HUMAN PRESCRIPTION DRUG	Citalopram		citalopram	TABLET, FILM COATED	ORAL	20080728		ANDA	ANDA077042	NuCare Pharmaceuticals,Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
68071-3559_0e8b2109-84ce-2d92-e063-6394a90a5d16	68071-3559	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170614		ANDA	ANDA090693	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
68071-4007_0ac387c4-53d1-87de-e063-6394a90a6845	68071-4007	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	NuCare Pharmaceuticals,Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4022_d59255ac-41ad-6da2-e053-2a95a90a09d2	68071-4022	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-4026_d775f94b-8457-cd88-e053-2995a90a9924	68071-4026	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	19951204		ANDA	ANDA072641	NuCare Pharmaceuticals,Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68071-4028_fbd38614-fda5-2a5e-e053-6394a90ad49e	68071-4028	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	NuCare Pharmaceuticals,Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-4029_e313b30f-fbb7-577f-e053-2a95a90a0a38	68071-4029	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-4041_d60c8b7a-7046-4b42-e053-2995a90a55ab	68071-4041	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	NuCare Pharmaceuticals,Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68071-4049_d775fcda-1ab4-e852-e053-2995a90aed44	68071-4049	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	NuCare Pharmaceuticals,Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-4053_d775fcda-1ab5-e852-e053-2995a90aed44	68071-4053	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		GEMFIBROZIL	TABLET	ORAL	20170323		ANDA	ANDA077836	NuCare Pharmaceuticals,Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
68071-4060_d776018c-e8ad-3035-e053-2995a90a9171	68071-4060	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20120320		OTC MONOGRAPH NOT FINAL	part334	NuCare Pharmaceuticals,Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68071-4063_fab9ccfd-dc66-6bda-e053-6294a90ab109	68071-4063	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170620		ANDA	ANDA086727	NuCare Pharmaceuticals,Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
68071-4085_e41c3d84-a544-5a19-e053-2a95a90abeb4	68071-4085	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950227		ANDA	ANDA074223	NuCare Pharmaceuticals,Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-4096_d5930cc8-00b9-de99-e053-2a95a90ae51b	68071-4096	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-4103_00647c13-f753-0dd1-e063-6394a90a2545	68071-4103	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim	SOLUTION	OPHTHALMIC	19980416		ANDA	ANDA064211	NuCare Pharmaceuticals,Inc.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68071-4111_e42ed5e9-7e16-de3c-e053-2a95a90ace23	68071-4111	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20110608		ANDA	ANDA090480	NuCare Pharmaceuticals,Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
68071-4115_ff200d6f-f4a7-23f4-e053-6294a90a74e2	68071-4115	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	NuCare Pharmaceuticals,Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-4118_d6070f38-515c-049e-e053-2a95a90aade6	68071-4118	HUMAN OTC DRUG	ACETAMINOPHEN	Pain Reliever,Fever Reducer	ACETAMINOPHEN	TABLET	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68071-4119_d60637c5-dee4-8455-e053-2995a90a3c29	68071-4119	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20101115		ANDA	ANDA076003	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-4128_d7765fc5-3592-1e75-e053-2a95a90a5fbf	68071-4128	HUMAN OTC DRUG	Magnesium Citrate		Magnesium citrate	LIQUID	ORAL	20020301		OTC MONOGRAPH NOT FINAL	part334	NuCare Pharmaceuticals,Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68071-4138_d7765fc5-3593-1e75-e053-2a95a90a5fbf	68071-4138	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076999	NuCare Pharmaceuticals,Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
68071-4139_ec7fb989-5374-46f6-e053-2995a90a8436	68071-4139	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-4159_d6062cb5-9b1a-0d99-e053-2995a90a2449	68071-4159	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160523		ANDA	ANDA091617	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-4184_d5cbb80c-c31e-ac08-e053-2995a90a264d	68071-4184	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-4197_d58ee756-c607-ff9e-e053-2995a90ac6e4	68071-4197	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	NuCare Pharmaceuticals,Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68071-4201_d59270a1-8c33-f984-e053-2995a90a8dc7	68071-4201	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-4220_d5d0b340-3349-b4f9-e053-2995a90a0cbd	68071-4220	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-4223_e6eab8a7-ffb7-f3b6-e053-2995a90ad681	68071-4223	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	NuCare Pharmaceuticals,Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-4229_fe436f76-b810-7ad5-e053-6294a90a8ec8	68071-4229	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19960828		ANDA	ANDA064065	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68071-4235_e22146aa-0079-1fda-e053-2995a90a53ff	68071-4235	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20040507		NDA AUTHORIZED GENERIC	NDA019992	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-4238_d5cb3333-a783-01b4-e053-2995a90a3927	68071-4238	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771129		ANDA	ANDA085968	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-4251_edc6185d-3dd1-0f11-e053-2995a90a1148	68071-4251	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	NuCare Pharmaceuticals,Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-4271_e767aa2c-50dc-bf30-e053-2995a90a4a4e	68071-4271	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	NuCare Pharmaceuticals,Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-4285_fbfad43e-f33e-498f-e053-6294a90acf18	68071-4285	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20110620		OTC MONOGRAPH FINAL	part333B	NuCare Pharmaceuticals,Inc.	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
68071-4321_0946ade1-50ad-1df1-e063-6294a90a9ba3	68071-4321	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20050923		ANDA	ANDA065170	NuCare Pharmaceuticals,Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
68071-4322_ff97bead-a366-e646-e053-6294a90a42ba	68071-4322	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20130107		OTC MONOGRAPH FINAL	part347	NuCare Pharmaceuticals,Inc.	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; mg/mL			N	20241231
68071-4328_f1d95b71-d2ec-50ee-e053-2995a90a2d94	68071-4328	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	NuCare Pharmceuticals,Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-4331_f9a015ed-581b-15be-e053-6294a90a246c	68071-4331	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-4341_d60cf113-4ae5-4ae7-e053-2995a90ae9b2	68071-4341	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20151001		ANDA	ANDA078932	NuCare Pharmaceuticals,Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68071-4348_d606239d-e62c-0c39-e053-2995a90acaf5	68071-4348	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085969	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-4354_e236f6c5-b36a-7644-e053-2a95a90a6733	68071-4354	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline	CAPSULE	ORAL	20160628		ANDA	ANDA207289	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-4355_ece5ebf3-ae72-3f6a-e053-2a95a90aa222	68071-4355	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4367_f54d5edd-737f-7628-e053-2995a90a1d6b	68071-4367	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68071-4368_f54eacdf-613e-0f11-e053-2995a90ac208	68071-4368	HUMAN PRESCRIPTION DRUG	Proparacaine Hydrochloride		Proparacaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	19950929		ANDA	ANDA040074	NuCare Pharmaceuticals,Inc.	PROPARACAINE HYDROCHLORIDE	5	mg/mL	Local Anesthesia [PE], Local Anesthetic [EPC]		N	20241231
68071-4370_d60648f8-2fa4-0c8e-e053-2995a90acd94	68071-4370	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-4375_03b1dce2-bfc0-e1a5-e063-6394a90a50d6	68071-4375	HUMAN PRESCRIPTION DRUG	Neomycin Polymyxin B Sulfates and Dexamethasone		Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	19950913		ANDA	ANDA064135	NuCare Pharmaceuticals,Inc.	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68071-4385_d5cbbf1b-6fdb-f7cd-e053-2995a90a5e33	68071-4385	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20111101		ANDA	ANDA090935	NuCare Pharmaceuticals,Inc.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68071-4400_d5d0b340-3350-b4f9-e053-2995a90a0cbd	68071-4400	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-4405_d606694a-fb8d-c36f-e053-2995a90a461c	68071-4405	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085969	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-4406_dec17352-b889-4592-e053-2995a90ae707	68071-4406	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4410_02968188-5c14-180b-e063-6394a90a70c6	68071-4410	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	NuCare Pharmaceuticals,Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68071-4411_d7750461-1213-6fb1-e053-2a95a90a12d4	68071-4411	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20170215		ANDA	ANDA202987	NuCare Pharmaceuticals,Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-4423_ddbab484-7292-5f0a-e053-2a95a90afdb7	68071-4423	HUMAN OTC DRUG	PlusPharma Extra Strength	PAIN RELIEVER,FEVER REDUCER 500 mg	Acetaminophen	TABLET	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-4428_f6913dc3-cf8e-765d-e053-2a95a90a0289	68071-4428	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	NuCare Pharmaceuticals,Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68071-4429_fae55077-05d8-c6c7-e053-6294a90a3b2d	68071-4429	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4434_ffea2e97-7782-434b-e053-6394a90a3a63	68071-4434	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4441_d7750461-1212-6fb1-e053-2a95a90a12d4	68071-4441	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	CREAM	TOPICAL	19830831		NDA	NDA018861	NuCare Pharmaceuticals,Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-4443_f80e1bdd-82be-0027-e053-6394a90a0305	68071-4443	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	NuCare Pharmaceuticals,Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68071-4445_f98cf13c-4dde-850d-e053-6294a90a4f7f	68071-4445	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	NuCare Pharmaceuticals,Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68071-4448_d58ed481-1008-1737-e053-2995a90adc30	68071-4448	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-4450_d5931643-b080-22d0-e053-2995a90a43f9	68071-4450	HUMAN PRESCRIPTION DRUG	LAMIVUDINE and ZIDOVUDINE		LAMIVUDINE and ZIDOVUDINE	TABLET, FILM COATED	ORAL	20150918		ANDA	ANDA079124	NuCare Pharmaceuticals,Inc.	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
68071-4455_e8ce9367-f5fc-9b7f-e053-2a95a90a6549	68071-4455	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-4465_05bd9ef2-fe56-08b4-e063-6394a90a58ba	68071-4465	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4470_0e8a384c-3ede-b164-e063-6294a90adf09	68071-4470	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	NuCare Pharmaceuticals,Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
68071-4472_d6061620-04e5-34c6-e053-2a95a90a9ef1	68071-4472	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-4475_e06912e3-3ba6-6421-e053-2a95a90a4730	68071-4475	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20110706		ANDA	ANDA040419	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68071-4494_f18c5605-f636-621b-e053-2a95a90ae6bf	68071-4494	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-4498_d7750461-1211-6fb1-e053-2a95a90a12d4	68071-4498	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	NuCare Pharmaceuticals,Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-4500_d7750461-1210-6fb1-e053-2a95a90a12d4	68071-4500	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20101227		ANDA	ANDA077714	NuCare Pharmaceuticals,Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
68071-4501_ebc9a7b8-fd8a-a179-e053-2995a90ae3da	68071-4501	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	NuCare Pharmaceuticals,Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68071-4505_dfdebf53-9743-0e86-e053-2a95a90a9cfe	68071-4505	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	NuCare Pharmaceuticals,Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-4508_d7752081-7f50-ed06-e053-2a95a90add82	68071-4508	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	NuCare Pharmaceuticals,Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-4511_08156ef8-87e3-ec67-e063-6394a90a4f87	68071-4511	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20020930		ANDA	ANDA089682	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-4512_e194a72f-d89c-631b-e053-2a95a90ac3d3	68071-4512	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	NuCare Pharmaceuticals,Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
68071-4516_d7750461-120f-6fb1-e053-2a95a90a12d4	68071-4516	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4518_e1066126-030c-af83-e053-2995a90aaf7e	68071-4518	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20100406		ANDA	ANDA077157	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-4519_d6065309-8648-e06b-e053-2a95a90abc26	68071-4519	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19771121		ANDA	ANDA085966	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-4523_d775143a-5ca3-9d10-e053-2995a90a7eb7	68071-4523	HUMAN OTC DRUG	Bismuth subsalicylate		Sunmark Stomach relief	TABLET, CHEWABLE	ORAL	20110301		OTC MONOGRAPH FINAL	part335	NuCare Pharmaceuticals,Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68071-4533_dfafe4b7-d096-30d7-e053-2995a90ae538	68071-4533	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20110706		ANDA	ANDA040419	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68071-4538_d58ec974-8427-3bb4-e053-2995a90aaaaa	68071-4538	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	NuCare Pharmaceuticals,Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-4548_f98e5359-9316-9f38-e053-6294a90a2ba0	68071-4548	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-4568_d606239d-e620-0c39-e053-2995a90acaf5	68071-4568	HUMAN OTC DRUG	Fexofenadine HCl		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA204507	NuCare Pharmaceuticals,Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-4576_e194a68b-6a3e-1605-e053-2a95a90adeb1	68071-4576	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-4586_05f5a8cc-a3b5-b9d6-e063-6394a90a9bf3	68071-4586	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-4599_e94caa08-4e48-2c1b-e053-2a95a90a8481	68071-4599	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-4612_d775143a-5ca2-9d10-e053-2995a90a7eb7	68071-4612	HUMAN PRESCRIPTION DRUG	Latanoprost		latanoprost	SOLUTION/ DROPS	OPHTHALMIC	20110322		ANDA	ANDA201006	NuCare Pharmaceuticals,Inc.	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
68071-4619_ddb93ce2-2871-352f-e053-2a95a90a5824	68071-4619	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20171002		NDA	NDA016909	NuCare Pharmaceuticals,Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-4627_e5486dc8-d5a8-7aa6-e053-2a95a90a5248	68071-4627	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	NuCare Pharmaceuticals,Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68071-4642_d5cc1848-c4d0-1642-e053-2995a90a890a	68071-4642	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	NuCare Pharmaceuticals,Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-4648_d6071791-53cd-6fad-e053-2a95a90a8fc7	68071-4648	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	NuCare Pharmaceuticals,Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
68071-4655_dd7c4534-ec7e-3e00-e053-2995a90ae7b1	68071-4655	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	NuCare Pharmaceutuicals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-4673_004e0f79-3e03-904a-e063-6394a90ab225	68071-4673	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68071-4690_05bd941c-2cb0-08d4-e063-6394a90a5351	68071-4690	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	NuCare Pharmaceuticals,Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-4691_d58edd1a-6145-3f61-e053-2995a90a2345	68071-4691	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085161	NuCare Pharmaceuticals,Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-4693_0075a448-34a3-b4f9-e063-6294a90a40a4	68071-4693	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-4694_d58ecd75-209f-699e-e053-2a95a90a0730	68071-4694	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	NuCare Pharmaceuticals,Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68071-4722_05f5a35d-5ddc-bae5-e063-6294a90ad748	68071-4722	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	NuCare Pharmaceuticals,Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68071-4741_d58ec974-8426-3bb4-e053-2995a90aaaaa	68071-4741	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19900930		ANDA	ANDA061926	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-4753_de5f0ad2-6e06-7c86-e053-2995a90a28bf	68071-4753	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	NuCare Pharmaceuticals,Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-4755_e16b6f03-64f7-51b7-e053-2a95a90ab55b	68071-4755	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	NuCare Pharmaceuticals,Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-4760_fed3269d-5e97-bc08-e053-6394a90a0301	68071-4760	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	NuCare Pharmaceuticals,Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-4770_00603cad-3f22-478a-e063-6394a90ad108	68071-4770	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	NuCare Pharmaceuticals,Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-4779_e58111fa-7c55-62e0-e053-2995a90a3bfa	68071-4779	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-4799_0b7ab9a4-4a10-6376-e063-6294a90a30a9	68071-4799	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	NuCare Pharmaceuticals,Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68071-4809_de1dbcf6-4fa1-94fc-e053-2995a90a36c5	68071-4809	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	NuCare Pharmaceuticals,Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68071-4812_e23703bb-6086-7985-e053-2995a90aa5ec	68071-4812	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-4831_ff98f29b-dd92-61b6-e053-6294a90a0c5f	68071-4831	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-4834_f1d9b25b-ba26-7aa9-e053-2a95a90ae2bc	68071-4834	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	NuCare Pharmaceuticals,Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-4836_f8fe8785-47b2-7d73-e053-6394a90a6fd4	68071-4836	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA062269	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-4838_e1a7b155-f100-cb85-e053-2995a90a4a27	68071-4838	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	NuCare Pharmaceuticals,Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-4859_f2f1f5b5-c3d9-0514-e053-2a95a90acb25	68071-4859	HUMAN PRESCRIPTION DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20181127		ANDA	ANDA210893	NuCare Pharmaceuticals,Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-4865_deade5d2-4ce5-3b1b-e053-2a95a90a87ea	68071-4865	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	NuCare Pharmaceuticals,Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68071-4868_fbe618a0-6eea-f8ca-e053-6394a90afa86	68071-4868	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20060222		ANDA	ANDA076504	NuCare Pharmaceuticals,Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-4869_e65f407d-bcf8-4a99-e053-2995a90a948a	68071-4869	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	NuCare Pharmaceuticals,Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-4880_e35057e0-ec7c-d705-e053-2995a90afbe9	68071-4880	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	NuCare Pharmaceuticals,Inc.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-4881_f642f6ad-1931-3fb3-e053-2a95a90a99f2	68071-4881	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	NuCare Pharmaceuticals,Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-4916_ed25ab08-97e8-6310-e053-2995a90a7f3d	68071-4916	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	NuCare Pharmaceuticals,Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-4917_ea64758b-99e4-6fce-e053-2995a90a3b95	68071-4917	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	NuCare Pharmaceuticals,Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-4919_0bdd3648-d38e-9bcd-e063-6294a90a0c39	68071-4919	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	NuCare Pharmaceuticals,Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68071-4922_ff9952c9-1da7-82f0-e053-6294a90ae0c8	68071-4922	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	NuCare Pharmaceuticals,Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-4950_febefbfb-d428-91ee-e053-6394a90ac77f	68071-4950	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19900901		ANDA	ANDA062396	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-4951_de9b5ebf-7f55-5df0-e053-2995a90a4095	68071-4951	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	NuCare Pharmaceuticals,Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-4953_ffc17297-4635-7cc8-e053-6394a90a244b	68071-4953	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-4954_fc74c0f0-5690-0678-e053-6294a90a280c	68071-4954	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	NuCare Pharmaceuticals,Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-4963_f3ba76a5-30b3-5fb9-e053-2995a90a6550	68071-4963	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19730112		ANDA	ANDA083177	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-4964_f911bb33-ce37-3055-e053-6294a90ad641	68071-4964	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	NuCare Pharmaceuticals,Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68071-4968_0d6fb5cc-5199-0903-e063-6394a90a2b0e	68071-4968	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA078329	NuCare Pharmaceuticals,Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-4973_fe467606-6d65-b695-e053-6294a90aab5d	68071-4973	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	NuCare Pharmaceuticals,Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-4978_fe3ff918-21c4-0972-e053-6294a90a9a48	68071-4978	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	NuCare Pharmaceuticals,Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-4987_e845c388-28e4-2dd8-e053-2a95a90a8bfa	68071-4987	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	NuCare Pharmaceuticals,Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-4996_de1da9f6-7b8a-faa3-e053-2995a90ae40e	68071-4996	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	NuCare Pharmaceuticals,Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5010_de5aafb6-8cda-a9c1-e053-2995a90a002d	68071-5010	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20130415		ANDA	ANDA202800	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68071-5013_d60c97a9-991a-a16e-e053-2a95a90a986c	68071-5013	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	NuCare Pharmaceuticals,Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68071-5022_ecabad49-efa6-0003-e053-2995a90a7835	68071-5022	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	NuCare Pharmaceuticals,Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5038_f1d99e84-719e-5feb-e053-2a95a90aedf3	68071-5038	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-5039_ffc1ae0d-fbfe-f937-e053-6394a90a3565	68071-5039	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20190101		ANDA	ANDA204872	NuCare Pharmaceuticals,Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-5045_0bdef211-489c-372e-e063-6294a90a0a9a	68071-5045	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20120725		ANDA	ANDA065489	NuCare Pharmaceuticals,Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-5053_e4f3bab5-95e7-7314-e053-2a95a90af45c	68071-5053	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928		ANDA	ANDA202038	NuCare Pharmaceuticals,Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-5054_dda936ba-4c1b-7360-e053-2995a90ad60d	68071-5054	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68071-5057_d58edd1a-6147-3f61-e053-2995a90a2345	68071-5057	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20160823		ANDA	ANDA203824	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-5065_e8458c50-0070-5ba7-e053-2995a90a7559	68071-5065	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091569	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-5068_ec6fe851-d542-5da5-e053-2a95a90a3dbc	68071-5068	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	NuCare Pharmaceuticals,Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5083_e41c18c3-1077-89a9-e053-2a95a90a12f9	68071-5083	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	NuCare Pharmaceuticals,Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68071-5096_091ebe0c-3849-4fdb-e063-6394a90af218	68071-5096	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	NuCare Pharmaceuticals,Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68071-5112_e8937778-8bb1-05f5-e053-2995a90a3a98	68071-5112	HUMAN OTC DRUG	Sore Throat	Cherry	Phenol	SPRAY	ORAL	20140930		OTC MONOGRAPH NOT FINAL	part356	NuCare Pharmaceuticals,Inc.	PHENOL	1.4	g/100mL			N	20241231
68071-5113_f19f4f0d-3d62-ebfe-e053-2a95a90af6ea	68071-5113	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5119_e38dd792-9f68-8fc5-e053-2995a90afa1d	68071-5119	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180604		ANDA	ANDA205868	NuCare Pharmaceuticals,Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-5126_de978871-8f11-2659-e053-2995a90a931e	68071-5126	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	NuCare Pharmaceuticals,Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-5128_e8048c65-018a-11db-e053-2a95a90a8097	68071-5128	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5140_d58ed851-dde4-5b8b-e053-2a95a90ad1c4	68071-5140	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	NuCare Pharmaceuticals,Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-5142_e1f6a6b1-120d-0ea5-e053-2995a90a6d4f	68071-5142	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-5143_f5ca92dd-de22-60cb-e053-2a95a90ac79e	68071-5143	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	NuCare Pharmaceuticals,Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-5145_f7f8b78f-9b5d-1add-e053-6394a90a0761	68071-5145	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	NuCare Pharmaceuticals,Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-5151_0864ecf0-4b12-715e-e063-6294a90a1778	68071-5151	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	NuCare Pharmaceuticals,Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68071-5175_d6070f38-5159-049e-e053-2a95a90aade6	68071-5175	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-5177_d774f3b6-0219-ba6a-e053-2a95a90aae11	68071-5177	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-5178_d774f61d-cea4-4348-e053-2a95a90ac5e8	68071-5178	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20140707		ANDA	ANDA090032	NuCare Pharmaceuticals,Inc.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-5179_d774fe25-79b9-346e-e053-2a95a90af568	68071-5179	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	NuCare Pharmaceuticals,Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-5180_d774f61d-cea5-4348-e053-2a95a90ac5e8	68071-5180	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
68071-5181_d7750461-120c-6fb1-e053-2a95a90a12d4	68071-5181	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-5182_d7750696-c037-8bb2-e053-2a95a90ad1a5	68071-5182	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190205		ANDA	ANDA209907	NuCare Pharmaceuticals,Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-5183_d77509f2-49d7-5862-e053-2a95a90a0e1e	68071-5183	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA077459	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-5184_d7750461-120d-6fb1-e053-2a95a90a12d4	68071-5184	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA077459	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-5185_d774fe25-79ba-346e-e053-2a95a90af568	68071-5185	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20110808		ANDA	ANDA076447	NuCare Pharmaceuticals,Inc.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-5186_d7750461-120e-6fb1-e053-2a95a90a12d4	68071-5186	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	NuCare Pharmaceuticals,Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-5187_d775143a-5ca1-9d10-e053-2995a90a7eb7	68071-5187	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20181005		ANDA	ANDA206923	NuCare Pharmaceuticals,Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68071-5188_d774c803-fdce-5035-e053-2a95a90a1e6c	68071-5188	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5189_e6eabd52-7f27-7adf-e053-2995a90af33c	68071-5189	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	NuCare Pharmaceuticals,Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68071-5190_d7749c32-51c6-95a4-e053-2a95a90a44d7	68071-5190	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	NuCare Pharmaceuticals,Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68071-5191_d774a86f-537d-4344-e053-2a95a90a81e7	68071-5191	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20110103		ANDA	ANDA076502	NuCare Pharmaceuticals,Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68071-5192_02571a69-0c7f-21ee-e063-6394a90abe25	68071-5192	HUMAN OTC DRUG	Aspirin		Regular Strength Enteric coated aspirin	TABLET, COATED	ORAL	20000701		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmceuticals,Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68071-5193_d774a292-f38b-b4a6-e053-2995a90a772c	68071-5193	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	NuCare Pharmaceuticals,Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68071-5194_d7732030-409a-bd4c-e053-2995a90a9ecf	68071-5194	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5195_d7733683-3d05-d9bf-e053-2995a90acbde	68071-5195	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	NuCare Pharmaceuticals,Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-5196_d7732452-c96a-1a18-e053-2995a90a84a8	68071-5196	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181207		ANDA	ANDA211495	NuCare Pharmaceuticals,Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-5197_d7732452-c96b-1a18-e053-2995a90a84a8	68071-5197	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20120115		ANDA	ANDA040734	NuCare Pharmaceuticals,Inc.	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
68071-5198_d7733d3c-da08-ba37-e053-2a95a90acc4c	68071-5198	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180802		ANDA	ANDA207687	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5200_d773454e-9a56-5ee0-e053-2995a90a1dd7	68071-5200	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	CAPSULE	ORAL	19970228		ANDA	ANDA040204	NuCare Pharmaceuticals,Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68071-5201_d7733683-3d07-d9bf-e053-2995a90acbde	68071-5201	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20120411		ANDA	ANDA201013	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
68071-5202_d7733d3c-da0a-ba37-e053-2a95a90acc4c	68071-5202	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	NuCare Pharmaceuticals,Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-5203_d7733683-3d08-d9bf-e053-2995a90acbde	68071-5203	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	NuCare Pharmaceuticals,Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
68071-5204_dee79c9b-b495-2b98-e053-2a95a90a4756	68071-5204	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-5205_08f3ce32-81a8-f9d2-e063-6394a90ab17d	68071-5205	HUMAN OTC DRUG	hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20110413		OTC MONOGRAPH DRUG	M014	NuCare Pharmaceuticals,Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-5207_d7734182-be13-aa2b-e053-2995a90a5a39	68071-5207	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-5208_d7735e06-3217-e125-e053-2a95a90a93d8	68071-5208	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20050113		ANDA	ANDA065089	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-5209_d77360a1-6976-ef67-e053-2a95a90a7506	68071-5209	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-5210_d773894c-3daf-d8b3-e053-2995a90a6383	68071-5210	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	NuCare Pharmaceuticals,Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68071-5211_d773849a-0572-2183-e053-2995a90ad343	68071-5211	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-5212_d7739f30-38f3-54ff-e053-2a95a90aef1f	68071-5212	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	NuCare Pharmaceuticals,Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68071-5213_d7749c32-51c4-95a4-e053-2a95a90a44d7	68071-5213	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20180618		ANDA	ANDA203013	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-5214_d7749ec8-c01c-7a8d-e053-2995a90a1b05	68071-5214	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA202304	NuCare Pharmaceuticals,Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68071-5216_d772d56c-038d-2a52-e053-2995a90a59a7	68071-5216	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20020605		ANDA	ANDA065066	NuCare Pharmaceuticals,Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68071-5217_d772d56c-038e-2a52-e053-2995a90a59a7	68071-5217	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	NuCare Pharmaceuticals,Inc.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68071-5218_d772f84b-ab4c-ea8b-e053-2995a90a5867	68071-5218	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150921		ANDA	ANDA202784	NuCare Pharmaceuticals,Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68071-5219_d7730674-750e-52cf-e053-2995a90ab32c	68071-5219	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190624		ANDA	ANDA211063	NuCare Pharmaceuticals,Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
68071-5220_d7730674-7510-52cf-e053-2995a90ab32c	68071-5220	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	NuCare Pharmaceuticals,Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-5221_ef2eac69-ac08-f641-e053-2a95a90a945b	68071-5221	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	NuCare Pharmaceuticals,Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-5222_d772b1ea-b271-cf6e-e053-2a95a90aad25	68071-5222	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20181009		ANDA	ANDA200958	NuCare Pharmaceuticals,Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68071-5223_d4db2b32-98ba-37c2-e053-2995a90afd85	68071-5223	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	NuCare Pharmaceuticals,Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68071-5224_d7730674-7511-52cf-e053-2995a90ab32c	68071-5224	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	19830324		NDA	NDA018642	NuCare Pharmaceuticals,Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-5225_d7730674-7512-52cf-e053-2995a90ab32c	68071-5225	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5226_d7730e4b-5c41-7d9a-e053-2995a90a9cc3	68071-5226	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-5227_d77319ec-f9c9-1282-e053-2995a90a0bc6	68071-5227	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	NuCare Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-5228_d77319ec-f9cb-1282-e053-2995a90a0bc6	68071-5228	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	NuCare Pharmaceuticals,Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-5229_d77319ec-f9cc-1282-e053-2995a90a0bc6	68071-5229	HUMAN OTC DRUG	Extra Strength Acetaminophen		Acetaminophen	TABLET	ORAL	20180801		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-5230_d7732030-4098-bd4c-e053-2995a90a9ecf	68071-5230	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070802		ANDA	ANDA077557	NuCare Pharmaceuticals,Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68071-5232_d58edd1a-6146-3f61-e053-2995a90a2345	68071-5232	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		DOXYCYCLINE HYCLATE	CAPSULE	ORAL	19840911		ANDA	ANDA062500	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-5233_e157729b-18f3-5223-e053-2995a90a4018	68071-5233	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	NuCare Pharmaceuticals,Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-5234_d772d21b-0c91-18b0-e053-2a95a90ae709	68071-5234	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20070125		ANDA	ANDA065352	NuCare Pharmaceuticals,Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-5235_d772bc4a-2d3b-c724-e053-2a95a90a111f	68071-5235	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	NuCar Pharmaceuticals,Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68071-5236_d772c168-0102-44d7-e053-2995a90a2490	68071-5236	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	NuCare Pharmaceuticals,Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-5237_d772bc4a-2d39-c724-e053-2a95a90a111f	68071-5237	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5238_d772bc4a-2d38-c724-e053-2a95a90a111f	68071-5238	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210000	NuCare Pharmaceuticals,Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68071-5239_ffc1cb10-757b-41e2-e053-6394a90a7129	68071-5239	HUMAN OTC DRUG	Acetaminophen		Extra Strength Pain Relief	TABLET	ORAL	19890101		OTC MONOGRAPH NOT FINAL	part343	NuCare Pharmaceuticals,Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68071-5240_df51ae43-9f8b-1b8b-e053-2995a90aaa5d	68071-5240	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	NuCare Pharmaceuticals,Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-5241_d772bc4a-2d37-c724-e053-2a95a90a111f	68071-5241	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	NuCare Pharmaceuticals,Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68071-5242_de3466ae-481b-8b56-e053-2a95a90aabfc	68071-5242	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	NuCare Pharmaceuticals,Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68071-5243_e80466c7-3132-1e86-e053-2a95a90a2ebc	68071-5243	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5245_d772ad92-5910-907f-e053-2995a90a7a7d	68071-5245	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20150204		ANDA	ANDA077210	NuCare Pharmaceuticals,Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68071-5246_d772b51b-e29d-38b3-e053-2a95a90aadfd	68071-5246	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130405		ANDA	ANDA091624	NuCare Pharmaceuticals,Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5247_d772b1ea-b26f-cf6e-e053-2a95a90aad25	68071-5247	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	NuCare Pharmaceuticals,Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5248_f75a0321-19d9-8d9a-e053-6394a90a99ef	68071-5248	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	NuCare Pharmaceuticals,Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-5249_d772ad92-590e-907f-e053-2995a90a7a7d	68071-5249	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	NuCare Pharmaceuticals,Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-5250_ebcdff16-88ed-5f0c-e053-2995a90a7c11	68071-5250	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	NuCare Pharmaceuticals,Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5251_d77296ec-2679-cf6c-e053-2a95a90ac08f	68071-5251	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20180701		ANDA	ANDA204882	NuCare Pharmaceuticals,Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-5252_d77296ec-2678-cf6c-e053-2a95a90ac08f	68071-5252	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20200110		ANDA	ANDA211555	NuCare Pharmaceuticals,Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68071-5253_025c1886-67b9-1a69-e063-6294a90af544	68071-5253	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	19950110		OTC MONOGRAPH FINAL	part333B	NuCare Pharmaceuticals,Inc.	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
68071-5254_d77296ec-2676-cf6c-e053-2a95a90ac08f	68071-5254	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET	ORAL	20110815		ANDA	ANDA070929	NuCare Pharmaceuticals,Inc.	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68071-5255_d7729463-e91f-16cb-e053-2995a90aa55c	68071-5255	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	NuCare Pharmaceuticals,Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68071-5256_d7724119-ef66-d56b-e053-2a95a90ad682	68071-5256	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	19760701		ANDA	ANDA084769	NuCare Pharmaceuticals,Inc.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5257_d772369c-f849-5d04-e053-2a95a90ab458	68071-5257	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	NuCare Pharmaceuticals,Inc.	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68071-5258_d7727a07-9a37-6183-e053-2995a90a9851	68071-5258	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	NuCare Pharmaceuticals,Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68071-5259_dee7ac62-b7e6-6c56-e053-2995a90a9056	68071-5259	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		DOXYCYCLINE HYCLATE	CAPSULE	ORAL	19840911		ANDA	ANDA062500	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-5260_d772369c-f848-5d04-e053-2a95a90ab458	68071-5260	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	NuCare Pharmaceuticals,Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68071-5261_d7724981-3caf-cb8f-e053-2a95a90af84f	68071-5261	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	NuCare Pharmaceuticals,Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68071-5262_d7727f40-9cdf-efef-e053-2995a90aa93f	68071-5262	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	CAPSULE	ORAL	20171031		ANDA	ANDA063067	NuCare Pharmaceuticals,Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-5263_d7727a07-9a35-6183-e053-2995a90a9851	68071-5263	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	NuCare Pharmaceuticals,Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68071-5265_e069bc92-4cdb-d2db-e053-2995a90ab29f	68071-5265	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	NuCare Pharmaceuticals,Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68071-5266_d771c3c1-7088-12af-e053-2995a90ad8fb	68071-5266	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	NuCare PHarmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-5267_fd786a06-88b2-fa35-e053-6394a90a84a5	68071-5267	HUMAN PRESCRIPTION DRUG	Bacitracin Zinc and Polymyxin B Sulfate		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	OPHTHALMIC	20080425		ANDA	ANDA064046	NuCare Pharmaceuticals,Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68071-5268_f072a4a2-5a54-7373-e053-2995a90ad468	68071-5268	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	NuCare Pharmaceuticals,Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68071-5269_d7716189-8951-0dff-e053-2995a90aad23	68071-5269	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	NuCare Pharmaceuticals,Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68071-5271_d770e7d4-9a54-2f16-e053-2a95a90a184e	68071-5271	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	NuCare Pharmaceuticals,Inc.	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68071-5272_f75a09a6-49d1-571a-e053-6294a90a452c	68071-5272	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	NuCare Pharmaceuticals,Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68071-5273_d770e753-1f50-1f18-e053-2a95a90ad66d	68071-5273	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-5274_d770a1d7-b33c-bfb6-e053-2995a90a607e	68071-5274	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
68071-5275_d770aba6-60d6-72d9-e053-2a95a90a68d5	68071-5275	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	NuCare Pharmaceuticals,Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68071-5276_00758f9b-ba44-999b-e063-6394a90a3d09	68071-5276	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	NuCare Pharmaceuticals,Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68071-5277_0e8654f3-1482-f808-e063-6294a90a33d8	68071-5277	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20150915		ANDA	ANDA204165	NuCare Pharmaceuticals,Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20251231
68071-5278_e1a98bb7-6a9f-9c41-e053-2a95a90a3b33	68071-5278	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, FILM COATED	ORAL	20160101		ANDA	ANDA204290	NuCare Pharmaceuticals,Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68071-5279_d77077d1-83cc-f00b-e053-2995a90aec2f	68071-5279	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19960718		ANDA	ANDA064030	NuCare Pharmaceuticals,Inc.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
68071-5281_d7706010-8755-80b1-e053-2a95a90a5879	68071-5281	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin and Polymyxin B Sulfates and Dexamethasone	OINTMENT	OPHTHALMIC	19960221		NDA AUTHORIZED GENERIC	NDA050065	NuCare Pharmaceuticals,Inc.	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68071-5282_d60c9349-f452-3ea8-e053-2a95a90a8581	68071-5282	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207465	NuCare Pharmaceuticals,Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68071-5283_dd418e7d-d8ab-37fd-e053-2995a90a60c4	68071-5283	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20171129		ANDA	ANDA205245	NuCare Pharmaceuticals,Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68071-5284_dfc93cb0-dd47-7d7e-e053-2a95a90a5ef1	68071-5284	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68071-5285_d60c97a9-991b-a16e-e053-2a95a90a986c	68071-5285	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	NuCare Pharmaceuticals,Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68071-5286_d60ca35f-64af-0601-e053-2a95a90a4b91	68071-5286	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	NuCare Pharmaceuticals,Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68071-5287_d7702674-e950-6977-e053-2a95a90ad5aa	68071-5287	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20140411		ANDA	ANDA074661	NuCare Pharmaceuticals,Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68078-003_a934f1a5-3102-4d01-a6ee-b3da2758107a	68078-003	HUMAN OTC DRUG	Even Up Sunscreen SPF 50		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20151005		OTC MONOGRAPH NOT FINAL	part352	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	116; 86	mg/mL; mg/mL			N	20241231
68078-004_91a41ea7-3e1c-47a4-9df3-adf5c066bb94	68078-004	HUMAN OTC DRUG	Sunforgettable Tint du Soleil Foundation SPF 30 Sunscreen		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20151005		OTC MONOGRAPH DRUG	M020	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	48; 67	mg/mL; mg/mL			N	20241231
68078-013_9307976d-6502-4d25-b2cf-547f6d4ddc9e	68078-013	HUMAN OTC DRUG	Natural Finish Pressed Foundation SPF 20 Sunscreen		Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20160901		OTC MONOGRAPH NOT FINAL	part352	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	212; 120	mg/g; mg/g			N	20241231
68078-014_6c2e3bec-3d8c-40df-b456-09026ae0c4d9	68078-014	HUMAN OTC DRUG	Mineral Corrector Palette SPF 20 Sunscreen		Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	212; 120	mg/g; mg/g			N	20241231
68078-023_5bf19ac2-e992-4f0c-af76-7b4056568789	68078-023	HUMAN OTC DRUG	All Calm Clinical Redness Corrector SPF 50		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20170802		OTC MONOGRAPH NOT FINAL	part352	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	116; 86	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68078-024_1a6c24ee-eb7a-4c47-98e2-1422688c3a13	68078-024	HUMAN OTC DRUG	Total Eye 3-In-1 Renewal Therapy SPF 35		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20180119		OTC MONOGRAPH DRUG	M020	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	79; 67	mg/mL; mg/mL			N	20241231
68078-027_e4eaf14b-acfc-4cdd-9451-d88bfe9d801f	68078-027	HUMAN OTC DRUG	Sunforgettable Total Protection Brush-On Shield SPF 50		Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part352	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	225; 225	mg/g; mg/g			N	20241231
68078-028_a3a44ad0-feb1-4361-8ec0-ce172a0656f1	68078-028	HUMAN OTC DRUG	Lip Shine SPF35 Sunscreen		Zinc Oxide	LIQUID	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	66	mg/mL			N	20241231
68078-033_f655f118-0402-6fa2-e053-2a95a90acf21	68078-033	HUMAN OTC DRUG	Sunforgettable Total Protection Color Balm (Berry)		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	125	mg/g			N	20241231
68078-034_f655e96b-9352-19c1-e053-2995a90ab46d	68078-034	HUMAN OTC DRUG	Sunforgettable Total Protection Color Balm (Blush)		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	125	mg/g			N	20241231
68078-035_f655c2f2-bdc5-b1b3-e053-2a95a90ae784	68078-035	HUMAN OTC DRUG	Sunforgettable Total Protection Color Balm (Bronze)		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	125	mg/g			N	20241231
68078-036_8e86f733-4007-4357-baf9-2425cd8a22e5	68078-036	HUMAN OTC DRUG	Sunforgettable Total Protection Sheet Matte Sunscreen SPF 30		Zinc Oxide	POWDER	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	225	mg/g			N	20241231
68078-037_47dfede6-58db-4fd2-9cf2-614f8495787c	68078-037	HUMAN OTC DRUG	Brightening Primer SPF 20		titanium dioxide and zinc oxide	LIQUID	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	50; 4.5	mg/mL; mg/mL			N	20241231
68078-038_f6554be0-1d0a-3c35-e053-2a95a90a01d8	68078-038	HUMAN OTC DRUG	Sunforgettable Total Protection Face Shield Matte		Zinc Oxide	LOTION	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	135.6	mg/mL			N	20241231
68078-039_74bcc582-d1d7-4c72-a68a-694e2f2c1461	68078-039	HUMAN OTC DRUG	Mattifying Primer SPF 20		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20200101		OTC MONOGRAPH DRUG	M020	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	50; 4.5	mg/mL; mg/mL			N	20241231
68078-040_ce4f32cf-3ed6-42ff-89d8-256307ffa4b3	68078-040	HUMAN OTC DRUG	Calming Primer SPF 20		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	54; 54	mg/mL; mg/mL			N	20241231
68078-041_f6554a92-11a5-4c4f-e053-2995a90adc5a	68078-041	HUMAN OTC DRUG	Sunforgettable Total Protection Face Shield Glow		Zinc Oxide	LOTION	TOPICAL	20210627		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	135.6	mg/mL			N	20241231
68078-042_f6556e35-2e50-1e1d-e053-2995a90a3ff2	68078-042	HUMAN OTC DRUG	Sunforgettable Total Protection Face Shield Flex		Zinc Oxide	LOTION	TOPICAL	20210506		OTC MONOGRAPH NOT FINAL	part352	Nanophase Technologies Corporation	ZINC OXIDE	135.6	mg/mL			N	20241231
68078-043_f655478e-4421-4c4b-e053-2995a90a46e6	68078-043	HUMAN OTC DRUG	Sunforgettable Total Protection Face Shield Bronze		Zinc Oxide	LOTION	TOPICAL	20210524		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	135.6	mg/mL			N	20241231
68078-044_f65540a4-3e8d-6477-e053-2a95a90a50d5	68078-044	HUMAN OTC DRUG	Sunforgettable Total Protection Body Shield Bronze		Zinc Oxide	LOTION	TOPICAL	20210602		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	135.6	mg/mL			N	20241231
68078-045_5bfcb736-1f2b-416e-acf4-a2bf2b7161e9	68078-045	HUMAN OTC DRUG	Bronzing Primer SPF 20		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20200101		OTC MONOGRAPH DRUG	M020	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	50; 4.5	mg/mL; mg/mL			N	20241231
68078-046_1a6c24ee-eb7a-4c47-98e2-1422688c3a13	68078-046	HUMAN OTC DRUG	Total Eye 3-In-1 Renewal Therapy SPF 35 (Fair)		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20180119		OTC MONOGRAPH DRUG	M020	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	79; 67	mg/mL; mg/mL			N	20241231
68078-047_1a6c24ee-eb7a-4c47-98e2-1422688c3a13	68078-047	HUMAN OTC DRUG	Total Eye 3-In-1 Renewal Therapy SPF 35 (Tan)		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20180119		OTC MONOGRAPH DRUG	M020	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	79; 67	mg/mL; mg/mL			N	20241231
68078-048_1a6c24ee-eb7a-4c47-98e2-1422688c3a13	68078-048	HUMAN OTC DRUG	Total Eye 3-In-1 Renewal Therapy SPF 35 (Deep)		Titanium Dioxide and Zinc Oxide	LIQUID	TOPICAL	20180119		OTC MONOGRAPH DRUG	M020	Colorescience	TITANIUM DIOXIDE; ZINC OXIDE	79; 67	mg/mL; mg/mL			N	20241231
68078-050_f6552b9b-92ad-3aa3-e053-2995a90a5fd4	68078-050	HUMAN OTC DRUG	Sunforgettable Total Protection Sport Stick		Zinc Oxide	STICK	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	135	mg/g			N	20241231
68078-055_f6552cad-acbb-3b75-e053-2995a90a2ca8	68078-055	HUMAN OTC DRUG	Sunforgettable Total Protection Body Shield		Zinc Oxide	LOTION	TOPICAL	20210802		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	135.6	mg/mL			N	20241231
68078-060_f65528d6-5697-2632-e053-2995a90af78f	68078-060	HUMAN OTC DRUG	SUNFORGETTABLE TOTAL FACE PROTECTION FACE SHIELD CLASSIC		Zinc Oxide	LOTION	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	135.6	mg/mL			N	20241231
68078-065_f65442f9-6f92-3425-e053-2a95a90a589a	68078-065	HUMAN OTC DRUG	SUNFORGETTABLE TOTAL PROTECTION COLOR BALM COLLECTION ENDLESSS ENDLESS SUNSET		Zinc Oxide	STICK	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	125	mg/g			N	20241231
68078-066_00d8c237-3ef0-1d9f-e063-6394a90aeb86	68078-066	HUMAN OTC DRUG	Colorescience Total Protection No Show Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20230320		OTC MONOGRAPH NOT FINAL	part352	Colorescience	ZINC OXIDE	107	mg/mL			N	20241231
68083-101_e47b17c4-e913-43cf-8406-c38e16f5ae36	68083-101	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION	INTRAVENOUS	20130401		ANDA	ANDA077283	Gland Pharma Limited	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
68083-103_b50a70ef-f6e8-482d-855d-ea87f0620f00	68083-103	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150724		ANDA	ANDA076722	Gland Pharma Limited	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68083-104_b50a70ef-f6e8-482d-855d-ea87f0620f00	68083-104	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150724		ANDA	ANDA076722	Gland Pharma Limited	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68083-106_7cdbef99-3a3a-4612-ab9f-eeb13fbd7066	68083-106	HUMAN PRESCRIPTION DRUG	Midazolam hydrochloride		Midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120601		ANDA	ANDA090696	Gland Pharma Limited	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68083-108_3b7a93cb-a43a-46d0-ad52-6fba91da232d	68083-108	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120601		ANDA	ANDA090850	Gland Pharma Limited	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68083-111_fba0917f-0e92-4c6e-a245-ccc28823abc3	68083-111	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20120419		ANDA	ANDA090699	Gland Pharma Limited	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68083-112_2c1bc6a8-20ff-483a-ae28-fb31fa5f684a	68083-112	HUMAN PRESCRIPTION DRUG	Amiodarone hydrochloride		Amiodarone hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20130715		ANDA	ANDA077161	Gland Pharma Limited	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68083-113_7fc0a5d4-4030-468f-a0f7-6d9a03c45190	68083-113	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20090925		ANDA	ANDA079224	Gland Pharma Limited	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68083-114_b745a8c7-baa3-4680-aaf4-6421bc2cebbe	68083-114	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20120615		ANDA	ANDA090648	Gland Pharma Limited	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68083-116_c08f4eee-1566-4493-83f7-48fa1319a234	68083-116	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20130920		ANDA	ANDA202930	Gland Pharma Limited	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68083-117_d7a7863e-2dcd-4a36-a3dc-858fcb233304	68083-117	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	INJECTION	INTRAMUSCULAR	20160104		ANDA	ANDA076774	Gland Pharma Limited	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
68083-131_32f3e39e-0df1-4cd0-96f1-14d69d7b827d	68083-131	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	INJECTION	INTRAVENOUS	20141006		ANDA	ANDA204205	Gland Pharma Limited	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68083-132_7ac26bd9-6c6a-4c85-853e-3acb0da314b9	68083-132	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20161201		ANDA	ANDA204216	Gland Pharma Limited	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68083-133_7ac26bd9-6c6a-4c85-853e-3acb0da314b9	68083-133	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20161201		ANDA	ANDA204216	Gland Pharma Limited	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68083-134_7ac26bd9-6c6a-4c85-853e-3acb0da314b9	68083-134	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20161201		ANDA	ANDA204216	Gland Pharma Limited	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68083-135_43f14b85-c7dd-4e64-aed3-082a18d9eb20	68083-135	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20160915		ANDA	ANDA204217	Gland Pharma Limited	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68083-136_7cbd4d06-799c-4796-b9de-bdceb49088b5	68083-136	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20170309		ANDA	ANDA205323	Gland Pharma Limited	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
68083-137_e1da9ade-d859-4a35-9100-b99816455f1d	68083-137	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20170116		ANDA	ANDA205241	Gland Pharma Limited	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
68083-138_e1da9ade-d859-4a35-9100-b99816455f1d	68083-138	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20170116		ANDA	ANDA205241	Gland Pharma Limited	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
68083-139_60496581-8e9a-46d7-8e91-d253123af10d	68083-139	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160630		ANDA	ANDA205390	Gland Pharma Limited	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
68083-140_60496581-8e9a-46d7-8e91-d253123af10d	68083-140	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160630		ANDA	ANDA205390	Gland Pharma Limited	VECURONIUM BROMIDE	1	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
68083-141_69efc0d6-1280-4920-b920-c56bfc353602	68083-141	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	SOLUTION	INTRAVENOUS	20170526		ANDA	ANDA205570	Gland Pharma Limited	ARGATROBAN	125	mg/125mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
68083-142_a1d17413-5a66-4bc0-8369-c91d360bc2a8	68083-142	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		zoledronic Acid	INJECTION	INTRAVENOUS	20180705		ANDA	ANDA205749	Gland Pharma Limited	ZOLEDRONIC ACID	4	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68083-143_8db1f95e-ef2b-4796-9b88-b3c481d47fcc	68083-143	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160223		ANDA	ANDA205694	Gland Pharma Limited	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68083-144_8db1f95e-ef2b-4796-9b88-b3c481d47fcc	68083-144	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160223		ANDA	ANDA205694	Gland Pharma Limited	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68083-145_a206685a-4e0d-40a1-8f39-a4b2f660d7d7	68083-145	HUMAN PRESCRIPTION DRUG	Tirofiban hydrochloride		Tirofiban	INJECTION, SOLUTION	INTRAVENOUS	20210415		ANDA	ANDA206888	Gland Pharma Limited	TIROFIBAN HYDROCHLORIDE	12.5	mg/250mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
68083-146_a0ea01bb-04f0-48bc-b613-88cb673ffc1d	68083-146	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION	INTRAVENOUS	20170428		ANDA	ANDA206141	Gland Pharma Limited	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
68083-147_a0ea01bb-04f0-48bc-b613-88cb673ffc1d	68083-147	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION	INTRAVENOUS	20170428		ANDA	ANDA206141	Gland Pharma Limited	MEROPENEM	1	g/30mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
68083-148_b95ab1d2-37c1-42a3-a019-151ea3812cf9	68083-148	HUMAN PRESCRIPTION DRUG	gemcitabine hydrochloride		gemcitabine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160201		ANDA	ANDA204520	Gland Pharma Limited	GEMCITABINE HYDROCHLORIDE	200	mg/5mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-149_b95ab1d2-37c1-42a3-a019-151ea3812cf9	68083-149	HUMAN PRESCRIPTION DRUG	gemcitabine hydrochloride		gemcitabine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160201		ANDA	ANDA204520	Gland Pharma Limited	GEMCITABINE HYDROCHLORIDE	1	g/25mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-152_3e1fe76f-a307-43e5-9330-c169a11c1f38	68083-152	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20171107		ANDA	ANDA206880	Gland Pharma Limited	LEVETIRACETAM	5	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68083-153_3e1fe76f-a307-43e5-9330-c169a11c1f38	68083-153	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20171107		ANDA	ANDA206880	Gland Pharma Limited	LEVETIRACETAM	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68083-154_3e1fe76f-a307-43e5-9330-c169a11c1f38	68083-154	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20171107		ANDA	ANDA206880	Gland Pharma Limited	LEVETIRACETAM	15	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68083-156_acdf6567-6d2d-4adc-9ba2-c4528fe02a05	68083-156	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	SOLUTION	INTRAVENOUS	20170113		ANDA	ANDA206778	Gland Pharma Limited	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
68083-157_acdf6567-6d2d-4adc-9ba2-c4528fe02a05	68083-157	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	SOLUTION	INTRAVENOUS	20170113		ANDA	ANDA206778	Gland Pharma Limited	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
68083-158_0ebc13ad-ba33-408f-8af3-cf995efc4df2	68083-158	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171029		ANDA	ANDA207092	Gland Pharma Limited	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
68083-159_0ebc13ad-ba33-408f-8af3-cf995efc4df2	68083-159	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20171029		ANDA	ANDA207092	Gland Pharma Limited	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
68083-160_596c391f-6690-463d-b688-769779a8486c	68083-160	HUMAN PRESCRIPTION DRUG	Tranexamic acid		Tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20170222		ANDA	ANDA207239	Gland Pharma Limited	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
68083-161_b61d560c-02fd-4ae7-a6f7-fa7edb0a0d3f	68083-161	HUMAN PRESCRIPTION DRUG	Mesna		Mesna Injection	SOLUTION	INTRAVENOUS	20171220		ANDA	ANDA206992	Gland Pharma Limited	MESNA	100	mg/mL	Cytoprotective Agent [EPC]		N	20241231
68083-162_89007399-3c34-40d2-8068-a0b8e09cbef8	68083-162	HUMAN PRESCRIPTION DRUG	CISPLATIN		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20170403		ANDA	ANDA207323	Gland Pharma Limited	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-163_89007399-3c34-40d2-8068-a0b8e09cbef8	68083-163	HUMAN PRESCRIPTION DRUG	CISPLATIN		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20170403		ANDA	ANDA207323	Gland Pharma Limited	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-170_0d039035-85d1-40d4-8ee6-540026ab7a5c	68083-170	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170529		ANDA	ANDA207385	Gland Pharma Limited	OXALIPLATIN	50	mg/10mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-171_0d039035-85d1-40d4-8ee6-540026ab7a5c	68083-171	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170529		ANDA	ANDA207385	Gland Pharma Limited	OXALIPLATIN	100	mg/20mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-172_1242fa67-81da-4c6a-8ec4-81ddfcfb1273	68083-172	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate		Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171009		ANDA	ANDA207384	Gland Pharma Limited	DEFEROXAMINE MESYLATE	500	mg/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
68083-173_1242fa67-81da-4c6a-8ec4-81ddfcfb1273	68083-173	HUMAN PRESCRIPTION DRUG	Deferoxamine mesylate		Deferoxamine mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20171009		ANDA	ANDA207384	Gland Pharma Limited	DEFEROXAMINE MESYLATE	2	g/1	Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
68083-174_c9fda199-cbc5-417b-a2cc-fe5e8f19e4a2	68083-174	HUMAN PRESCRIPTION DRUG	POLYMYXIN B		POLYMYXIN B SULFATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	20160601		ANDA	ANDA207322	Gland Pharma Limited	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68083-175_549593f6-8cfc-4182-8f3c-a60870187d8f	68083-175	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20220712		ANDA	ANDA207320	Gland Pharma Limited	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
68083-176_4ccc9b7c-9bf8-4e27-8c38-f98e80360fcf	68083-176	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20171106		ANDA	ANDA207325	Gland Pharma Limited	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-177_4ccc9b7c-9bf8-4e27-8c38-f98e80360fcf	68083-177	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20171106		ANDA	ANDA207325	Gland Pharma Limited	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-178_aeff20f1-c4e7-46c6-a6cb-f0aab334571b	68083-178	HUMAN PRESCRIPTION DRUG	PACLITAXEL	PACLITAXEL	paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20160930		ANDA	ANDA207326	Gland Pharma Limited	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68083-179_aeff20f1-c4e7-46c6-a6cb-f0aab334571b	68083-179	HUMAN PRESCRIPTION DRUG	PACLITAXEL	PACLITAXEL	paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20160930		ANDA	ANDA207326	Gland Pharma Limited	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68083-180_aeff20f1-c4e7-46c6-a6cb-f0aab334571b	68083-180	HUMAN PRESCRIPTION DRUG	PACLITAXEL	PACLITAXEL	paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20160930		ANDA	ANDA207326	Gland Pharma Limited	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68083-190_f171db85-7a96-42ae-a443-f31586f94803	68083-190	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20170220		ANDA	ANDA207324	Gland Pharma Limited	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-191_f171db85-7a96-42ae-a443-f31586f94803	68083-191	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20170220		ANDA	ANDA207324	Gland Pharma Limited	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-192_f171db85-7a96-42ae-a443-f31586f94803	68083-192	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20170220		ANDA	ANDA207324	Gland Pharma Limited	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-193_f171db85-7a96-42ae-a443-f31586f94803	68083-193	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		Carboplatin	INJECTION, SOLUTION	INTRAVENOUS	20170220		ANDA	ANDA207324	Gland Pharma Limited	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-195_9ced7ea2-4a3a-45fa-95c3-2d3135fc35ab	68083-195	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane for Injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20161205		ANDA	ANDA207321	Gland Pharma Limited	DEXRAZOXANE HYDROCHLORIDE	500	mg/50mL	Cytoprotective Agent [EPC]		N	20241231
68083-199_d0a507c6-cb4b-4295-bf17-48bb8e4b03f3	68083-199	HUMAN PRESCRIPTION DRUG	Azithromycin monohydrate		Azithromycin monohydrate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20091109		ANDA	ANDA065501	Gland Pharma Limited	AZITHROMYCIN MONOHYDRATE	500	mg/10mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68083-202_6dd61a73-2d62-4f94-9617-643d8b896fde	68083-202	HUMAN PRESCRIPTION DRUG	Temsirolimus		Temsirolimus Injection	KIT		20190826		ANDA	ANDA207383	Gland Pharma Limited						N	20241231
68083-210_1762525e-0af9-445f-ab67-00bfa954dc7d	68083-210	HUMAN PRESCRIPTION DRUG	Moxifloxacin Ophthalmic Solution		Moxifloxacin Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200330		ANDA	ANDA208778	Gland Pharma Limited	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68083-211_91f3287c-e1f4-48a0-a37e-74da91240a2d	68083-211	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	20190819		ANDA	ANDA208538	Gland Pharma Limited	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68083-231_9a4c58dc-aee6-441f-8081-608e4fd36193	68083-231	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20200520		ANDA	ANDA209752	Gland Pharma Limited	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
68083-233_450522bc-fc66-430c-aac2-9e00ea54f34a	68083-233	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20240103		ANDA	ANDA212605	Gland Pharma Limited	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20251231
68083-234_3e4fa967-6ab9-4de0-af94-f9c479504b20	68083-234	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate Injection	SOLUTION	INTRAVENOUS	20170520		ANDA	ANDA209058	Gland Pharma Limited	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
68083-235_3e4fa967-6ab9-4de0-af94-f9c479504b20	68083-235	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate Injection	SOLUTION	INTRAVENOUS	20170520		ANDA	ANDA209058	Gland Pharma Limited	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
68083-238_e9bec92b-b87c-4b81-b51e-9dd7e87c0a59	68083-238	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION	INTRAVENOUS	20200603		ANDA	ANDA209307	Gland Pharma Limited	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
68083-239_e9bec92b-b87c-4b81-b51e-9dd7e87c0a59	68083-239	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION	INTRAVENOUS	20200603		ANDA	ANDA209307	Gland Pharma Limited	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
68083-241_7dec68fc-8f9a-4a26-9578-81bb22a5a1b5	68083-241	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAVENOUS	20210209		ANDA	ANDA209346	Gland Pharma Limited	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68083-248_cab63015-13f2-4579-9d23-4a210b56a21a	68083-248	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20170822		ANDA	ANDA209825	Gland Pharma Limited	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
68083-249_cab63015-13f2-4579-9d23-4a210b56a21a	68083-249	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20170822		ANDA	ANDA209825	Gland Pharma Limited	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
68083-250_cab63015-13f2-4579-9d23-4a210b56a21a	68083-250	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20170822		ANDA	ANDA209825	Gland Pharma Limited	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
68083-253_5af7f80d-4d6d-404f-9ff7-1a8315625d8b	68083-253	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210211		ANDA	ANDA209621	Gland Pharma Limited	TOBRAMYCIN SULFATE	10	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68083-254_5af7f80d-4d6d-404f-9ff7-1a8315625d8b	68083-254	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210211		ANDA	ANDA209621	Gland Pharma Limited	TOBRAMYCIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68083-256_cdf79a61-6cf0-4d17-a950-a562f1a77428	68083-256	HUMAN PRESCRIPTION DRUG	Zoledronic acid		Zoledronic acid	INJECTION	INTRAVENOUS	20170313		ANDA	ANDA209578	Gland Pharma Limited	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68083-259_c1a5c2ee-7acc-44f6-8e95-534a2d88e223	68083-259	HUMAN PRESCRIPTION DRUG	Melphalan hydrochloride		Melphalan hydrochloride	KIT		20190610		ANDA	ANDA209826	Gland Pharma Limited						N	20241231
68083-262_59ffca85-dbbf-49c1-8516-027b9de5f396	68083-262	HUMAN PRESCRIPTION DRUG	Ropivacaine hydrochloride		Ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20220818		ANDA	ANDA210102	Gland Pharma Limited	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
68083-263_59ffca85-dbbf-49c1-8516-027b9de5f396	68083-263	HUMAN PRESCRIPTION DRUG	Ropivacaine hydrochloride		Ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20220818		ANDA	ANDA210102	Gland Pharma Limited	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
68083-269_4b57432f-c80b-4f87-87e7-4ec0c246f848	68083-269	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20171107		ANDA	ANDA210123	Gland Pharma Limited	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-270_4b57432f-c80b-4f87-87e7-4ec0c246f848	68083-270	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20171107		ANDA	ANDA210123	Gland Pharma Limited	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-278_c3b9daf5-c553-46af-b651-841b43b2e706	68083-278	HUMAN PRESCRIPTION DRUG	levoleucovorin		Levoleucovorin	INJECTION	INTRAVENOUS	20180920		ANDA	ANDA210892	Gland Pharma Limited	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
68083-279_c3b9daf5-c553-46af-b651-841b43b2e706	68083-279	HUMAN PRESCRIPTION DRUG	levoleucovorin		Levoleucovorin	INJECTION	INTRAVENOUS	20180920		ANDA	ANDA210892	Gland Pharma Limited	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
68083-287_1d3aa46c-c96c-4a67-b2e1-0a4551bc1b15	68083-287	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		Azelastine Hydrochloride	SOLUTION/ DROPS	INTRAOCULAR	20200225		ANDA	ANDA210092	Gland Pharma Limited	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68083-292_5b20d465-b554-40ba-9ce0-98d956db8e14	68083-292	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20180105		ANDA	ANDA210124	Gland Pharma Limited	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-293_5b20d465-b554-40ba-9ce0-98d956db8e14	68083-293	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20180105		ANDA	ANDA210124	Gland Pharma Limited	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-295_512bd5c6-1e5d-4423-b06e-9fe80ff833c2	68083-295	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20190212		ANDA	ANDA210126	Gland Pharma Limited	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
68083-296_512bd5c6-1e5d-4423-b06e-9fe80ff833c2	68083-296	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20190212		ANDA	ANDA210126	Gland Pharma Limited	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
68083-312_a13f2109-eb69-4d3a-9203-790cb6520e78	68083-312	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210518		ANDA	ANDA211189	Gland Pharma Limited	TOBRAMYCIN SULFATE	1.2	g/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68083-313_4aed36ae-5bc7-4be8-a511-a9126050e7de	68083-313	HUMAN PRESCRIPTION DRUG	BROMFENAC		Bromfenac	SOLUTION/ DROPS	OPHTHALMIC	20200317		ANDA	ANDA211029	Gland Pharma Limited	BROMFENAC SODIUM	.9	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68083-314_4ccc9b7c-9bf8-4e27-8c38-f98e80360fcf	68083-314	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20171106		ANDA	ANDA207325	Gland Pharma Limited	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
68083-316_7e6d4205-3332-4f96-b258-8ffde9119ed4	68083-316	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	INJECTION	INTRAVENOUS	20200203		ANDA	ANDA211030	Gland Pharma Limited	CALCITRIOL	1	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
68083-317_36c2242f-82d7-4faa-a640-0a6e269038ff	68083-317	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20181101		ANDA	ANDA211504	Gland Pharma Limited	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68083-320_3b7a6d2b-8d0d-45e3-9778-9a9e010aaf42	68083-320	HUMAN PRESCRIPTION DRUG	DICYCLOMINE HYDROCHLORIDE		Dicyclomine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	20171220		ANDA	ANDA210979	Gland Pharma Limited	DICYCLOMINE HYDROCHLORIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68083-321_d235436a-8134-4073-ae4c-bd698e784e56	68083-321	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200331		ANDA	ANDA211099	Gland Pharma Limited	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68083-337_b913ae17-4b11-4748-a883-eba1bc9e9c06	68083-337	HUMAN PRESCRIPTION DRUG	Cytarabine		Cytarabine	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20191223		ANDA	ANDA211938	Gland Pharma Limited	CYTARABINE	100	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-338_61b63c37-7fc9-4557-acf6-eea73b84b4c3	68083-338	HUMAN PRESCRIPTION DRUG	phenylephrine hydrochloride		phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20201021		ANDA	ANDA211920	Gland Pharma Limited	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68083-339_61b63c37-7fc9-4557-acf6-eea73b84b4c3	68083-339	HUMAN PRESCRIPTION DRUG	phenylephrine hydrochloride		phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20201021		ANDA	ANDA211920	Gland Pharma Limited	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68083-340_900a6ad2-22e8-44dc-8e77-33f832cd7696	68083-340	HUMAN PRESCRIPTION DRUG	ziprasidone mesylate		ziprasidone mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20191226		ANDA	ANDA211908	Gland Pharma Limited	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
68083-343_47628a16-dba0-4e55-ac61-70fc4d94730a	68083-343	HUMAN PRESCRIPTION DRUG	Cytarabine		Cytarabine	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20191223		ANDA	ANDA211937	Gland Pharma Limited	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-351_71422270-6a76-40e5-bd89-643b8b2fafd5	68083-351	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210326		ANDA	ANDA212040	Gland Pharma Limited	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
68083-364_4cca9732-e96d-46cd-acdb-92afa1845fc8	68083-364	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20180518		ANDA	ANDA205656	Gland Pharma Limited	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
68083-365_4cca9732-e96d-46cd-acdb-92afa1845fc8	68083-365	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20180518		ANDA	ANDA205656	Gland Pharma Limited	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
68083-373_ea6a766c-e5ff-4dd1-984d-b68fb144033f	68083-373	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	INJECTION, SOLUTION	INTRAVENOUS	20200803		ANDA	ANDA212435	Gland Pharma Limited	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68083-374_f43b227e-3e24-428d-bef1-4f32628a786e	68083-374	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20210309		ANDA	ANDA212628	Gland Pharma Limited	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68083-376_8b3e5fda-528f-4f65-8d46-6a3b7e287430	68083-376	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191009		ANDA	ANDA212612	Gland Pharma Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68083-377_8b3e5fda-528f-4f65-8d46-6a3b7e287430	68083-377	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191009		ANDA	ANDA212612	Gland Pharma Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68083-378_8b3e5fda-528f-4f65-8d46-6a3b7e287430	68083-378	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191009		ANDA	ANDA212612	Gland Pharma Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68083-379_8b3e5fda-528f-4f65-8d46-6a3b7e287430	68083-379	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191009		ANDA	ANDA212612	Gland Pharma Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68083-380_6a0eaf66-34ca-4ba5-a2c6-a3c369ddf30c	68083-380	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220126		ANDA	ANDA212363	Gland Pharma Limited	ALLOPURINOL SODIUM	500	mg/25mL	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68083-381_a1ced9af-9117-485c-925d-47f7266bc9df	68083-381	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloide		Irinotecan hydrochloide	INJECTION	INTRAVENOUS	20191118		ANDA	ANDA212993	Gland Pharma Limited	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
68083-382_a1ced9af-9117-485c-925d-47f7266bc9df	68083-382	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloride		Irinotecan hydrochloride	INJECTION	INTRAVENOUS	20191118		ANDA	ANDA212993	Gland Pharma Limited	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
68083-383_d23bd0d2-5553-4a34-bf15-81349c82eabe	68083-383	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20191021		ANDA	ANDA212968	Gland Pharma Limited	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68083-384_d23bd0d2-5553-4a34-bf15-81349c82eabe	68083-384	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20191021		ANDA	ANDA212968	Gland Pharma Limited	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68083-386_e35a63ca-af60-4142-a5af-37640734e820	68083-386	HUMAN PRESCRIPTION DRUG	Clofarabine		Clofarabine	INJECTION	INTRAVENOUS	20181114		ANDA	ANDA207831	Gland Pharma Limited	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-388_9ced7ea2-4a3a-45fa-95c3-2d3135fc35ab	68083-388	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane for Injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191216		ANDA	ANDA207321	Gland Pharma Limited	DEXRAZOXANE HYDROCHLORIDE	250	mg/25mL	Cytoprotective Agent [EPC]		N	20241231
68083-389_e7d4415b-96cc-4f7b-b639-7369baf4871a	68083-389	HUMAN PRESCRIPTION DRUG	Foscarnet Sodium		Foscarnet Sodium	INJECTION, SOLUTION	INTRAVENOUS	20210421		ANDA	ANDA213001	Gland Pharma Limited	FOSCARNET SODIUM	24	mg/mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
68083-394_d97ee850-7e44-4d56-b45c-b2338cce3b92	68083-394	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	INJECTION, SOLUTION	INTRAVENOUS	20200422		ANDA	ANDA205540	Gland Pharma Limited	LEVOFLOXACIN	25	mg/mL			N	20241231
68083-395_d97ee850-7e44-4d56-b45c-b2338cce3b92	68083-395	HUMAN PRESCRIPTION DRUG	LEVOFLOXACIN		LEVOFLOXACIN	INJECTION, SOLUTION	INTRAVENOUS	20200422		ANDA	ANDA205540	Gland Pharma Limited	LEVOFLOXACIN	25	mg/mL			N	20241231
68083-396_4166c4fd-2951-4ab0-ab2a-6da9dd39927e	68083-396	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20200710		ANDA	ANDA213917	Gland Pharma Limited	MAGNESIUM SULFATE HEPTAHYDRATE	2	g/50mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68083-397_4166c4fd-2951-4ab0-ab2a-6da9dd39927e	68083-397	HUMAN PRESCRIPTION DRUG	MAGNESIUM SULFATE		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20200710		ANDA	ANDA213917	Gland Pharma Limited	MAGNESIUM SULFATE HEPTAHYDRATE	4	g/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68083-399_98672249-02db-4f71-9b49-a76e3ef56a21	68083-399	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20210701		ANDA	ANDA213510	Gland Pharma Limited	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68083-400_98672249-02db-4f71-9b49-a76e3ef56a21	68083-400	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20210701		ANDA	ANDA213510	Gland Pharma Limited	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68083-401_98672249-02db-4f71-9b49-a76e3ef56a21	68083-401	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20210701		ANDA	ANDA213510	Gland Pharma Limited	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68083-410_4522009c-38db-44c1-8d16-c44f674a9920	68083-410	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20200716		ANDA	ANDA213585	Gland Pharma Limited	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
68083-411_4522009c-38db-44c1-8d16-c44f674a9920	68083-411	HUMAN PRESCRIPTION DRUG	Milrinone Lactate in Dextrose		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20200716		ANDA	ANDA213585	Gland Pharma Limited	MILRINONE LACTATE	.2	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
68083-414_c513dd75-73c5-45bd-981d-0ad4c261f075	68083-414	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20201230		ANDA	ANDA206908	Gland Pharma Limited	LEVOFLOXACIN	250	mg/50mL			N	20241231
68083-415_c513dd75-73c5-45bd-981d-0ad4c261f075	68083-415	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20201230		ANDA	ANDA206908	Gland Pharma Limited	LEVOFLOXACIN	500	mg/100mL			N	20241231
68083-416_c513dd75-73c5-45bd-981d-0ad4c261f075	68083-416	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20201230		ANDA	ANDA206908	Gland Pharma Limited	LEVOFLOXACIN	750	mg/150mL			N	20241231
68083-427_7cbd4d06-799c-4796-b9de-bdceb49088b5	68083-427	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20191118		ANDA	ANDA205323	Gland Pharma Limited	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
68083-428_7cbd4d06-799c-4796-b9de-bdceb49088b5	68083-428	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20191118		ANDA	ANDA205323	Gland Pharma Limited	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
68083-432_e7bd6ac5-0b85-49a8-b4a3-131d95b1764a	68083-432	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200701		ANDA	ANDA213902	Gland Pharma Limited	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68083-433_e7bd6ac5-0b85-49a8-b4a3-131d95b1764a	68083-433	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200701		ANDA	ANDA213902	Gland Pharma Limited	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68083-434_e7bd6ac5-0b85-49a8-b4a3-131d95b1764a	68083-434	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200701		ANDA	ANDA213902	Gland Pharma Limited	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68083-435_615de440-2d5d-4133-8a51-df363130496a	68083-435	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210922		ANDA	ANDA214107	Gland Pharma Limited	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68083-436_615de440-2d5d-4133-8a51-df363130496a	68083-436	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210922		ANDA	ANDA214107	Gland Pharma Limited	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68083-437_7009a490-d2e2-4103-9f20-c5e400891261	68083-437	HUMAN PRESCRIPTION DRUG	Norepinephrine bitartrate		Norepinephrine bitartrate	INJECTION	INTRAVENOUS	20210512		ANDA	ANDA214323	Gland Pharma Limited	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
68083-439_512bd5c6-1e5d-4423-b06e-9fe80ff833c2	68083-439	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20200812		ANDA	ANDA210126	Gland Pharma Limited	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
68083-446_283f8e9e-6f72-4e0b-9459-e7d4430ad0ee	68083-446	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20210308		ANDA	ANDA214222	Gland Pharma Limited	THIOTEPA	15	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68083-447_97d5fbfc-783f-4d2d-a178-1ac1ff0d6a55	68083-447	HUMAN PRESCRIPTION DRUG	Verapamil hydrochloride		Verapamil hydrochloride	INJECTION	INTRAVENOUS	20201015		ANDA	ANDA214361	Gland Pharma Limited	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68083-448_97d5fbfc-783f-4d2d-a178-1ac1ff0d6a55	68083-448	HUMAN PRESCRIPTION DRUG	Verapamil hydrochloride		Verapamil hydrochloride	INJECTION	INTRAVENOUS	20201015		ANDA	ANDA214361	Gland Pharma Limited	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68083-449_771cf601-8f92-4e4f-a29f-b18e71b1ba96	68083-449	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20200924		ANDA	ANDA214390	Gland Pharma Limited	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
68083-450_b08b61a2-a183-429e-8cf0-d78a71692f18	68083-450	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200616		ANDA	ANDA214246	Gland Pharma Limited	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
68083-451_e8d62781-b9de-4d02-b5d2-02b024895c95	68083-451	HUMAN PRESCRIPTION DRUG	Esomeprazole Sodium		Esomeprazole Sodium	INJECTION	INTRAVENOUS	20200401		ANDA	ANDA203349	Gland Pharma Limited	ESOMEPRAZOLE SODIUM	20	mg/5mL	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68083-452_e8d62781-b9de-4d02-b5d2-02b024895c95	68083-452	HUMAN PRESCRIPTION DRUG	Esomeprazole Sodium		Esomeprazole Sodium	INJECTION	INTRAVENOUS	20200401		ANDA	ANDA203349	Gland Pharma Limited	ESOMEPRAZOLE SODIUM	40	mg/5mL	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68083-457_0c73f98d-4f49-415a-abc5-2d253061e669	68083-457	HUMAN PRESCRIPTION DRUG	timolol maleate ophthalmic gel forming solution		timolol maleate ophthalmic gel forming solution	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20220624		ANDA	ANDA214645	Gland Pharma Limited	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68083-458_0c73f98d-4f49-415a-abc5-2d253061e669	68083-458	HUMAN PRESCRIPTION DRUG	timolol maleate ophthalmic gel forming solution		timolol maleate ophthalmic gel forming	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20230214		ANDA	ANDA214645	Gland Pharma Limited	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68083-460_00f57b3c-3819-440e-a928-eeec0fee27aa	68083-460	HUMAN PRESCRIPTION DRUG	Fosphenytoin sodium		Fosphenytoin sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231013		ANDA	ANDA214926	Gland Pharma Limited	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68083-461_00f57b3c-3819-440e-a928-eeec0fee27aa	68083-461	HUMAN PRESCRIPTION DRUG	Fosphenytoin sodium		Fosphenytoin sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231013		ANDA	ANDA214926	Gland Pharma Limited	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68083-462_9e5d3f7f-e2bd-472c-81ce-b29fbbc71942	68083-462	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION	INTRAVENOUS	20211007		ANDA	ANDA215059	Gland Pharma Limited	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
68083-465_61b63c37-7fc9-4557-acf6-eea73b84b4c3	68083-465	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride	Phenylephrine Hydrochloride	Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210414		ANDA	ANDA211920	Gland Pharma Limited	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68083-466_a1a6aeb0-fb61-46bf-8b3f-7ed1a9cc21ae	68083-466	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20230818		ANDA	ANDA215623	Gland Pharma Limited	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
68083-472_9d647fa7-adc3-4767-a8e5-1b44b07cdd34	68083-472	HUMAN PRESCRIPTION DRUG	GANIRELIX ACETATE		GANIRELIX ACETATE	INJECTION, SOLUTION	SUBCUTANEOUS	20230228		ANDA	ANDA215658	Gland Pharma Limited	GANIRELIX ACETATE	250	ug/.5mL	Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]		N	20241231
68083-473_69f93f62-6e71-4adc-b05e-d655cfd8f664	68083-473	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20210804		ANDA	ANDA215654	Gland Pharma Limited	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68083-474_69f93f62-6e71-4adc-b05e-d655cfd8f664	68083-474	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20210804		ANDA	ANDA215654	Gland Pharma Limited	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68083-476_aa890b19-6014-4de9-a0c3-dd54f179c5e1	68083-476	HUMAN PRESCRIPTION DRUG	fluphenazine decanoate		fluphenazine decanoate	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20230330		ANDA	ANDA215509	Gland Pharma Limited	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68083-477_e7907389-32be-4d83-a6e6-4360842d4893	68083-477	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20170214		ANDA	ANDA209619	Gland Pharma Limited	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
68083-478_084e1826-51be-4e48-aae4-b6affb80853f	68083-478	HUMAN PRESCRIPTION DRUG	lincomycin hydrochloride		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20220926		ANDA	ANDA215657	Gland Pharma Limited	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
68083-479_084e1826-51be-4e48-aae4-b6affb80853f	68083-479	HUMAN PRESCRIPTION DRUG	Lincomycin hydrochloride		lincomycin hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL	20220926		ANDA	ANDA215657	Gland Pharma Limited	LINCOMYCIN HYDROCHLORIDE	300	mg/mL			N	20241231
68083-480_e0b6312d-15c2-44a1-b58c-c89822b334e5	68083-480	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	INJECTION	INTRAVENOUS	20220919		ANDA	ANDA215628	Gland Pharma Limited	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
68083-481_b36ae163-cb51-4170-86b1-ddf1cdd0c01b	68083-481	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230412		ANDA	ANDA215583	Gland Pharma Limited	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68083-483_64496224-9cec-48bb-a750-db192dd7780c	68083-483	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211020		ANDA	ANDA215687	Gland Pharma Limited	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68083-484_64496224-9cec-48bb-a750-db192dd7780c	68083-484	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211020		ANDA	ANDA215687	Gland Pharma Limited	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68083-489_766f1b4c-c211-43ff-97c0-3b06a918b650	68083-489	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride		Dorzolamide Hydrochloride	SOLUTION	OPHTHALMIC	20220127		ANDA	ANDA215660	Gland Pharma Limited	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
68083-490_667d6816-c17b-4ebb-8605-348d0251434a	68083-490	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20220919		ANDA	ANDA215520	Gland Pharma Limited	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68083-493_78f46cc5-62b3-492d-ba0f-0dac899a926c	68083-493	HUMAN PRESCRIPTION DRUG	Pantoprazole sodium		Pantoprazole sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220518		ANDA	ANDA204400	Gland Pharma Limited	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68083-495_0b79ab41-7c76-4459-8021-57b4364d7dcd	68083-495	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20220225		ANDA	ANDA216146	Gland Pharma Limited	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
68083-496_d9e3877d-de1a-4047-9866-413958c4cca0	68083-496	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220526		ANDA	ANDA216434	Gland Pharma Limited	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68083-497_d9e3877d-de1a-4047-9866-413958c4cca0	68083-497	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220526		ANDA	ANDA216434	Gland Pharma Limited	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68083-498_cfa59996-1de2-4313-a7ac-1766764513e2	68083-498	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20220503		ANDA	ANDA216249	Gland Pharma Limited	ZINC SULFATE	3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68083-499_cfa59996-1de2-4313-a7ac-1766764513e2	68083-499	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20220503		ANDA	ANDA216249	Gland Pharma Limited	ZINC SULFATE	5	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68083-502_5a0916d0-90cc-4ac2-82ba-e44138161853	68083-502	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221122		ANDA	ANDA216648	Gland Pharma Limited	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68083-503_283f8e9e-6f72-4e0b-9459-e7d4430ad0ee	68083-503	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20220103		ANDA	ANDA214222	Gland Pharma Limited	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68083-504_d22e9ca5-0df4-480c-90f6-79edd508a00d	68083-504	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230124		ANDA	ANDA216809	Gland Pharma Limited	KETAMINE HYDROCHLORIDE	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
68083-505_d22e9ca5-0df4-480c-90f6-79edd508a00d	68083-505	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230124		ANDA	ANDA216809	Gland Pharma Limited	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
68083-506_d22e9ca5-0df4-480c-90f6-79edd508a00d	68083-506	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230124		ANDA	ANDA216809	Gland Pharma Limited	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
68083-510_69c8a021-8f8d-4989-b5b5-976c1ec5b7b2	68083-510	HUMAN PRESCRIPTION DRUG	Fomepizole		Fomepizole	INJECTION	INTRAVENOUS	20230706		ANDA	ANDA216791	Gland Pharma Limited	FOMEPIZOLE	1	g/mL	Antidote [EPC]		N	20241231
68083-515_67e9b5c7-c86b-4a79-aa2b-6d768c520ead	68083-515	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230613		ANDA	ANDA216807	Gland Pharma Limited	OCTREOTIDE ACETATE	200	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
68083-516_67e9b5c7-c86b-4a79-aa2b-6d768c520ead	68083-516	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230613		ANDA	ANDA216807	Gland Pharma Limited	OCTREOTIDE ACETATE	1000	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
68083-517_084fb633-d8d7-4a6e-8e52-c5eb6bc3ffd1	68083-517	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230622		ANDA	ANDA216839	Gland Pharma Limited	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
68083-527_714cc0d2-8a4c-40c0-8ef0-dcfde4c46989	68083-527	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		Dexmedetomidine	INJECTION, SOLUTION	INTRAVENOUS	20210628		ANDA	ANDA202126	Gland Pharma Limited	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
68083-528_39a26b24-e9d4-4974-9788-d025c51fc94f	68083-528	HUMAN PRESCRIPTION DRUG	decitabine		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201123		ANDA	ANDA205539	Gland Pharma Limited	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
68083-535_9e5d3f7f-e2bd-472c-81ce-b29fbbc71942	68083-535	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION	INTRAVENOUS	20220422		ANDA	ANDA215059	Gland Pharma Limited	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
68083-549_87b1a5b9-034c-401b-9be9-236571d01e14	68083-549	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230320		ANDA	ANDA216904	Gland Pharma Limited	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
68083-550_0f297b51-3d85-43b9-b96b-88a82858fe3c	68083-550	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20221116		ANDA	ANDA216922	Gland Pharma Limited	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
68083-560_084fb633-d8d7-4a6e-8e52-c5eb6bc3ffd1	68083-560	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230622		ANDA	ANDA216839	Gland Pharma Limited	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
68083-561_771cf601-8f92-4e4f-a29f-b18e71b1ba96	68083-561	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20221014		ANDA	ANDA214390	Gland Pharma Limited	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
68083-562_771cf601-8f92-4e4f-a29f-b18e71b1ba96	68083-562	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20221014		ANDA	ANDA214390	Gland Pharma Limited	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
68083-568_0f487fff-cf82-44ce-bc1b-c32fa7bdf1c7	68083-568	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION, SOLUTION	INTRAVENOUS	20230731		ANDA	ANDA217848	Gland Pharma Limited	ARGATROBAN	50	mg/50mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
68083-569_c45949e7-eaef-4e97-8a8e-9134855ee6a4	68083-569	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230606		ANDA	ANDA205694	Gland Pharma Limited	VANCOMYCIN HYDROCHLORIDE	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68083-570_c45949e7-eaef-4e97-8a8e-9134855ee6a4	68083-570	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230606		ANDA	ANDA205694	Gland Pharma Limited	VANCOMYCIN HYDROCHLORIDE	10	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68083-577_82592eeb-2109-4990-8d99-001f07e1c6cb	68083-577	HUMAN PRESCRIPTION DRUG	posaconazole		posaconazole	INJECTION, SOLUTION	INTRAVENOUS	20231226		ANDA	ANDA217553	Gland Pharma Limited	POSACONAZOLE	18	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68083-584_ed3dacb6-5a1e-4499-bec2-5ec46a0399ad	68083-584	HUMAN PRESCRIPTION DRUG	carboprost tromethamine		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230807		ANDA	ANDA217657	Gland Pharma Limited	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
68083-607_69f93f62-6e71-4adc-b05e-d655cfd8f664	68083-607	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20230925		ANDA	ANDA215654	Gland Pharma Limited	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68083-608_cfa59996-1de2-4313-a7ac-1766764513e2	68083-608	HUMAN PRESCRIPTION DRUG	Zinc Sulfate		Zinc Sulfate	INJECTION, SOLUTION	INTRAVENOUS	20230901		ANDA	ANDA216249	Gland Pharma Limited	ZINC SULFATE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68083-615_c08f4eee-1566-4493-83f7-48fa1319a234	68083-615	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20231108		ANDA	ANDA202930	Gland Pharma Limited	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68083-634_65025e0d-eb54-4c4e-bd14-f294ce038902	68083-634	HUMAN PRESCRIPTION DRUG	ENOXAPARIN SODIUM		ENOXAPARIN SODIUM	INJECTION	SUBCUTANEOUS	20230711		ANDA	ANDA078990	Gland Pharma Limited	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68083-635_65025e0d-eb54-4c4e-bd14-f294ce038902	68083-635	HUMAN PRESCRIPTION DRUG	ENOXAPARIN SODIUM		ENOXAPARIN SODIUM	INJECTION	SUBCUTANEOUS	20230711		ANDA	ANDA078990	Gland Pharma Limited	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68083-636_65025e0d-eb54-4c4e-bd14-f294ce038902	68083-636	HUMAN PRESCRIPTION DRUG	ENOXAPARIN SODIUM		ENOXAPARIN SODIUM	INJECTION	SUBCUTANEOUS	20230711		ANDA	ANDA078990	Gland Pharma Limited	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68083-637_65025e0d-eb54-4c4e-bd14-f294ce038902	68083-637	HUMAN PRESCRIPTION DRUG	ENOXAPARIN SODIUM		ENOXAPARIN SODIUM	INJECTION	SUBCUTANEOUS	20230711		ANDA	ANDA078990	Gland Pharma Limited	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68083-638_65025e0d-eb54-4c4e-bd14-f294ce038902	68083-638	HUMAN PRESCRIPTION DRUG	ENOXAPARIN SODIUM		ENOXAPARIN SODIUM	INJECTION	SUBCUTANEOUS	20230711		ANDA	ANDA078990	Gland Pharma Limited	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68083-639_65025e0d-eb54-4c4e-bd14-f294ce038902	68083-639	HUMAN PRESCRIPTION DRUG	ENOXAPARIN SODIUM		ENOXAPARIN SODIUM	INJECTION	SUBCUTANEOUS	20230711		ANDA	ANDA078990	Gland Pharma Limited	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68083-640_65025e0d-eb54-4c4e-bd14-f294ce038902	68083-640	HUMAN PRESCRIPTION DRUG	ENOXAPARIN SODIUM		ENOXAPARIN SODIUM	INJECTION	SUBCUTANEOUS	20230711		ANDA	ANDA078990	Gland Pharma Limited	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
68084-021_deaccc09-6ff2-b25d-e053-2a95a90a6929	68084-021	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET, FILM COATED	ORAL	20130124		ANDA	ANDA077844	American Health Packaging	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
68084-027_0c797863-656f-17dc-e063-6294a90a493f	68084-027	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20050601		ANDA	ANDA040301	American Health Packaging	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68084-040_f92913ff-ba8d-7764-e053-6294a90a7242	68084-040	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20130708	20240229	ANDA	ANDA091667	American Health Packaging	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	
68084-041_f92913ff-ba8d-7764-e053-6294a90a7242	68084-041	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20130708	20240229	ANDA	ANDA091667	American Health Packaging	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	
68084-044_ea3fd8db-eb10-57fb-e053-2995a90a895f	68084-044	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20080116		ANDA	ANDA077584	American Health Packaging	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68084-045_ea3fd8db-eb10-57fb-e053-2995a90a895f	68084-045	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20080318		ANDA	ANDA077584	American Health Packaging	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68084-046_ea3fd8db-eb10-57fb-e053-2995a90a895f	68084-046	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20080110		ANDA	ANDA077584	American Health Packaging	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68084-047_ea3fd8db-eb10-57fb-e053-2995a90a895f	68084-047	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20080618		ANDA	ANDA077584	American Health Packaging	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68084-059_ea3cdd3e-3b31-1141-e053-2a95a90ac833	68084-059	HUMAN PRESCRIPTION DRUG	Zafirlukast		Zafirlukast	TABLET, FILM COATED	ORAL	20130522		ANDA	ANDA090372	American Health Packaging	ZAFIRLUKAST	20	mg/1	Cytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68084-070_fea6bf57-b220-7dc4-e053-6294a90a9da8	68084-070	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20040818		ANDA	ANDA076794	American Health Packaging	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68084-075_ea3cc717-df5c-044b-e053-2a95a90af99b	68084-075	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE	ORAL	20130718		ANDA	ANDA201687	American Health Packaging	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68084-082_04269f25-ab7f-27a7-e063-6394a90abaec	68084-082	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	20131009		ANDA	ANDA086925	American Health Packaging	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68084-083_04269f25-ab7f-27a7-e063-6394a90abaec	68084-083	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	20131009		ANDA	ANDA087537	American Health Packaging	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68084-094_e271574d-49f1-bde0-e053-2995a90a64f5	68084-094	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20060824		ANDA	ANDA074260	American Health Packaging	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
68084-097_f3d2b803-1f91-6a77-e053-2a95a90aaebb	68084-097	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130729		ANDA	ANDA090548	American Health Packaging	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68084-098_f3d2b803-1f91-6a77-e053-2a95a90aaebb	68084-098	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130618		ANDA	ANDA090548	American Health Packaging	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68084-099_f3d2b803-1f91-6a77-e053-2a95a90aaebb	68084-099	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20130821		ANDA	ANDA090548	American Health Packaging	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68084-103_e95abac5-3cd4-ad35-e053-2995a90aa682	68084-103	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20141124		ANDA	ANDA077561	American Health Packaging	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-104_e95abac5-3cd4-ad35-e053-2995a90aa682	68084-104	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20141124		ANDA	ANDA077561	American Health Packaging	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-105_e95abac5-3cd4-ad35-e053-2995a90aa682	68084-105	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20141124		ANDA	ANDA077561	American Health Packaging	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-106_e95abac5-3cd4-ad35-e053-2995a90aa682	68084-106	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20141124		ANDA	ANDA077561	American Health Packaging	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-107_ea3f2ca8-e079-f820-e053-2995a90a5631	68084-107	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20140121		ANDA	ANDA075677	American Health Packaging	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68084-108_ea3f34c4-3cf7-5f29-e053-2995a90ac0bf	68084-108	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20140121		ANDA	ANDA077309	American Health Packaging	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68084-109_ea3f34c4-3cf7-5f29-e053-2995a90ac0bf	68084-109	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20140121		ANDA	ANDA077309	American Health Packaging	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68084-111_0566d5be-a3b3-7374-e063-6394a90aa44d	68084-111	HUMAN PRESCRIPTION DRUG	Glipizide	ER	Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080611	20240930	ANDA	ANDA076467	American Health Packaging	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
68084-112_0566d5be-a3b3-7374-e063-6394a90aa44d	68084-112	HUMAN PRESCRIPTION DRUG	Glipizide	ER	Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080611	20240531	ANDA	ANDA076467	American Health Packaging	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
68084-119_026f532e-34e1-5c57-e063-6394a90a6666	68084-119	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20051031		ANDA	ANDA076921	American Health Packaging	MIRTAZAPINE	15	mg/1			N	20241231
68084-120_026f532e-34e1-5c57-e063-6394a90a6666	68084-120	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20051025		ANDA	ANDA076921	American Health Packaging	MIRTAZAPINE	30	mg/1			N	20241231
68084-121_026f532e-34e1-5c57-e063-6394a90a6666	68084-121	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20051028		ANDA	ANDA076921	American Health Packaging	MIRTAZAPINE	45	mg/1			N	20241231
68084-149_ea4005d6-4242-8992-e053-2a95a90a587e	68084-149	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20131113		ANDA	ANDA040183	American Health Packaging	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68084-155_e5f7019a-713b-0cf9-e053-2a95a90a8d49	68084-155	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20060830		ANDA	ANDA040596	American Health Packaging	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68084-157_e7001e33-8507-53e2-e053-2995a90a623d	68084-157	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20131021		ANDA	ANDA074862	American Health Packaging	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-158_e7001e33-8507-53e2-e053-2995a90a623d	68084-158	HUMAN PRESCRIPTION DRUG	Morphine Sulfate	Extended Release	Morphine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130827		ANDA	ANDA074862	American Health Packaging	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-189_09a9e52b-ae02-2cdd-e063-6294a90a56f9	68084-189	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20140107		ANDA	ANDA077322	American Health Packaging	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68084-202_ea3fcc22-7cf8-39fd-e053-2995a90aa937	68084-202	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20070612		ANDA	ANDA084903	American Health Packaging	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-203_ea3fcc22-7cf8-39fd-e053-2995a90aa937	68084-203	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20070612		ANDA	ANDA084903	American Health Packaging	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-204_ea3fd8db-eb0e-57fb-e053-2995a90a895f	68084-204	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	20070705		ANDA	ANDA071826	American Health Packaging	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68084-205_ea3fd8db-eb0e-57fb-e053-2995a90a895f	68084-205	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	20070705		ANDA	ANDA071839	American Health Packaging	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68084-214_e78cece8-6968-298c-e053-2995a90a1b85	68084-214	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20111003		ANDA	ANDA040597	American Health Packaging	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68084-215_ead79cc6-4cf4-acd6-e053-2a95a90a163a	68084-215	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20140617		ANDA	ANDA090682	American Health Packaging	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68084-220_01e2289d-60f6-260c-e063-6394a90a96f6	68084-220	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA078539	American Health Packaging	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68084-221_01e2289d-60f6-260c-e063-6394a90a96f6	68084-221	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA078539	American Health Packaging	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68084-229_0402f48a-3ee4-9f7e-e063-6294a90af9c3	68084-229	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20080222		ANDA	ANDA077621	American Health Packaging	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68084-243_07e99cc8-b180-e825-e063-6394a90a10d0	68084-243	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20080430		ANDA	ANDA065061	American Health Packaging	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68084-244_07e99cc8-b180-e825-e063-6394a90a10d0	68084-244	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20080430		ANDA	ANDA065061	American Health Packaging	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68084-248_ea3f438d-b00a-e171-e053-2995a90a32e7	68084-248	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20071109		ANDA	ANDA076134	American Health Packaging	LORATADINE	10	mg/1			N	20241231
68084-249_ea3cb158-5ed0-3869-e053-2a95a90a33cb	68084-249	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080303		ANDA	ANDA077580	American Health Packaging	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
68084-250_ea3cb158-5ed0-3869-e053-2a95a90a33cb	68084-250	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20100328		ANDA	ANDA077580	American Health Packaging	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
68084-252_00eb9960-935c-38b5-e063-6294a90ab044	68084-252	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080605		ANDA	ANDA077284	American Health Packaging	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68084-269_fd0300a2-0a63-326c-e053-6394a90a4531	68084-269	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20080724		ANDA	ANDA040657	American Health Packaging	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
68084-270_d4c672e0-8f40-3cd5-e053-2a95a90abe12	68084-270	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, FILM COATED	ORAL	20081124		ANDA	ANDA078040	American Health Packaging	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-271_d4c672e0-8f40-3cd5-e053-2a95a90abe12	68084-271	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, FILM COATED	ORAL	20081124		ANDA	ANDA078040	American Health Packaging	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-272_d4c672e0-8f40-3cd5-e053-2a95a90abe12	68084-272	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, FILM COATED	ORAL	20081124		ANDA	ANDA078040	American Health Packaging	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-273_d4c672e0-8f40-3cd5-e053-2a95a90abe12	68084-273	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, FILM COATED	ORAL	20081124		ANDA	ANDA078040	American Health Packaging	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-274_d4c672e0-8f40-3cd5-e053-2a95a90abe12	68084-274	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, FILM COATED	ORAL	20081124		ANDA	ANDA078040	American Health Packaging	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-277_d4c672e0-8f40-3cd5-e053-2a95a90abe12	68084-277	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, FILM COATED	ORAL	20081124		ANDA	ANDA078040	American Health Packaging	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-280_e33bae9c-0cb8-2b56-e053-2a95a90a519a	68084-280	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET	ORAL	20091102		ANDA	ANDA078939	American Health Packaging	ETHAMBUTOL HYDROCHLORIDE	400	mg/1	Antimycobacterial [EPC]		N	20241231
68084-281_ea3f438d-b00d-e171-e053-2995a90a32e7	68084-281	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20080822		ANDA	ANDA077828	American Health Packaging	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
68084-282_ea3f438d-b00d-e171-e053-2995a90a32e7	68084-282	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20080822		ANDA	ANDA077828	American Health Packaging	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
68084-284_06c1ec5e-8608-09c9-e063-6394a90a189a	68084-284	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	20080917		ANDA	ANDA075340	American Health Packaging	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
68084-288_f2b49da5-e190-805e-e053-2a95a90a0c72	68084-288	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		Fludrocortisone Acetate	TABLET	ORAL	20080909		ANDA	ANDA040431	American Health Packaging	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
68084-291_026d4218-73a0-a907-e063-6394a90af2b5	68084-291	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		naltrexone hydrochloride	TABLET, FILM COATED	ORAL	20121206		ANDA	ANDA076264	American Health Packaging	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
68084-299_087b80ba-e524-0956-e063-6394a90ac539	68084-299	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20140117		ANDA	ANDA078225	American Health Packaging	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68084-300_ea3fb07f-0002-8a55-e053-2a95a90a8243	68084-300	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		Dantrolene Sodium	CAPSULE	ORAL	20080929		ANDA	ANDA076856	American Health Packaging	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
68084-309_ead79cc6-4cf4-acd6-e053-2a95a90a163a	68084-309	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20140219		ANDA	ANDA090682	American Health Packaging	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68084-310_f40eb4e3-6561-bb82-e053-2995a90a9b0c	68084-310	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20131121		ANDA	ANDA078239	American Health Packaging	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68084-313_0c930b31-1700-ef83-e063-6394a90af90d	68084-313	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	CAPSULE, COATED PELLETS	ORAL	20090318		ANDA	ANDA078919	American Health Packaging	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68084-318_0c3f091e-ff53-8243-e063-6294a90a38ec	68084-318	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090707		ANDA	ANDA077633	American Health Packaging	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68084-319_0c3f091e-ff53-8243-e063-6294a90a38ec	68084-319	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090707		ANDA	ANDA077633	American Health Packaging	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68084-326_ea3fda1e-efe9-6d95-e053-2995a90adada	68084-326	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20090422		ANDA	ANDA077091	American Health Packaging	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68084-327_ea3fda1e-efe9-6d95-e053-2995a90adada	68084-327	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20090422		ANDA	ANDA077091	American Health Packaging	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68084-342_087c12f7-e830-4d20-e063-6294a90a570b	68084-342	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090410		ANDA	ANDA078235	American Health Packaging	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-343_087c12f7-e830-4d20-e063-6294a90a570b	68084-343	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20191108		ANDA	ANDA078235	American Health Packaging	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-344_087c12f7-e830-4d20-e063-6294a90a570b	68084-344	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090421		ANDA	ANDA078235	American Health Packaging	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-345_087c12f7-e830-4d20-e063-6294a90a570b	68084-345	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090413		ANDA	ANDA078235	American Health Packaging	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-346_04c79d4f-46d9-0d85-e063-6394a90aa650	68084-346	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101012		ANDA	ANDA078243	American Health Packaging	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68084-347_04c79d4f-46d9-0d85-e063-6394a90aa650	68084-347	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101012		ANDA	ANDA078243	American Health Packaging	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68084-348_04c79d4f-46d9-0d85-e063-6394a90aa650	68084-348	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101013		ANDA	ANDA078243	American Health Packaging	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68084-354_04b40472-2476-abc1-e063-6294a90a6bad	68084-354	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20091124		ANDA	ANDA091393	American Health Packaging	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-376_0c7e8671-e6ca-563e-e063-6294a90a4590	68084-376	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20100517		ANDA	ANDA040765	American Health Packaging	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-381_f40e5386-976b-90cd-e053-2a95a90a9b4a	68084-381	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine Mesylate	TABLET	ORAL	20091101		ANDA	ANDA040715	American Health Packaging	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
68084-388_f40e5386-976b-90cd-e053-2a95a90a9b4a	68084-388	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine Mesylate	TABLET	ORAL	20091218		ANDA	ANDA040715	American Health Packaging	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
68084-389_f40e5386-976b-90cd-e053-2a95a90a9b4a	68084-389	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine Mesylate	TABLET	ORAL	20091218		ANDA	ANDA040715	American Health Packaging	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
68084-396_eb6af194-aa1d-a7ab-e053-2995a90a8278	68084-396	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	TABLET	ORAL	20090908	20240331	ANDA	ANDA040511	American Health Packaging	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	
68084-411_064731c8-64a0-8c51-e063-6294a90aad40	68084-411	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20100326		ANDA	ANDA079175	American Health Packaging	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68084-415_f40eb4e3-6561-bb82-e053-2995a90a9b0c	68084-415	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20131121		ANDA	ANDA078239	American Health Packaging	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68084-444_fb449fe9-9eef-1718-e053-6394a90a6ba6	68084-444	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20230522		ANDA	ANDA075948	American Health Packaging	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68084-447_f2f6a6a4-9f02-25f4-e053-2995a90adfc3	68084-447	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET, FILM COATED	ORAL	20100903		ANDA	ANDA086242	American Health Packaging	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68084-449_0bde6cb8-4e4f-da1f-e063-6294a90a0fd4	68084-449	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100803		ANDA	ANDA090509	American Health Packaging	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68084-450_0bde6cb8-4e4f-da1f-e063-6294a90a0fd4	68084-450	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100803		ANDA	ANDA090509	American Health Packaging	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68084-451_0bde6cb8-4e4f-da1f-e063-6294a90a0fd4	68084-451	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20100803		ANDA	ANDA090509	American Health Packaging	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68084-479_ea3f8253-7785-c365-e053-2995a90ad26b	68084-479	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20130718		ANDA	ANDA077728	American Health Packaging	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68084-480_f4205a46-04e4-78a4-e053-2995a90af5b1	68084-480	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20120105		ANDA	ANDA078503	American Health Packaging	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68084-490_fa44327b-5a2a-5ec0-e053-6294a90aaea3	68084-490	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20110718		ANDA	ANDA201451	American Health Packaging	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68084-491_fa44327b-5a2a-5ec0-e053-6294a90aaea3	68084-491	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20110714	20240630	ANDA	ANDA201451	American Health Packaging	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
68084-494_fb451364-d1ee-a7f6-e053-6394a90a5de9	68084-494	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		Pyridostigmine Bromide	TABLET	ORAL	20230515		ANDA	ANDA040502	American Health Packaging	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68084-511_f9df6f67-0e01-6177-e053-6294a90a9317	68084-511	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20110721		ANDA	ANDA078103	American Health Packaging	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68084-512_f9df6f67-0e01-6177-e053-6294a90a9317	68084-512	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20110908		ANDA	ANDA078103	American Health Packaging	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68084-525_ea3fd61a-7ea8-388d-e053-2995a90a621e	68084-525	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120425		ANDA	ANDA076255	American Health Packaging	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-528_e0df5c46-0b6b-034b-e053-2995a90a45b5	68084-528	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120425		ANDA	ANDA076133	American Health Packaging	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-529_e0df5c46-0b6b-034b-e053-2995a90a45b5	68084-529	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120425		ANDA	ANDA076133	American Health Packaging	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-536_0293643f-caee-3cd3-e063-6294a90a8003	68084-536	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20140314		ANDA	ANDA076274	American Health Packaging	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
68084-539_ea3f438d-b00c-e171-e053-2995a90a32e7	68084-539	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20111019		ANDA	ANDA079234	American Health Packaging	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68084-549_d54026f0-1687-61d1-e053-2995a90a4947	68084-549	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20111214		NDA	NDA018163	American Health Packaging	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68084-572_ea3f438d-b00b-e171-e053-2995a90a32e7	68084-572	HUMAN OTC DRUG	Mucinex		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20160210		NDA	NDA021282	American Health Packaging	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68084-590_f3d2b803-1f91-6a77-e053-2a95a90aaebb	68084-590	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20121109		ANDA	ANDA090548	American Health Packaging	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68084-597_f4215b6f-5ed6-4d93-e053-2995a90ae237	68084-597	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120524		ANDA	ANDA077127	American Health Packaging	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68084-598_f4215b6f-5ed6-4d93-e053-2995a90ae237	68084-598	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120807		ANDA	ANDA077127	American Health Packaging	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68084-602_ea3fb07f-0007-8a55-e053-2a95a90a8243	68084-602	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	20120726		ANDA	ANDA040226	American Health Packaging	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68084-603_f4215b6f-5ed6-4d93-e053-2995a90ae237	68084-603	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120607		ANDA	ANDA077127	American Health Packaging	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68084-604_f75984f7-ae2f-bc40-e053-6394a90a00c2	68084-604	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20121106	20240131	ANDA	ANDA076470	American Health Packaging	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
68084-607_ea3fb07f-0007-8a55-e053-2a95a90a8243	68084-607	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	20120524		ANDA	ANDA040226	American Health Packaging	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68084-610_f4205a46-04e4-78a4-e053-2995a90af5b1	68084-610	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20121106		ANDA	ANDA078503	American Health Packaging	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68084-617_f4abb4a4-2561-a8bb-e053-2995a90a4023	68084-617	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20121008		ANDA	ANDA090432	American Health Packaging	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68084-618_f4abb4a4-2561-a8bb-e053-2995a90a4023	68084-618	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20121008		ANDA	ANDA090432	American Health Packaging	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68084-621_0c548d2f-983d-fa8f-e063-6394a90ac2c6	68084-621	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20130603		ANDA	ANDA202566	American Health Packaging	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
68084-632_f7599ba9-73d9-4158-e053-6294a90ac9c2	68084-632	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20130306	20240131	ANDA	ANDA075604	American Health Packaging	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
68084-640_ea3fb07e-ffff-8a55-e053-2a95a90a8243	68084-640	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20141001		ANDA	ANDA076832	American Health Packaging	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
68084-645_0bd8630d-9d19-7c5e-e063-6294a90a4550	68084-645	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130911		ANDA	ANDA076286	American Health Packaging	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68084-654_ead70ad6-398c-21c4-e053-2a95a90a756b	68084-654	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20140311		ANDA	ANDA076140	American Health Packaging	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
68084-655_ea3f5799-f6b4-6653-e053-2a95a90a4544	68084-655	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20140103		ANDA	ANDA076691	American Health Packaging	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20241231
68084-675_fa673623-4a09-e48b-e053-6394a90a5a1e	68084-675	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131217	20240430	ANDA	ANDA090694	American Health Packaging	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
68084-683_fa673623-4a09-e48b-e053-6394a90a5a1e	68084-683	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131217	20240229	ANDA	ANDA090694	American Health Packaging	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
68084-692_fa673623-4a09-e48b-e053-6394a90a5a1e	68084-692	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131217	20240430	ANDA	ANDA090694	American Health Packaging	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
68084-697_05b66665-77a7-598f-e063-6394a90a5af9	68084-697	HUMAN PRESCRIPTION DRUG	BuPROPion Hydrochloride		bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150401		ANDA	ANDA079095	American Health Packaging	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68084-698_0c950b34-da95-1f3f-e063-6294a90aaa23	68084-698	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140203		ANDA	ANDA200834	American Health Packaging	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68084-699_d4c880f3-8c95-3bb7-e053-2a95a90aa273	68084-699	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140606		ANDA	ANDA202677	American Health Packaging	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-708_05b66665-77a7-598f-e063-6394a90a5af9	68084-708	HUMAN PRESCRIPTION DRUG	BuPROPion Hydrochloride		bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150401		ANDA	ANDA079095	American Health Packaging	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68084-709_0c950b34-da95-1f3f-e063-6294a90aaa23	68084-709	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA200834	American Health Packaging	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68084-710_d4c880f3-8c95-3bb7-e053-2a95a90aa273	68084-710	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140604		ANDA	ANDA202677	American Health Packaging	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-713_0c950b34-da95-1f3f-e063-6294a90aaa23	68084-713	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140401		ANDA	ANDA200834	American Health Packaging	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68084-721_0c548d2f-983d-fa8f-e063-6394a90ac2c6	68084-721	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20140602		ANDA	ANDA202566	American Health Packaging	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
68084-722_ec560f8d-7309-20f7-e053-2a95a90a008e	68084-722	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20140319		ANDA	ANDA202632	American Health Packaging	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68084-723_ea3fd61a-7ea8-388d-e053-2995a90a621e	68084-723	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140407		ANDA	ANDA076255	American Health Packaging	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-728_f202f8b0-d53b-9117-e053-2a95a90a97bf	68084-728	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20141022		ANDA	ANDA077731	American Health Packaging	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68084-729_dee97832-8daf-6478-e053-2a95a90af1f5	68084-729	HUMAN PRESCRIPTION DRUG	Galantamine		Galantamine	TABLET, FILM COATED	ORAL	20140611		ANDA	ANDA090957	American Health Packaging	GALANTAMINE HYDROBROMIDE	4	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68084-735_f202f8b0-d53b-9117-e053-2a95a90a97bf	68084-735	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20140813		ANDA	ANDA077731	American Health Packaging	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68084-737_f40da8e7-5bd7-d8ef-e053-2995a90a6b35	68084-737	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20140318	20240930	ANDA	ANDA077031	American Health Packaging	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
68084-738_02e49cbb-46e5-ccf0-e063-6294a90a47d4	68084-738	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20140911	20241130	ANDA	ANDA090635	American Health Packaging	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
68084-740_ea3fd61a-7ea8-388d-e053-2995a90a621e	68084-740	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140407		ANDA	ANDA076255	American Health Packaging	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68084-743_f5b0dc63-6fcb-5f25-e053-2a95a90a5c01	68084-743	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20140513	20240531	ANDA	ANDA065055	American Health Packaging	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
68084-750_ea4addff-a117-ed7f-e053-2995a90a624c	68084-750	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20140530		ANDA	ANDA071251	American Health Packaging	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68084-752_0293643f-caee-3cd3-e063-6294a90a8003	68084-752	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20140328		ANDA	ANDA076274	American Health Packaging	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
68084-753_0296fa11-1cc1-58ac-e063-6294a90ac22a	68084-753	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20160104		ANDA	ANDA078048	American Health Packaging	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68084-765_e5e7f0cf-70c2-2247-e053-2a95a90a314d	68084-765	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20140531	20240131	ANDA	ANDA077321	American Health Packaging	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
68084-775_0bd8630d-9d19-7c5e-e063-6294a90a4550	68084-775	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20140521		ANDA	ANDA076286	American Health Packaging	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68084-776_05bc13a8-84ea-4f3d-e063-6294a90a9279	68084-776	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20150302		ANDA	ANDA090554	American Health Packaging	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68084-777_e0e00d71-fc23-d450-e053-2a95a90a4f7a	68084-777	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140818		ANDA	ANDA076200	American Health Packaging	ACETAMINOPHEN	650	mg/1			N	20241231
68084-782_05bc13a8-84ea-4f3d-e063-6294a90a9279	68084-782	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20160126		ANDA	ANDA090554	American Health Packaging	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68084-788_ea3fda1e-efe9-6d95-e053-2995a90adada	68084-788	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20140721		ANDA	ANDA077091	American Health Packaging	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68084-790_ea3f34c4-3cf9-5f29-e053-2995a90ac0bf	68084-790	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	20140829		ANDA	ANDA074694	American Health Packaging	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68084-805_0b75d309-c5ea-367f-e063-6294a90ab90c	68084-805	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20140930		ANDA	ANDA040300	American Health Packaging	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68084-808_0c965ac3-bb0f-b2eb-e063-6394a90a45c9	68084-808	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20140805		ANDA	ANDA076003	American Health Packaging	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68084-813_ec553cdc-a2d5-4a9b-e053-2a95a90abe52	68084-813	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20141119		ANDA	ANDA078281	American Health Packaging	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68084-818_ea3f34c4-3cf9-5f29-e053-2995a90ac0bf	68084-818	HUMAN PRESCRIPTION DRUG	CLOMIPRAMINE HYDROCHLORIDE		Clomipramine Hydrochloride	CAPSULE	ORAL	20140910		ANDA	ANDA074694	American Health Packaging	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68084-823_0b75d309-c5ea-367f-e063-6294a90ab90c	68084-823	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET	ORAL	20140930		ANDA	ANDA040300	American Health Packaging	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68084-825_fdb84177-39a0-15d9-e053-6294a90adc77	68084-825	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20140805	20240331	ANDA	ANDA077184	American Health Packaging	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	
68084-836_e41a39e2-56e3-5d10-e053-2995a90a006b	68084-836	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20140916		ANDA	ANDA075580	American Health Packaging	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68084-841_ffd6cd57-6387-5aeb-e053-6394a90aea7b	68084-841	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Ibuprofen		Hydrocodone Bitartrate and Ibuprofen	TABLET	ORAL	20140924	20240930	ANDA	ANDA076642	American Health Packaging	HYDROCODONE BITARTRATE; IBUPROFEN	7.5; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	
68084-844_ead988cf-06bf-596f-e053-2995a90a5492	68084-844	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20150417		ANDA	ANDA077653	American Health Packaging	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68084-845_f5b0e087-90a8-59c2-e053-2a95a90a19f6	68084-845	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20141104	20240731	ANDA	ANDA078069	American Health Packaging	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
68084-846_ea3f5929-0eeb-517b-e053-2995a90a1f33	68084-846	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20141003		ANDA	ANDA089742	American Health Packaging	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68084-847_fdf6f2d5-f066-9e30-e053-6394a90ae7e3	68084-847	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20150210		ANDA	ANDA087479	American Health Packaging	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68084-850_e8956671-7b62-6b39-e053-2a95a90a7fe9	68084-850	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140915		ANDA	ANDA203546	American Health Packaging	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
68084-851_e41a39e2-56e3-5d10-e053-2995a90a006b	68084-851	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20140916		ANDA	ANDA075580	American Health Packaging	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68084-853_f5b0e087-90a8-59c2-e053-2a95a90a19f6	68084-853	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20141105	20240930	ANDA	ANDA078069	American Health Packaging	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
68084-854_ea3fda1e-efe6-6d95-e053-2995a90adada	68084-854	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20150504		ANDA	ANDA077614	American Health Packaging	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68084-856_ead988cf-06bf-596f-e053-2995a90a5492	68084-856	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20150306		ANDA	ANDA077653	American Health Packaging	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68084-859_0c028bc3-b0e2-466a-e063-6294a90aac1e	68084-859	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20150204		ANDA	ANDA078993	American Health Packaging	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-862_e41a39e2-56e3-5d10-e053-2995a90a006b	68084-862	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20140916		ANDA	ANDA075580	American Health Packaging	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68084-867_f5b0e087-90a8-59c2-e053-2a95a90a19f6	68084-867	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20141203	20240630	ANDA	ANDA078069	American Health Packaging	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
68084-875_0c8d7246-69fa-f3fb-e063-6394a90aae51	68084-875	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, COATED	ORAL	20150402		ANDA	ANDA201582	American Health Packaging	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68084-879_ea3f3d6d-abd7-5a52-e053-2995a90a2a45	68084-879	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, GELATIN COATED	ORAL	20150930		ANDA	ANDA065040	American Health Packaging	CYCLOSPORINE	25	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68084-882_0c028bc3-b0e2-466a-e063-6294a90aac1e	68084-882	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20150501		ANDA	ANDA078993	American Health Packaging	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68084-895_ffd6ce9d-be4b-a5b8-e053-6394a90ac2da	68084-895	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20140926	20240930	ANDA	ANDA040736	American Health Packaging	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	
68084-896_ead988cf-06bf-596f-e053-2995a90a5492	68084-896	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20150215		ANDA	ANDA077653	American Health Packaging	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68084-899_f5b0f5f8-218d-5bf5-e053-2995a90abf33	68084-899	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20150924	20240331	ANDA	ANDA077690	American Health Packaging	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
68084-907_0d20d8af-8af2-b292-e063-6394a90afc44	68084-907	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20150202		ANDA	ANDA091558	American Health Packaging	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
68084-918_0d20d8af-8af2-b292-e063-6394a90afc44	68084-918	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20150320		ANDA	ANDA091558	American Health Packaging	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
68084-921_ea3f3d6d-abd7-5a52-e053-2995a90a2a45	68084-921	HUMAN PRESCRIPTION DRUG	Cyclosporine		Cyclosporine	CAPSULE, GELATIN COATED	ORAL	20151103		ANDA	ANDA065040	American Health Packaging	CYCLOSPORINE	100	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68084-928_ea3f4d52-015a-e0be-e053-2995a90a1325	68084-928	HUMAN PRESCRIPTION DRUG	Pilocarpine hydrochloride		Pilocarpine hydrochloride	TABLET, FILM COATED	ORAL	20150824		NDA AUTHORIZED GENERIC	NDA020237	American Health Packaging	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
68084-947_fdb79bcb-8f70-30db-e053-6394a90a4ed1	68084-947	HUMAN PRESCRIPTION DRUG	Quinine Sulfate		Quinine Sulfate	CAPSULE	ORAL	20151130	20240331	NDA AUTHORIZED GENERIC	NDA021799	American Health Packaging	QUININE SULFATE	324	mg/1	Antimalarial [EPC]		N	
68084-949_ea3ce764-6a19-559c-e053-2a95a90add3c	68084-949	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	TABLET	ORAL	20150818		ANDA	ANDA072637	American Health Packaging	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68084-950_ea3f5929-0eeb-517b-e053-2995a90a1f33	68084-950	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20151001		ANDA	ANDA089743	American Health Packaging	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68084-952_ea3ce764-6a19-559c-e053-2a95a90add3c	68084-952	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	TABLET	ORAL	20150916		ANDA	ANDA072637	American Health Packaging	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68084-964_ea3f6d5b-ef17-4ffa-e053-2995a90aeab6	68084-964	HUMAN PRESCRIPTION DRUG	Propylthiouracil		Propylthiouracil	TABLET	ORAL	20150915		NDA	NDA006188	American Health Packaging	PROPYLTHIOURACIL	50	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
68084-965_eb02e56c-06b8-6d05-e053-2a95a90ab9a1	68084-965	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	TABLET, FILM COATED	ORAL	20150107		ANDA	ANDA203511	American Health Packaging	VALGANCICLOVIR HYDROCHLORIDE	450	mg/1	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68084-968_04b40472-2476-abc1-e063-6294a90a6bad	68084-968	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20190208		ANDA	ANDA091393	American Health Packaging	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-975_04b40472-2476-abc1-e063-6294a90a6bad	68084-975	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20200225		ANDA	ANDA091393	American Health Packaging	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-983_04b40472-2476-abc1-e063-6294a90a6bad	68084-983	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20200210		ANDA	ANDA091393	American Health Packaging	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68084-988_e7119579-fda9-e094-e053-2995a90a9da9	68084-988	HUMAN OTC DRUG	Antacid	Peppermint Flavour Regular Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20151116		OTC MONOGRAPH FINAL	part331	American Health Packaging	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68084-996_d96aaafc-1916-44fc-e053-2995a90afc59	68084-996	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20150331		ANDA	ANDA071745	American Health Packaging	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68084-997_d96aaafc-1916-44fc-e053-2995a90afc59	68084-997	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20150331		ANDA	ANDA071745	American Health Packaging	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68089-004_97538efd-6ffa-95d1-e053-2995a90a17ff	68089-004	HUMAN OTC DRUG	Clear Sinus and Ear		Pulsatilla Vulgaris, Euphorbia Resinifera Resin, Calcium Sulfate and Oyster Shell Calcium Carbonate, Crude	CAPSULE	ORAL	20080801		UNAPPROVED HOMEOPATHIC		Clear Products, Inc.	CALCIUM SULFATE; EUPHORBIA RESINIFERA RESIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS	3; 6; 3; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68093-0668_7c5d8463-5311-a397-e053-2991aa0abc29	68093-0668	HUMAN OTC DRUG	Yeast Gard Advanced		Berberis Vulgaris, Borax, Collinsonia Canadensis, Hamamelis Virginiana	DOUCHE	VAGINAL	20071001		UNAPPROVED HOMEOPATHIC		Wisconsin Pharmacal Company	BERBERIS VULGARIS ROOT BARK; COLLINSONIA CANADENSIS ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; SODIUM BORATE	6; 3; 6; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
68093-4501_5f0c1b2c-d045-7aed-e053-2991aa0a4e8c	68093-4501	HUMAN OTC DRUG	ENT Essentials All Dry Ear Drying Drops		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20170201		OTC MONOGRAPH FINAL	part344	Wisconsin Pharmacal Company	ISOPROPYL ALCOHOL	.95	g/100g			N	20241231
68093-4503_5d7d078f-ef8b-8aa7-e053-2a91aa0ae3b1	68093-4503	HUMAN OTC DRUG	ENT Essentials Ear Wax Remvoer		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20170201		OTC MONOGRAPH NOT FINAL	part356	Wisconsin Pharmacal Company	CARBAMIDE PEROXIDE	.065	g/g			N	20241231
68093-5105_5f0d0717-3ece-3aa7-e053-2991aa0a256e	68093-5105	HUMAN OTC DRUG	MG217 Baby Eczema		Colloidal Oatmeal	LOTION	TOPICAL	20160201		OTC MONOGRAPH FINAL	part347	Wisconsin Pharmacal Company	OATMEAL	.02	g/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
68093-5106_5f10a2eb-7531-4860-e053-2991aa0a8efc	68093-5106	HUMAN OTC DRUG	MG217 Eczema Body		Colloidal Oatmeal	LOTION	TOPICAL	20160301		OTC MONOGRAPH FINAL	part347	Wisconsin Pharmacal Company	OATMEAL	.02	g/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
68093-5206_7caf9ab6-f870-25f4-e053-2a91aa0aa16d	68093-5206	HUMAN OTC DRUG	MG217 Psoriasis	Therapeutic Scalp Treatment	Coal Tar	SHAMPOO	TOPICAL	20140701		OTC MONOGRAPH FINAL	part358H	Wisconsin Pharmacal Company	COAL TAR	.03	g/g			N	20241231
68093-7106_7c5d8463-52ff-a397-e053-2991aa0abc29	68093-7106	HUMAN OTC DRUG	Yeast Gard Advanced		Borax, Collinsonia Canadensis, Berberis Vulgaris, Hamamelis Virginiana	SUPPOSITORY	VAGINAL	20080501		UNAPPROVED HOMEOPATHIC		Wisconsin Pharmacal Company	BERBERIS VULGARIS ROOT BARK; COLLINSONIA CANADENSIS ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; SODIUM BORATE	6; 3; 6; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
68093-7203_244a1452-5d59-3219-e054-00144ff88e88	68093-7203	HUMAN OTC DRUG	MG217 Psoriasis		Salicylic Acid	SHAMPOO	TOPICAL	20130901		OTC MONOGRAPH FINAL	part333D	Wisconsin Pharmacal Company	SALICYLIC ACID	.03	g/g			N	20241231
68093-7232_7cafb511-0ab8-f3b4-e053-2991aa0a2e0b	68093-7232	HUMAN OTC DRUG	MG217 Psoriasis	Medicated Conditioning	Coal Tar	SHAMPOO	TOPICAL	20150301		OTC MONOGRAPH FINAL	part358H	Wisconsin Pharmacal Company	COAL TAR	.03	g/g			N	20241231
68093-7233_7cb04d20-9b3d-27bb-e053-2a91aa0a5bc4	68093-7233	HUMAN OTC DRUG	MG217 Psoriasis	Medicated multi-symptom	Coal Tar	OINTMENT	TOPICAL	20180201		OTC MONOGRAPH FINAL	part358H	Wisconsin Pharmacal Company	COAL TAR	.03	g/g			N	20241231
68093-7242_2e961928-db05-3cfd-e054-00144ff88e88	68093-7242	HUMAN OTC DRUG	MG217 Psoriasis Therapeutic Conditioner		Salicylic Acid	SHAMPOO	TOPICAL	20151101		OTC MONOGRAPH FINAL	part333D	Wisconsin Pharmacal Company	SALICYLIC ACID	.03	g/g			N	20241231
68093-7245_5f3c3d06-3e3f-1f9d-e053-2991aa0a02d1	68093-7245	HUMAN OTC DRUG	MG217 Eczema Face		Colloidal Oatmeal	LOTION	TOPICAL	20160301		OTC MONOGRAPH FINAL	part347	Wisconsin Pharmacal Company	OATMEAL	.02	g/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
68093-7247_7c5d8463-52e0-a397-e053-2991aa0abc29	68093-7247	HUMAN OTC DRUG	Yeast Gard Homeopathic Gel	Homeopathic Gel Treatment	Borax, Collinsonia Canadensis, berberis Vulgaris, Hamamelis Virginiana	GEL	VAGINAL	20070401		UNAPPROVED HOMEOPATHIC		Wisconsin Pharmacal Company	BERBERIS VULGARIS ROOT BARK; COLLINSONIA CANADENSIS ROOT; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; SODIUM BORATE	6; 3; 6; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
68094-001_1f2a8101-4faa-43f9-924e-0a7f6bce3fc8	68094-001	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20160229		NDA	NDA022195	Precision Dose Inc.	MORPHINE SULFATE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-004_ad976192-fd11-49d6-84f5-b619a78ef3ab	68094-004	HUMAN OTC DRUG	Dye Free Childrens Cetirizine Hydrocholride		Cetirizine Hydrochloride	SOLUTION	ORAL	20161026		ANDA	ANDA204226	Precision Dose, Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68094-005_3d850f72-a4ba-4d3f-9104-7db743a6e9ca	68094-005	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20161221		ANDA	ANDA203638	Precision Dose, Inc.	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-015_b356b25c-c430-49a8-b4b0-fb7937bf1bcb	68094-015	HUMAN OTC DRUG	Dye Free Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20170113		OTC MONOGRAPH NOT FINAL	part343	Precision Dose, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68094-018_f4d57ff3-eddc-4cac-ab43-1800e4aa6334	68094-018	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	TABLET	ORAL	20190715		OTC MONOGRAPH FINAL	part341	Precision Dose, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68094-022_4d0f881b-19ef-46b4-ae56-fd7d96e90e78	68094-022	HUMAN OTC DRUG	Dye Free Childrens Diphenhydramine Hydrochloride		diphenhydramine hydrochloride	LIQUID	ORAL	20181227		OTC MONOGRAPH FINAL	part341	Precision Dose, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68094-030_fbe393c7-00fc-4124-9fff-d62d0c479904	68094-030	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20190906		OTC MONOGRAPH DRUG	M013	Precision Dose, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20251231
68094-031_fe6c2301-06fd-43ca-900c-55e84bd5e300	68094-031	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	20201223		ANDA	ANDA087393	Precision Dose, Inc.	METHADONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-034_1e36e1e8-db52-4247-9c4d-895cbfdb1304	68094-034	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA207288	Precision Dose, Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68094-038_a924aa6a-978b-4ebf-b5ab-6829c749f2e6	68094-038	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20220930		OTC MONOGRAPH NOT FINAL	part343	Precision Dose, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68094-043_e709264f-e345-4d4a-9e22-b95ff61dfc45	68094-043	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20200319		NDA AUTHORIZED GENERIC	NDA019183	Precision Dose, Inc.	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
68094-044_20816a35-ca8c-45fe-b785-1ca9f6abcc51	68094-044	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20180629		ANDA	ANDA091312	Precision Dose, Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68094-045_cc30f742-9c62-4633-912f-a2afb4d39510	68094-045	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20201101		NDA	NDA022195	Precision Dose, Inc.	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-047_a72b052a-5da7-47b1-bac2-572daa7f434b	68094-047	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride in Sodium Chloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201123		ANDA	ANDA212857	Precision Dose, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
68094-048_1361c408-4dfb-47f9-8f81-37eb00b70b2f	68094-048	HUMAN OTC DRUG	Guaifenesin Extended-Release		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20230322		ANDA	ANDA078912	Precision Dose Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68094-050_ff490680-2a2c-4968-9b55-f2b890852a67	68094-050	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20221130		ANDA	ANDA209421	Precision Dose, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68094-052_5fb1f9b8-3b86-4009-ad70-e115b351cf4e	68094-052	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20220930		OTC MONOGRAPH NOT FINAL	part334	Precision Dose, Inc.	DOCUSATE SODIUM	250	mg/1			N	20241231
68094-056_e75a31a9-7e47-4403-9e73-c022ebcc6cc6	68094-056	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20220930		NDA	NDA022195	Precision Dose, Inc.	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-061_575f0aa1-2883-4348-ac6a-be697ccb4825	68094-061	HUMAN OTC DRUG	Dye Free Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20220802		OTC MONOGRAPH NOT FINAL	part343	Precision Dose Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68094-063_dd5c7296-d590-438f-b528-68568b7cb1bd	68094-063	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20220711		ANDA	ANDA075671	Precision Dose Inc.	MEGESTROL ACETATE	40	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68094-065_89aa48b9-29bc-4a20-b44e-d29a67eb515a	68094-065	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20230131		ANDA	ANDA075109	Precision Dose, Inc.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68094-101_ff65fd62-d66a-48f3-bd95-2870b8cf74cf	68094-101	HUMAN PRESCRIPTION DRUG	PHENTOLAMINE MESYLATE		PHENTOLAMINE MESYLATE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170715		ANDA	ANDA207686	Precision Dose Inc.	PHENTOLAMINE MESYLATE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68094-123_43ea970d-701d-409d-b9a1-4e0c171ede4d	68094-123	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	SUSPENSION	ORAL	20170913		ANDA	ANDA202961	Precision Dose, Inc.	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68094-129_f98b5ff5-b3a6-44ea-a041-4195f03104c4	68094-129	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	SOLUTION	ORAL	20200518		ANDA	ANDA091292	Precision Dose, Inc.	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68094-130_563275ce-eba6-4d17-b50e-ef4c5de130f8	68094-130	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20230731		OTC MONOGRAPH DRUG	M013	Precision Dose, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20251231
68094-147_a72b052a-5da7-47b1-bac2-572daa7f434b	68094-147	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride in Sodium Chloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201123		ANDA	ANDA212857	Precision Dose, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
68094-174_65e3c2a0-597c-4196-8720-7fe16c7147a3	68094-174	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20220711		ANDA	ANDA075671	Precision Dose Inc.	MEGESTROL ACETATE	40	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68094-231_5997f1f8-31b3-46d5-9f34-1bb13f0fc07b	68094-231	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20200401		OTC MONOGRAPH DRUG	M013	Precision Dose, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20251231
68094-247_a72b052a-5da7-47b1-bac2-572daa7f434b	68094-247	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride in Sodium Chloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201123		ANDA	ANDA212857	Precision Dose, Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
68094-256_ed58600e-8c1a-4ab1-8862-1b16ee7425f0	68094-256	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20230815		NDA	NDA022195	Precision Dose, Inc.	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-313_0bba81a4-5da8-6200-e063-6394a90a1d16	68094-313	HUMAN PRESCRIPTION DRUG	Levetiracetam		levetiracetam	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20181130		ANDA	ANDA209781	Precision Dose, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68094-330_d4fc779f-d83b-4501-9e41-37a310110946	68094-330	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20200115		OTC MONOGRAPH DRUG	M013	Precision Dose, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20251231
68094-331_7d77635d-662f-433e-9d39-6a71efb8b4be	68094-331	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	SOLUTION	ORAL	20231229		ANDA	ANDA087393	Precision Dose, Inc.	METHADONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-356_7494caf0-f71a-48fd-8317-f5a903ae0df8	68094-356	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20231130		NDA	NDA022195	Precision Dose, Inc.	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68094-494_2f3a75bd-a31d-4a17-aaf6-d305d979f14d	68094-494	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20040413		ANDA	ANDA074937	Precision Dose Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68094-503_c193083c-e326-49d7-945c-ecf5375ecd57	68094-503	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20060914		ANDA	ANDA074937	Precision Dose Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68094-586_116fc781-0f7a-4c21-bdec-36186b2c9cfe	68094-586	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20140730	20240531	OTC MONOGRAPH DRUG	M013	Precision Dose Inc.	ACETAMINOPHEN	160	mg/5mL			N	
68094-599_86bf7f7b-cb8b-4592-98f3-c8733cd080f9	68094-599	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20051215	20240430	ANDA	ANDA062512	Precision Dose, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	
68094-600_99978a1f-48a4-4a21-986c-c07dfb811414	68094-600	HUMAN OTC DRUG	Dye Free Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20150826		ANDA	ANDA074937	Precision Dose Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68094-702_30034c7f-dd34-4dc7-b4d0-4dfabc577159	68094-702	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	Precision Dose Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
68094-750_5d2dcdd9-3580-4b6a-a805-d8b9a91a1c2c	68094-750	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	SOLUTION	ORAL	20120222		ANDA	ANDA070928	Precision Dose Inc.	DIAZEPAM	5	mg/5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68094-756_2a35f26b-d831-48a5-ab87-14c61f0341bf	68094-756	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	SOLUTION	ORAL	20121023		ANDA	ANDA070434	Precision Dose Inc.	FUROSEMIDE	40	mg/4mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68094-762_b6abf23a-687d-4a1e-aaf9-a09f91b82af3	68094-762	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20150526		ANDA	ANDA075873	Precision Dose Inc.	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68094-763_9071264d-d331-4b7e-aff8-4a752ed9d163	68094-763	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	SOLUTION	ORAL	20150227		ANDA	ANDA076960	Precision Dose Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68094-764_e03eddfa-bfc5-4106-b80d-71a30e47352c	68094-764	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20150526		ANDA	ANDA075873	Precision Dose Inc.	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68094-802_b2acfae6-fd41-4bfc-a3b3-f097ec8635bb	68094-802	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Precision Dose Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
68094-805_aca55884-1eb4-4a76-8c7f-96c782849337	68094-805	HUMAN PRESCRIPTION DRUG	Tetrabenazine		TETRABENAZINE	TABLET	ORAL	20231201		ANDA	ANDA207682	Precision Dose Inc.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
68094-808_5dc8c6ca-5710-4369-b0ae-37666210f03b	68094-808	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20231130		ANDA	ANDA215615	Precision Dose, Inc.	METHAZOLAMIDE	50	mg/1			N	20241231
68094-853_3b9769f8-1b0e-4dcf-8e88-1b7221f0a588	68094-853	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20141029		ANDA	ANDA075274	Precision Dose Inc.	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
68094-867_8557da4f-e76b-4d3e-9216-d52a3cc4a91f	68094-867	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	SOLUTION	ORAL	20160128		ANDA	ANDA070433	Precision Dose Inc.	FUROSEMIDE	40	mg/5mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68094-905_aca55884-1eb4-4a76-8c7f-96c782849337	68094-905	HUMAN PRESCRIPTION DRUG	Tetrabenazine		TETRABENAZINE	TABLET	ORAL	20231201		ANDA	ANDA207682	Precision Dose Inc.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
68094-906_37093f43-91d8-424c-98d9-8a07334454ad	68094-906	HUMAN PRESCRIPTION DRUG	Cholestyramine		Cholestyramine	POWDER, FOR SUSPENSION	ORAL	20231215		ANDA	ANDA209599	Precision Dose, Inc.	CHOLESTYRAMINE	4	g/4.8g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
68094-908_5dc8c6ca-5710-4369-b0ae-37666210f03b	68094-908	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20231130		ANDA	ANDA215615	Precision Dose, Inc.	METHAZOLAMIDE	25	mg/1			N	20241231
68094-909_63c38be3-b7e3-4fd9-8093-f8eaf6745193	68094-909	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20130923		ANDA	ANDA075274	Precision Dose Inc.	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
68094-910_b2acfae6-fd41-4bfc-a3b3-f097ec8635bb	68094-910	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Precision Dose Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
68118-100_f87746a1-78c9-df32-e053-6294a90a80da	68118-100	HUMAN PRESCRIPTION DRUG	Zanosar		Streptozocin	POWDER, FOR SOLUTION	INTRAVENOUS	20230201		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		ESTEVE PHARMACEUTICALS, S.A.	STREPTOZOCIN	1	g/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68134-401_db4788b4-a23c-5ed7-e053-2995a90a48d1	68134-401	HUMAN PRESCRIPTION DRUG	BACLOFEN		Baclofen	SOLUTION	ORAL	20220315		NDA AUTHORIZED GENERIC	NDA208193	Palmetto Pharmaceuticals Inc.	BACLOFEN	5	mg/5mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68134-402_0d083748-6330-274a-e063-6294a90a943e	68134-402	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	SOLUTION	ORAL	20200911		NDA AUTHORIZED GENERIC	NDA214044	Palmetto Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68134-603_0eb6eb87-c779-3b79-e063-6294a90a5944	68134-603	HUMAN PRESCRIPTION DRUG	Clonidine		Clonidine	TABLET, EXTENDED RELEASE	ORAL	20220301		NDA AUTHORIZED GENERIC	NDA022500	PALMETTO PHARMACEUTICALS INC.	CLONIDINE	.17	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
68134-801_f57446a6-f0c3-41a3-e053-2a95a90a0b22	68134-801	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20230224		UNAPPROVED DRUG OTHER		Palmetto Pharmaceuticals Inc.	UREA	400	mg/g			N	20241231
68135-020_88747f73-fa02-4a28-8ab8-63ff7ded49ec	68135-020	HUMAN PRESCRIPTION DRUG	NAGLAZYME		galsulfase	SOLUTION	INTRAVENOUS	20050609		BLA	BLA125117	BioMarin Pharmaceutical Inc.	GALSULFASE	5	mg/5mL	Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
68135-058_24831ce1-fc13-4fd1-9659-d95257ba807b	68135-058	HUMAN PRESCRIPTION DRUG	Palynziq		pegvaliase-pqpz	INJECTION, SOLUTION	SUBCUTANEOUS	20180524		BLA	BLA761079	BioMarin Pharmaceutical Inc.	PEGVALIASE	2.5	mg/.5mL	Phenylalanine Ammonia-Lyase [CS], Phenylalanine Metabolizing Enzyme [EPC]		N	20241231
68135-082_ee42ea03-f427-4099-98f7-c7464dee8030	68135-082	HUMAN PRESCRIPTION DRUG	VOXZOGO 0.4mg		vosoritide	KIT		20211119		NDA	NDA214938	BioMarin Pharmaceutical Inc.						N	20241231
68135-100_8c7a8949-b407-41ab-b2e3-88c83b6a9213	68135-100	HUMAN PRESCRIPTION DRUG	VIMIZIM		elosulfase alfa	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140214		BLA	BLA125460	BioMarin Pharmaceutical Inc.	ELOSULFASE ALFA	5	mg/5mL	Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]		N	20241231
68135-119_ee42ea03-f427-4099-98f7-c7464dee8030	68135-119	HUMAN PRESCRIPTION DRUG	VOXZOGO 0.56mg		vosoritide	KIT		20211119		NDA	NDA214938	BioMarin Pharmaceutical Inc.						N	20241231
68135-181_ee42ea03-f427-4099-98f7-c7464dee8030	68135-181	HUMAN PRESCRIPTION DRUG	VOXZOGO 1.2mg		vosoritide	KIT		20211119		NDA	NDA214938	BioMarin Pharmaceutical Inc.						N	20241231
68135-300_066f16a3-911d-43b6-950d-fde21585985b	68135-300	HUMAN PRESCRIPTION DRUG	Kuvan		SAPROPTERIN DIHYDROCHLORIDE	TABLET	ORAL	20071214		NDA	NDA022181	BioMarin Pharmaceutical Inc.	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
68135-301_066f16a3-911d-43b6-950d-fde21585985b	68135-301	HUMAN PRESCRIPTION DRUG	Kuvan		SAPROPTERIN DIHYDROCHLORIDE	POWDER, FOR SOLUTION	ORAL	20140221		NDA	NDA205065	BioMarin Pharmaceutical Inc.	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
68135-482_066f16a3-911d-43b6-950d-fde21585985b	68135-482	HUMAN PRESCRIPTION DRUG	Kuvan		sapropterin dihydrochloride	POWDER, FOR SOLUTION	ORAL	20150527		NDA	NDA205065	BioMarin Pharmaceutical Inc.	SAPROPTERIN DIHYDROCHLORIDE	500	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
68135-673_24831ce1-fc13-4fd1-9659-d95257ba807b	68135-673	HUMAN PRESCRIPTION DRUG	Palynziq		pegvaliase-pqpz	INJECTION, SOLUTION	SUBCUTANEOUS	20180524		BLA	BLA761079	BioMarin Pharmaceutical Inc.	PEGVALIASE	20	mg/mL	Phenylalanine Ammonia-Lyase [CS], Phenylalanine Metabolizing Enzyme [EPC]		N	20241231
68135-756_24831ce1-fc13-4fd1-9659-d95257ba807b	68135-756	HUMAN PRESCRIPTION DRUG	Palynziq		pegvaliase-pqpz	INJECTION, SOLUTION	SUBCUTANEOUS	20180524		BLA	BLA761079	BioMarin Pharmaceutical Inc.	PEGVALIASE	10	mg/.5mL	Phenylalanine Ammonia-Lyase [CS], Phenylalanine Metabolizing Enzyme [EPC]		N	20241231
68135-811_16b9611a-cd8a-4505-b095-de5ab4054b37	68135-811	HUMAN PRESCRIPTION DRUG	Brineura		cerliponase alfa	KIT		20170427		BLA	BLA761052	BioMarin Pharmaceutical Inc.						N	20241231
68135-927_74c0e6b6-6cba-45ce-83cf-80aebe9fefaa	68135-927	HUMAN PRESCRIPTION DRUG	ROCTAVIAN		valoctocogene roxaparvovec-rvox	INJECTION, SOLUTION	INTRAVENOUS	20230629		BLA	BLA125720	BioMarin Pharmaceutical Inc.	VALOCTOCOGENE ROXAPARVOVEC	20000000000000	{GC}/mL			N	20241231
68163-011_9c6389bd-8a0d-4ebf-ad5c-4b28f2e13239	68163-011	HUMAN OTC DRUG	Fast Acting Heartburn Relief	Peppermint Flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190522		OTC MONOGRAPH FINAL	part331	Raritan Pharmaceuticals Inc	CALCIUM CARBONATE	500	mg/1			N	20241231
68163-012_ba4c5b20-6a7b-4cac-83d9-23a4c8291f77	68163-012	HUMAN OTC DRUG	Drx Choice childrens allergy chews		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20220704		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68163-100_0c6caad9-7bfa-495a-9f01-f00a5cda9a4d	68163-100	HUMAN OTC DRUG	Regular Strength	Tropical Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH FINAL	part331	RARITAN PHARMACEUTICALS INC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68163-101_670269c9-d989-4a74-8cdc-8183ad7a0660	68163-101	HUMAN OTC DRUG	DRx CHOICE Antacid Calcium	Regular Strength	Calcium Carbonate 500mg	TABLET, CHEWABLE	ORAL	20181217		OTC MONOGRAPH FINAL	part331	Raritan Pharmaceuticals Inc	CALCIUM CARBONATE	500	mg/1			N	20241231
68163-102_14c2d852-802c-4d00-8efe-440bd762899d	68163-102	HUMAN OTC DRUG	Extra Strength Antacid	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190201		OTC MONOGRAPH FINAL	part331	RARITAN PHARMACEUTICALS INC	CALCIUM CARBONATE	750	mg/1			N	20241231
68163-111_7acae853-642c-4bc4-ad63-f82f332334dc	68163-111	HUMAN OTC DRUG	Gas Relief	Mint Flavor	Simethicone	TABLET, CHEWABLE	ORAL	20190417		OTC MONOGRAPH FINAL	part332	Raritan Pharmaceuticals Inc	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
68163-115_410c0334-ac7e-4ad7-bbf9-4f45f4674533	68163-115	HUMAN OTC DRUG	Extra Strength Natural Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20200427		OTC MONOGRAPH DRUG	M001	Raritan Pharmaceuticals Inc	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68163-116_6eb07854-d4a5-4bb2-b0fa-1a28a2c02f71	68163-116	HUMAN OTC DRUG	Bisacodyl	Stimulant Laxative	Bisacodyl	TABLET, COATED	ORAL	20191029		OTC MONOGRAPH NOT FINAL	part334	Raritan Pharmaceuticals Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68163-118_87a91add-93bf-4ee6-a934-e3816d9555a4	68163-118	HUMAN OTC DRUG	Zinc Cold Therapy	Citrus Flavor	ZINC GLUCONATE	TABLET, CHEWABLE	ORAL	20190419		UNAPPROVED HOMEOPATHIC		RARITAN PHARMACEUTICALS INC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68163-119_b050a634-0e8a-496b-9862-9f3263207bcf	68163-119	HUMAN OTC DRUG	fiber laxative		Psyllium Husk	CAPSULE	ORAL	20190416		OTC MONOGRAPH NOT FINAL	part334	Raritan Pharmaceuticals Inc	PSYLLIUM HUSK	.52	g/1			N	20241231
68163-122_2c692e71-b563-491d-b998-ae80d7b4a38f	68163-122	HUMAN OTC DRUG	DRx Choice Fiber Therapy		Methylcellulose	TABLET	ORAL	20220720		OTC MONOGRAPH NOT FINAL	part334	RARITAN PHARMACEUTICALS INC	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
68163-307_43529355-7d38-4bad-a740-71edddac6173	68163-307	HUMAN OTC DRUG	DRx Choice Sore Throat	Menthol Flavor	Phenol	SPRAY	ORAL	20221017		OTC MONOGRAPH NOT FINAL	part356	RARITAN PHARMACEUTICALS INC	PHENOL	1.4	g/100mL			N	20241231
68163-515_e663d7b0-0aca-45c8-b133-bb8ba441123e	68163-515	HUMAN OTC DRUG	Daily Fiber	Sugar Free	Psyllium Husk	POWDER	ORAL	20190312		OTC MONOGRAPH NOT FINAL	part334	Raritan Pharmaceuticals Inc	PSYLLIUM HUSK	3.4	g/5.79g			N	20241231
68163-517_c6bf4a13-3458-4d6c-aa53-187bdb64a03d	68163-517	HUMAN OTC DRUG	DRx Choice Fiber Therapy		methylcellulose	POWDER, FOR SOLUTION	ORAL	20220718		OTC MONOGRAPH NOT FINAL	part334	RARITAN PHARMACEUTICALS INC	METHYLCELLULOSE (4000 MPA.S)	2	g/10.2g			N	20241231
68163-540_b8261276-9d14-47e8-803b-588f0b1ee570	68163-540	HUMAN OTC DRUG	severe cold and cough	daytime	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20190314		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68163-541_3f1d50f4-cc55-4e17-a032-a9dba3bb04ed	68163-541	HUMAN OTC DRUG	Nighttime Severe Cold and Cough		ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE	POWDER, FOR SOLUTION	ORAL	20190322		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68163-547_f9a929c3-58fa-4859-abea-4d8846a4cdfc	68163-547	HUMAN OTC DRUG	Multi Symptom Severe Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	POWDER, FOR SOLUTION	ORAL	20190410		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68163-570_30f1ff53-5eaf-45e5-ad1d-c302b48687d2	68163-570	HUMAN OTC DRUG	Unflavored Organic Natural Fiber		Psyllium husk	POWDER	ORAL	20190320		OTC MONOGRAPH DRUG	M007	Raritan Pharmaceuticals Inc	PSYLLIUM HUSK	3.4	g/7g			N	20241231
68163-571_b5e7a80f-227b-45ff-b5e1-8cf10572804d	68163-571	HUMAN OTC DRUG	Natural Orange Flavor	Organic Natural Fiber	Psyllium husk	POWDER	ORAL	20190320		OTC MONOGRAPH DRUG	M007	Raritan Pharmaceuticals Inc	PSYLLIUM HUSK	3.4	g/12g			N	20241231
68163-575_dca61397-0956-45bd-830e-17589e557b3f	68163-575	HUMAN OTC DRUG	Ultra Organic Fiber	Sugar Free	Psyllium husk	POWDER	ORAL	20190318		OTC MONOGRAPH DRUG	M007	Raritan Pharmaceuticals Inc	PSYLLIUM HUSK	3.4	g/7g			N	20241231
68163-605_4898b1c2-55ef-4589-982b-2279c01707e5	68163-605	HUMAN OTC DRUG	Mucus Relief DM Honey and Berry Flavor		Dextromethorphan Hydrobromide and Guaifenesin	SOLUTION	ORAL	20230421		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68163-660_778ec0df-2baa-4ae3-8072-38ab4e3bf2be	68163-660	HUMAN OTC DRUG	HoneyWorks Plus Adult Nighttime Cough Syrup		dextromethorphan hbr, doxylamine succinate	SOLUTION	ORAL	20230201		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	20; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68163-661_43230b3b-2984-4924-b46d-dc73a8194d23	68163-661	HUMAN OTC DRUG	Childrens HoneyWorks Plus Nighttime Cough Syrup		dextromethorphan hbr, doxylamine succinate	SOLUTION	ORAL	20230201		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	15; 6.25	mg/10mL; mg/10mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68163-695_339b0dcb-1efb-4dd7-b2d7-aea86734e633	68163-695	HUMAN OTC DRUG	ADWE Childrens Pain Fever		Acetaminophen	SUSPENSION	ORAL	20220117		OTC MONOGRAPH NOT FINAL	part343	RARITAN PHARMACEUTICALS INC	ACETAMINOPHEN	160	mg/5mL			N	20241231
68163-698_eef00453-9f4f-4a05-bb4e-49b94705b52c	68163-698	HUMAN OTC DRUG	Overnight Cold and Flu		Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20230421		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68163-700_9ca8fe34-e54f-4fe5-a5e4-8fcc4d71d393	68163-700	HUMAN OTC DRUG	EXTRA STRENGTH	gas relief	SIMETHICONE	LIQUID	ORAL	20200826		OTC MONOGRAPH DRUG	M002	Raritan Pharmaceuticals Inc	DIMETHICONE	125	mg/5mL	Skin Barrier Activity [PE]		N	20241231
68163-703_2744c4a1-81af-4181-afec-439c242dc6d1	68163-703	HUMAN OTC DRUG	SORE THROAT		Phenol	SPRAY	ORAL	20200729		OTC MONOGRAPH NOT FINAL	part356	Raritan Pharmaceuticals Inc	PHENOL	1.4	g/100mL			N	20241231
68163-704_27201814-3088-41a2-8111-9634841e2a4d	68163-704	HUMAN OTC DRUG	Saline		Nasal	SPRAY	NASAL	20200930		OTC MONOGRAPH FINAL	part349	Raritan Pharmaceuiticals Inc	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
68163-706_158591c7-8458-4cb3-91fb-17e84fb756d1	68163-706	HUMAN OTC DRUG	Regular Strength	Pink Bismuth	Bismuth subsalicylate	SUSPENSION	ORAL	20190513		OTC MONOGRAPH FINAL	part335	Raritan Pharmaceuticals Inc	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
68163-707_8e463638-9e24-4d82-8718-d8655b17df5b	68163-707	HUMAN OTC DRUG	DRx Choice Stomach Relief	Regular Strength	Bismuth subsalicylate	SUSPENSION	ORAL	20211206		OTC MONOGRAPH FINAL	part335	RARITAN PHAMACEUTICALS INC	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
68163-710_bf8be390-9745-4ac3-868a-126c1fd8feac	68163-710	HUMAN OTC DRUG	ADWE dye-free childrens allergy		Diphenhydramine hydrochloride	SYRUP	ORAL	20211122		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68163-730_e9704c5e-a6d0-4c56-8b29-007585c433d5	68163-730	HUMAN OTC DRUG	Nighttime Sleep Aid	Berry Flavor	DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20190417		OTC MONOGRAPH FINAL	part341	Raritan Pharmaceuticals Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68163-737_1517cebe-1dda-41ed-a58c-f7cb96b99bc1	68163-737	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20190205		OTC MONOGRAPH FINAL	part341	Raritan Pharmaceuticals Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68163-738_26176948-7eb1-419c-bcb5-9435d3d21b5d	68163-738	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20190205		OTC MONOGRAPH FINAL	part341	Raritan Pharmaceuticals Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68163-742_875b40bd-7955-4048-abbf-7f43d9ea3ac5	68163-742	HUMAN OTC DRUG	DRx Choice Long Acting Cough		Dextromethorphan HBr	LIQUID	ORAL	20230424		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68163-743_20dc7a0b-4e2c-4743-87f9-5bafffdbf003	68163-743	HUMAN OTC DRUG	DRx Choice	Fruit Punch	Guaifenesin	SYRUP	ORAL	20190515		OTC MONOGRAPH FINAL	part341	Raritan Pharmaceuticals Inc	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68163-747_25fff2a6-ecb1-4117-bd11-e5ec3e3d09a9	68163-747	HUMAN OTC DRUG	DRx Choice Children daytime	Cough and Chest Congestion	Dextromethorphan HBr and Guaifenesin	LIQUID	ORAL	20230424		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68163-748_7a3bb739-ff50-4d29-b270-d6b084906493	68163-748	HUMAN OTC DRUG	DRx Choice Childrens Stuffy Nose and Chest Congestion		Guaifenesin and Phenylephrine Hcl	SOLUTION	ORAL	20230424		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	100; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68163-749_a096cb76-0d1c-4ca8-854a-5199da0bc8f7	68163-749	HUMAN OTC DRUG	DRx Choice maximum strength Severe	Cough plus sore throat	Acetaminophen, Dextromethorphan HBr	SOLUTION	ORAL	20230424		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68163-771_74820932-1195-4913-b375-0a809b3e5710	68163-771	HUMAN OTC DRUG	Honey Works	Kids Honey Cough Syrup	Dextromethorphan HBr	SYRUP	ORAL	20221226		OTC MONOGRAPH FINAL	part341	RARITAN PHARMACEUTICALS INC	DEXTROMETHORPHAN HYDROBROMIDE	5	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68180-101_537df828-cd82-4b5e-9d0d-da8bd1cfd736	68180-101	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-102_537df828-cd82-4b5e-9d0d-da8bd1cfd736	68180-102	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-103_537df828-cd82-4b5e-9d0d-da8bd1cfd736	68180-103	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-104_537df828-cd82-4b5e-9d0d-da8bd1cfd736	68180-104	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-105_537df828-cd82-4b5e-9d0d-da8bd1cfd736	68180-105	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-112_bc8c9f7a-7249-497f-ba33-4148d2313d4e	68180-112	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078154	Lupin Pharmaceuticals, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68180-113_bc8c9f7a-7249-497f-ba33-4148d2313d4e	68180-113	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078154	Lupin Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68180-114_bc8c9f7a-7249-497f-ba33-4148d2313d4e	68180-114	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078154	Lupin Pharmaceuticals, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68180-115_bc8c9f7a-7249-497f-ba33-4148d2313d4e	68180-115	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA090025	Lupin Pharmaceuticals, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68180-117_1ec91e13-a4b5-46d9-9e60-8ff227e367c4	68180-117	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20110912		ANDA	ANDA091399	Lupin Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68180-118_1ec91e13-a4b5-46d9-9e60-8ff227e367c4	68180-118	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20110912		ANDA	ANDA091399	Lupin Pharmaceuticals, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68180-121_ad1b5895-d12b-4ceb-aef4-691da109bf6c	68180-121	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	Lupin Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-122_ad1b5895-d12b-4ceb-aef4-691da109bf6c	68180-122	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	Lupin Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-128_574221bf-1643-4dd4-8ac6-29f387ce5eaf	68180-128	HUMAN PRESCRIPTION DRUG	Fenofibric acid		Fenofibric acid	CAPSULE, DELAYED RELEASE	ORAL	20131204		ANDA	ANDA200750	Lupin Pharmaceuticals, Inc.	CHOLINE FENOFIBRATE	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-129_574221bf-1643-4dd4-8ac6-29f387ce5eaf	68180-129	HUMAN PRESCRIPTION DRUG	Fenofibric acid		Fenofibric acid	CAPSULE, DELAYED RELEASE	ORAL	20131204		ANDA	ANDA200750	Lupin Pharmaceuticals, Inc.	CHOLINE FENOFIBRATE	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-130_aeaeb09e-aa67-40ec-b6a8-e0f3fda00c35	68180-130	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20130222		NDA AUTHORIZED GENERIC	NDA021695	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	43	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-131_aeaeb09e-aa67-40ec-b6a8-e0f3fda00c35	68180-131	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20130222		NDA AUTHORIZED GENERIC	NDA021695	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	130	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-135_a752cb19-7de3-4b6d-aa44-03b7027ea60b	68180-135	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20120910	20240531	ANDA	ANDA078169	Lupin Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
68180-136_a752cb19-7de3-4b6d-aa44-03b7027ea60b	68180-136	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20120910	20240531	ANDA	ANDA078169	Lupin Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
68180-137_a752cb19-7de3-4b6d-aa44-03b7027ea60b	68180-137	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20120910		ANDA	ANDA078169	Lupin Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-141_54834b73-96d1-4f73-953d-a3407be454d6	68180-141	HUMAN PRESCRIPTION DRUG	Nabumetone		nabumetone	TABLET, FILM COATED	ORAL	20110112		ANDA	ANDA090445	Lupin Pharmaceuticals, Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-142_54834b73-96d1-4f73-953d-a3407be454d6	68180-142	HUMAN PRESCRIPTION DRUG	Nabumetone		nabumetone	TABLET, FILM COATED	ORAL	20110112		ANDA	ANDA090445	Lupin Pharmaceuticals, Inc.	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-150_93d01e19-749c-4f2e-bbdc-e3eda54a9dca	68180-150	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SUSPENSION	ORAL	20100629		ANDA	ANDA090440	Lupin Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68180-153_4645dca0-0380-4f47-8fd8-43c3ce8c3b71	68180-153	HUMAN PRESCRIPTION DRUG	DESLORATADINE		DESLORATADINE	TABLET, FILM COATED	ORAL	20130225		ANDA	ANDA078352	Lupin Pharmaceuticals, Inc.	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
68180-157_e15f3b95-c7f0-46b9-93cf-3ad532c7a2ae	68180-157	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20190508		ANDA	ANDA210545	Lupin Pharmaceuticals, Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
68180-158_e15f3b95-c7f0-46b9-93cf-3ad532c7a2ae	68180-158	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20190508		ANDA	ANDA210545	Lupin Pharmaceuticals, Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
68180-159_5097aa6d-a331-468d-92b6-6446c3199d3f	68180-159	HUMAN PRESCRIPTION DRUG	Ethacrynic Acid		Ethacrynic Acid	TABLET	ORAL	20200224		ANDA	ANDA211719	Lupin Pharmaceuticals, Inc.	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68180-160_dc93f95a-ad94-4629-9104-6740e9a21929	68180-160	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818	20240731	ANDA	ANDA065398	Lupin Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
68180-161_dc93f95a-ad94-4629-9104-6740e9a21929	68180-161	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818	20240731	ANDA	ANDA065399	Lupin Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
68180-162_e6e8dd21-bd53-43d4-80d1-61eb0ba449c3	68180-162	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818	20240531	ANDA	ANDA065400	Lupin Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	
68180-166_cf4678a5-2147-44e8-80c2-2a5c699140b6	68180-166	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20150327		ANDA	ANDA090439	Lupin Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68180-167_cf4678a5-2147-44e8-80c2-2a5c699140b6	68180-167	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20150327		ANDA	ANDA090439	Lupin Pharmaceuticals, Inc.	VANCOMYCIN HYDROCHLORIDE	250	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
68180-180_90eb48ed-ba9a-44f9-9d4a-3e0ef569c040	68180-180	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20080423		ANDA	ANDA065392	Lupin Pharmaceuticals, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-181_c7269fc3-8852-4fd3-b0ab-630806f20902	68180-181	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20080423		ANDA	ANDA065396	Lupin Pharmaceuticals, Inc.	CEFADROXIL	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-182_c7269fc3-8852-4fd3-b0ab-630806f20902	68180-182	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	POWDER, FOR SUSPENSION	ORAL	20080423		ANDA	ANDA065396	Lupin Pharmaceuticals, Inc.	CEFADROXIL	500	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-185_8b5a92b7-2f16-4ed0-adc7-4d6ec0baaaf8	68180-185	HUMAN PRESCRIPTION DRUG	Mefenamic Acid		Mefenamic Acid	CAPSULE	ORAL	20110906		ANDA	ANDA091322	Lupin Pharmaceuticals, Inc.	MEFENAMIC ACID	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-188_911f7643-cd10-49b3-8b4b-18a8cb6752d6	68180-188	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	CAPSULE	ORAL	20201222		ANDA	ANDA209487	Lupin Pharmaceuticals, Inc.	MELOXICAM	5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-189_911f7643-cd10-49b3-8b4b-18a8cb6752d6	68180-189	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	CAPSULE	ORAL	20201222		ANDA	ANDA209487	Lupin Pharmaceuticals, Inc.	MELOXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-193_f43ef4e7-e34c-40c7-b776-2381db92162f	68180-193	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20140807		ANDA	ANDA091351	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-194_f43ef4e7-e34c-40c7-b776-2381db92162f	68180-194	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20140807		ANDA	ANDA091351	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-195_f43ef4e7-e34c-40c7-b776-2381db92162f	68180-195	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20140807		ANDA	ANDA091351	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-196_17a6182b-5050-470e-aa1d-1605fa9e088e	68180-196	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		Telmisartan and Amlodipine	TABLET	ORAL	20140108		ANDA	ANDA201586	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; TELMISARTAN	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-197_17a6182b-5050-470e-aa1d-1605fa9e088e	68180-197	HUMAN PRESCRIPTION DRUG	Telmisartan and Amlodipine		Telmisartan and Amlodipine	TABLET	ORAL	20140108		ANDA	ANDA201586	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; TELMISARTAN	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-210_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-210	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-211_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-211	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-212_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-212	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-214_708db859-37f8-4e63-94cb-ebd9db031480	68180-214	HUMAN PRESCRIPTION DRUG	CYCLOSPORINE		cyclosporine	EMULSION	OPHTHALMIC	20220511		NDA AUTHORIZED GENERIC	NDA050790	Lupin Pharmaceuticals, Inc.	CYCLOSPORINE	.5	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68180-215_69e6f6ca-f561-4079-8cb6-37cef1ab50b7	68180-215	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20101006		ANDA	ANDA078245	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-216_69e6f6ca-f561-4079-8cb6-37cef1ab50b7	68180-216	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20101006		ANDA	ANDA078245	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-217_69e6f6ca-f561-4079-8cb6-37cef1ab50b7	68180-217	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20101006		ANDA	ANDA078245	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-222_309a40e8-333f-478a-8a94-beff7f3ca5b2	68180-222	HUMAN PRESCRIPTION DRUG	NIACIN		NIACIN	TABLET, EXTENDED RELEASE	ORAL	20140320		ANDA	ANDA090892	Lupin Pharmaceuticals, Inc.	NIACIN	750	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
68180-229_f2ba8fc0-17d6-4185-8752-afd536cfbc6a	68180-229	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	TABLET, FILM COATED	ORAL	20150713		ANDA	ANDA090051	Lupin Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68180-230_f2ba8fc0-17d6-4185-8752-afd536cfbc6a	68180-230	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	TABLET, FILM COATED	ORAL	20150713		ANDA	ANDA090051	Lupin Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68180-231_c6eed481-efea-443c-bac5-db0043f88187	68180-231	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20200701		ANDA	ANDA204019	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-232_c6eed481-efea-443c-bac5-db0043f88187	68180-232	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20200701		ANDA	ANDA204019	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-240_33f7d8ad-94a2-4570-8160-fe0c0c1b025d	68180-240	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA078424	Lupin Pharmaceuticals, Inc.	LEVOFLOXACIN	250	mg/1			N	20241231
68180-241_33f7d8ad-94a2-4570-8160-fe0c0c1b025d	68180-241	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA078424	Lupin Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
68180-242_33f7d8ad-94a2-4570-8160-fe0c0c1b025d	68180-242	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA078424	Lupin Pharmaceuticals, Inc.	LEVOFLOXACIN	750	mg/1			N	20241231
68180-246_5d2878d6-1662-42c9-8aed-3d8b8204e2b8	68180-246	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Lupin Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68180-247_5d2878d6-1662-42c9-8aed-3d8b8204e2b8	68180-247	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Lupin Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68180-248_5d2878d6-1662-42c9-8aed-3d8b8204e2b8	68180-248	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Lupin Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68180-249_5d2878d6-1662-42c9-8aed-3d8b8204e2b8	68180-249	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180220		ANDA	ANDA206028	Lupin Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68180-260_7b753d89-ac34-4feb-b573-302a1f3c1fca	68180-260	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20200918		ANDA	ANDA209286	Lupin Pharmaceuticals, Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68180-261_7b753d89-ac34-4feb-b573-302a1f3c1fca	68180-261	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20200918		ANDA	ANDA209286	Lupin Pharmaceuticals, Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68180-265_8c674191-c109-4a9c-9cbc-7c1e2491ccd4	68180-265	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078790	Lupin Pharmaceuticals, Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
68180-266_8c674191-c109-4a9c-9cbc-7c1e2491ccd4	68180-266	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078790	Lupin Pharmaceuticals, Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
68180-267_8c674191-c109-4a9c-9cbc-7c1e2491ccd4	68180-267	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078790	Lupin Pharmaceuticals, Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
68180-276_cbe7d5e6-eabd-4d1a-a66e-4a2e46c76804	68180-276	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20150105		ANDA	ANDA201677	Lupin Pharmaceuticals, Inc.	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-280_dbe51867-ce72-4fbe-92d7-e5e95190339f	68180-280	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET	ORAL	20090710		ANDA	ANDA078939	Lupin Pharmaceuticals, Inc.	ETHAMBUTOL HYDROCHLORIDE	100	mg/1	Antimycobacterial [EPC]		N	20241231
68180-281_dbe51867-ce72-4fbe-92d7-e5e95190339f	68180-281	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET	ORAL	20090704		ANDA	ANDA078939	Lupin Pharmaceuticals, Inc.	ETHAMBUTOL HYDROCHLORIDE	400	mg/1	Antimycobacterial [EPC]		N	20241231
68180-283_18727593-f734-4bd5-88eb-625779d35660	68180-283	HUMAN PRESCRIPTION DRUG	SILDENAFIL		Sildenafil	POWDER, FOR SUSPENSION	ORAL	20220928		ANDA	ANDA211638	Lupin Pharmaceuticals, Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68180-285_37e2f25d-c2b3-4d13-b33e-6a9ffafc99ff	68180-285	HUMAN PRESCRIPTION DRUG	rifabutin		rifabutin	CAPSULE	ORAL	20140326		ANDA	ANDA090033	Lupin Pharmaceuticals, Inc.	RIFABUTIN	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
68180-286_e180b9ff-1e7c-422a-9fe7-afd39eee3e4e	68180-286	HUMAN PRESCRIPTION DRUG	ABACAVIR, LAMIVUDINE AND ZIDOVUDINE		ABACAVIR , LAMIVUDINE AND ZIDOVUDINE	TABLET	ORAL	20131217		ANDA	ANDA202912	Lupin Pharmaceuticals, Inc.	ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE	300; 150; 300	mg/1; mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
68180-287_1b7981ee-8124-46a2-9aab-f9b85d982650	68180-287	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA204131	Lupin Pharmaceuticals, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
68180-288_61b0304c-2258-40ed-9fc8-bc363b0906f6	68180-288	HUMAN PRESCRIPTION DRUG	Abacavir and Lamivudine		Abacavir and Lamivudine	TABLET, FILM COATED	ORAL	20170328		ANDA	ANDA204990	Lupin Pharmaceuticals, Inc.	ABACAVIR SULFATE; LAMIVUDINE	600; 300	mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
68180-294_d87ec3ae-b1d4-4419-b47d-12375d7aa77e	68180-294	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	Lupin Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68180-295_d87ec3ae-b1d4-4419-b47d-12375d7aa77e	68180-295	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	Lupin Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68180-296_d87ec3ae-b1d4-4419-b47d-12375d7aa77e	68180-296	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090694	Lupin Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68180-297_d87ec3ae-b1d4-4419-b47d-12375d7aa77e	68180-297	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20150525		ANDA	ANDA090694	Lupin Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68180-302_f9b501a4-841f-4f42-9dd4-d421528b1916	68180-302	HUMAN PRESCRIPTION DRUG	cefuroxime axetil		cefuroxime axetil	TABLET	ORAL	20081008	20250430	ANDA	ANDA065135	Lupin Pharmaceuticals, Inc.	CEFUROXIME AXETIL	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
68180-303_f9b501a4-841f-4f42-9dd4-d421528b1916	68180-303	HUMAN PRESCRIPTION DRUG	cefuroxime axetil		cefuroxime axetil	TABLET	ORAL	20081008	20241031	ANDA	ANDA065135	Lupin Pharmaceuticals, Inc.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
68180-307_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-307	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20150212		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-308_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-308	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20150212		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-309_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-309	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20150212		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-311_b891d3a3-3346-441e-99cc-03528b4afa46	68180-311	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20101221		ANDA	ANDA090443	Lupin Pharmaceuticals, Inc.	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-312_b891d3a3-3346-441e-99cc-03528b4afa46	68180-312	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20101221		ANDA	ANDA090442	Lupin Pharmaceuticals, Inc.	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-313_b891d3a3-3346-441e-99cc-03528b4afa46	68180-313	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20101221		ANDA	ANDA090441	Lupin Pharmaceuticals, Inc.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-314_8f335412-54c9-428f-afac-c0bdae6384b8	68180-314	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100416		ANDA	ANDA090444	Lupin Pharmaceuticals, Inc.	IMIPRAMINE PAMOATE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-315_8f335412-54c9-428f-afac-c0bdae6384b8	68180-315	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100416		ANDA	ANDA090444	Lupin Pharmaceuticals, Inc.	IMIPRAMINE PAMOATE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-316_8f335412-54c9-428f-afac-c0bdae6384b8	68180-316	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100416		ANDA	ANDA090444	Lupin Pharmaceuticals, Inc.	IMIPRAMINE PAMOATE	125	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-317_8f335412-54c9-428f-afac-c0bdae6384b8	68180-317	HUMAN PRESCRIPTION DRUG	Imipramine Pamoate		Imipramine Pamoate	CAPSULE	ORAL	20100416		ANDA	ANDA090444	Lupin Pharmaceuticals, Inc.	IMIPRAMINE PAMOATE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-319_892e560b-2014-4a1f-8c76-fe16285bf48f	68180-319	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170614		ANDA	ANDA090693	Lupin Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68180-320_892e560b-2014-4a1f-8c76-fe16285bf48f	68180-320	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170614		ANDA	ANDA090693	Lupin Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68180-322_99cace87-04c3-4b0f-98ee-1f450c30a116	68180-322	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091124	Lupin Pharmaceuticals, Inc.	ESZOPICLONE	1	mg/1		CIV	N	20251231
68180-323_99cace87-04c3-4b0f-98ee-1f450c30a116	68180-323	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091124	Lupin Pharmaceuticals, Inc.	ESZOPICLONE	2	mg/1		CIV	N	20251231
68180-324_99cace87-04c3-4b0f-98ee-1f450c30a116	68180-324	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091124	Lupin Pharmaceuticals, Inc.	ESZOPICLONE	3	mg/1		CIV	N	20251231
68180-336_7225eab3-cf76-4c19-a339-49082dec4fb9	68180-336	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110930		ANDA	ANDA090692	Lupin Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68180-337_7225eab3-cf76-4c19-a339-49082dec4fb9	68180-337	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110930		ANDA	ANDA090692	Lupin Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68180-338_28e237fd-5569-4af9-8c15-bed92c928bfa	68180-338	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160201		ANDA	ANDA091664	Lupin Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68180-339_28e237fd-5569-4af9-8c15-bed92c928bfa	68180-339	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160201		ANDA	ANDA091664	Lupin Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68180-345_fccb1fe2-381c-475f-9e6e-8293981babab	68180-345	HUMAN PRESCRIPTION DRUG	DARUNAVIR		DARUNAVIR	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA202073	Lupin Pharmaceuticals, Inc.	DARUNAVIR ETHANOLATE	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
68180-346_fccb1fe2-381c-475f-9e6e-8293981babab	68180-346	HUMAN PRESCRIPTION DRUG	DARUNAVIR		DARUNAVIR	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA202073	Lupin Pharmaceuticals, Inc.	DARUNAVIR ETHANOLATE	800	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
68180-351_914cec41-7acb-476e-9e06-fa9d1474052d	68180-351	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Lupin Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-352_914cec41-7acb-476e-9e06-fa9d1474052d	68180-352	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Lupin Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-353_914cec41-7acb-476e-9e06-fa9d1474052d	68180-353	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Lupin Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-354_e5f38101-deda-4a41-8c51-76edce7df3e8	68180-354	HUMAN PRESCRIPTION DRUG	RANOLAZINE		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190227		ANDA	ANDA201046	Lupin Pharmaceuticals, Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68180-355_e5f38101-deda-4a41-8c51-76edce7df3e8	68180-355	HUMAN PRESCRIPTION DRUG	RANOLAZINE		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190227		ANDA	ANDA201046	Lupin Pharmaceuticals, Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68180-360_a56b8c46-bfe6-48eb-97fa-3b100078fb9c	68180-360	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20121119		ANDA	ANDA090856	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-361_a56b8c46-bfe6-48eb-97fa-3b100078fb9c	68180-361	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20121119		ANDA	ANDA090856	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-362_c6eed481-efea-443c-bac5-db0043f88187	68180-362	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20151123		ANDA	ANDA204019	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-363_c6eed481-efea-443c-bac5-db0043f88187	68180-363	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20151123		ANDA	ANDA204019	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-376_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-376	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20171101		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-377_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-377	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20171101		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-378_7959b869-dd7a-45d9-82d6-0e97b788bfc4	68180-378	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20171101		ANDA	ANDA078232	Lupin Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
68180-379_ad320f99-9382-4ef0-b6b6-86542020555a	68180-379	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120214		ANDA	ANDA091424	Lupin Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-380_ad320f99-9382-4ef0-b6b6-86542020555a	68180-380	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120214		ANDA	ANDA091424	Lupin Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-381_ad320f99-9382-4ef0-b6b6-86542020555a	68180-381	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20120214		ANDA	ANDA091424	Lupin Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-383_e674f8e1-d70a-4e39-b2c3-6b7ad77e3796	68180-383	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110926		ANDA	ANDA200503	Lupin Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68180-384_e674f8e1-d70a-4e39-b2c3-6b7ad77e3796	68180-384	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110926		ANDA	ANDA200503	Lupin Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68180-385_e674f8e1-d70a-4e39-b2c3-6b7ad77e3796	68180-385	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20110926		ANDA	ANDA200503	Lupin Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68180-388_a56b8c46-bfe6-48eb-97fa-3b100078fb9c	68180-388	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20200801		ANDA	ANDA090856	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-389_a56b8c46-bfe6-48eb-97fa-3b100078fb9c	68180-389	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20200801		ANDA	ANDA090856	Lupin Pharmaceuticals, Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68180-395_c7509f8b-4cac-4294-8e22-0e954c75f793	68180-395	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20151001		ANDA	ANDA202240	Lupin Pharmaceuticals, Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-396_c7509f8b-4cac-4294-8e22-0e954c75f793	68180-396	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20150807		ANDA	ANDA202240	Lupin Pharmaceuticals, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-398_c7509f8b-4cac-4294-8e22-0e954c75f793	68180-398	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20150807		ANDA	ANDA202240	Lupin Pharmaceuticals, Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-399_c7509f8b-4cac-4294-8e22-0e954c75f793	68180-399	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20191209		ANDA	ANDA202240	Lupin Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-401_d49ce223-c292-4c1a-b41e-508022d0602d	68180-401	HUMAN PRESCRIPTION DRUG	CEFPROZIL		CEFPROZIL	POWDER, FOR SUSPENSION	ORAL	20051201		ANDA	ANDA065261	Lupin Pharmaceuticals, Inc.	CEFPROZIL	125	mg/5mL			N	20241231
68180-402_d49ce223-c292-4c1a-b41e-508022d0602d	68180-402	HUMAN PRESCRIPTION DRUG	CEFPROZIL		CEFPROZIL	POWDER, FOR SUSPENSION	ORAL	20051201		ANDA	ANDA065261	Lupin Pharmaceuticals, Inc.	CEFPROZIL	250	mg/5mL			N	20241231
68180-403_f8f9eaa3-357f-4a73-b4f1-4b53794d3662	68180-403	HUMAN PRESCRIPTION DRUG	CEFPROZIL		CEFPROZIL	TABLET	ORAL	20051201		ANDA	ANDA065276	Lupin Pharmaceuticals, Inc.	CEFPROZIL	250	mg/1			N	20241231
68180-404_f8f9eaa3-357f-4a73-b4f1-4b53794d3662	68180-404	HUMAN PRESCRIPTION DRUG	CEFPROZIL		CEFPROZIL	TABLET	ORAL	20051201		ANDA	ANDA065276	Lupin Pharmaceuticals, Inc.	CEFPROZIL	500	mg/1			N	20241231
68180-405_8b1eb90e-2cfa-4ea7-b191-66017220852b	68180-405	HUMAN PRESCRIPTION DRUG	CEFIXIME		CEFIXIME	POWDER, FOR SUSPENSION	ORAL	20150424		ANDA	ANDA065129	Lupin Pharmaceuticals, Inc.	CEFIXIME	100	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-407_8b1eb90e-2cfa-4ea7-b191-66017220852b	68180-407	HUMAN PRESCRIPTION DRUG	CEFIXIME		CEFIXIME	POWDER, FOR SUSPENSION	ORAL	20150424		ANDA	ANDA065355	Lupin Pharmaceuticals, Inc.	CEFIXIME	200	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-411_22c8bdba-6c34-485a-af89-3aafd7fd8605	68180-411	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20121023		ANDA	ANDA201531	Lupin Pharmaceuticals, Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68180-412_22c8bdba-6c34-485a-af89-3aafd7fd8605	68180-412	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20121023		ANDA	ANDA201531	Lupin Pharmaceuticals, Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68180-413_55ace114-f3c7-42d9-a5c3-19a5175e8474	68180-413	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130404		ANDA	ANDA201524	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-414_55ace114-f3c7-42d9-a5c3-19a5175e8474	68180-414	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130404		ANDA	ANDA201524	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-421_2c774519-5c69-4c3b-899d-7f8d1c5df1f3	68180-421	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN		MOXIFLOXACIN	SOLUTION	OPHTHALMIC	20200213		ANDA	ANDA204079	Lupin Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68180-422_074e7497-9c60-4050-bfd9-288bd169fae3	68180-422	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20170701		ANDA	ANDA202867	Lupin Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68180-423_8b1eb90e-2cfa-4ea7-b191-66017220852b	68180-423	HUMAN PRESCRIPTION DRUG	CEFIXIME		CEFIXIME	CAPSULE	ORAL	20201014		NDA AUTHORIZED GENERIC	NDA203195	Lupin Pharmaceuticals, Inc.	CEFIXIME	400	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-433_61d0e0ec-a82b-4711-8b03-5c40fc33ae22	68180-433	HUMAN PRESCRIPTION DRUG	bromfenac sodium		bromfenac sodium	SOLUTION/ DROPS	OPHTHALMIC	20231220		ANDA	ANDA206027	Lupin Pharmaceuticals, Inc.	BROMFENAC SODIUM	.805	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-436_89d1ce54-bacd-4cf8-a2ec-e0daa92961c2	68180-436	HUMAN PRESCRIPTION DRUG	Bromfenac		Bromfenac	SOLUTION	OPHTHALMIC	20240101		ANDA	ANDA202903	Lupin Pharmaceuticals, Inc.	BROMFENAC SODIUM	.9	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-440_5f2ff403-3c61-427f-b742-84cc96b416a1	68180-440	HUMAN PRESCRIPTION DRUG	cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20170821		ANDA	ANDA065234	Lupin Pharmaceuticals, Inc.	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-441_5f2ff403-3c61-427f-b742-84cc96b416a1	68180-441	HUMAN PRESCRIPTION DRUG	cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20170906		ANDA	ANDA065234	Lupin Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-445_53628f3c-6211-499a-ac03-b3da860dde8a	68180-445	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-446_53628f3c-6211-499a-ac03-b3da860dde8a	68180-446	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-447_53628f3c-6211-499a-ac03-b3da860dde8a	68180-447	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-448_53628f3c-6211-499a-ac03-b3da860dde8a	68180-448	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-449_53628f3c-6211-499a-ac03-b3da860dde8a	68180-449	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-450_53628f3c-6211-499a-ac03-b3da860dde8a	68180-450	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-459_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-459	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100205		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-460_ad320f99-9382-4ef0-b6b6-86542020555a	68180-460	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190222		ANDA	ANDA091424	Lupin Pharmaceuticals, Inc.	MINOCYCLINE HYDROCHLORIDE	55	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-463_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-463	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20181004		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-464_751a4a5d-986d-4dbe-a09f-2cf83466bf47	68180-464	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	Lupin Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-465_751a4a5d-986d-4dbe-a09f-2cf83466bf47	68180-465	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160105		ANDA	ANDA078103	Lupin Pharmaceuticals, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-467_2a7b570f-e6b0-4311-abd0-c13a87a0b164	68180-467	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20080314		ANDA	ANDA078296	Lupin Pharmaceuticals, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-468_2a7b570f-e6b0-4311-abd0-c13a87a0b164	68180-468	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Lupin Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-469_2a7b570f-e6b0-4311-abd0-c13a87a0b164	68180-469	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Lupin Pharmaceuticals, Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-472_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-472	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100205		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-473_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-473	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20181004		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-478_751a4a5d-986d-4dbe-a09f-2cf83466bf47	68180-478	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	Lupin Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-479_751a4a5d-986d-4dbe-a09f-2cf83466bf47	68180-479	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	Lupin Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-480_751a4a5d-986d-4dbe-a09f-2cf83466bf47	68180-480	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20151123		ANDA	ANDA078103	Lupin Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-481_751a4a5d-986d-4dbe-a09f-2cf83466bf47	68180-481	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20151123		ANDA	ANDA078103	Lupin Pharmaceuticals, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-482_751a4a5d-986d-4dbe-a09f-2cf83466bf47	68180-482	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20090714		ANDA	ANDA078103	Lupin Pharmaceuticals, Inc.	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-485_a173dd76-57cb-4066-a51f-26adfb79e861	68180-485	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20080724		ANDA	ANDA077917	Lupin Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-486_a173dd76-57cb-4066-a51f-26adfb79e861	68180-486	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20080724		ANDA	ANDA077917	Lupin Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-487_a173dd76-57cb-4066-a51f-26adfb79e861	68180-487	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20080724		ANDA	ANDA077917	Lupin Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-488_a173dd76-57cb-4066-a51f-26adfb79e861	68180-488	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20080724		ANDA	ANDA077917	Lupin Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-492_bf488b59-d48a-4a26-9c4f-52179d33761f	68180-492	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride Capsules	CAPSULE	ORAL	20190204		ANDA	ANDA209294	Lupin Pharmaceuticals, Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-493_bf488b59-d48a-4a26-9c4f-52179d33761f	68180-493	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride Capsules	CAPSULE	ORAL	20190204		ANDA	ANDA209294	Lupin Pharmaceuticals, Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-494_bf488b59-d48a-4a26-9c4f-52179d33761f	68180-494	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride Capsules	CAPSULE	ORAL	20190204		ANDA	ANDA209294	Lupin Pharmaceuticals, Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68180-501_885efb0a-78aa-455b-b5a1-b3dd2fc2c6e1	68180-501	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077944	Lupin Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-502_885efb0a-78aa-455b-b5a1-b3dd2fc2c6e1	68180-502	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077944	Lupin Pharmaceuticals, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-512_fe3a0b50-c6f5-4fdc-8bd9-60016deb4525	68180-512	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Lupin Pharmaceuticals, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-513_fe3a0b50-c6f5-4fdc-8bd9-60016deb4525	68180-513	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Lupin Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-517_fe3a0b50-c6f5-4fdc-8bd9-60016deb4525	68180-517	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Lupin Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-518_1474b42e-df82-41d5-9cbd-ebe3c45dcc9d	68180-518	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-519_1474b42e-df82-41d5-9cbd-ebe3c45dcc9d	68180-519	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-520_1474b42e-df82-41d5-9cbd-ebe3c45dcc9d	68180-520	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-523_571e9112-2a63-4feb-aa8f-26f6c99c8e78	68180-523	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20221019		ANDA	ANDA208643	Lupin Pharmaceuticals, Inc.	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-524_571e9112-2a63-4feb-aa8f-26f6c99c8e78	68180-524	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20221019		ANDA	ANDA208643	Lupin Pharmaceuticals, Inc.	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-525_571e9112-2a63-4feb-aa8f-26f6c99c8e78	68180-525	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20221019		ANDA	ANDA208643	Lupin Pharmaceuticals, Inc.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-526_571e9112-2a63-4feb-aa8f-26f6c99c8e78	68180-526	HUMAN PRESCRIPTION DRUG	Paliperidone		Paliperidone	TABLET, EXTENDED RELEASE	ORAL	20221019		ANDA	ANDA208643	Lupin Pharmaceuticals, Inc.	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-527_b387274f-edee-4d21-92af-fae0a7c430f2	68180-527	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET	ORAL	20151221		ANDA	ANDA202782	Lupin Pharmaceuticals, Inc.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68180-536_b189e225-f908-4e33-a9c9-0b90047d09c9	68180-536	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	LOTION	TOPICAL	20180130		ANDA	ANDA209147	Lupin Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-537_b385f9bc-6ae3-45a6-8e32-eb902dd89ed9	68180-537	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20231030		ANDA	ANDA208021	Lupin Pharmaceuticals, Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-538_cf519ecb-f36c-409b-a376-4d7514075aa0	68180-538	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20160706		ANDA	ANDA204132	Lupin Pharmaceuticals, Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68180-545_3af1b7c7-383a-4cc1-9a97-37179e9fb4f5	68180-545	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20181129		ANDA	ANDA208205	Lupin Pharmaceuticals, Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
68180-554_a9598a21-6f99-4c86-ace6-b5638da2bec8	68180-554	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20070226		ANDA	ANDA077690	Lupin Pharmaceuticals, Inc.	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-556_a9598a21-6f99-4c86-ace6-b5638da2bec8	68180-556	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20070226	20240331	ANDA	ANDA077690	Lupin Pharmaceuticals, Inc.	QUINAPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
68180-557_a9598a21-6f99-4c86-ace6-b5638da2bec8	68180-557	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20070226		ANDA	ANDA077690	Lupin Pharmaceuticals, Inc.	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-558_a9598a21-6f99-4c86-ace6-b5638da2bec8	68180-558	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20070226		ANDA	ANDA077690	Lupin Pharmaceuticals, Inc.	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-559_a9598a21-6f99-4c86-ace6-b5638da2bec8	68180-559	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20070226		ANDA	ANDA077690	Lupin Pharmaceuticals, Inc.	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-560_93b0a585-9424-4e78-93c0-2e0c151475f1	68180-560	HUMAN PRESCRIPTION DRUG	QUININE SULFATE		QUININE SULFATE	CAPSULE	ORAL	20150804		ANDA	ANDA203112	Lupin Pharmaceuticals, Inc.	QUININE SULFATE	324	mg/1	Antimalarial [EPC]		N	20241231
68180-566_db3d8012-2159-47f6-8f40-1e86d2d3b8d3	68180-566	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070611		ANDA	ANDA077522	Lupin Pharmaceuticals, Inc.	TRANDOLAPRIL	1	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-567_db3d8012-2159-47f6-8f40-1e86d2d3b8d3	68180-567	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070611		ANDA	ANDA077522	Lupin Pharmaceuticals, Inc.	TRANDOLAPRIL	2	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-568_db3d8012-2159-47f6-8f40-1e86d2d3b8d3	68180-568	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070611		ANDA	ANDA077522	Lupin Pharmaceuticals, Inc.	TRANDOLAPRIL	4	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-588_95708342-0ee3-42dd-b6c6-66ce6f2821ca	68180-588	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	Lupin Pharmaceuticals, Inc.	RAMIPRIL	1.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-589_95708342-0ee3-42dd-b6c6-66ce6f2821ca	68180-589	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	Lupin Pharmaceuticals, Inc.	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-590_95708342-0ee3-42dd-b6c6-66ce6f2821ca	68180-590	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	Lupin Pharmaceuticals, Inc.	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-591_95708342-0ee3-42dd-b6c6-66ce6f2821ca	68180-591	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	Lupin Pharmaceuticals, Inc.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-592_0c852142-62ca-4f6d-b812-dac42121e7dd	68180-592	HUMAN PRESCRIPTION DRUG	Desvenlafaxine Succinate		Desvenlafaxine Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204172	Lupin Pharmaceuticals, Inc.	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68180-593_0c852142-62ca-4f6d-b812-dac42121e7dd	68180-593	HUMAN PRESCRIPTION DRUG	Desvenlafaxine Succinate		Desvenlafaxine Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204172	Lupin Pharmaceuticals, Inc.	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68180-602_0852eda3-c1d3-426d-b73d-c7f08dfd9584	68180-602	HUMAN PRESCRIPTION DRUG	Lamivudine		Lamivudine	TABLET, FILM COATED	ORAL	20150325		ANDA	ANDA205217	Lupin Pharmaceuticals, Inc.	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20251231
68180-604_0c852142-62ca-4f6d-b812-dac42121e7dd	68180-604	HUMAN PRESCRIPTION DRUG	Desvenlafaxine Succinate		Desvenlafaxine Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220825		ANDA	ANDA204172	Lupin Pharmaceuticals, Inc.	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68180-606_deb39225-24ce-45aa-a32b-bfa70bb8d25b	68180-606	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180207		ANDA	ANDA209285	Lupin Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68180-612_67dea7ed-30b2-4211-b3f0-de5fc6473ce6	68180-612	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-613_67dea7ed-30b2-4211-b3f0-de5fc6473ce6	68180-613	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-614_67dea7ed-30b2-4211-b3f0-de5fc6473ce6	68180-614	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-615_67dea7ed-30b2-4211-b3f0-de5fc6473ce6	68180-615	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-616_67dea7ed-30b2-4211-b3f0-de5fc6473ce6	68180-616	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, EXTENDED RELEASE	ORAL	20170822		ANDA	ANDA204203	Lupin Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-635_ab716c10-785b-4d43-a5f0-59f95b0b78c8	68180-635	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	Lupin Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-636_ab716c10-785b-4d43-a5f0-59f95b0b78c8	68180-636	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	Lupin Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-637_ab716c10-785b-4d43-a5f0-59f95b0b78c8	68180-637	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	Lupin Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-638_ab716c10-785b-4d43-a5f0-59f95b0b78c8	68180-638	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	Lupin Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68180-645_1a9bc25c-db83-42a0-851a-30212ee10cc6	68180-645	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170306		ANDA	ANDA204134	Lupin Pharmaceuticals, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-646_1a9bc25c-db83-42a0-851a-30212ee10cc6	68180-646	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170306		ANDA	ANDA204134	Lupin Pharmaceuticals, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-647_1a9bc25c-db83-42a0-851a-30212ee10cc6	68180-647	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170306		ANDA	ANDA204134	Lupin Pharmaceuticals, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-650_16f7a4ab-b0e6-4429-b586-fb5e9dd7314a	68180-650	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20150220		ANDA	ANDA204234	Lupin Pharmaceuticals, Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-652_16f7a4ab-b0e6-4429-b586-fb5e9dd7314a	68180-652	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20150220		ANDA	ANDA204234	Lupin Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-653_72a79b0e-c3c7-4a63-a6d6-571f8205eb71	68180-653	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxyclycline hyclate	TABLET, COATED	ORAL	20171030		ANDA	ANDA208818	Lupin Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-654_72a79b0e-c3c7-4a63-a6d6-571f8205eb71	68180-654	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxyclycline hyclate	TABLET, COATED	ORAL	20171030		ANDA	ANDA208818	Lupin Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-657_c09eb87b-5a56-4166-a905-f2bac5fcd4b2	68180-657	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	FOR SUSPENSION	ORAL	20130611		ANDA	ANDA201678	Lupin Pharmaceuticals, Inc.	DOXYCYCLINE	25	mg/5mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68180-658_4b14de8b-899b-4094-bcbd-11bc06803054	68180-658	HUMAN PRESCRIPTION DRUG	rifampin		rifampin	CAPSULE	ORAL	20140108		ANDA	ANDA090034	Lupin Pharmaceuticals, Inc.	RIFAMPIN	150	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
68180-659_4b14de8b-899b-4094-bcbd-11bc06803054	68180-659	HUMAN PRESCRIPTION DRUG	rifampin		rifampin	CAPSULE	ORAL	20140108		ANDA	ANDA090034	Lupin Pharmaceuticals, Inc.	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
68180-670_e2ebb3d3-ad13-4700-b079-a4d98226ae99	68180-670	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208031	Lupin Pharmaceuticals, Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-671_e2ebb3d3-ad13-4700-b079-a4d98226ae99	68180-671	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208031	Lupin Pharmaceuticals, Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-672_e2ebb3d3-ad13-4700-b079-a4d98226ae99	68180-672	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208031	Lupin Pharmaceuticals, Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-673_e2ebb3d3-ad13-4700-b079-a4d98226ae99	68180-673	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208031	Lupin Pharmaceuticals, Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-674_e2ebb3d3-ad13-4700-b079-a4d98226ae99	68180-674	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET	ORAL	20230220		ANDA	ANDA208031	Lupin Pharmaceuticals, Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68180-675_1306cb36-8db1-44f2-8fbc-360591ed7e60	68180-675	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20180209		ANDA	ANDA208348	Lupin Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68180-676_1306cb36-8db1-44f2-8fbc-360591ed7e60	68180-676	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20180209		ANDA	ANDA208348	Lupin Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68180-677_1306cb36-8db1-44f2-8fbc-360591ed7e60	68180-677	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20180209		ANDA	ANDA208348	Lupin Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68180-678_8cf469f4-34f9-4b85-b8c2-a899a3296dd9	68180-678	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20180221		ANDA	ANDA208347	Lupin Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68180-690_042fe743-11d7-4ab1-aceb-b591b4345707	68180-690	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200925	20240131	ANDA	ANDA210689	Lupin Pharmaceuticals, Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	
68180-697_9358ada6-2966-4b2a-8519-ef02728d6313	68180-697	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Lupin Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68180-698_9358ada6-2966-4b2a-8519-ef02728d6313	68180-698	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Lupin Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68180-699_9358ada6-2966-4b2a-8519-ef02728d6313	68180-699	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Lupin Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68180-711_4172b8a9-7052-439a-8f44-916358bdee22	68180-711	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20060530		ANDA	ANDA065264	Lupin Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-718_aebb9485-72fe-4b2d-85af-913f29954bfe	68180-718	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20191217		ANDA	ANDA210801	Lupin Pharmaceuticals, Inc.	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
68180-719_3e68d200-f847-4f79-bfef-f5f4cfb30378	68180-719	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20181031		ANDA	ANDA078043	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-720_3e68d200-f847-4f79-bfef-f5f4cfb30378	68180-720	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20180815		ANDA	ANDA078043	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-721_3e68d200-f847-4f79-bfef-f5f4cfb30378	68180-721	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20180815		ANDA	ANDA078043	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-722_63353f80-7738-4179-8947-509e71c34033	68180-722	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20060531		ANDA	ANDA065259	Lupin Pharmaceuticals, Inc.	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-723_63353f80-7738-4179-8947-509e71c34033	68180-723	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070507		ANDA	ANDA065259	Lupin Pharmaceuticals, Inc.	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68180-740_ea8e8335-ff34-45ba-b81a-68ec9d74e34f	68180-740	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA206541	Lupin Pharmaceuticals, Inc.	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68180-741_ea8e8335-ff34-45ba-b81a-68ec9d74e34f	68180-741	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA206541	Lupin Pharmaceuticals, Inc.	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68180-755_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-755	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100205		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	2.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-756_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-756	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100205		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-757_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-757	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100205		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-758_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-758	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20100205		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-759_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-759	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-760_3f88556b-447a-40c5-917a-e50e0d818c5a	68180-760	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20110705		ANDA	ANDA078466	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-764_e0777a79-35ef-4f69-b6ac-94d31f7ca6fb	68180-764	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET	ORAL	20150331		ANDA	ANDA090245	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-765_e0777a79-35ef-4f69-b6ac-94d31f7ca6fb	68180-765	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET	ORAL	20150331		ANDA	ANDA090245	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-766_e0777a79-35ef-4f69-b6ac-94d31f7ca6fb	68180-766	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET	ORAL	20150331		ANDA	ANDA090245	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; VALSARTAN	5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-767_e0777a79-35ef-4f69-b6ac-94d31f7ca6fb	68180-767	HUMAN PRESCRIPTION DRUG	Amlodipine and Valsartan		Amlodipine and Valsartan	TABLET	ORAL	20150331		ANDA	ANDA090245	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; VALSARTAN	10; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68180-771_5e938b33-b86d-40ab-b5c5-b7137ef9404d	68180-771	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150604		ANDA	ANDA200797	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-772_5e938b33-b86d-40ab-b5c5-b7137ef9404d	68180-772	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150604		ANDA	ANDA200797	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 12.5; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-773_5e938b33-b86d-40ab-b5c5-b7137ef9404d	68180-773	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150604		ANDA	ANDA200797	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	5; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-774_5e938b33-b86d-40ab-b5c5-b7137ef9404d	68180-774	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150604		ANDA	ANDA200797	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 160	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-775_5e938b33-b86d-40ab-b5c5-b7137ef9404d	68180-775	HUMAN PRESCRIPTION DRUG	Amlodipine, Valsartan and Hydrochlorothiazide		Amlodipine, Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150604		ANDA	ANDA200797	Lupin Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN	10; 25; 320	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68180-779_fef74408-8859-4678-a888-6dc9e836b4dd	68180-779	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20140411		ANDA	ANDA078970	Lupin Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68180-780_fef74408-8859-4678-a888-6dc9e836b4dd	68180-780	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20140411		ANDA	ANDA078970	Lupin Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68180-797_62e20062-a660-4d04-bc5e-b064aa001b41	68180-797	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	SUSPENSION	ORAL	20230622		ANDA	ANDA213457	Lupin Pharmaceuticals, Inc.	RUFINAMIDE	40	mg/mL			N	20241231
68180-798_d5646d4c-67ac-4e51-85a9-cc8a6e60bebe	68180-798	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20160118	20260331	ANDA	ANDA203002	Lupin Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	8	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
68180-799_d5646d4c-67ac-4e51-85a9-cc8a6e60bebe	68180-799	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20160118		ANDA	ANDA203002	Lupin Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68180-801_83e11e1b-056e-4c28-b2d3-825ff1b804e1	68180-801	HUMAN PRESCRIPTION DRUG	Lapatinib		lapatinib	TABLET	ORAL	20200929		ANDA	ANDA203007	Lupin Pharmaceuticals, Inc.	LAPATINIB DITOSYLATE	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
68180-803_da135ff1-3f86-4a94-bc34-99add0b676df	68180-803	HUMAN PRESCRIPTION DRUG	RUFINAMIDE		rufinamide	TABLET, FILM COATED	ORAL	20221128		ANDA	ANDA204964	Lupin Pharmaceuticals, Inc.	RUFINAMIDE	200	mg/1			N	20241231
68180-804_da135ff1-3f86-4a94-bc34-99add0b676df	68180-804	HUMAN PRESCRIPTION DRUG	RUFINAMIDE		rufinamide	TABLET, FILM COATED	ORAL	20221128		ANDA	ANDA204964	Lupin Pharmaceuticals, Inc.	RUFINAMIDE	400	mg/1			N	20241231
68180-819_bc36731d-a505-42f3-a4a7-296ef34993d8	68180-819	HUMAN PRESCRIPTION DRUG	Lanthanum Carbonate		Lanthanum Carbonate	TABLET, CHEWABLE	ORAL	20170830		ANDA	ANDA090978	Lupin Pharmaceuticals, Inc.	LANTHANUM CARBONATE	500	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68180-820_bc36731d-a505-42f3-a4a7-296ef34993d8	68180-820	HUMAN PRESCRIPTION DRUG	Lanthanum Carbonate		Lanthanum Carbonate	TABLET, CHEWABLE	ORAL	20170830		ANDA	ANDA090978	Lupin Pharmaceuticals, Inc.	LANTHANUM CARBONATE	750	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68180-821_bc36731d-a505-42f3-a4a7-296ef34993d8	68180-821	HUMAN PRESCRIPTION DRUG	Lanthanum Carbonate		Lanthanum Carbonate	TABLET, CHEWABLE	ORAL	20170830		ANDA	ANDA090978	Lupin Pharmaceuticals, Inc.	LANTHANUM CARBONATE	1000	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68180-827_2500f16a-bfc1-4a8d-9ddc-6f5a218a0682	68180-827	HUMAN PRESCRIPTION DRUG	Fyavolv		Norethindrone Acetate and Ethinyl Estradiol	TABLET, FILM COATED	ORAL	20160315		ANDA	ANDA204213	Lupin Pharmaceuticals, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.0025; .5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68180-828_2500f16a-bfc1-4a8d-9ddc-6f5a218a0682	68180-828	HUMAN PRESCRIPTION DRUG	Fyavolv		Norethindrone Acetate and Ethinyl Estradiol	TABLET, FILM COATED	ORAL	20160315		ANDA	ANDA204213	Lupin Pharmaceuticals, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.005; 1	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68180-829_ea126b9d-ba9c-454e-9dda-c13552b42d0d	68180-829	HUMAN PRESCRIPTION DRUG	AMABELZ		estradiol and norethindrone acetate	TABLET	ORAL	20201008		ANDA	ANDA203339	Lupin Pharmaceuticals, Inc.	ESTRADIOL; NORETHINDRONE	.5; .1	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68180-830_ea126b9d-ba9c-454e-9dda-c13552b42d0d	68180-830	HUMAN PRESCRIPTION DRUG	AMABELZ		estradiol and norethindrone acetate	TABLET	ORAL	20201008		ANDA	ANDA203339	Lupin Pharmaceuticals, Inc.	ESTRADIOL; NORETHINDRONE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68180-837_3d8fc3a5-463f-4d31-9e8b-d6af9ff87cef	68180-837	HUMAN PRESCRIPTION DRUG	TRI-LO-MARZIA		norgestimate and ethinyl estradiol	KIT		20200108		ANDA	ANDA200541	Lupin Pharmaceuticals, Inc.						N	20241231
68180-838_75ff3464-62ce-4b99-bf22-d87368396538	68180-838	HUMAN PRESCRIPTION DRUG	Norgestimate and ethinyl estradiol		Norgestimate and ethinyl estradiol	KIT		20190808		ANDA	ANDA205588	Lupin Pharmaceuticals, Inc.						N	20251231
68180-840_c7364e2d-226e-48af-b819-ca16c5ddac7f	68180-840	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20191201		ANDA	ANDA205630	Lupin Pharmaceuticals, Inc.						N	20251231
68180-843_1064ce06-e247-4c3f-8acd-b499b0d2eaeb	68180-843	HUMAN PRESCRIPTION DRUG	Levonorgestrel and Ethinyl Estradiol		Levonorgestrel and Ethinyl Estradiol	KIT		20121024		ANDA	ANDA091440	Lupin Pharmaceuticals, Inc.						N	20241231
68180-844_81182444-a687-4c1d-a6fd-70a1079fd5c9	68180-844	HUMAN PRESCRIPTION DRUG	Kurvelo		levonorgestrel and ethinyl estradiol	KIT		20210207		ANDA	ANDA091408	Lupin Pharmaceuticals, Inc.						N	20241231
68180-846_800391c6-15d9-4412-bf57-9428c93940c0	68180-846	HUMAN PRESCRIPTION DRUG	Daysee		LEVONORGESTREL AND ETHINYL ESTRADIOL	KIT		20130410		ANDA	ANDA091467	Lupin Pharmaceuticals, Inc.						N	20241231
68180-848_8e5d1995-ee34-4007-8328-e334a514f09b	68180-848	HUMAN PRESCRIPTION DRUG	Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol		levonorgestrel and ethinyl estradiol	KIT		20111202		ANDA	ANDA091674	Lupin Pharmaceuticals, Inc.						N	20241231
68180-852_b2f86a0c-33da-4792-b5f3-1da2e8799dab	68180-852	HUMAN OTC DRUG	My Way		levonorgestrel	TABLET	ORAL	20170425		ANDA	ANDA201446	Lupin Pharmaceuticals, Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
68180-854_968c9233-ef32-4f95-b839-2f6364c3f3c8	68180-854	HUMAN PRESCRIPTION DRUG	Levonorgestrel and Ethinyl Estradiol		Levonorgestrel and Ethinyl Estradiol	KIT		20190703		ANDA	ANDA091425	Lupin Pharmaceuticals, Inc.						N	20241231
68180-857_109cbd41-b6a4-42c1-b225-9fe24e02341a	68180-857	HUMAN PRESCRIPTION DRUG	Levonorgestrel and Ethinyl Estradiol		Levonorgestrel and Ethinyl Estradiol	KIT		20200830		ANDA	ANDA200248	Lupin Pharmaceuticals, Inc.						N	20251231
68180-861_79042cc1-cd04-48c1-8117-18f8492f30ba	68180-861	HUMAN PRESCRIPTION DRUG	azithromycin dihydrate		azithromycin dihydrate	TABLET	ORAL	20221117		ANDA	ANDA065398	Lupin Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68180-862_79042cc1-cd04-48c1-8117-18f8492f30ba	68180-862	HUMAN PRESCRIPTION DRUG	azithromycin dihydrate		azithromycin dihydrate	TABLET	ORAL	20150818		ANDA	ANDA065399	Lupin Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68180-863_d977d2b9-9d4c-47d0-9668-0382bfaab4bc	68180-863	HUMAN PRESCRIPTION DRUG	azithromycin dihydrate		azithromycin dihydrate	TABLET	ORAL	20221117		ANDA	ANDA065400	Lupin Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68180-864_4db673b0-257b-4b00-bc0f-2c75c7e34ef6	68180-864	HUMAN PRESCRIPTION DRUG	Blisovi 24 Fe		norethindrone acetate and ethinyl estradiol	KIT		20191107		ANDA	ANDA091398	Lupin Pharmaceuticals, Inc.						N	20241231
68180-865_e3160339-bf50-4338-a492-1155f0b2d5cc	68180-865	HUMAN PRESCRIPTION DRUG	Blisovi Fe 1/20		norethindrone acetate and ethinyl estradiol	KIT		20190401		ANDA	ANDA201584	Lupin Pharmaceuticals, Inc.						N	20241231
68180-866_59a7394e-f4a1-410c-b0d0-3d4b3fe7a6a8	68180-866	HUMAN PRESCRIPTION DRUG	BLISOVI FE 1.5/30		norethindrone acetate and ethinyl estradiol	KIT		20191107		ANDA	ANDA201585	Lupin Pharmaceuticals, Inc.						N	20241231
68180-868_8078efb3-da22-41a3-96fd-0740b5a9c5f7	68180-868	HUMAN PRESCRIPTION DRUG	DROSPIRENONE AND ETHINYL ESTRADIOL		DROSPIRENONE AND ETHINYL ESTRADIOL	KIT		20220415		ANDA	ANDA201663	Lupin Pharmaceuticals, Inc.						N	20251231
68180-873_e78d8479-4c99-42bb-9da0-e8cf5103131b	68180-873	HUMAN PRESCRIPTION DRUG	WYMZYA Fe		NORETHINDRONE AND ETHINYL ESTRADIOL	KIT		20201130		ANDA	ANDA091332	Lupin Pharmaceuticals, Inc.						N	20241231
68180-875_051f5861-51bc-4564-9ec9-4e2b8dd1cc94	68180-875	HUMAN PRESCRIPTION DRUG	Vyfemla		norethindrone and ethinyl estradiol	KIT		20201104		ANDA	ANDA201886	Lupin Pharmaceuticals, Inc.						N	20241231
68180-876_482dbde2-d80c-4ae3-b706-11fc45743da3	68180-876	HUMAN PRESCRIPTION DRUG	NORETHINDRONE		NORETHINDRONE	TABLET	ORAL	20201111		ANDA	ANDA091325	Lupin Pharmaceuticals, Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68180-877_cc2f499d-f31d-4ee5-b09f-1a235c11ccd1	68180-877	HUMAN PRESCRIPTION DRUG	Jencycla		norethindrone	TABLET	ORAL	20200707		ANDA	ANDA091323	Lupin Pharmaceuticals, Inc.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68180-886_8a72e2ca-d75d-46b1-be5c-0df8e00da657	68180-886	HUMAN PRESCRIPTION DRUG	Nikki		drospirenone and ethinyl estradiol	KIT		20191130		ANDA	ANDA201661	Lupin Pharmaceuticals, Inc.						N	20251231
68180-891_a5a87110-7bdb-4d01-8a80-336f5798cc05	68180-891	HUMAN PRESCRIPTION DRUG	ENSKYCE		desogestrel and ethinyl estradiol	KIT		20200208	20260831	ANDA	ANDA201887	Lupin Pharmaceuticals, Inc.						N	
68180-892_d5ca2ea1-c107-4395-9f84-7980860ad1b8	68180-892	HUMAN PRESCRIPTION DRUG	PIRMELLA 7/7/7		NORETHINDRONE AND ETHINYL ESTRADIOL	KIT		20190816	20240228	ANDA	ANDA201510	Lupin Pharmaceuticals, Inc.						N	
68180-893_d5ca2ea1-c107-4395-9f84-7980860ad1b8	68180-893	HUMAN PRESCRIPTION DRUG	PIRMELLA 1/35		NORETHINDRONE AND ETHINYL ESTRADIOL	KIT		20190816	20250131	ANDA	ANDA201512	Lupin Pharmaceuticals, Inc.						N	
68180-894_a2ac2336-c4f1-4a34-a399-2911801ad3d9	68180-894	HUMAN PRESCRIPTION DRUG	drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium		drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium	KIT		20180822		ANDA	ANDA205947	Lupin Pharmaceuticals, Inc.						N	20241231
68180-895_d8d50b25-b488-4881-87d4-b427f4b2487f	68180-895	HUMAN PRESCRIPTION DRUG	Turqoz		norgestrel and ethinyl estradiol	KIT		20231129		ANDA	ANDA202980	Lupin Pharmaceuticals, Inc.						N	20241231
68180-902_e6f0f0c9-e865-49ed-826d-3adc0c404052	68180-902	HUMAN PRESCRIPTION DRUG	drospirenone and ethinyl estradiol		drospirenone and ethinyl estradiol	KIT		20210207	20240131	ANDA	ANDA201663	Lupin Pharmaceuticals, Inc.						N	
68180-903_5adb7a1a-458b-4b8f-a162-796aeaf5bb0c	68180-903	HUMAN PRESCRIPTION DRUG	Kaitlib Fe		norethindrone and ethinyl estradiol	KIT		20210207		ANDA	ANDA203448	Lupin Pharmaceuticals, Inc.						N	20241231
68180-904_c6feb4ef-1d94-4a96-acab-a1b365285676	68180-904	HUMAN PRESCRIPTION DRUG	Tydemy		Drospirenone, Ethinyl Estradiol and Levomefolate Calcium and Levomefolate Calcium	KIT		20201120		ANDA	ANDA205948	Lupin Pharmaceuticals, Inc.						N	20241231
68180-911_f2464175-fccb-4c96-ba35-fba30e8cf7cc	68180-911	HUMAN PRESCRIPTION DRUG	Mibelas 24 Fe		NORETHINDRONE ACETATE, ETHINYL ESTRADIOL AND FERROUS FUMARATE	KIT		20200331		ANDA	ANDA206287	Lupin Pharmaceuticals, Inc.						N	20241231
68180-914_0c0d591e-f35b-4e3d-bdcb-7d3a1c8e6a2f	68180-914	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190211		ANDA	ANDA210572	Lupin Pharmaceuticals, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68180-919_cc75b69d-d0f0-4eda-8737-c870dbeee6a1	68180-919	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190329	20241101	ANDA	ANDA210567	Lupin Pharmaceuticals, Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
68180-920_cc75b69d-d0f0-4eda-8737-c870dbeee6a1	68180-920	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190329	20241101	ANDA	ANDA210567	Lupin Pharmaceuticals, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
68180-921_cc75b69d-d0f0-4eda-8737-c870dbeee6a1	68180-921	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190329	20241101	ANDA	ANDA210567	Lupin Pharmaceuticals, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
68180-922_cc75b69d-d0f0-4eda-8737-c870dbeee6a1	68180-922	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190329	20241101	ANDA	ANDA210567	Lupin Pharmaceuticals, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
68180-941_a11c56a6-b81c-46bf-a1e0-67231dc21add	68180-941	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL	TRANSDERMAL	20190410		ANDA	ANDA208560	Lupin Pharmaceuticals, Inc.	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
68180-943_81b2c5e2-9afb-4322-addb-1ec807fdb065	68180-943	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	SOLUTION	TOPICAL	20180223		ANDA	ANDA208061	Lupin Pharmaceuticals, Inc.	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
68180-944_e22b1aa0-698e-4f66-b965-c649cebd1ef9	68180-944	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	SPRAY	TOPICAL	20180720		ANDA	ANDA208124	Lupin Pharmaceuticals, Inc.	DESOXIMETASONE	2.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-946_bb8f41b1-1c84-4641-8385-fb167046e99a	68180-946	HUMAN PRESCRIPTION DRUG	DESOXIMETASONE		DESOXIMETASONE	OINTMENT	TOPICAL	20170510		ANDA	ANDA208104	Lupin Pharmaceuticals, Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-947_7ac02053-f43f-4b99-973e-4fe100953749	68180-947	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	OINTMENT, AUGMENTED	TOPICAL	20200319		ANDA	ANDA209106	Lupin Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-948_976666e7-1848-4642-a07b-4dc4efba02df	68180-948	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20170425		ANDA	ANDA208044	Lupin Pharmaceuticals, Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-949_4d85fbde-9bff-4e72-8760-fa27398a3a66	68180-949	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20170620		ANDA	ANDA208163	Lupin Pharmaceuticals, Inc.	DESOXIMETASONE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-950_2a4ec491-511e-499d-9c09-8e2f649175db	68180-950	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20170620		ANDA	ANDA208164	Lupin Pharmaceuticals, Inc.	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-951_02b1142f-ced2-47db-8817-fa46d61176c6	68180-951	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		Hydrocortisone Butyrate	LOTION	TOPICAL	20180817		ANDA	ANDA210209	Lupin Pharmaceuticals, Inc.	HYDROCORTISONE BUTYRATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-954_7b162949-cd57-4f50-91ce-170c555d5e79	68180-954	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE VALERATE		HYDROCORTISONE VALERATE	CREAM	TOPICAL	20191119		ANDA	ANDA210307	Lupin Pharmaceuticals, Inc.	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-956_b4959711-b750-4051-991d-7eda51bba7c4	68180-956	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180817		ANDA	ANDA210208	Lupin Pharmaceuticals, Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-962_838a8c52-e2aa-4b5c-8c97-47fed7f31dca	68180-962	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20180612		ANDA	ANDA208964	Lupin Pharmaceuticals, Inc.	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68180-963_382c4f16-1c97-487e-9937-996183f94f4a	68180-963	HUMAN PRESCRIPTION DRUG	Albuterol sulfate		Albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200825		ANDA	ANDA209954	Lupin Pharmaceuticals, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68180-964_f20b1a24-28fb-4a43-8a77-4c91e871f3ef	68180-964	HUMAN PRESCRIPTION DRUG	Tiotropium Bromide		Tiotropium Bromide	CAPSULE	ORAL; RESPIRATORY (INHALATION)	20230816		ANDA	ANDA211287	Lupin Pharmaceuticals, Inc.	TIOTROPIUM BROMIDE MONOHYDRATE	18	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68180-965_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-965	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-966_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-966	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190502		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-967_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-967	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-968_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-968	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-969_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-969	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-970_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-970	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-971_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-971	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-972_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-972	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-973_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-973	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-974_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-974	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-975_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-975	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.2	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-976_3ff4b5b2-76ce-46fa-9db8-13eb29ce1d27	68180-976	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20190320		ANDA	ANDA209713	Lupin Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.3	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68180-979_fe3a0b50-c6f5-4fdc-8bd9-60016deb4525	68180-979	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210601		ANDA	ANDA077321	Lupin Pharmaceuticals, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-980_fe3a0b50-c6f5-4fdc-8bd9-60016deb4525	68180-980	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	Lupin Pharmaceuticals, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-981_fe3a0b50-c6f5-4fdc-8bd9-60016deb4525	68180-981	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	Lupin Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-982_fe3a0b50-c6f5-4fdc-8bd9-60016deb4525	68180-982	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170417		ANDA	ANDA077321	Lupin Pharmaceuticals, Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68180-984_a48c45fc-d25c-4e9f-a161-57950d1fb92c	68180-984	HUMAN PRESCRIPTION DRUG	budesonide inhalation		budesonide inhalation	SUSPENSION	RESPIRATORY (INHALATION)	20190521		ANDA	ANDA210897	Lupin Pharmaceuticals, Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68180-987_0098094d-a0c0-4b55-9851-68aaf0109233	68180-987	HUMAN PRESCRIPTION DRUG	DROXIDOPA		DROXIDOPA	CAPSULE	ORAL	20210924		ANDA	ANDA211652	Lupin Pharmaceuticals, Inc.	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
68180-988_0098094d-a0c0-4b55-9851-68aaf0109233	68180-988	HUMAN PRESCRIPTION DRUG	DROXIDOPA		DROXIDOPA	CAPSULE	ORAL	20210924		ANDA	ANDA211652	Lupin Pharmaceuticals, Inc.	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
68180-989_0098094d-a0c0-4b55-9851-68aaf0109233	68180-989	HUMAN PRESCRIPTION DRUG	DROXIDOPA		DROXIDOPA	CAPSULE	ORAL	20210924		ANDA	ANDA211652	Lupin Pharmaceuticals, Inc.	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
68180-997_1049c10a-5271-4168-bef1-bf9ff35658bb	68180-997	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET	ORAL	20190409		ANDA	ANDA211632	Lupin Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-998_71041a6b-43e4-415c-a1a6-dbd55a09a0d6	68180-998	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET	ORAL	20190807		ANDA	ANDA211653	Lupin Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68180-999_71041a6b-43e4-415c-a1a6-dbd55a09a0d6	68180-999	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	TABLET	ORAL	20190807		ANDA	ANDA211653	Lupin Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68196-005_2ad62695-900d-4c63-8e35-8e5ae2906efd	68196-005	HUMAN OTC DRUG	members mark ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20150518		ANDA	ANDA072096	Sam's West Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-012_471eeb91-eeb2-4622-84cb-6ea1e1fbfada	68196-012	HUMAN OTC DRUG	Members Mark Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20170406		ANDA	ANDA206394	Sam's West Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-029_407045b6-66c8-4d99-9961-1587cfbc3747	68196-029	HUMAN OTC DRUG	members mark nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20050930		ANDA	ANDA076775	Sam's West Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-032_9418d9cc-1571-4a72-bc15-b36d98f27b31	68196-032	HUMAN OTC DRUG	members mark hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20210519		ANDA	ANDA075598	Sam's West Inc	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68196-045_ff5c8c63-493b-a17d-e053-6294a90ae14d	68196-045	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190819		ANDA	ANDA202194	Sam's West Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68196-082_380b806d-3995-432f-97ab-2b912d06346b	68196-082	HUMAN OTC DRUG	members mark nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150729		ANDA	ANDA077007	Sam's West Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-084_797e8772-f1d8-4f87-b6a8-b5dd799fb6d9	68196-084	HUMAN OTC DRUG	members mark nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200805		ANDA	ANDA203690	Sam's West Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-102_351aad60-18d7-4c75-bb72-5e05538da592	68196-102	HUMAN OTC DRUG	SIMPLY RIGHT	childrens cetirizine	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Sam's West Inc	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68196-103_6817e949-59d0-46a6-8698-06d18818ed77	68196-103	HUMAN OTC DRUG	Ultra Strength	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190515		OTC MONOGRAPH DRUG	M001	SAM'S WEST INC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68196-107_573483c1-14c7-7ff1-a6ee-2d01a988333a	68196-107	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20170509		ANDA	ANDA076502	Sam's West Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68196-119_9ec3c4e0-69ba-4962-aea6-89dd7f596e73	68196-119	HUMAN OTC DRUG	SAMS WEST		Psyllium Husk	CAPSULE	ORAL	20190521		OTC MONOGRAPH DRUG	M007	SAM'S WEST INC	PSYLLIUM HUSK	.52	g/1			N	20241231
68196-121_de23a229-72f0-4c61-b84b-33520ffc023a	68196-121	HUMAN OTC DRUG	members mark acid pep		Famotidine	TABLET, FILM COATED	ORAL	20200504		ANDA	ANDA077351	Sam's West Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68196-170_054b7095-8d84-4da9-8602-61b7b0ba17fd	68196-170	HUMAN OTC DRUG	members mark nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20051005		ANDA	ANDA076789	Sam's West Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-204_b22ca9ba-71ee-41a5-8395-85eeea13f4a4	68196-204	HUMAN OTC DRUG	Pseudoephedrine hydrochloride		Pseudoephedrine hydrochloride	TABLET, FILM COATED	ORAL	20120207		ANDA	ANDA077442	SAM'S WEST INC	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68196-208_11bef410-0a4c-a975-904b-43439f12bd88	68196-208	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20191118	20240329	ANDA	ANDA208150	Sam's West Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
68196-210_972c0d0d-5415-4d1c-1d03-9c1bfb9eb707	68196-210	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20210127		ANDA	ANDA208150	Sam's West Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68196-255_e9b90efe-f0fa-bb3f-0aa4-2e3ad5118758	68196-255	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, COATED	ORAL	19980729		ANDA	ANDA075168	SAM'S WEST INC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-268_2a5f185d-c36e-4a1f-84b7-fb85faf9ad6f	68196-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20141130		OTC MONOGRAPH NOT FINAL	part356	Sam's West, Inc	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
68196-269_04c3aab3-93bd-41b8-be3f-7c278c37bcd8	68196-269	HUMAN OTC DRUG	members mark nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190821		ANDA	ANDA206394	Sam's West Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-277_fe991987-0d53-41db-bfb4-d1390eefc0e2	68196-277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20141130		OTC MONOGRAPH NOT FINAL	part333A	Sam's West, Inc	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
68196-291_5a76d962-daf0-4516-b1b6-8b794d0d1cda	68196-291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Sam's West Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-301_b4b4cfd3-368e-4b21-a188-6ff1d70ee2d6	68196-301	HUMAN OTC DRUG	Members Mark Aller-itin		Loratadine	TABLET	ORAL	20200713		ANDA	ANDA076301	Sam's West Inc	LORATADINE	10	mg/1			N	20241231
68196-303_8ece4520-ea8a-4372-86c6-964dfcef18b2	68196-303	HUMAN OTC DRUG	Members Mark Omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180510		NDA	NDA209400	Sam's West Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68196-306_f5343aab-fd50-4516-83a1-d4f2ea9b6eb8	68196-306	HUMAN OTC DRUG	Members Mark clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091008		ANDA	ANDA090685	Sam's West Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68196-309_4e3dba0a-180c-40ae-84e2-df66d05acc82	68196-309	HUMAN OTC DRUG	members mark nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170405		ANDA	ANDA206393	Sam's West Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-310_0bdef7a9-9220-8119-e063-6394a90aa386	68196-310	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20210113		OTC MONOGRAPH DRUG	M013	SAM'S WEST INC	ACETAMINOPHEN	500	mg/1			N	20241231
68196-365_fceafb96-e070-4c3a-9f41-f3f749b2a030	68196-365	HUMAN OTC DRUG	members mark nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200630		ANDA	ANDA091349	Sam's West Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-368_a9d57247-5fca-4414-b7a9-4de832187c2a	68196-368	HUMAN OTC DRUG	members mark naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20070529		ANDA	ANDA074661	Sam's West Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-370_cb5c39c6-6207-4013-ba61-cfe83a804034	68196-370	HUMAN OTC DRUG	Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20170817		OTC MONOGRAPH NOT FINAL	part333A	Sam's West Inc.	ALCOHOL	700	mg/mL			N	20241231
68196-395_1b41f11a-4cb9-4edd-b86f-5a1cf4f5bcd2	68196-395	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20190228		OTC MONOGRAPH NOT FINAL	part334	Sam's West, Inc	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68196-404_e21bf988-bd36-4367-a8c0-a9e0ed063083	68196-404	HUMAN OTC DRUG	Members Mark Alcohol Prep Pads, Sterile		Isopropyl Alcohol	SWAB	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	Sam's Club West Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
68196-405_0c56dc36-69d1-5cdc-e063-6294a90a84a3	68196-405	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20231006		ANDA	ANDA213420	SAM'S WEST INC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
68196-406_183c1a08-71dd-6915-1425-7ad1935c098d	68196-406	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20200624		ANDA	ANDA210375	SAM'S WEST INC	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68196-442_f77ddf63-2e32-4695-b031-35bee2d82ef7	68196-442	HUMAN OTC DRUG	members mark nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20200630		ANDA	ANDA091354	Sam's West Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-469_92035e10-e7af-4599-b34a-27ae35c9cf91	68196-469	HUMAN OTC DRUG	members mark hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20170622		ANDA	ANDA091344	Sam's West Inc	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68196-484_9f9a0ad9-96fb-406c-a42b-a2a6ec88cae8	68196-484	HUMAN OTC DRUG	Members Mark Acetaminophen		Acetaminophen	TABLET	ORAL	20100208		OTC MONOGRAPH NOT FINAL	part343	Sam's West Inc	ACETAMINOPHEN	500	mg/1			N	20241231
68196-500_08a53046-0fbe-ddf3-e063-6394a90a3cd7	68196-500	HUMAN OTC DRUG	Members Mark		isopropyl alcohol	SWAB	TOPICAL	20200101		OTC MONOGRAPH DRUG	M003	Sams West Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
68196-502_4cb0687e-30df-4bd9-84dc-b09d25fe4ac1	68196-502	HUMAN OTC DRUG	members mark aller zyr		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20200326		ANDA	ANDA078336	Sam's West Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68196-544_18ba5bb0-9698-4792-badc-3239855dbea5	68196-544	HUMAN OTC DRUG	members mark arthritis pain		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20050831		ANDA	ANDA075077	Sam's West Inc	ACETAMINOPHEN	650	mg/1			N	20241231
68196-556_af821796-e406-43db-a660-af951ea9148e	68196-556	HUMAN OTC DRUG	acetaminophen pm	extra strength	acetaminophen, diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	Sam's West Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68196-578_f90c59a1-279d-4e9a-aa32-a1137851c685	68196-578	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180930	20250930	OTC MONOGRAPH NOT FINAL	part334	Sam's West, Inc	DOCUSATE SODIUM	100	mg/1			N	
68196-664_984654ee-e969-48b9-8325-2f40ef3a51f7	68196-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19980315		OTC MONOGRAPH NOT FINAL	part356	SAM'S WEST INC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68196-734_322c98be-8adb-4506-beb3-ef72f724f58a	68196-734	HUMAN OTC DRUG	members mark Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150721		ANDA	ANDA203690	Sam's West Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-745_ba6bc443-ef55-4d7b-9226-e1556b754c88	68196-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180831		ANDA	ANDA206568	Sam's West, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-787_ec5bd205-eb1a-8d5b-e053-2a95a90ac478	68196-787	HUMAN OTC DRUG	Members Mark Value Size SPORT SUNSCREEN BROAD SPECTRUM SPF 50		Avobenzone Homosalate Octisalate Octocrylene Oxybenzone	SPRAY	TOPICAL	20190208		OTC MONOGRAPH NOT FINAL	part352	Sam's West Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
68196-811_9b1653ea-d928-4552-8ae3-617c9d0c7e04	68196-811	HUMAN OTC DRUG	members mark nicotine		nicotine polacrilex	LOZENGE	ORAL	20200715		ANDA	ANDA203690	Sam's West Inc	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-823_8175efe7-f27c-49f9-b251-d37ff6dc8a8c	68196-823	HUMAN OTC DRUG	members mark hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20180703		ANDA	ANDA075598	Sam's West Inc	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68196-829_b02cbf4d-99ef-46a2-9baf-c189f4d30d5d	68196-829	HUMAN OTC DRUG	Aller-Ben		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20200218		OTC MONOGRAPH DRUG	M012	Sam's West Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68196-835_6b6e5611-7b60-4621-85bf-858807d8b709	68196-835	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20190331	20241227	OTC MONOGRAPH FINAL	part338	Sam's West, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
68196-853_6f564798-a10d-4107-a2a3-83efbc1a063d	68196-853	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210528		OTC MONOGRAPH NOT FINAL	part334	Sam's West, Inc	DOCUSATE SODIUM	100	mg/1			N	20241231
68196-870_47503ae4-acd1-4c85-b7a0-0880bc0f02ab	68196-870	HUMAN OTC DRUG	members mark arthritis pain reliever		diclofenac sodium	GEL	TOPICAL	20230302		ANDA	ANDA211253	Sam's West Inc	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-873_87cf27c3-0deb-4671-a424-fbfecb1cca25	68196-873	HUMAN OTC DRUG	Members Mark Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20070907		ANDA	ANDA077007	Sam's West Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-898_f136b3a1-bfc6-4c7e-924e-eff09e06df7d	68196-898	HUMAN OTC DRUG	members mark esomeprazole magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191206		ANDA	ANDA207193	Sam's West Inc	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68196-901_5b9af1bd-59f6-410b-8b69-4c35ffccaddc	68196-901	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Sam's West Inc	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68196-915_e8de4708-5e58-48d0-8ee8-289097cc6f74	68196-915	HUMAN OTC DRUG	members mark omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080225		NDA	NDA022032	Sam's West Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68196-916_4f87a407-a03e-49ba-8e5e-c634dd9b3ee5	68196-916	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCL	CAPSULE	ORAL	20200401	20250401	OTC MONOGRAPH FINAL	part338	Sam's West, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
68196-919_55a567c1-640e-45fb-93f5-fefd2a2e59ae	68196-919	HUMAN OTC DRUG	acetaminophen	extra strength	acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	Sam's West Inc	ACETAMINOPHEN	500	mg/1			N	20241231
68196-935_0c56bfe9-ea36-a29a-e063-6394a90ae956	68196-935	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20221228		ANDA	ANDA211544	SAM'S WEST INC	ACETAMINOPHEN	650	mg/1			N	20251231
68196-951_f00c2141-4bc5-4733-a9ca-50a5b7ca73a2	68196-951	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140908		OTC MONOGRAPH NOT FINAL	part333A	Sam's West Inc	ALCOHOL	578	mg/mL			N	20241231
68196-957_72578cdc-b15f-40b6-9f12-a2c1eeb3fde2	68196-957	HUMAN OTC DRUG	members mark mini nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150721		ANDA	ANDA203690	Sam's West Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-971_203d1afb-3910-4c9d-9d7c-b78325074efc	68196-971	HUMAN OTC DRUG	Members Mark Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20190816		ANDA	ANDA206393	Sam's West Inc	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68196-973_36b45e33-771c-4d88-a3c0-7746d5f9f71e	68196-973	HUMAN OTC DRUG	members mark hydrocortisone		hydrocortisone	CREAM	TOPICAL	20190530		OTC MONOGRAPH NOT FINAL	part348	Sam's West Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68196-980_912e20c5-a582-4dc7-8145-add220729b11	68196-980	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20171113		ANDA	ANDA206568	Sam's West, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-981_e4667347-d34f-4bf3-9429-bdd094012601	68196-981	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180416		ANDA	ANDA206568	Sam's West, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68196-985_a8d2a7e2-d0b6-465d-8fe0-369740fab30a	68196-985	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET, COATED	ORAL	20110105		ANDA	ANDA078192	Sam's West Inc	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68196-995_eac8782d-f58e-481d-9409-619a2b439795	68196-995	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE	ORAL	20180208		OTC MONOGRAPH NOT FINAL	part334	Sam's West Inc	DOCUSATE SODIUM	100	mg/1			N	20241231
68196-996_1cb900ed-18b4-4999-a149-0b4667abcda1	68196-996	HUMAN OTC DRUG	Guaifenesin	Extended Release	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220112		ANDA	ANDA209254	SAM'S WEST INC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68196-998_9acb3481-79dc-4d06-8d87-446873f296ae	68196-998	HUMAN OTC DRUG	Stool Softener	Regular Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20220715		OTC MONOGRAPH NOT FINAL	part334	Sam's West, Inc	DOCUSATE SODIUM	100	mg/1			N	20241231
68210-0022_0c05fe40-a794-5c2f-e063-6294a90a52ca	68210-0022	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20170519		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	325	mg/1			N	20241231
68210-0023_0c05fe40-a795-5c2f-e063-6294a90a52ca	68210-0023	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20180410		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	325	mg/1			N	20241231
68210-0025_0bef6553-51aa-fba4-e063-6394a90aeb75	68210-0025	HUMAN OTC DRUG	VALUMEDS ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20180417		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-0026_0bf2d31c-2704-0b42-e063-6394a90a7d8a	68210-0026	HUMAN OTC DRUG	Cabinet Pain Reliever and Fever Reducer		Ibuprofen	TABLET, FILM COATED	ORAL	20191030		ANDA	ANDA079174	Spirit Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-0031_0c042273-a201-c585-e063-6294a90a87ff	68210-0031	HUMAN OTC DRUG	VALUMEDS NATURAL LAXATIVE		SENNOSIDES	TABLET, FILM COATED	ORAL	20200310		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	SENNOSIDES	8.6	mg/1			N	20241231
68210-0081_9aa3804d-71f0-03d5-e053-2a95a90a7111	68210-0081	HUMAN OTC DRUG	Assured Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20171215		ANDA	ANDA079174	Spirit Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-0099_0befcd6a-990e-210f-e063-6394a90a3dfc	68210-0099	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF PM		ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20180410		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceutical LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-0106_0bf1fc02-10a4-522b-e063-6294a90a15f1	68210-0106	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20180410		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-0107_0c055eef-1458-67a0-e063-6394a90aa2e7	68210-0107	HUMAN OTC DRUG	EXTRA STRENGHT HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20200310		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceutical LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68210-0116_f28eadfc-4cce-52f4-e053-2a95a90a928e	68210-0116	HUMAN OTC DRUG	MUCUS RELIEF		GUAIFENESIN	TABLET	ORAL	20180315		OTC MONOGRAPH FINAL	part341	SPIRIT PHARMACEUTICALS LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68210-0119_0befdbae-25f7-261d-e063-6394a90aacd4	68210-0119	HUMAN OTC DRUG	CABINET Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20191025		ANDA	ANDA209274	Spirit Pharmaceutical LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-0120_0c05d68c-0fdb-50d9-e063-6294a90a1b4c	68210-0120	HUMAN OTC DRUG	REGULAR STRENGTH PAIN RELIEF		ACETAMINOPHEN	CAPSULE, GELATIN COATED	ORAL	20180410		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	325	mg/1			N	20241231
68210-0122_0befdbae-25f5-261d-e063-6394a90aacd4	68210-0122	HUMAN OTC DRUG	FEXOFENADINE HYDROCHLORIDE		FEXOFENADINE HYDROCHLORIDE	TABLET	ORAL	20190321		ANDA	ANDA210137	Spirit Pharmaceuticals LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-0130_0c05e75e-4816-22e3-e063-6294a90a2a1e	68210-0130	HUMAN OTC DRUG	VALUMEDS EXTRA STRENGTH PAIN RELIEF		ACETAMINOPHEN	TABLET	ORAL	20170515		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-0150_0c05b1cc-f9eb-1af0-e063-6294a90aea2b	68210-0150	HUMAN OTC DRUG	VALUMEDS ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20170515		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-0190_0bf1fc02-10a5-522b-e063-6294a90a15f1	68210-0190	HUMAN OTC DRUG	TENSION HEADACHE RELIEF		ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20180410		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-0200_0c053d9f-ebf1-61fc-e063-6394a90a2718	68210-0200	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20180410		ANDA	ANDA079205	SPIRIT PHARMACEUTICALS,LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-0203_0bf0c21c-acc4-3164-e063-6294a90abe45	68210-0203	HUMAN OTC DRUG	VALUMEDS NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20180410		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-0302_0c0560be-fb16-509d-e063-6394a90ab6f7	68210-0302	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM AND SENNOSIDES	TABLET	ORAL	20170519		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
68210-0305_0c057139-0e22-f234-e063-6294a90ab03f	68210-0305	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170518		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
68210-0310_0bef4471-e36a-83e6-e063-6294a90a6a5d	68210-0310	HUMAN OTC DRUG	VALUMEDS NATURAL LAXATIVE		SENNOSIDES	TABLET, FILM COATED	ORAL	20170518		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	SENNOSIDES	8.6	mg/1			N	20241231
68210-0314_0c03ca81-8dad-7a9a-e063-6294a90adf99	68210-0314	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, GELATIN COATED	ORAL	20200310		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-0350_0c05770e-40d3-fb46-e063-6294a90a64ab	68210-0350	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200310		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
68210-0403_0c6ae634-4d33-246c-e063-6394a90af1ac	68210-0403	HUMAN OTC DRUG	Valumeds Maximum Strength Stay Awake		Caffeine 200 mg Tablets	TABLET	ORAL	20190806		OTC MONOGRAPH DRUG	M011	Spirit Pharmaceuticals LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-0469_0c037956-1605-1dc4-e063-6294a90aa53a	68210-0469	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20190628		OTC MONOGRAPH DRUG	M008	Spirit Pharmaceuticals LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68210-0611_0bb2d6f0-e6d3-f229-e063-6394a90ada14	68210-0611	HUMAN OTC DRUG	MUCUS RELIEF		GUAIFENESIN	TABLET	ORAL	20200211		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68210-0800_0c05e920-ff9e-7bd4-e063-6294a90aad3e	68210-0800	HUMAN OTC DRUG	VALUMEDS IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20170519		ANDA	ANDA091239	SPIRIT PHARMACEUTICALS LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-1040_0c054670-1e47-d10b-e063-6294a90a7014	68210-1040	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180418		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-1050_0c04eac9-e486-7dc6-e063-6294a90a818d	68210-1050	HUMAN OTC DRUG	MULTI-SYMPTOM NITETIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20180416		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-1190_0befd4fd-6808-1928-e063-6394a90a129b	68210-1190	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20200612		ANDA	ANDA077829	Spirit Pharmaceutical LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-1200_0bef34dc-5127-ccef-e063-6294a90a3d6f	68210-1200	HUMAN OTC DRUG	VALUMEDS ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180416		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-1280_0bf3276b-9fee-25b0-e063-6394a90ac688	68210-1280	HUMAN OTC DRUG	Cabinet Allergy Relief		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20191016		OTC MONOGRAPH DRUG	M017	Spirit Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-1300_0bf1fc02-10a6-522b-e063-6294a90a15f1	68210-1300	HUMAN OTC DRUG	VALUMEDS EXTRA STRENGTH PAIN RELIEF		ACETAMINOPHEN	TABLET	ORAL	20180410		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-1700_0c05574c-f9a1-5d92-e063-6394a90a9d00	68210-1700	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEVER		ACETAMINOPHEN, ASPIRIN, AND CAFFEINE	TABLET	ORAL	20180410		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68210-1930_0c050cbf-7108-4d2d-e063-6394a90abc65	68210-1930	HUMAN OTC DRUG	MUCUS RELIEF DM		GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20200312		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-2002_0c05f0ee-205a-9e91-e063-6394a90a00e5	68210-2002	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20200310		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	325	mg/1			N	20241231
68210-2010_0bef702c-78b2-0b40-e063-6394a90a0cb4	68210-2010	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180416		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-2020_0bef6815-624b-033a-e063-6294a90a398a	68210-2020	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180416		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-2210_0befd4f8-b613-2139-e063-6394a90a7d54	68210-2210	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET, FILM COATED	ORAL	20200317		ANDA	ANDA204507	SPIRIT PHARMACEUTICALS LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-2500_0c05a4f3-1bbf-f41c-e063-6294a90ac64b	68210-2500	HUMAN OTC DRUG	VALUMEDS ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20200310		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-3002_0bef55f1-2de6-c348-e063-6294a90a7128	68210-3002	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM AND SENNOSIDES	TABLET	ORAL	20180417		OTC MONOGRAPH DRUG	M007	SPIRIT PHARMACEUTICALS LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
68210-3130_0bf21b7e-fb6a-ce8e-e063-6394a90a555e	68210-3130	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200316		OTC MONOGRAPH DRUG	M002	SPIRIT PHARMACEUTICALS LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4010_0c053d9f-ebee-61fc-e063-6394a90a2718	68210-4010	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20180418		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4083_0c023eb3-c0f1-0c95-e063-6294a90ab934	68210-4083	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4084_0c0239c7-91a3-0fef-e063-6294a90aa2b8	68210-4084	HUMAN OTC DRUG	COLD and FLU	DAYTIME MAXIMUM STRENGTH NON-DROWSY SEVERE	ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4085_0c020d8c-dfc3-5e75-e063-6394a90a48b7	68210-4085	HUMAN OTC DRUG	MUCUS RELIEF DM		GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4086_0c023614-7628-f7eb-e063-6294a90a4a48	68210-4086	HUMAN OTC DRUG	MULTI-SYMPTOM NITETIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4087_0c01ef09-a31c-5d64-e063-6394a90a0edc	68210-4087	HUMAN OTC DRUG	SEVERE NIGHTTIME COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20200702		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4089_0bf31114-1aa7-2361-e063-6394a90a4750	68210-4089	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4090_0bf31911-9c23-24fc-e063-6394a90a6386	68210-4090	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET, FILM COATED	ORAL	20200702		ANDA	ANDA204507	SPIRIT PHARMACEUTICALS LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4091_0bf2d31c-2709-0b42-e063-6394a90a7d8a	68210-4091	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M002	SPIRIT PHARMACEUTICALS LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4092_0e9c8e78-4ba1-4ade-e063-6394a90a8fff	68210-4092	HUMAN OTC DRUG	Stomach Relief		Bismuth Subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M008	Spirit Pharmaceuticals LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20251231
68210-4093_0bf2c2b7-cc0d-0ab9-e063-6394a90a2d4b	68210-4093	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20200702		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-4094_0bf2d427-0ecd-ff82-e063-6394a90a0fd3	68210-4094	HUMAN OTC DRUG	EXTRA STRENGHT HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20200702		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceutical LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68210-4095_0bf2c2b7-cc0a-0ab9-e063-6394a90a2d4b	68210-4095	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF PM		ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20200702		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4096_0bf2dd18-a81b-f8b0-e063-6394a90a575d	68210-4096	HUMAN OTC DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200702		ANDA	ANDA091353	SPIRIT PHARMACEUTICALS,LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4097_0bf2dd18-a81a-f8b0-e063-6394a90a575d	68210-4097	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20200702		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-4098_0bf2c2a9-bbda-0825-e063-6394a90a79ef	68210-4098	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20200702		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-4099_0bf2d007-20f2-feca-e063-6294a90a3ae7	68210-4099	HUMAN OTC DRUG	MAXIMUM STRENGTH SLEEP AID		DIPHENHYDRAMINE HCl	CAPSULE, GELATIN COATED	ORAL	20200702		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4101_0bf2679d-0179-dd94-e063-6394a90afed3	68210-4101	HUMAN OTC DRUG	VALUMEDS NATURAL LAXATIVE		SENNOSIDES	TABLET, FILM COATED	ORAL	20200702		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	SENNOSIDES	8.6	mg/1			N	20241231
68210-4102_0bf26a01-4551-9d8b-e063-6294a90a9602	68210-4102	HUMAN OTC DRUG	MUCUS RELIEF		GUAIFENESIN	TABLET	ORAL	20200702		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68210-4103_0c078cc2-5c75-2306-e063-6394a90a4519	68210-4103	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM AND SENNOSIDES	TABLET	ORAL	20200702		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
68210-4104_0bf203ee-fd9b-552b-e063-6294a90a9000	68210-4104	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200702		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
68210-4105_0bf02249-f336-3752-e063-6394a90a171e	68210-4105	HUMAN OTC DRUG	Magnesium Oxide 400mg		Magnesium Oxide 400mg	TABLET	ORAL	20200702		OTC MONOGRAPH DRUG	M001	Spirit Pharmaceuticals LLC	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68210-4106_0bf272db-b1ba-dfec-e063-6394a90a3a1b	68210-4106	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET	ORAL	20200706		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68210-4107_0c0330c2-4821-fcdf-e063-6294a90ad750	68210-4107	HUMAN OTC DRUG	MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM		Dextromethorphan Hydrobromide and Guaifenesin	CAPSULE, GELATIN COATED	ORAL	20200730		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4108_0bf03b7b-629c-cc72-e063-6294a90aeb79	68210-4108	HUMAN OTC DRUG	TENSION HEADACHE RELIEF		ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20200805		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-4109_0bf2680a-32cb-b0d9-e063-6294a90a3333	68210-4109	HUMAN OTC DRUG	Nasal Decongestant		Phenylephrine HCl	TABLET	ORAL	20200911		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4110_0c03e40f-f857-f472-e063-6394a90a0948	68210-4110	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20200911		ANDA	ANDA210722	Spirit Pharmaceuticals LLC	LORATADINE	10	mg/1			N	20241231
68210-4112_0bf02388-01c1-3778-e063-6394a90ab793	68210-4112	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA077829	Spirit Pharmaceutical LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4125_0c031bc3-42c4-dd6b-e063-6294a90ae2c8	68210-4125	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20210406		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN	325	mg/1			N	20241231
68210-4127_0bf203ee-fd9a-552b-e063-6294a90a9000	68210-4127	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20210427		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4128_0bf2780d-ed3c-9ec5-e063-6294a90a0327	68210-4128	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20210427		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-4129_0bf2a07a-9fce-9cbc-e063-6394a90a58bd	68210-4129	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210427		OTC MONOGRAPH DRUG	M002	SPIRIT PHARMACEUTICALS LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4130_0bf276e8-ab20-e443-e063-6394a90aa19e	68210-4130	HUMAN OTC DRUG	MUCUS RELIEF		GUAIFENESIN	TABLET	ORAL	20210427		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68210-4131_0bf31114-1aa2-2361-e063-6394a90a4750	68210-4131	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210427		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4132_0bf2f33a-af9b-30a8-e063-6294a90a9349	68210-4132	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20210428		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4133_0bf290f6-9eed-9970-e063-6294a90abb7d	68210-4133	HUMAN OTC DRUG	DEXTROMETHORPHAN Hydrobromide		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20210428		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4134_0bf2a221-6574-c75b-e063-6294a90abb1f	68210-4134	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210428		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4135_0bf27dfd-0d52-de8f-e063-6394a90a0178	68210-4135	HUMAN OTC DRUG	Assured Headache PM (Aspirin Free)		Acetaminophen and Diphenhydramine Citrate	TABLET, COATED	ORAL	20210428		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceutical LLC	ACETAMINOPHEN; DIPHENHYDRAMINE CITRATE	500; 38	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4136_0bf265c1-183d-971c-e063-6294a90aa93c	68210-4136	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20210428		ANDA	ANDA077829	Spirit Pharmaceutical LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4137_0bf290f6-9eec-9970-e063-6294a90abb7d	68210-4137	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20200323		ANDA	ANDA207612	Spirit Pharmaceuticals LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4138_0bf2a221-6576-c75b-e063-6294a90abb1f	68210-4138	HUMAN OTC DRUG	EXTRA STRENGHT HEADACHE RELIEF		ACETAMINOPHEN, ASPIRIN, CAFFEINE	TABLET	ORAL	20210428		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceutical LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68210-4139_0bf272db-b1bc-dfec-e063-6394a90a3a1b	68210-4139	HUMAN OTC DRUG	Assured Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20190225		ANDA	ANDA202312	Spirit Pharmaceuticals LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4140_0bf2c2a9-bbd7-0825-e063-6394a90a79ef	68210-4140	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20210428		ANDA	ANDA079174	Spirit Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4142_0bf2d427-0ec9-ff82-e063-6394a90a0fd3	68210-4142	HUMAN OTC DRUG	Nasal Decongestant		Phenylephrine HCl	TABLET	ORAL	20210428		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4143_0bf2d427-0ece-ff82-e063-6394a90a0fd3	68210-4143	HUMAN OTC DRUG	MULTI-SYMPTOM NITETIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20210428		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4144_0bf31baa-e05f-1378-e063-6294a90a37f7	68210-4144	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELEIF		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20210428		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-4145_0bf321f6-af55-2482-e063-6394a90aa1cc	68210-4145	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF PM		ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20210428		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4146_0c01ef09-a31b-5d64-e063-6394a90a0edc	68210-4146	HUMAN OTC DRUG	TENSION HEADACHE RELIEF		ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20210428		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-4147_0c020efe-316a-e904-e063-6294a90ad157	68210-4147	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210428		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4148_0c022a8b-a5df-04c7-e063-6294a90a1446	68210-4148	HUMAN OTC DRUG	FEXOFENADINE HCl		FEXOFENADINE HCl	TABLET, FILM COATED	ORAL	20210428		ANDA	ANDA210137	Spirit Pharmaceuticals LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4149_0c020d8c-dfc2-5e75-e063-6394a90a48b7	68210-4149	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210428		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4151_0c028125-966b-580f-e063-6294a90ab9ad	68210-4151	HUMAN OTC DRUG	Stay Awake		Caffeine 200 mg Tablets	TABLET	ORAL	20210429		OTC MONOGRAPH DRUG	M011	Spirit Pharmaceuticals LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-4152_0c02babe-3af8-acbd-e063-6394a90a2007	68210-4152	HUMAN OTC DRUG	Bismuth Subsalicylate		Bismuth Subsalicylate	CAPSULE, GELATIN COATED	ORAL	20210429		OTC MONOGRAPH DRUG	M008	Spirit Pharmaceuticals LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68210-4153_0c02caa3-b649-8bbe-e063-6394a90a6499	68210-4153	HUMAN OTC DRUG	MUCUS RELIEF DM		GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20210429		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4154_0c02caa3-b64b-8bbe-e063-6394a90a6499	68210-4154	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, GELATIN COATED	ORAL	20210429		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4157_0c031bc3-42ca-dd6b-e063-6294a90ae2c8	68210-4157	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210520		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4158_0c03269a-340a-ca37-e063-6294a90a8c06	68210-4158	HUMAN OTC DRUG	MUCUS RELIEF		GUAIFENESIN	TABLET	ORAL	20200310		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68210-4159_0c0330c2-4818-fcdf-e063-6294a90ad750	68210-4159	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20210428		ANDA	ANDA077829	Spirit Pharmaceutical LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4160_0c03089e-e92f-d0b2-e063-6294a90ab34f	68210-4160	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210614		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4164_0c02fa25-1eb2-b8da-e063-6394a90af29d	68210-4164	HUMAN OTC DRUG	Non-Drowsy Daytime Severe Sinus Congestion and Pain		Acetaminophen, Guaifenesin and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210623		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4165_0bf2144c-eef9-ba0f-e063-6394a90a65d9	68210-4165	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, GELATIN COATED	ORAL	20210623		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4166_0c02da0c-d1b3-a118-e063-6294a90adbd8	68210-4166	HUMAN OTC DRUG	Non-Drowsy Daytime Severe Cold Multi-Symptom		Acetaminophen, Phenylephrine HCl, Dextromethorphan HBr and Guaifenesin	TABLET, FILM COATED	ORAL	20210629		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4167_0c0756fc-65fb-e814-e063-6294a90a32bf	68210-4167	HUMAN OTC DRUG	Daytime Severe Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20211119		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4168_0bf022a6-8a11-36f9-e063-6394a90a0c29	68210-4168	HUMAN OTC DRUG	Pain Reliever and Fever Reducer		Acetaminophen	TABLET, FILM COATED	ORAL	20211122		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-4169_0bf0000f-5c92-8731-e063-6294a90a52df	68210-4169	HUMAN OTC DRUG	Allergy Relief		Diphenhydraime HCl	TABLET, FILM COATED	ORAL	20211116		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4170_0befda4d-7104-1da8-e063-6394a90a1600	68210-4170	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20211122		OTC MONOGRAPH DRUG	M008	Spirit Pharmaceuticals LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68210-4171_0befeb8e-e40d-0b7f-e063-6394a90aaa17	68210-4171	HUMAN OTC DRUG	Antacid		Magnesium Oxide	TABLET	ORAL	20211116		OTC MONOGRAPH DRUG	M001	Spirit Pharmaceuticals LLC	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68210-4172_0befe1f8-169f-2256-e063-6394a90a6680	68210-4172	HUMAN OTC DRUG	Nasal Decongestant		Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20211122		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4173_0befda4d-7103-1da8-e063-6394a90a1600	68210-4173	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20211119		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68210-4176_0bdfb32e-3ef7-af4d-e063-6394a90a03ab	68210-4176	HUMAN OTC DRUG	Stool Softener Regular Strength		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20211122		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
68210-4177_0bdf9f38-5766-a4d0-e063-6394a90a41dc	68210-4177	HUMAN OTC DRUG	Pain Reliever		Aspirin	TABLET, COATED	ORAL	20211122		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-4178_0bdfa38b-0b6a-1720-e063-6294a90a85b5	68210-4178	HUMAN OTC DRUG	Pain Reliever		Aspirin	TABLET, COATED	ORAL	20211123		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-4179_0bdf6fb3-0645-9ed1-e063-6394a90a3143	68210-4179	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20211121		OTC MONOGRAPH DRUG	M010	Spirit Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4181_0bdf7c4c-ecad-a69e-e063-6394a90a1139	68210-4181	HUMAN OTC DRUG	Cough Relief		Dextromethorphan Hydrobromide	CAPSULE, LIQUID FILLED	ORAL	20211117		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4182_0bdf6bbd-fd6f-9660-e063-6294a90a2f2c	68210-4182	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20211119		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4183_0bdf5586-3eec-97ef-e063-6394a90a163d	68210-4183	HUMAN OTC DRUG	Extra Strength Headache Relief		Acetaminophen, Aspirin, and Caffeine	TABLET, COATED	ORAL	20211119		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
68210-4184_0bdf41c7-aa04-949b-e063-6394a90a064b	68210-4184	HUMAN OTC DRUG	Tension Headache Relief		Acetaminophen and Caffeine	TABLET, FILM COATED	ORAL	20211122		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-4185_0bdf41c7-aa03-949b-e063-6394a90a064b	68210-4185	HUMAN OTC DRUG	Pain Reliever and Sleep Aid		Acetaminophen, and Diphenhydramine hydrochloride	TABLET, FILM COATED	ORAL	20211122		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4190_0c02e9b6-ff79-c0c7-e063-6294a90adbe3	68210-4190	HUMAN OTC DRUG	Allergy plus Sinus Headache		Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	TABLET, COATED	ORAL	20211111		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4192_0c033cee-58bb-cce7-e063-6394a90a2d32	68210-4192	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211208		ANDA	ANDA079174	Spirit Pharmaceuticals LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4194_0c034fd6-25db-0f2d-e063-6294a90a6398	68210-4194	HUMAN OTC DRUG	Maximum Strength Severe Congestion Relief		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20211228		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4195_0c035fd4-cfb0-c132-e063-6394a90afeee	68210-4195	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20211228		OTC MONOGRAPH DRUG	M010	Spirit Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4196_0c045fe8-f6b8-1f65-e063-6394a90ad727	68210-4196	HUMAN OTC DRUG	Maximum Strength Nasal Decongestant		Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20211228		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4199_0bf2780d-ed3e-9ec5-e063-6294a90a0327	68210-4199	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220615		ANDA	ANDA079129	Spirit Pharmaceuticals LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4200_0bf2c2a9-bbd9-0825-e063-6394a90a79ef	68210-4200	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20220615		ANDA	ANDA091355	Spirit Pharmaceuticals LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4201_0c034dc5-a76b-cff1-e063-6394a90a32e1	68210-4201	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220706		ANDA	ANDA079129	Spirit Pharmaceuticals LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4204_0c046516-3ae7-25e6-e063-6394a90a2ea9	68210-4204	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELEIF		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20210428		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-4205_0bf2d427-0ec8-ff82-e063-6394a90a0fd3	68210-4205	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20220721		ANDA	ANDA204469	SPIRIT PHARMACEUTICALS,LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-4208_0c7f71c9-6a6f-00e3-e063-6294a90a726e	68210-4208	HUMAN OTC DRUG	Maximum Strength Daytime Non Drowsy Severe Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220819		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4209_0c7f6971-1953-ad84-e063-6394a90ac8e8	68210-4209	HUMAN OTC DRUG	Maximum Strength Cold, Flu and Sore Throat		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220819		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4211_0c04acfa-89ba-55d7-e063-6294a90a97f5	68210-4211	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20220822		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-4214_0c027c1e-a976-53b1-e063-6294a90a82d9	68210-4214	HUMAN OTC DRUG	Cold and Flu Non Drowsy Daytime and Nighttime		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20221019		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC						N	20241231
68210-4217_0c034dc5-a76c-cff1-e063-6394a90a32e1	68210-4217	HUMAN OTC DRUG	Cold and Flu Non Drowsy Daytime and Nighttime		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20221019		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC						N	20241231
68210-4218_0bdf3bc9-3714-9494-e063-6394a90a573f	68210-4218	HUMAN OTC DRUG	Allergy Relief		Diphenhydraime HCl	TABLET, FILM COATED	ORAL	20221114		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4219_0bdf3c65-1a82-92d4-e063-6394a90a46b9	68210-4219	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20221114		ANDA	ANDA209274	Spirit Pharmaceutical LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4222_0bdef7a9-921e-8119-e063-6394a90aa386	68210-4222	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20221114		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4223_0bded316-3e85-7173-e063-6394a90ac7b8	68210-4223	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20221115		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4224_0bdec856-e79a-32a5-e063-6294a90a4430	68210-4224	HUMAN OTC DRUG	Nasal Decongestant		Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20221115		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4226_0bdea30a-39e1-6611-e063-6394a90aa4cf	68210-4226	HUMAN OTC DRUG	Pain Reliever and Sleep Aid		Acetaminophen, and Diphenhydramine hydrochloride	TABLET, FILM COATED	ORAL	20221115		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4228_0bdea30a-39d4-6611-e063-6394a90aa4cf	68210-4228	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20221115		OTC MONOGRAPH DRUG	M008	Spirit Pharmaceuticals LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68210-4229_0bde3e63-1c4d-3d9c-e063-6394a90ac09c	68210-4229	HUMAN OTC DRUG	Allergy Relief		Diphenhydraime HCl	TABLET, FILM COATED	ORAL	20221116		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4230_0bde5cd4-6043-3d42-e063-6394a90ac001	68210-4230	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20221116		ANDA	ANDA209274	Spirit Pharmaceutical LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4231_0bde2d80-055e-36db-e063-6394a90aee4a	68210-4231	HUMAN OTC DRUG	Daytime Severe Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20221116		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4232_0bde2d80-055d-36db-e063-6394a90aee4a	68210-4232	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20221117		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4233_0bde0cd1-45db-2b4c-e063-6394a90a51f2	68210-4233	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20221117		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-4234_0bddd6d1-34dc-2327-e063-6394a90a7ae4	68210-4234	HUMAN OTC DRUG	Nasal Decongestant		Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20221117		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-4235_0bddd6d1-34db-2327-e063-6394a90a7ae4	68210-4235	HUMAN OTC DRUG	Pain Reliever and Fever Reducer		Acetaminophen	TABLET, FILM COATED	ORAL	20221115		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-4236_0bdda4a2-7587-3225-e063-6294a90a0087	68210-4236	HUMAN OTC DRUG	Pain Reliever and Sleep Aid		Acetaminophen, and Diphenhydramine hydrochloride	TABLET, FILM COATED	ORAL	20221117		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4237_0bddbb71-fa3f-0eac-e063-6394a90a851d	68210-4237	HUMAN OTC DRUG	SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20221117		OTC MONOGRAPH DRUG	M010	SPIRIT PHARMACEUTICALS LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-4238_0bdd74f8-161c-0524-e063-6394a90a92e5	68210-4238	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	CAPSULE, LIQUID FILLED	ORAL	20221117		OTC MONOGRAPH DRUG	M008	Spirit Pharmaceuticals LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68210-4239_0bde8c09-5f6e-5c07-e063-6394a90ab48c	68210-4239	HUMAN OTC DRUG	TENSION HEADACHE RELIEF		ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20221229		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-4240_0bde5cd4-6047-3d42-e063-6394a90ac001	68210-4240	HUMAN OTC DRUG	Cough Relief		DEXTROMETHORPHAN HBr	CAPSULE, LIQUID FILLED	ORAL	20221230		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-4241_0bdd5cf0-abdf-fa85-e063-6394a90a4b83	68210-4241	HUMAN OTC DRUG	TENSION HEADACHE RELIEF		ACETAMINOPHEN AND CAFFEINE	TABLET	ORAL	20221229		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68210-4242_0bdd4770-5c0f-f6bb-e063-6394a90a617e	68210-4242	HUMAN OTC DRUG	Cough Relief		DEXTROMETHORPHAN HBr	CAPSULE, LIQUID FILLED	ORAL	20230103		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-5000_0c023eb3-c0f0-0c95-e063-6294a90ab934	68210-5000	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20221207		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-5001_0bf2a07a-9fcd-9cbc-e063-6394a90a58bd	68210-5001	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20221207		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-5002_0bf2ddb2-5d63-1839-e063-6294a90ad075	68210-5002	HUMAN OTC DRUG	MULTI-SYMPTOM NITETIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20221207		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-5003_0c054ae6-f13d-655d-e063-6394a90a72e7	68210-5003	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20230217		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-5005_0c04ef09-1090-4c9f-e063-6394a90a3bbf	68210-5005	HUMAN OTC DRUG	MULTI-SYMPTOM NITETIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20221212		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-5008_0c03089e-e92a-d0b2-e063-6294a90ab34f	68210-5008	HUMAN OTC DRUG	Daytime Non Drows Cold and Flu and Nighttime Cold and		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20221019		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC						N	20241231
68210-5011_0c046878-f130-29b5-e063-6394a90a2828	68210-5011	HUMAN OTC DRUG	Maximum Strength Nasal Decongestant		Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20230210		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-5012_0c04ef09-109c-4c9f-e063-6394a90a3bbf	68210-5012	HUMAN OTC DRUG	MULTI-SYMPTOM NITETIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20230217		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-5015_0c033cee-58b8-cce7-e063-6394a90a2d32	68210-5015	HUMAN OTC DRUG	Daytime Non Drows Cold and Flu and Nighttime Cold and		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20230526		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC						N	20241231
68210-5016_0bf31911-9c26-24fc-e063-6394a90a6386	68210-5016	HUMAN OTC DRUG	Regular Strength Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20230705		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN	325	mg/1			N	20241231
68210-5017_0c04f045-f4f8-3909-e063-6394a90a86b6	68210-5017	HUMAN OTC DRUG	Vegetable Laxative		SENNOSIDES	TABLET	ORAL	20231129		OTC MONOGRAPH DRUG	M007	Spirit Pharmaceuticals LLC	SENNOSIDES	8.6	mg/1			N	20241231
68210-5018_0c04f115-6b0a-417f-e063-6394a90ac489	68210-5018	HUMAN OTC DRUG	Bismuth Subsalicylate		Bismuth Subsalicylate	CAPSULE, GELATIN COATED	ORAL	20230719		OTC MONOGRAPH DRUG	M008	Spirit Pharmaceuticals LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68210-5019_0bf31911-9c24-24fc-e063-6394a90a6386	68210-5019	HUMAN OTC DRUG	Regular Strength Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20230407		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ACETAMINOPHEN	325	mg/1			N	20241231
68210-5026_0c6bf284-3fb7-b013-e063-6394a90a74cf	68210-5026	HUMAN OTC DRUG	Gas Relief		Simethicone 125 mg	CAPSULE, LIQUID FILLED	ORAL	20231213		OTC MONOGRAPH DRUG	M002	Spirit Pharmaceuticals LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68210-5027_0c7edd77-fd8d-8ea8-e063-6294a90a66aa	68210-5027	HUMAN OTC DRUG	Calcium carbonate		Calcium carbonate	TABLET, CHEWABLE	ORAL	20231214		OTC MONOGRAPH DRUG	M	Spirit Pharmaceutical LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68210-5029_0c7c4492-ef51-0614-e063-6294a90a78ba	68210-5029	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20231214		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceuticals LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-5030_0cf6fbb7-d2c2-88fe-e063-6294a90a89b2	68210-5030	HUMAN OTC DRUG	Daytime Non Drowsy Cold and Flu and Nighttime Cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20231220		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC						N	20241231
68210-5033_0c7cd738-6774-c3f5-e063-6394a90aee5c	68210-5033	HUMAN OTC DRUG	Calcium Carbonate 500mg		Calcium Carbonate 500mg	TABLET, CHEWABLE	ORAL	20231214		OTC MONOGRAPH DRUG	M001	Spirit Pharmaceuticals LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68210-5100_0c05a5a7-f606-8e46-e063-6394a90abb5d	68210-5100	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20200310		OTC MONOGRAPH DRUG	M013	SPIRIT PHARMACEUTICALS LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68210-6010_0bf2c2a9-bbd8-0825-e063-6394a90a79ef	68210-6010	HUMAN OTC DRUG	Cabinet Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20191028		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceuticals LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68210-6110_0bf0cfa0-f0bf-3ef5-e063-6294a90a7948	68210-6110	HUMAN OTC DRUG	MUCUS RELIEF		GUAIFENESIN	TABLET	ORAL	20200310		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68210-6111_0c0560be-fb14-509d-e063-6394a90ab6f7	68210-6111	HUMAN OTC DRUG	MULTI-SYMPTOM DAYTIME		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20200406		OTC MONOGRAPH DRUG	M012	SPIRIT PHARMACEUTICALS LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68210-6112_0c057139-0e28-f234-e063-6294a90ab03f	68210-6112	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200406		OTC MONOGRAPH DRUG	M012	Spirit Pharmaceutical LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68210-6113_0c057139-0e27-f234-e063-6294a90ab03f	68210-6113	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20200406		OTC MONOGRAPH DRUG	M013	Spirit Pharmaceutical LLC	ACETAMINOPHEN	500	mg/1			N	20241231
68210-6114_0c058b1e-6c19-6bc6-e063-6394a90a3d24	68210-6114	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200406		ANDA	ANDA079174	Spirit Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68210-8100_0c04f918-69e3-944b-e063-6294a90ac478	68210-8100	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200310		ANDA	ANDA079174	Spirit Pharmaceutical LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68229-100_0a36e014-0858-7715-e063-6394a90a9142	68229-100	HUMAN OTC DRUG	Skin Tag Relief		Thuja Occidentalis Leafy Twig	OIL	TOPICAL	20130521		UNAPPROVED HOMEOPATHIC		Quest Products, Inc.	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/10mL			N	20241231
68229-102_fa2f4f27-a806-045c-e053-6294a90aa449	68229-102	HUMAN OTC DRUG	Clinere Ear Wax Remover		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20220304		OTC MONOGRAPH FINAL	part344	Quest Products	CARBAMIDE PEROXIDE	.065	g/mL			N	20241231
68229-201_0a36dd61-f41e-689a-e063-6294a90afbf2	68229-201	HUMAN OTC DRUG	Alocane Emergency Burn		Lidocaine Hydrochloride	GEL	TOPICAL	20190301		OTC MONOGRAPH DRUG	M017	Quest Products, LLC.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-300_0a36aba0-d57e-46ba-e063-6294a90a238f	68229-300	HUMAN OTC DRUG	Alocane Plus		Lidocaine Hydrochloride and Benzalkonium Chloride	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	M017	Quest Products LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-300_0e75f143-c791-4323-e063-6294a90a9cdb	68229-300	HUMAN OTC DRUG	Alocane Plus		Lidocaine Hydrochloride and Benzalkonium Chloride	GEL	TOPICAL	20131211		OTC MONOGRAPH DRUG	M017	Quest Products, Inc.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
68229-403_0a36c585-782d-7493-e063-6394a90aecbb	68229-403	HUMAN OTC DRUG	Alocane Emergency Burn Pads		LIDOCAINE HYDROCHLORIDE	SWAB	TOPICAL	20170213		OTC MONOGRAPH DRUG	M017	Quest Products, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-404_0a36ea8d-bd18-8b31-e063-6394a90a852f	68229-404	HUMAN OTC DRUG	Alocane Plus		Lidocaine Hydrochloride and Benzalkonium Chloride	GEL	TOPICAL	20211203		OTC MONOGRAPH DRUG	M017	Quest Products, Inc.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-405_02a8e5c7-56f5-eb0d-e063-6294a90a80cd	68229-405	HUMAN OTC DRUG	Alocane Botanicals		Lidocaine Hydrochloride	SPRAY	TOPICAL	20230811		OTC MONOGRAPH NOT FINAL	part348	Quest Products, LLC.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-406_0a342930-143a-3e10-e063-6394a90aeb8e	68229-406	HUMAN OTC DRUG	Alocane Max		Lidocaine Hydrochloride and Benzalkonium Chloride	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	M017	Quest Products LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-407_0a35ac19-6884-a733-e063-6294a90ad22d	68229-407	HUMAN OTC DRUG	Alocane Max		Lidocaine Hydrochloride and Benzalkonium Chloride	LIQUID	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	Quest Products LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-408_0a35221a-2fcc-2735-e063-6294a90a88ca	68229-408	HUMAN OTC DRUG	Alocane Max		Lidocaine Hydrochloride and Benzalkonium Chloride	SPRAY	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	Quest Products LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 4	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-502_f1eb69f4-cbdc-df82-e053-2a95a90a5ab2	68229-502	HUMAN OTC DRUG	CopperFixx		Copper and Arnica Montana	OINTMENT	TOPICAL	20160101		UNAPPROVED HOMEOPATHIC		Quest Products, Inc.	ARNICA MONTANA; COPPER	4; 11	[hp_X]/57g; [hp_X]/57g	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
68229-600_0a36e97f-6aba-7afa-e063-6394a90a1f02	68229-600	HUMAN OTC DRUG	SunBurnt PLUS		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20200701		OTC MONOGRAPH DRUG	M017	Quest Products, LLC.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68229-700_070dae82-14c3-66d2-e063-6394a90ab259	68229-700	HUMAN OTC DRUG	CankerMelts		benzocaine	LOZENGE	ORAL	20231006		OTC MONOGRAPH DRUG	M022	Quest Products, LLC	BENZOCAINE	15	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68254-5000_9e24d603-61b9-4022-ac52-c9690afb5e26	68254-5000	HUMAN PRESCRIPTION DRUG	MYCOPHENOLATE MOFETIL		mycophenolate mofetil	CAPSULE	ORAL	20191001		ANDA	ANDA210181	CONCORD BIOTECH LIMITED	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
68254-5001_4473c34f-12d4-4ad1-b344-7d3141bbd743	68254-5001	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20191213		ANDA	ANDA211173	CONCORD BIOTECH LIMITED	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
68254-5002_4473c34f-12d4-4ad1-b344-7d3141bbd743	68254-5002	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20191213		ANDA	ANDA211173	CONCORD BIOTECH LIMITED	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
68254-5003_9e24d603-61b9-4022-ac52-c9690afb5e26	68254-5003	HUMAN PRESCRIPTION DRUG	MYCOPHENOLATE MOFETIL		MYCOPHENOLATE MOFETIL	TABLET	ORAL	20201221		ANDA	ANDA212087	CONCORD BIOTECH LIMITED	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
68254-5004_76ffdfc1-7f00-49da-9578-5352593b4830	68254-5004	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201123		ANDA	ANDA213112	CONCORD BIOTECH LIMITED	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68254-5005_76ffdfc1-7f00-49da-9578-5352593b4830	68254-5005	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201123		ANDA	ANDA213112	CONCORD BIOTECH LIMITED	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68254-5006_76ffdfc1-7f00-49da-9578-5352593b4830	68254-5006	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201123		ANDA	ANDA213112	CONCORD BIOTECH LIMITED	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68306-106_0b2854ca-a078-02f0-e063-6294a90a41a7	68306-106	HUMAN OTC DRUG	Avant Original - Fragrance Free		Alcohol	GEL	TOPICAL	20100515		OTC MONOGRAPH DRUG	505G(a)(3)	B4 Ventures LLC	ALCOHOL	60	mL/100mL			N	20241231
68306-109_0ab00ee0-4d1d-8f03-e063-6294a90a351b	68306-109	HUMAN OTC DRUG	Avant Foaming Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20101208		OTC MONOGRAPH DRUG	505G(a)(3)	B4 Ventures LLC	ALCOHOL	62	mL/100mL			N	20241231
68306-112_0b391ae2-97f1-aeed-e063-6294a90a0d16	68306-112	HUMAN OTC DRUG	Avant Alcohol-Free Instant Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20120101		OTC MONOGRAPH DRUG	505G(a)(3)	B4 Ventures LLC	BENZALKONIUM CHLORIDE	1	g/1000mL			N	20241231
68306-115_0b28a4a1-45ec-3afa-e063-6294a90a4322	68306-115	HUMAN OTC DRUG	Aterra7 Antibacterial Foaming Hand		Benzalkonium Chloride	SOAP	TOPICAL	20180926		OTC MONOGRAPH DRUG	505G(a)(3)	B4 Ventures LLC	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
68306-116_0a9bb5e2-3bbe-c534-e063-6394a90ac288	68306-116	HUMAN OTC DRUG	Avant 70% Alcohol Gel		Alcohol	GEL	TOPICAL	20230112		OTC MONOGRAPH DRUG	505G(a)(3)	B4 Ventures LLC	ALCOHOL	70	mL/100mL			N	20241231
68308-020_ffbe4241-8070-ab91-e053-6294a90ac780	68308-020	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20140612		ANDA	ANDA204092	Mayne Pharma Commercial LLC	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68308-115_ffc2cd39-e42b-5821-e053-6394a90a9974	68308-115	HUMAN PRESCRIPTION DRUG	Methamphetamine Hydrochloride		METHAMPHETAMINE HYDROCHLORIDE	TABLET	ORAL	20100426		ANDA	ANDA091189	Mayne Pharma Commercial LLC	METHAMPHETAMINE HYDROCHLORIDE	5	mg/1	Amphetamine Anorectic [EPC], Amphetamines [CS], Appetite Suppression [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE]	CII	N	20241231
68308-145_ffc31b8b-7c5a-98da-e053-6394a90ae96f	68308-145	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	CAPSULE	ORAL	20120731		ANDA	ANDA203107	Mayne Pharma Commercial LLC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68308-152_9bd397a3-24b8-4420-9adb-9917a8d6b233	68308-152	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	POWDER	TOPICAL	20040715		ANDA	ANDA065203	Mayne Pharma Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68308-219_0e8524af-e875-ecb7-e063-6394a90aa259	68308-219	HUMAN PRESCRIPTION DRUG	Esgic		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20140501		ANDA	ANDA089007	Mayne Pharma Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20251231
68308-220_0e852152-43e9-e20e-e063-6394a90ac07d	68308-220	HUMAN PRESCRIPTION DRUG	Esgic		butalbital, acetaminophen and caffeine	TABLET	ORAL	20140501	20250331	ANDA	ANDA089175	Mayne Pharma Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	
68308-250_e3b51258-b7cf-4198-b841-72ee6704e8a5	68308-250	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130729		NDA AUTHORIZED GENERIC	NDA050536	Mayne Pharma Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
68308-342_44ea31a4-e871-4362-a2fa-1fe60b2d06b2	68308-342	HUMAN PRESCRIPTION DRUG	Dapsone		Dapsone	GEL	TOPICAL	20220211		ANDA	ANDA214722	Mayne Pharma Commercial LLC	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
68308-475_151b3ec5-d0f2-446d-9db9-c9e5238fb5ae	68308-475	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone Hydrochloride and Acetaminophen	TABLET	ORAL	20081216		ANDA	ANDA090177	Mayne Pharma Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68308-480_151b3ec5-d0f2-446d-9db9-c9e5238fb5ae	68308-480	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone Hydrochloride and Acetaminophen	TABLET	ORAL	20081216		ANDA	ANDA090177	Mayne Pharma Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
68308-570_66d6a601-cb08-4662-a043-537a6f8d935b	68308-570	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210921		ANDA	ANDA212333	Mayne Pharma	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-571_66d6a601-cb08-4662-a043-537a6f8d935b	68308-571	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210921		ANDA	ANDA212333	Mayne Pharma	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-573_66d6a601-cb08-4662-a043-537a6f8d935b	68308-573	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210921		ANDA	ANDA212333	Mayne Pharma	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-575_52056651-f1ce-4586-9c28-f919591060a4	68308-575	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20210903		ANDA	ANDA213571	Mayne Pharma	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-662_9d93fe57-cd04-40ff-abe4-a18c27768f9c	68308-662	HUMAN PRESCRIPTION DRUG	adapalene and benzoyl peroxide		adapalene and benzoyl peroxide	GEL	TOPICAL	20220201		NDA AUTHORIZED GENERIC	NDA207917	Mayne Pharma Inc.	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-663_b7cc14b3-8c2a-4201-b42e-fbf50af55f29	68308-663	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	GEL	TOPICAL	20231110		NDA AUTHORIZED GENERIC	NDA021789	Mayne Pharma Inc.	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68308-664_677660bb-7f93-465a-b924-4e477acb4362	68308-664	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	SHAMPOO	TOPICAL	20231103		NDA AUTHORIZED GENERIC	NDA021644	Mayne Pharma Inc.	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68308-665_1a9de7b9-1855-4fef-8095-2590498f49f8	68308-665	HUMAN PRESCRIPTION DRUG	Calcitrol		calcitriol	OINTMENT	TOPICAL	20230721		NDA AUTHORIZED GENERIC	NDA022087	Mayne Pharma Commercial LLC.	CALCITRIOL	3	ug/g	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
68308-668_20777e01-9ea8-40df-adc1-12426990f9c3	68308-668	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20230227		NDA AUTHORIZED GENERIC	NDA050805	Mayne Pharma Inc.	DOXYCYCLINE	40	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68308-685_451596c3-6559-45f8-aab7-9c682b85e8c8	68308-685	HUMAN PRESCRIPTION DRUG	tazarotene		tazarotene	AEROSOL, FOAM	TOPICAL	20210423		NDA AUTHORIZED GENERIC	NDA202428	Mayne Pharma Inc.	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-701_180415ea-bcf7-49ef-92f4-41d58324d752	68308-701	HUMAN PRESCRIPTION DRUG	IVERMECTIN		IVERMECTIN	CREAM	TOPICAL	20240108		NDA AUTHORIZED GENERIC	NDA206255	Mayne Pharma Inc.	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
68308-703_17fe82b9-3290-4be0-a337-0988b69b1265	68308-703	HUMAN PRESCRIPTION DRUG	Tacrolimus		tacrolimus	OINTMENT	TOPICAL	20140909		ANDA	ANDA200744	Mayne Pharma Inc.	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68308-715_2dfd52bf-9160-40a3-bc83-231da76391db	68308-715	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20130708	20240731	NDA AUTHORIZED GENERIC	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
68308-716_2dfd52bf-9160-40a3-bc83-231da76391db	68308-716	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20160201		NDA AUTHORIZED GENERIC	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	200	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68308-745_0b49ce09-9124-6516-e063-6394a90a8b78	68308-745	HUMAN PRESCRIPTION DRUG	Tazarotene		TAZAROTENE	CREAM	TOPICAL	20211110		ANDA	ANDA208662	Mayne Pharma	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-750_05cdbb95-8c57-4385-81eb-b36426776e64	68308-750	HUMAN PRESCRIPTION DRUG	Bijuva		estradiol and progesterone	CAPSULE	ORAL	20231218		NDA	NDA210132	Mayne Pharma	ESTRADIOL; PROGESTERONE	1; 100	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone [CS], Progesterone [EPC]		N	20241231
68308-751_05cdbb95-8c57-4385-81eb-b36426776e64	68308-751	HUMAN PRESCRIPTION DRUG	Bijuva		estradiol and progesterone	CAPSULE	ORAL	20231201		NDA	NDA210132	Mayne Pharma	ESTRADIOL; PROGESTERONE	.5; 100	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone [CS], Progesterone [EPC]		N	20241231
68308-769_c27ece10-4835-453a-a873-6db8d2f29d63	68308-769	HUMAN PRESCRIPTION DRUG	Halobetasol propionate		Halobetasol propionate	AEROSOL, FOAM	TOPICAL	20231127		ANDA	ANDA215266	Mayne Pharma	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68308-775_2dfd52bf-9160-40a3-bc83-231da76391db	68308-775	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20130708	20240731	NDA AUTHORIZED GENERIC	NDA050795	Mayne Pharma Commercial LLC	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
68308-781_ff060e85-efb7-4b9f-a624-2a63effa65fe	68308-781	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20120501		ANDA	ANDA076485	Mayne Pharma	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-782_ff060e85-efb7-4b9f-a624-2a63effa65fe	68308-782	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20120501		ANDA	ANDA076485	Mayne Pharma	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-783_ff060e85-efb7-4b9f-a624-2a63effa65fe	68308-783	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20120501		ANDA	ANDA076485	Mayne Pharma	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68308-784_ff060e85-efb7-4b9f-a624-2a63effa65fe	68308-784	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20120501		ANDA	ANDA076485	Mayne Pharma	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68317-001_f5b51d91-905e-f2c9-e053-2a95a90a7407	68317-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110831		UNAPPROVED MEDICAL GAS		Ray's Pharmacy, Inc. dba Hi Plains Oxygen	OXYGEN	99	L/100L			N	20241231
68327-073_6f90fc3d-7ba9-89be-e053-2991aa0a0533	68327-073	HUMAN OTC DRUG	Cover FX Mattifying Primer Plus Acne Treatment		Salicylic Acid	GEL	TOPICAL	20181129		OTC MONOGRAPH FINAL	part333D	Cover FX Skin Care Inc	SALICYLIC ACID	1	g/100mL			N	20241231
68343-123_d61a6354-8195-da19-e053-2995a90a7e22	68343-123	HUMAN OTC DRUG	Dermisa Acne Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20130228		OTC MONOGRAPH FINAL	part333D	Montani Cosmetics Inc	BENZOYL PEROXIDE	5	g/100g			N	20241231
68352-001_f346bee7-dce1-3f6f-e053-2a95a90a7b18	68352-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130411		UNAPPROVED MEDICAL GAS		Oxy Respiratory & Home Medical Equipment Specialists, Inc. dba Oxy Respiratory & HME Specialists, Inc.	OXYGEN	99	L/100L			N	20241231
68354-131_069728be-5884-9de6-e063-6394a90afc4b	68354-131	HUMAN OTC DRUG	ARTREX		Camphor, Menthol, and Turpentine	CREAM	TOPICAL	20040401		OTC MONOGRAPH NOT FINAL	part348	Bioved Pharmaceuticals	CAMPHOR (NATURAL); MENTHOL; TURPENTINE	3; 1.8; 6	g/60g; g/60g; g/60g			N	20241231
68356-103_08132dd1-5d57-d380-e063-6394a90a4aeb	68356-103	HUMAN OTC DRUG	ISOPROPYL ALCOHOL PREP PAD		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20150110		OTC MONOGRAPH DRUG	505G(a)(3)	LernaPharm Loris Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
68356-117_08471877-6552-4d69-e063-6294a90a411c	68356-117	HUMAN OTC DRUG	ISOPROPYL ALCOHOL		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20100104		OTC MONOGRAPH DRUG	505G(a)(3)	LernaPharm Loris Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
68356-119_0846ed3a-679e-003b-e063-6294a90ad4ed	68356-119	HUMAN OTC DRUG	Loris Povidone-Iodine	Solution	Povidone-Iodine	LIQUID	TOPICAL	20130413		OTC MONOGRAPH DRUG	505G(a)(3)	LernaPharm Loris Inc.	POVIDONE-IODINE	1	g/100mL			N	20241231
68356-126_f4bf1f9b-4838-70b2-e053-2995a90a7854	68356-126	HUMAN OTC DRUG	Loris BZK	Antiseptic Wipes	Benzalkonium Chloride	SWAB	TOPICAL	20121121		OTC MONOGRAPH DRUG	M003	LernaPharm Loris Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
68382-001_3dbda37c-9453-474f-a247-fceb50497ae8	68382-001	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Pharmaceuticals USA Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68382-003_b29ef0a3-f5cc-4527-8e32-b38274d8d486	68382-003	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20070711		ANDA	ANDA077621	Zydus Pharmaceuticals USA Inc.	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68382-004_183548de-1a46-463b-82ed-791f3331a4a4	68382-004	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	CAPSULE, COATED PELLETS	ORAL	20091014		ANDA	ANDA078877	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	15	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-005_183548de-1a46-463b-82ed-791f3331a4a4	68382-005	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	CAPSULE, COATED PELLETS	ORAL	20091014		ANDA	ANDA078877	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-006_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-006	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-007_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-007	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-008_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-008	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-009_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-009	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-010_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-010	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-011_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-011	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-012_29a5000d-5ff1-4482-ad9d-3d36570b1e67	68382-012	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20080919		ANDA	ANDA078620	Zydus Pharmaceuticals USA Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-013_29a5000d-5ff1-4482-ad9d-3d36570b1e67	68382-013	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20080919		ANDA	ANDA078620	Zydus Pharmaceuticals USA Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-014_29a5000d-5ff1-4482-ad9d-3d36570b1e67	68382-014	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20080919		ANDA	ANDA078620	Zydus Pharmaceuticals USA Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-018_ea404f6c-7e07-4779-a52c-8cffb92718ef	68382-018	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-019_ea404f6c-7e07-4779-a52c-8cffb92718ef	68382-019	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-020_ea404f6c-7e07-4779-a52c-8cffb92718ef	68382-020	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-021_ea404f6c-7e07-4779-a52c-8cffb92718ef	68382-021	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-022_79761da4-661a-4e54-9ec4-032a420f3120	68382-022	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	Zydus Pharmaceuticals USA Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-023_79761da4-661a-4e54-9ec4-032a420f3120	68382-023	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	Zydus Pharmaceuticals USA Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-024_79761da4-661a-4e54-9ec4-032a420f3120	68382-024	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	Zydus Pharmaceuticals USA Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-031_2ff00ecb-deca-4c29-823b-6e76890b2869	68382-031	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20100306		ANDA	ANDA077100	Zydus Pharmaceuticals (USA) Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-032_2ff00ecb-deca-4c29-823b-6e76890b2869	68382-032	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20100306		ANDA	ANDA077100	Zydus Pharmaceuticals (USA) Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-033_2ff00ecb-deca-4c29-823b-6e76890b2869	68382-033	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20100306		ANDA	ANDA077100	Zydus Pharmaceuticals (USA) Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-034_8c02c121-fe14-45f5-b2bc-b09fd377531f	68382-034	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-035_8c02c121-fe14-45f5-b2bc-b09fd377531f	68382-035	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-036_8c02c121-fe14-45f5-b2bc-b09fd377531f	68382-036	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-040_d461a206-0842-428f-ad9b-a4aac8193fe9	68382-040	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Zydus Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68382-041_d461a206-0842-428f-ad9b-a4aac8193fe9	68382-041	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Zydus Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68382-042_d461a206-0842-428f-ad9b-a4aac8193fe9	68382-042	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Zydus Pharmaceuticals USA Inc.	PROMETHAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68382-046_731a7612-d6ab-4a9c-9347-d3e16fcfbefb	68382-046	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Pharmaceuticals USA Inc.	RIBAVIRIN	200	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68382-048_515388e8-636f-42f6-a39e-bb4fc7c2e7cb	68382-048	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, SOLUTION	INTRAVENOUS	20181127		ANDA	ANDA206535	Zydus Pharmaceuticals (USA) Inc.	ACYCLOVIR SODIUM	50	mg/mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68382-049_515388e8-636f-42f6-a39e-bb4fc7c2e7cb	68382-049	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, SOLUTION	INTRAVENOUS	20181127		ANDA	ANDA206535	Zydus Pharmaceuticals (USA) Inc.	ACYCLOVIR SODIUM	50	mg/mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68382-050_908d74ea-85e2-4e46-9f64-ddc2158c3544	68382-050	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Zydus Pharmaceuticals USA Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-051_908d74ea-85e2-4e46-9f64-ddc2158c3544	68382-051	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Zydus Pharmaceuticals USA Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-052_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-052	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-053_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-053	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-054_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-054	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-055_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-055	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-056_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-056	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-057_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-057	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-058_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-058	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-059_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-059	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-064_5bff866a-04d9-4326-83d3-4e9607b2e860	68382-064	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20060619		ANDA	ANDA040663	Zydus Pharmaceuticals USA Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68382-065_e092e3e3-d4b5-4714-b8f9-27c70ba79f2c	68382-065	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Pharmaceuticals USA Inc.	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-066_e092e3e3-d4b5-4714-b8f9-27c70ba79f2c	68382-066	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Pharmaceuticals USA Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-067_e092e3e3-d4b5-4714-b8f9-27c70ba79f2c	68382-067	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Pharmaceuticals USA Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-068_e092e3e3-d4b5-4714-b8f9-27c70ba79f2c	68382-068	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Pharmaceuticals USA Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-069_e092e3e3-d4b5-4714-b8f9-27c70ba79f2c	68382-069	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077837	Zydus Pharmaceuticals USA Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-070_12014495-c66a-407e-aa7b-5c58596230ce	68382-070	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Pharmaceuticals USA Inc.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-071_12014495-c66a-407e-aa7b-5c58596230ce	68382-071	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Pharmaceuticals USA Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-072_12014495-c66a-407e-aa7b-5c58596230ce	68382-072	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Pharmaceuticals USA Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-073_12014495-c66a-407e-aa7b-5c58596230ce	68382-073	HUMAN PRESCRIPTION DRUG	pravastatin sodium		pravastatin sodium	TABLET	ORAL	20100330		ANDA	ANDA077751	Zydus Pharmaceuticals USA Inc.	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-074_ef9bed6a-e82b-403a-b2fc-1bb536f8f896	68382-074	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA078900	Zydus Pharmaceuticals USA Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68382-075_3cbf30c0-30dd-4022-88b6-86a84697379c	68382-075	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, DELAYED RELEASE	ORAL	20190410		ANDA	ANDA203822	Zydus Pharmaceuticals USA Inc.	RISEDRONATE SODIUM ANHYDROUS	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68382-076_f3f5740a-6137-468d-8dfb-fda06361592d	68382-076	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200109		ANDA	ANDA206533	Zydus Pharmaceuticals USA Inc.	ACETAZOLAMIDE SODIUM	500	mg/5mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68382-079_7c91727c-f19f-4d12-bfd8-f610cc1d3782	68382-079	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
68382-080_7c91727c-f19f-4d12-bfd8-f610cc1d3782	68382-080	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
68382-081_7c91727c-f19f-4d12-bfd8-f610cc1d3782	68382-081	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20080103		ANDA	ANDA077580	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
68382-082_23abf603-605b-4df3-ba70-f29173b80393	68382-082	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Pharmaceuticals USA Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-083_23abf603-605b-4df3-ba70-f29173b80393	68382-083	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Pharmaceuticals USA Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-084_23abf603-605b-4df3-ba70-f29173b80393	68382-084	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Pharmaceuticals USA Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-085_23abf603-605b-4df3-ba70-f29173b80393	68382-085	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Pharmaceuticals USA Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-086_23abf603-605b-4df3-ba70-f29173b80393	68382-086	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Pharmaceuticals USA Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-091_52dc3ff3-f01b-4820-ba1e-b043a5b2c49a	68382-091	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070409		ANDA	ANDA040597	Zydus Pharmaceuticals USA Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68382-092_2e368267-8da4-4606-9348-0246a064016c	68382-092	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Pharmaceuticals USA Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68382-093_2e368267-8da4-4606-9348-0246a064016c	68382-093	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Pharmaceuticals USA Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68382-094_2e368267-8da4-4606-9348-0246a064016c	68382-094	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Pharmaceuticals USA Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68382-095_2e368267-8da4-4606-9348-0246a064016c	68382-095	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Zydus Pharmaceuticals USA Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68382-096_8b9ea8e4-c27b-4b81-b8d0-2d5eddcec21a	68382-096	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	Zydus Pharmaceuticals USA Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
68382-097_3dbda37c-9453-474f-a247-fceb50497ae8	68382-097	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Pharmaceuticals USA Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68382-098_3dbda37c-9453-474f-a247-fceb50497ae8	68382-098	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Pharmaceuticals USA Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68382-099_3dbda37c-9453-474f-a247-fceb50497ae8	68382-099	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Zydus Pharmaceuticals USA Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68382-101_ea404f6c-7e07-4779-a52c-8cffb92718ef	68382-101	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-105_281d1f1b-df9d-4c11-86c3-df47e59fe8b0	68382-105	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20230103		ANDA	ANDA204020	Zydus Pharmaceuticals USA Inc.	DESVENLAFAXINE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-106_ffa6763e-f2cd-447c-b174-684e10c57488	68382-106	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	CAPSULE, COATED PELLETS	ORAL	20090127		ANDA	ANDA078919	Zydus Pharmaceuticals USA Inc.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-108_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-108	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090123		ANDA	ANDA078009	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-109_6ab4eff7-1c04-465f-a752-63149bca1d36	68382-109	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090123		ANDA	ANDA078009	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-110_b9165827-6509-4d3c-813a-547929b720da	68382-110	HUMAN PRESCRIPTION DRUG	Bromocriptine mesylate		Bromocriptine mesylate	CAPSULE	ORAL	20090123		ANDA	ANDA078899	Zydus Pharmaceuticals USA Inc.	BROMOCRIPTINE MESYLATE	5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
68382-112_fc6e6540-fc7f-4329-b05b-5ec4ffd57000	68382-112	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-113_fc6e6540-fc7f-4329-b05b-5ec4ffd57000	68382-113	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-114_fc6e6540-fc7f-4329-b05b-5ec4ffd57000	68382-114	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-115_fc6e6540-fc7f-4329-b05b-5ec4ffd57000	68382-115	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-116_fc6e6540-fc7f-4329-b05b-5ec4ffd57000	68382-116	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-117_fc6e6540-fc7f-4329-b05b-5ec4ffd57000	68382-117	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20081113		ANDA	ANDA078040	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-118_0a7bf937-cf39-4abe-9c1c-6c01480af687	68382-118	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20171202		ANDA	ANDA077621	Zydus Pharmaceuticals USA Inc.	AZATHIOPRINE	25	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68382-119_0a7bf937-cf39-4abe-9c1c-6c01480af687	68382-119	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20171202		ANDA	ANDA077621	Zydus Pharmaceuticals USA Inc.	AZATHIOPRINE	75	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68382-120_0a7bf937-cf39-4abe-9c1c-6c01480af687	68382-120	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20171202		ANDA	ANDA077621	Zydus Pharmaceuticals USA Inc.	AZATHIOPRINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68382-121_36812bc2-e5a7-4241-95d0-1e015ddbaf29	68382-121	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070921		ANDA	ANDA078226	Zydus Pharmaceuticals USA Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-122_36812bc2-e5a7-4241-95d0-1e015ddbaf29	68382-122	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070921		ANDA	ANDA078226	Zydus Pharmaceuticals USA Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-123_36812bc2-e5a7-4241-95d0-1e015ddbaf29	68382-123	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20070921		ANDA	ANDA078226	Zydus Pharmaceuticals USA Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-124_e8989b43-f766-4563-92e4-5bd26365ef17	68382-124	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		dexmedetomidine hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180614		ANDA	ANDA206798	Zydus Pharmaceuticals USA Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
68382-125_0ff593fa-7941-4ca2-a780-120a96b7217a	68382-125	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170817		ANDA	ANDA206606	Zydus Pharmaceuticals USA Inc.	ACYCLOVIR SODIUM	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68382-126_0ff593fa-7941-4ca2-a780-120a96b7217a	68382-126	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170817		ANDA	ANDA206606	Zydus Pharmaceuticals USA Inc.	ACYCLOVIR SODIUM	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68382-127_731a7612-d6ab-4a9c-9347-d3e16fcfbefb	68382-127	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Pharmaceuticals USA Inc.	RIBAVIRIN	400	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68382-128_731a7612-d6ab-4a9c-9347-d3e16fcfbefb	68382-128	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Pharmaceuticals USA Inc.	RIBAVIRIN	500	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68382-129_731a7612-d6ab-4a9c-9347-d3e16fcfbefb	68382-129	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	TABLET, FILM COATED	ORAL	20051205		ANDA	ANDA077094	Zydus Pharmaceuticals USA Inc.	RIBAVIRIN	600	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68382-132_ee9d9efd-0c79-4993-bfd7-d4c30e20bddd	68382-132	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078225	Zydus Pharmaceuticals USA Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68382-133_7e8dacdf-99f4-4f10-91a1-a817ceed50ca	68382-133	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130107		ANDA	ANDA078239	Zydus Pharmaceuticals USA Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-134_7e8dacdf-99f4-4f10-91a1-a817ceed50ca	68382-134	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130107		ANDA	ANDA078239	Zydus Pharmaceuticals USA Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-135_6cc1d73f-0d63-43bc-a54c-6c2295338016	68382-135	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Zydus Pharmaceuticals USA Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-136_6cc1d73f-0d63-43bc-a54c-6c2295338016	68382-136	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Zydus Pharmaceuticals USA Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-137_6cc1d73f-0d63-43bc-a54c-6c2295338016	68382-137	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078243	Zydus Pharmaceuticals USA Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-138_ec0f1b9c-c4d4-4a11-8e1f-f63661e18eea	68382-138	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-139_ec0f1b9c-c4d4-4a11-8e1f-f63661e18eea	68382-139	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-140_ec0f1b9c-c4d4-4a11-8e1f-f63661e18eea	68382-140	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-141_ec0f1b9c-c4d4-4a11-8e1f-f63661e18eea	68382-141	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-142_6a7df105-427c-4995-92c3-1c3b21149a33	68382-142	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078385	Zydus Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-143_6a7df105-427c-4995-92c3-1c3b21149a33	68382-143	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20101004		ANDA	ANDA078385	Zydus Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-144_f36e6ac7-0cfb-4450-a2f2-84064a9c7d3a	68382-144	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-145_f36e6ac7-0cfb-4450-a2f2-84064a9c7d3a	68382-145	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-146_f36e6ac7-0cfb-4450-a2f2-84064a9c7d3a	68382-146	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-147_f36e6ac7-0cfb-4450-a2f2-84064a9c7d3a	68382-147	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20101120		ANDA	ANDA078832	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-154_039dfd45-2fd7-4938-a2a7-3959fa4e1ee6	68382-154	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100629		ANDA	ANDA078516	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-155_039dfd45-2fd7-4938-a2a7-3959fa4e1ee6	68382-155	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100629		ANDA	ANDA078516	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-156_039dfd45-2fd7-4938-a2a7-3959fa4e1ee6	68382-156	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20100629		ANDA	ANDA078516	Zydus Pharmaceuticals USA Inc.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-161_60266847-3378-4bb7-9b45-1f6917e5b965	68382-161	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Pharmaceuticals USA Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-162_60266847-3378-4bb7-9b45-1f6917e5b965	68382-162	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Pharmaceuticals USA Inc.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-163_60266847-3378-4bb7-9b45-1f6917e5b965	68382-163	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Pharmaceuticals USA Inc.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-164_60266847-3378-4bb7-9b45-1f6917e5b965	68382-164	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20140415		ANDA	ANDA090321	Zydus Pharmaceuticals USA Inc.	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-165_6de7446d-247a-4750-8acc-be270272417c	68382-165	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA078918	Zydus Pharmaceuticals USA Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-168_6de7446d-247a-4750-8acc-be270272417c	68382-168	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA078918	Zydus Pharmaceuticals USA Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-177_ca872164-fc8d-4d1e-aee1-9626e8480cbc	68382-177	HUMAN PRESCRIPTION DRUG	galantamine		galantamine	TABLET, FILM COATED	ORAL	20111010		ANDA	ANDA078898	Zydus Pharmaceuticals USA Inc.	GALANTAMINE HYDROBROMIDE	4	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68382-178_ca872164-fc8d-4d1e-aee1-9626e8480cbc	68382-178	HUMAN PRESCRIPTION DRUG	galantamine		galantamine	TABLET, FILM COATED	ORAL	20111010		ANDA	ANDA078898	Zydus Pharmaceuticals USA Inc.	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68382-179_ca872164-fc8d-4d1e-aee1-9626e8480cbc	68382-179	HUMAN PRESCRIPTION DRUG	galantamine		galantamine	TABLET, FILM COATED	ORAL	20111010		ANDA	ANDA078898	Zydus Pharmaceuticals USA Inc.	GALANTAMINE HYDROBROMIDE	12	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68382-180_3f939480-7edb-406e-896a-c2055d0b09ea	68382-180	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Pharmaceuticals USA Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
68382-181_3f939480-7edb-406e-896a-c2055d0b09ea	68382-181	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Pharmaceuticals USA Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
68382-182_3f939480-7edb-406e-896a-c2055d0b09ea	68382-182	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Pharmaceuticals USA Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
68382-183_3f939480-7edb-406e-896a-c2055d0b09ea	68382-183	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Zydus Pharmaceuticals USA Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
68382-184_6a952de4-8cf7-4c86-87a3-8054c6993288	68382-184	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	Zydus Pharmaceuticals USA Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-185_6a952de4-8cf7-4c86-87a3-8054c6993288	68382-185	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	Zydus Pharmaceuticals USA Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-186_6a952de4-8cf7-4c86-87a3-8054c6993288	68382-186	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20160505		ANDA	ANDA078905	Zydus Pharmaceuticals USA Inc.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-187_8b638b19-214a-4a58-a336-656d690130e3	68382-187	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA040874	Zydus Pharmaceuticals USA Inc.	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
68382-188_8b638b19-214a-4a58-a336-656d690130e3	68382-188	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA040874	Zydus Pharmaceuticals USA Inc.	DIPYRIDAMOLE	50	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
68382-189_8b638b19-214a-4a58-a336-656d690130e3	68382-189	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA040874	Zydus Pharmaceuticals USA Inc.	DIPYRIDAMOLE	75	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
68382-190_da3d5c58-fa7e-45a0-87fe-baa52e23a3fd	68382-190	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Pharmaceuticals USA Inc.	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-191_da3d5c58-fa7e-45a0-87fe-baa52e23a3fd	68382-191	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Pharmaceuticals USA Inc.	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-192_da3d5c58-fa7e-45a0-87fe-baa52e23a3fd	68382-192	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Pharmaceuticals USA Inc.	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-193_da3d5c58-fa7e-45a0-87fe-baa52e23a3fd	68382-193	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Pharmaceuticals USA Inc.	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-194_7750ee73-dc70-452f-87f1-f38216254e35	68382-194	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20180414		ANDA	ANDA203466	Zydus Pharmaceuticals USA Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-195_7750ee73-dc70-452f-87f1-f38216254e35	68382-195	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20180414		ANDA	ANDA203466	Zydus Pharmaceuticals USA Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-196_8906b45d-eaeb-4e7f-9aa2-dffa89109a8a	68382-196	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-197_8906b45d-eaeb-4e7f-9aa2-dffa89109a8a	68382-197	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-198_8906b45d-eaeb-4e7f-9aa2-dffa89109a8a	68382-198	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-199_8906b45d-eaeb-4e7f-9aa2-dffa89109a8a	68382-199	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-200_8906b45d-eaeb-4e7f-9aa2-dffa89109a8a	68382-200	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20100710		ANDA	ANDA078920	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-204_22ce4ea0-1cf7-4364-878a-d9e08f1934fd	68382-204	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	Zydus Pharmaceuticals USA Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-205_22ce4ea0-1cf7-4364-878a-d9e08f1934fd	68382-205	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	Zydus Pharmaceuticals USA Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-209_0e329121-c871-4e5e-9ef7-e37168387c09	68382-209	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, COATED	ORAL	20100627		ANDA	ANDA078921	Zydus Pharmaceuticals USA Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
68382-215_f9e4c151-6cdd-4f22-9798-8b01dd940233	68382-215	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20230405		ANDA	ANDA079017	Zydus Pharmaceuticals USA Inc.	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-216_f9e4c151-6cdd-4f22-9798-8b01dd940233	68382-216	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170612		ANDA	ANDA079017	Zydus Pharmaceuticals USA Inc.	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-217_f9e4c151-6cdd-4f22-9798-8b01dd940233	68382-217	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170612		ANDA	ANDA079017	Zydus Pharmaceuticals USA Inc.	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-218_f9e4c151-6cdd-4f22-9798-8b01dd940233	68382-218	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170612		ANDA	ANDA079017	Zydus Pharmaceuticals USA Inc.	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-219_f9e4c151-6cdd-4f22-9798-8b01dd940233	68382-219	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170612		ANDA	ANDA079017	Zydus Pharmaceuticals USA Inc.	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-220_f9e4c151-6cdd-4f22-9798-8b01dd940233	68382-220	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170612		ANDA	ANDA079017	Zydus Pharmaceuticals USA Inc.	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-223_f9e4c151-6cdd-4f22-9798-8b01dd940233	68382-223	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170612		ANDA	ANDA079017	Zydus Pharmaceuticals USA Inc.	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-227_b3f11ad6-9f3b-4054-9c51-3d2614c1002e	68382-227	HUMAN PRESCRIPTION DRUG	amiodarone hydrochloride		amiodarone hydrochloride	TABLET	ORAL	20090810		ANDA	ANDA079029	Zydus Pharmaceuticals USA Inc.	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68382-234_0da48542-bb29-4e27-bdd8-fe497cb75820	68382-234	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20171117		ANDA	ANDA065217	Zydus Pharmaceuticals USA Inc.	CLINDAMYCIN HYDROCHLORIDE	75	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68382-235_0da48542-bb29-4e27-bdd8-fe497cb75820	68382-235	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20171123		ANDA	ANDA065217	Zydus Pharmaceuticals USA Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68382-236_0da48542-bb29-4e27-bdd8-fe497cb75820	68382-236	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20171123		ANDA	ANDA065217	Zydus Pharmaceuticals USA Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68382-244_5ff42e82-696c-45bc-9cff-d0d3efe2cf4a	68382-244	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA210658	Zydus Pharmaceuticals USA Inc.	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
68382-245_5ff42e82-696c-45bc-9cff-d0d3efe2cf4a	68382-245	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA210658	Zydus Pharmaceuticals USA Inc.	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
68382-246_8d05996d-e08d-415c-921c-0ad9b70dfbdd	68382-246	HUMAN PRESCRIPTION DRUG	Ethacrynate Sodium		Ethacrynate Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180124		ANDA	ANDA207758	Zydus Pharmaceuticals USA Inc.	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68382-247_52dc3ff3-f01b-4820-ba1e-b043a5b2c49a	68382-247	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20070409		ANDA	ANDA040597	Zydus Pharmaceuticals USA Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68382-249_9f29c71a-6cd5-4e5d-add8-3e913ad14c2b	68382-249	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Pharmaceuticals USA Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-250_9f29c71a-6cd5-4e5d-add8-3e913ad14c2b	68382-250	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Pharmaceuticals USA Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-251_9f29c71a-6cd5-4e5d-add8-3e913ad14c2b	68382-251	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Pharmaceuticals USA Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-252_9f29c71a-6cd5-4e5d-add8-3e913ad14c2b	68382-252	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Pharmaceuticals USA Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-255_f54e4d4e-91be-4e10-a446-57ed5e1843a1	68382-255	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	Zydus Pharmaceuticals USA Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68382-256_f54e4d4e-91be-4e10-a446-57ed5e1843a1	68382-256	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	Zydus Pharmaceuticals USA Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68382-257_f54e4d4e-91be-4e10-a446-57ed5e1843a1	68382-257	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	Zydus Pharmaceuticals USA Inc.	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68382-260_df68a938-0878-48b3-ba09-d9f17930a6c9	68382-260	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	CAPSULE	ORAL	20060125		ANDA	ANDA077224	Zydus Pharmaceuticals USA Inc.	RIBAVIRIN	200	mg/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68382-271_b45f7f27-ffc6-40a9-a0f5-b80933d641b2	68382-271	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Zydus Pharmaceuticals USA Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-272_b45f7f27-ffc6-40a9-a0f5-b80933d641b2	68382-272	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Zydus Pharmaceuticals USA Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-273_b45f7f27-ffc6-40a9-a0f5-b80933d641b2	68382-273	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA091134	Zydus Pharmaceuticals USA Inc.	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-297_b3f11ad6-9f3b-4054-9c51-3d2614c1002e	68382-297	HUMAN PRESCRIPTION DRUG	amiodarone hydrochloride		amiodarone hydrochloride	TABLET	ORAL	20230209		ANDA	ANDA079029	Zydus Pharmaceuticals USA Inc.	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68382-298_b3f11ad6-9f3b-4054-9c51-3d2614c1002e	68382-298	HUMAN PRESCRIPTION DRUG	amiodarone hydrochloride		amiodarone hydrochloride	TABLET	ORAL	20230209		ANDA	ANDA079029	Zydus Pharmaceuticals USA Inc.	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68382-299_3d8cb010-c629-4de6-9bb1-caaa7463e37c	68382-299	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20171208		ANDA	ANDA079213	Zydus Pharmaceuticals USA Inc.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-300_3d8cb010-c629-4de6-9bb1-caaa7463e37c	68382-300	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20171208		ANDA	ANDA079213	Zydus Pharmaceuticals USA Inc.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-301_3d8cb010-c629-4de6-9bb1-caaa7463e37c	68382-301	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20171208		ANDA	ANDA079213	Zydus Pharmaceuticals USA Inc.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-306_16e816dd-13f7-4e4d-a58a-6d2e6090b0d2	68382-306	HUMAN PRESCRIPTION DRUG	pioglitazone		pioglitazone	TABLET	ORAL	20161116		ANDA	ANDA202456	Zydus Pharmaceuticals USA Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68382-307_16e816dd-13f7-4e4d-a58a-6d2e6090b0d2	68382-307	HUMAN PRESCRIPTION DRUG	pioglitazone		pioglitazone	TABLET	ORAL	20161116		ANDA	ANDA202456	Zydus Pharmaceuticals USA Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68382-308_16e816dd-13f7-4e4d-a58a-6d2e6090b0d2	68382-308	HUMAN PRESCRIPTION DRUG	pioglitazone		pioglitazone	TABLET	ORAL	20161116		ANDA	ANDA202456	Zydus Pharmaceuticals USA Inc.	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68382-316_a9f99da5-a3f3-4374-bf4b-476992f67719	68382-316	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20170403		ANDA	ANDA063011	Zydus Pharmaceuticals USA Inc.	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-317_a9f99da5-a3f3-4374-bf4b-476992f67719	68382-317	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20170403		ANDA	ANDA063009	Zydus Pharmaceuticals USA Inc.	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-318_a9f99da5-a3f3-4374-bf4b-476992f67719	68382-318	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20170403		ANDA	ANDA063009	Zydus Pharmaceuticals USA Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-319_bb1192b5-c05a-487b-aae7-c226512dd45b	68382-319	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA090404	Zydus Pharmaceuticals USA Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68382-320_97c5fe79-4eb3-47e6-8fec-b4c10710e5a6	68382-320	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170601		NDA AUTHORIZED GENERIC	NDA018279	Zydus Pharmaceuticals USA Inc	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68382-323_d2877798-77ea-4f75-b632-9b16be09042f	68382-323	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA204379	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.014	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68382-324_456a0f03-c5af-42fd-a057-a706354179c4	68382-324	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68382-325_456a0f03-c5af-42fd-a057-a706354179c4	68382-325	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68382-326_456a0f03-c5af-42fd-a057-a706354179c4	68382-326	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68382-327_456a0f03-c5af-42fd-a057-a706354179c4	68382-327	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.06	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68382-328_456a0f03-c5af-42fd-a057-a706354179c4	68382-328	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68382-329_456a0f03-c5af-42fd-a057-a706354179c4	68382-329	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68382-331_b2849062-d60a-4f02-a1ad-dfe8e07eaa49	68382-331	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE, LIQUID FILLED	ORAL	20180420	20240407	NDA AUTHORIZED GENERIC	NDA021606	Zydus Pharmaceuticals USA Inc	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	
68382-334_3acb87d9-5a97-427a-a9f2-d1f158f60337	68382-334	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20121015		ANDA	ANDA090460	Zydus Pharmaceuticals USA Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68382-335_b7eb0015-2bd0-4e12-b35c-e63cd69c5c93	68382-335	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA203499	Zydus Pharmaceuticals USA Inc.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-336_b7eb0015-2bd0-4e12-b35c-e63cd69c5c93	68382-336	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA203499	Zydus Pharmaceuticals USA Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-337_b7eb0015-2bd0-4e12-b35c-e63cd69c5c93	68382-337	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA203499	Zydus Pharmaceuticals USA Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-346_8c8f4e5f-acf1-443f-a890-6665c7cc9aa4	68382-346	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20110511		ANDA	ANDA090175	Zydus Pharmaceuticals USA Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68382-347_8c8f4e5f-acf1-443f-a890-6665c7cc9aa4	68382-347	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20110511		ANDA	ANDA090175	Zydus Pharmaceuticals USA Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68382-351_f54f3f24-5d0f-44a1-a4ca-03950954826f	68382-351	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20230216		ANDA	ANDA201676	Zydus Pharmaceuticals USA Inc.	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
68382-352_f54f3f24-5d0f-44a1-a4ca-03950954826f	68382-352	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20230216		ANDA	ANDA201676	Zydus Pharmaceuticals USA Inc.	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
68382-353_59f7c443-2368-4c0b-8f54-ee0e234b79d9	68382-353	HUMAN PRESCRIPTION DRUG	bupropion		bupropion	TABLET, EXTENDED RELEASE	ORAL	20180802		ANDA	ANDA201567	Zydus Pharmaceuticals USA Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-354_59f7c443-2368-4c0b-8f54-ee0e234b79d9	68382-354	HUMAN PRESCRIPTION DRUG	bupropion		bupropion	TABLET, EXTENDED RELEASE	ORAL	20140215		ANDA	ANDA201567	Zydus Pharmaceuticals USA Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68382-358_e0c15ca7-80f7-4b91-b6bb-b3f552c8c647	68382-358	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20231113		ANDA	ANDA207382	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-364_07ce1a1f-b10a-4dfc-a96e-15d1d7db3678	68382-364	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Pharmaceuticals USA Inc.	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-365_07ce1a1f-b10a-4dfc-a96e-15d1d7db3678	68382-365	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Pharmaceuticals USA Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-366_07ce1a1f-b10a-4dfc-a96e-15d1d7db3678	68382-366	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Pharmaceuticals USA Inc.	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-367_07ce1a1f-b10a-4dfc-a96e-15d1d7db3678	68382-367	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Pharmaceuticals USA Inc.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-368_07ce1a1f-b10a-4dfc-a96e-15d1d7db3678	68382-368	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Pharmaceuticals USA Inc.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-369_07ce1a1f-b10a-4dfc-a96e-15d1d7db3678	68382-369	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Pharmaceuticals USA Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-370_7f7aaf27-0265-40b9-a900-341232347fad	68382-370	HUMAN PRESCRIPTION DRUG	NYSTATIN		nystatin	POWDER	TOPICAL	20211006		ANDA	ANDA208581	Zydus Pharmaceuticals USA Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68382-371_6a8d17f4-ca06-487a-9507-2d4f50e89dbe	68382-371	HUMAN PRESCRIPTION DRUG	indomethacin		indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20180208		ANDA	ANDA202711	Zydus Pharmaceuticals USA Inc.	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-374_0fcc9d88-ecff-40db-a5bf-870d917146ea	68382-374	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-375_0fcc9d88-ecff-40db-a5bf-870d917146ea	68382-375	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-376_0fcc9d88-ecff-40db-a5bf-870d917146ea	68382-376	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-377_0fcc9d88-ecff-40db-a5bf-870d917146ea	68382-377	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	TABLET	ORAL	20171205		ANDA	ANDA090697	Zydus Pharmaceuticals USA Inc.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68382-383_68c616eb-0fad-435b-9ad5-54fe27704a41	68382-383	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET	ORAL	20181008		ANDA	ANDA202602	Zydus Pharmaceuticals USA Inc.	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
68382-384_d1257ed5-d032-4453-98b4-e9f791a6cbdf	68382-384	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SPRAY	NASAL	20180201		ANDA	ANDA091345	Zydus Pharmaceuticals USA Inc.	DESMOPRESSIN ACETATE	.1	mg/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
68382-385_f95fe0a8-5492-4210-87a3-1881b4e98372	68382-385	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090739	Zydus Pharmaceuticals (USA) Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-386_f95fe0a8-5492-4210-87a3-1881b4e98372	68382-386	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090739	Zydus Pharmaceuticals (USA) Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-387_f95fe0a8-5492-4210-87a3-1881b4e98372	68382-387	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090739	Zydus Pharmaceuticals (USA) Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-393_bb1e2740-998b-4afe-84e3-5cc301c1a526	68382-393	HUMAN PRESCRIPTION DRUG	doxepin		doxepin	TABLET	ORAL	20230825		ANDA	ANDA202761	Zydus Pharmaceuticals USA Inc.	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68382-394_bb1e2740-998b-4afe-84e3-5cc301c1a526	68382-394	HUMAN PRESCRIPTION DRUG	doxepin		doxepin	TABLET	ORAL	20230825		ANDA	ANDA202761	Zydus Pharmaceuticals USA Inc.	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68382-395_5b244567-d037-4fbd-9e2b-ed394e1c07b4	68382-395	HUMAN PRESCRIPTION DRUG	RIBAVIRIN		ribavirin	POWDER, FOR SOLUTION	RESPIRATORY (INHALATION)	20161215		ANDA	ANDA207366	Zydus Pharmaceuticals USA Inc.	RIBAVIRIN	6	g/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68382-396_41052ba8-e11b-444d-8e3a-e2045768f7e3	68382-396	HUMAN PRESCRIPTION DRUG	SODIUM PHENYLACETATE AND SODIUM BENZOATE		sodium phenylacetate and sodium benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210208		ANDA	ANDA205880	Zydus Pharmaceuticals USA Inc.	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
68382-398_97c5fe79-4eb3-47e6-8fec-b4c10710e5a6	68382-398	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140116		NDA AUTHORIZED GENERIC	NDA018279	Zydus Pharmaceuticals USA Inc	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68382-407_7c91727c-f19f-4d12-bfd8-f610cc1d3782	68382-407	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230201		ANDA	ANDA077580	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
68382-408_7c91727c-f19f-4d12-bfd8-f610cc1d3782	68382-408	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230201		ANDA	ANDA077580	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
68382-409_7c91727c-f19f-4d12-bfd8-f610cc1d3782	68382-409	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230201		ANDA	ANDA077580	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
68382-411_d0074baa-52cb-4039-9bd8-966a36ff70da	68382-411	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Zydus Pharmaceuticals USA Inc.	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-412_d0074baa-52cb-4039-9bd8-966a36ff70da	68382-412	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Zydus Pharmaceuticals USA Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-413_936ad52c-acf7-45da-9c28-7cf85e61fcdb	68382-413	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20170809		ANDA	ANDA206097	Zydus Pharmaceuticals USA Inc.	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
68382-415_fe0d4dc9-dc25-42ad-b6e4-0159f604f1d5	68382-415	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SPRAY, METERED	NASAL	20180201		ANDA	ANDA091409	Zydus Pharmaceuticals USA Inc.	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68382-416_7750ee73-dc70-452f-87f1-f38216254e35	68382-416	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20180414		ANDA	ANDA203466	Zydus Pharmaceuticals USA Inc.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 25	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-422_d6e75dff-353f-4d1b-ab11-f8151b12c6b4	68382-422	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130301		ANDA	ANDA091534	Zydus Pharmaceuticals USA Inc.	RANITIDINE HYDROCHLORIDE	25	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68382-423_d6e75dff-353f-4d1b-ab11-f8151b12c6b4	68382-423	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20130301		ANDA	ANDA091534	Zydus Pharmaceuticals USA Inc.	RANITIDINE HYDROCHLORIDE	25	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68382-424_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-424	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-425_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-425	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-426_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-426	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-427_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-427	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-428_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-428	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-429_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-429	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-430_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-430	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-431_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-431	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-432_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-432	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-433_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-433	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-434_63951023-2bfe-4973-87f2-07b3f5a010fd	68382-434	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Pharmaceuticals (USA) Inc.	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-435_c2b40002-6c58-4c89-b178-c915a59cb2dd	68382-435	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	TABLET, DELAYED RELEASE	ORAL	20180802		ANDA	ANDA203286	Zydus Pharmaceuticals USA Inc.	MESALAMINE	800	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
68382-439_23abf603-605b-4df3-ba70-f29173b80393	68382-439	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Pharmaceuticals USA Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-440_8906b45d-eaeb-4e7f-9aa2-dffa89109a8a	68382-440	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20221123		ANDA	ANDA078920	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-441_191ecc74-2bd4-48e3-a0f6-c7284b4d27e7	68382-441	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190530		ANDA	ANDA206296	Zydus Pharmaceuticals USA Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-442_191ecc74-2bd4-48e3-a0f6-c7284b4d27e7	68382-442	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190530		ANDA	ANDA206296	Zydus Pharmaceuticals USA Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-444_707e6805-7f07-43d1-b65b-4afbb9e9e95e	68382-444	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		famotidine	POWDER, FOR SUSPENSION	ORAL	20210422		ANDA	ANDA091020	Zydus Pharmaceuticals USA Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68382-446_a8ee488d-716d-48e1-b150-4345366166ca	68382-446	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET, COATED	ORAL	20190501		ANDA	ANDA207760	Zydus Pharmaceuticals USA Inc.	BOSENTAN	62.5	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
68382-447_a8ee488d-716d-48e1-b150-4345366166ca	68382-447	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET, COATED	ORAL	20190501		ANDA	ANDA207760	Zydus Pharmaceuticals USA Inc.	BOSENTAN	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
68382-452_1d3ac6ac-1404-492a-890f-5ed6e250b380	68382-452	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20210813		ANDA	ANDA208954	Zydus Pharmaceuticals USA Inc.	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
68382-469_281d1f1b-df9d-4c11-86c3-df47e59fe8b0	68382-469	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20180508		ANDA	ANDA204020	Zydus Pharmaceuticals USA Inc.	DESVENLAFAXINE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-470_37cff808-1732-462d-857b-6173382e5cba	68382-470	HUMAN PRESCRIPTION DRUG	INDOMETHACIN		INDOMETHACIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210515		ANDA	ANDA206561	Zydus Pharmaceuticals USA Inc.	INDOMETHACIN SODIUM	1	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-471_99f660d2-4407-490e-a79f-6523bece714d	68382-471	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20140827		ANDA	ANDA203325	Zydus Pharmaceuticals USA Inc.	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-472_99f660d2-4407-490e-a79f-6523bece714d	68382-472	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20140827		ANDA	ANDA203325	Zydus Pharmaceuticals USA Inc.	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-473_99f660d2-4407-490e-a79f-6523bece714d	68382-473	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20140827		ANDA	ANDA203325	Zydus Pharmaceuticals USA Inc.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-474_4c93c76b-c6af-4d4c-b8b6-c5bc60829ae5	68382-474	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-475_4c93c76b-c6af-4d4c-b8b6-c5bc60829ae5	68382-475	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-476_4c93c76b-c6af-4d4c-b8b6-c5bc60829ae5	68382-476	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-477_4c93c76b-c6af-4d4c-b8b6-c5bc60829ae5	68382-477	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-478_4c93c76b-c6af-4d4c-b8b6-c5bc60829ae5	68382-478	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-479_83c43462-1843-41ed-b0d7-ea91563513c0	68382-479	HUMAN PRESCRIPTION DRUG	fesoterodine fumarate		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171207		ANDA	ANDA204946	Zydus Pharmaceuticals USA Inc.	FESOTERODINE FUMARATE	4	mg/1			N	20241231
68382-480_83c43462-1843-41ed-b0d7-ea91563513c0	68382-480	HUMAN PRESCRIPTION DRUG	fesoterodine fumarate		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171207		ANDA	ANDA204946	Zydus Pharmaceuticals USA Inc.	FESOTERODINE FUMARATE	8	mg/1			N	20241231
68382-481_644c459a-eddd-446c-a0b0-f6cb22d5c07d	68382-481	HUMAN PRESCRIPTION DRUG	pitavastatin calcium		pitavastatin calcium	TABLET	ORAL	20231102		ANDA	ANDA206047	Zydus Pharmaceuticals USA Inc.	PITAVASTATIN CALCIUM	1	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-482_644c459a-eddd-446c-a0b0-f6cb22d5c07d	68382-482	HUMAN PRESCRIPTION DRUG	pitavastatin calcium		pitavastatin calcium	TABLET	ORAL	20231102		ANDA	ANDA206047	Zydus Pharmaceuticals USA Inc.	PITAVASTATIN CALCIUM	2	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-483_644c459a-eddd-446c-a0b0-f6cb22d5c07d	68382-483	HUMAN PRESCRIPTION DRUG	pitavastatin calcium		pitavastatin calcium	TABLET	ORAL	20231102		ANDA	ANDA206047	Zydus Pharmaceuticals USA Inc.	PITAVASTATIN CALCIUM	4	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68382-500_d0074baa-52cb-4039-9bd8-966a36ff70da	68382-500	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Zydus Pharmaceuticals USA Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-501_3da7ee05-d809-433e-86ea-e6b399939f8d	68382-501	HUMAN PRESCRIPTION DRUG	omeprazole and sodium bicarbonate		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20180529		ANDA	ANDA203290	Zydus Pharmaceuticals USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-502_3da7ee05-d809-433e-86ea-e6b399939f8d	68382-502	HUMAN PRESCRIPTION DRUG	omeprazole and sodium bicarbonate		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20180529		ANDA	ANDA203290	Zydus Pharmaceuticals USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-503_07494f08-60c9-4350-a91e-944730e677e0	68382-503	HUMAN OTC DRUG	omeprazole and sodium bicarbonate		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20180719		ANDA	ANDA203345	Zydus Pharmaceuticals USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-512_0c36333f-c50c-419a-8cd4-289e4684f4b5	68382-512	HUMAN PRESCRIPTION DRUG	amantadine hydrochloride		amantadine hydrochloride	CAPSULE	ORAL	20160804		ANDA	ANDA208278	Zydus Pharmaceuticals (USA) Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
68382-513_cba2a5ed-ad88-490f-b1c8-ee9360af5002	68382-513	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20171012		ANDA	ANDA204221	Zydus Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-514_cba2a5ed-ad88-490f-b1c8-ee9360af5002	68382-514	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20171012		ANDA	ANDA204221	Zydus Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-515_cba2a5ed-ad88-490f-b1c8-ee9360af5002	68382-515	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20171012		ANDA	ANDA204221	Zydus Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-520_f54f3f24-5d0f-44a1-a4ca-03950954826f	68382-520	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20140115		ANDA	ANDA201676	Zydus Pharmaceuticals USA Inc.	SIROLIMUS	.5	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
68382-521_d68becc7-a913-4a96-8aa0-b7a50253053a	68382-521	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20180307		ANDA	ANDA203162	Zydus Pharmaceuticals USA Inc.	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68382-522_880b042a-a73d-4032-92d1-e3d1c5f3c97e	68382-522	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202		ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
68382-523_880b042a-a73d-4032-92d1-e3d1c5f3c97e	68382-523	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202		ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
68382-524_880b042a-a73d-4032-92d1-e3d1c5f3c97e	68382-524	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202		ANDA	ANDA214184	Zydus Pharmaceuticals (USA) Inc.	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
68382-525_58b3bb3b-6096-42fd-aebc-c856c3050071	68382-525	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	Zydus Pharmaceuticals (USA) Inc.	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68382-526_58b3bb3b-6096-42fd-aebc-c856c3050071	68382-526	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	Zydus Pharmaceuticals (USA) Inc.	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68382-527_58b3bb3b-6096-42fd-aebc-c856c3050071	68382-527	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	Zydus Pharmaceuticals (USA) Inc.	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68382-528_b1884e46-cf18-4a7e-b003-761878e77bf1	68382-528	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		CHOLESTYRAMINE	POWDER, FOR SUSPENSION	ORAL	20180801		ANDA	ANDA202901	Zydus Pharmaceuticals (USA) Inc.	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20251231
68382-529_b17c4084-665b-4a32-9005-745519c4a926	68382-529	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		CHOLESTYRAMINE	POWDER, FOR SUSPENSION	ORAL	20170608		ANDA	ANDA202902	Zydus Pharmaceuticals (USA) Inc.	CHOLESTYRAMINE	4	g/5.5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
68382-530_84f6b758-3b9e-4868-b136-657cf2d25d10	68382-530	HUMAN PRESCRIPTION DRUG	Diflunisal		Diflunisal	TABLET	ORAL	20170914		ANDA	ANDA203547	Zydus Pharmaceuticals (USA) Inc.	DIFLUNISAL	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68382-531_fe782f9a-84d1-4e4a-ad19-83b869ee07ad	68382-531	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Pharmaceuticals (USA) Inc.	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-533_fe782f9a-84d1-4e4a-ad19-83b869ee07ad	68382-533	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Pharmaceuticals (USA) Inc.	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-535_fe782f9a-84d1-4e4a-ad19-83b869ee07ad	68382-535	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Pharmaceuticals (USA) Inc.	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-536_b0382b88-fcc4-44de-b66d-a93dabc596f8	68382-536	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140812		ANDA	ANDA203546	Zydus Pharmaceuticals (USA) Inc.	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
68382-537_b0382b88-fcc4-44de-b66d-a93dabc596f8	68382-537	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140812		ANDA	ANDA203546	Zydus Pharmaceuticals (USA) Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
68382-538_b0382b88-fcc4-44de-b66d-a93dabc596f8	68382-538	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20140812		ANDA	ANDA203546	Zydus Pharmaceuticals (USA) Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
68382-543_b828e447-56b6-4cab-bd49-053bcd4be948	68382-543	HUMAN PRESCRIPTION DRUG	lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130823		ANDA	ANDA202366	Zydus Pharmaceuticals USA Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-544_b828e447-56b6-4cab-bd49-053bcd4be948	68382-544	HUMAN PRESCRIPTION DRUG	lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130823		ANDA	ANDA202366	Zydus Pharmaceuticals USA Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-545_22814fa3-e57a-4f2c-bab5-e9f44b0132b4	68382-545	HUMAN PRESCRIPTION DRUG	etomidate		etomidate	INJECTION, SOLUTION	INTRAVENOUS	20150403		ANDA	ANDA202360	Zydus Pharmaceuticals USA Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
68382-546_079cb172-4d62-4571-98b9-5ad01706dbee	68382-546	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Pharmaceuticals USA Inc.	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68382-547_079cb172-4d62-4571-98b9-5ad01706dbee	68382-547	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Pharmaceuticals USA Inc.	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68382-548_079cb172-4d62-4571-98b9-5ad01706dbee	68382-548	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Pharmaceuticals USA Inc.	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68382-549_079cb172-4d62-4571-98b9-5ad01706dbee	68382-549	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Pharmaceuticals USA Inc.	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68382-551_fe782f9a-84d1-4e4a-ad19-83b869ee07ad	68382-551	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Pharmaceuticals (USA) Inc.	MINOCYCLINE HYDROCHLORIDE	80	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-552_fe782f9a-84d1-4e4a-ad19-83b869ee07ad	68382-552	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Pharmaceuticals (USA) Inc.	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-553_02ea511e-b0ab-4c32-966f-0fd3343ffb68	68382-553	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20190115		ANDA	ANDA204189	Zydus Pharmaceuticals (USA) Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
68382-555_2e6324a8-5ac0-4eae-ab20-d98b1c3292b9	68382-555	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA205571	Zydus Pharmaceuticals (USA) Inc.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-556_2e6324a8-5ac0-4eae-ab20-d98b1c3292b9	68382-556	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA205571	Zydus Pharmaceuticals (USA) Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-557_2e6324a8-5ac0-4eae-ab20-d98b1c3292b9	68382-557	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA205571	Zydus Pharmaceuticals (USA) Inc.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68382-559_0d11f48c-867f-471c-a74c-9d50f6a76cfd	68382-559	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20180215		ANDA	ANDA205005	Zydus Pharmaceuticals (USA) Inc.	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68382-560_0d11f48c-867f-471c-a74c-9d50f6a76cfd	68382-560	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20180215		ANDA	ANDA205005	Zydus Pharmaceuticals (USA) Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
68382-564_4bae87cf-a624-4270-8223-dcce723c352d	68382-564	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Pharmaceuticals (USA) Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-565_4bae87cf-a624-4270-8223-dcce723c352d	68382-565	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Pharmaceuticals (USA) Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-566_4bae87cf-a624-4270-8223-dcce723c352d	68382-566	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Pharmaceuticals (USA) Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-567_4bae87cf-a624-4270-8223-dcce723c352d	68382-567	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Pharmaceuticals (USA) Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-569_2e5f04a0-3e2d-494f-837b-18570b6a8546	68382-569	HUMAN PRESCRIPTION DRUG	acamprosate calcium		acamprosate calcium	TABLET, DELAYED RELEASE	ORAL	20170601		ANDA	ANDA205995	Zydus Pharmaceuticals (USA) Inc.	ACAMPROSATE CALCIUM	333	mg/1			N	20241231
68382-582_15ed7dff-a305-4a76-aedd-f932fa27b36c	68382-582	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	Zydus Pharmaceuticals (USA) Inc.	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
68382-583_15ed7dff-a305-4a76-aedd-f932fa27b36c	68382-583	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	Zydus Pharmaceuticals (USA) Inc.	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
68382-584_15ed7dff-a305-4a76-aedd-f932fa27b36c	68382-584	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	Zydus Pharmaceuticals (USA) Inc.	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
68382-591_0aa00a79-3824-48b4-b106-754ce62d706f	68382-591	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Pharmaceuticals (USA) Inc.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68382-592_0aa00a79-3824-48b4-b106-754ce62d706f	68382-592	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Pharmaceuticals (USA) Inc.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68382-593_0aa00a79-3824-48b4-b106-754ce62d706f	68382-593	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Pharmaceuticals (USA) Inc.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68382-594_0aa00a79-3824-48b4-b106-754ce62d706f	68382-594	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Pharmaceuticals (USA) Inc.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68382-595_dd6b1df6-addf-4e4b-a934-16b28f6cfa9e	68382-595	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-596_dd6b1df6-addf-4e4b-a934-16b28f6cfa9e	68382-596	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-597_dd6b1df6-addf-4e4b-a934-16b28f6cfa9e	68382-597	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-598_dd6b1df6-addf-4e4b-a934-16b28f6cfa9e	68382-598	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-599_dd6b1df6-addf-4e4b-a934-16b28f6cfa9e	68382-599	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-600_97c5fe79-4eb3-47e6-8fec-b4c10710e5a6	68382-600	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110222		NDA AUTHORIZED GENERIC	NDA018279	Zydus Pharmaceuticals USA Inc	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68382-601_2a09376a-cfc6-4134-8f2d-9e198f6d863c	68382-601	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	INJECTION, SOLUTION	EPIDURAL	20180131		ANDA	ANDA202601	Zydus Pharmaceuticals USA Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68382-602_2a09376a-cfc6-4134-8f2d-9e198f6d863c	68382-602	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	INJECTION, SOLUTION	EPIDURAL	20180131		ANDA	ANDA202601	Zydus Pharmaceuticals USA Inc.	CLONIDINE HYDROCHLORIDE	.5	mg/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68382-618_79e77a71-5dcf-48ac-8483-a8540a112457	68382-618	HUMAN PRESCRIPTION DRUG	aspirin-dipyridamole		aspirin-dipyridamole	CAPSULE	ORAL	20180104		ANDA	ANDA206753	Zydus Pharmaceuticals USA Inc.	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68382-619_bd5f9caf-784b-4565-a8b4-d330d3e93160	68382-619	HUMAN PRESCRIPTION DRUG	Colesevelam		Colesevelam	TABLET, FILM COATED	ORAL	20191011		ANDA	ANDA207765	Zydus Pharmaceuticals USA Inc.	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
68382-623_3f939480-7edb-406e-896a-c2055d0b09ea	68382-623	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20230321		ANDA	ANDA078888	Zydus Pharmaceuticals USA Inc.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
68382-624_09d92588-691b-4f6f-9cba-b1fa3548c24d	68382-624	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20230518		ANDA	ANDA208303	Zydus Pharmaceuticals USA Inc.	ROFLUMILAST	250	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
68382-640_82a42093-2426-48c6-aee7-1ac70e2dab57	68382-640	HUMAN PRESCRIPTION DRUG	Dutasteride and tamsulosin hydrochloride		Dutasteride and tamsulosin hydrochloride	CAPSULE	ORAL	20180604		ANDA	ANDA207769	Zydus Pharmaceuticals USA Inc.	DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE	.5; .4	mg/1; mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA], Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68382-643_0fb52f36-690a-4321-a374-345bfacf74b0	68382-643	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205192	Zydus Pharmaceuticals USA Inc.	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-644_0fb52f36-690a-4321-a374-345bfacf74b0	68382-644	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205192	Zydus Pharmaceuticals USA Inc.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-645_0fb52f36-690a-4321-a374-345bfacf74b0	68382-645	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205192	Zydus Pharmaceuticals USA Inc.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68382-653_62c61687-f428-4878-834c-0709dae888db	68382-653	HUMAN PRESCRIPTION DRUG	glyburide and metformin hydrochloride		glyburide and metformin hydrochloride	TABLET	ORAL	20160407		ANDA	ANDA206748	Zydus Pharmaceuticals (USA) Inc.	GLYBURIDE; METFORMIN HYDROCHLORIDE	1.25; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-654_62c61687-f428-4878-834c-0709dae888db	68382-654	HUMAN PRESCRIPTION DRUG	glyburide and metformin hydrochloride		glyburide and metformin hydrochloride	TABLET	ORAL	20160407		ANDA	ANDA206748	Zydus Pharmaceuticals (USA) Inc.	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-655_62c61687-f428-4878-834c-0709dae888db	68382-655	HUMAN PRESCRIPTION DRUG	glyburide and metformin hydrochloride		glyburide and metformin hydrochloride	TABLET	ORAL	20160407		ANDA	ANDA206748	Zydus Pharmaceuticals (USA) Inc.	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-656_1ff75368-1bfd-4173-b0aa-18eca2c97a4f	68382-656	HUMAN PRESCRIPTION DRUG	glyburide		glyburide	TABLET	ORAL	20160602		ANDA	ANDA206749	Zydus Pharmaceuticals (USA) Inc.	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-657_1ff75368-1bfd-4173-b0aa-18eca2c97a4f	68382-657	HUMAN PRESCRIPTION DRUG	glyburide		glyburide	TABLET	ORAL	20160602		ANDA	ANDA206749	Zydus Pharmaceuticals (USA) Inc.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-658_1ff75368-1bfd-4173-b0aa-18eca2c97a4f	68382-658	HUMAN PRESCRIPTION DRUG	glyburide		glyburide	TABLET	ORAL	20160602		ANDA	ANDA206749	Zydus Pharmaceuticals (USA) Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68382-659_5439e6be-2d67-4bbd-b72f-3364cb62f907	68382-659	HUMAN PRESCRIPTION DRUG	pyridostigmine bromide		pyridostigmine bromide	TABLET	ORAL	20150807		ANDA	ANDA205650	Zydus Pharmaceuticals (USA) Inc.	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68382-660_19dcadf3-8242-413a-9a0d-a2181ef1e2ff	68382-660	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Zydus Pharmaceuticals (USA) Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68382-661_19dcadf3-8242-413a-9a0d-a2181ef1e2ff	68382-661	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Zydus Pharmaceuticals (USA) Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68382-662_19dcadf3-8242-413a-9a0d-a2181ef1e2ff	68382-662	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Zydus Pharmaceuticals (USA) Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68382-669_cc8e588c-c147-4d3f-ad02-d002b7dc651a	68382-669	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170922		ANDA	ANDA204473	Zydus Pharmaceuticals USA Inc.	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
68382-670_80a20fab-b983-406b-a7e2-10b50f38e512	68382-670	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20180208		ANDA	ANDA204663	Zydus Pharmaceuticals USA Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68382-685_b6e99c32-9f84-4bb8-b6cb-fafcc8d409ad	68382-685	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA210012	Zydus Pharmaceuticals (USA) Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-686_b6e99c32-9f84-4bb8-b6cb-fafcc8d409ad	68382-686	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA210012	Zydus Pharmaceuticals (USA) Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-687_b6e99c32-9f84-4bb8-b6cb-fafcc8d409ad	68382-687	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA210012	Zydus Pharmaceuticals (USA) Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-688_67c7517f-8d53-4cc2-a358-0dd343cf7148	68382-688	HUMAN PRESCRIPTION DRUG	NIFEDIPINE		NIFEDIPINE	TABLET, EXTENDED RELEASE	ORAL	20180818		ANDA	ANDA210184	Zydus Pharmaceuticals (USA) Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-689_67c7517f-8d53-4cc2-a358-0dd343cf7148	68382-689	HUMAN PRESCRIPTION DRUG	NIFEDIPINE		NIFEDIPINE	TABLET, EXTENDED RELEASE	ORAL	20180818		ANDA	ANDA210184	Zydus Pharmaceuticals (USA) Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-690_67c7517f-8d53-4cc2-a358-0dd343cf7148	68382-690	HUMAN PRESCRIPTION DRUG	NIFEDIPINE		NIFEDIPINE	TABLET, EXTENDED RELEASE	ORAL	20180818		ANDA	ANDA210184	Zydus Pharmaceuticals (USA) Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-697_d4524b32-b45b-4b9c-b709-a197ef0f3851	68382-697	HUMAN PRESCRIPTION DRUG	itraconazole		itraconazole	CAPSULE	ORAL	20180306		ANDA	ANDA204672	Zydus Pharmaceuticals USA Inc.	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68382-703_80a20fab-b983-406b-a7e2-10b50f38e512	68382-703	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20180208		ANDA	ANDA204663	Zydus Pharmaceuticals USA Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68382-704_80a20fab-b983-406b-a7e2-10b50f38e512	68382-704	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20180208		ANDA	ANDA204663	Zydus Pharmaceuticals USA Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68382-706_9d689079-6de1-4288-af1b-d9505c626c19	68382-706	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-707_9d689079-6de1-4288-af1b-d9505c626c19	68382-707	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-708_38662a6c-8d26-43d6-a6af-722b15d4a41a	68382-708	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	TABLET	ORAL	20181221		ANDA	ANDA206772	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-709_38662a6c-8d26-43d6-a6af-722b15d4a41a	68382-709	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	TABLET	ORAL	20181221		ANDA	ANDA206772	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-710_38662a6c-8d26-43d6-a6af-722b15d4a41a	68382-710	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	TABLET	ORAL	20181221		ANDA	ANDA206772	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-711_d9ce9589-6aee-4dc3-a71b-f1c32ab9f552	68382-711	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	TABLET, DELAYED RELEASE	ORAL	20170619		ANDA	ANDA091640	Zydus Pharmaceuticals USA Inc.	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
68382-712_69253ff3-21fa-46de-8f27-668eb8aa6e94	68382-712	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20181112		ANDA	ANDA203019	Zydus Pharmaceuticals USA Inc.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68382-714_69253ff3-21fa-46de-8f27-668eb8aa6e94	68382-714	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20181112		ANDA	ANDA203019	Zydus Pharmaceuticals USA Inc.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68382-715_c8bbe1ff-34e4-4638-ac8a-00b1ceb2f310	68382-715	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20130516		ANDA	ANDA202890	Zydus Pharmaceuticals USA Inc.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68382-717_c8bbe1ff-34e4-4638-ac8a-00b1ceb2f310	68382-717	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20130516		ANDA	ANDA202890	Zydus Pharmaceuticals USA Inc.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68382-720_6325fb93-302b-443f-bc10-49e8c0e75b46	68382-720	HUMAN PRESCRIPTION DRUG	budesonide		budesonide	CAPSULE, COATED PELLETS	ORAL	20170608		ANDA	ANDA206134	Zydus Pharmaceuticals USA Inc.	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68382-721_061a2260-2804-4753-b443-17943eca74dd	68382-721	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA205248	Zydus Pharmaceuticals USA Inc.	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
68382-722_061a2260-2804-4753-b443-17943eca74dd	68382-722	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA205248	Zydus Pharmaceuticals USA Inc.	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
68382-732_d91f4594-496e-49f2-a187-ddd86f8634b4	68382-732	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170808		ANDA	ANDA207761	Zydus Pharmaceuticals USA Inc.	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
68382-733_d91f4594-496e-49f2-a187-ddd86f8634b4	68382-733	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170808		ANDA	ANDA207761	Zydus Pharmaceuticals USA Inc.	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
68382-734_d91f4594-496e-49f2-a187-ddd86f8634b4	68382-734	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170808		ANDA	ANDA207761	Zydus Pharmaceuticals USA Inc.	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
68382-737_50d50f95-13e5-48b8-8843-b9e8e86c56cf	68382-737	HUMAN PRESCRIPTION DRUG	Midodrine hydrochloride		Midodrine hydrochloride	TABLET	ORAL	20200917		ANDA	ANDA213055	Zydus Pharmaceuticals (USA) Inc.	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68382-738_50d50f95-13e5-48b8-8843-b9e8e86c56cf	68382-738	HUMAN PRESCRIPTION DRUG	Midodrine hydrochloride		Midodrine hydrochloride	TABLET	ORAL	20200917		ANDA	ANDA213055	Zydus Pharmaceuticals (USA) Inc.	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68382-739_50d50f95-13e5-48b8-8843-b9e8e86c56cf	68382-739	HUMAN PRESCRIPTION DRUG	Midodrine hydrochloride		Midodrine hydrochloride	TABLET	ORAL	20200917		ANDA	ANDA213055	Zydus Pharmaceuticals (USA) Inc.	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68382-740_5e98c67f-9957-446f-bcf6-4ed08def954f	68382-740	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20220203		ANDA	ANDA210395	Zydus Pharmaceuticals (USA) Inc.	POTASSIUM CHLORIDE	1500	mg/1			N	20241231
68382-741_281d1f1b-df9d-4c11-86c3-df47e59fe8b0	68382-741	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20180508		ANDA	ANDA204020	Zydus Pharmaceuticals USA Inc.	DESVENLAFAXINE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68382-745_6465fb5f-8c9e-4da0-846e-74d2d98dfa4f	68382-745	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-746_6465fb5f-8c9e-4da0-846e-74d2d98dfa4f	68382-746	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-747_6465fb5f-8c9e-4da0-846e-74d2d98dfa4f	68382-747	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-748_6465fb5f-8c9e-4da0-846e-74d2d98dfa4f	68382-748	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-749_6465fb5f-8c9e-4da0-846e-74d2d98dfa4f	68382-749	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-750_6465fb5f-8c9e-4da0-846e-74d2d98dfa4f	68382-750	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Pharmaceuticals (USA) Inc.	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68382-751_2da71848-9a09-45b2-820e-c43f37b0fe3e	68382-751	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Pharmaceuticals USA Inc.	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68382-752_2da71848-9a09-45b2-820e-c43f37b0fe3e	68382-752	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Pharmaceuticals USA Inc.	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68382-753_2da71848-9a09-45b2-820e-c43f37b0fe3e	68382-753	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Pharmaceuticals USA Inc.	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68382-754_2da71848-9a09-45b2-820e-c43f37b0fe3e	68382-754	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Pharmaceuticals USA Inc.	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68382-755_2da71848-9a09-45b2-820e-c43f37b0fe3e	68382-755	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Pharmaceuticals USA Inc.	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68382-756_2da71848-9a09-45b2-820e-c43f37b0fe3e	68382-756	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Pharmaceuticals USA Inc.	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68382-758_cb5dfb45-8968-4a83-a807-d225b427b1cb	68382-758	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA203686	Zydus Pharmaceuticals USA Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68382-759_cb5dfb45-8968-4a83-a807-d225b427b1cb	68382-759	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA203686	Zydus Pharmaceuticals USA Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68382-760_cb5dfb45-8968-4a83-a807-d225b427b1cb	68382-760	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141209		ANDA	ANDA203686	Zydus Pharmaceuticals USA Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68382-769_e0c15ca7-80f7-4b91-b6bb-b3f552c8c647	68382-769	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20180405		ANDA	ANDA207382	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-771_3de4f129-dc87-48e1-b934-b2a038df8cf7	68382-771	HUMAN PRESCRIPTION DRUG	LANSOPRAZOLE		LANSOPRAZOLE	TABLET, ORALLY DISINTEGRATING	ORAL	20181130		ANDA	ANDA200816	Zydus Pharmaceuticals USA Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-772_3de4f129-dc87-48e1-b934-b2a038df8cf7	68382-772	HUMAN PRESCRIPTION DRUG	LANSOPRAZOLE		LANSOPRAZOLE	TABLET, ORALLY DISINTEGRATING	ORAL	20181130		ANDA	ANDA200816	Zydus Pharmaceuticals USA Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-773_53f72cd3-d678-431b-a11a-604a302ddf79	68382-773	HUMAN PRESCRIPTION DRUG	ezetimibe		ezetimibe	TABLET	ORAL	20170809		ANDA	ANDA204331	Zydus Pharmaceuticals USA Inc.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
68382-775_12e61f0c-901b-4891-9a52-0cf78ebe64b6	68382-775	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20170209		ANDA	ANDA207812	Zydus Pharmaceuticals USA Inc.	METHOTREXATE	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
68382-776_97c5fe79-4eb3-47e6-8fec-b4c10710e5a6	68382-776	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140116		NDA AUTHORIZED GENERIC	NDA018279	Zydus Pharmaceuticals USA Inc	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68382-782_9d689079-6de1-4288-af1b-d9505c626c19	68382-782	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-783_92ead971-9de8-4240-b2c7-fc2e9abac7dd	68382-783	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Pharmaceuticals USA Inc.	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68382-784_92ead971-9de8-4240-b2c7-fc2e9abac7dd	68382-784	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Pharmaceuticals USA Inc.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68382-785_92ead971-9de8-4240-b2c7-fc2e9abac7dd	68382-785	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Pharmaceuticals USA Inc.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68382-786_92ead971-9de8-4240-b2c7-fc2e9abac7dd	68382-786	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Pharmaceuticals USA Inc.	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68382-791_f313ad5b-1038-4737-951d-97d96a3d2813	68382-791	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20140910		ANDA	ANDA204314	Zydus Pharmaceuticals (USA) Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68382-792_f313ad5b-1038-4737-951d-97d96a3d2813	68382-792	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20140910		ANDA	ANDA204314	Zydus Pharmaceuticals (USA) Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68382-798_f4b4d2f0-55ad-4eda-a128-5f0c21dbe86b	68382-798	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Zydus Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-799_f4b4d2f0-55ad-4eda-a128-5f0c21dbe86b	68382-799	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Zydus Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-800_f4b4d2f0-55ad-4eda-a128-5f0c21dbe86b	68382-800	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Zydus Pharmaceuticals USA Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68382-805_c143f2d9-f753-4519-b4ee-2f60583c3307	68382-805	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Pharmaceuticals USA Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68382-806_c143f2d9-f753-4519-b4ee-2f60583c3307	68382-806	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Pharmaceuticals USA Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68382-807_c143f2d9-f753-4519-b4ee-2f60583c3307	68382-807	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Pharmaceuticals USA Inc.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68382-808_c143f2d9-f753-4519-b4ee-2f60583c3307	68382-808	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Pharmaceuticals USA Inc.	TRAZODONE HYDROCHLORIDE	300	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68382-824_c36f7488-a329-4113-8027-dfc92bbc6bbc	68382-824	HUMAN PRESCRIPTION DRUG	Sevelamer carbonate		Sevelamer carbonate	TABLET, FILM COATED	ORAL	20200917		ANDA	ANDA207759	Zydus Pharmaceuticals USA Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68382-826_3c910886-2c1b-4da0-944d-c7064b571d24	68382-826	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20180103		ANDA	ANDA206694	Zydus Pharmaceuticals USA Inc.	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68382-827_3c910886-2c1b-4da0-944d-c7064b571d24	68382-827	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20180103		ANDA	ANDA206694	Zydus Pharmaceuticals USA Inc.	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68382-848_bc31956a-671b-4ca3-b9dd-1fdb03003cae	68382-848	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	GRANULE, DELAYED RELEASE	ORAL	20230630		ANDA	ANDA206055	Zydus Pharmaceuticals USA Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-849_bc31956a-671b-4ca3-b9dd-1fdb03003cae	68382-849	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	GRANULE, DELAYED RELEASE	ORAL	20230630		ANDA	ANDA206055	Zydus Pharmaceuticals USA Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68382-853_37302db1-d7cc-4b79-8b3e-f14d40342ef4	68382-853	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	CAPSULE, EXTENDED RELEASE	ORAL	20190630		ANDA	ANDA208445	Zydus Pharmaceuticals (USA) Inc.	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68382-854_37302db1-d7cc-4b79-8b3e-f14d40342ef4	68382-854	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	CAPSULE, EXTENDED RELEASE	ORAL	20190630		ANDA	ANDA208445	Zydus Pharmaceuticals (USA) Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68382-855_062dc3f3-09ea-4f21-9435-025c4e9d460b	68382-855	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20190331		ANDA	ANDA208358	Zydus Pharmaceuticals (USA) Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-856_e0a51d55-991a-463a-a382-428f33488d77	68382-856	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20180904		ANDA	ANDA208360	Zydus Pharmaceuticals (USA) Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-857_e0a51d55-991a-463a-a382-428f33488d77	68382-857	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20180904		ANDA	ANDA208360	Zydus Pharmaceuticals (USA) Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68382-859_8432a974-7edb-4544-ab9b-c57912dd6780	68382-859	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Pharmaceuticals USA Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-860_ae4dfaeb-246c-4530-b473-656cce5da837	68382-860	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201230		ANDA	ANDA091525	Zydus Pharmaceuticals USA Inc.	BENZTROPINE MESYLATE	1	mg/mL	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
68382-861_5e98c67f-9957-446f-bcf6-4ed08def954f	68382-861	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20220203		ANDA	ANDA210395	Zydus Pharmaceuticals (USA) Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68382-863_e0c15ca7-80f7-4b91-b6bb-b3f552c8c647	68382-863	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20180405		ANDA	ANDA207382	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-864_e0c15ca7-80f7-4b91-b6bb-b3f552c8c647	68382-864	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20180405		ANDA	ANDA207382	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68382-874_4c93c76b-c6af-4d4c-b8b6-c5bc60829ae5	68382-874	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-875_4c93c76b-c6af-4d4c-b8b6-c5bc60829ae5	68382-875	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Pharmaceuticals USA Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	3.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
68382-891_93749b6f-9e7d-47ca-bfc1-e776914ddbaf	68382-891	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION	INTRAVENOUS	20171004		ANDA	ANDA205228	Zydus Pharmaceuticals (USA) Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
68382-896_5a958db7-5c0e-4cf0-9227-230886cf9bf8	68382-896	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Pharmaceuticals USA Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68382-897_5a958db7-5c0e-4cf0-9227-230886cf9bf8	68382-897	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Pharmaceuticals USA Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68382-898_5a958db7-5c0e-4cf0-9227-230886cf9bf8	68382-898	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Pharmaceuticals USA Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68382-899_5a958db7-5c0e-4cf0-9227-230886cf9bf8	68382-899	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Pharmaceuticals USA Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68382-910_c89e4254-ee90-4bcc-8f75-ecac716a8f1b	68382-910	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180201		ANDA	ANDA207757	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-911_c89e4254-ee90-4bcc-8f75-ecac716a8f1b	68382-911	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180201		ANDA	ANDA207757	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE HYCLATE	200	mg/20mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68382-912_cf2c3e5b-9c4b-455b-8f0b-d2573bf6e339	68382-912	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod	CAPSULE	ORAL	20221011		ANDA	ANDA207994	Zydus Pharmaceuticals USA Inc.	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
68382-913_e34fafdf-2fda-4031-9202-6d7e85925dc1	68382-913	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET	ORAL	20200430		ANDA	ANDA213065	Zydus Pharmaceuticals USA Inc.	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
68382-914_e34fafdf-2fda-4031-9202-6d7e85925dc1	68382-914	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET	ORAL	20200430		ANDA	ANDA213065	Zydus Pharmaceuticals USA Inc.	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
68382-915_e34fafdf-2fda-4031-9202-6d7e85925dc1	68382-915	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET	ORAL	20200430		ANDA	ANDA213065	Zydus Pharmaceuticals USA Inc.	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
68382-916_67799c09-3d66-47e4-99f4-7dca4fc3344c	68382-916	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Pharmaceuticals USA Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68382-917_67799c09-3d66-47e4-99f4-7dca4fc3344c	68382-917	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Pharmaceuticals USA Inc.	METHYLPREDNISOLONE	8	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68382-918_67799c09-3d66-47e4-99f4-7dca4fc3344c	68382-918	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Pharmaceuticals USA Inc.	METHYLPREDNISOLONE	16	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68382-919_67799c09-3d66-47e4-99f4-7dca4fc3344c	68382-919	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Pharmaceuticals USA Inc.	METHYLPREDNISOLONE	32	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68382-920_b9646f09-8d5b-4271-b2b1-b1d66a91ed73	68382-920	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20170810		ANDA	ANDA206745	Zydus Pharmaceuticals USA Inc.	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
68382-921_b9646f09-8d5b-4271-b2b1-b1d66a91ed73	68382-921	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20170810		ANDA	ANDA206745	Zydus Pharmaceuticals USA Inc.	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
68382-922_669aad4d-c160-4be8-bca9-bdbaf0f3c8a3	68382-922	HUMAN PRESCRIPTION DRUG	Eletriptan hydrobromide		Eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170712		ANDA	ANDA206409	Zydus Pharmaceuticals USA Inc.	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68382-923_669aad4d-c160-4be8-bca9-bdbaf0f3c8a3	68382-923	HUMAN PRESCRIPTION DRUG	Eletriptan hydrobromide		Eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170712		ANDA	ANDA206409	Zydus Pharmaceuticals USA Inc.	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68382-927_cf71e29b-40b3-470b-b837-5a4bdd6f9409	68382-927	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Pharmaceuticals USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-928_cf71e29b-40b3-470b-b837-5a4bdd6f9409	68382-928	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Pharmaceuticals USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-929_cf71e29b-40b3-470b-b837-5a4bdd6f9409	68382-929	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Pharmaceuticals USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-930_cf71e29b-40b3-470b-b837-5a4bdd6f9409	68382-930	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Pharmaceuticals USA Inc.	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68382-965_8432a974-7edb-4544-ab9b-c57912dd6780	68382-965	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Pharmaceuticals USA Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-966_8432a974-7edb-4544-ab9b-c57912dd6780	68382-966	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Pharmaceuticals USA Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-967_8432a974-7edb-4544-ab9b-c57912dd6780	68382-967	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Pharmaceuticals USA Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-968_8432a974-7edb-4544-ab9b-c57912dd6780	68382-968	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Pharmaceuticals USA Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68382-969_09d92588-691b-4f6f-9cba-b1fa3548c24d	68382-969	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20221003		ANDA	ANDA208303	Zydus Pharmaceuticals USA Inc.	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
68382-970_1db5deb3-2699-4c73-a11e-1e4aa12e97fb	68382-970	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190515		ANDA	ANDA207813	Zydus Pharmaceuticals USA Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
68382-971_1db5deb3-2699-4c73-a11e-1e4aa12e97fb	68382-971	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190515		ANDA	ANDA207813	Zydus Pharmaceuticals USA Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
68382-979_11b431ca-e7f1-4ef2-b2d6-1be2294d09b2	68382-979	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-980_11b431ca-e7f1-4ef2-b2d6-1be2294d09b2	68382-980	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-981_11b431ca-e7f1-4ef2-b2d6-1be2294d09b2	68382-981	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-982_11b431ca-e7f1-4ef2-b2d6-1be2294d09b2	68382-982	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-983_11b431ca-e7f1-4ef2-b2d6-1be2294d09b2	68382-983	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-984_11b431ca-e7f1-4ef2-b2d6-1be2294d09b2	68382-984	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Pharmaceuticals USA Inc.	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68382-987_a91df415-ca99-476a-b7b7-11e5d2c169db	68382-987	HUMAN PRESCRIPTION DRUG	Solifenacin		Solifenacin	TABLET, FILM COATED	ORAL	20220210		ANDA	ANDA207721	Zydus Pharmaceuticals USA Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68382-988_a91df415-ca99-476a-b7b7-11e5d2c169db	68382-988	HUMAN PRESCRIPTION DRUG	Solifenacin		Solifenacin	TABLET, FILM COATED	ORAL	20220210		ANDA	ANDA207721	Zydus Pharmaceuticals USA Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68382-989_0a3420aa-1a9c-4595-89e2-01c2a433a504	68382-989	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20170801		ANDA	ANDA205968	Zydus Pharmaceuticals USA Inc.	LEVOFLOXACIN	25	mg/mL			N	20241231
68382-997_11b2ed41-29fc-4198-8d2e-1c353893fd8f	68382-997	HUMAN PRESCRIPTION DRUG	Arsenic trioxide		Arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20181114		ANDA	ANDA206228	Zydus Pharmaceuticals USA Inc.	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
68382-998_4c2a6cc1-353f-4ed0-8a4a-a4d693d3e624	68382-998	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	SPRAY	TOPICAL	20170712		ANDA	ANDA206378	Zydus Pharmaceuticals USA Inc.	CLOBETASOL PROPIONATE	.05	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68391-000_6792a293-6488-4eb4-adb6-0d8dbe93d4fc	68391-000	HUMAN OTC DRUG	berkley and jensen mucus relief		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210404		ANDA	ANDA213420	BJWC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68391-002_066d006e-0a03-0290-e063-6394a90af03c	68391-002	HUMAN OTC DRUG	Berkley Jensen Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20200220		OTC MONOGRAPH FINAL	M020	BJWC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
68391-004_4ff2945e-937d-4b35-9505-c8003c392f22	68391-004	HUMAN OTC DRUG	Berley and Jensen Pain Relief		Acetaminophen	TABLET, FILM COATED	ORAL	20151130		OTC MONOGRAPH NOT FINAL	part343	BJWC	ACETAMINOPHEN	500	mg/1			N	20241231
68391-012_d64daaf2-8413-4aec-ad60-dbf40838021f	68391-012	HUMAN OTC DRUG	Berkley and Jensen NICOTINE		Nicotine polacrilex	GUM, CHEWING	ORAL	20170228		ANDA	ANDA206394	BJWC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-023_07f395ea-0370-4519-868f-7a1d94cc3b88	68391-023	HUMAN OTC DRUG	Berkley and Jensen Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210730		ANDA	ANDA203690	BJWC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-029_0da9972a-25e2-480d-bdf7-1e7a28bdfb77	68391-029	HUMAN OTC DRUG	berkley and jensen nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20060119		ANDA	ANDA076775	BJWC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-041_41e5a780-8e3d-48d5-8f50-94f15ca7cd39	68391-041	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210131		OTC MONOGRAPH NOT FINAL	part334	BJWC (Berkley & Jensen / BJ's)	DOCUSATE SODIUM	100	mg/1			N	20241231
68391-063_f5b3f4ae-a3a8-4ca3-ab34-71a029ad478b	68391-063	HUMAN OTC DRUG	Aspirin	Low Dose Safety Coated	Aspirin	TABLET, COATED	ORAL	20210820		OTC MONOGRAPH FINAL	part343	BJWC (Berkley & Jensen / BJ's)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68391-100_d324b538-0044-49fa-ae94-6b0276ffe73a	68391-100	HUMAN OTC DRUG	berkley and jensen anti itch		Hydrocortisone	CREAM	TOPICAL	20141209		OTC MONOGRAPH NOT FINAL	part348	BJWC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68391-102_200512e5-2925-40cc-adeb-af2d7863f26d	68391-102	HUMAN OTC DRUG	Extra Strength	Assorted Berry	calcium carbonate	TABLET, CHEWABLE	ORAL	20190514		OTC MONOGRAPH FINAL	part331	BJWC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68391-103_1729c60d-3475-45cd-b192-f88438403d1a	68391-103	HUMAN OTC DRUG	berkley and jensen omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20200309		NDA	NDA209400	BJWC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68391-117_db94410d-dbc3-4ed3-a44b-d46bcadad19a	68391-117	HUMAN OTC DRUG	Berkley and Jensen Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20120522		ANDA	ANDA202319	BJWC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68391-133_1c9af35f-9524-4371-82ef-c5d10c72ba5d	68391-133	HUMAN OTC DRUG	Berkley and Jensen Allergy Relief		Fluticasone propionate	SPRAY, METERED	NASAL	20160627		ANDA	ANDA207957	BJWC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68391-170_5af637bc-d55b-4928-9cd3-fb25c58b6ee1	68391-170	HUMAN OTC DRUG	berkley and jensen nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20060118		ANDA	ANDA076789	BJWC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-186_6bfbe7eb-4619-430d-a7be-01a2e2e67868	68391-186	HUMAN OTC DRUG	berkley and jensen sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20200723		OTC MONOGRAPH FINAL	part338	BJWC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68391-199_c8eba165-67d4-497a-98dd-42b4b17592dd	68391-199	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20130515	20240515	ANDA	ANDA078682	BJWC (Berkley & Jensen / BJ's)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
68391-200_0422837a-c7cb-4809-9ba6-2b013d09a569	68391-200	HUMAN OTC DRUG	Berkley and Jensen Allergy Relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20131210		OTC MONOGRAPH FINAL	part341	BJWC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68391-205_f8497dc3-9d28-4ad9-8770-eb36ed0563cb	68391-205	HUMAN OTC DRUG	berkley and jensen arthritis pain		diclofenac sodium	KIT		20211110		ANDA	ANDA211253	BJWC						N	20241231
68391-207_efdbd98a-633f-4055-a8f0-4bda06cb1817	68391-207	HUMAN OTC DRUG	berkley and jensen triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20141030		OTC MONOGRAPH FINAL	part333B	BJWC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68391-212_f048e58a-629a-281a-e053-2995a90aa20c	68391-212	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190814		ANDA	ANDA078682	BJWC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68391-224_b07567e4-fd50-4071-b5c7-79b02aab0ea5	68391-224	HUMAN OTC DRUG	berkley and jensen anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030419		ANDA	ANDA075232	BJWC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68391-227_22501613-13a3-46c3-8baa-42ec3ced2f32	68391-227	HUMAN OTC DRUG	Aspirin	Low Dose Safety Coated	Aspirin	TABLET, COATED	ORAL	20130331	20240331	OTC MONOGRAPH FINAL	part343	BJWC (Berkley & Jensen / BJ's)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
68391-288_5fc8e055-c4c7-4b44-9783-b3a2c2f1123d	68391-288	HUMAN OTC DRUG	Childrens Pain Reliever		Acetaminophen	SUSPENSION	ORAL	20190830		OTC MONOGRAPH NOT FINAL	part343	BJWC (Berkley & Jensen / BJ's)	ACETAMINOPHEN	160	mg/5mL			N	20241231
68391-294_e97e443a-b083-4785-9b18-b32253ceec58	68391-294	HUMAN OTC DRUG	berkley and jensen minoxidil		Minoxidil	AEROSOL, FOAM	TOPICAL	20181101		ANDA	ANDA091344	BJWC	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68391-299_b2de91c9-6af0-4881-8d2d-a69d90c8dfcd	68391-299	HUMAN OTC DRUG	berkley and jensen tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20220102		OTC MONOGRAPH FINAL	part341	BJWC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68391-300_125eed5f-e261-4ae2-b9b0-74d9fa795de7	68391-300	HUMAN OTC DRUG	berkley and jensen famotidine		Famotidine	TABLET, FILM COATED	ORAL	20131209		ANDA	ANDA077351	BJWC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68391-301_d225af70-1bf7-41ab-8bd9-1e7450f85932	68391-301	HUMAN OTC DRUG	Berkley and Jensen Childrens Allergy Relief		loratadine	TABLET, CHEWABLE	ORAL	20220125		ANDA	ANDA210033	BJWC	LORATADINE	5	mg/1			N	20241231
68391-302_564e9005-27b3-4caa-ab1d-eaf4817b35c2	68391-302	HUMAN OTC DRUG	berkley and jensen minoxidil		minoxidil	SOLUTION	TOPICAL	20220723		ANDA	ANDA075598	BJWC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68391-306_96160276-65ec-4a20-b8e0-c8c38a87bc6a	68391-306	HUMAN OTC DRUG	berkley and jensen clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091217		ANDA	ANDA090685	BJWC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68391-309_8e17de16-e2e0-4498-be13-7e4348a539ec	68391-309	HUMAN OTC DRUG	Berkley and Jensen Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20170228		ANDA	ANDA206393	BJWC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-314_757f7ce9-6aa1-4244-88ac-5c09cbbbd33d	68391-314	HUMAN OTC DRUG	Berkley and Jensen Allergy Relief		Loratadine	TABLET	ORAL	20090417		ANDA	ANDA076301	BJWC	LORATADINE	10	mg/1			N	20241231
68391-344_857cf1ac-8862-44a6-b145-a03cce37cf13	68391-344	HUMAN OTC DRUG	berkley and jensen nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20060502		ANDA	ANDA077007	BJWC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-368_e7a353d9-6154-4649-9678-110b5813a41f	68391-368	HUMAN OTC DRUG	Berkley and Jensen Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20070917		ANDA	ANDA074661	BJWC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68391-416_792779e3-a56d-40f4-84e9-f17a27376db2	68391-416	HUMAN OTC DRUG	Berkley and Jensen Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20080723		OTC MONOGRAPH NOT FINAL	part343	BJWC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68391-484_8c54db67-470a-4e48-9cbb-cbae2bf904b6	68391-484	HUMAN OTC DRUG	berkley and jensen pain relief	extra strength	Acetaminophen	TABLET	ORAL	20060918		OTC MONOGRAPH NOT FINAL	part343	BJWC	ACETAMINOPHEN	500	mg/1			N	20241231
68391-487_32a9f115-701e-4e94-835c-d412cac18883	68391-487	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20180228		OTC MONOGRAPH FINAL	part347	BJWC (Berkley & Jensen / BJ's)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68391-500_ba24d91e-8050-4e3d-a014-ee048e9388b3	68391-500	HUMAN OTC DRUG	Berkley and Jensen Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20131126		ANDA	ANDA078336	BJWC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68391-578_171b571a-de2b-494d-b369-0257ec099a39	68391-578	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180131	20241227	OTC MONOGRAPH NOT FINAL	part334	BJWC (Berkley & Jensen / BJ's)	DOCUSATE SODIUM	100	mg/1			N	
68391-597_8059a5cb-cb4b-4222-b7ae-513801f65690	68391-597	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20191030		OTC MONOGRAPH FINAL	part347	BJWC (Berkley & Jensen / BJ's)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68391-604_4fb939fe-b1fa-428c-8cd2-31908d56a1fb	68391-604	HUMAN OTC DRUG	Berkley and Jensen Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20070620		ANDA	ANDA072096	BJWC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68391-659_dee57d73-73ac-48bb-b1da-9971f1ff21c4	68391-659	HUMAN OTC DRUG	berkley and jensen acetaminophen		Acetaminophen	TABLET	ORAL	20230321		OTC MONOGRAPH NOT FINAL	part343	BJWC	ACETAMINOPHEN	500	mg/1			N	20241231
68391-669_847d579b-ba77-4b03-9578-12f0a63960b2	68391-669	HUMAN OTC DRUG	Berkley and Jensen Arthritis Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140508	20240331	ANDA	ANDA075077	BJWC	ACETAMINOPHEN	650	mg/1			N	
68391-721_77cbe75d-4ed9-4a8b-91dc-1cc28af25508	68391-721	HUMAN OTC DRUG	berkley and jensen nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20210604		OTC MONOGRAPH FINAL	part341	BJWC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
68391-734_1055f032-3a6e-40d3-8343-d144953c143d	68391-734	HUMAN OTC DRUG	berkley and jensen nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20171106		ANDA	ANDA203690	BJWC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-744_6f8f3a3e-4d0c-4da4-b27e-e26e498184c1	68391-744	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20180630	20241227	OTC MONOGRAPH FINAL	part341	BJWC (Berkley & Jensen / BJ's)						N	
68391-800_79a851a4-de62-432f-8365-cb272a98c56b	68391-800	HUMAN OTC DRUG	bjwc nicotine		nicotine polacrilex	LOZENGE	ORAL	20210730		ANDA	ANDA203690	BJWC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-812_d3b94cce-e6f3-43ec-a927-7b7183744433	68391-812	HUMAN OTC DRUG	Berkley and Jensen Mucus Relief DM		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20200715		ANDA	ANDA207602	BJWC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68391-847_2f073639-3684-424e-ac35-b21ec71c63ec	68391-847	HUMAN OTC DRUG	berkley jensen allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20220227		ANDA	ANDA212971	BJWC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68391-850_227ba4a9-aa60-4cb3-b71a-cdf1ecb2d878	68391-850	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief	Multi Symptom	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20191030	20241231	OTC MONOGRAPH DRUG	M012	BJWC (Berkley & Jensen / BJ's)						N	
68391-853_853abc1f-500d-47e6-a3fc-4adf5f13ba87	68391-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210129		OTC MONOGRAPH NOT FINAL	part334	BJWC (Berkley & Jensen / BJ's)	DOCUSATE SODIUM	100	mg/1			N	20241231
68391-863_255c3ac8-87c2-4a37-a86f-32ded4abe485	68391-863	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCL	TABLET, COATED	ORAL	20191129		OTC MONOGRAPH NOT FINAL	part343	BJWC (Berkley & Jensen / BJ's)	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68391-867_0bc6e394-ee04-4b0b-afe4-8732c2b961d5	68391-867	HUMAN OTC DRUG	Aspirin	Enteric Safety-Coated	Aspirin	TABLET	ORAL	20210226		OTC MONOGRAPH NOT FINAL	part343	BJWC (Berkley & Jensen / BJ's)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68391-873_1bed10ac-1a5d-47cb-9133-d47dbae120ca	68391-873	HUMAN OTC DRUG	berkley and jensen nicotine polacrilex		Nicotine Polacrilex	LOZENGE	ORAL	20060502		ANDA	ANDA077007	BJWC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68391-898_d6ed604d-d246-4192-bc98-bfad41f9f49b	68391-898	HUMAN OTC DRUG	berkley and jensen heartburn treatment		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170925		ANDA	ANDA207193	BJWC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68391-915_f64cd02d-1553-4a2c-9f60-87a508231444	68391-915	HUMAN OTC DRUG	Berkley and Jensen Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20080228		NDA	NDA022032	BJWC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68391-957_357123fc-0972-4683-ab52-f95d46c1b6c9	68391-957	HUMAN OTC DRUG	berkley and jensen nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20171106		ANDA	ANDA203690	BJWC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
68400-105_d5f6075e-a449-6903-e053-2995a90a44c0	68400-105	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-106_d5f621e8-9a23-8add-e053-2a95a90a5ddf	68400-106	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-107_d5f621e8-9a2d-8add-e053-2a95a90a5ddf	68400-107	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121218		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-108_d5f638bd-b417-b909-e053-2a95a90a6cdc	68400-108	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-109_d5f64c1b-8495-1049-e053-2995a90a7d33	68400-109	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-110_d5f4f5b4-2d8a-6c1b-e053-2995a90ab23b	68400-110	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-111_d5f663e8-fcb5-21f9-e053-2995a90a98d1	68400-111	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-114_d5f6c7fd-92e2-07ba-e053-2995a90adf52	68400-114	HUMAN PRESCRIPTION DRUG	Gelato Neutral pH		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	4.086	g/454g			N	20241231
68400-115_d5f6699c-aeb6-1447-e053-2995a90a8b66	68400-115	HUMAN PRESCRIPTION DRUG	Gelato Neutral pH		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	4.086	g/454g			N	20241231
68400-120_d604bf8a-9ce7-09a3-e053-2a95a90a92c6	68400-120	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-121_d604cb55-d4d7-4124-e053-2995a90ac30c	68400-121	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-122_d604cf11-7991-e39b-e053-2a95a90acc87	68400-122	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-135_d6070e3f-0e5d-579e-e053-2995a90ad0a5	68400-135	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20121218		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-136_d6072267-0a66-4b92-e053-2995a90a5673	68400-136	HUMAN PRESCRIPTION DRUG	Gelato Neutral pH		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	SODIUM FLUORIDE	4.086	g/454g			N	20241231
68400-201_d6094e54-f558-efa4-e053-2995a90a273e	68400-201	HUMAN OTC DRUG	Gelato Homecare		Stannous Fluoride	GEL	DENTAL	20130105		OTC MONOGRAPH FINAL	part355	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	STANNOUS FLUORIDE	.116	g/120g			N	20241231
68400-202_d60949c4-3bc6-2cd9-e053-2a95a90af5d7	68400-202	HUMAN PRESCRIPTION DRUG	Gelato Perio Maintenance Rinse		Stannous Fluoride	CONCENTRATE	DENTAL	20130201		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	STANNOUS FLUORIDE	.34	g/283.5g			N	20241231
68400-203_d6095e73-2eed-5f18-e053-2995a90abe8f	68400-203	HUMAN PRESCRIPTION DRUG	Hemox A		Aluminum Chloride	SOLUTION	DENTAL	20130115		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	ALUMINUM CHLORIDE	7500	mg/30mL			N	20241231
68400-205_d60925e7-e4c8-13e5-e053-2a95a90a42ec	68400-205	HUMAN OTC DRUG	Gelato Homecare		Stannous Fluoride	GEL	DENTAL	20130105		OTC MONOGRAPH FINAL	part355	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	STANNOUS FLUORIDE	.116	g/120g			N	20241231
68400-206_d6095e73-2efc-5f18-e053-2995a90abe8f	68400-206	HUMAN PRESCRIPTION DRUG	Gelato Perio Maintenance Rinse		Stannous Fluoride	CONCENTRATE	DENTAL	20130201		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	STANNOUS FLUORIDE	.34	g/283.5g			N	20241231
68400-313_d6193ae4-a608-c9ad-e053-2a95a90a3bc1	68400-313	HUMAN PRESCRIPTION DRUG	Gelato APF		Sodium Fluoride	GEL	DENTAL	20140401		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-324_d619b7f1-b496-dafb-e053-2995a90a321d	68400-324	HUMAN PRESCRIPTION DRUG	Gelato Neutral pH		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	SODIUM FLUORIDE	4.086	g/454g			N	20241231
68400-350_0bf0bc6f-cf4d-609d-e063-6394a90af47f	68400-350	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-351_0bf0c3c9-9905-5fdc-e063-6394a90a3ea3	68400-351	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-352_0bf1220f-a6ad-8a62-e063-6394a90af47e	68400-352	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-353_0bf12605-5efb-3444-e063-6394a90aa494	68400-353	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-354_0bf1202d-1d68-7707-e063-6394a90a8ce4	68400-354	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-355_0bf12bf6-737a-87c1-e063-6394a90aa1dd	68400-355	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-357_0bf0efac-c20b-5e3a-e063-6394a90a6d53	68400-357	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-358_0bf12c6e-a371-7f42-e063-6294a90a7a42	68400-358	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-359_0bf139da-afbc-8990-e063-6294a90ab1c4	68400-359	HUMAN OTC DRUG	Gelato Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-456_d66f5dca-ff7f-25ca-e053-2995a90a2101	68400-456	HUMAN OTC DRUG	Comfortcaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20181101		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-457_d66f5b8f-1adc-0c5d-e053-2995a90ab9b3	68400-457	HUMAN OTC DRUG	Comfortcaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20181101		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-458_d66f5dca-ff8b-25ca-e053-2995a90a2101	68400-458	HUMAN OTC DRUG	Comfortcaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20181101		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-459_d66f5b8f-1ae8-0c5d-e053-2995a90ab9b3	68400-459	HUMAN OTC DRUG	Comfortcaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20181101		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-460_d66f65f3-e6f2-4b55-e053-2a95a90a380b	68400-460	HUMAN OTC DRUG	Comfortcaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20181101		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-461_d66f65f3-e6fe-4b55-e053-2a95a90a380b	68400-461	HUMAN OTC DRUG	Comfortcaine Topical Anesthetic		Benzocaine	GEL	DENTAL	20181101		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-475_d721864d-0951-8379-e053-2a95a90a3bcb	68400-475	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20220203		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-477_d72206de-36a0-b772-e053-2a95a90a0c69	68400-477	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20220203		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-478_d722bf24-ae86-54f6-e053-2995a90a1d35	68400-478	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20220203		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-479_d722dff9-a204-754f-e053-2a95a90a56ea	68400-479	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20220203		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-486_d66bd464-a6ab-5665-e053-2995a90ab79c	68400-486	HUMAN OTC DRUG	Optimize Thick Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-486_d66c045d-d1ec-2bd7-e053-2a95a90ae72c	68400-486	HUMAN OTC DRUG	Optimize Thick Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-486_d66c3b0a-efc3-f4ba-e053-2995a90af59b	68400-486	HUMAN OTC DRUG	Optimize Thick Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-486_d66c4db5-8521-62f9-e053-2995a90a91a8	68400-486	HUMAN OTC DRUG	Optimize Thick Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-486_d66c5ac2-a8d8-9c68-e053-2a95a90ad687	68400-486	HUMAN OTC DRUG	Optimize Thick Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-487_d66c3279-d348-13b5-e053-2a95a90a6ba1	68400-487	HUMAN OTC DRUG	Thick Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-488_d66c5bc3-023c-3bf7-e053-2a95a90a240d	68400-488	HUMAN OTC DRUG	Boys Lie Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-489_d66f0cf8-0961-252a-e053-2a95a90aee09	68400-489	HUMAN OTC DRUG	Alcohol Antiseptic 70% Topical Solution		ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	L/100L			N	20241231
68400-489_d66f23da-49d1-9990-e053-2a95a90a4df5	68400-489	HUMAN OTC DRUG	Alcohol Antiseptic 70% Topical Solution		ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	L/100L			N	20241231
68400-489_d66f4041-2b1c-9a59-e053-2995a90adf3c	68400-489	HUMAN OTC DRUG	Alcohol Antiseptic 70% Topical Solution		ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	L/100L			N	20241231
68400-490_d66f4853-2e4b-0fcb-e053-2a95a90a54a6	68400-490	HUMAN OTC DRUG	Thick Hand Sanitizer - Ocean Breeze		ALCOHOL	GEL	TOPICAL	20201013		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	L/100L			N	20241231
68400-498_d7203ffc-628b-5342-e053-2a95a90a0df7	68400-498	HUMAN OTC DRUG	Hand Sanitizer With Aloe Vera Vitamin E		ALCOHOL	GEL	TOPICAL	20220203		OTC MONOGRAPH NOT FINAL	part333A	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc	ALCOHOL	70	mL/100mL			N	20241231
68400-508_0bdc149b-b8e4-879e-e063-6394a90a13b3	68400-508	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20220203		OTC MONOGRAPH DRUG	M022	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-509_d7c6b892-9e3a-347e-e053-2995a90a9800	68400-509	HUMAN OTC DRUG	Quala Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20220203		OTC MONOGRAPH NOT FINAL	part356	Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68400-700_d65b4b20-1bc2-ae1d-e053-2a95a90a0eea	68400-700	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-701_d65b30ba-bedf-e771-e053-2a95a90a8928	68400-701	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-702_d65b464a-7582-b814-e053-2995a90aec49	68400-702	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-703_d65b464a-7578-b814-e053-2995a90aec49	68400-703	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-704_d65b464a-758e-b814-e053-2995a90aec49	68400-704	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-705_d65b50b3-5ae1-dd76-e053-2a95a90aafc8	68400-705	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-706_d65b53aa-3769-3e4c-e053-2995a90abb64	68400-706	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-707_d65b53aa-3773-3e4c-e053-2995a90abb64	68400-707	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68400-708_d65b586d-bd13-b808-e053-2995a90a0c6b	68400-708	HUMAN PRESCRIPTION DRUG	Sorbet APF		Sodium Fluoride	GEL	DENTAL	20121214		UNAPPROVED DRUG OTHER		Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68403-1100_a07b1223-ea6c-43d6-9c57-2fcd604e982f	68403-1100	HUMAN PRESCRIPTION DRUG	BabyBIG		human botulinum neurotoxin a/b immune globulin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20031023		BLA	BLA125034	CALIFORNIA DEPARTMENT OF PUBLIC HEALTH	HUMAN BOTULINUM NEUROTOXIN A/B IMMUNE GLOBULIN	50	mg/mL	Antitoxins [CS], Bacterial Neurotoxin Neutralization [MoA], Human Immunoglobulin G [EPC], Passively Acquired Immunity [PE]		N	20241231
68421-8100_d33a6568-11e9-426b-8eb0-0cfd44ede2ff	68421-8100	HUMAN OTC DRUG	Dental Relief		benzocaine	LIQUID	TOPICAL	20160506		OTC MONOGRAPH NOT FINAL	part356	Cintas First Aid & Safety	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68428-000_7e3e9fce-f333-8cc9-e053-2a91aa0aad73	68428-000	HUMAN OTC DRUG	Abelmoschus		ABELMOSCHUS MOSCHATUS SEED	LIQUID	ORAL	20110126		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ABELMOSCHUS MOSCHATUS SEED	30	[hp_C]/mL			N	20241231
68428-001_9a67169d-6b04-3406-e053-2995a90a60e4	68428-001	HUMAN OTC DRUG	Spongatos		ACONITUM NAPELLUS - IPECAC - CALCIUM SULFIDE - SPONGIA OFFICINALIS	LIQUID	ORAL	20100407		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACONITUM NAPELLUS; CALCIUM SULFIDE; IPECAC; SPONGIA OFFICINALIS SKELETON, ROASTED	3; 12; 4; 3	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL			N	20241231
68428-002_9a673225-27bd-040a-e053-2a95a90a0a98	68428-002	HUMAN OTC DRUG	Diarrhea		ARSENIC TRIOXIDE - CUPRIC ARSENITE - VERATRUM ALBUM ROOT	PELLET	ORAL	20100812		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; CUPRIC ARSENITE; VERATRUM ALBUM ROOT	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-003_9a673a65-fc4e-3d9e-e053-2a95a90ad2f0	68428-003	HUMAN OTC DRUG	Sinus		CALCIUM CARBONATE - GOLDENSEAL - POTASSIUM DICHROMATE	PELLET	ORAL	20100512		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GOLDENSEAL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-004_9a673e6b-e0e5-77c2-e053-2995a90ac766	68428-004	HUMAN OTC DRUG	Stomach Disorders		SOLANUM DULCAMARA TOP - ACTIVATED CHARCOAL - CHELONE GLABRA - GOLDENSEAL	PELLET	ORAL	20100713		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACTIVATED CHARCOAL; CHELONE GLABRA; GOLDENSEAL; SOLANUM DULCAMARA TOP	6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-005_9a673e6b-e0ec-77c2-e053-2995a90ac766	68428-005	HUMAN OTC DRUG	Teething		TRIBASIC CALCIUM PHOSPHATE - MATRICARIA RECUTITA - ARABICA COFFEE BEAN	PELLET	ORAL	20100824		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN; MATRICARIA RECUTITA; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-007_9a67a37f-e5f7-494f-e053-2a95a90a6651	68428-007	HUMAN OTC DRUG	Flatulence		FERULA ASSA-FOETIDA RESIN - STRYCHNOS IGNATII SEED - NUTMEG	PELLET	ORAL	20100713		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FERULA ASSA-FOETIDA RESIN; NUTMEG; STRYCHNOS IGNATII SEED	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-009_9a67d130-efc3-5822-e053-2a95a90afe04	68428-009	HUMAN OTC DRUG	Fungus		GRAPHITE - SEPIA OFFICINALIS JUICE - SULFUR - THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	20100707		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GRAPHITE; SEPIA OFFICINALIS JUICE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-010_9a67e388-d7bb-0ce6-e053-2995a90ae5c4	68428-010	HUMAN OTC DRUG	Constipation		CAPSICUM - GOLDENSEAL - VERONICASTRUM VIRGINICUM ROOT - STRYCHNOS NUX-VOMICA SEED - PODOPHYLLUM RESIN	PELLET	ORAL	20100707		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAPSICUM; GOLDENSEAL; PODOPHYLLUM RESIN; STRYCHNOS NUX-VOMICA SEED; VERONICASTRUM VIRGINICUM ROOT	6; 6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
68428-011_9a67f656-fb6a-5877-e053-2a95a90ad2f5	68428-011	HUMAN OTC DRUG	Hay Fever		ONION - ANTHOXANTHUM ODORATUM - SCHOENOCAULON OFFICINALE SEED	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANTHOXANTHUM ODORATUM; ONION; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
68428-012_9a67a989-ec6d-4a26-e053-2a95a90a826d	68428-012	HUMAN OTC DRUG	Headache Congested		CALCIUM FLUORIDE - FERRUM PHOSPHORICUM - SODIUM PHOSPHATE, DIBASIC ANHYDROUS - SODIUM CHLORIDE	PELLET	ORAL	20100504		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALCIUM FLUORIDE; FERROSOFERRIC PHOSPHATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-013_9a67fe5d-8137-5964-e053-2a95a90a6460	68428-013	HUMAN OTC DRUG	Minor Arthritic Pain		APIS MELLIFERA - BLACK COHOSH - CALCIUM FLUORIDE - SODIUM PHOSPHATE, DIBASIC ANHYDROUS - SODIUM CHLORIDE - TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	20100707		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	APIS MELLIFERA; BLACK COHOSH; CALCIUM FLUORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
68428-017_9a681267-5565-53f6-e053-2a95a90a4182	68428-017	HUMAN OTC DRUG	Acne		ANTIMONY TRISULFIDE - MAHONIA AQUIFOLIUM ROOT BARK - LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	20100402		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANTIMONY TRISULFIDE; MAHONIA AQUIFOLIUM ROOT BARK; SEPIA OFFICINALIS JUICE	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-020_9a67a33c-d8e6-3ae2-e053-2a95a90a0915	68428-020	HUMAN OTC DRUG	Hot Flashes		AMYL NITRITE - LACHESIS MUTA VENOM - SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	20100402		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	AMYL NITRITE; LACHESIS MUTA VENOM; SANGUINARIA CANADENSIS ROOT	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-021_9a67a989-ec5d-4a26-e053-2a95a90a826d	68428-021	HUMAN OTC DRUG	Insomnia		MATRICARIA RECUTITA - ARABICA COFFEE BEAN - HYOSCYAMUS NIGER - STRYCHNOS IGNATII SEED - PASSIFLORA INCARNATA TOP	PELLET	ORAL	20100402		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN; HYOSCYAMUS NIGER; MATRICARIA RECUTITA; PASSIFLORA INCARNATA TOP; STRYCHNOS IGNATII SEED	6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-022_9a67a37f-e5cf-494f-e053-2a95a90a6651	68428-022	HUMAN OTC DRUG	Low Back Pain		BLACK COHOSH - COLCHICUM AUTUMNALE BULB - POTASSIUM IODIDE	PELLET	ORAL	20100727		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BLACK COHOSH; COLCHICUM AUTUMNALE BULB; POTASSIUM IODIDE	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-023_9a673ea2-c141-53d6-e053-2995a90ad929	68428-023	HUMAN OTC DRUG	Headache		EPIFAGUS VIRGINIANA - IRIS VERSICOLOR ROOT - STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20100331		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EPIFAGUS VIRGINIANA; IRIS VERSICOLOR ROOT; STRYCHNOS NUX-VOMICA SEED	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-024_9a67802e-98c8-0967-e053-2995a90a73c2	68428-024	HUMAN OTC DRUG	Motion Sickness		ANAMIRTA COCCULUS SEED - STRYCHNOS NUX-VOMICA SEED - KEROSENE	PELLET	ORAL	20100505		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANAMIRTA COCCULUS SEED; KEROSENE; STRYCHNOS NUX-VOMICA SEED	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-025_9a677023-7776-8f74-e053-2a95a90a7939	68428-025	HUMAN OTC DRUG	Stop Smoking		DIEFFENBACHIA SEGUINE - DAPHNE ODORA BARK - STRYCHNOS NUX-VOMICA SEED - PLANTAGO MAJOR - DELPHINIUM STAPHISAGRIA SEED - TOBACCO LEAF	PELLET	ORAL	20100402		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DAPHNE ODORA BARK; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; PLANTAGO MAJOR; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	6; 6; 6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-026_99776952-6d8f-4a7b-e053-2995a90a9435	68428-026	HUMAN OTC DRUG	Aconitum Napellus Kit Refill		ACONITUM NAPELLUS	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACONITUM NAPELLUS	200	[hp_C]/1			N	20241231
68428-028_997a31dc-4b5e-4949-e053-2a95a90aaa61	68428-028	HUMAN OTC DRUG	Allium Cepa Kit Refill		ONION	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ONION	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
68428-030_997b814d-bf24-40b4-e053-2995a90a91db	68428-030	HUMAN OTC DRUG	Apis Mellifica Kit Refill		APIS MELLIFERA	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	APIS MELLIFERA	200	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
68428-032_997ba2de-d39a-fb8a-e053-2a95a90a0755	68428-032	HUMAN OTC DRUG	Arnica Montana Kit Refill		ARNICA MONTANA	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARNICA MONTANA	200	[hp_C]/1			N	20241231
68428-033_997bbecb-032a-fb80-e053-2a95a90a13d4	68428-033	HUMAN OTC DRUG	Arsenicum Album Kit Refill		ARSENIC TRIOXIDE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE	200	[hp_C]/1			N	20241231
68428-034_997c26cb-49fa-afc0-e053-2995a90a0d18	68428-034	HUMAN OTC DRUG	Belladonna Kit Refill		ATROPA BELLADONNA	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ATROPA BELLADONNA	200	[hp_C]/1			N	20241231
68428-035_997c464d-6377-3855-e053-2a95a90ad37f	68428-035	HUMAN OTC DRUG	Bryonia Alba Kit Refill		BRYONIA ALBA ROOT	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BRYONIA ALBA ROOT	200	[hp_C]/1			N	20241231
68428-036_997d2f0a-32d0-1b1e-e053-2a95a90a4661	68428-036	HUMAN OTC DRUG	Calcarea Carbonica Kit Refill		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	OYSTER SHELL CALCIUM CARBONATE, CRUDE	200	[hp_C]/1			N	20241231
68428-040_998e2152-1ff8-6fb3-e053-2995a90a1a6e	68428-040	HUMAN OTC DRUG	Caulophyllum Thal Kit Refill		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAULOPHYLLUM THALICTROIDES ROOT	200	[hp_C]/1			N	20241231
68428-041_998e43ac-853c-d53c-e053-2a95a90aa5ba	68428-041	HUMAN OTC DRUG	Causticum Kit Refill		CAUSTICUM	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAUSTICUM	200	[hp_C]/1			N	20241231
68428-042_998e6088-f940-7eab-e053-2a95a90a7b6b	68428-042	HUMAN OTC DRUG	Chamomilla Kit Refill		MATRICARIA RECUTITA	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MATRICARIA RECUTITA	200	[hp_C]/1			N	20241231
68428-044_998ed35f-ff34-681d-e053-2995a90a8b2f	68428-044	HUMAN OTC DRUG	Cocculus Indicus Kit Refill		ANAMIRTA COCCULUS SEED	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANAMIRTA COCCULUS SEED	200	[hp_C]/1			N	20241231
68428-045_998f07c1-7ffe-a842-e053-2995a90a473f	68428-045	HUMAN OTC DRUG	Coffea Cruda Kit Refill		ARABICA COFFEE BEAN	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-047_998f5b7f-3aeb-7f8f-e053-2995a90ae9bc	68428-047	HUMAN OTC DRUG	Euphrasia Officinalis Kit Refill		EUPHRASIA STRICTA	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUPHRASIA STRICTA	200	[hp_C]/1			N	20241231
68428-048_998f86c3-9445-0557-e053-2995a90ad792	68428-048	HUMAN OTC DRUG	Ferrum Phos Kit Refill		FERRUM PHOSPHORICUM	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FERRUM PHOSPHORICUM	200	[hp_C]/1			N	20241231
68428-049_998f8d2e-08e3-7491-e053-2a95a90a271a	68428-049	HUMAN OTC DRUG	Gelsemium Semp Kit Refill		Gelsemium Sempervirens Root	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GELSEMIUM SEMPERVIRENS ROOT	200	[hp_C]/1			N	20241231
68428-051_998fbc9d-db72-a81b-e053-2995a90a01c9	68428-051	HUMAN OTC DRUG	Hepar Sulph Calc Kit Refill		CALCIUM SULFIDE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALCIUM SULFIDE	200	[hp_C]/1			N	20241231
68428-052_998f91ae-7bd0-764a-e053-2a95a90ad25e	68428-052	HUMAN OTC DRUG	Hypericum Perf Kit Refill		HYPERICUM PERFORATUM	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HYPERICUM PERFORATUM	200	[hp_C]/1			N	20241231
68428-053_998fd098-2159-a60b-e053-2995a90a65db	68428-053	HUMAN OTC DRUG	Ignatia Amara Kit Refill		STRYCHNOS IGNATII SEED	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STRYCHNOS IGNATII SEED	200	[hp_C]/1			N	20241231
68428-054_99900187-8c39-663d-e053-2995a90a51de	68428-054	HUMAN OTC DRUG	Ipecacuanha Kit Refill		IPECAC	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	IPECAC	200	[hp_C]/1			N	20241231
68428-055_99902885-d26c-8bb3-e053-2995a90a8b53	68428-055	HUMAN OTC DRUG	Kali Bichromicum Kit Refill		POTASSIUM DICHROMATE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM DICHROMATE	200	[hp_C]/1			N	20241231
68428-056_99905744-d002-eed5-e053-2a95a90ac7ce	68428-056	HUMAN OTC DRUG	Lachesis Mutus Kit Refill		LACHESIS MUTA VENOM	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LACHESIS MUTA VENOM	200	[hp_C]/1			N	20241231
68428-057_999d5710-189b-3227-e053-2a95a90abbfc	68428-057	HUMAN OTC DRUG	Ledum Palustre Kit Refill		LEDUM PALUSTRE TWIG	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LEDUM PALUSTRE TWIG	200	[hp_C]/1			N	20241231
68428-058_999d568b-27cc-19b7-e053-2995a90a3790	68428-058	HUMAN OTC DRUG	Lycopodium Kit Refill		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LYCOPODIUM CLAVATUM SPORE	200	[hp_C]/1			N	20241231
68428-059_999d8fda-fb09-7e51-e053-2995a90a8d30	68428-059	HUMAN OTC DRUG	Magnesia Phos Kit Refill		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	200	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68428-061_999dae3c-d803-3197-e053-2995a90ae600	68428-061	HUMAN OTC DRUG	Natrum Muriaticum Kit Refill		SODIUM CHLORIDE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SODIUM CHLORIDE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
68428-062_999daf1d-7fbe-77f5-e053-2995a90a7a0d	68428-062	HUMAN OTC DRUG	Nux Vomica Kit Refill		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STRYCHNOS NUX-VOMICA SEED	200	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-064_999e8fc9-b487-4a4b-e053-2a95a90a2f1e	68428-064	HUMAN OTC DRUG	Phytolacca Kit Refill		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PHYTOLACCA AMERICANA ROOT	200	[hp_C]/1			N	20241231
68428-065_999ea441-65f4-9946-e053-2a95a90a0753	68428-065	HUMAN OTC DRUG	Pulsatilla Kit Refill		PULSATILLA VULGARIS	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PULSATILLA VULGARIS	200	[hp_C]/1			N	20241231
68428-066_999ea554-e6c2-a381-e053-2a95a90a45bc	68428-066	HUMAN OTC DRUG	Pyrogenium Kit Refill		RANCID BEEF	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	RANCID BEEF	200	[hp_C]/1			N	20241231
68428-067_999e79c3-4b11-066c-e053-2a95a90a7790	68428-067	HUMAN OTC DRUG	Rhus Tox Kit Refill		TOXICODENDRON RADICANS LEAF	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	TOXICODENDRON RADICANS LEAF	200	[hp_C]/1			N	20241231
68428-069_999f4290-560c-605a-e053-2995a90a4ef1	68428-069	HUMAN OTC DRUG	Sepia Kit Refill		SEPIA OFFICINALIS JUICE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SEPIA OFFICINALIS JUICE	200	[hp_C]/1			N	20241231
68428-071_999f652e-d76d-5b56-e053-2a95a90ab61e	68428-071	HUMAN OTC DRUG	Spongia Tosta Kit Refill		SILICON DIOXIDE	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SPONGIA OFFICINALIS SKELETON, ROASTED	200	[hp_C]/1			N	20241231
68428-072_999f5b2d-dd58-5ae9-e053-2a95a90a361d	68428-072	HUMAN OTC DRUG	Staphysagria Kit Refill		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DELPHINIUM STAPHISAGRIA SEED	200	[hp_C]/1			N	20241231
68428-073_999f8a13-6c50-5d2d-e053-2a95a90a185f	68428-073	HUMAN OTC DRUG	Sulphur Kit Refill		SULFUR	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SULFUR	200	[hp_C]/1			N	20241231
68428-074_999fcc37-bc80-65e2-e053-2a95a90a5469	68428-074	HUMAN OTC DRUG	Symphytum Off Kit Refill		COMFREY ROOT	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	COMFREY ROOT	200	[hp_C]/1			N	20241231
68428-075_99a03afd-0464-ca74-e053-2a95a90ac28a	68428-075	HUMAN OTC DRUG	Thuja Occidentalis Kit Refill		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	20100503		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	THUJA OCCIDENTALIS LEAFY TWIG	200	[hp_C]/1			N	20241231
68428-077_99767997-9ee3-9611-e053-2995a90ab44e	68428-077	HUMAN OTC DRUG	Aconitum Napellus Kit Refill		ACONITUM NAPELLUS	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACONITUM NAPELLUS	30	[hp_C]/1			N	20241231
68428-078_997a2252-3f0e-277d-e053-2995a90a4143	68428-078	HUMAN OTC DRUG	Allium Cepa Kit Refill		ONION	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ONION	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
68428-080_997b814d-bf22-40b4-e053-2995a90a91db	68428-080	HUMAN OTC DRUG	Apis Mellifica Kit Refill		APIS MELLIFERA	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	APIS MELLIFERA	30	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
68428-082_997ba2de-d396-fb8a-e053-2a95a90a0755	68428-082	HUMAN OTC DRUG	Arnica Montana Kit Refill		ARNICA MONTANA	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARNICA MONTANA	30	[hp_C]/1			N	20241231
68428-083_997bbecb-031e-fb80-e053-2a95a90a13d4	68428-083	HUMAN OTC DRUG	Arsenicum Album Kit Refill		ARSENIC TRIOXIDE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE	30	[hp_C]/1			N	20241231
68428-084_997c464d-6374-3855-e053-2a95a90ad37f	68428-084	HUMAN OTC DRUG	Belladonna Kit Refill		ATROPA BELLADONNA	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ATROPA BELLADONNA	30	[hp_C]/1			N	20241231
68428-085_997c5432-06fc-1419-e053-2995a90a24ea	68428-085	HUMAN OTC DRUG	Bryonia Alba Kit Refill		BRYONIA ALBA ROOT	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BRYONIA ALBA ROOT	30	[hp_C]/1			N	20241231
68428-086_997cfc56-947d-0c12-e053-2a95a90a88a9	68428-086	HUMAN OTC DRUG	Calcarea Carbonica Kit Refill		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_C]/1			N	20241231
68428-090_998e29d0-adfc-d534-e053-2a95a90a2d34	68428-090	HUMAN OTC DRUG	Caulophyllum Thal Kit Refill		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAULOPHYLLUM THALICTROIDES ROOT	30	[hp_C]/1			N	20241231
68428-091_998e43ac-8531-d53c-e053-2a95a90aa5ba	68428-091	HUMAN OTC DRUG	Causticum Kit Refill		CAUSTICUM	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAUSTICUM	30	[hp_C]/1			N	20241231
68428-092_998e4b1f-4bb4-168b-e053-2a95a90ad395	68428-092	HUMAN OTC DRUG	Chamomilla Kit Refill		MATRICARIA RECUTITA	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MATRICARIA RECUTITA	30	[hp_C]/1			N	20241231
68428-094_998edc4b-7665-7d47-e053-2995a90ab1dd	68428-094	HUMAN OTC DRUG	Cocculus Indicus Kit Refill		ANAMIRTA COCCULUS SEED	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANAMIRTA COCCULUS SEED	30	[hp_C]/1			N	20241231
68428-095_998efe58-d464-ac20-e053-2995a90a0a39	68428-095	HUMAN OTC DRUG	Coffea Cruda Kit Refill		ARABICA COFFEE BEAN	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-097_998f2bc3-5ea7-7f65-e053-2995a90a7fd2	68428-097	HUMAN OTC DRUG	Euphrasia Officinalis Kit Refill		EUPHRASIA STRICTA	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUPHRASIA STRICTA	30	[hp_C]/1			N	20241231
68428-098_998f5b7f-3aef-7f8f-e053-2995a90ae9bc	68428-098	HUMAN OTC DRUG	Ferrum Phos Kit Refill		FERRUM PHOSPHORICUM	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FERRUM PHOSPHORICUM	30	[hp_C]/1			N	20241231
68428-099_998f91ae-7bc5-764a-e053-2a95a90ad25e	68428-099	HUMAN OTC DRUG	Gelsemium Semp Kit Refill		Gelsemium Sempervirens Root	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_C]/1			N	20241231
68428-101_998fac33-b862-07c6-e053-2a95a90ab532	68428-101	HUMAN OTC DRUG	Hepar Sulph Calc Kit Refill		CALCIUM SULFIDE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALCIUM SULFIDE	30	[hp_C]/1			N	20241231
68428-102_998fa9e4-9eff-d9e3-e053-2a95a90a6a1d	68428-102	HUMAN OTC DRUG	Hypericum Perf Kit Refill		HYPERICUM PERFORATUM	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HYPERICUM PERFORATUM	30	[hp_C]/1			N	20241231
68428-103_998fe860-cef5-676c-e053-2995a90ac9b4	68428-103	HUMAN OTC DRUG	Ignatia Amara Kit Refill		STRYCHNOS IGNATII SEED	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STRYCHNOS IGNATII SEED	30	[hp_C]/1			N	20241231
68428-104_99900187-8c38-663d-e053-2995a90a51de	68428-104	HUMAN OTC DRUG	Ipecacuanha Kit Refill		IPECAC	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	IPECAC	30	[hp_C]/1			N	20241231
68428-105_99902885-d261-8bb3-e053-2995a90a8b53	68428-105	HUMAN OTC DRUG	Kali Bichromicum Kit Refill		POTASSIUM DICHROMATE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM DICHROMATE	30	[hp_C]/1			N	20241231
68428-106_99905aa0-4ba2-27e3-e053-2995a90a0e2d	68428-106	HUMAN OTC DRUG	Lachesis Mutus Kit Refill		LACHESIS MUTA VENOM	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LACHESIS MUTA VENOM	30	[hp_C]/1			N	20241231
68428-107_999d43b6-5207-c42d-e053-2995a90a19f7	68428-107	HUMAN OTC DRUG	Ledum Palustre Kit Refill		LEDUM PALUSTRE TWIG	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LEDUM PALUSTRE TWIG	30	[hp_C]/1			N	20241231
68428-108_999d568b-27c6-19b7-e053-2995a90a3790	68428-108	HUMAN OTC DRUG	Lycopodium Kit Refill		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LYCOPODIUM CLAVATUM SPORE	30	[hp_C]/1			N	20241231
68428-109_999d6c43-bb1f-369f-e053-2a95a90a84ce	68428-109	HUMAN OTC DRUG	Magnesia Phos Kit Refill		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68428-111_999df46d-8a12-0632-e053-2a95a90a3727	68428-111	HUMAN OTC DRUG	Natrum Muriaticum Kit Refill		SODIUM CHLORIDE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SODIUM CHLORIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
68428-112_999dae3c-d812-3197-e053-2995a90ae600	68428-112	HUMAN OTC DRUG	Nux Vomica Kit Refill		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-114_999e969e-d5ed-6f84-e053-2a95a90aa273	68428-114	HUMAN OTC DRUG	Phytolacca Kit Refill		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PHYTOLACCA AMERICANA ROOT	30	[hp_C]/1			N	20241231
68428-115_999eb4cc-297f-d0e6-e053-2a95a90a7070	68428-115	HUMAN OTC DRUG	Pulsatilla Kit Refill		PULSATILLA VULGARIS	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PULSATILLA VULGARIS	30	[hp_C]/1			N	20241231
68428-116_999ea441-65f7-9946-e053-2a95a90a0753	68428-116	HUMAN OTC DRUG	Pyrogenium Kit Refill		RANCID BEEF	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	RANCID BEEF	30	[hp_C]/1			N	20241231
68428-117_999ea554-e6c7-a381-e053-2a95a90a45bc	68428-117	HUMAN OTC DRUG	Rhus Tox Kit Refill		TOXICODENDRON RADICANS LEAF	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	TOXICODENDRON RADICANS LEAF	30	[hp_C]/1			N	20241231
68428-119_999f4290-55fe-605a-e053-2995a90a4ef1	68428-119	HUMAN OTC DRUG	Sepia Kit Refill		SEPIA OFFICINALIS JUICE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SEPIA OFFICINALIS JUICE	30	[hp_C]/1			N	20241231
68428-121_999f5c85-7990-4c80-e053-2995a90acc44	68428-121	HUMAN OTC DRUG	Spongia Tosta Kit Refill		SILICON DIOXIDE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_C]/1			N	20241231
68428-122_999f8a13-6c33-5d2d-e053-2a95a90a185f	68428-122	HUMAN OTC DRUG	Staphysagria Kit Refill		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DELPHINIUM STAPHISAGRIA SEED	30	[hp_C]/1			N	20241231
68428-123_999f9fe3-f825-5334-e053-2995a90a269a	68428-123	HUMAN OTC DRUG	Sulphur Kit Refill		SULFUR	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SULFUR	30	[hp_C]/1			N	20241231
68428-124_999fb38c-adc5-40d2-e053-2a95a90a6432	68428-124	HUMAN OTC DRUG	Symphytum Off Kit Refill		COMFREY ROOT	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	COMFREY ROOT	30	[hp_C]/1			N	20241231
68428-125_99a03238-31b8-2d32-e053-2995a90aac3f	68428-125	HUMAN OTC DRUG	Thuja Occidentalis Kit Refill		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/1			N	20241231
68428-127_9975a0f6-056c-4210-e053-2a95a90a9a7c	68428-127	HUMAN OTC DRUG	Aesculus Hipp Kit Refill		HORSE CHESTNUT	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HORSE CHESTNUT	30	[hp_C]/1			N	20241231
68428-131_997a5d44-063b-52b0-e053-2a95a90ad9b9	68428-131	HUMAN OTC DRUG	Antimonium Crudum Kit Refill		ANTIMONY TRISULFIDE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANTIMONY TRISULFIDE	30	[hp_C]/1			N	20241231
68428-132_997c0db4-415f-11e0-e053-2a95a90a8755	68428-132	HUMAN OTC DRUG	Baptisia Tinctoria Kit Refill		BAPTISIA TINCTORIA ROOT	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BAPTISIA TINCTORIA ROOT	30	[hp_C]/1			N	20241231
68428-133_997c23d3-c712-abba-e053-2a95a90abc42	68428-133	HUMAN OTC DRUG	Bellis Perennis Kit Refill		BELLIS PERENNIS	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BELLIS PERENNIS	30	[hp_C]/1			N	20241231
68428-134_997c3ee0-a5b7-162a-e053-2995a90a6424	68428-134	HUMAN OTC DRUG	Berberis Vulgaris Kit Refill		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BERBERIS VULGARIS ROOT BARK	30	[hp_C]/1			N	20241231
68428-138_998ed35f-ff24-681d-e053-2995a90a8b2f	68428-138	HUMAN OTC DRUG	Cimicifuga Racemosa Kit Refill		BLACK COHOSH	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BLACK COHOSH	30	[hp_C]/1			N	20241231
68428-141_998f3a70-9065-7fcc-e053-2995a90ae404	68428-141	HUMAN OTC DRUG	Digitalis Purpurea Kit Refill		DIGITALIS	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DIGITALIS	30	[hp_C]/1			N	20241231
68428-142_998f2bc5-1426-97dc-e053-2a95a90ad94b	68428-142	HUMAN OTC DRUG	Drosera Rotundifolia Kit Refill		DROSERA ROTUNDIFOLIA	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DROSERA ROTUNDIFOLIA	30	[hp_C]/1			N	20241231
68428-144_998f0fc9-6a50-23f7-e053-2a95a90a8ba4	68428-144	HUMAN OTC DRUG	Eupatorium Perf Kit Refill		Eupatorium Perfoliatum Flowering Top	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUPATORIUM PERFOLIATUM FLOWERING TOP	30	[hp_C]/1			N	20241231
68428-146_998fac33-b85f-07c6-e053-2a95a90ab532	68428-146	HUMAN OTC DRUG	Hamamelis Virginiana Kit Refill		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	30	[hp_C]/1			N	20241231
68428-147_99903aa6-bfe3-1813-e053-2995a90adb8e	68428-147	HUMAN OTC DRUG	Kali Carbonicum Kit Refill		POTASSIUM CARBONATE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM CARBONATE	30	[hp_C]/1			N	20241231
68428-148_998fa9bd-d7c3-8320-e053-2995a90a345f	68428-148	HUMAN OTC DRUG	Kali Muriaticum Kit Refill		POTASSIUM CHLORIDE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM CHLORIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68428-149_99903aa6-bfef-1813-e053-2995a90adb8e	68428-149	HUMAN OTC DRUG	Kali Phosphoricum Kit Refill		POTASSIUM PHOSPHATE, DIBASIC	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM PHOSPHATE, DIBASIC	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68428-154_999e16b3-498a-32e7-e053-2a95a90a30b3	68428-154	HUMAN OTC DRUG	Petroleum Kit Refill		KEROSENE	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	KEROSENE	30	[hp_C]/1			N	20241231
68428-155_999dae3c-d81e-3197-e053-2995a90ae600	68428-155	HUMAN OTC DRUG	Phosphoricum Acidum Kit Refill		PHOSPHORIC ACID	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PHOSPHORIC ACID	30	[hp_C]/1			N	20241231
68428-156_999e969e-d611-6f84-e053-2a95a90aa273	68428-156	HUMAN OTC DRUG	Podophyllum Pelt Kit Refill		PODOPHYLLUM	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PODOPHYLLUM	30	[hp_C]/1			N	20241231
68428-161_999f1ee4-5476-e6a8-e053-2a95a90aca40	68428-161	HUMAN OTC DRUG	Sarsaparilla Kit Refill		SARSAPARILLA ROOT	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SARSAPARILLA ROOT	30	[hp_C]/1			N	20241231
68428-165_99a03238-31cf-2d32-e053-2995a90aac3f	68428-165	HUMAN OTC DRUG	Valeriana Officinalis Kit Refill		VALERIAN	PELLET	ORAL	20091009		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	VALERIAN	30	[hp_C]/1			N	20241231
68428-177_0801db1a-6a2d-c572-e063-6394a90a00a1	68428-177	HUMAN OTC DRUG	Aconitum napellus		ACONITUM NAPELLUS	PELLET	ORAL	20110126		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACONITUM NAPELLUS	30	[hp_C]/1			N	20241231
68428-182_0802489a-3814-cc8b-e063-6294a90a9b4e	68428-182	HUMAN OTC DRUG	Aesculus hippocastanum		HORSE CHESTNUT	PELLET	ORAL	20110126		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HORSE CHESTNUT	30	[hp_C]/1			N	20241231
68428-188_080250a0-64ad-c5ba-e063-6394a90a10c4	68428-188	HUMAN OTC DRUG	Allium Cepa		ONION	PELLET	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ONION	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
68428-212_08025ff2-44b9-2581-e063-6294a90a2884	68428-212	HUMAN OTC DRUG	Antimonium crudum		ANTIMONY TRISULFIDE	PELLET	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANTIMONY TRISULFIDE	30	[hp_C]/1			N	20241231
68428-214_08028b08-3d92-6e5e-e063-6294a90a42e2	68428-214	HUMAN OTC DRUG	Apis mellifica		APIS MELLIFERA	PELLET	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	APIS MELLIFERA	30	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
68428-223_080297ff-a3db-398b-e063-6394a90a2f28	68428-223	HUMAN OTC DRUG	Arnica montana		ARNICA MONTANA	PELLET	ORAL	20090828		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARNICA MONTANA	30	[hp_C]/1			N	20241231
68428-225_08025e53-5dc5-37f7-e063-6394a90a50c9	68428-225	HUMAN OTC DRUG	Arsenicum album		ARSENIC TRIOXIDE	PELLET	ORAL	20090831		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE	30	[hp_C]/1			N	20241231
68428-247_08028540-807a-ca20-e063-6394a90a80e8	68428-247	HUMAN OTC DRUG	Baptisia tinctoria		BAPTISIA TINCTORIA ROOT	PELLET	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BAPTISIA TINCTORIA ROOT	30	[hp_C]/1			N	20241231
68428-251_08029ab0-4abe-5dcb-e063-6394a90a48d2	68428-251	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ATROPA BELLADONNA	30	[hp_C]/1			N	20241231
68428-252_0802ac5f-caad-0225-e063-6294a90ab398	68428-252	HUMAN OTC DRUG	Bellis perennis		BELLIS PERENNIS	PELLET	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BELLIS PERENNIS	30	[hp_C]/1			N	20241231
68428-257_0802dd28-f40d-cac6-e063-6394a90af6ff	68428-257	HUMAN OTC DRUG	Berberis vulgaris		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BERBERIS VULGARIS ROOT BARK	30	[hp_C]/1			N	20241231
68428-265_08624c71-e6ed-11a5-e063-6394a90a043d	68428-265	HUMAN OTC DRUG	Bryonia alba		BRYONIA ALBA ROOT	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BRYONIA ALBA ROOT	30	[hp_C]/1			N	20241231
68428-273_08031467-57ee-f232-e063-6394a90a4092	68428-273	HUMAN OTC DRUG	Calcarea carbonica		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_C]/1			N	20241231
68428-280_08037697-40bc-0d40-e063-6294a90a69a0	68428-280	HUMAN OTC DRUG	Calendula officinalis		Calendula Officinalis Flowering Top	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALENDULA OFFICINALIS FLOWERING TOP	30	[hp_C]/1			N	20241231
68428-294_08037c8d-ab1f-5308-e063-6394a90abd8d	68428-294	HUMAN OTC DRUG	Caulophyllum thalictroides		CAULOPHYLLUM THALICTROIDES ROOT	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAULOPHYLLUM THALICTROIDES ROOT	30	[hp_C]/1			N	20241231
68428-295_08038465-947a-30aa-e063-6394a90a9ee3	68428-295	HUMAN OTC DRUG	Causticum		CAUSTICUM	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAUSTICUM	30	[hp_C]/1			N	20241231
68428-300_0803a394-b217-6549-e063-6294a90a0906	68428-300	HUMAN OTC DRUG	Chamomilla		MATRICARIA RECUTITA	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MATRICARIA RECUTITA	30	[hp_C]/1			N	20241231
68428-302_08037c4e-4e9e-315b-e063-6394a90aaba8	68428-302	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CHELIDONIUM MAJUS	30	[hp_C]/1			N	20241231
68428-318_086299e1-e480-5e65-e063-6394a90a29fb	68428-318	HUMAN OTC DRUG	Cimicifuga racemosa		BLACK COHOSH	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BLACK COHOSH	30	[hp_C]/1			N	20241231
68428-329_0803b71c-ea8f-8f79-e063-6294a90a5b51	68428-329	HUMAN OTC DRUG	Cocculus indicus		ANAMIRTA COCCULUS SEED	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANAMIRTA COCCULUS SEED	30	[hp_C]/1			N	20241231
68428-331_0803f6f1-9d70-230d-e063-6294a90a6831	68428-331	HUMAN OTC DRUG	Coffea cruda		ARABICA COFFEE BEAN	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-357_ef52ae2e-91a6-85d4-e053-2a95a90a117d	68428-357	HUMAN OTC DRUG	Digitalis pupurea		DIGITALIS	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DIGITALIS	30	[hp_C]/1			N	20241231
68428-359_0803ff4c-33a6-3105-e063-6294a90a866b	68428-359	HUMAN OTC DRUG	Drosera rotundifolia		DROSERA ROTUNDIFOLIA	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DROSERA ROTUNDIFOLIA	30	[hp_C]/1			N	20241231
68428-376_0803f98e-7348-2595-e063-6394a90af8dd	68428-376	HUMAN OTC DRUG	Eupatorium perfoliatum		Eupatorium Perfoliatum Flowering Top	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUPATORIUM PERFOLIATUM FLOWERING TOP	30	[hp_C]/1			N	20241231
68428-377_0803ff4c-33a9-3105-e063-6294a90a866b	68428-377	HUMAN OTC DRUG	Euphrasia officinalis		EUPHRASIA STRICTA	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUPHRASIA STRICTA	30	[hp_C]/1			N	20241231
68428-385_08041278-3229-35d1-e063-6394a90a748b	68428-385	HUMAN OTC DRUG	Ferrum phosphoricum		FERROSOFERRIC PHOSPHATE	PELLET	ORAL	20100319		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FERROSOFERRIC PHOSPHATE	30	[hp_C]/1			N	20241231
68428-402_080423a5-9565-828e-e063-6394a90aa422	68428-402	HUMAN OTC DRUG	Gelsemium sempervirens		Gelsemium Sempervirens Root	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_C]/1			N	20241231
68428-418_081235d3-8b8e-a1db-e063-6394a90a28a3	68428-418	HUMAN OTC DRUG	Hamamelis virginiana		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	30	[hp_C]/1			N	20241231
68428-422_08123fda-addf-7f37-e063-6294a90a91bf	68428-422	HUMAN OTC DRUG	Helleborus niger		HELLEBORUS NIGER ROOT	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HELLEBORUS NIGER ROOT	30	[hp_C]/1			N	20241231
68428-424_08124588-ca19-8c31-e063-6294a90ae8a2	68428-424	HUMAN OTC DRUG	Hepar sulphuris calcareum		CALCIUM SULFIDE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALCIUM SULFIDE	30	[hp_C]/1			N	20241231
68428-428_081242ad-b00c-e723-e063-6394a90a50e1	68428-428	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GOLDENSEAL	30	[hp_C]/1			N	20241231
68428-432_081269ed-ff3a-fcfd-e063-6294a90a3df4	68428-432	HUMAN OTC DRUG	Hypericum perforatum		HYPERICUM PERFORATUM	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HYPERICUM PERFORATUM	30	[hp_C]/1			N	20241231
68428-435_0812710b-8eb5-36eb-e063-6394a90a74d2	68428-435	HUMAN OTC DRUG	Ignatia amara		STRYCHNOS IGNATII SEED	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STRYCHNOS IGNATII SEED	30	[hp_C]/1			N	20241231
68428-441_0812aa17-c627-a629-e063-6394a90a71c4	68428-441	HUMAN OTC DRUG	Ipecacuanha		IPECAC	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	IPECAC	30	[hp_C]/1			N	20241231
68428-449_0812aed3-1d00-751d-e063-6294a90acf78	68428-449	HUMAN OTC DRUG	Kali bichromicum		POTASSIUM DICHROMATE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM DICHROMATE	30	[hp_C]/1			N	20241231
68428-451_0812f0c1-ccc2-6586-e063-6394a90a4999	68428-451	HUMAN OTC DRUG	Kali carbonicum		POTASSIUM CARBONATE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM CARBONATE	30	[hp_C]/1			N	20241231
68428-454_0812d64c-c4c7-3416-e063-6394a90ae5af	68428-454	HUMAN OTC DRUG	Kali muriaticum		POTASSIUM CHLORIDE	PELLET	ORAL	20101021		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM CHLORIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68428-456_08130921-bf43-751c-e063-6294a90a23ce	68428-456	HUMAN OTC DRUG	Kali phosphoricum		DIBASIC POTASSIUM PHOSPHATE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DIBASIC POTASSIUM PHOSPHATE	30	[hp_C]/1			N	20241231
68428-462_75ce6aad-d998-70ad-e053-2a91aa0aa8e2	68428-462	HUMAN OTC DRUG	Lac caninum		CANIS LUPUS FAMILIARIS MILK	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CANIS LUPUS FAMILIARIS MILK	30	[hp_C]/1			N	20241231
68428-464_08132dd1-5d59-d380-e063-6394a90a4aeb	68428-464	HUMAN OTC DRUG	Lachesis mutus		LACHESIS MUTA VENOM	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LACHESIS MUTA VENOM	30	[hp_C]/1			N	20241231
68428-473_08132dd1-5d5d-d380-e063-6394a90a4aeb	68428-473	HUMAN OTC DRUG	Ledum palustre		LEDUM PALUSTRE TWIG	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LEDUM PALUSTRE TWIG	30	[hp_C]/1			N	20241231
68428-485_08136a20-f515-61d8-e063-6394a90a4719	68428-485	HUMAN OTC DRUG	Lycopodium clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LYCOPODIUM CLAVATUM SPORE	30	[hp_C]/1			N	20241231
68428-489_0813d1d7-a4ec-6f7b-e063-6394a90a9626	68428-489	HUMAN OTC DRUG	Magnesia phosphorica		MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68428-508_b7a8437a-b279-232f-e053-2a95a90aa688	68428-508	HUMAN OTC DRUG	Mercurius sulphuratus ruber		MERCURIC SULFIDE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MERCURIC SULFIDE	30	[hp_C]/1			N	20241231
68428-526_0813ba80-f216-494e-e063-6394a90a0e7d	68428-526	HUMAN OTC DRUG	Natrum muriaticum		SODIUM CHLORIDE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SODIUM CHLORIDE	30	[hp_C]/1			N	20241231
68428-537_08147f6e-c318-6a8c-e063-6294a90a16b1	68428-537	HUMAN OTC DRUG	Nux vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-559_0814ce6b-2e8e-e68b-e063-6294a90a3daf	68428-559	HUMAN OTC DRUG	Petroleum		KEROSENE	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	KEROSENE	30	[hp_C]/1			N	20241231
68428-560_0814b1f4-fb55-3c7c-e063-6394a90abe4e	68428-560	HUMAN OTC DRUG	Phosphoricum acidum		PHOSPHORIC ACID	PELLET	ORAL	20100112		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PHOSPHORIC ACID	30	[hp_C]/1			N	20241231
68428-563_081719c1-49e2-825f-e063-6294a90a70d3	68428-563	HUMAN OTC DRUG	Phytolacca decandra		PHYTOLACCA AMERICANA ROOT	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PHYTOLACCA AMERICANA ROOT	30	[hp_C]/1			N	20241231
68428-577_08171e41-8daf-67c3-e063-6394a90a0c12	68428-577	HUMAN OTC DRUG	Podophyllum peltatum		PODOPHYLLUM	PELLET	ORAL	20100630		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PODOPHYLLUM	30	[hp_C]/1			N	20241231
68428-585_08170934-feb1-58dc-e063-6294a90a092c	68428-585	HUMAN OTC DRUG	Pulsatilla		PULSATILLA VULGARIS	PELLET	ORAL	20091110		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PULSATILLA VULGARIS	30	[hp_C]/1			N	20241231
68428-586_75e0ab17-326c-517f-e053-2a91aa0affc1	68428-586	HUMAN OTC DRUG	Pulsatilla nuttalliana		ANEMONE PATENS	PELLET	ORAL	20101208		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANEMONE PATENS	30	[hp_C]/1			N	20241231
68428-602_081719c1-49ea-825f-e063-6294a90a70d3	68428-602	HUMAN OTC DRUG	Rhus toxicodendron		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	20100514		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	TOXICODENDRON PUBESCENS LEAF	30	[hp_C]/1			N	20241231
68428-609_081757dd-3a2a-2449-e063-6394a90a9c56	68428-609	HUMAN OTC DRUG	Ruta graveolens		Ruta Graveolens Flowering Top	PELLET	ORAL	20091231		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	RUTA GRAVEOLENS FLOWERING TOP	30	[hp_C]/1			N	20241231
68428-625_08282f31-3b44-1284-e063-6394a90a99eb	68428-625	HUMAN OTC DRUG	Sarsaparilla		SARSAPARILLA ROOT	PELLET	ORAL	20100504		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SARSAPARILLA ROOT	30	[hp_C]/1			N	20241231
68428-635_08283825-c631-0b49-e063-6294a90a1bad	68428-635	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	PELLET	ORAL	20091112		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SEPIA OFFICINALIS JUICE	30	[hp_C]/1			N	20241231
68428-644_08282f31-3b45-1284-e063-6394a90a99eb	68428-644	HUMAN OTC DRUG	Spongia Tosta		SILICON DIOXIDE	PELLET	ORAL	20091120		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_C]/1			N	20241231
68428-647_08283236-4ea1-1ab1-e063-6294a90ab1f7	68428-647	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	20091016		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DELPHINIUM STAPHISAGRIA SEED	30	[hp_C]/1			N	20241231
68428-655_08284fe6-80ae-1d3d-e063-6294a90acea2	68428-655	HUMAN OTC DRUG	Sulphur		SULFUR	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SULFUR	30	[hp_C]/1			N	20241231
68428-659_08285592-854e-6b96-e063-6294a90a0f41	68428-659	HUMAN OTC DRUG	Symphytum Off		COMFREY ROOT	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	COMFREY ROOT	30	[hp_C]/1			N	20241231
68428-674_082856c9-a018-3b54-e063-6394a90af3c3	68428-674	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ALLYLTHIOUREA	30	[hp_C]/1			N	20241231
68428-677_08285f08-aeba-7a19-e063-6294a90a1810	68428-677	HUMAN OTC DRUG	Thuja Occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/1			N	20241231
68428-693_082853cf-9eed-6eea-e063-6294a90ab4f2	68428-693	HUMAN OTC DRUG	Valeriana Officinalis		VALERIAN	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	VALERIAN	30	[hp_C]/1			N	20241231
68428-718_9a5b4c82-e790-023d-e053-2995a90aea03	68428-718	HUMAN OTC DRUG	Be gone Bruises and Bumps	TM	ARNICA MONTANA	OINTMENT	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARNICA MONTANA	1	[hp_X]/56g			N	20241231
68428-719_9a5b5e5b-360d-005f-e053-2995a90a5d71	68428-719	HUMAN OTC DRUG	Be gone Cuts and Scrapes	TM	Calendula Officinalis Flowering Top	OINTMENT	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/56g			N	20241231
68428-720_9a5b5ee4-9a46-b68a-e053-2a95a90a182e	68428-720	HUMAN OTC DRUG	Be gone Minor Arthritic Pain	TM	ARNICA MONTANA - RHUS TOXICODENDRON - RUTA GRAVEOLENS	OINTMENT	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARNICA MONTANA; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	3; 3; 3	[hp_X]/56g; [hp_X]/56g; [hp_X]/56g			N	20241231
68428-721_9a5b5ee4-9a51-b68a-e053-2a95a90a182e	68428-721	HUMAN OTC DRUG	Be gone Scars	TM	THIOSINAMINUM	OINTMENT	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ALLYLTHIOUREA	2	[hp_X]/56g			N	20241231
68428-722_9a5b87b3-7dfc-b675-e053-2a95a90aff63	68428-722	HUMAN OTC DRUG	Be gone Warts and Tired Feet	TM	THUJA OCCIDENTALIS	OINTMENT	TOPICAL	20130315		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	THUJA OCCIDENTALIS LEAFY TWIG	1	[hp_X]/56g			N	20241231
68428-723_9a5b92c9-586b-84aa-e053-2995a90ab5d7	68428-723	HUMAN OTC DRUG	Poison Ivy Pills		TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	20100824		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	TOXICODENDRON PUBESCENS LEAF	4	[hp_X]/28g			N	20241231
68428-725_8bb6dd21-4430-d2e1-e053-2a95a90a146c	68428-725	HUMAN OTC DRUG	Be gone Poison Ivy	TM	TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	20130228		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	TOXICODENDRON PUBESCENS LEAF	4	[hp_X]/1			N	20241231
68428-726_7aaa6336-3bc4-1aad-e053-2991aa0ac829	68428-726	HUMAN OTC DRUG	Be gone Insomnia		MATRICARIA RECUTITA - ARABICA COFFEE BEAN - HYOSCYAMUS NIGER - STRYCHNOS IGNATII SEED - STRYCHNOS NUX-VOMICA SEED -PASSIFLORA INCARNATA TOP	PELLET	ORAL	20130301		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN; HYOSCYAMUS NIGER; MATRICARIA RECUTITA; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-728_9a633bfa-1887-dd42-e053-2995a90ad3aa	68428-728	HUMAN OTC DRUG	WHP Be gone Minor Arthritic Pain	TM	APIS MELLIFERA, BLACK COHOSH, CALCIUM FLUORIDE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, TOXICODENDRON PUBESCENS LEAF	PELLET	ORAL	20130228		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	APIS MELLIFERA; BLACK COHOSH; CALCIUM FLUORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
68428-729_9a6338cf-def4-d1e2-e053-2995a90a5c98	68428-729	HUMAN OTC DRUG	Be gone Motion Sickness	TM	ANAMIRTA COCCULUS SEED - STRYCHNOS NUX-VOMICA SEED - KEROSENE	PELLET	ORAL	20130228		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANAMIRTA COCCULUS SEED; KEROSENE; STRYCHNOS NUX-VOMICA SEED	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-730_9a632e2b-7b2e-b17d-e053-2a95a90a095d	68428-730	HUMAN OTC DRUG	Be gone Sinus Congestion	TM	OYSTER SHELL CALCIUM CARBONATE, CRUDE - GOLDENSEAL - POTASSIUM DICHROMATE	PELLET	ORAL	20130228		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GOLDENSEAL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-731_7abbd54f-e6ee-75d2-e053-2a91aa0aad4c	68428-731	HUMAN OTC DRUG	Be gone Smoking		DIEFFENBACHIA SEGUINE - DAPHNE ODORA BARK - STRYCHNOS NUX-VOMICA SEED - PLANTAGO MAJOR - DELPHINIUM STAPHISAGRIA SEED - TOBACCO LEAF	PELLET	ORAL	20130301		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DAPHNE ODORA BARK; DELPHINIUM STAPHISAGRIA SEED; DIEFFENBACHIA SEGUINE; PLANTAGO MAJOR; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF	6; 6; 6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-732_7abc835a-2c37-542f-e053-2991aa0afe8f	68428-732	HUMAN OTC DRUG	Be gone Stomach Disorders	TM	SOLANUM DULCAMARA TOP - ACTIVATED CHARCOAL - CHELONE GLABRA - GOLDENSEAL	PELLET	ORAL	20130311		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACTIVATED CHARCOAL; CHELONE GLABRA; GOLDENSEAL; SOLANUM DULCAMARA TOP	6; 6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-741_7aaa6336-3bbf-1aad-e053-2991aa0ac829	68428-741	HUMAN OTC DRUG	WHP Be gone Colds and Cough	TM	ACONITUM NAPELLUS - BRYONIA ALBA ROOT - SANGUINARIA CANADENSIS ROOT	PELLET	ORAL	20130909		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; SANGUINARIA CANADENSIS ROOT	6; 6; 6	[hp_C]/28g; [hp_C]/28g; [hp_C]/28g			N	20241231
68428-744_d1dc460f-ee68-422a-96ae-e77842e50d66	68428-744	HUMAN OTC DRUG	WHP Be gone Wheezing	TM	ARSENIC TRIOXIDE - BLATTA ORIENTALIS - LACHESIS MUTA VENOM	PELLET	ORAL	20130910		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; BLATTA ORIENTALIS; LACHESIS MUTA VENOM	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
68428-745_4d71b0fe-d9d2-4c93-82a7-eddc1fa66b05	68428-745	HUMAN OTC DRUG	WHP Be gone Diarrhea	TM	ARSENIC TRIOXIDE - CUPRIC ARSENITE - VERATRUM ALBUM ROOT	PELLET	ORAL	20140508		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; CUPRIC ARSENITE; VERATRUM ALBUM ROOT	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
68428-746_cbd2b212-d2ea-4eb7-9ba3-6e5c80fe9d72	68428-746	HUMAN OTC DRUG	WHP Be gone Flatulence	TM	FERULA ASSA-FOETIDA RESIN, STRYCHNOS IGNATII SEED, NUTMEG	PELLET	ORAL	20140508		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FERULA ASSA-FOETIDA RESIN; NUTMEG; STRYCHNOS IGNATII SEED	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-747_2193909a-ed77-4a94-911f-8d327395b775	68428-747	HUMAN OTC DRUG	WHP Be gone Congested Headache	TM	CALCIUM FLUORIDE - FERROSOFERRIC PHOSPHATE - SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE - SODIUM CHLORIDE	PELLET	ORAL	20140508		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALCIUM FLUORIDE; FERROSOFERRIC PHOSPHATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
68428-749_3323800d-6584-41fa-95e2-0a0aadcee362	68428-749	HUMAN OTC DRUG	WHP Be gone Skin Irritation	TM	ARSENIC TRIOXIDE - CALCIUM SULFATE ANHYDROUS - SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE - SILICON DIOXIDE	PELLET	ORAL	20140508		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; CALCIUM SULFATE ANHYDROUS; SILICON DIOXIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68428-862_733afb95-1344-4adf-a336-bff36baaebcc	68428-862	HUMAN OTC DRUG	WHP Be gone Teething	TM	TRIBASIC CALCIUM PHOSPHATE - MATRICARIA CHAMOMILLA - ARABICA COFFEE BEAN	PELLET	ORAL	20140508		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN; MATRICARIA CHAMOMILLA; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-864_25872dd6-637f-4a7b-97fe-e0a5c96dad6d	68428-864	HUMAN OTC DRUG	Aconitum Lycoctonum		ACONITUM LYCOCTONUM	PELLET	ORAL	20111011		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACONITUM LYCOCTONUM	30	[hp_C]/1			N	20241231
68428-867_82556f8e-d23b-4d41-87c1-d6f2b0f5b68c	68428-867	HUMAN OTC DRUG	Aesculus Glabra		AESCULUS GLABRA NUT	PELLET	ORAL	20111205		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	AESCULUS GLABRA NUT	30	[hp_C]/1			N	20241231
68428-870_4498946a-c823-417e-8431-65d175d0da1c	68428-870	HUMAN OTC DRUG	Agraphis nutans		HYACINTHOIDES NON-SCRIPTA	PELLET	ORAL	20120418		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HYACINTHOIDES NON-SCRIPTA	30	[hp_C]/1			N	20241231
68428-872_d87b455b-79c6-4d11-88ba-4f850ae62f67	68428-872	HUMAN OTC DRUG	Alfalfa		ALFALFA	PELLET	ORAL	20110517		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ALFALFA	30	[hp_C]/1			N	20241231
68428-874_ed8fe4d6-104a-49c3-8ae4-b4f4eff0d9e9	68428-874	HUMAN OTC DRUG	Alumina silicata		KAOLIN	PELLET	ORAL	20120106		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	KAOLIN	30	[hp_C]/1			N	20241231
68428-878_590d1cab-15cb-4a69-b9b8-875469be2e78	68428-878	HUMAN OTC DRUG	Ammonium causticum		AMMONIA	PELLET	ORAL	20110421		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	AMMONIA	30	[hp_C]/1			N	20241231
68428-885_820b94e5-4258-4612-a255-78fd52c21244	68428-885	HUMAN OTC DRUG	Aqua marina		SODIUM CHLORIDE	PELLET	ORAL	20110707		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SODIUM CHLORIDE	30	[hp_C]/1			N	20241231
68428-886_fccdfde9-e626-45de-9be2-2ae299497c50	68428-886	HUMAN OTC DRUG	Aquilegia vulgaris		AQUILEGIA VULGARIS	PELLET	ORAL	20110421		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	AQUILEGIA VULGARIS	30	[hp_C]/1			N	20241231
68428-887_99d100fd-c926-4fc5-8aeb-69d34d8c6215	68428-887	HUMAN OTC DRUG	Aralia quinquefolia		AMERICAN GINSENG	PELLET	ORAL	20151016		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	AMERICAN GINSENG	30	[hp_C]/1			N	20241231
68428-888_7c75b3ff-de0c-449b-baa0-618d0a84c992	68428-888	HUMAN OTC DRUG	Aranea diadema		ARANEUS DIADEMATUS	PELLET	ORAL	20110727		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARANEUS DIADEMATUS	30	[hp_C]/1			N	20241231
68428-890_6d18e50d-029b-432b-a754-65be46c0b723	68428-890	HUMAN OTC DRUG	Argentum muriaticum		SILVER CHLORIDE	PELLET	ORAL	20151030		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SILVER CHLORIDE	30	[hp_C]/1			N	20241231
68428-892_f43dbeb7-abff-4363-8112-f178af218cb2	68428-892	HUMAN OTC DRUG	Artemisia vulgaris		ARTEMISIA VULGARIS ROOT	PELLET	ORAL	20110406		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARTEMISIA VULGARIS ROOT	30	[hp_C]/1			N	20241231
68428-896_fb08bff5-0a07-49bd-ac75-205067b3d9aa	68428-896	HUMAN OTC DRUG	Beryllium metallicum		BERYLLIUM	PELLET	ORAL	20120611		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BERYLLIUM	30	[hp_C]/1			N	20241231
68428-902_593a97d2-c8e4-4019-8563-15c84ea7935b	68428-902	HUMAN OTC DRUG	Cadmium metallicum		CADMIUM	PELLET	ORAL	20110404		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CADMIUM	30	[hp_C]/1			N	20241231
68428-904_c90deb8d-5606-40cd-acbb-a06e5b4287cd	68428-904	HUMAN OTC DRUG	Calcarea muriatica		CALCIUM CHLORIDE	PELLET	ORAL	20120125		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALCIUM CHLORIDE	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68428-905_97500256-2ed1-45ae-b10f-545002e6c197	68428-905	HUMAN OTC DRUG	Calcarea silicata		CALCIUM SILICATE	PELLET	ORAL	20120713		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CALCIUM SILICATE	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68428-906_2e423525-e444-42ff-9157-f5535e05380a	68428-906	HUMAN OTC DRUG	Candida parapsilosis		CANDIDA PARAPSILOSIS	PELLET	ORAL	20130226		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CANDIDA PARAPSILOSIS	30	[hp_C]/1			N	20241231
68428-907_d27cae1e-9cc2-487b-8930-d72812cf6dd2	68428-907	HUMAN OTC DRUG	Carbo animalis		CARBO ANIMALIS	LIQUID	ORAL	20100513		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CARBO ANIMALIS	30	[hp_C]/mL			N	20241231
68428-920_df79bf00-1c64-4507-932c-5004f8e083cb	68428-920	HUMAN OTC DRUG	Colibacillinum cum natrum muriaticum		ESCHERICHIA COLI	PELLET	ORAL	20121026		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ESCHERICHIA COLI	30	[hp_C]/1			N	20241231
68428-922_e1b32354-8a4a-4c91-beaa-ebbd7928f316	68428-922	HUMAN OTC DRUG	Copaiva officinalis		COPAIFERA OFFICINALIS RESIN	PELLET	ORAL	20120221		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	COPAIFERA OFFICINALIS RESIN	30	[hp_C]/1			N	20241231
68428-924_b8406d39-47d3-49ee-bb8f-924a9c2a68b0	68428-924	HUMAN OTC DRUG	Crotalus cascavella		CROTALUS DURISSUS TERRIFICUS VENOM	PELLET	ORAL	20130605		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CROTALUS DURISSUS TERRIFICUS VENOM	30	[hp_C]/1			N	20241231
68428-928_b2c14222-58d0-4d1d-a8ab-32e870a78d05	68428-928	HUMAN OTC DRUG	Cuprum aceticum		CUPRIC ACETATE	PELLET	ORAL	20120904		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CUPRIC ACETATE	30	[hp_C]/1			N	20241231
68428-933_eef10eb8-425d-45d4-ae2d-ebc0e0c00524	68428-933	HUMAN OTC DRUG	Digitalinum		DIGITALIN	PELLET	ORAL	20110526		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DIGITALIN	30	[hp_C]/1			N	20241231
68428-934_3726b468-a5b1-46aa-b346-28ba414a3edb	68428-934	HUMAN OTC DRUG	Dolichos pruriens		MUCUNA PRURIENS FRUIT TRICHOME	PELLET	ORAL	20110624		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MUCUNA PRURIENS FRUIT TRICHOME	30	[hp_C]/1			N	20241231
68428-937_e61dfd2b-5a9f-4d88-a430-50794bdd0635	68428-937	HUMAN OTC DRUG	Eupatorium purp		EUTROCHIUM PURPUREUM ROOT	PELLET	ORAL	20111025		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUTROCHIUM PURPUREUM ROOT	30	[hp_C]/1			N	20241231
68428-939_2794ca97-e800-45dd-9748-1af9a2388042	68428-939	HUMAN OTC DRUG	Euphorbium officinarum		EUPHORBIA RESINIFERA RESIN	PELLET	ORAL	20100517		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUPHORBIA RESINIFERA RESIN	30	[hp_C]/1			N	20241231
68428-944_b4dca049-6bfa-4113-b625-20ad7cc53e27	68428-944	HUMAN OTC DRUG	Fucus vesiculosus		FUCUS VESICULOSUS	PELLET	ORAL	20130925		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FUCUS VESICULOSUS	30	[hp_C]/1			N	20241231
68428-947_ccf7329c-1e2d-4f0a-86c0-297cacd86821	68428-947	HUMAN OTC DRUG	Gratiola officinalis		GRATIOLA OFFICINALIS	PELLET	ORAL	20130227		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GRATIOLA OFFICINALIS	30	[hp_C]/1			N	20241231
68428-949_787dac5b-55d8-4714-b560-5fcb86a5048a	68428-949	HUMAN OTC DRUG	Helix tosta		ESCARGOT SHELL, COOKED	PELLET	ORAL	20121129		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ESCARGOT SHELL, COOKED	30	[hp_C]/1			N	20241231
68428-950_64a3458c-6058-41cc-83bf-fe0285dc310c	68428-950	HUMAN OTC DRUG	Heloderma		HELODERMA HORRIDUM VENOM	PELLET	ORAL	20111116		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HELODERMA HORRIDUM VENOM	30	[hp_C]/1			N	20241231
68428-953_9b814732-c1ae-4cb0-90ff-94b105a5f7b0	68428-953	HUMAN OTC DRUG	Homarus gam		HOMARUS AMERICANUS DIGESTIVE FLUID	PELLET	ORAL	20120326		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HOMARUS AMERICANUS DIGESTIVE FLUID	30	[hp_C]/1			N	20241231
68428-955_2e2deccc-51bb-4f44-820d-38a497ebf04c	68428-955	HUMAN OTC DRUG	Hydrocyanicum acidum		HYDROGEN CYANIDE	PELLET	ORAL	20160610		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HYDROGEN CYANIDE	30	[hp_C]/1			N	20241231
68428-956_249c9c79-2f5c-4acd-a09c-a7acfbd8f98a	68428-956	HUMAN OTC DRUG	Ichthyolum		ICHTHAMMOL	PELLET	ORAL	20110421		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ICHTHAMMOL	30	[hp_C]/1			N	20241231
68428-960_d90c4ad0-64b8-40b4-89ce-96c7e3ef05b3	68428-960	HUMAN OTC DRUG	Iris tenax		IRIS TENAX	PELLET	ORAL	20140320		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	IRIS TENAX	30	[hp_C]/1			N	20241231
68428-963_613ea30c-483a-4903-8a35-9af45c35f91c	68428-963	HUMAN OTC DRUG	Juniperus communis		JUNIPER BERRY	PELLET	ORAL	20110401		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	JUNIPER BERRY	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
68428-966_4abf1e41-8f6b-4501-a8ca-fc323633f785	68428-966	HUMAN OTC DRUG	Kali silicatum		POTASSIUM SILICATE	PELLET	ORAL	20150727		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM SILICATE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68428-969_dbde33e4-e5f0-4291-b7c1-94ec1eed575c	68428-969	HUMAN OTC DRUG	Lac felinum		FELIS CATUS MILK	PELLET	ORAL	20110707		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FELIS CATUS MILK	30	[hp_C]/1			N	20241231
68428-970_765a9082-b030-4299-9cb5-f5c4af57c271	68428-970	HUMAN OTC DRUG	Laurocerasus		PRUNUS LAUROCERASUS LEAF	PELLET	ORAL	20110419		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PRUNUS LAUROCERASUS LEAF	30	[hp_C]/1			N	20241231
68428-971_e4ac2322-b8a7-421c-b5a6-0dd01ab3d4e9	68428-971	HUMAN OTC DRUG	Lemna minor		LEMNA MINOR	PELLET	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LEMNA MINOR	30	[hp_C]/1			N	20241231
68428-975_5db768e5-87d9-4158-9fd2-b26da6689631	68428-975	HUMAN OTC DRUG	Lithium muriaticum		LITHIUM CHLORIDE	PELLET	ORAL	20111104		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LITHIUM CHLORIDE	30	[hp_C]/1	Mood Stabilizer [EPC]		N	20241231
68428-978_9b86f1ff-77a7-4e91-b4fb-6c992d0181f3	68428-978	HUMAN OTC DRUG	Lycopersicum esculentum		SOLANUM LYCOPERSICUM	PELLET	ORAL	20120404		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SOLANUM LYCOPERSICUM	30	[hp_C]/1			N	20241231
68428-979_d2316874-e3ca-4c35-a620-9b5bca9b29e3	68428-979	HUMAN OTC DRUG	Macrotinum		BLACK COHOSH	PELLET	ORAL	20120615		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BLACK COHOSH	30	[hp_C]/1			N	20241231
68428-980_98f1b31f-3727-45b2-aef2-a89bf8c8508d	68428-980	HUMAN OTC DRUG	Magnesia sulphurica		MAGNESIUM SULFATE HEPTAHYDRATE	PELLET	ORAL	20110627		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MAGNESIUM SULFATE HEPTAHYDRATE	30	[hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68428-981_f66824cf-f8b0-4a71-b798-821343c5a77b	68428-981	HUMAN OTC DRUG	Magnesium metallicum		MAGNESIUM	PELLET	ORAL	20111013		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MAGNESIUM	30	[hp_C]/1			N	20241231
68428-988_d7022a8a-6df5-4673-abc8-037891af1680	68428-988	HUMAN OTC DRUG	Mercurius cyanatus		MERCURIC CYANIDE	PELLET	ORAL	20120125		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MERCURIC CYANIDE	30	[hp_C]/1			N	20241231
68428-990_ea292449-736b-4619-b733-da224daaa03d	68428-990	HUMAN OTC DRUG	Morbillinum		MEASLES VIRUS	PELLET	ORAL	20110615		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	MEASLES VIRUS	30	[hp_C]/1			N	20241231
68428-997_52885602-e642-444a-a75c-a532f6fdc2e9	68428-997	HUMAN OTC DRUG	WHP Be gone Hangover	TM	ACTIVATED CHARCOAL, ARABICA COFFEE BEAN, IPECAC, STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20160513		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACTIVATED CHARCOAL; ARABICA COFFEE BEAN; IPECAC; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68428-998_9630bf23-14c7-4aef-9e55-e085efef2564	68428-998	HUMAN OTC DRUG	WHP Be gone Stings	TM	APIS MELLIFERA, ARABICA COFFEE BEAN, IPECAC, STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20160513		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	APIS MELLIFERA; HYPERICUM PERFORATUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; URTICA URENS	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
68436-120_0d69a13b-41e2-22ae-e063-6294a90ad6b2	68436-120	HUMAN OTC DRUG	Sorbutuss	NR	Sorbutuss	LIQUID	ORAL	20070101		OTC MONOGRAPH DRUG	M012	Dextrum Laboratories Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68437-010_eb0475c6-c759-55a1-e053-2a95a90a69e9	68437-010	HUMAN OTC DRUG	Sulfur		Sulfur	OINTMENT	TOPICAL	20121201		OTC MONOGRAPH FINAL	M006	GRISI Hnos, S.A DE C.V	SULFUR	10	g/100g			N	20241231
68437-011_eb044ac3-0b3a-0ec2-e053-2995a90a1c8b	68437-011	HUMAN OTC DRUG	Sulfur		Sulfur	SOAP	TOPICAL	20121201		OTC MONOGRAPH FINAL	M006	GRISI Hnos, S.A DE C.V	SULFUR	10	g/100g			N	20241231
68437-012_eb0475c6-c75a-55a1-e053-2a95a90a69e9	68437-012	HUMAN OTC DRUG	Sulfur Facial Wash	Acne Cleanser	Sulfur	LIQUID	TOPICAL	20190708		OTC MONOGRAPH FINAL	M006	GRISI Hnos, S.A DE C.V	SULFUR	3	g/100mL			N	20241231
68462-101_9614f9c3-532b-429c-8917-714e356b67cf	68462-101	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	Glenmark Pharmaceuticals Inc., USA	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68462-102_9614f9c3-532b-429c-8917-714e356b67cf	68462-102	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	Glenmark Pharmaceuticals Inc., USA	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68462-104_9614f9c3-532b-429c-8917-714e356b67cf	68462-104	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20060125		ANDA	ANDA077253	Glenmark Pharmaceuticals Inc., USA	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68462-105_ca1eb3c3-a781-4b63-bbdb-e0d2e3c9c8c5	68462-105	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077535	Glenmark Pharmaceuticals Inc., USA	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
68462-106_ca1eb3c3-a781-4b63-bbdb-e0d2e3c9c8c5	68462-106	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077535	Glenmark Pharmaceuticals Inc., USA	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
68462-108_6b889c5a-4b85-4976-925e-54befbdf8fe8	68462-108	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-109_6b889c5a-4b85-4976-925e-54befbdf8fe8	68462-109	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-110_6b889c5a-4b85-4976-925e-54befbdf8fe8	68462-110	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-112_7afb84b5-c519-4774-a8ce-099011b09a6b	68462-112	HUMAN PRESCRIPTION DRUG	Aprepitant		Aprepitant	KIT		20171012		ANDA	ANDA207777	Glenmark Pharmaceuticals Inc., USA						N	20251231
68462-119_9614f9c3-532b-429c-8917-714e356b67cf	68462-119	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	Glenmark Pharmaceuticals Inc., USA	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68462-120_c2edaac3-c5ea-4d04-b23b-d5a30c656f36	68462-120	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20221216		ANDA	ANDA216357	Glenmark Pharmaceuticals Inc., USA	NICARDIPINE HYDROCHLORIDE	20	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
68462-121_c2edaac3-c5ea-4d04-b23b-d5a30c656f36	68462-121	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20221216		ANDA	ANDA216357	Glenmark Pharmaceuticals Inc., USA	NICARDIPINE HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
68462-126_bf6177b4-adf4-4473-b9f5-61a22a0e1bba	68462-126	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401		ANDA	ANDA077662	Glenmark Pharmaceuticals Inc., USA	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-127_bf6177b4-adf4-4473-b9f5-61a22a0e1bba	68462-127	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20060401		ANDA	ANDA077662	Glenmark Pharmaceuticals Inc., USA	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-128_1f29917c-511d-4169-b593-27fb11dca1ec	68462-128	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060130		ANDA	ANDA077651	Glenmark Pharmaceuticals Inc., USA	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68462-129_1f29917c-511d-4169-b593-27fb11dca1ec	68462-129	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060130		ANDA	ANDA077651	Glenmark Pharmaceuticals Inc., USA	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68462-130_1f29917c-511d-4169-b593-27fb11dca1ec	68462-130	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060130		ANDA	ANDA077651	Glenmark Pharmaceuticals Inc., USA	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68462-131_496c34f9-7262-4814-a065-fc59809748b3	68462-131	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20160805		ANDA	ANDA207117	Glenmark Pharmaceuticals Inc., USA	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-132_4017e248-0242-49de-8a14-a5cc3a97a5a7	68462-132	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20160120		ANDA	ANDA206969	Glenmark Pharmaceuticals Inc., USA	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.02; 1	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68462-135_55e39d73-7edc-4719-9343-db296e0609cb	68462-135	HUMAN PRESCRIPTION DRUG	abiraterone acetate		abiraterone acetate	TABLET	ORAL	20191016		ANDA	ANDA209227	Glenmark Pharmaceuticals Inc., USA	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20251231
68462-137_a47a76fe-644a-48a7-b41b-062961a7d7ef	68462-137	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077802	Glenmark Pharmaceuticals Inc., USA	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
68462-138_a47a76fe-644a-48a7-b41b-062961a7d7ef	68462-138	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077802	Glenmark Pharmaceuticals Inc., USA	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
68462-139_a47a76fe-644a-48a7-b41b-062961a7d7ef	68462-139	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077802	Glenmark Pharmaceuticals Inc., USA	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
68462-140_3e836c85-ec02-4086-b2de-c6b17672ebd3	68462-140	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20210601		ANDA	ANDA077932	Glenmark Pharmaceuticals Inc., USA	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-141_3e836c85-ec02-4086-b2de-c6b17672ebd3	68462-141	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20210601		ANDA	ANDA077932	Glenmark Pharmaceuticals Inc., USA	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-142_8e66de7a-d9d4-4562-bc99-80489d482da4	68462-142	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20230310		ANDA	ANDA216957	GLENMARK PHARMACEUTICALS INC., USA	CLINDAMYCIN HYDROCHLORIDE	75	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68462-143_8e66de7a-d9d4-4562-bc99-80489d482da4	68462-143	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20230310		ANDA	ANDA216957	GLENMARK PHARMACEUTICALS INC., USA	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68462-144_8e66de7a-d9d4-4562-bc99-80489d482da4	68462-144	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20230310		ANDA	ANDA216957	GLENMARK PHARMACEUTICALS INC., USA	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68462-153_6b889c5a-4b85-4976-925e-54befbdf8fe8	68462-153	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA077627	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-157_ca1eb3c3-a781-4b63-bbdb-e0d2e3c9c8c5	68462-157	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	Glenmark Pharmaceuticals Inc., USA	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
68462-158_ca1eb3c3-a781-4b63-bbdb-e0d2e3c9c8c5	68462-158	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	Glenmark Pharmaceuticals Inc., USA	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
68462-162_2155a4b3-b3d1-4dba-81d9-b8b7f7fe2cce	68462-162	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Glenmark Pharmaceuticals Inc., USA	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68462-163_2155a4b3-b3d1-4dba-81d9-b8b7f7fe2cce	68462-163	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Glenmark Pharmaceuticals Inc., USA	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68462-164_2155a4b3-b3d1-4dba-81d9-b8b7f7fe2cce	68462-164	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Glenmark Pharmaceuticals Inc., USA	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68462-165_2155a4b3-b3d1-4dba-81d9-b8b7f7fe2cce	68462-165	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Glenmark Pharmaceuticals Inc., USA	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68462-166_2581e472-3525-45d0-abf1-536df92793b4	68462-166	HUMAN PRESCRIPTION DRUG	fingolimod		fingolimod	CAPSULE	ORAL	20220928		ANDA	ANDA207985	Glenmark Pharmaceuticals Inc., USA	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
68462-178_8566ce5e-a915-4ca9-a51a-0f957f394e66	68462-178	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20070801		ANDA	ANDA078314	Glenmark Pharmaceuticals Inc., USA	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-179_8566ce5e-a915-4ca9-a51a-0f957f394e66	68462-179	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20070801		ANDA	ANDA078314	Glenmark Pharmaceuticals Inc., USA	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-180_548852be-c664-4193-8a01-ad60ac6a9460	68462-180	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20110608		ANDA	ANDA090480	Glenmark Pharmaceuticals Inc., USA	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
68462-181_487b2001-756b-4446-aafa-b9b1e523833e	68462-181	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20100804		ANDA	ANDA090219	Glenmark Pharmaceuticals Inc., USA	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68462-184_88fe7a8e-5faa-4065-a56c-775f367742a0	68462-184	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	VAGINAL	20220127		ANDA	ANDA215794	GLENMARK PHARMACEUTICALS INC., USA	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
68462-185_cc1f615e-6cb2-4721-84c6-e5f170b64d90	68462-185	HUMAN PRESCRIPTION DRUG	fluocinolone acetonide		fluocinolone acetonide	OIL	AURICULAR (OTIC)	20181218		ANDA	ANDA211815	Glenmark Pharmaceuticals Inc., USA	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-188_8566ce5e-a915-4ca9-a51a-0f957f394e66	68462-188	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Glenmark Pharmaceuticals Inc., USA	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-189_8566ce5e-a915-4ca9-a51a-0f957f394e66	68462-189	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Glenmark Pharmaceuticals Inc., USA	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-190_8566ce5e-a915-4ca9-a51a-0f957f394e66	68462-190	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Glenmark Pharmaceuticals Inc., USA	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-192_42b90831-6019-4d81-aa0d-6fb75c4d51a1	68462-192	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20080528		ANDA	ANDA078541	Glenmark Pharmaceuticals Inc., USA	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-195_a6e006b3-4256-4cbb-8ad1-b71f363430cd	68462-195	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	Glenmark Pharmaceuticals Inc., USA	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-196_a6e006b3-4256-4cbb-8ad1-b71f363430cd	68462-196	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	Glenmark Pharmaceuticals Inc., USA	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-197_a6e006b3-4256-4cbb-8ad1-b71f363430cd	68462-197	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20070511		ANDA	ANDA077987	Glenmark Pharmaceuticals Inc., USA	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-198_a6e006b3-4256-4cbb-8ad1-b71f363430cd	68462-198	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20071228		ANDA	ANDA077987	Glenmark Pharmaceuticals Inc., USA	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-199_7e3e0f17-43ef-4dfc-9b0a-596284c66016	68462-199	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20140707		ANDA	ANDA090032	Glenmark Pharmaceuticals Inc., USA	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68462-200_7e3e0f17-43ef-4dfc-9b0a-596284c66016	68462-200	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20140707		ANDA	ANDA090032	Glenmark Pharmaceuticals Inc., USA	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68462-201_7e3e0f17-43ef-4dfc-9b0a-596284c66016	68462-201	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20140707		ANDA	ANDA090032	Glenmark Pharmaceuticals Inc., USA	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68462-208_4ed36996-d19e-470c-91d6-a296ea64b753	68462-208	HUMAN PRESCRIPTION DRUG	Moexipril Hydrochloride		Moexipril Hydrochloride	TABLET, FILM COATED	ORAL	20101231		ANDA	ANDA090416	Glenmark Pharmaceuticals Inc., USA	MOEXIPRIL HYDROCHLORIDE	15	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
68462-209_4ed36996-d19e-470c-91d6-a296ea64b753	68462-209	HUMAN PRESCRIPTION DRUG	Moexipril Hydrochloride		Moexipril Hydrochloride	TABLET, FILM COATED	ORAL	20101231		ANDA	ANDA090416	Glenmark Pharmaceuticals Inc., USA	MOEXIPRIL HYDROCHLORIDE	7.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
68462-220_cdd20960-5c1d-40fc-8f45-572d5bd58fe1	68462-220	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20090203		ANDA	ANDA079139	Glenmark Pharmaceuticals Inc., USA	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
68462-221_cdd20960-5c1d-40fc-8f45-572d5bd58fe1	68462-221	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20090203		ANDA	ANDA079139	Glenmark Pharmaceuticals Inc., USA	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
68462-222_cdd20960-5c1d-40fc-8f45-572d5bd58fe1	68462-222	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20090203		ANDA	ANDA079139	Glenmark Pharmaceuticals Inc., USA	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
68462-223_1d4aa691-d3b1-49a4-8759-a5ecfcfd8a73	68462-223	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101227		ANDA	ANDA091544	Glenmark Pharmaceuticals Inc., USA	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20251231
68462-224_40f67069-ceed-4584-b275-fa49492fa895	68462-224	HUMAN PRESCRIPTION DRUG	Lithium Carbonate	ER	Lithium Carbonate	TABLET	ORAL	20110214		ANDA	ANDA091616	Glenmark Pharmaceuticals Inc., USA	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20251231
68462-225_68dd082e-2bd7-43d5-9dd2-948bd2cd4637	68462-225	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone furoate	OINTMENT	TOPICAL	20080528		ANDA	ANDA078571	Glenmark Pharmaceuticals Inc., USA	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-226_cc16332b-ad89-4549-aea5-41f21053eb03	68462-226	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20220429		ANDA	ANDA078560	Glenmark Pharmaceuticals Inc., USA	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
68462-228_4b6c4092-c0df-45a4-a1ab-9fcc9b5b8ded	68462-228	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090219		ANDA	ANDA079099	Glenmark Pharmaceuticals Inc., USA	LAMOTRIGINE	5	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
68462-229_4b6c4092-c0df-45a4-a1ab-9fcc9b5b8ded	68462-229	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, CHEWABLE	ORAL	20090219		ANDA	ANDA079099	Glenmark Pharmaceuticals Inc., USA	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
68462-233_6fe9a510-0582-4372-a70e-fdf3fc23dfff	68462-233	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101220		ANDA	ANDA090365	Glenmark Pharmaceuticals Inc., USA	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68462-234_6fe9a510-0582-4372-a70e-fdf3fc23dfff	68462-234	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101220		ANDA	ANDA090365	Glenmark Pharmaceuticals Inc., USA	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68462-235_6fe9a510-0582-4372-a70e-fdf3fc23dfff	68462-235	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101220		ANDA	ANDA090365	Glenmark Pharmaceuticals Inc., USA	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68462-253_d1cd5f31-bcae-416e-908d-d2cacb15e945	68462-253	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	Glenmark Pharmaceuticals Inc., USA	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-254_d1cd5f31-bcae-416e-908d-d2cacb15e945	68462-254	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	Glenmark Pharmaceuticals Inc., USA	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-255_d1cd5f31-bcae-416e-908d-d2cacb15e945	68462-255	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	Glenmark Pharmaceuticals Inc., USA	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-256_d1cd5f31-bcae-416e-908d-d2cacb15e945	68462-256	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	Glenmark Pharmaceuticals Inc., USA	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-257_d1cd5f31-bcae-416e-908d-d2cacb15e945	68462-257	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	Glenmark Pharmaceuticals Inc., USA	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-258_d1cd5f31-bcae-416e-908d-d2cacb15e945	68462-258	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	Glenmark Pharmaceuticals Inc., USA	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-259_d1cd5f31-bcae-416e-908d-d2cacb15e945	68462-259	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20100225		ANDA	ANDA090135	Glenmark Pharmaceuticals Inc., USA	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-260_d1db2ec0-ce9d-4f3a-a2ca-c85b752a09a7	68462-260	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090917		ANDA	ANDA078906	Glenmark Pharmaceuticals Inc., USA	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-261_2cd18bbe-10e6-4c9b-90f1-dd0150d955db	68462-261	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079172	Glenmark Pharmaceutials Inc., USA	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-262_2cd18bbe-10e6-4c9b-90f1-dd0150d955db	68462-262	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079172	Glenmark Pharmaceutials Inc., USA	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-263_2cd18bbe-10e6-4c9b-90f1-dd0150d955db	68462-263	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079172	Glenmark Pharmaceutials Inc., USA	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-264_2cd18bbe-10e6-4c9b-90f1-dd0150d955db	68462-264	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079172	Glenmark Pharmaceutials Inc., USA	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68462-265_84dc1413-a85b-41f6-a3e3-6e76c01f6803	68462-265	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079019	Glenmark Pharmaceuticals Inc., USA	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68462-266_84dc1413-a85b-41f6-a3e3-6e76c01f6803	68462-266	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079019	Glenmark Pharmaceuticals Inc., USA	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68462-267_84dc1413-a85b-41f6-a3e3-6e76c01f6803	68462-267	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079019	Glenmark Pharmaceuticals Inc., USA	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68462-268_84dc1413-a85b-41f6-a3e3-6e76c01f6803	68462-268	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079019	Glenmark Pharmaceuticals Inc., USA	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68462-269_84dc1413-a85b-41f6-a3e3-6e76c01f6803	68462-269	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079019	Glenmark Pharmaceuticals Inc., USA	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68462-270_84dc1413-a85b-41f6-a3e3-6e76c01f6803	68462-270	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079019	Glenmark Pharmaceuticals Inc., USA	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68462-271_84dc1413-a85b-41f6-a3e3-6e76c01f6803	68462-271	HUMAN PRESCRIPTION DRUG	atomoxetine		atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079019	Glenmark Pharmaceuticals Inc., USA	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68462-275_d9414e03-41d5-4e96-9ce6-b298c365281d	68462-275	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20150528		ANDA	ANDA201831	Glenmark Pharmaceuticals Inc.,USA	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20251231
68462-276_d9414e03-41d5-4e96-9ce6-b298c365281d	68462-276	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20150528		ANDA	ANDA201831	Glenmark Pharmaceuticals Inc.,USA	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20251231
68462-290_49430c58-2f86-4962-82fa-5cb71e6e53b4	68462-290	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20080923		ANDA	ANDA078930	Glenmark Pharmaceuticals Inc., USA	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-292_d1db2ec0-ce9d-4f3a-a2ca-c85b752a09a7	68462-292	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110805		ANDA	ANDA090700	Glenmark Pharmaceuticals Inc., USA	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-293_d1db2ec0-ce9d-4f3a-a2ca-c85b752a09a7	68462-293	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110805		ANDA	ANDA090700	Glenmark Pharmaceuticals Inc., USA	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-294_a3d55a5c-1f69-456d-a01a-60c18b186264	68462-294	HUMAN PRESCRIPTION DRUG	Trandolapril and Verapamil Hydrochloride		Trandolapril and Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150225		ANDA	ANDA079135	Glenmark Pharmaceuticals Inc., USA	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	1; 240	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-295_a3d55a5c-1f69-456d-a01a-60c18b186264	68462-295	HUMAN PRESCRIPTION DRUG	Trandolapril and Verapamil Hydrochloride		Trandolapril and Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150225		ANDA	ANDA079135	Glenmark Pharmaceuticals Inc., USA	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	2; 180	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-296_a3d55a5c-1f69-456d-a01a-60c18b186264	68462-296	HUMAN PRESCRIPTION DRUG	Trandolapril and Verapamil Hydrochloride		Trandolapril and Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150225		ANDA	ANDA079135	Glenmark Pharmaceuticals Inc., USA	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	2; 240	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-297_d7f35f0f-7e23-4425-8de5-e5a4230ddd2e	68462-297	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	CREAM	TOPICAL	20091113		ANDA	ANDA090273	Glenmark Pharmaceuticals Inc., USA	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20251231
68462-298_2fc6dcb9-879f-4d6e-8194-4a30af922986	68462-298	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20151106		ANDA	ANDA202894	Glenmark Pharmaceuticals Inc. USA	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-299_ecc3db25-26c2-45e6-a872-416be399403f	68462-299	HUMAN PRESCRIPTION DRUG	Alclometasone Dipropionate		Alclometasone Dipropionate	OINTMENT	TOPICAL	20090730		ANDA	ANDA079227	Glenmark Pharmaceuticals Inc., USA	ALCLOMETASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-300_ecc3db25-26c2-45e6-a872-416be399403f	68462-300	HUMAN PRESCRIPTION DRUG	Alclometasone Dipropionate		Alclometasone Dipropionate	CREAM	TOPICAL	20090623		ANDA	ANDA079061	Glenmark Pharmaceuticals Inc., USA	ALCLOMETASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-301_597d44e5-14c5-4e81-b693-3725f8f4a39f	68462-301	HUMAN PRESCRIPTION DRUG	adapalene and benzoyl peroxide		adapalene and benzoyl peroxide	GEL	TOPICAL	20191108		ANDA	ANDA208108	Glenmark Pharmaceuticals Inc., USA	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68462-302_407baab2-bbf5-4a15-8f17-d0a072945266	68462-302	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	Glenmark Pharmaceuticals Inc., USA	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-303_030e355d-8ad8-45c0-aa2b-20751f319c58	68462-303	HUMAN PRESCRIPTION DRUG	HEATHER		Norethindrone	TABLET	ORAL	20100423		ANDA	ANDA090454	Glenmark Pharmaceuticals Inc., USA	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20251231
68462-304_a52ea7a3-e37e-42f7-9519-63b85c663931	68462-304	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate		Norethindrone Acetate	TABLET	ORAL	20100721		ANDA	ANDA091090	Glenmark Pharmaceuticals Inc., USA	NORETHINDRONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20251231
68462-305_8c26b4a6-dbf4-4166-817f-2a802f2ded2a	68462-305	HUMAN PRESCRIPTION DRUG	Norethindrone		Norethindrone	TABLET	ORAL	20101103		ANDA	ANDA091209	Glenmark Pharmaceuticals Inc., USA	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20251231
68462-307_78932bd8-681c-4420-9efb-66df23f14d84	68462-307	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		dimethyl-fumarate	CAPSULE	ORAL	20201006		ANDA	ANDA210309	Glenmark Pharmaceuticals Inc., USA	DIMETHYL FUMARATE	120	mg/1			N	20241231
68462-308_78932bd8-681c-4420-9efb-66df23f14d84	68462-308	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		dimethyl-fumarate	CAPSULE	ORAL	20201006		ANDA	ANDA210309	Glenmark Pharmaceuticals Inc., USA	DIMETHYL FUMARATE	240	mg/1			N	20241231
68462-309_05142abd-63f7-4025-8b10-1d7dec036750	68462-309	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20120406		ANDA	ANDA200538	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-310_0eb6468e-a970-4e6c-9c70-84c05e9ea49a	68462-310	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	OINTMENT	TOPICAL	20100324		ANDA	ANDA090633	Glenmark Pharmaceuticals Inc., USA	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20251231
68462-314_39b52cdc-3387-4aac-9a01-e4c6ae68f282	68462-314	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20161024		ANDA	ANDA208136	Glenmark Pharmaceuticals Inc., USA	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
68462-316_9b338ff5-7a2d-48c0-a897-78aece12c9b0	68462-316	HUMAN PRESCRIPTION DRUG	BRIELLYN		Norethindrone and Ethinyl Estradiol	KIT		20110323		ANDA	ANDA090538	Glenmark Pharmaceuticals Inc., USA						N	20251231
68462-317_867a3f96-4ba4-4edb-8efd-e266ec71b35a	68462-317	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20190822		ANDA	ANDA207754	GLENMARK PHARMACEUTICALS INC., USA	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
68462-318_f4ae3e02-1bb4-4df8-b9ad-f03d7dd079cb	68462-318	HUMAN PRESCRIPTION DRUG	VIORELE		Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol	KIT		20120404		ANDA	ANDA091346	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-319_8872581f-53be-4bde-8d22-c6960f11e9d6	68462-319	HUMAN PRESCRIPTION DRUG	Ranolazine		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190705		ANDA	ANDA211082	Glenmark Pharmaceuticals Inc., USA	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-320_8872581f-53be-4bde-8d22-c6960f11e9d6	68462-320	HUMAN PRESCRIPTION DRUG	Ranolazine		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190705		ANDA	ANDA211082	Glenmark Pharmaceuticals Inc., USA	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-321_e4414c0e-2df1-4511-8149-3ad9e2cf99ad	68462-321	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190627		ANDA	ANDA208699	Glenmark Pharmaceuticals Inc., USA	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
68462-322_e4414c0e-2df1-4511-8149-3ad9e2cf99ad	68462-322	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190627		ANDA	ANDA208699	Glenmark Pharmaceuticals Inc., USA	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
68462-323_e4414c0e-2df1-4511-8149-3ad9e2cf99ad	68462-323	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190627		ANDA	ANDA208699	Glenmark Pharmaceuticals Inc., USA	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
68462-324_e4414c0e-2df1-4511-8149-3ad9e2cf99ad	68462-324	HUMAN PRESCRIPTION DRUG	ezetimibe and simvastatin		ezetimibe and simvastatin	TABLET	ORAL	20190627		ANDA	ANDA208699	Glenmark Pharmaceuticals Inc., USA	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
68462-325_3e56ab33-0411-43c3-a97c-0139ec343d0d	68462-325	HUMAN PRESCRIPTION DRUG	indomethacin		indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20170622		ANDA	ANDA203501	Glenmark Pharmaceuticals Inc., USA	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-329_a3d55a5c-1f69-456d-a01a-60c18b186264	68462-329	HUMAN PRESCRIPTION DRUG	Trandolapril and Verapamil Hydrochloride		Trandolapril and Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20150225		ANDA	ANDA079135	Glenmark Pharmaceuticals Inc., USA	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	4; 240	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
68462-330_d625660d-78d1-4e40-bc41-1f1f74e56744	68462-330	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090781	Glenmark Pharmaceuticals Inc., USA	PRAMIPEXOLE DIHYDROCHLORIDE	.125	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-331_d625660d-78d1-4e40-bc41-1f1f74e56744	68462-331	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090781	Glenmark Pharmaceuticals Inc., USA	PRAMIPEXOLE DIHYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-332_d625660d-78d1-4e40-bc41-1f1f74e56744	68462-332	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090781	Glenmark Pharmaceuticals Inc., USA	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-333_d625660d-78d1-4e40-bc41-1f1f74e56744	68462-333	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090781	Glenmark Pharmaceuticals Inc., USA	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-334_d625660d-78d1-4e40-bc41-1f1f74e56744	68462-334	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090781	Glenmark Pharmaceuticals Inc., USA	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-335_4c3eea71-a7a1-4eda-9871-034ddeb83ed6	68462-335	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20231106		ANDA	ANDA216350	Glenmark Pharmaceuticals Inc., USA	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68462-336_4c3eea71-a7a1-4eda-9871-034ddeb83ed6	68462-336	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20231106		ANDA	ANDA216350	Glenmark Pharmaceuticals Inc., USA	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68462-337_4c3eea71-a7a1-4eda-9871-034ddeb83ed6	68462-337	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20231106		ANDA	ANDA216350	Glenmark Pharmaceuticals Inc., USA	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68462-338_4c3eea71-a7a1-4eda-9871-034ddeb83ed6	68462-338	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20231106		ANDA	ANDA216350	Glenmark Pharmaceuticals Inc., USA	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68462-346_95657ca2-e04d-4b92-8954-3c3efd4d7e24	68462-346	HUMAN PRESCRIPTION DRUG	LEVOCETIRIZINE DIHYDROCHLORIDE		levocetirizine dihydrochloride	TABLET	ORAL	20110225		ANDA	ANDA090385	Glenmark Pharmaceuticals Inc., USA	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
68462-355_8893641f-f168-45df-b876-e3e130c25957	68462-355	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20160913		ANDA	ANDA208301	GLENMARK PHARMACEUTICALS INC., USA	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68462-356_aaa6684e-4eef-42a8-92b6-8f317e570903	68462-356	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20100713		ANDA	ANDA090355	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	600	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20251231
68462-357_b0251572-aa7f-434a-a7ff-33ccbc37dfaf	68462-357	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20160120		ANDA	ANDA202868	Glenmark Pharmaceuticals Inc., USA	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
68462-370_7f0d0a6d-ed07-4d39-8327-f6b04ecb25ce	68462-370	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	150	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-371_7f0d0a6d-ed07-4d39-8327-f6b04ecb25ce	68462-371	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-372_7f0d0a6d-ed07-4d39-8327-f6b04ecb25ce	68462-372	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-373_7f0d0a6d-ed07-4d39-8327-f6b04ecb25ce	68462-373	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-374_7f0d0a6d-ed07-4d39-8327-f6b04ecb25ce	68462-374	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA210278	Glenmark Pharmaceuticals Inc., USA	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-376_c38d6eb8-e70a-415a-ae54-daf53998112a	68462-376	HUMAN PRESCRIPTION DRUG	norethindrone acetate and ethinyl estradiol and ferrous fumarate		norethindrone acetate and ethinyl estradiol and ferrous fumarate	KIT		20171226		ANDA	ANDA210369	Glenmark Pharmaceuticals Inc., USA						N	20251231
68462-380_aaa6684e-4eef-42a8-92b6-8f317e570903	68462-380	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20100713		ANDA	ANDA090355	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	400	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20251231
68462-381_e8a81e60-47b6-4097-9e49-48eb88e694f6	68462-381	HUMAN PRESCRIPTION DRUG	riluzole		riluzole	TABLET, FILM COATED	ORAL	20130618		ANDA	ANDA091394	Glenmark Pharmaceuticals Inc., USA	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20251231
68462-382_82513ec5-c7be-4c3d-83c0-9987df88664d	68462-382	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091166	Glenmark Pharmaceuticals Inc. USA	ESZOPICLONE	1	mg/1		CIV	N	20241231
68462-383_82513ec5-c7be-4c3d-83c0-9987df88664d	68462-383	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091166	Glenmark Pharmaceuticals Inc. USA	ESZOPICLONE	2	mg/1		CIV	N	20241231
68462-384_82513ec5-c7be-4c3d-83c0-9987df88664d	68462-384	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091166	Glenmark Pharmaceuticals Inc. USA	ESZOPICLONE	3	mg/1		CIV	N	20241231
68462-385_fca48ee3-83aa-4615-9aa2-d8e8b2550069	68462-385	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	LOTION	TOPICAL	20200601		ANDA	ANDA090506	Glenmark Pharmaceuticals Inc., USA	MOMETASONE FUROATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-386_9cfcab1d-64ac-457b-979f-41cf6547a63a	68462-386	HUMAN PRESCRIPTION DRUG	solifenacin succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA209239	Glenmark Pharmaceuticals Inc., USA	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
68462-387_9cfcab1d-64ac-457b-979f-41cf6547a63a	68462-387	HUMAN PRESCRIPTION DRUG	solifenacin succinate		solifenacin succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190520		ANDA	ANDA209239	Glenmark Pharmaceuticals Inc., USA	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
68462-388_3394a3a1-cdf8-4577-81a1-5998ad508722	68462-388	HUMAN PRESCRIPTION DRUG	MARLISSA		Levonorgestrel and Ethinyl Estradiol	KIT		20120229		ANDA	ANDA091452	Glenmark Pharmaceuticals Inc., USA						N	20251231
68462-390_22d2d621-3bab-4b65-85bd-4a3c396a4be6	68462-390	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20211101		ANDA	ANDA209495	Glenmark Pharmaceuticals Inc., USA	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68462-391_22d2d621-3bab-4b65-85bd-4a3c396a4be6	68462-391	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20211101		ANDA	ANDA209495	Glenmark Pharmaceuticals Inc., USA	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68462-394_b51f50e3-0557-4880-8d34-42113b2c8115	68462-394	HUMAN PRESCRIPTION DRUG	ALYACEN 1/35		norethindrone and ethinyl estradiol	KIT		20120119		ANDA	ANDA091634	Glenmark Pharmaceuticals Inc., USA						N	20251231
68462-395_0d1658f1-003c-466b-b6a5-0804f44e4927	68462-395	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Glenmark Pharmaceuticals Inc., USA	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68462-396_0d1658f1-003c-466b-b6a5-0804f44e4927	68462-396	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Glenmark Pharmaceuticals Inc., USA	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68462-397_0d1658f1-003c-466b-b6a5-0804f44e4927	68462-397	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Glenmark Pharmaceuticals Inc., USA	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68462-402_822b0bad-700b-4e88-8c10-7492bc8b1e1d	68462-402	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride Pediatric		Atovaquone and Proguanil Hydrochloride Pediatric	TABLET, FILM COATED	ORAL	20150408		ANDA	ANDA091211	Glenmark Pharmaceuticals Inc.,USA	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	62.5; 25	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
68462-404_822b0bad-700b-4e88-8c10-7492bc8b1e1d	68462-404	HUMAN PRESCRIPTION DRUG	Atovaquone and Proguanil Hydrochloride		Atovaquone and Proguanil Hydrochloride	TABLET, FILM COATED	ORAL	20110915		ANDA	ANDA091211	Glenmark Pharmaceuticals Inc.,USA	ATOVAQUONE; PROGUANIL HYDROCHLORIDE	250; 100	mg/1; mg/1	Antimalarial [EPC], Antimalarial [EPC], Antiprotozoal [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
68462-405_1d9d072a-e721-450d-b80d-12dd480e6f5d	68462-405	HUMAN PRESCRIPTION DRUG	ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE		ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE	CAPSULE	ORAL	20190524		ANDA	ANDA210318	Glenmark Pharmaceuticals Inc., USA	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20251231
68462-406_407baab2-bbf5-4a15-8f17-d0a072945266	68462-406	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	Glenmark Pharmaceuticals Inc., USA	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68462-408_064ec508-4c51-41fa-929f-0abe45b4779b	68462-408	HUMAN PRESCRIPTION DRUG	propafenone hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170908		ANDA	ANDA205268	Glenmark Pharmaceuticals Inc., USA	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20251231
68462-409_064ec508-4c51-41fa-929f-0abe45b4779b	68462-409	HUMAN PRESCRIPTION DRUG	propafenone hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170908		ANDA	ANDA205268	Glenmark Pharmaceuticals Inc., USA	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20251231
68462-410_064ec508-4c51-41fa-929f-0abe45b4779b	68462-410	HUMAN PRESCRIPTION DRUG	propafenone hydrochloride		propafenone hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170908		ANDA	ANDA205268	Glenmark Pharmaceuticals Inc., USA	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20251231
68462-418_e7d81e46-e9d0-42ff-bcf8-ec4828368bea	68462-418	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20160701		ANDA	ANDA206498	Glenmark Pharmaceuticals Inc., USA	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
68462-419_111f1be0-6680-4632-9e6f-7a61f09c0a22	68462-419	HUMAN PRESCRIPTION DRUG	HAILEY Fe 1/20		norethindrone acetate and ethinyl estradiol and ferrous fumarate	KIT		20171121		ANDA	ANDA206597	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-421_9084fbfb-e877-45a3-9126-58a03737adf8	68462-421	HUMAN PRESCRIPTION DRUG	atovaquone		atovaquone	SUSPENSION	ORAL	20171231		ANDA	ANDA209685	Glenmark Pharmaceuticals Inc., USA	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20251231
68462-423_cb431ea0-ba0f-4b5d-a50d-f8c050762242	68462-423	HUMAN PRESCRIPTION DRUG	teriflunomide		teriflunomide	TABLET, FILM COATED	ORAL	20230119		ANDA	ANDA209663	Glenmark Pharmaceuticals Inc., USA	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
68462-424_cb431ea0-ba0f-4b5d-a50d-f8c050762242	68462-424	HUMAN PRESCRIPTION DRUG	teriflunomide		teriflunomide	TABLET, FILM COATED	ORAL	20230119		ANDA	ANDA209663	Glenmark Pharmaceuticals Inc., USA	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
68462-427_033b2fba-d1e5-4bb5-8b20-005d905056bb	68462-427	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	LOTION	TOPICAL	20111013		ANDA	ANDA090759	Glenmark Pharmaceuticals Inc., USA	FLUTICASONE PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-433_836cbdcd-e2b0-468f-8aff-32ecd9760e78	68462-433	HUMAN PRESCRIPTION DRUG	colesevelam hydrochloride		colesevelam hydrochloride	TABLET, FILM COATED	ORAL	20180518		ANDA	ANDA203480	Glenmark Pharmaceuticals Inc., USA	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
68462-435_5f5e5bc7-8b3b-42d6-9252-399bdfe407aa	68462-435	HUMAN PRESCRIPTION DRUG	Acamprosate Calcium		Acamprosate Calcium	TABLET, DELAYED RELEASE	ORAL	20130716		ANDA	ANDA202229	Glenmark Pharmaceuticals Inc., USA	ACAMPROSATE CALCIUM	333	mg/1			N	20241231
68462-436_aa9a7b83-61b7-40c9-9fa0-4d627324b7bc	68462-436	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170525		ANDA	ANDA203281	Glenmark Pharmaceuticals Inc., USA	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68462-437_aa9a7b83-61b7-40c9-9fa0-4d627324b7bc	68462-437	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170525		ANDA	ANDA203281	Glenmark Pharmaceuticals Inc., USA	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68462-438_aa9a7b83-61b7-40c9-9fa0-4d627324b7bc	68462-438	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170525		ANDA	ANDA203281	Glenmark Pharmaceuticals Inc., USA	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68462-446_ed77c1c3-86c5-4165-b713-e3d5fff10b17	68462-446	HUMAN PRESCRIPTION DRUG	sevelamer hydrochloride		sevelamer hydrochloride	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA204724	Glenmark Pharmaceuticals Inc., USA	SEVELAMER HYDROCHLORIDE	400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20251231
68462-447_ed77c1c3-86c5-4165-b713-e3d5fff10b17	68462-447	HUMAN PRESCRIPTION DRUG	sevelamer hydrochloride		sevelamer hydrochloride	TABLET, FILM COATED	PARENTERAL	20190208		ANDA	ANDA204724	Glenmark Pharmaceuticals Inc., USA	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20251231
68462-455_f4188436-4d86-48c2-89a9-7c73862bb8fe	68462-455	HUMAN PRESCRIPTION DRUG	ciclopirox		ciclopirox	GEL	TOPICAL	20120229		ANDA	ANDA091595	Glenmark Pharmaceuticals Inc., USA	CICLOPIROX	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
68462-461_81f089dd-217e-40df-abcf-bc98996ce31f	68462-461	HUMAN PRESCRIPTION DRUG	Trospium Chloride		Trospium Chloride	TABLET, FILM COATED	ORAL	20100813		ANDA	ANDA091575	Glenmark Pharmaceuticals Inc., USA	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68462-464_6e46589c-87ad-46fb-8dae-ae1690e68f01	68462-464	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		Hydrocortisone Butyrate	CREAM	TOPICAL	20131205		ANDA	ANDA202145	Glenmark Pharmaceuticals Inc., USA	HYDROCORTISONE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-465_c7909d7b-34a6-42b0-ad12-eb25f3ce886e	68462-465	HUMAN PRESCRIPTION DRUG	rizatriptan benzoate		rizatriptan benzoate	TABLET	ORAL	20121231		ANDA	ANDA201967	Glenmark Pharmaceuticals Inc., USA	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-466_c7909d7b-34a6-42b0-ad12-eb25f3ce886e	68462-466	HUMAN PRESCRIPTION DRUG	rizatriptan benzoate		rizatriptan benzoate	TABLET	ORAL	20121231		ANDA	ANDA201967	Glenmark Pharmaceuticals Inc., USA	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-467_d0d83e24-265b-4802-96e0-e0d18bef299d	68462-467	HUMAN PRESCRIPTION DRUG	rizatriptan benzoate		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA201914	Glenmark Pharmaceuticals Inc., USA	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-468_d0d83e24-265b-4802-96e0-e0d18bef299d	68462-468	HUMAN PRESCRIPTION DRUG	rizatriptan benzoate		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA201914	Glenmark Pharmaceuticals Inc., USA	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-469_680563fe-5d3a-49bc-86a5-740bda2acebe	68462-469	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230101		ANDA	ANDA216434	GLENMARK PHARMACEUTICALS INC., USA	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68462-470_680563fe-5d3a-49bc-86a5-740bda2acebe	68462-470	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230101		ANDA	ANDA216434	GLENMARK PHARMACEUTICALS INC., USA	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68462-471_1ee2b3cb-f4b4-4efc-a7a2-3be15cf4b6cc	68462-471	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20160726		ANDA	ANDA203562	Glenmark Pharmaceuticals Inc., USA	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
68462-472_1ee2b3cb-f4b4-4efc-a7a2-3be15cf4b6cc	68462-472	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20160726		ANDA	ANDA203562	Glenmark Pharmaceuticals Inc., USA	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
68462-473_f2c1fcd8-7d64-42c8-bd0b-5579592e127f	68462-473	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20110712		ANDA	ANDA090801	Glenmark Pharmaceuticals Inc., USA	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
68462-474_f2c1fcd8-7d64-42c8-bd0b-5579592e127f	68462-474	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20110712		ANDA	ANDA090801	Glenmark Pharmaceuticals Inc., USA	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
68462-480_a827f327-e5a8-4162-9f5a-1215bcb449ec	68462-480	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	SPRAY	TOPICAL	20180326		ANDA	ANDA209004	Glenmark Pharmaceuticals Inc., USA	CLOBETASOL PROPIONATE	.05	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-486_c014804c-8a69-496c-b151-67ccfbeb6aa3	68462-486	HUMAN PRESCRIPTION DRUG	clindamycin and benzoyl peroxide		clindamycin and benzoyl peroxide	GEL	TOPICAL	20190314		ANDA	ANDA209252	Glenmark Pharmaceuticals Inc., USA	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
68462-494_1595b336-a89a-49bc-b0b8-13c204726f13	68462-494	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106		ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20251231
68462-495_1595b336-a89a-49bc-b0b8-13c204726f13	68462-495	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106		ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20251231
68462-496_1595b336-a89a-49bc-b0b8-13c204726f13	68462-496	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20200106		ANDA	ANDA209433	Glenmark Pharmaceuticals Inc., USA	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20251231
68462-497_9534f816-5c39-41ef-ac03-27dadb46ddeb	68462-497	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20130514		ANDA	ANDA201779	Glenmark Pharmaceuticals Inc.,USA	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-498_9534f816-5c39-41ef-ac03-27dadb46ddeb	68462-498	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20130514		ANDA	ANDA201779	Glenmark Pharmaceuticals Inc.,USA	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-499_6ee6f1b7-e5f0-4273-897c-b771a8f1c828	68462-499	HUMAN PRESCRIPTION DRUG	zolmiptriptan		zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20130514		ANDA	ANDA202560	Glenmark Pharmaceuticals Inc., USA	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-500_6ee6f1b7-e5f0-4273-897c-b771a8f1c828	68462-500	HUMAN PRESCRIPTION DRUG	zolmiptriptan		zolmitriptan	TABLET, ORALLY DISINTEGRATING	ORAL	20130514		ANDA	ANDA202560	Glenmark Pharmaceuticals Inc., USA	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-501_2b7d2f2f-514a-4bc1-baea-9b6ee2b17300	68462-501	HUMAN PRESCRIPTION DRUG	calcipotriene		calcipotriene	CREAM	TOPICAL	20150610		ANDA	ANDA205772	Glenmark Pharmaceuticals Inc.,USA	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
68462-502_0ccedf12-88a5-9a0e-e063-6294a90a3a5f	68462-502	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	19990801		ANDA	ANDA075252	Glenmark Pharmaceuticals, Inc	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68462-503_ca6e466e-b3a7-428b-8519-d8d6caa5279a	68462-503	HUMAN PRESCRIPTION DRUG	Hailey Fe 1.5/30		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20180605		ANDA	ANDA209031	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-504_ce49bb41-d3a6-4514-a140-dea4787f1d2f	68462-504	HUMAN PRESCRIPTION DRUG	Hailey 1.5/30		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20180605		ANDA	ANDA209297	Glenmark Pharmaceuticals Inc., USA	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.03; 1.5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68462-505_9c6c8ea8-4836-4bb8-882b-2375184485d2	68462-505	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20140714		ANDA	ANDA091282	Glenmark Pharmaceuticals Inc., USA	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-520_ef160cca-85e2-440c-997f-0535914b4d3f	68462-520	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191125		ANDA	ANDA212969	GLENMARK PHARMACEUTICALS INC., USA	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
68462-521_ef160cca-85e2-440c-997f-0535914b4d3f	68462-521	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191125		ANDA	ANDA212969	GLENMARK PHARMACEUTICALS INC., USA	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
68462-529_62379b8a-c43a-473b-8a1b-d5ad146dc6bf	68462-529	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180510		ANDA	ANDA209095	Glenmark Pharmaceutcials Inc., USA	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-530_923024a2-fbce-4487-872f-98e4016183c3	68462-530	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	OINTMENT	TOPICAL	20170320		ANDA	ANDA208933	Glenmark Pharmaceuticals Inc., USA	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-531_15a31bdf-5162-42bd-a3d5-7e21bac5f49f	68462-531	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20130920		ANDA	ANDA202838	Glenmark Pharmaceuticals Inc., USA	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-532_8a5a06f3-bb61-4854-8c74-673747cbcfdd	68462-532	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	SOLUTION	TOPICAL	20180418		ANDA	ANDA210190	Glenmark Pharmaceuticals Inc., USA	CLOBETASOL PROPIONATE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-534_7443dde6-3783-407b-b78e-d50e9ffbb9e8	68462-534	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	OINTMENT	TOPICAL	20180416		ANDA	ANDA210393	Glenmark Pharmaceuticals Inc., USA	TACROLIMUS	1	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68462-536_10e87665-15c2-432b-8e28-8ec8e5d347f1	68462-536	HUMAN PRESCRIPTION DRUG	Imiquimod		Imiquimod	CREAM	TOPICAL	20120306		ANDA	ANDA201994	Glenmark Pharmaceuticals Inc., USA	IMIQUIMOD	50	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20251231
68462-556_b51f50e3-0557-4880-8d34-42113b2c8115	68462-556	HUMAN PRESCRIPTION DRUG	ALYACEN 7/7/7		norethindrone and ethinyl estradiol	KIT		20120119		ANDA	ANDA091636	Glenmark Pharmaceuticals Inc., USA						N	20251231
68462-560_dc6f3960-2e28-46f1-8619-de5aee5f97ad	68462-560	HUMAN PRESCRIPTION DRUG	Pirnuo		Mupirocin	CREAM	TOPICAL	20170729		ANDA	ANDA201587	Glenmark Pharmaceuticals Inc., USA	MUPIROCIN CALCIUM	2	g/100g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20251231
68462-562_52b392c0-72cb-4a91-8d27-5cacdb8a7778	68462-562	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210322		ANDA	ANDA212317	GLENMARK PHARMACEUTICALS INC., USA	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
68462-564_4d903d30-cc63-4585-bb9c-70fe90da514c	68462-564	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	CREAM	TOPICAL	20130124		ANDA	ANDA201587	Glenmark Pharmaceuticals Inc., USA	MUPIROCIN CALCIUM	2	g/100g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20251231
68462-565_05142abd-63f7-4025-8b10-1d7dec036750	68462-565	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20110617		ANDA	ANDA200494	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-566_6de4a776-9973-4410-ae04-99544813d920	68462-566	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170705		ANDA	ANDA207807	Glenmark Pharmaceuticals Inc., USA	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
68462-567_6de4a776-9973-4410-ae04-99544813d920	68462-567	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170705		ANDA	ANDA207807	Glenmark Pharmaceuticals Inc., USA	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
68462-568_6de4a776-9973-4410-ae04-99544813d920	68462-568	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170705		ANDA	ANDA207807	Glenmark Pharmaceuticals Inc., USA	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
68462-569_6de4a776-9973-4410-ae04-99544813d920	68462-569	HUMAN PRESCRIPTION DRUG	Amlodipine and Olmesartan Medoxomil		Amlodipine and Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170705		ANDA	ANDA207807	Glenmark Pharmaceuticals Inc., USA	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
68462-570_78932bd8-681c-4420-9efb-66df23f14d84	68462-570	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		dimethyl fumarate kit	KIT		20201006		ANDA	ANDA210309	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-572_ff13e93d-2bfa-45e7-80c2-4555ef1abc9c	68462-572	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20150904		ANDA	ANDA203503	Glenmark Pharmaceuticals Inc., USA	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
68462-573_ff13e93d-2bfa-45e7-80c2-4555ef1abc9c	68462-573	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET, FILM COATED	ORAL	20150904		ANDA	ANDA203503	Glenmark Pharmaceuticals Inc., USA	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
68462-575_49d0e1ac-2ed1-4ea7-ac59-03d0c141a7a5	68462-575	HUMAN PRESCRIPTION DRUG	Hydrocortisone valerate		Hydrocortisone valerate	CREAM	TOPICAL	20181015		ANDA	ANDA211129	Glenamrk Pharmaceuticals Inc., USA	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-576_51b0aed8-a229-4d2c-8fdf-aa957fddc41b	68462-576	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20150317		ANDA	ANDA076631	Glenmark Pharmaceuticals Inc., USA	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68462-577_51b0aed8-a229-4d2c-8fdf-aa957fddc41b	68462-577	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20140404		ANDA	ANDA076631	Glenmark Pharmaceuticals Inc., USA	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68462-578_51b0aed8-a229-4d2c-8fdf-aa957fddc41b	68462-578	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20040211		ANDA	ANDA076631	Glenmark Pharmaceuticals Inc., USA	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68462-579_51b0aed8-a229-4d2c-8fdf-aa957fddc41b	68462-579	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride and Hydrochlorothiazide		Benazepril Hydrochloride and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20040211		ANDA	ANDA076631	Glenmark Pharmaceuticals Inc., USA	BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE	20; 25	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68462-580_65523b48-95b4-4491-94cc-5c3c79ac41a8	68462-580	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	CAPSULE	ORAL	20170407		ANDA	ANDA205566	Glenmark Pharmaceuticals Inc., USA	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
68462-581_65523b48-95b4-4491-94cc-5c3c79ac41a8	68462-581	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	CAPSULE	ORAL	20170407		ANDA	ANDA205566	Glenmark Pharmaceuticals Inc., USA	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
68462-582_65523b48-95b4-4491-94cc-5c3c79ac41a8	68462-582	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	CAPSULE	ORAL	20170407		ANDA	ANDA205566	Glenmark Pharmaceuticals Inc., USA	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
68462-583_7afb84b5-c519-4774-a8ce-099011b09a6b	68462-583	HUMAN PRESCRIPTION DRUG	Aprepitant		Aprepitant	CAPSULE	ORAL	20171012		ANDA	ANDA207777	Glenmark Pharmaceuticals Inc., USA	APREPITANT	40	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20251231
68462-584_7afb84b5-c519-4774-a8ce-099011b09a6b	68462-584	HUMAN PRESCRIPTION DRUG	Aprepitant		Aprepitant	CAPSULE	ORAL	20171012		ANDA	ANDA207777	Glenmark Pharmaceuticals Inc., USA	APREPITANT	80	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20251231
68462-585_7afb84b5-c519-4774-a8ce-099011b09a6b	68462-585	HUMAN PRESCRIPTION DRUG	Aprepitant		Aprepitant	CAPSULE	ORAL	20171012		ANDA	ANDA207777	Glenmark Pharmaceuticals Inc., USA	APREPITANT	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20251231
68462-590_49e4ce6d-f8e8-48f5-90e5-ad7b43170026	68462-590	HUMAN PRESCRIPTION DRUG	FLUOCINOLONE ACETONIDE		fluocinolone acetonide	OIL	TOPICAL	20181030		ANDA	ANDA210539	Glenmark Pharmaceuticals Inc., USA	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-591_524ed646-4d02-4d0d-a1a4-100ca274ab3f	68462-591	HUMAN PRESCRIPTION DRUG	FLUOCINOLONE ACETONIDE		fluocinolone acetonide	OIL	TOPICAL	20181026		ANDA	ANDA210556	Glenmark Pharmaceuticals Inc., USA	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-608_9e397c0b-af80-45db-a7d6-232077c35622	68462-608	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	AEROSOL, FOAM	TOPICAL	20190216		ANDA	ANDA210809	Glenmark Pharmaceuticals Inc., USA	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68462-609_6e0c796e-79a3-4633-9f49-6dee1aabcf12	68462-609	HUMAN PRESCRIPTION DRUG	Pimecrolimus		Pimecrolimus	CREAM	TOPICAL	20190829		ANDA	ANDA211769	Glenmark Pharmaceuticals Inc., USA	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
68462-615_151f00ae-13ed-4174-bf4d-bc30f1fb9d69	68462-615	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol hydrochloride	TABLET	ORAL	20170525		ANDA	ANDA203821	Glenmark Pharmaceuticals Inc., USA	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68462-616_151f00ae-13ed-4174-bf4d-bc30f1fb9d69	68462-616	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol hydrochloride	TABLET	ORAL	20170525		ANDA	ANDA203821	Glenmark Pharmaceuticals Inc., USA	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68462-617_151f00ae-13ed-4174-bf4d-bc30f1fb9d69	68462-617	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol hydrochloride	TABLET	ORAL	20170525		ANDA	ANDA203821	Glenmark Pharmaceuticals Inc., USA	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68462-618_151f00ae-13ed-4174-bf4d-bc30f1fb9d69	68462-618	HUMAN PRESCRIPTION DRUG	nebivolol		nebivolol hydrochloride	TABLET	ORAL	20170525		ANDA	ANDA203821	Glenmark Pharmaceuticals Inc., USA	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68462-620_5f515aef-92b4-47c3-8d27-3e02239f01aa	68462-620	HUMAN PRESCRIPTION DRUG	Colesevelam Hydrochloride		Colesevelam Hydrochloride	POWDER, FOR SUSPENSION	ORAL	20180716		ANDA	ANDA202190	Glenmark Pharmaceuticals Inc.,USA	COLESEVELAM HYDROCHLORIDE	3.75	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
68462-621_a0def32c-e693-43e5-9509-0cef9642441c	68462-621	HUMAN PRESCRIPTION DRUG	Fosphenytoin sodium		Fosphenytoin sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231013		ANDA	ANDA214926	GLENMARK PHARMACEUTICALS INC., USA	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-622_a0def32c-e693-43e5-9509-0cef9642441c	68462-622	HUMAN PRESCRIPTION DRUG	Fosphenytoin sodium		Fosphenytoin sodium	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231013		ANDA	ANDA214926	GLENMARK PHARMACEUTICALS INC., USA	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68462-625_8507d82a-a572-4ecf-b14a-2fd69129e09d	68462-625	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	AEROSOL, FOAM	TOPICAL	20190909		ANDA	ANDA211450	Glenmark Pharmaceuticals Inc., USA	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-626_28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6	68462-626	HUMAN PRESCRIPTION DRUG	azelaic acid		azelaic acid	GEL	TOPICAL	20181119		ANDA	ANDA204637	Glenmark Pharmaceuticals Inc., USA	AZELAIC ACID	.15	g/g	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20251231
68462-627_d625660d-78d1-4e40-bc41-1f1f74e56744	68462-627	HUMAN PRESCRIPTION DRUG	Pramipexole dihydrochloride		Pramipexole dihydrochloride	TABLET	ORAL	20160131		ANDA	ANDA090781	Glenmark Pharmaceuticals Inc., USA	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20251231
68462-637_e328bb05-a540-4589-bcc5-5615efb0c55b	68462-637	HUMAN PRESCRIPTION DRUG	Levonorgestrel and Ethinyl Estradiol		Levonorgestrel and Ethinyl Estradiol	TABLET	ORAL	20150409		ANDA	ANDA202791	Glenmark Pharmaceuticals Inc., USA	ETHINYL ESTRADIOL; LEVONORGESTREL	20; 90	ug/1; ug/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20251231
68462-638_91f10148-6ba2-41ef-b454-0f22741a77d3	68462-638	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20170819		ANDA	ANDA206391	Glenmark Pharmaceuticals Inc., USA	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
68462-639_91f10148-6ba2-41ef-b454-0f22741a77d3	68462-639	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20170919		ANDA	ANDA206391	Glenmark Pharmaceuticals Inc., USA	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
68462-640_91f10148-6ba2-41ef-b454-0f22741a77d3	68462-640	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20170919		ANDA	ANDA206391	Glenmark Pharmaceuticals Inc., USA	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
68462-646_b8b50735-8d18-4eae-9b80-933716e02f05	68462-646	HUMAN PRESCRIPTION DRUG	Ashlyna		Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol	KIT		20150223		ANDA	ANDA203163	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-656_0f4548a3-173f-44b3-8b50-d2f2a0df55ea	68462-656	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20150402		ANDA	ANDA203038	Glenmark Pharmaceuticals Inc., USA	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	2.5; .5	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68462-657_0f4548a3-173f-44b3-8b50-d2f2a0df55ea	68462-657	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20150402		ANDA	ANDA203038	Glenmark Pharmaceuticals Inc., USA	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	5; 1	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68462-672_a31050f5-9a9d-4d18-8b54-61b2508b2929	68462-672	HUMAN PRESCRIPTION DRUG	levonorgestrel and ethinyl estradiol		levonorgestrel and ethinyl estradiol	KIT		20150612		ANDA	ANDA203164	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-678_a65056ce-b6e9-4bed-adbd-98052a2e705e	68462-678	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205006	Glenmark Pharmaceuticals Inc. USA	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
68462-679_a65056ce-b6e9-4bed-adbd-98052a2e705e	68462-679	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205006	Glenmark Pharmaceuticals Inc. USA	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
68462-680_a65056ce-b6e9-4bed-adbd-98052a2e705e	68462-680	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205006	Glenmark Pharmaceuticals Inc. USA	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
68462-681_a65056ce-b6e9-4bed-adbd-98052a2e705e	68462-681	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220318		ANDA	ANDA205006	Glenmark Pharmaceuticals Inc. USA	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
68462-682_1c410c5a-1723-4bd2-a054-e6516eb3d6df	68462-682	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20201016		ANDA	ANDA208691	Glenmark Pharmaceuticals Inc., USA	SIROLIMUS	.5	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
68462-683_1c410c5a-1723-4bd2-a054-e6516eb3d6df	68462-683	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20201016		ANDA	ANDA208691	Glenmark Pharmaceuticals Inc., USA	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
68462-684_1c410c5a-1723-4bd2-a054-e6516eb3d6df	68462-684	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	TABLET, FILM COATED	ORAL	20201016		ANDA	ANDA208691	Glenmark Pharmaceuticals Inc., USA	SIROLIMUS	2	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
68462-685_222e5e02-7296-4d3f-adf7-4d412eee7957	68462-685	HUMAN PRESCRIPTION DRUG	tacrolimus		tacrolimus	CAPSULE	ORAL	20201110		ANDA	ANDA206662	Glenmark Pharmaceuticals Inc., USA	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68462-686_222e5e02-7296-4d3f-adf7-4d412eee7957	68462-686	HUMAN PRESCRIPTION DRUG	tacrolimus		tacrolimus	CAPSULE	ORAL	20201110		ANDA	ANDA206662	Glenmark Pharmaceuticals Inc., USA	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68462-687_222e5e02-7296-4d3f-adf7-4d412eee7957	68462-687	HUMAN PRESCRIPTION DRUG	tacrolimus		tacrolimus	CAPSULE	ORAL	20201110		ANDA	ANDA206662	Glenmark Pharmaceuticals Inc., USA	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68462-694_49e68dd9-06c7-4d54-afa9-9016ae0b6995	68462-694	HUMAN PRESCRIPTION DRUG	frovatriptan succinate		frovatriptan succinate	TABLET, FILM COATED	ORAL	20160311		ANDA	ANDA204730	Glenmark Pharmaceuticals Inc., USA	FROVATRIPTAN SUCCINATE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
68462-711_e6f81656-d248-4997-89c0-aefc6bcadf62	68462-711	HUMAN PRESCRIPTION DRUG	ESTRADIOL VAGINAL INSERTS		estradiol	TABLET, FILM COATED	VAGINAL	20180917		ANDA	ANDA210264	Glenmark Pharmaceuticals Inc., USA	ESTRADIOL	10	ug/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
68462-713_087abf2a-9b50-469c-ac8b-5d3eb98c3b62	68462-713	HUMAN PRESCRIPTION DRUG	rufinamide		rufinamide	TABLET, FILM COATED	ORAL	20160516		ANDA	ANDA205075	Glenmark Pharmaceuticals Inc., USA	RUFINAMIDE	200	mg/1			N	20251231
68462-714_087abf2a-9b50-469c-ac8b-5d3eb98c3b62	68462-714	HUMAN PRESCRIPTION DRUG	rufinamide		rufinamide	TABLET, FILM COATED	ORAL	20160516		ANDA	ANDA205075	Glenmark Pharmaceuticals Inc., USA	RUFINAMIDE	400	mg/1			N	20251231
68462-720_fca78b67-8f13-4047-bfd0-0f4e03bd1688	68462-720	HUMAN PRESCRIPTION DRUG	drospirenone and ethinyl estradiol		drospirenone and ethinyl estradiol	KIT		20150817		ANDA	ANDA204296	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-721_d84aadfd-1dcd-491e-a463-744b8a3e558f	68462-721	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603		ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20251231
68462-722_d84aadfd-1dcd-491e-a463-744b8a3e558f	68462-722	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20210603		ANDA	ANDA212184	Glenmark Pharmaceuticals Inc., USA	THEOPHYLLINE ANHYDROUS	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20251231
68462-726_e286ffd4-c598-47fb-af06-2e15f7e6f99f	68462-726	HUMAN PRESCRIPTION DRUG	SAXAGLIPTIN		SAXAGLIPTIN	TABLET, FILM COATED	ORAL	20230731		ANDA	ANDA205994	Glenmark Pharmaceuticals Inc., USA	SAXAGLIPTIN HYDROCHLORIDE	2.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
68462-727_e286ffd4-c598-47fb-af06-2e15f7e6f99f	68462-727	HUMAN PRESCRIPTION DRUG	SAXAGLIPTIN		SAXAGLIPTIN	TABLET, FILM COATED	ORAL	20230731		ANDA	ANDA205994	Glenmark Pharmaceuticals Inc., USA	SAXAGLIPTIN HYDROCHLORIDE	5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
68462-731_073c10e9-08de-4219-bb96-a1030f3d0a15	68462-731	HUMAN PRESCRIPTION DRUG	Hailey 24 Fe		norethindrone acetate and ethinyl estradiol, and ferrous fumarate	KIT		20171117		ANDA	ANDA204847	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-733_d1a2774f-d740-48c2-840a-507b1ac24abe	68462-733	HUMAN PRESCRIPTION DRUG	drospirenone and ethinyl estradiol		drospirenone and ethinyl estradiol	KIT		20160325		ANDA	ANDA204848	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-746_9846c58b-949f-48bd-a2c9-a8418a113b8f	68462-746	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	OINTMENT	TOPICAL	20170731		ANDA	ANDA205510	Glenmark Pharmaceuticals Inc., USA	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
68462-755_ce992bee-a9f5-48bd-a00e-513f590d69f2	68462-755	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231019		ANDA	ANDA217789	GLENMARK PHARMACEUTICALS INC., USA	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68462-756_ce992bee-a9f5-48bd-a00e-513f590d69f2	68462-756	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231019		ANDA	ANDA217789	GLENMARK PHARMACEUTICALS INC., USA	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68462-792_181ce30d-7447-4758-a9fc-359da0876cf2	68462-792	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	CAPSULE	ORAL	20161223		ANDA	ANDA208279	Glenmark Pharmaceuticals Inc., USA	TRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68462-797_86e1691e-dc73-4277-ab05-ad6a4bfda76d	68462-797	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20170822		ANDA	ANDA208320	Glenmark Pharmaceuticals Inc., USA	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-798_86e1691e-dc73-4277-ab05-ad6a4bfda76d	68462-798	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20160722		ANDA	ANDA206379	Glenmark Pharmaceuticals Inc., USA	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-799_1b44d0f9-1191-4cbc-aa20-4b66772f030d	68462-799	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20160623		ANDA	ANDA208300	Glenmark Pharmaceuticals Inc., USA	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
68462-836_555ffb0f-8e6b-4516-9e48-8dae3acf428f	68462-836	HUMAN PRESCRIPTION DRUG	Hydrocortisone Valerate		HYDROCORTISONE VALERATE	OINTMENT	TOPICAL	20190305		ANDA	ANDA211750	Glenmark Pharmaceuticals Inc., USA	HYDROCORTISONE VALERATE	2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68462-840_7c90ec7d-2149-4237-8f29-af6c571d3a77	68462-840	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20190304		ANDA	ANDA202544	Glenmark Pharmaceuticals Inc., USA	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68462-841_7c90ec7d-2149-4237-8f29-af6c571d3a77	68462-841	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20190304		ANDA	ANDA202544	Glenmark Pharmaceuticals Inc., USA	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68462-842_7c90ec7d-2149-4237-8f29-af6c571d3a77	68462-842	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20190304		ANDA	ANDA202544	Glenmark Pharmaceuticals Inc., USA	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68462-849_baa5b4f9-75e9-4012-bc14-dc6628056a66	68462-849	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20220727		ANDA	ANDA213418	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-850_52b392c0-72cb-4a91-8d27-5cacdb8a7778	68462-850	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210322		ANDA	ANDA212317	GLENMARK PHARMACEUTICALS INC., USA	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
68462-851_52b392c0-72cb-4a91-8d27-5cacdb8a7778	68462-851	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210322		ANDA	ANDA212317	GLENMARK PHARMACEUTICALS INC., USA	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
68462-852_8f5bb7c6-61a2-4301-93da-12e34649ede6	68462-852	HUMAN PRESCRIPTION DRUG	Charlotte 24Fe		norethindrone acetate and ethinyl estradiol and ferrous fumarate	KIT		20200220		ANDA	ANDA210369	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-853_2c63a7e3-94f0-4a60-9169-bd7665f1c131	68462-853	HUMAN PRESCRIPTION DRUG	sodium phenylbutyrate		sodium phenylbutyrate	TABLET	ORAL	20221101		ANDA	ANDA216462	GLENMARK PHARMACEUTICALS INC., USA	SODIUM PHENYLBUTYRATE	500	mg/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20251231
68462-859_c014804c-8a69-496c-b151-67ccfbeb6aa3	68462-859	HUMAN PRESCRIPTION DRUG	clindamycin and benzoyl peroxide		clindamycin and benzoyl peroxide	GEL	TOPICAL	20210924		ANDA	ANDA209252	Glenmark Pharmaceuticals Inc., USA	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
68462-861_7b80a6a5-1223-49ec-af0e-50f6584a77b7	68462-861	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20210323		ANDA	ANDA212144	Glenmark Pharmaceuticals Inc., USA	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
68462-862_7b80a6a5-1223-49ec-af0e-50f6584a77b7	68462-862	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20210323		ANDA	ANDA212144	Glenmark Pharmaceuticals Inc., USA	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
68462-863_7b80a6a5-1223-49ec-af0e-50f6584a77b7	68462-863	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20210323		ANDA	ANDA212144	Glenmark Pharmaceuticals Inc., USA	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
68462-864_7b80a6a5-1223-49ec-af0e-50f6584a77b7	68462-864	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20210323		ANDA	ANDA212144	Glenmark Pharmaceuticals Inc., USA	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
68462-865_7b80a6a5-1223-49ec-af0e-50f6584a77b7	68462-865	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20210323		ANDA	ANDA212144	Glenmark Pharmaceuticals Inc., USA	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
68462-866_145aa545-3996-4b65-b3f3-8a31d88740af	68462-866	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	GEL	TOPICAL	20210210		ANDA	ANDA214251	GLENMARK PHARMACEUTICALS INC., USA	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
68462-878_75c16277-3d61-4c27-a853-485aa7669c0e	68462-878	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220126		ANDA	ANDA215995	GLENMARK PHARMACEUTICALS INC., USA	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
68462-879_75c16277-3d61-4c27-a853-485aa7669c0e	68462-879	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220126		ANDA	ANDA215995	GLENMARK PHARMACEUTICALS INC., USA	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
68462-880_75c16277-3d61-4c27-a853-485aa7669c0e	68462-880	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220126		ANDA	ANDA215995	GLENMARK PHARMACEUTICALS INC., USA	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
68462-881_7443dde6-3783-407b-b78e-d50e9ffbb9e8	68462-881	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	OINTMENT	TOPICAL	20230816		ANDA	ANDA210393	Glenmark Pharmaceuticals Inc., USA	TACROLIMUS	.3	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68462-882_55e39d73-7edc-4719-9343-db296e0609cb	68462-882	HUMAN PRESCRIPTION DRUG	abiraterone acetate		abiraterone acetate	TABLET	ORAL	20220519		ANDA	ANDA209227	Glenmark Pharmaceuticals Inc., USA	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20251231
68462-889_9c806152-70d0-43eb-b183-b51b12b82b31	68462-889	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		PROCHLORPERAZINE MALEATE	TABLET	ORAL	20230317		ANDA	ANDA216595	GLENMARK PHARMACEUTICALS INC., USA	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68462-890_9c806152-70d0-43eb-b183-b51b12b82b31	68462-890	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		PROCHLORPERAZINE MALEATE	TABLET	ORAL	20230317		ANDA	ANDA216595	GLENMARK PHARMACEUTICALS INC., USA	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68462-893_89b8956b-cf71-4791-8e55-598ff52656f3	68462-893	HUMAN PRESCRIPTION DRUG	varenicline tartrate		varenicline tartrate	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA214255	Glenmark Pharmaceuticals Inc., USA	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
68462-894_89b8956b-cf71-4791-8e55-598ff52656f3	68462-894	HUMAN PRESCRIPTION DRUG	varenicline tartrate		varenicline tartrate	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA214255	Glenmark Pharmaceuticals Inc., USA	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
68462-895_89b8956b-cf71-4791-8e55-598ff52656f3	68462-895	HUMAN PRESCRIPTION DRUG	varenicline tartrate		varenicline tartrate	KIT		20230822		ANDA	ANDA214255	Glenmark Pharmaceuticals Inc., USA						N	20241231
68462-896_387d7f8d-9762-4f6b-99e1-bdc50b8a1633	68462-896	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230809		ANDA	ANDA216839	GLENMARK PHARMACEUTICALS INC., USA	OCTREOTIDE ACETATE	100	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
68462-897_387d7f8d-9762-4f6b-99e1-bdc50b8a1633	68462-897	HUMAN PRESCRIPTION DRUG	Octreotide Acetate		Octreotide Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230809		ANDA	ANDA216839	GLENMARK PHARMACEUTICALS INC., USA	OCTREOTIDE ACETATE	500	ug/mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
68462-904_a2ba0343-cd17-4b23-8356-005a1dfd0b35	68462-904	HUMAN PRESCRIPTION DRUG	posaconazole		posaconazole	INJECTION, SOLUTION	INTRAVENOUS	20231227		ANDA	ANDA217553	GLENMARK PHARMACEUTICALS INC., USA	POSACONAZOLE	18	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68466-0002_5b224bcf-118c-4703-80c8-906c48ed5701	68466-0002	HUMAN OTC DRUG	Sports For Trauma Gel		Bellis Perennis, Hypericum Perfomatum,Toxicodendron Pubscens Leaf, Ruta Graveolens Flowering Top	GEL	TOPICAL; TOPICAL; TOPICAL	20040701	20240131	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	BELLIS PERENNIS; HYPERICUM PERFORATUM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	1; 2; 1; 3	[hp_X]/71g; [hp_X]/71g; [hp_X]/71g; [hp_X]/71g			N	
68466-0003_026452f6-aab7-4e6e-94ba-2a961e7bf0ad	68466-0003	HUMAN OTC DRUG	Florasone Cream		CARDIOSPERMUM HALICACABUM FLOWERING TOP	CREAM	TOPICAL; TOPICAL	20060101		UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	CARDIOSPERMUM HALICACABUM FLOWERING TOP	1	[hp_X]/28g			N	20241231
68466-0004_69277f76-834e-4d9d-92dc-4e737c11a835	68466-0004	HUMAN OTC DRUG	Arniflora Gel		ARNICA MONTANA	GEL	TOPICAL; TOPICAL	20110101		UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V.	ARNICA MONTANA	1	[hp_X]/28g			N	20241231
68466-0007_d2c4b78b-c7bb-4f92-b2f4-5ef151e1e28c	68466-0007	HUMAN OTC DRUG	Califlora Calendula Gel		CALENDULA OFFICINALIS FLOWERING TOP	GEL	TOPICAL; TOPICAL	20060101	20250331	UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de D.V	CALENDULA OFFICINALIS FLOWERING TOP	1	[hp_X]/78g			N	
68466-0008_65c109c7-871d-4789-b985-1c760cbe5660	68466-0008	HUMAN OTC DRUG	Cough and Bronchial Daytime Syrup		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN	SYRUP	ORAL; ORAL	20040701	20241031	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 3; 6; 3; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_C]/118mL; [hp_X]/118mL; [hp_C]/118mL			N	
68466-0009_cc781c8c-7064-406a-8313-d06422a1e3e9	68466-0009	HUMAN OTC DRUG	Cough and Bronchial Nighttime Syrup		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN, MEDICAGO SATIVA LEAF, OAT, ARABICA COFFEE BEAN	SYRUP	ORAL; ORAL	20040701	20250131	UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. DE C.V.	ACONITUM NAPELLUS; ARABICA COFFEE BEAN; BRYONIA ALBA ROOT; CALCIUM SULFIDE; MEDICAGO SATIVA LEAF; OAT; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 6; 3; 6; 1; 1; 3; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_C]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_C]/118mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
68466-0098_a3487f14-01d4-404b-852a-5b6997d7fe41	68466-0098	HUMAN OTC DRUG	CHILDRENS ALPHA CF		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS	TABLET	SUBLINGUAL; SUBLINGUAL	20170701	20250131	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS	7; 7; 7; 7; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-0598_a26775b5-f587-41fb-b4fb-6966ab439191	68466-0598	HUMAN OTC DRUG	SMOKE FREE		DIEFFENBACHIA SEGUINE, DAPHNE ODORA BARK, GRAPHITES, VALERIAN	TABLET	SUBLINGUAL; SUBLINGUAL	20170601	20251230	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	DAPHNE ODORA BARK; DIEFFENBACHIA SEGUINE; GRAPHITE; VALERIAN	12; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-1002_d9ed8605-21c0-4a8d-b0f2-413f96f25116	68466-1002	HUMAN OTC DRUG	Sports For Trauma Gel		Bellis Perennis, Hypericum Perfomatum,Toxicodendron Pubscens Leaf, Ruta Graveolens Flowering Top	GEL	TOPICAL; TOPICAL; TOPICAL	20210903		UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	BELLIS PERENNIS; HYPERICUM PERFORATUM; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	1; 2; 1; 4	[hp_X]/70g; [hp_X]/70g; [hp_X]/70g; [hp_X]/70g			N	20241231
68466-1008_c7a4c8cb-17ed-48cb-b2e3-05a1dc5c9971	68466-1008	HUMAN OTC DRUG	Cough and Bronchial Daytime Syrup		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN	SYRUP	ORAL; ORAL	20230228		UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CALCIUM SULFIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 3; 6; 3; 6	[hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL; [hp_X]/120mL; [hp_C]/120mL			N	20241231
68466-1009_5e9cd0ba-bb4a-422b-8362-5b65438ede35	68466-1009	HUMAN OTC DRUG	Cough and Bronchial Nighttime Syrup		ACONITUM NAPELLUS, BRYONIA ROOT, CALCIUM CATION, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN, MEDICAGO SATIVA LEAF, OAT, ARABICA COFFEE BEAN	SYRUP	ORAL; ORAL	20230303		UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. DE C.V.	ACONITUM NAPELLUS; ARABICA COFFEE BEAN; BRYONIA ALBA ROOT; CALCIUM SULFIDE; MEDICAGO SATIVA LEAF; OAT; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 6; 3; 6; 1; 1; 3; 6	[hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_X]/120mL; [hp_C]/120mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68466-1012_2e17e0e0-99ed-4f2e-a6d5-24004ed91ecf	68466-1012	HUMAN OTC DRUG	Cough and Bronchial with Zinc Syrup		ANTIMONY PENTASULFIDE, BRYONIA ALBA ROOT, DROSERA ROTUNDIFOLIA, EUCALYPTUS GLOBULUS LEAF, IPECAC, SPONGIA OFFICINALIS SKELETON, ROASTED, ZINC GLUCONATE	SYRUP	ORAL; ORAL	20040701	20240430	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ANTIMONY PENTASULFIDE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA FLOWERING TOP; EUCALYPTUS GLOBULUS LEAF; IPECAC; SPONGIA OFFICINALIS SKELETON, ROASTED; ZINC GLUCONATE	8; 3; 4; 3; 4; 3; 1	[hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
68466-1015_9662258e-4e7a-4058-99e1-0fb090bf7c49	68466-1015	HUMAN OTC DRUG	Oral Ivy Liquid		TOXICODENDRON PUBESCENS LEAF	LIQUID	ORAL; ORAL	20211117	20240430	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	TOXICODENDRON PUBESCENS LEAF	4	[hp_X]/29mL			N	
68466-1041_cd693332-cf97-4139-a5df-0c7164f94730	68466-1041	HUMAN OTC DRUG	Arnica Montana 30C		Arnica Montana	TABLET	SUBLINGUAL; SUBLINGUAL; SUBLINGUAL	20060101	20270331	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ARNICA MONTANA	30	[hp_C]/1			N	
68466-1042_b761eb18-d7fd-4067-8d84-bb0b4c1b5268	68466-1042	HUMAN OTC DRUG	Arnica Montana 30X		Arnica Montana	TABLET	SUBLINGUAL; SUBLINGUAL; SUBLINGUAL	20060101	20250630	UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V.	ARNICA MONTANA	30	[hp_X]/1			N	
68466-1043_d58e6d89-ba28-4961-b136-3235edceabe8	68466-1043	HUMAN OTC DRUG	Arnica Montana 6X		ARNICA MONTANA	TABLET	ORAL; ORAL; ORAL	20060101	20251031	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ARNICA MONTANA	6	[hp_X]/1			N	
68466-2001_3ab87f67-00b9-4995-9c3d-3263f075c7dc	68466-2001	HUMAN OTC DRUG	Triflora Gel		URTICA DIOICA, TOXICODENDRON PUBESCENS LEAF, LEDUM PALUSTRE TWIG	GEL	TOPICAL; TOPICAL	20211001		UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V.	LEDUM PALUSTRE TWIG; TOXICODENDRON PUBESCENS LEAF; URTICA DIOICA	2; 4; 1	[hp_X]/77g; [hp_X]/77g; [hp_X]/77g			N	20241231
68466-2005_ca1edb7b-4094-4c3c-a231-184d22b55be5	68466-2005	HUMAN OTC DRUG	PSORIAFLORA		MAHONIA AQUIFOLIUM ROOT BARK	CREAM	TOPICAL	20220422		UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	MAHONIA AQUIFOLIUM ROOT BARK	2	[hp_X]/28g			N	20241231
68466-2006_6a04c566-e877-4f9e-87a7-a05799f96611	68466-2006	HUMAN OTC DRUG	Ssssting Stop Gel		Echinacea Angustifolia, Ledum Palustre Twig, Urtica Dioica,	GEL	TOPICAL	20201019		UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ECHINACEA ANGUSTIFOLIA; LEDUM PALUSTRE TWIG; URTICA DIOICA	1; 2; 1	[hp_X]/78g; [hp_X]/78g; [hp_X]/78g			N	20241231
68466-2010_bf4b13c0-c299-45a2-b503-8850e0f275d3	68466-2010	HUMAN OTC DRUG	Cough and Bronchial Childrens Syrup		ANTIMONY PENTASULFIDE, BRYONIA ALBA ROOT, DROSERA ROTUNDIFOLIA, EUCALYPTUS GLOBULUS LEAF, IPECAC, ILLICIUM ANISATUM WHOLE	SYRUP	ORAL; ORAL	20211014	20240331	UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V.	ANTIMONY PENTASULFIDE; BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA FLOWERING TOP; EUCALYPTUS GLOBULUS LEAF; ILLICIUM VERUM WHOLE; IPECAC	6; 3; 4; 3; 3; 4	[hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL; [hp_X]/240mL			N	
68466-2015_fb2a4179-44a2-4029-8cb1-2a93db8d4a6d	68466-2015	HUMAN OTC DRUG	Oral Ivy Liquid		TOXICODENDRON PUBESCENS LEAF	LIQUID	ORAL; ORAL	20230309		UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	TOXICODENDRON PUBESCENS LEAF	4	[hp_X]/30mL			N	20241231
68466-2391_6ef6d2c9-91ab-4182-a27f-3ca487f06c4f	68466-2391	HUMAN OTC DRUG	Migraide		CYCLAMEN PURPURASCENS TUBER, BLACK COHOSH, IRIS VERSICOLOR WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, SANGUINARIA CANADENSIS ROOT	TABLET	SUBLINGUAL; SUBLINGUAL	20150702	20261231	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	BLACK COHOSH; CYCLAMEN PURPURASCENS TUBER; GELSEMIUM SEMPERVIRENS WHOLE; IRIS VERSICOLOR WHOLE; SANGUINARIA CANADENSIS ROOT	3; 3; 3; 2; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-2590_27481679-bdb1-47b5-8b95-0994640ac42d	68466-2590	HUMAN OTC DRUG	Allergiemittel		CARDIOSPERMUM HALICACABUM FLOWERING TOP, GALPHIMIA GLAUCA FLOWERING TOP, LUFFA OPERCULATA FRUIT	TABLET	SUBLINGUAL; SUBLINGUAL; SUBLINGUAL; SUBLINGUAL	20170401	20250130	UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V.	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT	3; 3; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-2798_e6a8c0cb-2b63-42ba-a988-69acb5a6a1ab	68466-2798	HUMAN OTC DRUG	SCIATICAIDE		ARSENIC TRIOXIDE, CHAMOMILE, CITRULLUS COLOCYNTHIS FRUIT PULP, SULFUR	TABLET	SUBLINGUAL; SUBLINGUAL	20110818	20270630	UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V.	ARSENIC TRIOXIDE; CHAMOMILE; CITRULLUS COLOCYNTHIS FRUIT PULP; SULFUR	12; 3; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-3391_d8cde9a0-94e3-4efe-b12f-e2e1284f32ca	68466-3391	HUMAN OTC DRUG	Migraide		CYCLAMEN PURPURASCENS TUBER, BLACK COHOSH, IRIS VERSICOLOR WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, SANGUINARIA CANADENSIS ROOT	TABLET	SUBLINGUAL; SUBLINGUAL	20211109	20270131	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	BLACK COHOSH; CYCLAMEN PURPURASCENS TUBER; GELSEMIUM SEMPERVIRENS WHOLE; IRIS VERSICOLOR WHOLE; SANGUINARIA CANADENSIS ROOT	3; 3; 3; 4; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-3398_508e09f9-a43d-4cd5-9896-9c4eea845c8f	68466-3398	HUMAN OTC DRUG	ALPHA CF		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS	TABLET	SUBLINGUAL; SUBLINGUAL; SUBLINGUAL	20170401	20270331	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS	4; 4; 2; 6; 4; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-3590_29f4c6e1-694b-4251-9636-3204b6e831cf	68466-3590	HUMAN OTC DRUG	Allergiemittel		CARDIOSPERMUM HALICACABUM FLOWERING TOP, GALPHIMIA GLAUCA FLOWERING TOP, LUFFA OPERCULATA FRUIT	TABLET	SUBLINGUAL; SUBLINGUAL; SUBLINGUAL; SUBLINGUAL	20200428		UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V.	CARDIOSPERMUM HALICACABUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT	3; 3; 5	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
68466-4098_77d164c2-7115-4f23-8763-1ae460afd147	68466-4098	HUMAN OTC DRUG	Bronchial and Breathing Aide		ACONITUM NAPELLUS, CALCIUM SULFIDE, SPONGIA OFFICINALIS SKELETON, ROASTED, TIN	TABLET	SUBLINGUAL; SUBLINGUAL	20170401	20270331	UNAPPROVED HOMEOPATHIC		Schwabe Mexico S.A. de C.V	ACONITUM NAPELLUS; CALCIUM SULFIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; TIN	3; 12; 3; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68466-4191_32449721-13e2-4194-b1c1-8e1dc3b33de4	68466-4191	HUMAN OTC DRUG	ALPHA SH		SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS	TABLET	SUBLINGUAL	20201016	20270131	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	GOLDENSEAL; POTASSIUM CHLORIDE; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; SILICON DIOXIDE	6; 3; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
68466-9490_4cb85325-023b-4465-86cc-f6e0c26ad05a	68466-9490	HUMAN OTC DRUG	ALPHA CF		ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUCALYPTUS GLOBULUS LEAF, EUPATORIUM PERFOLIATUM FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, IPECAC, PHOSPHORUS	TABLET	SUBLINGUAL	20180713	20250930	UNAPPROVED HOMEOPATHIC		Schwabe Mexico, S.A. de C.V.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PHOSPHORUS	4; 4; 2; 6; 4; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
68470-1001_07fe6c1e-41b6-8171-e063-6394a90a5956	68470-1001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20051111		UNAPPROVED MEDICAL GAS		Super Care Inc	OXYGEN	99	L/100L			N	20241231
68472-234_5f3b2c58-c3d3-50e4-e053-2a91aa0a33c7	68472-234	HUMAN OTC DRUG	YourGoodSkin	Active Treatment Tonic	Salicylic Acid	LIQUID	TOPICAL	20180201		OTC MONOGRAPH FINAL	part333D	BOOTS RETAIL USA INC	SALICYLIC ACID	5	mg/mL			N	20241231
68472-235_ec5c116b-c3b0-91a3-e053-2995a90a56ec	68472-235	HUMAN OTC DRUG	YourGoodSkin	Anti-Acne Base	Salicylic Acid	LOTION	TOPICAL	20171212		OTC MONOGRAPH FINAL	part333D	BOOTS RETAIL USA INC	SALICYLIC ACID	10	mg/mL			N	20241231
68472-236_db3b5b68-22cb-93c2-e053-2995a90a222b	68472-236	HUMAN OTC DRUG	YourGoodSkin	Calming Cleanser	Salicylic Acid	CREAM	TOPICAL	20170516		OTC MONOGRAPH FINAL	part333D	BOOTS RETAIL USA INC	SALICYLIC ACID	10	mg/mL			N	20241231
68472-237_6429872b-bb2a-a235-e053-2991aa0a25f7	68472-237	HUMAN OTC DRUG	YourGoodSkin	Rapid Rescue Treatment	Salicylic Acid	GEL	TOPICAL	20171219		OTC MONOGRAPH FINAL	part333D	BOOTS RETAIL USA INC	SALICYLIC ACID	20	mg/mL			N	20241231
68472-238_f0594f27-39d6-b805-e053-2995a90abad1	68472-238	HUMAN OTC DRUG	YourGoodSkin	Blackhead Clearing Scrub	Salicylic Acid	CREAM	TOPICAL	20170307		OTC MONOGRAPH FINAL	part333D	BOOTS RETAIL USA INC	SALICYLIC ACID	10	mg/mL			N	20241231
68475-001_ba395792-1598-42a7-8473-f7a677e40441	68475-001	HUMAN PRESCRIPTION DRUG	Sodium Phenylacetate and sodium benzoate		Sodium Phenylacetate and sodium benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210304		ANDA	ANDA205880	Navinta LLC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
68475-002_18f370d8-7ea7-4595-bcdf-ad0b80a1c193	68475-002	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201222		ANDA	ANDA206071	Navinta LLC	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68475-003_76819c30-2ece-43cf-a329-6bc3720ac870	68475-003	HUMAN PRESCRIPTION DRUG	RIBAVIRIN		ribavirin	POWDER, FOR SOLUTION	RESPIRATORY (INHALATION)	20200421		ANDA	ANDA207366	Navinta LLC	RIBAVIRIN	6	g/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68475-006_aba5a223-eb30-4693-8927-ad30a916aba4	68475-006	HUMAN PRESCRIPTION DRUG	Carglumic acid		Carglumic acid	TABLET, FOR SUSPENSION	ORAL	20220801		ANDA	ANDA213395	Navinta LLC	CARGLUMIC ACID	200	mg/1	Carbamoyl Phosphate Synthetase 1 Activator [EPC], Carbamoyl Phosphate Synthetase 1 Activators [MoA]		N	20241231
68475-200_849d2ff0-5492-4a06-85cd-4d006c6105c1	68475-200	HUMAN PRESCRIPTION DRUG	Trientine Hydrochloride		Trientine Hydrochloride	CAPSULE	ORAL	20201205		ANDA	ANDA211251	Navinta LLC	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
68475-201_0ee5ea02-a892-408f-aa5d-42ab034bdfc4	68475-201	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20220101		ANDA	ANDA214363	Navinta LLC	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
68475-400_12419fdc-7a4c-4762-806c-0d56b478ef9d	68475-400	HUMAN PRESCRIPTION DRUG	famotidine		famotidine	POWDER, FOR SUSPENSION	ORAL	20210422		ANDA	ANDA091020	Navinta LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68475-503_6fab4765-a76c-4f5a-8d4f-4c23b1dd4b6c	68475-503	HUMAN PRESCRIPTION DRUG	Carmustine		carmustine	KIT		20201229		ANDA	ANDA210179	Navinta LLC						N	20241231
68475-510_8f5acbbd-682d-4d8f-ae76-2669424bdfcc	68475-510	HUMAN PRESCRIPTION DRUG	Fomepizole		Fomepizole	INJECTION, SOLUTION	INTRAVENOUS	20210402		ANDA	ANDA078537	Navinta LLC	FOMEPIZOLE	1	g/mL	Antidote [EPC]		N	20241231
68475-512_7bed6c98-81d0-48cc-be85-6d472453df53	68475-512	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine Mesylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201124		ANDA	ANDA091525	Navinta LLC	BENZTROPINE MESYLATE	1	mg/mL	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
68479-013_b28c1c0a-4ba6-40a3-ab04-ea6e82af4635	68479-013	HUMAN OTC DRUG	Sebum Clearing Masque		Salicylic Acid	LOTION	TOPICAL	20110513		OTC MONOGRAPH FINAL	part358H	Dermalogica	SALICYLIC ACID	5	mg/mL			N	20241231
68479-020_1f4f1c23-f768-4643-b06e-dc8dcd62b399	68479-020	HUMAN OTC DRUG	Powerbright Moisturizer SPF 50		Octocrylene, Homosalate, Avobenzone, and Octisalate	LOTION	TOPICAL	20210304		OTC MONOGRAPH FINAL	part352	Dermalogica, LLC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68479-101_b6389c44-01c9-4752-844f-79906849db1b	68479-101	HUMAN OTC DRUG	Breakout Clearing Foaming Wash		Salicylic Acid	LIQUID	TOPICAL	20130513		OTC MONOGRAPH FINAL	part358H	Dermalogica	SALICYLIC ACID	5	mg/mL			N	20241231
68479-110_431afe17-dbcb-4046-8ef5-b9d351a9d2ab	68479-110	HUMAN OTC DRUG	Oil Free Matte	SPF 30	Avobenzone, Homosalate, Octisalate, and Oxybenzone	LOTION	TOPICAL	20120216		OTC MONOGRAPH FINAL	part352	Dermalogica	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	30; 80; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68479-130_adb2dff4-e406-4123-9624-2d0c12bcb6ef	68479-130	HUMAN OTC DRUG	SkinPerfect Primer	SPF 30	Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20120213		OTC MONOGRAPH FINAL	part352	Dermalogica, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	40; 140	mg/mL; mg/mL			N	20241231
68479-141_abe33a3e-04e9-49fa-adca-30a31ef38ed3	68479-141	HUMAN OTC DRUG	RETINOL CLEARING		Salicylic Acid	OIL	TOPICAL	20190827		OTC MONOGRAPH FINAL	part333D	Dermalogica, LLC.	SALICYLIC ACID	2	mg/100mL			N	20241231
68479-184_d8ed5501-6f00-495d-aefe-0d83e491e596	68479-184	HUMAN OTC DRUG	AGE Bright Clearing Serum		Salicylic Acid	LIQUID	TOPICAL	20190606		OTC MONOGRAPH FINAL	part333D	Dermalogica, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
68479-232_a1838a21-18ab-4c11-a6c4-8dcff1d4cdc5	68479-232	HUMAN OTC DRUG	Protection 50 Sport		Homosalate, Octocrylene, Octisalate, and Avobenzone	LOTION	TOPICAL	20190805		OTC MONOGRAPH FINAL	part352	Dermalogica, LLC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
68479-240_6df854ae-1949-4b52-9208-b82fc73d8b7d	68479-240	HUMAN OTC DRUG	DEEP ACNE		Sulfur	GEL	TOPICAL	20221201		OTC MONOGRAPH FINAL	part333D	Dermalogica, LLC.	SULFUR	5	mg/100mL			N	20241231
68479-291_4a597566-2390-4f4e-bc17-1950aa54222f	68479-291	HUMAN OTC DRUG	PORESCREEN SPF40		Zinc Oxide	LOTION	TOPICAL	20221201		OTC MONOGRAPH FINAL	part352	Dermalogica, LLC.	ZINC OXIDE	10	mg/100mL			N	20241231
68479-318_7aca4605-2bd4-44ae-a956-40adf3228316	68479-318	HUMAN OTC DRUG	Dynamic Skin Recovery	SPF 50	Avobenzone and Octinoxate	LOTION	TOPICAL	20131209		OTC MONOGRAPH FINAL	part352	Dermalogica, Inc.	AVOBENZONE; OCTINOXATE	30; 75	mg/mL; mg/mL			N	20241231
68479-382_60818057-7884-47d4-989a-88af70010149	68479-382	HUMAN OTC DRUG	dermalogica dynamic skin recovery spf 50		Sunscreen	LOTION	TOPICAL	20220117		OTC MONOGRAPH DRUG	M020	Dermalogica, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 3; 7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68479-706_62468211-f4d7-4ee3-8905-89633321a074	68479-706	HUMAN OTC DRUG	Overnight Clearing		Salicylic Acid	GEL	TOPICAL	20070501		OTC MONOGRAPH FINAL	part358H	Dermalogica, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
68479-772_ac848366-5a97-4fe7-8e93-32f7304b1846	68479-772	HUMAN OTC DRUG	BREAKOUT CLEARING BOOSTER		Salicylic Acid	LIQUID	TOPICAL	20210409		OTC MONOGRAPH FINAL	part333D	Dermalogica, Inc.	SALICYLIC ACID	2	mg/100mL			N	20241231
68479-782_66616c3c-aaa8-4308-a8f0-a7903d74f465	68479-782	HUMAN OTC DRUG	Clarifying Bacne		Salicylic Acid	SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M006	Dermalogica, LLC.	SALICYLIC ACID	1	g/100mL			N	20241231
68479-807_5352caa8-77b3-4f40-b974-c5781d4c3f87	68479-807	HUMAN OTC DRUG	Clearing Defense SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201201		OTC MONOGRAPH FINAL	part352	Dermalogica, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68479-851_47cb5545-95f3-40a6-8813-78e4cb9a2407	68479-851	HUMAN OTC DRUG	PRISMA PROTECT SPF30		Homosalate, Octocrylene, Octisalate, and Avobenzone	LOTION	TOPICAL	20211112		OTC MONOGRAPH FINAL	part352	Dermalogica, LLC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68479-941_bb416380-b5f3-436d-bb9a-021602243c9a	68479-941	HUMAN OTC DRUG	Clearing Skin Wash		Salicylic Acid	LIQUID	TOPICAL	20220401		OTC MONOGRAPH FINAL	part333D	Dermalogica, LLC	SALICYLIC ACID	.5	mg/100mL			N	20241231
68479-991_7c9b996d-94d7-4522-8a05-9319e797dd64	68479-991	HUMAN OTC DRUG	INVISIBLE PHYSICAL DEFENSE SPF30		Zinc Oxide	LOTION	TOPICAL	20220101		OTC MONOGRAPH FINAL	part352	Dermalogica, Inc.	ZINC OXIDE	20.9	mg/mL			N	20241231
68511-997_0c0d4eac-351f-250d-e063-6294a90aad14	68511-997	HUMAN OTC DRUG	Ma Ying Long Musk Hemorrhoids		PETROLATUM, ZINC OXIDE	OINTMENT	TOPICAL	20031215		OTC MONOGRAPH DRUG	M015	Mayinglong Pharmaceutical Group Co., Ltd.	PETROLATUM; ZINC OXIDE	779.9; 76	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68511-998_0c0d598f-0e8d-46aa-e063-6394a90a90fc	68511-998	HUMAN OTC DRUG	Mayinglong Hemorrhoidal		PETROLATUM, ZINC OXIDE	OINTMENT	TOPICAL	20180801		OTC MONOGRAPH DRUG	M015	Mayinglong Pharmaceutical Group Co., Ltd.	PETROLATUM; ZINC OXIDE	779.9; 76	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68516-3207_5ec0b9da-ec79-4c49-8631-13152be222ed	68516-3207	PLASMA DERIVATIVE	Profilnine		factor ix complex	KIT	INTRAVENOUS	19810720		BLA	BLA102476	GRIFOLS USA, LLC						N	20241231
68516-3208_5ec0b9da-ec79-4c49-8631-13152be222ed	68516-3208	PLASMA DERIVATIVE	Profilnine		factor ix complex	KIT	INTRAVENOUS	19810720		BLA	BLA102476	GRIFOLS USA, LLC						N	20241231
68516-3209_5ec0b9da-ec79-4c49-8631-13152be222ed	68516-3209	PLASMA DERIVATIVE	Profilnine		factor ix complex	KIT	INTRAVENOUS	19810720		BLA	BLA102476	GRIFOLS USA, LLC						N	20241231
68516-3210_5ec0b9da-ec79-4c49-8631-13152be222ed	68516-3210	PLASMA DERIVATIVE	Profilnine		factor ix complex	KIT	INTRAVENOUS	19810720		BLA	BLA102476	GRIFOLS USA, LLC						N	20241231
68516-3211_5ec0b9da-ec79-4c49-8631-13152be222ed	68516-3211	PLASMA DERIVATIVE	Profilnine		factor ix complex	KIT	INTRAVENOUS	19810720		BLA	BLA102476	GRIFOLS USA, LLC						N	20241231
68516-3212_5ec0b9da-ec79-4c49-8631-13152be222ed	68516-3212	PLASMA DERIVATIVE	Profilnine		factor ix complex	KIT	INTRAVENOUS	19810720		BLA	BLA102476	GRIFOLS USA, LLC						N	20241231
68516-3607_fe5f116e-60dd-464b-9a6c-3e0e32d6928a	68516-3607	PLASMA DERIVATIVE	AlphaNine	SD	COAGULATION FACTOR IX (HUMAN)	KIT	INTRAVENOUS	19901231		BLA	BLA103249	GRIFOLS USA, LLC						N	20241231
68516-3608_fe5f116e-60dd-464b-9a6c-3e0e32d6928a	68516-3608	PLASMA DERIVATIVE	AlphaNine	SD	COAGULATION FACTOR IX (HUMAN)	KIT	INTRAVENOUS	19901231		BLA	BLA103249	GRIFOLS USA, LLC						N	20241231
68516-3609_fe5f116e-60dd-464b-9a6c-3e0e32d6928a	68516-3609	PLASMA DERIVATIVE	AlphaNine	SD	COAGULATION FACTOR IX (HUMAN)	KIT	INTRAVENOUS	19901231		BLA	BLA103249	GRIFOLS USA, LLC						N	20241231
68516-3610_fe5f116e-60dd-464b-9a6c-3e0e32d6928a	68516-3610	PLASMA DERIVATIVE	AlphaNine	SD	COAGULATION FACTOR IX (HUMAN)	KIT	INTRAVENOUS	19901231		BLA	BLA103249	GRIFOLS USA, LLC						N	20241231
68516-3611_fe5f116e-60dd-464b-9a6c-3e0e32d6928a	68516-3611	PLASMA DERIVATIVE	AlphaNine	SD	COAGULATION FACTOR IX (HUMAN)	KIT	INTRAVENOUS	19901231		BLA	BLA103249	GRIFOLS USA, LLC						N	20241231
68516-3612_fe5f116e-60dd-464b-9a6c-3e0e32d6928a	68516-3612	PLASMA DERIVATIVE	AlphaNine	SD	COAGULATION FACTOR IX (HUMAN)	KIT	INTRAVENOUS	19901231		BLA	BLA103249	GRIFOLS USA, LLC						N	20241231
68516-4611_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4611	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4612_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4612	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4613_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4613	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4614_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4614	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4615_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4615	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	20140626		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4616_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4616	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4617_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4617	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4618_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4618	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4619_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4619	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	19780815		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-4620_990cfe61-19d9-4a0e-846a-a0a5b964ec6a	68516-4620	PLASMA DERIVATIVE	Alphanate		Antihemophilic Factor/von Willebrand Factor Complex (Human)	KIT	INTRAVENOUS	20140626		BLA	BLA102475	GRIFOLS USA, LLC						N	20241231
68516-5214_791985ea-4873-4266-8194-8d1eba6ddc58	68516-5214	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20220301		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/250mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68516-5214_95be7155-08d6-43ae-a69a-939364acc3a3	68516-5214	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20211108	20250724	BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/250mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	
68516-5215_2d59e24e-f0a6-47ea-a434-62ab125a0f6d	68516-5215	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20220301		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	10	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68516-5215_9ce4535f-0508-4deb-92ec-df631ef18d79	68516-5215	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20211108		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	10	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68516-5216_aca50751-9cdb-480f-aba1-64d20f95ba6a	68516-5216	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20220301		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68516-5216_f72b411e-76e3-41ba-9466-4e00bcf99359	68516-5216	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20220301		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20251231
68516-5217_95be7155-08d6-43ae-a69a-939364acc3a3	68516-5217	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20231115		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/250mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68516-5218_95be7155-08d6-43ae-a69a-939364acc3a3	68516-5218	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20231115		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/250mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68516-5219_95be7155-08d6-43ae-a69a-939364acc3a3	68516-5219	PLASMA DERIVATIVE	ALBUTEIN		ALBUMIN (HUMAN)	INJECTION, SOLUTION	INTRAVENOUS	20231109		BLA	BLA102478	GRIFOLS USA, LLC	ALBUMIN HUMAN	12.5	g/250mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68534-001_08b42e54-2f86-2978-e063-6394a90af105	68534-001	HUMAN OTC DRUG	Mrs. Meyers Hand Sanitizer Lavender Scent		Ethyl Alcohol	LIQUID	TOPICAL	20220711		OTC MONOGRAPH DRUG	M003	METROPOLITANGRAPHIC ARTS, Inc.	ALCOHOL	62	mL/100mL			N	20241231
68534-002_08b43046-a9cc-9f33-e063-6294a90a561d	68534-002	HUMAN OTC DRUG	Mrs. Meyers Hand Sanitizer Basil Scent		Ethyl Alcohol	LIQUID	TOPICAL	20220711		OTC MONOGRAPH DRUG	M003	METROPOLITANGRAPHIC ARTS, Inc.	ALCOHOL	62	mL/100mL			N	20241231
68540-001_0802da16-fec8-cf04-e063-6394a90ab0ff	68540-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020101		NDA	NDA205820	Price Rite Medical Equipment, Inc.	OXYGEN	990	mL/L			N	20241231
68546-142_3bb32e3e-96c1-4f44-8c70-07719729077b	68546-142	HUMAN PRESCRIPTION DRUG	Azilect		Rasagiline mesylate	TABLET	ORAL	20060710		NDA	NDA021641	Teva Neuroscience, Inc.	RASAGILINE MESYLATE	.5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
68546-170_8603d46a-08de-4614-82a0-6794b0922785	68546-170	HUMAN PRESCRIPTION DRUG	Austedo		Deutetrabenazine	TABLET, COATED	ORAL	20170412		NDA	NDA208082	Teva Neuroscience, Inc.	DEUTETRABENAZINE	6	mg/1			N	20241231
68546-171_8603d46a-08de-4614-82a0-6794b0922785	68546-171	HUMAN PRESCRIPTION DRUG	Austedo		Deutetrabenazine	TABLET, COATED	ORAL	20170412		NDA	NDA208082	Teva Neuroscience, Inc.	DEUTETRABENAZINE	9	mg/1			N	20241231
68546-172_8603d46a-08de-4614-82a0-6794b0922785	68546-172	HUMAN PRESCRIPTION DRUG	Austedo		Deutetrabenazine	TABLET, COATED	ORAL	20170412		NDA	NDA208082	Teva Neuroscience, Inc.	DEUTETRABENAZINE	12	mg/1			N	20241231
68546-176_8603d46a-08de-4614-82a0-6794b0922785	68546-176	HUMAN PRESCRIPTION DRUG	AUSTEDO		deutetrabenazine	KIT		20200201		NDA	NDA208082	Teva Neuroscience, Inc.						N	20241231
68546-182_8603d46a-08de-4614-82a0-6794b0922785	68546-182	HUMAN PRESCRIPTION DRUG	AUSTEDO		deutetrabenazine	KIT		20210506	20240229	NDA	NDA208082	Teva Neuroscience, Inc.						N	
68546-229_3bb32e3e-96c1-4f44-8c70-07719729077b	68546-229	HUMAN PRESCRIPTION DRUG	Azilect		Rasagiline mesylate	TABLET	ORAL	20060710		NDA	NDA021641	Teva Neuroscience, Inc.	RASAGILINE MESYLATE	1	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
68546-317_d3c2bb3f-c354-430c-9cad-68ff376f0508	68546-317	HUMAN PRESCRIPTION DRUG	Copaxone		Glatiramer Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20080428		NDA	NDA020622	Teva Neuroscience, Inc.	GLATIRAMER ACETATE	20	mg/mL			N	20241231
68546-325_d3c2bb3f-c354-430c-9cad-68ff376f0508	68546-325	HUMAN PRESCRIPTION DRUG	Copaxone		Glatiramer Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20140129		NDA	NDA020622	Teva Neuroscience, Inc.	GLATIRAMER ACETATE	40	mg/mL			N	20241231
68546-470_8603d46a-08de-4614-82a0-6794b0922785	68546-470	HUMAN PRESCRIPTION DRUG	AUSTEDO XR		deutetrabenazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230221		NDA	NDA216354	Teva Neuroscience, Inc.	DEUTETRABENAZINE	6	mg/1			N	20241231
68546-471_8603d46a-08de-4614-82a0-6794b0922785	68546-471	HUMAN PRESCRIPTION DRUG	AUSTEDO XR		deutetrabenazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230221		NDA	NDA216354	Teva Neuroscience, Inc.	DEUTETRABENAZINE	12	mg/1			N	20241231
68546-472_8603d46a-08de-4614-82a0-6794b0922785	68546-472	HUMAN PRESCRIPTION DRUG	AUSTEDO XR		deutetrabenazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230221		NDA	NDA216354	Teva Neuroscience, Inc.	DEUTETRABENAZINE	24	mg/1			N	20241231
68546-490_8603d46a-08de-4614-82a0-6794b0922785	68546-490	HUMAN PRESCRIPTION DRUG	AUSTEDO XR		deutetrabenazine	KIT		20230221		NDA	NDA216354	Teva Neuroscience, Inc.						N	20241231
68547-005_efe1c60f-f03b-c3d7-e053-2a95a90a7dd5	68547-005	HUMAN PRESCRIPTION DRUG	Giapreza		angiotensin II	INJECTION	INTRAVENOUS	20220915		NDA	NDA209360	La Jolla Pharmaceutical Company	ANGIOTENSIN II	.5	mg/mL	Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
68547-111_24b2fe17-e590-4538-8394-e57dcddf7ee3	68547-111	HUMAN PRESCRIPTION DRUG	Xacduro		sulbactam and durlobactam	KIT		20230606		NDA	NDA216974	LaJolla Pharmaceutical Company						N	20241231
68547-501_efe1c60f-f03b-c3d7-e053-2a95a90a7dd5	68547-501	HUMAN PRESCRIPTION DRUG	Giapreza		angiotensin II	INJECTION	INTRAVENOUS	20180205		NDA	NDA209360	La Jolla Pharmaceutical Company	ANGIOTENSIN II	2.5	mg/mL	Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
68577-110_06ad2b03-0359-354f-e063-6294a90a0063	68577-110	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-111_0cc97b34-e9d6-ef6a-e063-6394a90aee89	68577-111	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-112_0cc96e84-f44f-de6e-e063-6294a90a272e	68577-112	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-113_0752d79d-5d72-0367-e063-6394a90a4f1c	68577-113	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-114_0d338580-a3af-0112-e063-6394a90a985d	68577-114	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-115_0d33888d-20a3-f912-e063-6394a90a25dc	68577-115	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-116_0d3379ba-465f-a889-e063-6394a90aaf23	68577-116	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-117_0d338ec2-dca2-e032-e063-6394a90a69aa	68577-117	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-118_07522c32-d98c-fac4-e063-6294a90affe5	68577-118	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-119_0d339273-6d84-0979-e063-6394a90a3de7	68577-119	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-120_0752fbdc-2cf8-18a0-e063-6294a90adbd4	68577-120	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-121_0752745e-6f0a-fddf-e063-6294a90aaa3f	68577-121	HUMAN OTC DRUG	Leg Body Makeup		Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	OCTISALATE; OCTOCRYLENE	3.2; 6	mg/100mg; mg/100mg			N	20241231
68577-122_06ad3c09-9f1c-b25c-e063-6294a90aebe1	68577-122	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-123_06b19585-59ac-7023-e063-6394a90a55fc	68577-123	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-124_06b19585-59bf-7023-e063-6394a90a55fc	68577-124	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-125_06b14a17-cabf-1b3e-e063-6394a90afe5d	68577-125	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-126_06b19585-59d6-7023-e063-6394a90a55fc	68577-126	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-127_06b19585-59e6-7023-e063-6394a90a55fc	68577-127	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-128_06b19585-59f6-7023-e063-6394a90a55fc	68577-128	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-129_06b26dd0-44cf-91a7-e063-6394a90a603a	68577-129	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-130_06b24ab5-d139-c4aa-e063-6394a90a3d28	68577-130	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-131_06b26dd0-44e0-91a7-e063-6394a90a603a	68577-131	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-132_06b24ab5-d149-c4aa-e063-6394a90a3d28	68577-132	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-133_06c5ea16-96b4-7bc7-e063-6394a90a40b6	68577-133	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-134_06c6035e-c159-b3e6-e063-6394a90a86cd	68577-134	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-135_06c5efde-42d2-e4fc-e063-6394a90a491d	68577-135	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-136_06c6035e-c169-b3e6-e063-6394a90a86cd	68577-136	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-137_06c62206-d81f-8d9a-e063-6394a90a4c69	68577-137	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-138_06c618ae-3d15-8c87-e063-6394a90a5396	68577-138	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-139_06c61c42-edcb-1ebd-e063-6294a90aee13	68577-139	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-140_06c64cc0-be23-c210-e063-6394a90a6d9a	68577-140	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-141_06c64cc0-be33-c210-e063-6394a90a6d9a	68577-141	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-142_06c618ae-3d2c-8c87-e063-6394a90a5396	68577-142	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-143_06c64cc0-be44-c210-e063-6394a90a6d9a	68577-143	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-144_06c618ae-3d3c-8c87-e063-6394a90a5396	68577-144	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-145_06c6035e-c17b-b3e6-e063-6394a90a86cd	68577-145	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-146_06c6035e-c18b-b3e6-e063-6394a90a86cd	68577-146	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-147_06c677e1-2e50-bbf7-e063-6294a90ac70f	68577-147	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-148_06c677e1-2e61-bbf7-e063-6294a90ac70f	68577-148	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-149_06c61c42-eddd-1ebd-e063-6294a90aee13	68577-149	HUMAN OTC DRUG	Buildable Blur		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	HOMOSALATE; OCTISALATE; ZINC OXIDE	9; 4.5; 7.8	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-151_0d346392-6ee3-3062-e063-6394a90a548d	68577-151	HUMAN OTC DRUG	Morphe SPF 30 Broad Spectrum Sunsetter Setting		Octisalate, Octocrylene, Avobenzone, Homosalate	SPRAY	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 9; 4.5; 2	mg/100mg; mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-152_0d438692-cd75-ea42-e063-6394a90a862d	68577-152	HUMAN OTC DRUG	GLOSSIER INVISIBLE SHIELD DAILY SUNSCREEN BROAD SPECTRUM SPF 35		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 6; 5	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-153_0d3631c5-841a-8d32-e063-6294a90abbdb	68577-153	HUMAN OTC DRUG	KOPARI Sun Shield Soft Glow Daily Face SPF30		Octisalate, Octocrylene, Avobenzone, Homosalate	SPRAY	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 4	mg/100mg; mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-154_0d439a42-d88d-e333-e063-6294a90a2315	68577-154	HUMAN OTC DRUG	KOPARI Antioxidant Face Shield Mineral SPF 30		ZINC OXIDE	LOTION	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	ZINC OXIDE	14.4	mg/100mg			N	20241231
68577-155_0d435c9a-c8bc-bb02-e063-6394a90aa117	68577-155	HUMAN OTC DRUG	KOPARI Sun Shield Soft Glow Daily Face SPF30		Octisalate, Octocrylene, Avobenzone, Homosalate	LOTION	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 4	mg/100mg; mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-156_0d35fa3c-e6dc-d9ff-e063-6394a90a5a6e	68577-156	HUMAN OTC DRUG	Bubble Solar Mate Daily Mineral Sunscreen SPF 40		Zinc Oxide	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	ZINC OXIDE	12	mg/100mg			N	20241231
68577-157_0d584736-3f46-2542-e063-6294a90af3cf	68577-157	HUMAN OTC DRUG	NEORA Invisibloc Sunscreen Gel Broad Spectrum SPF40		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 9.5; 5	mg/100mg; mg/100mg; mg/100mg			N	20241231
68577-158_0d484b7c-721e-fe0c-e063-6294a90aa0bd	68577-158	HUMAN OTC DRUG	NORWEX Protect Prevent Mineral Facial Sunscreen Broad Spectrum SPF30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230901		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	TITANIUM DIOXIDE; ZINC OXIDE	2.88; 6.8	mg/100mg; mg/100mg			N	20241231
68577-159_0d594707-352f-8a58-e063-6294a90a81e8	68577-159	HUMAN OTC DRUG	NARS Radiance Primer Broad Spectrum SPF 35 Sunscreen		Octisalate, Octocrylene, Avobenzone, Homosalate	LOTION	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	COSMAX USA, CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 6; 5; 1.6	mg/100mg; mg/100mg; mg/100mg; mg/100mg			N	20241231
68586-219_802747b3-9844-5600-e053-2991aa0a2ef5	68586-219	HUMAN OTC DRUG	Villa Floriani Mint Purifying Day SPF 20		Avobenzone, Octocrylene, Octinoxate, and Octisalate	LOTION	TOPICAL	20160822		OTC MONOGRAPH FINAL	part352	Originitalia srl	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 35; 50; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68586-220_8026fded-44f7-36ce-e053-2991aa0aa770	68586-220	HUMAN OTC DRUG	Villa Floriani Chamomile Calming Day SPF 20		Avobenzone, Octocrylene, Octinoxate, and Octisalate	LOTION	TOPICAL	20161107		OTC MONOGRAPH FINAL	part352	Originitalia srl	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 35; 50; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68586-225_8abf339f-0a49-68e7-e053-2a95a90abcfe	68586-225	HUMAN OTC DRUG	VILLA FLORIANI ALOE ULTRA-HYDRATING DAY SPF 20		Avobenzone, Octinoxate, Octisalate, Octocrylene	LOTION	TOPICAL	20190607		OTC MONOGRAPH NOT FINAL	part352	Originitalia srl	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 35; 50; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68599-0123_b8e13ac8-cb70-fc2c-e053-2a95a90a7306	68599-0123	HUMAN OTC DRUG	McKesson Fluoride		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20120217		OTC MONOGRAPH FINAL	part355	McKesson Medical-Surgical	SODIUM MONOFLUOROPHOSPHATE	2.43	mg/g			N	20241231
68599-0204_079a8686-9931-7125-e063-6394a90a11db	68599-0204	HUMAN OTC DRUG	THERA Moisturizing Body Shield		Dimethicone	CREAM	TOPICAL	20110901		OTC MONOGRAPH DRUG	M016	McKesson Medical-Surgical Inc.	DIMETHICONE	15	mg/g	Skin Barrier Activity [PE]		N	20241231
68599-0205_c9c46863-67f1-f016-e053-2995a90a0d7f	68599-0205	HUMAN OTC DRUG	THERA Calazinc Body Shield		Zinc Oxide	PASTE	TOPICAL	20110901		OTC MONOGRAPH FINAL	part347	McKesson Medical-Surgical Inc.	ZINC OXIDE	200	mg/g			N	20241231
68599-0206_a838352c-5a96-9c32-e053-2a95a90aa3a6	68599-0206	HUMAN OTC DRUG	Antifungal Body		Miconazole Nitrate	CREAM	TOPICAL	20170601		OTC MONOGRAPH FINAL	part333C	McKesson	MICONAZOLE NITRATE	2	mg/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68599-0207_b8e1f33c-9d43-0ded-e053-2995a90abf98	68599-0207	HUMAN OTC DRUG	THERA Antifungal Body		Miconazole Nitrate	POWDER	TOPICAL	20110901		OTC MONOGRAPH FINAL	part333C	McKesson Medical-Surgical Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68599-0212_cc994062-9f0e-8be3-e053-2995a90a3f8b	68599-0212	HUMAN OTC DRUG	Dimethicone		Body Cleanser	LIQUID	TOPICAL	20190813		OTC MONOGRAPH FINAL	part347	McKesson	DIMETHICONE	17.5	ug/mg	Skin Barrier Activity [PE]		N	20241231
68599-0213_b8e111ef-8ba1-5293-e053-2995a90ad928	68599-0213	HUMAN OTC DRUG	Dimethicone		Body Shield	CREAM	TOPICAL	20190812		OTC MONOGRAPH FINAL	part347	McKesson	DIMETHICONE	50	ug/mg	Skin Barrier Activity [PE]		N	20241231
68599-0214_eb4fffa4-2100-217e-e053-2995a90a2c68	68599-0214	HUMAN OTC DRUG	Antimicrobial		Body Cleanser	LIQUID	TOPICAL	20190812		OTC MONOGRAPH NOT FINAL	part333E	McKesson	BENZALKONIUM CHLORIDE	1.3	ug/mg			N	20241231
68599-0218_cc6ec5ba-542e-5f7e-e053-2a95a90aec43	68599-0218	HUMAN OTC DRUG	Dimethicone		Skin Protectant	CREAM	TOPICAL	20191104		OTC MONOGRAPH FINAL	part347	McKesson	DIMETHICONE	17.5	ug/mg	Skin Barrier Activity [PE]		N	20241231
68599-0464_eb8d9394-648f-8f21-e053-2995a90a91aa	68599-0464	HUMAN OTC DRUG	Menthol		Cough Suppressant	LOZENGE	ORAL	20200129		OTC MONOGRAPH FINAL	part341	McKesson	MENTHOL, UNSPECIFIED FORM	.7	g/g			N	20241231
68599-0465_eb8da125-52ae-3e18-e053-2a95a90a557a	68599-0465	HUMAN OTC DRUG	Menthol		Cough suppressant	LOZENGE	ORAL	20200130		OTC MONOGRAPH FINAL	part341	McKesson	MENTHOL, UNSPECIFIED FORM	.86	g/g			N	20241231
68599-1090_e0dfa6ca-b312-25cb-e053-2a95a90a12cc	68599-1090	HUMAN OTC DRUG	McKesson Sugar Free Cough Suppressant Oral Anesthetic		Menthol lozenge	LOZENGE	ORAL	20220901		OTC MONOGRAPH FINAL	part341	McKesson Medical-Surgical	MENTHOL, UNSPECIFIED FORM	5.8	mg/1			N	20241231
68599-1120_eb532e3a-a26a-2c89-e053-2995a90a3b9a	68599-1120	HUMAN OTC DRUG	McKesson Antiseptic Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20211004		OTC MONOGRAPH NOT FINAL	part333E	McKesson Medical-Surgical	ALCOHOL	665	g/L			N	20241231
68599-1182_f18aa597-e5af-3d56-e053-2a95a90a6230	68599-1182	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone Cream	CREAM	TOPICAL	20190313	20240701	OTC MONOGRAPH NOT FINAL	part348	McKesson	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
68599-1183_f189e99d-37df-58a7-e053-2a95a90a8642	68599-1183	HUMAN OTC DRUG	Antibiotic		Bacitracin Zinc	OINTMENT	TOPICAL	20190201	20240301	OTC MONOGRAPH FINAL	M004	McKesson	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
68599-1183_f189f2f6-31ff-4190-e053-2a95a90ac614	68599-1183	HUMAN OTC DRUG	Antibiotic		Bacitracin Zinc	OINTMENT	TOPICAL	20170922	20240301	OTC MONOGRAPH FINAL	M004	McKesson	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
68599-1184_f189eb8a-5003-77e9-e053-2995a90a2477	68599-1184	HUMAN OTC DRUG	McKesson Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20190201	20240701	OTC MONOGRAPH FINAL	M004	McKesson	BACITRACIN ZINC	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	
68599-1184_f18a058b-b4c8-1f61-e053-2995a90ae221	68599-1184	HUMAN OTC DRUG	McKesson Bacitracin Zinc		BACITRACIN ZINC	OINTMENT	TOPICAL	20160714	20240701	OTC MONOGRAPH FINAL	M004	McKesson Medical-Surgical Inc.	BACITRACIN ZINC	500	[iU]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	
68599-1185_f1635e9d-d19a-883f-e053-2a95a90a54a8	68599-1185	HUMAN OTC DRUG	Skin Protectant		Petrolatum	OINTMENT	TOPICAL	20171018	20250301	OTC MONOGRAPH FINAL	M016	McKesson	PETROLATUM	93.5	g/100g			N	
68599-1186_f1637e72-6270-2b1e-e053-2995a90a5b73	68599-1186	HUMAN OTC DRUG	Skin Protectant		Petrolatum	OINTMENT	TOPICAL	20171018	20240901	OTC MONOGRAPH FINAL	M016	McKesson	PETROLATUM	93.5	g/100g			N	
68599-1187_f1639345-e3bc-e144-e053-2a95a90aa0e9	68599-1187	HUMAN OTC DRUG	Skin Protectant		Petrolatum	OINTMENT	TOPICAL	20171019	20250501	OTC MONOGRAPH FINAL	M016	McKesson	PETROLATUM	93.5	g/100g			N	
68599-1311_f1ee0704-ce27-9256-e053-2a95a90adee4	68599-1311	HUMAN OTC DRUG	McKesson Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20220502		OTC MONOGRAPH NOT FINAL	part343	McKesson Medical-Surgical	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68599-1411_da31dd86-ab50-60ec-e053-2995a90a7758	68599-1411	HUMAN OTC DRUG	McKesson Antacid Calcium Carbonate		Calcium carbonate	TABLET, CHEWABLE	ORAL	20210701		OTC MONOGRAPH FINAL	part331	McKesson Medical-Surgical	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
68599-1471_cbe47117-e4c8-5428-e053-2a95a90a962e	68599-1471	HUMAN OTC DRUG	Miconazole Nitrate		Antifungal	CREAM	TOPICAL	20190725		OTC MONOGRAPH FINAL	part333C	McKesson	MICONAZOLE NITRATE	2	mg/100mg	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68599-1631_e09060f7-ca0c-5f7c-e053-2995a90ab344	68599-1631	HUMAN OTC DRUG	McKesson Phenylephrine HCl		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20220901		OTC MONOGRAPH FINAL	part341	McKesson Medical-Surgical	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68599-1981_eb5593ea-1774-70fc-e053-2995a90ab7a0	68599-1981	HUMAN OTC DRUG	Eye wash		Purified Water	LIQUID	IRRIGATION	20210401		NDA	NDA022305	McKesson	WATER	98.3	mL/100mL			N	20241231
68599-2301_07894af1-a76b-4d27-e063-6294a90a5c1d	68599-2301	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20131009		OTC MONOGRAPH DRUG	M003	McKesson Medical-Surgical Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
68599-2302_079834c3-fb59-0ccb-e063-6294a90a7497	68599-2302	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20131009		OTC MONOGRAPH DRUG	M003	McKesson Medical-Surgical Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
68599-2303_079b36ec-18c5-ec89-e063-6394a90ae679	68599-2303	HUMAN OTC DRUG	Roll On Anti-Perspirant (Alcohol Free)		ALUMINUM CHLOROHYDRATE	SOLUTION	TOPICAL	20130805		OTC MONOGRAPH DRUG	M019	McKesson Medical-Surgical, Inc.	ALUMINUM CHLOROHYDRATE	.1	mg/mL			N	20241231
68599-2304_0a45f0f2-2a78-d802-e063-6394a90a91a8	68599-2304	HUMAN OTC DRUG	Anti-Perspirant Deodorant		ALUMINUM CHLOROHYDRATE	SPRAY	TOPICAL	20131009		OTC MONOGRAPH DRUG	M019	McKesson Medical-Surgical Inc.	ALUMINUM CHLOROHYDRATE	130	mg/mL			N	20241231
68599-2305_0789097c-7d5f-9e01-e063-6394a90a9619	68599-2305	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20131114		OTC MONOGRAPH DRUG	M003	McKesson Medical-Surgical Inc.	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
68599-2306_079901c8-3623-e860-e063-6394a90a8340	68599-2306	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20131114		OTC MONOGRAPH DRUG	M003	McKesson Medical-Surgical Inc.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
68599-3500_a62b5dce-2e7c-9688-e053-2995a90a3967	68599-3500	HUMAN OTC DRUG	McKesson PVP Prep	Solution	Povidone-Iodine	LIQUID	TOPICAL	20161017		OTC MONOGRAPH NOT FINAL	part333E	McKesson Medical-Surgical	POVIDONE-IODINE	1	mg/10mL			N	20241231
68599-3501_a62baf21-9aa7-0488-e053-2a95a90a4029	68599-3501	HUMAN OTC DRUG	PVP Scrub Solution		Povidone Iodine	SOLUTION	TOPICAL	20170303		OTC MONOGRAPH NOT FINAL	part333E	McKesson Medical-Surgical Inc.	POVIDONE-IODINE	7.5	mg/1			N	20241231
68599-3502_a62b5dce-2e7c-9688-e053-2995a90a3967	68599-3502	HUMAN OTC DRUG	McKesson PVP Prep	Solution	Povidone-Iodine	LIQUID	TOPICAL	20161017		OTC MONOGRAPH NOT FINAL	part333E	McKesson Medical-Surgical	POVIDONE-IODINE	1	mg/10mL			N	20241231
68599-4679_e08f79bc-2edd-2aad-e053-2a95a90a560b	68599-4679	HUMAN OTC DRUG	McKesson Acetaminophen 325		Acetaminophen	TABLET, COATED	ORAL	20210401		OTC MONOGRAPH NOT FINAL	part343	McKesson Medical-Surgical, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68599-4681_f6edc9b0-fd0e-9bcc-e053-6394a90aef12	68599-4681	HUMAN OTC DRUG	Acetaminophen		Pain reliever	TABLET	ORAL	20200130		OTC MONOGRAPH NOT FINAL	part343	McKesson	ACETAMINOPHEN	.5	g/g			N	20241231
68599-4744_e81c7511-8434-1d43-e053-2a95a90a008e	68599-4744	HUMAN OTC DRUG	McKesson Bismuth		bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20220301		OTC MONOGRAPH FINAL	part335	McKesson Medical-Surgical	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68599-4751_e0cbb213-4f50-4045-e053-2a95a90a2a18	68599-4751	HUMAN OTC DRUG	McKesson Sinus Pain and Pressure Relief		Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20220901		OTC MONOGRAPH FINAL	part341	McKesson Medical-Surgical	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68599-4784_da44c621-69f9-92a4-e053-2a95a90a4053	68599-4784	HUMAN OTC DRUG	McKesson Loratadine		Loratadine 10 mg	TABLET, FILM COATED	ORAL	20210802		ANDA	ANDA076134	McKesson Medical Surgical	LORATADINE	10	mg/1			N	20241231
68599-5201_fa2d17df-a214-d8eb-e053-6294a90a724e	68599-5201	HUMAN OTC DRUG	Premium Hand Sanitizer		ethanol	GEL	TOPICAL	20150109		OTC MONOGRAPH NOT FINAL	part333A	MCKESSON MEDICAL-SURGICAL INC.	ALCOHOL	70	g/100g			N	20241231
68599-5202_fa2cc6fd-dbff-4aeb-e053-6294a90a8ed8	68599-5202	HUMAN OTC DRUG	Premium Hand Sanitizer with Aloe		ethanol	GEL	TOPICAL	20150109		OTC MONOGRAPH NOT FINAL	part333A	MCKESSON MEDICAL-SURGICAL INC.	ALCOHOL	70	g/100g			N	20241231
68599-5204_cc9a5343-2be1-2938-e053-2a95a90aafc5	68599-5204	HUMAN OTC DRUG	Mckesson Hand Cleanse and Soothe with Aloe		Chloroxylenol	GEL	TOPICAL	20150109		OTC MONOGRAPH NOT FINAL	part333A	Mckesson Medical-Surgical Inc.	CHLOROXYLENOL	.95	g/g			N	20241231
68599-5205_fd2ba851-3047-7b7d-e053-6294a90a2cf1	68599-5205	HUMAN OTC DRUG	Foaming Instant Hand Sanitizer with Aloe		ethanol	GEL	TOPICAL	20150109		OTC MONOGRAPH NOT FINAL	part333A	MCKESSON MEDICAL-SURGICAL INC.	ALCOHOL	70	g/100g			N	20241231
68599-5312_b8e18826-ca3f-ba68-e053-2a95a90a2a3d	68599-5312	HUMAN OTC DRUG	McKesson Skin Protectant		ZINC OXIDE	CREAM	TOPICAL	20140424		OTC MONOGRAPH FINAL	part347	McKesson Medical-Surgical Inc.	ZINC OXIDE	50	mg/mL			N	20241231
68599-5322_a7473592-080f-10a4-e053-2995a90ac0ca	68599-5322	HUMAN OTC DRUG	Antiseptic		Ethanol	GEL	TOPICAL	20180227		OTC MONOGRAPH NOT FINAL	part333A	McKesson	ALCOHOL	.62	mL/mL			N	20241231
68599-5400_0788f671-79f0-9f8e-e063-6394a90a4b8a	68599-5400	HUMAN OTC DRUG	CHLORHEXIDINE GLUCONATE		ANTISEPTIC SKIN CLEANSER	GEL	TOPICAL	20180312		NDA	NDA019125	McKesson	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
68599-5401_0788c3b6-d85f-b337-e063-6294a90acd3a	68599-5401	HUMAN OTC DRUG	Antiseptic Skin Cleanser		CHLORHEXIDINE GLUCONATE	SOLUTION	TOPICAL	20170601		NDA	NDA019125	McKesson Medical-Surgical	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
68599-5501_afda6fc3-7606-b0be-e053-2995a90a6208	68599-5501	HUMAN OTC DRUG	Antibacterial		Benzethonium Chloride	LIQUID	TOPICAL	20170929		OTC MONOGRAPH NOT FINAL	part333A	McKesson	BENZETHONIUM CHLORIDE	.13	g/100mL			N	20241231
68599-5502_a1e9d042-77a8-14ef-e053-2995a90a244c	68599-5502	HUMAN OTC DRUG	Antibacterial		Benzethonium Chloride	LIQUID	TOPICAL	20170929		OTC MONOGRAPH NOT FINAL	part333A	McKesson	BENZETHONIUM CHLORIDE	.13	g/100mL			N	20241231
68599-5803_cc0eceaa-7d0f-5e7a-e053-2a95a90aca25	68599-5803	HUMAN OTC DRUG	Alcohol Disinfecting Wipe		Alcohol	SWAB	TOPICAL	20170701		OTC MONOGRAPH NOT FINAL	part333A	McKesson Medical-Surgical	ALCOHOL	70	mL/1			N	20241231
68599-5804_0a54bdc3-15ad-9ce8-e063-6294a90a9b87	68599-5804	HUMAN OTC DRUG	McKesson Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20100409		OTC MONOGRAPH DRUG	M003	McKesson Medical-Surgical	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
68599-5806_ad4d3217-d918-9dbe-e053-2995a90a709a	68599-5806	HUMAN OTC DRUG	McKesson Obstetrical Antiseptic Towelette		Benzalkonium Chloride	SWAB	TOPICAL	20160729		OTC MONOGRAPH NOT FINAL	part333E	McKesson Medical-Surgical	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
68599-5807_ad4d43ac-b729-81a2-e053-2a95a90a1657	68599-5807	HUMAN OTC DRUG	McKesson Benzalkonium Chloride Towelette		Benzalkonium Chloride	SWAB	TOPICAL	20160729		OTC MONOGRAPH NOT FINAL	part333E	McKesson Medical-Surgical	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
68599-5808_f9d876e1-b338-adf9-e053-6394a90a4d9b	68599-5808	HUMAN OTC DRUG	Instant Hand Sanitizing Wipe		Ethyl Alcohol	SWAB	TOPICAL	20200224		OTC MONOGRAPH NOT FINAL	part333A	McKesson	ALCOHOL	65.9	mg/1			N	20241231
68599-6111_a1ea3224-39f7-ba85-e053-2995a90a8fc1	68599-6111	HUMAN OTC DRUG	McKesson Unna Boot 3		Zinc Oxide	DRESSING	TOPICAL	20140701		OTC MONOGRAPH FINAL	part347	McKesson Medical-Surgical	ZINC OXIDE	19.8	g/165g			N	20241231
68599-6112_d5774a0d-c985-b089-e053-2a95a90ad47c	68599-6112	HUMAN OTC DRUG	McKesson Unna Boot with Calamine 3		Zinc Oxide and Ferric Oxide Red	DRESSING	TOPICAL	20140701		OTC MONOGRAPH FINAL	part347	McKesson Medical-Surgical	FERRIC OXIDE RED; ZINC OXIDE	.35; 4.95	g/165g; g/165g			N	20241231
68599-6113_a1ea3224-39f7-ba85-e053-2995a90a8fc1	68599-6113	HUMAN OTC DRUG	McKesson Unna Boot 4		Zinc Oxide	DRESSING	TOPICAL	20140701		OTC MONOGRAPH FINAL	part347	McKesson Medical-Surgical	ZINC OXIDE	24.6	g/205g			N	20241231
68599-6114_d5774a0d-c985-b089-e053-2a95a90ad47c	68599-6114	HUMAN OTC DRUG	McKesson Unna Boot with Calamine 4		Zinc Oxide and Ferric Oxide Red	DRESSING	TOPICAL	20140701		OTC MONOGRAPH FINAL	part347	McKesson Medical-Surgical	FERRIC OXIDE RED; ZINC OXIDE	.43; 6.15	g/205g; g/205g			N	20241231
68599-6202_eb50a722-2cf4-4c89-e053-2a95a90a014f	68599-6202	HUMAN OTC DRUG	Skin Protectant with Lanolin		Lanolin	CREAM	TOPICAL	20170105		OTC MONOGRAPH FINAL	part347	McKesson Medical-Surgical Inc.	LANOLIN	50	g/100g			N	20241231
68599-6203_b8e1d61f-0667-e873-e053-2995a90aeb4c	68599-6203	HUMAN OTC DRUG	Skin Protectant with Lanolin		Lanolin	CREAM	TOPICAL	20171004		OTC MONOGRAPH FINAL	part347	McKesson	LANOLIN	50	g/100g			N	20241231
68599-6302_b8f04a60-f66a-fc15-e053-2995a90a5dab	68599-6302	HUMAN PRESCRIPTION DRUG	SILVER NITRATE POTASSIUM NITRATE		Silver Nitrate Applicators	STICK	TOPICAL	20180316	20260111	UNAPPROVED DRUG OTHER		McKesson Medical-Surgical	POTASSIUM NITRATE; SILVER NITRATE	75; 25	mg/g; mg/g			N	
68599-6303_a7e1f146-9efb-29e1-e053-2995a90aa6ec	68599-6303	HUMAN PRESCRIPTION DRUG	Swabs		Silver Nitrate	SWAB	TOPICAL	20200421		UNAPPROVED DRUG OTHER		McKesson	POTASSIUM NITRATE; SILVER NITRATE	75; 25	mg/1; mg/1			N	20241231
68599-7100_cb090ad6-5323-3f20-e053-2995a90aa2a2	68599-7100	HUMAN OTC DRUG	Ammonia		Inhalant	AEROSOL	RESPIRATORY (INHALATION)	20200116	20260901	UNAPPROVED DRUG OTHER		McKesson	AMMONIA	.15	g/g			N	
68599-8051_e4b75b23-32a9-1796-e053-2995a90abcaf	68599-8051	HUMAN OTC DRUG	McKesson Ibuprofen 200 mg		Ibuprofen	TABLET, COATED	ORAL	20210901		ANDA	ANDA079174	McKesson Medical-Surgical	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68599-8247_ebdd753c-7c87-4956-e053-2995a90abc35	68599-8247	HUMAN OTC DRUG	McKesson Orasol Gel		Benzocaine 20%	GEL	TOPICAL	20211004		OTC MONOGRAPH NOT FINAL	part356	McKesson Medical-Surgical	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68599-8630_478d95ed-86a3-2465-e054-00144ff8d46c	68599-8630	HUMAN OTC DRUG	Swab		Povidone-Iodine	SWAB	TOPICAL	20170117		OTC MONOGRAPH FINAL	part333C	McKesson Medical-Surgical Inc.	POVIDONE-IODINE	10	mg/1			N	20241231
68599-8635_73a1562f-6f32-c158-e053-2a91aa0abc31	68599-8635	HUMAN OTC DRUG	Swabs		Isopropyl Alcohol	STICK	TOPICAL	20170117		OTC MONOGRAPH FINAL	part344	McKesson	ISOPROPYL ALCOHOL	70	1/1001			N	20241231
68599-9560_cb090ad6-5331-3f20-e053-2995a90aa2a2	68599-9560	HUMAN OTC DRUG	Benzocaine		Medicaine	SWAB	TOPICAL	20200116	20240601	UNAPPROVED DRUG OTHER		McKesson	BENZOCAINE; LEVOMENTHOL	20; 1	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
68605-1040_1f44bd00-e1af-4707-b56f-aa1bdcafdecd	68605-1040	HUMAN OTC DRUG	Antimicrobial cleansing gel		Benzethonium Chloride	LOTION	CUTANEOUS	20220501		OTC MONOGRAPH NOT FINAL	part333E	ABBE Laboratories, Inc.	BENZETHONIUM CHLORIDE	2	mg/mL			N	20241231
68605-2001_7dcb1e34-4d5b-4e08-8de5-846f29e34ed0	68605-2001	HUMAN OTC DRUG	END-ZIT		SULFUR	LOTION, AUGMENTED	TOPICAL	20040420		OTC MONOGRAPH DRUG	333D	ABBE Laboratories, Inc.	SULFUR	.05	g/mL			N	20241231
68605-2002_7dcb1e34-4d5b-4e08-8de5-846f29e34ed0	68605-2002	HUMAN OTC DRUG	END-ZIT		SULFUR	LOTION, AUGMENTED	TOPICAL	20040420		OTC MONOGRAPH DRUG	333D	ABBE Laboratories, Inc.	SULFUR	.05	g/g			N	20241231
68605-2007_5db7d7f5-8fe7-4aa8-8c3d-65649f27cabc	68605-2007	HUMAN OTC DRUG	Grandma Els		Diaper Rash Ointment	OINTMENT	TOPICAL	20150201		OTC MONOGRAPH FINAL	part347	ABBE Laboratories, Inc.	LANOLIN; PETROLATUM	.155; .7595	g/g; g/g			N	20241231
68605-3700_7ae28294-d931-4ffa-80c3-f86fcec1c331	68605-3700	HUMAN OTC DRUG	VERADEX-E		Petrolatum and Lanolin	OINTMENT	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	ABBE Laboratories, Inc.	LANOLIN; PETROLATUM	350; 589.5	mg/g; mg/g			N	20241231
68605-7171_1e2f1cc7-f104-47db-8b58-2dde00d15964	68605-7171	HUMAN OTC DRUG	Antisepation		Benzethonium Chloride	LOTION	CUTANEOUS	20220501		OTC MONOGRAPH NOT FINAL	part333E	ABBE Laboratories, Inc.	BENZETHONIUM CHLORIDE	2	mg/mL			N	20241231
68605-8640_1d4a9e27-e665-46a8-90de-3f6d94adc50d	68605-8640	HUMAN OTC DRUG	Pro-Tect Sports Sunscreen SPF 20		Meradimate, Octinoxate, Octisalate, Oxybenzone	LOTION	CUTANEOUS	20220501		OTC MONOGRAPH NOT FINAL	part352	ABBE Laboratories, Inc.	MERADIMATE; OCTINOXATE; OCTISALATE; OXYBENZONE	50; 75; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68609-457_664ff45b-ec78-488b-a9d5-43626b8f0217	68609-457	HUMAN OTC DRUG	Sani Foam Instant Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20191015		OTC MONOGRAPH NOT FINAL	part333E	General Products & Supply, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
68611-180_2faf720d-d2ed-4cc5-b126-6e654201d245	68611-180	HUMAN PRESCRIPTION DRUG	YUTIQ		FLUOCINOLONE ACETONIDE	IMPLANT	INTRAVITREAL	20230517		NDA	NDA210331	Alimera Sciences, Inc.	FLUOCINOLONE ACETONIDE	.18	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68611-190_2e50d171-115e-4ccd-b0d2-d0c4bc335f6a	68611-190	HUMAN PRESCRIPTION DRUG	Iluvien		fluocinolone acetonide	IMPLANT	INTRAVITREAL	20141015		NDA	NDA201923	Alimera Sciences, Inc.	FLUOCINOLONE ACETONIDE	.19	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68634-054_15f54cb0-4f74-494b-93f9-bf839c81a4b5	68634-054	HUMAN OTC DRUG	Beauty 360 Accelerated Wrinkle Repair Moisturizer		homosalate, octisalate, avobenzone, octocrylene	LIQUID	TOPICAL	20160401		OTC MONOGRAPH NOT FINAL	part352	AMCOL Health & Beauty Solutions, Inc. DBA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	g/2mL; g/2mL; g/2mL; g/2mL			N	20241231
68634-056_9c75bb55-628e-4a53-a181-e103b6dca019	68634-056	HUMAN OTC DRUG	SkinPharmacy Advanced Anti-Aging Therapy Retinol Day Moisturizer SPF 30		homosalate, octisalate, avobenzone, octocrylene, oxybenzone	LIQUID	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part352	AMCOL Health & Beauty Solutions, Inc. DBA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 100; 50; 15; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68634-057_74081f12-5dd9-4899-9c79-88e580b656ea	68634-057	HUMAN OTC DRUG	SKIN PHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACID		salicylic acid	LIQUID	TOPICAL	20140501		OTC MONOGRAPH FINAL	part333D	AMCOL Health & Beauty Solutions, Inc. DBA	SALICYLIC ACID	20	g/2mL			N	20241231
68634-058_9ac1aa59-1826-4501-9662-aae66dd7bc6c	68634-058	HUMAN OTC DRUG	SKIN PHARMACY ADVANCED ACNE THERAPY PORE REFINING FACIAL MASK		salicylic acid	LIQUID	TOPICAL	20160701		OTC MONOGRAPH FINAL	part333D	AMCOL Health & Beauty Solutions, Inc. DBA	SALICYLIC ACID	5	g/2mL			N	20241231
68634-062_72b7755f-10f7-405f-893e-52536e721ec1	68634-062	HUMAN OTC DRUG	SkinPharmacy Advanced Anti-Aging Therapy Glycolic Day Moisturizer SPF 30		homosalate, octisalate, avobenzone, octocrylene, oxybenzone	LOTION	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part352	AMCOL Health & Beauty Solutions, Inc. DBA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 50	g/2mL; g/2mL; g/2mL; g/2mL; g/2mL			N	20241231
68634-063_13aca11f-558b-4916-b2fa-6c87d34c5abb	68634-063	HUMAN OTC DRUG	Age Renewal Firming		octinoxate, octisalate, oxybenzone, titanium dioxide, zinc oxide	LOTION	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part352	AMCOL Health & Beauty Solutions, Inc. DBA	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	60; 50; 40; 39; 20	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
68634-064_2943c83f-45b4-44d0-aed1-25a8a5c9cdfe	68634-064	HUMAN OTC DRUG	SKIN PHARMACY ADVANCED ACNE THERAPY CLARIFYING DAILY CLEANSER		salicylic acid	LIQUID	TOPICAL	20140701		OTC MONOGRAPH FINAL	part333D	AMCOL Health & Beauty Solutions, Inc. DBA	SALICYLIC ACID	20	g/2mL			N	20241231
68634-067_c948108b-a725-4a89-9e82-dd618c74720e	68634-067	HUMAN OTC DRUG	Skin Pharmacy Advanced Acne Therapy Kit		salicylic acid, benzoyl peroxide	KIT	TOPICAL	20141001		OTC MONOGRAPH FINAL	part333D	AMCOL Health & Beauty Solutions, Inc. DBA						N	20241231
68634-068_2899eda0-eccc-4180-9f5a-cf5af7e568be	68634-068	HUMAN OTC DRUG	Skin Pharmacy Advanced Acne Therapy	Targeted Treatment Wipes	benzoyl peroxide	SWAB	TOPICAL	20140501		OTC MONOGRAPH FINAL	part333D	AMCOL Health & Beauty Solutions, Inc. DBA	BENZOYL PEROXIDE	25	mg/mL			N	20241231
68638-876_3e5d52ba-aa29-4123-9163-f93560aa33ac	68638-876	HUMAN OTC DRUG	Harmony High Foaming Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part333E	Ric Mar Industries, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
68639-0001_0787f5d5-42af-575b-e063-6394a90ad4ce	68639-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20031013		UNAPPROVED MEDICAL GAS		RXO2 Oxygen & Medical Equipment Supply Co. Inc.	OXYGEN	99	L/100L			N	20241231
68642-457_321414e0-e66e-4c01-928c-860fcb9c5711	68642-457	HUMAN OTC DRUG	Foam Magic Instant Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20190812		OTC MONOGRAPH NOT FINAL	part333E	Omega Industrial Supply, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
68642-693_bda9cd00-adf2-6766-e053-2a95a90a0dc5	68642-693	HUMAN OTC DRUG	Sani Gel		Sani Gel	LIQUID	TOPICAL	20121116		OTC MONOGRAPH NOT FINAL	part333A	Omega Industrial Supply	ALCOHOL	67	mL/100mL			N	20241231
68642-876_7245a12c-468b-4373-b7ef-28ffd13eef81	68642-876	HUMAN OTC DRUG	Healthy Hands Aloe Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170421		OTC MONOGRAPH NOT FINAL	part333E	Omega Industrial Supply, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
68645-130_0c06e3d2-447e-f4b5-e063-6394a90a0608	68645-130	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20110125		ANDA	ANDA076001	Legacy Pharmaceutical Packaging, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-131_0c06e3d2-447e-f4b5-e063-6394a90a0608	68645-131	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20110125		ANDA	ANDA076001	Legacy Pharmaceutical Packaging, LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-140_0c071da6-bf8f-9261-e063-6294a90ab0c5	68645-140	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20091026		ANDA	ANDA075511	Legacy Pharmaceutical Packaging, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68645-190_0816f132-ccd7-f3e6-e063-6394a90a88c3	68645-190	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Legacy Pharmaceutical Packaging, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68645-191_0816f132-ccd7-f3e6-e063-6394a90a88c3	68645-191	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Legacy Pharmaceutical Packaging, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68645-300_0c6a0fe9-1886-a87a-e063-6294a90a891d	68645-300	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20120113		ANDA	ANDA077095	Legacy Pharmaceutical Packaging, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68645-350_08b56b76-cc9a-f182-e063-6294a90acbba	68645-350	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Legacy Pharmaceutical Packaging, LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68645-351_08b56b76-cc9a-f182-e063-6294a90acbba	68645-351	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Legacy Pharmaceutical Packaging, LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68645-455_0c5847d7-d98a-566d-e063-6394a90a67b0	68645-455	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Legacy Pharmaceutical Packaging, LLC	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68645-456_0c5847d7-d98a-566d-e063-6394a90a67b0	68645-456	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Legacy Pharmaceutical Packaging, LLC	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68645-457_0c5847d7-d98a-566d-e063-6394a90a67b0	68645-457	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Legacy Pharmaceutical Packaging, LLC	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68645-470_08b8b37d-b2d5-3d68-e063-6294a90a894b	68645-470	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20070601		ANDA	ANDA078103	Legacy Pharmaceutical Packaging, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68645-477_08b41e64-6a33-9100-e063-6294a90afa46	68645-477	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Legacy Pharmaceutical Packaging, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68645-478_08b41e64-6a33-9100-e063-6294a90afa46	68645-478	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Legacy Pharmaceutical Packaging, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68645-479_0c6a2e89-2ce9-b52d-e063-6294a90a8659	68645-479	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Legacy Pharmaceutical Packaging, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68645-496_08b56b76-cc9a-f182-e063-6294a90acbba	68645-496	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Legacy Pharmaceutical Packaging, LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68645-510_f68efd55-b90c-cf82-e053-2995a90ae41a	68645-510	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19730112		ANDA	ANDA083177	Legacy Pharmaceutical Packaging, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68645-512_0865fba8-cb1a-d3ab-e063-6394a90ab222	68645-512	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Legacy Pharmaceutical Packaging, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68645-513_0865fba8-cb1a-d3ab-e063-6394a90ab222	68645-513	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Legacy Pharmaceutical Packaging, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68645-515_0c07dc64-c246-52a5-e063-6294a90a8664	68645-515	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20160701		ANDA	ANDA077955	Legacy Pharmaceutical Packaging, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68645-516_0c07dc64-c246-52a5-e063-6294a90a8664	68645-516	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20160701		ANDA	ANDA077955	Legacy Pharmaceutical Packaging, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68645-519_0c671ba8-7fe2-e91a-e063-6294a90ae2a9	68645-519	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram	TABLET, FILM COATED	ORAL	20160616		ANDA	ANDA078604	Legacy Pharmaceutical Packaging, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-520_0c671ba8-7fe2-e91a-e063-6294a90ae2a9	68645-520	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram	TABLET, FILM COATED	ORAL	20160616		ANDA	ANDA078604	Legacy Pharmaceutical Packaging, LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-521_0c6a56f2-3201-f4b8-e063-6394a90a788f	68645-521	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Legacy Pharmaceutical Packaging, LLC	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-522_0c6a56f2-3201-f4b8-e063-6394a90a788f	68645-522	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Legacy Pharmaceutical Packaging, LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-523_0c6a56f2-3201-f4b8-e063-6394a90a788f	68645-523	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Legacy Pharmaceutical Packaging, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-527_08b8b37d-b2d5-3d68-e063-6294a90a894b	68645-527	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20151202		ANDA	ANDA078103	Legacy Pharmaceutical Packaging, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68645-532_0c68d373-18f4-80f1-e063-6394a90a7790	68645-532	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-541_0c076225-74ed-e46f-e063-6294a90aa134	68645-541	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150613		ANDA	ANDA090061	Legacy Pharmaceutical Packaging, LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68645-550_0c68f059-7d18-199f-e063-6294a90adeac	68645-550	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-551_0c68f059-7d18-199f-e063-6294a90adeac	68645-551	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-552_0c68f059-7d18-199f-e063-6294a90adeac	68645-552	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-553_0c68f059-7d18-199f-e063-6294a90adeac	68645-553	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-554_0c68f059-7d18-199f-e063-6294a90adeac	68645-554	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-555_0c68f059-7d18-199f-e063-6294a90adeac	68645-555	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113	20240331	ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
68645-556_0c69b964-fd80-7504-e063-6294a90a1650	68645-556	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	Legacy Pharmaceutical Packaging, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68645-557_0c69b964-fd80-7504-e063-6294a90a1650	68645-557	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060410		ANDA	ANDA077912	Legacy Pharmaceutical Packaging, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68645-558_0c69b964-fd80-7504-e063-6294a90a1650	68645-558	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060410		ANDA	ANDA077912	Legacy Pharmaceutical Packaging, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68645-559_08f44528-66be-21ff-e063-6394a90a1972	68645-559	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Legacy Pharmaceutical Packaging, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68645-560_0c6a5156-248c-f98e-e063-6394a90aedba	68645-560	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	Legacy Pharmaceutical Packaging, LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68645-562_0c68be81-f879-fb37-e063-6294a90ad514	68645-562	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Legacy Pharmaceutical Packaging, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68645-563_0c68be81-f879-fb37-e063-6294a90ad514	68645-563	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Legacy Pharmaceutical Packaging, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68645-566_0c69de0f-072e-8de5-e063-6294a90a35fe	68645-566	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Legacy Pharmaceutical Packaging, LLC	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68645-567_0c69de0f-072e-8de5-e063-6294a90a35fe	68645-567	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Legacy Pharmaceutical Packaging, LLC	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68645-572_0c67bf10-842a-2003-e063-6294a90a77d7	68645-572	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	Legacy Pharmaceutical Packaging, LLC	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68645-573_0c67bf10-842a-2003-e063-6294a90a77d7	68645-573	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20051006		ANDA	ANDA077091	Legacy Pharmaceutical Packaging, LLC	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68645-574_0c682657-1d56-98b7-e063-6294a90a9794	68645-574	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Legacy Pharmaceutical Packaging, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68645-575_0c682657-1d56-98b7-e063-6294a90a9794	68645-575	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Legacy Pharmaceutical Packaging, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68645-580_0c581608-8efa-5c72-e063-6294a90a72e9	68645-580	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110425		ANDA	ANDA078552	Legacy Pharmaceutical Packaging, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68645-582_0867da12-c42d-d353-e063-6294a90ae2af	68645-582	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET	ORAL	20190607		ANDA	ANDA090564	Legacy Pharmaceutical Packaging, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68645-583_0867da12-c42d-d353-e063-6294a90ae2af	68645-583	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET	ORAL	20190607		ANDA	ANDA090564	Legacy Pharmaceutical Packaging, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68645-584_0867da12-c42d-d353-e063-6294a90ae2af	68645-584	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET	ORAL	20190607		ANDA	ANDA090564	Legacy Pharmaceutical Packaging, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68645-586_091d0a94-3fda-a6a9-e063-6394a90ac0df	68645-586	HUMAN PRESCRIPTION DRUG	Losortan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101004	20240131	ANDA	ANDA078243	Legacy Pharmaceutical Packaging, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
68645-587_0c69a53d-bf0c-6d7e-e063-6294a90a534c	68645-587	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-590_087c97db-9d5c-9b76-e063-6294a90a140c	68645-590	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	Legacy Pharmaceutical Packaging, LLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
68645-593_0c68f059-7d18-199f-e063-6294a90adeac	68645-593	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210818		ANDA	ANDA077321	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-594_0c074f33-113d-c3d6-e063-6294a90aa992	68645-594	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20210922		ANDA	ANDA075718	Legacy Pharmaceutical Packaging, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68645-595_08ba30f7-fa47-3aec-e063-6394a90aa060	68645-595	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20220310		ANDA	ANDA209313	Legacy Pharmaceutical Packaging, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68645-596_0c6a6ca3-3089-bc43-e063-6294a90a2183	68645-596	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Legacy Pharmaceutical Packaging, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68645-599_0c69e908-40c8-9491-e063-6294a90a5420	68645-599	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Legacy Pharmaceutical Packaging, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68645-603_086761d2-4eb1-bd9b-e063-6294a90a490c	68645-603	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Legacy Pharmaceutical Packaging, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68645-604_086761d2-4eb1-bd9b-e063-6294a90a490c	68645-604	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20051121		ANDA	ANDA077127	Legacy Pharmaceutical Packaging, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68645-605_0c586317-b834-976c-e063-6294a90a031a	68645-605	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20200428		ANDA	ANDA075479	Legacy Pharmaceutical Packaging, LLC	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68645-606_0c586317-b834-976c-e063-6294a90a031a	68645-606	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	Legacy Pharmaceutical Packaging, LLC	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68645-607_0c586317-b834-976c-e063-6294a90a031a	68645-607	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20201001		ANDA	ANDA075479	Legacy Pharmaceutical Packaging, LLC	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68645-608_f656ccbc-4f13-bc71-e053-2995a90a7920	68645-608	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-609_f656ccbc-4f13-bc71-e053-2995a90a7920	68645-609	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-610_f656ccbc-4f13-bc71-e053-2995a90a7920	68645-610	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-611_f656ccbc-4f13-bc71-e053-2995a90a7920	68645-611	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-612_f656ccbc-4f13-bc71-e053-2995a90a7920	68645-612	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68645-613_f656ccbc-4f13-bc71-e053-2995a90a7920	68645-613	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	Legacy Pharmaceutical Packaging, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68654-086_de96aecc-8b06-ad07-e053-2995a90a0270	68654-086	HUMAN OTC DRUG	Insti-Foam Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20220509		OTC MONOGRAPH NOT FINAL	part333E	Share Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
68654-855_7a98da8b-ae38-4a6d-b2e1-5a198f11ffd0	68654-855	HUMAN OTC DRUG	Foamahol		ALCOHOL	LIQUID	TOPICAL	20190711		OTC MONOGRAPH NOT FINAL	part333E	Share Corporation	ALCOHOL	.62	mL/mL			N	20241231
68663-876_a064514b-9855-474d-8b43-e1bfd7a5d8cf	68663-876	HUMAN OTC DRUG	Medicascrub High Foaming Antiseptic Hand Cleaner		CHLOROXYLENOL	SOAP	TOPICAL	20170118		OTC MONOGRAPH NOT FINAL	part333E	First Medical Infection Control Associates, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
68682-001_9c478558-474f-487f-bde2-1ebdc80f1ee3	68682-001	HUMAN PRESCRIPTION DRUG	SODIUM PHENYLACETATE AND SODIUM BENZOATE		SODIUM PHENYLACETATE AND SODIUM BENZOATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170315		NDA AUTHORIZED GENERIC	NDA020645	Oceanside Pharmaceuticals	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
68682-002_edd0c9df-745b-4e32-a0a5-959d414f7547	68682-002	HUMAN PRESCRIPTION DRUG	bexarotene		bexarotene	GEL	TOPICAL	20000628		NDA AUTHORIZED GENERIC	NDA021056	Oceanside Pharmaceuticals	BEXAROTENE	1	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
68682-003_22590cf5-85a5-4129-a313-2e1cb2aba25d	68682-003	HUMAN PRESCRIPTION DRUG	bexarotene		bexarotene	CAPSULE, LIQUID FILLED	ORAL	20151217		NDA AUTHORIZED GENERIC	NDA021055	Oceanside Pharmaceuticals	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
68682-006_06626a5d-987f-4d1c-9ffc-28fd51362900	68682-006	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-007_06626a5d-987f-4d1c-9ffc-28fd51362900	68682-007	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-008_06626a5d-987f-4d1c-9ffc-28fd51362900	68682-008	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-009_06626a5d-987f-4d1c-9ffc-28fd51362900	68682-009	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-010_4dcab06b-56fb-4e42-aae0-6e8840ddd80a	68682-010	HUMAN PRESCRIPTION DRUG	Sodium sulfacetamide		Sodium sulfacetamide	LOTION	TOPICAL	20151218		NDA AUTHORIZED GENERIC	NDA019931	Oceanside Pharmaceuticals	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
68682-011_043cfa0f-595d-17b9-e063-6394a90a31f3	68682-011	HUMAN PRESCRIPTION DRUG	ethacrynic acid		ethacrynic acid	TABLET	ORAL	19670110		NDA AUTHORIZED GENERIC	NDA016092	Oceanside Pharmaceuticals	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68682-012_043cfa0f-595d-17b9-e063-6394a90a31f3	68682-012	HUMAN PRESCRIPTION DRUG	ethacrynic sodium		ethacrynic sodium	POWDER, FOR SOLUTION	INTRAVENOUS	19670110		NDA AUTHORIZED GENERIC	NDA016093	Oceanside Pharmaceuticals	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68682-012_4180744c-a9ab-48e6-9b25-ea37a04add74	68682-012	HUMAN PRESCRIPTION DRUG	ethacrynic sodium		ethacrynic sodium	POWDER, FOR SOLUTION	INTRAVENOUS	19670110		NDA AUTHORIZED GENERIC	NDA016093	Oceanside Pharmaceuticals	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68682-018_61b0353e-333a-4040-af33-b853b4d9a992	68682-018	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20080617		NDA AUTHORIZED GENERIC	NDA021748	Oceanside Pharmaceuticals	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68682-019_6b3c6edc-c735-46e0-9b31-fac85dda0992	68682-019	HUMAN PRESCRIPTION DRUG	Ribavirin		Ribavirin	POWDER, FOR SOLUTION	RESPIRATORY (INHALATION)	20170414		NDA	NDA018859	Oceanside Pharmaceuticals	RIBAVIRIN	6	g/1	Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
68682-020_d757682f-6e86-47d9-a2f0-fb914bbcfadf	68682-020	HUMAN PRESCRIPTION DRUG	penicillamine		penicillamine	CAPSULE	ORAL	19701204		NDA AUTHORIZED GENERIC	NDA019853	Oceanside Pharmaceuticals	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
68682-021_61b0353e-333a-4040-af33-b853b4d9a992	68682-021	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180320		NDA AUTHORIZED GENERIC	NDA021748	Oceanside Pharmaceuticals	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68682-022_0962cf33-b872-4006-82f8-8610567a07d6	68682-022	HUMAN PRESCRIPTION DRUG	Methazolamide		methazolamide	TABLET	ORAL	20201002		ANDA	ANDA207438	Oceanside Pharmaceuticals	METHAZOLAMIDE	25	mg/1			N	20241231
68682-023_0962cf33-b872-4006-82f8-8610567a07d6	68682-023	HUMAN PRESCRIPTION DRUG	Methazolamide		methazolamide	TABLET	ORAL	20201002		ANDA	ANDA207438	Oceanside Pharmaceuticals	METHAZOLAMIDE	50	mg/1			N	20241231
68682-045_9ec6544e-8fd7-4541-ab00-f8fa87227d9c	68682-045	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20180530		NDA AUTHORIZED GENERIC	NDA021516	Oceanside Pharmaceuticals	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68682-101_67e482c0-c704-4a68-a7e5-d867fb5fc485	68682-101	HUMAN PRESCRIPTION DRUG	Pentoxifylline		Pentoxifylline	TABLET, EXTENDED RELEASE	ORAL	20140822		ANDA	ANDA075028	Oceanside Pharmaceuticals	PENTOXIFYLLINE	400	mg/1	Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]		N	20241231
68682-102_0772e77f-5a7a-e170-e063-6394a90a1272	68682-102	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		omeprazole, sodium bicarbonate	CAPSULE	ORAL	20060227		NDA AUTHORIZED GENERIC	NDA021849	Oceanside Pharmaceuticals	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68682-103_9ea6a78f-a3f5-4f7b-88ba-ce8bc915034b	68682-103	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000228		ANDA	ANDA075492	Oceanside Pharmaceuticals	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68682-104_0772e77f-5a7a-e170-e063-6394a90a1272	68682-104	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		omeprazole, sodium bicarbonate	CAPSULE	ORAL	20060227		NDA AUTHORIZED GENERIC	NDA021849	Oceanside Pharmaceuticals	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68682-105_64ad6e32-2e35-4042-ad92-cd44e38b32fc	68682-105	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20121018		ANDA	ANDA075269	Oceanside Pharmaceuticals	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68682-106_cf1f37b3-6eeb-4b2c-b2d6-b1d580eb3b73	68682-106	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20001204		ANDA	ANDA075269	Oceanside Pharmaceuticals	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68682-107_f5cdd553-72f0-4dca-90f1-1ab8e17b9f68	68682-107	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20020816		ANDA	ANDA076070	Oceanside Pharmaceuticals	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68682-108_cf3be00c-100a-4a69-a222-7f0a6910fed6	68682-108	HUMAN PRESCRIPTION DRUG	nifedipine		nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000927		ANDA	ANDA075289	Oceanside Pharmaceuticals	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68682-109_cf3be00c-100a-4a69-a222-7f0a6910fed6	68682-109	HUMAN PRESCRIPTION DRUG	nifedipine		nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000927		ANDA	ANDA075289	Oceanside Pharmaceuticals	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68682-110_7234f339-90cb-4fbf-9477-6bd577fcc009	68682-110	HUMAN PRESCRIPTION DRUG	Pimecrolimus		Pimecrolimus	CREAM	TOPICAL	20181126		NDA AUTHORIZED GENERIC	NDA021302	Oceanside Pharmaceuticals	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68682-111_7234f339-90cb-4fbf-9477-6bd577fcc009	68682-111	HUMAN PRESCRIPTION DRUG	Pimecrolimus		Pimecrolimus	CREAM	TOPICAL	20181126		NDA AUTHORIZED GENERIC	NDA021302	Oceanside Pharmaceuticals	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68682-112_7234f339-90cb-4fbf-9477-6bd577fcc009	68682-112	HUMAN PRESCRIPTION DRUG	Pimecrolimus		Pimecrolimus	CREAM	TOPICAL	20181126		NDA AUTHORIZED GENERIC	NDA021302	Oceanside Pharmaceuticals	PIMECROLIMUS	10	mg/g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68682-113_0ce2b1db-0b45-4548-e063-6294a90a84f1	68682-113	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20180719		NDA AUTHORIZED GENERIC	NDA022301	Oceanside Pharmaceuticals	MESALAMINE	375	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
68682-132_18705773-78c3-4eac-a1a7-f4ac6f667ef2	68682-132	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20180702		NDA AUTHORIZED GENERIC	NDA050819	Oceanside Pharmaceuticals	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	25; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
68682-133_c198435e-4173-42de-b599-5d2e24096b70	68682-133	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20231002		NDA AUTHORIZED GENERIC	NDA050819	Oceanside Pharmaceuticals	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	37.5; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68682-192_723d9f78-9d77-4575-af27-1aa117e6b8d7	68682-192	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	20200302		NDA	NDA012093	Oceanside Pharmaceuticals	ISOSORBIDE DINITRATE	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68682-193_723d9f78-9d77-4575-af27-1aa117e6b8d7	68682-193	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		isosorbide dinitrate	TABLET	ORAL	20200302		NDA	NDA012093	Oceanside Pharmaceuticals	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
68682-200_ccf10efe-4fda-40a4-8f20-1ccefb151a15	68682-200	HUMAN PRESCRIPTION DRUG	Carbidopa		Carbidopa Tablets	TABLET	ORAL	20140404		NDA AUTHORIZED GENERIC	NDA017830	Oceanside Pharmaceuticals	CARBIDOPA	25	mg/1			N	20241231
68682-201_d78ca78b-9390-4b13-948f-e1ec6609f4da	68682-201	HUMAN PRESCRIPTION DRUG	PEG-3350, Electrolytes, and Ascorbate		polyethylene glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid	KIT		20061001		NDA	NDA021881	Oceanside Pharmaceuticals						N	20241231
68682-202_0e74a7e8-92d3-4287-a130-b80624733587	68682-202	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	CREAM	TOPICAL	20230801		NDA	NDA020743	Oceanside Pharmaceuticals	METRONIDAZOLE	10	mg/60g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68682-212_165de6fb-5a03-4acb-8cc2-433bc8c7cc92	68682-212	HUMAN PRESCRIPTION DRUG	Trientine Hydrochloride		trientine hydrochloride	CAPSULE	ORAL	20180209		NDA AUTHORIZED GENERIC	NDA019194	Oceanside Pharmaceutials	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
68682-231_0ccecc16-9926-909d-e063-6294a90a4d88	68682-231	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20230204		ANDA	ANDA075252	Oceanside Pharmaceuticals	AZATHIOPRINE	75	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68682-241_0ccecc16-9926-909d-e063-6294a90a4d88	68682-241	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20230204		ANDA	ANDA075252	Oceanside Pharmaceuticals	AZATHIOPRINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
68682-271_01f93fa6-5fea-4b3e-aa41-e8e0269257ee	68682-271	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		hydrocortisone butyrate	OINTMENT	TOPICAL	20090901		NDA	NDA018652	Oceanside Pharmaceuticals	HYDROCORTISONE BUTYRATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68682-272_c41475ad-d688-41c2-a38a-bc26f7935490	68682-272	HUMAN PRESCRIPTION DRUG	Imiquimod		imiquimod	CREAM	TOPICAL	20180627		NDA	NDA022483	Oceanside Pharmacueticals	IMIQUIMOD	37.5	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
68682-299_3246bcdf-e795-46ef-b613-612c0105b693	68682-299	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		loteprednol etabonate	SUSPENSION/ DROPS	OPHTHALMIC	20190701		NDA AUTHORIZED GENERIC	NDA020583	Oceanside Pharmaceuticals	LOTEPREDNOL ETABONATE	5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68682-300_63b2e85d-8fe5-4f18-9e85-8492c49a7520	68682-300	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate 1.2% and Tretinoin 0.025%		clindamycin phosphate and tretinoin	GEL	TOPICAL	20200804		NDA AUTHORIZED GENERIC	NDA050802	Oceanside Pharmaceuticals	CLINDAMYCIN PHOSPHATE; TRETINOIN	12; .25	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Retinoid [EPC], Retinoids [CS]		N	20241231
68682-301_4823269e-594b-4f83-99ce-e9d2436bc5f1	68682-301	HUMAN PRESCRIPTION DRUG	pyridostigmine bromide		pyridostigmine bromide	TABLET, EXTENDED RELEASE	ORAL	19590112		NDA AUTHORIZED GENERIC	NDA011665	Oceanside Pharmaceuticals	PYRIDOSTIGMINE BROMIDE	180	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68682-302_ae224c35-5c76-4a51-a7b3-ac20f5e92bca	68682-302	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		Pyridostigmine Bromide	TABLET	ORAL	20071030		NDA AUTHORIZED GENERIC	NDA009829	Oceanside Pharmaceuticals	PYRIDOSTIGMINE BROMIDE	60	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68682-306_3f21cb4d-0b19-441c-a6df-2c3077e1fede	68682-306	HUMAN PRESCRIPTION DRUG	Butalbital and Acetaminophen		Butalbital and Acetaminophen tablets	TABLET	ORAL	20170619		ANDA	ANDA090956	Oceanside Pharmaceuticals	ACETAMINOPHEN; BUTALBITAL	300; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
68682-307_dea0cb1f-7ec8-4f54-968f-8f095fa8ac95	68682-307	HUMAN PRESCRIPTION DRUG	pyridostigmine bromide		pyridostigmine bromide	SOLUTION	ORAL	20190701		NDA AUTHORIZED GENERIC	NDA015193	Oceanside Pharmaceuticals	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68682-309_8c472bf5-1337-4135-a2c4-ef6d4f5f3ece	68682-309	HUMAN PRESCRIPTION DRUG	budesonide		budesonide	TABLET, EXTENDED RELEASE	ORAL	20180710		NDA AUTHORIZED GENERIC	NDA203634	Oceanside Pharmaceuticals	BUDESONIDE	9	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68682-310_e61c29ce-16b2-415c-b203-28bc9d45bb5f	68682-310	HUMAN PRESCRIPTION DRUG	Metyrosine		Metyrosine	CAPSULE	ORAL	20200907		NDA AUTHORIZED GENERIC	NDA017871	Oceanside Pharmaceuticals	METYROSINE	250	mg/1	Catecholamine Synthesis Inhibitor [EPC], Catecholamine Synthesis Inhibitors [MoA]		N	20241231
68682-357_3a0bb159-f5e7-4c42-adfd-b407d0b6b12c	68682-357	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		dihydroergotamine mesylate	SPRAY	NASAL	20130318		NDA AUTHORIZED GENERIC	NDA020148	Oceanside Pharmaceuticals	DIHYDROERGOTAMINE MESYLATE	4	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
68682-367_0352d742-4500-41b7-923c-8387d29ff82a	68682-367	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA AUTHORIZED GENERIC	NDA020401	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-368_0352d742-4500-41b7-923c-8387d29ff82a	68682-368	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA AUTHORIZED GENERIC	NDA020401	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-369_0352d742-4500-41b7-923c-8387d29ff82a	68682-369	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA AUTHORIZED GENERIC	NDA020401	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-370_0352d742-4500-41b7-923c-8387d29ff82a	68682-370	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA AUTHORIZED GENERIC	NDA020401	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-371_0352d742-4500-41b7-923c-8387d29ff82a	68682-371	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA AUTHORIZED GENERIC	NDA020401	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-372_0352d742-4500-41b7-923c-8387d29ff82a	68682-372	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA AUTHORIZED GENERIC	NDA020401	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-384_31d37245-efd3-445f-b6e1-3f4920597dbc	68682-384	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		HYDROCORTISONE BUTYRATE	CREAM	TOPICAL	20130703		NDA AUTHORIZED GENERIC	NDA020769	Oceanside Pharmaceuticals	HYDROCORTISONE BUTYRATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68682-392_0c3dd77c-bf7a-57ed-e063-6294a90a5293	68682-392	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE BUTYRATE		HYDROCORTISONE BUTYRATE	LOTION	TOPICAL	20180608		NDA AUTHORIZED GENERIC	NDA022076	Oceanside Pharmaceuticals	HYDROCORTISONE BUTYRATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68682-421_586baf1c-9d44-4772-9736-5073591ed41a	68682-421	HUMAN PRESCRIPTION DRUG	tetrabenazine		tetrabenazine	TABLET	ORAL	20150720		NDA AUTHORIZED GENERIC	NDA021894	Oceanside Pharmaceuticals	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
68682-422_586baf1c-9d44-4772-9736-5073591ed41a	68682-422	HUMAN PRESCRIPTION DRUG	tetrabenazine		tetrabenazine	TABLET	ORAL	20150720		NDA AUTHORIZED GENERIC	NDA021894	Oceanside Pharmaceuticals	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
68682-455_65a9e9bc-c5ac-401a-addf-2d83b0df83a8	68682-455	HUMAN PRESCRIPTION DRUG	Metronidazole		metronidazole	GEL	VAGINAL	20150401		NDA AUTHORIZED GENERIC	NDA020208	Oceanside Pharmaceuticals	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68682-462_03e270d2-c8f6-4f3e-b6a8-a1e6a465ec1d	68682-462	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	GEL	TOPICAL	20180608		NDA AUTHORIZED GENERIC	NDA050782	Oceanside Pharmaceuticals	CLINDAMYCIN PHOSPHATE	1	g/10mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
68682-464_fb7229d4-522e-4cb2-b513-9d34f3ded591	68682-464	HUMAN PRESCRIPTION DRUG	BRINZOLAMIDE		brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	20210825		ANDA	ANDA204884	Oceanside Pharmaceuticals.	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
68682-490_e580947c-c955-4810-8182-05d47b35bfeb	68682-490	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET	ORAL	20210316		NDA	NDA022118	Oceanside Pharmaceuticals	FENOFIBRATE	40	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68682-495_e580947c-c955-4810-8182-05d47b35bfeb	68682-495	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET	ORAL	20210316		NDA AUTHORIZED GENERIC	NDA022118	Oceanside Pharmaceuticals	FENOFIBRATE	120	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68682-513_ca108a61-c4ca-4149-bf9a-31e513efc0b0	68682-513	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20130314		NDA AUTHORIZED GENERIC	NDA020475	Oceanside Pharmaceuticals	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68682-514_ca108a61-c4ca-4149-bf9a-31e513efc0b0	68682-514	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20130314		NDA AUTHORIZED GENERIC	NDA020475	Oceanside Pharmaceuticals	TRETINOIN	.4	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68682-515_ca108a61-c4ca-4149-bf9a-31e513efc0b0	68682-515	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20231201		NDA AUTHORIZED GENERIC	NDA020475	Oceanside Pharmaceuticals	TRETINOIN	.8	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
68682-521_d6cc69c3-44a9-43e4-9b6a-2851c2e16b15	68682-521	HUMAN PRESCRIPTION DRUG	Diltiazem HCl CD		Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20010411		NDA	NDA020062	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-650_0e23d654-d8b9-af1c-e063-6294a90a6f14	68682-650	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	GEL	RECTAL	19970729		NDA AUTHORIZED GENERIC	NDA020648	Oceanside Pharmaceuticals	DIAZEPAM	2.5	mg/.5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
68682-652_0e23d654-d8b9-af1c-e063-6294a90a6f14	68682-652	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	GEL	RECTAL	19970729		NDA AUTHORIZED GENERIC	NDA020648	Oceanside Pharmaceuticals	DIAZEPAM	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
68682-655_0e23d654-d8b9-af1c-e063-6294a90a6f14	68682-655	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	GEL	RECTAL	19970729		NDA AUTHORIZED GENERIC	NDA020648	Oceanside Pharmaceuticals	DIAZEPAM	20	mg/4mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
68682-658_0af5ea8f-47ef-487d-b981-6ee9a7a5b03e	68682-658	HUMAN PRESCRIPTION DRUG	budesonide		budesonide	AEROSOL, FOAM	RECTAL	20220715		NDA	NDA205613	Oceanside Pharmaceuticals	BUDESONIDE	28	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68682-704_8e9b891f-d9a7-48a6-b5fe-cbc59668352d	68682-704	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride Extended-Release Tablets	TABLET, EXTENDED RELEASE	ORAL	20191001		NDA AUTHORIZED GENERIC	NDA021392	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-705_8e9b891f-d9a7-48a6-b5fe-cbc59668352d	68682-705	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride Extended-Release Tablets	TABLET, EXTENDED RELEASE	ORAL	20140206		NDA AUTHORIZED GENERIC	NDA021392	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-706_8e9b891f-d9a7-48a6-b5fe-cbc59668352d	68682-706	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride Extended-Release Tablets	TABLET, EXTENDED RELEASE	ORAL	20140206		NDA AUTHORIZED GENERIC	NDA021392	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-707_8e9b891f-d9a7-48a6-b5fe-cbc59668352d	68682-707	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride Extended-Release Tablets	TABLET, EXTENDED RELEASE	ORAL	20140206		NDA AUTHORIZED GENERIC	NDA021392	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-708_8e9b891f-d9a7-48a6-b5fe-cbc59668352d	68682-708	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride Extended-Release Tablets	TABLET, EXTENDED RELEASE	ORAL	20140206		NDA AUTHORIZED GENERIC	NDA021392	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-709_8e9b891f-d9a7-48a6-b5fe-cbc59668352d	68682-709	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride Extended-Release Tablets	TABLET, EXTENDED RELEASE	ORAL	20140206		NDA AUTHORIZED GENERIC	NDA021392	Oceanside Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-710_6771388d-89b3-43ec-b69e-9cebeaa2a00a	68682-710	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	19880726		NDA AUTHORIZED GENERIC	NDA018998	OCEANSIDE PHARMACEUTICALS	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68682-711_6771388d-89b3-43ec-b69e-9cebeaa2a00a	68682-711	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	19851224		NDA AUTHORIZED GENERIC	NDA018998	OCEANSIDE PHARMACEUTICALS	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68682-712_6771388d-89b3-43ec-b69e-9cebeaa2a00a	68682-712	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	19851224		NDA AUTHORIZED GENERIC	NDA018998	OCEANSIDE PHARMACEUTICALS	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68682-713_6771388d-89b3-43ec-b69e-9cebeaa2a00a	68682-713	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	19851224		NDA AUTHORIZED GENERIC	NDA018998	OCEANSIDE PHARMACEUTICALS	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68682-732_580c7f94-7013-4b7a-9010-4d37186f5758	68682-732	HUMAN PRESCRIPTION DRUG	Fluorescein Sodium and Benoxinate Hydrochloride		Fluorescein Sodium and Benoxinate Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20210325		NDA AUTHORIZED GENERIC	NDA211039	Oceanside Pharmaceuticals	BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM	4.4; 2.6	mg/mL; mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
68682-750_00adff93-53db-4332-b772-bb0b7a132ddd	68682-750	HUMAN PRESCRIPTION DRUG	balsalazide disodium		balsalazide disodium	CAPSULE	ORAL	20000718		NDA AUTHORIZED GENERIC	NDA020610	Oceanside Pharmaceuticals	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
68682-800_3c24c81d-6a1d-4a3f-856e-a1055e11c62c	68682-800	HUMAN PRESCRIPTION DRUG	Tretinoin		Tretinoin	GEL	TOPICAL	20070726		NDA AUTHORIZED GENERIC	NDA022070	Oceanside Pharmaceuticals	TRETINOIN	.05	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
68682-812_64bbf424-1af1-428a-a819-633739e8e3fc	68682-812	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20200601		NDA AUTHORIZED GENERIC	NDA018086	Oceanside Pharmaceuticals	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68682-813_64bbf424-1af1-428a-a819-633739e8e3fc	68682-813	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20200601		NDA AUTHORIZED GENERIC	NDA018086	Oceanside Pharmaceuticals	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68682-850_c35b1d80-c764-4bf5-86e0-91ddb5ea4021	68682-850	HUMAN PRESCRIPTION DRUG	LULICONAZOLE		LULICONAZOLE	CREAM	TOPICAL	20180615		NDA	NDA204153	Oceanside Pharmaceuticals	LULICONAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA]		N	20241231
68682-900_eba108cb-67ec-4f94-8fad-0afb3a52899b	68682-900	HUMAN PRESCRIPTION DRUG	Erythromycin and Benzoyl Peroxide		Erythromycin and Benzoyl Peroxide	KIT		19841026		NDA AUTHORIZED GENERIC	NDA050557	Oceanside Pharmaceuticals						N	20241231
68682-901_eba108cb-67ec-4f94-8fad-0afb3a52899b	68682-901	HUMAN PRESCRIPTION DRUG	Erythromycin and Benzoyl Peroxide		Erythromycin and Benzoyl Peroxide	KIT		19841026		NDA AUTHORIZED GENERIC	NDA050557	Oceanside Pharmaceuticals						N	20241231
68682-920_7dfd254d-312e-4a8c-901b-f29cd79760bc	68682-920	HUMAN PRESCRIPTION DRUG	Tetracaine Hydrochloride		Tetracaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20190627		NDA	NDA210821	Oceanside Pharmaceuticals	TETRACAINE HYDROCHLORIDE	5	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
68682-938_9ec63a14-0b6a-47eb-9258-19b6e3cb5b25	68682-938	HUMAN PRESCRIPTION DRUG	Tolcapone		Tolcapone	TABLET, FILM COATED	ORAL	20040727		NDA AUTHORIZED GENERIC	NDA020697	Oceanside Pharmaceuticals	TOLCAPONE	100	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
68682-990_0772e77f-5a7a-e170-e063-6394a90a1272	68682-990	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		omeprazole, sodium bicarbonate	POWDER, FOR SUSPENSION	ORAL	20040615		NDA AUTHORIZED GENERIC	NDA021636	Oceanside Pharmaceuticals	OMEPRAZOLE; SODIUM BICARBONATE	20; 1680	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68682-991_0772e77f-5a7a-e170-e063-6394a90a1272	68682-991	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		omeprazole, sodium bicarbonate	POWDER, FOR SUSPENSION	ORAL	20040615		NDA AUTHORIZED GENERIC	NDA021636	Oceanside Pharmaceuticals	OMEPRAZOLE; SODIUM BICARBONATE	40; 1680	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68682-993_7ba020e2-1dbc-42f4-8bcd-02cabaacf3a9	68682-993	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	OCEANSIDE PHARMACEUTICALS	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-994_7ba020e2-1dbc-42f4-8bcd-02cabaacf3a9	68682-994	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	OCEANSIDE PHARMACEUTICALS	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-997_7ba020e2-1dbc-42f4-8bcd-02cabaacf3a9	68682-997	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	OCEANSIDE PHARMACEUTICALS	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68682-998_7ba020e2-1dbc-42f4-8bcd-02cabaacf3a9	68682-998	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	OCEANSIDE PHARMACEUTICALS	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
68703-214_f61f07f7-d1a9-2c3b-e053-2995a90a4b2c	68703-214	HUMAN OTC DRUG	Eczema Remedy		Carbolicum acidum, Fagopyrum esculentum, hydrastis canadensis, Hydrocotyle asiatica, Juglans regia, Vinca minor	LOTION	TOPICAL	20171211		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CENTELLA ASIATICA; FAGOPYRUM ESCULENTUM; HYDRASTIS CANADENSIS WHOLE; JUGLANS REGIA LEAF; PHENOL; VINCA MINOR	30; 30; 30; 30; 30; 30	[hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g			N	20241231
68703-215_f61f02a9-dcf5-c0d9-e053-2a95a90a57e5	68703-215	HUMAN OTC DRUG	Neck Back Sciatic Remedy		Phytolacca Decandra, Gnaphalium Polycephalum, Hypericum Perforatum, Colocynthis, Gelsemium Sempervirens, Guaiacum, Ledum Palustre, Conium Maculatum	LOTION	TOPICAL	20171211		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CITRULLUS COLOCYNTHIS FRUIT; CONIUM MACULATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GUAIACUM OFFICINALE RESIN; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; PHYTOLACCA AMERICANA ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM	6; 30; 6; 6; 3; 6; 1; 3	[hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g; [hp_X]/113g			N	20241231
68703-216_f61f0171-b132-3a1a-e053-2a95a90ab299	68703-216	HUMAN OTC DRUG	Healthful Naturals Mole Remover		Mole Remover	LIQUID	TOPICAL	20180806		UNAPPROVED HOMEOPATHIC		Healthful Naturals Mole Remover - 15 ml	GRAPHITE; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; RADIUM BROMIDE; SANGUINARIA CANADENSIS ROOT; THUJA OCCIDENTALIS LEAFY TWIG	6; 30; 6; 30; 6; 30	[hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_X]/15mL; [hp_C]/15mL			N	20241231
68703-218_f61eb0d3-4d22-85d3-e053-2a95a90ac8bc	68703-218	HUMAN OTC DRUG	Gout Calm		Antimonium crudum, Berberis vulgaris, Lithium carbonicum	SPRAY	TOPICAL	20190114		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ANTIMONY TRISULFIDE; BERBERIS VULGARIS FRUIT; LITHIUM CARBONATE	6; 30; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL	Mood Stabilizer [EPC]		N	20241231
68703-256_0d765c7e-2520-97ab-e063-6294a90a04a1	68703-256	HUMAN OTC DRUG	Sweat-Less		Arg nit, Castoreum, Humulus, Iodum, Kali phos, Nat mur	LIQUID	ORAL	20160607		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CASTOR CANADENSIS SCENT GLAND SECRETION; HOPS; IODINE; POTASSIUM PHOSPHATE, DIBASIC; SILVER NITRATE; SODIUM CHLORIDE	30; 30; 30; 30; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
68703-257_0d762a5b-29b9-8b91-e063-6294a90afee0	68703-257	HUMAN OTC DRUG	Epi-Still-M		Cicuta virosa, Cuprum metallicum, Ignatia amara, Passiflora incamata, Scutellaria lateriflora, Zincum metallicum	LIQUID	ORAL	20160801		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CICUTA VIROSA ROOT; COPPER; PASSIFLORA INCARNATA FLOWER; SCUTELLARIA LATERIFLORA; STRYCHNOS IGNATII SEED; ZINC	30; 30; 2; 2; 8; 8	[hp_C]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
68703-289_f61f02a9-dcf8-c0d9-e053-2a95a90a57e5	68703-289	HUMAN OTC DRUG	XX Health Pro		Lachesis, Nat mur, Pulsatilla, Sepia, Sulphur	SPRAY	ORAL	20170417		UNAPPROVED HOMEOPATHIC		Silver Star Brands	LACHESIS MUTA VENOM; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SULFUR	30; 30; 30; 30; 30	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-302_f61f02a9-dcf7-c0d9-e053-2a95a90a57e5	68703-302	HUMAN OTC DRUG	EndometrEase		Cimicifuga racemosa, Ipecacuanha, Lilium tigrinum, Pulsatilla, Sulphur	SPRAY	ORAL	20170605		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ANEMONE PULSATILLA; BLACK COHOSH; IPECAC; LILIUM LANCIFOLIUM WHOLE FLOWERING; SULFUR	30; 30; 30; 30; 30	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-303_f61f07f7-d1aa-2c3b-e053-2995a90a4b2c	68703-303	HUMAN OTC DRUG	GasTamer S.O.S.		Antimon crud, Carbo veg, Lycopodium, Silicea, Sulphur	SPRAY	ORAL	20170816		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; LYCOPODIUM CLAVATUM SPORE; SILICON DIOXIDE; SULFUR	6; 30; 6; 30; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-313_0d7619a6-af5e-8c29-e063-6294a90a3dce	68703-313	HUMAN OTC DRUG	NeuropathEase		Agaricus musc, Arsenicum alb, Hypericum, Phos, Silicea	LIQUID	ORAL	20181119		UNAPPROVED HOMEOPATHIC		Silver Star Brands	AMANITA MUSCARIA FRUITING BODY; ARSENIC TRIOXIDE; HYPERICUM PERFORATUM; PHOSPHORUS; SILICON DIOXIDE	30; 30; 30; 30; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-314_0d61926f-f94d-fa84-e063-6294a90a14e2	68703-314	HUMAN OTC DRUG	Bio-Cheer		Anacardium, Graphites, Lilium, Sepia, Staphysag	TABLET	ORAL	20181217		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ANACARDIUM OCCIDENTALE FRUIT; DELPHINIUM STAPHISAGRIA WHOLE; GRAPHITE; LILIUM LANCIFOLIUM WHOLE; SEPIA OFFICINALIS JUICE	30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
68703-315_f61eec61-48ba-a3cb-e053-2995a90a7db2	68703-315	HUMAN OTC DRUG	Migo-Ease		Aconitum nap, Lycopodium, Nat mur, Nux vom, Pulsatilla	TABLET	ORAL	20181217		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	30; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-316_f61ec2fc-47dc-d715-e053-2a95a90a96f6	68703-316	HUMAN OTC DRUG	Sleepy Jr		Chamomilla, Cina, Cinchona, Coffea cruda, Nux vom	TABLET	ORAL	20181217		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARTEMISIA CINA FLOWER; CINCHONA OFFICINALIS BARK; COFFEA ARABICA FRUIT; MATRICARIA CHAMOMILLA FLOWERING TOP OIL; STRYCHNOS NUX-VOMICA SEED	30; 30; 6; 6; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-317_f61ee5d0-4116-9962-e053-2995a90ab487	68703-317	HUMAN OTC DRUG	Liver Boost		Arsenicum alb, Carbo veg, Carduus mar, Chelidonium maj, Nux vom	TABLET	ORAL	20181217		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; CHELIDONIUM MAJUS; SILYBUM MARIANUM SEED; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-318_f61eec61-48b8-a3cb-e053-2995a90a7db2	68703-318	HUMAN OTC DRUG	Well-Ex		Arsenicum alb, Graphites, Hepar sulph calc, Radium brom, Viola tric	TABLET	ORAL	20181217		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARSENIC TRIOXIDE; CALCIUM SULFIDE; GRAPHITE; RADIUM BROMIDE; VIOLA TRICOLOR	6; 6; 6; 30; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
68703-319_f61ea762-d520-7742-e053-2a95a90ad527	68703-319	HUMAN OTC DRUG	Junior Moves		Anacardium, Bryonia, Mag mur, Nat mur, Plumb met	TABLET	ORAL	20181217		UNAPPROVED HOMEOPATHIC		Silver Star Brands	BRYONIA ALBA ROOT; LEAD; MAGNESIUM CHLORIDE; SEMECARPUS ANACARDIUM JUICE; SODIUM CHLORIDE	30; 30; 30; 30; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-320_0d61926f-f94a-fa84-e063-6294a90a14e2	68703-320	HUMAN OTC DRUG	Behavior-Rite		Anacard or, Chamomilla, Cina, Thea sinensis, Viola tric	TABLET	ORAL	20181217		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARTEMISIA CINA FLOWER; CAMELLIA SINENSIS FLOWER; MATRICARIA RECUTITA; SEMECARPUS ANACARDIUM JUICE; VIOLA TRICOLOR	30; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
68703-322_0d76368c-7559-93a0-e063-6294a90a654d	68703-322	HUMAN OTC DRUG	EarStill		Calc fluor, Carboneum sulph, Chininum sulph, Mang met, Salicylicum ac	LIQUID	ORAL	20190304		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM FLUORIDE; CARBON DISULFIDE; MANGANESE; QUININE SULFATE; SALICYLIC ACID	30; 6; 6; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL	Antimalarial [EPC]		N	20241231
68703-323_0d766f51-42b9-132e-e063-6294a90adcb5	68703-323	HUMAN OTC DRUG	MediCrave		Arnica, Caladium seguinum, Lobelia inf, Petroleum, Tabacum	LIQUID	ORAL	20190304		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARNICA MONTANA; DIEFFENBACHIA SEGUINE; LIQUID PETROLEUM; LOBELIA INFLATA; TOBACCO LEAF	30; 6; 30; 30; 12	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
68703-324_0d766f51-42ba-132e-e063-6294a90adcb5	68703-324	HUMAN OTC DRUG	Mucus-Clear Nighttime		Hepar sulph, Kali bic, Kali carb, Kali mur, Nux vom	LIQUID	ORAL	20190225		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM SULFIDE; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED	6; 30; 6; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS]		N	20241231
68703-325_0d6172e9-f611-ba73-e063-6394a90a70ea	68703-325	HUMAN OTC DRUG	Mucus-Clear Jr.		Allium cepa, Ferrum phos, Kali bic, Kali carb, Kali mur	LIQUID	ORAL	20190513		UNAPPROVED HOMEOPATHIC		Silver Star Brands	FERROSOFERRIC PHOSPHATE; ONION; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE	6; 6; 30; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS]		N	20241231
68703-326_0d761e04-467a-5162-e063-6294a90a9185	68703-326	HUMAN OTC DRUG	Mucus-Clear Jr. Nighttime		Chamomilla, Cina, Kali bic, Kali carb, Kali mur, Pulsatilla	LIQUID	ORAL	20190513		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARTEMISIA CINA FLOWER; MATRICARIA RECUTITA; POTASSIUM CARBONATE; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS	6; 6; 30; 6; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68703-335_f61ea762-d522-7742-e053-2a95a90ad527	68703-335	HUMAN OTC DRUG	SciatiGon-M		Aconitum napellus, Berberis vulgaris, Chamomilla, Colocynthis, Magnesia phosphorica, Rhus tox	LIQUID	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACONITUM NAPELLUS; BERBERIS VULGARIS FRUIT; CITRULLUS COLOCYNTHIS FRUIT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; TOXICODENDRON RADICANS LEAF	6; 6; 30; 8; 6; 30	[hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-338_0d61dd1f-b283-ddc6-e063-6394a90ac167	68703-338	HUMAN OTC DRUG	N-Con Tonic		Calc fluor, Equisetum arv, Nat phos, Nat sulphuricum, Pulsatilla	TABLET	ORAL	20190909		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM FLUORIDE; EQUISETUM ARVENSE BRANCH; PULSATILLA VULGARIS; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM SULFATE	6; 6; 6; 6; 6	[hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_C]/1			N	20241231
68703-341_0d766155-d1a3-7bf3-e063-6394a90a17b6	68703-341	HUMAN OTC DRUG	AllergiClear-M		Adrenalinum, Calcarea fluorica, Calcarea phosphorica, Euphrasia officinalis, Histaminum hydrochloricum, Kali muriaticum, Natrum muriaticum, Silicea	LIQUID	ORAL	20191001		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM FLUORIDE; CALCIUM PHOSPHATE; EPINEPHRINE; EUPHRASIA OFFICINALIS LEAF; HISTAMINE DIHYDROCHLORIDE; POTASSIUM CHLORIDE; SILICON DIOXIDE; SODIUM CHLORIDE	8; 8; 7; 4; 7; 8; 8; 8	[hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
68703-345_f61eccf8-21a4-33fe-e053-2995a90a2b2b	68703-345	HUMAN OTC DRUG	Cough and Cold Relief		Arg met, Arsenicum alb, Baptisia, Bryonia, Causticum, Dulcamara, Echinacea angustifolia, Echinacea purp, Kali bic, Merc coros, Phos, Pulsatilla nutt, Senega, Zinc pic, Zinc val	SPRAY	ORAL	20191001		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ANEMONE PATENS WHOLE; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; CAUSTICUM; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; MERCURIC CHLORIDE; PHOSPHORUS; POLYGALA SENEGA ROOT; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; SILVER; SOLANUM DULCAMARA FLOWER; ZINC PICRATE; ZINC VALERATE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68703-346_0d629dc7-8752-4667-e063-6394a90af8d6	68703-346	HUMAN OTC DRUG	Good Night Sleep		Aconitum nap,Aesculus hipp, flos, Avena, Cocculus, Coffea cruda, Hyoscyamus, Ignatia, Passiflora, Pulsatilla nutt, Staphysag, Valeriana	SPRAY	ORAL	20191001		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACONITUM NAPELLUS; AESCULUS HIPPOCASTANUM FLOWER; ANAMIRTA COCCULUS SEED; ANEMONE PATENS WHOLE; AVENA SATIVA LEAF; COFFEA ARABICA FRUIT; DELPHINIUM STAPHISAGRIA SEED; HYOSCYAMUS NIGER; PASSIFLORA INCARNATA FLOWER; STRYCHNOS IGNATII WHOLE; VALERIANA OFFICINALIS WHOLE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
68703-349_f61ed053-6c72-26c9-e053-2a95a90ab4ab	68703-349	HUMAN OTC DRUG	Stress Away Anxiety Relief		Aconitum nap, Alfalfa, Avena, chamomilla, Gelsemium, Humulus lupulus, Ignatia, Kali ars, kali phos, Muriaticum ac, nat phos, Passiflora, Phos, Staphysag, Stramonium	SPRAY	ORAL	20191001		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACONITUM NAPELLUS; ALFALFA; AVENA SATIVA LEAF; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; HUMULUS LUPULUS WHOLE; HYDROCHLORIC ACID; MATRICARIA CHAMOMILLA FLOWERING TOP OIL; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS P-32; POTASSIUM ARSENITE ANHYDROUS; POTASSIUM PHOSPHATE, UNSPECIFIED FORM; SODIUM PHOSPHATE, DIBASIC; STRYCHNOS IGNATII WHOLE	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
68703-351_0d6236d4-f86a-e3e7-e063-6394a90ab57a	68703-351	HUMAN OTC DRUG	AppetiteGo		Adrenalinum, Agrimonia eupatoria flos, Anacardium, Antimon crud, Calc carb, Castanea sativa flos, Cortisone aceticum, Fucus, Hypothalmus, Kali bic, Oleander, Pituitarum posterium, Sabadilla, Staphysagria, Thyroidinum	SPRAY	ORAL	20130810		UNAPPROVED HOMEOPATHIC		Silver Star Brands	AGRIMONIA EUPATORIA FLOWER; ANACARDIUM OCCIDENTALE FRUIT; ANTIMONY TRISULFIDE; CASTANEA SATIVA FLOWER; CORTISONE ACETATE; DELPHINIUM STAPHISAGRIA SEED; EPINEPHRINE; FUCUS VESICULOSUS; NERIUM OLEANDER LEAF; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIED	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
68703-352_0d61e46b-12ed-e586-e063-6394a90acb8f	68703-352	HUMAN OTC DRUG	TremorSoothe		Agaricus musc, Mag phos, Stramonium, Tarentula hisp	TABLET	ORAL	20201225		UNAPPROVED HOMEOPATHIC		Silver Star Brands	AMANITA MUSCARIA FRUITING BODY; DATURA STRAMONIUM; LYCOSA TARANTULA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6; 6; 6; 8	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_X]/1801	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-353_0d61d8a9-fe82-0afe-e063-6294a90a4268	68703-353	HUMAN OTC DRUG	VertiFree		Bryonia, Cocculus, Gesemium, Lobelia	TABLET	ORAL	20201225		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ANAMIRTA COCCULUS SEED; BRYONIA CRETICA SUBSP. DIOICA ROOT; GELSEMIUM SEMPERVIRENS ROOT; LOBELIA INFLATA	30; 30; 30; 30	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801			N	20241231
68703-358_0d6236d4-f867-e3e7-e063-6394a90ab57a	68703-358	HUMAN OTC DRUG	Brightspark		Arg nit, Arsenicum iod, Hyoscyamus, Veratrum alb	TABLET	ORAL	20201225		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARSENIC TRIIODIDE; HYOSCYAMUS NIGER LEAF; SILVER NITRATE; VERATRUM ALBUM ROOT	30; 30; 6; 30	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801			N	20241231
68703-359_0d61d8a9-fe80-0afe-e063-6294a90a4268	68703-359	HUMAN OTC DRUG	Candidate S.O.S		Calc carb, Carbo veg, Ferrum met, Lycopodium, Sulphur	TABLET	ORAL	20210111		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTIVATED CHARCOAL; IRON; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SULFUR	30; 30; 30; 30; 30	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801			N	20241231
68703-361_0d61926f-f989-fa84-e063-6294a90a14e2	68703-361	HUMAN OTC DRUG	MoodCalm		Hyoscyamus, Kali phos, Nat sulphuricum, Tarentula hisp	TABLET	ORAL	20210111		UNAPPROVED HOMEOPATHIC		Silver Star Brands	HYOSCYAMUS NIGER LEAF; LYCOSA TARANTULA; POTASSIUM PHOSPHATE, DIBASIC; SODIUM SULFATE	6; 6; 6; 6	[hp_C]/1801; [hp_C]/1801; [hp_X]/1801; [hp_X]/1801			N	20241231
68703-365_0d61dd1f-b282-ddc6-e063-6394a90ac167	68703-365	HUMAN OTC DRUG	Tula Tantrum Tamer		Chamomilla, Cina	PELLET	ORAL	20210222		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARTEMISIA CINA FLOWER; MATRICARIA RECUTITA	6; 6	[hp_C]/26g; [hp_C]/26g			N	20241231
68703-369_0d7619a6-af57-8c29-e063-6294a90a3dce	68703-369	HUMAN OTC DRUG	Mucus-Clear Flu Relief		Anas barbariae, Arsenicum alb, Baptisia, Echinacea purp, Gelsemium, Influenzinum, Phytolacca, Sarcolacticum ac, Sulphur, Zinc acet, Zinc mur, Zinc oxy	LIQUID	ORAL	20210907		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; ECHINACEA PURPUREA; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS WHOLE; INFLUENZA B VIRUS WHOLE; LACTIC ACID, L-; PHYTOLACCA AMERICANA ROOT; SULFUR; ZINC ACETATE; ZINC CHLORIDE; ZINC OXIDE	60; 60; 60; 60; 60; 60; 60; 60; 60; 60; 60; 60; 60	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
68703-370_0d7619a6-af56-8c29-e063-6294a90a3dce	68703-370	HUMAN OTC DRUG	Mucus-Clear Sinus Relief		Belladonna, Hepar sulph calc, Kali bic, Pulsatilla, Sanguinaria, Spigelia Anth	LIQUID	ORAL	20210907		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ATROPA BELLADONNA; CALCIUM SULFIDE; POTASSIUM DICHROMATE; PULSATILLA PATENS WHOLE; SANGUINARIA CANADENSIS ROOT; SPIGELIA ANTHELMIA	6; 6; 6; 6; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-371_0d61114d-8056-9cdf-e063-6394a90ac84c	68703-371	HUMAN OTC DRUG	Stress Away Anxiety Relief		Aconitum nap, Alfalfa, Avena, Chamomilla, Gelsemium, Humulus Iupulus, Ignatia, Kali ars, Kali phos, Muriaticum ac, Nat phos, Passiflora, Phosphorus, Staphysagria, Stramonium	SPRAY	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACONITUM NAPELLUS; ALFALFA; AVENA SATIVA LEAF; DATURA STRAMONIUM; DELPHINIUM STAPHISAGRIA SEED; GELSEMIUM SEMPERVIRENS ROOT; HUMULUS LUPULUS WHOLE; HYDROCHLORIC ACID; MATRICARIA CHAMOMILLA FLOWERING TOP OIL; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; POTASSIUM ARSENITE ANHYDROUS; POTASSIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, DIBASIC; STRYCHNOS IGNATII WHOLE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
68703-373_0d6289d8-bfa4-b844-e063-6294a90a131a	68703-373	HUMAN OTC DRUG	NativeRemedies Backache Ease		Arnica, Bryonia, Cimicifuga, Hypericum, Ignatia, Kali carb, Nux vom, Rhus tox, Ruta	TABLET	ORAL	20210907		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTAEA CIMICIFUGA ROOT; ARNICA ANGUSTIFOLIA FLOWER; BRYONIA ALBA ROOT; HYPERICUM PERFORATUM; POTASSIUM CARBONATE; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON RADICANS LEAF	12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-374_0d624c26-dae8-2ee5-e063-6394a90af49c	68703-374	HUMAN OTC DRUG	Headache Ease		Aur met, Belladonna, Bryonia, Gelseisum, Ignatia, Kali phos, Nat mur, Nux vom, Sepia	TABLET	ORAL	20211220		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ATROPA BELLADONNA; BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; GOLD; POTASSIUM PHOSPHATE, DIBASIC; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
68703-375_0d6289d8-bfa5-b844-e063-6294a90a131a	68703-375	HUMAN OTC DRUG	Migraine Ease		Belladonna, Bryonia, Cimicifuga, Gelsemium, Glonoinum, Ignatia, Iris vers, Nux vom, Sanguinaria, Sepia, Spigelia anth	TABLET	ORAL	20211220		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTAEA CIMICIFUGA ROOT; ATROPA BELLADONNA; BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; IRIS VERSICOLOR ROOT; NITROGLYCERIN; SANGUINARIA CANADENSIS ROOT; SEPIA OFFICINALIS JUICE; SPIGELIA ANTHELMIA; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vasodilation [PE]		N	20241231
68703-376_0d62983a-5b7a-8254-e063-6294a90a24f7	68703-376	HUMAN OTC DRUG	Arthritis Ease		Arnica, Benzoicum ac, Bryonia, Calc phos, Colchium, Rhus tox, Ruta	TABLET	ORAL	20211220		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARNICA MONTANA; BENZOIC ACID; BRYONIA ALBA ROOT; CALCIUM PHOSPHATE; COLCHICUM AUTUMNALE BULB; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON RADICANS LEAF	12; 12; 12; 12; 12; 12; 12	[hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801; [hp_C]/1801	Ammonium Ion Binding Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Nitrogen Binding Agent [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68703-377_0d624e00-7ca1-2f48-e063-6394a90a129d	68703-377	HUMAN OTC DRUG	Mucus-Clear		Kali bic, Kali mur, Kali sulph	LIQUID	ORAL	20211104		UNAPPROVED HOMEOPATHIC		Silver Star Brands	POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; POTASSIUM SULFATE	6; 6; 9	[hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
68703-378_0d766155-d1a1-7bf3-e063-6394a90a17b6	68703-378	HUMAN OTC DRUG	NativeRemedies Acid Free-Flux		Calc phos 9X, Carbo veg 6C, Mag carb 6C, Nat phos 9X, Silicea 9X	LIQUID	ORAL	20211215		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTIVATED CHARCOAL; CALCIUM PHOSPHATE; MAGNESIUM CARBONATE HYDROXIDE; SILICON DIOXIDE; SODIUM PHOSPHATE, DIBASIC	6; 9; 6; 9; 9	[hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-381_d66d4ba2-8918-ae07-e053-2995a90abbd0	68703-381	HUMAN OTC DRUG	Good Night Sleep		Aconitum nap, Aesculus hipp, flos, Avena, Cocculus, coffea cruda, Hyoscyamus, Ignatia, Passiflora, Pulsatilla nutt, Staphysagria, Valeriana	SPRAY	ORAL	20220315		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACONITUM NAPELLUS; AESCULUS HIPPOCASTANUM FLOWER; ANAMIRTA COCCULUS SEED; ANEMONE NEMOROSA EXTRACT; AVENA SATIVA LEAF; COFFEA ARABICA FRUIT; DELPHINIUM STAPHISAGRIA SEED; HYOSCYAMUS NIGER; PASSIFLORA INCARNATA FLOWER; STRYCHNOS IGNATII SEED; VALERIAN	10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
68703-382_0d62ab9f-72b5-49a2-e063-6394a90ae95e	68703-382	HUMAN OTC DRUG	Hormoslim		Calc carb, Nux vom, Sepia, Spongia, Sulphur	SPRAY	ORAL	20220307		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM CARBONATE; SEPIA OFFICINALIS JUICE; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-383_0d6289d8-bfa6-b844-e063-6294a90a131a	68703-383	HUMAN OTC DRUG	Belly Calm		Arg nit, Asafoetida, Carbo veg, Chamomilla, Lycopodium, Mag phos, Nat phos, Nux mosch, Zingiber.	TABLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTIVATED CHARCOAL; FERULA SUMBUL ROOT; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; NUTMEG; SILVER NITRATE; SODIUM PHOSPHATE, DIBASIC	6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-384_e0048c51-74e4-a7ff-e053-2995a90a1d41	68703-384	HUMAN OTC DRUG	Stomach Saver		Abies nig, Antimon crud, Arg nit, Arsenicum alb, Carbo veg, Cinchona, Lycopodium, Nat phos, Nux mosch, Nux vom, Podoph pelt, Robinia	TABLET	ORAL	20221017		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACTIVATED CHARCOAL; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; LYCOPODIUM CLAVATUM SPORE; NUTMEG; PICEA MARIANA RESIN; PODOPHYLLUM PELTATUM ROOT; ROBINIA PSEUDOACACIA BARK; SILVER NITRATE; SODIUM PHOSPHATE, DIBASIC; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-385_0d7619a6-af55-8c29-e063-6294a90a3dce	68703-385	HUMAN OTC DRUG	Mucus Clear Cough and Cold Relief		Arg met, Arsenicum alb, Baptisia, Brypnia, Causticum, Dulcamara, Echinacea angustifolia, Echinacea purp, Kali bic, Kali mur, Merc corros, Phos, Pulsatilla nutt, Senega, Zinc pic, Zinc val.	LIQUID	ORAL	20230208		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA WHOLE; BRYONIA ALBA ROOT; CAUSTICUM; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; MERCURIC CHLORIDE; PHOSPHORUS; POLYGALA SENEGA ROOT; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; PULSATILLA PATENS WHOLE; SILVER; SOLANUM DULCAMARA STEM; ZINC OXIDE; ZINC VALERATE DIHYDRATE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68703-386_0d761e04-4679-5162-e063-6294a90a9185	68703-386	HUMAN OTC DRUG	Mucus Clear Allergy Relief		Alliu cepa, Calc phos, Euphrasia, Ignatia, Kali mur, Nat mur, Nux vom, Pulsatilla, Silica	LIQUID	ORAL	20230220		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM PHOSPHATE; EUPHRASIA STRICTA; ONION; POTASSIUM CHLORIDE; PULSATILLA PATENS WHOLE; SILICON DIOXIDE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
68703-387_f4d4943b-cb79-aa71-e053-2a95a90ac638	68703-387	HUMAN OTC DRUG	EyeClear Pro		Calc carb, Calc fluor, Causticum, Cineraria, Euphrasia, Naphthalinum, Nat mur, Phos, Quassia, Silicea	LIQUID	ORAL	20230313		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM FLUORIDE; CAUSTICUM; EUPHRASIA STRICTA; NAPHTHALENE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; QUASSIA AMARA WOOD; SENECIO VULGARIS; SILICON DIOXIDE; SODIUM CHLORIDE	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
68703-388_0d6172e9-f614-ba73-e063-6394a90a70ea	68703-388	HUMAN OTC DRUG	Triple Complex Sleep Tonic		Calc phos, Clac sulph, Mag phos	LIQUID	ORAL	20230309		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM PHOSPHATE; CALCIUM SULFIDE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	8; 8; 8	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-389_0d762cea-b5e0-6ff1-e063-6394a90aee03	68703-389	HUMAN OTC DRUG	NativeRemedies Kidney Stone Clear		Belladonna,Berberis vulgaris, Calc carb, Cantharis, Lycopodium	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ATROPA BELLADONNA; BERBERIS VULGARIS FRUIT; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; OYSTER SHELL CALCIUM CARBONATE, CRUDE	6; 6; 6; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-390_0d76368c-7556-93a0-e063-6294a90a654d	68703-390	HUMAN OTC DRUG	NativeRemedies Gout-Gone		Antimon crud, Benzoicum ac, Ledum, Nux vom, Quercus, Rhododendron, Silicea	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ANTIMONY TRISULFIDE; BENZOIC ACID; LEDUM PALUSTRE TWIG; QUERCUS ROBUR FLOWER; RHODODENDRON AUREUM LEAF; SILICON DIOXIDE; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 12; 6; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-391_0d762cea-b5e4-6ff1-e063-6394a90aee03	68703-391	HUMAN OTC DRUG	NativeRemedies InflammaGo		Arnica, Berberis, Bryonia, Dulcamara, Rhus tox	LIQUID	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARNICA MONTANA; BERBERIS VULGARIS FRUIT; BRYONIA ALBA ROOT; SOLANUM DULCAMARA STEM; TOXICODENDRON RADICANS LEAF	6; 6; 6; 6; 30	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-392_0d76368c-7557-93a0-e063-6294a90a654d	68703-392	HUMAN OTC DRUG	NativeRemedies Anger-Soothe		Chamomilla, Lycopodium, Nux vomica	LIQUID	ORAL	20230320		UNAPPROVED HOMEOPATHIC		Silver Star Brands	LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; STRYCHNOS NUX-VOMICA SEED	6; 6; 6	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
68703-393_0d76368c-7558-93a0-e063-6294a90a654d	68703-393	HUMAN OTC DRUG	NativeRemedies Sciatigon M		Aconitum napellus, Berberis vulgaris, Chamomilla, Colocynthis, Magnesia phosphorica, Rhus tox.	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ACONITUM NAPELLUS; BERBERIS VULGARIS FRUIT; CITRULLUS COLOCYNTHIS FRUIT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; TOXICODENDRON RADICANS LEAF	6; 3; 30; 8; 2; 30	[hp_C]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-394_0d6172e9-f60e-ba73-e063-6394a90a70ea	68703-394	HUMAN OTC DRUG	NativeRemedies Triple Complex Calm Tonic		Ferrum phos, Kali phos, Mag phos	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM PHOSPHATE, DIBASIC	8; 8; 9	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-395_0d616415-6bdf-b417-e063-6394a90a6498	68703-395	HUMAN OTC DRUG	NativeRemedies Triple Complex UT Tonic		Ferrum phos, Kalii sulph, Nat phos.	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	FERROSOFERRIC PHOSPHATE; POTASSIUM SULFATE; SODIUM PHOSPHATE, DIBASIC	8; 6; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68703-396_0d61114d-8059-9cdf-e063-6394a90ac84c	68703-396	HUMAN OTC DRUG	NativeRemedies Triple Complex Mood Tonic		Kali phos, Nat phos, Nat sulph.	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	POTASSIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, DIBASIC; SODIUM SULFATE	6; 6; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
68703-397_0d612796-c9a4-9ae5-e063-6394a90a4f59	68703-397	HUMAN OTC DRUG	NativeRemedies Triple Complex BronchoSoothe		Kali phos, Mag phos, Nat sulph	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM SULFATE	8; 9; 9	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68703-398_0d766f51-42b8-132e-e063-6294a90adcb5	68703-398	HUMAN OTC DRUG	NativeRemedies Tic Tamer		Chamomilla, Cina, Hyoscyamus, Zinc met	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	ARTEMISIA CINA FLOWER; HYOSCYAMUS NIGER; MATRICARIA RECUTITA; ZINC	30; 30; 12; 30	[hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL; [hp_C]/59mL			N	20241231
68703-399_0d617493-a9b5-b84e-e063-6394a90af96b	68703-399	HUMAN OTC DRUG	NativeRemedies Triple Complex Brain Tonic		Calc phos, Kali phos, Nat mur.	LIQUID	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Silver Star Brands	CALCIUM PHOSPHATE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE	8; 6; 6	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68726-123_32f417ac-7367-42b1-8adf-7a7dd43ce2ac	68726-123	HUMAN OTC DRUG	CliniCalm		Hydrocortisone	CREAM	TOPICAL	20150601	20240430	OTC MONOGRAPH DRUG	M017	CP Skin Health Group, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
68726-168_ec94d19c-33dc-dc02-e053-2995a90a01be	68726-168	HUMAN OTC DRUG	PCA SKIN BPO Cleanser		Benzoyl Peroxide	GEL	TOPICAL	20100401		OTC MONOGRAPH FINAL	M006	CP Skin Health Group, Inc.	BENZOYL PEROXIDE	5	g/100mL			N	20241231
68726-169_ec945104-25da-3e1f-e053-2a95a90ac559	68726-169	HUMAN OTC DRUG	PCA SKIN Acne		Benzoyl Perozide	CREAM	TOPICAL	20100401		OTC MONOGRAPH FINAL	M006	CP Skin Health Group, Inc.	BENZOYL PEROXIDE	5	g/100g			N	20241231
68726-262_f0d03d57-bc21-ee5b-e053-2a95a90ab23a	68726-262	HUMAN OTC DRUG	Weightless Protection	SPF 45	Sunscreen Broad Spectrum	LOTION	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part352	CP Skin Health Group, Inc.	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	5; 2; 8.4	g/100mL; g/100mL; g/100mL			N	20241231
68726-359_ec94d68f-be6b-90bf-e053-2a95a90a597c	68726-359	HUMAN OTC DRUG	PCA SKIN Intensive Clarity Treatment		SALICYLIC ACID	GEL	TOPICAL	20180608		OTC MONOGRAPH FINAL	M006	CP Skin Health Group, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
68726-439_f2191231-0b82-4538-badb-eede64cf4a0e	68726-439	HUMAN OTC DRUG	Blemish Control Bar		Salicylic Acid	SOAP	TOPICAL	20160422		OTC MONOGRAPH FINAL	part333D	CP Skin Health Group, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
68726-445_ec962c47-04a9-f80c-e053-2995a90a6c47	68726-445	HUMAN OTC DRUG	PCA Gel		Salicylic Acid	GEL	TOPICAL	20200801		OTC MONOGRAPH FINAL	M006	CP Skin Health Group, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
68726-504_febcf7e8-668d-a5c9-e053-6394a90aec39	68726-504	HUMAN OTC DRUG	CliniCalm		Hydrocortisone	CREAM	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part348	CP Skin Health Group, Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68726-680_f37d8482-987b-4ecc-e053-2995a90a7b38	68726-680	HUMAN OTC DRUG	PCA Skin Skin Procedure		PETROLATUM	OINTMENT	TOPICAL	20190910		OTC MONOGRAPH FINAL	M016	CP Skin Health Group, Inc.	PETROLATUM	600	mg/mL			N	20241231
68726-800_91e2ee90-4164-4458-bdfb-4125adb5fa28	68726-800	HUMAN OTC DRUG	Dry Skin Relief Bar		Salicylic Acid	SOAP	TOPICAL	20160222		OTC MONOGRAPH FINAL	part358H	CP Skin Health Group, Inc.	SALICYLIC ACID	3	g/100g			N	20241231
68727-100_c0195565-56b4-426a-8b1a-868519d6dfaa	68727-100	HUMAN PRESCRIPTION DRUG	Xyrem		sodium oxybate	SOLUTION	ORAL	20020717		NDA	NDA021196	Jazz Pharmaceuticals, Inc.	SODIUM OXYBATE	.5	g/mL	Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
68727-150_86a47492-82fd-4903-a8a2-2356393074f4	68727-150	HUMAN PRESCRIPTION DRUG	XYWAV		(calcium, magnesium, potassium, and sodium oxybates)	SOLUTION	ORAL	20201102		NDA	NDA212690	Jazz Pharmaceuticals, Inc.	CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE	.5; .5; .5; .5	g/mL; g/mL; g/mL; g/mL	Central Nervous System Depressant [EPC], Central Nervous System Depressant [EPC], Central Nervous System Depressant [EPC], Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Central Nervous System Depression [PE], Central Nervous System Depression [PE], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE], Decreased Central Nervous System Organized Electrical Activity [PE], Decreased Central Nervous System Organized Electrical Activity [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
68727-350_81387972-eb98-4943-a04e-4b8a727e23bf	68727-350	HUMAN PRESCRIPTION DRUG	SUNOSI		solriamfetol	TABLET, FILM COATED	ORAL	20190618	20251031	NDA	NDA211230	Jazz Pharmaceuticals, Inc.	SOLRIAMFETOL	75	mg/1		CIV	N	
68727-351_81387972-eb98-4943-a04e-4b8a727e23bf	68727-351	HUMAN PRESCRIPTION DRUG	SUNOSI		solriamfetol	TABLET, FILM COATED	ORAL	20190618	20251031	NDA	NDA211230	Jazz Pharmaceuticals, Inc.	SOLRIAMFETOL	150	mg/1		CIV	N	
68727-712_3d667d47-35e9-4eeb-a5a6-2a879f52eac5	68727-712	HUMAN PRESCRIPTION DRUG	ZEPZELCA		Lurbinectedin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200615		NDA	NDA213702	Jazz Pharmaceuticals, Inc.	LURBINECTEDIN	.5	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
68727-745_83857dc4-2e28-4030-ac34-87408d28e337	68727-745	HUMAN PRESCRIPTION DRUG	VYXEOS		(daunorubicin and cytarabine) liposome	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20170803		NDA	NDA209401	Jazz Pharmaceuticals, Inc.	CYTARABINE; DAUNORUBICIN	100; 44	mg/20mL; mg/20mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
68727-800_0173efe0-e4e2-41f6-b044-81f707120906	68727-800	HUMAN PRESCRIPTION DRUG	DEFITELIO		defibrotide sodium	INJECTION, SOLUTION	INTRAVENOUS	20160330		NDA	NDA208114	Jazz Pharmaceuticals, Inc.	DEFIBROTIDE SODIUM	80	mg/mL			N	20241231
68727-900_19a01d9d-35ce-49dc-a2c9-958a1db5f895	68727-900	HUMAN PRESCRIPTION DRUG	Rylaze		asparaginase erwinia chrysanthemi (recombinant)-rywn	INJECTION	INTRAMUSCULAR	20210630		BLA	BLA761179	Jazz Pharmaceuticals, Inc.	ASPARAGINASE	20	mg/mL	Asparaginase [CS], Asparagine-specific Enzyme [EPC]		N	20241231
68745-2117_f482e734-4944-4288-9380-c521b844c4ec	68745-2117	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B10	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2118_f482e734-4944-4288-9380-c521b844c4ec	68745-2118	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen BR12	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2119_f482e734-4944-4288-9380-c521b844c4ec	68745-2119	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B20	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2120_f482e734-4944-4288-9380-c521b844c4ec	68745-2120	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen BR22	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2121_f482e734-4944-4288-9380-c521b844c4ec	68745-2121	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B30	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2122_f482e734-4944-4288-9380-c521b844c4ec	68745-2122	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen BR32	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2123_f482e734-4944-4288-9380-c521b844c4ec	68745-2123	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B40	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2124_f482e734-4944-4288-9380-c521b844c4ec	68745-2124	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen BR42	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2125_f482e734-4944-4288-9380-c521b844c4ec	68745-2125	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B50	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2126_f482e734-4944-4288-9380-c521b844c4ec	68745-2126	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B60	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2127_f482e734-4944-4288-9380-c521b844c4ec	68745-2127	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen B70	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 31	mg/mL; mg/mL			N	20241231
68745-2128_081c28cf-593a-4273-a02b-1a1b0261a20c	68745-2128	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen BD91	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 42	mg/mL; mg/mL			N	20241231
68745-2129_081c28cf-593a-4273-a02b-1a1b0261a20c	68745-2129	HUMAN OTC DRUG	Ultra Le Teint Velvet	Blurring Smooth-Effect Foundation Velvet Matte Finish Broad Spectrum SPF 15 Sunscreen BD121	OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20190815		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	OCTINOXATE; TITANIUM DIOXIDE	50; 42	mg/mL; mg/mL			N	20241231
68745-2133_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2133	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 12 BEIGE ROSE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2134_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2134	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 22 BEIGE ROSE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2135_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2135	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 32 BEIGE ROSE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2136_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2136	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 42 BEIGE ROSE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2137_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2137	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 52 BEIGE ROSE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2138_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2138	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 10 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2139_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2139	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 20 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2140_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2140	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 30 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2141_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2141	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 40 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2142_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2142	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 50 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2143_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2143	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 70 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2144_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2144	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 21 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2145_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2145	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 60 BEIGE	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2146_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2146	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 91	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2147_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2147	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 121	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2148_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2148	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 132	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2149_851f841b-c2a4-4b31-b7d0-a557d96e4f65	68745-2149	HUMAN OTC DRUG	VITALUMIERE AQUA	ULTRA-LIGHT SKIN PERFECTING SUNSCREEN MAKEUP BROAD SPECTRUM SPF 15, 152	TITANIUM DIOXIDE	EMULSION	TOPICAL	20210522		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	TITANIUM DIOXIDE	64	mg/mL			N	20241231
68745-2150_d75b2737-ecf2-420d-87cf-40b0139dba2c	68745-2150	HUMAN OTC DRUG	CC	SUPER ACTIVE COMPLETE CORRECTION SUNSCREEN BROAD SPECTRUM SPF 50 10 BEIGE	ENSULIZOLE, HOMOSALATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20230310		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	ENSULIZOLE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	27; 90; 45; 97; 152	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68745-2151_d75b2737-ecf2-420d-87cf-40b0139dba2c	68745-2151	HUMAN OTC DRUG	CC	SUPER ACTIVE COMPLETE CORRECTION SUNSCREEN BROAD SPECTRUM SPF 50 20 BEIGE	ENSULIZOLE, HOMOSALATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20221114		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	ENSULIZOLE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	27; 90; 45; 97; 152	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68745-2152_d75b2737-ecf2-420d-87cf-40b0139dba2c	68745-2152	HUMAN OTC DRUG	CC	SUPER ACTIVE COMPLETE CORRECTION SUNSCREEN BROAD SPECTRUM SPF 50 30 BEIGE	ENSULIZOLE, HOMOSALATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20221104		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	ENSULIZOLE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	27; 90; 45; 97; 152	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68745-2153_d75b2737-ecf2-420d-87cf-40b0139dba2c	68745-2153	HUMAN OTC DRUG	CC	SUPER ACTIVE COMPLETE CORRECTION SUNSCREEN BROAD SPECTRUM SPF 50 40 BEIGE	ENSULIZOLE, HOMOSALATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20221118		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	ENSULIZOLE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	27; 90; 45; 97; 152	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68745-2154_d75b2737-ecf2-420d-87cf-40b0139dba2c	68745-2154	HUMAN OTC DRUG	CC	SUPER ACTIVE COMPLETE CORRECTION SUNSCREEN BROAD SPECTRUM SPF 50 50 BEIGE	ENSULIZOLE, HOMOSALATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20230213		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	ENSULIZOLE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	27; 90; 45; 97; 152	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68745-2155_d75b2737-ecf2-420d-87cf-40b0139dba2c	68745-2155	HUMAN OTC DRUG	CC	SUPER ACTIVE COMPLETE CORRECTION SUNSCREEN BROAD SPECTRUM SPF 50 60 BEIGE	ENSULIZOLE, HOMOSALATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	ENSULIZOLE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	27; 90; 45; 97; 152	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68745-2156_d75b2737-ecf2-420d-87cf-40b0139dba2c	68745-2156	HUMAN OTC DRUG	CC	SUPER ACTIVE COMPLETE CORRECTION SUNSCREEN BROAD SPECTRUM SPF 50 70 BEIGE	ENSULIZOLE, HOMOSALATE, OCTISALATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	ENSULIZOLE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	27; 90; 45; 97; 152	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68745-2157_906a450c-6216-4a1f-b770-9f59bf353e13	68745-2157	HUMAN OTC DRUG	UV ESSENTIEL	COMPLETE UV PROTECTION SUNSCREEN ANTIOXIDANT ANTI-POLLUTION BROAD SPECTRUM SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	EMULSION	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	CHANEL PARFUMS BEAUTE	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68769-002_0b37a3a8-ade5-e9a3-e063-6394a90a9d51	68769-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110201		UNAPPROVED MEDICAL GAS		Colorado Compressed Gases	OXYGEN	99	L/100L			N	20241231
68769-005_0b37a539-2a84-16f9-e063-6394a90aa043	68769-005	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		Colorado Compressed Gases	NITROGEN	99	L/100L			N	20241231
68770-140_0dd79dde-3e34-6073-e063-6294a90a0f06	68770-140	HUMAN OTC DRUG	Floater		CHELIDONIUM MAJUS WHOLE, POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, PHYSOSTIGMA VENENOSUM SEED, SEPIA OFFICINALIS JUICE, SILICON DIOXIDE	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Natural Ophthalmics, Inc	CHELIDONIUM MAJUS WHOLE; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; POTASSIUM SULFATE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; SODIUM CHLORIDE	6; 12; 12; 10; 7; 12; 10	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
68770-190_0dd7c659-d4e2-4616-e063-6394a90a059d	68770-190	HUMAN OTC DRUG	Macula		calcium fluoride, calcium phosphate, carbon disulfide, dibasic potassium phosphate, sodium chloride	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Natural Ophthalmics, Inc	CALCIUM FLUORIDE; CALCIUM PHOSPHATE; CARBON DISULFIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE	12; 10; 11; 7; 9	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68770-210_0dd79dde-3e32-6073-e063-6294a90a0f06	68770-210	HUMAN OTC DRUG	Cataract		CALCIUM FLUORIDE, TRIBASIC CALCIUM PHOSPHATE, CAUSTICUM, JACOBAEA MARITIMA WHOLE, EUPHRASIA STRICTA, SEPIA OFFICINALIS JUICE, SILICON DIOXIDE	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Natural Ophthalmics, Inc	CALCIUM FLUORIDE; CAUSTICUM; EUPHRASIA STRICTA; JACOBAEA MARITIMA WHOLE; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; TRIBASIC CALCIUM PHOSPHATE	12; 12; 7; 6; 7; 13; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
68770-220_0dd7e749-079d-319c-e063-6394a90a0cbf	68770-220	HUMAN OTC DRUG	Glaucoma		arnica montana, gelsemium sempervirens, lycopodium clavatum, phosphorus, physostigma venenosum	PELLET	ORAL	20220427		UNAPPROVED HOMEOPATHIC		Natural Ophthalmics, Inc	ARNICA MONTANA; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED	12; 6; 12; 12; 12	[hp_X]/1; [hp_C]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1			N	20241231
68776-1001_393889d2-a2a3-42b3-a693-0648791ba86c	68776-1001	HUMAN OTC DRUG	Wyandotte Sanifect E3		ALCOHOL	LOTION	TOPICAL	20061001		OTC MONOGRAPH DRUG	M007	Acuity Specialty Products, Inc dba AFCO US	ALCOHOL	60.1	L/100L			N	20241231
68776-1005_81906ac9-c6ff-4263-b3cc-07433f6d84cd	68776-1005	HUMAN OTC DRUG	WYANDOTTE SANIFECT FOAM-E II		CHLOROXYLENOL	LIQUID	TOPICAL	20090106		OTC MONOGRAPH DRUG	M003	Alex C. Fergusson, Inc.	CHLOROXYLENOL	2081980	mg/208198mL			N	20241231
68776-1007_034f2bfe-a2de-464f-ad7c-b2fc34d2aafb	68776-1007	HUMAN OTC DRUG	AFCO 5515 Hand Sanitizer		ISOPROPYL ALCOHOL	LOTION	TOPICAL	20200316		OTC MONOGRAPH DRUG	M007	Acuity Specialty Products, Inc dba AFCO US	ISOPROPYL ALCOHOL	.7575	g/mL			N	20241231
68776-1007_2b7d1ffd-b157-4e9f-b90a-cff128d99881	68776-1007	HUMAN OTC DRUG	AFCO 5515 Hand Sanitizer		ISOPROPYL ALCOHOL	LOTION	TOPICAL	20200316		OTC MONOGRAPH DRUG	M007	Acuity Specialty Products, Inc dba AFCO US	ISOPROPYL ALCOHOL	.7575	g/mL			N	20241231
68776-1007_5216746a-98f4-4708-aaab-2938ec77e68c	68776-1007	HUMAN OTC DRUG	AFCO 5515 Hand Sanitizer		ISOPROPYL ALCOHOL	LOTION	TOPICAL	20200316		OTC MONOGRAPH DRUG	M007	Acuity Specialty Products, Inc dba AFCO US	ISOPROPYL ALCOHOL	.7575	g/mL			N	20241231
68776-1007_74ea963f-5d77-45f1-91b0-f27878294b3a	68776-1007	HUMAN OTC DRUG	AFCO 5515 Hand Sanitizer		ISOPROPYL ALCOHOL	LOTION	TOPICAL	20200316		OTC MONOGRAPH DRUG	M007	Acuity Specialty Products, Inc dba AFCO US	ISOPROPYL ALCOHOL	.7575	g/mL			N	20241231
68786-120_0e97499c-f708-5ad7-e063-6394a90ae681	68786-120	HUMAN OTC DRUG	alcohol		alcohol	SWAB	TOPICAL	20111219		OTC MONOGRAPH DRUG	M003	Sion Biotext Medical Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20251231
68786-122_0e974eb7-4480-7447-e063-6394a90ab8dc	68786-122	HUMAN OTC DRUG	alcohol		alcohol	SWAB	TOPICAL	20140425		OTC MONOGRAPH DRUG	M003	Sion Biotext Medical Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20251231
68786-300_0e974eb7-4481-7447-e063-6394a90ab8dc	68786-300	HUMAN OTC DRUG	Alcohol		Alcohol	SWAB	TOPICAL	20201009		OTC MONOGRAPH DRUG	M003	Sion Biotext Medical Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20251231
68788-0047_84220810-cad8-4d8a-8568-a756ef21c98a	68788-0047	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20110331		ANDA	ANDA065191	Preferred Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANIC ACID	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-0141_f7839db3-97db-4989-a7d1-f341f0b5c66e	68788-0141	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20130218		ANDA	ANDA075795	Preferred Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-0142_f7839db3-97db-4989-a7d1-f341f0b5c66e	68788-0142	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20130218		ANDA	ANDA075795	Preferred Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-0292_266ac551-e64e-4ab9-9a0f-034accc3134e	68788-0292	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20180419		OTC MONOGRAPH FINAL	part347	Preferred Pharmaceuticals Inc.	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; mg/mL			N	20241231
68788-0483_bcfa2d42-9140-4ab0-8651-f9a97599e581	68788-0483	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111107		ANDA	ANDA201091	Preferred Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-0598_84220810-cad8-4d8a-8568-a756ef21c98a	68788-0598	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20110331		ANDA	ANDA065191	Preferred Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANIC ACID	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-0600_9877746f-c5ce-4349-a5cb-6a956f7de635	68788-0600	HUMAN PRESCRIPTION DRUG	Thermazene	Silver Sulfadiazine	Silver Sulfadiazine	CREAM	TOPICAL	20130904		NDA	NDA018810	Preferred Pharmaceuticals, Inc.	SILVER SULFADIAZINE	10	mg/g			N	20241231
68788-0790_44eefbe7-0698-4819-bcc1-4b92b2e6004d	68788-0790	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20091001		ANDA	ANDA077829	Preferred Pharmaceuticals, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-0797_ce8e78f7-4179-4a17-9577-2740ff389abc	68788-0797	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Preferred Pharmaceuticals, Inc	PAROXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-0802_d9295642-13dc-4089-83fb-d662003acafd	68788-0802	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20130326		ANDA	ANDA078216	Preferred Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-4593_0f6b14c8-d9f6-48ff-8da9-527b8e450f31	68788-4593	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20130903		ANDA	ANDA040189	Preferred Pharmaceuticals, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-6320_c506f3e8-b75f-431b-bcae-b44898d0f4ec	68788-6320	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20161010		ANDA	ANDA202446	Preferred Pharamaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-6323_a66f87bb-d1de-4be4-a1af-3a49e197d75f	68788-6323	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20161017		ANDA	ANDA203154	Preferred Pharmaceuticals Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68788-6325_ed978946-ac8d-4221-bb86-0efbb9391689	68788-6325	HUMAN PRESCRIPTION DRUG	Tri-Sprintec		norgestimate and ethinyl estradiol	KIT		20161018		ANDA	ANDA075808	Preferred Pharmaceuticals Inc.						N	20241231
68788-6326_54866283-1092-4c41-ae42-bad7a974f36a	68788-6326	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20161018		ANDA	ANDA090074	Preferred Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-6328_b383ddc5-c20a-40aa-82ae-102ccf3a9e5a	68788-6328	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161017		ANDA	ANDA090700	Preferred Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-6329_119a0eb6-cbee-4594-8b37-3dca84bff45e	68788-6329	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161017		ANDA	ANDA091629	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-6374_ffa613d3-8d13-4847-bcf9-8ce414177b87	68788-6374	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20160413		ANDA	ANDA064076	Preferred Pharmaceuticals Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-6384_84039c94-7f39-4dbf-8bb4-0ffd9af9d596	68788-6384	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20160504		ANDA	ANDA077241	Preferred Pharmaceuticals Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68788-6386_28a69d55-76f6-4725-b8ec-20ac419ec575	68788-6386	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20160504		ANDA	ANDA077073	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-6388_cd166268-60a8-4612-b407-d6aa4084e21b	68788-6388	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160505		ANDA	ANDA075492	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-6390_0b692abb-c3cb-4ce4-bd02-82bd5952498a	68788-6390	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20160520		ANDA	ANDA091269	Preferred Pharmaceuticals Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-6407_6e407ab2-61f2-4388-877a-4c0d1b3af5e2	68788-6407	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20160610		ANDA	ANDA076180	Preferred Pharmaceuticals Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-6429_91833446-afe1-4296-85c2-26260ebcc1b9	68788-6429	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20160628		ANDA	ANDA077206	Preferred Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-6432_395d1f93-b30d-4f87-bd84-d4a7c270e958	68788-6432	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160629		ANDA	ANDA202446	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-6437_a9827348-8ce3-465d-a7b1-210b213862ca	68788-6437	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20160725		ANDA	ANDA077206	Preferred Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-6440_cff38d44-141c-4d60-98ba-3ebae35cc93b	68788-6440	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20170221		ANDA	ANDA040362	Preferred Pharmaceuticals Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-6448_9aff8f68-efcc-4b8a-8989-db3349769166	68788-6448	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160805		ANDA	ANDA091276	Preferred Pharmaceuticals Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-6452_0fe67bfb-f39c-4242-9b79-2f4c8c2bff47	68788-6452	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160805		ANDA	ANDA091629	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-6769_093e62aa-1e37-43ba-bf38-2ac87ac0337b	68788-6769	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20161024		ANDA	ANDA078327	Preferred Pharmaceuticals Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68788-6778_c441bcc1-c732-40d8-a962-f2b4377a5d16	68788-6778	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20161024		ANDA	ANDA078327	Preferred Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68788-6784_7150b756-c8b2-4962-ac95-3faeaf1f9c9c	68788-6784	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20161025		ANDA	ANDA077293	Preferred Pharmaceuticals, Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68788-6792_1d1a749a-edab-4f4a-8100-898ef1011f5d	68788-6792	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	SUSPENSION	ORAL	20161102		ANDA	ANDA062512	Preferred Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68788-6797_456d24ee-f6f5-4103-b3ae-abebab35f4aa	68788-6797	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SOLUTION	TOPICAL	20161103		ANDA	ANDA077623	Preferred Pharmaceuticals, Inc.	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
68788-6806_13ee81d3-45ad-464d-89d5-4506f5680064	68788-6806	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20161107		ANDA	ANDA090174	Preferred Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-6812_802bf9c3-f03c-4375-9f48-ca8a6de2c93a	68788-6812	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161206		ANDA	ANDA091629	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-6820_37c48444-e7a6-4d49-b6ef-dd7334b20bd7	68788-6820	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Preferred Pharmaceuticals, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-6825_3dd86714-e8a1-44cc-b46d-c0eaacdd7f8b	68788-6825	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20161116		ANDA	ANDA202446	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-6832_7b42fc46-0722-4dc8-9cab-997261cccae3	68788-6832	HUMAN PRESCRIPTION DRUG	Junel Fe 1/20		norethindrone acetate and ethinyl estradiol, and ferrous fumarate	KIT		20161121		ANDA	ANDA076081	Preferred Pharmaceuticals Inc.						N	20241231
68788-6835_3e49b997-5252-48ee-a264-1f996e6f656f	68788-6835	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20161121		ANDA	ANDA077206	Preferred Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-6844_5e0b65d5-50d9-4879-8cb5-de8e2fa0a032	68788-6844	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20161206		ANDA	ANDA202556	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-6855_d2d138fd-64e6-4b5f-82c8-926508b7beb3	68788-6855	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20161213		ANDA	ANDA078494	Preferred Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-6857_5f4d12b8-6521-4152-9d31-3a367153f2ae	68788-6857	HUMAN OTC DRUG	Muscle Rub		Menthol, Methyl salicylate	CREAM	TOPICAL	20161222		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals Inc.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
68788-6859_14d41297-b478-43e4-ba80-85d9035e4753	68788-6859	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20161222		ANDA	ANDA078916	Preferred Pharmaceuticals Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-6868_b357038d-0cb0-4337-ba7a-4899d6b0de1f	68788-6868	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, EXTENDED RELEASE	ORAL	20170111		ANDA	ANDA202383	Preferred Pharmaceuticals Inc.	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68788-6870_0989f385-25c9-49fd-9bc4-9fecb2b5480f	68788-6870	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20170111		ANDA	ANDA077584	Preferred Pharmaceuticals Inc.	PAROXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-6881_652067ed-baa7-414e-88a2-599c665749ec	68788-6881	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170120		ANDA	ANDA091672	Preferred Pharmaceuticals Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-6886_8022ccf7-d208-463a-9302-adad560ff513	68788-6886	HUMAN OTC DRUG	Childrens Silapap		Acetaminophen	LIQUID	ORAL	20170201	20240530	OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	160	mg/5mL			N	
68788-6889_79f2950a-e3b6-46a9-ab13-8f1038f5f982	68788-6889	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20170206		ANDA	ANDA076118	Preferred Pharmaceuticals Inc.	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-6896_8fa04a03-72ac-40fa-a3d9-423cfd9fa7d0	68788-6896	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20170213		ANDA	ANDA077135	Preferred Pharmaceuticals Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-6899_bec94029-7c0e-4737-9518-6257107a1015	68788-6899	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170214		ANDA	ANDA202446	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-6920_9389b3e1-a9b6-4ec0-8c5b-9a541bdea6e4	68788-6920	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20170306		ANDA	ANDA076164	Preferred Pharmaceuticals Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-6926_4e862d16-8331-43e5-801b-ffe4f551f9a7	68788-6926	HUMAN PRESCRIPTION DRUG	FLOVENT	HFA	fluticasone propionate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20170405		NDA	NDA021433	Preferred Pharmaceuticals Inc.	FLUTICASONE PROPIONATE	44	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-6927_7ef715ed-4a92-4149-8ee4-31f57aefeba2	68788-6927	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim	SOLUTION	OPHTHALMIC	20180330		ANDA	ANDA064211	Preferred Pharmacetucials Inc.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-6933_9ff36f94-2335-4e79-84df-1d372ec9ecd1	68788-6933	HUMAN OTC DRUG	good sense tussin dm		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20170327		OTC MONOGRAPH DRUG	341	Preferred Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68788-6938_4845c0ff-5e90-4016-81cb-ebbfab97b2ce	68788-6938	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20170404		ANDA	ANDA202801	Preferred Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
68788-6948_a9719e77-0475-4b9f-b11e-5a060547f9d5	68788-6948	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20170417		ANDA	ANDA077293	Preferred Pharmaceuticals Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68788-6957_0885eb85-36bc-401f-b687-d81d238546e5	68788-6957	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20170502		ANDA	ANDA076118	Preferred Pharmaceuticals Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-6960_f9196445-d840-430e-936a-d76d061c566f	68788-6960	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20170509		ANDA	ANDA203458	Preferred Pharmaceuticals Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68788-6976_95594087-846b-479e-9ba2-4871c93b41c1	68788-6976	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20170606		ANDA	ANDA090121	Preferred Pharmacetucals Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68788-6984_d1995f7d-f4a2-4b42-9b79-814c1cad25cf	68788-6984	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170705		ANDA	ANDA202557	Preferred Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
68788-6990_5f2eede5-afd6-4222-a04e-8a1d4cc77393	68788-6990	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20170713		ANDA	ANDA202894	Preferred Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-6995_8623a199-bf3c-407a-aae7-dd15baffff19	68788-6995	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20171027		ANDA	ANDA091672	Preferred Pharmaceuticals Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-7006_3d359b53-9006-4c31-ab1d-1606f50642da	68788-7006	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20170816		ANDA	ANDA201519	Preferred Pharmaceuticals Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7009_5cdf4d7d-1dde-4a70-b932-87aabe6ebbd5	68788-7009	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20220927		ANDA	ANDA076341	Preferred Pharmaceuticals Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7012_a76e8495-0aa6-44e6-ba8f-bd2e4b6ff34b	68788-7012	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20180104		ANDA	ANDA076164	Preferred Pharmaceuticals Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-7018_70fc9abd-d193-4364-8172-ad77e46deb3a	68788-7018	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20171011		ANDA	ANDA203695	Preferred Pharmaceuticals Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-7019_e0766e29-c69c-48b8-9801-a5565697c2b6	68788-7019	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20171011		ANDA	ANDA203512	Preferred Pharmaceuticals Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68788-7024_c15d1251-dc47-4656-b4aa-7b8b03ed0764	68788-7024	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200601		ANDA	ANDA090007	Preferred Pharmaceuticals Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7029_6b3a64e9-d810-4957-b8f6-113c93ef4412	68788-7029	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20171012		ANDA	ANDA202929	Preferred Pharmaceuticals Inc.	ESZOPICLONE	2	mg/1		CIV	N	20241231
68788-7036_83bb7299-46b0-412e-93db-ec509e879f66	68788-7036	HUMAN PRESCRIPTION DRUG	Tri-Lo-Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20171017		ANDA	ANDA076784	Preferred Pharmaceuticals Inc.						N	20241231
68788-7038_0e62457c-c0ce-44ab-bde0-3c3b364d8c93	68788-7038	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200501		ANDA	ANDA090007	Preferred Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7050_d2f7abf7-662b-4760-8edb-6e99fa170f47	68788-7050	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20200601		ANDA	ANDA202433	Preferred Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-7051_4c3deb65-33fd-47b7-b18a-393255ad1a79	68788-7051	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20171106		ANDA	ANDA203512	Preferred Pharmaceuticals Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68788-7052_3f6075b8-fc06-4e3e-bda6-ec3a5bab7c49	68788-7052	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20171106		ANDA	ANDA065470	Preferred Pharmaceuticals Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68788-7053_9dfea42e-cd2f-4e5d-b5c2-7a8fb71ef672	68788-7053	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20171106		ANDA	ANDA204418	Preferred Pharmaceuticals Inc.	FOLIC ACID	1	mg/1			N	20241231
68788-7056_4f8a14bc-3825-4c94-bf93-7f94fa6ffe7a	68788-7056	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20180105		ANDA	ANDA075991	Preferred Pharmaceuticals Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7061_dcce663d-ea50-435a-8ec8-4559b25cba05	68788-7061	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA202446	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-7063_2068c32e-ef07-45e5-b6c6-b1fb68f28a50	68788-7063	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20180105		ANDA	ANDA201519	Preferred Pharmaceuticals Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7080_60282a42-bd45-4577-83a4-1d5e5250adff	68788-7080	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA091625	Preferred Pharmaceuticals Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7086_46c4d201-de4e-41c4-bee9-7653daf2760f	68788-7086	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20180126		ANDA	ANDA206434	Preferred Pharmaceuticals Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7090_609cac6f-3c10-4e14-8b84-549308b67241	68788-7090	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20180129		ANDA	ANDA075927	Preferred Pharmaceuticals Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7091_a8f94cf3-c693-48c6-b46d-169f56893137	68788-7091	HUMAN PRESCRIPTION DRUG	PROCTOZONE-HC		Hydrocortisone 2.5%	CREAM	TOPICAL	20180212		ANDA	ANDA040879	Preferred Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7092_dbae6e29-106a-446e-9ce1-c29b7875cb4e	68788-7092	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20180212		ANDA	ANDA077066	Preferred Pharmaceuticals Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68788-7102_e472cd72-3a14-4c49-bed0-b1e23cd43ead	68788-7102	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20180312		ANDA	ANDA040275	Preferred Pharmaceuticals Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68788-7103_70cdd102-b3a2-4576-9567-309ca4732305	68788-7103	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20180313		ANDA	ANDA203995	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
68788-7114_c3fa33e1-bf30-4701-ac67-f6f201646e5f	68788-7114	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180312		ANDA	ANDA091625	Preferred Pharmaceuticals Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7118_707d68fe-7aa8-4733-bc3c-e688acbcb298	68788-7118	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20180309		ANDA	ANDA205253	Preferred Pharmaceuticals Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20251231
68788-7119_4f8cbfcf-b6d8-49f7-8cb0-03cc8fda0fdf	68788-7119	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Preferred Pharmaceuticals Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7122_2c7021ab-616a-42fe-83e1-7bea2eddd77f	68788-7122	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20190114		ANDA	ANDA090624	Preferred Pharmaceuticals Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
68788-7123_72b10432-367c-4bac-b9a7-53e71aaba683	68788-7123	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	SYRUP	ORAL	20180322		ANDA	ANDA203375	Preferred Pharmaceuticals Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68788-7125_8285e8a9-26fd-47dd-8bdc-5d7f54d51de3	68788-7125	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20180322		ANDA	ANDA203584	Preferred Pharmaceuticals Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-7127_2ab54b6f-24fe-48ea-8a8d-e809f2f4e7d3	68788-7127	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20180323		ANDA	ANDA065162	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-7130_ed6fa6c9-f75d-400a-b68b-b4b24320eda0	68788-7130	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20180330		ANDA	ANDA076768	Preferred Pharmaceuticals Inc.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68788-7137_0238b34b-c188-4e1e-b42f-45dc954915d2	68788-7137	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20180410		ANDA	ANDA205253	Preferred Pharmaceuticals Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68788-7140_e09b08be-8e27-4f7c-947f-bfc3fa1ca8c6	68788-7140	HUMAN OTC DRUG	Bismatrol		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20180419		OTC MONOGRAPH FINAL	part335	Preferred Pharmaceuticals Inc.	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
68788-7142_4a39b5a3-5ab2-4ad0-b2e7-7e39bc82fdf7	68788-7142	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20180419		ANDA	ANDA084612	Preferred Pharmaceuticals Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7145_584a6016-7cb6-4433-8287-6f01320ec911	68788-7145	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20180423		ANDA	ANDA091368	Preferred Pharmaceuticals Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-7150_339fc443-3f9f-4c97-a404-03530f89dcb0	68788-7150	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20180509		ANDA	ANDA208963	Preferred Pharmaceuticals Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68788-7159_35ed2854-7fe2-4cc1-bfd6-8e8131e27b7d	68788-7159	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20180604		NDA AUTHORIZED GENERIC	NDA020612	Preferred Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-7161_c25e307b-8bb2-4652-9275-10f5683a5271	68788-7161	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20180605		ANDA	ANDA202862	Preferred Pharmaceuticals Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7166_75076ffc-da8e-4e93-9da4-f94f954ca8fc	68788-7166	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20180605		ANDA	ANDA205253	Preferred Pharmaceuticals Inc.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
68788-7168_d1ebdc93-09b8-48d0-9435-37939924e789	68788-7168	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180611		ANDA	ANDA090170	Preferred Pharmaceuticals Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68788-7169_9c5a33e7-778f-4ab2-b2c0-3bdfc08dc624	68788-7169	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202929	Preferred Pharmaceuticals Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
68788-7175_acdff26b-e48e-4f25-a5dc-b0b21c14641c	68788-7175	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20180611		ANDA	ANDA204003	Preferred Pharmaceuticals Inc.	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-7177_4f75e66d-ac8c-43a8-9a9a-64c0d6efe120	68788-7177	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180717		ANDA	ANDA202419	Preferred Pharmaceuticals Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68788-7180_4f83f783-3e86-4550-a346-a56c079abb5b	68788-7180	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20180716		ANDA	ANDA077870	Preferred Pharmaceuticals Inc.	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-7181_9384c980-dc7a-486c-b1de-36850ad572ea	68788-7181	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180716		ANDA	ANDA077147	Preferred Pharmaceuticals Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7183_c9671f91-170e-4a01-9176-edf52ad73c25	68788-7183	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20180717		ANDA	ANDA079163	Preferred Pharmaceuticals Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68788-7186_c6a90e32-3885-4eb0-abf0-a7abfb3f2d61	68788-7186	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20180614		ANDA	ANDA202152	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7191_9146e20c-3e12-4fa6-8ae7-cbfc581cb097	68788-7191	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20180718		ANDA	ANDA078916	Preferred Pharmaceuticals Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-7194_25478037-08dc-452a-9499-732032a1fd9f	68788-7194	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20180718		ANDA	ANDA204003	Preferred Pharmaceutical, Inc.	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-7204_9d6f1684-6fb4-4761-9c34-656eb7bb18b1	68788-7204	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180723		ANDA	ANDA078321	Preferred Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-7208_bb92a900-8579-4c66-a0a7-0306d58cb90a	68788-7208	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20180806		ANDA	ANDA078989	Preferred Pharmaceuticals Inc.	ZALEPLON	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
68788-7210_ad266b16-5d64-4721-9c16-c45dd6af2bdb	68788-7210	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20180806		ANDA	ANDA075948	Preferred Pharmaceuticals Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68788-7216_6fbd0255-18da-4f2b-8664-d6150d9cd99b	68788-7216	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20180723		ANDA	ANDA075520	Preferred Pharmaceuticals Inc	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-7219_47da7e9a-4b00-4345-83ed-19f6a3fd8b68	68788-7219	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20180727		NDA AUTHORIZED GENERIC	NDA021519	Preferred Pharmaceuticals, Inc.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7223_6c403c72-1406-4e8a-a025-bcefbc0dc7e7	68788-7223	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20180726		ANDA	ANDA090170	Preferred Pharmaceuticals Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68788-7236_d2d294ac-e7ec-4e00-a1c5-f43943a5165a	68788-7236	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20180813		ANDA	ANDA091042	Preferred Pharmaceuticals Inc.	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
68788-7241_42781634-b87c-467f-a6a2-21e45a910a72	68788-7241	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20180813		ANDA	ANDA078930	Preferred Pharmaceuticals Inc., USA	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7247_f9100e26-4974-404a-8602-83289d21e619	68788-7247	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20180820		ANDA	ANDA074722	Preferred Pharmaceuticals Inc.	INDAPAMIDE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
68788-7251_7b33d4be-2695-4b20-bc7f-0b723c18ca4c	68788-7251	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20180828		ANDA	ANDA076921	Preferred Pharmaceuticals Inc.	MIRTAZAPINE	15	mg/1			N	20241231
68788-7252_30387a1f-163d-4639-8927-da7908f84252	68788-7252	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20180829		ANDA	ANDA207444	Preferred Pharmaceuticals Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68788-7264_a73bf8b1-40ad-43d3-a0e6-cda58fc4e7f4	68788-7264	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20200414		ANDA	ANDA204590	Preferred Pharmaceuticals Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7265_afc689af-7530-4305-a162-ab9493d5814e	68788-7265	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20180924		ANDA	ANDA076796	Preferred Pharmaceuticals Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68788-7266_7ffdfb75-35ed-41de-a0ed-80fc5b1d12b7	68788-7266	HUMAN OTC DRUG	Artificial Tears		Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20210311		OTC MONOGRAPH FINAL	part349	Preferred Pharmaceuticals Inc.	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.002; .002; .01	mg/mg; mg/mg; mg/mg	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
68788-7267_f854501d-8848-4699-99a9-2cac346ffbbb	68788-7267	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20180925		ANDA	ANDA084613	Preferred Pharmaceuticals Inc.	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7269_db7483ea-0afc-4849-be24-3fe2b0314b1d	68788-7269	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20190111		ANDA	ANDA200295	Preferred Pharmaceuticals Inc.	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
68788-7270_7b661abe-bd3b-4ecd-91a1-becb8aa119ed	68788-7270	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20190111		ANDA	ANDA206116	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7286_2ff258e4-1347-4f4f-9f38-813f75901ee3	68788-7286	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Preferred Pharmaceuticals, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7290_f7d85dbe-2901-4a02-b09e-5a3ac66e9884	68788-7290	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20190121		ANDA	ANDA205710	Preferred Pharmaceuticals Inc.	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7291_e6f82c70-e6e4-4ea6-b753-34cd6b511f69	68788-7291	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20190122		ANDA	ANDA077421	Preferred Pharmaceuticals Inc.	LORATADINE	5	mg/5mL			N	20241231
68788-7293_a8f05b33-0085-465b-9461-3a917ebefc00	68788-7293	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20190104		ANDA	ANDA077731	Preferred Pharmaceuticals Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68788-7297_5da00d87-d660-4548-9751-ce1f73d97bfa	68788-7297	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20190108		ANDA	ANDA203512	Preferred Pharmaceuticals Inc..	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68788-7300_562c23cc-fe09-4ca5-8c0d-d01ced448bb9	68788-7300	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20190107		ANDA	ANDA208834	Preferred Pharmaceuticals Inc.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7314_f10b11cb-07a1-4946-bc5e-803512b6e5dc	68788-7314	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20190102		ANDA	ANDA205710	Preferred Pharmaceuticals Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7315_3434dd84-f91b-42a2-b28e-224dfdb2ed4f	68788-7315	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20190102		ANDA	ANDA208834	Preferred Pharmaceuticals Inc.	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
68788-7318_b6a6083e-b395-4ff5-8e6c-66777f240721	68788-7318	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20190116		ANDA	ANDA065334	Preferred Pharmaceuticals Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-7321_08f90c33-3faf-4dfc-8e61-a4a5da0339c6	68788-7321	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20190312		ANDA	ANDA075964	Preferred Pharmaceuticals Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68788-7323_93b911d1-d6a2-43cc-887b-31060cfb1ac7	68788-7323	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	Preferred Pharmaceuticals Inc.	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-7324_6f243595-a044-42f9-8f67-686ffc98125e	68788-7324	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20201123		ANDA	ANDA076921	Preferred Pharmaceuticals Inc.	MIRTAZAPINE	30	mg/1			N	20241231
68788-7332_eae598d1-fee2-4712-aa51-f5072dc196a1	68788-7332	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20190312		ANDA	ANDA040275	Preferred Pharmaceuticals Inc.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68788-7334_9bf5571b-54c3-4475-b99c-57ed307a1aa0	68788-7334	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20190312	20240331	ANDA	ANDA077321	Preferred Pharmaceuticals Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
68788-7335_2644de22-5b34-44c9-934d-0056e74ddb2e	68788-7335	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20190312		ANDA	ANDA071745	Preferred Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-7336_07972543-4271-4589-a45a-6e5acb873efb	68788-7336	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION	OPHTHALMIC	20190312		ANDA	ANDA062196	Preferred Pharmaceuticals Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68788-7339_ff144e7e-75ac-4506-b851-bb415dfee3b8	68788-7339	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20190312		ANDA	ANDA065434	Preferred Pharmaceuticals Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7341_71057574-1b88-42a6-a5bd-c2144044726a	68788-7341	HUMAN PRESCRIPTION DRUG	Flurbiprofen		Flurbiprofen	TABLET, FILM COATED	ORAL	20190308		ANDA	ANDA074431	Preferred Pharmaceuticals Inc.	FLURBIPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7345_a702383c-a960-4cac-bf40-5d14b0ddbd98	68788-7345	HUMAN PRESCRIPTION DRUG	SULFATRIM		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20200601		NDA	NDA018615	Preferred Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
68788-7350_6d22b01b-4bf6-4b10-b411-4c78fe82a253	68788-7350	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20190307		ANDA	ANDA070177	Preferred Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7351_cc74c1b1-32f3-4055-9a74-070c5bd2e72b	68788-7351	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20190227		ANDA	ANDA078235	Preferred Pharmaceuticals Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7354_8c972293-aa0f-4fca-9f11-39cf70bca6c9	68788-7354	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20190227		ANDA	ANDA076796	Preferred Pharmaceuticals Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
68788-7355_d6011298-42b8-4eff-ad47-1c5980db2afb	68788-7355	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20190227		ANDA	ANDA203572	Preferred Pharmaceuticals Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7357_ec7036ad-ad9b-42b1-84c8-f243798c3d5c	68788-7357	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Preferred Pharmaceuticals, Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68788-7358_d1dc1fac-0695-4b54-86a8-5c3306a4752c	68788-7358	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Preferred Pharmaceuticals, Inc.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68788-7359_b9df78a3-865e-4796-a08b-7b4767722f8d	68788-7359	HUMAN OTC DRUG	Regular Strength Pain Relief		Acetaminophen	TABLET	ORAL	20190821		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68788-7369_d92f1b08-19ef-40ec-91bd-d995c612e78c	68788-7369	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20160825		ANDA	ANDA076497	Preferred Pharmaceuticals Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68788-7372_cff38d44-141c-4d60-98ba-3ebae35cc93b	68788-7372	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20170221		ANDA	ANDA040362	Preferred Pharmaceuticals Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7376_80eb0bc8-ef22-4792-986b-6cd87fd360be	68788-7376	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20160823		ANDA	ANDA206297	Preferred Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-7383_0529b533-c3d2-4b8d-a5a3-ef9f1375d3a7	68788-7383	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20160913		ANDA	ANDA203154	Preferred Pharmaceuticals Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68788-7394_418c4711-ed57-440a-8689-6d85aca9f363	68788-7394	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20160928		ANDA	ANDA077147	Preferred Pharmaceuticals Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7402_00d9ff23-856b-4e2c-b9cd-c5cdc5b40251	68788-7402	HUMAN OTC DRUG	clotrimazole		Clotrimazole	CREAM	TOPICAL	20161010		OTC MONOGRAPH FINAL	part333C	Preferred Pharmaceuticals Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-7405_5ae50387-ddfb-4abd-b833-49a0dc671453	68788-7405	HUMAN PRESCRIPTION DRUG	LIDOTHOL		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20180611		UNAPPROVED DRUG OTHER		Preferred Pharmaceuticals Inc.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4.5; 5	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-7410_0a97d86e-7048-48b0-90ba-6f1079afb93a	68788-7410	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20180606		ANDA	ANDA077584	Preferred Pharmaceuticals Inc.	PAROXETINE HYDROCHLORIDE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7414_5682f98b-22a7-4b4d-beb1-dd061850baa7	68788-7414	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20200325		ANDA	ANDA065256	Preferred Pharmaceuticals Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-7422_48cee32e-38ff-478d-a552-d101bf4a485d	68788-7422	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20140411		ANDA	ANDA078970	Preferred Pharmaceuticals, Inc..	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68788-7428_5c9f985f-7246-4142-bbef-4054ddf37b0b	68788-7428	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Preferred Pharmaceuticals, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7429_136ece9b-21ce-4c8c-ab8e-42c23a733c9d	68788-7429	HUMAN PRESCRIPTION DRUG	Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20191001		ANDA	ANDA075804	Preferred Pharmaceuticals, Inc.						N	20241231
68788-7430_33fb6506-f36e-41f3-8085-36c833b150e1	68788-7430	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Preferred Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7438_14bf1a22-2abe-4710-a538-8b9686857c8c	68788-7438	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060317		ANDA	ANDA077634	Preferred Pharmaceuticals, Inc.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
68788-7445_76ad737f-76ea-470c-b812-c573135b1db6	68788-7445	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Preferred Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-7449_74ac42b3-65d0-4c78-af04-75b8990ac95b	68788-7449	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20160819		ANDA	ANDA204097	Preferred Pharmaceuticals, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-7450_5cc27987-281a-4eb9-ad7c-cda32888d892	68788-7450	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	Preferred Pharmaceuticals, Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
68788-7451_a7cf5886-e307-4b19-98c6-8f5494705523	68788-7451	HUMAN PRESCRIPTION DRUG	BETAMETHASONE VALERATE		Betamethasone Valerate	CREAM	TOPICAL	19880106		ANDA	ANDA072041	Preferred Pharmaceuticals, Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7452_db9ef1cb-0230-4586-9b89-4238a96c9ecc	68788-7452	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	Preferred Pharmaceuticals, Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7458_c0d57910-3a94-402f-a0eb-10d0cf879ba0	68788-7458	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Preferred Pharmaceuticals, Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7459_c32edf52-7b6d-4c5e-96d2-f6bfe394a58f	68788-7459	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	Preferred Pharmaceuticals, Inc.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-7460_cef00cc1-e89d-464c-820a-6e94edb480b9	68788-7460	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Preferred Pharmaceuticals, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7461_340198fd-4d37-4b67-bf4e-038a0e77d2c1	68788-7461	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	Preferred Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7462_caea9dd5-6f61-4311-a590-8e390519c808	68788-7462	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Preferred Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
68788-7468_4c6cf981-d613-4d32-b1d7-7a036620edb7	68788-7468	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20200302		ANDA	ANDA078235	Preferred Pharmaceuticals Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7478_0a9842b0-1791-42dd-8060-b9e3bbe339bd	68788-7478	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20200413		ANDA	ANDA065473	Preferred Pharmaceuticals Inc.	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7484_f683604e-da39-488d-8705-2e4e2755f182	68788-7484	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20200302		ANDA	ANDA065352	Preferred Pharmaceuticals Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7492_b963694c-bce2-4fb6-b0d4-0e4218699476	68788-7492	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20200601		ANDA	ANDA076921	Preferred Pharmaceuticals, Inc.	MIRTAZAPINE	15	mg/1			N	20241231
68788-7499_12586cc6-c145-4acd-b6f4-c9727a7f9ffe	68788-7499	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	Preferred Pharmaceuticals, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-7500_02dc54cd-de6a-463a-844a-6529f24bbbc1	68788-7500	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20181101		ANDA	ANDA077568	Preferred Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-7506_178fe4ed-990a-49c4-9002-01e7b842b925	68788-7506	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	Preferred Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7508_31c61a4f-b9e8-4316-be12-de3f54d6e3dd	68788-7508	HUMAN OTC DRUG	GAVILAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091009		ANDA	ANDA091077	Preferred Pharmaceuticals, Inc.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
68788-7510_fb946f14-a59d-4a87-882c-de778cd2a6a8	68788-7510	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	Preferred Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7511_20a6b3ce-aca5-4cfa-baa2-6f4b5fcd6c11	68788-7511	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Preferred Pharmaceuticals, Inc.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68788-7514_6fd10cc5-59f8-4432-9849-6d269c7635de	68788-7514	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Preferred Pharmaceuticals, Inc.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
68788-7515_45f344ff-8eb8-4606-ac89-8a4faf6ad1de	68788-7515	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Preferred Pharmaceuticals, Inc.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68788-7516_d43ec6a1-6889-4f85-8edd-d922ccf74488	68788-7516	HUMAN OTC DRUG	Oxymethazoline HCL		Oxymethazoline HCL	SPRAY	NASAL	20200211		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/1	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
68788-7520_f47ada4c-7ff1-4442-a533-cefaaff90a2b	68788-7520	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Preferred Pharmaceuticals, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
68788-7521_f183e6f7-1b5a-4dbe-a5d6-4a964869e731	68788-7521	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Preferred Pharmaceuticals, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
68788-7522_ec0ba4fe-db58-43dd-b2f6-9a6981c51fa8	68788-7522	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Preferred Pharmaceuticals, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
68788-7523_a87fe526-0ff7-4dce-ac3a-002c7a5c09ae	68788-7523	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Preferred Pharmaceuticals, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
68788-7524_8c7c9962-66aa-4dc5-abeb-50ffe550807a	68788-7524	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20191227		ANDA	ANDA208677	Preferred Pharmaceuticals, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
68788-7525_84fdffdb-4b66-4d42-bddd-466330b8d964	68788-7525	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA209288	Preferred Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7526_d5670dd9-6234-4b22-b8a7-3dcb6b295b8a	68788-7526	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA073449	Preferred Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-7527_5125d078-42e6-4ecc-ab63-b37db408cb56	68788-7527	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Preferred Pharmaceuticals, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
68788-7529_22758463-598f-4fd4-b090-6f2eebeb52a4	68788-7529	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20190328		ANDA	ANDA210221	Preferred Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7531_9c63659e-afea-4110-a0f3-a16f85fd07dc	68788-7531	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200311		ANDA	ANDA204755	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-7533_7f07f692-871a-4e1a-a731-57dc01a6d750	68788-7533	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Preferred Pharmaceuticals, Inc.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7535_c7553c13-a944-49e0-ac5c-2de9cfd1033d	68788-7535	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Preferred Pharmaceuticals, Inc.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7536_76bc1381-c66c-4cbd-80c5-f96359750ae0	68788-7536	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Preferred Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-7539_eaeb433f-752a-41f7-8ecb-9b367d5c266c	68788-7539	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Preferred Pharmaceuticals, Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7544_bcaa32a9-b4fd-418e-9a58-01299c640fb5	68788-7544	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Preferred Pharmaceuticals, Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68788-7548_e500f28d-e660-4eb6-ae28-5629ebc91c16	68788-7548	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Preferred Pharmaceuticals, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7549_baa9cb83-a55e-42bc-b4b1-a6f5107dd733	68788-7549	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	PARENTERAL	20180410		ANDA	ANDA207531	Preferred Pharmaceuticals, Inc.	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
68788-7556_3a6d563c-c24d-4530-8b83-b222da444bae	68788-7556	HUMAN OTC DRUG	robafen		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	19910315		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68788-7565_0cd5ffc6-20fb-4e0d-bcc3-c799271ed0de	68788-7565	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20191227		ANDA	ANDA090469	Preferred Pharmaceuticals, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68788-7568_d7a8cdd0-607d-4bf2-9194-d5a1d81bf5e4	68788-7568	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Preferred Pharmaceuticals, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7569_687f7201-fc1f-4deb-a1a2-89701d13f6b9	68788-7569	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Preferred Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68788-7572_2b345464-792b-481d-80ac-9a1f9f3627a8	68788-7572	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20190101		ANDA	ANDA204872	Preferred Pharmaceuticals, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7573_87300377-c28a-467d-aba7-a26ab138b34b	68788-7573	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	SYRUP	ORAL	20200501		ANDA	ANDA212197	Preferred Pharmaceuticals, Inc.	ALBUTEROL SULFATE	2	mg/5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68788-7575_df5c5f64-1417-49f9-bed8-c35bde04a7a1	68788-7575	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20131129		ANDA	ANDA203834	Preferred Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-7584_057b97b0-a420-4269-a37b-c43f979e5577	68788-7584	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20220927		ANDA	ANDA076341	Preferred Pharmaceuticals Inc..	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7587_8baeb69b-a962-4adb-9250-877e1faff5e9	68788-7587	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	Preferred Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-7589_ee77b49a-d928-409e-9006-610dcdfafd62	68788-7589	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20090102		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-7593_1a750eba-15bd-4c78-85cb-d66d5e847b83	68788-7593	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20200214		ANDA	ANDA206069	Preferred Pharmaceuticals Inc.	ARMODAFINIL	250	mg/1		CIV	N	20241231
68788-7594_bfff34b0-12dc-4ff0-947f-4e3797fc51d8	68788-7594	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20200213		ANDA	ANDA207507	Preferred Pharmaceuticals Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7595_635b5b0f-a104-4e46-a6ab-eb59a7dd6d4b	68788-7595	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20200213		ANDA	ANDA207507	Preferred Pharmaceuticals Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7596_b0f5e512-a094-42a4-9c39-9f6eb1353a6a	68788-7596	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20200213		ANDA	ANDA207507	Preferred Pharmaceuticals Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7597_85bb965e-abab-4fa0-878e-558f8b9ecec4	68788-7597	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20200213		ANDA	ANDA078420	Preferred Pharmaceuticals Inc.	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7598_8612ae40-76c6-459a-aaa3-f2ed8a66a7f2	68788-7598	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20200213		ANDA	ANDA207398	Preferred Pharmaceuticals Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
68788-7599_6fd4e6b6-098e-4fc9-8e2f-879c3b3b178f	68788-7599	HUMAN PRESCRIPTION DRUG	Bacitracin Zinc and Polymyxin B Sulfate		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	OPHTHALMIC	20200327		ANDA	ANDA064046	Preferred Pharmaceuticals Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-7600_08b4c6e5-5cce-43ed-89b0-54bb813557c8	68788-7600	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	FOR SUSPENSION	ORAL	20200213		ANDA	ANDA209113	Preferred Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68788-7601_ccfb0ca6-90ae-4ad2-afa3-72c2812b6faa	68788-7601	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200206		ANDA	ANDA200503	Preferred Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68788-7603_821557a6-b35d-4f15-be4c-014e7d21b8bd	68788-7603	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20200207		ANDA	ANDA078251	Preferred Pharmaceuticals Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7607_369f9c65-d641-4e47-8e35-ca8b1f232175	68788-7607	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20200207		ANDA	ANDA206948	Preferred Pharmaceuticals Inc	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68788-7611_39c3a811-fdab-49bc-9e99-1df3136cc2c8	68788-7611	HUMAN OTC DRUG	Clear Eyes Redness Relief		Naphazoline Hydrochloride and Glycerin	LIQUID	OPHTHALMIC	20200207		OTC MONOGRAPH FINAL	part349	Preferred Pharmaceuticals Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	2.5; .12	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
68788-7612_ca7dacde-016c-4b9b-bbc7-9dd6bec68600	68788-7612	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20200601		ANDA	ANDA208898	Preferred Pharmaceuticals, Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7613_9d12f56d-03b6-4e84-a574-11b157d02734	68788-7613	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20200207		ANDA	ANDA207507	Preferred Pharmaceuticals Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7616_b316ff00-ae03-4d49-af08-031411ca4158	68788-7616	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20200207		ANDA	ANDA077443	Preferred Pharmaceuticals, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7617_8ed8f5c8-5b8e-43ce-8eeb-ad4d17d2df9e	68788-7617	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20200207		ANDA	ANDA200675	Preferred Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-7622_809a8d35-4f1e-4605-b101-8bbdd68fd3c3	68788-7622	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20200214		ANDA	ANDA090624	Preferred Pharmaceuticals Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
68788-7627_20380377-28d8-479e-8a25-f2117c769cc2	68788-7627	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20200601		ANDA	ANDA090455	Preferred Pharmaceuticals, Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
68788-7628_cbcfc4b2-f8ad-4f64-b961-cf1039e0daab	68788-7628	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	20200305		ANDA	ANDA040268	Preferred Pharmaceuticlas Inc.	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68788-7630_9306c3e0-a260-4d70-9d65-e821a561492d	68788-7630	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200305		ANDA	ANDA207687	Preferred Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7631_9306c3e0-a260-4d70-9d65-e821a561492d	68788-7631	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200305		ANDA	ANDA207687	Preferred Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7636_73cd5765-5891-43d5-9335-f61a98426297	68788-7636	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	20200310		ANDA	ANDA207531	Preferred Pharmaceuticals Inc.	AZITHROMYCIN MONOHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68788-7638_983316a4-4b74-4956-8cef-e8efaa807e25	68788-7638	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200310		ANDA	ANDA062505	Preferred Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68788-7639_4c52b781-b6aa-43c3-9e84-7bd452a210e3	68788-7639	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20200601		ANDA	ANDA065442	Preferred Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68788-7641_5d32a174-d8a6-4796-b70c-27e2f570f4c5	68788-7641	HUMAN OTC DRUG	ANTACID ANTIGAS	NTA	aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20200228		OTC MONOGRAPH FINAL	part331	Preferred Pharmaceuticals, Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68788-7642_50a36e7a-1abc-441e-b1ef-f166e72063ae	68788-7642	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20200228		ANDA	ANDA210614	Preferred Pharmaceuticals, Inc.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-7644_0fb92ec6-cb9b-4e45-9a58-627cb0051aed	68788-7644	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20200228		ANDA	ANDA090469	Preferred Pharmaceuticals, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68788-7647_984b499a-3e8b-41fb-8a06-41874cde7295	68788-7647	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20200417		ANDA	ANDA090170	Preferred Pharmaceuticals, Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68788-7656_4c293e55-2ec5-4fd9-9c99-4429385b4b13	68788-7656	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20200228		ANDA	ANDA208677	Preferred Pharmaceuticals, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
68788-7657_fdd4533c-57fe-40fd-ab14-eff41f36cf2b	68788-7657	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20200228		ANDA	ANDA205761	Preferred Pharmaceuticals, Inc.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-7660_5de54449-f40b-4ffc-b2df-e06bd674f4bd	68788-7660	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20220927		ANDA	ANDA076341	Preferred Pharmaceuticals Inc..	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7663_24442718-fba3-49d2-9894-aa2da0b438ef	68788-7663	HUMAN OTC DRUG	robafen		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20200601		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68788-7664_3d91389d-7bfa-42ee-9ca1-ee5f42bd681f	68788-7664	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200228		ANDA	ANDA203835	Preferred Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68788-7665_1b936c65-53d9-4d5f-81e7-c9e543c10575	68788-7665	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200228		ANDA	ANDA203835	Preferred Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68788-7666_cf54898c-256e-4038-bbb2-9021d7e04f6c	68788-7666	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200228		ANDA	ANDA077321	Preferred Pharmaceuticals, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-7667_b3e3627f-3c04-41c9-befe-fbdbe794deab	68788-7667	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20200228		ANDA	ANDA208451	Preferred Pharmaceuticals, Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
68788-7669_3aa29558-9bf7-432c-bb4b-4c64815be27b	68788-7669	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20200228		ANDA	ANDA204093	Preferred Pharmaceuticals, Inc.	MONTELUKAST	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68788-7670_e942792d-a334-42d3-9458-7145e1d4d7e9	68788-7670	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM, AUGMENTED	TOPICAL	20200228		ANDA	ANDA076543	Preferred Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7671_049254dd-4ab8-43b6-9005-55fb553e0dde	68788-7671	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20200228		ANDA	ANDA075483	Preferred Pharmaceuticals, Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-7672_c9410237-e733-4e97-a8e8-814931b521db	68788-7672	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20200228		ANDA	ANDA208706	Preferred Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-7674_920cd213-d185-4d3a-8ecf-ad9ae648bbc6	68788-7674	HUMAN OTC DRUG	Stimulant Laxative Plus Stool Softener		Docusate Sodium 50 mg and Sennosides 8.6 mg	TABLET, FILM COATED	ORAL	20200228		OTC MONOGRAPH NOT FINAL	part334	Preferred Pharmaceuticals, Inc.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
68788-7675_2559cfc3-459b-42ef-94d2-90322ed5e96c	68788-7675	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20200302		ANDA	ANDA204770	Preferred Pharmaceuticals, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-7676_34f51202-01f6-487d-a6cf-daec0125f88c	68788-7676	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20200302		ANDA	ANDA088617	Preferred Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68788-7679_27da88fa-e55c-43e5-9f27-b53b1991d666	68788-7679	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20200402		ANDA	ANDA203245	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-7683_e984b63e-d6d4-4d20-b549-fc0ce4f6f3e6	68788-7683	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20200302		ANDA	ANDA203561	Preferred Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-7687_f97193e7-58a3-4f26-a8ad-71192156b71e	68788-7687	HUMAN OTC DRUG	LidoPro Patch		Lidocaine, Menthol, and Methyl Salicylate	PATCH	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	4; 5; 4	mg/100mg; mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-7690_28a9783b-a110-491a-b3b6-672e76540c55	68788-7690	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20200416		ANDA	ANDA200981	Preferred Pharmaceuticals Inc	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7692_5d5bae67-f875-425b-940a-e9b228dd6e08	68788-7692	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200401		ANDA	ANDA080356	Preferred Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7693_81bb960e-e9a4-4b91-90b3-ab9366f9b302	68788-7693	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20200401		ANDA	ANDA076622	Preferred Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-7694_1138af8f-cb84-40f3-b2ca-2c7b24da1731	68788-7694	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20200401		ANDA	ANDA077091	Preferred Pharmaceuticals, Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-7696_2bc94211-0709-41b9-8c63-a66363eeba96	68788-7696	HUMAN OTC DRUG	Dendracin Neurodendraxcin		Methyl Salicylate, Menthol and Capsaicin	LOTION	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals, Inc.	CAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.015; 6; 18	g/60mL; g/60mL; g/60mL			N	20241231
68788-7699_c556d256-726e-4e47-a199-18b1ba8ba9b6	68788-7699	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20200401		ANDA	ANDA202046	Preferred Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-7700_c3470464-9722-41b3-855c-33113a5d7521	68788-7700	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA204165	Preferred Pharmaceuticals, Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
68788-7702_45e0bf78-d406-46c8-a44f-ebaead33aa7b	68788-7702	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20200501		ANDA	ANDA074880	Preferred Pharmaceuticals, Inc.	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68788-7704_62a4ed20-632a-44fe-a41d-7f5abeb0cd36	68788-7704	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20200501		NDA	NDA021116	Preferred Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7708_ccc3562c-f23b-44e3-8230-6655c7051b15	68788-7708	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20200601		ANDA	ANDA076913	Preferred Pharmaceuticals, Inc.	PREDNISOLONE SODIUM PHOSPHATE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7715_e71d36df-9331-4b36-94d5-f57582754c64	68788-7715	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20200601		ANDA	ANDA203818	Preferred Pharmaceuticals, Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7717_06dd5b23-27d2-46e4-946b-81d182643bb1	68788-7717	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril	TABLET	ORAL	20200601		ANDA	ANDA077222	Preferred Pharmaceuticals, Inc.	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-7721_2c3e87d4-38ae-40fd-94fc-063dd096e936	68788-7721	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200701		ANDA	ANDA202784	Preferred Pharmaceuticals, Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-7726_164705bd-2469-4163-b739-2b5f1cbfa0a4	68788-7726	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20200701		ANDA	ANDA077921	Preferred Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7730_7aa0d444-fe04-45b4-948c-cfe3abb74431	68788-7730	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA090961	Preferred Pharmaceuticals, Inc.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
68788-7733_a57fada2-7c64-43e4-a1b7-33a82649398f	68788-7733	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200701		ANDA	ANDA207105	Preferred Pharmaceuticals, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7737_c0d8c580-365c-4cee-b441-cbf8c2ae8871	68788-7737	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200701		ANDA	ANDA203835	Preferred Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68788-7738_fa885f9e-b7b6-442a-8cc9-4dc347b1ba8a	68788-7738	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20200701		ANDA	ANDA077147	Preferred Pharmaceuticals, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-7740_1c0964c0-ac18-4bf8-bac3-b253d05d53c0	68788-7740	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20200701		ANDA	ANDA205019	Preferred Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68788-7741_ad15fcc6-2919-48ae-8dc5-7d9f3f1674e9	68788-7741	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20200701		ANDA	ANDA204597	Preferred Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7742_7191d247-c504-47a3-827b-d724486d0dd7	68788-7742	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200701		ANDA	ANDA205868	Preferred Pharmaceuticals, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-7745_eae45ecc-731a-418e-8a94-cef595fb83c3	68788-7745	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20200701		ANDA	ANDA090796	Preferred Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7747_0f1dcd3d-ee8d-4ca2-801b-cd30199a4358	68788-7747	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20200701		ANDA	ANDA040657	Preferred Pharmaceuticals, Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
68788-7749_1c42ba3d-81cf-404b-bbff-e0d4cf2c6c6e	68788-7749	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200701		ANDA	ANDA206174	Preferred Pharmaceuticals, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7753_b3f6d0fa-dc04-4741-823e-59c0ce5a3ec6	68788-7753	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20200701		ANDA	ANDA207402	Preferred Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68788-7754_6ccb8f08-9d9e-4f1a-b22f-5e92644ea125	68788-7754	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20200701		ANDA	ANDA076921	Preferred Pharmaceuticals, Inc.	MIRTAZAPINE	45	mg/1			N	20241231
68788-7755_ab8c8416-9d1b-47da-82f1-a5da185ded4b	68788-7755	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20200701		ANDA	ANDA075581	Preferred Pharmaceuticals, Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-7757_0dc411a8-2fc7-4de4-aec5-d3b2ee475725	68788-7757	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20200701		ANDA	ANDA205101	Preferred Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7760_cd714d65-bfd6-4c4b-8ea6-54263a3caaa6	68788-7760	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20200701		ANDA	ANDA077309	Preferred Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-7761_923ca1b2-5f10-421a-a374-724a70ca561b	68788-7761	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20200701		ANDA	ANDA065229	Preferred Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7762_a2de0e33-bcec-45ac-b242-0b9e1ca6da96	68788-7762	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200722		ANDA	ANDA201384	Preferred Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68788-7763_2980e491-7b1c-460b-a96a-ae5862c35300	68788-7763	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200722		ANDA	ANDA201384	Preferred Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68788-7764_8ca362a7-2269-4786-8197-da16fbf1c6ac	68788-7764	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20200722		NDA	NDA021116	Preferred Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7765_ca79a1a0-f306-4f52-aa81-e571949441b0	68788-7765	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20200715		ANDA	ANDA078420	Preferred Pharmaceuticals, Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7767_d3799a08-1b2f-44a0-a027-5007f01c0e34	68788-7767	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20200803		ANDA	ANDA201507	Preferred Pharmaceuticals, Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68788-7769_e9e7316d-b2cf-4f2a-bca1-a2dc72404e3c	68788-7769	HUMAN OTC DRUG	Allergy Relief	Non drowsy	Loratadine	TABLET	ORAL	20200803		ANDA	ANDA075209	Preferred Pharmaceuticals, Inc.	LORATADINE	10	mg/1			N	20241231
68788-7771_f4536b1f-5711-43d4-96e0-c2e992fa546c	68788-7771	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20200803		ANDA	ANDA204093	Preferred Pharmaceuticals, Inc.	MONTELUKAST	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68788-7772_1996a577-bdaa-4519-a931-a13f82ece529	68788-7772	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200803		ANDA	ANDA210986	Preferred Pharmaceuticals, Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7774_dc527551-8197-476a-9608-80a54065e9ce	68788-7774	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20200824		ANDA	ANDA205101	Preferred Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7778_ca2cc838-6233-4bbe-9682-cf1a8550cbc5	68788-7778	HUMAN OTC DRUG	Preferred Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20200909		UNAPPROVED DRUG OTHER		Preferred Pharmaceuticals Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
68788-7779_4449811a-e212-4455-9c26-0fc26938b375	68788-7779	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20220927		ANDA	ANDA076341	Preferred Pharmaceuticals Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7780_e191a76f-bd96-4944-960c-aa63d19dce6e	68788-7780	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20200901		ANDA	ANDA204645	Preferred Pharmaceuticals, Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-7781_7540ec2c-76a8-4516-83b3-c885203741c7	68788-7781	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20200901		ANDA	ANDA076286	Preferred Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-7784_f6de1e88-e392-4f12-b72c-006ff3b44d70	68788-7784	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	20201020		ANDA	ANDA073457	Preferred Pharmaceuticals Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7785_1e9349c6-bff5-422d-b826-a0b0a103e9f9	68788-7785	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20201020		ANDA	ANDA211062	Preferred Pharmaceuticals Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68788-7786_e7f0f983-b361-4a18-be5a-9a8bcb88a36b	68788-7786	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201021		ANDA	ANDA210497	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-7787_5abb20c9-dc32-4de2-8b85-8d81255b231b	68788-7787	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension		neomycin and polymyxin B sulfates and hydrocortisone otic	SUSPENSION	AURICULAR (OTIC)	20201021		NDA AUTHORIZED GENERIC	NDA060613	Preferred Pharmaceuticals, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-7788_de1b484d-8be5-4035-a01b-e7e1d22c959d	68788-7788	HUMAN PRESCRIPTION DRUG	FLUTICASONE		fluticasone propionate	SPRAY, METERED	NASAL	20201021		ANDA	ANDA078492	Preferred Pharmaceuticals Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7790_3d1d97dd-b16b-439a-9345-c7d6cc514ae5	68788-7790	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20201021		ANDA	ANDA085182	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-7791_092ea2fa-a0d2-47b0-8981-93f19a257f47	68788-7791	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20201021		ANDA	ANDA070322	Preferred Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7793_c9bccbb5-ec25-477b-b676-ee26da6b8e6e	68788-7793	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201013		ANDA	ANDA205794	Preferred Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-7796_e6515eba-e259-48d3-9c53-d1e8b301ad82	68788-7796	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20201013		ANDA	ANDA210221	Preferred Pharmaceuticlas Inc.	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7797_203c95bb-c9ef-42d3-a92e-ab7a9b2eb5bc	68788-7797	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20201001		ANDA	ANDA209535	Preferred Pharmaceuticals Inc	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
68788-7798_d0a539a0-52e5-4b61-9e39-a9c432e0aac3	68788-7798	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Preferred Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-7800_d27525a3-7d35-445d-b231-3418b1810c40	68788-7800	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20201013		ANDA	ANDA212199	Preferred Pharmaceuticals, Inc.	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7805_4f5888a0-2575-4e10-9b4b-70419e0e3a38	68788-7805	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20201028		ANDA	ANDA203824	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-7807_b89b2320-b90c-4d07-8bf5-6d1c01dff9d9	68788-7807	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201028		ANDA	ANDA205794	Preferred Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-7808_d91c6681-924d-492f-a3c9-046ac06fb3ba	68788-7808	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201028		ANDA	ANDA207105	Prefferred Pharmaceuticals Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7810_0e72eb91-2771-4848-912a-31c7cb229dc2	68788-7810	HUMAN PRESCRIPTION DRUG	Clindamycin Phoaphate Topical Solution, 1%		Clindamycin Phosphate Topical Solution, 1%	SOLUTION	TOPICAL	20201029		ANDA	ANDA209914	Preferred Pharmaceuticals Inc.	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68788-7811_6d10f246-919e-49ff-a6d6-1bd1afd2fff1	68788-7811	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20201103		ANDA	ANDA040230	Preferred Pharmaceuticals Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68788-7813_00b0ca25-83b2-489d-8dff-e3db7cfbb351	68788-7813	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20201030		ANDA	ANDA201504	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7814_b87046ec-5c0f-42f4-93b9-84ff8d62713d	68788-7814	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	PASTE	DENTAL	20201103		ANDA	ANDA070730	Preferred Pharmaceuticals Inc	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7815_d2340be8-fc09-4fd0-a49e-d35e902c9a07	68788-7815	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20201113		ANDA	ANDA206560	Preferred Pharmaceuticals Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68788-7816_6d1eda16-5a85-4b3c-af06-e3df7bf4b3cd	68788-7816	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20201106		ANDA	ANDA213864	Preferred Pharmaceuticals Inc.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68788-7817_7f989052-8f3f-4914-9575-6898384a43bc	68788-7817	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20201106		ANDA	ANDA204597	Preferred Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7819_2c6cad76-c277-4051-b7ba-1c5bb8817f44	68788-7819	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201113		ANDA	ANDA205794	Preferred Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-7821_fae3a376-6c0c-4508-89e6-9d72bbb82cf2	68788-7821	HUMAN OTC DRUG	New Terocin		Methyl Salicylate, Capsaicin, and Menthol	LOTION	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals Inc.	CAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.025; 10; 25	g/100mL; g/100mL; g/100mL			N	20241231
68788-7825_73b884d3-e9d2-4d1b-9c92-75535ec1d51e	68788-7825	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20210108		ANDA	ANDA207798	Preferred Pharmaceuticals Inc.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68788-7826_caa0743b-c9a3-4c7a-a5b0-ff77471f5499	68788-7826	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20210105		ANDA	ANDA206069	Preferred Pharmaceuticals Inc.	ARMODAFINIL	200	mg/1		CIV	N	20241231
68788-7827_f4da1ae2-1e84-4438-a14d-af83b143fc0f	68788-7827	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	OINTMENT	TOPICAL	20210107		ANDA	ANDA070069	Preferred Pharmaceuticals, Inc.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7830_272acdc5-0689-4d51-850e-18e747ea6050	68788-7830	HUMAN OTC DRUG	Banophen		diphenhydramine hcl	CAPSULE	ORAL	20210108		OTC MONOGRAPH DRUG	341	Preferred Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
68788-7832_4f01e3cf-8b6f-4535-9f85-8fdbe757cd19	68788-7832	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20210113		ANDA	ANDA200981	Preferred Pharmaceuticals Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7833_c93486e2-f392-4c2a-8421-9fb7e27dd937	68788-7833	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20210105		ANDA	ANDA204072	Preferred Pharmaceuticals Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7834_187ab27a-3c0d-4a69-b1d6-4c7a3ad80107	68788-7834	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20210113		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68788-7835_f33f3617-375c-4d2b-80f7-119265552514	68788-7835	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20210118		ANDA	ANDA040419	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68788-7840_db899a8e-3256-4f7e-a845-0c9d871d55af	68788-7840	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20210118		ANDA	ANDA205101	Preferred Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7841_7d9f9912-affb-425b-a3a7-6e66044b56f5	68788-7841	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20210119		OTC MONOGRAPH FINAL	part331	Preferred Pharmaceuticals Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68788-7842_759fed69-33a2-489d-bdbc-22bfe8e89522	68788-7842	HUMAN OTC DRUG	loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20210119		ANDA	ANDA091292	Preferred Pharmaceuticals Inc.	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68788-7844_1cb342e5-93b4-4627-8a3f-ca77622afd3d	68788-7844	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20210120		ANDA	ANDA065473	Preferred Pharmaceuticals Inc.	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7845_c183262b-6b36-47a8-a177-aa6530cc4e34	68788-7845	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20210120		ANDA	ANDA078212	Preferred Pharmaceuticlas Inc.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-7847_1a7e2b67-cc71-4fa1-938c-257977596e4c	68788-7847	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20210121		ANDA	ANDA205101	Preferred Pharmaceuticals Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7849_19c367ef-60c5-4324-8a11-d0e48cef8b85	68788-7849	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20210126		ANDA	ANDA210971	Preferred Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-7853_c9b914a2-0c99-4bcb-9416-a34e7c44703b	68788-7853	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20210129		ANDA	ANDA075805	Preferred Pharmaceuticals Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-7854_089b6097-a264-46f5-9395-1c321083bb29	68788-7854	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20210129		ANDA	ANDA204279	Preferred Pharmaceuticals Incl	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68788-7855_ebb92eef-c6da-45cb-bef8-73ca08fa66db	68788-7855	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET	ORAL	20210129		ANDA	ANDA090485	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68788-7856_535183dc-255d-41d6-a4a9-305fb5f1d55a	68788-7856	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210129		ANDA	ANDA204720	Preferred Pharmaceuticals Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-7859_8f613454-d719-424a-9814-93e4598773c4	68788-7859	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20210205		ANDA	ANDA040419	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
68788-7860_3e6c5e72-9df8-4a94-bdfc-09aadc8a7e82	68788-7860	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210208		ANDA	ANDA070322	Preferred Pharmaceuticals Inc.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7861_db4a1770-19a0-4c16-9eee-2185bb83e341	68788-7861	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	SYRUP	ORAL	20210208		ANDA	ANDA088811	Preferred Pharmaceuticals Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68788-7862_396fe458-7cac-4050-89b8-6d7f89199fd5	68788-7862	HUMAN OTC DRUG	ASPIRIN LOW DOSE		Aspirin	TABLET, COATED	ORAL	20210208		OTC MONOGRAPH FINAL	part343	Preferred Pharmaceuticals Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68788-7864_68389c6b-d37b-4c3f-9023-425d6df0cdf3	68788-7864	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA076558	Preferred Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-7865_b3702979-80b0-4ca0-8367-f3a121de612e	68788-7865	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20210212		ANDA	ANDA086724	Preferred Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-7866_2cafffd2-984b-490c-b9ee-c6dc0eefd01c	68788-7866	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20210215		ANDA	ANDA078069	Preferred Pharmaceuticals Inc.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7870_669b9ff2-34e1-42ad-abc2-e3f9e81ed64c	68788-7870	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA208783	Preferred Pharmaceuticals Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68788-7873_a0a09bcd-2b4e-4a65-a9ee-a255ee423ffa	68788-7873	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20210219		OTC MONOGRAPH FINAL	part336	Preferred Pharmaceuticals Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68788-7874_52f97ead-1668-46e0-b3f2-987738c81f83	68788-7874	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210308		ANDA	ANDA090548	Preferred Pharmaceuticals Inc	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7876_8eaa23b0-7eb5-44f0-b898-aa7d1fc9fffb	68788-7876	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20210308		ANDA	ANDA078512	Preferred Pharmaceuticals Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7877_ff5cd762-d2d0-4696-9d0e-341b761c3db3	68788-7877	HUMAN PRESCRIPTION DRUG	FOLIC ACID		FOLIC ACID	TABLET	ORAL	20210308		ANDA	ANDA040796	Preferred Pharmaceuticals Inc.	FOLIC ACID	1	mg/1			N	20241231
68788-7879_de58415a-b480-4aeb-afc9-e666d5617b21	68788-7879	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20210308		ANDA	ANDA202659	Preferred Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68788-7880_69b65bd6-50bd-4ce5-9373-36fc248041b4	68788-7880	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20210308		ANDA	ANDA206069	Preferred Pharmaceuticals Inc.	ARMODAFINIL	150	mg/1		CIV	N	20241231
68788-7884_8be0902e-b902-41dd-a9ef-e8f4f5c7d287	68788-7884	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20210329		ANDA	ANDA090515	Preferred Pharmaceuticals, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-7886_355e2e5b-b1b5-44af-9286-e6ca0dec2e93	68788-7886	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20210416		ANDA	ANDA040596	Preferred Pharmaceuticals Inc.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68788-7890_44f01bc9-0559-4cbd-9313-81b7916d6e8a	68788-7890	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210423		OTC MONOGRAPH FINAL	part332	Preferred Pharmaceuticals Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
68788-7891_90993cb1-48af-44f4-8ede-e15bbf6456a8	68788-7891	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210423		ANDA	ANDA212277	Preferred Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-7893_da5d9f41-149f-4f60-96fa-74613d7d8c12	68788-7893	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20210426		ANDA	ANDA071251	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-7894_0a0dfc04-3b40-4839-bc44-ac84c366cf91	68788-7894	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20210429		ANDA	ANDA200494	Preferred Pharmaceuticals Inc						N	20241231
68788-7895_1899ecfe-afda-47df-a28c-7025b4be7e3f	68788-7895	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20210429		ANDA	ANDA077309	Preferred Pharmaceuticals Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-7897_a6ae9d16-605d-470c-bc9a-52b4d545fe61	68788-7897	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20210514		ANDA	ANDA203088	Preferred Pharmaceuticals Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-7899_b7089293-b899-484d-bbc1-4ba3bf923da3	68788-7899	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20210514		ANDA	ANDA077534	Preferred Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7900_60c1f2ee-fdff-4abf-ada2-b9c397c55fc4	68788-7900	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20210514		ANDA	ANDA209288	Preferred Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7901_7a56529d-adf5-4db7-9433-8acd3c0813cb	68788-7901	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20210514		ANDA	ANDA203769	Preferred Pharmaceuticals Inc	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-7902_f733174f-9a2d-4089-8fa0-c27003c7faad	68788-7902	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20210514		UNAPPROVED DRUG OTHER		Preferred Pharmaceuticals Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
68788-7903_75bee46f-9d62-4821-adc0-c3077afbb45e	68788-7903	HUMAN PRESCRIPTION DRUG	Zolpidem tartrate		Zolpidem tartrate	TABLET, EXTENDED RELEASE	ORAL	20210514		ANDA	ANDA090107	Preferred Pharmaceuticals Inc.	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68788-7904_27ce1925-bacb-4464-a4fc-38bc448e7878	68788-7904	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20210514		ANDA	ANDA077921	Preferred Pharmaceuticals Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7905_7e34396c-570e-4db0-91f2-3886424bc1f8	68788-7905	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20210518		ANDA	ANDA076558	Preferred Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-7906_a6e3706f-bcac-43d9-8cf9-567ab3884997	68788-7906	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20210518		ANDA	ANDA205008	Preferred Pharmaceuticals Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68788-7909_1de94bdf-cc07-4433-b48d-e47aca6ca2bf	68788-7909	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20210518		ANDA	ANDA204597	Preferred Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7910_812a2f68-9c5a-4448-946a-77db8215000a	68788-7910	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20220412		ANDA	ANDA078251	Preferred Pharmaceuticals Inc.,	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7911_6ee6076b-5957-45cd-9c5c-f612ed75665d	68788-7911	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210518		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7912_5f19b7b0-a4ab-405f-a017-2e468cb6db50	68788-7912	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20210518		ANDA	ANDA202389	Preferred Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7917_df16c16f-8de0-4edc-9242-4e3eed2321ea	68788-7917	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20210527		ANDA	ANDA074164	Preferred Pharmaceuticals Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-7919_6ea92e7b-a870-44a9-862c-c6a8b06991ef	68788-7919	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210614		ANDA	ANDA200834	Preferred Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-7922_c2bfe453-e0a6-4f85-9145-2f8e2e3ca733	68788-7922	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20210614		ANDA	ANDA075805	Preferred Pharmaceuticals Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-7923_081019f7-9011-438f-a7df-34d87dcb77ec	68788-7923	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20210614		ANDA	ANDA075382	Preferred Pharmaceuticals Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-7925_4d86001b-82d6-4e65-a2ed-6bd2a87e557c	68788-7925	HUMAN OTC DRUG	Methyl Salicylate		Methyl Salicylate	CREAM	TOPICAL	20210813		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals Inc.	METHYL SALICYLATE	250	mg/g			N	20241231
68788-7928_18c5a1e9-f709-44b0-930e-569111b0a5e6	68788-7928	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210614		ANDA	ANDA202825	Preferred Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-7929_1e1c21d0-0258-40ca-9f5b-2376582f4e90	68788-7929	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210615		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7930_af079ff8-1b9f-4677-b275-40f571041737	68788-7930	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20210615		ANDA	ANDA070184	Preferred Pharmaceuticals Inc.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
68788-7932_1a02e10f-117f-453b-bf91-a42fded4dac9	68788-7932	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20210615		ANDA	ANDA202856	Preferred Pharmaceuticals Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68788-7933_c23aa91f-b0c8-4559-9df8-833e5956bf43	68788-7933	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20210615		ANDA	ANDA065136	Preferred Pharmaceuticals Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-7934_e09ab3c1-d858-43d3-938c-ccb18b9c5043	68788-7934	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20210615		ANDA	ANDA203646	Preferred Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-7935_ad65c260-197e-4345-9055-5ae4fa06d0c9	68788-7935	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20210615		ANDA	ANDA208706	Preferred Pharmaceuticals Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-7938_4cb17467-13d8-4c90-9afe-4f67878cd5fa	68788-7938	HUMAN PRESCRIPTION DRUG	cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20210616		ANDA	ANDA065234	Preferred Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7942_4a2100d7-2af6-4bbb-9cd9-85088345ae07	68788-7942	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210628		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7943_4a2100d7-2af6-4bbb-9cd9-85088345ae07	68788-7943	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210628		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7944_552ce1fa-7683-470c-914c-9c608892e75e	68788-7944	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210628		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7945_4a2100d7-2af6-4bbb-9cd9-85088345ae07	68788-7945	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210628		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7946_e029d00f-d267-4529-9a97-bd3538fc64fe	68788-7946	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210628		ANDA	ANDA212517	Preferred Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7947_4f0aad5d-1b09-4db5-a190-f7e7bb45e177	68788-7947	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20210629		ANDA	ANDA206465	Preferred Pharmaceuticals Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7949_d82065e0-0df4-4aeb-a281-2a1fd4fa6ef8	68788-7949	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20210708		ANDA	ANDA064022	Preferred Pharmaceuticals Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68788-7950_44678f7b-2185-44ca-a1c3-9f77881b41f2	68788-7950	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20210708		ANDA	ANDA201190	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7952_8efbb2a3-8549-4ab1-9fcc-15875e7237ad	68788-7952	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210709		ANDA	ANDA210907	Preferred Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
68788-7953_08fd9a60-213e-466a-8730-46dc333cedf2	68788-7953	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210709		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7954_33c297b0-4a28-4cc1-ab67-3ce7a6b95ffc	68788-7954	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210709		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7958_e6eb4cfa-12a1-4888-b0ed-fc2650843cce	68788-7958	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20210719		ANDA	ANDA065063	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-7959_25efdfe8-826c-449e-97a5-8dbffeb583d3	68788-7959	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210719		ANDA	ANDA077253	Preferred Pharmaceuticals Inc., USA	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68788-7960_b0ffe826-92ff-4e1a-854b-142c672e9059	68788-7960	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20210719		ANDA	ANDA201190	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-7961_de14c74e-414e-44da-a4bf-481c38c9d1f7	68788-7961	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20210716		ANDA	ANDA040197	Preferred Pharmaceuticals Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68788-7962_b1fe2196-547b-4023-9c0b-768b663efc97	68788-7962	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20210719		ANDA	ANDA212196	Preferred Pharmaceuticals Inc.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-7963_59038817-adeb-4749-a2ea-43fa09c77d5a	68788-7963	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment, 0.05%	OINTMENT	TOPICAL	20210719		ANDA	ANDA211295	Preferred Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-7964_d58aa377-a202-474b-b64d-44509b805e44	68788-7964	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210720		ANDA	ANDA214603	Preferred Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
68788-7965_65b788c9-2cbb-4bfe-97a6-8942a2bace1b	68788-7965	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA065064	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20251231
68788-7967_9f348283-85fb-4fa5-b194-e30f7e3c0a02	68788-7967	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20210720		ANDA	ANDA075657	Preferred Pharmaceuticals Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-7968_92db0ea3-1a0f-42e3-82e9-b5f71f70189a	68788-7968	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210720		ANDA	ANDA210907	Preferred Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
68788-7969_9af6d07b-7fb3-48b2-9681-aa5a09dcb46a	68788-7969	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20210728		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-7971_7ea49369-2878-4f77-aaad-bf7d1cb24407	68788-7971	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20210721		ANDA	ANDA206434	Preferred Pharmaceuticals Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7972_11786ed0-7f96-4c2a-8deb-ed27f9d8376f	68788-7972	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20210728		ANDA	ANDA205019	Preferred Pharmaceuticals Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
68788-7973_3b72f17b-9c55-42ff-8c3b-df47535be470	68788-7973	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20210728		ANDA	ANDA040489	Preferred Pharmaceuticals, Inc	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-7974_e30a4fd2-902e-48e7-8b2f-bd07ac046e16	68788-7974	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20210728		ANDA	ANDA210394	Preferred Pharmaceuticals Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68788-7979_b9f9361f-bc19-4149-8bc2-dbd2b2de12a3	68788-7979	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20210728		ANDA	ANDA204991	Preferred Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-7980_d9851aa7-a1d7-483e-b83f-bfc45638dd00	68788-7980	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Preferred Pharmaceuticals Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-7981_d2fb7834-8b32-4d3c-9421-a944a41f0321	68788-7981	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20210728		UNAPPROVED DRUG OTHER		Preferred Pharmaceuticals Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
68788-7982_7a562594-c818-445c-a456-131c699b97b7	68788-7982	HUMAN OTC DRUG	Meclizine HCL 25 mg		Meclizine HCL	TABLET	ORAL	20210728		OTC MONOGRAPH FINAL	part336	Preferred Pharmaceuticals Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68788-7983_668d9d13-6cb2-472b-a2fa-964294f7ba9d	68788-7983	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA072096	Preferred Pharmaceuticals Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7984_10cc1fb4-65ee-4370-b8cd-4b025a6865ee	68788-7984	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20210805		ANDA	ANDA210602	Preferred Pharmaceuticals Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-7985_70bfe4da-e246-4ec7-8709-61e8bf9dffb9	68788-7985	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20210806		ANDA	ANDA078925	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-7987_a5d88471-92f1-4e3a-a690-c39ed5157cf5	68788-7987	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210806		ANDA	ANDA210220	Preferred Pharmaceuticals Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-7988_a2f75478-729b-4a9f-9cec-0f3daf8bdadc	68788-7988	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20210806		ANDA	ANDA076143	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-7990_2fb7ac0f-980a-4a48-bca5-3c64ffba0ba2	68788-7990	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20210806		ANDA	ANDA208767	Preferred Pharmaceuticals Inc	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68788-7991_a6badcda-77d2-46d3-965a-39c01f2f2015	68788-7991	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210806		ANDA	ANDA076286	Preferred Pharmaceuticals Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-7992_c0d1f778-84d9-4e1a-9d0e-c69ef4fb15be	68788-7992	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20210806		ANDA	ANDA210497	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-7993_81dd4010-3672-4ad8-9f32-812480226310	68788-7993	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20210809		ANDA	ANDA065170	Preferred Pharmaceuticals Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
68788-7994_bd63d0b9-5a79-4540-a12e-d3572d8a5272	68788-7994	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Allergy		Diphenhydramine Hydrochloride	SOLUTION	ORAL	20210809		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-7995_eb9af565-8a75-4d4d-94d7-d2d23faf62d7	68788-7995	HUMAN OTC DRUG	FIBER THERAPY		methylcellulose	POWDER, FOR SOLUTION	ORAL	20210809		OTC MONOGRAPH NOT FINAL	part334	Preferred Pharmaceuticals Inc.	METHYLCELLULOSE (4000 MPA.S)	2	g/19g			N	20241231
68788-7997_3b93ee74-6b0a-454f-92ea-364037bfdf3b	68788-7997	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210810		ANDA	ANDA203894	Preferred Pharmaceuticals Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-7998_94c3a387-12ad-4800-9d0f-84c8c6a9a93b	68788-7998	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20210810		ANDA	ANDA205707	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-7999_6ff46ded-0e89-474b-a90a-5b5933b51aef	68788-7999	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		lidocaine hydrochloride	SOLUTION	TOPICAL	20210806		ANDA	ANDA087872	Preferred Pharmaceuticals Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-8000_30a866a9-f7a7-40f9-96d6-e5686512b207	68788-8000	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20210810		ANDA	ANDA065066	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8061_ad56491f-ac93-4191-9d4e-042943451fbd	68788-8061	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20210813		ANDA	ANDA075483	Preferred Pharmaceuticals Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-8062_d28ea6e9-e5af-4384-af05-a8b9d7f56644	68788-8062	HUMAN PRESCRIPTION DRUG	cefdinir		cefdinir	POWDER, FOR SUSPENSION	ORAL	20210813		ANDA	ANDA210534	Preferred Pharmaceuticals Inc.	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-8064_4322dcac-90b2-4d70-b3a9-0d716983ab8c	68788-8064	HUMAN OTC DRUG	Methyl Salicylate		Methyl Salicylate	PATCH	TOPICAL	20210816		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals Inc.	METHYL SALICYLATE	10	g/100g			N	20241231
68788-8066_0b0478bb-f82e-4d9c-8ed7-58a8e7c696f8	68788-8066	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20210816		ANDA	ANDA078181	Preferred Pharmaceuticals Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8068_13a3e429-19fe-4a3e-af4e-00f6aa40101f	68788-8068	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210823		ANDA	ANDA212277	Preferred Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-8069_4104232b-6aaa-4cc4-ae87-567f5c63f1dc	68788-8069	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210823		ANDA	ANDA203894	Preferred Pharmaceuticals Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8070_69068071-af12-4af0-b6ce-db3a2cc6a5a4	68788-8070	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20210823		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
68788-8072_29d04893-4075-49ec-b3e7-73435fbffa36	68788-8072	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20210827		ANDA	ANDA212277	Preferred Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-8074_7dfcf237-2a14-4e9d-9edf-f2ee8dd25783	68788-8074	HUMAN PRESCRIPTION DRUG	SSD Cream		Silver Sulfadiazine	CREAM	TOPICAL	20210827		NDA	NDA018578	Preferred Pharmaceuticals Inc.	SILVER SULFADIAZINE	10	g/1000g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
68788-8075_7ecf75df-6453-4df7-86df-8375875ed082	68788-8075	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20210827		ANDA	ANDA204058	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8077_fd831539-c8e1-463e-abd6-af6647c99dc5	68788-8077	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20210903		ANDA	ANDA091166	Preferred Pharmaceuticals Inc. USA	ESZOPICLONE	2	mg/1		CIV	N	20241231
68788-8078_0ac2c31f-4781-48fc-b941-20b1c106fe7c	68788-8078	HUMAN OTC DRUG	hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20210903		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals Inc.	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8079_cbb62785-0f16-42d9-8b8b-0c4fdeb7fd9d	68788-8079	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20210903		ANDA	ANDA078963	Preferred Pharmaceuticals Inc.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
68788-8080_1fa34928-3f90-412d-af5c-fcc93550f468	68788-8080	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20211005		ANDA	ANDA091368	Preferred Pharmaceuticals Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-8081_8225fd87-6b4e-4c84-8c32-e956fd73d096	68788-8081	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20211005		ANDA	ANDA071457	Preferred Pharmaceuticals Inc.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8084_fbc5a375-6159-46fa-9377-0b9f9384ca60	68788-8084	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium 1.5%		Diclofenac Sodium Topical	SOLUTION	TOPICAL	20211005		ANDA	ANDA204132	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8086_c075a410-5095-4410-9924-ba3b3b9171a2	68788-8086	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20211005		ANDA	ANDA210907	Preferred Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
68788-8087_9ab2b672-be92-4652-b711-48ff95cdb6d7	68788-8087	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20211005		ANDA	ANDA040901	Preferred Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68788-8089_3773d251-15f1-4fac-bf11-53452baf7d12	68788-8089	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20211005		ANDA	ANDA207105	Preferred Pharmaceuticals Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-8090_a01e2557-025a-4759-8bd7-d027d823bddd	68788-8090	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20211006		ANDA	ANDA213413	Preferred Pharmaceuticals Inc.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
68788-8091_47a86774-e854-4fcc-85d7-5b651b7ca7e6	68788-8091	HUMAN OTC DRUG	RUGBY ANTIFUNGAL CLOTRIMAZOLE		CLOTRIMAZOLE	CREAM	TOPICAL	20211005		OTC MONOGRAPH FINAL	part333C	Preferred Pharmaceuticals Inc.	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-8092_495d6038-043e-4ce4-a280-79c1dcf7b54e	68788-8092	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20211005		ANDA	ANDA091240	Preferred Pharmaceuticals, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8094_2f2f742e-55ea-435a-8f86-e3350e942f66	68788-8094	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20211006		ANDA	ANDA211933	Preferred Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8095_0a11a287-52a6-4163-b1f9-6d424d7fcb70	68788-8095	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20211006		ANDA	ANDA078181	Preferred Pharmaceuticals Inc.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8096_7d37f656-9cfe-4d85-8998-5652b74f5779	68788-8096	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20211006		ANDA	ANDA075483	Preferred Pharmaceuticals Inc.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-8098_4f6273fa-5419-4524-85b9-abe9eff599d3	68788-8098	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20211006		ANDA	ANDA203894	Preferred Pharmaceuticals Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8099_5f41caa4-4f82-4bbf-a39b-60b0076f59b2	68788-8099	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20211006		ANDA	ANDA202843	Preferred Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68788-8100_506173b9-9487-4d9c-addf-ad9d4149d714	68788-8100	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution		Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution	SOLUTION	ORAL	20211008		ANDA	ANDA040649	Preferred Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68788-8102_9db15672-9009-49cb-8070-5767cd79c154	68788-8102	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20211014		OTC MONOGRAPH DRUG	333B	Preferred Pharmaceuticals Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-8103_1b96f8fe-35cf-4441-aee7-6a0a22eee112	68788-8103	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20211014		ANDA	ANDA076749	Preferred Pharmaceuticals Inc.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	3; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68788-8104_dd215a05-ffe6-4ad2-8409-f72f3c95052e	68788-8104	HUMAN OTC DRUG	Geri-Dryl allergy relief		Diphenhydramine HCl	TABLET, COATED	ORAL	20211021		OTC MONOGRAPH FINAL	part336	Preferred Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8105_d1c68847-dbaa-4ae2-85f3-10b36192ddf7	68788-8105	HUMAN PRESCRIPTION DRUG	Fluocinonide Cream		Fluocinonide	CREAM	TOPICAL	20211103		ANDA	ANDA210554	Preferred Pharmaceuticals Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8106_ca89504a-6242-4472-923b-e6d3ede2df87	68788-8106	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20211103		ANDA	ANDA204598	Preferred Pharmaceuticals, Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
68788-8107_e76d58ca-e436-4e3a-b429-95486caf5423	68788-8107	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	20211103		OTC MONOGRAPH FINAL	part333C	Preferred Pharmaceuticals Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-8109_a8162fd6-3cf1-4c23-b4dc-a5e72a2e53c8	68788-8109	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20211203		ANDA	ANDA202825	Preferred Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-8110_6f72b1ac-c66c-4a9c-a28e-5a1f7398abc2	68788-8110	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20211203		ANDA	ANDA203769	Preferred Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8111_2bcf26b3-1912-4b24-be10-d78416e03e27	68788-8111	HUMAN PRESCRIPTION DRUG	Hydroxyzine pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20211203		ANDA	ANDA086183	Preferred Pharmaceuticals Inc.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68788-8112_fd788af4-a4b5-4ad6-ba31-604acac081d9	68788-8112	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	20211206		ANDA	ANDA040159	Preferred Pharmaceuticals Inc.	MEDROXYPROGESTERONE ACETATE	5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68788-8115_58fabf70-c5a2-482c-8352-897d476a239e	68788-8115	HUMAN PRESCRIPTION DRUG	cefdinir		cefdinir	POWDER, FOR SUSPENSION	ORAL	20211207		ANDA	ANDA210534	Preferred Pharmaceuticals Inc.	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-8117_7cd9fb7f-814c-4a87-9f24-44a82654b97b	68788-8117	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20211210		ANDA	ANDA091240	Preferred Pharmaceuticals, Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8118_65c9dd36-b55c-4431-9d38-e9d6cc978bea	68788-8118	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20211210	20260330	ANDA	ANDA213592	Preferred Pharmaceuticals Inc.	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	
68788-8119_1bcc59f7-7551-4b25-9d31-5a13e5a98f81	68788-8119	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20211213		ANDA	ANDA087479	Preferred Pharmaceuticals Inc.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
68788-8121_12b13df9-610e-4714-adbd-415d89ce746c	68788-8121	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20220105		ANDA	ANDA208708	Preferred Pharmaceuticals Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68788-8122_ae87aa7e-b3b3-4e2c-ba5a-562371b58cc3	68788-8122	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20220110		ANDA	ANDA209421	Preferred Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68788-8123_361dee37-4de9-4343-9484-8ba84dbb9d0a	68788-8123	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	FOR SUSPENSION	ORAL	20220110		ANDA	ANDA212784	Preferred Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68788-8127_c24a9ef9-d836-485d-95a9-cc87294e7dc0	68788-8127	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20220117		ANDA	ANDA040682	Preferred Pharmaceuticals Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68788-8129_5dfa5551-8dbb-4892-a1f8-036d26a99662	68788-8129	HUMAN PRESCRIPTION DRUG	Lidothol		LIDOCAINE HCl, MENTHOL	GEL	TOPICAL	20220203		UNAPPROVED DRUG OTHER		Preferred Pharmaceuticals Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4.5; 5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-8130_e2814386-5b78-45d8-8dc2-398dc77ccbb3	68788-8130	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		neomycin sulfate, polymyxin b sulfate and hydrocortisone	SUSPENSION	AURICULAR (OTIC)	20220203		ANDA	ANDA062488	Preferred Pharmaceuticals Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-8131_c1e8d01f-577e-4a31-a121-f4e53c3d43af	68788-8131	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20220204		ANDA	ANDA211977	Preferred Pharmaceuticals, Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8133_ac6d2900-ffec-4218-8d8b-fcfbc8d3f781	68788-8133	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20220203		ANDA	ANDA081297	Preferred Pharmaceuticals Inc..	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68788-8135_4060a23e-c633-4e02-9522-ec844221212b	68788-8135	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220203		ANDA	ANDA079170	Preferred Pharmaceuticals Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8136_8413e0fa-b71d-4ed2-b2c2-34e305244f7b	68788-8136	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20220203		ANDA	ANDA077859	Preferred Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-8137_6beb0447-2292-4320-8e3f-b4fc79873abf	68788-8137	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20220211		ANDA	ANDA209587	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
68788-8138_9e4ae4bc-580d-4dde-9b32-3ca7d472cdca	68788-8138	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20220211		ANDA	ANDA074223	Preferred Pharmaceuticals Inc..	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8140_480bf283-fa06-42f2-9cff-2d7ca9afebfc	68788-8140	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220211		ANDA	ANDA200834	Preferred Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-8141_6c540df9-b063-46c7-9321-763225b8f3d3	68788-8141	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20220211		ANDA	ANDA209335	Preferred Pharmaceuticals Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
68788-8142_40e7b36f-b258-4381-96d1-9d7176c43df9	68788-8142	HUMAN OTC DRUG	Tussin Multi Symptom Cold CF	Adult	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20220901		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68788-8143_ef0b6ebd-071e-4f42-85d4-b97dbe097268	68788-8143	HUMAN OTC DRUG	Siltussin DM DAS Cough Formula		Guaifenesin and Dextromethorphan Hydrobromide	LIQUID	ORAL	20230921	20240330	OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
68788-8144_46408bd0-e906-4272-b9ed-afb019d911e1	68788-8144	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20220215		ANDA	ANDA214608	Preferred Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-8145_47b55346-82a8-4df4-9bf8-f40ea7048fd3	68788-8145	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20220222		ANDA	ANDA090554	Preferred Pharmaceuticals Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68788-8147_164dcc67-7173-460f-a7f7-6d6bd9b96149	68788-8147	HUMAN OTC DRUG	Tussin Multi Symptom Cold CF	Adult	Dextromethorphan HBr, Guaifenesin, Phenylephrine	LIQUID	ORAL	20220901		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68788-8148_d6bddd8c-7577-4c50-9d2a-97beb43ca297	68788-8148	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220303		ANDA	ANDA072096	Preferred Pharmaceuticals Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8149_3d1afde8-fc64-48c1-a95e-6db993c6452c	68788-8149	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20220304		ANDA	ANDA074754	Preferred Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8150_69fed044-a6b8-40a7-9ba1-7fb10435ca74	68788-8150	HUMAN PRESCRIPTION DRUG	Lidocaine and Prilocaine		lidocaine and prilocaine	CREAM	TOPICAL	20030818		ANDA	ANDA076453	Preferred Pharmaceuticals Inc.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
68788-8151_b0f5bca1-d0d1-4d77-92b5-7872daa01e63	68788-8151	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20220304		ANDA	ANDA078251	Preferred Pharmaceuticals Inc.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8152_b068d3f0-5361-41fd-abfd-d6a3dd70382e	68788-8152	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20220314		ANDA	ANDA064120	Preferred Pharmaceuticals Inc.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-8153_e5b99a0c-aab1-458e-ab34-406bc9294125	68788-8153	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20220314		ANDA	ANDA209167	Preferred Pharmaceuticals Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68788-8156_66409998-481a-4906-bcfd-2190a12dfade	68788-8156	HUMAN PRESCRIPTION DRUG	NYSTATIN AND TRIAMCINOLONE ACETONIDE		nystatin, triamcinolone acetonide	CREAM	TOPICAL	20220317		ANDA	ANDA208479	Preferred Pharmaceuticals Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68788-8157_337f637f-f388-4146-ae24-e976130fc94c	68788-8157	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	SUSPENSION	ORAL	20220317		ANDA	ANDA065358	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8158_92d01c07-af13-48c1-8eec-f2044af0496d	68788-8158	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220324		ANDA	ANDA073556	Preferred Pharmaceuticals Inc.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-8159_85199d07-1e48-462a-ab6e-99d3c691f091	68788-8159	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20220324		ANDA	ANDA204058	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8160_d452cfb2-7bda-45a8-ad5d-a3f754d08477	68788-8160	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20220401		ANDA	ANDA211977	Preferred Pharmaceuticals, Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8162_bcef1943-a118-49e5-93ca-637551cd71ec	68788-8162	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SOLUTION	ORAL	20220404		ANDA	ANDA040643	Preferred Pharmaceuticals Inc.	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
68788-8163_62cbc29d-8a44-47e0-8ed6-b81f0237558c	68788-8163	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20220404		ANDA	ANDA091368	Preferred Pharmaceuticals Inc.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-8164_ca07b9ff-53d7-42c4-8356-a65f497a3af3	68788-8164	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20220404		ANDA	ANDA210614	Preferred Pharmaceuticals Inc.	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-8166_0e81640f-f171-44f3-bfbd-0f2c1d7c14df	68788-8166	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220408		ANDA	ANDA208412	Preferred Pharmaceuticals Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8167_4287a8d2-795f-46a6-a02c-498b829f8474	68788-8167	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20220408		ANDA	ANDA078643	Preferred Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-8168_80b2982c-965b-4b07-a70c-4956908f577a	68788-8168	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20220408		ANDA	ANDA077183	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-8169_27848ae0-3b2f-4bfe-8856-4b8de419091e	68788-8169	HUMAN OTC DRUG	GERI-LANTA ANTACID ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20220711		OTC MONOGRAPH FINAL	part331	Preferred Pharmaceuticals Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68788-8170_ac3b65e6-95fe-49a7-88e0-ed60b37ef737	68788-8170	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20220411		ANDA	ANDA076479	Preferred Pharmaceuticals Inc.	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-8171_462d6fa8-b4c5-44cc-a2fd-ad7eb7b9ddcb	68788-8171	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20220425		ANDA	ANDA075614	Preferred Pharmaceuticals Inc.	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-8172_8a381378-265e-40b4-9059-bca4b582b46b	68788-8172	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20220425		ANDA	ANDA209312	Preferred Pharmaceuticals Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-8173_8b307e95-2148-4676-b7b2-eb3fc58f903a	68788-8173	HUMAN PRESCRIPTION DRUG	CHLORHEXIDINE GLUCONATE		CHLORHEXIDINE GLUCONATE	RINSE	ORAL	20220427		ANDA	ANDA074522	Preferred Pharmaceuticals Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
68788-8174_6fdc1425-1760-41f3-9ee0-d456e583142e	68788-8174	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20220427		ANDA	ANDA076005	Preferred Pharmaceuticals Inc.	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-8175_63041617-af15-425b-b2f4-9f2828e12bcf	68788-8175	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	TABLET	ORAL	20220427		ANDA	ANDA075902	Preferred Pharmaceuticals Inc.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-8176_72974a87-1f1a-43bd-8655-906e00f15225	68788-8176	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20220427		ANDA	ANDA075360	Preferred Pharmaceuticals Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8177_a6567980-c9d2-4fc9-9305-98edc520e018	68788-8177	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20220428		ANDA	ANDA078165	Preferred Pharmaceuticals Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8178_bc2a6389-9fd7-47e1-b265-8c5c98d624d4	68788-8178	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20220428		ANDA	ANDA076513	Preferred Pharmaceuticals Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-8179_6407766f-9b68-4644-ad7f-b624435a3c7e	68788-8179	HUMAN PRESCRIPTION DRUG	Accucaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION	20230301		UNAPPROVED DRUG OTHER		Preferred Pharmaceuticals Inc..	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-8183_77f8fb47-525c-4061-9f13-fcbb42aaaffa	68788-8183	HUMAN PRESCRIPTION DRUG	ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20220429		ANDA	ANDA202413	Preferred Pharmaceuticals Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8184_e3e5f077-a164-48f1-b95f-c6ab39585bcf	68788-8184	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220506		ANDA	ANDA209727	Preferred Pharmaceuticals Inc.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8185_e4a77e1e-6d02-4b36-9075-4167b52b274a	68788-8185	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20220506		ANDA	ANDA202050	Preferred Pharmaceuticals Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-8186_887d116e-38cf-4769-9683-e1780624288b	68788-8186	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220506		ANDA	ANDA091497	Preferred Pharmaceuticals Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68788-8187_26cd3105-f1bd-4a64-aabc-bbf98fae4ed0	68788-8187	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220510		ANDA	ANDA204901	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8188_c1c4d97c-4870-4fc6-bd4c-27498dc9d986	68788-8188	HUMAN OTC DRUG	childrens cetirizine hydrochloride		Cetirizine HCl	SOLUTION	ORAL	20220513		ANDA	ANDA204226	Preferred Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8189_e4aecef2-0fa1-41b7-b0a0-36123c90392c	68788-8189	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20220513		ANDA	ANDA091497	Preferred Pharmaceuticals Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68788-8190_ff387c79-28f2-472e-bb5c-66dee28d316d	68788-8190	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET, FILM COATED	ORAL	20220516		ANDA	ANDA202925	Preferred Pharmaceuticals Inc.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
68788-8191_10062554-ea10-484d-9088-51e6f773bdd7	68788-8191	HUMAN OTC DRUG	childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20230419		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68788-8192_41995f7d-014d-4926-9247-9cced32516bb	68788-8192	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20220516		ANDA	ANDA074497	Preferred Pharmaceuticals, Inc.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8193_c336c770-0aec-4a50-8e06-7ca4c178e9d4	68788-8193	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20220516		ANDA	ANDA077863	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8194_0bb81549-c16d-414f-80e9-e416e6724c5b	68788-8194	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220526		ANDA	ANDA206943	Preferred Pharmaceuticals Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8195_3d3c6c74-3112-40bb-9514-5cc9b381521b	68788-8195	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20220526		ANDA	ANDA076407	Preferred Pharmaceuticals Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-8196_7073872b-7cdd-40dd-8966-c459145bf92b	68788-8196	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20220523		ANDA	ANDA214452	Preferred Pharmaceuticals Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68788-8197_3c252813-39e5-4c03-bef9-a25a253f5e77	68788-8197	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20220523		ANDA	ANDA205129	Preferred Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8198_8a35f9db-aeba-4d9c-b391-80772ca98205	68788-8198	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20220523		NDA AUTHORIZED GENERIC	NDA019992	Preferred Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-8199_4df0f5b3-a86f-48c3-a12e-c48504f55833	68788-8199	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220523		ANDA	ANDA206943	Preferred Pharmaceuticals Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8200_6c7d11ed-df40-498a-ba52-117e0b43c482	68788-8200	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20220524		ANDA	ANDA208921	Preferred Pharmaceuticals Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-8201_efe52dcf-fcb1-4037-b54f-8daa51d9b5f8	68788-8201	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220523		ANDA	ANDA071268	Preferred Pharmaceuticals Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8202_fe9b5359-b999-4dd1-9382-65884c539c1c	68788-8202	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220526		ANDA	ANDA073556	Preferred Pharmaceuticals Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-8203_ea6fb7a8-80b1-4a00-af54-e55ca13084a2	68788-8203	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20220526		ANDA	ANDA209366	Preferred Pharmaceuticals Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-8204_73122009-531b-4929-bf57-494a6fc65b73	68788-8204	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20220401		ANDA	ANDA090760	Preferred Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8205_8aacda90-5fcf-424f-bd78-573963e3bf33	68788-8205	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20220527		ANDA	ANDA078295	Preferred Pharmaceuticals Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68788-8206_d35d9494-4190-41a8-80d4-c9d877c432e9	68788-8206	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230102		ANDA	ANDA205129	Preferred Pharmaceuticals, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8207_0c7f540c-2387-4cff-90d9-d367871365ac	68788-8207	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20220602		ANDA	ANDA077739	Preferred Pharmaceuticals Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8208_0f20a41d-8a80-4e65-a138-11aaefe01b3f	68788-8208	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20220603		ANDA	ANDA090056	Preferred Pharmaceuticals Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
68788-8209_d5651caf-9083-4e55-9dfd-258ff88f0e14	68788-8209	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20220908		ANDA	ANDA065271	Preferred Phamraceuticals Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8210_768b6153-8bf6-420c-99a1-930196dfa08a	68788-8210	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA202825	Preferred Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-8212_7f7d7047-ff65-4a9a-9b06-723aabb85d2c	68788-8212	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20220607		ANDA	ANDA213386	Preferred Pharmaceuticals Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8213_5e49afbe-3944-462e-87a8-3ed1b01d25aa	68788-8213	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20220908		ANDA	ANDA209312	Preferred Pharmaceuticals Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-8214_c2e7d1d2-eafe-4647-b3c8-df56974e24e9	68788-8214	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium/Misoprostol	diclofenac-sodium-misoprostol	Diclofenac Sodium/Misoprostol	TABLET	ORAL	20220908		ANDA	ANDA204355	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
68788-8216_11d18b41-5592-4dbf-9bd6-92e3c9a355c0	68788-8216	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20220908		OTC MONOGRAPH FINAL	part333C	Preferred Pharmaceuticals Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-8217_e8052b4f-6799-4115-b7c3-719fd68d79eb	68788-8217	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20220908		ANDA	ANDA207773	Preferred Pharmaceuticals Inc	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68788-8218_326820fb-d01b-4539-a613-1dfa0c31003e	68788-8218	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20220908		ANDA	ANDA214548	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-8219_cee09eb6-0e71-46d9-957f-03e0683ef780	68788-8219	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20220909		ANDA	ANDA065061	Preferred Pharmaceuticals Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68788-8220_23b88b0c-787e-48e3-aa59-2aa146f0227c	68788-8220	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20220909		ANDA	ANDA077253	Preferred Pharmaceuticals Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68788-8221_a83675cd-146c-4fd6-a28c-591941432c0a	68788-8221	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20220909		ANDA	ANDA078643	Preferred Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-8222_d3b65dc2-6251-42d6-be03-11477dcb1598	68788-8222	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20220909		ANDA	ANDA209201	Preferred Pharmaceuticals Inc.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68788-8223_50a6ccb0-54be-4d12-b3b4-50e8c40ca64e	68788-8223	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20220912		ANDA	ANDA215106	Preferred Pharmaceuticals Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8224_0d84d665-fb95-4804-b371-4298d671bf29	68788-8224	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20220912		ANDA	ANDA076230	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8225_17b9f92d-686f-494b-aba9-2343c655e463	68788-8225	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20220912		ANDA	ANDA090295	Preferred PHarmaceuticals Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8226_0e1065e5-4e6f-4412-8799-388089d998d1	68788-8226	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20220808		ANDA	ANDA040734	Preferred Pharmaceuticals Inc.	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
68788-8227_99029603-2069-46ec-91fe-a1f311bad2cb	68788-8227	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20220808		ANDA	ANDA040734	Preferred Pharmaceuticals Inc.	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
68788-8229_56816c9e-b202-408a-bb06-b12a9ee8036c	68788-8229	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20220808		ANDA	ANDA211147	Preferred Pharmaceuticals Inc.	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68788-8230_d94dd7ab-fa4e-46e2-ab8d-d0780346f777	68788-8230	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20220808		ANDA	ANDA203974	Preferred Pharmaceuticals Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68788-8231_00b95d2f-768f-453e-a628-cf0824ddf87a	68788-8231	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20220808		ANDA	ANDA078165	Preferred Pharmaceuticals Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8232_99ed9dfa-e7ca-4457-9fa9-d270c949140a	68788-8232	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20220808		ANDA	ANDA078296	Preferred Pharmaceuticals, Inc.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8233_b6265768-42cb-449b-84a0-5e9875af94bd	68788-8233	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole Cream, 2%	CREAM	TOPICAL	20220808		ANDA	ANDA212443	Preferred Pharmaceuticals Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-8234_cd8ffc89-2ec2-4af2-b66f-bdb44be833b5	68788-8234	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin Cream	CREAM	TOPICAL	20220809		ANDA	ANDA061966	Preferred Pharmaceuticals, Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68788-8235_fefb14a4-cbf3-4d26-bca5-0a1b9d487799	68788-8235	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20220809		ANDA	ANDA090124	Preferred Pharmaceuticals, Inc.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
68788-8236_c700f5f3-3ec7-4daa-bf70-b277c97ef7fd	68788-8236	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20220809		ANDA	ANDA206298	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8237_417b16cf-5ba8-487e-a0d0-af2e783d6f1c	68788-8237	HUMAN PRESCRIPTION DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20220809		ANDA	ANDA210893	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8238_5c2a52e3-7865-4888-8b1e-4f63eb5df4e1	68788-8238	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	OINTMENT	TOPICAL	20220809		ANDA	ANDA074407	Preferred Pharmaceuticals Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8239_69b9999f-c2e5-43a6-891f-0e24d3c343a4	68788-8239	HUMAN OTC DRUG	Major Bismuth Subsalicylate		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20230406		OTC MONOGRAPH FINAL	part335	Preferred Pharmaceuticals Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68788-8240_6e9f949f-9a0a-43fb-87e3-7209fe91ae2c	68788-8240	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20220809		ANDA	ANDA065271	Preferred Pharmaceuticals Inc.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8241_89929cec-5c61-4cbc-a309-7510ebd3c230	68788-8241	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20220809		ANDA	ANDA076230	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8242_12c70429-85e8-4f67-9248-d2fa9222a384	68788-8242	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20220809		ANDA	ANDA090549	Preferred Pharmaceuticals Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8244_225342fb-cf70-4a08-be7a-14a2f0144c1f	68788-8244	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220809		ANDA	ANDA071268	Preferred Pharmaceuticals Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8245_cf3212e7-ff59-45c4-9619-f435e181623e	68788-8245	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20220818		ANDA	ANDA208136	Preferred Pharmaceuticals Inc., USA	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68788-8246_bab14a0c-b420-40e1-b622-d41931bf5a69	68788-8246	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20220825		ANDA	ANDA211147	Preferred Pharmaceuticals Inc.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68788-8247_c38da635-04c6-4629-9c7c-24c691ddc5c9	68788-8247	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	OINTMENT	TOPICAL	20220819		ANDA	ANDA205974	Preferred Pharmaceuticals Inc	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-8248_a7b04c43-642f-4460-8b63-60b33a7fad86	68788-8248	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	20220819		ANDA	ANDA064052	Preferred Pharmaceuticals Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
68788-8251_01657941-43a6-46bd-9780-7626a4dacf65	68788-8251	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20220819		ANDA	ANDA090682	Preferred Pharmaceuticals Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-8252_f8646777-b427-49f5-81fc-e3b153ed1451	68788-8252	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20220902		ANDA	ANDA077614	Preferred Pharmaceuticals Inc.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8253_fc4d7d0e-78a6-4d7e-ba53-aeeb008aa2dc	68788-8253	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20221001		ANDA	ANDA076230	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8254_8574db6d-7394-4b2a-aab5-e62f69ecc05d	68788-8254	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220902		ANDA	ANDA078154	Preferred Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8255_21c9de02-db65-4202-9ac7-d5ccb2c882c0	68788-8255	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20220902		ANDA	ANDA078889	Preferred Pharmaceuticals Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8256_82332c30-934b-472c-bf52-74a48248a473	68788-8256	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20220916		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68788-8257_b399ed86-a9fe-44b0-a480-1d7c1bbf5873	68788-8257	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	SHAMPOO, SUSPENSION	TOPICAL	20220916		ANDA	ANDA076942	Preferred Pharmaceuticals Inc.	KETOCONAZOLE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-8258_b2d4906a-1d3d-4ca9-9a95-f0913c41eff9	68788-8258	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20220916		ANDA	ANDA208516	Preferred Pharmaceuticals Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
68788-8260_239f7ac8-2a54-4e4c-95af-f74ca29dfb13	68788-8260	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20101217		ANDA	ANDA065246	Preferred Pharmaceuticals Inc.	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
68788-8261_9837d1d9-6e0f-462c-ae10-a64cf0d8e2a2	68788-8261	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20220919		ANDA	ANDA065392	Preferred Pharmaceuticals, Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-8262_ac80cc85-ba56-4839-af93-3c0d36e8b2bf	68788-8262	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220919		ANDA	ANDA210921	Preferred Pharmaceuticals Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
68788-8263_aa7e1b29-ddfa-4e61-bf1d-835dc093cbe4	68788-8263	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20220919		ANDA	ANDA078925	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-8264_cac55618-a8b1-4b57-aa11-42093a8050be	68788-8264	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	OPHTHALMIC	20220926		ANDA	ANDA078559	Preferred Pharmaceuticals, Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-8265_d48c58ff-022b-4562-9af0-69e0bf91c87c	68788-8265	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20220926		ANDA	ANDA065062	Preferred Pharmaceuticals Inc.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68788-8266_99d81f54-5853-4884-b0a1-a59e8022e7c0	68788-8266	HUMAN OTC DRUG	Childrens Loratadine		Loratadine	SOLUTION	ORAL	20220923		ANDA	ANDA076805	Preferred Pharmaceuticals Inc.	LORATADINE	5	mg/5mL			N	20241231
68788-8267_72d2c2ee-c419-4546-bb56-51f71e79597a	68788-8267	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20220923		ANDA	ANDA213385	Preferred Pharmaceuticals Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8268_b2053de0-7ff4-48ea-b230-8859cfcc98c4	68788-8268	HUMAN OTC DRUG	robafen dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220923		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68788-8269_75256e01-b443-47e7-9b38-6d59281f399a	68788-8269	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20221013		ANDA	ANDA216441	Preferred Pharmaceuticals Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-8270_d3afe782-bbc0-4021-b2af-30655651f8fc	68788-8270	HUMAN OTC DRUG	Good Sense First Aid Antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20221013		OTC MONOGRAPH DRUG	333B	Preferred Pharmaceuticals Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-8271_e145894f-8684-42fc-90fe-cdfcee583130	68788-8271	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20221013		ANDA	ANDA065096	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8272_40cd22ae-a4e3-4fd7-a90f-8b5f04c6d60f	68788-8272	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20221013		ANDA	ANDA211020	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-8274_a8cc22b2-64cc-44a1-8e5f-7caebd31870f	68788-8274	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	SOLUTION	ORAL	20221014		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8275_ed8276e9-5a50-40a0-a3e5-32a5c244cf73	68788-8275	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, COATED	ORAL	20221014		ANDA	ANDA207750	Preferred Pharmaceuticals Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68788-8276_3febad34-57c1-40cd-b600-024b20864375	68788-8276	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20221014		ANDA	ANDA206751	Preferred Pharmaceuticals Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8277_2f8935c5-0bc0-4276-916f-ce8d1267a908	68788-8277	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20230926		ANDA	ANDA090931	Preferred Pharmaceuticals Inc.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-8278_361f4e27-fa69-4128-8875-f20b5a6048cc	68788-8278	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20230713		ANDA	ANDA071268	Preferred Pharmaceuticals Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8279_597a7784-cc9f-4674-8f78-75725b89778a	68788-8279	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20221103		NDA AUTHORIZED GENERIC	NDA012827	Preferred Pharmaceuticals Inc.	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68788-8280_e1d27551-c5a5-4869-9452-70abdd88083e	68788-8280	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20221103		ANDA	ANDA078963	Preferred Pharmaceuticals Inc.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
68788-8281_8c83124c-c953-4ead-83a5-a337c57d2741	68788-8281	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20221104		ANDA	ANDA071135	Preferred Pharmaceuticals Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8282_7e94be37-0971-44b3-9857-f56330d810b6	68788-8282	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20231025		ANDA	ANDA076601	Preferred Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8283_e1ae8ffa-469a-4281-b5e3-70f9a2556792	68788-8283	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230309		ANDA	ANDA091568	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8284_408bee83-d5d6-4196-809d-6b6c4ba2ac24	68788-8284	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20221117		ANDA	ANDA075657	Preferred Pharmaceuticals Inc.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-8285_d676aebc-3a86-4f40-9aac-0498b92e2670	68788-8285	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20221117		ANDA	ANDA216441	Preferred Pharmaceuticals Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-8286_6781840f-79cf-4168-b5d2-a6f2d4120294	68788-8286	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20221129		ANDA	ANDA076805	Preferred Pharmaceuticals Inc.	LORATADINE	5	mg/5mL			N	20241231
68788-8287_8a4d54a1-a63c-4de2-a1bb-54c73880cb04	68788-8287	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20221117		ANDA	ANDA078296	Preferred Pharmaceuticals, Inc.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8288_edfe97b7-737f-45bb-b71b-e430ff2a2c9a	68788-8288	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20221129		ANDA	ANDA209207	Preferred Pharmaceuticals Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8292_f0823c0b-74b9-495b-a3a9-9ab7733264d8	68788-8292	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20221128		ANDA	ANDA209654	Preferred Pharmaceuticals Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68788-8293_5e2150d8-de93-4db4-86c5-db0c15483648	68788-8293	HUMAN PRESCRIPTION DRUG	dexamethasone		dexamethasone	TABLET	ORAL	20221129		ANDA	ANDA215106	Preferred Pharmaceuticals Inc.	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8294_e9bb28a7-0dd5-42e2-a639-b9c8c1edc98e	68788-8294	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20221129		ANDA	ANDA214129	Preferred Pharmaceuticals Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
68788-8295_277a9589-0982-4b95-ae93-3a2c6ba1b531	68788-8295	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20221129		ANDA	ANDA205229	Preferred Pharmaceuticals Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68788-8296_277a9589-0982-4b95-ae93-3a2c6ba1b531	68788-8296	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20221129		ANDA	ANDA205229	Preferred Pharmaceuticals Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
68788-8297_1baaf941-4027-4f1f-bf95-9c5d81df5061	68788-8297	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20221129		ANDA	ANDA209234	Preferred Pharmaceuticals Inc.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
68788-8298_b140ab9c-60f5-498a-a89a-6b327a589dc1	68788-8298	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20221129		ANDA	ANDA213853	Preferred Pharmaceuticals Inc.	ATORVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8299_37cc211b-4398-4c2a-a16a-d49bedb6705e	68788-8299	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	SUSPENSION	ORAL	20221129		ANDA	ANDA065373	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8300_14e95af5-5962-4c32-bc78-54f34690a40f	68788-8300	HUMAN OTC DRUG	good sense tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20221130		OTC MONOGRAPH DRUG	341	Preferred Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68788-8301_996bbea4-fee7-4ce1-a4fd-561d44632146	68788-8301	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20221130		ANDA	ANDA206401	Preferred Pharmaceuticals Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68788-8302_b441a662-9a2c-40a5-b002-c5e7672fff80	68788-8302	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20221219		ANDA	ANDA080706	Preferred Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8303_c0f389ec-a683-4555-8892-896b3165952a	68788-8303	HUMAN OTC DRUG	rugby cough syrup		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20230123		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68788-8304_fcb57fb3-bbfe-4671-8934-a0724549d673	68788-8304	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20230123		ANDA	ANDA204030	Preferred Pharmaceuticals Inc.	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8305_e25cddd4-c3a3-464a-91de-8db52b86f602	68788-8305	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20221219		ANDA	ANDA065066	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8306_471168b2-d286-44e5-add2-fa2c7e41bf90	68788-8306	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20221220		ANDA	ANDA201090	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	200; 28.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8308_fff91468-8944-4642-a23e-4162c3d94a69	68788-8308	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20221220		ANDA	ANDA065101	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8309_e5d9fc26-66bf-4250-9f1e-b2f4c8e8dd54	68788-8309	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20221220		ANDA	ANDA212544	Preferred Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68788-8310_0144e4c0-dad4-4d5e-ae57-1a2d42ef41e5	68788-8310	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20221220		ANDA	ANDA077321	Preferred Pharmaceuticals, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-8312_cb86614d-fad8-4c2d-acf0-5d928d44e72e	68788-8312	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20221220		ANDA	ANDA207465	Preferred Pharmaceuticals Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8313_03aaa74d-9bc4-4a88-8384-f7a58e9adf73	68788-8313	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20221221		ANDA	ANDA203245	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-8314_3b5ea9b4-6a5b-4ee8-b4d8-ece9b840adfd	68788-8314	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20220708		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals Inc.	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-8316_b524bb52-dbc2-45a2-a97e-430b9686f41b	68788-8316	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20221223		NDA AUTHORIZED GENERIC	NDA018333	Preferred Pharmaceuticals Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
68788-8317_76ecf6b1-a6b2-4d25-8b0a-32c9d1dda0fb	68788-8317	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20221223		ANDA	ANDA091569	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8318_bec5218f-b346-4723-93b7-606a56fff8d4	68788-8318	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20221223		ANDA	ANDA201090	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8319_0cd98946-3696-4497-b41f-7ed78fbb58cc	68788-8319	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20221223		ANDA	ANDA213794	Preferred Pharmaceuticals Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8320_9e277302-6e6c-4a95-8f25-aaff64fb0b82	68788-8320	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20230124		ANDA	ANDA213273	Preferred Pharmaceuticals Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-8321_5bae2a9b-5272-4099-8202-9c8cb7a71827	68788-8321	HUMAN PRESCRIPTION DRUG	oseltamivir phosphate		oseltamivir phosphate	POWDER, FOR SUSPENSION	ORAL	20230124		ANDA	ANDA215313	Preferred Pharmaceuticals Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
68788-8322_65f1ddd2-7b55-4cce-bed6-07e9cf29e3ae	68788-8322	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20230123		ANDA	ANDA076925	Preferred Pharmaceuticals Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8323_8787ea15-bf90-4178-9b0f-08b075f1aa3d	68788-8323	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20230123		ANDA	ANDA065264	Preferred Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-8324_573fcf4a-2b87-45d9-ac73-e1dec4fbc28b	68788-8324	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20230119		ANDA	ANDA065334	Preferred Pharmaceuticals Inc.	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8325_573fcf4a-2b87-45d9-ac73-e1dec4fbc28b	68788-8325	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20230119		ANDA	ANDA065334	Preferred Pharmaceuticals Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8326_22c9f2d8-7bcd-4415-bbc8-505720033966	68788-8326	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20230119		ANDA	ANDA078296	Preferred Pharmaceuticals, Inc.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8327_553d8c0e-6b78-4a91-8a69-8f85b1311f1c	68788-8327	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230120		ANDA	ANDA213854	Preferred Pharmaceuticals Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8328_46d2be17-cfef-4bbe-94d7-15e2b76a0192	68788-8328	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20230120		ANDA	ANDA210559	Preferred Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8329_f2cd05a6-2b8b-4731-b97b-b6677fbabbcf	68788-8329	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20230120		ANDA	ANDA206948	Preferred Pharmaceuticals Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68788-8330_80d67df3-843d-47bb-85a2-d2f26a824336	68788-8330	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20230120		ANDA	ANDA074165	Preferred Pharmaceuticals Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-8331_397fe51d-b548-4fbb-8246-5f7c3ae80e97	68788-8331	HUMAN OTC DRUG	Good Sense Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20230123		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68788-8333_784a225a-bd32-40a9-a8f5-557491aa57b9	68788-8333	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20230123		ANDA	ANDA214374	Preferred Pharmaceuticals, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68788-8334_994fca33-7720-44bf-8db8-ce561d626189	68788-8334	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20230123		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68788-8335_9900ba32-01f1-4c03-aa76-d0dfde751894	68788-8335	HUMAN OTC DRUG	Loratadine		Loratadine Oral	SOLUTION	ORAL	20230123		ANDA	ANDA208931	Preferred Pharmaceuticals Inc.	LORATADINE	5	mg/5mL			N	20241231
68788-8336_fe5e8a94-ac75-4657-a45a-1fe94dbe0d43	68788-8336	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20230406		ANDA	ANDA211518	Preferred Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68788-8337_6d2f2f76-0f2b-45c4-affe-77bd927df589	68788-8337	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230123		ANDA	ANDA204467	Preferred Pharmaceuticals Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68788-8338_c7a54ee0-80c0-4c7e-a6a3-cb60142f860c	68788-8338	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20230202		ANDA	ANDA071881	Preferred Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-8339_8b10ac1a-cf66-4efa-9abc-498b2f8a1613	68788-8339	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230202		ANDA	ANDA214548	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-8340_2a8676a9-247f-4fdb-b644-e9785d98771f	68788-8340	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20230202		ANDA	ANDA202801	Preferred Pharmaceuticals, Inc.	LEVOFLOXACIN	750	mg/1			N	20241231
68788-8341_c284c146-436b-4eea-9dca-d7d21c82778c	68788-8341	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20230210		ANDA	ANDA077870	Preferred Pharmaceuticals Inc.	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8342_3f6fad0b-0278-433f-86db-761b673a5803	68788-8342	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230203		ANDA	ANDA078103	Preferred Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8343_910b21d2-231d-4b72-9eca-d384ed4280b3	68788-8343	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20230203		ANDA	ANDA090937	Preferred Pharmaceuticals Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8344_ebc05cf9-e82b-4f7d-b5e7-3e62025ce68c	68788-8344	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20230206		ANDA	ANDA206463	Preferred Pharmaceuticals Inc.	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-8345_f14e5eb6-bc64-41eb-9c6c-1c1a1f512601	68788-8345	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20230206		ANDA	ANDA078541	Preferred Pharmaceuticals Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8346_ba6a83c4-2993-40ca-bb8f-2d6c5c3e3e26	68788-8346	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230206		ANDA	ANDA214548	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-8347_afc4f37c-660c-4130-9666-4384a89edf1a	68788-8347	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230206		ANDA	ANDA207799	Preferred Pharmaceuticals Inc.	PREGABALIN	150	mg/1		CV	N	20241231
68788-8348_067ddff0-c646-4658-bc56-6ef37b5e0003	68788-8348	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20230206		ANDA	ANDA201190	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-8349_87a5dd6d-5250-4131-a13e-7be63c80e3d2	68788-8349	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET	ORAL	20230207		ANDA	ANDA210722	Preferred Pharmaceuticals Inc.	LORATADINE	10	mg/1			N	20241231
68788-8350_df6f5944-ba12-4731-9749-9095b3570dd3	68788-8350	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20230207		ANDA	ANDA086413	Preferred Pharmaceuticals Inc	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8351_b53aee22-52c7-47b1-95fc-e5383b5e6f58	68788-8351	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230207		ANDA	ANDA077321	Preferred Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
68788-8352_799ee199-95cb-4801-9dde-1f8478b7ddab	68788-8352	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, COATED	ORAL	20230207		ANDA	ANDA065255	Preferred Pharmaceuticals Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8353_bcc23066-e9cd-47c9-ba52-85f9357b04c1	68788-8353	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20230207		ANDA	ANDA207029	Preferred Pharmaceuticals Inc.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8354_13fd4401-1821-4f2b-a44e-96aa2fa75b5c	68788-8354	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230210		ANDA	ANDA213794	Preferred Pharmaceuticals Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8355_1e14346e-1998-4ec3-a5ee-df556c07f6d0	68788-8355	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20230210		ANDA	ANDA203824	Preferred Pharmaceuticals Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-8356_8fac3d6d-0329-4ac1-8c9c-cd92a051f545	68788-8356	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20230210		ANDA	ANDA040039	Preferred Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8357_bfe3d098-a5f8-4e5d-9fa6-eac167bad3e9	68788-8357	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20230210		ANDA	ANDA076067	Preferred Pharmaceuticals Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8358_83a77f60-ed58-4fa0-a584-e6a0c767d19d	68788-8358	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20230213		ANDA	ANDA209286	Preferred Pharmaceuticals, Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
68788-8359_c2453023-a5a9-49ab-afe7-862e125a239e	68788-8359	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230201		ANDA	ANDA211685	Preferred Pharmaceuticals Inc.	PREGABALIN	100	mg/1		CV	N	20241231
68788-8360_e8e272a4-c181-4573-822b-2bb315b6ad37	68788-8360	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230201		ANDA	ANDA207799	Preferred Pharmaceuticals Inc.	PREGABALIN	100	mg/1		CV	N	20241231
68788-8361_f5265ae5-db8e-428d-90e9-5eda6a8a22bd	68788-8361	HUMAN OTC DRUG	Guaifenesin and Codeine Phosphate		Guaifenesin and Codeine Phosphate	SOLUTION	ORAL	20230201		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals Inc.	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
68788-8362_2316e81f-0341-4217-94da-9b40e182c015	68788-8362	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20230201		ANDA	ANDA203088	Preferred Pharmaceuticals Inc.	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
68788-8363_6f0c2fd1-0e0d-4f5f-80c4-266fcee09fa8	68788-8363	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230201		ANDA	ANDA214548	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-8364_7f9ad8db-ae68-4a0c-b858-1e727bc98130	68788-8364	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230201		ANDA	ANDA204467	Preferred Pharmaceuticals Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68788-8365_859c4689-f1af-46a6-9526-435d04c3e7ae	68788-8365	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	SOLUTION	ORAL	20230201		ANDA	ANDA091342	Preferred Pharmaceuticals Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68788-8366_fe20c5e1-0d5e-4ba2-9047-c582090f9ae9	68788-8366	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide	SYRUP	ORAL	20230201		ANDA	ANDA205292	Preferred Pharmaceuticals Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
68788-8367_c30f6e9e-8014-40fc-9615-a6b8654137c1	68788-8367	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20230201		ANDA	ANDA200503	Preferred Pharmaceuticals, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
68788-8368_e432e043-c019-4d58-94ca-7c1d85f5cd40	68788-8368	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20230201		ANDA	ANDA079172	Preferred Pharmaceuticals Inc.,	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8369_e73ec981-e477-4412-befd-7b807aceb32e	68788-8369	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230201		ANDA	ANDA078103	Preferred Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8370_70efd593-7f56-4f9c-8a66-247863bee8db	68788-8370	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20230201		ANDA	ANDA076477	Preferred Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8371_7d924d16-8a10-411d-be57-97c450f56de7	68788-8371	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20230201		ANDA	ANDA090939	Preferred Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-8373_cf411266-784d-4dfe-8de6-90081e3d6621	68788-8373	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230315		ANDA	ANDA084285	Preferred Pharmaceuticals Inc..	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68788-8374_23300ef2-8133-4056-9684-92b9a9192e30	68788-8374	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230224		NDA AUTHORIZED GENERIC	NDA020538	Preferred Pharmaceuticals Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68788-8375_e18294f5-8fd5-4ac6-802c-f6d257e8bee7	68788-8375	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEF		Acetaminophen	SUSPENSION	ORAL	20230224		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	500	mg/15mL			N	20241231
68788-8376_625fad5b-8817-4773-a2fc-20b662140e6e	68788-8376	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230301		ANDA	ANDA204170	Preferred Pharmaceuticals Inc.	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68788-8377_9ae38bf5-17d7-4af1-922f-b3edb1e65392	68788-8377	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20230228		ANDA	ANDA090061	Preferred Pharmaceuticals, Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
68788-8378_f9bcd976-5f25-4656-b656-2d5b33fb30b0	68788-8378	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230228		ANDA	ANDA083177	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8379_d11c1e95-fbf4-44dc-8adb-75d1042129d1	68788-8379	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20220901		ANDA	ANDA078103	Preferred Pharmaceuticals Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8380_cf03c1a1-cbd5-47dc-a5e8-70ec32b71cb1	68788-8380	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230307		ANDA	ANDA214548	Preferred Pharmaceuticals Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
68788-8381_b68235bb-0940-4810-bbf4-2a7a0881de68	68788-8381	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230228		ANDA	ANDA040750	Preferred Pharmaceuticals, Inc	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68788-8382_e36f4119-f2b5-4d7a-9180-1cbc5d5da3c2	68788-8382	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20230301		ANDA	ANDA207588	Preferred Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-8383_82c5b964-958e-4913-b9cc-9032921ae86e	68788-8383	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230301		ANDA	ANDA207799	Preferred Pharmaceuticals Inc.	PREGABALIN	50	mg/1		CV	N	20241231
68788-8384_b94b5b36-c04e-45ee-b933-59c4302f2661	68788-8384	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA208898	Preferred Pharmaceuticals Inc.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8385_898b36d6-320f-4d6c-9734-0be8363dc3d7	68788-8385	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20230301		ANDA	ANDA213273	Preferred Pharmaceuicals Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-8386_a1633e66-2ce8-42e4-8046-ac10dadfa34b	68788-8386	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	PASTE	TOPICAL	20230301		ANDA	ANDA040771	Preferred Pharmaceuticals, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8387_0102ea59-77b1-4e74-83ec-1d205563b55f	68788-8387	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA091166	Preferred Pharmaceuticals Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
68788-8388_77c958db-a255-4863-9142-cb1915aed11e	68788-8388	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20230301		ANDA	ANDA076002	Preferred Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8390_4b6d6099-17ab-4d33-a350-aa90ed27d6e7	68788-8390	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA091388	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-8391_a0da0534-b386-4c93-ae89-03b0e3325e02	68788-8391	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230301		ANDA	ANDA207799	Preferred Pharmaceuticals Inc.	PREGABALIN	75	mg/1		CV	N	20241231
68788-8392_c4c275e9-f4ac-4875-b7a9-9fec41e5ab7c	68788-8392	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230301		ANDA	ANDA078525	Preferred Pharmaeuticals Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
68788-8393_5b173bb9-3cca-44ce-9bcb-b9ecc93d3dcf	68788-8393	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	20230301		ANDA	ANDA206548	Preferred Pharmaceuticals Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68788-8394_dc130aae-4510-4de7-a750-4a144e88208d	68788-8394	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230301		ANDA	ANDA203346	PreferredPharmaceuticals Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8396_54df7353-5411-43ad-bd7b-a3d4d62c72c6	68788-8396	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20230301		ANDA	ANDA206498	Preferred Pharmaceuticals Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-8397_68e214cd-2d09-42d0-a4e9-b1b81af6be3c	68788-8397	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20230301		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68788-8399_c90e80b2-882e-4c0c-bfac-d67eb1da724d	68788-8399	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20230301		ANDA	ANDA077839	Preferred Pharmaceuticals Inc.	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68788-8400_01f1c931-c796-4834-89ba-f5971d865de9	68788-8400	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	SOLUTION/ DROPS	OPHTHALMIC	20230301		ANDA	ANDA076109	Preferred Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8401_87f362a7-cf66-4166-af51-ac2da473cf6b	68788-8401	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230321		ANDA	ANDA077856	Preferred Pharmaceuticals Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8402_ac117f50-8e67-4203-8d97-e53dd0687c20	68788-8402	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20230321		ANDA	ANDA202202	Preferred Pharmaceuticals Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
68788-8403_af64b39e-5047-4a7d-bf27-ad79c69a272a	68788-8403	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20230327		ANDA	ANDA078169	Preferred Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-8404_2da6eb80-63b0-4377-8d7b-865733ebbab1	68788-8404	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20230327		ANDA	ANDA065434	Preferred Pharmaceuticals Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-8405_6f7f4a31-99ec-45ca-84d7-0be3640d1e0b	68788-8405	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20230329		ANDA	ANDA040597	Preferred Pharmaceuticals Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
68788-8406_68f6c856-ea98-4872-b4df-a6e9e70444fc	68788-8406	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20230329		ANDA	ANDA078103	Preferred Pharmaceuticals, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8407_a00dc563-6611-46b8-ab5c-1b2c602f3c68	68788-8407	HUMAN OTC DRUG	Good Sense Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20230329		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68788-8409_7792fa71-4daa-4116-864b-c248344a6034	68788-8409	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	Preferred Pharmaceuticals Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8410_73c1d1dc-ade2-4bb4-b109-83bd63acd15c	68788-8410	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230322		ANDA	ANDA203346	Preferred Pharmaceuticals Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8412_2110eec5-949d-4718-ad6d-3629e5db8a07	68788-8412	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20230406		ANDA	ANDA075580	Preferred Pharmaceuticals Inc.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-8413_eecae5f9-a49c-4a8f-8611-d9e235087ce6	68788-8413	HUMAN OTC DRUG	MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	LIQUID	ORAL	20230406		OTC MONOGRAPH NOT FINAL	part334	Preferred Pharmaceuticals Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68788-8414_78682252-e448-4b20-b49d-27c2c70e4cb3	68788-8414	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230407		ANDA	ANDA203346	Preferred Pharmaceuticals Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8415_ea6b75ce-daf8-4dd3-bef0-89d599be8b3d	68788-8415	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230412		NDA AUTHORIZED GENERIC	NDA204623	Preferred Pharmaceuticals, Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8416_14d3b7df-d0df-4f1b-abd4-d733be7433a5	68788-8416	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20230411		ANDA	ANDA213853	Preferred Pharmaceuticals Inc.	ATORVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8417_f2c4f233-215f-4211-8278-11706288de54	68788-8417	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230410		ANDA	ANDA040907	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8419_196e24fc-3315-4366-ad40-51b7ea54b211	68788-8419	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20230411		ANDA	ANDA075673	Preferred Pharmaceuticals Inc.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8420_939dee35-3987-4ce2-9985-3751ceffa20e	68788-8420	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230413		ANDA	ANDA077856	Preferred Pharmaceuticals Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8421_095ac6fd-fdfb-4207-b15d-8e93bee378c3	68788-8421	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20230417		ANDA	ANDA077987	Preferred Pharmaceuticals Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8422_e046e0b7-f510-4318-9884-034d683864d4	68788-8422	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20230413		ANDA	ANDA075580	Preferred Pharmaceuticals Inc.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-8423_ea8d75ef-0e9b-4177-99f7-c901eb44f888	68788-8423	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate Gel USP, 1%	GEL	TOPICAL	20230413		ANDA	ANDA212438	Preferred Pharmaceuticals Inc.	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
68788-8424_7c7eafa6-5411-470c-8a45-cfbc85d3e335	68788-8424	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20230414		ANDA	ANDA018659	Preferred Pharmaceuticals Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68788-8425_095ac6fd-fdfb-4207-b15d-8e93bee378c3	68788-8425	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20230417		ANDA	ANDA077987	Preferred Pharmaceuticals Inc.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8428_31b3894a-1139-4f07-ac29-dda53844dc4b	68788-8428	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20230420		ANDA	ANDA208898	Preferred Pharmaceuticals Inc.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8429_1d139a25-9c17-4b3e-8ffd-b2d562cc00ee	68788-8429	HUMAN PRESCRIPTION DRUG	Budesonide Inhalation		Budesonide	SUSPENSION	RESPIRATORY (INHALATION)	20230424		ANDA	ANDA078404	Preferred Pharmaceuticals Inc.	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8430_62ca8af4-ff91-4bf6-b7c6-895b3b5ce8c3	68788-8430	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20230426		ANDA	ANDA090564	Preferred Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8431_6c70018b-d2f6-409e-a493-78f7e61367f4	68788-8431	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230426		ANDA	ANDA205606	Preferred Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8432_744a5cca-7863-491a-b43a-1b649791702c	68788-8432	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230427		ANDA	ANDA202759	Preferred Pharmaceuticals Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8434_54e3d636-5963-43e9-81f3-b578fddcfc7a	68788-8434	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230427		ANDA	ANDA209366	Preferred Pharmaceuticals Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-8435_14a885e5-5e75-4a18-b5bc-6aaa748712db	68788-8435	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20230427		ANDA	ANDA078343	Preferred Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8436_b76065bb-a10d-4b10-ac29-df07e88da8b1	68788-8436	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20230428		ANDA	ANDA062225	Preferred Pharmaceuticals Inc.	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68788-8437_5596ba00-4a1c-4503-99db-3a9617ed17c0	68788-8437	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20230428		ANDA	ANDA213273	Preferred Pharmaceuticals Inc.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-8438_bdc3f482-6fba-4420-9118-0f5cb7744e97	68788-8438	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230428		ANDA	ANDA213794	Preferred Pharmaceuticals Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8439_d0d6b1ac-2f3a-433b-ba2b-832be3e0f93f	68788-8439	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin Cream 5% w/w	CREAM	TOPICAL	20230605		ANDA	ANDA211303	Preferred Pharmaceuticals Inc.	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
68788-8440_963e9245-ec7a-4bf6-9fc0-80f54e3657f0	68788-8440	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20230502		ANDA	ANDA205150	Preferred Pharmaceuticals Inc.	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68788-8441_f6da5155-9c26-46bb-bc0f-ece4ea21405f	68788-8441	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20230502		ANDA	ANDA205150	Preferred Pharmaceuticals Inc.	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
68788-8442_22e5d50a-a772-4e90-82f8-b49ecdf91610	68788-8442	HUMAN PRESCRIPTION DRUG	Cryselle		Norgestrel and Ethinyl Estradiol	KIT		20230504		ANDA	ANDA075840	Preferred Pharmaceuticals Inc.						N	20241231
68788-8443_2183df53-ac90-4d43-8a5d-8421036bc4cb	68788-8443	HUMAN OTC DRUG	Good Sense Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20230510		ANDA	ANDA074661	Preferred Pharmaceuticals Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8444_1fbbccd4-9a5c-47a8-b102-ccf658cf5f7b	68788-8444	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20230511		ANDA	ANDA201109	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-8445_761dc0f8-2f65-4615-ab49-a4bcffd40ce9	68788-8445	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230515		ANDA	ANDA209654	Preferred Pharmaceuticals Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68788-8446_0a3447a1-407c-40a8-99bb-7e9a86eb37df	68788-8446	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20230518		ANDA	ANDA076504	Preferred Pharmaceuticals Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8447_217e6748-787e-4704-968e-701a53e0b27d	68788-8447	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20230517		ANDA	ANDA074661	Preferred Pharmaceuticals Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8448_0ded3105-b962-4748-bf5b-fca7a4557562	68788-8448	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20230515		ANDA	ANDA207206	Preferred Pharmaceuticals Inc	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8449_306ed758-3c43-4f42-bd44-562ec65891dc	68788-8449	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20230525		ANDA	ANDA215886	Preferred Pharmaceuticals Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-8450_985d1f62-4bff-4bf1-b7c7-96cb456ef83d	68788-8450	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	CREAM	TOPICAL	20230526		NDA	NDA018861	Preferred Pharmaceuticals Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8451_ea9f44a1-96cf-496a-8c07-18d8de27e512	68788-8451	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	10 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20230530		ANDA	ANDA078414	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-8452_5e456f3c-f93e-41c6-80c5-a737ed70feda	68788-8452	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230530		ANDA	ANDA040750	Preferred Pharmaceuticals Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68788-8453_0dea4818-e9d6-42f2-a702-90419fff2695	68788-8453	HUMAN PRESCRIPTION DRUG	fluticasone propionate and salmeterol		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20230530		ANDA	ANDA203433	Preferred Pharmaceuticals Inc.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
68788-8454_b25681a9-7b0e-40f9-844e-ec4842e3713c	68788-8454	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20230602		ANDA	ANDA202239	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-8455_0bbb8a63-ae1d-41d7-b201-d1b171b31f46	68788-8455	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20230605		ANDA	ANDA040646	Preferred Pharmaceuticals Inc.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8456_6d5243ae-4a1a-4583-9337-085520e1f14a	68788-8456	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical	GEL	TOPICAL	20230608		ANDA	ANDA212351	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8457_777c3cb9-da2b-431c-934f-f3c70f93d6cb	68788-8457	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20230607		ANDA	ANDA088042	Preferred Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8458_e11e94b9-d897-48ce-9a80-aa6b8b5fde02	68788-8458	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230614		ANDA	ANDA211820	Preferred Pharmaceuticals Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
68788-8459_2a0689ae-5650-42d1-ac9d-56dd2b467727	68788-8459	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20230614		ANDA	ANDA076921	Preferred Pharmaceuticals Inc.	MIRTAZAPINE	45	mg/1			N	20241231
68788-8461_b5f8bcda-3453-4091-9a57-7d2c08da33ed	68788-8461	HUMAN OTC DRUG	childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20230628		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68788-8462_6dcbb5e9-1e8f-4069-9244-adb46356714d	68788-8462	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	20230621		ANDA	ANDA070325	Preferred Pharmaceuticals Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8463_d09747f0-029e-4090-949b-e939948249b5	68788-8463	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230623		ANDA	ANDA206083	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8464_11f191cd-1a69-4cef-a92b-ef0a0eacdc0d	68788-8464	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20230623		ANDA	ANDA211343	Preferred Pharmaceuticals Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68788-8465_66e24ced-0008-40cb-b242-9d9add1f665c	68788-8465	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20230623		ANDA	ANDA210609	Preferred Pharmaceuticals Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
68788-8466_7646785b-dabc-482d-bf42-06177f00aca2	68788-8466	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	20230619		ANDA	ANDA070325	Preferred Pharmaceuticals Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8467_c4d1e578-a1d2-4d5e-8426-6b2c39f0d9bd	68788-8467	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230626		ANDA	ANDA215604	Preferred Pharmaceuticals, Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8468_180b99a5-7d3d-4ee5-a0cc-1ae0ede646ee	68788-8468	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20230626		ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8470_2cf1de22-3333-4622-b4ae-fd15dd4d45bc	68788-8470	HUMAN OTC DRUG	Good Sense Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20230628		ANDA	ANDA204226	Preferred Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8471_e4e8bab3-c5e7-4d2b-9692-ee6c6799b120	68788-8471	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20230629		ANDA	ANDA208170	Preferred Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-8472_7f29991e-3bf5-4e48-8fa3-6d4e932ed6de	68788-8472	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230629		ANDA	ANDA206912	Preferred Pharmaceuticals Inc.	PREGABALIN	50	mg/1		CV	N	20241231
68788-8473_f803fefc-69ff-4963-950b-48c13998bc2c	68788-8473	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230630		ANDA	ANDA075468	Preferred Pharmaceuticals Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8474_e343fd12-1ca2-418a-b690-f3e8f567596d	68788-8474	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20230701		ANDA	ANDA208170	Preferred Pharmaceuticals Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-8475_b1c2f960-fed4-428b-b505-d038057ceb4f	68788-8475	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230705		ANDA	ANDA207099	Preferred Pharmaceuticals Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8476_38119f2e-33b3-4c3c-99b7-9335d8d280d4	68788-8476	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20230705		ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8477_b5971407-2d95-4edb-88fe-0bd82d911683	68788-8477	HUMAN OTC DRUG	good sense childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20230628		OTC MONOGRAPH NOT FINAL	part343	Preferred Pharmaceuticals Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
68788-8478_ae9b6808-632f-4204-8581-bf146dcab69f	68788-8478	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		tizanidine hydrochloride	CAPSULE	ORAL	20230706		ANDA	ANDA210267	Preferred Pharmaceuticals Inc.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-8479_41bc5f5a-5e1d-4cb6-a795-9f1756a8f074	68788-8479	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20230713		ANDA	ANDA065352	Preferred Pharmaceuticals Inc.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-8480_81c0c69e-b1ae-42f3-9e85-09b8daa75d8d	68788-8480	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20230713		ANDA	ANDA065489	Preferred Pharmaceuticals Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-8481_06b4e41f-f15b-47c7-b5ad-dd7feb11fff2	68788-8481	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230713		ANDA	ANDA040197	Preferred Pharmaceuticals Inc.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68788-8482_9eff97fa-095c-483c-a4eb-e46e5fef7785	68788-8482	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		valacyclovir	TABLET, FILM COATED	ORAL	20230714		ANDA	ANDA078518	Preferred Pharmaceuticals Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
68788-8485_b445a613-eaa8-45e8-be1f-5848bfd1dd36	68788-8485	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20230718		ANDA	ANDA215630	Preferred Pharmaceuticals Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-8486_35229f3f-5a21-4749-8235-3c0239089cce	68788-8486	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230719		ANDA	ANDA090617	Preferred Pharmaceuticals Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8487_4632b4ec-d2f1-40cc-8ef4-256413d8dbec	68788-8487	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230719		ANDA	ANDA204720	Preferred Pharmaceuticals Inc.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8488_35da078b-0da0-4757-a6c4-a9144c37e8e1	68788-8488	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20230721		ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8489_e3429322-c442-4146-bb68-bcc3a8d01552	68788-8489	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230721		ANDA	ANDA204989	Preferred Pharmaceuticals Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8490_18892411-465f-4d8d-9550-7dafa6c6a0a3	68788-8490	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION/ DROPS	OPHTHALMIC	20230721		ANDA	ANDA075282	Preferred Pharmaceuticals Inc.	CROMOLYN SODIUM	40	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
68788-8491_fd010006-f646-46ed-841a-9f247b19e397	68788-8491	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20230724		ANDA	ANDA074165	Preferred Pharmaceuticals Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-8492_5de6a189-a8b7-4b33-b162-add6b6e4b275	68788-8492	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		albuterol sulfate	SOLUTION	RESPIRATORY (INHALATION)	20230724		ANDA	ANDA207857	Preferred Pharmaceuticals Inc.	ALBUTEROL SULFATE	.83	mg/mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
68788-8493_cbe5bd6a-f36a-4557-82d8-ef4e49d310e9	68788-8493	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20230724		ANDA	ANDA211542	Preferred Pharmaceuticals Inc.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8494_55ab721b-7b4c-42d5-99e3-745008fe139c	68788-8494	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20230726		ANDA	ANDA078895	Preferred Pharmaceuticals Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
68788-8495_f29892f8-142e-4d24-9ccd-5d6b408328cd	68788-8495	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20230726		ANDA	ANDA209313	Preferred Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8496_50d4763d-5a84-4c45-be06-040c4a527470	68788-8496	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	OINTMENT	TOPICAL	20230726		NDA	NDA018865	Preferred Pharmaceuticals Inc.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8497_4a469a1d-3851-48dc-8e79-28ffca872eaa	68788-8497	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20230727		ANDA	ANDA205236	Preferred Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
68788-8498_0f251f2c-97f3-4048-84f2-81fea03685aa	68788-8498	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA209882	Preferred Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8499_2fe0d214-9c4d-4a0c-9024-c2076c092c1a	68788-8499	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230801		ANDA	ANDA077856	Preferred Pharmaceuticals Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-8500_361dc5f9-aa20-42a5-b0d5-d8c732751915	68788-8500	HUMAN OTC DRUG	DICLOFENAC SODIUM		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20230811		ANDA	ANDA210986	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8501_867a7771-6846-427d-b526-b964d74f7700	68788-8501	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20230809		OTC MONOGRAPH NOT FINAL	part334	Preferred Pharmaceuticals Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
68788-8502_02a4af27-c83c-4166-950c-7a1cb12d198d	68788-8502	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230809		ANDA	ANDA202101	Preferred Pharmaceuticals Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-8503_dd74e446-7c1b-4f02-9c73-ba716572ee77	68788-8503	HUMAN PRESCRIPTION DRUG	budesonide inhalation		budesonide inhalation	SUSPENSION	RESPIRATORY (INHALATION)	20230809		ANDA	ANDA210897	Preferred Pharmaceuticals, Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8504_76b52d47-8a89-4579-a361-053da6e676e8	68788-8504	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA210616	Preferred Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8505_bb1e79ad-ff52-4696-8743-523f793b29d3	68788-8505	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20230815		ANDA	ANDA077619	Preferred Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8506_aec9829d-6687-4bb0-86af-66df13967d8a	68788-8506	HUMAN OTC DRUG	Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20210602		OTC MONOGRAPH FINAL	part331	Preferred Pharmaceuticals Inc.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68788-8507_55aa77b8-7601-4432-8631-bfec58daf247	68788-8507	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		Lidocaine hydrochloride	SOLUTION	ORAL; TOPICAL	20230816		ANDA	ANDA216780	Preferred Pharmaceuticals Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-8508_cf21c8c0-7247-4d5b-97f8-ae4016144642	68788-8508	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20230816		ANDA	ANDA203379	Preferred Pharmaceuticals Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8509_35922e9c-6a4c-446a-8294-a4cd3f3f0d10	68788-8509	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA200981	Preferred Pharmaceuticals Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8510_0f0c7234-b605-440f-abed-44f992d189a2	68788-8510	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20230822		ANDA	ANDA078245	Lupin Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8511_a9d05a38-08db-4710-b6f3-20c92ce885d5	68788-8511	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230822		ANDA	ANDA078279	Preferred Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8512_65ddb8b3-19d4-482f-8aec-49dc167a4c40	68788-8512	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20230825		ANDA	ANDA074223	Preferred Pharmaceuticals Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8514_37c40f8d-269c-4df8-8ac7-cbe78f4ca5c4	68788-8514	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SPRAY, METERED	NASAL	20230901		ANDA	ANDA212289	Preferred Pharmaceuticals Inc.	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8515_5701a07f-bd22-4bc7-95ff-0c5444ea5971	68788-8515	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	CREAM	TOPICAL	20230901		ANDA	ANDA085692	Preferred Pharmaceuticals Inc.	TRIAMCINOLONE ACETONIDE	.25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8516_093172ac-9e6b-4da7-8a14-42aa1aa4b3b3	68788-8516	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	OINTMENT	OPHTHALMIC	20230901		ANDA	ANDA062447	Preferred Pharmaceuticals Inc.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
68788-8517_99f45e08-897d-44dd-b48d-aa6d78981f0c	68788-8517	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230901		ANDA	ANDA040907	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8518_dbf94314-3a34-4f03-80b1-296559b7d6a5	68788-8518	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA215630	Preferred Pharmaceuticals Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
68788-8519_4579cd55-1dbe-40b8-86f0-33a319c934de	68788-8519	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20230905		ANDA	ANDA065291	Preferred Pharmaceuticals Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-8520_14238afd-200d-4a05-b731-647c43cecbc3	68788-8520	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230901		ANDA	ANDA090692	Preferred Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8521_0ba9b2c9-0754-4f96-b0a9-aaa61f6e75d5	68788-8521	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20230908		ANDA	ANDA212399	Preferred Pharmaceuticals Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
68788-8522_550d3e5a-c95f-4094-a500-1a02ea35a18d	68788-8522	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230912		ANDA	ANDA091281	Preferred Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-8523_e874264a-becc-45d0-b934-779eab5f5085	68788-8523	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine hydrochloride	SOLUTION	ORAL	20230913		ANDA	ANDA078398	Preferred Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-8524_2d21ed0b-a089-46f4-9ebb-f24f9f3af61d	68788-8524	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230914		ANDA	ANDA213486	Preferred Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8525_05ea2a62-8ed7-453b-a44f-4e273189b548	68788-8525	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230914		ANDA	ANDA217054	Preferred Pharmaceuticals Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68788-8526_eeeb82e1-d668-418e-9716-f8bcf72f80c0	68788-8526	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20230920		ANDA	ANDA077731	Preferred Pharmaceuticals Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
68788-8527_82100fc8-5a5a-4d80-8101-72024ee0abef	68788-8527	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20231006		ANDA	ANDA077443	Preferred Pharmaceuticals Inc.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
68788-8528_902d1bc4-3f1f-4a1a-86d7-cf98c56a3684	68788-8528	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20231006		ANDA	ANDA090564	Preferred Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8529_a7f3f32a-0651-4e55-ac51-c85a23352a24	68788-8529	HUMAN OTC DRUG	Meclizine HCl		MECLIZINE HYDROCHLORIDE CHEWABLE	TABLET, CHEWABLE	ORAL	20231006		OTC MONOGRAPH DRUG	336	Preferred Pharmaceuticals Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
68788-8530_8acc0ed3-6e4f-4799-8252-5a163938fddc	68788-8530	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20231006		ANDA	ANDA091388	Preferred Pharmaceuticals Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
68788-8531_06710aef-2631-4925-8e9e-33bae84b5912	68788-8531	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20231006		ANDA	ANDA078329	Preferred Pharmaceuticals Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8532_676b38b2-17dc-45ab-a7ac-dc2f6258ac46	68788-8532	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20231003		ANDA	ANDA077336	Preferred Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
68788-8533_979588e5-d266-4728-aa58-36cd6a217584	68788-8533	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20231005		ANDA	ANDA207616	Preferred Pharmaceuticals Inc.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-8534_06a4ee22-d8f8-4a8a-8666-82b14f2d8476	68788-8534	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20231023		ANDA	ANDA090480	Preferred Pharmaceuticals Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
68788-8535_ff08b9ee-03bf-4f5b-930e-233a3b8866af	68788-8535	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20231023		ANDA	ANDA078284	Preferred Pharmaceuticals Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68788-8536_4582d443-f1be-4f94-85da-49aa603f54e4	68788-8536	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20231019		ANDA	ANDA204237	Preferred Pharmaceuticals Inc.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8537_24ede961-8849-4f44-b007-8d120624a578	68788-8537	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20231019		ANDA	ANDA206556	Preferred Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
68788-8538_52d8a080-eafc-46fe-82d9-6b69c6a3a38a	68788-8538	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20231019		ANDA	ANDA065253	Preferred Pharmaceuticals Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-8539_8f75883c-7454-41b3-b433-2017c7bdd88f	68788-8539	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20231019		ANDA	ANDA208360	Preferred Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-8540_516031cf-97ee-4838-90ef-a43dedd2f598	68788-8540	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20231110		ANDA	ANDA216782	Preferred Pharmaceuticals Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68788-8541_15b280a1-4964-4636-833b-3db44044d289	68788-8541	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20231025		ANDA	ANDA213040	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8542_8da38550-db12-4068-8e92-54cdbcca3ed3	68788-8542	HUMAN PRESCRIPTION DRUG	Pantoprazole sodium delayed-release		Pantoprazole sodium delayed-release	TABLET	ORAL	20240101		ANDA	ANDA215880	Preferred Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
68788-8543_743ae641-14e1-456b-80e6-c6f7d621e969	68788-8543	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20231106		ANDA	ANDA203245	Preferred Pharmaceuticals Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-8544_9e7568b6-52ae-4f7a-9bfd-503fd80a297e	68788-8544	HUMAN OTC DRUG	Muscle Rub Cream		Menthol 10%, Methyl Salicylate 15%	CREAM	TOPICAL	20231106		OTC MONOGRAPH DRUG	348	Preferred Pharmaceuticals Inc.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
68788-8545_4290b3ec-8993-47d4-bfe3-fcb81d7baed8	68788-8545	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20231107		ANDA	ANDA040750	Preferred Pharmaceuticals Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
68788-8546_78e478bf-1aa2-47c5-9aa6-bcb35c9674b9	68788-8546	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20231107		ANDA	ANDA207099	Preferred Pharmaceuticals Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-8548_831f7694-8153-4a79-a453-48020b26f035	68788-8548	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	CREAM	TOPICAL	20231114		ANDA	ANDA076679	Preferred Pharmaceuticals Inc.	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8549_92546f61-bbd8-430a-ac92-89dfbe8e2f29	68788-8549	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	SOLUTION	OPHTHALMIC	20231115		ANDA	ANDA203410	Preferred Pharmaceuticals Inc.	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8550_d1d1a0f2-fd7d-42d9-9a92-12f742c833cc	68788-8550	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20240101		ANDA	ANDA074497	Preferred Pharmaceuticals Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
68788-8551_adad0c8f-f591-4bac-a1bd-4e2a451f4f35	68788-8551	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin otic	SOLUTION	AURICULAR (OTIC)	20231115		ANDA	ANDA216130	Preferred Pharmaceuticals Inc.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-8552_59e53582-244a-4e9d-b18e-75dddc6a5052	68788-8552	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	CREAM	TOPICAL	20231120		ANDA	ANDA217128	Preferred Pharmaceuticals Inc.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
68788-8553_4fd65dbf-8e50-4a4a-b06d-e5abab0f3dcd	68788-8553	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20231120		ANDA	ANDA062364	Preferred Pharmaceuticals Inc.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
68788-8554_80b72854-3fae-4cc7-bc41-2bdeb3e2cbe1	68788-8554	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20231120		ANDA	ANDA075008	Preferred Pharmaceuticals Inc.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-8555_92f5adde-16ca-4e48-b88b-5e744afbbb0f	68788-8555	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20240101		ANDA	ANDA214374	Preferred Pharmaceuticals Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68788-8640_93ebf4ff-bd4f-4e6c-9449-a0aa93d980d4	68788-8640	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230620		ANDA	ANDA206912	Preferred Pharmaceuticals Inc.	PREGABALIN	150	mg/1		CV	N	20241231
68788-8919_6a04f36c-0e54-45ac-977d-e941e5c72a98	68788-8919	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20150918		OTC MONOGRAPH NOT FINAL	part334	Preferred Pharmaceuticals Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
68788-8946_aebe7d47-2d63-4441-8856-3c13e82e0e99	68788-8946	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20151027		ANDA	ANDA070848	Preferred Pharmaceuticals Inc.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
68788-8951_2f41e613-639e-4b45-a269-ac0c70accbc8	68788-8951	HUMAN OTC DRUG	anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20151120		ANDA	ANDA075232	Preferred Pharmaceuticals Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68788-8952_d7a8177e-1021-442e-8a9e-e2cc07a3d6a2	68788-8952	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20151120		ANDA	ANDA075185	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-8962_88bd9f99-7dcd-40a2-9591-4aac5cd82645	68788-8962	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20160104		ANDA	ANDA078216	Preferred Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-9006_ff470c89-9638-4e39-a5fa-aa0dfafdbe3e	68788-9006	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20110614		ANDA	ANDA075593	Preferred Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-9012_99fe21ea-3a82-44fb-963a-4916c3be5d01	68788-9012	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	Preferred Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-9017_9d0accbb-9d90-4351-a6a8-abe66ccfdf3f	68788-9017	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20110615		ANDA	ANDA065322	Preferred Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-9018_9d0accbb-9d90-4351-a6a8-abe66ccfdf3f	68788-9018	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20110615		ANDA	ANDA065325	Preferred Pharmaceuticals, Inc.	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-9019_9d0accbb-9d90-4351-a6a8-abe66ccfdf3f	68788-9019	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20110615		ANDA	ANDA065322	Preferred Pharmaceuticals, Inc.	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-9024_ff470c89-9638-4e39-a5fa-aa0dfafdbe3e	68788-9024	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	Preferred Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68788-9074_ce8e78f7-4179-4a17-9577-2740ff389abc	68788-9074	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine Hydrochloride	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Preferred Pharmaceuticals, Inc	PAROXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-9098_f767c242-3fa1-4296-948e-ee62456b73b0	68788-9098	HUMAN OTC DRUG	Siltussin SA		Guaifenesin	LIQUID	ORAL	19981005	20241230	OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals, Inc	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
68788-9110_46ea9447-4923-470c-8b85-016228721454	68788-9110	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Preferred Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-9111_46ea9447-4923-470c-8b85-016228721454	68788-9111	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Preferred Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-9112_46ea9447-4923-470c-8b85-016228721454	68788-9112	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Preferred Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-9126_9dada94b-b3f3-4afa-8d0d-ba6046a5c676	68788-9126	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Preferred Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68788-9127_9dada94b-b3f3-4afa-8d0d-ba6046a5c676	68788-9127	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Preferred Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
68788-9138_e153b955-5bb8-4b76-a91a-63b980805259	68788-9138	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate		Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	Preferred Pharmaceuticals, Inc.	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68788-9207_0111ebf2-6a14-487d-9195-17ab09cea7e3	68788-9207	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20111109		ANDA	ANDA071322	Preferred Pharmaceuticals, Inc.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-9219_170ec1c9-cde1-4293-aec4-560107bfed43	68788-9219	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20140919		ANDA	ANDA076592	Preferred Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-9246_fe9fc30e-3c00-40ab-917e-c7e821036428	68788-9246	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20141022		ANDA	ANDA078220	Preferred Pharmaceuticals, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
68788-9265_87297e6c-ee70-45f9-8b40-ce5bc07faad7	68788-9265	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20141203		ANDA	ANDA077614	Preferred Pharmaceuticals,Inc.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-9280_99fe21ea-3a82-44fb-963a-4916c3be5d01	68788-9280	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20150129		ANDA	ANDA076639	Preferred Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
68788-9290_8a36a7ef-9876-4311-8d05-e8bc3d0185f7	68788-9290	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium and Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20150302		ANDA	ANDA201089	Preferred Pharmaceuticals, Inc.	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
68788-9313_2d035976-2983-47e0-abfc-9c1611a6d57e	68788-9313	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20150325		ANDA	ANDA076118	Preferred Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-9319_04b9f077-0db1-45b5-9d6f-ddf4142892b6	68788-9319	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20150413		ANDA	ANDA065093	Preferred Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
68788-9326_58a84b05-6cba-4aba-9707-ff30adb6787a	68788-9326	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20150409		ANDA	ANDA090836	Preferred Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-9327_2d035976-2983-47e0-abfc-9c1611a6d57e	68788-9327	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20150325		ANDA	ANDA076118	Preferred Pharmaceuticals, Inc.	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
68788-9345_622d5715-f293-4c21-894a-193517eaeb08	68788-9345	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20151124		ANDA	ANDA078925	Preferred Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
68788-9368_d4ce06ae-a386-41a4-828c-72391dda6f7d	68788-9368	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20120612		ANDA	ANDA078539	Preferred Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68788-9402_d4ce06ae-a386-41a4-828c-72391dda6f7d	68788-9402	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20120612		ANDA	ANDA078539	Preferred Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68788-9405_d58d6706-cb1f-4a5e-afba-3808feb8d006	68788-9405	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	20141103		ANDA	ANDA080937	Preferred Pharmaceuticals, Inc.	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
68788-9429_2148c5fd-f2d5-4104-a622-8d2dfd560a14	68788-9429	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20141021		ANDA	ANDA078155	Preferred Pharmaceuticals, Inc.	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-9435_9fef82ed-1b0c-4fa2-b4b0-605251d87fed	68788-9435	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20180608		ANDA	ANDA208301	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-9438_120398b7-b229-4b38-bc58-c0e9c3e450e4	68788-9438	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20160617		ANDA	ANDA202717	Preferred Pharmaceuticals Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
68788-9509_d5438590-d730-459f-b2ea-9b8b459662f9	68788-9509	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140228		ANDA	ANDA090858	Preferred Pharmaceuticals, Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
68788-9525_96b0bc9f-5f8c-4bf7-aa8d-6b69b5913f55	68788-9525	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20140221		ANDA	ANDA085223	Preferred Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68788-9538_e12b622a-fc89-4f4e-871e-c651fa5e612a	68788-9538	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	20131203		ANDA	ANDA062703	Preferred Pharmaceuticals, Inc.	CEPHALEXIN	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-9539_e12b622a-fc89-4f4e-871e-c651fa5e612a	68788-9539	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	POWDER, FOR SUSPENSION	ORAL	20131203		ANDA	ANDA062703	Preferred Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-9546_c2a41704-88f1-4d8e-af33-198b50b8eb97	68788-9546	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate		Chlorhexidine Gluconate	RINSE	ORAL	20131022		ANDA	ANDA077789	Preferred Pharmaceuticals, Inc.	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
68788-9547_ca0d4734-381e-4370-9649-5d882339d8d6	68788-9547	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20131024		ANDA	ANDA078327	Preferred Pharmaceuticals, Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
68788-9551_86ebe5a5-20ba-4f77-9776-d01ae8ababa5	68788-9551	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20140423		ANDA	ANDA040256	Preferred Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-9555_9237084f-2a83-480e-bebc-27ebc9a82bb8	68788-9555	HUMAN OTC DRUG	Terocin		Lidocaine, Menthol	PATCH	TOPICAL	20130923		OTC MONOGRAPH NOT FINAL	part348	Preferred Pharmaceuticals, Inc.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	600; 600	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
68788-9559_e5770a0f-473d-421b-a041-3624554a55b0	68788-9559	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20130827		ANDA	ANDA090469	Preferred Pharmaceuticals, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
68788-9665_355c5ca8-faeb-4552-9b1c-4b3e83e9630e	68788-9665	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20130805		ANDA	ANDA072641	Preferred Pharmaceuticals, Inc.	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68788-9678_d76d3d26-3d19-4e8e-872f-0bc9fd201088	68788-9678	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20130422		ANDA	ANDA077538	Preferred Pharmaceuticals, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-9682_28a776a4-65f4-4581-882d-350aa1bd3f41	68788-9682	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20130422		ANDA	ANDA090871	Preferred Pharmaceuticals, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
68788-9687_85290f0b-6449-4e00-82a5-34b5f6ce3317	68788-9687	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20130327		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-9688_85290f0b-6449-4e00-82a5-34b5f6ce3317	68788-9688	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	Preferred Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68788-9692_d9295642-13dc-4089-83fb-d662003acafd	68788-9692	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20130326		ANDA	ANDA078216	Preferred Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
68788-9702_5a06ff11-5880-4cac-885a-b02291572dc2	68788-9702	HUMAN PRESCRIPTION DRUG	Neomycin Polymyxin B Sulfates and Dexamethasone		Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20130314		ANDA	ANDA064135	Preferred Pharmaceuticals, Inc.	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-9705_79cfac20-dccd-4c8b-a135-fd352cbb0f7e	68788-9705	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20130218		ANDA	ANDA085082	Preferred Pharmaceuticals, Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
68788-9713_58a84b05-6cba-4aba-9707-ff30adb6787a	68788-9713	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20130205		ANDA	ANDA090836	Preferred Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
68788-9747_2148c5fd-f2d5-4104-a622-8d2dfd560a14	68788-9747	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20120228		ANDA	ANDA078155	Preferred Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-9789_87297e6c-ee70-45f9-8b40-ce5bc07faad7	68788-9789	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20120604		ANDA	ANDA077614	Preferred Pharmaceuticals,Inc.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
68788-9790_2670d26e-9e30-4047-9c81-f16519170b92	68788-9790	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120604		ANDA	ANDA078906	Preferred Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
68788-9794_0cb4638f-8a1c-4f5b-938b-2bb44a83dea5	68788-9794	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	20120430		OTC MONOGRAPH FINAL	part333B	Preferred Pharmaceuticals, Inc	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
68788-9804_1a47edb0-e1cd-46e0-b7cd-637963a15648	68788-9804	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20120423		ANDA	ANDA078930	Preferred Pharmaceuticals, Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-9806_23d5e877-1dfa-44be-8f7b-ef9d35e8dd3d	68788-9806	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20150831		ANDA	ANDA075185	Preferred Pharmaceuticals Inc.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68788-9807_22174160-fad5-4ae2-aa4d-9929ce23e5b5	68788-9807	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20120423		ANDA	ANDA077912	Preferred Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-9808_22174160-fad5-4ae2-aa4d-9929ce23e5b5	68788-9808	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20120423		ANDA	ANDA077912	Preferred Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-9809_22174160-fad5-4ae2-aa4d-9929ce23e5b5	68788-9809	HUMAN PRESCRIPTION DRUG	LISINOPRIL AND HYDROCHLOROTHIAZIDE		LISINOPRIL AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20120423		ANDA	ANDA077912	Preferred Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
68788-9814_41b23666-e3a2-4367-82db-fcd5bb056d5e	68788-9814	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20120405		ANDA	ANDA077511	Preferred Pharmaceuticals, Inc	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
68788-9815_fa184eb0-fc36-4025-a3ba-643c213e6b67	68788-9815	HUMAN PRESCRIPTION DRUG	Terazosin hydrochloride		Terazosin hydrochloride	CAPSULE	ORAL	20120405		ANDA	ANDA075317	Preferred Pharmaceuticals, Inc	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-9816_fa184eb0-fc36-4025-a3ba-643c213e6b67	68788-9816	HUMAN PRESCRIPTION DRUG	Terazosin hydrochloride		Terazosin hydrochloride	CAPSULE	ORAL	20120405		ANDA	ANDA075317	Preferred Pharmaceuticals, Inc	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-9817_fa184eb0-fc36-4025-a3ba-643c213e6b67	68788-9817	HUMAN PRESCRIPTION DRUG	Terazosin hydrochloride		Terazosin hydrochloride	CAPSULE	ORAL	20120405		ANDA	ANDA075317	Preferred Pharmaceuticals, Inc	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
68788-9852_79d215fa-0f32-4b62-a002-02673068c889	68788-9852	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	20120314		ANDA	ANDA060456	Preferred Pharmaceuticals, Inc	PENICILLIN V POTASSIUM	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-9853_79d215fa-0f32-4b62-a002-02673068c889	68788-9853	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	POWDER, FOR SOLUTION	ORAL	20120314		ANDA	ANDA060456	Preferred Pharmaceuticals, Inc	PENICILLIN V POTASSIUM	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-9868_2148c5fd-f2d5-4104-a622-8d2dfd560a14	68788-9868	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20120228		ANDA	ANDA078155	Preferred Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-9869_2148c5fd-f2d5-4104-a622-8d2dfd560a14	68788-9869	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20120228		ANDA	ANDA078155	Preferred Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
68788-9871_6f33538f-916e-45f8-a361-e0f879608175	68788-9871	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		sulfacetamide sodium	SOLUTION/ DROPS	OPHTHALMIC	20120228		ANDA	ANDA040066	Preferred Pharmaceuticals, Inc	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
68788-9891_0f0a9809-bac5-40bb-a039-1d796ad35034	68788-9891	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20140214		ANDA	ANDA065123	Preferred Pharmaceuticals, Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
68788-9922_bb91b9e1-1a1c-4f65-b063-4290ebd6893c	68788-9922	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20120127		ANDA	ANDA085025	Preferred Pharmaceuticals, Inc.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68788-9924_0ddd7481-e9f8-4f1a-82d8-b9b036c926bf	68788-9924	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20120118		ANDA	ANDA064065	Preferred Pharmaceuticals, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
68788-9948_357df73e-dbed-47e8-a0c7-5706f94cd063	68788-9948	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20120112		ANDA	ANDA065387	Preferred Pharmaceuticals, Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-9949_357df73e-dbed-47e8-a0c7-5706f94cd063	68788-9949	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20120112		ANDA	ANDA065387	Preferred Pharmaceuticals, Inc.	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68788-9967_34b5f2c8-deda-41f0-baf8-8761aebf1ed6	68788-9967	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20150501		ANDA	ANDA078722	Preferred Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
68791-102_063282d0-339f-495a-8e2a-ebf51a78970e	68791-102	HUMAN PRESCRIPTION DRUG	Derma-Smoothe/FS		fluocinolone acetonide	OIL	TOPICAL	19950216		NDA	NDA019452	Royal Pharmaceuticals	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68791-104_5e5a5e2b-b12a-42d8-b375-11fbffb050b4	68791-104	HUMAN PRESCRIPTION DRUG	PEDIAPRED		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20180207		NDA	NDA019157	Royal Pharmaceuticals	PREDNISOLONE SODIUM PHOSPHATE	5	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68794-001_08b6e513-4db7-0376-e063-6294a90a3cd3	68794-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		Professional Medical Services & Products, Inc.	OXYGEN	99	L/100L			N	20241231
68803-612_06f72c6d-7e67-2caf-e063-6394a90a60b7	68803-612	HUMAN PRESCRIPTION DRUG	VISIONBLUE		Trypan Blue	INJECTION, SOLUTION	INTRAOCULAR; OPHTHALMIC	20041216		NDA	NDA021670	D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.	TRYPAN BLUE	.3	mg/.5mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
68803-722_06f734b1-f19f-b1a1-e063-6294a90a7172	68803-722	HUMAN PRESCRIPTION DRUG	TISSUEBLUE		Brilliant Blue G	INJECTION, SOLUTION	INTRAOCULAR; OPHTHALMIC	20191231		NDA	NDA209569	D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.	BRILLIANT BLUE G	.0125	mg/.5mL	Disclosing Agent [EPC], Dyes [MoA]		N	20241231
68814-010_08c2302a-f845-448d-e063-6394a90a3f3e	68814-010	HUMAN OTC DRUG	Molton Brown Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201110		OTC MONOGRAPH DRUG	505G(a)(3)	Molton Brown Ltd.	ALCOHOL	.76	mL/mL			N	20241231
68817-134_25a98542-1909-490d-b162-6e36d3997d8a	68817-134	HUMAN PRESCRIPTION DRUG	ABRAXANE		Paclitaxel	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20050210		NDA	NDA021660	Abraxis BioScience, LLC	PACLITAXEL	100	mg/20mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
68828-001_0daa9458-c98e-994e-e063-6294a90a6c02	68828-001	HUMAN OTC DRUG	Clear Smart Charcoal Blackhead Scrub		salicylic acid	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M006	Jafra Cosmetics International Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
68828-002_0daad028-416a-b080-e063-6294a90a14b7	68828-002	HUMAN OTC DRUG	Spa Dry Heel Foot Relief		DIMETHICONE	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M016	Jafra Cosmetics International Inc	DIMETHICONE	4	g/100mL	Skin Barrier Activity [PE]		N	20241231
68828-003_0daa8799-54e9-25fc-e063-6294a90ac46a	68828-003	HUMAN OTC DRUG	Spa Niacinamide And Vitamin E Hand Cream Broad Spectrum SPF 15		avobenzone, homosalate, octisalate, octocrylene	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 5; 7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68828-004_0daa6114-98bb-7f8b-e063-6294a90a6fc5	68828-004	HUMAN OTC DRUG	Royal Jelly Scar Balm		DIMETHICONE	CREAM	TOPICAL	20220615		OTC MONOGRAPH DRUG	M016	Jafra Cosmetics International Inc	DIMETHICONE	2	g/100mL	Skin Barrier Activity [PE]		N	20241231
68828-010_f929eebf-660c-dd0a-e053-6294a90a38fd	68828-010	HUMAN OTC DRUG	JAFRA Fruteria Coco Fresco Lip Balm		DIMETHICONE	GEL	TOPICAL	20230601		OTC MONOGRAPH FINAL	part347	Jafra Cosmetics International, Inc.	DIMETHICONE	1	g/100mL	Skin Barrier Activity [PE]		N	20241231
68828-011_f9250aad-a61a-ab75-e053-6394a90a5fb4	68828-011	HUMAN OTC DRUG	JAFRA Fruteria So Citrico		DIMETHICONE	GEL	TOPICAL	20230601		OTC MONOGRAPH FINAL	part347	Jafra Cosmetics International, Inc.	DIMETHICONE	1	g/100mL	Skin Barrier Activity [PE]		N	20241231
68828-012_0d6b7b9c-a987-073b-e063-6294a90ac47d	68828-012	HUMAN OTC DRUG	JAFRA Fruteria Very Verde Lip Balm		DIMETHICONE	GEL	TOPICAL	20230601		OTC MONOGRAPH DRUG	M016	Jafra Cosmetics International, Inc.	DIMETHICONE	1	g/100mL	Skin Barrier Activity [PE]		N	20241231
68828-099_0d6bf85c-3baf-4b8d-e063-6294a90a728e	68828-099	HUMAN OTC DRUG	Gold Dynamics Skin Boosting Moisturizer Broad Spectrum SPF 15 Sunscreen		avobenzone, oxybenzone, octisalate, octinoxate	CREAM	TOPICAL	20220413		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	2.5; 7.5; 4; 2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68828-172_0e373947-51f8-dd83-e063-6294a90a4e57	68828-172	HUMAN OTC DRUG	Dark Skin Defense Concealer Broad Spectrum SPF 15	Jafra	Octinoxate, Octisalate, Oxybenzone	CREAM	TOPICAL	20130522		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International Inc	OCTINOXATE; OCTISALATE; OXYBENZONE	7; 3; 2	g/100mL; g/100mL; g/100mL			N	20251231
68828-244_0da71c47-3ed0-5bc1-e063-6394a90ab9cf	68828-244	HUMAN OTC DRUG	Clear Smart Clarifying Cleansing Foam		Salicylic Acid	LIQUID	TOPICAL	20200511		OTC MONOGRAPH DRUG	M006	Jafra Cosmetics International Inc	SALICYLIC ACID	.5	g/100mL			N	20251231
68828-245_0d98b1ec-bfa3-011f-e063-6394a90ac61f	68828-245	HUMAN OTC DRUG	Clear Smart Blemish Spot Treatment		Salicyclic Acid	GEL	TOPICAL	20200511		OTC MONOGRAPH DRUG	M006	Jafra Cosmetics International Inc	SALICYLIC ACID	1	g/100mL			N	20251231
68828-289_0da74bb0-a007-76ce-e063-6394a90a3d27	68828-289	HUMAN OTC DRUG	Clear Smart Clear Complexion Toner		Salicylic Acid	LIQUID	TOPICAL	20200507		OTC MONOGRAPH DRUG	M006	Jafra Cosmetics International Inc	SALICYLIC ACID	.5	g/100mL			N	20251231
68828-290_0d98af39-3010-002d-e063-6394a90ab12d	68828-290	HUMAN OTC DRUG	Clear Smart Shine Control Sunscreen Broad Spectrum SPF 25		Avobenzone,Homosalate,Octisalate,Octocrylene	CREAM	TOPICAL	20200511		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 9	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
68828-293_0daacdd3-b900-bea3-e063-6394a90a8a24	68828-293	HUMAN OTC DRUG	Jafra Sun tinted face protector sunscreen broad spectrum 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20210114		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics Internationl	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68828-294_0dab9500-f089-0b97-e063-6294a90a9f10	68828-294	HUMAN OTC DRUG	Jafra Sun body protector sunscreen broad spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20210114		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68828-295_0daad476-bd28-bd5d-e063-6394a90ac74a	68828-295	HUMAN OTC DRUG	Sun face protector sunscreen broad spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20210114		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68828-296_0daa99ad-e907-9a09-e063-6294a90a02c0	68828-296	HUMAN OTC DRUG	Jafra Sun sunscreen broad spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210114		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
68828-444_0e0b7696-7976-10ab-e063-6294a90a6fb7	68828-444	HUMAN OTC DRUG	Tender Moments Baby Sunscreen Broad Spectrum SPF 50 Water Resistant (40 minutes)		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20210610		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
68828-502_0e74a2cd-7ce2-ed9a-e063-6394a90a3104	68828-502	HUMAN OTC DRUG	Clear Smart Clear Complexion Toner		Salicyclic Acid	LIQUID	TOPICAL	20220823	20240331	OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International Inc	SALICYLIC ACID	.5	g/100mL			N	
68828-504_faa605a1-f85d-37d4-e053-6394a90a5d36	68828-504	HUMAN OTC DRUG	Royal Jelly Radiance Foundation Broad Spectrum SPF 20 Earth		octinoxate, zinc oxide	LIQUID	TOPICAL	20220906		OTC MONOGRAPH FINAL	part352	Jafra Cosmetics International Inc	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
68828-507_0e370144-a560-bd28-e063-6294a90abd59	68828-507	HUMAN OTC DRUG	Sun Face Protector Sunscreen Broad Spectrum SPF 50		avobenzone, homosalate, octisalate, octocrylene	CREAM	TOPICAL	20220824	20240831	OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	
68828-513_eb6948f3-d3a3-3fdd-e053-2995a90afc1e	68828-513	HUMAN OTC DRUG	Jafra Royal Defy Travel Kit		Avobenzone, Homosalate, Octisalate, Octocrylene	KIT	TOPICAL	20220822		OTC MONOGRAPH FINAL	part352	Jafra cosmetics International						N	20241231
68828-700_0daa74d4-147a-a7ea-e063-6394a90a84f4	68828-700	HUMAN OTC DRUG	Tender Moments Delicate Baby Diaper Rash Balm		DIMETHICONE,ZINC OXIDE	CREAM	TOPICAL	20211229		OTC MONOGRAPH DRUG	M016	Jafra Cosmetics International, Inc.	DIMETHICONE; ZINC OXIDE	2; 10	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Skin Barrier Activity [PE]		N	20241231
68828-701_0d98a22b-74de-2f81-e063-6294a90ae16a	68828-701	HUMAN OTC DRUG	Clear Smart Clear Pore Hydrator		Salicylic Acid	GEL	TOPICAL	20220104		OTC MONOGRAPH DRUG	M006	Jafra Cosmetics International Inc	SALICYLIC ACID	.5	g/100mL			N	20251231
68828-702_0d6bba93-a863-8d50-e063-6394a90ac09f	68828-702	HUMAN OTC DRUG	Jafra Daily Antiperspirant Deodorant Roll-on		Aluminum Chlorohydrate	LIQUID	TOPICAL	20211231		OTC MONOGRAPH DRUG	M019	Jafra Cosmetics International	ALUMINUM CHLOROHYDRATE	12.3	g/100mL			N	20241231
68828-703_0dcb27f1-3356-8bd2-e063-6394a90a4c39	68828-703	HUMAN OTC DRUG	Jafra Daily Hair Minimizing Antiperspirant Deodorant Roll-on		Aluminum Chlorohydrate	LIQUID	TOPICAL	20211231		OTC MONOGRAPH DRUG	M019	Jafra Cosmetics International	ALUMINUM CHLOROHYDRATE	12.3	g/100mL			N	20241231
68828-704_0dcb36a2-5b2b-37bf-e063-6394a90a3b4f	68828-704	HUMAN OTC DRUG	Royal Jelly Berry Powerful Lip Care		Dimethicone	STICK	TOPICAL	20171013		OTC MONOGRAPH DRUG	M016	JAFRA COSMETICS INTERNATIONAL	DIMETHICONE	2	g/100g	Skin Barrier Activity [PE]		N	20241231
68828-705_0daaed20-1e99-b0e4-e063-6294a90a0f19	68828-705	HUMAN OTC DRUG	Jafra Daily Sensitive Skin Antiperspirant Deodorant Roll-on		Aluminum Chlorohydrate	LIQUID	TOPICAL	20211231		OTC MONOGRAPH DRUG	M019	Jafra Cosmetics International	ALUMINUM CHLOROHYDRATE	12.3	g/100mL			N	20241231
68828-710_0da78c11-1669-721b-e063-6294a90a2c7c	68828-710	HUMAN OTC DRUG	Always Foundation Makeup Broad Spectrum SPF 15 Shell		Homosalate, Octisalate, Zinc Oxide	LIQUID	TOPICAL	20220104		OTC MONOGRAPH DRUG	M020	JAFRA COSMETICS INTERNATIONAL	HOMOSALATE; OCTISALATE; ZINC OXIDE	4.25; 4.75; 7	g/100mL; g/100mL; g/100mL			N	20241231
68828-714_0da79845-42b0-906e-e063-6394a90aade9	68828-714	HUMAN OTC DRUG	Always Foundation Makeup Broad Spectrum SPF 15 Bisque		Homosalate, Octisalate, Zinc Oxide	LIQUID	TOPICAL	20220103		OTC MONOGRAPH DRUG	M020	JAFRA COSMETICS INTERNATIONAL	HOMOSALATE; OCTISALATE; ZINC OXIDE	4.25; 4.75; 7	g/100mL; g/100mL; g/100mL			N	20241231
68828-727_faa5a993-be08-088f-e053-6394a90ac0c0	68828-727	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20 - Bare		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220107		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-728_faa5fc8c-eaa7-3e8a-e053-6394a90a1b45	68828-728	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20 - Bronze		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220107		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-730_faa6059a-4b28-12f9-e053-6394a90acbd8	68828-730	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20 - Honey		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220107		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-731_faa5a993-bdf2-088f-e053-6394a90ac0c0	68828-731	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20- Natural		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220110		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-732_faa5a993-bdfd-088f-e053-6394a90ac0c0	68828-732	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20-Nude		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220110		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-733_faa60385-6dc6-81b8-e053-6294a90a6e8c	68828-733	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20 -Spice		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220110		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-734_faa5bc84-c64e-10d1-e053-6394a90ad681	68828-734	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20 - Tawny		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220110		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-735_faa62b7a-7aa2-5c38-e053-6394a90a5bcd	68828-735	HUMAN OTC DRUG	Radiance Foundation Broad Spectrum SPF 20 - Cappuccino		Octinoxate, Zinc Oxide	LIQUID	TOPICAL	20220110		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL	OCTINOXATE; ZINC OXIDE	3; 6.8	g/100mL; g/100mL			N	20241231
68828-749_0dfcf4a4-bed8-596a-e063-6294a90a66e3	68828-749	HUMAN OTC DRUG	Royal Boost Cover Me Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220111		OTC MONOGRAPH DRUG	M020	Jafra Cosmetics International	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 7	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
68828-750_014f1032-f856-a0ab-e063-6294a90a7585	68828-750	HUMAN OTC DRUG	Time Dynamics Defy Time Protector Moisturizer Broad Spectrum SPF 15		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20220111		OTC MONOGRAPH FINAL	part352	Jafra Cosmetics International	OCTINOXATE; ZINC OXIDE	7.5; 3	g/100mL; g/100mL			N	20241231
68828-757_014f6f01-6a6c-72f7-e063-6394a90aa56e	68828-757	HUMAN OTC DRUG	Jafra Royal Luna Bright Kit		Avobenzone, Homosalate, Octisalate, Octocrylene	KIT		20220112		OTC MONOGRAPH FINAL	part352	JAFRA COSMETICS INTERNATIONAL INC						N	20241231
68828-759_0d6b930a-db3d-190b-e063-6294a90a5e75	68828-759	HUMAN OTC DRUG	Jafra Daily Skin Brightening Antiperspirant Deodorant Roll-on		Aluminum Chlorohydrate	LIQUID	TOPICAL	20220112		OTC MONOGRAPH DRUG	M019	Jafra cosmetics International	ALUMINUM CHLOROHYDRATE	12.3	g/100mL			N	20241231
68828-760_dec40947-2d53-daad-e053-2995a90a0714	68828-760	HUMAN OTC DRUG	Jafra Royal Defy Sample Kit		Avobenzone, Homosalate, Octisalate, Octocrylene	KIT	TOPICAL	20220112		OTC MONOGRAPH FINAL	part352	Jafra cosmetics International						N	20241231
68828-765_0e349c45-5eb7-f77c-e063-6294a90afb25	68828-765	HUMAN OTC DRUG	Royal Men Sample Set		Avobenzone, Homosalate, Octisalate, Octocrylene	KIT		20220309	20240630	OTC MONOGRAPH DRUG	M020	Jafra International Cosmetics						N	
68828-767_0e349c45-5eb7-f77c-e063-6294a90afb25	68828-767	HUMAN OTC DRUG	Royal Men 3-in-1 Face Moisturizer Broad Spectrum SPF 20		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220309	20240630	OTC MONOGRAPH DRUG	M020	Jafra International Cosmetics	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	
68850-010_d811b183-f875-3ea9-e053-2995a90af90f	68850-010	HUMAN PRESCRIPTION DRUG	Myambutol		Ethambutol hydrochloride	TABLET, FILM COATED	ORAL	20070810		NDA	NDA016320	STI Pharma, LLC	ETHAMBUTOL HYDROCHLORIDE	100	mg/1	Antimycobacterial [EPC]		N	20241231
68850-012_d811b183-f875-3ea9-e053-2995a90af90f	68850-012	HUMAN PRESCRIPTION DRUG	Myambutol		Ethambutol hydrochloride	TABLET, FILM COATED	ORAL	20070810		NDA	NDA016320	STI Pharma, LLC	ETHAMBUTOL HYDROCHLORIDE	400	mg/1	Antimycobacterial [EPC]		N	20241231
68875-0101_a78a4c75-4c8b-4740-a83e-8afe0256a0c1	68875-0101	HUMAN PRESCRIPTION DRUG	Gattex		teduglutide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20121221		NDA	NDA203441	Takeda Pharmaceuticals America, Inc.	TEDUGLUTIDE	5	mg/.5mL	Analogs/Derivatives [Chemical/Ingredient], GLP-2 Analog [EPC], Glucagon-Like Peptide 2 [Chemical/Ingredient], Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]		N	20241231
68875-0102_a78a4c75-4c8b-4740-a83e-8afe0256a0c1	68875-0102	HUMAN PRESCRIPTION DRUG	Gattex		teduglutide	KIT		20121221		NDA	NDA203441	Takeda Pharmaceuticals America, Inc.						N	20241231
68875-0103_a78a4c75-4c8b-4740-a83e-8afe0256a0c1	68875-0103	HUMAN PRESCRIPTION DRUG	Gattex		teduglutide	KIT		20121221		NDA	NDA203441	Takeda Pharmaceuticals America, Inc.						N	20241231
68875-0202_c630d391-7567-400e-803c-b3e3bd13c9f5	68875-0202	HUMAN PRESCRIPTION DRUG	NATPARA (parathyroid hormone)		PARATHYROID HORMONE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20150123		BLA	BLA125511	Takeda Pharmaceuticals America, Inc.	PARATHYROID HORMONE	25	ug/.08mL	Parathyroid Hormone [CS], Parathyroid Hormone [EPC]		N	20241231
68875-0203_c630d391-7567-400e-803c-b3e3bd13c9f5	68875-0203	HUMAN PRESCRIPTION DRUG	NATPARA (parathyroid hormone)		PARATHYROID HORMONE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20150123		BLA	BLA125511	Takeda Pharmaceuticals America, Inc.	PARATHYROID HORMONE	50	ug/.08mL	Parathyroid Hormone [CS], Parathyroid Hormone [EPC]		N	20241231
68875-0204_c630d391-7567-400e-803c-b3e3bd13c9f5	68875-0204	HUMAN PRESCRIPTION DRUG	NATPARA (parathyroid hormone)		PARATHYROID HORMONE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20150123		BLA	BLA125511	Takeda Pharmaceuticals America, Inc.	PARATHYROID HORMONE	75	ug/.08mL	Parathyroid Hormone [CS], Parathyroid Hormone [EPC]		N	20241231
68875-0205_c630d391-7567-400e-803c-b3e3bd13c9f5	68875-0205	HUMAN PRESCRIPTION DRUG	NATPARA (parathyroid hormone)		PARATHYROID HORMONE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20150123		BLA	BLA125511	Takeda Pharmaceuticals America, Inc.	PARATHYROID HORMONE	100	ug/.08mL	Parathyroid Hormone [CS], Parathyroid Hormone [EPC]		N	20241231
68877-001_0804636f-d98e-8566-e063-6294a90a1a4e	68877-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20040525		NDA	NDA205849	United States Cylinder Gas Corporation	OXYGEN	990	mL/L			N	20241231
68877-003_08046b49-a8b7-a78d-e063-6394a90a80fa	68877-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20101010		NDA	NDA205850	United States Cylinder Gas Corporation	NITROGEN	990	mL/L			N	20241231
68927-3490_0976dfc5-c387-11fe-e063-6294a90aa2bb	68927-3490	HUMAN OTC DRUG	ClotrimazOil Antifungal		CLOTRIMAZOLE	SOLUTION	TOPICAL	20130619		OTC MONOGRAPH DRUG	M005	Pedifix, Inc.	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
68957-2000_0e0c62d9-cfba-4f18-e063-6394a90a8150	68957-2000	HUMAN OTC DRUG	BSAFE3 Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Active Creations LLC	ALCOHOL	.7	mL/mL			N	20251231
68957-2001_0e0c9b50-2b05-680c-e063-6394a90ae2a0	68957-2001	HUMAN OTC DRUG	BSAFE3 Sanitizing		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Active Creations LLC	ALCOHOL	.7	mL/mL			N	20251231
68957-2003_0e0ca73c-b761-6843-e063-6394a90a97b6	68957-2003	HUMAN OTC DRUG	BSAFE3 Sanitizing		ALCOHOL	LIQUID	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Active Creations LLC	ALCOHOL	.7	mL/mL			N	20251231
68968-0172_f98aaf2b-9c84-489d-9693-49b246c37aac	68968-0172	HUMAN PRESCRIPTION DRUG	SECUADO		ASENAPINE	FILM, EXTENDED RELEASE	TRANSDERMAL	20200212		NDA	NDA212268	Noven Therapeutics, LLC	ASENAPINE	3.8	mg/d	Atypical Antipsychotic [EPC]		N	20241231
68968-0173_f98aaf2b-9c84-489d-9693-49b246c37aac	68968-0173	HUMAN PRESCRIPTION DRUG	SECUADO		ASENAPINE	FILM, EXTENDED RELEASE	TRANSDERMAL	20200212		NDA	NDA212268	Noven Therapeutics, LLC	ASENAPINE	5.7	mg/d	Atypical Antipsychotic [EPC]		N	20241231
68968-0174_f98aaf2b-9c84-489d-9693-49b246c37aac	68968-0174	HUMAN PRESCRIPTION DRUG	SECUADO		ASENAPINE	FILM, EXTENDED RELEASE	TRANSDERMAL	20200212		NDA	NDA212268	Noven Therapeutics, LLC	ASENAPINE	7.6	mg/d	Atypical Antipsychotic [EPC]		N	20241231
68968-0205_e5900a68-2bd4-4c69-9caf-131164062979	68968-0205	HUMAN PRESCRIPTION DRUG	XELSTRYM		DEXTROAMPHETAMINE	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230515		NDA	NDA215401	Noven Therapeutics, LLC	DEXTROAMPHETAMINE	4.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-0210_e5900a68-2bd4-4c69-9caf-131164062979	68968-0210	HUMAN PRESCRIPTION DRUG	XELSTRYM		DEXTROAMPHETAMINE	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230515		NDA	NDA215401	Noven Therapeutics, LLC	DEXTROAMPHETAMINE	9	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-0215_e5900a68-2bd4-4c69-9caf-131164062979	68968-0215	HUMAN PRESCRIPTION DRUG	XELSTRYM		DEXTROAMPHETAMINE	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230515		NDA	NDA215401	Noven Therapeutics, LLC	DEXTROAMPHETAMINE	13.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-0220_e5900a68-2bd4-4c69-9caf-131164062979	68968-0220	HUMAN PRESCRIPTION DRUG	XELSTRYM		DEXTROAMPHETAMINE	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230515		NDA	NDA215401	Noven Therapeutics, LLC	DEXTROAMPHETAMINE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-0514_896bcf80-71a5-11ed-8a30-0800200c9a66	68968-0514	HUMAN PRESCRIPTION DRUG	CombiPatch (estradiol/norethindrone acetate transdermal system)		estradiol/norethindrone acetate transdermal system	PATCH, EXTENDED RELEASE	TRANSDERMAL	19980807		NDA	NDA020870	Noven Therapeutics, LLC	ESTRADIOL; NORETHINDRONE ACETATE	.05; .14	mg/d; mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68968-0525_896bcf80-71a5-11ed-8a30-0800200c9a66	68968-0525	HUMAN PRESCRIPTION DRUG	CombiPatch (estradiol/norethindrone acetate transdermal system)		estradiol/norethindrone acetate transdermal system	PATCH, EXTENDED RELEASE	TRANSDERMAL	19980807		NDA	NDA020870	Noven Therapeutics, LLC	ESTRADIOL; NORETHINDRONE ACETATE	.05; .25	mg/d; mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
68968-3410_fbb23644-32d7-41d3-aee8-3cc21be5e20b	68968-3410	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20180101		NDA AUTHORIZED GENERIC	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-3425_fbb23644-32d7-41d3-aee8-3cc21be5e20b	68968-3425	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20180101		NDA AUTHORIZED GENERIC	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-3437_fbb23644-32d7-41d3-aee8-3cc21be5e20b	68968-3437	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20180101		NDA AUTHORIZED GENERIC	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-3450_fbb23644-32d7-41d3-aee8-3cc21be5e20b	68968-3450	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20180101		NDA AUTHORIZED GENERIC	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-3475_fbb23644-32d7-41d3-aee8-3cc21be5e20b	68968-3475	HUMAN PRESCRIPTION DRUG	Estradiol		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20180101		NDA AUTHORIZED GENERIC	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-5552_10543bdb-c8d6-4e0a-acb9-a890c888afe7	68968-5552	HUMAN PRESCRIPTION DRUG	Daytrana		methylphenidate	PATCH	TRANSDERMAL	20060406		NDA	NDA021514	Noven Therapeutics, LLC	METHYLPHENIDATE	10	mg/9h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-5553_10543bdb-c8d6-4e0a-acb9-a890c888afe7	68968-5553	HUMAN PRESCRIPTION DRUG	Daytrana		methylphenidate	PATCH	TRANSDERMAL	20060406		NDA	NDA021514	Noven Therapeutics, LLC	METHYLPHENIDATE	15	mg/9h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-5554_10543bdb-c8d6-4e0a-acb9-a890c888afe7	68968-5554	HUMAN PRESCRIPTION DRUG	Daytrana		methylphenidate	PATCH	TRANSDERMAL	20060406		NDA	NDA021514	Noven Therapeutics, LLC	METHYLPHENIDATE	20	mg/9h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-5555_10543bdb-c8d6-4e0a-acb9-a890c888afe7	68968-5555	HUMAN PRESCRIPTION DRUG	Daytrana		methylphenidate	PATCH	TRANSDERMAL	20060406		NDA	NDA021514	Noven Therapeutics, LLC	METHYLPHENIDATE	30	mg/9h	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
68968-6610_d8c14d54-7bf5-4d33-ba1c-c71232d556ca	68968-6610	HUMAN PRESCRIPTION DRUG	Minivelle		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20121220		NDA	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-6625_d8c14d54-7bf5-4d33-ba1c-c71232d556ca	68968-6625	HUMAN PRESCRIPTION DRUG	Minivelle		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20121220		NDA	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-6637_d8c14d54-7bf5-4d33-ba1c-c71232d556ca	68968-6637	HUMAN PRESCRIPTION DRUG	Minivelle		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20121220		NDA	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-6650_d8c14d54-7bf5-4d33-ba1c-c71232d556ca	68968-6650	HUMAN PRESCRIPTION DRUG	Minivelle		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20121220		NDA	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68968-6675_d8c14d54-7bf5-4d33-ba1c-c71232d556ca	68968-6675	HUMAN PRESCRIPTION DRUG	Minivelle		estradiol	FILM, EXTENDED RELEASE	TRANSDERMAL	20121220		NDA	NDA203752	Noven Therapeutics, LLC	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
68974-200_6ed15d2c-3348-4c27-9853-414cb9e4bb94	68974-200	HUMAN PRESCRIPTION DRUG	FILSPARI		sparsentan	TABLET, FILM COATED	ORAL	20230217		NDA	NDA216403	Travere Therapeutics, Inc.	SPARSENTAN	200	mg/1			N	20241231
68974-400_6ed15d2c-3348-4c27-9853-414cb9e4bb94	68974-400	HUMAN PRESCRIPTION DRUG	FILSPARI		sparsentan	TABLET, FILM COATED	ORAL	20230217		NDA	NDA216403	Travere Therapeutics, Inc.	SPARSENTAN	400	mg/1			N	20241231
68974-876_7575f72a-6d23-4d7e-b2a7-ca8f5c70b3e3	68974-876	HUMAN PRESCRIPTION DRUG	Chenodal		Chenodiol	TABLET, FILM COATED	ORAL	20151228		ANDA	ANDA091019	Travere Therapeutics	CHENODIOL	250	mg/1			N	20241231
68978-141_87fc1214-a21a-32df-e053-2995a90a72e4	68978-141	HUMAN OTC DRUG	Medi-Hands		Chloroxylenol	SOAP	TOPICAL	20140506		OTC MONOGRAPH NOT FINAL	part333A	Topmost Chemical & Paper Corporation	CHLOROXYLENOL	3.75	mg/mL			N	20241231
68978-708_ab973869-205b-7943-e053-2a95a90a7700	68978-708	HUMAN OTC DRUG	Medi-Hands		Chloroxylenol	SOAP	TOPICAL	20140506		OTC MONOGRAPH NOT FINAL	part333A	Topmost Chemical & Paper Corporation	CHLOROXYLENOL	3.75	mg/mL			N	20241231
68982-139_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-139	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20160101		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-141_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-141	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20160101		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-143_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-143	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20160101		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-145_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-145	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20160101		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-147_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-147	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20170801		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-149_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-149	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20170801		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-151_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-151	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20170801		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-153_b820bdc4-4c06-2947-c30d-fc0a44c57507	68982-153	PLASMA DERIVATIVE	NUWIQ		Antihemophilic Factor (Recombinant)	KIT	INTRAVENOUS	20211212		BLA	BLA125555	Octapharma USA Inc						N	20241231
68982-182_9edf9c27-9e48-3067-d2ef-007960627f79	68982-182	PLASMA DERIVATIVE	Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human)		von Willebrand Factor/Coagulation Factor VIII Complex (Human)	POWDER, FOR SOLUTION	INTRAVENOUS	20091204		BLA	BLA125251	Octapharma USA Inc	ANTIHEMOPHILIC FACTOR HUMAN; VON WILLEBRAND FACTOR HUMAN	100; 100	[iU]/mL; [iU]/mL	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Factor VIII [CS], Human Antihemophilic Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Increased Platelet Aggregation [PE], von Willebrand Factor [CS]		N	20241231
68982-261_5be10bd2-a785-7f3b-0d28-d066cd5f7d24	68982-261	PLASMA DERIVATIVE	Balfaxar		Prothrombin Complex Concentrate (Human)	POWDER, FOR SOLUTION	INTRAVENOUS	20231130		BLA	BLA125776	Octapharma USA Inc	COAGULATION FACTOR IX HUMAN; COAGULATION FACTOR VII HUMAN; COAGULATION FACTOR X HUMAN; PROTEIN C; PROTEIN S HUMAN; PROTHROMBIN	25.5; 16.5; 24; 22; 22; 26	[iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL	Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Decreased Coagulation Factor Activity [PE], Enzyme Precursors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Protein C [CS]		N	20241231
68982-347_0bdefd2a-8e03-2f0f-b075-c3b2b1574807	68982-347	PLASMA DERIVATIVE	Fibryga		Fibrinogen (Human)	KIT	INTRAVENOUS	20171016		BLA	BLA125612	Octapharma USA Inc						N	20241231
68982-623_48ce7e9f-0239-c1b5-ee8e-004cbe7b87ab	68982-623	PLASMA DERIVATIVE	Albumin (Human)		Albumin Human	SOLUTION	INTRAVENOUS	20061017		BLA	BLA125154	Octapharma USA Inc	ALBUMIN HUMAN	50	g/1000mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68982-633_056bff0d-c240-6ab8-a600-8d5de369b733	68982-633	PLASMA DERIVATIVE	Albumin (Human)		Albumin Human	SOLUTION	INTRAVENOUS	20061017		BLA	BLA125154	Octapharma USA Inc	ALBUMIN HUMAN	200	g/1000mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68982-643_a7f20f1e-404c-4c20-9cf6-e0f6074aa531	68982-643	PLASMA DERIVATIVE	Albumin (Human)		Albumin Human	SOLUTION	INTRAVENOUS	20061017		BLA	BLA125154	Octapharma USA Inc	ALBUMIN HUMAN	250	g/1000mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
68982-810_92279fbb-b633-80a9-0e99-5883db7ca60b	68982-810	PLASMA DERIVATIVE	Cutaquig		immunoglobulin G	SOLUTION	SUBCUTANEOUS	20190503		BLA	BLA125668	Octapharma USA Inc	HUMAN IMMUNOGLOBULIN G	165	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
68982-822_1db52a61-d294-2673-1e73-d47e89ca3d24	68982-822	PLASMA DERIVATIVE	Panzyga		immune globulin intravenous (human)	SOLUTION	INTRAVENOUS	20181112		BLA	BLA125587	Octapharma USA Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
68982-840_1ceaed06-d43c-a23d-a4e0-dce0de4ad7f0	68982-840	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20040521		BLA	BLA125062	Octapharma USA Inc	HUMAN IMMUNOGLOBULIN G	50	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
68982-850_3341403e-ae11-5eae-adf5-63ebc0703d25	68982-850	PLASMA DERIVATIVE	Octagam Immune Globulin (Human)		Immune Globulin	SOLUTION	INTRAVENOUS	20040521		BLA	BLA125062	Octapharma USA Inc	HUMAN IMMUNOGLOBULIN G	100	mg/mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
68982-952_803d75a2-619b-bbe1-1e3e-9575acdb8b80	68982-952	PLASMA DERIVATIVE	Octaplas		human plasma proteins	SOLUTION	INTRAVENOUS	20130718		BLA	BLA125416	Octapharma USA Inc	PLASMA PROTEIN FRACTION (HUMAN)	11.5	g/200mL			N	20241231
68982-953_80af7944-a20d-fdcb-7545-4d4619cb06a7	68982-953	PLASMA DERIVATIVE	Octaplas		human plasma proteins	SOLUTION	INTRAVENOUS	20130718		BLA	BLA125416	Octapharma USA Inc	PLASMA PROTEIN FRACTION (HUMAN)	11.5	g/200mL			N	20241231
68982-954_da7c6b0f-9f51-72d3-b19a-abaf528b6250	68982-954	PLASMA DERIVATIVE	Octaplas		human plasma proteins	SOLUTION	INTRAVENOUS	20130718		BLA	BLA125416	Octapharma USA Inc	PLASMA PROTEIN FRACTION (HUMAN)	11.5	g/200mL			N	20241231
68982-955_647c0d20-be60-9d53-0905-4a6567b2c115	68982-955	PLASMA DERIVATIVE	Octaplas		human plasma proteins	SOLUTION	INTRAVENOUS	20130718		BLA	BLA125416	Octapharma USA Inc	PLASMA PROTEIN FRACTION (HUMAN)	11.5	g/200mL			N	20241231
68984-001_1d588a49-74f5-42d1-8e55-5c6e2fcd7e89	68984-001	HUMAN OTC DRUG	Vagical		Calendula Officinalis Flowering Top	INSERT	VAGINAL	20140529		UNAPPROVED HOMEOPATHIC		Farmina sp. z o.o.	CALENDULA OFFICINALIS FLOWERING TOP	150	mg/1			N	20241231
68984-121_fb3e279d-b2f7-a3bb-e053-6394a90a3851	68984-121	HUMAN OTC DRUG	Unpaste		Zero waste fluoride cinnamon tooth tabs	TABLET, CHEWABLE	DENTAL	20220110		OTC MONOGRAPH FINAL	part355	Farmina sp. z.o.o.	SODIUM FLUORIDE	.62	mg/1			N	20241231
68984-122_fb3e3520-7412-7e8e-e053-6294a90ae0cc	68984-122	HUMAN OTC DRUG	Unpaste		Zero waste fluoride mint tooth tabs	TABLET, CHEWABLE	DENTAL	20220110		OTC MONOGRAPH FINAL	part355	Farmina sp. z.o.o.	SODIUM FLUORIDE	.62	mg/1			N	20241231
68987-001_d5941b5e-5884-3b4d-e053-2995a90a4234	68987-001	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-002_d59426f2-5b8a-f07d-e053-2a95a90a782c	68987-002	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-003_d59426f2-5b96-f07d-e053-2a95a90a782c	68987-003	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-004_d5942fdf-570d-12d8-e053-2995a90a636b	68987-004	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-005_d5943415-2569-3bc5-e053-2995a90ad8ff	68987-005	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-006_d5943415-2575-3bc5-e053-2995a90ad8ff	68987-006	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-007_d5943415-2581-3bc5-e053-2995a90ad8ff	68987-007	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-008_d5944422-d62c-8304-e053-2a95a90a70d4	68987-008	HUMAN OTC DRUG	PureLife Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	PureLife Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
68987-010_d5f3265c-e761-acf1-e053-2a95a90ae389	68987-010	HUMAN PRESCRIPTION DRUG	PureLife APF		Sodium Fluoride	GEL	DENTAL	20121218		UNAPPROVED DRUG OTHER		PureLife Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68987-011_d5f37b59-8611-1f0e-e053-2995a90a3bd9	68987-011	HUMAN PRESCRIPTION DRUG	PureLife APF		Sodium Fluoride	GEL	DENTAL	20121218		UNAPPROVED DRUG OTHER		PureLife Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68987-012_d5f3e776-11ac-7413-e053-2995a90a4603	68987-012	HUMAN PRESCRIPTION DRUG	PureLife APF		Sodium Fluoride	GEL	DENTAL	20121218		UNAPPROVED DRUG OTHER		PureLife Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68987-013_d5f3e776-11f8-7413-e053-2995a90a4603	68987-013	HUMAN PRESCRIPTION DRUG	PureLife APF		Sodium Fluoride	GEL	DENTAL	20121218		UNAPPROVED DRUG OTHER		PureLife Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68987-014_d5f3f5c7-2f83-2e1c-e053-2995a90a1e8a	68987-014	HUMAN PRESCRIPTION DRUG	PureLife APF		Sodium Fluoride	GEL	DENTAL	20121218		UNAPPROVED DRUG OTHER		PureLife Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
68991-002_f70f2964-008f-4700-ba0a-fb8c2efe885e	68991-002	HUMAN OTC DRUG	Mayer /Kang Du Qing Cybercy		POLOXAMER 188	GEL	VAGINAL	20110520		OTC MONOGRAPH DRUG	M003	Shenzhen Senton Science & Technology Co. Ltd	POLOXAMER 188	2.7	g/100g			N	20241231
68992-3010_143068f5-f67c-457f-b742-a5a6abafb36b	68992-3010	HUMAN PRESCRIPTION DRUG	Envarsus	XR	Tacrolimus	TABLET, EXTENDED RELEASE	ORAL	20150901		NDA	NDA206406	Veloxis Pharmaceuticals, Inc	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68992-3040_143068f5-f67c-457f-b742-a5a6abafb36b	68992-3040	HUMAN PRESCRIPTION DRUG	Envarsus	XR	Tacrolimus	TABLET, EXTENDED RELEASE	ORAL	20150901		NDA	NDA206406	Veloxis Pharmaceuticals, Inc	TACROLIMUS	4	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68992-3075_143068f5-f67c-457f-b742-a5a6abafb36b	68992-3075	HUMAN PRESCRIPTION DRUG	Envarsus	XR	Tacrolimus	TABLET, EXTENDED RELEASE	ORAL	20150901		NDA	NDA206406	Veloxis Pharmaceuticals, Inc	TACROLIMUS	.75	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
68998-001_7cc4c7e9-5d9c-01f9-e053-2a91aa0ad740	68998-001	HUMAN OTC DRUG	Pain Reliever	Regular Strength	Acetaminophen	TABLET	ORAL	20080301		OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
68998-004_efba9699-c519-1808-e053-2a95a90a2c75	68998-004	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20080301	20241231	OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ACETAMINOPHEN	500	mg/1			N	
68998-011_af0f9bd2-3b61-967a-e053-2995a90a9f6a	68998-011	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200501		ANDA	ANDA202312	MARC GLASSMAN, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68998-012_af0fa2a5-9869-287f-e053-2995a90acc5d	68998-012	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200301		ANDA	ANDA202312	MARC GLASSMAN, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68998-018_7cc4d165-c2d6-1dab-e053-2a91aa0a3207	68998-018	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20091101		OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68998-046_81a0328d-4a00-4331-b9c3-aaedaf455e51	68998-046	HUMAN OTC DRUG	Bismuth Chewable		Bismuth Subsalicylate 262 mg	TABLET, CHEWABLE	ORAL	20030428		OTC MONOGRAPH DRUG	M008	Marc Glassman, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
68998-070_e8ce9208-e38f-f34d-e053-2995a90aedf7	68998-070	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20220915		OTC MONOGRAPH NOT FINAL	part343	MARC GLASSMAN, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
68998-071_e8ce9367-f5e8-9b7f-e053-2a95a90a6549	68998-071	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20220915		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-072_b810f5f7-60ee-4ece-9681-f891f1ed0ea0	68998-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyol salicylate, Thymol	MOUTHWASH	ORAL	20190422		OTC MONOGRAPH NOT FINAL	part348	Marc Glassman, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68998-076_d7ab9f11-858d-41fb-b64f-614a194703c2	68998-076	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET, COATED	ORAL	20140701		OTC MONOGRAPH DRUG	M011	Marc Glassman, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
68998-080_91ceb6fb-68f0-1c2f-e053-2a95a90a8e5e	68998-080	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20080304		OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68998-081_7cc4dcfc-cae1-94f8-e053-2991aa0a8852	68998-081	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20080301		OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68998-090_ea619c46-d70a-ef45-e053-2a95a90a124c	68998-090	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20080301		OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-091_ea619c46-d6f8-ef45-e053-2a95a90a124c	68998-091	HUMAN OTC DRUG	Rest Simply		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20081231		OTC MONOGRAPH FINAL	part338	Marc Glassman, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-092_f49e1fac-fc0e-7b74-e053-2995a90a37eb	68998-092	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20131231	20250630	OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ACETAMINOPHEN	500	mg/1			N	
68998-095_ee9df20b-781a-49e7-e053-2a95a90a00ac	68998-095	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20080301	20250228	OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
68998-098_ef2c4b1c-1688-adeb-e053-2995a90afa8f	68998-098	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20100101	20240630	OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ACETAMINOPHEN	500	mg/1			N	
68998-101_756b0957-6550-42d2-ac67-4465b91cb9a5	68998-101	HUMAN OTC DRUG	Regular strength	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190418		OTC MONOGRAPH DRUG	M001	MARC GLASSMAN, INC.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
68998-102_1a1f691c-c582-4c8b-a8d3-4a1ca4cfe662	68998-102	HUMAN OTC DRUG	Marc Glassman	Extra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH DRUG	M001	MARC GLASSMAN, INC.	CALCIUM CARBONATE	750	mg/1			N	20241231
68998-103_77cecae7-89b0-486a-b34d-8654a439cbe0	68998-103	HUMAN OTC DRUG	Marc Glassman	Ultra Strength	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190417		OTC MONOGRAPH DRUG	M001	MARC GLASSMAN, INC	CALCIUM CARBONATE	1000	mg/1			N	20241231
68998-104_ea619c46-d71b-ef45-e053-2a95a90a124c	68998-104	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH NOT FINAL	part343	MARC GLASSMAN, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
68998-109_91c2173e-e271-55d6-e053-2995a90ab631	68998-109	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20090601		ANDA	ANDA079174	Marc Glassman, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68998-110_7cecdc2f-b792-7be8-e053-2991aa0aae42	68998-110	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20090601		ANDA	ANDA079174	Marc Glassman, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68998-113_ea616a84-8b87-221e-e053-2995a90a1851	68998-113	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20080301		OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-114_958d9b42-6cb8-4086-89d4-0949d88ad5f7	68998-114	HUMAN OTC DRUG	Marcs Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20120801		OTC MONOGRAPH FINAL	part341	Marc Glassman Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
68998-119_efbab02f-5bcd-47cd-e053-2a95a90ac36c	68998-119	HUMAN OTC DRUG	Severe Sinus		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20100201	20241231	OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
68998-123_0ea71997-4922-a72e-e063-6294a90a52da	68998-123	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	TABLET	ORAL	20180501		ANDA	ANDA074091	Marc Glassman, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
68998-131_7cebbd3e-ef50-2e48-e053-2a91aa0ac225	68998-131	HUMAN OTC DRUG	Nasal Decongestant		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20080301		OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-132_eaa7ebdb-6e4a-4368-a51c-587ed79bfdac	68998-132	HUMAN OTC DRUG	Marcs 2 in 1 Everyday Care Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20131115		OTC MONOGRAPH FINAL	part358H	Mark Glassman, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
68998-133_0f88d6a9-5970-46fb-9243-16475b5df7ae	68998-133	HUMAN OTC DRUG	Marcs Dry Scalp Care Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20131004		OTC MONOGRAPH FINAL	part358H	Mark Glassman, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
68998-134_ee9556ed-7632-4103-a40a-3b2b0ba47214	68998-134	HUMAN OTC DRUG	Marcs Everyday Care Dandruff	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20111130		OTC MONOGRAPH FINAL	part358H	Mark Glassman, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
68998-136_ee9df20b-781b-49e7-e053-2a95a90a00ac	68998-136	HUMAN OTC DRUG	Severe Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20100201	20240531	OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
68998-138_efbaaf1e-839c-2719-e053-2995a90a702b	68998-138	HUMAN OTC DRUG	Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20100201	20240630	OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
68998-139_ea60b4c2-b652-61cf-e053-2995a90a6f56	68998-139	HUMAN OTC DRUG	Cold Multi-Symptom Nighttime		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20100127		OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-144_7cebb078-e291-4d1a-e053-2991aa0af859	68998-144	HUMAN OTC DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET, COATED	ORAL	20090601		ANDA	ANDA079096	Marc Glassman, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68998-145_7cebb3f5-350d-4d1c-e053-2991aa0a481d	68998-145	HUMAN OTC DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET, COATED	ORAL	20090531		ANDA	ANDA079096	Marc Glassman, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68998-146_7cebac84-e0fe-7ae3-e053-2a91aa0a3ff5	68998-146	HUMAN OTC DRUG	ASPIRIN	Low Dose	ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20100601		OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68998-163_efbabe49-d1cd-1865-e053-2995a90aff0f	68998-163	HUMAN OTC DRUG	Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120901	20241231	OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
68998-170_ed9801e3-ba8a-009b-e053-2995a90a8af2	68998-170	HUMAN OTC DRUG	Pain Reliever	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20140501	20250131	OTC MONOGRAPH NOT FINAL	part343	Marc Glassman, Inc.	ACETAMINOPHEN	500	mg/1			N	
68998-175_7cebf003-9b2e-f398-e053-2a91aa0a62c2	68998-175	HUMAN OTC DRUG	Severe Cold Head Congestion		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20150401		OTC MONOGRAPH FINAL	part341	Marc Glassman, Inc.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-185_7cecc416-5bfa-02fd-e053-2991aa0aa6e1	68998-185	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170901		ANDA	ANDA079205	MARC GLASSMAN, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
68998-194_ea60a2f4-2e8f-c1f1-e053-2a95a90a286a	68998-194	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20200301		ANDA	ANDA209274	MARC GLASSMAN, INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-195_ea619a0f-a337-6ff9-e053-2995a90af10e	68998-195	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-198_ea618fdb-b393-6ff7-e053-2995a90a830f	68998-198	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH NOT FINAL	part343	MARC GLASSMAN, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
68998-200_ec6cbc71-8e03-61ba-e053-2a95a90a68f7	68998-200	HUMAN OTC DRUG	Marcs	Daily Moisturizing with Natural Colloidal Oatmeal	Dimethicone	LOTION	TOPICAL	20190909		OTC MONOGRAPH FINAL	part347	MARC GLASSMAN, INC.	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
68998-201_ec6ce63a-065e-272d-e053-2a95a90a5472	68998-201	HUMAN OTC DRUG	Marcs	Daily Moisturizing with Soy and Natural Colloidal Oatmeal	Dimethicone	LOTION	TOPICAL	20190909		OTC MONOGRAPH FINAL	part347	MARC GLASSMAN, INC.	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
68998-205_d0d5af0f-efdd-05c7-e053-2a95a90a6c16	68998-205	HUMAN OTC DRUG	Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20210831		OTC MONOGRAPH NOT FINAL	part343	MARC GLASSMAN, INC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
68998-219_ea616a84-8b72-221e-e053-2995a90a1851	68998-219	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-220_ea616a84-8b5b-221e-e053-2995a90a1851	68998-220	HUMAN OTC DRUG	Sinus Pressure plus Pain PE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200622		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-228_ea60c0b6-969f-18fc-e053-2995a90a347d	68998-228	HUMAN OTC DRUG	Allergy Multi Symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200622		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-231_ea60bde8-95fb-0d77-e053-2995a90a4a9f	68998-231	HUMAN OTC DRUG	Sinus Congestion PE	Maximum Strength	PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-233_766a5d7c-4e26-4cf0-bce7-d522db810f82	68998-233	HUMAN OTC DRUG	Marcs Twin Pack		SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20170206		OTC MONOGRAPH NOT FINAL	part334	Marc Glassman Inc.	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	19; 7	g/133mL; g/133mL			N	20241231
68998-238_ea60c0b6-9689-18fc-e053-2995a90a347d	68998-238	HUMAN OTC DRUG	Cold Max		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-248_a9d20c87-e8b0-43dc-9a44-806668617978	68998-248	HUMAN OTC DRUG	Anti-Diarrheal		Marc Glassman	CAPSULE	ORAL	20050503		ANDA	ANDA076497	Marc Glassman, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
68998-263_ea60b4c2-b63c-61cf-e053-2995a90a6f56	68998-263	HUMAN OTC DRUG	Cold plus Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-275_ea60a08a-f526-c484-e053-2a95a90a8e54	68998-275	HUMAN OTC DRUG	Cold plus Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-277_260b7a08-4f47-40ca-aa36-7647d20d7edd	68998-277	HUMAN OTC DRUG	Allergy		Chlorpheniramine Maleate	TABLET, COATED	ORAL	20141215		OTC MONOGRAPH DRUG	M012	Marc Glassman, Inc.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-292_ea60b4c2-b62a-61cf-e053-2995a90a6f56	68998-292	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210709		ANDA	ANDA211075	MARC GLASSMAN, INC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68998-300_bccb55cc-368a-54a0-e053-2a95a90ad8eb	68998-300	HUMAN OTC DRUG	Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20200331		ANDA	ANDA211544	MARC GLASSMAN, INC.	ACETAMINOPHEN	650	mg/1			N	20241231
68998-301_ec7dc1f6-1fbb-4bf1-e053-2a95a90a3b93	68998-301	HUMAN OTC DRUG	Pain Relief	Regular Strength	Acetaminophen	TABLET	ORAL	20221005		OTC MONOGRAPH NOT FINAL	part343	MARC GLASSMAN, INC.	ACETAMINOPHEN	325	mg/1			N	20241231
68998-318_bae06680-a2f2-4e68-b45c-d752e1a71b42	68998-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20190415		OTC MONOGRAPH NOT FINAL	part356	Marc Glassman, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68998-323_ea616a84-8b46-221e-e053-2995a90a1851	68998-323	HUMAN OTC DRUG	Sinus plus Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200615		OTC MONOGRAPH FINAL	part341	MARC GLASSMAN, INC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
68998-370_2d873edb-e680-4901-9949-882207b56a17	68998-370	HUMAN OTC DRUG	Advanced		Ethyl Alcohol	GEL	TOPICAL	20120927		OTC MONOGRAPH NOT FINAL	part333A	Marc Glassman, Inc	ALCOHOL	70	mL/100mL			N	20241231
68998-373_2094582c-bfb6-4ec7-8ca6-673215095a70	68998-373	HUMAN OTC DRUG	Senna-Lax		Sennosides	TABLET	ORAL	20140701		OTC MONOGRAPH DRUG	M007	Marc Glassman, Inc.	SENNOSIDES	8.6	mg/1			N	20241231
68998-392_ea619a0f-a34d-6ff9-e053-2995a90af10e	68998-392	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20221005		OTC MONOGRAPH NOT FINAL	part343	MARC GLASSMAN, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
68998-398_7b1da38c-162c-40c4-9d28-8a44e56bc993	68998-398	HUMAN OTC DRUG	Womens Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20140701		OTC MONOGRAPH DRUG	M007	Marc Glassman, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68998-401_092dc75a-fb8c-5f53-e063-6294a90adf6b	68998-401	HUMAN OTC DRUG	8 Hour Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20221005		ANDA	ANDA211544	MARC GLASSMAN, INC.	ACETAMINOPHEN	650	mg/1			N	20241231
68998-404_c6ba2070-1a43-4ee2-b6f6-93c290c183c5	68998-404	HUMAN OTC DRUG	Laxative	Enteric Coated	Bisacodyl 5mg	TABLET, SUGAR COATED	ORAL	20020325		OTC MONOGRAPH DRUG	M007	Marc Glassman, Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
68998-414_ad095cf5-0a18-4a1f-8881-b6b2cd4fa1f7	68998-414	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20200501		ANDA	ANDA210722	Marc Glassman, Inc.	LORATADINE	10	mg/1			N	20241231
68998-419_26a0fc9c-23e3-4cb0-bed3-a9c451b3c66b	68998-419	HUMAN OTC DRUG	Anti-Gas		Simethicone	CAPSULE	ORAL	20150128		OTC MONOGRAPH DRUG	M002	Marc Glassman, Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
68998-420_c80e0e2e-d701-4de9-97cc-a908e9301d59	68998-420	HUMAN OTC DRUG	Stool Softener		Marc Glassman	CAPSULE	ORAL	20150410		OTC MONOGRAPH DRUG	M007	Marc Glassman, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
68998-600_ed84f2f6-af2e-f245-0d4b-cf2da42329de	68998-600	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20170703		ANDA	ANDA208150	Marc Glassman, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
68998-664_de385003-b713-4d74-9499-cfe16bb0adb6	68998-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20190422		OTC MONOGRAPH NOT FINAL	part356	Marc Glassman, Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
68998-715_ba88ea2b-c7bd-41b5-95ea-8c8218bafd22	68998-715	HUMAN OTC DRUG	Marc Glassman	Maximum Strength	oxymetazoline hydrochloride	SPRAY	NASAL	20190516		OTC MONOGRAPH DRUG	M012	MARC GLASSMAN, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
68998-845_5a5b4d60-6d2b-4bf3-990d-648a2146358a	68998-845	HUMAN OTC DRUG	Marcs Mucus Relief		Guaifenesin	TABLET	ORAL	20200226		OTC MONOGRAPH FINAL	part341	Marc Glassman Inc	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
68998-939_1e5b54b1-a7d9-44ae-b2e5-0a77793ad13a	68998-939	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20121101		ANDA	ANDA077498	Marc Glassman, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
68999-309_f049eb75-5f01-5caa-e053-2a95a90a804c	68999-309	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	CHARTWELL GOVERNMENTAL & SPECIALTY RX LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
68999-417_00c95f8e-5b21-33ce-e063-6394a90aff5d	68999-417	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	POWDER, FOR SUSPENSION	ORAL	20080716		ANDA	ANDA065454	Chartwell Governmental & Specialty RX, LLC	DOXYCYCLINE	25	mg/5mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68999-625_00c95f8e-5b21-33ce-e063-6394a90aff5d	68999-625	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20210721		ANDA	ANDA062505	Chartwell Governmental & Specialty RX, LLC	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68999-626_00c95f8e-5b21-33ce-e063-6394a90aff5d	68999-626	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Chartwell Governmental & Specialty RX, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68999-825_06d2f795-50e9-fb94-e063-6294a90ae3f6	68999-825	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19780308		ANDA	ANDA062058	Chartwell Governmental & Specialty RX, LLC	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
68999-984_00c95f8e-5b21-33ce-e063-6394a90aff5d	68999-984	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Chartwell Governmental & Specialty RX, LLC	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
68999-985_00c95f8e-5b21-33ce-e063-6394a90aff5d	68999-985	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Chartwell Governmental & Specialty RX, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69004-001_d5f4ec89-a2a2-7062-e053-2a95a90a7ca3	69004-001	HUMAN OTC DRUG	GPS Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Group Practice Solutions, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69004-002_d65a579d-85f9-e5db-e053-2995a90a2a0e	69004-002	HUMAN OTC DRUG	GPS Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Group Practice Solutions, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69004-003_d5f5074d-2cda-0908-e053-2a95a90a8cdc	69004-003	HUMAN OTC DRUG	GPS Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Group Practice Solutions, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69004-004_d5f5120b-6212-8289-e053-2995a90a66e4	69004-004	HUMAN OTC DRUG	GPS Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Group Practice Solutions, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69004-005_d5f5156a-b773-2835-e053-2995a90a9543	69004-005	HUMAN OTC DRUG	GPS Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Group Practice Solutions, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69004-006_d5f52a0d-c5c6-7cb5-e053-2a95a90a3cb6	69004-006	HUMAN OTC DRUG	GPS Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	Group Practice Solutions, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69006-005_0b5a06ca-a315-a426-e063-6394a90a2de0	69006-005	HUMAN OTC DRUG	Viabecline First Aid Antibiotic		TETRACYCLINE HYDROCHLORIDE	OINTMENT	TOPICAL	20170513		OTC MONOGRAPH DRUG	M004	VIADERMA II, INC.	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
69006-010_0b592614-6dac-6464-e063-6294a90a68a0	69006-010	HUMAN OTC DRUG	Prolayed		LIDOCAINE	OINTMENT	TOPICAL	20170623		OTC MONOGRAPH DRUG	M004	ViaDerma, Inc	LIDOCAINE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69006-011_0b5a06ca-a305-a426-e063-6394a90a2de0	69006-011	HUMAN OTC DRUG	BWell First Aid Antibiotic		TETRACYCLINE HYDROCHLORIDE	OINTMENT	TOPICAL	20200501		OTC MONOGRAPH DRUG	M004	Viaderma II, Inc	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
69006-012_0b5a0b1d-6e4b-58f0-e063-6294a90af9fc	69006-012	HUMAN OTC DRUG	BWell First Aid Antibiotic		TETRACYCLINE HYDROCHLORIDE	SPRAY	TOPICAL	20200501		OTC MONOGRAPH DRUG	M004	Viaderma II, Inc	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
69019-001_f28bed30-758c-8f24-e053-2a95a90a41d2	69019-001	HUMAN OTC DRUG	Mens pura dor Hair Loss MD		Minoxidil 5%	SOLUTION	TOPICAL	20190927		ANDA	ANDA076239	Vitals International Group	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69024-001_06d2fbd2-874a-da4f-e063-6294a90a6f2f	69024-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140206		UNAPPROVED MEDICAL GAS		OxyPros Plus	OXYGEN	99	L/100L			N	20241231
69025-129_f544455d-fd74-454c-e053-2995a90a9bd9	69025-129	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209702	AIZANT DRUG RESEARCH SOLUTIONS PVT LTD	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69025-130_f544455d-fd74-454c-e053-2995a90a9bd9	69025-130	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209702	AIZANT DRUG RESEARCH SOLUTIONS PVT LTD	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69025-133_052773ec-d52e-718a-e063-6294a90a0587	69025-133	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211130		ANDA	ANDA215629	Aizant Drug Research Solutions PVT LTD	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
69026-279_ec962a22-a2e3-340c-e053-2995a90ab15d	69026-279	HUMAN OTC DRUG	Beauty Counter Dew Skin Moisturizer Fair	SPF 20	Zinc Oxide	LOTION	TOPICAL	20150401		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-280_ec963123-4b5b-6828-e053-2a95a90a0d9b	69026-280	HUMAN OTC DRUG	Beauty Counter Dew Skin Moisturizer Light	SPF 20	Zinc Oxide	LOTION	TOPICAL	20150401		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-281_ec963123-4b6a-6828-e053-2a95a90a0d9b	69026-281	HUMAN OTC DRUG	Beauty Counter Dew Skin Moisturizer Medium	SPF 20	Zinc Oxide	LOTION	TOPICAL	20150401		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LCC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-362_ec963504-a813-1d4b-e053-2995a90ae1fd	69026-362	HUMAN OTC DRUG	BeautyCounter Countersun Mineral Sunscreen	SPF30	Zinc Oxide	LOTION	TOPICAL	20180607		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	19	g/100mL			N	20241231
69026-363_ec963504-a822-1d4b-e053-2995a90ae1fd	69026-363	HUMAN OTC DRUG	BeautyCounter Countersun Mineral Sunscreen	SPF30	Zinc Oxide	STICK	TOPICAL	20180607		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	15.4	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-483_ec963504-a830-1d4b-e053-2995a90ae1fd	69026-483	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-484_ed37a7c4-6203-4d7d-e053-2995a90aa934	69026-484	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum No2	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-485_ec963ac5-9ae8-0d98-e053-2a95a90ad6d3	69026-485	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum No3	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-486_ec963ac5-9af5-0d98-e053-2a95a90ad6d3	69026-486	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum No4	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-487_ec963504-a841-1d4b-e053-2995a90ae1fd	69026-487	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum No5	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-488_ec963123-4b86-6828-e053-2a95a90a0d9b	69026-488	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum No6	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-489_ec9635b9-ba60-0bd6-e053-2a95a90aecb2	69026-489	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum No7	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-490_ec975b32-5ea6-3575-e053-2995a90a6780	69026-490	HUMAN OTC DRUG	Dew Skin Tinted Moisturizer Broad Spectrum No8	SPF 20	Zinc Oxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69026-497_ec975c9d-a140-db6c-e053-2995a90a9e8f	69026-497	HUMAN OTC DRUG	BeautyCounter Countersun Daily Sheer Defense for Face	SPF25	Zinc Oxide	LOTION	TOPICAL	20220501		OTC MONOGRAPH NOT FINAL	part352	Beauty Counter, LLC	ZINC OXIDE	14.9	g/100mL			N	20241231
69028-0003_a526f439-a9d4-c1c9-e053-2995a90ac78d	69028-0003	HUMAN OTC DRUG	Drainage		Cynara scolymus, Solidago virgaurea, Taraxacum officinale, Benzoicum acidum, Berberis vulgaris, Bryonia, Cantharis, Carduus benedictus, Carduus marianus, Ceanothus americanus, Chelidonium majus, Chionanthus virginica, Cinchona officinalis, Dioscorea villosa, Dolichos pruriens, Iris versicolor, Juniperus communis, Nux vomica, Ptelea trifoliata, Taraxacum officinale, Uricum.	LIQUID	ORAL	20200508		UNAPPROVED HOMEOPATHIC		Xymogen	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69039-212_d72d6e06-e4cd-bebc-e053-2995a90afb6a	69039-212	HUMAN OTC DRUG	Sun Bum SPF 15 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170824		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 50; 20; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-212_d912dabd-2535-7b4e-e053-2995a90ae323	69039-212	HUMAN OTC DRUG	SUN BUM SPF 15 PREMIUM MOISTURIZING SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220216		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 50; 20; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-213_d72e06bf-2f76-8e44-e053-2995a90a4fce	69039-213	HUMAN OTC DRUG	Sun Bum SPF 15 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170825		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 50; 20; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-214_d72f0aae-eeba-4887-e053-2995a90ab337	69039-214	HUMAN OTC DRUG	Sun Bum SPF 15 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170825		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 50; 20; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-215_d72f2bad-f097-0021-e053-2995a90ac3a2	69039-215	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-216_d72d067d-a30c-ae9a-e053-2a95a90a9c5e	69039-216	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-217_d73da236-d6dd-f6ff-e053-2995a90afd9c	69039-217	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-218_d73ddb3c-dd50-57a7-e053-2995a90af960	69039-218	HUMAN OTC DRUG	Sun Bum SPF 50 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-219_d72eac9b-f192-864f-e053-2995a90a1b08	69039-219	HUMAN OTC DRUG	Sun Bum SPF 50 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-220_d73ca301-044e-0fbd-e053-2995a90a64bd	69039-220	HUMAN OTC DRUG	Sun Bum SPF 50 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-224_f15c9a25-c4dc-e94c-e053-2995a90aba01	69039-224	HUMAN OTC DRUG	Sun Bum SPF 15 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 60; 50; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-225_d73dcc44-3c04-320b-e053-2995a90acaef	69039-225	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 37.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-226_d73e3bc5-eedb-5945-e053-2995a90a3daa	69039-226	HUMAN OTC DRUG	Sun Bum SPF 50 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-227_f15cbfe3-9f4a-267c-e053-2a95a90a71d7	69039-227	HUMAN OTC DRUG	Sun Bum SPF 70 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20170826		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-229_d815acef-7a4a-b5c6-e053-2995a90a1ca6	69039-229	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20120307		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-230_d73c9582-b734-a076-e053-2a95a90a51af	69039-230	HUMAN OTC DRUG	Sun Bum SPF 50 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20120510		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-231_d72e6591-a94c-6103-e053-2a95a90aeb46	69039-231	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20130308		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 100	g/L; g/L; g/L; g/L			N	20241231
69039-232_d72f3561-be17-7ef3-e053-2995a90a1bc0	69039-232	HUMAN OTC DRUG	Sun Bum SPF 50 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20120828		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	g/L; g/L; g/L; g/L			N	20241231
69039-233_f15c76cd-dec2-5d47-e053-2995a90ab8d6	69039-233	HUMAN OTC DRUG	Premium Moisturizing Sunscreen SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220809		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 37.5	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-234_0a2216c6-ceed-4dd6-e063-6294a90a5f30	69039-234	HUMAN OTC DRUG	Premium Moisturizing Sunscreen SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220809		OTC MONOGRAPH DRUG	M020	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-235_e684d71d-ba63-c82f-e053-2995a90adadf	69039-235	HUMAN OTC DRUG	Sun Bum Premium Sunscreen Face SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20220809		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-236_fa42fd71-8c56-a7c8-e053-6394a90aa749	69039-236	HUMAN OTC DRUG	Sun Bum Kids Sunscreen SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20220901		OTC MONOGRAPH FINAL	M020	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-237_e684ef19-5456-f816-e053-2995a90a3ffb	69039-237	HUMAN OTC DRUG	Sun Bum Kids Face SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-250_d72e8d59-6a21-0574-e053-2995a90aadb8	69039-250	HUMAN OTC DRUG	Sun Bum Face 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20171005		OTC MONOGRAPH NOT FINAL	part352	SUN BUM, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-253_d72e8d59-6a22-0574-e053-2995a90aadb8	69039-253	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20170724		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 30; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-254_d72dd64e-9fc3-377a-e053-2995a90aaf75	69039-254	HUMAN OTC DRUG	Sun Bum SPF 30 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20190128		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 37.5	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-255_d73e1de4-1087-baed-e053-2995a90a9545	69039-255	HUMAN OTC DRUG	Baby Bum SPF50 Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20171011		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-275_d73e0d78-a865-ed82-e053-2995a90ab98d	69039-275	HUMAN OTC DRUG	Sun Bum Mineral SPF30 Sunscreen		ZINC OXIDE	STICK	TOPICAL	20180613		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	ZINC OXIDE	80	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-277_d73db8fb-2659-6dd3-e053-2a95a90a13cc	69039-277	HUMAN OTC DRUG	Sun Bum Signature SPF 30 Sunscreen Lip Balm		ZINC OXIDE	STICK	TOPICAL	20180315		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	ZINC OXIDE	80	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-278_d73e275e-1d37-528b-e053-2a95a90a64d4	69039-278	HUMAN OTC DRUG	Sun Bum Premium SPF 15 Sunscreen Tanning		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	OIL	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-280_dd7ed2d0-b189-6745-e053-2a95a90a26e1	69039-280	HUMAN OTC DRUG	SPF 30 Scalp and Hair Mist		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-601_d72da2b6-e0ad-7e63-e053-2995a90ab55c	69039-601	HUMAN OTC DRUG	Sun Bum Sunscreen Lip Balm Broad Spectrum SPF 30 Watermelon		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-602_d72cfe03-622e-472b-e053-2a95a90af784	69039-602	HUMAN OTC DRUG	Sun Bum Sunscreen Lip Balm Broad Spectrum SPF 30 Coconut		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-603_dad05995-2d76-8081-e053-2995a90a4159	69039-603	HUMAN OTC DRUG	Sun Bum Sunscreen Lip Balm Broad Spectrum SPF 30 Pomegranate		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-604_dad07dc2-45bd-4fa0-e053-2995a90a882d	69039-604	HUMAN OTC DRUG	Sun Bum Sunscreen Lip Balm Broad Spectrum SPF 30 Banana		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-605_dad090d6-f5be-974d-e053-2a95a90a736c	69039-605	HUMAN OTC DRUG	Sun Bum Sunscreen Lip Balm Broad Spectrum SPF 30 Pineapple		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-606_dad095a8-c0b7-d7ca-e053-2a95a90a4657	69039-606	HUMAN OTC DRUG	Sun Bum Sunscreen Lip Balm Broad Spectrum SPF 30 Mango		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-607_dad090d6-f5bf-974d-e053-2a95a90a736c	69039-607	HUMAN OTC DRUG	Sun Bum Sunscreen Lip Balm Broad Spectrum SPF 30 Keylime		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-608_dad0bb80-bd33-d33e-e053-2a95a90a8640	69039-608	HUMAN OTC DRUG	Sun Bum Clear Zinc SPF 50 Sunscreen		HOMOSALATE, OCTISALATE, OCTOCRYLENE, ZINC OXIDE	CREAM	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 100; 70	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-609_dad0dcb7-36e8-ee68-e053-2a95a90a4060	69039-609	HUMAN OTC DRUG	Signature SPF 50 Tinted Face		TITANIUM DIOXIDE	STICK	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	TITANIUM DIOXIDE	208	mg/g			N	20241231
69039-610_dad0eae6-2ce1-087b-e053-2a95a90a03cb	69039-610	HUMAN OTC DRUG	Signature SPF 50 Clear Face		HOMOSALATE, OCTOCRYLENE, OCTISALATE, TITANIUM DIOXIDE, ZINC OXIDE	STICK	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	100; 50; 100; 42.3; 70	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-611_d72eac9b-f193-864f-e053-2995a90a1b08	69039-611	HUMAN OTC DRUG	Sun Bum SPF 70 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-612_d73cc235-fd96-3010-e053-2a95a90afbf9	69039-612	HUMAN OTC DRUG	Sun Bum SPF 70 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-613_d72dae17-c5a1-f98d-e053-2995a90aab5c	69039-613	HUMAN OTC DRUG	Sun Bum SPF 70 Premium Moisturizing Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-614_d73ce260-5876-2584-e053-2995a90a9707	69039-614	HUMAN OTC DRUG	Baby Bum Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333E	Sun Bum LLC	ALCOHOL	.62	mL/mL			N	20241231
69039-615_d72e1cad-4a07-3068-e053-2995a90a97ba	69039-615	HUMAN OTC DRUG	Sun Bum Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333E	Sun Bum LLC	ALCOHOL	.62	mL/mL			N	20241231
69039-617_d73c8765-0e86-fde2-e053-2995a90ae4c2	69039-617	HUMAN OTC DRUG	Sun Bum Signature Clear SPF 50		OCTISALATE, OCTOCRYLENE, ZINC OXIDE	LOTION	TOPICAL	20201111		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 100; 100	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-618_d72dfcb6-2155-66d2-e053-2995a90a171a	69039-618	HUMAN OTC DRUG	Sun Bum Face SPF 70		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20201125		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-619_d72f3561-be1c-7ef3-e053-2995a90a1bc0	69039-619	HUMAN OTC DRUG	Sun Bum Face Mist SPF 45		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LIQUID	TOPICAL	20201125		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-620_d73e04d8-62f1-ed7f-e053-2995a90a663f	69039-620	HUMAN OTC DRUG	Sun Bum Mineral Sunscreen Face Stick SPF 50		ZINC OXIDE	STICK	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	ZINC OXIDE	192	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-621_d73ebe28-76db-938f-e053-2a95a90a8c3f	69039-621	HUMAN OTC DRUG	Sun Bum Tinted Sunscreen Face UVA/UVB Broad Spectrum SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	TITANIUM DIOXIDE; ZINC OXIDE	53; 24	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-622_d73e84a0-dbac-e578-e053-2a95a90ad91a	69039-622	HUMAN OTC DRUG	Sun Bum Mineral Sunscreen Broad Spectrum SPF 30		ZINC OXIDE	LOTION	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	ZINC OXIDE	147	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-623_d72eed5b-3a59-08db-e053-2995a90a9668	69039-623	HUMAN OTC DRUG	Sun Bum Mineral Sunscreen Broad Spectrum SPF 50		ZINC OXIDE	LOTION	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-624_d73e9fdb-db80-9410-e053-2a95a90a6e09	69039-624	HUMAN OTC DRUG	Sun Bum Mineral Sunscreen Broad Spectrum SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	LIQUID	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	TITANIUM DIOXIDE; ZINC OXIDE	34; 160	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-625_d72dd64e-9fc2-377a-e053-2995a90aaf75	69039-625	HUMAN OTC DRUG	Sun bum Daily Sunscreen Moisturizer SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210512		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-630_d73d2253-0e46-b785-e053-2995a90a20ab	69039-630	HUMAN OTC DRUG	Sun Bum Mineral Sunscreen SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	LIQUID	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	TITANIUM DIOXIDE; ZINC OXIDE	34; 160	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-635_d72e35e5-e467-f0a9-e053-2a95a90a30f8	69039-635	HUMAN OTC DRUG	Sun Bum Daily Mineral Sunscreen Moisturizer SPF30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210519		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-636_d72ecfcd-347b-65c0-e053-2995a90a97f3	69039-636	HUMAN OTC DRUG	Sun Bum Daily Sunscreen Face Mist SPF30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210519		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-637_d72ec72a-41d9-02c4-e053-2995a90a64c4	69039-637	HUMAN OTC DRUG	Sun Bum Hand Cream SPF15		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20210519		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 50; 20; 10	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-638_d72d2eea-7fea-a664-e053-2a95a90ab645	69039-638	HUMAN OTC DRUG	Baby Bum Diaper Rash		ZINC OXIDE	CREAM	TOPICAL	20210602		OTC MONOGRAPH FINAL	part347	Sun Bum LLC	ZINC OXIDE	160	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-639_d72e53ac-d432-8cba-e053-2995a90a14dc	69039-639	HUMAN OTC DRUG	Premium Moisturizing Sunscreen SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210602		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 37.5	mg/g; mg/g; mg/g; mg/g			N	20241231
69039-640_d72dae17-c5a3-f98d-e053-2995a90aab5c	69039-640	HUMAN OTC DRUG	Sun Bum GLOW 30 Moisturizing Sunscreen Face SPF 30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
69039-641_d73e77bb-4167-11c8-e053-2995a90a7627	69039-641	HUMAN OTC DRUG	Sun Bum Mineral Sunscreen Roll On SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	TITANIUM DIOXIDE; ZINC OXIDE	34; 160	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69039-642_d73e6c85-e9bd-02c1-e053-2995a90ad446	69039-642	HUMAN OTC DRUG	Sun Bum Premium Moisturizing Sunscreen Roll On SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-643_d72f4c3b-3ea9-5a84-e053-2995a90a9557	69039-643	HUMAN OTC DRUG	Sun Bum Premium Sunscreen Browning SPF 15		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 50; 20; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-644_d72d4b2a-ab13-ffdb-e053-2995a90a6e6d	69039-644	HUMAN OTC DRUG	Sun Bum Sunscreen Oil SPF 30 with Coconut Oil		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	OIL	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-645_ca523d8d-78ba-40c7-e053-2995a90a86c7	69039-645	HUMAN OTC DRUG	Sun Bum Skin Care Essentials Kit		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	KIT		20210817		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC						N	20241231
69039-660_ec51e4ed-cd57-6622-e053-2a95a90a7f1b	69039-660	HUMAN OTC DRUG	Kids SPF 50 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20221025		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69039-661_f29b7f9f-86cc-72f5-e053-2995a90ab4f6	69039-661	HUMAN OTC DRUG	Face Cream 50		HOMOSALATE, OCTISALATE, OCTOCRYLENE, ZINC OXIDE	CREAM	TOPICAL	20230106		OTC MONOGRAPH NOT FINAL	part352	Sun Bum LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 100; 70	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69043-006_36f0759f-b50b-4a49-869b-d73f5ad7d8cf	69043-006	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	Cronus Pharma LLC	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
69043-007_36f0759f-b50b-4a49-869b-d73f5ad7d8cf	69043-007	HUMAN PRESCRIPTION DRUG	CEFPODOXIME PROXETIL		CEFPODOXIME PROXETIL	TABLET, FILM COATED	ORAL	20070611		ANDA	ANDA065370	Cronus Pharma LLC	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
69043-008_32fa5659-788c-41c5-9f9c-682503719cba	69043-008	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	Cronus Pharma LLC	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69043-009_32fa5659-788c-41c5-9f9c-682503719cba	69043-009	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20051116		ANDA	ANDA065253	Cronus Pharma LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69043-010_d3627ece-8d8e-480c-8c8a-ced1134592b2	69043-010	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Cronus Pharma LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
69043-011_d3627ece-8d8e-480c-8c8a-ced1134592b2	69043-011	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Cronus Pharma LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
69051-202_06fbe45e-807d-9a07-e063-6394a90a00a1	69051-202	HUMAN OTC DRUG	Rhinase D Gel Moisturizing Nasal Decongestant		Oxymetazoline HCL 0.5%	JELLY	NASAL	20201221		OTC MONOGRAPH DRUG	M012	Profounda Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	{VP}/100{VP}	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69051-300_9b007e6d-4b61-4af7-81bc-f6089d2cb42f	69051-300	HUMAN PRESCRIPTION DRUG	IMPAVIDO		miltefosine	CAPSULE	ORAL	20151029		NDA	NDA204684	Profounda, Inc.	MILTEFOSINE	50	mg/1	Antileishmanial [EPC]		N	20241231
69067-240_0e8bb742-a412-53cc-e063-6394a90a2001	69067-240	HUMAN PRESCRIPTION DRUG	Carbinoxamine Maleate		CARBINOXAMINE MALEATE	TABLET	ORAL	20171218		ANDA	ANDA207484	Foxland Pharmaceuticals, Inc.	CARBINOXAMINE MALEATE	6	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
69070-300_f0d0c465-e772-40cf-a657-076f473deb53	69070-300	HUMAN OTC DRUG	E MEI SHAN MEDICATED		CAMPHOR, MENTHOL	PLASTER	TRANSDERMAL	20180917		OTC MONOGRAPH NOT FINAL	part348	Zhejiang Dingtai Pharmaceutical Co., Ltd	CAMPHOR (SYNTHETIC); MENTHOL	31; 26	mg/1; mg/1			N	20241231
69070-301_9dfc64cd-b0ca-439c-8006-4e439fb3ec99	69070-301	HUMAN OTC DRUG	TONG FENG DING PAIN RELIEF		CAMPHOR AND MENTHOL	PATCH	TRANSDERMAL	20190131		OTC MONOGRAPH NOT FINAL	part348	Zhejiang Dingtai Pharmaceutical Co., Ltd	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 2.6	g/100g; g/100g			N	20241231
69070-302_c65099fc-5557-4c39-a098-ffc9276b6017	69070-302	HUMAN OTC DRUG	YAT TIP TOR		SALICYLIC ACID	PLASTER	TOPICAL	20181210		OTC MONOGRAPH FINAL	part358F	Zhejiang Dingtai Pharmaceutical Co., Ltd	SALICYLIC ACID	40	g/1			N	20241231
69070-303_29610cf1-7f09-436e-8a4b-0422caed4498	69070-303	HUMAN OTC DRUG	PerfectHeal Antifungal		Clotrimazole	CREAM	TOPICAL	20181206		OTC MONOGRAPH FINAL	part333C	Zhejiang Dingtai Pharmaceutical Co., Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69070-304_e4be5949-fbd0-4511-bd03-0d8f078b69dd	69070-304	HUMAN OTC DRUG	PiYanPing Antifungal		Miconazole Nitrate	CREAM	TOPICAL	20181206		OTC MONOGRAPH FINAL	part333C	Zhejiang Dingtai Pharmaceutical Co., Ltd	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69070-305_2dc3b15b-09a1-4998-84d3-fc00d4083403	69070-305	HUMAN OTC DRUG	SKINHEAL ANTIFUNGAL		Tolnaftate	CREAM	TOPICAL	20181210		OTC MONOGRAPH FINAL	part333C	Zhejiang Dingtai Pharmaceutical Co., Ltd	TOLNAFTATE	1	g/100g			N	20241231
69070-306_f2274abd-890a-4140-ae41-ec8c65394b74	69070-306	HUMAN OTC DRUG	Au Kah Chuen Fugical		Calamine and Diphenhydramine hydrochlorid	CREAM	TOPICAL	20190610		OTC MONOGRAPH FINAL	part347	Zhejiang Dingtai Pharmaceutical Co., Ltd	DIPHENHYDRAMINE HYDROCHLORIDE; FERRIC OXIDE RED; ZINC OXIDE	2; .05; 9.95	g/100g; g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69070-307_074012ed-36ae-4a6a-94b9-7b5c2d877f91	69070-307	HUMAN OTC DRUG	EXTRA STRENGTH HUA TUO PAIN RELIEVING		Camphor and Menthol	PLASTER	TRANSDERMAL	20190409		OTC MONOGRAPH NOT FINAL	part348	Zhejiang Dingtai Pharmaceutical Co., Ltd	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 2.6	g/100g; g/100g			N	20241231
69075-001_0a4a4e6d-9f4b-d55b-e063-6394a90ab7eb	69075-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140801		NDA	NDA205865	VirtAir Inc.	OXYGEN	990	mL/L			N	20241231
69076-105_07593d0e-3940-3c53-e063-6294a90a7468	69076-105	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, COATED	ORAL	20200101		ANDA	ANDA209498	Quinn Pharmaceuticals	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
69076-146_f03d714d-ed3a-60fc-e053-2995a90a3153	69076-146	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20210527		ANDA	ANDA075090	Quinn Pharmaceuticals	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69076-200_06cc81b5-dfdb-72e2-e063-6394a90aaa1d	69076-200	HUMAN PRESCRIPTION DRUG	Riluzole		riluzole	TABLET, FILM COATED	ORAL	20200101		ANDA	ANDA206045	Quinn Pharmaceuticals	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20241231
69076-475_f03d88ab-275e-39b2-e053-2a95a90a22a6	69076-475	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20210501		ANDA	ANDA091182	Quinn Pharmaceuticals	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
69076-476_f03d88ab-275e-39b2-e053-2a95a90a22a6	69076-476	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20210501		ANDA	ANDA091182	Quinn Pharmaceuticals	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
69076-913_0e0eee20-c44e-6528-e063-6294a90a2e04	69076-913	HUMAN PRESCRIPTION DRUG	Mercaptopurine		Mercaptopurine	TABLET	ORAL	20161005		NDA AUTHORIZED GENERIC	NDA009053	Quinn Pharmaceuticals	MERCAPTOPURINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20251231
69081-002_087b236a-7f6d-2751-e063-6394a90ac291	69081-002	HUMAN OTC DRUG	Gloves in a Bottle with SPF15		Octinoxate, octisalate, homosalate	LOTION	TOPICAL	20140707		OTC MONOGRAPH DRUG	M020	Gloves in a Bottle, Inc	HOMOSALATE; OCTINOXATE; OCTISALATE	.03; .07; .05	g/g; g/g; g/g			N	20241231
69085-466_0636f99e-76fd-c317-e063-6294a90a5e8f	69085-466	HUMAN OTC DRUG	Omnicide Antimicrobial		benzalkonium chloride	GEL	TOPICAL	20140702		OTC MONOGRAPH NOT FINAL	part333A	SteriWeb Medical, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
69085-466_0646c72c-ab44-dff6-e063-6394a90ae622	69085-466	HUMAN OTC DRUG	Omnicide Antimicrobial		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20160507		OTC MONOGRAPH NOT FINAL	part333A	SteriWeb Medical, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
69087-158_9d993a99-6347-4121-a2b9-51e90565161f	69087-158	HUMAN PRESCRIPTION DRUG	Jatenzo		testosterone undecanoate	CAPSULE, LIQUID FILLED	ORAL	20190801		NDA	NDA206089	TOLMAR Inc.	TESTOSTERONE UNDECANOATE	158	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69087-198_9d993a99-6347-4121-a2b9-51e90565161f	69087-198	HUMAN PRESCRIPTION DRUG	Jatenzo		testosterone undecanoate	CAPSULE, LIQUID FILLED	ORAL	20190801		NDA	NDA206089	TOLMAR Inc.	TESTOSTERONE UNDECANOATE	198	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69087-237_9d993a99-6347-4121-a2b9-51e90565161f	69087-237	HUMAN PRESCRIPTION DRUG	Jatenzo		testosterone undecanoate	CAPSULE, LIQUID FILLED	ORAL	20190801		NDA	NDA206089	TOLMAR Inc.	TESTOSTERONE UNDECANOATE	237	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69090-0100_f1c8acfa-9931-4285-9cf9-81498f75c8fe	69090-0100	HUMAN OTC DRUG	SPF-30 BB		Zinc Oxide	LOTION	TOPICAL	20140120		OTC MONOGRAPH FINAL	part352	ZION HEALTH	ZINC OXIDE	20	g/100mL			N	20241231
69097-071_9c292b5a-2a09-4f01-b1fe-8652dd577542	69097-071	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231025		ANDA	ANDA207479	Cipla USA., Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-072_9c292b5a-2a09-4f01-b1fe-8652dd577542	69097-072	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231025		ANDA	ANDA207479	Cipla USA., Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-112_1f0cca72-092c-456d-b7b2-c94ef16e0ccc	69097-112	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET	ORAL	20141120		ANDA	ANDA077335	Cipla USA Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
69097-122_ccc519e8-e3fe-4f3e-8d0d-76cc282bf6de	69097-122	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Cipla USA Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-123_ccc519e8-e3fe-4f3e-8d0d-76cc282bf6de	69097-123	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Cipla USA Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-124_ccc519e8-e3fe-4f3e-8d0d-76cc282bf6de	69097-124	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Cipla USA Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-125_ccc519e8-e3fe-4f3e-8d0d-76cc282bf6de	69097-125	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Cipla USA Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-126_acf4c672-f280-41fe-a57c-67df24582038	69097-126	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	Cipla USA Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69097-127_acf4c672-f280-41fe-a57c-67df24582038	69097-127	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	Cipla USA Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69097-128_acf4c672-f280-41fe-a57c-67df24582038	69097-128	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20070926		ANDA	ANDA077073	Cipla USA Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69097-142_234fba93-8b9b-46de-8d61-088bd0a30b98	69097-142	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		albuterol sulfate	INHALANT	RESPIRATORY (INHALATION)	20200408		ANDA	ANDA209959	Cipla USA Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
69097-148_60f518f2-5321-454d-aef0-49b3b3f8a36d	69097-148	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		Lamotrigine	TABLET	ORAL	20101101		ANDA	ANDA077783	Cipla USA Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69097-149_60f518f2-5321-454d-aef0-49b3b3f8a36d	69097-149	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		Lamotrigine	TABLET	ORAL	20101101		ANDA	ANDA077783	Cipla USA Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69097-151_60f518f2-5321-454d-aef0-49b3b3f8a36d	69097-151	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		Lamotrigine	TABLET	ORAL	20101101		ANDA	ANDA077783	Cipla USA Inc.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69097-152_60f518f2-5321-454d-aef0-49b3b3f8a36d	69097-152	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		Lamotrigine	TABLET	ORAL	20101101		ANDA	ANDA077783	Cipla USA Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69097-153_b56b9a21-be9f-4ba6-84ca-b08de39b9f3b	69097-153	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077135	Cipla USA Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69097-154_b56b9a21-be9f-4ba6-84ca-b08de39b9f3b	69097-154	HUMAN PRESCRIPTION DRUG	Valacyclovir hydrochloride		Valacyclovir hydrochloride	TABLET	ORAL	20100524		ANDA	ANDA077135	Cipla USA Inc.	VALACYCLOVIR HYDROCHLORIDE	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69097-158_12079e0e-d8ec-44ae-b810-0a9194c72dee	69097-158	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	Cipla USA Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-159_12079e0e-d8ec-44ae-b810-0a9194c72dee	69097-159	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	Cipla USA Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-166_65d03051-a84c-49d7-928b-515cb1769bec	69097-166	HUMAN PRESCRIPTION DRUG	LAMIVUDINE		LAMIVUDINE	TABLET	ORAL	20170303		ANDA	ANDA077221	Cipla USA Inc.	LAMIVUDINE	150	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
69097-167_65d03051-a84c-49d7-928b-515cb1769bec	69097-167	HUMAN PRESCRIPTION DRUG	LAMIVUDINE		LAMIVUDINE	TABLET	ORAL	20170303		ANDA	ANDA077221	Cipla USA Inc.	LAMIVUDINE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
69097-168_b4866add-e9d7-4933-988a-256ecc149be9	69097-168	HUMAN PRESCRIPTION DRUG	arformoterol tartrate		arformoterol tartrate	SOLUTION	RESPIRATORY (INHALATION)	20210622		ANDA	ANDA207306	Cipla USA Inc.	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
69097-173_914605d4-7326-445d-b20e-6771eb67f7c4	69097-173	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20071231		ANDA	ANDA077559	Cipla USA Inc.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
69097-209_59017833-74a7-4af8-b04d-6128c57b46be	69097-209	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA090958	Cipla USA Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
69097-210_4ba582f2-65bd-44e0-9930-1f4b40025133	69097-210	HUMAN PRESCRIPTION DRUG	efavirenz, emtricitabine and tenofovir disoproxil fumarate		efavirenz, emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA206894	Cipla USA Inc.	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
69097-221_7141ddf2-9c11-4d86-a0b3-ec7fd7e035b0	69097-221	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190528		ANDA	ANDA211291	Cipla USA Inc.	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69097-222_7141ddf2-9c11-4d86-a0b3-ec7fd7e035b0	69097-222	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190528		ANDA	ANDA211291	Cipla USA Inc.	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69097-223_1203dd0c-809a-4409-b948-b5e816b8a63a	69097-223	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20080804		ANDA	ANDA076768	Cipla USA Inc.	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
69097-224_1203dd0c-809a-4409-b948-b5e816b8a63a	69097-224	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20080804		ANDA	ANDA076768	Cipla USA Inc.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
69097-237_f1655e51-6ba7-4a47-8acf-cbbf44e10db5	69097-237	HUMAN PRESCRIPTION DRUG	ALBENDAZOLE		albendazole	TABLET	ORAL	20180924		ANDA	ANDA210434	Cipla USA Inc.	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
69097-244_bdbfc235-3cca-4fa0-be70-9c34cfb91feb	69097-244	HUMAN PRESCRIPTION DRUG	Darunavir 600 and 800 mg		darunavir	TABLET	ORAL	20231129		ANDA	ANDA206288	Cipla USA Inc.	DARUNAVIR HYDRATE	800	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
69097-248_bdbfc235-3cca-4fa0-be70-9c34cfb91feb	69097-248	HUMAN PRESCRIPTION DRUG	Darunavir 600 and 800 mg		darunavir	TABLET	ORAL	20231129		ANDA	ANDA206288	Cipla USA Inc.	DARUNAVIR HYDRATE	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
69097-259_13de71d6-5be1-49ee-b2cf-e3d7c8fd7b45	69097-259	HUMAN PRESCRIPTION DRUG	SOLIFENACINE SUCCINATE		solifenacine succinate	TABLET	ORAL	20190520		ANDA	ANDA209839	Cipla USA Inc.	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69097-261_13de71d6-5be1-49ee-b2cf-e3d7c8fd7b45	69097-261	HUMAN PRESCRIPTION DRUG	SOLIFENACINE SUCCINATE		solifenacine succinate	TABLET	ORAL	20190520		ANDA	ANDA209839	Cipla USA Inc.	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69097-301_5d9e4420-d4df-4348-a5b3-91670a479ca1	69097-301	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	TABLET, FILM COATED	ORAL	20180618		ANDA	ANDA204766	Cipla USA Inc.	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
69097-316_edfb31df-8ec2-440f-84ca-5e86c10bbc46	69097-316	HUMAN PRESCRIPTION DRUG	EXEMESTANE		exemestane	TABLET	ORAL	20180427		ANDA	ANDA210323	Cipla USA Inc.	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
69097-318_87894b75-a8c5-4d48-81bd-5ad43d66afc3	69097-318	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20171116		ANDA	ANDA205710	Cipla USA Inc.	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69097-319_87894b75-a8c5-4d48-81bd-5ad43d66afc3	69097-319	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20171116		ANDA	ANDA205710	Cipla USA Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69097-321_87894b75-a8c5-4d48-81bd-5ad43d66afc3	69097-321	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20171116		ANDA	ANDA205710	Cipla USA Inc.	BUDESONIDE	1	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69097-322_6dfb9c9b-7f8a-49a4-8e01-4b214282412f	69097-322	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		DIMETHYL FUMARATE	CAPSULE, DELAYED RELEASE	ORAL	20200924		ANDA	ANDA210305	Cipla USA Inc.	DIMETHYL FUMARATE	120	mg/1			N	20251231
69097-323_6dfb9c9b-7f8a-49a4-8e01-4b214282412f	69097-323	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		DIMETHYL FUMARATE	CAPSULE, DELAYED RELEASE	ORAL	20200924		ANDA	ANDA210305	Cipla USA Inc.	DIMETHYL FUMARATE	240	mg/1			N	20251231
69097-341_825a55a7-ffdf-4fde-bbb2-486cbd16e602	69097-341	HUMAN PRESCRIPTION DRUG	DIFLUPREDNATE		DIFLUPREDNATE	EMULSION	OPHTHALMIC	20210809		ANDA	ANDA211776	Cipla USA Inc.	DIFLUPREDNATE	.5	mg/mL			N	20241231
69097-361_883762d6-5d17-4ccd-99e6-254a6ad208ef	69097-361	HUMAN PRESCRIPTION DRUG	grisofulvin		grisofulvin	SUSPENSION	ORAL	20170306		ANDA	ANDA065354	Cipla USA Inc.	GRISEOFULVIN	125	mg/5mL	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]		N	20241231
69097-362_1a48f22b-e37b-4221-9f99-a9e149279630	69097-362	HUMAN PRESCRIPTION DRUG	Abacavir and Lamivudine		Abacavir and lamivudine	TABLET, FILM COATED	ORAL	20170328		ANDA	ANDA091144	Cipla USA Inc.	ABACAVIR SULFATE; LAMIVUDINE	600; 300	mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
69097-363_8e2118ec-ffa6-4ed8-a582-dbb161ac36e3	69097-363	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	SOLUTION	TOPICAL	20180330		ANDA	ANDA209533	Cipla USA Inc.	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69097-364_0014ce7e-f3e5-467c-a1a4-6bf8c2aefd3c	69097-364	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin	INJECTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20190311		ANDA	ANDA209439	Cipla USA Inc.	BLEOMYCIN SULFATE	15	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
69097-368_2413bf0f-e9bf-441a-9389-229c5ae8fa40	69097-368	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180504		ANDA	ANDA209540	Cipla USA Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69097-373_92ec5f3d-f54d-4f28-bac6-b606c99b17c9	69097-373	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209539	Cipla USA Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-374_92ec5f3d-f54d-4f28-bac6-b606c99b17c9	69097-374	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209539	Cipla USA Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-375_92ec5f3d-f54d-4f28-bac6-b606c99b17c9	69097-375	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209539	Cipla USA Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-376_92ec5f3d-f54d-4f28-bac6-b606c99b17c9	69097-376	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209539	Cipla USA Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-381_eeb99fdb-805d-41fb-981e-ec8a442f4e82	69097-381	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Cipla USA Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
69097-382_eeb99fdb-805d-41fb-981e-ec8a442f4e82	69097-382	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Cipla USA Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
69097-383_eeb99fdb-805d-41fb-981e-ec8a442f4e82	69097-383	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Cipla USA Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
69097-384_eeb99fdb-805d-41fb-981e-ec8a442f4e82	69097-384	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20230307		ANDA	ANDA210435	Cipla USA Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
69097-385_eeb99fdb-805d-41fb-981e-ec8a442f4e82	69097-385	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Cipla USA Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
69097-386_0c6a8398-6d21-40fd-a789-e7b22966f1a2	69097-386	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA210715	Cipla USA Inc.	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
69097-387_0c6a8398-6d21-40fd-a789-e7b22966f1a2	69097-387	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA210715	Cipla USA Inc.	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
69097-391_dfe125b8-f47a-4e92-96f2-08eff47d838f	69097-391	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, COATED	ORAL	20200213		ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69097-392_dfe125b8-f47a-4e92-96f2-08eff47d838f	69097-392	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, COATED	ORAL	20200614		ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69097-393_dfe125b8-f47a-4e92-96f2-08eff47d838f	69097-393	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, COATED	ORAL	20200213		ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69097-407_95bb3551-0e88-47cc-95e9-35c6dc731faf	69097-407	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207465	Cipla USA Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69097-408_95bb3551-0e88-47cc-95e9-35c6dc731faf	69097-408	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207465	Cipla USA Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69097-409_95bb3551-0e88-47cc-95e9-35c6dc731faf	69097-409	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207465	Cipla USA Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69097-410_92469745-009c-4a66-96a2-31efb78dd138	69097-410	HUMAN PRESCRIPTION DRUG	CINACALCET		CINACALCET	TABLET	ORAL	20180308		ANDA	ANDA208915	Cipla USA Inc.	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
69097-411_92469745-009c-4a66-96a2-31efb78dd138	69097-411	HUMAN PRESCRIPTION DRUG	CINACALCET		CINACALCET	TABLET	ORAL	20180308		ANDA	ANDA208915	Cipla USA Inc.	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
69097-412_92469745-009c-4a66-96a2-31efb78dd138	69097-412	HUMAN PRESCRIPTION DRUG	CINACALCET		CINACALCET	TABLET	ORAL	20180308		ANDA	ANDA208915	Cipla USA Inc.	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
69097-420_d31e9071-fe34-48e2-a8a3-0c8eca1b9ef4	69097-420	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20150923		ANDA	ANDA207446	Cipla USA Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-421_d31e9071-fe34-48e2-a8a3-0c8eca1b9ef4	69097-421	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20150923		ANDA	ANDA207446	Cipla USA Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-422_d31e9071-fe34-48e2-a8a3-0c8eca1b9ef4	69097-422	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20150923		ANDA	ANDA207446	Cipla USA Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-423_d31e9071-fe34-48e2-a8a3-0c8eca1b9ef4	69097-423	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20150923		ANDA	ANDA207446	Cipla USA Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-425_f11e1153-612f-4924-86b1-6739d755e3c1	69097-425	HUMAN PRESCRIPTION DRUG	ENTECAVIR		ENTECAVIR	TABLET, FILM COATED	ORAL	20161206		ANDA	ANDA206872	Cipla USA Inc.	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
69097-426_f11e1153-612f-4924-86b1-6739d755e3c1	69097-426	HUMAN PRESCRIPTION DRUG	ENTECAVIR		ENTECAVIR	TABLET, FILM COATED	ORAL	20161206		ANDA	ANDA206872	Cipla USA Inc.	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
69097-431_ac7bdb75-9e1e-4255-9766-d1e85dd97d14	69097-431	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20160901		ANDA	ANDA207664	Cipla USA Inc.	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69097-432_ac7bdb75-9e1e-4255-9766-d1e85dd97d14	69097-432	HUMAN PRESCRIPTION DRUG	Darifenacin		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20160901		ANDA	ANDA207664	Cipla USA Inc.	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69097-439_b4ddbb13-5b11-40b1-b126-dc2d1b44c9dd	69097-439	HUMAN PRESCRIPTION DRUG	Palonosetron hydrochloride		Palonsetron hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20211010		ANDA	ANDA206396	Cipla USA Inc.	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69097-458_9d158bc3-817b-4c3a-8f35-566d9f67bf84	69097-458	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20161215		ANDA	ANDA208709	Cipla USA Inc.	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69097-459_9d158bc3-817b-4c3a-8f35-566d9f67bf84	69097-459	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20161215		ANDA	ANDA208709	Cipla USA Inc.	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69097-514_cf84089d-b713-40b8-a815-b66f4119982e	69097-514	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA078119	Cipla USA Inc.	ABACAVIR SULFATE	300	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
69097-516_f57dbebf-f145-4e3c-bfef-b7907f6e01eb	69097-516	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20190118		ANDA	ANDA211608	Cipla USA Inc.	CYCLOPHOSPHAMIDE ANHYDROUS	25	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69097-517_f57dbebf-f145-4e3c-bfef-b7907f6e01eb	69097-517	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	CAPSULE	ORAL	20190118		ANDA	ANDA211608	Cipla USA Inc.	CYCLOPHOSPHAMIDE ANHYDROUS	50	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69097-524_1d880e10-e221-4622-b6ed-c8f73e9bdde4	69097-524	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20180816		ANDA	ANDA209903	Cipla USA Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-526_f5c8b23e-51e5-4264-8328-437c9d11939a	69097-526	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190205		ANDA	ANDA210255	Cipla USA Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-527_38b99ff6-f631-4f9c-9e0a-63701a2f27e6	69097-527	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		ESOMEPRAZOLE MAGNESIUM	GRANULE, FOR SUSPENSION, EXTENDED RELEASE	ORAL	20200324		ANDA	ANDA211752	Cipla USA Inc.	ESOMEPRAZOLE MAGNESIUM	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69097-528_0b7acb76-71c2-4354-ac51-986e40767c6e	69097-528	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	FOR SUSPENSION	ORAL	20200324		ANDA	ANDA211751	Cipla USA Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69097-529_0b7acb76-71c2-4354-ac51-986e40767c6e	69097-529	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	FOR SUSPENSION	ORAL	20200324		ANDA	ANDA211751	Cipla USA Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69097-532_5dd9b567-3a8b-4cf1-a2cd-9197b04f42a1	69097-532	HUMAN PRESCRIPTION DRUG	SODIUM NITROPRUSSIDE		SODIUM NITROPRUSSIDE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180716		ANDA	ANDA210855	Cipla USA Inc.	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
69097-533_8a4fe8a6-9007-4d92-be69-bca24535e4e9	69097-533	HUMAN PRESCRIPTION DRUG	Tenofovir disoproxil fumarate		Tenofovir disoproxil fumarate	TABLET	ORAL	20180126		ANDA	ANDA078800	Cipla USA Inc.	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
69097-536_69a264d4-a98c-419c-94fd-3b74f6e8c03c	69097-536	HUMAN PRESCRIPTION DRUG	TESTOSTERONE CYPIONATE		testosterone cypionate	INJECTION	INTRAMUSCULAR	20230915		ANDA	ANDA210362	Cipla USA Inc.	TESTOSTERONE CYPIONATE	100	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69097-537_69a264d4-a98c-419c-94fd-3b74f6e8c03c	69097-537	HUMAN PRESCRIPTION DRUG	TESTOSTERONE CYPIONATE		testosterone cypionate	INJECTION	INTRAMUSCULAR	20230915		ANDA	ANDA210362	Cipla USA Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69097-539_3b389352-a6a3-45ea-9335-b3df361f7d87	69097-539	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20190125		ANDA	ANDA210335	Cipla USA Inc.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
69097-550_ce7e02d0-319e-4a5b-87e1-c6550ab4322c	69097-550	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	GRANULE	ORAL	20220223		ANDA	ANDA215026	Cipla USA Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69097-552_6dfb9c9b-7f8a-49a4-8e01-4b214282412f	69097-552	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		DIMETHYL FUMARATE	KIT		20200924		ANDA	ANDA210305	Cipla USA Inc.						N	20251231
69097-560_ce7e02d0-319e-4a5b-87e1-c6550ab4322c	69097-560	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	GRANULE	ORAL	20220223		ANDA	ANDA215026	Cipla USA Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69097-570_ce7e02d0-319e-4a5b-87e1-c6550ab4322c	69097-570	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	GRANULE	ORAL	20220223		ANDA	ANDA215026	Cipla USA Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69097-579_066fd4fd-2c6d-477c-a342-92f05fe6b0f4	69097-579	HUMAN PRESCRIPTION DRUG	FOSFOMYCIN TROMETHAMINE		FOSFOMYCIN TROMETHAMINE	GRANULE, FOR SOLUTION	ORAL	20220126		ANDA	ANDA211881	Cipla USA Inc.	FOSFOMYCIN TROMETHAMINE	3	g/1			N	20241231
69097-600_8ab00345-d0c7-4f29-9990-b23c67657888	69097-600	HUMAN OTC DRUG	Olopatadine Hydrochloride		Olopatadine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20210319		ANDA	ANDA206087	Cipla USA Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
69097-604_8eeb4be1-20a8-4250-b002-ec6705fb1e18	69097-604	HUMAN PRESCRIPTION DRUG	Lenalidomide		Lenalidomide	CAPSULE	ORAL	20230309		ANDA	ANDA214618	Cipla USA Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
69097-642_a418c3cc-cc07-4640-b6aa-27dd83d21844	69097-642	HUMAN PRESCRIPTION DRUG	emtricitabine		emtricitabine	CAPSULE	ORAL	20200831		ANDA	ANDA091168	Cipla USA Inc.	EMTRICITABINE	200	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
69097-644_03eac73c-4dcc-4cc5-b0b1-28820f24f390	69097-644	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	SPRAY	NASAL	20210222		ANDA	ANDA214209	Cipla USA Inc.	SUMATRIPTAN	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69097-655_eeb20aab-f62a-4d80-92d1-2d6b3e2a5758	69097-655	HUMAN PRESCRIPTION DRUG	Ritonavir	film coated	ritonavir 100 mg	TABLET	ORAL	20220323		ANDA	ANDA202573	Cipla USA Inc.	RITONAVIR	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]		N	20241231
69097-656_38490f0b-817a-4f99-ada0-06d8854b5c75	69097-656	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	TOPICAL	20190118		ANDA	ANDA211794	Cipla USA Inc.	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69097-664_3c1d55c7-6696-40da-86f4-b6e00e8bc6fe	69097-664	HUMAN PRESCRIPTION DRUG	ICATIBANT		ICATIBANT	INJECTION	SUBCUTANEOUS	20200713		ANDA	ANDA212446	Cipla USA Inc.	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
69097-677_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-677	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	25	mg/1		CV	N	20241231
69097-678_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-678	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	50	mg/1		CV	N	20241231
69097-679_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-679	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	75	mg/1		CV	N	20241231
69097-681_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-681	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	100	mg/1		CV	N	20241231
69097-682_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-682	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	150	mg/1		CV	N	20241231
69097-683_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-683	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	200	mg/1		CV	N	20241231
69097-684_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-684	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	225	mg/1		CV	N	20241231
69097-685_03a1965c-9956-486f-8599-7f5ecbf6c3b5	69097-685	HUMAN PRESCRIPTION DRUG	PREGABALIN capsules, CV		PREGABALIN capsules, CV	CAPSULE	ORAL	20200110		ANDA	ANDA212280	Cipla USA Inc.	PREGABALIN	300	mg/1		CV	N	20241231
69097-686_5b14d29f-abb3-489c-ab42-74eb7343991f	69097-686	HUMAN PRESCRIPTION DRUG	TAVABOROLE		TAVABOROLE	SOLUTION	TOPICAL	20210218		ANDA	ANDA212224	Cipla USA Inc.	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20251231
69097-708_b623ef25-80f6-4d7a-aab3-f7aaa4a044b1	69097-708	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220427		ANDA	ANDA214596	Cipla USA Inc.	PHYTONADIONE	10	mg/mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20251231
69097-709_b623ef25-80f6-4d7a-aab3-f7aaa4a044b1	69097-709	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220427		ANDA	ANDA214596	Cipla USA Inc.	PHYTONADIONE	1	mg/.5mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20251231
69097-731_feb4ee13-5f95-4a62-8395-55bad95c424b	69097-731	HUMAN PRESCRIPTION DRUG	TERBINAFINE HYDROCHLORIDE		Terbinafine Tablets 250 mg	TABLET	ORAL	20210108		ANDA	ANDA077137	Cipla USA Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
69097-741_1df3a5d3-e2df-4b4b-be4d-ed1983255d4d	69097-741	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20211101		ANDA	ANDA090958	Cipla USA Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
69097-805_391107e4-0c56-4c1f-b73b-b703bbb3ef47	69097-805	HUMAN PRESCRIPTION DRUG	azacitidine for		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20190326		ANDA	ANDA207518	Cipla USA Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69097-807_f23eb777-6de7-4b66-8fe9-1f0a70e7f225	69097-807	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190923		ANDA	ANDA212513	Cipla USA Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
69097-811_69887d93-de9a-4397-a629-a0ce8e62c69a	69097-811	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160722		ANDA	ANDA202764	Cipla USA Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-812_69887d93-de9a-4397-a629-a0ce8e62c69a	69097-812	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160722		ANDA	ANDA202764	Cipla USA Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-813_63f1d03b-8e01-4338-8627-c9e1e900bc75	69097-813	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160629		ANDA	ANDA090705	Cipla USA Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-814_63f1d03b-8e01-4338-8627-c9e1e900bc75	69097-814	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160629		ANDA	ANDA090705	Cipla USA Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-815_63f1d03b-8e01-4338-8627-c9e1e900bc75	69097-815	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160629		ANDA	ANDA090705	Cipla USA Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-816_89be4260-9b25-42aa-8ab8-936e9f1717ba	69097-816	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20160722		ANDA	ANDA079162	Cipla USA Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-817_89be4260-9b25-42aa-8ab8-936e9f1717ba	69097-817	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20160722		ANDA	ANDA079162	Cipla USA Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-818_89be4260-9b25-42aa-8ab8-936e9f1717ba	69097-818	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20160722		ANDA	ANDA079162	Cipla USA Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-819_89be4260-9b25-42aa-8ab8-936e9f1717ba	69097-819	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20160722		ANDA	ANDA079162	Cipla USA Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-820_3c4cf8ae-081c-476a-8c47-581407c20fe2	69097-820	HUMAN PRESCRIPTION DRUG	Zemdri (plazomicin)		Plazomicin	INJECTION	INTRAVENOUS	20180716		NDA	NDA210303	Cipla USA Inc.	PLAZOMICIN	500	mg/10mL			N	20241231
69097-821_2d16c495-7862-4ffc-a9ee-a1c816af5ae5	69097-821	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20161013		ANDA	ANDA077836	Cipla USA Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
69097-822_f6e72240-0d92-418a-b6d2-9658e8caf652	69097-822	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20160722		ANDA	ANDA077534	Cipla USA Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-823_f6e72240-0d92-418a-b6d2-9658e8caf652	69097-823	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20160722		ANDA	ANDA077534	Cipla USA Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-824_f6e72240-0d92-418a-b6d2-9658e8caf652	69097-824	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20160722		ANDA	ANDA077534	Cipla USA Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-825_ebab2c47-9350-447a-9372-7ade623d5bb1	69097-825	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene	TABLET	ORAL	20160629		ANDA	ANDA090842	Cipla USA Inc.	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
69097-826_3d362141-de53-4949-b9a5-34f2b7bb0e75	69097-826	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine	TABLET	ORAL	20160629		ANDA	ANDA090294	Cipla USA Inc.	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
69097-827_3d362141-de53-4949-b9a5-34f2b7bb0e75	69097-827	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine	TABLET	ORAL	20160629		ANDA	ANDA090294	Cipla USA Inc.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
69097-828_4d3f7e7a-ed61-4df6-bc45-f38fb4117406	69097-828	HUMAN PRESCRIPTION DRUG	Quinapril and Hydrochlorothiazide 10/12.5		quinapril and Hydrochlorothiazide 10/12.5	TABLET	ORAL	20160720		ANDA	ANDA201356	Cipla USA Inc.	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-829_4d3f7e7a-ed61-4df6-bc45-f38fb4117406	69097-829	HUMAN PRESCRIPTION DRUG	Quinapril and Hydrochlorothiazide 20/12.5		Quinapril and Hydrochlorothiazide 20/12.5	TABLET	ORAL	20160720		ANDA	ANDA201356	Cipla USA Inc.	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-830_5d828458-1e4f-4e36-9e9f-74c846722b04	69097-830	HUMAN PRESCRIPTION DRUG	fosaprepitant		fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190905		ANDA	ANDA212309	Cipla USA Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
69097-831_4d3f7e7a-ed61-4df6-bc45-f38fb4117406	69097-831	HUMAN PRESCRIPTION DRUG	Quinapril and Hydrochlorothiazide 20/25		Quinapril and Hydrochlorothiazide 20/25	TABLET	ORAL	20160720		ANDA	ANDA201356	Cipla USA Inc.	HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-832_3d362141-de53-4949-b9a5-34f2b7bb0e75	69097-832	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		Benztropine	TABLET	ORAL	20160629		ANDA	ANDA090294	Cipla USA Inc.	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
69097-833_02dd3b66-2b5f-4429-aa84-9743724d356c	69097-833	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Cipla USA Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-834_02dd3b66-2b5f-4429-aa84-9743724d356c	69097-834	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Cipla USA Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-835_02dd3b66-2b5f-4429-aa84-9743724d356c	69097-835	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20160721		ANDA	ANDA077397	Cipla USA Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-836_adb955ec-2369-441f-9db6-0a22bb5b2e7e	69097-836	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20160701		ANDA	ANDA077955	Cipla USA Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69097-837_adb955ec-2369-441f-9db6-0a22bb5b2e7e	69097-837	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20160701		ANDA	ANDA077955	Cipla USA Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69097-838_adb955ec-2369-441f-9db6-0a22bb5b2e7e	69097-838	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20160701		ANDA	ANDA077955	Cipla USA Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69097-839_56ce107f-65d9-4ec8-8859-6a256b27dc57	69097-839	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20160722		ANDA	ANDA078457	Cipla USA Inc.	QUINAPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69097-840_14b7dfcc-b3a8-4027-9544-8d52ec2aacf3	69097-840	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20200601		ANDA	ANDA202496	Cipla USA Inc.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
69097-841_56ce107f-65d9-4ec8-8859-6a256b27dc57	69097-841	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20160722		ANDA	ANDA078457	Cipla USA Inc.	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69097-842_56ce107f-65d9-4ec8-8859-6a256b27dc57	69097-842	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20160722		ANDA	ANDA078457	Cipla USA Inc.	QUINAPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69097-843_56ce107f-65d9-4ec8-8859-6a256b27dc57	69097-843	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20160722		ANDA	ANDA078457	Cipla USA Inc.	QUINAPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69097-844_497e0a60-9b09-4dcc-8cc6-1f13196f2db4	69097-844	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride	extended release	Alfuzosin Hydrochloride	TABLET	ORAL	20160630		ANDA	ANDA090284	Cipla USA Inc.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
69097-845_0e5c376d-9599-4825-9226-016d40cf6113	69097-845	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA090478	Cipla USA Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69097-846_0e5c376d-9599-4825-9226-016d40cf6113	69097-846	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20160722		ANDA	ANDA090478	Cipla USA Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69097-847_6be56b0b-d420-453e-8529-bfa2a8ff012f	69097-847	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram	TABLET, FILM COATED	ORAL	20160616		ANDA	ANDA078604	Cipla USA Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-848_6be56b0b-d420-453e-8529-bfa2a8ff012f	69097-848	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram	TABLET, FILM COATED	ORAL	20160616		ANDA	ANDA078604	Cipla USA Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-849_6be56b0b-d420-453e-8529-bfa2a8ff012f	69097-849	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram	TABLET, FILM COATED	ORAL	20160616		ANDA	ANDA078604	Cipla USA Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69097-850_219e8987-0f88-4149-80e3-77d97e555791	69097-850	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210326		ANDA	ANDA213425	Cipla USA Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
69097-851_dcfba184-4397-4934-9392-2ac42f65e9e5	69097-851	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	20160705		ANDA	ANDA091432	Cipla USA Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-852_dcfba184-4397-4934-9392-2ac42f65e9e5	69097-852	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	20160705		ANDA	ANDA091432	Cipla USA Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-853_598c64ad-f0c4-495e-b2c2-cde215d2572d	69097-853	HUMAN PRESCRIPTION DRUG	naproxen		naproxen	TABLET	ORAL	20160705		ANDA	ANDA091305	Cipla USA Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-854_598c64ad-f0c4-495e-b2c2-cde215d2572d	69097-854	HUMAN PRESCRIPTION DRUG	naproxen		naproxen	TABLET	ORAL	20160705		ANDA	ANDA091305	Cipla USA Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-855_598c64ad-f0c4-495e-b2c2-cde215d2572d	69097-855	HUMAN PRESCRIPTION DRUG	naproxen		naproxen	TABLET	ORAL	20160705		ANDA	ANDA091305	Cipla USA Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-856_6d672087-9b6a-4afe-8c3e-0616943a82cf	69097-856	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril	TABLET	ORAL	20160616		ANDA	ANDA077222	Cipla USA Inc.	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69097-857_6d672087-9b6a-4afe-8c3e-0616943a82cf	69097-857	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril	TABLET	ORAL	20160616		ANDA	ANDA077222	Cipla USA Inc.	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69097-858_6d672087-9b6a-4afe-8c3e-0616943a82cf	69097-858	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril	TABLET	ORAL	20160616		ANDA	ANDA077222	Cipla USA Inc.	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69097-859_05ca19e5-4fab-490c-ac56-07c8de803e84	69097-859	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine	TABLET	ORAL	20160627		ANDA	ANDA077533	Cipla USA Inc.	TERBINAFINE HYDROCHLORIDE	250	1/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
69097-861_37025923-f696-46ab-95fb-b38c30e6004b	69097-861	HUMAN PRESCRIPTION DRUG	zonisamide		zonisamide	CAPSULE	ORAL	20160713		ANDA	ANDA077869	Cipla USA Inc.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
69097-862_7749772b-1a26-4b2e-b97d-3ee29611d035	69097-862	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20160726		ANDA	ANDA203135	Cipla USA Inc.,	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69097-863_dcf24dee-fe87-4adf-b572-16c08868a355	69097-863	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160720		ANDA	ANDA204284	Cipla USA Inc.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69097-864_dcf24dee-fe87-4adf-b572-16c08868a355	69097-864	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20160720		ANDA	ANDA204284	Cipla USA Inc.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69097-865_6ace7fac-e700-4a32-95ce-07ffbd0201ea	69097-865	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20160722		ANDA	ANDA204339	Cipla USA Inc.	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69097-866_6ace7fac-e700-4a32-95ce-07ffbd0201ea	69097-866	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20160722		ANDA	ANDA204339	Cipla USA Inc.	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69097-867_04cca80e-cd0b-467d-9017-32fe1380e044	69097-867	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	Cipla USA Inc.	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69097-868_04cca80e-cd0b-467d-9017-32fe1380e044	69097-868	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	Cipla USA Inc.	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69097-869_04cca80e-cd0b-467d-9017-32fe1380e044	69097-869	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20160223		ANDA	ANDA203455	Cipla USA Inc.	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69097-870_9f320a1b-c81d-43e7-8add-3934ff3c7394	69097-870	HUMAN PRESCRIPTION DRUG	Lanreotide Acetate		lanreotide acetate	INJECTION	SUBCUTANEOUS	20211224		NDA	NDA215395	Cipla USA Inc.	LANREOTIDE ACETATE	120	mg/.5mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
69097-875_6fb20e45-74e9-4038-9db0-9eaf24b5560a	69097-875	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160829		ANDA	ANDA206556	CIPLA USA INC.,	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-876_6fb20e45-74e9-4038-9db0-9eaf24b5560a	69097-876	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160829		ANDA	ANDA206556	CIPLA USA INC.,	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-877_a9b85841-5a69-4df1-a22d-3d4cf174e9a6	69097-877	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE (SR)		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160725		ANDA	ANDA206674	Cipla USA Inc.,	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-878_a9b85841-5a69-4df1-a22d-3d4cf174e9a6	69097-878	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE (SR)		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160725		ANDA	ANDA206674	Cipla USA Inc.,	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-879_a9b85841-5a69-4df1-a22d-3d4cf174e9a6	69097-879	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE (SR)		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160725		ANDA	ANDA206674	Cipla USA Inc.,	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-880_9f320a1b-c81d-43e7-8add-3934ff3c7394	69097-880	HUMAN PRESCRIPTION DRUG	Lanreotide Acetate		lanreotide acetate	INJECTION	SUBCUTANEOUS	20211224		NDA	NDA215395	Cipla USA Inc.	LANREOTIDE ACETATE	60	mg/.2mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
69097-890_9f320a1b-c81d-43e7-8add-3934ff3c7394	69097-890	HUMAN PRESCRIPTION DRUG	Lanreotide Acetate		lanreotide acetate	INJECTION	SUBCUTANEOUS	20211224		NDA	NDA215395	Cipla USA Inc.	LANREOTIDE ACETATE	90	mg/.3mL	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
69097-893_b4a439b7-08e8-4d1b-abea-f7976010d323	69097-893	HUMAN PRESCRIPTION DRUG	Sevelamer carbonate		SEVELAMER CARBONATE	TABLET, FILM COATED	ORAL	20171026		ANDA	ANDA203860	Cipla USA Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69097-894_06d917b6-6950-4b49-b830-a1fa0b8ac0b1	69097-894	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20170330		ANDA	ANDA207378	Cipla USA Inc.,	FENOFIBRATE	67	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69097-895_06d917b6-6950-4b49-b830-a1fa0b8ac0b1	69097-895	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20170330		ANDA	ANDA207378	Cipla USA Inc.,	FENOFIBRATE	134	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69097-896_06d917b6-6950-4b49-b830-a1fa0b8ac0b1	69097-896	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	CAPSULE	ORAL	20170330		ANDA	ANDA207378	Cipla USA Inc.,	FENOFIBRATE	200	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69097-897_ee5777b3-1606-4a9c-b761-211b47d28522	69097-897	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-898_ee5777b3-1606-4a9c-b761-211b47d28522	69097-898	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-899_ee5777b3-1606-4a9c-b761-211b47d28522	69097-899	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-904_4e8c50c0-4026-4047-ac0b-6d8bbb56f923	69097-904	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	FOR SUSPENSION	ORAL	20230116		ANDA	ANDA212858	Cipla USA, Inc	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69097-905_320d4f65-fe3b-4b9b-a504-98302ebd56b5	69097-905	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION	INTRAVENOUS	20210917		ANDA	ANDA205539	Cipla USA Inc.	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69097-909_cd91db22-5bb6-4fae-9b5a-95a82c35931a	69097-909	HUMAN PRESCRIPTION DRUG	LEUPROLIDE ACETATE DEPOT		leuprolide acetate	KIT		20220715		NDA	NDA205054	CIPLA USA INC.						N	20241231
69097-911_ee5777b3-1606-4a9c-b761-211b47d28522	69097-911	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160804		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-912_9058b0be-0e24-418e-9be7-597c00fe8b70	69097-912	HUMAN PRESCRIPTION DRUG	Trospium Chloride		Trospium Chloride	TABLET, FILM COATED	ORAL	20160923		ANDA	ANDA091688	CIPLA USA INC.,	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69097-913_d7eae0fc-9dfd-48d5-9491-e785fd66d5ec	69097-913	HUMAN PRESCRIPTION DRUG	omeprazole sodium bicarbonate		omeprazole sodium bicarbonate	CAPSULE	ORAL	20170130		ANDA	ANDA207476	Cipla USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69097-914_d7eae0fc-9dfd-48d5-9491-e785fd66d5ec	69097-914	HUMAN PRESCRIPTION DRUG	omeprazole sodium bicarbonate		omeprazole sodium bicarbonate	CAPSULE	ORAL	20170130		ANDA	ANDA207476	Cipla USA Inc.	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69097-915_b002fcb1-d247-4333-b38a-6b1de5a05a2c	69097-915	HUMAN PRESCRIPTION DRUG	FLUTAMIDE		FLUTAMIDE	CAPSULE	ORAL	20160921		ANDA	ANDA075780	Cipla USA Inc.	FLUTAMIDE	125	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
69097-917_c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee	69097-917	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20180526		ANDA	ANDA207389	CIPLA USA INC.,	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-918_c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee	69097-918	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20180526		ANDA	ANDA207389	CIPLA USA INC.,	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69097-927_04460041-adec-463b-ba9d-6a12038ab672	69097-927	HUMAN PRESCRIPTION DRUG	palonosetron hydrochloride		palonosetron hydrochloride	INJECTION	INTRAVENOUS	20180323		NDA AUTHORIZED GENERIC	NDA021372	Cipla USA Inc.	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69097-934_7c3ceaf0-a123-46d4-ba5d-43f0808f8b31	69097-934	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20220125		ANDA	ANDA206868	Cipla USA Inc.	LANTHANUM CARBONATE	500	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69097-935_7c3ceaf0-a123-46d4-ba5d-43f0808f8b31	69097-935	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20220125		ANDA	ANDA206868	Cipla USA Inc.	LANTHANUM CARBONATE	750	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69097-936_7c3ceaf0-a123-46d4-ba5d-43f0808f8b31	69097-936	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20220125		ANDA	ANDA206868	Cipla USA Inc.	LANTHANUM CARBONATE	1000	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69097-937_5441d59a-23e6-42bd-b5d0-a6a2259126aa	69097-937	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Cipla USA, Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69097-938_5441d59a-23e6-42bd-b5d0-a6a2259126aa	69097-938	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Cipla USA, Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69097-939_5441d59a-23e6-42bd-b5d0-a6a2259126aa	69097-939	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Cipla USA, Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69097-940_160109da-da53-45a8-840a-e41384710033	69097-940	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	CAPSULE	ORAL	20220802		ANDA	ANDA212077	Cipla USA Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69097-941_5441d59a-23e6-42bd-b5d0-a6a2259126aa	69097-941	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Cipla USA, Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69097-942_5441d59a-23e6-42bd-b5d0-a6a2259126aa	69097-942	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Cipla USA, Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69097-943_63f1d03b-8e01-4338-8627-c9e1e900bc75	69097-943	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20171205		ANDA	ANDA090705	Cipla USA Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69097-944_ee5777b3-1606-4a9c-b761-211b47d28522	69097-944	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-945_ee5777b3-1606-4a9c-b761-211b47d28522	69097-945	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-946_ee5777b3-1606-4a9c-b761-211b47d28522	69097-946	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-947_ee5777b3-1606-4a9c-b761-211b47d28522	69097-947	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA205519	Cipla USA Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69097-948_c1549b67-948e-402d-9ba4-6fc16237df8f	69097-948	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20230701		ANDA	ANDA209365	Cipla USA Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69097-949_c1549b67-948e-402d-9ba4-6fc16237df8f	69097-949	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20230701		ANDA	ANDA209365	Cipla USA Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69097-951_31499b53-d7e9-49e4-8eaa-c527c7403f9c	69097-951	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20200710		ANDA	ANDA207178	CIPLA USA INC.,	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-952_31499b53-d7e9-49e4-8eaa-c527c7403f9c	69097-952	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20200710		ANDA	ANDA207178	CIPLA USA INC.,	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-953_31499b53-d7e9-49e4-8eaa-c527c7403f9c	69097-953	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20200710		ANDA	ANDA207178	CIPLA USA INC.,	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69097-954_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-954	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
69097-955_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-955	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
69097-956_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-956	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
69097-957_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-957	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
69097-958_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-958	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
69097-959_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-959	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
69097-961_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-961	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	225	mg/1		CV	N	20241231
69097-962_4215d7b7-2c7f-4fda-a0a9-110abfd0e167	69097-962	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Cipla USA, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
69097-964_4cdad60f-7614-47cb-8594-3c0257e55c28	69097-964	HUMAN PRESCRIPTION DRUG	VIGABATRIN		vigabatrin	POWDER, FOR SOLUTION	ORAL	20191204		ANDA	ANDA211592	Cipla USA, Inc.	VIGABATRIN	500	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
69097-965_5a9cecab-f412-4dfe-ace3-7de5c8106c0a	69097-965	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA078671	Cipla USA Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-966_5a9cecab-f412-4dfe-ace3-7de5c8106c0a	69097-966	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA078671	Cipla USA Inc.	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69097-967_444a974f-7f31-4b53-93c9-f5b9a251f711	69097-967	HUMAN PRESCRIPTION DRUG	Sevelamer carbonate		SEVELAMER CARBONATE	TABLET, FILM COATED	ORAL	20171026		ANDA	ANDA203860	Cipla USA Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69097-968_2815b0ef-9835-4b49-b98d-8519e7005dc1	69097-968	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	Cipla USA Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-969_2815b0ef-9835-4b49-b98d-8519e7005dc1	69097-969	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	Cipla USA Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-971_2815b0ef-9835-4b49-b98d-8519e7005dc1	69097-971	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	Cipla USA Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-972_25e66ad5-947a-4262-a996-a9695601d301	69097-972	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium and Hydrochlorothiazide		Fosinopril Sodium and Hydrochlorothiazide	TABLET	ORAL	20200724		ANDA	ANDA090228	CIPLA USA INC.	FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE	10; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-973_25e66ad5-947a-4262-a996-a9695601d301	69097-973	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium and Hydrochlorothiazide		Fosinopril Sodium and Hydrochlorothiazide	TABLET	ORAL	20200724		ANDA	ANDA090228	CIPLA USA INC.	FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE	20; 12.5	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69097-974_1fe09b66-c58f-4d50-8932-96f52bda4bcb	69097-974	HUMAN PRESCRIPTION DRUG	Meprobamate		Meprobamate	TABLET	ORAL	20210607		ANDA	ANDA040797	Cipla USA Inc.	MEPROBAMATE	200	mg/1		CIV	N	20241231
69097-975_1fe09b66-c58f-4d50-8932-96f52bda4bcb	69097-975	HUMAN PRESCRIPTION DRUG	Meprobamate		Meprobamate	TABLET	ORAL	20210607		ANDA	ANDA040797	Cipla USA Inc.	MEPROBAMATE	400	mg/1		CIV	N	20241231
69097-979_3580ca45-da9b-4714-b4b9-9637a2d7b87c	69097-979	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET, FILM COATED	ORAL	20230123		ANDA	ANDA208200	Cipla USA Inc.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
69097-981_3580ca45-da9b-4714-b4b9-9637a2d7b87c	69097-981	HUMAN PRESCRIPTION DRUG	Vilazodone hydrochloride		Vilazodone hydrochloride	TABLET, FILM COATED	ORAL	20230123		ANDA	ANDA208200	Cipla USA Inc.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
69097-982_3580ca45-da9b-4714-b4b9-9637a2d7b87c	69097-982	HUMAN PRESCRIPTION DRUG	Vilazodone hydrochloride		Vilazodone hydrochloride	TABLET, FILM COATED	ORAL	20230123		ANDA	ANDA208200	Cipla USA Inc.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
69097-987_398a92b7-8db3-4604-9004-892c41721294	69097-987	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220802		ANDA	ANDA212078	Cipla USA Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69097-988_398a92b7-8db3-4604-9004-892c41721294	69097-988	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220802		ANDA	ANDA212078	Cipla USA Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69097-992_8da140e7-0298-4985-a4a1-f8dd5cbbfccd	69097-992	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230612		ANDA	ANDA216327	Cipla USA, Inc.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
69097-993_8da140e7-0298-4985-a4a1-f8dd5cbbfccd	69097-993	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230612		ANDA	ANDA216327	Cipla USA, Inc.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
69097-994_8da140e7-0298-4985-a4a1-f8dd5cbbfccd	69097-994	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230612		ANDA	ANDA216327	Cipla USA, Inc.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
69097-995_8da140e7-0298-4985-a4a1-f8dd5cbbfccd	69097-995	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230612		ANDA	ANDA216327	Cipla USA, Inc.	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
69097-996_8da140e7-0298-4985-a4a1-f8dd5cbbfccd	69097-996	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230612		ANDA	ANDA216327	Cipla USA, Inc.	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
69097-997_8da140e7-0298-4985-a4a1-f8dd5cbbfccd	69097-997	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		diltiazem hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230612		ANDA	ANDA216327	Cipla USA, Inc.	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
69097-998_ab6ad4e1-6b03-45c9-b4d0-59bda8e3b35d	69097-998	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20230612		ANDA	ANDA207466	CIPLA USA INC.	METAXALONE	400	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69097-999_82b768e9-502a-4b78-8200-c6bc4d0d76b1	69097-999	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20231201		ANDA	ANDA213329	Cipla USA., Inc.	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20251231
69102-105_14899d4b-b295-431e-b1d5-d8163bdadb87	69102-105	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20201028		ANDA	ANDA078858	OWP Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69102-106_14899d4b-b295-431e-b1d5-d8163bdadb87	69102-106	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20201028		ANDA	ANDA078858	OWP Pharmaceuticals, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69102-107_14899d4b-b295-431e-b1d5-d8163bdadb87	69102-107	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20201028		ANDA	ANDA078858	OWP Pharmaceuticals, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69102-108_14899d4b-b295-431e-b1d5-d8163bdadb87	69102-108	HUMAN PRESCRIPTION DRUG	Roweepra		Levetiracetam	TABLET	ORAL	20201028		ANDA	ANDA078858	OWP Pharmaceuticals, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69103-2507_f18bebf2-192a-658f-e053-2a95a90a5012	69103-2507	HUMAN OTC DRUG	PAIN TERMINATOR		ASPIRIN, ACETAMINOPHEN, CAFFEINE, SALICYLAMIDE	TABLET	ORAL	20150331	20240701	OTC MONOGRAPH NOT FINAL	part343	Provision Medical Products	ACETAMINOPHEN; ASPIRIN; SALICYLAMIDE	110; 162; 152	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
69103-2516_f18f3ef4-76b6-33a5-e053-2995a90aeba4	69103-2516	HUMAN OTC DRUG	RAZZMATAZZ ANTACID		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20150331	20240701	OTC MONOGRAPH FINAL	part331	Provision Medical Products	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
69103-2522_f19abc4d-12f8-5e80-e053-2995a90aab8e	69103-2522	HUMAN OTC DRUG	Max Non Aspirin		Acetaminophen	TABLET	ORAL	20150331	20240201	OTC MONOGRAPH NOT FINAL	part343	Provision Medical Products	ACETAMINOPHEN	500	mg/1			N	
69103-2525_f18ebbe5-cd44-8c27-e053-2a95a90ab79b	69103-2525	HUMAN OTC DRUG	Flex-Prin		Ibuprofen	TABLET	ORAL	20150331		ANDA	ANDA079129	Provision Medical Products	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69103-2552_f18f3ef4-76c2-33a5-e053-2995a90aeba4	69103-2552	HUMAN OTC DRUG	POLARIS MINT ANTACID		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20150331	20240501	OTC MONOGRAPH FINAL	part331	Provision Medical Products	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
69103-4506_f19adc9a-00e1-54c6-e053-2995a90a9638	69103-4506	HUMAN OTC DRUG	Itch and Rash Cream		Hydrocortisone	CREAM	TOPICAL	20150331	20240701	OTC MONOGRAPH NOT FINAL	part348	Provision Medical Products	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
69113-001_f28c1222-500f-ab06-e053-2995a90ad004	69113-001	HUMAN OTC DRUG	Bosley MD Regular Strength for Women		Minoxidil 2%	SOLUTION	TOPICAL	20200521		ANDA	ANDA078176	Scientific Hair Research, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69113-002_f28bbeee-ee59-4aba-e053-2995a90ade84	69113-002	HUMAN OTC DRUG	Bosley MD Extra Strength for Men		Minoxidil 5%	SOLUTION	TOPICAL	20200521		ANDA	ANDA076239	Scientific Hair Research, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69113-003_f28bb4d2-d57e-1a62-e053-2995a90aa0c6	69113-003	HUMAN OTC DRUG	Bosley MD Extra Strength for Men		Minoxidil 5%	SOLUTION	TOPICAL	20200521		ANDA	ANDA076239	Scientific Hair Research, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69113-004_f28bc12c-2022-4ddc-e053-2a95a90abaa0	69113-004	HUMAN OTC DRUG	Bosley MD Regular Strength for Women		Minoxidil 2%	SOLUTION	TOPICAL	20200521		ANDA	ANDA078176	Scientific Hair Research, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69113-128_a2f52a07-dc82-4e04-bff8-492d1307d579	69113-128	HUMAN OTC DRUG	Minoxidil	(for Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20201223		ANDA	ANDA209074	SCIENTIFIC HAIR RESEARCH, LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69113-129_5754886d-9ef9-41c9-88ab-696180bcfbb4	69113-129	HUMAN OTC DRUG	Minoxidil	(for Women)	Minoxidil	AEROSOL, FOAM	TOPICAL	20201223		ANDA	ANDA209074	SCIENTIFIC HAIR RESEARCH, LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69113-431_089b11e3-3fe0-9d14-e063-6394a90a418d	69113-431	HUMAN OTC DRUG	BOSLEY Man 5 Minoxidil Topical Solution		MINOXIDIL	SOLUTION	TOPICAL	20231103		ANDA	ANDA076239	Scientific Hair Research, LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69113-432_0cc5f9cd-a030-7ea6-e063-6394a90a2fa4	69113-432	HUMAN OTC DRUG	BOSLEY Woman 2 Minoxidil Topical Solution		MINOXIDIL	SOLUTION	TOPICAL	20231103		ANDA	ANDA078176	Scientific Hair Research, LLC	MINOXIDIL	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69117-0003_0da71c65-aad3-6d6c-e063-6394a90a64eb	69117-0003	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole Tablets	TABLET	ORAL	20190228		ANDA	ANDA206037	Yiling Pharmaceutical, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
69117-0004_0da71c65-aad4-6d6c-e063-6394a90a64eb	69117-0004	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole Tablets	TABLET, FILM COATED	ORAL	20190905		ANDA	ANDA205869	Yiling Pharmaceutical, Inc.	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
69117-0008_0da6e293-914e-3146-e063-6394a90a0399	69117-0008	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Tablets	TABLET, COATED	ORAL	20190713		ANDA	ANDA208921	Yiling Pharmaceutical, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
69117-0009_0da6e293-914e-3146-e063-6394a90a0399	69117-0009	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Tablets	TABLET, COATED	ORAL	20190713		ANDA	ANDA208921	Yiling Pharmaceutical, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
69117-0010_0da6b94c-7d16-2385-e063-6394a90ad5b3	69117-0010	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20181001		ANDA	ANDA209553	Yiling Pharmaceutical, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69117-0011_0da6b94c-7d16-2385-e063-6394a90ad5b3	69117-0011	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir Hydrochloride	TABLET	ORAL	20181001		ANDA	ANDA209553	Yiling Pharmaceutical, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69117-0018_f1661d30-ce6f-102a-e053-2995a90a796b	69117-0018	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20180504		ANDA	ANDA210401	YILING PHARMACEUTICAL, INC.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69117-0019_0da6772f-5483-1c69-e063-6394a90a070d	69117-0019	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20180504		ANDA	ANDA210401	YILING PHARMACEUTICAL, INC.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69117-0020_0da6c352-abf9-0297-e063-6294a90a799d	69117-0020	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200306		ANDA	ANDA211412	Yiling Pharmaceutical, Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69117-0021_0da6c352-abf9-0297-e063-6294a90a799d	69117-0021	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200306		ANDA	ANDA211412	Yiling Pharmaceutical, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69117-0022_0da6c352-abf9-0297-e063-6294a90a799d	69117-0022	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200306		ANDA	ANDA211412	Yiling Pharmaceutical, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69117-0023_0da6c352-abf9-0297-e063-6294a90a799d	69117-0023	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20200306		ANDA	ANDA211412	Yiling Pharmaceutical, Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69117-0024_0c455955-e88f-acfa-e063-6294a90a224c	69117-0024	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Yiling Pharmaceutical, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69117-0025_0c455955-e88f-acfa-e063-6294a90a224c	69117-0025	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Yiling Pharmaceutical, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69117-0026_0c455955-e88f-acfa-e063-6294a90a224c	69117-0026	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Yiling Pharmaceutical, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69117-0027_0c455955-e88f-acfa-e063-6294a90a224c	69117-0027	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20211102		ANDA	ANDA211248	Yiling Pharmaceutical, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69117-0028_f16664c7-8b29-4b33-e053-2a95a90a5c9d	69117-0028	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine Extended-release Tablets	TABLET, EXTENDED RELEASE	ORAL	20190801		ANDA	ANDA210847	Yiling Pharmaceutical Inc.	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69117-0029_f16664c7-8b29-4b33-e053-2a95a90a5c9d	69117-0029	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine Extended-release Tablets	TABLET, EXTENDED RELEASE	ORAL	20190801		ANDA	ANDA210847	Yiling Pharmaceutical Inc.	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69117-0030_f16664c7-8b29-4b33-e053-2a95a90a5c9d	69117-0030	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine Extended-release Tablets	TABLET, EXTENDED RELEASE	ORAL	20190801		ANDA	ANDA210847	Yiling Pharmaceutical Inc.	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69117-0036_fe0f66e2-1fb0-fab6-e053-6394a90abe48	69117-0036	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200915		ANDA	ANDA212041	Yiling Pharmaceutical, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69117-0037_fe0f66e2-1fb0-fab6-e053-6394a90abe48	69117-0037	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200915		ANDA	ANDA212041	Yiling Pharmaceutical, Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69117-0038_fe0f66e2-1fb0-fab6-e053-6394a90abe48	69117-0038	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200915		ANDA	ANDA212041	Yiling Pharmaceutical, Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69117-0039_f20e0ca1-50b5-db28-e053-2995a90a847e	69117-0039	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20210312		ANDA	ANDA212173	YILING PHARMACEUTICAL, INC.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69117-0040_f16635a5-7e1a-534a-e053-2995a90a9355	69117-0040	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20191030		ANDA	ANDA202087	Yiling Pharmaceutical, Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
69117-0041_f16635a5-7e1a-534a-e053-2995a90a9355	69117-0041	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20191030		ANDA	ANDA202087	Yiling Pharmaceutical, Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
69117-0042_f16635a5-7e1a-534a-e053-2995a90a9355	69117-0042	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20191030		ANDA	ANDA202087	Yiling Pharmaceutical, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
69117-0043_f16635a5-7e1a-534a-e053-2995a90a9355	69117-0043	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20191030		ANDA	ANDA202087	Yiling Pharmaceutical, Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
69117-1001_fe0f66e2-1fb0-fab6-e053-6394a90abe48	69117-1001	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210304		ANDA	ANDA208920	Yiling Pharmaceutical, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69117-1002_fe0f66e2-1fb0-fab6-e053-6394a90abe48	69117-1002	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210304		ANDA	ANDA208920	Yiling Pharmaceutical, Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69117-1003_fe0f66e2-1fb0-fab6-e053-6394a90abe48	69117-1003	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210304		ANDA	ANDA208920	Yiling Pharmaceutical, Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69125-001_0772d642-82e2-cbb6-e063-6394a90a0b91	69125-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140721		UNAPPROVED MEDICAL GAS		Penn Highlands Home Medical Equipment, LLC	OXYGEN	99	L/100L			N	20241231
69128-001_06e60501-155c-6bef-e063-6294a90a20a9	69128-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140721		UNAPPROVED MEDICAL GAS		iMedEquip LLC dba Independent Medical Equipment	OXYGEN	99	L/100L			N	20241231
69134-0002_3c903520-1049-4e22-94ce-226a0fb2d005	69134-0002	HUMAN OTC DRUG	Lymph Drainage		Baptisia Tinctoria, Citrus Limonum, Echinacea (Angustifolia), Lobelia Inflata, Phytolacca Decandra, Pinus Sylvestris, Teucrium Scorodonia, Thuja Occidentalis, Capsicum Annuum, Cuprum Sulphuricum, Kali Muriaticum, Manganum Muriaticum, Arsenicum Iodatum, Carpinus Betulus, Flos, Centaurium Umbellatum, Flos, Galium Aparine, Larix Decidua, Flos, Rosa Canina, Scrophularia Nodosa, Zincum Gluconicum, Aranea Diadema, Calcarea Carbonica, Carbo Vegetabilis, Ceanothus Americanus, Lachesis Mutus	LIQUID	ORAL	20220906		UNAPPROVED HOMEOPATHIC		Carnivora Research International	ACTIVATED CHARCOAL; ARANEUS DIADEMATUS; ARSENIC TRIIODIDE; BAPTISIA TINCTORIA WHOLE; CAPSICUM; CARPINUS BETULUS FLOWERING TOP; CEANOTHUS AMERICANUS LEAF; CENTAURIUM ERYTHRAEA FLOWER; CUPRIC SULFATE; ECHINACEA ANGUSTIFOLIA WHOLE; GALIUM APARINE WHOLE; LACHESIS MUTA VENOM; LARIX DECIDUA FLOWERING TOP; LEMON JUICE; LOBELIA INFLATA WHOLE; MANGANESE CHLORIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; POTASSIUM CHLORIDE; ROSA CANINA FRUIT; SCROPHULARIA NODOSA WHOLE; TEUCRIUM SCORODONIA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG; ZINC GLUCONATE	12; 12; 8; 3; 6; 8; 12; 8; 6; 3; 8; 12; 8; 3; 4; 6; 12; 4; 4; 6; 8; 8; 4; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS]		N	20241231
69138-783_72578738-6824-44ad-9201-b56999c7fcc9	69138-783	HUMAN OTC DRUG	Sani Claw Wipes		ALCOHOL	CLOTH	TOPICAL	20140801		OTC MONOGRAPH NOT FINAL	part333E	Homeland Industrial Supply	ALCOHOL	620	mg/g			N	20241231
69139-001_f60bbb82-b941-0567-e053-2995a90afe68	69139-001	HUMAN OTC DRUG	Alcohol Prep Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20230304		OTC MONOGRAPH NOT FINAL	part333A	YIWU HAODING MEDICAL CO.,LTD	ALCOHOL	70	mL/100mL			N	20241231
69139-106_f60c4312-ccb9-3e9c-e053-2995a90a2524	69139-106	HUMAN OTC DRUG	coralite ANTIBACTERIAL BANDAGES		benzalkonium chloride	SWAB	TOPICAL	20230304		OTC MONOGRAPH NOT FINAL	part333A	YIWU HAODING MEDICAL CO.,LTD	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
69139-120_e5fc306c-a556-40de-b3aa-3d6ff3d05704	69139-120	HUMAN OTC DRUG	Salicylic Acid Acne Patches		Salicylic acid 0.5%	PATCH	TOPICAL	20220915		OTC MONOGRAPH FINAL	part333D	YIWU HAODING MEDICAL CO.,LTD	SALICYLIC ACID	.5	mg/100mg			N	20241231
69139-201_952d234d-62d2-4e43-aff6-9a55028a60f8	69139-201	HUMAN OTC DRUG	Smileplus Alcohol Pad		Alcohol	SWAB	TOPICAL	20240109		OTC MONOGRAPH DRUG	M003	YIWU HAODING MEDICAL CO.,LTD	ALCOHOL	70	g/100g			N	20251231
69139-202_d1ab06db-d9b9-4603-961e-37e1e9d5a399	69139-202	HUMAN OTC DRUG	aid and first antiseptic cleansing wipe		benzalkonium chloride	SWAB	TOPICAL	20240109		OTC MONOGRAPH DRUG	M003	YIWU HAODING MEDICAL CO.,LTD	BENZALKONIUM CHLORIDE	.4	g/100g			N	20251231
69139-203_475b9c81-d306-490b-9041-11268af23317	69139-203	HUMAN OTC DRUG	aid and first sting relief prep pad		Benzocaine 6%, SD alcohol 60%	SWAB	TOPICAL	20240109		OTC MONOGRAPH DRUG	M003	YIWU HAODING MEDICAL CO.,LTD	BENZOCAINE; ISOPROPYL ALCOHOL	6; 60	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
69139-212_f60c626d-78e3-5903-e053-2a95a90abf25	69139-212	HUMAN OTC DRUG	Jensil Alcohol Pad		Alcohol	SWAB	TOPICAL	20230304		OTC MONOGRAPH NOT FINAL	part333E	YIWU HAODING MEDICAL CO.,LTD	ALCOHOL	70	g/100g			N	20241231
69139-216_f60c7828-29ca-aa0c-e053-2995a90a84af	69139-216	HUMAN OTC DRUG	myabetic Alcohol Prep Pads		Alcohol	SWAB	TOPICAL	20230304		OTC MONOGRAPH NOT FINAL	part333E	YIWU HAODING MEDICAL CO.,LTD	ALCOHOL	70	g/100g			N	20241231
69139-400_f60c4312-ccae-3e9c-e053-2995a90a2524	69139-400	HUMAN OTC DRUG	BZK ANTIBACTERIAL		benzalkonium chloride	SWAB	TOPICAL	20230304		OTC MONOGRAPH NOT FINAL	part333A	YIWU HAODING MEDICAL CO.,LTD	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
69139-601_7afc51be-fbb1-4ccd-87ef-e679426e37f9	69139-601	HUMAN OTC DRUG	Spalife Soft As Heel Oil-Gel smoothing Heel Patch		SALICYLIC ACID	SWAB	TOPICAL	20230313		OTC MONOGRAPH FINAL	part333D	YIWU HAODING MEDICAL CO.,LTD	SALICYLIC ACID	3	g/100g			N	20241231
69139-606_0c7915cc-4ceb-460a-85ab-701153479a86	69139-606	HUMAN OTC DRUG	Solos Sterile Alcohol Prep Pad		Alcohol	SWAB	TOPICAL	20230325		OTC MONOGRAPH NOT FINAL	part333E	YIWU HAODING MEDICAL CO.,LTD	ALCOHOL	70	g/100g			N	20241231
69145-201_09745e88-e6dc-aa2c-e063-6394a90a954f	69145-201	HUMAN OTC DRUG	Desert Harvest RELEVEUM		LIDOCAINE	CREAM	TOPICAL	20140730		OTC MONOGRAPH DRUG	M017	Desert Harvest Inc.	LIDOCAINE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69159-301_6ed2325c-59c4-455b-8a40-0e583b37e645	69159-301	HUMAN OTC DRUG	GUTONG TIEGAO PAIN RELIEVING		Camphor and Menthol	PATCH	TOPICAL	20160413		OTC MONOGRAPH NOT FINAL	part348	FOSHAN AQUA GEL BIOTECH CO LTD	CAMPHOR (SYNTHETIC); MENTHOL	248; 100	mg/1; mg/1			N	20241231
69159-910_5d53bb54-e7d7-724f-e053-2a91aa0a5618	69159-910	HUMAN OTC DRUG	Ultimate Topical Pain Relief Patch		CAPSAICIN and MENTHOL, UNSPECIFIED FORM	PATCH	TOPICAL	20160501		OTC MONOGRAPH NOT FINAL	part348	Foshan Aqua Gel Biotech Co.,Ltd.	CAPSAICIN; MENTHOL, UNSPECIFIED FORM	.0375; 5	g/100g; g/100g			N	20241231
69159-920_5d539dfd-9d87-c162-e053-2991aa0a51c0	69159-920	HUMAN OTC DRUG	Lidocaine Pain Relief Patch		LIDOCAINE and MENTHOL, UNSPECIFIED FORM	PATCH	TOPICAL	20160901		OTC MONOGRAPH NOT FINAL	part348	Foshan Aqua Gel Biotech Co.,Ltd.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69164-0001_fbf008ae-7aeb-665b-e053-6394a90af63c	69164-0001	HUMAN OTC DRUG	COLLOIDAL IODINEINJECTION		IODINE	SOLUTION	SUBCUTANEOUS	20230518		UNAPPROVED DRUG OTHER		JCI Colloidal Iodine Laboratory Co., Ltd.	IODINE	2	g/100mL			N	20241231
69164-0003_fc5a79ce-4051-8660-e053-6394a90a8472	69164-0003	HUMAN OTC DRUG	Colloidal Iodine Solution		Sodium Iodide	SOLUTION	ORAL	20230518		UNAPPROVED DRUG OTHER		JCI Colloidal Iodine Laboratory Co., Ltd.	IODINE	2	g/100mL			N	20241231
69168-001_0801608d-547e-4a42-aaa5-7b2c6a1d7075	69168-001	HUMAN OTC DRUG	Tension Headache Relief		Tension Headache Relief	CAPSULE, COATED	ORAL	20211122		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69168-002_36c028e5-005a-42eb-958c-9fed406827b3	69168-002	HUMAN OTC DRUG	Diphenhydramine HCl 25mg		Sleep Aid	TABLET, COATED	ORAL	20211123		OTC MONOGRAPH DRUG	M010	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-003_d3d02f1a-47df-498e-871d-58e79640fe81	69168-003	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Pain Relief PM	TABLET	ORAL	20211123		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-004_1e175274-049d-41ae-bef0-2a243661be70	69168-004	HUMAN OTC DRUG	Cold Medicine		Cold Medicine	TABLET	ORAL	20211112		OTC MONOGRAPH DRUG	M012	Allegiant Health	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-005_88c123d3-f75c-4305-b47f-e5398ac27959	69168-005	HUMAN OTC DRUG	Pain Relief	Extra Strength	Pain Relief	TABLET	ORAL	20211123		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN	500	mg/1			N	20241231
69168-006_c9ba8718-60d6-4ef0-ae21-dddb9ee11bc8	69168-006	HUMAN OTC DRUG	Aspirin 81mg Enteric coated	Low Strength Aspirin Regimen	Aspirin	TABLET, DELAYED RELEASE	ORAL	20211119		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-010_92f2ab65-26c5-4e2e-9f13-1d7836c8d559	69168-010	HUMAN OTC DRUG	Acetaminophen 325mg	RS	Acetaminophen 325mg	TABLET	ORAL	20160415		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN	325	mg/1			N	20241231
69168-011_13dbf279-c8b9-4a5c-8bed-0db001fe0c18	69168-011	HUMAN OTC DRUG	Acetaminophen 500mg	ES	Acetaminophen 500mg	TABLET	ORAL	20160415		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN	500	mg/1			N	20241231
69168-029_5fa5b219-61a3-4b4b-bc29-a3982701ebce	69168-029	HUMAN OTC DRUG	Tension Headache Relief		Tension Headache Relief	CAPSULE	ORAL	20141126		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69168-046_e750abb2-da83-4d54-a036-274a36c9551d	69168-046	HUMAN OTC DRUG	Bismuth		Bismuth subsalicylate	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M008	Allegiant Health	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
69168-048_b53853c5-5f00-41ab-8d0d-eb40aba6e67b	69168-048	HUMAN OTC DRUG	Allergy		Diphenhydramine HCl	TABLET	ORAL	20141215		OTC MONOGRAPH DRUG	M012	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-076_548c1927-d2e5-460c-bb6e-3315f97d2d5f	69168-076	HUMAN OTC DRUG	Stay Awake		Caffeine	TABLET, COATED	ORAL	20140701		OTC MONOGRAPH DRUG	M011	Allegiant Health	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69168-174_6225e033-9578-451d-ba0b-16e2a5e0322c	69168-174	HUMAN OTC DRUG	Magnesium Oxide 400mg		Magnesium Oxide 400mg	TABLET	ORAL	20031203		OTC MONOGRAPH DRUG	M001	Allegiant Health	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69168-219_60233481-e279-4395-9bb3-0fcfd04a93c1	69168-219	HUMAN OTC DRUG	Calcium Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20141216		OTC MONOGRAPH DRUG	M001	Allegiant Health	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69168-229_f559e909-43ef-41ef-b159-50da4d916f0b	69168-229	HUMAN OTC DRUG	Calcium Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20141216		OTC MONOGRAPH DRUG	M001	Allegiant Health	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69168-247_51f0777e-6c05-48ee-bb31-a53f18c04627	69168-247	HUMAN OTC DRUG	Sleep Tabs	For Nighttime use	Diphenhydramine HCl Tablets	TABLET	ORAL	20150428		OTC MONOGRAPH DRUG	M012	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-248_ef9b20dc-0119-49c1-bc31-2c9fc1f4d772	69168-248	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET, COATED	ORAL	20050503		ANDA	ANDA076497	Allegiant Health	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
69168-263_27eb9a00-8cc4-47e4-837f-e1583b995b3c	69168-263	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl 25 mg	TABLET	ORAL	20150303		OTC MONOGRAPH DRUG	M012	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-270_f2ef7d62-ece4-4c18-9efe-5c2cdc5a5743	69168-270	HUMAN OTC DRUG	Sinus Headache PEMaximum Strength Non-Drowsy	Maximum Strength Non-Drowsy	Acetaminophen and Phenylephrine HCl	TABLET	ORAL	20141222		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-271_8e542cf6-e07c-443a-9e26-9b4a2b7393ee	69168-271	HUMAN OTC DRUG	Decongestant PE	Non Drowsy	Phenylephrine HCl	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M012	Allegiant Health	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-272_a65a38d6-7a2e-4115-b442-66dd91fb0f7e	69168-272	HUMAN OTC DRUG	Nasal Decongestant PE	Maximum Strength Non-Drowsy	Phenylephrine 10 mg	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M012	Allegiant Health	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-277_aa78dfc9-7395-4619-9e32-91ea3b546ee9	69168-277	HUMAN OTC DRUG	Allergy		Chlorpheniramine maleate	TABLET	ORAL	20141215		OTC MONOGRAPH DRUG	M012	Allegiant Health	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-285_62d55418-7d3d-4708-af3a-2969be915e4a	69168-285	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin and Caffeine	TABLET, FILM COATED	ORAL	20100215		NDA	NDA020802	Allegiant Health	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69168-288_4c94e807-e4ed-45b7-84ed-9611542472f7	69168-288	HUMAN OTC DRUG	Aspirin	Chewable	Aspirin 81 mg	TABLET	ORAL	20141218		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-309_960f6080-bc4a-4168-97c5-a3654cce4014	69168-309	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20141216		ANDA	ANDA076471	Allegiant Health	LORATADINE	10	mg/1			N	20241231
69168-312_9d8da072-5538-4dfa-91fe-8aa7f3c09010	69168-312	HUMAN OTC DRUG	Aspirin		Aspirin 325 mg	TABLET	ORAL	20141218		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-318_2899105f-ce56-4f8f-8966-0f18aed41d75	69168-318	HUMAN OTC DRUG	ASPIRIN	Enteric Coated	Aspirin 81 MG	TABLET	ORAL	20141218		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-318_e6eab4fe-e1dc-4b80-9711-d4c74618eb4b	69168-318	HUMAN OTC DRUG	Aspirin	Enteric Coated	Aspirin 81 mg	TABLET	ORAL	20141218		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-319_2c10d41f-cfbb-48dc-851f-b2959d12e075	69168-319	HUMAN OTC DRUG	Cold Multi-Symptom	Night-time	Acetaminophen,Chlorpheniramine maleate, Dextromethorphan HBr and Phenylephrine HCI	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-324_b31c44ba-30a7-4731-8169-2a3f2a5de4d5	69168-324	HUMAN OTC DRUG	Cold Multi-Symptom		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, COATED	ORAL	20150815		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-328_7ed5b51e-f50e-42cd-965e-2962d68ec75f	69168-328	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen 500 mg	TABLET	ORAL	20141217		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN	500	mg/1			N	20241231
69168-335_efd20a4b-fd12-46e4-ad80-5065264a4203	69168-335	HUMAN OTC DRUG	Ibuprofen	Fast relief medicine for pain	Ibuprofen 200 mg	TABLET	ORAL	20141219		ANDA	ANDA079129	Allegiant Health	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-362_18185cb8-53e0-4d19-ba7f-46d57e6f911a	69168-362	HUMAN OTC DRUG	Naproxen Caplets	All day relief for pain	Naproxen Sodium 220 mg	TABLET	ORAL	20141223		ANDA	ANDA090545	Allegiant Health	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-368_2384fd3b-de52-46c9-bea9-4d8a0342fe59	69168-368	HUMAN OTC DRUG	Ibuprofen 200 mg		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20141222		ANDA	ANDA079205	Allegiant Health	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-370_e6dbafa2-0868-44ec-b764-f15b26a97fce	69168-370	HUMAN OTC DRUG	Mucus Relief	Immediate Release	GUAIFENESIN	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M012	Allegiant Health	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69168-371_3d9f08e0-645d-4780-93aa-1982483e7b90	69168-371	HUMAN OTC DRUG	Senna Lax		Sennosides 8.6mg	TABLET	ORAL	20140701		OTC MONOGRAPH DRUG	M007	Allegiant Health	SENNOSIDES	8.6	mg/1			N	20241231
69168-372_4432946a-b57f-406d-adf9-c2e95bf478ba	69168-372	HUMAN OTC DRUG	Aspirin	Enteric Coated	Aspirin 81 mg	TABLET	ORAL	20201111		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-380_284c5e1b-f092-4520-b00f-f3511387d4a3	69168-380	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20170517		ANDA	ANDA208150	Allegiant Health	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69168-381_ccb176fa-b1be-4552-ab01-c8a0643e063c	69168-381	HUMAN OTC DRUG	Ibuprofen 200mg		Ibuprofen	TABLET	ORAL	20211116		ANDA	ANDA079174	Allegiant Health	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-382_ae3533a4-7870-48e8-b17e-512cc50190b1	69168-382	HUMAN OTC DRUG	Ibuprofen 200mg		Ibuprofen 200mg	TABLET	ORAL	20141223		ANDA	ANDA079174	Allegiant Health	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-390_9d7fe948-b8c9-4798-b9bf-0cedd86f069b	69168-390	HUMAN OTC DRUG	Ibuprofen 200mg		Ibuprofen 200mg	TABLET, FILM COATED	ORAL	20141223		ANDA	ANDA077349	Allegiant Health	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-392_9dbab14c-2a68-408a-961c-6325df359d73	69168-392	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl 10 mg	CAPSULE, LIQUID FILLED	ORAL	20141216		ANDA	ANDA078317	Allegiant Health	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-393_d525d4d3-adac-40fb-a927-832f7d6a831b	69168-393	HUMAN OTC DRUG	Pain Relief PM	Extra Strength	Acetaminophen 500 mg and Diphenhydramine HCl 25 mg	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-394_f6b88aa9-7608-49e8-9841-2cf702715869	69168-394	HUMAN OTC DRUG	Naproxen Caplets		Naproxen Sodium 220 mg	TABLET	ORAL	20141223		ANDA	ANDA090545	Allegiant Health	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-395_08dc5597-5820-47c7-aec4-72336b5b7089	69168-395	HUMAN OTC DRUG	Naproxen Sodium 220mg		Naproxen Sodium 220mg	TABLET, COATED	ORAL	20110504		ANDA	ANDA090545	Allegiant Health	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-396_4abb634f-fd27-49e4-8dbc-d47ba4b23bc2	69168-396	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl 10 mg	TABLET	ORAL	20141216		ANDA	ANDA209274	Allegiant Health	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-398_51618dba-c9a7-42eb-b54d-8e691f19a020	69168-398	HUMAN OTC DRUG	Bisacodyl 5mg		Bisacodyl 5mg	TABLET, COATED	ORAL	20141223		OTC MONOGRAPH DRUG	M007	Allegiant Health	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69168-400_aacad958-9ade-44c9-9f58-77521d876ff6	69168-400	HUMAN OTC DRUG	Aspirin	Enteric Coated	Aspirin 325 mg	TABLET	ORAL	20141218	20240331	OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
69168-404_755e478f-3c15-4175-9f32-45d2a751e282	69168-404	HUMAN OTC DRUG	Laxative	Enteric Coated	Bisacodyl 5mg	TABLET, SUGAR COATED	ORAL	20020325		OTC MONOGRAPH DRUG	M007	Allegiant Health	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69168-405_45839c39-884d-4298-8cdc-8fd596059613	69168-405	HUMAN OTC DRUG	Aspirin 81mg Enteric coated	Delayed Release	Aspirin	TABLET, COATED	ORAL	20211215		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-406_6a26079c-017d-4117-9dbe-cb9e7fa7c86e	69168-406	HUMAN OTC DRUG	Cold and Allergy		Phenylephrine HCl and Chlorpheniramine maleate	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M012	Allegiant Health	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-408_af82475f-bf55-4df7-a75c-2e1cc7788785	69168-408	HUMAN OTC DRUG	Motion Sickness Relief		Dimenhydrinate 50mg	TABLET	ORAL	20120115		OTC MONOGRAPH DRUG	M009	Allegiant Health	DIMENHYDRINATE	50	mg/1			N	20241231
69168-409_681dea0e-f646-4966-8649-54ba9aff1159	69168-409	HUMAN OTC DRUG	Allergy DyeFree		Allergy DyeFree	CAPSULE, LIQUID FILLED	ORAL	20130915		OTC MONOGRAPH DRUG	M009	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-410_aeadde5e-c4dd-453e-9dc6-1dfe096b0280	69168-410	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20201109		OTC MONOGRAPH DRUG	M010	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-413_0a40994a-7a09-45c8-bebc-d4d99ce63d0f	69168-413	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	CAPSULE, COATED	ORAL	20210322		ANDA	ANDA211075	Allegiant Health	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-414_41e9118f-1555-4bf6-81d0-1b29a1e1e35a	69168-414	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20200501		ANDA	ANDA210722	Allegiant Health	LORATADINE	10	mg/1			N	20241231
69168-416_054a111e-78f9-453f-8ee2-c54d64c116e4	69168-416	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	CAPSULE, COATED	ORAL	20141226		ANDA	ANDA204507	Allegiant Health	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-417_c2498c7c-a983-4ee4-b796-e0f844c9fcd0	69168-417	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen 325mg/ Dextromethorphan HBr 10mg/ Phenylephrine HCl 5mg	CAPSULE	ORAL	20201111		OTC MONOGRAPH DRUG	M012	Allegiant Health	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69168-418_166f76f4-a4bb-4208-b083-eae909251ba5	69168-418	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen	CAPSULE	ORAL	20201111		OTC MONOGRAPH DRUG	M012	Allegiant Health	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69168-419_f7cf9dfe-6d4e-47e6-a205-6f0692507b20	69168-419	HUMAN OTC DRUG	Anti-Gas		Simethicone	CAPSULE	ORAL	20150128		OTC MONOGRAPH DRUG	M002	Allegiant Health	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
69168-420_6eb62390-6dc1-4038-a518-5a8b94cc51dc	69168-420	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE	ORAL	20150410		OTC MONOGRAPH DRUG	M007	Allegiant Health	DOCUSATE SODIUM	100	mg/1			N	20241231
69168-424_c35dda2c-6127-4f02-9ae2-330b7a22a973	69168-424	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20150128		OTC MONOGRAPH DRUG	M007	Allegiant Health	DOCUSATE SODIUM	100	mg/1			N	20241231
69168-426_c63a3602-871f-4cfe-9af5-aa8192dae33b	69168-426	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen 500mg	CAPSULE, COATED	ORAL	20141217		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN	500	mg/1			N	20241231
69168-430_7cbd38b6-7f1c-484f-9610-500b0063741f	69168-430	HUMAN OTC DRUG	Aspirin 81mg Enteric coated	Low Strength Aspirin Regimen	Aspirin	TABLET, COATED	ORAL	20211014		OTC MONOGRAPH DRUG	M013	Allegiant Health	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69168-431_62066173-2e1d-4eea-b495-d9944694b297	69168-431	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210921		OTC MONOGRAPH DRUG	M011	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-432_751cf188-7b5f-4f9d-ba3e-8ce7997ecd31	69168-432	HUMAN OTC DRUG	Mucus Relief DM	Immediate Release	Mucus Relief DM	TABLET	ORAL	20220518		OTC MONOGRAPH DRUG	M012	Allegiant Health	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69168-433_80f1974f-6d46-4bc6-b157-830436065c9a	69168-433	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20120201		OTC MONOGRAPH DRUG	M002	Allegiant Health	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
69168-434_dae575ea-2ca1-493f-9f74-2232f61a0ae4	69168-434	HUMAN OTC DRUG	Gas Relief	Maximum Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20160111		OTC MONOGRAPH DRUG	M002	Allegiant Health	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
69168-437_e22c3475-957c-4b4a-8ed2-760d3dc534be	69168-437	HUMAN OTC DRUG	Allergy Relief	Non Drowsy	Fexofenadine HCl	TABLET, FILM COATED	ORAL	20220518		ANDA	ANDA211075	Allegiant Health	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-438_d9eb6828-a31e-48c5-a6fd-f446f8845020	69168-438	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu Relief Combo Pack		Daytime Nighttime Cold and Flu	KIT		20220520		OTC MONOGRAPH DRUG	M012	Allegiant Health						N	20241231
69168-439_8accb0e9-d994-4b6a-acc3-4b416f3f65ba	69168-439	HUMAN OTC DRUG	Nighttime Sleep Aid		Nighttime Sleep Aid	TABLET	ORAL	20230516		ANDA	ANDA040564	Allegiant Health	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
69168-440_002d3925-b6c2-46c6-bc21-68926caa58ff	69168-440	HUMAN OTC DRUG	Children Pain Relief		Children Pain Relief	TABLET, CHEWABLE	ORAL	20230718		OTC MONOGRAPH DRUG	M013	Allegiant Health	ACETAMINOPHEN	160	mg/1			N	20241231
69168-448_1f772537-33ec-4be3-b542-9160056eceac	69168-448	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20231210		ANDA	ANDA077538	Allegiant Health	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69168-914_77768280-6364-4000-9ed6-b71dd594d95f	69168-914	HUMAN OTC DRUG	Sound Body Ibuprofen		Ibuprofen 200 mg	CAPSULE, LIQUID FILLED	ORAL	20141222		ANDA	ANDA079205	Allegiant Health	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69168-916_2fcbb552-7ed4-46aa-8537-6abcdfaf9d46	69168-916	HUMAN OTC DRUG	Mucus Relief	Immediate Release	Mucus Relief	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M012	Allegiant Health	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69168-917_8d85cfb4-db0f-4905-849d-d6c9d955263a	69168-917	HUMAN OTC DRUG	Sleep Aid		Sleep Aid	CAPSULE, LIQUID FILLED	ORAL	20070101		OTC MONOGRAPH DRUG	M010	Allegiant Health	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69168-999_dba89c73-da63-4f67-85e3-89d478cc70ee	69168-999	HUMAN OTC DRUG	Gastrobiz		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20140704		OTC MONOGRAPH DRUG	M008	Allegiant Health	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
69179-000_09ceda1d-1293-bf08-e063-6394a90a0795	69179-000	HUMAN OTC DRUG	Marvelous		STANNOUS FLUORIDE	PASTE	DENTAL	20220801		OTC MONOGRAPH DRUG	M021	Batool Pharma International, Inc.	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69188-001_f28bee5b-84a4-8821-e053-2995a90a2218	69188-001	HUMAN OTC DRUG	Mens SPECTRAL UHP EXTRA STRENGTH HAIR REGROWTH TREATMENT		Minoxidil 5%	SOLUTION	TOPICAL	20201219		ANDA	ANDA076239	DS Healthcare Group, Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69188-100_0a477c8f-3ef0-697a-e063-6394a90acf21	69188-100	HUMAN OTC DRUG	Divine Dandrene 1%		Zinc Pyrithione	SHAMPOO	TOPICAL	20210601		OTC MONOGRAPH DRUG	M032	DS Healthcare Group, Inc.	PYRITHIONE ZINC	1	g/100mL			N	20241231
69188-200_0a477e72-d543-61d2-e063-6394a90a37e3	69188-200	HUMAN OTC DRUG	Divine Dandrene 2%		Zinc Pyrithione	SHAMPOO	TOPICAL	20210601		OTC MONOGRAPH DRUG	M032	DS Healthcare Group, Inc.	PYRITHIONE ZINC	2	g/100mL			N	20241231
69188-300_0a474406-c3e7-5a47-e063-6394a90a8cbc	69188-300	HUMAN OTC DRUG	Dandrene Anti-Dandruff Conditioner		Zinc Pyrithione	LOTION	TOPICAL	20161220		OTC MONOGRAPH DRUG	M032	DS Healthcare Group, Inc.	PYRITHIONE ZINC	1	g/100mL			N	20241231
69196-1001_f39be985-f473-fa84-e053-2a95a90a8cd9	69196-1001	HUMAN OTC DRUG	Niagara S		GLYCERIN	SOAP	TOPICAL	20140911		OTC MONOGRAPH FINAL	part347	Sungwon Cosmetics	GLYCERIN	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69196-2001_f39be985-f47d-fa84-e053-2a95a90a8cd9	69196-2001	HUMAN OTC DRUG	Miracle of the Mose Hair Bar		GLYCERIN	SOAP	TOPICAL	20140911		OTC MONOGRAPH FINAL	part347	Sungwon Cosmetics	GLYCERIN	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69196-2002_f39beeb3-3fd2-fa82-e053-2a95a90ad3f4	69196-2002	HUMAN OTC DRUG	Monagra		GLYCERIN	SOAP	TOPICAL	20140911		OTC MONOGRAPH FINAL	part347	Sungwon Cosmetics	GLYCERIN	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69196-3001_f39bf0ee-23d5-accc-e053-2a95a90ab4a8	69196-3001	HUMAN OTC DRUG	Dr. Protector		CETYLPYRIDINIUM CHLORIDE	LIQUID	TOPICAL	20200304		UNAPPROVED DRUG OTHER		Sungwon Cosmetic Inc.	CETYLPYRIDINIUM CHLORIDE	.05	g/100mL			N	20241231
69197-029_bd14fe1d-1a3f-4854-aab9-dbcd09046365	69197-029	HUMAN OTC DRUG	SED-MAX		Acetaminophen 500 mg with Caffeine 65mg	TABLET, COATED	ORAL	20141126		OTC MONOGRAPH DRUG	M013	Command Brands, LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69197-394_3441a647-8818-4c13-9ba8-6a012e46b508	69197-394	HUMAN OTC DRUG	Naproxen Sodium 220mg		Naproxen Sodium 220mg	TABLET, COATED	ORAL	20141223		ANDA	ANDA090545	Command Brands, LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69201-874_27466c82-4e69-4bb9-ade7-c33c5cbb4a4e	69201-874	HUMAN OTC DRUG	Venofye Orchard Bee Brilliance SPF 30		Octinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone	CREAM	TOPICAL	20150104		OTC MONOGRAPH NOT FINAL	part352	Vivo Per-lei, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
69201-928_b6c723de-1db9-4e94-b0a0-4fea860bfd6e	69201-928	HUMAN OTC DRUG	Vine Vera Resveratrol Cabernet Replenishing Moisture		Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20210315		OTC MONOGRAPH NOT FINAL	part352	Vivo Per-lei, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
69201-952_65cbc280-cab2-482b-b657-e889b789a9bc	69201-952	HUMAN OTC DRUG	24K Skin Tone Moisturizer SPF 30		Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20190729		OTC MONOGRAPH NOT FINAL	part352	Vivo Per-lei, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
69204-002_781d3c8d-7b1d-e973-e053-2991aa0aaa78	69204-002	HUMAN OTC DRUG	Chest Comfort		Menthol	SALVE	TOPICAL	20161016		OTC MONOGRAPH FINAL	part341	Natures Formulae Health Products Ltd.	MENTHOL	27.6	mg/g			N	20241231
69204-003_781d53cf-b3de-3e2b-e053-2a91aa0a7dcd	69204-003	HUMAN OTC DRUG	Fortify		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH FINAL	part341	Natures Formulae Health Products Ltd.	MENTHOL	24	mg/mL			N	20241231
69204-004_781e94d5-1d21-7202-e053-2991aa0ae768	69204-004	HUMAN OTC DRUG	Sweet Comfort		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH FINAL	part341	Natures Formulae Health Products Ltd.	MENTHOL	24.56	mg/mL			N	20241231
69204-005_781d3c8d-7b71-e973-e053-2991aa0aaa78	69204-005	HUMAN OTC DRUG	Pain Release		Menthol	GRANULE	TOPICAL	20161016		OTC MONOGRAPH NOT FINAL	part348	Natures Formulae Health Products Ltd.	MENTHOL	1.6	mg/g			N	20241231
69204-007_781d53cf-b3e0-3e2b-e053-2a91aa0a7dcd	69204-007	HUMAN OTC DRUG	Pain Release		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH NOT FINAL	part348	Natures Formulae Health Products Ltd.	MENTHOL	17.62	mg/mL			N	20241231
69204-008_781dfd66-f007-a2d7-e053-2991aa0a170c	69204-008	HUMAN OTC DRUG	Pain Release		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH NOT FINAL	part348	Natures Formulae Health Products Ltd.	MENTHOL	12.18	mg/mL			N	20241231
69204-010_781ec1ad-a214-5df4-e053-2991aa0a6341	69204-010	HUMAN OTC DRUG	Trauma Less		Menthol	OINTMENT	TOPICAL	20161016		OTC MONOGRAPH NOT FINAL	part348	Natures Formulae Health Products Ltd.	MENTHOL	12.7	mg/g			N	20241231
69204-014_781dfd66-f02d-a2d7-e053-2991aa0a170c	69204-014	HUMAN OTC DRUG	Pocket Farmacy		Menthol	KIT		20161016		OTC MONOGRAPH FINAL	part341	Natures Formulae Health Products Ltd.						N	20241231
69204-015_781dfd66-f008-a2d7-e053-2991aa0a170c	69204-015	HUMAN OTC DRUG	Pocket Farmacy		Menthol	KIT		20161016		OTC MONOGRAPH FINAL	part341	Natures Formulae Health Products Ltd.						N	20241231
69204-023_781e4746-4216-851a-e053-2a91aa0a42ca	69204-023	HUMAN OTC DRUG	Restoral		Menthol	OINTMENT	TOPICAL	20180912		OTC MONOGRAPH NOT FINAL	part348	Natures Formulae Health Products Ltd.	MENTHOL	.2	g/100g			N	20241231
69204-025_a7da5211-25d8-7bda-e053-2a95a90a34f7	69204-025	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Natures Formulae Health Products Ltd.	ALCOHOL	68	mL/100mL			N	20241231
69204-027_d91985f6-bc48-69b6-e053-2995a90abfea	69204-027	HUMAN OTC DRUG	Extra Strength		Menthol and Methyl Salicylate	OIL	TOPICAL	20190513		OTC MONOGRAPH NOT FINAL	part348	NATURES FORMULAE HEALTH PRODUCTS LTD.	MENTHOL; METHYL SALICYLATE	94.41; 123.74	mg/mL; mg/mL			N	20241231
69206-990_154c7ce6-9ff4-464f-b95c-7dbbb1fc3085	69206-990	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20230201		ANDA	ANDA078876	Aventura Pharmaceuticals, LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69207-0001_bcb536df-98eb-4986-a4e3-e28648cbb546	69207-0001	HUMAN OTC DRUG	ESSENTIAL WEIGHT LOSS		AMMONIUM BROMATUM, FUCUS VESICULOSUS, NATRUM SULPHURICUM, NICOTINAMIDUM, SPONGIA TOSTA, THIAMINUM HYDROCHLORICUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, THYROIDINUM (BOVINE), CALCAREA CARBONICA, GRAPHITES	LIQUID	ORAL	20141203		UNAPPROVED HOMEOPATHIC		Integrative Health Alliance	AMMONIUM BROMIDE; FUCUS VESICULOSUS; GRAPHITE; NIACINAMIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED; THIAMINE HYDROCHLORIDE; THYROID, BOVINE	3; 3; 12; 3; 12; 6; 6; 3; 3; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
69208-000_0e8ab181-d634-dacf-e063-6394a90a26f4	69208-000	HUMAN PRESCRIPTION DRUG	Sodium Iodide I-131		Sodium Iodide I-131	KIT	ORAL	20200316		ANDA	ANDA209166	International Isotopes Inc						N	20251231
69216-001_076297e6-ab1d-6651-e063-6294a90adab0	69216-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140901		UNAPPROVED MEDICAL GAS		StateServ Medical, LLC	OXYGEN	99	L/100L			N	20241231
69219-102_0c7e7997-ab76-2b88-e063-6294a90a4fff	69219-102	HUMAN OTC DRUG	ECLIPSE SPF 50	ALL SHADES	TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20141001		OTC MONOGRAPH DRUG	M020	SCIENCE OF SKINCARE LLC	TITANIUM DIOXIDE; ZINC OXIDE	5.2; 1.1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69219-103_0c7f5769-e88b-acc1-e063-6294a90afc7e	69219-103	HUMAN OTC DRUG	EXTREME PROTECT SPF 30		OCTINOXATE, ZINC OXIDE	LOTION	TOPICAL	20141001		OTC MONOGRAPH DRUG	M020	SCIENCE OF SKINCARE LLC	OCTINOXATE; ZINC OXIDE	5.5; 4.12	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69219-107_0c7f1f64-4a29-8d71-e063-6394a90a7bf9	69219-107	HUMAN OTC DRUG	ECLIPSE SPF 50 PERFECTINT BEIGE		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20141001		OTC MONOGRAPH DRUG	M020	SCIENCE OF SKINCARE LLC	TITANIUM DIOXIDE; ZINC OXIDE	5.2; 1.1	g/100g; g/100g			N	20241231
69219-108_0ce0a50e-d1aa-14a8-e063-6294a90a9ef4	69219-108	HUMAN OTC DRUG	Extreme Protect SPF 40	All Shades	Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20210301		OTC MONOGRAPH DRUG	M020	Science of Skincare, LLC.	TITANIUM DIOXIDE; ZINC OXIDE	1.3; 15.3	g/100g; g/100g			N	20241231
69219-111_0ce672e2-39c4-7f43-e063-6394a90ac4ba	69219-111	HUMAN OTC DRUG	PerfecTint Powder SPF 40	All Shades	Zinc Oxide	POWDER	TOPICAL	20231219		OTC MONOGRAPH DRUG	M020	Science of Skincare	ZINC OXIDE	25	g/100g			N	20241231
69219-112_0d0a1a6f-605a-2d77-e063-6294a90ab898	69219-112	HUMAN OTC DRUG	LiProtect SPF 35		Zinc Oxide, Titanium Dioxide	STICK	TOPICAL	20231231		OTC MONOGRAPH DRUG	M020	Science of Skincare	TITANIUM DIOXIDE; ZINC OXIDE	1; 10.2	g/100g; g/100g			N	20241231
69221-601_efcd2530-aba4-50b5-e053-2a95a90a7365	69221-601	HUMAN OTC DRUG	Zoono Alcohol Free Hand Sanitizer		benzalkonium chloride	SOLUTION	TOPICAL	20201120	20240331	OTC MONOGRAPH NOT FINAL	part333E	Zoono Holdings USA LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
69230-201_09845f21-f05e-34b2-e063-6394a90a7677	69230-201	HUMAN OTC DRUG	Fexofenadine HCl		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20211208		ANDA	ANDA204507	Camber Consumer Care	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69230-202_09845f21-f05e-34b2-e063-6394a90a7677	69230-202	HUMAN OTC DRUG	Fexofenadine HCl		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA204507	Camber Consumer Care	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69230-300_eb46135f-d536-4328-96dc-30a2b16fe9d2	69230-300	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20160819		ANDA	ANDA204097	Camber Consumer Care	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69230-301_eb46135f-d536-4328-96dc-30a2b16fe9d2	69230-301	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20160819		ANDA	ANDA204097	Camber Consumer Care	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69230-303_d291abe1-e239-4db3-a7ea-a3a7422c681e	69230-303	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20181231	20241231	ANDA	ANDA207235	Camber Consumer Care	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69230-304_951f3aa5-bd24-4e43-84e5-2ecc1c399149	69230-304	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20181231	20241231	ANDA	ANDA209274	Camber Consumer Care	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69230-305_f5930012-f774-4daa-ab14-786c7301620a	69230-305	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20181231	20241231	ANDA	ANDA208363	Camber Consumer Care	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
69230-308_d5da8441-4fbc-aafb-e053-2995a90a5b42	69230-308	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20181123		ANDA	ANDA210602	Camber Consumer Care Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69230-309_d5da8441-4fbc-aafb-e053-2995a90a5b42	69230-309	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20190918		ANDA	ANDA210602	Camber Consumer Care Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69230-310_d5da8441-4fbc-aafb-e053-2995a90a5b42	69230-310	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20190918		ANDA	ANDA210602	Camber Consumer Care Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69230-311_d5da8441-4fbc-aafb-e053-2995a90a5b42	69230-311	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20190918		ANDA	ANDA210602	Camber Consumer Care Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69230-316_941e4aa9-6388-424c-87ad-3ea2ec5aafea	69230-316	HUMAN OTC DRUG	CHILDRENS ALLERGY RELIEF		cetirizine hydrochloride	SOLUTION	ORAL	20190313		ANDA	ANDA210622	Camber Consumer Care	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69230-317_f4b879d5-580f-45b2-9a1a-34dcbc31d9d2	69230-317	HUMAN OTC DRUG	Allergy Relief	Non drowsy	Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	Camber Consumer Care	LORATADINE	10	mg/1			N	20241231
69230-318_ee873df8-2b35-9bc7-e053-2a95a90a0f83	69230-318	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200325		ANDA	ANDA211732	Camber Consumer Care Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69230-320_f314566e-27c9-2871-e053-2995a90a7850	69230-320	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA212507	Camber Consumer Care Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69230-321_7ca0cee0-b628-4266-b361-ad5c52b6f11e	69230-321	HUMAN OTC DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20201028		ANDA	ANDA213513	Camber Consumer Care Inc	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69230-322_c35ffdd1-2e08-3a8d-e053-2a95a90aed41	69230-322	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20210507		ANDA	ANDA210409	Camber Consumer Care Inc	LORATADINE	5	mg/5mL			N	20241231
69230-323_04d9c5a8-1f42-f7c0-e063-6294a90a92ae	69230-323	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20230728		ANDA	ANDA211718	Camber Consumer Care Inc	LORATADINE	10	mg/1			N	20241231
69230-324_f638e43b-0a1c-1a5d-e053-2a95a90a4caf	69230-324	HUMAN OTC DRUG	Polyethylene Glycol 3350		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20210414		ANDA	ANDA214990	Camber Consumer Care Inc	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69230-325_e875c38b-493f-1f9f-e053-2995a90a6cd1	69230-325	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20210617		ANDA	ANDA211438	Camber Consumer Care Inc	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
69230-326_eabd2ff8-a7d9-2ac4-e053-2995a90a3b40	69230-326	HUMAN OTC DRUG	famotidine		famotidine	TABLET, FILM COATED	ORAL	20211108		ANDA	ANDA215766	Camber Consumer Care Inc	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69230-327_eabd2ff8-a7d9-2ac4-e053-2995a90a3b40	69230-327	HUMAN OTC DRUG	famotidine		famotidine	TABLET, FILM COATED	ORAL	20211108		ANDA	ANDA215766	Camber Consumer Care Inc	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69230-328_ef239f47-2514-8b93-e053-2a95a90a4b71	69230-328	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET	ORAL	20220731		ANDA	ANDA210722	Camber Consumer Care Inc	LORATADINE	10	mg/1			N	20241231
69230-329_ee21e0f7-9f32-6c63-e053-2a95a90ac996	69230-329	HUMAN OTC DRUG	Naproxen sodium		Naproxen sodium	TABLET, FILM COATED	ORAL	20221028		ANDA	ANDA211065	Camber Consumer Care Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69231-023_7b64e812-af99-c18b-e053-2991aa0afc67	69231-023	HUMAN OTC DRUG	CLE CCC Warm Light		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20181123		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.6376	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-024_7bae89f3-eaf5-6777-e053-2a91aa0ab92f	69231-024	HUMAN OTC DRUG	CLE CCC Warm Medium Light		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20181127		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.5215	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-025_7baea303-1384-5a69-e053-2991aa0a5f54	69231-025	HUMAN OTC DRUG	CLE CCC Warm Medium		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20181127		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.52846	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-026_7bd7c746-f6cb-6cf7-e053-2a91aa0a68cc	69231-026	HUMAN OTC DRUG	CLE CCC Warm Medium Deep		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20181129		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.5215	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-027_7c2408f5-6ee1-3d9c-e053-2a91aa0a1bae	69231-027	HUMAN OTC DRUG	CLE CCC Golden Medium Deep		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20181203		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.51454	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-028_eb58d603-a2ee-fd50-e053-2a95a90a0ec9	69231-028	HUMAN OTC DRUG	CLE CCC Neutral Light		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20221018		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.6628	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-029_eb58e8af-2cd3-31aa-e053-2995a90a9a01	69231-029	HUMAN OTC DRUG	CLE CCC Neutral Medium Light		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20221018		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.7096	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-030_eb58fa24-2877-ba75-e053-2a95a90a85a6	69231-030	HUMAN OTC DRUG	CLE CCC Neutral Medium		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20221018		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.7888	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-031_ebd04156-e45e-0a28-e053-2995a90afb64	69231-031	HUMAN OTC DRUG	CLE CCC Cool Medium Deep		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20221024		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.535	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-032_ecfae75f-358e-b98e-e053-2a95a90ac271	69231-032	HUMAN OTC DRUG	CLE CCC Warm Deep		Titanium Dioxide, Octinoxate, Octisalate, Avobenzone	CREAM	TOPICAL	20221108		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	.156; 2.1; .6; .51	mg/30mL; mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-033_ebd0b625-0f63-8d8b-e053-2995a90a85d7	69231-033	HUMAN OTC DRUG	CLE CCC Neutral Fair		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20221024		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.757	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-034_ebe44dc1-172a-1a6e-e053-2995a90aff9d	69231-034	HUMAN OTC DRUG	CLE CCC Golden Medium		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20221025		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.751	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-035_ebe49b87-d9b7-3625-e053-2a95a90ac076	69231-035	HUMAN OTC DRUG	CLE CCC Olive Medium Deep		Titanium Dioxide, Octinoxate, Octisalate	CREAM	TOPICAL	20221025		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	2.1; .9; 2.561	mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-036_ed0eed21-4e48-24e9-e053-2a95a90a4ad5	69231-036	HUMAN OTC DRUG	CLE CCC Neutral Deep		Titanium Dioxide, Octinoxate, Octisalate, Avobenzone	CREAM	TOPICAL	20221109		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	.156; 2.1; .6; .279	mg/30mL; mg/30mL; mg/30mL; mg/30mL			N	20241231
69231-037_ed121855-acca-2a71-e053-2a95a90a5f57	69231-037	HUMAN OTC DRUG	CLE CCC Cool Deep		Titanium Dioxide, Octinoxate, Octisalate, Avobenzone	CREAM	TOPICAL	20221109		OTC MONOGRAPH NOT FINAL	part352	KW ABSC, INC.	AVOBENZONE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	.156; 2.1; .6; .081	mg/30mL; mg/30mL; mg/30mL; mg/30mL			N	20241231
69233-122_09d3f7f9-7d2e-fb8b-e063-6394a90a6a41	69233-122	HUMAN OTC DRUG	SYREN INTIMATE PAIN RELIEF		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20200110		OTC MONOGRAPH DRUG	M017	Icon Health Science, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69233-444_0e96ec46-236c-190c-e063-6294a90a3e7a	69233-444	HUMAN OTC DRUG	SYREN Intimate Relief		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20231227		OTC MONOGRAPH DRUG	M017	Icon Health Science, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
69233-843_097485a4-b57f-a87a-e063-6394a90a8e52	69233-843	HUMAN OTC DRUG	SYREN Intimate Relief Topical Pain Relief		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20170828		OTC MONOGRAPH DRUG	M017	Icon Health Science	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69238-1013_e5e4b07a-825e-49e5-9f21-5f0f5b8e5109	69238-1013	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL, METERED	TOPICAL	20190410		ANDA	ANDA207373	Amneal Pharmaceuticals NY LLC	TESTOSTERONE	20.25	mg/1.25g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69238-1017_c2645360-e4a8-4737-9065-3dbbd4b6e6b7	69238-1017	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20171002		ANDA	ANDA207792	Amneal Pharmaceuticals NY LLC	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
69238-1031_ef7d6985-bc76-4ecc-9774-7edfacbef22c	69238-1031	HUMAN PRESCRIPTION DRUG	Melodetta 24 Fe		Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate	KIT		20170921		ANDA	ANDA207514	Amneal Pharmaceuticals NY LLC						N	20241231
69238-1050_d20e1cc4-a282-4842-8e10-a365e2d6a32b	69238-1050	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190605		ANDA	ANDA209716	Amneal Pharmaceuticals NY LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69238-1053_b6366e4a-379b-4402-bd51-9c951d8a6ec5	69238-1053	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine	TABLET, FILM COATED	ORAL	20160321		ANDA	ANDA208105	Amneal Pharmaceuticals NY LLC	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1054_8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2	69238-1054	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180912		ANDA	ANDA209755	Amneal Pharmaceuticals NY LLC	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1055_b6366e4a-379b-4402-bd51-9c951d8a6ec5	69238-1055	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine	TABLET, FILM COATED	ORAL	20160321		ANDA	ANDA208105	Amneal Pharmaceuticals NY LLC	DESIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1056_8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2	69238-1056	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180912		ANDA	ANDA209755	Amneal Pharmaceuticals NY LLC	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1057_b6366e4a-379b-4402-bd51-9c951d8a6ec5	69238-1057	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine	TABLET, FILM COATED	ORAL	20160321		ANDA	ANDA208105	Amneal Pharmaceuticals NY LLC	DESIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1058_8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2	69238-1058	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180912		ANDA	ANDA209755	Amneal Pharmaceuticals NY LLC	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1059_b6366e4a-379b-4402-bd51-9c951d8a6ec5	69238-1059	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine	TABLET, FILM COATED	ORAL	20160321		ANDA	ANDA208105	Amneal Pharmaceuticals NY LLC	DESIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1060_8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2	69238-1060	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180912		ANDA	ANDA209755	Amneal Pharmaceuticals NY LLC	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1061_b6366e4a-379b-4402-bd51-9c951d8a6ec5	69238-1061	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine	TABLET, FILM COATED	ORAL	20160321		ANDA	ANDA208105	Amneal Pharmaceuticals NY LLC	DESIPRAMINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1062_8c2ad75b-ee8b-4f55-b77f-c23a1a7cf5a2	69238-1062	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180912		ANDA	ANDA209755	Amneal Pharmaceuticals NY LLC	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1063_b6366e4a-379b-4402-bd51-9c951d8a6ec5	69238-1063	HUMAN PRESCRIPTION DRUG	Desipramine Hydrochloride		Desipramine	TABLET, FILM COATED	ORAL	20160321		ANDA	ANDA208105	Amneal Pharmaceuticals NY LLC	DESIPRAMINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1065_fce0bed3-7798-466b-915b-4b6de9c366bb	69238-1065	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200511		ANDA	ANDA212861	Amneal Pharmaceuticals NY LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69238-1067_fce0bed3-7798-466b-915b-4b6de9c366bb	69238-1067	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200511		ANDA	ANDA212861	Amneal Pharmaceuticals NY LLC	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69238-1069_fce0bed3-7798-466b-915b-4b6de9c366bb	69238-1069	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200511		ANDA	ANDA212861	Amneal Pharmaceuticals NY LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69238-1076_d4549001-c251-4461-b3ff-5d25e9243918	69238-1076	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20150202		ANDA	ANDA074069	Amneal Pharmaceuticals NY LLC	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
69238-1100_8f97206a-613d-46cd-9455-109713a390f0	69238-1100	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline	CAPSULE	ORAL	20160628		ANDA	ANDA207289	Amneal Pharmaceuticals NY LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69238-1101_9fdca868-ff3e-4871-9921-9ef7adc577e5	69238-1101	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA078329	Amneal Pharmaceuticals NY LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-1102_9fdca868-ff3e-4871-9921-9ef7adc577e5	69238-1102	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA078329	Amneal Pharmaceuticals NY LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-1103_9fdca868-ff3e-4871-9921-9ef7adc577e5	69238-1103	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20140401		ANDA	ANDA078329	Amneal Pharmaceuticals NY LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-1104_6365c695-acda-442b-aca2-7fb3d0961bc3	69238-1104	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine	TABLET	ORAL	20171208		ANDA	ANDA208181	Amneal Pharmaceuticals NY LLC	TIAGABINE HYDROCHLORIDE	2	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
69238-1105_6365c695-acda-442b-aca2-7fb3d0961bc3	69238-1105	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine	TABLET	ORAL	20171208		ANDA	ANDA208181	Amneal Pharmaceuticals NY LLC	TIAGABINE HYDROCHLORIDE	4	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
69238-1106_6365c695-acda-442b-aca2-7fb3d0961bc3	69238-1106	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine	TABLET	ORAL	20171208		ANDA	ANDA208181	Amneal Pharmaceuticals NY LLC	TIAGABINE HYDROCHLORIDE	12	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
69238-1107_6365c695-acda-442b-aca2-7fb3d0961bc3	69238-1107	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine	TABLET	ORAL	20171208		ANDA	ANDA208181	Amneal Pharmaceuticals NY LLC	TIAGABINE HYDROCHLORIDE	16	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
69238-1108_39681504-d56d-4a06-88a8-cc781d95d9ad	69238-1108	HUMAN PRESCRIPTION DRUG	Clomipramine HCl		Clomipramine HCl	CAPSULE	ORAL	20181031		ANDA	ANDA208632	Amneal Pharmaceuticals NY LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1109_39681504-d56d-4a06-88a8-cc781d95d9ad	69238-1109	HUMAN PRESCRIPTION DRUG	Clomipramine HCl		Clomipramine HCl	CAPSULE	ORAL	20181031		ANDA	ANDA208632	Amneal Pharmaceuticals NY LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1110_39681504-d56d-4a06-88a8-cc781d95d9ad	69238-1110	HUMAN PRESCRIPTION DRUG	Clomipramine HCl		Clomipramine HCl	CAPSULE	ORAL	20181031		ANDA	ANDA208632	Amneal Pharmaceuticals NY LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1115_7b8fd50c-80f2-47f1-86dc-ceececd7630d	69238-1115	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20170524		ANDA	ANDA208829	Amneal Pharmaceuticals NY LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
69238-1116_7b8fd50c-80f2-47f1-86dc-ceececd7630d	69238-1116	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20170524		ANDA	ANDA208829	Amneal Pharmaceuticals NY LLC	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
69238-1117_7b8fd50c-80f2-47f1-86dc-ceececd7630d	69238-1117	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20170524		ANDA	ANDA208829	Amneal Pharmaceuticals NY LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
69238-1118_7b8fd50c-80f2-47f1-86dc-ceececd7630d	69238-1118	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20170524		ANDA	ANDA208829	Amneal Pharmaceuticals NY LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
69238-1119_7b8fd50c-80f2-47f1-86dc-ceececd7630d	69238-1119	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20170524		ANDA	ANDA208829	Amneal Pharmaceuticals NY LLC	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
69238-1120_aeda0ffa-9ca4-4c32-a2b9-ff7eec60ca1d	69238-1120	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20170504		ANDA	ANDA208633	Amneal Pharmaceuticals NY LLC	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-1123_a6a0d395-ff79-4d4c-90cc-beb20a949c66	69238-1123	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170602		ANDA	ANDA208832	Amneal Pharmaceuticals NY LLC	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-1124_a6a0d395-ff79-4d4c-90cc-beb20a949c66	69238-1124	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170602		ANDA	ANDA208832	Amneal Pharmaceuticals NY LLC	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-1125_a6a0d395-ff79-4d4c-90cc-beb20a949c66	69238-1125	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170602		ANDA	ANDA208832	Amneal Pharmaceuticals NY LLC	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-1126_34abb8e8-74dd-4eae-ace0-987aa877b657	69238-1126	HUMAN PRESCRIPTION DRUG	Ethacrynic Acid		Ethacrynic Acid	TABLET	ORAL	20180514		ANDA	ANDA208805	Amneal Pharmaceuticals NY LLC	ETHACRYNIC ACID	25	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69238-1134_20a35c67-8adf-43b9-9dbb-ecfabd97ab54	69238-1134	HUMAN PRESCRIPTION DRUG	ticagrelor		ticagrelor	TABLET	ORAL	20190123		ANDA	ANDA208531	Amneal Pharmaceuticals NY LLC	TICAGRELOR	90	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
69238-1135_34ba05ce-ed7e-4a2d-bb15-2146e9e0f760	69238-1135	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20200603		ANDA	ANDA209717	Amneal Pharmaceuticals NY LLC	ATAZANAVIR SULFATE	100	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
69238-1136_34ba05ce-ed7e-4a2d-bb15-2146e9e0f760	69238-1136	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20200603		ANDA	ANDA209717	Amneal Pharmaceuticals NY LLC	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
69238-1137_34ba05ce-ed7e-4a2d-bb15-2146e9e0f760	69238-1137	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20200603		ANDA	ANDA209717	Amneal Pharmaceuticals NY LLC	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
69238-1138_34ba05ce-ed7e-4a2d-bb15-2146e9e0f760	69238-1138	HUMAN PRESCRIPTION DRUG	Atazanavir		Atazanavir	CAPSULE	ORAL	20200603		ANDA	ANDA209717	Amneal Pharmaceuticals NY LLC	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
69238-1146_02d43322-f298-4c79-b95f-d739c7c3196d	69238-1146	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20181022		ANDA	ANDA208850	Amneal Pharmaceuticals NY LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1147_02d43322-f298-4c79-b95f-d739c7c3196d	69238-1147	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20181022		ANDA	ANDA208850	Amneal Pharmaceuticals NY LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1148_02d43322-f298-4c79-b95f-d739c7c3196d	69238-1148	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20181022		ANDA	ANDA208850	Amneal Pharmaceuticals NY LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1149_02d43322-f298-4c79-b95f-d739c7c3196d	69238-1149	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20181022		ANDA	ANDA208850	Amneal Pharmaceuticals NY LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1151_12d047d4-2d50-4d2a-9f6b-22c13162b0c8	69238-1151	HUMAN PRESCRIPTION DRUG	Vardenafil hydrochloride		Vardenafil hydrochloride	TABLET, FILM COATED	ORAL	20181031		ANDA	ANDA210738	Amneal Pharmaceuticals NY LLC	VARDENAFIL HYDROCHLORIDE	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69238-1152_12d047d4-2d50-4d2a-9f6b-22c13162b0c8	69238-1152	HUMAN PRESCRIPTION DRUG	Vardenafil hydrochloride		Vardenafil hydrochloride	TABLET, FILM COATED	ORAL	20181031		ANDA	ANDA210738	Amneal Pharmaceuticals NY LLC	VARDENAFIL HYDROCHLORIDE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69238-1153_12d047d4-2d50-4d2a-9f6b-22c13162b0c8	69238-1153	HUMAN PRESCRIPTION DRUG	Vardenafil hydrochloride		Vardenafil hydrochloride	TABLET, FILM COATED	ORAL	20181031		ANDA	ANDA210738	Amneal Pharmaceuticals NY LLC	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69238-1154_334ca858-da48-4282-a396-44e28b23d6e5	69238-1154	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA208803	Amneal Pharmaceuticals NY LLC	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
69238-1155_d2799fe1-dd94-4839-b771-d264a95b75f2	69238-1155	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1156_d2799fe1-dd94-4839-b771-d264a95b75f2	69238-1156	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1157_d2799fe1-dd94-4839-b771-d264a95b75f2	69238-1157	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1158_d2799fe1-dd94-4839-b771-d264a95b75f2	69238-1158	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20171121		ANDA	ANDA208831	Amneal Pharmaceuticals NY LLC	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69238-1163_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1163	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1164_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1164	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1165_c03e6ebe-681b-40c0-b123-741dd35fd558	69238-1165	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		Abiraterone	TABLET	ORAL	20190107		ANDA	ANDA208327	Amneal Pharmaceuticals NY LLC	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
69238-1166_d0d1af67-92d4-4ff0-b99f-b1164285bea1	69238-1166	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Amneal Pharmaceuticals NY LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1168_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1168	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1169_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1169	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1170_d0d1af67-92d4-4ff0-b99f-b1164285bea1	69238-1170	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Amneal Pharmaceuticals NY LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1171_d0d1af67-92d4-4ff0-b99f-b1164285bea1	69238-1171	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20160628		ANDA	ANDA207482	Amneal Pharmaceuticals NY LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1172_d0d1af67-92d4-4ff0-b99f-b1164285bea1	69238-1172	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Amneal Pharmaceuticals NY LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1173_d0d1af67-92d4-4ff0-b99f-b1164285bea1	69238-1173	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170628		ANDA	ANDA207482	Amneal Pharmaceuticals NY LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69238-1174_c2645360-e4a8-4737-9065-3dbbd4b6e6b7	69238-1174	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20171002		ANDA	ANDA207792	Amneal Pharmaceuticals NY LLC	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
69238-1175_c2645360-e4a8-4737-9065-3dbbd4b6e6b7	69238-1175	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20171002		ANDA	ANDA207792	Amneal Pharmaceuticals NY LLC	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
69238-1176_c2645360-e4a8-4737-9065-3dbbd4b6e6b7	69238-1176	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE, LIQUID FILLED	ORAL	20171002		ANDA	ANDA207792	Amneal Pharmaceuticals NY LLC	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
69238-1177_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1177	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1178_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1178	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1183_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1183	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1202_4d818427-3174-46f1-9b3d-5a0b0cd203df	69238-1202	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200420		ANDA	ANDA211586	Amneal Pharmaceuticals NY LLC	BUPRENORPHINE	5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
69238-1203_4d818427-3174-46f1-9b3d-5a0b0cd203df	69238-1203	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200420		ANDA	ANDA211586	Amneal Pharmaceuticals NY LLC	BUPRENORPHINE	10	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
69238-1204_4d818427-3174-46f1-9b3d-5a0b0cd203df	69238-1204	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200420		ANDA	ANDA211586	Amneal Pharmaceuticals NY LLC	BUPRENORPHINE	15	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
69238-1205_4d818427-3174-46f1-9b3d-5a0b0cd203df	69238-1205	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200420		ANDA	ANDA211586	Amneal Pharmaceuticals NY LLC	BUPRENORPHINE	20	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
69238-1213_34cb3f00-0c8e-4a65-9cc5-54d9393dd666	69238-1213	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230925		ANDA	ANDA212704	Amneal Pharmaceuticals NY LLC	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69238-1214_34cb3f00-0c8e-4a65-9cc5-54d9393dd666	69238-1214	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230925		ANDA	ANDA212704	Amneal Pharmaceuticals NY LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69238-1215_34cb3f00-0c8e-4a65-9cc5-54d9393dd666	69238-1215	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230925		ANDA	ANDA212704	Amneal Pharmaceuticals NY LLC	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69238-1247_8318c463-e796-4d9a-b86b-700cf42fedf4	69238-1247	HUMAN PRESCRIPTION DRUG	Memantine and Donepezil Hydrochlorides Extended-release		Memantine and Donepezil	CAPSULE, EXTENDED RELEASE	ORAL	20170201		ANDA	ANDA208328	Amneal Pharmaceuticals NY LLC	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 28	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
69238-1248_8318c463-e796-4d9a-b86b-700cf42fedf4	69238-1248	HUMAN PRESCRIPTION DRUG	Memantine and Donepezil Hydrochlorides Extended-release		Memantine and Donepezil	CAPSULE, EXTENDED RELEASE	ORAL	20170201		ANDA	ANDA208328	Amneal Pharmaceuticals NY LLC	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 14	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
69238-1250_9e70a6ae-538e-406a-9814-a0a21121ba3d	69238-1250	HUMAN PRESCRIPTION DRUG	Bexarotene		Bexarotene	CAPSULE	ORAL	20180904		ANDA	ANDA210105	Amneal Pharmaceuticals NY LLC	BEXAROTENE	75	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
69238-1251_16c8c503-117a-47cf-9770-b7c5185e20cf	69238-1251	HUMAN PRESCRIPTION DRUG	Lopreeza		estradiol/norethindrone acetate	TABLET, FILM COATED	ORAL	20141001		NDA AUTHORIZED GENERIC	NDA020907	Amneal Pharmaceuticals NY LLC	ESTRADIOL; NORETHINDRONE ACETATE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
69238-1252_16c8c503-117a-47cf-9770-b7c5185e20cf	69238-1252	HUMAN PRESCRIPTION DRUG	Lopreeza		estradiol/norethindrone acetate	TABLET, FILM COATED	ORAL	20141001		NDA AUTHORIZED GENERIC	NDA020907	Amneal Pharmaceuticals NY LLC	ESTRADIOL; NORETHINDRONE ACETATE	.5; .1	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
69238-1260_9b3ef46f-acf5-4097-9e08-24ce165a165f	69238-1260	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20180215		ANDA	ANDA209951	Amneal Pharmaceuticals NY LLC	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69238-1261_9b3ef46f-acf5-4097-9e08-24ce165a165f	69238-1261	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20180215		ANDA	ANDA209951	Amneal Pharmaceuticals NY LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69238-1262_83cbfdb7-7c9b-437a-95da-c0a800e7cb60	69238-1262	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20180323		ANDA	ANDA209950	Amneal Pharmaceuticals NY LLC	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69238-1263_83cbfdb7-7c9b-437a-95da-c0a800e7cb60	69238-1263	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20180323		ANDA	ANDA209950	Amneal Pharmaceuticals NY LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69238-1264_1a821b0c-d9cd-4915-8b49-4b60bddfbe43	69238-1264	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir	CAPSULE	ORAL	20170521		ANDA	ANDA209093	Amneal Pharmaceuticals NY LLC	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69238-1265_1a821b0c-d9cd-4915-8b49-4b60bddfbe43	69238-1265	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir	CAPSULE	ORAL	20170521		ANDA	ANDA209093	Amneal Pharmaceuticals NY LLC	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69238-1266_1a821b0c-d9cd-4915-8b49-4b60bddfbe43	69238-1266	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir	CAPSULE	ORAL	20170521		ANDA	ANDA209093	Amneal Pharmaceuticals NY LLC	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69238-1271_534cb52e-44ab-4aba-abc5-bcc9cab4de8f	69238-1271	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20180731		ANDA	ANDA211111	Amneal Pharmaceuticals NY LLC	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-1273_7555923d-e9a7-4472-8acc-f90061f8cc5d	69238-1273	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	FOR SUSPENSION	ORAL	20180305		ANDA	ANDA210186	Amneal Pharmaceuticals NY LLC	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69238-1275_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1275	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1276_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1276	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1277_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1277	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1278_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1278	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1279_d902b268-8d83-4f6d-a91a-bb744b7aabe7	69238-1279	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20210315		ANDA	ANDA210831	Amneal Pharmaceuticals NY LLC	LEVOTHYROXINE SODIUM	300	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
69238-1293_b4ee5287-817d-428e-afe1-61df99c0732f	69238-1293	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1294_b4ee5287-817d-428e-afe1-61df99c0732f	69238-1294	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1295_b4ee5287-817d-428e-afe1-61df99c0732f	69238-1295	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1296_b4ee5287-817d-428e-afe1-61df99c0732f	69238-1296	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1303_bafefe8a-7b62-4e17-906c-a8c0b756ac5d	69238-1303	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20181001		ANDA	ANDA209613	Amneal Pharmaceuticals NY LLC	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69238-1304_bafefe8a-7b62-4e17-906c-a8c0b756ac5d	69238-1304	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20181001		ANDA	ANDA209613	Amneal Pharmaceuticals NY LLC	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69238-1305_48029ff1-cbec-40f3-97a2-30b4503cfd93	69238-1305	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20181022		ANDA	ANDA209718	Amneal Pharmaceuticals NY LLC	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69238-1306_48029ff1-cbec-40f3-97a2-30b4503cfd93	69238-1306	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20181022		ANDA	ANDA209718	Amneal Pharmaceuticals NY LLC	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69238-1308_9dd3c9fc-e538-4c9c-a56c-17859ade1dfd	69238-1308	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA209719	Amneal Pharmaceuticals NY LLC	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69238-1309_9dd3c9fc-e538-4c9c-a56c-17859ade1dfd	69238-1309	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA209719	Amneal Pharmaceuticals NY LLC	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69238-1310_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1310	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	25	mg/1		CV	N	20241231
69238-1311_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1311	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	50	mg/1		CV	N	20241231
69238-1312_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1312	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	75	mg/1		CV	N	20241231
69238-1313_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1313	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	100	mg/1		CV	N	20241231
69238-1314_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1314	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	150	mg/1		CV	N	20241231
69238-1315_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1315	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	200	mg/1		CV	N	20241231
69238-1316_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1316	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	225	mg/1		CV	N	20241231
69238-1317_1ed260fd-920a-4726-b56c-05e4f95bd907	69238-1317	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Amneal Pharmaceuticals NY LLC	PREGABALIN	300	mg/1		CV	N	20241231
69238-1318_11d5133d-e9f9-4b51-8fd1-afb3c105e834	69238-1318	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210402	Amneal Pharmaceuticals NY LLC	DIMETHYL FUMARATE	120	mg/1			N	20241231
69238-1319_11d5133d-e9f9-4b51-8fd1-afb3c105e834	69238-1319	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210402	Amneal Pharmaceuticals NY LLC	DIMETHYL FUMARATE	240	mg/1			N	20241231
69238-1342_2843e039-6c98-4c69-8e23-a82bb1ba9862	69238-1342	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	Amneal Pharmaceuticals NY LLC	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-1343_2843e039-6c98-4c69-8e23-a82bb1ba9862	69238-1343	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	Amneal Pharmaceuticals NY LLC	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-1344_11f9f1a6-b541-49de-9a5a-8b5a910945bb	69238-1344	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20180524		ANDA	ANDA208804	Amneal Pharmaceuticals NY LLC	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
69238-1345_11f9f1a6-b541-49de-9a5a-8b5a910945bb	69238-1345	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20180524		ANDA	ANDA208804	Amneal Pharmaceuticals NY LLC	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
69238-1346_a1a287aa-cff3-4f22-8f82-5cb8b67c4918	69238-1346	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209744	Amneal Pharmaceuticals NY LLC	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
69238-1347_a1a287aa-cff3-4f22-8f82-5cb8b67c4918	69238-1347	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209744	Amneal Pharmaceuticals NY LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
69238-1348_a1a287aa-cff3-4f22-8f82-5cb8b67c4918	69238-1348	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209744	Amneal Pharmaceuticals NY LLC	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
69238-1349_a1a287aa-cff3-4f22-8f82-5cb8b67c4918	69238-1349	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209744	Amneal Pharmaceuticals NY LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
69238-1373_57bd132b-a197-4a34-b7c2-420074d222be	69238-1373	HUMAN PRESCRIPTION DRUG	tobramycin and dexamethasone		tobramycin and dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20210717		ANDA	ANDA212991	Amneal Pharmaceuticals NY LLC	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-1374_57bd132b-a197-4a34-b7c2-420074d222be	69238-1374	HUMAN PRESCRIPTION DRUG	tobramycin and dexamethasone		tobramycin and dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20210717		ANDA	ANDA212991	Amneal Pharmaceuticals NY LLC	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-1375_57bd132b-a197-4a34-b7c2-420074d222be	69238-1375	HUMAN PRESCRIPTION DRUG	tobramycin and dexamethasone		tobramycin and dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20210717		ANDA	ANDA212991	Amneal Pharmaceuticals NY LLC	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-1380_bf12796f-bfde-49ed-8c4a-72aebbe1a5a7	69238-1380	HUMAN PRESCRIPTION DRUG	Difluprednate		Difluprednate ophthalmic	EMULSION	OPHTHALMIC	20211118		ANDA	ANDA211526	Amneal Pharmaceuticals NY LLC	DIFLUPREDNATE	.5	mg/mL			N	20241231
69238-1420_2ae50691-7fd9-4a62-894c-535faada8041	69238-1420	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA209745	Amneal Pharmaceuticals NY LLC	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
69238-1421_2ae50691-7fd9-4a62-894c-535faada8041	69238-1421	HUMAN PRESCRIPTION DRUG	Silodosin		Silodosin	CAPSULE	ORAL	20181203		ANDA	ANDA209745	Amneal Pharmaceuticals NY LLC	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
69238-1422_b9db3e35-7654-4bf3-8536-38f56b8780c7	69238-1422	HUMAN OTC DRUG	Naproxen Sodium and Diphenhydramine HCl		Naproxen Sodium and Diphenhydramine	TABLET, FILM COATED	ORAL	20181023		ANDA	ANDA209726	Amneal Pharmaceuticals NY LLC	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-1423_efc08af1-49d5-4361-81ab-0d23e19d3f4c	69238-1423	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20171229		ANDA	ANDA210040	Amneal Pharmaceuticals NY LLC	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
69238-1424_f96350dd-5f75-4fa5-88be-938717a804b0	69238-1424	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	TABLET	ORAL	20220627		ANDA	ANDA210042	Amneal Pharmaceuticals NY LLC	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
69238-1425_cb7e94d1-fc6e-4b9e-a58d-575d7a8a06a8	69238-1425	HUMAN PRESCRIPTION DRUG	Vigabatrin		Vigabatrin	FOR SOLUTION	ORAL	20180319		ANDA	ANDA210155	Amneal Pharmaceuticals NY LLC	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
69238-1426_b926aea0-d7fa-47f3-b054-356901e5229c	69238-1426	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine	TABLET, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA210052	Amneal Pharmaceuticals NY LLC	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
69238-1447_b4ee5287-817d-428e-afe1-61df99c0732f	69238-1447	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200930		ANDA	ANDA211396	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1458_9bb17bdb-ffd3-4e09-a1d9-d21ae0f5f686	69238-1458	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20180724		ANDA	ANDA210041	Amneal Pharmaceuticals NY LLC	POTASSIUM CHLORIDE	3	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69238-1459_9bb17bdb-ffd3-4e09-a1d9-d21ae0f5f686	69238-1459	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	SOLUTION	ORAL	20180724		ANDA	ANDA210041	Amneal Pharmaceuticals NY LLC	POTASSIUM CHLORIDE	1.5	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69238-1471_bb2561ee-b370-49e6-8115-e424f7b92db1	69238-1471	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20190707		ANDA	ANDA210954	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
69238-1472_bb2561ee-b370-49e6-8115-e424f7b92db1	69238-1472	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20190707		ANDA	ANDA210954	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN	333	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
69238-1473_bb2561ee-b370-49e6-8115-e424f7b92db1	69238-1473	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, DELAYED RELEASE	ORAL	20190707		ANDA	ANDA210954	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
69238-1476_31289fcf-8f5c-4312-8f45-40ad7fd04325	69238-1476	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20221230		ANDA	ANDA216626	Amneal Pharmaceuticals NY LLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69238-1484_61ae864e-1e74-40c1-b67f-22ea1e6f9f21	69238-1484	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20180311		ANDA	ANDA209720	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
69238-1485_61ae864e-1e74-40c1-b67f-22ea1e6f9f21	69238-1485	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20180311		ANDA	ANDA209720	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
69238-1486_0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7	69238-1486	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20200102		ANDA	ANDA210727	Amneal Pharmaceuticals NY LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69238-1487_0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7	69238-1487	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20200615		ANDA	ANDA210727	Amneal Pharmaceuticals NY LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69238-1488_0b0b3d91-33d4-46b8-8bdc-fb9b5a9e99c7	69238-1488	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FILM COATED	ORAL	20200102		ANDA	ANDA210727	Amneal Pharmaceuticals NY LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69238-1489_d1961e90-3fcc-4b72-b207-6c9de6d66557	69238-1489	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	Amneal Pharmaceuticals NY LLC	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69238-1490_d1961e90-3fcc-4b72-b207-6c9de6d66557	69238-1490	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	Amneal Pharmaceuticals NY LLC	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69238-1491_d1961e90-3fcc-4b72-b207-6c9de6d66557	69238-1491	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	20171018		ANDA	ANDA209724	Amneal Pharmaceuticals NY LLC	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69238-1500_d5057c66-d16c-4e22-963d-88451f6e62d7	69238-1500	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline	TABLET	ORAL	20171009		ANDA	ANDA209372	Amneal Pharmaceuticals NY LLC	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69238-1501_d5057c66-d16c-4e22-963d-88451f6e62d7	69238-1501	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline	TABLET	ORAL	20171009		ANDA	ANDA209372	Amneal Pharmaceuticals NY LLC	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69238-1503_85c41da0-5783-4194-8bb5-7b14ad975d25	69238-1503	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin	SUSPENSION	ORAL	20191104		ANDA	ANDA211204	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
69238-1504_85c41da0-5783-4194-8bb5-7b14ad975d25	69238-1504	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin	SUSPENSION	ORAL	20191104		ANDA	ANDA211204	Amneal Pharmaceuticals NY LLC	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
69238-1505_4d818427-3174-46f1-9b3d-5a0b0cd203df	69238-1505	HUMAN PRESCRIPTION DRUG	Buprenorphine		Buprenorphine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20200420		ANDA	ANDA211586	Amneal Pharmaceuticals NY LLC	BUPRENORPHINE	7.5	ug/h	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
69238-1521_0a63a330-c4d1-4fb0-8e11-10b2971f1a57	69238-1521	HUMAN PRESCRIPTION DRUG	Norelgestromin and Ethinly Estradiol		Norelgestromin and Ethinly Estradiol	PATCH	TRANSDERMAL	20210226		ANDA	ANDA213950	Amneal Pharmaceuticals NY LLC	ETHINYL ESTRADIOL; NORELGESTROMIN	35; 150	ug/d; ug/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
69238-1522_ec134ef2-046e-45ed-9191-5d111e38bb2e	69238-1522	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20180921		ANDA	ANDA210674	Amneal Pharmaceuticals NY LLC	TETRACYCLINE HYDROCHLORIDE	250	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
69238-1523_ec134ef2-046e-45ed-9191-5d111e38bb2e	69238-1523	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20180921		ANDA	ANDA210674	Amneal Pharmaceuticals NY LLC	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
69238-1532_df6ce06d-306e-47db-8130-24bc017bcf6e	69238-1532	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20181228		ANDA	ANDA211256	Amneal Pharmaceuticals NY LLC	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-1534_48b8c88f-032a-487a-a336-bcd5ea43a3f7	69238-1534	HUMAN PRESCRIPTION DRUG	Fluocinonide Cream		Fluocinonide	CREAM	TOPICAL	20171001		ANDA	ANDA210554	Amneal Pharmaceuticals NY LLC	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-1535_6331cd55-afa1-431f-947b-b4577321171f	69238-1535	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20181022		ANDA	ANDA210039	Amneal Pharmaceuticals NY LLC	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69238-1539_17108066-165c-4ffa-ac20-53facca9a414	69238-1539	HUMAN PRESCRIPTION DRUG	Frovatriptan		Frovatriptan succinate	TABLET, FILM COATED	ORAL	20181113		ANDA	ANDA211292	Amneal Pharmaceuticals NY LLC	FROVATRIPTAN SUCCINATE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69238-1540_245bed22-c8f4-411e-8dec-0768fe56ef83	69238-1540	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20181022		ANDA	ANDA211301	Amneal Pharmaceuticals NY LLC	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20251231
69238-1544_51e0c750-7749-4c87-8808-99239073a41b	69238-1544	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20180517		ANDA	ANDA210577	Amneal Pharmaceuticals NY LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20251231
69238-1551_a123a86f-1a2a-4e89-9627-1bbcf9f237d2	69238-1551	HUMAN PRESCRIPTION DRUG	Femynor		norgestimate and ethinyl estradiol	KIT		20160615		ANDA	ANDA203865	Amneal Pharmaceuticals NY LLC						N	20241231
69238-1552_8318c463-e796-4d9a-b86b-700cf42fedf4	69238-1552	HUMAN PRESCRIPTION DRUG	Memantine and Donepezil Hydrochlorides Extended-release		Memantine and Donepezil	CAPSULE, EXTENDED RELEASE	ORAL	20170201		ANDA	ANDA208328	Amneal Pharmaceuticals NY LLC	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 7	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
69238-1553_8318c463-e796-4d9a-b86b-700cf42fedf4	69238-1553	HUMAN PRESCRIPTION DRUG	Memantine and Donepezil Hydrochlorides Extended-release		Memantine and Donepezil	CAPSULE, EXTENDED RELEASE	ORAL	20170201		ANDA	ANDA208328	Amneal Pharmaceuticals NY LLC	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	10; 21	mg/1; mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
69238-1563_f7ef4e4d-2d95-4c96-aee4-bef97ccf3ba7	69238-1563	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine	TABLET	ORAL	20180928		ANDA	ANDA211139	Amneal Pharmaceuticals NY LLC	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
69238-1564_f7ef4e4d-2d95-4c96-aee4-bef97ccf3ba7	69238-1564	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine	TABLET	ORAL	20180928		ANDA	ANDA211139	Amneal Pharmaceuticals NY LLC	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
69238-1574_df0f005f-46cc-4357-9ee1-3cd736b7e5a3	69238-1574	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	POWDER, FOR SUSPENSION	ORAL	20191206		ANDA	ANDA211092	Amneal Pharmaceuticals NY LLC	SILDENAFIL	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69238-1581_44ee7abe-a384-4540-82e8-55c44c05863e	69238-1581	HUMAN PRESCRIPTION DRUG	Zenchent FE		Norethindrone and Ethinyl Estradiol	KIT	ORAL	20180629		ANDA	ANDA078892	Amneal Pharmaceuticals NY LLC						N	20241231
69238-1582_253289e9-7759-4877-af0b-0bdc09f556b1	69238-1582	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol	KIT	ORAL	20131220		ANDA	ANDA078267	Amneal Pharmaceuticals NY LLC						N	20241231
69238-1583_a665a6f9-0269-4bbc-a201-aef2c4082583	69238-1583	HUMAN PRESCRIPTION DRUG	Norlyda		norethindrone	KIT		20160916	20241001	ANDA	ANDA202260	Amneal Pharmaceuticals NY LLC						N	
69238-1594_52988495-39c7-4c01-810f-b72a81df06f0	69238-1594	HUMAN PRESCRIPTION DRUG	Sirolimus		SIrolimus	SOLUTION	ORAL	20191025		ANDA	ANDA211212	Amneal Pharmaceuticals NY LLC	SIROLIMUS	1	mg/mL	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
69238-1595_56ca2623-bacf-47dc-b752-3ffd96113714	69238-1595	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	POWDER, FOR SUSPENSION	ORAL	20211105		ANDA	ANDA214871	Amneal Pharmaceuticals NY LLC	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
69238-1596_2b9785d5-ea90-465b-a9f5-2c70e578799a	69238-1596	HUMAN PRESCRIPTION DRUG	Aminocaproic acid		Aminocaproic acid	SOLUTION	ORAL	20190823		ANDA	ANDA212780	Amneal Pharmaceuticals NY LLC	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
69238-1607_1d7fbcd7-6b87-431b-9b8f-9b3722a4a186	69238-1607	HUMAN PRESCRIPTION DRUG	Tri Femynor		norgestimate and ethinyl estradiol	KIT		20161028		ANDA	ANDA203870	Amneal Pharmaceuticals NY LLC						N	20241231
69238-1610_9d5caf69-177f-4dd0-93aa-4bb90e1910bb	69238-1610	HUMAN PRESCRIPTION DRUG	LOPREEZA		estradiol/norethindrone acetate	TABLET, FILM COATED	ORAL	20190107		NDA	NDA020907	Amneal Pharmaceuticals NY LLC	ESTRADIOL; NORETHINDRONE ACETATE	1; .5	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
69238-1615_75af74cd-3e96-411a-b33d-34ad01e7b21d	69238-1615	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin Otic	SOLUTION	AURICULAR (OTIC)	20200317		ANDA	ANDA211525	Amneal Pharmaceuticals NY LLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
69238-1616_75af74cd-3e96-411a-b33d-34ad01e7b21d	69238-1616	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin Otic	SOLUTION	AURICULAR (OTIC)	20190830		ANDA	ANDA211525	Amneal Pharmaceuticals NY LLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
69238-1621_fe7e12ab-6604-4e78-94c1-e64237cd1289	69238-1621	HUMAN PRESCRIPTION DRUG	metyrosine		metyrosine	CAPSULE	ORAL	20200724		ANDA	ANDA213734	Amneal Pharmaceuticals NY LLC	METYROSINE	250	mg/1	Catecholamine Synthesis Inhibitor [EPC], Catecholamine Synthesis Inhibitors [MoA]		N	20241231
69238-1626_11d5133d-e9f9-4b51-8fd1-afb3c105e834	69238-1626	HUMAN PRESCRIPTION DRUG	DIMETHYL FUMARATE		DIMETHYL FUMARATE	KIT		20200928		ANDA	ANDA210402	Amneal Pharmaceuticals NY LLC						N	20241231
69238-1627_0622cdcc-1196-4a2f-8c85-6f34f0f97f9d	69238-1627	HUMAN PRESCRIPTION DRUG	Dapsone		Daspone	GEL	TOPICAL	20230602		ANDA	ANDA212701	Amneal Pharmaceuticals NY LLC	DAPSONE	75	mg/g	Sulfone [EPC], Sulfones [CS]		N	20241231
69238-1629_ed29cb78-715c-4c3b-a046-177839df39a2	69238-1629	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1630_ed29cb78-715c-4c3b-a046-177839df39a2	69238-1630	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1631_ed29cb78-715c-4c3b-a046-177839df39a2	69238-1631	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1632_ed29cb78-715c-4c3b-a046-177839df39a2	69238-1632	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1633_ed29cb78-715c-4c3b-a046-177839df39a2	69238-1633	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Amneal Pharmaceuticals NY LLC	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
69238-1637_6091bbf2-e45e-416d-bd4e-fc95dfeb609a	69238-1637	HUMAN PRESCRIPTION DRUG	Aminocaproic acid		Aminocaproic acid	TABLET	ORAL	20191130		ANDA	ANDA212492	Amneal Pharmaceuticals NY LLC	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
69238-1640_08b2264e-d081-4558-9893-0a11d25e7a39	69238-1640	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20230228		ANDA	ANDA212570	Amneal Pharmaceuticals NY LLC	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69238-1641_08b2264e-d081-4558-9893-0a11d25e7a39	69238-1641	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20230228		ANDA	ANDA212570	Amneal Pharmaceuticals NY LLC	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69238-1642_f3adb01b-7d3d-4632-860c-8f3caf7e4bd3	69238-1642	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	CAPSULE	ORAL	20220107		ANDA	ANDA212569	Amneal Pharmaceuticals NY LLC	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69238-1656_507ba68d-7593-4545-bbe1-dc9463c1a893	69238-1656	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20220422		ANDA	ANDA215576	Amneal Pharmaceuticals NY LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
69238-1657_84f7f3e4-e52f-4054-ad9c-d57fc99f52ce	69238-1657	HUMAN PRESCRIPTION DRUG	Tavaborole		Tavaborole	SOLUTION	TOPICAL	20201128		ANDA	ANDA212256	Amneal Pharmaceuticals NY LLC	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
69238-1678_47a90e7b-4fe1-47a7-a427-de52037fb30b	69238-1678	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20200711		ANDA	ANDA213647	Amneal Pharmaceuticals NY LLC	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1679_47a90e7b-4fe1-47a7-a427-de52037fb30b	69238-1679	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20200711		ANDA	ANDA213647	Amneal Pharmaceuticals NY LLC	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1680_47a90e7b-4fe1-47a7-a427-de52037fb30b	69238-1680	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20200711		ANDA	ANDA213647	Amneal Pharmaceuticals NY LLC	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1681_47a90e7b-4fe1-47a7-a427-de52037fb30b	69238-1681	HUMAN PRESCRIPTION DRUG	fluphenazine hydrochloride		fluphenazine hydrochloride	TABLET, FILM COATED	ORAL	20200711		ANDA	ANDA213647	Amneal Pharmaceuticals NY LLC	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69238-1686_eaacb828-e8db-45c4-882b-a6ddf46bf7f0	69238-1686	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate		Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate	KIT	ORAL	20210726		ANDA	ANDA214292	Amneal Pharmaceuticals NY LLC						N	20241231
69238-1690_2f673209-ddd3-4b75-8799-06391fdf7faa	69238-1690	HUMAN PRESCRIPTION DRUG	Estradiol and Progesterone		Estradiol and Progesterone	CAPSULE	ORAL	20220520		ANDA	ANDA214293	Amneal Pharmaceuticals NY LLC	ESTRADIOL; PROGESTERONE	1; 100	mg/1; mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone [CS], Progesterone [EPC]		N	20241231
69238-1702_cd673946-3321-416a-9ea1-06b8a23f1329	69238-1702	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	GRANULE	ORAL	20210804		ANDA	ANDA214194	Amneal Pharmaceuticals NY LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69238-1703_cd673946-3321-416a-9ea1-06b8a23f1329	69238-1703	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	GRANULE	ORAL	20210209		ANDA	ANDA214194	Amneal Pharmaceuticals NY LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69238-1704_cd673946-3321-416a-9ea1-06b8a23f1329	69238-1704	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	GRANULE	ORAL	20210209		ANDA	ANDA214194	Amneal Pharmaceuticals NY LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69238-1720_d7bd3088-24b6-48bf-b3d2-990948ac576b	69238-1720	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20210614		ANDA	ANDA214196	Amneal Pharmaceuticals NY LLC	ETRAVIRINE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69238-1721_d7bd3088-24b6-48bf-b3d2-990948ac576b	69238-1721	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20210614		ANDA	ANDA214196	Amneal Pharmaceuticals NY LLC	ETRAVIRINE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69238-1722_d7bd3088-24b6-48bf-b3d2-990948ac576b	69238-1722	HUMAN PRESCRIPTION DRUG	etravirine		etravirine	TABLET	ORAL	20210614		ANDA	ANDA214196	Amneal Pharmaceuticals NY LLC	ETRAVIRINE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69238-1729_30d9ad7e-d316-428f-a2aa-321f9dafdd84	69238-1729	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril	SOLUTION	ORAL	20191201		ANDA	ANDA212894	Amneal Pharmaceuticals NY LLC	ENALAPRIL MALEATE	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
69238-1732_f50085cc-bc01-4826-8582-0a557d5f0273	69238-1732	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	SHAMPOO	TOPICAL	20210615		ANDA	ANDA214895	Amneal Pharmaceuticals NY LLC	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-1733_8c0a4714-cdc3-4adc-a439-678ac48a3465	69238-1733	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CREAM	TOPICAL	20230821		ANDA	ANDA212357	Amneal Pharmaceuticals NY LLC	DOXEPIN HYDROCHLORIDE	50	mg/g	Tricyclic Antidepressant [EPC]		N	20241231
69238-1745_f97f3499-d6c9-4a0a-8d42-f44b9bbc1813	69238-1745	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20200923		ANDA	ANDA214193	Amneal Pharmaceuticals NY LLC	PILOCARPINE HYDROCHLORIDE	10	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
69238-1746_f97f3499-d6c9-4a0a-8d42-f44b9bbc1813	69238-1746	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20200923		ANDA	ANDA214193	Amneal Pharmaceuticals NY LLC	PILOCARPINE HYDROCHLORIDE	20	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
69238-1747_f97f3499-d6c9-4a0a-8d42-f44b9bbc1813	69238-1747	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20200923		ANDA	ANDA214193	Amneal Pharmaceuticals NY LLC	PILOCARPINE HYDROCHLORIDE	40	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
69238-1754_c03e6ebe-681b-40c0-b123-741dd35fd558	69238-1754	HUMAN PRESCRIPTION DRUG	ABIRATERONE ACETATE		ABIRATERONE	TABLET	ORAL	20190107		ANDA	ANDA208327	Amneal Pharmaceuticals NY LLC	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
69238-1991_e9480117-8eb3-41e7-8928-1573d3d21d0e	69238-1991	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20190401		ANDA	ANDA076268	Amneal Pharmaceuticals NY LLC	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
69238-1992_e9480117-8eb3-41e7-8928-1573d3d21d0e	69238-1992	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20190401		ANDA	ANDA076268	Amneal Pharmaceuticals NY LLC	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
69238-1993_c5c722ff-80b5-448e-9cee-8fe3f786f4ae	69238-1993	HUMAN PRESCRIPTION DRUG	Butalbital, Aspirin, Caffeine and Codeine Phosphate		Butalbital, Aspirin, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20190401		ANDA	ANDA074951	Amneal Pharmaceuticals NY LLC	ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Opioid Agonist [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]	CIII	N	20241231
69238-2006_cfd2bfd2-862b-4c07-a985-4a73ba07c19a	69238-2006	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	SPRAY, METERED	NASAL	20210118		NDA AUTHORIZED GENERIC	NDA021450	Amneal Pharmaceuticals	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69238-2007_cfd2bfd2-862b-4c07-a985-4a73ba07c19a	69238-2007	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	SPRAY, METERED	NASAL	20210118		NDA AUTHORIZED GENERIC	NDA021450	Amneal Pharmaceuticals	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69238-2016_1c1d7d62-9ebf-49eb-9eb2-471f9ce73637	69238-2016	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY	NASAL	20220818		ANDA	ANDA215104	Amneal Pharmaceuticals NY LLC	IPRATROPIUM BROMIDE	21	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
69238-2017_671db709-62da-467f-bcee-d67bf6f975a1	69238-2017	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY	NASAL	20220818		ANDA	ANDA215105	Amneal Pharmaceuticals NY LLC	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
69238-2026_f18fa3f2-2d8f-499f-9708-3748fee89eb3	69238-2026	HUMAN PRESCRIPTION DRUG	Amlodipine		Amlodipine	SUSPENSION	ORAL	20230616		ANDA	ANDA215035	Amneal Pharmaceuticals NY LLC	AMLODIPINE BENZOATE	1	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69238-2027_e25b36dd-7948-4481-8994-13658f1f337f	69238-2027	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	SUSPENSION	ORAL	20230908		ANDA	ANDA215572	Amneal Pharmaceuticals NY LLC	SPIRONOLACTONE	25	mg/5mL	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
69238-2029_e5ab6651-9d45-4c0d-9c8c-6845054f4991	69238-2029	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	CREAM	TOPICAL	20221117		ANDA	ANDA214811	Amneal Pharmaceuticals NY LLC	MUPIROCIN CALCIUM	2	g/100g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
69238-2030_577561cd-5f28-4b41-9037-0bbc3b6a20df	69238-2030	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	GEL	TOPICAL	20221107		ANDA	ANDA215219	Amneal Pharmaceuticals NY LLC	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
69238-2031_1366a717-0c59-4532-a999-6ffafc67c57f	69238-2031	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	GEL	TOPICAL	20220808		ANDA	ANDA214668	Amneal Pharmaceuticals NY LLC	CLINDAMYCIN PHOSPHATE	1	g/10mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
69238-2053_a723bc13-8e04-48e5-8427-5cb5e6471e4a	69238-2053	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac	GEL	TOPICAL	20160321		ANDA	ANDA208077	Amneal Pharmaceuticals NY LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69238-2077_ac6890b3-ec2c-45db-a61c-0bb816fea5b0	69238-2077	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071972	Amneal Pharmaceuticals NY LLC	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-2078_ac6890b3-ec2c-45db-a61c-0bb816fea5b0	69238-2078	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071972	Amneal Pharmaceuticals NY LLC	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-2079_ac6890b3-ec2c-45db-a61c-0bb816fea5b0	69238-2079	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071972	Amneal Pharmaceuticals NY LLC	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-2080_ac6890b3-ec2c-45db-a61c-0bb816fea5b0	69238-2080	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071976	Amneal Pharmaceuticals NY LLC	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-2081_ac6890b3-ec2c-45db-a61c-0bb816fea5b0	69238-2081	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210603		ANDA	ANDA071976	Amneal Pharmaceuticals NY LLC	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69238-2088_e90bb84a-0b45-4163-92da-d8ed239a0b1d	69238-2088	HUMAN PRESCRIPTION DRUG	Bexarotene		Bexarotene	GEL	TOPICAL	20220504		ANDA	ANDA215398	Amneal Pharmaceuticals NY LLC	BEXAROTENE	10	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
69238-2090_ddc06a12-1bc6-4006-ba9c-ed389599b532	69238-2090	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SUSPENSION	ORAL	20220805		ANDA	ANDA216427	Amneal Pharmaceuticals NY LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69238-2092_e3f72707-b2b3-49e4-8b28-a9311e1358cf	69238-2092	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180826		ANDA	ANDA209721	Amneal Pharmaceuticals NY LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	100; 150	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
69238-2093_e3f72707-b2b3-49e4-8b28-a9311e1358cf	69238-2093	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180826		ANDA	ANDA209721	Amneal Pharmaceuticals NY LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	133; 200	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
69238-2094_e3f72707-b2b3-49e4-8b28-a9311e1358cf	69238-2094	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180826		ANDA	ANDA209721	Amneal Pharmaceuticals NY LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	167; 250	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
69238-2095_e3f72707-b2b3-49e4-8b28-a9311e1358cf	69238-2095	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20180826		ANDA	ANDA209721	Amneal Pharmaceuticals NY LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
69238-2108_5de18b48-88b2-43e7-b5be-9a4e8eabd466	69238-2108	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210801		ANDA	ANDA078071	Amneal Pharmaceuticals NY LLC	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20251231
69238-2109_5de18b48-88b2-43e7-b5be-9a4e8eabd466	69238-2109	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210801		ANDA	ANDA078071	Amneal Pharmaceuticals NY LLC	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
69238-2110_5de18b48-88b2-43e7-b5be-9a4e8eabd466	69238-2110	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210801		ANDA	ANDA078071	Amneal Pharmaceuticals NY LLC	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20251231
69238-2111_5de18b48-88b2-43e7-b5be-9a4e8eabd466	69238-2111	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210801		ANDA	ANDA078071	Amneal Pharmaceuticals NY LLC	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20251231
69238-2112_5de18b48-88b2-43e7-b5be-9a4e8eabd466	69238-2112	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210801		ANDA	ANDA078071	Amneal Pharmaceuticals NY LLC	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20251231
69238-2113_5de18b48-88b2-43e7-b5be-9a4e8eabd466	69238-2113	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210801		ANDA	ANDA078071	Amneal Pharmaceuticals NY LLC	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20251231
69238-2121_f118e287-5acc-4a8b-bcf0-01436de5bdf9	69238-2121	HUMAN PRESCRIPTION DRUG	clindamycin hydrochloride		clindamycin hydrochloride	CAPSULE, GELATIN COATED	ORAL	20220425		ANDA	ANDA065194	Amneal Pharmaceuticals NY LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
69238-2122_8e99cf23-8172-4781-9ae0-856dee87a74e	69238-2122	HUMAN PRESCRIPTION DRUG	Prednisolone Sodium Phosphate		Prednisolone Sodium Phosphate	SOLUTION	ORAL	20221027		ANDA	ANDA216715	Amneal Pharmaceuticals NY LLC	PREDNISOLONE SODIUM PHOSPHATE	15	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-2125_5b3e39b5-4ec9-480e-8485-65a801d56028	69238-2125	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20091202		ANDA	ANDA078596	Amneal Pharmaceuticals NY LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
69238-2126_5b3e39b5-4ec9-480e-8485-65a801d56028	69238-2126	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20100226		ANDA	ANDA078596	Amneal Pharmaceuticals NY LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
69238-2141_ddab86a7-99c5-4f3d-9bc9-bfd33b2886e4	69238-2141	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril	SOLUTION	ORAL	20220323		NDA AUTHORIZED GENERIC	NDA208686	Amneal Pharmaceuticals NY LLC	ENALAPRIL MALEATE	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
69238-2261_4709fe67-0ab3-4727-950f-b926a7bb21df	69238-2261	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	SOLUTION	ORAL	20230626		ANDA	ANDA215338	Amneal Pharmaceuticals NY LLC	VANCOMYCIN HYDROCHLORIDE	250	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
69238-2294_32e0a011-6ef8-4c45-b080-33acd76a1bea	69238-2294	HUMAN PRESCRIPTION DRUG	Oxycodone HCl		Oxycodone HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022272	Amneal Pharmaceuticals NY LLC	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
69238-2296_32e0a011-6ef8-4c45-b080-33acd76a1bea	69238-2296	HUMAN PRESCRIPTION DRUG	Oxycodone HCl		Oxycodone HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022272	Amneal Pharmaceuticals NY LLC	OXYCODONE HYDROCHLORIDE	20	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
69238-2298_32e0a011-6ef8-4c45-b080-33acd76a1bea	69238-2298	HUMAN PRESCRIPTION DRUG	Oxycodone HCl		Oxycodone HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022272	Amneal Pharmaceuticals NY LLC	OXYCODONE HYDROCHLORIDE	40	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
69238-2300_32e0a011-6ef8-4c45-b080-33acd76a1bea	69238-2300	HUMAN PRESCRIPTION DRUG	Oxycodone HCl		Oxycodone HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022272	Amneal Pharmaceuticals NY LLC	OXYCODONE HYDROCHLORIDE	80	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
69238-2348_5616ac62-c719-48eb-a1fa-0a94f8c90747	69238-2348	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20101115		ANDA	ANDA076003	Amneal Pharmaceuticals NY LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
69238-2391_a6c17f6f-46bc-4852-a825-07f49cc08495	69238-2391	HUMAN PRESCRIPTION DRUG	sodium oxybate		sodium oxybate	SOLUTION	ORAL	20230703		NDA AUTHORIZED GENERIC	NDA021196	Amneal Pharmaceuticals NY LLC	SODIUM OXYBATE	.5	g/mL	Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]	CIII	N	20241231
69238-2446_027da4f6-e305-453e-af7e-35225b4965f2	69238-2446	HUMAN OTC DRUG	Mometasone Furoate		Mometasone	SPRAY, METERED	NASAL	20230616		ANDA	ANDA207989	Amneal Pharmaceuticals NY LLC	MOMETASONE FUROATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69238-2512_c2f0a95d-6604-4880-bff0-4d14331aa4ea	69238-2512	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20210531		ANDA	ANDA201679	Amneal Pharmaceuticals NY LLC	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
69238-2548_071804f4-9647-4a4d-a394-55b9e976dc9f	69238-2548	HUMAN PRESCRIPTION DRUG	Tasimelteon		Tasimelteon	CAPSULE	ORAL	20230224		ANDA	ANDA211654	Amneal Pharmaceuticals NY LLC	TASIMELTEON	20	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
69238-2597_fe8e2734-2b8b-4580-9336-ccfb0da6e812	69238-2597	HUMAN PRESCRIPTION DRUG	Icosapent ethyl		Icosapent ethyl	CAPSULE	ORAL	20231101		ANDA	ANDA217844	Amneal Pharmaceuticals LLC	ICOSAPENT ETHYL	.5	g/1			N	20241231
69238-2598_fe8e2734-2b8b-4580-9336-ccfb0da6e812	69238-2598	HUMAN PRESCRIPTION DRUG	Icosapent ethyl		Icosapent ethyl	CAPSULE	ORAL	20231101		ANDA	ANDA217844	Amneal Pharmaceuticals LLC	ICOSAPENT ETHYL	1	g/1			N	20241231
69238-7033_e873ee22-d1ef-496a-864d-d4820c76ea17	69238-7033	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		FLUDROCORTISONE ACETATE	TABLET	ORAL	20020318		ANDA	ANDA040431	Amneal Pharmaceuticals NY LLC	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
69240-001_299e2a9c-08b6-4966-b150-467771c24419	69240-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20140901		NDA	NDA205767	Acute Care Gases II, LLC	OXYGEN	99	L/100L			N	20241231
69241-001_b4c17424-d5eb-4830-b942-f256b73b8896	69241-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20140901		NDA	NDA205849	RTA Pediatric Care Inc.	OXYGEN	99	L/100L			N	20241231
69249-000_0d000ab5-873c-ef8c-e063-6394a90a77fd	69249-000	HUMAN OTC DRUG	POVIOFIX Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20140925		OTC MONOGRAPH DRUG	505G(a)(3)	NATUREL MEDIKAL ILAC SANAYI VE TICARET LIMITED SIRKETI	POVIDONE-IODINE	100	mg/mL			N	20241231
69250-661_0e9d506d-8c0f-ab6b-e063-6294a90a5ab6	69250-661	HUMAN OTC DRUG	Alcohol Prep Pad		Alcohol Prep Pad	SPONGE	TOPICAL	20141030		UNAPPROVED DRUG OTHER		BioMed Resource Inc.	ISOPROPYL ALCOHOL	7	mL/10mL			N	20251231
69256-001_44de94ae-f1d1-4f0f-9725-55611fa2e528	69256-001	HUMAN OTC DRUG	harris teeter hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20171012		OTC MONOGRAPH FINAL	part346	Harris Teeter, LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69256-002_5e6171d8-a497-480b-a63f-aebbfe8b7720	69256-002	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220803		ANDA	ANDA206531	HARRIS TEETER, LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69256-006_c6265707-f02c-40ff-81b8-42b989cbcd02	69256-006	HUMAN OTC DRUG	harris teeter tussin		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180910		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-007_106ba2aa-6ede-42bf-ad2f-22947d4dc0ba	69256-007	HUMAN OTC DRUG	harris teeter acid reducer		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191127		ANDA	ANDA207193	Harris Teeter, LLC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69256-012_e6818362-908b-4ab5-899a-82678d07320e	69256-012	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20210129		ANDA	ANDA208077	Harris Teeter, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69256-030_f2a34cdd-8f65-58af-e053-2a95a90a87d6	69256-030	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20171220		OTC MONOGRAPH FINAL	part358F	Harris Teeter, LLC	SALICYLIC ACID	40	mg/91			N	20241231
69256-031_f2a34cdd-8f66-58af-e053-2a95a90a87d6	69256-031	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20120103		OTC MONOGRAPH FINAL	part358F	Harris Teeter, LLC	SALICYLIC ACID	40	mg/41			N	20241231
69256-034_f2a34be7-9f72-c6e0-e053-2995a90a4e36	69256-034	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20171221		OTC MONOGRAPH FINAL	part333C	Harris Teeter, LLC	TOLNAFTATE	1.5	g/150g			N	20241231
69256-035_f2a34be7-9f71-c6e0-e053-2995a90a4e36	69256-035	HUMAN OTC DRUG	Salicylic Acid		Wart Remover Liquid	LIQUID	TOPICAL	20171221		OTC MONOGRAPH FINAL	part358B	Harris Teeter, LLC	SALICYLIC ACID	.17	mg/9mL			N	20241231
69256-036_f2a3548a-c958-73df-e053-2a95a90a9422	69256-036	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20171221		OTC MONOGRAPH FINAL	part358B	Harris Teeter, LLC	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
69256-037_f2a34bb2-7d5b-21ef-e053-2a95a90ac66c	69256-037	HUMAN OTC DRUG	Benzethonium chloride Plus Dyclonine hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20140710		OTC MONOGRAPH NOT FINAL	part333A	Harris Teeter, LLC	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
69256-038_f2a34114-a9af-35f8-e053-2a95a90a9e0e	69256-038	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20171221		OTC MONOGRAPH FINAL	part333C	Harris Teeter, LLC	MICONAZOLE NITRATE	1.3	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69256-040_0c3b66bb-a7d2-4125-9aea-9b089704446c	69256-040	HUMAN OTC DRUG	harris teeter sinus relief		acetaminophen, guaifenesin, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20191217		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC						N	20241231
69256-056_ef356dc9-8d79-45cb-b683-d1f808fd5270	69256-056	HUMAN OTC DRUG	Harris Teeter NightTime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20151121		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-058_0d37718d-85d8-696a-e063-6394a90a291e	69256-058	HUMAN OTC DRUG	Harris Teeter Eye Drops Maximum Redness Relief		glycerin, naphazoline hydrochloride	SOLUTION	OPHTHALMIC	20230324		OTC MONOGRAPH DRUG	M018	Harris Teeter, LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69256-061_f3ceeac0-5af3-4fdd-a650-5a244b74e989	69256-061	HUMAN OTC DRUG	Harris Teeter Allergy Relief Nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160731		ANDA	ANDA207957	Harris Teeter, LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69256-105_e68633ed-5077-4acf-9152-a255fb2b9eb4	69256-105	HUMAN OTC DRUG	Harris Teeter Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20151121		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69256-117_dda4c4bf-425f-4fff-e053-2a95a90a51bc	69256-117	HUMAN OTC DRUG	Harris Teeter Earwax Removal Drops		Carbamide Peroxide 6.5%	LIQUID	TOPICAL	20220427		OTC MONOGRAPH FINAL	part344	Harris Teeter LLC	CARBAMIDE PEROXIDE	6.5	g/100mL			N	20241231
69256-144_85cad90e-ecb9-4c87-b971-bf60578a5c2e	69256-144	HUMAN OTC DRUG	Harris Teeter Mucus Relief D		Guaifenesin, pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160916		ANDA	ANDA091071	Harris Teeter, LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
69256-161_01eb9cca-82fd-41a7-be6a-cf0e7421178a	69256-161	HUMAN OTC DRUG	Harris Teeter Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20151121		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69256-175_273420c3-f7d3-4e71-bf7a-d25f29577b96	69256-175	HUMAN OTC DRUG	Harris Teeter Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20151121		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69256-176_dd0cc1c1-04c8-43de-9564-e4215bbbbe64	69256-176	HUMAN OTC DRUG	harris teeter all day allergy d		Cetirizine HCl, Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20150724		ANDA	ANDA077170	Harris Teeter, LLC	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
69256-213_0cf5023b-7534-fac7-e063-6394a90a531f	69256-213	HUMAN OTC DRUG	Harris Teeter Iodine Tincture Mild		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	19790101		OTC MONOGRAPH DRUG	M003	Harris Teeter, LLC	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
69256-257_ab8ef16b-a54b-4cf6-b9c7-12610ffb9a76	69256-257	HUMAN OTC DRUG	Harris Teeter Allergy and Congestion Relief		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180709		ANDA	ANDA076050	Harris Teeter, LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
69256-268_f378ebf1-a5fe-419c-b3fd-1bf84affb663	69256-268	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20141031		OTC MONOGRAPH NOT FINAL	part356	Harris Teeter, LLC	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
69256-275_f3ddbde5-4d7b-4238-938b-087c3fe8f299	69256-275	HUMAN OTC DRUG	Rubbing Alcohol	70 Percent Isopropyl	Isopropyl Alcohol	LIQUID	TOPICAL	20141031		OTC MONOGRAPH NOT FINAL	part333A	Harris Teeter, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
69256-276_2717b373-6007-4bef-bfea-d11b4398d6fc	69256-276	HUMAN OTC DRUG	Isopropyl alcohol	70 percent Wintergreen	Isopropyl alcohol	LIQUID	TOPICAL	20141231		OTC MONOGRAPH NOT FINAL	part333A	Harris Teeter, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
69256-277_bd2d2db2-17f0-420e-8dc4-b06be6dab7a5	69256-277	HUMAN OTC DRUG	Isopropyl alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20170228		OTC MONOGRAPH NOT FINAL	part333A	Harris Teeter, LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
69256-293_f1a10c26-fa1f-40ee-b80f-afe1dfe4d236	69256-293	HUMAN OTC DRUG	Childrens Allergy	Dye Free	Diphenhydramine Hydrochloride	LIQUID	ORAL	20210528	20250528	OTC MONOGRAPH DRUG	M012	Harris Teeter, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69256-310_b8cb6088-52ac-45b6-941a-d5e36432fc48	69256-310	HUMAN OTC DRUG	Harris Teeter Tussin		Guaifenesin	SOLUTION	ORAL	20150924		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	GUAIFENESIN	200	mg/10mL			N	20241231
69256-337_c83fe9d7-c4ea-4f7f-bd50-1dd1c39c095d	69256-337	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough	Maximum Strength	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	LIQUID	ORAL	20210528		OTC MONOGRAPH DRUG	M012	Harris Teeter, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69256-343_21ecfe8e-136a-4498-93af-b2ffcc2dbe26	69256-343	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20210430		OTC MONOGRAPH DRUG	M012	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-344_9355aa79-cd37-4539-8b96-ba82ba712ad4	69256-344	HUMAN OTC DRUG	Night Time Cold and Flu	original	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20210430		OTC MONOGRAPH DRUG	M012	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-357_cf8f0cce-db06-4b2e-950e-07965d1d9920	69256-357	HUMAN OTC DRUG	Harris Teeter Antacid	Regular Strength	Aluminum hydroxide, Magnesium hydroxide, Simethicone	SUSPENSION	ORAL	20150330		OTC MONOGRAPH FINAL	part331	Harris Teeter, LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69256-379_7c9a9117-8bcc-4c01-b735-5091ba915a8d	69256-379	HUMAN OTC DRUG	Harris Teeter Childrens Allergy		Diphenhydramine HCl	SOLUTION	ORAL	20150624		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69256-385_a2be82d6-08e2-4538-b06a-829f2323611d	69256-385	HUMAN OTC DRUG	Tussin Cough and Chest Congestion DM	adult	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20210430		OTC MONOGRAPH DRUG	M012	Harris Teeter, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-390_1ea35d26-b6d9-4e1b-9a56-f6749509c549	69256-390	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20170228	20250228	OTC MONOGRAPH FINAL	part347	Harris Teeter, LLC	WITCH HAZEL	842	mg/mL			N	
69256-395_46dc4473-762d-41a6-978a-f0205fad8d07	69256-395	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part334	Harris Teeter, LLC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69256-397_66384803-a49e-4b2e-be34-09d0da95c0f4	69256-397	HUMAN OTC DRUG	Harris Teeter Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20151121		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69256-400_0cf50dbf-e934-7116-e063-6294a90a5b4e	69256-400	HUMAN OTC DRUG	Harris Teetter Calagesic		Zinc Acetate and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Harris Tetter, LLC.	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69256-401_7526c9b9-385f-454d-a1b0-15a8e48cb5bf	69256-401	HUMAN OTC DRUG	harris teeter acid reducer		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20150330		ANDA	ANDA202319	Harris Teeter, LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69256-413_0cf50e80-8b01-ed5f-e063-6394a90a8275	69256-413	HUMAN OTC DRUG	Harris Teeter Calamine		Zinc Oxide	LIQUID	TOPICAL	20171026		OTC MONOGRAPH DRUG	M016	Harris Teeter, LLC.	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69256-432_d9a05a0b-6049-435e-bc79-b54793aa5d42	69256-432	HUMAN OTC DRUG	Harris Teeter Sinus		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20150623		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
69256-441_e70f249b-dd0e-410d-84b3-701352f18974	69256-441	HUMAN OTC DRUG	Harris Teeter Sleep Aid		Doxylamine succinate	TABLET	ORAL	20151121		ANDA	ANDA040167	Harris Teeter, LLC	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
69256-458_ef06666e-8842-4b57-ad46-bbcd3840632a	69256-458	HUMAN OTC DRUG	Harris Teeter All Day Allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20150624		ANDA	ANDA078336	Harris Teeter, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69256-466_917756bb-218a-4377-a6b8-afc8ad4789cb	69256-466	HUMAN OTC DRUG	Daytime Cold and Flu	Non drowsy	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20210430		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69256-467_33cabeaa-54b6-4ec7-9f49-505b010e2df2	69256-467	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen Dextromethorphan HBr Phenylephrine HCI DoxylamineSucinate	KIT		20210528		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC						N	20241231
69256-486_c1a9edcb-d7a5-4049-9813-f2b01b2d837e	69256-486	HUMAN OTC DRUG	Harris Teeter Stool Softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20171024		OTC MONOGRAPH NOT FINAL	part334	Harris Teeter, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
69256-505_90b85a44-fb63-44d5-ae9a-9bbad6571944	69256-505	HUMAN OTC DRUG	Mucus Relief DM Max	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20210528		OTC MONOGRAPH DRUG	M012	Harris Teeter, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-515_0cf50e80-8b04-ed5f-e063-6394a90a8275	69256-515	HUMAN OTC DRUG	Harris Teeter Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Harris Teeter, LLC	CASTOR OIL	1	mg/mL			N	20241231
69256-516_adecf344-5b3d-40a3-9426-ad88a81b7f8a	69256-516	HUMAN OTC DRUG	Harris Teeter Tussin		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20151121		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69256-544_5f01ce69-dc19-42c8-9980-0d7e1c634752	69256-544	HUMAN OTC DRUG	Harris Teeter Arthritis Pain		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151121		ANDA	ANDA075077	Harris Teeter, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
69256-580_0d516f27-8035-41af-a462-45802764cef0	69256-580	HUMAN OTC DRUG	Harris Teeter DayTime NightTime		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20151121		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC						N	20241231
69256-590_d1d6b5fe-931d-458c-8df2-a9769698f3c7	69256-590	HUMAN OTC DRUG	Harris Teeter Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20160128		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69256-612_b5e50bd3-4505-42eb-96e9-fa851d1cfb04	69256-612	HUMAN OTC DRUG	Harris Teeter Allergy Relief		Loratadine	TABLET	ORAL	20150624		ANDA	ANDA076301	Harris Teeter, LLC	LORATADINE	10	mg/1			N	20241231
69256-656_c95c6172-5db4-4401-9dbf-52830c13324d	69256-656	HUMAN OTC DRUG	Harris Teeter DayTime		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20150924		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69256-662_0d376b0b-0988-5527-e063-6394a90acce9	69256-662	HUMAN OTC DRUG	Harris Teeter Eye Drops Advanced Relief		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20230319		OTC MONOGRAPH DRUG	M018	Harris Teeter, LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	.1; 1; 1; .05	g/100mL; g/100mL; g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
69256-732_a8470f88-4371-42be-83f8-089b425029f1	69256-732	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20210528		ANDA	ANDA207342	Harris Teeter, LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69256-733_cc2c3c93-d2f8-4cdd-bf0c-7d5d800e3069	69256-733	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20210528		ANDA	ANDA209692	Harris Teeter, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-734_86cce47a-3e3f-4d35-bd0f-076a6d427b2f	69256-734	HUMAN OTC DRUG	Harris Teeter Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150604		ANDA	ANDA203690	Harris Teeter, LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69256-742_8c50597c-6dc7-4d6b-be51-0558e9bcb64c	69256-742	HUMAN OTC DRUG	DayTime Cold Flu	Non Drowsy	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20180930	20241227	OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69256-766_3b5a633f-2d4e-49a2-b905-1563a2e9da21	69256-766	HUMAN OTC DRUG	Harris Teeter Pain and Fever	Infants	Acetaminophen	SUSPENSION	ORAL	20151121		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69256-767_d47446ff-f66e-4a6d-98ba-1883f84b4dd4	69256-767	HUMAN OTC DRUG	Harris Teeter Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20191223		UNAPPROVED DRUG OTHER		Harris T eeter, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
69256-823_0d376274-1a77-5fbc-e063-6394a90a2cf2	69256-823	HUMAN OTC DRUG	Harris Teeter Eye Drops Artificial Tears		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20190430		OTC MONOGRAPH DRUG	M018	Harris Teeter, LLC.	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69256-825_63e06c0b-664a-40ea-87ba-4f19451d0820	69256-825	HUMAN OTC DRUG	Harris Teeter Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20151121		ANDA	ANDA074760	Harris Teeter, LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69256-831_3df488a8-1d29-4140-8737-8811427accf5	69256-831	HUMAN OTC DRUG	Harris Teeter		Mineral	OIL	ORAL	20170503		OTC MONOGRAPH NOT FINAL	part334	Harris Teeter	MINERAL OIL	999	mg/mL			N	20241231
69256-834_fea10120-9e8c-4277-b166-47da8e1f91dc	69256-834	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20210528		ANDA	ANDA209692	Harris Teeter, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-837_aaab4a5f-43cf-420c-8198-7447d51acad5	69256-837	HUMAN OTC DRUG	Harris Teeter Acetaminophen PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20160613		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69256-843_0f9f6083-e0e1-477e-9fbd-dbc004974058	69256-843	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200327		ANDA	ANDA206568	Harris Teeter, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69256-860_7aeea2c3-2910-41a8-88dd-750366333bbf	69256-860	HUMAN OTC DRUG	Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20200131		OTC MONOGRAPH FINAL	part338	Harris Teeter, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69256-882_c5cee0a9-3f80-41f1-99a2-868b44c9f4cb	69256-882	HUMAN OTC DRUG	Harris Teeter Infants Gas Relief		Simethicone	EMULSION	ORAL	20150330		OTC MONOGRAPH FINAL	part332	Harris Teeter, LLC	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
69256-897_2a11b3d2-a518-4048-8cdf-3d67eaeca92f	69256-897	HUMAN OTC DRUG	Harris Teeter Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20160614		ANDA	ANDA074937	Harris Teeter, LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69256-898_e45d92ac-9430-413f-8764-4234421ffa6e	69256-898	HUMAN OTC DRUG	DayTime Cold Flu	Non Drowsy	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69256-899_36b11a6f-d0fc-4fa2-af8c-fc41b47dbb96	69256-899	HUMAN OTC DRUG	Nighttime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20210528		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69256-901_da82feb6-dbbb-46ae-a0c4-e8e4d156a4ca	69256-901	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20210528		OTC MONOGRAPH FINAL	part341	Harris Teeter, LLC						N	20241231
69256-915_9de8ecfb-edd8-4b4d-8d5a-dc591386b691	69256-915	HUMAN OTC DRUG	Harris Teeter Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20150330		NDA	NDA022032	Harris Teeter, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69256-916_6f6b567c-1b7c-4ea1-aa21-1290eb5637cd	69256-916	HUMAN OTC DRUG	Nighttime Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20200131		OTC MONOGRAPH FINAL	part338	Harris Teeter, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69256-957_131a6bec-c859-467e-a2ba-7dd0babd3106	69256-957	HUMAN OTC DRUG	Harris Teeter Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20150604		ANDA	ANDA203690	Harris Teeter, LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69256-966_3809e367-3e36-473a-8187-999f3e006c80	69256-966	HUMAN OTC DRUG	Harris Teeter Arthritis Pain		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20151121		ANDA	ANDA075077	Harris Teeter, LLC	ACETAMINOPHEN	650	mg/1			N	20241231
69256-970_0439d791-feb9-110e-e063-6394a90a4773	69256-970	HUMAN OTC DRUG	Harris Teeter		Isopropyl Alcohol	SWAB	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Harris Teeter, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
69259-0399_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0399	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Fair	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0405_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0405	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Light	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0412_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0412	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Medium	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0429_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0429	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Medium Tan	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0436_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0436	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Neutral Tan	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0443_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0443	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Rich	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0450_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0450	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Deep	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0644_73c86913-f3be-4b29-b3c7-f9065fd66d2e	69259-0644	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	FAIR	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0651_03935149-b0b2-495d-b9c9-403eca265426	69259-0651	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	LIGHT	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0668_35a395fa-570b-4220-9eab-4f3b904e9a2d	69259-0668	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	MEDIUM	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0675_f65428cd-b3ec-4a19-b586-48be965ef76d	69259-0675	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	TAN	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0682_7c250a2d-752a-4037-866a-cdbc1239c5aa	69259-0682	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	RICH	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20160809		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0719_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0719	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Neutral Medium	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-0733_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-0733	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Rich Honey	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1101_7b241c38-211f-4ed8-a5dd-02ce2b51f0dd	69259-1101	HUMAN OTC DRUG	YOUR SKIN BUT BETTER	FAIR	Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20170727		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1101_cc8ce034-19ff-4ec2-91e2-daa0ac9d4815	69259-1101	HUMAN OTC DRUG	YOUR SKIN BUT BETTER	FAIR	Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20170727		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1334_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-1334	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Fair Light	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1341_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-1341	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Light Medium	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1358_86b8bb95-03f0-4faf-9e5a-13e5529f400a	69259-1358	HUMAN OTC DRUG	Bye Bye Foundation Full Coverage Moisturizer SPF 50	Tan	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170823		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1542_73c86913-f3be-4b29-b3c7-f9065fd66d2e	69259-1542	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	FAIR	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1559_73c86913-f3be-4b29-b3c7-f9065fd66d2e	69259-1559	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	FAIR	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1566_03935149-b0b2-495d-b9c9-403eca265426	69259-1566	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	LIGHT	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1573_35a395fa-570b-4220-9eab-4f3b904e9a2d	69259-1573	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	MEDIUM	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1580_f65428cd-b3ec-4a19-b586-48be965ef76d	69259-1580	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	TAN	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1597_7c250a2d-752a-4037-866a-cdbc1239c5aa	69259-1597	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	RICH	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20160809		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1603_03935149-b0b2-495d-b9c9-403eca265426	69259-1603	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	LIGHT	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1610_35a395fa-570b-4220-9eab-4f3b904e9a2d	69259-1610	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	MEDIUM	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1627_f65428cd-b3ec-4a19-b586-48be965ef76d	69259-1627	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	TAN	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-1634_7c250a2d-752a-4037-866a-cdbc1239c5aa	69259-1634	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	RICH	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20160809		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-2372_73c86913-f3be-4b29-b3c7-f9065fd66d2e	69259-2372	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	FAIR	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-2389_03935149-b0b2-495d-b9c9-403eca265426	69259-2389	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	LIGHT	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-2396_35a395fa-570b-4220-9eab-4f3b904e9a2d	69259-2396	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	MEDIUM	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-2402_f65428cd-b3ec-4a19-b586-48be965ef76d	69259-2402	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	TAN	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-2419_7c250a2d-752a-4037-866a-cdbc1239c5aa	69259-2419	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	RICH	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20160809		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-2522_c8ea87e8-573f-43cc-bef7-3fafa3a493f6	69259-2522	HUMAN OTC DRUG	it cosmetics Your Skin But Better CC Plus Oil Free Matte Poreless Finish Full Coverage Broad Spectrum SPF 40 Sunscreen All Shades		Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	74; 63	mg/mL; mg/mL			N	20241231
69259-2888_a3ca8ffa-5eb1-488a-b77e-5cef704ccc9d	69259-2888	HUMAN OTC DRUG	it cosmetics Bye Bye Foundation Full Coverage Moisturizer Broad Spectrum 50 Plus Sunscreen All Shades		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	89; 63	mg/mL; mg/mL			N	20241231
69259-3904_ae989301-4577-49e4-90b5-eeb5b6d656c1	69259-3904	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC ILLUMINATION	FAIR	Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180306		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-3911_ae989301-4577-49e4-90b5-eeb5b6d656c1	69259-3911	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC ILLUMINATION	LIGHT	Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180306		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-3928_ae989301-4577-49e4-90b5-eeb5b6d656c1	69259-3928	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC ILLUMINATION	MEDIUM	Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180306		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-3935_ae989301-4577-49e4-90b5-eeb5b6d656c1	69259-3935	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC ILLUMINATION	TAN	Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180306		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-3942_ae989301-4577-49e4-90b5-eeb5b6d656c1	69259-3942	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC ILLUMINATION	RICH	Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180306		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-4244_4fb65bad-5e95-43e0-ac6d-8097eff66da0	69259-4244	HUMAN OTC DRUG	it cosmetics Bye Bye Foundation Full Coverage Moisturizer Oil Free Matte Broad Spectrum 50 Plus Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20190601		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	74; 63	mg/mL; mg/mL			N	20241231
69259-5908_9a1c4120-5994-49ae-9720-bc56792569c0	69259-5908	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Color Correcting Full Coverage Antiaging Hydrating Serum Broad Spectrum SPF 50 Plus Clear Sunscreen		Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20221101		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE	100; 50; 40	mg/mL; mg/mL; mg/mL			N	20241231
69259-5968_61ee5e52-fad5-43e2-aa3f-58b6dd0b79e0	69259-5968	HUMAN OTC DRUG	IT Cosmetics Your Skin But Better CC Plus Nude Glow Color Correcting Medium Coverage Skin Tint Brightening Glow Serum Broad Spectrum SPF 40 Sunscreen All Shades		Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20220318		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE	83; 45; 56	mg/mL; mg/mL; mg/mL			N	20241231
69259-7524_e7d5341b-c2fe-4f87-b88f-6e33867bca33	69259-7524	HUMAN OTC DRUG	it cosmetics Your Skin But Better CC Plus Color Correcting Broad Spectrum SPF 50 Plus Sunscreen Full Coverage Deep FairLight Neutral Tan Rich Honey LightMedium and Neutral Medium		Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180314		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
69259-7685_9c1dca06-04eb-4ffa-aa8c-bce3ec1b80ae	69259-7685	HUMAN OTC DRUG	it cosmetics Your Skin But Better CC Plus Illumination Color Correcting Illuminating Broad Spectrum SPF 50 Plus Sunscreen Full Coverage FairLight NeutralTan RichHoney LightMedium and NeutralMedium		Titanium dioxide and Zinc oxide	CREAM	TOPICAL	20180305		OTC MONOGRAPH DRUG	M020	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	90; 63	mg/mL; mg/mL			N	20241231
69259-8077_e3ae7662-8e5e-430f-b07d-5c83826fde04	69259-8077	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	MEDIUM-TAN	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-8084_e3ae7662-8e5e-430f-b07d-5c83826fde04	69259-8084	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	DEEP	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-8091_f8661a3e-9416-4845-ae2e-a2f46dca48bf	69259-8091	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC ILLUMINATION	MEDIUM-TAN	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170120		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-8107_f8661a3e-9416-4845-ae2e-a2f46dca48bf	69259-8107	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC ILLUMINATION	DEEP	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170120		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-9876_e3ae7662-8e5e-430f-b07d-5c83826fde04	69259-9876	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	MEDIUM TAN	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-9883_e3ae7662-8e5e-430f-b07d-5c83826fde04	69259-9883	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	RICH	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69259-9890_e3ae7662-8e5e-430f-b07d-5c83826fde04	69259-9890	HUMAN OTC DRUG	YOUR SKIN BUT BETTER CC COLOR CORRECTING FULL COVERAGE SPF 50	DEEP	TITANIUM DIOXIDE AND ZINC OXIDE	CREAM	TOPICAL	20170727		OTC MONOGRAPH NOT FINAL	part352	IT COSMETICS, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100mL; g/100mL			N	20241231
69263-820_0c5831ae-2019-828f-e063-6294a90a2723	69263-820	HUMAN PRESCRIPTION DRUG	Pro-C-Dure 5 Kit		kenalog	KIT	INTRA-ARTICULAR; INTRAMUSCULAR	20211004		UNAPPROVED DRUG OTHER		Oaklock, LLC						N	20241231
69263-821_0c659735-9814-912a-e063-6294a90a9051	69263-821	HUMAN PRESCRIPTION DRUG	Pro-C-Dure 6 Kit		kenalog	KIT	INTRA-ARTICULAR; INTRAMUSCULAR	20150817		UNAPPROVED DRUG OTHER		Oaklock, LLC						N	20241231
69263-822_0c575686-2b73-89b9-e063-6294a90a812a	69263-822	HUMAN PRESCRIPTION DRUG	Beta 1 Kit		Betamethasone Sodium Phosphate, Betamethasone Acetate	KIT	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR	20150825		ANDA	ANDA090747	Oaklock, LLC						N	20241231
69282-001_07626570-287c-56cf-e063-6294a90a4646	69282-001	HUMAN OTC DRUG	Nioxin Hair Regrowth Treatment for Women		Minoxidil	SOLUTION	TOPICAL	20141101		ANDA	ANDA075357	The Wella Corporation	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69282-002_07628c3a-ed61-8402-e063-6294a90ae329	69282-002	HUMAN OTC DRUG	Nioxin Hair Regrowth Treatment Extra Strength for Men		Minoxidil	SOLUTION	TOPICAL	20141101		ANDA	ANDA075598	The Wella Corporation	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69282-005_b67c989b-8972-9576-e053-2995a90aef3a	69282-005	HUMAN OTC DRUG	Nioxin Scalp Recovery	Medicating Cleanser	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20160701		OTC MONOGRAPH FINAL	part358H	The Wella Corporation	PYRITHIONE ZINC	1	g/100mL			N	20241231
69282-006_b67ccbc3-0ac6-37ff-e053-2a95a90ab124	69282-006	HUMAN OTC DRUG	Nioxin Scalp Recovery	Soothing Serum	Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20160701		OTC MONOGRAPH FINAL	part358H	The Wella Corporation	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69282-007_b67c989b-8982-9576-e053-2995a90aef3a	69282-007	HUMAN OTC DRUG	Nioxin Scalp Recovery	Medicating Cleanser	Pyrithione Zinc	LOTION	TOPICAL	20160701		OTC MONOGRAPH FINAL	part358H	The Wella Corporation	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69282-008_07a0c3aa-e99c-18c1-e063-6394a90a4fda	69282-008	HUMAN OTC DRUG	Sebastian Purist Antidandruff		pyrithione zinc	SHAMPOO	TOPICAL	20190627		OTC MONOGRAPH DRUG	M032	THE WELLA CORPORATION	PYRITHIONE ZINC	1	g/100mL			N	20241231
69286-001_0b4d8b21-21fa-dcfc-e063-6294a90aa3ab	69286-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141014		NDA	NDA205849	Advantage Respiratory Services	OXYGEN	900	mL/L			N	20241231
69291-6215_fda3bd7d-76cd-ca9b-e053-6394a90a4ec9	69291-6215	HUMAN OTC DRUG	Silagen		Zinc Oxide, Sunscreen	GEL	TOPICAL	20150601		OTC MONOGRAPH FINAL	part352	NewMedical Technology Inc.	ZINC OXIDE	20	g/100g			N	20241231
69291-6230_fda3bd7d-76cd-ca9b-e053-6394a90a4ec9	69291-6230	HUMAN OTC DRUG	Silagen		Zinc Oxide, Sunscreen	GEL	TOPICAL	20150601		OTC MONOGRAPH FINAL	part352	NewMedical Technology Inc.	ZINC OXIDE	20	g/100g			N	20241231
69291-8050_fda3bb96-7606-a5b6-e053-6294a90a792e	69291-8050	HUMAN OTC DRUG	NewGel Plus SPF		Zinc Oxide, Sunscreen	GEL	TOPICAL	20161001		OTC MONOGRAPH FINAL	part352	Newmedical Technology, Inc.	ZINC OXIDE	20	g/100g			N	20241231
69291-9020_fda3bb96-7606-a5b6-e053-6294a90a792e	69291-9020	HUMAN OTC DRUG	Bruise MD		Allantoin	GEL	TOPICAL	20190120		OTC MONOGRAPH FINAL	part347	Newmedical Technology, Inc.	ALLANTOIN	.55	g/100g			N	20241231
69292-207_6923386b-b746-42f8-b793-140a4dc1f9cc	69292-207	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190826		ANDA	ANDA070772	AMICI PHARMACEUTICALS LLC	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
69292-208_59d602e4-c806-4582-a744-321b056cd7bb	69292-208	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20191122		ANDA	ANDA070772	AMICI PHARMACEUTICALS LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
69292-265_e96671e2-f7a8-4d58-8b7f-35b9b7fab5a6	69292-265	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		PILOCARPINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220726		ANDA	ANDA076963	AMICI PHARMACEUTICALS LLC	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
69292-510_849a91fa-6412-4985-a567-528c508e6815	69292-510	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20220826		ANDA	ANDA210568	Amici Pharmaceuticals, LLC.	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69292-512_849a91fa-6412-4985-a567-528c508e6815	69292-512	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20220826		ANDA	ANDA210568	Amici Pharmaceuticals, LLC.	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69292-514_157c18ee-7809-4e05-8caa-0359ef50142e	69292-514	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20221221		ANDA	ANDA210568	Amici Pharmaceuticals, LLC.	CEFPODOXIME PROXETIL	100	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69292-516_157c18ee-7809-4e05-8caa-0359ef50142e	69292-516	HUMAN PRESCRIPTION DRUG	Cefpodoxime Proxetil		Cefpodoxime Proxetil	TABLET, FILM COATED	ORAL	20221221		ANDA	ANDA210568	Amici Pharmaceuticals, LLC.	CEFPODOXIME PROXETIL	200	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69292-522_3c84f646-b8fb-4b17-9c1f-90ed0e5e6344	69292-522	HUMAN PRESCRIPTION DRUG	captopril		captopril	TABLET	ORAL	20190820		ANDA	ANDA074677	AMICI PHARMACEUTICALS LLC	CAPTOPRIL	12.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69292-524_3c84f646-b8fb-4b17-9c1f-90ed0e5e6344	69292-524	HUMAN PRESCRIPTION DRUG	captopril		captopril	TABLET	ORAL	20190820		ANDA	ANDA074677	AMICI PHARMACEUTICALS LLC	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69292-526_3c84f646-b8fb-4b17-9c1f-90ed0e5e6344	69292-526	HUMAN PRESCRIPTION DRUG	captopril		captopril	TABLET	ORAL	20190820		ANDA	ANDA074677	AMICI PHARMACEUTICALS LLC	CAPTOPRIL	50	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69292-528_3c84f646-b8fb-4b17-9c1f-90ed0e5e6344	69292-528	HUMAN PRESCRIPTION DRUG	captopril		captopril	TABLET	ORAL	20190820		ANDA	ANDA074677	AMICI PHARMACEUTICALS LLC	CAPTOPRIL	100	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
69292-530_ce606d4c-3af5-4274-b843-d8d8fe2c96ab	69292-530	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	AMICI PHARMACEUTICALS LLC	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69292-532_ce606d4c-3af5-4274-b843-d8d8fe2c96ab	69292-532	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	AMICI PHARMACEUTICALS LLC	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69292-534_ce606d4c-3af5-4274-b843-d8d8fe2c96ab	69292-534	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	AMICI PHARMACEUTICALS LLC	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69292-536_ce606d4c-3af5-4274-b843-d8d8fe2c96ab	69292-536	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	AMICI PHARMACEUTICALS LLC	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69292-538_ce606d4c-3af5-4274-b843-d8d8fe2c96ab	69292-538	HUMAN PRESCRIPTION DRUG	Propranolol hydrochloride		Propranolol hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	AMICI PHARMACEUTICALS LLC	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69292-550_7047447f-a693-4693-a200-736b3ad58e54	69292-550	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	20201211		ANDA	ANDA076561	Amici Pharmaceuticals LLC.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69292-562_902d2f39-6ce5-46e7-8b93-9b95ce475734	69292-562	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210515		ANDA	ANDA213827	Amici Pharmaceuticals LLC.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
69292-564_902d2f39-6ce5-46e7-8b93-9b95ce475734	69292-564	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210515		ANDA	ANDA213827	Amici Pharmaceuticals LLC.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
69292-566_902d2f39-6ce5-46e7-8b93-9b95ce475734	69292-566	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210515		ANDA	ANDA213827	Amici Pharmaceuticals LLC.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
69292-580_8c9cdd3d-9751-404a-9ceb-276e8dfa6391	69292-580	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220418		ANDA	ANDA071173	Amici Pharmaceuticals, LLC	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
69292-582_8c9cdd3d-9751-404a-9ceb-276e8dfa6391	69292-582	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220418		ANDA	ANDA071173	Amici Pharmaceuticals, LLC	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
69292-584_8c9cdd3d-9751-404a-9ceb-276e8dfa6391	69292-584	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220418		ANDA	ANDA071173	Amici Pharmaceuticals, LLC	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
69292-586_8c9cdd3d-9751-404a-9ceb-276e8dfa6391	69292-586	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220418		ANDA	ANDA071173	Amici Pharmaceuticals, LLC	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
69292-588_8c9cdd3d-9751-404a-9ceb-276e8dfa6391	69292-588	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220418		ANDA	ANDA071173	Amici Pharmaceuticals, LLC	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
69292-590_8c9cdd3d-9751-404a-9ceb-276e8dfa6391	69292-590	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220418		ANDA	ANDA071173	Amici Pharmaceuticals, LLC	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
69292-605_075de7e1-ffae-b39c-e063-6294a90a7152	69292-605	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	SOLUTION	ORAL	20220610		ANDA	ANDA215209	Amici Pharmaceuticals, LLC	DIGOXIN	.05	mg/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
69292-722_82e60777-58c3-4432-b6d8-150f32091bf9	69292-722	HUMAN PRESCRIPTION DRUG	Flurbiprofen Sodium		Flurbiprofen Sodium	SOLUTION/ DROPS	OPHTHALMIC	20180331		ANDA	ANDA074447	AMICI PHARMACEUTICALS LLC	FLURBIPROFEN SODIUM	.3	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69301-001_d5f58d3a-9165-99c2-e053-2995a90afd1e	69301-001	HUMAN OTC DRUG	Top Quality Mfg. Topical Anesthetic		Benzocaine	GEL	DENTAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Top Quality Manufacturing, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69301-002_d5f57dd1-e5db-6b82-e053-2a95a90ae7db	69301-002	HUMAN OTC DRUG	Top Quality Mfg. Topical Anesthetic		Benzocaine	GEL	DENTAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Top Quality Manufacturing, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69301-003_d5f581ca-1704-ec51-e053-2a95a90a4428	69301-003	HUMAN OTC DRUG	Top Quality Mfg. Topical Anesthetic		Benzocaine	GEL	DENTAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Top Quality Manufacturing, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69301-004_d5f58f6c-aaf3-b782-e053-2995a90a4d0e	69301-004	HUMAN OTC DRUG	Top Quality Mfg. Topical Anesthetic		Benzocaine	GEL	DENTAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Top Quality Manufacturing, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69301-005_d5f58f6c-aaff-b782-e053-2995a90a4d0e	69301-005	HUMAN OTC DRUG	Top Quality Mfg. Topical Anesthetic		Benzocaine	GEL	DENTAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Top Quality Manufacturing, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69301-006_d5f58d3a-9171-99c2-e053-2995a90afd1e	69301-006	HUMAN OTC DRUG	Top Quality Mfg. Topical Anesthetic		Benzocaine	GEL	DENTAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Top Quality Manufacturing, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69301-007_d5f59666-5be7-6b88-e053-2a95a90a3cc1	69301-007	HUMAN OTC DRUG	Top Quality Mfg. Topical Anesthetic		Benzocaine	GEL	DENTAL	20140501		OTC MONOGRAPH NOT FINAL	part356	Top Quality Manufacturing, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69301-025_d606f5bb-d20e-cfdd-e053-2995a90aa9cc	69301-025	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-026_d6062348-df98-6e3d-e053-2995a90a2fe3	69301-026	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-027_d60603e7-15c8-7b01-e053-2995a90ad252	69301-027	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-028_d606694a-fb90-c36f-e053-2995a90a461c	69301-028	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-029_d60648f8-2f9b-0c8e-e053-2995a90acd94	69301-029	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-030_d6062348-dfa3-6e3d-e053-2995a90a2fe3	69301-030	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-031_d606239d-e622-0c39-e053-2995a90acaf5	69301-031	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-032_d6061877-9780-6555-e053-2a95a90a9737	69301-032	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-033_d6062cf6-8084-60a6-e053-2995a90aac7e	69301-033	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69301-034_d60637c5-dee7-8455-e053-2995a90a3c29	69301-034	HUMAN PRESCRIPTION DRUG	Top Quality Mfg APF		Sodium Fluoride	GEL	DENTAL	20140501		UNAPPROVED DRUG OTHER		Top Quality Manufacturing, Inc.	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69306-004_eb848bd5-eb69-58b1-e053-2a95a90a577e	69306-004	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	Doc Rx	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69306-016_eb848fb7-9c35-ea59-e053-2a95a90ac3ce	69306-016	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20080116		ANDA	ANDA077570	Doc Rx	FLUTICASONE PROPIONATE	50	ug/.1g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69306-020_cd0929e3-c3ce-c89a-e053-2a95a90a7b2a	69306-020	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	Doc Rx	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69306-050_c479d482-243c-2bb3-e053-2a95a90a0b0b	69306-050	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Doc Rx	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69306-075_cd092b93-57b8-bffc-e053-2a95a90a1a77	69306-075	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20180116		ANDA	ANDA078722	Doc Rx	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69306-100_cd0929e3-c3b2-c89a-e053-2a95a90a7b2a	69306-100	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20190401		ANDA	ANDA203695	Doc Rx	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
69306-111_c479d9ec-ec8d-7228-e053-2a95a90a9644	69306-111	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19830915		ANDA	ANDA088306	Doc Rx	DEXAMETHASONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69306-112_c479d9ec-ec8d-7228-e053-2a95a90a9644	69306-112	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19820826		ANDA	ANDA087916	Doc Rx	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69306-114_c479d9ec-ec8d-7228-e053-2a95a90a9644	69306-114	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	19780719		ANDA	ANDA084612	Doc Rx	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69306-250_c479da04-f3f7-fa5f-e053-2995a90a9ef8	69306-250	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210000	Doc Rx	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
69306-266_e76f4259-9a0c-b18e-e053-2995a90aede8	69306-266	HUMAN PRESCRIPTION DRUG	Ibuprofen and famotidine		Ibuprofen and famotidine	TABLET, FILM COATED	ORAL	20210804		ANDA	ANDA211890	Doc Rx	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69306-311_db68fb1f-5ead-7808-e053-2995a90a0f27	69306-311	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Doc Rx	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
69306-400_c479dc26-1a87-14c5-e053-2995a90a8aad	69306-400	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	Doc Rx	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69311-0005_0504b68b-8133-4c62-9718-98574e440982	69311-0005	HUMAN OTC DRUG	Weight Management Support		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum (Suis), Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), Aacg-A, Aacg-B, Calcarea Carbonica, Gambogia, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, 7-Keto (3-Acetyl-7-Oxo-Dehydroepiandrosterone), Adenosinum Triphosphoricum Dinatrum, Glucagon, Insulinum, Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20160623		UNAPPROVED HOMEOPATHIC		Lifetime Fat Loss Centers	7-KETO-DEHYDROEPIANDROSTERONE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GLUCAGON; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	30; 30; 8; 8; 6; 6; 12; 12; 30; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antihypoglycemic Agent [EPC], Cell-mediated Immunity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69311-0009_41f733fd-e24d-42e6-a692-03b2bde94e1e	69311-0009	HUMAN OTC DRUG	Weight Management		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum (Suis), Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gambogia, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, 7-Keto (3-Acetyl-7-Oxo-Dehydroepiandrosterone), Adenosinum Triphosphoricum Dinatrum, Insulinum, Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20190827	20240131	UNAPPROVED HOMEOPATHIC		Lifetime Fat Loss Centers	7-KETO-DEHYDROEPIANDROSTERONE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	30; 30; 8; 8; 6; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
69315-116_445bfa17-a52c-4492-9dbc-94218b30c1db	69315-116	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Leading Pharma, LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69315-117_445bfa17-a52c-4492-9dbc-94218b30c1db	69315-117	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Leading Pharma, LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69315-118_445bfa17-a52c-4492-9dbc-94218b30c1db	69315-118	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Leading Pharma, LLC	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69315-127_92322e52-3179-4738-8c8a-14fef62311d4	69315-127	HUMAN PRESCRIPTION DRUG	FOLIC ACID		FOLIC ACID	TABLET	ORAL	20090112		ANDA	ANDA040796	Leading Pharma, LLC	FOLIC ACID	1	mg/1			N	20241231
69315-130_c0e8b578-c86a-4d9d-9bfb-c32976fcdc6b	69315-130	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20160401		ANDA	ANDA040702	Leading Pharma, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69315-131_c0e8b578-c86a-4d9d-9bfb-c32976fcdc6b	69315-131	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20160401		ANDA	ANDA040702	Leading Pharma, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69315-133_d68e4e6a-ae70-4f94-b19a-32b58b5d1d8b	69315-133	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20160407		ANDA	ANDA040903	Leading Pharma, LLC	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-134_d68e4e6a-ae70-4f94-b19a-32b58b5d1d8b	69315-134	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20160407		ANDA	ANDA040903	Leading Pharma, LLC	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-135_d68e4e6a-ae70-4f94-b19a-32b58b5d1d8b	69315-135	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20160407		ANDA	ANDA040903	Leading Pharma, LLC	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-136_f61e0118-7898-42cf-9e27-e5f2dabe6ea4	69315-136	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20121128		ANDA	ANDA090168	Leading Pharma, LLC	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
69315-137_f61e0118-7898-42cf-9e27-e5f2dabe6ea4	69315-137	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20121128		ANDA	ANDA090168	Leading Pharma, LLC	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
69315-138_f61e0118-7898-42cf-9e27-e5f2dabe6ea4	69315-138	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20121128		ANDA	ANDA090168	Leading Pharma, LLC	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
69315-139_08c87c2b-682a-4c9e-add5-70e3b8d7b973	69315-139	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20180922		ANDA	ANDA090195	Leading Pharma, LLC	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
69315-140_08c87c2b-682a-4c9e-add5-70e3b8d7b973	69315-140	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20180922		ANDA	ANDA090195	Leading Pharma, LLC	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
69315-155_c0e8b578-c86a-4d9d-9bfb-c32976fcdc6b	69315-155	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20191101		ANDA	ANDA040702	Leading Pharma, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69315-158_472664f9-ac9d-408e-9077-a711815717a0	69315-158	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210415		ANDA	ANDA211619	Leading Pharma, LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-159_472664f9-ac9d-408e-9077-a711815717a0	69315-159	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210415		ANDA	ANDA211619	Leading Pharma, LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-160_472664f9-ac9d-408e-9077-a711815717a0	69315-160	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210415		ANDA	ANDA211619	Leading Pharma, LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-161_472664f9-ac9d-408e-9077-a711815717a0	69315-161	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210415		ANDA	ANDA211619	Leading Pharma, LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-162_472664f9-ac9d-408e-9077-a711815717a0	69315-162	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210415		ANDA	ANDA211619	Leading Pharma, LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-163_175fe510-713b-46fe-8630-bdc88f32cd81	69315-163	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210415		ANDA	ANDA211618	Leading Pharma, LLC	DOXEPIN HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-164_bdd2125d-d24c-4494-8dfc-d3d365c7ae5c	69315-164	HUMAN PRESCRIPTION DRUG	HYDROXYUREA		HYDROXYUREA	CAPSULE	ORAL	20200709		ANDA	ANDA213438	Leading Pharma, LLC	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
69315-165_9be56bf0-c664-4574-b715-b2ecbb2d84ce	69315-165	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200310		ANDA	ANDA211364	Leading Pharma, LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-166_9be56bf0-c664-4574-b715-b2ecbb2d84ce	69315-166	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200310		ANDA	ANDA211364	Leading Pharma, LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-167_9be56bf0-c664-4574-b715-b2ecbb2d84ce	69315-167	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200310		ANDA	ANDA211364	Leading Pharma, LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69315-174_4edfa8df-c8f9-4442-8fa0-21c145c64fe1	69315-174	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	SUSPENSION	ORAL	20220601		ANDA	ANDA214949	Leading Pharma, LLC	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20251231
69315-182_da4b3e8b-09d1-4ef3-a24a-ef078f13bd92	69315-182	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20191101		ANDA	ANDA212798	Leading Pharma, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69315-184_f6c54ab5-7d54-4530-955d-206903b9dcad	69315-184	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	TABLET	ORAL	20201116		ANDA	ANDA213929	Leading Pharma, LLC	LEUCOVORIN CALCIUM	5	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
69315-185_f6c54ab5-7d54-4530-955d-206903b9dcad	69315-185	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	TABLET	ORAL	20201116		ANDA	ANDA213929	Leading Pharma, LLC	LEUCOVORIN CALCIUM	10	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
69315-186_f6c54ab5-7d54-4530-955d-206903b9dcad	69315-186	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	TABLET	ORAL	20201116		ANDA	ANDA213929	Leading Pharma, LLC	LEUCOVORIN CALCIUM	15	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
69315-187_f6c54ab5-7d54-4530-955d-206903b9dcad	69315-187	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	TABLET	ORAL	20201116		ANDA	ANDA213929	Leading Pharma, LLC	LEUCOVORIN CALCIUM	25	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
69315-211_a607bc3d-16ea-433c-b575-0acf8254c5e0	69315-211	HUMAN PRESCRIPTION DRUG	NIFEdipine		NIFEdipine	CAPSULE	ORAL	20161123		ANDA	ANDA073250	Leading Pharma, LLC	NIFEDIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69315-212_cbea7f1e-ca83-42dd-9723-ced0b26af334	69315-212	HUMAN PRESCRIPTION DRUG	NIFEDIPINE		NIFEDIPINE	CAPSULE	ORAL	20161123		ANDA	ANDA074045	Leading Pharma, LLC	NIFEDIPINE	20	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69315-226_e3d2a7aa-e63e-479b-97d0-98bcda025b2e	69315-226	HUMAN PRESCRIPTION DRUG	THEOPHYLLINE		THEOPHYLLINE	TABLET, EXTENDED RELEASE	ORAL	20230515		ANDA	ANDA214950	Leading Pharma, LLC	THEOPHYLLINE	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
69315-227_e3d2a7aa-e63e-479b-97d0-98bcda025b2e	69315-227	HUMAN PRESCRIPTION DRUG	THEOPHYLLINE		THEOPHYLLINE	TABLET, EXTENDED RELEASE	ORAL	20230515		ANDA	ANDA214950	Leading Pharma, LLC	THEOPHYLLINE	450	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
69315-236_a3e23d12-00dc-4474-b995-7cacd29f93de	69315-236	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		MEXILETINE HYDROCHLORIDE	CAPSULE	ORAL	20230727		ANDA	ANDA215876	Leading Pharma, LLC	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
69315-237_a3e23d12-00dc-4474-b995-7cacd29f93de	69315-237	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		MEXILETINE HYDROCHLORIDE	CAPSULE	ORAL	20230727		ANDA	ANDA215876	Leading Pharma, LLC	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
69315-238_a3e23d12-00dc-4474-b995-7cacd29f93de	69315-238	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		MEXILETINE HYDROCHLORIDE	CAPSULE	ORAL	20230727		ANDA	ANDA215876	Leading Pharma, LLC	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
69315-260_06712ce8-8fcc-4ee6-aa43-1cabcadfb916	69315-260	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	TABLET, FILM COATED	ORAL	20230723		ANDA	ANDA215745	Leading Pharma, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69315-275_1d4a25f0-1299-4d73-92f8-13154729a8cc	69315-275	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	CAPSULE, LIQUID FILLED	ORAL	20220324		NDA AUTHORIZED GENERIC	NDA022202	Leading Pharma, LLC	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69315-281_999a762b-5f7b-4750-8b48-7ddf77203dd2	69315-281	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID		FENOFIBRIC ACID	CAPSULE, DELAYED RELEASE	ORAL	20190718		ANDA	ANDA211626	Leading Pharma, LLC	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69315-282_999a762b-5f7b-4750-8b48-7ddf77203dd2	69315-282	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID		FENOFIBRIC ACID	CAPSULE, DELAYED RELEASE	ORAL	20190718		ANDA	ANDA211626	Leading Pharma, LLC	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69315-283_b0329bda-d477-4eed-815c-1049532e1bb0	69315-283	HUMAN PRESCRIPTION DRUG	ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE		ESTERIFIED ESTROGENS, METHYLTESTOSTERONE	TABLET	ORAL	20221001		UNAPPROVED DRUG OTHER		Leading Pharmaceuticals, LLC	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	.625; 1.25	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
69315-284_b0329bda-d477-4eed-815c-1049532e1bb0	69315-284	HUMAN PRESCRIPTION DRUG	ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE		ESTERIFIED ESTROGENS, METHYLTESTOSTERONE	TABLET	ORAL	20221001		UNAPPROVED DRUG OTHER		Leading Pharmaceuticals, LLC	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	1.25; 2.5	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20251231
69315-285_f356d1ba-3572-4a79-9846-94ee2030f04b	69315-285	HUMAN PRESCRIPTION DRUG	ETRAVIRINE		ETRAVIRINE	TABLET	ORAL	20220605		ANDA	ANDA215402	Leading Pharma, LLC	ETRAVIRINE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
69315-286_f356d1ba-3572-4a79-9846-94ee2030f04b	69315-286	HUMAN PRESCRIPTION DRUG	ETRAVIRINE		ETRAVIRINE	TABLET	ORAL	20220605		ANDA	ANDA215402	Leading Pharma, LLC	ETRAVIRINE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
69315-287_256d68e4-5603-401b-b20a-6bd7a936c6a8	69315-287	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20220718		ANDA	ANDA211122	Leading Pharma, LLC	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69315-288_256d68e4-5603-401b-b20a-6bd7a936c6a8	69315-288	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20220718		ANDA	ANDA211122	Leading Pharma, LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69315-289_85129477-f246-4f5e-895c-7c2e1dda1896	69315-289	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20220820		ANDA	ANDA210606	Leading Pharma, LLC	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69315-290_85129477-f246-4f5e-895c-7c2e1dda1896	69315-290	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20220820		ANDA	ANDA210606	Leading Pharma, LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69315-291_5aadc35e-aa8a-4018-b456-c88c9884d6f6	69315-291	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230403		ANDA	ANDA214443	Leading Pharma, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
69315-292_5aadc35e-aa8a-4018-b456-c88c9884d6f6	69315-292	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230403		ANDA	ANDA214443	Leading Pharma, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
69315-301_97a3ef32-4387-45ae-80b9-faceaf833a9c	69315-301	HUMAN OTC DRUG	RectaSmoothe		Lidocaine 5%	CREAM	TOPICAL	20110401		OTC MONOGRAPH FINAL	part346	Leading Pharma, LLC	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69315-304_5c9a6cd0-6ad4-4862-b6ca-22f4c9768890	69315-304	HUMAN PRESCRIPTION DRUG	Dorzolamide hydrochloride		Dorzolamide hydrochloride	SOLUTION	OPHTHALMIC	20191201		ANDA	ANDA205294	Leading Pharma, LLC	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
69315-305_be87baf2-ac60-4540-8cf2-1d6be01acff8	69315-305	HUMAN PRESCRIPTION DRUG	Dorzolamide and Timolol		Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution	SOLUTION	OPHTHALMIC	20170518		ANDA	ANDA205295	Leading Pharma, LLC	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69315-306_537f7da0-c60f-4c3f-9f74-ce5bd49dddc6	69315-306	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	POWDER	TOPICAL	20180423		ANDA	ANDA208838	Leading Pharma, LLC	NYSTATIN	100000	1/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
69315-307_520822eb-a9f1-4017-9a73-1979ee53f4e9	69315-307	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	OINTMENT	TOPICAL	20190819		ANDA	ANDA209082	Leading Pharma, LLC	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
69315-308_a42d7cc0-22bd-f683-e053-2995a90a91ec	69315-308	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20181101		ANDA	ANDA077568	Leading Pharma, LLC	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
69315-312_f28d7c04-0990-4b94-ad73-a914aef50364	69315-312	HUMAN PRESCRIPTION DRUG	Procto-Med HC		HYDROCORTISONE	CREAM	TOPICAL	20200214		ANDA	ANDA085025	Leading Pharma, LLC	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69315-318_a6251270-fa62-4c7c-9bb4-ca0d88ec77b3	69315-318	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20230206		ANDA	ANDA216461	Leading Pharma, LLC	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69315-402_73d01bd5-c900-436d-8a67-de772f720875	69315-402	HUMAN PRESCRIPTION DRUG	VARENICLINE TARTRATE		VARENICLINE TARTRATE	TABLET, FILM COATED	ORAL	20231001		ANDA	ANDA217151	Leading Pharma, LLC	VARENICLINE TARTRATE	.5	mg/561	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
69315-403_73d01bd5-c900-436d-8a67-de772f720875	69315-403	HUMAN PRESCRIPTION DRUG	VARENICLINE TARTRATE		VARENICLINE TARTRATE	TABLET, FILM COATED	ORAL	20231001		ANDA	ANDA217151	Leading Pharma, LLC	VARENICLINE TARTRATE	1	mg/561	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
69315-404_73d01bd5-c900-436d-8a67-de772f720875	69315-404	HUMAN PRESCRIPTION DRUG	VARENICLINE TARTRATE		VARENICLINE TARTRATE	KIT		20231001		ANDA	ANDA217151	Leading Pharma, LLC						N	20241231
69315-504_65730b91-5b22-4bfa-a3ca-13f12c7a2eed	69315-504	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	SUSPENSION	ORAL	20221205		ANDA	ANDA214346	Leading Pharma, LLC	NYSTATIN	100000	[USP'U]/mL	Polyene Antifungal [EPC], Polyenes [CS]		N	20251231
69315-506_9c24af27-0a21-4fb7-a8fb-55c92373b852	69315-506	HUMAN PRESCRIPTION DRUG	DICLOFENAC POTASSIUM		DICLOFENAC POTASSIUM	POWDER, FOR SOLUTION	ORAL	20221220		NDA AUTHORIZED GENERIC	NDA022165	Leading Pharma, LLC	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
69315-701_f07b4be7-32d2-4173-8a3a-75065b78079d	69315-701	HUMAN PRESCRIPTION DRUG	ETHACRYNATE SODIUM		ETHACRYNATE SODIUM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201015		ANDA	ANDA208663	Leading Pharma, LLC	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69315-904_40249bb6-0d25-4b2f-aa4b-85c15af6bf8b	69315-904	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	Leading Pharma, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69315-905_40249bb6-0d25-4b2f-aa4b-85c15af6bf8b	69315-905	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	Leading Pharma, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69315-906_40249bb6-0d25-4b2f-aa4b-85c15af6bf8b	69315-906	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	Leading Pharma, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69315-910_af054a1c-a0a1-4097-8170-3e7b070ad830	69315-910	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	Leading Pharma, LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
69335-001_9d34a4ae-ab30-7542-e053-2a95a90ae476	69335-001	HUMAN OTC DRUG	Alpha BAC Stop E-2		CHLOROXYLENOL	SOLUTION	TOPICAL	20141104		OTC MONOGRAPH NOT FINAL	part333A	Alpha Chemical Services, Inc.	CHLOROXYLENOL	1.5	g/100mL			N	20241231
69335-002_9d3464ae-4f4e-102b-e053-2995a90af3de	69335-002	HUMAN OTC DRUG	Alpha E-3 Instant Hand Sanitizer		Ethanol	SPRAY	TOPICAL	20141104		OTC MONOGRAPH NOT FINAL	part333E	Alpha Chemical Services, Inc.	ALCOHOL	710	g/1000mL			N	20241231
69339-136_5efc8ca3-615b-4550-b8fb-c981bb4d84ed	69339-136	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190322		ANDA	ANDA210363	Natco Pharma USA LLC	DIAZEPAM	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69339-137_2ca4b440-fd2b-4f20-b44b-7e0c01cbf6d6	69339-137	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20221020		ANDA	ANDA211998	Natco Pharma USA LLC	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69339-137_5bec8040-d103-440c-8cd4-0c91608bb3e3	69339-137	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200701		ANDA	ANDA211998	Natco Pharma USA LLC	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69339-138_2e6b1725-1082-4541-9725-2fb49ae15817	69339-138	HUMAN PRESCRIPTION DRUG	DASH Chlorhexidine Gluconate 0.12% Oral Rinse		Chlorhexidine Gluconate 0.12% Oral Rinse	LIQUID	ORAL	20180425		ANDA	ANDA074291	Natco Pharma USA LLC	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
69339-148_4f2d0850-0a70-4509-aed1-8844b5f095c6	69339-148	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	SUSPENSION	ORAL	20210127		NDA	NDA019183	Natco Pharma USA LLC	SUCRALFATE	1	g/10mL	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
69339-149_6bc4ec89-dcf0-4e03-ac41-abb85c1a5efd	69339-149	HUMAN OTC DRUG	Guaifenesin Syrup and Dextromethorphan		Guaifenesin Syrup and Dextromethorphan	SYRUP	ORAL	20201019		OTC MONOGRAPH DRUG	M012	Natco Pharma USA LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69339-150_6bc4ec89-dcf0-4e03-ac41-abb85c1a5efd	69339-150	HUMAN OTC DRUG	Guaifenesin Syrup and Dextromethorphan		Guaifenesin Syrup and Dextromethorphan	SYRUP	ORAL	20201019		OTC MONOGRAPH DRUG	M012	Natco Pharma USA LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69339-151_6c998d25-3573-4c6b-822a-1c16eeddd642	69339-151	HUMAN OTC DRUG	Diphenhydramine HCl Oral Solution		diphenhydramine hydrochloride	SOLUTION	ORAL	20201214		OTC MONOGRAPH DRUG	M012	Natco Pharma USA LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69339-152_6c998d25-3573-4c6b-822a-1c16eeddd642	69339-152	HUMAN OTC DRUG	Diphenhydramine HCl Oral Solution		diphenhydramine hydrochloride	SOLUTION	ORAL	20201214		OTC MONOGRAPH DRUG	M012	Natco Pharma USA LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69339-153_4bc3038a-573b-40e4-909f-b67f30c0a1db	69339-153	HUMAN OTC DRUG	milk of magnesia		magnesium hydroxide	SUSPENSION	ORAL	20211227		OTC MONOGRAPH DRUG	M007	Natco Pharma USA LLC	MAGNESIUM HYDROXIDE	2400	mg/30mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69339-157_2ec94a03-8590-4617-a6e6-782e0aae7037	69339-157	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20210131		ANDA	ANDA203052	Natco Pharma USA LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69339-158_4a4930e7-f65c-4293-8590-f0d673b8485e	69339-158	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	SOLUTION	TOPICAL	20210712		ANDA	ANDA212301	Natco Pharma USA LLC	TESTOSTERONE	30	mg/1.5mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
69339-159_2af07b39-fe93-4961-90cb-ed9c5e2f424d	69339-159	HUMAN PRESCRIPTION DRUG	Itraconazole Oral		Itraconazole	SOLUTION	ORAL	20220425		ANDA	ANDA212239	Natco Pharma USA LLC	ITRACONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69339-160_1eab62f4-fc42-489f-860e-543882a0795d	69339-160	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20230731		ANDA	ANDA075671	Natco Pharma USA LLC	MEGESTROL ACETATE	40	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
69339-162_6df395b5-aab5-47f8-9a3b-28eecb59c33e	69339-162	HUMAN PRESCRIPTION DRUG	LUBIPROSTONE		LUBIPROSTONE	CAPSULE	ORAL	20221017		NDA AUTHORIZED GENERIC	NDA021908	Natco Pharma USA LLC	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
69339-163_6df395b5-aab5-47f8-9a3b-28eecb59c33e	69339-163	HUMAN PRESCRIPTION DRUG	LUBIPROSTONE		LUBIPROSTONE	CAPSULE	ORAL	20221017		NDA AUTHORIZED GENERIC	NDA021908	Natco Pharma USA LLC	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
69339-168_5040d82b-d57a-46c3-a888-414848563438	69339-168	HUMAN PRESCRIPTION DRUG	Gefitinib		Gefitinib	TABLET, FILM COATED	ORAL	20230605		ANDA	ANDA212827	Natco Pharma USA LLC	GEFITINIB	250	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
69339-169_70bc9344-abbf-4aca-96c0-7f10cfe9aae4	69339-169	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET	ORAL	20230617		ANDA	ANDA209555	Natco Pharma USA LLC	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20251231
69339-170_70bc9344-abbf-4aca-96c0-7f10cfe9aae4	69339-170	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET	ORAL	20230617		ANDA	ANDA209555	Natco Pharma USA LLC	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20251231
69339-171_6d27f218-e964-4ae5-8dc7-fa8b4bda500f	69339-171	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20221024		ANDA	ANDA077851	Natco Pharma USA LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69339-172_6d27f218-e964-4ae5-8dc7-fa8b4bda500f	69339-172	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20221024		ANDA	ANDA077851	Natco Pharma USA LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69339-173_aeb4c868-1d42-4183-b86f-4ae1dc0aa6d3	69339-173	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20221003		ANDA	ANDA211604	Natco Pharma USA LLC	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
69339-174_aeb4c868-1d42-4183-b86f-4ae1dc0aa6d3	69339-174	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20221003		ANDA	ANDA211604	Natco Pharma USA LLC	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
69339-175_aeb4c868-1d42-4183-b86f-4ae1dc0aa6d3	69339-175	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20221003		ANDA	ANDA211604	Natco Pharma USA LLC	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
69339-177_de2f0921-e791-426c-9192-2b7162e2158c	69339-177	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20230323		ANDA	ANDA202768	DASH Pharmaceuticals LLC	ARMODAFINIL	50	mg/1		CIV	N	20241231
69339-178_de2f0921-e791-426c-9192-2b7162e2158c	69339-178	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20230323		ANDA	ANDA202768	DASH Pharmaceuticals LLC	ARMODAFINIL	150	mg/1		CIV	N	20241231
69339-179_de2f0921-e791-426c-9192-2b7162e2158c	69339-179	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20230323		ANDA	ANDA202768	DASH Pharmaceuticals LLC	ARMODAFINIL	200	mg/1		CIV	N	20241231
69339-180_de2f0921-e791-426c-9192-2b7162e2158c	69339-180	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20230323		ANDA	ANDA202768	DASH Pharmaceuticals LLC	ARMODAFINIL	250	mg/1		CIV	N	20241231
69339-181_856d65dc-f330-4195-b271-d0bdbe99519d	69339-181	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014		ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69339-182_856d65dc-f330-4195-b271-d0bdbe99519d	69339-182	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014		ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69339-183_856d65dc-f330-4195-b271-d0bdbe99519d	69339-183	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014		ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69339-184_856d65dc-f330-4195-b271-d0bdbe99519d	69339-184	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014		ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69339-185_856d65dc-f330-4195-b271-d0bdbe99519d	69339-185	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014		ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69339-186_856d65dc-f330-4195-b271-d0bdbe99519d	69339-186	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014		ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69339-199_d205e7df-6526-4c47-90bb-d4479ba12033	69339-199	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230728		ANDA	ANDA200739	Natco Pharma USA LLC	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69339-200_d205e7df-6526-4c47-90bb-d4479ba12033	69339-200	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230728		ANDA	ANDA200739	Natco Pharma USA LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69339-201_d205e7df-6526-4c47-90bb-d4479ba12033	69339-201	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230728		ANDA	ANDA200739	Natco Pharma USA LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69339-202_d205e7df-6526-4c47-90bb-d4479ba12033	69339-202	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230728		ANDA	ANDA200739	Natco Pharma USA LLC	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
69343-121_850f0387-d884-4ef1-9ee6-36661c4fcde4	69343-121	HUMAN OTC DRUG	Elyptol Antimicrobial Hand Gel		Ethanol	GEL	TOPICAL	20141101		OTC MONOGRAPH NOT FINAL	part333A	Elyptol Inc.	ALCOHOL	7	mL/10mL			N	20241231
69343-221_c47506d3-a699-4f9a-b9bd-6f26219d8fa0	69343-221	HUMAN OTC DRUG	Elyptol Antimicrobial Rub		Ethanol	SOLUTION	TOPICAL	20141101		OTC MONOGRAPH NOT FINAL	part333A	Elyptol Inc.	ALCOHOL	7	mL/10mL			N	20241231
69343-222_228bd35d-7546-49f1-b9e6-708b790d2286	69343-222	HUMAN OTC DRUG	elyptol ANTIMICROBIAL MOISTURIZING HAND SANITIZER		Ethyl Alcohol	SPRAY	TOPICAL	20201021		OTC MONOGRAPH NOT FINAL	part333A	Elyptol Inc.	ALCOHOL	70	mL/100mL			N	20241231
69343-421_d8b2683b-636f-482f-8943-736c5a441097	69343-421	HUMAN OTC DRUG	Elyptol Light Scent- Antimicrobial Hand Gel		Ethanol	GEL	TOPICAL	20160601		OTC MONOGRAPH NOT FINAL	part333A	ELYPTOL INC.	ALCOHOL	7	mL/10mL			N	20241231
69343-521_bf6d4352-dc20-4f1d-99ff-e9e85ddb1513	69343-521	HUMAN OTC DRUG	Elyptol Light Scent Antimicrobial		Ethanol	SPRAY	TOPICAL	20160601		OTC MONOGRAPH NOT FINAL	part333A	ELYPTOL INC.	ALCOHOL	7	mL/10mL			N	20241231
69344-101_f12331c3-419d-4797-9f43-b28289acd0b4	69344-101	HUMAN PRESCRIPTION DRUG	Indocin		indomethacin	SUSPENSION	ORAL	20190204		NDA	NDA018332	Zyla Life Sciences US LLC	INDOMETHACIN	25	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69344-102_848f696a-1807-4425-8904-fdeb275f939d	69344-102	HUMAN PRESCRIPTION DRUG	INDOCIN		Indomethacin	SUPPOSITORY	RECTAL	19920831		ANDA	ANDA073314	Zyla Life Sciences US LLC	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69344-113_c4122474-c904-4f43-85d8-6de6f8f0f0d3	69344-113	HUMAN PRESCRIPTION DRUG	OXAYDO		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20150901		NDA	NDA202080	Zyla Life Sciences US LLC	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
69344-144_f1358780-ada4-44e5-8a19-54a729d14b38	69344-144	HUMAN PRESCRIPTION DRUG	Sprix		ketorolac tromethamine	SPRAY, METERED	NASAL	20110426		NDA	NDA022382	Zyla Life Sciences US LLC	KETOROLAC TROMETHAMINE	15.75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69344-213_c4122474-c904-4f43-85d8-6de6f8f0f0d3	69344-213	HUMAN PRESCRIPTION DRUG	OXAYDO		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20150901		NDA	NDA202080	Zyla Life Sciences US LLC	OXYCODONE HYDROCHLORIDE	7.5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
69345-200_83ad0fce-61bd-425f-ab57-02cab0c2a3bc	69345-200	HUMAN OTC DRUG	Altitude Medical Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20161207		OTC MONOGRAPH NOT FINAL	part333E	Altitude Medical	ALCOHOL	69.8	mL/100mL			N	20241231
69366-211_eea45f30-6df4-40d3-e053-2a95a90aea65	69366-211	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2.4; 13	mg/100mL; mg/100mL			N	20241231
69366-214_eea48655-aa6d-c74f-e053-2a95a90aa56f	69366-214	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2.4; 13	mg/100mL; mg/100mL			N	20241231
69366-215_eea49213-f997-c0f8-e053-2a95a90af19d	69366-215	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2.4; 13	mg/100mL; mg/100mL			N	20241231
69366-216_eea49463-720b-12d8-e053-2995a90ac3f5	69366-216	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2.4; 13	mg/100mL; mg/100mL			N	20241231
69366-217_eea49877-6cd7-66be-e053-2995a90a11c7	69366-217	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2.4; 13	mg/100mL; mg/100mL			N	20241231
69366-218_eea49d43-f637-116e-e053-2a95a90ad7b7	69366-218	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2.4; 13	mg/100mL; mg/100mL			N	20241231
69366-223_0bcac538-af49-c0f1-e063-6394a90a8e7a	69366-223	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	ZINC OXIDE	13	mg/100mL			N	20241231
69366-224_eea4a5c6-72a1-de41-e053-2995a90ad87e	69366-224	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	ZINC OXIDE	13	mg/100mL			N	20241231
69366-225_eea58d52-ed2d-172e-e053-2a95a90aef96	69366-225	HUMAN OTC DRUG	CCC Clean Corrective with Vitamin C Tinted Moisturizer Broad Spectrum SPF 30		Zinc Oxide	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	The Honest Company, Inc.	ZINC OXIDE	13	mg/100mL			N	20241231
69366-310_b9bf2f13-c3c8-baa9-e053-2995a90ad0a5	69366-310	HUMAN OTC DRUG	Hand Sanitizer	Coastal Surf	62% Ethyl Alcohol	SPRAY	TOPICAL	20170731		OTC MONOGRAPH NOT FINAL	part333A	The Honest Company	ALCOHOL	62	mL/100mL			N	20241231
69366-311_b9bf16a5-784d-44bc-e053-2995a90ade44	69366-311	HUMAN OTC DRUG	Hand Sanitizer	Free and Clear	62% Ethyl Alcohol	SPRAY	TOPICAL	20170731		OTC MONOGRAPH NOT FINAL	part333A	The Honest Company	ALCOHOL	62	mL/100mL			N	20241231
69366-312_b9bf3362-dc19-3897-e053-2a95a90ad8cb	69366-312	HUMAN OTC DRUG	Hand Sanitizer	Graepfruit Grove	62% Ethyl Alcohol	SPRAY	TOPICAL	20170731		OTC MONOGRAPH NOT FINAL	part333A	The Honest Company	ALCOHOL	62	mL/100mL			N	20241231
69366-316_0ce3e7ee-aa51-16bc-e063-6294a90a527d	69366-316	HUMAN OTC DRUG	Sanitizing Wipes Fragrance Free		Alcohol	CLOTH	TOPICAL	20230201		OTC MONOGRAPH DRUG	M003	The Honest Company	ALCOHOL	65	mL/100mL			N	20241231
69366-317_0ce1edfd-7217-e6d8-e063-6394a90ada61	69366-317	HUMAN OTC DRUG	Sanitizing wipes with aloe Grapefruit Grove		ALCOHOL	CLOTH	TOPICAL	20220501		OTC MONOGRAPH DRUG	M003	The Honest Company	ALCOHOL	65	mL/100mL			N	20241231
69366-318_f438f430-d6ed-eb58-e053-2995a90ae20a	69366-318	HUMAN OTC DRUG	Sanitizing wipes with aloe Lavender Field		ALCOHOL	CLOTH	TOPICAL	20220501	20240630	OTC MONOGRAPH DRUG	M003	The Honest Company	ALCOHOL	65	mL/100mL			N	
69366-412_0ce46087-f196-a862-e063-6294a90aa421	69366-412	HUMAN OTC DRUG	Spot Stopper Acne Spot Treatment		Salicylic Acid	GEL	TOPICAL	20220501		OTC MONOGRAPH DRUG	M006	The Honest Company, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
69366-413_0ce464c9-f393-df0e-e063-6394a90a7230	69366-413	HUMAN OTC DRUG	Get Clarity Foaming Acne Cleanser		Sulfur	CREAM	TOPICAL	20220501		OTC MONOGRAPH DRUG	M006	The Honest Company, Inc	SULFUR	3.3	g/100mL			N	20241231
69366-414_0ce46076-c2ed-251d-e063-6294a90a3d36	69366-414	HUMAN OTC DRUG	In the Clear Acne Serum		Salicylic Acid	LIQUID	TOPICAL	20220501		OTC MONOGRAPH DRUG	M006	The Honest Company, Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
69366-503_e8cc80b7-6294-1ea6-e053-2995a90a6cae	69366-503	HUMAN OTC DRUG	Honest Eczema Balm		Colloidal Oatmeal	OINTMENT	TOPICAL	20190701		OTC MONOGRAPH FINAL	M016	The Honest Company, Inc.	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69366-504_f071be22-2e95-72e5-e053-2a95a90a7664	69366-504	HUMAN OTC DRUG	Honest Eczema Cream		Colloidal Oatmeal	CREAM	TOPICAL	20190701		OTC MONOGRAPH DRUG	M016	The Honest Company, Inc.	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69366-505_eea2ae69-c25a-a9e0-e053-2a95a90a144b	69366-505	HUMAN OTC DRUG	Calm and Heal Melting Balm		Allantoin	CREAM	TOPICAL	20200929		OTC MONOGRAPH DRUG	M016	The Honest Company, Inc.	ALLANTOIN	.5	g/100g			N	20241231
69366-507_f564ef0b-3cd2-6745-e053-2a95a90a1dea	69366-507	HUMAN OTC DRUG	Everyday Diaper Rash Cream		Zinc Oxide	CREAM	TOPICAL	20230417		OTC MONOGRAPH DRUG	M016	The Honest Company, Inc	ZINC OXIDE	14	g/100g			N	20241231
69366-508_f5651e4b-5d84-0a6c-e053-2a95a90a0555	69366-508	HUMAN OTC DRUG	Healing Head to Toe		Allantoin	OINTMENT	TOPICAL	20230306		OTC MONOGRAPH DRUG	M016	The Honest Company, Inc	ALLANTOIN	.5	g/100g			N	20241231
69366-509_0ce7fe34-2c97-cffd-e063-6294a90a81b7	69366-509	HUMAN OTC DRUG	Sprayable Diaper Rash Cream		Zinc Oxide	SPRAY	TOPICAL	20220606		OTC MONOGRAPH DRUG	M016	The Honest Company, Inc.	ZINC OXIDE	10	g/100mL			N	20241231
69367-131_c7304051-6eae-403b-9f3c-e04be1b0d892	69367-131	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Westminster Pharmaceuticals, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-132_c7304051-6eae-403b-9f3c-e04be1b0d892	69367-132	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Westminster Pharmaceuticals, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-133_c7304051-6eae-403b-9f3c-e04be1b0d892	69367-133	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Westminster Pharmaceuticals, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-134_1647af99-e383-471a-a4fd-15dad8bfc4e3	69367-134	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160411		ANDA	ANDA205101	Westminster Pharmaceuticals, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-135_1647af99-e383-471a-a4fd-15dad8bfc4e3	69367-135	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160411		ANDA	ANDA205101	Westminster Pharmaceuticals, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-137_12e91d37-d793-4a08-9455-fefe6eb0d2c7	69367-137	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230620		ANDA	ANDA210401	Westminster Pharmaceuticals, LLC	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69367-138_12e91d37-d793-4a08-9455-fefe6eb0d2c7	69367-138	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230620		ANDA	ANDA210401	Westminster Pharmaceuticals, LLC	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69367-160_30852376-68c7-4708-8a53-a9c412e909b8	69367-160	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET, FILM COATED	ORAL	20170824	20240430	UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SALSALATE	500	mg/1			N	
69367-162_f36159c3-cec5-4eb6-8fa5-5672c0119e54	69367-162	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110	20240630	UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	
69367-163_f36159c3-cec5-4eb6-8fa5-5672c0119e54	69367-163	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110	20240630	UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	
69367-172_4d63f5b1-856c-4e52-9543-390de94a2f40	69367-172	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	ELIXIR	ORAL	20190708		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
69367-174_c975cd31-f562-40a2-ae14-f31a00c5164e	69367-174	HUMAN PRESCRIPTION DRUG	Hydroquinone		Hydroquinone	CREAM	TOPICAL	20180416		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
69367-180_fef0f898-a921-462b-9625-626d0e52d8f5	69367-180	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Westminster Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
69367-181_fef0f898-a921-462b-9625-626d0e52d8f5	69367-181	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Westminster Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
69367-182_fef0f898-a921-462b-9625-626d0e52d8f5	69367-182	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Westminster Pharmaceuticals, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
69367-183_96d9744b-983e-49ca-8be6-0d2fa89a8e4f	69367-183	HUMAN OTC DRUG	chlophedianol hydrochloride, dexchlorpheniramine maleate, and pseudoephedrine hydrochloride		chlophedianol hydrochloride, dexchlorpheniramine maleate, and pseudoephedrine hydrochloride	LIQUID	ORAL	20210729	20241001	OTC MONOGRAPH DRUG	M012	Westminster Pharmaceuticals, LLC	CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE	12.5; 1; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
69367-184_4bb61a68-58fa-45ed-b9e8-4a5f83f7046b	69367-184	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE		DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20180315		OTC MONOGRAPH DRUG	M012	Westminster Pharmaceuticals, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	18; 200; 10	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69367-190_d8c7e44e-b472-4c33-bfd7-1eb9d18b4a0f	69367-190	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION	INTRAVENOUS	20230202		ANDA	ANDA202923	Westminster Pharmaceuticals, LLC	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
69367-191_2a6760cc-0ff6-480b-8045-e4744664cad8	69367-191	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508	20240424	UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	
69367-192_2a6760cc-0ff6-480b-8045-e4744664cad8	69367-192	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
69367-194_175ba166-6dc4-41d9-a75e-853cb6d47aeb	69367-194	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20180727		ANDA	ANDA204165	Westminster Pharmaceuticals, LLC	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
69367-195_47e61f16-2a2b-4707-bea9-242d0829f442	69367-195	HUMAN PRESCRIPTION DRUG	Omeprazole/Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE, GELATIN COATED	ORAL	20180727		ANDA	ANDA207476	Westminster Pharmaceuticals, LLC	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69367-196_47e61f16-2a2b-4707-bea9-242d0829f442	69367-196	HUMAN PRESCRIPTION DRUG	Omeprazole/Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE, GELATIN COATED	ORAL	20180727		ANDA	ANDA207476	Westminster Pharmaceuticals, LLC	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69367-197_3cb2fbe4-e0ed-49e2-9668-4c5e8e43791c	69367-197	HUMAN OTC DRUG	Dexbrompheniramine Maleate and Phenylephrine Hydrochloride		Dexbrompheniramine Maleate and Phenylephrine Hydrochloride	TABLET	ORAL	20181025	20240603	OTC MONOGRAPH FINAL	part341	Westminster Pharmaceuticals, LLC	DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69367-198_5eda0c05-7c22-4189-8594-7e5d39ac4c17	69367-198	HUMAN OTC DRUG	Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride		Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20181025	20240401	OTC MONOGRAPH FINAL	part341	Westminster Pharmaceuticals, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	17.5; 385; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69367-199_5adc9106-0cb7-47e5-9975-14625d9ff0ca	69367-199	HUMAN OTC DRUG	Doxylamine Succinate and Phenylephrine Hydrochloride		Doxylamine Succinate and Phenylephrine Hydrochloride	TABLET	ORAL	20181025	20240501	OTC MONOGRAPH FINAL	part341	Westminster Pharmaceuticals, LLC	DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	7.5; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69367-200_175ba166-6dc4-41d9-a75e-853cb6d47aeb	69367-200	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA204165	Westminster Pharmaceuticals, LLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
69367-202_4aef6520-8f5d-47b8-aa1c-2b194a4fb8fd	69367-202	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		lidocaine hydrochloride	CREAM	TOPICAL	20190819		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	LIDOCAINE HYDROCHLORIDE	30	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69367-203_23d91a38-6b01-4d89-a454-45a9cac1a294	69367-203	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20190305		ANDA	ANDA209587	Westminster Pharmaceuticals, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
69367-209_1164f62c-c45c-4545-9280-f6c2c020dca1	69367-209	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20230420		ANDA	ANDA090779	Westminster Pharmaceuticals, LLC	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
69367-211_40a3c918-199c-482d-956d-4fbd42adcde9	69367-211	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
69367-212_40a3c918-199c-482d-956d-4fbd42adcde9	69367-212	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
69367-213_40a3c918-199c-482d-956d-4fbd42adcde9	69367-213	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
69367-214_40a3c918-199c-482d-956d-4fbd42adcde9	69367-214	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
69367-219_43b28163-bdd8-4531-9532-1624c5ef198c	69367-219	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190607		ANDA	ANDA203561	Westminster Pharmaceuticals	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69367-229_05217713-57ab-4098-98dd-d77e0ab21c48	69367-229	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		Selenium Sulfide	SHAMPOO	TOPICAL	20190909		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SELENIUM SULFIDE	22.5	mg/mL			N	20241231
69367-235_3318cf07-324e-4af0-9f9c-c806ed566672	69367-235	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	Westminster Pharmaceuticals, LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69367-236_3318cf07-324e-4af0-9f9c-c806ed566672	69367-236	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	Westminster Pharmaceuticals, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69367-237_3318cf07-324e-4af0-9f9c-c806ed566672	69367-237	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	Westminster Pharmaceuticals, LLC	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69367-238_bc557f2b-5eeb-40b8-aa7f-5da30f5f8b21	69367-238	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20190919		ANDA	ANDA203646	Westminster Pharmaceuticals	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69367-241_f3d2c192-1ab9-401c-8e5c-307dc6137a2a	69367-241	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190925		ANDA	ANDA078420	Westminster Pharmaceuticals, LLC	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69367-242_f3d2c192-1ab9-401c-8e5c-307dc6137a2a	69367-242	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190925		ANDA	ANDA078420	Westminster Pharmaceuticals, LLC	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69367-243_577eb17a-1bc7-47e8-a2ab-902a838bdcf4	69367-243	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20200205		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69367-244_05416a4a-e9a8-4ed8-a182-2b5eef3f24ac	69367-244	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		sulfacetamide sodium and sulfur	LIQUID	TOPICAL	20200505		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
69367-245_7ad361e4-dfcb-4af3-83f7-5716cf1861ec	69367-245	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide and Sulfur		Sodium Sulfacetamide and Sulfur	SUSPENSION	TOPICAL	20210618		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	80; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
69367-246_b5c541ec-cd1b-42d8-a3fb-cd4adb2cf2cf	69367-246	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20200106		ANDA	ANDA207555	Westminster Pharmaceuticals, LLC	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
69367-247_b8912cd5-1e15-4a87-a059-531250adcdfe	69367-247	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE, SULFUR		sulfacetamide sodium and sulfur	LIQUID	TOPICAL	20200505		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
69367-248_2f284aec-10cc-427f-a1e3-3048432ad160	69367-248	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20230719		ANDA	ANDA216326	Westminster Pharmaceuticals, LLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69367-253_63d97fa4-9b2d-4eef-8865-0cc4af5bc9e8	69367-253	HUMAN OTC DRUG	TRIPROLIDINE HYDROCHLORIDE		TRIPROLIDINE HYDROCHLORIDE	SYRUP	ORAL	20200309		OTC MONOGRAPH DRUG	M012	Westminster Pharmaceuticals, LLC	TRIPROLIDINE HYDROCHLORIDE	.938	mg/mL			N	20241231
69367-254_4f2db75a-65b8-401b-adf1-c60062fdf706	69367-254	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200423		ANDA	ANDA207803	Westminster Pharmaceuticals, LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69367-255_b933400c-92c2-487f-9bbb-6885e55bd8a4	69367-255	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20200720		ANDA	ANDA200958	Westminster Pharmaceuticals, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69367-256_b933400c-92c2-487f-9bbb-6885e55bd8a4	69367-256	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20200720		ANDA	ANDA200958	Westminster Pharmaceuticals, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69367-258_82f114d3-a311-47b8-81cf-0eac0131813d	69367-258	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	TABLET	ORAL	20221010		OTC MONOGRAPH DRUG	M001	Westminster Pharmaceuticals, LLC	SODIUM BICARBONATE	650	mg/1	Alkalinizing Activity [MoA]		N	20241231
69367-262_e4d63fde-89fa-4570-9939-6f9f2cad56bf	69367-262	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20230214		ANDA	ANDA209553	Westminster Pharmaceuticals, LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69367-263_e4d63fde-89fa-4570-9939-6f9f2cad56bf	69367-263	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20230214		ANDA	ANDA209553	Westminster Pharmaceuticals, LLC	VALACYCLOVIR HYDROCHLORIDE	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69367-264_51791555-1064-4991-b58c-3a37ce596d60	69367-264	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20230331		ANDA	ANDA210847	Westminster Pharmaceuticals, LLC	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69367-265_51791555-1064-4991-b58c-3a37ce596d60	69367-265	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20230331		ANDA	ANDA210847	Westminster Pharmaceuticals, LLC	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69367-266_51791555-1064-4991-b58c-3a37ce596d60	69367-266	HUMAN PRESCRIPTION DRUG	Felopdipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20230331		ANDA	ANDA210847	Westminster Pharmaceuticals, LLC	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69367-272_cbe76591-a4c9-48fd-9552-303dc6f46bc7	69367-272	HUMAN OTC DRUG	Codeine-Guaifenesin		Codeine Phosphate and Guaifenesin	SOLUTION	ORAL	20200715		OTC MONOGRAPH DRUG	M012	Westminster Pharmaceuticals, LLC	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
69367-286_e97f278d-147f-4fba-8ea3-0159d32fcfc4	69367-286	HUMAN PRESCRIPTION DRUG	Hydrocortisone Iodoquinol		Hydrocortisone and Iodoquinol	CREAM	TOPICAL	20200917		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	HYDROCORTISONE; IODOQUINOL	10; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69367-287_0e8ee65a-2fe1-cd68-e063-6294a90a2db5	69367-287	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET	ORAL	20160530		ANDA	ANDA205683	Westminster Pharmaceuticals, LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20251231
69367-288_02759ef0-9ecd-a315-e063-6294a90a8e26	69367-288	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171001		ANDA	ANDA207224	Westminster Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69367-289_02759ef0-9ecd-a315-e063-6294a90a8e26	69367-289	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171001		ANDA	ANDA207224	Westminster Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69367-293_38a38464-5bd7-40e4-82fc-2fc5fe42cef8	69367-293	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210824		ANDA	ANDA211829	Westminster Pharmaceuticals, LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69367-294_38a38464-5bd7-40e4-82fc-2fc5fe42cef8	69367-294	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210824		ANDA	ANDA211829	Westminster Pharmaceuticals, LLC	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69367-298_6c38c4e9-2f99-4caa-b626-68651a96e47a	69367-298	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20201015		OTC MONOGRAPH DRUG	M001	Westminster Pharmaceuticals, LLC	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69367-301_3bface0e-2d99-4eaa-8503-316925d1a551	69367-301	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201221		ANDA	ANDA210071	Westminster Pharmaceuticals, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69367-302_3bface0e-2d99-4eaa-8503-316925d1a551	69367-302	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201221		ANDA	ANDA210071	Westminster Pharmaceuticals, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69367-303_d28d00da-e102-098c-e053-2995a90a8121	69367-303	HUMAN PRESCRIPTION DRUG	Miglitol		Miglitol	TABLET, COATED	ORAL	20210115		ANDA	ANDA203965	Westminster Pharmaceuticals, LLC	MIGLITOL	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
69367-304_d28d00da-e102-098c-e053-2995a90a8121	69367-304	HUMAN PRESCRIPTION DRUG	Miglitol		Miglitol	TABLET, COATED	ORAL	20210115		ANDA	ANDA203965	Westminster Pharmaceuticals, LLC	MIGLITOL	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
69367-305_d28d00da-e102-098c-e053-2995a90a8121	69367-305	HUMAN PRESCRIPTION DRUG	Miglitol		Miglitol	TABLET, COATED	ORAL	20210115		ANDA	ANDA203965	Westminster Pharmaceuticals, LLC	MIGLITOL	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
69367-307_905d6ee4-8099-4afa-8535-a9511d468ccc	69367-307	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, COATED	ORAL	20211108		ANDA	ANDA207842	Westminster Pharmaceuticals, LLC	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
69367-308_905d6ee4-8099-4afa-8535-a9511d468ccc	69367-308	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, COATED	ORAL	20211108		ANDA	ANDA207842	Westminster Pharmaceuticals, LLC	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
69367-309_2c5374da-64f6-41f0-8b2a-f23c76dbc3a5	69367-309	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 Plus		Sodium Fluoride	CREAM	DENTAL	20210309		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SODIUM FLUORIDE	5	mg/g			N	20241231
69367-310_4251b577-cd67-4556-a1cc-207aea831860	69367-310	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 1.1% Gel		Sodium Fluoride	GEL	DENTAL	20210309		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SODIUM FLUORIDE	5	mg/g			N	20241231
69367-311_84c383e6-b936-4ab2-a099-900f5b05b541	69367-311	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 PPM		Sodium Fluoride	PASTE	DENTAL	20210616		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SODIUM FLUORIDE	6	mg/mL			N	20241231
69367-312_84c383e6-b936-4ab2-a099-900f5b05b541	69367-312	HUMAN PRESCRIPTION DRUG	Sodium Fluoride 5000 PPM		Sodium Fluoride	PASTE	DENTAL	20210616		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SODIUM FLUORIDE	6	mg/mL			N	20241231
69367-318_b80ec57b-26dc-4f9a-b35e-4df666802dc1	69367-318	HUMAN PRESCRIPTION DRUG	Sodium Fluoride and Potassium Nitrate		Sodium Fluoride and Potassium Nitrate	GEL	DENTAL	20220615		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	57.5; 5.8	mg/mL; mg/mL			N	20241231
69367-323_f382f280-b5cf-4f4b-869b-285ed012c19e	69367-323	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	LIQUID	ORAL	20210505		OTC MONOGRAPH DRUG	M013	Westminster Pharmaceuticals, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69367-324_87ed00b2-f063-4027-982e-62c247979669	69367-324	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	25	mg/1		CV	N	20241231
69367-325_87ed00b2-f063-4027-982e-62c247979669	69367-325	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	50	mg/1		CV	N	20241231
69367-326_87ed00b2-f063-4027-982e-62c247979669	69367-326	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	75	mg/1		CV	N	20241231
69367-327_87ed00b2-f063-4027-982e-62c247979669	69367-327	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	100	mg/1		CV	N	20241231
69367-328_87ed00b2-f063-4027-982e-62c247979669	69367-328	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	150	mg/1		CV	N	20241231
69367-329_87ed00b2-f063-4027-982e-62c247979669	69367-329	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	200	mg/1		CV	N	20241231
69367-330_87ed00b2-f063-4027-982e-62c247979669	69367-330	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	225	mg/1		CV	N	20241231
69367-331_87ed00b2-f063-4027-982e-62c247979669	69367-331	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Westminster Pharmaceuticals, LLC	PREGABALIN	300	mg/1		CV	N	20241231
69367-332_d047ef92-3b3a-46b9-bf99-a74202c325fc	69367-332	HUMAN PRESCRIPTION DRUG	Levetiracetam	ER	Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210930		ANDA	ANDA205130	Westminster Pharmaceuticals, LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-333_d047ef92-3b3a-46b9-bf99-a74202c325fc	69367-333	HUMAN PRESCRIPTION DRUG	Levetiracetam	ER	Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210930		ANDA	ANDA205130	Westminster Pharmaceuticals, LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-334_08a5f7d6-6f1b-4d1c-8f06-1672bda7ea3a	69367-334	HUMAN OTC DRUG	WesTussin DM		dexchlorpheniramine maleate, dextromethorphan hbr, phenylephrine hcl	SYRUP	ORAL	20210729		OTC MONOGRAPH FINAL	part341	Westminster Pharmaceuticals, LLC	DEXCHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	1; 10; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69367-335_0a272d00-5b37-47b2-870a-0028ca799109	69367-335	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210726		ANDA	ANDA213485	Westminster Pharmaceuticals, LLC	PAROXETINE HYDROCHLORIDE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69367-336_0a272d00-5b37-47b2-870a-0028ca799109	69367-336	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210726		ANDA	ANDA213485	Westminster Pharmaceuticals, LLC	PAROXETINE HYDROCHLORIDE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69367-337_0a272d00-5b37-47b2-870a-0028ca799109	69367-337	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210726		ANDA	ANDA213485	Westminster Pharmaceuticals, LLC	PAROXETINE HYDROCHLORIDE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69367-338_2226fb84-50af-45b1-8a9f-72984e331519	69367-338	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210930		ANDA	ANDA214092	Westminster Pharmaceuticals, LLC	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
69367-339_2226fb84-50af-45b1-8a9f-72984e331519	69367-339	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210930		ANDA	ANDA214092	Westminster Pharmaceuticals, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
69367-340_2226fb84-50af-45b1-8a9f-72984e331519	69367-340	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210930		ANDA	ANDA214092	Westminster Pharmaceuticals, LLC	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
69367-343_3a13536f-f1bb-41d8-96a7-7d0c4068c465	69367-343	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20211101		ANDA	ANDA075477	Westminster Pharmaceuticals, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-344_3a13536f-f1bb-41d8-96a7-7d0c4068c465	69367-344	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20211101		ANDA	ANDA075477	Westminster Pharmaceuticals, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-345_3a13536f-f1bb-41d8-96a7-7d0c4068c465	69367-345	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20211101		ANDA	ANDA075477	Westminster Pharmaceuticals, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-346_6c7ae5f2-73ce-4d0d-b515-610f52610eee	69367-346	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20211101		ANDA	ANDA207057	Westminster Pharmaceuticals, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-347_6c7ae5f2-73ce-4d0d-b515-610f52610eee	69367-347	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20211101		ANDA	ANDA207057	Westminster Pharmaceuticals, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69367-348_b30038df-c85b-4f1e-9828-653698a5a5a1	69367-348	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230710		ANDA	ANDA205237	Westminster Pharmaceuticals, LLC	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69367-349_b30038df-c85b-4f1e-9828-653698a5a5a1	69367-349	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230710		ANDA	ANDA205237	Westminster Pharmaceuticals, LLC	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69367-350_b30038df-c85b-4f1e-9828-653698a5a5a1	69367-350	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230710		ANDA	ANDA205237	Westminster Pharmaceuticals, LLC	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69367-351_b30038df-c85b-4f1e-9828-653698a5a5a1	69367-351	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET, FILM COATED	ORAL	20230710		ANDA	ANDA205237	Westminster Pharmaceuticals, LLC	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69367-353_229e97f4-f9ac-4cd6-a3c0-a357d7f897a5	69367-353	HUMAN OTC DRUG	WesTussin DM NF		WesTussin DM NF	LIQUID	ORAL	20230719		OTC MONOGRAPH DRUG	M012	Westminster Pharmaceuticals, LLC	DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 15; 7.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69367-354_2b6758c1-03aa-48e3-a803-edef84022f78	69367-354	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		metoprolol tartrate	TABLET	ORAL	20231218		ANDA	ANDA074453	Westminster Pharmaceuticals, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69367-355_2b6758c1-03aa-48e3-a803-edef84022f78	69367-355	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		metoprolol tartrate	TABLET	ORAL	20231218		ANDA	ANDA074453	Westminster Pharmaceuticals, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69367-356_d089e30b-f16a-42f9-8e8c-47ecfc0d9536	69367-356	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, COATED	ORAL	20230908		ANDA	ANDA215435	Westminster Pharmaceuticals, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
69367-357_f77fff71-2dd3-4759-ae5b-a5b40c86693c	69367-357	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	LIQUID	ORAL	20231013		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
69367-611_6f4d2d9d-4389-4d76-9f5e-e004d7b09a49	69367-611	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231019		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
69367-612_6f4d2d9d-4389-4d76-9f5e-e004d7b09a49	69367-612	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231019		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
69367-615_e88fb4f9-5256-46cc-8ba3-b072925fdc0b	69367-615	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20231115		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SALSALATE	500	mg/1			N	20241231
69367-616_e88fb4f9-5256-46cc-8ba3-b072925fdc0b	69367-616	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20231115		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	SALSALATE	750	mg/1			N	20241231
69367-625_416b2000-403b-4793-a23c-ae42ab04a24e	69367-625	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
69367-626_416b2000-403b-4793-a23c-ae42ab04a24e	69367-626	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
69367-627_416b2000-403b-4793-a23c-ae42ab04a24e	69367-627	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
69367-628_416b2000-403b-4793-a23c-ae42ab04a24e	69367-628	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
69367-691_b8256561-2c8d-4b02-8a59-5fbc524e4eb3	69367-691	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	15	mg/1		CIV	N	20241231
69367-692_b8256561-2c8d-4b02-8a59-5fbc524e4eb3	69367-692	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	30	mg/1		CIV	N	20241231
69367-693_b8256561-2c8d-4b02-8a59-5fbc524e4eb3	69367-693	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	60	mg/1		CIV	N	20241231
69367-694_b8256561-2c8d-4b02-8a59-5fbc524e4eb3	69367-694	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20230908		UNAPPROVED DRUG OTHER		Westminster Pharmaceuticals, LLC	PHENOBARBITAL	100	mg/1		CIV	N	20241231
69375-006_5995814e-4d5d-4385-952b-f6bf98815585	69375-006	HUMAN OTC DRUG	Capsaicin HP Arthritis Pain Relief		capsaicin	CREAM	TOPICAL	20230821		OTC MONOGRAPH NOT FINAL	part348	Nationwide Pharmaceutical LLC	CAPSAICIN	.1	g/100g			N	20241231
69377-002_09866e0b-736a-2316-e063-6294a90a5009	69377-002	HUMAN OTC DRUG	Flaxendol Extra Strength Acetaminophen		ACETAMINOPHEN	CAPSULE	ORAL	20220701		OTC MONOGRAPH DRUG	M013	Gelpharma S.A. de C.V.	ACETAMINOPHEN	500	mg/1			N	20241231
69377-003_09af864d-38ec-3881-e063-6394a90a3efb	69377-003	HUMAN OTC DRUG	Algidol Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE	KIT		20220901		OTC MONOGRAPH DRUG	M012	Gelpharma S.A. de C.V.						N	20241231
69387-001_568f17b2-0555-4c16-a50f-aa5bd4801605	69387-001	HUMAN PRESCRIPTION DRUG	BAFIERTAM		monomethyl fumarate	CAPSULE	ORAL	20200428		NDA	NDA210296	Banner Life Sciences LLC	MONOMETHYL FUMARATE	95	mg/1			N	20241231
69390-001_d44a9ea9-4e01-ec6c-e053-2a95a90a2bd5	69390-001	HUMAN OTC DRUG	EAR RX		Aconitum nap, Baryta carb, Belladonna, Calc carb, Capsicum, Carbo veg, Causticum, Chamomilla, Ferrum phos, Hepar sulph calc, Kali mur, Lachesis, Lycopodium, Mercurius sol, Natrum mur, Plantago, Pulsatilla, Silicea, Sulphur, Verbascum	LIQUID	ORAL	20151123		UNAPPROVED HOMEOPATHIC		Miami Beach Pediatrics pa	ACONITUM NAPELLUS; ACTIVATED CHARCOAL; ATROPA BELLADONNA; BARIUM CARBONATE; CALCIUM SULFIDE; CAPSICUM; CAUSTICUM; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PLANTAGO MAJOR; POTASSIUM CHLORIDE; PULSATILLA VULGARIS; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR; VERBASCUM THAPSUS	6; 12; 9; 10; 10; 9; 8; 9; 8; 6; 9; 12; 6; 9; 10; 9; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS]		N	20241231
69390-002_d44a944e-7622-dc11-e053-2995a90a2b29	69390-002	HUMAN OTC DRUG	SINUS RX		Calcarea carb, Euphorbium, Hydrastis, Kali bic, Kali iod, Lycopodium, Phosphorus, Pulsatilla, Thuja occ, Sanguinaria	LIQUID	ORAL	20151123		UNAPPROVED HOMEOPATHIC		Miami Beach Pediatrics pa	EUPHORBIA RESINIFERA RESIN; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PULSATILLA VULGARIS; SANGUINARIA CANADENSIS ROOT; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 9; 10; 9; 8; 4; 9; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
69394-005_03890899-669f-bacb-e063-6394a90ad7ab	69394-005	HUMAN OTC DRUG	Antibacterial Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20230822		OTC MONOGRAPH NOT FINAL	part333A	AAkron Rule Corporation	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
69396-001_09d3c52c-988e-eb94-e063-6394a90ae298	69396-001	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20150310		OTC MONOGRAPH DRUG	M005	TRIFECTA PHARMACEUTICALS USA LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69396-002_fbe78692-c017-4e0c-e053-6294a90a7b3a	69396-002	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate.	OINTMENT	TOPICAL	20150310		OTC MONOGRAPH FINAL	part333B	TRIFECTA PHARMACEUTICALS USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-003_f2769d17-818c-866d-e053-2995a90afa2c	69396-003	HUMAN OTC DRUG	Hydrocortisone		HYDROCORTISONE	OINTMENT	TOPICAL	20150310		OTC MONOGRAPH NOT FINAL	part348	TRIFECTA PHARMACEUTICALS USA LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-004_05bab187-0aec-3f35-e063-6394a90a8c0f	69396-004	HUMAN OTC DRUG	Ichthammol 20%		Ichthammol	OINTMENT	TOPICAL	20150712		UNAPPROVED HOMEOPATHIC		TRIFECTA PHARMACEUTICALS USA LLC	ICHTHAMMOL	20	g/100g			N	20241231
69396-005_f276bd5c-09eb-171f-e053-2995a90a9260	69396-005	HUMAN OTC DRUG	Hydrocortisone 1% with healing aloe		Hydrocortisone	CREAM	TOPICAL	20151223		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals Usa Llc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-008_ffc0c4b1-347b-46f0-e053-6294a90a57ab	69396-008	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20200401	20240701	OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	
69396-009_f276bf49-c7be-c273-e053-2995a90abe84	69396-009	HUMAN OTC DRUG	Vitamin A and D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20170103		OTC MONOGRAPH FINAL	part347	Trifecta Pharmaceuticals USA LLC	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
69396-010_f276b26f-0802-a8aa-e053-2a95a90af504	69396-010	HUMAN OTC DRUG	TRIMOL		Ichthammol 20%	SALVE	TOPICAL	20180329		UNAPPROVED HOMEOPATHIC		Trifecta Pharmaceuticals USA LLC	ICHTHAMMOL	20	g/100g			N	20241231
69396-014_fcee9816-ebd3-47e1-e053-6294a90a64b2	69396-014	HUMAN OTC DRUG	MICONAZOLE Nitrate 2% Cream ANTIFUNGAL		MICONAZOLE NITRATE	CREAM	TOPICAL	20160322		OTC MONOGRAPH FINAL	part333C	Trifecta Pharmaceuticals Usa Llc	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69396-015_f2766ee8-5652-b088-e053-2a95a90a6c0d	69396-015	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate	OINTMENT	TOPICAL	20160318		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals Usa Llc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-016_f276c50b-f4b6-92d8-e053-2a95a90a9b76	69396-016	HUMAN OTC DRUG	Tolnaftate Cream 1% ANTIFUNGAL		Tolnaftate	CREAM	TOPICAL	20160409		OTC MONOGRAPH FINAL	part333C	Trifecta Pharmaceuticals Usa Llc	TOLNAFTATE	1	g/100g			N	20241231
69396-017_f276c674-f984-d6a5-e053-2a95a90a8e75	69396-017	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	OINTMENT	TOPICAL	20160409		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals Usa Llc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-018_fc498b3e-720f-a793-e053-6294a90a8498	69396-018	HUMAN OTC DRUG	Vitamin A and D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20170105		OTC MONOGRAPH FINAL	part347	Trifecta Pharmaceuticals USA LLC	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
69396-020_065de75b-ad40-f49e-e063-6394a90a7216	69396-020	HUMAN OTC DRUG	HemorrhoidalOintment		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20170504		OTC MONOGRAPH FINAL	part346	Trifecta Pharmaceuticals USA LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69396-021_f276c50b-f4b7-92d8-e053-2a95a90a9b76	69396-021	HUMAN OTC DRUG	Zinc Oxide 20%		Zinc Oxide	OINTMENT	TOPICAL	20180126		OTC MONOGRAPH FINAL	part347	Trifecta Pharmaceuticals USA	ZINC OXIDE	.2	g/g			N	20241231
69396-021_fa15ac73-f4f5-7a6b-e053-6294a90a4f4e	69396-021	HUMAN OTC DRUG	Zinc Oxide 20%		Zinc Oxide	OINTMENT	TOPICAL	20190701		OTC MONOGRAPH FINAL	part347	Trifecta Pharmaceuticals USA	ZINC OXIDE	.2	g/g			N	20241231
69396-023_0df7b6dd-a4d8-c9a6-e063-6394a90a0f52	69396-023	HUMAN OTC DRUG	Dibucaine		Dibucaine 1%	OINTMENT	TOPICAL	20220914		OTC MONOGRAPH DRUG	M017	Trifecta Pharmaceuticals USA LLC	DIBUCAINE	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
69396-024_f276c9eb-88f9-64d7-e053-2a95a90a8952	69396-024	HUMAN OTC DRUG	Muscle Rub Cream		Menthol 10%, Methyl Salicylate 15%	CREAM	TOPICAL	20161229		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals USA, LLC.	MENTHOL; METHYL SALICYLATE	.1; .15	g/100g; g/100g			N	20241231
69396-025_0df7f83e-5adb-ec48-e063-6294a90a198e	69396-025	HUMAN OTC DRUG	Anti-Itch Cream		Diphenhydramine hydrochloride 2%, zinc acetate 0.1%	CREAM	TOPICAL	20161229		OTC MONOGRAPH DRUG	M017	Trifecta Pharmaceuticals USA, LLC.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
69396-027_065df2c4-5b2b-1209-e063-6394a90ad421	69396-027	HUMAN OTC DRUG	Bacitracin		Bacitracin Zinc	OINTMENT	TOPICAL	20170315		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA, LLC.	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
69396-028_0658f836-2e96-b62e-e063-6294a90a49a2	69396-028	HUMAN OTC DRUG	Hydrocortisone Cream		Hydrocortisone	CREAM	TOPICAL	20170407		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals USA	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-029_f276c674-f98a-d6a5-e053-2a95a90a8e75	69396-029	HUMAN OTC DRUG	doubleantibioticointment		bacitracin zinc, polymyxin B sulfate	OINTMENT	TOPICAL	20170504		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA LLC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-030_f276cc9f-388d-4fe7-e053-2995a90abc00	69396-030	HUMAN OTC DRUG	Tripleantibioticointmentandpainrelief		Bacitracin,Neomycin,Polymxin, Pramoxine	OINTMENT	TOPICAL	20170720		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA	BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/100g; mg/100g; [USP'U]/100g; mg/100g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-031_f276c674-f98b-d6a5-e053-2a95a90a8e75	69396-031	HUMAN OTC DRUG	Rhuli Gel		Camphor, Menthol	GEL	TOPICAL	20170517		OTC MONOGRAPH FINAL	part341	Trifecta Pharmaceuticals USA, LLC.	CAMPHOR (SYNTHETIC); MENTHOL	.3; .3	g/100g; g/100g			N	20241231
69396-032_f276cc9f-388e-4fe7-e053-2995a90abc00	69396-032	HUMAN OTC DRUG	Hemorroidal Cooling gel		Phenylephrine, Witch Hazel	GEL	TOPICAL	20180213		OTC MONOGRAPH FINAL	part346	Trifecta Pharmaceuticals Usa Llc	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	.25; .5	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69396-033_f276d390-8f30-8921-e053-2a95a90a0f2d	69396-033	HUMAN OTC DRUG	Hemorrhoidal Cream		Glycerol, Phenylephine, Pramoxine, Petrolatum	CREAM	TOPICAL	20190125		OTC MONOGRAPH FINAL	part346	Trifecta Pharmaceuticals Usa Llc	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69396-037_f276d390-8f33-8921-e053-2a95a90a0f2d	69396-037	HUMAN OTC DRUG	Family Wellness First Aid Antibiotic		Family Wellness bacitracin zinc, polymyxin B sulfate	OINTMENT	TOPICAL	20190829		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA, LLC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-038_f276d390-8f34-8921-e053-2a95a90a0f2d	69396-038	HUMAN OTC DRUG	Clotrimazole		Family Wellness Clotrimazole	CREAM	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333C	Trifecta Pharmaceuticals USA LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69396-041_f276d390-8f35-8921-e053-2a95a90a0f2d	69396-041	HUMAN OTC DRUG	Family Wellness Original		Family Wellness Bacitracin, Neomycin, Polymyxin B	OINTMENT	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA LLC.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-042_f276d390-8f36-8921-e053-2a95a90a0f2d	69396-042	HUMAN OTC DRUG	Tolnaftate Cream 1% ANTIFUNGAL		Family Wellness Tolnaftate	CREAM	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333C	Trifecta Pharmaceuticals USA, LLC	TOLNAFTATE	1	g/100g			N	20241231
69396-044_f276e313-0900-e0d8-e053-2a95a90a52a5	69396-044	HUMAN OTC DRUG	Tripleantibioticointmentandpainrelief		Family Wellness Bacitracin,Neomycin,PolymyxinB,Pramoxine	OINTMENT	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceutical USA LLC	BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/100g; mg/100g; [USP'U]/100g; mg/100g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-045_f276edd1-49ad-2200-e053-2a95a90afb39	69396-045	HUMAN OTC DRUG	Tripleantibioticapainscaritch		Family Wellness Bacitracin,Neomycin,PolymyxinB,PramoxineHCL	OINTMENT	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceutical USA LLC	BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/100g; mg/100g; [USP'U]/100g; mg/100g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-050_0df822d2-3f10-e65c-e063-6394a90a3a39	69396-050	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20191212		OTC MONOGRAPH DRUG	M016	Trifecta Pharmaceuticals Usa Llc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
69396-054_f276f813-a268-42ad-e053-2a95a90a70fd	69396-054	HUMAN OTC DRUG	Family Wellness Pain Scar Itch		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B, Pramoxine HCL	OINTMENT	TOPICAL	20190830		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceutical USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-055_f276fb3e-1afd-7a6c-e053-2995a90a0904	69396-055	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20190220		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals Usa Llc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-057_f276f813-a269-42ad-e053-2a95a90a70fd	69396-057	HUMAN OTC DRUG	Itch Relief		Hydrocortisone 1%	CREAM	TOPICAL	20200915		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals USA LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-070_f276f813-a26a-42ad-e053-2a95a90a70fd	69396-070	HUMAN OTC DRUG	RectaEase Hemorrhoid Relief Cream		Lidocaine	CREAM	TOPICAL	20210419		OTC MONOGRAPH FINAL	part346	Trifecta Pharmaceuticals USA LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69396-071_f276f813-a26b-42ad-e053-2a95a90a70fd	69396-071	HUMAN OTC DRUG	Dual Action Cream		NeomycinSulfate,PolymyxinBSulfate,PramoxineHCL	CREAM	TOPICAL	20210106		OTC MONOGRAPH NOT FINAL	part347	Trifecta Pharmaceutical USA LLC	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-072_f276ff14-e5bf-7534-e053-2995a90a1e39	69396-072	HUMAN OTC DRUG	Multi Action		Bacitracinzinc,NeomycinSulfate,PolymyxinBSulfate,PramoxineHCL	OINTMENT	TOPICAL	20210122		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceutical USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-081_f276ff14-e5c0-7534-e053-2995a90a1e39	69396-081	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals Usa Llc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-082_f276e9b4-863e-415e-e053-2995a90abc62	69396-082	HUMAN OTC DRUG	HemorrhoidalOintment		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20210618		OTC MONOGRAPH FINAL	part346	Trifecta Pharmaceuticals USA LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69396-083_f27700e1-f00b-6ae0-e053-2995a90a58c7	69396-083	HUMAN OTC DRUG	HemorrhoidalOintment		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20210628		OTC MONOGRAPH FINAL	part346	Trifecta Pharmaceuticals USA LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69396-086_fcef2e0c-24d7-21d3-e053-6394a90a2623	69396-086	HUMAN OTC DRUG	Zinc Oxide 20%		Zinc Oxide	OINTMENT	TOPICAL	20230530		OTC MONOGRAPH DRUG	M016	Trifecta Pharmaceuticals USA	ZINC OXIDE	.2	g/g			N	20251231
69396-087_0df86641-b2ce-5bc7-e063-6294a90ac623	69396-087	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20220408		OTC MONOGRAPH DRUG	M017	TRIFECTA PHARMACEUTICALS USA LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20251231
69396-096_065de60d-bd33-6cef-e063-6394a90a25c7	69396-096	HUMAN OTC DRUG	Hydrocortisone Cream		Hydrocortisone	CREAM	TOPICAL	20220113		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals USA	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-098_0df88619-92b4-53c2-e063-6294a90a45fe	69396-098	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20220310		OTC MONOGRAPH DRUG	M004	Trifecta Pharmaceuticals USA LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20251231
69396-103_02e86bc1-eb13-b6e7-e063-6294a90a5f27	69396-103	HUMAN OTC DRUG	Capsaicin Cream		Capsaicin	CREAM	TOPICAL	20220514		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals USA LLC	CAPSAICIN	.1	g/100g			N	20241231
69396-104_04db4a1e-a2d2-56d9-e063-6294a90a401e	69396-104	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20200421		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
69396-105_0df88619-92b6-53c2-e063-6294a90a45fe	69396-105	HUMAN OTC DRUG	Burn Cream		Benzalkonium Chloride, Lidocaine HCI	CREAM	TOPICAL	20220927		OTC MONOGRAPH DRUG	M013	Trifecta Pharmaceuticals USA LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.0013; .005	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
69396-106_0df86c68-116e-515e-e063-6294a90a416a	69396-106	HUMAN OTC DRUG	Burn Gel		Lidocaine HCI	GEL	TOPICAL	20220927		OTC MONOGRAPH DRUG	M017	Trifecta Pharmaceuticals USA LLC	LIDOCAINE HYDROCHLORIDE	.02	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
69396-107_0df8849d-f3de-0b16-e063-6394a90af7bf	69396-107	HUMAN OTC DRUG	Burn Relief		Lidocaine HCI 2.0%	SPRAY	TOPICAL	20220728		OTC MONOGRAPH DRUG	M017	Trifecta Pharmaceuticals USA, LLC.	LIDOCAINE HYDROCHLORIDE	20	g/L	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
69396-108_0df88ec4-4620-1282-e063-6394a90a5a3d	69396-108	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide 3.0%	SPRAY	TOPICAL	20220728		OTC MONOGRAPH DRUG	M003	Trifecta Pharmaceuticals USA, LLC.	HYDROGEN PEROXIDE	30	mL/L			N	20251231
69396-110_0df86c68-116f-515e-e063-6294a90a416a	69396-110	HUMAN OTC DRUG	Muscle Rub Cream		Menthol 10%, Methyl Salicylate 15%	CREAM	TOPICAL	20220604		OTC MONOGRAPH DRUG	M017	Trifecta Pharmaceuticals USA, LLC.	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20251231
69396-112_f80cccd2-1511-2ddb-e053-6394a90aca81	69396-112	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine 10%	OINTMENT	TOPICAL	20221223		OTC MONOGRAPH NOT FINAL	part333A	Trifecta Pharmaceuticals USA LLC	POVIDONE-IODINE	100	mg/g			N	20241231
69396-114_f1eb10de-7b10-cac4-e053-2995a90a6d8e	69396-114	HUMAN OTC DRUG	White Petrolatum		Petrolatum	OINTMENT	TOPICAL	20221014		OTC MONOGRAPH FINAL	part347	Trifecta Pharmaceuticals USA LLC	PETROLATUM	100	g/100g			N	20241231
69396-118_fd06a5e7-32da-72bc-e053-6394a90a460d	69396-118	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals Usa Llc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-120_f40b19a8-795d-f514-e053-2a95a90a6d15	69396-120	HUMAN OTC DRUG	Pain Itch Relief		Lidocaine HCI	CREAM	TOPICAL	20230106		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceutical USA LLC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69396-121_f71f002e-9e8e-2b26-e053-6294a90ac27b	69396-121	HUMAN OTC DRUG	Vitamin A and D		Petrolatum	OINTMENT	TOPICAL	20221014		OTC MONOGRAPH FINAL	part347	Trifecta Pharmaceuticals USA LLC	PETROLATUM	76	g/100g			N	20241231
69396-124_00b82ca7-a3b0-f359-e063-6394a90a82a8	69396-124	HUMAN OTC DRUG	Burn Cream		Benzalkonium Chloride, Lidocaine HCI	CREAM	TOPICAL	20230302		OTC MONOGRAPH NOT FINAL	part348	Trifecta Pharmaceuticals USA LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.0013; .005	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69396-125_00c51ee1-d7e8-17f1-e063-6394a90ac336	69396-125	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate.	OINTMENT	TOPICAL	20230718		OTC MONOGRAPH FINAL	part333B	TRIFECTA PHARMACEUTICALS USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-127_02e903fc-005f-1f28-e063-6394a90ac2b4	69396-127	HUMAN OTC DRUG	Hydro Gel		Glycerin 20%	GEL	TOPICAL	20230814		OTC MONOGRAPH DRUG	M016	Trifecta Pharmaceuticals USA LLC	GLYCERIN	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69396-129_0a59f129-9e48-0c01-e063-6394a90a74f9	69396-129	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20231110		OTC MONOGRAPH DRUG	M016	Trifecta Pharmaceuticals Usa Llc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69396-130_091b65be-036f-7431-e063-6394a90a6772	69396-130	HUMAN OTC DRUG	Tolnaftate		Tolnaftate 1%	CREAM	TOPICAL	20230630		OTC MONOGRAPH DRUG	M005	Trifecta Pharmaceuticals USA, LLC	TOLNAFTATE	1	g/100g			N	20241231
69396-131_0c017b20-0f95-80e4-e063-6294a90a9550	69396-131	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate	OINTMENT	TOPICAL	20231208		OTC MONOGRAPH DRUG	M004	TRIFECTA PHARMACEUTICALS USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-132_0bf08cf6-be40-f9aa-e063-6294a90a4393	69396-132	HUMAN OTC DRUG	Triple Antibiotic and Pain Relief		Bacitracin,Neomycin,PolymyxinB,Pramoxine	OINTMENT	TOPICAL	20231207		OTC MONOGRAPH DRUG	M004	Trifecta Pharmaceutical USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/100g; mg/100g; [USP'U]/100g; mg/100g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-133_fe18fa61-83fa-8bf9-e053-6294a90a7585	69396-133	HUMAN OTC DRUG	HemorrhoidalOintment		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20230601		OTC MONOGRAPH FINAL	part346	Trifecta Pharmaceuticals USA LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69396-135_087d58d8-6682-d72c-e063-6294a90a068e	69396-135	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20231023		OTC MONOGRAPH DRUG	M004	Trifecta Pharmaceuticals USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-136_08a13e35-789e-3322-e063-6294a90a47fa	69396-136	HUMAN OTC DRUG	Burn Cream		Benzalkonium Chloride, Lidocaine HCI	CREAM	TOPICAL	20231023		OTC MONOGRAPH DRUG	M003	Trifecta Pharmaceuticals USA LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.0013; .005	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69396-137_0ba469ee-9dfd-e824-e063-6294a90a1c40	69396-137	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20231203		OTC MONOGRAPH DRUG	505G(a)(3)	Trifecta Pharmaceuticals USA	ALCOHOL	62	g/100g			N	20241231
69396-138_048871fe-40a9-4877-e063-6394a90addbd	69396-138	HUMAN OTC DRUG	First Aid Antibiotic plus Burn Relief		Bacitracinzinc,NeomycinSulfate,PolymxinBSulfate,PramoxineHCI	OINTMENT	TOPICAL	20230904		OTC MONOGRAPH FINAL	part333B	Trifecta Pharmaceuticals USA LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69396-139_0ac4d57d-56ed-7dda-e063-6394a90a9a51	69396-139	HUMAN OTC DRUG	Pain Relieving Cream Lidocaine		Benzyl alcohol, Lidocaine HCI	CREAM	TOPICAL	20220823		OTC MONOGRAPH DRUG	M017	Trifecta Pharmaceuticals USA LLC	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	10; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
69396-140_09920754-aaba-5cfa-e063-6294a90ac9a1	69396-140	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230808		OTC MONOGRAPH DRUG	M013	Trifecta Pharmaceuticals USA LLC	ACETAMINOPHEN	500	mg/1			N	20241231
69396-144_09935a81-941d-1499-e063-6294a90a049c	69396-144	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230808		OTC MONOGRAPH DRUG	M013	Trifecta Pharmaceuticals USA LLC	ACETAMINOPHEN	500	mg/1			N	20241231
69396-145_09970125-f920-00c3-e063-6394a90a219e	69396-145	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230808		ANDA	ANDA207095	Trifecta Pharmaceuticals USA LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69401-000_4e9fb5c9-453a-4e24-ad62-4ea03ac734e0	69401-000	VACCINE	Vivotif		Salmonella typhi Ty21a	CAPSULE, COATED	ORAL	19920316		BLA	BLA103123	Emergent Travel Health Inc.	SALMONELLA TYPHI TY21A LIVE ANTIGEN	6000000000	[CFU]/1	Actively Acquired Immunity [PE], Live Attenuated Salmonella Typhi Vaccine [EPC], Vaccines, Attenuated [CS], Vaccines, Typhoid [CS]		N	20241231
69413-330_ca65359c-029c-44f4-ba89-c4058ddd4e30	69413-330	HUMAN PRESCRIPTION DRUG	Daraprim		pyrimethamine	TABLET	ORAL	19530123		NDA	NDA008578	Vyera Pharmaceuticals LLC	PYRIMETHAMINE	25	mg/1	Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
69413-558_a29db678-f591-44c7-be1c-3ec7ae06bea7	69413-558	HUMAN PRESCRIPTION DRUG	Vecamyl		Mecamylamine Hydrochloride	TABLET	ORAL	20130319		ANDA	ANDA204054	Vyera Pharmaceuticals, LLC	MECAMYLAMINE HYDROCHLORIDE	2.5	mg/1	Autonomic Ganglionic Blocker [EPC], Decreased Autonomic Ganglionic Activity [PE]		N	20241231
69417-130_7af8271a-4ca7-4c83-ae75-af76d10eb53e	69417-130	HUMAN OTC DRUG	TATCHA THE SILK SUNSCREEN		Zinc Oxide	LOTION	TOPICAL	20220308		OTC MONOGRAPH FINAL	part352	TATCHA INC.	ZINC OXIDE	100	mg/mL			N	20241231
69417-140_c13fe4eb-4c7f-4786-b14c-725e93a8085d	69417-140	HUMAN OTC DRUG	THE INDIGO CALMING		Colloidal Oatmeal	CREAM	TOPICAL	20230426		OTC MONOGRAPH FINAL	part347	TATCHA INC.	OATMEAL	20	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69417-150_106d6736-4362-402f-a391-ce245362fd0f	69417-150	HUMAN OTC DRUG	SILKEN pore perfecting sunscreen broad spectrum SPF 35		Octisalate, Zinc Oxide	LOTION	TOPICAL	20230426		OTC MONOGRAPH FINAL	part352	TATCHA INC.	OCTISALATE; ZINC OXIDE	5; 15	g/100mL; g/100mL			N	20241231
69420-1001_2bf3a68c-688f-44be-bb49-37d647ffd58f	69420-1001	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20150325		ANDA	ANDA078722	SA3, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69420-1375_f34d9d85-4a82-43b6-bf5b-3b2893c6b009	69420-1375	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190501		NDA AUTHORIZED GENERIC	NDA020353	SA3, LLC	NAPROXEN SODIUM	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69420-6025_e7e22437-209f-43e4-b698-2df6bd05a46b	69420-6025	HUMAN OTC DRUG	Capsaicin		Capsaicin	CREAM	TOPICAL	20210611		OTC MONOGRAPH NOT FINAL	part348	SA3, LLC	CAPSAICIN	.025	g/100g			N	20241231
69420-6262_2ea89708-c9d8-4d24-af09-b3b6ddd53bd0	69420-6262	HUMAN OTC DRUG	Lidocaine 4 Percent		Lidocaine	CREAM	TOPICAL	20220601		OTC MONOGRAPH NOT FINAL	part348	SA3, LLC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69420-7025_02a6e5f4-9757-449d-bb9f-7bb2ac22439a	69420-7025	HUMAN OTC DRUG	Capsaicin		Capsaicin	PATCH	TOPICAL	20210611		OTC MONOGRAPH NOT FINAL	part348	SA3, LLC	CAPSAICIN	.025	g/100g			N	20241231
69422-1003_0e766448-875f-76db-e063-6394a90a0ab1	69422-1003	HUMAN OTC DRUG	Carecella Velvet Cover BB Cream		Octinoxate, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20190510		OTC MONOGRAPH DRUG	M020	General Bio Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3.75; 2.1; 3.5	g/50g; g/50g; g/50g			N	20251231
69422-1004_0e769106-2fd2-6e50-e063-6394a90aa02a	69422-1004	HUMAN OTC DRUG	Carecella Daily Sun Cream		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTINOXATE, OCTISALATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20201007		OTC MONOGRAPH DRUG	M020	General Bio Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE	2.97; 7.5; 7; 5; 7.5; 5.3	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g			N	20251231
69422-1005_0e769d13-23f0-f61f-e063-6294a90a8cd1	69422-1005	HUMAN OTC DRUG	Carecella Velvet Cover BB Cream No 25		Octyl methoxycinnamate, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20201026		OTC MONOGRAPH DRUG	M020	General Bio Co., Ltd.	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	7.5; 4.2; 7	g/100mL; g/100mL; g/100mL			N	20251231
69422-1006_0e75f143-c797-4323-e063-6294a90a9cdb	69422-1006	HUMAN OTC DRUG	Carecella Sun Cream		Amiloxate, Ethylhexyl Triazone	CREAM	TOPICAL	20230719		UNAPPROVED DRUG OTHER		General Bio Co., Ltd.	AMILOXATE; ETHYLHEXYL TRIAZONE	7.49; 4.5	g/100mL; g/100mL			N	20251231
69423-013_f7919e44-0091-0dab-e053-6294a90a9dbd	69423-013	HUMAN OTC DRUG	Secret Clinical Strength Clear Stress Response		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20150209		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-015_fb461668-5698-0e27-e053-6294a90a9a03	69423-015	HUMAN OTC DRUG	Secret Sweet Nectarine Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-042_f1ef45a9-2eca-0679-e053-2a95a90ac1b6	69423-042	HUMAN OTC DRUG	Head and Shoulders Complete Scalp Care 2in1		Pyrithione Zinc	SHAMPOO	TOPICAL	20160112		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-053_f1f0239c-808e-5c55-e053-2995a90a12ca	69423-053	HUMAN OTC DRUG	Safeguard Antibacterial Hand		Chloroxylenol	LIQUID	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part333E	The Procter & Gamble Manufacturing Company	CHLOROXYLENOL	.5	mg/100mL			N	20241231
69423-055_0cf366bb-c145-73fb-e063-6394a90acb23	69423-055	HUMAN OTC DRUG	Old Spice Sweat Defense Pure Sport Plus		Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20151030		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	19	g/100g			N	20241231
69423-057_0cf3ee47-fa6b-9cba-e063-6394a90aeecb	69423-057	HUMAN OTC DRUG	Old Spice Sweat Defense Extra Fresh	Extra Strong Anti-perspirant Deodorant	Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20151117	20250101	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	19	g/100g			N	
69423-069_ff0ae767-1e5e-d383-e053-6394a90a66a2	69423-069	HUMAN OTC DRUG	Secret Clinical Strength Invisible	Completely Clean	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20151102	20250201	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	
69423-070_0cf61b9c-fc3f-30e9-e063-6294a90a4dd4	69423-070	HUMAN OTC DRUG	Secret Clinical Strength Invisible	Protection	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20151116	20240901	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	
69423-073_0cf8b6df-9b79-33b7-e063-6294a90a5feb	69423-073	HUMAN OTC DRUG	Secret Clinical Strength Invisible	Stress Response	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20151117	20240901	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	
69423-103_f8885390-38d2-25d0-e053-6294a90afa63	69423-103	HUMAN OTC DRUG	Head and Shoulders Conditioner	Smooth and Silky	Pyrithione Zinc	LOTION	TOPICAL	20161110		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-130_fed305f1-e329-e1ff-e053-6294a90a273d	69423-130	HUMAN OTC DRUG	Secret Clinical Strength Soft Waterproof		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20161108	20250101	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	
69423-137_fecec13e-6b39-f0fc-e053-6394a90af495	69423-137	HUMAN OTC DRUG	Secret Clinical Strength Soft Stress Response		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20161108	20250101	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	
69423-138_0cf91b03-89d2-7bd3-e063-6294a90a7fab	69423-138	HUMAN OTC DRUG	Secret Clinical Strength Soft Light and Fresh		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20161108	20250101	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	
69423-150_f8238867-7bbd-6601-e053-6394a90a4a8d	69423-150	HUMAN OTC DRUG	Head and Shoulders	Volume Boost	Pyrithione Zinc	SHAMPOO	TOPICAL	20161121	20241201	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-151_f823b431-d149-da33-e053-6294a90ad29c	69423-151	HUMAN OTC DRUG	Head and ShouldersVolume Boost Hair and Scalp Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20161121	20241201	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	
69423-160_f5f13b54-de15-47ce-e053-2995a90a7bf8	69423-160	HUMAN OTC DRUG	Head and Shoulders Dry Scalp Care	Hair and Scalp Conditioner	Pyrithione Zinc	LOTION	TOPICAL	20161110		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-171_f5b1d26c-8b97-1d82-e053-2a95a90a1da8	69423-171	HUMAN OTC DRUG	Head and Shoulders Hair and Scalp Conditioner	Classic Clean	Pyrithione Zinc	LOTION	TOPICAL	20161001		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-172_0c91796a-5641-6f4d-e063-6394a90adece	69423-172	HUMAN OTC DRUG	Head and Shoulders Hair and Scalp Conditioner	Green Apple	Pyrithione Zinc	LOTION	TOPICAL	20161001		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-176_0e1f4dc8-25c7-8860-e063-6394a90a0bf1	69423-176	HUMAN OTC DRUG	Secret Clinical Strength Invisible	Clean Lavender	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20170210	20240901	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	
69423-177_01e0efa4-2950-c341-e063-6394a90a995d	69423-177	HUMAN OTC DRUG	Secret Clinical Strength Clear Clean Lavender		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20170206	20250101	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	
69423-197_f83263cb-8711-3696-e053-6294a90a59f1	69423-197	HUMAN OTC DRUG	Head and Shoulders Deep Moisture Hair and Scalp Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20170911		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-209_c8208bac-9d33-7694-e053-2a95a90a746c	69423-209	HUMAN OTC DRUG	Head and Shoulders Dual Pack Green Apple		Pyrithione Zinc	KIT		20200315		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company						N	20241231
69423-210_d6a7d024-b11c-0df5-e053-2a95a90adf39	69423-210	HUMAN OTC DRUG	Head and Shoulders Dual Pack	Smooth and Silky	Pyrithione Zinc	KIT		20200115		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company						N	20241231
69423-245_f5b37791-1d37-c233-e053-2995a90ae25e	69423-245	HUMAN OTC DRUG	Gillette Clinical Soft Sport Triumph		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20170807		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-247_f831e37f-0fa9-0471-e053-6294a90ae51c	69423-247	HUMAN OTC DRUG	Head and Shoulders Deep Moisture		pyrithione zinc	SHAMPOO	TOPICAL	20171201		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-248_f8322b5b-5652-3335-e053-6394a90ae167	69423-248	HUMAN OTC DRUG	Head and Shoulders Deep Moisture 2in1		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20171201	20241201	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-256_f4347f6a-d808-38bd-e053-2a95a90ac480	69423-256	HUMAN OTC DRUG	Gillette Clinical Soft Ultimate Fresh		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20170807		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-259_f5b38040-05c9-22e3-e053-2995a90a63e6	69423-259	HUMAN OTC DRUG	Olay Age Defying Classic Daily Renewal	Broad Spectrum SPF 15	Octinoxate and Zinc Oxide	LOTION	TOPICAL	20170811		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	OCTINOXATE; ZINC OXIDE	6; 3	g/100mL; g/100mL			N	20241231
69423-278_f834cf94-d71b-1e6a-e053-6394a90a7731	69423-278	HUMAN OTC DRUG	Head and Shoulders Charcoal Daily		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20181115		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-279_0c91894f-a406-73e9-e063-6394a90ab807	69423-279	HUMAN OTC DRUG	Head and Shoulders White Charcoal Daily Hair and Scalp Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20181115		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-284_f1ed85b1-03f1-4de8-e053-2a95a90a8f68	69423-284	HUMAN OTC DRUG	Old Spice Wilderness with Lavender		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20180801		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-286_f63c0cf0-2a16-66b5-e053-2995a90a8584	69423-286	HUMAN OTC DRUG	Safeguard Antibacterial Hand Wash	Notes of Aloe	Chloroxylenol	SOAP	TOPICAL	20230127		OTC MONOGRAPH FINAL	M005	The Procter & Gamble Manufacturing Company	CHLOROXYLENOL	.5	g/100mL			N	20241231
69423-287_f63e3714-5ff7-1984-e053-2a95a90ad564	69423-287	HUMAN OTC DRUG	Safeguard Antibacterial Hand Wash	Fresh Clean Scent	Chloroxylenol	LIQUID	TOPICAL	20230127		OTC MONOGRAPH FINAL	M005	The Procter & Gamble Manufacturing Company	CHLOROXYLENOL	.5	g/100mL			N	20241231
69423-290_0e1f43fb-2f3f-8741-e063-6394a90ac198	69423-290	HUMAN OTC DRUG	Old Spice Volcano with Charcoal		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20181218		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20251231
69423-291_f63e791f-f655-1bb5-e053-2995a90a0a69	69423-291	HUMAN OTC DRUG	Safeguard Antibacterial Hand Wash	Notes of Citrus	Chloroxylenol	LIQUID	TOPICAL	20230127		OTC MONOGRAPH FINAL	M005	The Procter & Gamble Manufacturing Company	CHLOROXYLENOL	.5	g/100mL			N	20241231
69423-292_0e1f91fa-a033-857e-e063-6394a90a68c9	69423-292	HUMAN OTC DRUG	Old Spice Deep Sea with Ocean Elements		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20181218		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20251231
69423-293_f5f1d3da-52fc-8211-e053-2a95a90a323a	69423-293	HUMAN OTC DRUG	Head and Shoulders 2in1 Men Advanced Series Pure Sport Old Spice		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-294_f7f8df66-9d5a-7aac-e053-6294a90a0392	69423-294	HUMAN OTC DRUG	Head and Shoulders MEN Old Spice Pure Sport		Pyrithione Zinc	SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-307_ffd8ac02-2f7f-fe55-e053-6394a90af454	69423-307	HUMAN OTC DRUG	Head and Shoulders Royal Oils Daily Moisture Scalp		Pyrithione Zinc	CREAM	TOPICAL	20180830		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-309_0c8ff74c-2e0b-a801-e063-6294a90ab767	69423-309	HUMAN OTC DRUG	Head and Shoulders Royal Oils Instant Soothe Scalp		Pyrithione Zinc	LOTION	TOPICAL	20180830		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-311_f836f88c-89d8-78d3-e053-6294a90aeee0	69423-311	HUMAN OTC DRUG	Head and Shoulders Men Advanced Series Refreshing Menthol		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-312_f8377a86-3d73-e2af-e053-6294a90a0b6c	69423-312	HUMAN OTC DRUG	Head and Shoulders Men Advanced Series Refreshing 2in1 Menthol		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-315_f5f305df-f7ed-079e-e053-2995a90adc99	69423-315	HUMAN OTC DRUG	Head and Shoulders Coconut Daily		Pyrithione Zinc	SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-316_f7fbab8d-01d7-7533-e053-6294a90a03f0	69423-316	HUMAN OTC DRUG	Head and Shoulders Coconut 2in1		Pyrithione Zinc	SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-319_f8879c09-e944-331d-e053-6294a90a7083	69423-319	HUMAN OTC DRUG	Head and Shoulders Coconut	Daily Hair and Scalp Conditioner	Pyrithione Zinc	LOTION	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-320_f833c75f-f3b8-d9c1-e053-6394a90a1119	69423-320	HUMAN OTC DRUG	Head and Shoulders Calming Lavender	Daily Hair and Scalp Conditioner	Pyrithione Zinc	LOTION	TOPICAL	20180806	20240901	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	
69423-325_f8336c4a-9e96-b8d2-e053-6394a90a5dfe	69423-325	HUMAN OTC DRUG	Head and Shoulders Calming Lavender Daily		Pyrithione Zinc	SHAMPOO	TOPICAL	20180806	20240901	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-326_f7f96317-d916-ddcc-e053-6294a90a4e64	69423-326	HUMAN OTC DRUG	Head and Shoulders Men Advanced Series Swagger Old Spice		Pyrithione Zinc	SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-327_f5f46710-485a-2d7f-e053-2a95a90ae074	69423-327	HUMAN OTC DRUG	Head and Shoulders 2in1 Men Advanced Series Swagger Old Spice		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-329_f7f79e9b-5cf0-c4ab-e053-6394a90afae3	69423-329	HUMAN OTC DRUG	Head and Shoulders 2in1 Men Advanced Series Full and Thick		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20181129		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-336_f200144c-ea33-09c6-e053-2a95a90a590f	69423-336	HUMAN OTC DRUG	Olay Regenerist Micro-Sculpting Anti-Aging Moisturize	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20190201		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
69423-343_ffd767d8-95e4-6458-e053-6394a90a58d2	69423-343	HUMAN OTC DRUG	Head and Shoulders Supreme Detox and Hydrate		Pyrithione Zinc	SHAMPOO	TOPICAL	20190501		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-344_ffd767d8-962b-6458-e053-6394a90a58d2	69423-344	HUMAN OTC DRUG	Head and Shoulders Supreme Nourish and Smooth		Pyrithione Zinc	SHAMPOO	TOPICAL	20190502		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-345_f88719ba-d5b4-4dcd-e053-6394a90a9be3	69423-345	HUMAN OTC DRUG	Head and Shoulders Supreme Soothe and Strengthen		Pyrithione Zinc	SHAMPOO	TOPICAL	20190502		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-346_ffd7b11d-735a-ef91-e053-6294a90a574d	69423-346	HUMAN OTC DRUG	Head and Shoulders Supreme Color Protect		Pyrithione Zinc	SHAMPOO	TOPICAL	20190502		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-347_ffd7b11d-735c-ef91-e053-6294a90a574d	69423-347	HUMAN OTC DRUG	Head and Shoulders Supreme Detox and Hydrate Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20190502		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-348_ffd8120d-fc3b-58f7-e053-6394a90a2430	69423-348	HUMAN OTC DRUG	Head and Shoulders Supreme Nourish and Smooth Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20190502		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-349_ffd82cb4-5992-6d04-e053-6294a90a9fa6	69423-349	HUMAN OTC DRUG	Head and Shoulders Supreme Soothe and Strengthen Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20190502		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-350_ffd84ac7-7379-5a41-e053-6394a90a31ba	69423-350	HUMAN OTC DRUG	Head and Shoulders Supreme Color Protect Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20190502		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-359_f21598bb-34d1-3abd-e053-2995a90aeb30	69423-359	HUMAN OTC DRUG	Olay Regenerist Whip Active Moisturizer Broad Spectrum SPF 40 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part352	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 9	g/100g; g/100g; g/100g; g/100g			N	20241231
69423-360_f215bd63-381e-508b-e053-2a95a90aaa48	69423-360	HUMAN OTC DRUG	Olay Total Effects Whip Active Moisturizer Broad Spectrum SPF 40 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20190901	20240301	OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 9	g/100g; g/100g; g/100g; g/100g			N	
69423-361_f5b46ab4-e5d6-d474-e053-2a95a90a6935	69423-361	HUMAN OTC DRUG	Secret with Essential Oils Rose and Charcoal Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191014		OTC MONOGRAPH FINAL	part350	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-366_f215ddd3-2868-ad07-e053-2995a90a7f18	69423-366	HUMAN OTC DRUG	Secret Cucumber Water Invisible Solid		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191217		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-369_f41f1180-0168-5390-e053-2a95a90a9c56	69423-369	HUMAN OTC DRUG	Secret Rose Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191230	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	
69423-371_f5b46e9c-4ee1-e556-e053-2a95a90ab49d	69423-371	HUMAN OTC DRUG	Secret Lavender Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191230	20240701	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	
69423-372_f446371f-9acc-02e0-e053-2a95a90a9736	69423-372	HUMAN OTC DRUG	Secret Citrus Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20200201	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	
69423-374_f7a750a0-9556-6222-e053-6394a90afee7	69423-374	HUMAN OTC DRUG	Secret Waterlily Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191230	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	
69423-375_f6780bf9-1499-7083-e053-2a95a90a86fb	69423-375	HUMAN OTC DRUG	Secret Coconut Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191214	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	
69423-376_f6684421-ed22-29ca-e053-2995a90a91af	69423-376	HUMAN OTC DRUG	Secret Cocoa Butter Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-377_fb463af6-3dfa-4026-e053-6394a90ad14a	69423-377	HUMAN OTC DRUG	Secret Nectarine Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20200123	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	
69423-379_fd7aa2a2-efaa-7909-e053-6394a90a8c68	69423-379	HUMAN OTC DRUG	Secret Vanilla Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20200201	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	
69423-388_f8883f15-9ed3-7f6c-e053-6394a90a8c7f	69423-388	HUMAN OTC DRUG	Olay Total Effects Moisturizer with Sunscreen	Broad Spectrum SPF 15 Fragrance-Free	Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20190710		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4; 4.5; 2.6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
69423-389_f2163e55-994a-5d2b-e053-2995a90a1cb1	69423-389	HUMAN OTC DRUG	Olay Total Effects Moisturizer	Broad Spectrum SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20190813		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
69423-390_f41eb4ab-870b-09dc-e053-2995a90a93f8	69423-390	HUMAN OTC DRUG	Secret Delicate Rose Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-391_f6550d9a-cb71-9261-e053-2a95a90a8df7	69423-391	HUMAN OTC DRUG	Secret Clinical Invisible Nurturing Coconut		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230110		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-399_f6564bf0-705e-639a-e053-2a95a90afe71	69423-399	HUMAN OTC DRUG	Secret Clinical Strength Odor Shield with Charcoal Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20200107	20240801	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	
69423-405_f4382fa6-a8c5-5e00-e053-2995a90a7e51	69423-405	HUMAN OTC DRUG	Secret Outlast Completely Clean Invisible	Completely Clean	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221218		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
69423-407_ffd85a45-d9d2-255f-e053-6294a90aad85	69423-407	HUMAN OTC DRUG	Head and Shoulders Supreme Detoxifying Pre-Wash Mask		Pyrithione Zinc	CREAM	TOPICAL	20191121	20240901	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-412_f7fcbf28-7922-521d-e053-6294a90a0a0e	69423-412	HUMAN OTC DRUG	Head and Shoulders MEN Advanced Series Bourbon 2in1		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20191121		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-413_f83447a5-0975-63bd-e053-6294a90a855c	69423-413	HUMAN OTC DRUG	Head and Shoulders MEN Advanced Series Sage and Mint 2in1		Pyrithione Zinc	SHAMPOO	TOPICAL	20191121	20241001	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-415_f7fe8244-fd00-622b-e053-6394a90a19bb	69423-415	HUMAN OTC DRUG	Head and Shoulders MEN Advanced Series Sandalwood 2in1		Pyrithione Zinc	SHAMPOO	TOPICAL	20191121		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-416_f643b7d5-8ab4-43af-e053-2a95a90a13d1	69423-416	HUMAN OTC DRUG	Head and Shoulders Tea Tree Oil Daily		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20191121		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-417_f885dc26-3e63-fa76-e053-6394a90a7bf0	69423-417	HUMAN OTC DRUG	Head and Shoulders Tea Tree Oil 2in1		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20191121		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-422_f6556e35-2e4e-1e1d-e053-2995a90a3ff2	69423-422	HUMAN OTC DRUG	Secret Clinical Invisible Clean Lavender		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-423_eaef2df3-f709-a589-e053-2a95a90abd65	69423-423	HUMAN OTC DRUG	Head and Shoulders Styling Gel		Pyrithione Zinc	GEL	TOPICAL	20191121		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-426_ea4a6a6c-8b54-2a72-e053-2a95a90ad263	69423-426	HUMAN OTC DRUG	Head and Shoulders Supreme Hydrating Scalp Serum		Pyrithione Zinc	LIQUID	TOPICAL	20191216		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-432_f3817b35-9fa6-d69f-e053-2a95a90a5944	69423-432	HUMAN OTC DRUG	Secret Lavender Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20190929		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16	g/100g			N	20241231
69423-435_f39365b1-0e81-f3f6-e053-2995a90ac86a	69423-435	HUMAN OTC DRUG	Secret Vanilla Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20190915		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16	g/100g			N	20241231
69423-439_f39368d4-bc14-341b-e053-2a95a90a1644	69423-439	HUMAN OTC DRUG	Secret Nectarine Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20191201		OTC MONOGRAPH FINAL	part350	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16	g/100g			N	20241231
69423-448_b696d280-4854-2259-e053-2a95a90a6061	69423-448	HUMAN OTC DRUG	Old Spice GentleMan s Blend Aloe and Wild Sage		Aluminum zirconium tetrachlorohydrex Gly	STICK	TOPICAL	20200130		OTC MONOGRAPH FINAL	part350	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-456_fda28b92-f8d3-4fe8-e053-6294a90a0771	69423-456	HUMAN OTC DRUG	Secret Outlast Protecting Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20200323		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-460_fda38594-7527-7a23-e053-6394a90a0da3	69423-460	HUMAN OTC DRUG	Secret Outlast Unscented Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20200215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-462_ffd84ac7-737c-5a41-e053-6394a90a31ba	69423-462	HUMAN OTC DRUG	My Black is Beautiful Scalp Care Calming Scalp and Hair		Pyrithione Zinc	LOTION	TOPICAL	20200401		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-463_e6efa84b-7c75-912e-e053-2995a90a164e	69423-463	HUMAN OTC DRUG	My Black is Beautiful Scalp Care Cooling Scalp Serum		Pyrithione Zinc	LIQUID	TOPICAL	20200401		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-464_ff23495d-9994-2410-e053-6294a90ac543	69423-464	HUMAN OTC DRUG	Secret Outlast Invisible Protecting		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20200130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
69423-466_fda3bb96-7607-a5b6-e053-6294a90a792e	69423-466	HUMAN OTC DRUG	Olay Regenerist Whip Moisturizer Broad Spectrum SPF 25 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20200801		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
69423-467_f3937066-43d8-49f8-e053-2995a90ad579	69423-467	HUMAN OTC DRUG	Safeguard Hand Sanitizer Fresh Clean Scent		Ethyl Alcohol	GEL	TOPICAL	20200521		OTC MONOGRAPH NOT FINAL	part333A	The Procter & Gamble Manufacturing Company	ALCOHOL	69.9	mL/100mL			N	20241231
69423-477_fdb7810c-6d94-04e0-e053-6394a90a74fb	69423-477	HUMAN OTC DRUG	Secret Outlast Completely Clean		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20200415		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-483_f5f0fecb-9471-3998-e053-2a95a90aac8c	69423-483	HUMAN OTC DRUG	Old Spice Swagger Refillable		Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20201125	20240801	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	18	g/100g			N	
69423-484_f7a8f76c-8fb9-84db-e053-6394a90a5c8c	69423-484	HUMAN OTC DRUG	Secret Derma Plus Antiperspirant Cooling		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20201125	20240401	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	
69423-485_f7a90745-b704-a4a5-e053-6394a90a20cf	69423-485	HUMAN OTC DRUG	Secret Derma Plus Antiperspirant Even Tone		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20201125	20240401	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	
69423-486_f7a90694-48b7-f062-e053-6294a90a28b5	69423-486	HUMAN OTC DRUG	Secret Derma Plus Antiperspirant Nourishing		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20201125	20240401	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	
69423-487_f7a90694-48b8-f062-e053-6294a90a28b5	69423-487	HUMAN OTC DRUG	Secret Derma Plus Antiperspirant Fragrance Free		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20201125	20240401	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	
69423-488_fdf13ddd-3544-c650-e053-6394a90aec56	69423-488	HUMAN OTC DRUG	Olay Regenerist Mineral Sunscreen Hydrating Moisturizer Broad Spectrum SPF 30		Zinc Oxide	LOTION	TOPICAL	20201125		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	ZINC OXIDE	17.5	g/100mL			N	20241231
69423-489_fdf17ffa-6817-2809-e053-6394a90a5b6e	69423-489	HUMAN OTC DRUG	Olay Regenerist Mineral Sunscreen Hydrating Moisturizer Broad Spectrum SPF 15		Zinc Oxide	LOTION	TOPICAL	20211125	20240801	OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	ZINC OXIDE	9.7	g/100mL			N	
69423-495_fdf25652-ed71-be2d-e053-6294a90a89d4	69423-495	HUMAN OTC DRUG	Secret Fresh Linen Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-496_fdf2bfc8-f637-a809-e053-6394a90a9dff	69423-496	HUMAN OTC DRUG	Secret Outlast Tea Tree Oil Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
69423-497_ff095814-8c1a-e307-e053-6394a90a19af	69423-497	HUMAN OTC DRUG	Secret Outlast Almond Oil Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
69423-498_ff239f43-e4db-0d72-e053-6294a90a8064	69423-498	HUMAN OTC DRUG	Secret Outlast Argan Oil Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
69423-499_01668f13-2c82-d543-e063-6394a90a570b	69423-499	HUMAN OTC DRUG	Secret Clinical Strength Shower Fresh Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	
69423-500_fdf318a8-cb6c-6bb9-e053-6394a90a56dd	69423-500	HUMAN OTC DRUG	Secret Clinical Strength Fresh and Sensitive Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	
69423-501_fe03b9f5-90b8-b07c-e053-6394a90afac9	69423-501	HUMAN OTC DRUG	Secret Clinical Strength Active Fresh Soft		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20201222	20250101	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	
69423-502_fe06d714-48a5-ddee-e053-6294a90ae64e	69423-502	HUMAN OTC DRUG	Secret Clinical Strength Free and Sensitive Soft		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-503_fe06da1b-c495-e238-e053-6294a90a9195	69423-503	HUMAN OTC DRUG	Old Spice High Endurance Clear Pure Sport		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-507_f8affb41-fd2e-536b-e053-6294a90a6ac6	69423-507	HUMAN OTC DRUG	Old Spice Tigerclaw		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-508_f899b126-38aa-d5eb-e053-6394a90ad092	69423-508	HUMAN OTC DRUG	Old Spice Nightpanther		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-509_f89a50ec-98f3-1560-e053-6294a90a16ce	69423-509	HUMAN OTC DRUG	Old Spice Elklord		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-512_f393799b-9f66-6c8f-e053-2995a90a77bd	69423-512	HUMAN OTC DRUG	Old Spice Sea Antiperspirant	and Deodorant	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	part350	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-513_f8af48d3-0068-2014-e053-6294a90aa178	69423-513	HUMAN OTC DRUG	Old Spice Steel Titan		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-514_f89acb90-cfe6-fd79-e053-6294a90a5615	69423-514	HUMAN OTC DRUG	Old Spice Canyon		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-515_f899f554-a4d2-e4dd-e053-6294a90a4d1a	69423-515	HUMAN OTC DRUG	Old Spice Alpine		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-518_fe07d966-edcf-401a-e053-6394a90a1fbc	69423-518	HUMAN OTC DRUG	Old Spice Clinical Sweat Defense Stronger Swagger Soft		Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-521_f823f6b8-0ba9-ae15-e053-6294a90a078c	69423-521	HUMAN OTC DRUG	Head and Shoulders Apple Cider Vinegar		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-522_f824a968-fe7d-ca39-e053-6294a90a89c4	69423-522	HUMAN OTC DRUG	Head and Shoulders Apple Cider Vinegar 2in1		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-523_f7ab6d5e-76a4-a512-e053-6294a90a5c2d	69423-523	HUMAN OTC DRUG	Head and Shoulders Clinical Strength Dandruff Defense Dry Scalp Rescue		Selenium Sulfide	LOTION/SHAMPOO	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	SELENIUM SULFIDE	1	g/100mL			N	20241231
69423-524_fe088cbe-ef68-7d1f-e053-6294a90afe39	69423-524	HUMAN OTC DRUG	Head and Shoulders 2in1 Clinical Strength Dandruff Defense Advanced Oil Control		Selenium Sulfide	LOTION/SHAMPOO	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	SELENIUM SULFIDE	1	g/100mL			N	20241231
69423-525_fb36a5cc-6c41-0cc8-e053-6394a90abf6e	69423-525	HUMAN OTC DRUG	Head and Shoulders Clinical Strength Dandruff Defense Advanced Oil Control		Selenium Sulfide	LOTION/SHAMPOO	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	SELENIUM SULFIDE	1	g/100mL			N	20241231
69423-526_fb36d298-b693-6731-e053-6394a90adc44	69423-526	HUMAN OTC DRUG	Head and Shoulders Clinical Strength Dandruff Defense Intensive Itch Relief		Selenium Sulfide	LOTION/SHAMPOO	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	SELENIUM SULFIDE	1	g/100mL			N	20241231
69423-527_f7ab4292-1c56-416b-e053-6294a90a3b40	69423-527	HUMAN OTC DRUG	Head and Shoulders 2in1 Clinical Strength Dandruff Defense Intensive Itch Relief		Selenium Sulfide	LOTION/SHAMPOO	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	SELENIUM SULFIDE	1	g/100mL			N	20241231
69423-529_ec092c92-70fd-665f-e053-2a95a90afdd0	69423-529	HUMAN OTC DRUG	Head and Shoulders Clinical Itch Relief Scalp Mist		Pyrithione Zinc	LIQUID	TOPICAL	20201117		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-530_f3939bae-6fd3-5913-e053-2995a90a8a09	69423-530	HUMAN OTC DRUG	Head and Shoulders Cleansing Cucumber		Pyrithione Zinc	SHAMPOO	TOPICAL	20210315		OTC MONOGRAPH FINAL	part358H	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-531_0e21b4fe-7467-7d2e-e063-6294a90ad993	69423-531	HUMAN OTC DRUG	Old Spice Sweat Defense Knockout Dry		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20201222	20240301	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	23.5	g/100g			N	
69423-532_f8afb9e3-d406-4e59-e053-6294a90afcdf	69423-532	HUMAN OTC DRUG	Old Spice Red Collection After Hours		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-533_f89a7f9d-bc54-8fc2-e053-6294a90ac847	69423-533	HUMAN OTC DRUG	Old Spice Krakengard		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-534_f89b3ca4-d8d8-694f-e053-6294a90abc11	69423-534	HUMAN OTC DRUG	Old Spice Red Collection Swagger		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-535_f655c763-1001-19d3-e053-2995a90a7822	69423-535	HUMAN OTC DRUG	Secret Clinical Invisible Stress Response		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-536_f8b014a8-363c-c8a5-e053-6394a90a3ad1	69423-536	HUMAN OTC DRUG	Old Spice Wild Collection Dragonblast		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-537_f8b05d84-ec34-d1f1-e053-6294a90aa673	69423-537	HUMAN OTC DRUG	Old Spice Wolfthorn		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20210701		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-538_f89c77d6-63f9-08d2-e053-6394a90abc7d	69423-538	HUMAN OTC DRUG	Old Spice Bearglove		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-539_f89a1877-953c-81bd-e053-6394a90aac86	69423-539	HUMAN OTC DRUG	Old Spice Red Collection Captain		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20210801		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-540_f89c4050-da5a-7c5a-e053-6394a90a51bc	69423-540	HUMAN OTC DRUG	Old Spice Timber with Sandalwood Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-541_f89d1d79-4880-ceab-e053-6394a90a2527	69423-541	HUMAN OTC DRUG	Old Spice Fiji with Palm Tree		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-542_fe090ed0-21ab-0ec9-e053-6294a90a71b9	69423-542	HUMAN OTC DRUG	Old Spice High Endurance Pure Sport		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20201130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-544_fe091d4d-e47a-9830-e053-6294a90a07d7	69423-544	HUMAN OTC DRUG	Old Spice Clinical Sweat Defense Pure Sport Plus Soft		Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20201222		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-546_fbfa23c2-dadf-4f45-e053-6394a90a4fef	69423-546	HUMAN OTC DRUG	Safeguard Moisturizing Hand Sanitizer Ocean Breeze		Ethyl Alcohol	GEL	TOPICAL	20210215	20240124	OTC MONOGRAPH NOT FINAL	part333A	The Procter & Gamble Manufacturing Company	ALCOHOL	69.9	mL/100mL			N	
69423-548_ffd59bae-a35d-38cc-e053-6294a90a0ad6	69423-548	HUMAN OTC DRUG	Native Mineral Face Broad Spectrum SPF 30 Unscented		Zinc Oxide	LOTION	TOPICAL	20210401		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	ZINC OXIDE	20	g/100mL			N	20241231
69423-549_ffd70a87-6fa9-2453-e053-6294a90adace	69423-549	HUMAN OTC DRUG	Native Mineral Face Broad Spectrum SPF 30 Coconut and Pineapple		Zinc Oxide	LOTION	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part352	The Procter & Gamble Manufacturing Company	ZINC OXIDE	20	g/100mL			N	20241231
69423-554_018ed2dc-a48a-0727-e063-6394a90adfda	69423-554	HUMAN OTC DRUG	First Aid Beauty FAB Pharma BHA Acne Spot Treatment		Salicylic Acid	GEL	TOPICAL	20210101	20251212	OTC MONOGRAPH FINAL	M006	The Procter & Gamble Manufacturing Company	SALICYLIC ACID	2	g/100mL			N	
69423-558_0b3df391-1fe0-cdf2-e063-6394a90adbec	69423-558	HUMAN OTC DRUG	Head and Shoulders Scalp X Minoxidil Hair Regrowth Treatment for Women		Minoxidil	SOLUTION	TOPICAL	20230115		ANDA	ANDA091344	The Procter & Gamble Manufacturing Company	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69423-559_f28f61e3-5708-16d5-e053-2a95a90a61c1	69423-559	HUMAN OTC DRUG	Head and Shoulders Scalp X Minoxidil Hair Regrowth Treatment for Men		Minoxidil	SOLUTION	TOPICAL	20230115		ANDA	ANDA091344	The Procter & Gamble Manufacturing Company	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69423-560_f2682ce3-8cfa-df80-e053-2a95a90ac08a	69423-560	HUMAN OTC DRUG	SEEME BEAUTY Moisturizer with Sunscreen SPF 30		Avobenzone, Homosalate, Octocrylene, Octyl Salicylate	LOTION	TOPICAL	20210706		OTC MONOGRAPH NOT FINAL	part352	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 6	g/100g; g/100g; g/100g; g/100g			N	20241231
69423-561_f445fb24-de3c-5741-e053-2a95a90a59a9	69423-561	HUMAN OTC DRUG	Secret Invigorating Citrus Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-562_f6560d6e-03d4-6b22-e053-2a95a90ae625	69423-562	HUMAN OTC DRUG	Secret Clinical Invisible Free and Sensitive		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-563_f19b3828-02cb-b8de-e053-2a95a90a8411	69423-563	HUMAN OTC DRUG	First Aid Beauty FAB Ultra Repair Intense Hydration Skin Protectant Vanilla		Colloidal Oatmeal	CREAM	TOPICAL	20230101		OTC MONOGRAPH FINAL	M016	The Procter & Gamble Manufacturing Company	OATMEAL	.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69423-564_f19bb7b2-65b9-fdad-e053-2995a90a6768	69423-564	HUMAN OTC DRUG	First Aid Beauty FAB Ultra Repair Intense Hydration Skin Protectant White Tea and Apricot		Colloidal Oatmeal	CREAM	TOPICAL	20230101		OTC MONOGRAPH FINAL	M016	The Procter & Gamble Manufacturing Company	OATMEAL	.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69423-565_f4464200-a3e7-0a78-e053-2a95a90a88b8	69423-565	HUMAN OTC DRUG	First Aid Beauty FAB Ultra Repair Intense Hydration Skin Protectant Cranberry Pomegranate		Colloidal Oatmeal	CREAM	TOPICAL	20230101		OTC MONOGRAPH FINAL	M016	The Procter & Gamble Manufacturing Company	OATMEAL	.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69423-567_f198f572-1f93-771e-e053-2995a90ac06d	69423-567	HUMAN OTC DRUG	First Aid Beauty FAB Ultra Repair Skin Protectant Pink Grapefruit		Colloidal Oatmeal	CREAM	TOPICAL	20210101		OTC MONOGRAPH FINAL	M016	The Procter & Gamble Manufacturing Company	OATMEAL	.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69423-568_fb36a5cc-6c42-0cc8-e053-6394a90abf6e	69423-568	HUMAN OTC DRUG	Head and Shoulders Clinical Dandruff Defense Dry Scalp Rescue		Pyrithione Zinc	LOTION	TOPICAL	20210111		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.75	g/100mL			N	20241231
69423-570_fb36f3eb-46f8-b316-e053-6394a90a231d	69423-570	HUMAN OTC DRUG	Royal Oils by Head and Shoulders Moisture Boost Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20210501		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-571_fb432d21-12f3-a890-e053-6294a90aef9d	69423-571	HUMAN OTC DRUG	Royal Oils by head and shoulders Moisture Renewal Scalp Balancing Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20210501		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-572_f39270cb-76d1-1c65-e053-2995a90a9d52	69423-572	HUMAN OTC DRUG	Gillette Clear Plus Dri-Tech Scent Xtend		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20210601		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-573_f3926f3c-1601-0fc3-e053-2a95a90a66fc	69423-573	HUMAN OTC DRUG	Gillette Clear Plus Dri-Tech Pacific Tide		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20210601		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-575_0e226eae-e1d7-dae4-e063-6294a90abfbe	69423-575	HUMAN OTC DRUG	Gillette Clear Plus Dri-Tech Cool Wave		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20211130	20250101	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	
69423-576_ffd85a45-d9d4-255f-e053-6294a90aad85	69423-576	HUMAN OTC DRUG	Royal Oils by Head and Shoulders Moisturizing Hair and Scalp Co-Wash		Pyrithione Zinc	LOTION	TOPICAL	20210120	20240901	OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	
69423-578_0e2299b7-0ed0-bfbf-e063-6394a90a8c7d	69423-578	HUMAN OTC DRUG	Gillette Clear Plus Dri-Tech Skin Guard		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20210901	20240701	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	
69423-579_0e2475f8-63e4-4f1e-e063-6394a90a3b33	69423-579	HUMAN OTC DRUG	Gillette Clear Plus Dri-Tech Power Rush		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20210901	20250201	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	
69423-581_0e24e82c-aa04-839b-e063-6394a90a6d59	69423-581	HUMAN OTC DRUG	Gillette Clear Plus Dri-Tech Wild Rain		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20220103	20250101	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	
69423-584_0e256302-98b1-a665-e063-6394a90a04b4	69423-584	HUMAN OTC DRUG	Gillette Clinical Protection Cool Wave Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20210101		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	20251231
69423-585_0e264e7b-bc9a-279b-e063-6394a90a6fd2	69423-585	HUMAN OTC DRUG	Gillette Clear Plus Scent Boost Cool Wave		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20220103		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20251231
69423-586_f290326b-c489-2380-e053-2a95a90a88e1	69423-586	HUMAN OTC DRUG	Head and Shoulders Scalp X Minoxidil Hair Regrowth Treatment for Women		Minoxidil	AEROSOL, FOAM	TOPICAL	20211101	20241215	ANDA	ANDA091344	The Procter & Gamble Manufacturing Company	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
69423-587_f27b41f1-f63c-1c1c-e053-2a95a90a3518	69423-587	HUMAN OTC DRUG	Head and Shoulders Scalp X Minoxidil Hair Regrowth Treatment for Men		Minoxidil	AEROSOL, FOAM	TOPICAL	20211101	20241215	ANDA	ANDA091344	The Procter & Gamble Manufacturing Company	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
69423-588_fa2b1f1d-2bd5-c8cc-e053-6394a90a79c4	69423-588	HUMAN OTC DRUG	Old Spice Bald Care System Scalp Moisturizer Broad Spectrum SPF 25 Sunscreen		Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20211001		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
69423-589_0c91fa8f-dc46-e004-e063-6294a90a6c3e	69423-589	HUMAN OTC DRUG	Head and Shoulders Moisturizing Avocado Oil		Pyrithione Zinc	SHAMPOO	TOPICAL	20210315		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-591_f3923a8c-e905-81e6-e053-2995a90a1f8b	69423-591	HUMAN OTC DRUG	First Aid Beauty Anti-Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20210730		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-596_0e265997-851f-8b4f-e063-6294a90a6896	69423-596	HUMAN OTC DRUG	Old Spice Game Day	High Endurance Antiperspirant and Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20210730		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	17	g/100g			N	20251231
69423-597_0e268b3a-7fa3-2acc-e063-6394a90a74b9	69423-597	HUMAN OTC DRUG	Old Spice Playmaker	High Endurance	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20210815		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	17	g/100g			N	20251231
69423-598_0a335f61-34be-f26f-e063-6394a90a057a	69423-598	HUMAN OTC DRUG	Bodewell Psoriasis Calming		Salicylic Acid	CREAM	TOPICAL	20220215	20241231	OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	SALICYLIC ACID	2	g/100mL			N	
69423-599_0e26b3b0-1659-dfa7-e063-6294a90ae51f	69423-599	HUMAN OTC DRUG	Secret Invisible Spring Breeze		Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20190101	20241001	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	18	g/100g			N	
69423-607_0c920bb1-8987-923f-e063-6394a90a37e4	69423-607	HUMAN OTC DRUG	Royal Oils by Head and Shoulders Moisture Boost 2in1		Pyrithione Zinc	SHAMPOO	TOPICAL	20211001	20240201	OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-608_0c92250a-7939-f6b2-e063-6294a90a6008	69423-608	HUMAN OTC DRUG	Royal Oils by Head and Shoulders Sulfate Free Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20211030		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-609_0e36c32f-fdd9-8bb5-e063-6294a90a451a	69423-609	HUMAN OTC DRUG	Old Spice Fresh	High Endurance Antiperspirant and Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20211231		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	17	g/100g			N	20251231
69423-610_0e373e16-e580-4e88-e063-6394a90a3ca9	69423-610	HUMAN OTC DRUG	Old Spice Oasis with Vanilla Notes		Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20211230	20240201	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	
69423-611_0e378f25-9986-5ec7-e063-6394a90a135a	69423-611	HUMAN OTC DRUG	Old Spice Pure Sport High Endurance		Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220130		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	15	g/100g			N	20251231
69423-612_0e37e212-e803-7fc1-e063-6394a90a2a3b	69423-612	HUMAN OTC DRUG	Old Spice Original	High Endurance Antiperspirant and Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20211231		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	17	g/100g			N	20251231
69423-613_0e38ede2-9ffa-e698-e063-6294a90abc4a	69423-613	HUMAN OTC DRUG	Secret Outlast Shower Fresh Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220115	20240201	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	
69423-614_0a32f947-7ac6-c4ba-e063-6394a90afe23	69423-614	HUMAN OTC DRUG	Bodewell Eczema Daily Calming		Colloidal Oatmeal	CREAM	TOPICAL	20220215	20240430	OTC MONOGRAPH DRUG	M016	The Procter & Gamble Manufacturing Company	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
69423-615_0a33fa8a-8af2-30ed-e063-6394a90a1808	69423-615	HUMAN OTC DRUG	Bodewell Eczema Daily Soothing		Colloidal Oatmeal	SPRAY	TOPICAL	20220215	20240430	OTC MONOGRAPH DRUG	M016	The Procter & Gamble Manufacturing Company	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
69423-616_0a339cdd-091a-28c6-e063-6294a90ade78	69423-616	HUMAN OTC DRUG	Bodewell Psoriasis Soothing		Salicylic Acid	SPRAY	TOPICAL	20220215	20240430	OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	SALICYLIC ACID	1.8	g/100mL			N	
69423-617_0a33c788-2066-5531-e063-6294a90a9598	69423-617	HUMAN OTC DRUG	Bodewell Psoriasis Scalp Relief Treatment		Salicylic Acid	SPRAY	TOPICAL	20220215	20240430	OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	SALICYLIC ACID	1.95	g/100mL			N	
69423-618_ffd80f45-e9b0-6e24-e053-6294a90a3b02	69423-618	HUMAN OTC DRUG	Head and Shoulders Supreme Clarify and Volumize Scalp and Hair Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20220115		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-619_f833ec76-676e-22a1-e053-6394a90a6b92	69423-619	HUMAN OTC DRUG	Head and Shoulders MEN Advanced Series Lavender Mint 2in1		Pyrithione Zinc	SHAMPOO	TOPICAL	20220201		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-620_0b3ae643-cf31-c609-e063-6394a90a88e8	69423-620	HUMAN OTC DRUG	Head and Shoulders Lemon Oil 2in1		Pyrithione Zinc	SHAMPOO	TOPICAL	20220215		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-623_0e39ad6c-5cf5-3c1e-e063-6294a90a1994	69423-623	HUMAN OTC DRUG	Gillette Clear Plus Dri-Tech Arctic Ice		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20210901	20240201	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	
69423-624_0ce04f85-f007-4b7b-e063-6394a90a4eb5	69423-624	HUMAN OTC DRUG	Secret Powder Fresh Antiperspirant and Deodorant	Wide	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-625_0e3a4320-5cb5-3eb0-e063-6394a90a389e	69423-625	HUMAN OTC DRUG	Secret Unscented Invisible		Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	20251231
69423-626_0e3ac88a-d901-a81d-e063-6394a90a55ef	69423-626	HUMAN OTC DRUG	Secret Shower Fresh Invisible	Antiperspirant/Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103	20250901	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	
69423-627_09a7b8c3-de99-d440-e063-6294a90ac455	69423-627	HUMAN OTC DRUG	Secret Spring Breeze Invisible	Antiperspirant/Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	20241231
69423-628_0ce0d22c-5347-13f9-e063-6294a90af9da	69423-628	HUMAN OTC DRUG	Secret Shower Fresh Antiperspirant and Deodorant	Wide	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-629_0cf2896d-0aaf-f45b-e063-6394a90a91a9	69423-629	HUMAN OTC DRUG	Secret Tropical Orchid Invisible	Antiperspirant/Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	20241231
69423-630_0e3accc7-093a-9b80-e063-6394a90ab7d5	69423-630	HUMAN OTC DRUG	Secret Sheer Clean Invisible	Antiperspirant/Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103	20251001	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	
69423-631_f5f07d17-76c9-3677-e053-2995a90aada4	69423-631	HUMAN OTC DRUG	Secret Fresh Invisible	Antiperspirant/Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	20241231
69423-632_0ce67c30-a179-72a5-e063-6394a90ab02c	69423-632	HUMAN OTC DRUG	Secret Clean Lavender Invisible	Antiperspirant/Deodorant	Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20220103	20250601	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	
69423-634_f7952074-1a31-a93b-e053-6294a90a5dc3	69423-634	HUMAN OTC DRUG	Secret Cozy Vanilla Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220715	20240601	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	
69423-636_017c1721-a78b-2f8e-e063-6294a90aa77f	69423-636	HUMAN OTC DRUG	Secret Relaxing Lavender Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220301	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	
69423-637_0e9b56a3-f6ef-fccf-e063-6394a90aade0	69423-637	HUMAN OTC DRUG	Secret Outlast Advanced Invisible Completely Clean		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220422		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20251231
69423-638_0c92579b-5d45-ac10-e063-6394a90aa854	69423-638	HUMAN OTC DRUG	Head and Shoulders Supreme Clarify and Volumize		Pyrithione Zinc	SHAMPOO	TOPICAL	20220122	20250501	OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-640_f5dea744-ed28-bf66-e053-2a95a90a5cf1	69423-640	HUMAN OTC DRUG	Old Spice Aqua Reef Dry Antiperspirant		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20221017		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	25	g/100g			N	20241231
69423-642_0c929c77-c696-a582-e063-6394a90aeab1	69423-642	HUMAN OTC DRUG	Head and Shoulders Clinical Strength Dandruff Defense Sensitive Scalp		Selenium Sulfide	LOTION/SHAMPOO	TOPICAL	20220422		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	SELENIUM SULFIDE	1	g/100mL			N	20241231
69423-643_0c92b8c4-4cff-5478-e063-6294a90a7c3e	69423-643	HUMAN OTC DRUG	Head and Shoulders Scalp X		Pyrithione Zinc	SHAMPOO	TOPICAL	20220901	20240901	OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-644_0c92d0b3-1764-de2d-e063-6394a90a34d1	69423-644	HUMAN OTC DRUG	Head and Shoulders Scalp X for Men		Pyrithione Zinc	SHAMPOO	TOPICAL	20220901	20240901	OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	
69423-646_0c92d58b-b1c5-dc2c-e063-6394a90a4d7a	69423-646	HUMAN OTC DRUG	Head and Shoulders Scalp Restore		Pyrithione Zinc	SHAMPOO	TOPICAL	20220601		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-647_0c92d0b3-1769-de2d-e063-6394a90a34d1	69423-647	HUMAN OTC DRUG	Head and Shoulders Classic Clean with Vitamin E		Pyrithione Zinc	SHAMPOO	TOPICAL	20220601		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-648_0c930b31-173e-ef83-e063-6394a90af90d	69423-648	HUMAN OTC DRUG	Head and Shoulders 2in1 Dry Scalp Care with Almond and Coconut Oil		Pyrithione Zinc	SHAMPOO	TOPICAL	20220601		OTC MONOGRAPH DRUG	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-652_fe44f6d1-afb9-4e59-e053-6294a90ad638	69423-652	HUMAN OTC DRUG	Gillette Comfort plus Dri-Tech Cool Wave		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220122	20240901	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	
69423-653_fe32786d-88f8-e2de-e053-6394a90acb47	69423-653	HUMAN OTC DRUG	Gillette Comfort plus Dri-Tech Clean Rush		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220322	20240701	OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	
69423-662_f656a168-a95e-89e4-e053-2995a90acd9d	69423-662	HUMAN OTC DRUG	Secret Island Breeze Invisible		Aluminum Zirconium Trichlorohydrex Gly	STICK	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	18	g/100g			N	20241231
69423-663_f656d9b2-0619-247c-e053-2a95a90a7f34	69423-663	HUMAN OTC DRUG	Secret Invisible Mountain Spring		Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	18	g/100g			N	20241231
69423-664_f657788d-043b-650b-e053-2995a90a546c	69423-664	HUMAN OTC DRUG	Secret Tropical Hibiscus Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20230125		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-667_f43419b3-cda2-8212-e053-2995a90a8957	69423-667	HUMAN OTC DRUG	Gillette Clinical Soft Arctic Ice		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-668_f8254f9f-844f-1553-e053-6294a90a4901	69423-668	HUMAN OTC DRUG	Head and Shoulders 2in1 MEN Eucalyptus and Neem		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20221215		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-669_f7ff4442-5d3e-034a-e053-6394a90a686d	69423-669	HUMAN OTC DRUG	Head and Shoulders Shea Butter Hair and Scalp Conditioner		Pyrithione Zinc	OIL	TOPICAL	20230201		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.5	g/100mL			N	20241231
69423-670_f80a83ae-26c3-e690-e053-6294a90ad359	69423-670	HUMAN OTC DRUG	Head and Shoulders Ginger 2in1		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20221215		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-671_f80a1580-38b9-3dae-e053-6394a90aff5d	69423-671	HUMAN OTC DRUG	Head and Shoulders Shea Butter		Pyrithione Zinc	SHAMPOO	TOPICAL	20221215		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-672_f80af1c2-6a90-e346-e053-6394a90a4b0b	69423-672	HUMAN OTC DRUG	Head and Shoulders Deep Scalp Hydration Daily		Pyrithione Zinc	SHAMPOO	TOPICAL	20221215		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-674_f6641904-b7e7-0e4e-e053-2a95a90a1b17	69423-674	HUMAN OTC DRUG	Secret Nurturing Coconut Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-675_ffe74edd-a684-81af-e053-6394a90a35ea	69423-675	HUMAN OTC DRUG	Secret Weightless Dry Waterlily plus Argan Oil		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-676_f5dd6ecc-4405-6c47-e053-2a95a90a92d3	69423-676	HUMAN OTC DRUG	Secret Weightless Dry White Peach plus Argan Oil		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-677_f5ddd639-e622-08ab-e053-2995a90a01d2	69423-677	HUMAN OTC DRUG	Secret Weightless Dry Vanilla plus Argan Oil		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-678_f5dde062-e0f8-28ee-e053-2995a90a3c7e	69423-678	HUMAN OTC DRUG	Secret Weightless Dry Wild Rose plus Argan Oil		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-679_f5ddd639-e625-08ab-e053-2995a90a01d2	69423-679	HUMAN OTC DRUG	Secret Weightless Dry Relaxing Lavender plus Argan Oil		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-680_f5de2372-763d-1357-e053-2995a90af183	69423-680	HUMAN OTC DRUG	Secret Weightless Dry Refreshing Berry plus Argan Oil		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-681_f5de405a-73c0-99a8-e053-2a95a90a805f	69423-681	HUMAN OTC DRUG	Secret Weightless Dry Tropical Hibiscus plus Argan Oil		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20221215		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-682_f5de6ef4-92ba-f17e-e053-2995a90a2ef4	69423-682	HUMAN OTC DRUG	Old Spice Sweat Defense Knockout Dry Antiperspirant		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-683_f5debac9-0ebc-71e5-e053-2995a90a1d94	69423-683	HUMAN OTC DRUG	Old Spice Sweat Defense Dry Fast Break		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-684_0cf5c07f-8c95-2ee6-e063-6394a90a893d	69423-684	HUMAN OTC DRUG	Old Spice Sweat Defense Stronger Swagger Dry Antiperspirant		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101	20250301	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	
69423-685_f5df34a5-d37b-4a89-e053-2a95a90aaa47	69423-685	HUMAN OTC DRUG	Old Spice Sweat Defense Pure Sport Plus Dry Antiperspirant		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-686_0cf5ec14-fc25-d7e3-e063-6294a90a324a	69423-686	HUMAN OTC DRUG	Old Spice Sweat Defense Ultimate Captain Dry Antiperspirant		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20220101	20240901	OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	
69423-687_f604128f-5df6-4a92-e053-2a95a90ab82a	69423-687	HUMAN OTC DRUG	Secret Clinical Clear Clean Coconut		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20230303		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-688_f604828f-0d2d-aa58-e053-2995a90a96d6	69423-688	HUMAN OTC DRUG	Secret Crisp Cucumber Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-689_01f4adeb-7331-6b14-e063-6294a90af0f8	69423-689	HUMAN OTC DRUG	Old Spice Sharkhammer		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-690_017d933f-87c2-5b88-e063-6294a90a9e23	69423-690	HUMAN OTC DRUG	First Aid Beauty FAB Weightless Mineral Sunscreen Broad Spectrum SPF 30		Zinc Oxide	LIQUID	TOPICAL	20230501		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	ZINC OXIDE	22	g/100mL			N	20241231
69423-691_f68014f5-02d9-d3ac-e053-2a95a90ac96f	69423-691	HUMAN OTC DRUG	First Aid Beauty FAB Ultra Repair Face Moisturizer with Sunscreen Broad Spectrum SPF 30		Octocrylene, and Zinc Oxide	LOTION	TOPICAL	20230214		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	OCTOCRYLENE; ZINC OXIDE	10; 10.13	g/100mL; g/100mL			N	20241231
69423-692_f6425582-326e-7fb5-e053-2995a90a322a	69423-692	HUMAN OTC DRUG	Good Skin MD Facial Moisturizer with Sunscreen Broad Spectrum SPF 15		Zinc Oxide	LOTION	TOPICAL	20220301		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	ZINC OXIDE	9.7	g/100mL			N	20241231
69423-693_f792c548-1e2d-895a-e053-6394a90aae6c	69423-693	HUMAN OTC DRUG	Secret Clinical Clear	Completely Clean	Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-694_f7948bed-ae48-b710-e053-6394a90a399a	69423-694	HUMAN OTC DRUG	Secret Cozy Vanilla Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-695_f7a6e1aa-1022-f113-e053-6294a90a6d81	69423-695	HUMAN OTC DRUG	Secret Cool Waterlily Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-696_f80e8a60-2b0e-dce2-e053-6394a90ab275	69423-696	HUMAN OTC DRUG	Head and Shoulders Deep Scalp Hydration 2in1		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20221215		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-697_f81e660d-48f5-2b56-e053-6294a90ab0c9	69423-697	HUMAN OTC DRUG	Head and Shoulders Deep Scalp Cleanse Daily		Pyrithione Zinc	SHAMPOO	TOPICAL	20221215		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-698_f81eae6d-eb09-cfcc-e053-6394a90ac898	69423-698	HUMAN OTC DRUG	Head and Shoulders Deep Scalp Cleanse 2in1		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20221215		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-699_f81ffd5e-f0f7-4725-e053-6294a90aba65	69423-699	HUMAN OTC DRUG	Olay Sensitive Eczema Therapy Skin Relief Skin Protectant		Colloidal Oatmeal	CREAM	TOPICAL	20230306		OTC MONOGRAPH FINAL	M016	The Procter & Gamble Manufacturing Company	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69423-701_f89886b7-a825-0a96-e053-6294a90a4c25	69423-701	HUMAN OTC DRUG	Old Spice Oasis with Vanilla Notes		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220801		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-702_fd9d7b2f-c43a-56b6-e053-6294a90a58d4	69423-702	HUMAN OTC DRUG	Secret Delicate Rose Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20220701		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-703_fe03f6d8-1f17-fbf9-e053-6294a90abe9f	69423-703	HUMAN OTC DRUG	Secret Clinical Active Fresh Soft		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20230301		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-704_fe069fd7-a7a0-ad66-e053-6394a90ae747	69423-704	HUMAN OTC DRUG	Secret Clinical Free and Sensitive Soft		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20230301		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-705_fe1859e8-e6af-9503-e053-6294a90a72b7	69423-705	HUMAN OTC DRUG	Old Spice High Endurance Pure Sport Invisible		Aluminum Zirconium Pentachlorohydrex Gly	STICK	TOPICAL	20221201		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-706_fe322fd2-748d-74ab-e053-6294a90ab8e2	69423-706	HUMAN OTC DRUG	Gillette Comfort plus Dri-Tech Clean Rush		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-707_fe44d1ee-1e04-b74f-e053-6294a90a8bb4	69423-707	HUMAN OTC DRUG	Gillette Dryshield Cool Wave Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230401		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-708_fea4bb71-d5d9-b5e5-e053-6394a90aa865	69423-708	HUMAN OTC DRUG	First Aid Beauty FAB Ultra Repair Skin Protectant Vanilla Cookie		Colloidal Oatmeal	CREAM	TOPICAL	20210101		OTC MONOGRAPH FINAL	M016	The Procter & Gamble Manufacturing Company	OATMEAL	.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69423-710_fece65c0-fdbe-61d8-e053-6294a90a9a68	69423-710	HUMAN OTC DRUG	Secret Clinical Stress Response Soft		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20230301		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-711_fed200e2-e17e-af55-e053-6294a90a5752	69423-711	HUMAN OTC DRUG	Secret Clinical Light and Fresh Soft		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20230301		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-712_fed2a37a-e24d-42cb-e053-6394a90afe4d	69423-712	HUMAN OTC DRUG	Secret Clinical Waterproof Soft		Aluminum Zirconium Trichlorohydrex Gly	CREAM	TOPICAL	20230301		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69423-713_ff095814-8c16-e307-e053-6394a90a19af	69423-713	HUMAN OTC DRUG	Secret Clinical Shower Fresh Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-714_ff0a8c70-6e29-2140-e053-6294a90ad9b9	69423-714	HUMAN OTC DRUG	Secret Clinical Completely Clean Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221201		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-715_ff30d274-515b-c3f9-e053-6294a90a0b45	69423-715	HUMAN OTC DRUG	Secret Clinical Protection Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230101		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-718_ff585684-0db0-6f4b-e053-6294a90a5c9e	69423-718	HUMAN OTC DRUG	Secret Relaxing Lavender Invisible		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20221230		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-719_0027a6cc-35f2-4b64-e063-6394a90ac29a	69423-719	HUMAN OTC DRUG	Olay Regenerist Regenerating with Sunscreen Broad Spectrum SPF 15		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20230101		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4; 4.5; 2.6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
69423-720_00367a29-3ec2-b194-e063-6394a90a82b2	69423-720	HUMAN OTC DRUG	My Black is Beautiful Cooling Scalp Serum		Pyrithione Zinc	LIQUID	TOPICAL	20231101		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	.1	g/100mL			N	20241231
69423-721_003c9d8b-4eb1-8a88-e063-6294a90afe9a	69423-721	HUMAN OTC DRUG	Head and Shoulders Bare Minimal Ingredients		Pyrithione Zinc	SHAMPOO	TOPICAL	20230401		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-722_003d1624-50c7-20ad-e063-6394a90ada00	69423-722	HUMAN OTC DRUG	Head and Shoulders Bare Minimal Ingredients Soothing Hydration		Pyrithione Zinc	SHAMPOO	TOPICAL	20230401		OTC MONOGRAPH FINAL	M032	The Procter & Gamble Manufacturing Company	PYRITHIONE ZINC	1	g/100mL			N	20241231
69423-723_018ca38b-6e15-01f8-e063-6394a90a8320	69423-723	HUMAN OTC DRUG	Olay Sensitive Mineral Sunscreen with Colloidal Oatmeal Broad Spectrum SPF 30		Zinc Oxide	LOTION	TOPICAL	20230301		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	ZINC OXIDE	17.5	g/100mL			N	20241231
69423-724_018e1bfe-e100-46d3-e063-6394a90af69b	69423-724	HUMAN OTC DRUG	First Aid Beauty FAB Acne Spot Treatment		Salicylic Acid	GEL	TOPICAL	20230801		OTC MONOGRAPH FINAL	M006	The Procter & Gamble Manufacturing Company	SALICYLIC ACID	2	g/100mL			N	20241231
69423-725_01e0cb6a-e3a9-9a5d-e063-6394a90acca6	69423-725	HUMAN OTC DRUG	Secret Clinical Clear Clean Lavender		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20230301		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	20	g/100g			N	20241231
69423-728_026975ec-0b37-6f5c-e063-6294a90a03d3	69423-728	HUMAN OTC DRUG	Old Spice Champion		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230130		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-729_026998ed-ed37-48b9-e063-6394a90a20c7	69423-729	HUMAN OTC DRUG	Old Spice Prestige		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230103		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-730_0269aedc-574b-d6a3-e063-6294a90a50d5	69423-730	HUMAN OTC DRUG	Old Spice Harbor		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230103		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100g			N	20241231
69423-731_026dcac2-5636-8d11-e063-6394a90a5e1a	69423-731	HUMAN OTC DRUG	Native Mineral Sunscreen Broad Spectrum SPF 30 Sweet Peach and Nectar		Zinc Oxide	LOTION	TOPICAL	20230301		OTC MONOGRAPH FINAL	M020	The Procter & Gamble Manufacturing Company	ZINC OXIDE	20	g/100mL			N	20241231
69423-732_0296e85e-320c-b371-e063-6394a90a385e	69423-732	HUMAN OTC DRUG	Secret Nurturing Coconut Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-733_02966b28-2acb-8b74-e063-6294a90ab95c	69423-733	HUMAN OTC DRUG	Secret Cocoa Butter Clear		Aluminum Zirconium Octachlorohydrex Gly	GEL	TOPICAL	20230115		OTC MONOGRAPH FINAL	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-737_0ce5fc4e-571c-c120-e063-6294a90a5a82	69423-737	HUMAN OTC DRUG	Secret Clean Lavender Invisible	Antiperspirant/Deodorant	Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20230701		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	17	g/100g			N	20241231
69423-738_0cf4a599-3c4d-29d1-e063-6294a90a978d	69423-738	HUMAN OTC DRUG	Old Spice Captain Scent of Bergamot Dry		Aluminum chlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH DRUG	M019	The Procter & Gamble Manufacturing Company	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
69423-750_08a030af-1af7-0100-e063-6294a90a9b88	69423-750	HUMAN OTC DRUG	Crest 3D White Brilliance	Pro Enamel Protect	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230126		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-751_07844922-ce5d-2542-e063-6294a90aa922	69423-751	HUMAN OTC DRUG	Crest Pro-Health Advanced Complete Care	Anticavity Fluoride	Sodium Fluoride	RINSE	ORAL	20230102		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69423-752_07844922-ce5e-2542-e063-6294a90aa922	69423-752	HUMAN OTC DRUG	Crest 3D White Advanced		Sodium monofluorophosphate	PASTE, DENTIFRICE	ORAL	20230110		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	SODIUM MONOFLUOROPHOSPHATE	1.7	mg/g			N	20241231
69423-753_07841210-dd80-6178-e063-6294a90a306b	69423-753	HUMAN OTC DRUG	Crest Pro-Health	Densify Sensitive Care	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230208		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-754_07840195-bb24-941c-e063-6394a90a58ea	69423-754	HUMAN OTC DRUG	Crest Pro-Health	Densify Active Repair	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230209		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-755_0784ac7f-0a83-7c10-e063-6394a90add39	69423-755	HUMAN OTC DRUG	Crest Pro-Health	Densify Pro Intensive Repair	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230210		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-756_0784ddc8-f115-add6-e063-6394a90a5398	69423-756	HUMAN OTC DRUG	Crest Pro-health	Gum Detoxify Deep Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230213		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-757_0784f380-8ce5-5894-e063-6294a90a09a2	69423-757	HUMAN OTC DRUG	Crest Pro-health	Gum Detoxify Deep Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230213		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-758_07851937-ed19-f0ab-e063-6294a90a14e8	69423-758	HUMAN OTC DRUG	Crest Pro-Health	Gum Detoxify Gentle Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230213		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-760_0784ddc8-f117-add6-e063-6394a90a5398	69423-760	HUMAN OTC DRUG	Crest 3D White	Brilliance Pro Ultra White	Sodium monofluorophosphate	PASTE, DENTIFRICE	ORAL	20230110		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM MONOFLUOROPHOSPHATE	1.7	mg/g			N	20241231
69423-761_0785234b-745f-f0cb-e063-6294a90ace75	69423-761	HUMAN OTC DRUG	Crest Pro Health	Enamel Repair and Gum Intensive Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230215		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-762_0784f380-8ce7-5894-e063-6294a90a09a2	69423-762	HUMAN OTC DRUG	Crest 3D White	Advanced Express White	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230215		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-763_0784e4b5-9fdc-0dc8-e063-6294a90a1cc7	69423-763	HUMAN OTC DRUG	Crest Pro Health	Gum Detoxify and Restore Pro Deep Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230215		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-764_078510e1-1ce4-58f4-e063-6294a90a06fb	69423-764	HUMAN OTC DRUG	Crest Pro Health	Gum Detoxify and Restore Pro Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230216		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-765_07853ef8-152d-63dd-e063-6394a90a26c6	69423-765	HUMAN OTC DRUG	Crest Pro-Health	Sensitive and Gum All Day Protection	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20230216		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-766_0785234b-7462-f0cb-e063-6294a90ace75	69423-766	HUMAN OTC DRUG	Crest Pro Health	Enamel Repair and Gum Advanced Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230208		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-767_07851937-ed21-f0ab-e063-6294a90a14e8	69423-767	HUMAN OTC DRUG	Crest 3D White	Advanced Charcoal	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230217		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-768_07853ef8-152f-63dd-e063-6394a90a26c6	69423-768	HUMAN OTC DRUG	Crest 3D White	Advanced Glamorous White	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201011		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-769_078559ad-26e5-f477-e063-6394a90a959a	69423-769	HUMAN OTC DRUG	Crest 3D White	Advanced Luminous Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201011		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-770_0788c151-3a31-42d6-e063-6394a90a79df	69423-770	HUMAN OTC DRUG	Crest 3D White	Advanced Radiant Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201011		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-771_0788d9bf-2b14-e81a-e063-6294a90ae43c	69423-771	HUMAN OTC DRUG	Crest Pro Health	Gum Detoxify Ultra	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20230215		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-772_0788fd02-6709-acd8-e063-6294a90aa51f	69423-772	HUMAN OTC DRUG	Crest 3D White	Advanced Stain Shield	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201011		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-773_0788f51e-79b4-1420-e063-6294a90a902f	69423-773	HUMAN OTC DRUG	Crest 3D White	Stain Eraser Icy Clean Mint	Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20190709		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-774_0788e40d-c3b4-85e0-e063-6394a90a5678	69423-774	HUMAN OTC DRUG	Crest 3D White	Vibrant Mint	Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20230306		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-778_078abdf3-4fe4-9cd7-e063-6394a90a328d	69423-778	HUMAN OTC DRUG	Vicks DayQuil Kids BERRY	COLD and COUGH plus MUCUS	Guaifenesin, Phenylephrine HCl, Dextromethorphan HBr	LIQUID	ORAL	20230606		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-779_078ad01e-940b-f46a-e063-6294a90ac146	69423-779	HUMAN OTC DRUG	Vicks NyQuil Kids BERRY	COLD and COUGH plus RUNNY NOSE	Chlorpheniramine maleate, Dextromethorphan HBr	LIQUID	ORAL	20230606		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/15mL; mg/15mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-780_07d8ef11-de72-d74b-e063-6294a90a6ca3	69423-780	HUMAN OTC DRUG	Vicks DayQuil NyQuil BERRY Kids	COLD and COUGH plus	Chlorpheniramine maleate, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	KIT	ORAL	20230606		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-781_0789097c-7d6e-9e01-e063-6394a90a9619	69423-781	HUMAN OTC DRUG	Crest	Pro Health Clean Mint	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20221003		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-782_0788d9bf-2b15-e81a-e063-6294a90ae43c	69423-782	HUMAN OTC DRUG	Crest	Pro Health Clean and Free	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20221003		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-783_0788d9bf-2b16-e81a-e063-6294a90ae43c	69423-783	HUMAN OTC DRUG	Crest	Pro Health Sensitive and Enamel Shield	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20221003		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-784_07891d62-394e-4976-e063-6294a90a1644	69423-784	HUMAN OTC DRUG	Crest	Pro Health with a Touch of Scope	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20221003		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-785_0788f671-79fe-9f8e-e063-6394a90a4b8a	69423-785	HUMAN OTC DRUG	ARC	Enamel Protection	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-786_07891d62-394f-4976-e063-6294a90a1644	69423-786	HUMAN OTC DRUG	Crest	Pro Health Whitening Gel	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20221230		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-787_0789097c-7d70-9e01-e063-6394a90a9619	69423-787	HUMAN OTC DRUG	Crest	3D White Brilliance Luminous Purple	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20220615		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-788_07de3e34-75ce-bf7e-e063-6394a90a72f3	69423-788	HUMAN OTC DRUG	Vicks DayQuil	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	LIQUID	ORAL	20200101		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-789_078af979-2183-2617-e063-6294a90a113d	69423-789	HUMAN OTC DRUG	Vicks NyQuil	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate	LIQUID	ORAL	20220101		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-790_fd2a6ebb-3392-9032-e053-6394a90a2c04	69423-790	HUMAN OTC DRUG	Crest 3D White Brilliance Hydrogen Peroxide Deep Clean		Sodium monofluorophosphate	PASTE, DENTIFRICE	ORAL	20220615		OTC MONOGRAPH FINAL	M021	The Procter & Gamble Manufacturing Company	SODIUM MONOFLUOROPHOSPHATE	1.7	mg/g			N	20241231
69423-791_078af979-2184-2617-e063-6294a90a113d	69423-791	HUMAN OTC DRUG	Vicks NyQuil	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate	LIQUID	ORAL	20220101		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-792_fe03f173-8ac8-2849-e053-6394a90a6337	69423-792	HUMAN OTC DRUG	Crest 3D White Whitening Therapy Charcoal		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230101		OTC MONOGRAPH FINAL	part355	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-795_078b75d6-f2de-e197-e063-6294a90a9430	69423-795	HUMAN OTC DRUG	VICKS ZzzQuil	NIGHTTIME SLEEP-AID Diphenhydramine HCl FREE OF	Diphenhydramine Hydrochloride	LIQUID	ORAL	20210419		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69423-796_07fe6213-8b54-248b-e063-6294a90ae070	69423-796	HUMAN OTC DRUG	Vicks VapoCool	SEVERE	Menthol	LOZENGE	ORAL	20210713		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	MENTHOL	20	mg/1			N	20241231
69423-797_079bba3f-893f-6be7-e063-6294a90af77b	69423-797	HUMAN OTC DRUG	Vicks VapoCOOL	SEVERE	Menthol	LOZENGE	ORAL	20210703		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	MENTHOL	20	mg/1			N	20241231
69423-798_07d692a8-5faa-3a23-e063-6294a90ab92a	69423-798	HUMAN OTC DRUG	Vicks DayQuil and Vicks NyQuil	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Doxylamine Succinate	KIT	ORAL	20130701		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-799_07d86448-2321-e5ae-e063-6294a90a3d61	69423-799	HUMAN OTC DRUG	Vicks VapoCOOL HYDRASOOTHE	WINTERFROST	Menthol	LOZENGE	ORAL	20200201	20240228	OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	MENTHOL	15	mg/1			N	
69423-800_078b72bb-24e5-82fb-e063-6294a90a4c95	69423-800	HUMAN OTC DRUG	Vicks DayQuil	ULTRA CONCENTRATED COLD and FLU	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20230706		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-801_079c88e3-076b-b41c-e063-6394a90ae1e3	69423-801	HUMAN OTC DRUG	Vicks NyQuil	ULTRA CONCENTRATED COLD and FLU	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20230706		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 10; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-802_07d836c9-3f74-6396-e063-6394a90a689e	69423-802	HUMAN OTC DRUG	Vicks DayQuil NyQuil	ULTRA CONCENTRATED COLD and FLU	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT	ORAL	20230711		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-803_078b5083-a80a-df14-e063-6394a90abd3e	69423-803	HUMAN OTC DRUG	Vicks DayQuil	HIGH BLOOD PRESSURE COLD and FLU	Acetaminophen, Dextromethorphan HBr	CAPSULE, LIQUID FILLED	ORAL	20230711		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	325; 10	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-804_078b71c7-78b6-d7cb-e063-6294a90a8172	69423-804	HUMAN OTC DRUG	Vicks NyQuil	HIGH BLOOD PRESSURE COLD and FLU	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20230711		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 10; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-805_07d815ea-8594-ea8f-e063-6294a90ac84d	69423-805	HUMAN OTC DRUG	Vicks DayQuil NyQuil	HIGH BLOOD PRESSURE COLD and FLU	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	KIT	ORAL	20230711		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-806_079b30d6-3e94-03d1-e063-6394a90a3f22	69423-806	HUMAN OTC DRUG	VICKS DayQuil SEVERE HONEY FLAVOR	COLD and FLU	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20210707		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-807_079b36ec-18c6-ec89-e063-6394a90ae679	69423-807	HUMAN OTC DRUG	VICKS NyQuil SEVERE HONEY FLAVOR	COLD and FLU	Acetaminophen, Dextromethrophan, Doxylamine succinate, Phenylephrine HCl	LIQUID	ORAL	20210707		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-809_07d8af16-836b-8939-e063-6294a90a8471	69423-809	HUMAN OTC DRUG	VICKS FORMULA 44DM	COUGH	Dextromethorphan HBr	LIQUID	ORAL	20201221		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/15mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-810_07d8e230-b7b7-4016-e063-6294a90aa435	69423-810	HUMAN OTC DRUG	VICKS FORMULA 44DM	COUGH and CHEST CONGESTION	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20201221		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/15mL; mg/15mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-811_07d8b8f4-36b5-631d-e063-6294a90a6f6d	69423-811	HUMAN OTC DRUG	VICKS FORMULA 44DM	NIGHTTIME COUGH and COLD	Acetaminophen, Dextromethorphan HBr, Chlorpheniramine Maleate	LIQUID	ORAL	20210125		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	650; 4; 30	mg/15mL; mg/15mL; mg/15mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-812_07d85b48-ad42-5ee1-e063-6294a90a6380	69423-812	HUMAN OTC DRUG	VICKS ZzzQuil	NIGHTTIME SLEEP-AID	Diphenhydramine HCl	LIQUID	ORAL	20150203		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69423-813_0776319a-4fb5-b90b-e063-6294a90a8b4b	69423-813	HUMAN OTC DRUG	Burts Bees	Extra White Mountain Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20190109		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
69423-814_07ed7ad3-ba86-fd4a-e063-6394a90a5a1d	69423-814	HUMAN OTC DRUG	Crest Plus Baking Soda and Peroxide	Whitening with Tartar Protection	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20231113		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-816_08131727-6d66-b070-e063-6394a90a4d94	69423-816	HUMAN OTC DRUG	Crest Plus Cavity Protection	Cool Mint Gel	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20231113		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-817_08767979-343e-0003-e063-6394a90ad89f	69423-817	HUMAN OTC DRUG	Crest Plus Tartar Protection		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20231113		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-818_08775c13-9298-fa4f-e063-6394a90ad1d9	69423-818	HUMAN OTC DRUG	Crest plus	Tartar Protection Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20231113		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-819_087b236a-7f78-2751-e063-6394a90ac291	69423-819	HUMAN OTC DRUG	Burts Bees Kids	Strawberry Splash	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20231001		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
69423-820_0a32a345-1f60-b957-e063-6294a90a9c46	69423-820	HUMAN OTC DRUG	Crest Pro-Health Advanced	Antibac Protection	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20231218		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-821_0a33f9a9-1fda-7cdf-e063-6294a90adca1	69423-821	HUMAN OTC DRUG	Crest Pro Health	Gum and Sensitivity All Day Protection	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20231218		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-824_0c65d7fb-c756-e2d7-e063-6294a90a097a	69423-824	HUMAN OTC DRUG	Rolaids Advanced Antacid plus Anti-Gas	Soft Chews	Calcium carbonate, Simethicone and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20240101		OTC MONOGRAPH DRUG	M001	The Procter & Gamble Manufacturing Company	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1330; 40; 235	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69423-825_0cc9d6a5-706b-0981-e063-6394a90a98ac	69423-825	HUMAN OTC DRUG	Rolaids Ultra Strength Antacid	Assorted Fruit	Calcium carbonate, Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20240101		OTC MONOGRAPH DRUG	M001	THE PROCTER & GAMBLE MANUFACTURING COMPANY	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	1000; 200	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69423-826_0e0b3dcf-21f6-ebc8-e063-6394a90ac79e	69423-826	HUMAN OTC DRUG	Rolaids Multi-Symptom Advanced Antacid plus Anti-gas	Wild Berry	Calcium carbonate, Magnesium hydroxide and Simethicone	TABLET, CHEWABLE	ORAL	20240101		OTC MONOGRAPH DRUG	M001	THE PROCTER & GAMBLE MANUFACTURING COMPANY	CALCIUM CARBONATE; DIMETHICONE; MAGNESIUM HYDROXIDE	1000; 40; 200	mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
69423-827_0ce3e815-72bc-7da1-e063-6394a90a3ed6	69423-827	HUMAN OTC DRUG	Rolaids Extra Strength Antacid	Mint	Calcium carbonate and Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20240101		OTC MONOGRAPH DRUG	M001	THE PROCTER & GAMBLE MANUFACTURING COMPANY	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	675; 135	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69423-850_0789347c-8b39-e3dc-e063-6394a90a612b	69423-850	HUMAN OTC DRUG	Crest 3D White	Ultra Vivid Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20211201		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-851_0789097c-7d71-9e01-e063-6394a90a9619	69423-851	HUMAN OTC DRUG	Crest	Simply Clean	Sodium Fluoride	GEL, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-852_0789347c-8b3a-e3dc-e063-6394a90a612b	69423-852	HUMAN OTC DRUG	Crest	4in1	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-853_0789097c-7d72-9e01-e063-6394a90a9619	69423-853	HUMAN OTC DRUG	Crest 3D White	Advanced Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20211227		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-854_07894af1-a767-4d27-e063-6294a90a5c1d	69423-854	HUMAN OTC DRUG	Crest 3D White	Enamel Protect	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20220111		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-855_07894af1-a768-4d27-e063-6294a90a5c1d	69423-855	HUMAN OTC DRUG	Oral B Plaque Defense	Special Care Oral Rinse	Cetylpyridinium chloride	RINSE	ORAL	20220101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.07	g/mL			N	20241231
69423-856_07891d62-3956-4976-e063-6294a90a1644	69423-856	HUMAN OTC DRUG	Scope All Day CPC Antigingivitis/Antiplaque Mouthwash	All Day	Cetylpyridinium chloride	RINSE	ORAL	20220101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.07	g/mL			N	20241231
69423-857_0789347c-8b3c-e3dc-e063-6394a90a612b	69423-857	HUMAN OTC DRUG	Crest	Pro Health Advanced Antibacterial Protection	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220114		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-858_0789347c-8b3d-e3dc-e063-6394a90a612b	69423-858	HUMAN OTC DRUG	Scope	Get Fresh CPC Antigingivitis/Antiplaque Mouthwash	Cetylpyridinium chloride	RINSE	ORAL	20220124		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.05	g/mL			N	20241231
69423-859_07895277-4271-508f-e063-6394a90a40ea	69423-859	HUMAN OTC DRUG	Scope	Stay Strong	Sodium Fluoride	RINSE	ORAL	20220124		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.02	mg/mL			N	20241231
69423-860_0789347c-8b41-e3dc-e063-6394a90a612b	69423-860	HUMAN OTC DRUG	Crest	Pro Health Advanced Whitening Charcoal	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220131		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-861_07894af1-a77b-4d27-e063-6294a90a5c1d	69423-861	HUMAN OTC DRUG	Crest	Pro Health Advanced Whitening Intensive Cleaning	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220201		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-862_07893f29-be71-6e93-e063-6294a90a0b4f	69423-862	HUMAN OTC DRUG	KIDS Crest	Advanced Enamel Plus Cavity Protection	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-863_07893f29-be72-6e93-e063-6294a90a0b4f	69423-863	HUMAN OTC DRUG	Crest Pro-Health	Breath Purify and Gum Care	Cetylpyridinium chloride	RINSE	ORAL	20220203		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.07	g/mL			N	20241231
69423-864_07993531-f947-9f64-e063-6294a90a5402	69423-864	HUMAN OTC DRUG	Crest Pro-Health	Gum Care	Cetylpyridinium chloride	RINSE	ORAL	20220203		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.07	g/mL			N	20241231
69423-865_07990a5d-c906-86df-e063-6394a90a2360	69423-865	HUMAN OTC DRUG	Crest	Densify Dual Action	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220203		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-866_079da64c-2dd9-608c-e063-6394a90aeb10	69423-866	HUMAN OTC DRUG	Crest	Pro Health Advanced Extra Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220207		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-867_079db935-619c-2c7e-e063-6394a90ad189	69423-867	HUMAN OTC DRUG	Crest	Pro Health Advanced Gum Protection	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220207		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-868_079db935-619d-2c7e-e063-6394a90ad189	69423-868	HUMAN OTC DRUG	Crest	Pro Health Advanced Sensitive Relief	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220207		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-869_079e260a-4be8-a423-e063-6394a90aaf0d	69423-869	HUMAN OTC DRUG	Crest	Pro Health Advanced Deep Clean Mint	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220207		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-873_079e260a-4be9-a423-e063-6394a90aaf0d	69423-873	HUMAN OTC DRUG	Crest	Densify Daily Protection	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-874_079e140a-b397-1c2e-e063-6394a90a8491	69423-874	HUMAN OTC DRUG	Crest 3D White	Professional Ultra White	Sodium monofluorophosphate	PASTE, DENTIFRICE	ORAL	20220101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	SODIUM MONOFLUOROPHOSPHATE	1.7	mg/g			N	20241231
69423-875_079e1875-4733-5711-e063-6294a90a5846	69423-875	HUMAN OTC DRUG	Crest	Densify Daily Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.5	mg/g			N	20241231
69423-876_079e260a-4c35-a423-e063-6394a90aaf0d	69423-876	HUMAN OTC DRUG	Crest Pro-Health	Whitening	Whitening	GEL, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-877_079e140a-b39a-1c2e-e063-6394a90a8491	69423-877	HUMAN OTC DRUG	Crest	Pro Health Advanced Enamel Restore	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-878_079e0819-6b5e-f6fd-e063-6294a90ae92e	69423-878	HUMAN OTC DRUG	Crest Pro-Health	Advanced Plus Scope	Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-879_079e21a0-89d8-1f42-e063-6394a90aa9d6	69423-879	HUMAN OTC DRUG	Crest	Braces Care Cavity Protection	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-880_079e140a-b39d-1c2e-e063-6394a90a8491	69423-880	HUMAN OTC DRUG	Crest Pro-Health	With a Touch of Scope	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-881_079e0819-6b5f-f6fd-e063-6294a90ae92e	69423-881	HUMAN OTC DRUG	Crest Braces Care	Anticavity Fluoride Rinse	Sodium Fluoride	RINSE	ORAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69423-882_079e140a-b39e-1c2e-e063-6394a90a8491	69423-882	HUMAN OTC DRUG	Crest Pro Health	Densify Rinse	Sodium Fluoride	RINSE	ORAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69423-883_079e140a-b3a1-1c2e-e063-6394a90a8491	69423-883	HUMAN OTC DRUG	Crest Pro Health	Complete Protection Bacteria Shield	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-884_07d4d163-5e75-4035-e063-6294a90a01d5	69423-884	HUMAN OTC DRUG	Crest	Pro Health Complete Protection Intensive Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-886_07d4fa29-6260-87b5-e063-6394a90ada96	69423-886	HUMAN OTC DRUG	Crest 3D White	Ultra	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20211117		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-887_07d4ddd0-e5ff-1a2c-e063-6294a90ad5e4	69423-887	HUMAN OTC DRUG	Crest Kids	Cavity Protection	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20211101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-888_07d4e51d-5337-4028-e063-6294a90ad443	69423-888	HUMAN OTC DRUG	ARC	After Whitening Rinse	Sodium Fluoride	RINSE	ORAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69423-889_07d55581-35bb-6405-e063-6294a90a080e	69423-889	HUMAN OTC DRUG	ARC	Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210105		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
69423-890_07d531c5-c3d0-35c1-e063-6294a90a0374	69423-890	HUMAN OTC DRUG	ARC	WHITENING	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210104		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
69423-891_07d76dec-5fca-ec4a-e063-6394a90a33a4	69423-891	HUMAN OTC DRUG	Crest 3D White	Stain Eraser Fresh Mint	Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20190709		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-892_07e9ebda-2280-0f4c-e063-6394a90a1309	69423-892	HUMAN OTC DRUG	Crest 3D White	Charcoal	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210426		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-893_07e9f804-c1d1-cb31-e063-6294a90ae096	69423-893	HUMAN OTC DRUG	Crest Pro-Health	Advantage	Cetylpyridinium chloride	RINSE	ORAL	20151028		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.07	g/mL			N	20241231
69423-894_07ea0f33-ca5d-4b08-e063-6294a90a02dc	69423-894	HUMAN OTC DRUG	Crest Complete plus Whitening		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20220531		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-895_07ea098f-0251-21d5-e063-6294a90a3be5	69423-895	HUMAN OTC DRUG	Kids Crest	Strawberry Rush	Sodium Fluoride	RINSE	ORAL	20220701		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69423-896_07e9f804-c1d2-cb31-e063-6294a90ae096	69423-896	HUMAN OTC DRUG	KIDS Crest	Advanced Fluoride Anticavity Color Changing	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20230101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM MONOFLUOROPHOSPHATE	1.6	mg/g			N	20241231
69423-897_07ea12d8-e34b-63a7-e063-6394a90afa01	69423-897	HUMAN OTC DRUG	Crest	Fresh and White	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20211001		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-898_07d8af16-8368-8939-e063-6294a90a8471	69423-898	HUMAN OTC DRUG	Vicks NyQuil childrens	COLD and COUGH	Chlorpheniramine maleate, Dextromethorphan HBr	LIQUID	ORAL	20200507	20250606	OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/15mL; mg/15mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
69423-899_078b2bd6-a56a-c676-e063-6394a90a82ff	69423-899	HUMAN OTC DRUG	Vicks NyQuil Alcohol Free	Cold and Flu Nighttime Relief	Acetaminophen, Chlorpheniramine maleate, and Dextromethorphan Hydrobromide	LIQUID	ORAL	20210120		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	650; 4; 30	mg/30mL; mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-901_079b569d-fc41-e36b-e063-6294a90a6378	69423-901	HUMAN OTC DRUG	Vicks VapoCool	Sore Throat	Benzocaine and Menthol	SPRAY	ORAL	20210602		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	BENZOCAINE; MENTHOL	5; 1	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69423-902_0bebf28c-d90d-ccfa-e063-6394a90a1a13	69423-902	HUMAN OTC DRUG	Vicks ZzzQuil	Ultra	Doxylamine succinate	TABLET	ORAL	20210301		ANDA	ANDA040167	The Procter & Gamble Manufacturing Company	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
69423-903_07ea187d-b3d4-16a6-e063-6394a90a13e4	69423-903	HUMAN OTC DRUG	Native	Sensitivity	Potassium Nitrate, Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210510		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.4	mg/g; mg/g			N	20241231
69423-904_07ea12d8-e34c-63a7-e063-6394a90afa01	69423-904	HUMAN OTC DRUG	Crest Pro-Health Advanced	Sensitive Relief	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20201231		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-905_07ea0f33-ca62-4b08-e063-6294a90a02dc	69423-905	HUMAN OTC DRUG	Crest Pro-Health	Bacteria Guard	Cetylpyridinium chloride	RINSE	ORAL	20210101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.05	g/mL			N	20241231
69423-906_07ea0edf-bc61-4837-e063-6294a90a80bb	69423-906	HUMAN OTC DRUG	Oral B Gum Detoxify	Special Care Rinse	Cetylpyridinium chloride	RINSE	ORAL	20210101		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.07	g/mL			N	20241231
69423-907_07ea0dc0-3c28-494e-e063-6294a90a2e44	69423-907	HUMAN OTC DRUG	GLEEM	Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210104		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manfuacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-908_07ea0edf-bc63-4837-e063-6294a90a80bb	69423-908	HUMAN OTC DRUG	GLEEM	Protection	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20210104		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-909_07ea4bec-728e-e516-e063-6294a90a5bea	69423-909	HUMAN OTC DRUG	Crest Pro-Health	Restore Enamel	Sodium Fluoride	RINSE	ORAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	.2	mg/10mL			N	20241231
69423-910_07ea12d8-e350-63a7-e063-6394a90afa01	69423-910	HUMAN OTC DRUG	Crest Complete plus	Scope Advanced Active Foam	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-911_07ea4bec-728f-e516-e063-6294a90a5bea	69423-911	HUMAN OTC DRUG	Crest Complete plus	Whitening Deep Clean	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-912_07ea14a6-e9ce-0ced-e063-6394a90ad25e	69423-912	HUMAN OTC DRUG	Crest Premium Plus	Breath Bacteria Blast	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-913_07ea4568-ceeb-c585-e063-6294a90ac984	69423-913	HUMAN OTC DRUG	Crest 3D White	Advanced Triple Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201011		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-914_07ea454a-1e7b-9afd-e063-6294a90a42fe	69423-914	HUMAN OTC DRUG	Crest 3D White	Glamorous White	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201011		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.6	mg/g			N	20241231
69423-915_07ea6ebf-da76-fbed-e063-6394a90a4205	69423-915	HUMAN OTC DRUG	Crest Pro-Health	Gum and Bacteria Shield	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210122		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-916_07ea4bec-7290-e516-e063-6294a90a5bea	69423-916	HUMAN OTC DRUG	Crest Pro-Health	Complete Protection Bacteria Shield	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210122		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-917_07ea4bec-7291-e516-e063-6294a90a5bea	69423-917	HUMAN OTC DRUG	Crest Pro-Health	Complete Protection Intensive Clean plus Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210122		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-918_07ea74ae-b598-10c3-e063-6294a90aec6c	69423-918	HUMAN OTC DRUG	Crest Complete Plus	Scope Outlast Ultra	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210105		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-919_07ea6a8d-402f-0c5e-e063-6294a90a4a6e	69423-919	HUMAN OTC DRUG	Theory	Freshness Care Essential Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210105		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-920_07ea6980-5fe4-1ca3-e063-6394a90ade5e	69423-920	HUMAN OTC DRUG	Theory	Enamel Care Wild Peppermint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210105		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-922_07de98ba-083a-e8d7-e063-6294a90a1556	69423-922	HUMAN OTC DRUG	Vicks DayQuil	Cough DM plus Congestion	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN and PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20210101		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-925_07753de0-d2d0-05bc-e063-6394a90a5568	69423-925	HUMAN OTC DRUG	Crest Pro-Health	Advanced Gum Restore Deep Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210104		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-926_07ea4bec-7292-e516-e063-6294a90a5bea	69423-926	HUMAN OTC DRUG	Crest Pro-Health	Advanced Gum Restore Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210104		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-930_07753de0-d2d1-05bc-e063-6394a90a5568	69423-930	HUMAN OTC DRUG	Crest Pro Health	Advanced Antibacterial Protection	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210104		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-931_07754710-b338-b814-e063-6294a90ae260	69423-931	HUMAN OTC DRUG	Crest Pro Health	Gum plus Bacteria Guard	Cetylpyridinium chloride	RINSE	ORAL	20210104		OTC MONOGRAPH DRUG	M022	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.014	g/mL			N	20241231
69423-932_07754710-b339-b814-e063-6294a90ae260	69423-932	HUMAN OTC DRUG	Crest Complete Plus	Active Fresh plus Whitening Scope	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210105		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-933_07753f77-8d98-d755-e063-6394a90a87c6	69423-933	HUMAN OTC DRUG	Crest Complete plus	Whitening plus Scope	Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-934_07752349-e850-c2fe-e063-6394a90a508a	69423-934	HUMAN OTC DRUG	Crest 3D White	Enamel Renewal	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210630		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-935_07753f77-8d99-d755-e063-6394a90a87c6	69423-935	HUMAN OTC DRUG	Crest Pro Health	Breath Purify and Gum Deep Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-936_077558ff-d6e7-be71-e063-6294a90aa9db	69423-936	HUMAN OTC DRUG	Crest Pro Health	Breath Purify and Gum Healthy White	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-937_07ea7ac6-f74c-469a-e063-6394a90ad7bd	69423-937	HUMAN OTC DRUG	Crest Pro-Health	Sensitive and Gum All Day Protection	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-938_07ea4bec-7293-e516-e063-6294a90a5bea	69423-938	HUMAN OTC DRUG	Crest Pro-Health Advanced	Extra Whitening	Stannous Fluoride	GEL, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.6	mg/g			N	20241231
69423-939_07ea7ac6-f74d-469a-e063-6394a90ad7bd	69423-939	HUMAN OTC DRUG	Crest Pro-Health	Germ Guard	Cetylpyridinium chloride	RINSE	ORAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	CETYLPYRIDINIUM CHLORIDE	.014	g/mL			N	20241231
69423-943_06e8fdb7-42c6-e4e7-e063-6394a90a3c7b	69423-943	HUMAN OTC DRUG	Crest 3D White	Luminous Mint	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-946_078ac8db-9812-5ec2-e063-6294a90a872b	69423-946	HUMAN OTC DRUG	Vicks DayQuil Kids	Cold Cough plus Mucus	GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	LIQUID	ORAL	20210708		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-947_07ea8a3a-35fa-4030-e063-6394a90ac9d0	69423-947	HUMAN OTC DRUG	Native	Whitening Candy Cane	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20201006		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.4	mg/g			N	20241231
69423-949_07ea6ebf-da7d-fbed-e063-6394a90a4205	69423-949	HUMAN OTC DRUG	Crest Premium Plus	Active Foam Whitening scope	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210101		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-950_07ea6a8d-4035-0c5e-e063-6294a90a4a6e	69423-950	HUMAN OTC DRUG	Crest Pro-Health	Gum Detoxify Advanced	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-951_080348e9-944e-b6fc-e063-6294a90a401e	69423-951	HUMAN OTC DRUG	Crest Pro-Health	Gum Detoxify Charcoal Mint	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-952_08034a76-4f14-e56c-e063-6394a90a12d8	69423-952	HUMAN OTC DRUG	Crest Pro-Health	Gum Detoxify Ultra	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-953_080348e9-9451-b6fc-e063-6294a90a401e	69423-953	HUMAN OTC DRUG	Crest Pro-Health	Enamel Repair and Gum Advanced Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-954_06fcf70d-513f-6752-e063-6294a90a1d4a	69423-954	HUMAN OTC DRUG	Crest Pro-Health	Enamel Repair and Gum Intensive Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-955_06fcc433-2505-8d19-e063-6294a90a156c	69423-955	HUMAN OTC DRUG	Crest Pro-Health	Sensitive and Gum Gentle Whitening	Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-956_06fd175e-7ebb-fe99-e063-6294a90ab489	69423-956	HUMAN OTC DRUG	Crest Pro-Health	Bacteria Shield and Gum Deep Clean	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210601		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	STANNOUS FLUORIDE	1.4	mg/g			N	20241231
69423-958_08034a76-4f19-e56c-e063-6394a90a12d8	69423-958	HUMAN OTC DRUG	Crest 3D White	Stain Eraser Polishing Mint	Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20190709		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.5	mg/g			N	20241231
69423-959_080348e9-9456-b6fc-e063-6294a90a401e	69423-959	HUMAN OTC DRUG	Crest 3D White Brilliance	Advanced Whitening Fresh Mint	Sodium monofluorophosphate	PASTE, DENTIFRICE	ORAL	20210728		OTC MONOGRAPH DRUG	M021	The Procter & Gamble Manufacturing Company	SODIUM MONOFLUOROPHOSPHATE	1.7	mg/g			N	20241231
69423-961_080357d4-6a34-e795-e063-6394a90af25a	69423-961	HUMAN OTC DRUG	Burts Bees	Deep Clean plus Whitening	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210930		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
69423-962_08037ad4-2b3f-2824-e063-6294a90ac6da	69423-962	HUMAN OTC DRUG	Burts Bees	Extra White	Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20210930		OTC MONOGRAPH DRUG	M021	Procter & Gamble Manufacturing Company	SODIUM FLUORIDE	1.3	mg/g			N	20241231
69423-963_070fbf6b-abb7-06e2-e063-6394a90a5e56	69423-963	HUMAN OTC DRUG	Pepto Bismol	Chews	Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20200901		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
69423-964_08b52ade-593a-c69d-e063-6294a90adc5c	69423-964	HUMAN OTC DRUG	Vicks Formula 44	VapoCool Cough and Chest Congestion	acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin	SOLUTION	ORAL	20201001		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-966_070cce46-7ee7-2f00-e063-6394a90ae6da	69423-966	HUMAN OTC DRUG	Pepto Bismol	Ultra	Bismuth subsalicylate	SUSPENSION	ORAL	20220307		OTC MONOGRAPH DRUG	M008	The Procter & Gamble Manufacturing Company	BISMUTH SUBSALICYLATE	525	mg/15mL			N	20241231
69423-967_07d633f6-3554-70bf-e063-6294a90af5a0	69423-967	HUMAN OTC DRUG	Vicks DayQuil Severe Honey	Cold and Flu	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20210707		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-968_07d6467d-e0ad-107a-e063-6394a90acb3a	69423-968	HUMAN OTC DRUG	Vicks NyQuil Severe Honey	Cold and Flu	Acetaminophen, Dextromethrophan, Doxylamine succinate, Phenylephrine HCl	LIQUID	ORAL	20210707		OTC MONOGRAPH DRUG	M012	Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-969_07d9cd54-c4d3-8669-e063-6394a90a15d4	69423-969	HUMAN OTC DRUG	Vicks DayQuil NyQuil Severe Honey	Cold and Flu	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl and Doxylamine succinate	KIT	ORAL	20200428		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-970_09049c73-5d6e-dc91-e063-6294a90a05a8	69423-970	HUMAN OTC DRUG	Nervive Pain Relieving	Liquid Roll-on	Lidocaine HCl and Menthol	LIQUID	TOPICAL	20220208		OTC MONOGRAPH DRUG	M017	The Procter & Gamble Manufacturing Company	LIDOCAINE; MENTHOL	.04; 1	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69423-971_09049c73-5d6f-dc91-e063-6294a90a05a8	69423-971	HUMAN OTC DRUG	Nervive Pain Relieving	Cream	Lidocaine HCl and Menthol	CREAM	TOPICAL	20220208		OTC MONOGRAPH DRUG	M017	The Procter & Gamble Manufacturing Company	LIDOCAINE; MENTHOL	.04; 1	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69423-972_07de694d-d16d-9c2f-e063-6394a90aefd1	69423-972	HUMAN OTC DRUG	Vicks DayQuil HIGH BLOOD PRESSURE	Cold and Flu	Acetaminophen, Dextromethorphan	LIQUID	ORAL	20220712		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/30mL; mg/30mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-973_07de694d-d16e-9c2f-e063-6394a90aefd1	69423-973	HUMAN OTC DRUG	Vicks NyQuil HIGH BLOOD PRESSURE	Cold and Flu	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate	LIQUID	ORAL	20220712		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-974_07da7be6-5b1f-5728-e063-6294a90a6eec	69423-974	HUMAN OTC DRUG	Vicks DayQuil and Vicks NyQuil HIGH BLOOD PRESSURE	COLD and FLU	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	KIT	ORAL	20220712		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-979_079b6d78-8c20-4f5f-e063-6394a90a1800	69423-979	HUMAN OTC DRUG	ZzzQuil	Nighttime Sleep-Aid	DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20220512		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69423-980_079b5898-0a81-bac4-e063-6394a90ab017	69423-980	HUMAN OTC DRUG	Vicks DayQuil	Cold and Flu Multi-Symptom Relief	Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	LIQUID	ORAL	20220512		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-981_078ae1f5-9b34-384a-e063-6394a90a915a	69423-981	HUMAN OTC DRUG	Vicks NyQuil	Cold and Flu Nighttime Relief	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate	LIQUID	ORAL	20220512		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-982_079b6d78-8c18-4f5f-e063-6394a90a1800	69423-982	HUMAN OTC DRUG	Vicks childrens	Cough Congestion	Phenylephrine HCl, Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20190422		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 200; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-983_078ab558-5f5f-e466-e063-6394a90ad5a4	69423-983	HUMAN OTC DRUG	Vicks NyQuil Kids	Honey Cold Cough Congestion	Doxylamine Succinate, Phenylephrine Hydrochloride and Dextromethorphan Hydrobromide	LIQUID	ORAL	20210707		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-985_07d8a696-faef-b738-e063-6294a90a455c	69423-985	HUMAN OTC DRUG	Vicks ZzzQuil	Night Pain	Diphenhydramine Hydrochloride and Acetaminophen	LIQUID	ORAL	20230303		OTC MONOGRAPH DRUG	M010	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69423-986_08b56524-79b7-f698-e063-6294a90ae8a6	69423-986	HUMAN OTC DRUG	Vicks NyQuil VapoCOOL Severe	COLD and FLU plus CONGESTION	Acetaminophen, Phenylephrine Hydrochloride, Doxylamine Succinate, and Dextromethorphan Hydrobromide	TABLET, COATED	ORAL	20210322		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-987_08b52437-eab2-fee1-e063-6394a90a290e	69423-987	HUMAN OTC DRUG	Vicks DayQuil VapoCOOL SEVERE	COLD and FLU plus CONGESTION	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	TABLET	ORAL	20180801		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-988_0789ea54-ccb8-ae0a-e063-6394a90a817d	69423-988	HUMAN OTC DRUG	Vicks DayQuil and Nyquil VapoCOOL Severe	COLD and FLU plus CONGESTION	Acetaminophen, Phenylephrine Hydrochloride, and Doxylamine Succinate	KIT	ORAL	20210322		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-989_078aebc0-bc7d-a3b4-e063-6294a90ab4d8	69423-989	HUMAN OTC DRUG	NyQuil VapoCOOL SEVERE	COLD and FLU plus CONGESTION	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and phenylephrine hydrochloride	SOLUTION	ORAL	20210322		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-990_078b0982-112f-4a78-e063-6294a90a8de6	69423-990	HUMAN OTC DRUG	DayQuil VapoCOOL SEVERE	COLD and FLU plus CONGESTION	acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin	SOLUTION	ORAL	20210322		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-991_07d68a77-977e-26a5-e063-6394a90a4a4b	69423-991	HUMAN OTC DRUG	DayQuil and NyQuil VapoCOOL SEVERE	COLD and FLU plus CONGESTION	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Guaifenesin, Phenylephrine hydrochloride	KIT	ORAL	20210322		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-993_07d6467d-e0b2-107a-e063-6394a90acb3a	69423-993	HUMAN OTC DRUG	Vicks DayQuil Kids Honey and Vicks NyQuil Kids Honey	COLD and COUGH plus	Doxylamine Succinate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide	KIT	ORAL	20210712		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-994_078aebc0-bc7a-a3b4-e063-6294a90ab4d8	69423-994	HUMAN OTC DRUG	Vicks DayQuil	COLD and FLU	Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20200101		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69423-995_078af2c5-a283-834b-e063-6394a90a2a2b	69423-995	HUMAN OTC DRUG	Vicks NyQuil	COLD and FLU	Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20210101		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69423-996_07d96576-fd7c-acf3-e063-6394a90af45b	69423-996	HUMAN OTC DRUG	Vicks DayQuil and Vicks NyQuil	COLD and FLU	Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, and Doxylamine Succinate	KIT		20200101		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-997_07da7e0c-6d90-7c2f-e063-6294a90a04bf	69423-997	HUMAN OTC DRUG	VICKS CHILDRENS	COUGH CONGESTION	Dextromethorphan Hydrobromide, Diphenhydramine HCl, Guaifenesin, Phenylephrine Hydrochloride	KIT	ORAL	20190709		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company						N	20241231
69423-999_07d66fb2-f4d0-479c-e063-6394a90a5e91	69423-999	HUMAN OTC DRUG	Vicks NyQuil	Cough DM plus Congestion	Dextromethorphan Hydrobromide, Doxylamine succinate and Phenylephrine Hydrochloride	LIQUID	ORAL	20200708		OTC MONOGRAPH DRUG	M012	The Procter & Gamble Manufacturing Company	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69428-001_0c800d63-0aa2-caf5-e063-6294a90ab48e	69428-001	HUMAN OTC DRUG	Hal Hen Earwax Removal Aid Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20140501		OTC MONOGRAPH DRUG	M014	Warner Tech-care Products, LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
69428-002_0c801272-bac4-b525-e063-6294a90a3b82	69428-002	HUMAN OTC DRUG	Tech Care Earwax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20140501		OTC MONOGRAPH DRUG	M014	Warner Tech-care Products, LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
69435-1301_fade88a1-651e-39b4-e053-6294a90a6051	69435-1301	HUMAN OTC DRUG	Teevodar		Allantoin	CREAM	TOPICAL	20230515		OTC MONOGRAPH FINAL	part347	PEER PHARM LTD.	ALLANTOIN	.5	g/100g			N	20241231
69435-1401_f448371e-7479-377f-e053-2995a90aa195	69435-1401	HUMAN OTC DRUG	Fre Glow Me Lightweight Tinted Moisturizer Light Medium		ZINC OXIDE	CREAM	TOPICAL	20230215		OTC MONOGRAPH NOT FINAL	part352	Peer Pharm Ltd.	ZINC OXIDE	19.2	g/100mL			N	20241231
69435-1402_f4482e8b-cdfb-a420-e053-2a95a90a8eab	69435-1402	HUMAN OTC DRUG	Fre Glow Me Lightweight Tinted Moisturizer Medium Deep		ZINC OXIDE	CREAM	TOPICAL	20230215		OTC MONOGRAPH NOT FINAL	part352	Peer Pharm Ltd.	ZINC OXIDE	19.2	g/100mL			N	20241231
69435-1403_f44839d4-6655-7a91-e053-2995a90a22ee	69435-1403	HUMAN OTC DRUG	Fre Protect Me Lightweight Daily Moisturizer SPF 30		ZINC OXIDE	CREAM	TOPICAL	20230215		OTC MONOGRAPH NOT FINAL	part352	Peer Pharm Ltd.	ZINC OXIDE	19.2	g/100mL			N	20241231
69435-1404_f44839d4-6662-7a91-e053-2995a90a22ee	69435-1404	HUMAN OTC DRUG	Fre Protect Me Lightweight Daily Moisturizer SPF 50		ZINC OXIDE	CREAM	TOPICAL	20230215		OTC MONOGRAPH NOT FINAL	part352	Peer Pharm Ltd.	ZINC OXIDE	24	g/100mL			N	20241231
69435-1405_f6791073-a681-67ed-e053-2a95a90a4dff	69435-1405	HUMAN OTC DRUG	Botao Kids Strawberry Flavored with Fluoride		Botao Kids Strawberry Flavored Toothpaste with Fluoride	PASTE	DENTAL	20221219		OTC MONOGRAPH FINAL	part355	Peer Pharm Ltd.	SODIUM FLUORIDE	.122	g/100mL			N	20241231
69437-203_30e34aeb-4e90-4ba5-adc7-343806b104c6	69437-203	HUMAN PRESCRIPTION DRUG	Anaprox DS		naproxen sodium	TABLET	ORAL	20160601		NDA	NDA018164	Canton Laboratories	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69437-316_30e34aeb-4e90-4ba5-adc7-343806b104c6	69437-316	HUMAN PRESCRIPTION DRUG	Naprosyn		naproxen	TABLET	ORAL	20160601		NDA	NDA017581	Canton Laboratories	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69437-341_08a5607b-4e82-72e4-e063-6394a90a7ec3	69437-341	HUMAN PRESCRIPTION DRUG	Urea Cream 41%		Urea	CREAM	TOPICAL	20220701		UNAPPROVED DRUG OTHER		Canton Laboratories	UREA	410	mg/g			N	20241231
69437-415_30e34aeb-4e90-4ba5-adc7-343806b104c6	69437-415	HUMAN PRESCRIPTION DRUG	EC-Naprosyn		naproxen	TABLET, DELAYED RELEASE	ORAL	20160601		NDA	NDA020067	Canton Laboratories	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69437-416_30e34aeb-4e90-4ba5-adc7-343806b104c6	69437-416	HUMAN PRESCRIPTION DRUG	EC-Naprosyn		naproxen	TABLET, DELAYED RELEASE	ORAL	20160601		NDA	NDA020067	Canton Laboratories	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69440-007_b553bb21-4705-45e1-a49b-336b022680db	69440-007	HUMAN OTC DRUG	Siterol		Lidocaine HCL, Menthol	PATCH	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part348	Binger Consulting Corporation	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	3.99; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69440-008_ff4b111d-47cb-490d-8122-af553944dc5d	69440-008	HUMAN OTC DRUG	Thritex		Menthol	PATCH	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part348	Binger Consulting Corporation	MENTHOL, UNSPECIFIED FORM	5	g/100g			N	20241231
69440-009_8546bcf1-481e-4142-87f3-0c95fb3927b1	69440-009	HUMAN OTC DRUG	Dermovix		Allantoin,Petrolatum	PATCH	TOPICAL	20150101		OTC MONOGRAPH FINAL	part347	Binger Consulting Corporation	ALLANTOIN; PETROLATUM	2; 30	g/100g; g/100g			N	20241231
69446-200_086338ca-cba3-c774-e063-6294a90ab7fc	69446-200	HUMAN OTC DRUG	EZ-448 Antibacterial Moist Hand		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20171217		OTC MONOGRAPH DRUG	505G(a)(3)	Ez Products Of South Florida, LLC	BENZALKONIUM CHLORIDE	.11	g/100g			N	20241231
69446-210_08633e75-f6f2-2da5-e063-6394a90ab70f	69446-210	HUMAN OTC DRUG	Antibacterial Hand Wipes with Aloe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200901		OTC MONOGRAPH DRUG	505G(a)(3)	Ez Products Of South Florida, LLC	BENZALKONIUM CHLORIDE	1.1	mg/g			N	20241231
69446-220_086318bd-5057-477e-e063-6294a90ab2dd	69446-220	HUMAN OTC DRUG	Hand Sanitizing Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210430		OTC MONOGRAPH DRUG	505G(a)(3)	Ez Products Of South Florida, LLC	BENZALKONIUM CHLORIDE	1	mg/g			N	20241231
69448-001_55ab68d0-c46a-2f41-e054-00144ff88e88	69448-001	HUMAN PRESCRIPTION DRUG	MUTAMYCIN		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170725		ANDA	ANDA064144	Accord BioPharma Inc.	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69448-002_55ab68d0-c46a-2f41-e054-00144ff88e88	69448-002	HUMAN PRESCRIPTION DRUG	MUTAMYCIN		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170725		ANDA	ANDA064144	Accord BioPharma Inc.	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69448-003_55ab68d0-c46a-2f41-e054-00144ff88e88	69448-003	HUMAN PRESCRIPTION DRUG	MUTAMYCIN		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170725		ANDA	ANDA064144	Accord BioPharma Inc.	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69448-005_e69a06ea-e917-25ea-e053-2995a90a6f6f	69448-005	HUMAN PRESCRIPTION DRUG	PARAPLATIN		Carboplatin	INJECTION	INTRAVENOUS	20200212		ANDA	ANDA206775	Accord BioPharma Inc.	CARBOPLATIN	10	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
69448-014_f86fb59e-2cfd-e617-e053-6394a90ae577	69448-014	HUMAN PRESCRIPTION DRUG	CAMCEVI		LEUPROLIDE	INJECTION, EMULSION	SUBCUTANEOUS	20220405		NDA	NDA211488	Accord BioPharma, Inc.	LEUPROLIDE MESYLATE	42	mg/.37g	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
69449-1010_69416f7e-6588-4d0c-9186-64efdcb9e461	69449-1010	HUMAN OTC DRUG	REAL SUMMER		IRON	PATCH	TOPICAL	20230801		UNAPPROVED DRUG OTHER		KAYONE	IRON	.76	g/1			N	20241231
69452-114_f1ed5637-3115-3407-e053-2a95a90a83a3	69452-114	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20171020		ANDA	ANDA208825	Bionpharma Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69452-115_f1ed5637-3115-3407-e053-2a95a90a83a3	69452-115	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	TABLET	ORAL	20171020		ANDA	ANDA208825	Bionpharma Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69452-116_07d9f0f5-f808-f03d-e063-6394a90ae826	69452-116	HUMAN PRESCRIPTION DRUG	Clobazam		Clobazam	SUSPENSION	ORAL	20171020		ANDA	ANDA208819	Bionpharma Inc.	CLOBAZAM	2.5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69452-117_1ec6b48d-337a-4802-b993-5358b3705bc1	69452-117	HUMAN PRESCRIPTION DRUG	TETRABENAZINE		TETRABENAZINE	TABLET	ORAL	20180115		ANDA	ANDA208826	Bionpharma Inc.	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
69452-118_1ec6b48d-337a-4802-b993-5358b3705bc1	69452-118	HUMAN PRESCRIPTION DRUG	TETRABENAZINE		TETRABENAZINE	TABLET	ORAL	20180115		ANDA	ANDA208826	Bionpharma Inc.	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
69452-119_e6dd7ccd-4715-8af8-e053-2a95a90aa6b7	69452-119	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA210717	Bionpharma Inc.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69452-120_e6dd7ccd-4715-8af8-e053-2a95a90aa6b7	69452-120	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA210717	Bionpharma Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69452-121_e6dd7ccd-4715-8af8-e053-2a95a90aa6b7	69452-121	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA210717	Bionpharma Inc.	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69452-125_f4ac45b3-8794-355d-e053-2a95a90a7862	69452-125	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	SUSPENSION	ORAL	20230214		ANDA	ANDA209652	Bionpharma Inc.	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69452-126_cfe71a81-2560-6b66-e053-2995a90ab337	69452-126	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	POWDER, FOR SUSPENSION	ORAL	20210901		ANDA	ANDA209374	Bionpharma Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69452-127_cfe71a81-2560-6b66-e053-2995a90ab337	69452-127	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	POWDER, FOR SUSPENSION	ORAL	20210901		ANDA	ANDA209374	Bionpharma Inc.	SEVELAMER CARBONATE	2400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69452-131_f7811d48-6a19-d784-e053-6394a90aac27	69452-131	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180411		ANDA	ANDA208625	Bionpharma Inc.	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
69452-132_f7811d48-6a19-d784-e053-6394a90aac27	69452-132	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180411		ANDA	ANDA208625	Bionpharma Inc.	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
69452-133_f7811d48-6a19-d784-e053-6394a90aac27	69452-133	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20180411		ANDA	ANDA208625	Bionpharma Inc.	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
69452-142_0d5f496b-ece9-b416-e063-6294a90a781c	69452-142	HUMAN PRESCRIPTION DRUG	Amantadine HCl		AMANTADINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20160815		ANDA	ANDA078720	Bionpharma Inc.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
69452-143_0d820d0e-22ef-4327-e063-6294a90a2c21	69452-143	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Bionpharma Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
69452-144_0d820d0e-22ef-4327-e063-6294a90a2c21	69452-144	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Bionpharma Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
69452-145_0d856fce-7c7d-18e7-e063-6394a90ac945	69452-145	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160816		ANDA	ANDA202539	Bionpharma Inc.	PARICALCITOL	1	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
69452-146_0d856fce-7c7d-18e7-e063-6394a90ac945	69452-146	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160816		ANDA	ANDA202539	Bionpharma Inc.	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
69452-147_0d856fce-7c7d-18e7-e063-6394a90ac945	69452-147	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160816		ANDA	ANDA202539	Bionpharma Inc.	PARICALCITOL	4	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
69452-148_73113fdd-1ff9-419e-8c29-3e82c8898cce	69452-148	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20160920		ANDA	ANDA200900	Bionpharma Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69452-149_73113fdd-1ff9-419e-8c29-3e82c8898cce	69452-149	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20160920		ANDA	ANDA200900	Bionpharma Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69452-150_0d63317a-4ea1-2c87-e063-6294a90a0a08	69452-150	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20160715		ANDA	ANDA073484	Bionpharma Inc.	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
69452-151_0d827847-5726-a43d-e063-6294a90a2f45	69452-151	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	Bionpharma Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
69452-152_0d82d9c4-814d-ed9b-e063-6294a90a6522	69452-152	HUMAN PRESCRIPTION DRUG	Ethosuximide		Ethosuximide	CAPSULE, LIQUID FILLED	ORAL	20161021		ANDA	ANDA040430	Bionpharma Inc.	ETHOSUXIMIDE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69452-153_b748f1a3-f852-4326-e053-2995a90ac2c1	69452-153	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	20160226		ANDA	ANDA090802	BionPharma Inc.,	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
69452-154_b748f1a3-f852-4326-e053-2995a90ac2c1	69452-154	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	20160226		ANDA	ANDA090802	BionPharma Inc.,	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
69452-155_b748f1a3-f852-4326-e053-2995a90ac2c1	69452-155	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE, GELATIN COATED	ORAL	20160226		ANDA	ANDA090802	BionPharma Inc.,	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
69452-156_bc889905-a174-9524-e053-2995a90a679c	69452-156	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20170117		ANDA	ANDA204722	Bionpharma Inc.,	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69452-157_bc889905-a174-9524-e053-2995a90a679c	69452-157	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20170117		ANDA	ANDA204722	Bionpharma Inc.,	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69452-158_f4acb4c7-9485-7a2c-e053-2995a90ae9ad	69452-158	HUMAN PRESCRIPTION DRUG	COLESEVELAM HYDROCHLORIDE		colesevelam hydrochloride	TABLET, FILM COATED	ORAL	20191202		ANDA	ANDA208670	Bionpharma Inc.	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
69452-159_f1ee8cb0-3294-a9a9-e053-2a95a90a1061	69452-159	HUMAN PRESCRIPTION DRUG	Deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20180928		ANDA	ANDA210920	Bionpharma Inc.	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69452-160_f1ee8cb0-3294-a9a9-e053-2a95a90a1061	69452-160	HUMAN PRESCRIPTION DRUG	Deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20180928		ANDA	ANDA210920	Bionpharma Inc.	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69452-161_f1ee8cb0-3294-a9a9-e053-2a95a90a1061	69452-161	HUMAN PRESCRIPTION DRUG	Deferasirox		deferasirox	TABLET, FOR SUSPENSION	ORAL	20180928		ANDA	ANDA210920	Bionpharma Inc.	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69452-171_07d90abf-0441-2917-e063-6294a90a61e9	69452-171	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210000	Bionpharma Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
69452-172_07d90abf-0441-2917-e063-6294a90a61e9	69452-172	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210001	Bionpharma Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
69452-173_0d48a6b6-8e7f-a3ae-e063-6394a90ada0c	69452-173	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20181226		ANDA	ANDA209999	Bionpharma Inc.	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
69452-175_c1aebacc-8c18-3f0d-e053-2a95a90ab85a	69452-175	HUMAN PRESCRIPTION DRUG	Omega-3-Acid Ethyl Ester		omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20170115		ANDA	ANDA206455	Bionpharma Inc.	OMEGA-3-ACID ETHYL ESTERS	900	mg/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
69452-176_a3d76812-4130-4578-a272-e165f67d9238	69452-176	HUMAN OTC DRUG	anti-diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190802		NDA	NDA021855	Bionpharma Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
69452-179_0d85dc59-4954-47fc-e063-6394a90a01cd	69452-179	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20181101		NDA	NDA021920	Bionpharma Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-182_b22f13d8-16e6-79a9-e053-2a95a90a920f	69452-182	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA212182	Bionpharma Inc.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69452-183_b22f13d8-16e6-79a9-e053-2a95a90a920f	69452-183	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	CAPSULE, EXTENDED RELEASE	ORAL	20200701		ANDA	ANDA212182	Bionpharma Inc.	FLUVOXAMINE MALEATE	150	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69452-193_07d99454-004f-d684-e063-6294a90afa51	69452-193	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20191214		ANDA	ANDA212799	Bionpharma Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
69452-194_07d99454-004f-d684-e063-6294a90afa51	69452-194	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20191214		ANDA	ANDA212799	Bionpharma Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
69452-205_0f6b5911-edb2-4e3a-b121-45c609b4c60e	69452-205	HUMAN OTC DRUG	IBUPROFEN, DIPHENHYDRAMINE HCL		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20181101		ANDA	ANDA090397	Bionpharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-206_0c40dd2a-b6a4-7a91-e063-6294a90a1cb5	69452-206	HUMAN PRESCRIPTION DRUG	Doxylamine succinate and Pyridoxine hydrochloride		Doxylamine succinate and Pyridoxine hydrochloride	TABLET, DELAYED RELEASE	ORAL	20231211		ANDA	ANDA217000	Bionpharma Inc.,	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
69452-207_0d616415-6be2-b417-e063-6394a90a6498	69452-207	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20180612		ANDA	ANDA091174	BIONPHARMA INC.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
69452-208_0d616415-6be2-b417-e063-6394a90a6498	69452-208	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20180612		ANDA	ANDA091174	BIONPHARMA INC.	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
69452-209_0d844a7d-9918-a816-e063-6294a90a00c0	69452-209	HUMAN PRESCRIPTION DRUG	Nimodipine		Nimodipine	CAPSULE, LIQUID FILLED	ORAL	20171121		ANDA	ANDA076740	BIONPHARMA INC.	NIMODIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69452-210_ceb56ab8-4a61-6dee-e053-2995a90aab30	69452-210	HUMAN OTC DRUG	Loperamide hydrochloride and Simethicone		loperamide hydrochloride and simethicone	TABLET	ORAL	20211201		ANDA	ANDA213484	Bionpharma Inc.	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
69452-211_932678d1-e6bf-4154-ac00-b6b9c9fbd16e	69452-211	HUMAN OTC DRUG	LORATADINE		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20190301		ANDA	ANDA202538	Bionpharma Inc.	LORATADINE	10	mg/1			N	20241231
69452-212_0d805053-0600-f7dc-e063-6394a90a8c40	69452-212	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20181101		ANDA	ANDA078682	Bionpharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-223_01e52daf-03d4-3600-e063-6294a90a7c9b	69452-223	HUMAN PRESCRIPTION DRUG	Rufinamide		Rufinamide	SUSPENSION	ORAL	20181219		ANDA	ANDA211388	Bionpharma Inc.	RUFINAMIDE	40	mg/mL			N	20241231
69452-227_9845d365-ee3e-5db9-e053-2a95a90a81db	69452-227	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine	TABLET	ORAL	20200115		ANDA	ANDA212919	Bionpharma Inc.	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
69452-228_9845d365-ee3e-5db9-e053-2a95a90a81db	69452-228	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine	TABLET	ORAL	20200115		ANDA	ANDA212919	Bionpharma Inc.	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
69452-233_02a7aa33-804c-ffaf-e063-6294a90a1c60	69452-233	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	Bionpharma Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69452-234_02a7aa33-804c-ffaf-e063-6294a90a1c60	69452-234	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	Bionpharma Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69452-237_0d824dc5-7c9c-ed4a-e063-6394a90a0f13	69452-237	HUMAN PRESCRIPTION DRUG	Enalapril maleate oral solution		Enalapril maleate	SOLUTION	ORAL	20210811		ANDA	ANDA212408	Bionpharma Inc.	ENALAPRIL MALEATE	1	mg/mL	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
69452-239_8a81171c-e615-44f0-917b-a520ff7cb07c	69452-239	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190802		ANDA	ANDA078682	Bionpharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-241_4d4d473e-4f84-43e7-bb17-49e8dc1e97fd	69452-241	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20181215		ANDA	ANDA091630	Bionpharma Inc.	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
69452-242_4d4d473e-4f84-43e7-bb17-49e8dc1e97fd	69452-242	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20181215		ANDA	ANDA091630	Bionpharma Inc.	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
69452-252_0d5fc0ab-9cfa-0a79-e063-6394a90a2b61	69452-252	HUMAN PRESCRIPTION DRUG	Atovaquone		Atovaquone	SUSPENSION	ORAL	20210601		ANDA	ANDA212918	Bionpharma Inc.	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
69452-256_c3cfd280-3549-b590-e053-2a95a90a5eb3	69452-256	HUMAN PRESCRIPTION DRUG	DROXIDOPA		DROXIDOPA	CAPSULE	ORAL	20211001		ANDA	ANDA213033	Bionpharma Inc.	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
69452-257_c3cfd280-3549-b590-e053-2a95a90a5eb3	69452-257	HUMAN PRESCRIPTION DRUG	DROXIDOPA		DROXIDOPA	CAPSULE	ORAL	20211001		ANDA	ANDA213033	Bionpharma Inc.	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
69452-258_c3cfd280-3549-b590-e053-2a95a90a5eb3	69452-258	HUMAN PRESCRIPTION DRUG	DROXIDOPA		DROXIDOPA	CAPSULE	ORAL	20211001		ANDA	ANDA213033	Bionpharma Inc.	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
69452-259_0d655c1f-5dbe-7ce3-e063-6294a90a4885	69452-259	HUMAN OTC DRUG	naproxen sodium		naproxen sodium	CAPSULE, LIQUID FILLED	ORAL	20190802		NDA	NDA021920	Bionpharma Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-260_0d6487bf-2c3c-e99e-e063-6394a90aed12	69452-260	HUMAN OTC DRUG	pain relief		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190501		ANDA	ANDA078682	Bionpharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-262_f036153c-281c-7947-e053-2a95a90a35b7	69452-262	HUMAN OTC DRUG	pain relief		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200320		ANDA	ANDA078682	Bionpharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-263_ca5396c7-f0d8-e3df-e053-2a95a90aa107	69452-263	HUMAN OTC DRUG	Migraine Relief		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20190501		ANDA	ANDA078682	Bionpharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-264_f0471f5f-e8eb-fe08-e053-2995a90a50f6	69452-264	HUMAN OTC DRUG	pain relief pm		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190501		ANDA	ANDA090397	Bionpharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-265_f0ff2942-7718-4f25-e053-2a95a90aa7df	69452-265	HUMAN OTC DRUG	Cetirizine HCl		Cetirizine HCl	CAPSULE	ORAL	20190501		NDA	NDA022429	Bionpharma Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69452-266_0d650c1b-bb45-6131-e063-6294a90a369e	69452-266	HUMAN OTC DRUG	anti-diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190802		NDA	NDA021855	Bionpharma Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
69452-267_07895277-4273-508f-e063-6394a90a40ea	69452-267	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	TABLET, EXTENDED RELEASE	ORAL	20231012		ANDA	ANDA216300	Bionpharma Inc.,	THEOPHYLLINE ANHYDROUS	300	mg/1	Methylxanthine [EPC], Xanthines [CS]		N	20241231
69452-271_0d83f614-6730-7d3a-e063-6294a90a6b11	69452-271	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215579	Bionpharma Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
69452-275_f6427906-293d-19ac-e053-2995a90a1df1	69452-275	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20230310		ANDA	ANDA216759	Bionpharma Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-276_01e5314f-6509-8b22-e063-6394a90aa940	69452-276	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230801		ANDA	ANDA217538	Bionpharma Inc.,	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69452-277_01e538d1-fc4d-8650-e063-6394a90aa169	69452-277	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230801		ANDA	ANDA217001	Bionpharma Inc.,	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69452-278_01e538d1-fc4d-8650-e063-6394a90aa169	69452-278	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230801		ANDA	ANDA217001	Bionpharma Inc.,	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69452-283_f0ffe026-a3b1-2ac7-e053-2a95a90a9c83	69452-283	HUMAN OTC DRUG	LORATADINE		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20200320		ANDA	ANDA202538	Bionpharma Inc.	LORATADINE	10	mg/1			N	20241231
69452-284_0d716cf5-bf20-b0e9-e063-6394a90a092d	69452-284	HUMAN OTC DRUG	naproxen sodium		naproxen sodium	CAPSULE, LIQUID FILLED	ORAL	20210122		NDA	NDA021920	Bionpharma Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-290_a0977267-e400-48f6-99fa-dafcc483e96e	69452-290	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	Bionpharma Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69452-291_a0977267-e400-48f6-99fa-dafcc483e96e	69452-291	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	Bionpharma Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
69452-302_f04854ae-9a49-72a5-e053-2995a90a0bb1	69452-302	HUMAN OTC DRUG	dye-free pain relief		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210305		ANDA	ANDA078682	Bionpharma Inc.	IBUPROFEN	200	mg/1201	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-305_f045660a-fbf8-5a1e-e053-2a95a90a4136	69452-305	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210204		ANDA	ANDA078682	Bionpharma Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69452-309_052d50df-8dca-905c-e063-6294a90ab0a5	69452-309	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine Maleate	TABLET, FILM COATED	ORAL	20230913		ANDA	ANDA217478	Bionpharma Inc.	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69452-310_052d50df-8dca-905c-e063-6294a90ab0a5	69452-310	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine Maleate	TABLET, FILM COATED	ORAL	20230913		ANDA	ANDA217478	Bionpharma Inc.	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
69452-311_051c0230-0e32-31e2-e063-6394a90a8067	69452-311	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20230913		ANDA	ANDA217916	Bionpharma Inc.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
69452-322_0d63c644-46c2-b4c0-e063-6394a90a9dd3	69452-322	HUMAN OTC DRUG	nighttime sleep-aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210427		OTC MONOGRAPH DRUG	M010	Bionpharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69452-336_8419864e-04e1-46e7-8a45-4fd631e889c7	69452-336	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA065064	Bionpharma Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
69452-337_8419864e-04e1-46e7-8a45-4fd631e889c7	69452-337	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA065063	Bionpharma Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
69452-338_5c10101e-866c-43e3-b22b-902bf2a72d02	69452-338	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220207		ANDA	ANDA202547	Bionpharma Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69452-339_5c10101e-866c-43e3-b22b-902bf2a72d02	69452-339	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220207		ANDA	ANDA202547	Bionpharma Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69452-340_4dcbf4e0-a9ed-44d9-b610-024173094971	69452-340	HUMAN PRESCRIPTION DRUG	Naratriptan		Naratriptan	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA091441	Bionpharma Inc.	NARATRIPTAN HYDROCHLORIDE	1	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69452-341_4dcbf4e0-a9ed-44d9-b610-024173094971	69452-341	HUMAN PRESCRIPTION DRUG	Naratriptan		Naratriptan	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA091441	Bionpharma Inc.	NARATRIPTAN HYDROCHLORIDE	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69452-342_45322b3a-fdbe-466f-a2d3-b64e12b36efe	69452-342	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20220228		ANDA	ANDA078963	Bionpharma Inc.	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
69452-343_45322b3a-fdbe-466f-a2d3-b64e12b36efe	69452-343	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20220228		ANDA	ANDA078963	Bionpharma Inc.	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
69452-344_025c1199-46e1-4e03-8489-8a24a0834891	69452-344	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20220218		ANDA	ANDA078284	Bionpharma Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69452-345_025c1199-46e1-4e03-8489-8a24a0834891	69452-345	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20220218		ANDA	ANDA078284	Bionpharma Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69452-346_025c1199-46e1-4e03-8489-8a24a0834891	69452-346	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20220218		ANDA	ANDA078284	Bionpharma Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
69452-347_903d952f-704a-4227-a829-5bddbd5793cb	69452-347	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA091113	Bionpharma Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
69452-348_903d952f-704a-4227-a829-5bddbd5793cb	69452-348	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA091113	Bionpharma Inc.	ESZOPICLONE	2	mg/1		CIV	N	20241231
69452-349_903d952f-704a-4227-a829-5bddbd5793cb	69452-349	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA091113	Bionpharma Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
69452-350_cfe3b317-aba5-46b3-83fd-df5a6d71ea76	69452-350	HUMAN PRESCRIPTION DRUG	Granisetron Hydrochloride		Granisetron Hydrochloride	TABLET, FILM COATED	ORAL	20220228		ANDA	ANDA078678	Bionpharma Inc.	GRANISETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69452-351_e5bac6ce-1039-4166-a7e4-0c61686dec76	69452-351	HUMAN PRESCRIPTION DRUG	terbinafine hydrochloride		terbinafine hydrochloride	TABLET	ORAL	20220128		ANDA	ANDA078163	Bionpharma Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
69452-356_fa1451cc-4c3a-4f53-a848-685a3e5d9f89	69452-356	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bionpharma Inc.	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69452-357_fa1451cc-4c3a-4f53-a848-685a3e5d9f89	69452-357	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bionpharma Inc.	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69452-358_fa1451cc-4c3a-4f53-a848-685a3e5d9f89	69452-358	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bionpharma Inc.	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69452-359_fa1451cc-4c3a-4f53-a848-685a3e5d9f89	69452-359	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bionpharma Inc.	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69452-360_fa1451cc-4c3a-4f53-a848-685a3e5d9f89	69452-360	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bionpharma Inc.	ROPINIROLE HYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69452-361_fa1451cc-4c3a-4f53-a848-685a3e5d9f89	69452-361	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bionpharma Inc.	ROPINIROLE HYDROCHLORIDE	4	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69452-362_fa1451cc-4c3a-4f53-a848-685a3e5d9f89	69452-362	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bionpharma Inc.	ROPINIROLE HYDROCHLORIDE	5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69452-363_63a77a01-b991-4f03-8f9f-4dd09c8302c4	69452-363	HUMAN PRESCRIPTION DRUG	Desloratadine		Desloratadine	TABLET, FILM COATED	ORAL	20231128		ANDA	ANDA078357	Bionpharma Inc.	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69452-375_ec6f2790-9d24-62cd-e053-2995a90a46dd	69452-375	HUMAN OTC DRUG	cool and heat pain relieving liquid		Menthol	LIQUID	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part348	Bionpharma Inc.	MENTHOL	16	mg/100mL			N	20241231
69452-376_0d9a178a-24f8-29ac-e063-6294a90a2db2	69452-376	HUMAN OTC DRUG	A Health Itch Relief Gel		Itch Relief Gel	GEL	TOPICAL	20221108		OTC MONOGRAPH DRUG	M017	Bionpharma, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	2	mg/100mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69452-377_f383c4d4-d788-59e7-e053-2a95a90af26f	69452-377	HUMAN OTC DRUG	ear drops		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20220915		OTC MONOGRAPH FINAL	M014	Bionpharma Inc.	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
69452-378_7c860070-7f7a-4217-9cfb-f5536fd736b4	69452-378	HUMAN PRESCRIPTION DRUG	IBANDRONATE SODIUM		IBANDRONATE SODIUM	TABLET	ORAL	20230526		ANDA	ANDA078998	Bionpharma Inc.	IBANDRONATE SODIUM	150	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
69452-389_0cf518b8-b230-7118-e063-6294a90a391d	69452-389	HUMAN OTC DRUG	Magnesium Citrate		Be Health Magnesium Citrate Oral Solution - Lemon	LIQUID	ORAL	20221227		OTC MONOGRAPH DRUG	M007	Bionpharma, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69452-390_0cf50dbf-e935-7116-e063-6294a90a5b4e	69452-390	HUMAN OTC DRUG	Magnesium Citrate		Be Health Magnesium Citrate Oral Solution - Cherry	LIQUID	ORAL	20221227		OTC MONOGRAPH DRUG	M007	Bionpharma, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69452-391_0cf518b8-b231-7118-e063-6294a90a391d	69452-391	HUMAN OTC DRUG	Magnesium Citrate		Be Health Magnesium Citrate Oral Solution - Grape	LIQUID	ORAL	20221227		OTC MONOGRAPH DRUG	M007	Bionpharma, Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69452-393_f607b6e9-27eb-1978-e053-2995a90a7bcd	69452-393	HUMAN OTC DRUG	pain relief roll-on		Lidocaine 4%	LIQUID	TOPICAL	20230220		OTC MONOGRAPH NOT FINAL	part348	Bionpharma Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69452-394_04ccd213-0a71-bd26-e063-6294a90a728d	69452-394	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET, FILM COATED	ORAL	20230908		ANDA	ANDA216999	Bionpharma Inc.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69455-463_8e80f47b-c919-43cf-83e3-c228f76b524d	69455-463	HUMAN OTC DRUG	Drunk Elephant	Umbre Tinte Physical Daily Defense Protection SPF-30	Zinc Oxide	LOTION	TOPICAL	20190115		OTC MONOGRAPH FINAL	part352	Drunk Elephant, LLC	ZINC OXIDE	20	mg/100mL			N	20241231
69455-964_9a109fc3-9f85-43db-8b2e-3f49d78e407b	69455-964	HUMAN OTC DRUG	Drunk Elephant	Umbre Sheer Defense SPF-30	ZINC OXIDE	LOTION	TOPICAL	20181213		OTC MONOGRAPH FINAL	part352	Drunk Elephant, LLC	ZINC OXIDE	20	mg/100mL			N	20241231
69464-901_0cd0c858-0fa3-9de0-e063-6394a90a3c23	69464-901	HUMAN OTC DRUG	CliniClean		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20230315		NDA	NDA019125	HR Pharmaceuticals, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
69464-901_0cdf20e0-a727-cea8-e063-6394a90a2efd	69464-901	HUMAN OTC DRUG	CliniClean		CHLORHEXIDINE GLUCONATE 4%	SOLUTION	TOPICAL	20230323		NDA	NDA019125	HR Pharmaceuticals, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
69464-901_f7984bbf-bc63-ea71-e053-6394a90add2c	69464-901	HUMAN OTC DRUG	CliniClean		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20230323		NDA	NDA019125	HR Pharmaceuticals, Inc.	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
69468-151_8e64b577-1ecb-46f2-a7c8-3577a16f8837	69468-151	HUMAN PRESCRIPTION DRUG	VISTOGARD		uridine triacetate	GRANULE	ORAL	20160301		NDA	NDA208159	Wellstat Therapeutics Corporation	URIDINE TRIACETATE	951	mg/g	Analogs/Derivatives [Chemical/Ingredient], Pyrimidine Analog [EPC], Pyrimidines [Chemical/Ingredient]		N	20241231
69468-152_ad981e1e-0654-40b1-807a-f4e228c7ae11	69468-152	HUMAN PRESCRIPTION DRUG	XURIDEN		uridine triacetate	GRANULE	ORAL	20150908		NDA	NDA208169	Wellstat Therapeutics Corporation	URIDINE TRIACETATE	951	mg/g	Analogs/Derivatives [Chemical/Ingredient], Pyrimidine Analog [EPC], Pyrimidines [Chemical/Ingredient]		N	20241231
69473-001_d9b61959-9fd6-92cf-e053-2a95a90aa80a	69473-001	HUMAN OTC DRUG	Alumier MD Acne Clarifying Cleanser		Salicylic Acid	GEL	TOPICAL	20190701		OTC MONOGRAPH FINAL	part333D	Alumier Labs	SALICYLIC ACID	20	mg/mL			N	20241231
69473-002_87eb6adc-c38f-d7df-e053-2a95a90aa747	69473-002	HUMAN OTC DRUG	Alumier MD Acne Balancing Serum		Salicylic Acid	CREAM	TOPICAL	20190701		OTC MONOGRAPH FINAL	part333D	Alumier Labs	SALICYLIC ACID	20	mg/mL			N	20241231
69473-003_08f20eec-9495-4f85-e063-6294a90a3e10	69473-003	HUMAN OTC DRUG	Alumier MD HydraSmooth Non-Comedogenic Moisturizer		Salicylic Acid	CREAM	TOPICAL	20190701		OTC MONOGRAPH DRUG	M006	Alumier Labs	SALICYLIC ACID	10	mg/mL			N	20241231
69473-006_db49f453-2212-4969-e053-2995a90abb0f	69473-006	HUMAN OTC DRUG	Alumier MD Sheer Hydration		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20190701		OTC MONOGRAPH NOT FINAL	part352	Alumier Labs	TITANIUM DIOXIDE; ZINC OXIDE	70; 62.8	mg/mL; mg/mL			N	20241231
69473-010_d967372e-1743-437d-e053-2995a90aae09	69473-010	HUMAN OTC DRUG	Alumier MD Sheer Hydration Tinted Moisturizing Sunscreen		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200630		OTC MONOGRAPH NOT FINAL	part352	Alumier Labs	TITANIUM DIOXIDE; ZINC OXIDE	70; 62.8	mg/mL; mg/mL			N	20241231
69473-011_d9b62909-e620-e60c-e053-2995a90ae713	69473-011	HUMAN OTC DRUG	Alumier MD Clear Shield Broad Spectrum SPF 42 Sunscreen		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part352	Alumier Labs	TITANIUM DIOXIDE; ZINC OXIDE	70; 61.8	mg/mL; mg/mL			N	20241231
69473-012_ecfac4c2-efaf-37b2-e053-2a95a90a3ad5	69473-012	HUMAN OTC DRUG	Alumier MD Post Procedure Kit		Titanium Dioxide, Zinc Oxide	KIT	TOPICAL	20201130		OTC MONOGRAPH NOT FINAL	part352	Alumier Labs						N	20241231
69473-014_d9b597f3-6f69-a0d0-e053-2995a90a3a28	69473-014	HUMAN OTC DRUG	Alumier MD Moisture Matte Broad Spectrum SPF 40 Sunscreen Amber		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	Alumier Labs	TITANIUM DIOXIDE; ZINC OXIDE	83; 90	mg/mL; mg/mL			N	20241231
69473-015_d9b597f3-6f69-a0d0-e053-2995a90a3a28	69473-015	HUMAN OTC DRUG	Alumier MD Moisture Matte Broad Spectrum SPF 40 Sunscreen Ivory		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	Alumier Labs	TITANIUM DIOXIDE; ZINC OXIDE	78; 90	mg/mL; mg/mL			N	20241231
69473-016_d9b597f3-6f69-a0d0-e053-2995a90a3a28	69473-016	HUMAN OTC DRUG	Alumier MD Moisture Matte Broad Spectrum SPF 40 Sunscreen Sand		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	Alumier Labs	TITANIUM DIOXIDE; ZINC OXIDE	78; 90	mg/mL; mg/mL			N	20241231
69473-017_d9b6cdd6-c2e8-5c1a-e053-2995a90ad8ee	69473-017	HUMAN OTC DRUG	Alumier MD Intensive Recovery		Hydrocortisone	CREAM	TOPICAL	20220308		OTC MONOGRAPH NOT FINAL	part348	Alumier Labs	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69473-018_08f23bf7-be52-6dc4-e063-6294a90a846a	69473-018	HUMAN OTC DRUG	Alumier MD Post Procedure Kit with Hydrocortisone		Titanium Dioxide, Zinc Oxide, Hydrocortisone	KIT	TOPICAL	20220322		OTC MONOGRAPH DRUG	M017	Alumier Labs						N	20241231
69481-333_a020aafe-45f3-4bdf-a910-f54c81709979	69481-333	HUMAN OTC DRUG	Clarisonic Pore and Blemish Cleanser Acne Treatment		Salicylic Acid	GEL	TOPICAL	20170810	20240610	OTC MONOGRAPH DRUG	M006	Pacific Bioscience Laboratories, Inc.	SALICYLIC ACID	20	mg/mL			N	
69482-600_30fffade-6854-0f85-e054-00144ff88e88	69482-600	HUMAN PRESCRIPTION DRUG	Tridesilon Cream		desonide 0.05%	CREAM	TOPICAL	20161001		NDA	NDA017010	Encore Dermatology Inc	DESONIDE	.03	g/60g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69483-001_d61d6be1-6055-3344-e053-2995a90a23b2	69483-001	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-002_d61d5c61-3fbe-7c55-e053-2995a90a8555	69483-002	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-003_d61d5c6c-536d-cae4-e053-2a95a90ac1cf	69483-003	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-004_d61d6be1-6031-3344-e053-2995a90a23b2	69483-004	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-005_d61d6be1-603d-3344-e053-2995a90a23b2	69483-005	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-006_d61d623c-bad3-de20-e053-2995a90ac35f	69483-006	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-007_d61d6be1-6049-3344-e053-2995a90a23b2	69483-007	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-008_d61d623c-badf-de20-e053-2995a90ac35f	69483-008	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69483-009_d61d4efd-4957-81ec-e053-2a95a90a7a6e	69483-009	HUMAN OTC DRUG	Dental City Topical Anesthetic		Benzocaine	GEL	DENTAL	20140401		OTC MONOGRAPH NOT FINAL	part356	ICP Inc DBA Dental City	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69484-001_d6089184-12ae-2697-e053-2a95a90a3c24	69484-001	HUMAN OTC DRUG	Tiger Supply Inc Topical Anesthetic		Benzocaine	GEL	DENTAL	20130508		OTC MONOGRAPH NOT FINAL	part356	Tiger Supply Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69484-002_d6089524-e8ec-20a8-e053-2995a90af677	69484-002	HUMAN OTC DRUG	Tiger Supply Inc Topical Anesthetic		Benzocaine	GEL	DENTAL	20130508		OTC MONOGRAPH NOT FINAL	part356	Tiger Supply Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69484-003_d6089184-12bb-2697-e053-2a95a90a3c24	69484-003	HUMAN OTC DRUG	Tiger Supply Inc Topical Anesthetic		Benzocaine	GEL	DENTAL	20130508		OTC MONOGRAPH NOT FINAL	part356	Tiger Supply Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69484-004_d6088fb7-3969-5f8f-e053-2a95a90a671d	69484-004	HUMAN OTC DRUG	Tiger Supply Inc Topical Anesthetic		Benzocaine	GEL	DENTAL	20130508		OTC MONOGRAPH NOT FINAL	part356	Tiger Supply Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69484-005_d6089b27-8088-7076-e053-2a95a90a2efd	69484-005	HUMAN OTC DRUG	Tiger Supply Inc Topical Anesthetic		Benzocaine	GEL	DENTAL	20130508		OTC MONOGRAPH NOT FINAL	part356	Tiger Supply Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69484-006_d6089524-e8f8-20a8-e053-2995a90af677	69484-006	HUMAN OTC DRUG	Tiger Supply Inc Topical Anesthetic		Benzocaine	GEL	DENTAL	20130508		OTC MONOGRAPH NOT FINAL	part356	Tiger Supply Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69484-050_d608a58b-315f-8753-e053-2995a90ab4c5	69484-050	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69484-051_d6089b27-80a3-7076-e053-2a95a90a2efd	69484-051	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69484-052_d6089b27-8099-7076-e053-2a95a90a2efd	69484-052	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69484-053_d608a8d3-12ef-a7b3-e053-2a95a90acd6c	69484-053	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69484-054_d608a579-c28b-a7af-e053-2a95a90a7dbc	69484-054	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69484-055_d608b4fd-25ac-536c-e053-2a95a90a73b7	69484-055	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69484-056_d608a579-c281-a7af-e053-2a95a90a7dbc	69484-056	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69484-057_d608ae37-9903-d0b9-e053-2995a90ac494	69484-057	HUMAN PRESCRIPTION DRUG	Tiger Supply Inc APF		Sodium Fluoride	GEL	DENTAL	20130301		UNAPPROVED DRUG OTHER		Tiger Supply Inc	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69488-001_ee9e655a-fd9e-4b39-acf7-992a4b545fc9	69488-001	HUMAN PRESCRIPTION DRUG	NETSPOT		68Ga-DOTATATE	KIT	INTRAVENOUS	20160601		NDA	NDA208547	Advanced Accelerator Applications USA, Inc						N	20241231
69488-003_9bceadb5-9b6c-494d-af79-db912a16791b	69488-003	HUMAN PRESCRIPTION DRUG	Lutathera		Lutetium Lu 177 dotatate	INJECTION	INTRAVENOUS	20180126		NDA	NDA208700	Advanced Accelerator Applications USA, Inc	LUTETIUM OXODOTREOTIDE LU-177	10	mCi/mL			N	20241231
69488-010_fc9c3c57-55b4-4586-a8c4-fde74e46a895	69488-010	HUMAN PRESCRIPTION DRUG	PLUVICTO		lutetium Lu 177 vipivotide tetraxetan	INJECTION, SOLUTION	INTRAVENOUS	20220323		NDA	NDA215833	Advanced Accelerator Applications USA, Inc	LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN	27	mCi/mL	Radioligand Activity [MoA], Radioligand Therapeutic Agent [EPC]		N	20241231
69488-017_682570f6-0a9b-43f9-9d37-421d541dd2d6	69488-017	HUMAN PRESCRIPTION DRUG	LOCAMETZ		kit for the preparation of gallium Ga 68 gozetotide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220323		NDA	NDA215841	Advanced Accelerator Applications USA, Inc	GOZETOTIDE	25	ug/1			N	20241231
69489-111_a1ba7998-5594-449a-b1ac-6ffde5a5c494	69489-111	HUMAN PRESCRIPTION DRUG	TARGADOX		doxycycline hyclate	TABLET	ORAL	20160829		ANDA	ANDA062269	Journey Medical Corporation	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69489-121_a963e02a-adbc-49f1-9e74-c1722f92902d	69489-121	HUMAN PRESCRIPTION DRUG	Ximino		minocycline hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20201108	20240331	NDA	NDA201922	Journey Medical Corporation	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
69489-122_a963e02a-adbc-49f1-9e74-c1722f92902d	69489-122	HUMAN PRESCRIPTION DRUG	Ximino		minocycline hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20201108	20240331	NDA	NDA201922	Journey Medical Corporation	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
69489-123_a963e02a-adbc-49f1-9e74-c1722f92902d	69489-123	HUMAN PRESCRIPTION DRUG	Ximino		minocycline hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20201108	20240331	NDA	NDA201922	Journey Medical Corporation	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
69489-201_37f39a30-51db-490a-af6f-8f0fc0bd9994	69489-201	HUMAN PRESCRIPTION DRUG	AMZEEQ		Minocycline	AEROSOL, FOAM	TOPICAL	20220325		NDA	NDA212379	Journey Medical Corporation	MINOCYCLINE HYDROCHLORIDE	40	mg/g	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69489-212_4ab22cac-50b3-4814-8eac-a6c41700462b	69489-212	HUMAN PRESCRIPTION DRUG	ZILXI		Minocycline	AEROSOL, FOAM	TOPICAL	20221001		NDA	NDA213690	Journey Medical Corporation	MINOCYCLINE HYDROCHLORIDE	15	mg/g	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69489-411_78796126-f6ed-42e3-b40d-ea5723b89516	69489-411	HUMAN PRESCRIPTION DRUG	Qbrexza		glycopyrronium	CLOTH	TOPICAL	20180628		NDA	NDA210361	Journey Medical Corporation	GLYCOPYRRONIUM TOSYLATE	2.4	g/100g	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69489-711_f03361cb-005c-4d0c-bc27-033484f02624	69489-711	HUMAN PRESCRIPTION DRUG	Exelderm		Sulconazole Nitrate	CREAM	TOPICAL	20190607		NDA	NDA018737	Journey Medical Corporation	SULCONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69489-721_af026933-9a3d-4027-90f6-57fe4349d11e	69489-721	HUMAN PRESCRIPTION DRUG	Exelderm		Sulconazole Nitrate	SOLUTION	TOPICAL	20190607		NDA	NDA018738	Journey Medical Corporation	SULCONAZOLE NITRATE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69491-033_f114a573-ef41-639c-e053-2a95a90a1021	69491-033	HUMAN OTC DRUG	Colgate Anticavity		SODIUM MONOFLUOROPHOSPHATE	PASTE	DENTAL	20201015		OTC MONOGRAPH FINAL	part355	Buzz Export Services Pty., Ltd.	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
69491-034_f11406bd-7ad6-f31d-e053-2995a90ac673	69491-034	HUMAN OTC DRUG	Murchison Hume Dental Kit		SODIUM MONOFLUOROPHOSPHATE	KIT		20201015		OTC MONOGRAPH FINAL	part355	Buzz Export Services Pty., Ltd.						N	20241231
69491-035_0cfd8a92-6e7d-3ec8-e063-6294a90a058a	69491-035	HUMAN OTC DRUG	Sanitizer Wipe in Sachet		ALCOHOL	CLOTH	TOPICAL	20220215		OTC MONOGRAPH DRUG	505G(a)(3)	Buzz Export Services Pty Ltd (Buzz Products)	ALCOHOL	75	mL/100mL			N	20241231
69491-036_f1143924-17c0-6de9-e053-2995a90a481f	69491-036	HUMAN OTC DRUG	United Airlines Polaris Kit		SODIUM MONOFLUOROPHOSPHATE, ALCOHOL	KIT		20220215		OTC MONOGRAPH NOT FINAL	part355	Buzz Export Services Pty Ltd (Buzz Products)						N	20241231
69491-037_f1143b1b-9ad7-25f8-e053-2a95a90a3ad3	69491-037	HUMAN OTC DRUG	United Airlines UPP Kit		SODIUM MONOFLUOROPHOSPHATE, ALCOHOL	KIT		20220215		OTC MONOGRAPH NOT FINAL	part355	Buzz Export Services Pty Ltd (Buzz Products)						N	20241231
69491-038_f114122c-4ba0-f1ad-e053-2995a90aa66b	69491-038	HUMAN OTC DRUG	United Airlines Transcon Kit		SODIUM MONOFLUOROPHOSPHATE, ALCOHOL	KIT		20220215		OTC MONOGRAPH NOT FINAL	part355	Buzz Export Services Pty Ltd (Buzz Products)						N	20241231
69491-039_f1145c4f-05cb-487d-e053-2995a90a1ef8	69491-039	HUMAN OTC DRUG	Delta Travel Kit Comfort plus		SODIUM MONOFLUOROPHOSPHATE	KIT		20220501		OTC MONOGRAPH NOT FINAL	part355	Buzz Export Services Pty Ltd (Buzz Products)						N	20241231
69491-040_0cff8c8a-1480-b201-e063-6394a90a8544	69491-040	HUMAN OTC DRUG	United Airlines UPP Kit with Colgate		SODIUM MONOFLUOROPHOSPHATE	KIT		20220515		OTC MONOGRAPH DRUG	M021	Buzz Export Services Pty Ltd (Buzz Products)						N	20241231
69491-041_0cfd9cc7-c30c-6671-e063-6294a90ac6a1	69491-041	HUMAN OTC DRUG	United Airlines Polaris Kit with Colgate		SODIUM MONOFLUOROPHOSPHATE	KIT		20220515		OTC MONOGRAPH DRUG	M021	Buzz Export Services Pty Ltd (Buzz Products)						N	20241231
69491-042_0cfd8f6d-6d43-02b1-e063-6394a90a40eb	69491-042	HUMAN OTC DRUG	United Airlines Transcon Kit with Colgate		SODIUM MONOFLUOROPHOSPHATE	KIT		20220515		OTC MONOGRAPH DRUG	M021	Buzz Export Services Pty Ltd (Buzz Products)						N	20241231
69494-003_164bcfe1-858b-4d49-b3b7-8348db4c6cbb	69494-003	HUMAN OTC DRUG	Eryfotona Ageless		Zinc Oxide	LOTION	TOPICAL	20190610		OTC MONOGRAPH DRUG	M020	ISDIN Corp.	ZINC OXIDE	107	mg/mL			N	20241231
69494-010_a97c70d2-9934-4953-aa8c-70744eda4b0a	69494-010	HUMAN OTC DRUG	Fusion Water Magic		Octocrylene, Homosalate, Octisalate, and Avobenzone	SOLUTION	TOPICAL	20231215		OTC MONOGRAPH DRUG	M020	ISDIN Corp.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	27; 73; 45; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69494-014_ecadd9b1-4dc2-4988-9f7b-f662c5d06db2	69494-014	HUMAN OTC DRUG	Fusion Mineral Body		Zinc Oxide	LOTION	TOPICAL	20231013		OTC MONOGRAPH DRUG	M020	ISDIN Corp.	ZINC OXIDE	120	mg/mL			N	20241231
69494-015_b9cd8079-90a4-421c-84f0-f3a187724985	69494-015	HUMAN OTC DRUG	Fusion Mineral Facial		Zinc Oxide	LOTION	TOPICAL	20230915		OTC MONOGRAPH DRUG	M020	ISDIN Corp.	ZINC OXIDE	120	mg/mL			N	20241231
69494-302_4d52d730-0283-4d78-85a9-08b54ed51afd	69494-302	HUMAN OTC DRUG	Eryfotona Actinica Ultralight Emulsion		Sunscreen	EMULSION	TOPICAL	20150817		OTC MONOGRAPH DRUG	M020	ISDIN Corp	ZINC OXIDE	11	g/100mL			N	20241231
69498-001_d61dad6d-b2f4-7019-e053-2995a90a00b5	69498-001	HUMAN OTC DRUG	iSmile Topical Anesthetic		Benzocaine	GEL	DENTAL	20140601		OTC MONOGRAPH NOT FINAL	part356	iSmile Dental Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69498-002_d61d9e1e-3290-114e-e053-2a95a90a6746	69498-002	HUMAN OTC DRUG	iSmile Topical Anesthetic		Benzocaine	GEL	DENTAL	20140601		OTC MONOGRAPH NOT FINAL	part356	iSmile Dental Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69498-003_d61dad6d-b2db-7019-e053-2995a90a00b5	69498-003	HUMAN OTC DRUG	iSmile Topical Anesthetic		Benzocaine	GEL	DENTAL	20140601		OTC MONOGRAPH NOT FINAL	part356	iSmile Dental Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69498-004_d61db399-41cb-43e5-e053-2a95a90aeb10	69498-004	HUMAN OTC DRUG	iSmile Topical Anesthetic		Benzocaine	GEL	DENTAL	20140601		OTC MONOGRAPH NOT FINAL	part356	iSmile Dental Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69498-005_d61db60d-aeaf-51c1-e053-2995a90aab45	69498-005	HUMAN OTC DRUG	iSmile Topical Anesthetic		Benzocaine	GEL	DENTAL	20140601		OTC MONOGRAPH NOT FINAL	part356	iSmile Dental Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69498-006_d61dad6d-b2e8-7019-e053-2995a90a00b5	69498-006	HUMAN OTC DRUG	iSmile Topical Anesthetic		Benzocaine	GEL	DENTAL	20140601		OTC MONOGRAPH NOT FINAL	part356	iSmile Dental Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69499-330_08208e68-931a-4c0d-a9d8-64410e2fc8cc	69499-330	HUMAN PRESCRIPTION DRUG	chlorzoxazone		chlorzoxazone	TABLET	ORAL	20170830		ANDA	ANDA207483	Solubiomix	CHLORZOXAZONE	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69499-403_2a9f0c9d-1176-47b7-ab2c-eab764403fdf	69499-403	HUMAN PRESCRIPTION DRUG	Coxanto		oxaprozin	CAPSULE	ORAL	20231024		NDA	NDA217927	Solubiomix, LLC	OXAPROZIN	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69503-003_37e43655-eaee-40c7-88e7-8ae787ca41f2	69503-003	HUMAN OTC DRUG	Doc Johnson Prolonging Ginseng		Benzocaine	CREAM	TOPICAL	20230523		OTC MONOGRAPH DRUG	M017	Health Devices Corporation	BENZOCAINE	7.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-001_d6075cb4-b53a-7c7e-e053-2a95a90ab12a	69509-001	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-002_d6079d0b-08e0-0a13-e053-2a95a90aa4eb	69509-002	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-003_d6079d0b-08ec-0a13-e053-2a95a90aa4eb	69509-003	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-004_d6077dc7-4388-05a2-e053-2a95a90a9d98	69509-004	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-005_d607703e-6f53-e9b0-e053-2a95a90a480a	69509-005	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-006_d6079374-ec45-3f94-e053-2a95a90a28b9	69509-006	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-007_d607703e-6f46-e9b0-e053-2a95a90a480a	69509-007	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-008_d6073b54-6e3d-3706-e053-2a95a90a2502	69509-008	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-009_d607875b-aeec-798e-e053-2a95a90aa0d4	69509-009	HUMAN OTC DRUG	Primo Topical Anesthetic		Benzocaine	GEL	DENTAL	20140301		OTC MONOGRAPH NOT FINAL	part356	Tri State Dental	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69509-050_d607eca8-5abe-57dc-e053-2995a90a4396	69509-050	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-051_d607dc44-94a3-62b3-e053-2a95a90ad02b	69509-051	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-052_d6080607-6ef9-71ca-e053-2a95a90a72bf	69509-052	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-053_d6080607-6ee1-71ca-e053-2a95a90a72bf	69509-053	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-054_d607ffd6-fb16-35ba-e053-2995a90abc1e	69509-054	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-055_d60811f7-b1d3-719b-e053-2a95a90ab2fc	69509-055	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-056_d6080b18-4117-5384-e053-2a95a90a7df5	69509-056	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-057_d607de86-93aa-744b-e053-2995a90aff70	69509-057	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-058_d60800ed-6e82-71c8-e053-2a95a90a7254	69509-058	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69509-059_d6080607-6eeb-71ca-e053-2a95a90a72bf	69509-059	HUMAN PRESCRIPTION DRUG	Primo APF		Sodium Fluoride	GEL	DENTAL	20130901		UNAPPROVED DRUG OTHER		Tri State Dental	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69510-010_0b50c16d-53c5-8086-e063-6294a90ac5ef	69510-010	HUMAN OTC DRUG	Ipana Wintergreen Fluoride		SODIUM MONOFLUOROPHOSPHATE	PASTE	DENTAL	20141231		OTC MONOGRAPH DRUG	M021	Maxill Inc.	SODIUM MONOFLUOROPHOSPHATE	.1	g/100g			N	20241231
69510-020_0b50c461-6ad7-8b89-e063-6294a90a1784	69510-020	HUMAN OTC DRUG	Ipana Bucky Beaver Bubble Gum Childrens Fluoride		SODIUM MONOFLUOROPHOSPHATE	PASTE	DENTAL	20141231		OTC MONOGRAPH DRUG	M021	Maxill Inc	SODIUM MONOFLUOROPHOSPHATE	.1	g/100g			N	20241231
69510-351_0b50b7ba-44f2-624f-e063-6294a90a02fd	69510-351	HUMAN OTC DRUG	Ipana 20% Benzocaine Topical		Benzocaine	GEL	DENTAL	20160801		OTC MONOGRAPH DRUG	M022	Maxill Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69510-352_0b50c461-6ad0-8b89-e063-6294a90a1784	69510-352	HUMAN OTC DRUG	Ipana 20% Benzocaine Topical		Benzocaine	GEL	DENTAL	20160801		OTC MONOGRAPH DRUG	M022	Maxill Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69510-353_0b50c7d2-07e6-96f5-e063-6394a90aece9	69510-353	HUMAN OTC DRUG	Ipana 20% Benzocaine Topical		Benzocaine	GEL	DENTAL	20160801		OTC MONOGRAPH DRUG	M022	Maxill Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69510-355_0b50c461-6ad1-8b89-e063-6294a90a1784	69510-355	HUMAN OTC DRUG	Ipana 20% Benzocaine Topical		Benzocaine	GEL	DENTAL	20160801		OTC MONOGRAPH DRUG	M022	Maxill Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69510-358_0b50dd66-3e27-cea8-e063-6394a90a3f9e	69510-358	HUMAN OTC DRUG	Ipana 20% Benzocaine Topical		Benzocaine	GEL	DENTAL	20160801		OTC MONOGRAPH DRUG	M022	Maxill Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69514-300_f2b695d5-6132-43b5-e053-2a95a90a3450	69514-300	HUMAN OTC DRUG	Mineral Wear Airbrushing Pressed Powder		Titanium Dioxide, Zinc Oxide	POWDER	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Markwins Beauty Brands	TITANIUM DIOXIDE; ZINC OXIDE	15; 10	g/100g; g/100g			N	20241231
69514-301_f2f5ee7a-4f50-12e9-e053-2a95a90a7eae	69514-301	HUMAN OTC DRUG	Super CC Color Correction Care Cream		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Markwins Beauty Brands	TITANIUM DIOXIDE; ZINC OXIDE	5.76; 2.94	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69514-302_f30b53b1-f72a-211b-e053-2995a90adab8	69514-302	HUMAN OTC DRUG	Super CC Color-Correction Care All Over Blur CC Cream		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Markwins Beauty Brands	TITANIUM DIOXIDE; ZINC OXIDE	2.3; 6.3	g/100g; g/100g			N	20241231
69514-304_f30cc928-d60e-3431-e053-2a95a90a6800	69514-304	HUMAN OTC DRUG	Mineral Wear Talc Free Mineral Face Powder	SPF 16	Titanium Dioxide, Zinc Oxide	POWDER	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Markwins Beauty Brands	TITANIUM DIOXIDE; ZINC OXIDE	6; 4.2	g/100g; g/100g			N	20241231
69516-005_1d6c9e9d-e17d-4609-91fa-75e5bdbc5114	69516-005	HUMAN PRESCRIPTION DRUG	Ocaliva		Obeticholic Acid	TABLET, FILM COATED	ORAL	20160527		NDA	NDA207999	Intercept Pharmaceuticals Inc	OBETICHOLIC ACID	5	mg/1	Farnesoid X Receptor Agonist [EPC], Farnesoid X Receptor Agonists [MoA]		N	20241231
69516-010_1d6c9e9d-e17d-4609-91fa-75e5bdbc5114	69516-010	HUMAN PRESCRIPTION DRUG	Ocaliva		Obeticholic Acid	TABLET, FILM COATED	ORAL	20160527		NDA	NDA207999	Intercept Pharmaceuticals Inc	OBETICHOLIC ACID	10	mg/1	Farnesoid X Receptor Agonist [EPC], Farnesoid X Receptor Agonists [MoA]		N	20241231
69517-104_0b58610e-943c-7655-e063-6394a90af56f	69517-104	HUMAN OTC DRUG	Pain Reliever		Aspirin 81 mg	TABLET, DELAYED RELEASE	ORAL	20160209		OTC MONOGRAPH DRUG	M013	HealthLife Of USA	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69517-106_08334647-cb66-edcf-e063-6294a90a8de0	69517-106	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20120512		OTC MONOGRAPH DRUG	M012	HealthLife of USA	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69517-107_0833d389-a7f4-9d58-e063-6294a90a4fc9	69517-107	HUMAN OTC DRUG	Extra Strenghth Acetaminophen		Acetaminophen	TABLET	ORAL	20170731		OTC MONOGRAPH DRUG	M013	HealthLife of USA	ACETAMINOPHEN	500	mg/1			N	20241231
69517-109_046b91ed-d78b-42c0-b822-77fcbdeff84b	69517-109	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium Tablets, 220 mg	TABLET	ORAL	20110930		ANDA	ANDA091353	HealthLife of USA LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69517-111_8e733e89-3460-49b9-a157-4f2f91bb14cc	69517-111	HUMAN OTC DRUG	Fast Pain Relief		Ibuprofen	TABLET, COATED	ORAL	20110101		ANDA	ANDA079174	HealthLife of USA LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69517-112_0833ffd4-f988-f2c5-e063-6394a90a305c	69517-112	HUMAN OTC DRUG	Antigrip		Acetaminophen, Phenylephrine HCl, Chlorpheniramine Maleate, Dextromethorphan HBr	CAPSULE, LIQUID FILLED	ORAL	20170324		OTC MONOGRAPH DRUG	M012	HEALTHLIFE OF USA LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69517-119_083389ce-8dc1-a654-e063-6294a90a76fa	69517-119	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 400 mg	TABLET	ORAL	20160413		OTC MONOGRAPH DRUG	M012	HealthLife of USA LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69517-120_08337902-0be2-a579-e063-6294a90afc67	69517-120	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr Tablets	TABLET	ORAL	20170531		OTC MONOGRAPH DRUG	M012	Healthlife of USA LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	15; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69517-124_08339f10-1c23-0a07-e063-6294a90aa4de	69517-124	HUMAN OTC DRUG	Gentle Relief Stool Softner		Gentle Relief Stool Softnet	CAPSULE, GELATIN COATED	ORAL	20170531		OTC MONOGRAPH DRUG	M007	Healthlife of USA	DOCUSATE SODIUM	100	mg/1			N	20241231
69517-130_08343e8a-faa7-79f6-e063-6294a90a4417	69517-130	HUMAN OTC DRUG	Menstrual Complete		Menstrual Complete	TABLET, COATED	ORAL	20170531		OTC MONOGRAPH DRUG	M013	Healthlife of USA	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69517-131_083396b6-6a49-ffc7-e063-6294a90ad8e2	69517-131	HUMAN OTC DRUG	SENNA-S		Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg	TABLET, COATED	ORAL	20160307		OTC MONOGRAPH DRUG	505G(a)(3)	HealthLife of USA LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69517-148_0833715d-c7e1-a281-e063-6394a90a2138	69517-148	HUMAN OTC DRUG	Guaifenesin 200mg		Guaifenesin	TABLET	ORAL	20220128		OTC MONOGRAPH DRUG	M012	HEALTHLIFE OF USA LLC	GUAIFENESIN	200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69517-155_083396b6-6a36-ffc7-e063-6294a90ad8e2	69517-155	HUMAN OTC DRUG	PENTREXCILINA		Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide	TABLET	ORAL	20180105		OTC MONOGRAPH DRUG	M012	Healthlife of USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 15; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69517-160_08337902-0be0-a579-e063-6294a90afc67	69517-160	HUMAN OTC DRUG	Day-Time Cold and Flu Relief		Acetaminophen, Phenylephrine, Dextromethorphan	CAPSULE, LIQUID FILLED	ORAL	20230404		OTC MONOGRAPH DRUG	M012	HealthLife of USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69517-161_0833784b-16a9-75f4-e063-6394a90a47d6	69517-161	HUMAN OTC DRUG	Night-Time Cold and Flu Relief		Acetaminophen, Doxylamine Succinate, Dextromethorphan HBr	CAPSULE, LIQUID FILLED	ORAL	20230404		OTC MONOGRAPH DRUG	M012	HealthLife of USA	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69522-2618_f21455ad-23e0-554c-e053-2a95a90a8d40	69522-2618	HUMAN OTC DRUG	Big Cloud Defend Daily Face Moisturizer Broad Spectrum SPF30		Avobenzone, Homosalate and Octocrylene Lotion	LOTION	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part352	Dollar Shave Club, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2.5; 7; 4.5	mg/100mg; mg/100mg; mg/100mg			N	20241231
69528-302_dd9c8f4b-836c-4fdc-96cb-37042fa6dfcb	69528-302	HUMAN PRESCRIPTION DRUG	OZOBAX	DS	Baclofen	SOLUTION	ORAL	20231012		NDA	NDA208193	Metacel Pharmaceuticals, LLC	BACLOFEN	10	mg/5mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
69536-103_3a89dc68-ce64-462c-8040-2f21f57b6f28	69536-103	HUMAN OTC DRUG	Aftera		LEVONORGESTREL	TABLET	ORAL	20180510		NDA AUTHORIZED GENERIC	NDA021998	Foundation Consumer Healthcare LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69536-108_8fe320b6-b4dd-4a46-b364-8ca4e775dab3	69536-108	HUMAN OTC DRUG	Campho-Phenique	Cold Sore Treatment	CAMPHOR (SYNTHETIC) and PHENOL	GEL	TOPICAL	20170801		OTC MONOGRAPH NOT FINAL	part348	Foundation Consumer Healthcare LLC	CAMPHOR (SYNTHETIC); PHENOL	10.8; 4.7	g/100g; g/100g			N	20241231
69536-109_dacb6501-315d-4a7f-aaff-253db030f9a9	69536-109	HUMAN OTC DRUG	Campho-Phenique	Antiseptic	Camphor (synthetic) and Phenol	GEL	TOPICAL	20211115		OTC MONOGRAPH NOT FINAL	part348	Foundation Consumer Healthcare	CAMPHOR (SYNTHETIC); PHENOL	10.8; 4.7	g/100g; g/100g			N	20241231
69536-110_2104ca4d-c06c-422a-be6d-ae2dc2cdb138	69536-110	HUMAN OTC DRUG	Campho-Phenique	Antiseptic	CAMPHOR (SYNTHETIC) and PHENOL	LIQUID	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Foundation Consumer Healthcare LLC	CAMPHOR (SYNTHETIC); PHENOL	10.8; 4.7	mg/100mL; mg/100mL			N	20241231
69536-133_8f7e3809-e396-473e-833a-1939cf1a78be	69536-133	HUMAN OTC DRUG	Next Choice One Dose		levonorgestrel	TABLET	ORAL	20190615		NDA AUTHORIZED GENERIC	NDA021998	Foundation Consumer Healthcare LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69536-146_a0190797-2a39-47be-803b-bec877085166	69536-146	HUMAN OTC DRUG	Plan B One-Step		levonorgestrel	TABLET	ORAL	20180510		NDA	NDA021998	Foundation Consumer Healthcare LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69536-162_a0190797-2a39-47be-803b-bec877085166	69536-162	HUMAN OTC DRUG	Plan B One-Step		levonorgestrel	TABLET	ORAL	20180510		NDA	NDA021998	Foundation Consumer Healthcare LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69536-181_14b7f46c-7a78-4078-8ddc-02ee3f7e3134	69536-181	HUMAN OTC DRUG	St. Joseph Low Dose Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20170217		OTC MONOGRAPH NOT FINAL	part343	Foundation Consumer Healthcare	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69536-200_2e871e24-100b-4a74-959d-8df23d97e979	69536-200	HUMAN OTC DRUG	Take Action		levonorgestrel	TABLET	ORAL	20180510		NDA AUTHORIZED GENERIC	NDA021998	Foundation Consumer Healthcare LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69536-281_a05b20f6-7b08-4d5f-96b9-5edf889aa8bc	69536-281	HUMAN OTC DRUG	St. Joseph Chewable Low Dose Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20170217		OTC MONOGRAPH NOT FINAL	part343	Foundation Consumer Healthcare LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69539-006_b58ce71b-fdf0-436d-9592-83b423a71deb	69539-006	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride Tablets, 400 mg		Moxifloxacin Hydrochloride Tablets, 400 mg	TABLET, FILM COATED	ORAL	20170922		ANDA	ANDA208682	MSN LABORATORIES PRIVATE LIMITED	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
69539-008_e62cab33-dce6-4858-8628-f5d97cb83f48	69539-008	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	MSN LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-009_e62cab33-dce6-4858-8628-f5d97cb83f48	69539-009	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	MSN LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-010_e62cab33-dce6-4858-8628-f5d97cb83f48	69539-010	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	MSN LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-011_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-011	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	25	mg/1		CV	N	20241231
69539-012_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-012	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	50	mg/1		CV	N	20241231
69539-013_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-013	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	75	mg/1		CV	N	20241231
69539-014_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-014	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	100	mg/1		CV	N	20241231
69539-015_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-015	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	150	mg/1		CV	N	20241231
69539-016_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-016	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	200	mg/1		CV	N	20241231
69539-017_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-017	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	225	mg/1		CV	N	20241231
69539-018_bc069afb-a7ac-4ac9-9b67-2b67f91b20ac	69539-018	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	300	mg/1		CV	N	20241231
69539-019_03289f80-d73d-48c6-b3b9-938b9c45edf3	69539-019	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20180702		ANDA	ANDA209365	MSN LABORATORIES PRIVATE LIMITED	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69539-020_03289f80-d73d-48c6-b3b9-938b9c45edf3	69539-020	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20180702		ANDA	ANDA209365	MSN LABORATORIES PRIVATE LIMITED	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69539-021_4b237031-5375-4a5a-8a5d-21527f6fc7da	69539-021	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191120		ANDA	ANDA209878	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-022_4b237031-5375-4a5a-8a5d-21527f6fc7da	69539-022	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191120		ANDA	ANDA209878	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-023_4b237031-5375-4a5a-8a5d-21527f6fc7da	69539-023	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET, FOR SUSPENSION	ORAL	20191120		ANDA	ANDA209878	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-025_421cfdea-11a0-4fd7-8b8f-79711f1e5f89	69539-025	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA204921	MSN LABORATORIES PRIVATE LIMITED	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69539-026_421cfdea-11a0-4fd7-8b8f-79711f1e5f89	69539-026	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA204921	MSN LABORATORIES PRIVATE LIMITED	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69539-027_421cfdea-11a0-4fd7-8b8f-79711f1e5f89	69539-027	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA204921	MSN LABORATORIES PRIVATE LIMITED	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69539-028_421cfdea-11a0-4fd7-8b8f-79711f1e5f89	69539-028	HUMAN PRESCRIPTION DRUG	lacosamide		lacosamide	TABLET, FILM COATED	ORAL	20220319		ANDA	ANDA204921	MSN LABORATORIES PRIVATE LIMITED	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69539-032_3b178225-b3ba-4c9f-bde6-a5e076697980	69539-032	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209623	MSN LABORATORIES PRIVATE LIMITED	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69539-033_3b178225-b3ba-4c9f-bde6-a5e076697980	69539-033	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209623	MSN LABORATORIES PRIVATE LIMITED	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69539-034_1ace4714-01cd-47be-8c71-f08093c20862	69539-034	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190905		ANDA	ANDA209965	MSN LABORATORIES PRIVATE LIMITED	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
69539-035_69201d68-7ddf-4bd8-9393-c40e57c50adb	69539-035	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	MSN LABORATORIES PRIVATE LIMITED	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
69539-036_69201d68-7ddf-4bd8-9393-c40e57c50adb	69539-036	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	MSN LABORATORIES PRIVATE LIMITED	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
69539-042_1e7672d0-2532-401b-81a2-dd76968d2745	69539-042	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210460	MSN LABORATORIES PRIVATE LIMITED	DIMETHYL FUMARATE	120	mg/1			N	20241231
69539-043_1e7672d0-2532-401b-81a2-dd76968d2745	69539-043	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210460	MSN LABORATORIES PRIVATE LIMITED	DIMETHYL FUMARATE	240	mg/1			N	20241231
69539-049_2c63b39b-45a2-48d0-a2c4-c39b2e5e4861	69539-049	HUMAN PRESCRIPTION DRUG	Abiraterone		Abiraterone acetate	TABLET	ORAL	20190710		ANDA	ANDA210686	MSN LABORATORIES PRIVATE LIMITED	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
69539-050_e4d7d9f6-481e-4029-9b0d-74c291550367	69539-050	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET	ORAL	20190520		ANDA	ANDA210688	MSN LABORATORIES PRIVATE LIMITED	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69539-051_e4d7d9f6-481e-4029-9b0d-74c291550367	69539-051	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET	ORAL	20190520		ANDA	ANDA210688	MSN LABORATORIES PRIVATE LIMITED	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69539-052_d7005459-601a-4bf9-9278-3cb2b06566b5	69539-052	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181203		ANDA	ANDA210687	MSN LABORATORIES PRIVATE LIMITED	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
69539-053_d7005459-601a-4bf9-9278-3cb2b06566b5	69539-053	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181203		ANDA	ANDA210687	MSN LABORATORIES PRIVATE LIMITED	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
69539-057_0c0d566e-5315-4e29-a207-5f2eb75910f0	69539-057	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20210827		ANDA	ANDA205960	MSN LABORATORIES PRIVATE LIMITED	ASENAPINE MALEATE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69539-058_0c0d566e-5315-4e29-a207-5f2eb75910f0	69539-058	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20210827		ANDA	ANDA205960	MSN LABORATORIES PRIVATE LIMITED	ASENAPINE MALEATE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69539-059_0c0d566e-5315-4e29-a207-5f2eb75910f0	69539-059	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20210827		ANDA	ANDA205960	MSN LABORATORIES PRIVATE LIMITED	ASENAPINE MALEATE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69539-060_0c0d566e-5315-4e29-a207-5f2eb75910f0	69539-060	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20210827		ANDA	ANDA205960	MSN LABORATORIES PRIVATE LIMITED	ASENAPINE MALEATE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69539-073_da168049-e499-4563-afe8-82ae754ed640	69539-073	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20191120		ANDA	ANDA210945	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-074_da168049-e499-4563-afe8-82ae754ed640	69539-074	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20200616		ANDA	ANDA210945	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-075_da168049-e499-4563-afe8-82ae754ed640	69539-075	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20191120		ANDA	ANDA210945	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-078_8908d8af-fa31-4711-a33c-f4b7fbf7d31f	69539-078	HUMAN PRESCRIPTION DRUG	Trientine hydrochloride		Trientine hydrochloride	CAPSULE	ORAL	20190522		ANDA	ANDA211134	MSN LABORATORIES PRIVATE LIMITED	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
69539-088_700c0bc6-b089-4478-8e62-4232cad2348e	69539-088	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	MSN LABORATORIES PRIVATE LIMITED	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
69539-089_700c0bc6-b089-4478-8e62-4232cad2348e	69539-089	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	MSN LABORATORIES PRIVATE LIMITED	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
69539-090_a94a0c14-c037-49e2-80a0-9e273d538c58	69539-090	HUMAN PRESCRIPTION DRUG	Erlotinib Hydrochloride		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA214366	MSN LABORATORIES PRIVATE LIMITED	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
69539-091_a94a0c14-c037-49e2-80a0-9e273d538c58	69539-091	HUMAN PRESCRIPTION DRUG	Erlotinib Hydrochloride		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA214366	MSN LABORATORIES PRIVATE LIMITED	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
69539-092_a94a0c14-c037-49e2-80a0-9e273d538c58	69539-092	HUMAN PRESCRIPTION DRUG	Erlotinib Hydrochloride		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA214366	MSN LABORATORIES PRIVATE LIMITED	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
69539-093_1b01b7d7-ae87-40d4-8492-a5262e6ad6c9	69539-093	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	MSN LABORATORIES PRIVATE LIMITED	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-094_1b01b7d7-ae87-40d4-8492-a5262e6ad6c9	69539-094	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	MSN LABORATORIES PRIVATE LIMITED	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-095_1b01b7d7-ae87-40d4-8492-a5262e6ad6c9	69539-095	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	MSN LABORATORIES PRIVATE LIMITED	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-096_1b01b7d7-ae87-40d4-8492-a5262e6ad6c9	69539-096	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	MSN LABORATORIES PRIVATE LIMITED	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-109_63981466-2961-4ed3-9e86-d1c78a9a17bf	69539-109	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20200522		ANDA	ANDA212544	MSN LABORATORIES PRIVATE LIMITED	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69539-110_63981466-2961-4ed3-9e86-d1c78a9a17bf	69539-110	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20200522		ANDA	ANDA212544	MSN LABORATORIES PRIVATE LIMITED	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69539-111_63981466-2961-4ed3-9e86-d1c78a9a17bf	69539-111	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20200522		ANDA	ANDA212544	MSN LABORATORIES PRIVATE LIMITED	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
69539-115_57209c15-d635-40bf-9d16-c664ddfc49a4	69539-115	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190828		ANDA	ANDA212265	MSN LABORATORIES PRIVATE LIMITED	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
69539-119_dc08f8a2-3b7a-467c-9a29-3dc8bfc3643c	69539-119	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET, FILM COATED	ORAL	20220524		ANDA	ANDA212772	MSN LABORATORIES PRIVATE LIMITED	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69539-120_dc08f8a2-3b7a-467c-9a29-3dc8bfc3643c	69539-120	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET, FILM COATED	ORAL	20220524		ANDA	ANDA212772	MSN LABORATORIES PRIVATE LIMITED	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
69539-123_1c6a2caa-abd7-4e8b-830f-e4fcf73e949a	69539-123	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20200304		ANDA	ANDA213049	MSN LABORATORIES PRIVATE LIMITED	THIOTEPA	15	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69539-124_1c6a2caa-abd7-4e8b-830f-e4fcf73e949a	69539-124	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20200304		ANDA	ANDA213049	MSN LABORATORIES PRIVATE LIMITED	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69539-127_912e357e-eaaf-403c-b5a8-3b5b65f0656d	69539-127	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213226	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	82.5	mg/1		CV	N	20241231
69539-128_912e357e-eaaf-403c-b5a8-3b5b65f0656d	69539-128	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213226	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	165	mg/1		CV	N	20241231
69539-129_912e357e-eaaf-403c-b5a8-3b5b65f0656d	69539-129	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213226	MSN LABORATORIES PRIVATE LIMITED	PREGABALIN	330	mg/1		CV	N	20241231
69539-130_6c77ee89-1263-47a5-9782-2ef5a58d24ac	69539-130	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200129		ANDA	ANDA213220	MSN LABORATORIES PRIVATE LIMITED	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
69539-131_6c77ee89-1263-47a5-9782-2ef5a58d24ac	69539-131	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200129		ANDA	ANDA213220	MSN LABORATORIES PRIVATE LIMITED	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
69539-132_6c77ee89-1263-47a5-9782-2ef5a58d24ac	69539-132	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200129		ANDA	ANDA213220	MSN LABORATORIES PRIVATE LIMITED	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
69539-146_700c0bc6-b089-4478-8e62-4232cad2348e	69539-146	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	MSN LABORATORIES PRIVATE LIMITED	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
69539-151_9d29c5a2-af85-47b7-b59f-abf7f5ccaeb2	69539-151	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET	ORAL	20210125		ANDA	ANDA213435	MSN LABORATORIES PRIVATE LIMITED	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
69539-152_f83cd504-03ae-4889-887b-fec152850ce2	69539-152	HUMAN PRESCRIPTION DRUG	toremifene citrate		toremifene citrate	TABLET	ORAL	20200820		ANDA	ANDA212818	MSN LABORATORIES PRIVATE LIMITED	TOREMIFENE CITRATE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
69539-153_f0859b0e-5ed1-4d6c-a3ae-7b6d8a2adb02	69539-153	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20210512		ANDA	ANDA213404	MSN LABORATORIES PRIVATE LIMITED	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69539-154_f0859b0e-5ed1-4d6c-a3ae-7b6d8a2adb02	69539-154	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20210512		ANDA	ANDA213404	MSN LABORATORIES PRIVATE LIMITED	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
69539-157_31f88042-2842-4bbb-9075-1fadffef637b	69539-157	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20200826		ANDA	ANDA213434	MSN LABORATORIES PRIVATE LIMITED	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
69539-158_31f88042-2842-4bbb-9075-1fadffef637b	69539-158	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20200826		ANDA	ANDA213434	MSN LABORATORIES PRIVATE LIMITED	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
69539-159_31f88042-2842-4bbb-9075-1fadffef637b	69539-159	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20200826		ANDA	ANDA213434	MSN LABORATORIES PRIVATE LIMITED	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
69539-160_e62cab33-dce6-4858-8628-f5d97cb83f48	69539-160	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190507		ANDA	ANDA208898	MSN LABORATORIES PRIVATE LIMITED	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69539-181_1639612b-41ec-4f2b-a514-967000c5214e	69539-181	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200210		ANDA	ANDA209965	MSN LABORATORIES PRIVATE LIMITED	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
69539-199_40154b92-b71c-4ccc-b959-99b5c1528d25	69539-199	HUMAN PRESCRIPTION DRUG	Deferasorox		Deferasirox	GRANULE	ORAL	20210318		ANDA	ANDA214650	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-200_40154b92-b71c-4ccc-b959-99b5c1528d25	69539-200	HUMAN PRESCRIPTION DRUG	Deferasorox		Deferasirox	GRANULE	ORAL	20210318		ANDA	ANDA214650	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-240_1e7672d0-2532-401b-81a2-dd76968d2745	69539-240	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	KIT		20210520		ANDA	ANDA210460	MSN LABORATORIES PRIVATE LIMITED						N	20241231
69539-245_0c0d566e-5315-4e29-a207-5f2eb75910f0	69539-245	HUMAN PRESCRIPTION DRUG	Asenapine		ASENAPINE MALEATE	TABLET	SUBLINGUAL	20210827		ANDA	ANDA205960	MSN LABORATORIES PRIVATE LIMITED	ASENAPINE MALEATE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69539-303_40154b92-b71c-4ccc-b959-99b5c1528d25	69539-303	HUMAN PRESCRIPTION DRUG	Deferasorox		Deferasirox	GRANULE	ORAL	20220429		ANDA	ANDA214650	MSN LABORATORIES PRIVATE LIMITED	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
69539-315_3b178225-b3ba-4c9f-bde6-a5e076697980	69539-315	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209623	MSN LABORATORIES PRIVATE LIMITED	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69539-316_3b178225-b3ba-4c9f-bde6-a5e076697980	69539-316	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20190424		ANDA	ANDA209623	MSN LABORATORIES PRIVATE LIMITED	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
69540-0025_f3bfb61d-b5c7-815a-e053-2a95a90a3f92	69540-0025	HUMAN OTC DRUG	Clorox Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210319		OTC MONOGRAPH NOT FINAL	part333E	Brand Buzz LLC	ALCOHOL	71	mL/100mL			N	20241231
69540-0026_f3bfaa81-b47e-293c-e053-2995a90a1aec	69540-0026	HUMAN OTC DRUG	Clorox HealthCare GBG AloeGel Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20190709		OTC MONOGRAPH NOT FINAL	part333E	Brand Buzz LLC	ALCOHOL	71	mL/100mL			N	20241231
69540-0027_f3bd5852-8e38-6b5d-e053-2995a90a194f	69540-0027	HUMAN OTC DRUG	Clorox HealthCare AloeGuard Antimicrobial		Chloroxylenol	LIQUID	TOPICAL	20210420		OTC MONOGRAPH NOT FINAL	part333A	Brand Buzz LLC	CHLOROXYLENOL	.75	mg/100mL			N	20241231
69540-0028_f3bf0eb2-f1f7-2b17-e053-2a95a90a747e	69540-0028	HUMAN OTC DRUG	Clorox Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20210420		OTC MONOGRAPH NOT FINAL	part333E	Brand Buzz LLC	ALCOHOL	71	mL/100mL			N	20241231
69540-0031_f3bfba89-6b35-864d-e053-2a95a90aae7e	69540-0031	HUMAN OTC DRUG	Clorox Antimicrobial		Benzalkonium Chloride	SOAP	TOPICAL	20140407		OTC MONOGRAPH NOT FINAL	part333A	Brand Buzz LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
69540-0033_f12d5d94-9d6f-e514-e053-2a95a90a85cd	69540-0033	HUMAN OTC DRUG	Clorox Antibacterial		Chloroxylenol	SOAP	TOPICAL	20210516		OTC MONOGRAPH NOT FINAL	part333E	Brand Buzz	CHLOROXYLENOL	.003	g/mL			N	20241231
69540-0035_f12d5c87-eb66-0b6d-e053-2995a90a6163	69540-0035	HUMAN OTC DRUG	Clorox Antibacterial		Chloroxylenol	SOAP	TOPICAL	20210513		OTC MONOGRAPH NOT FINAL	part333E	Brand Buzz	CHLOROXYLENOL	.003	g/mL			N	20241231
69540-0036_f12d9b35-ab1a-7323-e053-2a95a90a8665	69540-0036	HUMAN OTC DRUG	Clorox Hand Sanitizer		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210824		OTC MONOGRAPH DRUG	M003	Brand Buzz LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20251231
69543-107_665247b4-5af0-4559-b49f-0660a3a511ea	69543-107	HUMAN PRESCRIPTION DRUG	Desloratadine		Desloratadine	TABLET	ORAL	20150612		ANDA	ANDA078355	Virtus Pharmaceuticals	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69543-120_2fe4e6ff-b000-436f-9a4c-530a190f081f	69543-120	HUMAN PRESCRIPTION DRUG	ACARBOSE		ACARBOSE	TABLET	ORAL	20150201		ANDA	ANDA091343	Virtus Pharmaceuticals LLC	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
69543-121_2fe4e6ff-b000-436f-9a4c-530a190f081f	69543-121	HUMAN PRESCRIPTION DRUG	ACARBOSE		ACARBOSE	TABLET	ORAL	20150201		ANDA	ANDA091343	Virtus Pharmaceuticals LLC	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
69543-122_2fe4e6ff-b000-436f-9a4c-530a190f081f	69543-122	HUMAN PRESCRIPTION DRUG	ACARBOSE		ACARBOSE	TABLET	ORAL	20150201		ANDA	ANDA091343	Virtus Pharmaceuticals LLC	ACARBOSE	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
69543-123_d8f2bca6-5e18-4a1f-b782-9b6e7ba83bc3	69543-123	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20150714		ANDA	ANDA202112	Virtus Pharmaceuticals	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
69543-124_d8f2bca6-5e18-4a1f-b782-9b6e7ba83bc3	69543-124	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20150714		ANDA	ANDA202112	Virtus Pharmaceuticals	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
69543-125_d8f2bca6-5e18-4a1f-b782-9b6e7ba83bc3	69543-125	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20150714		ANDA	ANDA202112	Virtus Pharmaceuticals	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
69543-130_91a3617f-bde7-4868-9334-f6f61e8440d1	69543-130	HUMAN PRESCRIPTION DRUG	Alendronate		ALENDRONATE SODIUM	TABLET	ORAL	20160512	20240330	ANDA	ANDA090258	Virtus Pharmaceuticals	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	
69543-131_91a3617f-bde7-4868-9334-f6f61e8440d1	69543-131	HUMAN PRESCRIPTION DRUG	Alendronate		ALENDRONATE SODIUM	TABLET	ORAL	20151002	20240330	ANDA	ANDA090258	Virtus Pharmaceuticals	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	
69543-290_b9cd2b2e-478c-4585-b027-a678b625ba49	69543-290	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20181027		ANDA	ANDA211397	Virtus Pharmaceuticals LLC	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
69543-291_b9cd2b2e-478c-4585-b027-a678b625ba49	69543-291	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20181027		ANDA	ANDA211397	Virtus Pharmaceuticals LLC	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
69543-371_403a85d2-4ea8-458e-942f-e8005bc2d3b4	69543-371	HUMAN PRESCRIPTION DRUG	Palonosetron hydrochloride		Palonosetron hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180919	20260131	ANDA	ANDA209287	Virtus Pharmaceuticals, LLC	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
69543-372_5ddff444-38c1-455f-a911-bd5d31f56275	69543-372	HUMAN PRESCRIPTION DRUG	Prometrium		Progesterone	CAPSULE	ORAL	20160715		NDA	NDA019781	Virtus Pharmaceuticals	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69543-373_5ddff444-38c1-455f-a911-bd5d31f56275	69543-373	HUMAN PRESCRIPTION DRUG	Prometrium		Progesterone	CAPSULE	ORAL	20160715		NDA	NDA019781	Virtus Pharmaceuticals	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69543-374_2ed02d5f-7930-444e-842f-207821d6b3e0	69543-374	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20160713		NDA	NDA019781	Virtus Pharmaceuticals	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69543-375_2ed02d5f-7930-444e-842f-207821d6b3e0	69543-375	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20160713		NDA	NDA019781	Virtus Pharmaceuticals	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
69543-380_e78e66e4-82ab-47a9-8633-d304cb6bac1e	69543-380	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Virtus Pharmaceuticals, LLC	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69543-381_e78e66e4-82ab-47a9-8633-d304cb6bac1e	69543-381	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Virtus Pharmaceuticals, LLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69543-382_e78e66e4-82ab-47a9-8633-d304cb6bac1e	69543-382	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Virtus Pharmaceuticals, LLC	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69543-383_e78e66e4-82ab-47a9-8633-d304cb6bac1e	69543-383	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Virtus Pharmaceuticals, LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69543-384_e78e66e4-82ab-47a9-8633-d304cb6bac1e	69543-384	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Virtus Pharmaceuticals, LLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69543-385_e78e66e4-82ab-47a9-8633-d304cb6bac1e	69543-385	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Virtus Pharmaceuticals, LLC	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69543-388_7a8ad75f-f969-495b-bc73-f8fb86085b83	69543-388	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20181011	20240930	ANDA	ANDA210616	Virtus Pharmaceuticals, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
69543-409_67788713-a4bc-480f-858a-606cd0d0800b	69543-409	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	CAPSULE, EXTENDED RELEASE	ORAL	20180701		NDA	NDA018074	Virtus Pharmaceuticals, LLC	PHENDIMETRAZINE TARTRATE	105	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
69543-410_77274915-a6d1-4f30-ab91-04a3bdaad399	69543-410	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	TABLET	ORAL	20180701		ANDA	ANDA085588	Virtus Pharmaceuticals, LLC	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
69543-412_781b9064-30b2-45e1-acb4-de5132843e2e	69543-412	HUMAN PRESCRIPTION DRUG	Levorphanol Tartrate		Levorphanol Tartrate	TABLET	ORAL	20181213	20240228	ANDA	ANDA211484	Virtus Pharmaceuticals, LLC	LEVORPHANOL TARTRATE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	
69543-417_63084311-77c9-42d5-ab3b-44f4dc54e886	69543-417	HUMAN PRESCRIPTION DRUG	Levorphanol Tartrate		Levorphanol Tartrate	TABLET	ORAL	20200901		ANDA	ANDA211484	Virtus Pharmaceuticals, LLC	LEVORPHANOL TARTRATE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
69543-419_4590293f-8e4f-4d48-873e-c3b8542995c4	69543-419	HUMAN PRESCRIPTION DRUG	sildenafil		sildenafil	FOR SUSPENSION	ORAL	20210802		ANDA	ANDA213814	Virtus Pharmaceuticals, LLC	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69543-425_2c77658c-b5b6-4d22-a218-1334a0d13c02	69543-425	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET, DELAYED RELEASE	ORAL	20191115		ANDA	ANDA091432	Virtus Pharmaceuticals, LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69543-426_2c77658c-b5b6-4d22-a218-1334a0d13c02	69543-426	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET, DELAYED RELEASE	ORAL	20191115		ANDA	ANDA091432	Virtus Pharmaceuticals, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69543-451_33769767-b0ac-4d32-a9a5-6c077348d174	69543-451	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20210101		ANDA	ANDA210200	Virtus Pharmaceuticals, LLC	POTASSIUM CHLORIDE	1.5	g/1.77g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69543-455_1172c722-f7e9-43c5-9078-0b7586a13295	69543-455	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	INJECTION, SOLUTION	INTRAVENOUS	20230417		ANDA	ANDA215628	Virtus Pharmaceuticals, LLC	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
69546-201_4b833d7a-f957-4e65-be5b-177149314958	69546-201	HUMAN OTC DRUG	Zitlox Salicylic Acne		Salicylic Acid	GEL	TOPICAL	20220630		OTC MONOGRAPH FINAL	part333D	ASA Universal Inc. dba: SONAGE	SALICYLIC ACID	1.5	g/100mL			N	20241231
69546-313_fd14df2e-cc9c-0480-e053-6394a90a553f	69546-313	HUMAN OTC DRUG	Sonage Roux Tinted Day Creme with SPF 30	Sheer Tinted Moisturizer	Zinc Oxide	LOTION	TOPICAL	20230608		OTC MONOGRAPH FINAL	M020	ASA Universal Inc. dba: Sonage	ZINC OXIDE	13	g/100mL			N	20241231
69546-322_d92fc1df-bbec-592a-e053-2a95a90a6951	69546-322	HUMAN OTC DRUG	Sonage Protec Plus SPF 30 Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20220225		OTC MONOGRAPH FINAL	part352	ASA Universal Inc. dba: Sonage	ZINC OXIDE	15.7	g/100mL			N	20241231
69547-212_1d0be895-cd43-49f3-98d4-72a9c3088616	69547-212	HUMAN PRESCRIPTION DRUG	Narcan		naloxone hydrochloride	SPRAY	NASAL	20170124		NDA	NDA208411	Emergent Devices Inc.	NALOXONE HYDROCHLORIDE	2	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
69547-353_1d0be895-cd43-49f3-98d4-72a9c3088616	69547-353	HUMAN PRESCRIPTION DRUG	Narcan		Naloxone Hydrochloride	SPRAY	NASAL	20170124		NDA	NDA208411	Emergent Devices Inc.	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
69547-627_eca68b75-c15c-4ee0-a352-a4ec66e57424	69547-627	HUMAN OTC DRUG	NARCAN		naloxone hydrochloride nasal	SPRAY	NASAL	20230828		NDA	NDA208411	Emergent Devices Inc.	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
69550-324_f291e7ed-a8b2-3b29-e053-2995a90ad428	69550-324	HUMAN OTC DRUG	Assist II	Anorectal (Hemorrhoidal)	Benzocaine	LIQUID	TOPICAL	20150706		OTC MONOGRAPH FINAL	part346	Texas Electrolysis Supply	BENZOCAINE	20	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69555-020_0c4174c2-1bc8-d676-e063-6394a90ac085	69555-020	HUMAN OTC DRUG	Stream2Sea Broad Spectrum 20		Titanium Dioxide	LOTION	TOPICAL	20150701		OTC MONOGRAPH DRUG	M020	Stream2Sea, LLC	TITANIUM DIOXIDE	1	g/66mL			N	20241231
69555-021_0c4174c2-1bc8-d676-e063-6394a90ac085	69555-021	HUMAN OTC DRUG	Stream2Sea Broad Spectrum 20 - Tinted		Titanium Dioxide	LOTION	TOPICAL	20210213		OTC MONOGRAPH DRUG	M020	Stream2Sea, LLC	TITANIUM DIOXIDE	1	g/66mL			N	20241231
69555-030_0c4174c2-1bc8-d676-e063-6394a90ac085	69555-030	HUMAN OTC DRUG	Stream2Sea Broad Spectrum 30		Titanium Dioxide	LOTION	TOPICAL	20150701		OTC MONOGRAPH DRUG	M020	Stream2Sea, LLC	TITANIUM DIOXIDE	1	g/88mL			N	20241231
69555-031_0c4174c2-1bc8-d676-e063-6394a90ac085	69555-031	HUMAN OTC DRUG	Stream2Sea Broad Spectrum 30 - Tinted		Titanium Dioxide	LOTION	TOPICAL	20210213		OTC MONOGRAPH DRUG	M020	Stream2Sea, LLC	TITANIUM DIOXIDE	1	g/88mL			N	20241231
69555-035_f21e2664-1fbc-c019-e053-2a95a90a747f	69555-035	HUMAN OTC DRUG	EcoStick Sunscreen	SPF 35	Zinc Oxide, Titanium Dioxide	STICK	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part352	Stream2Sea, LLC	TITANIUM DIOXIDE; ZINC OXIDE	7; 6	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69555-036_f21e2f96-6c05-fbe5-e053-2995a90a3948	69555-036	HUMAN OTC DRUG	SUN PROTECT LIP BALM SPF 30		ZINC OXIDE AND TITANIUM DIOXIDE	CREAM	TOPICAL	20210710		OTC MONOGRAPH FINAL	part352	Stream2Sea, LLC	TITANIUM DIOXIDE; ZINC OXIDE	280; 240	mg/4g; mg/4g			N	20241231
69555-037_e2408455-777c-3611-e053-2995a90aeee1	69555-037	HUMAN OTC DRUG	Planet Protecting Sunscreen 30		TITANIUM DIOXIDE	LOTION	TOPICAL	20220701		OTC MONOGRAPH FINAL	part352	Stream2Sea, LLC	TITANIUM DIOXIDE	8.8	g/100mL			N	20241231
69555-040_f88ffbb5-1ca7-ecdb-e053-6394a90ae83a	69555-040	HUMAN OTC DRUG	4ocean REEF SAFE SUNSCREEN SPF 40		Zinc Oxide	CREAM	TOPICAL	20230327		OTC MONOGRAPH FINAL	part352	Stream2Sea, LLC	ZINC OXIDE	.2	g/80g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69555-041_f88ffbb5-1ca7-ecdb-e053-6394a90ae83a	69555-041	HUMAN OTC DRUG	SPORT SUNSCREEN SPF40		Zinc Oxide	CREAM	TOPICAL	20230327		OTC MONOGRAPH FINAL	part352	Stream2Sea, LLC	ZINC OXIDE	.2	g/80g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69555-042_f88ffbb5-1ca7-ecdb-e053-6394a90ae83a	69555-042	HUMAN OTC DRUG	SOGGY DOLLAR ZINC SUN SCREEN SPF 40		ZINC OXIDE	CREAM	TOPICAL	20230327		OTC MONOGRAPH FINAL	part352	Stream2Sea, LLC	ZINC OXIDE	.2	g/80g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69555-043_f88fb3ff-ddc3-a2b3-e053-6394a90a8e6c	69555-043	HUMAN OTC DRUG	ALLSWELL MINERAL SUNSCREEN SPF 30		Zinc Oxide	LOTION	TOPICAL	20230328		OTC MONOGRAPH NOT FINAL	part352	Stream2Sea, LLC	ZINC OXIDE	22	g/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69555-044_f87be121-abd0-1c5a-e053-6394a90a0356	69555-044	HUMAN OTC DRUG	Baby Donna SHeer SPF Sunscreen Stick		Zinc Oxide	STICK	TOPICAL	20230328		OTC MONOGRAPH NOT FINAL	part352	Stream2Sea, LLC	ZINC OXIDE	19	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69555-045_0c3e85be-38f8-14b6-e063-6294a90a2d31	69555-045	HUMAN OTC DRUG	EVERY DAY MINERAL SUN SCREEN SPF 45		ZINC OXIDE	CREAM	TOPICAL	20211111		OTC MONOGRAPH DRUG	M020	Stream2Sea, LLC	ZINC OXIDE	190	mg/mL			N	20241231
69555-062_f21e38bd-8171-30eb-e053-2995a90a2b6a	69555-062	HUMAN OTC DRUG	Stream2Sea Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200409		OTC MONOGRAPH NOT FINAL	part333A	Stream2Sea, LLC	ALCOHOL	620	mL/1000mL			N	20241231
69556-650_08143360-0cef-2b3c-e063-6394a90adc13	69556-650	HUMAN OTC DRUG	Alcohol Prep Pad Medium		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20150122		OTC MONOGRAPH DRUG	M003	Kentron HealthCare, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
69557-111_872c61e4-45ed-45ee-9fb7-0f3cc1c3170e	69557-111	HUMAN PRESCRIPTION DRUG	Ztlido		Lidocaine	PATCH	TOPICAL	20180426		NDA	NDA207962	Scilex Pharmaceuticals Inc.	LIDOCAINE	36	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69557-333_0a9bb5e6-a761-a19d-e063-6394a90a33ab	69557-333	HUMAN PRESCRIPTION DRUG	ELYXYB - celecoxib		celecoxib	LIQUID	ORAL	20231127		NDA	NDA212157	SCILEX PHARMACEUTICALS INC.	CELECOXIB	120	mg/4.8mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69560-012_efe8f228-9585-4ca2-8aa8-4b9646bce5b2	69560-012	HUMAN OTC DRUG	Berkley Jensen Dishwashing and Antibacterial Hand	Green Apple Scent	Chloroxylenol	SOLUTION	TOPICAL	20210701		OTC MONOGRAPH NOT FINAL	part333E	MID-CONTINENT PACKAGING, INC.	CHLOROXYLENOL	.3	g/100mL			N	20241231
69560-234_0e5de26c-4336-4e49-89c7-38a694dd43e9	69560-234	HUMAN OTC DRUG	Dial Complete Antibacterial Hand	Spring Water	Benzalkonium Chloride	SOLUTION	TOPICAL	20210505		OTC MONOGRAPH NOT FINAL	part333E	MID-CONTINENT PACKAGING, INC.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69560-345_528a44be-234a-4ffb-bd02-7ead1f66049d	69560-345	HUMAN OTC DRUG	Dial Complete Antibacterial Liquid Hand	Gold	Benzalkonium Chloride	SOLUTION	TOPICAL	20210505		OTC MONOGRAPH NOT FINAL	part333E	MID-CONTINENT PACKAGING, INC.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69560-456_4e58585e-f0c1-473e-b58f-590429610961	69560-456	HUMAN OTC DRUG	Dial Complete Antibacterial Foaming Hand Wash	Spring Water	Benzalkonium Chloride	SOLUTION	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part333E	MID-CONTINENT PACKAGING, INC.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69560-567_53e8aed6-3d2b-4b5a-adfc-10251b96d11e	69560-567	HUMAN OTC DRUG	Dial Complete Antibacterial Foaming Hand Wash	Fresh Pear	Benzalkonium Chloride	SOLUTION	TOPICAL	20210505		OTC MONOGRAPH NOT FINAL	part333E	MID-CONTINENT PACKAGING, INC.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69571-003_08ad67a5-b3c7-1db5-e063-6294a90a20d3	69571-003	HUMAN OTC DRUG	Family wellness		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20170222		OTC MONOGRAPH DRUG	M004	FRONT PHARMACEUTICAL PLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	.41; .0035; .52	g/100g; g/100g; g/100g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69571-004_08a17869-d45f-18ce-e063-6394a90adbbb	69571-004	HUMAN OTC DRUG	Family Wellness		GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, PETROLATUM	CREAM	TOPICAL	20170314		OTC MONOGRAPH DRUG	M015	FRONT PHARMACEUTICAL PLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69571-005_08a16eed-ba21-b1fa-e063-6294a90a6615	69571-005	HUMAN OTC DRUG	Family Wellness		DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE	CREAM	TOPICAL	20170329		OTC MONOGRAPH DRUG	M017	FRONT PHARMACEUTICAL PLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69571-006_08ad6b35-733b-c9d3-e063-6294a90acfed	69571-006	HUMAN OTC DRUG	Family wellness		Mineral oil, Petrolatum, Phenylephrine HCl	OINTMENT	TOPICAL	20170330		OTC MONOGRAPH DRUG	M015	FRONT PHARMACEUTICAL PLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69571-007_08a19db8-4da9-6529-e063-6394a90a1b4d	69571-007	HUMAN OTC DRUG	Family Wellness Antiseptic and Pain Relief		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE	OINTMENT	TOPICAL	20170613		OTC MONOGRAPH DRUG	M004	FRONT PHARMACEUTICAL PLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	.51; .0035; 1; .01	g/100g; g/100g; g/100g; g/100g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69571-008_08ad6b35-732f-c9d3-e063-6294a90acfed	69571-008	HUMAN OTC DRUG	Family Wellness		BACITRACIN ZINC	OINTMENT	TOPICAL	20170613		OTC MONOGRAPH DRUG	M004	FRONT PHARMACEUTICAL PLC	BACITRACIN ZINC	.51	g/100g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
69571-009_08ad6eaa-df8b-8f2e-e063-6394a90a16b0	69571-009	HUMAN OTC DRUG	Family Wellness		HYDROCORTISONE 1%	CREAM	TOPICAL	20170618		OTC MONOGRAPH DRUG	M017	FRONT PHARMACEUTICAL PLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69571-010_08a1a1e3-05bb-5508-e063-6294a90a8fa0	69571-010	HUMAN OTC DRUG	CVS Health	Hemorrhoidal Cream	GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM	CREAM	TOPICAL	20180212		OTC MONOGRAPH DRUG	M015	FRONT PHARMACEUTICAL PLC	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69571-011_05d3f15b-bb35-191a-e063-6294a90a3b4a	69571-011	HUMAN OTC DRUG	Anti-Itch Cream		Diphenhydramine HCl / Zinc Acetate	CREAM	TOPICAL	20230925		OTC MONOGRAPH NOT FINAL	part348	Front Pharmaceutical PLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69574-005_093a31eb-8b66-5af7-e063-6394a90aca53	69574-005	HUMAN OTC DRUG	NOVUM	APR	menthol	SPRAY	TOPICAL	20150519		OTC MONOGRAPH DRUG	M017	NOVUM SOLUTIONS INC	MENTHOL	.5	g/100mL			N	20241231
69584-021_1df1b770-b3be-477d-9ebf-c542a9469883	69584-021	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	2.5 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	Oxford Pharmaceuticals, LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69584-022_1df1b770-b3be-477d-9ebf-c542a9469883	69584-022	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	5 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	Oxford Pharmaceuticals, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69584-023_1df1b770-b3be-477d-9ebf-c542a9469883	69584-023	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	10 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	Oxford Pharmaceuticals, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
69584-091_7698fae2-3715-49a5-86c1-254451fbd8d8	69584-091	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Oxford Pharmaceuticals, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
69584-092_7698fae2-3715-49a5-86c1-254451fbd8d8	69584-092	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Oxford Pharmaceuticals, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
69584-093_7698fae2-3715-49a5-86c1-254451fbd8d8	69584-093	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Oxford Pharmaceuticals, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
69584-094_7698fae2-3715-49a5-86c1-254451fbd8d8	69584-094	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200501		ANDA	ANDA078302	Oxford Pharmaceuticals, LLC	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
69584-111_70a7521f-840e-4720-bc2e-10e3e3d23b75	69584-111	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	Oxford Pharmaceuticals, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
69584-181_6cf8d202-17fc-4c56-be33-4d74f6591077	69584-181	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20210415		ANDA	ANDA040542	Oxford Pharmaceuticals, LLC	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
69584-182_6cf8d202-17fc-4c56-be33-4d74f6591077	69584-182	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20210415		ANDA	ANDA040542	Oxford Pharmaceuticals, LLC	DIPYRIDAMOLE	50	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
69584-183_6cf8d202-17fc-4c56-be33-4d74f6591077	69584-183	HUMAN PRESCRIPTION DRUG	Dipyridamole		Dipyridamole	TABLET, FILM COATED	ORAL	20210415		ANDA	ANDA040542	Oxford Pharmaceuticals, LLC	DIPYRIDAMOLE	75	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
69584-361_bee60bdd-14c0-4a2d-8104-6671ec3b5bfa	69584-361	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20200925		ANDA	ANDA087059	Oxford Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69584-362_bee60bdd-14c0-4a2d-8104-6671ec3b5bfa	69584-362	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20200925		ANDA	ANDA087068	Oxford Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
69584-425_dd6df556-9b32-4091-a004-f10f45c7c9fe	69584-425	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20200801		ANDA	ANDA040751	Oxford Pharmaceuticals, LLC	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69584-426_dd6df556-9b32-4091-a004-f10f45c7c9fe	69584-426	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20200801		ANDA	ANDA040751	Oxford Pharmaceuticals, LLC	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69584-427_dd6df556-9b32-4091-a004-f10f45c7c9fe	69584-427	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20200801		ANDA	ANDA040751	Oxford Pharmaceuticals, LLC	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69584-611_cd98f657-ec8a-413c-b064-ddd9837ee28e	69584-611	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Oxford Pharmaceuticals, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69584-612_cd98f657-ec8a-413c-b064-ddd9837ee28e	69584-612	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Oxford Pharmaceuticals, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69584-671_34bdd845-562e-4195-9516-977a36d11f8b	69584-671	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20221114		ANDA	ANDA076968	Oxford Pharmaceuticals, LLC	PAROXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69584-672_34bdd845-562e-4195-9516-977a36d11f8b	69584-672	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20221114		ANDA	ANDA076968	Oxford Pharmaceuticals, LLC	PAROXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69584-673_34bdd845-562e-4195-9516-977a36d11f8b	69584-673	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20221114		ANDA	ANDA076968	Oxford Pharmaceuticals, LLC	PAROXETINE HYDROCHLORIDE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69584-674_34bdd845-562e-4195-9516-977a36d11f8b	69584-674	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20221114		ANDA	ANDA076968	Oxford Pharmaceuticals, LLC	PAROXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69584-684_86b0848d-c247-4e50-bc01-dce7dc157605	69584-684	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	Oxford Pharmaceuticals, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69584-685_86b0848d-c247-4e50-bc01-dce7dc157605	69584-685	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	Oxford Pharmaceuticals, LLC	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69584-841_71c67f34-73e1-4e4c-9c72-56f4b9222a88	69584-841	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Oxford Pharmaceuticals, LLC	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
69584-842_71c67f34-73e1-4e4c-9c72-56f4b9222a88	69584-842	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Oxford Pharmaceuticals, LLC	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
69584-843_71c67f34-73e1-4e4c-9c72-56f4b9222a88	69584-843	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Oxford Pharmaceuticals, LLC	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
69584-844_71c67f34-73e1-4e4c-9c72-56f4b9222a88	69584-844	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Oxford Pharmaceuticals, LLC	SOTALOL HYDROCHLORIDE	240	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
69584-852_1441d9fe-cf67-4ec4-a4c9-3cf3b9dfff66	69584-852	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	Oxford Pharmaceuticals, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
69584-853_1441d9fe-cf67-4ec4-a4c9-3cf3b9dfff66	69584-853	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	Oxford Pharmaceuticals, LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
69584-854_1441d9fe-cf67-4ec4-a4c9-3cf3b9dfff66	69584-854	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	Oxford Pharmaceuticals, LLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
69584-884_21124c29-b0a7-4729-90f8-0e971d265b61	69584-884	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	20230101		ANDA	ANDA072192	Oxford Pharmaceuticals, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
69584-885_21124c29-b0a7-4729-90f8-0e971d265b61	69584-885	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA072193	Oxford Pharmaceuticals, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
69587-001_0d1eca7c-d913-3809-e063-6394a90a4fba	69587-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose	F18	Fludeoxyglucose F18	INJECTION	INTRAVENOUS	20150228		ANDA	ANDA204472	MIPS Cyclotron & Radiochemistry Facility	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69604-204_b835bae3-1dac-4644-b01e-24838e6c99d0	69604-204	HUMAN PRESCRIPTION DRUG	Anthim		obiltoxaximab	SOLUTION	INTRAVENOUS	20160318		BLA	BLA125509	Elusys Therapeutics, Inc.	OBILTOXAXIMAB	100	mg/mL	Anthrax Protective Antigen-directed Antibody Interactions [MoA], Anthrax Protective Antigen-directed Antibody [EPC]		N	20241231
69607-0867_1ea101f7-291f-4040-a270-7c317863ea68	69607-0867	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, COATED	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part343	WR Group, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69607-0916_0223c2c7-0b58-4fea-8dea-98eb7ab1f626	69607-0916	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20210806		OTC MONOGRAPH FINAL	part338	WR Group, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69612-002_e0e19609-466d-edc6-e053-2995a90a3473	69612-002	HUMAN OTC DRUG	PSP Isopropyl Rubbing		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20180301	20240228	OTC MONOGRAPH NOT FINAL	part333A	RW Consumer Products Ltd	ISOPROPYL ALCOHOL	700	mg/mL			N	
69612-003_e0e11d11-8afa-6423-e053-2995a90a207e	69612-003	HUMAN OTC DRUG	PSP GO Isopropryl Rubbing		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20180301	20240228	OTC MONOGRAPH NOT FINAL	part333A	RW Consumer Products Ltd	ISOPROPYL ALCOHOL	700	mg/mL			N	
69612-014_df726058-91e0-45df-e053-2995a90a2e69	69612-014	HUMAN OTC DRUG	PSP 70 Isopropyl rubbing alcohol first antiseptic		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20211001	20240228	OTC MONOGRAPH NOT FINAL	part333A	RW Consumer Products Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	
69612-623_df73be6f-d7b5-371e-e053-2a95a90afecf	69612-623	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20170418	20240229	OTC MONOGRAPH NOT FINAL	part333A	RW Consumer Products Ltd	ISOPROPYL ALCOHOL	30	mg/mL			N	
69616-211_3c96579b-d68e-4460-8873-39d086998176	69616-211	HUMAN PRESCRIPTION DRUG	Firdapse		amifampridine phosphate	TABLET	ORAL	20190107		NDA	NDA208078	Catalyst Pharmaceuticals, Inc.	AMIFAMPRIDINE PHOSPHATE	10	mg/1	Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]		N	20241231
69616-272_98f5e818-1e3f-43a8-9a56-9c44e639f431	69616-272	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20240102		NDA	NDA202834	Catalyst Pharmaceuticals, Inc.	PERAMPANEL	2	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20251231
69616-274_98f5e818-1e3f-43a8-9a56-9c44e639f431	69616-274	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20240102		NDA	NDA202834	Catalyst Pharmaceuticals, Inc.	PERAMPANEL	4	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20251231
69616-276_98f5e818-1e3f-43a8-9a56-9c44e639f431	69616-276	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20240102		NDA	NDA202834	Catalyst Pharmaceuticals, Inc.	PERAMPANEL	6	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20251231
69616-278_98f5e818-1e3f-43a8-9a56-9c44e639f431	69616-278	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20240102		NDA	NDA202834	Catalyst Pharmaceuticals, Inc.	PERAMPANEL	8	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20251231
69616-280_98f5e818-1e3f-43a8-9a56-9c44e639f431	69616-280	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20240102		NDA	NDA202834	Catalyst Pharmaceuticals, Inc.	PERAMPANEL	10	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20251231
69616-282_98f5e818-1e3f-43a8-9a56-9c44e639f431	69616-282	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	TABLET	ORAL	20240102		NDA	NDA202834	Catalyst Pharmaceuticals, Inc.	PERAMPANEL	12	mg/1	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20251231
69616-290_98f5e818-1e3f-43a8-9a56-9c44e639f431	69616-290	HUMAN PRESCRIPTION DRUG	Fycompa		perampanel	SUSPENSION	ORAL	20240102		NDA	NDA208277	Catalyst Pharmaceuticals, Inc.	PERAMPANEL	.5	mg/mL	AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]	CIII	N	20251231
69618-010_f8122293-96de-9ff2-e053-6394a90a7142	69618-010	HUMAN OTC DRUG	ACETAMINOPHEN 325 MG		ACETAMINOPHEN	TABLET	ORAL	20151101		OTC MONOGRAPH NOT FINAL	part343	Reliable 1 Laboratories LLC	ACETAMINOPHEN	325	mg/1			N	20241231
69618-011_f811ae1c-35c3-1de0-e053-6294a90a5f6d	69618-011	HUMAN OTC DRUG	ACETAMINOPHEN 500 MG		ACETAMINOPHEN	TABLET	ORAL	20151101		OTC MONOGRAPH NOT FINAL	part343	Reliable 1 Laboratories LLC	ACETAMINOPHEN	500	mg/1			N	20241231
69618-014_f811e96c-0896-d200-e053-6294a90a588d	69618-014	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin	TABLET, CHEWABLE	ORAL	20151101		OTC MONOGRAPH FINAL	part343	Reliable 1 Laboratories LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69618-015_f811e96c-0897-d200-e053-6294a90a588d	69618-015	HUMAN OTC DRUG	ASPIRIN 325 MG EC		ASPIRIN	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part343	Reliable 1 Laboratories LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69618-020_f8100557-3c93-f208-e053-6294a90aa752	69618-020	HUMAN OTC DRUG	Calcium Carbonate 500 mg		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20151101		OTC MONOGRAPH FINAL	part331	Reliable 1 Laboratories LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69618-022_f811e228-e47f-e4b4-e053-6394a90a3a0d	69618-022	HUMAN OTC DRUG	Chlorpheniramine Maleate 4 mg		Chlorpheniramine Maleate	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part341	Reliable 1 Laboratories LLC	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69618-024_f811d0c1-fdfc-a4ad-e053-6294a90ad0b5	69618-024	HUMAN OTC DRUG	Diphenhydramine HCl 25 mg		Diphenhydramine HCl	CAPSULE	ORAL	20151101		OTC MONOGRAPH FINAL	part341	Reliable 1 Laboratories LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69618-025_f811d81d-eb3d-bf06-e053-6294a90a242b	69618-025	HUMAN OTC DRUG	Diphenhydramine HCL 25 mg		Diphenhydramine HCL	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part341	Reliable 1 Laboratories LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69618-027_f811f2b6-1ae8-fb64-e053-6294a90aaeb9	69618-027	HUMAN OTC DRUG	Meclizine HCL 12.5 mg		Meclizine HCL 12.5 mg	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part336	Reliable 1 Laboratories LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
69618-028_f810e82a-48a5-507c-e053-6294a90a9cdc	69618-028	HUMAN OTC DRUG	Meclizine HCL 25 mg		Meclizine HCL	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part336	Reliable 1 Laboratories LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
69618-029_f811e96c-0895-d200-e053-6294a90a588d	69618-029	HUMAN OTC DRUG	Bismuth Subsalicylate 262 mg		Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20151101		OTC MONOGRAPH FINAL	part335	Reliable 1 Laboratories LLC	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
69618-032_f81204a6-6271-0d93-e053-6294a90abb5a	69618-032	HUMAN OTC DRUG	Simethicone 125 mg		Simethicone	TABLET, CHEWABLE	ORAL	20180425		OTC MONOGRAPH FINAL	part332	Reliable 1 Laboratires LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
69618-033_f811c405-db55-e785-e053-6394a90a4c0f	69618-033	HUMAN OTC DRUG	Simethicone 80 mg		Simethicone	TABLET, CHEWABLE	ORAL	20180424		OTC MONOGRAPH FINAL	part332	Reliable 1 Laboratories LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
69618-043_3b94cfb2-6dd2-4b3c-9047-e2a97e458efb	69618-043	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE	ORAL	20160401		OTC MONOGRAPH NOT FINAL	part334	Reliable 1 Laboratories LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
69618-045_78fed69f-82c1-48d2-a323-0c0144246e20	69618-045	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20170713		OTC MONOGRAPH FINAL	part332	RELIABLE 1 LABORATORIES LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
69618-046_f811d81d-eb3b-bf06-e053-6294a90a242b	69618-046	HUMAN OTC DRUG	Aspirin 81 mg Enteric Coated		Aspirin	TABLET	ORAL	20180510		OTC MONOGRAPH FINAL	part343	Reliable 1 Laboratories LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69618-048_f810e82a-48a9-507c-e053-6294a90a9cdc	69618-048	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20180801		OTC MONOGRAPH NOT FINAL	part334	Reliable 1 Laboratories LLC	SENNOSIDES A AND B	8.6	mg/1			N	20241231
69618-050_f811d0c1-fdfb-a4ad-e053-6294a90ad0b5	69618-050	HUMAN OTC DRUG	Oxymethazoline HCL		Oxymethazoline HCL	SPRAY	NASAL	20190101		OTC MONOGRAPH FINAL	part341	Reliable 1 Laboratories	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/1	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69618-052_f811cbee-bcac-6bda-e053-6294a90a4bee	69618-052	HUMAN OTC DRUG	Boroleum		Camphor, Menthol, White Petrolatum	OINTMENT	TOPICAL	20190416		OTC MONOGRAPH NOT FINAL	part348	Reliable 1 Laboratories	CAMPHOR (SYNTHETIC); MENTHOL; WHITE PETROLATUM	1; .54; 97.92	g/100g; g/100g; g/100g			N	20241231
69618-054_ba632dd1-c85a-49c0-88a6-6d10ddbff1af	69618-054	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20210311		ANDA	ANDA206877	RELIABLE 1 LABORATORIES LLC	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69618-058_0864ecf0-4b0f-715e-e063-6294a90a1778	69618-058	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, COATED	ORAL	20200101	20240131	OTC MONOGRAPH DRUG	M007	RELIABLE 1 LABORATORIES LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
69618-059_0994a4fb-0731-0f98-e063-6394a90a8a58	69618-059	HUMAN OTC DRUG	INFANTS GAS RELIEF DROPS		Simethicone	SUSPENSION/ DROPS	ORAL	20200201		OTC MONOGRAPH DRUG	M002	RELIABLE 1 LABORATORIES	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
69618-060_baec8045-97ff-6f60-e053-2a95a90a050e	69618-060	HUMAN OTC DRUG	Lubricant Eye PM		Mineral Oil, White Petrolatum	OINTMENT	OPHTHALMIC	20220101		OTC MONOGRAPH FINAL	M018	Reliable 1 Laboratories LLC	MINERAL OIL; WHITE PETROLATUM	42.5; 57.3	g/100g; g/100g			N	20241231
69618-061_f810438c-ac8c-a572-e053-6394a90a363e	69618-061	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20200801		OTC MONOGRAPH FINAL	part341	Reliable 1 Laboratories LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69618-064_030f92bf-a137-0ef3-e063-6294a90ab464	69618-064	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20200801		OTC MONOGRAPH NOT FINAL	part334	Reliable 1 Laboratories LLC	SENNOSIDES A AND B	8.6	mg/1			N	20241231
69618-065_0424f184-bd82-fc4d-e063-6394a90aa923	69618-065	HUMAN OTC DRUG	Sennosides and Docusate Sodium		Sennosides, Docusate Sodium	TABLET	ORAL	20200801		OTC MONOGRAPH NOT FINAL	part334	Reliable-1 Laboratories LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69618-066_0425633d-054a-bcef-e063-6294a90a1d32	69618-066	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin	TABLET, COATED	ORAL	20201001		OTC MONOGRAPH FINAL	part343	Reliable 1 Laboratories LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69618-067_09fb2810-0cc2-b2e2-e063-6294a90a4576	69618-067	HUMAN OTC DRUG	Calprotect		Menthol, Zinc Oxide	OINTMENT	TOPICAL	20210101		OTC MONOGRAPH DRUG	M015	Reliable 1 Laboratories LLC	MENTHOL; ZINC OXIDE	.44; 20.6	g/100g; g/100g			N	20241231
69618-072_dc9c8613-cf2d-42ba-8791-572b1c63b744	69618-072	HUMAN OTC DRUG	Tussin DMMax		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20221201		OTC MONOGRAPH FINAL	part341	RELIABLE 1 LABORATORIES LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69618-073_7b9c7db0-8cc4-4e45-9715-69be0c208ca5	69618-073	HUMAN OTC DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20230414		ANDA	ANDA216349	Reliable 1 Laboratories LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69625-019_c41bcab3-9d2a-451f-a678-8fbb37a53161	69625-019	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 50 Tinted Mineral Face Broad Spectrum SPF 50 Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	TITANIUM DIOXIDE	110	mg/mL			N	20241231
69625-023_f4abef3e-0a76-4674-a2a5-f057d61432e7	69625-023	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 50 Ultra Light Tinted Mineral Face Broad Spectrum SPF 50 Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20170130		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	TITANIUM DIOXIDE	110	mg/mL			N	20251231
69625-069_21a4518e-3bc9-4dff-93c8-59fa0bcf37bb	69625-069	HUMAN OTC DRUG	SkinCeuticals Silymarin CF Acne Treatment Antioxidant		Salicylic Acid	SOLUTION	TOPICAL	20201231		OTC MONOGRAPH DRUG	M006	Cosmetique Active Production	SALICYLIC ACID	5	mg/mL			N	20241231
69625-113_c5fb25ac-e3d6-475d-981d-0ea1acdc16e8	69625-113	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Mela B3 UV Daily Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20231015		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69625-127_a93095d6-a19f-441c-a183-7e83b2c2eae0	69625-127	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Hydraphase UV Intense 24 Hour Hydrating Moisturizer Broad Spectrum SPF 20 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20120901		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 47; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69625-203_a881be8a-582c-4f9b-a31c-8577b2005101	69625-203	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Tinted Mineral Light Fluid Sunscreen Broad Spectrum SPF 40 Deep		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20231215		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	TITANIUM DIOXIDE; ZINC OXIDE	170; 80	mg/mL; mg/mL			N	20241231
69625-210_679e94b4-2ee7-4048-8dbb-2d7c01384ddc	69625-210	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Tinted Mineral Light Fluid Sunscreen Broad Spectrum SPF 40 Medium		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20231215		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	TITANIUM DIOXIDE; ZINC OXIDE	170; 80	mg/mL; mg/mL			N	20241231
69625-231_57f0b452-ea26-4d24-b1ae-8f18320959ee	69625-231	HUMAN OTC DRUG	Vichy Laboratoires Normaderm BHA Exfoliating Acne Treatment		Salicylic acid	LOTION	TOPICAL	20221212		OTC MONOGRAPH DRUG	M006	COSMETIQUE ACTIVE PRODUCTION	SALICYLIC ACID	10	mg/mL			N	20241231
69625-306_f5c7a4cb-2a93-45e0-ba5a-50c2984a3bce	69625-306	HUMAN OTC DRUG	Vichy Laboratoires Normaderm Phytoaction Deep Cleansing		Salicylic Acid	GEL	TOPICAL	20200415		OTC MONOGRAPH DRUG	M006	COSMETIQUE ACTIVE PRODUCTION	SALICYLIC ACID	5	mg/mL			N	20241231
69625-528_bf420a7d-24ee-4246-8b2d-e05bb9cbf268	69625-528	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Effaclar AntiAcne Pore Refining Acne Treatment		Salicylic acid	LIQUID	TOPICAL	20220501		OTC MONOGRAPH DRUG	M006	COSMETIQUE ACTIVE PRODUCTION	SALICYLIC ACID	15	mg/mL			N	20241231
69625-583_ede125c1-2ea9-4a60-8108-59f32cc634c4	69625-583	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Toleriane Double Repair UV Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20161221		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69625-587_ffa0730d-097a-45f4-96a5-f56763bb26bd	69625-587	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5		Glycerin	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M016	Cosmetique Active Production	GLYCERIN	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69625-605_ba3f1ff3-c274-4e40-bc71-d4647f5e2271	69625-605	HUMAN OTC DRUG	Vichy Laboratoires Normaderm Phytoaction Acne Control Moisturizer		Salicylic Acid	GEL	TOPICAL	20200901		OTC MONOGRAPH DRUG	M006	COSMETIQUE ACTIVE PRODUCTION	SALICYLIC ACID	20	mg/mL			N	20241231
69625-620_a082a6e5-afa5-40e4-bc71-4525a7029a0f	69625-620	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Lipikar Eczema Relief		Oatmeal	CREAM	TOPICAL	20171121		OTC MONOGRAPH DRUG	M016	COSMETIQUE ACTIVE PRODUCTION	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69625-651_afe73251-3232-4f07-ad34-d62fbaa4f0d5	69625-651	HUMAN OTC DRUG	Vichy Laboratoires Capital Soleil 60 Mineral Broad Spectrum SPF 60 Water Resistant 80 Minutes Sheer Tint Ultra Lightweight Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	TITANIUM DIOXIDE	148	mg/mL			N	20241231
69625-661_34aa8648-77df-491b-ad70-c44b075921d4	69625-661	HUMAN OTC DRUG	Vichy Laboratoires Normaderm Acne Control Moisturizer		Salicylic Acid	GEL	TOPICAL	20230601		OTC MONOGRAPH DRUG	M006	COSMETIQUE ACTIVE PRODUCTION	SALICYLIC ACID	20	mg/mL			N	20241231
69625-685_a9def1dc-12a3-43db-9333-26c648b899c4	69625-685	HUMAN OTC DRUG	Vichy Laboratories LiftActiv Peptide-C SPF 30 Sunscreen Phyto Peptides Vitamin C		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20191227		OTC MONOGRAPH DRUG	M020	Cosmetique Active Products	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69625-743_b682c3f3-ceb6-4711-9a04-f3e2c6320d32	69625-743	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Cicaplast Balm B5 Therapeutic Multipurpose		Dimethicone	CREAM	TOPICAL	20210315		OTC MONOGRAPH DRUG	M016	Cosmetique Active Production	DIMETHICONE	10	mg/mL	Skin Barrier Activity [PE]		N	20241231
69625-868_3f1f045d-92c5-49bb-804e-ee794f1814b3	69625-868	HUMAN OTC DRUG	Vichy Laboratoires Aqualia Thermal UV Defense Broad Spectrum SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate and Octocrylene	LOTION	TOPICAL	20190527		OTC MONOGRAPH FINAL	M020	Cosmetique Active Production	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69625-908_52bd923b-28c8-4baf-afca-eeac9d5adb70	69625-908	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios 50 Mineral Ultra Light Broad Spectrum SPF 50 Sunscreen		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20110701		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	TITANIUM DIOXIDE; ZINC OXIDE	60; 50	mg/mL; mg/mL			N	20241231
69625-943_f47c8208-14ef-4148-becf-d8eb9ad8ff38	69625-943	HUMAN OTC DRUG	La Roche Posay Laboratoire Dermatologique Anthelios Tinted Mineral Light Fluid Sunscreen Broad Spectrum SPF 40 Medium Deep		Titanium dioxide and Zinc oxide	LOTION	TOPICAL	20231215		OTC MONOGRAPH DRUG	M020	Cosmetique Active Production	TITANIUM DIOXIDE; ZINC OXIDE	170; 80	mg/mL; mg/mL			N	20241231
69626-0008_b710646e-0417-39cb-e053-2995a90a917b	69626-0008	HUMAN OTC DRUG	CHOOZ		Calcium Carbonate	GUM, CHEWING	ORAL	20141101		OTC MONOGRAPH FINAL	part331	Leosons Overseas Corp.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69626-0042_f1108e2e-81d1-62da-e053-2a95a90a167b	69626-0042	HUMAN OTC DRUG	Nice Cherry Cough Drops		Menthol	LOZENGE	ORAL	20191108		OTC MONOGRAPH FINAL	part341	Leosons International	MENTHOL	5	mg/1			N	20241231
69626-0043_f110a537-5c1b-1a8b-e053-2995a90aa116	69626-0043	HUMAN OTC DRUG	NICE Menthol Cough Drops		Menthol	LOZENGE	ORAL	20191108		OTC MONOGRAPH FINAL	part341	Leosons International	MENTHOL	5	mg/1			N	20241231
69626-0044_f0ffb3f2-b921-1554-e053-2995a90aa68a	69626-0044	HUMAN OTC DRUG	NICE Citrus Cough Drops		Menthol	LOZENGE	ORAL	20191108		OTC MONOGRAPH FINAL	part341	Leosons International	MENTHOL	5	mg/1			N	20241231
69626-0045_f110a979-3f82-4a90-e053-2995a90a73ff	69626-0045	HUMAN OTC DRUG	NICE Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20191108		OTC MONOGRAPH FINAL	part341	Leosons International	MENTHOL	5	mg/1			N	20241231
69626-0046_f1108d88-decd-65e1-e053-2a95a90a5b8a	69626-0046	HUMAN OTC DRUG	NICE Assorted Cough Drops		Menthol	LOZENGE	ORAL	20191108		OTC MONOGRAPH FINAL	part341	Leosons	MENTHOL	5	mg/1			N	20241231
69626-0064_d3ac34fe-c663-23ed-e053-2a95a90aeb8b	69626-0064	HUMAN OTC DRUG	Clear Mist		Sodium Chloride	LIQUID	NASAL	20160101		OTC MONOGRAPH FINAL	part349	Leosons Overseas Corp	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
69626-0084_b6ca079e-e502-099e-e053-2a95a90afff7	69626-0084	HUMAN OTC DRUG	Relief		SODIUM PHOSPHATE, MONOBASIC and SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	ENEMA	RECTAL	20150209		OTC MONOGRAPH NOT FINAL	part334	Leosons Overseas Corp	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC	7; 19	g/133mL; g/133mL			N	20241231
69626-0085_f0ffc0e9-bf91-a842-e053-2a95a90aa2f8	69626-0085	HUMAN OTC DRUG	REFLIEF SALINE LAXATIVE PEDIATRIC READY TO USE		SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20191001		OTC MONOGRAPH NOT FINAL	part334	Leosons International	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	3.5; 9.5	g/59mL; g/59mL			N	20241231
69626-5200_29b85677-458a-4cf5-a64d-32db05506977	69626-5200	HUMAN OTC DRUG	Gas-Aid Drops for infants		simethicone	EMULSION	ORAL	20150808		OTC MONOGRAPH FINAL	part332	Leosons	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
69626-7197_efe7fe37-a53a-4844-8589-01850ac45d66	69626-7197	HUMAN OTC DRUG	Gas-Aid		simethicone	TABLET, CHEWABLE	ORAL	20150808		OTC MONOGRAPH FINAL	part332	Leosons Overseas Corp	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
69634-020_d692436a-acd7-24b3-e053-2a95a90a34bb	69634-020	HUMAN OTC DRUG	Health-Tec Topical Anesthetic		Benzocaine	GEL	DENTAL	20150401		OTC MONOGRAPH NOT FINAL	part356	Dental Health Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69634-021_d692436a-ace3-24b3-e053-2a95a90a34bb	69634-021	HUMAN OTC DRUG	Health-Tec Topical Anesthetic		Benzocaine	GEL	DENTAL	20150401		OTC MONOGRAPH NOT FINAL	part356	Dental Health Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69634-022_d61d3545-f918-85c1-e053-2995a90aff61	69634-022	HUMAN OTC DRUG	Health-Tec Topical Anesthetic		Benzocaine	GEL	DENTAL	20150401		OTC MONOGRAPH NOT FINAL	part356	Dental Health Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69634-023_d6925cf5-1f8e-5f01-e053-2995a90a1d12	69634-023	HUMAN OTC DRUG	Health-Tec Topical Anesthetic		Benzocaine	GEL	DENTAL	20150401		OTC MONOGRAPH NOT FINAL	part356	Dental Health Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69634-025_d6926e61-256b-1bfa-e053-2995a90a75c7	69634-025	HUMAN OTC DRUG	Health-Tec Topical Anesthetic		Benzocaine	GEL	DENTAL	20150401		OTC MONOGRAPH NOT FINAL	part356	Dental Health Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69634-026_d6925cf5-1f9a-5f01-e053-2995a90a1d12	69634-026	HUMAN OTC DRUG	Health-Tec Topical Anesthetic		Benzocaine	GEL	DENTAL	20150401		OTC MONOGRAPH NOT FINAL	part356	Dental Health Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69634-027_d61d3545-f90c-85c1-e053-2995a90aff61	69634-027	HUMAN OTC DRUG	Health-Tec Topical Anesthetic		Benzocaine	GEL	DENTAL	20150401		OTC MONOGRAPH NOT FINAL	part356	Dental Health Products, Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69638-060_2fd3a1ff-365b-467b-8f5f-76996c77f34d	69638-060	HUMAN OTC DRUG	Scotts Select Topical Anesthetic		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH NOT FINAL	part356	Scott's Dental Supply LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69638-061_2fd3a1ff-365b-467b-8f5f-76996c77f34d	69638-061	HUMAN OTC DRUG	Scotts Select Topical Anesthetic		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH NOT FINAL	part356	Scott's Dental Supply LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69638-062_2fd3a1ff-365b-467b-8f5f-76996c77f34d	69638-062	HUMAN OTC DRUG	Scotts Select Topical Anesthetic		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH NOT FINAL	part356	Scott's Dental Supply LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69638-063_2fd3a1ff-365b-467b-8f5f-76996c77f34d	69638-063	HUMAN OTC DRUG	Scotts Select Topical Anesthetic		Benzocaine	GEL	DENTAL; ORAL	20170720		OTC MONOGRAPH NOT FINAL	part356	Scott's Dental Supply LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69638-064_2fd3a1ff-365b-467b-8f5f-76996c77f34d	69638-064	HUMAN OTC DRUG	Scotts Select Topical Anesthetic		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH NOT FINAL	part356	Scott's Dental Supply LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69638-065_2fd3a1ff-365b-467b-8f5f-76996c77f34d	69638-065	HUMAN OTC DRUG	Scotts Select Topical Anesthetic		Benzocaine	GEL	DENTAL; ORAL	20170723		OTC MONOGRAPH NOT FINAL	part356	Scott's Dental Supply LLC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69638-069_24ca9bb3-17b2-42b1-9ef9-5b39eb5af769	69638-069	HUMAN OTC DRUG	Scotts Select Perio Rinse Stannous Fluoride		STANNOUS FLUORIDE	MOUTHWASH	DENTAL	20150802		OTC MONOGRAPH FINAL	part355	Scott's Dental Supply LLC	STANNOUS FLUORIDE	.63	mg/100mL			N	20241231
69639-101_3730c0de-198d-4359-8dbd-aaaf47814560	69639-101	HUMAN PRESCRIPTION DRUG	AKYNZEO		Netupitant and Palonosetron	CAPSULE	ORAL	20141013		NDA	NDA205718	Helsinn Therapeutics (U.S.), Inc.	NETUPITANT; PALONOSETRON	300; .5	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], P-Glycoprotein Inhibitors [MoA], Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
69639-102_3730c0de-198d-4359-8dbd-aaaf47814560	69639-102	HUMAN PRESCRIPTION DRUG	AKYNZEO		Fosnetupitant and Palonosetron	INJECTION	INTRAVENOUS	20180420		NDA	NDA210493	Helsinn Therapeutics (U.S.), Inc.	FOSNETUPITANT; PALONOSETRON HYDROCHLORIDE	260; .28	mg/1; mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69639-105_3730c0de-198d-4359-8dbd-aaaf47814560	69639-105	HUMAN PRESCRIPTION DRUG	AKYNZEO		Fosnetupitant and Palonosetron	INJECTION	INTRAVENOUS	20200615		NDA	NDA210493	Helsinn Therapeutics (U.S.), Inc.	FOSNETUPITANT; PALONOSETRON HYDROCHLORIDE	260; .28	mg/20mL; mg/20mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69639-106_3730c0de-198d-4359-8dbd-aaaf47814560	69639-106	HUMAN PRESCRIPTION DRUG	AKYNZEO		Fosnetupitant and Palonosetron	INJECTION	INTRAVENOUS	20230801		NDA	NDA210493	Helsinn Therapeutics (U.S.), Inc.	FOSNETUPITANT; PALONOSETRON HYDROCHLORIDE	260; .28	mg/20mL; mg/20mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
69639-120_d070f59c-df60-4c99-ac38-6434a70a977d	69639-120	HUMAN PRESCRIPTION DRUG	VALCHLOR		mechlorethamine hydrochloride	GEL	TOPICAL	20181108		NDA	NDA202317	Helsinn Therapeutics (U.S.), Inc.	MECHLORETHAMINE	.012	g/60g	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69656-103_c9d12e85-a660-4183-9522-76d5c8e43cab	69656-103	HUMAN PRESCRIPTION DRUG	ZEJULA		niraparib	CAPSULE	ORAL	20170327		NDA	NDA208447	GlaxoSmithKline LLC	NIRAPARIB	100	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
69660-201_0aeb47f7-f854-e93d-e063-6394a90a4350	69660-201	HUMAN PRESCRIPTION DRUG	Rubraca		rucaparib	TABLET, FILM COATED	ORAL	20161219		NDA	NDA209115	Clovis Oncology, Inc.	RUCAPARIB CAMSYLATE	200	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
69660-202_0aeb47f7-f854-e93d-e063-6394a90a4350	69660-202	HUMAN PRESCRIPTION DRUG	Rubraca		rucaparib	TABLET, FILM COATED	ORAL	20170501		NDA	NDA209115	Clovis Oncology, Inc.	RUCAPARIB CAMSYLATE	250	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
69660-203_0aeb47f7-f854-e93d-e063-6394a90a4350	69660-203	HUMAN PRESCRIPTION DRUG	Rubraca		rucaparib	TABLET, FILM COATED	ORAL	20161219		NDA	NDA209115	Clovis Oncology, Inc.	RUCAPARIB CAMSYLATE	300	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
69662-111_e2cf4d39-e104-484e-ad78-e756fd48f821	69662-111	HUMAN OTC DRUG	Refresher		alcohol	LIQUID	TOPICAL	20160330		OTC MONOGRAPH DRUG	M003	Jao Limited	ALCOHOL	65	mL/100mL			N	20251231
69664-001_07d880c0-95b6-c6f7-e063-6294a90a1dab	69664-001	HUMAN OTC DRUG	DYNAMO DELAY		lidocaine	SPRAY	TOPICAL	20150513		UNAPPROVED DRUG OTHER		Momentum Management LLC	LIDOCAINE	10	mg/.08mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69665-216_33089567-2266-4ba7-90a7-43ea4e62eea5	69665-216	HUMAN PRESCRIPTION DRUG	Omeprazole and Sodium Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE	ORAL	20170701		ANDA	ANDA204922	Medarbor Llc	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69666-187_0bdcb1fc-f6dc-5184-e063-6294a90a6aa3	69666-187	HUMAN OTC DRUG	Boraqua Eye Wash		water	SOLUTION	OPHTHALMIC	20231204		OTC MONOGRAPH DRUG	M018	Genuine Drugs	WATER	99.05	mL/100mL			N	20241231
69666-252_f4ee990c-0635-122a-e053-2995a90a948e	69666-252	HUMAN OTC DRUG	Manteca Maslac		Camphor,Menthol, methyl salicylate	OINTMENT	TOPICAL	20150317		OTC MONOGRAPH NOT FINAL	part348	Genuine Drugs	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	5; 1.25; 10	g/100g; g/100g; g/100g			N	20241231
69666-831_f4ee990c-0636-122a-e053-2995a90a948e	69666-831	HUMAN OTC DRUG	Bengama Antifungal		Tolnaftate	SOLUTION	TOPICAL	20150420		OTC MONOGRAPH FINAL	part333C	Genuine Drugs	TOLNAFTATE	1	mg/100mL			N	20241231
69666-871_0bb8ccaf-c290-96c5-e063-6394a90ab905	69666-871	HUMAN OTC DRUG	Boraqua Eye Wash		water	SOLUTION	OPHTHALMIC	20150420		OTC MONOGRAPH DRUG	M018	Genuine Drugs	WATER	99.05	mL/100mL			N	20241231
69666-962_f4ee870c-a1de-1d42-e053-2a95a90ada2d	69666-962	HUMAN OTC DRUG	Balsang Pain Relief		Camphor,Menthol, methyl salicylate	SOLUTION	TOPICAL	20150420		OTC MONOGRAPH NOT FINAL	part348	Genuine Drugs	CAMPHOR, (-)-; MENTHOL, (+)-; METHYL SALICYLATE	1.5; 1.5; 5	mg/100mL; mg/100mL; mg/100mL			N	20241231
69668-515_6ce404bd-62b7-4aeb-e053-2a91aa0ade68	69668-515	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		DOXYCYCLINE HYCLATE	TABLET, DELAYED RELEASE	ORAL	20161128		ANDA	ANDA207494	Sonoma Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
69674-100_7e8358db-8957-169c-e053-2991aa0a545d	69674-100	HUMAN OTC DRUG	Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20160414		OTC MONOGRAPH NOT FINAL	part333E	Saraya Healthcare	ALCOHOL	62	mL/100mL			N	20241231
69674-210_7e8358db-8965-169c-e053-2991aa0a545d	69674-210	HUMAN OTC DRUG	Antimicrobial Foaming Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20160414		OTC MONOGRAPH NOT FINAL	part333E	Saraya Healthcare	BENZALKONIUM CHLORIDE	.12	mg/100mL			N	20241231
69676-0004_90140c05-4b61-f124-e053-2995a90a3a7f	69676-0004	HUMAN OTC DRUG	Pain Crush		Menthol	GEL	TOPICAL	20180613		OTC MONOGRAPH NOT FINAL	part348	Genexa Inc.	MENTHOL	7	g/100mL			N	20241231
69676-0005_a7d2be02-c8c9-f36c-e053-2a95a90a0a82	69676-0005	HUMAN OTC DRUG	Cold Crush Childrens		Allium cepa, Belladonna, Bryonia alba, Chamomilla, Echinacea angustifolia, Euphrasia officinalis, Gelsemium sempervirens, Ipecacuanha, Pulsatilla, Sambucus nigra	TABLET, CHEWABLE	ORAL	20180703		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; MATRICARIA CHAMOMILLA WHOLE; ONION; PULSATILLA PRATENSIS; SAMBUCUS NIGRA FLOWER	12; 9; 6; 6; 12; 12; 6; 6; 9; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
69676-0006_f5d9a016-4931-3eda-e053-2995a90a0300	69676-0006	HUMAN OTC DRUG	Cold Crush Adult		Aconitum napellus, Allium cepa, Bryonia alba, Euphrasia officinalis, Gelsemium sempervirens, Nux vomica, Pulsatilla, Rhus toxicodendron, Sabadilla	TABLET, CHEWABLE	ORAL	20180711		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; ONION; PULSATILLA PRATENSIS; SCHOENOCAULON OFFICINALE SEED; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS SHOOT	6; 12; 6; 12; 6; 6; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
69676-0010_0bf272db-b1bb-dfec-e063-6394a90a3a1b	69676-0010	HUMAN OTC DRUG	Flu Fix		Aconitum napellus, Allium cepa, Anis barbariae, Bryonia alba, Echinacea angustifolia, Eupatorium perfollatum, Gelsemium sempervirens, Ipecacauanha, Nux vomica, Pulsatilla, Rhus toxicodendron	TABLET, CHEWABLE	ORAL	20180711		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; ONION; PULSATILLA PRATENSIS; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS SHOOT	12; 9; 6; 6; 6; 6; 12; 12; 6; 9; 12; 12	[hp_X]/1; [hp_X]/1; [hp_C]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
69676-0012_ffd2a1bb-d06f-8af8-e053-6394a90a48ed	69676-0012	HUMAN OTC DRUG	Sleepology		Alfalfa, Avena sativa, Chamomilla, Eschscholtzia californica, Gelsemium sempervirens, Nux moschata, Passiflora incarnata, Piper methysticum, Valeriana officinalis	TABLET, CHEWABLE	ORAL	20160321		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ALFALFA; AVENA SATIVA FLOWERING TOP; ESCHSCHOLZIA CALIFORNICA; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA WHOLE; NUTMEG; PASSIFLORA INCARNATA FLOWERING TOP; PIPER METHYSTICUM ROOT; VALERIAN	6; 6; 6; 12; 6; 9; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69676-0028_f2b47931-684b-6863-e053-2a95a90ae152	69676-0028	HUMAN OTC DRUG	Genexa Motion Sickness Relief		Bryonia alba, Cinnamonum, Cocculus indica, Colchicum autumnale, Iris versicolor, Kali carbonicum, Nux moschata, Staphysagria, Tabacum, Zingiber officinale	TABLET, CHEWABLE	ORAL	20200121		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ANAMIRTA COCCULUS SEED; BRYONIA ALBA WHOLE; CINNAMON; COLCHICUM AUTUMNALE BULB; DELPHINIUM STAPHISAGRIA SEED; GINGER; IRIS VERSICOLOR ROOT; NUTMEG; POTASSIUM CARBONATE; TOBACCO LEAF	30; 6; 6; 12; 6; 6; 12; 6; 6; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69676-0037_024ad0f4-ba81-1aaf-e063-6394a90a3753	69676-0037	HUMAN OTC DRUG	Kids Cough and Chest Congestion		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20200701		OTC MONOGRAPH FINAL	part341	Genexa Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69676-0041_0bf12bf6-737b-87c1-e063-6394a90aa1dd	69676-0041	HUMAN OTC DRUG	Kids Pain and Fever		Acetaminophen	LIQUID	ORAL	20230913		OTC MONOGRAPH DRUG	M013	Genexa Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
69676-0042_0c43c7ef-0e60-d1e4-e063-6294a90a2d09	69676-0042	HUMAN OTC DRUG	Genexa Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20231107		OTC MONOGRAPH DRUG	M013	Genexa Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
69676-0044_e4910702-42fd-6cec-e053-2995a90a5692	69676-0044	HUMAN OTC DRUG	Genexa Arnica Pain		Arnica montana, Calendula officinalis, Ledum palustre, Rhus toxicodendron, Ruta graveolens	TABLET, CHEWABLE	ORAL	20201220		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; LEDUM PALUSTRE TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	30; 6; 6; 6; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
69676-0045_e4914aab-4d72-4762-e053-2995a90a29f4	69676-0045	HUMAN OTC DRUG	Genexa Leg Cramps		Angustura vera, Berberis vulgaris, Chamomilla, Colchicum autumnale, Colocynthis, Ignatia amara, Jatropha curcas, Lycopodium clavatum, Nux moshchata, Rhus toxicodendron, Secale cornutum, Veratrum album	TABLET, CHEWABLE	ORAL	20200915		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ANGOSTURA BARK; BERBERIS VULGARIS ROOT BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; CLAVICEPS PURPUREA SCLEROTIUM; COLCHICUM AUTUMNALE BULB; JATROPHA CURCAS SEED; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA; NUTMEG; STRYCHNOS IGNATII SEED; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	12; 6; 12; 12; 12; 12; 6; 6; 6; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69676-0047_de2013bd-d72d-3294-e053-2a95a90a069d	69676-0047	HUMAN OTC DRUG	Genexa Jet Lag		Arnica montana, Cinchona officinalis, Cocculus indicus, Coffea cruda, Tabacum	TABLET, CHEWABLE	ORAL	20211104		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ANAMIRTA COCCULUS SEED; ARABICA COFFEE BEAN; ARNICA MONTANA; CINCHONA OFFICINALIS BARK; TOBACCO LEAF	12; 6; 6; 12; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69676-0048_ef564950-b112-8d47-e053-2995a90a877e	69676-0048	HUMAN OTC DRUG	Genexa Stress		Aconitum napellus, Calcarea carbonica, Gelsemium sempervirens, Lycopodium clavatum, Nux vomica, Passiflora incarnata, Valeriana officinalis	TABLET, CHEWABLE	ORAL	20210107		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ACONITUM NAPELLUS; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; VALERIAN	12; 12; 12; 8; 3; 12; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69676-0049_f5d860bd-d54d-42dd-e053-2995a90a2e54	69676-0049	HUMAN OTC DRUG	Genexa Kids Cold Crush		Aconitum napellus, Allium cepa, Bryonia alba, Chamomilla, Echinacea angustifolia, Euphrasia officinalis, Gelsemium sempervirens, Ipecacuanha, Pulsatilla, Sambucus nigra	TABLET, CHEWABLE	ORAL	20200731		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; MATRICARIA CHAMOMILLA WHOLE; ONION; PULSATILLA PRATENSIS; SAMBUCUS NIGRA FLOWER	12; 9; 6; 6; 12; 12; 6; 6; 9; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
69676-0050_e49141aa-f61d-538d-e053-2995a90a609f	69676-0050	HUMAN OTC DRUG	Genexa Senna Laxative		Sennosides	TABLET	ORAL	20201020		OTC MONOGRAPH NOT FINAL	part334	Genexa Inc.	SENNOSIDES	12	mg/1			N	20241231
69676-0052_03b033d9-d1d4-c956-e063-6294a90add91	69676-0052	HUMAN OTC DRUG	Genexa Allergy Care		Allium cepa, Ambrosia artemisiifolia, Arundo mauritanica, Dulcamara, Euphrasia officinalis, Nux vomica, Pulsatilla, Ranunculus bulbosus, Sabadilla, Sinapis nigra, Sticta pulmonaria, Wyethia helenoides	TABLET, CHEWABLE	ORAL	20201201		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ALLIUM CEPA WHOLE; AMBROSIA ARTEMISIIFOLIA; ARUNDO PLINIANA ROOT; BLACK MUSTARD SEED; EUPHRASIA STRICTA; LOBARIA PULMONARIA; PULSATILLA PRATENSIS; RANUNCULUS BULBOSUS WHOLE; SCHOENOCAULON OFFICINALE SEED; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED; WYETHIA HELENIOIDES ROOT	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
69676-0053_f2b87655-93c2-16a5-e053-2a95a90a593c	69676-0053	HUMAN OTC DRUG	Genexa Kids Sleepology		Alfalfa, Calcarea phosphorica, Chamomilla, Eschscholtzia californica, Melissa officinalis, Passiflora incarnata, Pulsatilla, Scutellaria lateriflora, Valeriana officinalis	TABLET, CHEWABLE	ORAL	20210128		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ALFALFA; ESCHSCHOLZIA CALIFORNICA; MATRICARIA CHAMOMILLA WHOLE; MELISSA OFFICINALIS LEAF; PASSIFLORA INCARNATA FLOWERING TOP; PULSATILLA VULGARIS; SCUTELLARIA LATERIFLORA TOP; TRIBASIC CALCIUM PHOSPHATE; VALERIAN	6; 6; 6; 3; 6; 12; 3; 8; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
69676-0054_f2b8f1e4-c7e8-62d6-e053-2995a90a6165	69676-0054	HUMAN OTC DRUG	Genexa Kids Calm Keeper		Aconitum napellus, Calcarea phosphorica, Chamomilla, Gelsemium sepervirens, Ignatia amara, Kali carbonicum, Passiflora incarnata, Valeriana officinalis	TABLET, CHEWABLE	ORAL	20210201		UNAPPROVED HOMEOPATHIC		Genexa Inc.	ACONITUM NAPELLUS; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; STRYCHNOS IGNATII SEED; TRIBASIC CALCIUM PHOSPHATE; VALERIAN	12; 12; 6; 3; 8; 12; 8; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69676-0055_f2b8faed-ff20-80cd-e053-2a95a90a6082	69676-0055	HUMAN OTC DRUG	Genexa Kids Allergy Care		Allium cepa, Dulcamara, Euphrasia officinalis, Nux vomica, Pulsatilla, Rosa damascena, Sabidilla, Sinapis nigra, Wyethia helenoides	TABLET, CHEWABLE	ORAL	20210120		UNAPPROVED HOMEOPATHIC		Genexa Inc.	BLACK MUSTARD SEED; EUPHRASIA STRICTA; ONION; PULSATILLA PRATENSIS; ROSA DAMASCENA FLOWERING TOP; SCHOENOCAULON OFFICINALE SEED; SOLANUM DULCAMARA STEM; STRYCHNOS NUX-VOMICA SEED; WYETHIA HELENIOIDES ROOT	12; 12; 12; 12; 6; 12; 12; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
69676-0056_f2b9b257-f8ea-15a3-e053-2a95a90a5abe	69676-0056	HUMAN OTC DRUG	Genexa Kids Senna Laxative		Sennosides	TABLET, CHEWABLE	ORAL	20210702		OTC MONOGRAPH NOT FINAL	part334	Genexa Inc.	SENNOSIDES	3	mg/1			N	20241231
69676-0058_e779cfbf-ee36-35cc-e053-2995a90a3815	69676-0058	HUMAN OTC DRUG	Genexa Childrens Acetaminophen		Acetaminophen	TABLET, CHEWABLE	ORAL	20220228		OTC MONOGRAPH NOT FINAL	part343	Genexa Inc.	ACETAMINOPHEN	80	mg/1			N	20241231
69676-0059_f1f0d8a9-4bbb-7cca-e053-2995a90a56e7	69676-0059	HUMAN OTC DRUG	Genexa Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20220217		OTC MONOGRAPH NOT FINAL	part343	Genexa Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
69676-0060_f4d39d3e-82d1-2673-e053-2995a90a7d2a	69676-0060	HUMAN OTC DRUG	Childrens Tummy Relief		Calcium carbonate	TABLET, CHEWABLE	ORAL	20221021		OTC MONOGRAPH FINAL	part331	Genexa Inc.	CALCIUM CARBONATE	400	mg/1			N	20241231
69676-0063_0c51f135-ce39-35e9-e063-6294a90acb8b	69676-0063	HUMAN OTC DRUG	Genexa Acetaminophen PM	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20220217		OTC MONOGRAPH DRUG	M013	Genexa Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69676-0068_d4eb1687-0545-5aa0-e053-2995a90a0280	69676-0068	HUMAN OTC DRUG	Genexa Antacid	Maximum Strength	Calcium carbonate	TABLET, CHEWABLE	ORAL	20211207		OTC MONOGRAPH FINAL	part331	Genexa Inc.	CALCIUM CARBONATE	1000	mg/1			N	20241231
69676-0069_0e1068bb-e2db-4820-e063-6294a90a9161	69676-0069	HUMAN OTC DRUG	Childrens Acetaminophen Oral Suspension		Acetaminophen	SUSPENSION	ORAL	20220510		OTC MONOGRAPH DRUG	M013	Genexa Inc.	ACETAMINOPHEN	160	mg/5mL			N	20251231
69676-0072_ffd3ac0e-b878-2c28-e053-6294a90a0494	69676-0072	HUMAN OTC DRUG	Genexa Antacid	Maximum Strength	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220726		OTC MONOGRAPH FINAL	part331	Genexa Inc.	CALCIUM CARBONATE	1000	mg/1			N	20241231
69676-0074_e880b8d7-61c2-41cc-e053-2995a90aaaeb	69676-0074	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine HCl	SOLUTION	ORAL	20220426		OTC MONOGRAPH DRUG	M013	Genexa Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69676-0081_091dd1e7-2485-cdbf-e063-6394a90a2189	69676-0081	HUMAN OTC DRUG	Genexa Kids Pain and Fever		Acetaminophen	TABLET, CHEWABLE	ORAL	20220228		OTC MONOGRAPH DRUG	M013	Genexa, Inc.	ACETAMINOPHEN	80	mg/1			N	20241231
69676-0084_fd002709-7cc2-4e8f-e053-6294a90ac180	69676-0084	HUMAN OTC DRUG	Kids Pain and Fever		Acetaminophen	LIQUID	ORAL	20230530		OTC MONOGRAPH NOT FINAL	part343	Genexa Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
69676-0085_0247cd44-fd98-72df-e063-6294a90a1e87	69676-0085	HUMAN OTC DRUG	Kids Cough and Chest Congestion		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20230806		OTC MONOGRAPH FINAL	part341	Genexa Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69676-0087_0bf12c6e-a370-7f42-e063-6294a90a7a42	69676-0087	HUMAN OTC DRUG	Multi-Symptom Cold and Flu-Kids		Acetaminophen 320 mg, Dextromethorphan HBr 5 mg, Guaifenesin 100 mg	SUSPENSION	ORAL	20230815		OTC MONOGRAPH DRUG	M013	Genexa Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	320; 5; 100	mg/10mL; mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69676-0088_024bb864-4215-1d8b-e063-6394a90aa573	69676-0088	HUMAN OTC DRUG	Nighttime Cough-Kids		Chlorpheniramine maleate, Dextromethorphan HBr	SOLUTION	ORAL	20230815		OTC MONOGRAPH FINAL	part341	Genexa	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	2; 15	mg/10mL; mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69676-0089_fcff84cb-5dbd-d36c-e053-6394a90a8a6d	69676-0089	HUMAN OTC DRUG	Kids Pain and Fever		Acetaminophen	LIQUID	ORAL	20230530		OTC MONOGRAPH NOT FINAL	part343	Genexa Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
69676-0090_036face4-d68a-362b-e063-6294a90a81d1	69676-0090	HUMAN OTC DRUG	Kids Cough Daytime Nighttime Combo		Dextromethorphan HBr, Guaifenesin, Chlorpheniramine Maleate	KIT	ORAL	20230828		OTC MONOGRAPH FINAL	part341	Genexa Inc.						N	20241231
69678-232_68339a6b-5993-4fd6-ad33-56de341762df	69678-232	HUMAN OTC DRUG	REVIVE 1		MENTHOL	LIQUID	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part348	EEZAWAY RELIEF INC	MENTHOL, UNSPECIFIED FORM	2.5	g/100mL			N	20241231
69678-348_90f483e7-759b-47d2-acea-e8409e42a1fb	69678-348	HUMAN OTC DRUG	R3		Menthol	LIQUID	TOPICAL	20221109		OTC MONOGRAPH NOT FINAL	part348	EEZAWAY RELIEF INC	MENTHOL, UNSPECIFIED FORM	2.75	g/100mL			N	20241231
69678-424_751cee69-aa4a-4566-a6f8-65afa658895d	69678-424	HUMAN OTC DRUG	Revive 2		Menthol	LIQUID	TOPICAL	20220517		OTC MONOGRAPH NOT FINAL	part348	EEZAWAY RELIEF INC	MENTHOL, UNSPECIFIED FORM	2.75	g/100mL			N	20241231
69680-112_4d6ed18f-fafe-4fa2-9a76-a2ef0797d451	69680-112	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR	20190102		ANDA	ANDA209255	Vitruvias Therapeutics	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
69680-113_4d6ed18f-fafe-4fa2-9a76-a2ef0797d451	69680-113	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR	20190102		ANDA	ANDA209255	Vitruvias Therapeutics	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
69680-115_236ce9f5-3f2f-438f-a82d-04fc57314bf7	69680-115	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	TABLET	ORAL	20181203		ANDA	ANDA209060	Vitruvias Therapeutics	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
69680-116_236ce9f5-3f2f-438f-a82d-04fc57314bf7	69680-116	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	TABLET	ORAL	20181203		ANDA	ANDA209060	Vitruvias Therapeutics	AMINOCAPROIC ACID	1000	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
69680-121_4d6ed18f-fafe-4fa2-9a76-a2ef0797d451	69680-121	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR	20200212		ANDA	ANDA209255	Vitruvias Therapeutics	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
69680-130_9d838091-196e-4b3f-b98e-8d64e147c174	69680-130	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20190128		ANDA	ANDA210339	Vitruvias Therapeutics	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
69680-131_9d838091-196e-4b3f-b98e-8d64e147c174	69680-131	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20190128		ANDA	ANDA210339	Vitruvias Therapeutics	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
69680-132_9d838091-196e-4b3f-b98e-8d64e147c174	69680-132	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20190128		ANDA	ANDA210339	Vitruvias Therapeutics	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
69680-133_c5f69d55-8a9e-4227-b3d6-728df4cd0eb2	69680-133	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200701		ANDA	ANDA209688	Vitruvias Therapeutics	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69680-134_c5f69d55-8a9e-4227-b3d6-728df4cd0eb2	69680-134	HUMAN PRESCRIPTION DRUG	Potassium Chloride	Extended-Release	Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200701		ANDA	ANDA209688	Vitruvias Therapeutics	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
69680-144_a2a2c475-b0da-4c91-ad4f-10801861271a	69680-144	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	20210601		UNAPPROVED DRUG OTHER		Vitruvias Therapeutics	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69680-145_0f19330e-fd91-4c1a-9051-8e3414e2c3a0	69680-145	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride	Extended-Release	Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210827		ANDA	ANDA212797	Vitruvias Therapeutics, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69680-146_0f19330e-fd91-4c1a-9051-8e3414e2c3a0	69680-146	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210827		ANDA	ANDA212797	Vitruvias Therapeutics, Inc.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
69680-149_959639a8-31f0-43ca-b23c-7797910609db	69680-149	HUMAN PRESCRIPTION DRUG	APur Thyroid		THYROID	TABLET	ORAL	20240112		UNAPPROVED DRUG OTHER		Vitruvias Therapeutics	THYROID	15	mg/1			N	20251231
69680-150_959639a8-31f0-43ca-b23c-7797910609db	69680-150	HUMAN PRESCRIPTION DRUG	APur Thyroid		THYROID	TABLET	ORAL	20240112		UNAPPROVED DRUG OTHER		Vitruvias Therapeutics	THYROID	30	mg/1			N	20251231
69680-151_959639a8-31f0-43ca-b23c-7797910609db	69680-151	HUMAN PRESCRIPTION DRUG	APur Thyroid		THYROID	TABLET	ORAL	20240112		UNAPPROVED DRUG OTHER		Vitruvias Therapeutics	THYROID	60	mg/1			N	20251231
69680-152_959639a8-31f0-43ca-b23c-7797910609db	69680-152	HUMAN PRESCRIPTION DRUG	APur Thyroid		THYROID	TABLET	ORAL	20240112		UNAPPROVED DRUG OTHER		Vitruvias Therapeutics	THYROID	90	mg/1			N	20251231
69680-153_959639a8-31f0-43ca-b23c-7797910609db	69680-153	HUMAN PRESCRIPTION DRUG	APur Thyroid		THYROID	TABLET	ORAL	20240112		UNAPPROVED DRUG OTHER		Vitruvias Therapeutics	THYROID	120	mg/1			N	20251231
69680-157_11dda443-b3cc-4f2d-a8eb-7bb8ec794fa6	69680-157	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride (XL)		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230417		ANDA	ANDA208652	Vitruvias Therapeutics	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69680-158_11dda443-b3cc-4f2d-a8eb-7bb8ec794fa6	69680-158	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride (XL)		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230417		ANDA	ANDA208652	Vitruvias Therapeutics	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69680-161_6d571abb-865b-4a76-874f-c9ba6369267b	69680-161	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20231215		ANDA	ANDA213985	Vitruvias Therapeutics	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
69680-162_6d571abb-865b-4a76-874f-c9ba6369267b	69680-162	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20231215		ANDA	ANDA213985	Vitruvias Therapeutics	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
69680-164_6d571abb-865b-4a76-874f-c9ba6369267b	69680-164	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20231215		ANDA	ANDA213985	Vitruvias Therapeutics	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
69681-125_e788df3c-753e-4bf8-8289-d68f4f452038	69681-125	HUMAN PRESCRIPTION DRUG	ENTADFI		finasteride and tadalafil	CAPSULE	ORAL	20211212		NDA	NDA215423	Veru Inc.	FINASTERIDE; TADALAFIL	5; 5	mg/1; mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA], Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
69681-432_036fa5d4-a566-486a-aa26-c9a3f01fbcfe	69681-432	HUMAN OTC DRUG	Preboost		benzocaine	LIQUID	TOPICAL	20150330		OTC MONOGRAPH NOT FINAL	part348	The Female Health Company d/b/a Veru Healthcare	BENZOCAINE	4	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69683-101_06d42f39-2499-7b3d-e063-6294a90ab05c	69683-101	HUMAN OTC DRUG	DERMOSCRIBE ICHYBUM		HYDROCORTISONE, CLIOQUINOL, ZINC OXIDE	CREAM	TOPICAL	20150323		OTC MONOGRAPH NOT FINAL	part348	DERMOSCRIBE PTY LTD	CLIOQUINOL; HYDROCORTISONE	1; 1	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69683-202_06d42c95-c8cd-7972-e063-6294a90aab3b	69683-202	HUMAN OTC DRUG	DERMOSCRIBE SEBORRHEIC DERMATITIS		SULFUR, SALICYLIC ACID, HYDROCORTISONE	CREAM	TOPICAL	20150323		OTC MONOGRAPH NOT FINAL	part348	DERMOSCRIBE PTY LTD	HYDROCORTISONE; SALICYLIC ACID; SULFUR	1; 3; 3	g/100g; g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69685-103_d56fc1fe-c89e-062b-e053-2a95a90aefd4	69685-103	HUMAN OTC DRUG	StellaLife VEGA Oral Care Rinse		Rinse	RINSE	DENTAL	20190208		UNAPPROVED HOMEOPATHIC		StellaLife, Inc.	AZADIRACHTA INDICA BARK; CALENDULA OFFICINALIS FLOWER; ECHINACEA PURPUREA; PLANTAGO MAJOR	1; 1; 1; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
69685-113_ca787fd0-fddb-8961-e053-2a95a90a9d88	69685-113	HUMAN OTC DRUG	StellaLife VEGA Oral Care Coconut		Risne	RINSE	DENTAL	20210108		UNAPPROVED HOMEOPATHIC		StellaLife, Inc.	APIS MELLIFERA; AZADIRACHTA INDICA BARK; CALENDULA OFFICINALIS FLOWER; ECHINACEA PURPUREA; OKOUBAKA AUBREVILLEI BARK; PHOSPHORUS; PLANTAGO MAJOR; STRONTIUM; THUJA OCCIDENTALIS LEAFY TWIG	12; 1; 1; 1; 6; 12; 1; 30; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
69685-201_f26c0ad9-f669-e27f-e053-2a95a90a8dec	69685-201	HUMAN OTC DRUG	StellaLife Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200523		OTC MONOGRAPH NOT FINAL	part333A	StellaLife, Inc.	ALCOHOL	80	mL/100mL			N	20241231
69693-411_741609b7-3811-49e3-a3f9-8f39a1af91ea	69693-411	HUMAN OTC DRUG	Absorbine Jr.	Plus	Menthol	LIQUID	TOPICAL	20100624		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	MENTHOL	4	g/100mL			N	20241231
69693-412_e3070df6-a36f-4f6f-977f-c644f75dfaf3	69693-412	HUMAN OTC DRUG	ABSORBINE JR		MENTHOL	PATCH	TOPICAL	20180215		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	MENTHOL	5000	mg/h			N	20241231
69693-413_4a44ff49-ea80-4055-a87c-0c58a09ed450	69693-413	HUMAN OTC DRUG	ABSORBINE JR PLUS ULTRA STRENGTH PAIN		MENTHOL	PATCH	TOPICAL	20150815		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	MENTHOL	6500	mg/h			N	20241231
69693-415_39881d9c-7472-477c-af44-be24823a36c2	69693-415	HUMAN OTC DRUG	ABSORBINE jr. PLUS Pain Relief MICRO		Camphor, Menthol	PATCH	TOPICAL	20220101		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	7; 7	mg/100mg; mg/100mg			N	20241231
69693-416_3c5f2215-a089-4c97-9a35-0673afe0c6c0	69693-416	HUMAN OTC DRUG	ABSORBINE jr. PLUS Knee		Camphor, Menthol	PATCH	TOPICAL	20220101		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	7; 7	mg/100mg; mg/100mg			N	20241231
69693-417_9ecacd69-e4e9-4fc6-8003-474351359edc	69693-417	HUMAN OTC DRUG	Cystex	PM	Acetaminophen, Diphenhydramine HCl	TABLET	ORAL	20220128		OTC MONOGRAPH DRUG	M013	Clarion Brands, LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69693-418_6a7f3e6c-d435-4db6-ba5f-639cac95d772	69693-418	HUMAN OTC DRUG	Absorbine Jr Pro Cream		Lidocaine HCl, Phenol	CREAM	TOPICAL	20230215		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	LIDOCAINE; PHENOL	40; 15	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69693-419_d6c62985-2299-4449-b4eb-c9291debf45e	69693-419	HUMAN OTC DRUG	Absorbine Jr Pro No Mess Roll-on	Plus	Lidocaine HCl, Phenol	CREAM	TOPICAL	20230215		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	LIDOCAINE; PHENOL	40; 15	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69693-420_ab3c7b03-ee41-468e-85f3-33ad1495c2dc	69693-420	HUMAN OTC DRUG	ABSORBINE jr.		Lidocaine HCl, Phenol	SPRAY	TOPICAL	20230601		OTC MONOGRAPH DRUG	M017	Clarion Brands, LLC	LIDOCAINE HYDROCHLORIDE; PHENOL	.04; .015	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69693-512_5c0841ac-f54c-42c3-ba94-20a80d1264b0	69693-512	HUMAN OTC DRUG	Cystex	Plus	methenamine, sodium salicylate	TABLET	ORAL	20151101		UNAPPROVED DRUG OTHER		Clarion Brands, LLC	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
69693-513_74264a2c-679d-4574-b9e7-3086777baaf0	69693-513	HUMAN OTC DRUG	Cystex		methenamine, sodium salicylate	TABLET	ORAL	20220601		UNAPPROVED DRUG OTHER		Clarion Brands, LLC	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
69693-715_f5408e17-7b9e-455d-b4b7-b7e4ee97a537	69693-715	HUMAN OTC DRUG	CERTAIN DRI	ROLL-ON	Aluminum Chloride	LIQUID	TOPICAL	20151101		OTC MONOGRAPH DRUG	M019	Clarion Brands, LLC	ALUMINUM CHLORIDE	.12	mg/mL			N	20241231
69693-716_1e9282a1-3e92-412c-b40b-e9b66ca96ada	69693-716	HUMAN OTC DRUG	CERTAIN DRI	SOLID	Aluminum Sesquichlorohydrate	STICK	TOPICAL	20151101		OTC MONOGRAPH DRUG	M019	Clarion Brands, LLC	ALUMINUM SESQUICHLOROHYDRATE	.25	g/g			N	20241231
69693-718_3437d9e0-cec3-4469-a048-56b7c1c8c10f	69693-718	HUMAN OTC DRUG	CERTAIN DRI AM	ROLL-ON	Aluminum zirconium tetrachlorohydrex glycine	LIQUID	TOPICAL	20150616		OTC MONOGRAPH DRUG	M019	Clarion Brands, LLC	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100mL			N	20241231
69693-719_374fdf38-d970-45f5-9939-bb03b82a19e4	69693-719	HUMAN OTC DRUG	Certain Dri Everyday Strength Clinical	SOLID	Aluminum Zirconium Trichlorohydrex Glycine	STICK	TOPICAL	20150616		OTC MONOGRAPH DRUG	M019	Clarion Brands, LLC	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69693-720_99b69cfb-787e-49b5-bba5-8fbde1ed0196	69693-720	HUMAN OTC DRUG	CERTAIN DRI		Aluminum Chlorohydrate	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	M019	Clarion Brands, LLC	ALUMINUM CHLOROHYDRATE	25	g/100mL			N	20241231
69693-721_2edf743d-54bf-4ea7-8faa-6572894378a0	69693-721	HUMAN OTC DRUG	Certain Dri Cucumber Fresh		Aluminum Chlorohydrate	SPRAY	TOPICAL	20230501		OTC MONOGRAPH DRUG	M019	Clarion Brands, LLC	ALUMINUM CHLOROHYDRATE	25	g/100g			N	20241231
69693-725_323189ec-a720-4047-88e6-06d16e617650	69693-725	HUMAN OTC DRUG	CERTAIN DRI		Aluminum Chlorohydrate	CLOTH	TOPICAL	20231001		OTC MONOGRAPH DRUG	M019	Clarion Brands, LLC	ALUMINUM CHLOROHYDRATE	.15	g/g			N	20241231
69693-818_d13574c1-5dbd-4fc8-876c-e1de08d6a867	69693-818	HUMAN OTC DRUG	BABY ANTI MONKEY BUTT DIAPER RASH		ZINC OXIDE, CALAMINE	CREAM	TOPICAL	20160301		OTC MONOGRAPH DRUG	M016	Clarion Brands, LLC	FERRIC OXIDE RED; ZINC OXIDE	.02; .12	g/g; g/g			N	20241231
69710-115_078a0d3b-383a-cdf7-e063-6294a90a26e8	69710-115	HUMAN OTC DRUG	SYMBIO PARA DROPS		Candida parapsilosis	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	CANDIDA PARAPSILOSIS	4	[hp_X]/mL			N	20241231
69710-125_07875ca0-8ea8-5f33-e063-6394a90a61ed	69710-125	HUMAN OTC DRUG	SYMBIO MUC EYE DROPS		Mucor racemosus	LIQUID	OPHTHALMIC	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	MUCOR RACEMOSUS	5	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69710-135_07870fce-1432-cd3c-e063-6294a90ad2f7	69710-135	HUMAN OTC DRUG	SYMBIO MUC DROPS		Mucor racemosus	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	MUCOR RACEMOSUS	4	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69710-145_0787f880-0799-5d41-e063-6294a90abf43	69710-145	HUMAN OTC DRUG	SYMBIO MUC/ASPERGILLUS DROPS		Mucor racemosus, Aspergillus niger	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	ASPERGILLUS NIGER VAR. NIGER; MUCOR RACEMOSUS	4; 4	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69710-155_07884264-eb49-b43d-e063-6394a90a5850	69710-155	HUMAN OTC DRUG	SYMBIO NOT DROPS		Penicillium notatum	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	4	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69710-165_0788c3b6-d877-b337-e063-6294a90acd3a	69710-165	HUMAN OTC DRUG	SYMBIO PARA/ROQUEFORTI DROPS		Candida parapsilosis, Penicillium roqueforti	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI	4; 4	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69710-175_07891d62-3952-4976-e063-6294a90a1644	69710-175	HUMAN OTC DRUG	SYMBIO QUENT DROPS		Penicillium frequentans	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	PENICILLIUM GLABRUM	4	[hp_X]/mL			N	20241231
69710-185_0786b805-30a6-d557-e063-6294a90a7f9e	69710-185	HUMAN OTC DRUG	SYMBIO FORTI DROPS		Penicillium roqueforti	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	PENICILLIUM ROQUEFORTI	4	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69710-205_0789835a-511f-e10b-e063-6294a90a14a7	69710-205	HUMAN OTC DRUG	SYMBIO CERE DROPS		Bacillus cereus	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	BACILLUS CEREUS	6	[hp_X]/mL			N	20241231
69710-235_078a5329-cc17-6ef9-e063-6394a90a7e78	69710-235	HUMAN OTC DRUG	SYMBIO TILIS DROPS		Bacillus subtilis	LIQUID	ORAL	20231008		UNAPPROVED HOMEOPATHIC		Symbiopathic	BACILLUS SUBTILIS	6	[hp_X]/mL			N	20241231
69711-115_fbbf4fd1-a7ff-fc54-e053-6294a90af912	69711-115	HUMAN OTC DRUG	SYMBIO PARA DROPS		Candida parapsilosis	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	CANDIDA PARAPSILOSIS	4	[hp_X]/mL			N	20241231
69711-125_fbbe5a98-d573-4c1f-e053-6294a90a51f1	69711-125	HUMAN OTC DRUG	SYMBIO MUC EYE DROPS		Mucor racemosus	LIQUID	OPHTHALMIC	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	MUCOR RACEMOSUS	5	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69711-135_fbbe1d34-ea0d-cd65-e053-6294a90aaeef	69711-135	HUMAN OTC DRUG	SYMBIO MUC DROPS		Mucor racemosus	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	MUCOR RACEMOSUS	4	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69711-145_fbbeaf38-2590-c315-e053-6394a90a825d	69711-145	HUMAN OTC DRUG	SYMBIO MUC/ASPERGILLUS DROPS		Mucor racemosus, Aspergillus niger	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	ASPERGILLUS NIGER VAR. NIGER; MUCOR RACEMOSUS	4; 4	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69711-155_fbbf0aa9-b287-107d-e053-6394a90aa9a9	69711-155	HUMAN OTC DRUG	SYMBIO NOT DROPS		Penicillium notatum	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	4	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69711-165_fbbfa61a-cbb6-3104-e053-6394a90a832f	69711-165	HUMAN OTC DRUG	SYMBIO PARA/ROQUEFORTI DROPS		Candida parapsilosis, Penicillium roqueforti	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI	4; 4	[hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69711-175_fbbfbed5-fa9e-c901-e053-6394a90a3239	69711-175	HUMAN OTC DRUG	SYMBIO QUENT DROPS		Penicillium frequentans	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	PENICILLIUM GLABRUM	4	[hp_X]/mL			N	20241231
69711-185_fbbddf4e-0aba-44ab-e053-6294a90ae4eb	69711-185	HUMAN OTC DRUG	SYMBIO FORTI DROPS		Penicillium roqueforti	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	PENICILLIUM ROQUEFORTI	4	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
69711-205_fbbd7013-c4a1-bd14-e053-6294a90ab2c6	69711-205	HUMAN OTC DRUG	SYMBIO CERE DROPS		Bacillus cereus	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	BACILLUS CEREUS	6	[hp_X]/mL			N	20241231
69711-235_fbc07808-d60a-70a4-e053-6394a90aa231	69711-235	HUMAN OTC DRUG	SYMBIO TILIS DROPS		Bacillus subtilis	LIQUID	ORAL	20160825		UNAPPROVED HOMEOPATHIC		Symbiopathic	BACILLUS SUBTILIS	6	[hp_X]/mL			N	20241231
69711-255_02eb2676-2ef2-1a92-e063-6294a90a3a0a	69711-255	HUMAN OTC DRUG	SYMBIOPATHIC		Symbio Myco Phlei Drops 6X	LIQUID	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Symbiopathic	MYCOBACTERIUM PHLEI	6	[hp_X]/mL			N	20241231
69714-001_cd92ce5b-7907-4c42-a0c4-150ca07565fc	69714-001	HUMAN PRESCRIPTION DRUG	Ammonia N 13		NH3N13	INJECTION	INTRAVENOUS	20181001		ANDA	ANDA211698	University of Alabama at Birmingham	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69715-100_3aac80e8-bf49-479b-8de4-5bee0ba27986	69715-100	HUMAN OTC DRUG	Pedi-Derm Bum		Zinc Oxide	PASTE	TOPICAL	20151005		OTC MONOGRAPH DRUG	M016	Elixir Solutions, Inc.	ZINC OXIDE	25	g/100g			N	20241231
69721-005_2fd19b71-8c97-47da-964c-ac6f2ef142b5	69721-005	HUMAN OTC DRUG	Somnapure	Clinical Strength	Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20180320		OTC MONOGRAPH FINAL	part338	Force Factor Brands LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69724-112_06fd9a7b-3afe-6e0c-e063-6394a90aba46	69724-112	HUMAN PRESCRIPTION DRUG	Sotalol hydrochloride		Sotalol hydrochloride	INJECTION	INTRAVENOUS	20151015		NDA	NDA022306	ALTATHERA Pharmaceuticals, LLC	SOTALOL HYDROCHLORIDE	15	mg/mL	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
69727-0002_0f098bcf-d688-4ae4-a25e-2bb572b5322b	69727-0002	HUMAN OTC DRUG	Ultra Advantage		Abrotanum (Artemisia Abrotanum), Anacardium Orientale, Fucus Vesiculosus, Helleborus Niger, Hypothalamus Suis, Lycopodium Clavatum, Thymolum, Thymus Serpyllum, Thyroidinum (Bovine), Glandula Suprarenalis Suis, Hepar Suis, Pancreas Suis, Cinchona Officinalis, Graphites, Nicotinamidum, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Magnesia Phosphorica, Solidago Virgaurea	LIQUID	ORAL	20181212		UNAPPROVED HOMEOPATHIC		ELTTAC Inc DBA SWL	ARTEMISIA ABROTANUM FLOWERING TOP; BARIUM CARBONATE; CINCHONA OFFICINALIS BARK; FUCUS VESICULOSUS; GRAPHITE; HELLEBORUS NIGER ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NIACINAMIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK LIVER; SEMECARPUS ANACARDIUM JUICE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; THYMOL; THYMUS SERPYLLUM; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE	8; 12; 8; 8; 8; 8; 8; 12; 8; 12; 8; 8; 12; 8; 8; 8; 8; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69727-0003_3891c044-b855-4cf2-80ec-d4d8f7f60dcc	69727-0003	HUMAN OTC DRUG	Ultra Advantage		Abrotanum (Artemisia Abrotanum), Anacardium Orientale, Fucus Vesiculosus, Helleborus Niger, Hypothalamus Suis, Lycopodium Clavatum, Thymolum, Thymus Serpyllum, Thyroidinum (Bovine), Glandula Suprarenalis Suis, Hepar Suis, Pancreas Suis, Cinchona Officinalis, Nicotinamidum, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Magnesia Phosphorica, Solidago Virgaurea, Graphites	LIQUID	ORAL	20190903		UNAPPROVED HOMEOPATHIC		ELTTAC Inc DBA SWL	ARTEMISIA ABROTANUM FLOWERING TOP; BARIUM CARBONATE; CINCHONA OFFICINALIS BARK; FUCUS VESICULOSUS; GRAPHITE; HELLEBORUS NIGER ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NIACINAMIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK LIVER; SEMECARPUS ANACARDIUM JUICE; SOLIDAGO VIRGAUREA FLOWERING TOP; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; THYMOL; THYMUS SERPYLLUM; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE	8; 12; 8; 8; 12; 8; 8; 12; 8; 12; 8; 8; 12; 8; 8; 8; 8; 8; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69729-006_ff603dad-925c-e38f-e053-6394a90ac4c5	69729-006	HUMAN OTC DRUG	Temperal-ito		Acetaminophen	SUSPENSION	ORAL	20230602		OTC MONOGRAPH NOT FINAL	part343	OPMX Chula Vista	ACETAMINOPHEN	160	mg/5mL			N	20241231
69729-008_ffbfe3e0-3d6c-dd69-e053-6294a90aad68	69729-008	HUMAN OTC DRUG	Activcin		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220523		OTC MONOGRAPH FINAL	part341	OPMX LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-028_fd7c1e8e-4a73-1040-e053-6394a90a7564	69729-028	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69729-032_ff65db5b-8d1c-fdae-e053-6294a90a20c8	69729-032	HUMAN OTC DRUG	Desinflamax - Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20230630		ANDA	ANDA091353	OPMX LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69729-035_762692cb-fe65-4a55-ad14-f92f1f3909bf	69729-035	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	SYRUP	ORAL	20210201		OTC MONOGRAPH FINAL	part341	OPMX Chula Vista	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69729-036_762692cb-fe65-4a55-ad14-f92f1f3909bf	69729-036	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	SYRUP	ORAL	20210201		OTC MONOGRAPH FINAL	part341	OPMX Chula Vista	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69729-040_8b28016c-a3c3-43e6-a4f2-dffe924d041d	69729-040	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	SYRUP	ORAL	20210201		OTC MONOGRAPH FINAL	part341	OPMX Chula Vista	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 300	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69729-047_fd7c1e8e-4a73-1040-e053-6394a90a7564	69729-047	HUMAN OTC DRUG	Temp X		Acetaminophen	SUSPENSION	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69729-047_fd7c1e8e-4a75-1040-e053-6394a90a7564	69729-047	HUMAN OTC DRUG	Temp X		Acetaminophen	SUSPENSION	ORAL	20230602		OTC MONOGRAPH NOT FINAL	part343	OPMX Chula Vista	ACETAMINOPHEN	160	mg/5mL			N	20241231
69729-051_05cd9513-1a40-e990-e063-6294a90a57df	69729-051	HUMAN OTC DRUG	Tenalif Multi Symptom Relief		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SYRUP	ORAL	20230918		OTC MONOGRAPH FINAL	part341	OPMX LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	500; 26.66; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-054_0b3f5376-2245-a722-e063-6394a90a87e2	69729-054	HUMAN OTC DRUG	Nitecin		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20220523		OTC MONOGRAPH DRUG	M012	OPMX LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69729-062_8b28016c-a3c3-43e6-a4f2-dffe924d041d	69729-062	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	SYRUP	ORAL	20210201		OTC MONOGRAPH FINAL	part341	OPMX Chula Vista	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 300	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69729-068_fd7c1e8e-4a73-1040-e053-6394a90a7564	69729-068	HUMAN OTC DRUG	Mejoralito		Acetaminophen	SUSPENSION	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
69729-068_fd7c1e8e-4a77-1040-e053-6394a90a7564	69729-068	HUMAN OTC DRUG	Mejoralito		Acetaminophen	SUSPENSION	ORAL	20230602		OTC MONOGRAPH NOT FINAL	part343	OPMX Chula Vista	ACETAMINOPHEN	160	mg/5mL			N	20241231
69729-069_762692cb-fe65-4a55-ad14-f92f1f3909bf	69729-069	HUMAN OTC DRUG	DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN		DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN	SYRUP	ORAL	20210201		OTC MONOGRAPH FINAL	part341	OPMX Chula Vista	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69729-070_05cd8eb4-47a6-c63c-e063-6294a90a9667	69729-070	HUMAN OTC DRUG	Tenalif Children		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SYRUP	ORAL	20230918		OTC MONOGRAPH FINAL	part341	OPMX LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	250; 13.33; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-104_037746a5-0e11-8bc9-e063-6394a90a0cc1	69729-104	HUMAN OTC DRUG	CARDIASPIRIN PROTECT		Aspirin	TABLET, COATED	ORAL	20230821		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69729-105_f885c9f2-7638-e872-e053-6394a90a8585	69729-105	HUMAN OTC DRUG	ARTRIFIN 24 CAPLETS		Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20220908		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69729-107_0c91fa8f-dc41-e004-e063-6294a90a6c3e	69729-107	HUMAN OTC DRUG	Extra Strenghth Acetaminophen		Acetaminophen	TABLET	ORAL	20170731		OTC MONOGRAPH DRUG	M013	OPMX LLC	ACETAMINOPHEN	500	mg/1			N	20241231
69729-118_fd3cca0a-be6c-d8b0-e053-6394a90a4004	69729-118	HUMAN OTC DRUG	Neo-Lubrina		Acetaminophen	SUSPENSION	ORAL	20230602		OTC MONOGRAPH NOT FINAL	part343	OPMX Chula Vista	ACETAMINOPHEN	160	mg/5mL			N	20241231
69729-120_ff5d43ec-7de9-231e-e053-6394a90a935c	69729-120	HUMAN OTC DRUG	Coldtac Plus Softgels		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20230630		OTC MONOGRAPH FINAL	part341	OPMX LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-121_ff5dd700-3ae7-b615-e053-6294a90a5fe8	69729-121	HUMAN OTC DRUG	Desresfriol-DX Softgels		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20230630		OTC MONOGRAPH FINAL	part341	OPMX LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-122_0491e78f-0bf4-9cde-e063-6294a90ab152	69729-122	HUMAN OTC DRUG	Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl		Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl	TABLET	ORAL	20190826		OTC MONOGRAPH FINAL	part341	OPMX LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	500; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-123_0d811063-82c1-bf9f-e063-6294a90aa371	69729-123	HUMAN OTC DRUG	PROXEN NP 660		Naproxen Sodium	TABLET	ORAL	20231107		ANDA	ANDA091353	OPMX LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69729-131_0bc7bb2c-d5c0-c5a0-e063-6394a90ade4f	69729-131	HUMAN OTC DRUG	Buscapina		Acetaminophen, Caffeine, Pyrilamine Maleate	TABLET, COATED	ORAL	20220606		OTC MONOGRAPH DRUG	M013	OPMX LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69729-132_048ca26b-673c-e466-e063-6394a90aee6d	69729-132	HUMAN OTC DRUG	Buscapina		Acetaminophen, Caffeine, Pyrilamine Maleate	TABLET, COATED	ORAL	20230904		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69729-133_0e9d09fa-8211-74f2-e063-6394a90ab952	69729-133	HUMAN OTC DRUG	COLDTAC ULTRA		Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl	TABLET	ORAL	20240110		OTC MONOGRAPH DRUG	M012	OPMX LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	500; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20251231
69729-141_0e9a9b7f-5780-be13-e063-6394a90afd47	69729-141	HUMAN OTC DRUG	VRMX 500		PYRANTEL PAMOATE	TABLET	ORAL	20220610		OTC MONOGRAPH DRUG	M024	OPMX LLC	PYRANTEL PAMOATE	180	mg/1			N	20251231
69729-143_04555f0d-3615-fdd7-e063-6294a90a0234	69729-143	HUMAN OTC DRUG	COLDTAC Plus		Acetaminophen, Phenylephrin Hydrochloride, Dextromethorphan Hydrobromide	TABLET	ORAL	20180105		OTC MONOGRAPH FINAL	part341	OPMX LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 15; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-147_0288397a-65e8-6339-e063-6294a90a71c3	69729-147	HUMAN OTC DRUG	CAFIZETAMOL FORTE		Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20230809		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69729-148_028859b9-c9fa-9d5c-e063-6294a90ae018	69729-148	HUMAN OTC DRUG	Migrafein FORTE		Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20230809		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69729-149_0288a986-addd-6c58-e063-6394a90aba0f	69729-149	HUMAN OTC DRUG	Neo-Lubrina Fuerte		Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20230809		OTC MONOGRAPH NOT FINAL	part343	OPMX LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69729-151_0a4d2a80-bbdc-f5c4-e063-6394a90ad8b5	69729-151	HUMAN OTC DRUG	CHUPANZON Colon Detox		Docusate sodium and Sennosides	TABLET	ORAL	20231116		OTC MONOGRAPH DRUG	M007	OPMX LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69729-152_0b3e9959-4a77-59de-e063-6394a90acfde	69729-152	HUMAN OTC DRUG	tabcin ACTIVE		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20231128		OTC MONOGRAPH DRUG	M012	OPMX LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-153_0bb2579c-0871-da9c-e063-6394a90ae170	69729-153	HUMAN OTC DRUG	tabcin NIGHT		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20231128		OTC MONOGRAPH DRUG	M012	OPMX LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69729-154_0bccf053-0b1b-85aa-e063-6394a90a29f5	69729-154	HUMAN OTC DRUG	Mejoral		Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20231205		OTC MONOGRAPH DRUG	M013	OPMX LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69729-157_0daf1b9c-b64c-5616-e063-6294a90ab3c2	69729-157	HUMAN OTC DRUG	Ibuwin Forte		Ibuprofen	TABLET	ORAL	20231229		ANDA	ANDA079174	OPMX LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69729-222_048e2463-1588-38a4-e063-6394a90a06d5	69729-222	HUMAN OTC DRUG	Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl		Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl	TABLET	ORAL	20190826		OTC MONOGRAPH FINAL	part341	OPMX LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	500; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-223_0e8ae188-4fcb-0b55-e063-6394a90ad68c	69729-223	HUMAN OTC DRUG	Pentrexcilina Daytime		Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl	TABLET	ORAL	20201230		OTC MONOGRAPH DRUG	M012	OPMX LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	500; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20251231
69729-269_0bb8304b-0ea3-8c48-e063-6394a90a3a15	69729-269	HUMAN OTC DRUG	Quatriderm Anti-itch		Hydrocortisone	CREAM	TOPICAL	20190303		OTC MONOGRAPH DRUG	M017	OPMX LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69729-301_0bb887e1-9825-0191-e063-6294a90a6c82	69729-301	HUMAN OTC DRUG	Barmicil Anti-itch		HYDROCORTISONE	CREAM	TOPICAL	20160210		OTC MONOGRAPH DRUG	M017	OPMX LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69729-323_0e9fb0fd-49f0-78b1-e063-6294a90af049	69729-323	HUMAN OTC DRUG	RESFRIOL D		Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl	TABLET	ORAL	20240110		OTC MONOGRAPH DRUG	M012	OPMX LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	500; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20251231
69729-452_e11cc0b1-b375-6f1f-e053-2995a90a1e40	69729-452	HUMAN OTC DRUG	Lidocaine HCl 4% Menthol 1%		Lidocaine HCl 4% Menthol 1%	OINTMENT	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part348	OPMX LLC	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69729-784_05ce0c8b-0eb5-28d1-e063-6394a90ababf	69729-784	HUMAN OTC DRUG	Rompe Tos X Children		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SYRUP	ORAL	20230918		OTC MONOGRAPH FINAL	part341	OPMX LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	250; 13.33; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69729-785_05cd1600-0e39-f93a-e063-6294a90affd3	69729-785	HUMAN OTC DRUG	Rompe Tos X Adults		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SYRUP	ORAL	20230918		OTC MONOGRAPH FINAL	part341	OPMX LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	500; 26.66; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69732-006_f15f058b-5008-715c-e053-2a95a90ad385	69732-006	HUMAN OTC DRUG	Extra Strength Pain Aid		Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200430		OTC MONOGRAPH NOT FINAL	part343	Hi-Tech Nutaceuticals, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69744-0201_fbd67f4c-cf73-ea24-e053-6294a90a1713	69744-0201	HUMAN OTC DRUG	TOUCH Sanitizing Germ Block, Unscented, 1oz (28.35g)		benzalkonium chloride	AEROSOL, SPRAY	TOPICAL	20210507	20270501	OTC MONOGRAPH NOT FINAL	part333A	Relevo, Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	
69744-0202_fbd67f4c-cf73-ea24-e053-6294a90a1713	69744-0202	HUMAN OTC DRUG	TOUCH Sanitizing Germ Block, Mint Green Tea Aloe, 1oz (28.35g)		benzalkonium chloride	AEROSOL, SPRAY	TOPICAL	20210507	20270501	OTC MONOGRAPH NOT FINAL	part333A	Relevo, Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	
69744-0203_fbd67f4c-cf73-ea24-e053-6294a90a1713	69744-0203	HUMAN OTC DRUG	TOUCH Sanitizing Germ Block, Tropical Breeze, 1oz (28.35g)		benzalkonium chloride	AEROSOL, SPRAY	TOPICAL	20210506	20270501	OTC MONOGRAPH NOT FINAL	part333A	Relevo, Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	
69744-0204_fbd67f4c-cf73-ea24-e053-6294a90a1713	69744-0204	HUMAN OTC DRUG	TOUCH Sanitizing Germ Block, Ocean Mist, 1oz (28.35g)		benzalkonium chloride	AEROSOL, SPRAY	TOPICAL	20210507	20270501	OTC MONOGRAPH NOT FINAL	part333A	Relevo, Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	
69745-010_d61c28e6-9c62-12db-e053-2a95a90a4e97	69745-010	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-011_d61c1f05-1870-dc0f-e053-2995a90a0c20	69745-011	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-012_d61c23a5-aaef-a749-e053-2a95a90a97a2	69745-012	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-013_d61c1f05-187a-dc0f-e053-2995a90a0c20	69745-013	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-014_d692a9a3-4201-6eec-e053-2a95a90a26e5	69745-014	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-015_d61bfd43-0866-e23d-e053-2a95a90ac456	69745-015	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-016_d61c2edd-0204-04be-e053-2a95a90ac50e	69745-016	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-017_d61c28e1-2939-5f2a-e053-2995a90a5342	69745-017	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-018_d61c2edd-020e-04be-e053-2a95a90ac50e	69745-018	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-019_d61c28e6-9c57-12db-e053-2a95a90a4e97	69745-019	HUMAN PRESCRIPTION DRUG	MS APF		Sodium Fluoride	GEL	DENTAL	20141001		UNAPPROVED DRUG OTHER		M&S Dental Supply Co., LLC	SODIUM FLUORIDE	5.6	g/454g			N	20241231
69745-060_d60a5c8c-77ad-97e3-e053-2995a90a763a	69745-060	HUMAN OTC DRUG	MS Topical Anesthetic		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	M&S Dental Supply Co., LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69745-061_d60a7ae2-df0d-5c4d-e053-2a95a90a02ca	69745-061	HUMAN OTC DRUG	MS Topical Anesthetic		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	M&S Dental Supply Co., LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69745-062_d60a7ec1-fa45-5ab9-e053-2995a90ace0e	69745-062	HUMAN OTC DRUG	MS Topical Anesthetic		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	M&S Dental Supply Co., LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69745-063_d60a7ae2-df19-5c4d-e053-2a95a90a02ca	69745-063	HUMAN OTC DRUG	MS Topical Anesthetic		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	M&S Dental Supply Co., LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69745-064_d60a8546-de04-c2a3-e053-2a95a90a83f4	69745-064	HUMAN OTC DRUG	MS Topical Anesthetic		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	M&S Dental Supply Co., LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69745-065_d60a8546-de10-c2a3-e053-2a95a90a83f4	69745-065	HUMAN OTC DRUG	MS Topical Anesthetic		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	M&S Dental Supply Co., LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69745-066_d60a8b06-9f21-b272-e053-2a95a90a8bc2	69745-066	HUMAN OTC DRUG	MS Topical Anesthetic		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	M&S Dental Supply Co., LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69747-040_0c5b770a-fe14-17be-e063-6294a90a40a0	69747-040	HUMAN OTC DRUG	Greencaine Blast		Lidocaine	GEL	TOPICAL	20180118		OTC MONOGRAPH DRUG	M017	ALMA Laboratories, Inc.	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69751-100_11e3cfeb-3ae2-4e97-88f9-3e4cdf770659	69751-100	HUMAN PRESCRIPTION DRUG	Phexxi		lactic acid, L-, citric acid monohydrate, and potassium bitartrate	GEL	VAGINAL	20200801		NDA	NDA208352	Evofem, Inc.	CITRIC ACID MONOHYDRATE; LACTIC ACID, L-; POTASSIUM BITARTRATE	50; 90; 20	mg/5g; mg/5g; mg/5g	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
69764-001_8e953dcc-1215-4c00-b59b-c9b1236a7be0	69764-001	HUMAN OTC DRUG	Gene 16 Whitening Factor		Allantoin	TABLET, SOLUBLE	TOPICAL	20140925		OTC MONOGRAPH DRUG	M016	Shanghai Liang Liang International Inc	ALLANTOIN	.5	mg/100mg			N	20241231
69771-001_09cc2f82-4eef-753a-e063-6294a90a8644	69771-001	HUMAN OTC DRUG	GeriGentle Hand Wipes		Alcohol	GEL	TOPICAL	20150616		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Gentle Corporation	ALCOHOL	69.5	g/100g			N	20241231
69771-002_09cc4940-bb28-879d-e063-6294a90ad6a1	69771-002	HUMAN OTC DRUG	Antimicrobial Alcohol Hand		ALCOHOL	PATCH	TOPICAL	20170405		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Gentle Corporation	ALCOHOL	65.9	g/100g			N	20241231
69771-003_09cc4e19-cd60-81f6-e063-6394a90acda0	69771-003	HUMAN OTC DRUG	Alcohol Prep		ISOPROPYL ALCOHOL	PATCH	TOPICAL	20170405		OTC MONOGRAPH DRUG	M003	Geri-Gentle Corporation	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
69771-005_09cc536e-d4c9-7786-e063-6294a90a7f16	69771-005	HUMAN OTC DRUG	TenderSant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Gentle Corporation	ALCOHOL	700	mg/mL			N	20241231
69771-006_09cc6a06-d5e5-872d-e063-6294a90aae93	69771-006	HUMAN OTC DRUG	TenderLaven Hand		CHLOROXYLENOL	GEL	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Gentle Corporation	CHLOROXYLENOL	2	mg/mL			N	20241231
69771-007_09cc53e4-cfc0-b540-e063-6394a90ae031	69771-007	HUMAN OTC DRUG	Tendersant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200901		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Gentle Corporation	ALCOHOL	.7	mL/mL			N	20241231
69771-010_09cc536e-d4d7-7786-e063-6294a90a7f16	69771-010	HUMAN OTC DRUG	GeriGentle FrostyHeat Pain Relief Patch 4 Lodocaine Back		LIDOCAINE	PATCH	TOPICAL	20220716		OTC MONOGRAPH DRUG	M017	Geri-Gentle Corporation	LIDOCAINE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69771-011_09cc6a06-d5f2-872d-e063-6294a90aae93	69771-011	HUMAN OTC DRUG	GeriGentle FrostyHeat Pain Relief Patch Arm and Neck		MENTHOL	PATCH	TOPICAL	20220716		OTC MONOGRAPH DRUG	M017	Geri-Gentle Corporation	MENTHOL	50	mg/mL			N	20241231
69771-012_09cc827d-1654-bacb-e063-6394a90afbf0	69771-012	HUMAN OTC DRUG	GeriGentle FrostyHeat Pain Relief Patch Back		MENTHOL	PATCH	TOPICAL	20220716		OTC MONOGRAPH DRUG	M017	Geri-Gentle Corporation	MENTHOL	50	mg/mL			N	20241231
69771-015_09cc6a06-d611-872d-e063-6294a90aae93	69771-015	HUMAN OTC DRUG	GeriGentle Alcohol Pads		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20231001		OTC MONOGRAPH DRUG	505G(a)(3)	Geri-Gentle Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
69771-016_0adfbbad-a274-97f9-e063-6394a90a1536	69771-016	HUMAN OTC DRUG	Geri-Gentle petrolatum		White Petrolatum	OINTMENT	TOPICAL	20130923		OTC MONOGRAPH DRUG	M016	Geri-gentle corporation	PETROLATUM	100	g/100g			N	20241231
69771-050_09cc891e-7100-8e21-e063-6294a90a6f26	69771-050	HUMAN OTC DRUG	GeriGard		ZINC OXIDE	OINTMENT	TOPICAL	20180807		OTC MONOGRAPH DRUG	M016	Geri-Gentle Corporation	ZINC OXIDE	18	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69771-165_0ae03b59-dfe3-f9dd-e063-6394a90a4fe0	69771-165	HUMAN OTC DRUG	GeriGentle Miconazole nitrate		Antifungal	POWDER	TOPICAL	20220819		OTC MONOGRAPH DRUG	M005	GERI-GENTLE CORPORATION	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69771-192_0adfa2e8-9220-55d1-e063-6294a90a48b5	69771-192	HUMAN OTC DRUG	Gerigentle		Hydrocortisone	CREAM	TOPICAL	20231123		OTC MONOGRAPH DRUG	M017	GERI-GENTLE CORPORATION	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69777-180_91d76267-19a1-41fd-b1bb-c212c33fa582	69777-180	HUMAN OTC DRUG	OrgaPlus Super Care Balm for combination and oi ly skin type	14g	SUNFLOWER	STICK	TOPICAL	20171101		UNAPPROVED DRUG OTHER		NATURE & NATURE CO.,LTD.	SUNFLOWER OIL	7.92	g/14g			N	20241231
69777-190_22054f73-b662-410f-b79d-ad6837379a76	69777-190	HUMAN OTC DRUG	OrgaPlus Super Care Balm for combination and oi ly skin type	20g	SUNFLOWER	STICK	TOPICAL	20171101		UNAPPROVED DRUG OTHER		NATURE & NATURE CO.,LTD.	SUNFLOWER OIL	11.31	g/20g			N	20241231
69777-220_a1fe465d-cb79-49d4-8e23-9428030ec2d1	69777-220	HUMAN OTC DRUG	May New York Super Clear Pure Sun Ultra	22g	Octinoxate, Octisalate, Octocrylene	STICK	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part352	NATURE & NATURE CO.,LTD.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.54; .99; .44	g/22g; g/22g; g/22g			N	20241231
69777-230_6c5e11fe-3108-4f08-a5af-4e8f18a4e887	69777-230	HUMAN OTC DRUG	May New York Super Clear Pure Sun Ultra	17g	Octinoxate, Octisalate, Octocrylene	STICK	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part352	NATURE & NATURE CO.,LTD.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.19; .76; .34	g/17g; g/17g; g/17g			N	20241231
69777-240_f0ca90d9-295f-4148-8d2f-07cdf6cbb03e	69777-240	HUMAN OTC DRUG	OrgaPlus Ultra Pure Sun EX	15g	Octinoxate, Octisalate, Octocrylene	STICK	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part352	NATURE & NATURE CO.,LTD.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.05; .67; .3	g/15g; g/15g; g/15g			N	20241231
69777-250_ec1c8892-ed60-4b06-b2de-51d2ddde7c8f	69777-250	HUMAN OTC DRUG	OrgaPlus Ultra Pure Sun EX	22g	Octinoxate, Octisalate, Octocrylene	STICK	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part352	NATURE & NATURE CO.,LTD.	OCTINOXATE; OCTISALATE; OCTOCRYLENE	1.54; .99; .44	g/22g; g/22g; g/22g			N	20241231
69777-260_e85ff1c0-0b65-41d1-9b77-6af8e2dc6778	69777-260	HUMAN OTC DRUG	Secret Muse Vita Blue Sun		Homosalate, Octocrylene, Octisalate, Avobenzone	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	NATURE & NATURE CO.,LTD.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.5; 4.75; 2.25; 2.5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
69777-270_ee3e1090-437a-40e5-bfed-493661bc32de	69777-270	HUMAN OTC DRUG	May New York Secret Muse Himiznohana Cover Pact No 21		Titanium Dioxide, Octisalate, Zinc Oxide	POWDER	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	NATURE & NATURE CO.,LTD.	OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	1.4; 4.31; .98	g/20g; g/20g; g/20g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69777-280_05b230ad-9c5f-4b2b-a65e-58cf5656eae5	69777-280	HUMAN OTC DRUG	May New York Secret Muse UV Vita Sun Cushion		ZINC OXIDE, OCTINOXATE, OCTISALATE, HOMOSALATE, TITANIUM DIOXIDE	POWDER	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	NATURE & NATURE CO.,LTD.	HOMOSALATE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	.69; 1.38; .92; .46; 2.07	g/23g; g/23g; g/23g; g/23g; g/23g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69778-930_5f2379e6-9041-4de6-83a2-f63fa36db0d9	69778-930	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20101015		ANDA	ANDA065152	Pharma-C, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69778-931_5f2379e6-9041-4de6-83a2-f63fa36db0d9	69778-931	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20101015		ANDA	ANDA065152	Pharma-C, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
69784-130_079e668d-2765-9ed2-e063-6294a90a791d	69784-130	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		pyridostigmine bromide	SOLUTION	ORAL	20221215		ANDA	ANDA212405	Woodward Pharma Services LLC	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
69784-139_34aa881a-3df4-460b-acad-fb9975ca3a06	69784-139	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Woodward Pharma Services LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-140_34aa881a-3df4-460b-acad-fb9975ca3a06	69784-140	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Woodward Pharma Services LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-141_34aa881a-3df4-460b-acad-fb9975ca3a06	69784-141	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Woodward Pharma Services LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-142_34aa881a-3df4-460b-acad-fb9975ca3a06	69784-142	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Woodward Pharma Services LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-180_41a32cdc-41d3-4f7c-9cff-d2847dc52b12	69784-180	HUMAN OTC DRUG	POLYETHYLENE GLYCOL 3350 NF		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20180606		ANDA	ANDA206105	Woodward Pharma Services LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69784-200_dde8609f-d587-4882-9a15-3fd5565dd2b7	69784-200	HUMAN PRESCRIPTION DRUG	CROMOLYN SODIUM		CROMOLYN SODIUM	SOLUTION, CONCENTRATE	ORAL	20171016		ANDA	ANDA209264	Woodward Pharma Services LLC	CROMOLYN SODIUM	100	mg/5mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
69784-205_fd9a8121-c6e6-47d6-b324-283786f6e7ae	69784-205	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION	INTRABRONCHIAL	20171016		ANDA	ANDA209453	Woodward Pharma Services LLC	CROMOLYN SODIUM	20	mg/2mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
69784-230_091ffeb5-7ec4-d28c-e063-6394a90a03c8	69784-230	HUMAN PRESCRIPTION DRUG	SODIUM ACETATE		SODIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210601		ANDA	ANDA214805	Woodward Pharma Services LLC	SODIUM ACETATE	164	mg/mL			N	20241231
69784-231_091ffeb5-7ec4-d28c-e063-6394a90a03c8	69784-231	HUMAN PRESCRIPTION DRUG	SODIUM ACETATE		SODIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210601		ANDA	ANDA214805	Woodward Pharma Services LLC	SODIUM ACETATE	164	mg/mL			N	20241231
69784-232_091ffeb5-7ec4-d28c-e063-6394a90a03c8	69784-232	HUMAN PRESCRIPTION DRUG	SODIUM ACETATE		SODIUM ACETATE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210601		ANDA	ANDA214805	Woodward Pharma Services LLC	SODIUM ACETATE	328	mg/mL			N	20241231
69784-240_f90c32f2-3f5e-73ba-e053-6294a90a074b	69784-240	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20210315		ANDA	ANDA213118	Woodward Pharma Services LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
69784-243_be3a78bc-4f9c-473f-bb62-bd1d6920b5ec	69784-243	HUMAN PRESCRIPTION DRUG	Aciphex		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20220515		NDA	NDA020973	Woodward Pharma Services LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69784-261_957fcf46-6682-44d5-ad7f-5ce3c51bef52	69784-261	HUMAN PRESCRIPTION DRUG	Fluconazole in Sodium Chloride		Fluconazole, Sodium Chloride	INJECTION	INTRAVENOUS	20201001		ANDA	ANDA077909	Woodward Pharma Services LLC	FLUCONAZOLE	2	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
69784-383_fc8f3de9-212f-45be-a09b-a17800978c1d	69784-383	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-385_fc8f3de9-212f-45be-a09b-a17800978c1d	69784-385	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-387_fc8f3de9-212f-45be-a09b-a17800978c1d	69784-387	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-388_fc8f3de9-212f-45be-a09b-a17800978c1d	69784-388	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-420_de927620-9977-4b52-9807-61fd73df8a20	69784-420	HUMAN PRESCRIPTION DRUG	LOVAZA		Omega-3-Acid Ethyl Esters	CAPSULE, LIQUID FILLED	ORAL	20151130		ANDA	ANDA204940	Woodward Pharma Services LLC	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
69784-500_e7975860-648a-454a-b324-9d7824f92521	69784-500	HUMAN PRESCRIPTION DRUG	EC-NAPROXEN		naproxen	TABLET, DELAYED RELEASE	ORAL	20181015		NDA	NDA020067	Woodward Pharma Services LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69784-501_e7975860-648a-454a-b324-9d7824f92521	69784-501	HUMAN PRESCRIPTION DRUG	EC-NAPROXEN		naproxen	TABLET, DELAYED RELEASE	ORAL	20181015		NDA	NDA020067	Woodward Pharma Services LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69784-550_e7975860-648a-454a-b324-9d7824f92521	69784-550	HUMAN PRESCRIPTION DRUG	NAPROXEN SODIUM DS		naproxen sodium	TABLET	ORAL	20181015		NDA	NDA018164	Woodward Pharma Services LLC	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69784-601_26c3d899-f3f8-4f0e-8d69-cbe5c8b0eb04	69784-601	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA216407	WOODWARD PHARMA SERVICES LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69784-610_3f5cf902-16b6-45d9-8949-37e87cdd0e2e	69784-610	HUMAN PRESCRIPTION DRUG	LEUKERAN		chlorambucil	TABLET, FILM COATED	ORAL	20220630		NDA	NDA010669	Woodward Pharma Services LLC	CHLORAMBUCIL	2	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69784-620_f68d65a9-9f60-4ff8-9eb4-36d86b364683	69784-620	HUMAN PRESCRIPTION DRUG	MYLERAN		busulfan	TABLET, FILM COATED	ORAL	20220630		NDA	NDA009386	Woodward Pharma Services LLC	BUSULFAN	2	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
69784-630_bb1f2055-e87c-4ac6-9427-715f4fa65d28	69784-630	HUMAN PRESCRIPTION DRUG	TABLOID		thioguanine	TABLET	ORAL	20220630		NDA	NDA012429	Woodward Pharma Services LLC	THIOGUANINE	40	mg/1	Antimetabolite [EPC]		N	20241231
69784-713_7adb58e6-cb02-4ab0-a01c-93956b503544	69784-713	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-714_7adb58e6-cb02-4ab0-a01c-93956b503544	69784-714	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-715_7adb58e6-cb02-4ab0-a01c-93956b503544	69784-715	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-716_7adb58e6-cb02-4ab0-a01c-93956b503544	69784-716	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20220401		NDA AUTHORIZED GENERIC	NDA022012	Woodward Pharma Services LLC	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
69784-810_c67d4fea-9479-42bf-bfdd-368a520dcbfb	69784-810	HUMAN PRESCRIPTION DRUG	SODIUM PHENYLACETATE and SODIUM BENZOATE		sodium phenylacetate and sodium benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210515		ANDA	ANDA207096	Woodward Pharma Services LLC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
69784-811_f6bb9d57-63e4-43c6-a3c2-0aa979d1c603	69784-811	HUMAN PRESCRIPTION DRUG	SODIUM PHENYLACETATE and SODIUM BENZOATE		sodium phenylacetate and sodium benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20211215		ANDA	ANDA207096	Woodward Pharma Services LLC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
69784-840_0e72ffb7-8a0c-4a1e-96a8-dc9ee085f7d2	69784-840	HUMAN PRESCRIPTION DRUG	Selenious Acid		Selenious Acid	INJECTION, SOLUTION	INTRAVENOUS	20220315		UNAPPROVED DRUG OTHER		Woodward Pharma Services LLC	SELENIUM	40	ug/mL			N	20241231
69790-161_f17410f3-fd4e-29e2-e053-2a95a90ab717	69790-161	HUMAN OTC DRUG	Uline Sinus and Congestion		phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20191007		OTC MONOGRAPH FINAL	part341	Uline	PHENYLEPHRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69790-279_f8a3d248-1e66-41a8-bf14-c56f9d217db1	69790-279	HUMAN OTC DRUG	Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20150119		OTC MONOGRAPH NOT FINAL	part333A	Uline	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
69790-456_09b0e2d7-32b9-4d0c-b265-1152a4a75eb9	69790-456	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20201208		OTC MONOGRAPH NOT FINAL	part333A	Uline	ALCOHOL	70	mL/100mL			N	20241231
69790-466_21d0ab7d-c8c2-40fb-8ef7-b179c0278ac6	69790-466	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20160217		OTC MONOGRAPH NOT FINAL	part333A	ULINE	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69790-488_c0b92930-c293-4c07-99cf-0647bae4e0c0	69790-488	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride 0.13%	LIQUID	TOPICAL	20180527		OTC MONOGRAPH NOT FINAL	part333A	Uline	BENZALKONIUM CHLORIDE	1.313	mg/mL			N	20241231
69790-609_f17096c9-03cf-12f1-e053-2995a90a5f1d	69790-609	HUMAN OTC DRUG	Uline Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20220404		ANDA	ANDA075010	Uline	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69790-616_f171ca36-6103-17ee-e053-2995a90a1912	69790-616	HUMAN OTC DRUG	ULINE Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200720		OTC MONOGRAPH NOT FINAL	part343	ULINE	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69790-640_03a8a3c7-0f60-277e-e063-6294a90ac88d	69790-640	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	SOAP	TOPICAL	20170912		OTC MONOGRAPH NOT FINAL	part333A	Uline	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
69790-709_f17096c9-03cf-12f1-e053-2995a90a5f1d	69790-709	HUMAN OTC DRUG	Uline Ibuprofen		Ibuprofen	TABLET	ORAL	20220404		ANDA	ANDA079174	Uline	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69790-770_d072034d-2c05-4950-b004-b7d10bff294f	69790-770	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160328		OTC MONOGRAPH NOT FINAL	part333A	Uline	ALCOHOL	70	mL/100mL			N	20241231
69790-801_a7aa183f-8450-ff69-e053-2a95a90af0e0	69790-801	HUMAN OTC DRUG	Uline Hand Sanitizer		Alcohol	GEL	TOPICAL	20200608		OTC MONOGRAPH NOT FINAL	part333E	Uline	ALCOHOL	.7	mL/mL			N	20241231
69790-804_02e81847-81c2-5687-e063-6394a90add85	69790-804	HUMAN OTC DRUG	Uline Acetaminophen Extra Strength		acetaminophen	TABLET, FILM COATED	ORAL	20191007		OTC MONOGRAPH NOT FINAL	part343	Uline	ACETAMINOPHEN	500	mg/1			N	20241231
69790-820_0296f568-5312-c611-e063-6394a90a85ad	69790-820	HUMAN OTC DRUG	Uline Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20191007		OTC MONOGRAPH FINAL	part331	Uline	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69790-849_bcfe354e-85e8-40e5-ab7f-02a1ca7ab3cd	69790-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190719		OTC MONOGRAPH NOT FINAL	part333A	Uline	ALCOHOL	62	mg/mL			N	20241231
69794-001_1b14c170-a976-444f-a1be-edc59d532721	69794-001	HUMAN PRESCRIPTION DRUG	MEPSEVII		vestronidase alfa	INJECTION	INTRAVENOUS	20171115		BLA	BLA761047	Ultragenyx Pharmaceutical Inc.	VESTRONIDASE ALFA	2	mg/mL	Lysosomal beta Glucuronidase [EPC]		N	20241231
69794-050_1ebc609a-c9b5-4c9a-b434-26c25afc608b	69794-050	HUMAN PRESCRIPTION DRUG	DOJOLVI		Triheptanoin	LIQUID	ORAL	20200701		NDA	NDA213687	Ultragenyx Pharmaceutical Inc.	TRIHEPTANOIN	.96	g/mL	Medium-chain Triglyceride [EPC], Triglycerides [CS]		N	20241231
69794-102_81078e03-384d-40f9-a5e9-9b8b49163a32	69794-102	HUMAN PRESCRIPTION DRUG	CRYSVITA		Burosumab	INJECTION	SUBCUTANEOUS	20180418		BLA	BLA761068	Ultragenyx Pharmaceutical Inc.	BUROSUMAB	10	mg/mL			N	20241231
69794-203_81078e03-384d-40f9-a5e9-9b8b49163a32	69794-203	HUMAN PRESCRIPTION DRUG	CRYSVITA		Burosumab	INJECTION	SUBCUTANEOUS	20180418		BLA	BLA761068	Ultragenyx Pharmaceutical Inc.	BUROSUMAB	20	mg/mL			N	20241231
69794-304_81078e03-384d-40f9-a5e9-9b8b49163a32	69794-304	HUMAN PRESCRIPTION DRUG	CRYSVITA		Burosumab	INJECTION	SUBCUTANEOUS	20180418		BLA	BLA761068	Ultragenyx Pharmaceutical Inc.	BUROSUMAB	30	mg/mL			N	20241231
69800-0250_0553a56d-4759-e952-e063-6294a90abe3d	69800-0250	HUMAN PRESCRIPTION DRUG	ASCENIV		HUMAN IMMUNOGLOBULIN G	LIQUID	INTRAVENOUS	20190401		BLA	BLA125590	ADMA Biologics, Inc.	HUMAN IMMUNOGLOBULIN G	5	g/50mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
69800-4202_ee1560c0-18e1-b617-e053-2a95a90aa1af	69800-4202	HUMAN PRESCRIPTION DRUG	Nabi-HB		Hepatitis B Immune Globulin (Human)	LIQUID	INTRAMUSCULAR	20011023		BLA	BLA103945	ADMA Biologics, Inc.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	312	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
69800-4203_ee1560c0-18e1-b617-e053-2a95a90aa1af	69800-4203	HUMAN PRESCRIPTION DRUG	Nabi-HB		Hepatitis B Immune Globulin (Human)	LIQUID	INTRAMUSCULAR	20011023		BLA	BLA103945	ADMA Biologics, Inc.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	1560	[iU]/5mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
69800-6502_0c65ff36-cb57-49ea-e063-6394a90aeaf5	69800-6502	HUMAN PRESCRIPTION DRUG	BIVIGAM		Immune Globulin Intravenous (Human) 10%	INJECTION, SOLUTION	INTRAVENOUS	20130121		BLA	BLA125389	ADMA Biologics, Inc.	HUMAN IMMUNOGLOBULIN G	5	g/50mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
69800-6503_0c65ff36-cb57-49ea-e063-6394a90aeaf5	69800-6503	HUMAN PRESCRIPTION DRUG	BIVIGAM		Immune Globulin Intravenous (Human) 10%	INJECTION, SOLUTION	INTRAVENOUS	20130121		BLA	BLA125389	ADMA Biologics, Inc.	HUMAN IMMUNOGLOBULIN G	10	g/100mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
69805-400_065a6eec-3897-0da8-e063-6394a90a849d	69805-400	HUMAN OTC DRUG	Zensa Numbing Gel		Lidocaine 5%, Phenylephrine Hydrochloride 0.25%	GEL	RECTAL	20230925		OTC MONOGRAPH DRUG	M015	Alera Skin Care Products Inc.	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	5; .25	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69805-786_0c3fe142-06b3-4689-e063-6394a90a662a	69805-786	HUMAN OTC DRUG	Zensa		Lidocaine	CREAM	TOPICAL	20160104		OTC MONOGRAPH DRUG	M015	Alera Skin Care Products Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69809-0126_b7c0aa10-fef2-4930-94ff-2801c699d491	69809-0126	HUMAN PRESCRIPTION DRUG	Clozaril		clozapine	TABLET	ORAL	20160506		NDA	NDA019758	HLS Therapeutics (USA), Inc.	CLOZAPINE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69809-0127_b7c0aa10-fef2-4930-94ff-2801c699d491	69809-0127	HUMAN PRESCRIPTION DRUG	Clozaril		clozapine	TABLET	ORAL	20160506		NDA	NDA019758	HLS Therapeutics (USA), Inc.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69809-0130_b7c0aa10-fef2-4930-94ff-2801c699d491	69809-0130	HUMAN PRESCRIPTION DRUG	Clozaril		clozapine	TABLET	ORAL	20191217		NDA	NDA019758	HLS Therapeutics (USA), Inc.	CLOZAPINE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69809-0135_b7c0aa10-fef2-4930-94ff-2801c699d491	69809-0135	HUMAN PRESCRIPTION DRUG	Clozaril		clozapine	TABLET	ORAL	20191217		NDA	NDA019758	HLS Therapeutics (USA), Inc.	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
69822-003_0b57cdd0-d6fd-4e06-e063-6294a90a5af5	69822-003	HUMAN OTC DRUG	Akin Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20190425		OTC MONOGRAPH DRUG	M016	Southern Sales & Service, Inc.	ZINC OXIDE	50	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69822-012_00383aa5-130c-f75f-e063-6294a90ab305	69822-012	HUMAN OTC DRUG	IceQuake Coldn Hot Medicated		Menthol	PATCH	TOPICAL	20190301	20250831	OTC MONOGRAPH NOT FINAL	part348	Southern Sales & Service, Inc.	MENTHOL	50	mg/mL			N	
69822-014_0b57dc81-5724-2787-e063-6394a90a04b0	69822-014	HUMAN OTC DRUG	Icequake Coldn Hot medicated patch		MENTHOL	CLOTH	TOPICAL	20221102		OTC MONOGRAPH DRUG	M017	Southern Sales & Service, Inc.	MENTHOL	50	mg/g			N	20241231
69822-100_0b57cdd0-d6ef-4e06-e063-6294a90a5af5	69822-100	HUMAN OTC DRUG	Ice Quake		Menthol	GEL	TOPICAL	20150104		OTC MONOGRAPH DRUG	M017	Southern Sales & Service, Inc.	MENTHOL	.15	g/g			N	20241231
69822-103_0b57d91e-06ca-37f8-e063-6294a90a6515	69822-103	HUMAN OTC DRUG	ICE MUSCLE RUB Leon M.C		Menthol	GEL	TOPICAL	20150104		OTC MONOGRAPH DRUG	M017	Southern Sales & Service, Inc.	MENTHOL	.02	g/g			N	20241231
69822-104_0b57eba9-b6a0-4dfa-e063-6294a90a06e2	69822-104	HUMAN OTC DRUG	Ice Quake Muscle Rub Blue		Menthol	GEL	TOPICAL	20170104		OTC MONOGRAPH DRUG	M017	Southern Sales & Service, Inc.	MENTHOL	.02	g/g			N	20241231
69822-200_0b57e902-44f1-494e-e063-6294a90af7e1	69822-200	HUMAN OTC DRUG	Akin		GUAIFENESIN	SOLUTION	ORAL	20150104		OTC MONOGRAPH DRUG	M012	Southern Sales & Service, Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69822-202_0b57eba9-b690-4dfa-e063-6294a90a06e2	69822-202	HUMAN OTC DRUG	Akin Cough Formula DM		DEXTROMETHORPHAN, GUAIFENESIN	LIQUID	ORAL	20140104		OTC MONOGRAPH DRUG	M012	Southern Sales & Service, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69822-211_0b57d80b-329c-212b-e063-6394a90a4e18	69822-211	HUMAN OTC DRUG	Akin Cough Formula DM Strawberry Banana		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	M012	Southern Sales & Service, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69822-212_0b57d778-6038-5046-e063-6294a90ab89e	69822-212	HUMAN OTC DRUG	Akin Expectorant Formula Strawberry Banana		GUAIFENESIN	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	M012	Southern Sales & Service, Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69822-254_0b57d8e4-f9ea-2401-e063-6394a90a31dc	69822-254	HUMAN OTC DRUG	AKIN ANTI-FUNGAL		CLOTRIMAZOLE	SOLUTION	TOPICAL	20170101		OTC MONOGRAPH DRUG	M005	Southern Sales & Service, Inc.	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69822-310_0b57d91e-06d8-37f8-e063-6294a90a6515	69822-310	HUMAN OTC DRUG	IceQuake Analgestic White		METHYL SALICYLATE, menthol	CREAM	TOPICAL	20220801		OTC MONOGRAPH DRUG	M017	Southern Sales & Service, Inc.	MENTHOL; METHYL SALICYLATE	2; 10	g/100g; g/100g			N	20241231
69822-430_0b57eb9f-300d-283f-e063-6394a90a2f97	69822-430	HUMAN OTC DRUG	IceQuake Lidocaine Analgesic		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20220801		OTC MONOGRAPH DRUG	M017	Southern Sales & Service, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69822-692_0b57cdc0-3b62-26fd-e063-6394a90ad4fa	69822-692	HUMAN OTC DRUG	Acetaminophen		ACETAMINOPHEN	TABLET	ORAL	20190101		OTC MONOGRAPH DRUG	M013	Southern Sales & Service, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
69822-693_ec578861-5a51-5362-e053-2995a90ab54a	69822-693	HUMAN OTC DRUG	Ibuprofen 200mg		Ibuprofen 200mg	TABLET, FILM COATED	ORAL	20221031		ANDA	ANDA072096	Southern Sales & Services, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69840-003_bd16754a-8763-4a88-b647-db359ee0ec60	69840-003	HUMAN OTC DRUG	Yes To Tomatoes Detoxifying Charcoal Cleanser		Salicylic Acid	CREAM	TOPICAL	20150609		OTC MONOGRAPH DRUG	M032	Yes To Incorporated	SALICYLIC ACID	10	mg/mL			N	20241231
69840-004_727d8a26-4b8d-45ca-88dc-3957a3e77625	69840-004	HUMAN OTC DRUG	Yes To Tomatoes Acne Clearing Facial Toner		Salicylic Acid	LIQUID	TOPICAL	20150611		OTC MONOGRAPH DRUG	M032	Yes To Incorporated	SALICYLIC ACID	5	mg/mL			N	20241231
69840-005_4abca4c2-0e47-46cd-9dc8-6470c53581b4	69840-005	HUMAN OTC DRUG	Yes To Tomatoes Detoxifying Charcoal Mud Mask		Salicylic Acid	CREAM	TOPICAL	20150611		OTC MONOGRAPH DRUG	M032	Yes To Incorporated	SALICYLIC ACID	5	mg/mL			N	20241231
69840-008_b8594e62-b2c1-4286-98be-b38e4af6b64d	69840-008	HUMAN OTC DRUG	Yes To Tomatoes Detoxifying Charcoal Sleeping Mask		Salicylic Acid	CREAM	TOPICAL	20170615		OTC MONOGRAPH DRUG	M032	Yes To Incorporated	SALICYLIC ACID	5	mg/mL			N	20241231
69842-001_18d1c6f8-e675-4419-045a-fa1c380a5a98	69842-001	HUMAN OTC DRUG	Budesonide		Budesonide	SPRAY, METERED	NASAL	20160409		ANDA	ANDA078949	CVS Pharmacy	BUDESONIDE	32	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-008_20a73c30-07f2-4b90-928a-7291621933b7	69842-008	HUMAN OTC DRUG	Sore Mouth Cleanser		Hydrogen Peroxide	MOUTHWASH	TOPICAL	20120203		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	HYDROGEN PEROXIDE	150	mg/10mL			N	20241231
69842-010_913ae9ae-3319-4ac9-8fc6-04bc82caa4c4	69842-010	HUMAN OTC DRUG	naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20160315		ANDA	ANDA074661	CVS Pharmacy	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-014_92c1171e-08f2-492e-ae7b-d45efce0bbf4	69842-014	HUMAN OTC DRUG	Chest Congestion and Cough HBP		Dextromethorphan hydrobromide, Guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20170413		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-015_5dec7bb7-ac4f-43d4-b815-f48f0a612b8b	69842-015	HUMAN OTC DRUG	Childrens Antacid Extra Strength		Calcium carbonate	TABLET, CHEWABLE	ORAL	20160509		OTC MONOGRAPH FINAL	part331	CVS Pharmacy,Inc	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-017_e6e972a9-298c-488a-b9fc-2bcce75c289b	69842-017	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine Maleate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100615		ANDA	ANDA040829	CVS Pharmacy	CHLORPHENIRAMINE MALEATE	12	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-018_2d3aa9a0-cabc-4b4b-9acd-9723873a1a74	69842-018	HUMAN OTC DRUG	Daytime Congestion Pressure and Pain		acetaminophen, phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170413		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-021_869054ce-7c49-458f-95b0-7a042ed0adbb	69842-021	HUMAN OTC DRUG	SkinPharmacy Advanced Sun Therapy Broad Spectrum SPF 50 Face		homosalate, oxybenzone, octisalate, avobenzone, octocrylene	LIQUID	TOPICAL	20160401		OTC MONOGRAPH NOT FINAL	part352	CVS Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-022_60a54a3a-98ed-4ece-999a-75df89236947	69842-022	HUMAN OTC DRUG	SkinPharmacy Advanced Anti-Aging Therapy Retinol Day Moisturizer SPF 30		homosalate, octisalate, avobenzone, octocrylene, oxybenzone	LIQUID	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part352	CVS Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	20; 100; 50; 15; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-023_7792c247-8fcd-4031-9940-c226c9c79dff	69842-023	HUMAN OTC DRUG	SkinPharmacy Advanced Acne Therapy Spot Treatment		benzoyl peroxide	LIQUID	TOPICAL	20140601		OTC MONOGRAPH FINAL	part333D	CVS Health	BENZOYL PEROXIDE	50	mg/mL			N	20241231
69842-024_5a2b44c9-eb69-4c5d-9ade-f2783c4c3d7e	69842-024	HUMAN OTC DRUG	Nicotine Polacrilex	coated fruit	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079044	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-025_5a2b44c9-eb69-4c5d-9ade-f2783c4c3d7e	69842-025	HUMAN OTC DRUG	Nicotine Polacrilex	coated fruit	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079038	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-026_3643f618-f6f8-46f1-a01c-2f95655dd967	69842-026	HUMAN OTC DRUG	Nicotine Polacrilex	coated cinnamon	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079216	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-027_8d69a799-d39a-af02-6fab-2e8b9f832e3d	69842-027	HUMAN OTC DRUG	Omeprazole Magnesium		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20111101		ANDA	ANDA078878	CVS Health Corp.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-028_3643f618-f6f8-46f1-a01c-2f95655dd967	69842-028	HUMAN OTC DRUG	Nicotine Polacrilex	coated cinnamon	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA079219	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-029_0cf906b2-86d2-6289-e063-6394a90a6c9b	69842-029	HUMAN OTC DRUG	Lidocaine Pain Relief Roll-On		Lidocaine 4%	LIQUID	TOPICAL	20190605		OTC MONOGRAPH DRUG	M017	CVS Pharmacy	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-037_aec43528-68f6-4295-9247-6de49200bb29	69842-037	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20201223		ANDA	ANDA207229	CVS Pharmacy, Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
69842-052_704d6528-78b3-f58e-42d6-91175ceb49ea	69842-052	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20110401		ANDA	ANDA076502	CVS Health Corp.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-057_f6e98cea-f7c9-4fab-941a-e0f4024c2c05	69842-057	HUMAN OTC DRUG	Mucus DM Extended Release		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	CVS Pharmacy, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-058_dba58892-fd3f-44a7-ade6-17333844b05f	69842-058	HUMAN OTC DRUG	CVS Health Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	20100331		OTC MONOGRAPH FINAL	part347	CVS Health	ZINC OXIDE	400	mg/g			N	20241231
69842-059_f2662c89-3570-417e-adf0-6449ea8f9f1a	69842-059	HUMAN OTC DRUG	Maximum Strength Mucus DM Extended Release		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	CVS Pharmacy, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-060_540899f4-cc24-4b11-895b-addff93ccb7c	69842-060	HUMAN OTC DRUG	Antacid Extra Strength Wintergreen		Calcium carbonate	TABLET, CHEWABLE	ORAL	20150401		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-061_e6dd2b85-39ab-f7b4-e053-2995a90aa460	69842-061	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20181204		NDA	NDA021855	CVS Pharmacy, Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
69842-062_e7c23104-3edf-47b4-934f-b61aa7ae2f5e	69842-062	HUMAN OTC DRUG	CVS Pharmacy	Clotrimazole 3	Clotrimazole	CREAM	VAGINAL	20000412		NDA	NDA021143	CVS Pharmacy	CLOTRIMAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69842-063_7c1db656-788f-44fa-89af-aafa124ae0c0	69842-063	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20200203		ANDA	ANDA206531	CVS Pharmacy, Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
69842-064_7e7500ac-ddbd-4f11-bdea-5a0ba5f34096	69842-064	HUMAN OTC DRUG	SKIN PHARMACY ADVANCED ACNE THERAPY CLARIFYING DAILY CLEANSER		salicylic acid	LIQUID	TOPICAL	20140701		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/mL			N	20241231
69842-065_8381d820-c27a-48ef-9d01-e9540c49362e	69842-065	HUMAN OTC DRUG	CVS Zinc Oxide		Zinc Oxide	OINTMENT	TOPICAL	20140530		OTC MONOGRAPH FINAL	part347	CVS Health	ZINC OXIDE	200	mg/g			N	20241231
69842-066_aca57bce-04c3-47ee-ad55-0c0957e12453	69842-066	HUMAN OTC DRUG	SKINPHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACID		salicylic acid	LIQUID	TOPICAL	20140501		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/mL			N	20241231
69842-067_c6218db0-9871-4176-a9a8-f22485d60ee7	69842-067	HUMAN OTC DRUG	Age Renewal Firming and Hydrating Moisturizer SPF 30		octinoxate, octisalate, oxybenzone, titanium dioxide, zinc oxide	LOTION	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part352	CVS Health	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	60; 50; 40; 39; 20	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-068_baf4d896-375c-41e3-926f-739f09d72d84	69842-068	HUMAN OTC DRUG	Maximum Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20161213		OTC MONOGRAPH FINAL	part332	CVS PHARMACY, INC.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
69842-069_7ea6304f-4726-43ba-ae1c-1c2fb369c1bf	69842-069	HUMAN OTC DRUG	DAY Cold and Flu Plus and NIGHTTIME Cold and Flu Plus		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20161213		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.						N	20241231
69842-070_64c78614-cffb-4f8b-a371-3508efe03060	69842-070	HUMAN OTC DRUG	CVS Daytime COLD and FLU RELIEF and Nighttime COLD and FLU RELIEF		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, guaifenesin, phenylephrine hydrochloride	KIT		20161213		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.						N	20241231
69842-071_cf195dcc-7557-4b4e-bd8d-140ad35ffbe0	69842-071	HUMAN OTC DRUG	Maximum Strength Nighttime Cold/Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCI	CAPSULE, LIQUID FILLED	ORAL	20161214		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-072_95861d39-f88d-4c68-aa90-3fc440be8a80	69842-072	HUMAN OTC DRUG	STOOL SOFTENER DOCUSATE SODIUM 50 MG		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20161214		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY, INC.	DOCUSATE SODIUM	50	mg/1			N	20241231
69842-073_8911d415-855f-46c1-af23-1544f1d89c71	69842-073	HUMAN OTC DRUG	Pain Relief Extra Strength		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20161214		OTC MONOGRAPH NOT FINAL	part343	CVS PHARMACY, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
69842-075_4e80b344-df44-471e-bf7e-27ebcb09fe12	69842-075	HUMAN OTC DRUG	Regular Strength Pain Relief		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20161229		OTC MONOGRAPH NOT FINAL	part343	CVS PHARMACY, INC.	ACETAMINOPHEN	325	mg/1			N	20241231
69842-076_cfadec28-3acb-4c75-8489-1e3e3e798353	69842-076	HUMAN OTC DRUG	SkinPharmacy Advanced Acne Therapy Active Clearing		benzoyl peroxide	LIQUID	TOPICAL	20140601		OTC MONOGRAPH FINAL	part333D	CVS Health	BENZOYL PEROXIDE	25	mg/mL			N	20241231
69842-077_94fc9904-3118-4e9f-8e1f-a640f2cfbfa8	69842-077	HUMAN OTC DRUG	SKINPHARMACY ADVANCED ACNE THERAPY PORE REFINING FACIAL MASK		salicylic acid	LIQUID	TOPICAL	20160701		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	5	mg/mL			N	20241231
69842-078_76fd610d-0991-40ee-8492-2a00eb555223	69842-078	HUMAN OTC DRUG	Skin Pharmacy Advanced Sun Therapy Broad Spectrum SPF 30 Sun		Homosalate, Octisalate, Avobenzone, Oxybenzone, Octocrylene	LIQUID	TOPICAL	20160401		OTC MONOGRAPH NOT FINAL	part352	CVS Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 40; 40; 20; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-079_551d728f-ceca-4e0f-a46c-5055e1090b2b	69842-079	HUMAN OTC DRUG	SkinPharmacy Advanced Anti-Aging Therapy Glycolic Day Moisturizer SPF 30		homosalate, octisalate, avobenzone, octocrylene, oxybenzone	LOTION	TOPICAL	20141001		OTC MONOGRAPH NOT FINAL	part352	CVS Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-080_16872f78-fbf7-4de9-b9f3-6f5361bd3dfd	69842-080	HUMAN OTC DRUG	Beauty 360 Accelerated Wrinkle Repair Moisturizer		homosalate, octisalate, avobenzone, octocrylene	LIQUID	TOPICAL	20170401		OTC MONOGRAPH NOT FINAL	part352	CVS Health	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-081_d00668ab-878f-41cf-b6b4-22adeb50e99b	69842-081	HUMAN OTC DRUG	SkinPharmacy Advanced Acne Therapy	Targeted Treatment Wipes	benzoyl peroxide	SWAB	TOPICAL	20140501		OTC MONOGRAPH FINAL	part333D	CVS Health	BENZOYL PEROXIDE	25	mg/mL			N	20241231
69842-082_80cecb53-6a09-4802-95fd-8d4130be8aa7	69842-082	HUMAN OTC DRUG	SkinPharmacy Advanced Acne Therapy Kit		salicylic acid, benzoyl peroxide	KIT	TOPICAL	20141001		OTC MONOGRAPH FINAL	part333D	CVS Health						N	20241231
69842-083_51e197be-8f55-40e7-ba69-f81ba388c08e	69842-083	HUMAN OTC DRUG	Sport Sunstick SPF 30 Sunscreen		avobenzone, octinoxate, octisalate	STICK	TOPICAL	20170401		OTC MONOGRAPH NOT FINAL	part352	CVS Health	AVOBENZONE; OCTINOXATE; OCTISALATE	20; 75; 30	mg/g; mg/g; mg/g			N	20241231
69842-084_f2292312-16c8-28d6-e053-2995a90a3c18	69842-084	HUMAN OTC DRUG	Benzethonium Chloride and Dyclonine Hydrochloride		Liquid Bandage	LIQUID	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/10mL; mg/10mL			N	20241231
69842-085_580a1e22-4b2a-4b87-a799-066a11bc7818	69842-085	HUMAN OTC DRUG	Loratadine ODT		Loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20180411		ANDA	ANDA208477	CVS Pharmacy, Inc.	LORATADINE	10	mg/1			N	20241231
69842-086_840d217a-3427-46db-8f2e-28f814dde95f	69842-086	HUMAN OTC DRUG	Nighttime HBP Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20201204		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-087_fe9a2cc4-b5bc-4941-a4a1-040f4c5393bd	69842-087	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20200203		ANDA	ANDA206531	CVS Pharmacy, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
69842-088_6a3d0823-a715-4ab0-8dcf-d5390f4cef82	69842-088	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20190801		ANDA	ANDA091314	CVS Pharmacy	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
69842-089_ad9f82c7-c0d4-9ca7-e053-2a95a90a391a	69842-089	HUMAN OTC DRUG	WOMENS GENTLE LAXATIVE		BISACODYL	TABLET, COATED	ORAL	20200824		OTC MONOGRAPH NOT FINAL	part334	CVS HEALTH CORP	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-091_db8be0b3-c560-7200-e053-2995a90aaac7	69842-091	HUMAN OTC DRUG	CVS Medicated Heat		Capsicum Extract	PATCH	TOPICAL	20190213		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	CAPSICUM	.025	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
69842-092_061cf29a-2116-4ec4-be03-68d22da02b3e	69842-092	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine HCl		Ibuprofen and Pseudoephedrine HCl	CAPSULE, LIQUID FILLED	ORAL	20171201		ANDA	ANDA209235	CVS Pharmacy, Inc.	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-093_6d2d12fa-f4f2-494e-a20f-e887a56f35c8	69842-093	HUMAN OTC DRUG	Acetaminophen	Extended Release	Acetaminophen	TABLET	ORAL	20200401	20250430	ANDA	ANDA207035	CVS Pharmacy	ACETAMINOPHEN	650	mg/1			N	
69842-095_4c9c1b28-0e68-0ea3-34ad-4b880907ba9d	69842-095	HUMAN OTC DRUG	Mucus D		Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg	TABLET, EXTENDED RELEASE	ORAL	20200701		ANDA	ANDA208369	CVS Health Corp	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-096_0d9ae9cc-a0ca-e3ad-e063-6394a90aa4d9	69842-096	HUMAN OTC DRUG	Earwax Removal Drops		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20190605	20240531	OTC MONOGRAPH DRUG	M014	CVS Pharmacy	CARBAMIDE PEROXIDE	.065	mg/mL			N	
69842-097_0cf923ef-4234-8454-e063-6294a90afe9c	69842-097	HUMAN OTC DRUG	Ear Drops		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20190604		OTC MONOGRAPH DRUG	M017	CVS Pharmacy	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
69842-098_0cf923ef-4235-8454-e063-6294a90afe9c	69842-098	HUMAN OTC DRUG	CVS Ear Drops for Swimmers		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20080101		OTC MONOGRAPH DRUG	M014	CVS Pharmacy	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
69842-101_ec58966f-c22a-38a1-e053-2a95a90ae7e0	69842-101	HUMAN OTC DRUG	CVS Health	Ultra Protection SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170109		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-102_ecfd05ba-5b62-178b-e053-2995a90a9746	69842-102	HUMAN OTC DRUG	CVS Health	Ultra Protection SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20170109		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-103_ecfeaff7-d5ae-99f6-e053-2995a90a1ef6	69842-103	HUMAN OTC DRUG	CVS Health	Sport SPF 50 Sun	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-104_d5569df5-a295-5c4b-e053-2a95a90a1201	69842-104	HUMAN OTC DRUG	CVS Health	Sport SPF 30 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-105_c702ff24-2b64-515f-e053-2995a90a31a3	69842-105	HUMAN OTC DRUG	CVS Health	SPF 15 Clear	Avobenzone, Homosalate, Octisalate, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20150421		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-106_ed0d6771-6e20-1ebc-e053-2a95a90ab36c	69842-106	HUMAN OTC DRUG	CVS Health	Sport SPF 15 Clear	Avobenzone, Homosalate, Octisalate, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-107_ed0df233-ddf2-b405-e053-2a95a90a387c	69842-107	HUMAN OTC DRUG	CVS Health	Aftersun Aloe Vera Cooling	Lidocaine	GEL	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	LIDOCAINE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-108_d61d2451-59ce-3f00-e053-2995a90aa6c8	69842-108	HUMAN OTC DRUG	CVS Pharmacy	Kids SPF 50 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20061122		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-109_ed0e2c19-b4d0-9c69-e053-2995a90a8560	69842-109	HUMAN OTC DRUG	CVS Health	Baby SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-110_b791ad13-78af-d227-e053-2a95a90a89fe	69842-110	HUMAN OTC DRUG	CVS Health	SPF 50 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170428		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-111_ed0ea246-982b-7940-e053-2995a90aa637	69842-111	HUMAN OTC DRUG	CVS Health	SPF 30 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-112_c5ef35d8-36ad-c533-e053-2995a90aefc5	69842-112	HUMAN OTC DRUG	CVS Health	SPF 55 Ultra Sheer	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20120323		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-113_ed10d16f-1e1b-42fe-e053-2a95a90a149d	69842-113	HUMAN OTC DRUG	CVS Health	SPF 30 Oil Free Sun	Avobenzone, Homosalate, Octinoxate, Octisalate	STICK	TOPICAL	20151026		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	20; 150; 75; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
69842-114_f0cb4699-e643-e01a-e053-2995a90a06c6	69842-114	HUMAN OTC DRUG	CVS Health	Sport SPF 50 Face	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-115_c67acea8-4f6c-105d-e053-2995a90ac5c1	69842-115	HUMAN OTC DRUG	CVS Health	SPF 70 Sheer Mist	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170119		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	300; 1500; 500; 400; 600	mg/10g; mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-116_b79cff79-f7a5-d946-e053-2a95a90a2756	69842-116	HUMAN OTC DRUG	CVS Health	Sport SPF 50 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170306		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-118_ed3964cc-0140-39cb-e053-2a95a90a78c1	69842-118	HUMAN OTC DRUG	CVS Health	SPF 30 Ultra Sheer	Avobenzone, Homosalate, Octinoxate, Octisalate, Oxybenzone	LOTION	TOPICAL	20170124		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	20; 70; 75; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-119_ed39baca-bbbe-14f1-e053-2a95a90a50a7	69842-119	HUMAN OTC DRUG	CVS Health	Age Defense SPF 70 Face	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-120_ec6d0cc7-ede3-df6e-e053-2a95a90a5786	69842-120	HUMAN OTC DRUG	CVS Health	SPF 45 Sheer Mist	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20160419		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	300; 1500; 500; 235; 600	mg/10g; mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-121_ec6dbf5a-8bab-2573-e053-2a95a90a20f1	69842-121	HUMAN OTC DRUG	CVS Health	Acne Fighting Moisturizer	Salicylic Acid	LOTION	TOPICAL	20170201		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy	SALICYLIC ACID	5	mg/mL			N	20241231
69842-122_ed39cd5d-5510-2be7-e053-2a95a90a8a51	69842-122	HUMAN OTC DRUG	CVS Health	SPF 45 Ultra Sheer	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 28; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-123_ed3a5fbc-c05e-dde9-e053-2995a90aac9e	69842-123	HUMAN OTC DRUG	CVS Health	60 Plus Sensitive Skin Sun	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	TITANIUM DIOXIDE; ZINC OXIDE	49.39; 47.145	mg/mL; mg/mL			N	20241231
69842-124_f17712f9-5498-c17d-e053-2a95a90a1ff9	69842-124	HUMAN OTC DRUG	CVS Pharmacy	Kids SPF 70 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20090828		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-125_f035731e-c2f8-59c9-e053-2a95a90a8137	69842-125	HUMAN OTC DRUG	CVS Health	SPF 100 Ultra Sheer	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-127_f1763bc1-dea1-e5ff-e053-2995a90a316f	69842-127	HUMAN OTC DRUG	CVS Health	SPF 70 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-129_f036cdff-ab76-5b70-e053-2995a90ae476	69842-129	HUMAN OTC DRUG	CVS Health	Sport SPF 70 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-130_c62b7fa0-5ada-276c-e053-2995a90ade25	69842-130	HUMAN OTC DRUG	CVS Health	Sport SPF 100 Plus Clear	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 20; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-131_f0464c7d-3e58-34bd-e053-2995a90a97da	69842-131	HUMAN OTC DRUG	CVS Health	SPF 100 Clear	Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 20; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-132_f05f2b96-79d5-6c12-e053-2a95a90a80c9	69842-132	HUMAN OTC DRUG	CVS Health	Ultra Protection SPF 100	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-133_f049930d-dcc0-4762-e053-2a95a90ae747	69842-133	HUMAN OTC DRUG	CVS Pharmacy	Beauty 360 SPF 15 7-in-1 Complete Daily Moisturizer	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20151218		OTC MONOGRAPH FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 50; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-134_c6a3f429-e95d-0b00-e053-2995a90aee88	69842-134	HUMAN OTC DRUG	CVS Health	Childrens SPF 70 Plus Wet and Dry	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-135_c6a3e121-302c-9443-e053-2995a90a254a	69842-135	HUMAN OTC DRUG	CVS Pharmacy	SPF 30 Wet and Dry	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 80; 40; 80; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-136_c6a3f320-3a44-ed31-e053-2995a90a7366	69842-136	HUMAN OTC DRUG	CVS Health	SPF 85 Wet and Dry	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-138_f05dffc1-20bf-ddd6-e053-2995a90aab21	69842-138	HUMAN OTC DRUG	CVS Health	Baby SPF 50 Sun	Octinoxate, Octisalate, Zinc Oxide	LOTION	TOPICAL	20160309		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 145	mg/mL; mg/mL; mg/mL			N	20241231
69842-139_ec83a377-c026-8d08-e053-2a95a90a9f0b	69842-139	HUMAN OTC DRUG	CVS Health	AM Moisturizing Facial	Homosalate, Octinoxate, Zinc Oxide, Octocrylene	LOTION	TOPICAL	20170203		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	HOMOSALATE; OCTINOXATE; OCTOCRYLENE; ZINC OXIDE	120; 75; 20; 35	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-140_f0c88788-5604-2ed9-e053-2a95a90a09d5	69842-140	HUMAN OTC DRUG	CVS Health	Sport SPF 50 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene,	AEROSOL, SPRAY	TOPICAL	20170505		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-141_f0c981ce-4ac4-d936-e053-2995a90abb56	69842-141	HUMAN OTC DRUG	CVS Health	Sport SPF 30 Clear	Avobenzone, Homosalate, Octocrylene,	AEROSOL, SPRAY	TOPICAL	20160127		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	20; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
69842-142_c6a3f429-e970-0b00-e053-2995a90aee88	69842-142	HUMAN OTC DRUG	CVS Health	SPF 50 Vanishing Zinc Sun	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20170203		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	TITANIUM DIOXIDE; ZINC OXIDE	49; 47	mg/g; mg/g			N	20241231
69842-143_f04a14db-269c-efc4-e053-2995a90a6323	69842-143	HUMAN OTC DRUG	CVS Health	SPF 50 Vanishing Zinc Sun Face	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20160208		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	TITANIUM DIOXIDE; ZINC OXIDE	50.6; 48.3	mg/g; mg/g			N	20241231
69842-144_b779660f-7269-380b-e053-2a95a90a2627	69842-144	HUMAN OTC DRUG	CVS Pharmacy	SPF 30 Beach Guard Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170505		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	300; 800; 400; 200; 500	mg/10g; mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-145_b78f9cb2-56fd-2741-e053-2995a90a85ae	69842-145	HUMAN OTC DRUG	CVS Pharmacy	SPF 70 Beach Guard Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170505		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	300; 1500; 500; 400; 600	mg/10g; mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-146_ecacbcfa-a637-f23c-e053-2a95a90a810e	69842-146	HUMAN OTC DRUG	CVS Pharmacy	SPF 30 Beach Guard Sun	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20170316		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 80; 50; 35; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-147_f04ad2c4-42f8-3f3b-e053-2995a90a0b47	69842-147	HUMAN OTC DRUG	CVS Health	Sport SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-148_c57651d5-30cb-52dd-e053-2995a90ae79b	69842-148	HUMAN OTC DRUG	CVS Health	SPF 70 Beach Guard Sun	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20141003		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 45; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-149_df2595d6-ec57-602b-e053-2995a90af4c4	69842-149	HUMAN OTC DRUG	CVS Pharmacy	SPF 50 Beach Guard Sun	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	STICK	TOPICAL	20151030		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-151_dfc50b73-ad82-0976-e053-2995a90afc2f	69842-151	HUMAN OTC DRUG	CVS Health	SPF 30 Sheer Mist	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20170504		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	300; 800; 400; 235; 500	mg/10g; mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-152_f058f476-eab3-4287-e053-2995a90ad7e0	69842-152	HUMAN OTC DRUG	CVS Health	SPF 30 Coconut Scented Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20161219		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-153_f04af359-b53c-4f3a-e053-2995a90a5ddd	69842-153	HUMAN OTC DRUG	CVS Health	SPF 50 Coconut Scented Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20161219		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-155_f2d069a5-01ea-4533-bdf2-0c6c8cfd01a7	69842-155	HUMAN OTC DRUG	CVS Health Hydrocortisone Anti Itch		Hydrocortisone	CREAM	TOPICAL	20170428		OTC MONOGRAPH NOT FINAL	part348	CVS Health	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-156_16494bb9-6e26-4d17-81c3-114ccda788f4	69842-156	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20180205		OTC MONOGRAPH FINAL	part338	CVS PHARMACY, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-157_c708aa55-92bb-2f89-e053-2995a90ac176	69842-157	HUMAN OTC DRUG	CVS Health	Ultra Protection SPF 70	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20151026		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-158_b841f513-8c1a-4361-9068-9ce18c49543e	69842-158	HUMAN OTC DRUG	Day and Night Severe Sinus Congestion and Cough	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20180208		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.						N	20241231
69842-159_aabd3dea-bc1e-46fd-800b-35b559dc6f91	69842-159	HUMAN OTC DRUG	CVS A and D All-Purpose Skin Protectant		All-Purpose Skin Protectant	OINTMENT	TOPICAL	20110211		OTC MONOGRAPH FINAL	part347	CVS Health	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
69842-160_ffda3815-4e95-4c21-8491-e88f2a74e2f6	69842-160	HUMAN OTC DRUG	Childrens Pain Relief		Acetaminophen	TABLET, CHEWABLE	ORAL	20171101		OTC MONOGRAPH DRUG	M013	CVS Pharmacy,Inc.	ACETAMINOPHEN	160	mg/1			N	20251231
69842-161_5cc951e4-45bd-4c40-9d78-95f8233e7002	69842-161	HUMAN OTC DRUG	CVS Health Triple Antibiotic with Pain Relief		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate and Pramoxine HCL	OINTMENT	TOPICAL	20170428		OTC MONOGRAPH FINAL	part333B	CVS Health	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-162_7cf7e6a3-9aac-45ce-8e26-3ab9bb349aee	69842-162	HUMAN OTC DRUG	CVS Health Triple Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate	OINTMENT	TOPICAL	20170428		OTC MONOGRAPH FINAL	part333B	CVS Health	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-163_2295c6b6-1473-4b34-82c6-f069d1bd6aaf	69842-163	HUMAN OTC DRUG	CVS Health Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20170428		OTC MONOGRAPH FINAL	part333B	CVS Health	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
69842-164_f40ecb2a-cc3f-2b8a-e053-2a95a90a2908	69842-164	HUMAN OTC DRUG	CVS Health	SPF 70 Sun	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20180126		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-166_b766068a-d4af-452a-9838-1db86127026d	69842-166	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20180208		OTC MONOGRAPH FINAL	part332	CVS PHARMACY, INC.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
69842-168_b0133bb3-d20d-4c8c-b1f8-a68126eb2a14	69842-168	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20180716		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	500	mg/1			N	20241231
69842-169_468f2bab-b388-4bfc-af88-abacdd46a129	69842-169	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180212		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY, INC.	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-170_93b69773-9d11-4080-9618-d5df0ddc0b20	69842-170	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180213		ANDA	ANDA206568	CVS PHARMACY, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-171_ce8cfb77-e2d9-42a6-985c-534591993edb	69842-171	HUMAN OTC DRUG	Ultra Strength Antacid		Calcium Antacid	TABLET, CHEWABLE	ORAL	20111209		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-172_16c744c8-fe46-4bb4-b272-1a51095acda0	69842-172	HUMAN OTC DRUG	Stomach relief		Bismuth subsalicylate	TABLET	ORAL	20110808		OTC MONOGRAPH FINAL	part335	CVS	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
69842-173_e974ee4d-e008-4907-b46a-b088fa6f153a	69842-173	HUMAN OTC DRUG	Extra Strength Smooth Antacid Assorted Fruit		Calcium antacid	TABLET, CHEWABLE	ORAL	20141103		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-174_33029659-6c90-43de-9010-80f241098621	69842-174	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20210126		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/20mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-175_f1196d05-c03e-3f52-e053-2a95a90a0208	69842-175	HUMAN OTC DRUG	CVS Health	Sport SPF 100 Clear	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20171218		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-176_d4d86ad7-5982-c346-e053-2a95a90a3164	69842-176	HUMAN OTC DRUG	CVS Health	SPF 55 Clear Face	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20180104		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 40; 45; 60; 45	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-177_c50f6097-33ca-0b8a-e053-2995a90a6328	69842-177	HUMAN OTC DRUG	CVS Health	SPF 70 Ultra Sheer	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20180312		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-178_b7a5b305-3eae-077b-e053-2a95a90a30a1	69842-178	HUMAN OTC DRUG	CVS Health	Baby SPF 50 Mineral-Based Sun	Octinoxate, Octisalate, Zinc Oxide	LOTION	TOPICAL	20180309		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 145	mg/mL; mg/mL; mg/mL			N	20241231
69842-182_291b103c-e5d5-4393-8692-25b5e1b6d639	69842-182	HUMAN OTC DRUG	cooling severe daytime		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20190620		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-184_3052bc73-94ed-4b29-9672-65a48a393d6e	69842-184	HUMAN OTC DRUG	Antacid Extra Strength Assorted Berry		Calcium carbonate	TABLET, CHEWABLE	ORAL	20150401		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-185_f228ee7d-c4c8-e363-e053-2a95a90aeefb	69842-185	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20180731		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	TOLNAFTATE	1.5	g/150g			N	20241231
69842-187_f3f9f5c5-c0b4-469f-b867-1eec53e07fce	69842-187	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
69842-188_51ba46a4-5adc-4aad-a0d1-342a833e89cc	69842-188	HUMAN OTC DRUG	Baby Eczema Therapy		Colloidal oatmeal	CREAM	TOPICAL	20201201		OTC MONOGRAPH FINAL	part347	CVS	OATMEAL	10.4	kg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69842-191_d6b953cd-40ee-49ee-9890-486e10d29791	69842-191	HUMAN OTC DRUG	Loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20180628		ANDA	ANDA091292	CVS Pharmacy	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
69842-192_efe74b5d-d515-6be9-e053-2995a90aec23	69842-192	HUMAN OTC DRUG	Anti-Itch Regular Strength		Hydrocortisone	CREAM	TOPICAL	20200302		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	HYDROCORTISONE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-194_56b940ee-d513-463b-ac30-e9a0e72ac749	69842-194	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	20190715		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-195_b566de65-d8ca-8e97-e053-2995a90a10cd	69842-195	HUMAN OTC DRUG	MAXIMUM STRENGTH LAXATIVE		SENNOSIDES	TABLET, COATED	ORAL	20201201		OTC MONOGRAPH NOT FINAL	part334	CVS HEALTH	SENNOSIDES	25	mg/1			N	20241231
69842-196_f229159f-5990-e603-e053-2995a90ab0c3	69842-196	HUMAN OTC DRUG	Tolnaftate		Antifungal Athlete Foot Cream to Powder Tolnaftate	CREAM	TOPICAL	20210415		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	TOLNAFTATE	.15	g/15g			N	20241231
69842-199_2a4f54ea-dfd6-4b82-b904-7d3e6b3443d3	69842-199	HUMAN OTC DRUG	Antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20160804		OTC MONOGRAPH FINAL	part333B	CVS Pharmacy	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-201_f229259d-846f-32ae-e053-2995a90a9b26	69842-201	HUMAN OTC DRUG	Salicylic Acid		Gel Corn Remover	PATCH	TOPICAL	20180731		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/61			N	20241231
69842-202_f2291abd-fc0a-2720-e053-2a95a90ad3a2	69842-202	HUMAN OTC DRUG	Salicylic Acid		Gel Callus Remover	PATCH	TOPICAL	20180731		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/41			N	20241231
69842-205_1171e561-e905-4504-af17-75edfb5e988f	69842-205	HUMAN OTC DRUG	cold flu and sore throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20180626		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-206_d114c3af-521e-a2e8-e053-2a95a90a0151	69842-206	HUMAN OTC DRUG	Dimenhydrinate		Dimenhydrinate	TABLET	ORAL	20180703		OTC MONOGRAPH FINAL	part336	CVS Pharmacy, Inc.	DIMENHYDRINATE	50	mg/1			N	20241231
69842-207_0cf9243f-d986-5d7d-e063-6394a90a6a9f	69842-207	HUMAN OTC DRUG	CVS Decolorized Iodine		Alcohol	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	CVS Pharmacy	ALCOHOL	.48	mL/mL			N	20241231
69842-211_3211160c-b403-c103-be6c-14fe09d47a5c	69842-211	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA208369	CVS Health Corp	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-213_0cf9243f-d987-5d7d-e063-6394a90a6a9f	69842-213	HUMAN OTC DRUG	CVS Iodine		Iodine, Sodium Iodide and Alcohol	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	CVS Pharmacy	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
69842-216_04909347-d1ee-44d4-90b3-1e20f20e41aa	69842-216	HUMAN OTC DRUG	Nicotine Polacrilex	coated ice mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20160501		ANDA	ANDA204794	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-217_04909347-d1ee-44d4-90b3-1e20f20e41aa	69842-217	HUMAN OTC DRUG	Nicotine Polacrilex	coated ice mint	Nicotine Polacrilex Gum	GUM, CHEWING	BUCCAL	20160501		ANDA	ANDA204833	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-218_f32d88fe-ea78-2ddb-e053-2995a90a497c	69842-218	HUMAN OTC DRUG	CVS Restore and Defend Sensitive	Whitening	Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190211		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	STANNOUS FLUORIDE	.454	g/100g			N	20241231
69842-220_c447ed19-7c43-22d2-e053-2a95a90aaae6	69842-220	HUMAN OTC DRUG	SENNOSIDES		SENNOSIDES	TABLET, FILM COATED	ORAL	20180703		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy, Inc.	SENNOSIDES	8.6	mg/1			N	20241231
69842-221_f7fe56d0-9e85-4bed-a9be-99ab5fb07b9f	69842-221	HUMAN OTC DRUG	CVS Health Stomach relief	Cherry Flavor	Bismuth Subsalicylate	TABLET, CHEWABLE	ORAL	20190319		OTC MONOGRAPH FINAL	part335	CVS PHARMACY,INC.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
69842-227_b0cfbaab-3d51-4192-9553-b5401e2363dc	69842-227	HUMAN OTC DRUG	Stomach Relief	regular strength	Bismuth subsalicylate	LIQUID	ORAL	20190131		OTC MONOGRAPH FINAL	part335	CVS Pharmacy	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
69842-228_a6c6350f-dc7f-245c-bcbb-8c20e720b408	69842-228	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20200311		ANDA	ANDA208150	CVS Pharmacy	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-229_cdb4ed23-fb96-440c-984c-a1ebcd2f390a	69842-229	HUMAN OTC DRUG	Stomach Relief	Maximum Strength	Bismuth subsalicylate	LIQUID	ORAL	20200131		OTC MONOGRAPH DRUG	M008	CVS Pharmacy	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20251231
69842-234_c4f1154b-b7cd-4ba1-a94e-7fd476d4ce3e	69842-234	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20200911		ANDA	ANDA213557	CVS Pharmacy, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-235_f2291d69-a3b0-2a6c-e053-2995a90ad8ad	69842-235	HUMAN OTC DRUG	Itch Relief		Diphenhydramine HCl and Zinc Acetate	AEROSOL, SPRAY	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1.5; .076	g/76g; g/76g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-236_f2296788-53b5-7157-e053-2a95a90a5e16	69842-236	HUMAN OTC DRUG	Burn Relief		Lidocaine	AEROSOL, SPRAY	TOPICAL	20190201		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-237_6b0eaece-8dca-4d44-b2fb-a650f1cfad0f	69842-237	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20190726		ANDA	ANDA090760	CVS Pharmacy, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-238_0cf938d0-a50b-841b-e063-6394a90a3131	69842-238	HUMAN OTC DRUG	CVS Mineral Oil		Mineral Oil	LIQUID	ORAL	20200131		OTC MONOGRAPH DRUG	M007	CVS	MINERAL OIL	1000	mg/mL			N	20241231
69842-240_0370bbfc-c5a8-66e7-e063-6294a90acee1	69842-240	HUMAN OTC DRUG	CVS Alcohol Swabsticks		Isopropyl Alcohol	SWAB	TOPICAL	20210401	20251231	OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	ISOPROPYL ALCOHOL	70	mL/100mL			N	
69842-242_c20d242b-5d25-4a2f-9429-d6bd1d976772	69842-242	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190826		ANDA	ANDA208314	CVS Pharmacy, Inc.	LORATADINE	10	mg/1			N	20241231
69842-243_ddbf21d9-24eb-32c8-e053-2995a90a43d1	69842-243	HUMAN OTC DRUG	CVS Cold and Hot		Menthol	PATCH	TOPICAL	20201002		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	MENTHOL	50	mg/1			N	20241231
69842-245_f0369265-d688-a665-e053-2995a90a09b9	69842-245	HUMAN OTC DRUG	CVS Cold and Hot		Menthol	PATCH	TOPICAL	20201002		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	MENTHOL	50	mg/1			N	20241231
69842-248_9f5258ba-e377-4ef5-ad0e-4868eef60210	69842-248	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190709		ANDA	ANDA209339	CVS Pharmacy, Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-249_e441b034-f450-a8e3-e9c0-9d93f884c742	69842-249	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCI		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20190719		ANDA	ANDA076667	CVS Pharmacy	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-250_b43b52f5-6cd6-c4c2-e053-2a95a90aa368	69842-250	HUMAN OTC DRUG	CVS Health Lice Killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20101028		OTC MONOGRAPH FINAL	part358G	CVS	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
69842-251_f32d8ebf-9660-2ed4-e053-2995a90abe6a	69842-251	HUMAN OTC DRUG	CVS Pharmacy	Restore and Defend	Fluoride	PASTE, DENTIFRICE	DENTAL	20141001		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	STANNOUS FLUORIDE	.454	g/100g			N	20241231
69842-252_f32d8f4b-3cae-0a84-e053-2995a90a49f1	69842-252	HUMAN OTC DRUG	CVS Rapid Protection Sensitive		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20190207		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	STANNOUS FLUORIDE	.454	g/100g			N	20241231
69842-253_f32d9da8-b881-433f-e053-2995a90a6290	69842-253	HUMAN OTC DRUG	CVS Pharmacy	Dry Mouth	Fluoride	PASTE, DENTIFRICE	DENTAL	20151001		OTC MONOGRAPH FINAL	part355	CVS Pharmacy	SODIUM FLUORIDE	.243	g/100g			N	20241231
69842-255_0c05a2e7-eb57-2619-e063-6294a90a35c7	69842-255	HUMAN OTC DRUG	CVS 3 Step Lice Solution		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20140103		OTC MONOGRAPH DRUG	M031	CVS						N	20241231
69842-255_0c065bee-86a8-e5d7-e063-6294a90a15dd	69842-255	HUMAN OTC DRUG	CVS 3 Step Lice Solution		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20101028		OTC MONOGRAPH DRUG	M031	CVS						N	20241231
69842-256_0c18fedf-07d3-e2dc-e063-6294a90adc53	69842-256	HUMAN OTC DRUG	CVS Vapor Steam		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20111102		OTC MONOGRAPH DRUG	M012	CVS	CAMPHOR (SYNTHETIC)	.623	g/10mL			N	20241231
69842-257_c4fde69f-86e3-25b4-e053-2995a90acd71	69842-257	HUMAN OTC DRUG	CVS CHILDRENS BABYS SPF50		Titanium Dioxide, Zinc oxide	LOTION	TOPICAL	20161115		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	TITANIUM DIOXIDE; ZINC OXIDE	31; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-258_f086a5bf-48b6-919b-e053-2995a90ab245	69842-258	HUMAN OTC DRUG	Infants Pain and Fever		ACETAMINOPHEN	SOLUTION	ORAL	20181228	20240228	OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	
69842-263_87fc1214-a21c-32df-e053-2995a90a72e4	69842-263	HUMAN OTC DRUG	CVS Anti-Itch		Pramoxine HCL	LOTION	TOPICAL	20160414		OTC MONOGRAPH NOT FINAL	part348	CVS	PRAMOXINE HYDROCHLORIDE	1	g/100g			N	20241231
69842-264_c0aec685-4037-4e5f-abab-2814ae318862	69842-264	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20160819		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-265_0c531457-76c7-6d06-e063-6394a90abb0d	69842-265	HUMAN OTC DRUG	CVS Medicated anti itch		Pramoxine hydrochloride, menthol	CREAM	TOPICAL	20140413		OTC MONOGRAPH DRUG	M017	CVS	MENTHOL; PRAMOXINE HYDROCHLORIDE	1; 1	g/100g; g/100g			N	20241231
69842-266_3f8c03a2-d0bc-71f3-4f53-4d5a3453f198	69842-266	HUMAN OTC DRUG	Acid Controller	Original Strength	Famotidine	TABLET	ORAL	20201001		ANDA	ANDA077367	CVS Health Corp	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69842-267_3f8c03a2-d0bc-71f3-4f53-4d5a3453f198	69842-267	HUMAN OTC DRUG	Acid Controller	Maximum Strength	Famotidine	TABLET	ORAL	20201001		ANDA	ANDA077367	CVS Health Corp	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69842-268_9a99b420-f017-3545-a253-d126b9d8f7c9	69842-268	HUMAN OTC DRUG	CVS Eye Allergy Itch Relief	Twice Daily	Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200920		ANDA	ANDA209619	CVS Health Corp	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
69842-269_ed94036e-3b0e-ab4c-02d4-5e9125fc045a	69842-269	HUMAN OTC DRUG	CVS Eye Allergy Itch Relief	Once Daily	Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20200920		ANDA	ANDA209752	CVS Health Corp	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
69842-270_2a96a3ac-62d1-9b8b-7846-df7af17f82ae	69842-270	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20201223		ANDA	ANDA202194	CVS Health Corp	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-271_4843cda5-1e50-4369-84fd-25d0fdc0a475	69842-271	HUMAN OTC DRUG	Ultra Strength Antacid Assorted Berries		Calcium carbonate	TABLET, CHEWABLE	ORAL	20111209		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-274_f228f1c0-fcc0-2dfd-e053-2995a90a205b	69842-274	HUMAN OTC DRUG	Tolnaftate		Toe Area Treatment	LIQUID	TOPICAL	20210201		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	TOLNAFTATE	.3	g/30mL			N	20241231
69842-275_78d5dd08-d712-41b8-9bb6-4138306db975	69842-275	HUMAN OTC DRUG	Eye Itch Relief		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20200401		NDA	NDA021996	CVS Pharmacy	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
69842-276_adc04b9d-ae8b-422c-8dbf-9820cdde9c3a	69842-276	HUMAN OTC DRUG	Colloidal oatmeal		Colloidal oatmeal	CREAM	TOPICAL	20200624		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	OATMEAL	10.4	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69842-277_f1350304-e58d-4214-dc0e-bcede211a3d0	69842-277	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190102		ANDA	ANDA207673	CVS Pharmacy	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-278_09078c35-a634-db7f-e063-6394a90ae2d1	69842-278	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	LIQUID	ORAL	20150701		OTC MONOGRAPH DRUG	M007	CVS	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-280_f0499ffa-cbfa-43c7-98c5-36f7ff13e424	69842-280	HUMAN OTC DRUG	CVS Health Extra Strength	Sugar Free	Antacid	TABLET, CHEWABLE	ORAL	20201019		OTC MONOGRAPH FINAL	part331	CVS PHARMACY, INC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69842-284_b6a78ec5-e645-443e-b525-3f9f7591f60e	69842-284	HUMAN OTC DRUG	Sodium Chloride Hypertonicity		sodium chloride	SOLUTION	OPHTHALMIC	20200501		OTC MONOGRAPH FINAL	part349	CVS Pharmacy	SODIUM CHLORIDE	50	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
69842-285_7f3b23e6-ecb8-44b2-9e66-71deb246bc35	69842-285	HUMAN OTC DRUG	Sodium Chloride Hypertonicity		sodium chloride	OINTMENT	OPHTHALMIC	20200501		OTC MONOGRAPH FINAL	part349	CVS PHARMACY	SODIUM CHLORIDE	50	mg/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
69842-286_09077980-a69e-3bc0-e063-6294a90a436a	69842-286	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20150601		OTC MONOGRAPH DRUG	M001	CVS	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-289_c50d0b8b-212c-35a7-e053-2995a90aca3a	69842-289	HUMAN OTC DRUG	CVS CHILDRENS BABYS SPF50		Titanium Dioxide, Zinc oxide	LOTION	TOPICAL	20181031		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	TITANIUM DIOXIDE; ZINC OXIDE	31; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-292_884d6853-556b-fd3f-e053-2995a90aeb3e	69842-292	HUMAN OTC DRUG	CVS Anti itch		HYDROCORTISONE	CREAM	TOPICAL	20130210		OTC MONOGRAPH NOT FINAL	part348	CVS	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-294_f22910c2-a493-3670-e053-2a95a90a2047	69842-294	HUMAN OTC DRUG	Salicylic Acid		Hydrogel Clear Wart Remover	PATCH	TOPICAL	20200201		OTC MONOGRAPH FINAL	part358F	CVS Pharmacy	SALICYLIC ACID	40	mg/121			N	20241231
69842-295_0ce28410-686b-2791-e063-6294a90ac0f5	69842-295	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230303		OTC MONOGRAPH DRUG	M013	CVS PHARMACY, INC	ACETAMINOPHEN	500	mg/1			N	20241231
69842-296_0907ea6f-327f-c57c-e063-6294a90a7e79	69842-296	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID MINT		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20150601		OTC MONOGRAPH DRUG	M001	CVS	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-297_0ce04f85-f00e-4b7b-e063-6394a90a4eb5	69842-297	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200130		ANDA	ANDA211544	CVS PHARMACY iNC	ACETAMINOPHEN	650	mg/1			N	20241231
69842-298_04020582-1e29-0e5d-e063-6394a90a3b90	69842-298	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20190401		OTC MONOGRAPH DRUG	M013	CVS PHARMACY, INC	ACETAMINOPHEN	500	mg/1			N	20241231
69842-299_f6f2e270-c957-cb1c-e053-6394a90ab90a	69842-299	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	TABLET	ORAL	20170818		OTC MONOGRAPH FINAL	part338	CVS PHARMACY, INC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-301_374e7c96-103f-4cb5-8def-ca5d2889804b	69842-301	HUMAN OTC DRUG	CVS Arthritis Pain Relief		Arthritis Pain Relief	CREAM	TOPICAL	20160530		OTC MONOGRAPH NOT FINAL	part348	CVS Health	HISTAMINE DIHYDROCHLORIDE	.025	g/100g			N	20241231
69842-306_f6f28eff-817e-4335-e053-6294a90a748a	69842-306	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCl		Acetaminophen Diphenhydramine HCl	TABLET	ORAL	20180716		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-308_f6f2b94f-7b8d-b198-e053-6294a90a40ca	69842-308	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCl		Acetaminophen Diphenhydramine HCl	TABLET	ORAL	20190129		OTC MONOGRAPH NOT FINAL	part343	CVS PHARMACY, INC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-310_0bdd2b40-8bc1-f0fa-e063-6394a90a1ecf	69842-310	HUMAN OTC DRUG	SENNA-S		DOCUSATE SODIUM and SENNOSIDES	CAPSULE, GELATIN COATED	ORAL	20170210		OTC MONOGRAPH DRUG	M007	CVS	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69842-312_23a19a33-f659-47fe-ba3e-5318e3037d24	69842-312	HUMAN OTC DRUG	No Drip Nasal Mist		Oxymetazoline Spray	LIQUID	NASAL	20180830		OTC MONOGRAPH FINAL	part341	CVS Health	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-313_88750203-90e0-bce5-e053-2a95a90a6079	69842-313	HUMAN OTC DRUG	CVS Capsaicin arthritis pain relief		capsaicin	LIQUID	TOPICAL	20190326		OTC MONOGRAPH NOT FINAL	part348	CVS	CAPSAICIN	.15	g/100g			N	20241231
69842-314_64c7993c-34e6-49c3-a57b-79f7e0a26b9d	69842-314	HUMAN OTC DRUG	CVS Antibacterial Plus Urinary Pain Relief		METHENAMINE, SODIUM SALICYLATE	TABLET	ORAL	20170222		UNAPPROVED DRUG OTHER		CVS Pharmacy, Inc	METHENAMINE; SODIUM SALICYLATE	162; 162.5	mg/1; mg/1			N	20241231
69842-315_53b1a4bc-6e13-4f86-b352-67fc5650c075	69842-315	HUMAN OTC DRUG	No Drip Severe Nasal Mist		Oxymetazoline Spray	LIQUID	NASAL	20180830		OTC MONOGRAPH FINAL	part341	CVS Health	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-316_b9d7cb32-c78c-49b6-9cfb-10577f2a27ec	69842-316	HUMAN OTC DRUG	Maximum Strength Nasal Decongestant		Oxymetazoline Spray	LIQUID	NASAL	20180830		OTC MONOGRAPH FINAL	part341	CVS Health	OXYMETAZOLINE HYDROCHLORIDE	50	mg/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-317_6ec35f46-0bed-47d7-a8c9-fc9fe89c518c	69842-317	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210730		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-318_0907a0a3-e619-4ead-e063-6394a90ab040	69842-318	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20150701		OTC MONOGRAPH DRUG	M007	CVS	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-319_0bdd5cf0-abdd-fa85-e063-6394a90a4b83	69842-319	HUMAN OTC DRUG	STOOL SOFTENER		DOCUSATE SODIUM AND SENNOSIDES	CAPSULE, GELATIN COATED	ORAL	20180315		OTC MONOGRAPH DRUG	M007	CVS	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69842-320_0bdd54b1-35ed-e3e7-e063-6294a90adf62	69842-320	HUMAN OTC DRUG	SENNA		SENNOSIDES	CAPSULE, GELATIN COATED	ORAL	20180314		OTC MONOGRAPH DRUG	M007	CVS	SENNOSIDES	8.6	mg/1			N	20241231
69842-321_0c4126c4-62eb-8844-e063-6294a90adab8	69842-321	HUMAN OTC DRUG	CVS Extra Strength Itch Stopping		Diphenhydramine hydrochloride and Zinc acetate	CREAM	TOPICAL	20140317		OTC MONOGRAPH DRUG	M017	CVS	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-322_0ce0a8e4-bc4f-71e7-e063-6394a90a1154	69842-322	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210201		ANDA	ANDA211544	CVS PHARMACY INC	ACETAMINOPHEN	650	mg/1			N	20241231
69842-323_3b066e4e-2170-4d3b-ae9f-6a1e23212abf	69842-323	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20160413		ANDA	ANDA074937	CVS Pharmacy	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-325_0cf95509-d4ed-83fb-e063-6394a90a4e08	69842-325	HUMAN OTC DRUG	CVS Povidone-Iodine		Povidone Iodine	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	CVS Pharmacy	POVIDONE-IODINE	100	mg/mL			N	20241231
69842-326_7abfa28c-eae8-41d1-b7fd-fa8070e6820e	69842-326	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20201208		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
69842-327_0ac8656c-08d1-0701-e063-6394a90a558e	69842-327	HUMAN OTC DRUG	CVS Antiseptic Wound Wash		BENZETHONIUM CHLORIDE	SOLUTION	TOPICAL	20201027		OTC MONOGRAPH DRUG	505G(a)(3)	CVS Pharmacy	BENZETHONIUM CHLORIDE	1.3	mg/g			N	20241231
69842-328_0ce25b64-7c21-017c-e063-6394a90a3d8e	69842-328	HUMAN OTC DRUG	Naproxen Sodium Diphenhydramine HCl		Naproxen Sodium Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210514		ANDA	ANDA213663	CVS PHARMACY, INC	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-329_7d310b06-c8c7-4c73-ba74-d4909ccf4d90	69842-329	HUMAN OTC DRUG	childrens ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20190611		ANDA	ANDA076359	CVS Pharmacy	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-330_f58ac34a-dc69-0f66-e053-2a95a90a912b	69842-330	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20230224		OTC MONOGRAPH FINAL	part347	CVS HEALTH	WITCH HAZEL	84	g/100mL			N	20241231
69842-332_09077980-a69d-3bc0-e063-6294a90a436a	69842-332	HUMAN OTC DRUG	MILK OF MAGNESIA CHERRY		magnesium hydroxide	LIQUID	ORAL	20150701		OTC MONOGRAPH DRUG	M007	CVS	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-335_0ce25ea1-786b-0225-e063-6394a90a7df2	69842-335	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210301		ANDA	ANDA213420	CVS PHARMACY, INC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69842-336_fd2dbab8-0d71-1d9e-e053-6394a90a7704	69842-336	HUMAN OTC DRUG	CVS Health Athletes Foot		Tolnaftate	CREAM	TOPICAL	20200727		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy, Inc.	TOLNAFTATE	10	mg/g			N	20241231
69842-337_9521e252-c92e-422d-be52-1dd55829135f	69842-337	HUMAN OTC DRUG	Childrens Allergy		Loratadine	SOLUTION	ORAL	20180620		ANDA	ANDA075728	CVS Pharmacy	LORATADINE	5	mg/5mL			N	20241231
69842-338_c520f5b2-553d-666e-e053-2a95a90a5a48	69842-338	HUMAN OTC DRUG	CVS Live Better Body Mineral Sunscreen Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20200122		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/g; mg/g			N	20241231
69842-339_004d896e-0d66-933b-e063-6294a90ac745	69842-339	HUMAN OTC DRUG	CVS Health Ultra Sheer SPF 100 Sunscreen		avobenzone, homosalate, octisalate, octocrylene, oxybenzone	LOTION	TOPICAL	20191203		OTC MONOGRAPH FINAL	M020	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-341_c5ea5a7a-c808-e5e0-e053-2995a90a15e9	69842-341	HUMAN OTC DRUG	CVS Health Ultra Sheer Broad Spectrum SPF 45 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 28	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-346_8f0ee43b-27e9-05bf-e053-2a95a90ac659	69842-346	HUMAN OTC DRUG	Bismuth Subsalicylate		Bismuth Subsalicylate	TABLET, FILM COATED	ORAL	20180706		OTC MONOGRAPH FINAL	part335	CVS Pharmacy, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
69842-347_4a28a11a-529c-4072-b54d-66bd54cade6d	69842-347	HUMAN OTC DRUG	Laxative	Regular Strength	Sennosides	TABLET, SUGAR COATED	ORAL	20031208		OTC MONOGRAPH DRUG	505G(a)(3)	CVS PHARMACY	SENNOSIDES	15	mg/1			N	20241231
69842-349_a7827f06-1b8b-112c-e053-2a95a90a9455	69842-349	HUMAN OTC DRUG	CVS		Sodium Chloride, Sodium Bicarbonate	KIT		20160325		UNAPPROVED DRUG OTHER		CVS Pharmacy, Inc.						N	20241231
69842-349_a7827f06-1b98-112c-e053-2a95a90a9455	69842-349	HUMAN OTC DRUG	CVS		Sodium Chloride, Sodium Bicarbonate	KIT		20150701		UNAPPROVED DRUG OTHER		CVS Pharmacy						N	20241231
69842-349_a7fc0481-3323-79b8-e053-2995a90a25ac	69842-349	HUMAN OTC DRUG	CVS		Sodium Chloride, Sodium Bicarbonate	KIT		20130401		UNAPPROVED DRUG OTHER		CVS Pharmacy						N	20241231
69842-353_f32db032-c55a-5e80-e053-2995a90af098	69842-353	HUMAN OTC DRUG	Toothache and Gum Relief		Benzocaine, menthol	LIQUID	TOPICAL	20190207		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	BENZOCAINE; MENTHOL	20; .1	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-355_09078cb4-3b10-f9a0-e063-6394a90a4321	69842-355	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID MINT		aluminum hydroxide, magnesium hydroxide, dimethicone	LIQUID	ORAL	20150601		OTC MONOGRAPH DRUG	M001	CVS	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-360_06c23317-c6ba-811e-e063-6294a90af9b1	69842-360	HUMAN OTC DRUG	Antacid Fruit Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170105		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69842-362_06c2144d-23a1-3b9d-e063-6394a90a5666	69842-362	HUMAN OTC DRUG	Heartburn and gas fruit chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170105		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
69842-363_06c2248d-739d-6f0c-e063-6294a90a16ea	69842-363	HUMAN OTC DRUG	Orange Antacid Soft Chew		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20170203		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69842-368_06c22d8b-bfef-5d9e-e063-6394a90ad387	69842-368	HUMAN OTC DRUG	Cherry Antacid Soft Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20180103		OTC MONOGRAPH FINAL	part331	CVS Pharmacy	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69842-371_499e4dc9-c79d-42f9-b47e-f1d1fcb20ce1	69842-371	HUMAN OTC DRUG	Ultra Strength Antacid Tropical fruit		Calcium antacid	TABLET, CHEWABLE	ORAL	20111209		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-374_c70440e0-b2c3-48e2-ac1c-513891a4a278	69842-374	HUMAN OTC DRUG	CVS Maximum Strength Cold and Hot Pain Relief	Topical Analgesic	Menthol, Unspecified Form	LIQUID	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part348	CVS Health	MENTHOL, UNSPECIFIED FORM	160	mg/mL			N	20241231
69842-375_c617cdff-fff5-4b0c-e053-2a95a90a3b14	69842-375	HUMAN OTC DRUG	CVS Health SPF 55 Ultra Sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20181115		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-376_ed173af0-eb0a-4c2e-9e0b-b2b787f77103	69842-376	HUMAN OTC DRUG	CVS Health Extra Strength	Antacid	aluminum hydroxide and magnesium carbonate	LIQUID	ORAL	20190515		OTC MONOGRAPH FINAL	part331	CVS PHARMACY	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
69842-377_06c1eb9b-2ef2-1bc3-e063-6394a90a00c2	69842-377	HUMAN OTC DRUG	Mixed Berry Throat and Cough Lozenges		Benzocaine	LOZENGE	ORAL	20180815		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-378_cd62345c-3df7-4e50-9ef7-c39a5c116aa7	69842-378	HUMAN OTC DRUG	Daytime Cold Cough	Childrens	Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20180430	20250430	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	5; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69842-379_e4eb66f0-7647-420d-9da5-6bca356a8d65	69842-379	HUMAN OTC DRUG	Nighttime Cold and Cough	childrens	Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20180430	20250430	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
69842-384_56f25788-02ad-41ff-bce4-8b80f38336f6	69842-384	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20201202		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69842-385_f0ebf0db-b1dd-3d5a-e053-2995a90a88e2	69842-385	HUMAN OTC DRUG	CVS Health Sport Clear Broad Spectrum SPF 100 Plus Sunscreen		Avobenzone, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20151023		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 20; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-386_ecf4cea2-5e08-46a1-b102-5d3b80b42459	69842-386	HUMAN OTC DRUG	Nighttime Sleep Aid		Doxylamine succinate	TABLET	ORAL	20190720		ANDA	ANDA040564	CVS PHARMACY	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
69842-388_efb6375d-9b54-404d-9946-4e719b04e467	69842-388	HUMAN OTC DRUG	CVS Eczema Relief	Skin Protectant	Oatmeal	CREAM	TOPICAL	20140101		OTC MONOGRAPH FINAL	part347	CVS Health	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69842-390_8e71c727-66ab-497b-ad8e-0230b43f9a1d	69842-390	HUMAN OTC DRUG	Extra Strength Acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20171109		OTC MONOGRAPH NOT FINAL	part343	CVS PHARMACY, INC.	ACETAMINOPHEN	500	mg/1			N	20241231
69842-391_71d1d56e-b34c-430b-a083-f305487ebfe6	69842-391	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20171109		ANDA	ANDA079174	CVS PHARMACY, INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-392_21ae68a1-a4ba-4f6f-87fa-135baf475fb5	69842-392	HUMAN OTC DRUG	MAXIMUM STRENGTH Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170925		OTC MONOGRAPH FINAL	part338	CVS PHARMACY, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-393_126bd7e7-6159-489b-91fe-3ec8d5305b6a	69842-393	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20170925		OTC MONOGRAPH FINAL	part338	CVS PHARMACY, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-394_77bb30e0-35b0-40c8-a07e-98dfa91c1ce9	69842-394	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20171128		OTC MONOGRAPH FINAL	part335	CVS PHARMACY, INC.	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
69842-395_05742d9a-1a56-4982-b872-366f86091bbb	69842-395	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, CHEWABLE	ORAL	20171128		OTC MONOGRAPH FINAL	part336	CVS PHARMACY, INC.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
69842-396_60ea7f8f-808e-403f-a349-474a3247b2c5	69842-396	HUMAN OTC DRUG	Extra Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20171213		OTC MONOGRAPH FINAL	part331	CVS PHARMACY, INC.	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-397_08293a41-d333-6a1a-e063-6294a90acb7d	69842-397	HUMAN OTC DRUG	CVS Strawberry-Lime Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20200114		OTC MONOGRAPH DRUG	M001	CVS Pharmacy	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69842-398_082942ea-4827-6b7a-e063-6394a90afa60	69842-398	HUMAN OTC DRUG	CVS Berry Antacid Heartburn and Gas		Simethicone	TABLET, CHEWABLE	ORAL	20200114		OTC MONOGRAPH DRUG	M001	CVS Pharmacy	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
69842-399_0cf95166-c4ea-954e-e063-6294a90ae29e	69842-399	HUMAN OTC DRUG	CVS Cold and Hot Roll-On		Cool and Heat Pain Relief	LIQUID	TOPICAL	20210113		OTC MONOGRAPH DRUG	M017	CVS Pharmacy	MENTHOL	16	mg/100mL			N	20241231
69842-400_0cf95509-d4ee-83fb-e063-6394a90a4e08	69842-400	HUMAN OTC DRUG	CVS Itch Relief		Pramoxine Hydrochloride and Zinc Acetate	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	CVS Pharmacy	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-413_3973ab80-c2e4-4b26-bb94-261d295bfba6	69842-413	HUMAN OTC DRUG	cooling severe nighttime		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20191217		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-415_11def938-c22e-4c3d-9b65-8bcace1d1b09	69842-415	HUMAN OTC DRUG	allergy relief d		cetirizine hydrochloride, pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200401		ANDA	ANDA210719	CVS Pharmacy	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-417_ec8d3c6b-21d7-4b50-ae35-4451cf6bbdef	69842-417	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20190119	20240405	ANDA	ANDA204872	CVS PHARMACY	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
69842-420_0d19a0a5-ed0b-1796-e063-6294a90a7e8f	69842-420	HUMAN OTC DRUG	CVS Calamine Plus		zinc oxide	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	CVS Pharmacy	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-421_ef6bf1ec-3b80-2465-e053-2995a90aa2d7	69842-421	HUMAN OTC DRUG	CVS Health Antacid and Pain Reliever		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20061201		OTC MONOGRAPH FINAL	part343	CVS Pharmacy	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69842-422_19d250c7-1043-499e-8d45-0e181ba3d036	69842-422	HUMAN OTC DRUG	Daytime Nighttime Cold and Cough	Childrens	Dextromethorphan HBr, Phenylephrine HCl, Diphenhydramine HCl, Phenylephrine HCl	KIT		20180430	20250430	OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	
69842-423_b91f90b8-639c-4576-a777-5235f0328c9d	69842-423	HUMAN OTC DRUG	CVS Health	Nausea Relief	Sodium Citrate dihydrate	TABLET, CHEWABLE	ORAL	20190522		UNAPPROVED DRUG OTHER		CVS PHARMACY,INC.	TRISODIUM CITRATE DIHYDRATE	230	mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
69842-424_c68b587f-14ed-395a-e053-2a95a90ae801	69842-424	HUMAN OTC DRUG	CVS Health Ultra Sheer Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20190104		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-424_c68c4421-f984-eac1-e053-2a95a90a0d23	69842-424	HUMAN OTC DRUG	CVS Health Ultra Sheer Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20190104		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69842-428_de524b13-051d-4c30-b7d0-ab7572f9a6ab	69842-428	HUMAN OTC DRUG	Nicotine Polacrilex	coated mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA078699	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-430_de524b13-051d-4c30-b7d0-ab7572f9a6ab	69842-430	HUMAN OTC DRUG	Nicotine Polacrilex	coated mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA078697	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-431_4607e85f-e560-4200-a047-5db9fcfbe9e7	69842-431	HUMAN OTC DRUG	Cold, Flu, and Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200502	20241206	OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69842-432_00e60e31-75c9-4671-921b-5f1bcbfbb54c	69842-432	HUMAN OTC DRUG	Triple Antibiotic and Burn Relief		bacitracin zinc, neomycin sulfate, polymyxin b sulfate, pramoxine hydrochloride	OINTMENT	TOPICAL	20210305		OTC MONOGRAPH FINAL	part333B	CVS Pharmacy	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-434_08294b9d-8611-6fc0-e063-6394a90a6220	69842-434	HUMAN OTC DRUG	CVS Cherry Zinc Cold Relief 25ct		Zinc Gluconate	LOZENGE	ORAL	20200504		UNAPPROVED HOMEOPATHIC		CVS Pharmacy	ZINC GLUCONATE	2	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-435_082954b1-6fac-93c0-e063-6294a90a0828	69842-435	HUMAN OTC DRUG	CVS Honey Lemon Zinc Cold Relief Lozenges		Zinc Gluconate	LOZENGE	ORAL	20200504		UNAPPROVED HOMEOPATHIC		CVS Pharmacy	ZINC GLUCONATE	2	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-436_08295b65-04c9-b49d-e063-6394a90a47e1	69842-436	HUMAN OTC DRUG	CVS Antacid Lime-Berry Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210408		OTC MONOGRAPH DRUG	M001	CVS Pharmacy	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
69842-437_26c499d8-9743-4ed1-bdad-645dd0daad00	69842-437	HUMAN OTC DRUG	daily moisturizer		Octinoxate, Octisalate	LOTION	TOPICAL	20180426		OTC MONOGRAPH FINAL	part352	CVS Pharmacy	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
69842-438_63816762-f23b-4161-8809-23c8a6eed233	69842-438	HUMAN OTC DRUG	CVS Saline		Nasal	SPRAY	NASAL	20210215		OTC MONOGRAPH FINAL	part349	CVS PHARMACY	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
69842-440_08296762-7c49-f08d-e063-6294a90a9ce0	69842-440	HUMAN OTC DRUG	CVS Berry Antacid HBG Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210408		OTC MONOGRAPH DRUG	M001	CVS Pharmacy	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
69842-441_80f33843-8d21-4910-b8eb-29f88f1e278c	69842-441	HUMAN OTC DRUG	EYE ALLERGY RELIEF		Naphazoline hydrochloride and Pheniramine maleate	SOLUTION/ DROPS	OPHTHALMIC	20170201		NDA	NDA020065	CVS PHARMACY	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.2675; 3.15	mg/mL; mg/mL			N	20241231
69842-442_c6726e12-06a6-0370-e053-2a95a90a7dd6	69842-442	HUMAN OTC DRUG	MAXIMUM STRENGTH DAYTIME NIGHTTIME SINUS RELIEF		Acetaminophen Dextromethorphan HBr Guaifenesin Phenylephrine HCl And Acetaminophen Dextromethorphan HBr Doxylamine Succinate Phenylephrine HCl	KIT	ORAL	20210710		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc.						N	20241231
69842-443_f5ee781c-b0c4-47c8-8126-13ce5bcce9b2	69842-443	HUMAN OTC DRUG	Extra Strength Nasal		Phenylephrine Hydrochloride	SPRAY	NASAL	20200921		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-445_d802c1c8-1587-4693-89bd-2ecd88be2450	69842-445	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20210409		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	1000	mg/30mL			N	20241231
69842-446_0d378048-39d4-421b-e063-6294a90ac848	69842-446	HUMAN OTC DRUG	CVS Lubricant Eye Drops 15mL		Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190920		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
69842-447_e368dc83-7015-4354-9dc3-b34d768b91e2	69842-447	HUMAN OTC DRUG	Acetaminophen PM	Extra strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20180331	20240126	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69842-448_eff3e166-88cf-4a58-b95d-defde8f22122	69842-448	HUMAN OTC DRUG	CVS Nighttime	Sleep Aid	Diphenhydramine Hydrochloride and Acetaminophen	LIQUID	ORAL	20210212		OTC MONOGRAPH NOT FINAL	part343	CVS PHARMACY	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-449_efde2d48-f8d1-4a81-a806-34647298b0ec	69842-449	HUMAN OTC DRUG	Pain Relief	childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	160	mg/1			N	20241231
69842-450_6fef9dcd-cd69-4e0e-b4ac-0d494da9abc8	69842-450	HUMAN OTC DRUG	Pain Relief	childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	160	mg/1			N	20241231
69842-451_c65b3a54-736f-fcbc-e053-2a95a90a47db	69842-451	HUMAN OTC DRUG	MAXIMUM STRENGTH DAYTIME NIGHTTIME COLD AND FLU		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	KIT	ORAL	20210710		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc.						N	20241231
69842-452_f40f2a17-6207-1d9e-e053-2995a90a4043	69842-452	HUMAN OTC DRUG	CVS Health SPF 15 Clear Hawaii Compliant		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20181120		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE	20; 100; 50	mg/g; mg/g; mg/g			N	20241231
69842-453_a7708891-8271-72cc-e053-2995a90a1c39	69842-453	HUMAN OTC DRUG	CVS		Sodium Chloride, Sodium Bicarbonate	KIT		20170424		UNAPPROVED DRUG OTHER		CVS Pharmacy, Inc.						N	20241231
69842-454_c799a350-ac20-4182-87df-58bc32dd46c4	69842-454	HUMAN OTC DRUG	Artificial Tears Lubricant Eye Drops		glycerin, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20100901		OTC MONOGRAPH FINAL	part349	CVS Pharmacy	GLYCERIN; PROPYLENE GLYCOL	3; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69842-455_c89a28ac-ab54-46dd-e053-2a95a90a3284	69842-455	HUMAN OTC DRUG	CVS HEALTH CONTINUOUS HAND SANITIZER		ALCOHOL	AEROSOL, SPRAY	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333A	CVS PHARMACY	ALCOHOL	70	mg/100g			N	20241231
69842-456_afd25422-a67d-4811-9e78-c9d30c3492ae	69842-456	HUMAN OTC DRUG	CVS Oil Free Acne Facial Cleanser-Pink Grapefruit	Acne Treatment	Salicylic Acid	LOTION	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/mL			N	20241231
69842-457_1c1bc1d1-7a59-4b2f-84ed-b5bc479a5c55	69842-457	HUMAN OTC DRUG	CVS Clarifying Acne Body Wash-Pink Grapefruit	Acne Treatment	Salicylic Acid	LOTION	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/mL			N	20241231
69842-458_c2f00796-37fc-425a-86a4-dd05d0f0efe9	69842-458	HUMAN OTC DRUG	purelax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20221014		ANDA	ANDA090685	CVS Pharmacy	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-459_d4dea022-a885-c686-e053-2a95a90a9be8	69842-459	HUMAN OTC DRUG	CVS Health SPF 55 Clear Face Paraben and Phthalate Free		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20181031		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 40; 45; 60; 45	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69842-460_5e9793a7-faec-40bc-b8dc-ba9e65e47932	69842-460	HUMAN OTC DRUG	Pain Reliever PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20180331	20250331	OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69842-461_782ad9a0-33f2-4056-83f8-9f4238a5cbf8	69842-461	HUMAN OTC DRUG	Sinus Relief Congestion and Cough	Maximum Strength	Acetaminophen, Diphenhydramine HCI, Phenylephrine HCl	LIQUID	ORAL	20180430		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-463_14e9d2f4-3656-4ea7-90fb-9e7917612426	69842-463	HUMAN OTC DRUG	Clear Skin		Salicylic acid	LIQUID	TOPICAL	20160916		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy, Inc	SALICYLIC ACID	3.57	mg/mL			N	20241231
69842-464_df24ce83-6144-44c0-e053-2995a90af52e	69842-464	HUMAN OTC DRUG	CVS Health Advanced Acne Spot Treatment		SALICYLIC ACID	GEL	TOPICAL	20190514		OTC MONOGRAPH FINAL	part333D	CVS PHARMACY	SALICYLIC ACID	20	mg/mL			N	20241231
69842-465_b596a958-49b5-1ac7-e053-2995a90a52f0	69842-465	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180806		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
69842-466_d501dcd9-2c84-c860-e053-2a95a90a2062	69842-466	HUMAN OTC DRUG	CVS Health SPF 50 Zinc Sheer Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20171204		OTC MONOGRAPH FINAL	part346	CVS PHARMACY	ZINC OXIDE	216	mg/mL			N	20241231
69842-467_4ca6b63a-f55f-45ae-8b9b-deee313c466d	69842-467	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20191201		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy, Inc	ALCOHOL	62	mL/100mL			N	20241231
69842-468_06fe2d5f-6460-45c6-9327-0e8efba5bf62	69842-468	HUMAN OTC DRUG	Zinc Oxide		ZINC OXIDE	PASTE	TOPICAL	20080324		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	ZINC OXIDE	532	mg/g			N	20241231
69842-469_d50a9c2a-215b-f2e8-e053-2a95a90aeeb6	69842-469	HUMAN OTC DRUG	CVS Health SPF 50 Zinc Face Sheer		ZINC OXIDE	LOTION	TOPICAL	20180122		OTC MONOGRAPH FINAL	part346	CVS PHARMACY	ZINC OXIDE	216	mg/mL			N	20241231
69842-470_d8b7a3b6-4d65-4447-8424-f6040d7c5548	69842-470	HUMAN OTC DRUG	Sleep-Aid		Diphenhydramine HCl	SOLUTION	ORAL	20190301		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-471_620018e6-f51b-4a85-8738-b5aa434e3e73	69842-471	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	CVS	ALCOHOL	62	mL/100mL			N	20241231
69842-472_f2e4dd44-e6c8-1eaf-e053-2a95a90a35b1	69842-472	HUMAN OTC DRUG	CVS Health Sterile Saline Mist		Sodium Chloride	SPRAY	NASAL	20210313		UNAPPROVED DRUG OTHER		CVS Pharmacy	SODIUM CHLORIDE	.9	g/100g			N	20241231
69842-473_effedd26-9390-4417-e053-2a95a90acc04	69842-473	HUMAN OTC DRUG	CVS Health Sterile Saline Mist		Sodium Chloride	SPRAY	NASAL	20210313		UNAPPROVED DRUG OTHER		CVS Pharmacy	SODIUM CHLORIDE	3	g/100g			N	20241231
69842-474_0d376274-1a78-5fbc-e063-6394a90a2cf2	69842-474	HUMAN OTC DRUG	CVS Gentle Tears		Dextran 70, Hypromellose	SOLUTION/ DROPS	OPHTHALMIC	20200101		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	DEXTRAN 70; HYPROMELLOSE, UNSPECIFIED	.1; .3	g/100mL; g/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
69842-475_2dbe71dc-9217-4112-bbe0-37dae7ff287a	69842-475	HUMAN OTC DRUG	Multi-Symptom Cold and Fever	Childrens	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20210610		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-476_db336685-048b-e5cb-e053-2a95a90a5b05	69842-476	HUMAN OTC DRUG	CVS Health SPF 30 Beach Guard Clear		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20181212		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	300; 1000; 400; 200	mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-478_0b9e5756-235a-4b06-b02c-d8ce47454770	69842-478	HUMAN OTC DRUG	Sinus Relief Severe Congestion	Maximum Strength	Acetaminophen, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20180430	20240430	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	
69842-480_fc8b0648-7c2b-498a-b375-5bd1fe6907f3	69842-480	HUMAN OTC DRUG	CVS Health Blackhead Clearing Scrub	Acne Medication	Salicylic Acid	CREAM	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/g			N	20241231
69842-481_dbeefd5f-2ec8-4349-e053-2a95a90a6815	69842-481	HUMAN OTC DRUG	CVS Health 30 Zinc Sheer		Zinc Oxide	LOTION	TOPICAL	20171204		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	ZINC OXIDE	182.4	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-484_d15c7d61-714e-46f8-a48f-18c40f98c367	69842-484	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20180612		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	500	mg/1			N	20241231
69842-485_dca9ca83-91c7-5b4b-e053-2995a90a543d	69842-485	HUMAN OTC DRUG	CVS Maximum Strength Anti-Itch Cream		Hydrocortisone 1%	CREAM	TOPICAL	20220406		OTC MONOGRAPH NOT FINAL	part348	CVS Health	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-487_199c6736-a59d-4ef3-8188-640e2621447d	69842-487	HUMAN OTC DRUG	CVS		Childrens Stuffy Nose and Cold	SOLUTION	ORAL	20220301		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	100; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-488_396cf289-6934-4589-8cc8-48d178e65cdc	69842-488	HUMAN OTC DRUG	Lanolin, Petrolatum		Lanolin, Petrolatum	OINTMENT	TOPICAL	20201230		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	LANOLIN; PETROLATUM	155; 534	mg/g; mg/g			N	20241231
69842-489_f702aaf7-5c49-3292-e053-6394a90a71a7	69842-489	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20211218		ANDA	ANDA091237	CVS Pharmacy.Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-490_f2291d89-d78f-532a-e053-2a95a90a752b	69842-490	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20170904		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69842-491_0ce1d1f5-6fcb-defc-e063-6394a90a82ee	69842-491	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20210726		OTC MONOGRAPH DRUG	M013	CVS PHARMACY, INC	ACETAMINOPHEN	500	mg/1			N	20241231
69842-492_ccc272d1-72f9-2aaa-e053-2a95a90a61a3	69842-492	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210924		ANDA	ANDA211075	CVS PHARMACY	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-493_df42ba54-95e6-54c7-e053-2995a90accbd	69842-493	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20220523		ANDA	ANDA091237	CVS Pharmacy. Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-500_a8236c97-2060-6634-e053-2995a90a6a51	69842-500	HUMAN OTC DRUG	Caffeine		Caffeine	TABLET	ORAL	20180628		OTC MONOGRAPH FINAL	part340	CVS Pharmacy, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69842-501_f2292312-16ca-28d6-e053-2995a90a3c18	69842-501	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20170403		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69842-502_f2292312-16cb-28d6-e053-2995a90a3c18	69842-502	HUMAN OTC DRUG	Miconazole Nitrate		Jock Itch Spray	AEROSOL, SPRAY	TOPICAL	20170610		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	MICONAZOLE NITRATE	1.3	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69842-503_83d19b42-9210-4a8c-ad73-2bc3f7bf8620	69842-503	HUMAN OTC DRUG	Severe Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050804		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-505_b7e6c6c4-21e6-467e-9a77-ddb8e15b0f24	69842-505	HUMAN OTC DRUG	Severe Cold	Daytime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	CAPSULE	ORAL	20191227		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-506_9f35dd1a-cc20-4aed-824f-8604692d4643	69842-506	HUMAN OTC DRUG	Multi Symptom NightTime Cold		Acetaminophen Diphenhydramine HCI Phenylephrine HCI	LIQUID	ORAL	20180430	20250430	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 12.5; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
69842-507_f00521f6-5a04-4017-9dd0-3fe9a9d16b73	69842-507	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20171202		NDA	NDA208025	CVS Pharmacy	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-508_3557256e-e823-4bb3-85db-ca11abbea728	69842-508	HUMAN OTC DRUG	Antacid		Aluminum Hydroxide, Magnesium Hydroxide and Simethicone	SUSPENSION	ORAL	20110309		OTC MONOGRAPH FINAL	part332	CVS	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-509_affdea64-df8d-8dc5-e053-2a95a90ac947	69842-509	HUMAN OTC DRUG	Caffeine		Caffeine	TABLET	ORAL	20180622		OTC MONOGRAPH FINAL	part340	CVS Pharmacy, Inc.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
69842-511_f229388d-50ab-092a-e053-2995a90aecac	69842-511	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Powder Spray Talc Free	AEROSOL, POWDER	TOPICAL	20170522		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69842-512_f2292312-16c9-28d6-e053-2995a90a3c18	69842-512	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20170522		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	TOLNAFTATE	1.3	g/130g			N	20241231
69842-513_933f7778-738c-4ad6-ab7a-55411deeb812	69842-513	HUMAN OTC DRUG	adult tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220712		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-515_0a849f0b-2906-4859-bf06-b7562f54310d	69842-515	HUMAN OTC DRUG	Antiseptic Mouth Sore		hydrogen peroxide, menthol	RINSE	PERIODONTAL	20210618		OTC MONOGRAPH NOT FINAL	part356	CVS Pharmacy	HYDROGEN PEROXIDE; MENTHOL, UNSPECIFIED FORM	15; 1	mg/mL; mg/mL			N	20241231
69842-521_f0a24bcd-5b47-46e7-b049-e94df302d340	69842-521	HUMAN OTC DRUG	childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190529		ANDA	ANDA076359	CVS Pharmacy	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-522_0bdd78c5-378b-082a-e063-6294a90aedea	69842-522	HUMAN OTC DRUG	CVS Health Stool Softener Clear		Docusate sodium	CAPSULE	ORAL	20190605		OTC MONOGRAPH DRUG	M007	CVS Pharmacy	DOCUSATE SODIUM	50	mg/1			N	20241231
69842-523_0bdef49b-25e8-8335-e063-6394a90abed0	69842-523	HUMAN OTC DRUG	CVS Health Stool Softener		Docusate sodium	CAPSULE	ORAL	20190605		OTC MONOGRAPH DRUG	M007	CVS Pharmacy	DOCUSATE SODIUM	50	mg/1			N	20241231
69842-524_5e42292e-67e1-41a4-966c-197bf7c261c0	69842-524	HUMAN OTC DRUG	CVS Health		Natural Fiber Supplement	POWDER	ORAL	20190515		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy,Inc.	PSYLLIUM HUSK	6	g/6g			N	20241231
69842-525_49e0dfb1-c90c-4831-864d-bb4594023a3d	69842-525	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20171231	20241231	OTC MONOGRAPH DRUG	M013	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
69842-526_df262800-68ad-4d21-e053-2a95a90ad176	69842-526	HUMAN OTC DRUG	CVS Health SPF 50 Beach Guard		Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20190115		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69842-528_6e37d3f7-9589-427c-ae57-03b39833caf9	69842-528	HUMAN OTC DRUG	Maximum strength Stomach Relief		Bismuth Subsalicylate	LIQUID	ORAL	20080908		OTC MONOGRAPH FINAL	part335	CVS	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
69842-532_06c2144d-23a2-3b9d-e063-6394a90a5666	69842-532	HUMAN OTC DRUG	CVS Cherry Cough Drops		Menthol	LOZENGE	ORAL	20220506		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
69842-533_bd7523d2-d68b-7e86-e053-2995a90a4785	69842-533	HUMAN OTC DRUG	CVS Health Sterile Saline Mist	Live Better	Sodium Chloride	SPRAY	NASAL	20210313		UNAPPROVED DRUG OTHER		CVS Pharmacy	SODIUM CHLORIDE	.9	g/100g			N	20241231
69842-534_06c22d8b-bff0-5d9e-e063-6394a90ad387	69842-534	HUMAN OTC DRUG	CVS Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20220509		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	7.5	mg/1			N	20241231
69842-535_5e079d68-d863-485e-b46f-d9a6c4fbface	69842-535	HUMAN OTC DRUG	Childrens Allergy		Loratadine	SOLUTION	ORAL	20161212		ANDA	ANDA201865	CVS Pharmacy	LORATADINE	5	mg/5mL			N	20241231
69842-536_06c2144d-23a3-3b9d-e063-6394a90a5666	69842-536	HUMAN OTC DRUG	CVS Menthol Cough Drops		Menthol	LOZENGE	ORAL	20220509		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	5.4	mg/1			N	20241231
69842-537_9090b252-88b4-8521-e053-2995a90a025e	69842-537	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	CAPSULE	ORAL	20180622		OTC MONOGRAPH FINAL	part338	CVS Pharmacy, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-539_dfb56532-6f74-1e4d-e053-2a95a90a1c05	69842-539	HUMAN OTC DRUG	CVS Health SPF 55 Ultra Sheer Face Mist		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	300; 1000; 500; 1000	mg/10mL; mg/10mL; mg/10mL; mg/10mL			N	20241231
69842-540_047304ed-07c9-4711-b694-5bf7c3809ca2	69842-540	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	CVS Pharmacy	LORATADINE	5	mg/5mL			N	20241231
69842-541_c549964f-aa7e-a0fc-e053-2a95a90abeef	69842-541	HUMAN OTC DRUG	Acetaminophen, Aspirin, Caffeine		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20180622		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy, Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69842-542_c016ecdf-7856-7d07-e053-2995a90ac71b	69842-542	HUMAN OTC DRUG	CVS Health Extra Strength Antacid and Pain Reliever		Aspirin, Anhydrous Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20201230		OTC MONOGRAPH FINAL	part343	CVS Pharmacy	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 500; 1985	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69842-543_c8a81a2c-d73f-0b0a-e053-2a95a90ace9d	69842-543	HUMAN OTC DRUG	Lidocaine Dry		lidocaine	SPRAY	TOPICAL	20210722		OTC MONOGRAPH NOT FINAL	part348	CVS	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-544_02c06538-5e4a-4e81-aea3-d37110e05856	69842-544	HUMAN OTC DRUG	8HR Arthritis Pain Relief		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000531		ANDA	ANDA075077	CVS Pharmacy	ACETAMINOPHEN	650	mg/1			N	20241231
69842-546_a6f0a9bc-1b9d-476f-8292-9e12d32d1db2	69842-546	HUMAN OTC DRUG	SEVERE COLD PLUS FLU DAYTIME NIGHTTIME		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride, and Doxylamine succinate	KIT		20170714		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.						N	20241231
69842-548_f8f73418-e006-48b8-a1de-b151269a50c5	69842-548	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20210420		OTC MONOGRAPH FINAL	part355	CVS Pharmacy, Inc	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69842-549_f2f23228-fc34-2678-e053-2995a90a599d	69842-549	HUMAN OTC DRUG	CVS Complete Protection		Stannous flouride	PASTE, DENTIFRICE	DENTAL	20201215		OTC MONOGRAPH FINAL	part355	CVS	STANNOUS FLUORIDE	.454	g/100g			N	20241231
69842-551_84a621fe-890e-4c88-9f26-f013c32b52b7	69842-551	HUMAN OTC DRUG	CVS Health Cherry SPF 15 Lip Balm		Oxybenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20150817		OTC MONOGRAPH NOT FINAL	part352	CVS	OCTINOXATE; OXYBENZONE; PETROLATUM	7.5; 3.5; 44	mg/g; mg/g; mg/g			N	20241231
69842-551_bfbf0241-51a6-4d9d-bee1-741d1645037d	69842-551	HUMAN OTC DRUG	CVS Health Cherry SPF 15 Lip Balm		Oxybenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20150817		OTC MONOGRAPH NOT FINAL	part352	CVS	OCTINOXATE; OXYBENZONE; PETROLATUM	7.5; 3.5; 44	mg/g; mg/g; mg/g			N	20241231
69842-552_6d58a18c-62ba-4cee-b3cc-51db746ba50e	69842-552	HUMAN OTC DRUG	CVS Health Original SPF 15 Lip Balm		Oxybenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20150817		OTC MONOGRAPH NOT FINAL	part352	CVS	OCTINOXATE; OXYBENZONE; PETROLATUM	7.5; 3.5; 44	mg/g; mg/g; mg/g			N	20241231
69842-552_e49680bd-bd61-40cf-abc8-51a1c8808726	69842-552	HUMAN OTC DRUG	CVS Health Original SPF 15 Lip Balm		Oxybenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20150817		OTC MONOGRAPH NOT FINAL	part352	CVS	OCTINOXATE; OXYBENZONE; PETROLATUM	7.5; 3.5; 44	mg/g; mg/g; mg/g			N	20241231
69842-557_d0081c50-c0d2-436a-ba83-5d1982ae64b7	69842-557	HUMAN OTC DRUG	CVS Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20150817		OTC MONOGRAPH NOT FINAL	part333A	CVS	ALCOHOL	56	mg/g			N	20241231
69842-562_a8b4963b-7cd3-4c15-b4f6-c58e2e05d277	69842-562	HUMAN OTC DRUG	triple antibiotic and pain relief		bacitracin, neomycin, polymyxin B, pramoxine hydrochloride	OINTMENT	TOPICAL	20200909		OTC MONOGRAPH FINAL	part333B	CVS Pharmacy	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-563_f2f236d8-72ff-7583-e053-2a95a90a426e	69842-563	HUMAN OTC DRUG	CVS Sens Whtng		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20211027		OTC MONOGRAPH FINAL	part355	CVS	STANNOUS FLUORIDE	.454	g/100g			N	20241231
69842-564_da20b0a7-14b7-49eb-90c7-86cc890aff8b	69842-564	HUMAN OTC DRUG	Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200529		ANDA	ANDA207868	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-565_c1cae744-6b76-4a96-b40c-599b0fd28049	69842-565	HUMAN OTC DRUG	Severe Tussin CF		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20180625		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-566_3acdaedf-3ee5-4dd4-9a67-66db12d0e8c0	69842-566	HUMAN OTC DRUG	CVS Maximum Strength Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin ,Phenylephrine HCL	LIQUID	ORAL	20220311		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-567_dfc766f4-9d8f-5948-e053-2a95a90a5a61	69842-567	HUMAN OTC DRUG	CVS Health SPF 30 Ultra Sheer Mist		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20181211		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	300; 1000; 500; 235	mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-570_a4e239f7-caff-4f7d-890d-c6bea9d71fba	69842-570	HUMAN OTC DRUG	Cold	Childrens, Multi Symptom	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20180731		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-571_4ee139ca-1a0a-4fbf-975a-a7397d3eeb37	69842-571	HUMAN OTC DRUG	CVS Health Acne Control Cleanser	Acne Medication	Benzoyl Peroxide	LOTION	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	BENZOYL PEROXIDE	100	mg/g			N	20241231
69842-572_c45b60fa-1318-497e-e053-2a95a90ab0fc	69842-572	HUMAN OTC DRUG	ACETAMINOPHEN, DIPHENHYDRAMINE HCL		ACETAMINOPHEN, DIPHENHYDRAMINE HCL	TABLET, FILM COATED	ORAL	20180723		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-573_0b18b264-b5a9-74b9-e063-6394a90aba9a	69842-573	HUMAN OTC DRUG	CVS Maximum Strength LIDOCAINE PLUS		Benzyl alcohol, Lidocaine hydrochloride	SPRAY	TOPICAL	20200515		OTC MONOGRAPH DRUG	505G(a)(3)	CVS Pharmacy Inc.	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	10; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
69842-575_ba7f3b09-4197-4366-b406-a4d7c4c68aab	69842-575	HUMAN OTC DRUG	CVS Health		Nasal Oxymetazoline HCl	SPRAY	NASAL	20190418		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-576_dfca4f02-201e-4c8d-e053-2a95a90a22ac	69842-576	HUMAN OTC DRUG	CVS Health SPF 30 Ultra Sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190904		OTC MONOGRAPH NOT FINAL	part352	CVS Pharmacy	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	300; 1000; 500; 235	mg/10g; mg/10g; mg/10g; mg/10g			N	20241231
69842-577_b393cff3-b041-4127-8cda-2e88bf558e5c	69842-577	HUMAN OTC DRUG	CVS Childrens Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN	LIQUID	ORAL	20220314		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-579_34da7efb-f493-4124-8ae7-1174ee958326	69842-579	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-580_b2de1110-f38e-4acf-99d5-db1cf321372b	69842-580	HUMAN OTC DRUG	CVS Oil Free Acne Cleanser	Acne Treatment	Salicylic Acid	CREAM	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/mL			N	20241231
69842-581_ba76ba34-a9b7-4773-868e-b601a87bbdd6	69842-581	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20170124		OTC MONOGRAPH FINAL	part355	CVS Pharmacy	SODIUM FLUORIDE	.2	mg/mL			N	20241231
69842-583_deabcef9-8d54-42c0-be33-6d09d20da1f5	69842-583	HUMAN OTC DRUG	CVS Clarifying Body Wash	Acne Treatment	Salicylic Acid	LOTION	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/mL			N	20241231
69842-584_90febb8c-1c79-4260-bbc7-39e2a4c2e9c3	69842-584	HUMAN OTC DRUG	CVS Foaming Hand Sanitizer	Antibacterial	Benzalkonium Chloride	LIQUID	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part333E	CVS Health	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69842-585_b8d356db-554a-4251-875a-2d35dd6d7328	69842-585	HUMAN OTC DRUG	cooling severe daytime cooling severe nighttime		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20191216		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-586_858dbe9f-cafa-4f2e-8bb9-4d7f1f49f3ac	69842-586	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20180831		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69842-588_15fdd717-e419-42b1-ad9f-46873e96ede4	69842-588	HUMAN OTC DRUG	Anti-Itch Medicated Maximum Strength		Benzocaine and Resorcinol	CREAM	TOPICAL	20210930		OTC MONOGRAPH NOT FINAL	part348	CVS Health	BENZOCAINE; RESORCINOL	200; 30	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-589_e4589123-8f95-5960-e053-2a95a90a3f3c	69842-589	HUMAN OTC DRUG	CVS Health Sport SPF 30 Clear	Broad Spectrum	Avobenzone, Homosalate,Octisalate,Octocrylene	SPRAY	TOPICAL	20181120		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
69842-590_c80a52d4-7c58-4d4e-a789-c47a705697e0	69842-590	HUMAN OTC DRUG	cooling severe nighttime		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20190620		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-591_4294912b-eb1e-42a2-a2bb-b0016a86cf21	69842-591	HUMAN OTC DRUG	Acetaminophen 250mg Aspirin 250mg Caffeine 65mg		Acetaminophen 250mg Aspirin 250mg Caffeine 65mg	TABLET	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69842-592_c62ecadd-c384-4f9b-bfa3-51f2a5c0852f	69842-592	HUMAN OTC DRUG	Acetaminophen 250mg Aspirin 250mg Caffeine 65mg		Acetaminophen 250mg Aspirin 250mg Caffeine 65mg	TABLET	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69842-593_06c22e1f-80f3-8127-e063-6294a90a2481	69842-593	HUMAN OTC DRUG	CVS SF Menthol Cough Drops		Menthol	LOZENGE	ORAL	20220603		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	5.8	mg/1			N	20241231
69842-594_06c24116-7192-9803-e063-6294a90ac79d	69842-594	HUMAN OTC DRUG	CVS SF Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20220606		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	MENTHOL	7.6	mg/1			N	20241231
69842-595_aaa93030-2592-4773-8175-43ca8fd471ab	69842-595	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20230822		ANDA	ANDA077007	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-596_ed205944-d294-14bf-e053-2a95a90af7c7	69842-596	HUMAN OTC DRUG	SALICYLIC ACID WART REMOVER		Salicylic Acid	STRIP	TOPICAL	20160101		OTC MONOGRAPH FINAL	part358H	CVS Pharmacy	SALICYLIC ACID	40	mg/1			N	20241231
69842-597_e4581d0e-ce6e-7898-e053-2a95a90a02b5	69842-597	HUMAN OTC DRUG	CVS Health Kids SPF 50 Clear		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20190521		OTC MONOGRAPH NOT FINAL	part352	CVS PHARMACY	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
69842-598_c9d3a27c-54d6-4951-adab-a20dd4ff113b	69842-598	HUMAN OTC DRUG	Hair Regrowth Treatment		minoxidil	SOLUTION	TOPICAL	20210521		ANDA	ANDA075598	CVS Pharmacy	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69842-599_e137ee8d-efe2-4483-8661-518e762a4898	69842-599	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20170307		ANDA	ANDA091344	CVS Pharmacy	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69842-602_59415fc0-7ae0-4511-85da-be97a9e10533	69842-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL	19980715		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-603_f5428414-6e2e-489c-bf9b-d8dcc5b29ee2	69842-603	HUMAN OTC DRUG	CVS Oil Free Acne Foaming Scrub-Pink Grapefruit	Acne Medication	Salicylic Acid	LOTION	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	SALICYLIC ACID	20	mg/mL			N	20241231
69842-604_5c336936-df75-4eff-a26f-b2764db6deb2	69842-604	HUMAN OTC DRUG	CVS Baby Diaper Rash and Skin Protectant	Skin Protectant	Lanolin and Petrolatum	OINTMENT	TOPICAL	20140101		OTC MONOGRAPH FINAL	part347	CVS Health	LANOLIN; PETROLATUM	155; 535	mg/g; mg/g			N	20241231
69842-605_dec6d2db-ae98-4e60-9d62-95417809c95c	69842-605	HUMAN OTC DRUG	nicotine		nicotine	LOZENGE	ORAL	20200204		ANDA	ANDA203690	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-608_8c4c6c95-e5bb-4e23-b64b-9de253d67de0	69842-608	HUMAN OTC DRUG	Nicotine Polacrilex	original	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA074507	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-609_8c4c6c95-e5bb-4e23-b64b-9de253d67de0	69842-609	HUMAN OTC DRUG	Nicotine Polacrilex	original	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20140101		ANDA	ANDA074707	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-610_45d5e475-0982-038e-e054-00144ff88e88	69842-610	HUMAN OTC DRUG	CVS Triple Antibiotic		Bacitracin, Neomycin, Polymyxin B	OINTMENT	TOPICAL	20081101		OTC MONOGRAPH FINAL	part333B	CVS Pharmacy	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-611_0d378048-39d5-421b-e063-6294a90ac848	69842-611	HUMAN OTC DRUG	CVS Astringent Eye		Tetrahydrozoline HCl, Zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20071101		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	50; 250	mg/100mL; mg/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-614_9cd63fd5-c270-47f6-8261-da6eac39d30e	69842-614	HUMAN OTC DRUG	CVS Severe Nasal Congestion Relief	Clear and Cool	Oxymetazoline Hydrochloride	SPRAY	NASAL	20220310		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-615_45d91c02-243a-6ebe-e054-00144ff88e88	69842-615	HUMAN OTC DRUG	CVS Pain Relieving First Aid Antiseptic		Lidocaine Hydrochloride, Benzalkonium Chloride	SPRAY	TOPICAL	20140415		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.0013; .025	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-616_f145be69-d5c0-1a7f-e053-2a95a90ad926	69842-616	HUMAN OTC DRUG	MAXIMUM STRENGTH COLD, FLU AND SORE THROAT		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210710		OTC MONOGRAPH DRUG	M012	CVS Pharmacy, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-618_21974f8f-ff08-4c92-aab4-3ffb8d50de48	69842-618	HUMAN OTC DRUG	CVS Pinworm Treatment		PYRANTEL PAMOATE	SUSPENSION	ORAL	20161215		OTC MONOGRAPH FINAL	part357B	CVS PHARMACY INC	PYRANTEL PAMOATE	144	mg/mL			N	20241231
69842-619_09078cb4-3b11-f9a0-e063-6394a90a4321	69842-619	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200901		OTC MONOGRAPH DRUG	M001	CVS PHARMACY	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-620_88393be8-74bf-6648-e053-2a95a90a6665	69842-620	HUMAN OTC DRUG	Itch Stopping		Diphenhydramine HCl	GEL	TOPICAL	20140514		OTC MONOGRAPH NOT FINAL	part348	CVS	DIPHENHYDRAMINE HYDROCHLORIDE	2	g/100g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-621_0c41d2ea-62ed-3ceb-e063-6294a90ab561	69842-621	HUMAN OTC DRUG	CVS Regular Strength Itch Stopping		Diphenhydramine hydrochloride, Zinc acetate	CREAM	TOPICAL	20140317		OTC MONOGRAPH DRUG	M017	CVS	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-623_0a5a9c44-1464-541c-e063-6394a90aa3cd	69842-623	HUMAN OTC DRUG	PM Toothache Relief		Benzocaine	CREAM	DENTAL	20231117		OTC MONOGRAPH DRUG	M017	CVS	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL; ZINC CHLORIDE	.13; 20; .26; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-626_87715662-c789-9a8d-e053-2a95a90acb53	69842-626	HUMAN OTC DRUG	CVS Anti-Itch		Camphor, Menthol	LOTION	TOPICAL	20160414		OTC MONOGRAPH NOT FINAL	part348	CVS	CAMPHOR (SYNTHETIC); MENTHOL	.5; .5	g/100g; g/100g			N	20241231
69842-628_09079688-4a35-fb60-e063-6394a90ae488	69842-628	HUMAN OTC DRUG	EXTRA STRENGTH HEARTBURN RELIEF		aluminum hydroxide and magnesium carbonate	SUSPENSION	ORAL	20170201		OTC MONOGRAPH DRUG	M001	CVS PHARMACY,INC.	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
69842-631_f2f236d8-7300-7583-e053-2a95a90a426e	69842-631	HUMAN OTC DRUG	4x Medicated Toothache and Gum Cream		Benzocaine	CREAM	ORAL	20200605		OTC MONOGRAPH NOT FINAL	part356	CVS	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .26; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-633_0bdf3bc9-3715-9494-e063-6394a90a573f	69842-633	HUMAN OTC DRUG	CVS Health Stool Softener Clear		Docusate sodium	CAPSULE	ORAL	20200211		OTC MONOGRAPH DRUG	M007	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-634_b289087c-c663-48d8-9962-2eeaf3d53e4e	69842-634	HUMAN OTC DRUG	CVS Long Acting Cough		Dextromethorphan HBr	LIQUID	ORAL	20220502		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-635_f76cc0a2-3113-4f4b-8fc9-79df584c9195	69842-635	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20221013		ANDA	ANDA207229	CVS Pharmacy, Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
69842-636_0bdd9005-2c8f-0df3-e063-6394a90ae2b4	69842-636	HUMAN OTC DRUG	CVS Health Extra Strength Acetaminophen Softgels		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20190605		OTC MONOGRAPH DRUG	M013	CVS Pharrmacy	ACETAMINOPHEN	500	mg/1			N	20241231
69842-637_b238bebf-2797-4cc8-bdab-e9ada225f9f7	69842-637	HUMAN OTC DRUG	CVS Health Maximum Strength Acne Treatment	Acne Medication	Benzoyl Peroxide	GEL	TOPICAL	20140101		OTC MONOGRAPH FINAL	part333D	CVS Health	BENZOYL PEROXIDE	100	mg/mL			N	20241231
69842-638_45d94180-4436-7298-e054-00144ff88e88	69842-638	HUMAN OTC DRUG	CVS Pharmacy	Sensitive Medicated Cream	Benzocaine, Benzalkonium Chloride	CREAM	TOPICAL	20050501		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	BENZALKONIUM CHLORIDE; BENZOCAINE	.0013; .05	g/g; g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-639_e99c6777-bbfc-42dc-b9ec-088404d20c0f	69842-639	HUMAN OTC DRUG	CVS Childrens Cold and Allergy		Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20200330		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-641_d5d6dc11-5ff8-49d1-9a3a-1ba9a49b30ce	69842-641	HUMAN OTC DRUG	allergy relief d 12		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180419		ANDA	ANDA076050	CVS Pharmacy	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-642_f2f23d5b-d690-7f6b-e053-2995a90a7e84	69842-642	HUMAN OTC DRUG	4x Medicated Toothache and Gum Gel		Benzocaine	GEL	ORAL	20200605		OTC MONOGRAPH NOT FINAL	part356	CVS	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	.13; 20; .5; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-643_0f10ca23-0d40-4a56-a047-2fa14c9dd477	69842-643	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20181231		ANDA	ANDA206568	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-644_17d2a71f-84ad-4373-9129-3d652c73ec6b	69842-644	HUMAN OTC DRUG	anti diarrheal and anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20190806		ANDA	ANDA209837	CVS Pharmacy	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
69842-646_a0389aed-6c48-4448-bb74-2c81bd9cf46a	69842-646	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20190322		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy	BENZOYL PEROXIDE	1	mg/g			N	20241231
69842-647_d32db7b7-d4e4-4f10-a5df-223c0a18192d	69842-647	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	CVS	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-648_ee3fdd69-4492-418d-b14c-42c4a1851548	69842-648	HUMAN OTC DRUG	Nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20180625		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-649_ba266ea0-de18-4934-9684-c6cb72c5ff3e	69842-649	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20181231		ANDA	ANDA206568	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-651_0356707f-b9fd-4977-b551-04c22cc079bd	69842-651	HUMAN OTC DRUG	Congestion and Headache		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20130630		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-652_043e00d5-418d-0cc7-e063-6394a90ac25d	69842-652	HUMAN OTC DRUG	Antibacterial Lidocaine Wound Gel		benzalkonium chloride, lidocaine hydrochloride	GEL	TOPICAL	20191028		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; 2	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-655_0bde79c5-e528-ea0b-e063-6294a90a0ab9	69842-655	HUMAN OTC DRUG	CVS Health Maximum Strength Non Drowsy Day and Night Cold and Flu Max Softgels Minis		acetaminophen, dextrmethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20190606		OTC MONOGRAPH DRUG	M012	CVS Pharmacy						N	20241231
69842-656_a4876887-b6b9-4582-a51e-7b009939b832	69842-656	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190331	20250331	ANDA	ANDA200888	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
69842-657_488d4a61-8130-45bc-b2b3-9000dd42a1c3	69842-657	HUMAN OTC DRUG	Daytime and Nighttime Cough and Chest Congestion	Childrens	Dextromethorphan HBr, Guaifenesin, Chlorpheniramine maleate	KIT		20190219		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-659_8c8f53ee-d7fa-421d-a68a-94999fed0c8e	69842-659	HUMAN OTC DRUG	acid reducer		famotidine	TABLET, FILM COATED	ORAL	20220404		ANDA	ANDA077351	CVS Pharmacy	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69842-660_f2f236d8-7301-7583-e053-2a95a90a426e	69842-660	HUMAN OTC DRUG	3x Medicated Mouth Sore Gel		Benzocaine	GEL	ORAL	20200605		OTC MONOGRAPH NOT FINAL	part356	CVS	BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	20; .1; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-661_da99bac0-618e-4d9f-919f-4a55b1358e39	69842-661	HUMAN OTC DRUG	Omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220328		NDA	NDA022032	CVS Pharmacy	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-662_e28966ae-f1f7-42af-a43c-0ceca673e4f6	69842-662	HUMAN OTC DRUG	Nicotine	Sugar Free	nicotine polacrilex	LOZENGE	ORAL	20200529		ANDA	ANDA207868	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-664_e81d5bbf-61f6-2913-e053-2995a90aa1ce	69842-664	HUMAN OTC DRUG	CVS HEALTH LIVE BETTER BODY MINERAL SUNSCREEN SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20200121		OTC MONOGRAPH FINAL	part347	CVS PHARMACY	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/mL; mg/mL			N	20241231
69842-665_5975ecc9-d39c-47a0-ac84-ec5052c96ec8	69842-665	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20200529	20250529	OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
69842-669_40b0afde-51a3-4375-8e4d-1cea34494e2e	69842-669	HUMAN OTC DRUG	Antibiotic, Pain and Scar		Bacitracin Zinc, Neomycin sulfate, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20170220		OTC MONOGRAPH FINAL	part333B	CVS Pharmacy	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-672_463121c0-3b4b-455d-aba4-72d168f223c1	69842-672	HUMAN OTC DRUG	Sleep-Aid	Nighttime	diphenhydramine HCl	TABLET, FILM COATED	ORAL	20150724		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-677_0bdd9005-2c95-0df3-e063-6394a90ae2b4	69842-677	HUMAN OTC DRUG	CVS Health Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20190605		OTC MONOGRAPH DRUG	M002	CVS Pharmacy	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
69842-679_5f6c3507-6538-413e-bcd1-3aa073eaa213	69842-679	HUMAN OTC DRUG	Acid Reducer		Esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20211231		ANDA	ANDA212088	CVS Pharmacy	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-680_0ce259b1-3dc4-177f-e063-6294a90a29d0	69842-680	HUMAN OTC DRUG	Acetaminophen Aspirin Caffeine		Acetaminophen Aspirin Caffeine	TABLET	ORAL	20210705		ANDA	ANDA214039	CVS PHARMACY, INC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
69842-683_0907bdf4-478e-5168-e063-6294a90abb1a	69842-683	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID CHERRY		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	20180201		OTC MONOGRAPH DRUG	M001	CVS	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-685_978437c9-4f32-40d3-b19b-a0b3e5a76ed8	69842-685	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20180531		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-686_ed31ddeb-d2ac-0c91-e053-2a95a90adc39	69842-686	HUMAN OTC DRUG	LORATADINE		LORATADINE	CAPSULE, LIQUID FILLED	ORAL	20170131		ANDA	ANDA206214	CVS HEALTH CORP	LORATADINE	10	mg/1			N	20241231
69842-687_51a1cf2b-23a4-42f4-81f3-0ca3d8c06ad1	69842-687	HUMAN OTC DRUG	CVS Health Cold Remedy	Cherry Flavor	Zincum Gluconicum	TABLET	ORAL	20190417		UNAPPROVED HOMEOPATHIC		CVS PHARMACY, INC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-688_611f7b44-4b18-48c4-92d5-d81222e67ebe	69842-688	HUMAN OTC DRUG	CVS Health Cold Remedy	Citrus Flavor	ZINC GLUCONATE	TABLET	ORAL	20190418		UNAPPROVED HOMEOPATHIC		CVS PHARMACY, INC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-689_5b7349a8-3f2d-4d4d-a018-f3011e05820b	69842-689	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-690_b3be5d2e-a30d-46b2-acd7-5a82a93415e6	69842-690	HUMAN OTC DRUG	CVS Health Cold Remedy	Lemon Flavor	Zincum Gluconicum	TABLET	ORAL	20190416		UNAPPROVED HOMEOPATHIC		CVS PHARMACY, INC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-691_db14a231-2e33-4bdf-9148-1f4b4ed81e1c	69842-691	HUMAN OTC DRUG	CVS Health Cold Remedy	Orange Cream Flavor	Zincum Gluconicum	TABLET	ORAL	20190418		UNAPPROVED HOMEOPATHIC		CVS PHARMACY, INC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-692_c2c9d7c0-a092-4cb6-973f-456b2a1d8fef	69842-692	HUMAN OTC DRUG	Cold and Flu HBP		Acetaminophen, Chlorpheniramine maleate	TABLET, FILM COATED	ORAL	20170716		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	325; 2	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-693_f2f23228-fc35-2678-e053-2995a90a599d	69842-693	HUMAN OTC DRUG	3x Medicated Toothache and Gum Gel		Benzocaine	GEL	ORAL	20200605		OTC MONOGRAPH NOT FINAL	part356	CVS	BENZOCAINE; MENTHOL, UNSPECIFIED FORM; ZINC CHLORIDE	20; .26; .15	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
69842-695_83b6c762-ae49-4ed8-bb5b-010176af9f44	69842-695	HUMAN OTC DRUG	Cold Sore Treatment		Camphor, Menthol, Phenol, White Petrolatum	GEL	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part333E	CVS Pharmacy	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
69842-696_f66bc48f-4891-443a-8333-cd83aca44f47	69842-696	HUMAN OTC DRUG	CVS Mucus Relief DM and Overnight Cold and Flu		Dextromethorphan HBr, Guaifenesin, Acetaminophen and Triprolidine HCl	KIT		20200330		OTC MONOGRAPH FINAL	part341	CVS						N	20241231
69842-697_6dc7eb3a-fa46-45c8-a21b-a1321e3b121a	69842-697	HUMAN OTC DRUG	oil-free moisturizer		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20200315		OTC MONOGRAPH FINAL	part352	CVS Pharmacy	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
69842-699_e93cba5c-e83c-4022-b558-ec30dd54dc76	69842-699	HUMAN OTC DRUG	Tussin DM		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20180625		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/20mL; mg/20mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-702_204ed9e4-75aa-4484-b447-fa87287035bf	69842-702	HUMAN OTC DRUG	CVS Health Diaper Rash		Zinc Oxide	OINTMENT	TOPICAL	20180630		OTC MONOGRAPH FINAL	part347	CVS Health	ZINC OXIDE	400	mg/g			N	20241231
69842-703_a326bb0f-7501-4052-97a3-440d4e2d88c9	69842-703	HUMAN OTC DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200319		ANDA	ANDA207193	CVS Pharmacy	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-704_16c67165-aacb-4f32-b65b-949261ac97de	69842-704	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20171031	20250530	ANDA	ANDA079112	CVS Pharmacy	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69842-706_2ec13f9a-0bce-4cb0-85c9-5f764f00dea3	69842-706	HUMAN OTC DRUG	childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20190611		ANDA	ANDA076359	CVS Pharmacy	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-708_29e8cf2c-fa9e-4b91-b7ef-63604406a056	69842-708	HUMAN OTC DRUG	CVS Anti Nausea	Cherry Flavor	Dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20200331		UNAPPROVED DRUG OTHER		CVS PHARMACY	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
69842-712_45d99cac-2d16-0806-e054-00144ff88e88	69842-712	HUMAN OTC DRUG	CVS Sore Muscle Rub	Vanishing Scent	Menthol	CREAM	TOPICAL	20080601		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	MENTHOL	.025	g/g			N	20241231
69842-713_45f70daf-ddf2-4a0d-ab8d-6858e4ac9905	69842-713	HUMAN OTC DRUG	CVS Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190918		UNAPPROVED DRUG OTHER		CVS PHARMACY INC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
69842-714_dc124a43-a8f3-48ea-bb6e-f24fb67192d9	69842-714	HUMAN OTC DRUG	CVS Stool Softener	Fruit Punch	Docusate sodium	LIQUID	ORAL	20190425		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY, INC	DOCUSATE SODIUM	50	mg/5mL			N	20241231
69842-715_6c748dbd-48e5-475e-85a5-26f126622565	69842-715	HUMAN OTC DRUG	CVS Health	Sinus	Oxymetazoline Hydrochloride	SPRAY	NASAL	20190312		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-716_2c9624ef-c015-4ae6-b341-8968a375832d	69842-716	HUMAN OTC DRUG	Extra Strength Smooth Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20151103		OTC MONOGRAPH FINAL	part331	CVS	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
69842-717_ae26cea0-9a19-4b46-9635-633c3bab6dea	69842-717	HUMAN OTC DRUG	CVS Severe Congestion and Pain Relief		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20200330		OTC MONOGRAPH FINAL	part341	CVS	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-718_45d9c7f6-bb6a-11cd-e054-00144ff88e88	69842-718	HUMAN OTC DRUG	CVS Pharmacy	Maximum Strength Antifungal Liquid with Aloe and Vitamin E	Undecylenic acid	LIQUID	TOPICAL	20100501		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	UNDECYLENIC ACID	.25	g/L			N	20241231
69842-719_33c0de71-7f74-445c-87f8-b4631cc0828c	69842-719	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20200805		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-720_2dfce218-f1f0-48fe-a467-19ff5856b3cb	69842-720	HUMAN OTC DRUG	Mucus Relief Daytime Severe Cold Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20190130	20240426	OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	
69842-721_aff8b9ea-3f0a-4112-881f-9662e1e62570	69842-721	HUMAN OTC DRUG	CVS Senna Laxative		SENNOSIDES	LIQUID	ORAL	20190409		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY	SENNOSIDES	25	mg/15mL			N	20241231
69842-722_0c004bf0-9028-5ffc-e063-6294a90a6c3c	69842-722	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20160818		OTC MONOGRAPH DRUG	M007	CVS Pharmacy	GLYCERIN	1	g/1.21	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69842-723_ab8cbab2-d180-4955-adc1-2971427018df	69842-723	HUMAN OTC DRUG	cooling severe daytime		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20200207		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-724_0c003fc8-46ef-594e-e063-6294a90ae91d	69842-724	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20191014		OTC MONOGRAPH DRUG	M007	CVS Pharmacy	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69842-725_ad666a58-7ef0-483f-81cd-ca2dc9f751ad	69842-725	HUMAN OTC DRUG	CVS Health Advanced Scar Gel		Advanced Scar Gel	GEL	TOPICAL	20190522		OTC MONOGRAPH FINAL	part347	CVS Health	ALLANTOIN	5	mg/g			N	20241231
69842-725_d59ccac7-3944-4bbb-9dcc-4a5d8ea7b9cb	69842-725	HUMAN OTC DRUG	CVS Health Advanced Scar Gel		Advanced Scar Gel	GEL	TOPICAL	20190522		OTC MONOGRAPH FINAL	part347	CVS Health	ALLANTOIN	5	mg/g			N	20241231
69842-726_7a55e355-1551-4eb3-a05d-b377212acf04	69842-726	HUMAN OTC DRUG	CVS Health	Ultra Fine Mist	Oxymetazoline Hydrochloride	SPRAY	NASAL	20190312		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-729_4b888c31-3c17-4569-a939-eac83fb67dd6	69842-729	HUMAN OTC DRUG	Diclofenac Sodium		diclofenac sodium	GEL	TOPICAL	20210928		ANDA	ANDA211253	CVS Pharmacy	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-732_04b72517-4fa1-4bdf-a254-a582c6d5e542	69842-732	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20190228		ANDA	ANDA207342	CVS Pharmacy	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69842-733_58c5339b-d42e-458a-ada8-fcb073b82270	69842-733	HUMAN OTC DRUG	Daytime Nighttime	cold and flu relief	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20160623		OTC MONOGRAPH DRUG	M012	CVS Pharmacy						N	20241231
69842-734_25a03ccc-2e3b-49c9-a8ae-33e1dfb1395c	69842-734	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20181231	20240426	OTC MONOGRAPH FINAL	part338	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69842-737_a7d5d483-8562-4633-a497-5f4467d0cb48	69842-737	HUMAN OTC DRUG	cooling severe daytime cooling severe nighttime		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride,Guaifenesin	KIT		20190723		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-738_a72acf62-e1d5-4549-bba8-0d2edf24e724	69842-738	HUMAN OTC DRUG	Flu HBP	Maximum Strength	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20200109	20240624	OTC MONOGRAPH DRUG	M012	CVS PHARMACY	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
69842-740_2fdeea47-113e-4512-aa51-21f30755c96c	69842-740	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210801		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	250	mg/1			N	20241231
69842-741_67ce91b6-27ea-48a9-8179-d2d0a69d3a8b	69842-741	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180228		ANDA	ANDA207235	CVS Pharmacy	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-742_ff4ad0b3-8cdc-4aee-ae0d-00ca51a1d1b0	69842-742	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20180930	20240426	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69842-744_7204ca0a-3bd2-46b9-8d26-9a28f1e1d3ae	69842-744	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20181231	20240426	OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	
69842-745_64e51d67-6cc0-4168-9bc6-c9cf2b3e1920	69842-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA206568	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-746_0d378c3a-a2a7-2c6e-e063-6294a90a3a73	69842-746	HUMAN OTC DRUG	CVS Lubricant Eye Drops Original		Polyethylene glycol 400, Propylene glycol	SOLUTION	OPHTHALMIC	20210212		OTC MONOGRAPH DRUG	M018	CVS	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
69842-747_58d441ae-019c-4660-a7cd-d3d02a8f5f72	69842-747	HUMAN OTC DRUG	Stimulant Laxative		Sennosides	TABLET, SUGAR COATED	ORAL	20200330		OTC MONOGRAPH DRUG	505G(a)(3)	CVS PHARMACY	SENNOSIDES	15	mg/1			N	20241231
69842-748_60d52aff-3426-4077-bcff-2ae91c96bd0f	69842-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20180401		ANDA	ANDA208363	CVS Pharmacy	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-749_0d19a0a5-ed0c-1796-e063-6294a90a7e8f	69842-749	HUMAN OTC DRUG	CVS Merthiolate		Benzalkonium Chloride	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	CVS Pharmacy	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69842-750_db4848e4-a6f5-4c39-b942-1adfc70b5ea4	69842-750	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	19930402		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	500	mg/1			N	20241231
69842-752_0d376b0b-0989-5527-e063-6394a90acce9	69842-752	HUMAN OTC DRUG	CVS Lubricant Eye Drops Ultra		Polyethylene glycol 400, Propylene glycol	SOLUTION	OPHTHALMIC	20210212		OTC MONOGRAPH DRUG	M018	CVS	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
69842-753_03f521f4-d35f-4f66-b3ad-7e58a244eb93	69842-753	HUMAN OTC DRUG	CVS Health Nighttime Sleep Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20171011		OTC MONOGRAPH FINAL	part341	CVS Pharmacy,Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-754_c4869f73-31e9-4854-8985-f1fa6c68e946	69842-754	HUMAN OTC DRUG	Antibiotic and Pain Relief		neomycin, polymyxin B, pramoxine hydrochloride	CREAM	TOPICAL	20210205		OTC MONOGRAPH FINAL	part333B	CVS Pharmacy	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69842-755_4d0ac191-1594-4d7a-a882-dc063c14a767	69842-755	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190331		ANDA	ANDA203187	CVS Pharmacy	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-756_903ba3b4-663f-4abb-9905-a2b5cd19d65f	69842-756	HUMAN OTC DRUG	Congestion and Cough	Childrens	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20180701		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-757_fa539000-9f49-4f9f-ba36-86c458d50a26	69842-757	HUMAN OTC DRUG	FLUTICASONE PROPIONATE		Fluticasone Propionate	SPRAY, METERED	NASAL	20180625		ANDA	ANDA207957	CVS Pharmacy	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-760_b5faeb31-67c8-2000-e053-2995a90a1409	69842-760	HUMAN OTC DRUG	CVS Hand Sanitizer		Alcohol	GEL	TOPICAL	20201208		OTC MONOGRAPH NOT FINAL	part333A	CVS	ALCOHOL	70	mL/100mL			N	20241231
69842-761_862da1ce-f44c-38d1-f480-a713d662fa8c	69842-761	HUMAN OTC DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180415		ANDA	ANDA210375	CVS PHARMACY	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-763_306659a3-5ba2-4d79-b5fd-569588bacf22	69842-763	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-764_04c68b4d-db0c-4722-b1e1-4eaf855dbbd2	69842-764	HUMAN OTC DRUG	8HR muscle aches and pain		acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200109		ANDA	ANDA075077	CVS Pharmacy	ACETAMINOPHEN	650	mg/1			N	20241231
69842-765_1a4825e1-3a0f-1ef9-f831-aeb01e991873	69842-765	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20190912		ANDA	ANDA208150	CVS Pharmacy	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-766_72b25d39-4aa6-457f-9538-8040add3ecd9	69842-766	HUMAN OTC DRUG	regular strength	pink bismuth	Bismuth subsalicylate	SUSPENSION	ORAL	20190925		OTC MONOGRAPH FINAL	part335	CVS PHARMACY, INC.	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
69842-767_b0215cc4-5274-4460-8716-ec190132d6a1	69842-767	HUMAN OTC DRUG	CVS Maximum Strength Severe Congestion and Cough		dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	LIQUID	ORAL	20200331		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-768_ef6c032d-7807-d552-e053-2a95a90a84dc	69842-768	HUMAN OTC DRUG	Effervescent Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20151029	20241231	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	
69842-769_5e872aa2-43c0-44fb-bc9c-9bbe46aec672	69842-769	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20190417		ANDA	ANDA203690	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-770_3e9cf347-40fe-5a04-bc8e-1b9cb39df09c	69842-770	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20190912		ANDA	ANDA208150	CVS Pharmacy	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-771_dc7d799e-e92f-44cd-85c1-72d419b5e79c	69842-771	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20201214		OTC MONOGRAPH FINAL	part347	CVS Pharmacy	DIMETHICONE	1.3	kg/100mL	Skin Barrier Activity [PE]		N	20241231
69842-773_d67d1e22-fdfe-359d-e053-2a95a90a7ab0	69842-773	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210108		OTC MONOGRAPH NOT FINAL	part333A	Moisturizing Hand Sanitizer	ALCOHOL	70	mL/100mL			N	20241231
69842-773_d67eaefa-0f6d-9b65-e053-2a95a90a8098	69842-773	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210108		OTC MONOGRAPH NOT FINAL	part333A	Moisturizing Hand Sanitizer	ALCOHOL	70	mL/100mL			N	20241231
69842-773_d67eb6da-5476-736c-e053-2995a90a4c21	69842-773	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210108		OTC MONOGRAPH NOT FINAL	part333A	Moisturizing Hand Sanitizer	ALCOHOL	70	mL/100mL			N	20241231
69842-773_d67eb6da-5484-736c-e053-2995a90a4c21	69842-773	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210108		OTC MONOGRAPH NOT FINAL	part333A	Moisturizing Hand Sanitizer	ALCOHOL	70	mL/100mL			N	20241231
69842-773_d69747d8-db98-b662-e053-2995a90ab0a4	69842-773	HUMAN OTC DRUG	Moisturizing Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210108		OTC MONOGRAPH NOT FINAL	part333A	Moisturizing Hand Sanitizer	ALCOHOL	70	mL/100mL			N	20241231
69842-775_b576e066-b68f-46b2-96e2-f6d36cd1e811	69842-775	HUMAN OTC DRUG	Salicylic Acid		Astringent	LIQUID	TOPICAL	20090605		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy, Inc	SALICYLIC ACID	5	mg/mL			N	20241231
69842-776_bff8e8db-446f-416e-997a-08582ff06de4	69842-776	HUMAN OTC DRUG	Laxative Stool Softener		Docusate Sodium, Sennosides	TABLET	ORAL	20191227		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69842-779_a2191412-369e-4c58-a944-494f25213329	69842-779	HUMAN OTC DRUG	Childrens Cold and Allergy		Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20210201		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-780_0bf1bed2-016a-0e32-e063-6294a90a025c	69842-780	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20201021		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	500	mg/1			N	20241231
69842-781_33418f42-d235-4368-abf7-751c070208ef	69842-781	HUMAN OTC DRUG	CVS Health	No Drip	Allergy Nasal	SPRAY	NASAL	20190522		OTC MONOGRAPH FINAL	part341	CVS PHARMACY,INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-782_046a25ea-8ea1-4923-b1df-075952ff0c53	69842-782	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210205		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-783_0bdfa38b-0b6c-1720-e063-6294a90a85b5	69842-783	HUMAN OTC DRUG	MAXIMUM STRENGTH CHEST CONGESTION AND COUGH		Dextromethorphan Hydrobromide and Guaifenesin	CAPSULE, GELATIN COATED	ORAL	20210113		OTC MONOGRAPH DRUG	M012	CVS PHARMACY, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-785_0c00ce17-e62d-f818-e063-6394a90ae5be	69842-785	HUMAN OTC DRUG	Hemorrhoidal		Cocoa Butter, Phenylephrine HCl	SUPPOSITORY	RECTAL	20190315		OTC MONOGRAPH DRUG	M015	CVS Pharmacy	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2.39; 6.75	g/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-786_af0ab06f-bec4-2922-e053-2a95a90a01ac	69842-786	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion and Pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200901		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-787_0bdee259-a5be-7554-e063-6394a90a1b1f	69842-787	HUMAN OTC DRUG	Daytime Severe Cold and Flu Relief		ACETAMINOHPEN, DEXTROMETHORPHAN HBr, Guaifenesin, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20210825		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-789_c65be4e4-2653-5d9e-e053-2a95a90a16ee	69842-789	HUMAN OTC DRUG	MAXIMUM STRENGTH COLD AND FLU		ACETAMINOPHEN,DEXTROMETHORPHAN HYDROBROMIDE,GUAIFENESIN,PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210710		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-791_deedf3aa-2740-4762-b2c9-482226945660	69842-791	HUMAN OTC DRUG	Omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180227		NDA	NDA209400	CVS Pharmacy	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-792_92119f48-aa75-4f6c-8d76-72a4ad428f1d	69842-792	HUMAN OTC DRUG	CVS Childrens	Cold plus Cough plus Runny Nose	Acetaminophen, Chlorpheniramine Maleate, and Dextromethorphan Hydrobromide	SUSPENSION	ORAL	20200330		OTC MONOGRAPH FINAL	part341	CVS	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	160; 1; 5	mg/5mL; mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-794_466b7fbc-8c30-44b4-ac05-fe0fa3ddab95	69842-794	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210205		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-796_efb77d3a-f511-9cca-e053-2a95a90af1c7	69842-796	HUMAN OTC DRUG	Mucus Relief Sinus Pressure Pain and Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200901		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-797_a0c6d7af-954c-4198-af09-908b388a3423	69842-797	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20211222		ANDA	ANDA075357	CVS Pharmacy	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69842-798_f362428e-d139-4c4f-a2e6-de433db1b6ca	69842-798	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	SOLUTION	ORAL	20201027		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/20mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-799_0bdf40ec-f2ef-97df-e063-6394a90a6ca8	69842-799	HUMAN OTC DRUG	Bismuth Subsalicylate		Bismuth Subsalicylate	CAPSULE, GELATIN COATED	ORAL	20200709		OTC MONOGRAPH DRUG	M008	CVS PHARMACY, INC.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
69842-800_3f31a8d2-7ca8-4f62-92d6-880885ec2000	69842-800	HUMAN OTC DRUG	Nighttime Severe		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	SOLUTION	ORAL	20160623		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-801_4663a201-42a7-692b-e054-00144ff88e88	69842-801	HUMAN OTC DRUG	Nuance Salma Hayek Renewed Radiance Brightening BB Cream Broad Spectrum SPF 30 Sunscreen		Nuance Salma Hayek Renewed Radiance Brightening BB Cream Broad Spectrum SPF 30 Sunscreen	LOTION	TOPICAL	20170118		OTC MONOGRAPH FINAL	part352	CVS Pharmacy, Inc	OCTINOXATE; TITANIUM DIOXIDE	7.5; 10	g/100g; g/100g			N	20241231
69842-803_f72949c7-5072-452f-a793-98f123121921	69842-803	HUMAN OTC DRUG	Severe Cold and Flu Relief	Daytime/Nighttime	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	KIT		20050804		OTC MONOGRAPH DRUG	M012	CVS PHARMACY						N	20241231
69842-804_0d3793db-6202-5761-e063-6394a90ae69b	69842-804	HUMAN OTC DRUG	CVS Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20190730		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
69842-806_8204b2b0-52b9-4233-b583-b2d294d13c77	69842-806	HUMAN OTC DRUG	mucus		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA078912	CVS Pharmacy	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69842-807_005cc87d-19ba-4fe3-aa68-a460e81b7d3a	69842-807	HUMAN OTC DRUG	loperamide hydrochloride and simethicone		loperamide hydrochloride, simethicone	TABLET	ORAL	20181008		ANDA	ANDA209837	CVS Pharmacy	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
69842-811_9b8acc2e-f0a1-419f-974c-20ef73d95503	69842-811	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20180509		ANDA	ANDA074661	CVS Pharmacy	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-812_1bc37ee4-df27-4358-b724-6b55406dbce6	69842-812	HUMAN OTC DRUG	mucus dm extended release		guaifenesin, dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20180503		ANDA	ANDA207602	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-814_e305b3f8-061c-467b-bd2a-be3d7b5dd39b	69842-814	HUMAN OTC DRUG	CVS Health Lidocaine Cream		Lidocaine	CREAM	TOPICAL	20190903		OTC MONOGRAPH NOT FINAL	part348	CVS Health	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-815_8f42d7b5-5a90-463a-a35e-9f281b0f67d3	69842-815	HUMAN OTC DRUG	CVS Health	No Drip	Nasal Mist	SPRAY	NASAL	20190522		OTC MONOGRAPH FINAL	part341	CVS PHARMACY,INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
69842-816_0c004bf0-9025-5ffc-e063-6294a90a6c3c	69842-816	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	SUPPOSITORY	RECTAL	20210414		OTC MONOGRAPH DRUG	M007	CVS Pharmacy	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-819_b24c3c42-6811-43e8-9339-f5d718fb9268	69842-819	HUMAN OTC DRUG	tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180504		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-820_3a14690c-cb44-4546-8fab-3ef6f892a773	69842-820	HUMAN OTC DRUG	Multi Symptom Cold and Multi Symptom Nighttime Cold	Childrens	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	KIT		20170228	20250228	OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	
69842-821_1b2f3171-7abb-4c20-a5af-c767982f5060	69842-821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	CREAM	TOPICAL	20201230		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy	SALICYLIC ACID	20	mg/mL			N	20241231
69842-822_cc7d4a02-a75c-4807-8b6e-f748e8a4b42c	69842-822	HUMAN OTC DRUG	Daytime Nighttime Sinus Relief	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl,Guaifenesin	KIT		20190131	20241231	OTC MONOGRAPH DRUG	M012	CVS Pharmacy						N	
69842-823_79ae440c-e1fd-419f-a635-a5ac72792844	69842-823	HUMAN OTC DRUG	severe cold		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20180803		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-824_0c7dc0e1-7c50-ab15-e063-6294a90a15b5	69842-824	HUMAN OTC DRUG	Non Drowsy DAYTIME and NIGHTTIME Sinus Congestion and Cough Relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT	ORAL	20210825		OTC MONOGRAPH DRUG	M012	CVS PHARMACY, INC.						N	20241231
69842-825_a615a8dd-50bc-1a0b-e053-2995a90a28a6	69842-825	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20180620		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-826_76ee9ab0-0ce8-4adf-8694-f8b9056402d3	69842-826	HUMAN OTC DRUG	Aspirin	Enteric Safety Coated	Aspirin	TABLET	ORAL	20180831	20250831	OTC MONOGRAPH FINAL	part343	CVS Pharmacy	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
69842-828_fcada799-a1d2-4935-879c-0642b4270ac4	69842-828	HUMAN OTC DRUG	nicotine		nicotine	LOZENGE	ORAL	20200204		ANDA	ANDA203690	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-829_dfd06582-9355-4abc-8190-6bd6e6dfb1f4	69842-829	HUMAN OTC DRUG	Stool Softener	With Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20190430	20250430	OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
69842-830_c1552c5d-2e53-4348-a7f5-4bee56b8e317	69842-830	HUMAN OTC DRUG	Laxative Stool Softener		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20190501	20250501	OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
69842-831_08a00f71-95e3-6877-e063-6294a90a547f	69842-831	HUMAN OTC DRUG	CVS MAXIMUM STRENGTH ANTI FUNGAL PEN 25		UNDECYLENIC ACID	LIQUID	TOPICAL	20190109		OTC MONOGRAPH DRUG	M005	CVS Pharmacy	UNDECYLENIC ACID	250	mg/100mL			N	20241231
69842-832_e3cc371c-3222-4817-a498-47e737163f85	69842-832	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20181231		OTC MONOGRAPH FINAL	part332	CVS Pharmacy	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
69842-833_0bf19c0d-b3ac-f6f1-e063-6294a90a511f	69842-833	HUMAN OTC DRUG	SEVERE NIGHTTIME COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, GELATIN COATED	ORAL	20210825		OTC MONOGRAPH DRUG	M012	CVS PHARMACY, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-834_b61ddd66-9b48-12ae-e053-2995a90a3639	69842-834	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180723		OTC MONOGRAPH FINAL	part338	CVS Pharmacy, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-836_0bdf2125-a990-89f2-e063-6394a90aaa73	69842-836	HUMAN OTC DRUG	MAXIMUM STRENGTH Nighttime Sleep Aid		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210825		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-837_429baad8-4444-4353-9aa2-e0a422f44055	69842-837	HUMAN OTC DRUG	Severe Cold	Daytime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	CAPSULE	ORAL	20190130	20241231	OTC MONOGRAPH DRUG	M012	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
69842-843_ba6f8a55-3732-42a1-8f49-40c4f05225f0	69842-843	HUMAN OTC DRUG	CVS HEALTH HEMORRHOIDAL COOLING	HEMORRHOIDAL	PHENYLEPHRINE HYDROCHLORIDE and WITCH HAZEL	GEL	RECTAL	20040101		OTC MONOGRAPH FINAL	part346	CVS	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	2.5; 500	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-846_0bb2dd97-489e-faf1-e063-6394a90abccb	69842-846	HUMAN OTC DRUG	Calcium Polycarbophil		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20210517		OTC MONOGRAPH DRUG	M007	CVS Pharmacy, Inc	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
69842-847_d3dbef7a-21e6-4d69-bd91-067d5eb1390f	69842-847	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190331		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-848_50904651-bbc3-4de3-8d3e-9c26d8ddcac5	69842-848	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20190331		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-851_f6f48d8e-bfda-414f-b667-bd57156b55db	69842-851	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180930	20250530	ANDA	ANDA206999	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
69842-852_e60ea729-7ad9-46b8-82ee-626b15a83410	69842-852	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20190601		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-857_ef570c52-e4a8-1ee2-e053-2a95a90afc3f	69842-857	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200813		OTC MONOGRAPH FINAL	part336	CVS Pharmacy, Inc	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
69842-858_0937c3fe-baba-4460-a6b3-51676cbcafad	69842-858	HUMAN OTC DRUG	Nicotine	Sugar Free	nicotine polacrilex	LOZENGE	ORAL	20190430		ANDA	ANDA209206	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-860_631e762a-ccbb-4b39-805c-8b23bad7005b	69842-860	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCL	CAPSULE	ORAL	20191129		OTC MONOGRAPH FINAL	part338	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-861_e7f8d1ad-af8a-44fc-840b-f520ecbf4d2e	69842-861	HUMAN OTC DRUG	Stool Softener		Docusate sodium	CAPSULE	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-862_51e5ab39-3077-4422-8d49-9666baf1519e	69842-862	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE	ORAL	20200131		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-863_cc9ada24-75bb-46e2-9a5b-a4f31e88594c	69842-863	HUMAN OTC DRUG	Nasal Decongestant	PE, Non-Drowsy	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200618		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-864_c4473ee6-4e02-1ec2-e053-2995a90ac513	69842-864	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20210317		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
69842-866_3cc572bc-ed77-43f1-a68f-007c98b78e08	69842-866	HUMAN OTC DRUG	CVS Clotrimazole	Maximum Strength	CLOTRIMAZOLE	SOLUTION	TOPICAL	20020201		OTC MONOGRAPH FINAL	part333C	CVS Pharmacy	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69842-867_414659a4-05cd-1c8a-b639-93e755fd20a6	69842-867	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA078343	CVS Health Corp.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-868_8bdb6c84-caff-4d94-8cba-b7f70c39c90a	69842-868	HUMAN OTC DRUG	Stool Softener Laxative		Docusate calcium	CAPSULE, LIQUID FILLED	ORAL	20191227		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE CALCIUM	240	mg/1			N	20241231
69842-869_bacda134-86bb-85b2-6559-07560c8feccf	69842-869	HUMAN OTC DRUG	Acid Reducer		Ranitidine	TABLET, COATED	ORAL	20100501		ANDA	ANDA078192	CVS HEALTH CORP	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69842-870_f0d4869d-7769-7121-e053-2995a90a562e	69842-870	HUMAN OTC DRUG	Ibuprofen PM		IBUPROFEN, DIPHENHYDRAMINE HCL	CAPSULE, LIQUID FILLED	ORAL	20211019		ANDA	ANDA090397	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-871_22059598-a557-ec16-5c0a-46053a31f4ac	69842-871	HUMAN OTC DRUG	Acid Reducer		Ranitidine	TABLET	ORAL	20090701		ANDA	ANDA075294	CVS HEALTH CORP	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69842-872_fbc01f5d-ad83-5da3-e053-6294a90a3786	69842-872	HUMAN OTC DRUG	CVS Pharmacy	Pro Defense	Fluoride	PASTE, DENTIFRICE	DENTAL	20170601		OTC MONOGRAPH FINAL	part355	CVS Pharmacy	STANNOUS FLUORIDE	.454	g/100g			N	20241231
69842-875_c09556b4-ace0-c375-e053-2995a90ac3cb	69842-875	HUMAN OTC DRUG	Effervescent Orange Cold Relief		Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate	TABLET, EFFERVESCENT	ORAL	20170310		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc.	ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE	325; 2; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-876_26560bd5-d0a8-4367-aaab-bcecf88c98ec	69842-876	HUMAN OTC DRUG	Acetaminophen	Regular Strength	Acetaminophen	TABLET, COATED	ORAL	20150724		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	325	mg/1			N	20241231
69842-878_175758e6-6486-46a0-bb42-a0c13d26c002	69842-878	HUMAN OTC DRUG	Pain Reliever fever Reducer	Extra Strength	Acetaminophen	LIQUID	ORAL	20180430		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	500	mg/15mL			N	20241231
69842-879_9d2ca0b0-4250-4f91-a580-3a4793aa62c6	69842-879	HUMAN OTC DRUG	Stool Softener	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	250	mg/1			N	20241231
69842-881_f810382a-707e-4ba3-8349-0fdf060420fb	69842-881	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69842-882_adcb86c5-c053-4a28-9b1b-9da6742d3b04	69842-882	HUMAN OTC DRUG	Sinus Relief	Daytime, Nighttime, Maximum Strength	Acetaminophen, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20170701		OTC MONOGRAPH DRUG	M012	CVS PHARMACY						N	20241231
69842-883_69ee57a4-727b-4263-8deb-86daa89b04d5	69842-883	HUMAN OTC DRUG	Senna Plus		DOCUSATE SODIUM, SENNOSIDES	TABLET	ORAL	20191227		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69842-884_0d378c3a-a2a8-2c6e-e063-6294a90a3a73	69842-884	HUMAN OTC DRUG	CVS Multi-Symptom Eye Drops		Polyethylene glycol 400, Tetrahydrozoline HCl, Zinc Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20220516		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	1; .05; .25	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69842-886_bcb70aaa-3715-4f90-a12f-804b1b1c7531	69842-886	HUMAN OTC DRUG	CVS Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20200330		OTC MONOGRAPH FINAL	part341	CVS HEALTH	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-887_b711c9fd-2c23-41dc-8ead-f9a90c99f7db	69842-887	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20210201		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
69842-892_f0d44a8a-f4d2-dabb-e053-2995a90a561a	69842-892	HUMAN OTC DRUG	Ibuprofen Migraine		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20211020		ANDA	ANDA078682	CVS Pharmacy	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-893_062987b9-9fad-472d-9e18-98179492806d	69842-893	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210730		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	DOCUSATE SODIUM	100	mg/1			N	20241231
69842-894_0ea6e88f-9c32-1fe5-e063-6394a90ae867	69842-894	HUMAN OTC DRUG	Dye-Free Childrens Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20200817		ANDA	ANDA210088	CVS PHARMACY, INC	LORATADINE	5	mg/1			N	20251231
69842-895_0ea6ebde-dfba-7e7e-e063-6294a90a812c	69842-895	HUMAN OTC DRUG	Dye-Free Childrens Loratadine		Loratadine	TABLET, CHEWABLE	ORAL	20200817		ANDA	ANDA210088	CVS PHARMACY, INC	LORATADINE	5	mg/1			N	20251231
69842-896_7273a7b2-a79e-477f-ab90-b9d7deb2b191	69842-896	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20190731		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-897_ddff6713-061b-4601-b363-4965190421ea	69842-897	HUMAN OTC DRUG	Daytime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190731		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-899_a4f56d6a-a0fa-4246-a8ff-2f038718ebc4	69842-899	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190731		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-900_561d4e90-77b1-4221-994c-72a9640d9578	69842-900	HUMAN OTC DRUG	Fluticasone Propionate Nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20161217		ANDA	ANDA207957	CVS Pharmacy	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69842-901_f584b696-f71e-4449-849e-58128c6fdef0	69842-901	HUMAN OTC DRUG	Pink Eye		Belladonna, Euphrasia officinalis, Hepar sulphuris	SOLUTION/ DROPS	OPHTHALMIC	20190215		UNAPPROVED HOMEOPATHIC		CVS Pharmacy	ATROPA BELLADONNA; CALCIUM SULFIDE; EUPHRASIA STRICTA	6; 12; 6	[hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL			N	20241231
69842-902_03e9708f-b75b-4a4f-af47-828b4002f872	69842-902	HUMAN OTC DRUG	CVS Health Extra Strength Sugar Free Antacid		Antacid	TABLET, CHEWABLE	ORAL	20170207		OTC MONOGRAPH FINAL	part331	CVS Pharmacy,Inc.	CALCIUM CARBONATE	750	mg/1			N	20241231
69842-903_1069bc21-c361-4636-8ba2-e95411986826	69842-903	HUMAN OTC DRUG	CVS Maximum Strength Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin ,Phenylephrine HCL	LIQUID	ORAL	20210210		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-904_2a7dd85e-7e51-445e-b1fd-264b970e0133	69842-904	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan Hydrobromide Guaifenesin	LIQUID	ORAL	20200529		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-906_97feb939-cd6a-4176-9e0c-7a590d010f72	69842-906	HUMAN OTC DRUG	Daytime Mucus Relief Severe Cold and Nighttime Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL,Guaifenesin	KIT		20191129		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-908_079658f5-d4fc-4977-917c-0d9f9463d195	69842-908	HUMAN OTC DRUG	Daytime Nighttime Sinus Relief	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL,Guaifenesin	KIT	ORAL	20191030		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-909_299f5d24-f0b5-427a-a8c6-9a53a5e2f2d5	69842-909	HUMAN OTC DRUG	Sunburn Relief Gel		Lidocaine HCl	GEL	TOPICAL	20180831		OTC MONOGRAPH NOT FINAL	part348	CVS	LIDOCAINE HYDROCHLORIDE	5.05	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-910_f851bc16-636e-4f77-9ca7-dd3f30e9c6e3	69842-910	HUMAN OTC DRUG	Charcoal Blackhead Clearing Scrub		Salicylic Acid	CREAM	TOPICAL	20160301		OTC MONOGRAPH FINAL	part333D	CVS Pharmacy, Inc.	SALICYLIC ACID	20.6	mg/mL			N	20241231
69842-911_d0d86b6d-0d35-4796-bbad-e54de47044f4	69842-911	HUMAN OTC DRUG	ALLERGY RELIEF		Cetirizine Hydrochloride	CAPSULE	ORAL	20180206	20240419	NDA	NDA022429	CVS Pharmacy	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
69842-912_f4ba5f8a-f7ac-4a69-93bd-ed5928c6659f	69842-912	HUMAN OTC DRUG	CVS Health Childrens	Saline Laxative	Magnesium hydroxide	TABLET, CHEWABLE	ORAL	20190516		OTC MONOGRAPH NOT FINAL	part334	CVS PHARMACY,INC.	MAGNESIUM HYDROXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-913_800db074-ff42-4c68-90e9-fac42516c02e	69842-913	HUMAN OTC DRUG	Ibuprofen PM		Ibuprofen, Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20200529		ANDA	ANDA210676	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-915_8d53489c-2add-4c9b-8366-d3529206c8c8	69842-915	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20200220		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	500	mg/1			N	20241231
69842-916_1059a874-001d-46e9-8413-292ac7967648	69842-916	HUMAN OTC DRUG	Sleep Aid	Nighttime	Diphenhydramine HCl	CAPSULE	ORAL	20191129		OTC MONOGRAPH FINAL	part338	CVS Pharmacy	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-919_e4c78945-8033-4556-9865-6d23dd39d96d	69842-919	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20190417		ANDA	ANDA203690	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-921_0c542a31-945d-c12d-e063-6394a90a1b9e	69842-921	HUMAN OTC DRUG	CVS Lidocaine	Maximum Strength	Lidocaine HCl	CREAM	TOPICAL	20180115		OTC MONOGRAPH DRUG	M017	CVS Pharmacy	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-922_f44b234a-9555-fa94-e053-2995a90a6cbd	69842-922	HUMAN OTC DRUG	Ephedrine Sulfate		Ephedrine Sulfate	TABLET, FILM COATED	ORAL	20221228		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc	EPHEDRINE SULFATE	25	mg/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
69842-923_918db6b0-10f0-4f7e-9822-3500462b6ff7	69842-923	HUMAN OTC DRUG	Allergy Relief	children	Fexofenadine HCL	SUSPENSION	ORAL	20200331		ANDA	ANDA203330	CVS Pharmacy	FEXOFENADINE HYDROCHLORIDE	30	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-924_1f56a1b3-355d-4671-92cf-097bcfd7d818	69842-924	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20210628		ANDA	ANDA206531	CVS Pharmacy, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69842-925_53ac017a-eccc-3b24-e054-00144ff88e88	69842-925	HUMAN OTC DRUG	CVS Health Antiseptic Wound Wash		Lidocaine Hydrochloride, Benzalkonium Chloride	RINSE	TOPICAL	20170301		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.0013; .025	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-926_1fccae20-a780-4c26-b523-5ae01babcd38	69842-926	HUMAN OTC DRUG	Cough and Chest Congestion DM	Adult	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20200529		OTC MONOGRAPH DRUG	M012	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-927_a2f048ca-42bb-46b4-9b05-af33a72258ca	69842-927	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20190301		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
69842-928_3cdcb752-f916-4fdc-b05a-ad3d0a0b5d9e	69842-928	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20210628		ANDA	ANDA206531	CVS Pharmacy, Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
69842-929_85edd34b-e4fe-45e0-bd6c-4179f3777023	69842-929	HUMAN OTC DRUG	tussin dm max daytime nighttime		dextromethorphan hbr, doxylamine succinate, guaifesesin	KIT		20180720		OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	20241231
69842-930_f2378d31-1cbd-4647-b9af-d3277278508e	69842-930	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20121221		ANDA	ANDA078569	CVS Pharmacy	ACETAMINOPHEN	650	mg/1			N	20241231
69842-931_a4cbfe04-6e96-4f46-93b6-d5b2dcff142f	69842-931	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, FILM COATED	ORAL	20051211		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN	500	mg/1			N	20241231
69842-932_cd8872c7-4512-446a-9676-ec16c786e9fc	69842-932	HUMAN OTC DRUG	Nicotine	Sugar Free	nicotine polacrilex	LOZENGE	ORAL	20200529		ANDA	ANDA210711	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-933_5006c0e1-76cd-4ae5-8fd3-fe3dcd12151d	69842-933	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190228		ANDA	ANDA209692	CVS Pharmacy	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-934_0f4d1eb9-ae2e-42dd-b64d-c461b8586afd	69842-934	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200630		ANDA	ANDA210711	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-935_0ac17604-230e-aa81-e063-6294a90a8a45	69842-935	HUMAN OTC DRUG	CVS Povidone Iodine		Povidone Iodine	SWAB	TOPICAL	20200901		OTC MONOGRAPH DRUG	M003	CVS Pharmacy Inc	POVIDONE-IODINE	10	mg/mL			N	20241231
69842-937_a726084c-18d3-420d-a42e-e74a4553f809	69842-937	HUMAN OTC DRUG	CVS Mucus Relief DM	Maximum Strength	Dextromethorphan HBr and Guaifenesin	SOLUTION	ORAL	20200330		OTC MONOGRAPH FINAL	part341	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-938_bfc892cd-24fb-4f85-b954-3bb2989e027c	69842-938	HUMAN OTC DRUG	Daytime and Nighttime Sinus Congestion	PE	Diphenhydramine HCl, Phenylephrine HCl	KIT		20190610		OTC MONOGRAPH DRUG	M012	CVS PHARMACY						N	20241231
69842-939_fe5cdffc-7cb6-4905-a4ee-5abe87118d88	69842-939	HUMAN OTC DRUG	DayTime Severe Congestion Relief and Nighttime Severe Cough and Congestion Relief	Maximum Strength	Daytime Acetaminophen, Guaifenesin, Phenylephrine HCI, NightTime Acetaminophen, Diphenhydramine HCI, Phenylephrine HCI	KIT		20180430	20240430	OTC MONOGRAPH FINAL	part341	CVS Pharmacy						N	
69842-941_e78315ba-6a94-4db1-baa9-01065f3be142	69842-941	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20200923		ANDA	ANDA206877	CVS Pharmacy, Inc.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69842-942_783b7ab3-d2a5-4460-b23f-0f814f7149d6	69842-942	HUMAN OTC DRUG	Severe Cough and Congestion		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20201117		OTC MONOGRAPH DRUG	M012	CVS PHARMACY	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-943_e5daca4b-eb55-43d7-b93b-8fffbcce531a	69842-943	HUMAN OTC DRUG	Night Time Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20181231	20240426	OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
69842-946_e0caa2d1-1c4f-4273-8a8c-27fcb691eca5	69842-946	HUMAN OTC DRUG	Chloroxylenol 0.3%		Chloroxylenol 0.3%	LIQUID	TOPICAL	20170117		OTC MONOGRAPH NOT FINAL	part333A	CVS Pharmacy	CHLOROXYLENOL	3	mg/mL			N	20241231
69842-948_f2f236d8-7302-7583-e053-2a95a90a426e	69842-948	HUMAN OTC DRUG	Gum Detoxify		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210701		OTC MONOGRAPH FINAL	part355	CVS	STANNOUS FLUORIDE	.454	g/100g			N	20241231
69842-949_eb27aefc-491c-4d61-9791-fecf30a6858d	69842-949	HUMAN OTC DRUG	severe cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20180914		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-950_02e48e12-a4e5-4d00-802f-96225b2c80cb	69842-950	HUMAN OTC DRUG	Miconazole 3		Miconazole nitrate	KIT	TOPICAL; VAGINAL	19960416		NDA	NDA020670	CVS Pharmacy						N	20241231
69842-952_8723bb57-31e5-54d6-e053-2a91aa0a3e90	69842-952	HUMAN OTC DRUG	CVS Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20140414		OTC MONOGRAPH NOT FINAL	part348	CVS	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-953_c1f71960-9126-4c9d-a1d5-89348c888233	69842-953	HUMAN OTC DRUG	CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20180501		ANDA	ANDA210088	CVS PHARMACY, INC	LORATADINE	5	mg/1			N	20241231
69842-954_d9290585-ce58-4f75-9974-2236d3cbc24a	69842-954	HUMAN OTC DRUG	CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20180701		ANDA	ANDA210088	CVS PHARMACY, INC	LORATADINE	5	mg/1			N	20241231
69842-955_12590adf-18e1-450c-95d3-87040f0d1a64	69842-955	HUMAN OTC DRUG	Medicated Cornstarch Baby Powder		Active Corn Starch, Zinc Oxide, Kaolin	POWDER	TOPICAL	20170110		OTC MONOGRAPH FINAL	part347	CVS	KAOLIN; STARCH, CORN; ZINC OXIDE	4.52; 89.27; 16.95	g/113g; g/113g; g/113g			N	20241231
69842-956_9c538ac2-c6e2-4c72-9341-db83be00a5f1	69842-956	HUMAN OTC DRUG	Acetaminophen PM	Extra Strength	Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20071217		OTC MONOGRAPH DRUG	M013	CVS PHARMACY	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-957_ec206b52-b162-4555-b1be-5cb6c987dc3c	69842-957	HUMAN OTC DRUG	Nicotine	Sugar Free	nicotine polacrilex	LOZENGE	ORAL	20200529		ANDA	ANDA209206	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-958_d9412030-1fb0-4f72-a454-fbf505b48a19	69842-958	HUMAN OTC DRUG	Sleep-Aid Chewables	Nighttime	Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20180731		OTC MONOGRAPH DRUG	M010	CVS PHARMACY	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-959_9ebd1b01-164d-46c7-804e-6a4a245fb9e2	69842-959	HUMAN OTC DRUG	childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20170627		OTC MONOGRAPH NOT FINAL	part343	CVS Pharmacy	ACETAMINOPHEN	160	mg/5mL			N	20241231
69842-961_7b75b7b7-17b9-4a60-b19a-65adaaf246b0	69842-961	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20210201		ANDA	ANDA213557	CVS Pharmacy, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-964_9193c7a3-ad5b-41bf-b90e-33c736e4b312	69842-964	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20200630		ANDA	ANDA212057	CVS Pharmacy	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-965_996b9c87-881b-4da5-e053-2995a90a25db	69842-965	HUMAN OTC DRUG	CVS Skin Tag		THUJA OCCIDENTALIS LEAFY TWIG	OIL	TOPICAL	20191218		UNAPPROVED HOMEOPATHIC		CVS Pharmacy	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/10mL			N	20241231
69842-966_816344be-6fa4-48fe-bd69-7e84138dc173	69842-966	HUMAN OTC DRUG	CVS Overnight Cold and Flu Clear and Cool		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE	SOLUTION	ORAL	20200331		OTC MONOGRAPH FINAL	part341	CVS PHARMACY, INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-968_02b8ae54-ac75-1ede-e063-6294a90a3463	69842-968	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20210410		OTC MONOGRAPH NOT FINAL	part343	CVS HEALTH CORP	ACETAMINOPHEN	325	mg/1			N	20241231
69842-969_3d1ba0b9-7a6e-4c50-b097-c98805dcfdac	69842-969	HUMAN OTC DRUG	Mucus Relief Cold Flu Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20190830		OTC MONOGRAPH FINAL	part341	CVS Pharmacy	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69842-973_07060ec7-8d0c-40db-a42d-c6b2f8d66d3b	69842-973	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200827		ANDA	ANDA090818	CVS Pharmacy	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-974_285d4730-6a27-433e-808f-eff62a944015	69842-974	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20210503		ANDA	ANDA208077	CVS Pharmacy	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69842-976_e8b039b8-6665-4958-a671-719f86e86409	69842-976	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20200731		ANDA	ANDA212057	CVS Pharmacy	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
69842-977_83004baa-4226-4c24-a063-a134cff60866	69842-977	HUMAN OTC DRUG	CVS Health Anti gas		Simethicone	SUSPENSION/ DROPS	ORAL	20190410		OTC MONOGRAPH FINAL	part332	CVS PHARMACY	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
69842-978_2b3b88dd-d101-42b4-a548-82003f724fd6	69842-978	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	20090520		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	CASTOR OIL	1	mg/mL			N	20241231
69842-979_4880fbdf-cf5a-4a73-8817-0649bf856cde	69842-979	HUMAN OTC DRUG	CVS Health Infant	Gas Relief	Simethicone	SUSPENSION/ DROPS	ORAL	20191223		OTC MONOGRAPH FINAL	part332	CVS PHARMACY	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
69842-980_ff34cb10-8c9b-23db-e053-6394a90a47ab	69842-980	HUMAN OTC DRUG	CVS Health Lidocaine Pain Relief		Lidocaine HCl	CREAM	TOPICAL	20180901		OTC MONOGRAPH NOT FINAL	part348	CVS Pharmacy	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69842-981_d09e79a4-e305-619e-e053-2a95a90ab566	69842-981	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20200923		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69842-983_977ac671-966d-437a-b748-a90f946e3e1c	69842-983	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	CVS Pharmacy	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
69842-986_4986696d-4576-466f-ad73-22779c63223f	69842-986	HUMAN OTC DRUG	Athletes Foot		Butenafine Hydrochloride	CREAM	TOPICAL	20171117		ANDA	ANDA205181	CVS Pharmacy	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
69842-987_89a5fd6c-a531-41b7-b37d-212b3d4a02f7	69842-987	HUMAN OTC DRUG	Severe Congestion and Cough, Cold and Flu	Daytime, Nighttime	Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20170701	20240204	OTC MONOGRAPH NOT FINAL	part341	CVS PHARMACY						N	
69842-988_6c8d7eb7-29c4-4200-96e0-ad110f253215	69842-988	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	19970113		ANDA	ANDA074444	CVS Pharmacy	MICONAZOLE NITRATE	20	mg/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
69842-989_f31c11d9-11db-4642-a8d9-609f1861f5a5	69842-989	HUMAN OTC DRUG	Butenafine Hydrochloride 1%		Butenafine Hydrochloride	CREAM	TOPICAL	20181018		ANDA	ANDA205181	CVS Pharmacy	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
69842-990_f6c3f3ab-f5b1-40d1-8ca9-51f55b9c66a9	69842-990	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180301		ANDA	ANDA090818	CVS Pharmacy	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-992_7719b4b0-f144-4471-aa17-7b7f21227b76	69842-992	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	CVS	ALCOHOL	62	mL/100mL			N	20241231
69842-993_0d37718d-85d9-696a-e063-6394a90a291e	69842-993	HUMAN OTC DRUG	CVS Lubricant Eye Drops 30 ct		Carboxymethylcellulose soduim	SOLUTION/ DROPS	OPHTHALMIC	20190715		OTC MONOGRAPH DRUG	M018	CVS Pharmacy, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
69842-994_e4a21deb-1124-4b86-a6da-4d6bdd06111a	69842-994	HUMAN OTC DRUG	Allergy Relief-D		Cetirizine hydrochloride and pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190630		ANDA	ANDA090922	CVS PHARMACY	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
69842-996_9aa43dcf-2d6c-4948-bb12-36e656146d90	69842-996	HUMAN OTC DRUG	CVS Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20091207		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
69842-997_556ade8f-417c-4095-b54a-dce71643fc04	69842-997	HUMAN OTC DRUG	CVS Health Chest Congestion Relief PE		Guaifenesin/phenylephrine	TABLET	ORAL	20060605		OTC MONOGRAPH FINAL	part341	CVS Pharmacy, Inc.	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
69844-001_ecc42b35-e7c6-42b4-974f-d65ad3850ca7	69844-001	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Graviti Pharmaceuticals Private Limited	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69844-002_ecc42b35-e7c6-42b4-974f-d65ad3850ca7	69844-002	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Graviti Pharmaceuticals Private Limited	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69844-003_ecc42b35-e7c6-42b4-974f-d65ad3850ca7	69844-003	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Graviti Pharmaceuticals Private Limited	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69844-004_ecc42b35-e7c6-42b4-974f-d65ad3850ca7	69844-004	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Graviti Pharmaceuticals Private Limited	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
69844-008_ef12b8d9-a584-4ab2-e053-2995a90ad8ed	69844-008	HUMAN PRESCRIPTION DRUG	Fenofibrate	film coated	fenofibrate	TABLET	ORAL	20180817		ANDA	ANDA210606	Graviti Pharmaceuticals Private Limited	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69844-009_ef12b8d9-a584-4ab2-e053-2995a90ad8ed	69844-009	HUMAN PRESCRIPTION DRUG	Fenofibrate	film coated	fenofibrate	TABLET	ORAL	20180817		ANDA	ANDA210606	Graviti Pharmaceuticals Private Limited	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69844-012_ef139fab-94f6-8568-e053-2a95a90a33bb	69844-012	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20200318		ANDA	ANDA211122	Graviti Pharmaceuticals Private Limited	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69844-013_ef139fab-94f6-8568-e053-2a95a90a33bb	69844-013	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20200318		ANDA	ANDA211122	Graviti Pharmaceuticals Private Limited	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69844-022_ef1386ae-152d-95cc-e053-2995a90a3053	69844-022	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID DELAYED-RELEASE		FENOFIBRIC ACID	CAPSULE, DELAYED RELEASE	ORAL	20190718		ANDA	ANDA211626	Graviti Pharmaceuticals Private Limited	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69844-023_ef1386ae-152d-95cc-e053-2995a90a3053	69844-023	HUMAN PRESCRIPTION DRUG	FENOFIBRIC ACID DELAYED-RELEASE		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20190718		ANDA	ANDA211626	Graviti Pharmaceuticals Private Limited	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
69844-024_ef140e7b-b519-b66d-e053-2a95a90a2305	69844-024	HUMAN PRESCRIPTION DRUG	ranolazine		extended-release	TABLET	ORAL	20210128		ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69844-025_ef140e7b-b519-b66d-e053-2a95a90a2305	69844-025	HUMAN PRESCRIPTION DRUG	ranolazine		extended-release	TABLET	ORAL	20210128		ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
69844-031_16ad196e-3de2-46e4-94af-511fe4bf80d3	69844-031	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210319		ANDA	ANDA213486	Graviti Pharmaceuticals Private Limited	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69844-032_16ad196e-3de2-46e4-94af-511fe4bf80d3	69844-032	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210319		ANDA	ANDA213486	Graviti Pharmaceuticals Private Limited	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69844-036_ef39ff78-4d7c-1d27-e053-2995a90a1075	69844-036	HUMAN PRESCRIPTION DRUG	CLOPIDOGREL BISULFATE		CLOPIDOGREL BISULFATE	TABLET	ORAL	20200406		ANDA	ANDA204359	Graviti Pharmaceuticals Private Limited	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
69844-037_aeee6596-ef9b-401a-8e9d-3d2d7c86a74f	69844-037	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200406		ANDA	ANDA202114	Graviti Pharmaceuticals Private Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
69844-038_aeee6596-ef9b-401a-8e9d-3d2d7c86a74f	69844-038	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200406		ANDA	ANDA202114	Graviti Pharmaceuticals Private Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
69844-047_8b8bc113-cf28-40be-96fd-9d89f67a3219	69844-047	HUMAN PRESCRIPTION DRUG	SOLIFENACIN SUCCINATE		SOLIFENACIN SUCCINATE	TABLET, FILM COATED	ORAL	20200406		ANDA	ANDA211423	Graviti Pharmaceuticals Private Limited	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69844-048_8b8bc113-cf28-40be-96fd-9d89f67a3219	69844-048	HUMAN PRESCRIPTION DRUG	SOLIFENACIN SUCCINATE		SOLIFENACIN SUCCINATE	TABLET, FILM COATED	ORAL	20200406		ANDA	ANDA211423	Graviti Pharmaceuticals Private Limited	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
69844-050_130aabb3-95f2-4a4e-8365-61bbb3e8436b	69844-050	HUMAN OTC DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20220624		ANDA	ANDA216349	Graviti Pharmaceuticals Private Limited	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
69844-051_415be125-eca2-43d6-b544-947647377f3b	69844-051	HUMAN PRESCRIPTION DRUG	furosemide		furosemide	TABLET	ORAL	20221017		ANDA	ANDA216629	Graviti Pharmaceuticals Private Limited	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69844-052_415be125-eca2-43d6-b544-947647377f3b	69844-052	HUMAN PRESCRIPTION DRUG	furosemide		furosemide	TABLET	ORAL	20221017		ANDA	ANDA216629	Graviti Pharmaceuticals Private Limited	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69844-053_415be125-eca2-43d6-b544-947647377f3b	69844-053	HUMAN PRESCRIPTION DRUG	furosemide		furosemide	TABLET	ORAL	20221017		ANDA	ANDA216629	Graviti Pharmaceuticals Private Limited	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
69844-054_6aa2d773-3dc6-4e89-abcb-ec859b5f7951	69844-054	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20230809		ANDA	ANDA216925	Graviti Pharmaceuticals Private Limited	CHLORZOXAZONE	250	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
69844-055_71839518-5d2d-48b6-ae80-c0325e6c9931	69844-055	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170324		ANDA	ANDA207099	Graviti Pharmaceuticals Private Limited	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69844-056_71839518-5d2d-48b6-ae80-c0325e6c9931	69844-056	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170324		ANDA	ANDA207099	Graviti Pharmaceuticals Private Limited	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69844-057_71839518-5d2d-48b6-ae80-c0325e6c9931	69844-057	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170324		ANDA	ANDA207099	Graviti Pharmaceuticals Private Limited	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69844-058_86bc0ee4-97cb-44a6-8627-254718bb6259	69844-058	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230526		ANDA	ANDA217411	Graviti Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69844-059_86bc0ee4-97cb-44a6-8627-254718bb6259	69844-059	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230526		ANDA	ANDA217411	Graviti Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69844-060_86bc0ee4-97cb-44a6-8627-254718bb6259	69844-060	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230526		ANDA	ANDA217411	Graviti Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69844-061_86bc0ee4-97cb-44a6-8627-254718bb6259	69844-061	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230526		ANDA	ANDA217411	Graviti Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69844-062_86bc0ee4-97cb-44a6-8627-254718bb6259	69844-062	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230526		ANDA	ANDA217411	Graviti Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69844-063_86bc0ee4-97cb-44a6-8627-254718bb6259	69844-063	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET	ORAL	20230526		ANDA	ANDA217411	Graviti Pharmaceuticals Private Limited	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
69844-064_252da699-f39a-4df8-83af-b6c0a1d90426	69844-064	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride		extended-release	TABLET	ORAL	20190128		ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69844-065_252da699-f39a-4df8-83af-b6c0a1d90426	69844-065	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride		extended-release	TABLET	ORAL	20190128		ANDA	ANDA211020	Graviti Pharmaceuticals Private Limited	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
69844-071_2fff40ef-b12c-40e7-8cc6-4dd7557ef675	69844-071	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA217652	Graviti Pharmaceuticals Private Limited	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
69844-072_2fff40ef-b12c-40e7-8cc6-4dd7557ef675	69844-072	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA217652	Graviti Pharmaceuticals Private Limited	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
69844-073_2fff40ef-b12c-40e7-8cc6-4dd7557ef675	69844-073	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20230822		ANDA	ANDA217652	Graviti Pharmaceuticals Private Limited	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
69844-074_b287c48f-bf1c-4830-ba9a-92c83f468448	69844-074	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, CHEWABLE	ORAL	20220114		ANDA	ANDA209011	Graviti Pharmaceuticals Private Limited	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
69844-075_b287c48f-bf1c-4830-ba9a-92c83f468448	69844-075	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, CHEWABLE	ORAL	20220114		ANDA	ANDA209011	Graviti Pharmaceuticals Private Limited	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
69844-076_d32e1626-8663-4fb2-8c21-d3df59cd61db	69844-076	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET	ORAL	20220121		ANDA	ANDA209012	Graviti Pharmaceuticals Private Limited	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
69844-077_91c50906-24c9-4305-89cc-063d106a1833	69844-077	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20230531		ANDA	ANDA078777	Graviti Pharmaceuticals Private Limited	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69844-078_91c50906-24c9-4305-89cc-063d106a1833	69844-078	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20230531		ANDA	ANDA078777	Graviti Pharmaceuticals Private Limited	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69844-079_91c50906-24c9-4305-89cc-063d106a1833	69844-079	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20230531		ANDA	ANDA078777	Graviti Pharmaceuticals Private Limited	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69844-091_23eda39a-2084-494c-8c8c-1bedc4e1f139	69844-091	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20230719		ANDA	ANDA217995	Graviti Pharmaceuticals Private Limited	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69844-092_23eda39a-2084-494c-8c8c-1bedc4e1f139	69844-092	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20230719		ANDA	ANDA217995	Graviti Pharmaceuticals Private Limited	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
69844-095_d302c518-bb18-4003-bd44-c84c94b3d4d6	69844-095	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20231222		ANDA	ANDA218181	Graviti Pharmaceuticals Private Limited	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
69844-096_d302c518-bb18-4003-bd44-c84c94b3d4d6	69844-096	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20231222		ANDA	ANDA218181	Graviti Pharmaceuticals Private Limited	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
69845-031_8ac1414d-55c0-4c4a-88e9-07161adcfbc9	69845-031	HUMAN OTC DRUG	BAG BALM Skin Protectant		Petrolatum	OINTMENT	TOPICAL	20180301		OTC MONOGRAPH FINAL	part347	VERMONT`S ORIGINAL, LLC	PETROLATUM	84.3	g/100g			N	20241231
69846-000_fa1d680d-4825-457c-a9b2-de9b3eddfadc	69846-000	HUMAN OTC DRUG	Equalactin Laxative		Calcium polycarbophil	TABLET	ORAL	19861121		OTC MONOGRAPH DRUG	M007	NUMARK BRANDS, INC	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
69846-140_9faaaa26-db8a-445d-9740-5055cd186b43	69846-140	HUMAN OTC DRUG	Alophen		Bisacodyl	TABLET, COATED	ORAL	19070415	20240601	OTC MONOGRAPH DRUG	M007	NUMARK BRANDS, INC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
69846-860_d7507e37-39fb-4998-86f2-eda583669d1d	69846-860	HUMAN OTC DRUG	S.T.37		Hexylresorcinol	SOLUTION	ORAL; TOPICAL	19291120		UNAPPROVED DRUG OTHER		NUMARK BRANDS, INC	HEXYLRESORCINOL	1.1	mg/mL			N	20241231
69847-001_ad7ba069-0e97-4ec8-b650-5cdd3b87db17	69847-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20170401		NDA	NDA205865	Respiratory Care Partners, Inc	OXYGEN	99	L/100L			N	20241231
69848-001_0dfda666-4ad4-d1d5-e063-6394a90ad8fc	69848-001	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M005	Granules USA, Inc.	CLOTRIMAZOLE	1	g/mL	Azole Antifungal [EPC], Azoles [CS]		N	20251231
69848-003_04020582-1e3a-0e5d-e063-6394a90a3b90	69848-003	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20190701		OTC MONOGRAPH DRUG	M013	Granules USA, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
69848-006_0c8ecc47-6442-6193-e063-6394a90afecc	69848-006	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20210630		ANDA	ANDA209274	Granules USA, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69848-008_0c9169ec-48ea-7b03-e063-6294a90a8f6e	69848-008	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20200501		OTC MONOGRAPH DRUG	M013	Granules USA, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
69848-010_0dfd5775-138c-c205-e063-6394a90a2022	69848-010	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20190701		ANDA	ANDA091353	Granules USA, Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
69848-011_0d1d24e9-1861-af97-e063-6394a90a6e29	69848-011	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20190701		ANDA	ANDA079174	Granules USA, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69848-012_0d1d24e9-1861-af97-e063-6394a90a6e29	69848-012	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20190701		ANDA	ANDA079174	Granules USA, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
69848-014_f2a17b6d-b2a3-c71e-e053-2a95a90a249f	69848-014	HUMAN OTC DRUG	Acetaminophen Diphenhydramine HCl		Acetaminophen Diphenhydramine HCl	TABLET	ORAL	20190701		OTC MONOGRAPH NOT FINAL	part343	Granules USA, Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69848-015_0ccb85a5-4b8d-b30a-e063-6294a90a781b	69848-015	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191231		ANDA	ANDA211544	Granules USA, Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
69848-016_0d80da2f-713a-6768-e063-6394a90aed00	69848-016	HUMAN OTC DRUG	Sennosides		Sennosides	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH DRUG	M007	Granules USA Inc	SENNOSIDES	17.2	mg/17.21			N	20241231
69848-017_0ccbb268-ec56-c8eb-e063-6394a90a44b4	69848-017	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20211231		ANDA	ANDA213420	GRANULES USA, INC.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
69848-018_0dfd5775-138b-c205-e063-6394a90a2022	69848-018	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210221		ANDA	ANDA213420	GRANULES USA, INC.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
69848-019_0cccbfd2-0ed3-2335-e063-6294a90a47e4	69848-019	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210726		ANDA	ANDA210722	GRANULES USA, INC.	LORATADINE	10	mg/1			N	20241231
69853-0102_cbcf849a-3069-4f9c-af6b-54364b3172d6	69853-0102	HUMAN PRESCRIPTION DRUG	ANDEXXA		andexanet alfa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190108	20241130	BLA	BLA125586	Alexion Pharmaceuticals, Inc.	ANDEXANET ALFA	200	mg/20mL			N	
69864-001_c961907a-db84-c6f2-e053-2995a90aefd2	69864-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F18		Fludeoxyglucose F18	INJECTION, SOLUTION	INTRAVENOUS	20120423		ANDA	ANDA203904	The Methodist Hospital Research Institute	FLUDEOXYGLUCOSE F-18	.3	Ci/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69864-002_0ce4c7b6-2913-fecf-e063-6394a90ab438	69864-002	HUMAN PRESCRIPTION DRUG	Ammonia N-13		Ammonia N-13	INJECTION	INTRAVENOUS	20210709		ANDA	ANDA215083	The Methodist Hospital Research Institute	AMMONIA N-13	260	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69866-1030_fde88bef-fa85-4f86-8c0c-e4ad5668e202	69866-1030	CELLULAR THERAPY	MACI		autologous cultured chondrocytes	IMPLANT	INTRA-ARTICULAR	20170609		BLA	BLA125603	Vericel Corporation	AUTOLOGOUS CULTURED CHONDROCYTES; PORK COLLAGEN	15000000; 15	1/1; cm2/1	Autologous Cultured Cell [EPC], Cells, Cultured, Autologous [EXT], Chondrocytes [CS]		N	20241231
69866-2002_1a4bb6de-49ed-4757-8bca-c52624a7badf	69866-2002	HUMAN PRESCRIPTION DRUG	NEXOBRID		ANACAULASE-BCDB	KIT	TOPICAL	20221229		BLA	BLA761192	Vericel Corporation						N	20241231
69866-2005_1a4bb6de-49ed-4757-8bca-c52624a7badf	69866-2005	HUMAN PRESCRIPTION DRUG	NEXOBRID		ANACAULASE-BCDB	KIT	TOPICAL	20221229		BLA	BLA761192	Vericel Corporation						N	20241231
69872-003_081cea40-e699-66af-e063-6294a90a15d6	69872-003	HUMAN OTC DRUG	SWISS NAVY Endurance Rx		LIDOCAINE	SPRAY	TOPICAL	20170801		OTC MONOGRAPH DRUG	M017	PACKAGE SOLUTIONS LLC	LIDOCAINE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69876-1740_09d72589-142c-349f-e063-6294a90a4d95	69876-1740	HUMAN OTC DRUG	NEUROFLEX Topical Pain Relieving Liquid		CAMPHOR (SYNTHETIC), MENTHOL	SOLUTION	TOPICAL	20210401		OTC MONOGRAPH DRUG	M017	Almark Products Inc	CAMPHOR (SYNTHETIC); MENTHOL	30; 20	mg/mL; mg/mL			N	20241231
69879-101_045f2a36-df20-4d07-e063-6394a90aaef1	69879-101	HUMAN OTC DRUG	Cover-Expert Sunscreen Broad Spectrum SPF 15 No.1 Fair Beige		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150731	20250129	OTC MONOGRAPH NOT FINAL	part352	Luxe Art Beaute SAS	TITANIUM DIOXIDE; ZINC OXIDE	51; 28	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
69879-102_045f2f75-e1b8-0e55-e063-6394a90a208e	69879-102	HUMAN OTC DRUG	Cover-Expert Sunscreen Broad Spectrum SPF 15 No.2 Neutral Beige		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150731	20240828	OTC MONOGRAPH NOT FINAL	part352	Luxe Art Beaute SAS	TITANIUM DIOXIDE; ZINC OXIDE	51; 28	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
69879-112_045ff8c8-1f5f-c70d-e063-6294a90ae8a4	69879-112	HUMAN OTC DRUG	Cover-Expert Sunscreen Broad Spectrum SPF 15 No.12 Warm Copper		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20150731	20250501	OTC MONOGRAPH NOT FINAL	part352	Luxe Art Beaute SAS	TITANIUM DIOXIDE; ZINC OXIDE	51; 28	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
69880-120_f780b6da-1e1f-4192-86f6-b93c9e4955ca	69880-120	HUMAN PRESCRIPTION DRUG	Mycapssa		Octreotide	CAPSULE, DELAYED RELEASE	ORAL	20200706		NDA	NDA208232	Amryt Pharmaceuticals Designated Activity Company	OCTREOTIDE	20	mg/1	Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]		N	20241231
69882-726_09d75c0c-2944-98b9-e063-6394a90aa287	69882-726	HUMAN OTC DRUG	Signature Black Bottle Tea Tree Antifungal Foot and Body Wash		TOLNAFTATE	LOTION	TOPICAL	20160210		OTC MONOGRAPH DRUG	M005	Restoration Rockstar, Llc (dba: Kroning Signature Black Bottle)	TOLNAFTATE	10	mg/mL			N	20241231
69884-700_d6e219a6-f4d7-b8df-e053-2995a90a5803	69884-700	HUMAN OTC DRUG	SAN X E3		Alcohol	SPRAY	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part333E	Amerisan, LLC	ALCOHOL	71	mL/100mL			N	20241231
69884-703_d6e64ced-b3c0-115b-e053-2995a90a16b9	69884-703	HUMAN OTC DRUG	San-X E3		Ethanol	LIQUID	TOPICAL	20160212	20241130	OTC MONOGRAPH NOT FINAL	part333E	Amerisan, LLC	ALCOHOL	62	mL/100mL			N	
69884-706_d6e2f275-460a-24e6-e053-2995a90a8dd3	69884-706	HUMAN OTC DRUG	SAN X E2		Benzalkonium chloride	LIQUID	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part333E	Amerisan, LLC	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
69884-707_d6e62ace-e129-ceba-e053-2a95a90a4cba	69884-707	HUMAN OTC DRUG	San-X E2		Benzalkonium chloride	LIQUID	TOPICAL	20160219	20241231	OTC MONOGRAPH NOT FINAL	part333E	Amerisan, LLC	BENZALKONIUM CHLORIDE	.12	mg/100mL			N	
69886-111_f68dd9eb-35b7-34e1-e053-2a95a90addca	69886-111	HUMAN OTC DRUG	PSSI E-San		ALCOHOL	LIQUID	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part333A	Safe Foods Chemical Innovations	ALCOHOL	.08	L/.1L			N	20241231
69886-111_f75a98a2-c41f-5b8b-e053-6294a90ae7ff	69886-111	HUMAN OTC DRUG	PSSI E-San		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Safe Foods Chemical Innovations	ALCOHOL	.08	L/.1L			N	20241231
69886-111_f75ab85c-fc62-d51d-e053-6294a90a83c5	69886-111	HUMAN OTC DRUG	PSSI E-San		ALCOHOL	LIQUID	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part333A	Safe Foods Chemical Innovations	ALCOHOL	.08	L/.1L			N	20241231
69901-522_aa27a298-111e-4be6-817a-b9888eed57ff	69901-522	HUMAN OTC DRUG	Vicks VapoSteam		Camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	19950228		OTC MONOGRAPH FINAL	part341	Kaz USA, Inc	CAMPHOR (SYNTHETIC)	.062	g/mL			N	20241231
69911-474_757ccd2f-85b7-440f-905f-b999e2d1dd4b	69911-474	PLASMA DERIVATIVE	AFSTYLA	Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT		20160525		BLA	BLA125591	CSL Behring Lengnau AG						N	20241231
69911-475_757ccd2f-85b7-440f-905f-b999e2d1dd4b	69911-475	PLASMA DERIVATIVE	AFSTYLA	Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT		20160525		BLA	BLA125591	CSL Behring Lengnau AG						N	20241231
69911-476_757ccd2f-85b7-440f-905f-b999e2d1dd4b	69911-476	PLASMA DERIVATIVE	AFSTYLA	Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT		20160525		BLA	BLA125591	CSL Behring Lengnau AG						N	20241231
69911-477_757ccd2f-85b7-440f-905f-b999e2d1dd4b	69911-477	PLASMA DERIVATIVE	AFSTYLA	Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT		20160525		BLA	BLA125591	CSL Behring Lengnau AG						N	20241231
69911-478_757ccd2f-85b7-440f-905f-b999e2d1dd4b	69911-478	PLASMA DERIVATIVE	AFSTYLA	Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT		20160525		BLA	BLA125591	CSL Behring Lengnau AG						N	20241231
69911-480_757ccd2f-85b7-440f-905f-b999e2d1dd4b	69911-480	PLASMA DERIVATIVE	AFSTYLA	Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT		20170328		BLA	BLA125591	CSL Behring Lengnau AG						N	20241231
69911-481_757ccd2f-85b7-440f-905f-b999e2d1dd4b	69911-481	PLASMA DERIVATIVE	AFSTYLA	Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT		20170328		BLA	BLA125591	CSL Behring Lengnau AG						N	20241231
69911-864_fc29c907-a767-4a0e-b077-8c197e7ce8b3	69911-864	PLASMA DERIVATIVE	IDELVION		Coagulation Factor IX Recombinant Human	KIT		20160304		BLA	BLA125582	CSL Behring Lengnau AG						N	20241231
69911-865_fc29c907-a767-4a0e-b077-8c197e7ce8b3	69911-865	PLASMA DERIVATIVE	IDELVION		Coagulation Factor IX Recombinant Human	KIT		20160304		BLA	BLA125582	CSL Behring Lengnau AG						N	20241231
69911-866_fc29c907-a767-4a0e-b077-8c197e7ce8b3	69911-866	PLASMA DERIVATIVE	IDELVION		Coagulation Factor IX Recombinant Human	KIT		20160304		BLA	BLA125582	CSL Behring Lengnau AG						N	20241231
69911-867_fc29c907-a767-4a0e-b077-8c197e7ce8b3	69911-867	PLASMA DERIVATIVE	IDELVION		Coagulation Factor IX Recombinant Human	KIT		20160304		BLA	BLA125582	CSL Behring Lengnau AG						N	20241231
69911-869_fc29c907-a767-4a0e-b077-8c197e7ce8b3	69911-869	PLASMA DERIVATIVE	IDELVION		Coagulation Factor IX Recombinant Human	KIT		20180530		BLA	BLA125582	CSL Behring Lengnau AG						N	20241231
69913-350_ebd482fb-dd8a-6296-e053-2a95a90ad5e1	69913-350	HUMAN PRESCRIPTION DRUG	Ruconest		c1 esterase inhibitor recombinant	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160919		BLA	BLA125495	Tjoapack Netherlands BV	CONESTAT ALFA	2100	U/1			N	20241231
69918-101_715323c7-7859-4c7b-9c07-7d177fe2cd34	69918-101	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20151210		NDA	NDA019955	Amring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
69918-201_715323c7-7859-4c7b-9c07-7d177fe2cd34	69918-201	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20151210		NDA	NDA019955	Amring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
69918-300_25ba7e46-0431-4948-8543-052c26bdabe8	69918-300	HUMAN PRESCRIPTION DRUG	Lysteda		Tranexamic Acid	TABLET	ORAL	20100517		NDA	NDA022430	Amring Pharmaceuticals Inc.	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
69918-301_6bab5d63-fe96-47a6-bc5c-88919abee2c2	69918-301	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET	ORAL	20160301		NDA AUTHORIZED GENERIC	NDA022430	Amring Pharmaceuticals, Inc.	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
69918-350_13c8e906-3bea-45d6-96fa-056b0ce4562c	69918-350	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20220214		ANDA	ANDA214124	Amring Pharmaceuticals Inc.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
69918-360_13c8e906-3bea-45d6-96fa-056b0ce4562c	69918-360	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20220214		ANDA	ANDA214124	Amring Pharmaceuticals Inc.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
69918-370_13c8e906-3bea-45d6-96fa-056b0ce4562c	69918-370	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20220214		ANDA	ANDA214124	Amring Pharmaceuticals Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
69918-380_13c8e906-3bea-45d6-96fa-056b0ce4562c	69918-380	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20220214		ANDA	ANDA214124	Amring Pharmaceuticals Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
69918-560_795356f9-9817-4b51-8de6-4504a2a48abd	69918-560	HUMAN PRESCRIPTION DRUG	Mesalamine Rectal		Mesalamine	SUPPOSITORY	RECTAL	20190624		ANDA	ANDA208362	Amring Pharmaceuticals Inc.	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
69918-601_1a4d5b53-65eb-4b2d-9ded-526f8ad9b51d	69918-601	HUMAN PRESCRIPTION DRUG	Timoptic in Ocudose		Timolol Maleate	SOLUTION	OPHTHALMIC	20220226		ANDA	ANDA212592	Amring Pharmaceuticals Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69918-602_1a4d5b53-65eb-4b2d-9ded-526f8ad9b51d	69918-602	HUMAN PRESCRIPTION DRUG	Timoptic in Ocudose		Timolol Maleate	SOLUTION	OPHTHALMIC	20220226		ANDA	ANDA212592	Amring Pharmaceuticals Inc.	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
69918-700_3b824b51-28be-4372-94f2-82046b092f5a	69918-700	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20221021		ANDA	ANDA214308	Amring Pharmaceuticals Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
69918-700_3bd5699f-1372-4a1b-9a38-268ae334183c	69918-700	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220908		ANDA	ANDA214308	Amring Pharmaceuticals Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
69918-700_5f54fedd-a275-47f4-9d31-48e5510f02b2	69918-700	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191004		ANDA	ANDA210231	Amring Pharmaceuticals Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
69918-700_6b0dd7d4-8a1d-40b7-8116-793ce6f06a18	69918-700	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190410		ANDA	ANDA210231	Amring Pharmaceuticals Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
69918-720_8041e445-2568-4525-9799-2a205ded11b4	69918-720	HUMAN PRESCRIPTION DRUG	ARSENIC TRIOXIDE		Arsenic Trioxide	INJECTION, SOLUTION	INTRAVENOUS	20181114		ANDA	ANDA210802	Amring Pharmaceuticals Inc.	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
69918-731_1f38ab5d-0223-4a6f-92cd-a480deff703f	69918-731	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210801		ANDA	ANDA211237	Amring Pharmaceuticals Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
69918-735_1f38ab5d-0223-4a6f-92cd-a480deff703f	69918-735	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210801		ANDA	ANDA211237	Amring Pharmaceuticals Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
69918-899_48b56cc1-16dd-4ce3-9f3a-85f6071a5cf4	69918-899	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SOLUTION	INTRAVENOUS	20220107		NDA	NDA018938	Amring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
69918-899_917d7f70-f6ba-4fc8-81c7-540e00a62ea8	69918-899	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SOLUTION	INTRAVENOUS	20160120		NDA	NDA018938	Amring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
69918-901_471e8b17-8b0a-4545-bf40-e39376e4bbef	69918-901	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SOLUTION	INTRAVENOUS	20220509		NDA	NDA018938	Amring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
69918-901_48b56cc1-16dd-4ce3-9f3a-85f6071a5cf4	69918-901	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SOLUTION	INTRAVENOUS	20220107		NDA	NDA018938	Amring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
69918-901_917d7f70-f6ba-4fc8-81c7-540e00a62ea8	69918-901	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SOLUTION	INTRAVENOUS	20160120		NDA	NDA018938	Amring Pharmaceuticals Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
69919-021_097483fe-a24d-b6fc-e063-6394a90a44dd	69919-021	HUMAN OTC DRUG	humane acne wash		Benzoly Peroxide	CREAM	TOPICAL	20150528		OTC MONOGRAPH DRUG	M006	Humane Consumer, LLC	BENZOYL PEROXIDE	100	mg/mL			N	20241231
69921-024_09d6b845-ce5a-6bac-e063-6394a90a1369	69921-024	HUMAN OTC DRUG	Dr. Carrasco Pain Relief		MENTHOL	CREAM	TOPICAL	20150621		OTC MONOGRAPH DRUG	M017	Carrasco Enterprises, Inc.	MENTHOL	40	mg/mL			N	20241231
69922-001_65fb5237-2679-4175-b361-3bb0f144b95c	69922-001	HUMAN OTC DRUG	Marcelle CC Cream Complete Correction Sunscreen Broad Spectrum SPF 35		Octinoxate and Oxybenzone	CREAM	TOPICAL	20160401		OTC MONOGRAPH NOT FINAL	part352	Groupe Marcelle Inc.	OCTINOXATE; OXYBENZONE	2.25; .9	g/30mL; g/30mL			N	20241231
69922-003_dfa6f7d5-5b32-4228-94ff-6ce5ac3cc3a3	69922-003	HUMAN OTC DRUG	Marcelle CC Cream Complete Correction Sunscreen Broad Spectrum SPF 35		Octinoxate and Oxybenzone	CREAM	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part352	Groupe Marcelle Inc.	OCTINOXATE; OXYBENZONE	.525; .21	g/7mL; g/7mL			N	20241231
69924-058_0d0fee12-b08c-1172-e063-6294a90acb09	69924-058	HUMAN OTC DRUG	NEOGEN DERMALOGY DAY-LIGHT PROTECTION AIRY SUNSCREEN		Homosalate, Octocrylene, Avobenzone	CREAM	TOPICAL	20201209		OTC MONOGRAPH DRUG	M020	OUTIN FUTURES CORP.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 80; 80	mg/mL; mg/mL; mg/mL			N	20241231
69932-001_09a64dae-597b-1d75-e063-6294a90a1f6a	69932-001	HUMAN PRESCRIPTION DRUG	Axumin		Fluciclovine F-18	INJECTION, SOLUTION	INTRAVENOUS	20160527		NDA	NDA208054	Blue Earth Diagnostics	FLUCICLOVINE F-18	221	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
69932-002_0c033cee-58ba-cce7-e063-6394a90a2d32	69932-002	HUMAN PRESCRIPTION DRUG	POSLUMA		flotufolastat F-18	INJECTION	INTRAVENOUS	20230525		NDA	NDA216023	Blue Earth Diagnostics	FLOTUFOLASTAT F-18	158	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
69933-140_4189ef56-b331-4ccd-b1f7-a2a1591cbb56	69933-140	HUMAN OTC DRUG	ALCHEMY LIVING HAND SANITIZER COCONUT FRAGRANCE		Ethyl Alcohol	LIQUID	TOPICAL	20230414		OTC MONOGRAPH NOT FINAL	part333A	Pearl World Inc.	ALCOHOL	70	mL/100mL			N	20241231
69933-240_6a4fcb32-b774-444d-9ec7-3bf9e29dcb5b	69933-240	HUMAN OTC DRUG	ALCHEMY LIVING HAND SANITIZER CUCUMBER MELON FRAGRANCE		Ethyl Alcohol	LIQUID	TOPICAL	20230414		OTC MONOGRAPH NOT FINAL	part333A	Pearl World Inc.	ALCOHOL	70	mL/100mL			N	20241231
69933-340_55db94f8-537a-4f51-8836-3f75710a6fe3	69933-340	HUMAN OTC DRUG	ALCHEMY LIVING HAND SANITIZER STRAWBERRY SHORT CAKE FRAGRANCE		Ethyl Alcohol	LIQUID	TOPICAL	20230414		OTC MONOGRAPH NOT FINAL	part333A	Pearl World Inc.	ALCOHOL	70	mL/100mL			N	20241231
69933-440_4f093b8a-4981-4c32-9f1d-a9773464f3a6	69933-440	HUMAN OTC DRUG	ALCHEMY LIVING HAND SANITIZER BLACK CHERRY FRAGRANCE		Ethyl Alcohol	LIQUID	TOPICAL	20230414		OTC MONOGRAPH NOT FINAL	part333A	Pearl World Inc.	ALCOHOL	70	mL/100mL			N	20241231
69933-605_c31d6861-855d-4ce8-97a2-3ffc89cce550	69933-605	HUMAN OTC DRUG	Smoke and Mirrors Hand Sanitizer Aloe Vera Soothing		Ethyl Alcohol	GEL	TOPICAL	20230608		OTC MONOGRAPH NOT FINAL	part333A	Pearl World Inc.	ALCOHOL	70	mL/100mL			N	20241231
69933-895_e7cd8160-35bc-48e4-9104-659e0d853381	69933-895	HUMAN OTC DRUG	Smoke and Mirrors Hand Sanitizer Pink Melon		Ethyl Alcohol	GEL	TOPICAL	20230608		OTC MONOGRAPH NOT FINAL	part333A	Pearl World Inc.	ALCOHOL	70	mL/100mL			N	20241231
69933-905_5cd3d4d4-0673-4ef7-bf89-8867a96aec1a	69933-905	HUMAN OTC DRUG	Smoke and Mirrors Hand Sanitizer Coconut Vanilla		Ethyl Alcohol	GEL	TOPICAL	20230608		OTC MONOGRAPH NOT FINAL	part333A	Pearl World Inc.	ALCOHOL	70	mL/100mL			N	20241231
69945-010_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-010	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	1	Ci/1			N	20241231
69945-015_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-015	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	1.5	Ci/1			N	20241231
69945-020_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-020	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	2	Ci/1			N	20241231
69945-025_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-025	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	2.5	Ci/1			N	20241231
69945-030_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-030	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	3	Ci/1			N	20241231
69945-035_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-035	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	3.5	Ci/1			N	20241231
69945-050_3d7648ab-7b11-495d-925c-3a991065237e	69945-050	HUMAN PRESCRIPTION DRUG	OCTREOSCAN		Indium In -111 Pentetreotide	KIT		20151014		NDA	NDA020314	Curium US LLC						N	20241231
69945-051_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-051	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	5	Ci/1			N	20241231
69945-060_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-060	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	6	Ci/1			N	20241231
69945-064_5d19005e-b316-4d35-a7a7-e03cea55d866	69945-064	HUMAN PRESCRIPTION DRUG	Detectnet		copper Cu 64 Dotatate	INJECTION, SOLUTION	INTRAVENOUS	20200914		NDA	NDA213227	CURIUM US LLC	COPPER OXODOTREOTIDE CU-64	1	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
69945-068_4c6f70aa-7423-4c74-ac27-7aba10169c16	69945-068	HUMAN PRESCRIPTION DRUG	Ultratag	RBC	Technetium Tc 99m-Labeled Red Blood Cells	KIT		19910610		NDA	NDA019981	Curium US LLC						N	20241231
69945-075_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-075	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	7.5	Ci/1			N	20241231
69945-091_cc5ce259-75af-4d0b-9ad2-bd6eb4f1c58d	69945-091	HUMAN PRESCRIPTION DRUG	Technescan HDP		Technetium Tc 99m Oxidronate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151013		NDA	NDA018321	Curium US LLC	OXIDRONATE DISODIUM	3.15	mg/1			N	20241231
69945-092_4b00526c-6250-49d7-ba34-459ef89c8f43	69945-092	HUMAN PRESCRIPTION DRUG	Technetium Tc 99m Sestamibi		Technetium Tc 99m Sestamibi	INJECTION	INTRAVENOUS	20111031		ANDA	ANDA078098	Curium US LLC	TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE	1	mg/mL			N	20241231
69945-094_f3bd9776-8df8-4b77-baaa-105ea6e55b67	69945-094	HUMAN PRESCRIPTION DRUG	Technescan PYP		Technetium Tc 99m Pyrophosphate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20151014		NDA	NDA017538	Curium US LLC	SODIUM PYROPHOSPHATE; STANNOUS CHLORIDE	11.9; 3.2	mg/10mL; mg/10mL			N	20241231
69945-096_b49d268a-0044-4f26-9310-544eddd7f2c2	69945-096	HUMAN PRESCRIPTION DRUG	Technescan MAG3		Technescan Tc 99m Mertiatide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19900615		NDA	NDA019882	Curium US LLC	BETIATIDE	1	mg/1			N	20241231
69945-097_ea92d06d-fbc1-48b1-a965-1c6f8ae7481b	69945-097	HUMAN PRESCRIPTION DRUG	Xenon, Xe-133		Xenon	GAS	RESPIRATORY (INHALATION)	20160330		NDA	NDA018327	Curium US LLC	XENON XE-133	5	mCi/mL	Inhalation Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69945-098_ea92d06d-fbc1-48b1-a965-1c6f8ae7481b	69945-098	HUMAN PRESCRIPTION DRUG	Xenon, Xe-133		Xenon	GAS	RESPIRATORY (INHALATION)	20160330		NDA	NDA018327	Curium US LLC	XENON XE-133	10	mCi/mL	Inhalation Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69945-110_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-110	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	11	Ci/1			N	20241231
69945-120_6d01f05b-0d24-42ee-bf79-df98b72bc06f	69945-120	HUMAN PRESCRIPTION DRUG	THALLOUS CHLORIDE Tl 201		thallous chloride, Tl 201	INJECTION, SOLUTION	INTRAVENOUS	20151104		NDA	NDA018150	Curium US LLC	THALLOUS CHLORIDE TL-201	1	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69945-132_16ea81c7-f65b-4d99-b234-16e447a6d1dc	69945-132	HUMAN PRESCRIPTION DRUG	INDIUM IN 111 CHLORIDE		indium in 111 chloride	SOLUTION	INTRAVENOUS	20071207		NDA	NDA019841	Curium US LLC	INDIUM CHLORIDE IN-111	10	mCi/mL			N	20241231
69945-139_99f3c790-3984-43a9-8ff1-d53032b4be48	69945-139	HUMAN PRESCRIPTION DRUG	Pulmotech MAA		kit for the preparation of technetium Tc 99m albumin aggregated	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAPERITONEAL; INTRAVENOUS	20200320		BLA	BLA210089	Curium US LLC	ALBUMIN AGGREGATED	2	mg/15mL			N	20241231
69945-140_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-140	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	14	Ci/1			N	20241231
69945-160_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-160	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	16	Ci/1			N	20241231
69945-166_c6a56613-3636-4736-bdaf-db89d8a8448b	69945-166	HUMAN PRESCRIPTION DRUG	Ioflupane I 123		IOFLUPANE I-123	INJECTION, SOLUTION	INTRAVENOUS	20220331		ANDA	ANDA213792	Curium US LLC	IOFLUPANE I-123	2	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
69945-180_2dd13def-19aa-4317-8688-920ed1c8cca6	69945-180	HUMAN PRESCRIPTION DRUG	GALLIUM CITRATE GA-67		gallium citrate ga-67	INJECTION, SOLUTION	INTRAVENOUS	20080221		NDA	NDA018058	Curium US LLC	GALLIUM CHLORIDE GA-67	2	mCi/mL			N	20241231
69945-190_51ec0396-8805-40b2-b600-06c81f8d43f8	69945-190	HUMAN PRESCRIPTION DRUG	Ultra-Technekow	V4	Technetium Tc-99m	INJECTION, SOLUTION	INTRAVENOUS	20140610		NDA	NDA017243	Curium US LLC	TECHNETIUM TC-99M SODIUM PERTECHNETATE	19	Ci/1			N	20241231
69945-601_ea1c4784-f57d-42a0-8203-d0fcfc6a3598	69945-601	HUMAN PRESCRIPTION DRUG	SODIUM IODIDE I 123		sodium iodide i 123	CAPSULE, GELATIN COATED	ORAL	20151104		ANDA	ANDA071909	Curium US LLC	SODIUM IODIDE I-123	100	uCi/1			N	20241231
69945-602_ea1c4784-f57d-42a0-8203-d0fcfc6a3598	69945-602	HUMAN PRESCRIPTION DRUG	SODIUM IODIDE I 123		sodium iodide i 123	CAPSULE, GELATIN COATED	ORAL	20070411		ANDA	ANDA071910	Curium US LLC	SODIUM IODIDE I-123	200	uCi/1			N	20241231
69947-120_7e555ba3-c6a3-0808-e053-2991aa0a0b25	69947-120	HUMAN OTC DRUG	Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20150903		OTC MONOGRAPH NOT FINAL	part333E	Alsco Inc.	ALCOHOL	71	mL/100mL			N	20241231
69949-010_a70fb398-5ec9-413f-a186-d71d197af74e	69949-010	HUMAN OTC DRUG	NATURAL MOISTURIZING FACE SUNSCREEN and PRIMER		Zinc Oxide	CREAM	TOPICAL	20100812		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-051_93e73eaa-54cc-4cd3-b4d1-dfbae774fd29	69949-051	HUMAN OTC DRUG	5-IN-1 TINTED FACE SUNSCREEN - FAIR		Zinc Oxide	CREAM	TOPICAL	20130701		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-052_93e73eaa-54cc-4cd3-b4d1-dfbae774fd29	69949-052	HUMAN OTC DRUG	5-IN-1 TINTED FACE SUNSCREEN - LIGHT		Zinc Oxide	CREAM	TOPICAL	20130701		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-053_93e73eaa-54cc-4cd3-b4d1-dfbae774fd29	69949-053	HUMAN OTC DRUG	5-IN-1 TINTED FACE SUNSCREEN - GOLDEN LIGHT		Zinc Oxide	CREAM	TOPICAL	20151001		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-054_93e73eaa-54cc-4cd3-b4d1-dfbae774fd29	69949-054	HUMAN OTC DRUG	5-IN-1 TINTED FACE SUNSCREEN - MEDIUM		Zinc Oxide	CREAM	TOPICAL	20130701		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-100_d766b759-22f6-4ade-a65b-efa6d043596f	69949-100	HUMAN OTC DRUG	NATURAL MINERAL BODY SUNSCREEN		Zinc Oxide	CREAM	TOPICAL	20100812		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-111_d101177c-d1c9-42bf-b3db-9a6e9e48a158	69949-111	HUMAN OTC DRUG	MINERAL BODY SUNSCREEN UNSCENTED		Zinc Oxide	CREAM	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-151_9013d884-7a0e-4316-960d-a49cdffccf02	69949-151	HUMAN OTC DRUG	IMPECCABLE SKIN - IVORY		Zinc Oxide	CREAM	TOPICAL	20180801		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	150	mg/g			N	20241231
69949-152_9013d884-7a0e-4316-960d-a49cdffccf02	69949-152	HUMAN OTC DRUG	IMPECCABLE SKIN - BUFF		Zinc Oxide	CREAM	TOPICAL	20180801		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	150	mg/g			N	20241231
69949-153_9013d884-7a0e-4316-960d-a49cdffccf02	69949-153	HUMAN OTC DRUG	IMPECCABLE SKIN - SAND		Zinc Oxide	CREAM	TOPICAL	20180801		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	150	mg/g			N	20241231
69949-154_9013d884-7a0e-4316-960d-a49cdffccf02	69949-154	HUMAN OTC DRUG	IMPECCABLE SKIN - TAN		Zinc Oxide	CREAM	TOPICAL	20180801		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	150	mg/g			N	20241231
69949-155_9013d884-7a0e-4316-960d-a49cdffccf02	69949-155	HUMAN OTC DRUG	IMPECCABLE SKIN - BRONZE		Zinc Oxide	CREAM	TOPICAL	20180801		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	150	mg/g			N	20241231
69949-156_9013d884-7a0e-4316-960d-a49cdffccf02	69949-156	HUMAN OTC DRUG	IMPECCABLE SKIN - NUDE		Zinc Oxide	CREAM	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	150	mg/g			N	20241231
69949-157_9013d884-7a0e-4316-960d-a49cdffccf02	69949-157	HUMAN OTC DRUG	IMPECCABLE SKIN - MOCHA		Zinc Oxide	CREAM	TOPICAL	20231001		OTC MONOGRAPH DRUG	M020	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	150	mg/g			N	20241231
69949-201_cda3ecfa-a3be-4252-be27-b42770d27a7c	69949-201	HUMAN OTC DRUG	SPORT MINERAL SUN		Zinc Oxide	STICK	TOPICAL	20180801		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	200	mg/g			N	20241231
69949-250_adfc66f9-01f9-4c95-904d-e1eb24b24fbf	69949-250	HUMAN OTC DRUG	ClearSPF Sheer Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	20	g/100g			N	20241231
69949-251_cc81fa5d-d2ff-4cfc-8a7a-c7e0eabc96d6	69949-251	HUMAN OTC DRUG	ClearSPF Tinted Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	ZINC OXIDE	20	g/100g			N	20241231
69949-400_d46b486a-6ad5-427e-9ee3-7474977b0901	69949-400	HUMAN OTC DRUG	MILKY MINERAL SUN SERUM		TITANIUM DIOXIDE and ZINC OXIDE	LOTION	TOPICAL	20220401		OTC MONOGRAPH FINAL	part352	Synchronicity Spa, Inc. DBA Suntegrity	TITANIUM DIOXIDE; ZINC OXIDE	72; 95	mg/mL; mg/mL			N	20241231
69951-001_02f77e83-2c24-332d-e063-6394a90a1e9d	69951-001	HUMAN OTC DRUG	Prevention Oncology Mouth Rinse		Glycerin	LIQUID	ORAL	20230110		OTC MONOGRAPH NOT FINAL	part356	Prevention Health Sciences, Inc.	GLYCERIN	4.5	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
69951-002_02f77e83-2c26-332d-e063-6394a90a1e9d	69951-002	HUMAN OTC DRUG	Prevention Mouth Rinse		Hydrogen peroxide	LIQUID	TOPICAL	20231001		OTC MONOGRAPH NOT FINAL	part356	Prevention Health Sciences, Inc.	HYDROGEN PEROXIDE	1.5	g/100mL			N	20241231
69953-515_677aa953-3c31-4ce5-e053-2991aa0ab2b2	69953-515	HUMAN OTC DRUG	Morning After		Levonorgestrel	TABLET	ORAL	20180322		ANDA	ANDA206867	Rapha Pharmaceuticals, Inc.	LEVONORGESTREL	1.5	mg/1.5mg	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69953-516_f0fabe80-87bc-9b65-e053-2995a90a582b	69953-516	HUMAN OTC DRUG	Morning After		Levonorgestrel	TABLET	ORAL	20221230		ANDA	ANDA205329	Rapha Pharmaceuticals, Inc.	LEVONORGESTREL	1.5	mg/1.5mg	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69953-517_f0fabe80-87bc-9b65-e053-2995a90a582b	69953-517	HUMAN OTC DRUG	Morning After		Levonorgestrel	TABLET	ORAL	20221230		ANDA	ANDA205329	Rapha Pharmaceuticals, Inc.	LEVONORGESTREL	1.5	mg/1.5mg	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
69953-553_f2a6518b-83a0-3cb5-e053-2995a90aadd4	69953-553	HUMAN OTC DRUG	DentaKoteS		DentaKoteS	GEL	TOPICAL	20230118		UNAPPROVED HOMEOPATHIC		Rapha Pharmaceuticals, Inc.	ACONITUM NAPELLUS; BELLIS PERENNIS; FERROSOFERRIC PHOSPHATE; METHYL SALICYLATE	6; 6; 6; 6	[hp_X]/6[hp_X]; [hp_X]/6[hp_X]; [hp_X]/6[hp_X]; [hp_X]/6[hp_X]			N	20241231
69953-617_0aab0d9b-3db7-7c71-e063-6394a90a9c89	69953-617	HUMAN OTC DRUG	PostDay One-Step		Levonorgestrel	TABLET	ORAL	20230116		ANDA	ANDA205329	Rapha Pharmaceuticals, Inc.	LEVONORGESTREL	1.5	mg/1.5mg	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
69953-618_0aab0d9b-3db7-7c71-e063-6394a90a9c89	69953-618	HUMAN OTC DRUG	PostDay One-Step		Levonorgestrel	TABLET	ORAL	20231121		ANDA	ANDA205329	Rapha Pharmaceuticals, Inc.	LEVONORGESTREL	1.5	mg/1.5mg	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
69953-628_0aab0d9b-3db7-7c71-e063-6394a90a9c89	69953-628	HUMAN OTC DRUG	PostDay One-Step		Levonorgestrel	TABLET	ORAL	20230116		ANDA	ANDA205329	Rapha Pharmaceuticals, Inc.	LEVONORGESTREL	1.5	mg/1.5mg	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
69968-0013_edf589c4-e913-5cfa-e053-2995a90ae311	69968-0013	HUMAN OTC DRUG	Clean and Clear acne triple clear exfoliating scrub		Salicylic Acid	GEL	TOPICAL	20161101		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/g			N	20241231
69968-0026_ee323333-c884-25d1-e053-2995a90acddc	69968-0026	HUMAN OTC DRUG	Neutrogena Clear Pore Cleanser Mask		Benzoyl Peroxide	GEL	TOPICAL	20160401		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	BENZOYL PEROXIDE	35	mg/mL			N	20241231
69968-0028_ee331a9e-ed16-24ad-e053-2a95a90a5b3b	69968-0028	HUMAN OTC DRUG	Neutrogena Clear Pore Oil-Eliminating Astringent		Salicylic Acid	LIQUID	TOPICAL	20200131		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0030_ee3348ed-b763-f3dc-e053-2a95a90a36ce	69968-0030	HUMAN OTC DRUG	Womens Rogaine Unscented		Minoxidil	AEROSOL, FOAM	TOPICAL	20110401		NDA	NDA021812	Johnson & Johnson Consumer Inc.	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69968-0031_ee337887-e684-792b-e053-2a95a90a2e9f	69968-0031	HUMAN OTC DRUG	Mens rogaine Minoxidil	Unscented Formula	Minoxidil	AEROSOL, FOAM	TOPICAL	20101001		NDA	NDA021812	Johnson & Johnson Consumer Inc.	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69968-0043_ee3435ac-44a2-7683-e053-2a95a90a5c75	69968-0043	HUMAN OTC DRUG	Neutrogena Rapid Clear Stubborn Acne Spot		Benzoyl Peroxide	GEL	TOPICAL	20140905		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	BENZOYL PEROXIDE	100	mg/g			N	20241231
69968-0054_ee34169f-8a4f-6405-e053-2995a90a52ad	69968-0054	HUMAN OTC DRUG	Neosporin Kids Plus Pain Relief		Neomycin Sulfate, Polymyxin B Sulfate, and PRAMOXINE HYDROCHLORIDE	CREAM	TOPICAL	20161108		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0055_ef5fc4a8-9eaf-560a-e053-2995a90ab071	69968-0055	HUMAN OTC DRUG	Neosporin Plus Pain Relief	First Aid Antibiotic/Pain Relieving	Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	CREAM	TOPICAL	20091201		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0056_ee34b763-4be7-7080-e053-2995a90a202b	69968-0056	HUMAN OTC DRUG	Neosporin Original		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20160903		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0057_ee351b0e-75be-75a8-e053-2995a90a53ba	69968-0057	HUMAN OTC DRUG	Neosporin Plus Pain Relief		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20091201		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0060_ee353eb7-8318-cf81-e053-2995a90a5bb4	69968-0060	HUMAN OTC DRUG	Polysporin First Aid Antibiotic		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	TOPICAL	20130709		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0061_0aa80fcc-7dd4-a600-e063-6294a90aad3d	69968-0061	HUMAN OTC DRUG	Desitin Maximum Strength Diaper Rash		Zinc Oxide	PASTE	TOPICAL	20151116		OTC MONOGRAPH DRUG	M016	Johnson & Johnson Consumer Inc.	ZINC OXIDE	400	mg/g			N	20241231
69968-0073_f2294af7-5efe-3441-e053-2995a90ae708	69968-0073	HUMAN OTC DRUG	Neutrogena Oil Free Acne Stress Control Power Clear Scrub		Salicylic Acid	GEL	TOPICAL	20161101		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0075_ee366b10-be28-e9c3-e053-2995a90a2603	69968-0075	HUMAN OTC DRUG	Neutrogena Oil-Free Acne Wash Daily Scrub		Salicylic acid	GEL	TOPICAL	20160601		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0076_f33a5252-b98e-87de-e053-2a95a90aef52	69968-0076	HUMAN OTC DRUG	Neutrogena Healthy Skin Anti-Aging Perfector Sunscreen Broad Spectrum SPF 20	Ivory to Fair 10	Octinoxate and Octisalate	LOTION	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OCTISALATE	70; 30	mg/mL; mg/mL			N	20241231
69968-0077_f33a5252-b98e-87de-e053-2a95a90aef52	69968-0077	HUMAN OTC DRUG	Neutrogena Healthy Skin Anti-Aging Perfector Sunscreen Broad Spectrum SPF 20	Fair to Light 20	Octinoxate and Octisalate	LOTION	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OCTISALATE	70; 30	mg/mL; mg/mL			N	20241231
69968-0078_f33a5252-b98e-87de-e053-2a95a90aef52	69968-0078	HUMAN OTC DRUG	Neutrogena Healthy Skin Anti-Aging Perfector Sunscreen Broad Spectrum SPF 20	Light to Neutral 30	Octinoxate and Octisalate	LOTION	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OCTISALATE	70; 30	mg/mL; mg/mL			N	20241231
69968-0079_f33a5252-b98e-87de-e053-2a95a90aef52	69968-0079	HUMAN OTC DRUG	Neutrogena Healthy Skin Anti-Aging Perfector Sunscreen Broad Spectrum SPF 20	Neutral to Tan 40	Octinoxate and Octisalate	LOTION	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OCTISALATE	70; 30	mg/mL; mg/mL			N	20241231
69968-0080_f33a5252-b98e-87de-e053-2a95a90aef52	69968-0080	HUMAN OTC DRUG	Neutrogena Healthy Skin Anti-Aging Perfector Sunscreen Broad Spectrum SPF 20	Tan to Medium 50	Octinoxate and Octisalate	LOTION	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OCTISALATE	70; 30	mg/mL; mg/mL			N	20241231
69968-0081_f33a5252-b98e-87de-e053-2a95a90aef52	69968-0081	HUMAN OTC DRUG	Neutrogena Healthy Skin Anti-Aging Perfector Sunscreen Broad Spectrum SPF 20	Medium to Deep 60	Octinoxate and Octisalate	LOTION	TOPICAL	20151101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OCTISALATE	70; 30	mg/mL; mg/mL			N	20241231
69968-0089_f9368225-dee1-1f9c-e053-6294a90a6d5b	69968-0089	HUMAN OTC DRUG	Mens Rogaine Extra Strength Unscented		Minoxidil	SOLUTION	TOPICAL	20100716		NDA	NDA020834	Johnson & Johnson Consumer Inc.	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69968-0090_f9369ecb-f3c5-fb90-e053-6294a90a2a1d	69968-0090	HUMAN OTC DRUG	Womens Rogaine Unscented		Minoxidil	SOLUTION	TOPICAL	20100801		NDA	NDA019501	Johnson & Johnson Consumer Inc.	MINOXIDIL	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
69968-0092_ee357351-b2f2-d494-e053-2a95a90a4e69	69968-0092	HUMAN OTC DRUG	Neutrogena All in 1 Acne Control Daily Scrub		Salicylic Acid	LIQUID	TOPICAL	20160601		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0093_ee357c8d-ed78-130c-e053-2a95a90ae4b7	69968-0093	HUMAN OTC DRUG	Neosporin Pain Itch Scar		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20160115		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0101_07d485a9-7727-b0ac-e063-6394a90a95e0	69968-0101	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection	Sunscreen Broad Spectrum SPF30	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	SPRAY	TOPICAL	20161001		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 30; 40; 20; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0110_f7897499-42b3-06c3-e053-6294a90af294	69968-0110	HUMAN OTC DRUG	Neutrogena Acne Proofing cleanser		Salicylic Acid	GEL	TOPICAL	20171001	20240312	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/g			N	
69968-0112_fd81dd4b-9616-f4c1-e053-6394a90a5e72	69968-0112	HUMAN OTC DRUG	Neutrogena Acne Proofing daily scrub		Salicylic Acid	GEL	TOPICAL	20171001	20240522	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/g			N	
69968-0114_ee451607-ce5e-6927-e053-2a95a90a9545	69968-0114	HUMAN OTC DRUG	Neutrogena Healthy Skin Glow Sheers Illuminating Tinted Moisturizer - Light to Medium 30	Sunscreen Broad Spectrum SPF30	Homosalate, Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	LIQUID	TOPICAL	20130523		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	50; 75; 50; 20; 29	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0115_ee451607-ce5e-6927-e053-2a95a90a9545	69968-0115	HUMAN OTC DRUG	Neutrogena Healthy Skin Glow Sheers Illuminating Tinted Moisturizer - Fair to Light 20	Sunscreen Broad Spectrum SPF30	Homosalate, Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	LIQUID	TOPICAL	20130523		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	50; 75; 50; 20; 29	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0116_ee451607-ce5e-6927-e053-2a95a90a9545	69968-0116	HUMAN OTC DRUG	Neutrogena Healthy Skin Glow Sheers Illuminating Tinted Moisturizer - Ivory to Fair 10	Sunscreen Broad Spectrum SPF30	Homosalate, Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	LIQUID	TOPICAL	20130523		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	50; 75; 50; 20; 29	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0126_ee453d40-a5e3-7086-e053-2a95a90a30d5	69968-0126	HUMAN OTC DRUG	Clean and Clear Advantage Acne Spot Treatment		Salicylic Acid	LOTION	TOPICAL	20061001		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0132_f9d4d80e-44fd-ea05-e053-6394a90a8937	69968-0132	HUMAN OTC DRUG	Neutrogena Healthy Skin Firming	Sunscreen Broad Spectrum SPF15	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20101002	20240626	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 120; 50; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0140_f33a92cf-298c-051f-e053-2a95a90af599	69968-0140	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Classic Ivory 10	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0141_f33a92cf-298c-051f-e053-2a95a90af599	69968-0141	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Natural Ivory 20	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0142_f33a92cf-298c-051f-e053-2a95a90af599	69968-0142	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Buff 30	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0143_f33a92cf-298c-051f-e053-2a95a90af599	69968-0143	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Nude 40	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0144_f33a92cf-298c-051f-e053-2a95a90af599	69968-0144	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Soft Beige 50	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0145_f33a92cf-298c-051f-e053-2a95a90af599	69968-0145	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Natural Beige 60	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0146_f33a92cf-298c-051f-e053-2a95a90af599	69968-0146	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Fresh Beige 70	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0147_f33a92cf-298c-051f-e053-2a95a90af599	69968-0147	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Medium Beige 80	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0148_f33a92cf-298c-051f-e053-2a95a90af599	69968-0148	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Warm Beige 90	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0149_f33a92cf-298c-051f-e053-2a95a90af599	69968-0149	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Natural Tan 100	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0150_f33a92cf-298c-051f-e053-2a95a90af599	69968-0150	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Honey 85	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0151_f33a92cf-298c-051f-e053-2a95a90af599	69968-0151	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Caramel 105	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0152_f33a92cf-298c-051f-e053-2a95a90af599	69968-0152	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Cocoa 115	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0153_f33a92cf-298c-051f-e053-2a95a90af599	69968-0153	HUMAN OTC DRUG	Neutrogena Healthy Skin Makeup	Sunscreen Broad Spectrum SPF20 - Chestnut 135	Titanium Dioxide	LIQUID	TOPICAL	20160118		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	24	mg/mL			N	20241231
69968-0155_ee47969a-cb1d-2730-e053-2a95a90a95e2	69968-0155	HUMAN OTC DRUG	Neutrogena Oil Free Acne Wash Cleanser		Salicylic Acid	CREAM	TOPICAL	20110215		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0158_ee47ce04-58dc-fbec-e053-2995a90a6f56	69968-0158	HUMAN OTC DRUG	Neutrogena Rapid Clear 2 in 1 Fight and Fade Toner		Salicylic Acid	SOLUTION	TOPICAL	20091001		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0164_ee47f95a-886b-6ad6-e053-2995a90aeeb4	69968-0164	HUMAN OTC DRUG	Neutrogena On-the-Spot Acne Treatment	Vanishing Formula	Benzoyl Peroxide	CREAM	TOPICAL	20160201		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	BENZOYL PEROXIDE	25	mg/g			N	20241231
69968-0169_07d491c5-f5aa-a449-e063-6394a90a90fc	69968-0169	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection	Sunscreen Broad Spectrum SPF70	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	AEROSOL, SPRAY	TOPICAL	20120605		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0171_07d4da22-2ce9-4755-e063-6294a90a5bdf	69968-0171	HUMAN OTC DRUG	Neutrogena Ultra Sheer Body Mist	Sunscreen Broad Spectrum SPF 70	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	AEROSOL, SPRAY	TOPICAL	20071005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 40; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0178_0aa8ed47-18b8-4084-e063-6394a90a2c1b	69968-0178	HUMAN OTC DRUG	Listerine Total Care Fresh Mint	Anticavity	Sodium Fluoride	MOUTHWASH	ORAL	20091101		OTC MONOGRAPH DRUG	M021	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0193_ee48e897-4afd-6915-e053-2a95a90a4376	69968-0193	HUMAN OTC DRUG	Neutrogena Oil Free Acne Moisturizer Pink Grapefruit		Salicylic Acid	LOTION	TOPICAL	20190402		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0194_ee49185a-800b-fc97-e053-2995a90a60ea	69968-0194	HUMAN OTC DRUG	Listerine Total Care Zero Alcohol Anticavity	Fresh Mint	Sodium Fluoride	MOUTHWASH	ORAL	20120725		OTC MONOGRAPH FINAL	part355	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0200_f78e33a4-4b41-7243-e053-6394a90af6f5	69968-0200	HUMAN OTC DRUG	Neutrogena Healthy Skin Compact Makeup with sunscreen broad spectrum	SPF Nude 40	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20101101	20240531	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	28; 80; 40; 90; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	
69968-0203_f78e33a4-4b41-7243-e053-6394a90af6f5	69968-0203	HUMAN OTC DRUG	Neutrogena Healthy Skin Compact Makeup with sunscreen broad spectrum	SPF 55 Natural Beige 60	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20101101	20240531	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	28; 80; 40; 90; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	
69968-0205_f78e33a4-4b41-7243-e053-6394a90af6f5	69968-0205	HUMAN OTC DRUG	Neutrogena Healthy Skin Compact Makeup with sunscreen broad spectrum	SPF 55 Classic Ivory 10	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20101101	20240430	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	28; 80; 40; 90; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	
69968-0206_f78e33a4-4b41-7243-e053-6394a90af6f5	69968-0206	HUMAN OTC DRUG	Neutrogena Healthy Skin Compact Makeup with sunscreen broad spectrum	SPF55 Natural Ivory 20	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20101101	20240531	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	28; 80; 40; 90; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	
69968-0208_ee463053-5c9f-d84d-e053-2995a90a2aa9	69968-0208	HUMAN OTC DRUG	Neosporin Lip Health	Overnight Renewal Therapy	Petrolatum	OINTMENT	TOPICAL	20090603		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	PETROLATUM	774	mg/g			N	20241231
69968-0209_ee466e83-f613-4ffb-e053-2995a90a063b	69968-0209	HUMAN OTC DRUG	Clean and Clear Essentials Deep Cleaning	Astringent	Salicylic Acid	LIQUID	TOPICAL	20120430		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0212_ee467c02-d833-59d6-e053-2a95a90afd0a	69968-0212	HUMAN OTC DRUG	Clean and Clear Persa-Gel 10		Benzoyl Peroxide	GEL	TOPICAL	20091101		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	BENZOYL PEROXIDE	100	mg/g			N	20241231
69968-0223_f2266ae9-09a1-0340-e053-2995a90aab4a	69968-0223	HUMAN OTC DRUG	Benadryl Extra Strength	Itch Stopping	Diphenhydramine Hydrochloride and Zinc Acetate	CREAM	TOPICAL	20091101		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69968-0234_ee48b183-b39d-fcbf-e053-2a95a90a4bee	69968-0234	HUMAN OTC DRUG	Clean and Clear blackhead eraser scrub		Salicylic Acid	CREAM	TOPICAL	20160601		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/g			N	20241231
69968-0236_ee48ddc1-5dc6-46fe-e053-2a95a90a161f	69968-0236	HUMAN OTC DRUG	Aveeno Skin Relief Moisturizing	Fragrance Free	Dimethicone	LOTION	TOPICAL	20180901		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
69968-0239_ee817c31-6fe2-fb3e-e053-2995a90adc43	69968-0239	HUMAN OTC DRUG	Listerine FreshBurst Antiseptic		Eucalyptol, MENTHOL, UNSPECIFIED FORM, Methyl Salicylate, and Thymol	MOUTHWASH	ORAL	20180817		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0242_ff551aa3-60da-056f-e053-6394a90a662f	69968-0242	HUMAN OTC DRUG	Benadryl Extra Strength Itch Stopping		Diphenhydramine Hydrochloride	GEL	TOPICAL	20131001		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	20	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69968-0247_ee823645-c544-7480-e053-2995a90abbcd	69968-0247	HUMAN OTC DRUG	Neutrogena Oil-Free Acne Wash Pink Grapefruit Foaming Scrub		Salicylic acid	GEL	TOPICAL	20160601		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0251_ee82b88c-e151-0978-e053-2a95a90ab5f1	69968-0251	HUMAN OTC DRUG	Neutrogena Revitalizing Lip Balm	SPF 20 - Sheeer Shimmer 10	Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20101101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 50	mg/g; mg/g			N	20241231
69968-0252_ee82b88c-e151-0978-e053-2a95a90ab5f1	69968-0252	HUMAN OTC DRUG	Neutrogena Revitalizing Lip Balm	SPF 20 - Soft Caramel 50	Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20101101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 50	mg/g; mg/g			N	20241231
69968-0253_ee82b88c-e151-0978-e053-2a95a90ab5f1	69968-0253	HUMAN OTC DRUG	Neutrogena Revitalizing Lip Balm	SPF 20 - Healthy Blush 20	Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20101101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 50	mg/g; mg/g			N	20241231
69968-0254_ee82b88c-e151-0978-e053-2a95a90ab5f1	69968-0254	HUMAN OTC DRUG	Neutrogena Revitalizing Lip Balm	SPF 20 - Petal Glow 40	Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20101101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 50	mg/g; mg/g			N	20241231
69968-0255_ee82b88c-e151-0978-e053-2a95a90ab5f1	69968-0255	HUMAN OTC DRUG	Neutrogena Revitalizing Lip Balm	SPF 20 - Sunny Berry 30	Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20101101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 50	mg/g; mg/g			N	20241231
69968-0256_ee82b88c-e151-0978-e053-2a95a90ab5f1	69968-0256	HUMAN OTC DRUG	Neutrogena Revitalizing Lip Balm	SPF 20 - Fresh Plum 60	Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20101101		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	OCTINOXATE; OXYBENZONE	75; 50	mg/g; mg/g			N	20241231
69968-0264_f33b488f-b723-6d8a-e053-2a95a90ae3f9	69968-0264	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral - Honey Beige		Salicylic Acid	POWDER	TOPICAL	20091130		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0265_f33b488f-b723-6d8a-e053-2a95a90ae3f9	69968-0265	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral - Soft Beige		Salicylic Acid	POWDER	TOPICAL	20091130		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0266_f33b488f-b723-6d8a-e053-2a95a90ae3f9	69968-0266	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral - Nude		Salicylic Acid	POWDER	TOPICAL	20091130		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0267_f33b488f-b723-6d8a-e053-2a95a90ae3f9	69968-0267	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral - Buff		Salicylic Acid	POWDER	TOPICAL	20091130		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0268_f33b488f-b723-6d8a-e053-2a95a90ae3f9	69968-0268	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral - Natural Ivory		Salicylic Acid	POWDER	TOPICAL	20091130		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0270_fb2b8c17-ccf6-3595-e053-6294a90af5dc	69968-0270	HUMAN OTC DRUG	Benadryl Extra Strength Itch Cooling		Diphenhydramine Hydrochloride and Zinc Acetate	SPRAY	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69968-0273_f78dc3cd-9c25-252b-e053-6394a90a8b3f	69968-0273	HUMAN OTC DRUG	Clean and Clear Essentials Deep Cleansing Toner	Sensitive Skin	Salicylic Acid	LIQUID	TOPICAL	20120427	20240620	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	
69968-0275_ee997e27-b4ca-9e61-e053-2a95a90ab2a6	69968-0275	HUMAN OTC DRUG	Neutrogena pure and free baby	SUNSCREEN Broad Spectrum SPF 50	Zinc Oxide	LOTION	TOPICAL	20161001		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	20241231
69968-0299_f78df2c0-3015-20a8-e053-6294a90a75f4	69968-0299	HUMAN OTC DRUG	Neutrogena Healthy Skin Face	Sunscreen Broad Spectrum SPF15	Avobenzone, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20140401	20250731	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	15; 50; 30; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0300_f5584d72-9b69-6dca-e053-2a95a90a3288	69968-0300	HUMAN OTC DRUG	Neutrogena Ultra Sheer Body Mist	Sunscreen Broad Spectrum SPF 100 Plus	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	AEROSOL, SPRAY	TOPICAL	20091001	20240530	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	
69968-0304_fab14a17-1ba2-5c47-e053-6294a90afd94	69968-0304	HUMAN OTC DRUG	Aveeno Baby continuous protection sensitive skin	Sunscreen Broad Spectrum SPF50	Zinc Oxide	LOTION	TOPICAL	20161001		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	20241231
69968-0309_f33b488f-b723-6d8a-e053-2a95a90ae3f9	69968-0309	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral - Classic Ivory		Salicylic Acid	POWDER	TOPICAL	20091130		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0310_f33b488f-b723-6d8a-e053-2a95a90ae3f9	69968-0310	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral - Natural Beige		Salicylic Acid	POWDER	TOPICAL	20091130		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0316_09cacefc-75a9-b700-e063-6294a90a3bb5	69968-0316	HUMAN OTC DRUG	Neutrogena HydroBoost Water Gel Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20171001	20241022	OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	15; 50; 40; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0338_ee85cd0a-114e-8067-e053-2995a90a51cb	69968-0338	HUMAN OTC DRUG	Neutrogena	Skin Clearing Blemish Concealer - Deep 20	Salicylic Acid	LIQUID	TOPICAL	20171002		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0340_ee825456-25e4-77e9-e053-2a95a90a8b77	69968-0340	HUMAN OTC DRUG	Neutrogena SkinClearing Mineral Powder - Chestnut 135		Salicylic Acid	CREAM	TOPICAL	20171002		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0342_f93125a9-354a-31d9-e053-6394a90a213f	69968-0342	HUMAN OTC DRUG	Neutrogena Oil-Free Moisture	Sunscreen Broad Spectrum SPF 35	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20100601	20241007	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 120; 50; 23.5; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0355_ee82e447-8cee-03fb-e053-2995a90a7729	69968-0355	HUMAN OTC DRUG	Visine Red Eye Comfort		Tetrahydrozoline Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20200427		OTC MONOGRAPH FINAL	part349	Johnson & Johnson Consumer Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.5	mg/mL			N	20241231
69968-0356_ee83fbf4-ce99-eb42-e053-2995a90aa4ff	69968-0356	HUMAN OTC DRUG	Visine Red Eye Hydrating Comfort	Eye Drops	TETRAHYDROZOLINE HYDROCHLORIDE and Polyethylene Glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20200427		OTC MONOGRAPH FINAL	part349	Johnson & Johnson Consumer Inc.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE	10; .5	mg/mL; mg/mL			N	20241231
69968-0360_ee85f1da-cc45-70a6-e053-2a95a90a94db	69968-0360	HUMAN OTC DRUG	Visine Red Eye Total Comfort Multi-Symptom		TETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, and ZINC SULFATE, UNSPECIFIED FORM	SOLUTION/ DROPS	OPHTHALMIC	20200427		OTC MONOGRAPH FINAL	part349	Johnson & Johnson Consumer Inc.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM	10; .5; 2.5	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69968-0363_ee861900-0c71-68e7-e053-2a95a90abd70	69968-0363	HUMAN OTC DRUG	Visine Dry Eye Relief		Polyethylene Glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20200427		OTC MONOGRAPH FINAL	part349	Johnson & Johnson Consumer Inc.	POLYETHYLENE GLYCOL 400	10	mg/mL			N	20241231
69968-0364_ee8635c6-8a2a-0d83-e053-2a95a90a1b66	69968-0364	HUMAN OTC DRUG	Visine Dry Eye Relief	Eye Drops	Polyethylene Glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20200427		OTC MONOGRAPH FINAL	part349	Johnson & Johnson Consumer Inc.	POLYETHYLENE GLYCOL 400	10	mg/mL			N	20241231
69968-0365_ee868077-23e8-2ec4-e053-2995a90a88fd	69968-0365	HUMAN OTC DRUG	Visine Dry Eye Relief		Polyethylene Glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20200427		OTC MONOGRAPH FINAL	part349	Johnson & Johnson Consumer Inc.	POLYETHYLENE GLYCOL 400	10	mg/mL			N	20241231
69968-0366_ee86a572-acb1-7a48-e053-2995a90aa347	69968-0366	HUMAN OTC DRUG	Visine A.C. Itchy Eye Relief		Tetrahydrozoline Hydrochloride and Zinc Sulfate, Unspecified Form	SOLUTION/ DROPS	OPHTHALMIC	20190506		OTC MONOGRAPH FINAL	part349	Johnson & Johnson Consumer Inc.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM	.5; 2.5	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
69968-0367_0c3541e7-1c48-653e-e063-6394a90ae492	69968-0367	HUMAN OTC DRUG	Visine Allergy Eye Relief Multi-Action		Naphazoline Hydrochloride and Pheniramine Maleate	SOLUTION/ DROPS	OPHTHALMIC	20190506		NDA	NDA020485	Johnson & Johnson Consumer Inc.	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	.25; 3	mg/mL; mg/mL			N	20241231
69968-0370_f930a668-4b16-b074-e053-6294a90ab7d5	69968-0370	HUMAN OTC DRUG	Aveeno Positively Radiant Daily Moisturizer sunscreen	Broad Spectrum SPF30	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20060901	20240403	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 120; 50; 17; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0371_fc6fcb09-5d47-2abf-e053-6294a90a3c43	69968-0371	HUMAN OTC DRUG	Aveeno positively radiant daily moisturizer sunscreen broad spectrum SPF 15		Avobenzone, Octinoxate, and Octisalate	LOTION	TOPICAL	20151201	20240208	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	
69968-0372_ee967105-e90c-08bd-e053-2995a90ad52f	69968-0372	HUMAN OTC DRUG	Aveeno clear complexion daily moisturizer		Salicylic Acid	LOTION	TOPICAL	20040101		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0394_f427abba-d10f-356d-e053-2a95a90a65c1	69968-0394	HUMAN OTC DRUG	Aveeno Positively Mineral Sensitive Skin Sunscreen for Face Broad Spectrum SPF 50		Zinc Oxide	LOTION	TOPICAL	20181001	20241217	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	
69968-0395_fc7031f4-4d26-a376-e053-6394a90ab971	69968-0395	HUMAN OTC DRUG	Aveeno Positively Mineral Sensitive Skin Sunscreen Broad Spectrum SPF 50		Zinc Oxide	LOTION	TOPICAL	20181001	20241127	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	
69968-0396_ee9868bd-f90a-6539-e053-2995a90a9768	69968-0396	HUMAN OTC DRUG	Desitin Maximum Strength Zinc Oxide Diaper Rash		Zinc Oxide	PASTE	TOPICAL	20180601		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	ZINC OXIDE	400	mg/g			N	20241231
69968-0397_07d577bc-6ef1-1adf-e063-6294a90a0743	69968-0397	HUMAN OTC DRUG	Neutrogena Hydro Boost City Shield water Broad Spectrum SPF 25		Avobenzone, Homosalate, Octisalate, and Octocrylene	GEL	TOPICAL	20181001		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0400_f82dfc62-7343-330f-e053-6294a90aaf7e	69968-0400	HUMAN OTC DRUG	LISTERINE	Original Antiseptic	Eucalyptol, Menthol, Unspecified Form, Methyl Salicylate, and Thymol	MOUTHWASH	ORAL	20190106		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0404_ee980f9e-632d-3246-e053-2a95a90a9fb0	69968-0404	HUMAN OTC DRUG	Aveeno Baby Eczema Therapy Moisturizing		Oatmeal	CREAM	TOPICAL	20100601		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0405_ee988b07-ad94-6c05-e053-2995a90aa524	69968-0405	HUMAN OTC DRUG	Aveeno Soothing Bath Treatment		Oatmeal	POWDER	TOPICAL	20190218		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	1000	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0408_ee98faf0-14f4-9bb4-e053-2995a90a458c	69968-0408	HUMAN OTC DRUG	Aveeno Skin Relief Moisturizing	Fragrance Free	Dimethicone	LOTION	TOPICAL	20051201		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
69968-0409_ee994f14-e42b-531a-e053-2a95a90adbfe	69968-0409	HUMAN OTC DRUG	Aveeno Skin Relief Moisturizing	Fragrance Free	Dimethicone	LOTION	TOPICAL	20051201		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
69968-0414_07d5cf07-ea73-8957-e063-6294a90ae42e	69968-0414	HUMAN OTC DRUG	Neutrogena Triple Age Repair Moisturizer with Sunscreen Broad Spectrum SPF 25		Avobenzone, Homosalate, Octisalate, and Octocrylene	CREAM	TOPICAL	20191030		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0416_f306cbaf-1b73-304e-e053-2a95a90a2398	69968-0416	HUMAN OTC DRUG	Neutrogena Wet Skin Kids Beach and Pool Sunscreen Broad Spectrum SPF 70 Plus		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	STICK	TOPICAL	20191030	20240128	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	
69968-0419_ee9af894-30a6-840a-e053-2a95a90af3fa	69968-0419	HUMAN OTC DRUG	Aveeno Eczema Therapy Itch Relief Balm		Oatmeal	CREAM	TOPICAL	20160901		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0421_ee9af64f-cea6-5ea8-e053-2a95a90abdd3	69968-0421	HUMAN OTC DRUG	Aveeno Eczema Therapy daily moisturizing		Oatmeal	CREAM	TOPICAL	20101001		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0434_ee9ef8ac-e9bc-d3b3-e053-2995a90af2f5	69968-0434	HUMAN OTC DRUG	Neutrogena T/Sal Therapeutic		Salicylic Acid	SHAMPOO	TOPICAL	20200206		OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	30	mg/mL			N	20241231
69968-0441_0aa7c9cc-32ec-a279-e063-6294a90a6186	69968-0441	HUMAN OTC DRUG	Aveeno Baby Daily Moisture		Dimethicone	LOTION	TOPICAL	20010801		OTC MONOGRAPH DRUG	M016	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
69968-0454_eeaa3f9f-cdbb-268b-e053-2a95a90a78e4	69968-0454	HUMAN OTC DRUG	Aveeno DAILY MOISTURIZING		Dimethicone	LOTION	TOPICAL	20040201		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
69968-0459_070c0154-d121-711f-e063-6394a90a8763	69968-0459	HUMAN OTC DRUG	Benadryl Extra Strength Itch Relief		DIPHENHYDRAMINE HYDROCHLORIDE and Zinc Acetate	SOLUTION	TOPICAL	20190601		OTC MONOGRAPH DRUG	M017	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69968-0467_f78d9764-fdf7-ca42-e053-6394a90a5737	69968-0467	HUMAN OTC DRUG	Aveeno Absolutely Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20151201	20240515	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0470_fdfaf8c6-6685-3bd9-e053-6394a90a5666	69968-0470	HUMAN OTC DRUG	Aveeno POSITIVELY RADIANT sheer daily moisturizer sunscreen BROAD SPECTRUM SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20171001	20240522	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	15; 50; 40; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0471_eeacf0ac-4836-b96f-e053-2995a90ab6e3	69968-0471	HUMAN OTC DRUG	Aveeno CLEAR COMPLEXION foaming cleanser		Salicylic Acid	LIQUID	TOPICAL	20080201		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0472_eeacfe2b-a156-7f83-e053-2a95a90a5f7b	69968-0472	HUMAN OTC DRUG	Neutrogena Rapid Clear Acne Eliminating Spot		Salicylic Acid	GEL	TOPICAL	20191030		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0475_eeab2dde-03c8-4805-e053-2a95a90a710d	69968-0475	HUMAN OTC DRUG	Aveeno Anti-Itch Concentrated		Zinc Oxide, Ferric Oxide Red, and Pramoxine Hydrochloride	LOTION	TOPICAL	20190301		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	.6; 10; 29.4	mg/mL; mg/mL; mg/mL			N	20241231
69968-0476_04121368-f619-4b7d-e063-6394a90ade78	69968-0476	HUMAN OTC DRUG	Neutrogena Sheer Zinc DRY-TOUCH	Sunscreen Broad Spectrum SPF50	Zinc Oxide	LOTION	TOPICAL	20161017		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	20241231
69968-0480_fab3c321-167b-50cd-e053-6294a90a054a	69968-0480	HUMAN OTC DRUG	Aveeno FAVORITES morning radiance regimen		Avobenzone, Octinoxate, and Octisalate	KIT		20160422	20240208	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.						N	
69968-0483_eeab84aa-9569-1b5a-e053-2a95a90ab7ba	69968-0483	HUMAN OTC DRUG	Aveeno Kids Continuous Protection Sensitive Skin	Sunscreen Broad Spectrum SPF 50	Zinc Oxide	LOTION	TOPICAL	20181201		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	20241231
69968-0487_07d3138f-5746-ad20-e063-6394a90a87ab	69968-0487	HUMAN OTC DRUG	Bengay Ultra Strength	Large Size	Menthol, Unspecified Form	PATCH	TOPICAL	20190403		OTC MONOGRAPH DRUG	M017	Johnson & Johnson Consumer Inc.	MENTHOL, UNSPECIFIED FORM	50	mg/1			N	20241231
69968-0488_eeabafb5-f796-755e-e053-2995a90a52e5	69968-0488	HUMAN OTC DRUG	Aveeno Skin Relief Overnight		Dimethicone	CREAM	TOPICAL	20070522		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
69968-0494_eeabce69-623d-6f7c-e053-2a95a90ad20c	69968-0494	HUMAN OTC DRUG	Desitin Multi-Purpose Healing		Petrolatum	OINTMENT	TOPICAL	20190225		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	PETROLATUM	713	mg/g			N	20241231
69968-0504_fc84a5fe-863a-65d7-e053-6394a90a6ac1	69968-0504	HUMAN OTC DRUG	Neutrogena Healthy Skin Primer		Avobenzone, Homosalate, and Octinoxate	LOTION	TOPICAL	20181101	20240630	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE	20; 30; 40	mg/mL; mg/mL; mg/mL			N	
69968-0511_eeabe7eb-f0af-2757-e053-2a95a90aee7d	69968-0511	HUMAN OTC DRUG	Aveeno Hydrocortisone ANTI-ITCH		Hydrocortisone	CREAM	TOPICAL	20190301		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
69968-0514_eeac0ced-0251-3d09-e053-2995a90a500e	69968-0514	HUMAN OTC DRUG	Neutrogena Ultra Sheer Dry Touch	Sunscreen Broad Spectrum SPF100 Plus	Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20100401	20240520	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0515_0be57719-e550-ab99-e063-6294a90ae1a5	69968-0515	HUMAN OTC DRUG	Neutrogena HEALTHY DEFENSE daily moisturizer with sunscreen Broad Spectrum SPF 50		titanium dioxide and zinc oxide	LOTION	TOPICAL	20091201	20240720	OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	50; 30	mg/mL; mg/mL			N	
69968-0516_eeac8137-142f-21dd-e053-2995a90a7c88	69968-0516	HUMAN OTC DRUG	Neutrogena Oil Free Acne Wash		Salicylic Acid	LOTION	TOPICAL	20090201		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0518_eeac9760-b681-9586-e053-2a95a90a6a2e	69968-0518	HUMAN OTC DRUG	NEOSPORIN Plus BURN RELIEF		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	OINTMENT	TOPICAL	20190201		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0519_eeac69b9-1e44-20cc-e053-2995a90a7b64	69968-0519	HUMAN OTC DRUG	Neutrogena Oil-Free Acne Stress Control Power-Cream Wash		Salicylic Acid	CREAM	TOPICAL	20190330		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0520_f5d0427f-5895-f2ba-e053-2a95a90a422a	69968-0520	HUMAN OTC DRUG	Neutrogena Men Triple Protect Face With Sunscreen Broad Spectrum SPF 20		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20190517	20240822	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 120; 50; 17; 30	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0521_eeacced5-76c2-0a34-e053-2995a90adef3	69968-0521	HUMAN OTC DRUG	Neutrogena Oil Free Acne Stress Control Triple Action Toner		Salicylic Acid	LIQUID	TOPICAL	20190301		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0537_eebd0549-241c-7f12-e053-2a95a90a32a1	69968-0537	HUMAN OTC DRUG	Listerine Total Care Stain Remover Anticavity Fluoride Fresh Mint		Sodium Fluoride	MOUTHWASH	ORAL	20100601		OTC MONOGRAPH FINAL	part355	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0538_fa20e94c-d7d4-cbfc-e053-6394a90a0ccc	69968-0538	HUMAN OTC DRUG	BENGAY ULTRA STRENGTH NON-GREASY		CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate	CREAM	TOPICAL	20180601		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
69968-0539_f789c892-8cfb-f80a-e053-6394a90ad09a	69968-0539	HUMAN OTC DRUG	Listerine Ultraclean Antiseptic	Cool Mint	Eucalyptol, Menthol, unspecified form, Methyl Salicylate, and Thymol	MOUTHWASH	ORAL	20120601		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0540_eebe1803-1011-1f8f-e053-2a95a90a7266	69968-0540	HUMAN OTC DRUG	Aveeno Baby Eczema Therapy Nighttime Balm		Oatmeal	CREAM	TOPICAL	20190325		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0541_fab5261a-489f-8725-e053-6394a90ae729	69968-0541	HUMAN OTC DRUG	Aveeno Baby Eczema Therapy Soothing Bath Treatment		Oatmeal	POWDER	TOPICAL	20120101		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	430	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0546_0be54d9c-5485-6c88-e063-6294a90ad626	69968-0546	HUMAN OTC DRUG	Neutrogena Sheer Zinc Mineral Sunscreen Broad Spectrum SPF 50 Plus		Zinc Oxide	STICK	TOPICAL	20191001	20251116	OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	
69968-0547_eebf907b-189b-77c0-e053-2995a90ae61b	69968-0547	HUMAN OTC DRUG	Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus		Zinc Oxide	STICK	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0549_fab5261a-48a0-8725-e053-6394a90ae729	69968-0549	HUMAN OTC DRUG	Johnsons Bath Discovery Baby Gift Set		Zinc Oxide	KIT		20181231	20240605	OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	
69968-0550_f33d2a07-4d47-346d-e053-2a95a90a7156	69968-0550	HUMAN OTC DRUG	Listerine Cool Mint Antiseptic		Eucalyptol, Menthol, Unspecified Form, Methyl Salicylate, and Thymol	LIQUID	ORAL	20181203		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0551_eebf40a3-22b1-5d0d-e053-2a95a90a3800	69968-0551	HUMAN OTC DRUG	Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus		Zinc Oxide	LOTION	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	20241231
69968-0552_07e84e83-b57f-3d22-e063-6394a90a8d8d	69968-0552	HUMAN OTC DRUG	Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 60; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0553_07e88e27-58c7-fc2a-e063-6394a90a807f	69968-0553	HUMAN OTC DRUG	Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF45		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0559_07e8a92a-cf56-3d19-e063-6294a90a0d60	69968-0559	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF30		avobenzone, homosalate, octisalate, and octocrylene	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 60; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0560_07e88e27-58cd-fc2a-e063-6394a90a807f	69968-0560	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 45; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0561_07e8a92a-cf8b-3d19-e063-6294a90a0d60	69968-0561	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20190901		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0569_f93147f7-e43a-6c2e-e053-6394a90a5980	69968-0569	HUMAN OTC DRUG	Neutrogena CoolDry Sport Sunscreen Broad Spectrum SPF 50		avobenzone, homosalate, octisalate, and octocrylene	SPRAY	TOPICAL	20190901	20240201	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	
69968-0571_07e8b20a-f470-78ed-e063-6394a90a3340	69968-0571	HUMAN OTC DRUG	Neutrogena Clear Face Breakout Free Oil Free Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 80; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0572_07e90038-367e-e6e5-e063-6394a90abd94	69968-0572	HUMAN OTC DRUG	Neutrogena Clear Body Breakout Free Oil Free Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	25; 80; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0573_07e9c65c-52e3-9e0a-e063-6394a90a671d	69968-0573	HUMAN OTC DRUG	Neutrogena Clear Face Breakout Free Oil Free Broad Spectrum SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 40; 45; 60; 45	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0574_0aa9c98c-a4f5-3ba2-e063-6294a90a51f8	69968-0574	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Stick Broad Spectrum SPF 50 Plus		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0576_0bd77640-5f3c-abe5-e063-6294a90ae610	69968-0576	HUMAN OTC DRUG	Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF55		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0577_07ea098f-0252-21d5-e063-6294a90a3be5	69968-0577	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0578_07ea14a6-e9cb-0ced-e063-6394a90ad25e	69968-0578	HUMAN OTC DRUG	Neutrogena Ultra Sheer Body Mist Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20190901		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0579_07fdebdd-d7fc-fe7e-e063-6394a90aae35	69968-0579	HUMAN OTC DRUG	Neutrogena Ultra Sheer Body Mist Sunscreen Broad Spectrum SPF 45		avobenzone, homosalate, octisalate, and octocrylene	SPRAY	TOPICAL	20190901		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0582_eec1d4cd-61b4-52e3-e053-2a95a90a34bf	69968-0582	HUMAN OTC DRUG	Aveeno Positively Mineral Sensitive Skin Sunscreen Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0583_eec1e59e-89a9-abf7-e053-2a95a90ade4f	69968-0583	HUMAN OTC DRUG	Aveeno Baby Continuous Protection Sensitive Skin Sunscreen Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0589_031fb2a5-a665-e887-e063-6394a90afba8	69968-0589	HUMAN OTC DRUG	Clean and Clear Dual Action Moisturizer		Salicylic Acid	LOTION	TOPICAL	20190301	20240925	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	
69968-0592_eed484d7-0b56-1e20-e053-2a95a90a3cd4	69968-0592	HUMAN OTC DRUG	Aveeno Baby Daily Care Set		Dimethicone	KIT		20191101		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0593_eed496ff-5cac-1eab-e053-2a95a90a8229	69968-0593	HUMAN OTC DRUG	Aveeno Baby Bathtime Solutions Baby and Mommy Gift Set		Dimethicone	KIT		20190616		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0595_07d3cbc3-3465-d46d-e063-6294a90a0d58	69968-0595	HUMAN OTC DRUG	Bengay Vanishing Scent		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20190403		OTC MONOGRAPH DRUG	M017	Johnson & Johnson Consumer Inc.	MENTHOL, UNSPECIFIED FORM	25	mg/g			N	20241231
69968-0597_f87b1ad6-9270-286b-e053-6394a90ae6f8	69968-0597	HUMAN OTC DRUG	Aveeno Clear Complexion Daily Cleansing Pads		Salicylic Acid	CLOTH	TOPICAL	20200824	20240625	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	6	mg/1			N	
69968-0599_07fe09fd-39ac-5ffc-e063-6294a90afd0d	69968-0599	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF50		avobenzone, homosalate, octisalate, and octocrylene	LOTION	TOPICAL	20191007		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0600_0aaa26bf-3b1d-f015-e063-6394a90ac873	69968-0600	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20190901		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0601_0aa9e2fb-e8c0-af02-e063-6394a90a8efa	69968-0601	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 60 Plus		avobenzone, homosalate, octisalate, and octocrylene	SPRAY	TOPICAL	20190901		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0602_eed64f23-75d9-1065-e053-2995a90a3e1f	69968-0602	HUMAN OTC DRUG	Aveeno Kids Continuous Protection Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0603_ef2371d2-640f-30be-e053-2a95a90a672a	69968-0603	HUMAN OTC DRUG	Desitin Daily Defense Zinc Oxide Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20181201		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	ZINC OXIDE	130	mg/g			N	20241231
69968-0606_eed330b1-f9d1-6768-e053-2995a90a17bb	69968-0606	HUMAN OTC DRUG	Listerine Smart Rinse Berry Splash		Sodium Fluoride	MOUTHWASH	ORAL	20200106		OTC MONOGRAPH FINAL	part355	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0607_f33de44e-1faa-d3ea-e053-2995a90a9dc7	69968-0607	HUMAN OTC DRUG	Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 30, Sheer Ivory 10		Homosalate, Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	LOTION	TOPICAL	20191104		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	50; 75; 50; 20; 29	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0608_f33de44e-1faa-d3ea-e053-2995a90a9dc7	69968-0608	HUMAN OTC DRUG	Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 30, Sheer Fair 20		Homosalate, Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	LOTION	TOPICAL	20191104		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	50; 75; 50; 20; 29	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0609_f33de44e-1faa-d3ea-e053-2995a90a9dc7	69968-0609	HUMAN OTC DRUG	Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 30, Sheer Tan 30		Homosalate, Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	LOTION	TOPICAL	20191104		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	50; 75; 50; 20; 29	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0610_f640d50c-1aa6-96c1-e053-2995a90a543e	69968-0610	HUMAN OTC DRUG	Neutrogena Oil Free Acne Wash Pink Grapefruit Foaming Scrub		Salicylic Acid	GEL	TOPICAL	20191209		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0611_eed661e0-4e00-aaf6-e053-2995a90adc55	69968-0611	HUMAN OTC DRUG	Neutrogena Age Shield Face Oil Free Sunscreen Broad Spectrum SPF 110		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20200131	20240902	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0612_eed3f006-aa3f-49eb-e053-2a95a90af417	69968-0612	HUMAN OTC DRUG	Simply Neosporin	First Aid Antibiotic	Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	TOPICAL	20200224		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[iU]/g; [iU]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0613_0433b42e-4a93-b1e0-e063-6294a90a3902	69968-0613	HUMAN OTC DRUG	Neutrogena Sheer Zinc Mineral Sunscreen Broad Spectrum SPF 50		Zinc Oxide	LOTION	TOPICAL	20200131		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	20241231
69968-0614_eed146aa-98f6-51b8-e053-2a95a90aa023	69968-0614	HUMAN OTC DRUG	BENGAY	Tropical Jasmine	Lidocaine	CREAM	TOPICAL	20200121		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69968-0615_eed15b7c-54df-269e-e053-2a95a90a3172	69968-0615	HUMAN OTC DRUG	BENGAY	Ginger Citrus	Lidocaine	CREAM	TOPICAL	20200121		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69968-0616_07fe247b-9a03-88f4-e063-6294a90ae555	69968-0616	HUMAN OTC DRUG	Neutrogena Oil Free Moisture Broad Spectrum SPF15		Avobenzone, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20190621		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	15; 50; 30; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0619_f78d1ce3-1d90-c377-e053-6394a90af787	69968-0619	HUMAN OTC DRUG	Neutrogena Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 60 plus		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20200131	20240429	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	49; 47	mg/mL; mg/mL			N	
69968-0623_eed1bbbb-a172-aedd-e053-2995a90a1eee	69968-0623	HUMAN OTC DRUG	Neutrogena Sheer Zinc Face Mineral Sunscreen Broad Spectrum SPF 50		Zinc Oxide	LOTION	TOPICAL	20200131		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/mL			N	20241231
69968-0625_031ffba3-c373-c7b7-e063-6394a90ab78d	69968-0625	HUMAN OTC DRUG	Benadryl Original Strength Itch Stopping		Diphenhydramine Hydrochloride and Zinc Acetate	CREAM	TOPICAL	20200131		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
69968-0627_f6d679d0-64ba-1950-e053-6294a90a4ccc	69968-0627	HUMAN OTC DRUG	Neutrogena Healthy Defense Daily Moisturizer Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	LOTION	TOPICAL	20200131	20240720	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 120; 50; 23.5; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0628_eed25d18-52b0-9772-e053-2995a90aed1b	69968-0628	HUMAN OTC DRUG	Neutrogena Body Clear Body Scrub		Salicylic Acid	SUSPENSION	TOPICAL	20200224		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0629_eed26443-7b61-0f14-e053-2a95a90a4a55	69968-0629	HUMAN OTC DRUG	Aveeno Baby Calming Comfort		Dimethicone	LOTION	TOPICAL	20200601		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
69968-0631_eed88025-99c5-9c0e-e053-2a95a90ae312	69968-0631	HUMAN OTC DRUG	Aveeno Baby Calming Comfort Bath Plus Set		Dimethicone	KIT		20200803		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0632_eeaa1977-2ba8-e11e-e053-2995a90ab0ff	69968-0632	HUMAN OTC DRUG	Aveeno Baby Daily Care Set		Dimethicone	KIT		20201130		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0633_eed916fb-ec70-9876-e053-2995a90a4741	69968-0633	HUMAN OTC DRUG	Neutrogena Body Clear Body Wash Pink Grapefruit		Salicylic Acid	SUSPENSION	TOPICAL	20200505		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0634_eed93bc3-352e-9e14-e053-2a95a90ae36c	69968-0634	HUMAN OTC DRUG	Neosporin Original		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20210104		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0635_eed995dc-4d17-7bd9-e053-2995a90ab520	69968-0635	HUMAN OTC DRUG	Johnsons First Touch Baby Gift Set		Zinc Oxide	KIT		20200501	20240525	OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	
69968-0637_eed9d1c8-0744-7fb5-e053-2a95a90a4c1b	69968-0637	HUMAN OTC DRUG	Aveeno Restorative Skin Therapy Itch Relief Balm		PRAMOXINE HYDROCHLORIDE	CREAM	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	PRAMOXINE HYDROCHLORIDE	5	mg/g			N	20241231
69968-0638_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0638	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Nude 40		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0639_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0639	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Natural Beige 60		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0640_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0640	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Natural Ivory 20		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0641_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0641	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Buff 30		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0642_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0642	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Soft Beige 50		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0643_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0643	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Fresh Beige 70		Salicylic Acid	LIQUID	TOPICAL	20200731	20240630	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	
69968-0644_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0644	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Medium Beige 80		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0645_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0645	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Classic Ivory 10		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0646_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0646	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Warm Beige 90		Salicylic Acid	LIQUID	TOPICAL	20200731	20240228	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	
69968-0647_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0647	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Natural Tan 100		Salicylic Acid	LIQUID	TOPICAL	20200731	20240228	OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	
69968-0648_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0648	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Honey 85		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0649_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0649	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Cocoa 115		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0650_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0650	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Chestnut 135		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0651_037fdddc-00b5-b8af-e063-6294a90a5616	69968-0651	HUMAN OTC DRUG	Neutrogena SkinClearing Oil Free Makeup - Caramel 105		Salicylic Acid	LIQUID	TOPICAL	20200731		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0653_ef106a31-2623-0a68-e053-2995a90abce4	69968-0653	HUMAN OTC DRUG	Neutrogena Stubborn Acne AM Treatment		Benzoyl Peroxide	GEL	TOPICAL	20200803		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	BENZOYL PEROXIDE	25	mg/g			N	20241231
69968-0654_07febab8-1a9b-e264-e063-6394a90abdac	69968-0654	HUMAN OTC DRUG	Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20200814		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0655_ef129d45-0660-fa72-e053-2a95a90a4096	69968-0655	HUMAN OTC DRUG	Neutrogena Body Clear Body Wash		SALICYLIC ACID	LIQUID	TOPICAL	20200518		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0656_f1daa508-7d20-806d-e053-2995a90a577a	69968-0656	HUMAN OTC DRUG	Aveeno Baby Calming Comfort		Dimethicone	LOTION	TOPICAL	20200601		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
69968-0657_07ff001d-eebf-6d30-e063-6294a90ae811	69968-0657	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0661_0be73cd2-3857-3b6c-e063-6294a90a05ef	69968-0661	HUMAN OTC DRUG	Neutrogena Invisible Daily Defense Sunscreen Broad Spectrum SPF 60 Plus		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0662_0be6f7bc-a984-c0b5-e063-6294a90a4081	69968-0662	HUMAN OTC DRUG	Neutrogena Clear Face Breakout Free oil Free Sunscreen Broad Spectrum SPF 50		avobenzone, homosalate, octisalate, and octocrylene	LOTION	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0663_0aa9cfee-a51f-a90c-e063-6394a90a124c	69968-0663	HUMAN OTC DRUG	Neutrogena Ultra Sheer Body Mist Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0664_080e28ad-d192-ad81-e063-6394a90ad576	69968-0664	HUMAN OTC DRUG	Neutrogena Cool Dry Sport Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0665_080e0e95-4c8b-5935-e063-6294a90a1e78	69968-0665	HUMAN OTC DRUG	Aveeno Protect Plus Hydrate Sunscreen Broad Spectrum Body SPF 60		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0666_080e561f-13c3-3ac7-e063-6294a90a35a7	69968-0666	HUMAN OTC DRUG	Aveeno Protect Plus Hydrate Sunscreen Broad Spectrum Face SPF 60		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0667_080e8c1b-7cbd-7582-e063-6394a90a05d4	69968-0667	HUMAN OTC DRUG	Aveeno Protect Plus Hydrate Sunscreen Broad Spectrum Body SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	15; 50; 40; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0669_080ea246-c3d7-f2a6-e063-6394a90a8e11	69968-0669	HUMAN OTC DRUG	Neutrogena Hydro Boost Water Gel Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0670_080ebc22-30f6-fad4-e063-6394a90aeb06	69968-0670	HUMAN OTC DRUG	Neutrogena Sport Face Oil Free Sunscreen Broad Spectrum SPF 70 Plus		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20200814		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0672_080ed6de-e7d9-336f-e063-6294a90a6cfd	69968-0672	HUMAN OTC DRUG	Neutrogena Age Shield Face Oil Free Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20200814		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0675_ef17cfe5-8b52-8530-e053-2995a90a4571	69968-0675	HUMAN OTC DRUG	Neutrogena Oil Free Acne Wash		Salicylic Acid	LIQUID	TOPICAL	20200713		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0677_ef17decd-a1fa-48ce-e053-2995a90a25d1	69968-0677	HUMAN OTC DRUG	Neutrogena Pure And Free Sunscreen Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20201005		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0679_ef1812dd-7f08-3033-e053-2995a90a8e10	69968-0679	HUMAN OTC DRUG	Aveeno Baby Daily Moisture		Dimethicone	LOTION	TOPICAL	20010801		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
69968-0680_ef182a47-c605-b719-e053-2a95a90a9567	69968-0680	HUMAN OTC DRUG	Aveeno Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20040201		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
69968-0681_09920569-69b7-5ed1-e063-6294a90a028e	69968-0681	HUMAN OTC DRUG	Neutrogena Invisible Daily Defense Face Serum Sunscreen Broad Spectrum SPF 60 Plus		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0682_f6d7244a-4b34-3bb6-e053-6394a90a46ff	69968-0682	HUMAN OTC DRUG	Neutrogena Invisible Daily Defense Body Sunscreen Broad Spectrum SPF 60 Plus		avobenzone, homosalate, octocrylene, and octisalate	SPRAY	TOPICAL	20201005	20240407	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	
69968-0683_080f367c-8738-1a61-e063-6394a90ae503	69968-0683	HUMAN OTC DRUG	Neutrogena Invisible Daily Defense Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20201005		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	15; 50; 40; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0686_ef18c594-7dfa-77ec-e053-2995a90ade28	69968-0686	HUMAN OTC DRUG	Neutrogena Oil Free Acne Wash Pink Grapefruit Facial Cleanser		SALICYLIC ACID	LIQUID	TOPICAL	20200713		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0687_ef18e9c4-80ea-9c7f-e053-2995a90a0e2d	69968-0687	HUMAN OTC DRUG	Listerine Smart Rinse Anticavity Fluoride Rinse - Berry Splash		Sodium Fluoride	MOUTHWASH	ORAL	20210101		OTC MONOGRAPH FINAL	part355	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0689_ef191b7d-b8d4-4683-e053-2a95a90af655	69968-0689	HUMAN OTC DRUG	Listerine Smart Rinse Anticavity Fluoride Rinse - Mint Shield		Sodium Fluoride	MOUTHWASH	ORAL	20210101		OTC MONOGRAPH FINAL	part355	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0690_ef217a29-d70f-4db7-e053-2995a90ab065	69968-0690	HUMAN OTC DRUG	Listerine Smart Rinse Anticavity Fluoride Rinse - Bubble Blast		Sodium Fluoride	MOUTHWASH	ORAL	20210101		OTC MONOGRAPH FINAL	part355	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0691_ef22fd2b-e36a-8406-e053-2995a90ad7fe	69968-0691	HUMAN OTC DRUG	Listerine Smart Rinse Anticavity Fluoride Rinse - Pink Lemonade Flavor		Sodium Fluoride	MOUTHWASH	ORAL	20210101		OTC MONOGRAPH FINAL	part355	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0692_ef233a5a-151c-7a0c-e053-2a95a90a41a2	69968-0692	HUMAN OTC DRUG	Aveeno Baby Bathtime Solutions Mommy and Me Gift Set		Dimethicone	KIT		20200907		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0693_f78a6445-8e46-0015-e053-6294a90a2f95	69968-0693	HUMAN OTC DRUG	Neutrogena T/Gel Therapeutic Original Formula		Coal Tar	SHAMPOO	TOPICAL	20201201	20240311	OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	COAL TAR	5	mg/mL			N	
69968-0694_f6d63b11-1a32-cd80-e053-6394a90a54ce	69968-0694	HUMAN OTC DRUG	Neutrogena T/Gel Therapeutic Extra Strength		Coal Tar	SHAMPOO	TOPICAL	20201201	20240523	OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	COAL TAR	10	mg/mL			N	
69968-0699_ef245f92-7eca-533d-e053-2a95a90a27ff	69968-0699	HUMAN OTC DRUG	Aveeno Baby Eczema Therapy Moisturizing		Oatmeal	CREAM	TOPICAL	20100601		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	10	g/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0701_08eb2050-a10d-c40c-e063-6394a90a3e72	69968-0701	HUMAN OTC DRUG	Listerine Essential Care		Sodium Monofluorophosphate	GEL, DENTIFRICE	ORAL	20210303		OTC MONOGRAPH DRUG	M022	Johnson & Johnson Consumer Inc.	SODIUM MONOFLUOROPHOSPHATE	1.3	mg/g			N	20241231
69968-0702_08116b30-013a-ea6a-e063-6394a90a4b33	69968-0702	HUMAN OTC DRUG	Neutrogena Hydro Boost Hyaluronic Acid Moisturizer with Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20210805		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0703_ef243f8d-288a-1bea-e053-2a95a90a037d	69968-0703	HUMAN OTC DRUG	Neutrogena Stubborn Blackheads Daily Serum		Salicylic Acid	LOTION	TOPICAL	20210802		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0704_0d1bc7a7-b2ab-5368-e063-6294a90ad3d9	69968-0704	HUMAN OTC DRUG	Neutrogena Stubborn Texture Daily Cleanser		Salicylic Acid	GEL	TOPICAL	20210802		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	10	mg/mL			N	20241231
69968-0705_f306682d-ee5b-7340-e053-2995a90a7504	69968-0705	HUMAN OTC DRUG	Neutrogena Rapid Tone Repair Retinol Plus Vitamin C Moisturizer Sunscreen Broad Spectrum SPF 30 Day		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20210601	20240829	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	
69968-0706_081188cc-595f-3ae1-e063-6394a90a9df0	69968-0706	HUMAN OTC DRUG	Neutrogena Rapid Wrinkle Repair Retinol Moisturizer Sunscreen Broad Spectrum SPF 30 Day		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20210601		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0707_01eb5036-0e14-aa8e-e063-6294a90a4839	69968-0707	HUMAN OTC DRUG	Neutrogena Healthy Skin Brightening Eye Perfector SPF 20 - Fair 05		Titanium Dioxide	CREAM	TOPICAL	20210618	20240430	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	25.2	mg/g			N	
69968-0708_01eb5036-0e14-aa8e-e063-6294a90a4839	69968-0708	HUMAN OTC DRUG	Neutrogena Healthy Skin Brightening Eye Perfector SPF 20 - Buff 09		Titanium Dioxide	CREAM	TOPICAL	20210618	20240430	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	25.2	mg/g			N	
69968-0709_01eb5036-0e14-aa8e-e063-6294a90a4839	69968-0709	HUMAN OTC DRUG	Neutrogena Healthy Skin Brightening Eye Perfector SPF 20 - Light 10		Titanium Dioxide	CREAM	TOPICAL	20210618	20240831	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	25.2	mg/g			N	
69968-0710_01eb5036-0e14-aa8e-e063-6294a90a4839	69968-0710	HUMAN OTC DRUG	Neutrogena Healthy Skin Brightening Eye Perfector SPF 20 - Medium 15		Titanium Dioxide	CREAM	TOPICAL	20210618	20240331	OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	25.2	mg/g			N	
69968-0711_ee34fe5e-1802-20f7-e053-2995a90aa651	69968-0711	HUMAN OTC DRUG	Johnson and Johnson All Purpose First Aid Kit		Acetaminophen, Diphenhydramine Hydrochloride, Zinc Acetate, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	KIT		20210816		OTC MONOGRAPH FINAL	part348	Johnson & Johnson Consumer Inc.						N	20241231
69968-0712_f6d82443-7579-bc58-e053-6394a90a5ed2	69968-0712	HUMAN OTC DRUG	Johnsons Welcome Baby Gift Set		Zinc Oxide	KIT		20210701	20240601	OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	
69968-0713_ef2395e1-2435-803c-e053-2a95a90a26ee	69968-0713	HUMAN OTC DRUG	Johnsons Baby Care Essentials Gift Set		Zinc Oxide	KIT		20210702		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0715_ef239f47-2511-8b93-e053-2a95a90a4b71	69968-0715	HUMAN OTC DRUG	Neutrogena Mineral Ultra Sheer Dry-Touch Face and Body Sunscreen Broad Spectrum UVA-UVB SPF 50		Zinc Oxide	STICK	TOPICAL	20211004		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0716_08118417-19d8-012d-e063-6294a90af19c	69968-0716	HUMAN OTC DRUG	Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20211206		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0717_089c2bff-57fa-36fd-e063-6294a90a0493	69968-0717	HUMAN OTC DRUG	Neutrogena Ultra Sheer Moisturizing Face Serum Sunscreen Broad Spectrum SPF 60 Plus		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20211207		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0719_ef270a9e-6d92-7e90-e053-2995a90a3a70	69968-0719	HUMAN OTC DRUG	Neutrogena Rapid Clear Treatment Pads		Salicylic Acid	CLOTH	TOPICAL	20221110		OTC MONOGRAPH FINAL	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/1			N	20241231
69968-0720_fb2e36fb-ee1d-c8a0-e053-6294a90a8c5a	69968-0720	HUMAN OTC DRUG	Clean and Clear persa-gel 10 Maximum Strength		Benzoyl Peroxide	GEL	TOPICAL	20211101		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	BENZOYL PEROXIDE	100	mg/g			N	20241231
69968-0721_ef273221-f2dd-1139-e053-2a95a90a4a43	69968-0721	HUMAN OTC DRUG	Neutrogena Sun Rescue After Sun Medicated Relief		CAMPHOR (SYNTHETIC)	GEL	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	CAMPHOR (SYNTHETIC)	4.5	mg/g			N	20241231
69968-0722_ef273f64-2b22-1728-e053-2995a90a85e3	69968-0722	HUMAN OTC DRUG	Neutrogena Scalp Therapy Anti-Dandruff Daily Control		Salicylic Acid	SHAMPOO	TOPICAL	20211206		OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	18	mg/mL			N	20241231
69968-0723_ef288706-f919-c8ce-e053-2a95a90aa36c	69968-0723	HUMAN OTC DRUG	Neutrogena Scalp Therapy Anti-Dandruff Extra Strength		Salicylic Acid	SHAMPOO	TOPICAL	20211206		OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	30	mg/mL			N	20241231
69968-0724_ef28be24-2a3e-33f8-e053-2995a90a9478	69968-0724	HUMAN OTC DRUG	Neutrogena Scalp Therapy Anti-Dandruff Scalp Build-Up Control		Salicylic Acid	SHAMPOO	TOPICAL	20211206		OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	25	mg/mL			N	20241231
69968-0725_ef28d198-5b65-7b8f-e053-2995a90ae178	69968-0725	HUMAN OTC DRUG	Neutrogena Scalp Therapy Anti-Dandruff Itchy Scalp		Salicylic Acid	SHAMPOO	TOPICAL	20211206		OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	25	mg/mL			N	20241231
69968-0726_f3932104-900f-9b56-e053-2a95a90a093a	69968-0726	HUMAN OTC DRUG	Johnson and Johnson First Aid All Purpose	160 CT	Acetaminophen, Diphenhydramine Hydrochloride, Zinc Acetate, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	KIT		20220131		OTC MONOGRAPH FINAL	part348	Johnson & Johnson Consumer Inc.						N	20241231
69968-0727_ef28e037-80ff-e477-e053-2a95a90af5be	69968-0727	HUMAN OTC DRUG	Band Aid Antiseptic Cleansing To Go		Benzalkonium Chloride, Pramoxine HCl	SPRAY	TOPICAL	20220130		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	BENZALKONIUM CHLORIDE; PRAMOXINE HYDROCHLORIDE	1.3; 10	mg/mL; mg/mL			N	20241231
69968-0728_ef37c093-6a08-168b-e053-2995a90a07bf	69968-0728	HUMAN OTC DRUG	Band Aid Antiseptic Cleansing		Benzalkonium Chloride	AEROSOL, FOAM	TOPICAL	20211229		OTC MONOGRAPH NOT FINAL	part333A	Johnson & Johnson Consumer Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
69968-0729_ef382a2d-b869-0d9a-e053-2a95a90a43e9	69968-0729	HUMAN OTC DRUG	Band Aid Antiseptic Cleansing		Benzalkonium Chloride, Pramoxine HCl	SPRAY	TOPICAL	20220130		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	BENZALKONIUM CHLORIDE; PRAMOXINE HYDROCHLORIDE	1.3; 10	mg/mL; mg/mL			N	20241231
69968-0730_ef3852ba-33ef-2adb-e053-2995a90ae32e	69968-0730	HUMAN OTC DRUG	Band Aid Antiseptic Cleansing Liquid		Benzalkonium Chloride and Lidocaine Hydrochloride	LIQUID	TOPICAL	20220103		OTC MONOGRAPH NOT FINAL	part333A	Johnson & Johnson Consumer Inc.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 20	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69968-0731_ef387515-60af-8255-e053-2995a90aae1d	69968-0731	HUMAN OTC DRUG	Neosporin Plus Lidocaine		Bacitracin, Neomycin, Polymyxin B, Lidocaine	OINTMENT	TOPICAL	20230130		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.	BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	500; 40; 3.5; 10000	[iU]/g; mg/g; mg/g; [iU]/g	Amide Local Anesthetic [EPC], Amides [CS], Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Antiarrhythmic [EPC], Decreased Cell Wall Synthesis & Repair [PE], Local Anesthesia [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
69968-0737_0811a07d-be63-3109-e063-6294a90af41f	69968-0737	HUMAN OTC DRUG	Neutrogena Invisible Daily Defense Fragrance Free SPF 60 Plus		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0738_ef38a4c4-b81f-5a9d-e053-2a95a90ac034	69968-0738	HUMAN OTC DRUG	Aveeno Positively Radiant Clear Complexion Daily Moisturizer		Salicylic Acid	LOTION	TOPICAL	20220812		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0739_f1f79341-31bf-27e8-e053-2995a90a73e9	69968-0739	HUMAN OTC DRUG	Johnsons First Touch Baby Gift Set		Zinc Oxide	KIT		20220425		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0740_ef38da42-d5dc-05f5-e053-2a95a90ae419	69968-0740	HUMAN OTC DRUG	Neutrogena deep clean purifying cooling gel scrub		Salicylic Acid	GEL	TOPICAL	20171001		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0741_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0741	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Classic Ivory 10		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0742_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0742	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Natural Ivory 20		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0743_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0743	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Buff 30		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0744_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0744	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Nude 40		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0745_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0745	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Soft Beige 50		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0746_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0746	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Natural Beige 60		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0747_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0747	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Fresh Beige 70		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0748_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0748	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Medium Beige 80		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0749_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0749	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Warm Beige 90		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0750_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0750	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Natural Tan 100		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0751_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0751	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Honey 85		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0752_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0752	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Caramel 105		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0753_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0753	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Cocoa 115		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0754_ef3b5761-bcef-5bcc-e053-2995a90a25fa	69968-0754	HUMAN OTC DRUG	Neutrogena Healthy Skin Liquid Makeup SPF 20 - Chestnut 135		Titanium Dioxide	CREAM	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE	36	mg/mL			N	20241231
69968-0755_f1d675e1-7cef-d719-e053-2995a90a1971	69968-0755	HUMAN OTC DRUG	Aveeno Calm Plus Restore Skin Therapy Balm		Colloidal Oatmeal	CREAM	TOPICAL	20220728		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0756_f8faef73-39a7-f2d6-e053-6294a90a86cf	69968-0756	HUMAN OTC DRUG	Aveeno Baby Bathtime Solutions Baby and Me Gift Set		Dimethicone	KIT		20220601		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0758_ef3c0346-61c5-a592-e053-2995a90a70e3	69968-0758	HUMAN OTC DRUG	Neutrogena Stubborn Body Acne Treatment		Salicylic Acid	SPRAY	TOPICAL	20220801		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0759_ef3c178c-5d82-f4d5-e053-2995a90a2011	69968-0759	HUMAN OTC DRUG	Neutrogena Stubborn Body Acne Cleanser and Exfoliator		Salicylic Acid	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	10	mg/mL			N	20241231
69968-0760_0811aad4-5c7e-362d-e063-6294a90ad550	69968-0760	HUMAN OTC DRUG	Aveeno Positively Radiant Daily Moisturizer Sunscreen Broad Spectrum SPF 15		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 115; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0761_ef3c381a-33ef-ee17-e053-2a95a90abd43	69968-0761	HUMAN OTC DRUG	Neutrogena Stubborn Acne Spot Drying		Sulfur	LOTION	TOPICAL	20220801		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SULFUR	100	mg/mL			N	20241231
69968-0762_ef3c4563-50fd-3dfe-e053-2a95a90a961a	69968-0762	HUMAN OTC DRUG	Aveeno Baby Daily Moisture with Coconut Oil and Shea Butter		Dimethicone	CREAM	TOPICAL	20221115		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.	DIMETHICONE	12	mg/mL	Skin Barrier Activity [PE]		N	20241231
69968-0763_f78a9d44-0ca4-2512-e053-6394a90a3f20	69968-0763	HUMAN OTC DRUG	Neutrogena T/Gel Therapeutic Original Formula		Coal Tar	SHAMPOO	TOPICAL	20220801	20241009	OTC MONOGRAPH FINAL	part358H	Johnson & Johnson Consumer Inc.	COAL TAR	5	mg/mL			N	
69968-0765_0811aad4-5c7f-362d-e063-6294a90ad550	69968-0765	HUMAN OTC DRUG	Aveeno Positively Radiant Daily Moisturizer Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220728		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	15; 50; 40; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0766_ef392a85-f11e-febe-e053-2a95a90a9d20	69968-0766	HUMAN OTC DRUG	Aveeno Baby Welcome Little One Gift Basket		Dimethicone	KIT		20220601		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0769_f16bee9f-8997-bb63-e053-2a95a90a1743	69968-0769	HUMAN OTC DRUG	Aveeno Positively Radiant Clear Complexion Foaming Cleanser		Salicylic Acid	LIQUID	TOPICAL	20221115		OTC MONOGRAPH FINAL	part333D	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0770_0aaa26bf-3b1c-f015-e063-6394a90ac873	69968-0770	HUMAN OTC DRUG	Neutrogena Oil Free Acne Wash		Salicylic Acid	LIQUID	TOPICAL	20220729		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0771_ef4b1364-2ccb-8902-e053-2995a90aaa43	69968-0771	HUMAN OTC DRUG	Aveeno Protect Plus Soothe Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	65; 187	mg/mL; mg/mL			N	20241231
69968-0772_ef4b26fd-b43f-88f6-e053-2995a90a0d2a	69968-0772	HUMAN OTC DRUG	Aveeno Eczema Therapy Nighttime Itch Relief Balm		Colloidal Oatmeal	CREAM	TOPICAL	20220801		OTC MONOGRAPH FINAL	M016	Johnson & Johnson Consumer Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0773_ef4b305a-80f6-ceaf-e053-2a95a90a1ad3	69968-0773	HUMAN OTC DRUG	Neutrogena Mineral Beach Defense Active Performance Sunscreen Broad Spectrum SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	65; 187	mg/mL; mg/mL			N	20241231
69968-0774_040bf280-673f-895f-e063-6394a90afb66	69968-0774	HUMAN OTC DRUG	Aveeno Eczema Therapy Daily Moisturizing		Colloidal Oatmeal	CREAM	TOPICAL	20220806		OTC MONOGRAPH FINAL	M016	Johnson & Johnson Consumer Inc.	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0775_f04f5a32-e0e7-1414-e053-2a95a90afed5	69968-0775	HUMAN OTC DRUG	Neutrogena Mineral Beach Defense On-The-Go Body SPF 50		Zinc Oxide	STICK	TOPICAL	20221031		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0776_ef4bbdc1-b31e-963b-e053-2a95a90a92f6	69968-0776	HUMAN OTC DRUG	Neutrogena Mineral Ultra Sheer Dry Touch SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221206		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	66; 180	mg/mL; mg/mL			N	20241231
69968-0777_0bd7bd7d-1c16-fbba-e063-6294a90a3fe5	69968-0777	HUMAN OTC DRUG	Neutrogena Clear Face Serum Fragrance Free SPF 60 Plus		Avobenzone, Homosalate, Octisalate, Octocrylene	LIQUID	TOPICAL	20221019		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0778_082010ed-dbc5-21a0-e063-6294a90a0472	69968-0778	HUMAN OTC DRUG	Neutrogena Invisible Daily Defense Sunscreen Body SPF 60 plus		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0779_0823056a-e074-38e5-e063-6294a90a2b11	69968-0779	HUMAN OTC DRUG	Neutrogena Beach Defense Kids Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0780_ef4c01d8-47d8-8c74-e053-2a95a90a8f57	69968-0780	HUMAN OTC DRUG	Aveeno Protect Plus Soothe Mineral Sunscreen Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20221129		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0781_0d00b355-ef5d-3da7-e063-6394a90a483c	69968-0781	HUMAN OTC DRUG	Neutrogena MINERAL UV TINT FACE LIGHT SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	32; 216	mg/mL; mg/mL			N	20241231
69968-0782_0d00b355-ef5d-3da7-e063-6394a90a483c	69968-0782	HUMAN OTC DRUG	Neutrogena MINERAL UV TINT FACE MEDIUM SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	32; 216	mg/mL; mg/mL			N	20241231
69968-0783_0d00b355-ef5d-3da7-e063-6394a90a483c	69968-0783	HUMAN OTC DRUG	Neutrogena MINERAL UV TINT FACE DEEP SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	32; 216	mg/mL; mg/mL			N	20241231
69968-0784_0d00b355-ef5d-3da7-e063-6394a90a483c	69968-0784	HUMAN OTC DRUG	Neutrogena MINERAL UV TINT FACE MEDIUM DEEP SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	32; 216	mg/mL; mg/mL			N	20241231
69968-0786_ef4c1a00-33dc-f893-e053-2a95a90ae4a3	69968-0786	HUMAN OTC DRUG	Aveeno Protect Plus Soothe Face Mineral Sunscreen SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20221206		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	66; 180	mg/mL; mg/mL			N	20241231
69968-0787_0aa8bc4b-4658-256d-e063-6294a90ae69a	69968-0787	HUMAN OTC DRUG	Listerine Total Care Fresh Mint Anticavity Fluoride		Sodium Fluoride	MOUTHWASH	ORAL	20230113		OTC MONOGRAPH DRUG	M021	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0788_031f1954-f96a-63dd-e063-6394a90a50fb	69968-0788	HUMAN OTC DRUG	Listerine Ultraclean Antiseptic	Cool Mint	Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20230205		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0789_ee35430b-263e-3207-e053-2995a90ae6f2	69968-0789	HUMAN OTC DRUG	Johnsons Baby Care Essentials Gift Set		Zinc Oxide	KIT		20230201		OTC MONOGRAPH FINAL	part347	Johnson & Johnson Consumer Inc.						N	20241231
69968-0790_00d36520-83db-5e24-e063-6394a90a0232	69968-0790	HUMAN OTC DRUG	Listerine Gum Therapy	Glacier Mint	Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20230213		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0791_031f6392-1d9e-8e4f-e063-6294a90a7863	69968-0791	HUMAN OTC DRUG	Listerine Cool Mint Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20230321		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0792_0380dc0f-048e-6ffc-e063-6394a90afee7	69968-0792	HUMAN OTC DRUG	Listerine Freshburst Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20230421		OTC MONOGRAPH NOT FINAL	part356	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0793_fc7bceea-a843-54b6-e053-6394a90a8d5a	69968-0793	HUMAN OTC DRUG	Tylenol Precise Cooling Pain Relieving		Lidocaine, Menthol	CREAM	TOPICAL	20230703		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69968-0795_fc7fcb56-e818-07d5-e053-6294a90a3818	69968-0795	HUMAN OTC DRUG	Tylenol Precise Pain Relieving		Lidocaine	CREAM	TOPICAL	20230703		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69968-0796_f17dcc88-303c-4e1f-e053-2a95a90ae08d	69968-0796	HUMAN OTC DRUG	Aveeno Calm Plus Restore Itch Relief Balm		PRAMOXINE HYDROCHLORIDE	CREAM	TOPICAL	20230703		OTC MONOGRAPH NOT FINAL	part348	Johnson & Johnson Consumer Inc.	PRAMOXINE HYDROCHLORIDE	5	mg/g			N	20241231
69968-0798_f2fd12cf-45c1-163f-e053-2a95a90ad459	69968-0798	HUMAN OTC DRUG	Aveeno Baby Continuous Protection Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20231001		OTC MONOGRAPH FINAL	M016	Johnson & Johnson Consumer Inc.	ZINC OXIDE	216	mg/g			N	20241231
69968-0799_f388f105-48bb-4616-e053-2a95a90a0049	69968-0799	HUMAN OTC DRUG	Johnson and Johnson First Aid Travel Ready	80 CT	Acetaminophen, Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine Hydrochloride	KIT		20220131		OTC MONOGRAPH FINAL	part348	Johnson & Johnson Consumer Inc.						N	20241231
69968-0800_082038ec-06b4-e255-e063-6394a90a56cb	69968-0800	HUMAN OTC DRUG	Aveeno Favorites		Avobenzone, Homosalate, Octisalate, Octocrylene	KIT		20230215		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.						N	20241231
69968-0801_f45439b8-0451-267b-e053-2995a90ae848	69968-0801	HUMAN OTC DRUG	Neosporin Plus Pain Relief	Clubtray	Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride	KIT		20220601		OTC MONOGRAPH FINAL	part333B	Johnson & Johnson Consumer Inc.						N	20241231
69968-0802_0b37d50b-7bb7-1c1a-e063-6394a90afa90	69968-0802	HUMAN OTC DRUG	Aveeno Eczema Therapy Rescue Relief Treatment		Colloidal Oatmeal	CREAM	TOPICAL	20220905		OTC MONOGRAPH DRUG	M016	Johnson & Johnson Consumer Inc.	OATMEAL	20	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
69968-0803_0a3c7781-3423-eeb1-e063-6294a90a958d	69968-0803	HUMAN OTC DRUG	Clean and Clear Essentials Dual Action Moisturizer		Salicylic Acid	LOTION	TOPICAL	20230814		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
69968-0804_098e0f91-4afb-ea12-e063-6394a90a1021	69968-0804	HUMAN OTC DRUG	Clean and Clear Acne Spot Treatment		Salicylic Acid	GEL	TOPICAL	20231113		OTC MONOGRAPH DRUG	M006	Clean and Clear Acne Spot Treatment	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0805_0c672736-4b1d-e927-e063-6394a90a9837	69968-0805	HUMAN OTC DRUG	Neutrogena Skin Clearing Blemish Concealer - Light 10		Salicylic Acid	CREAM	TOPICAL	20231222		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0810_0c672736-4b1d-e927-e063-6394a90a9837	69968-0810	HUMAN OTC DRUG	Neutrogena Skin Clearing Blemish Concealer - Fair 05		Salicylic Acid	CREAM	TOPICAL	20231222		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0811_0c672736-4b1d-e927-e063-6394a90a9837	69968-0811	HUMAN OTC DRUG	Neutrogena Skin Clearing Blemish Concealer - Buff 09		Salicylic Acid	CREAM	TOPICAL	20231222		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0812_0c672736-4b1d-e927-e063-6394a90a9837	69968-0812	HUMAN OTC DRUG	Neutrogena Skin Clearing Blemish Concealer - Medium 15		Salicylic Acid	CREAM	TOPICAL	20231222		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	5	mg/g			N	20241231
69968-0813_fbf8b4f9-cf3a-e216-e053-6394a90ab35e	69968-0813	HUMAN OTC DRUG	Aveeno Calm Plus Restore Daily Moisturizer Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part352	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	58; 125	mg/mL; mg/mL			N	20241231
69968-0815_0c360d65-f12f-fc61-e063-6294a90a3a3b	69968-0815	HUMAN OTC DRUG	Neutrogena Mineral Invisible Daily Defense Face Sunscreen Broad Spectrum SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230821		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	49; 216	mg/mL; mg/mL			N	20241231
69968-0816_08231f7d-8071-887a-e063-6294a90ae2c1	69968-0816	HUMAN OTC DRUG	Neutrogena Beach Defense Kids Sunscreen SPF 60 Plus		Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20230826		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0818_06e10b84-2988-febb-e063-6394a90a8ec8	69968-0818	HUMAN OTC DRUG	Listerine Clinical Solutions Gum Health Icy Mint		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20231016		OTC MONOGRAPH DRUG	M022	Johnson & Johnson Consumer Inc.	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0819_06e2a660-0efc-fb5d-e063-6394a90a1c5b	69968-0819	HUMAN OTC DRUG	Listerine Clinical Solutions Teeth Strength Alpine Mint		Sodium Fluoride	MOUTHWASH	ORAL	20231016		OTC MONOGRAPH DRUG	M022	Johnson & Johnson Consumer Inc.	SODIUM FLUORIDE	.1	mg/mL			N	20241231
69968-0820_06cd0416-0443-65c2-e063-6294a90afb7c	69968-0820	HUMAN OTC DRUG	Clean and Clear Essentials Acne Toner		Salicylic Acid	LIQUID	TOPICAL	20231016		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0822_09a06fb6-7282-e4b7-e063-6394a90a2bed	69968-0822	HUMAN OTC DRUG	Clean and Clear Acne Exfoliating Cleanser		Salicylic Acid	LIQUID	TOPICAL	20231129		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0823_0562bb4a-f700-656e-e063-6294a90a8d74	69968-0823	HUMAN OTC DRUG	Neutrogena Sport Active Defense SPF 70		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20231204		OTC MONOGRAPH FINAL	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0824_05641dda-9798-9585-e063-6394a90a6391	69968-0824	HUMAN OTC DRUG	Neutrogena Sport Active Defense SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20231204		OTC MONOGRAPH FINAL	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
69968-0825_06804af5-1bbf-d012-e063-6294a90a41de	69968-0825	HUMAN OTC DRUG	Neutrogena Rapid Clear Acne Eliminating Spot		Salicylic Acid	GEL	TOPICAL	20230830		OTC MONOGRAPH DRUG	M006	Johnson & Johnson Consumer Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
69968-0826_0682cce6-d302-c1b7-e063-6294a90ae92f	69968-0826	HUMAN OTC DRUG	Neutrogena Adapalene 0.1% Acne Treatment		Adapalene	GEL	TOPICAL	20231204		ANDA	ANDA090962	Johnson & Johnson Consumer Inc.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
69968-0827_08997bec-8f7d-2d24-e063-6294a90ad9f7	69968-0827	HUMAN OTC DRUG	Neutrogena Invisible Daily Defense Face Serum Sunscreen Broad Spectrum SPF 60		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0828_09cccc31-458f-e72e-e063-6394a90ab35a	69968-0828	HUMAN OTC DRUG	Neutrogena Clear Face Serum Sunscreen Broad Spectrum SPF 60		Avobenzone, Homosalate, Octisalate, Octocrylene	LIQUID	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0829_089b7971-bb45-618c-e063-6294a90a8e66	69968-0829	HUMAN OTC DRUG	Neutrogena Ultra Sheer Face Serum Sunscreen Broad Spectrum SPF 60		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 135; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
69968-0830_0a063d7f-23b3-c949-e063-6294a90a5b57	69968-0830	HUMAN OTC DRUG	Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 25, Sheer Ivory 10		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 92.8	mg/mL; mg/mL			N	20241231
69968-0831_0a063d7f-23b3-c949-e063-6294a90a5b57	69968-0831	HUMAN OTC DRUG	Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 25, Sheer Fair 20		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 92.8	mg/mL; mg/mL			N	20241231
69968-0832_0a063d7f-23b3-c949-e063-6294a90a5b57	69968-0832	HUMAN OTC DRUG	Neutrogena Healthy Skin Radiant Tinted Moisturizer Sunscreen Broad Spectrum SPF 25, Sheer Tan 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 92.8	mg/mL; mg/mL			N	20241231
69968-0843_0ad214fb-0b72-0eeb-e063-6394a90a5a72	69968-0843	HUMAN OTC DRUG	Neosporin Original		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	KIT		20220601		OTC MONOGRAPH DRUG	M004	Johnson & Johnson Consumer Inc.						N	20241231
69968-0844_0bc0ddb3-a084-b451-e063-6394a90af22b	69968-0844	HUMAN OTC DRUG	Visine Red Eye Total Comfort and Tears Dry Eye Relief		Tetrahydrozoline HCl, Polyethylene Glycol 400, Zinc Sulfate	KIT		20200608		OTC MONOGRAPH DRUG	M018	Johnson & Johnson Consumer Inc.						N	20241231
69968-0845_0acd8136-06ec-4ea4-e063-6394a90a5b51	69968-0845	HUMAN OTC DRUG	Neutrogena Boost Your Skins Vitals Team Regenerate		Avobenzone, Homosalate, Octisalate, and Octocrylene	KIT		20230810		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.						N	20241231
69968-0847_0bd53e08-c555-6360-e063-6394a90ab34a	69968-0847	HUMAN OTC DRUG	Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF 55	Clubtray	Avobenzone, Homosalate, Octisalate, and Octocrylene	KIT		20231208		OTC MONOGRAPH DRUG	M020	Johnson & Johnson Consumer Inc.						N	20241231
69981-194_09d3f033-a63a-0c08-e063-6394a90a8d60	69981-194	HUMAN OTC DRUG	CUREFINI Skin Protection Cream		PETROLATUM	CREAM	TOPICAL	20210712		OTC MONOGRAPH DRUG	M016	Rev Pharma Corp	PETROLATUM	300	mg/mL			N	20241231
69981-704_09d72d1b-d34e-923b-e063-6394a90a0cfc	69981-704	HUMAN OTC DRUG	CUREFINI Dermal		PETROLATUM, COD LIVER	CREAM	TOPICAL	20220110		OTC MONOGRAPH DRUG	M016	Rev Pharma Corporation	COD LIVER OIL; PETROLATUM	100; 300	mg/mL; mg/mL			N	20241231
69981-710_09d72589-143a-349f-e063-6294a90a4d95	69981-710	HUMAN OTC DRUG	CURACID Dermal for cuts and burns		PETROLATUM, COD LIVER	OINTMENT	TOPICAL	20190501		OTC MONOGRAPH DRUG	M016	Rev Pharma Corp.	COD LIVER OIL; PETROLATUM	100; 300	mg/mL; mg/mL			N	20241231
69981-712_0974736c-8d14-767b-e063-6294a90a5abe	69981-712	HUMAN OTC DRUG	CUREFINI		PETROLATUM, COD LIVER	OINTMENT	TOPICAL	20130117		OTC MONOGRAPH DRUG	M016	Rev Pharma Corp.	COD LIVER OIL; PETROLATUM	100; 300	mg/mL; mg/mL			N	20241231
69981-729_09d74b93-96fc-917f-e063-6394a90a830e	69981-729	HUMAN OTC DRUG	Curefini Dermal		PETROLATUM	CREAM	TOPICAL	20170208		OTC MONOGRAPH DRUG	M016	Rev Pharma Corp.	PETROLATUM	300	mg/mL			N	20241231
69981-754_097483fe-a25b-b6fc-e063-6394a90a44dd	69981-754	HUMAN OTC DRUG	Curefini Dermal		PETROLATUM, COD LIVER	OINTMENT	TOPICAL	20160802		OTC MONOGRAPH DRUG	M016	Rev Pharma Corp	COD LIVER OIL; PETROLATUM	100; 300	mg/mL; mg/mL			N	20241231
69986-011_41b87ea2-a153-4bdf-9b43-7173b394943d	69986-011	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231222		ANDA	ANDA213612	Sinotherapeutics Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69986-012_41b87ea2-a153-4bdf-9b43-7173b394943d	69986-012	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231222		ANDA	ANDA213612	Sinotherapeutics Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69986-013_701a4c60-c022-4281-88d8-3984d5f56092	69986-013	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231130		ANDA	ANDA214496	Sinotherapeutics Inc.	PREGABALIN	82.5	mg/1		CV	N	20241231
69986-014_701a4c60-c022-4281-88d8-3984d5f56092	69986-014	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231130		ANDA	ANDA214496	Sinotherapeutics Inc.	PREGABALIN	165	mg/1		CV	N	20241231
69986-015_701a4c60-c022-4281-88d8-3984d5f56092	69986-015	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231130		ANDA	ANDA214496	Sinotherapeutics Inc.	PREGABALIN	330	mg/1		CV	N	20241231
69986-017_41b87ea2-a153-4bdf-9b43-7173b394943d	69986-017	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231222		ANDA	ANDA213612	Sinotherapeutics Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
69990-102_09d141b4-b9b2-37ff-e063-6294a90ad5d2	69990-102	HUMAN OTC DRUG	Duradry PM Sweat Minimizing Antiperspirant Gel		Aluminum Chloride Hexahydrate	GEL	TOPICAL	20150101		OTC MONOGRAPH DRUG	M019	Novadore USA Inc	ALUMINUM CHLORIDE	150	mg/mL			N	20241231
69990-315_09d2c6cd-1a36-8326-e063-6394a90a9803	69990-315	HUMAN OTC DRUG	Duradry AM Deodorant and Antiperspirant		Aluminum Zirconium Trichlorohydrex Glycine	STICK	TOPICAL	20210127		OTC MONOGRAPH DRUG	M019	NOVADORE USA Inc	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	20	g/100g			N	20241231
69990-401_09d13b82-192a-0750-e063-6294a90a5396	69990-401	HUMAN OTC DRUG	Duradry Antiperspirant Wipes		aluminum sesquichlorohydrate	CLOTH	TOPICAL	20220329		OTC MONOGRAPH DRUG	M019	Novadore USA Inc	ALUMINUM SESQUICHLOROHYDRATE	200	mg/mL			N	20241231
69993-100_551c0e94-d8b7-468e-9e7f-96af8ef69ec5	69993-100	HUMAN OTC DRUG	Maximum Strength Blue Emu Pain Relief	Blu Emu	Trolamine Salicylate	SPRAY	TOPICAL	20120604		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	TROLAMINE SALICYLATE	10	g/100mL			N	20241231
69993-200_450129ab-f868-4f4f-ab27-258d8b35940d	69993-200	HUMAN OTC DRUG	Blue-Emu Ultra with Hemp Seed		TROLAMINE SALICYLATE	CREAM	TOPICAL	20210405		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	TROLAMINE SALICYLATE	.1	g/g			N	20241231
69993-300_20bf327e-ed64-443d-b0c6-1e331991f977	69993-300	HUMAN OTC DRUG	Blue-Emu Maximum Pain Relief		TROLAMINE SALICYLATE	CREAM	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	TROLAMINE SALICYLATE	.1	g/g			N	20241231
69993-350_5405ca08-c74e-43d8-ac41-5c8d5008e6b1	69993-350	HUMAN OTC DRUG	Blue-Emu Lidocaine Pain Relief Cream		lidocaine cream 4%	CREAM	TOPICAL	20170301		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69993-400_46bf15ae-d13d-4154-a435-b9952e567126	69993-400	HUMAN OTC DRUG	Lidocare	03	4% Lidocaine	PATCH	TOPICAL	20160501		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	LIDOCAINE	4	g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69993-425_d45b5e74-2200-4bbf-96aa-47c889158b3d	69993-425	HUMAN OTC DRUG	Blue-Emu Lidocaine Dry		Lidocaine	PATCH	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	LIDOCAINE	22	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69993-450_ff471fd0-426b-4266-af1a-df3e3734e5a3	69993-450	HUMAN OTC DRUG	Lidocare Arm, Neck, Leg		4% Lidocaine	PATCH	TOPICAL	20160501		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	LIDOCAINE	11	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
69993-500_d333481b-290d-4b42-b193-c10189465647	69993-500	HUMAN OTC DRUG	Blue-Emu Pain Relief Micro-Foam		TROLAMINE SALICYLATE	AEROSOL, FOAM	TOPICAL	20210405		OTC MONOGRAPH NOT FINAL	part348	NFI, LLC	TROLAMINE SALICYLATE	.1	g/g			N	20241231
69995-8915_9f4b03b1-4a90-43fd-8e25-3b1fea1c9567	69995-8915	HUMAN PRESCRIPTION DRUG	Oxygen Compressed		Oxygen Gas	GAS	RESPIRATORY (INHALATION)	20150716		NDA	NDA205840	A + OXYGEN & D.M.E.	OXYGEN	992	mL/100mL			N	20241231
70000-0001_f320e8fc-c536-403d-ac55-ea0ce6c767ab	70000-0001	HUMAN OTC DRUG	leader nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20200114		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
70000-0002_917a4b9a-62f0-479e-8b1f-6c8b37e5ec5f	70000-0002	HUMAN OTC DRUG	Leader Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20191220		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0003_c06732f4-4dd1-443f-911d-09e0d78f28a5	70000-0003	HUMAN OTC DRUG	leader ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20191218		ANDA	ANDA077349	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0004_68cf9472-3051-4fc0-b05f-9c6e5523c922	70000-0004	HUMAN OTC DRUG	leader mucus relief d		Guaifenesin, pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200116		ANDA	ANDA091071	Cardinal Health 110, LLC. dba Leader	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0006_d5f4ad88-7d96-4830-acce-d13b2b15c815	70000-0006	HUMAN OTC DRUG	leader severe cold and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20191113		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0007_b4ceea27-1fc3-426a-80ce-64535b72b747	70000-0007	HUMAN OTC DRUG	leader tussin		Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20191108		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0008_21ff8830-55fc-4f93-a854-a5750e3ba605	70000-0008	HUMAN OTC DRUG	leader childrens mucus and cough relief		Dextromethorphan hbr, Guaifenesin	SOLUTION	ORAL	20200128		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0009_ada4cc53-448f-43e0-b6b5-97d5f516628b	70000-0009	HUMAN OTC DRUG	Miconazole 7		Miconazole Nitrate	CREAM	VAGINAL	20190701		ANDA	ANDA074164	Cardinal Health (Leader) 70000	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70000-0010_0d37bf18-e4e8-6459-e063-6294a90af2ff	70000-0010	HUMAN OTC DRUG	Leader Eye Drops Redness Relief		Glycerin, Naphazoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20190430		OTC MONOGRAPH DRUG	M018	Cardinal Health	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70000-0011_0d376274-1a79-5fbc-e063-6394a90a2cf2	70000-0011	HUMAN OTC DRUG	Leader Artificial Tears 15 mL		Polyvinyl Alcohol, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20190703		OTC MONOGRAPH DRUG	M018	Cardinal Health	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
70000-0012_0d376274-1a7a-5fbc-e063-6394a90a2cf2	70000-0012	HUMAN OTC DRUG	Leader Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20190713		OTC MONOGRAPH DRUG	M018	Cardinal Health	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
70000-0013_0d37718d-85da-696a-e063-6394a90a291e	70000-0013	HUMAN OTC DRUG	Leader Restorative Formula Lubricant Eye Drops		propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190430		OTC MONOGRAPH DRUG	M018	Cardinal Health	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
70000-0014_08f19f3e-edb4-bdd2-e063-6394a90ac626	70000-0014	HUMAN OTC DRUG	Regular Strength Aspirin		Aspirin	TABLET, COATED	ORAL	20190401		OTC MONOGRAPH DRUG	M013	CARDINAL HEALTH, INC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0016_ecaf88a1-a3fc-6306-e053-2a95a90af778	70000-0016	HUMAN OTC DRUG	Leader	Baby SPF 50	avobenzone, homosalate, octisalate, octocrylene, oxybenzone	LOTION	TOPICAL	20191030		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70000-0017_0d37718d-85db-696a-e063-6394a90a291e	70000-0017	HUMAN OTC DRUG	Leader Lubricant Eye Drops 30ct		Polyethylene Glycol 400, Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20190718		OTC MONOGRAPH DRUG	M018	Cardinal Health	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
70000-0018_0d37dad1-2198-7c25-e063-6394a90a7eb7	70000-0018	HUMAN OTC DRUG	Leader Eye Wash		purified water	SOLUTION	OPHTHALMIC	20190709		OTC MONOGRAPH DRUG	M018	Cardinal Health	WATER	99.05	g/100mL			N	20241231
70000-0020_124c29ba-ac04-44d1-a3b6-abb8e1877e8a	70000-0020	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl alcohol	LIQUID	TOPICAL	20190318		OTC MONOGRAPH NOT FINAL	part333A	Cardinal Health, 110 dba Leader	ALCOHOL	70	mL/100mL			N	20241231
70000-0021_c61d2ec2-9f0a-47ee-b087-6a1854d0f3a0	70000-0021	HUMAN OTC DRUG	Epsom Salt		MAGNESIUM SULFATE	CRYSTAL	ORAL; TOPICAL	20120326		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health, 110 dba Leader	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0022_5d8d8ba4-6f77-4cf6-ab0e-80a858f2c6fd	70000-0022	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20190319		OTC MONOGRAPH NOT FINAL	part333A	Cardinal Health, 110 dba Leader	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
70000-0023_6cc51c6c-1c0d-4de7-92ab-27b00f98a667	70000-0023	HUMAN OTC DRUG	Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20110802		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba Leader	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0024_0907154c-ecfb-46ab-8b02-d12b2c4a2740	70000-0024	HUMAN OTC DRUG	Leader Castor Oil		Castor oil	OIL	ORAL	20190312		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	CASTOR OIL	1	g/mL			N	20241231
70000-0025_a6bb2a5b-bfd0-4738-b23f-346c21b494b5	70000-0025	HUMAN OTC DRUG	Miconazole 3 Combination Pack		miconazole nitrate	KIT	VAGINAL	20190701		ANDA	ANDA074926	Cardinal Health (Leader) 70000						N	20241231
70000-0026_09c4e710-ee01-7f9b-e063-6294a90ab999	70000-0026	HUMAN OTC DRUG	Leader Alcohol 70 Isopropyl Alcohol		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20190601		OTC MONOGRAPH DRUG	M003	Cardinal Health	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
70000-0027_05dcd345-846d-42b8-b098-4f0a3f5e15ba	70000-0027	HUMAN OTC DRUG	leader milk of magnesia		Magnesium hydroxide	SUSPENSION	ORAL	20200129		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health 110, LLC. dba Leader	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0028_719482d5-a36a-455c-a388-c352ef1ca67b	70000-0028	HUMAN OTC DRUG	leader childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20191204		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	160	mg/5mL			N	20241231
70000-0032_3ed9bec3-6217-126f-dd7b-1437e0c8e1bd	70000-0032	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190528		ANDA	ANDA207673	CARDINAL HEALTH	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70000-0033_3eae53a8-c3bf-455b-f5f6-a73e2c827133	70000-0033	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET	ORAL	20190528		ANDA	ANDA075294	CARDINAL HEALTH	RANITIDINE HYDROCHLORIDE	75	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70000-0034_a7d436ec-805e-4261-a4ab-585b40d439e4	70000-0034	HUMAN OTC DRUG	Regular Strength Antacid	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20190416		OTC MONOGRAPH FINAL	part331	CARDINAL HEALTH	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70000-0035_ec0b764a-16bb-4b49-a02d-0eef31f1faf7	70000-0035	HUMAN OTC DRUG	Aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190725		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0036_c4fd0858-6115-0db0-e053-2a95a90ac8d9	70000-0036	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20190528		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health	ACETAMINOPHEN	500	mg/1			N	20241231
70000-0037_0a1f1b53-3751-8087-e063-6394a90a9ca4	70000-0037	HUMAN OTC DRUG	Lidocaine		Burn Relief	AEROSOL, SPRAY	TOPICAL	20200215		OTC MONOGRAPH DRUG	M017	LEADER/ Cardinal Health 110, Inc.	LIDOCAINE	.64	g/127g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0041_9ed62a87-32e5-44a6-be7f-55f84168a898	70000-0041	HUMAN OTC DRUG	leader lice treatment		Permethrin	LOTION	TOPICAL	20200319		ANDA	ANDA076090	Cardinal Health 110, LLC. dba Leader	PERMETHRIN	1	g/100mL	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
70000-0042_57e2382c-9767-4be7-8d6b-db00e13b8276	70000-0042	HUMAN OTC DRUG	Leader Allergy Relief D		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200309		ANDA	ANDA210719	Cardinal Health 110, LLC. dba Leader	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0043_99da7230-9480-4b05-91c7-f8609f34ab01	70000-0043	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20190219		ANDA	ANDA091314	Cardinal Health (Leader) 70000	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
70000-0044_b709d9f1-e1cc-456f-9201-995cec6727e9	70000-0044	HUMAN OTC DRUG	Stomach Relief	Original Strength	Bismuth subsalicylate	LIQUID	ORAL	20200225		OTC MONOGRAPH DRUG	M008	Cardinal Health (Leader) 70000	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
70000-0045_db5d6bf5-885d-40b4-ba34-6d108c313ac0	70000-0045	HUMAN OTC DRUG	Stomach Relief Ultra		Bismuth subsalicylate	LIQUID	ORAL	20200225		OTC MONOGRAPH FINAL	part335	Cardinal Health (Leader) 70000	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
70000-0046_0dfb52dc-3d4c-6ce3-e063-6294a90ac192	70000-0046	HUMAN OTC DRUG	Hemorrhoidal		Mineral Oil, Petrolatum, Phenylephrine HCI	OINTMENT	TOPICAL	20200514		OTC MONOGRAPH DRUG	M015	Cardinal Health 110 dba LEADER	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
70000-0047_3516544d-5a68-417f-be0e-47914dd86b38	70000-0047	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride Allergy	TABLET	ORAL	20200326		ANDA	ANDA090760	Cardinal Health	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0048_d407f522-787b-455d-920f-2c92b89e3007	70000-0048	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20200404		ANDA	ANDA206531	Cardinal Health	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70000-0049_e3d4e274-9609-4c0c-acc2-99010743ffe3	70000-0049	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20200404		ANDA	ANDA206531	Cardinal Health	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70000-0050_7ebf1dfb-81f5-4336-b77e-60eee4545d51	70000-0050	HUMAN OTC DRUG	Flu HBP	Maximum Strength	Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20200617		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	325; 2; 10	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0051_2514dc38-f5be-4534-a2e4-cec992c97edb	70000-0051	HUMAN OTC DRUG	Cardinal Health Infants Gas Relief		Simethicone	SUSPENSION/ DROPS	ORAL	20200902		OTC MONOGRAPH FINAL	part332	CARDINAL HEALTH	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
70000-0052_b89a4c1c-be39-4866-a575-56c0bf5bffaa	70000-0052	HUMAN OTC DRUG	Anti Nausea		dextrose(glucose),Levulose(fructose),Phosphoric acid	LIQUID	ORAL	20200727		UNAPPROVED DRUG OTHER		Cardinal Health	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
70000-0053_c40bfeba-0342-e7a1-17d9-7c0c303e3591	70000-0053	HUMAN OTC DRUG	Eye Allergy Itch Relief		Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210115		ANDA	ANDA209752	LEADER/ Cardinal Health 110, Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
70000-0054_543ebf27-515c-012c-68e1-e506f4aa6a89	70000-0054	HUMAN OTC DRUG	Eye Allergy Itch and Redness Relief		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20210115		ANDA	ANDA209619	LEADER/ Cardinal Health 110, Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
70000-0055_24e91938-0c62-4f6c-840d-1605ea9449ac	70000-0055	HUMAN OTC DRUG	Leader Chest Congestion Relief	G450	Guaifenesin	TABLET	ORAL	20200901		OTC MONOGRAPH FINAL	part341	Cardinal Health	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70000-0056_8d2e88f2-eef4-42dd-842d-97783af92136	70000-0056	HUMAN OTC DRUG	Leader Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20200901		OTC MONOGRAPH FINAL	part341	Cardinal Health	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0057_fc275ffc-7cc7-4a6b-9481-d25128d54c01	70000-0057	HUMAN OTC DRUG	Childrens Dibromm Cold and Allergy		Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20200430		OTC MONOGRAPH FINAL	part341	Cardinal Health (Leader) 70000	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0058_221e58c9-24b9-488c-bdf3-9ba8b6b5d1f1	70000-0058	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin-B Sulfate	OINTMENT	TOPICAL	20201231		OTC MONOGRAPH DRUG	M004	Cardinal Health (Leader) 70000	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70000-0059_0b3d3b8e-6a9a-5e98-e063-6394a90ab0aa	70000-0059	HUMAN OTC DRUG	CR-5667753 Leader Daily Moisturizer		CR-5667753 Leader Daily Moisturizer	OINTMENT	TOPICAL	20210126		OTC MONOGRAPH DRUG	M016	Cardinal Health	PETROLATUM	41	g/100g			N	20241231
70000-0060_0b3d5420-d60e-8385-e063-6394a90abb6c	70000-0060	HUMAN OTC DRUG	Leader Povidone-Iodine 10% Topical Solution		Povidone Iodine Prep Solution 10%	LIQUID	TOPICAL	20200925		OTC MONOGRAPH DRUG	M003	Cardinal Health	POVIDONE-IODINE	10	mg/mL			N	20241231
70000-0061_0993972d-ea49-33b3-e063-6294a90a3af8	70000-0061	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20200801		OTC MONOGRAPH DRUG	M007	CARDINAL HEALTH	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0062_0993b1ce-d4aa-6ac6-e063-6394a90a51fd	70000-0062	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200901		OTC MONOGRAPH DRUG	M001	CARDINAL HEALTH	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0063_0993b01a-3d48-37df-e063-6294a90a1767	70000-0063	HUMAN OTC DRUG	ANTACID MINT		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200801		OTC MONOGRAPH DRUG	M001	CARDINAL HEALTH	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0064_09935f6d-4287-4f4c-e063-6394a90a940a	70000-0064	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20200901		OTC MONOGRAPH DRUG	M007	CARDINAL HEALTH	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0065_09937eb4-1d9c-4ffb-e063-6394a90ad694	70000-0065	HUMAN OTC DRUG	MILK OF MAGNESIA MINT		magnesium hydroxide	SUSPENSION	ORAL	20200801		OTC MONOGRAPH DRUG	M007	CARDINAL HEALTH	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0066_c4fcfaa7-996d-7aaa-e053-2995a90a61de	70000-0066	HUMAN OTC DRUG	Acetaminophen, Aspirin, Caffeine		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20201106		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70000-0067_e41a4808-26e4-190c-e053-2995a90ac0b7	70000-0067	HUMAN OTC DRUG	Calcium Polycarbophil		Calcium Polycarbophil	TABLET, FILM COATED	ORAL	20201118		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
70000-0069_3dbdd26c-792f-e69f-c0e8-47de9571b8f6	70000-0069	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20201030		ANDA	ANDA202194	Cardinal Health	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70000-0070_2d1ce8ad-b2bb-4a42-bfbb-1edc9d4634db	70000-0070	HUMAN OTC DRUG	Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate	OINTMENT	TOPICAL	20201231		OTC MONOGRAPH FINAL	part333B	Cardinal Health (Leader) 70000	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[iU]/g; [iU]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70000-0071_e3de7290-f06e-a3e5-e053-2a95a90abf50	70000-0071	HUMAN OTC DRUG	Cardinal Health Leader Kids Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201209		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0072_e715df51-25f5-298a-e053-2a95a90a0464	70000-0072	HUMAN OTC DRUG	Cardinal Health Leader General Protection SPF 70 Sunscreen		Avobenzone, Homosalate, Octisalate, Octcrylene	SPRAY	TOPICAL	20201209		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0073_ecb00e67-a580-1f4c-e053-2995a90a488d	70000-0073	HUMAN OTC DRUG	Cardinal Health Leader General Protection Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201209		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0074_e3de612e-1cb5-0414-e053-2a95a90a966c	70000-0074	HUMAN OTC DRUG	Cardinal Health Leader Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201210		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0075_ecb04a97-493b-b148-e053-2995a90abf15	70000-0075	HUMAN OTC DRUG	Cardinal Health Leader General Protection Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201210		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0076_ecb04a97-493c-b148-e053-2995a90abf15	70000-0076	HUMAN OTC DRUG	Cardinal Health Leader Baby Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201211		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0077_0ea4ae4b-da7f-7127-e063-6294a90a9af2	70000-0077	HUMAN OTC DRUG	MAXIMUM STRENGTH LAXATIVE		SENNOSIDES	TABLET	ORAL	20210111		OTC MONOGRAPH DRUG	M007	CARDINAL HEALTH	SENNOSIDES	25	mg/1			N	20251231
70000-0079_0b3d986c-eeae-adbe-e063-6294a90a0fb2	70000-0079	HUMAN OTC DRUG	Leader Baby Skin Protectant		Baby Skin Protectant	OINTMENT	TOPICAL	20210208		OTC MONOGRAPH DRUG	M016	Cardinal Health	PETROLATUM	41	g/100g			N	20241231
70000-0080_09cdae13-2487-43f9-e063-6394a90af7f5	70000-0080	HUMAN OTC DRUG	Sinus Relief Severe Congestion and Pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210127		OTC MONOGRAPH DRUG	M012	CARDINAL HEALTH	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0083_7169b437-5734-4e8a-9c15-d1622fda44e9	70000-0083	HUMAN OTC DRUG	Head Congestion and Mucus		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210311		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0084_0dfbb924-3ca1-3df8-e063-6394a90af9ce	70000-0084	HUMAN OTC DRUG	Tolnaftate Cream 1% ANTIFUNGAL		Tolnaftate	CREAM	TOPICAL	20210211		OTC MONOGRAPH DRUG	M005	CARDINAL HEALTH 110 dba LEADER	TOLNAFTATE	1	g/100g			N	20251231
70000-0091_fbfabd84-1a2a-426e-9aaf-1d8da06dfa04	70000-0091	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210131		OTC MONOGRAPH DRUG	M007	Cardinal Health (Leader) 70000	DOCUSATE SODIUM	100	mg/1			N	20251231
70000-0092_0ea4c89f-dd36-749d-e063-6294a90a7cb0	70000-0092	HUMAN OTC DRUG	Regular Strength Acetaminophen		Acetaminophen	TABLET	ORAL	20210505		OTC MONOGRAPH DRUG	M013	CARDINAL HEALTH	ACETAMINOPHEN	325	mg/1			N	20251231
70000-0093_f0916063-f6cb-4160-96fb-f2362dd726dd	70000-0093	HUMAN OTC DRUG	Leader Poly Bacitracin		FIRST AID ANTIBIOTIC	OINTMENT	TOPICAL	20210601		OTC MONOGRAPH FINAL	part333B	Cardinal Health 110, Inc.	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70000-0094_70fffc61-ff81-4f78-8d01-09ef9e8675cc	70000-0094	HUMAN OTC DRUG	Leader Triple Antibiotic		First Aid Triple Antibiotic	OINTMENT	TOPICAL	20210601		OTC MONOGRAPH FINAL	part333B	Cardinal Health 110,Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70000-0095_1a222320-7601-4402-82d4-b6f5cb0c4d04	70000-0095	HUMAN OTC DRUG	Acid Reducer		Esomeprazole magnesium	TABLET, DELAYED RELEASE	ORAL	20210430		ANDA	ANDA212088	Cardinal Health (Leader) 70000	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70000-0097_dd5611ac-4fcd-4b80-9107-a528f652b90e	70000-0097	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET	ORAL	20210511		OTC MONOGRAPH DRUG	M009	Cardinal Health 110, LLC. DBA Leader	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70000-0098_cea6bd2d-a266-1209-e053-2995a90ab0a5	70000-0098	HUMAN OTC DRUG	Leader		Lidocaine HCL	CREAM	TOPICAL	20211018		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0099_d3499047-8807-7fe9-e053-2a95a90a19bb	70000-0099	HUMAN OTC DRUG	Leader Lidocaine		Lidocaine HCl	LIQUID	TOPICAL	20211020		OTC MONOGRAPH NOT FINAL	part348	CARDINAL HEALTH	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0108_fbed22ae-8e60-422a-a89b-fc7b907049d6	70000-0108	HUMAN OTC DRUG	Leader Ready to Use Saline	Laxative	Sodium Phosphate, Dibasic and Sodium Phosphate, Monobasic, Unspecified Form	ENEMA	RECTAL	20130219		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
70000-0109_910137c1-0d26-40d8-9898-0d39c1a5e8e7	70000-0109	HUMAN OTC DRUG	Leader Ready to Use Mineral Oil	Laxative	mineral oil	ENEMA	RECTAL	20130219		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	MINERAL OIL	118	g/118mL			N	20241231
70000-0110_a4440b09-5cc0-4394-b00c-75987cc911bf	70000-0110	HUMAN OTC DRUG	leader allergy relief nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20160527		ANDA	ANDA207957	Cardinal Health 110, LLC. dba Leader	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70000-0112_0a531330-b38b-79fa-e063-6394a90a5d55	70000-0112	HUMAN OTC DRUG	Alcohol Prep		isopropyl alcohol	SWAB	TOPICAL	20160621		OTC MONOGRAPH DRUG	M003	Cardinal Health	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
70000-0113_75ed1b5c-c233-1c47-d098-b018094751aa	70000-0113	HUMAN OTC DRUG	Nicotine	transdermal system step 3	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160331		NDA	NDA020076	Cardinal Health	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0114_75ed1b5c-c233-1c47-d098-b018094751aa	70000-0114	HUMAN OTC DRUG	Nicotine	transdermal system step 2	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160331		NDA	NDA020076	Cardinal Health	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0115_75ed1b5c-c233-1c47-d098-b018094751aa	70000-0115	HUMAN OTC DRUG	Nicotine	transdermal system step 1	Nicotine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20160331		NDA	NDA020076	Cardinal Health	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0117_24ab5894-ad52-453b-a3ed-263cb6af5bf5	70000-0117	HUMAN OTC DRUG	Leader Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20160920		ANDA	ANDA203690	Cardinal Health 110, LLC. dba Leader	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0121_3164ba9f-09a7-4805-8d4c-9e3dad2aae38	70000-0121	HUMAN OTC DRUG	Leader Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20160927		ANDA	ANDA203690	Cardinal Health 110, LLC. dba Leader	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0125_88e1fe57-4ad1-4646-b639-e935285aec4b	70000-0125	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20040820		ANDA	ANDA076805	Cardinal Health, 110 dba LEADER	LORATADINE	5	mg/5mL			N	20241231
70000-0126_0d1ab708-9b21-4ac6-8846-fee9967b09d4	70000-0126	HUMAN OTC DRUG	Nasal Decongestant PE	Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050114		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0127_cad678ae-811f-45c4-99a6-eb55317ce6ea	70000-0127	HUMAN OTC DRUG	Back and Body	Extra Strength	Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20040412		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ASPIRIN; CAFFEINE	500; 32.5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70000-0129_c732d183-f208-4fc8-b41f-d8856298cf51	70000-0129	HUMAN OTC DRUG	Maximum Strength Mucus Relief DM		Dextromethorphan hydrobromide and Guaifenesin	SOLUTION	ORAL	20170306		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0130_9a45bf4a-435e-419f-b9b7-340d52857230	70000-0130	HUMAN OTC DRUG	Zinc Cold Remedy		ZINC ACETATE ANHYDROUS and ZINC GLUCONATE	TABLET	ORAL	20170515		UNAPPROVED HOMEOPATHIC		CARDINAL HEALTH	ZINC ACETATE ANHYDROUS; ZINC GLUCONATE	2; 1	[hp_X]/1; [hp_X]/1	Copper Absorption Inhibitor [EPC], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Decreased Copper Ion Absorption [PE]		N	20241231
70000-0131_af533bfd-677c-4624-8024-dcee88b4b680	70000-0131	HUMAN OTC DRUG	Childrens Mucus and Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN	LIQUID	ORAL	20170505		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0132_e57de515-a1b5-44cd-9694-b95d6ad91252	70000-0132	HUMAN OTC DRUG	Extra Strength Sinus Relief Nasal Decongestant		Phenylephrine Hydrochloride	SPRAY	NASAL	20170606		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0133_2d61d893-6188-43a0-8894-41a15d02f201	70000-0133	HUMAN OTC DRUG	Tussin	Multi Symptom Cold CF	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI	LIQUID	ORAL	20170131	20241231	OTC MONOGRAPH DRUG	M012	Cardinal Health (Leader) 70000	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
70000-0136_88ecb774-43a4-45ea-8b93-4c89f08604b9	70000-0136	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0141_fb21b9d3-efd0-47e5-a982-51bb52de8029	70000-0141	HUMAN OTC DRUG	Mucus Relief PE Sinus Congestion		Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20060415		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0143_92d6f707-7e64-4dd6-bbde-88e26ca4ecbb	70000-0143	HUMAN OTC DRUG	Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20161031	20241231	OTC MONOGRAPH NOT FINAL	part343	Cardinal Health (Leader) 70000	ACETAMINOPHEN	160	mg/5mL			N	
70000-0145_103fc0e0-e4b6-419f-8ca6-cc5831aa28b2	70000-0145	HUMAN OTC DRUG	Menstrual Relief	Maximum Strength Multi Symptom	Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20150113		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
70000-0146_0750f0ef-1085-40f5-9335-bcb2949a8cbd	70000-0146	HUMAN OTC DRUG	Headache Relief	Extra Strength	Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20080313		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70000-0147_a371753e-5301-4678-b4c5-c93efa1a9c08	70000-0147	HUMAN OTC DRUG	Buffered Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19900330		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0156_cbd730a1-723e-464d-95ad-2c346802cc91	70000-0156	HUMAN OTC DRUG	Leader multi symptom flu and severe cold		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	POWDER, FOR SOLUTION	ORAL	20170131		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0157_6011b752-50db-4d7d-a4f9-a40e8827eebd	70000-0157	HUMAN OTC DRUG	Leader Ibuprofen PM		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20161123		ANDA	ANDA079113	Cardinal Health 110, LLC. dba Leader	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0159_583737de-cb78-4cf6-9ef2-e21f3d6e6984	70000-0159	HUMAN OTC DRUG	Tension Headache		Acetaminophen, Caffeine	TABLET, FILM COATED	ORAL	20070117		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
70000-0160_270ecf6e-c22f-438a-a87d-02be09d41c6a	70000-0160	HUMAN OTC DRUG	Allergy Relief	4 Hour	Chlorpheniramine maleate	TABLET	ORAL	19921219		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0161_de2d3aa1-81b2-492b-95c5-f314789a5a25	70000-0161	HUMAN OTC DRUG	Sinus Pressure and Pain	Maximum Strength	Acetaminophen, Phenylephrine HCl	TABLET	ORAL	20050623		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0162_2aa29226-da73-4113-9dbd-ed13b345464d	70000-0162	HUMAN OTC DRUG	Leader Allergy Relief D-24		Loratadine and Pseudoephedrine Sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170215		ANDA	ANDA076557	Cardinal Health	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0164_2729ed53-f924-47da-b2e8-31fe5851ce90	70000-0164	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170215		ANDA	ANDA077442	Cardinal Health	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0168_c483a495-875b-45ee-8492-ea79e4ef85ee	70000-0168	HUMAN OTC DRUG	Leader Cold Relief		Acetaminophen, Dextromethorphan hbr, Phenylephrine hcl	TABLET, FILM COATED	ORAL	20161207		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0169_872dde69-3513-4be6-95f4-f411373ab41e	70000-0169	HUMAN OTC DRUG	Leader Maximum Strength Pain Relieving	Analgesic	Trolamine Salicylate	CREAM	TOPICAL	20170831		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	TROLAMINE SALICYLATE	100	mg/g			N	20241231
70000-0171_08607397-3a56-44b0-93f8-d7d5ca745786	70000-0171	HUMAN OTC DRUG	Leader All Day Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20161129		ANDA	ANDA074661	Cardinal Health 110, LLC. dba Leader	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0174_21798cd3-0347-4fe0-92ac-c161fd3fadb6	70000-0174	HUMAN OTC DRUG	LEADER Nighttime Sleep-Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20170313		OTC MONOGRAPH FINAL	part338	CARDINAL HEALTH	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0174_c527047a-68ec-4720-840d-b7fb12c1cb89	70000-0174	HUMAN OTC DRUG	LEADER Nighttime Sleep-Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20170117		OTC MONOGRAPH FINAL	part338	CARDINAL HEALTH	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0175_24f2a43d-3ad8-4285-865a-df2b8bb3331f	70000-0175	HUMAN OTC DRUG	Leader Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20161130		ANDA	ANDA072096	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0176_020b49b8-8ec8-45ab-8005-9ecfef33577b	70000-0176	HUMAN OTC DRUG	Leader Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20161130		ANDA	ANDA072096	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0178_bb33f0df-dd50-47a5-8009-c6012689fb60	70000-0178	HUMAN OTC DRUG	Adult Aspirin Regimen		Aspirin	TABLET, FILM COATED	ORAL	20110501	20240622	OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. DBA Leader	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
70000-0180_1260d5f8-f420-4ed8-a57c-268c902bed73	70000-0180	HUMAN OTC DRUG	Leader 8HR Arthritis Pain		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170117		ANDA	ANDA075077	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	650	mg/1			N	20241231
70000-0181_a3fbf4a8-8ab6-45cd-85ed-ccceb48dc876	70000-0181	HUMAN OTC DRUG	Leader Childrens Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20161104		ANDA	ANDA074937	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0182_4a96798a-c688-4ade-a3ce-70274eb86cd5	70000-0182	HUMAN OTC DRUG	Leader Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20161115		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0183_a179ec7e-a683-4741-b016-171bd0f1e5f4	70000-0183	HUMAN OTC DRUG	Leader Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20161116		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0184_313161e6-7cdd-41d2-a470-eff8f6816689	70000-0184	HUMAN OTC DRUG	Leader Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20161115		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0186_bbf00b58-0216-4d6f-a634-16aab9ccc733	70000-0186	HUMAN OTC DRUG	Leader Childrens All Day Allergy		cetirizine Hydrochloride	SOLUTION	ORAL	20170213		ANDA	ANDA090254	Cardinal Health 110, LLC. dba Leader	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0187_c7e0e21c-3ebe-4c97-88db-13613bd11a7d	70000-0187	HUMAN OTC DRUG	Leader Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20161205		ANDA	ANDA091135	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0189_db22ac87-0f12-4fcf-95bd-9c1e1b896245	70000-0189	HUMAN OTC DRUG	Leader Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20161121		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0191_458017fe-13e5-48e3-9a79-7a4b45283645	70000-0191	HUMAN OTC DRUG	Leader Daytime Cold and Flu		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20161214		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0192_e9314bb8-3696-43ff-a31b-972a47195ca6	70000-0192	HUMAN OTC DRUG	Leader Daytime Severe Cold and Flu		acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl	SOLUTION	ORAL	20161123		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0193_cefe432b-99ca-4f90-b5dd-82aa3517a062	70000-0193	HUMAN OTC DRUG	Leader Nighttime Cough		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20161129		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0195_780efed5-fb7e-4bde-baa4-37807cd96914	70000-0195	HUMAN OTC DRUG	leader childrens cough dm		dextromethorphan polistirex	SUSPENSION	ORAL	20161115		ANDA	ANDA091135	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0201_69d17371-5fee-4491-8373-8d323f376262	70000-0201	HUMAN OTC DRUG	Leader All Day Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20161207		ANDA	ANDA074661	Cardinal Health 110, LLC. dba Leader	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0204_c8578c47-a9e5-47db-822e-a906e2f80f1f	70000-0204	HUMAN OTC DRUG	Leader Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20161215		ANDA	ANDA078104	Cardinal Health 110, LLC. dba Leader	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70000-0207_c4fcd8bc-0bb7-c0a3-e053-2995a90a8b49	70000-0207	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20170113		OTC MONOGRAPH FINAL	part341	Cardinal Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0208_4dd04a0a-4683-4513-ac17-2d76095a575d	70000-0208	HUMAN OTC DRUG	Leader Ultra Strength Muscle Rub	Topical Analgesic	Camphor (Synthetic), Menthol, Unspecified Form, and Methyl Salicylate	CREAM	TOPICAL	20170524		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
70000-0211_6e46bc4b-7906-45d8-b7d0-e5233acd607b	70000-0211	HUMAN OTC DRUG	Allergy	Multi-Symptom	Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050628		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0213_ec189fca-238d-44d2-9881-4f0408eafe7e	70000-0213	HUMAN OTC DRUG	Leader Allergy Relief		Loratadine	TABLET	ORAL	20161209		ANDA	ANDA076301	Cardinal Health 110, LLC. dba Leader	LORATADINE	10	mg/1			N	20241231
70000-0214_9f319209-117d-4696-b132-2b99e4c75cd7	70000-0214	HUMAN OTC DRUG	Leader Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20170228		ANDA	ANDA204226	Cardinal Health 110, LLC. dba Leader	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0215_a6d04163-a740-4606-a64e-133c0fb30098	70000-0215	HUMAN OTC DRUG	Leader Childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20170210		ANDA	ANDA204226	Cardinal Health 110, LLC. dba Leader	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0218_b9fe5739-9b0c-44d0-9785-d70b7c2da122	70000-0218	HUMAN OTC DRUG	Adult Aspirin Regimen	Low Dose	Aspirin	TABLET, DELAYED RELEASE	ORAL	20140725	20241011	OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. DBA Leader	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
70000-0221_75e7c8cb-656c-47b6-917e-7708747cc2cf	70000-0221	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 110, LLC. DBA Leader	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0223_446e6cb3-0983-4a7f-bf0a-1834cf7cd7ae	70000-0223	HUMAN OTC DRUG	Leader Hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20170117		OTC MONOGRAPH FINAL	part346	Cardinal Health 110, LLC. dba Leader	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0224_78f0d543-3ce4-4cc8-868e-6ef3b84855cc	70000-0224	HUMAN OTC DRUG	Leader Anti Diarrheal		loperamide HCl	SUSPENSION	ORAL	20170119		ANDA	ANDA091292	Cardinal Health	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70000-0225_b6dc4239-25d5-46bf-a14d-3ed2df60dbf1	70000-0225	HUMAN OTC DRUG	Leader Anti Diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20170117		ANDA	ANDA075232	Cardinal Health 110, LLC. dba Leader	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70000-0228_0ea4f3bf-8efe-8ec6-e063-6294a90a6cfd	70000-0228	HUMAN OTC DRUG	STIMULANT LAXATIVE		BISACODYL	TABLET, DELAYED RELEASE	ORAL	20170124		OTC MONOGRAPH DRUG	M007	CARDINAL HEALTH	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
70000-0232_bf0c6bee-49dd-6188-4549-db04db012cff	70000-0232	HUMAN OTC DRUG	Acid Reducer		Omeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20170307		ANDA	ANDA078878	LEADER/ Cardinal Health 110, Inc.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70000-0234_62644c94-7e47-4c5b-aa40-35afad2665c2	70000-0234	HUMAN OTC DRUG	Extra Strength Antacid	Original Flavor	aluminum hydroxide and magnesium carbonate	TABLET, CHEWABLE	ORAL	20190304		OTC MONOGRAPH FINAL	part331	Cardinal Health	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
70000-0239_b63994ba-0a78-4864-8979-bebf7ae0ea82	70000-0239	HUMAN OTC DRUG	Leader Ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20170421		ANDA	ANDA076359	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0241_16326945-97af-4f03-ab90-67614ed345a8	70000-0241	HUMAN OTC DRUG	Leader Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20170201		UNAPPROVED DRUG OTHER		Cardinal Health	PHENAZOPYRIDINE HYDROCHLORIDE	97.5	mg/1			N	20241231
70000-0243_2192239a-b80f-46ab-bee1-a978c2c4db82	70000-0243	HUMAN OTC DRUG	Leader Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Cardinal Health	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
70000-0244_d1448021-847e-4fa7-92fe-539182b700d1	70000-0244	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610		OTC MONOGRAPH DRUG	M010	Cardinal Health 110, LLC. DBA Leader	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0245_0477dfdd-0813-4e10-8c31-9c2574bc7370	70000-0245	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine hydrochloride	SOLUTION	ORAL	20170504		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0245_c2bb8947-4f69-40bf-b270-79169d6b06d2	70000-0245	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine hydrochloride	SOLUTION	ORAL	20170502		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0247_db3fd8b0-2223-4bb1-89e7-62391d9b341a	70000-0247	HUMAN OTC DRUG	Leader Migraine Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20170216		ANDA	ANDA075794	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70000-0252_b7c1c7fe-bfb1-43f2-9e62-386605512797	70000-0252	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Cardinal Health	LORATADINE	5	mg/5mL			N	20241231
70000-0253_34c6d83b-9c4b-46e6-b5be-2e41db16746d	70000-0253	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19960210		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0257_ecb062bc-15d8-ea4f-e053-2995a90a9927	70000-0257	HUMAN OTC DRUG	Leader	Sport Sunscreen SPF 50 Moisturizing	avobenzone, homosalate, octisalate, octocrylene	LOTION	TOPICAL	20191122		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70000-0259_a46485e2-bf7e-436f-89b7-e1566d857709	70000-0259	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20170915	20241231	ANDA	ANDA074916	Cardinal Health (Leader) 70000	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70000-0260_151e8370-02bc-48ac-bda5-3b951ac4322c	70000-0260	HUMAN OTC DRUG	Leader Ice Blue	Analgesic	Menthol, Unspecified Form	GEL	TOPICAL	20170531		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	MENTHOL, UNSPECIFIED FORM	20	mg/g			N	20241231
70000-0261_8912357d-0ea4-4b1e-9713-0c8ffe838cc5	70000-0261	HUMAN OTC DRUG	Leader Childrens Mucus Relief		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20170322		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0262_5bb4c9b8-d744-4c29-bb3f-88f494c8c1fb	70000-0262	HUMAN OTC DRUG	Leader Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170501		ANDA	ANDA074937	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0263_99e314d3-60e6-4ea9-bd2f-890712aa9f71	70000-0263	HUMAN OTC DRUG	LEADER CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20170328		ANDA	ANDA074937	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0264_b1912c88-6233-401a-a321-4340809fa5ae	70000-0264	HUMAN OTC DRUG	leader Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170405		ANDA	ANDA074937	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0268_08171e41-8db3-67c3-e063-6394a90a0c12	70000-0268	HUMAN OTC DRUG	Menthol Cough Drop		Menthol	LOZENGE	ORAL	20170307		OTC MONOGRAPH DRUG	M012	Cardinal Health	MENTHOL	5.4	mg/1			N	20241231
70000-0270_0a9dba46-110e-1751-e063-6394a90a70ac	70000-0270	HUMAN OTC DRUG	Leader Sinus Wash Saline Refill Packets		SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20130401		UNAPPROVED DRUG OTHER		Cardinal Health, 110 dba LEADER	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3g; mg/3g	Alkalinizing Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
70000-0277_f55a916e-830a-472f-9761-8ae37ccc9eee	70000-0277	HUMAN OTC DRUG	Sore Throat Relief	Cherry	Phenol	SPRAY	ORAL	20170331	20241231	OTC MONOGRAPH NOT FINAL	part356	Cardinal Health (Leader) 70000	PHENOL	1.4	g/100mL			N	
70000-0278_91f1d137-4c13-4150-bc73-71bf16388295	70000-0278	HUMAN OTC DRUG	Mucus Relief DM Cough	Maximum Strength	Dextromethorphan HBr and Guaifenesin	TABLET, FILM COATED	ORAL	20051231		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0284_9613ef5d-8ed3-4f94-aa11-1023b6c3e3f3	70000-0284	HUMAN OTC DRUG	Leader Mucus Relief Cold Flu and Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20170706		OTC MONOGRAPH FINAL	part341	Cardinal Health	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0289_7de51b59-e452-4202-999a-0364af99050c	70000-0289	HUMAN OTC DRUG	Severe Cold and Flu	Maximum Strength, Daytime, Non-Drowsy	Acetaminophen. Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20140227	20250131	OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
70000-0290_0817588e-1acb-24e3-e063-6394a90ac6ba	70000-0290	HUMAN OTC DRUG	SF Cherry Cough Drop		Menthol	LOZENGE	ORAL	20170307		OTC MONOGRAPH DRUG	M012	Cardinal Health	MENTHOL	5.8	mg/1			N	20241231
70000-0291_a5b6fae3-7c66-4914-9848-64e9b5138d79	70000-0291	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19990301		ANDA	ANDA075139	Cardinal Health 110, LLC. DBA Leader	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0298_c977d929-8c86-49a2-a0a0-907c399bffc6	70000-0298	HUMAN OTC DRUG	leader infants ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20170607		ANDA	ANDA075217	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0299_14189b6e-33d2-4be9-906c-002ce1c12c4f	70000-0299	HUMAN OTC DRUG	Leader Tussin		Guaifenesin	SOLUTION	ORAL	20170606		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	GUAIFENESIN	200	mg/10mL			N	20241231
70000-0301_65ac435d-daa3-4fe3-8a18-69cc6776929b	70000-0301	HUMAN OTC DRUG	leader tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20170721		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0302_705b6716-957d-40f2-b881-8fd36f0ea549	70000-0302	HUMAN OTC DRUG	Leader Cough	DM	dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20170606		ANDA	ANDA091135	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0306_da4f44f4-a384-4d41-9a0b-d2aad94db013	70000-0306	HUMAN OTC DRUG	Leader 8 HR Muscle Aches and Pain		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170505		ANDA	ANDA075077	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	650	mg/1			N	20241231
70000-0308_d7f8632e-0b5b-495f-85f0-15ee9742fc40	70000-0308	HUMAN OTC DRUG	leader ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20170601		ANDA	ANDA077349	Cardinal Health 110, LLC. dba Leader	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0309_28eefc42-57cb-449b-bedb-5ee2ff2744a8	70000-0309	HUMAN OTC DRUG	Chewable Acetaminophen	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050128		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN	160	mg/1			N	20241231
70000-0310_1bab2a2c-91d0-46d3-b298-ee9bd73b7ec5	70000-0310	HUMAN OTC DRUG	Chewable Acetaminophen	Childrens	Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN	160	mg/1			N	20241231
70000-0312_b3e52dba-1c80-4e30-a4fa-2444840f8f42	70000-0312	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20040510		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN	500	mg/1			N	20241231
70000-0313_96048177-9113-4f78-b3a9-8a54e96f5a60	70000-0313	HUMAN OTC DRUG	Leader Tussin CF		Acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20170605		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0319_f5f1eacd-cb94-4b4e-8a8f-097eeee3bf2f	70000-0319	HUMAN OTC DRUG	Leader Tussin DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20171101		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0321_0a1f97b8-390a-bdf0-e063-6394a90aafe0	70000-0321	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20171020		OTC MONOGRAPH DRUG	M005	Cardinal Health	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70000-0322_0a1f98bc-1f97-a898-e063-6294a90af5c7	70000-0322	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray - Talc Free	AEROSOL, SPRAY	TOPICAL	20171020		OTC MONOGRAPH DRUG	M005	LEADER/ Cardinal Health 110, Inc.	TOLNAFTATE	1.3	g/130g			N	20241231
70000-0323_0a1fa998-dcd1-c181-e063-6294a90ad098	70000-0323	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20171020		OTC MONOGRAPH DRUG	M005	LEADER/ Cardinal Health 110, Inc.	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70000-0324_529c5a30-d32d-4bef-aa8c-c054693d809b	70000-0324	HUMAN OTC DRUG	Cough and Cold HBP		Chlorpheniramine maleate, Dextromethorphan HBr	TABLET, FILM COATED	ORAL	20170515		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	4; 30	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0325_d60b4ba3-0528-8221-e053-2a95a90ae68e	70000-0325	HUMAN OTC DRUG	Cardinal Health Leader	SPF 50 Kids Sunscreen Clear Continuous	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180220		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0326_65b0fc20-7257-5319-e053-2a91aa0a3f5c	70000-0326	HUMAN OTC DRUG	Cardinal Health Leader	SPF 70 General Protection Sunscreen Clear Continuous	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180220		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0327_65ae16df-411e-213c-e053-2a91aa0ad3d2	70000-0327	HUMAN OTC DRUG	Cardinal Health Leader	SPF 30 General Protection Sunscreen Clear Continuous	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180220		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0328_d569d6e3-ede9-17c1-e053-2a95a90a4951	70000-0328	HUMAN OTC DRUG	Cardinal Health Leader	SPF 30 Sport Sunscreen Clear Continuous	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180220		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
70000-0329_0a1f677f-a24a-8ef4-e063-6294a90a5f72	70000-0329	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20180209		OTC MONOGRAPH DRUG	M028	LEADER/ Cardinal Health 110, Inc.	SALICYLIC ACID	17	g/100mL			N	20241231
70000-0330_0a1f49d4-a5f9-a666-e063-6394a90a16c0	70000-0330	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20180221		OTC MONOGRAPH DRUG	M030	LEADER/ Cardinal Health 110, Inc.	SALICYLIC ACID	400	mg/g			N	20241231
70000-0331_0c660bfc-a377-f907-e063-6294a90abd4a	70000-0331	HUMAN OTC DRUG	Salicylic Acid		One Step Clear Wart Remover	PATCH	TOPICAL	20171229	20240331	OTC MONOGRAPH DRUG	M028	LEADER/ Cardinal Health 110, Inc.	SALICYLIC ACID	40	mg/141			N	
70000-0332_0a1f677f-a249-8ef4-e063-6294a90a5f72	70000-0332	HUMAN OTC DRUG	Salicylic Acid		Liquid Corn and Callus Remover	LIQUID	TOPICAL	20180202		OTC MONOGRAPH DRUG	M030	LEADER/ Cardinal Health 110, Inc.	SALICYLIC ACID	17	g/100mL			N	20241231
70000-0333_0a1f38b6-4e1c-9ba9-e063-6394a90ac482	70000-0333	HUMAN OTC DRUG	Salicylic Acid		Medicated Callus Removers	PATCH	TOPICAL	20180221		OTC MONOGRAPH DRUG	M030	LEADER/ Cardinal Health 110, Inc.	SALICYLIC ACID	400	mg/g			N	20241231
70000-0334_6a6c2b6c-078c-4816-a9bc-1e03130793cf	70000-0334	HUMAN OTC DRUG	Leader Zinc Oxide		Zinc Oxide	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH FINAL	part347	Cardinal Health 110,Inc.	ZINC OXIDE	200	mg/g			N	20241231
70000-0338_2d2e23c4-e450-485f-aa1a-17f160d979e3	70000-0338	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20180730		ANDA	ANDA077511	Cardinal Health, 110 dba LEADER	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
70000-0341_0d78ef05-d996-4dc3-b144-2b8c4ced1c0a	70000-0341	HUMAN OTC DRUG	Nicotine Polacrilex	Original	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA074707	Cardinal Health (Leader) 70000	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0342_858e3dac-68bd-46dc-a8df-9fee1ad46489	70000-0342	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Fruit	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA079038	Cardinal Health (Leader) 70000	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0343_01df7772-0b7e-4b23-97eb-31611854af8b	70000-0343	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA078697	Cardinal Health (Leader) 70000	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0344_cc1147b6-8d4f-4692-925a-a1e3574c00c7	70000-0344	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Ice Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA204833	Cardinal Health (Leader) 70000	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0345_0d78ef05-d996-4dc3-b144-2b8c4ced1c0a	70000-0345	HUMAN OTC DRUG	Nicotine Polacrilex	Original	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA074507	Cardinal Health (Leader) 70000	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0346_858e3dac-68bd-46dc-a8df-9fee1ad46489	70000-0346	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Fruit	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA079044	Cardinal Health (Leader) 70000	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0347_01df7772-0b7e-4b23-97eb-31611854af8b	70000-0347	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA078699	Cardinal Health (Leader) 70000	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0348_cc1147b6-8d4f-4692-925a-a1e3574c00c7	70000-0348	HUMAN OTC DRUG	Nicotine Polacrilex	Coated Ice Mint	Nicotine Polacrilex	GUM, CHEWING	BUCCAL	20180703		ANDA	ANDA204794	Cardinal Health (Leader) 70000	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0350_d6ac3b90-c324-49a7-979d-0b0ed7f54ba4	70000-0350	HUMAN OTC DRUG	leader nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20180417		ANDA	ANDA077007	Cardinal Health 110, LLC. dba Leader	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0352_cdc419bf-c092-420f-874f-c3cc49071f21	70000-0352	HUMAN OTC DRUG	leader lubricating plus		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20180417		OTC MONOGRAPH FINAL	part349	Cardinal Health	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
70000-0357_07e94be0-0bcc-4f3a-a57d-b40d5f82846b	70000-0357	HUMAN OTC DRUG	Leader Ticonazole		Tioconazole	OINTMENT	VAGINAL	20180420		ANDA	ANDA075915	Cardinal Health 110, LLC. dba Leader	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70000-0358_0b3d6c4b-b0e9-9d01-e063-6394a90ac03e	70000-0358	HUMAN OTC DRUG	LDR Vitamans A and D		Vitamins A and D Ointment	OINTMENT	TOPICAL	20181005		OTC MONOGRAPH DRUG	M016	Cardinal Health	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
70000-0360_4ac32c62-c5e5-44ee-87e8-6e69b9422817	70000-0360	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180228		ANDA	ANDA206568	Cardinal Health (Leader) 70000	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0361_069eb55b-d2f0-1a2e-5ad8-ef68f7501c26	70000-0361	HUMAN OTC DRUG	24HR Allergy Relief		Fexofenadine hydrochloride	TABLET	ORAL	20180427		ANDA	ANDA076502	LEADER/ Cardinal Health 110, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0362_10a7d6bf-835e-7003-a8ea-44e297365dd8	70000-0362	HUMAN OTC DRUG	24HR Allergy Relief		levocetirizine dihydrochloride	TABLET, COATED	ORAL	20180312		ANDA	ANDA210375	LEADER/ Cardinal Health 110, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0363_0993a2d5-6d02-678d-e063-6394a90a2ac5	70000-0363	HUMAN OTC DRUG	EXTRA STRENGTH HEARTBURN RELIEF		aluminum hydroxide and magnesium carbonate	SUSPENSION	ORAL	20190101		OTC MONOGRAPH DRUG	M001	CARDINAL HEALTH	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	254; 237.5	mg/5mL; mg/5mL			N	20241231
70000-0364_eea0fefa-4a58-2f0f-e053-2a95a90a58b6	70000-0364	HUMAN OTC DRUG	Medicated Hemorrhoidal Pads		WITCH HAZEL	CLOTH	TOPICAL	20190213		OTC MONOGRAPH FINAL	part346	Cardinal Health	WITCH HAZEL	500	mg/mL			N	20241231
70000-0365_ecfb6a9c-4f35-442e-ae23-80c8eae05687	70000-0365	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180630		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health (Leader) 70000	DOCUSATE SODIUM	100	mg/1			N	20241231
70000-0366_f2030d89-1514-cec9-e053-2a95a90ab8c3	70000-0366	HUMAN OTC DRUG	Leader PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0367_f202f8b0-d570-9117-e053-2a95a90a97bf	70000-0367	HUMAN OTC DRUG	Extra Strength Cold-Hot Medicated Patches		MENTHOL	PATCH	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	MENTHOL	5	g/1			N	20241231
70000-0368_f202f8b0-d56f-9117-e053-2a95a90a97bf	70000-0368	HUMAN OTC DRUG	Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20190301		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
70000-0372_e61d17e0-8113-4c17-8628-a8e38d22312b	70000-0372	HUMAN OTC DRUG	Leader Mucus DM		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180507		ANDA	ANDA207602	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0373_7926415e-e0c7-4376-b60c-76c0fb0e1e62	70000-0373	HUMAN OTC DRUG	leader Acetaminophen		Acetaminophen	TABLET	ORAL	20180813		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	500	mg/1			N	20241231
70000-0374_e24db952-2536-4334-a443-5f48bd06ddf3	70000-0374	HUMAN OTC DRUG	leader acetaminophen		Acetaminophen	TABLET	ORAL	20180822		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	325	mg/1			N	20241231
70000-0380_f33da0d4-21e4-4c75-8bea-2e5f72a6b817	70000-0380	HUMAN OTC DRUG	leader all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20180813		ANDA	ANDA078336	Cardinal Health 110, LLC. dba Leader	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0381_487374b4-a751-46cc-bc58-6e2dc8589846	70000-0381	HUMAN OTC DRUG	Leader Omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20180820		NDA	NDA209400	Cardinal Health 110, LLC. dba Leader	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70000-0382_77e44ebd-2e4a-4054-b297-1975a1974c56	70000-0382	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20180930	20241231	OTC MONOGRAPH DRUG	M016	Cardinal Health (Leader) 70000	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	
70000-0383_b56c659e-47c3-4019-bbc1-54a1f98015dd	70000-0383	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20181109	20241227	OTC MONOGRAPH FINAL	part332	Cardinal Health (Leader) 70000	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
70000-0385_32ff80d2-03b1-40ca-8dfd-ae57227f0f58	70000-0385	HUMAN OTC DRUG	Stool Softener	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20180930	20241227	OTC MONOGRAPH NOT FINAL	part334	Cardinal Health (Leader) 70000	DOCUSATE SODIUM	250	mg/1			N	
70000-0386_8c27b71b-96b5-496a-9378-ee50010446ba	70000-0386	HUMAN OTC DRUG	Laxative Pills	Maximum Strength	Sennosides	TABLET	ORAL	20181109		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health (Leader) 70000	SENNOSIDES	25	mg/1			N	20241231
70000-0387_6d329a7c-032d-44ef-b786-8d36ec984d92	70000-0387	HUMAN OTC DRUG	LEADER TUSSIN DM COUGH PLUS CHEST CONGESTION DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20180820		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0388_115d6d67-ce3b-4747-beef-686b6cd30add	70000-0388	HUMAN OTC DRUG	leader anti itch		Diphenhydramine Hydrochloride, Zinc Acetate	CREAM	TOPICAL	20181213		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health 110, LLC. dba Leader	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0390_2fb4e4f2-a5cc-4a7c-9239-ece2c46a8ac0	70000-0390	HUMAN OTC DRUG	leader triple antibiotic and pain relief		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20181213		OTC MONOGRAPH FINAL	part333B	Cardinal Health 110, LLC. dba Leader	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70000-0391_95a93920-4632-480d-8328-2a7d7c7769ee	70000-0391	HUMAN OTC DRUG	Zinc Cold Therapy		ZINC GLUCONATE	TABLET	ORAL	20180510		UNAPPROVED HOMEOPATHIC		CARDINAL HEALTH	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70000-0396_0d197bc5-3780-1794-e063-6294a90a4123	70000-0396	HUMAN OTC DRUG	LEADER Camphor Spirit		Camphor (natural)	LIQUID	TOPICAL	20181217		OTC MONOGRAPH DRUG	M017	Cardinal Health, 110 dba Leader	CAMPHOR (NATURAL)	100	mg/mL			N	20241231
70000-0400_0d1994b2-3c1b-6322-e063-6394a90a1b6c	70000-0400	HUMAN OTC DRUG	Leader Calamine Plus		zinc oxide lotion	LOTION	TOPICAL	20190215		OTC MONOGRAPH DRUG	M016	Cardinal Health, 110 dba Leader	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70000-0404_d114a2fc-8171-0aeb-e053-2a95a90a743e	70000-0404	HUMAN OTC DRUG	Dimenhydrinate		Dimenhydrinate	TABLET	ORAL	20190104		OTC MONOGRAPH FINAL	part336	Cardinal Health	DIMENHYDRINATE	50	mg/1			N	20241231
70000-0407_092d7b7d-c5a4-6e45-e063-6394a90ab8e3	70000-0407	HUMAN OTC DRUG	Antiseptic Skin Cleanser		Chlorhexidine Gluconate	LIQUID	TOPICAL	20120101		NDA	NDA019125	Cardinal Health	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
70000-0408_c6a39b7d-295e-bd32-e053-2995a90a4893	70000-0408	HUMAN OTC DRUG	CARDINAL HEALTH LEADER SPF 50 General Protection Sunscreen		avobenzone,homosalate, octisalate, octocrylene, oxybenzone.	LOTION	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70000-0409_c4fcfd23-b004-55f8-e053-2a95a90a9532	70000-0409	HUMAN OTC DRUG	Caffeine		Caffeine	TABLET	ORAL	20190405		OTC MONOGRAPH FINAL	part340	Cardinal Health	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
70000-0410_c4fd0858-6115-0db0-e053-2a95a90ac8d9	70000-0410	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20181105		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health	ACETAMINOPHEN	500	mg/1			N	20241231
70000-0411_c4fcd8bc-0bb6-c0a3-e053-2995a90a8b49	70000-0411	HUMAN OTC DRUG	Acetaminophen, Diphenhydramine Hydrochloride		Acetaminophen, Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20181129		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0415_abf92abe-b5f3-4925-823f-5b28d0b15253	70000-0415	HUMAN OTC DRUG	leader clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20181227		ANDA	ANDA090685	Cardinal Health 110, LLC. dba Leader	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0416_65c3304d-fd1b-4ea5-b96b-9f69197a4ea8	70000-0416	HUMAN OTC DRUG	leader acid reducer complete		Famotidine, Calcium Carbonate, Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20180928		ANDA	ANDA077355	Cardinal Health 110, LLC. dba Leader	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0417_a947c813-d7d7-4a60-8ace-2a10d0832d60	70000-0417	HUMAN OTC DRUG	leader anti diarrheal		loperamide HCl	SOLUTION	ORAL	20180716		ANDA	ANDA091292	Cardinal Health 110, LLC. dba Leader	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70000-0418_c8ab3cf1-fd82-474b-80e1-1eb9bc522206	70000-0418	HUMAN OTC DRUG	leader anti diarrheal		Loperamide HCl	SUSPENSION	ORAL	20180813		ANDA	ANDA091292	Cardinal Health 110, LLC. dba Leader	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70000-0419_54c56bbd-266e-4a90-b519-9662bbd0b04a	70000-0419	HUMAN OTC DRUG	leader aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20180813		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0420_371e2947-1081-49e7-b394-09ae44afb701	70000-0420	HUMAN OTC DRUG	leader aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20180813		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0421_ef6c032d-7808-d552-e053-2a95a90a84dc	70000-0421	HUMAN OTC DRUG	Leader Effervescent Antacid and Pain Relief		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20190410	20241231	OTC MONOGRAPH FINAL	part343	Cardinal Health	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
70000-0422_09939b31-cbee-6536-e063-6394a90ae969	70000-0422	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	20190101		OTC MONOGRAPH DRUG	M001	CARDINAL HEALTH	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0424_aa703d3b-8fb7-48b3-9689-bbd024b326db	70000-0424	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health110 dba Leader	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0425_0884bc8d-70d0-80db-e063-6294a90a6582	70000-0425	HUMAN OTC DRUG	Hemorrhoidal Cream		Glycerin, Phenylephrine Hydrochloride, Pramoxine Hydrochloride, White Petrolatum	CREAM	TOPICAL	20201230		OTC MONOGRAPH DRUG	M015	Cardinal Health 110, LLC. dba Leader	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	4.032; 4.2; .07; .28	g/28g; g/28g; g/28g; g/28g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0426_7037c4af-6235-4973-bf91-2fcd4ac55596	70000-0426	HUMAN OTC DRUG	Nighttime Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20190228	20241227	OTC MONOGRAPH FINAL	part338	Cardinal Health (Leader) 70000	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70000-0427_236933cb-e9d5-4230-a4f1-c0ab76d5bc6d	70000-0427	HUMAN OTC DRUG	NightTime Cold and Flu	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20181201	20241227	OTC MONOGRAPH FINAL	part341	Cardinal Health (Leader) 70000	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
70000-0429_0c002c9f-ad8c-6cba-e063-6294a90a5295	70000-0429	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20190102		OTC MONOGRAPH DRUG	M007	Cardinal Health	GLYCERIN	1	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70000-0430_330f85cb-99db-4b19-acd1-cf5d77c41b8d	70000-0430	HUMAN OTC DRUG	Leader Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190710		OTC MONOGRAPH FINAL	part331	CARDINAL HEALTH 110, LLC. DBA LEADER	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70000-0431_cd0ebfdf-92db-4b86-ab32-77d00f643c96	70000-0431	HUMAN OTC DRUG	Leader Extra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190717		OTC MONOGRAPH FINAL	part331	CARDINAL HEALTH 110, LLC. DBA LEADER	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70000-0434_45569495-dac6-44ea-b3bb-f3f18000e734	70000-0434	HUMAN OTC DRUG	Leader Gas relief		Simethicone	TABLET, CHEWABLE	ORAL	20190607		OTC MONOGRAPH FINAL	part332	CARDINAL HEALTH 110, LLC. DBA LEADER	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
70000-0436_89423db3-9c88-42f2-9bcf-0968d0d0085d	70000-0436	HUMAN OTC DRUG	Leader Ultra Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190710		OTC MONOGRAPH FINAL	part331	CARDINAL HEALTH 110, LLC. DBA LEADER	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70000-0441_0bdcf009-4ddc-e3d1-e063-6394a90ace29	70000-0441	HUMAN OTC DRUG	SENNA		SENNOSIDES	CAPSULE, GELATIN COATED	ORAL	20181226		OTC MONOGRAPH DRUG	M007	Cardinal Health	SENNOSIDES	8.6	mg/1			N	20241231
70000-0442_0bdd371a-6c4d-f363-e063-6394a90a7f7a	70000-0442	HUMAN OTC DRUG	STOOL SOFTENER AND STIMULANT LAXATIVE		DOCUSATE SODIUM AND SENNOSIDES	CAPSULE, GELATIN COATED	ORAL	20190130		OTC MONOGRAPH DRUG	M007	Cardinal Health	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
70000-0443_65db726f-5ce2-4e21-b6b0-74f409300667	70000-0443	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, SUGAR COATED	ORAL	20190301		OTC MONOGRAPH DRUG	505G(a)(3)	Cardinal Health 110, LLC. DBA Leader	SENNOSIDES	15	mg/1			N	20241231
70000-0445_0bdd2b40-8b6a-f0fa-e063-6394a90a1ecf	70000-0445	HUMAN OTC DRUG	Senna Plus		Docusate Sodium, 50 mg Sennosides, 8.6 mg	CAPSULE, GELATIN COATED	ORAL	20190115		OTC MONOGRAPH DRUG	M007	Cardinal Health	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
70000-0447_c4fce82a-fcad-3682-e053-2995a90a89c8	70000-0447	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, FILM COATED	ORAL	20181114		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	SENNOSIDES	8.6	mg/1			N	20241231
70000-0448_0d19a0a5-ed0d-1796-e063-6294a90a7e8f	70000-0448	HUMAN OTC DRUG	LEADER Mineral Oil		Mineral Oil	LIQUID	ORAL	20181218		OTC MONOGRAPH DRUG	M007	Cardinal Health, 110 dba Leader	MINERAL OIL	1000	mg/mL			N	20241231
70000-0449_609aad0c-e36d-4fa1-8ab5-bfd23965ffc7	70000-0449	HUMAN OTC DRUG	leader nausea relief		Dextrose (glucose), Levulose (fructose), Phosphoric Acid	SOLUTION	ORAL	20181127		UNAPPROVED DRUG OTHER		Cardinal Health 110, LLC. dba Leader	DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID	1.87; 1.87; 21.5	g/5mL; g/5mL; mg/5mL			N	20241231
70000-0451_f20158fa-62a0-1513-e053-2995a90a4104	70000-0451	HUMAN OTC DRUG	Leader Gentle Laxative		Bisacodyl Suppository	SUPPOSITORY	RECTAL	20190123		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health, 110 dba LEADER	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0451_f2658039-a515-1dff-e053-2995a90a63ba	70000-0451	HUMAN OTC DRUG	Leader Gentle Laxative		Bisacodyl Suppository	SUPPOSITORY	RECTAL	20190124		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health, 110 dba LEADER	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0454_0d37dad1-2199-7c25-e063-6394a90a7eb7	70000-0454	HUMAN OTC DRUG	Leader Original Eye Drops		Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20190219		OTC MONOGRAPH DRUG	M018	Cardinal Health	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
70000-0455_0d37718d-85dc-696a-e063-6394a90a291e	70000-0455	HUMAN OTC DRUG	Leader Long Lasting Lubricant Eye Drops		Polyethylene glycol 400, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190219		OTC MONOGRAPH DRUG	M018	Cardinal Health	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
70000-0456_0d37dad1-219a-7c25-e063-6394a90a7eb7	70000-0456	HUMAN OTC DRUG	Leader Advanced Relief Eye Drops		DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCl	SOLUTION/ DROPS	OPHTHALMIC	20190219		OTC MONOGRAPH DRUG	M018	Cardinal Health	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE; TETRAHYDROZOLINE HYDROCHLORIDE	100; 1000; 1000; 50	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
70000-0457_0d37f259-8846-1554-e063-6294a90a639a	70000-0457	HUMAN OTC DRUG	Leader Ultra Lubricating Eye Drops		Polyethylene glycol 400, propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20190219		OTC MONOGRAPH DRUG	M018	Cardinal Health	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
70000-0458_746083ad-7f0d-4e3c-9489-cbb4bccad091	70000-0458	HUMAN OTC DRUG	Sore Throat Relief	Cherry Flavor	Phenol	SPRAY	ORAL	20190212		OTC MONOGRAPH NOT FINAL	part356	Cardinal Health	PHENOL	1.4	g/100mL			N	20241231
70000-0459_13e26627-3ae0-43b5-ac89-b4910083a32c	70000-0459	HUMAN OTC DRUG	LEADER Ultra Strength	Peppermint Flavor	Chewable Antacid Tablets	TABLET, CHEWABLE	ORAL	20181218		OTC MONOGRAPH FINAL	part331	Cardinal Health	CALCIUM CARBONATE	1000	mg/1			N	20241231
70000-0460_fa3e4525-9ebf-4038-bfc8-888bae5fe2fe	70000-0460	HUMAN OTC DRUG	Leader Extra Strength Sugar Free Antacid		Antacid	TABLET, CHEWABLE	ORAL	20190204		OTC MONOGRAPH FINAL	part331	Cardinal Health	CALCIUM CARBONATE	750	mg/1			N	20241231
70000-0461_df632120-a1f3-1513-e053-2a95a90a9bfd	70000-0461	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20190121		NDA	NDA021855	CARDINAL HEALTH	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70000-0463_79296621-e708-413b-a30c-aa1b018e4f29	70000-0463	HUMAN OTC DRUG	DayTime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl	CAPSULE, LIQUID FILLED	ORAL	20181231	20241227	OTC MONOGRAPH FINAL	part341	Cardinal Health (Leader) 70000	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
70000-0464_55dad94f-71e8-4e1e-bd70-520033e6d8cd	70000-0464	HUMAN OTC DRUG	Mucus Relief DM Extended Release Caplets		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20181231		ANDA	ANDA209692	Cardinal Health (Leader) 70000	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0467_c03e7e53-70fb-4baa-a4ec-5865acb7a6ac	70000-0467	HUMAN OTC DRUG	leader sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20190225		OTC MONOGRAPH FINAL	part338	Cardinal Health 110, LLC. dba Leader	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0469_0b3a868e-3889-cbec-e063-6294a90ab15c	70000-0469	HUMAN OTC DRUG	Zinc Oxide 40%		Diaper Rash Skin Protectent	OINTMENT	TOPICAL	20190130		OTC MONOGRAPH DRUG	M016	Cardinal Health	ZINC OXIDE	40	g/100g			N	20241231
70000-0472_1f3eb8f8-a02a-48b7-9b8c-0811f0a29331	70000-0472	HUMAN OTC DRUG	leader infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20190312		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	160	mg/5mL			N	20241231
70000-0473_dcec05fa-b447-436b-ac94-01c75b950693	70000-0473	HUMAN OTC DRUG	leader childrens allergy relief		Loratadine	SOLUTION	ORAL	20200123		ANDA	ANDA075728	Cardinal Health 110, LLC. dba Leader	LORATADINE	5	mg/5mL			N	20241231
70000-0474_85e232bd-910c-4d4a-b055-4c7442cdd381	70000-0474	HUMAN OTC DRUG	leader childrens allergy relief		Diphenhydramine HCl	SOLUTION	ORAL	20191204		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0475_eaa94c7a-a0d3-4a1d-bb3c-aacf5b7dd3af	70000-0475	HUMAN OTC DRUG	leader 12 hour nasal decongestant		Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190211		ANDA	ANDA075153	Cardinal Health 110, LLC. dba Leader	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0477_f03bf333-9d19-47ba-b6e3-82c9c42811bf	70000-0477	HUMAN OTC DRUG	Leader Regular Strength Chocolate Laxative sennosides		sennosides	TABLET	ORAL	20190101		OTC MONOGRAPH NOT FINAL	part334	CARDINAL HEALTH	SENNOSIDES	15	mg/1			N	20241231
70000-0478_0d19b149-c1b1-5180-e063-6394a90ad905	70000-0478	HUMAN OTC DRUG	LEADER Ear Drops for Swimmers		LEADER Ear Drops for Swimmers	LIQUID	AURICULAR (OTIC)	20190424		OTC MONOGRAPH DRUG	M014	Cardinal Health, 110 dba Leader	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
70000-0479_5a6297be-3167-4cd2-80c7-b1a62fdbce54	70000-0479	HUMAN OTC DRUG	Mucus Relief Extended Release	Maximum Strength	Guaifenesin	TABLET	ORAL	20190131		ANDA	ANDA207342	Cardinal Health (Leader) 70000	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70000-0480_f1ffb392-34de-1049-e053-2a95a90a9c90	70000-0480	HUMAN OTC DRUG	Medicated Chest Rub		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20190128		OTC MONOGRAPH FINAL	part341	Cardinal Health, 110 dba LEADER	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
70000-0481_c48e9535-0df0-4922-b09e-5ba84ba1ee60	70000-0481	HUMAN OTC DRUG	leader childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20190225		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	160	mg/5mL			N	20241231
70000-0485_0b3b966c-0170-7a02-e063-6394a90ad97e	70000-0485	HUMAN OTC DRUG	Hydrocortisone		Anti-pruritic	CREAM	TOPICAL	20190118		OTC MONOGRAPH DRUG	M017	Cardinal Health	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70000-0487_0b50d52f-528c-628c-e063-6294a90aca2d	70000-0487	HUMAN OTC DRUG	White Petrolatum		Skin Protectant	OINTMENT	TOPICAL	20190124		OTC MONOGRAPH DRUG	M016	Cardinal Health	PETROLATUM	1	g/g			N	20241231
70000-0487_0b50e93d-8533-9c39-e063-6294a90a7783	70000-0487	HUMAN OTC DRUG	White Petrolatum		Skin Protectant	OINTMENT	TOPICAL	20210215		OTC MONOGRAPH DRUG	M016	Cardinal Health	PETROLATUM	100	g/100g			N	20241231
70000-0488_0b3a8cc1-a49a-e1e5-e063-6394a90a1c06	70000-0488	HUMAN OTC DRUG	Skin Protectant		Zinc Oxide 25%	OINTMENT	TOPICAL	20190116		OTC MONOGRAPH DRUG	M016	Cardinal Health	ZINC OXIDE	25	mg/100mg			N	20241231
70000-0489_0b3d5569-03f7-6e0f-e063-6294a90ad872	70000-0489	HUMAN OTC DRUG	Hydrocortisone		Anti-Itch	OINTMENT	TOPICAL	20190201		OTC MONOGRAPH DRUG	M017	Cardinal Health	HYDROCORTISONE ACETATE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70000-0490_0d1c6332-5e35-680c-e063-6394a90a70bd	70000-0490	HUMAN OTC DRUG	LEADER Earwax Removal Kit		carbamide peroxide 6.50% kit	LIQUID	AURICULAR (OTIC)	20190506		OTC MONOGRAPH DRUG	M014	Cardinal Health, 110 dba Leader	CARBAMIDE PEROXIDE	6.5	g/100mL			N	20241231
70000-0491_652a4e99-837b-443e-869e-b689d6505585	70000-0491	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20190131		ANDA	ANDA209692	Cardinal Health (Leader) 70000	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0492_3a79fdf6-9c5e-4a15-a35a-50ba8d02fec4	70000-0492	HUMAN OTC DRUG	Allergy Relief	Childrens Allergy	Diphenhydramine Hydrochloride	LIQUID	ORAL	20190228		OTC MONOGRAPH FINAL	part341	Cardinal Health (Leader) 70000	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0493_270881c1-63da-41eb-994d-9905abc1859d	70000-0493	HUMAN OTC DRUG	Athletes Foot		CLOTRIMAZOLE	CREAM	TOPICAL	20190515		OTC MONOGRAPH FINAL	part333C	Cardinal Health 110,Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70000-0494_d2bf5f45-dbfc-4550-92a4-eac31c7c0d57	70000-0494	HUMAN OTC DRUG	Tolnaftate		TOLNAFTATE	CREAM	TOPICAL	20190515		OTC MONOGRAPH FINAL	part333C	Cardinal Health 110,Inc.	TOLNAFTATE	10	mg/g			N	20241231
70000-0496_f3287b3d-8323-4209-b9e1-1dccfb9828a3	70000-0496	HUMAN OTC DRUG	leader childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20190226		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN	160	mg/5mL			N	20241231
70000-0497_582ac8f2-e03e-4d90-98b2-d2c26dba8b3b	70000-0497	HUMAN OTC DRUG	Isopropyl alcohol	70 percent	Isopropyl alcohol	LIQUID	TOPICAL	20190419		OTC MONOGRAPH DRUG	M003	Cardinal Health (Leader) 70000	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
70000-0498_0be8da64-465c-4ce8-8df6-f3e86eedce5d	70000-0498	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol	91 percent	Isopropyl alcohol	LIQUID	TOPICAL	20190419		OTC MONOGRAPH DRUG	M003	Cardinal Health (Leader) 70000	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
70000-0499_c5107786-3856-4657-ba4f-107d634041c9	70000-0499	HUMAN OTC DRUG	Isopropyl alcohol Wintergreen	70 percent Wintergreen	Isopropyl alcohol	LIQUID	TOPICAL	20190419	20241231	OTC MONOGRAPH DRUG	M003	Cardinal Health (Leader) 70000	ISOPROPYL ALCOHOL	70	mL/100mL			N	
70000-0500_8f01e30e-b867-4d6f-b248-13ce6e17fcf5	70000-0500	HUMAN OTC DRUG	Hydrogen Peroxide	3 Percent	Hydrogen Peroxide	LIQUID	TOPICAL	20190228		OTC MONOGRAPH DRUG	M022	Cardinal Health (Leader) 70000	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
70000-0501_efe4c0c1-9b77-9339-e053-2995a90abe37	70000-0501	HUMAN OTC DRUG	Leader Preservative-Free Ultra Lubricating Eye Drops		Polyethylene glycol, propylene glycol	LIQUID	OPHTHALMIC	20190430		OTC MONOGRAPH FINAL	part349	Cardinal Health	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
70000-0502_0d378048-39d6-421b-e063-6294a90ac848	70000-0502	HUMAN OTC DRUG	Leader Dry Eye Relief Eye Drops		Glycerin, Hypromellose, Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20190430		OTC MONOGRAPH DRUG	M018	Cardinal Health	GLYCERIN; HYPROMELLOSE, UNSPECIFIED; POLYETHYLENE GLYCOL 400	.2; .2; 1	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70000-0504_ae900734-0351-4a74-98a0-4af543e1882d	70000-0504	HUMAN OTC DRUG	Leader Allergy Relief D12		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200109		ANDA	ANDA076050	Cardinal Health 110, LLC. dba Leader	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0507_e5dddd55-2980-4ca4-ac54-e5674ddbff32	70000-0507	HUMAN OTC DRUG	leader aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200121		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0508_286ac402-ec14-4285-a56c-06ae757d37f9	70000-0508	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190731	20241231	ANDA	ANDA203187	Cardinal Health (Leader) 70000	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
70000-0509_0bb70789-af21-4ff0-e063-6394a90acdfc	70000-0509	HUMAN OTC DRUG	Leader Extra Strength Acetaminophen		ACETAMINOPHEN	CAPSULE, LIQUID FILLED	ORAL	20190710		OTC MONOGRAPH DRUG	M013	Cardinal Health	ACETAMINOPHEN	500	mg/1			N	20241231
70000-0510_005c2190-a0a4-1581-e063-6394a90a2e1b	70000-0510	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190719		ANDA	ANDA074612	Cardinal Health	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0511_005c2190-a0a4-1581-e063-6394a90a2e1b	70000-0511	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190719		ANDA	ANDA074612	Cardinal Health	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0512_005c2190-a0a4-1581-e063-6394a90a2e1b	70000-0512	HUMAN OTC DRUG	Nicotine Transdermal System		Nicotine Transdermal System	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190719		ANDA	ANDA074612	Cardinal Health	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0514_8305d25b-d840-37cc-3a06-70421d4fca76	70000-0514	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, GELATIN COATED	ORAL	20190724	20240930	OTC MONOGRAPH FINAL	part332	Cardinal Health	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	
70000-0515_9d7eef25-78fb-40ae-a2cb-4bee2f13b2ba	70000-0515	HUMAN OTC DRUG	DayTime Cold and Flu	Non Drowsy	ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20190830		OTC MONOGRAPH FINAL	part341	Cardinal Health (Leader) 70000	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0516_bf2ddad9-dcf5-4364-82be-ddb321d14685	70000-0516	HUMAN OTC DRUG	NightTime Cold and Flu	Multi Symptom	ACETAMINOPHEN DEXTROMETHORPHAN HYDROBROMIDE DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190830		OTC MONOGRAPH FINAL	part341	Cardinal Health (Leader) 70000	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0517_07bd4fc5-e4fc-41b0-bb91-909b2fcca0f7	70000-0517	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20190917		ANDA	ANDA208754	Cardinal Health (Leader) 70000	DOCOSANOL	100	mg/g			N	20241231
70000-0518_3e0fb8ba-3cc8-ca0a-94da-62af8d6689aa	70000-0518	HUMAN OTC DRUG	12HR Allergy and Congestion Relief		Fexofenadine HCl and Pseudoephedrine HCI	TABLET, EXTENDED RELEASE	ORAL	20191008		ANDA	ANDA076667	Cardinal Health	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0520_cc53f049-bcf4-4d17-b5b1-47b6061f618a	70000-0520	HUMAN OTC DRUG	Senna Plus		Docusate Sodium 50 mg and Sennosides 8.6 mg	TABLET, FILM COATED	ORAL	20191023		OTC MONOGRAPH NOT FINAL	part334	CARDINAL HEALTH, 110 DBA LEADER	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
70000-0521_231f5194-4f7d-486d-8b54-926777d5260d	70000-0521	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20180606		ANDA	ANDA206877	Cardinal Health	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70000-0522_5f7ef9e0-7c0a-4e3e-b943-e1b47e3e2623	70000-0522	HUMAN OTC DRUG	Eye Itch Relief		ketotifen fumarate	SOLUTION	OPHTHALMIC	20200807		NDA	NDA021996	Cardinal Health	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
70000-0523_92cfa4d4-64ba-44ab-93ea-99d2bf229586	70000-0523	HUMAN OTC DRUG	Leader Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20191010		UNAPPROVED DRUG OTHER		Cardinal Health	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
70000-0525_1cb50ec6-9895-4e74-bf20-93019d965a28	70000-0525	HUMAN OTC DRUG	Severe Cold and Flu		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20191025		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0526_5814ba2a-3485-4aec-b499-cb9e43aa1c08	70000-0526	HUMAN OTC DRUG	Stool Softener plus Stimulant Laxative		Docusate Sodium 50 mg and Sennosides 8.6 mg	TABLET, FILM COATED	ORAL	20191023		OTC MONOGRAPH NOT FINAL	part334	CARDINAL HEALTH, 110 DBA LEADER	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
70000-0527_076a6570-cd2b-4679-87d7-0ff3f7d7f426	70000-0527	HUMAN OTC DRUG	Nighttime Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20191020		OTC MONOGRAPH FINAL	part338	Cardinal Health (Leader) 70000	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0528_18fd20ea-9e63-4930-949b-c5d334dd4b87	70000-0528	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19970615		OTC MONOGRAPH NOT FINAL	part356	Cardinal Health, 110 dba Leader	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70000-0529_1e64d412-0ca8-4631-abce-7c38f6b2a79a	70000-0529	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20191126		OTC MONOGRAPH FINAL	part347	Cardinal Health (Leader) 70000	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
70000-0530_f3fe5ea4-3880-407f-aaa1-3377c8f14c24	70000-0530	HUMAN OTC DRUG	Stool Softener Laxative	Extra Strength	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20191126	20241227	OTC MONOGRAPH NOT FINAL	part334	Cardinal Health (Leader) 70000	DOCUSATE SODIUM	250	mg/1			N	
70000-0531_e122849f-e03f-4efd-9355-0d1dba2385c6	70000-0531	HUMAN OTC DRUG	Leader Medicated Dandruff	Anti-Seborrheic Dermatitis, Anti-Dandruff	Selenium Sulfide	SHAMPOO	TOPICAL	20191105		OTC MONOGRAPH FINAL	part358H	Cardinal Health, 110 dba LEADER	SELENIUM SULFIDE	10	mg/mL			N	20241231
70000-0533_02098680-dc3a-44f9-9498-697f2d0cd16e	70000-0533	HUMAN OTC DRUG	Leader Dandruff Everyday Clean	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20191010		OTC MONOGRAPH FINAL	part358H	Cardinal Health, 110 dba LEADER	PYRITHIONE ZINC	10	mg/mL			N	20241231
70000-0534_ecb10671-a18a-69dc-e053-2995a90ab6d9	70000-0534	HUMAN OTC DRUG	Leader	After Sun Cooling	Lidocaine Hydrochloride	GEL	TOPICAL	20191104		OTC MONOGRAPH NOT FINAL	part348	CARDINAL HEALTH, INC.	LIDOCAINE HYDROCHLORIDE	5	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0535_c52b3594-22eb-b20b-e053-2995a90a98a2	70000-0535	HUMAN OTC DRUG	Leader	Ultra Sheer SPF 100 Sunscreen	avobenzone, homosalate, octisalate, octocrylene, oxybenzone	LOTION	TOPICAL	20191203		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70000-0536_ecb182a4-c794-1c87-e053-2995a90a222d	70000-0536	HUMAN OTC DRUG	Leader	General Protection SPF 30 Sunscreen	avobenzone, homosalate, octisalate, octocrylene	LOTION	TOPICAL	20191019		OTC MONOGRAPH NOT FINAL	part352	CARDINAL HEALTH, INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70000-0537_ecb1e0a4-1731-d4cf-e053-2995a90aaf79	70000-0537	HUMAN OTC DRUG	Leader	Burn Relief	Lidocaine Hydrochloride	GEL	TOPICAL	20191204		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health	LIDOCAINE HYDROCHLORIDE	10	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0538_0bdcdd75-0629-bd6b-e063-6394a90a6d38	70000-0538	HUMAN OTC DRUG	Gentle Laxative		Bisacodyl	TABLET	ORAL	20191101		OTC MONOGRAPH DRUG	505G(a)(3)	CARDINAL HEALTH	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0540_d853f11e-8604-4767-8175-effe249c05cc	70000-0540	HUMAN OTC DRUG	leader lice killing		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20191212		OTC MONOGRAPH FINAL	part358G	Cardinal Health 110, LLC. dba Leader	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
70000-0542_020cf38b-8d65-46d4-8ea7-246fd0acec6a	70000-0542	HUMAN OTC DRUG	LEADER ATHLETES FOOT CLOTRIMAZOLE		CLOTRIMAZOLE	CREAM	TOPICAL	20200117		OTC MONOGRAPH FINAL	part333C	LEADER	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70000-0543_4e79ce8c-37fe-401f-be8f-1d087904f721	70000-0543	HUMAN OTC DRUG	LEADER HYDROCORTISONE WITH ALOE		HYDROCORTISONE	CREAM	TOPICAL	20200117		OTC MONOGRAPH NOT FINAL	part348	LEADER	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70000-0545_ecb20e59-ea53-0799-e053-2a95a90aad1a	70000-0545	HUMAN OTC DRUG	Leader	Kids Sunscreen SPF 50	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20191211		OTC MONOGRAPH NOT FINAL	part352	Cardinal Health	TITANIUM DIOXIDE; ZINC OXIDE	45; 65	mg/mL; mg/mL			N	20241231
70000-0546_0e211875-3644-fbb8-e063-6394a90aa840	70000-0546	HUMAN OTC DRUG	Leader Anti-Itch		Camphor, Menthol	LOTION	TOPICAL	20200121		OTC MONOGRAPH DRUG	M017	LEADER/Cardinal Health 110, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	.5; .5	g/100g; g/100g			N	20251231
70000-0547_0dfb5775-0208-7561-e063-6294a90aa188	70000-0547	HUMAN OTC DRUG	Leader Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20200415		OTC MONOGRAPH DRUG	M004	Cardinal Health 110 dba LEADER	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20251231
70000-0549_0e9d0a54-5ad2-85fc-e063-6394a90a1513	70000-0549	HUMAN OTC DRUG	Leader Capsaicin Pain Relief Cream		Capsaicin	CREAM	TOPICAL	20200511		OTC MONOGRAPH DRUG	M017	Cardinal Health 110 dba LEADER	CAPSAICIN	.1	g/100g			N	20251231
70000-0550_782516f2-a194-4e9f-aaea-f44a4d3c6a20	70000-0550	HUMAN OTC DRUG	Leader Therapeutic Dandruff	Anti-Dandruff, anti-seborrheic dematitis and anti-psoriasis	Salicylic Acid	SHAMPOO	TOPICAL	20220830		OTC MONOGRAPH FINAL	part358H	Cardinal Health	SALICYLIC ACID	30	mg/mL			N	20241231
70000-0552_081793ca-59e6-86cb-e063-6394a90a9d39	70000-0552	HUMAN OTC DRUG	Leader Mixed Berry Benz-Dex Lozenges		Benzocaine	LOZENGE	ORAL	20200608		OTC MONOGRAPH DRUG	M012	Cardinal Health	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0554_0817588e-1ad3-24e3-e063-6394a90ac6ba	70000-0554	HUMAN OTC DRUG	Leader Cherry Sore Throat Lozenges		Benzocaine	LOZENGE	ORAL	20200604		OTC MONOGRAPH DRUG	M012	Cardinal Health	BENZOCAINE; MENTHOL	15; 3.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70000-0555_d6668957-258f-49af-97c8-a75bf4e2e913	70000-0555	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac sodium	GEL	TOPICAL	20200914		ANDA	ANDA208077	Cardinal Health (Leader) 70000	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0556_f202f8b0-d56e-9117-e053-2a95a90a97bf	70000-0556	HUMAN OTC DRUG	CAPSAICIN HOT PATCHES		CAPSAICIN	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	CAPSAICIN	.025	g/100g			N	20241231
70000-0557_f202ddb9-d750-257f-e053-2a95a90a2824	70000-0557	HUMAN OTC DRUG	Leader PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0558_f202f70a-2943-8a32-e053-2a95a90a5b68	70000-0558	HUMAN OTC DRUG	Cold and Heat Lidocaine Patch Plus Menthol		Lidocaine, Menthol	PATCH	TOPICAL	20180701		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0559_f92c07e9-3ced-4d93-90fe-52aae594b153	70000-0559	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20200424		ANDA	ANDA207868	Cardinal Health (Leader) 70000	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0560_d184b646-5c82-4e91-b029-d3b0576a9aec	70000-0560	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20191227		ANDA	ANDA207868	Cardinal Health (Leader) 70000	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0561_68f0502e-c46e-4e7b-b3f8-ed8f12326542	70000-0561	HUMAN OTC DRUG	Maxi Nicotine		nicotine polacrilex	LOZENGE	ORAL	20200701		ANDA	ANDA209206	Cardinal Health (Leader) 70000	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0562_80a9a13d-3966-4433-b92b-e1af1519b840	70000-0562	HUMAN OTC DRUG	Nicotine		nicotine polacrilex	LOZENGE	ORAL	20200701		ANDA	ANDA209206	Cardinal Health (Leader) 70000	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70000-0563_0eb1de79-7e0e-0d59-e063-6394a90add5a	70000-0563	HUMAN OTC DRUG	Leader Vapor Steam camphor (synthetic)		camphor (synthetic)	LIQUID	RESPIRATORY (INHALATION)	20200902		OTC MONOGRAPH DRUG	M012	LEADER/Cardinal Health 110, Inc.	CAMPHOR (SYNTHETIC)	.062	g/mL			N	20251231
70000-0564_ebc3fad2-55e2-4ca0-b786-031650479512	70000-0564	HUMAN OTC DRUG	leader aspirin		aspirin	TABLET, FILM COATED	ORAL	20200819		OTC MONOGRAPH NOT FINAL	part343	Cardinal Health 110, LLC. dba Leader	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0565_3cf5c25c-bdbf-4f5e-ab05-e445d4c83c59	70000-0565	HUMAN OTC DRUG	Mucus Relief DM	Maximum Strength	Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20200430		OTC MONOGRAPH FINAL	part341	Cardinal Health (Leader) 70000	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0566_8c8db630-462c-4f93-9568-0c4f12620471	70000-0566	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200529		OTC MONOGRAPH FINAL	part332	Cardinal Health (Leader) 70000	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
70000-0567_5fa8337b-fc5a-4014-871e-8785eefe3825	70000-0567	HUMAN OTC DRUG	Sleep-Aid		Doxylamine succinate	TABLET	ORAL	20200723		ANDA	ANDA040564	Cardinal Health 110, LLC. DBA Leader	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70000-0568_e3ce24ad-14ea-4fb6-9cb9-2397d5ad9a21	70000-0568	HUMAN OTC DRUG	Sinus and Headache		Acetaminophen and Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0570_0eaa0deb-1a55-deb7-e063-6294a90a21e5	70000-0570	HUMAN OTC DRUG	WOMENS LAXATIVE ENTERIC COATED		BISACODYL	TABLET, COATED	ORAL	20200724		OTC MONOGRAPH DRUG	M007	CARDINAL HEALTH	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
70000-0571_dc8d76a0-1607-4304-b442-9f61392bdb41	70000-0571	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20210430		ANDA	ANDA078682	Cardinal Health (Leader) 70000	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0572_0c00740b-aad7-e263-e063-6394a90a2d68	70000-0572	HUMAN OTC DRUG	Glycerin		Glycerin	SUPPOSITORY	RECTAL	20210519		OTC MONOGRAPH DRUG	M007	Cardinal Health	GLYCERIN	2	g/1	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70000-0573_0c006801-5c13-68ae-e063-6294a90aa1b5	70000-0573	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	SUPPOSITORY	RECTAL	20210519		OTC MONOGRAPH DRUG	M007	Cardinal Health	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0574_c5d7bf5f-3e5a-52f2-e053-2a95a90a4a00	70000-0574	HUMAN OTC DRUG	Leader Extra Strength Effervescent Antacid and Pain Reliever		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20210625		OTC MONOGRAPH FINAL	part343	Cardinal Health	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 500; 1985	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0575_34a14226-f097-425a-89d2-d812e791810f	70000-0575	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	SOLUTION	ORAL	20210910		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	MAGNESIUM CITRATE	.059	g/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0576_d0e8b5ed-e3e8-4e24-90fe-ab8716ff6020	70000-0576	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20210910		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0578_0a533dba-d9b8-22dd-e063-6294a90aa5aa	70000-0578	HUMAN OTC DRUG	Alcohol Wipe		Isopropyl Alcohol	SWAB	TOPICAL	20210813		OTC MONOGRAPH DRUG	M003	Cardinal Health	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
70000-0579_0a532499-a5fd-a333-e063-6394a90a19fd	70000-0579	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	CLOTH	TOPICAL	20210920		OTC MONOGRAPH DRUG	M003	Cardinal Health	ALCOHOL	70	mL/100mL			N	20241231
70000-0580_7c1294bf-52e9-4e14-afdf-220a15503883	70000-0580	HUMAN OTC DRUG	Guaifenesin D		Guaifenesin and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210506		ANDA	ANDA212542	CARDINAL HEALTH 110, LLC. DBA LEADER	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0582_8cbe4df0-e9f5-4370-ba9d-5f43f43d36bf	70000-0582	HUMAN OTC DRUG	leader acid reducer complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20211214		ANDA	ANDA077355	Cardinal Health 110, LLC. dba Leader	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0583_1b68378d-974a-4931-9677-64bb652eeb84	70000-0583	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210830		ANDA	ANDA208314	Cardinal Health	LORATADINE	10	mg/1			N	20241231
70000-0584_004690af-a93c-41c3-9100-ea013630a57f	70000-0584	HUMAN OTC DRUG	Sleep-Aid Diphenhydramine HCl		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210915		OTC MONOGRAPH FINAL	part338	Cardinal Health 110, LLC. DBA Leader	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0585_5b379804-dab6-4f68-8af6-71d1e01c1b19	70000-0585	HUMAN OTC DRUG	Allergy Relief Diphenhydramine HCl		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210915		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. DBA Leader	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0586_ccc271cc-6aa2-f753-e053-2995a90a1161	70000-0586	HUMAN OTC DRUG	12HR Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210924		ANDA	ANDA211075	CARDINAL HEALTH	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0589_6761d752-f529-41a7-9b33-73c79481d481	70000-0589	HUMAN OTC DRUG	leader anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20211007		ANDA	ANDA075232	Cardinal Health 110, LLC. dba Leader	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70000-0590_d27d7318-cf0a-3084-e053-2995a90ac079	70000-0590	HUMAN OTC DRUG	Allergy Relief DIPHENHYDRAMINE HCI, 25 mg Antihistamine		Diphenhydramine HCl	BAR, CHEWABLE	ORAL	20211206		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0591_d641541d-4012-465e-9401-8bbb16ed06ee	70000-0591	HUMAN OTC DRUG	Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20211005		OTC MONOGRAPH FINAL	part335	CARDINAL HEALTH 110, LLC. DBA LEADER	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
70000-0592_07590688-4455-4621-b0c0-a97126dded44	70000-0592	HUMAN OTC DRUG	CardinalExtra Strength	Antacid Wintergreen flavor	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210927		OTC MONOGRAPH FINAL	part331	CARDINAL HEALTH	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70000-0593_2cb3cb23-fb8f-4bed-a79b-83e1fbd55df9	70000-0593	HUMAN OTC DRUG	Cardinal Extra Strength Smooth Antacid	Assorted Fruits	Calcium carbonate	TABLET, CHEWABLE	ORAL	20210927		OTC MONOGRAPH FINAL	part331	CARDINAL HEALTH	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70000-0594_d4af6694-910d-da17-e053-2995a90a8454	70000-0594	HUMAN OTC DRUG	Bismuth Subsalicylate		Bismuth Subsalicylate	TABLET, FILM COATED	ORAL	20220103		OTC MONOGRAPH FINAL	part335	Cardinal Health	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
70000-0596_b418c10c-528b-4395-944e-af959b639ec2	70000-0596	HUMAN OTC DRUG	leader tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20211124		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0597_dfbbde4f-633e-6d57-e053-2a95a90ad82f	70000-0597	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20220525		ANDA	ANDA091237	CARDINAL HEALTH	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70000-0598_e33cbd1d-1849-145a-e053-2995a90aeb50	70000-0598	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220707		OTC MONOGRAPH FINAL	part341	Cardinal Health	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0599_0a200849-baf5-e508-e063-6394a90a07cf	70000-0599	HUMAN OTC DRUG	Leader Liquid Bandage		Benzethonium chloride Dyclonine hydrochloride	LIQUID	TOPICAL	20220412		OTC MONOGRAPH DRUG	M003	LEADER/ Cardinal Health 110, Inc.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/10mL; mg/10mL			N	20241231
70000-0600_22674ee5-1f31-4caa-aaed-96d3dd6d1b2f	70000-0600	HUMAN OTC DRUG	LEADER Emergency Contraceptive Levonorgestrel		levonorgestrel	TABLET	ORAL	20220322		ANDA	ANDA202635	Cardinal Health 110, LLC. DBA Leader	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
70000-0601_604a27bc-af28-4609-a9a2-33c2c60e090a	70000-0601	HUMAN OTC DRUG	Pseudoephedrine Hydrochloride		Pseudoephedrine Hydrochloride	TABLET	ORAL	20220309		ANDA	ANDA077442	CARDINAL HEALTH 110, LLC DBA LEADER	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0602_b5d6426e-cfcc-40c9-b289-c2365eaf0fbb	70000-0602	HUMAN OTC DRUG	IBUPROFEN and PSEUDOEPHEDRINE HYDROCHLORIDE		IBUPROFEN and PSEUDOEPHEDRINE HYDROCHLORIDE	TABLET	ORAL	20220523		ANDA	ANDA074567	CARDINAL HEALTH 110, LLC DBA LEADER	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0603_04938432-3603-4ed5-a03d-204a41dc76d5	70000-0603	HUMAN OTC DRUG	Aspirin Regimen		Aspirin	TABLET, DELAYED RELEASE	ORAL	20220505		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0604_1327a4df-d789-4bb2-92df-936c97656306	70000-0604	HUMAN OTC DRUG	Aspirin Regimen		Aspirin	TABLET, DELAYED RELEASE	ORAL	20220601		OTC MONOGRAPH DRUG	M013	Cardinal Health 110, LLC. DBA Leader	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70000-0605_83f7cfbb-ab84-4594-ae7a-4a657385c8a7	70000-0605	HUMAN OTC DRUG	Leader All Day Sinus and Cold D		Naproxen sodium, Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220519		ANDA	ANDA076518	Cardinal Health 110, LLC. dba Leader	NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE	220; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0606_a9283a3d-bd95-4fe1-a249-7ae83d243919	70000-0606	HUMAN OTC DRUG	Ibuprofen and Pseudoephedrine HCl		Ibuprofen and Pseudoephedrine HCl	CAPSULE, LIQUID FILLED	ORAL	20220507		ANDA	ANDA209235	Cardinal Health	IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE	200; 30	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0607_49851b31-5017-df77-993d-cea2cb53809a	70000-0607	HUMAN OTC DRUG	Fexofenadine HCl and Pseudoephedrine HCl	24 Hour	Fexofenadine HCl and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20220516		ANDA	ANDA079043	Cardinal Health	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	180; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0608_39352457-da2a-6d79-6fd8-d53d45c4703d	70000-0608	HUMAN OTC DRUG	Mucus Relief D		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20220516		ANDA	ANDA208369	LEADER/ Cardinal Health 110, Inc.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0610_e3c7ece8-82f4-cd0c-e053-2995a90ad800	70000-0610	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, FILM COATED	ORAL	20220714		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health	SENNOSIDES	8.6	mg/1			N	20241231
70000-0611_edf22989-fa56-4d83-9b88-912e0d14ac86	70000-0611	HUMAN OTC DRUG	leader migraine relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220808		ANDA	ANDA075794	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70000-0612_663748d1-5987-a253-4071-669b837d7174	70000-0612	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221026		ANDA	ANDA202194	LEADER/ Cardinal Health 110, Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70000-0613_e21cd863-05d5-43ac-9b73-e45c066028b1	70000-0613	HUMAN OTC DRUG	Allergy Relief		fluticasone propionate	SPRAY, METERED	NASAL	20230131		ANDA	ANDA208024	Cardinal Health (Leader) 70000	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70000-0614_acf4947f-5124-40e6-9f64-75a5c77e84ae	70000-0614	HUMAN OTC DRUG	Epsom Salt		Magnesium sulfate	GRANULE	ORAL; TOPICAL	20230203		OTC MONOGRAPH NOT FINAL	part334	Cardinal Health (Leader) 70000	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0615_d9d73eee-b6dc-4737-8832-4a56a0da6c4d	70000-0615	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20220930		OTC MONOGRAPH FINAL	part347	Cardinal Health (Leader) 70000	WITCH HAZEL	842	mg/mL			N	20241231
70000-0616_22d14777-c422-4e23-a085-6568f18d4c92	70000-0616	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20221028		OTC MONOGRAPH FINAL	part338	Cardinal Health (Leader) 70000	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70000-0617_a0d1ff90-28b8-45b2-adf9-0ba487f5be98	70000-0617	HUMAN OTC DRUG	Leader Roll-On Cooling Pain Relief	Topical Analgesic	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20221103		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
70000-0618_80f93347-8d75-4cfc-bb7b-770a53a969ff	70000-0618	HUMAN OTC DRUG	Leader Cooling Pain Relief	Topical Analgesic	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20221103		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health, 110 dba LEADER	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
70000-0619_f5b752d0-f3ce-fc26-e053-2a95a90a9b25	70000-0619	HUMAN OTC DRUG	Leader	Saline Laxative - Cherry	Magnesium Citrate	LIQUID	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part334	CARDINAL HEALTH	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0620_f5b747cf-711d-466f-e053-2a95a90a5b1b	70000-0620	HUMAN OTC DRUG	Leader	Saline Laxative - Grape	Magnesium Citrate	LIQUID	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part334	CARDINAL HEALTH	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0621_f5b74f1a-7344-0940-e053-2a95a90ae4c1	70000-0621	HUMAN OTC DRUG	Leader	Saline Laxative - Lemon	Magnesium Citrate	LIQUID	ORAL	20230201		OTC MONOGRAPH NOT FINAL	part334	CARDINAL HEALTH	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70000-0622_0c53ba22-2f07-b5be-e063-6394a90a957c	70000-0622	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET	ORAL	20230715		ANDA	ANDA216592	LEADER/ Cardinal Health 110, Inc.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70000-0623_b3e3699b-b36c-453c-8f3b-0001388c8e82	70000-0623	HUMAN OTC DRUG	leader tussin cf		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230131		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0624_f4e8e3b7-fd85-bdbc-e053-2a95a90aeab2	70000-0624	HUMAN OTC DRUG	Leader Burn Relief		Lidocaine	SPRAY	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part348	Cardinal Health	LIDOCAINE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70000-0625_0e9d17d0-8094-85ff-e063-6394a90a40a1	70000-0625	HUMAN OTC DRUG	Leader Triple antibiotic and pain relief		Bacitracin,Neomycin,Polymxin, Pramoxine	OINTMENT	TOPICAL	20230215		OTC MONOGRAPH DRUG	M004	Cardinal Health 110 dba LEADER	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
70000-0626_0c560ef9-46a7-6e7a-e063-6394a90ae32f	70000-0626	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230302		ANDA	ANDA211544	LEADER/ Cardinal Health 110, Inc	ACETAMINOPHEN	650	mg/1			N	20241231
70000-0627_0c5647a1-cff4-7fb0-e063-6394a90a2efe	70000-0627	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230323		ANDA	ANDA211544	LEADER/ Cardinal Health 110, Inc	ACETAMINOPHEN	650	mg/1			N	20241231
70000-0628_01aba767-cacb-4dc3-abac-56e76b813dec	70000-0628	HUMAN OTC DRUG	Tussin DM		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20230316		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0629_24a5872f-a700-44a8-b48d-e30d58abbf71	70000-0629	HUMAN OTC DRUG	Leader Childrens Multi Symptom Cold		Dextromethorphan HBr, guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20230315		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH 110, LLC. DBA LEADER	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0630_125eeb3d-0ee2-45bb-81c0-4ca699979886	70000-0630	HUMAN OTC DRUG	Childrens Mucus and Cough Relief		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20230322		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH 110, LLC. DBA LEADER	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70000-0631_24c1f90c-7b2e-4e86-a2f6-d23f74e0708b	70000-0631	HUMAN OTC DRUG	Childrens Cold and Cough		Brompheniramine maleate, Dextromethorphan, Phenylephrine HCl	LIQUID	ORAL	20230330		OTC MONOGRAPH FINAL	part341	CARDINAL HEALTH 110, LLC. DBA LEADER	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0632_7fa12904-d840-42a5-8fc6-5f1f58528521	70000-0632	HUMAN OTC DRUG	Maximum Strength Gas Relief Softgel		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230220		OTC MONOGRAPH FINAL	part332	Cardinal Health 110, LLC. DBA Leader	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
70000-0633_0eb1e28b-2725-0a0a-e063-6394a90ae463	70000-0633	HUMAN OTC DRUG	Leader Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20230621		OTC MONOGRAPH DRUG	M031	LEADER/ Cardinal Health 110, Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20251231
70000-0634_32ee51e9-8935-4970-7ffc-1c677d232d62	70000-0634	HUMAN OTC DRUG	12HR ALLERGY AND CONGESTION RELIEF		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA215434	LEADER/ Cardinal Health 110, Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70000-0635_26f0fd3d-1bb5-46ac-a995-cfd48249bad8	70000-0635	HUMAN OTC DRUG	Leader Nasal		mometasone furoate	SPRAY	NASAL	20230922		NDA	NDA215712	Cardinal Health 110, LLC. dba Leader	MOMETASONE FUROATE MONOHYDRATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70000-0636_cc2f3734-f274-478a-a8a9-f816117d31e9	70000-0636	HUMAN OTC DRUG	Leader Daytime Severe Cold and Flu Relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20230615		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, LLC. dba Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0637_0a1eceaf-d664-78eb-e063-6394a90a3923	70000-0637	HUMAN OTC DRUG	Tolnaftate		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20230518		OTC MONOGRAPH DRUG	M005	LEADER/ Cardinal Health 110, Inc.	TOLNAFTATE	10	mg/mL			N	20241231
70000-0638_fe5b863b-31b4-380e-e053-6294a90adc2a	70000-0638	HUMAN OTC DRUG	Cough Drops Menthol		Menthol Cough Drops	PASTILLE	ORAL	20230617		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, Inc.	MENTHOL	5.4	mg/1			N	20241231
70000-0639_fe5b557e-a686-a32c-e053-6294a90aadbd	70000-0639	HUMAN OTC DRUG	Cough Drops Menthol Honey Lemon		Cough Drops Menthol	PASTILLE	ORAL	20230617		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, Inc.	MENTHOL	7.5	mg/1			N	20241231
70000-0640_fe5b5e6e-1eec-8408-e053-6294a90a3107	70000-0640	HUMAN OTC DRUG	Cough Drops Cherry		Cherry Flavor Cough Drops	PASTILLE	ORAL	20230617		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, Inc.	MENTHOL	5.8	mg/1			N	20241231
70000-0641_fe91476f-37c6-3d40-e053-6394a90ae7e5	70000-0641	HUMAN OTC DRUG	Sugar Free Cough Drops		Menthol	PASTILLE	ORAL	20230620		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, Inc.	MENTHOL	5.8	mg/1			N	20241231
70000-0642_fe90cb93-e572-88d7-e053-6294a90ab9a3	70000-0642	HUMAN OTC DRUG	Sugar Free Cough Drops Honey Lemon		Menthol	PASTILLE	ORAL	20230620		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, Inc.	MENTHOL	7.6	mg/1			N	20241231
70000-0643_fe90cb93-e56f-88d7-e053-6294a90ab9a3	70000-0643	HUMAN OTC DRUG	Sugar Free Cough Drops Black Cherry		Menthol	PASTILLE	ORAL	20230620		OTC MONOGRAPH FINAL	part341	Cardinal Health 110, Inc.	MENTHOL	5.8	mg/1			N	20241231
70000-0647_69e7f90d-64f0-4a2e-80ba-e10221b3b2cb	70000-0647	HUMAN OTC DRUG	Emergency Contraceptive		Levonorgestrel	TABLET	ORAL	20230915		ANDA	ANDA205329	Cardinal Health (Leader) 70000	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
70000-0652_7a3ff954-29a7-4cb3-a0e3-3a1ffcf91558	70000-0652	HUMAN OTC DRUG	Cold Relief	Multi-Symptom	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20231025		OTC MONOGRAPH DRUG	M012	Cardinal Health 110, LLC. DBA Leader	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70000-0663_18a4f12a-8297-4abb-80f2-c98aec492b8d	70000-0663	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL	20230417		OTC MONOGRAPH DRUG	M007	Cardinal Health, 110 dba Leader	MINERAL OIL	999	mg/mL			N	20241231
70006-500_08632219-c5e7-6c06-e063-6294a90a4dbe	70006-500	HUMAN OTC DRUG	VIAMED Alcohol Prep Pad		ALCOHOL	SWAB	TOPICAL	20150910		OTC MONOGRAPH DRUG	505G(a)(3)	Rece International Corp	ALCOHOL	70	g/100g			N	20241231
70010-002_018d4e2e-c594-17cf-e063-6294a90a7bb2	70010-002	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20200513		ANDA	ANDA210425	Granules Pharmaceuticals Inc.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
70010-004_09b64b00-f134-5ebb-e063-6394a90a1289	70010-004	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-005_09b64b00-f134-5ebb-e063-6394a90a1289	70010-005	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-006_09b64b00-f134-5ebb-e063-6394a90a1289	70010-006	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-007_09b64b00-f134-5ebb-e063-6394a90a1289	70010-007	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-008_09b64b00-f134-5ebb-e063-6394a90a1289	70010-008	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-009_09b64b00-f134-5ebb-e063-6394a90a1289	70010-009	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-010_09b64b00-f134-5ebb-e063-6394a90a1289	70010-010	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-011_09b64b00-f134-5ebb-e063-6394a90a1289	70010-011	HUMAN PRESCRIPTION DRUG	DEXMETHYLPHENIDATE HYDROCHLORIDE		DEXMETHYLPHENIDATE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20201201		ANDA	ANDA213813	Granules Pharmaceuticals Inc.	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-012_08addde0-3405-11be-e063-6294a90a3449	70010-012	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA211796	Granules Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-013_08addde0-3405-11be-e063-6294a90a3449	70010-013	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA211796	Granules Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-014_08addde0-3405-11be-e063-6294a90a3449	70010-014	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA211796	Granules Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-015_08addde0-3405-11be-e063-6294a90a3449	70010-015	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA211796	Granules Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-016_08addde0-3405-11be-e063-6294a90a3449	70010-016	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA211796	Granules Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-021_f33d5a34-e5e7-a85f-e053-2995a90a6db3	70010-021	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE EXTENDED RELEASE		POTASSIUM CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201022		ANDA	ANDA211797	Granules Pharmaceuticals Inc.	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70010-022_f33d5a34-e5e7-a85f-e053-2995a90a6db3	70010-022	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE EXTENDED RELEASE		POTASSIUM CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201022		ANDA	ANDA211797	Granules Pharmaceuticals Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70010-027_0194b277-edb7-e7f8-e063-6394a90a6c25	70010-027	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200819		ANDA	ANDA213185	Granules Pharmaceuticals Inc.	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70010-028_019388a3-ecda-7396-e063-6294a90a62b6	70010-028	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20201001		ANDA	ANDA213186	Granules Pharmaceuticals Inc.	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
70010-029_09de0247-9e7d-fcfe-e063-6394a90a5817	70010-029	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20230220		ANDA	ANDA217027	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-030_09de0247-9e7d-fcfe-e063-6394a90a5817	70010-030	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20230220		ANDA	ANDA217027	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-031_09de0247-9e7d-fcfe-e063-6394a90a5817	70010-031	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20230220		ANDA	ANDA217027	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-032_09de0247-9e7d-fcfe-e063-6394a90a5817	70010-032	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20230220		ANDA	ANDA217027	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-033_09de0247-9e7d-fcfe-e063-6394a90a5817	70010-033	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20230220		ANDA	ANDA217027	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-034_09de0247-9e7d-fcfe-e063-6394a90a5817	70010-034	HUMAN PRESCRIPTION DRUG	dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate		dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20230220		ANDA	ANDA217027	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-040_07cf15a8-e495-3949-e063-6394a90a97a0	70010-040	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20190815		ANDA	ANDA212619	Granules Pharmaceuticals Inc.	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-041_07cf15a8-e495-3949-e063-6394a90a97a0	70010-041	HUMAN PRESCRIPTION DRUG	Amphetamine Sulfate		Amphetamine Sulfate	TABLET	ORAL	20190815		ANDA	ANDA212619	Granules Pharmaceuticals Inc.	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-042_01906f91-4732-ffa5-e063-6294a90ab7d9	70010-042	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181217		ANDA	ANDA210992	Granules Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-043_01906f91-4732-ffa5-e063-6294a90ab7d9	70010-043	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181217		ANDA	ANDA210992	Granules Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-044_f42785c5-6835-b2f5-e053-2995a90a727a	70010-044	HUMAN PRESCRIPTION DRUG	Butalbita,Acetaminophen and Caffeine		Butalbita,Acetaminophen and Caffeine	CAPSULE	ORAL	20200505		ANDA	ANDA213321	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
70010-051_f33edadd-2b11-5034-e053-2a95a90afc12	70010-051	HUMAN PRESCRIPTION DRUG	VALGANCICLOVIR HYDROCHLORIDE		VALGANCICLOVIR	FOR SOLUTION	ORAL	20210701		ANDA	ANDA213306	Granules Pharmaceuticals Inc.	VALGANCICLOVIR	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog [EXT]		N	20241231
70010-054_f4a2f8f9-7dc7-395b-e053-2995a90a6f00	70010-054	HUMAN PRESCRIPTION DRUG	butalbital and acetaminophen		butalbital and acetaminophen	CAPSULE	ORAL	20200120		ANDA	ANDA213115	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; BUTALBITAL	300; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
70010-063_0266503f-0f1a-38e0-e063-6294a90a606f	70010-063	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Granules Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70010-064_0266503f-0f1a-38e0-e063-6294a90a606f	70010-064	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Granules Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70010-065_0266503f-0f1a-38e0-e063-6294a90a606f	70010-065	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Granules Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70010-071_036803fa-4856-53ea-e063-6294a90aca3c	70010-071	HUMAN PRESCRIPTION DRUG	Potassium Chloride for Oral Solution		Potassium Chloride	FOR SOLUTION	ORAL	20230901		ANDA	ANDA213467	Granules Pharmaceuticals Inc.	POTASSIUM CHLORIDE	1.5	g/1.58g			N	20241231
70010-084_f33ec453-81c2-bacc-e053-2995a90a1eea	70010-084	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20220103		ANDA	ANDA214608	Granules Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70010-085_f33ec453-81c2-bacc-e053-2995a90a1eea	70010-085	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20220103		ANDA	ANDA214608	Granules Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70010-086_f33ec453-81c2-bacc-e053-2995a90a1eea	70010-086	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20220103		ANDA	ANDA214608	Granules Pharmaceuticals Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70010-108_f4cd4556-7453-2869-e053-2a95a90a76e4	70010-108	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Granules Pharmaceuticals Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70010-109_f4cd4556-7453-2869-e053-2a95a90a76e4	70010-109	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Granules Pharmaceuticals Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70010-111_09c619c3-c30d-e491-e063-6294a90ad58f	70010-111	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20230328		ANDA	ANDA215771	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-112_09c619c3-c30d-e491-e063-6294a90ad58f	70010-112	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20230328		ANDA	ANDA215771	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-113_09c619c3-c30d-e491-e063-6294a90ad58f	70010-113	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20230328		ANDA	ANDA215771	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-114_09c619c3-c30d-e491-e063-6294a90ad58f	70010-114	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20230328		ANDA	ANDA215771	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-115_09c619c3-c30d-e491-e063-6294a90ad58f	70010-115	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20230328		ANDA	ANDA215771	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-116_09c619c3-c30d-e491-e063-6294a90ad58f	70010-116	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20230328		ANDA	ANDA215771	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-117_09c619c3-c30d-e491-e063-6294a90ad58f	70010-117	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20230328		ANDA	ANDA215771	Granules Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
70010-118_f4cd4556-7453-2869-e053-2a95a90a76e4	70010-118	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Granules Pharmaceuticals Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70010-131_00acf0ce-9a5a-7359-e063-6394a90a9766	70010-131	HUMAN OTC DRUG	Acetaminophen and Ibuprofen		Acetaminophen and Ibuprofen	TABLET	ORAL	20230724		ANDA	ANDA216592	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70010-133_0a03dc95-e1df-e521-e063-6394a90ad65d	70010-133	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20231018		ANDA	ANDA217427	Granules Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70010-134_0a03dc95-e1df-e521-e063-6394a90ad65d	70010-134	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20231018		ANDA	ANDA217427	Granules Pharmaceuticals Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70010-135_06bdbb3a-1cd0-a9eb-e063-6294a90aa4a9	70010-135	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Granules Pharmaceuticals Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70010-136_06bdbb3a-1cd0-a9eb-e063-6294a90aa4a9	70010-136	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Granules Pharmaceuticals Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70010-137_018ffdd3-bc90-fb23-e063-6394a90a3e1e	70010-137	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20210415		ANDA	ANDA074140	Granules Pharmaceuticals Inc.	NAPROXEN SODIUM	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70010-138_018ffdd3-bc90-fb23-e063-6394a90a3e1e	70010-138	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20210415		ANDA	ANDA074140	Granules Pharmaceuticals Inc.	NAPROXEN SODIUM	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70010-139_018ffdd3-bc90-fb23-e063-6394a90a3e1e	70010-139	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20210415		ANDA	ANDA074140	Granules Pharmaceuticals Inc.	NAPROXEN SODIUM	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70010-147_f33d13aa-3835-e830-e053-2a95a90a53ed	70010-147	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20210301		ANDA	ANDA214686	Granules Pharmaceuticals Inc	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70010-148_f33d13aa-3835-e830-e053-2a95a90a53ed	70010-148	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20210301		ANDA	ANDA214686	Granules Pharmaceuticals Inc	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70010-149_f33d40cf-0771-0e21-e053-2a95a90aa8ed	70010-149	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	TABLET	ORAL	20220629		ANDA	ANDA040864	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
70010-160_f33c11e5-8a34-6e95-e053-2a95a90a9145	70010-160	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, EXTENDED RELEASE	ORAL	20220215		ANDA	ANDA211544	Granules Pharmaceuticals Inc.	ACETAMINOPHEN	650	mg/1			N	20241231
70010-161_f33e0609-4fde-5223-e053-2a95a90ad30a	70010-161	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20220215		OTC MONOGRAPH NOT FINAL	part343	Granules Pharmaceuticals Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
70010-162_f33cca66-3283-4931-e053-2a95a90a7583	70010-162	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20200101		ANDA	ANDA210722	Granules Pharmaceuticals Inc.	LORATADINE	10	mg/1			N	20241231
70010-163_f33ce337-fb4a-2f7e-e053-2a95a90a700e	70010-163	HUMAN OTC DRUG	Cetirizine hydrochloride		Cetirizine hydrochloride	TABLET, COATED	ORAL	20220113		ANDA	ANDA209274	Granules Pharmaceuticals Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70010-183_fa30c8ce-ad9e-b6fe-e053-6294a90a2443	70010-183	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20230425		ANDA	ANDA211075	GRANULES PHARMACEUTICALS INC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70010-184_0a2be1e8-3b0f-43e7-e063-6294a90a72ce	70010-184	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230925		ANDA	ANDA217390	Granules Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70010-185_0a2be1e8-3b0f-43e7-e063-6294a90a72ce	70010-185	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230925		ANDA	ANDA217390	Granules Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70010-186_0a2be1e8-3b0f-43e7-e063-6294a90a72ce	70010-186	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230925		ANDA	ANDA217390	Granules Pharmaceuticals Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70010-187_06ce684e-c85b-e50e-e063-6294a90a440c	70010-187	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20230929		ANDA	ANDA218015	Granules Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70010-188_06ce684e-c85b-e50e-e063-6294a90a440c	70010-188	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20230929		ANDA	ANDA218015	Granules Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70010-189_06ce684e-c85b-e50e-e063-6294a90a440c	70010-189	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20230929		ANDA	ANDA218015	Granules Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70010-199_f33b13e3-09ff-7678-e053-2995a90a174e	70010-199	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	TABLET, EXTENDED RELEASE	ORAL	20220819		ANDA	ANDA213420	GRANULES PHARMACEUTICALS INC.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70010-203_f8a6adef-9801-1f56-e053-6294a90ad6a1	70010-203	HUMAN PRESCRIPTION DRUG	Sertraline hydrochloride		Sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA078403	Granules Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70010-204_f8a6adef-9801-1f56-e053-6294a90ad6a1	70010-204	HUMAN PRESCRIPTION DRUG	Sertraline hydrochloride		Sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA078403	Granules Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70010-205_f8a6adef-9801-1f56-e053-6294a90ad6a1	70010-205	HUMAN PRESCRIPTION DRUG	Sertraline hydrochloride		Sertraline hydrochloride	TABLET, FILM COATED	ORAL	20230515		ANDA	ANDA078403	Granules Pharmaceuticals Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70010-227_fc5cd0f5-29ce-00c3-e053-6394a90aac29	70010-227	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20230627		ANDA	ANDA217116	Granules Pharmaceuticals Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70010-228_fc5cd0f5-29ce-00c3-e053-6394a90aac29	70010-228	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20230627		ANDA	ANDA217116	Granules Pharmaceuticals Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70010-491_089baf91-1883-0d64-e063-6294a90a4df8	70010-491	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20180731		ANDA	ANDA209313	Granules Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70010-492_089baf91-1883-0d64-e063-6294a90a4df8	70010-492	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 750 mg	TABLET	ORAL	20180731		ANDA	ANDA209313	Granules Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70010-496_08a37d7f-cd0d-d20c-e063-6394a90a091b	70010-496	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210122		ANDA	ANDA213344	Granules Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70010-497_08a37d7f-cd0d-d20c-e063-6394a90a091b	70010-497	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210122		ANDA	ANDA213344	Granules Pharmaceuticals Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70010-667_054b5e37-1936-f03a-e063-6294a90a3d5d	70010-667	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20220101		ANDA	ANDA211708	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
70010-668_054b5e37-1936-f03a-e063-6294a90a3d5d	70010-668	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20220101		ANDA	ANDA211708	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
70010-669_054b5e37-1936-f03a-e063-6294a90a3d5d	70010-669	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20220101		ANDA	ANDA211708	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
70010-670_054b5e37-1936-f03a-e063-6294a90a3d5d	70010-670	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20220101		ANDA	ANDA211708	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
70010-672_0c7164b6-c532-8273-e063-6394a90ae878	70010-672	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20210818		ANDA	ANDA211729	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
70010-673_0c7164b6-c532-8273-e063-6394a90ae878	70010-673	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20210818		ANDA	ANDA211729	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
70010-674_0c7164b6-c532-8273-e063-6394a90ae878	70010-674	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20210818		ANDA	ANDA211729	Granules Pharmaceuticals Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
70010-741_f5bbaa8b-e39b-2a5f-e053-2995a90a0170	70010-741	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan	TABLET	ORAL	20230308		ANDA	ANDA215959	Granules Pharmaceuticals Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70010-742_f5bbaa8b-e39b-2a5f-e053-2995a90a0170	70010-742	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan	TABLET	ORAL	20230308		ANDA	ANDA215959	Granules Pharmaceuticals Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70010-743_f5bbaa8b-e39b-2a5f-e053-2995a90a0170	70010-743	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan	TABLET	ORAL	20230308		ANDA	ANDA215959	Granules Pharmaceuticals Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70010-754_f4cd2e4b-5488-61d4-e053-2a95a90a30bc	70010-754	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	Granules Pharmaceuticals Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70010-770_f4cd2e4b-5488-61d4-e053-2a95a90a30bc	70010-770	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	Granules Pharmaceuticals Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70010-780_ff17c36b-d787-e505-e053-6394a90a8ceb	70010-780	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231002		ANDA	ANDA216916	Granules Pharmaceuticals Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70010-781_ff17c36b-d787-e505-e053-6394a90a8ceb	70010-781	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231002		ANDA	ANDA216916	Granules Pharmaceuticals Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70010-782_ff17c36b-d787-e505-e053-6394a90a8ceb	70010-782	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231002		ANDA	ANDA216916	Granules Pharmaceuticals Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70010-783_ff17c36b-d787-e505-e053-6394a90a8ceb	70010-783	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231002		ANDA	ANDA216916	Granules Pharmaceuticals Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70010-784_0bfdb8c7-f993-4161-e063-6294a90aa7b3	70010-784	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET	ORAL	20221215		ANDA	ANDA215568	Granules Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
70010-785_0bfdb8c7-f993-4161-e063-6294a90aa7b3	70010-785	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET	ORAL	20221215		ANDA	ANDA215568	Granules Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
70010-786_015ec4e5-a4ae-38e7-e063-6394a90abbc6	70010-786	HUMAN PRESCRIPTION DRUG	Methylergonovine Maleate		Methylergonovine Maleate	TABLET	ORAL	20180525		ANDA	ANDA210424	Granules Pharmaceuticals Inc.	METHYLERGONOVINE MALEATE	.2	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
70010-907_f4cc7cbb-e87f-50db-e053-2a95a90a8d35	70010-907	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20201221		ANDA	ANDA211735	Granules Pharmaceuticals Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
70010-926_01a29c86-d413-7f66-e063-6394a90a323c	70010-926	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20210901		ANDA	ANDA075360	Granules Pharmaceuticals Inc	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70010-927_01a29c86-d413-7f66-e063-6394a90a323c	70010-927	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20210901		ANDA	ANDA075360	Granules Pharmaceuticals Inc	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70010-928_01a29c86-d413-7f66-e063-6394a90a323c	70010-928	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20210901		ANDA	ANDA075360	Granules Pharmaceuticals Inc	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70014-0703_0a960f6c-5b88-b557-e063-6294a90ac9f4	70014-0703	HUMAN OTC DRUG	Beam		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL; ORAL	20151105		OTC MONOGRAPH DRUG	M021	Beam	SODIUM FLUORIDE	1.1	mg/g			N	20241231
70020-1910_f316ca9e-c6df-3ee3-e053-2995a90a7e67	70020-1910	HUMAN PRESCRIPTION DRUG	IXEMPRA		ixabepilone	KIT		20071016		NDA	NDA022065	R-Pharm US Operating, LLC						N	20241231
70020-1911_f316ca9e-c6df-3ee3-e053-2995a90a7e67	70020-1911	HUMAN PRESCRIPTION DRUG	IXEMPRA		ixabepilone	KIT	INTRAVENOUS	20071016		NDA	NDA022065	R-Pharm US Operating, LLC						N	20241231
70026-001_eeb5d4f1-8cac-9ef6-e053-2a95a90a823f	70026-001	HUMAN OTC DRUG	Yonis Bliss		Chamomilla, Natrum Muriaticum	GEL	TOPICAL	20151023		UNAPPROVED HOMEOPATHIC		Brookhaus Essentials LLC	MATRICARIA RECUTITA; SODIUM CHLORIDE	6; 6	[hp_C]/g; [hp_C]/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
70031-001_da8e3936-9206-730c-e053-2995a90a5a73	70031-001	HUMAN OTC DRUG	Antibacterial Wipes		benzethonium chloride	SWAB	TOPICAL	20150805		OTC MONOGRAPH NOT FINAL	part333A	TIANJIN YANSHENG INDUSTRIAL TRADE COMPANY	BENZETHONIUM CHLORIDE	.3	g/100g			N	20241231
70031-003_da8daf04-fa21-2ea3-e053-2a95a90a2761	70031-003	HUMAN OTC DRUG	Antibacterial Wet Wipes		benzethonium chloride	SWAB	TOPICAL	20160310		OTC MONOGRAPH NOT FINAL	part333A	TIANJIN YANSHENG INDUSTRIAL TRADE COMPANY	BENZETHONIUM CHLORIDE	.115	g/100g			N	20241231
70038-131_0a9ab9fc-583e-fb27-e063-6294a90ad1c3	70038-131	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20240101		ANDA	ANDA216592	RAONBIO CORP	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70039-200_c8af1885-9106-25c3-e053-2a95a90ae185	70039-200	HUMAN OTC DRUG	Professional Therapy MuscleCare	Extra Strength	Menthol, Camphor	GEL	CUTANEOUS; TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part348	Active and Innovative Inc.	CAMPHOR (SYNTHETIC); MENTHOL	40; 100	mg/g; mg/g			N	20241231
70039-201_42f1e14a-3ac7-01c1-e054-00144ff8d46c	70039-201	HUMAN OTC DRUG	Professional Therapy MuscleCare	Turbo	Menthol, Camphor	GEL	CUTANEOUS; TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part348	Active and Innovative Inc.	CAMPHOR (SYNTHETIC); MENTHOL	100; 140	mg/g; mg/g			N	20241231
70039-283_39bd979f-91a1-0554-e054-00144ff8d46c	70039-283	HUMAN OTC DRUG	Professional Therapy MuscleCare pain relieving gel	Extra Strength	Camphor, Menthol	GEL	CUTANEOUS; TOPICAL	20150601		OTC MONOGRAPH NOT FINAL	part348	Active and Innovative Inc.	CAMPHOR (SYNTHETIC); MENTHOL	40; 100	mg/g; mg/g			N	20241231
70039-298_39cf0152-0f2a-1077-e054-00144ff8d46c	70039-298	HUMAN OTC DRUG	Professional Therapy MuscleCare		Camphor, Menthol	CREAM	CUTANEOUS; TOPICAL	20150601		OTC MONOGRAPH NOT FINAL	part348	Active and Innovative Inc.	CAMPHOR (SYNTHETIC); MENTHOL	40; 40	mg/g; mg/g			N	20241231
70039-300_c8ae83ef-887b-14da-e053-2995a90ae49d	70039-300	HUMAN OTC DRUG	Professional Therapy MuscleCare Pain Relieving		Menthol, Camphor	OINTMENT	CUTANEOUS; TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part348	Active and Innovative Inc.	CAMPHOR (SYNTHETIC); MENTHOL	40; 40	mg/g; mg/g			N	20241231
70042-0016_0b696764-c661-1feb-e063-6294a90a036b	70042-0016	HUMAN OTC DRUG	Goodoh EnergyCream		Dimethyl Sulfone, Glucosamine	CREAM	TOPICAL	20210524		UNAPPROVED DRUG OTHER		PowerfulX	DIMETHYL SULFONE; N-ACETYLGLUCOSAMINE	1; 1	g/100mL; g/100mL			N	20241231
70058-001_0d8211c7-12fa-57dc-e063-6294a90abecc	70058-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20150824		UNAPPROVED MEDICAL GAS		Central Medical Supply	OXYGEN	99	L/100L			N	20241231
70060-1502_09cc99c7-b674-c4c5-e063-6394a90a73c1	70060-1502	HUMAN OTC DRUG	Daily Replenishing SPF 30		Sunscreen	CREAM	TOPICAL	20150818		OTC MONOGRAPH DRUG	M020	CosMedical Technologies, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 7.5	g/60mL; g/60mL			N	20241231
70060-1503_09cc9c48-693d-c9bc-e063-6394a90a52c4	70060-1503	HUMAN OTC DRUG	Salicylic Face and Body Wash		Salicylic Acid Soap	LIQUID	TOPICAL	20151104		OTC MONOGRAPH DRUG	M006	CosMedical Technologies	SALICYLIC ACID	20	mg/mL			N	20241231
70060-1505_09cc9eb2-c581-d6fa-e063-6394a90a4ea2	70060-1505	HUMAN OTC DRUG	Acne Spot Treatment		Salicylic Acid Acne Treatment	LIQUID	TOPICAL	20151104		OTC MONOGRAPH DRUG	M006	CosMedical Technologies	SALICYLIC ACID	20	mg/mL			N	20241231
70060-1506_09cca59b-e102-a52d-e063-6294a90a076b	70060-1506	HUMAN OTC DRUG	Overnight Spot Treatment		Acne Treatment	LIQUID	TOPICAL	20151104		OTC MONOGRAPH DRUG	M006	CosMedical Technologies	SULFUR	100	mg/mL			N	20241231
70060-1507_0d947aa6-0465-d001-e063-6294a90a3657	70060-1507	HUMAN OTC DRUG	Radiant Shield Broad spectrum SPF 40 Tinted Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20240102		OTC MONOGRAPH DRUG	M020	CosMedical Technologies, LLC	ZINC OXIDE	170	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70060-1901_09cca94c-caf2-1c88-e063-6294a90a90e5	70060-1901	HUMAN OTC DRUG	Ultra Replenishing Sunscreen SPF 40		Homosalate, Octisalate, Octocrylene, Zinc Oxyide cream	CREAM	TOPICAL	20190916		OTC MONOGRAPH DRUG	M020	CosMedical Technologies, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	80; 50; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70069-005_0e24643e-b0c4-42ab-a1c9-f7a170ee8d76	70069-005	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20151211		ANDA	ANDA206503	Somerset Therapeutics, LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70069-008_bc4f6808-8013-4af0-b622-e8b809aa6371	70069-008	HUMAN PRESCRIPTION DRUG	EPINASTINE HYDROCHLORIDE		EPINASTINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20160914		ANDA	ANDA090951	Somerset Therapeutics, LLC	EPINASTINE HYDROCHLORIDE	.5	mg/mL	Adrenergic Agonists [MoA], Adrenergic Receptor Agonist [EPC], Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
70069-011_1cf06d0b-356a-4f2a-af3c-bbcd7e24aae9	70069-011	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220129		ANDA	ANDA211705	Somerset Therapeutics, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70069-012_1cf06d0b-356a-4f2a-af3c-bbcd7e24aae9	70069-012	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220129		ANDA	ANDA211705	Somerset Therapeutics, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70069-013_1cf06d0b-356a-4f2a-af3c-bbcd7e24aae9	70069-013	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220129		ANDA	ANDA211705	Somerset Therapeutics, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70069-014_1cf06d0b-356a-4f2a-af3c-bbcd7e24aae9	70069-014	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220129		ANDA	ANDA211705	Somerset Therapeutics, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70069-021_98ed05e5-3e3f-425c-bccd-498d96b78153	70069-021	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180419		ANDA	ANDA207442	Somerset Therapeutics, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70069-022_5368b1d7-8c74-4e4b-8233-20030539f180	70069-022	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20180608		ANDA	ANDA207521	Somerset Therapeutics, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70069-023_5368b1d7-8c74-4e4b-8233-20030539f180	70069-023	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20180608		ANDA	ANDA207521	Somerset Therapeutics, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70069-024_5368b1d7-8c74-4e4b-8233-20030539f180	70069-024	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20180608		ANDA	ANDA207521	Somerset Therapeutics, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70069-025_910a3ad7-3a7d-4889-8aec-af9304febedf	70069-025	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190611		ANDA	ANDA211036	Somerset Therapeutics, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70069-030_f6d888a0-65a7-4073-8671-b00b4bfaff4c	70069-030	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20180703		ANDA	ANDA209101	Somerset Therapeutics, LLC	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70069-031_f6d888a0-65a7-4073-8671-b00b4bfaff4c	70069-031	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20180703		ANDA	ANDA209101	Somerset Therapeutics, LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70069-051_3acff60b-3a7a-4b15-8d13-950b9cd77f81	70069-051	HUMAN PRESCRIPTION DRUG	DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE		DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE	SOLUTION	OPHTHALMIC	20190625		ANDA	ANDA207523	Somerset Therapeutics, LLC	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70069-061_5d7b0e44-19ce-4127-b3e8-d7e6e65f1818	70069-061	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20180615		ANDA	ANDA207636	Somerset Therapeutics, LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-062_5d7b0e44-19ce-4127-b3e8-d7e6e65f1818	70069-062	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20180615		ANDA	ANDA207636	Somerset Therapeutics, LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-063_5d7b0e44-19ce-4127-b3e8-d7e6e65f1818	70069-063	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20180615		ANDA	ANDA207636	Somerset Therapeutics, LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-064_5d7b0e44-19ce-4127-b3e8-d7e6e65f1818	70069-064	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20180615		ANDA	ANDA207636	Somerset Therapeutics, LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-065_5d7b0e44-19ce-4127-b3e8-d7e6e65f1818	70069-065	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; PERINEURAL	20180615		ANDA	ANDA207636	Somerset Therapeutics, LLC	ROPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-066_5d7b0e44-19ce-4127-b3e8-d7e6e65f1818	70069-066	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL	20180615		ANDA	ANDA207636	Somerset Therapeutics, LLC	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-067_5d7b0e44-19ce-4127-b3e8-d7e6e65f1818	70069-067	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL	20180615		ANDA	ANDA207636	Somerset Therapeutics, LLC	ROPIVACAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-071_52551e7c-39ae-4d67-be09-97a5368ba6e4	70069-071	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170808		ANDA	ANDA207633	Somerset Therapeutics, LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
70069-072_7a544942-0f60-4ed3-91df-049b7f74812e	70069-072	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170726		ANDA	ANDA207634	Somerset Therapeutics, LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
70069-091_99a056e5-2dcd-4102-8132-55bf9b3ba069	70069-091	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		Azelastine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20190408		ANDA	ANDA207411	Somerset Therapeutics, LLC	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70069-101_61aecfa5-6ec8-4811-901b-fb5eb33ef659	70069-101	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170731		ANDA	ANDA207522	Somerset Therapeutics, LLC	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70069-121_5ca4f6bb-209e-4235-8fbb-97b14cf679c8	70069-121	HUMAN PRESCRIPTION DRUG	Tropicamide		Tropicamide	SOLUTION/ DROPS	OPHTHALMIC	20191212		ANDA	ANDA207524	Somerset Therapeutics, LLC	TROPICAMIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70069-131_a45353e5-3631-4a52-9ac6-feac3187a08d	70069-131	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20200811		ANDA	ANDA207444	Somerset Therapeutics, LLC	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70069-141_757aedc0-ad65-446a-81ed-09afbe8cc595	70069-141	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20190204		ANDA	ANDA206791	Somerset Therapeutics, LLC	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70069-151_757aedc0-ad65-446a-81ed-09afbe8cc595	70069-151	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20190204		ANDA	ANDA206791	Somerset Therapeutics, LLC	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70069-161_e6611fa7-05cc-4ab3-996b-e41903444a68	70069-161	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION	INTRAVENOUS	20190802		ANDA	ANDA209132	Somerset Therapeutics, LLC	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70069-171_9f0dee6d-ee88-43df-9e7b-a3f345734210	70069-171	HUMAN PRESCRIPTION DRUG	CYANOCOBALAMIN		CYANOCOBALAMIN	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20181218		ANDA	ANDA209429	Somerset Therapeutics, LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70069-172_0e24643e-b0c4-42ab-a1c9-f7a170ee8d76	70069-172	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20170627		ANDA	ANDA206503	Somerset Therapeutics, LLC	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70069-181_00cc0387-57e5-4b0a-80db-568df6402eb9	70069-181	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride Ophthalmic Solution	SOLUTION/ DROPS	OPHTHALMIC	20191125		ANDA	ANDA210384	Somerset Therapeutics, LLC	PILOCARPINE HYDROCHLORIDE	10	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
70069-191_00cc0387-57e5-4b0a-80db-568df6402eb9	70069-191	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride Ophthalmic Solution	SOLUTION/ DROPS	OPHTHALMIC	20191125		ANDA	ANDA210384	Somerset Therapeutics, LLC	PILOCARPINE HYDROCHLORIDE	20	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
70069-201_00cc0387-57e5-4b0a-80db-568df6402eb9	70069-201	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride Ophthalmic Solution	SOLUTION/ DROPS	OPHTHALMIC	20191125		ANDA	ANDA210384	Somerset Therapeutics, LLC	PILOCARPINE HYDROCHLORIDE	40	mg/mL	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
70069-221_70bc6d04-06a8-40ab-a5fd-2d955a4b4f1d	70069-221	HUMAN PRESCRIPTION DRUG	Isosulfan Blue		Isosulfan Blue	INJECTION, SOLUTION	SUBCUTANEOUS	20190723		ANDA	ANDA210558	Somerset Therapeutics, LLC	ISOSULFAN BLUE	10	mg/mL			N	20241231
70069-231_f8354a00-0f1d-4060-973f-b6558a5d39f7	70069-231	HUMAN PRESCRIPTION DRUG	BRIMONIDINE TARTRATE		BRIMONIDINE TARTRATE	SOLUTION/ DROPS	OPHTHALMIC	20190311		ANDA	ANDA208992	Somerset Therapeutics, LLC	BRIMONIDINE TARTRATE	2	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70069-232_f8354a00-0f1d-4060-973f-b6558a5d39f7	70069-232	HUMAN PRESCRIPTION DRUG	BRIMONIDINE TARTRATE		BRIMONIDINE TARTRATE	SOLUTION/ DROPS	OPHTHALMIC	20190311		ANDA	ANDA208992	Somerset Therapeutics, LLC	BRIMONIDINE TARTRATE	2	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70069-233_f8354a00-0f1d-4060-973f-b6558a5d39f7	70069-233	HUMAN PRESCRIPTION DRUG	BRIMONIDINE TARTRATE		BRIMONIDINE TARTRATE	SOLUTION/ DROPS	OPHTHALMIC	20190311		ANDA	ANDA208992	Somerset Therapeutics, LLC	BRIMONIDINE TARTRATE	2	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70069-261_040ec67b-55ea-41fd-ae73-8d1ef5ca145b	70069-261	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180817		ANDA	ANDA210882	Somerset Therapeutics, LLC	SODIUM NITROPRUSSIDE	25	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
70069-271_6d4f205d-626c-4285-ba7b-c0ca536c7875	70069-271	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180618		ANDA	ANDA211015	Somerset Therapeutics, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70069-272_6d4f205d-626c-4285-ba7b-c0ca536c7875	70069-272	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180618		ANDA	ANDA211015	Somerset Therapeutics, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70069-273_6d4f205d-626c-4285-ba7b-c0ca536c7875	70069-273	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180618		ANDA	ANDA211035	Somerset Therapeutics, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70069-301_e7e7642e-acaa-4907-aa55-14d509aab194	70069-301	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200115		ANDA	ANDA211589	Somerset Therapeutics, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
70069-361_55953381-5afa-4a77-8ac7-e07b5c35e3dc	70069-361	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20190829		ANDA	ANDA212231	Somerset Therapeutics, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70069-362_55953381-5afa-4a77-8ac7-e07b5c35e3dc	70069-362	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20190829		ANDA	ANDA212231	Somerset Therapeutics, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70069-363_55953381-5afa-4a77-8ac7-e07b5c35e3dc	70069-363	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20190829		ANDA	ANDA212231	Somerset Therapeutics, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	80; 16	mg/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70069-381_f6d888a0-65a7-4073-8671-b00b4bfaff4c	70069-381	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20190404		ANDA	ANDA209101	Somerset Therapeutics, LLC	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70069-382_f6d888a0-65a7-4073-8671-b00b4bfaff4c	70069-382	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20190404		ANDA	ANDA209101	Somerset Therapeutics, LLC	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70069-383_f6d888a0-65a7-4073-8671-b00b4bfaff4c	70069-383	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20190404		ANDA	ANDA209101	Somerset Therapeutics, LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70069-384_f6d888a0-65a7-4073-8671-b00b4bfaff4c	70069-384	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20190404		ANDA	ANDA209101	Somerset Therapeutics, LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70069-401_3d6036b6-41d9-44e4-ac8d-e00b8d6974ea	70069-401	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20190619		ANDA	ANDA207601	Somerset Therapeutics, LLC	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
70069-402_3d6036b6-41d9-44e4-ac8d-e00b8d6974ea	70069-402	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20190619		ANDA	ANDA207601	Somerset Therapeutics, LLC	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
70069-403_3d6036b6-41d9-44e4-ac8d-e00b8d6974ea	70069-403	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20190619		ANDA	ANDA207601	Somerset Therapeutics, LLC	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
70069-421_4f3d23f0-a32c-4496-8aae-b5cc4da5ee08	70069-421	HUMAN PRESCRIPTION DRUG	LATANOPROST		LATANOPROST	SOLUTION/ DROPS	OPHTHALMIC	20191203		ANDA	ANDA201786	Somerset Therapeutics, LLC	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
70069-616_7230fa8a-7cda-458d-baa6-31149a64cd3e	70069-616	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220218		ANDA	ANDA207639	Somerset Therapeutics, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70069-727_1f5d8743-2de0-4cab-9a81-612ab186b91f	70069-727	HUMAN PRESCRIPTION DRUG	CALCIUM GLUCONATE		CALCIUM GLUCONATE	INJECTION, SOLUTION	INTRAVENOUS	20231020		ANDA	ANDA217689	Somerset Therapeutics, LLC	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70069-728_1f5d8743-2de0-4cab-9a81-612ab186b91f	70069-728	HUMAN PRESCRIPTION DRUG	CALCIUM GLUCONATE		CALCIUM GLUCONATE	INJECTION, SOLUTION	INTRAVENOUS	20231020		ANDA	ANDA217689	Somerset Therapeutics, LLC	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70069-752_86b0d5d5-6a92-419f-9060-25598fe19aae	70069-752	HUMAN PRESCRIPTION DRUG	Bupivacaine hydrochloride		Bupivacaine hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20231127		ANDA	ANDA217792	Somerset Therapeutics, LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-753_86b0d5d5-6a92-419f-9060-25598fe19aae	70069-753	HUMAN PRESCRIPTION DRUG	Bupivacaine hydrochloride		Bupivacaine hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20231127		ANDA	ANDA217792	Somerset Therapeutics, LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70069-783_5c6877a5-1296-4619-9a7c-01dae4ddf5ac	70069-783	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230530		ANDA	ANDA211589	Somerset Therapeutics, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
70069-801_90a3853e-49d6-4536-be72-82cc875bcf74	70069-801	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210922		ANDA	ANDA213318	Somerset Therapeutics, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70069-802_90a3853e-49d6-4536-be72-82cc875bcf74	70069-802	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210922		ANDA	ANDA213318	Somerset Therapeutics, LLC	PHENYLEPHRINE HYDROCHLORIDE	50	mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70069-803_90a3853e-49d6-4536-be72-82cc875bcf74	70069-803	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210922		ANDA	ANDA213318	Somerset Therapeutics, LLC	PHENYLEPHRINE HYDROCHLORIDE	100	mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70069-804_53c62307-bd19-4418-b1b0-c0274b5595df	70069-804	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	INJECTION, SOLUTION	SUBCUTANEOUS	20211025		ANDA	ANDA213998	Somerset Therapeutics, LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
70069-805_ea767851-b0ab-4a4c-a4b2-680ff4086636	70069-805	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20220110		ANDA	ANDA213074	Somerset Therapeutics, LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70069-806_ea767851-b0ab-4a4c-a4b2-680ff4086636	70069-806	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20220110		ANDA	ANDA213074	Somerset Therapeutics, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70069-807_ce43e850-4e80-4c5b-8811-9cb65824768c	70069-807	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20220923		ANDA	ANDA214380	Somerset Therapeutics, LLC	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
70069-808_ce43e850-4e80-4c5b-8811-9cb65824768c	70069-808	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20220923		ANDA	ANDA214380	Somerset Therapeutics, LLC	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
70069-809_ce43e850-4e80-4c5b-8811-9cb65824768c	70069-809	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20220923		ANDA	ANDA214380	Somerset Therapeutics, LLC	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
70069-811_18b65b44-fdd1-4385-b6f8-cf3cbdc8d0e6	70069-811	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20230717		ANDA	ANDA213318	Somerset Therapeutics, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70069-812_18b65b44-fdd1-4385-b6f8-cf3cbdc8d0e6	70069-812	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20230717		ANDA	ANDA213318	Somerset Therapeutics, LLC	PHENYLEPHRINE HYDROCHLORIDE	50	mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70069-813_18b65b44-fdd1-4385-b6f8-cf3cbdc8d0e6	70069-813	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20230717		ANDA	ANDA213318	Somerset Therapeutics, LLC	PHENYLEPHRINE HYDROCHLORIDE	100	mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70069-814_0ae16705-1e65-c053-e063-6394a90a1d29	70069-814	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230815		ANDA	ANDA213859	Somerset Therapeutics, LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70069-815_0ae16705-1e65-c053-e063-6394a90a1d29	70069-815	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230815		ANDA	ANDA213859	Somerset Therapeutics, LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70069-816_0bbe4e90-4c26-cbbb-e063-6294a90aad1b	70069-816	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231205		ANDA	ANDA090315	SOMERSET THERAPEUTICS, LLC	MIDAZOLAM HYDROCHLORIDE	2	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70069-817_0bbe4e90-4c26-cbbb-e063-6294a90aad1b	70069-817	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231205		ANDA	ANDA090315	SOMERSET THERAPEUTICS, LLC	MIDAZOLAM HYDROCHLORIDE	5	mg/5mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70069-818_0bbe7c1c-5228-e584-e063-6294a90ad750	70069-818	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231205		ANDA	ANDA090316	SOMERSET THERAPEUTICS, LLC	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70082-008_08b602a8-f86a-d47b-e063-6294a90ab627	70082-008	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20120315		OTC MONOGRAPH DRUG	505G(a)(3)	DealMed Medical Supplies LLC	WITCH HAZEL	86	g/100mL			N	20241231
70082-111_08b653ec-1f12-ef53-e063-6294a90afec3	70082-111	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20180718		OTC MONOGRAPH DRUG	M003	DealMed Medical Supplies LLC	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
70082-222_08b602a8-f877-d47b-e063-6294a90ab627	70082-222	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20180718		OTC MONOGRAPH DRUG	M003	DealMed Medical Supplies LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
70084-210_579ffd26-0f74-4d65-8010-0b6cb79c7ba8	70084-210	HUMAN OTC DRUG	Lip Clear Lysine Plus Coldstick		Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	19970106		OTC MONOGRAPH FINAL	part352	Quantum, Inc.	OCTINOXATE; OXYBENZONE	70; 50	mg/g; mg/g			N	20241231
70084-220_8b4341bf-f8f0-441a-8138-f8f2ab6f6400	70084-220	HUMAN OTC DRUG	Super Lysine Plus Coldstick		Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	19970106		OTC MONOGRAPH FINAL	part352	Quantum, Inc.	OCTINOXATE; OXYBENZONE	70; 50	mg/g; mg/g			N	20241231
70084-230_27514af2-16c3-423c-9415-7551f266f3a3	70084-230	HUMAN OTC DRUG	Super Lysine Plus Tangerine Lip Treatment		Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20010402		OTC MONOGRAPH FINAL	part352	Quantum, Inc.	OCTINOXATE; OXYBENZONE	70; 50	mg/g; mg/g			N	20241231
70084-240_c9f27853-ad4d-4ff2-9349-41403b4d19bb	70084-240	HUMAN OTC DRUG	Super Lysine Plus Strawberry Lip Treatment		Octinoxate and Oxybenzone	LIPSTICK	TOPICAL	20010402		OTC MONOGRAPH FINAL	part352	Quantum, Inc.	OCTINOXATE; OXYBENZONE	70; 50	mg/g; mg/g			N	20241231
70084-320_95556ee0-1660-473a-97d6-56d2c7723aee	70084-320	HUMAN OTC DRUG	Lip Clear Lysine Plus		Menthol, Unspecified Form	OINTMENT	TOPICAL	19841001		OTC MONOGRAPH FINAL	part341	Quantum, Inc.	MENTHOL, UNSPECIFIED FORM	1	mg/g			N	20241231
70084-420_285c7d8d-a34b-495b-bf08-c073e5a11d44	70084-420	HUMAN OTC DRUG	Super Lysine plus		Menthol, Unspecified Form	OINTMENT	TOPICAL	19841001		OTC MONOGRAPH FINAL	part341	Quantum, Inc.	MENTHOL, UNSPECIFIED FORM	1	mg/g			N	20241231
70084-500_1a9fd3a5-65c9-4c9d-8f4a-c4c035dba8b5	70084-500	HUMAN OTC DRUG	Canker Care Plus		Menthol, Unspecified Form	LIQUID	TOPICAL	20030401		OTC MONOGRAPH NOT FINAL	part356	Quantum, Inc.	MENTHOL, UNSPECIFIED FORM	5	mg/mL			N	20241231
70084-510_790b88b0-4df5-48a7-8e32-cff2599c0059	70084-510	HUMAN OTC DRUG	Athletes Foot		Tolnaftate	CREAM	TOPICAL	20051205		OTC MONOGRAPH FINAL	part333C	Quantum, Inc.	TOLNAFTATE	10	mg/g			N	20241231
70084-605_732e9f14-b444-4f42-91f4-b7d4aab1a7c9	70084-605	HUMAN OTC DRUG	Quantum Health Meyer Lemon and Honey Flavor		Menthol, Unspecified Form	LOZENGE	ORAL	20170501		OTC MONOGRAPH FINAL	part341	Quantum, Inc.	MENTHOL, UNSPECIFIED FORM	5	mg/1			N	20241231
70084-610_051613a4-f9e4-4dcf-a628-3dd64be69efa	70084-610	HUMAN OTC DRUG	Quantum Health Bing Cherry Flavor		Menthol, Unspecified Form	LOZENGE	ORAL	20170501		OTC MONOGRAPH FINAL	part341	Quantum, Inc.	MENTHOL, UNSPECIFIED FORM	5	mg/1			N	20241231
70084-611_f1ec7607-56cd-4ee1-e053-2a95a90a54ea	70084-611	HUMAN OTC DRUG	Bing Cherry - Cough Relief		Menthol	LOZENGE	ORAL	20191210		OTC MONOGRAPH FINAL	part341	Quantum Inc.	MENTHOL	5.97	mg/1			N	20241231
70084-612_f1ec79eb-d3b6-628e-e053-2a95a90a02ac	70084-612	HUMAN OTC DRUG	Bing Cherry Cough Antitussif Relief	Antitussif	Menthol	LOZENGE	ORAL	20191211		OTC MONOGRAPH FINAL	part341	Quantum Inc.	MENTHOL	5	mg/1			N	20241231
70084-614_f1ec79eb-d3b9-628e-e053-2a95a90a02ac	70084-614	HUMAN OTC DRUG	Meyer Lemon and Honey-Cough Relief Lozenges (Oral Anesthetic)		Menthol	LOZENGE	ORAL	20200115		OTC MONOGRAPH FINAL	part341	Quantum, Inc.	MENTHOL	5	mg/1			N	20241231
70084-710_42623a14-715e-4a68-8d78-2a84aff8bcfe	70084-710	HUMAN OTC DRUG	Scar Reducer	Intensive Herbal and Nutrient	Allantoin	CREAM	TOPICAL	20211025		OTC MONOGRAPH NOT FINAL	part348	Quantum, Inc	ALLANTOIN	1	g/100g			N	20241231
70094-001_098688fd-eb21-29d6-e063-6294a90ade41	70094-001	HUMAN OTC DRUG	Hygienic Ear Care Antiseptic		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20200101		OTC MONOGRAPH DRUG	M003	The Richline Group, Inc.	BENZALKONIUM CHLORIDE	1.2	mg/mL			N	20241231
70094-002_09af694f-d176-2b9c-e063-6394a90a4dfc	70094-002	HUMAN OTC DRUG	Inverness Ear Piercing		BENZALKONIUM CHLORIDE	KIT		20200101		OTC MONOGRAPH DRUG	M003	The Richline Group, Inc.						N	20241231
70095-024_158455b2-3512-46c8-9022-4366f33ac14f	70095-024	HUMAN PRESCRIPTION DRUG	Pantoprazole sodium		Pantoprazole sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230403		ANDA	ANDA204400	Sun Pharmaceutical Industries Limited	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70095-025_dd9fbcb9-f8e5-417f-98b0-6ba9939982c1	70095-025	HUMAN PRESCRIPTION DRUG	Azithromycin monohydrate		Azithromycin monohydrate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230327		ANDA	ANDA065501	Sun Pharmaceutical Industries Limited	AZITHROMYCIN MONOHYDRATE	500	mg/10mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70095-026_353c7624-9af3-4103-9223-af53bc7371a5	70095-026	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230403		ANDA	ANDA216922	Sun Pharmaceutical Industries Limited	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
70095-031_2a4f6931-2711-4831-8096-7acb266f4e22	70095-031	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230620		ANDA	ANDA216904	Sun Pharmaceutical Industries Limited	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
70097-001_0802dd28-f414-cac6-e063-6394a90af6ff	70097-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20040101		NDA	NDA205712	Precision Oxygen & Supply	OXYGEN	990	mL/L			N	20241231
70097-002_0802d889-c3aa-47e6-e063-6294a90ab900	70097-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20040101		NDA	NDA205766	Precision Oxygen & Supply	NITROGEN	990	mL/L			N	20241231
70100-424_a89c3dd8-4be6-4a81-869b-86adf6de3d53	70100-424	HUMAN PRESCRIPTION DRUG	Indocyanine Green		Indocyanine Green and Water	KIT		20080101		ANDA	ANDA040811	Renew Pharmaceuticals Limited						N	20241231
70101-001_0802113f-b61d-2ff9-e063-6294a90a5cb1	70101-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130401		NDA	NDA205712	Gas and Supply	OXYGEN	995	mL/L			N	20241231
70101-002_0802129d-1bb4-2371-e063-6394a90aa730	70101-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20130401		NDA	NDA205713	Gas and Supply	NITROGEN	995	mL/L			N	20241231
70108-008_25a7fd21-6967-4450-a8e9-f3a4f8a490ba	70108-008	HUMAN OTC DRUG	Shopkins Mouth wash		Sodium Fluoride	LIQUID	DENTAL	20161006		OTC MONOGRAPH FINAL	part355	Ashtel Studios Inc.	SODIUM FLUORIDE	.05	mg/100g			N	20241231
70108-019_c00b0a4c-e260-4d40-be41-8cdf4dbc1f06	70108-019	HUMAN OTC DRUG	MINIONS ANTIBACTERIAL HAND WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20190826		OTC MONOGRAPH NOT FINAL	part333A	Ashtel Studios, Inc.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
70108-020_a4e481bd-d899-4898-a8dc-44997b431918	70108-020	HUMAN OTC DRUG	PAW PATROL ANTIBACTERIAL HAND WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20190826		OTC MONOGRAPH NOT FINAL	part333A	Ashtel Studios, Inc.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
70108-028_e9f6912c-77ef-4435-b5e0-c2b61e63a648	70108-028	HUMAN OTC DRUG	Premier Value Medicated Wipes		Witch Hazel	CLOTH	TOPICAL	20191210		OTC MONOGRAPH FINAL	part346	Ashtel Studios, Inc.	WITCH HAZEL	.02	g/1			N	20241231
70108-029_48d3e8ff-45bd-4b6f-8c00-b5b357c49182	70108-029	HUMAN OTC DRUG	Premier Value Medicated Pads		Witch Hazel	CLOTH	TOPICAL	20191210		OTC MONOGRAPH FINAL	part346	Ashtel Studios, Inc.	WITCH HAZEL	.0086	g/1			N	20241231
70108-030_6e54b59d-672f-447b-8d16-90ce7c5cb6f9	70108-030	HUMAN OTC DRUG	Brush Buddies Value 2 pack Whitening		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20191215		OTC MONOGRAPH FINAL	part355	Ashtel Studios, Inc	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
70108-075_484e2a2a-82ae-45d2-a87d-4b858ac13108	70108-075	HUMAN OTC DRUG	Ultimate White Sensitive Whitening		Potassium Nitrate, Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230324		OTC MONOGRAPH NOT FINAL	part356	Ashtel Studios, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
70108-076_dfc47e55-32b0-4cc2-8796-d68e81080c64	70108-076	HUMAN OTC DRUG	Crayola ANTICAVITY BUBBLE GUM FLAVOR		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20230906		OTC MONOGRAPH FINAL	M021	Ashtel Studios, Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
70108-077_9300f219-fcfc-44fb-ae7d-a0a69b0e5dde	70108-077	HUMAN OTC DRUG	Smart Care Antibacterial Hand Sanitizing Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20230906		OTC MONOGRAPH NOT FINAL	part333A	Ashtel Studios, Inc.	BENZALKONIUM CHLORIDE	.11	g/100mL			N	20241231
70108-078_600168c1-11e7-403d-80dd-0f1e09bcfc1c	70108-078	HUMAN OTC DRUG	Brush Buddies TOTAL CARE ANTI-CAVITY Protection		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20230907		OTC MONOGRAPH FINAL	M021	Ashtel Studios, Inc.	SODIUM MONOFLUOROPHOSPHATE	.13	g/100g			N	20241231
70108-079_cfaf57e8-0123-44b9-8eb7-ef9518d06fbe	70108-079	HUMAN OTC DRUG	Brush Buddies SENSITIVE Extra Whitening		Potassium Nitrate, Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230907		OTC MONOGRAPH FINAL	M022	Ashtel Studios, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
70108-080_b94fca8e-a537-49c5-9cda-75584532f635	70108-080	HUMAN OTC DRUG	Crayola ANTICAVITY STRAWBERRY FLAVOR		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20230906		OTC MONOGRAPH FINAL	M021	Ashtel Studios, Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
70108-081_0d4b022c-5125-4884-a7c3-bd165b31b42a	70108-081	HUMAN OTC DRUG	Crayola ANTICAVITY WATERMELON FLAVOR		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20230906		OTC MONOGRAPH FINAL	M021	Ashtel Studios, Inc.	SODIUM FLUORIDE	.243	g/100g			N	20241231
70114-101_dc3e9559-32df-41f3-a8fa-57ce4fb2ca6c	70114-101	HUMAN PRESCRIPTION DRUG	UDENYCA		pegfilgrastim-cbqv	INJECTION, SOLUTION	SUBCUTANEOUS	20181102		BLA	BLA761039	Coherus BioSciences Inc	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20251231
70114-120_dc3e9559-32df-41f3-a8fa-57ce4fb2ca6c	70114-120	HUMAN PRESCRIPTION DRUG	UDENYCA		pegfilgrastim-cbqv	INJECTION, SOLUTION	SUBCUTANEOUS	20230306		BLA	BLA761039	Coherus BioSciences Inc	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20251231
70114-130_dc3e9559-32df-41f3-a8fa-57ce4fb2ca6c	70114-130	HUMAN PRESCRIPTION DRUG	UDENYCA		pegfilgrastim-cbqv	INJECTION, SOLUTION	SUBCUTANEOUS	20231222		BLA	BLA761039	Coherus BioSciences Inc	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20251231
70114-210_02396ea7-3594-4b29-8f8e-7d187692161f	70114-210	HUMAN PRESCRIPTION DRUG	YUSIMRY		adalimumab-aqvh	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761216	Coherus BioSciences Inc	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
70114-220_02396ea7-3594-4b29-8f8e-7d187692161f	70114-220	HUMAN PRESCRIPTION DRUG	YUSIMRY		adalimumab-aqvh	INJECTION, SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761216	Coherus BioSciences Inc	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
70114-340_176dc546-a574-4e35-ab3e-809df4e8f28e	70114-340	HUMAN PRESCRIPTION DRUG	LOQTORZI		toripalimab	INJECTION	INTRAVENOUS	20231027		BLA	BLA761240	Coherus BioSciences, Inc.	TORIPALIMAB	240	mg/6mL			N	20241231
70114-440_3aea9d56-8673-49fb-be41-a7d7cff4e3a2	70114-440	HUMAN PRESCRIPTION DRUG	CIMERLI		ranibizumab-eqrn	INJECTION, SOLUTION	INTRAVITREAL	20221003		BLA	BLA761165	Coherus BioSciences Inc	RANIBIZUMAB	.3	mg/.05mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
70114-441_3aea9d56-8673-49fb-be41-a7d7cff4e3a2	70114-441	HUMAN PRESCRIPTION DRUG	CIMERLI		ranibizumab-eqrn	INJECTION, SOLUTION	INTRAVITREAL	20221003		BLA	BLA761165	Coherus BioSciences Inc	RANIBIZUMAB	.5	mg/.05mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]		N	20241231
70116-004_080454b1-0a3d-2c42-e063-6394a90a92c3	70116-004	HUMAN OTC DRUG	Eezy Pro SPF 30		Meradimate, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200317		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	MERADIMATE; OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	3; 7.5; 4; 5; 9	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-005_08045fbe-f687-f070-e063-6394a90a59b9	70116-005	HUMAN OTC DRUG	Eezy Pro SPF 50		Meradimate, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200317		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	MERADIMATE; OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	5; 7.5; 8; 7; 11	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-006_0804658c-3a03-4213-e063-6394a90ab25c	70116-006	HUMAN OTC DRUG	Eezy Pro SPF30		Meradimate, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200317		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	MERADIMATE; OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	3; 7.5; 4; 5; 9	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-007_0804536d-bb6f-ef23-e063-6394a90af31b	70116-007	HUMAN OTC DRUG	Eezy Pro SPF30		Meradimate, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200317		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	MERADIMATE; OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	3; 7.5; 4; 5; 9	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-008_080470f2-af99-8e56-e063-6294a90a38b3	70116-008	HUMAN OTC DRUG	Eezy Pro SPF50		Meradimate, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200317		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	MERADIMATE; OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	5; 7.5; 8; 7; 11	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-009_080481fe-6388-0252-e063-6294a90a3b13	70116-009	HUMAN OTC DRUG	Eezy Pro SPF50		Meradimate, Octinoxate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200317		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	MERADIMATE; OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	5; 7.5; 8; 7; 11	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-010_08048b9f-ec6a-cc7e-e063-6394a90a957a	70116-010	HUMAN OTC DRUG	Eezy pro		meradimate, octinoxate, octocrylene, titanium dioxide, zinc oxide	CREAM	TOPICAL	20200828		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	MERADIMATE; OCTINOXATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	5; 7.5; 8; 7; 11	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-011_080481fe-6394-0252-e063-6294a90a3b13	70116-011	HUMAN OTC DRUG	Eezysun Aloe Vera After Sun		Aniba Rosaedora, Calendula Officinails, Hyaluronic Acid, Lavandula Officinalis, Matricaria Chamomilla, Mentha Piperita	GEL	TOPICAL	20210326		UNAPPROVED HOMEOPATHIC		BIO EARTH MANUFACTURING (PTY) LTD	ANIBA ROSAEODORA WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; HYALURONIC ACID; LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWER; MATRICARIA CHAMOMILLA WHOLE; MENTHA X PIPERITA WHOLE	.1; .1; .5; .3; .4; .15	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70116-012_08049312-2606-2d06-e063-6294a90a54a2	70116-012	HUMAN OTC DRUG	Eezysun Sunscreen SPF 50 with Aloe Vera, Marine Friendly		Titanium Dioxide,Zinc Oxide	CREAM	TOPICAL	20210330		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.5; 9.5	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-013_0804955c-809b-ff9e-e063-6294a90ac9f0	70116-013	HUMAN OTC DRUG	Eezysun SPF50 Babies and Kids		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	BIO EARTH MANUFACTURING (PTY) LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.5; 9.5	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70116-014_fda4a80b-b5ef-ab65-e053-6394a90ac5a9	70116-014	HUMAN OTC DRUG	Eezysun SPF 50		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230630		OTC MONOGRAPH NOT FINAL	part352	BIO EARTH MANUFACTURING (PTY) LTD	TITANIUM DIOXIDE; ZINC OXIDE	8; 10	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70121-1000_2aa217c3-8a65-429b-9ec4-922151926fe9	70121-1000	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20161111		ANDA	ANDA207549	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1001_2aa217c3-8a65-429b-9ec4-922151926fe9	70121-1001	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20161111		ANDA	ANDA207549	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1002_36507d1c-5ac6-470d-aa90-ae27f1c9cc0d	70121-1002	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION	INTRAVENOUS	20161208		ANDA	ANDA205581	Amneal Pharmaceuticals LLC	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
70121-1003_36507d1c-5ac6-470d-aa90-ae27f1c9cc0d	70121-1003	HUMAN PRESCRIPTION DRUG	Eptifibatide		Eptifibatide	INJECTION	INTRAVENOUS	20161208		ANDA	ANDA205581	Amneal Pharmaceuticals LLC	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
70121-1033_1e855663-7ddb-4179-96ab-587d88fca4c0	70121-1033	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION	INTRAVENOUS	20170309		ANDA	ANDA206699	Amneal Pharmaceuticals LLC	PARICALCITOL	2	ug/mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
70121-1034_1e855663-7ddb-4179-96ab-587d88fca4c0	70121-1034	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION	INTRAVENOUS	20170309		ANDA	ANDA206699	Amneal Pharmaceuticals LLC	PARICALCITOL	5	ug/mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
70121-1035_1e855663-7ddb-4179-96ab-587d88fca4c0	70121-1035	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION	INTRAVENOUS	20170309		ANDA	ANDA206699	Amneal Pharmaceuticals LLC	PARICALCITOL	10	ug/2mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
70121-1036_1e855663-7ddb-4179-96ab-587d88fca4c0	70121-1036	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	INJECTION	INTRAVENOUS	20170309		ANDA	ANDA206699	Amneal Pharmaceuticals LLC	PARICALCITOL	10	ug/2mL	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
70121-1037_f7911ddf-f082-4900-9504-d45cc15861c0	70121-1037	HUMAN PRESCRIPTION DRUG	Argatroban		Argatroban	INJECTION, SOLUTION	INTRAVENOUS	20180126		ANDA	ANDA206698	Amneal Pharmaceuticals LLC	ARGATROBAN	100	mg/mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
70121-1049_991aad0d-7e5f-42d7-b31e-ca6429fe8985	70121-1049	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1076_ea35ac1b-9376-43dd-a285-64954995e9b6	70121-1076	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160725		ANDA	ANDA207552	Amneal Pharmaceuticals LLC	FUROSEMIDE	100	mg/10mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70121-1099_433492d2-85f4-489a-8708-72cd0cf653b5	70121-1099	HUMAN PRESCRIPTION DRUG	Levoleucovorin		Levoleucovorin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170213		ANDA	ANDA207547	Amneal Pharmaceuticals LLC	LEVOLEUCOVORIN CALCIUM	50	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70121-1163_ea35ac1b-9376-43dd-a285-64954995e9b6	70121-1163	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160725		ANDA	ANDA207552	Amneal Pharmaceuticals LLC	FUROSEMIDE	20	mg/2mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70121-1164_ea35ac1b-9376-43dd-a285-64954995e9b6	70121-1164	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160725		ANDA	ANDA207552	Amneal Pharmaceuticals LLC	FUROSEMIDE	40	mg/4mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70121-1168_991aad0d-7e5f-42d7-b31e-ca6429fe8985	70121-1168	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	200	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1169_991aad0d-7e5f-42d7-b31e-ca6429fe8985	70121-1169	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	400	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1189_cc899e8d-21c8-4fd7-be36-6d9d4386f47a	70121-1189	HUMAN PRESCRIPTION DRUG	Sodium nitroprusside		Sodium nitroprusside	INJECTION	INTRAVENOUS	20171107		ANDA	ANDA209493	Amneal Pharmaceuticals LLC	SODIUM NITROPRUSSIDE	25	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
70121-1218_7ae0f211-f911-4fa7-96e1-8d77f5f943d9	70121-1218	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170217		ANDA	ANDA208888	Amneal Pharmaceuticals LLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
70121-1219_7ae0f211-f911-4fa7-96e1-8d77f5f943d9	70121-1219	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170217		ANDA	ANDA208888	Amneal Pharmaceuticals LLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
70121-1221_4220059e-d6ae-4759-9df0-16dbd6e7bb5b	70121-1221	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20180119		ANDA	ANDA209640	Amneal Pharmaceuticals LLC	DOCETAXEL ANHYDROUS	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
70121-1222_4220059e-d6ae-4759-9df0-16dbd6e7bb5b	70121-1222	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20180119		ANDA	ANDA209640	Amneal Pharmaceuticals LLC	DOCETAXEL ANHYDROUS	80	mg/4mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
70121-1223_4220059e-d6ae-4759-9df0-16dbd6e7bb5b	70121-1223	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20180119		ANDA	ANDA209640	Amneal Pharmaceuticals LLC	DOCETAXEL ANHYDROUS	160	mg/8mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
70121-1232_d7983a3d-4cda-43e9-abc7-605305d13b20	70121-1232	HUMAN PRESCRIPTION DRUG	Pemetrexed disodium		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230516		ANDA	ANDA210047	Amneal Pharmaceuticals LLC	PEMETREXED DISODIUM	100	mg/10mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70121-1233_d7983a3d-4cda-43e9-abc7-605305d13b20	70121-1233	HUMAN PRESCRIPTION DRUG	Pemetrexed disodium		Pemetrexed	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220810		ANDA	ANDA210047	Amneal Pharmaceuticals LLC	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70121-1236_9371cb36-5f01-4afa-bbd4-6886ae0fc277	70121-1236	HUMAN PRESCRIPTION DRUG	Clofarabine		Clofarabine	INJECTION	INTRAVENOUS	20171106		ANDA	ANDA208857	Amneal Pharmaceuticals LLC	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70121-1237_f065d5fa-b8e9-4497-890c-130d58417e8c	70121-1237	HUMAN PRESCRIPTION DRUG	AZACITIDINE		AZACITIDINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220209		ANDA	ANDA211549	Amneal Pharmaceuticals LLC	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70121-1238_34a01262-75d3-4c57-baad-2f6d4c0ca8c3	70121-1238	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20180531		ANDA	ANDA210046	Amneal Pharmaceuticals LLC	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70121-1239_34a01262-75d3-4c57-baad-2f6d4c0ca8c3	70121-1239	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20180531		ANDA	ANDA210046	Amneal Pharmaceuticals LLC	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70121-1240_34a01262-75d3-4c57-baad-2f6d4c0ca8c3	70121-1240	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20180531		ANDA	ANDA210046	Amneal Pharmaceuticals LLC	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70121-1244_973e7d91-192a-4dea-9056-4f98c37cdc6f	70121-1244	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION	INTRAVENOUS	20171218		ANDA	ANDA209580	Amneal Pharmaceuticals LLC	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70121-1381_fb1aef5f-1027-46cc-a032-deda9f0b9668	70121-1381	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160811		ANDA	ANDA078476	Amneal Pharmaceuticals LLC	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70121-1388_ae8803ae-20f2-4988-8671-6e64acd094bd	70121-1388	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200520		ANDA	ANDA207551	Amneal Pharmaceuticals LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
70121-1389_ae8803ae-20f2-4988-8671-6e64acd094bd	70121-1389	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20200520		ANDA	ANDA207551	Amneal Pharmaceuticals LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
70121-1390_fb1aef5f-1027-46cc-a032-deda9f0b9668	70121-1390	HUMAN PRESCRIPTION DRUG	Fosphenytoin Sodium		Fosphenytoin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160811		ANDA	ANDA078476	Amneal Pharmaceuticals LLC	FOSPHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70121-1392_0371cb71-1535-42f5-8aec-46c9bd3faa2c	70121-1392	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20170524		ANDA	ANDA208974	Amneal Pharmaceuticals LLC	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
70121-1393_0371cb71-1535-42f5-8aec-46c9bd3faa2c	70121-1393	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20170524		ANDA	ANDA208974	Amneal Pharmaceuticals LLC	DOXERCALCIFEROL	2	ug/mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
70121-1394_c891516f-2a9d-4020-986e-5a741fa4e38b	70121-1394	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170615		ANDA	ANDA208973	Amneal Pharmaceuticals LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70121-1395_c891516f-2a9d-4020-986e-5a741fa4e38b	70121-1395	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170615		ANDA	ANDA208973	Amneal Pharmaceuticals LLC	GLYCOPYRROLATE	.4	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70121-1396_c891516f-2a9d-4020-986e-5a741fa4e38b	70121-1396	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170615		ANDA	ANDA208973	Amneal Pharmaceuticals LLC	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70121-1397_c891516f-2a9d-4020-986e-5a741fa4e38b	70121-1397	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170615		ANDA	ANDA208973	Amneal Pharmaceuticals LLC	GLYCOPYRROLATE	4	mg/20mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70121-1398_6a161eef-6321-4cfa-8a45-404c5ab1002c	70121-1398	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20170228		ANDA	ANDA208840	Amneal Pharmaceuticals LLC	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
70121-1399_b820cb78-dd45-4ae1-a320-6e2cae858397	70121-1399	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180826		ANDA	ANDA208690	Amneal Pharmaceuticals LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1408_a8507e62-a417-4c3b-901a-d8f7f3f7e8e2	70121-1408	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20170524		ANDA	ANDA208975	Amneal Pharmaceuticals LLC	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
70121-1450_1b862eec-8fa0-4754-b86f-3abde3ce497e	70121-1450	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20180827		ANDA	ANDA208689	Amneal Pharmaceuticals LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1451_1b862eec-8fa0-4754-b86f-3abde3ce497e	70121-1451	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20180827		ANDA	ANDA208689	Amneal Pharmaceuticals LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1452_1b862eec-8fa0-4754-b86f-3abde3ce497e	70121-1452	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20180827		ANDA	ANDA208689	Amneal Pharmaceuticals LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1453_1b9cc775-816d-4614-8088-e1998334171a	70121-1453	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160509		ANDA	ANDA205883	Amneal Pharmaceuticals LLC	MEROPENEM	1	g/30mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
70121-1454_1b9cc775-816d-4614-8088-e1998334171a	70121-1454	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160509		ANDA	ANDA205883	Amneal Pharmaceuticals LLC	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
70121-1463_57de7dfe-c139-4710-838f-416643a906d8	70121-1463	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20190304		ANDA	ANDA210044	Amneal Pharmaceuticals LLC	FULVESTRANT	250	mg/5mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
70121-1467_e180a01e-88b5-421f-8fa3-20c65c2368f5	70121-1467	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20230613		ANDA	ANDA215397	Amneal Pharmaceuticals LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70121-1478_d79bf3ed-fad4-4f14-a27c-8e79aaaa703c	70121-1478	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20180620		ANDA	ANDA210051	Amneal Pharmaceuticals LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70121-1479_d79bf3ed-fad4-4f14-a27c-8e79aaaa703c	70121-1479	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20180620		ANDA	ANDA210051	Amneal Pharmaceuticals LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70121-1480_e180a01e-88b5-421f-8fa3-20c65c2368f5	70121-1480	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20230613		ANDA	ANDA215397	Amneal Pharmaceuticals LLC	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70121-1482_811400a5-1133-45dc-8b6f-23e74c92d206	70121-1482	HUMAN PRESCRIPTION DRUG	carmustine		carmustine	KIT		20181022		ANDA	ANDA211229	Amneal Pharmaceuticals LLC						N	20241231
70121-1483_773ddbdb-5a14-4f97-8db8-9a874d129153	70121-1483	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION, SOLUTION	INTRAVENOUS	20210125		ANDA	ANDA210739	Amneal Pharmaceuticals LLC	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
70121-1552_20a4cc60-46fa-42e9-908a-f5e75c955823	70121-1552	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20211101		ANDA	ANDA210043	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1567_1f5a11cf-7247-4659-9e50-716901d87c8f	70121-1567	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS	20160620		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Amneal Pharmaceuticals LLC	BLEOMYCIN SULFATE	15000	[iU]/1	Cytoprotective Agent [EPC]		N	20241231
70121-1568_453cee35-313d-43db-ad1a-ce8fe5d3a56c	70121-1568	HUMAN PRESCRIPTION DRUG	RELEUKO		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220225		BLA	BLA761082	Amneal Pharmaceuticals LLC	FILGRASTIM	300	ug/.5mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
70121-1569_453cee35-313d-43db-ad1a-ce8fe5d3a56c	70121-1569	HUMAN PRESCRIPTION DRUG	RELEUKO		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220225		BLA	BLA761082	Amneal Pharmaceuticals LLC	FILGRASTIM	300	ug/mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
70121-1570_453cee35-313d-43db-ad1a-ce8fe5d3a56c	70121-1570	HUMAN PRESCRIPTION DRUG	RELEUKO		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220225		BLA	BLA761082	Amneal Pharmaceuticals LLC	FILGRASTIM	480	ug/.8mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
70121-1571_453cee35-313d-43db-ad1a-ce8fe5d3a56c	70121-1571	HUMAN PRESCRIPTION DRUG	RELEUKO		Filgrastim	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220225		BLA	BLA761082	Amneal Pharmaceuticals LLC	FILGRASTIM	480	ug/1.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
70121-1572_dde4d69c-d760-4655-a17b-38e4bb2014cd	70121-1572	HUMAN PRESCRIPTION DRUG	Levoleucovorin Calcium		Levoleucovorin	INJECTION, SOLUTION	INTRAVENOUS	20170908		ANDA	ANDA207548	Amneal Pharmaceuticals LLC	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70121-1573_d27a5d31-1bb0-4064-8174-4dc824c02e21	70121-1573	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20190520		ANDA	ANDA210043	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1574_d27a5d31-1bb0-4064-8174-4dc824c02e21	70121-1574	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20190520		ANDA	ANDA210043	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1576_b511a0ea-05b9-4e2b-9323-15e8e44ccf60	70121-1576	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		Norepinephrine Bitartrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20181217		ANDA	ANDA210839	Amneal Pharmaceuticals LLC	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
70121-1577_053f7ef1-afb9-4535-ab92-3c6ca4f6c360	70121-1577	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20180707		ANDA	ANDA211079	Amneal Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70121-1578_5e1820b5-d85d-4628-817a-9929cc70d3bb	70121-1578	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20180724		ANDA	ANDA211078	Amneal Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70121-1579_5e1820b5-d85d-4628-817a-9929cc70d3bb	70121-1579	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20180724		ANDA	ANDA211078	Amneal Pharmaceuticals LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70121-1580_7b04e23e-b98c-46e5-b39b-c3aa10e5b753	70121-1580	HUMAN PRESCRIPTION DRUG	prochlorperazine edisylate		prochlorperazine edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20221212		ANDA	ANDA214192	Amneal Pharmaceuticals LLC	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70121-1581_5ded1dd2-4978-4bd9-a201-397835469adf	70121-1581	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		SUCCINYLCHOLINE CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181120		ANDA	ANDA211432	Amneal Pharmaceuticals LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
70121-1584_41205c84-3420-48fc-b753-b5d57c4ac7d7	70121-1584	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210307		ANDA	ANDA211374	Amneal Pharmaceuticals LLC	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
70121-1585_8392894d-bc98-4bab-a08d-3d31225e97af	70121-1585	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180717		ANDA	ANDA210994	Amneal Pharmaceuticals LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70121-1586_8392894d-bc98-4bab-a08d-3d31225e97af	70121-1586	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180717		ANDA	ANDA210994	Amneal Pharmaceuticals LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70121-1604_8c64f438-7d75-430c-8176-2653f7cc8d0c	70121-1604	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20181022		ANDA	ANDA210576	Amneal Pharmaceuticals LLC	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
70121-1605_8c64f438-7d75-430c-8176-2653f7cc8d0c	70121-1605	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20181022		ANDA	ANDA210576	Amneal Pharmaceuticals LLC	ISOPROTERENOL HYDROCHLORIDE	1	mg/5mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
70121-1609_1f4ff988-a647-4ed8-bc8b-cfa13b037cee	70121-1609	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20231110		ANDA	ANDA216502	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1610_1f4ff988-a647-4ed8-bc8b-cfa13b037cee	70121-1610	HUMAN PRESCRIPTION DRUG	Methylprednisolone acetate		Methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE	20231110		ANDA	ANDA216502	Amneal Pharmaceuticals LLC	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1627_b512ecac-1a1c-41ad-bbeb-f46cc90c1333	70121-1627	HUMAN PRESCRIPTION DRUG	FYLNETRA		pegfilgrastim	INJECTION	SUBCUTANEOUS	20220531		BLA	BLA761084	Amneal Pharmaceuticals LLC	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
70121-1630_efb00209-b6cb-4f50-9546-b0ea0e4db28f	70121-1630	HUMAN PRESCRIPTION DRUG	TEPADINA		THIOTEPA	INJECTION, POWDER, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20170815		NDA	NDA208264	Amneal Pharmaceuticals LLC	THIOTEPA	15	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70121-1631_efb00209-b6cb-4f50-9546-b0ea0e4db28f	70121-1631	HUMAN PRESCRIPTION DRUG	TEPADINA		THIOTEPA	INJECTION, POWDER, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20170815		NDA	NDA208264	Amneal Pharmaceuticals LLC	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70121-1637_1fbe12bc-b6af-4cd5-be5c-7e9b305c0970	70121-1637	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20191023		ANDA	ANDA212932	Amneal Pharmaceuticals LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70121-1642_276406b1-43ac-4278-90d6-af301044269e	70121-1642	HUMAN PRESCRIPTION DRUG	vasopressin		vasopressin	INJECTION	INTRAVENOUS	20220811		ANDA	ANDA212944	Amneal Pharmaceuticals LLC	VASOPRESSIN	20	[USP'U]/mL	Decreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]		N	20241231
70121-1644_5b9c6cb1-3315-4023-8a3b-9c92596d01f9	70121-1644	HUMAN PRESCRIPTION DRUG	Decitabine		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191201		ANDA	ANDA206033	Amneal Pharmaceuticals LLC	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70121-1647_6139ed2b-7362-4408-84e0-8c34fe97e2a5	70121-1647	HUMAN PRESCRIPTION DRUG	Tigecycline		Tigecycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180131		NDA	NDA211158	Amneal Pharmaceuticals LLC	TIGECYCLINE	50	mg/5mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
70121-1651_1fd7c712-ee9d-4d81-967a-c09fdf3407eb	70121-1651	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1652_1fd7c712-ee9d-4d81-967a-c09fdf3407eb	70121-1652	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	200	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1653_1fd7c712-ee9d-4d81-967a-c09fdf3407eb	70121-1653	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	400	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1654_96c0858b-8b74-4e04-8929-5507c5432445	70121-1654	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	200	mg/5mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1655_96c0858b-8b74-4e04-8929-5507c5432445	70121-1655	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	400	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1657_96c0858b-8b74-4e04-8929-5507c5432445	70121-1657	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20171211		ANDA	ANDA207550	Amneal Pharmaceuticals LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70121-1658_773ddbdb-5a14-4f97-8db8-9a874d129153	70121-1658	HUMAN PRESCRIPTION DRUG	Arsenic Trioxide		Arsenic Trioxide	INJECTION, SOLUTION	INTRAVENOUS	20210820		ANDA	ANDA210739	Amneal Pharmaceuticals LLC	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
70121-1680_23ee4fca-cc2b-4d35-a3f4-ecfa9e3ff93d	70121-1680	HUMAN PRESCRIPTION DRUG	carboprost tromethamine		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20220130		ANDA	ANDA215337	Amneal Pharmaceuticals LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
70121-1694_8a7da718-3cab-4731-9590-e90224f56405	70121-1694	HUMAN PRESCRIPTION DRUG	plerixafor		plerixafor	INJECTION, SOLUTION	SUBCUTANEOUS	20230725		ANDA	ANDA215334	Amneal Pharmaceuticals LLC	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
70121-1698_4a4ed4be-8aa5-4b2a-a43d-c40f04a8a852	70121-1698	HUMAN PRESCRIPTION DRUG	glycopyrrolate		glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20221025		ANDA	ANDA215333	Amneal Pharmaceuticals LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70121-1699_4a4ed4be-8aa5-4b2a-a43d-c40f04a8a852	70121-1699	HUMAN PRESCRIPTION DRUG	glycopyrrolate		glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20221025		ANDA	ANDA215333	Amneal Pharmaceuticals LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70121-1705_0d7529b1-f9ae-4868-a72a-22db9440b004	70121-1705	HUMAN PRESCRIPTION DRUG	atropine sulfate		atropine sulfate	INJECTION, SOLUTION	INTRAVENOUS	20220129		ANDA	ANDA215342	Amneal Pharmaceuticals LLC	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
70121-1706_0d7529b1-f9ae-4868-a72a-22db9440b004	70121-1706	HUMAN PRESCRIPTION DRUG	atropine sulfate		atropine sulfate	INJECTION, SOLUTION	INTRAVENOUS	20240109		ANDA	ANDA215342	Amneal Pharmaceuticals LLC	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
70121-1711_a492a1df-8edf-4e8d-974b-7a8b5092b3ce	70121-1711	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride in Sodium Chloride	INJECTION	INTRAVENOUS	20230519		ANDA	ANDA216604	Amneal Pharmaceuticals LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
70121-1712_a492a1df-8edf-4e8d-974b-7a8b5092b3ce	70121-1712	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride in Sodium Chloride	INJECTION	INTRAVENOUS	20230519		ANDA	ANDA216604	Amneal Pharmaceuticals LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
70121-1716_e592dca3-9291-45b8-bf12-5f670f883eda	70121-1716	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride in Sodium Chloride	INJECTION	INTRAVENOUS	20221216		ANDA	ANDA216603	Amneal Pharmaceuticals LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70121-1717_e592dca3-9291-45b8-bf12-5f670f883eda	70121-1717	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride in Sodium Chloride	INJECTION	INTRAVENOUS	20221216		ANDA	ANDA216603	Amneal Pharmaceuticals LLC	ESMOLOL HYDROCHLORIDE	20	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70121-1719_1481000a-c6ce-4187-bfc1-419b5001b5dd	70121-1719	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate In Water For	INJECTION	INTRAVENOUS	20230220		ANDA	ANDA216597	Amneal Pharmaceuticals LLC	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70121-1720_1481000a-c6ce-4187-bfc1-419b5001b5dd	70121-1720	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		Magnesium Sulfate In Water For	INJECTION	INTRAVENOUS	20230220		ANDA	ANDA216597	Amneal Pharmaceuticals LLC	MAGNESIUM SULFATE HEPTAHYDRATE	40	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70121-1732_f7295675-6696-4c6e-8742-cb4017d4b353	70121-1732	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20230317		ANDA	ANDA216605	Amneal Pharmaceuticals LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70121-1733_f7295675-6696-4c6e-8742-cb4017d4b353	70121-1733	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20230317		ANDA	ANDA216605	Amneal Pharmaceuticals LLC	ROPIVACAINE HYDROCHLORIDE	2	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70121-1734_f7295675-6696-4c6e-8742-cb4017d4b353	70121-1734	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20230317		ANDA	ANDA216605	Amneal Pharmaceuticals LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70121-1735_f7295675-6696-4c6e-8742-cb4017d4b353	70121-1735	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20230317		ANDA	ANDA216605	Amneal Pharmaceuticals LLC	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70121-1743_e6bfc4a7-d457-4955-b35a-4c9ca86bac56	70121-1743	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20230410		ANDA	ANDA216346	Amneal Pharmaceuticals LLC	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70121-1754_eef75c43-bea4-4772-a341-c33ab0c5216a	70121-1754	HUMAN PRESCRIPTION DRUG	ALYMSYS		bevacizumab-maly	INJECTION, SOLUTION	INTRAVENOUS	20220415		BLA	BLA761231	Amneal Pharmaceuticals LLC	BEVACIZUMAB	100	mg/4mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
70121-1755_eef75c43-bea4-4772-a341-c33ab0c5216a	70121-1755	HUMAN PRESCRIPTION DRUG	ALYMSYS		bevacizumab-maly	INJECTION, SOLUTION	INTRAVENOUS	20220415		BLA	BLA761231	Amneal Pharmaceuticals LLC	BEVACIZUMAB	400	mg/16mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
70121-2453_2d0d55a0-41c4-4779-ac69-3cac11200e8d	70121-2453	HUMAN PRESCRIPTION DRUG	PEMRYDI RTU		Pemetrexed disodium	INJECTION	INTRAVENOUS	20230606		NDA	NDA215179	Amneal Pharmaceuticals LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/10mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70121-2461_2d0d55a0-41c4-4779-ac69-3cac11200e8d	70121-2461	HUMAN PRESCRIPTION DRUG	PEMRYDI RTU		Pemetrexed disodium	INJECTION	INTRAVENOUS	20230606		NDA	NDA215179	Amneal Pharmaceuticals LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/50mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70121-2462_2d0d55a0-41c4-4779-ac69-3cac11200e8d	70121-2462	HUMAN PRESCRIPTION DRUG	PEMRYDI RTU		Pemetrexed disodium	INJECTION	INTRAVENOUS	20230606		NDA	NDA215179	Amneal Pharmaceuticals LLC	PEMETREXED DISODIUM HEMIPENTAHYDRATE	1000	mg/100mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70121-2496_597f2ccc-ff28-4551-a2a1-ea2f9f9c2a61	70121-2496	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	INJECTION	INTRATHECAL	20220612	20241130	NDA	NDA020075	Amneal Pharmaceuticals LLC	BACLOFEN	.05	mg/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
70121-2501_597f2ccc-ff28-4551-a2a1-ea2f9f9c2a61	70121-2501	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	KIT	INTRATHECAL	20220612	20241130	NDA	NDA020075	Amneal Pharmaceuticals LLC						N	
70121-2502_597f2ccc-ff28-4551-a2a1-ea2f9f9c2a61	70121-2502	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	KIT	INTRATHECAL	20220612	20241130	NDA	NDA020075	Amneal Pharmaceuticals LLC						N	
70121-2503_597f2ccc-ff28-4551-a2a1-ea2f9f9c2a61	70121-2503	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	KIT	INTRATHECAL	20220612	20241130	NDA	NDA020075	Amneal Pharmaceuticals LLC						N	
70121-2504_597f2ccc-ff28-4551-a2a1-ea2f9f9c2a61	70121-2504	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	KIT	INTRATHECAL	20220612	20241130	NDA	NDA020075	Amneal Pharmaceuticals LLC						N	
70121-2505_597f2ccc-ff28-4551-a2a1-ea2f9f9c2a61	70121-2505	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	KIT	INTRATHECAL	20220612	20241130	NDA	NDA020075	Amneal Pharmaceuticals LLC						N	
70121-2537_47116caf-d600-44ba-9527-7c92840a8416	70121-2537	HUMAN PRESCRIPTION DRUG	leuprolide acetate		leuprolide acetate	KIT	SUBCUTANEOUS	20221107		ANDA	ANDA215336	Amneal Pharmaceuticals LLC						N	20241231
70124-110_225371d6-5a66-6fac-e054-00144ff88e88	70124-110	HUMAN OTC DRUG	Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20150720		OTC MONOGRAPH NOT FINAL	part333E	Sloan Valve Company	ALCOHOL	71	mL/100mL			N	20241231
70127-100_a9349679-6f2d-4117-a877-041d387a9c9e	70127-100	HUMAN PRESCRIPTION DRUG	Epidiolex		cannabidiol	SOLUTION	ORAL	20181005		NDA	NDA210365	Jazz Pharmaceuticals, Inc.	CANNABIDIOL	100	mg/mL	Cannabinoids [CS], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]		N	20241231
70146-000_c3f30ec6-a8a5-2744-e053-2995a90a1002	70146-000	HUMAN OTC DRUG	Relief Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20151015		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 10; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-001_c3f33ddd-6b56-95fe-e053-2995a90ad643	70146-001	HUMAN OTC DRUG	Womens Relief Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20151015		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 10; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-002_c3f3297a-3108-3ba2-e053-2995a90ab6a6	70146-002	HUMAN OTC DRUG	Sports Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20151015		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 10; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-003_c3f34047-8553-95f7-e053-2995a90a55f9	70146-003	HUMAN OTC DRUG	Womens Sports Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20151015		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 10; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-004_c3f340c0-6241-0f00-e053-2a95a90a9914	70146-004	HUMAN OTC DRUG	Relief Balm		camphor, eucalyptus oil, menthol	CREAM	TOPICAL	20160721		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	11; 10; 8	g/100g; g/100g; g/100g			N	20241231
70146-005_c3f3546f-9772-95fb-e053-2995a90acc99	70146-005	HUMAN OTC DRUG	Sports Balm		camphor, eucalyptus oil, menthol	CREAM	TOPICAL	20160721		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	11; 10; 8	g/100g; g/100g; g/100g			N	20241231
70146-006_c3f30ec6-a8ab-2744-e053-2995a90a1002	70146-006	HUMAN OTC DRUG	Womens Relief Balm		camphor, eucalyptus oil, menthol	CREAM	TOPICAL	20160721		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	11; 10; 8	g/100g; g/100g; g/100g			N	20241231
70146-007_c3f3546f-9773-95fb-e053-2995a90acc99	70146-007	HUMAN OTC DRUG	Womens Sports Balm		camphor, eucalyptus oil, menthol	CREAM	TOPICAL	20160721		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	11; 10; 8	g/100g; g/100g; g/100g			N	20241231
70146-008_c3f3297a-310b-3ba2-e053-2995a90ab6a6	70146-008	HUMAN OTC DRUG	Relief Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20161025		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 8; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-009_c3f350bb-6d7c-47b4-e053-2995a90a0117	70146-009	HUMAN OTC DRUG	Sports Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20161025		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 8; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-010_c3f35f80-e4ad-95f5-e053-2995a90a1b64	70146-010	HUMAN OTC DRUG	Womens Relief Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20161025		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 8; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-011_c3f35f80-e4b0-95f5-e053-2995a90a1b64	70146-011	HUMAN OTC DRUG	Womens Sports Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20161025		OTC MONOGRAPH NOT FINAL	part348	Dr.Sankunni's Ayurvedic Research Foundation Private Limited	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 8; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
70146-012_a79548c3-a02a-d774-e053-2a95a90a422d	70146-012	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Dr.Sankunnis Ayurvedic Research Foundation Pvt Ltd	ALCOHOL	70	mL/100mL			N	20241231
70150-001_f28be15d-27ad-563f-e053-2995a90aef6f	70150-001	HUMAN OTC DRUG	EXT Hair Regrowth Treatment for Women		Minoxidil 2%	SOLUTION	TOPICAL	20190910		ANDA	ANDA078176	TTEM, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70150-002_f28bdfa1-c6c2-452a-e053-2995a90adcdd	70150-002	HUMAN OTC DRUG	EXT Hair Regrowth Treatment for Men 2%		Minoxidil 2%	SOLUTION	TOPICAL	20190910		ANDA	ANDA078176	TTEM, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70150-003_f28bda57-5c2c-c91f-e053-2995a90af83c	70150-003	HUMAN OTC DRUG	EXT Hair Regrowth Treatment for Men 5%		Minoxidil 5%	SOLUTION	TOPICAL	20190910		ANDA	ANDA076239	TTEM, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70150-004_f28bb4d2-d581-1a62-e053-2995a90aa0c6	70150-004	HUMAN OTC DRUG	Rootly Hair Regrowth Treatment for Women		Minoxidil 2%	SOLUTION	TOPICAL	20210822		ANDA	ANDA078176	TTEM, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70150-005_f28bbeee-ee5a-4aba-e053-2995a90ade84	70150-005	HUMAN OTC DRUG	Rootly Extra Strength Hair Regrowth Treatment for Men		Minoxidil 5%	SOLUTION	TOPICAL	20210824		ANDA	ANDA076239	TTEM, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70151-001_0711bcf8-71bb-6bf7-e063-6294a90ab7f6	70151-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20151115		NDA	NDA205712	Central Welding Supply Company	OXYGEN	990	mL/L			N	20241231
70151-003_0711bcf8-71ba-6bf7-e063-6294a90ab7f6	70151-003	HUMAN PRESCRIPTION DRUG	Air		Air	GAS	RESPIRATORY (INHALATION)	20151115		NDA	NDA205712	Central Welding Supply Company	OXYGEN	210	mL/L			N	20241231
70151-004_0711ce37-abcf-4be4-e063-6394a90a29b4	70151-004	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20160301		NDA	NDA205704	Central Welding Supply Company	NITROUS OXIDE	990	mL/L			N	20241231
70151-021_0711d72c-2130-49bf-e063-6394a90a484b	70151-021	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20151115		NDA	NDA205713	Central Welding Supply Company	NITROGEN	990	mL/L			N	20241231
70154-204_911fd39d-9c95-52ae-e053-2a95a90a13f3	70154-204	HUMAN OTC DRUG	TRIPROLIDINE HYDROCHLORIDE		Triprolidine Hydrochloride	LIQUID	ORAL	20190819	20241031	OTC MONOGRAPH FINAL	M012	Monarch PCM, LLC	TRIPROLIDINE HYDROCHLORIDE	.938	mg/mL			N	
70157-002_ee14a64b-ec3d-0a71-e053-2995a90ad15e	70157-002	HUMAN OTC DRUG	City Sunscreen serum Broad Spectrum SPF 30	Supergoop	Homosalate, Octisalate, Avobenzene, Octocrylene	CREAM	TOPICAL	20101207		OTC MONOGRAPH FINAL	M020	Baxter Laboratories Pty. Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4; 2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70157-004_ee14bfe3-fcfc-19f1-e053-2a95a90accb8	70157-004	HUMAN OTC DRUG	City Sunscreen serum Broad Spectrum SPF 30	Supergoop	Homosalate, Octisalate, Avobenzene, Octocrylene	CREAM	TOPICAL	20101207		OTC MONOGRAPH FINAL	M020	Baxter Laboratories Pty. Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4; 2	g/100kg; g/100kg; g/100kg; g/100kg			N	20241231
70157-005_ee14c4c1-1f8d-518d-e053-2a95a90aba9a	70157-005	HUMAN OTC DRUG	Soft Focus City Suncreen Serum Broad Spectrum SPF 30	Supergoop	Avobenzone, Homosalate, Octisalate, Octocrylene	LIQUID	TOPICAL	20141230		OTC MONOGRAPH FINAL	M020	Baxter Laboratories Pty. Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4; 2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70157-008_eea19e7f-66b2-2aa2-e053-2995a90aedb3	70157-008	HUMAN OTC DRUG	UVA and UVB Broad Spectrum SPF30 Sunscreen Oil with golden shimmer		Homosalate, Octocrylene, Avobenzone	OIL	TOPICAL	20221201		OTC MONOGRAPH FINAL	M020	Baxter Laboratories Pty. Ltd.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 8	g/100mL; g/100mL; g/100mL			N	20241231
70157-009_eea4461d-3ccc-a410-e053-2995a90a5558	70157-009	HUMAN OTC DRUG	Hydrating Body Sunscreen UVA and UVB Broad Spectrum SPF50		Homosalate, Octocrylene, Octisalate, Avobenzone	CREAM	TOPICAL	20221201		OTC MONOGRAPH FINAL	M020	Baxter Laboratories Pty. Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70162-102_0e5e4315-4dc0-0fe6-e063-6294a90a3d65	70162-102	HUMAN OTC DRUG	BPT3.1 ACNE TREATMENT		BENZOYL PEROXIDE	LOTION	TOPICAL	20200727		OTC MONOGRAPH DRUG	M006	Create Cosmetics, LLC	BENZOYL PEROXIDE	3	g/100mL			N	20251231
70162-103_0e5e208a-01b5-acda-e063-6394a90aee16	70162-103	HUMAN OTC DRUG	BPT10.1 ACNE TREATMENT		BENZOYL PEROXIDE	LOTION	TOPICAL	20200727		OTC MONOGRAPH DRUG	M006	Create Cosmetics, LLC	BENZOYL PEROXIDE	10	g/100mL			N	20251231
70163-0001_0d37567f-e29d-4e20-9e93-cf8d93ad521c	70163-0001	HUMAN OTC DRUG	Insomnia	HP	Arsenicum Album, Avena Sativa, Coffea Cruda, Kali Carbonicum, Magnesia Carbonica, Nux Vomica, Passiflora Incarnata, Sepia, Valeriana Officinalis	LIQUID	ORAL	20151123	20240124	UNAPPROVED HOMEOPATHIC		Grato Holdings, Inc.	ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; MAGNESIUM CARBONATE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; VALERIAN	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	
70163-0002_f934b0f4-d90e-42ff-9226-839dd03bcb38	70163-0002	HUMAN OTC DRUG	Sleep HP		Arsenicum Album, Avena Sativa, Coffea Cruda, Kali Carbonicum, Magnesia Carbonica, Nux Vomica, Passiflora Incarnata, Sepia, Valeriana Officinalis	LIQUID	ORAL	20201130		UNAPPROVED HOMEOPATHIC		Grato Holdings, Inc.	ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; MAGNESIUM CARBONATE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; VALERIAN	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; 1/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
70165-005_0cf33da6-d664-3c5e-e063-6394a90ae5ac	70165-005	HUMAN PRESCRIPTION DRUG	Adzenys XR-ODT		Amphetamine	TABLET, ORALLY DISINTEGRATING	ORAL	20160216		NDA	NDA204326	Neos Therapeutics Brands, LLC	AMPHETAMINE	3.1	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-010_0cf33da6-d664-3c5e-e063-6394a90ae5ac	70165-010	HUMAN PRESCRIPTION DRUG	Adzenys XR-ODT		Amphetamine	TABLET, ORALLY DISINTEGRATING	ORAL	20160216		NDA	NDA204326	Neos Therapeutics Brands, LLC	AMPHETAMINE	6.3	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-015_0cf33da6-d664-3c5e-e063-6394a90ae5ac	70165-015	HUMAN PRESCRIPTION DRUG	Adzenys XR-ODT		Amphetamine	TABLET, ORALLY DISINTEGRATING	ORAL	20160216		NDA	NDA204326	Neos Therapeutics Brands, LLC	AMPHETAMINE	9.4	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-020_0cf33da6-d664-3c5e-e063-6394a90ae5ac	70165-020	HUMAN PRESCRIPTION DRUG	Adzenys XR-ODT		Amphetamine	TABLET, ORALLY DISINTEGRATING	ORAL	20160216		NDA	NDA204326	Neos Therapeutics Brands, LLC	AMPHETAMINE	12.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-025_0cf33da6-d664-3c5e-e063-6394a90ae5ac	70165-025	HUMAN PRESCRIPTION DRUG	Adzenys XR-ODT		Amphetamine	TABLET, ORALLY DISINTEGRATING	ORAL	20160216		NDA	NDA204326	Neos Therapeutics Brands, LLC	AMPHETAMINE	15.7	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-030_0cf33da6-d664-3c5e-e063-6394a90ae5ac	70165-030	HUMAN PRESCRIPTION DRUG	Adzenys XR-ODT		Amphetamine	TABLET, ORALLY DISINTEGRATING	ORAL	20160216		NDA	NDA204326	Neos Therapeutics Brands, LLC	AMPHETAMINE	18.8	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-100_0bdd78c5-378c-082a-e063-6294a90aedea	70165-100	HUMAN PRESCRIPTION DRUG	Cotempla XR-ODT		Methylphenidate	TABLET, ORALLY DISINTEGRATING	ORAL	20170620		NDA	NDA205489	Neos Therapeutics Brands, LLC	METHYLPHENIDATE	8.6	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-200_0bdd78c5-378c-082a-e063-6294a90aedea	70165-200	HUMAN PRESCRIPTION DRUG	Cotempla XR-ODT		Methylphenidate	TABLET, ORALLY DISINTEGRATING	ORAL	20170620		NDA	NDA205489	Neos Therapeutics Brands, LLC	METHYLPHENIDATE	17.3	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70165-300_0bdd78c5-378c-082a-e063-6294a90aedea	70165-300	HUMAN PRESCRIPTION DRUG	Cotempla XR-ODT		Methylphenidate	TABLET, ORALLY DISINTEGRATING	ORAL	20170620		NDA	NDA205489	Neos Therapeutics Brands, LLC	METHYLPHENIDATE	25.9	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70170-0015_1864c74d-f841-4ee1-a09d-ddda4d5aff6a	70170-0015	HUMAN OTC DRUG	eos THE GUARDIAN 100% NATURAL SPF 30 COCONUT SUN PROTECT SUNSCREEN LIP BALM		Zinc Oxide	STICK	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part352	eos Products LLC	ZINC OXIDE	.4	g/4g			N	20241231
70170-0016_8d615bd1-38cb-4777-8f3b-b6a66442aa55	70170-0016	HUMAN OTC DRUG	eos THE GUARDIAN 100% NATURAL SPF 30 WATERMELON SUN PROTECT SUNSCREEN LIP BALM		Zinc Oxide	STICK	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	eos Products LLC	ZINC OXIDE	.4	g/4g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70170-0017_923d6b66-42f4-4461-9885-b806f5e74ddd	70170-0017	HUMAN OTC DRUG	eos THE FIXER HEAL REPAIR MEDICATED ANALGESIC LIP		Menthol, Camphor, Allantoin	OINTMENT	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part348	eos Products LLC	ALLANTOIN; CAMPHOR (NATURAL); MENTHOL	.0475; .0475; .0594	g/10mL; g/10mL; g/10mL			N	20241231
70170-0020_30e38e20-2f73-4e8b-aae5-8b1f580f475f	70170-0020	HUMAN OTC DRUG	eos SHEA BETTERTM HYDRATING HAND SANITIZER pomegranate raspberry		Ethyl Alcohol	GEL	TOPICAL	20210118		OTC MONOGRAPH NOT FINAL	part333A	eos Products LLC	ALCOHOL	165.2	mL/236mL			N	20241231
70170-0021_c2b9e452-0f51-4074-84ee-fe82a1eff911	70170-0021	HUMAN OTC DRUG	eos SHEA BETTERTM HYDRATING HAND SANITIZER coconut waters		Ethyl Alcohol	GEL	TOPICAL	20210118		OTC MONOGRAPH NOT FINAL	part333A	eos Products LLC	ALCOHOL	165.2	mL/236mL			N	20241231
70170-0022_039ca738-c2c2-41c8-e063-6394a90ab4c4	70170-0022	HUMAN OTC DRUG	eos Natural SPF 15 Lip Balm	Pineapple Coconut	Zinc Oxide	STICK	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	eos Products LLC	ZINC OXIDE	.32	g/4g			N	20241231
70183-125_ae1ad7b7-cff2-46e1-8995-56adf7b4212c	70183-125	HUMAN PRESCRIPTION DRUG	Xermelo		telotristat ethyl	TABLET	ORAL	20170301		NDA	NDA208794	Lexicon Pharmaceuticals, Inc.	TELOTRISTAT ETHYL	250	mg/1	Tryptophan Hydroxylase Inhibitor [EPC], Tryptophan Hydroxylase Inhibitors [MoA]		N	20241231
70183-125_b3b84922-3dcf-4c02-91ea-856e4882a271	70183-125	HUMAN PRESCRIPTION DRUG	Xermelo		telotristat ethyl	TABLET	ORAL	20170301		NDA	NDA208794	Lexicon Pharmaceuticals, Inc.	TELOTRISTAT ETHYL	250	mg/1	Tryptophan Hydroxylase Inhibitor [EPC], Tryptophan Hydroxylase Inhibitors [MoA]		N	20241231
70183-220_8c3687e7-b8b3-4586-976b-98035bb896ac	70183-220	HUMAN PRESCRIPTION DRUG	INPEFA		sotagliflozin	TABLET	ORAL	20230526		NDA	NDA216203	Lexicon Pharmaceuticals, Inc.	SOTAGLIFLOZIN	200	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
70183-221_8c3687e7-b8b3-4586-976b-98035bb896ac	70183-221	HUMAN PRESCRIPTION DRUG	INPEFA		sotagliflozin	TABLET	ORAL	20230526		NDA	NDA216203	Lexicon Pharmaceuticals, Inc.	SOTAGLIFLOZIN	200	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
70183-241_8c3687e7-b8b3-4586-976b-98035bb896ac	70183-241	HUMAN PRESCRIPTION DRUG	INPEFA		sotagliflozin	TABLET	ORAL	20230526		NDA	NDA216203	Lexicon Pharmaceuticals, Inc.	SOTAGLIFLOZIN	400	mg/1	P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
70186-600_0c272e95-3147-462b-86c5-a2412725bfd3	70186-600	HUMAN OTC DRUG	LIGHTWEIGHT MIRACLE MOISTURISER SUNSCREEN BROAD SPECTRUM SPF 20		Avobenzone, Homosalate, Octisalate and Octocrylene	CREAM	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.158; .525; .263; .525	g/5mL; g/5mL; g/5mL; g/5mL			N	20241231
70186-601_822be17d-994f-45a1-b89b-e42459b6422f	70186-601	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1; 1.76	g/40mL; g/40mL			N	20241231
70186-602_822be17d-994f-45a1-b89b-e42459b6422f	70186-602	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-603_822be17d-994f-45a1-b89b-e42459b6422f	70186-603	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-604_822be17d-994f-45a1-b89b-e42459b6422f	70186-604	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-605_822be17d-994f-45a1-b89b-e42459b6422f	70186-605	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-606_822be17d-994f-45a1-b89b-e42459b6422f	70186-606	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-607_822be17d-994f-45a1-b89b-e42459b6422f	70186-607	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-608_822be17d-994f-45a1-b89b-e42459b6422f	70186-608	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-609_822be17d-994f-45a1-b89b-e42459b6422f	70186-609	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-610_822be17d-994f-45a1-b89b-e42459b6422f	70186-610	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-611_822be17d-994f-45a1-b89b-e42459b6422f	70186-611	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-612_822be17d-994f-45a1-b89b-e42459b6422f	70186-612	HUMAN OTC DRUG	LIGHT WONDER YOUR LIGHT, DREAM SKIN FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15		Octinoxate and Titanium Dioxide	SUSPENSION	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	OCTINOXATE; TITANIUM DIOXIDE	1.76; 1	g/40mL; g/40mL			N	20241231
70186-700_d34669b8-acbd-7c93-e053-2a95a90adbe4	70186-700	HUMAN OTC DRUG	CHARLOTTE TILBURY Broad Spectrum SPF 50 Sunscreen Invisible UV Flawless Primer		Avobenzone, Octinoxate, Octisalate, Octocrylene	CREAM	TOPICAL	20220519		OTC MONOGRAPH NOT FINAL	part352	Charlotte Tilbury Beauty Ltd.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.918; 2.038; 1.377; .612	g/30mL; g/30mL; g/30mL; g/30mL			N	20241231
70188-005_f13b322e-28cf-42e1-a2c8-fa78be44c236	70188-005	HUMAN OTC DRUG	Derma Numb Pain Relief		Lidocaine HCL	GEL	TOPICAL	20150701		OTC MONOGRAPH NOT FINAL	part348	A.T.S. Laboratories, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70188-006_d3633961-95d7-4497-8dd6-58996b071624	70188-006	HUMAN OTC DRUG	DermaNumb Analgesic		Lidocaine HCL	GEL	TOPICAL	20150701		OTC MONOGRAPH NOT FINAL	part348	A.T.S. Laboratories, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70199-001_fbaeb9d5-4b22-4528-9421-9954e53887c9	70199-001	HUMAN PRESCRIPTION DRUG	Thalitone		chlorthalidone	TABLET	ORAL	20191127		NDA	NDA019574	Casper Pharma LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70199-002_085f1a70-ff63-4c02-ac05-2579fe2ef002	70199-002	HUMAN PRESCRIPTION DRUG	Antivert		meclizine HCl	TABLET	ORAL	20200115		NDA	NDA010721	Casper Pharma LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70199-003_085f1a70-ff63-4c02-ac05-2579fe2ef002	70199-003	HUMAN PRESCRIPTION DRUG	Antivert		meclizine HCl	TABLET	ORAL	20200115		NDA	NDA010721	Casper Pharma LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70199-004_085f1a70-ff63-4c02-ac05-2579fe2ef002	70199-004	HUMAN PRESCRIPTION DRUG	Antivert		meclizine hcl	TABLET	ORAL	20200115		NDA	NDA010721	Casper Pharma LLC	MECLIZINE HYDROCHLORIDE	50	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70199-006_4dee1029-b1b5-4d30-8022-a33868ca8467	70199-006	HUMAN PRESCRIPTION DRUG	Furadantin		Nitrofurantoin	SUSPENSION	ORAL	20201223		NDA	NDA009175	Casper Pharma LLC	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70199-007_1c57b7db-a3c3-4635-b324-a3ebfa585feb	70199-007	HUMAN PRESCRIPTION DRUG	Robinul		Glycopyrrolate	TABLET	ORAL	20201006		NDA	NDA012827	Casper Pharma LLC	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70199-008_1c57b7db-a3c3-4635-b324-a3ebfa585feb	70199-008	HUMAN PRESCRIPTION DRUG	Robinul Forte		Glycopyrrolate	TABLET	ORAL	20201006		NDA	NDA012827	Casper Pharma LLC	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70199-010_27b51a77-a690-42ca-ad60-6f657202a198	70199-010	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B sulfates, Bacitracin zinc		Neomycin and Polymyxin B sulfates, Bacitracin zinc	OINTMENT	OPHTHALMIC	20170407		NDA	NDA050417	Casper Pharma LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 10000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70199-011_26e37e84-0edd-410d-be1a-2bf71d2fe133	70199-011	HUMAN PRESCRIPTION DRUG	CASPORYN HC		neomycin and polymyxin B sulfates and hydrocortisone otic	SUSPENSION	AURICULAR (OTIC)	20190315		NDA	NDA060613	Casper Pharma LLC	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70199-014_7c0ac2af-9747-4d57-8c57-9b0c033c97d1	70199-014	HUMAN PRESCRIPTION DRUG	Fexmid		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20180430		ANDA	ANDA071611	Casper Pharma LLC	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70199-017_fbaeb9d5-4b22-4528-9421-9954e53887c9	70199-017	HUMAN PRESCRIPTION DRUG	Thalitone		Chlorthalidone	TABLET	ORAL	20191127		NDA	NDA019574	Casper Pharma LLC	CHLORTHALIDONE	15	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70199-018_085f1a70-ff63-4c02-ac05-2579fe2ef002	70199-018	HUMAN PRESCRIPTION DRUG	Antivert		meclizine hcl	TABLET, CHEWABLE	ORAL	20200115		NDA	NDA010721	Casper Pharma LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70199-026_ec825f1c-c15f-44de-ad46-8ab9c49ec21c	70199-026	HUMAN PRESCRIPTION DRUG	AQUASOL A		VITAMIN A PALMITATE	INJECTION, SOLUTION	INTRAMUSCULAR	20201001		NDA	NDA006823	Casper Pharma LLC	VITAMIN A PALMITATE	15	mg/mL			N	20241231
70199-031_a7d28982-23c9-4e82-b73c-7b2cd0079d0e	70199-031	HUMAN PRESCRIPTION DRUG	Zyloprim		allopurinol	TABLET	ORAL	20230921		NDA	NDA016084	Casper Pharma LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70199-032_a7d28982-23c9-4e82-b73c-7b2cd0079d0e	70199-032	HUMAN PRESCRIPTION DRUG	Zyloprim		allopurinol	TABLET	ORAL	20230921		NDA	NDA016084	Casper Pharma LLC	ALLOPURINOL	200	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70199-033_a7d28982-23c9-4e82-b73c-7b2cd0079d0e	70199-033	HUMAN PRESCRIPTION DRUG	Zyloprim		allopurinol	TABLET	ORAL	20230921		NDA	NDA016084	Casper Pharma LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70199-034_8f3d6db4-736a-490a-8e52-d92e778cd138	70199-034	HUMAN PRESCRIPTION DRUG	Edetate Calcium Disodium		Edetate Calcium Disodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230503		ANDA	ANDA216435	Casper Pharma LLC	EDETATE CALCIUM DISODIUM	200	mg/mL	Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Decreased Coagulation Factor Activity [PE], Lead Chelating Activity [MoA], Lead Chelator [EPC]		N	20241231
70199-036_4dee1029-b1b5-4d30-8022-a33868ca8467	70199-036	HUMAN PRESCRIPTION DRUG	Furadantin		Nitrofurantoin	SUSPENSION	ORAL	20230609		NDA	NDA009175	Casper Pharma LLC	NITROFURANTOIN	50	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70204-100_0aacd913-975b-b6f8-e063-6294a90a5f3e	70204-100	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20160524		OTC MONOGRAPH DRUG	505G(a)(3)	Hit Promotional Products	ALCOHOL	620	mg/mL			N	20241231
70204-509_efd70d99-7b25-53f8-e053-2a95a90aa5cf	70204-509	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200427	20240430	OTC MONOGRAPH NOT FINAL	part333A	Hit Promotional Products, Inc.	ALCOHOL	62	mL/100mL			N	
70204-513_efe1bc1f-fea8-358c-e053-2a95a90ad693	70204-513	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200813	20240831	OTC MONOGRAPH NOT FINAL	part333A	Hit Promotional Products, Inc.	ALCOHOL	62	mL/100mL			N	
70205-544_61f31abb-c1ff-4169-a498-b64add632037	70205-544	HUMAN OTC DRUG	Gold Antiseptic		CHLOROXYLENOL	SOAP	TOPICAL	20190909		OTC MONOGRAPH NOT FINAL	part333E	Stigler Supply	CHLOROXYLENOL	3	mg/mL			N	20241231
70211-702_f18f35fc-91a0-c061-e053-2a95a90a2e48	70211-702	HUMAN OTC DRUG	COATS ALOE		ALLANTOIN	LOTION	TOPICAL	20151102		OTC MONOGRAPH FINAL	part347	TYCHASIS CORPORATION	ALLANTOIN	.5	g/100mL			N	20241231
70211-703_f18f1137-4bda-6155-e053-2995a90a688f	70211-703	HUMAN OTC DRUG	COATS ALOE		ALLANTOIN	CREAM	TOPICAL	20151102		OTC MONOGRAPH FINAL	part347	TYCHASIS CORPORATION	ALLANTOIN	.5	mg/100g			N	20241231
70211-704_fb362ebb-d8ea-4617-e053-6394a90a7f9d	70211-704	HUMAN OTC DRUG	COATS ALOE ANALGESIC		METHYL SALICYLATE	LOTION	TOPICAL	20151102		OTC MONOGRAPH FINAL	M017	TYCHASIS CORPORATION	METHYL SALICYLATE	10	g/100mL			N	20241231
70211-705_f18f3ef4-76c0-33a5-e053-2995a90aeba4	70211-705	HUMAN OTC DRUG	COATS ALOE		ALLANTOIN	JELLY	TOPICAL	20151102		OTC MONOGRAPH FINAL	part347	TYCHASIS CORPORATION	ALLANTOIN	.5	g/100mL			N	20241231
70242-109_d97deb5c-1e1f-4f60-922a-e85da3fa743c	70242-109	HUMAN OTC DRUG	Iodine Tincture White		Iodine tincture	SOLUTION/ DROPS	TOPICAL	20150808		OTC MONOGRAPH DRUG	M005	Dannso Corp./d.b.a. Essential Products	IODINE	20	mg/mL			N	20241231
70242-110_b385a98c-f9f2-4f1d-9f59-1fbeade2b007	70242-110	HUMAN OTC DRUG	Iodine Tincture Rojo		Iodine tincture	SOLUTION/ DROPS	TOPICAL	20150808		OTC MONOGRAPH DRUG	M005	Dannso Corp./d.b.a. Essential Products	IODINE	20	mg/mL			N	20241231
70242-125_9e1e40f9-eaf4-4983-ab11-836fdb440760	70242-125	HUMAN OTC DRUG	Veneno de Abeja	Aceite De Vibora Brand	Methyl Salicylate	OINTMENT	TOPICAL	20150501		OTC MONOGRAPH DRUG	M017	Dannso Corp./d.b.a. Essential Products	METHYL SALICYLATE	15.75	g/150g			N	20241231
70242-127_1a368815-91d9-41ba-aa3e-809ee1b2e4ce	70242-127	HUMAN OTC DRUG	Miel Rosada		SODIUM BORATE, GLYCERIN	SOLUTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M022	Dannso Corp./d.b.a. Essential Products	GLYCERIN; SODIUM BORATE	.4; .1	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70242-128_711e6a3b-4abb-44f9-a13e-fe08246c681c	70242-128	HUMAN OTC DRUG	Tintuta de Mentiolate/Menthiolate Tincture		Benzalkonium Chloride	SOLUTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M006	Dannso Corp./d.b.a. Essential Products	BENZALKONIUM CHLORIDE	.13	g/mL			N	20241231
70242-129_eff1a220-7f80-4490-b718-2e654cfb3057	70242-129	HUMAN OTC DRUG	Tintura de Arnica		Isopropyl Alcohol and Arnica Extract	SOLUTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M014	Dannso Corp./d.b.a. Essential Products	ISOPROPYL ALCOHOL	.13	g/mL			N	20241231
70242-130_bfcc970e-bc07-42c6-91a9-b8967bb6dc55	70242-130	HUMAN OTC DRUG	Mercurochrome		Benzalkonium Chloride	SOLUTION	TOPICAL	20150101		OTC MONOGRAPH DRUG	M003	Dannso Corp./d.b.a. Essential Products	BENZALKONIUM CHLORIDE	.13	g/mL			N	20241231
70242-139_c792f1dc-b2e2-4302-8aac-faa9b172b4eb	70242-139	HUMAN OTC DRUG	elp essential DM		Dextromethorphan hydrobromide, Guaifenesin	SYRUP	ORAL	20231026		OTC MONOGRAPH DRUG	M012	Dannso Corp./d.b.a. Essential Products	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70247-006_0e79df8a-c332-bfea-e063-6394a90ac812	70247-006	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20161010		ANDA	ANDA208856	Qingdao BAHEAL Pharmaceutical Co., Ltd.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70247-007_0e79df8a-c332-bfea-e063-6394a90ac812	70247-007	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20161010		ANDA	ANDA208856	Qingdao BAHEAL Pharmaceutical Co., Ltd.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70247-008_0e79df8a-c332-bfea-e063-6394a90ac812	70247-008	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20161010		ANDA	ANDA208856	Qingdao BAHEAL Pharmaceutical Co., Ltd.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70247-009_0e79df8a-c332-bfea-e063-6394a90ac812	70247-009	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20161010		ANDA	ANDA208856	Qingdao BAHEAL Pharmaceutical Co., Ltd.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70247-012_0e7aeb3b-385c-1ee3-e063-6394a90a9d2f	70247-012	HUMAN PRESCRIPTION DRUG	NA		Duloxetine delayed-release capsules	CAPSULE, DELAYED RELEASE	ORAL	20180505		ANDA	ANDA210599	Qingdao BAHEAL Pharmaceutical Co., Ltd.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
70247-013_0e7aeb3b-385c-1ee3-e063-6394a90a9d2f	70247-013	HUMAN PRESCRIPTION DRUG	NA		Duloxetine delayed-release capsules	CAPSULE, DELAYED RELEASE	ORAL	20180505		ANDA	ANDA210599	Qingdao BAHEAL Pharmaceutical Co., Ltd.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
70247-014_0e7aeb3b-385c-1ee3-e063-6394a90a9d2f	70247-014	HUMAN PRESCRIPTION DRUG	NA		Duloxetine delayed-release capsules	CAPSULE, DELAYED RELEASE	ORAL	20180505		ANDA	ANDA210599	Qingdao BAHEAL Pharmaceutical Co., Ltd.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
70255-010_4e0f2551-01a9-46c6-8019-bd5535c09ee6	70255-010	HUMAN PRESCRIPTION DRUG	MEKTOVI		BINIMETINIB	TABLET, FILM COATED	ORAL	20180627		NDA	NDA210498	Array BioPharma Inc.	BINIMETINIB	15	mg/1			N	20241231
70255-025_c2eedf4c-59b6-43ed-9820-a5621fa3e18f	70255-025	HUMAN PRESCRIPTION DRUG	BRAFTOVI		Encorafenib	CAPSULE	ORAL	20180627		NDA	NDA210496	Array BioPharma Inc.	ENCORAFENIB	75	mg/1			N	20241231
70257-051_239012ee-5f14-4aed-9b1d-4e3e3283406f	70257-051	HUMAN PRESCRIPTION DRUG	HepaGam B		Hepatitis B Immune Globulin Intravenous (Human)	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190301		BLA	BLA125035	Saol Therapeutics Inc.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	312	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
70257-052_239012ee-5f14-4aed-9b1d-4e3e3283406f	70257-052	HUMAN PRESCRIPTION DRUG	HepaGam B		Hepatitis B Immune Globulin Intravenous (Human)	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190301		BLA	BLA125035	Saol Therapeutics Inc.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	312	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
70257-053_56525de0-f47d-11eb-85b4-0800200c9a66	70257-053	HUMAN PRESCRIPTION DRUG	HepaGam B		human hepatitis B virus immune globulin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180620		BLA	BLA125035	Saol Therapeutics Inc.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	312	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
70257-054_56525de0-f47d-11eb-85b4-0800200c9a66	70257-054	HUMAN PRESCRIPTION DRUG	HepaGam B		human hepatitis B virus immune globulin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180620		BLA	BLA125035	Saol Therapeutics Inc.	HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN	312	[iU]/mL	Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]		N	20241231
70257-126_acfa976e-7b2c-4238-be60-dc597273c52a	70257-126	HUMAN PRESCRIPTION DRUG	VARIZIG		HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN	SOLUTION	INTRAMUSCULAR	20190301		BLA	BLA125430	Saol Therapeutics	HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN	125	[iU]/1.2mL			N	20241231
70257-300_40b487d4-5658-437b-99de-c0130d5d6bbb	70257-300	HUMAN PRESCRIPTION DRUG	WinRho SDF		rho (d) immune globulin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190301		BLA	BLA103649	Saol Therapeutics Inc.	HUMAN RHO(D) IMMUNE GLOBULIN	15000	[iU]/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
70257-310_40b487d4-5658-437b-99de-c0130d5d6bbb	70257-310	HUMAN PRESCRIPTION DRUG	WinRho SDF		rho (d) immune globulin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190301		BLA	BLA103649	Saol Therapeutics Inc.	HUMAN RHO(D) IMMUNE GLOBULIN	5000	[iU]/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
70257-330_40b487d4-5658-437b-99de-c0130d5d6bbb	70257-330	HUMAN PRESCRIPTION DRUG	WinRho SDF		rho (d) immune globulin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190301		BLA	BLA103649	Saol Therapeutics Inc.	HUMAN RHO(D) IMMUNE GLOBULIN	1500	[iU]/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
70257-350_40b487d4-5658-437b-99de-c0130d5d6bbb	70257-350	HUMAN PRESCRIPTION DRUG	WinRho SDF		rho (d) immune globulin	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190301		BLA	BLA103649	Saol Therapeutics Inc.	HUMAN RHO(D) IMMUNE GLOBULIN	2500	[iU]/1	Endogenous Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
70257-412_4057e10f-332f-48e1-8c97-e80b93331add	70257-412	HUMAN PRESCRIPTION DRUG	Lyvispah		baclofen	GRANULE	ORAL	20211122		NDA	NDA215422	Saol Therapeutics Inc	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70257-414_4057e10f-332f-48e1-8c97-e80b93331add	70257-414	HUMAN PRESCRIPTION DRUG	Lyvispah		baclofen	GRANULE	ORAL	20211122		NDA	NDA215422	Saol Therapeutics Inc	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70257-416_4057e10f-332f-48e1-8c97-e80b93331add	70257-416	HUMAN PRESCRIPTION DRUG	Lyvispah		baclofen	GRANULE	ORAL	20211122		NDA	NDA215422	Saol Therapeutics Inc	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70257-560_7280e190-0f51-11ed-aa05-0800200c9a66	70257-560	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	INJECTION	INTRATHECAL	20220612	20241130	NDA	NDA020075	Saol Therapeutics Inc.	BACLOFEN	10	mg/20mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
70257-561_7280e190-0f51-11ed-aa05-0800200c9a66	70257-561	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	INJECTION	INTRATHECAL	20220612	20241130	NDA	NDA020075	Saol Therapeutics Inc.	BACLOFEN	10	mg/5mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
70257-562_7280e190-0f51-11ed-aa05-0800200c9a66	70257-562	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	INJECTION	INTRATHECAL	20220612	20241130	NDA	NDA020075	Saol Therapeutics Inc.	BACLOFEN	.05	mg/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
70257-563_7280e190-0f51-11ed-aa05-0800200c9a66	70257-563	HUMAN PRESCRIPTION DRUG	Lioresal (baclofen)		baclofen	INJECTION	INTRATHECAL	20220612	20241130	NDA	NDA020075	Saol Therapeutics Inc.	BACLOFEN	40	mg/20mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
70264-011_077fdb85-4219-1309-e063-6294a90a6bc8	70264-011	HUMAN OTC DRUG	Aleve		NAPROXEN SODIUM	TABLET	ORAL	20140226		NDA	NDA020204	R J General Corporation	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70264-012_07cf3b5b-9d54-6517-e063-6394a90ae43f	70264-012	HUMAN OTC DRUG	MIDOL COMPLETE		acetaminophen, caffeine, and pyrilamine maleate	TABLET	ORAL	20140210		OTC MONOGRAPH DRUG	M013	R J General Corporation	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
70264-013_077fc13d-fbe0-a75d-e063-6394a90ab78c	70264-013	HUMAN OTC DRUG	Bayer Genuine Aspirin		Aspirin	TABLET	ORAL	20140731		OTC MONOGRAPH DRUG	M013	R J General Corporation	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70264-014_0781f47f-c496-a320-e063-6294a90ad304	70264-014	HUMAN OTC DRUG	Alka-Seltzer Original		ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE	TABLET, EFFERVESCENT	ORAL	20100302		OTC MONOGRAPH DRUG	M013	R J General Corporation	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70264-016_07cf16fa-4aed-5be5-e063-6294a90a4350	70264-016	HUMAN OTC DRUG	Alka-Seltzer Plus Severe Cold and Flu PowerFast Fizz		chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide	TABLET, EFFERVESCENT	ORAL	20230316		OTC MONOGRAPH DRUG	M012	R J General Corporation	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70264-024_077fcaea-e46b-2fbe-e063-6294a90a22b2	70264-024	HUMAN OTC DRUG	Benadryl Allergy		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20220301		OTC MONOGRAPH DRUG	M012	R J General Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70264-025_077fbb47-d437-fd1e-e063-6294a90a34e5	70264-025	HUMAN OTC DRUG	TYLENOL COLD AND FLU		ACETAMINPHEN	TABLET, FILM COATED	ORAL	20210501		OTC MONOGRAPH DRUG	M012	R J General Corporation	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70264-026_0780b863-71cb-5c40-e063-6294a90a1a1b	70264-026	HUMAN OTC DRUG	TYLENOL SINUS SEVERE		ACETAMINOPHEN	TABLET, COATED	ORAL	20210501		OTC MONOGRAPH DRUG	M012	R J General Corporation	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70264-027_077fbb47-d438-fd1e-e063-6294a90a34e5	70264-027	HUMAN OTC DRUG	TYLENOL EXTRA STRENGTH		ACETAMINOPHEN	TABLET	ORAL	20210501		OTC MONOGRAPH DRUG	M013	R J General Corporation	ACETAMINOPHEN	500	mg/1			N	20241231
70264-028_077fd5bd-1060-c1d1-e063-6394a90aa122	70264-028	HUMAN OTC DRUG	TYLENOL PM EXTRA STRENGTH		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20210501		OTC MONOGRAPH DRUG	M013	R J General Corporation	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70264-029_077fcbdf-8dc0-bee3-e063-6394a90a2887	70264-029	HUMAN OTC DRUG	MOTRIN IB		IBUPROFEN	TABLET, FILM COATED	ORAL	20210501		OTC MONOGRAPH DRUG	M013	R J General Corporation	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70264-030_077fcbdf-8dc2-bee3-e063-6394a90a2887	70264-030	HUMAN OTC DRUG	Claritin		Loratadine	TABLET	ORAL	20210301		NDA	NDA019658	R J General Corporation	LORATADINE	10	mg/1			N	20241231
70264-034_077fdb85-421a-1309-e063-6294a90a6bc8	70264-034	HUMAN OTC DRUG	Pepcid Complete		famotidine, calcium carbonate, and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20220109		NDA	NDA020958	R J General Corporation	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70273-001_07eec224-b9de-c6c5-e063-6394a90acb30	70273-001	HUMAN PRESCRIPTION DRUG	oxygen		oxygen	GAS	RESPIRATORY (INHALATION)	19920630		NDA	NDA205767	A & E Mill & Welding Supply Company	OXYGEN	990	mL/L			N	20241231
70275-201_f1ee2867-e303-65a9-e053-2995a90a1c66	70275-201	HUMAN OTC DRUG	PRO-SYS		Oral Wound Cleanser	LIQUID	BUCCAL	20220516		OTC MONOGRAPH NOT FINAL	part356	Forward Science Technologies LLC	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
70275-936_f1ee2b70-afe2-a0d5-e053-2995a90a3481	70275-936	HUMAN OTC DRUG	TheraStom		antigingivitis/antiplaque mouth rinse	RINSE	ORAL	20210405		OTC MONOGRAPH NOT FINAL	part356	Forward Science Technologies LLC	CETYLPYRIDINIUM CHLORIDE	.075	mg/.1mL			N	20241231
70275-937_f1ee2867-e303-65a9-e053-2995a90a1c66	70275-937	HUMAN OTC DRUG	OxiStom		Oral Wound Cleanser	LIQUID	BUCCAL	20210526		OTC MONOGRAPH NOT FINAL	part356	Forward Science Technologies LLC	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
70287-716_0974579b-6f66-6b47-e063-6294a90a0217	70287-716	HUMAN OTC DRUG	Velatrin Pain Relief		METHYL SALICYLATE, MENTHOL, UNSPECIFIED FORM	CREAM	TOPICAL	20151125		OTC MONOGRAPH DRUG	M017	Quality Nature, Inc.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 15	mg/g; mg/g			N	20241231
70288-173_09d7675e-8ab0-ac1b-e063-6394a90a58bb	70288-173	HUMAN OTC DRUG	SKIN A COOL Hydrocortisone Anti-Itch		HYDROCORTISONE	CREAM	TOPICAL	20210301		OTC MONOGRAPH DRUG	M017	Ana-Cool, LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70288-714_09749db1-1991-799e-e063-6294a90a47eb	70288-714	HUMAN OTC DRUG	Ana Cool Rapid Soothing Cooling Formula		HYDROCORTISONE	CREAM	TOPICAL	20151125		OTC MONOGRAPH DRUG	M017	Ana-Cool, LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70290-120_b5a621c1-ea1a-f533-e053-2a95a90a541a	70290-120	HUMAN OTC DRUG	Eyewash Station Additive Concentrate		Chlorhexidine gluconate and Propylene Glycol	LIQUID	OPHTHALMIC	20201202		OTC MONOGRAPH NOT FINAL	part349	Encon Safety Products, Inc.	CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL	145.6; 280	kg/2800L; kg/2800L	Decreased Cell Wall Integrity [PE]		N	20241231
70290-310_a463a828-aa27-1ff1-e053-2a95a90a4379	70290-310	HUMAN OTC DRUG	Firstep Firstflush		Eyewash	SOLUTION	OPHTHALMIC	20200427		NDA	NDA022305	Encon Safety Products, Inc.	WATER	465	mL/473mL			N	20241231
70299-001_09c28e4c-ceb0-8f33-e063-6294a90a580e	70299-001	HUMAN OTC DRUG	Vytis Shield Aloe Vera Foam Hand Sanitizer		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20151203		OTC MONOGRAPH DRUG	505G(a)(3)	Vytis Shield, Llc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
70301-1001_168e1482-e6a5-416d-9711-2c8d9c0dfebe	70301-1001	HUMAN PRESCRIPTION DRUG	Rayaldee		calcifediol	CAPSULE, EXTENDED RELEASE	ORAL	20161025		NDA	NDA208010	OPKO Pharmaceuticals LLC	CALCIFEDIOL	30	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
70313-001_0d1c0b7f-8dee-5bdf-e063-6394a90abb25	70313-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		United Respiratory Services, LLC	OXYGEN	99	L/100L			N	20241231
70317-004_08181605-eabc-ccbf-e063-6294a90aba2a	70317-004	HUMAN OTC DRUG	Mask RX		Salicylic Acid	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M006	Remeverse	SALICYLIC ACID	.225	g/15g			N	20241231
70317-005_03110b38-0c54-17d6-e063-6394a90a7d86	70317-005	HUMAN OTC DRUG	KO Pink Pain Relief Cream		Lidocaine HCl and Phenolate Sodium	CREAM	TOPICAL	20230901		OTC MONOGRAPH DRUG	M017	Remeverse	LIDOCAINE HYDROCHLORIDE; PHENOLATE SODIUM	.04; .005	g/mL; g/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70317-145_08b9673b-56d2-7fa7-e063-6394a90afca0	70317-145	HUMAN OTC DRUG	RemeVerse Instant Foam Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20200331		OTC MONOGRAPH DRUG	M003	RemeVerse	BENZALKONIUM CHLORIDE	.1	g/300mL			N	20241231
70317-146_0b764602-0e21-cb23-e063-6394a90a1498	70317-146	HUMAN OTC DRUG	So Clear Cleanse Acne Cleanser		Benzoyl Peroxide	LIQUID	TOPICAL	20210331		OTC MONOGRAPH DRUG	M006	RemeVerse	BENZOYL PEROXIDE	3.6	g/120mL			N	20241231
70317-147_08b887d6-3d7f-1112-e063-6394a90abd8b	70317-147	HUMAN OTC DRUG	So Clear Protect Protective Treatment		So Clear Protect Protective Treatment	CREAM	TOPICAL	20210331		OTC MONOGRAPH DRUG	M006	RemeVerse	BENZOYL PEROXIDE	.8	g/30mL			N	20241231
70317-148_0b764b7f-cb88-cbc3-e063-6394a90a4bb2	70317-148	HUMAN OTC DRUG	So Clear Repair Spot Treatment		So Clear Repair Spot Treatment	LIQUID	TOPICAL	20210331		OTC MONOGRAPH DRUG	M006	RemeVerse LLC	BENZOYL PEROXIDE	.7875	g/15mL			N	20241231
70319-220_ef5c4400-5bc5-9a6d-e053-2a95a90a93eb	70319-220	HUMAN OTC DRUG	COSRX		Vitamin E Vitalizing Sunscreen	LOTION	TOPICAL	20220601		OTC MONOGRAPH NOT FINAL	part352	COSRX inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.25; 4.5; 4.5; 2.25	mg/50mL; mg/50mL; mg/50mL; mg/50mL			N	20241231
70321-0003_a135565d-8c93-458b-ad68-3aab3acb954d	70321-0003	HUMAN OTC DRUG	Energize		Colchicum Autumnale, Conium Maculatum, Hydrastis Canadensis, Vaccinium Myrtillus, Podophyllum Peltatum, Ascorbic Acid, Galium Aparine, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, Norepinephrine, Alpha-Lipoicum Acidum, Natrum Oxalaceticum, Sulphur, Acetylsalicylicum Acidum, Adenosinum Triphosphoricum Dinatrum, Anthrachinonum, Histaminum Hydrochloricum, Magnesium Gluconicum Dihydricum, Nadidum, Naphthochinonum, Pantothenic Acid	LIQUID	ORAL	20160427		UNAPPROVED HOMEOPATHIC		Parasitology Center Inc.	1,4-NAPHTHOQUINONE; ADENOSINE TRIPHOSPHATE DISODIUM; ASCORBIC ACID; ASPIRIN; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BILBERRY; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; GALIUM APARINE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; HYDROQUININE; LACTIC ACID, L-; MAGNESIUM GLUCONATE; MANGANESE PHOSPHATE, DIBASIC; NADIDE; NIACINAMIDE; NOREPINEPHRINE; PANTOTHENIC ACID; PODOPHYLLUM; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SULFUR; THIAMINE HYDROCHLORIDE; THIOCTIC ACID; UBIDECARENONE	10; 10; 6; 10; 10; 4; 4; 4; 6; 4; 10; 3; 6; 10; 15; 10; 6; 6; 10; 5; 6; 6; 30; 8; 8; 6; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Anti-Inflammatory Agents, Non-Steroidal [CS], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Platelet Aggregation Inhibitor [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
70323-123_0e72d208-65a3-695f-e063-6394a90a027a	70323-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20010301		UNAPPROVED MEDICAL GAS		Inmon Respiratory Services Inc.	OXYGEN	99	L/100L			N	20251231
70325-3001_3eb45df8-baeb-4c87-9b92-94b0b50f6095	70325-3001	HUMAN OTC DRUG	bu SPF 30 Broad Spectrum on Alcohol-Free Performance Sunscreen - Fragrance Free		OCTINOXATE, OCTOCRYLENE, OCTISALATE, and AVOBENZONE	SPRAY	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part352	Bu Brands, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7.5; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70325-3002_77a1d78a-b461-4896-ba41-d767668d7188	70325-3002	HUMAN OTC DRUG	bu SPF 30 Broad Spectrum Alcohol-Free Performance Sunscreen - Natural White Sage Scent		OCTINOXATE, OCTOCRYLENE, OCTISALATE, and AVOBENZONE	SPRAY	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part352	Bu Brands, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7.5; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70325-3003_bc56010e-8220-493a-9584-22b3ece2b373	70325-3003	HUMAN OTC DRUG	bu SPF 30 Broad Spectrum Alcohol-Free Performance Sunscreen - Natural Citrus Scent		OCTINOXATE, OCTOCRYLENE, OCTISALATE, and AVOBENZONE	SPRAY	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part352	Bu Brands, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.5; 7.5; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70325-5002_3ee36a5c-108a-4f48-907c-4d8fb9372f34	70325-5002	HUMAN OTC DRUG	bu SPF 50 KIDS Broad Spectrum Alcohol-Free Performance Sunscreen - Fragrance Free		OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE, and HOMOSALATE	SPRAY	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part352	Bu Brands, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 7.5; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70325-5003_99a841bc-60c6-4150-ac36-8b604277fa77	70325-5003	HUMAN OTC DRUG	bu SPF 50 S Broad Spectrum Alcohol-Free Performance Sunscreen - Natural White Sage Scent		OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE, and HOMOSALATE	SPRAY	TOPICAL	20161201		OTC MONOGRAPH NOT FINAL	part352	Bu Brands, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 7.5; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70329-717_09d769cf-cc1f-9fd3-e063-6394a90ac18e	70329-717	HUMAN OTC DRUG	Teeter reNEW MUSCLES Pain Relieving		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20151209		OTC MONOGRAPH DRUG	M017	STL International INC	MENTHOL; METHYL SALICYLATE	7; 10	mg/g; mg/g			N	20241231
70329-730_09d74877-2b50-391f-e063-6294a90a331d	70329-730	HUMAN OTC DRUG	Teeter Renew Muscles Pain Relieving		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20160312		OTC MONOGRAPH DRUG	M017	STL International INC	MENTHOL; METHYL SALICYLATE	70; 100	mg/mL; mg/mL			N	20241231
70335-010_0d0d72fe-2bc6-9864-e063-6294a90af88c	70335-010	HUMAN OTC DRUG	GERMISEPT ANTIBACTERIAL HAND SANITIZING ALCOHOL WIPES		ALCOHOL	CLOTH	TOPICAL	20201115		OTC MONOGRAPH DRUG	505G(a)(3)	Innovent, Inc.	ALCOHOL	.75	mL/mL			N	20241231
70335-011_0d0d6d39-a9c7-e084-e063-6394a90af89e	70335-011	HUMAN OTC DRUG	GERMisept Antibacterial Hand Sanitizing Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20210210		OTC MONOGRAPH DRUG	505G(a)(3)	Innovent Inc	ALCOHOL	75	mL/100mL			N	20241231
70335-012_0d0d5824-168c-a063-e063-6294a90aa025	70335-012	HUMAN OTC DRUG	GERMisept Antibacterial Hand Sanitizing Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210210		OTC MONOGRAPH DRUG	505G(a)(3)	Innovent Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
70335-301_f15ea0dc-53e3-6360-e053-2a95a90ae304	70335-301	HUMAN OTC DRUG	GERMISEPT Antibacterial Hand Sanitizing Wipes		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20160906	20251130	OTC MONOGRAPH NOT FINAL	part333E	Innovent Inc.	BENZALKONIUM CHLORIDE	.12	g/100g			N	
70335-304_f15eb023-71c9-5903-e053-2a95a90af72b	70335-304	HUMAN OTC DRUG	Germisept Antibacterial Hand Sanitizing Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200415	20251130	OTC MONOGRAPH NOT FINAL	part333E	Innovent Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	
70335-306_f15ebef1-c38a-9743-e053-2a95a90adaac	70335-306	HUMAN OTC DRUG	Germisept Antibacterial Alcohol		ALCOHOL	CLOTH	TOPICAL	20200710	20251130	OTC MONOGRAPH NOT FINAL	part333E	INNOVENT INC	ALCOHOL	.75	mL/mL			N	
70335-310_f15eccca-7e89-69c2-e053-2a95a90a5a04	70335-310	HUMAN OTC DRUG	GERMISEPT Bran ANTIBACTERIAL MOIST		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20190110	20251130	OTC MONOGRAPH NOT FINAL	part333E	Innovent Inc.	BENZALKONIUM CHLORIDE	1.15	mg/mL			N	
70347-025_1455bfee-c47d-4e63-8b1f-06654b5def99	70347-025	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA	NDA019962	Aralez Pharmaceuticals US Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70347-050_1455bfee-c47d-4e63-8b1f-06654b5def99	70347-050	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA	NDA019962	Aralez Pharmaceuticals US Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70347-100_1455bfee-c47d-4e63-8b1f-06654b5def99	70347-100	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA	NDA019962	Aralez Pharmaceuticals US Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70347-200_1455bfee-c47d-4e63-8b1f-06654b5def99	70347-200	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA	NDA019962	Aralez Pharmaceuticals US Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70356-001_42b2fcc6-ec9f-543f-e054-00144ff8d46c	70356-001	HUMAN OTC DRUG	Aftate Athlete Foot Cream		Tolnaftate	CREAM	TOPICAL	20161201		OTC MONOGRAPH FINAL	part333C	Sabel Med LLC	TOLNAFTATE	1	g/100g			N	20241231
70369-001_a9025118-be54-ebc4-e053-2995a90a9af9	70369-001	HUMAN OTC DRUG	Sodium Bicarbonate	10 gr (650 mg)	Sodium Bicarbonate	TABLET	ORAL	20180416		OTC MONOGRAPH FINAL	part331	CitraGen Pharmaceuticals Inc.	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
70369-002_b7c04e09-4756-2129-e053-2995a90a09f7	70369-002	HUMAN OTC DRUG	Sodium Bicarbonate	5 gr (325 mg)	Sodium Bicarbonate	TABLET	ORAL	20180420		OTC MONOGRAPH FINAL	part331	CitraGen Pharmaceuticals Inc.	SODIUM BICARBONATE	325	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
70369-004_b7c04e09-4757-2129-e053-2995a90a09f7	70369-004	HUMAN OTC DRUG	Calcium Carbonate	10 gr (648 mg)	Calcium Carbonate	TABLET	ORAL	20180807		OTC MONOGRAPH FINAL	part331	CitraGen Pharmaceuticals, Inc.	CALCIUM CARBONATE	648	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70369-005_b7c052ea-a1aa-043e-e053-2995a90acebf	70369-005	HUMAN OTC DRUG	Calcium Carbonate	1250 mg	Calcium Carbonate	TABLET	ORAL	20180926		OTC MONOGRAPH FINAL	part331	CitraGen Pharmaceuticals, Inc.	CALCIUM CARBONATE	1250	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70369-007_f076147b-3fb4-578b-e053-2995a90a858e	70369-007	HUMAN OTC DRUG	Sodium Chloride	Normal Salt	Sodium Chloride	TABLET	ORAL	20190322		OTC MONOGRAPH FINAL	part349	Citragen Pharmaceuticals Inc	SODIUM CHLORIDE	1	g/1			N	20241231
70369-010_f075f533-aec5-1793-e053-2a95a90a786b	70369-010	HUMAN OTC DRUG	Sodium Chloride	Normal Salt	Sodium Chloride	TABLET	ORAL	20200720		OTC MONOGRAPH FINAL	part349	Citragen Pharmaceuticals Inc	SODIUM CHLORIDE	500	mg/1			N	20241231
70370-1060_43ebd1dd-e577-46d6-a7be-a1d408bbd9c0	70370-1060	HUMAN PRESCRIPTION DRUG	INGREZZA		Valbenazine	CAPSULE	ORAL	20210423		NDA	NDA209241	Neurocrine Biosciences, Inc.	VALBENAZINE TOSYLATE	60	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
70370-1080_43ebd1dd-e577-46d6-a7be-a1d408bbd9c0	70370-1080	HUMAN PRESCRIPTION DRUG	INGREZZA		Valbenazine	CAPSULE	ORAL	20171004		NDA	NDA209241	Neurocrine Biosciences, Inc.	VALBENAZINE TOSYLATE	80	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
70370-2040_43ebd1dd-e577-46d6-a7be-a1d408bbd9c0	70370-2040	HUMAN PRESCRIPTION DRUG	INGREZZA		Valbenazine	CAPSULE	ORAL	20181214		NDA	NDA209241	Neurocrine Biosciences, Inc.	VALBENAZINE TOSYLATE	40	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
70370-2046_43ebd1dd-e577-46d6-a7be-a1d408bbd9c0	70370-2046	HUMAN PRESCRIPTION DRUG	INGREZZA		Valbenazine	KIT	ORAL	20230818		NDA	NDA209241	Neurocrine Biosciences, Inc.						N	20241231
70370-2048_43ebd1dd-e577-46d6-a7be-a1d408bbd9c0	70370-2048	HUMAN PRESCRIPTION DRUG	INGREZZA		Valbenazine	KIT	ORAL	20181214		NDA	NDA209241	Neurocrine Biosciences, Inc.						N	20241231
70370-3025_d2eba1fb-35ba-40ed-802b-a9c46e36178b	70370-3025	HUMAN PRESCRIPTION DRUG	ONGENTYS		opicapone	CAPSULE	ORAL	20200424		NDA	NDA212489	Neurocrine Biosciences, Inc.	OPICAPONE	25	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
70370-3050_d2eba1fb-35ba-40ed-802b-a9c46e36178b	70370-3050	HUMAN PRESCRIPTION DRUG	ONGENTYS		opicapone	CAPSULE	ORAL	20200424		NDA	NDA212489	Neurocrine Biosciences, Inc.	OPICAPONE	50	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
70372-722_097485a4-b58d-a87a-e063-6394a90a8e52	70372-722	HUMAN OTC DRUG	LidoSport Pain Relief		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20151225		OTC MONOGRAPH DRUG	M017	Centura Pharmaceuticals, Inc	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70372-723_0974a459-5faf-aaff-e063-6394a90a5f25	70372-723	HUMAN OTC DRUG	LidoPlus Pain Relief		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20151225		OTC MONOGRAPH DRUG	M017	Centura Pharmaceuticals, Inc	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70372-727_f65a9de3-2103-9e4f-e053-2995a90a996b	70372-727	HUMAN OTC DRUG	BLT 1		BENZOCAINE	OINTMENT	TOPICAL	20161015		OTC MONOGRAPH NOT FINAL	part348	CENTURA PHARMACEUTICALS INC	BENZOCAINE	20	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70372-728_f65ab6c0-1913-f6d5-e053-2995a90a34c2	70372-728	HUMAN OTC DRUG	BLT 2		LIDOCAINE HCL	OINTMENT	TOPICAL	20161121		OTC MONOGRAPH NOT FINAL	part348	CENTURA PHARMACEUTICALS INC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70372-729_f61a1702-f878-7041-e053-2995a90a912b	70372-729	HUMAN OTC DRUG	BLT 3		TETRACAINE	OINTMENT	TOPICAL	20161030		OTC MONOGRAPH NOT FINAL	part348	CENTURA PHARMACEUTICALS INC	TETRACAINE	2	g/100g	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
70372-731_fcb7278d-5059-728d-e053-6394a90acf69	70372-731	HUMAN OTC DRUG	BOTTOMS UP HEALTH		LIDOCAINE,GLYCERIN,CALAMINE,WITCH HAZEL	CREAM	TOPICAL	20230527		OTC MONOGRAPH FINAL	M015	CENTURA PHARMACEUTICALS INC	GLYCERIN; LIDOCAINE; WITCH HAZEL; ZINC OXIDE	35; 5; 10; 15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70377-001_5d539d78-3e96-f6bd-7d41-24f3bd1e1280	70377-001	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Biocon Pharma Inc,	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-002_5d539d78-3e96-f6bd-7d41-24f3bd1e1280	70377-002	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Biocon Pharma Inc,	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-003_5d539d78-3e96-f6bd-7d41-24f3bd1e1280	70377-003	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Biocon Pharma Inc,	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-004_5d539d78-3e96-f6bd-7d41-24f3bd1e1280	70377-004	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Biocon Pharma Inc,	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-005_5d539d78-3e96-f6bd-7d41-24f3bd1e1280	70377-005	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Biocon Pharma Inc,	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-006_60a43550-a61a-3b7d-b049-64a5a9fb4f26	70377-006	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Biocon Pharma Inc	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-007_60a43550-a61a-3b7d-b049-64a5a9fb4f26	70377-007	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Biocon Pharma Inc	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-008_60a43550-a61a-3b7d-b049-64a5a9fb4f26	70377-008	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Biocon Pharma Inc	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-009_60a43550-a61a-3b7d-b049-64a5a9fb4f26	70377-009	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Biocon Pharma Inc	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-010_c9b1595f-d199-a6c4-6ca0-c3d1a751c94c	70377-010	HUMAN PRESCRIPTION DRUG	EVEROLIMUS		everolimus	TABLET	ORAL	20211001		ANDA	ANDA214182	Biocon Pharma Inc.	EVEROLIMUS	2.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
70377-011_c9b1595f-d199-a6c4-6ca0-c3d1a751c94c	70377-011	HUMAN PRESCRIPTION DRUG	EVEROLIMUS		everolimus	TABLET	ORAL	20211001		ANDA	ANDA214182	Biocon Pharma Inc.	EVEROLIMUS	5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
70377-012_c9b1595f-d199-a6c4-6ca0-c3d1a751c94c	70377-012	HUMAN PRESCRIPTION DRUG	EVEROLIMUS		everolimus	TABLET	ORAL	20211001		ANDA	ANDA214182	Biocon Pharma Inc.	EVEROLIMUS	7.5	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
70377-013_c9b1595f-d199-a6c4-6ca0-c3d1a751c94c	70377-013	HUMAN PRESCRIPTION DRUG	EVEROLIMUS		everolimus	TABLET	ORAL	20211001		ANDA	ANDA214182	Biocon Pharma Inc.	EVEROLIMUS	10	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
70377-014_f5edcc10-9b30-4cbb-7ba0-da5030de6e40	70377-014	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201223		ANDA	ANDA212297	Biocon Pharma Inc.	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
70377-015_f5edcc10-9b30-4cbb-7ba0-da5030de6e40	70377-015	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201223		ANDA	ANDA212297	Biocon Pharma Inc.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
70377-016_f5edcc10-9b30-4cbb-7ba0-da5030de6e40	70377-016	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20201223		ANDA	ANDA212297	Biocon Pharma Inc.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
70377-017_624b7010-224a-32c9-d9be-950b2fc2a3ec	70377-017	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209639	Biocon Pharma Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70377-018_624b7010-224a-32c9-d9be-950b2fc2a3ec	70377-018	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA209639	Biocon Pharma Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70377-022_861554f3-28b8-8298-8739-56e9ded0e3ab	70377-022	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221231		ANDA	ANDA211090	Biocon Pharma Inc	PEMETREXED DISODIUM HEMIPENTAHYDRATE	1000	mg/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
70377-027_c8ace345-ce52-482e-93b9-6b81fe40c1fd	70377-027	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Biocon Pharma Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-028_c8ace345-ce52-482e-93b9-6b81fe40c1fd	70377-028	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Biocon Pharma Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-029_c8ace345-ce52-482e-93b9-6b81fe40c1fd	70377-029	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Biocon Pharma Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-030_c8ace345-ce52-482e-93b9-6b81fe40c1fd	70377-030	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Biocon Pharma Inc.,	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-038_b7a2fd29-83b5-6ae6-775c-98f91a6c0ea4	70377-038	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20220308		ANDA	ANDA214476	Biocon Phama Inc.	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70377-039_d952d72b-b839-6754-be70-05129b101d22	70377-039	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20220530		ANDA	ANDA214630	Biocon Pharma Inc.	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70377-040_d952d72b-b839-6754-be70-05129b101d22	70377-040	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20220530		ANDA	ANDA214630	Biocon Pharma Inc.	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70377-045_9a19d946-77c8-2872-fe06-7f4ab48059ef	70377-045	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	BIOCON PHARMA INC.,	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-046_9a19d946-77c8-2872-fe06-7f4ab48059ef	70377-046	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	BIOCON PHARMA INC.,	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-047_9a19d946-77c8-2872-fe06-7f4ab48059ef	70377-047	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	BIOCON PHARMA INC.,	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-048_9a19d946-77c8-2872-fe06-7f4ab48059ef	70377-048	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	BIOCON PHARMA INC.,	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-055_08c6914d-11cb-4548-83df-4c636933e97d	70377-055	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210319		ANDA	ANDA213486	Biocon Pharma Inc.,	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70377-056_08c6914d-11cb-4548-83df-4c636933e97d	70377-056	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210319		ANDA	ANDA213486	Biocon Pharma Inc.,	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70377-060_27e4ab03-c17b-4268-912c-e45a5e8f8dd8	70377-060	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Biocon Pharma Inc.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70377-061_27e4ab03-c17b-4268-912c-e45a5e8f8dd8	70377-061	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Biocon Pharma Inc.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70377-062_27e4ab03-c17b-4268-912c-e45a5e8f8dd8	70377-062	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210527		ANDA	ANDA209603	Biocon Pharma Inc.	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70377-066_a7c5a1a0-36c3-44ca-ab95-cef208074850	70377-066	HUMAN PRESCRIPTION DRUG	Prazosin hydrochloride		Prazosin hydrochloride	CAPSULE	ORAL	20230109		ANDA	ANDA213406	Biocon Pharma Inc.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70377-067_a7c5a1a0-36c3-44ca-ab95-cef208074850	70377-067	HUMAN PRESCRIPTION DRUG	Prazosin hydrochloride		Prazosin hydrochloride	CAPSULE	ORAL	20230109		ANDA	ANDA213406	Biocon Pharma Inc.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70377-068_a7c5a1a0-36c3-44ca-ab95-cef208074850	70377-068	HUMAN PRESCRIPTION DRUG	Prazosin hydrochloride		Prazosin hydrochloride	CAPSULE	ORAL	20230109		ANDA	ANDA213406	Biocon Pharma Inc.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70377-077_1c9249c1-130c-3b16-8f34-aee732802039	70377-077	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA216436	Biocon Pharma Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-078_1c9249c1-130c-3b16-8f34-aee732802039	70377-078	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA216436	Biocon Pharma Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-079_1c9249c1-130c-3b16-8f34-aee732802039	70377-079	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA216436	Biocon Pharma Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-080_1c9249c1-130c-3b16-8f34-aee732802039	70377-080	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA216436	Biocon Pharma Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70377-081_56fdb140-a79c-468a-80b4-88e846618064	70377-081	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride		Dorzolamide	SOLUTION/ DROPS	OPHTHALMIC	20220108		ANDA	ANDA202053	Biocon Pharma Inc.	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
70377-082_46ba7958-0844-4809-b1e4-2bbb5fa86459	70377-082	HUMAN PRESCRIPTION DRUG	DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE		dorzolamide hydrochloride timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20220108		ANDA	ANDA202054	Biocon Pharma Inc.	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70377-089_81074a20-6150-469d-9293-22f31b25ff20	70377-089	HUMAN PRESCRIPTION DRUG	VIGABATRIN		VIGABATRIN	POWDER, FOR SOLUTION	ORAL	20220829		ANDA	ANDA213390	Biocon Pharma Inc.	VIGABATRIN	500	mg/10mL	Anti-epileptic Agent [EPC]		N	20241231
70377-102_2681dc2f-b544-e29d-90af-ce64675fdd8b	70377-102	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	TABLET	ORAL	20210315		ANDA	ANDA213928	Biocon Pharma Inc.	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
70377-103_2681dc2f-b544-e29d-90af-ce64675fdd8b	70377-103	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	TABLET	ORAL	20210315		ANDA	ANDA213928	Biocon Pharma Inc.	AMINOCAPROIC ACID	1000	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
70377-104_4c94e9c7-476c-8256-83cf-723ff8e5107b	70377-104	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	SOLUTION	ORAL	20210318		ANDA	ANDA214140	Biocon Pharma Inc.	AMINOCAPROIC ACID	.25	g/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
70377-113_c9c5c51c-c406-82ad-ad7b-ff0dac43503a	70377-113	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	POWDER, FOR SUSPENSION	ORAL	20230901		ANDA	ANDA217137	Biocon Pharma Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70381-120_0ae34360-6ea7-4bf0-a07e-a7eff4f3a48f	70381-120	HUMAN OTC DRUG	Correct and Protect Serum Broad Spectrum	SPF 45	Zinc Oxide	LOTION	TOPICAL	20220103		OTC MONOGRAPH FINAL	part352	Murad, LLC	ZINC OXIDE	17	g/100mL			N	20241231
70382-204_dc8152c2-9452-4ae6-85d8-e47723b32c5a	70382-204	HUMAN PRESCRIPTION DRUG	DEXTENZA		dexamethasone	INSERT	INTRACANALICULAR; OPHTHALMIC	20190107		NDA	NDA208742	Ocular Therapeutix, Inc.	DEXAMETHASONE	.4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70393-400_0a57a78c-4cf1-f09b-e063-6294a90ae67d	70393-400	HUMAN OTC DRUG	CareTouch Alcohol Prep Pad		isopropyl alcohol	SWAB	TOPICAL	20160108		OTC MONOGRAPH DRUG	M003	Future Diagnostics Llc	ISOPROPYL ALCOHOL	.7	mL/1			N	20241231
70393-415_0a5774c4-55ba-f7ec-e063-6294a90a1a03	70393-415	HUMAN OTC DRUG	CareTouch		Ethyl alcohol	CLOTH	TOPICAL	20170523		OTC MONOGRAPH DRUG	M003	Future Diagnostics Llc	ALCOHOL	.62	mL/mL			N	20241231
70401-150_eea1704f-9bac-9f9e-e053-2a95a90a1d57	70401-150	HUMAN OTC DRUG	Zoom Wipes		Benzalkonium chloride	SWAB	TOPICAL	20160520		OTC MONOGRAPH NOT FINAL	part333A	ZOOM PRODUCTS LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
70403-920_6eb34145-5774-4fda-8120-6feb6c58bd47	70403-920	HUMAN OTC DRUG	ARTIFICIAL TEARS		Polyvinyl Alcohol	SOLUTION/ DROPS	OPHTHALMIC	20200331	20250331	OTC MONOGRAPH FINAL	part349	Aru Pharma Inc.	POLYVINYL ALCOHOL, UNSPECIFIED	14	mg/mL			N	
70403-921_b8bff17c-747c-4819-9d1a-579a1bedbc90	70403-921	HUMAN OTC DRUG	ARTIFICIAL TEARS		Carboxymethylcellulose Sodium	SOLUTION/ DROPS	OPHTHALMIC	20180122	20250331	OTC MONOGRAPH FINAL	part349	Aru Pharma Inc.	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	10	mg/mL			N	
70403-922_fb4fc19b-b329-466b-828f-86a7593b44a5	70403-922	HUMAN OTC DRUG	HYDROCORTISONE MAXIMUM STRENGTH		Hydrocortisone	OINTMENT	TOPICAL	20180101	20250331	OTC MONOGRAPH NOT FINAL	part348	Aru Pharma Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
70403-923_435da8cc-a197-4520-a760-06e0c310628b	70403-923	HUMAN OTC DRUG	HYDROCORTISONE MAXIMUM STRENGTH		Hydrocortisone	CREAM	TOPICAL	20180101	20250331	OTC MONOGRAPH NOT FINAL	part348	Aru Pharma Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
70403-924_cb0873b4-3fda-4b20-8f61-bc86c04f5f2c	70403-924	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	20180101	20250331	OTC MONOGRAPH FINAL	part333C	Aru Pharma Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
70403-925_5ba145b6-c454-4250-8bad-282d6ac47b3b	70403-925	HUMAN OTC DRUG	CLOTRIMAZOLE ANTIFUNGAL		Clotrimazole	CREAM	TOPICAL	20180101	20250331	OTC MONOGRAPH FINAL	part333C	Aru Pharma Inc.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
70408-146_8e72e736-c53d-4393-a078-b7b2a231055b	70408-146	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	SOLUTION	ORAL	20090313		ANDA	ANDA040891	Nostrum Laboratories, Inc.	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70408-185_e78195f4-5ace-42b1-b42b-df1546e5b596	70408-185	HUMAN PRESCRIPTION DRUG	promethazine hydrochloride and codeine phosphate		promethazine hydrochloride and codeine phosphate	SOLUTION	ORAL	20100317		ANDA	ANDA090180	Nostrum Laboratories, Inc.	CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE	10; 6.25	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]	CV	N	20241231
70408-239_686f8b08-4e54-4cb2-abdd-595c3fb3d16e	70408-239	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	SUSPENSION	ORAL	20120304		ANDA	ANDA201355	Nostrum Laboratories, Inc.	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70408-644_50870177-6eff-41c1-85a4-670836703a30	70408-644	HUMAN PRESCRIPTION DRUG	ELIXOPHYLLIN		THEOPHYLLINE ANHYDROUS	LIQUID	ORAL	20091001		ANDA	ANDA085186	Nostrum Laboratories, Inc.	THEOPHYLLINE ANHYDROUS	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
70411-100_bc855e90-86d4-4147-a724-35eb812ecfaa	70411-100	HUMAN OTC DRUG	Blue Green Foam		Benzalkonium Chloride	LIQUID	TOPICAL	20160215		OTC MONOGRAPH DRUG	M003	H2Ocean, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
70411-102_ec7d90f8-f52d-40ac-95f0-1e40b1df56eb	70411-102	HUMAN OTC DRUG	Nothing		Lidocaine	LIQUID	TOPICAL	20180207		OTC MONOGRAPH DRUG	M017	H2Ocean, LLC	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70411-103_f3ebbff0-8901-40d3-a1c8-823063a7dab7	70411-103	HUMAN OTC DRUG	Blue Green		Benzalkonium chloride	LIQUID	TOPICAL	20180725		OTC MONOGRAPH DRUG	M003	H2Ocean, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
70412-110_0986c648-5f14-7c4c-e063-6394a90abd3d	70412-110	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20160119		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-111_0a259db2-a0e9-63b6-e063-6394a90a5af5	70412-111	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20160118		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-112_0986c304-34e0-5421-e063-6294a90a65ba	70412-112	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20160118		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-114_0986d7b9-4c52-5ca1-e063-6294a90a391b	70412-114	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20160204		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-119_0986c648-5f24-7c4c-e063-6394a90abd3d	70412-119	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ETHYL ALCOHOL	SPRAY	TOPICAL	20160118		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-120_0986d827-1f1f-802d-e063-6394a90aa6b9	70412-120	HUMAN OTC DRUG	Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20160118		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
70412-131_0986e098-aa81-59ca-e063-6294a90a4c0f	70412-131	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200117		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-132_0986c304-34ef-5421-e063-6294a90a65ba	70412-132	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200117		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-133_0986d827-1f2d-802d-e063-6394a90aa6b9	70412-133	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200117		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-134_0986c648-5f33-7c4c-e063-6394a90abd3d	70412-134	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200117		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-135_0986e098-aa8f-59ca-e063-6294a90a4c0f	70412-135	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200117		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-140_0986ff76-6503-7704-e063-6294a90a9be2	70412-140	HUMAN OTC DRUG	Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	BENZALKONIUM CHLORIDE	10	mg/mL			N	20241231
70412-141_09870258-c959-57da-e063-6294a90aa301	70412-141	HUMAN OTC DRUG	Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	BENZALKONIUM CHLORIDE	10	mg/mL			N	20241231
70412-142_09870258-c967-57da-e063-6294a90aa301	70412-142	HUMAN OTC DRUG	Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	BENZALKONIUM CHLORIDE	10	mg/mL			N	20241231
70412-150_0986d827-1f3b-802d-e063-6394a90aa6b9	70412-150	HUMAN OTC DRUG	Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	BENZALKONIUM CHLORIDE	10	mg/mL			N	20241231
70412-190_0aae1be1-9960-7662-e063-6394a90acb98	70412-190	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20160927		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	620	mg/mL			N	20241231
70412-191_098716b8-14a3-8ab4-e063-6394a90a2bc8	70412-191	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	.62	mL/mL			N	20241231
70412-192_098708e4-06e4-7b7e-e063-6294a90ad447	70412-192	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	.7	mL/mL			N	20241231
70412-194_0986d827-1f4a-802d-e063-6394a90aa6b9	70412-194	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	ALCOHOL	.7	mL/mL			N	20241231
70412-211_09872012-330d-a9dd-e063-6394a90a8545	70412-211	HUMAN OTC DRUG	SPF30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co.,Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
70412-212_098725d4-ed76-891b-e063-6294a90a051e	70412-212	HUMAN OTC DRUG	SPF15 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20181001		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co.,Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 80; 20; 55	mg/g; mg/g; mg/g; mg/g			N	20241231
70412-231_098708e4-06f3-7b7e-e063-6294a90ad447	70412-231	HUMAN OTC DRUG	SPF30 Sunscreen		Avobenzone, Homosalate, Octocrylene, Ocitsalate	LOTION	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70412-238_0986ff76-6513-7704-e063-6294a90a9be2	70412-238	HUMAN OTC DRUG	SPF30 Sunscreen		Avobenzone, Homosalate, Octocrylene, Ocitsalate	SPRAY	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70412-316_09afb7ba-9ddf-7b82-e063-6294a90a9be6	70412-316	HUMAN OTC DRUG	SPF15		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	LIPSTICK	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co.,Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 80; 20; 55	mg/g; mg/g; mg/g; mg/g			N	20241231
70412-411_0aadd7d7-6eea-5012-e063-6394a90a0e4c	70412-411	HUMAN OTC DRUG	Acne Fighting Spot with Aloe clear		SALICYLIC ACID	GEL	TOPICAL	20180601		OTC MONOGRAPH DRUG	M006	Zhejiang Ayan Biotech Co.,Ltd.	SALICYLIC ACID	10	mg/mL			N	20241231
70412-435_098738da-207e-8b6a-e063-6294a90ae6e2	70412-435	HUMAN OTC DRUG	Acne Fighting Foundation Caramel		SALICYLIC ACID	CREAM	TOPICAL	20181101		OTC MONOGRAPH DRUG	M006	Zhejiang Ayan Biotech Co.,Ltd.	SALICYLIC ACID	5	mg/mL			N	20241231
70412-500_09874009-51dc-ac30-e063-6394a90ae5b4	70412-500	HUMAN OTC DRUG	Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200415		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Ayan Biotech Co.,Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
70412-817_09874009-51eb-ac30-e063-6394a90ae5b4	70412-817	HUMAN OTC DRUG	SPF30 Sunscreen and Antibacterial Hand Sanitizer		ALCOHOL, AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	KIT	TOPICAL	20180901		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co., Ltd.						N	20241231
70412-818_09874a42-6241-b23c-e063-6394a90a889f	70412-818	HUMAN OTC DRUG	SPF30 Sunscreen and SPF15		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	KIT		20181201		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co.,Ltd.						N	20241231
70412-819_0b38525a-c4e7-7c88-e063-6394a90ae1a9	70412-819	HUMAN OTC DRUG	SPF 15 Lip and SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	KIT	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Zhejiang Ayan Biotech Co.,Ltd.						N	20241231
70413-553_6920e63a-abd8-4a25-a17f-28482303333e	70413-553	HUMAN OTC DRUG	Lice Ladies Defend Conditioner		Sabadilla	LIQUID	TOPICAL	20140101		UNAPPROVED HOMEOPATHIC		Lice Ladies Atlanta, LLC	SCHOENOCAULON OFFICINALE SEED	6	[hp_X]/mL			N	20241231
70413-554_af69b292-a119-49e4-b8cc-d07a48a138c6	70413-554	HUMAN OTC DRUG	Lice Ladies Defend		Sabadilla	SHAMPOO	TOPICAL	20140101		UNAPPROVED HOMEOPATHIC		Lice Ladies Atlanta, LLC	SCHOENOCAULON OFFICINALE SEED	6	[hp_X]/mL			N	20241231
70413-555_b5412941-3f02-4ad4-b241-055a1ac51fb0	70413-555	HUMAN OTC DRUG	Lice Ladies Prevent		Sabadilla	SPRAY	TOPICAL	20110101		UNAPPROVED HOMEOPATHIC		Lice Ladies Atlanta, LLC	SCHOENOCAULON OFFICINALE SEED	6	[hp_X]/mL			N	20241231
70413-920_fe601674-61d1-4297-bd59-67ec5ee61497	70413-920	HUMAN OTC DRUG	EVICT		Sabadilla	SOLUTION	TOPICAL	20180212		UNAPPROVED HOMEOPATHIC		Lice Ladies Atlanta, LLC	SCHOENOCAULON OFFICINALE SEED	6	[hp_X]/mL			N	20241231
70413-930_7883b402-b270-4e6a-81fa-a5af3c68cbe1	70413-930	HUMAN OTC DRUG	EVICT		Sabadilla	SOLUTION	TOPICAL	20180212		UNAPPROVED HOMEOPATHIC		Lice Ladies Atlanta, LLC	SCHOENOCAULON OFFICINALE SEED	6	[hp_X]/mL			N	20241231
70415-001_05dfa030-a4f4-13c3-e063-6394a90a8f74	70415-001	HUMAN OTC DRUG	Sierra Soft Antibacterial Wash		CHLOROXYLENOL	LIQUID	TOPICAL	20160201		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	CHLOROXYLENOL	5	g/L			N	20241231
70415-002_05df821f-093e-180c-e063-6394a90ab4e0	70415-002	HUMAN OTC DRUG	Sierra Soft Alcohol Hand Sanitizer		ETHYL ALCOHOL	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	ALCOHOL	700	g/L			N	20241231
70415-100_05df9026-0425-1813-e063-6394a90a81da	70415-100	HUMAN OTC DRUG	Sierra Soft Alcohol Hand Sanitizer		ETHYL ALCOHOL	LIQUID	TOPICAL	20160504		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	ALCOHOL	700	mg/mL			N	20241231
70415-101_05df88fd-24f9-0572-e063-6294a90a4dd0	70415-101	HUMAN OTC DRUG	Sierra Soft Antibacterial Wash		CHLOROXYLENOL	LIQUID	TOPICAL	20160504		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	CHLOROXYLENOL	5	mg/mL			N	20241231
70415-102_05df627c-b879-a543-e063-6294a90a28bc	70415-102	HUMAN OTC DRUG	Sierra Soft Alcohol Foam Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20160504		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	ALCOHOL	1	g/100mL			N	20241231
70415-103_05df979c-969e-55f4-e063-6294a90a1613	70415-103	HUMAN OTC DRUG	Sierra Soft Non-Alcohol Foam Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20160504		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
70415-104_05dfc63b-68cd-55fd-e063-6294a90aad84	70415-104	HUMAN OTC DRUG	Sierra Soft Non-Alcohol Hand Sanitizer Foam		BENZETHONIUM CHLORIDE	LIQUID	TOPICAL	20161213		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	BENZETHONIUM CHLORIDE	2.5	g/L			N	20241231
70415-106_05df88fd-2504-0572-e063-6294a90a4dd0	70415-106	HUMAN OTC DRUG	Sierra Soft Non-Alcohol Foam Hand Sanitizer		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20160504		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
70415-107_05df821f-0933-180c-e063-6394a90ab4e0	70415-107	HUMAN OTC DRUG	ALCOHOL HAND SANITIZER		ETHYL ALCOHOL	SOLUTION	TOPICAL	20200414		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	ALCOHOL	70	mL/100mL			N	20241231
70415-201_05df627c-b86e-a543-e063-6294a90a28bc	70415-201	HUMAN OTC DRUG	Royal Antibacterial Foam Hand Wash		CHLOROXYLENOL	SOLUTION	TOPICAL	20160504		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	CHLOROXYLENOL	.5	g/100mL			N	20241231
70415-202_05df95b5-e64c-13ab-e063-6394a90ab8ea	70415-202	HUMAN OTC DRUG	Royal 70-percent Alcohol Foam Hand Sanitizer		ETHYL ALCOHOL	LIQUID	TOPICAL	20160201		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	ALCOHOL	70	mL/100mL			N	20241231
70415-203_05dfc63b-68b6-55fd-e063-6294a90aad84	70415-203	HUMAN OTC DRUG	FRESH HAND FOAMING HAND SANITIZER ALCOHOL FOAM		ETHYL ALCOHOL	SOLUTION	TOPICAL	20200804		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	ALCOHOL	70	mL/100mL			N	20241231
70415-204_05df821f-0926-180c-e063-6394a90ab4e0	70415-204	HUMAN OTC DRUG	FRESH HAND FOAMING HAND SANITIZER NON-ALCOHOL FOAM		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20200805		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
70415-205_05df979c-9693-55f4-e063-6294a90a1613	70415-205	HUMAN OTC DRUG	Royal Non-Alcohol Foam Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20170322		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
70415-301_05df821f-0918-180c-e063-6394a90ab4e0	70415-301	HUMAN OTC DRUG	PIONEER ECLIPSE TOUCHE FOAMING ANTIBACTERIAL GREEN		CHLOROXYLENOL	LIQUID	TOPICAL	20160504		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	CHLOROXYLENOL	.5	g/100mL			N	20241231
70415-302_05df9026-041a-1813-e063-6394a90a81da	70415-302	HUMAN OTC DRUG	PIONEER ECLIPSE TOUCHE FOAMING HAND SANITIZER		ETHYL ALCOHOL	LIQUID	TOPICAL	20160201		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	ALCOHOL	70	mL/100mL			N	20241231
70415-305_05df5eea-c8ac-7d7a-e063-6294a90a68ac	70415-305	HUMAN OTC DRUG	Pioneer Eclipse Touche Foaming Non-Alcohol Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20170804		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
70415-401_05df5ec1-e3f2-a683-e063-6294a90a91f0	70415-401	HUMAN OTC DRUG	Puro Antibacterial Wash Foam		CHLOROXYLENOL	SOLUTION	TOPICAL	20160504		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	CHLOROXYLENOL	.5	g/100mL			N	20241231
70415-402_05df627c-b857-a543-e063-6294a90a28bc	70415-402	HUMAN OTC DRUG	Puro 70 Percent Alcohol Foaming Hand Sanitizer		ETHYL ALCOHOL	SOLUTION	TOPICAL	20170804		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	ALCOHOL	70	mL/100mL			N	20241231
70415-405_05df95b5-e641-13ab-e063-6394a90ab8ea	70415-405	HUMAN OTC DRUG	Puro Non-Alcohol Foam Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20170322		OTC MONOGRAPH DRUG	M003	CWGC LA Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
70415-511_05df9026-040d-1813-e063-6394a90a81da	70415-511	HUMAN OTC DRUG	KEKE HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333E	CWGC LA Inc.	ALCOHOL	75	mL/100mL			N	20241231
70430-001_081d5418-e5f1-446f-e063-6294a90a6d1d	70430-001	HUMAN OTC DRUG	Alcohol Pad		ISOPROPYL ALCOHOL	PATCH	TOPICAL	20170427		OTC MONOGRAPH DRUG	M003	LaMi Products INC.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
70436-001_0bbe89e3-5884-ccca-e063-6394a90a328f	70436-001	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181115		ANDA	ANDA209314	Slate Run Pharmaceuticals, LLC	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70436-002_0bbe89e3-5884-ccca-e063-6394a90a328f	70436-002	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20181115		ANDA	ANDA209314	Slate Run Pharmaceuticals, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70436-004_085d8e68-8e6f-25d5-e063-6394a90a177a	70436-004	HUMAN PRESCRIPTION DRUG	Galantamine		galantamine	TABLET, FILM COATED	ORAL	20170802		ANDA	ANDA077604	Slate Run Pharmaceuticals, LLC	GALANTAMINE HYDROBROMIDE	4	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70436-005_085d8e68-8e6f-25d5-e063-6394a90a177a	70436-005	HUMAN PRESCRIPTION DRUG	Galantamine		galantamine	TABLET, FILM COATED	ORAL	20170802		ANDA	ANDA077604	Slate Run Pharmaceuticals, LLC	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70436-006_085d8e68-8e6f-25d5-e063-6394a90a177a	70436-006	HUMAN PRESCRIPTION DRUG	Galantamine		galantamine	TABLET, FILM COATED	ORAL	20170802		ANDA	ANDA077604	Slate Run Pharmaceuticals, LLC	GALANTAMINE HYDROBROMIDE	12	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70436-007_ecb540af-5b79-40d7-84c2-de15c86c0048	70436-007	HUMAN PRESCRIPTION DRUG	cinacalcet hydrochloride		cinacalcet hydrochloride	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA210207	Slate Run Pharmaceuticals	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
70436-008_ecb540af-5b79-40d7-84c2-de15c86c0048	70436-008	HUMAN PRESCRIPTION DRUG	cinacalcet hydrochloride		cinacalcet hydrochloride	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA210207	Slate Run Pharmaceuticals	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
70436-009_ecb540af-5b79-40d7-84c2-de15c86c0048	70436-009	HUMAN PRESCRIPTION DRUG	cinacalcet hydrochloride		cinacalcet hydrochloride	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA210207	Slate Run Pharmaceuticals	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
70436-010_0bbe18c6-1055-b079-e063-6394a90adf1d	70436-010	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA210015	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70436-011_0bbe18c6-1055-b079-e063-6394a90adf1d	70436-011	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA210015	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70436-012_0d8eaf78-5729-5827-e063-6394a90a24b7	70436-012	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20200801		ANDA	ANDA210014	Slate Run Pharmaceuticals, LLC	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70436-013_0d8eaf78-5729-5827-e063-6394a90a24b7	70436-013	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20200801		ANDA	ANDA210014	Slate Run Pharmaceuticals, LLC	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70436-019_ebe5ec1e-9891-ae48-e053-2a95a90afff6	70436-019	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin Dihydrate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181219		ANDA	ANDA203412	Slate Run Pharmaceuticals	AZITHROMYCIN DIHYDRATE	500	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70436-020_c84f514d-5dae-00ff-e053-2a95a90a6fbb	70436-020	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190603		ANDA	ANDA212332	Slate Run Pharmaceuticals, LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70436-021_c84f514d-5dae-00ff-e053-2a95a90a6fbb	70436-021	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190603		ANDA	ANDA212332	Slate Run Pharmaceuticals, LLC	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70436-022_d1af3995-ce44-521d-e053-2a95a90ada94	70436-022	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210206		ANDA	ANDA215821	Slate Run Pharmaceuticals, LLC	VANCOMYCIN HYDROCHLORIDE	5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70436-023_d1af3995-ce44-521d-e053-2a95a90ada94	70436-023	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210206		ANDA	ANDA215821	Slate Run Pharmaceuticals, LLC	VANCOMYCIN HYDROCHLORIDE	10	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70436-025_c44f8757-1a09-ab1e-e053-2a95a90a44e1	70436-025	HUMAN PRESCRIPTION DRUG	bivalirudin		bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20210630		ANDA	ANDA213078	Slate Run Pharmaceuticals, LLC	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
70436-026_ee33453c-6399-e547-e053-2a95a90aeb82	70436-026	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION	INTRAVENOUS	20190722		ANDA	ANDA209864	Slate Run Pharmaceuticals, LLC	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
70436-027_ee33453c-6399-e547-e053-2a95a90aeb82	70436-027	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION	INTRAVENOUS	20190722		ANDA	ANDA209864	Slate Run Pharmaceuticals, LLC	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
70436-028_b17353da-2c56-d579-e053-2995a90a8227	70436-028	HUMAN PRESCRIPTION DRUG	sodium nitroprusside		sodium nitroprusside	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20201015		ANDA	ANDA214199	Slate Run Pharmaceuticals, LLC	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
70436-029_f182272e-a30e-149d-e053-2a95a90a5d0f	70436-029	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190128		ANDA	ANDA211661	Slate Run Pharmaceuticals	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-033_e6b9cc81-2724-1ecb-e053-2995a90a13c1	70436-033	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20221001		ANDA	ANDA215890	Slate Run Pharmaceuticals, LLC	DAPTOMYCIN	500	mg/20mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
70436-034_f79cdb51-41ca-2bb3-e053-6294a90abb15	70436-034	HUMAN PRESCRIPTION DRUG	lincomycin		lincomycin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230223		ANDA	ANDA216662	Slate Run Pharmaceuticals, LLC	LINCOMYCIN	300	mg/mL			N	20241231
70436-035_f79cdb51-41ca-2bb3-e053-6294a90abb15	70436-035	HUMAN PRESCRIPTION DRUG	lincomycin		lincomycin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230223		ANDA	ANDA216662	Slate Run Pharmaceuticals, LLC	LINCOMYCIN	300	mg/mL			N	20241231
70436-036_0d8eaf78-5729-5827-e063-6394a90a24b7	70436-036	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210105		ANDA	ANDA210014	Slate Run Pharmaceuticals, LLC	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70436-039_0c604d5f-31b0-7c5b-e063-6294a90a6072	70436-039	HUMAN PRESCRIPTION DRUG	Guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20220801		ANDA	ANDA213428	Slate Run Pharmaceuticals, LLC	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70436-040_0c604d5f-31b0-7c5b-e063-6294a90a6072	70436-040	HUMAN PRESCRIPTION DRUG	Guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20220801		ANDA	ANDA213428	Slate Run Pharmaceuticals, LLC	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70436-041_0c604d5f-31b0-7c5b-e063-6294a90a6072	70436-041	HUMAN PRESCRIPTION DRUG	Guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20220801		ANDA	ANDA213428	Slate Run Pharmaceuticals, LLC	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70436-042_0c604d5f-31b0-7c5b-e063-6294a90a6072	70436-042	HUMAN PRESCRIPTION DRUG	Guanfacine		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20220801		ANDA	ANDA213428	Slate Run Pharmaceuticals, LLC	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70436-054_0be785f7-f9b1-6c6d-e063-6294a90aad7f	70436-054	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211115		ANDA	ANDA211100	Slate Run Pharmaceuticals, LLC	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70436-055_0be785f7-f9b1-6c6d-e063-6294a90aad7f	70436-055	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211115		ANDA	ANDA211100	Slate Run Pharmaceuticals, LLC	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70436-056_0be785f7-f9b1-6c6d-e063-6294a90aad7f	70436-056	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211115		ANDA	ANDA211100	Slate Run Pharmaceuticals, LLC	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70436-057_0be785f7-f9b1-6c6d-e063-6294a90aad7f	70436-057	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20211115		ANDA	ANDA211100	Slate Run Pharmaceuticals, LLC	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70436-058_0be38732-59de-e837-e063-6394a90a7cf4	70436-058	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102		ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70436-059_0be38732-59de-e837-e063-6394a90a7cf4	70436-059	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102		ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70436-060_0be38732-59de-e837-e063-6394a90a7cf4	70436-060	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102		ANDA	ANDA211347	Slate Run Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70436-089_caff19b0-1b5b-e732-e053-2a95a90a0ba0	70436-089	HUMAN PRESCRIPTION DRUG	Ganciclovir		ganciclovir sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENTRICULAR	20190101		ANDA	ANDA204204	Slate Run Pharmaceuticals, LLC	GANCICLOVIR SODIUM	500	mg/10mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
70436-090_ff407f66-1098-2364-e053-6394a90a6fe5	70436-090	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20180313		ANDA	ANDA205695	Slate Run Pharmaceuticals, LLC.	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
70436-091_ff407f66-1098-2364-e053-6394a90a6fe5	70436-091	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20180313		ANDA	ANDA205695	Slate Run Pharmaceuticals, LLC.	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
70436-093_7e79d402-c6b9-4d74-b4f8-7d98cc2fd577	70436-093	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA212091	Slate Run Pharmaceuticals, LLC	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70436-094_7e79d402-c6b9-4d74-b4f8-7d98cc2fd577	70436-094	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA212091	Slate Run Pharmaceuticals, LLC	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70436-095_7e79d402-c6b9-4d74-b4f8-7d98cc2fd577	70436-095	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA212091	Slate Run Pharmaceuticals, LLC	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70436-096_7e79d402-c6b9-4d74-b4f8-7d98cc2fd577	70436-096	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA212091	Slate Run Pharmaceuticals, LLC	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70436-097_7e79d402-c6b9-4d74-b4f8-7d98cc2fd577	70436-097	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA212091	Slate Run Pharmaceuticals, LLC	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70436-098_6514e849-b6de-4c32-bc36-0e3a5b431cee	70436-098	HUMAN PRESCRIPTION DRUG	eplerenone		eplerenone	TABLET, FILM COATED	ORAL	20210104		ANDA	ANDA212765	Slate Run Pharmaceuticals, LLC	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70436-099_6514e849-b6de-4c32-bc36-0e3a5b431cee	70436-099	HUMAN PRESCRIPTION DRUG	eplerenone		eplerenone	TABLET, FILM COATED	ORAL	20210104		ANDA	ANDA212765	Slate Run Pharmaceuticals, LLC	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70436-101_de4c0693-1b76-4026-bd94-a7a5dcc8a376	70436-101	HUMAN PRESCRIPTION DRUG	tetrabenazine		tetrabenazine	TABLET	ORAL	20200302		ANDA	ANDA213316	Slate Run Pharmaceuticals, LLC	TETRABENAZINE	12.5	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
70436-102_de4c0693-1b76-4026-bd94-a7a5dcc8a376	70436-102	HUMAN PRESCRIPTION DRUG	tetrabenazine		tetrabenazine	TABLET	ORAL	20200302		ANDA	ANDA213316	Slate Run Pharmaceuticals, LLC	TETRABENAZINE	25	mg/1	Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA]		N	20241231
70436-103_7610b62e-bdf5-47bd-8bbf-37654ab727bf	70436-103	HUMAN PRESCRIPTION DRUG	Ranolazine		ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230725		ANDA	ANDA213085	Slate Run Pharmaceuticals	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70436-104_7610b62e-bdf5-47bd-8bbf-37654ab727bf	70436-104	HUMAN PRESCRIPTION DRUG	Ranolazine		ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230725		ANDA	ANDA213085	Slate Run Pharmaceuticals	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70436-110_09af6337-0c92-4cb7-e063-6294a90a0e4a	70436-110	HUMAN PRESCRIPTION DRUG	tobramycin		tobramycin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20230201		ANDA	ANDA217029	Slate Run Pharmaceuticals, LLC	TOBRAMYCIN	1200	mg/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70436-116_00bc6a8c-a137-07f6-e063-6394a90acfbf	70436-116	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230710		ANDA	ANDA217021	Slate Run Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	50	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70436-117_00bc6a8c-a137-07f6-e063-6394a90acfbf	70436-117	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230710		ANDA	ANDA217021	Slate Run Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	100	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70436-118_00bc6a8c-a137-07f6-e063-6394a90acfbf	70436-118	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230710		ANDA	ANDA217021	Slate Run Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	200	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70436-120_00bc6a8c-a137-07f6-e063-6394a90acfbf	70436-120	HUMAN PRESCRIPTION DRUG	Leucovorin Calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230710		ANDA	ANDA217021	Slate Run Pharmaceuticals, LLC	LEUCOVORIN CALCIUM	500	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70436-124_07448694-086d-2663-e063-6294a90af277	70436-124	HUMAN PRESCRIPTION DRUG	iopamidol		iopamidol	INJECTION, SOLUTION	INTRATHECAL	20230720		ANDA	ANDA215382	Slate Run Pharmaceuticals	IOPAMIDOL	408	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
70436-126_07448694-086d-2663-e063-6294a90af277	70436-126	HUMAN PRESCRIPTION DRUG	iopamidol		iopamidol	INJECTION, SOLUTION	INTRATHECAL	20230720		ANDA	ANDA215382	Slate Run Pharmaceuticals	IOPAMIDOL	612	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
70436-140_1af8aeac-14cf-4330-bf4e-3e50348268c1	70436-140	HUMAN PRESCRIPTION DRUG	droxidopa		droxidopa	CAPSULE	ORAL	20211110		ANDA	ANDA215265	Slate Run Pharmaceuticals, LLC	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70436-141_1af8aeac-14cf-4330-bf4e-3e50348268c1	70436-141	HUMAN PRESCRIPTION DRUG	droxidopa		droxidopa	CAPSULE	ORAL	20211110		ANDA	ANDA215265	Slate Run Pharmaceuticals, LLC	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70436-142_1af8aeac-14cf-4330-bf4e-3e50348268c1	70436-142	HUMAN PRESCRIPTION DRUG	droxidopa		droxidopa	CAPSULE	ORAL	20211110		ANDA	ANDA215265	Slate Run Pharmaceuticals, LLC	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70436-147_47a4b0ae-7e39-408b-82b1-15940cb36472	70436-147	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	INJECTION	INTRAMUSCULAR	20210923		ANDA	ANDA207076	Slate Run Pharmaceuticals, LLC	DICYCLOMINE HYDROCHLORIDE	20	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70436-151_3bd6ebed-0405-445a-8613-ae20b2e70703	70436-151	HUMAN PRESCRIPTION DRUG	Arformoterol Tartrate Inhalation		Arformoterol Tartrate Inhalation	SOLUTION	RESPIRATORY (INHALATION)	20210622		ANDA	ANDA213762	Slate Run Pharmaceuticals	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70436-152_0be5e160-b6f1-731f-e063-6394a90a9b35	70436-152	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200201		ANDA	ANDA212561	Slate Run Pharmaceuticals, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70436-153_0be5e160-b6f1-731f-e063-6394a90a9b35	70436-153	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200201		ANDA	ANDA212561	Slate Run Pharmaceuticals, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70436-155_4aa2923b-2421-409b-bcc6-75dc0c318cbe	70436-155	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution		Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution	SOLUTION	ORAL	20201005		ANDA	ANDA040649	Slate Run Pharmaceuticals, LLC	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70436-156_6f884760-fd87-4147-8d31-760ed0f49864	70436-156	HUMAN PRESCRIPTION DRUG	Cilostazol		cilostazol	TABLET	ORAL	20180101		ANDA	ANDA077208	Slate Run Pharmaceuticals, LLC	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
70436-157_6f884760-fd87-4147-8d31-760ed0f49864	70436-157	HUMAN PRESCRIPTION DRUG	Cilostazol		cilostazol	TABLET	ORAL	20180101		ANDA	ANDA077208	Slate Run Pharmaceuticals, LLC	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
70436-160_0c61c496-0936-e618-e063-6394a90aa7b2	70436-160	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412		ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70436-161_0c61c496-0936-e618-e063-6394a90aa7b2	70436-161	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	CAPSULE, EXTENDED RELEASE	ORAL	20210412		ANDA	ANDA213858	Slate Run Pharmaceuticals, LLC	TOLTERODINE TARTRATE	4	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70436-162_ee34183e-b5a0-7896-e053-2995a90a5ac2	70436-162	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION	INTRAVENOUS	20190601		ANDA	ANDA209864	Slate Run Pharmaceuticals, LLC	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
70436-163_ee34183e-b5a0-7896-e053-2995a90a5ac2	70436-163	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION	INTRAVENOUS	20190601		ANDA	ANDA209864	Slate Run Pharmaceuticals, LLC	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
70436-166_0be686f0-10ed-a18c-e063-6294a90ae686	70436-166	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210429		ANDA	ANDA213854	Slate Run Pharmaceuticals, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70436-167_0be686f0-10ed-a18c-e063-6294a90ae686	70436-167	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210429		ANDA	ANDA213854	Slate Run Pharmaceuticals, LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70436-168_0be7fc70-4f49-b40d-e063-6294a90a5e6d	70436-168	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20220411		ANDA	ANDA212562	Slate Run Pharmaceuticals, LLC	FENOFIBRIC ACID	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
70436-169_0be7fc70-4f49-b40d-e063-6294a90a5e6d	70436-169	HUMAN PRESCRIPTION DRUG	Fenofibric Acid		Fenofibric Acid	CAPSULE, DELAYED RELEASE	ORAL	20220411		ANDA	ANDA212562	Slate Run Pharmaceuticals, LLC	FENOFIBRIC ACID	135	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
70436-172_0c46ca07-e1af-620b-e063-6294a90aaff1	70436-172	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20210519		ANDA	ANDA214376	Slate Run Pharmaceuticals, LLC	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70436-173_0c46ca07-e1af-620b-e063-6294a90aaff1	70436-173	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20210519		ANDA	ANDA214376	Slate Run Pharmaceuticals, LLC	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70436-174_0be3a0f9-e04b-f94d-e063-6394a90aa643	70436-174	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20210621		ANDA	ANDA214760	Slate Run Pharmaceuticals, LLC	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70436-180_0c72414c-ec04-cbbe-e063-6294a90af219	70436-180	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20220725		ANDA	ANDA215318	Slate Run Pharmaceuticals, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70436-181_0c72414c-ec04-cbbe-e063-6294a90af219	70436-181	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20220725		ANDA	ANDA215318	Slate Run Pharmaceuticals, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70436-182_0c72414c-ec04-cbbe-e063-6294a90af219	70436-182	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20220725		ANDA	ANDA215318	Slate Run Pharmaceuticals, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70436-183_0be686f0-10ed-a18c-e063-6294a90ae686	70436-183	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20211216		ANDA	ANDA213854	Slate Run Pharmaceuticals, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70436-190_0899c795-cde2-c60b-e063-6394a90a518a	70436-190	HUMAN PRESCRIPTION DRUG	Esomeprazole sodium		Esomeprazole sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220225		ANDA	ANDA215732	Slate Run Pharmaceuticals, LLC	ESOMEPRAZOLE SODIUM	40	mg/5mL	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70436-191_0bf7302e-22e3-3a81-e063-6294a90a07be	70436-191	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220905		ANDA	ANDA216304	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-192_0bf7302e-22e3-3a81-e063-6294a90a07be	70436-192	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220905		ANDA	ANDA216304	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-193_0bf7302e-22e3-3a81-e063-6294a90a07be	70436-193	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220905		ANDA	ANDA216304	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-195_0bf763a5-e281-7ec0-e063-6294a90a0930	70436-195	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA216439	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-196_0bf763a5-e281-7ec0-e063-6294a90a0930	70436-196	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA216439	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-197_0bf763a5-e281-7ec0-e063-6294a90a0930	70436-197	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA216439	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-198_0bf763a5-e281-7ec0-e063-6294a90a0930	70436-198	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA216439	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-199_0bf763a5-e281-7ec0-e063-6294a90a0930	70436-199	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA216439	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-200_0bf763a5-e281-7ec0-e063-6294a90a0930	70436-200	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA216439	Slate Run Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70436-202_0be686f0-10ed-a18c-e063-6294a90ae686	70436-202	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20221028		ANDA	ANDA213854	Slate Run Pharmaceuticals, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70436-203_f5cd978c-4e1d-2447-e053-2a95a90add3f	70436-203	HUMAN PRESCRIPTION DRUG	Dobutamine		dobutamine	INJECTION	INTRAVENOUS	20230403		ANDA	ANDA216131	Slate Run Pharmaceuticals	DOBUTAMINE HYDROCHLORIDE	250	mg/20mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
70436-205_09c94d69-7bea-2491-e063-6394a90a6438	70436-205	HUMAN PRESCRIPTION DRUG	sodium nitroprusside in 0.9% sodium chloride		sodium nitroprusside in 0.9% sodium chloride	INJECTION	INTRAVENOUS	20221231		ANDA	ANDA215846	Slate Run Pharmaceuticals, LLC	SODIUM NITROPRUSSIDE	.2	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
70436-206_09c94d69-7bea-2491-e063-6394a90a6438	70436-206	HUMAN PRESCRIPTION DRUG	sodium nitroprusside in 0.9% sodium chloride		sodium nitroprusside in 0.9% sodium chloride	INJECTION	INTRAVENOUS	20221231		ANDA	ANDA215846	Slate Run Pharmaceuticals, LLC	SODIUM NITROPRUSSIDE	.2	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
70436-207_09c94d69-7bea-2491-e063-6394a90a6438	70436-207	HUMAN PRESCRIPTION DRUG	sodium nitroprusside in 0.9% sodium chloride		sodium nitroprusside in 0.9% sodium chloride	INJECTION	INTRAVENOUS	20221231		ANDA	ANDA215846	Slate Run Pharmaceuticals, LLC	SODIUM NITROPRUSSIDE	.5	mg/mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
70436-209_041b2b7e-33b8-a347-e063-6394a90acbc2	70436-209	HUMAN PRESCRIPTION DRUG	LEVOLEUCOVORIN CALCIUM		levoleucovorin injection	INJECTION, SOLUTION	INTRAVENOUS	20230801		ANDA	ANDA217314	Slate Run Pharmaceuticals	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70436-210_041b2b7e-33b8-a347-e063-6394a90acbc2	70436-210	HUMAN PRESCRIPTION DRUG	LEVOLEUCOVORIN CALCIUM		levoleucovorin injection	INJECTION, SOLUTION	INTRAVENOUS	20230801		ANDA	ANDA217314	Slate Run Pharmaceuticals	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
70436-211_0766fa73-6d2f-748f-e063-6294a90a5c7f	70436-211	HUMAN PRESCRIPTION DRUG	iopamidol		iopamidol	INJECTION, SOLUTION	INTRAVASCULAR	20230927		ANDA	ANDA217134	Slate Run Pharmaceuticals, LLC	IOPAMIDOL	408	mg/mL	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
70436-212_099b1475-9a8e-2d9a-e063-6294a90a9f8b	70436-212	HUMAN PRESCRIPTION DRUG	gadobutrol		gadobutrol	INJECTION	INTRAVENOUS	20231020		ANDA	ANDA217480	Slate Run Pharmaceuticals, LLC	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
70436-214_099b1475-9a8e-2d9a-e063-6294a90a9f8b	70436-214	HUMAN PRESCRIPTION DRUG	gadobutrol		gadobutrol	INJECTION	INTRAVENOUS	20231020		ANDA	ANDA217480	Slate Run Pharmaceuticals, LLC	GADOBUTROL	604.72	mg/mL	Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]		N	20241231
70437-240_0b2d093c-1603-e3dc-e063-6294a90a6f81	70437-240	HUMAN PRESCRIPTION DRUG	Nerlynx		neratinib	TABLET	ORAL	20170717		NDA	NDA208051	Puma Biotechnology, Inc.	NERATINIB MALEATE	40	mg/1	Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70441-0002_996ae46c-4e06-b774-e053-2a95a90aec5b	70441-0002	HUMAN OTC DRUG	Skin Barista Rice Bran Cleansing Foam		ALLANTOIN	LIQUID	TOPICAL	20160204		OTC MONOGRAPH FINAL	part347	Pioom Cosmetic Co.,ltd	ALLANTOIN	.3	g/100mL			N	20241231
70441-0003_996ae065-8805-695f-e053-2995a90a0dff	70441-0003	HUMAN OTC DRUG	Skin Barista 2in1 White Body Perfection		DIMETHICONE	CREAM	TOPICAL	20160307		OTC MONOGRAPH FINAL	part347	Pioom Cosmetic Co.,ltd	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	20241231
70441-0004_34e79668-0711-5753-e054-00144ff88e88	70441-0004	HUMAN OTC DRUG	ARGAN AIR WATER BANG ESSENCE		DIMETHICONE	CREAM	TOPICAL	20160608		OTC MONOGRAPH FINAL	part347	Pioom Cosmetic Co.,ltd	DIMETHICONE	.01	g/100mL	Skin Barrier Activity [PE]		N	20241231
70441-0005_50b7db48-7b56-6df4-e054-00144ff88e88	70441-0005	HUMAN OTC DRUG	FIND BICHON CLEANSING MASK		GLYCERIN	LIQUID	TOPICAL	20170501		UNAPPROVED DRUG OTHER		Pioom Cosmetic Co.,ltd	GLYCERIN	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70445-300_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-300	HUMAN OTC DRUG	LB60-Peppermint		SPF 15 Lip Moisturizer Peppermint Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-301_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-301	HUMAN OTC DRUG	LB60-UNFLAVORED		SPF 15 Lip Moisturizer	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-302_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-302	HUMAN OTC DRUG	LB60-Watermelon		SPF 15 Lip Moisturizer Watermelon Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-303_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-303	HUMAN OTC DRUG	LB60-Vanilla Mint		SPF 15 Lip Moisturizer Vanilla Mint Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-304_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-304	HUMAN OTC DRUG	LB60-Vanilla		SPF 15 Lip Moisturizer Vanilla Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-305_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-305	HUMAN OTC DRUG	LB60-Tropical Punch		SPF 15 Lip Moisturizer Tropical Punch Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-306_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-306	HUMAN OTC DRUG	LB60-Pina Colada		SPF 15 Lip Moisturizer Pina Colada Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-307_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-307	HUMAN OTC DRUG	LB60-Peach		SPF 15 Lip Moisturizer Peach Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-308_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-308	HUMAN OTC DRUG	LB60-Cherry		SPF 15 Lip Moisturizer Cherry Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-309_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-309	HUMAN OTC DRUG	LB60-Chocolate		SPF 15 Lip Moisturizer Chocolate Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-310_0e10afc2-4d54-6cc0-e063-6294a90ac3bc	70445-310	HUMAN OTC DRUG	LB60-Birthday cake		SPF 15 Lip Moisturizer Birthday Cake Flavored	LIPSTICK	TOPICAL	20240103		OTC MONOGRAPH DRUG	M020	Beacon Promotions Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	1.5; 3.6; 2.5	g/100g; g/100g; g/100g			N	20251231
70445-600_0dad5b9f-61d4-8e15-e063-6394a90ac078	70445-600	HUMAN OTC DRUG	SANMO-RD		Hand Sanitizer with Red Beads	GEL	TOPICAL	20240101		OTC MONOGRAPH DRUG	M003	Beacon Promotions, Inc.	ALCOHOL	62	mL/100mL			N	20251231
70445-601_0dad5b9f-61d4-8e15-e063-6394a90ac078	70445-601	HUMAN OTC DRUG	SANMO-WH		Antibacterial Hand Sanitizer with White Beads	GEL	TOPICAL	20240103		OTC MONOGRAPH DRUG	M003	Beacon Promotions, Inc.	ALCOHOL	63	mL/100mL			N	20251231
70445-602_0dad5b9f-61d4-8e15-e063-6394a90ac078	70445-602	HUMAN OTC DRUG	SANMO-BL		Antibacterial Hand Sanitizer with Blue Beads	GEL	TOPICAL	20240103		OTC MONOGRAPH DRUG	M003	Beacon Promotions, Inc.	ALCOHOL	63	mL/100mL			N	20251231
70445-603_0dad5b9f-61d4-8e15-e063-6394a90ac078	70445-603	HUMAN OTC DRUG	SANMO-GR		Antibacterial Hand Sanitizer with Green Beads	GEL	TOPICAL	20240103		OTC MONOGRAPH DRUG	M003	Beacon Promotions, Inc.	ALCOHOL	62	mL/100mL			N	20251231
70445-604_0dad5b9f-61d4-8e15-e063-6394a90ac078	70445-604	HUMAN OTC DRUG	SAN-UN		Antibacterial Hand Sanitizer UNSCENTED	GEL	TOPICAL	20240103		OTC MONOGRAPH DRUG	M003	Beacon Promotions, Inc.	ALCOHOL	63	mL/100mL			N	20251231
70445-605_0e243179-37f7-45dc-e063-6394a90a5f80	70445-605	HUMAN OTC DRUG	SANSPRAY		Antibacterial Sanitizer Spray	SPRAY	TOPICAL	20240104		OTC MONOGRAPH DRUG	M003	Beacon Promotions Inc	ALCOHOL	62	mL/100mL			N	20251231
70445-606_0e0fef1d-85c0-e65e-e063-6294a90ab631	70445-606	HUMAN OTC DRUG	SANSPRAY-NA		Non-Alcohol Antibacterial Hand Sanitizer	SPRAY	TOPICAL	20240103		OTC MONOGRAPH DRUG	M003	Beacon Promotions, Inc.	BENZALKONIUM CHLORIDE	1	mg/100mL			N	20251231
70449-1000_ece6292a-bef6-d9ac-e053-2995a90af580	70449-1000	HUMAN OTC DRUG	Cold Bee Gone		Kali Bichromicum 6X, Sabadilla 6X, Luffa Operculata 6X	LIQUID	NASAL	20131101		UNAPPROVED HOMEOPATHIC		Buzzagogo, Inc	LUFFA OPERCULATA FRUIT; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
70449-1001_ece63611-9589-6b27-e053-2a95a90afb12	70449-1001	HUMAN OTC DRUG	Allergy Bee Gone		Kali Bichromicum 6X, Sabadilla 6X, Luffa Operculata 6X	LIQUID	NASAL	20200109		UNAPPROVED HOMEOPATHIC		Buzzagogo, Inc	GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
70449-1003_ece63ce8-74af-1097-e053-2995a90ae840	70449-1003	HUMAN OTC DRUG	Cold Bee Gone For Kids		Kali Bichromicum 6X, Sabadilla 6X, Luffa Operculata 6X	LIQUID	NASAL	20200311		UNAPPROVED HOMEOPATHIC		Buzzagogo, Inc	LUFFA OPERCULATA FRUIT; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
70449-1004_ece633df-b269-6cb7-e053-2a95a90a23ea	70449-1004	HUMAN OTC DRUG	Allergy Bee Gone For Kids		Kali Bichromicum 6X, Sabadilla 6X, Luffa Operculata 6X	LIQUID	NASAL	20200109		UNAPPROVED HOMEOPATHIC		Buzzagogo, Inc	GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
70453-001_09c78b92-8f3e-7c88-e063-6394a90a370c	70453-001	HUMAN OTC DRUG	Protect and Prime Broad Spectrum SPF30		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20160203		OTC MONOGRAPH DRUG	M020	Emma Hardie Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	30; 75; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70460-004_c4f8e152-b451-43bd-84af-4e55a682c251	70460-004	VACCINE	Vaxchora		Cholera Vaccine, Live, Oral	KIT		20200213		BLA	BLA125597	Emergent Travel Health Inc.						N	20241231
70461-123_9efd347a-1e22-47de-a534-3035826e4be0	70461-123	VACCINE	FLUAD QUADRIVALENT		INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230701	20240731	BLA	BLA125510	Seqirus, Inc.	INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
70461-323_e4039832-988f-48b8-a5eb-23a23287e791	70461-323	VACCINE	Flucelvax Quadrivalent		INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230701	20240731	BLA	BLA125408	Seqirus Inc.	INFLUENZA A VIRUS A/DARWIN/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
70461-423_e4039832-988f-48b8-a5eb-23a23287e791	70461-423	VACCINE	Flucelvax Quadrivalent		INFLUENZA A VIRUS A/Georgia/12/2022 CRV-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, ROPIOLACTONE INACTIVATED),INFLUENZA B VIRUS B/Singapore/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)	INJECTION, SUSPENSION	INTRAMUSCULAR	20230701	20240731	BLA	BLA125408	Seqirus Inc.	INFLUENZA A VIRUS A/DARWIN/11/2021 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)	15; 15; 15; 15	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL			N	
70463-000_09890742-72e3-73b6-e063-6294a90a9590	70463-000	HUMAN OTC DRUG	SOMXL		SALICYLIC ACID	SOLUTION	TOPICAL	20230626		OTC MONOGRAPH DRUG	M028	WR Group Skin Care Ltd	SALICYLIC ACID	170	mg/g			N	20241231
70466-001_09c2a962-02bb-050f-e063-6394a90a6f8a	70466-001	HUMAN OTC DRUG	Bed Bug Instant Bite Relief		LIDOCAINE	GEL	TOPICAL	20160204		OTC MONOGRAPH DRUG	M017	P.F. Harris Mfg. Co. LLC	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70476-0002_e5c550dc-4e59-4583-922a-c88d7d101caf	70476-0002	HUMAN OTC DRUG	Happy Happy		Lithium Carbonicum, Aurum Metallicum, Serotonin (Hydrochloride)	LIQUID	ORAL	20180115		UNAPPROVED HOMEOPATHIC		Holistic Haven	GOLD; LITHIUM CARBONATE; SEROTONIN HYDROCHLORIDE	12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Mood Stabilizer [EPC], Standardized Chemical Allergen [EPC]		N	20241231
70476-0003_01e5b3d6-d978-4131-aafe-034e4bf0c6a7	70476-0003	HUMAN OTC DRUG	Heal Grief		Natrum Muriaticum, Staphysagria, Ignatia Amara, Phosphoricum Acidum	LIQUID	ORAL	20191010		UNAPPROVED HOMEOPATHIC		Holistic Haven	DELPHINIUM STAPHISAGRIA SEED; PHOSPHORIC ACID; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	12; 30; 12; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
70476-0004_6795a2e1-af67-476f-b018-81fbc9ec7f1d	70476-0004	HUMAN OTC DRUG	Quiet Calm		Avena Sativa, Ammonium Bromatum, Chamomilla, Coffea Cruda, Gelsemium Sempervirens, L-Tryptophan, Phosphoricum Acidum, Valeriana Officinalis	LIQUID	ORAL	20191010		UNAPPROVED HOMEOPATHIC		Holistic Haven	AMMONIUM BROMIDE; ARABICA COFFEE BEAN; AVENA SATIVA FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; MATRICARIA CHAMOMILLA; PHOSPHORIC ACID; TRYPTOPHAN; VALERIAN	3; 6; 1; 6; 6; 6; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
70476-0005_028e877b-5171-4735-8a80-10d1d07d6f07	70476-0005	HUMAN OTC DRUG	Stay Well		Echinacea Purpurea, Argentum Nitricum, Baptisia Tinctoria, Galium Aparine, Pulsatilla (Vulgaris), Thuja Occidentalis, Phosphorus, Thymus Serpyllum, Echinacea (Angustifolia), Sulphur	LIQUID	ORAL	20180119		UNAPPROVED HOMEOPATHIC		Holistic Haven	ANEMONE PULSATILLA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; GALIUM APARINE; PHOSPHORUS; SILVER NITRATE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG; THYMUS SERPYLLUM	6; 6; 6; 3; 6; 6; 6; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
70476-0006_b0a4afe4-7f0d-4f2f-b2a2-5320d35c2a85	70476-0006	HUMAN OTC DRUG	Stomach Relief		Arsenicum Album, Carbo Vegetabilis, Nux Vomica, Robinia Pseudoacacia	LIQUID	ORAL	20180118		UNAPPROVED HOMEOPATHIC		Holistic Haven	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; ROBINIA PSEUDOACACIA BARK; STRYCHNOS NUX-VOMICA SEED	30; 30; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
70476-0007_66a1a976-12db-496c-81fd-ff16f86760f9	70476-0007	HUMAN OTC DRUG	High Potency Heal Grief		Ignatia Amara, Natrum Muriaticum, Staphysagria	LIQUID	ORAL	20180524		UNAPPROVED HOMEOPATHIC		Holistic Haven	DELPHINIUM STAPHISAGRIA SEED; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	200; 200; 200	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
70498-1100_cd883ec9-3113-f54c-e053-2995a90a30dc	70498-1100	HUMAN OTC DRUG	Lil Goats Petite Chevre Fragrance free		zinc oxide and kaolin	OINTMENT	TOPICAL	20160523		OTC MONOGRAPH FINAL	part347	Produits De Soins Pour La Peau Au Lait De Chevre Canus Inc	KAOLIN; ZINC OXIDE	145; 250	mg/g; mg/g			N	20241231
70498-1150_cd883ec9-3113-f54c-e053-2995a90a30dc	70498-1150	HUMAN OTC DRUG	Lil Goats Petite Chevre Original		zinc oxide and kaolin	OINTMENT	TOPICAL	20160523		OTC MONOGRAPH FINAL	part347	Produits De Soins Pour La Peau Au Lait De Chevre Canus Inc	KAOLIN; ZINC OXIDE	145; 250	mg/g; mg/g			N	20241231
70505-100_c00647cd-942d-4f63-beb3-70961bbde266	70505-100	HUMAN PRESCRIPTION DRUG	Doxylamine succinate and pyridoxine hydrochloride		Doxylamine succinate and pyridoxine hydrochloride	TABLET, DELAYED RELEASE	ORAL	20181115		NDA AUTHORIZED GENERIC	NDA021876	Analog Pharma	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
70505-202_8f419112-c2e0-4234-b0d9-f98fbd5c6459	70505-202	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20220615		ANDA	ANDA212390	Analog Pharma	NITISINONE	2	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
70505-205_8f419112-c2e0-4234-b0d9-f98fbd5c6459	70505-205	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20220615		ANDA	ANDA212390	Analog Pharma	NITISINONE	5	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
70505-210_8f419112-c2e0-4234-b0d9-f98fbd5c6459	70505-210	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20220615		ANDA	ANDA212390	Analog Pharma	NITISINONE	10	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
70505-220_8f419112-c2e0-4234-b0d9-f98fbd5c6459	70505-220	HUMAN PRESCRIPTION DRUG	Nitisinone		Nitisinone	CAPSULE	ORAL	20230508		ANDA	ANDA212390	Analog Pharma	NITISINONE	20	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
70510-2171_d3d515d2-5301-4038-9eff-558de3b0e48d	70510-2171	HUMAN PRESCRIPTION DRUG	RADICAVA		EDARAVONE	INJECTION	INTRAVENOUS	20170505		NDA	NDA209176	Mitsubishi Tanabe Pharma America, Inc.	EDARAVONE	30	mg/100mL			N	20241231
70510-2201_b0b60143-27ab-439c-b949-10ddb0e54984	70510-2201	HUMAN PRESCRIPTION DRUG	Exservan		riluzole	FILM	ORAL	20210501		NDA	NDA212640	Mitsubishi Tanabe Pharma America, Inc.	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20241231
70510-2321_d3d515d2-5301-4038-9eff-558de3b0e48d	70510-2321	HUMAN PRESCRIPTION DRUG	RADICAVA ORS		EDARAVONE	KIT		20220512		NDA	NDA215446	Mitsubishi Tanabe Pharma America, Inc.						N	20241231
70510-2322_d3d515d2-5301-4038-9eff-558de3b0e48d	70510-2322	HUMAN PRESCRIPTION DRUG	RADICAVA ORS		EDARAVONE	KIT		20220512		NDA	NDA215446	Mitsubishi Tanabe Pharma America, Inc.						N	20241231
70511-101_c158c088-1ab5-4099-a174-96aba96feb11	70511-101	HUMAN PRESCRIPTION DRUG	SODIUM PHENYLACETATE AND SODIUM BENZOATE		sodium phenylacetate and sodium benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20170522		ANDA	ANDA208521	MAIA PHARMACEUTICALS, INC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
70511-102_b14a3aa1-8456-404a-8afd-85d7ca272ab1	70511-102	HUMAN PRESCRIPTION DRUG	Sodium Phenylacetate and Sodium Benzoate		Sodium Phenylacetate and Sodium Benzoate	INJECTION	INTRAVENOUS	20210701		NDA	NDA215025	MAIA PHARMACEUTICALS	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
70511-111_9efa2867-7721-478a-a1c3-e34eeb3a1937	70511-111	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181227		ANDA	ANDA208749	MAIA Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	100	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
70511-112_9efa2867-7721-478a-a1c3-e34eeb3a1937	70511-112	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181227		ANDA	ANDA208749	MAIA Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	200	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
70511-113_9efa2867-7721-478a-a1c3-e34eeb3a1937	70511-113	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		LEVOTHYROXINE SODIUM ANHYDROUS	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181227		ANDA	ANDA208749	MAIA Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM ANHYDROUS	500	ug/5mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
70511-121_58150ebf-c2d6-49be-a519-06d839637462	70511-121	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION	INTRATHECAL	20210402		ANDA	ANDA210777	MAlA Pharmaceuticals, Inc.	BACLOFEN	50	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70511-122_c15b60c7-4e21-4e28-898c-31e23052737a	70511-122	HUMAN PRESCRIPTION DRUG	Baclofen (Intrathecal)		baclofen	INJECTION	INTRATHECAL	20190925		ANDA	ANDA210048	MAIA Pharmaceuticals, Inc.	BACLOFEN	500	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70511-123_c25028b0-ac87-4b40-b8e4-fef625b32ccb	70511-123	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	INJECTION	INTRATHECAL	20201223		ANDA	ANDA210315	MAlA Pharmaceuticals, Inc.	BACLOFEN	1000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70511-124_c15b60c7-4e21-4e28-898c-31e23052737a	70511-124	HUMAN PRESCRIPTION DRUG	Baclofen (Intrathecal)		Baclofen	INJECTION	INTRATHECAL	20190925		ANDA	ANDA210048	MAIA Pharmaceuticals, Inc.	BACLOFEN	2000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70511-131_f79a9ced-87d3-4e83-af8c-1451fcec4520	70511-131	HUMAN PRESCRIPTION DRUG	Sincalide		Sincalide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221125		NDA	NDA210850	MAIA Pharmaceuticals, Inc.	SINCALIDE	5	ug/5mL	Cholecystokinin Analog [EPC], Cholecystokinin [CS]		N	20241231
70511-141_c8f326c4-cccd-4985-b1ee-54db1bc52d50	70511-141	HUMAN PRESCRIPTION DRUG	Angiomax RTU		bivalirudin	INJECTION, SOLUTION	INTRAVENOUS	20190808		NDA	NDA211215	MAIA Pharmaceuticals, Inc.	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
70511-161_2cc294fe-75e3-4ed9-8259-c6e5bc5e8286	70511-161	HUMAN PRESCRIPTION DRUG	Bortezomib		bortezomib	INJECTION	INTRAVENOUS	20220811		NDA	NDA215331	MAIA Pharmaceuticals, Inc.	BORTEZOMIB	1	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
70511-162_2cc294fe-75e3-4ed9-8259-c6e5bc5e8286	70511-162	HUMAN PRESCRIPTION DRUG	Bortezomib		bortezomib	INJECTION	INTRAVENOUS	20220810		NDA	NDA215331	MAIA Pharmaceuticals, Inc.	BORTEZOMIB	2.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
70512-012_0e8855e7-139f-59ca-e063-6294a90a9f4e	70512-012	HUMAN OTC DRUG	LidaFlex		Lidocaine	PATCH	TOPICAL	20210127		OTC MONOGRAPH DRUG	M017	SOLA Pharmaceuticals	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
70512-013_0e886b57-4fc9-12b2-e063-6294a90ac4b7	70512-013	HUMAN OTC DRUG	LenzaPro Flex		Lidocaine/Menthol	PATCH	TOPICAL	20210201		OTC MONOGRAPH DRUG	M017	SOLA Pharmaceuticals	LIDOCAINE; MENTHOL	40; 40	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
70512-014_078b72bb-24e4-82fb-e063-6294a90a4c95	70512-014	HUMAN OTC DRUG	Lidocaine 4% Patch		Lidocaine 4%	PATCH	TOPICAL	20210524		OTC MONOGRAPH DRUG	M017	SOLA Pharmaceuticals	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70512-015_0e885b70-a70b-5d10-e063-6294a90a1a99	70512-015	HUMAN OTC DRUG	SynoFlex Patch		SynoFlex Patch	PATCH	TOPICAL	20220428		OTC MONOGRAPH DRUG	M017	Sola Pharmaceuticals	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 50	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
70512-016_0e886ead-e308-0d05-e063-6394a90a21d7	70512-016	HUMAN OTC DRUG	Capsimide		Capsaicin 0.025% Topical Patch	PATCH	TOPICAL	20220907		OTC MONOGRAPH DRUG	M017	Sola Pharmaceuticals	CAPSAICIN	.025	g/100g			N	20251231
70512-017_0e884df8-757e-2374-e063-6394a90ab34a	70512-017	HUMAN OTC DRUG	Triceptin		Lidocaine / Menthol / Methyl Salicylate	PATCH	TOPICAL	20221205		OTC MONOGRAPH DRUG	M017	SOLA Pharmaceuticals	LIDOCAINE; MENTHOL; METHYL SALICYLATE	40; 10; 20	mg/g; mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
70512-038_0a4bd04a-9e8d-7437-e063-6394a90ae5b6	70512-038	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium 1.5%		Diclofenac Sodium Topical	SOLUTION	TOPICAL	20210604		ANDA	ANDA204132	SOLA Pharmaceuticals	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70512-104_078b76a8-4b19-0a13-e063-6294a90a7096	70512-104	HUMAN OTC DRUG	Neuracin Topical Gel		Neuracin Topical Analgesic Gel	GEL	TOPICAL	20210524		OTC MONOGRAPH DRUG	M017	SOLA Pharmaceuticals	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
70512-106_078ba85f-36a4-56a3-e063-6394a90a312b	70512-106	HUMAN OTC DRUG	Diclofenac Sodium		Diclofenac Sodium 1%	GEL	TOPICAL	20210317		ANDA	ANDA210986	SOLA Pharmaceuticals	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70512-520_0a4bd65a-f2eb-7ab9-e063-6394a90a9dae	70512-520	HUMAN OTC DRUG	Olopatadine Hcl		Olopatadine Hcl	SOLUTION/ DROPS	OPHTHALMIC	20220705		ANDA	ANDA203152	Sola Pharmaceuticals	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
70512-810_01416fba-ded0-7877-e063-6294a90ace05	70512-810	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230701		ANDA	ANDA206116	SOLA Pharmaceuticals, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70512-812_0b641ea8-2aa6-07c2-e063-6394a90a6d0f	70512-812	HUMAN OTC DRUG	Lidocaine 4% Patch		Lidocaine 4%	PATCH	TOPICAL	20231012		OTC MONOGRAPH DRUG	505G(a)(3)	SOLA Pharmaceuticals	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70512-840_0a4bd04a-9e8f-7437-e063-6394a90ae5b6	70512-840	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20220803		ANDA	ANDA215417	SOLA Pharmaceuticals	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70512-841_bd9c4af6-989b-4a7d-a97f-e494780948d6	70512-841	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20170525		ANDA	ANDA207956	SOLA Pharmaceuticals, LLC	SODIUM CHLORIDE	9	g/1000mL			N	20241231
70512-842_055829ef-d514-267e-e063-6394a90ac8c3	70512-842	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR	20230701		ANDA	ANDA217789	SOLA Pharmaceuticals, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70512-843_055829ef-d514-267e-e063-6394a90ac8c3	70512-843	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230701		ANDA	ANDA217789	SOLA Pharmaceuticals, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70512-850_09a9b0fe-cfa6-13de-e063-6294a90ab8f5	70512-850	HUMAN PRESCRIPTION DRUG	teriflunomide		teriflunomide	TABLET, COATED	ORAL	20230312		ANDA	ANDA209677	SOLA Pharmaceuticals, LLC	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70512-851_09a9b0fe-cfa6-13de-e063-6294a90ab8f5	70512-851	HUMAN PRESCRIPTION DRUG	teriflunomide		teriflunomide	TABLET, COATED	ORAL	20230312		ANDA	ANDA209677	SOLA Pharmaceuticals, LLC	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70512-852_fae1e494-b068-701c-e053-6294a90ae45e	70512-852	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	CAPSULE, DELAYED RELEASE	ORAL	20230131		ANDA	ANDA210436	SOLA Pharmaceuticals, LLC	DIMETHYL FUMARATE	120	mg/1			N	20241231
70512-853_fae1e494-b068-701c-e053-6294a90ae45e	70512-853	HUMAN PRESCRIPTION DRUG	Dimethyl Fumarate		Dimethyl Fumarate	CAPSULE, DELAYED RELEASE	ORAL	20230131		ANDA	ANDA210436	SOLA Pharmaceuticals, LLC	DIMETHYL FUMARATE	240	mg/1			N	20241231
70512-859_0636db63-3bfa-6b53-e063-6294a90a16d7	70512-859	HUMAN PRESCRIPTION DRUG	carboprost tromethamine		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230925		ANDA	ANDA216824	SOLA Pharmaceuticals, LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
70512-860_fbc1bfde-2fbf-fee7-e053-6294a90ad3b7	70512-860	HUMAN PRESCRIPTION DRUG	Cabergoline		cabergoline	TABLET	ORAL	20230508		ANDA	ANDA076310	SOLA Pharmaceuticals, LLC	CABERGOLINE	.5	mg/1	Ergolines [CS], Ergot Derivative [EPC]		N	20241231
70513-001_076194c3-566f-c83c-e063-6294a90aa582	70513-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20151227		NDA	NDA205767	MedCare Equipment Company, LLC	OXYGEN	990	mL/L			N	20241231
70515-001_2eba3089-28b4-4190-9fba-2511246cfd16	70515-001	HUMAN PRESCRIPTION DRUG	DUAKLIR PRESSAIR		aclidinium bromide and formoterol fumarate	POWDER, METERED	RESPIRATORY (INHALATION)	20190329		NDA	NDA210595	Covis Pharma US, Inc	ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE	400; 12	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70515-002_86a2e74d-bbf7-4de6-af00-3d23ee80630a	70515-002	HUMAN PRESCRIPTION DRUG	Tudorza Pressair		aclidinium bromide	POWDER, METERED	RESPIRATORY (INHALATION)	20150701		NDA	NDA202450	Covis Pharma US, Inc	ACLIDINIUM BROMIDE	400	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70515-105_2e894da6-0d45-4db6-b0d2-8667c989d155	70515-105	HUMAN PRESCRIPTION DRUG	BETAPACE		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Covis Pharma US, Inc	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
70515-106_2e894da6-0d45-4db6-b0d2-8667c989d155	70515-106	HUMAN PRESCRIPTION DRUG	BETAPACE		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Covis Pharma US, Inc	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
70515-109_2e894da6-0d45-4db6-b0d2-8667c989d155	70515-109	HUMAN PRESCRIPTION DRUG	BETAPACE		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Covis Pharma US, Inc	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
70515-115_2e894da6-0d45-4db6-b0d2-8667c989d155	70515-115	HUMAN PRESCRIPTION DRUG	BETAPACE AF		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA021151	Covis Pharma US, Inc	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
70515-116_2e894da6-0d45-4db6-b0d2-8667c989d155	70515-116	HUMAN PRESCRIPTION DRUG	BETAPACE AF		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA021151	Covis Pharma US, Inc	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
70515-119_2e894da6-0d45-4db6-b0d2-8667c989d155	70515-119	HUMAN PRESCRIPTION DRUG	BETAPACE AF		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA021151	Covis Pharma US, Inc	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
70515-260_927c8802-a699-43d8-8a2e-199cc5b56c05	70515-260	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170915		NDA	NDA009330	Covis Pharma US, Inc	DIGOXIN	250	ug/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70515-261_927c8802-a699-43d8-8a2e-199cc5b56c05	70515-261	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191029		NDA	NDA009330	Covis Pharma US, Inc	DIGOXIN	250	ug/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70515-262_927c8802-a699-43d8-8a2e-199cc5b56c05	70515-262	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170915		NDA	NDA009330	Covis Pharma US, Inc	DIGOXIN	100	ug/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70515-263_927c8802-a699-43d8-8a2e-199cc5b56c05	70515-263	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191029		NDA	NDA009330	Covis Pharma US, Inc	DIGOXIN	100	ug/mL	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70515-500_b1f33d4e-acf6-4b44-af7d-83829b7fc808	70515-500	HUMAN PRESCRIPTION DRUG	Sular		nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170203		NDA	NDA020356	Covis Pharma US, Inc	NISOLDIPINE	8.5	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70515-501_b1f33d4e-acf6-4b44-af7d-83829b7fc808	70515-501	HUMAN PRESCRIPTION DRUG	Sular		nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170203		NDA	NDA020356	Covis Pharma US, Inc	NISOLDIPINE	17	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70515-503_b1f33d4e-acf6-4b44-af7d-83829b7fc808	70515-503	HUMAN PRESCRIPTION DRUG	Sular		nisoldipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170203		NDA	NDA020356	Covis Pharma US, Inc	NISOLDIPINE	34	mg/1	Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70515-594_4caebc2e-bf10-442a-b24d-c3b51876c67f	70515-594	HUMAN PRESCRIPTION DRUG	Zanaflex		tizanidine hydrochloride	TABLET	ORAL	20180801		NDA	NDA020397	Covis Pharma US, Inc	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70515-602_4caebc2e-bf10-442a-b24d-c3b51876c67f	70515-602	HUMAN PRESCRIPTION DRUG	Zanaflex		tizanidine hydrochloride	CAPSULE	ORAL	20180801		NDA	NDA021447	Covis Pharma US, Inc	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70515-604_4caebc2e-bf10-442a-b24d-c3b51876c67f	70515-604	HUMAN PRESCRIPTION DRUG	Zanaflex		tizanidine hydrochloride	CAPSULE	ORAL	20180801		NDA	NDA021447	Covis Pharma US, Inc	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70515-606_4caebc2e-bf10-442a-b24d-c3b51876c67f	70515-606	HUMAN PRESCRIPTION DRUG	Zanaflex		tizanidine hydrochloride	CAPSULE	ORAL	20180801		NDA	NDA021447	Covis Pharma US, Inc	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70515-610_ba93d1bb-75ca-407c-b2e0-9aa66d8eed84	70515-610	HUMAN PRESCRIPTION DRUG	Prilosec		omeprazole magnesium	GRANULE, DELAYED RELEASE	ORAL	20170825		NDA	NDA022056	Covis Pharma US, Inc	OMEPRAZOLE MAGNESIUM	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70515-625_ba93d1bb-75ca-407c-b2e0-9aa66d8eed84	70515-625	HUMAN PRESCRIPTION DRUG	Prilosec		omeprazole magnesium	GRANULE, DELAYED RELEASE	ORAL	20170825		NDA	NDA022056	Covis Pharma US, Inc	OMEPRAZOLE MAGNESIUM	2.5	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70515-628_6ae2aacf-9571-4194-ac9a-14e29cd9061a	70515-628	HUMAN PRESCRIPTION DRUG	Altoprev		lovastatin	TABLET, EXTENDED RELEASE	ORAL	20160501		NDA	NDA021316	Covis Pharma US, Inc	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70515-629_6ae2aacf-9571-4194-ac9a-14e29cd9061a	70515-629	HUMAN PRESCRIPTION DRUG	Altoprev		lovastatin	TABLET, EXTENDED RELEASE	ORAL	20160501		NDA	NDA021316	Covis Pharma US, Inc	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70515-630_6ae2aacf-9571-4194-ac9a-14e29cd9061a	70515-630	HUMAN PRESCRIPTION DRUG	Altoprev		lovastatin	TABLET, EXTENDED RELEASE	ORAL	20160501		NDA	NDA021316	Covis Pharma US, Inc	LOVASTATIN	60	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70515-700_6f43fef8-e4d9-4552-81f5-f6fd7f961de0	70515-700	HUMAN PRESCRIPTION DRUG	Rilutek		riluzole	TABLET	ORAL	20160801		NDA	NDA020599	Covis Pharma US, Inc	RILUZOLE	50	mg/1	Benzothiazole [EPC], Benzothiazoles [CS]		N	20241231
70515-701_fa248cfa-08c9-43a3-8289-a28e5447cb1d	70515-701	HUMAN PRESCRIPTION DRUG	Omnaris		ciclesonide	SPRAY	NASAL	20180423		NDA	NDA022004	Covis Pharma US, Inc	CICLESONIDE	50	ug/1			N	20241231
70515-711_8cf0f1e5-eba3-405e-8ef5-ee3231ffd3cb	70515-711	HUMAN PRESCRIPTION DRUG	Alvesco		ciclesonide	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180326		NDA	NDA021658	Covis Pharma US, Inc	CICLESONIDE	80	ug/1			N	20241231
70515-712_8cf0f1e5-eba3-405e-8ef5-ee3231ffd3cb	70515-712	HUMAN PRESCRIPTION DRUG	Alvesco		ciclesonide	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180326		NDA	NDA021658	Covis Pharma US, Inc	CICLESONIDE	160	ug/1			N	20241231
70515-737_3d716591-a0dd-4444-a3ec-9bc01749c2e0	70515-737	HUMAN PRESCRIPTION DRUG	Zetonna		ciclesonide	AEROSOL, METERED	NASAL	20180430		NDA	NDA202129	Covis Pharma US, Inc	CICLESONIDE	37	ug/1			N	20241231
70518-0003_0e0ca886-d825-67bb-e063-6394a90a2b47	70518-0003	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20161123		ANDA	ANDA077584	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-0005_0e0ca589-8349-495b-e063-6394a90afbd0	70518-0005	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20161117		ANDA	ANDA090796	REMEDYREPACK INC.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0013_0e0ce085-5ba8-7a08-e063-6394a90ab047	70518-0013	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161123		ANDA	ANDA070027	REMEDYREPACK INC.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
70518-0014_0e0cd179-8676-d1a5-e063-6294a90a7ff8	70518-0014	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20161130		ANDA	ANDA071322	REMEDYREPACK INC.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
70518-0015_0e0cd179-8677-d1a5-e063-6294a90a7ff8	70518-0015	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20161123		ANDA	ANDA084769	REMEDYREPACK INC.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
70518-0016_01f3ffdc-9a37-613b-e063-6294a90ac642	70518-0016	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, SUGAR COATED	ORAL	20161125		ANDA	ANDA084113	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-0028_0e0cd179-8678-d1a5-e063-6294a90a7ff8	70518-0028	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20161201		ANDA	ANDA075483	REMEDYREPACK INC.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
70518-0033_0e0d0262-2610-7ffe-e063-6394a90a48b4	70518-0033	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20161201		ANDA	ANDA076768	REMEDYREPACK INC.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20251231
70518-0035_fb6a116c-d636-b175-e053-6294a90a5c86	70518-0035	HUMAN PRESCRIPTION DRUG	Haloperidol		HALOPERIDOL LACTATE	INJECTION, SOLUTION	INTRAMUSCULAR	20161202		ANDA	ANDA075689	REMEDYREPACK INC.	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70518-0038_0e0d0237-175c-685f-e063-6394a90a2735	70518-0038	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET	ORAL	20161205		ANDA	ANDA091605	REMEDYREPACK INC.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
70518-0041_0e0d0262-261c-7ffe-e063-6394a90a48b4	70518-0041	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20170606		ANDA	ANDA078327	REMEDYREPACK INC.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20251231
70518-0045_0e0d5df5-79ed-8b29-e063-6294a90a29dd	70518-0045	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20161207		ANDA	ANDA075657	REMEDYREPACK INC.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20251231
70518-0048_0e0d5c5e-eaac-8820-e063-6294a90a87c0	70518-0048	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20161209		ANDA	ANDA074754	REMEDYREPACK INC.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0050_0e0d6d16-38fe-7dff-e063-6394a90a1ac1	70518-0050	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20161212		ANDA	ANDA077293	REMEDYREPACK INC.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
70518-0053_0e0d5c5e-eaad-8820-e063-6294a90a87c0	70518-0053	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20161212		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-0058_0e0d6d16-3903-7dff-e063-6394a90a1ac1	70518-0058	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20161213		ANDA	ANDA203458	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
70518-0060_0e0d9e04-b182-ef6d-e063-6394a90a7bab	70518-0060	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20161213		ANDA	ANDA078155	REMEDYREPACK INC.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0061_0e0db4b6-339f-f876-e063-6394a90a72ca	70518-0061	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20161213		ANDA	ANDA078155	REMEDYREPACK INC.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0063_0e0da1dd-ea31-ef9a-e063-6394a90adc12	70518-0063	HUMAN PRESCRIPTION DRUG	Isosorbide Dinitrate		Isosorbide Dinitrate	TABLET	ORAL	20161214		ANDA	ANDA086223	REMEDYREPACK INC.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
70518-0064_0e0dd6a8-9d71-f6a6-e063-6394a90a5674	70518-0064	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20161214		ANDA	ANDA078155	REMEDYREPACK INC.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0070_0e0dee3f-1d7e-01e4-e063-6394a90af653	70518-0070	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20161216		ANDA	ANDA078216	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-0071_f31aa1c4-ed7e-35ea-e053-2995a90a588c	70518-0071	HUMAN PRESCRIPTION DRUG	metformin hydrochloride		metformin hydrochloride	TABLET	ORAL	20161219		ANDA	ANDA090564	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-0072_0e0dd88e-62e8-02c8-e063-6394a90a63d8	70518-0072	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20161219		ANDA	ANDA073192	REMEDYREPACK INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
70518-0079_0e0f22e9-5533-6212-e063-6394a90a92c3	70518-0079	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20161223		ANDA	ANDA073484	REMEDYREPACK INC.	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
70518-0082_0e0f22e9-5571-6212-e063-6394a90a92c3	70518-0082	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine	TABLET, FILM COATED	ORAL	20161223		ANDA	ANDA090478	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
70518-0088_0e0f551e-2f53-6f3f-e063-6394a90ae8ee	70518-0088	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20161228		ANDA	ANDA203458	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
70518-0090_0e0f551e-2f54-6f3f-e063-6394a90ae8ee	70518-0090	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161228		ANDA	ANDA070027	REMEDYREPACK INC.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
70518-0096_0e0f6dfc-557f-9ac6-e063-6294a90a669a	70518-0096	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	20161230		ANDA	ANDA080936	REMEDYREPACK INC.	ISONIAZID	100	mg/1	Antimycobacterial [EPC]		N	20251231
70518-0103_0e0f6dfc-5581-9ac6-e063-6294a90a669a	70518-0103	HUMAN PRESCRIPTION DRUG	Nitrofurantion Macrocrystals		Nitrofurantion Macrocrystals	CAPSULE	ORAL	20170105		NDA	NDA016620	REMEDYREPACK INC.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20251231
70518-0104_0e0f62d4-cf78-7b12-e063-6394a90aa547	70518-0104	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20170109		ANDA	ANDA075795	REMEDYREPACK INC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
70518-0107_0e0f83c7-bf24-79be-e063-6394a90ad161	70518-0107	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20170106		ANDA	ANDA040684	REMEDYREPACK INC.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-0109_0e0f9f5b-6422-8af5-e063-6394a90af9e2	70518-0109	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20170109		ANDA	ANDA074185	REMEDYREPACK INC.	DILTIAZEM HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
70518-0110_0e0f905f-3b0f-cf4e-e063-6294a90a44be	70518-0110	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20170110		ANDA	ANDA076255	REMEDYREPACK INC.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0113_0e0fbad3-4971-d6bb-e063-6294a90ace6c	70518-0113	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20170110		ANDA	ANDA075991	REMEDYREPACK INC.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0117_0e0fbbf7-a42f-e101-e063-6294a90a6977	70518-0117	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20170112		ANDA	ANDA076180	REMEDYREPACK INC.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
70518-0118_0e0fd6bf-1a83-ebfd-e063-6294a90a2910	70518-0118	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20170112		ANDA	ANDA076003	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
70518-0123_0e1016e2-3020-0bec-e063-6294a90a6c87	70518-0123	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20170113		ANDA	ANDA078332	REMEDYREPACK INC.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
70518-0132_0e100ebd-7261-a244-e063-6394a90abd37	70518-0132	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170117		ANDA	ANDA040742	REMEDYREPACK INC.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20251231
70518-0133_0e105d5d-66de-d05c-e063-6394a90a761a	70518-0133	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20170107		ANDA	ANDA076286	REMEDYREPACK INC.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
70518-0151_0e1068bb-e2da-4820-e063-6294a90a9161	70518-0151	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20170119		ANDA	ANDA091625	REMEDYREPACK INC.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0153_0e105d5d-66e2-d05c-e063-6394a90a761a	70518-0153	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20170102		ANDA	ANDA077670	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-0157_0e106498-496b-d00b-e063-6394a90ac625	70518-0157	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20170119		ANDA	ANDA084769	REMEDYREPACK INC.	CHLORDIAZEPOXIDE HYDROCHLORIDE	25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
70518-0162_0e107541-6b4f-601a-e063-6294a90a8a0c	70518-0162	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20170123		ANDA	ANDA071322	REMEDYREPACK INC.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
70518-0163_0e10afc2-4d50-6cc0-e063-6294a90ac3bc	70518-0163	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20170120		ANDA	ANDA075511	REMEDYREPACK INC.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
70518-0164_08024afc-6224-fcf5-e063-6294a90afbf2	70518-0164	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20170120		ANDA	ANDA070177	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-0171_0e10a105-8bab-7a1f-e063-6294a90a80fc	70518-0171	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20170123		ANDA	ANDA077929	REMEDYREPACK INC.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0174_0e1f43fb-2f3c-8741-e063-6394a90ac198	70518-0174	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20170123		ANDA	ANDA077912	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-0177_0e1f944c-bb85-a463-e063-6394a90a4d4c	70518-0177	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20170125		ANDA	ANDA080704	REMEDYREPACK INC.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20251231
70518-0179_0e1fb14a-f976-a82d-e063-6394a90adb94	70518-0179	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170126		ANDA	ANDA202433	REMEDYREPACK INC.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
70518-0180_0e1f91fa-a036-857e-e063-6394a90a68c9	70518-0180	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20170126		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	15	mg/1			N	20251231
70518-0181_0e1fc304-1131-f0f7-e063-6294a90a47b2	70518-0181	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20170127		ANDA	ANDA078115	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
70518-0185_0e20252a-5ecd-2526-e063-6294a90a8cde	70518-0185	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20170130	20241130	ANDA	ANDA085828	REMEDYREPACK INC.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	
70518-0186_0e20252a-5ece-2526-e063-6294a90a8cde	70518-0186	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20170131		ANDA	ANDA090548	REMEDYREPACK INC.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0187_f34200f3-2884-6a0c-e053-2a95a90a9156	70518-0187	HUMAN PRESCRIPTION DRUG	Doxycycline		doxycycline	CAPSULE	ORAL	20170131	20241231	ANDA	ANDA065055	REMEDYREPACK INC.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70518-0191_0e209831-72f8-5f32-e063-6294a90a6b8b	70518-0191	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20170202		ANDA	ANDA078048	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
70518-0192_0e20973d-8f2b-61e0-e063-6294a90a92a4	70518-0192	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20170202		ANDA	ANDA076407	REMEDYREPACK INC.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20251231
70518-0196_0e20a506-e85f-79ab-e063-6294a90a38fc	70518-0196	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20170202		ANDA	ANDA077912	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-0199_0e20d78c-38fc-082b-e063-6394a90a6887	70518-0199	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170206		ANDA	ANDA091672	REMEDYREPACK INC.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
70518-0200_0e210217-e013-c0e3-e063-6294a90a4c13	70518-0200	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20170206		ANDA	ANDA077929	REMEDYREPACK INC.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0204_0e20e7be-5dbf-af63-e063-6294a90a0d3e	70518-0204	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20170207		ANDA	ANDA065489	REMEDYREPACK INC.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20251231
70518-0208_0e211875-3643-fbb8-e063-6394a90aa840	70518-0208	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20170209		ANDA	ANDA078250	REMEDYREPACK INC.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0209_0e214500-f8c9-04ad-e063-6294a90ac0f3	70518-0209	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20170209		ANDA	ANDA087479	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
70518-0210_0e215787-2503-cc30-e063-6294a90af884	70518-0210	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20170209		ANDA	ANDA202556	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-0213_0e2175b7-d2a6-67d6-e063-6394a90a159b	70518-0213	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20170210		ANDA	ANDA204234	REMEDYREPACK INC.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
70518-0215_0e2179c1-097f-69b4-e063-6394a90aa6e8	70518-0215	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20170210		ANDA	ANDA077156	REMEDYREPACK INC.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
70518-0224_0e21a571-2666-cf0d-e063-6294a90aa9ec	70518-0224	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20170215		ANDA	ANDA090548	REMEDYREPACK INC.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0233_0e21b4fe-7465-7d2e-e063-6294a90ad993	70518-0233	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20170216		ANDA	ANDA078235	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-0235_0e22fa1f-1122-2f5a-e063-6294a90aa1b6	70518-0235	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	TABLET, ORALLY DISINTEGRATING	ORAL	20170217		ANDA	ANDA077557	REMEDYREPACK INC.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20251231
70518-0239_0e22e630-85e1-ddb1-e063-6394a90a6ab2	70518-0239	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20170220		ANDA	ANDA202152	REMEDYREPACK INC.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0242_0e235eba-5bb8-060e-e063-6394a90a78fe	70518-0242	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20170220		ANDA	ANDA040362	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-0245_0e239b53-79dc-8bd2-e063-6294a90ab85e	70518-0245	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20170221		ANDA	ANDA090083	REMEDYREPACK INC.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
70518-0251_0e23937f-d09b-101d-e063-6394a90ae795	70518-0251	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20170222		ANDA	ANDA077293	REMEDYREPACK INC.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
70518-0253_0e239b99-f6f6-88cd-e063-6294a90a7560	70518-0253	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20170223		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20251231
70518-0254_0e23c593-a428-27f5-e063-6394a90a63ed	70518-0254	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20170223		ANDA	ANDA091276	REMEDYREPACK INC.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0255_0e23d3d5-dbb8-b79b-e063-6294a90a9528	70518-0255	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20170223		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20251231
70518-0258_0e23d3d5-dbba-b79b-e063-6294a90a9528	70518-0258	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20170223		ANDA	ANDA075964	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
70518-0261_0e23c0a8-e986-27e1-e063-6394a90ae5db	70518-0261	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20170223		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20251231
70518-0265_0e2402a0-f3b9-8f5c-e063-6294a90af13c	70518-0265	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20170228		NDA	NDA020064	REMEDYREPACK INC.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20251231
70518-0266_0e24069e-c74f-3a7f-e063-6394a90a865a	70518-0266	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20170228		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20251231
70518-0271_0e241343-db5f-3f1c-e063-6394a90ab538	70518-0271	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20170302		ANDA	ANDA064120	REMEDYREPACK INC.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
70518-0273_0e2424f4-0010-42b0-e063-6394a90a780d	70518-0273	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20170302		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20251231
70518-0274_0e2424f4-0013-42b0-e063-6394a90a780d	70518-0274	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20170302		ANDA	ANDA077073	REMEDYREPACK INC.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
70518-0275_0e244020-fede-0438-e063-6294a90a32ae	70518-0275	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170302		ANDA	ANDA078203	REMEDYREPACK INC.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
70518-0280_0e244294-bfba-4740-e063-6394a90a9c73	70518-0280	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20170302		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20251231
70518-0282_0e244020-fee2-0438-e063-6294a90a32ae	70518-0282	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20170303		ANDA	ANDA079163	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
70518-0289_0e245912-675b-0d82-e063-6294a90afc33	70518-0289	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20170307		ANDA	ANDA202152	REMEDYREPACK INC.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0293_0e2453e7-6b57-8acd-e063-6294a90ac36f	70518-0293	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170308		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-0297_0c56621d-1ebd-0dad-e063-6294a90a7146	70518-0297	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20170308		ANDA	ANDA077073	REMEDYREPACK INC.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-0302_0e2475f8-63e1-4f1e-e063-6394a90a3b33	70518-0302	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20170309		ANDA	ANDA085082	REMEDYREPACK INC.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
70518-0305_0e246e70-6edc-5711-e063-6394a90a3879	70518-0305	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20170310		ANDA	ANDA040256	REMEDYREPACK INC.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-0306_0e24855a-6c4d-5087-e063-6394a90ae1c7	70518-0306	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20170310		ANDA	ANDA084283	REMEDYREPACK INC.	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-0307_0e24855a-6c50-5087-e063-6394a90ae1c7	70518-0307	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20170310		ANDA	ANDA040256	REMEDYREPACK INC.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-0313_0e249cae-aaa9-396a-e063-6294a90ab801	70518-0313	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20170313		ANDA	ANDA072741	REMEDYREPACK INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
70518-0314_0e249cae-aaac-396a-e063-6294a90ab801	70518-0314	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20170314		ANDA	ANDA090798	REMEDYREPACK INC.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0319_0e24ae84-255f-4c38-e063-6294a90aa226	70518-0319	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	20170315		ANDA	ANDA064052	REMEDYREPACK INC.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
70518-0324_0e24c801-b00a-6bd6-e063-6394a90ace1b	70518-0324	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20170316		ANDA	ANDA070027	REMEDYREPACK INC.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
70518-0327_0e24bff2-8d0c-691c-e063-6394a90a1b1e	70518-0327	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20170317		ANDA	ANDA084285	REMEDYREPACK INC.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
70518-0335_0e24ae84-2560-4c38-e063-6294a90aa226	70518-0335	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20170317		ANDA	ANDA090510	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-0336_0e24e7cb-1946-6686-e063-6394a90a4760	70518-0336	HUMAN PRESCRIPTION DRUG	Zithromax		azithromycin dihydrate	TABLET, FILM COATED	ORAL	20170320		NDA	NDA050784	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
70518-0339_0e24fac2-82ba-89b9-e063-6394a90a8938	70518-0339	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20170320		ANDA	ANDA075502	REMEDYREPACK INC.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-0346_0e259131-aa0e-c9d3-e063-6294a90aeead	70518-0346	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20170321		ANDA	ANDA072204	REMEDYREPACK INC.	LOXAPINE SUCCINATE	5	mg/1			N	20251231
70518-0347_0e2584c4-4fd3-af9d-e063-6394a90a0411	70518-0347	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20170321		ANDA	ANDA072206	REMEDYREPACK INC.	LOXAPINE SUCCINATE	25	mg/1			N	20251231
70518-0356_0e2584c4-4fd6-af9d-e063-6394a90a0411	70518-0356	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20170323		ANDA	ANDA077614	REMEDYREPACK INC.	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
70518-0362_0e3385b2-0fbe-4e70-e063-6294a90ae7b4	70518-0362	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20170324		ANDA	ANDA078220	REMEDYREPACK INC.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
70518-0364_0e3385b2-0fbf-4e70-e063-6294a90ae7b4	70518-0364	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20170327		ANDA	ANDA201003	REMEDYREPACK INC.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0365_0e3385b2-0fc0-4e70-e063-6294a90ae7b4	70518-0365	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20170327		ANDA	ANDA078106	REMEDYREPACK INC.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-0369_0e338f2b-18ee-fcf7-e063-6394a90a703c	70518-0369	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20170329		ANDA	ANDA078619	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-0373_0e33b914-78b9-714c-e063-6294a90a939f	70518-0373	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20170403		ANDA	ANDA077270	REMEDYREPACK INC.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
70518-0374_0e33ad5c-2315-68fb-e063-6294a90a337f	70518-0374	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20170407		ANDA	ANDA078597	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
70518-0375_0e33c6e0-8a6f-05f5-e063-6394a90affba	70518-0375	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20170605		ANDA	ANDA206434	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0380_0e33e6de-9516-148f-e063-6394a90a1419	70518-0380	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20170403		ANDA	ANDA078888	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20251231
70518-0381_0e34a163-f638-42ab-e063-6394a90af5b7	70518-0381	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20170403		ANDA	ANDA076704	REMEDYREPACK INC.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
70518-0382_0e35228b-eb31-7031-e063-6394a90ab3e6	70518-0382	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20170403		ANDA	ANDA077912	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-0386_0e35228b-eb34-7031-e063-6394a90ab3e6	70518-0386	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20170403		ANDA	ANDA071669	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
70518-0391_0e35360e-5e12-5725-e063-6394a90ae55b	70518-0391	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20170404		ANDA	ANDA090617	REMEDYREPACK INC.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
70518-0392_0e354350-7b51-30c2-e063-6294a90a2d55	70518-0392	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	OINTMENT	OPHTHALMIC	20170404		ANDA	ANDA062447	REMEDYREPACK INC.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20251231
70518-0397_0e354bc3-b402-52bd-e063-6294a90ac8ea	70518-0397	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20170404		ANDA	ANDA090121	REMEDYREPACK INC.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20251231
70518-0400_0e35df86-d850-0913-e063-6294a90a421f	70518-0400	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20170405		ANDA	ANDA202928	REMEDYREPACK INC.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20251231
70518-0403_0e35df86-d851-0913-e063-6294a90a421f	70518-0403	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170405		ANDA	ANDA203270	REMEDYREPACK INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
70518-0405_0e36078a-558b-dd8d-e063-6394a90ac090	70518-0405	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20171121		ANDA	ANDA078181	REMEDYREPACK INC.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
70518-0410_0e360e15-b0be-ef3b-e063-6394a90a17c1	70518-0410	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	SOLUTION/ DROPS	OPHTHALMIC	20170406		ANDA	ANDA040069	REMEDYREPACK INC.	DEXAMETHASONE SODIUM PHOSPHATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-0416_0e361d63-a3aa-f2bd-e063-6394a90a98ce	70518-0416	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20170410		ANDA	ANDA072062	REMEDYREPACK INC.	LOXAPINE SUCCINATE	50	mg/1			N	20251231
70518-0417_0e3633ec-5bc2-f30d-e063-6394a90aa334	70518-0417	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20170410		ANDA	ANDA078619	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-0424_0e362027-4cb8-3a18-e063-6294a90a0e50	70518-0424	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20170412		ANDA	ANDA065061	REMEDYREPACK INC.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
70518-0425_0e365639-e410-0fec-e063-6394a90a018c	70518-0425	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20170414		ANDA	ANDA204279	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
70518-0426_0e3666b9-d95f-4bac-e063-6294a90a1fd1	70518-0426	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20170417		ANDA	ANDA077614	REMEDYREPACK INC.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
70518-0427_0e367d6f-b7e4-6e1c-e063-6294a90aea64	70518-0427	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20170417		ANDA	ANDA077309	REMEDYREPACK INC.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
70518-0437_0e366f9c-9682-17bd-e063-6394a90a9461	70518-0437	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20170419		ANDA	ANDA090702	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20251231
70518-0445_0e3689ba-372c-715f-e063-6294a90ae6f8	70518-0445	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170420		ANDA	ANDA078203	REMEDYREPACK INC.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
70518-0451_0e36beb1-f027-8687-e063-6294a90aef25	70518-0451	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20170421		ANDA	ANDA203154	REMEDYREPACK INC.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20251231
70518-0452_0e36c039-1f22-2004-e063-6394a90addf4	70518-0452	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20170421		ANDA	ANDA200292	REMEDYREPACK INC.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20251231
70518-0453_0e36d74f-b987-1929-e063-6394a90a5bd5	70518-0453	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20170421		ANDA	ANDA076710	REMEDYREPACK INC.	LEVOFLOXACIN	500	mg/1			N	20251231
70518-0455_0e37337f-d9e6-4369-e063-6394a90a7225	70518-0455	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20170424		ANDA	ANDA091426	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
70518-0458_0e3768e6-ed9b-f374-e063-6294a90acbf7	70518-0458	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA040226	REMEDYREPACK INC.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
70518-0465_0e3768e6-ed9d-f374-e063-6294a90acbf7	70518-0465	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	20170426		ANDA	ANDA064067	REMEDYREPACK INC.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20251231
70518-0468_0e373947-5202-dd83-e063-6294a90a4e57	70518-0468	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170427		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
70518-0471_0e37864c-6936-58c2-e063-6394a90a08e2	70518-0471	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel bisulphate	TABLET, FILM COATED	ORAL	20170428		ANDA	ANDA202925	REMEDYREPACK INC.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20251231
70518-0478_0e378f6f-1bae-21ae-e063-6294a90a1a76	70518-0478	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200504		ANDA	ANDA090174	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
70518-0484_0dfae59f-c361-eb47-e063-6394a90a394a	70518-0484	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20170505		ANDA	ANDA206434	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0486_0dfb11d9-f490-56ee-e063-6294a90ad256	70518-0486	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170508		ANDA	ANDA078203	REMEDYREPACK INC.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
70518-0487_0e37a8e7-3601-7ab1-e063-6394a90abf46	70518-0487	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20170508		ANDA	ANDA204279	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
70518-0488_0e37aef4-d615-3ad1-e063-6294a90a7b09	70518-0488	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20170508		ANDA	ANDA204279	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20251231
70518-0512_0e37aef4-d616-3ad1-e063-6294a90a7b09	70518-0512	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170509		ANDA	ANDA078321	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20251231
70518-0515_0e38ca12-cd25-affb-e063-6394a90a357b	70518-0515	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20170510		ANDA	ANDA201807	REMEDYREPACK INC.	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0530_0e38f7ba-3672-ea39-e063-6294a90a8ed2	70518-0530	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA076180	REMEDYREPACK INC.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
70518-0539_0e38f630-ead0-ce23-e063-6394a90ac49c	70518-0539	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	VAGINAL	20170515	20241130	ANDA	ANDA077264	REMEDYREPACK INC.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	
70518-0542_0e39227b-9919-d843-e063-6394a90a4c21	70518-0542	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20170517		ANDA	ANDA078216	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-0544_0e715c5a-2241-c00c-e063-6394a90a5a7c	70518-0544	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170517		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
70518-0549_0dfc4de0-d191-6579-e063-6394a90a8e15	70518-0549	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170519		ANDA	ANDA076341	REMEDYREPACK INC.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0552_0dfc606d-7270-9680-e063-6294a90a5ea2	70518-0552	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20170525		ANDA	ANDA075795	REMEDYREPACK INC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
70518-0558_0e7185d7-3f03-6ca0-e063-6294a90afa49	70518-0558	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170530		ANDA	ANDA090174	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
70518-0560_0e7194f0-660d-db75-e063-6394a90ac72e	70518-0560	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20170601		ANDA	ANDA077731	REMEDYREPACK INC.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
70518-0563_0e71a5b7-c43e-c5fe-e063-6394a90a32bf	70518-0563	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA089424	REMEDYREPACK INC.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
70518-0567_0eae256f-b622-d7b9-e063-6394a90a4982	70518-0567	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20170606		ANDA	ANDA091226	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-0570_0dfcc44b-d699-3d49-e063-6294a90a0805	70518-0570	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20170606		ANDA	ANDA202152	REMEDYREPACK INC.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0573_0e7189ee-7834-762b-e063-6294a90a42b9	70518-0573	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20170612		ANDA	ANDA076286	REMEDYREPACK INC.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
70518-0577_0e71e2c5-d418-10ff-e063-6394a90abc09	70518-0577	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20170619		ANDA	ANDA090168	REMEDYREPACK INC.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20251231
70518-0579_0e0b3dcf-21c6-ebc8-e063-6394a90ac79e	70518-0579	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20170620		ANDA	ANDA075795	REMEDYREPACK INC.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
70518-0587_0e720cdb-4500-3307-e063-6394a90a58bf	70518-0587	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20170626		ANDA	ANDA202801	REMEDYREPACK INC.	LEVOFLOXACIN	500	mg/1			N	20251231
70518-0594_0e0c5e5c-adb7-1b9e-e063-6394a90a4283	70518-0594	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20170627		ANDA	ANDA201190	REMEDYREPACK INC.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0597_0e72607d-0ac6-3eef-e063-6394a90a08d2	70518-0597	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20170628		ANDA	ANDA083177	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-0599_0e726f43-c15a-4e60-e063-6394a90af3e3	70518-0599	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20170628		ANDA	ANDA065223	REMEDYREPACK INC.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
70518-0603_0e7322b8-c840-b4a5-e063-6294a90a2f03	70518-0603	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170629		ANDA	ANDA203253	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20251231
70518-0605_0e733807-36cf-cc05-e063-6294a90aa130	70518-0605	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170703		ANDA	ANDA090700	REMEDYREPACK INC.	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
70518-0608_0e73746f-0d28-9444-e063-6394a90a83a2	70518-0608	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20170706		ANDA	ANDA204779	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20251231
70518-0616_0e75a3df-70dd-3516-e063-6294a90a33aa	70518-0616	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20170712		ANDA	ANDA076133	REMEDYREPACK INC.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0625_0e75a5a3-8de1-1b3c-e063-6294a90ab767	70518-0625	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20170717		ANDA	ANDA076343	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-0627_0e75b984-22fc-4dfb-e063-6294a90a0bb3	70518-0627	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20170718		ANDA	ANDA075185	REMEDYREPACK INC.	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-0632_0e75c887-44ed-4912-e063-6394a90a1863	70518-0632	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20170721		ANDA	ANDA040362	REMEDYREPACK INC.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-0637_0e75d235-5055-514b-e063-6394a90a6e8e	70518-0637	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170725		ANDA	ANDA088467	REMEDYREPACK INC.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
70518-0638_0e75e7a3-8cb0-49fa-e063-6394a90a646c	70518-0638	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20170725		ANDA	ANDA202674	REMEDYREPACK INC.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-0645_026d586a-b14c-3205-e063-6394a90a5162	70518-0645	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20170728		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0647_097eb14f-ad1e-0086-e063-6294a90ac521	70518-0647	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	20170728		ANDA	ANDA071456	REMEDYREPACK INC.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-0659_f27659ed-b731-5e36-e053-2a95a90a38e0	70518-0659	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170802		ANDA	ANDA065169	REMEDYREPACK INC.	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-0666_0c794a3e-2b70-8b9d-e063-6394a90a2e20	70518-0666	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20170810		ANDA	ANDA086242	REMEDYREPACK INC.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70518-0668_0cf2f650-fcac-11a7-e063-6394a90a2094	70518-0668	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20170810		ANDA	ANDA079139	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-0669_f3bb5105-34ed-ef74-e053-2995a90a3789	70518-0669	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20190814		ANDA	ANDA070184	REMEDYREPACK INC.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
70518-0682_f8974df5-6940-161c-e053-6394a90adb3f	70518-0682	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170816		ANDA	ANDA202330	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
70518-0693_026e67c7-3dfd-7412-e063-6394a90a5dbb	70518-0693	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20170817		ANDA	ANDA075593	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-0702_f4e7ab1c-33bb-9a88-e053-2995a90a4a6b	70518-0702	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170818		ANDA	ANDA075520	REMEDYREPACK INC.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-0708_f4e7f272-416c-efe2-e053-2a95a90a603e	70518-0708	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20190822		ANDA	ANDA075520	REMEDYREPACK INC.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-0710_f4e7f1c8-e45d-0860-e053-2a95a90a1bf0	70518-0710	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20170823		ANDA	ANDA207582	REMEDYREPACK INC.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-0718_026e9929-e532-5f3a-e063-6394a90a1a02	70518-0718	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20170830		ANDA	ANDA090083	REMEDYREPACK INC.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-0719_026ea3e0-e1c4-c5dd-e063-6294a90a2912	70518-0719	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20170830		ANDA	ANDA202801	REMEDYREPACK INC.	LEVOFLOXACIN	250	mg/1			N	20241231
70518-0721_070d2ce0-89c9-a615-e063-6294a90ab944	70518-0721	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	CREAM	TOPICAL	20170831		NDA	NDA018861	REMEDYREPACK INC.	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-0727_026ebca5-8e98-f043-e063-6394a90add7e	70518-0727	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20170911		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-0730_026ecad8-e07f-2dc5-e063-6294a90a88e6	70518-0730	HUMAN PRESCRIPTION DRUG	valproic acid		valproic acid	CAPSULE	ORAL	20170911		ANDA	ANDA073229	REMEDYREPACK INC.	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-0731_f4e8ef6e-e45c-56d2-e053-2995a90a1f57	70518-0731	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20170912		ANDA	ANDA207582	REMEDYREPACK INC.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-0732_05423ab5-f73f-9993-e063-6294a90a8be2	70518-0732	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20170912		ANDA	ANDA065061	REMEDYREPACK INC.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70518-0741_f45c2980-bc71-35bc-e053-2a95a90a470f	70518-0741	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20170919		ANDA	ANDA075520	REMEDYREPACK INC.	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-0743_026f2b86-9b55-f5e9-e063-6294a90a4f90	70518-0743	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170920		ANDA	ANDA204375	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0752_f898694c-aab8-71eb-e053-6294a90a1b4a	70518-0752	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20170929		ANDA	ANDA202152	REMEDYREPACK INC.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0755_02818b70-7258-29dc-e063-6294a90a746f	70518-0755	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20171002		ANDA	ANDA040230	REMEDYREPACK INC.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70518-0757_02820621-d2bc-e5a5-e063-6294a90a58c8	70518-0757	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20171004		ANDA	ANDA204375	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0761_02823eed-6ab8-3317-e063-6394a90af080	70518-0761	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20171006		ANDA	ANDA091625	REMEDYREPACK INC.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-0763_02822586-c7ef-fb1e-e063-6394a90a10fc	70518-0763	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone	SOLUTION/ DROPS	AURICULAR (OTIC)	20171006		ANDA	ANDA064053	REMEDYREPACK INC.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70518-0767_0282a6fb-ebde-b276-e063-6394a90a6234	70518-0767	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20171009		ANDA	ANDA201190	REMEDYREPACK INC.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0771_f898a9cf-b136-f586-e053-6394a90ad57d	70518-0771	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20171009		ANDA	ANDA204770	REMEDYREPACK INC.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-0775_f304e68b-842a-6d6b-e053-2995a90aa689	70518-0775	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20171010		ANDA	ANDA070848	REMEDYREPACK INC.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
70518-0782_0282febb-b385-8d4a-e063-6294a90af8d2	70518-0782	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20171011		ANDA	ANDA204375	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0784_02832aae-ee3a-5fc7-e063-6394a90aa888	70518-0784	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20171012		ANDA	ANDA065225	REMEDYREPACK INC.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-0786_087a33ad-bb10-440e-e063-6294a90a7e6c	70518-0786	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20171012		ANDA	ANDA091617	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-0787_02833c43-7d8c-5fc5-e063-6394a90ae757	70518-0787	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20171013		ANDA	ANDA204375	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0791_0a1d013f-9f68-b6ae-e063-6394a90ace3f	70518-0791	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20171017		ANDA	ANDA090939	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-0793_f522a12b-2879-5f95-e053-2a95a90a6255	70518-0793	HUMAN PRESCRIPTION DRUG	Guanfacine Hydrochloride		Guanfacine	TABLET	ORAL	20171017		ANDA	ANDA075109	REMEDYREPACK INC.	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-0809_f5235b23-babe-b58f-e053-2995a90a185f	70518-0809	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20171027		NDA	NDA018823	REMEDYREPACK INC.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70518-0815_f528294f-6590-1325-e053-2995a90a764e	70518-0815	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, COATED	ORAL	20171102		ANDA	ANDA091024	REMEDYREPACK INC.	ESZOPICLONE	3	mg/1		CIV	N	20241231
70518-0818_0d1c9183-3dc4-4f82-e063-6294a90a98e1	70518-0818	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20171102		ANDA	ANDA203695	REMEDYREPACK INC.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-0820_f537c531-b29e-2c5c-e053-2995a90abc78	70518-0820	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20171106		ANDA	ANDA074185	REMEDYREPACK INC.	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
70518-0831_f899477a-afa8-0163-e053-6294a90ab60f	70518-0831	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20171109		ANDA	ANDA077580	REMEDYREPACK INC.	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-0832_029315bd-a497-508b-e063-6294a90a9c26	70518-0832	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20171109		ANDA	ANDA086242	REMEDYREPACK INC.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70518-0834_029358d0-7183-27ec-e063-6294a90a4c98	70518-0834	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20171109		ANDA	ANDA040197	REMEDYREPACK INC.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-0835_fdf3b90e-a3f7-49b2-e053-6394a90ab175	70518-0835	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20171110		ANDA	ANDA077073	REMEDYREPACK INC.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-0841_f53a5556-6f37-916c-e053-2995a90a1710	70518-0841	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	TABLET, CHEWABLE	ORAL	20171110		ANDA	ANDA200565	REMEDYREPACK INC.	PHENYTOIN	50	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-0842_029399a1-c9d1-3b0f-e063-6394a90a9d4a	70518-0842	HUMAN PRESCRIPTION DRUG	Tri-Sprintec		norgestimate and ethinyl estradiol	KIT		20171110		ANDA	ANDA075808	REMEDYREPACK INC.						N	20241231
70518-0844_f53a7da5-2bf6-2e1c-e053-2a95a90afa34	70518-0844	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171110		ANDA	ANDA078321	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-0860_087b6258-8cbb-737d-e063-6294a90ac57e	70518-0860	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20171120		ANDA	ANDA202038	REMEDYREPACK INC.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-0863_0d1c8cd2-44d6-8be6-e063-6394a90a9478	70518-0863	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20171124		ANDA	ANDA090624	REMEDYREPACK INC.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70518-0866_0293d5de-f0ba-acc0-e063-6294a90a3d29	70518-0866	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20171124		ANDA	ANDA204418	REMEDYREPACK INC.	FOLIC ACID	1	mg/1			N	20241231
70518-0871_f63dd836-9948-8f1a-e053-2995a90a3740	70518-0871	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20171127		ANDA	ANDA206116	REMEDYREPACK INC.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-0876_0c3f44dc-290a-20a9-e063-6394a90a0649	70518-0876	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20171129		ANDA	ANDA076341	REMEDYREPACK INC.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-0881_f53b33b7-a36c-0881-e053-2a95a90af66b	70518-0881	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20171130	20240531	ANDA	ANDA204713	REMEDYREPACK INC.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
70518-0882_0293d3bf-b3d1-bbf3-e063-6394a90a79e5	70518-0882	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20171130		ANDA	ANDA074056	REMEDYREPACK INC.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-0886_088bac61-5fb6-62c4-e063-6294a90a108f	70518-0886	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20171204		ANDA	ANDA200503	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
70518-0887_02948142-37a2-7687-e063-6394a90a1bc5	70518-0887	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20171204		ANDA	ANDA090278	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-0890_f53c19da-934b-f8cb-e053-2a95a90af773	70518-0890	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20171208		ANDA	ANDA076368	REMEDYREPACK INC.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-0893_0294ba1c-9f63-b7b7-e063-6394a90a5979	70518-0893	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20171214		ANDA	ANDA072741	REMEDYREPACK INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70518-0894_0a203694-ecda-efb1-e063-6394a90a3194	70518-0894	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20171212		ANDA	ANDA078069	REMEDYREPACK INC.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-0895_fe17e03e-e7ac-8e29-e053-6394a90a5ff3	70518-0895	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20171212		ANDA	ANDA065271	REMEDYREPACK INC.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-0898_f89be964-c1be-4e49-e053-6294a90ae70a	70518-0898	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20171212		ANDA	ANDA070974	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-0904_f54e29f8-3e96-6655-e053-2995a90a287e	70518-0904	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		lithium carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171212		ANDA	ANDA202288	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-0908_0a2067a7-6cbb-1084-e063-6394a90a6fec	70518-0908	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin Hydrochloride		Glipizide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20171213		ANDA	ANDA078905	REMEDYREPACK INC.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-0911_fd00105b-dcaf-f5dd-e053-6294a90a70b8	70518-0911	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20171214		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
70518-0915_088d558e-3097-61a6-e063-6294a90aa695	70518-0915	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	TABLET	ORAL	20171220		ANDA	ANDA075319	REMEDYREPACK INC.	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-0916_029572af-3c34-d6a1-e063-6394a90adfa4	70518-0916	HUMAN PRESCRIPTION DRUG	Hydroxyurea		Hydroxyurea	CAPSULE	ORAL	20171220		ANDA	ANDA075340	REMEDYREPACK INC.	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
70518-0920_f54e4090-f7f0-e6b5-e053-2995a90a11f2	70518-0920	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20171222		ANDA	ANDA040197	REMEDYREPACK INC.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-0921_f54ea036-a44e-cfda-e053-2995a90aa3a3	70518-0921	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA202862	REMEDYREPACK INC.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0926_0295a85b-afbb-0226-e063-6394a90a4c62	70518-0926	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20180103		ANDA	ANDA200675	REMEDYREPACK INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-0932_0d6bf85c-3b4f-4b8d-e063-6294a90a728e	70518-0932	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20180105		ANDA	ANDA076710	REMEDYREPACK INC.	LEVOFLOXACIN	750	mg/1			N	20241231
70518-0935_05cb568c-e8af-8dd4-e063-6294a90a9e10	70518-0935	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20180105		ANDA	ANDA202862	REMEDYREPACK INC.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0937_088d92cb-ad4e-e902-e063-6294a90a681e	70518-0937	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20190425		ANDA	ANDA090778	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-0942_0a20c959-33cc-23c3-e063-6394a90a369a	70518-0942	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20180109		ANDA	ANDA200503	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
70518-0947_0296b40d-7ab4-6dc2-e063-6394a90a6338	70518-0947	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20180110		ANDA	ANDA090515	REMEDYREPACK INC.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-0948_0322da2e-85ae-2bd7-e063-6294a90abb04	70518-0948	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20180110		ANDA	ANDA040362	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-0964_088f5106-92ac-2c97-e063-6394a90ab1f9	70518-0964	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20180117		ANDA	ANDA075356	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE ANHYDROUS	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-0968_0296d0d8-0569-b057-e063-6394a90a2b22	70518-0968	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20180122		ANDA	ANDA202801	REMEDYREPACK INC.	LEVOFLOXACIN	750	mg/1			N	20241231
70518-0970_06349548-79c3-894b-e063-6294a90afe69	70518-0970	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20180122		ANDA	ANDA204838	REMEDYREPACK INC.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0975_f564352a-8ddb-7f45-e053-2995a90acdc5	70518-0975	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20180122		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0978_0a210ac2-e5e1-655f-e063-6294a90afb2d	70518-0978	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20180122		ANDA	ANDA078040	REMEDYREPACK INC.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-0982_0c78a608-5d92-89a7-e063-6294a90aed27	70518-0982	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180122		ANDA	ANDA200834	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-0987_088f9ca1-82a9-d520-e063-6394a90a1257	70518-0987	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180125		ANDA	ANDA079170	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-0993_088fcdb9-943c-b26b-e063-6294a90a772b	70518-0993	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20180129		ANDA	ANDA075356	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE ANHYDROUS	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1000_f63cf002-1fdf-22d2-e053-2a95a90a2cc4	70518-1000	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20180202		ANDA	ANDA091368	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-1001_f8ada627-3e44-0dc3-e053-6394a90a6326	70518-1001	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20180202		ANDA	ANDA075805	REMEDYREPACK INC.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70518-1006_f19c906b-cfd1-9859-e053-2995a90a8991	70518-1006	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20180208		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-1007_02979cee-659f-abc9-e063-6394a90a5f5e	70518-1007	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl and Naloxone HCl		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20180208		ANDA	ANDA203136	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-1011_08902b43-841f-98e5-e063-6294a90aa13f	70518-1011	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20180212		ANDA	ANDA208706	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1017_02a54692-396b-650d-e063-6394a90ae716	70518-1017	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20180214		ANDA	ANDA074984	REMEDYREPACK INC.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-1018_f8ae6b41-35e0-38a6-e053-6294a90a292a	70518-1018	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20180214		ANDA	ANDA202674	REMEDYREPACK INC.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1021_02a57e20-35fa-d361-e063-6394a90aa12f	70518-1021	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20180216		ANDA	ANDA084363	REMEDYREPACK INC.	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
70518-1027_0c64004a-6975-dbaf-e063-6294a90a43e4	70518-1027	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20180220		ANDA	ANDA077794	REMEDYREPACK INC.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1034_02a5c8df-bfcf-0959-e063-6394a90a8cc4	70518-1034	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20180227		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1040_f8af26fc-0ddc-2204-e053-6294a90a4a15	70518-1040	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20180301		ANDA	ANDA077670	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1050_0907e376-6d59-4981-e063-6294a90a70f5	70518-1050	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20180301		ANDA	ANDA078888	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
70518-1051_01c98bb0-36fd-805f-e063-6294a90aad4c	70518-1051	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180301		ANDA	ANDA091625	REMEDYREPACK INC.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1053_02a5e92a-e864-34fa-e063-6394a90a5852	70518-1053	HUMAN PRESCRIPTION DRUG	HALOPERIDOL LACTATE		HALOPERIDOL LACTATE	INJECTION, SOLUTION	INTRAMUSCULAR	20180307		ANDA	ANDA078347	REMEDYREPACK INC.	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70518-1054_065792a6-5466-f5ae-e063-6294a90a7532	70518-1054	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20180309		ANDA	ANDA208706	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1055_02a62773-837b-a611-e063-6394a90a3268	70518-1055	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20180312		ANDA	ANDA077794	REMEDYREPACK INC.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1057_0a95f22a-81ad-486e-e063-6394a90a712b	70518-1057	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20180313		NDA AUTHORIZED GENERIC	NDA021519	REMEDYREPACK INC.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1063_02a68654-f6ec-c351-e063-6294a90a94c2	70518-1063	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180313		ANDA	ANDA204720	REMEDYREPACK INC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-1081_02a69ca4-b56e-345e-e063-6394a90ad2ff	70518-1081	HUMAN PRESCRIPTION DRUG	VENTOLIN	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180324		NDA	NDA020983	REMEDYREPACK INC.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70518-1087_0918baa1-54cf-162b-e063-6294a90a6af9	70518-1087	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20180329		ANDA	ANDA077066	REMEDYREPACK INC.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
70518-1094_02a69ca4-b571-345e-e063-6394a90ad2ff	70518-1094	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20180403		ANDA	ANDA088042	REMEDYREPACK INC.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-1103_0c53aee6-7f5b-b0e2-e063-6394a90a6989	70518-1103	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20180409		ANDA	ANDA090432	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1109_01c89a44-0a74-ff8e-e063-6394a90adeb9	70518-1109	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20180411		ANDA	ANDA205973	REMEDYREPACK INC.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-1114_f37eff0e-a352-29d6-e053-2a95a90abfe8	70518-1114	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	20180412		ANDA	ANDA062364	REMEDYREPACK INC.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
70518-1120_02a7421f-3842-f5f5-e063-6294a90a8042	70518-1120	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20180413		ANDA	ANDA040256	REMEDYREPACK INC.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-1124_f41eb59b-25d0-15bf-e053-2995a90a1587	70518-1124	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20180419		ANDA	ANDA074223	REMEDYREPACK INC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-1128_02a7775a-2ef6-7790-e063-6294a90ae55b	70518-1128	HUMAN PRESCRIPTION DRUG	DULOXETINE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20180419		ANDA	ANDA206653	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1132_f8fc8d27-e863-a242-e053-6394a90a848b	70518-1132	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20180424		ANDA	ANDA207743	REMEDYREPACK INC.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1134_07842e5c-7e31-e9ad-e063-6294a90a4e48	70518-1134	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, and Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20180425		ANDA	ANDA200243	REMEDYREPACK INC.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
70518-1138_0e34badf-c880-08c1-e063-6294a90aeefd	70518-1138	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20180425		ANDA	ANDA090161	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
70518-1139_09197c92-2366-c098-e063-6394a90a359c	70518-1139	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20180425		ANDA	ANDA208706	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1140_f901436b-02a5-0993-e053-6394a90a516e	70518-1140	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20180426		ANDA	ANDA084364	REMEDYREPACK INC.	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
70518-1146_02a7b3c7-42eb-056e-e063-6294a90ac13c	70518-1146	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20180427		ANDA	ANDA091205	REMEDYREPACK INC.	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
70518-1149_f90f0a09-0fd4-0b09-e053-6394a90a3388	70518-1149	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20180501		ANDA	ANDA077095	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-1150_f914771c-bae1-a8c5-e053-6294a90ad193	70518-1150	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20180501		ANDA	ANDA088496	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-1151_0a222fd7-f2cc-301c-e063-6294a90a6d81	70518-1151	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20180501		ANDA	ANDA078040	REMEDYREPACK INC.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1152_091999f7-d8b8-87b4-e063-6294a90a1dd8	70518-1152	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180501		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-1156_091999f7-d8f5-87b4-e063-6294a90a1dd8	70518-1156	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180502		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-1157_f9234234-69b6-a472-e053-6394a90ae4f9	70518-1157	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20180502		ANDA	ANDA207068	REMEDYREPACK INC.	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1170_0321d8d6-35dc-c45a-e063-6294a90a646b	70518-1170	HUMAN PRESCRIPTION DRUG	Ciprofloxacin Hydrochloride		Ciprofloxacin Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20180515		NDA AUTHORIZED GENERIC	NDA019992	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-1174_0d1d3144-164c-a57a-e063-6294a90a1dce	70518-1174	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20180514		ANDA	ANDA078619	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1180_02a8253d-a99c-6aee-e063-6394a90a9bb4	70518-1180	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20180514		ANDA	ANDA078235	REMEDYREPACK INC.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1182_f7f94328-f58a-885c-e053-6294a90acf24	70518-1182	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20180514		ANDA	ANDA077580	REMEDYREPACK INC.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-1183_02a8521f-ae67-b1eb-e063-6394a90a7a40	70518-1183	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20180514		ANDA	ANDA078295	REMEDYREPACK INC.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
70518-1184_f9258387-4817-a9e7-e053-6394a90a743b	70518-1184	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20180514		ANDA	ANDA078327	REMEDYREPACK INC.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
70518-1190_02a86985-3239-176d-e063-6294a90aeaa2	70518-1190	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20180514		NDA AUTHORIZED GENERIC	NDA018998	REMEDYREPACK INC.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-1193_02a86985-323a-176d-e063-6294a90aeaa2	70518-1193	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	20180514		ANDA	ANDA070184	REMEDYREPACK INC.	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
70518-1196_02a8903e-c3c8-4e6c-e063-6294a90ad62e	70518-1196	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20180515		ANDA	ANDA076343	REMEDYREPACK INC.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1201_f1d6b207-24ee-031f-e053-2a95a90a5d3f	70518-1201	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20180515		ANDA	ANDA090937	REMEDYREPACK INC.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-1203_094182b0-0781-263d-e063-6294a90a86b4	70518-1203	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20180515		ANDA	ANDA202868	REMEDYREPACK INC.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-1204_0d6d3e65-d4f9-4414-e063-6394a90a691f	70518-1204	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20180515		ANDA	ANDA205253	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-1215_0a3465d4-79aa-9357-e063-6294a90a4620	70518-1215	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180517		NDA	NDA205029	REMEDYREPACK INC.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-1216_f938818c-90cf-1937-e053-6294a90afa43	70518-1216	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180517		ANDA	ANDA077342	REMEDYREPACK INC.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-1221_02a94996-749c-22e2-e063-6394a90a90e9	70518-1221	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE	EXTENDED RELEASE	POTASSIUM CITRATE	TABLET	ORAL	20180521		ANDA	ANDA206813	REMEDYREPACK INC.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
70518-1224_f938e403-78ca-86e6-e053-6394a90a8115	70518-1224	HUMAN PRESCRIPTION DRUG	EPIPEN		epinephrine	INJECTION	INTRAMUSCULAR	20180525		NDA	NDA019430	REMEDYREPACK INC.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-1236_02a97fa3-0680-4ff1-e063-6394a90adf91	70518-1236	HUMAN PRESCRIPTION DRUG	Bacteriostatic Water		Bacteriostatic Water	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180604		NDA	NDA018802	REMEDYREPACK INC.	WATER	1	mL/mL			N	20241231
70518-1237_0e76247c-ec86-6abd-e063-6394a90a99d5	70518-1237	HUMAN PRESCRIPTION DRUG	VENTOLIN	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20180530		NDA	NDA020983	REMEDYREPACK INC.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
70518-1240_fa2ec451-5fcd-1dea-e053-6294a90a0288	70518-1240	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20180601		ANDA	ANDA070033	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-1241_f21751a4-ce4a-53ea-e053-2a95a90a1dff	70518-1241	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20180601		ANDA	ANDA070033	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-1248_02a9a10f-7724-9479-e063-6394a90ac9c5	70518-1248	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20180608		ANDA	ANDA062676	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-1253_f93a697c-e39f-8f4b-e053-6294a90a2c77	70518-1253	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20180612		ANDA	ANDA203854	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1254_fd7b9bab-b42f-a258-e053-6294a90a3a56	70518-1254	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20180613		ANDA	ANDA075964	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
70518-1265_02a9cdf7-6f43-55dd-e063-6294a90a25d2	70518-1265	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20180619		ANDA	ANDA204279	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-1269_f94eab36-f76c-21b4-e053-6294a90aec5b	70518-1269	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20180619		ANDA	ANDA077580	REMEDYREPACK INC.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-1274_02a9e373-9b68-e981-e063-6394a90a5e7d	70518-1274	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET, FILM COATED	ORAL	20180621		ANDA	ANDA078119	REMEDYREPACK INC.	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
70518-1275_fb2d4f05-7e24-d206-e053-6294a90a60ce	70518-1275	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180627		NDA	NDA018140	REMEDYREPACK INC.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1278_0877d649-1dcd-e2c4-e063-6294a90ac907	70518-1278	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20180626		ANDA	ANDA077859	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-1290_0c690d73-f129-8db6-e063-6394a90a51ea	70518-1290	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20180709		ANDA	ANDA077670	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1293_02ab0421-f690-42e0-e063-6294a90a12a1	70518-1293	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20180711		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	45	mg/1			N	20241231
70518-1295_f9509b4c-405c-721b-e053-6294a90a3198	70518-1295	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20180711		ANDA	ANDA201519	REMEDYREPACK INC.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1297_02ab23f2-cf14-427f-e063-6294a90a4938	70518-1297	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180712		ANDA	ANDA077147	REMEDYREPACK INC.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1298_0a356b7b-468c-b866-e063-6394a90a54a4	70518-1298	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180712		ANDA	ANDA202038	REMEDYREPACK INC.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-1299_02ab8742-88aa-e6c9-e063-6294a90a7a40	70518-1299	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20180712		ANDA	ANDA077929	REMEDYREPACK INC.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1306_0a368d4d-f44b-2519-e063-6294a90a2a0f	70518-1306	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20180716		ANDA	ANDA040596	REMEDYREPACK INC.	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-1308_0cdd14c0-b5f9-2899-e063-6394a90ad2c8	70518-1308	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20180817		ANDA	ANDA040659	REMEDYREPACK INC.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70518-1309_f951efc8-e7cb-5936-e053-6294a90af65c	70518-1309	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20180718		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	30	mg/1			N	20241231
70518-1310_fd8b682a-2148-7841-e053-6394a90a5d00	70518-1310	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20180718		ANDA	ANDA208451	REMEDYREPACK INC.	ESZOPICLONE	2	mg/1		CIV	N	20241231
70518-1311_02e1ce62-74ea-5f83-e063-6394a90a9b81	70518-1311	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20180719		ANDA	ANDA206434	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1314_02e21033-7198-a990-e063-6394a90ad997	70518-1314	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20180721		ANDA	ANDA203512	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-1316_0a36b72b-2816-5600-e063-6294a90adcf2	70518-1316	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180723		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-1322_02e269ed-8d37-bc89-e063-6294a90a16a0	70518-1322	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180725		ANDA	ANDA090548	REMEDYREPACK INC.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1323_0e762779-4ed5-82eb-e063-6294a90a0299	70518-1323	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION	OPHTHALMIC	20180726		ANDA	ANDA062196	REMEDYREPACK INC.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
70518-1326_f98a9ad1-f6b1-ef3f-e053-6294a90af2d1	70518-1326	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180726		ANDA	ANDA078906	REMEDYREPACK INC.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-1334_02e34316-f344-f68a-e063-6294a90ab00f	70518-1334	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20180731		ANDA	ANDA203512	REMEDYREPACK INC.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-1336_02e3503d-47ae-1239-e063-6294a90a6485	70518-1336	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20180801		ANDA	ANDA065470	REMEDYREPACK INC.	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-1342_0a46f34a-ca9b-3dfd-e063-6394a90a7fb7	70518-1342	HUMAN PRESCRIPTION DRUG	Adrenalin		epinephrine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20180803		NDA	NDA204200	REMEDYREPACK INC.	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-1346_f98b6b1d-26b1-bbfb-e053-6294a90af762	70518-1346	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20180806		ANDA	ANDA204590	REMEDYREPACK INC.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1347_051951c2-93a4-3e79-e063-6294a90a2aaf	70518-1347	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		olmesartan medoxomil and hydrochlorothiazide	TABLET	ORAL	20180806		ANDA	ANDA207804	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-1350_f98bc55a-d68e-d01d-e053-6294a90a6733	70518-1350	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET	ORAL	20180807		ANDA	ANDA077397	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1353_02e36812-53c4-003b-e063-6394a90aed12	70518-1353	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180808		ANDA	ANDA077856	REMEDYREPACK INC.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1357_0a4715eb-3993-24ae-e063-6294a90abb81	70518-1357	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20180808		ANDA	ANDA078216	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1364_02f8b296-a78e-585e-e063-6294a90a7013	70518-1364	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180809		ANDA	ANDA091625	REMEDYREPACK INC.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1369_f99f33e6-d63f-cf88-e053-6294a90afd4a	70518-1369	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20180810		ANDA	ANDA074145	REMEDYREPACK INC.	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-1370_0a480d49-84e8-df0d-e063-6294a90a60b3	70518-1370	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20180813		ANDA	ANDA207444	REMEDYREPACK INC.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70518-1377_0a4838c8-3ecc-f047-e063-6294a90a5b35	70518-1377	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20180815		ANDA	ANDA077614	REMEDYREPACK INC.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1378_fa2e4d41-bbb4-d6c2-e053-6294a90ad971	70518-1378	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline	CAPSULE	ORAL	20180816		ANDA	ANDA207289	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-1385_09a6f385-0a8b-d55e-e063-6394a90a5e55	70518-1385	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20180824		ANDA	ANDA090555	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1397_f9a047f5-9ffc-6a28-e053-6294a90a745a	70518-1397	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20180831		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	15	mg/1			N	20241231
70518-1398_0a49a8eb-1829-a142-e063-6394a90ad3f7	70518-1398	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20180904		ANDA	ANDA207812	REMEDYREPACK INC.	METHOTREXATE	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70518-1402_0a49a8eb-1869-a142-e063-6394a90ad3f7	70518-1402	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine	TABLET	ORAL	20180906		ANDA	ANDA201451	REMEDYREPACK INC.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70518-1404_05e21b0d-f7b6-8bb8-e063-6394a90a3fe5	70518-1404	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20180907		ANDA	ANDA202557	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
70518-1406_0a4a0161-4b6e-c0b4-e063-6394a90a801f	70518-1406	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20180907		ANDA	ANDA203854	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1409_02e460fb-6bec-601e-e063-6294a90a5887	70518-1409	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180911		ANDA	ANDA091625	REMEDYREPACK INC.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1410_05ce29de-bd09-70ed-e063-6394a90a85f6	70518-1410	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20180911		ANDA	ANDA071258	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-1411_f2158c82-e7c4-8e7a-e053-2a95a90a1c3c	70518-1411	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20180911		ANDA	ANDA040156	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-1415_02e4bb9f-39a1-d0f2-e063-6294a90a7004	70518-1415	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20180917		ANDA	ANDA075511	REMEDYREPACK INC.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70518-1417_f2b63f5e-52f9-95cb-e053-2a95a90a0fc5	70518-1417	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20180917		ANDA	ANDA090931	REMEDYREPACK INC.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1426_0a59b164-f092-2069-e063-6294a90a07cb	70518-1426	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20180918		ANDA	ANDA078103	REMEDYREPACK INC.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1433_02e4ca4f-319f-0b44-e063-6294a90abee0	70518-1433	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	20180924		ANDA	ANDA075687	REMEDYREPACK INC.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1434_f9a1bb88-e436-b19b-e053-6394a90a8cc6	70518-1434	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	20180925		NDA	NDA017812	REMEDYREPACK INC.	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-1436_f9b3becd-18da-c94b-e053-6394a90a07dc	70518-1436	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20180926		ANDA	ANDA074649	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1443_f9b4c591-296e-3a1d-e053-6394a90a77fc	70518-1443	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20180928		ANDA	ANDA072575	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1447_02e551a6-79c1-cd08-e063-6294a90a1820	70518-1447	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20181001	20240630	ANDA	ANDA204713	REMEDYREPACK INC.	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
70518-1450_f9b4fff4-e63e-cfd8-e053-6294a90aad12	70518-1450	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20181002		ANDA	ANDA078250	REMEDYREPACK INC.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1460_0e70912b-b1a9-8732-e063-6394a90a2989	70518-1460	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20181004		ANDA	ANDA075356	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE ANHYDROUS	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-1463_f9b5a176-bc89-1827-e053-6394a90a2976	70518-1463	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181004		ANDA	ANDA078703	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1467_02e58325-0c10-1017-e063-6394a90a4722	70518-1467	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20181005		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-1469_0528a5f0-077c-37df-e063-6394a90a504a	70518-1469	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20181005		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1475_02e5a5c1-8f43-5e6d-e063-6294a90ab1b1	70518-1475	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20181006		ANDA	ANDA040734	REMEDYREPACK INC.	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
70518-1476_f9c62828-64d8-a97e-e053-6394a90a3361	70518-1476	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20181006		ANDA	ANDA072575	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1479_f80f5408-bc6e-269f-e053-6294a90ac1e8	70518-1479	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20181006		ANDA	ANDA090170	REMEDYREPACK INC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-1481_fdf1f562-3455-df5b-e053-6394a90ad092	70518-1481	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET	ORAL	20181006		NDA	NDA018558	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-1484_f9c7a504-3ca7-b1db-e053-6394a90a9243	70518-1484	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20181006		ANDA	ANDA202446	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-1485_091b9c2d-9ba7-601c-e063-6394a90ac8e5	70518-1485	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET	ORAL	20181008		ANDA	ANDA075037	REMEDYREPACK INC.	ISOSORBIDE MONONITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70518-1486_02e5e856-8b6c-de38-e063-6394a90a93c7	70518-1486	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20181006		ANDA	ANDA202556	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-1492_02e5ff11-5d97-de7d-e063-6394a90ad507	70518-1492	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20181006		ANDA	ANDA040616	REMEDYREPACK INC.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-1501_f9c95194-4f3e-1076-e053-6394a90ac8e0	70518-1501	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20181008		ANDA	ANDA076133	REMEDYREPACK INC.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1502_0658af56-5465-81c9-e063-6394a90a1710	70518-1502	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20181008		ANDA	ANDA201003	REMEDYREPACK INC.	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1503_02e6c515-b2cc-8055-e063-6294a90aded1	70518-1503	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20181008		ANDA	ANDA090278	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1504_f9da6845-e23f-dae9-e053-6294a90a2297	70518-1504	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20181008		ANDA	ANDA087479	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-1505_02e6d962-a836-7dcc-e063-6294a90ae800	70518-1505	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20181008		ANDA	ANDA202446	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-1506_02e7257a-33c6-75c4-e063-6394a90a0d21	70518-1506	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20181008		ANDA	ANDA040734	REMEDYREPACK INC.	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
70518-1510_f9daf82f-df8b-6714-e053-6394a90a7dfb	70518-1510	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel bisulphate	TABLET, FILM COATED	ORAL	20181009		ANDA	ANDA202925	REMEDYREPACK INC.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
70518-1512_0254e524-e5cb-4632-e063-6294a90a167d	70518-1512	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20181010		ANDA	ANDA091276	REMEDYREPACK INC.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1513_f9db84af-79aa-b444-e053-6294a90a001e	70518-1513	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20181010		ANDA	ANDA090937	REMEDYREPACK INC.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-1514_02e6f01d-5153-aad7-e063-6294a90a0946	70518-1514	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20181010		ANDA	ANDA090548	REMEDYREPACK INC.	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1516_02e74249-5219-aa03-e063-6394a90af5ab	70518-1516	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20181010		ANDA	ANDA078250	REMEDYREPACK INC.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1520_02e74249-521c-aa03-e063-6394a90af5ab	70518-1520	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20181011		ANDA	ANDA078203	REMEDYREPACK INC.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1521_02e79817-5a4c-a88d-e063-6294a90a5a52	70518-1521	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20181011		ANDA	ANDA077147	REMEDYREPACK INC.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1522_f9dbf3a4-20fe-a847-e053-6394a90ace6d	70518-1522	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20181011		ANDA	ANDA075520	REMEDYREPACK INC.	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-1523_0309c072-dec3-3a28-e063-6394a90ae0d0	70518-1523	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20181011		ANDA	ANDA078525	REMEDYREPACK INC.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-1530_0bc3ad97-fd3b-7d69-e063-6394a90a77d4	70518-1530	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20181015		ANDA	ANDA202557	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
70518-1534_03739293-48a0-6526-e063-6394a90a3edc	70518-1534	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20181015		ANDA	ANDA084612	REMEDYREPACK INC.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-1535_f9de39ce-e4ad-6746-e053-6294a90abe75	70518-1535	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20181015		ANDA	ANDA076255	REMEDYREPACK INC.	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1536_0a5e5a80-6e57-3345-e063-6394a90a1497	70518-1536	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20181015		ANDA	ANDA203458	REMEDYREPACK INC.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-1538_091c0eed-30b2-31ba-e063-6394a90afbd0	70518-1538	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20181016		ANDA	ANDA202446	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-1544_0a5e7dab-1ec7-1efe-e063-6394a90a3834	70518-1544	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20181017		ANDA	ANDA078787	REMEDYREPACK INC.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1545_030a4311-4bf5-4b69-e063-6394a90ab02e	70518-1545	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20181017		ANDA	ANDA078115	REMEDYREPACK INC.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1546_fa3f7bb7-e8e3-bec3-e053-6394a90af965	70518-1546	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA200908	REMEDYREPACK INC.	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1547_0a967fbc-538c-7fd7-e063-6294a90a7db0	70518-1547	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20181017		ANDA	ANDA078627	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1550_0a967ecf-45af-397a-e063-6294a90a0ef5	70518-1550	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20181018		ANDA	ANDA203072	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-1551_0ae8660a-b89e-9588-e063-6294a90a3bd4	70518-1551	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20181023		ANDA	ANDA090469	REMEDYREPACK INC.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70518-1553_fa454c5e-f16f-9cef-e053-6294a90a32ce	70518-1553	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20181019		ANDA	ANDA087342	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-1554_fa459556-303f-2731-e053-6294a90a32d6	70518-1554	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20181019		ANDA	ANDA090200	REMEDYREPACK INC.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-1556_0a972eaa-d6e7-090b-e063-6294a90a264f	70518-1556	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20181019		ANDA	ANDA203730	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1558_030b7186-c64f-aa8c-e063-6294a90a98a5	70518-1558	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20181019		ANDA	ANDA078597	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1559_030bcedf-5e4e-ea7e-e063-6394a90a3287	70518-1559	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20181019		ANDA	ANDA077147	REMEDYREPACK INC.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1560_fa56af05-a241-5823-e053-6394a90ab2dd	70518-1560	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20181019		ANDA	ANDA202824	REMEDYREPACK INC.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1561_fa57003b-5923-8849-e053-6294a90a22a6	70518-1561	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20181019		ANDA	ANDA085161	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-1562_fa69aa5f-c88d-7751-e053-6394a90a847e	70518-1562	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	20181019		NDA	NDA018810	REMEDYREPACK INC.	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
70518-1563_fa69dcbd-3142-77a0-e053-6394a90a8784	70518-1563	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20181022		ANDA	ANDA077836	REMEDYREPACK INC.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
70518-1564_030c6060-1b71-bf5e-e063-6394a90a5a85	70518-1564	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20181022		ANDA	ANDA075657	REMEDYREPACK INC.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-1566_f80c2553-b9aa-f1a8-e053-6294a90ae3fc	70518-1566	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20181022		ANDA	ANDA076143	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-1568_030c8101-fdf7-eef2-e063-6394a90a18a1	70518-1568	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20181022		ANDA	ANDA201003	REMEDYREPACK INC.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1574_0a980b28-acc5-9c01-e063-6294a90a36b8	70518-1574	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20181022		ANDA	ANDA078040	REMEDYREPACK INC.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1575_030d0aab-4a25-d44b-e063-6294a90aeb2d	70518-1575	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20181022		ANDA	ANDA201003	REMEDYREPACK INC.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1576_0c65bf4c-63bb-b5bc-e063-6294a90a5a96	70518-1576	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20181023		ANDA	ANDA071450	REMEDYREPACK INC.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70518-1582_faa19867-2e0c-e2dc-e053-6294a90a9818	70518-1582	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20181024		ANDA	ANDA076133	REMEDYREPACK INC.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1584_faa1c68a-9220-fdca-e053-6294a90a6a8f	70518-1584	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20181024		ANDA	ANDA076143	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-1585_0a984938-98b8-b96f-e063-6394a90aaa0b	70518-1585	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20181024		ANDA	ANDA078539	REMEDYREPACK INC.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70518-1586_05e1f96b-1774-21e5-e063-6294a90a9fee	70518-1586	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20181024		ANDA	ANDA077562	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1588_faa1f526-d95c-f82e-e053-6394a90a9b3c	70518-1588	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20181025		ANDA	ANDA040903	REMEDYREPACK INC.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-1594_01dd9f5e-974a-f233-e063-6294a90a6ef5	70518-1594	HUMAN PRESCRIPTION DRUG	glipizide and metformin hcl		glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20181026		ANDA	ANDA078728	REMEDYREPACK INC.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-1595_faa21cff-72e4-23ca-e053-6294a90a06e8	70518-1595	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20181026		ANDA	ANDA202556	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-1599_faa23f94-3fe3-1808-e053-6294a90aee89	70518-1599	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20181026		ANDA	ANDA077580	REMEDYREPACK INC.	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-1604_faa289ad-9bab-4b4b-e053-6294a90a066e	70518-1604	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20181026		ANDA	ANDA077565	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1605_faa33dce-a697-9d9e-e053-6394a90aa2ab	70518-1605	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20181026		ANDA	ANDA076255	REMEDYREPACK INC.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1606_0d1d76ea-019a-d426-e063-6294a90ac0c9	70518-1606	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181029		ANDA	ANDA077336	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-1611_030d29b5-26cc-4bff-e063-6394a90a8fe3	70518-1611	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20181029		ANDA	ANDA076255	REMEDYREPACK INC.	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1612_faa47fcd-2544-a946-e053-6294a90a05d2	70518-1612	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20181029		ANDA	ANDA084363	REMEDYREPACK INC.	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
70518-1613_030d7262-e6a9-4c16-e063-6394a90adf1a	70518-1613	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20181029		ANDA	ANDA201003	REMEDYREPACK INC.	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1615_030d82f1-e025-b934-e063-6394a90a35c5	70518-1615	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20181030		ANDA	ANDA202825	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1617_0a9b3755-c0dd-4282-e063-6394a90a0c08	70518-1617	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20181030		ANDA	ANDA077670	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1619_fdef6359-441f-d9f7-e053-6294a90a94f3	70518-1619	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20181031		ANDA	ANDA076001	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1623_0a9bea7b-a827-f4de-e063-6294a90aab60	70518-1623	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA078106	REMEDYREPACK INC.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1627_0bc402fc-f0a6-8ee5-e063-6394a90a1499	70518-1627	HUMAN PRESCRIPTION DRUG	Doxycyclate Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20181102		ANDA	ANDA062396	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-1630_0df8996c-a2d3-1280-e063-6394a90a4ffe	70518-1630	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20181105		ANDA	ANDA077929	REMEDYREPACK INC.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-1631_05de2a4c-6598-f02a-e063-6394a90ae73c	70518-1631	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20181105		ANDA	ANDA201003	REMEDYREPACK INC.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1633_030dd05a-e2d5-8d27-e063-6394a90a74c2	70518-1633	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20181105		ANDA	ANDA202446	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-1635_f2678e3c-6266-7611-e053-2995a90a3dba	70518-1635	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20181106		ANDA	ANDA076255	REMEDYREPACK INC.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1637_01e0d655-70d8-bf08-e063-6394a90aa813	70518-1637	HUMAN PRESCRIPTION DRUG	ketoconazole		ketoconazole	CREAM	TOPICAL	20181106		ANDA	ANDA076294	REMEDYREPACK INC.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-1638_fab9f77d-254a-fe10-e053-6394a90ae9f3	70518-1638	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride		Pioglitazone Hydrochloride	TABLET	ORAL	20181106	20250731	ANDA	ANDA200044	REMEDYREPACK INC.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	
70518-1640_fab9fbdb-50a7-a52f-e053-6294a90a0933	70518-1640	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20181107		ANDA	ANDA076118	REMEDYREPACK INC.	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-1641_faba59e5-eeb9-5e16-e053-6394a90ac6ea	70518-1641	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL	TABLET, FILM COATED	ORAL	20181107		ANDA	ANDA091448	REMEDYREPACK INC.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-1643_0a9bf7cb-9457-0328-e063-6294a90a9704	70518-1643	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20181007		NDA AUTHORIZED GENERIC	NDA021519	REMEDYREPACK INC.	FLUVOXAMINE MALEATE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1646_030e2f9f-f309-92cb-e063-6394a90af1aa	70518-1646	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20181107		ANDA	ANDA090937	REMEDYREPACK INC.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-1648_030e24c8-d69a-cada-e063-6294a90ab55b	70518-1648	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide		olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20181107	20240630	NDA AUTHORIZED GENERIC	NDA200175	REMEDYREPACK INC.	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
70518-1655_fabac923-0c36-e15b-e053-6394a90aa8db	70518-1655	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20181109		ANDA	ANDA077538	REMEDYREPACK INC.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-1656_030e22cc-e83f-90f4-e063-6394a90a0a0e	70518-1656	HUMAN PRESCRIPTION DRUG	Zidovudine		Zidovudine	TABLET	ORAL	20181108		ANDA	ANDA090092	REMEDYREPACK INC.	ZIDOVUDINE	300	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
70518-1657_facd2af7-53f3-37b3-e053-6394a90a4ba6	70518-1657	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	TABLET	ORAL	20181109		ANDA	ANDA084364	REMEDYREPACK INC.	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
70518-1662_0e764061-e7a3-6701-e063-6394a90a489f	70518-1662	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20181112		ANDA	ANDA073449	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-1663_fb2e406d-371b-0e34-e053-6294a90a2c0b	70518-1663	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20181112		ANDA	ANDA076410	REMEDYREPACK INC.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
70518-1664_030e7003-092b-b62f-e063-6394a90ad682	70518-1664	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20181112	20251130	ANDA	ANDA075657	REMEDYREPACK INC.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	
70518-1666_0aa9a918-977e-f816-e063-6294a90ad5af	70518-1666	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20181112		ANDA	ANDA200292	REMEDYREPACK INC.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70518-1676_facdf884-099c-f6a9-e053-6394a90ab7da	70518-1676	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20181116		ANDA	ANDA090510	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-1679_0b4d26d1-72ea-7689-e063-6294a90aeae7	70518-1679	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20181120		ANDA	ANDA078203	REMEDYREPACK INC.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1681_030efd44-9b44-b8d4-e063-6394a90a1340	70518-1681	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20181120		ANDA	ANDA090695	REMEDYREPACK INC.	LOXAPINE SUCCINATE	10	mg/1			N	20241231
70518-1682_0c50b401-60ac-7efd-e063-6294a90a93b9	70518-1682	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20181120		ANDA	ANDA091629	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-1685_030efd44-9b48-b8d4-e063-6394a90a1340	70518-1685	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20181121		ANDA	ANDA086242	REMEDYREPACK INC.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70518-1690_fa2f0650-fbc1-2bbd-e053-6294a90a183c	70518-1690	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20181123		ANDA	ANDA203071	REMEDYREPACK INC.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-1691_face2d84-bf36-4740-e053-6394a90a5d9c	70518-1691	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20181126	20240531	ANDA	ANDA204713	REMEDYREPACK INC.	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
70518-1692_05199f83-888a-a13e-e063-6394a90a30e1	70518-1692	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20181126		ANDA	ANDA204279	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-1705_0aabf9c9-53b5-07ce-e063-6294a90ad417	70518-1705	HUMAN OTC DRUG	Cetirizine		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20181203		ANDA	ANDA078336	REMEDYREPACK INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70518-1709_0e34cb09-d8c4-f8c0-e063-6294a90a0be0	70518-1709	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20181204	20240630	ANDA	ANDA204713	REMEDYREPACK INC.	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
70518-1713_030f218c-4475-9e91-e063-6394a90a2808	70518-1713	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20181206		ANDA	ANDA071321	REMEDYREPACK INC.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1718_030f429c-1291-ee8d-e063-6294a90a14c2	70518-1718	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20181207		ANDA	ANDA078235	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1723_0ae8bedc-337a-d90a-e063-6294a90ae9ed	70518-1723	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20181210		ANDA	ANDA209312	REMEDYREPACK INC.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-1730_0b5f5e7b-0fe1-a342-e063-6294a90ad2c8	70518-1730	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20181213		ANDA	ANDA040787	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-1735_0e7645b5-71a7-72fb-e063-6394a90ae398	70518-1735	HUMAN PRESCRIPTION DRUG	Polymyxin B Sulfate and Trimethoprim		Polymyxin B Sulfate and Trimethoprim	SOLUTION	OPHTHALMIC	20181214		ANDA	ANDA064211	REMEDYREPACK INC.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
70518-1738_fae2cde1-8276-0bab-e053-6394a90a936f	70518-1738	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20181217		ANDA	ANDA209312	REMEDYREPACK INC.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-1742_030f8be6-df68-8128-e063-6394a90a3da2	70518-1742	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20181218		ANDA	ANDA203512	REMEDYREPACK INC.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-1743_01f07b33-722e-afcf-e063-6394a90ae9e6	70518-1743	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20181218		ANDA	ANDA077714	REMEDYREPACK INC.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
70518-1746_030fe60f-28f8-3901-e063-6394a90a4aad	70518-1746	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20181220		ANDA	ANDA203512	REMEDYREPACK INC.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-1747_03242155-16f6-bdcc-e063-6294a90a1a8c	70518-1747	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20181221		ANDA	ANDA075022	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
70518-1748_0aac17cf-fc14-0b08-e063-6394a90a980c	70518-1748	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20190108		ANDA	ANDA077206	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1749_0bc36e68-c9aa-cb19-e063-6294a90aaa0a	70518-1749	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	CAPSULE, COATED PELLETS	ORAL	20181227		ANDA	ANDA078919	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1752_fb312032-663e-9b17-e053-6394a90a0744	70518-1752	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride		Chlordiazepoxide Hydrochloride	CAPSULE	ORAL	20181227		ANDA	ANDA083116	REMEDYREPACK INC.	CHLORDIAZEPOXIDE HYDROCHLORIDE	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-1753_fb317988-a4b1-9c9a-e053-6294a90a5990	70518-1753	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20181227		ANDA	ANDA090702	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-1755_fb319a97-b3b6-3ce0-e053-6394a90a68a9	70518-1755	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20181231		ANDA	ANDA203455	REMEDYREPACK INC.	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1756_f64107d9-af1a-2171-e053-2995a90ad75c	70518-1756	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20190101		ANDA	ANDA072575	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1758_fb31c57f-f2a4-61a4-e053-6394a90a19b8	70518-1758	HUMAN PRESCRIPTION DRUG	Depakote	ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20190101	20240621	NDA	NDA021168	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
70518-1760_05ddcdfa-0f86-5fc6-e063-6294a90ac6a8	70518-1760	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20190101		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1764_0335e1df-021a-b58d-e063-6294a90ac554	70518-1764	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20190102		ANDA	ANDA076255	REMEDYREPACK INC.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1765_0aad75f9-d7f2-08fc-e063-6394a90a29ce	70518-1765	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190102		ANDA	ANDA090694	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1766_f6416c1e-ea0e-f49c-e053-2a95a90a4903	70518-1766	HUMAN PRESCRIPTION DRUG	metformin hydrochloride		metformin hydrochloride	TABLET	ORAL	20190102		ANDA	ANDA090564	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-1767_02078e3c-532c-ed23-e063-6394a90a40e8	70518-1767	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20190102		ANDA	ANDA040230	REMEDYREPACK INC.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70518-1769_f6419680-82d2-0cda-e053-2a95a90a1cfa	70518-1769	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20190102		ANDA	ANDA078115	REMEDYREPACK INC.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1771_0336c8df-3f6f-4f98-e063-6394a90a3a00	70518-1771	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20190102		ANDA	ANDA201003	REMEDYREPACK INC.	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1772_0aaddde9-431d-a828-e063-6294a90a26d5	70518-1772	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190102		ANDA	ANDA078154	REMEDYREPACK INC.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1776_fb32d65a-9bbb-dab7-e053-6394a90aa1e2	70518-1776	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20190103		ANDA	ANDA040684	REMEDYREPACK INC.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1781_0bc365ef-711b-81c6-e063-6294a90a066a	70518-1781	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190107		ANDA	ANDA202419	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1784_0c3e891a-77eb-4d02-e063-6294a90af78b	70518-1784	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, COATED	ORAL	20190109		ANDA	ANDA201582	REMEDYREPACK INC.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
70518-1785_033757da-dcb1-8cb0-e063-6294a90aabb4	70518-1785	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20190109		ANDA	ANDA202389	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1788_0aadd43a-a229-4f78-e063-6394a90a1499	70518-1788	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20190111		ANDA	ANDA202038	REMEDYREPACK INC.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-1789_0337a065-a107-34ae-e063-6294a90a20a2	70518-1789	HUMAN PRESCRIPTION DRUG	fluvoxamine maleate		Fluvoxamine maleate	TABLET, COATED	ORAL	20190111		NDA AUTHORIZED GENERIC	NDA021519	REMEDYREPACK INC.	FLUVOXAMINE MALEATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1790_f641bd6a-46fc-261b-e053-2995a90aff27	70518-1790	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20210319		ANDA	ANDA076180	REMEDYREPACK INC.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-1792_0b2299ed-6cf5-297f-e063-6294a90a9499	70518-1792	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20190111		ANDA	ANDA090695	REMEDYREPACK INC.	LOXAPINE SUCCINATE	50	mg/1			N	20241231
70518-1793_0aae69f1-66c4-a199-e063-6394a90a3d75	70518-1793	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20190111	20240831	ANDA	ANDA088262	REMEDYREPACK INC.	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
70518-1795_f2653e2a-c171-2b57-e053-2a95a90a42de	70518-1795	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20190111		ANDA	ANDA091497	REMEDYREPACK INC.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-1796_0337fc06-59f1-642d-e063-6294a90a749f	70518-1796	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190114		ANDA	ANDA090515	REMEDYREPACK INC.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1804_0d1d9e1e-37c6-fd6e-e063-6294a90af5df	70518-1804	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20190117		ANDA	ANDA202824	REMEDYREPACK INC.	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1805_03381a95-0e8d-1040-e063-6394a90af47a	70518-1805	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20190117		ANDA	ANDA202389	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1806_fb483e5f-a6d1-3d2b-e053-6294a90af03f	70518-1806	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20190118		ANDA	ANDA203154	REMEDYREPACK INC.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70518-1807_033817a9-f6c9-65c4-e063-6294a90aff88	70518-1807	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20190121		ANDA	ANDA077662	REMEDYREPACK INC.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1808_03384c10-4ecc-0342-e063-6394a90a0515	70518-1808	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20190121		ANDA	ANDA065123	REMEDYREPACK INC.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
70518-1811_fb6af217-ae4e-1f51-e053-6294a90a6bb7	70518-1811	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20190123		ANDA	ANDA070976	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-1819_0aaf33b6-1e73-c897-e063-6294a90ae317	70518-1819	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190124		ANDA	ANDA208898	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1826_0aaf45f2-f8a6-23ed-e063-6394a90a5786	70518-1826	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20190126		ANDA	ANDA077614	REMEDYREPACK INC.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1827_0aaf392b-0d27-de6f-e063-6294a90a539b	70518-1827	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190126		ANDA	ANDA078154	REMEDYREPACK INC.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1828_0ae8afc0-46b3-56ab-e063-6394a90a171a	70518-1828	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20190128		ANDA	ANDA077921	REMEDYREPACK INC.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1829_091cf85b-dcd7-92a0-e063-6294a90aa4f7	70518-1829	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20190128		NDA AUTHORIZED GENERIC	NDA007073	REMEDYREPACK INC.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70518-1831_f641e7f1-1230-1034-e053-2a95a90ac10b	70518-1831	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190130		ANDA	ANDA078703	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1834_05d079c1-9401-e068-e063-6294a90a8ea6	70518-1834	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20190130		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1835_0abee4a1-f7b3-5aa0-e063-6294a90a335d	70518-1835	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20190130		ANDA	ANDA077565	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-1838_036ebdc5-986d-a9d2-e063-6394a90ad55a	70518-1838	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20190130		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	15	mg/1			N	20241231
70518-1842_fe1c44c6-61cd-374a-e053-6294a90a7b30	70518-1842	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20190201		ANDA	ANDA077794	REMEDYREPACK INC.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1844_fb7fa9b0-4433-aab0-e053-6394a90ae10e	70518-1844	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190204		ANDA	ANDA202659	REMEDYREPACK INC.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-1848_0d1dca99-e104-f2d3-e063-6394a90a9128	70518-1848	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190204		ANDA	ANDA204720	REMEDYREPACK INC.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-1858_fce8382f-c291-4ac3-e053-6394a90a3f05	70518-1858	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20190207		ANDA	ANDA091497	REMEDYREPACK INC.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-1860_036f228a-759f-4a17-e063-6294a90a7e12	70518-1860	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA078155	REMEDYREPACK INC.	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1861_fb80547e-d8fd-0716-e053-6294a90a5d7d	70518-1861	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20190208		NDA	NDA202155	REMEDYREPACK INC.	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
70518-1876_036f4d96-bdec-341a-e063-6294a90af69d	70518-1876	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20190215		ANDA	ANDA202389	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1877_0c5327cb-af98-7daf-e063-6394a90a8718	70518-1877	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20190215		ANDA	ANDA075511	REMEDYREPACK INC.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70518-1878_f64fd553-0faa-44e1-e053-2a95a90a112b	70518-1878	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20190218		ANDA	ANDA090455	REMEDYREPACK INC.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
70518-1880_0567990e-636d-af14-e063-6294a90a726f	70518-1880	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20190219		ANDA	ANDA065434	REMEDYREPACK INC.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-1884_0abfc30e-f961-121e-e063-6294a90a965d	70518-1884	HUMAN PRESCRIPTION DRUG	Prazosin		prazosin hydrochloride	CAPSULE	ORAL	20190219		NDA AUTHORIZED GENERIC	NDA017442	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1895_0d1dd2c2-ab07-fcc6-e063-6294a90ac460	70518-1895	HUMAN PRESCRIPTION DRUG	Prazosin		prazosin hydrochloride	CAPSULE	ORAL	20190221		NDA AUTHORIZED GENERIC	NDA017442	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-1896_036f76df-495a-9f8c-e063-6394a90ac976	70518-1896	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20190221		ANDA	ANDA090695	REMEDYREPACK INC.	LOXAPINE SUCCINATE	25	mg/1			N	20241231
70518-1897_0b4f6c20-f957-7bae-e063-6294a90a5246	70518-1897	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190222		ANDA	ANDA202419	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-1898_0ac046b4-e2c7-a82a-e063-6294a90a6205	70518-1898	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20190222		ANDA	ANDA090540	REMEDYREPACK INC.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
70518-1901_f65080d1-d9fe-31a7-e053-2995a90a2aaf	70518-1901	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190222		ANDA	ANDA090515	REMEDYREPACK INC.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1903_036fbb4c-cc94-062d-e063-6294a90adeb2	70518-1903	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, EXTENDED RELEASE	ORAL	20190225		ANDA	ANDA076201	REMEDYREPACK INC.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-1906_0ac19437-e8e7-c11e-e063-6294a90acc16	70518-1906	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20181029		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-1907_0ac1c9b1-40d8-bb71-e063-6394a90aa45e	70518-1907	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20190225		ANDA	ANDA090555	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1908_036fe76f-e584-5ee7-e063-6294a90affb9	70518-1908	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20190225		ANDA	ANDA090170	REMEDYREPACK INC.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-1910_09b89aa8-3016-7606-e063-6394a90ac279	70518-1910	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR	20190226		NDA AUTHORIZED GENERIC	NDA019430	REMEDYREPACK INC.	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-1917_0ac1f742-681e-f508-e063-6294a90a964b	70518-1917	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20190227		ANDA	ANDA078216	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-1921_0ae8f4c8-be66-0095-e063-6294a90a9f7e	70518-1921	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190228		ANDA	ANDA078154	REMEDYREPACK INC.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1922_fe30c879-b3b7-3f9f-e053-6394a90a6659	70518-1922	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190228		ANDA	ANDA207442	REMEDYREPACK INC.	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-1928_fb831f54-3cd9-c129-e053-6394a90a6fbd	70518-1928	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20190301		ANDA	ANDA202239	REMEDYREPACK INC.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-1937_fe305cf5-8f93-93cf-e053-6294a90a6d1a	70518-1937	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA078235	REMEDYREPACK INC.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1938_f6510364-d41a-7ac3-e053-2995a90a62cb	70518-1938	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20190306		ANDA	ANDA076341	REMEDYREPACK INC.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1939_fe3f2602-d3ea-2bb2-e053-6294a90a6649	70518-1939	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20190306		ANDA	ANDA204742	REMEDYREPACK INC.	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-1940_0c40eacd-c986-a1c0-e063-6394a90a383a	70518-1940	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190307		ANDA	ANDA204582	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
70518-1941_f82500f3-23cc-bd19-e053-6394a90adffd	70518-1941	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20190308		ANDA	ANDA209823	REMEDYREPACK INC.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70518-1946_0c8e9634-be65-5a02-e063-6394a90af2c4	70518-1946	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20190311		ANDA	ANDA207687	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1951_f6514a42-bf0e-5d85-e053-2995a90a00ae	70518-1951	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA203769	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-1953_fe3f9956-1fe4-81d4-e053-6294a90a4e9e	70518-1953	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20190313		ANDA	ANDA078235	REMEDYREPACK INC.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1954_05e2db2d-4086-1690-e063-6294a90a987c	70518-1954	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20190313		ANDA	ANDA070176	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-1955_fe403207-dfa9-b597-e053-6394a90a8a6b	70518-1955	HUMAN PRESCRIPTION DRUG	Ezetimibe and Simvastatin		Ezetimibe and Simvastatin	TABLET	ORAL	20190313		ANDA	ANDA209222	REMEDYREPACK INC.	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1959_03705afb-8c63-2cb3-e063-6294a90a6aa9	70518-1959	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20190314		ANDA	ANDA070975	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-1962_fe3ff918-21b7-0972-e053-6294a90a9a48	70518-1962	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20190318		ANDA	ANDA070974	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-1967_fe2f644f-cda0-b373-e053-6294a90aa20d	70518-1967	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20190320		ANDA	ANDA040521	REMEDYREPACK INC.	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1971_03705afb-8c67-2cb3-e063-6294a90a6aa9	70518-1971	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20190320		ANDA	ANDA078925	REMEDYREPACK INC.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-1976_0aea43c4-b0ed-2500-e063-6394a90ad58f	70518-1976	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20190325		ANDA	ANDA090555	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-1977_fe4115a3-30bf-3c75-e053-6294a90ad9dc	70518-1977	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20190325		ANDA	ANDA207687	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-1978_f651257e-2a63-89ae-e053-2a95a90a2f56	70518-1978	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20190325		ANDA	ANDA090170	REMEDYREPACK INC.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-1980_fe4148d9-3738-012a-e053-6394a90a76b8	70518-1980	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA077794	REMEDYREPACK INC.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1981_0bc3ad97-fd1e-7d69-e063-6394a90a77d4	70518-1981	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20190326		ANDA	ANDA078888	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
70518-1998_0aea8325-d096-14a5-e063-6294a90a123c	70518-1998	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190402		ANDA	ANDA090025	REMEDYREPACK INC.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-1999_07ff001d-eebe-6d30-e063-6294a90ae811	70518-1999	HUMAN PRESCRIPTION DRUG	tamsulosin hydrochloride		tamsulosin hydrochloride	CAPSULE	ORAL	20190402		ANDA	ANDA078015	REMEDYREPACK INC.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-2001_fe41a7bb-f49f-411f-e053-6394a90afd7e	70518-2001	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20190403		ANDA	ANDA078235	REMEDYREPACK INC.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2003_0aea93d4-7b04-5bcc-e063-6394a90a6bd7	70518-2003	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190408		ANDA	ANDA202419	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2009_0aeae27c-d4e9-8c66-e063-6294a90aba0a	70518-2009	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20190411		ANDA	ANDA078296	REMEDYREPACK INC.	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2014_0e88a32d-7c62-1344-e063-6394a90a8946	70518-2014	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20190412		ANDA	ANDA078633	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20251231
70518-2017_fe438d15-8f9c-16de-e053-6394a90ade31	70518-2017	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20190413		ANDA	ANDA079163	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2024_f652a0c8-e1db-cbdd-e053-2995a90a58f2	70518-2024	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20190416		ANDA	ANDA200981	REMEDYREPACK INC.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2029_0c645151-9c79-9a6f-e063-6394a90abc30	70518-2029	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190418		ANDA	ANDA079095	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-2031_037128d8-4b15-4e4c-e063-6394a90af681	70518-2031	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190418		ANDA	ANDA204582	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
70518-2036_09b960d9-3b0e-d89b-e063-6394a90af783	70518-2036	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20190424		ANDA	ANDA203730	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2037_0aeb6573-850e-f984-e063-6394a90a1954	70518-2037	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION	OPHTHALMIC	20190425		ANDA	ANDA078559	REMEDYREPACK INC.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70518-2039_06d0094f-04da-d4da-e063-6294a90ad2ca	70518-2039	HUMAN PRESCRIPTION DRUG	VALTREX		valacyclovir hydrochloride	TABLET, FILM COATED	ORAL	20190426		NDA	NDA020487	REMEDYREPACK INC.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2047_0aebc5ba-d612-f46f-e063-6294a90a1131	70518-2047	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20190429	20240131	ANDA	ANDA088276	REMEDYREPACK INC.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	
70518-2048_01f1d964-d6ac-96c2-e063-6294a90ad492	70518-2048	HUMAN PRESCRIPTION DRUG	epinephrine		epinephrine	INJECTION	SUBCUTANEOUS	20190429		NDA AUTHORIZED GENERIC	NDA020800	REMEDYREPACK INC.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-2051_0aebf422-6de5-46b3-e063-6394a90aef76	70518-2051	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190430		ANDA	ANDA210497	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-2052_f4d6b194-4f59-eeb9-e053-2995a90abd00	70518-2052	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20190430		ANDA	ANDA202433	REMEDYREPACK INC.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-2055_0b232ea7-2471-643f-e063-6294a90afb8e	70518-2055	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190501		ANDA	ANDA208898	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2058_0371e0af-8944-2c43-e063-6394a90a467d	70518-2058	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20190502		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	7.5	mg/1			N	20241231
70518-2066_fe8fecd0-fef9-57b6-e053-6294a90a0107	70518-2066	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20190507		ANDA	ANDA088618	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2080_f2a43424-2498-5b2e-e053-2a95a90a0e6b	70518-2080	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190514		ANDA	ANDA078889	REMEDYREPACK INC.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2085_03720a45-cf8a-868c-e063-6394a90a9204	70518-2085	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20190516		ANDA	ANDA074891	REMEDYREPACK INC.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2086_f654f651-6242-1c2d-e053-2995a90a48ff	70518-2086	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20190516		ANDA	ANDA205663	REMEDYREPACK INC.	LITHIUM CARBONATE	450	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-2090_0b2398f7-d678-8cda-e063-6294a90a164d	70518-2090	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA208898	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2095_03729efb-0e89-d4b1-e063-6394a90a2d30	70518-2095	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA040209	REMEDYREPACK INC.	TRIFLUOPERAZINE HYDROCHLORIDE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-2098_0b23a456-92a5-fb56-e063-6294a90a32f1	70518-2098	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20190522		ANDA	ANDA203244	REMEDYREPACK INC.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2102_0b23ecb5-3546-aded-e063-6394a90ad650	70518-2102	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20190522		ANDA	ANDA201109	REMEDYREPACK INC.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2104_0d937692-de8a-33aa-e063-6394a90a12de	70518-2104	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20190522		ANDA	ANDA078235	REMEDYREPACK INC.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2106_037356c2-e2b9-a9f1-e063-6294a90ada39	70518-2106	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		trifluoperazine hydrochloride	TABLET, FILM COATED	ORAL	20190523		ANDA	ANDA040209	REMEDYREPACK INC.	TRIFLUOPERAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-2107_05ce29de-bcb1-70ed-e063-6394a90a85f6	70518-2107	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190523		ANDA	ANDA200834	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2108_0c3ed6fe-8dc6-0496-e063-6394a90add56	70518-2108	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20190523		ANDA	ANDA078525	REMEDYREPACK INC.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-2109_0b24075d-23f3-bf3a-e063-6394a90a07f1	70518-2109	HUMAN PRESCRIPTION DRUG	Keppra	XR	levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190523		NDA	NDA022285	REMEDYREPACK INC.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2115_f654bb0d-4873-1b21-e053-2a95a90a2369	70518-2115	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20190523		ANDA	ANDA088832	REMEDYREPACK INC.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2117_03739956-c44f-dd93-e063-6294a90a9bc0	70518-2117	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20190528		ANDA	ANDA203834	REMEDYREPACK INC.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2121_0b251a58-3094-dfec-e063-6294a90a3b45	70518-2121	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA200834	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2122_0373b055-12d1-e970-e063-6394a90a1904	70518-2122	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20190529		ANDA	ANDA075522	REMEDYREPACK INC.	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70518-2125_0373f989-69ac-0332-e063-6394a90a8240	70518-2125	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20190531		ANDA	ANDA076118	REMEDYREPACK INC.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-2127_fe93a337-8cfd-35d3-e053-6294a90acb3c	70518-2127	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20190603		ANDA	ANDA207662	REMEDYREPACK INC.	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-2128_f6558454-52ac-2893-e053-2a95a90a2a37	70518-2128	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190604		ANDA	ANDA202659	REMEDYREPACK INC.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-2129_fe93fce1-409a-b35b-e053-6294a90af4ed	70518-2129	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20190604		ANDA	ANDA200268	REMEDYREPACK INC.	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
70518-2130_0b254d47-c39c-7a85-e063-6394a90a2f95	70518-2130	HUMAN PRESCRIPTION DRUG	risperidone		risperidone	TABLET, FILM COATED	ORAL	20190605		ANDA	ANDA078040	REMEDYREPACK INC.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2132_0d1dfe51-f03b-f1fe-e063-6394a90ae5c6	70518-2132	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20190605		ANDA	ANDA090083	REMEDYREPACK INC.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-2133_0b258621-bb05-5f4b-e063-6294a90a1819	70518-2133	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190606		ANDA	ANDA204106	REMEDYREPACK INC.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2134_0b25c8b8-9412-ca9a-e063-6294a90ab998	70518-2134	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190606		ANDA	ANDA078619	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2135_0b25ff8d-f055-f82f-e063-6294a90af572	70518-2135	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20190607		NDA AUTHORIZED GENERIC	NDA012462	REMEDYREPACK INC.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
70518-2138_fea7e69f-0e20-fd5a-e053-6394a90ad9da	70518-2138	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20190612		ANDA	ANDA087342	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2139_0b2603b6-0be9-b418-e063-6294a90abf32	70518-2139	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20190610		ANDA	ANDA207761	REMEDYREPACK INC.	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2141_0b262858-1daf-15f5-e063-6294a90afdf0	70518-2141	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190611		ANDA	ANDA079170	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2147_0b264b86-d171-0254-e063-6394a90a3179	70518-2147	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20190614		ANDA	ANDA207810	REMEDYREPACK INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-2153_0c8e4c1a-045d-5ab6-e063-6294a90a332f	70518-2153	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190626		ANDA	ANDA207402	REMEDYREPACK INC.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70518-2159_f7f8f606-436f-70dc-e053-6294a90afa75	70518-2159	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20190627		ANDA	ANDA088619	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2169_030f92bf-a135-0ef3-e063-6294a90ab464	70518-2169	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20190628		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
70518-2170_0320f3d3-4817-462f-e063-6294a90a0c52	70518-2170	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20190628		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
70518-2175_f7e5a410-7285-b778-e053-6294a90a79a7	70518-2175	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA202674	REMEDYREPACK INC.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2177_fea9548e-72b9-277a-e053-6394a90add93	70518-2177	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20190701		ANDA	ANDA210971	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-2178_05cbd6e9-a71b-3e3b-e063-6394a90af405	70518-2178	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20190701		ANDA	ANDA210971	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-2180_fea953d0-1920-60d1-e053-6294a90a9e8a	70518-2180	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20190701		ANDA	ANDA205253	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-2183_fea9a85f-0506-9427-e053-6394a90abeb1	70518-2183	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20190702		ANDA	ANDA202824	REMEDYREPACK INC.	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-2184_feb8eafb-68f1-ec29-e053-6294a90aae77	70518-2184	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190709		ANDA	ANDA071881	REMEDYREPACK INC.	VERAPAMIL HYDROCHLORIDE	80	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-2185_f6673514-5087-7ebd-e053-2a95a90a89cd	70518-2185	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	20190702	20240229	ANDA	ANDA075463	REMEDYREPACK INC.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70518-2188_f6677288-ae29-3f25-e053-2995a90a5dc6	70518-2188	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20190709		ANDA	ANDA064076	REMEDYREPACK INC.	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-2190_0b27559c-8830-b387-e063-6394a90a0a74	70518-2190	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20190709		ANDA	ANDA064076	REMEDYREPACK INC.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-2191_feb9cfa6-2295-4429-e053-6294a90a159b	70518-2191	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20190709		ANDA	ANDA065256	REMEDYREPACK INC.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-2193_f667a33f-b035-2e7f-e053-2995a90ac4f3	70518-2193	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20190709		ANDA	ANDA200981	REMEDYREPACK INC.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2196_03850f1a-fb0a-4962-e063-6294a90ac799	70518-2196	HUMAN PRESCRIPTION DRUG	glipizide and metformin hcl		glipizide and metformin hcl	TABLET, FILM COATED	ORAL	20190709		ANDA	ANDA078728	REMEDYREPACK INC.	GLIPIZIDE; METFORMIN HYDROCHLORIDE	2.5; 250	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-2203_f7e5dacd-0ba4-4ac4-e053-6394a90a457a	70518-2203	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20190710		ANDA	ANDA078895	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-2208_f6692bc1-e6c1-56fd-e053-2995a90a8b90	70518-2208	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20190711		ANDA	ANDA077027	REMEDYREPACK INC.	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
70518-2216_0b279036-7887-023a-e063-6294a90a15e4	70518-2216	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride		buprenorphine hydrochloride	TABLET	SUBLINGUAL	20190715	20250331	ANDA	ANDA090622	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	
70518-2217_03859559-a744-09c5-e063-6294a90ab890	70518-2217	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20190715		ANDA	ANDA207276	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-2225_03241bf4-2d94-9933-e063-6394a90a435a	70518-2225	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20190719		ANDA	ANDA091568	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-2226_0bda1a2c-d2fb-f957-e063-6394a90a965d	70518-2226	HUMAN PRESCRIPTION DRUG	Buprenorphine HCl		Buprenorphine HCl	TABLET	SUBLINGUAL	20190719		ANDA	ANDA078633	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE	2	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-2227_0b36729f-64a6-9eae-e063-6294a90a8d3c	70518-2227	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20190719		ANDA	ANDA204309	REMEDYREPACK INC.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2228_08010b5e-853b-096b-e063-6294a90ad443	70518-2228	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20190713		ANDA	ANDA077534	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2230_f66958b1-c384-d8fb-e053-2995a90a7c8b	70518-2230	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20190723		ANDA	ANDA090515	REMEDYREPACK INC.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2232_febd8ae0-ef93-f0ff-e053-6294a90ad1a5	70518-2232	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20190723		ANDA	ANDA077147	REMEDYREPACK INC.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2235_febd8ce9-c529-6a58-e053-6394a90a411f	70518-2235	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190725		ANDA	ANDA075410	REMEDYREPACK INC.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-2242_091cc039-6107-7114-e063-6294a90a03af	70518-2242	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20190731		ANDA	ANDA074649	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2245_0b36ed9f-c8ed-85b0-e063-6394a90a6f86	70518-2245	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20190801		ANDA	ANDA202910	REMEDYREPACK INC.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-2246_0b3706cd-8253-afa5-e063-6394a90ace18	70518-2246	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20190801		ANDA	ANDA202910	REMEDYREPACK INC.	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-2247_03860060-e110-d410-e063-6294a90a9ca1	70518-2247	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA077369	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2249_fed1660e-9cf4-0298-e053-6394a90af296	70518-2249	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20190802	20250721	ANDA	ANDA200839	REMEDYREPACK INC.	LEVOFLOXACIN	250	mg/1			N	
70518-2250_091bf671-be41-26fd-e063-6394a90afbc9	70518-2250	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20190802		ANDA	ANDA076749	REMEDYREPACK INC.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	3; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70518-2253_0b3740eb-9053-335a-e063-6294a90a93df	70518-2253	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20190805		ANDA	ANDA078069	REMEDYREPACK INC.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2254_0b37bfd0-426b-16e7-e063-6394a90aeb68	70518-2254	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20190805		ANDA	ANDA078069	REMEDYREPACK INC.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2258_0386afa4-b465-6e2a-e063-6294a90a1ecc	70518-2258	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190809		ANDA	ANDA202446	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-2259_09413dec-15d2-0ec8-e063-6294a90a191c	70518-2259	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190809		ANDA	ANDA200834	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2263_f897099d-910b-3a25-e053-6294a90af62c	70518-2263	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20190812		ANDA	ANDA204755	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-2266_0387bea1-488c-7afa-e063-6394a90a3417	70518-2266	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20190815		ANDA	ANDA090682	REMEDYREPACK INC.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2271_01de5a17-b6e5-c169-e063-6394a90af6b5	70518-2271	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20190819		ANDA	ANDA065352	REMEDYREPACK INC.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-2273_0d1a2d97-164d-4eab-e063-6294a90a0cda	70518-2273	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20190819		ANDA	ANDA090836	REMEDYREPACK INC.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-2276_0b386972-f108-f9a4-e063-6294a90a66a7	70518-2276	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20190822		ANDA	ANDA078069	REMEDYREPACK INC.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2279_0425da9b-867e-8fa0-e063-6394a90a1b36	70518-2279	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20190824		ANDA	ANDA088618	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2283_f6785591-c77c-3707-e053-2a95a90ad4aa	70518-2283	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20190826		ANDA	ANDA090589	REMEDYREPACK INC.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-2287_039775c8-836a-bd1f-e063-6294a90a3af3	70518-2287	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, COATED	ORAL	20190827		ANDA	ANDA207750	REMEDYREPACK INC.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70518-2293_0b39196d-61a9-aa3a-e063-6294a90a4feb	70518-2293	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20190903		ANDA	ANDA040684	REMEDYREPACK INC.	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2294_0b3909fb-0cac-ace3-e063-6294a90afa84	70518-2294	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20190903		ANDA	ANDA077565	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2295_0b3996de-237a-424c-e063-6394a90aac6e	70518-2295	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190903		ANDA	ANDA075757	REMEDYREPACK INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-2296_03985586-d2c3-920d-e063-6394a90a96c3	70518-2296	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20190903		ANDA	ANDA201507	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2299_f6787d2b-c2b9-072f-e053-2995a90afff7	70518-2299	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20190904		ANDA	ANDA204319	REMEDYREPACK INC.	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2301_0398573a-44fe-e0c6-e063-6394a90a9924	70518-2301	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190904		ANDA	ANDA065169	REMEDYREPACK INC.	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-2304_0b39d61b-222d-5fcf-e063-6394a90a5a9c	70518-2304	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20190909		ANDA	ANDA201451	REMEDYREPACK INC.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70518-2305_0b39fa41-ac79-6bef-e063-6394a90aa22e	70518-2305	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20190909		ANDA	ANDA203458	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-2308_0399996f-482a-bc32-e063-6394a90ae96c	70518-2308	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190911		ANDA	ANDA204720	REMEDYREPACK INC.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-2312_f7e38f90-9086-a9d9-e053-6294a90a639d	70518-2312	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20190913		ANDA	ANDA079139	REMEDYREPACK INC.	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-2314_f52581a6-7bc2-509c-e053-2995a90a7490	70518-2314	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20190916		ANDA	ANDA085161	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2317_0d1e7bc3-572a-2483-e063-6394a90a038e	70518-2317	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20190909		ANDA	ANDA078032	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2323_f2630912-8eac-cdf4-e053-2995a90a2c0b	70518-2323	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20190924		ANDA	ANDA200651	REMEDYREPACK INC.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2325_0d1ea4c6-d8bc-8d9a-e063-6294a90a2e68	70518-2325	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20190924		ANDA	ANDA065093	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-2326_039a963d-4e10-32ec-e063-6294a90af75a	70518-2326	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20190926		ANDA	ANDA202894	REMEDYREPACK INC.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2334_039acca9-61c9-afcf-e063-6394a90a105f	70518-2334	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20191001		ANDA	ANDA077147	REMEDYREPACK INC.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2342_039b8b45-79ac-65c8-e063-6394a90a2b86	70518-2342	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20191003	20240430	ANDA	ANDA085828	REMEDYREPACK INC.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	
70518-2344_039b7484-9cb0-0d40-e063-6294a90a422c	70518-2344	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20191004		ANDA	ANDA065170	REMEDYREPACK INC.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
70518-2345_09049c73-5d71-dc91-e063-6294a90a05a8	70518-2345	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	20191004		NDA	NDA017812	REMEDYREPACK INC.	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-2347_039be0d9-d480-685a-e063-6294a90ad14c	70518-2347	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20191004		ANDA	ANDA207662	REMEDYREPACK INC.	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-2350_039cd90c-ecd9-73fd-e063-6294a90a5b7c	70518-2350	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20191008		ANDA	ANDA201507	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2352_026d8220-869e-bdb4-e063-6394a90a0d07	70518-2352	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20191008		ANDA	ANDA075673	REMEDYREPACK INC.	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2356_f4d52783-b81a-ed9a-e053-2995a90a3e70	70518-2356	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA200651	REMEDYREPACK INC.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2357_0b3cf4c5-c49d-15b9-e063-6294a90a2b5c	70518-2357	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20191010		ANDA	ANDA090554	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2358_0b4acee8-808e-f767-e063-6394a90a844d	70518-2358	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191010		ANDA	ANDA210363	REMEDYREPACK INC.	DIAZEPAM	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2362_03fb7159-6f0c-75a7-e063-6294a90a5ce7	70518-2362	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20191011		ANDA	ANDA078169	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2363_03fbd386-9187-0b9a-e063-6394a90ac400	70518-2363	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20191016		ANDA	ANDA090121	REMEDYREPACK INC.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70518-2364_03fc0b25-7921-b400-e063-6394a90aeb61	70518-2364	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191016		ANDA	ANDA209743	REMEDYREPACK INC.	PREGABALIN	100	mg/1		CV	N	20241231
70518-2368_f67a5a6b-15c3-1873-e053-2a95a90a3601	70518-2368	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20191019		ANDA	ANDA040197	REMEDYREPACK INC.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-2369_0b4b01fb-da52-4326-e063-6394a90aa524	70518-2369	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20191019		ANDA	ANDA040197	REMEDYREPACK INC.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-2370_0b4c7578-1fff-dcc3-e063-6294a90ac305	70518-2370	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20191019		ANDA	ANDA078069	REMEDYREPACK INC.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2372_0b4cb7df-0790-1214-e063-6294a90a76c5	70518-2372	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20191021	20240331	NDA AUTHORIZED GENERIC	NDA021160	REMEDYREPACK INC.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	
70518-2373_03fe2996-6694-5973-e063-6294a90a5b95	70518-2373	HUMAN PRESCRIPTION DRUG	SSD Cream		Silver Sulfadiazine	CREAM	TOPICAL	20191021		NDA	NDA018578	REMEDYREPACK INC.	SILVER SULFADIAZINE	10	g/1000g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
70518-2374_03fe2996-6696-5973-e063-6294a90a5b95	70518-2374	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20191022		ANDA	ANDA077565	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2376_03fe7e0f-4839-1698-e063-6294a90a437f	70518-2376	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20191023		ANDA	ANDA203854	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2377_0b4cfc83-e7b1-549f-e063-6294a90af58a	70518-2377	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20191023		ANDA	ANDA078069	REMEDYREPACK INC.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2381_f67afbe2-fcb8-80ab-e053-2a95a90a6cda	70518-2381	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20191023		ANDA	ANDA202202	REMEDYREPACK INC.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-2382_f67b1f0c-d85b-1be9-e053-2a95a90acd06	70518-2382	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20191023		ANDA	ANDA202202	REMEDYREPACK INC.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-2384_065c53a2-35cf-24d4-e063-6394a90a0e5d	70518-2384	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20191024		ANDA	ANDA205936	REMEDYREPACK INC.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-2385_0b4d68c6-6eeb-c136-e063-6394a90ad95b	70518-2385	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20191024		ANDA	ANDA205936	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-2386_0b4d8336-4e76-df4f-e063-6294a90acb2b	70518-2386	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20191024		ANDA	ANDA205936	REMEDYREPACK INC.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-2387_0a9af55a-7fee-fc71-e063-6394a90a708a	70518-2387	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20191024		ANDA	ANDA203854	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2390_03ff88e3-61a3-0828-e063-6294a90ab37b	70518-2390	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20191025		ANDA	ANDA077568	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-2391_03ff9378-ca2d-e17e-e063-6394a90a838b	70518-2391	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20191028		ANDA	ANDA076343	REMEDYREPACK INC.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2392_04000d2d-67c1-83b0-e063-6294a90a7f1f	70518-2392	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20191026		ANDA	ANDA077856	REMEDYREPACK INC.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2393_040040cc-3c66-82e6-e063-6294a90ab383	70518-2393	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20191028		ANDA	ANDA040037	REMEDYREPACK INC.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2397_040040cc-3c6c-82e6-e063-6294a90ab383	70518-2397	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20191030		ANDA	ANDA209421	REMEDYREPACK INC.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70518-2402_0309b0ef-bac7-b41d-e063-6294a90a49d7	70518-2402	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20191104		ANDA	ANDA203047	REMEDYREPACK INC.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2404_0878c45f-4984-81f1-e063-6394a90a2bea	70518-2404	HUMAN PRESCRIPTION DRUG	rifampin		rifampin	CAPSULE	ORAL	20191105		ANDA	ANDA090034	REMEDYREPACK INC.	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
70518-2405_0400d131-c616-b6ff-e063-6394a90a3eae	70518-2405	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20191107		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
70518-2406_0400b860-6f4f-ba9d-e063-6394a90ae1e9	70518-2406	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20191108		ANDA	ANDA090170	REMEDYREPACK INC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-2407_040121c1-42d6-93eb-e063-6294a90a8c31	70518-2407	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20191108		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
70518-2409_04014c73-6d19-f3b1-e063-6294a90a88b0	70518-2409	HUMAN PRESCRIPTION DRUG	TRIHEXYPHENIDYL HYDROCHLORIDE		TRIHEXYPHENIDYL HYDROCHLORIDE	TABLET	ORAL	20191108		ANDA	ANDA040254	REMEDYREPACK INC.	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
70518-2410_fb6aee54-9ded-f039-e053-6294a90ac77b	70518-2410	HUMAN PRESCRIPTION DRUG	TRIHEXYPHENIDYL HYDROCHLORIDE		TRIHEXYPHENIDYL HYDROCHLORIDE	TABLET	ORAL	20191108		ANDA	ANDA040254	REMEDYREPACK INC.	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
70518-2411_04014c73-6d1b-f3b1-e063-6294a90a88b0	70518-2411	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20191110		ANDA	ANDA208963	REMEDYREPACK INC.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-2412_040f9099-40f1-94d5-e063-6394a90aa1e3	70518-2412	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20191110		ANDA	ANDA078181	REMEDYREPACK INC.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-2414_040f90c5-2cb8-6e6d-e063-6394a90a75af	70518-2414	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20191111		ANDA	ANDA209172	REMEDYREPACK INC.	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
70518-2415_040f90c5-2cc5-6e6d-e063-6394a90a75af	70518-2415	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20191111		ANDA	ANDA208963	REMEDYREPACK INC.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-2418_0411c0b5-a3cb-4ffb-e063-6294a90a33ee	70518-2418	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20191114		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
70518-2419_0411c0b5-a3ef-4ffb-e063-6294a90a33ee	70518-2419	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20191115		ANDA	ANDA076343	REMEDYREPACK INC.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2426_091cf276-ebb5-8fd3-e063-6294a90a66da	70518-2426	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	20191118		ANDA	ANDA075687	REMEDYREPACK INC.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2430_04128209-29bd-5e4f-e063-6294a90ae94c	70518-2430	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20191118		ANDA	ANDA078032	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2431_04128d32-be9d-3103-e063-6394a90a8b95	70518-2431	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20191118		ANDA	ANDA200268	REMEDYREPACK INC.	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
70518-2432_f67d5b96-c352-0f47-e053-2a95a90af1a2	70518-2432	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20191118		ANDA	ANDA090796	REMEDYREPACK INC.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2433_0412a938-bff5-139d-e063-6294a90ac9a2	70518-2433	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20191119		ANDA	ANDA207370	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-2435_0412be58-65e6-bff3-e063-6394a90a6cd9	70518-2435	HUMAN PRESCRIPTION DRUG	Myrbetriq		mirabegron	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191119		NDA	NDA202611	REMEDYREPACK INC.	MIRABEGRON	50	mg/1	Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]		N	20241231
70518-2437_f67d7226-7d2f-2224-e053-2995a90a36b2	70518-2437	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20191119		ANDA	ANDA200981	REMEDYREPACK INC.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2439_04139788-05ce-6d1f-e063-6294a90ae4e0	70518-2439	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20191120		ANDA	ANDA204022	REMEDYREPACK INC.	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70518-2442_0414ff5d-a4b1-74ef-e063-6294a90ab407	70518-2442	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20191121		ANDA	ANDA078203	REMEDYREPACK INC.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2445_0d1eaf06-134d-94bc-e063-6294a90a6b1e	70518-2445	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20191122		ANDA	ANDA075483	REMEDYREPACK INC.	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-2446_f67dc5d5-4904-36cd-e053-2995a90ab672	70518-2446	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20191122		ANDA	ANDA210028	REMEDYREPACK INC.	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2448_0b4e90dd-642b-afec-e063-6294a90a598e	70518-2448	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20191123		ANDA	ANDA077206	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2451_f19c0138-c1c6-9420-e053-2995a90a0e59	70518-2451	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride Extended-Release Tablets	TABLET, EXTENDED RELEASE	ORAL	20191125		NDA AUTHORIZED GENERIC	NDA021392	REMEDYREPACK INC.	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
70518-2453_04230ecd-9208-e232-e063-6394a90a29ac	70518-2453	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20191125		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	15	mg/1			N	20241231
70518-2454_0423270d-d2b0-e77a-e063-6394a90a007a	70518-2454	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20191125		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2455_0d05d6f3-bf7e-1c9c-e063-6394a90a8629	70518-2455	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20191125		ANDA	ANDA203834	REMEDYREPACK INC.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2456_0b4e9ed5-5a2b-cd68-e063-6294a90a8db2	70518-2456	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20191126		ANDA	ANDA077272	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2458_0c676ba6-ed97-1f18-e063-6294a90aff2c	70518-2458	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20191129		ANDA	ANDA210497	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-2461_04241428-86e5-0a63-e063-6294a90a3ebb	70518-2461	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20191206		ANDA	ANDA203512	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-2465_0b4f3d2f-d7e3-53e3-e063-6294a90a0434	70518-2465	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20191214		ANDA	ANDA077584	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2466_f68bfc95-c980-061d-e053-2995a90a828c	70518-2466	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20191205		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2467_04244ddb-ee24-3d27-e063-6394a90a386d	70518-2467	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20191205		ANDA	ANDA077856	REMEDYREPACK INC.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2472_0b5f1f81-414a-500b-e063-6294a90a6939	70518-2472	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20191206		ANDA	ANDA078032	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2476_042491f8-17c6-e7c2-e063-6394a90a876f	70518-2476	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20191211		ANDA	ANDA078110	REMEDYREPACK INC.	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70518-2479_0b4f332a-6a60-3bb4-e063-6294a90a61a2	70518-2479	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20191212		ANDA	ANDA203002	REMEDYREPACK INC.	POTASSIUM CHLORIDE	10	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-2480_04257efd-1f12-3ad1-e063-6394a90a1a92	70518-2480	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20191212		ANDA	ANDA090295	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-2483_04266b35-28d3-9fb3-e063-6294a90a54b9	70518-2483	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191213		ANDA	ANDA209743	REMEDYREPACK INC.	PREGABALIN	150	mg/1		CV	N	20241231
70518-2485_0426b1e9-063f-c1e6-e063-6294a90a2554	70518-2485	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20191213		ANDA	ANDA077856	REMEDYREPACK INC.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2486_052c7b56-af5d-4db3-e063-6294a90a5a77	70518-2486	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191215		ANDA	ANDA040362	REMEDYREPACK INC.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2487_04271538-75b4-7257-e063-6394a90ac03c	70518-2487	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20191216		ANDA	ANDA071620	REMEDYREPACK INC.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2488_0b4fe819-4476-778b-e063-6294a90aa355	70518-2488	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20191217		ANDA	ANDA040596	REMEDYREPACK INC.	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-2489_0b501298-2948-ef70-e063-6294a90a941d	70518-2489	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20191217		ANDA	ANDA077272	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2490_04507d9c-1115-f534-e063-6294a90afdd0	70518-2490	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20191217		NDA AUTHORIZED GENERIC	NDA022127	REMEDYREPACK INC.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70518-2491_042744bd-99ef-37c0-e063-6294a90aa4ac	70518-2491	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20191217		ANDA	ANDA206948	REMEDYREPACK INC.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
70518-2493_04276f2b-e766-a499-e063-6394a90a0783	70518-2493	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20191217		ANDA	ANDA090007	REMEDYREPACK INC.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2496_091c6a54-b04b-69bc-e063-6394a90ae007	70518-2496	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		acyclovir	CAPSULE	ORAL	20191218		ANDA	ANDA074889	REMEDYREPACK INC.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2501_f68d433d-1b93-6b17-e053-2995a90adac1	70518-2501	HUMAN PRESCRIPTION DRUG	Wixela Inhub		fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20191219		ANDA	ANDA208891	REMEDYREPACK INC.	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
70518-2502_0427e94a-5374-9991-e063-6294a90acc79	70518-2502	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20191223		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2505_04281248-15a2-9f62-e063-6294a90a0a13	70518-2505	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20191224		ANDA	ANDA076056	REMEDYREPACK INC.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2506_042817f9-6763-056a-e063-6394a90a2d97	70518-2506	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20191224		ANDA	ANDA205231	REMEDYREPACK INC.	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-2507_fd8a53ae-d780-8f15-e053-6294a90a65cf	70518-2507	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20191226		ANDA	ANDA074569	REMEDYREPACK INC.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2510_094103e7-ca0f-04c2-e063-6294a90a68cf	70518-2510	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20191227		ANDA	ANDA203730	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2513_0429b5de-1b1f-f85f-e063-6294a90a697c	70518-2513	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20191230		ANDA	ANDA078597	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2515_f8c12457-e732-a505-e053-6294a90a9c5c	70518-2515	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		aripiprazole	TABLET	ORAL	20191231		ANDA	ANDA205363	REMEDYREPACK INC.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2517_0429d816-f3ac-2076-e063-6394a90aef21	70518-2517	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200101		ANDA	ANDA076343	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2518_0d805053-05f1-f7dc-e063-6394a90a8c40	70518-2518	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200101		ANDA	ANDA203834	REMEDYREPACK INC.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-2521_f7f98ce2-7c8f-3978-e053-6294a90aeb7f	70518-2521	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20200103		ANDA	ANDA078169	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2522_0429b5de-1b68-f85f-e063-6294a90a697c	70518-2522	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20200104		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2523_0e766448-870f-76db-e063-6394a90a0ab1	70518-2523	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20200106		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-2525_f7fb5442-551b-830f-e053-6394a90a0cc2	70518-2525	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200106		ANDA	ANDA209357	REMEDYREPACK INC.	PREGABALIN	75	mg/1		CV	N	20241231
70518-2526_043734b8-9abc-cdf1-e063-6294a90aec60	70518-2526	HUMAN PRESCRIPTION DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20200106		ANDA	ANDA210893	REMEDYREPACK INC.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2527_044b3ef1-04cf-52e1-e063-6294a90a12d2	70518-2527	HUMAN PRESCRIPTION DRUG	divalproex sodium		divalproex sodium	CAPSULE, COATED PELLETS	ORAL	20200106		ANDA	ANDA078919	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2532_0c517db0-c52e-e417-e063-6294a90a2ce0	70518-2532	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200108		ANDA	ANDA200834	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2533_04c5f2f1-f625-58ab-e063-6394a90a92e6	70518-2533	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20200109		ANDA	ANDA077856	REMEDYREPACK INC.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2534_f69026f4-5e27-27d3-e053-2995a90ab147	70518-2534	HUMAN PRESCRIPTION DRUG	Pyrazinamide		Pyrazinamide	TABLET	ORAL	20200110		ANDA	ANDA081319	REMEDYREPACK INC.	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
70518-2535_0b5ff9d9-e00e-19db-e063-6294a90a9b60	70518-2535	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20200110		ANDA	ANDA077633	REMEDYREPACK INC.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-2536_0d1a0123-4831-5863-e063-6294a90adf52	70518-2536	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20200110		ANDA	ANDA201519	REMEDYREPACK INC.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2537_044e0d77-05a3-63b0-e063-6294a90a4f8d	70518-2537	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20200111		ANDA	ANDA065434	REMEDYREPACK INC.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-2538_044e45c3-c6b6-c5a7-e063-6394a90a7bce	70518-2538	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20200111		ANDA	ANDA065352	REMEDYREPACK INC.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-2541_044ea166-4c44-e2d4-e063-6294a90a26a8	70518-2541	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20200113		ANDA	ANDA204645	REMEDYREPACK INC.	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-2542_0b60b471-2463-a64f-e063-6294a90a1650	70518-2542	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20200114		ANDA	ANDA208898	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2550_f226d5b3-d3e1-6ec4-e053-2a95a90af61a	70518-2550	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20200120		ANDA	ANDA203561	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2551_044f8f46-a020-4748-e063-6294a90aca11	70518-2551	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20200122		ANDA	ANDA040901	REMEDYREPACK INC.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70518-2553_044f9b45-5bfa-65f8-e063-6294a90a79eb	70518-2553	HUMAN PRESCRIPTION DRUG	Citalopram		citalopram	TABLET, FILM COATED	ORAL	20200122		ANDA	ANDA077042	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2555_0aacd5a0-a277-b02d-e063-6394a90a9421	70518-2555	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200124		ANDA	ANDA040362	REMEDYREPACK INC.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2560_07482473-fa68-02e6-e063-6394a90abbca	70518-2560	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20200130		ANDA	ANDA211285	REMEDYREPACK INC.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
70518-2561_0b610515-dcf6-0406-e063-6294a90a5c9f	70518-2561	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200201		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-2563_0b62b660-87b2-88a7-e063-6294a90a3d26	70518-2563	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20200204		ANDA	ANDA077633	REMEDYREPACK INC.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-2564_0b62eb65-78a9-5135-e063-6394a90a42eb	70518-2564	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20200204		ANDA	ANDA078245	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2566_0b6305c6-d4f9-659f-e063-6394a90a7e75	70518-2566	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20200204		ANDA	ANDA078466	REMEDYREPACK INC.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-2568_0451857c-bd1f-1ef2-e063-6394a90a3c1d	70518-2568	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200205	20250930	NDA AUTHORIZED GENERIC	NDA021446	REMEDYREPACK INC.	PREGABALIN	150	mg/1		CV	N	
70518-2570_f6912f75-62ee-82ec-e053-2995a90a8255	70518-2570	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200206		ANDA	ANDA202446	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-2571_0451ace1-9b14-9e88-e063-6294a90a881e	70518-2571	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200207		ANDA	ANDA209743	REMEDYREPACK INC.	PREGABALIN	50	mg/1		CV	N	20241231
70518-2573_048771ab-4520-622c-e063-6294a90ab564	70518-2573	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20200218	20251031	ANDA	ANDA206928	REMEDYREPACK INC.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70518-2574_0b635029-0432-8ca2-e063-6394a90a42d5	70518-2574	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20200210		ANDA	ANDA078406	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2576_01c78350-4954-e818-e063-6294a90a57c8	70518-2576	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	20200213		ANDA	ANDA080937	REMEDYREPACK INC.	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
70518-2578_0d1ee8af-564f-327e-e063-6394a90a0f8f	70518-2578	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET	ORAL	20200214		ANDA	ANDA078245	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2580_0c695a0f-093d-4984-e063-6294a90a120b	70518-2580	HUMAN PRESCRIPTION DRUG	aripiprazole		aripiprazole	TABLET	ORAL	20200215		ANDA	ANDA201519	REMEDYREPACK INC.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2581_048800cd-9de3-0dbb-e063-6294a90adfe0	70518-2581	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20200216		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	45	mg/1			N	20241231
70518-2582_0488271a-16cf-5d5f-e063-6294a90ae6ea	70518-2582	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20200217		ANDA	ANDA076541	REMEDYREPACK INC.	MIRTAZAPINE	7.5	mg/1			N	20241231
70518-2585_0b63a97a-2b8d-d2b6-e063-6394a90a480a	70518-2585	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20200217		ANDA	ANDA205936	REMEDYREPACK INC.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-2588_0b63c97e-5021-e278-e063-6394a90a8f3d	70518-2588	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20200218		ANDA	ANDA205936	REMEDYREPACK INC.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-2589_0b63e10e-d98c-9295-e063-6294a90a88e7	70518-2589	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20200218		ANDA	ANDA205936	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-2590_048a4f17-f524-387e-e063-6294a90a74a3	70518-2590	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20200218		ANDA	ANDA208644	REMEDYREPACK INC.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-2595_0b64677e-d48b-0929-e063-6294a90af137	70518-2595	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20200225		ANDA	ANDA040197	REMEDYREPACK INC.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-2597_05cd7548-4b2c-da5b-e063-6394a90a4b3b	70518-2597	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20200225		ANDA	ANDA078032	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2598_f6ca1e42-b6ce-854e-e053-6394a90a912f	70518-2598	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20200225		ANDA	ANDA203854	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2601_048af70d-f8f2-c412-e063-6294a90a5509	70518-2601	HUMAN PRESCRIPTION DRUG	Citalopram		citalopram	TABLET, FILM COATED	ORAL	20200226		ANDA	ANDA077042	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2602_06f75748-42bf-1b9b-e063-6294a90a05e8	70518-2602	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20200226		ANDA	ANDA073652	REMEDYREPACK INC.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70518-2603_048b0096-3e2f-12fd-e063-6394a90aefe8	70518-2603	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET	ORAL	20200227		ANDA	ANDA203366	REMEDYREPACK INC.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
70518-2604_f9b2db5f-ff7e-0451-e053-6294a90a4b33	70518-2604	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20200228		ANDA	ANDA090624	REMEDYREPACK INC.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70518-2607_048b3c03-74a2-cb6a-e063-6294a90a4616	70518-2607	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	CAPSULE	ORAL	20200228		ANDA	ANDA064082	REMEDYREPACK INC.	AMPICILLIN TRIHYDRATE	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-2609_048b1edb-c78d-1cee-e063-6294a90ab93a	70518-2609	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20200302		ANDA	ANDA200268	REMEDYREPACK INC.	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
70518-2612_048ba478-b134-e492-e063-6294a90a053e	70518-2612	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20200304		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
70518-2613_f6cacd30-4137-745b-e053-6394a90a56ae	70518-2613	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20200305		ANDA	ANDA074880	REMEDYREPACK INC.	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70518-2614_048ba478-b156-e492-e063-6294a90a053e	70518-2614	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20200306		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2616_0902467e-16f7-8fe9-e063-6394a90aa5ca	70518-2616	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20200309		ANDA	ANDA200651	REMEDYREPACK INC.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2617_048c1cf6-2415-38b1-e063-6394a90a4ffe	70518-2617	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20200309		ANDA	ANDA077534	REMEDYREPACK INC.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2619_048c2817-d8fd-7b10-e063-6294a90aad11	70518-2619	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20200309		ANDA	ANDA077369	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 300	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2620_048c557f-80cf-b7bf-e063-6294a90af5f6	70518-2620	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200310		ANDA	ANDA211061	REMEDYREPACK INC.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-2621_048c66a3-ce5d-c936-e063-6294a90ac1dc	70518-2621	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20200310		ANDA	ANDA075483	REMEDYREPACK INC.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-2623_fdf1542e-6f9c-e1de-e053-6394a90a5330	70518-2623	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20200310		ANDA	ANDA204319	REMEDYREPACK INC.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2624_048ca26b-673e-e466-e063-6394a90aee6d	70518-2624	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20200312	20251130	ANDA	ANDA206928	REMEDYREPACK INC.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70518-2625_05e1f56d-2ee8-d13f-e063-6294a90afc91	70518-2625	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA205707	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-2626_048cf37e-3dc3-2c89-e063-6394a90a01da	70518-2626	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20200312		ANDA	ANDA079163	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2628_f6cada95-4920-88fe-e053-6394a90affcb	70518-2628	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20200312		ANDA	ANDA211610	REMEDYREPACK INC.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
70518-2630_0b64ff72-c4d9-8879-e063-6294a90a1f53	70518-2630	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20200316		ANDA	ANDA208706	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2631_048d4844-6443-c825-e063-6294a90ac117	70518-2631	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20200317		ANDA	ANDA077929	REMEDYREPACK INC.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2632_0c8d9899-4f35-ebc8-e063-6294a90a3b73	70518-2632	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20200317		ANDA	ANDA078925	REMEDYREPACK INC.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-2634_0b653792-353f-c0d6-e063-6394a90afe20	70518-2634	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200318		ANDA	ANDA210015	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-2635_0c78d401-5df6-4dad-e063-6394a90ab5d1	70518-2635	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20200318		ANDA	ANDA209912	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2639_048dce7a-48fc-f370-e063-6394a90aa9c3	70518-2639	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	20200526		ANDA	ANDA040226	REMEDYREPACK INC.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-2640_0c3debc9-8f17-684a-e063-6394a90a5067	70518-2640	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20200326		ANDA	ANDA209335	REMEDYREPACK INC.	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70518-2652_0b732ca9-7eab-bab8-e063-6394a90aa56a	70518-2652	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20200325		ANDA	ANDA090555	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2655_f6c83ee9-c07e-9fc8-e053-6394a90a2160	70518-2655	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20200325	20240331	ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
70518-2656_01cb7bba-ab50-2922-e063-6394a90a96e9	70518-2656	HUMAN PRESCRIPTION DRUG	PHENERGAN		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200325		ANDA	ANDA083312	REMEDYREPACK INC.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-2659_0b736ed7-f762-5700-e063-6294a90a7958	70518-2659	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20200327		ANDA	ANDA090555	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2660_0c535178-dd66-87cb-e063-6394a90ab1b3	70518-2660	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20200327		ANDA	ANDA204582	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
70518-2663_0b739813-afc6-6b2c-e063-6294a90a59da	70518-2663	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20200330		ANDA	ANDA206560	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-2665_0917b2f7-d3a8-8b76-e063-6294a90a85a9	70518-2665	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20200330		ANDA	ANDA078597	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2666_090465a3-dc8e-b4e0-e063-6394a90acfdf	70518-2666	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20200331		ANDA	ANDA040702	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2670_0baf087c-5bd4-b636-e063-6394a90a37e5	70518-2670	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20200403		ANDA	ANDA078181	REMEDYREPACK INC.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-2674_049d9da3-96d6-a56c-e063-6294a90a7936	70518-2674	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20200406		ANDA	ANDA078597	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2677_f4c3943f-3abc-5d50-e053-2a95a90a032c	70518-2677	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20200408		ANDA	ANDA090168	REMEDYREPACK INC.	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2679_049f1590-1a48-eecd-e063-6294a90ab6b2	70518-2679	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20200408		ANDA	ANDA210614	REMEDYREPACK INC.	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-2680_f20023b2-d2b2-67e4-e053-2995a90ac985	70518-2680	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200408		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-2682_f1d595ef-3386-d134-e053-2995a90a2ac6	70518-2682	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200408		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-2683_049f392a-1bd5-186e-e063-6294a90aca03	70518-2683	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET, FILM COATED	ORAL	20200408		ANDA	ANDA074185	REMEDYREPACK INC.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-2685_0bafa411-c816-e3ea-e063-6394a90a25fd	70518-2685	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20200410		ANDA	ANDA202910	REMEDYREPACK INC.	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-2687_049f770b-1dbc-ce8d-e063-6394a90abb63	70518-2687	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20200413		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-2694_fd612217-2e70-8e8a-e053-6294a90a3127	70518-2694	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20200415		ANDA	ANDA065496	REMEDYREPACK INC.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-2697_f6c933a5-c470-162a-e053-6394a90aeaf1	70518-2697	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20200416		ANDA	ANDA078947	REMEDYREPACK INC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-2698_04a0cb3e-be74-5e07-e063-6394a90a9f49	70518-2698	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20200417		ANDA	ANDA202862	REMEDYREPACK INC.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2699_0bafc901-c49b-0669-e063-6394a90a16c4	70518-2699	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET	ORAL	20200420		ANDA	ANDA091027	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-2705_0e32db13-b492-addb-e063-6394a90a7625	70518-2705	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20200423		ANDA	ANDA210971	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
70518-2707_f6c9a7aa-993c-2822-e053-6294a90ac5b2	70518-2707	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20200423		ANDA	ANDA075185	REMEDYREPACK INC.	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2709_04a1650b-b7bb-d9d3-e063-6294a90a43ad	70518-2709	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200424		ANDA	ANDA078321	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-2714_04a1650b-b7bc-d9d3-e063-6294a90a43ad	70518-2714	HUMAN PRESCRIPTION DRUG	cilostazol		cilostazol	TABLET	ORAL	20200429		ANDA	ANDA077030	REMEDYREPACK INC.	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
70518-2716_04a1e2f8-59b7-5008-e063-6294a90aa282	70518-2716	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211004		ANDA	ANDA078525	REMEDYREPACK INC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-2720_04a286fb-ccd0-4ce6-e063-6294a90af040	70518-2720	HUMAN PRESCRIPTION DRUG	Candesartan Cilexetil and Hydrochlorothiazide		Candesartan Cilexetil and Hydrochlorothiazide	TABLET	ORAL	20200501		NDA AUTHORIZED GENERIC	NDA021093	REMEDYREPACK INC.	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2726_0e32e05e-2cf9-f9c8-e063-6294a90a540f	70518-2726	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20200505		ANDA	ANDA201504	REMEDYREPACK INC.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-2727_0bb08bda-1c48-c24b-e063-6294a90a7afb	70518-2727	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20200505		ANDA	ANDA078296	REMEDYREPACK INC.	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2732_04b122d6-9025-6cc9-e063-6294a90a0e9f	70518-2732	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20200511		ANDA	ANDA090168	REMEDYREPACK INC.	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2735_f911611c-df7f-6133-e053-6394a90a3730	70518-2735	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20200512		ANDA	ANDA065442	REMEDYREPACK INC.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70518-2737_0c510c12-bd17-a757-e063-6294a90a53c8	70518-2737	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20200512		ANDA	ANDA091629	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2741_04b1a617-e18b-9f04-e063-6394a90a7c9c	70518-2741	HUMAN PRESCRIPTION DRUG	Tetracaine Hydrochloride		Tetracaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20200512		NDA	NDA210821	REMEDYREPACK INC.	TETRACAINE HYDROCHLORIDE	5	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
70518-2744_04b21d2e-fc30-37b7-e063-6394a90a274e	70518-2744	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20200513		ANDA	ANDA079234	REMEDYREPACK INC.	TORSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70518-2745_04b2262f-adea-c53b-e063-6294a90a3610	70518-2745	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200514		ANDA	ANDA209357	REMEDYREPACK INC.	PREGABALIN	100	mg/1		CV	N	20241231
70518-2748_f6cbc747-b256-3f6d-e053-6294a90a9f71	70518-2748	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20200519		ANDA	ANDA204776	REMEDYREPACK INC.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2749_0bc451ca-3379-8240-e063-6294a90a3000	70518-2749	HUMAN PRESCRIPTION DRUG	CEFIXIME		CEFIXIME	CAPSULE	ORAL	20200521		ANDA	ANDA210574	REMEDYREPACK INC.	CEFIXIME	400	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-2750_0bc45b8e-a2a6-5bbe-e063-6294a90aeb50	70518-2750	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20200522		ANDA	ANDA204022	REMEDYREPACK INC.	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70518-2755_04b36a73-c79b-c9bc-e063-6394a90adea0	70518-2755	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20200526		ANDA	ANDA078947	REMEDYREPACK INC.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-2758_fe17994c-6bae-5569-e053-6294a90a796f	70518-2758	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20200528		ANDA	ANDA065435	REMEDYREPACK INC.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-2762_f7fbe2da-2327-fa28-e053-6294a90aca80	70518-2762	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200603		ANDA	ANDA209357	REMEDYREPACK INC.	PREGABALIN	50	mg/1		CV	N	20241231
70518-2763_f7fb1828-f70d-1528-e053-6394a90a5e33	70518-2763	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200604		ANDA	ANDA209357	REMEDYREPACK INC.	PREGABALIN	200	mg/1		CV	N	20241231
70518-2764_04b39bf1-dccf-18b8-e063-6394a90a0229	70518-2764	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20200605		ANDA	ANDA211610	REMEDYREPACK INC.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
70518-2765_04b3e20f-a3e2-295a-e063-6394a90abe19	70518-2765	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200605		ANDA	ANDA206174	REMEDYREPACK INC.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2766_04b3c6ef-815c-f0a7-e063-6394a90ac717	70518-2766	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20200608		ANDA	ANDA076796	REMEDYREPACK INC.	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70518-2769_f3bc5a2e-d2f3-4d39-e053-2995a90a423e	70518-2769	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20200608		ANDA	ANDA088488	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	100	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2771_0bc49c99-4a64-a1e4-e063-6294a90a6b8e	70518-2771	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20200608		ANDA	ANDA201408	REMEDYREPACK INC.	GUANFACINE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-2772_f32ea844-df1e-e677-e053-2995a90a4724	70518-2772	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200608		ANDA	ANDA210497	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-2773_0bc72bd8-1eea-b01c-e063-6394a90a77ea	70518-2773	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20200609		ANDA	ANDA065136	REMEDYREPACK INC.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-2774_0bc8accb-5cee-8bd1-e063-6294a90a6f21	70518-2774	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20200609		ANDA	ANDA208898	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2775_e9d3511f-1326-31d4-e053-2995a90a1dac	70518-2775	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20200610	20240401	ANDA	ANDA211604	REMEDYREPACK INC.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
70518-2776_0bc8d8b3-90a5-253b-e063-6394a90a4dad	70518-2776	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20200610		ANDA	ANDA205101	REMEDYREPACK INC.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2777_0bc929a5-ed02-f40d-e063-6294a90a8294	70518-2777	HUMAN PRESCRIPTION DRUG	NYSTATIN AND TRIAMCINOLONE ACETONIDE		nystatin, triamcinolone acetonide	CREAM	TOPICAL	20200611		ANDA	ANDA208479	REMEDYREPACK INC.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
70518-2781_04b4a7f6-0eee-3320-e063-6394a90aea51	70518-2781	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRACARDIAC; INTRAVENOUS	20200611		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-2786_0d1f28e5-e5fb-6031-e063-6394a90a0815	70518-2786	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200614		ANDA	ANDA203835	REMEDYREPACK INC.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-2788_0c8d7246-6a2c-f3fb-e063-6394a90aae51	70518-2788	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA208170	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-2789_04b59d3c-6cb3-bf07-e063-6294a90ae391	70518-2789	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA205231	REMEDYREPACK INC.	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-2791_0d1f3e5c-4f17-6acc-e063-6394a90a423d	70518-2791	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200618		ANDA	ANDA075410	REMEDYREPACK INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-2792_04b6392e-ffd1-f58e-e063-6394a90a0f2a	70518-2792	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		AMIODARONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20200619		ANDA	ANDA075761	REMEDYREPACK INC.	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-2793_04b6392f-0025-f58e-e063-6394a90a0f2a	70518-2793	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA071525	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-2795_04b6992d-c786-56c7-e063-6394a90ae8d0	70518-2795	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200624		ANDA	ANDA200503	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
70518-2800_04c5f9f6-e544-d847-e063-6294a90abed7	70518-2800	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200625		ANDA	ANDA040188	REMEDYREPACK INC.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
70518-2803_f831eadb-ece6-a03d-e053-6394a90a4941	70518-2803	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA210907	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
70518-2806_0c51dfc1-f8b9-2a95-e063-6294a90ad78f	70518-2806	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200706		ANDA	ANDA207105	REMEDYREPACK INC.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2807_f2151442-dc79-e8a7-e053-2995a90a5ea5	70518-2807	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20200708		ANDA	ANDA204279	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-2811_04c6f92e-b2c0-39a3-e063-6294a90a7d2a	70518-2811	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20200710		ANDA	ANDA203818	REMEDYREPACK INC.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2812_04c6f8c5-13dd-a698-e063-6394a90ad24a	70518-2812	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20200710		ANDA	ANDA077206	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2813_04c75e93-b1da-2546-e063-6394a90af0e1	70518-2813	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200713		ANDA	ANDA210986	REMEDYREPACK INC.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2814_04c776dd-b5f5-23f6-e063-6394a90a247c	70518-2814	HUMAN PRESCRIPTION DRUG	metronidazole vaginal		metronidazole	GEL	VAGINAL	20200714		ANDA	ANDA211786	REMEDYREPACK INC.	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-2816_04c7a4e1-d804-fdf4-e063-6294a90a2711	70518-2816	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20200719		ANDA	ANDA202202	REMEDYREPACK INC.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-2819_01dd63f6-d7f7-20d1-e063-6394a90af545	70518-2819	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20200723		ANDA	ANDA076921	REMEDYREPACK INC.	MIRTAZAPINE	7.5	mg/1			N	20241231
70518-2820_04c7ce24-5ee9-b288-e063-6394a90ae03d	70518-2820	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200727		ANDA	ANDA207105	REMEDYREPACK INC.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2823_04c8a345-09d6-5a01-e063-6294a90a40d2	70518-2823	HUMAN PRESCRIPTION DRUG	Insulin Aspart		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200803		BLA	BLA020986	REMEDYREPACK INC.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
70518-2829_04c8f4f4-245c-e675-e063-6394a90a96f1	70518-2829	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20200807		ANDA	ANDA040275	REMEDYREPACK INC.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-2833_0c55d8b2-fc0a-c63a-e063-6294a90ad5b2	70518-2833	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20200814		ANDA	ANDA090564	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-2834_04c9bb1b-5eb5-e572-e063-6394a90ac1e2	70518-2834	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20200817		ANDA	ANDA208847	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2835_04c9ccda-6417-0cd0-e063-6394a90a32bf	70518-2835	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	CAPSULE	ORAL	20200818		ANDA	ANDA090253	REMEDYREPACK INC.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70518-2837_04ca1c40-b981-aeaf-e063-6294a90a34a7	70518-2837	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20200818		ANDA	ANDA076558	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-2838_fdf0b5ac-c7b5-a230-e053-6394a90ab991	70518-2838	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20200818		ANDA	ANDA076899	REMEDYREPACK INC.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70518-2841_04ca910c-ef25-f3f7-e063-6394a90a223b	70518-2841	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20200819		ANDA	ANDA207798	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-2855_04d84c8b-352c-daa7-e063-6294a90a35dc	70518-2855	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20200824		ANDA	ANDA203197	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-2861_04d90390-81f6-5d3d-e063-6294a90a36c0	70518-2861	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20200826		ANDA	ANDA208847	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-2862_01cde451-1a89-61af-e063-6294a90a815a	70518-2862	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200826		ANDA	ANDA210145	REMEDYREPACK INC.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-2863_04d95165-7b0b-36d1-e063-6294a90a5cf2	70518-2863	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20200827		ANDA	ANDA212199	REMEDYREPACK INC.	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2864_04d9bf46-56d5-79ba-e063-6394a90a7547	70518-2864	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20200828		ANDA	ANDA204072	REMEDYREPACK INC.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2865_04d9c5a8-1f56-f7c0-e063-6294a90a92ae	70518-2865	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20200901		ANDA	ANDA077903	REMEDYREPACK INC.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
70518-2868_fd7becc1-fb31-d790-e053-6394a90af769	70518-2868	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20200906		ANDA	ANDA207465	REMEDYREPACK INC.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2869_04daff19-2f79-52c1-e063-6394a90a242c	70518-2869	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200908		ANDA	ANDA207105	REMEDYREPACK INC.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2870_04db3876-a2d6-27aa-e063-6294a90ad49f	70518-2870	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20200908		ANDA	ANDA090871	REMEDYREPACK INC.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2871_f53723ca-d81b-12ef-e053-2a95a90a649d	70518-2871	HUMAN PRESCRIPTION DRUG	PAROXETINE		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20200908		ANDA	ANDA075356	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE ANHYDROUS	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-2872_0d6d5a93-c95b-3c03-e063-6394a90a9f4b	70518-2872	HUMAN PRESCRIPTION DRUG	Itraconazole		Itraconazole	CAPSULE, COATED PELLETS	ORAL	20200909		ANDA	ANDA208591	REMEDYREPACK INC.	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-2873_0322da2e-859e-2bd7-e063-6294a90abb04	70518-2873	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20200909		ANDA	ANDA206948	REMEDYREPACK INC.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
70518-2877_079f15aa-2ffc-e231-e063-6294a90a683b	70518-2877	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20200910		ANDA	ANDA065435	REMEDYREPACK INC.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-2887_04dbda97-f40f-846e-e063-6394a90afaf6	70518-2887	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20200915		ANDA	ANDA076056	REMEDYREPACK INC.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-2888_04dbec36-acb3-5d89-e063-6294a90a423a	70518-2888	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20200915	20251231	ANDA	ANDA206928	REMEDYREPACK INC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70518-2891_04dc6411-ba9d-4772-e063-6294a90a318f	70518-2891	HUMAN PRESCRIPTION DRUG	OLANZAPINE		olanzapine	TABLET	ORAL	20200917		ANDA	ANDA202050	REMEDYREPACK INC.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2897_04dc3397-5fed-da11-e063-6394a90aacea	70518-2897	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20200928		ANDA	ANDA207105	REMEDYREPACK INC.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2899_0e89697c-a2f3-6b95-e063-6394a90a8ba3	70518-2899	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20200930		ANDA	ANDA077627	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-2900_0425de88-1cd9-e1bc-e063-6294a90af03d	70518-2900	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20201005		ANDA	ANDA090935	REMEDYREPACK INC.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
70518-2905_04dd5e13-347a-160f-e063-6294a90a5360	70518-2905	HUMAN PRESCRIPTION DRUG	Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate		Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20201015		ANDA	ANDA091215	REMEDYREPACK INC.	EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	600; 200; 300	mg/1; mg/1; mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70518-2906_04dd1c10-eb05-0c5b-e063-6394a90a1648	70518-2906	HUMAN PRESCRIPTION DRUG	emtricitabine		emtricitabine	CAPSULE	ORAL	20201012		ANDA	ANDA091168	REMEDYREPACK INC.	EMTRICITABINE	200	mg/1	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
70518-2907_04dd90cf-7bdc-0146-e063-6294a90a8b49	70518-2907	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20201013		ANDA	ANDA213864	REMEDYREPACK INC.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
70518-2909_04de9792-f6ee-bb42-e063-6394a90a4230	70518-2909	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20201014	20241130	ANDA	ANDA074260	REMEDYREPACK INC.	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	
70518-2912_f80a6f30-878d-2640-e053-6394a90aaa0a	70518-2912	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20201020		ANDA	ANDA206402	REMEDYREPACK INC.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2913_04debb71-b247-8e08-e063-6394a90a788d	70518-2913	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		Ziprasidone HCl	CAPSULE	ORAL	20201020		ANDA	ANDA077561	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2921_05152bcc-8f28-a2a7-e063-6394a90ac8f0	70518-2921	HUMAN PRESCRIPTION DRUG	ARIPIPRAZOLE		ARIPIPRAZOLE	TABLET	ORAL	20201026		ANDA	ANDA206251	REMEDYREPACK INC.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2922_05166e8a-5be7-7850-e063-6394a90af5db	70518-2922	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20201026		ANDA	ANDA204590	REMEDYREPACK INC.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2926_f6ddc9c8-ee76-aa77-e053-6394a90a3b2a	70518-2926	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20201029		ANDA	ANDA071620	REMEDYREPACK INC.	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-2927_0516f266-6f64-f0f6-e063-6394a90aa0ff	70518-2927	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201030		ANDA	ANDA204216	REMEDYREPACK INC.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-2929_f1881438-43ca-08e4-e053-2995a90a3042	70518-2929	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201031		ANDA	ANDA071523	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-2934_0e850cbc-ba1a-9974-e063-6294a90af222	70518-2934	HUMAN PRESCRIPTION DRUG	bupropion Hydrochloride		bupropion Hydrochloride	TABLET	ORAL	20201104		ANDA	ANDA206975	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20251231
70518-2938_0517871f-8cd1-1978-e063-6394a90ad3a0	70518-2938	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20201111		ANDA	ANDA209535	REMEDYREPACK INC.	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2939_0517e3fd-f1e7-611a-e063-6294a90a7f7b	70518-2939	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20201111		ANDA	ANDA077443	REMEDYREPACK INC.	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-2940_0518ab6d-db6d-970d-e063-6394a90a8662	70518-2940	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20201113		ANDA	ANDA204117	REMEDYREPACK INC.	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2945_051ad7e9-c098-7e7c-e063-6294a90aa4a1	70518-2945	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin Cream 5% w/w	CREAM	TOPICAL	20190408		ANDA	ANDA211303	REMEDYREPACK INC.	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
70518-2947_051af1a8-f421-d1f3-e063-6294a90adcce	70518-2947	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20201127		ANDA	ANDA213864	REMEDYREPACK INC.	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
70518-2948_051aecb5-6381-b761-e063-6294a90ad010	70518-2948	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20201127		ANDA	ANDA209743	REMEDYREPACK INC.	PREGABALIN	75	mg/1		CV	N	20241231
70518-2949_051b2b01-1230-832d-e063-6394a90ae25f	70518-2949	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20201127		ANDA	ANDA213063	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-2950_0528fa93-c98d-cfda-e063-6394a90ae60f	70518-2950	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201201		ANDA	ANDA206174	REMEDYREPACK INC.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2959_052cf950-5b02-d48d-e063-6294a90ae4b5	70518-2959	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20201204		ANDA	ANDA076363	REMEDYREPACK INC.	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70518-2960_03bf4af4-10a1-4980-e063-6294a90abcd4	70518-2960	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20201207		ANDA	ANDA207057	REMEDYREPACK INC.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-2963_052d351a-9764-6fc3-e063-6294a90aef55	70518-2963	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20201208		ANDA	ANDA209535	REMEDYREPACK INC.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2964_052d1759-d9f5-6e44-e063-6394a90a482e	70518-2964	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201209		ANDA	ANDA210921	REMEDYREPACK INC.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-2966_052d6215-62bf-73bb-e063-6294a90a6535	70518-2966	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET	ORAL	20201211		ANDA	ANDA078939	REMEDYREPACK INC.	ETHAMBUTOL HYDROCHLORIDE	400	mg/1	Antimycobacterial [EPC]		N	20241231
70518-2972_052e8716-0048-6106-e063-6294a90aea7c	70518-2972	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201216		ANDA	ANDA209167	REMEDYREPACK INC.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-2973_052e8964-1076-7473-e063-6294a90ab218	70518-2973	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20210112		ANDA	ANDA071524	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-2974_052e8964-1078-7473-e063-6294a90ab218	70518-2974	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201217		ANDA	ANDA207105	REMEDYREPACK INC.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-2977_052f1dbd-68d6-3fac-e063-6294a90adbd1	70518-2977	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20201223		ANDA	ANDA075022	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
70518-2978_052f4520-c178-fa7c-e063-6294a90aa9cd	70518-2978	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20201228		ANDA	ANDA209743	REMEDYREPACK INC.	PREGABALIN	300	mg/1		CV	N	20241231
70518-2979_053d0412-6180-1bdf-e063-6394a90aa989	70518-2979	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20201229		ANDA	ANDA091124	REMEDYREPACK INC.	ESZOPICLONE	3	mg/1		CIV	N	20241231
70518-2980_05414a66-83f5-8f96-e063-6394a90a81c5	70518-2980	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210106		ANDA	ANDA209743	REMEDYREPACK INC.	PREGABALIN	225	mg/1		CV	N	20241231
70518-2981_0c8d5aa8-b21e-c7b9-e063-6294a90a566e	70518-2981	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20210106		ANDA	ANDA078925	REMEDYREPACK INC.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-2982_0541be35-cec3-f490-e063-6294a90a091e	70518-2982	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20210107		ANDA	ANDA040189	REMEDYREPACK INC.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-2984_f6deed0c-2b98-28a2-e053-6394a90a9e29	70518-2984	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210108		ANDA	ANDA213063	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-2985_f6df3b2b-97c6-db93-e053-6394a90a5c45	70518-2985	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20210108		ANDA	ANDA205056	REMEDYREPACK INC.	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-2989_f6df7e28-03f1-19db-e053-6294a90a164f	70518-2989	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20210114		ANDA	ANDA202800	REMEDYREPACK INC.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
70518-2995_eb3de85f-ffd7-1e9f-e053-2995a90a8985	70518-2995	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET, COATED	ORAL	20210119		ANDA	ANDA209587	REMEDYREPACK INC.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
70518-2998_f6e0597c-3c61-92a8-e053-6394a90a8a23	70518-2998	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20210125		ANDA	ANDA088316	REMEDYREPACK INC.	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3000_0542c6f3-d8ee-71f1-e063-6394a90ae318	70518-3000	HUMAN PRESCRIPTION DRUG	diclofenac epolamine		Diclofenac Epolamine	SYSTEM	TOPICAL	20210125	20250131	NDA AUTHORIZED GENERIC	NDA021234	REMEDYREPACK INC.	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70518-3007_0542f88c-b29e-d32c-e063-6294a90ab9ee	70518-3007	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20210202		ANDA	ANDA077443	REMEDYREPACK INC.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3017_05438006-8a12-8c47-e063-6394a90a4bc1	70518-3017	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210205		ANDA	ANDA213063	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3018_0c5325e3-4757-856c-e063-6394a90a1f90	70518-3018	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA205056	REMEDYREPACK INC.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3019_0550b799-f422-90ac-e063-6294a90af519	70518-3019	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20210208		ANDA	ANDA040803	REMEDYREPACK INC.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3020_0550c81f-d0fa-acfc-e063-6394a90aa643	70518-3020	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20210209		ANDA	ANDA213063	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3021_f6e25e85-9317-d83f-e053-6394a90a0c09	70518-3021	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210210		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-3023_fd119534-c858-28d8-e053-6294a90ad419	70518-3023	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20210212		ANDA	ANDA077921	REMEDYREPACK INC.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3027_f6f1c70b-8ae4-f521-e053-6394a90a1ecb	70518-3027	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20210223		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
70518-3029_f6f1f63f-2147-7458-e053-6294a90a225d	70518-3029	HUMAN PRESCRIPTION DRUG	Isibloom		desogestrel and ethinyl estradiol	KIT		20210225		ANDA	ANDA202789	REMEDYREPACK INC.						N	20241231
70518-3030_055147c5-f2f5-ec8d-e063-6294a90aefaf	70518-3030	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20210225		ANDA	ANDA078466	REMEDYREPACK INC.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 40	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-3031_f6f232f9-73ac-9247-e053-6294a90a23b8	70518-3031	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20210225		ANDA	ANDA207201	REMEDYREPACK INC.	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70518-3034_f6f2a55a-eccb-6145-e053-6394a90ab59b	70518-3034	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20210301		ANDA	ANDA213368	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3035_0e8940d5-0fd4-d33b-e063-6294a90a5c79	70518-3035	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20210301		ANDA	ANDA208921	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
70518-3036_05515ac0-ab9a-f09b-e063-6394a90a2246	70518-3036	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20210303		ANDA	ANDA078512	REMEDYREPACK INC.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3037_05519c1a-7cb1-6383-e063-6294a90a8d2d	70518-3037	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20210303		ANDA	ANDA209288	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3038_f6f2f152-50b7-e4fa-e053-6394a90afcc4	70518-3038	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20210303		ANDA	ANDA091604	REMEDYREPACK INC.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-3039_0c673104-4e84-e749-e063-6394a90a3b22	70518-3039	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20210304		ANDA	ANDA065095	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3040_05545507-3bf0-f3bd-e063-6394a90a09ab	70518-3040	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		OMEGA-3-ACID ETHYL ESTERS	CAPSULE, LIQUID FILLED	ORAL	20210304		ANDA	ANDA210093	REMEDYREPACK INC.	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
70518-3041_f6f2f6b8-93e2-f990-e053-6294a90ab9ac	70518-3041	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20210305		ANDA	ANDA201722	REMEDYREPACK INC.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70518-3042_f6f31fc4-af2c-32ce-e053-6394a90aa30d	70518-3042	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20210309		ANDA	ANDA206560	REMEDYREPACK INC.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-3044_05578f15-88a7-2a4e-e063-6294a90ae8d1	70518-3044	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210310		ANDA	ANDA078279	REMEDYREPACK INC.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-3047_05681997-8b09-626f-e063-6294a90ab216	70518-3047	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210312		ANDA	ANDA203661	REMEDYREPACK INC.	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3052_0d1f8666-95fe-7844-e063-6394a90af412	70518-3052	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20210319		ANDA	ANDA065435	REMEDYREPACK INC.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-3053_f6f3fd17-c1ef-cf80-e053-6294a90a9d40	70518-3053	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210322		ANDA	ANDA070322	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3055_05685fad-89bc-2716-e063-6394a90a4b13	70518-3055	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20210323		ANDA	ANDA090554	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3056_056893f2-b29b-2417-e063-6294a90a1839	70518-3056	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20210323		ANDA	ANDA086724	REMEDYREPACK INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3058_0568ab9a-c9d4-a305-e063-6394a90a35b8	70518-3058	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210326		ANDA	ANDA211347	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3059_0c8d451a-d59a-bfd2-e063-6294a90a7f64	70518-3059	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20210329		ANDA	ANDA090836	REMEDYREPACK INC.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3061_0b5ee700-1d8e-b8e9-e063-6394a90ad55f	70518-3061	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20210331		ANDA	ANDA076796	REMEDYREPACK INC.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70518-3063_0569a0fa-4a3f-f20e-e063-6394a90a400c	70518-3063	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20210402		ANDA	ANDA076558	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-3064_f6f4b927-64ac-a923-e053-6394a90a372e	70518-3064	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20210402		ANDA	ANDA075551	REMEDYREPACK INC.	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3065_05a13a79-adcd-9a19-e063-6294a90a6c79	70518-3065	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210406		ANDA	ANDA202330	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
70518-3066_05a13a79-ae02-9a19-e063-6294a90a6c79	70518-3066	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20210407		ANDA	ANDA065253	REMEDYREPACK INC.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3067_05a1eabd-354e-eddc-e063-6394a90acc7a	70518-3067	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20210407		ANDA	ANDA077627	REMEDYREPACK INC.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3068_f6f54e74-a05f-7f3e-e053-6394a90af26c	70518-3068	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	CAPSULE	ORAL	20210407		ANDA	ANDA200197	REMEDYREPACK INC.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70518-3070_05a23207-3801-9675-e063-6294a90a4b84	70518-3070	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	20210410		ANDA	ANDA040159	REMEDYREPACK INC.	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70518-3072_05a1eabd-3592-eddc-e063-6394a90acc7a	70518-3072	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium	TABLET, FILM COATED	ORAL	20210419		ANDA	ANDA075219	REMEDYREPACK INC.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3073_05a23207-3802-9675-e063-6294a90a4b84	70518-3073	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20210419		ANDA	ANDA205245	REMEDYREPACK INC.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-3074_0c8d16b4-0e7a-c200-e063-6394a90aee71	70518-3074	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20210419		ANDA	ANDA078212	REMEDYREPACK INC.	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-3075_f7096167-4b17-d504-e053-6294a90aee82	70518-3075	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20210420		ANDA	ANDA090469	REMEDYREPACK INC.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70518-3078_05a2b135-7782-cc15-e063-6294a90a1bcf	70518-3078	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20210422		ANDA	ANDA085025	REMEDYREPACK INC.	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3079_05a1ebf0-3a86-fcc4-e063-6294a90ae497	70518-3079	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210426		ANDA	ANDA211347	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3084_05a380c7-d11d-f740-e063-6394a90a6109	70518-3084	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20210504		ANDA	ANDA090564	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3089_05a53d3f-29b4-f08c-e063-6394a90ad6bc	70518-3089	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210510		ANDA	ANDA212378	REMEDYREPACK INC.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70518-3090_05a5d725-1d5e-8f04-e063-6394a90ae14b	70518-3090	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20210510		ANDA	ANDA207105	REMEDYREPACK INC.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3091_05a5aa03-df92-63dd-e063-6394a90ade65	70518-3091	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210510		ANDA	ANDA210907	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
70518-3092_05a62c11-f0a4-9938-e063-6394a90a79ae	70518-3092	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210510		ANDA	ANDA077253	REMEDYREPACK INC.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-3095_f70afd80-23f5-a3b4-e053-6394a90a187b	70518-3095	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20210517		ANDA	ANDA214674	REMEDYREPACK INC.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3096_07da099b-6b81-984d-e063-6294a90a12ac	70518-3096	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20210518		ANDA	ANDA040489	REMEDYREPACK INC.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3101_06426682-3f4b-31c8-e063-6294a90aafdb	70518-3101	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20210524		ANDA	ANDA090564	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3102_05a6706a-e8bb-56f6-e063-6294a90a8051	70518-3102	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20210526		ANDA	ANDA070322	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3103_f7f8dd65-6ed4-7678-e053-6294a90aad73	70518-3103	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20210526		ANDA	ANDA090007	REMEDYREPACK INC.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3104_f70bd8cf-2b99-1347-e053-6394a90a6d0c	70518-3104	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20210526		ANDA	ANDA079088	REMEDYREPACK INC.	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3105_f70be749-4559-2bee-e053-6394a90a8c55	70518-3105	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20210526		ANDA	ANDA040625	REMEDYREPACK INC.	FOLIC ACID	1	mg/1			N	20241231
70518-3108_05a722ef-c1ec-073a-e063-6294a90a8c10	70518-3108	HUMAN PRESCRIPTION DRUG	Perphenazine		Perphenazine	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA089685	REMEDYREPACK INC.	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3109_05a6fce8-1ff1-6832-e063-6394a90a793f	70518-3109	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20210528		ANDA	ANDA078956	REMEDYREPACK INC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-3110_05a743dd-7fea-28b0-e063-6394a90a8b48	70518-3110	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20210603		ANDA	ANDA203974	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-3113_f70c5b0b-fa75-d66f-e053-6394a90a4511	70518-3113	HUMAN PRESCRIPTION DRUG	Norethindrone		Norethindrone	TABLET	ORAL	20210608		ANDA	ANDA200980	REMEDYREPACK INC.	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70518-3115_f70cf400-70f0-c782-e053-6394a90ae703	70518-3115	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210609		ANDA	ANDA212378	REMEDYREPACK INC.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70518-3117_05671a95-d30f-be61-e063-6394a90a1e66	70518-3117	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20210610		ANDA	ANDA040489	REMEDYREPACK INC.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3118_044c464b-af32-d50f-e063-6394a90ade25	70518-3118	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20210610		ANDA	ANDA089424	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-3119_0c79613a-4caf-9815-e063-6394a90a7460	70518-3119	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20210614		ANDA	ANDA206781	REMEDYREPACK INC.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3120_05a7b2cc-a4c3-fd64-e063-6294a90aeab4	70518-3120	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	INTRAVENOUS	20210614		ANDA	ANDA212461	REMEDYREPACK INC.	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70518-3121_f15f6c59-d08c-2d63-e053-2a95a90abbaa	70518-3121	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20210615		ANDA	ANDA205232	REMEDYREPACK INC.	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3122_05a795e4-acfb-4685-e063-6294a90adc23	70518-3122	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210615		ANDA	ANDA203894	REMEDYREPACK INC.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3124_f718741b-f6ec-717f-e053-6294a90a78a9	70518-3124	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20210616		ANDA	ANDA077002	REMEDYREPACK INC.	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70518-3125_f7188f51-7b0f-e96c-e053-6294a90a2259	70518-3125	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	TABLET	ORAL	20210617		ANDA	ANDA201831	REMEDYREPACK INC.	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
70518-3127_05a7b287-c13d-fdff-e063-6394a90a8648	70518-3127	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20210617		ANDA	ANDA077802	REMEDYREPACK INC.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3128_05a8329a-bfde-903b-e063-6394a90afd20	70518-3128	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		METHYLPREDNISOLONE SODIUM SUCCINATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210617		ANDA	ANDA040583	REMEDYREPACK INC.	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3129_05b963da-b494-5ee0-e063-6394a90a2ac3	70518-3129	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20210617		ANDA	ANDA201633	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-3130_f188c00e-c4e8-55e0-e053-2a95a90a326f	70518-3130	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210618		ANDA	ANDA077095	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3132_f719cb38-c704-19c3-e053-6394a90a2dd7	70518-3132	HUMAN PRESCRIPTION DRUG	isosorbide mononitrate		isosorbide mononitrate	TABLET, EXTENDED RELEASE	ORAL	20210618	20240331	ANDA	ANDA075155	REMEDYREPACK INC.	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
70518-3133_05bb2c51-82fa-e9eb-e063-6294a90abe13	70518-3133	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20210618		ANDA	ANDA202843	REMEDYREPACK INC.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
70518-3135_f213753d-7d4e-25f1-e053-2995a90a1b27	70518-3135	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20210625		ANDA	ANDA062505	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3136_05bbad6a-a3f0-12c1-e063-6294a90ae43b	70518-3136	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20210630		ANDA	ANDA211323	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3137_05bc13a8-84e2-4f3d-e063-6294a90a9279	70518-3137	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	CREAM	TOPICAL	20210630		NDA	NDA018642	REMEDYREPACK INC.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3139_0657c9bc-9276-94e8-e063-6394a90a35cd	70518-3139	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20210702		ANDA	ANDA078956	REMEDYREPACK INC.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-3142_05ca7153-33eb-7892-e063-6294a90a9697	70518-3142	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20210705		ANDA	ANDA211575	REMEDYREPACK INC.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3143_05ca9f1b-9cab-b863-e063-6394a90abdd6	70518-3143	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210705		ANDA	ANDA203894	REMEDYREPACK INC.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3144_05caa87d-36eb-7ec7-e063-6294a90a71f4	70518-3144	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20210706		ANDA	ANDA074569	REMEDYREPACK INC.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3145_05cb1799-3462-bb43-e063-6394a90a1a3f	70518-3145	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210712		ANDA	ANDA202825	REMEDYREPACK INC.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3146_f45d84fa-9923-6954-e053-2a95a90a41cd	70518-3146	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20210713		ANDA	ANDA075948	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3148_f71bcca7-316a-3de0-e053-6394a90a297a	70518-3148	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20210713	20251231	ANDA	ANDA077414	REMEDYREPACK INC.	DESMOPRESSIN ACETATE	.1	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
70518-3149_f71c2123-02a5-1a4b-e053-6294a90a6454	70518-3149	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20210713	20251231	ANDA	ANDA077414	REMEDYREPACK INC.	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	
70518-3150_05cb2cd0-eb0a-1172-e063-6294a90a3813	70518-3150	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20210713		ANDA	ANDA078525	REMEDYREPACK INC.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-3151_05cf0a16-35a2-1b01-e063-6394a90a2705	70518-3151	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram	TABLET, FILM COATED	ORAL	20210714		ANDA	ANDA078604	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3152_05cf0a16-35a7-1b01-e063-6394a90a2705	70518-3152	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20210714		ANDA	ANDA091182	REMEDYREPACK INC.	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70518-3153_05cf428c-3b4d-5fcb-e063-6394a90a962a	70518-3153	HUMAN PRESCRIPTION DRUG	Fluvoxamine maleate		Fluvoxamine maleate	TABLET, FILM COATED	ORAL	20210714		ANDA	ANDA075888	REMEDYREPACK INC.	FLUVOXAMINE MALEATE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3157_05cfa036-7fb2-689d-e063-6294a90af42d	70518-3157	HUMAN PRESCRIPTION DRUG	Vraylar		cariprazine	CAPSULE, GELATIN COATED	ORAL	20210715		NDA	NDA204370	REMEDYREPACK INC.	CARIPRAZINE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3158_05e31aaa-a939-f48b-e063-6394a90af32e	70518-3158	HUMAN PRESCRIPTION DRUG	Myrbetriq		mirabegron	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210715		NDA	NDA202611	REMEDYREPACK INC.	MIRABEGRON	25	mg/1	Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]		N	20241231
70518-3160_05e36111-ed50-12de-e063-6294a90af639	70518-3160	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210715		ANDA	ANDA212779	REMEDYREPACK INC.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
70518-3162_fe1aa4d9-d15d-c995-e053-6394a90aa7ae	70518-3162	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20210719		ANDA	ANDA078895	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-3163_f71d1bc2-a10b-7d3e-e053-6394a90ac5ea	70518-3163	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA208834	REMEDYREPACK INC.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3164_05e3b293-4b31-f6f8-e063-6394a90af653	70518-3164	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210720		ANDA	ANDA203894	REMEDYREPACK INC.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3165_f754c0e1-3491-5264-e053-6394a90aced4	70518-3165	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20210720		ANDA	ANDA076008	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
70518-3166_05e3b293-4b6e-f6f8-e063-6394a90af653	70518-3166	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210720		ANDA	ANDA077321	REMEDYREPACK INC.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70518-3168_0aad51cc-bbdf-f044-e063-6394a90ae60f	70518-3168	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20210722		ANDA	ANDA208249	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-3170_05e42b63-5d8e-31bc-e063-6294a90ae47f	70518-3170	HUMAN PRESCRIPTION DRUG	HALOPERIDOL DECANOATE		HALOPERIDOL DECANOATE	INJECTION	INTRAMUSCULAR	20210726		ANDA	ANDA209101	REMEDYREPACK INC.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70518-3171_0c8d16ae-c7d4-a6cc-e063-6294a90a8062	70518-3171	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20210726		ANDA	ANDA078212	REMEDYREPACK INC.	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-3173_f7554e8e-eafb-c12d-e053-6294a90a2bbf	70518-3173	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20210727		ANDA	ANDA090589	REMEDYREPACK INC.	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-3174_05e45949-6202-abf3-e063-6294a90a3b07	70518-3174	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20210727		ANDA	ANDA211623	REMEDYREPACK INC.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3177_065aca19-dc39-9d08-e063-6294a90a0c5e	70518-3177	HUMAN PRESCRIPTION DRUG	DULOXETINE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20210731		ANDA	ANDA206653	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3178_07ff205c-c91c-9c76-e063-6394a90a7486	70518-3178	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20210802		ANDA	ANDA091625	REMEDYREPACK INC.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3180_f4999073-ee5e-b0b4-e053-2a95a90a1035	70518-3180	HUMAN PRESCRIPTION DRUG	zonisamide		zonisamide	CAPSULE	ORAL	20210804		ANDA	ANDA077869	REMEDYREPACK INC.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70518-3181_065af1b8-3624-a28f-e063-6294a90af703	70518-3181	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20210805		ANDA	ANDA076416	REMEDYREPACK INC.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-3182_fb2e406d-3714-0e34-e053-6294a90a2c0b	70518-3182	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20210805		ANDA	ANDA090061	REMEDYREPACK INC.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70518-3183_065b3b45-8269-a974-e063-6394a90afcef	70518-3183	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20210806		ANDA	ANDA209286	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3186_f7568102-35eb-94e8-e053-6394a90afa83	70518-3186	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20210810		ANDA	ANDA071745	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3187_f756af7b-6476-eca3-e053-6294a90a10fa	70518-3187	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210810		ANDA	ANDA207497	REMEDYREPACK INC.	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-3188_065b8f58-c8dd-1779-e063-6294a90a641f	70518-3188	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20210810		ANDA	ANDA072928	REMEDYREPACK INC.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3190_065bd748-a848-bad8-e063-6394a90affc6	70518-3190	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20210810		ANDA	ANDA201109	REMEDYREPACK INC.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3193_f1ffb70e-1473-f7d0-e053-2995a90a558c	70518-3193	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210812		ANDA	ANDA075614	REMEDYREPACK INC.	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3194_065bf35a-99ae-9e2a-e063-6294a90ad320	70518-3194	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20210817		ANDA	ANDA040156	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-3195_065c1306-22bf-f932-e063-6394a90a53ef	70518-3195	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210817		ANDA	ANDA210014	REMEDYREPACK INC.	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3197_065c7d6c-246a-c74f-e063-6394a90a6265	70518-3197	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20210818		ANDA	ANDA077802	REMEDYREPACK INC.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3198_065ccfc2-e8c0-398e-e063-6294a90a314c	70518-3198	HUMAN PRESCRIPTION DRUG	FOLIC ACID		FOLIC ACID	TABLET	ORAL	20210818		ANDA	ANDA040796	REMEDYREPACK INC.	FOLIC ACID	1	mg/1			N	20241231
70518-3200_065cc564-e553-6a57-e063-6394a90a5f83	70518-3200	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20210826		ANDA	ANDA077336	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3204_065cdb03-fb54-fb6c-e063-6294a90a2fa6	70518-3204	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20210827		ANDA	ANDA204776	REMEDYREPACK INC.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3206_065d16e7-87f6-ecaa-e063-6294a90abca7	70518-3206	HUMAN PRESCRIPTION DRUG	POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE		polymyxin B sulfate, trimethoprim sulfate	SOLUTION/ DROPS	OPHTHALMIC	20210830		NDA AUTHORIZED GENERIC	NDA050567	REMEDYREPACK INC.	POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE	10000; 1	[USP'U]/mL; mg/mL	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70518-3207_f76dc6db-da0f-b347-e053-6294a90a2416	70518-3207	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210830		ANDA	ANDA075768	REMEDYREPACK INC.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3209_065d250e-56e7-4be0-e063-6294a90a930f	70518-3209	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20210901		ANDA	ANDA204237	REMEDYREPACK INC.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-3211_066a2f0c-6eb6-b8e3-e063-6394a90a101f	70518-3211	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210903		ANDA	ANDA075614	REMEDYREPACK INC.	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3212_066a27d5-9c55-44b4-e063-6394a90a682d	70518-3212	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20210903		ANDA	ANDA205096	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3213_066a5ff9-a427-255d-e063-6294a90acdcf	70518-3213	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20210908		ANDA	ANDA062677	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3214_01f28542-eac9-cf14-e063-6294a90aa6b8	70518-3214	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20210908		ANDA	ANDA062269	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3215_09052efb-4b0d-2e52-e063-6294a90a9d84	70518-3215	HUMAN PRESCRIPTION DRUG	Cefuroxime Axetil		Cefuroxime Axetil	TABLET, FILM COATED	ORAL	20210908		ANDA	ANDA065308	REMEDYREPACK INC.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3216_f76e1aee-81e4-31af-e053-6394a90ae688	70518-3216	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20210909		ANDA	ANDA091195	REMEDYREPACK INC.	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
70518-3217_f76e5827-3d0b-8e27-e053-6394a90ae75c	70518-3217	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20210910		ANDA	ANDA065211	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-3218_f76e9146-af28-ffea-e053-6394a90a68c7	70518-3218	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20210913		ANDA	ANDA091558	REMEDYREPACK INC.	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70518-3219_f76ed829-a32a-0c37-e053-6294a90aa7f1	70518-3219	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20210913		ANDA	ANDA076690	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3221_066f566d-999b-5beb-e063-6394a90ab10a	70518-3221	HUMAN PRESCRIPTION DRUG	CEFIXIME		CEFIXIME	CAPSULE	ORAL	20210914		NDA AUTHORIZED GENERIC	NDA203195	REMEDYREPACK INC.	CEFIXIME	400	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3222_f77c9554-d1c1-1682-e053-6294a90ac572	70518-3222	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20210914		ANDA	ANDA214422	REMEDYREPACK INC.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-3224_066fa82e-2f0a-27f0-e063-6394a90a4e31	70518-3224	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210916		ANDA	ANDA077645	REMEDYREPACK INC.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70518-3225_066fb0e7-d3e1-81d4-e063-6394a90acc49	70518-3225	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210917		ANDA	ANDA076150	REMEDYREPACK INC.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3229_06709bb4-a829-6eb0-e063-6294a90ad86e	70518-3229	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20210928		ANDA	ANDA203482	REMEDYREPACK INC.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3231_0670a414-60a3-b3af-e063-6394a90adfe7	70518-3231	HUMAN PRESCRIPTION DRUG	Losartan potassium and Hydrochlorothiazide		Losartan potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20211005		ANDA	ANDA202289	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3232_091bb6cb-0f42-9077-e063-6294a90a2433	70518-3232	HUMAN PRESCRIPTION DRUG	Hydroxyzine pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20211011		ANDA	ANDA086183	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-3233_0670e4b8-34a1-5c31-e063-6394a90a6718	70518-3233	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	CREAM	TOPICAL	20211011		ANDA	ANDA075213	REMEDYREPACK INC.	TRETINOIN	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
70518-3234_0670e41c-4b35-59d4-e063-6394a90a3fe1	70518-3234	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20211011		ANDA	ANDA061926	REMEDYREPACK INC.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-3236_0670f9f9-cd1e-a7c8-e063-6394a90a4bc5	70518-3236	HUMAN PRESCRIPTION DRUG	Insulin Aspart Protamine and Insulin Aspart	Mix 70/30	insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20220128		BLA	BLA021172	REMEDYREPACK INC.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
70518-3239_f77d8e26-8aa9-8183-e053-6294a90a0d88	70518-3239	HUMAN PRESCRIPTION DRUG	MESALAMINE		MESALAMINE	CAPSULE, DELAYED RELEASE	ORAL	20211013		NDA AUTHORIZED GENERIC	NDA204412	REMEDYREPACK INC.	MESALAMINE	400	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70518-3246_f7936176-e699-88b0-e053-6394a90a1489	70518-3246	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20211015		ANDA	ANDA213446	REMEDYREPACK INC.	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-3249_06836abf-87c1-0813-e063-6394a90a4a3b	70518-3249	HUMAN PRESCRIPTION DRUG	Azithromycin dihydrate		Azithromycin dihydrate	TABLET, FILM COATED	ORAL	20211018		ANDA	ANDA207566	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	600	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-3251_f811583c-0f2b-566e-e053-6294a90a9384	70518-3251	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20211020		ANDA	ANDA213324	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3254_fa50ecdf-09aa-f0fc-e053-6294a90ab1f4	70518-3254	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20211023		ANDA	ANDA211792	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-3256_f7942a59-8cb9-193f-e053-6394a90a185e	70518-3256	HUMAN PRESCRIPTION DRUG	PROPOFOL		PROPOFOL	INJECTION, EMULSION	INTRAVENOUS	20211025		ANDA	ANDA074848	REMEDYREPACK INC.	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
70518-3257_f7944247-9a4a-54fd-e053-6394a90aac95	70518-3257	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20211027		ANDA	ANDA205232	REMEDYREPACK INC.	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3258_06bbb497-1b6f-b278-e063-6394a90ade7a	70518-3258	HUMAN PRESCRIPTION DRUG	Efavirenz		Efavirenz	TABLET, FILM COATED	ORAL	20211029		ANDA	ANDA077673	REMEDYREPACK INC.	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
70518-3259_f794627c-d191-7854-e053-6394a90af879	70518-3259	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20211029		ANDA	ANDA074342	REMEDYREPACK INC.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3260_06bbf597-92af-0d04-e063-6294a90a8abc	70518-3260	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE	ER	metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20211030		ANDA	ANDA201991	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3263_06bc5947-7cbe-3b4f-e063-6394a90ae327	70518-3263	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20211102		ANDA	ANDA213343	REMEDYREPACK INC.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70518-3265_0a489a85-2da2-d9fb-e063-6394a90af226	70518-3265	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20211108		ANDA	ANDA205245	REMEDYREPACK INC.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70518-3268_fb7ecf67-7f95-b3c3-e053-6294a90a88e7	70518-3268	HUMAN PRESCRIPTION DRUG	Trihexyphenidyl Hydrochloride		Trihexyphenidyl Hydrochloride	SOLUTION	ORAL	20211115		ANDA	ANDA040177	REMEDYREPACK INC.	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/5mL			N	20241231
70518-3271_0c51f565-4d57-f809-e063-6394a90a99e8	70518-3271	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20211117		NDA AUTHORIZED GENERIC	NDA017442	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3272_f7958f33-fc8c-1461-e053-6294a90adc5f	70518-3272	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20211118		ANDA	ANDA075614	REMEDYREPACK INC.	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3273_07edb8d0-2fab-4b40-e063-6294a90a2fe9	70518-3273	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20211123		ANDA	ANDA211933	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3275_f795967e-8eeb-af85-e053-6394a90a6627	70518-3275	HUMAN PRESCRIPTION DRUG	CORTEF		hydrocortisone	TABLET	ORAL	20211128		NDA	NDA008697	REMEDYREPACK INC.	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3277_0c521726-e4f3-fed6-e063-6394a90a9f5c	70518-3277	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20211129		ANDA	ANDA078406	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3278_06bce5e5-8acd-d2bb-e063-6394a90ae1b4	70518-3278	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20211129		ANDA	ANDA212977	REMEDYREPACK INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-3279_06bd735e-3639-e2ad-e063-6294a90a345e	70518-3279	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20211130		ANDA	ANDA210907	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
70518-3280_f795e94e-106b-5d13-e053-6394a90a9bd7	70518-3280	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20211201		ANDA	ANDA212144	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3281_06bd57d2-f4c9-e66e-e063-6294a90a701e	70518-3281	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20211203		ANDA	ANDA071972	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3282_0e0b3b0e-a024-ec42-e063-6394a90a27af	70518-3282	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20211206		ANDA	ANDA078232	REMEDYREPACK INC.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
70518-3286_06bd9bd7-d82a-8203-e063-6294a90a6c1e	70518-3286	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20211208		ANDA	ANDA205229	REMEDYREPACK INC.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
70518-3287_06bdcb1d-8d55-f233-e063-6394a90a9b18	70518-3287	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20211209		ANDA	ANDA208706	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3290_0d815da9-39fb-c9f8-e063-6294a90a6752	70518-3290	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20211213		ANDA	ANDA205253	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-3291_0645458e-5277-dee4-e063-6294a90a206c	70518-3291	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20211213		ANDA	ANDA077739	REMEDYREPACK INC.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3293_06be5cec-97d3-1a23-e063-6294a90a4f5d	70518-3293	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20211213		ANDA	ANDA077739	REMEDYREPACK INC.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3294_0335f66d-6231-d239-e063-6394a90ab96e	70518-3294	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20211214		ANDA	ANDA065271	REMEDYREPACK INC.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-3295_06be6c7b-5145-4f1a-e063-6294a90a49a2	70518-3295	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20211214		ANDA	ANDA202297	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-3298_06beb2c9-31b3-e46c-e063-6394a90a66d0	70518-3298	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20211215		ANDA	ANDA211933	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3300_06bedbe1-e9af-c8a2-e063-6294a90aba69	70518-3300	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20211220		ANDA	ANDA203325	REMEDYREPACK INC.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-3304_06bf4c31-6357-c7c3-e063-6294a90a4471	70518-3304	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20211222		ANDA	ANDA211933	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3305_0d815da9-3a00-c9f8-e063-6294a90a6752	70518-3305	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20211223		ANDA	ANDA090428	REMEDYREPACK INC.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-3306_f7a78b03-91ca-dcee-e053-6394a90a2dfb	70518-3306	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20211223		ANDA	ANDA075382	REMEDYREPACK INC.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-3308_f7a7d52e-3c09-40ba-e053-6294a90af0ed	70518-3308	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20211223	20240930	ANDA	ANDA210616	REMEDYREPACK INC.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70518-3310_f7a999ab-d458-4f2f-e053-6294a90abb13	70518-3310	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211227		ANDA	ANDA213474	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3311_01c7c334-3c86-cf24-e063-6394a90af4ca	70518-3311	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20211227		ANDA	ANDA088487	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-3312_06bf768f-6bea-a4d9-e063-6394a90ad050	70518-3312	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20211227		ANDA	ANDA077253	REMEDYREPACK INC.	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-3313_06bf8f3e-c279-31ae-e063-6294a90a728d	70518-3313	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20211228		ANDA	ANDA090796	REMEDYREPACK INC.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3314_06bfa8b2-eee3-4795-e063-6294a90adbf1	70518-3314	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211228		ANDA	ANDA213474	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3315_06bfed9f-8449-9281-e063-6294a90af7f5	70518-3315	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20211228		ANDA	ANDA208301	REMEDYREPACK INC.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3317_06bfe007-b26f-085c-e063-6394a90a3e39	70518-3317	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20211229		ANDA	ANDA090767	REMEDYREPACK INC.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3318_06bfed9f-847e-9281-e063-6294a90af7f5	70518-3318	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20211229		ANDA	ANDA202304	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3321_06c06105-7c7b-07f0-e063-6294a90a8e4d	70518-3321	HUMAN PRESCRIPTION DRUG	CHLORPROMAZINE HYDROCHLORIDE		CHLORPROMAZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20211229		ANDA	ANDA209755	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3322_06c07eb6-83a2-38b9-e063-6294a90ade6b	70518-3322	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20211229		ANDA	ANDA204597	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3323_06c0811c-ad09-22f5-e063-6294a90a934c	70518-3323	HUMAN PRESCRIPTION DRUG	Hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20211229		NDA AUTHORIZED GENERIC	NDA011459	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-3324_09041882-9bad-8e22-e063-6294a90a5099	70518-3324	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20211230		ANDA	ANDA091240	REMEDYREPACK INC.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3327_06c0e63c-1d68-166c-e063-6394a90ad3a6	70518-3327	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220111		ANDA	ANDA213474	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3328_06c0b84a-4aec-8b75-e063-6294a90a382d	70518-3328	HUMAN PRESCRIPTION DRUG	Potassium-cit		potassium-cit	TABLET, EXTENDED RELEASE	ORAL	20220111		ANDA	ANDA214426	REMEDYREPACK INC.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
70518-3329_fce9d0b3-f790-51b1-e053-6294a90a741e	70518-3329	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220111		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3330_06c0fe9a-92bd-1679-e063-6394a90a4bf8	70518-3330	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220111		ANDA	ANDA090858	REMEDYREPACK INC.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3331_06c15208-c5bf-7173-e063-6394a90a2f94	70518-3331	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20220112		ANDA	ANDA075382	REMEDYREPACK INC.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70518-3332_06c15ac6-fba0-6b22-e063-6294a90a87fe	70518-3332	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220112		ANDA	ANDA205723	REMEDYREPACK INC.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70518-3333_06c1a044-cb6b-be06-e063-6294a90a6687	70518-3333	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220113		ANDA	ANDA075768	REMEDYREPACK INC.	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3334_06c1a044-cb6c-be06-e063-6294a90a6687	70518-3334	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20220116		ANDA	ANDA203931	REMEDYREPACK INC.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
70518-3335_06c18cf2-4cc0-c400-e063-6394a90ac6e7	70518-3335	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET, EXTENDED RELEASE	ORAL	20220118		ANDA	ANDA211623	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3336_06c1ea2c-1aa0-194a-e063-6294a90a6170	70518-3336	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone acetate	INJECTION, SUSPENSION, EXTENDED RELEASE	INTRAMUSCULAR	20220119		ANDA	ANDA077334	REMEDYREPACK INC.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70518-3338_06c24116-7195-9803-e063-6294a90ac79d	70518-3338	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20220120		ANDA	ANDA090961	REMEDYREPACK INC.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70518-3339_0cf2a167-9fbc-f1e4-e063-6394a90a653d	70518-3339	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20220123		ANDA	ANDA211933	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3340_06cf0b5b-dcae-11fa-e063-6394a90a6aaa	70518-3340	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220124		ANDA	ANDA083312	REMEDYREPACK INC.	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3341_06d0a737-15b5-ca07-e063-6394a90a5cb1	70518-3341	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20220124		ANDA	ANDA076140	REMEDYREPACK INC.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
70518-3342_d800769e-9570-36c4-e053-2995a90a14da	70518-3342	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	20220126	20250301	ANDA	ANDA064150	REMEDYREPACK INC.	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	
70518-3345_f7fae3ce-cfdd-7863-e053-6294a90a1feb	70518-3345	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220127		ANDA	ANDA209357	REMEDYREPACK INC.	PREGABALIN	150	mg/1		CV	N	20241231
70518-3346_06d0e581-5efc-d072-e063-6294a90a6d92	70518-3346	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220127		ANDA	ANDA209357	REMEDYREPACK INC.	PREGABALIN	300	mg/1		CV	N	20241231
70518-3347_06d11fe4-98d8-8aec-e063-6394a90a9eeb	70518-3347	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20220128		ANDA	ANDA202496	REMEDYREPACK INC.	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70518-3348_06d15d06-c7ca-8e85-e063-6294a90ab2a2	70518-3348	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20220128		ANDA	ANDA213368	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3349_06d17b71-f9d3-e1f3-e063-6394a90aed38	70518-3349	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20220131		ANDA	ANDA078103	REMEDYREPACK INC.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3350_06d35adc-bf76-73dc-e063-6294a90a4b1b	70518-3350	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220131		ANDA	ANDA209686	REMEDYREPACK INC.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-3352_06d34c06-f0ec-0825-e063-6394a90ae0c9	70518-3352	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20220131		ANDA	ANDA071745	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3353_fb7ee4de-a368-2b56-e053-6394a90a19b4	70518-3353	HUMAN PRESCRIPTION DRUG	Phenytoin		Phenytoin	SUSPENSION	ORAL	20220201		ANDA	ANDA040610	REMEDYREPACK INC.	PHENYTOIN	125	mg/5mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3355_06e40819-252b-8ab8-e063-6294a90a4afe	70518-3355	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220202		ANDA	ANDA065342	REMEDYREPACK INC.	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3356_06e77370-10c5-6354-e063-6294a90ad20f	70518-3356	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20220203		ANDA	ANDA208170	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3357_0e85bc3d-4ef6-00d3-e063-6294a90a847a	70518-3357	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20220203		ANDA	ANDA206433	REMEDYREPACK INC.	CLOZAPINE	200	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-3359_0e85e93a-95b0-8e52-e063-6294a90a69fd	70518-3359	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20220207		ANDA	ANDA090682	REMEDYREPACK INC.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
70518-3360_0e860102-a89c-5dbd-e063-6394a90a69ff	70518-3360	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220207		ANDA	ANDA213474	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
70518-3362_0e860cef-ca7c-afc4-e063-6294a90a3bbb	70518-3362	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20220208		ANDA	ANDA062702	REMEDYREPACK INC.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20251231
70518-3363_0e860a6c-f029-af94-e063-6294a90a0704	70518-3363	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20220210		ANDA	ANDA210664	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
70518-3364_0e865196-129e-e7f5-e063-6294a90aa025	70518-3364	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20220211		ANDA	ANDA078182	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
70518-3365_0e867446-c661-7ca9-e063-6394a90a21c2	70518-3365	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20220214		ANDA	ANDA204234	REMEDYREPACK INC.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
70518-3366_0e869044-7b46-6f0a-e063-6394a90a1fb8	70518-3366	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20220214		ANDA	ANDA203646	REMEDYREPACK INC.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
70518-3367_0e8666d7-b6f4-f20b-e063-6294a90af644	70518-3367	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20220216		ANDA	ANDA075581	REMEDYREPACK INC.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
70518-3368_0e86a8db-6778-0a30-e063-6294a90a296e	70518-3368	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220221		ANDA	ANDA203270	REMEDYREPACK INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
70518-3370_0e86d599-768d-a657-e063-6394a90acfea	70518-3370	HUMAN PRESCRIPTION DRUG	Fenofibrate		FENOFIBRATE	TABLET, FILM COATED	ORAL	20220223		ANDA	ANDA210670	REMEDYREPACK INC.	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20251231
70518-3373_0e8765b0-2ef1-cf01-e063-6394a90af245	70518-3373	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20220225		ANDA	ANDA209828	REMEDYREPACK INC.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-3374_0e876826-b9d8-ce6b-e063-6394a90a8791	70518-3374	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220301		ANDA	ANDA213474	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
70518-3375_0e87896b-835b-d3f0-e063-6394a90a065e	70518-3375	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20220301		ANDA	ANDA071745	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
70518-3377_0e877aee-bf09-d8cd-e063-6394a90a1171	70518-3377	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20220306		ANDA	ANDA071972	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
70518-3378_08789d0d-1136-7467-e063-6294a90a2b7d	70518-3378	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20220308		ANDA	ANDA090836	REMEDYREPACK INC.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3379_0e87fc65-a557-da85-e063-6394a90a1ae5	70518-3379	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20220308		ANDA	ANDA040803	REMEDYREPACK INC.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70518-3380_0e88159b-f578-2bc8-e063-6294a90acce2	70518-3380	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20220309		ANDA	ANDA204838	REMEDYREPACK INC.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-3381_0e882546-9f5e-01eb-e063-6294a90a7fce	70518-3381	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		amantadine hydrochloride	TABLET	ORAL	20220310		ANDA	ANDA076186	REMEDYREPACK INC.	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20251231
70518-3382_0e886392-7fad-0d1a-e063-6394a90ae73f	70518-3382	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20220310		ANDA	ANDA202557	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20251231
70518-3384_0e9991c9-a604-cdbd-e063-6294a90ae5bc	70518-3384	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20220310		ANDA	ANDA208864	REMEDYREPACK INC.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
70518-3386_0e9a78e9-3335-a7fa-e063-6294a90a9779	70518-3386	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20220311		ANDA	ANDA201384	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
70518-3388_0e9a9db7-6a1c-d144-e063-6394a90ad796	70518-3388	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20220315		ANDA	ANDA206651	REMEDYREPACK INC.	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20251231
70518-3389_f2637702-9b60-8e18-e053-2a95a90a3e8d	70518-3389	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20220316		ANDA	ANDA205601	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-3391_0e9abeab-8088-d78f-e063-6394a90a1fba	70518-3391	HUMAN PRESCRIPTION DRUG	CLOZAPINE		CLOZAPINE	TABLET	ORAL	20220317		ANDA	ANDA206433	REMEDYREPACK INC.	CLOZAPINE	100	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-3392_f37db097-a2ee-e2ca-e053-2a95a90a0ba8	70518-3392	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20220318		ANDA	ANDA211285	REMEDYREPACK INC.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
70518-3395_0e9b359e-75ea-d979-e063-6394a90ab31d	70518-3395	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20220324		ANDA	ANDA208451	REMEDYREPACK INC.	ESZOPICLONE	3	mg/1		CIV	N	20251231
70518-3397_f52426c3-c459-6a1b-e053-2a95a90ad6cb	70518-3397	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20220328		ANDA	ANDA201384	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
70518-3398_0c6931f7-8e5a-39c9-e063-6294a90adec6	70518-3398	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220330		ANDA	ANDA204901	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3400_f4d664c5-a279-820b-e053-2995a90aa54c	70518-3400	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20220404		ANDA	ANDA215579	REMEDYREPACK INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70518-3401_09cf6708-7a45-f0f6-e063-6394a90af272	70518-3401	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220405		ANDA	ANDA208412	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3403_05cd1254-44db-24fb-e063-6394a90a23ce	70518-3403	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20220406		ANDA	ANDA071196	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-3407_0e9b359e-75eb-d979-e063-6394a90ab31d	70518-3407	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20220408		ANDA	ANDA040876	REMEDYREPACK INC.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20251231
70518-3408_0e9b4c85-e36f-eba1-e063-6394a90a95c8	70518-3408	HUMAN PRESCRIPTION DRUG	Proparacaine Hydrochloride		Proparacaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20220408		ANDA	ANDA080027	REMEDYREPACK INC.	PROPARACAINE HYDROCHLORIDE	5	mg/mL	Local Anesthesia [PE], Local Anesthetic [EPC]		N	20251231
70518-3409_0e9b6697-28a9-f69f-e063-6394a90a9d11	70518-3409	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA201845	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-3411_0e9b821a-f22f-0599-e063-6394a90ae09a	70518-3411	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20220414		ANDA	ANDA200908	REMEDYREPACK INC.	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
70518-3413_0e9b878a-6a17-7b1a-e063-6294a90a3494	70518-3413	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20220417		ANDA	ANDA215001	REMEDYREPACK INC.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20251231
70518-3414_f15f1ef1-765c-1814-e053-2995a90a5fa6	70518-3414	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220427		ANDA	ANDA204991	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3415_0e9ba0b2-6333-96ba-e063-6294a90a1b30	70518-3415	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20220429		ANDA	ANDA208170	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
70518-3416_0783e95c-bd8f-49de-e063-6394a90afe29	70518-3416	HUMAN OTC DRUG	Acetaminophen Regular Strength		ACETAMINOPHEN	TABLET	ORAL	20220505		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	ACETAMINOPHEN	325	mg/1			N	20241231
70518-3417_0e9baada-98de-0ea2-e063-6394a90a5aae	70518-3417	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20220511		ANDA	ANDA208921	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
70518-3418_0e9c0d21-9424-4009-e063-6394a90a51ce	70518-3418	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20220512		ANDA	ANDA201384	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20251231
70518-3419_0e9bfe8c-73ac-3e20-e063-6394a90aea41	70518-3419	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	20220515		ANDA	ANDA072709	REMEDYREPACK INC.	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
70518-3420_0e9c2bac-2d14-40b1-e063-6394a90a4a0a	70518-3420	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220516		ANDA	ANDA204901	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
70518-3421_0e9d1dc4-144b-8753-e063-6394a90af036	70518-3421	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220516		ANDA	ANDA076363	REMEDYREPACK INC.	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20251231
70518-3423_01ccf252-e052-d450-e063-6394a90a4a3d	70518-3423	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20220525		ANDA	ANDA072927	REMEDYREPACK INC.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3424_0e9d303d-0fae-86d6-e063-6294a90a37d2	70518-3424	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20220525		ANDA	ANDA210628	REMEDYREPACK INC.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-3425_0e9d3105-a526-9105-e063-6394a90af914	70518-3425	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20220525		ANDA	ANDA077633	REMEDYREPACK INC.	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20251231
70518-3426_0e9dbf6a-9705-c170-e063-6294a90a45f8	70518-3426	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20220525		ANDA	ANDA202180	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20251231
70518-3427_0eae721e-4d92-da4f-e063-6394a90a7b4b	70518-3427	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220526		ANDA	ANDA076565	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20251231
70518-3428_0eae8baf-b0a2-0907-e063-6394a90ac861	70518-3428	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20220526		ANDA	ANDA075521	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20251231
70518-3429_0eaeabea-7698-c10b-e063-6294a90a5b50	70518-3429	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20220526		ANDA	ANDA091388	REMEDYREPACK INC.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-3430_0eafa28e-87ed-4fda-e063-6394a90a99ca	70518-3430	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20220602		ANDA	ANDA077584	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
70518-3431_0eafc644-2804-81ef-e063-6294a90af8dc	70518-3431	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20220603		ANDA	ANDA078597	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20251231
70518-3432_f4d52a05-1844-46f2-e053-2995a90a16da	70518-3432	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20220608		ANDA	ANDA090624	REMEDYREPACK INC.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70518-3433_f80a07b7-7564-194a-e053-6394a90adc26	70518-3433	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20220609		ANDA	ANDA210394	REMEDYREPACK INC.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-3434_f225c93b-d7f5-2656-e053-2995a90a28d6	70518-3434	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20220609		ANDA	ANDA209654	REMEDYREPACK INC.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-3435_0eafcf50-c58a-8204-e063-6294a90a340d	70518-3435	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20220613		ANDA	ANDA212144	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
70518-3436_0eaff689-c7c4-6fde-e063-6394a90a139b	70518-3436	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20220614		ANDA	ANDA204313	REMEDYREPACK INC.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
70518-3437_0eb0029a-760c-7f57-e063-6394a90aec73	70518-3437	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220614		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20251231
70518-3438_0eb004f9-3830-9eab-e063-6294a90ad2ef	70518-3438	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20220614		ANDA	ANDA040751	REMEDYREPACK INC.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
70518-3439_0eb010b9-31db-90c7-e063-6294a90ad2af	70518-3439	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20220614		ANDA	ANDA078578	REMEDYREPACK INC.	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
70518-3440_0eb021d9-276f-862f-e063-6394a90a317a	70518-3440	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20220615		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20251231
70518-3441_0ccd1984-0a6f-4310-e063-6394a90a5eb5	70518-3441	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20220622		ANDA	ANDA090549	REMEDYREPACK INC.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-3443_03998940-092f-6db7-e063-6294a90a1dd6	70518-3443	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20220628		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
70518-3444_0eb0509d-a21a-c38a-e063-6294a90a8956	70518-3444	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20220629		ANDA	ANDA213057	REMEDYREPACK INC.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20251231
70518-3446_01f48edf-99f2-1d3a-e063-6294a90a8b33	70518-3446	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20220711		ANDA	ANDA075521	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
70518-3447_0eb0ee15-bb9e-bd77-e063-6394a90a0df7	70518-3447	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20220713		ANDA	ANDA204319	REMEDYREPACK INC.	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20251231
70518-3448_fd7b25a9-9c15-10c4-e053-6394a90ac119	70518-3448	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20210721		ANDA	ANDA065229	REMEDYREPACK INC.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3451_0eb116d0-46b1-c65e-e063-6394a90ae1a2	70518-3451	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		valacyclovir	TABLET, FILM COATED	ORAL	20220714		ANDA	ANDA078518	REMEDYREPACK INC.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
70518-3452_f2b65a80-c097-efe1-e053-2a95a90aa474	70518-3452	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20220715		ANDA	ANDA201507	REMEDYREPACK INC.	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-3454_049e74a4-64c1-28ed-e063-6294a90a045d	70518-3454	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20220718		ANDA	ANDA090624	REMEDYREPACK INC.	SULFAMETHOXAZOLE; TRIMETHOPRIM	400; 80	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70518-3456_0eb13c82-173d-7375-e063-6294a90a1557	70518-3456	HUMAN PRESCRIPTION DRUG	Flumazenil		FLUMAZENIL	INJECTION, SOLUTION	INTRAVENOUS	20210721		ANDA	ANDA076955	REMEDYREPACK INC.	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20251231
70518-3457_020678a1-8c84-42dd-e063-6294a90a6b39	70518-3457	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	CAPSULE, COATED PELLETS	ORAL	20220720		ANDA	ANDA213181	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3459_0659c576-6e2f-b4e1-e063-6294a90a37ad	70518-3459	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20220725		ANDA	ANDA078182	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3460_0eb15709-ae3a-d4ef-e063-6394a90a27db	70518-3460	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20220725		ANDA	ANDA078462	REMEDYREPACK INC.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70518-3461_05ceb6e6-7c64-28d4-e063-6394a90a40c9	70518-3461	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20220725		ANDA	ANDA076477	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3464_0eb183b2-58a2-e4b9-e063-6394a90a3de3	70518-3464	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20220728		ANDA	ANDA206298	REMEDYREPACK INC.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
70518-3465_0eb1890d-a27b-e9a9-e063-6394a90a31f8	70518-3465	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220801		ANDA	ANDA212026	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
70518-3466_0eb1a783-e499-c64c-e063-6294a90a11c4	70518-3466	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20220803		ANDA	ANDA071972	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
70518-3471_f27770fe-7175-05d0-e053-2a95a90a6581	70518-3471	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20220809		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
70518-3475_f2b79a12-2240-2f14-e053-2a95a90a0abc	70518-3475	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20220811		ANDA	ANDA076670	REMEDYREPACK INC.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3476_0d80590c-f621-b35e-e063-6294a90a27c0	70518-3476	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220816		ANDA	ANDA208412	REMEDYREPACK INC.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3477_039c3a30-6f43-23c1-e063-6394a90ace01	70518-3477	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20220816		ANDA	ANDA209286	REMEDYREPACK INC.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3478_f5375577-0a8f-6543-e053-2995a90aaac4	70518-3478	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20220817		ANDA	ANDA090135	REMEDYREPACK INC.	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70518-3479_fd791428-05d3-5c7b-e053-6294a90a2747	70518-3479	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20220816		ANDA	ANDA202180	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-3486_f15f8d2b-88a9-567e-e053-2995a90aa659	70518-3486	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20220819		ANDA	ANDA212517	REMEDYREPACK INC.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3488_088b6e83-b06a-c5ea-e063-6394a90ac361	70518-3488	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20220822		ANDA	ANDA209402	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3501_05ce8e8e-0b24-061e-e063-6394a90a2e92	70518-3501	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20220829		ANDA	ANDA208250	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-3512_0d6ccb8f-d9c1-28e6-e063-6294a90a8a87	70518-3512	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20220907		ANDA	ANDA078152	REMEDYREPACK INC.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70518-3517_f2b322d9-2deb-0834-e053-2a95a90ab5b9	70518-3517	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20220913		ANDA	ANDA212491	REMEDYREPACK INC.	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
70518-3524_f49a0f84-da6f-3ae7-e053-2a95a90a30ec	70518-3524	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20220917		ANDA	ANDA078165	REMEDYREPACK INC.	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3525_06471aaf-eb2c-9f20-e063-6294a90a75e5	70518-3525	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20220917		ANDA	ANDA212861	REMEDYREPACK INC.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-3529_01e25d7a-dd56-11d6-e063-6294a90ade58	70518-3529	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200920		ANDA	ANDA207290	REMEDYREPACK INC.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-3531_05bb2c51-82e0-e9eb-e063-6294a90abe13	70518-3531	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20220921		ANDA	ANDA078512	REMEDYREPACK INC.	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3534_fb7edaad-2868-3f8b-e053-6294a90ac6e4	70518-3534	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20220923		ANDA	ANDA078976	REMEDYREPACK INC.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3538_f8c0e607-6ee4-5e48-e053-6294a90a6a07	70518-3538	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	20220926		ANDA	ANDA215585	REMEDYREPACK INC.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3540_06473b07-9d4e-d652-e063-6394a90a103e	70518-3540	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20220926		ANDA	ANDA213386	REMEDYREPACK INC.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3542_049f9ce0-73ca-2865-e063-6394a90a505a	70518-3542	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20220929		ANDA	ANDA202765	REMEDYREPACK INC.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
70518-3545_01cbe715-daa9-0ee2-e063-6294a90aa210	70518-3545	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220930		ANDA	ANDA203699	REMEDYREPACK INC.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3553_fb7ef469-f873-b68c-e053-6394a90ab4a0	70518-3553	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	SOLUTION, CONCENTRATE	ORAL	20221011		ANDA	ANDA074725	REMEDYREPACK INC.	FLUPHENAZINE HYDROCHLORIDE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3554_f81070e6-1cd0-d1b2-e053-6294a90a8964	70518-3554	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20221013		ANDA	ANDA204597	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3565_066e7447-a3c3-8006-e063-6394a90a561e	70518-3565	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE	ORAL	20221031		ANDA	ANDA079139	REMEDYREPACK INC.	LITHIUM CARBONATE	150	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-3568_f1fffd68-843d-39af-e053-2a95a90a64ea	70518-3568	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20221102		ANDA	ANDA090798	REMEDYREPACK INC.	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3570_f1889bd9-fd47-33d8-e053-2995a90a04cb	70518-3570	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20221103		ANDA	ANDA209313	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3575_f3911d79-316a-71c3-e053-2a95a90ae843	70518-3575	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20221110		ANDA	ANDA040419	REMEDYREPACK INC.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
70518-3579_f15f058b-5000-715c-e053-2a95a90ad385	70518-3579	HUMAN PRESCRIPTION DRUG	M-Natal Plus		Vitamin A, Vitamin C, Vitamin D, Vitamin E, Thiamine, Riboflavin, Niacin, Vitamin B6, Folic Acid, Vitamin B12, Calcium, Iron, Zinc, Copper	TABLET	ORAL	20221105		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; CALCIUM; COPPER; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; NIACIN; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE; VITAMIN A; VITAMIN D; ZINC	22; 120; 200; 2; 12; 27; 1; 20; 10; 3; 1.84; 4000; 400; 25	[iU]/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calcium [CS], Calcium [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
70518-3583_f80b6750-8a00-3a40-e053-6294a90a1347	70518-3583	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20221204		ANDA	ANDA074569	REMEDYREPACK INC.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3588_f267225c-9ba7-5434-e053-2a95a90a8488	70518-3588	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20221206		ANDA	ANDA211020	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3590_f63e2d14-cdd9-39a1-e053-2995a90ade54	70518-3590	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20221207		ANDA	ANDA212996	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3592_f32d7d28-6f2a-769f-e053-2a95a90a178b	70518-3592	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20221207		ANDA	ANDA203245	REMEDYREPACK INC.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-3596_01f3b551-67c4-3b27-e063-6294a90afd46	70518-3596	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20221221		ANDA	ANDA211604	REMEDYREPACK INC.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70518-3597_f4d465e3-d16a-a055-e053-2a95a90ae2f3	70518-3597	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20221221		ANDA	ANDA207799	REMEDYREPACK INC.	PREGABALIN	75	mg/1		CV	N	20241231
70518-3600_fab6cafe-04fa-b241-e053-6294a90a7719	70518-3600	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20221228		ANDA	ANDA204304	REMEDYREPACK INC.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70518-3601_f2267e99-0cd6-b070-e053-2a95a90a5f93	70518-3601	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20221230		ANDA	ANDA204343	REMEDYREPACK INC.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3602_fb2e36fb-ee75-c8a0-e053-6294a90a8c5a	70518-3602	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230104		ANDA	ANDA078625	REMEDYREPACK INC.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-3603_f1dbd7c6-eef7-41ad-e053-2a95a90ace02	70518-3603	HUMAN PRESCRIPTION DRUG	Buprenorphine and Naloxone		Buprenorphine and Naloxone	TABLET	SUBLINGUAL	20230104		ANDA	ANDA201633	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-3604_f49a9e84-4bd6-068e-e053-2a95a90a6e4d	70518-3604	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA065096	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-3605_f174b7b1-39ba-8af0-e053-2995a90aea72	70518-3605	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20230104		ANDA	ANDA211542	REMEDYREPACK INC.	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3606_0c533053-553f-26e9-e063-6294a90a769c	70518-3606	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA077739	REMEDYREPACK INC.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3607_f4d6f20c-6339-ba67-e053-2a95a90a3b21	70518-3607	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20230104		ANDA	ANDA208972	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
70518-3608_05b96ecc-bb0b-e0ad-e063-6294a90a0ef3	70518-3608	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230104		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-3609_f1885673-34ae-8061-e053-2995a90af03b	70518-3609	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA091388	REMEDYREPACK INC.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3610_f18713f1-6382-059e-e053-2995a90ac3e4	70518-3610	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20230105		ANDA	ANDA078250	REMEDYREPACK INC.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3611_01e1b815-bede-0f28-e063-6394a90ad114	70518-3611	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20230105		ANDA	ANDA205096	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3612_f20367e7-11df-3a93-e053-2995a90a8f73	70518-3612	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20230108		ANDA	ANDA076511	REMEDYREPACK INC.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70518-3613_f1d8c7f1-90d2-94e8-e053-2a95a90af57f	70518-3613	HUMAN PRESCRIPTION DRUG	PAROXETINE		PAROXETINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230109		ANDA	ANDA204134	REMEDYREPACK INC.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3614_065969f0-8ea5-8bc2-e063-6394a90a633e	70518-3614	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20230109		ANDA	ANDA209102	REMEDYREPACK INC.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70518-3615_f1ffbc60-1388-2b82-e053-2995a90a9111	70518-3615	HUMAN PRESCRIPTION DRUG	HYDROXYUREA		HYDROXYUREA	CAPSULE	ORAL	20230110		ANDA	ANDA213438	REMEDYREPACK INC.	HYDROXYUREA	500	mg/1	Antimetabolite [EPC], Urea [CS]		N	20241231
70518-3616_fb6a850b-cdb7-4bde-e053-6294a90a8d31	70518-3616	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20230118		ANDA	ANDA078341	REMEDYREPACK INC.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70518-3618_f305ee7e-86e1-7600-e053-2a95a90a231c	70518-3618	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20230120		ANDA	ANDA090135	REMEDYREPACK INC.	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70518-3619_f2b41fc7-c877-c9ef-e053-2995a90ad6f1	70518-3619	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	CREAM	TOPICAL	20230120		ANDA	ANDA075883	REMEDYREPACK INC.	AMMONIUM LACTATE	120	mg/g	Acidifying Activity [MoA]		N	20241231
70518-3620_f7f9c421-891e-bd0c-e053-6294a90a8548	70518-3620	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20230121		ANDA	ANDA079163	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3621_0ead7c4b-8927-bb76-e063-6294a90a9535	70518-3621	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230125		ANDA	ANDA214548	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
70518-3622_f32d662f-49d4-981d-e053-2995a90a7d40	70518-3622	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20230125		ANDA	ANDA206751	REMEDYREPACK INC.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3623_f32fcc12-ae63-f0b6-e053-2a95a90a6d50	70518-3623	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20230125		ANDA	ANDA077653	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3624_f37ec4a3-f56a-9eb4-e053-2a95a90afd88	70518-3624	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230127		ANDA	ANDA065063	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-3625_f37e9182-26d3-ade7-e053-2995a90a0dd2	70518-3625	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230127		ANDA	ANDA040750	REMEDYREPACK INC.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-3626_f37dd2b4-fa2c-41d6-e053-2a95a90aa342	70518-3626	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20230129		ANDA	ANDA206094	REMEDYREPACK INC.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70518-3627_fcffa7e6-1462-6bc0-e053-6294a90a4751	70518-3627	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230129		ANDA	ANDA202759	REMEDYREPACK INC.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3628_f37ca22c-c64a-e2f4-e053-2a95a90ad6b1	70518-3628	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230130		ANDA	ANDA062366	REMEDYREPACK INC.	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70518-3630_f3badc0a-a181-e0a9-e053-2a95a90ade7a	70518-3630	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230131		ANDA	ANDA078034	REMEDYREPACK INC.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3631_f41fce39-4cee-e23f-e053-2995a90a2972	70518-3631	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230203		ANDA	ANDA065101	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-3632_f4d69065-b3a5-091b-e053-2995a90ac674	70518-3632	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20230206		ANDA	ANDA091236	REMEDYREPACK INC.	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-3633_01ce0bf5-1253-9287-e063-6294a90a142d	70518-3633	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20230206		ANDA	ANDA085182	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3635_f4466d0a-f686-f07f-e053-2995a90af45c	70518-3635	HUMAN PRESCRIPTION DRUG	VANCOMYCIN HYDROCHLORIDE		VANCOMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20230209		ANDA	ANDA210729	REMEDYREPACK INC.	VANCOMYCIN HYDROCHLORIDE	125	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70518-3636_fcfe9e3e-3702-e9c2-e053-6294a90a66ad	70518-3636	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230209		ANDA	ANDA207799	REMEDYREPACK INC.	PREGABALIN	50	mg/1		CV	N	20241231
70518-3637_f446a68b-2756-6d80-e053-2995a90ad21c	70518-3637	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20230209		ANDA	ANDA213057	REMEDYREPACK INC.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70518-3639_f49863ff-edde-08ca-e053-2a95a90a4989	70518-3639	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20230212		ANDA	ANDA207752	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3640_f4974856-71c0-149f-e053-2a95a90a793a	70518-3640	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20230212		ANDA	ANDA078332	REMEDYREPACK INC.	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3641_f9c67eb3-5c12-c5a2-e053-6294a90a9493	70518-3641	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA214548	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3642_f4c1e9ff-efd4-f3a5-e053-2995a90adda7	70518-3642	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230215		ANDA	ANDA207799	REMEDYREPACK INC.	PREGABALIN	225	mg/1		CV	N	20241231
70518-3643_f4c1ec9e-20ea-3f47-e053-2a95a90a604e	70518-3643	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230215		ANDA	ANDA207799	REMEDYREPACK INC.	PREGABALIN	100	mg/1		CV	N	20241231
70518-3644_f80b3146-6b5b-9e00-e053-6394a90a2dc4	70518-3644	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20230215		ANDA	ANDA204882	REMEDYREPACK INC.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-3645_f4d53c14-1b3e-0923-e053-2995a90ae49e	70518-3645	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230216		ANDA	ANDA203499	REMEDYREPACK INC.	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3646_f4d5e30f-e500-8af5-e053-2a95a90a1396	70518-3646	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230216		ANDA	ANDA207799	REMEDYREPACK INC.	PREGABALIN	300	mg/1		CV	N	20241231
70518-3647_f4d5ad9f-8cdf-3d6d-e053-2a95a90a685c	70518-3647	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230216		ANDA	ANDA207799	REMEDYREPACK INC.	PREGABALIN	150	mg/1		CV	N	20241231
70518-3648_f53924b5-5e9f-0329-e053-2a95a90a0cbd	70518-3648	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230216		ANDA	ANDA078034	REMEDYREPACK INC.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3649_f536ed59-266f-4e10-e053-2995a90a5711	70518-3649	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20230217		ANDA	ANDA076477	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3650_f522576e-4de9-6268-e053-2a95a90a1f9b	70518-3650	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230219		ANDA	ANDA078034	REMEDYREPACK INC.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3651_01c9c019-bfb2-ea4f-e063-6394a90aff45	70518-3651	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20230219		ANDA	ANDA207408	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3652_f9c6a806-3880-c4cc-e053-6394a90a0e88	70518-3652	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230220		ANDA	ANDA202112	REMEDYREPACK INC.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3653_fb303fbd-3293-beaf-e053-6394a90a9534	70518-3653	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, COATED	ORAL	20230220		ANDA	ANDA201619	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3654_07851a73-ee2a-399b-e063-6394a90a4d69	70518-3654	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA214548	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3655_f90fb0b8-2bea-e629-e053-6394a90a3eaf	70518-3655	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230221		ANDA	ANDA040750	REMEDYREPACK INC.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-3656_027fa872-d763-052e-e063-6294a90a959f	70518-3656	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230221		ANDA	ANDA091388	REMEDYREPACK INC.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3657_f54fee05-3022-334c-e053-2995a90a577b	70518-3657	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20230222		ANDA	ANDA202239	REMEDYREPACK INC.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70518-3658_01df97ac-1c3e-0535-e063-6394a90aa14d	70518-3658	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20230223		ANDA	ANDA076286	REMEDYREPACK INC.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-3660_f63f59c5-8f87-f31c-e053-2a95a90a3803	70518-3660	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230224		ANDA	ANDA211820	REMEDYREPACK INC.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70518-3661_f831cb27-1021-5311-e053-6394a90a2e5b	70518-3661	HUMAN PRESCRIPTION DRUG	Pyrazinamide		Pyrazinamide	TABLET	ORAL	20230226		ANDA	ANDA080157	REMEDYREPACK INC.	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
70518-3662_f825d306-3132-a8fc-e053-6294a90ae8f3	70518-3662	HUMAN PRESCRIPTION DRUG	Ethambutol Hydrochloride		Ethambutol Hydrochloride	TABLET	ORAL	20230226		ANDA	ANDA078939	REMEDYREPACK INC.	ETHAMBUTOL HYDROCHLORIDE	100	mg/1	Antimycobacterial [EPC]		N	20241231
70518-3664_fe8fb894-043b-57b8-e053-6294a90a7ee5	70518-3664	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230227		ANDA	ANDA077091	REMEDYREPACK INC.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3665_fea6d32a-fe7f-aba5-e053-6394a90a6b4f	70518-3665	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230227		ANDA	ANDA077091	REMEDYREPACK INC.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3667_f810bd88-f2ef-ca3d-e053-6394a90a8c52	70518-3667	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20230301		ANDA	ANDA075580	REMEDYREPACK INC.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3668_f8105b89-ed96-ef0b-e053-6394a90a32b6	70518-3668	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20230301		ANDA	ANDA071173	REMEDYREPACK INC.	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
70518-3669_07840195-bb25-941c-e063-6394a90a58ea	70518-3669	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230303		ANDA	ANDA215697	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3670_f63d52f2-93d5-ada6-e053-2a95a90a4f3f	70518-3670	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20230303		ANDA	ANDA212996	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3672_f63dd836-990c-8f1a-e053-2995a90a3740	70518-3672	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20230306		ANDA	ANDA210454	REMEDYREPACK INC.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70518-3673_f80bcafa-f355-144b-e053-6394a90a884c	70518-3673	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, COATED	ORAL	20230306		ANDA	ANDA212996	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3674_f80bfcee-bef2-8fe2-e053-6394a90a08c3	70518-3674	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20230306		ANDA	ANDA084113	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3676_f7e55ad0-09e3-10e6-e053-6394a90a3698	70518-3676	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230315		ANDA	ANDA091568	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-3677_09b981fb-056f-e359-e063-6394a90ae7e6	70518-3677	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20230308		ANDA	ANDA090636	REMEDYREPACK INC.	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
70518-3678_f809c783-1e6f-fc25-e053-6294a90adc15	70518-3678	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230309		ANDA	ANDA077691	REMEDYREPACK INC.	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3679_01dc9da1-7775-f026-e063-6394a90abd80	70518-3679	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230312		ANDA	ANDA215697	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3680_f7f9db2c-5af3-8675-e053-6394a90a4e42	70518-3680	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230313		ANDA	ANDA211143	REMEDYREPACK INC.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3681_f7e52f48-033c-a10c-e053-6294a90aff7e	70518-3681	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20230314		ANDA	ANDA076832	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-3682_f7e48dbc-c8ce-9641-e053-6394a90aca1b	70518-3682	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230316		ANDA	ANDA209314	REMEDYREPACK INC.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-3683_05671a95-d313-be61-e063-6394a90a1e66	70518-3683	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20230317		ANDA	ANDA090554	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3684_fe8f8dbc-ce12-639d-e053-6394a90aad22	70518-3684	HUMAN PRESCRIPTION DRUG	Methylprednisolone sodium succinate		Methylprednisolone sodium succinate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230317		ANDA	ANDA212396	REMEDYREPACK INC.	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3685_f7f7ac15-854b-e93f-e053-6394a90aadf7	70518-3685	HUMAN PRESCRIPTION DRUG	Diphenhydramine		DIPHENHYDRAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230320		ANDA	ANDA040466	REMEDYREPACK INC.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70518-3686_f7aa4f32-9034-ebba-e053-6294a90a9b13	70518-3686	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20230320		ANDA	ANDA210907	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
70518-3687_f927cb91-94c4-6da4-e053-6294a90a47ce	70518-3687	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20230320		ANDA	ANDA206465	REMEDYREPACK INC.	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3688_fd78191c-9c8d-3150-e053-6294a90ac7cb	70518-3688	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230321		ANDA	ANDA203499	REMEDYREPACK INC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3689_fe818ece-9e5b-d28e-e053-6294a90acd01	70518-3689	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20230322		ANDA	ANDA087385	REMEDYREPACK INC.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3690_f7a9dd72-8915-c9d4-e053-6294a90a7094	70518-3690	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20230323		ANDA	ANDA074415	REMEDYREPACK INC.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
70518-3691_03fd0201-406d-cfb7-e063-6294a90a813a	70518-3691	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230324		ANDA	ANDA214548	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3692_f7e42f56-740c-319a-e053-6294a90acd88	70518-3692	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230326		ANDA	ANDA206174	REMEDYREPACK INC.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3693_f8095955-c23c-c957-e053-6394a90a8f0a	70518-3693	HUMAN PRESCRIPTION DRUG	Dexlansoprazole		Dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20230328		ANDA	ANDA202294	REMEDYREPACK INC.	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-3694_f82570f6-75e7-cc6e-e053-6294a90a90d2	70518-3694	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, CHEWABLE	ORAL	20230330		ANDA	ANDA073524	REMEDYREPACK INC.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3695_f8254e60-4d4d-696e-e053-6294a90a0cf8	70518-3695	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20230330		ANDA	ANDA207773	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3697_0ead9074-3475-7c3d-e063-6394a90a9d27	70518-3697	HUMAN PRESCRIPTION DRUG	tadalafil		tadalafil	TABLET, FILM COATED	ORAL	20230402		ANDA	ANDA209250	REMEDYREPACK INC.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
70518-3699_fe807e20-f009-379b-e053-6294a90a6103	70518-3699	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230403		ANDA	ANDA216594	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3700_0c52a254-2793-6ad7-e063-6394a90a034a	70518-3700	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20230403		ANDA	ANDA211064	REMEDYREPACK INC.	FOLIC ACID	1	mg/1			N	20241231
70518-3701_f9b3887b-63b1-7660-e053-6394a90a0a68	70518-3701	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM, AUGMENTED	TOPICAL	20230404		ANDA	ANDA076543	REMEDYREPACK INC.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3702_f927df2e-d05a-8cc7-e053-6294a90afd7c	70518-3702	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20230406		ANDA	ANDA213324	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3704_f8c1892b-c7c1-2331-e053-6294a90a0592	70518-3704	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230407		ANDA	ANDA211820	REMEDYREPACK INC.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70518-3705_f8fb9e26-43bd-f51b-e053-6294a90aebe1	70518-3705	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20230410		ANDA	ANDA040419	REMEDYREPACK INC.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
70518-3706_f90f8749-0f33-b4bb-e053-6394a90aaed1	70518-3706	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	20230410		ANDA	ANDA062500	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3707_f910e4b7-34c6-7724-e053-6394a90aba85	70518-3707	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20230410		ANDA	ANDA215848	REMEDYREPACK INC.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3708_fb6b15b7-c135-42d5-e053-6394a90a6a4d	70518-3708	HUMAN PRESCRIPTION DRUG	Gabapentin		gabapentin	SOLUTION	ORAL	20230411		ANDA	ANDA076403	REMEDYREPACK INC.	GABAPENTIN	250	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3709_f9240c63-1da9-09c6-e053-6294a90a5570	70518-3709	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230411		ANDA	ANDA077091	REMEDYREPACK INC.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3710_f9c73f21-2ca6-9a92-e053-6294a90a4c55	70518-3710	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20230411		ANDA	ANDA215886	REMEDYREPACK INC.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70518-3712_fce88dd1-6579-5dd6-e053-6294a90aef62	70518-3712	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20230412		ANDA	ANDA201043	REMEDYREPACK INC.	LEVOFLOXACIN	500	mg/1			N	20241231
70518-3713_f937ad42-73b4-d22e-e053-6294a90a71a9	70518-3713	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20230412		ANDA	ANDA076938	REMEDYREPACK INC.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70518-3714_f938246a-3136-7c5c-e053-6294a90a0e34	70518-3714	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20230412		ANDA	ANDA077859	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70518-3715_f94e02e0-01e1-e1eb-e053-6394a90ad54d	70518-3715	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20230414		ANDA	ANDA075459	REMEDYREPACK INC.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-3716_f9b31939-dff5-5802-e053-6394a90adb29	70518-3716	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20230416		ANDA	ANDA090469	REMEDYREPACK INC.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70518-3717_07851937-ed1c-f0ab-e063-6294a90a14e8	70518-3717	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20230418		ANDA	ANDA208516	REMEDYREPACK INC.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
70518-3718_f9c719de-3ab1-cd35-e053-6394a90ad5c6	70518-3718	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		chlorthalidone	TABLET	ORAL	20230420		ANDA	ANDA215587	REMEDYREPACK INC.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70518-3719_fa1a59ef-ef15-afcf-e053-6294a90a06f4	70518-3719	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230424		ANDA	ANDA202112	REMEDYREPACK INC.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3721_01ccbd5d-c8a9-e3c5-e063-6394a90adbe4	70518-3721	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230424		ANDA	ANDA040750	REMEDYREPACK INC.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-3722_fa3eed82-93b2-95ec-e053-6294a90af04f	70518-3722	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230425		ANDA	ANDA202112	REMEDYREPACK INC.	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3723_fa3018c3-82c9-7f32-e053-6394a90a698a	70518-3723	HUMAN PRESCRIPTION DRUG	azithromycin dihydrate		azithromycin dihydrate	TABLET	ORAL	20230425		ANDA	ANDA065399	REMEDYREPACK INC.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70518-3724_fe80635d-9582-abf3-e053-6394a90aa78b	70518-3724	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20230425		ANDA	ANDA084282	REMEDYREPACK INC.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3725_faa125d5-b52f-9478-e053-6394a90af2a0	70518-3725	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20230427		ANDA	ANDA207182	REMEDYREPACK INC.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3726_febac2b0-83b1-df7d-e053-6394a90ab140	70518-3726	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20230430		ANDA	ANDA074140	REMEDYREPACK INC.	NAPROXEN SODIUM	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3727_fab839c0-99c5-a272-e053-6294a90a8046	70518-3727	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20230501		ANDA	ANDA202087	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
70518-3728_fae21111-25de-bf9a-e053-6294a90ab215	70518-3728	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20230504		ANDA	ANDA206463	REMEDYREPACK INC.	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3729_fb2f3db3-897a-5794-e053-6294a90a20d1	70518-3729	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20230504		ANDA	ANDA204446	REMEDYREPACK INC.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3730_fb6a5c51-04a0-4d7b-e053-6394a90a82f7	70518-3730	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230510		ANDA	ANDA203346	REMEDYREPACK INC.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3731_fce8657f-40b6-ed73-e053-6294a90a1154	70518-3731	HUMAN PRESCRIPTION DRUG	Mycobutin		rifabutin	CAPSULE	ORAL	20200514		NDA	NDA050689	REMEDYREPACK INC.	RIFABUTIN	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
70518-3732_fd109ad4-b2d5-26b2-e053-6394a90a0430	70518-3732	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20230522		ANDA	ANDA085828	REMEDYREPACK INC.	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70518-3733_05cd8071-32d6-daa1-e063-6394a90ac993	70518-3733	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230522		ANDA	ANDA205129	REMEDYREPACK INC.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3735_fd15ccdf-cad8-6616-e053-6394a90a7166	70518-3735	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20230523		ANDA	ANDA203769	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3736_fd784c99-14b3-a06d-e053-6394a90abb53	70518-3736	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20230524		ANDA	ANDA090564	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3737_fd79da76-7503-13c1-e053-6294a90a2d3d	70518-3737	HUMAN PRESCRIPTION DRUG	haloperidol		haloperidol lactate	INJECTION, SOLUTION	INTRAMUSCULAR	20230525		ANDA	ANDA091637	REMEDYREPACK INC.	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70518-3738_fd89c244-3694-5232-e053-6294a90a5e01	70518-3738	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN HYDROCHLORIDE		moxifloxacin hydrochloride	TABLET, FILM COATED	ORAL	20230530		ANDA	ANDA202632	REMEDYREPACK INC.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-3739_fd8bae35-15ae-3e2d-e053-6394a90afdb6	70518-3739	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20230531		ANDA	ANDA077322	REMEDYREPACK INC.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
70518-3740_fd8c1afe-6cb4-f527-e053-6294a90a225b	70518-3740	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230531		ANDA	ANDA078625	REMEDYREPACK INC.	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70518-3741_fdf06011-5ab4-da19-e053-6294a90a90fd	70518-3741	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	SOLUTION	ORAL	20230601		ANDA	ANDA079059	REMEDYREPACK INC.	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
70518-3742_fda1c9e1-2854-5a08-e053-6394a90a102a	70518-3742	HUMAN PRESCRIPTION DRUG	Levetiracetam	Levetiracetam	Levetiracetam	SOLUTION	ORAL	20230602		ANDA	ANDA203052	REMEDYREPACK INC.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3743_fd8f4df8-0943-2fbb-e053-6394a90a8546	70518-3743	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20230602		ANDA	ANDA214507	REMEDYREPACK INC.	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70518-3745_01f05205-8a8b-f569-e063-6294a90a83aa	70518-3745	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230605		ANDA	ANDA075468	REMEDYREPACK INC.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3746_fda2b03b-4f57-0fcd-e053-6394a90aa72a	70518-3746	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230605		ANDA	ANDA211697	REMEDYREPACK INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3748_fdef0815-48bb-43fb-e053-6294a90acd44	70518-3748	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20230606		ANDA	ANDA074140	REMEDYREPACK INC.	NAPROXEN SODIUM	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3749_fdee9ff6-2ddf-1b97-e053-6394a90a8d28	70518-3749	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230607		ANDA	ANDA040907	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3750_fdef5e00-a37d-5e78-e053-6394a90a4baa	70518-3750	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	20230607		ANDA	ANDA089424	REMEDYREPACK INC.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70518-3752_fdf4664e-9ccf-98c1-e053-6294a90a7da9	70518-3752	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20230608		ANDA	ANDA076001	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3754_fe8026d7-fdba-2e44-e053-6394a90a5a52	70518-3754	HUMAN PRESCRIPTION DRUG	Depakote	ER	Divalproex Sodium	TABLET, EXTENDED RELEASE	ORAL	20230608		NDA	NDA021168	REMEDYREPACK INC.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3755_fe074df9-358c-7be7-e053-6394a90a67b0	70518-3755	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20230609		ANDA	ANDA075360	REMEDYREPACK INC.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3756_fe181ae0-871c-213c-e053-6294a90af4a0	70518-3756	HUMAN PRESCRIPTION DRUG	TRAZODONE HYDROCHLORIDE		TRAZODONE HYDROCHLORIDE	TABLET	ORAL	20230611		ANDA	ANDA204852	REMEDYREPACK INC.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70518-3757_fe18be99-bc3e-0390-e053-6294a90a6896	70518-3757	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20230611		ANDA	ANDA216629	REMEDYREPACK INC.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70518-3758_fe18b2f6-3c0c-61f5-e053-6294a90a416d	70518-3758	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20230611		ANDA	ANDA078462	REMEDYREPACK INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3759_fe1b3122-b6ad-46fa-e053-6394a90afd59	70518-3759	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	CAPSULE	ORAL	20230611		ANDA	ANDA077242	REMEDYREPACK INC.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3760_fe1b8b23-8e11-14a8-e053-6394a90ab374	70518-3760	HUMAN PRESCRIPTION DRUG	Risperidone		risperidone	SOLUTION	ORAL	20230612		NDA	NDA020588	REMEDYREPACK INC.	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
70518-3761_fe2d9e90-ba54-0ffa-e053-6294a90a8633	70518-3761	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230612		ANDA	ANDA202674	REMEDYREPACK INC.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3762_fe2db3d8-db84-160c-e053-6394a90a5d9d	70518-3762	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230612		ANDA	ANDA208049	REMEDYREPACK INC.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3763_fe2e2762-d90f-b7b2-e053-6394a90ad7d6	70518-3763	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230613		ANDA	ANDA203346	REMEDYREPACK INC.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3764_fe2e570e-0a87-3b09-e053-6394a90a89dd	70518-3764	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20230613		ANDA	ANDA078643	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3765_fe2ebee2-3f8e-0697-e053-6294a90a1cf6	70518-3765	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230614		ANDA	ANDA215069	REMEDYREPACK INC.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3767_020764e0-ef40-c74c-e063-6394a90a5033	70518-3767	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20230616		ANDA	ANDA212624	REMEDYREPACK INC.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3768_fe7fc44e-1ca2-713b-e053-6394a90a64c6	70518-3768	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20230619		NDA AUTHORIZED GENERIC	NDA010721	REMEDYREPACK INC.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70518-3769_fe80992b-8197-dfca-e053-6294a90a9bef	70518-3769	HUMAN PRESCRIPTION DRUG	Levetiracetam	Levetiracetam	Levetiracetam	SOLUTION	ORAL	20230619		ANDA	ANDA203052	REMEDYREPACK INC.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3770_04b03bc7-1460-647e-e063-6294a90a3f8a	70518-3770	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230620		ANDA	ANDA215069	REMEDYREPACK INC.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3772_0e9b4b1e-a689-e2b1-e063-6394a90a5210	70518-3772	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20230621		ANDA	ANDA216957	REMEDYREPACK INC.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
70518-3773_febd195f-0d9c-69b0-e053-6294a90aba60	70518-3773	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230622		ANDA	ANDA216594	REMEDYREPACK INC.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3774_febd4b37-6002-5522-e053-6394a90a855f	70518-3774	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin Calcium	CREAM	TOPICAL	20230622		ANDA	ANDA207116	REMEDYREPACK INC.	MUPIROCIN CALCIUM	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
70518-3775_01f151e9-1516-4407-e063-6394a90a979e	70518-3775	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20230628		ANDA	ANDA071135	REMEDYREPACK INC.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3776_01f13040-1cf6-64fc-e063-6394a90af046	70518-3776	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20230628		ANDA	ANDA071136	REMEDYREPACK INC.	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3777_01f0f83f-0d28-ee7b-e063-6394a90a954f	70518-3777	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20230628		ANDA	ANDA081099	REMEDYREPACK INC.	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70518-3778_01f03cc3-2d7b-374f-e063-6394a90a7b2f	70518-3778	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20230705		ANDA	ANDA207466	REMEDYREPACK INC.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3779_01e2646a-b806-29ee-e063-6294a90a103c	70518-3779	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical	GEL	TOPICAL	20230707		ANDA	ANDA212351	REMEDYREPACK INC.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3780_0c5549ba-66f0-6914-e063-6294a90a6ce1	70518-3780	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20230709		ANDA	ANDA085182	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3782_0e9979dd-42e8-3a3f-e063-6294a90ab555	70518-3782	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230711		ANDA	ANDA202759	REMEDYREPACK INC.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
70518-3783_03fb2091-0e3e-86e9-e063-6294a90afceb	70518-3783	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20230711		ANDA	ANDA213853	REMEDYREPACK INC.	ATORVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3784_01e0236e-96f8-da14-e063-6294a90afef0	70518-3784	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230711		ANDA	ANDA206297	REMEDYREPACK INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3785_01e00684-aad8-2ce8-e063-6394a90a29f5	70518-3785	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20230711		ANDA	ANDA064048	REMEDYREPACK INC.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70518-3786_0d6bc5b8-e2c5-3f5e-e063-6294a90aaf18	70518-3786	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230711		ANDA	ANDA202759	REMEDYREPACK INC.	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3787_01f382aa-0e72-c03f-e063-6394a90a65c5	70518-3787	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230712		ANDA	ANDA205794	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3788_065971e2-29ab-c15c-e063-6294a90a19ae	70518-3788	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20230712		ANDA	ANDA215885	REMEDYREPACK INC.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70518-3789_01dc1391-15c7-a891-e063-6394a90ae2ec	70518-3789	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20230713		ANDA	ANDA204097	REMEDYREPACK INC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70518-3790_01dbd038-3942-e5be-e063-6294a90a072d	70518-3790	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230713		ANDA	ANDA207479	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3791_040f30e4-b0a9-b7e9-e063-6294a90a9c60	70518-3791	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20230714		ANDA	ANDA213853	REMEDYREPACK INC.	ATORVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3792_01dda9a5-f0d0-35b4-e063-6394a90a9ec1	70518-3792	HUMAN PRESCRIPTION DRUG	carisoprodol		carisoprodol	TABLET	ORAL	20230714		ANDA	ANDA040792	REMEDYREPACK INC.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
70518-3793_06469563-2c14-2c54-e063-6294a90ab7bb	70518-3793	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20230716		ANDA	ANDA200981	REMEDYREPACK INC.	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3795_01dc7bb5-0901-c8fe-e063-6394a90a7d3e	70518-3795	HUMAN PRESCRIPTION DRUG	Sirolimus		Sirolimus	TABLET	ORAL	20230717		ANDA	ANDA201578	REMEDYREPACK INC.	SIROLIMUS	1	mg/1	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
70518-3796_01dc1f0b-2968-adc9-e063-6394a90a84cd	70518-3796	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20230717		ANDA	ANDA078182	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3797_01dbf69a-1b62-8f52-e063-6394a90a1051	70518-3797	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20230718		ANDA	ANDA209838	REMEDYREPACK INC.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
70518-3798_01ce498a-aee5-36ca-e063-6394a90aa33c	70518-3798	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20230718		ANDA	ANDA205150	REMEDYREPACK INC.	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-3799_01cdb9a2-7a29-0561-e063-6394a90aac05	70518-3799	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	CAPSULE	ORAL	20230718		ANDA	ANDA090055	REMEDYREPACK INC.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
70518-3800_01cbe312-a586-b1a9-e063-6394a90ab834	70518-3800	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230719		ANDA	ANDA204216	REMEDYREPACK INC.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3801_01cc205b-a348-262a-e063-6394a90a955c	70518-3801	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20230721		ANDA	ANDA209582	REMEDYREPACK INC.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3802_01cb04f3-a72c-e44a-e063-6294a90a119b	70518-3802	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230724		ANDA	ANDA077548	REMEDYREPACK INC.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70518-3803_01caa5f2-706e-e26a-e063-6294a90a52cb	70518-3803	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20230724		ANDA	ANDA079063	REMEDYREPACK INC.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3804_01f32973-40f2-7625-e063-6394a90aa69b	70518-3804	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20230724		ANDA	ANDA079063	REMEDYREPACK INC.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3805_01ca2cfa-7576-527b-e063-6294a90a0e18	70518-3805	HUMAN PRESCRIPTION DRUG	VALPROIC ACID		VALPROIC ACID	SOLUTION	ORAL	20230725		ANDA	ANDA075379	REMEDYREPACK INC.	VALPROIC ACID	250	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3806_01cb6a0a-3f38-a106-e063-6394a90aefc3	70518-3806	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230725		ANDA	ANDA072926	REMEDYREPACK INC.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3809_01c9491c-4b33-8a0b-e063-6294a90af192	70518-3809	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20230729		ANDA	ANDA201408	REMEDYREPACK INC.	GUANFACINE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70518-3810_01c7fa12-dd47-1691-e063-6294a90abf67	70518-3810	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20230730		ANDA	ANDA211013	REMEDYREPACK INC.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
70518-3811_01c816dc-5615-ecff-e063-6394a90af1e9	70518-3811	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230730		ANDA	ANDA211347	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3812_01c83bcf-70bb-9899-e063-6294a90a2fd1	70518-3812	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230731		ANDA	ANDA208049	REMEDYREPACK INC.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3813_01df2ed2-3cfc-473c-e063-6294a90abb87	70518-3813	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20230731		ANDA	ANDA075496	REMEDYREPACK INC.	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-3814_0d6c345c-90cf-7ade-e063-6294a90a0ddb	70518-3814	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA208170	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3815_02061b52-9b43-1df6-e063-6394a90a86c2	70518-3815	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20230802		NDA AUTHORIZED GENERIC	NDA010721	REMEDYREPACK INC.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70518-3816_02071b22-0c58-05c5-e063-6394a90a55b1	70518-3816	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAVENOUS	20230802		NDA	NDA211363	REMEDYREPACK INC.	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70518-3818_025a0be4-1f87-9946-e063-6394a90aae3c	70518-3818	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20230803		ANDA	ANDA040275	REMEDYREPACK INC.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-3819_0259fc62-165c-b2dd-e063-6294a90a07b5	70518-3819	HUMAN PRESCRIPTION DRUG	EZETIMIBE		EZETIMIBE	TABLET	ORAL	20230803		ANDA	ANDA211550	REMEDYREPACK INC.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
70518-3820_09b8f7f7-0687-1346-e063-6294a90a054a	70518-3820	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20230803		ANDA	ANDA214127	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3821_0259615d-485f-e03b-e063-6394a90a5e91	70518-3821	HUMAN PRESCRIPTION DRUG	Lidocaine 5%		Lidocaine 5%	PATCH	TOPICAL	20230806		ANDA	ANDA209190	REMEDYREPACK INC.	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3822_0518e79e-e4e3-db7c-e063-6394a90a1f13	70518-3822	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20230806		ANDA	ANDA212517	REMEDYREPACK INC.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3823_025952ad-4f47-d524-e063-6294a90a7690	70518-3823	HUMAN PRESCRIPTION DRUG	Orphenadrine citrate		Orphenadrine citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230807		ANDA	ANDA040463	REMEDYREPACK INC.	ORPHENADRINE CITRATE	60	mg/2mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3824_044cc0e2-c54f-6fe0-e063-6294a90a1fda	70518-3824	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20230807		ANDA	ANDA208708	REMEDYREPACK INC.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
70518-3825_02800f53-4289-7ea2-e063-6294a90a29a3	70518-3825	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20230809		ANDA	ANDA213311	REMEDYREPACK INC.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3826_044deed9-e577-b3bc-e063-6394a90ab02e	70518-3826	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230812		ANDA	ANDA210071	REMEDYREPACK INC.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3827_02e10c13-d7aa-7bfa-e063-6294a90a58c0	70518-3827	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230812		ANDA	ANDA217272	REMEDYREPACK INC.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70518-3828_0a98e57c-f84e-f8a4-e063-6294a90a063d	70518-3828	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20230815		ANDA	ANDA078048	REMEDYREPACK INC.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70518-3829_0d6cd501-d9ab-0357-e063-6394a90a45d3	70518-3829	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20230815		ANDA	ANDA215630	REMEDYREPACK INC.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70518-3830_03096395-9ad6-f18f-e063-6394a90a5fd0	70518-3830	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20230815		ANDA	ANDA078671	REMEDYREPACK INC.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3831_06f7bc52-1783-c3d2-e063-6394a90a94f8	70518-3831	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20230816		ANDA	ANDA215630	REMEDYREPACK INC.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70518-3832_032401a0-237f-bdce-e063-6294a90a4e93	70518-3832	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20230816		ANDA	ANDA065271	REMEDYREPACK INC.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-3833_036de229-c1dd-176e-e063-6394a90af71a	70518-3833	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20230817		ANDA	ANDA078246	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
70518-3834_0334b2e5-65cc-1081-e063-6294a90a2f1e	70518-3834	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20230818		ANDA	ANDA065352	REMEDYREPACK INC.	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3835_0334ee42-1394-0ef3-e063-6294a90a2b88	70518-3835	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20230818		ANDA	ANDA078420	REMEDYREPACK INC.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3837_06fa2e87-9ff0-aca6-e063-6394a90ac254	70518-3837	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230818		ANDA	ANDA215604	REMEDYREPACK INC.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3838_06fa4655-e924-1965-e063-6294a90a6e88	70518-3838	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	SOLUTION	ORAL	20180821		ANDA	ANDA216448	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3839_0398aa98-75eb-ba9a-e063-6294a90af979	70518-3839	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20230823		ANDA	ANDA075126	REMEDYREPACK INC.	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3842_044d7835-c7e9-c334-e063-6294a90ab984	70518-3842	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20230823		ANDA	ANDA076513	REMEDYREPACK INC.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70518-3843_03becd6c-e122-7c0a-e063-6294a90ad417	70518-3843	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20230824		ANDA	ANDA076658	REMEDYREPACK INC.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-3844_06fa771c-e154-f5a9-e063-6394a90a90ab	70518-3844	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride and naloxone hydrochloride dihydrate		buprenorphine hydrochloride and naloxone hydrochloride dihydrate	TABLET	SUBLINGUAL	20230829		ANDA	ANDA203326	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-3845_042637ea-9a03-5486-e063-6294a90adaa0	70518-3845	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20230830		ANDA	ANDA076004	REMEDYREPACK INC.	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3846_0a95b0e6-05ba-0854-e063-6394a90a5140	70518-3846	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230831		ANDA	ANDA206556	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3847_044d1832-8385-3d13-e063-6394a90aa8cd	70518-3847	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate TAB		hyoscyamine sulfate	TABLET	ORAL	20230831		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
70518-3848_0c3de498-4e7c-6a1f-e063-6294a90a8c00	70518-3848	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20230831		ANDA	ANDA213853	REMEDYREPACK INC.	ATORVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3849_0450b0ae-c363-d66f-e063-6394a90af806	70518-3849	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230901		ANDA	ANDA075150	REMEDYREPACK INC.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3850_04889433-7697-4dd9-e063-6394a90ab3c5	70518-3850	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230902		ANDA	ANDA213486	REMEDYREPACK INC.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70518-3851_0488af65-4b76-84de-e063-6394a90ac86d	70518-3851	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20230902		ANDA	ANDA210425	REMEDYREPACK INC.	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
70518-3852_06fdaec0-7c85-70cd-e063-6394a90a1b46	70518-3852	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20230903		ANDA	ANDA205236	REMEDYREPACK INC.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70518-3853_049ec4eb-aa66-7d84-e063-6294a90af57b	70518-3853	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		enalapril maleate	TABLET	ORAL	20230905		ANDA	ANDA075459	REMEDYREPACK INC.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-3854_04b03bc7-1463-647e-e063-6294a90a3f8a	70518-3854	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230905		ANDA	ANDA217054	REMEDYREPACK INC.	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70518-3855_04b0f160-8a61-c494-e063-6394a90a64dc	70518-3855	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20230906		ANDA	ANDA203572	REMEDYREPACK INC.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3856_0519bfa3-0e85-2d63-e063-6294a90ab6e7	70518-3856	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230906		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
70518-3857_06469038-504d-30a9-e063-6294a90a430f	70518-3857	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20230907		ANDA	ANDA065229	REMEDYREPACK INC.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3858_0519f4f0-308b-7e38-e063-6294a90ac3b1	70518-3858	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	TABLET	ORAL	20230911		ANDA	ANDA040864	REMEDYREPACK INC.	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
70518-3859_05cc18f2-d40e-fa82-e063-6394a90a5b10	70518-3859	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20230911		ANDA	ANDA214982	REMEDYREPACK INC.	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70518-3860_05cc2736-5f92-fc16-e063-6394a90aec91	70518-3860	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20230911		ANDA	ANDA214982	REMEDYREPACK INC.	DIGOXIN	.25	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70518-3861_05423ab5-f774-9993-e063-6294a90a8be2	70518-3861	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230913		ANDA	ANDA213794	REMEDYREPACK INC.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3862_05679863-464f-1128-e063-6394a90a02fb	70518-3862	HUMAN PRESCRIPTION DRUG	buprenorphine hydrochloride and naloxone hydrochloride dihydrate		buprenorphine hydrochloride and naloxone hydrochloride dihydrate	TABLET	SUBLINGUAL	20230915		ANDA	ANDA203326	REMEDYREPACK INC.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	2; .5	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
70518-3864_05a56fa7-18d1-309c-e063-6294a90a146a	70518-3864	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20230918		ANDA	ANDA210609	REMEDYREPACK INC.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-3865_05a56fa7-1922-309c-e063-6294a90a146a	70518-3865	HUMAN PRESCRIPTION DRUG	Insulin Aspart		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230918		BLA	BLA020986	REMEDYREPACK INC.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
70518-3866_05b990a9-12b7-f4a6-e063-6394a90a4dbe	70518-3866	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230919		NDA AUTHORIZED GENERIC	NDA204623	REMEDYREPACK INC.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3867_05cc41b4-12d2-262c-e063-6394a90ac2a2	70518-3867	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20230919		ANDA	ANDA070175	REMEDYREPACK INC.	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3868_05e32cdd-41e7-f70f-e063-6394a90a0fc9	70518-3868	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20230921		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
70518-3869_09b92298-098c-c405-e063-6394a90aeaf8	70518-3869	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20230924		ANDA	ANDA211343	REMEDYREPACK INC.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3870_06cfd72c-5b8d-a1ae-e063-6294a90a96bd	70518-3870	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20230925		ANDA	ANDA203572	REMEDYREPACK INC.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3871_0656c654-7804-cf6a-e063-6294a90a39cb	70518-3871	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20230925		ANDA	ANDA065229	REMEDYREPACK INC.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3872_0645be57-dce8-102b-e063-6294a90adc16	70518-3872	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230926		ANDA	ANDA213320	REMEDYREPACK INC.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70518-3873_070c5a5d-15b5-f14a-e063-6394a90af1fd	70518-3873	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230926		ANDA	ANDA203802	REMEDYREPACK INC.	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3874_06574e56-139a-a3af-e063-6394a90a4867	70518-3874	HUMAN PRESCRIPTION DRUG	Enalapril maleate		Enalapril maleate	TABLET	ORAL	20230926		ANDA	ANDA075479	REMEDYREPACK INC.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70518-3875_0658a0c8-f5ba-b380-e063-6394a90afff5	70518-3875	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230926		ANDA	ANDA091544	REMEDYREPACK INC.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
70518-3876_0658b276-5ffe-19c8-e063-6294a90ae5a3	70518-3876	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230926		ANDA	ANDA203802	REMEDYREPACK INC.	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3877_065a226e-b58e-904a-e063-6294a90a48bb	70518-3877	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230926		ANDA	ANDA091388	REMEDYREPACK INC.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3878_065a6eec-3899-0da8-e063-6394a90a849d	70518-3878	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20230926		ANDA	ANDA074584	REMEDYREPACK INC.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70518-3879_0659c591-2c3c-b3bb-e063-6294a90ab528	70518-3879	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230926		ANDA	ANDA091388	REMEDYREPACK INC.	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3880_065a37b3-d5d5-c2cd-e063-6294a90ac98d	70518-3880	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230926		ANDA	ANDA091388	REMEDYREPACK INC.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3881_065a3fa4-0047-560a-e063-6394a90a1d8a	70518-3881	HUMAN PRESCRIPTION DRUG	Depakote		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20230926		NDA	NDA018723	REMEDYREPACK INC.	DIVALPROEX SODIUM	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3883_066f2213-b35d-e2ae-e063-6394a90aab42	70518-3883	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20230928		ANDA	ANDA077493	REMEDYREPACK INC.	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3884_06f75748-42b2-1b9b-e063-6294a90a05e8	70518-3884	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20231003		ANDA	ANDA070885	REMEDYREPACK INC.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70518-3886_070cd051-b932-2ba1-e063-6394a90a5049	70518-3886	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20231005		ANDA	ANDA065256	REMEDYREPACK INC.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-3887_0747b633-622b-f9f2-e063-6294a90a51dc	70518-3887	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20231007		ANDA	ANDA076558	REMEDYREPACK INC.	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70518-3888_074b2822-cc0c-d614-e063-6394a90a2665	70518-3888	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET, FILM COATED	ORAL	20231009		ANDA	ANDA203584	REMEDYREPACK INC.	CLARITHROMYCIN	250	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
70518-3889_0784ac7f-0a49-7c10-e063-6394a90add39	70518-3889	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20231009		ANDA	ANDA205391	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3891_0815f507-e493-1fef-e063-6394a90a7dcc	70518-3891	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20231010		ANDA	ANDA075468	REMEDYREPACK INC.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3892_0784f380-8ccc-5894-e063-6294a90a09a2	70518-3892	HUMAN PRESCRIPTION DRUG	clindamycin and benzoyl peroxide		clindamycin and benzoyl peroxide	GEL	TOPICAL	20231011		ANDA	ANDA209252	REMEDYREPACK INC.	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70518-3894_07d874ea-d5f2-f656-e063-6294a90aacda	70518-3894	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20231016		ANDA	ANDA203835	REMEDYREPACK INC.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-3895_07e894f7-f077-f706-e063-6294a90afdb3	70518-3895	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20231016		ANDA	ANDA091491	REMEDYREPACK INC.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3896_07e8a92a-cf58-3d19-e063-6294a90a0d60	70518-3896	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20231017		ANDA	ANDA203499	REMEDYREPACK INC.	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3897_0878d5b0-6728-da39-e063-6394a90a0068	70518-3897	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231017		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
70518-3898_081595a1-aa5e-2a79-e063-6394a90aa5b9	70518-3898	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20231017		ANDA	ANDA206928	REMEDYREPACK INC.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70518-3899_07ff6359-2541-8074-e063-6294a90ad811	70518-3899	HUMAN PRESCRIPTION DRUG	MEDROXYPROGESTERONE ACETATE		MEDROXYPROGESTERONE ACETATE	INJECTION, SUSPENSION	INTRAMUSCULAR	20231018		ANDA	ANDA212844	REMEDYREPACK INC.	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70518-3900_0813706c-d728-568a-e063-6294a90aaa0a	70518-3900	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan	TABLET	ORAL	20231018		ANDA	ANDA215959	REMEDYREPACK INC.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-3901_08157e80-efda-147b-e063-6394a90aca36	70518-3901	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20231018		ANDA	ANDA078423	REMEDYREPACK INC.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-3902_08787509-9e37-ddcb-e063-6394a90a0948	70518-3902	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20231020		ANDA	ANDA206498	REMEDYREPACK INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3903_088b794f-4ce0-3f80-e063-6294a90abda1	70518-3903	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20231024		ANDA	ANDA077625	REMEDYREPACK INC.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70518-3904_0941cfe7-1057-e1de-e063-6394a90aaa63	70518-3904	HUMAN PRESCRIPTION DRUG	Fluoxetine hydrochloride		Fluoxetine hydrochloride	FOR SOLUTION	ORAL	20231101		ANDA	ANDA216953	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3905_09417fc8-27ab-cf29-e063-6394a90ab087	70518-3905	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20231103		ANDA	ANDA075932	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3906_097e16d0-9f89-ba28-e063-6294a90af714	70518-3906	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20231103		ANDA	ANDA078888	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
70518-3907_097e38ee-9b59-bd75-e063-6294a90a036b	70518-3907	HUMAN PRESCRIPTION DRUG	terbinafine hydrochloride		terbinafine hydrochloride	TABLET	ORAL	20231103		ANDA	ANDA078163	REMEDYREPACK INC.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
70518-3908_097e6074-7ea0-ebaf-e063-6294a90a59b3	70518-3908	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20231106		ANDA	ANDA075468	REMEDYREPACK INC.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3910_09cf795b-75c2-f69e-e063-6394a90a494c	70518-3910	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20231107		ANDA	ANDA217334	REMEDYREPACK INC.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-3911_09a6a5ec-e763-4945-e063-6294a90a16cd	70518-3911	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20231107		ANDA	ANDA216594	REMEDYREPACK INC.	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3912_09b89b9f-5549-74a1-e063-6394a90adf11	70518-3912	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20231108		ANDA	ANDA210616	REMEDYREPACK INC.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70518-3913_09cf42a3-56dc-dd0b-e063-6394a90a9512	70518-3913	HUMAN PRESCRIPTION DRUG	medroxyprogesterone acetate		medroxyprogesterone acetate	TABLET	ORAL	20231110		NDA AUTHORIZED GENERIC	NDA011839	REMEDYREPACK INC.	MEDROXYPROGESTERONE ACETATE	10	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70518-3914_0a46e000-747a-330b-e063-6294a90afdc9	70518-3914	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20231113		ANDA	ANDA064076	REMEDYREPACK INC.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70518-3915_0a464b5d-8b90-f367-e063-6294a90a89af	70518-3915	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20231116		ANDA	ANDA213413	REMEDYREPACK INC.	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
70518-3916_0a5a4a8d-f952-3ca0-e063-6394a90a222a	70518-3916	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231117		ANDA	ANDA203702	REMEDYREPACK INC.	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70518-3917_0a95dad6-f606-d8e2-e063-6294a90a47d3	70518-3917	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20231119		ANDA	ANDA216782	REMEDYREPACK INC.	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70518-3918_0a95f22a-818c-486e-e063-6394a90a712b	70518-3918	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20231120		ANDA	ANDA078423	REMEDYREPACK INC.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-3919_0c669cd4-d4a4-76d9-e063-6394a90a9304	70518-3919	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20231120		ANDA	ANDA078297	REMEDYREPACK INC.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
70518-3920_0aa9b3a4-0bd3-ad37-e063-6394a90aa999	70518-3920	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20231121		ANDA	ANDA074132	REMEDYREPACK INC.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3921_0abe9c8a-b942-90a3-e063-6294a90a98a1	70518-3921	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20231122		ANDA	ANDA215939	REMEDYREPACK INC.	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3922_0ae842d4-75b5-0ec7-e063-6394a90a3397	70518-3922	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20231122		ANDA	ANDA217334	REMEDYREPACK INC.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70518-3923_0ae86ae4-386c-2986-e063-6394a90a3fc9	70518-3923	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20231122		ANDA	ANDA078777	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3924_0ae8ce63-55ac-dac6-e063-6294a90a8612	70518-3924	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20231124		ANDA	ANDA076658	REMEDYREPACK INC.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70518-3925_0b22b037-b45a-e5b3-e063-6394a90adf71	70518-3925	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20231126		ANDA	ANDA215939	REMEDYREPACK INC.	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3927_0b3a8b34-5ddc-e8d8-e063-6294a90a980b	70518-3927	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20231128		ANDA	ANDA208348	REMEDYREPACK INC.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70518-3928_0b5ed93f-6b6d-b871-e063-6394a90aceec	70518-3928	HUMAN PRESCRIPTION DRUG	Prazosin hydrochloride		Prazosin hydrochloride	CAPSULE	ORAL	20231129		ANDA	ANDA213406	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3929_0b785073-b0a3-6453-e063-6294a90a7669	70518-3929	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20231201		ANDA	ANDA205571	REMEDYREPACK INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70518-3931_0bb46a21-3ba7-681a-e063-6294a90abd1f	70518-3931	HUMAN PRESCRIPTION DRUG	TADALAFIL		tadalafil	TABLET	ORAL	20231204		ANDA	ANDA210608	REMEDYREPACK INC.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-3932_0bc34eba-9029-af53-e063-6294a90a5d32	70518-3932	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		hydroxyzine hydrochloride	TABLET, FILM COATED	ORAL	20231204		ANDA	ANDA040786	REMEDYREPACK INC.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70518-3933_0bd9ba85-2e70-d58a-e063-6294a90aff2f	70518-3933	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20231204		ANDA	ANDA091388	REMEDYREPACK INC.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3934_0bd7d730-ef05-1d48-e063-6294a90a8dfd	70518-3934	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET	ORAL	20231205		ANDA	ANDA090485	REMEDYREPACK INC.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
70518-3935_0c515353-ba39-c394-e063-6294a90abc56	70518-3935	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20231207		ANDA	ANDA090432	REMEDYREPACK INC.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3937_0c40f575-3d4c-a94d-e063-6294a90a9eaa	70518-3937	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20231206		ANDA	ANDA076006	REMEDYREPACK INC.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70518-3938_0c41318d-cc09-b0ba-e063-6394a90a72d3	70518-3938	HUMAN PRESCRIPTION DRUG	KLOR-CON		potassium chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231206		NDA	NDA019123	REMEDYREPACK INC.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70518-3939_0c519f44-6384-e029-e063-6394a90a8d02	70518-3939	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20231207		ANDA	ANDA078246	REMEDYREPACK INC.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
70518-3940_0c7983ed-afbe-f48e-e063-6294a90a511b	70518-3940	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20231206		ANDA	ANDA215939	REMEDYREPACK INC.	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70518-3941_0c53ce8d-6762-b95f-e063-6394a90aef31	70518-3941	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20231208		ANDA	ANDA077493	REMEDYREPACK INC.	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3942_0c53c982-3f04-a2d5-e063-6394a90acd55	70518-3942	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20231208		NDA AUTHORIZED GENERIC	NDA017442	REMEDYREPACK INC.	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3943_0c5325e3-475e-856c-e063-6394a90a1f90	70518-3943	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20231208		ANDA	ANDA078413	REMEDYREPACK INC.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
70518-3945_0c3dd77c-bf1f-57ed-e063-6294a90a5293	70518-3945	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20231211		ANDA	ANDA078251	REMEDYREPACK INC.	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3946_0c55a5ca-6383-b2cc-e063-6294a90ac738	70518-3946	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20231209		ANDA	ANDA206536	REMEDYREPACK INC.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70518-3947_0c797863-65bf-17dc-e063-6294a90a493f	70518-3947	HUMAN PRESCRIPTION DRUG	Losartan potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20231209		ANDA	ANDA202230	REMEDYREPACK INC.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70518-3948_0c3e209e-0b25-7794-e063-6294a90a8377	70518-3948	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20231211		ANDA	ANDA213854	REMEDYREPACK INC.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3949_0c3e1e58-37e9-9f8d-e063-6294a90aaee0	70518-3949	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20231211		ANDA	ANDA207465	REMEDYREPACK INC.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3950_0d6c345c-90c9-7ade-e063-6294a90a0ddb	70518-3950	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20231211		ANDA	ANDA200981	REMEDYREPACK INC.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70518-3951_0c3e5a0d-81c4-9f42-e063-6394a90aaf18	70518-3951	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20231211		ANDA	ANDA204165	REMEDYREPACK INC.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
70518-3952_0c511f89-8272-9e7b-e063-6394a90a0fac	70518-3952	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, FILM COATED	ORAL	20231211		ANDA	ANDA084112	REMEDYREPACK INC.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3953_0c42ac13-09e8-10bc-e063-6394a90af99b	70518-3953	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20231211		ANDA	ANDA213784	REMEDYREPACK INC.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70518-3954_0c7890d0-8731-8a6a-e063-6294a90aae64	70518-3954	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20231211		ANDA	ANDA213412	REMEDYREPACK INC.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70518-3955_0c42240b-57a3-eb4f-e063-6394a90a24ee	70518-3955	HUMAN PRESCRIPTION DRUG	REMERON		MIRTAZAPINE	TABLET, FILM COATED	ORAL	20231211		NDA	NDA020415	REMEDYREPACK INC.	MIRTAZAPINE	15	mg/1			N	20241231
70518-3956_0c3f4578-a458-2454-e063-6394a90a1e5b	70518-3956	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20231211		ANDA	ANDA078164	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3959_0c679485-34ef-155f-e063-6394a90a39cc	70518-3959	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20231213		ANDA	ANDA215705	REMEDYREPACK INC.	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
70518-3960_0c65d470-fcd0-9128-e063-6294a90a3656	70518-3960	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20231213		ANDA	ANDA075150	REMEDYREPACK INC.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70518-3961_0c783860-aac3-1b67-e063-6394a90ae93b	70518-3961	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET	ORAL	20231214		ANDA	ANDA208066	REMEDYREPACK INC.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70518-3962_0c787149-e4fb-321b-e063-6394a90aa92b	70518-3962	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20231214		ANDA	ANDA201407	REMEDYREPACK INC.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70518-3963_0cdd46bd-49fa-9c91-e063-6294a90aee91	70518-3963	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231214		ANDA	ANDA207479	REMEDYREPACK INC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
70518-3964_0c8c432a-0594-8701-e063-6394a90a5d96	70518-3964	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20231214		ANDA	ANDA213999	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70518-3965_0ccce00c-8fe4-7015-e063-6294a90a92ba	70518-3965	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20231217		ANDA	ANDA208719	REMEDYREPACK INC.	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70518-3967_0d9394e8-6006-f146-e063-6394a90a05b6	70518-3967	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20231219		ANDA	ANDA204755	REMEDYREPACK INC.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70518-3969_0d7ff7d3-5b54-f4f7-e063-6394a90a9427	70518-3969	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20231226		ANDA	ANDA209302	REMEDYREPACK INC.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70518-3970_0d80590c-f627-b35e-e063-6294a90a27c0	70518-3970	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20231226		ANDA	ANDA204234	REMEDYREPACK INC.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70518-3971_0d937692-de36-33aa-e063-6394a90a12de	70518-3971	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20231227		ANDA	ANDA214654	REMEDYREPACK INC.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70518-3972_0d9348e9-aa3c-b44e-e063-6294a90a7390	70518-3972	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20231228		ANDA	ANDA206498	REMEDYREPACK INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70518-3974_0e0bb3bc-36c0-38e9-e063-6294a90a3c94	70518-3974	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20240103		ANDA	ANDA209743	REMEDYREPACK INC.	PREGABALIN	25	mg/1		CV	N	20251231
70518-3975_0e70ee55-5909-6ffb-e063-6394a90aec88	70518-3975	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20240106		UNAPPROVED DRUG OTHER		REMEDYREPACK INC.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20251231
70518-3976_0e70d805-5af2-999f-e063-6394a90ac1f2	70518-3976	HUMAN PRESCRIPTION DRUG	Alogliptin		Alogliptin	TABLET, FILM COATED	ORAL	20240106		NDA AUTHORIZED GENERIC	NDA022271	REMEDYREPACK INC.	ALOGLIPTIN BENZOATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20251231
70518-3977_0e70bd41-d874-94e9-e063-6394a90a9e8e	70518-3977	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20240107		ANDA	ANDA077987	REMEDYREPACK INC.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70518-3979_0e9a4f79-4d79-9e5b-e063-6294a90a9d9c	70518-3979	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20240110		ANDA	ANDA214548	REMEDYREPACK INC.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
70518-3980_0e9d8748-4e55-9675-e063-6394a90a96b5	70518-3980	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine		Acetaminophen and Codeine	TABLET	ORAL	20240110		ANDA	ANDA040779	REMEDYREPACK INC.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20251231
70518-3981_0eae0bae-8bbd-eab2-e063-6294a90a9894	70518-3981	HUMAN PRESCRIPTION DRUG	Levetiracetam		LEVETIRACETAM	SOLUTION	ORAL	20240110		ANDA	ANDA201157	REMEDYREPACK INC.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
70533-001_2fab0ad2-7453-53fc-e054-00144ff8d46c	70533-001	HUMAN OTC DRUG	Daily Face Broad Spectrum		ZINC OXIDE	LOTION	TOPICAL	20160401		OTC MONOGRAPH NOT FINAL	part352	Harry's, Inc.	ZINC OXIDE	66	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70533-003_0d1e7b1a-5232-8009-e063-6294a90aca90	70533-003	HUMAN OTC DRUG	Zinc Pyrithione		Zinc Pyrithione	SHAMPOO	TOPICAL	20201001		OTC MONOGRAPH DRUG	M032	Harry's Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
70533-004_0d1e8c57-3daf-2740-e063-6394a90a4102	70533-004	HUMAN OTC DRUG	Zinc Pyrithione		Zinc Pyrithione	SHAMPOO	TOPICAL	20201001		OTC MONOGRAPH DRUG	M032	Harry's Inc.	PYRITHIONE ZINC	20	mg/2mL			N	20241231
70533-006_eb5161b2-b5b1-455c-e053-2995a90ac3f2	70533-006	HUMAN OTC DRUG	Harrys Antiperspirant Stone		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20220501		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	160	mg/g			N	20241231
70533-007_f06dda62-a7bd-4fff-e053-2995a90adff3	70533-007	HUMAN OTC DRUG	Harrys Antiperspirant Fig		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20201227		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	160	mg/g			N	20241231
70533-008_e55ca3f4-e515-94db-e053-2a95a90a87b1	70533-008	HUMAN OTC DRUG	Harrys Antiperspirant Redwood		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20220501		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	160	mg/g			N	20241231
70533-009_f06e6e94-f0e5-7303-e053-2a95a90afa61	70533-009	HUMAN OTC DRUG	Harrys Antiperspirant Shiso		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20201227		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	160	mg/g			N	20241231
70533-010_f06e9bc0-c295-c5ce-e053-2995a90a2113	70533-010	HUMAN OTC DRUG	Harrys Extra Strength Antiperspirant Shiso		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20201227		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/g			N	20241231
70533-011_eb546c4c-5683-d7ea-e053-2995a90a718b	70533-011	HUMAN OTC DRUG	Harrys Extra Strength Antiperspirant Stone		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20220501		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/g			N	20241231
70533-012_f06f368e-8310-7a49-e053-2a95a90a3aea	70533-012	HUMAN OTC DRUG	Harrys Extra Strength Antiperspirant Fig		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20201227		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/g			N	20241231
70533-013_eb5468dd-59aa-dcd0-e053-2995a90a7193	70533-013	HUMAN OTC DRUG	Harrys Extra Strength Antiperspirant Redwood		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20220501		OTC MONOGRAPH FINAL	M019	Harry's Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/g			N	20241231
70533-014_e9afb9d9-1c7b-247b-e053-2a95a90ae067	70533-014	HUMAN OTC DRUG	Harrys Antiperspirant Wildlands		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20221101		OTC MONOGRAPH FINAL	M019	Harry's, Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	160	mg/100g			N	20241231
70533-015_e9c02b1b-da97-6390-e053-2995a90a6194	70533-015	HUMAN OTC DRUG	Harrys Extra Strength Antiperspirant Wildlands		ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	STICK	TOPICAL	20221101		OTC MONOGRAPH FINAL	M019	Harry's, Inc.	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	200	mg/100g			N	20241231
70539-001_5c342488-a83e-4581-b45c-9261285c39d8	70539-001	HUMAN PRESCRIPTION DRUG	Tymlos		abaloparatide	INJECTION, SOLUTION	SUBCUTANEOUS	20170501		NDA	NDA208743	Radius Health, Inc.	ABALOPARATIDE	3.12	mg/1.56mL	Parathyroid Hormone-Related Peptide Analog [EPC], Parathyroid Hormone-Related Protein [CS]		N	20241231
70539-400_50c0bbe7-2306-45e4-9b52-fce8cca4fafa	70539-400	HUMAN PRESCRIPTION DRUG	Binosto		alendronate sodium	TABLET, EFFERVESCENT	ORAL	20120312		NDA	NDA202344	Radius Health, Inc.	ALENDRONATE SODIUM	91.37	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
70542-201_06d6afc1-a82b-ba88-e063-6394a90ad1d4	70542-201	HUMAN OTC DRUG	Maxim FDF		chloroxylenol	SOAP	TOPICAL	20190311		OTC MONOGRAPH DRUG	505G(a)(3)	Midlab Incorporated	CHLOROXYLENOL	.1	g/L			N	20241231
70542-202_f7e5da35-eae7-bca9-e053-6394a90a39db	70542-202	HUMAN OTC DRUG	Bright Solutions FDF		PCMX Hand Soap	SOAP	TOPICAL	20190311		OTC MONOGRAPH NOT FINAL	part333A	Midlab Incorporated	CHLOROXYLENOL	.1	g/L			N	20241231
70542-301_0e0f637b-91fe-739b-e063-6394a90ac7a4	70542-301	HUMAN OTC DRUG	Maxim Anti-Bacterial		PCMX, Hand Soap	SOAP	TOPICAL	20170201		OTC MONOGRAPH DRUG	505G(a)(3)	Midlab Incorporated	CHLOROXYLENOL	1	g/L			N	20251231
70542-303_0e20d78c-38fe-082b-e063-6394a90a6887	70542-303	HUMAN OTC DRUG	Bright Solutions antiseptic		PCMX, Hand Soap	SOAP	TOPICAL	20170201		OTC MONOGRAPH DRUG	505G(a)(3)	Midlab Incorporated	CHLOROXYLENOL	1	g/L			N	20251231
70542-701_09d2875a-c3d7-6749-e063-6394a90acba7	70542-701	HUMAN OTC DRUG	Maxim Assure		PCMX, Dishwashing and Hand Soap	SOAP	TOPICAL	20170112		OTC MONOGRAPH DRUG	505G(a)(3)	Midlab Incorporated	CHLOROXYLENOL	1	g/L			N	20241231
70542-707_09d2e7b6-65aa-0cec-e063-6294a90a9c9c	70542-707	HUMAN OTC DRUG	Smart Defender		PCMX, Dishwashing and Hand Soap	SOAP	TOPICAL	20190523		OTC MONOGRAPH DRUG	505G(a)(3)	Midlab, Inc	CHLOROXYLENOL	.1	g/L			N	20241231
70542-710_09d27f23-ff53-66b6-e063-6394a90a7aeb	70542-710	HUMAN OTC DRUG	Bright Solutions Antibacterial		PCMX, Hand Soap	SOAP	TOPICAL	20201231		OTC MONOGRAPH DRUG	505G(a)(3)	MIDLAB INCORPORATED	CHLOROXYLENOL	1	g/L			N	20241231
70547-200_7982efb6-1336-4549-b24e-3fadb276a4ee	70547-200	HUMAN OTC DRUG	Acne Blu Salicylic Acid Pads		salicylic acid	DISC	TOPICAL	20200106		OTC MONOGRAPH FINAL	part333D	INK Pharmaceuticals, Inc.	SALICYLIC ACID	20	g/1000g			N	20241231
70550-602_062add1a-666d-1441-e063-6294a90a5ed2	70550-602	HUMAN OTC DRUG	THICK HEAD Extra Strength for Men 5 Minoxidil Topical		MINOXIDIL	SPRAY	TOPICAL	20231002		ANDA	ANDA076239	PROFECTUS BEAUTY, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70550-605_24fea157-1a8d-4e35-8575-104eecb09af1	70550-605	HUMAN OTC DRUG	Minoxidil	5 Percent (For Women)	Minoxidil	AEROSOL, FOAM	TOPICAL	20220118		ANDA	ANDA209074	PROFECTUS BEAUTY LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
70554-229_09d769cf-cc30-9fd3-e063-6394a90ac18e	70554-229	HUMAN OTC DRUG	FEELGOOD LAB Natural Pain Cream		MENTHOL	CREAM	TOPICAL	20210526		OTC MONOGRAPH DRUG	M017	The Feel Good Lab, LLC	MENTHOL	12.5	mg/mL			N	20241231
70554-260_09745e88-e6e8-aa2c-e063-6394a90a954f	70554-260	HUMAN OTC DRUG	FEEL GOOD LABS NATURAL PAIN		MENTHOL	LOTION	TOPICAL	20180815		OTC MONOGRAPH DRUG	M017	The Feel Good Lab	MENTHOL	12.5	mg/mL			N	20241231
70554-261_09745e88-e6f7-aa2c-e063-6394a90a954f	70554-261	HUMAN OTC DRUG	FEEL GOOD LABS SPORT RECOVERY		MENTHOL	LOTION	TOPICAL	20180815		OTC MONOGRAPH DRUG	M017	The Feel Good Lab	MENTHOL	12.5	mg/mL			N	20241231
70554-291_09749db1-19a0-799e-e063-6294a90a47eb	70554-291	HUMAN OTC DRUG	FEEL GOOD LABS SPORT RECOVERY		MENTHOL	LOTION	TOPICAL	20200203		OTC MONOGRAPH DRUG	M017	THE FEEL GOOD LAB, LLC	MENTHOL	12.5	mg/mL			N	20241231
70554-339_09d77151-7a9f-89d3-e063-6394a90ac71a	70554-339	HUMAN OTC DRUG	FEEL GOOD LAB Natural Pain Cream		MENTHOL	CREAM	TOPICAL	20220715		OTC MONOGRAPH DRUG	M017	THE FEEL GOOD LAB, LLC	MENTHOL	12.5	mg/mL			N	20241231
70556-102_1773bf51-5735-4f4e-8270-cc1cc2d469ad	70556-102	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION	INTRABRONCHIAL	20171024		ANDA	ANDA209453	Ailex Pharmaceuticals, LLC	CROMOLYN SODIUM	20	mg/2mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
70557-002_06bedb97-d7e1-ea46-e063-6394a90a8696	70557-002	HUMAN OTC DRUG	Benchmarks Derma Shield		Dimethicone	AEROSOL	TOPICAL	20160427		OTC MONOGRAPH FINAL	part347	Delta Kits Inc	DIMETHICONE	2.7	g/100g	Skin Barrier Activity [PE]		N	20241231
70557-002_06bedbe1-e9e7-c8a2-e063-6294a90aba69	70557-002	HUMAN OTC DRUG	Benchmarks Derma Shield		Dimethicone	AEROSOL	TOPICAL	20160427		OTC MONOGRAPH FINAL	part347	Delta Kits Inc	DIMETHICONE	2.7	g/100g	Skin Barrier Activity [PE]		N	20241231
70557-002_06bf1dc8-2190-3c13-e063-6394a90a4d65	70557-002	HUMAN OTC DRUG	Benchmarks Derma Shield		Dimethicone	AEROSOL	TOPICAL	20160427		OTC MONOGRAPH FINAL	part347	Delta Kits Inc	DIMETHICONE	2.7	g/100g	Skin Barrier Activity [PE]		N	20241231
70558-0003_0c6d6cf7-607f-49e3-9844-4afdf9aced3f	70558-0003	HUMAN OTC DRUG	Appetite Control		Acetyl Coenzyme A, Adenosinum Triphosphoricum Dinatrum, Adrenal Cortex (Suis), Bacopa Speciosa, Dopamine Hydrochloride, Equol, Gambogia, Oxytocin Acetate, Rhodiola, Stomach (Suis), Thyroidinum, (Suis), Chininum Sulphuricum, Cina, Iodium, Lycopodium Clavatum, Phosphorous, Serotonin (Hydrochloride), Morgan Gaertner	LIQUID	ORAL	20181102		UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE DISODIUM; ARTEMISIA CINA PRE-FLOWERING TOP; BACOPA MONNIERI WHOLE; DOPAMINE HYDROCHLORIDE; EQUOL, (+/-)-; GAMBOGE; IODINE; LYCOPODIUM CLAVATUM SPORE; OXYTOCIN ACETATE; PHOSPHORUS; QUININE SULFATE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEDUM ROSEUM ROOT; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL CORTEX; SUS SCROFA STOMACH; SUS SCROFA THYROID	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 30; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
70558-0004_96b33bb4-6600-447b-bba5-6149d73fae33	70558-0004	HUMAN OTC DRUG	Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Sarsaparilla (Smilax Regelii), Gelsemium Sempervirens, Veratrum Album, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Vulgaris), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20181018		UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	BETA VULGARIS; CHELIDONIUM MAJUS; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PULSATILLA VULGARIS WHOLE; SELENIUM; SMILAX ORNATA ROOT; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	3; 3; 8; 12; 12; 12; 3; 12; 12; 6; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
70558-0005_e3194b8e-c885-464f-8ed8-24416dee7737	70558-0005	HUMAN OTC DRUG	Thyro Support		Sarcolacticum Acidum, Viscum Album, Iodium, Fucus Vesiculosus, Galium Aparine, Natrum Oxalaceticum, Thyroidinum (Suis), DHEA (Dehydroepiandrosterone), Phenyl Isothiocyanate, Tri-Iodothyronine, Tyramine, Alpha-Ketoglutaricum Acidum, Adenosinum Triphosphoricum Dinatrum, Fumaricum Acidum, Malic Acid, Colchicum Autumnale, Conium Maculatum, Funiculus Umbilicalis Suis, Hepar Suis, Medulla Ossis Suis, Pineal Gland (Suis), Spleen (Suis), Thymus (Suis), Calcarea Fluorica, Pulsatilla (Vulgaris), Spongia Tosta	LIQUID	ORAL	20181114	20240123	UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	.ALPHA.-KETOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; ANEMONE PULSATILLA; CALCIUM FLUORIDE; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ESCHERICHIA COLI; FUCUS VESICULOSUS; FUMARIC ACID; GALIUM APARINE; IODINE; LACTIC ACID, L-; LIOTHYRONINE; MALIC ACID; MERCURIC CHLORIDE; PHENYL ISOTHIOCYANATE; PORK LIVER; PRASTERONE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA BONE MARROW; SUS SCROFA PINEAL GLAND; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; SUS SCROFA THYROID; SUS SCROFA UMBILICAL CORD; TYRAMINE; VISCUM ALBUM FRUITING TOP	7; 7; 12; 12; 8; 8; 30; 30; 6; 7; 6; 3; 3; 6; 7; 60; 6; 8; 6; 30; 6; 12; 8; 8; 8; 8; 6; 8; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	
70558-0006_c8aa3747-abc6-4db1-b099-a53d95c0f805	70558-0006	HUMAN OTC DRUG	Weight Management		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, Gambogia, 7-OXO-Dehydroepiandrosterone 3-acetate (7-KETO), Adenosinum Triphosphoricum Dinatrum, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20200228		UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	30; 30; 8; 8; 6; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
70558-0007_cb6f98f6-6fd9-4868-953f-a5ab6dc2c6a9	70558-0007	HUMAN OTC DRUG	Hunger Control		Adenosinum Triphosphoricum Dinatrum, Adrenal Cortex (Suis), Bacopa Speciosa, Equol, Pantothenic Acid, Rhodiola, Stomach (Suis), Chininum Sulphuricum, Iodium, Lycopodium Clavatum, Phosphorous, Dopamine Hydrochloride, Thyroidinum (Suis), Cina, Serotonin (Hydrochloride), Oxytocin, Gambogia, Morgan Gaertner	LIQUID	ORAL	20201012		UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARTEMISIA CINA PRE-FLOWERING TOP; BACOPA MONNIERI WHOLE; DOPAMINE HYDROCHLORIDE; EQUOL, (+/-)-; GAMBOGE; IODINE; LYCOPODIUM CLAVATUM SPORE; OXYTOCIN; PANTOTHENIC ACID; PHOSPHORUS; QUININE SULFATE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SEDUM ROSEUM ROOT; SEROTONIN HYDROCHLORIDE; SUS SCROFA ADRENAL CORTEX; SUS SCROFA STOMACH; SUS SCROFA THYROID	6; 8; 6; 8; 6; 14; 6; 6; 12; 6; 6; 6; 30; 6; 8; 6; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC], Catecholamine [EPC], Catecholamines [CS], Increased Uterine Smooth Muscle Contraction or Tone [PE], Oxytocic [EPC], Oxytocin [CS]		N	20241231
70558-0009_62999abb-070a-4f06-b81a-d098fee3cbc8	70558-0009	HUMAN OTC DRUG	Thyro Support		Sarcolacticum Acidum, Viscum Album, Iodium, Fucus Vesiculosus, Galium Aparine, Natrum Oxalaceticum, Thyroidinum (Suis), DHEA (Dehydroepiandrosterone), Phenyl Isothiocyanate, Tyramine, Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Fumaricum Acidum, Malicum Acid, Colchicum Autumnale, Conium Maculatum, Funiculus Umbilicalis Suis, Hepar Suis, Medulla Ossis Suis, Pineal Gland (Suis), Spleen (Suis), Thymus (Suis), Calcarea Fluorica, Pulsatilla (Pratensis), Spongia Tosta, Cortisone Aceticum,	LIQUID	ORAL	20200929		UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	.ALPHA.-KETOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE DISODIUM; CALCIUM FLUORIDE; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; ESCHERICHIA COLI; FUCUS VESICULOSUS; FUMARIC ACID; GALIUM APARINE WHOLE; IODINE; LACTIC ACID, L-; LIOTHYRONINE; MALIC ACID; MERCURIC CHLORIDE; PHENYL ISOTHIOCYANATE; PORK LIVER; PRASTERONE; PULSATILLA PRATENSIS WHOLE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA BONE MARROW; SUS SCROFA PINEAL GLAND; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; SUS SCROFA UMBILICAL CORD; THYROID, PORCINE; TYRAMINE; VISCUM ALBUM FRUITING TOP	7; 7; 12; 8; 8; 30; 30; 6; 7; 6; 3; 3; 30; 7; 60; 6; 8; 6; 12; 30; 6; 12; 8; 8; 8; 8; 8; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
70558-0010_706ae87e-d4ae-4132-a930-23598e0fa7fe	70558-0010	HUMAN OTC DRUG	Calm Anxiety and Stress		Clematis Vitalba, Flos, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Passiflora Incarnata, Angelica Sinensis, Argentum Nitricum, Cacao, Lithium Carbonicum, Prunus Cerasifera, Flos, Valeriana Officinalis, Piper Methysticum, Glandula Suprarenalis Suis, Aconitum Napellus, Anacardium Orientale, Arsenicum Album, Calcarea Carbonica, Cocculus Indicus, Ignatia Amara, Gelsemium Sempervirens	LIQUID	ORAL	20210729		UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	ACONITUM NAPELLUS WHOLE; ANAMIRTA COCCULUS SEED; ANGELICA SINENSIS ROOT; ARSENIC TRIOXIDE; CLEMATIS VITALBA FLOWER; COCOA; GELSEMIUM SEMPERVIRENS ROOT; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; LITHIUM CARBONATE; MACROPIPER METHYSTICUM ROOT; ORNITHOGALUM UMBELLATUM FLOWERING TOP; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PRUNUS CERASIFERA FLOWER; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; STRYCHNOS IGNATII SEED; SUS SCROFA ADRENAL GLAND; VALERIAN	12; 12; 6; 12; 3; 6; 12; 3; 3; 6; 7; 3; 12; 3; 6; 12; 6; 12; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
70558-0011_88a30ca1-a920-4b4a-aa8f-2c7e92777efd	70558-0011	HUMAN OTC DRUG	Sleep Aid		Adenosinum Triphosphoricum Dinatrum, Pantothenic Acid, Pineal Gland (Suis), Sarcolacticum Acidum, Ubidecarenonum, L-Tryptophan, Melatonin, Pyrrole, Arsenicum Album, Avena Sativa, Chamomilla, Coffea Cruda, Mercurius Corrosivus, Passiflora Incarnata, Silicea, Zincum Valerianicum, Dysentery Bacillus, Gaertner Bacillus (Bach)	LIQUID	ORAL	20210716		UNAPPROVED HOMEOPATHIC		Pro Weight Loss Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; LACTIC ACID, L-; MATRICARIA CHAMOMILLA WHOLE; MELATONIN; MERCURIC CHLORIDE; PANTOTHENIC ACID; PASSIFLORA INCARNATA FLOWERING TOP; PYRROLE; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SHIGELLA DYSENTERIAE; SILICON DIOXIDE; SUS SCROFA PINEAL GLAND; TRYPTOPHAN; UBIDECARENONE; ZINC VALERATE DIHYDRATE	8; 10; 10; 10; 8; 10; 8; 10; 8; 10; 8; 30; 30; 10; 8; 8; 8; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
70565-580_3e0b2017-5e0d-44a4-9431-afd15bcb7822	70565-580	HUMAN OTC DRUG	Sal de Uvas Picot		Citric Acid monohydrate and Sodium bicarbonate	GRANULE, EFFERVESCENT	ORAL	20160331		OTC MONOGRAPH FINAL	part331	Reckitt Benckiser Mexico, S.A. de C.V.	CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE	1.9485; 2.485	g/1; g/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
70573-099_7f5ce7ac-ea59-4bc9-8ac6-4c996cf0dc9a	70573-099	PLASMA DERIVATIVE	Ryplazim		plasminogen	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210604		BLA	BLA125659	Prometic Biotherapeutics, Inc.	PLASMINOGEN	68.8	mg/1			N	20241231
70581-003_0c10187b-9943-d230-e063-6394a90a882d	70581-003	HUMAN OTC DRUG	Absolue Premium Bx Sunscreen Broad Spectrum SPF 15 Absolute Replenishing		AVOBENZONE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL; TOPICAL	20160409		OTC MONOGRAPH DRUG	M020	BPS 60	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 30; 80	mg/mL; mg/mL; mg/mL			N	20241231
70581-004_0c105dba-8846-8ec8-e063-6294a90a650a	70581-004	HUMAN OTC DRUG	Teint Miracle Octinoxate Sunscreen Broad Spectrum SPF 15		OCTINOXATE	CREAM	TOPICAL	20160406		OTC MONOGRAPH DRUG	M020	BPS 60	OCTINOXATE	30	mg/mL			N	20241231
70581-019_0c1057d4-fa32-85c9-e063-6294a90a7f0c	70581-019	HUMAN OTC DRUG	10 Armani Prima Control Glow Moisturizer SBS SPF 35		OCTINOXATE, TITANIUM DIOXIDE	CREAM	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	BPS 60	OCTINOXATE; TITANIUM DIOXIDE	50; 19	mg/mL; mg/mL			N	20241231
70589-100_089ee9d3-797b-9ff3-e063-6394a90ae14a	70589-100	HUMAN OTC DRUG	HER LH2473 Vanilla Scented Hand Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70589-102_089eb4e4-7f64-e9ef-e063-6294a90a7ff0	70589-102	HUMAN OTC DRUG	HER LH2475 Vanilla Scented Hand Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70589-104_089ed6a6-7e04-1220-e063-6294a90a09e9	70589-104	HUMAN OTC DRUG	HER LH2476 Citrus Scented Hand Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70589-106_089f44d8-df8a-5c35-e063-6394a90a5db9	70589-106	HUMAN OTC DRUG	HER LH2484 Strawberry Scented Hand Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70589-108_089ed321-d8e0-1955-e063-6294a90a62f2	70589-108	HUMAN OTC DRUG	HER LT279 Vanilla Limited Too Hand Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70589-110_0905ee66-ff92-4bb5-e063-6394a90a30ce	70589-110	HUMAN OTC DRUG	HER LT288 Citrus Limited Too Hand Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70589-112_0905e27f-6016-5060-e063-6394a90a0c2e	70589-112	HUMAN OTC DRUG	HER LT289 Vanilla Limited Too Hand Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70589-114_089fb769-85d7-7cbc-e063-6294a90ab5af	70589-114	HUMAN OTC DRUG	HER LT297 Strawberry Limited Too Sanitizer Kit		Alcohol	KIT		20160930		OTC MONOGRAPH DRUG	505G(a)(3)	HER ACCESSORIES						N	20241231
70594-023_6dc9b3c6-4bed-4c9f-829e-531ffa681d98	70594-023	HUMAN PRESCRIPTION DRUG	Colistimethate		Colistimethate Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181001		ANDA	ANDA205356	Xellia Pharmaceuticals USA LLC	COLISTIMETHATE SODIUM	150	mg/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70594-023_f84ff058-aba4-4a88-b117-8463f0ada951	70594-023	HUMAN PRESCRIPTION DRUG	Colistimethate		colistimethate sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220220		ANDA	ANDA205356	Xellia Pharmaceuticals USA LLC	COLISTIMETHATE SODIUM	150	mg/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70594-034_32561d31-66ad-4616-970c-2a7f043b0d0e	70594-034	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181001		ANDA	ANDA206005	Xellia Pharmaceuticals USA LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
70594-034_f40b0e0b-bbc7-4ac6-b98b-b55e6734fd92	70594-034	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210501		ANDA	ANDA206005	Xellia Pharmaceuticals USA LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
70594-036_e26f3507-cb01-46d6-8fa4-c64588a71574	70594-036	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210602	20251231	ANDA	ANDA211713	Xellia Pharmaceuticals USA LLC	MICAFUNGIN SODIUM	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	
70594-037_e26f3507-cb01-46d6-8fa4-c64588a71574	70594-037	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210602	20251231	ANDA	ANDA211713	Xellia Pharmaceuticals USA LLC	MICAFUNGIN SODIUM	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	
70594-040_3a74d633-9586-4c89-b417-056fd970463b	70594-040	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20210826		NDA	NDA213895	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-041_e49b6589-caca-4c8f-8c57-55a1ee7774cc	70594-041	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20190215		NDA	NDA211962	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	500	mg/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-042_e49b6589-caca-4c8f-8c57-55a1ee7774cc	70594-042	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20190215		NDA	NDA211962	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	1	g/200mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-043_e49b6589-caca-4c8f-8c57-55a1ee7774cc	70594-043	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20190215		NDA	NDA211962	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	1.5	g/300mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-044_e49b6589-caca-4c8f-8c57-55a1ee7774cc	70594-044	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20190215		NDA	NDA211962	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	2	g/400mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-045_d0999ed3-4357-4df9-998a-6b6a0e9bba52	70594-045	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190128		ANDA	ANDA204107	Xellia Pharmaceuticals USA LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-046_d0999ed3-4357-4df9-998a-6b6a0e9bba52	70594-046	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20181001		ANDA	ANDA204107	Xellia Pharmaceuticals USA LLC	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-047_97ab8feb-99b4-48f0-9cf0-72b81658e7ba	70594-047	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190402		ANDA	ANDA204125	Xellia Pharmaceuticals USA LLC	VANCOMYCIN HYDROCHLORIDE	5	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-048_97ab8feb-99b4-48f0-9cf0-72b81658e7ba	70594-048	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181001		ANDA	ANDA204125	Xellia Pharmaceuticals USA LLC	VANCOMYCIN HYDROCHLORIDE	10	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-049_a4b361e1-e0b1-414c-b1d8-158f901c7163	70594-049	HUMAN PRESCRIPTION DRUG	Polymyxin B		Polymyxin B Sulfate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	20181001		ANDA	ANDA202766	Xellia Pharmaceuticals USA LLC	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70594-053_0f048116-fbbd-4b91-ae1f-e11abebf0f3e	70594-053	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190315		NDA	NDA209949	Xellia Pharmaceuticals USA LLC	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
70594-056_e49b6589-caca-4c8f-8c57-55a1ee7774cc	70594-056	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20200513		NDA	NDA211962	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	750	mg/150mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-057_e49b6589-caca-4c8f-8c57-55a1ee7774cc	70594-057	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20190223		NDA	NDA211962	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	1.25	g/250mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-058_e49b6589-caca-4c8f-8c57-55a1ee7774cc	70594-058	HUMAN PRESCRIPTION DRUG	Vancomycin		Vancomycin	INJECTION, SOLUTION	INTRAVENOUS	20200513		NDA	NDA211962	Xellia Pharmaceuticals USA LLC	VANCOMYCIN	1.75	g/350mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-060_77b4504d-ddb3-40eb-9885-5c7c46a36dad	70594-060	HUMAN PRESCRIPTION DRUG	Daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231103		NDA	NDA217415	Xellia Pharmaceuticals USA LLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
70594-063_69ee5794-96b0-4975-aadd-d8dbcc73ca3f	70594-063	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20220101		ANDA	ANDA213318	Xellia Pharmaceuticals USA LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70594-064_69ee5794-96b0-4975-aadd-d8dbcc73ca3f	70594-064	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20220101		ANDA	ANDA213318	Xellia Pharmaceuticals USA LLC	PHENYLEPHRINE HYDROCHLORIDE	50	mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70594-065_69ee5794-96b0-4975-aadd-d8dbcc73ca3f	70594-065	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20220101		ANDA	ANDA213318	Xellia Pharmaceuticals USA LLC	PHENYLEPHRINE HYDROCHLORIDE	100	mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70594-066_77b4504d-ddb3-40eb-9885-5c7c46a36dad	70594-066	HUMAN PRESCRIPTION DRUG	Daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231103		NDA	NDA217415	Xellia Pharmaceuticals USA LLC	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
70594-067_57a39a42-1ca6-4a25-8c17-e64c3d29307a	70594-067	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230824		NDA	NDA208562	Xellia Pharmaceuticals USA LLC	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70594-068_44ed271d-bc7e-48f7-bb63-0ecdb70fdad4	70594-068	HUMAN PRESCRIPTION DRUG	Sumatriptan		SUMATRIPTAN SUCCINATE	INJECTION	SUBCUTANEOUS	20220101		ANDA	ANDA213998	Xellia Pharmaceuticals USA LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
70594-069_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90	70594-069	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20210110		ANDA	ANDA213074	Xellia Pharmaceuticals USA LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70594-072_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90	70594-072	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20210110		ANDA	ANDA213074	Xellia Pharmaceuticals USA LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70594-075_a3421d9b-03cd-422c-b907-b48970c50985	70594-075	HUMAN PRESCRIPTION DRUG	MEROPENEM		MEROPENEM	INJECTION	INTRAVENOUS	20210628		ANDA	ANDA206141	Xellia Pharmaceuticals USA LLC	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
70594-076_a3421d9b-03cd-422c-b907-b48970c50985	70594-076	HUMAN PRESCRIPTION DRUG	MEROPENEM		MEROPENEM	INJECTION	INTRAVENOUS	20210628		ANDA	ANDA206141	Xellia Pharmaceuticals USA LLC	MEROPENEM	1	g/30mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
70594-078_7b8413a0-a8bd-4899-8567-677034eb0a7d	70594-078	HUMAN PRESCRIPTION DRUG	PIPERACILLIN SODIUM and TAZOBACTAM SODIUM		PIPERACILLIN SODIUM and TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA212287	Xellia Pharmaceuticals USA LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; 250	g/50mL; mg/50mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70594-079_7b8413a0-a8bd-4899-8567-677034eb0a7d	70594-079	HUMAN PRESCRIPTION DRUG	PIPERACILLIN SODIUM and TAZOBACTAM SODIUM		PIPERACILLIN SODIUM and TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA212287	Xellia Pharmaceuticals USA LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; 375	g/100mL; mg/100mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70594-080_7b8413a0-a8bd-4899-8567-677034eb0a7d	70594-080	HUMAN PRESCRIPTION DRUG	PIPERACILLIN SODIUM and TAZOBACTAM SODIUM		PIPERACILLIN SODIUM and TAZOBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA212287	Xellia Pharmaceuticals USA LLC	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; 500	g/150mL; mg/150mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70594-081_58ec0103-d21b-41bf-ab48-85bee78c6b65	70594-081	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		AMPICILLIN SODIUM and SULBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210110		ANDA	ANDA090579	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70594-082_58ec0103-d21b-41bf-ab48-85bee78c6b65	70594-082	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		AMPICILLIN SODIUM and SULBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210110		ANDA	ANDA090579	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70594-083_7f6b70bd-3b9c-4e28-bd56-98d84bdd2acb	70594-083	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		AMPICILLIN SODIUM and SULBACTAM SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210110		ANDA	ANDA090578	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM; SULBACTAM SODIUM	100; 50	mg/mL; mg/mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70594-084_2c29bd08-f467-4028-aac6-0a5b3007a5d3	70594-084	HUMAN PRESCRIPTION DRUG	Ampicillin		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA090583	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70594-085_2c29bd08-f467-4028-aac6-0a5b3007a5d3	70594-085	HUMAN PRESCRIPTION DRUG	Ampicillin		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA090583	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70594-086_2c29bd08-f467-4028-aac6-0a5b3007a5d3	70594-086	HUMAN PRESCRIPTION DRUG	Ampicillin		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA090583	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70594-087_2c29bd08-f467-4028-aac6-0a5b3007a5d3	70594-087	HUMAN PRESCRIPTION DRUG	Ampicillin		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA090583	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70594-088_08b7d60c-7c8d-42bd-be84-ce5e18b4c74e	70594-088	HUMAN PRESCRIPTION DRUG	Ampicillin		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA090581	Xellia Pharmaceuticals USA LLC	AMPICILLIN SODIUM	10	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70594-089_5ceacb56-4bff-4036-aadd-2843c6fe45cc	70594-089	HUMAN PRESCRIPTION DRUG	CEFEPIME HYDROCHLORIDE		CEFEPIME HYDROCHLORIDE	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210110		ANDA	ANDA212721	Xellia Pharmaceuticals USA LLC	CEFEPIME HYDROCHLORIDE	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70594-090_5ceacb56-4bff-4036-aadd-2843c6fe45cc	70594-090	HUMAN PRESCRIPTION DRUG	CEFEPIME HYDROCHLORIDE		CEFEPIME HYDROCHLORIDE	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210110		ANDA	ANDA212721	Xellia Pharmaceuticals USA LLC	CEFEPIME HYDROCHLORIDE	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70594-094_b414c892-8c86-4df5-8085-737897006085	70594-094	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220106		ANDA	ANDA091049	Xellia Pharmaceuticals USA LLC	CEFTRIAXONE SODIUM	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70594-095_b414c892-8c86-4df5-8085-737897006085	70594-095	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220106		ANDA	ANDA091049	Xellia Pharmaceuticals USA LLC	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70594-096_b414c892-8c86-4df5-8085-737897006085	70594-096	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220106		ANDA	ANDA091049	Xellia Pharmaceuticals USA LLC	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70594-097_b414c892-8c86-4df5-8085-737897006085	70594-097	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220106		ANDA	ANDA091049	Xellia Pharmaceuticals USA LLC	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70594-098_d4819f4d-0e62-4647-b642-2727358f8727	70594-098	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220106		ANDA	ANDA091117	Xellia Pharmaceuticals USA LLC	CEFTRIAXONE SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
70594-111_bfb03f99-1389-424a-a457-efbb23f198ee	70594-111	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20230610		ANDA	ANDA217182	Xellia Pharmaceuticals USA LLC	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
70594-112_855a4bbb-d273-4372-8221-8fcff32bee92	70594-112	HUMAN PRESCRIPTION DRUG	Carboprost Tromethamine		carboprost tromethamine	SOLUTION	INTRAMUSCULAR	20231101		ANDA	ANDA216897	Xellia Pharmaceuticals USA LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
70594-114_afc179ac-71b9-4021-8b71-3372bf590e4a	70594-114	HUMAN PRESCRIPTION DRUG	Bupivacaine HCl		Bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20230601		ANDA	ANDA091487	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-115_afc179ac-71b9-4021-8b71-3372bf590e4a	70594-115	HUMAN PRESCRIPTION DRUG	BUPIVACAINE HCl		Bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20230601		ANDA	ANDA091487	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-116_6776a37a-5872-4c0c-b039-6d93e3604e7c	70594-116	HUMAN PRESCRIPTION DRUG	Bupivacaine HCl		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20230801		ANDA	ANDA091503	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-117_afc179ac-71b9-4021-8b71-3372bf590e4a	70594-117	HUMAN PRESCRIPTION DRUG	Bupivacaine HCl		Bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20230601		ANDA	ANDA091487	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-118_afc179ac-71b9-4021-8b71-3372bf590e4a	70594-118	HUMAN PRESCRIPTION DRUG	Bupivacaine HCl		Bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20230601		ANDA	ANDA091487	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-119_6776a37a-5872-4c0c-b039-6d93e3604e7c	70594-119	HUMAN PRESCRIPTION DRUG	Bupivacaine HCl		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20230801		ANDA	ANDA091503	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-120_afc179ac-71b9-4021-8b71-3372bf590e4a	70594-120	HUMAN PRESCRIPTION DRUG	Bupivacaine HCl		Bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20230601		ANDA	ANDA091487	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-121_afc179ac-71b9-4021-8b71-3372bf590e4a	70594-121	HUMAN PRESCRIPTION DRUG	Bupivacine HCl		Bupivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20230601		ANDA	ANDA091487	Xellia Pharmaceuticals USA LLC	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
70594-122_047a47f7-3fc4-4f77-aae1-a895c0f47e32	70594-122	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160223		ANDA	ANDA205694	Xellia Pharmaceuticals USA LLC	VANCOMYCIN HYDROCHLORIDE	500	mg/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70594-123_047a47f7-3fc4-4f77-aae1-a895c0f47e32	70594-123	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160223		ANDA	ANDA205694	Xellia Pharmaceuticals USA LLC	VANCOMYCIN HYDROCHLORIDE	1	g/1	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
70602-003_bd24d050-20b3-26d4-e053-2995a90a05b5	70602-003	HUMAN OTC DRUG	Exoden Powder		Cetylpyridinium Chloride, Domiphen Bromide	POWDER	TOPICAL	20210309		UNAPPROVED DRUG OTHER		LIFEON Corp.	CETYLPYRIDINIUM CHLORIDE; DOMIPHEN BROMIDE	.043; .12	g/100g; 1/100g			N	20241231
70602-004_d9ceb4d2-1f39-f556-e053-2a95a90a8f38	70602-004	HUMAN OTC DRUG	Exoden Cure Powder		Aluminum Chlorohydroxy Allantoinate	POWDER	TOPICAL	20210309		UNAPPROVED DRUG OTHER		LIFEON Corp.	ALCLOXA	.16	g/100g			N	20241231
70602-009_e3a47fdd-a5a0-0947-e053-2a95a90ab5b2	70602-009	HUMAN OTC DRUG	ANABIOSE PURIHEAL		SALICYLIC ACID	SHAMPOO	TOPICAL	20220712		OTC MONOGRAPH FINAL	part358H	LIFEON Corp.	SALICYLIC ACID	2.5	g/100mL			N	20241231
70602-010_e3b4a328-f6e8-7aaf-e053-2a95a90a5ab5	70602-010	HUMAN OTC DRUG	EXODEN ALL IN ONE		Silicon dioxide, Tetrasodium Pyrophosphate, Sodium Monofluorophosphate, sodium fluoride	PASTE	TOPICAL	20220713		UNAPPROVED DRUG OTHER		LIFEON Corp.	SILICON DIOXIDE; SODIUM FLUORIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	10; .11; .38; 3.4	g/100g; g/100g; g/100g; g/100g			N	20241231
70604-011_520cc1e1-f795-44d6-b0c7-da2f92a20c8b	70604-011	HUMAN OTC DRUG	HydraTint Pro Mineral Broad Spectrum Sunscreen SPF		TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20210924		OTC MONOGRAPH DRUG	M020	Alastin Skincare, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	.089; .034	g/g; g/g			N	20241231
70604-050_3414157e-6c31-4152-8042-3f53cb216c74	70604-050	HUMAN OTC DRUG	Daily Beauty Regimen with TriHex Technology		titanium dioxide and zinc oxide	KIT		20210924		OTC MONOGRAPH DRUG	M020	Alastin Skincare, Inc.						N	20251231
70605-013_c66018a7-5607-4530-98e5-5ce255618300	70605-013	HUMAN OTC DRUG	Meaningful Beauty Cindy Crawford Anti-Aging Day Creme with Environmental Protection Broad Spectrum SPF 30		avobenzone, homosalate, octisalate, and oxybenzone	CREAM	TOPICAL	20180201		OTC MONOGRAPH NOT FINAL	part352	Guthy-Renker LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	3; 10; 5; 4.5	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
70605-017_be5ac4d5-c1b3-4ce5-9afd-be6b0716d8f2	70605-017	HUMAN OTC DRUG	Principal Secret Advanced with Hydrospheres Continuous Moisture SPF8		Octinoxate and Octisalate	CREAM	TOPICAL	20171231		OTC MONOGRAPH DRUG	M020	Guthy-Renker LLC	OCTINOXATE; OCTISALATE	7.5; 1	g/100g; g/100g			N	20251231
70605-018_b202a8b7-147c-4873-9631-9d410bd997bd	70605-018	HUMAN OTC DRUG	Blemish Buster Solution Acne Treatment		SULFUR	CREAM	TOPICAL	20171231		OTC MONOGRAPH FINAL	part358H	Guthy-Renker LLC	SULFUR	10	mg/100mL			N	20241231
70605-024_8a6adae4-8102-43f8-8180-4f07b77bf408	70605-024	HUMAN OTC DRUG	Sheer Cover Nourishing Moisturizer	SPF 15	OCTINOXATE, OCTISALATE, and OXYBENZONE	LOTION	TOPICAL	20160531		OTC MONOGRAPH NOT FINAL	part352	Guthy-Renker LLC	OCTINOXATE; OCTISALATE; OXYBENZONE	7.5; 5; 3	mg/100mL; mg/100mL; mg/100mL			N	20241231
70605-026_10eeb294-5562-4a17-b200-85cdc0d48393	70605-026	HUMAN OTC DRUG	Jane Seymour Natural Advantage AM SPF 15 All Day Moisture with AHAs		Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20171230		OTC MONOGRAPH NOT FINAL	part352	Guthy-Renker,LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	2; 10; 5; 1.3; 4	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
70605-028_37b6796f-1be8-4628-913a-f5a10228c877	70605-028	HUMAN OTC DRUG	Principal Secret Reclaim Oil Control hydrator SPF-8		Titanium Dioxide	CREAM	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	Guthy-Renker LLC	TITANIUM DIOXIDE	4	mg/100mL			N	20251231
70605-042_24924a78-d0bd-4250-b6ee-bbdcecfa8232	70605-042	HUMAN OTC DRUG	Reclaim Revolutionary Anti-Aging Day SPF15		Octinoxate, Octisalate, and Oxybenzone	CREAM	TOPICAL	20171230		OTC MONOGRAPH NOT FINAL	part352	Guthy-Renker LLC	OCTINOXATE; OCTISALATE; OXYBENZONE	7.5; 5; 3	g/100g; g/100g; g/100g			N	20241231
70608-001_08a1a9ce-35dc-53c2-e063-6294a90a8e44	70608-001	HUMAN OTC DRUG	Kypris Pot of Shade Heliotropic Broad Spectrum SPF 30 Sunscreen And Primer		ZINC OXIDE	CREAM	TOPICAL	20160525		OTC MONOGRAPH DRUG	M020	Kypris Beauty LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70612-010_3a3614d6-ca20-4556-b768-6e1598e6aa0b	70612-010	HUMAN OTC DRUG	BIOCOOL	Tube Type	Menthol	GEL	TOPICAL	20160302		OTC MONOGRAPH NOT FINAL	part348	JJindustry.Co.Ltd	MENTHOL	4	g/100mL			N	20241231
70612-020_e42f8396-a01b-4156-9134-96245cbffa05	70612-020	HUMAN OTC DRUG	BIOCOOL	ROLL TYPE	Menthol	GEL	TOPICAL	20160302		OTC MONOGRAPH NOT FINAL	part348	JJindustry.Co.Ltd	MENTHOL	4	g/100mL			N	20241231
70612-030_5531c900-e104-4e29-9211-6fa662c84b91	70612-030	HUMAN OTC DRUG	Biocool Focus On		Menthol	GEL	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part348	JJindustry.Co.Ltd	MENTHOL	2.1	g/60mL			N	20241231
70616-370_c520f819-782f-4a1d-a53b-e7e348007378	70616-370	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20150202		OTC MONOGRAPH NOT FINAL	part333A	PERMATEX	ALCOHOL	70	mL/100mL			N	20241231
70616-628_e46bbf90-779c-45e2-8ca3-61209b32020d	70616-628	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part333A	Permatex	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
70616-743_351d4c37-3c05-499e-8d32-a5b941afa047	70616-743	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160512		OTC MONOGRAPH NOT FINAL	part333A	Permatex	BENZALKONIUM CHLORIDE	1.3091	mg/mL			N	20241231
70618-009_097b8a66-db6e-9b60-e063-6294a90aecff	70618-009	HUMAN OTC DRUG	THANK YOU FARMER Safe Sun Fluid Age 0880		Titanium Dioxide	CREAM	TOPICAL	20200210		OTC MONOGRAPH DRUG	M020	THANK YOU FARMER CO., LTD.	TITANIUM DIOXIDE	7.99	mg/100mL			N	20241231
70621-101_662d0dec-0f18-4a51-89e3-4d2252d38b1f	70621-101	HUMAN PRESCRIPTION DRUG	AMELUZ		aminolevulinic acid hydrochloride	GEL	TOPICAL	20160826		NDA	NDA208081	Biofrontera Inc.	AMINOLEVULINIC ACID HYDROCHLORIDE	100	mg/g	Fluorescence Contrast Activity [MoA], Optical Imaging Agent [EPC], Porphyrin Precursor [EPC], Porphyrinogens [CS]		N	20241231
70621-103_7a963358-d478-49ff-b7b8-fbfac556c4de	70621-103	HUMAN PRESCRIPTION DRUG	Xepi		ozenoxacin	CREAM	TOPICAL	20191219	20240731	NDA	NDA208945	Biofrontera Inc.	OZENOXACIN	10	mg/g	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	
70624-001_0864fa67-31dd-96f2-e063-6294a90a6916	70624-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20160301		UNAPPROVED MEDICAL GAS		Mobile Oxygen Services Inc	OXYGEN	99	L/100L			N	20241231
70625-206_0e05294c-89ef-6ceb-e063-6294a90a732c	70625-206	HUMAN PRESCRIPTION DRUG	Ranolazine		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200401		ANDA	ANDA212781	SunGen Pharma LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
70625-207_0e05294c-89ef-6ceb-e063-6294a90a732c	70625-207	HUMAN PRESCRIPTION DRUG	Ranolazine		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200401		ANDA	ANDA212781	SunGen Pharma LLC	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
70626-104_06bf5ae8-3c8a-d38b-e063-6294a90a80e2	70626-104	HUMAN OTC DRUG	SO TOTALLY CLEAN DEEP PORE CLEANSER		SALICYLIC ACID	LIQUID	TOPICAL	20160502		OTC MONOGRAPH FINAL	part333D	ASPIRE BRANDS INC	SALICYLIC ACID	.5	g/100mL			N	20241231
70626-105_06bf5ae8-3c7d-d38b-e063-6294a90a80e2	70626-105	HUMAN OTC DRUG	START SO FRESH		SALICYLIC ACID	GEL	TOPICAL	20201203		OTC MONOGRAPH FINAL	part333D	ASPIRE BRANDS INC	SALICYLIC ACID	2	g/100mL			N	20241231
70626-106_06bf5ae8-3c72-d38b-e063-6294a90a80e2	70626-106	HUMAN OTC DRUG	TREAT SO DEEP ACNE-FIGHTING TREATMENT		SALICYLIC ACID	GEL	TOPICAL	20201205		OTC MONOGRAPH FINAL	part333D	ASPIRE BRANDS INC	SALICYLIC ACID	2	g/100mL			N	20241231
70626-107_06bf7b01-e0ea-7434-e063-6394a90a1cb0	70626-107	HUMAN OTC DRUG	SCRUB SO CLEAN ACNE-FIGHTING SUPER SCRUB		SALICYLIC ACID	GEL	TOPICAL	20201206		OTC MONOGRAPH FINAL	part333D	ASPIRE BRANDS INC	SALICYLIC ACID	.5	g/100mL			N	20241231
70626-201_06bf4c31-6397-c7c3-e063-6294a90a4471	70626-201	HUMAN OTC DRUG	PICTURE PERFECT DAY DAILY MOISTURIZER		AVOBENZONE, OCTOCRYLENE, OCTISALATE	LOTION	TOPICAL	20160502		OTC MONOGRAPH FINAL	part352	ASPIRE BRANDS INC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2; 3; 6	g/100mL; g/100mL; g/100mL			N	20241231
70626-202_06bf5ae8-3c96-d38b-e063-6294a90a80e2	70626-202	HUMAN OTC DRUG	DAILY SHIELD	BROAD SPECTRUM SPF 20 MOISTURIZER	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20201206		OTC MONOGRAPH FINAL	part352	ASPIRE BRANDS INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
70626-504_06bf4c31-63b2-c7c3-e063-6294a90a4471	70626-504	HUMAN OTC DRUG	CLEAN GETAWAY BAG		SALICYLIC ACID	KIT		20170518		OTC MONOGRAPH FINAL	part333D	ASPIRE BRANDS INC						N	20241231
70630-0002_d280364f-752b-811d-e053-2995a90a4100	70630-0002	HUMAN OTC DRUG	Natural Tanning and Body Oil SPF15		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	25; 50; 60	mg/mL; mg/mL; mg/mL			N	20241231
70630-0003_d00ce943-7f5b-7e87-e053-2a95a90a8679	70630-0003	HUMAN OTC DRUG	Cacao Tanning Oil SPF6		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	5; 9; 10	mg/mL; mg/mL; mg/mL			N	20241231
70630-0004_d00cf53b-3131-ede2-e053-2a95a90a43a3	70630-0004	HUMAN OTC DRUG	Cacao Tanning Oil SPF15		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	15; 19; 30	mg/mL; mg/mL; mg/mL			N	20241231
70630-0005_cdb1442f-8d54-9a54-e053-2995a90accce	70630-0005	HUMAN OTC DRUG	Watermelon Tanning Oil SPF6		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	10; 25; 25	mg/mL; mg/mL; mg/mL			N	20241231
70630-0006_03fee4f3-ec50-6a59-e063-6294a90af81f	70630-0006	HUMAN OTC DRUG	Watermelon Tanning Oil SPF15		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	OIL	TOPICAL	20210101		OTC MONOGRAPH FINAL	M020	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
70630-0007_d28062a8-5a36-481c-e053-2995a90a5295	70630-0007	HUMAN OTC DRUG	Pineapple Tanning Oil SPF6		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	5; 10; 10	mg/mL; mg/mL; mg/mL			N	20241231
70630-0008_d28065f4-8a79-1f72-e053-2a95a90a09ee	70630-0008	HUMAN OTC DRUG	Pineapple Tanning Oil SPF15		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
70630-0017_db496783-c5b5-1dc0-e053-2995a90a9ce2	70630-0017	HUMAN OTC DRUG	Bali Body BB Cream SPF 15 Natural		OCTOCRYLENE, OCTINOXATE, AVOBENZONE, OXYBENZONE	CREAM	TOPICAL	20210430	20240209	OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	30; 49.95; 60; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	
70630-0021_d87a8dfc-dbf8-2fcb-e053-2995a90a09ab	70630-0021	HUMAN OTC DRUG	Bali Body Pineapple Tanning Oil SPF6		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20220220		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	10; 25; 25	mg/mL; mg/mL; mg/mL			N	20241231
70630-0022_d87aab0c-224f-1828-e053-2995a90ae35f	70630-0022	HUMAN OTC DRUG	Bali Body Cacao Tanning Oil SPF15		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20220220		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	15; 20; 30	mg/mL; mg/mL; mg/mL			N	20241231
70630-0023_d87ae2be-4ec5-e7b7-e053-2995a90a6b60	70630-0023	HUMAN OTC DRUG	Bali Body Cacao Tanning Oil SPF6		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20220220		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	5; 10; 10	mg/mL; mg/mL; mg/mL			N	20241231
70630-0024_d82cb4de-a9ac-6a8c-e053-2a95a90abc50	70630-0024	HUMAN OTC DRUG	Bali Body Face and Body Sunscreen SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL	TOPICAL	20220222		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	18; 90; 30; 60	mg/g; mg/g; mg/g; mg/g			N	20241231
70630-0025_d8dc40f3-c35e-30c3-e053-2995a90a155a	70630-0025	HUMAN OTC DRUG	Bali Body Hydrating Body Sunscreen SPF50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220225		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70630-0026_d8dbf727-4d7d-a96f-e053-2995a90ae10d	70630-0026	HUMAN OTC DRUG	Bali Body Hydrating Face Sunscreen SPF50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20220225		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70630-0027_d919cb9c-e4ac-6aa2-e053-2a95a90a5a88	70630-0027	HUMAN OTC DRUG	Natural Tanning and Body Oil SPF6		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20220228		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	12.5; 30; 30	mg/mL; mg/mL; mg/mL			N	20241231
70630-0028_d919f43b-e637-485b-e053-2a95a90a1c4c	70630-0028	HUMAN OTC DRUG	Peach Tanning Oil SPF6		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	OIL	TOPICAL	20220228		OTC MONOGRAPH FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	10; 25; 25	mg/mL; mg/mL; mg/mL			N	20241231
70630-0029_db0edf56-4f38-7b48-e053-2a95a90a9b42	70630-0029	HUMAN OTC DRUG	Bali Body BB Cream SPF 15 Natural		OCTOCRYLENE, OCTINOXATE, AVOBENZONE, OXYBENZONE	CREAM	TOPICAL	20220325		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	30; 50; 60; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70630-0030_db0f581e-e2b3-4092-e053-2a95a90a6465	70630-0030	HUMAN OTC DRUG	Bali Body BB Cream SPF 15 Tan		OCTOCRYLENE, OCTINOXATE, AVOBENZONE, OXYBENZONE	CREAM	TOPICAL	20220325		OTC MONOGRAPH NOT FINAL	part352	Bali Body Pty Ltd	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	30; 50; 60; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70630-0031_f8237e63-f80c-47c7-e053-6394a90a6056	70630-0031	HUMAN OTC DRUG	Bali Body Tinted Super Serum Natural SPF 30		Octisalate, Octocrylene, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230731		OTC MONOGRAPH FINAL	M020	Bali Body Pty Ltd	OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	31; 81; 32; 59	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70630-0032_f8237e63-f80c-47c7-e053-6394a90a6056	70630-0032	HUMAN OTC DRUG	Bali Body Tinted Super Serum Tan SPF 30		Octisalate, Octocrylene, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230731		OTC MONOGRAPH FINAL	M020	Bali Body Pty Ltd	OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	49; 78; 31; 56	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70630-0033_0370297f-845f-6803-e063-6294a90ae7d7	70630-0033	HUMAN OTC DRUG	Bali Body Watermelon Tanning Oil SPF 6		OCTOCRYLENE, OCTISALATE, AVOBENZONE	OIL	TOPICAL	20231201		OTC MONOGRAPH FINAL	M020	Bali Body Pty Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	10; 50; 30	mg/mL; mg/mL; mg/mL			N	20241231
70630-0034_03c0cd11-ea81-10d2-e063-6394a90a21a2	70630-0034	HUMAN OTC DRUG	Bali Body Cacao Tanning Oil SPF 15		OCTOCRYLENE, OCTISALATE, AVOBENZONE	OIL	TOPICAL	20231201		OTC MONOGRAPH FINAL	M020	Bali Body Pty Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 90	mg/mL; mg/mL; mg/mL			N	20241231
70630-0035_07d97aee-69dc-23be-e063-6294a90a7905	70630-0035	HUMAN OTC DRUG	Bali Body Watermelon Tanning Oil SPF 15		AVOBENZONE, OCTISALATE, OCTOCRYLENE	OIL	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Bali Body Pty Ltd	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 90	mg/mL; mg/mL; mg/mL			N	20241231
70631-057_f1d816a5-8f96-2b7b-e053-2995a90a585c	70631-057	HUMAN OTC DRUG	Thieves Essential Oil-Infused Chest Rub		CAMPHOR (NATURAL)	OINTMENT	TOPICAL	20200226		OTC MONOGRAPH FINAL	part341	Young Living Essential Oils	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	.053; .013; .028	g/g; g/g; g/g			N	20241231
70631-137_081d5e4b-f82d-2a9e-e063-6394a90a5c9e	70631-137	HUMAN OTC DRUG	Mineral Sunscreen SPF 50		Zinc oxide	LOTION	TOPICAL	20210723		OTC MONOGRAPH DRUG	M020	Young Living Essential Oils, LC	ZINC OXIDE	22	g/100g			N	20241231
70631-358_ec975dea-777f-2d4d-e053-2a95a90a0fa6	70631-358	HUMAN OTC DRUG	Acne Treatment Maximum Strength		Salicylic Acid	GEL	TOPICAL	20180607		OTC MONOGRAPH FINAL	M006	Young Living Essential Oils, LC	SALICYLIC ACID	2	g/100g			N	20241231
70644-899_8b4f3874-68ea-4d5f-96e6-77e293975402	70644-899	HUMAN PRESCRIPTION DRUG	Tobramycin	Inhalation Solution Pak	Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20160711		NDA AUTHORIZED GENERIC	NDA205433	Genericus, Inc.	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20251231
70645-123_7b0fc342-3d0b-b232-e053-2a91aa0a3021	70645-123	HUMAN PRESCRIPTION DRUG	Zingo		lidocaine hydrochloride monohydrate	POWDER	INTRADERMAL	20181120		NDA	NDA022114	7T Pharma LLC	LIDOCAINE HYDROCHLORIDE	.5	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70651-001_1b3410c5-6dba-401e-8a6e-4b483e65dc48	70651-001	HUMAN PRESCRIPTION DRUG	Pentetate calcium trisodium		pentetate calcium trisodium	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS; RESPIRATORY (INHALATION)	20040811	20260531	NDA	NDA021749	hameln pharma gmbh	PENTETATE CALCIUM TRISODIUM	1000	mg/5mL	Lead Chelating Activity [MoA], Lead Chelator [EPC]		N	
70651-002_191d11f2-a407-4cbf-8e8b-466e2bc03f2c	70651-002	HUMAN PRESCRIPTION DRUG	Pentetate zinc trisodium		Pentetate zinc trisodium	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS; RESPIRATORY (INHALATION)	20040811	20260531	NDA	NDA021751	hameln pharma gmbh	PENTETATE ZINC TRISODIUM	1000	mg/5mL	Lead Chelating Activity [MoA], Lead Chelator [EPC]		N	
70661-001_a3a6aab1-44b6-4670-bbdc-516f33274d99	70661-001	HUMAN PRESCRIPTION DRUG	ROSZET		rosuvastatin and ezetimibe	TABLET	ORAL	20210510		NDA	NDA213072	Althera Pharmaceuticals LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 5.2	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70661-002_a3a6aab1-44b6-4670-bbdc-516f33274d99	70661-002	HUMAN PRESCRIPTION DRUG	ROSZET		(rosuvastatin and ezetimibe)	TABLET	ORAL	20210510		NDA	NDA213072	Althera Pharmaceuticals LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 10.4	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70661-003_a3a6aab1-44b6-4670-bbdc-516f33274d99	70661-003	HUMAN PRESCRIPTION DRUG	ROSZET		(rosuvastatin and ezetimibe)	TABLET	ORAL	20210510		NDA	NDA213072	Althera Pharmaceuticals LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 20.8	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70661-004_a3a6aab1-44b6-4670-bbdc-516f33274d99	70661-004	HUMAN PRESCRIPTION DRUG	ROSZET		(rosuvastatin and ezetimibe)	TABLET	ORAL	20210510		NDA	NDA213072	Althera Pharmaceuticals LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 41.7	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70666-016_e06912e3-3ba5-6421-e053-2a95a90a4730	70666-016	HUMAN OTC DRUG	Coal Tar		Coal Tar	OINTMENT	TOPICAL	20161201		OTC MONOGRAPH FINAL	part358H	Nopsor USA Distribution Co., Inc.	COAL TAR	1.39	g/100mL			N	20241231
70666-022_e06912e3-3ba5-6421-e053-2a95a90a4730	70666-022	HUMAN OTC DRUG	Coal Tar		Coal Tar	SHAMPOO	TOPICAL	20161201		OTC MONOGRAPH FINAL	part358H	Nopsor USA Distribution Co., Inc.	COAL TAR	5.39	g/250mL			N	20241231
70672-001_078c1799-d9c8-1726-e063-6394a90af38e	70672-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091006		UNAPPROVED MEDICAL GAS		Dade Medical, Inc. dba Integrated Home Care	OXYGEN	99	L/100L			N	20241231
70673-297_09d7554e-93a1-9886-e063-6394a90a1a85	70673-297	HUMAN OTC DRUG	SMOOTH GATOR Foot and Leg Rub		CAMPHOR (SYNTHETIC), MENTHOL	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M017	Smooth Gator LLC	CAMPHOR (SYNTHETIC); MENTHOL	40; 12.5	mg/g; mg/g			N	20241231
70673-298_09d72589-1448-349f-e063-6294a90a4d95	70673-298	HUMAN OTC DRUG	SMOOTH GATOR 60-second Pain Relief		CAMPHOR (SYNTHETIC), MENTHOL	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M017	Smooth Gator LLC	CAMPHOR (SYNTHETIC); MENTHOL	30; 12.5	mg/g; mg/g			N	20241231
70673-747_09d7805e-6556-5fa8-e063-6294a90ac4bb	70673-747	HUMAN OTC DRUG	Smooth Gator Fungus Eliminator		CLOTRIMAZOLE	LIQUID	TOPICAL	20160429		OTC MONOGRAPH DRUG	M005	Smooth Gator, LLC	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70675-001_0acc9204-e964-42a6-e063-6294a90aae94	70675-001	HUMAN OTC DRUG	HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20231127		OTC MONOGRAPH DRUG	505G(a)(3)	Deqing Jiarou Daily Chemical Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
70677-0001_a6862b77-0e04-41d5-927f-6b521df4b34c	70677-0001	HUMAN OTC DRUG	nasal decongestant		Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180405		ANDA	ANDA077442	Strategic Sourcing Services	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-0002_f6e12717-2ee4-415d-908f-33c80ab0d174	70677-0002	HUMAN OTC DRUG	allergy relief		Diphenhydramine HCl	CAPSULE	ORAL	19900315	20250116	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70677-0003_fc02898c-4deb-44cc-8e6c-693338698238	70677-0003	HUMAN OTC DRUG	allergy relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302	20250228	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70677-0004_ef0d7b6e-93e4-4c40-bf02-760cff366807	70677-0004	HUMAN OTC DRUG	allergy		Chlorpheniramine maleate	TABLET	ORAL	19921219	20250316	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70677-0005_83ad0e9b-ce3d-47e7-87ce-c31c2fcc52da	70677-0005	HUMAN OTC DRUG	nasal decongestant	Maximum Strength	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825	20250323	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	
70677-0013_83944fc8-9a15-47c9-a952-e9bfcbfd8a2d	70677-0013	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Strategic Sourcing Services LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
70677-0014_9ff9fbe5-fc3e-4e00-9e43-53f9c9a7da7d	70677-0014	HUMAN OTC DRUG	Sunmark childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20161031		ANDA	ANDA204226	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0015_64197bed-0648-48d7-8f17-82e683204bf7	70677-0015	HUMAN OTC DRUG	Sunmark childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20161031		ANDA	ANDA204226	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0016_bfd96f42-794a-4baf-a2d9-99edf65dcf7d	70677-0016	HUMAN OTC DRUG	sunmark esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20170924		ANDA	ANDA207193	Strategic Sourcing Services LLC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70677-0017_7c1c3a67-c077-4c9b-948a-ebe3a22bd0b2	70677-0017	HUMAN OTC DRUG	Sunmark pain reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170530		ANDA	ANDA075077	Strategic Sourcing Services LLC	ACETAMINOPHEN	650	mg/1			N	20241231
70677-0018_7c525608-c31c-48fa-adb7-7ae0bc8e6d69	70677-0018	HUMAN OTC DRUG	Sunmark Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170526		ANDA	ANDA075077	Strategic Sourcing Services LLC	ACETAMINOPHEN	650	mg/1			N	20241231
70677-0021_a74a249c-208e-492d-93d1-3139530bacaf	70677-0021	HUMAN OTC DRUG	stay awake		caffeine	TABLET	ORAL	19961121	20241103	OTC MONOGRAPH DRUG	M011	Strategic Sourcing Services LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	
70677-0022_18234207-a919-461b-88b4-3ddc18b41c15	70677-0022	HUMAN OTC DRUG	motion sickness		Dimenhydrinate	TABLET	ORAL	19921201	20250508	OTC MONOGRAPH DRUG	M009	Strategic Sourcing Services LLC	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70677-0024_973e5cb5-1b40-4f76-9c93-5fdc7d638ccf	70677-0024	HUMAN OTC DRUG	nighttime sleep aid		diphenhydramine HCl	TABLET, FILM COATED	ORAL	20000610	20240614	OTC MONOGRAPH DRUG	M010	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70677-0026_1941baf2-1349-4c7b-a1b1-cb8265a24a18	70677-0026	HUMAN OTC DRUG	motion sickness		Meclizine HCl	TABLET	ORAL	20020624	20241209	OTC MONOGRAPH DRUG	M009	Strategic Sourcing Services LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
70677-0027_2483a725-3107-455e-bd8c-d96bcf174f6b	70677-0027	HUMAN OTC DRUG	Stool Softener		DOCUSATE CALCIUM	CAPSULE, LIQUID FILLED	ORAL	20170331	20240329	OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE CALCIUM	240	mg/1			N	
70677-0029_a81bce8a-b807-45fd-b326-6afe17312871	70677-0029	HUMAN OTC DRUG	SUNMARK CHILDRENS LORATADINE SRP SF GRAPE		Loratadine	SOLUTION	ORAL	20170317		ANDA	ANDA076805	Strategic Sourcing Services LLC	LORATADINE	5	mg/5mL			N	20241231
70677-0030_004fd044-e6f3-675d-e063-6394a90aa228	70677-0030	HUMAN OTC DRUG	Nicotine		Nicotine	PATCH	TRANSDERMAL	20171204		ANDA	ANDA074612	Strategic Sourcing Services LLC	NICOTINE	7	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0031_004fd044-e6f3-675d-e063-6394a90aa228	70677-0031	HUMAN OTC DRUG	Nicotine		Nicotine	PATCH	TRANSDERMAL	20171204		ANDA	ANDA074612	Strategic Sourcing Services LLC	NICOTINE	14	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0032_004fd044-e6f3-675d-e063-6394a90aa228	70677-0032	HUMAN OTC DRUG	Nicotine		Nicotine	PATCH	TRANSDERMAL	20171204		ANDA	ANDA074612	Strategic Sourcing Services LLC	NICOTINE	21	mg/24h	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0034_3bc6b532-7719-4bd0-8bba-f7d7e2c73963	70677-0034	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20170831		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
70677-0036_892cf1be-722b-4e30-943a-821b5d754edc	70677-0036	HUMAN OTC DRUG	sunmark loratadine d		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180604		ANDA	ANDA076050	Strategic Sourcing Services LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-0038_f070af44-13fb-47b0-845c-35284acf4378	70677-0038	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20171231		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-0039_a209fbd8-ee07-46be-8d84-b4c0fba9d26e	70677-0039	HUMAN OTC DRUG	sunmark lice solution kit		piperonyl butoxide, pyrethrum extract	KIT		20190318		OTC MONOGRAPH FINAL	part358G	Strategic Sourcing Services LLC						N	20241231
70677-0043_091c2efd-593f-1123-e063-6294a90acef1	70677-0043	HUMAN OTC DRUG	SUNMARK MILK OF MAGNESIA ORIGINAL		magnesium hydroxide	SUSPENSION	ORAL	20120401	20241101	OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
70677-0044_091c2efd-5942-1123-e063-6294a90acef1	70677-0044	HUMAN OTC DRUG	SUNMARK MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20120401	20250201	OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
70677-0046_4b1aa026-c771-4bde-8a5e-225ed09d1fb3	70677-0046	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20180131		ANDA	ANDA078682	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0048_7844b78a-2b52-4455-8573-65f119a75539	70677-0048	HUMAN OTC DRUG	sunmark tussin dm max		Dextromethorphan Hydrobromide, Guaifenesin	SOLUTION	ORAL	20181105		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-0049_6678d7e6-0696-4035-9340-746ab07b2aa6	70677-0049	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20180711	20250731	ANDA	ANDA207342	Strategic Sourcing Services LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
70677-0050_b2b16ecd-581b-4359-a604-38f0440bc00b	70677-0050	HUMAN OTC DRUG	Mucus Relief Extended-Release		Guaifenesin	TABLET	ORAL	20180711	20240928	ANDA	ANDA207342	Strategic Sourcing Services LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
70677-0051_b6e4d1e2-633f-43e3-a918-45c7ef1f94cd	70677-0051	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-0053_661805b8-59f9-428e-ab7f-b40cde3c8a36	70677-0053	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-0054_97bf2d1d-e4dd-4ae9-a328-711c184cd2c0	70677-0054	HUMAN OTC DRUG	sunmark anti diarrheal		loperamide HCl	SOLUTION	ORAL	20180611		ANDA	ANDA091292	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70677-0055_aa6a0923-2316-476f-9b8a-69ed302a1bd1	70677-0055	HUMAN OTC DRUG	Sunmark Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20180722		ANDA	ANDA209215	Strategic Sourcing Services LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70677-0056_96b1fd09-ed58-4440-ae00-6bb7e047251c	70677-0056	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20090518		OTC MONOGRAPH NOT FINAL	part333A	STRATEGIC SOURCING SERVICES LLC	ALCOHOL	610	mg/mL			N	20241231
70677-0058_ecf7a2a2-6a44-2e1c-e053-2a95a90aec90	70677-0058	HUMAN OTC DRUG	SENNA LAXATIVE		Sennosides	TABLET	ORAL	20181001	20240401	OTC MONOGRAPH NOT FINAL	part334	STRATEGIC SOURCING SERVICES LLC	SENNOSIDES	8.6	mg/1			N	
70677-0060_0e9bc88c-bd05-205e-e063-6394a90a37e9	70677-0060	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20181215	20251031	NDA	NDA021855	STRATEGIC SOURCING SERVICES, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	
70677-0064_891979aa-f275-4b36-bd90-473aaeee9653	70677-0064	HUMAN OTC DRUG	Naproxen Sodium PM		Naproxen Sodium	TABLET	ORAL	20181231		ANDA	ANDA209726	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0065_dbcc02a1-17b7-4daf-8ad4-805f33b11c6a	70677-0065	HUMAN OTC DRUG	Sunmark Extra Strength Antacid Assorted Fruit		Calcium carbonate	TABLET, CHEWABLE	ORAL	20220706		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70677-0066_b8c52e77-ef61-405e-864f-a8aee1a44300	70677-0066	HUMAN OTC DRUG	Sunmark Regular Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20190917		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70677-0067_afd0f732-94ac-4d78-9049-f9e298829fcc	70677-0067	HUMAN OTC DRUG	Sunmark Regular Strength Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20220706		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70677-0068_5afc9604-53bf-4826-af86-b83106ff3895	70677-0068	HUMAN OTC DRUG	Sleep Aid		Doxylamine Succinate	TABLET	ORAL	20190430	20250315	ANDA	ANDA040564	Strategic Sourcing Services LLC	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
70677-0071_08f39ac5-9535-bc11-e063-6394a90ad71e	70677-0071	HUMAN OTC DRUG	enteric coated aspirin	Regular Strength	Aspirin	TABLET, DELAYED RELEASE	ORAL	20190517	20250228	OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
70677-0072_d6f7fd41-af2e-4eca-869c-40fe5732d002	70677-0072	HUMAN OTC DRUG	sunmark childrens ibuprofen ib		Ibuprofen	TABLET, CHEWABLE	ORAL	20190604		ANDA	ANDA076359	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0074_b64fb858-98df-38a9-3f05-3fd6ee50e37d	70677-0074	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20190909		ANDA	ANDA076502	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0075_33bab6b9-056c-4029-96a2-ab334cd04322	70677-0075	HUMAN OTC DRUG	Sunmark All Day Allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20190816		ANDA	ANDA078336	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0077_6b84f9e8-6aae-45cd-86e5-70c03a834aa6	70677-0077	HUMAN OTC DRUG	sunmark all day allergy d		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200304		ANDA	ANDA210719	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-0078_62b755f6-7069-48fa-84a1-5f728f302495	70677-0078	HUMAN OTC DRUG	Sunmark Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190912		UNAPPROVED DRUG OTHER		Strategic Sourcing Services LLC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
70677-0079_134b961a-f1aa-4d4a-919f-e71f336bb581	70677-0079	HUMAN OTC DRUG	Sunmark Fexofenadine Hydrochloride		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20190821		ANDA	ANDA076447	Strategic Sourcing Services LLC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0081_8876ba9e-1ef6-48e2-ae19-674e4f259151	70677-0081	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen, Diphenhydramine HCL	TABLET, COATED	ORAL	20191227		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0083_a16ef9c8-460e-4ba4-a11e-13b5c1bace5e	70677-0083	HUMAN OTC DRUG	Stool Softener Laxative		docusate sodium and sennosides	TABLET	ORAL	20200730	20250828	OTC MONOGRAPH DRUG	M007	Strategic Sourcing Services LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	
70677-0084_44dc29f9-c672-4644-a194-451f76f36608	70677-0084	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20200529	20250428	OTC MONOGRAPH DRUG	M002	Strategic Sourcing Services LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	
70677-0085_21455933-e471-4a02-9e55-3c330f48973e	70677-0085	HUMAN OTC DRUG	sunmark nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20191207		ANDA	ANDA078547	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0086_b81965b7-88c5-474a-954d-d86b9ca38e9a	70677-0086	HUMAN OTC DRUG	sunmark nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20191207		ANDA	ANDA078546	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0087_16cc2940-644b-4908-9a7e-1e3259a5c05c	70677-0087	HUMAN OTC DRUG	sunmark nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200113		ANDA	ANDA090821	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0088_d64f34be-05e2-4991-8bc9-c81ec2702d2b	70677-0088	HUMAN OTC DRUG	sunmark nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200114		ANDA	ANDA090821	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0089_6a0758f3-eacb-42a0-84b2-8005d85f632b	70677-0089	HUMAN OTC DRUG	sunmark nicotine		nicotine polacrilex	LOZENGE	ORAL	20191226		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0090_dc9fb1f8-d278-45be-b212-744ac7ff43a3	70677-0090	HUMAN OTC DRUG	sunmark nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20191226		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0092_c9b5eb2f-4f83-4b56-babd-ee8d46f82c3b	70677-0092	HUMAN OTC DRUG	sunmark adult aspirin		aspirin	TABLET, FILM COATED	ORAL	20200304		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-0093_1e668f75-d4cd-4098-8e2b-0f44b30bbe85	70677-0093	HUMAN OTC DRUG	sunmark pain reliever		acetaminophen	TABLET, FILM COATED	ORAL	20200122		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70677-0094_01932531-972f-42aa-9090-a68e4ea3a8f6	70677-0094	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191129		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
70677-0100_ee9eb8a5-baff-76ef-e053-2a95a90a1aa1	70677-0100	HUMAN OTC DRUG	Cold Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200603	20240630	OTC MONOGRAPH FINAL	part341	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
70677-0101_1b678869-be0b-4cfc-a9bd-0e523472867e	70677-0101	HUMAN OTC DRUG	Childrens Cold and Allergy Relief		Brompheniramine maleate, Phenylephrine HCl	LIQUID	ORAL	20200131		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	2; 5	mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-0108_eeabac24-df5d-44be-b2a3-88b53441fb98	70677-0108	HUMAN OTC DRUG	Sunmark Arthritis Pain		diclofenac sodium	GEL	TOPICAL	20200603		ANDA	ANDA211253	Strategic Sourcing Services LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0109_7a956565-ff0a-498a-92cc-e529d47d28d9	70677-0109	HUMAN OTC DRUG	Nasal Decongestant PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200729	20240803	OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
70677-0110_9e566f31-286f-594b-84de-83414176390a	70677-0110	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20200727		ANDA	ANDA208369	Strategic Sourcing Services, LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-0115_091c35a0-b086-20e9-e063-6294a90a99f5	70677-0115	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20200701	20250301	OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
70677-0116_9bafe040-aa8b-4274-8098-f2638cdd4fd6	70677-0116	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
70677-0117_914492e7-2f6a-43c1-a65d-26aab66c7f8f	70677-0117	HUMAN OTC DRUG	Infants Pain Reliever		Acetaminophen	SUSPENSION	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
70677-0118_bfb7ffc1-d2fc-4ecb-aace-0dcb31e5d2f0	70677-0118	HUMAN OTC DRUG	Pain Reliever	Childrens dye free	Acetaminophen	SUSPENSION	ORAL	20200730		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
70677-0119_01e5e032-b63a-45c6-b6ec-d7ca02be89bf	70677-0119	HUMAN OTC DRUG	sunmark migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA075794	Strategic Sourcing Services LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70677-0120_f78d9a6e-8cf4-4278-b2c6-d36aa40905f3	70677-0120	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20180425		OTC MONOGRAPH FINAL	part347	Strategic Sourcing Services LLC	PETROLATUM	1	g/g			N	20241231
70677-0121_480bf717-f59e-4da4-8ced-7fb7a6d8080a	70677-0121	HUMAN OTC DRUG	Cold and Cough Relief	children	Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20201030		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-0122_9ff842bc-f469-44c2-3f3d-0204be3e1664	70677-0122	HUMAN OTC DRUG	Olopatadine Hydrochloride Ophthalmic Solution	Once Daily Relief	Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210315		ANDA	ANDA209752	Strategic Sourcing Specialists, LLC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
70677-0124_cf85d9c5-1539-4d5f-9673-640e79d10167	70677-0124	HUMAN OTC DRUG	sunmark lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20211213		ANDA	ANDA202319	Strategic Sourcing Services LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70677-0128_7e27e7d4-213d-7aad-c6f3-985f9b86eec3	70677-0128	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride 60 mg	TABLET	ORAL	20210730		ANDA	ANDA076502	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0131_0bdd2b40-8bc2-f0fa-e063-6394a90a1ecf	70677-0131	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20210706		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70677-0132_0bdd2b04-89a8-9dab-e063-6294a90a6b83	70677-0132	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20210706		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-0133_0bdcfa97-8964-e228-e063-6394a90a3b2e	70677-0133	HUMAN OTC DRUG	Senna Laxative		SENNOSIDES	TABLET	ORAL	20210706		OTC MONOGRAPH DRUG	M007	Strategic Sourcing Services, LLC	SENNOSIDES	8.6	mg/1			N	20241231
70677-0134_0bdcea53-4930-e15b-e063-6394a90a94d3	70677-0134	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210706		ANDA	ANDA214684	Strategic Sourcing Services, LLC	LORATADINE	10	mg/1			N	20241231
70677-0137_d843dd72-fb5f-4ed0-8a22-086dbc2b005f	70677-0137	HUMAN OTC DRUG	Sunmark Regular Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20210903		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70677-0138_cfd82fc9-0ace-4ff4-abec-dcff1b751034	70677-0138	HUMAN OTC DRUG	Sunmark Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20210908		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
70677-0139_6f701f12-e062-40ba-aa1d-d7b1ae773ada	70677-0139	HUMAN OTC DRUG	sunmark adult tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220427		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-0142_c5862f66-f88b-771c-6b0e-2b829dae9934	70677-0142	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20220512		ANDA	ANDA078343	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0143_eee3c707-8f38-9f46-669e-11f435207072	70677-0143	HUMAN OTC DRUG	Arthritis Pain		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20220706		ANDA	ANDA210986	Strategic Sourcing Services, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0144_fa1a53b5-1258-41c4-8662-b8e6d3d57ea8	70677-0144	HUMAN OTC DRUG	children allergy relief dye free cherry		Diphenhydramine HCl	SOLUTION	ORAL	20220422		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0145_c6f8eb9a-7278-4e74-ba3a-ac4a87043aca	70677-0145	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20220311		ANDA	ANDA075209	Strategic Sourcing Services LLC	LORATADINE	10	mg/1			N	20241231
70677-0146_694c3718-86b9-45ab-a49b-a4692b6e3fc9	70677-0146	HUMAN OTC DRUG	all day allergy-D		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA090922	Strategic Sourcing Services	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-0147_75f2c9e8-042e-4fa8-b2b9-7b24346a3d2c	70677-0147	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Strategic Sourcing Services	ACETAMINOPHEN	650	mg/1			N	20241231
70677-0148_b4a9538c-049e-45d3-8b28-581c68a36ed6	70677-0148	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20190101		ANDA	ANDA207891	Strategic Sourcing Services	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70677-0149_e4c85780-7cb5-b55c-e053-2995a90a0314	70677-0149	HUMAN OTC DRUG	CHILDRENS ALLERGY RELIEF		cetirizine hydrochloride	SOLUTION	ORAL	20220721		ANDA	ANDA210622	Strategic Sourcing Services	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0150_e5e79c54-bf94-3d7d-e053-2995a90a3812	70677-0150	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20181123		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0151_e5e79c54-bf94-3d7d-e053-2995a90a3812	70677-0151	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20220801		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0152_e5e79c54-bf94-3d7d-e053-2995a90a3812	70677-0152	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20220801		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0153_e5e79c54-bf94-3d7d-e053-2995a90a3812	70677-0153	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20220801		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-0160_6428c40a-3f3b-43a6-9881-e1ed10c1daf9	70677-0160	HUMAN OTC DRUG	Sunmark Severe Day Time		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20220614		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-0161_d7897ed1-91d4-4f96-a6e5-2490e5429704	70677-0161	HUMAN OTC DRUG	sunmark severe nite time cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20220614		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-0162_e20e49d9-a158-3e87-e053-2995a90a925c	70677-0162	HUMAN OTC DRUG	allergy relief Diphenhydramine HCI 25 mg Antihistamine		Diphenhydramine HCl	BAR, CHEWABLE	ORAL	20220622		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-0163_227fa62a-d94a-4708-a8c6-186b0c6ab926	70677-0163	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20220805		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-0164_e8631cb0-7c82-41ed-ba1f-f75218b40c78	70677-0164	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20220801		OTC MONOGRAPH DRUG	M007	Strategic Sourcing Services LLC	SENNOSIDES	8.6	mg/1			N	20241231
70677-0167_0b61edd3-f127-d8a9-e063-6294a90a17fa	70677-0167	HUMAN OTC DRUG	SENNA-S		Sennosides and Docusate Sodium	TABLET	ORAL	20220901		OTC MONOGRAPH DRUG	505G(a)(3)	STRATEGIC SOURCING SERVICES LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
70677-0168_08f3cf2b-895d-7c73-e063-6294a90a948d	70677-0168	HUMAN OTC DRUG	pain reliever		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20220923	20251130	ANDA	ANDA211544	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN	650	mg/1			N	
70677-0169_c8b99f3c-8564-4c1e-8f29-f274115dc71f	70677-0169	HUMAN OTC DRUG	sunmark nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20221128		ANDA	ANDA206394	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-0170_6bba7dbe-81fb-495a-9ab6-2ae507077301	70677-0170	HUMAN OTC DRUG	sunmark nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20221215		ANDA	ANDA206393	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1000_f414d867-f2b3-4554-b260-4fdd5475b1fb	70677-1000	HUMAN OTC DRUG	Miconazole Nitrate		Miconazole Nitrate	CREAM	TOPICAL	20230714		OTC MONOGRAPH FINAL	part333C	STRATEGIC SOURCING SERVICES LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70677-1001_5b041c7d-efd3-4d2b-a266-d45c78516574	70677-1001	HUMAN OTC DRUG	Tolnaftate Antifungal		Tolnaftate	CREAM	TOPICAL	20230622		OTC MONOGRAPH FINAL	part333C	STRATEGIC SOURCING SERVICES LLC	TOLNAFTATE	1	g/100g			N	20241231
70677-1002_2d2a0ddf-ae2e-4bce-ac56-e85cb939e1af	70677-1002	HUMAN OTC DRUG	Clotrimazole 1%	Athletes Foot	Clotrimazole	CREAM	TOPICAL	20230614		OTC MONOGRAPH FINAL	part333C	STRATEGIC SOURCING SERVICES LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70677-1003_bc058e1f-e6b9-40d9-a65e-82a2df0d3fb7	70677-1003	HUMAN OTC DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	CREAM	TOPICAL	20230630		ANDA	ANDA077511	STRATEGIC SOURCING SERVICES LLC	TERBINAFINE HYDROCHLORIDE	1	g/100g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
70677-1004_fa2f0650-fc4b-2bbd-e053-6294a90a183c	70677-1004	HUMAN OTC DRUG	Allergy Multi-Symptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230425		OTC MONOGRAPH FINAL	part341	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1005_fa2f0650-fc35-2bbd-e053-6294a90a183c	70677-1005	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230425		OTC MONOGRAPH FINAL	part341	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1007_873d9d8d-256d-9d79-dae1-4907db3fa0e8	70677-1007	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20220512		ANDA	ANDA078343	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1008_e4f24b7d-8765-52ac-8049-b693e87a5be9	70677-1008	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride 60 mg	TABLET	ORAL	20210730		ANDA	ANDA076502	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1009_1982b8ab-b306-c1f8-0490-943207d2b606	70677-1009	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine hydrochloride	TABLET	ORAL	20190909		ANDA	ANDA076502	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1010_f2ec6404-ee8c-4c0d-66d1-c37182305fe2	70677-1010	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA215434	Strategic Sourcing Services, LLC	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-1011_51515d6b-4c2a-ab66-0ec0-e664c3b01500	70677-1011	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCL	TABLET, EXTENDED RELEASE	ORAL	20200727		ANDA	ANDA208369	Strategic Sourcing Services, LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-1012_7eaba464-5cdb-4bd4-b272-38fa108658d5	70677-1012	HUMAN OTC DRUG	Foster and Thrive Childrens Allergy Relief		Diphenhydramine HCl	LIQUID	ORAL	20230412		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1013_f4ab5611-8abb-4c1f-8f85-917e2e1328e3	70677-1013	HUMAN OTC DRUG	Foster and Thrive Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230413		ANDA	ANDA209215	Strategic Sourcing Services LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70677-1014_e8b8f0dc-8b0c-4f0f-bdea-22928853d75a	70677-1014	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20230328		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1015_085e2d91-27df-488b-99d8-d4da23ddf0ed	70677-1015	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl	CAPSULE	ORAL	20230406		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1016_82bea54e-1c94-47f0-a382-63b507b685d1	70677-1016	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	20230422		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1017_899856bc-b6f0-4245-9f8c-3ab469df1563	70677-1017	HUMAN OTC DRUG	Nasal Decongestant	Maximum Strength	Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20230406		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-1018_d826c4a9-f53f-4dc4-9f97-08bf29685f3c	70677-1018	HUMAN OTC DRUG	Loratadine and Pseudoephedrine		loratadine and pseudoephedrine	TABLET, EXTENDED RELEASE	ORAL	20230810		ANDA	ANDA076557	STRATEGIC SOURCING SERVICES LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	10; 240	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-1019_a8f13ce3-e26c-4c8e-9946-bcc08d1a64bb	70677-1019	HUMAN OTC DRUG	Pseudoephedrine hydrochloride		Pseudoephedrine hydrochloride	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA077442	STRATEGIC SOURCING SERVICES LLC	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-1020_bf84463e-37af-4a03-8628-7b83ee907917	70677-1020	HUMAN OTC DRUG	Allergy relief-D		Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230811		ANDA	ANDA090922	STRATEGIC SOURCING SERVICES LLC	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-1021_67899c15-e5e5-4fe6-a639-71832969a761	70677-1021	HUMAN OTC DRUG	Foster and Thrive Allergy Relief		Fluticasone propionate	SPRAY, METERED	NASAL	20231129		ANDA	ANDA207957	Strategic Sourcing Services LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70677-1022_aff1ab34-51b0-488c-931e-c95aad226572	70677-1022	HUMAN OTC DRUG	foster and thrive allergy relief		Loratadine	TABLET	ORAL	20231218		ANDA	ANDA076301	Strategic Sourcing Services LLC	LORATADINE	10	mg/1			N	20251231
70677-1023_ce67844e-f1e1-442a-ac7f-396a17c21794	70677-1023	HUMAN OTC DRUG	foster and thrive 24 hour nasal allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20230630		ANDA	ANDA078104	Strategic Sourcing Services LLC	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70677-1024_a2444ffb-8066-49d3-975c-b2c67fbeed7c	70677-1024	HUMAN OTC DRUG	foster and thrive allergy D 12 hour		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231019		ANDA	ANDA076050	Strategic Sourcing Services LLC	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70677-1025_a615a896-a1fe-4a66-bee3-1f1adda9f27a	70677-1025	HUMAN OTC DRUG	foster and thrive 12 hour cough relief		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20230903		ANDA	ANDA091135	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1026_3c0e16ec-697f-49bd-ae2e-78eeec03b30f	70677-1026	HUMAN OTC DRUG	foster and thrive 12 hour cough relief		dextromethorphan polistirex	SUSPENSION	ORAL	20231004		ANDA	ANDA091135	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1027_98805892-4270-4475-bf72-1d778250ede8	70677-1027	HUMAN OTC DRUG	foster and thrive daytime severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20231016		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1028_c1ecc56b-8052-4b0a-900a-dc93a24771bd	70677-1028	HUMAN OTC DRUG	foster and thrive daytime cold and flu relief nighttime cold and flu relief		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20231030		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC						N	20241231
70677-1029_1f45bb63-9fe8-405f-9bd8-3d8b887b5d32	70677-1029	HUMAN OTC DRUG	foster and thrive daytime severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1030_995ecd17-b4de-4eb4-ab98-965ed82e8355	70677-1030	HUMAN OTC DRUG	foster and thrive nighttime severe cold and flu relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1031_066438c7-b4d3-4db1-9504-baaefdfb5fd0	70677-1031	HUMAN OTC DRUG	foster and thrive daytime cold and flu relief		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20231020		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1032_358925ba-6ff5-4ad4-b901-716e7a1ac65d	70677-1032	HUMAN OTC DRUG	foster and thrive nighttime cold and flu relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20231031		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1033_2056b8cf-5778-4ecb-ac8d-b62b58030187	70677-1033	HUMAN OTC DRUG	foster and thrive nighttime cold and flu relief		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate	SOLUTION	ORAL	20231017		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1035_f8933226-fbc9-44e3-a90f-4e6c1dbdb7b7	70677-1035	HUMAN OTC DRUG	foster and thrive adult tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20231025		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1036_5f6e4d56-4a66-4dbd-97c8-550310dea358	70677-1036	HUMAN OTC DRUG	Foster and Thrive Adult Tussin DM MAX		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20231127		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1037_4ff5a4ae-9649-4a6d-a5f8-ca23efbbb479	70677-1037	HUMAN OTC DRUG	foster and thrive nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20230914		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
70677-1039_a83c6a95-7357-4596-8119-be3275b3ba88	70677-1039	HUMAN OTC DRUG	foster and thrive nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20231018		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
70677-1040_b4cb2baf-ff62-43c5-abb1-4ab2b2749002	70677-1040	HUMAN OTC DRUG	foster and thrive nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20231030		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
70677-1042_71e135cb-29cd-4858-92ed-05fb09688563	70677-1042	HUMAN OTC DRUG	foster and thrive childrens allergy relief		Cetirizine HCl	SOLUTION	ORAL	20230920		ANDA	ANDA204226	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1043_e4dfb921-4f17-4a55-93c2-85d9f74edac9	70677-1043	HUMAN OTC DRUG	foster and thrive childrens allergy relief		loratadine	TABLET, CHEWABLE	ORAL	20231030		ANDA	ANDA210033	Strategic Sourcing Services LLC	LORATADINE	5	mg/1			N	20241231
70677-1044_91573d1c-b47a-4021-9a9a-a722db925588	70677-1044	HUMAN OTC DRUG	foster and thrive childrens cold and cough relief dm		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20230903		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1046_c54178fa-3115-4902-8123-016dbcf034f0	70677-1046	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230301		ANDA	ANDA208754	Strategic Sourcing Services LLC	DOCOSANOL	100	mg/g			N	20241231
70677-1047_01b8fa69-8221-45de-921b-c57c7b38b339	70677-1047	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20230301		ANDA	ANDA209274	Strategic Sourcing Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1049_cd619d8c-2e04-46b4-99d7-ab2563380e38	70677-1049	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20230301		ANDA	ANDA209692	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1050_a45e0443-d2dc-4262-9741-e4cd99d915d3	70677-1050	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20230331		ANDA	ANDA209692	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1051_a908cf86-1d0c-4eda-b6ad-139775d3c355	70677-1051	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230301		ANDA	ANDA207342	Strategic Sourcing Services LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70677-1052_cd45b857-7fb8-4b56-903d-149659d6cd15	70677-1052	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230331		ANDA	ANDA207342	Strategic Sourcing Services LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70677-1053_584bfa20-a66c-4fc1-a230-27780a232e49	70677-1053	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20230301		ANDA	ANDA075209	Strategic Sourcing Services LLC	LORATADINE	10	mg/1			N	20241231
70677-1054_89455b45-3e68-4768-98c9-57546dee51f5	70677-1054	HUMAN OTC DRUG	Foster and Thrive Chest Congestion Relief		Guaifenesin	TABLET	ORAL	20230127		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70677-1055_a354f2d7-147a-48c0-9c76-549117b46634	70677-1055	HUMAN OTC DRUG	Foster and Thrive Chest Congestion Relief DM	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20230127		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1056_07108d0e-f069-418b-a6ec-0d13861fe621	70677-1056	HUMAN OTC DRUG	Foster and Thrive Chest Congestion Relief PE	PE	Guaifenesin/phenylephrine	TABLET	ORAL	20230127		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1057_5af171c4-9c29-4f97-b2c9-6694f8f4720a	70677-1057	HUMAN OTC DRUG	Loratadine		Loratadine	SOLUTION	ORAL	20230801		ANDA	ANDA076805	STRATEGIC SOURCING SERVICES LLC	LORATADINE	5	mg/5mL			N	20241231
70677-1058_44f15dfb-a791-4b3d-a9b5-8ee9914cdd39	70677-1058	HUMAN OTC DRUG	Childrens Loratadine	Sugar Free	Loratadine	SOLUTION	ORAL	20230719		ANDA	ANDA076805	STRATEGIC SOURCING SERVICES LLC	LORATADINE	5	mg/5mL			N	20241231
70677-1059_fa58da35-2e29-99e7-e053-6394a90a6643	70677-1059	HUMAN OTC DRUG	Allergy Relief Diphenhydramine HCl 25 mg ANTIHISTAMINE		Diphenhydramine HCl	BAR, CHEWABLE	ORAL	20230427		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1061_f3284617-8e07-429c-9dfc-63c0100442d9	70677-1061	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	JELLY	TOPICAL	20230224		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
70677-1062_f9e03d2b-2ec1-322b-e053-6394a90a1599	70677-1062	HUMAN OTC DRUG	Anti-Diarrheal		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20230421		NDA	NDA021855	STRATEGIC SOURCING SERVICES	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70677-1063_09a70f75-c693-e4ef-e063-6394a90ac2c2	70677-1063	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID AND ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20230601		OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1064_09a70f75-c695-e4ef-e063-6394a90ac2c2	70677-1064	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20230501		OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1065_09a71fed-a621-6415-e063-6294a90a32e5	70677-1065	HUMAN OTC DRUG	MAXIMUM STRENGTH ANTACID AND ANTIGAS		aluminum hydroxide, magnesium hydroxide, simethicone	SUSPENSION	ORAL	20230501		OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1066_09a718a3-c0eb-8388-e063-6294a90ac57e	70677-1066	HUMAN OTC DRUG	REGULAR STRENGTH ANTACID AND ANTIGAS		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20230501		OTC MONOGRAPH DRUG	M001	STRATEGIC SOURCING SERVICES LLC	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	200; 20; 200	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1067_08a1ff0f-27e1-3b7b-e063-6394a90a9bb1	70677-1067	HUMAN OTC DRUG	GAS RELIEF		Simethicone	TABLET, CHEWABLE	ORAL	20230601		OTC MONOGRAPH DRUG	M002	STRATEGIC SOURCING SERVICES LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
70677-1068_041157c3-c795-3390-e063-6394a90ac9d2	70677-1068	HUMAN OTC DRUG	CLEARLAX		polyethylene glycol 3350	POWDER, FOR SOLUTION	ORAL	20230801		ANDA	ANDA090812	STRATEGIC SOURCING SERVICES LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1069_0b612f59-f256-25e6-e063-6294a90ace77	70677-1069	HUMAN OTC DRUG	SENNA-S		Sennosides and Docusate Sodium	TABLET	ORAL	20230501		OTC MONOGRAPH DRUG	505G(a)(3)	STRATEGIC SOURCING SERVICES LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
70677-1071_08648fce-28bf-9f95-e063-6394a90a0872	70677-1071	HUMAN OTC DRUG	Stool Softener		docusate sodium	TABLET	ORAL	20230601		OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
70677-1072_09a7141e-5879-df3c-e063-6394a90a9962	70677-1072	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20230701		OTC MONOGRAPH DRUG	M007	Strategic Sourcing Services LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1073_09a7141e-5878-df3c-e063-6394a90a9962	70677-1073	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20230701		OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1074_09a70f75-c696-e4ef-e063-6394a90ac2c2	70677-1074	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20230601		OTC MONOGRAPH DRUG	M007	STRATEGIC SOURCING SERVICES LLC	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1075_1aeb60fb-eebe-4e54-be1c-4e01f3b7269c	70677-1075	HUMAN OTC DRUG	Foster and Thrive Regular Strength Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20230426		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70677-1076_8b2fabf7-4dc6-445a-842c-b28ae081fdc8	70677-1076	HUMAN OTC DRUG	Foster and Thrive Extra Strength Antacid 127AF	Extra Strength Antacid Assorted Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20230712		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70677-1077_e47374c8-05c1-4874-871b-e83d9b305bd3	70677-1077	HUMAN OTC DRUG	Foster and Thrive Extra Strength Gas Relief Cherry		Simethicone	TABLET, CHEWABLE	ORAL	20230525		OTC MONOGRAPH FINAL	part332	Strategic Sourcing Services LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
70677-1078_824c9dff-0a26-4710-a25b-39df631d6fa6	70677-1078	HUMAN OTC DRUG	Foster and Thrive infants Gas relief		simethicone	SOLUTION/ DROPS	ORAL	20230612		OTC MONOGRAPH FINAL	part332	Strategic Sourcing Services LLC	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
70677-1079_fecec517-10c8-4bba-8cda-badbc45a1772	70677-1079	HUMAN OTC DRUG	Foster and Thrive Extra Strength Sugar Free Antacid Orange		calcium carbonate	TABLET, CHEWABLE	ORAL	20230614		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70677-1080_d18cd615-912a-4853-bb2e-225960cfe08b	70677-1080	HUMAN OTC DRUG	Foster and Thrive Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20230620		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
70677-1081_49d1b6c4-432b-44d3-b073-0185dbed7a90	70677-1081	HUMAN OTC DRUG	Foster and Thrive Regular Strength Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20230424		OTC MONOGRAPH FINAL	part331	Strategic Sourcing Services LLC	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
70677-1082_c73c6650-a7ac-4942-ae07-0bc660a0081f	70677-1082	HUMAN OTC DRUG	Foster and Thrive Stomach Relief		Bismuth subsalicylate	TABLET	ORAL	20230515		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
70677-1083_88d341a6-28aa-4a20-bfed-1d5f3106c2ae	70677-1083	HUMAN OTC DRUG	Foster and Thrive Fiber Laxative 147		Calcium polycarbophil	TABLET	ORAL	20230615		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
70677-1084_60edb8e8-3631-4fae-a761-73b52bdd6c22	70677-1084	HUMAN OTC DRUG	Foster and Thrive Fiber Laxative 188		Methylcellulose	TABLET	ORAL	20230613		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	METHYLCELLULOSE (4000 MPA.S)	500	mg/1			N	20241231
70677-1085_004d1dc2-47c2-84d1-e063-6394a90a2471	70677-1085	HUMAN OTC DRUG	Foster and Thrive Castor Oil		Castor Oil	LIQUID	ORAL	20230712		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services, LLC	CASTOR OIL	1	mg/mL			N	20241231
70677-1086_8c197ff1-91f2-4d78-ac95-c4ad1c57c92a	70677-1086	HUMAN OTC DRUG	Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20230415		OTC MONOGRAPH DRUG	505G(a)(3)	Strategic Sourcing Services LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1087_ebc41c13-5d5f-45e1-9df5-307ae43b98d5	70677-1087	HUMAN OTC DRUG	Motion Sickness		Dimenhydrinate	TABLET	ORAL	20230504		OTC MONOGRAPH DRUG	M009	Strategic Sourcing Services LLC	DIMENHYDRINATE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1088_83cae04e-7246-4b78-ba17-56d70c63dcf9	70677-1088	HUMAN OTC DRUG	Motion Sickness		Meclizine HCl	TABLET	ORAL	20230406		OTC MONOGRAPH DRUG	M009	Strategic Sourcing Services LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70677-1089_ef21424a-8972-4231-846a-135716d53b41	70677-1089	HUMAN OTC DRUG	Foster and Thrive Ready to Use Saline	Laxative	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20230502		OTC MONOGRAPH NOT FINAL	part334	McKesson	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
70677-1091_368eac86-7149-4231-a783-c238f044bf5e	70677-1091	HUMAN OTC DRUG	Foster and Thrive Gentle Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20230127		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	BISACODYL	10	mg/2000mg	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1092_9b4a3dbe-a05e-4647-9927-f286c460ce46	70677-1092	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230331		OTC MONOGRAPH FINAL	part347	Strategic Sourcing Services LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
70677-1093_864ab051-936c-4232-83b8-c180a40da965	70677-1093	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20230331		OTC MONOGRAPH FINAL	part332	Strategic Sourcing Services LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
70677-1094_28488756-3452-4351-b47e-6fcda51129b2	70677-1094	HUMAN OTC DRUG	Stool Softener		docusate sodium and sennosides	TABLET	ORAL	20230331		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
70677-1095_59d54290-a15f-48d7-9998-7230a722ab30	70677-1095	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20230301		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
70677-1096_d86fe2eb-e3cc-40b3-a382-d16101ac0e3f	70677-1096	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20230301		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
70677-1097_28bf7750-0210-45c4-bc3b-5bcd461cbab1	70677-1097	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20230331		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	SENNOSIDES	8.6	mg/1			N	20241231
70677-1098_252eeb77-6319-49df-9259-fcf2f917b2b5	70677-1098	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20230811		ANDA	ANDA207891	STRATEGIC SOURCING SERVICES LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70677-1100_e6987c81-756d-4977-ac7c-089b16174a75	70677-1100	HUMAN OTC DRUG	foster and thrive acid reducer antacid		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20231031		ANDA	ANDA077355	Strategic Sourcing Services LLC	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1101_620232ae-ad08-4de5-bfa8-e82d13fec30b	70677-1101	HUMAN OTC DRUG	foster and thrive acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20230831		ANDA	ANDA077351	Strategic Sourcing Services LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70677-1102_cce54ad3-b445-4aaf-8b49-8f635201ac20	70677-1102	HUMAN OTC DRUG	foster and thrive acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA075400	Strategic Sourcing Services LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70677-1103_0cef3ac4-fc0c-4d1e-a7e3-922b514edd40	70677-1103	HUMAN OTC DRUG	foster and thrive acid reducer		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20230914		ANDA	ANDA202319	Strategic Sourcing Services LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70677-1104_8bf2015d-efb9-4446-896d-6c6cb8f5ec4d	70677-1104	HUMAN OTC DRUG	foster and thrive omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20230816		NDA	NDA022032	Strategic Sourcing Services LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70677-1105_beab4c56-602f-45e0-8d58-7bce49fffa5e	70677-1105	HUMAN OTC DRUG	foster and thrive anti diarrheal anti gas		loperamide hydrochloride, simethicone	TABLET	ORAL	20231031		ANDA	ANDA209837	Strategic Sourcing Services LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
70677-1106_0283c3cc-141a-42d3-a80b-234ebb600654	70677-1106	HUMAN OTC DRUG	foster and thrive anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20231108		ANDA	ANDA075232	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70677-1107_e2074a9b-2702-470c-9112-e67ef5e4905c	70677-1107	HUMAN OTC DRUG	foster and thrive anti-diarrheal		loperamide HCl	SOLUTION	ORAL	20230919		ANDA	ANDA091292	Strategic Sourcing Services LLC	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70677-1108_9da843f2-e88c-432e-b091-a6acf81d856b	70677-1108	HUMAN OTC DRUG	foster and thrive hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20231017		OTC MONOGRAPH DRUG	M015	Strategic Sourcing Services LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1109_684e35cc-5a4f-458d-b5e7-e1933fea1139	70677-1109	HUMAN OTC DRUG	foster and thrive clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230905		ANDA	ANDA090685	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1110_d8fcef3f-26d7-49c6-b19e-f705785c8b56	70677-1110	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL	20230417		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	MINERAL OIL	999	mg/mL			N	20241231
70677-1111_f9e107e3-36e1-18b6-e053-6294a90ae618	70677-1111	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230421		OTC MONOGRAPH NOT FINAL	part334	STRATEGIC SOURCING SERVICES	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1112_f9e1291a-f64e-2431-e053-6394a90a35f1	70677-1112	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230421		OTC MONOGRAPH NOT FINAL	part334	STRATEGIC SOURCING SERVICES	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1113_2e787382-de51-4aea-bbe5-fe6c59978bdf	70677-1113	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230331		ANDA	ANDA206568	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1114_379c71b9-5793-4b6d-8857-e5ed28a7a29b	70677-1114	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230301		ANDA	ANDA206568	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1115_031db35d-db89-adbd-e063-6394a90ab57b	70677-1115	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20230809		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1116_031db35d-db89-adbd-e063-6394a90ab57b	70677-1116	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20230809		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1117_031db35d-db89-adbd-e063-6394a90ab57b	70677-1117	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20230809		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1118_031db35d-db89-adbd-e063-6394a90ab57b	70677-1118	HUMAN OTC DRUG	Ibuprofen Oral		Ibuprofen Oral	SUSPENSION	ORAL	20230809		ANDA	ANDA210602	Strategic Sourcing Services	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1119_fdb7ecd2-c4b4-90b6-e053-6294a90a69b1	70677-1119	HUMAN OTC DRUG	Pain Relief	Regular Strength	Acetaminophen	TABLET	ORAL	20230609		OTC MONOGRAPH NOT FINAL	part343	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN	325	mg/1			N	20241231
70677-1120_fdb7c5a5-f09c-deee-e053-6294a90a54bd	70677-1120	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20230609		OTC MONOGRAPH NOT FINAL	part343	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70677-1121_04a1f90b-3b1c-88e4-e063-6294a90a1bf5	70677-1121	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20230905		OTC MONOGRAPH NOT FINAL	part343	STRATEGIC SOURCING SERVICES LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-1122_04a1f7cb-17b8-a69d-e063-6394a90aeb19	70677-1122	HUMAN OTC DRUG	Enteric Coated Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20230905		OTC MONOGRAPH NOT FINAL	part343	STRATEGIC SOURCING SERVICES LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-1123_fdb7c5a5-f0b1-deee-e053-6294a90a54bd	70677-1123	HUMAN OTC DRUG	8 Hour Pain Relief		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20230609		ANDA	ANDA211544	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN	650	mg/1			N	20241231
70677-1124_fdefffbd-9bf1-fa30-e053-6394a90a34bc	70677-1124	HUMAN OTC DRUG	Pain Relief	Extra Strength	Acetaminophen	TABLET	ORAL	20230609		OTC MONOGRAPH NOT FINAL	part343	STRATEGIC SOURCING SERVICES LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70677-1125_92c02d84-df7c-960b-3507-ae974693001c	70677-1125	HUMAN OTC DRUG	Arthritis Pain		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20220706		ANDA	ANDA210986	Strategic Sourcing Services, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1126_a522fd02-962d-4e4d-9e42-f7f8c578a502	70677-1126	HUMAN OTC DRUG	Stay Awake		caffeine	TABLET	ORAL	20230512		OTC MONOGRAPH DRUG	M011	Strategic Sourcing Services LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
70677-1127_76412a1e-814a-435b-8bf7-664dded7b249	70677-1127	HUMAN OTC DRUG	Childrens Chewables		Acetaminophen	TABLET, CHEWABLE	ORAL	20230426		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/1			N	20241231
70677-1128_9b53f511-9e44-410b-b0d2-6801069cf9e3	70677-1128	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20230518		OTC MONOGRAPH DRUG	M010	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1129_c6f5047b-c5d2-44db-88b8-3a8a4ab9c729	70677-1129	HUMAN OTC DRUG	Sleep Aid		Doxylamine succinate	TABLET	ORAL	20230503		ANDA	ANDA040564	Strategic Sourcing Services LLC	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
70677-1130_0bf868e3-8ba6-b0ed-e063-6394a90a32fc	70677-1130	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Strategic Sourcing Services	ACETAMINOPHEN	650	mg/1			N	20241231
70677-1131_8691e397-e598-4e23-a389-2dbbb8f4496a	70677-1131	HUMAN OTC DRUG	foster and thrive ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20231101		ANDA	ANDA079113	Strategic Sourcing Services LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1132_90c92336-7176-4407-ac2f-8fa8985b5491	70677-1132	HUMAN OTC DRUG	foster and thrive ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20230915		ANDA	ANDA072096	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1133_1e45e743-5d31-496f-a4ae-1818eea40cb3	70677-1133	HUMAN OTC DRUG	foster and thrive migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20231018		ANDA	ANDA075794	Strategic Sourcing Services LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70677-1134_4d66a8a8-a1c1-4430-8845-21ae67700c39	70677-1134	HUMAN OTC DRUG	foster and thrive aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20231102		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-1136_cfa8578c-2bcc-4aa7-bb8c-0d0e193020ed	70677-1136	HUMAN OTC DRUG	foster and thrive ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20231020		ANDA	ANDA072096	Strategic Sourcing Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1137_97b3d2a5-d11b-4d12-a6e3-47c8f90c75aa	70677-1137	HUMAN OTC DRUG	foster and thrive all day pain relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20230914		ANDA	ANDA074661	Strategic Sourcing Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1138_b8ee568c-80cf-4e35-865e-35516bdab0fd	70677-1138	HUMAN OTC DRUG	foster and thrive pain reliever		Acetaminophen	TABLET	ORAL	20230918		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70677-1139_338021bd-b92b-45eb-a4b8-bc4a100ab718	70677-1139	HUMAN OTC DRUG	foster and thrive pain reliever		acetaminophen	TABLET, FILM COATED	ORAL	20231020		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70677-1142_0a4b10e3-29df-40a5-a3fa-0e9beeadfbb4	70677-1142	HUMAN OTC DRUG	foster and thrive childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20231020		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
70677-1143_e495a27e-eb64-4c42-8942-43bab9918172	70677-1143	HUMAN OTC DRUG	foster and thrive childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20231206		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
70677-1145_ac27249e-c6a7-49de-b447-226c3fc2e14e	70677-1145	HUMAN OTC DRUG	foster and thrive childrens ibuprofen ib		Ibuprofen	TABLET, CHEWABLE	ORAL	20231027		ANDA	ANDA076359	Strategic Sourcing Services LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1148_24b5df2d-bb93-4790-b72b-cb7d0f617f4e	70677-1148	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20230331		ANDA	ANDA208363	Strategic Sourcing Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70677-1149_a6225128-c20c-404d-a893-63687983057c	70677-1149	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20230401		OTC MONOGRAPH NOT FINAL	part343	Strategic Sourcing Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1150_a8f7ad08-805b-4ced-bf6c-71e2d5cecbf7	70677-1150	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20230401		OTC MONOGRAPH FINAL	part343	Strategic Sourcing Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-1151_6527efaf-36f9-4146-afb3-631b40e32fe8	70677-1151	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCL	CAPSULE	ORAL	20230331		OTC MONOGRAPH FINAL	part338	Strategic Sourcing Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1152_a7904093-df4f-4455-9368-05f0aee382f4	70677-1152	HUMAN OTC DRUG	Nasal Decongestant PE	Maximum Strength	Phenylephrine HCl	TABLET, FILM COATED	ORAL	20230405		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Services LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1153_0c868adb-99bd-5c7a-e063-6394a90a6638	70677-1153	HUMAN OTC DRUG	Foster and Thrive Earwax Removal Kit Ear wax drops		CARBAMIDE PEROXIDE	KIT		20230531		OTC MONOGRAPH DRUG	M014	Mckesson Corp. Via Strategic Sourcing Services						N	20241231
70677-1154_fd9f4d82-1f73-b1f6-e053-6394a90a33d8	70677-1154	HUMAN OTC DRUG	Foster and Thrive Earwax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	TOPICAL	20230531		OTC MONOGRAPH FINAL	M014	Mckesson Corp. Via Strategic Sourcing Services	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
70677-1155_faf51bcf-42aa-cd6c-62f0-5e503d7cd85d	70677-1155	HUMAN OTC DRUG	Eye Allergy Itch Relief	Once Daily Relief	Olopatadine Hydrochloride Ophthalmic	SOLUTION	OPHTHALMIC	20210315		ANDA	ANDA209752	Strategic Sourcing Services LLC	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
70677-1156_5ca16ba4-6038-2b06-6701-d9c809e3b2dd	70677-1156	HUMAN OTC DRUG	Eye Allergy Itch and Redness Relief		Olopatadine Hydrochloride Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20210315		ANDA	ANDA209619	Strategic Sourcing Services LLC	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
70677-1157_0d383700-e258-881f-e063-6294a90a347c	70677-1157	HUMAN OTC DRUG	Foster and Thrive Dry Eye Relief		Polyethylene glycol 400	SOLUTION/ DROPS	OPHTHALMIC	20230709		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 400	1	g/100mL			N	20241231
70677-1158_0d38267e-cdfc-a2c0-e063-6394a90ab84c	70677-1158	HUMAN OTC DRUG	Foster and Thrive Advanced Relief Eye Drops		Polyethylene glycol 400, Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230709		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE	1; .05	g/100mL; g/100mL			N	20241231
70677-1159_0d38a141-af13-a727-e063-6294a90a716c	70677-1159	HUMAN OTC DRUG	Foster and Thrive Original Formula Eye Drops		Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230709		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
70677-1160_0d38267e-cdfd-a2c0-e063-6394a90ab84c	70677-1160	HUMAN OTC DRUG	Foster and Thrive Lubricating Tears Lubricant Eye Drops		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20230711		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
70677-1161_0d383700-e259-881f-e063-6294a90a347c	70677-1161	HUMAN OTC DRUG	Foster and Thrive Redness Relief Eye Drops		Glycerin, Naphazoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230711		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70677-1162_0d388b03-19b7-acbc-e063-6294a90aa777	70677-1162	HUMAN OTC DRUG	Foster and Thrive Long Lasting Lubricant Eye Drops		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20230712		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
70677-1167_ed441987-007c-4bf4-91c4-bec140cb7189	70677-1167	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230828		ANDA	ANDA076789	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1170_a04a64bd-cf6c-4a8c-9922-12309a3e52c7	70677-1170	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230914		ANDA	ANDA076777	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1172_6c876bcc-9570-41ff-86e4-e41ecebdf27f	70677-1172	HUMAN OTC DRUG	Foster and Thrive Nicotine		nicotine polacrilex	LOZENGE	ORAL	20231016		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1173_0ae9c626-d0cb-4f93-8425-15eef002a30c	70677-1173	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231010		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1174_0b063240-67f0-4a04-8417-62d9fde5fb90	70677-1174	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231016		ANDA	ANDA090821	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1175_76b78d8c-5128-435f-91d9-b58a5513c683	70677-1175	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231013		ANDA	ANDA090821	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1176_435d770f-4f36-4da5-83b6-2c965318a930	70677-1176	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231025		ANDA	ANDA077007	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1177_eb00eeff-eaa6-4db1-9aa2-caeae9011abc	70677-1177	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231016		ANDA	ANDA077007	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1178_6c54bdf0-ce7a-4f8d-b2fe-be70fa6e43f9	70677-1178	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231016		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1179_4791cb2b-7d5d-4a91-b939-7760cd83847a	70677-1179	HUMAN OTC DRUG	foster and thrive nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20231016		ANDA	ANDA203690	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1184_0b51587b-01fe-2094-e063-6394a90a3753	70677-1184	HUMAN OTC DRUG	Foster and Thrive Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	Strategic Sourcing Services, LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
70677-1185_0b668990-fc84-d52f-e063-6294a90a968a	70677-1185	HUMAN OTC DRUG	Tussin DM		Dextromethorphan HBr, Guaifenesin	SYRUP	ORAL	20230601		OTC MONOGRAPH DRUG	M012	Strategic Sourcing Service, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70677-1186_031e2bbf-f68d-c982-e063-6394a90a6771	70677-1186	HUMAN OTC DRUG	Tussin		Guaifenesin	SOLUTION	ORAL	20230809		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
70677-1187_031de007-e388-59fe-e063-6294a90a14b8	70677-1187	HUMAN OTC DRUG	Tussin CF		Dextromethorphan HBr Guaifenesin Phenylephrine HCl	SOLUTION	ORAL	20230809		OTC MONOGRAPH FINAL	part341	Strategic Sourcing Services	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 200; 10	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70677-1188_0633827b-7511-39f9-e063-6294a90a509d	70677-1188	HUMAN OTC DRUG	Foster and Thrive		Lidocaine	PATCH	TOPICAL	20230901		OTC MONOGRAPH NOT FINAL	part348	STRATEGIC SOURCING SERVICES, LLC	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70677-1189_4b5b3fd1-f607-4f96-a7c8-ea08924bda49	70677-1189	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20230612		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70677-1190_0d388b03-19b6-acbc-e063-6294a90aa777	70677-1190	HUMAN OTC DRUG	Foster and Thrive Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20230511		OTC MONOGRAPH DRUG	M018	Strategic Sourcing Services LLC	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
70677-1191_f204f9ab-645b-4656-93a1-90aa4c369922	70677-1191	HUMAN OTC DRUG	Foster and Thrive Regular Strength Stomach Relief 527		Bismuth subsalicylate 525 mg	LIQUID	ORAL	20230802		OTC MONOGRAPH FINAL	part335	Strategic Sourcing Services LLC	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
70677-1192_36ab6094-a746-45d4-9fc8-5da0fef98d2a	70677-1192	HUMAN OTC DRUG	Foster and Thrive Nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230915		ANDA	ANDA206394	Strategic Sourcing Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1193_56441e3e-248c-4ab6-af17-06dad4bd5666	70677-1193	HUMAN OTC DRUG	foster and thrive nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230828		ANDA	ANDA206393	Strategic Sourcing Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
70677-1210_085515ef-a39d-4de6-8344-fe299a43ea6e	70677-1210	HUMAN OTC DRUG	Epsom Salt		Epsom Salt	GRANULE	ORAL; TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part334	Strategic Sourcing Services LLC	MAGNESIUM SULFATE, UNSPECIFIED	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70677-1211_0da311dd-bde4-c9d9-e063-6394a90aac78	70677-1211	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20231215		OTC MONOGRAPH DRUG	M004	STRATEGIC SOURCING SERVICES LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
70677-1212_0df67729-d79f-2970-e063-6394a90aaad2	70677-1212	HUMAN OTC DRUG	Double Antibiotic		Bacitracin Zinc and Polymyxin B Sulfate	OINTMENT	TOPICAL	20231215		OTC MONOGRAPH DRUG	M004	STRATEGIC SOURCING SERVICES LLC	BACITRACIN ZINC; POLYMYXIN B SULFATE	500; 10000	[USP'U]/g; [USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
70677-1213_0d127a82-5880-c5e5-e063-6294a90aec5b	70677-1213	HUMAN OTC DRUG	Diphenhydramine Hydrochloride and Zinc Acetate		Diphenhydramine Hydrochloride and Zinc Acetate	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M017	STRATEGIC SOURCING SERVICES LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70677-1214_0c42a83a-49b7-c4cc-e063-6294a90afd2d	70677-1214	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20231205		OTC MONOGRAPH DRUG	M017	STRATEGIC SOURCING SERVICES LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70677-1216_0e2b40cd-a73a-ab35-e063-6394a90ac784	70677-1216	HUMAN OTC DRUG	Hydrocortisone	with Aloe	Hydrocortisone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M017	STRATEGIC SOURCING SERVICES LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
70677-1220_6e37f4d9-274a-4ab1-af83-ea869c825988	70677-1220	HUMAN OTC DRUG	Ethyl alcohol		Ethyl alcohol	LIQUID	TOPICAL	20230602		OTC MONOGRAPH NOT FINAL	part333A	Strategic Sourcing Services LLC	ALCOHOL	70	mL/100mL			N	20241231
70677-1221_08b60f82-01dc-3451-e063-6294a90a2bdc	70677-1221	HUMAN OTC DRUG	Foster and Thrive		Chlorhexidine Gluconate 4%	SOLUTION	TOPICAL	20231027		NDA	NDA019125	McKesson Corporation	CHLORHEXIDINE GLUCONATE	4	g/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
70677-1222_09c4f6c9-ba51-47f4-95b4-d236fa45778b	70677-1222	HUMAN OTC DRUG	foster and thrive miconazole		Miconazole nitrate	CREAM	VAGINAL	20231025		ANDA	ANDA074760	Strategic Sourcing Services LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70677-1223_4c536e07-5e88-4bdd-a5b2-10226d5486ed	70677-1223	HUMAN OTC DRUG	foster and thrive miconazole 3		Miconazole nitrate	KIT		20231019		ANDA	ANDA076357	Strategic Sourcing Services LLC						N	20241231
70677-1224_daa1027d-de49-41dc-9d4d-9bbdd7b359c8	70677-1224	HUMAN OTC DRUG	foster and thrive tioconazole		Tioconazole	OINTMENT	VAGINAL	20231025		ANDA	ANDA075915	Strategic Sourcing Services LLC	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70677-1225_b06590b5-1dcf-47b7-8e81-5887b1c3893a	70677-1225	HUMAN OTC DRUG	foster and thrive miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20231105		ANDA	ANDA074760	Strategic Sourcing Services LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70677-1226_ba5d5b13-5604-4b8c-92b9-9f4174458029	70677-1226	HUMAN OTC DRUG	Foster and Thrive Miconazole 3		Miconazole nitrate	KIT		20231019		ANDA	ANDA075329	Strategic Sourcing Services LLC						N	20241231
70677-1228_36c36551-dc1c-4736-b0e6-c53445a4b5fc	70677-1228	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20230901		ANDA	ANDA074165	Strategic Sourcing Services LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70677-1229_ac3288bf-f0f0-44ce-8cd2-84acd084a06e	70677-1229	HUMAN OTC DRUG	Foster and Thrive Neighbor Pharmacy Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20230720		UNAPPROVED DRUG OTHER		Strategic Sourcing Services LLC	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
70677-1230_cde36443-f2d8-4881-bd57-5d2d9dc68083	70677-1230	HUMAN OTC DRUG	Foster and Thrive Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20230720		UNAPPROVED DRUG OTHER		Strategic Sourcing Services LLC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
70677-1231_0e7f63f6-45a5-0538-e063-6294a90a6324	70677-1231	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	VAGINAL	20231005		NDA	NDA021143	Foster and Thrive (Mckesson /STRATEGIC SOURCING SERVICES LLC)	CLOTRIMAZOLE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20251231
70677-1232_fdddd81a-de94-465c-ac39-2aa02c5d7c21	70677-1232	HUMAN OTC DRUG	Eucalyptol, Menthol, Methyl Salicylate, Thymol		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20230724		OTC MONOGRAPH NOT FINAL	part356	Strategic Sourcing Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70677-1233_ec0ca035-9877-4714-9116-06ef00ab3e88	70677-1233	HUMAN OTC DRUG	Eucalyptol, Menthol, Methyl salicylate, Thymol		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20230724		OTC MONOGRAPH NOT FINAL	part356	Strategic Sourcing Services LLC	EUCALYPTOL; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70677-1234_a56cac2a-d921-4ff0-9be8-ad869b6dd52f	70677-1234	HUMAN OTC DRUG	Eucalyptol, Menthol, Methyl Salicylate, Thymol		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part356	Strategic Sourcing Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70677-1235_263b178b-d92b-4235-8f0a-47627b3b2f31	70677-1235	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	19920615	20250425	OTC MONOGRAPH FINAL	part347	Strategic Sourcing Services LLC	PETROLATUM	1	g/g			N	
70677-1248_47f01d5c-0aaa-41d6-869b-21e12fa8741c	70677-1248	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	LIQUID	TOPICAL	20231001		OTC MONOGRAPH DRUG	M022	Strategic Sourcing Services LLC	HYDROGEN PEROXIDE	2.65	mL/100mL			N	20241231
70677-1249_6b8ad1b6-3272-44e6-8ae8-1d0e02c1e949	70677-1249	HUMAN OTC DRUG	Isopropyl alcohol Wintergreen		Isopropyl alcohol	LIQUID	TOPICAL	20231001		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
70677-1250_0aef6d81-f740-4f40-b95b-16e1a05c3605	70677-1250	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20231001		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
70677-1251_f5847171-35f0-46f1-94ec-8488802f401c	70677-1251	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20231001		OTC MONOGRAPH DRUG	M003	Strategic Sourcing Services LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
70677-1252_782669a3-9c1d-4866-948c-a904d897f9c8	70677-1252	HUMAN OTC DRUG	Witch Hazel		Witch hazel	LIQUID	TOPICAL	20231001		OTC MONOGRAPH DRUG	M016	Strategic Sourcing Services LLC	WITCH HAZEL	842	mg/mL			N	20241231
70677-1253_45770ad6-9bf7-41bd-a724-e5260cd31fa1	70677-1253	HUMAN OTC DRUG	foster and thrive infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20231221		OTC MONOGRAPH DRUG	M013	Strategic Sourcing Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20251231
70677-1254_ff3965d0-df91-4ac4-823a-8074cb43ddf8	70677-1254	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20240101		OTC MONOGRAPH DRUG	M002	Strategic Sourcing Services LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20251231
70680-300_09c2a084-c6d5-04eb-e063-6394a90adbcf	70680-300	HUMAN OTC DRUG	Raw Elements Eco Formula 30 Broad Spectrum SPF 30		ZINC OXIDE	CREAM	TOPICAL	20160502		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	230	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70680-301_09c29a75-14a4-1335-e063-6394a90a7f27	70680-301	HUMAN OTC DRUG	Raw Elements Lip Rescue 30 Broad Spectrum SPF 30		ZINC OXIDE	CREAM	TOPICAL	20160503		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	227.5	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70680-302_09c282c0-4e6a-8772-e063-6294a90ae4dd	70680-302	HUMAN OTC DRUG	Raw Elements Eco 30 Broad Spectrum SPF 30		ZINC OXIDE	STICK	TOPICAL	20160503		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	227.5	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70680-303_09c28e4c-cec1-8f33-e063-6294a90a580e	70680-303	HUMAN OTC DRUG	Raw Elements Tint 30 Broad Spectrum SPF 30		ZINC OXIDE	STICK	TOPICAL	20160503		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	227.5	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70680-304_09c2a962-02c8-050f-e063-6394a90a6f8a	70680-304	HUMAN OTC DRUG	Raw Elements Facial Moisturizer Tint Formula 30 SPF 30 Broad Spectrum		ZINC OXIDE	CREAM	TOPICAL	20160503		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	230	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70680-305_09c2a962-02d8-050f-e063-6394a90a6f8a	70680-305	HUMAN OTC DRUG	Raw Elements Daily Moisturizer Broad Spectrum SPF30		ZINC OXIDE	LOTION	TOPICAL	20190415		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	200	mg/mL			N	20241231
70680-306_09c29a75-14b4-1335-e063-6394a90a7f27	70680-306	HUMAN OTC DRUG	Raw Elements Baby Kids Broad Spectrum SPF30 Sunscreen		ZINC OXIDE	STICK	TOPICAL	20190415		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	250	mg/g			N	20241231
70680-307_09c28e4c-ced2-8f33-e063-6294a90a580e	70680-307	HUMAN OTC DRUG	Raw Elements Baby Kids Broad Spectrum SPF30		ZINC OXIDE	LOTION	TOPICAL	20190415		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	250	mg/g			N	20241231
70680-308_0c070987-c601-7b3b-e063-6294a90ad9de	70680-308	HUMAN OTC DRUG	Raw Elements Eco Formula SPF30 Sample Packs		ZINC OXIDE	LOTION	TOPICAL	20190816		OTC MONOGRAPH DRUG	M020	Raw Elements LLC	ZINC OXIDE	230	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70681-001_b2d6953c-71de-467f-ae45-54ce4f7a90db	70681-001	HUMAN PRESCRIPTION DRUG	Ammonia	N 13	AMMONIA N-13	INJECTION, SOLUTION	INTRAVENOUS	20200501		ANDA	ANDA209507	The University of Texas Southwestern Medical Center	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
70683-0703_0cdea24e-9733-6fc1-e063-6294a90afca9	70683-0703	HUMAN OTC DRUG	Dentisse		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL; ORAL	20140213		OTC MONOGRAPH DRUG	M021	Dentisse, Inc.	SODIUM FLUORIDE	1.1	mg/g			N	20241231
70691-900_09805f70-c9fc-7dd1-e063-6394a90ae450	70691-900	HUMAN OTC DRUG	Antibacterial Wipes		Benzalkonium chloride	SWAB	TOPICAL	20180521		OTC MONOGRAPH DRUG	M003	Glaro, Incorporated	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
70692-131_2648f1e4-8520-4530-ad29-1edf9d8871af	70692-131	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET	ORAL	20230405		OTC MONOGRAPH NOT FINAL	part343	Strive Pharmaceuticals Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
70692-132_8bd42c98-a763-4701-bd46-1b4d987dd694	70692-132	HUMAN OTC DRUG	EXTRA STRENGTH Headache Relief geltabs		Acetaminophen, Aspirin, Caffeine	TABLET	ORAL	20230405		OTC MONOGRAPH NOT FINAL	part343	Strive Pharmaceuticals Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70692-139_b451c631-6bdc-d42e-e053-2995a90af099	70692-139	HUMAN OTC DRUG	Cetirizine hydrochloride		Cetirizine hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA209274	Strive Pharmaceuticals Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70692-142_f94f328f-c98c-4a41-a8d4-3ad729b27bb0	70692-142	HUMAN OTC DRUG	Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, COATED	ORAL	20230406		OTC MONOGRAPH NOT FINAL	part343	Strive Pharmaceuticals Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
70692-148_0b316623-6548-4d98-b42a-07103c3deb2b	70692-148	HUMAN OTC DRUG	Diphenhydramine Hydrochloride 25mg		Diphenhydramine hydrochloride 25mg	TABLET	ORAL	20181220		OTC MONOGRAPH FINAL	part341	Strive Pharmaceuticals Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70692-149_f813df18-8e46-48b8-925e-dc4f8da0eb14	70692-149	HUMAN OTC DRUG	RIGHT REMEDIES EXTRA STRENGTH PM Pain Relief		Acetaminophen, Diphenhydramine hydrochloride	TABLET, FILM COATED	ORAL	20231113		OTC MONOGRAPH DRUG	M013	Strive Pharmaceuticals Inc.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70692-150_a7906dcf-5926-4fff-a7ba-0c73b394fab9	70692-150	HUMAN OTC DRUG	RIGHT REMEDIES Pain Relief Extra Strength Caplet		Acetaminophen	TABLET, COATED	ORAL	20220720		OTC MONOGRAPH DRUG	M013	Strive Pharmaceuticals Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
70692-151_82a2a38f-4425-47fe-a772-896a9e78b421	70692-151	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20230406		OTC MONOGRAPH FINAL	part338	Strive Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70692-163_968a35be-57d2-438e-b8c6-8b1f74e2f79d	70692-163	HUMAN OTC DRUG	RIGHT REMEDIES Maximum Strength Urinary Pain Relief		Phenazopyridine Hydrochloride	TABLET	ORAL	20231201		UNAPPROVED DRUG OTHER		Strive Pharmaceuticals Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
70692-167_5f72b3ca-3feb-4beb-a5af-5011ef7af376	70692-167	HUMAN OTC DRUG	GOOD REMEDIES GENTLE Laxative		Bisacodyl	TABLET, COATED	ORAL	20231110		OTC MONOGRAPH DRUG	505G(a)(3)	Strive Pharmaceuticals Inc.	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70692-778_62790fe4-e36a-46c8-838f-12ac96c0d420	70692-778	HUMAN OTC DRUG	Right Remedies Adult Long Lasting Cough Relief Softgel		Dextromethorphan hydrobromide	CAPSULE	ORAL	20220401		OTC MONOGRAPH DRUG	M012	Strive Pharmaceuticals Inc.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
70692-780_99bc62ba-e5fe-4d22-93b4-f5900e319e52	70692-780	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20230406		OTC MONOGRAPH FINAL	part341	Strive Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70692-807_e848826d-f6b9-425d-bbd0-3ed9e498e7c4	70692-807	HUMAN OTC DRUG	DayTime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20230405		OTC MONOGRAPH FINAL	part341	Strive Pharmaceuticals Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70692-808_8768aae3-6f83-48f7-8ec7-fb40bff1fca8	70692-808	HUMAN OTC DRUG	NightTime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20230405		OTC MONOGRAPH FINAL	part341	Strive Pharmaceuticals Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70692-809_0e1052d6-9326-4d18-a1ca-c0ca86d6a900	70692-809	HUMAN OTC DRUG	DayTime and NightTime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, Doxylamine succinate	KIT		20230405		OTC MONOGRAPH DRUG	M012	Strive Pharmaceuticals Inc.						N	20251231
70692-832_65757e2c-700d-4092-ac0d-f08ee7033eef	70692-832	HUMAN OTC DRUG	RIGHT REMEDIES Allergy Relief		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20211220		OTC MONOGRAPH FINAL	part341	Strive Pharmaceuticals Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70693-231_ec8de41f-e89d-46df-ae63-8b1d14e6284d	70693-231	HUMAN OTC DRUG	Protect SPF 30		Zinc Oxide, Octisalate, and Avobenzone	LOTION	CUTANEOUS	20230808		OTC MONOGRAPH FINAL	part352	Hunter Vaughan, LLC	AVOBENZONE; OCTISALATE; ZINC OXIDE	2; 3; 20	mg/mL; mg/mL; mg/mL			N	20241231
70697-805_f1f19ceb-b1a5-6624-e053-2995a90ae432	70697-805	HUMAN OTC DRUG	AQUARELLE		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333E	INDELPA, S.A DE C.V	BENZALKONIUM CHLORIDE	.125	mg/100mg			N	20241231
70697-806_f1f1b263-dca3-60e7-e053-2995a90ae493	70697-806	HUMAN OTC DRUG	SMART AND CLEAN		BENZALKONIUM CHORIDE	CLOTH	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part333E	INDELPA, S.A DE C.V	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
70700-101_0b7a2fac-2281-4c64-29aa-5e0d05d49236	70700-101	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol Tablets and Ferrous Fumarate Tablets	KIT	ORAL	20180824		ANDA	ANDA209609	Xiromed, LLC						N	20241231
70700-106_c89c3b09-de28-9c1d-1f88-db05969f1868	70700-106	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	OINTMENT	TOPICAL	20180501		ANDA	ANDA209701	Xiromed, LLC	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70700-107_9ef6e425-efa1-aec8-223d-fc9a670767b3	70700-107	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	OINTMENT	TOPICAL	20200130		ANDA	ANDA201501	Xiromed, LLC	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70700-109_ac70aefe-9ccc-2e31-1a2a-1f4a01cf7a46	70700-109	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20180619		ANDA	ANDA210034	Xiromed, LLC	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70700-112_32c70ba4-621c-c4ab-97e6-7b1be0b9478a	70700-112	HUMAN PRESCRIPTION DRUG	Testosterone		Testosterone	GEL, METERED	TRANSDERMAL	20200508		ANDA	ANDA210835	Xiromed, LLC	TESTOSTERONE	20.25	mg/1.25g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
70700-113_a1111ac2-cecd-156d-77fa-8590649e5542	70700-113	HUMAN PRESCRIPTION DRUG	Isibloom		desogestrel and ethinyl estradiol	KIT		20180201		ANDA	ANDA202789	Xiromed, LLC.						N	20241231
70700-114_7d092d47-a8c8-f64d-8c26-c42aa7fdbdb6	70700-114	HUMAN PRESCRIPTION DRUG	LORYNA		Drospirenone and Ethinyl Estradiol Tablets	KIT		20220609		ANDA	ANDA079221	Xiromed, LLC.						N	20241231
70700-115_9f57f11b-8425-7079-1c5c-cd2889945155	70700-115	HUMAN PRESCRIPTION DRUG	Syeda		Drospirenone and Ethinyl Estradiol	KIT		20171201		ANDA	ANDA090114	Xiromed, LLC.						N	20241231
70700-116_cd0fbf86-78dd-a8f2-7399-112a042ab767	70700-116	HUMAN PRESCRIPTION DRUG	ALTAVERA		Levonorgestrel and Ethinyl Estradiol	KIT		20220901		ANDA	ANDA079102	Xiromed, LLC.						N	20241231
70700-117_824be494-8fdb-e66e-e138-26efa1ed7c4a	70700-117	HUMAN PRESCRIPTION DRUG	Introvale		Levonorgestrel and Ethinyl Estradiol	KIT		20180201		ANDA	ANDA079064	Xiromed, LLC.						N	20241231
70700-118_b42f7e9f-5876-e213-2d55-6247356ea156	70700-118	HUMAN PRESCRIPTION DRUG	Vienva		Levonorgestrel and Ethinyl Estradiol	KIT		20180315		ANDA	ANDA201088	Xiromed, LLC.						N	20241231
70700-119_3549d0b1-c150-b3ab-8af6-ba777ffc229a	70700-119	HUMAN PRESCRIPTION DRUG	Estarylla		Norgestimate and ethinyl estradiol	KIT		20180101		ANDA	ANDA090794	Xiromed, LLC.						N	20241231
70700-120_b2a112e8-a8c4-2254-1046-9ee6263e66e1	70700-120	HUMAN PRESCRIPTION DRUG	Tri-Lo- Estarylla		norgestimate and ethinyl estradiol	KIT		20180101		ANDA	ANDA091232	Xiromed, LLC.						N	20241231
70700-121_e43facd8-dbf3-de33-00f7-d8e7fe7156dc	70700-121	HUMAN PRESCRIPTION DRUG	Tri-Estarylla		norgestimate and ethinyl estradiol	KIT		20220901		ANDA	ANDA090793	Xiromed, LLC.						N	20241231
70700-122_a76528bf-413e-fde6-6b5c-6bb35a1b63d8	70700-122	HUMAN PRESCRIPTION DRUG	Volnea		Desogestrel and Ethinyl Estradiol	KIT		20171201		ANDA	ANDA202689	Xiromed, LLC.						N	20241231
70700-123_5f63fa1c-5741-b43e-4872-9b5f7c7afcae	70700-123	HUMAN PRESCRIPTION DRUG	JAIMIESS		levonorgestrel / ethinyl estradiol and ethinyl estradiol	KIT		20180101		ANDA	ANDA203770	Xiromed, LLC.						N	20241231
70700-124_a0c0218d-c7a0-bab6-8579-8e539856d286	70700-124	HUMAN PRESCRIPTION DRUG	LoJaimiess		levonorgestrel/ethinyl estradiol and ethinyl estradiol	KIT		20190211		ANDA	ANDA205131	Xiromed, LLC.						N	20241231
70700-126_e0e8d0aa-672f-8821-87cc-3ccaf3f5315a	70700-126	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside Injection	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210211		ANDA	ANDA211277	Xiromed, LLC.	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
70700-141_1416b59b-95a1-e6da-c6e5-66348ea35d0c	70700-141	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate Foam	AEROSOL, FOAM	TOPICAL	20230510		ANDA	ANDA210639	Xiromed, LLC.	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70700-143_0929aa7e-87eb-b91f-5c23-de4a3353b744	70700-143	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol Gel 0.1%	GEL	TOPICAL	20221001		ANDA	ANDA211783	Xiromed, LLC	ESTRADIOL	.25	mg/.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-144_0929aa7e-87eb-b91f-5c23-de4a3353b744	70700-144	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol Gel 0.1%	GEL	TOPICAL	20221001		ANDA	ANDA211783	Xiromed, LLC	ESTRADIOL	.5	mg/.5g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-145_0929aa7e-87eb-b91f-5c23-de4a3353b744	70700-145	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol Gel 0.1%	GEL	TOPICAL	20221001		ANDA	ANDA211783	Xiromed, LLC	ESTRADIOL	1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-146_2bfc0a7d-82bb-11d0-8ea7-c2d2a9c836ac	70700-146	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	OINTMENT	TOPICAL	20191209		ANDA	ANDA212976	Xiromed LLC	FLUOCINONIDE	.05	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70700-149_2d9cdbe5-6e78-59b4-7625-c74fc592a2dd	70700-149	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190220		ANDA	ANDA212977	Xiromed, LLC	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70700-150_2d9cdbe5-6e78-59b4-7625-c74fc592a2dd	70700-150	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190220		ANDA	ANDA212977	Xiromed, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70700-152_da57e58b-738f-0ef3-d2a5-427bc267ed19	70700-152	HUMAN PRESCRIPTION DRUG	Gemmily		norethindrone acetate and ethinyl estradiol, and ferrous fumarate	KIT		20201109		ANDA	ANDA213317	Xiromed, LLC						N	20241231
70700-156_0adbfe5b-7131-bb67-7da1-3ea5a7b0f7e9	70700-156	HUMAN PRESCRIPTION DRUG	EnilloRing		Etonogestrel and Ethinyl Estradiol Vaginal	RING	VAGINAL	20230815		ANDA	ANDA211157	Xiromed, LLC	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70700-157_2214523a-41b1-3644-6e7c-abc4f8b0b5cc	70700-157	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Xiromed, LLC	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70700-158_2214523a-41b1-3644-6e7c-abc4f8b0b5cc	70700-158	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Xiromed, LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70700-159_2214523a-41b1-3644-6e7c-abc4f8b0b5cc	70700-159	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Xiromed, LLC	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70700-160_1d2842b4-06d6-8054-d485-cb30f0ed4f69	70700-160	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole Foam	AEROSOL, FOAM	TOPICAL	20210521		ANDA	ANDA213601	Xiromed, LLC	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70700-161_7ad13433-2f93-1881-5fe6-2e0630ac70fe	70700-161	HUMAN PRESCRIPTION DRUG	Naftifine hydrochloride		Naftifine hydrochloride	CREAM	TOPICAL	20210115		ANDA	ANDA210038	Xiromed, LLC	NAFTIFINE HYDROCHLORIDE	20	mg/g	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
70700-162_dad42a1d-ae11-c5b8-8dbf-2a97346eafb8	70700-162	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Xiromed, LLC	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
70700-163_dad42a1d-ae11-c5b8-8dbf-2a97346eafb8	70700-163	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Xiromed, LLC	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
70700-164_6ccbcf9e-fe8a-a97f-06f9-a4e4726d919c	70700-164	HUMAN OTC DRUG	Levonorgestrel		Levonorgestrel	TABLET	ORAL	20200313		ANDA	ANDA205329	Xiromed LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
70700-165_b2ad3a95-e0d9-f10b-7c11-e9e44072ce73	70700-165	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200909		ANDA	ANDA212612	Xiromed LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70700-166_b2ad3a95-e0d9-f10b-7c11-e9e44072ce73	70700-166	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200909		ANDA	ANDA212612	Xiromed LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70700-167_b2ad3a95-e0d9-f10b-7c11-e9e44072ce73	70700-167	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200909		ANDA	ANDA212612	Xiromed LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70700-168_b2ad3a95-e0d9-f10b-7c11-e9e44072ce73	70700-168	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200909		ANDA	ANDA212612	Xiromed LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70700-169_54edb26e-5716-7c16-d55c-f02e78162346	70700-169	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloide		Irinotecan hydrochloide	INJECTION	INTRAVENOUS	20191118		ANDA	ANDA212993	Xiromed LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
70700-170_54edb26e-5716-7c16-d55c-f02e78162346	70700-170	HUMAN PRESCRIPTION DRUG	Irinotecan hydrochloride		Irinotecan hydrochloride	INJECTION	INTRAVENOUS	20191118		ANDA	ANDA212993	Xiromed LLC	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
70700-171_57f6f9e0-6c6d-78fc-312a-e2ca5e729071	70700-171	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20200909		ANDA	ANDA212968	Xiromed LLC	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70700-172_57f6f9e0-6c6d-78fc-312a-e2ca5e729071	70700-172	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20200909		ANDA	ANDA212968	Xiromed LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70700-173_85d94342-3699-d4cb-69f5-391593a54ebe	70700-173	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210712		ANDA	ANDA211189	Xiromed LLC	TOBRAMYCIN SULFATE	1.2	g/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70700-174_5b73d1bb-972d-7aca-01d4-7564ef7d1849	70700-174	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20211025		ANDA	ANDA213510	Xiromed LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
70700-175_5b73d1bb-972d-7aca-01d4-7564ef7d1849	70700-175	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20211025		ANDA	ANDA213510	Xiromed LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
70700-176_5b73d1bb-972d-7aca-01d4-7564ef7d1849	70700-176	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20211025		ANDA	ANDA213510	Xiromed LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
70700-177_bbb60de7-73e4-f417-9c67-b24ededc3f3b	70700-177	HUMAN PRESCRIPTION DRUG	Joyeaux		Levonorgestrel and Ethinyl Estradiol and Ferrous Fumarate	KIT		20230817		ANDA	ANDA214640	Xiromed, LLC						N	20241231
70700-182_045ab360-9ad8-5d11-f670-a97c2604cb1c	70700-182	HUMAN PRESCRIPTION DRUG	Darifenacin 7.5 mg		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA209571	Xiromed, LLC	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70700-183_045ab360-9ad8-5d11-f670-a97c2604cb1c	70700-183	HUMAN PRESCRIPTION DRUG	Darifenacin 15 mg		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA209571	Xiromed, LLC	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70700-185_ecc2f423-75fd-f54d-def1-8e408ec46575	70700-185	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20210405		ANDA	ANDA210579	Xiromed, LLC	CHLORDIAZEPOXIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; 1/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
70700-186_15399d8f-0963-b5b3-deea-0826c8fe4406	70700-186	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20210813		ANDA	ANDA210123	Xiromed LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70700-187_15399d8f-0963-b5b3-deea-0826c8fe4406	70700-187	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20210813		ANDA	ANDA210123	Xiromed LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70700-188_87079551-2d25-a155-4b5f-f0be6a19fa7c	70700-188	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20210813		ANDA	ANDA210124	Xiromed LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70700-189_87079551-2d25-a155-4b5f-f0be6a19fa7c	70700-189	HUMAN PRESCRIPTION DRUG	Fluorouracil		Fluorouracil	INJECTION, SOLUTION	INTRAVENOUS	20210813		ANDA	ANDA210124	Xiromed LLC	FLUOROURACIL	50	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70700-194_0929aa7e-87eb-b91f-5c23-de4a3353b744	70700-194	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol Gel 0.1%	GEL	TOPICAL	20221001		ANDA	ANDA211783	Xiromed, LLC	ESTRADIOL	.75	mg/.75g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-195_0929aa7e-87eb-b91f-5c23-de4a3353b744	70700-195	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol Gel 0.1%	GEL	TOPICAL	20221001		ANDA	ANDA211783	Xiromed, LLC	ESTRADIOL	1.25	mg/1.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-249_d3361dc6-a75e-ad9e-74fb-50965204eca3	70700-249	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20220421		ANDA	ANDA215825	Xiromed, LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70700-262_ce9167b4-3b92-9cbd-f4f5-a8788ed0d47a	70700-262	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180824		ANDA	ANDA203203	Xiromed LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70700-263_ce9167b4-3b92-9cbd-f4f5-a8788ed0d47a	70700-263	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180824		ANDA	ANDA203203	Xiromed LLC	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70700-264_de0df13f-d2ca-26d3-fcf4-0eb177e4d1b8	70700-264	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE 1ML		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180803		ANDA	ANDA212227	XIROMED LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70700-268_3b3ab408-446e-20a4-a58c-46bc75451542	70700-268	HUMAN PRESCRIPTION DRUG	FOSFOMYCIN TROMETHAMINE		Granules for Oral Solution	POWDER	ORAL	20201006		ANDA	ANDA212548	XIROMED LLC	FOSFOMYCIN TROMETHAMINE	3	g/1			N	20241231
70700-269_dd91ef2b-408b-4ab1-97ed-7023803128d3	70700-269	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20200102		ANDA	ANDA212995	Xiromed, LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70700-270_dd91ef2b-408b-4ab1-97ed-7023803128d3	70700-270	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20200615		ANDA	ANDA212995	Xiromed, LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70700-271_dd91ef2b-408b-4ab1-97ed-7023803128d3	70700-271	HUMAN PRESCRIPTION DRUG	Deferasirox		Deferasirox	TABLET	ORAL	20200102		ANDA	ANDA212995	Xiromed, LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70700-272_15d4da7a-2091-e84d-872c-57ef7141d813	70700-272	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20221125		ANDA	ANDA216209	Xiromed, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
70700-273_99bad0d6-c288-5c98-b166-57a05adcd57a	70700-273	HUMAN PRESCRIPTION DRUG	Estradiol valerate		ESTRADIOL VALERATE	INJECTION	INTRAMUSCULAR	20230501		ANDA	ANDA216656	Xiromed, LLC	ESTRADIOL VALERATE	10	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-274_99bad0d6-c288-5c98-b166-57a05adcd57a	70700-274	HUMAN PRESCRIPTION DRUG	Estradiol valerate		ESTRADIOL VALERATE	INJECTION	INTRAMUSCULAR	20230501		ANDA	ANDA216656	Xiromed, LLC	ESTRADIOL VALERATE	20	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-275_99bad0d6-c288-5c98-b166-57a05adcd57a	70700-275	HUMAN PRESCRIPTION DRUG	Estradiol valerate		ESTRADIOL VALERATE	INJECTION	INTRAMUSCULAR	20230501		ANDA	ANDA216656	Xiromed, LLC	ESTRADIOL VALERATE	40	mg/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70700-278_bd5d2c52-f90f-7776-177d-4bc15dfba8e7	70700-278	HUMAN PRESCRIPTION DRUG	MELPHALAN HYDROCHLORIDE		MELPHALAN HYDROCHLORIDE	KIT		20210106		ANDA	ANDA210947	Xiromed, LLC						N	20241231
70700-284_6c925fcb-edcf-fdff-d723-603f4227821b	70700-284	HUMAN PRESCRIPTION DRUG	FULVESTRANT		fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20210819		ANDA	ANDA213553	Xiromed, LLC	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
70700-286_8f784e7f-71fa-4ffb-a8dc-7e46e99b1547	70700-286	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	INJECTION, SOLUTION	INTRAMUSCULAR	20220329		ANDA	ANDA215634	XIROMED, LLC	PROGESTERONE	50	mg/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
70700-288_c129a33b-1002-63ae-b863-2cc79696a848	70700-288	HUMAN PRESCRIPTION DRUG	testosterone cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20230428		ANDA	ANDA215351	Xiromed LLC	TESTOSTERONE CYPIONATE	100	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
70700-289_c129a33b-1002-63ae-b863-2cc79696a848	70700-289	HUMAN PRESCRIPTION DRUG	testosterone cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20230428		ANDA	ANDA215351	Xiromed LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
70700-290_c129a33b-1002-63ae-b863-2cc79696a848	70700-290	HUMAN PRESCRIPTION DRUG	testosterone cypionate		testosterone cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20230428		ANDA	ANDA215351	Xiromed LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
70700-902_11ca0e3f-3eb9-4172-2eea-3af0f4fe4ce1	70700-902	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211109		ANDA	ANDA212612	Xiromed, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70700-903_11ca0e3f-3eb9-4172-2eea-3af0f4fe4ce1	70700-903	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211109		ANDA	ANDA212612	Xiromed, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70707-101_0c864f2d-7b4f-370e-e063-6394a90ae1a4	70707-101	HUMAN OTC DRUG	Acne Face and Body		BENZOYL PEROXIDE	SHAMPOO, SUSPENSION	TOPICAL	20110915		OTC MONOGRAPH DRUG	M006	Face Reality, Inc.	BENZOYL PEROXIDE	25	mg/mL			N	20241231
70707-151_08a1e77e-79c0-fc5a-e063-6294a90aa903	70707-151	HUMAN OTC DRUG	10 Acne Med		BENZOYL PEROXIDE	GEL	TOPICAL	20111015		OTC MONOGRAPH DRUG	M006	Face Reality, Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
70707-152_08a1e862-b55e-fb84-e063-6294a90a016a	70707-152	HUMAN OTC DRUG	2.5 Acne Med		BENZOYL PEROXIDE	GEL	TOPICAL	20111123		OTC MONOGRAPH DRUG	M006	Face Reality, Inc.	BENZOYL PEROXIDE	25	mg/mL			N	20241231
70707-155_08a20e5b-ddd2-5cd1-e063-6294a90a7204	70707-155	HUMAN OTC DRUG	5 Acne Med		BENZOYL PEROXIDE	GEL	TOPICAL	20111015		OTC MONOGRAPH DRUG	M006	Face Reality, Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
70707-200_0c86777f-3ce7-5e1d-e063-6294a90a2369	70707-200	HUMAN OTC DRUG	Acne Med 2.5%		BENZOYL PEROXIDE	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M006	Face Reality, LLC	BENZOYL PEROXIDE	25	mg/mL			N	20241231
70707-211_0c8655bc-43b2-2b67-e063-6394a90aafa3	70707-211	HUMAN OTC DRUG	Acne Med 5%		BENZOYL PEROXIDE	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M006	Face Reality, LLC	BENZOYL PEROXIDE	50	mg/mL			N	20241231
70707-212_0c864236-9d5b-38e4-e063-6394a90aa4ec	70707-212	HUMAN OTC DRUG	Acne Med 10%		BENZOYL PEROXIDE	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M006	Face Reality, LLC	BENZOYL PEROXIDE	100	mg/mL			N	20241231
70707-400_08a2165d-7957-7fcf-e063-6394a90afbde	70707-400	HUMAN OTC DRUG	Daily SPF30		Octisalate 4.75%, Oxybenzone 4.25%, Octocrylene 2.80%, Avobenzone 3.005	CREAM	TOPICAL	20120503		OTC MONOGRAPH DRUG	M020	Face Reality Skin Care, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.03; .0475; .028; .0425	g/g; g/g; g/g; g/g			N	20241231
70707-440_08a1e0d1-9f26-f0c0-e063-6394a90a43c8	70707-440	HUMAN OTC DRUG	Sulfur Spot Treatment		SULFUR	GEL	TOPICAL	20200108		OTC MONOGRAPH DRUG	M006	Face Reality, Inc	SULFUR	60	mg/mL			N	20241231
70707-450_08a20c11-01d0-89a2-e063-6294a90ab908	70707-450	HUMAN OTC DRUG	Daily SPF 30		OCTISALATE, OXYBENZONE, OCTOCRYLENE, AVOBENZONE	CREAM	TOPICAL	20160620		OTC MONOGRAPH DRUG	M020	Face Reality, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 47.5; 28; 42.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
70707-619_08a2165d-7967-7fcf-e063-6394a90afbde	70707-619	HUMAN OTC DRUG	Ultimate Protection SPF28		ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20141001		OTC MONOGRAPH DRUG	M020	Face Reality Skin Care, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.0067; .116	g/g; g/g			N	20241231
70707-711_0c8661ec-0c91-22fe-e063-6394a90ae334	70707-711	HUMAN OTC DRUG	Acne Face and Body Wash		BENZOYL PEROXIDE	SHAMPOO, SUSPENSION	TOPICAL	20161231		OTC MONOGRAPH DRUG	M006	Face Reality Skin Care, LLC	BENZOYL PEROXIDE	25	mg/mL			N	20241231
70708-105_f89d80e8-bdea-597a-e053-6394a90a40c2	70708-105	HUMAN OTC DRUG	TrueMed	Saline Laxative - Lemon	Magnesium Citrate	LIQUID	ORAL	20230331		OTC MONOGRAPH NOT FINAL	part334	GURUNANDA, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70708-106_f88909d1-f11b-05cc-e053-6294a90a7602	70708-106	HUMAN OTC DRUG	TrueMed	Saline Laxative - Grape	Magnesium Citrate	LIQUID	ORAL	20230331		OTC MONOGRAPH NOT FINAL	part334	GURUNANDA, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70708-107_f89deda9-3a94-c999-e053-6394a90a2ac1	70708-107	HUMAN OTC DRUG	TrueMed	Saline Laxative - Cherry	Magnesium Citrate	LIQUID	ORAL	20230331		OTC MONOGRAPH NOT FINAL	part334	GURUNANDA, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70708-209_fa704404-d770-ff5a-e053-6394a90ab6cf	70708-209	HUMAN OTC DRUG	Simply Saline Refill Packets		SINUS WASH	POWDER, FOR SOLUTION	NASAL	20221001		UNAPPROVED DRUG OTHER		GURUNANDA, LLC	SODIUM BICARBONATE; SODIUM CHLORIDE	515; 1685	mg/2200mg; mg/2200mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
70709-000_d47c93a3-5ef3-48bc-aaab-0e873656c01d	70709-000	HUMAN PRESCRIPTION DRUG	NITYR		Nitisinone	TABLET	ORAL	20170726		NDA	NDA209449	Cycle Pharmaceuticals Ltd.	NITISINONE	10	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
70709-002_d47c93a3-5ef3-48bc-aaab-0e873656c01d	70709-002	HUMAN PRESCRIPTION DRUG	NITYR		Nitisinone	TABLET	ORAL	20170726		NDA	NDA209449	Cycle Pharmaceuticals Ltd.	NITISINONE	2	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
70709-005_d47c93a3-5ef3-48bc-aaab-0e873656c01d	70709-005	HUMAN PRESCRIPTION DRUG	NITYR		Nitisinone	TABLET	ORAL	20170726		NDA	NDA209449	Cycle Pharmaceuticals Ltd.	NITISINONE	5	mg/1	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2E1 Inducers [MoA], Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]		N	20241231
70709-013_9a487d0f-1d90-469a-93b7-fea866f8dd31	70709-013	HUMAN PRESCRIPTION DRUG	SAJAZIR		ICATIBANT	INJECTION	SUBCUTANEOUS	20210603		ANDA	ANDA212446	Cycle Pharmaceuticals Ltd-Uk	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
70709-062_1bbc20be-48e4-41e4-8657-7024d4f2172e	70709-062	HUMAN PRESCRIPTION DRUG	TASCENSO ODT		Fingolimod Lauryl Sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20230201		NDA	NDA214962	Cycle Pharmaceuticals Ltd	FINGOLIMOD LAURYL SULFATE	.25	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
70709-065_1bbc20be-48e4-41e4-8657-7024d4f2172e	70709-065	HUMAN PRESCRIPTION DRUG	TASCENSO ODT		Fingolimod Lauryl Sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20230201		NDA	NDA214962	Cycle Pharmaceuticals Ltd	FINGOLIMOD LAURYL SULFATE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
70710-1008_31f89cf8-7032-4ada-ac9a-471122dad992	70710-1008	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	Zydus Pharmaceuticals USA Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70710-1009_31f89cf8-7032-4ada-ac9a-471122dad992	70710-1009	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	Zydus Pharmaceuticals USA Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70710-1010_31f89cf8-7032-4ada-ac9a-471122dad992	70710-1010	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	Zydus Pharmaceuticals USA Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70710-1011_3e05f5bd-bd51-485f-97dd-5817d3f37658	70710-1011	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FOR SUSPENSION	ORAL	20210506		ANDA	ANDA208882	Zydus Pharmaceuticals USA Inc.	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70710-1012_3e05f5bd-bd51-485f-97dd-5817d3f37658	70710-1012	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FOR SUSPENSION	ORAL	20210506		ANDA	ANDA208882	Zydus Pharmaceuticals USA Inc.	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70710-1013_3e05f5bd-bd51-485f-97dd-5817d3f37658	70710-1013	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FOR SUSPENSION	ORAL	20210506		ANDA	ANDA208882	Zydus Pharmaceuticals USA Inc.	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70710-1014_fafb1d87-4f01-4303-b0b7-ca6b58ef838f	70710-1014	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20190222		ANDA	ANDA210189	Zydus Pharmaceuticals USA Inc.	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
70710-1015_cc19bb7d-8241-4ece-8fce-99c6029547c8	70710-1015	HUMAN PRESCRIPTION DRUG	ACETYLCYSTEINE		acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20190117		ANDA	ANDA208166	Zydus Pharmaceuticals USA Inc.	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
70710-1018_740a5750-4dba-4dfc-ab41-09d75902652b	70710-1018	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20230202		ANDA	ANDA210153	Zydus Pharmaceuticals (USA) Inc.	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1019_740a5750-4dba-4dfc-ab41-09d75902652b	70710-1019	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20230202		ANDA	ANDA210153	Zydus Pharmaceuticals (USA) Inc.	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1020_740a5750-4dba-4dfc-ab41-09d75902652b	70710-1020	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20230202		ANDA	ANDA210153	Zydus Pharmaceuticals (USA) Inc.	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1021_11738578-aa82-4857-8745-9ff4f6b9db13	70710-1021	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET, FILM COATED	ORAL	20181217		ANDA	ANDA208979	Zydus Pharmaceuticals USA Inc.	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
70710-1022_5fd19011-b3a6-4850-9dc6-9b5af2839e08	70710-1022	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Pharmaceuticals USA Inc.	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70710-1023_5fd19011-b3a6-4850-9dc6-9b5af2839e08	70710-1023	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Pharmaceuticals USA Inc.	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70710-1024_5fd19011-b3a6-4850-9dc6-9b5af2839e08	70710-1024	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Pharmaceuticals USA Inc.	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70710-1025_5fd19011-b3a6-4850-9dc6-9b5af2839e08	70710-1025	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Pharmaceuticals USA Inc.	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70710-1030_dd62b210-df43-4810-a3c1-808de81a012a	70710-1030	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230307		ANDA	ANDA210154	Zydus Pharmaceuticals USA Inc.	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
70710-1031_dd62b210-df43-4810-a3c1-808de81a012a	70710-1031	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Pharmaceuticals USA Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
70710-1032_dd62b210-df43-4810-a3c1-808de81a012a	70710-1032	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Pharmaceuticals USA Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
70710-1033_dd62b210-df43-4810-a3c1-808de81a012a	70710-1033	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Pharmaceuticals USA Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
70710-1034_dd62b210-df43-4810-a3c1-808de81a012a	70710-1034	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230307		ANDA	ANDA210154	Zydus Pharmaceuticals USA Inc.	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
70710-1035_dd62b210-df43-4810-a3c1-808de81a012a	70710-1035	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Pharmaceuticals USA Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
70710-1039_7f6d9f56-a84c-461b-ae19-c8a0d0e690a9	70710-1039	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70710-1040_7f6d9f56-a84c-461b-ae19-c8a0d0e690a9	70710-1040	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70710-1041_7f6d9f56-a84c-461b-ae19-c8a0d0e690a9	70710-1041	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70710-1042_7f6d9f56-a84c-461b-ae19-c8a0d0e690a9	70710-1042	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	150	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70710-1043_7f6d9f56-a84c-461b-ae19-c8a0d0e690a9	70710-1043	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Pharmaceuticals USA Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70710-1047_51fb8910-fb5a-4fb0-b2f4-f83d05b32697	70710-1047	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230630		ANDA	ANDA212693	Zydus Pharmaceuticals USA Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70710-1048_51fb8910-fb5a-4fb0-b2f4-f83d05b32697	70710-1048	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230630		ANDA	ANDA212693	Zydus Pharmaceuticals USA Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70710-1049_35bd1a78-3b48-4df3-ac63-6f5f14816922	70710-1049	HUMAN PRESCRIPTION DRUG	Abacavir and lamivudine		Abacavir and lamivudine	TABLET, FILM COATED	ORAL	20190314		ANDA	ANDA208990	Zydus Pharmaceuticals USA Inc.	ABACAVIR SULFATE; LAMIVUDINE	600; 300	mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
70710-1050_071de592-e6a5-46c9-a3c8-a582411c6fe7	70710-1050	HUMAN PRESCRIPTION DRUG	ATAZANAVIR		ATAZANAVIR	CAPSULE	ORAL	20210504		ANDA	ANDA210575	Zydus Pharmaceuticals USA Inc.	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
70710-1051_071de592-e6a5-46c9-a3c8-a582411c6fe7	70710-1051	HUMAN PRESCRIPTION DRUG	ATAZANAVIR		ATAZANAVIR	CAPSULE	ORAL	20210504		ANDA	ANDA210575	Zydus Pharmaceuticals USA Inc.	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
70710-1052_071de592-e6a5-46c9-a3c8-a582411c6fe7	70710-1052	HUMAN PRESCRIPTION DRUG	ATAZANAVIR		ATAZANAVIR	CAPSULE	ORAL	20210504		ANDA	ANDA210575	Zydus Pharmaceuticals USA Inc.	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
70710-1061_1d5b3219-efd5-4842-9b6e-2ea1874d0d4d	70710-1061	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20201023		ANDA	ANDA208884	Zydus Pharmaceuticals USA Inc.	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70710-1062_1d5b3219-efd5-4842-9b6e-2ea1874d0d4d	70710-1062	HUMAN PRESCRIPTION DRUG	Albuterol		Albuterol	TABLET	ORAL	20201023		ANDA	ANDA208884	Zydus Pharmaceuticals USA Inc.	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70710-1063_a480b773-72e8-460c-9541-89767ce97088	70710-1063	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20171107		ANDA	ANDA209866	Zydus Pharmaceuticals USA Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70710-1064_a480b773-72e8-460c-9541-89767ce97088	70710-1064	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20171107		ANDA	ANDA209866	Zydus Pharmaceuticals USA Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70710-1065_a988ebbb-6e0c-43ff-83a8-0cc0dc4259ce	70710-1065	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180503		ANDA	ANDA208961	Zydus Pharmaceuticals USA Inc.	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1066_a988ebbb-6e0c-43ff-83a8-0cc0dc4259ce	70710-1066	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180503		ANDA	ANDA208961	Zydus Pharmaceuticals USA Inc.	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1067_a988ebbb-6e0c-43ff-83a8-0cc0dc4259ce	70710-1067	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180503		ANDA	ANDA208961	Zydus Pharmaceuticals USA Inc.	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1068_e97a1af7-d019-47d4-85f4-7bcd58fc0389	70710-1068	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Pharmaceuticals USA Inc.	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70710-1069_e97a1af7-d019-47d4-85f4-7bcd58fc0389	70710-1069	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Pharmaceuticals USA Inc.	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70710-1070_e97a1af7-d019-47d4-85f4-7bcd58fc0389	70710-1070	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Pharmaceuticals USA Inc.	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70710-1071_e97a1af7-d019-47d4-85f4-7bcd58fc0389	70710-1071	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Pharmaceuticals USA Inc.	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70710-1110_b36a8686-4b30-4b42-a673-44cc58b775c3	70710-1110	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20170720		ANDA	ANDA208938	Zydus Pharmaceuticals USA Inc.	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
70710-1111_fab90530-24bb-45f5-8e57-ed55c85b5f3a	70710-1111	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20170427		ANDA	ANDA208622	Zydus Pharmaceuticals (USA) Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70710-1112_fab90530-24bb-45f5-8e57-ed55c85b5f3a	70710-1112	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20170427		ANDA	ANDA208622	Zydus Pharmaceuticals (USA) Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70710-1113_fab90530-24bb-45f5-8e57-ed55c85b5f3a	70710-1113	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20170427		ANDA	ANDA208622	Zydus Pharmaceuticals (USA) Inc.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70710-1114_3d0a3975-6caf-45a7-90a3-19f0725d4697	70710-1114	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209668	Zydus Pharmaceuticals USA Inc.	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70710-1115_3d0a3975-6caf-45a7-90a3-19f0725d4697	70710-1115	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209668	Zydus Pharmaceuticals USA Inc.	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70710-1121_80bbba02-bc83-4e88-af10-fea134197df4	70710-1121	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70710-1122_80bbba02-bc83-4e88-af10-fea134197df4	70710-1122	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70710-1123_80bbba02-bc83-4e88-af10-fea134197df4	70710-1123	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70710-1124_80bbba02-bc83-4e88-af10-fea134197df4	70710-1124	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Pharmaceuticals USA Inc.	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70710-1127_aa94a603-601a-4ec9-931c-a771da09840e	70710-1127	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20181107		ANDA	ANDA211145	Zydus Pharmaceuticals (USA) Inc.	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
70710-1128_aa94a603-601a-4ec9-931c-a771da09840e	70710-1128	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20181107		ANDA	ANDA211145	Zydus Pharmaceuticals (USA) Inc.	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
70710-1129_06a36270-392f-4867-86b3-b61c2eba2d36	70710-1129	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Pharmaceuticals (USA) Inc.	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1130_06a36270-392f-4867-86b3-b61c2eba2d36	70710-1130	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Pharmaceuticals (USA) Inc.	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1131_06a36270-392f-4867-86b3-b61c2eba2d36	70710-1131	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Pharmaceuticals (USA) Inc.	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1132_06a36270-392f-4867-86b3-b61c2eba2d36	70710-1132	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Pharmaceuticals (USA) Inc.	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1133_06a36270-392f-4867-86b3-b61c2eba2d36	70710-1133	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Pharmaceuticals (USA) Inc.	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1137_33fc30a5-64e7-4bee-a2b2-5982356a982b	70710-1137	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Pharmaceuticals (USA) Inc.	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70710-1138_33fc30a5-64e7-4bee-a2b2-5982356a982b	70710-1138	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Pharmaceuticals (USA) Inc.	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70710-1139_33fc30a5-64e7-4bee-a2b2-5982356a982b	70710-1139	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Pharmaceuticals (USA) Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70710-1140_33fc30a5-64e7-4bee-a2b2-5982356a982b	70710-1140	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Pharmaceuticals (USA) Inc.	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70710-1148_f2c34ec3-1ada-4f01-9cfe-07cfd7d781e0	70710-1148	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Pharmaceuticals (USA) Inc.	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1149_f2c34ec3-1ada-4f01-9cfe-07cfd7d781e0	70710-1149	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Pharmaceuticals (USA) Inc.	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1150_f2c34ec3-1ada-4f01-9cfe-07cfd7d781e0	70710-1150	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Pharmaceuticals (USA) Inc.	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1151_f2c34ec3-1ada-4f01-9cfe-07cfd7d781e0	70710-1151	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Pharmaceuticals (USA) Inc.	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1152_f2c34ec3-1ada-4f01-9cfe-07cfd7d781e0	70710-1152	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Pharmaceuticals (USA) Inc.	ISOSORBIDE DINITRATE	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70710-1153_ccad8198-5c8b-4406-a34c-71529c8d5ab2	70710-1153	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Zydus Pharmaceuticals (USA) Inc.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1154_ccad8198-5c8b-4406-a34c-71529c8d5ab2	70710-1154	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Zydus Pharmaceuticals (USA) Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1155_ccad8198-5c8b-4406-a34c-71529c8d5ab2	70710-1155	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Zydus Pharmaceuticals (USA) Inc.	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1156_ccad8198-5c8b-4406-a34c-71529c8d5ab2	70710-1156	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Zydus Pharmaceuticals (USA) Inc.	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1157_b9ae0559-441f-4be3-88e5-336b2bbfa2b2	70710-1157	HUMAN PRESCRIPTION DRUG	leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA212308	Zydus Pharmaceuticals (USA) Inc.	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
70710-1158_b9ae0559-441f-4be3-88e5-336b2bbfa2b2	70710-1158	HUMAN PRESCRIPTION DRUG	leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA212308	Zydus Pharmaceuticals (USA) Inc.	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
70710-1161_70fc6598-0591-4201-83d4-01fa12f806e3	70710-1161	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20201029		ANDA	ANDA213957	Zydus Pharmaceuticals (USA) Inc.	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70710-1162_70fc6598-0591-4201-83d4-01fa12f806e3	70710-1162	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20201029		ANDA	ANDA213957	Zydus Pharmaceuticals (USA) Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70710-1165_73c48039-409b-4769-ab13-fc929efe0e28	70710-1165	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	FOR SUSPENSION	ORAL	20170914		ANDA	ANDA209113	Zydus Pharmaceuticals USA Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70710-1167_f3604313-4dc9-49c1-911c-6178d9939f84	70710-1167	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20190312		ANDA	ANDA210028	Zydus Pharmaceuticals USA Inc.	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
70710-1168_f3604313-4dc9-49c1-911c-6178d9939f84	70710-1168	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20190312		ANDA	ANDA210028	Zydus Pharmaceuticals USA Inc.	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
70710-1179_bbe506db-b0b4-4ef0-9686-ab0b8d52c39d	70710-1179	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190412		ANDA	ANDA210058	Zydus Pharmaceuticals USA Inc.	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
70710-1180_bbe506db-b0b4-4ef0-9686-ab0b8d52c39d	70710-1180	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190412		ANDA	ANDA210058	Zydus Pharmaceuticals USA Inc.	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
70710-1190_bf1e449e-61d5-4038-b03c-8b9d576060c0	70710-1190	HUMAN PRESCRIPTION DRUG	norelgestromin and ethinyl estradiol		norelgestromin and ethinyl estradiol	PATCH	TRANSDERMAL	20231121		ANDA	ANDA214594	Zydus Pharmaceuticals USA Inc.	ETHINYL ESTRADIOL; NORELGESTROMIN	35; 150	ug/mg; ug/mg	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70710-1191_fabe46eb-9f99-46e5-bedd-677cc99a024d	70710-1191	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70710-1192_fabe46eb-9f99-46e5-bedd-677cc99a024d	70710-1192	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70710-1193_fabe46eb-9f99-46e5-bedd-677cc99a024d	70710-1193	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70710-1194_fabe46eb-9f99-46e5-bedd-677cc99a024d	70710-1194	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70710-1195_fabe46eb-9f99-46e5-bedd-677cc99a024d	70710-1195	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Pharmaceuticals USA Inc.	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70710-1196_f5859f1d-1a9a-4576-b177-12d8c0fa770e	70710-1196	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190306		ANDA	ANDA206318	Zydus Pharmaceuticals USA Inc.	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70710-1197_f5859f1d-1a9a-4576-b177-12d8c0fa770e	70710-1197	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190306		ANDA	ANDA206318	Zydus Pharmaceuticals USA Inc.	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70710-1198_f5859f1d-1a9a-4576-b177-12d8c0fa770e	70710-1198	HUMAN PRESCRIPTION DRUG	Rivastigmine		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190306		ANDA	ANDA206318	Zydus Pharmaceuticals USA Inc.	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70710-1203_5595b9a4-aa3e-4151-9bd5-32dd502b0b79	70710-1203	HUMAN PRESCRIPTION DRUG	Trientine hydrochloride		Trientine hydrochloride	CAPSULE	ORAL	20190429		ANDA	ANDA211554	Zydus Pharmaceuticals USA Inc.	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
70710-1204_906e7060-d5f6-408b-97c7-f598361c5840	70710-1204	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210538	Zydus Pharmaceuticals USA Inc.	DIMETHYL FUMARATE	120	mg/1			N	20241231
70710-1205_906e7060-d5f6-408b-97c7-f598361c5840	70710-1205	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210538	Zydus Pharmaceuticals USA Inc.	DIMETHYL FUMARATE	240	mg/1			N	20241231
70710-1208_4d6c653f-1d31-42ee-ac48-b78f9e3b9d63	70710-1208	HUMAN PRESCRIPTION DRUG	PLERIXAFOR		plerixafor	INJECTION	SUBCUTANEOUS	20230728		ANDA	ANDA208980	Zydus Pharmaceuticals USA Inc.	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
70710-1209_39e8378b-3c82-45f3-851f-4dcd13a0328b	70710-1209	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20180208		ANDA	ANDA210117	Zydus Pharmaceuticals (USA) Inc.	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70710-1210_39e8378b-3c82-45f3-851f-4dcd13a0328b	70710-1210	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20180208		ANDA	ANDA210117	Zydus Pharmaceuticals (USA) Inc.	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70710-1221_3abe5c9f-1e44-4fe7-b5d1-70f66f2bcfe1	70710-1221	HUMAN PRESCRIPTION DRUG	CARBIDOPA		CARBIDOPA	TABLET	ORAL	20180906		ANDA	ANDA209910	Zydus Pharmaceuticals USA Inc.	CARBIDOPA	25	mg/1			N	20241231
70710-1225_56107141-14d2-446c-9d42-e7f747f07bd7	70710-1225	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Pharmaceuticals USA Inc.	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1226_56107141-14d2-446c-9d42-e7f747f07bd7	70710-1226	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Pharmaceuticals USA Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1227_56107141-14d2-446c-9d42-e7f747f07bd7	70710-1227	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Pharmaceuticals USA Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1228_56107141-14d2-446c-9d42-e7f747f07bd7	70710-1228	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Pharmaceuticals USA Inc.	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1229_56107141-14d2-446c-9d42-e7f747f07bd7	70710-1229	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Pharmaceuticals USA Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1230_56107141-14d2-446c-9d42-e7f747f07bd7	70710-1230	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Pharmaceuticals USA Inc.	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70710-1233_fecfe1c4-1732-48a4-beaa-6bdc5577731a	70710-1233	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	CREAM	TOPICAL	20190226		ANDA	ANDA208885	Zydus Pharmaceuticals USA Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70710-1238_018236b7-89cf-4f06-be4d-925b4093d4b0	70710-1238	HUMAN PRESCRIPTION DRUG	acetaZOLAMIDE		acetaZOLAMIDE	TABLET	ORAL	20230804		ANDA	ANDA211069	Zydus Pharmaceuticals (USA) Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70710-1239_018236b7-89cf-4f06-be4d-925b4093d4b0	70710-1239	HUMAN PRESCRIPTION DRUG	acetaZOLAMIDE		acetaZOLAMIDE	TABLET	ORAL	20230804		ANDA	ANDA211069	Zydus Pharmaceuticals (USA) Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70710-1240_d2e68080-f67c-462b-a330-45012873d719	70710-1240	HUMAN PRESCRIPTION DRUG	ZITUVIO		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Pharmaceuticals (USA) Inc.	SITAGLIPTIN	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70710-1241_d2e68080-f67c-462b-a330-45012873d719	70710-1241	HUMAN PRESCRIPTION DRUG	ZITUVIO		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Pharmaceuticals (USA) Inc.	SITAGLIPTIN	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70710-1242_d2e68080-f67c-462b-a330-45012873d719	70710-1242	HUMAN PRESCRIPTION DRUG	ZITUVIO		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Pharmaceuticals (USA) Inc.	SITAGLIPTIN	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70710-1247_63f99ef1-dd00-4375-8baa-a06c2de48686	70710-1247	HUMAN PRESCRIPTION DRUG	VORICONAZOLE		voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190103		ANDA	ANDA208983	Zydus Pharmaceuticals USA Inc.	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70710-1275_b011a8f6-9341-4dfb-a7cf-eb30cdae32d2	70710-1275	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211383	Zydus Pharmaceuticals USA Inc.	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70710-1276_b011a8f6-9341-4dfb-a7cf-eb30cdae32d2	70710-1276	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA211383	Zydus Pharmaceuticals USA Inc.	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70710-1277_b011a8f6-9341-4dfb-a7cf-eb30cdae32d2	70710-1277	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211383	Zydus Pharmaceuticals USA Inc.	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70710-1284_bd0eaa0d-0a5b-48a2-bc7e-78b8bde33962	70710-1284	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	20181101		ANDA	ANDA208948	Zydus Pharmaceuticals USA Inc.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70710-1285_2fc8f977-f0eb-49b0-824b-98bc8fc089ae	70710-1285	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20181206		ANDA	ANDA211659	Zydus Pharmaceuticals (USA) Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70710-1286_2fc8f977-f0eb-49b0-824b-98bc8fc089ae	70710-1286	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20181206		ANDA	ANDA211659	Zydus Pharmaceuticals (USA) Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70710-1287_fcbe09cd-50af-4932-8f4a-6f6439068b4d	70710-1287	HUMAN PRESCRIPTION DRUG	vigabatrin		vigabatrin	TABLET, FILM COATED	ORAL	20220120		ANDA	ANDA215707	Zydus Pharmaceuticals (USA) Inc.	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
70710-1289_4c2fb12f-623b-4dc9-a9e0-7fac953f5cf0	70710-1289	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20221230		ANDA	ANDA213003	Zydus Pharmaceuticals USA Inc.	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70710-1302_c4a4a31c-618f-42e7-ba11-4bf5939dff5b	70710-1302	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUPPOSITORY	RECTAL	20200214		ANDA	ANDA208953	Zydus Pharmaceuticals USA Inc.	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70710-1325_84e61e3c-db62-4fd0-bcf5-c805067a0ac7	70710-1325	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20181022		ANDA	ANDA211449	Zydus Pharmaceuticals USA Inc.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
70710-1326_84e61e3c-db62-4fd0-bcf5-c805067a0ac7	70710-1326	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20181022		ANDA	ANDA211449	Zydus Pharmaceuticals USA Inc.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
70710-1344_6bc89997-a72b-415e-93d9-442ce2579bca	70710-1344	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20190723		ANDA	ANDA211567	Zydus Pharmaceuticals USA Inc.	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
70710-1348_479c565e-3c2f-42a1-8a19-b7a210e5f28d	70710-1348	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1349_479c565e-3c2f-42a1-8a19-b7a210e5f28d	70710-1349	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1350_479c565e-3c2f-42a1-8a19-b7a210e5f28d	70710-1350	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1351_cf874687-3377-4fd3-9616-6c1f74454ad3	70710-1351	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20190612		ANDA	ANDA211519	Zydus Pharmaceuticals USA Inc.	COLCHICEINE	.6	mg/1			N	20241231
70710-1352_479c565e-3c2f-42a1-8a19-b7a210e5f28d	70710-1352	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1359_be197211-9535-43ec-af98-4318fee3eb82	70710-1359	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		Lacosamide	INJECTION	INTRAVENOUS	20220629		ANDA	ANDA209465	Zydus Pharmaceuticals USA Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
70710-1364_aea4ca0a-a4ee-4895-ab93-010e118fa475	70710-1364	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA212689	Zydus Pharmaceuticals USA Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	100; 150	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70710-1365_aea4ca0a-a4ee-4895-ab93-010e118fa475	70710-1365	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA212689	Zydus Pharmaceuticals USA Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	133; 200	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70710-1366_aea4ca0a-a4ee-4895-ab93-010e118fa475	70710-1366	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA212689	Zydus Pharmaceuticals USA Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	167; 250	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70710-1367_aea4ca0a-a4ee-4895-ab93-010e118fa475	70710-1367	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210324		ANDA	ANDA212689	Zydus Pharmaceuticals USA Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70710-1377_bd190da3-9daf-4859-a431-87c693e18e90	70710-1377	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180510		ANDA	ANDA209467	Zydus Pharmaceuticals USA Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
70710-1389_98a2a992-f0a2-47e4-91c0-bdae39b73e63	70710-1389	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211818	Zydus Pharmaceuticals USA Inc.	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70710-1390_98a2a992-f0a2-47e4-91c0-bdae39b73e63	70710-1390	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211818	Zydus Pharmaceuticals USA Inc.	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70710-1391_98a2a992-f0a2-47e4-91c0-bdae39b73e63	70710-1391	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211818	Zydus Pharmaceuticals USA Inc.	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70710-1401_b34fed69-75ae-4d92-8329-5dd1cb3fca03	70710-1401	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	OINTMENT	TOPICAL	20180322		ANDA	ANDA210199	Zydus Pharmaceuticals USA Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70710-1411_77554fd4-a569-4180-9a5f-e51962f8524b	70710-1411	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		BORTEZOMIB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502		ANDA	ANDA210204	Zydus Pharmaceuticals USA Inc.	BORTEZOMIB	1	mg/mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
70710-1416_906e7060-d5f6-408b-97c7-f598361c5840	70710-1416	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	KIT		20200928		ANDA	ANDA210538	Zydus Pharmaceuticals USA Inc.						N	20241231
70710-1445_96b1eb6c-b99b-4509-a8eb-424123aead6a	70710-1445	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20190307		ANDA	ANDA210794	Zydus Pharmaceuticals USA Inc.	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70710-1456_81c51ba6-f3d8-4a34-9a8b-1834de862812	70710-1456	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20190109		ANDA	ANDA211074	Zydus Pharmaceuticals USA Inc.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70710-1457_23cec209-f778-4ca1-ab99-ae966996c9b0	70710-1457	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Pharmaceuticals USA Inc.	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70710-1458_23cec209-f778-4ca1-ab99-ae966996c9b0	70710-1458	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Pharmaceuticals USA Inc.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70710-1459_23cec209-f778-4ca1-ab99-ae966996c9b0	70710-1459	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Pharmaceuticals USA Inc.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70710-1460_23cec209-f778-4ca1-ab99-ae966996c9b0	70710-1460	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Pharmaceuticals USA Inc.	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70710-1461_fb9be645-3f94-4c69-9aca-148a03795a07	70710-1461	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70710-1462_fb9be645-3f94-4c69-9aca-148a03795a07	70710-1462	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70710-1463_fb9be645-3f94-4c69-9aca-148a03795a07	70710-1463	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70710-1464_fb9be645-3f94-4c69-9aca-148a03795a07	70710-1464	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Pharmaceuticals USA Inc.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70710-1467_4670c9c5-235f-4a77-8dd2-2f8eecbdcdb4	70710-1467	HUMAN PRESCRIPTION DRUG	Colestipol hydrochloride		Colestipol hydrochloride	TABLET, FILM COATED	ORAL	20220504		ANDA	ANDA215223	Zydus Pharmaceuticals USA Inc.	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
70710-1478_28adc8f9-39f6-44f5-ad0a-e1034885b13e	70710-1478	HUMAN PRESCRIPTION DRUG	Fomepizole		Fomepizole	INJECTION, SOLUTION	INTRAVENOUS	20210318		ANDA	ANDA078537	Zydus Pharmaceuticals USA Inc.	FOMEPIZOLE	1	g/mL	Antidote [EPC]		N	20241231
70710-1483_786e363a-6320-46bc-a472-6713abaeb450	70710-1483	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20210121		ANDA	ANDA214295	Zydus Pharmaceuticals (USA) Inc.	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
70710-1488_f3b6f558-bb8c-46ce-990f-7d07a807a4b5	70710-1488	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Pharmaceuticals (USA) Inc.	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1489_f3b6f558-bb8c-46ce-990f-7d07a807a4b5	70710-1489	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Pharmaceuticals (USA) Inc.	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1490_f3b6f558-bb8c-46ce-990f-7d07a807a4b5	70710-1490	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Pharmaceuticals (USA) Inc.	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1491_f3b6f558-bb8c-46ce-990f-7d07a807a4b5	70710-1491	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Pharmaceuticals (USA) Inc.	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1514_eee8e030-c955-4044-8b0d-4f30ce79bc5a	70710-1514	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Zydus Pharmaceuticals (USA) Inc.	FONDAPARINUX SODIUM	2.5	mg/.5mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
70710-1515_eee8e030-c955-4044-8b0d-4f30ce79bc5a	70710-1515	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Zydus Pharmaceuticals (USA) Inc.	FONDAPARINUX SODIUM	5	mg/.4mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
70710-1516_eee8e030-c955-4044-8b0d-4f30ce79bc5a	70710-1516	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Zydus Pharmaceuticals (USA) Inc.	FONDAPARINUX SODIUM	7.5	mg/.6mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
70710-1517_eee8e030-c955-4044-8b0d-4f30ce79bc5a	70710-1517	HUMAN PRESCRIPTION DRUG	fondaparinux sodium		fondaparinux sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20190206		ANDA	ANDA208615	Zydus Pharmaceuticals (USA) Inc.	FONDAPARINUX SODIUM	10	mg/.8mL	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
70710-1521_4c2fb12f-623b-4dc9-a9e0-7fac953f5cf0	70710-1521	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20221230		ANDA	ANDA213003	Zydus Pharmaceuticals USA Inc.	TRIAZOLAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70710-1525_39bea1cb-cd9e-4ff0-ad5d-03aa2e5ccf09	70710-1525	HUMAN PRESCRIPTION DRUG	carmustine		carmustine	KIT		20201224		ANDA	ANDA210179	Zydus Pharmaceuticals USA Inc.						N	20241231
70710-1530_6ba8cf1f-0639-4db5-a864-37077551bb70	70710-1530	HUMAN PRESCRIPTION DRUG	DOXORUBICIN HYDROCHLORIDE		doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20200914		ANDA	ANDA212299	Zydus Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
70710-1531_6ba8cf1f-0639-4db5-a864-37077551bb70	70710-1531	HUMAN PRESCRIPTION DRUG	DOXORUBICIN HYDROCHLORIDE		doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20200914		ANDA	ANDA212299	Zydus Pharmaceuticals USA Inc.	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
70710-1532_85cccd13-2916-487a-8fd6-598c06c3cfd3	70710-1532	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20200212		ANDA	ANDA212171	Zydus Pharmaceuticals USA Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70710-1533_f653bd7e-33c2-451a-b6bf-ba68bbcbf09b	70710-1533	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20201105		ANDA	ANDA213527	Zydus Pharmaceuticals USA Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70710-1534_85cccd13-2916-487a-8fd6-598c06c3cfd3	70710-1534	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20200212		ANDA	ANDA212171	Zydus Pharmaceuticals USA Inc.	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70710-1537_a2356703-66f4-491b-874e-d4a4a2183788	70710-1537	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090728	Zydus Pharmaceuticals USA Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1538_a2356703-66f4-491b-874e-d4a4a2183788	70710-1538	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090728	Zydus Pharmaceuticals USA Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1539_a2356703-66f4-491b-874e-d4a4a2183788	70710-1539	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090728	Zydus Pharmaceuticals USA Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1543_dcbddcc0-3d6a-4c4e-817c-699e31171810	70710-1543	HUMAN PRESCRIPTION DRUG	ZALDYON		mesalamine	TABLET, DELAYED RELEASE	ORAL	20190117		ANDA	ANDA203286	Zydus Pharmaceuticals USA Inc.	MESALAMINE	800	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70710-1550_e546b521-f703-4e72-88a5-31deacc116d7	70710-1550	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		Ranitidine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190221		ANDA	ANDA091534	Zydus Pharmaceuticals USA Inc.	RANITIDINE HYDROCHLORIDE	25	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70710-1571_cf874687-3377-4fd3-9616-6c1f74454ad3	70710-1571	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20210510		ANDA	ANDA211519	Zydus Pharmaceuticals USA Inc.	COLCHICEINE	.3	mg/1			N	20241231
70710-1591_02702bb6-2892-4f1a-b5d5-247f6be01242	70710-1591	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	CAPSULE	ORAL	20190508		ANDA	ANDA205301	Zydus Pharmaceuticals (USA) Inc.	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70710-1592_fdb3441d-f4bb-47e4-921c-1f59daeed07b	70710-1592	HUMAN PRESCRIPTION DRUG	icosapent ethyl		icosapent ethyl	CAPSULE	ORAL	20230804		ANDA	ANDA217656	Zydus Pharmaceuticals USA Inc.	ICOSAPENT ETHYL	1	g/1			N	20241231
70710-1609_2fc8f977-f0eb-49b0-824b-98bc8fc089ae	70710-1609	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20200507		ANDA	ANDA211659	Zydus Pharmaceuticals (USA) Inc.	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70710-1610_8b22e211-3392-4f39-9c2f-4ceee2da2302	70710-1610	HUMAN PRESCRIPTION DRUG	Arsenic trioxide		Arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20190903		ANDA	ANDA206228	Zydus Pharmaceuticals USA Inc.	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
70710-1613_9f834471-73ae-4ced-8677-158263f70404	70710-1613	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline	TABLET, FILM COATED	ORAL	20230613		ANDA	ANDA216723	Zydus Pharmaceuticals USA Inc.	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
70710-1614_9f834471-73ae-4ced-8677-158263f70404	70710-1614	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline	TABLET, FILM COATED	ORAL	20230613		ANDA	ANDA216723	Zydus Pharmaceuticals USA Inc.	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
70710-1615_581a51f5-a274-42ed-aa14-851067573d1a	70710-1615	HUMAN PRESCRIPTION DRUG	fosaprepitant		fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201101		ANDA	ANDA212957	Zydus Pharmaceuticals USA Inc.	FOSAPREPITANT	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
70710-1626_087014e2-5d4c-4ae8-a5d2-c79acfb83fde	70710-1626	HUMAN PRESCRIPTION DRUG	balsalazide disodium		balsalazide disodium	CAPSULE	ORAL	20230825		ANDA	ANDA217592	Zydus Pharmaceuticals (USA) Inc.	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70710-1641_f06e99fa-9894-48ab-99d8-914987dbb73f	70710-1641	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20230323		ANDA	ANDA214131	Zydus Pharmaceuticals USA Inc.	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
70710-1642_f06e99fa-9894-48ab-99d8-914987dbb73f	70710-1642	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20230323		ANDA	ANDA214131	Zydus Pharmaceuticals USA Inc.	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
70710-1643_ba7a1f8b-81a4-49ad-ae2c-2cd08a4ffffd	70710-1643	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201022		ANDA	ANDA214215	Zydus Pharmaceuticals USA Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70710-1644_ba7a1f8b-81a4-49ad-ae2c-2cd08a4ffffd	70710-1644	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201022		ANDA	ANDA214215	Zydus Pharmaceuticals USA Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70710-1645_c56593be-a843-4885-8af8-c8535654ef1d	70710-1645	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70710-1646_c56593be-a843-4885-8af8-c8535654ef1d	70710-1646	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70710-1647_c56593be-a843-4885-8af8-c8535654ef1d	70710-1647	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70710-1648_c56593be-a843-4885-8af8-c8535654ef1d	70710-1648	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Pharmaceuticals USA Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70710-1654_bf1de3fa-e7f8-4beb-beeb-6272709d13f2	70710-1654	HUMAN PRESCRIPTION DRUG	pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220526		ANDA	ANDA214073	Zydus Pharmaceuticals USA Inc.	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70710-1655_bf1de3fa-e7f8-4beb-beeb-6272709d13f2	70710-1655	HUMAN PRESCRIPTION DRUG	pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220526		ANDA	ANDA214073	Zydus Pharmaceuticals USA Inc.	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70710-1656_18173716-8d8a-4ae2-898f-90bc8a47e17b	70710-1656	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230511		ANDA	ANDA214486	Zydus Pharmaceuticals USA Inc.	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70710-1663_6ac6e28b-b969-4b66-bc1e-cca8a2cb66f3	70710-1663	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220505		ANDA	ANDA214655	Zydus Pharmaceuticals USA Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70710-1664_6ac6e28b-b969-4b66-bc1e-cca8a2cb66f3	70710-1664	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220505		ANDA	ANDA214655	Zydus Pharmaceuticals USA Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70710-1665_6ac6e28b-b969-4b66-bc1e-cca8a2cb66f3	70710-1665	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220505		ANDA	ANDA214655	Zydus Pharmaceuticals USA Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70710-1667_526a818f-9b98-4b47-9974-4c363151578e	70710-1667	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220810		ANDA	ANDA216495	Zydus Pharmaceuticals (USA) Inc.	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1668_526a818f-9b98-4b47-9974-4c363151578e	70710-1668	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220810		ANDA	ANDA216495	Zydus Pharmaceuticals (USA) Inc.	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70710-1674_bf1de3fa-e7f8-4beb-beeb-6272709d13f2	70710-1674	HUMAN PRESCRIPTION DRUG	pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220526		ANDA	ANDA214073	Zydus Pharmaceuticals USA Inc.	PEMETREXED DISODIUM	1000	mg/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70710-1683_5a3e9c70-b8f8-4866-b128-9f50272c03c0	70710-1683	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	Zydus Pharmaceuticals USA Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70710-1684_5a3e9c70-b8f8-4866-b128-9f50272c03c0	70710-1684	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	Zydus Pharmaceuticals USA Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70710-1688_75a779e9-12ef-4692-bce5-1e0d916c17af	70710-1688	HUMAN PRESCRIPTION DRUG	FULVESTRANT		fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20211214		ANDA	ANDA215234	Zydus Pharmaceuticals USA Inc.	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
70710-1698_29d6f5cb-58d4-4d82-966d-acd92b0431ee	70710-1698	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230518		ANDA	ANDA090174	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1699_29d6f5cb-58d4-4d82-966d-acd92b0431ee	70710-1699	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230518		ANDA	ANDA090174	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1700_29d6f5cb-58d4-4d82-966d-acd92b0431ee	70710-1700	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230518		ANDA	ANDA090174	Zydus Pharmaceuticals USA Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70710-1710_f51f134d-210d-4cb2-9e8a-14deec21817a	70710-1710	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20221110		ANDA	ANDA217038	Zydus Pharmaceuticals (USA) Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70710-1716_a63d8eda-a92a-44a6-9e5f-cfda2e568a1f	70710-1716	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil Citrate	POWDER, FOR SUSPENSION	ORAL	20221027		ANDA	ANDA215708	Zydus Pharmaceuticals (USA) Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70710-1724_fe33b956-b91b-4b63-856d-544e6cb1c250	70710-1724	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230410		ANDA	ANDA215241	Zydus Pharmaceuticals USA Inc.	MICAFUNGIN SODIUM	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
70710-1725_fe33b956-b91b-4b63-856d-544e6cb1c250	70710-1725	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230410		ANDA	ANDA215241	Zydus Pharmaceuticals USA Inc.	MICAFUNGIN SODIUM	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
70710-1726_aec0ec2a-d34b-480e-9d6e-d2fb681d9af8	70710-1726	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20211117		ANDA	ANDA215037	Zydus Pharmaceuticals USA Inc.	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70710-1738_fdb3441d-f4bb-47e4-921c-1f59daeed07b	70710-1738	HUMAN PRESCRIPTION DRUG	icosapent ethyl		icosapent ethyl	CAPSULE	ORAL	20230804		ANDA	ANDA217656	Zydus Pharmaceuticals USA Inc.	ICOSAPENT ETHYL	.5	g/1			N	20241231
70710-1755_2f98d90f-bd38-4e3f-99a0-16f2004fcc71	70710-1755	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230831		ANDA	ANDA215440	Zydus Pharmaceuticals USA Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70710-1756_2f98d90f-bd38-4e3f-99a0-16f2004fcc71	70710-1756	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230831		ANDA	ANDA215440	Zydus Pharmaceuticals USA Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70710-1757_55ef96d3-0a46-45ee-bb42-d2d23f76a80a	70710-1757	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Zydus Pharmaceuticals USA Inc.	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
70710-1758_55ef96d3-0a46-45ee-bb42-d2d23f76a80a	70710-1758	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Zydus Pharmaceuticals USA Inc.	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
70710-1759_55ef96d3-0a46-45ee-bb42-d2d23f76a80a	70710-1759	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Zydus Pharmaceuticals USA Inc.	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
70710-1760_55ef96d3-0a46-45ee-bb42-d2d23f76a80a	70710-1760	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Zydus Pharmaceuticals USA Inc.	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
70710-1761_55ef96d3-0a46-45ee-bb42-d2d23f76a80a	70710-1761	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Zydus Pharmaceuticals USA Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
70710-1762_55ef96d3-0a46-45ee-bb42-d2d23f76a80a	70710-1762	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Zydus Pharmaceuticals USA Inc.	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
70710-1763_55ef96d3-0a46-45ee-bb42-d2d23f76a80a	70710-1763	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20210401		ANDA	ANDA076726	Zydus Pharmaceuticals USA Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
70710-1832_0cf15f29-e59a-95c2-e063-6394a90acda0	70710-1832	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium Tablets	TABLET, FILM COATED	ORAL	20220512		ANDA	ANDA215750	Zydus Pharmaceuticals (USA) Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70710-1837_6e77f792-8b3b-480c-902c-03fa55478fde	70710-1837	HUMAN PRESCRIPTION DRUG	Methylene blue		Methylene blue	INJECTION	INTRAVENOUS	20231205		ANDA	ANDA215636	Zydus Pharmaceuticals USA Inc.	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
70710-1838_6e77f792-8b3b-480c-902c-03fa55478fde	70710-1838	HUMAN PRESCRIPTION DRUG	Methylene blue		Methylene blue	INJECTION	INTRAVENOUS	20231205		ANDA	ANDA215636	Zydus Pharmaceuticals USA Inc.	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
70710-1839_7b0a1790-c6e3-4f09-859f-1ae9db46b007	70710-1839	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20220624		ANDA	ANDA215037	Zydus Pharmaceuticals USA Inc.	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70710-1852_616c6373-b8ea-4f92-95ca-6508ec94a692	70710-1852	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	SUPPOSITORY	RECTAL	20230803		ANDA	ANDA216184	Zydus Pharmaceuticals USA Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70710-1876_7bf7761a-873d-48bc-b884-818f16215689	70710-1876	HUMAN PRESCRIPTION DRUG	zinc sulfate		zinc sulfate injection,	SOLUTION	INTRAVENOUS	20231207		ANDA	ANDA217074	Zydus Pharmaceuticals USA Inc.	ZINC SULFATE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70710-1877_7bf7761a-873d-48bc-b884-818f16215689	70710-1877	HUMAN PRESCRIPTION DRUG	zinc sulfate		zinc sulfate injection,	SOLUTION	INTRAVENOUS	20231207		ANDA	ANDA217074	Zydus Pharmaceuticals USA Inc.	ZINC SULFATE	3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70710-1878_7bf7761a-873d-48bc-b884-818f16215689	70710-1878	HUMAN PRESCRIPTION DRUG	zinc sulfate		zinc sulfate injection,	SOLUTION	INTRAVENOUS	20231207		ANDA	ANDA217074	Zydus Pharmaceuticals USA Inc.	ZINC SULFATE	5	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70710-1886_32f7b181-f883-4d8f-8557-2c5a4eac51ee	70710-1886	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		Lacosamide	INJECTION	INTRAVENOUS	20221110		ANDA	ANDA209465	Zydus Pharmaceuticals USA Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
70710-1895_b6e6e072-6d6b-47b1-bc40-811fbd58ed03	70710-1895	HUMAN PRESCRIPTION DRUG	Arsenic trioxide		Arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20230228		ANDA	ANDA206228	Zydus Pharmaceuticals USA Inc.	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
70710-1896_5972a909-5e2d-4dba-9b9c-35d076bd5ec6	70710-1896	HUMAN PRESCRIPTION DRUG	Arsenic trioxide		Arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20230228		ANDA	ANDA206228	Zydus Pharmaceuticals USA Inc.	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
70710-1899_e6912c3b-b985-4107-8093-82654bc1a3bb	70710-1899	HUMAN PRESCRIPTION DRUG	Sitagliptin		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Pharmaceuticals (USA) Inc.	SITAGLIPTIN	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70710-1900_e6912c3b-b985-4107-8093-82654bc1a3bb	70710-1900	HUMAN PRESCRIPTION DRUG	Sitagliptin		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Pharmaceuticals (USA) Inc.	SITAGLIPTIN	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70710-1901_e6912c3b-b985-4107-8093-82654bc1a3bb	70710-1901	HUMAN PRESCRIPTION DRUG	Sitagliptin		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Pharmaceuticals (USA) Inc.	SITAGLIPTIN	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70710-1926_fd646c47-7fcd-4d60-8f6c-29e13f611c6d	70710-1926	HUMAN PRESCRIPTION DRUG	Sodium phenylacetate and Sodium benzoate		Sodium phenylacetate and Sodium benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20230919		ANDA	ANDA217526	Zydus Pharmaceuticals USA Inc.	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
70710-1937_219a17e6-350f-413e-8f25-fcc3d998d9ac	70710-1937	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20231017		ANDA	ANDA214215	Zydus Pharmaceuticals USA Inc.	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70712-101_0e8c5b30-e8cf-8d66-e063-6394a90a40a6	70712-101	HUMAN OTC DRUG	ADVANCED PROTECTION SUNSCREEN SPF-30		OCTINOXATE, OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20170807		OTC MONOGRAPH DRUG	M020	BOTANICAL SCIENCE, INC.	OCTINOXATE; OCTISALATE; ZINC OXIDE	7.5; 5; 7	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20251231
70712-102_0e8c5b30-e8d0-8d66-e063-6394a90a40a6	70712-102	HUMAN OTC DRUG	WEIGHTLESS PROTECTION	SPF 30	OCTINOXATE, ZINC OXIDE, OCTISALATE	LOTION	TOPICAL	20220509		OTC MONOGRAPH DRUG	M020	Botanical Science Technologies	OCTINOXATE; OCTISALATE; ZINC OXIDE	7.5; 5; 7	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20251231
70719-0003_5b132501-f52a-410c-b606-b6142568bcd1	70719-0003	HUMAN OTC DRUG	Heilen		Galium Aparine, Agnus Castus, Apis Mellifica, Capsicum Annuum, Chelidonium Majus, Taraxacum Officinale, Urtica Dioica, Xanthoxylum Fraxineum, Fucus Vesiculosus, Kali Phosphoricum, Magnesia Phosphorica, Natrum Phosphoricum, Sarsaparilla (smilax Regelii), Ubidecarenonum, Calcarea Carbonica, Graphites, Lycopodium Clavatum, Anacardium Orientale, Colchicum Autumnale, Nux Vomica, Phytolacca Decandra, Pulsatilla (Pratensis), Histaminum Hydrochloricum	LIQUID	ORAL	20220121		UNAPPROVED HOMEOPATHIC		Heilen	APIS MELLIFERA; CAPSICUM; CHASTE TREE FRUIT; CHELIDONIUM MAJUS WHOLE; COLCHICUM AUTUMNALE BULB; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; GRAPHITE; HISTAMINE DIHYDROCHLORIDE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PULSATILLA PRATENSIS WHOLE; SEMECARPUS ANACARDIUM JUICE; SMILAX ORNATA ROOT; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; UBIDECARENONE; URTICA DIOICA WHOLE; ZANTHOXYLUM AMERICANUM BARK	6; 6; 6; 6; 30; 12; 6; 3; 12; 200; 12; 12; 12; 30; 30; 30; 12; 12; 30; 6; 12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
70720-100_23ae517f-48a0-46e7-a341-6381701b72fc	70720-100	HUMAN PRESCRIPTION DRUG	QUZYTTIR		Cetirizine Hydrochloride	INJECTION	INTRAVENOUS	20191113		NDA	NDA211415	TerSera Therapeutics LLC	CETIRIZINE HYDROCHLORIDE	10	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70720-101_5de36f8a-cbc2-4884-8fcf-e9302d41c2f8	70720-101	HUMAN PRESCRIPTION DRUG	Varubi		rolapitant	TABLET	ORAL	20151007		NDA	NDA206500	TerSera Therapeutics LLC	ROLAPITANT HYDROCHLORIDE	90	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], P-Glycoprotein Inhibitors [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
70720-120_2a704323-0860-4d2f-8743-f2b4d078f29c	70720-120	HUMAN PRESCRIPTION DRUG	Ergomar	Sublingual	Ergotamine Tartrate	TABLET	ORAL	20160920		ANDA	ANDA087693	TerSera Therapeutics, LLC	ERGOTAMINE TARTRATE	2	mg/1	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
70720-125_ba59d050-c350-492f-a421-f4b64f6fc60e	70720-125	HUMAN PRESCRIPTION DRUG	Xermelo		telotristat ethyl	TABLET	ORAL	20201005		NDA	NDA208794	TerSera Therapeutics LLC	TELOTRISTAT ETHYL	250	mg/1	Tryptophan Hydroxylase Inhibitor [EPC], Tryptophan Hydroxylase Inhibitors [MoA]		N	20241231
70720-720_e54fb2ff-1fa1-479d-8ec4-3eafc5c1920e	70720-720	HUMAN PRESCRIPTION DRUG	PRIALT		ziconotide acetate	INJECTION, SOLUTION	INTRATHECAL	20181015		NDA	NDA021060	TerSera Therapeutics LLC	ZICONOTIDE ACETATE	100	ug/mL	N-Calcium Channel Receptor Antagonists [MoA], N-type Calcium Channel Antagonist [EPC]		N	20241231
70720-722_e54fb2ff-1fa1-479d-8ec4-3eafc5c1920e	70720-722	HUMAN PRESCRIPTION DRUG	PRIALT		ziconotide acetate	INJECTION, SOLUTION	INTRATHECAL	20181015		NDA	NDA021060	TerSera Therapeutics LLC	ZICONOTIDE ACETATE	100	ug/mL	N-Calcium Channel Receptor Antagonists [MoA], N-type Calcium Channel Antagonist [EPC]		N	20241231
70720-723_e54fb2ff-1fa1-479d-8ec4-3eafc5c1920e	70720-723	HUMAN PRESCRIPTION DRUG	PRIALT		ziconotide acetate	INJECTION, SOLUTION	INTRATHECAL	20181015		NDA	NDA021060	TerSera Therapeutics LLC	ZICONOTIDE ACETATE	25	ug/mL	N-Calcium Channel Receptor Antagonists [MoA], N-type Calcium Channel Antagonist [EPC]		N	20241231
70720-950_71b8db45-e40e-4de5-bdab-c409c968c271	70720-950	HUMAN PRESCRIPTION DRUG	ZOLADEX		goserelin	IMPLANT	SUBCUTANEOUS	20180331		NDA	NDA019726	TerSera Therapeutics LLC	GOSERELIN ACETATE	3.6	mg/1	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
70720-951_2cec27f6-1a75-488e-b8fc-3b368818f97b	70720-951	HUMAN PRESCRIPTION DRUG	ZOLADEX		goserelin	IMPLANT	SUBCUTANEOUS	20180126		NDA	NDA020578	TerSera Therapeutics LLC	GOSERELIN ACETATE	10.8	mg/1	Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA]		N	20241231
70721-001_d65595c8-b75b-92a7-e053-2995a90a6a4b	70721-001	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-002_d6557787-2a5c-576f-e053-2a95a90a9025	70721-002	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-003_d655993c-e2e5-2ab8-e053-2995a90aa925	70721-003	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-004_d6559a98-9f76-7ab9-e053-2a95a90acd14	70721-004	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-005_d655993c-e2f1-2ab8-e053-2995a90aa925	70721-005	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-006_d655993c-e2fd-2ab8-e053-2995a90aa925	70721-006	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-007_d6559a98-9f83-7ab9-e053-2a95a90acd14	70721-007	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-008_d655993c-e309-2ab8-e053-2995a90aa925	70721-008	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70721-009_d6559a98-9f8f-7ab9-e053-2a95a90acd14	70721-009	HUMAN OTC DRUG	Defend		Benzocaine	GEL	DENTAL	20141101		OTC MONOGRAPH NOT FINAL	part356	Mydent International	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70722-203_b7b52adc-15dd-1a53-e053-2995a90a72b6	70722-203	HUMAN OTC DRUG	Aching Head Rub		camphor, menthol	OINTMENT	TOPICAL	20160926		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3.09; 2.55	g/100g; g/100g			N	20241231
70722-203_b7b57849-46b6-e7a4-e053-2a95a90ab190	70722-203	HUMAN OTC DRUG	Aching Head Rub		Camphor, menthol	OINTMENT	TOPICAL	20160926		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3.09; 2.55	g/100g; g/100g			N	20241231
70722-208_b7b52adc-15d0-1a53-e053-2995a90a72b6	70722-208	HUMAN OTC DRUG	Ass Kisser		Camphor, Menthol	CREAM	TOPICAL	20160929		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	1.35; 2.86	g/100g; g/100g			N	20241231
70722-208_b7b57a51-8298-5f3f-e053-2995a90ab88a	70722-208	HUMAN OTC DRUG	Ass Kisser		Camphor, Menthol	CREAM	TOPICAL	20160929		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	1.35; 2.86	g/100g; g/100g			N	20241231
70722-216_b7b52011-dfad-bc0c-e053-2995a90ab521	70722-216	HUMAN OTC DRUG	Asana Kisser		Camphor, Menthol	CREAM	TOPICAL	20160930		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	1.35; 2.86	g/100g; g/100g			N	20241231
70722-216_b7b57a51-829a-5f3f-e053-2995a90ab88a	70722-216	HUMAN OTC DRUG	Asana Kisser		Camphor, Menthol	CREAM	TOPICAL	20160930		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	1.35; 2.86	g/100g; g/100g			N	20241231
70722-229_b7b51fa5-ce96-b190-e053-2995a90a79d5	70722-229	HUMAN OTC DRUG	Vital Vapor		Camphor, Menthol	OINTMENT	TOPICAL	20161002		OTC MONOGRAPH NOT FINAL	part348	Little Moon essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	.6; 5.2	g/100g; g/100g			N	20241231
70722-229_b7b52a91-8d0a-1a5c-e053-2995a90a3048	70722-229	HUMAN OTC DRUG	Vital Vapor		Camphor, Menthol	OINTMENT	TOPICAL	20161002		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	.6; 5.2	g/100g; g/100g			N	20241231
70722-229_b7b573e9-183d-a5a2-e053-2a95a90ab938	70722-229	HUMAN OTC DRUG	Vital Vapor		Camphor, Menthol	OINTMENT	TOPICAL	20161002		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	.6; 5.2	g/100g; g/100g			N	20241231
70722-232_b7b519b7-b8f4-6d25-e053-2995a90a3dac	70722-232	HUMAN OTC DRUG	Dream Cream		Camphor, Menthol	CREAM	TOPICAL	20161004		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	.45; 5	g/100g; g/100g			N	20241231
70722-232_b7b57a51-829b-5f3f-e053-2995a90ab88a	70722-232	HUMAN OTC DRUG	Dream Cream		Camphor, Menthol	CREAM	TOPICAL	20161005		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	.45; 5	g/100g; g/100g			N	20241231
70722-246_b7b52a91-8d01-1a5c-e053-2995a90a3048	70722-246	HUMAN OTC DRUG	Magical Muscle Oil		Camphor, Menthol	OIL	TOPICAL	20160926		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	1.95; 3.75	g/100g; g/100g			N	20241231
70722-246_b7b52a91-8d04-1a5c-e053-2995a90a3048	70722-246	HUMAN OTC DRUG	Magical Muscle Oil		Camphor, Menthol	OIL	TOPICAL	20160927		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL); MENTHOL	1.95; 3.75	g/100g; g/100g			N	20241231
70722-260_b7b4fa51-fe6a-0c2a-e053-2995a90af780	70722-260	HUMAN OTC DRUG	Crampy Belly Rub		Camphor	OIL	TOPICAL	20160928		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL)	1.1	g/100g			N	20241231
70722-260_b7b586eb-be25-366a-e053-2a95a90a33ba	70722-260	HUMAN OTC DRUG	Crampy Belly Rub		Camphor	OIL	TOPICAL	20160928		OTC MONOGRAPH NOT FINAL	part348	Little Moon Essentials	CAMPHOR (NATURAL)	1.1	g/100g			N	20241231
70722-319_b7b58066-6356-0897-e053-2a95a90a68b4	70722-319	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	Little Moon Essentials	ALCOHOL	65	mL/100mL			N	20241231
70726-0304_0dff9f29-3548-afd6-e063-6294a90a9598	70726-0304	HUMAN PRESCRIPTION DRUG	TIGLUTIK		Riluzole	LIQUID	ORAL	20240101		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		EDW PHARMA, INC	RILUZOLE	50	mg/10mL	Benzothiazole [EPC], Benzothiazoles [CS]		N	20251231
70727-497_463edfde-9a0c-4281-a84f-15991f8a9ad0	70727-497	HUMAN PRESCRIPTION DRUG	Rhopressa		netarsudil	SOLUTION/ DROPS	OPHTHALMIC; TOPICAL	20171218		NDA	NDA208254	Alcon Laboratories, Inc.	NETARSUDIL MESYLATE	.2	mg/mL	Rho Kinase Inhibitor [EPC], Rho Kinase Inhibitors [MoA]		N	20241231
70727-529_7721cbf6-4cea-43c5-9b70-80411961a970	70727-529	HUMAN PRESCRIPTION DRUG	Rocklatan		netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%	SOLUTION/ DROPS	OPHTHALMIC; TOPICAL	20190312		NDA	NDA208259	Alcon Laboratories, Inc.	LATANOPROST; NETARSUDIL MESYLATE	.05; .2	mg/mL; mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS], Rho Kinase Inhibitor [EPC], Rho Kinase Inhibitors [MoA]		N	20241231
70729-001_62ddc12d-7480-4db8-a784-e2e1503fad2b	70729-001	HUMAN OTC DRUG	Acetaminophen Caplets		Acetaminophen	TABLET	ORAL	20170501		OTC MONOGRAPH NOT FINAL	part343	Breeden Brothers, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70729-002_e7bbd188-5e3e-4f1c-96d8-53f6de4b3120	70729-002	HUMAN OTC DRUG	Dye Free Ibuprofen		Ibuprofen	TABLET	ORAL	19990301		ANDA	ANDA075139	Breeden Brothers, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70729-175_62ddc12d-7480-4db8-a784-e2e1503fad2b	70729-175	HUMAN OTC DRUG	Acetaminophen Caplets		Acetaminophen	TABLET	ORAL	20170501		OTC MONOGRAPH NOT FINAL	part343	Breeden Brothers, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
70729-291_ddc06a6b-1e57-4d1b-83fe-28c4d68c4c8c	70729-291	HUMAN OTC DRUG	Ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	19880524		ANDA	ANDA075010	Breeden Brothers, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70741-003_26e3e44a-d064-4234-9563-f6e400df24a8	70741-003	HUMAN OTC DRUG	Mist		Alcohol	SPRAY	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	62	mL/100mL			N	20241231
70741-003_4e2103a0-f0ca-437e-bea8-a7dd9c4c1dd2	70741-003	HUMAN OTC DRUG	Mist		Alcohol	SPRAY	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	62	mL/100mL			N	20241231
70741-003_8fdae4fc-f36c-4b00-8274-a432fc7d950b	70741-003	HUMAN OTC DRUG	Mist		Alcohol	SPRAY	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	62	mL/100mL			N	20241231
70741-003_9f7fd2de-161d-4f9f-852c-451906983d16	70741-003	HUMAN OTC DRUG	Mist		Alcohol	SPRAY	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	62	mL/100mL			N	20241231
70741-003_f34541cf-7420-4a88-9c7a-5c6570a2a37d	70741-003	HUMAN OTC DRUG	Mist		Alcohol	SPRAY	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	62	mL/100mL			N	20241231
70741-003_f3ce414c-6395-486b-88a1-49dffe65acbb	70741-003	HUMAN OTC DRUG	Mist		Alcohol	SPRAY	TOPICAL	20160824		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	62	mL/100mL			N	20241231
70741-006_01293e18-9f77-4252-813b-1ec1184c5829	70741-006	HUMAN OTC DRUG	Hand		Lotion	LOTION	TOPICAL	20160831		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-006_6116a837-5624-40df-bba4-3d407b1731e3	70741-006	HUMAN OTC DRUG	Hand		Lotion	LOTION	TOPICAL	20160914		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-006_8630e4b9-226a-4e8e-8456-4ceab4567678	70741-006	HUMAN OTC DRUG	Hand		Lotion	LOTION	TOPICAL	20160914		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-006_9cc87965-f4d0-4baf-81a9-3cf7a4344ed0	70741-006	HUMAN OTC DRUG	Hand		Lotion	LOTION	TOPICAL	20160914		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-006_dd33199c-0804-4970-b7f4-dcbc37e8a6f6	70741-006	HUMAN OTC DRUG	Hand		Lotion	LOTION	TOPICAL	20160831		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-006_eea0dcab-4cac-400b-abda-325d39a7da89	70741-006	HUMAN OTC DRUG	Hand		Lotion	LOTION	TOPICAL	20160914		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-007_0791bf11-8f57-4897-86a7-c23c63a51422	70741-007	HUMAN OTC DRUG	Hand Recovery		Alcohol	LOTION	TOPICAL	20170106		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-007_248d94a8-4339-4178-bee2-d25764d19f7a	70741-007	HUMAN OTC DRUG	Hand Recovery		Alcohol	LOTION	TOPICAL	20170106		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-007_2eda5e3b-4207-41d4-b155-1bc95be65d00	70741-007	HUMAN OTC DRUG	Hand Recovery		Alcohol	LOTION	TOPICAL	20170106		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-007_38b92418-d5d4-492d-a5f2-c9b0b0ae688b	70741-007	HUMAN OTC DRUG	Hand Recovery		Alcohol	LOTION	TOPICAL	20170106		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-007_7c162c54-d500-49bf-8c7e-ee0a9ba06bf6	70741-007	HUMAN OTC DRUG	Hand Recovery		Alcohol	LOTION	TOPICAL	20170106		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-007_d0104888-4304-4a8c-a181-8a52b4dd13b9	70741-007	HUMAN OTC DRUG	Hand Recovery		Alcohol	LOTION	TOPICAL	20170106		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-012_146c3f64-f518-4788-80da-5641b20da483	70741-012	HUMAN OTC DRUG	Hand Relief		Lotion	LOTION	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-012_182f217f-dec1-4573-a387-b01ee10ddc12	70741-012	HUMAN OTC DRUG	Hand Relief		Lotion	LOTION	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-012_38e1bcfb-646b-4e5b-8273-3a45cbec7f87	70741-012	HUMAN OTC DRUG	Hand Relief		Lotion	LOTION	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-012_3d60a453-5668-4693-b0aa-e2fc6b97275f	70741-012	HUMAN OTC DRUG	Hand Relief		Lotion	LOTION	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-012_8662d5ec-a661-431b-b691-bd0982c43845	70741-012	HUMAN OTC DRUG	Hand Relief		Lotion	LOTION	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70741-012_d381052e-f323-4b93-a0b1-df7243f786b7	70741-012	HUMAN OTC DRUG	Hand Relief		Lotion	LOTION	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part333A	Derma Glove	ALCOHOL	70	mL/100mL			N	20241231
70742-180_09d769cf-cc3d-9fd3-e063-6394a90ac18e	70742-180	HUMAN OTC DRUG	HIGHER CONTROL Male Climax Control Lubricating		BENZOCAINE	GEL	TOPICAL	20180301		OTC MONOGRAPH DRUG	M017	Product Max Group Inc	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70742-282_09d7805e-6565-5fa8-e063-6294a90ac4bb	70742-282	HUMAN OTC DRUG	BODY ACTION PRODUCTS Climax Control Gel		BENZOCAINE	GEL	TOPICAL	20220429		OTC MONOGRAPH DRUG	M017	PRODUCT MAX GROUP INC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70742-284_09d78829-c1fe-59e1-e063-6294a90a4818	70742-284	HUMAN OTC DRUG	BODY ACTION PRODUCTS Endless Love for Men		BENZOCAINE	GEL	TOPICAL	20220429		OTC MONOGRAPH DRUG	M017	PRODUCT MAX GROUP INC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70742-286_09d78ab6-7257-6e40-e063-6294a90aef3e	70742-286	HUMAN OTC DRUG	BODY ACTION PRODUCTS Butt Eze Benzocaine		BENZOCAINE	GEL	TOPICAL	20220429		OTC MONOGRAPH DRUG	M015	PRODUCT MAX GROUP INC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70742-287_0974579b-6f75-6b47-e063-6294a90a0217	70742-287	HUMAN OTC DRUG	BODY ACTION PRODUCTS Anal Glide Extra		BENZOCAINE	GEL	TOPICAL	20220429		OTC MONOGRAPH DRUG	M015	PRODUCT MAX GROUP INC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70742-288_09d769cf-cc49-9fd3-e063-6394a90ac18e	70742-288	HUMAN OTC DRUG	BODY ACTION PRODUCTS Prolong Lubricating		BENZOCAINE	GEL	TOPICAL	20220429		OTC MONOGRAPH DRUG	M015	PRODUCT MAX GROUP INC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70742-292_09d78f85-d8e2-c97e-e063-6394a90a1c62	70742-292	HUMAN OTC DRUG	BODY ACTION PRODUCTS Higher Control Male Climax		BENZOCAINE	GEL	TOPICAL	20220429		OTC MONOGRAPH DRUG	M017	PRODUCT MAX GROUP INC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70742-360_09d78829-c20a-59e1-e063-6294a90a4818	70742-360	HUMAN OTC DRUG	Endless Love For Men		BENZOCAINE	GEL	TOPICAL	20171118		OTC MONOGRAPH DRUG	M017	Body Action Products, Inc	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70748-127_5f079949-4bdb-4c58-9608-31d9599f9a0b	70748-127	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA211862	Lupin Pharmaceuticals, Inc.	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
70748-128_5f079949-4bdb-4c58-9608-31d9599f9a0b	70748-128	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20240101		ANDA	ANDA211862	Lupin Pharmaceuticals, Inc.	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
70748-129_94bf71d8-81f1-4285-b2c0-364434bccc26	70748-129	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET, FILM COATED	ORAL	20200831		ANDA	ANDA211863	Lupin Pharmaceuticals, Inc.	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
70748-130_94bf71d8-81f1-4285-b2c0-364434bccc26	70748-130	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET, FILM COATED	ORAL	20200831		ANDA	ANDA211863	Lupin Pharmaceuticals, Inc.	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
70748-132_08817988-0d22-45f4-ae7a-af3a13bd47c3	70748-132	HUMAN PRESCRIPTION DRUG	SILDENAFIL		Sildenafil	TABLET, FILM COATED	ORAL	20190927	20240131	ANDA	ANDA212051	Lupin Pharmaceuticals, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
70748-133_08817988-0d22-45f4-ae7a-af3a13bd47c3	70748-133	HUMAN PRESCRIPTION DRUG	SILDENAFIL		Sildenafil	TABLET, FILM COATED	ORAL	20190927	20240131	ANDA	ANDA212051	Lupin Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
70748-153_99f3ca78-1663-47a1-9ed3-9c4eaa9f0271	70748-153	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	TABLET	ORAL	20210301		ANDA	ANDA212933	Lupin Pharmaceuticals, Inc.	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
70748-173_93a7ebf0-308a-4136-9501-3e63db37fc9c	70748-173	HUMAN PRESCRIPTION DRUG	Sevelamer hydrochloride		Sevelamer hydrochloride	TABLET	ORAL	20220225		ANDA	ANDA213145	Lupin Pharmaceuticals, Inc.	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70748-175_72398273-f1d5-451c-bd47-8ae85523f678	70748-175	HUMAN PRESCRIPTION DRUG	Arformoterol tartrate		Arformoterol tartrate	SOLUTION	RESPIRATORY (INHALATION)	20220727		ANDA	ANDA213068	Lupin Pharmaceuticals, Inc.	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70748-186_e34f18c0-ea7e-4fe9-a3cf-7e90017dba8b	70748-186	HUMAN PRESCRIPTION DRUG	MYCOPHENOLATE MOFETIL		mycophenolate mofetil	CAPSULE	ORAL	20191001	20250731	ANDA	ANDA210181	Lupin Pharmaceuticals, Inc.	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	
70748-214_7beebbf9-55b3-4f69-84c1-77480aaac46f	70748-214	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20200518	20250831	NDA AUTHORIZED GENERIC	NDA022301	Lupin Pharmaceuticals, Inc.	MESALAMINE	375	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	
70748-215_14b665df-829b-40b0-b381-1f19da5f0bde	70748-215	HUMAN PRESCRIPTION DRUG	NAPROXEN AND ESOMEPRAZOLE MAGNESIUM		NAPROXEN AND ESOMEPRAZOLE MAGNESIUM	TABLET, DELAYED RELEASE	ORAL	20200304	20240930	NDA AUTHORIZED GENERIC	NDA022511	Lupin Pharmaceuticals, Inc.	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 375	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
70748-258_f8811169-b9a7-4457-9b8d-0bb9ef93567d	70748-258	HUMAN PRESCRIPTION DRUG	POSACONAZOLE		POSACONAZOLE	TABLET, DELAYED RELEASE	ORAL	20210217		ANDA	ANDA213454	Lupin Pharmaceuticals, Inc.	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70748-261_7f2aa48f-af91-45e6-bc58-659eebd6138d	70748-261	HUMAN PRESCRIPTION DRUG	formoterol fumarate		formoterol fumarate	SOLUTION	RESPIRATORY (INHALATION)	20221128		ANDA	ANDA215053	Lupin Pharmaceuticals, Inc.	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70748-262_25edd212-97e5-4440-b79f-bfe48ab848c8	70748-262	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	TABLET	ORAL	20201221	20240331	ANDA	ANDA212087	Lupin Pharmaceuticals, Inc.	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	
70748-299_26a9360d-7db4-42fe-b9d2-ecddfe369d2e	70748-299	HUMAN PRESCRIPTION DRUG	ATOVAQUONE		ATOVAQUONE	SUSPENSION	ORAL	20210601		ANDA	ANDA210692	Lupin Pharmaceuticals, Inc.	ATOVAQUONE	750	mg/5mL	Antimalarial [EPC], Antiprotozoal [EPC]		N	20241231
70748-312_d0532dfa-e690-464f-be38-fce09adce154	70748-312	HUMAN PRESCRIPTION DRUG	Ibuprofen and Famotidine		Ibuprofen and Famotidine	TABLET, COATED	ORAL	20210914		NDA AUTHORIZED GENERIC	NDA022519	Lupin Pharmaceuticals, Inc.	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70748-335_4e722eb3-94e1-4855-b1ba-1e7eca5b292d	70748-335	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20221205	20240524	NDA AUTHORIZED GENERIC	NDA204623	Lupin Pharmaceuticals, Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70748-347_9428e78d-6196-49dc-a26c-031a38a5e153	70748-347	HUMAN PRESCRIPTION DRUG	THIAMINE HYDROCHLORIDE		THIAMINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230615		ANDA	ANDA215692	Lupin Pharmaceuticals, Inc.	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
70748-348_25a3b2f8-28e2-48fb-a9f6-50491f785eb0	70748-348	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20231023		ANDA	ANDA216234	Lupin Pharmaceuticals, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70748-349_25a3b2f8-28e2-48fb-a9f6-50491f785eb0	70748-349	HUMAN PRESCRIPTION DRUG	ROCURONIUM BROMIDE		ROCURONIUM BROMIDE	INJECTION, SOLUTION	INTRAVENOUS	20231023		ANDA	ANDA216234	Lupin Pharmaceuticals, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
70752-101_4a366894-b884-43f2-adc4-7ff0bfe260b9	70752-101	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	SOLUTION	ORAL	20190919		ANDA	ANDA212423	QUAGEN PHARMACEUTICALS LLC	CYPROHEPTADINE HYDROCHLORIDE	2	mg/5mL			N	20241231
70752-102_577f5263-a4fc-4e2b-8ccb-1c008138863c	70752-102	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	SYRUP	ORAL	20190906		ANDA	ANDA212197	QUAGEN PHARMACEUTICALS LLC	ALBUTEROL SULFATE	2	mg/5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70752-103_4f0e0478-595c-427d-ab15-37db872bcc72	70752-103	HUMAN OTC DRUG	CETIRIZINE HYDROCHLORIDE		CETIRIZINE HYDROCHLORIDE	SOLUTION	ORAL	20221015		ANDA	ANDA212266	QUAGEN PHARMACEUTICALS LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70752-104_4f0e0478-595c-427d-ab15-37db872bcc72	70752-104	HUMAN OTC DRUG	CETIRIZINE HYDROCHLORIDE		CETIRIZINE HYDROCHLORIDE	SOLUTION	ORAL	20221015		ANDA	ANDA212266	QUAGEN PHARMACEUTICALS LLC	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70752-107_c83adc2f-bfdf-4fa5-b95b-2a190a7fd78f	70752-107	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20210224		ANDA	ANDA212491	QUAGEN PHARMACEUTICALS LLC	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
70752-113_99e31c06-b379-4dfe-84e3-b810376bccd2	70752-113	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20210420		ANDA	ANDA212695	QUAGEN PHARMACEUTICALS LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70752-119_a0847638-e772-4074-a2b5-8069589cff02	70752-119	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	OINTMENT	TOPICAL	20201006		ANDA	ANDA213560	QUAGEN PHARMACEUTICALS LLC	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-129_d6950c0d-75d5-44aa-9a2a-30345597e9f1	70752-129	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	LOTION	TOPICAL	20200701		ANDA	ANDA213559	QUAGEN PHARMACEUTICALS LLC	TRIAMCINOLONE ACETONIDE	.25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-130_d6950c0d-75d5-44aa-9a2a-30345597e9f1	70752-130	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	LOTION	TOPICAL	20200701		ANDA	ANDA213559	QUAGEN PHARMACEUTICALS LLC	TRIAMCINOLONE ACETONIDE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-131_80b36f9d-4d27-46af-837b-70d2daec0dba	70752-131	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	SOLUTION	ORAL	20200604		ANDA	ANDA213567	QUAGEN PHARMACEUTICALS LLC	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70752-132_80b36f9d-4d27-46af-837b-70d2daec0dba	70752-132	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	SOLUTION	ORAL	20200604		ANDA	ANDA213567	QUAGEN PHARMACEUTICALS LLC	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
70752-136_16bbc411-6512-4799-a12d-12b7f3572afe	70752-136	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	SOLUTION	ORAL	20210602		ANDA	ANDA213761	QUAGEN PHARMACEUTICALS LLC	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
70752-137_16bbc411-6512-4799-a12d-12b7f3572afe	70752-137	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	SOLUTION	ORAL	20210602		ANDA	ANDA213761	QUAGEN PHARMACEUTICALS LLC	OXYCODONE HYDROCHLORIDE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
70752-138_63b61b41-3490-4c96-a50d-778498b51899	70752-138	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SOLUTION	ORAL	20210712		ANDA	ANDA213890	QUAGEN PHARMACEUTICALS LLC	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70752-139_ea7f15a6-079d-4146-a13d-74c129ec598e	70752-139	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Codeine Phosphate		Promethazine Hydrochloride and Codeine Phosphate	SOLUTION	ORAL	20201008		ANDA	ANDA214238	QUAGEN PHARMACEUTICALS LLC	CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE	10; 6.25	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]	CV	N	20241231
70752-140_169c7648-6f18-42cc-a6a9-c96a9bc16e9a	70752-140	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	PASTE	DENTAL	20230115		ANDA	ANDA214582	QUAGEN PHARMACEUTICALS LLC	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-156_90812613-ed90-4fb2-8f78-e8f8775fd75f	70752-156	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		fluocinolone acetonide	OIL	TOPICAL	20210402		ANDA	ANDA212760	Quagen Pharmaceuticals LLC	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-157_afd6b881-8495-4bba-a25e-92515aa4568a	70752-157	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	SOLUTION	ORAL	20200803		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
70752-158_bd02aa34-bd25-4a5b-8f8c-01a17d8410e3	70752-158	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		fluocinolone acetonide	OIL	TOPICAL	20210402		ANDA	ANDA212761	Quagen Pharmaceuticals LLC	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-159_c2b257ee-da2e-4af6-908a-aeb4838e698e	70752-159	HUMAN PRESCRIPTION DRUG	FLUOCINOLONE ACETONIDE		fluocinolone acetonide	OIL	AURICULAR (OTIC)	20210402		ANDA	ANDA212762	Quagen Pharmaceuticals LLC	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-161_234e0cf8-e1c9-47a2-8fa3-8a4db929c866	70752-161	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200915		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
70752-162_234e0cf8-e1c9-47a2-8fa3-8a4db929c866	70752-162	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200915		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
70752-163_234e0cf8-e1c9-47a2-8fa3-8a4db929c866	70752-163	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200915		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
70752-164_234e0cf8-e1c9-47a2-8fa3-8a4db929c866	70752-164	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200915		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
70752-165_b9516314-0ea2-46f0-9354-20bd0bb54e4a	70752-165	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200930		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	15	mg/1		CIV	N	20241231
70752-166_b9516314-0ea2-46f0-9354-20bd0bb54e4a	70752-166	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200930		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	30	mg/1		CIV	N	20241231
70752-167_b9516314-0ea2-46f0-9354-20bd0bb54e4a	70752-167	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200930		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	60	mg/1		CIV	N	20241231
70752-168_b9516314-0ea2-46f0-9354-20bd0bb54e4a	70752-168	HUMAN PRESCRIPTION DRUG	PHENOBARBITAL		PHENOBARBITAL	TABLET	ORAL	20200930		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	PHENOBARBITAL	100	mg/1		CIV	N	20241231
70752-169_f7679c3f-8095-41b8-8f9b-5e1f10b482b6	70752-169	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20220718		UNAPPROVED DRUG OTHER		QUAGEN PHARMACEUTICALS LLC	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70752-171_4a15d422-7a6a-4b92-a4cf-3632250c9580	70752-171	HUMAN PRESCRIPTION DRUG	PROPYLTHIOURACIL		PROPYLTHIOURACIL	TABLET	ORAL	20210318		ANDA	ANDA080154	QUAGEN PHARMACEUTICALS LLC	PROPYLTHIOURACIL	50	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
70752-177_13fcb9d6-8f2d-4cce-9a61-a87de3d92419	70752-177	HUMAN OTC DRUG	GUAIFENESIN and CODEINE PHOSPHATE		GUAIFENESIN and CODEINE PHOSPHATE	SOLUTION	ORAL	20220523		OTC MONOGRAPH FINAL	part341	QUAGEN PHARMACEUTICALS LLC	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
70752-180_09ec7e5f-a353-494b-981d-597276be1d4f	70752-180	HUMAN OTC DRUG	GUAIFENESIN and CODEINE PHOSPHATE		GUAIFENESIN and CODEINE PHOSPHATE	SOLUTION	ORAL	20220523		OTC MONOGRAPH FINAL	part341	QUAGEN PHARMACEUTICALS LLC	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
70752-204_03207aab-7e10-4fa8-848c-7a44368a5fd4	70752-204	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20230710		ANDA	ANDA091145	QUAGEN PHARMACEUTICALS LLC	FOLIC ACID	1	mg/1			N	20241231
70756-010_e8d87cc3-32ad-45ec-9e23-9e15d92e66b5	70756-010	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20231101		ANDA	ANDA217271	Lifestar Pharma LLC	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70756-011_88630c54-4fe3-47bb-9743-a7683a53874b	70756-011	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		chlorthalidone	TABLET	ORAL	20220805		ANDA	ANDA215587	Lifestar Pharma LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70756-013_c574860f-33a1-437b-82a8-377166a66474	70756-013	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20231205		ANDA	ANDA217970	Lifestar Pharma LLC	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70756-014_c574860f-33a1-437b-82a8-377166a66474	70756-014	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20231205		ANDA	ANDA217970	Lifestar Pharma LLC	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70756-016_c574860f-33a1-437b-82a8-377166a66474	70756-016	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20231205		ANDA	ANDA217970	Lifestar Pharma LLC	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70756-019_72239107-b805-4ca0-b0f3-3e4831bd9efe	70756-019	HUMAN PRESCRIPTION DRUG	Pantoprazole sodium delayed-release		Pantoprazole sodium delayed-release	TABLET	ORAL	20220727		ANDA	ANDA215880	Lifestar Pharma LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70756-020_88630c54-4fe3-47bb-9743-a7683a53874b	70756-020	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		chlorthalidone	TABLET	ORAL	20220805		ANDA	ANDA215587	Lifestar Pharma LLC	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70756-025_2ffb359c-7e4b-44ef-a0c7-451ac966f6b6	70756-025	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20221114		ANDA	ANDA216172	Lifestar Pharma LLC	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-049_e8d87cc3-32ad-45ec-9e23-9e15d92e66b5	70756-049	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20231101		ANDA	ANDA217271	Lifestar Pharma LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70756-050_e8d87cc3-32ad-45ec-9e23-9e15d92e66b5	70756-050	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20231101		ANDA	ANDA217271	Lifestar Pharma LLC	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70756-051_3f0b58d5-9dce-4423-af1b-feff246a1bfa	70756-051	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20231019		ANDA	ANDA075302	Lifestar Pharma LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70756-052_3f0b58d5-9dce-4423-af1b-feff246a1bfa	70756-052	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20231019		ANDA	ANDA075302	Lifestar Pharma LLC	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70756-085_f4a6e241-85f7-493a-ad95-90525076cf90	70756-085	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20220126		ANDA	ANDA215885	Lifestar Pharma LLC	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70756-201_7a7b6c33-050f-4ea4-aee4-d6e1f275ce4e	70756-201	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210223		ANDA	ANDA213999	Lifestar Pharma LLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-202_7a7b6c33-050f-4ea4-aee4-d6e1f275ce4e	70756-202	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210223		ANDA	ANDA213999	Lifestar Pharma LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-203_7a7b6c33-050f-4ea4-aee4-d6e1f275ce4e	70756-203	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210223		ANDA	ANDA213999	Lifestar Pharma LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-204_7a7b6c33-050f-4ea4-aee4-d6e1f275ce4e	70756-204	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210223		ANDA	ANDA213999	Lifestar Pharma LLC	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-205_7a7b6c33-050f-4ea4-aee4-d6e1f275ce4e	70756-205	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210223		ANDA	ANDA213999	Lifestar Pharma LLC	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-206_7a7b6c33-050f-4ea4-aee4-d6e1f275ce4e	70756-206	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210223		ANDA	ANDA213999	Lifestar Pharma LLC	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-214_2b91d291-51b0-44c0-ad9e-e5bf664590c8	70756-214	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20200910		ANDA	ANDA213864	Lifestar Pharma LLC	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
70756-215_2b91d291-51b0-44c0-ad9e-e5bf664590c8	70756-215	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20200910		ANDA	ANDA213864	Lifestar Pharma LLC	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
70756-247_96f45871-7175-49d8-8374-dfa2978d38c7	70756-247	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20240105		ANDA	ANDA217081	Lifestar Pharma LLC	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70756-248_96f45871-7175-49d8-8374-dfa2978d38c7	70756-248	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20240105		ANDA	ANDA217081	Lifestar Pharma LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70756-249_96f45871-7175-49d8-8374-dfa2978d38c7	70756-249	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20240105		ANDA	ANDA217081	Lifestar Pharma LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70756-250_96f45871-7175-49d8-8374-dfa2978d38c7	70756-250	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20240105		ANDA	ANDA217081	Lifestar Pharma LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
70756-288_f4a6e241-85f7-493a-ad95-90525076cf90	70756-288	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20220126		ANDA	ANDA215885	Lifestar Pharma LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70756-289_f4a6e241-85f7-493a-ad95-90525076cf90	70756-289	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20220126		ANDA	ANDA215885	Lifestar Pharma LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70756-291_2ffb359c-7e4b-44ef-a0c7-451ac966f6b6	70756-291	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20221114		ANDA	ANDA216172	Lifestar Pharma LLC	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-292_2ffb359c-7e4b-44ef-a0c7-451ac966f6b6	70756-292	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20221114		ANDA	ANDA216172	Lifestar Pharma LLC	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-293_2ffb359c-7e4b-44ef-a0c7-451ac966f6b6	70756-293	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20221114		ANDA	ANDA216172	Lifestar Pharma LLC	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-404_98c85803-fdee-41fa-af1a-98f05ef725d4	70756-404	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20230914		ANDA	ANDA217357	Lifestar Pharma LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
70756-405_0e501982-ad23-470b-bf7a-5af413644d25	70756-405	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200301		ANDA	ANDA211767	Lifestar Pharma LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-406_0e501982-ad23-470b-bf7a-5af413644d25	70756-406	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200301		ANDA	ANDA211767	Lifestar Pharma LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-407_0e501982-ad23-470b-bf7a-5af413644d25	70756-407	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200301		ANDA	ANDA211767	Lifestar Pharma LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-410_9add55a0-f57d-473d-9e83-ceffe099a1b1	70756-410	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230321		ANDA	ANDA217272	Lifestar Pharma LLC	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70756-411_9add55a0-f57d-473d-9e83-ceffe099a1b1	70756-411	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230321		ANDA	ANDA217272	Lifestar Pharma LLC	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70756-412_9add55a0-f57d-473d-9e83-ceffe099a1b1	70756-412	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230321		ANDA	ANDA217272	Lifestar Pharma LLC	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70756-423_333c335f-ed5e-4732-9f69-634f95c415a9	70756-423	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		Omega-3-acid ethyl esters capsules	CAPSULE, LIQUID FILLED	ORAL	20211116		ANDA	ANDA215458	Lifestar Pharma LLC	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
70756-424_4ee353f1-1a55-45c6-8142-ae7493f15ae9	70756-424	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA215710	Lifestar Pharma LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-425_4ee353f1-1a55-45c6-8142-ae7493f15ae9	70756-425	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA215710	Lifestar Pharma LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-426_4ee353f1-1a55-45c6-8142-ae7493f15ae9	70756-426	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA215710	Lifestar Pharma LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-427_4ee353f1-1a55-45c6-8142-ae7493f15ae9	70756-427	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA215710	Lifestar Pharma LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-428_4ee353f1-1a55-45c6-8142-ae7493f15ae9	70756-428	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA215710	Lifestar Pharma LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70756-429_c169af02-4ff1-45a0-8dca-2c91ea28e8ae	70756-429	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	Lifestar Pharma LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70756-430_c169af02-4ff1-45a0-8dca-2c91ea28e8ae	70756-430	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	Lifestar Pharma LLC	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70756-440_c169af02-4ff1-45a0-8dca-2c91ea28e8ae	70756-440	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	Lifestar Pharma LLC	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70756-604_aaee88c2-4961-48e7-aefb-86f1710bc60f	70756-604	HUMAN PRESCRIPTION DRUG	TOBRAMYCIN		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20230630		ANDA	ANDA214478	Lifestar Pharma LLC	TOBRAMYCIN	300	mg/5mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70756-605_17742043-6cd0-4437-98d8-5385ad302190	70756-605	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220616		ANDA	ANDA214653	Lifestar Pharma LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70756-606_17742043-6cd0-4437-98d8-5385ad302190	70756-606	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20220616		ANDA	ANDA214653	Lifestar Pharma LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70756-607_66cf1093-a724-4802-aa04-1c50b8a96c7e	70756-607	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20221207		ANDA	ANDA215886	Lifestar Pharma LLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70756-608_c3ca515e-71b9-44d6-ab30-8910e4ba69b6	70756-608	HUMAN PRESCRIPTION DRUG	Formoterol fumarate		Formoterol fumarate dihydrate	SOLUTION	RESPIRATORY (INHALATION)	20230322		ANDA	ANDA215883	Lifestar Pharma LLC	FORMOTEROL FUMARATE	20	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70756-609_7556cd96-134e-4aaa-bf2d-7b6f9c8133c9	70756-609	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin otic	SOLUTION	AURICULAR (OTIC)	20220715		ANDA	ANDA216130	Lifestar Pharma LLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70756-610_7556cd96-134e-4aaa-bf2d-7b6f9c8133c9	70756-610	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin otic	SOLUTION	AURICULAR (OTIC)	20220715		ANDA	ANDA216130	Lifestar Pharma LLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70756-611_abbedc8b-c9b5-4049-a31b-dbffb73c6556	70756-611	HUMAN PRESCRIPTION DRUG	Ephedrine sulfate		Ephedrine sulfate	INJECTION	INTRAVENOUS	20220415		ANDA	ANDA216129	Lifestar Pharma LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
70756-612_39904805-c87b-4b60-bb3e-2c63423f1cf3	70756-612	HUMAN PRESCRIPTION DRUG	arformoterol tartrate		arformoterol tartrate	SOLUTION	RESPIRATORY (INHALATION)	20221115		ANDA	ANDA216128	Lifestar Pharma LLC	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
70756-613_3e2c0166-09fa-449e-8cda-2240a841e1df	70756-613	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230202		ANDA	ANDA216127	Lifestar Pharma LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
70756-614_142b8516-38b4-4b3b-938a-39ca65c17bdc	70756-614	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20230118		ANDA	ANDA216496	Lifestar Pharma LLC	PHENYLEPHRINE HYDROCHLORIDE	100	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70756-615_74a4c0d9-515d-4e88-bae5-045ea55940ae	70756-615	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20230523		ANDA	ANDA216730	Lifestar Pharma LLC	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70756-616_74a4c0d9-515d-4e88-bae5-045ea55940ae	70756-616	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20230523		ANDA	ANDA216730	Lifestar Pharma LLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70756-617_e9af1897-30d0-4886-8e50-593b317c6001	70756-617	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	RESPIRATORY (INHALATION)	20220923		ANDA	ANDA216725	Lifestar Pharma LLC	TOBRAMYCIN	300	mg/4mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
70756-618_d4f07f52-c316-401b-b852-a1b29e3570b8	70756-618	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20221217		ANDA	ANDA216860	Lifestar Pharma LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70756-619_d4f07f52-c316-401b-b852-a1b29e3570b8	70756-619	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20221217		ANDA	ANDA216860	Lifestar Pharma LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70756-620_d4f07f52-c316-401b-b852-a1b29e3570b8	70756-620	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20221217		ANDA	ANDA216860	Lifestar Pharma LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70756-621_3332dd2d-6f93-464d-b13e-f72c5496cd9d	70756-621	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20220831		ANDA	ANDA217069	Lifestar Pharma LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70756-622_3332dd2d-6f93-464d-b13e-f72c5496cd9d	70756-622	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20220831		ANDA	ANDA217069	Lifestar Pharma LLC	PHENYLEPHRINE HYDROCHLORIDE	50	mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70756-623_3332dd2d-6f93-464d-b13e-f72c5496cd9d	70756-623	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20220831		ANDA	ANDA217069	Lifestar Pharma LLC	PHENYLEPHRINE HYDROCHLORIDE	100	mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70756-624_74a4c0d9-515d-4e88-bae5-045ea55940ae	70756-624	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20230523		ANDA	ANDA216730	Lifestar Pharma LLC	HALOPERIDOL DECANOATE	250	mg/5mL	Typical Antipsychotic [EPC]		N	20241231
70756-625_74a4c0d9-515d-4e88-bae5-045ea55940ae	70756-625	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20230523		ANDA	ANDA216730	Lifestar Pharma LLC	HALOPERIDOL DECANOATE	500	mg/5mL	Typical Antipsychotic [EPC]		N	20241231
70756-629_360ee544-f038-48b7-aab1-b1eb5f92463e	70756-629	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20221007		ANDA	ANDA216859	Lifestar Pharma LLC	PHENYLEPHRINE HYDROCHLORIDE	25	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70756-631_ee29d8b0-65b1-4822-9a08-3ec4b2b92198	70756-631	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230228		ANDA	ANDA217354	Lifestar Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70756-632_ee29d8b0-65b1-4822-9a08-3ec4b2b92198	70756-632	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230228		ANDA	ANDA217354	Lifestar Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70756-633_ee29d8b0-65b1-4822-9a08-3ec4b2b92198	70756-633	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230228		ANDA	ANDA217354	Lifestar Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70756-634_ee29d8b0-65b1-4822-9a08-3ec4b2b92198	70756-634	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230228		ANDA	ANDA217354	Lifestar Pharma LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70756-640_2e3fe36c-63f5-4fdf-8446-add2b8ef53d1	70756-640	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20230616		ANDA	ANDA217692	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-641_2e3fe36c-63f5-4fdf-8446-add2b8ef53d1	70756-641	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20230616		ANDA	ANDA217692	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-642_2e3fe36c-63f5-4fdf-8446-add2b8ef53d1	70756-642	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20230616		ANDA	ANDA217692	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-643_2e3fe36c-63f5-4fdf-8446-add2b8ef53d1	70756-643	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20230616		ANDA	ANDA217692	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-644_fcfc14a5-3c88-4426-8028-9368a254c203	70756-644	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20230914		ANDA	ANDA217693	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-645_fcfc14a5-3c88-4426-8028-9368a254c203	70756-645	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20230914		ANDA	ANDA217693	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-646_fcfc14a5-3c88-4426-8028-9368a254c203	70756-646	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20230914		ANDA	ANDA217693	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-647_fcfc14a5-3c88-4426-8028-9368a254c203	70756-647	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20230914		ANDA	ANDA217693	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-648_fcfc14a5-3c88-4426-8028-9368a254c203	70756-648	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20230914		ANDA	ANDA217693	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-649_360ee544-f038-48b7-aab1-b1eb5f92463e	70756-649	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20230315		ANDA	ANDA216859	Lifestar Pharma LLC	PHENYLEPHRINE HYDROCHLORIDE	25	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70756-650_66cf1093-a724-4802-aa04-1c50b8a96c7e	70756-650	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20230825		ANDA	ANDA215886	Lifestar Pharma LLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
70756-651_8779740c-ae77-4563-a355-89082be1dfd2	70756-651	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20240108		ANDA	ANDA218148	Lifestar Pharma LLC	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
70756-652_8779740c-ae77-4563-a355-89082be1dfd2	70756-652	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20240108		ANDA	ANDA218148	Lifestar Pharma LLC	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
70756-653_8779740c-ae77-4563-a355-89082be1dfd2	70756-653	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20240108		ANDA	ANDA218148	Lifestar Pharma LLC	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
70756-654_c1bf2590-7a5a-4213-909c-d843fdb72e08	70756-654	HUMAN PRESCRIPTION DRUG	timolol maleate		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20230626		ANDA	ANDA078771	Lifestar Pharma LLC	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-655_c1bf2590-7a5a-4213-909c-d843fdb72e08	70756-655	HUMAN PRESCRIPTION DRUG	timolol maleate		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20230626		ANDA	ANDA078771	Lifestar Pharma LLC	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-656_c1bf2590-7a5a-4213-909c-d843fdb72e08	70756-656	HUMAN PRESCRIPTION DRUG	timolol maleate		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20230626		ANDA	ANDA078771	Lifestar Pharma LLC	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-657_c1bf2590-7a5a-4213-909c-d843fdb72e08	70756-657	HUMAN PRESCRIPTION DRUG	timolol maleate		timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20230626		ANDA	ANDA078771	Lifestar Pharma LLC	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70756-666_fcfc14a5-3c88-4426-8028-9368a254c203	70756-666	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20231024		ANDA	ANDA217693	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-667_fcfc14a5-3c88-4426-8028-9368a254c203	70756-667	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20231024		ANDA	ANDA217693	Lifestar Pharma LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70756-701_c75cad2b-7d39-4c74-85ff-bff9f1f47a60	70756-701	HUMAN PRESCRIPTION DRUG	Alosetron		Alosetron	TABLET	ORAL	20200914		ANDA	ANDA213614	Lifestar Pharma LLC	ALOSETRON HYDROCHLORIDE	1	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70756-702_c75cad2b-7d39-4c74-85ff-bff9f1f47a60	70756-702	HUMAN PRESCRIPTION DRUG	Alosetron		Alosetron	TABLET	ORAL	20200914		ANDA	ANDA213614	Lifestar Pharma LLC	ALOSETRON HYDROCHLORIDE	.5	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
70756-703_55bd8080-2404-4c43-b01e-5853db93e5b1	70756-703	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200401		ANDA	ANDA212284	Lifestar Pharma LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70756-704_55bd8080-2404-4c43-b01e-5853db93e5b1	70756-704	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200401		ANDA	ANDA212284	Lifestar Pharma LLC	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70756-720_f0a12ae8-841c-4306-8d04-89993e4fc8f8	70756-720	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20201113		ANDA	ANDA214282	Lifestar Pharma LLC	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70756-721_f0a12ae8-841c-4306-8d04-89993e4fc8f8	70756-721	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20201113		ANDA	ANDA214282	Lifestar Pharma LLC	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70756-806_dab4135b-99b4-bb07-e053-2a95a90aae5d	70756-806	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180604		ANDA	ANDA205868	Lifestar Pharma LLC.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70756-807_dab4135b-99b4-bb07-e053-2a95a90aae5d	70756-807	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180604		ANDA	ANDA205868	Lifestar Pharma LLC.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70756-808_0cd7459c-f9d1-03cd-e063-6294a90a67bd	70756-808	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		OLMESARTAN MEDOXOMIL	TABLET	ORAL	20200501		ANDA	ANDA207135	Lifestar Pharma LLC	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70756-809_0cd7459c-f9d1-03cd-e063-6294a90a67bd	70756-809	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		OLMESARTAN MEDOXOMIL	TABLET	ORAL	20200501		ANDA	ANDA207135	Lifestar Pharma LLC	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70756-810_0cd7459c-f9d1-03cd-e063-6294a90a67bd	70756-810	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		OLMESARTAN MEDOXOMIL	TABLET	ORAL	20200501		ANDA	ANDA207135	Lifestar Pharma LLC	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70756-812_0cd75356-2c04-032e-e063-6394a90a13df	70756-812	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20201001		ANDA	ANDA208847	Lifestar Pharma LLC	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70756-813_0cd75356-2c04-032e-e063-6394a90a13df	70756-813	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20201001		ANDA	ANDA208847	Lifestar Pharma LLC	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70756-814_0cd75356-2c04-032e-e063-6394a90a13df	70756-814	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20201001		ANDA	ANDA208847	Lifestar Pharma LLC	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	25; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70756-815_4132123f-cf23-4361-ac1e-80771b1d7d85	70756-815	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20200901		ANDA	ANDA211724	Lifestar Pharma LLC	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70756-816_4132123f-cf23-4361-ac1e-80771b1d7d85	70756-816	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20200901		ANDA	ANDA211724	Lifestar Pharma LLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70764-102_05f62aec-cb95-4725-e063-6294a90a455e	70764-102	HUMAN OTC DRUG	SALICYLIC WASH		SALICYLIC ACID	LOTION	TOPICAL	20160609		OTC MONOGRAPH FINAL	part333D	CONTROL CORRECTIVE SKINCARE INC	SALICYLIC ACID	2	g/100mL			N	20241231
70764-103_05f62d61-d2d9-d8b2-e063-6294a90a6fd9	70764-103	HUMAN OTC DRUG	SULFUR CALMING MASK		SULFUR	CREAM	TOPICAL	20180911		OTC MONOGRAPH FINAL	part333D	CONTROL CORRECTIVE SKINCARE INC	SULFUR	10	g/100g			N	20241231
70764-104_05f5f522-ee62-6969-e063-6394a90a85d3	70764-104	HUMAN OTC DRUG	EXFO TONIC ACNE TREATMENT		SALICYLIC ACID	SOLUTION	TOPICAL	20160609		OTC MONOGRAPH FINAL	part333D	CONTROL CORRECTIVE SKINCARE INC	SALICYLIC ACID	2	g/100mL			N	20241231
70764-105_05f5e6e7-75c9-9b39-e063-6394a90ad79e	70764-105	HUMAN OTC DRUG	ACNE SPOT TREATMENT		SALICYLIC ACID	GEL	TOPICAL	20160609		OTC MONOGRAPH FINAL	part333D	CONTROL CORRECTIVE SKINCARE INC	SALICYLIC ACID	2	g/100mL			N	20241231
70764-106_05f61243-bd15-b321-e063-6294a90a5f9d	70764-106	HUMAN OTC DRUG	CLEAR MED	5%	BENZOYL PEROXIDE	LOTION	TOPICAL	20160609		OTC MONOGRAPH FINAL	M006	CONTROL CORRECTIVE SKINCARE INC	BENZOYL PEROXIDE	5	g/100mL			N	20241231
70764-107_05f61380-18b0-dc21-e063-6294a90adc73	70764-107	HUMAN OTC DRUG	CLEAR MED	10%	BENZOYL PEROXIDE	LOTION	TOPICAL	20160609		OTC MONOGRAPH FINAL	M006	CONTROL CORRECTIVE SKINCARE INC	BENZOYL PEROXIDE	10	g/100mL			N	20241231
70764-201_05f60b1c-0459-b259-e063-6294a90a7420	70764-201	HUMAN OTC DRUG	BOTANICAL SOOTHING	SPF-30	OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20160608		OTC MONOGRAPH FINAL	part352	CONTROL CORRECTIVE SKINCARE INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	6.9; 3; 4	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70764-204_05f5e6fd-f567-9e5d-e063-6394a90a176e	70764-204	HUMAN OTC DRUG	CONTROL CORRECTIVE SUNSCREEN	SPF-30	OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20180911		OTC MONOGRAPH FINAL	part352	CONTROL CORRECTIVE SKINCARE INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	6.9; 3; 4	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70764-205_05f609b5-8cfd-9b7b-e063-6394a90ad8ba	70764-205	HUMAN OTC DRUG	CONTROL CORRECTIVE INTENSIVE SKIN BRIGHTENING	SPF-30 SUNSCREEN	OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20180911		OTC MONOGRAPH FINAL	part352	CONTROL CORRECTIVE SKINCARE INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	6.9; 3; 4	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70764-206_05f61380-18bb-dc21-e063-6294a90adc73	70764-206	HUMAN OTC DRUG	CONTROL CORRECTIVE TINTED MOISTURIZER	SPF-30 SUNSCREEN	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20180911		OTC MONOGRAPH FINAL	part352	CONTROL CORRECTIVE SKINCARE INC	TITANIUM DIOXIDE; ZINC OXIDE	2.5; 6	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70764-208_05f5f522-ee55-6969-e063-6394a90a85d3	70764-208	HUMAN OTC DRUG	AROMA MATTE DAY	SUNSCREEN SPF-30	OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20180911		OTC MONOGRAPH FINAL	M020	CONTROL CORRECTIVE SKINCARE INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	6.9; 3; 4	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70766-001_0bf9a782-c0dc-85bf-e063-6294a90af815	70766-001	HUMAN OTC DRUG	Amerfresh		Sodium Fluoride	PASTE	DENTAL	20160301		OTC MONOGRAPH DRUG	M021	Yangzhou SION Commodity Co.,Ltd	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
70766-002_0bf9dc10-06e0-0ebc-e063-6294a90a734a	70766-002	HUMAN OTC DRUG	Amerfresh		Sodium Fluoride	PASTE	DENTAL	20160301		OTC MONOGRAPH DRUG	M021	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.22	g/100g			N	20241231
70766-003_0bf9c0df-767a-3060-e063-6394a90a16c7	70766-003	HUMAN OTC DRUG	Amerfresh		Sodium Fluoride	PASTE	TOPICAL	20160301		OTC MONOGRAPH DRUG	M021	Yangzhou SION Commodity Co.,Ltd	SODIUM MONOFLUOROPHOSPHATE	.22	g/100g			N	20241231
70766-004_f6fc76b5-723e-f9e3-e053-6394a90a184d	70766-004	HUMAN OTC DRUG	Amerfresh Tooth		Sodium Fluoride	POWDER	DENTAL	20180420		OTC MONOGRAPH NOT FINAL	part356	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.1	g/100g			N	20241231
70766-006_0bf9dc10-06df-0ebc-e063-6294a90a734a	70766-006	HUMAN OTC DRUG	MintBlast Cool Mint Flavor Anti Cavity Fluoride Tooth		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20201212		OTC MONOGRAPH DRUG	M021	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.15	g/100g			N	20241231
70766-007_0bf9c776-5752-3f39-e063-6394a90a6d5c	70766-007	HUMAN OTC DRUG	AdoptaPlatoon		Sodium Fluoride	PASTE, DENTIFRICE	TOPICAL	20220228		OTC MONOGRAPH DRUG	M021	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.1	g/100g			N	20241231
70766-008_f427f7be-6082-1f31-e053-2995a90ab6f5	70766-008	HUMAN OTC DRUG	AMERFRESH FLUORIDE gel		Sodium Fluoride	PASTE, DENTIFRICE	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part356	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.1	g/100g			N	20241231
70766-009_f428073f-6415-4923-e053-2a95a90a6483	70766-009	HUMAN OTC DRUG	AMERFRESH FLUORIDE		Sodium Fluoride	PASTE, DENTIFRICE	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part356	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.1	g/100g			N	20241231
70766-010_0bf9163b-29af-ac40-e063-6394a90a1649	70766-010	HUMAN OTC DRUG	Oral Fusion Anticavity		Sodium Fluoride	PASTE, DENTIFRICE	TOPICAL	20220428		OTC MONOGRAPH DRUG	M021	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.11	g/100g			N	20241231
70766-011_0bf9c776-573c-3f39-e063-6394a90a6d5c	70766-011	HUMAN OTC DRUG	Mint Fluoride Tooth		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20221113		OTC MONOGRAPH DRUG	M021	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.11	g/100g			N	20241231
70766-012_0e54f80c-ff8a-726a-e063-6294a90abba4	70766-012	HUMAN OTC DRUG	Plak Smacker Great White Shark Cool Berry Flavor Anti Cavity Fluoride Gel Tooth		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20240104		OTC MONOGRAPH DRUG	M005	Yangzhou SION Commodity Co.,Ltd	SODIUM FLUORIDE	.1	g/100g			N	20251231
70769-101_05f421d7-ff98-881c-e063-6394a90a4e99	70769-101	HUMAN OTC DRUG	CaineTips		BENZOCAINE	LIQUID	ORAL	20160606		OTC MONOGRAPH NOT FINAL	part348	J MORITA USA INC	BENZOCAINE	20	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
70771-1004_ef9d653e-f1bd-4781-b5f2-f8d68b7a6722	70771-1004	HUMAN PRESCRIPTION DRUG	indomethacin		indomethacin	CAPSULE	ORAL	20160721		ANDA	ANDA090403	Zydus Lifesciences Limited	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1005_ef9d653e-f1bd-4781-b5f2-f8d68b7a6722	70771-1005	HUMAN PRESCRIPTION DRUG	indomethacin		indomethacin	CAPSULE	ORAL	20160721		ANDA	ANDA090403	Zydus Lifesciences Limited	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1006_34ebea3c-dc3e-463e-a0dc-1e937babf554	70771-1006	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Lifesciences Limited	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1007_34ebea3c-dc3e-463e-a0dc-1e937babf554	70771-1007	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Lifesciences Limited	DOXYCYCLINE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1008_34ebea3c-dc3e-463e-a0dc-1e937babf554	70771-1008	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Lifesciences Limited	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1009_34ebea3c-dc3e-463e-a0dc-1e937babf554	70771-1009	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Zydus Lifesciences Limited	DOXYCYCLINE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1010_28263c9d-627b-4c94-a9d1-35e53be4217f	70771-1010	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209668	Zydus Lifesciences Limited	TERIFLUNOMIDE	7	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70771-1011_28263c9d-627b-4c94-a9d1-35e53be4217f	70771-1011	HUMAN PRESCRIPTION DRUG	Teriflunomide		Teriflunomide	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA209668	Zydus Lifesciences Limited	TERIFLUNOMIDE	14	mg/1	Dihydroorotate Dehydrogenase Inhibitors [MoA], Pyrimidine Synthesis Inhibitor [EPC]		N	20241231
70771-1012_43cb0e02-c8b4-4b9b-852d-c17340a3519e	70771-1012	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180503		ANDA	ANDA208961	Zydus Lifesciences Limited	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1013_43cb0e02-c8b4-4b9b-852d-c17340a3519e	70771-1013	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180503		ANDA	ANDA208961	Zydus Lifesciences Limited	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1014_43cb0e02-c8b4-4b9b-852d-c17340a3519e	70771-1014	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20180503		ANDA	ANDA208961	Zydus Lifesciences Limited	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1015_839b3e06-9d30-4463-bf31-ab45da94a990	70771-1015	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA205248	Zydus Lifesciences Limited	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
70771-1016_839b3e06-9d30-4463-bf31-ab45da94a990	70771-1016	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, FILM COATED	ORAL	20161027		ANDA	ANDA205248	Zydus Lifesciences Limited	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
70771-1017_72cf9a3c-efd1-4bc8-be9a-896b4d332667	70771-1017	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET	ORAL	20190501		ANDA	ANDA207760	Zydus Lifesciences Limited	BOSENTAN	62.5	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
70771-1018_72cf9a3c-efd1-4bc8-be9a-896b4d332667	70771-1018	HUMAN PRESCRIPTION DRUG	Bosentan		Bosentan	TABLET	ORAL	20190501		ANDA	ANDA207760	Zydus Lifesciences Limited	BOSENTAN	125	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
70771-1019_8732fe83-0be3-448d-ae9f-bdb21a027787	70771-1019	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20170810		ANDA	ANDA206745	Zydus Lifesciences Limited	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
70771-1020_8732fe83-0be3-448d-ae9f-bdb21a027787	70771-1020	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET, FILM COATED	ORAL	20170810		ANDA	ANDA206745	Zydus Lifesciences Limited	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
70771-1021_c03ba041-b002-4f31-9e0e-02951f9f7b06	70771-1021	HUMAN PRESCRIPTION DRUG	pioglitazone		pioglitazone	TABLET	ORAL	20161116		ANDA	ANDA202456	Zydus Lifesciences Limited	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
70771-1022_c03ba041-b002-4f31-9e0e-02951f9f7b06	70771-1022	HUMAN PRESCRIPTION DRUG	pioglitazone		pioglitazone	TABLET	ORAL	20161116		ANDA	ANDA202456	Zydus Lifesciences Limited	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
70771-1023_c03ba041-b002-4f31-9e0e-02951f9f7b06	70771-1023	HUMAN PRESCRIPTION DRUG	pioglitazone		pioglitazone	TABLET	ORAL	20161116		ANDA	ANDA202456	Zydus Lifesciences Limited	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
70771-1024_58cd32ca-26d5-4d9f-9c08-38c80720d7b4	70771-1024	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	Zydus Lifesciences Limited	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70771-1025_58cd32ca-26d5-4d9f-9c08-38c80720d7b4	70771-1025	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	Zydus Lifesciences Limited	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70771-1026_58cd32ca-26d5-4d9f-9c08-38c80720d7b4	70771-1026	HUMAN PRESCRIPTION DRUG	bumetanide		bumetanide	TABLET	ORAL	20180501		ANDA	ANDA202900	Zydus Lifesciences Limited	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70771-1027_02d0c314-7855-4bad-98f2-42849350f158	70771-1027	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Zydus Lifesciences Limited	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70771-1028_02d0c314-7855-4bad-98f2-42849350f158	70771-1028	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Zydus Lifesciences Limited	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70771-1029_02d0c314-7855-4bad-98f2-42849350f158	70771-1029	HUMAN PRESCRIPTION DRUG	spironolactone		spironolactone	TABLET	ORAL	20180815		ANDA	ANDA205936	Zydus Lifesciences Limited	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
70771-1030_6646b29d-f466-4a0f-9697-85abc155ad94	70771-1030	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1031_6646b29d-f466-4a0f-9697-85abc155ad94	70771-1031	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1032_6646b29d-f466-4a0f-9697-85abc155ad94	70771-1032	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1033_6646b29d-f466-4a0f-9697-85abc155ad94	70771-1033	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1034_6646b29d-f466-4a0f-9697-85abc155ad94	70771-1034	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1035_d9562cf5-4a1d-4848-a7bf-70384dfc3a73	70771-1035	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1036_d9562cf5-4a1d-4848-a7bf-70384dfc3a73	70771-1036	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1037_d9562cf5-4a1d-4848-a7bf-70384dfc3a73	70771-1037	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1038_d9562cf5-4a1d-4848-a7bf-70384dfc3a73	70771-1038	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1039_d9562cf5-4a1d-4848-a7bf-70384dfc3a73	70771-1039	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1040_d9562cf5-4a1d-4848-a7bf-70384dfc3a73	70771-1040	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Zydus Lifesciences Limited	DILTIAZEM HYDROCHLORIDE	420	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1041_60b13ede-7f74-46cd-b1ff-3febfcda2f5e	70771-1041	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Lifesciences Limited	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1042_60b13ede-7f74-46cd-b1ff-3febfcda2f5e	70771-1042	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Lifesciences Limited	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1043_60b13ede-7f74-46cd-b1ff-3febfcda2f5e	70771-1043	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Lifesciences Limited	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1044_60b13ede-7f74-46cd-b1ff-3febfcda2f5e	70771-1044	HUMAN PRESCRIPTION DRUG	perphenazine		perphenazine	TABLET	ORAL	20200716		ANDA	ANDA205232	Zydus Lifesciences Limited	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1047_5b0737e9-d383-448b-9468-7f44529294be	70771-1047	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Lifesciences Limited	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1048_5b0737e9-d383-448b-9468-7f44529294be	70771-1048	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Lifesciences Limited	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1049_5b0737e9-d383-448b-9468-7f44529294be	70771-1049	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Lifesciences Limited	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1050_5b0737e9-d383-448b-9468-7f44529294be	70771-1050	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Zydus Lifesciences Limited	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1051_3490f52c-d1ed-4c6a-9da3-27d06d7e8a0d	70771-1051	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20180104		ANDA	ANDA209966	Zydus Lifesciences Limited	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
70771-1052_3490f52c-d1ed-4c6a-9da3-27d06d7e8a0d	70771-1052	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20180104		ANDA	ANDA209966	Zydus Lifesciences Limited	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
70771-1053_47fd1d3f-78d9-4585-aa16-97f863500b58	70771-1053	HUMAN PRESCRIPTION DRUG	Abacavir and lamivudine		Abacavir and lamivudine	TABLET, FILM COATED	ORAL	20190314		ANDA	ANDA208990	Zydus Lifesciences Limited	ABACAVIR SULFATE; LAMIVUDINE	600; 300	mg/1; mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
70771-1057_c9752e78-2bf3-4e62-a947-a3d7fe757a1b	70771-1057	HUMAN PRESCRIPTION DRUG	acamprosate calcium		acamprosate calcium	TABLET, DELAYED RELEASE	ORAL	20170601		ANDA	ANDA205995	Zydus Lifesciences Limited	ACAMPROSATE CALCIUM	333	mg/1			N	20241231
70771-1058_9951fcc5-ba19-4d39-acd1-bf5220a2680f	70771-1058	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20170209		ANDA	ANDA207812	Zydus Lifesciences Limited	METHOTREXATE	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70771-1059_cfde6a89-090d-4b63-a11f-79c4919da819	70771-1059	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205192	Zydus Lifesciences Limited	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1060_cfde6a89-090d-4b63-a11f-79c4919da819	70771-1060	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205192	Zydus Lifesciences Limited	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1061_cfde6a89-090d-4b63-a11f-79c4919da819	70771-1061	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA205192	Zydus Lifesciences Limited	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1062_bd428201-b17b-4773-8211-eae7e0cb7940	70771-1062	HUMAN PRESCRIPTION DRUG	clopidogrel		clopidogrel	TABLET, FILM COATED	ORAL	20170208		ANDA	ANDA201686	Zydus Lifesciences Limited	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
70771-1063_53740e68-9c4e-4ef0-baf6-b4ec2ba52253	70771-1063	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Lifesciences Limited	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1064_53740e68-9c4e-4ef0-baf6-b4ec2ba52253	70771-1064	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Lifesciences Limited	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1065_53740e68-9c4e-4ef0-baf6-b4ec2ba52253	70771-1065	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Lifesciences Limited	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1066_53740e68-9c4e-4ef0-baf6-b4ec2ba52253	70771-1066	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Zydus Lifesciences Limited	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1067_ac68e443-89c9-42b1-aa4c-66a32746d81e	70771-1067	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20170427		ANDA	ANDA208622	Cadila Healthcare Limited	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70771-1068_ac68e443-89c9-42b1-aa4c-66a32746d81e	70771-1068	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20170427		ANDA	ANDA208622	Cadila Healthcare Limited	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70771-1069_ac68e443-89c9-42b1-aa4c-66a32746d81e	70771-1069	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20170427		ANDA	ANDA208622	Cadila Healthcare Limited	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70771-1070_983f483e-f0a1-46d9-854c-c5534bfbb5e0	70771-1070	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		CHOLESTYRAMINE	POWDER, FOR SUSPENSION	ORAL	20170608		ANDA	ANDA202902	Zydus Lifesciences Limited	CHOLESTYRAMINE	4	g/5.5g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
70771-1071_fbca41b2-19be-4a61-96d9-d75fb72d8474	70771-1071	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	TABLET, DELAYED RELEASE	ORAL	20170619		ANDA	ANDA091640	Zydus Lifesciences Limited	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70771-1075_fa729c07-3c70-4bd8-8056-beaad34b5779	70771-1075	HUMAN PRESCRIPTION DRUG	budesonide		budesonide	CAPSULE, COATED PELLETS	ORAL	20170608		ANDA	ANDA206134	Zydus Lifesciences Limited	BUDESONIDE	3	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1076_63a07323-9908-4a23-84dd-94f2771e6a79	70771-1076	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20170720		ANDA	ANDA208938	Zydus Lifesciences Limited	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
70771-1077_8ed3eb6a-7697-400c-ae6f-ff5387b71e0c	70771-1077	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20170815		ANDA	ANDA208970	Zydus Lifesciences Limited	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1078_8ed3eb6a-7697-400c-ae6f-ff5387b71e0c	70771-1078	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20170815		ANDA	ANDA208970	Zydus Lifesciences Limited	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1079_05a00452-026c-4ef9-b84c-4c77aa56c51b	70771-1079	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	INJECTION, SOLUTION	INTRAVENOUS	20170801		ANDA	ANDA205968	Zydus Lifesciences Limited	LEVOFLOXACIN	25	mg/mL			N	20241231
70771-1080_67d5459a-19cf-429d-937f-3d29482c5dbb	70771-1080	HUMAN PRESCRIPTION DRUG	clobetasol propionate		clobetasol propionate	SPRAY	TOPICAL	20170712		ANDA	ANDA206378	Zydus Lifesciences Limited	CLOBETASOL PROPIONATE	.05	g/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1081_6d339b2f-84ca-4174-8774-cbc1b9cec98a	70771-1081	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170817		ANDA	ANDA206606	Zydus Lifesciences Limited	ACYCLOVIR SODIUM	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70771-1082_6d339b2f-84ca-4174-8774-cbc1b9cec98a	70771-1082	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170817		ANDA	ANDA206606	Zydus Lifesciences Limited	ACYCLOVIR SODIUM	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70771-1083_70a93a13-8b9b-4d48-a79d-dd1d348ac8b6	70771-1083	HUMAN PRESCRIPTION DRUG	Diflunisal		Diflunisal	TABLET	ORAL	20170914		ANDA	ANDA203547	Zydus Lifesciences Limited	DIFLUNISAL	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1084_e4ef4cf9-a1a6-451a-bf13-3774806fc478	70771-1084	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170922		ANDA	ANDA204473	Zydus Lifesciences Limited	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
70771-1085_a570790b-00e9-493b-9605-3839d213d772	70771-1085	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	INJECTION	INTRAVENOUS	20171004		ANDA	ANDA205228	Zydus Lifesciences Limited	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
70771-1086_90fed2f4-c201-4cf0-b78b-4e9865ab667a	70771-1086	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	Zydus Lifesciences Limited	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70771-1087_90fed2f4-c201-4cf0-b78b-4e9865ab667a	70771-1087	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	Zydus Lifesciences Limited	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70771-1088_90fed2f4-c201-4cf0-b78b-4e9865ab667a	70771-1088	HUMAN PRESCRIPTION DRUG	oxybutynin		oxybutynin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170810		ANDA	ANDA202332	Zydus Lifesciences Limited	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70771-1089_12724794-e065-43e8-87ab-bf23f52ae01d	70771-1089	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170808		ANDA	ANDA207761	Zydus Lifesciences Limited	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1090_12724794-e065-43e8-87ab-bf23f52ae01d	70771-1090	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170808		ANDA	ANDA207761	Zydus Lifesciences Limited	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1091_12724794-e065-43e8-87ab-bf23f52ae01d	70771-1091	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170808		ANDA	ANDA207761	Zydus Lifesciences Limited	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1092_84b259e3-d098-4384-8e3d-d498ba589408	70771-1092	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Lifesciences Limited	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70771-1093_84b259e3-d098-4384-8e3d-d498ba589408	70771-1093	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Lifesciences Limited	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70771-1094_84b259e3-d098-4384-8e3d-d498ba589408	70771-1094	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Lifesciences Limited	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70771-1095_84b259e3-d098-4384-8e3d-d498ba589408	70771-1095	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Lifesciences Limited	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70771-1096_84b259e3-d098-4384-8e3d-d498ba589408	70771-1096	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Lifesciences Limited	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70771-1097_84b259e3-d098-4384-8e3d-d498ba589408	70771-1097	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20171026		ANDA	ANDA206750	Zydus Lifesciences Limited	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
70771-1098_dcd3fc9f-03e4-40da-b468-ec8710c648e7	70771-1098	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA203499	Zydus Lifesciences Limited	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70771-1099_dcd3fc9f-03e4-40da-b468-ec8710c648e7	70771-1099	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA203499	Zydus Lifesciences Limited	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70771-1100_dcd3fc9f-03e4-40da-b468-ec8710c648e7	70771-1100	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20180725		ANDA	ANDA203499	Zydus Lifesciences Limited	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
70771-1101_573de98e-0169-41ad-a380-ffa40f4d910f	70771-1101	HUMAN PRESCRIPTION DRUG	omeprazole and sodium bicarbonate		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20180529		ANDA	ANDA203290	Zydus Lifesciences Limited	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1102_573de98e-0169-41ad-a380-ffa40f4d910f	70771-1102	HUMAN PRESCRIPTION DRUG	omeprazole and sodium bicarbonate		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20180529		ANDA	ANDA203290	Zydus Lifesciences Limited	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1103_4efbee3c-4848-451c-9744-c3eca20c1c16	70771-1103	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET, FILM COATED	ORAL	20181217		ANDA	ANDA208979	Zydus Lifesciences Limited	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
70771-1104_57e3e983-6e66-48a0-8710-b3dd4a57cb15	70771-1104	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	TABLET	ORAL	20180402		ANDA	ANDA207773	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1105_da39de3d-cc21-4729-bfb8-3d36dba62098	70771-1105	HUMAN PRESCRIPTION DRUG	CHOLESTYRAMINE		CHOLESTYRAMINE	POWDER, FOR SUSPENSION	ORAL	20180801		ANDA	ANDA202901	Zydus Lifesciences Limited	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20251231
70771-1106_8c6cba9e-1244-4269-9cf5-6e23c8a694fc	70771-1106	HUMAN PRESCRIPTION DRUG	Ethacrynate Sodium		Ethacrynate Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180124		ANDA	ANDA207758	Zydus Lifesciences Limited	ETHACRYNATE SODIUM	50	mg/50mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
70771-1107_84ad48e6-e0f6-46ae-80b4-3784d8b8dd7a	70771-1107	HUMAN PRESCRIPTION DRUG	Eletriptan hydrobromide		Eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170712		ANDA	ANDA206409	Zydus Lifesciences Limited	ELETRIPTAN HYDROBROMIDE	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
70771-1108_84ad48e6-e0f6-46ae-80b4-3784d8b8dd7a	70771-1108	HUMAN PRESCRIPTION DRUG	Eletriptan hydrobromide		Eletriptan hydrobromide	TABLET, FILM COATED	ORAL	20170712		ANDA	ANDA206409	Zydus Lifesciences Limited	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
70771-1109_774be7a7-d346-44e5-9b48-c4cecb809064	70771-1109	HUMAN PRESCRIPTION DRUG	ezetimibe		ezetimibe	TABLET	ORAL	20170809		ANDA	ANDA204331	Zydus Lifesciences Limited	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
70771-1110_d2c38484-6336-42c1-9ad0-5c3a31eaf6bd	70771-1110	HUMAN PRESCRIPTION DRUG	mesalamine		mesalamine	TABLET, DELAYED RELEASE	ORAL	20180802		ANDA	ANDA203286	Zydus Lifesciences Limited	MESALAMINE	800	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70771-1111_4997a8cd-463d-4c0d-8b97-710ceb8b3cf5	70771-1111	HUMAN PRESCRIPTION DRUG	Linezolid		Linezolid	TABLET, FILM COATED	ORAL	20170809		ANDA	ANDA206097	Zydus Lifesciences Limited	LINEZOLID	600	mg/1	Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
70771-1112_48bd7791-467c-44e8-8c3a-fb1de8a4afa9	70771-1112	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Lifesciences Limited	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70771-1113_48bd7791-467c-44e8-8c3a-fb1de8a4afa9	70771-1113	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Lifesciences Limited	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70771-1114_48bd7791-467c-44e8-8c3a-fb1de8a4afa9	70771-1114	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Lifesciences Limited	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70771-1115_48bd7791-467c-44e8-8c3a-fb1de8a4afa9	70771-1115	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170831		ANDA	ANDA208719	Zydus Lifesciences Limited	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70771-1117_b7871e2f-7fc2-41a9-acd0-11c4af6e952c	70771-1117	HUMAN PRESCRIPTION DRUG	ZYPITAMAG		Pitavastatin Magnesium	TABLET, FILM COATED	ORAL	20180309		NDA	NDA208379	Zydus Lifesciences Limited	PITAVASTATIN	2	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1118_b7871e2f-7fc2-41a9-acd0-11c4af6e952c	70771-1118	HUMAN PRESCRIPTION DRUG	ZYPITAMAG		Pitavastatin Magnesium	TABLET, FILM COATED	ORAL	20180309		NDA	NDA208379	Zydus Lifesciences Limited	PITAVASTATIN	4	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1119_e53b65af-d322-4793-9596-545c33651261	70771-1119	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20170928		ANDA	ANDA090961	Zydus Lifesciences Limited	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70771-1120_e53b65af-d322-4793-9596-545c33651261	70771-1120	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20170928		ANDA	ANDA090961	Zydus Lifesciences Limited	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70771-1121_6782ec89-eb1e-4283-9b02-b9fda4793cd3	70771-1121	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180201		ANDA	ANDA207757	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1122_6782ec89-eb1e-4283-9b02-b9fda4793cd3	70771-1122	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180201		ANDA	ANDA207757	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	200	mg/20mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1123_83bc89db-4caf-4b60-899e-fd45a1474650	70771-1123	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20171012		ANDA	ANDA204221	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1124_83bc89db-4caf-4b60-899e-fd45a1474650	70771-1124	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20171012		ANDA	ANDA204221	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1125_83bc89db-4caf-4b60-899e-fd45a1474650	70771-1125	HUMAN PRESCRIPTION DRUG	Telmisartan and Hydrochlorothiazide		Telmisartan and Hydrochlorothiazide	TABLET	ORAL	20171012		ANDA	ANDA204221	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; TELMISARTAN	25; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1126_8d4db3a0-ae0f-437b-bc71-618e05af8621	70771-1126	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20180208		ANDA	ANDA210117	Zydus Lifesciences Limited	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70771-1127_8d4db3a0-ae0f-437b-bc71-618e05af8621	70771-1127	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20180208		ANDA	ANDA210117	Zydus Lifesciences Limited	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70771-1128_2dbb131b-8f01-4093-90bb-f12995b74ef2	70771-1128	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Lifesciences Limited	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70771-1129_2dbb131b-8f01-4093-90bb-f12995b74ef2	70771-1129	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Lifesciences Limited	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70771-1130_2dbb131b-8f01-4093-90bb-f12995b74ef2	70771-1130	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Lifesciences Limited	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70771-1131_2dbb131b-8f01-4093-90bb-f12995b74ef2	70771-1131	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Zydus Lifesciences Limited	TRAZODONE HYDROCHLORIDE	300	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
70771-1132_00dac09b-cb4b-47a1-bafb-8b6ae04b4e85	70771-1132	HUMAN PRESCRIPTION DRUG	LANSOPRAZOLE		LANSOPRAZOLE	TABLET, ORALLY DISINTEGRATING	ORAL	20181130		ANDA	ANDA200816	Zydus Lifesciences Limited	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1133_00dac09b-cb4b-47a1-bafb-8b6ae04b4e85	70771-1133	HUMAN PRESCRIPTION DRUG	LANSOPRAZOLE		LANSOPRAZOLE	TABLET, ORALLY DISINTEGRATING	ORAL	20181130		ANDA	ANDA200816	Zydus Lifesciences Limited	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1134_ec315429-b8ae-41bd-a745-bf607ec834d9	70771-1134	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20171107		ANDA	ANDA209866	Zydus Lifesciences Limited	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1135_ec315429-b8ae-41bd-a745-bf607ec834d9	70771-1135	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	20171107		ANDA	ANDA209866	Zydus Lifesciences Limited	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1136_980662dc-3ed2-4181-b2b9-4795eb815638	70771-1136	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20171117		ANDA	ANDA065217	Zydus Lifesciences Limited	CLINDAMYCIN HYDROCHLORIDE	75	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70771-1137_980662dc-3ed2-4181-b2b9-4795eb815638	70771-1137	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20171123		ANDA	ANDA065217	Zydus Lifesciences Limited	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70771-1138_163dc662-0414-4df6-aa07-0541cd1b4161	70771-1138	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1139_783f0657-1a40-4342-a9f4-7a0ddf22218d	70771-1139	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20171202		ANDA	ANDA077621	Zydus Lifesciences Limited	AZATHIOPRINE	25	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
70771-1140_783f0657-1a40-4342-a9f4-7a0ddf22218d	70771-1140	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20171202		ANDA	ANDA077621	Zydus Lifesciences Limited	AZATHIOPRINE	75	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
70771-1141_783f0657-1a40-4342-a9f4-7a0ddf22218d	70771-1141	HUMAN PRESCRIPTION DRUG	Azathioprine		Azathioprine	TABLET	ORAL	20171202		ANDA	ANDA077621	Zydus Lifesciences Limited	AZATHIOPRINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
70771-1142_c4382248-d7f2-4082-8ee9-dc4bf53779f7	70771-1142	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20171122		ANDA	ANDA077625	Zydus Lifesciences Limited	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70771-1143_c4382248-d7f2-4082-8ee9-dc4bf53779f7	70771-1143	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20171122		ANDA	ANDA077625	Zydus Lifesciences Limited	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70771-1144_c4382248-d7f2-4082-8ee9-dc4bf53779f7	70771-1144	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20171122		ANDA	ANDA077625	Zydus Lifesciences Limited	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70771-1145_9516c1f3-9d94-46aa-9516-35f68c184ad8	70771-1145	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20171207		ANDA	ANDA077734	Zydus Lifesciences Limited	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70771-1146_9516c1f3-9d94-46aa-9516-35f68c184ad8	70771-1146	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20171207		ANDA	ANDA077734	Zydus Lifesciences Limited	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70771-1147_9516c1f3-9d94-46aa-9516-35f68c184ad8	70771-1147	HUMAN PRESCRIPTION DRUG	escitalopram		escitalopram	TABLET, FILM COATED	ORAL	20171207		ANDA	ANDA077734	Zydus Lifesciences Limited	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70771-1148_5858760b-c49d-45f3-865a-ddb5533bdc68	70771-1148	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET, FILM COATED	ORAL	20171113		ANDA	ANDA078848	Zydus Lifesciences Limited	BENAZEPRIL HYDROCHLORIDE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70771-1149_5858760b-c49d-45f3-865a-ddb5533bdc68	70771-1149	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET, FILM COATED	ORAL	20171113		ANDA	ANDA078848	Zydus Lifesciences Limited	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70771-1150_5858760b-c49d-45f3-865a-ddb5533bdc68	70771-1150	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET, FILM COATED	ORAL	20171113		ANDA	ANDA078848	Zydus Lifesciences Limited	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70771-1151_5858760b-c49d-45f3-865a-ddb5533bdc68	70771-1151	HUMAN PRESCRIPTION DRUG	Benazepril hydrochloride		Benazepril hydrochloride	TABLET, FILM COATED	ORAL	20171113		ANDA	ANDA078848	Zydus Lifesciences Limited	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
70771-1152_5068fb9d-4d3e-4ebc-ac25-5a42a89a5efc	70771-1152	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA078900	Zydus Lifesciences Limited	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70771-1155_163dc662-0414-4df6-aa07-0541cd1b4161	70771-1155	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	80	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1156_163dc662-0414-4df6-aa07-0541cd1b4161	70771-1156	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1157_163dc662-0414-4df6-aa07-0541cd1b4161	70771-1157	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1159_120947cf-df25-4bbc-93bc-1ea48be2bdb4	70771-1159	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20171208		ANDA	ANDA079213	Zydus Lifesciences Limited	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1160_120947cf-df25-4bbc-93bc-1ea48be2bdb4	70771-1160	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20171208		ANDA	ANDA079213	Zydus Lifesciences Limited	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1161_120947cf-df25-4bbc-93bc-1ea48be2bdb4	70771-1161	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20171208		ANDA	ANDA079213	Zydus Lifesciences Limited	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1162_2fe3e1a1-2ef6-4bd9-8bdf-b5127873c393	70771-1162	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20221230		ANDA	ANDA213003	Zydus Lifesciences Limited	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70771-1163_6c51333c-cf96-480d-a340-f5680400cef4	70771-1163	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Zydus Lifesciences Limited	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1164_6c51333c-cf96-480d-a340-f5680400cef4	70771-1164	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Zydus Lifesciences Limited	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1165_6c51333c-cf96-480d-a340-f5680400cef4	70771-1165	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Zydus Lifesciences Limited	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1166_c534f84b-303a-446e-ad8f-fffdb9812ccc	70771-1166	HUMAN PRESCRIPTION DRUG	desoximetasone		desoximetasone	OINTMENT	TOPICAL	20171205		ANDA	ANDA205206	Zydus Lifesciences Limited	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1167_163dc662-0414-4df6-aa07-0541cd1b4161	70771-1167	HUMAN PRESCRIPTION DRUG	minocycline hydrochloride		minocycline hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180307		ANDA	ANDA203553	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1168_a0abd1f7-49a9-4698-8eb6-751e1039ae88	70771-1168	HUMAN PRESCRIPTION DRUG	fesoterodine fumarate		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171207		ANDA	ANDA204946	Zydus Lifesciences Limited	FESOTERODINE FUMARATE	4	mg/1			N	20241231
70771-1169_a0abd1f7-49a9-4698-8eb6-751e1039ae88	70771-1169	HUMAN PRESCRIPTION DRUG	fesoterodine fumarate		fesoterodine fumarate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171207		ANDA	ANDA204946	Zydus Lifesciences Limited	FESOTERODINE FUMARATE	8	mg/1			N	20241231
70771-1170_a2deefdc-9b32-44e4-a6bc-4eeae30e5c46	70771-1170	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20180215		ANDA	ANDA205005	Zydus Lifesciences Limited	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70771-1171_a2deefdc-9b32-44e4-a6bc-4eeae30e5c46	70771-1171	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20180215		ANDA	ANDA205005	Zydus Lifesciences Limited	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70771-1172_76d666a7-044a-49c0-ada8-1a0ee22d3dbc	70771-1172	HUMAN PRESCRIPTION DRUG	aspirin-dipyridamole		aspirin-dipyridamole	CAPSULE	ORAL	20180104		ANDA	ANDA206753	Zydus Lifesciences Limited	ASPIRIN; DIPYRIDAMOLE	25; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
70771-1173_67501ce8-1792-4ebc-b579-98977278d9bb	70771-1173	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Lifesciences Limited	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1174_67501ce8-1792-4ebc-b579-98977278d9bb	70771-1174	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Lifesciences Limited	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1175_67501ce8-1792-4ebc-b579-98977278d9bb	70771-1175	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Lifesciences Limited	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1176_67501ce8-1792-4ebc-b579-98977278d9bb	70771-1176	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Lifesciences Limited	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1177_67501ce8-1792-4ebc-b579-98977278d9bb	70771-1177	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Lifesciences Limited	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1178_67501ce8-1792-4ebc-b579-98977278d9bb	70771-1178	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20171226		ANDA	ANDA210086	Zydus Lifesciences Limited	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1179_4197528d-30cd-4d4c-ad6c-6e4f1fd0d1e2	70771-1179	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20171228		ANDA	ANDA208988	Zydus Lifesciences Limited	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1180_4197528d-30cd-4d4c-ad6c-6e4f1fd0d1e2	70771-1180	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20171228		ANDA	ANDA208988	Zydus Lifesciences Limited	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1181_4197528d-30cd-4d4c-ad6c-6e4f1fd0d1e2	70771-1181	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20171228		ANDA	ANDA208988	Zydus Lifesciences Limited	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1182_4197528d-30cd-4d4c-ad6c-6e4f1fd0d1e2	70771-1182	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20171228		ANDA	ANDA208988	Zydus Lifesciences Limited	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1183_980662dc-3ed2-4181-b2b9-4795eb815638	70771-1183	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE, GELATIN COATED	ORAL	20171123		ANDA	ANDA065217	Zydus Lifesciences Limited	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70771-1184_4d48092a-f1fb-4bcd-b109-b48cffacfaec	70771-1184	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20180103		ANDA	ANDA206694	Zydus Lifesciences Limited	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
70771-1185_4d48092a-f1fb-4bcd-b109-b48cffacfaec	70771-1185	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20180103		ANDA	ANDA206694	Zydus Lifesciences Limited	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
70771-1186_adc1edc9-9897-4ba0-a14d-08c8d29f9369	70771-1186	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1187_adc1edc9-9897-4ba0-a14d-08c8d29f9369	70771-1187	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 20	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1188_adc1edc9-9897-4ba0-a14d-08c8d29f9369	70771-1188	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1189_adc1edc9-9897-4ba0-a14d-08c8d29f9369	70771-1189	HUMAN PRESCRIPTION DRUG	Amlodipine and olmesartan medoxomil		Amlodipine and olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180104		ANDA	ANDA207771	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	10; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1190_853cd119-cd28-48ba-85ed-2da4e560fd56	70771-1190	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA210012	Cadila Healthcare Limited	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1191_853cd119-cd28-48ba-85ed-2da4e560fd56	70771-1191	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA210012	Cadila Healthcare Limited	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1192_853cd119-cd28-48ba-85ed-2da4e560fd56	70771-1192	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20180202		ANDA	ANDA210012	Cadila Healthcare Limited	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1193_561eb1c9-3e5d-4590-8435-d4d6244af487	70771-1193	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	INJECTION, SOLUTION	EPIDURAL	20180131		ANDA	ANDA202601	Zydus Lifesciences Limited	CLONIDINE HYDROCHLORIDE	.1	mg/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70771-1194_561eb1c9-3e5d-4590-8435-d4d6244af487	70771-1194	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	INJECTION, SOLUTION	EPIDURAL	20180131		ANDA	ANDA202601	Zydus Lifesciences Limited	CLONIDINE HYDROCHLORIDE	.5	mg/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70771-1200_e370bf4e-553c-4fe6-84ef-2a20fbd9e2ee	70771-1200	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20180208		ANDA	ANDA204663	Zydus Lifesciences Limited	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
70771-1201_e370bf4e-553c-4fe6-84ef-2a20fbd9e2ee	70771-1201	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20180208		ANDA	ANDA204663	Zydus Lifesciences Limited	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
70771-1202_e370bf4e-553c-4fe6-84ef-2a20fbd9e2ee	70771-1202	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET, ORALLY DISINTEGRATING	ORAL	20180208		ANDA	ANDA204663	Zydus Lifesciences Limited	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
70771-1203_a811c3c1-e63c-4731-9654-e879217f249e	70771-1203	HUMAN PRESCRIPTION DRUG	indomethacin		indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20180208		ANDA	ANDA202711	Zydus Lifesciences Limited	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1204_899700d2-3ce8-47df-8652-40319b2d9d04	70771-1204	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Lifesciences Limited	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1205_899700d2-3ce8-47df-8652-40319b2d9d04	70771-1205	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Lifesciences Limited	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1206_899700d2-3ce8-47df-8652-40319b2d9d04	70771-1206	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Lifesciences Limited	CANDESARTAN CILEXETIL	16	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1207_899700d2-3ce8-47df-8652-40319b2d9d04	70771-1207	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20180222		ANDA	ANDA091390	Zydus Lifesciences Limited	CANDESARTAN CILEXETIL	32	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70771-1208_babbe56a-aa0f-4c7b-93b6-1eef4d58c693	70771-1208	HUMAN PRESCRIPTION DRUG	itraconazole		itraconazole	CAPSULE	ORAL	20180306		ANDA	ANDA204672	Zydus Lifesciences Limited	ITRACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70771-1209_55bcee10-a9b6-400b-8683-1ffbd688390b	70771-1209	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	OINTMENT	TOPICAL	20180322		ANDA	ANDA210199	Zydus Lifesciences Limited	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1311_814c4c70-0fcf-4679-8890-2f3615558309	70771-1311	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20180508		ANDA	ANDA204020	Zydus Lifesciences Limited	DESVENLAFAXINE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1312_814c4c70-0fcf-4679-8890-2f3615558309	70771-1312	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20180508		ANDA	ANDA204020	Zydus Lifesciences Limited	DESVENLAFAXINE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1313_ca74e118-c739-4a6b-aee8-a32132d43374	70771-1313	HUMAN PRESCRIPTION DRUG	AZELASTINE HYDROCHLORIDE		AZELASTINE HYDROCHLORIDE	SPRAY, METERED	NASAL	20180201		ANDA	ANDA091409	Zydus Lifesciences Limited	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70771-1314_d7ff2b95-b76f-4587-a38a-4de57dd2c726	70771-1314	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		Desmopressin Acetate	SPRAY	NASAL	20180201		ANDA	ANDA091345	Zydus Lifesciences Limited	DESMOPRESSIN ACETATE	.1	mg/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
70771-1315_709dd70b-24e1-435f-8373-02e6dd538b2c	70771-1315	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20180405		ANDA	ANDA207382	Zydus Lifesciences Limited	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1316_709dd70b-24e1-435f-8373-02e6dd538b2c	70771-1316	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20180405		ANDA	ANDA207382	Zydus Lifesciences Limited	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1317_709dd70b-24e1-435f-8373-02e6dd538b2c	70771-1317	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20180405		ANDA	ANDA207382	Zydus Lifesciences Limited	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1318_40070531-4723-48f2-89b4-9efde4d1c71f	70771-1318	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20190222		ANDA	ANDA210189	Zydus Lifesciences Limited	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
70771-1319_ef257e34-8862-4020-895d-6d12f419f669	70771-1319	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		dexmedetomidine hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180614		ANDA	ANDA206798	Zydus Lifesciences Limited	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
70771-1320_4fadc3c5-6ef7-4a62-9444-0b66ce385a7c	70771-1320	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20180307		ANDA	ANDA203162	Zydus Lifesciences Limited	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70771-1321_493af1b5-8e55-4b04-b058-7f7d8572244e	70771-1321	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Lifesciences Limited	MEMANTINE HYDROCHLORIDE	7	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70771-1322_493af1b5-8e55-4b04-b058-7f7d8572244e	70771-1322	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Lifesciences Limited	MEMANTINE HYDROCHLORIDE	14	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70771-1323_493af1b5-8e55-4b04-b058-7f7d8572244e	70771-1323	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Lifesciences Limited	MEMANTINE HYDROCHLORIDE	21	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70771-1324_493af1b5-8e55-4b04-b058-7f7d8572244e	70771-1324	HUMAN PRESCRIPTION DRUG	Memantine hydrochloride		Memantine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20180408		ANDA	ANDA203293	Zydus Lifesciences Limited	MEMANTINE HYDROCHLORIDE	28	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
70771-1325_d579d9c3-cadd-4e79-bc27-ca62ac186781	70771-1325	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20180414		ANDA	ANDA203466	Zydus Lifesciences Limited	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	16; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1326_d579d9c3-cadd-4e79-bc27-ca62ac186781	70771-1326	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20180414		ANDA	ANDA203466	Zydus Lifesciences Limited	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 12.5	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1327_d579d9c3-cadd-4e79-bc27-ca62ac186781	70771-1327	HUMAN PRESCRIPTION DRUG	candesartan cilexetil and hydrochlorothiazide		candesartan cilexetil and hydrochlorothiazide	TABLET	ORAL	20180414		ANDA	ANDA203466	Zydus Lifesciences Limited	CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE	32; 25	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1328_e91fa361-7045-4e19-9ee8-0d2f389a9a6b	70771-1328	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70771-1329_e91fa361-7045-4e19-9ee8-0d2f389a9a6b	70771-1329	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70771-1330_e91fa361-7045-4e19-9ee8-0d2f389a9a6b	70771-1330	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	1.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70771-1331_e91fa361-7045-4e19-9ee8-0d2f389a9a6b	70771-1331	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	2.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70771-1332_e91fa361-7045-4e19-9ee8-0d2f389a9a6b	70771-1332	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	3	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70771-1333_e91fa361-7045-4e19-9ee8-0d2f389a9a6b	70771-1333	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	3.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70771-1334_e91fa361-7045-4e19-9ee8-0d2f389a9a6b	70771-1334	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180424		ANDA	ANDA202891	Zydus Lifesciences Limited	PRAMIPEXOLE DIHYDROCHLORIDE	4.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
70771-1335_74aceb7a-4290-4ed2-9136-07b27fff9cd9	70771-1335	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20180913		ANDA	ANDA208187	Zydus Lifesciences Limited	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70771-1336_74aceb7a-4290-4ed2-9136-07b27fff9cd9	70771-1336	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20180913		ANDA	ANDA208187	Zydus Lifesciences Limited	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
70771-1337_495f05e7-b156-43d9-b38e-0a5e19b958b5	70771-1337	HUMAN OTC DRUG	omeprazole and sodium bicarbonate		omeprazole and sodium bicarbonate	CAPSULE	ORAL	20180719		ANDA	ANDA203345	Zydus Lifesciences Limited	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1338_1c1180fc-f44c-4712-9be7-9d8cfe791c6f	70771-1338	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Lifesciences Limited	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1339_1c1180fc-f44c-4712-9be7-9d8cfe791c6f	70771-1339	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Lifesciences Limited	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1340_1c1180fc-f44c-4712-9be7-9d8cfe791c6f	70771-1340	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Lifesciences Limited	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1341_1c1180fc-f44c-4712-9be7-9d8cfe791c6f	70771-1341	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Zydus Lifesciences Limited	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1344_49e233c8-958a-4352-b1df-fbddbbb48a18	70771-1344	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090728	Zydus Lifesciences Limited	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1345_49e233c8-958a-4352-b1df-fbddbbb48a18	70771-1345	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090728	Zydus Lifesciences Limited	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1346_49e233c8-958a-4352-b1df-fbddbbb48a18	70771-1346	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20140527		ANDA	ANDA090728	Zydus Lifesciences Limited	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1347_a00cd4b7-4f64-4228-a425-995dcf1bc38d	70771-1347	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20180516		ANDA	ANDA204373	Zydus Lifesciences Limited	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
70771-1348_21e80f74-f0a4-4dc2-a415-b6b1bed285a7	70771-1348	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Lifesciences Limited	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1349_21e80f74-f0a4-4dc2-a415-b6b1bed285a7	70771-1349	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Lifesciences Limited	METHYLPREDNISOLONE	8	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1350_21e80f74-f0a4-4dc2-a415-b6b1bed285a7	70771-1350	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Lifesciences Limited	METHYLPREDNISOLONE	16	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1351_21e80f74-f0a4-4dc2-a415-b6b1bed285a7	70771-1351	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Zydus Lifesciences Limited	METHYLPREDNISOLONE	32	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1352_88c956e8-67e6-40b2-8b44-2d21e0e5fcf6	70771-1352	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180510		ANDA	ANDA209467	Zydus Lifesciences Limited	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
70771-1353_a82b38a9-8d59-4a84-a25a-4bf479c4843d	70771-1353	HUMAN PRESCRIPTION DRUG	ZALDYON		mesalamine	TABLET, DELAYED RELEASE	ORAL	20190117		ANDA	ANDA203286	Zydus Lifesciences Limited	MESALAMINE	800	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70771-1355_1e51c5e1-8573-4599-90e7-5d9a4a7f3d40	70771-1355	HUMAN PRESCRIPTION DRUG	CARBIDOPA		CARBIDOPA	TABLET	ORAL	20180906		ANDA	ANDA209910	Zydus Lifesciences Limited	CARBIDOPA	25	mg/1			N	20241231
70771-1356_458221ba-8343-44fb-a46c-d75b1f67f403	70771-1356	HUMAN PRESCRIPTION DRUG	Dutasteride and tamsulosin hydrochloride		Dutasteride and tamsulosin hydrochloride	CAPSULE	ORAL	20180604		ANDA	ANDA207769	Zydus Lifesciences Limited	DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE	.5; .4	mg/1; mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA], Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70771-1357_b425ab8b-fc3a-4183-972c-b93fe5014b27	70771-1357	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20180808		ANDA	ANDA207767	Zydus Lifesciences Limited	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
70771-1358_ca18b1ac-641b-494e-8ac1-04abfb64b84a	70771-1358	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20180912		ANDA	ANDA207774	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1359_ca18b1ac-641b-494e-8ac1-04abfb64b84a	70771-1359	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20180912		ANDA	ANDA207774	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1361_1b1be913-613c-469c-8665-13858922d5bf	70771-1361	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20180904		ANDA	ANDA208360	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1362_1b1be913-613c-469c-8665-13858922d5bf	70771-1362	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20180904		ANDA	ANDA208360	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1363_e0f3960c-b442-4433-995e-a40270f0ffc4	70771-1363	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190412		ANDA	ANDA210058	Zydus Lifesciences Limited	AMBRISENTAN	5	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
70771-1364_e0f3960c-b442-4433-995e-a40270f0ffc4	70771-1364	HUMAN PRESCRIPTION DRUG	Ambrisentan		Ambrisentan	TABLET, FILM COATED	ORAL	20190412		ANDA	ANDA210058	Zydus Lifesciences Limited	AMBRISENTAN	10	mg/1	Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]		N	20241231
70771-1365_70f6972e-feac-4c71-9b05-57caf18d0027	70771-1365	HUMAN PRESCRIPTION DRUG	NIFEDIPINE		NIFEDIPINE	TABLET, EXTENDED RELEASE	ORAL	20180818		ANDA	ANDA210184	Zydus Lifesciences Limited	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1366_70f6972e-feac-4c71-9b05-57caf18d0027	70771-1366	HUMAN PRESCRIPTION DRUG	NIFEDIPINE		NIFEDIPINE	TABLET, EXTENDED RELEASE	ORAL	20180818		ANDA	ANDA210184	Zydus Lifesciences Limited	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1367_70f6972e-feac-4c71-9b05-57caf18d0027	70771-1367	HUMAN PRESCRIPTION DRUG	NIFEDIPINE		NIFEDIPINE	TABLET, EXTENDED RELEASE	ORAL	20180818		ANDA	ANDA210184	Zydus Lifesciences Limited	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
70771-1369_bc699058-b43d-4b7a-87f4-7933e55f2322	70771-1369	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190515		ANDA	ANDA207813	Zydus Lifesciences Limited	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70771-1370_bc699058-b43d-4b7a-87f4-7933e55f2322	70771-1370	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190515		ANDA	ANDA207813	Zydus Lifesciences Limited	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
70771-1371_6b3fb34e-4207-4b9d-aa16-d88c08c92711	70771-1371	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	OINTMENT	TOPICAL	20190321		ANDA	ANDA205974	Zydus Lifesciences Limited	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70771-1372_3e5aa0e5-1009-4a3d-b4d0-a113ffcf394f	70771-1372	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20190312		ANDA	ANDA210028	Zydus Lifesciences Limited	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1373_3e5aa0e5-1009-4a3d-b4d0-a113ffcf394f	70771-1373	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20190312		ANDA	ANDA210028	Zydus Lifesciences Limited	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1374_e8bd43f9-3894-4892-a987-86c4cf42048d	70771-1374	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET	ORAL	20181008		ANDA	ANDA202602	Zydus Lifesciences Limited	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
70771-1375_5880cc88-7ad8-49aa-913b-e9546732c7fa	70771-1375	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	20181101		ANDA	ANDA208948	Zydus Lifesciences Limited	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1380_8bd7a74c-aa74-46e4-9aec-f374ac114646	70771-1380	HUMAN PRESCRIPTION DRUG	Betamethasone dipropionate		Betamethasone dipropionate	CREAM	TOPICAL	20190226		ANDA	ANDA208885	Zydus Lifesciences Limited	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1381_46734194-5ee5-457b-a660-fd67d965d92d	70771-1381	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20191125		ANDA	ANDA210198	Zydus Lifesciences Limited	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1383_0e2d2e97-1c08-4ae1-be53-ec77eb909a89	70771-1383	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, SOLUTION	INTRAVENOUS	20181127		ANDA	ANDA206535	Zydus Lifesciences Limited	ACYCLOVIR SODIUM	50	mg/mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70771-1384_0e2d2e97-1c08-4ae1-be53-ec77eb909a89	70771-1384	HUMAN PRESCRIPTION DRUG	acyclovir		ACYCLOVIR	INJECTION, SOLUTION	INTRAVENOUS	20181127		ANDA	ANDA206535	Zydus Lifesciences Limited	ACYCLOVIR SODIUM	50	mg/mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70771-1391_a5b5e9f5-6914-42f0-b51c-fe3a5fead746	70771-1391	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	GRANULE, DELAYED RELEASE	ORAL	20230630		ANDA	ANDA206055	Zydus Lifesciences Limited	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1392_a5b5e9f5-6914-42f0-b51c-fe3a5fead746	70771-1392	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	GRANULE, DELAYED RELEASE	ORAL	20230630		ANDA	ANDA206055	Zydus Lifesciences Limited	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1393_136191eb-82b0-4b79-880d-d42cb9622cee	70771-1393	HUMAN PRESCRIPTION DRUG	FLUOCINONIDE		FLUOCINONIDE	CREAM	TOPICAL	20200430		ANDA	ANDA208989	Zydus Lifesciences Limited	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1394_06c6e394-2d65-4e22-b9ac-cad74c839834	70771-1394	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA210658	Zydus Lifesciences Limited	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
70771-1395_06c6e394-2d65-4e22-b9ac-cad74c839834	70771-1395	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA210658	Zydus Lifesciences Limited	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
70771-1396_26e71de3-70d4-4786-83ad-e06dbdf9078c	70771-1396	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20190612		ANDA	ANDA211519	Zydus Lifesciences Limited	COLCHICEINE	.6	mg/1			N	20241231
70771-1400_7287c5b3-80de-4eab-9905-f597a4fbaf34	70771-1400	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA204379	Zydus Lifesciences Limited	ESTRADIOL	.014	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1401_93d304a6-249a-4887-9a4a-dfedbd209cc1	70771-1401	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Lifesciences Limited	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1402_93d304a6-249a-4887-9a4a-dfedbd209cc1	70771-1402	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Lifesciences Limited	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1403_93d304a6-249a-4887-9a4a-dfedbd209cc1	70771-1403	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Lifesciences Limited	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1404_93d304a6-249a-4887-9a4a-dfedbd209cc1	70771-1404	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Lifesciences Limited	ESTRADIOL	.06	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1405_93d304a6-249a-4887-9a4a-dfedbd209cc1	70771-1405	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Lifesciences Limited	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1406_93d304a6-249a-4887-9a4a-dfedbd209cc1	70771-1406	HUMAN PRESCRIPTION DRUG	estradiol		estradiol	PATCH	TRANSDERMAL	20231102		ANDA	ANDA202985	Zydus Lifesciences Limited	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1407_8e3461da-7a74-46b4-9a07-c7ff65b3d107	70771-1407	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20181107		ANDA	ANDA211145	Zydus Lifesciences Limited	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
70771-1408_8e3461da-7a74-46b4-9a07-c7ff65b3d107	70771-1408	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET	ORAL	20181107		ANDA	ANDA211145	Zydus Lifesciences Limited	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
70771-1409_67767520-52a9-41a3-8742-4eedb2e5952d	70771-1409	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FOR SUSPENSION	ORAL	20210506		ANDA	ANDA208882	Zydus Lifesciences Limited	DEFERASIROX	125	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70771-1410_67767520-52a9-41a3-8742-4eedb2e5952d	70771-1410	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FOR SUSPENSION	ORAL	20210506		ANDA	ANDA208882	Zydus Lifesciences Limited	DEFERASIROX	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70771-1411_67767520-52a9-41a3-8742-4eedb2e5952d	70771-1411	HUMAN PRESCRIPTION DRUG	DEFERASIROX		DEFERASIROX	TABLET, FOR SUSPENSION	ORAL	20210506		ANDA	ANDA208882	Zydus Lifesciences Limited	DEFERASIROX	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70771-1412_7037f12d-e0b0-4b4a-a7e2-76637374cfe3	70771-1412	HUMAN PRESCRIPTION DRUG	ACETYLCYSTEINE		acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20190117		ANDA	ANDA208166	Zydus Lifesciences Limited	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
70771-1413_4a0dfaa3-a2b7-4a4f-9dda-d8662ac705be	70771-1413	HUMAN PRESCRIPTION DRUG	VORICONAZOLE		voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190103		ANDA	ANDA208983	Zydus Lifesciences Limited	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70771-1414_1781206f-3ad3-4789-b4e4-e0b231b35539	70771-1414	HUMAN PRESCRIPTION DRUG	Clindamycin phosphate		Clindamycin phosphate	SOLUTION	TOPICAL	20190103		ANDA	ANDA208767	Zydus Lifesciences Limited	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70771-1415_be77ee21-4c1b-48e6-a256-8efb852ff892	70771-1415	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac sodium	LIQUID	TOPICAL	20180808		ANDA	ANDA206411	Zydus Lifesciences Limited	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1416_b5bdb05f-2cd0-4c67-9f4e-7e777929c87d	70771-1416	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Lifesciences Limited	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1417_b5bdb05f-2cd0-4c67-9f4e-7e777929c87d	70771-1417	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Lifesciences Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1418_b5bdb05f-2cd0-4c67-9f4e-7e777929c87d	70771-1418	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Lifesciences Limited	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1419_b5bdb05f-2cd0-4c67-9f4e-7e777929c87d	70771-1419	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Lifesciences Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1420_b5bdb05f-2cd0-4c67-9f4e-7e777929c87d	70771-1420	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Lifesciences Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1421_b5bdb05f-2cd0-4c67-9f4e-7e777929c87d	70771-1421	HUMAN PRESCRIPTION DRUG	olanzapine		olanzapine	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA090459	Zydus Lifesciences Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1422_71195440-c406-4cf2-8650-99b25fb5b933	70771-1422	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Lifesciences Limited	AZITHROMYCIN DIHYDRATE	100	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70771-1423_71195440-c406-4cf2-8650-99b25fb5b933	70771-1423	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Lifesciences Limited	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70771-1424_71195440-c406-4cf2-8650-99b25fb5b933	70771-1424	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Lifesciences Limited	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70771-1425_71195440-c406-4cf2-8650-99b25fb5b933	70771-1425	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Zydus Lifesciences Limited	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
70771-1426_85c24438-30d2-4bb9-986d-576088ff94e4	70771-1426	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20170403		ANDA	ANDA063011	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1427_85c24438-30d2-4bb9-986d-576088ff94e4	70771-1427	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20170403		ANDA	ANDA063009	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1428_85c24438-30d2-4bb9-986d-576088ff94e4	70771-1428	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20170403		ANDA	ANDA063009	Zydus Lifesciences Limited	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1429_85b5fc83-a71a-4b26-a788-91f3540456c0	70771-1429	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20190110		ANDA	ANDA205585	Zydus Lifesciences Limited	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1430_85b5fc83-a71a-4b26-a788-91f3540456c0	70771-1430	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20190110		ANDA	ANDA205585	Zydus Lifesciences Limited	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1431_2f3cb828-6ff1-428d-99c7-edb835d25d10	70771-1431	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20200221		ANDA	ANDA204189	Zydus Lifesciences Limited	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
70771-1436_b096fdce-d4ce-4802-873e-2bf83ce54ac6	70771-1436	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, DELAYED RELEASE	ORAL	20190410		ANDA	ANDA203822	Zydus Lifesciences Limited	RISEDRONATE SODIUM ANHYDROUS	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
70771-1437_7246b137-6edd-4cf9-b4b3-cfce5a900727	70771-1437	HUMAN PRESCRIPTION DRUG	desoximetasone		desoximetasone	CREAM	TOPICAL	20190212		ANDA	ANDA205620	Zydus Lifesciences Limited	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1438_b56c96f0-9299-4a89-af6b-ea1f2b6b7fa8	70771-1438	HUMAN PRESCRIPTION DRUG	Trientine hydrochloride		Trientine hydrochloride	CAPSULE	ORAL	20190429		ANDA	ANDA211554	Zydus Lifesciences Limited	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
70771-1440_330c7fc1-8c80-49e1-b573-76d9cc6c93d6	70771-1440	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20181022		ANDA	ANDA211449	Zydus Lifesciences Limited	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
70771-1441_330c7fc1-8c80-49e1-b573-76d9cc6c93d6	70771-1441	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20181022		ANDA	ANDA211449	Zydus Lifesciences Limited	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
70771-1442_5716599f-59a6-4553-97aa-98f944e05e38	70771-1442	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20190109		ANDA	ANDA211074	Zydus Lifesciences Limited	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1443_09caa07b-012e-4af9-9e91-02fbdfb929a0	70771-1443	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Lifesciences Limited	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1444_09caa07b-012e-4af9-9e91-02fbdfb929a0	70771-1444	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Lifesciences Limited	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1445_09caa07b-012e-4af9-9e91-02fbdfb929a0	70771-1445	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Lifesciences Limited	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1446_09caa07b-012e-4af9-9e91-02fbdfb929a0	70771-1446	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET	ORAL	20181121		ANDA	ANDA206536	Zydus Lifesciences Limited	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1447_0cf183cb-4f5e-48b2-8a50-3310a27c27b5	70771-1447	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20181120		ANDA	ANDA207764	Zydus Lifesciences Limited	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
70771-1448_f0366f32-8d09-4d7b-9577-a977212e109e	70771-1448	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20181206		ANDA	ANDA211659	Zydus Lifesciences Limited	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70771-1449_f0366f32-8d09-4d7b-9577-a977212e109e	70771-1449	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20181206		ANDA	ANDA211659	Zydus Lifesciences Limited	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70771-1450_372f8db2-a8fb-42e9-9239-1deb999e2ef9	70771-1450	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate and Benzoyl Peroxide	GEL	TOPICAL	20190307		ANDA	ANDA210794	Zydus Lifesciences Limited	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	50; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70771-1451_ce8e8e24-094f-4a86-b442-f31e6dd9ad31	70771-1451	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Lifesciences Limited	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1452_ce8e8e24-094f-4a86-b442-f31e6dd9ad31	70771-1452	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Lifesciences Limited	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1453_ce8e8e24-094f-4a86-b442-f31e6dd9ad31	70771-1453	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Lifesciences Limited	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1454_ce8e8e24-094f-4a86-b442-f31e6dd9ad31	70771-1454	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Lifesciences Limited	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1455_ce8e8e24-094f-4a86-b442-f31e6dd9ad31	70771-1455	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Lifesciences Limited	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1456_ce8e8e24-094f-4a86-b442-f31e6dd9ad31	70771-1456	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190604		ANDA	ANDA090472	Zydus Lifesciences Limited	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1457_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1457	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1458_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1458	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1459_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1459	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	2.5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1460_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1460	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1461_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1461	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1462_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1462	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1463_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1463	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1464_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1464	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1465_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1465	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1466_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1466	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1467_a4beebf9-4f71-45f0-8707-9273c8f02097	70771-1467	HUMAN PRESCRIPTION DRUG	Amlodipine and atorvastatin		Amlodipine and atorvastatin	TABLET, FILM COATED	ORAL	20190530		ANDA	ANDA207762	Zydus Lifesciences Limited	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 80	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1468_24bf0c4e-087e-4cc6-b854-dc3684aca4c7	70771-1468	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA205571	Zydus Lifesciences Limited	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70771-1469_24bf0c4e-087e-4cc6-b854-dc3684aca4c7	70771-1469	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA205571	Zydus Lifesciences Limited	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70771-1470_24bf0c4e-087e-4cc6-b854-dc3684aca4c7	70771-1470	HUMAN PRESCRIPTION DRUG	carbamazepine		carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA205571	Zydus Lifesciences Limited	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70771-1471_ba8b0a29-7725-46a5-9c73-95d1d3876195	70771-1471	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211383	Zydus Lifesciences Limited	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70771-1472_ba8b0a29-7725-46a5-9c73-95d1d3876195	70771-1472	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA211383	Zydus Lifesciences Limited	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70771-1473_ba8b0a29-7725-46a5-9c73-95d1d3876195	70771-1473	HUMAN PRESCRIPTION DRUG	deferasirox		deferasirox	TABLET, FILM COATED	ORAL	20191121		ANDA	ANDA211383	Zydus Lifesciences Limited	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
70771-1474_82aa9973-f70d-4c03-831e-b28f586e2915	70771-1474	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20200303		ANDA	ANDA208358	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1475_17cc882d-7e8b-4369-a880-0ae4dc4db607	70771-1475	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Lifesciences Limited	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1476_17cc882d-7e8b-4369-a880-0ae4dc4db607	70771-1476	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Lifesciences Limited	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1477_17cc882d-7e8b-4369-a880-0ae4dc4db607	70771-1477	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Lifesciences Limited	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1478_17cc882d-7e8b-4369-a880-0ae4dc4db607	70771-1478	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA206693	Zydus Lifesciences Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1485_be4934db-c496-4b06-84c6-587cb656d5fc	70771-1485	HUMAN PRESCRIPTION DRUG	valsartan and hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20200212		ANDA	ANDA203000	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1486_be4934db-c496-4b06-84c6-587cb656d5fc	70771-1486	HUMAN PRESCRIPTION DRUG	valsartan and hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20200212		ANDA	ANDA203000	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1487_be4934db-c496-4b06-84c6-587cb656d5fc	70771-1487	HUMAN PRESCRIPTION DRUG	valsartan and hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20200212		ANDA	ANDA203000	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1488_be4934db-c496-4b06-84c6-587cb656d5fc	70771-1488	HUMAN PRESCRIPTION DRUG	valsartan and hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20200212		ANDA	ANDA203000	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1489_be4934db-c496-4b06-84c6-587cb656d5fc	70771-1489	HUMAN PRESCRIPTION DRUG	valsartan and hydrochlorothiazide		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20200212		ANDA	ANDA203000	Zydus Lifesciences Limited	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
70771-1490_7cb9ae99-0542-483d-b7b2-8eef7154bcd5	70771-1490	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200109		ANDA	ANDA206533	Zydus Lifesciences Limited	ACETAZOLAMIDE SODIUM	500	mg/5mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70771-1491_66f093f5-72d2-40e3-bf48-12b511f5b79c	70771-1491	HUMAN PRESCRIPTION DRUG	leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA212308	Zydus Lifesciences Limited	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20241231
70771-1492_66f093f5-72d2-40e3-bf48-12b511f5b79c	70771-1492	HUMAN PRESCRIPTION DRUG	leflunomide		leflunomide	TABLET, FILM COATED	ORAL	20190426		ANDA	ANDA212308	Zydus Lifesciences Limited	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
70771-1493_22ed58e6-f8f2-422c-8db0-ce133bf187ae	70771-1493	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190530		ANDA	ANDA206296	Zydus Lifesciences Limited	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1494_22ed58e6-f8f2-422c-8db0-ce133bf187ae	70771-1494	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190530		ANDA	ANDA206296	Zydus Lifesciences Limited	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70771-1495_ccb643ba-3ba2-485e-9419-339d5c68dc1a	70771-1495	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20190723		ANDA	ANDA211567	Zydus Lifesciences Limited	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
70771-1498_c1298c3a-cf72-42be-8748-ad520666e589	70771-1498	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	LOTION	TOPICAL	20200430		ANDA	ANDA205249	Zydus Lifesciences Limited	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1499_4a21f8ec-5c2e-49ae-9927-2fd1fcb4fbd8	70771-1499	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA210188	Zydus Lifesciences Limited	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70771-1500_4a21f8ec-5c2e-49ae-9927-2fd1fcb4fbd8	70771-1500	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA210188	Zydus Lifesciences Limited	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70771-1501_3b64c3fa-5b13-4c53-96e1-221685297680	70771-1501	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Lifesciences Limited	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1502_3b64c3fa-5b13-4c53-96e1-221685297680	70771-1502	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Lifesciences Limited	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1503_3b64c3fa-5b13-4c53-96e1-221685297680	70771-1503	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Lifesciences Limited	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1504_3b64c3fa-5b13-4c53-96e1-221685297680	70771-1504	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Lifesciences Limited	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1505_3b64c3fa-5b13-4c53-96e1-221685297680	70771-1505	HUMAN PRESCRIPTION DRUG	Isosorbide dinitrate		Isosorbide dinitrate	TABLET	ORAL	20191125		ANDA	ANDA213057	Zydus Lifesciences Limited	ISOSORBIDE DINITRATE	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1506_d3461dfb-7d9c-4944-b9fc-eea60d27da40	70771-1506	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Lifesciences Limited	CHLORPROMAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1507_d3461dfb-7d9c-4944-b9fc-eea60d27da40	70771-1507	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Lifesciences Limited	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1508_d3461dfb-7d9c-4944-b9fc-eea60d27da40	70771-1508	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Lifesciences Limited	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1509_d3461dfb-7d9c-4944-b9fc-eea60d27da40	70771-1509	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Lifesciences Limited	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1510_d3461dfb-7d9c-4944-b9fc-eea60d27da40	70771-1510	HUMAN PRESCRIPTION DRUG	Chlorpromazine hydrochloride		Chlorpromazine hydrochloride	TABLET, FILM COATED	ORAL	20200127		ANDA	ANDA213368	Zydus Lifesciences Limited	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1513_2d9461f3-adf4-4c79-9cec-f4c224b24928	70771-1513	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	SUPPOSITORY	RECTAL	20200214		ANDA	ANDA208953	Zydus Lifesciences Limited	MESALAMINE	1000	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70771-1514_7a313df4-d238-43c3-a5e2-e68e45624a7b	70771-1514	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotirigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Lifesciences Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70771-1515_7a313df4-d238-43c3-a5e2-e68e45624a7b	70771-1515	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotirigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Lifesciences Limited	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70771-1516_7a313df4-d238-43c3-a5e2-e68e45624a7b	70771-1516	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotirigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Lifesciences Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70771-1517_7a313df4-d238-43c3-a5e2-e68e45624a7b	70771-1517	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotirigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Lifesciences Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70771-1518_7a313df4-d238-43c3-a5e2-e68e45624a7b	70771-1518	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotirigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Lifesciences Limited	LAMOTRIGINE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70771-1519_7a313df4-d238-43c3-a5e2-e68e45624a7b	70771-1519	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotirigine	TABLET, EXTENDED RELEASE	ORAL	20200514		ANDA	ANDA207763	Zydus Lifesciences Limited	LAMOTRIGINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70771-1520_166472cf-5039-4c67-8cde-2a4c13907fa3	70771-1520	HUMAN PRESCRIPTION DRUG	Sevelamer carbonate		Sevelamer carbonate	TABLET, FILM COATED	ORAL	20200917		ANDA	ANDA207759	Zydus Lifesciences Limited	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
70771-1521_5624fa69-eae5-43bf-aa7e-379266edd77f	70771-1521	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20200430		ANDA	ANDA213065	Cadila Healthcare Limited	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
70771-1522_5624fa69-eae5-43bf-aa7e-379266edd77f	70771-1522	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20200430		ANDA	ANDA213065	Cadila Healthcare Limited	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
70771-1523_5624fa69-eae5-43bf-aa7e-379266edd77f	70771-1523	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib	TABLET, FILM COATED	ORAL	20200430		ANDA	ANDA213065	Cadila Healthcare Limited	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
70771-1524_25890e36-58bd-40f6-91ea-9d48395d76bf	70771-1524	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20210121		ANDA	ANDA214295	Zydus Lifesciences Limited	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
70771-1525_e7389f3e-074b-44ca-b767-5520390265e5	70771-1525	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202		ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
70771-1526_e7389f3e-074b-44ca-b767-5520390265e5	70771-1526	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202		ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
70771-1527_e7389f3e-074b-44ca-b767-5520390265e5	70771-1527	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220202		ANDA	ANDA214184	Zydus Lifesciences Limited	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
70771-1528_7527369f-667a-4706-b7ac-6ea6bc643e88	70771-1528	HUMAN PRESCRIPTION DRUG	doxepin		doxepin	TABLET	ORAL	20230825		ANDA	ANDA202761	Zydus Lifesciences Limited	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1529_7527369f-667a-4706-b7ac-6ea6bc643e88	70771-1529	HUMAN PRESCRIPTION DRUG	doxepin		doxepin	TABLET	ORAL	20230825		ANDA	ANDA202761	Zydus Lifesciences Limited	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1530_71df19ca-2bf4-489c-a411-ee237d511b8b	70771-1530	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210538	Zydus Lifesciences Limited	DIMETHYL FUMARATE	120	mg/1			N	20241231
70771-1531_71df19ca-2bf4-489c-a411-ee237d511b8b	70771-1531	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	CAPSULE, DELAYED RELEASE	ORAL	20200928		ANDA	ANDA210538	Zydus Lifesciences Limited	DIMETHYL FUMARATE	240	mg/1			N	20241231
70771-1532_71df19ca-2bf4-489c-a411-ee237d511b8b	70771-1532	HUMAN PRESCRIPTION DRUG	dimethyl fumarate		dimethyl fumarate	KIT		20200928		ANDA	ANDA210538	Zydus Lifesciences Limited						N	20241231
70771-1539_83635604-72b7-4eb4-b8d9-5ae556041b4d	70771-1539	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20201029		ANDA	ANDA213957	Zydus Lifesciences Limited	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70771-1540_83635604-72b7-4eb4-b8d9-5ae556041b4d	70771-1540	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20201029		ANDA	ANDA213957	Zydus Lifesciences Limited	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70771-1548_35a32479-429b-4e71-9c5c-1e8ddbdff5e7	70771-1548	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230630		ANDA	ANDA212693	Zydus Lifesciences Limited	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70771-1549_35a32479-429b-4e71-9c5c-1e8ddbdff5e7	70771-1549	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230630		ANDA	ANDA212693	Zydus Lifesciences Limited	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70771-1550_34685b34-d41c-4a8b-b6db-9cd17e4ced70	70771-1550	HUMAN PRESCRIPTION DRUG	betamethasone dipropionate		betamethasone dipropionate	OINTMENT	TOPICAL	20200720		ANDA	ANDA214048	Zydus Lifesciences Limited	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70771-1552_4c93b558-a741-4ffc-b061-21e98465a727	70771-1552	HUMAN PRESCRIPTION DRUG	febuxostat		febuxostat	TABLET	ORAL	20230331		ANDA	ANDA205443	Zydus Lifesciences Limited	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70771-1553_4c93b558-a741-4ffc-b061-21e98465a727	70771-1553	HUMAN PRESCRIPTION DRUG	febuxostat		febuxostat	TABLET	ORAL	20230331		ANDA	ANDA205443	Zydus Lifesciences Limited	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
70771-1557_4d21b9d2-c843-4313-86db-bec7d4145863	70771-1557	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Lifesciences Limited	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70771-1558_4d21b9d2-c843-4313-86db-bec7d4145863	70771-1558	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Lifesciences Limited	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70771-1559_4d21b9d2-c843-4313-86db-bec7d4145863	70771-1559	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Lifesciences Limited	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70771-1560_4d21b9d2-c843-4313-86db-bec7d4145863	70771-1560	HUMAN PRESCRIPTION DRUG	Isotretinoin		Isotretinoin	CAPSULE	ORAL	20230912		ANDA	ANDA211568	Zydus Lifesciences Limited	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
70771-1563_260eb67a-a1fc-4dae-9f69-345ea6ad9f83	70771-1563	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Lifesciences Limited	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1564_260eb67a-a1fc-4dae-9f69-345ea6ad9f83	70771-1564	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Lifesciences Limited	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1565_260eb67a-a1fc-4dae-9f69-345ea6ad9f83	70771-1565	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Lifesciences Limited	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1566_260eb67a-a1fc-4dae-9f69-345ea6ad9f83	70771-1566	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Lifesciences Limited	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1567_260eb67a-a1fc-4dae-9f69-345ea6ad9f83	70771-1567	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20230413		ANDA	ANDA206241	Zydus Lifesciences Limited	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70771-1576_2fe3e1a1-2ef6-4bd9-8bdf-b5127873c393	70771-1576	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20221230		ANDA	ANDA213003	Zydus Lifesciences Limited	TRIAZOLAM	.125	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70771-1581_4ee0fdc9-c3a8-4cb4-8ad8-bd3223342619	70771-1581	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Lifesciences Limited	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1582_4ee0fdc9-c3a8-4cb4-8ad8-bd3223342619	70771-1582	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Lifesciences Limited	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1583_4ee0fdc9-c3a8-4cb4-8ad8-bd3223342619	70771-1583	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Lifesciences Limited	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1584_4ee0fdc9-c3a8-4cb4-8ad8-bd3223342619	70771-1584	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20210528		ANDA	ANDA214552	Zydus Lifesciences Limited	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1585_99c9fc84-8300-46fe-af6d-f4f9ca85de03	70771-1585	HUMAN PRESCRIPTION DRUG	NYSTATIN		nystatin	POWDER	TOPICAL	20211006		ANDA	ANDA208581	Zydus Lifesciences Limited	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
70771-1586_f0366f32-8d09-4d7b-9577-a977212e109e	70771-1586	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20200507		ANDA	ANDA211659	Zydus Lifesciences Limited	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
70771-1587_c38b68ec-9493-4652-bf9b-5a588566baa3	70771-1587	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20181221		ANDA	ANDA206772	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	75	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1588_c38b68ec-9493-4652-bf9b-5a588566baa3	70771-1588	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20181221		ANDA	ANDA206772	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1589_c38b68ec-9493-4652-bf9b-5a588566baa3	70771-1589	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, DELAYED RELEASE	ORAL	20181221		ANDA	ANDA206772	Zydus Lifesciences Limited	DOXYCYCLINE HYCLATE	150	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70771-1590_26e71de3-70d4-4786-83ad-e06dbdf9078c	70771-1590	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET	ORAL	20210510		ANDA	ANDA211519	Zydus Lifesciences Limited	COLCHICEINE	.3	mg/1			N	20241231
70771-1591_7d41e669-d7c9-44b9-9470-793e56fa1776	70771-1591	HUMAN PRESCRIPTION DRUG	ATAZANAVIR		ATAZANAVIR	CAPSULE	ORAL	20210504		ANDA	ANDA210575	Zydus Lifesciences Limited	ATAZANAVIR SULFATE	150	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
70771-1592_7d41e669-d7c9-44b9-9470-793e56fa1776	70771-1592	HUMAN PRESCRIPTION DRUG	ATAZANAVIR		ATAZANAVIR	CAPSULE	ORAL	20210504		ANDA	ANDA210575	Zydus Lifesciences Limited	ATAZANAVIR SULFATE	200	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
70771-1593_7d41e669-d7c9-44b9-9470-793e56fa1776	70771-1593	HUMAN PRESCRIPTION DRUG	ATAZANAVIR		ATAZANAVIR	CAPSULE	ORAL	20210504		ANDA	ANDA210575	Zydus Lifesciences Limited	ATAZANAVIR SULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]		N	20241231
70771-1595_027de750-bb64-4f6c-87ee-9c73862af579	70771-1595	HUMAN PRESCRIPTION DRUG	Midodrine hydrochloride		Midodrine hydrochloride	TABLET	ORAL	20200917		ANDA	ANDA213055	Zydus Lifesciences Limited	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70771-1596_027de750-bb64-4f6c-87ee-9c73862af579	70771-1596	HUMAN PRESCRIPTION DRUG	Midodrine hydrochloride		Midodrine hydrochloride	TABLET	ORAL	20200917		ANDA	ANDA213055	Zydus Lifesciences Limited	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70771-1597_027de750-bb64-4f6c-87ee-9c73862af579	70771-1597	HUMAN PRESCRIPTION DRUG	Midodrine hydrochloride		Midodrine hydrochloride	TABLET	ORAL	20200917		ANDA	ANDA213055	Zydus Lifesciences Limited	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70771-1598_396be9cc-cc64-4337-adf3-52339dd7f2ba	70771-1598	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		OSELTAMIVIR ACID	SUSPENSION	ORAL	20210805		ANDA	ANDA209113	Cadila Healthcare Limited	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70771-1599_c6b38e40-cd5a-41ed-92d6-eb25e9c0c725	70771-1599	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20220203		ANDA	ANDA210395	Zydus Lifesciences Limited	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70771-1600_c6b38e40-cd5a-41ed-92d6-eb25e9c0c725	70771-1600	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20220203		ANDA	ANDA210395	Zydus Lifesciences Limited	POTASSIUM CHLORIDE	1500	mg/1			N	20241231
70771-1601_f1081c30-3025-42ce-b222-824630689bb8	70771-1601	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201022		ANDA	ANDA214215	Zydus Lifesciences Limited	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70771-1602_f1081c30-3025-42ce-b222-824630689bb8	70771-1602	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201022		ANDA	ANDA214215	Zydus Lifesciences Limited	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
70771-1603_70276094-fd55-497a-bd17-fab2d24eae9a	70771-1603	HUMAN PRESCRIPTION DRUG	Fingolimod		Fingolimod	CAPSULE	ORAL	20221011		ANDA	ANDA207994	Zydus Lifesciences Limited	FINGOLIMOD HYDROCHLORIDE	.5	mg/1	Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]		N	20241231
70771-1604_205b6c54-6d0b-4c07-b4b8-7a95e9456282	70771-1604	HUMAN PRESCRIPTION DRUG	Solifenacin		Solifenacin	TABLET, FILM COATED	ORAL	20220210		ANDA	ANDA207721	Zydus Lifesciences Limited	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70771-1605_205b6c54-6d0b-4c07-b4b8-7a95e9456282	70771-1605	HUMAN PRESCRIPTION DRUG	Solifenacin		Solifenacin	TABLET, FILM COATED	ORAL	20220210		ANDA	ANDA207721	Zydus Lifesciences Limited	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70771-1606_a7867c77-59b5-4dd0-b4bf-25313acf1b50	70771-1606	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	Zydus Lifesciences Limited	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
70771-1607_a7867c77-59b5-4dd0-b4bf-25313acf1b50	70771-1607	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	Zydus Lifesciences Limited	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
70771-1608_a7867c77-59b5-4dd0-b4bf-25313acf1b50	70771-1608	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	Zydus Lifesciences Limited	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
70771-1609_1f3d60f8-b73c-459f-8f63-8cd6169a6431	70771-1609	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211818	Zydus Lifesciences Limited	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70771-1610_1f3d60f8-b73c-459f-8f63-8cd6169a6431	70771-1610	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211818	Zydus Lifesciences Limited	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70771-1611_1f3d60f8-b73c-459f-8f63-8cd6169a6431	70771-1611	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211818	Zydus Lifesciences Limited	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
70771-1612_2e1c5e82-2293-4241-87ff-df3a7398f7fc	70771-1612	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Cadila Healthcare Limited	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1613_2e1c5e82-2293-4241-87ff-df3a7398f7fc	70771-1613	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Cadila Healthcare Limited	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1614_2e1c5e82-2293-4241-87ff-df3a7398f7fc	70771-1614	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Cadila Healthcare Limited	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1615_2e1c5e82-2293-4241-87ff-df3a7398f7fc	70771-1615	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20220210		ANDA	ANDA213441	Cadila Healthcare Limited	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70771-1616_a9fd9410-c272-4f8b-b479-2ab5e9f07032	70771-1616	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Lifesciences Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70771-1617_a9fd9410-c272-4f8b-b479-2ab5e9f07032	70771-1617	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Lifesciences Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70771-1618_a9fd9410-c272-4f8b-b479-2ab5e9f07032	70771-1618	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Lifesciences Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70771-1619_a9fd9410-c272-4f8b-b479-2ab5e9f07032	70771-1619	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211118		ANDA	ANDA214213	Zydus Lifesciences Limited	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70771-1620_297635d6-fa5e-4be2-96c4-19f7139787ef	70771-1620	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA212689	Zydus Lifesciences Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	100; 150	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70771-1621_297635d6-fa5e-4be2-96c4-19f7139787ef	70771-1621	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA212689	Zydus Lifesciences Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	133; 200	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70771-1622_297635d6-fa5e-4be2-96c4-19f7139787ef	70771-1622	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210701		ANDA	ANDA212689	Zydus Lifesciences Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	167; 250	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70771-1625_be9fbab6-ec60-4e1c-9126-77029827d0fd	70771-1625	HUMAN PRESCRIPTION DRUG	Mesalamine		Mesalamine	CAPSULE, EXTENDED RELEASE	ORAL	20210813		ANDA	ANDA208954	Zydus Lifesciences Limited	MESALAMINE	.375	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70771-1626_6908877d-222b-43e6-a7e9-f264fae84be4	70771-1626	HUMAN PRESCRIPTION DRUG	FULVESTRANT		fulvestrant	INJECTION, SOLUTION	INTRAMUSCULAR	20211214		ANDA	ANDA215234	Zydus Lifesciences Limited	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
70771-1649_0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57	70771-1649	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1650_0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57	70771-1650	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1651_0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57	70771-1651	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1652_0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57	70771-1652	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20220901		ANDA	ANDA215622	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1653_9b0458b3-c649-4de2-b2b0-f9c295502d55	70771-1653	HUMAN PRESCRIPTION DRUG	Colestipol hydrochloride		Colestipol hydrochloride	TABLET, FILM COATED	ORAL	20220504		ANDA	ANDA215223	Zydus Lifesciences Limited	COLESTIPOL HYDROCHLORIDE	1	g/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
70771-1654_dda2d40b-9f09-4d9f-9073-6f6be5024838	70771-1654	HUMAN PRESCRIPTION DRUG	vigabatrin		vigabatrin	TABLET, FILM COATED	ORAL	20220120		ANDA	ANDA215707	Cadila Healthcare Limited	VIGABATRIN	500	mg/1	Anti-epileptic Agent [EPC]		N	20241231
70771-1656_432dc54b-f28b-48c9-b417-2fbae070f41b	70771-1656	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Lifesciences Limited	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1657_432dc54b-f28b-48c9-b417-2fbae070f41b	70771-1657	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Lifesciences Limited	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1658_432dc54b-f28b-48c9-b417-2fbae070f41b	70771-1658	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Lifesciences Limited	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1659_432dc54b-f28b-48c9-b417-2fbae070f41b	70771-1659	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Lifesciences Limited	TOPIRAMATE	150	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1660_432dc54b-f28b-48c9-b417-2fbae070f41b	70771-1660	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230117		ANDA	ANDA208949	Zydus Lifesciences Limited	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70771-1661_814c4c70-0fcf-4679-8890-2f3615558309	70771-1661	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20221130		ANDA	ANDA204020	Zydus Lifesciences Limited	DESVENLAFAXINE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1668_e90ee170-2f54-4826-b112-be7deab6cd36	70771-1668	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil Citrate	POWDER, FOR SUSPENSION	ORAL	20221027		ANDA	ANDA215708	Zydus Lifesciences Limited	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70771-1673_503db7e3-7dc2-4738-85d1-a0f1bfec0935	70771-1673	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20230518		ANDA	ANDA208303	Zydus Lifesciences Limited	ROFLUMILAST	250	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
70771-1674_503db7e3-7dc2-4738-85d1-a0f1bfec0935	70771-1674	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20221003		ANDA	ANDA208303	Zydus Lifesciences Limited	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
70771-1676_78176401-4605-43f7-b892-384b461ee9d8	70771-1676	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230307		ANDA	ANDA210154	Zydus Lifesciences Limited	LENALIDOMIDE	2.5	mg/1	Thalidomide Analog [EPC]		N	20241231
70771-1677_78176401-4605-43f7-b892-384b461ee9d8	70771-1677	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Lifesciences Limited	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
70771-1678_78176401-4605-43f7-b892-384b461ee9d8	70771-1678	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Lifesciences Limited	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
70771-1679_78176401-4605-43f7-b892-384b461ee9d8	70771-1679	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Lifesciences Limited	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
70771-1680_78176401-4605-43f7-b892-384b461ee9d8	70771-1680	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20230307		ANDA	ANDA210154	Zydus Lifesciences Limited	LENALIDOMIDE	20	mg/1	Thalidomide Analog [EPC]		N	20241231
70771-1681_78176401-4605-43f7-b892-384b461ee9d8	70771-1681	HUMAN PRESCRIPTION DRUG	LENALIDOMIDE		LENALIDOMIDE	CAPSULE	ORAL	20220912		ANDA	ANDA210154	Zydus Lifesciences Limited	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
70771-1682_96b87696-5bfd-4306-b00e-c66e7b93f071	70771-1682	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		Lacosamide	INJECTION	INTRAVENOUS	20220629		ANDA	ANDA209465	Zydus Lifesciences Limited	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
70771-1683_4a44243c-b3ef-4372-8084-914b28e38d84	70771-1683	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230410		ANDA	ANDA215241	Zydus Lifesciences Limited	MICAFUNGIN SODIUM	10	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
70771-1684_4a44243c-b3ef-4372-8084-914b28e38d84	70771-1684	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230410		ANDA	ANDA215241	Zydus Lifesciences Limited	MICAFUNGIN SODIUM	20	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
70771-1685_d96809f2-f942-4f6d-92b9-0a23ec84226d	70771-1685	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20211117		ANDA	ANDA215037	Zydus Lifesciences Limited	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70771-1688_8940ec64-b0cd-4f10-bc19-251146c9e552	70771-1688	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220505		ANDA	ANDA214655	Zydus Lifesciences Limited	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70771-1689_8940ec64-b0cd-4f10-bc19-251146c9e552	70771-1689	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220505		ANDA	ANDA214655	Zydus Lifesciences Limited	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70771-1690_8940ec64-b0cd-4f10-bc19-251146c9e552	70771-1690	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220505		ANDA	ANDA214655	Zydus Lifesciences Limited	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
70771-1691_fc5f4aa1-92c4-444b-8e64-53708c9a67bc	70771-1691	HUMAN PRESCRIPTION DRUG	pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220526		ANDA	ANDA214073	Zydus Lifesciences Limited	PEMETREXED DISODIUM	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70771-1692_fc5f4aa1-92c4-444b-8e64-53708c9a67bc	70771-1692	HUMAN PRESCRIPTION DRUG	pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220526		ANDA	ANDA214073	Zydus Lifesciences Limited	PEMETREXED DISODIUM	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70771-1693_fc5f4aa1-92c4-444b-8e64-53708c9a67bc	70771-1693	HUMAN PRESCRIPTION DRUG	pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220526		ANDA	ANDA214073	Zydus Lifesciences Limited	PEMETREXED DISODIUM	1000	mg/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70771-1697_d3a08f91-ab75-495d-916e-56c85cf0e29c	70771-1697	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220810		ANDA	ANDA216495	Zydus Lifesciences Limited	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1698_d3a08f91-ab75-495d-916e-56c85cf0e29c	70771-1698	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220810		ANDA	ANDA216495	Zydus Lifesciences Limited	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70771-1702_3e6a7405-b4c9-4034-8be6-41d8499ee9b2	70771-1702	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	Zydus Lifesciences Limited	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70771-1703_3e6a7405-b4c9-4034-8be6-41d8499ee9b2	70771-1703	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	Zydus Lifesciences Limited	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70771-1708_a7ff2205-566b-4fb5-8f33-bf73377ee093	70771-1708	HUMAN PRESCRIPTION DRUG	BORTEZOMIB		BORTEZOMIB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220502		ANDA	ANDA210204	Zydus Lifesciences Limited	BORTEZOMIB	1	mg/mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
70771-1709_297635d6-fa5e-4be2-96c4-19f7139787ef	70771-1709	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20210324		ANDA	ANDA212689	Zydus Lifesciences Limited	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
70771-1710_3564eb21-1990-45bf-a7a7-09cc7acc3e13	70771-1710	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	Zydus Lifesciences Limited	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70771-1711_3564eb21-1990-45bf-a7a7-09cc7acc3e13	70771-1711	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	Zydus Lifesciences Limited	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70771-1712_3564eb21-1990-45bf-a7a7-09cc7acc3e13	70771-1712	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		oseltamivir phosphate	CAPSULE	ORAL	20170224		ANDA	ANDA208578	Zydus Lifesciences Limited	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
70771-1713_ad7749b0-df9a-48bb-aea5-3a603ecb0704	70771-1713	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230511		ANDA	ANDA214486	Zydus Lifesciences Limited	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
70771-1716_c5532beb-3d81-414d-84ed-580b644495ec	70771-1716	HUMAN PRESCRIPTION DRUG	Adapalene and benzoyl peroxide		Adapalene and benzoyl peroxide	GEL	TOPICAL	20220606		ANDA	ANDA214553	Zydus Lifesciences Limited	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
70771-1717_03bde1e8-da6e-4438-8c4a-0f977198b100	70771-1717	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20230202		ANDA	ANDA210153	Zydus Lifesciences Limited	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1718_03bde1e8-da6e-4438-8c4a-0f977198b100	70771-1718	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20230202		ANDA	ANDA210153	Zydus Lifesciences Limited	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1719_03bde1e8-da6e-4438-8c4a-0f977198b100	70771-1719	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20230202		ANDA	ANDA210153	Zydus Lifesciences Limited	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
70771-1726_e6a69c5b-fe95-45b3-895f-259e4b49f6c5	70771-1726	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA215680	Zydus Lifesciences Limited	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1727_e6a69c5b-fe95-45b3-895f-259e4b49f6c5	70771-1727	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA215680	Zydus Lifesciences Limited	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1728_b32bd5aa-25fa-45a8-8efc-502e16d73735	70771-1728	HUMAN PRESCRIPTION DRUG	ivermectin		ivermectin	CREAM	TOPICAL	20230610		ANDA	ANDA215210	Zydus Lifesciences Limited	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
70771-1732_069fde5e-64e7-4a55-9647-60565ce7f7a6	70771-1732	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230831		ANDA	ANDA215440	Zydus Lifesciences Limited	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70771-1733_069fde5e-64e7-4a55-9647-60565ce7f7a6	70771-1733	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20230831		ANDA	ANDA215440	Zydus Lifesciences Limited	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
70771-1734_14f4886e-e6d8-4190-8af1-c617ccd306ae	70771-1734	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Lifesciences Limited	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1735_14f4886e-e6d8-4190-8af1-c617ccd306ae	70771-1735	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Lifesciences Limited	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1736_14f4886e-e6d8-4190-8af1-c617ccd306ae	70771-1736	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Lifesciences Limited	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1737_14f4886e-e6d8-4190-8af1-c617ccd306ae	70771-1737	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Lifesciences Limited	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1738_14f4886e-e6d8-4190-8af1-c617ccd306ae	70771-1738	HUMAN PRESCRIPTION DRUG	Lurasidone hydrochloride		Lurasidone hydrochloride	TABLET, COATED	ORAL	20230201		ANDA	ANDA208052	Zydus Lifesciences Limited	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
70771-1747_05746668-a976-45cb-bb37-7af00c9b4063	70771-1747	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20221110		ANDA	ANDA217038	Zydus Lifesciences Limited	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1760_9d6e36f0-a9e4-4b66-997a-fd5f8e4e1cf7	70771-1760	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA215666	Zydus Lifesciences Limited	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1761_9d6e36f0-a9e4-4b66-997a-fd5f8e4e1cf7	70771-1761	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA215666	Zydus Lifesciences Limited	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1762_9d6e36f0-a9e4-4b66-997a-fd5f8e4e1cf7	70771-1762	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA215666	Zydus Lifesciences Limited	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70771-1763_d529a527-d19e-4cec-a117-ddc6cab4a8b1	70771-1763	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20230323		ANDA	ANDA214131	Zydus Lifesciences Limited	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
70771-1764_d529a527-d19e-4cec-a117-ddc6cab4a8b1	70771-1764	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE	ORAL	20230323		ANDA	ANDA214131	Zydus Lifesciences Limited	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
70771-1766_6d0a7b56-9d42-4fe8-9166-408267ded644	70771-1766	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	SUPPOSITORY	RECTAL	20230803		ANDA	ANDA216184	Zydus Lifesciences Limited	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70771-1767_c12095f8-fb7f-4654-bcaf-e2068297c20d	70771-1767	HUMAN PRESCRIPTION DRUG	Methylene blue		Methylene blue	INJECTION	INTRAVENOUS	20231205		ANDA	ANDA215636	Zydus Lifesciences Limited	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
70771-1768_c12095f8-fb7f-4654-bcaf-e2068297c20d	70771-1768	HUMAN PRESCRIPTION DRUG	Methylene blue		Methylene blue	INJECTION	INTRAVENOUS	20231205		ANDA	ANDA215636	Zydus Lifesciences Limited	METHYLENE BLUE	5	mg/mL	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
70771-1769_b43ff8ed-7175-4a7a-8e42-5c66324b495c	70771-1769	HUMAN PRESCRIPTION DRUG	Loperamide hydrochloride		Loperamide hydrochloride	CAPSULE	ORAL	20230625		ANDA	ANDA217471	Zydus Lifesciences Limited	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
70771-1770_e935111f-7b36-4991-bc5b-2a45eecc9570	70771-1770	HUMAN PRESCRIPTION DRUG	ZITUVIO		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Lifesciences Limited	SITAGLIPTIN	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70771-1771_e935111f-7b36-4991-bc5b-2a45eecc9570	70771-1771	HUMAN PRESCRIPTION DRUG	ZITUVIO		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Lifesciences Limited	SITAGLIPTIN	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70771-1772_e935111f-7b36-4991-bc5b-2a45eecc9570	70771-1772	HUMAN PRESCRIPTION DRUG	ZITUVIO		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Lifesciences Limited	SITAGLIPTIN	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70771-1773_df89bfa8-f749-4840-a207-6499b82516f5	70771-1773	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline	TABLET, FILM COATED	ORAL	20230613		ANDA	ANDA216723	Zydus Lifesciences Limited	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
70771-1774_df89bfa8-f749-4840-a207-6499b82516f5	70771-1774	HUMAN PRESCRIPTION DRUG	Varenicline		Varenicline	TABLET, FILM COATED	ORAL	20230613		ANDA	ANDA216723	Zydus Lifesciences Limited	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
70771-1776_41b76e97-b780-4fc8-b073-13bf155ad8a5	70771-1776	HUMAN PRESCRIPTION DRUG	PLERIXAFOR		plerixafor	INJECTION	SUBCUTANEOUS	20230728		ANDA	ANDA208980	Zydus Lifesciences Limited	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
70771-1777_7b3c94ab-6f2b-494f-905f-35f06ff91d14	70771-1777	HUMAN PRESCRIPTION DRUG	norelgestromin and ethinyl estradiol		norelgestromin and ethinyl estradiol	PATCH	TRANSDERMAL	20231121		ANDA	ANDA214594	Zydus Lifesciences Limited	ETHINYL ESTRADIOL; NORELGESTROMIN	35; 150	ug/mg; ug/mg	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
70771-1784_5f0f2de1-374e-449c-8796-aab39f1eb0bd	70771-1784	HUMAN PRESCRIPTION DRUG	pitavastatin calcium		pitavastatin calcium	TABLET	ORAL	20231102		ANDA	ANDA206047	Zydus Lifesciences Limited	PITAVASTATIN CALCIUM	1	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1785_5f0f2de1-374e-449c-8796-aab39f1eb0bd	70771-1785	HUMAN PRESCRIPTION DRUG	pitavastatin calcium		pitavastatin calcium	TABLET	ORAL	20231102		ANDA	ANDA206047	Zydus Lifesciences Limited	PITAVASTATIN CALCIUM	2	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1786_5f0f2de1-374e-449c-8796-aab39f1eb0bd	70771-1786	HUMAN PRESCRIPTION DRUG	pitavastatin calcium		pitavastatin calcium	TABLET	ORAL	20231102		ANDA	ANDA206047	Zydus Lifesciences Limited	PITAVASTATIN CALCIUM	4	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
70771-1790_dc9e1209-8ee7-4ddb-aadc-7057ae2a3d23	70771-1790	HUMAN PRESCRIPTION DRUG	Sitagliptin		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Lifesciences Limited	SITAGLIPTIN	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70771-1791_dc9e1209-8ee7-4ddb-aadc-7057ae2a3d23	70771-1791	HUMAN PRESCRIPTION DRUG	Sitagliptin		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Lifesciences Limited	SITAGLIPTIN	50	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70771-1792_dc9e1209-8ee7-4ddb-aadc-7057ae2a3d23	70771-1792	HUMAN PRESCRIPTION DRUG	Sitagliptin		Sitagliptin	TABLET	ORAL	20231130		NDA	NDA211566	Zydus Lifesciences Limited	SITAGLIPTIN	100	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
70771-1808_4f3b08de-3446-4178-91d8-3d1a0d210034	70771-1808	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CREAM	TOPICAL	20230303		ANDA	ANDA206770	Zydus Lifesciences Limited	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70771-1826_2dc8a532-94cd-47eb-93d9-d0e1abd6ed57	70771-1826	HUMAN PRESCRIPTION DRUG	Tavaborole		Tavaborole	SOLUTION	TOPICAL	20230424		ANDA	ANDA212294	Zydus Lifesciences Limited	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
70771-1827_aacf2f32-87d2-4865-8d33-c96a03a202c6	70771-1827	HUMAN PRESCRIPTION DRUG	acetaZOLAMIDE		acetaZOLAMIDE	TABLET	ORAL	20230715		ANDA	ANDA211069	Zydus Lifesciences Limited	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70771-1828_aacf2f32-87d2-4865-8d33-c96a03a202c6	70771-1828	HUMAN PRESCRIPTION DRUG	acetaZOLAMIDE		acetaZOLAMIDE	TABLET	ORAL	20230715		ANDA	ANDA211069	Zydus Lifesciences Limited	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70771-1833_d11a3885-80a2-410a-959c-9f71ad56d4b3	70771-1833	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20230520		ANDA	ANDA215705	Zydus Lifesciences Limited	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
70771-1834_bac9d2c8-3d87-4ec8-aa22-760d3c66440b	70771-1834	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	CREAM	TOPICAL	20230531		ANDA	ANDA217128	Zydus Lifesciences Limited	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70771-1836_665f7293-1792-4b57-b8af-3e1fc33e8200	70771-1836	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230518		ANDA	ANDA090174	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1837_665f7293-1792-4b57-b8af-3e1fc33e8200	70771-1837	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230518		ANDA	ANDA090174	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1838_665f7293-1792-4b57-b8af-3e1fc33e8200	70771-1838	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230518		ANDA	ANDA090174	Zydus Lifesciences Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70771-1841_32052910-2906-4975-9e5f-9bab7c2d579d	70771-1841	HUMAN PRESCRIPTION DRUG	balsalazide disodium		balsalazide disodium	CAPSULE	ORAL	20230825		ANDA	ANDA217592	Zydus Lifesciences Limited	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
70771-1848_4a7d1f4a-5a38-48a6-9eae-0616d6c77ecd	70771-1848	HUMAN PRESCRIPTION DRUG	zinc sulfate		zinc sulfate	INJECTION, SOLUTION	INTRAVENOUS	20231207		ANDA	ANDA217074	Zydus Lifesciences Limited	ZINC SULFATE	1	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70771-1849_4a7d1f4a-5a38-48a6-9eae-0616d6c77ecd	70771-1849	HUMAN PRESCRIPTION DRUG	zinc sulfate		zinc sulfate	INJECTION, SOLUTION	INTRAVENOUS	20231207		ANDA	ANDA217074	Zydus Lifesciences Limited	ZINC SULFATE	3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70771-1850_4a7d1f4a-5a38-48a6-9eae-0616d6c77ecd	70771-1850	HUMAN PRESCRIPTION DRUG	zinc sulfate		zinc sulfate	INJECTION, SOLUTION	INTRAVENOUS	20231207		ANDA	ANDA217074	Zydus Lifesciences Limited	ZINC SULFATE	5	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70771-1851_04562fb6-450e-4345-ac35-6bc8c940682a	70771-1851	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Lifesciences Limited	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70771-1852_04562fb6-450e-4345-ac35-6bc8c940682a	70771-1852	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Lifesciences Limited	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70771-1853_04562fb6-450e-4345-ac35-6bc8c940682a	70771-1853	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Lifesciences Limited	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70771-1854_04562fb6-450e-4345-ac35-6bc8c940682a	70771-1854	HUMAN PRESCRIPTION DRUG	Haloperidol decanoate		Haloperidol decanoate	INJECTION	INTRAMUSCULAR	20191114		ANDA	ANDA211180	Zydus Lifesciences Limited	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
70771-1855_63bb3224-d5c6-4756-9e39-c6d82edac14d	70771-1855	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	GEL	TOPICAL	20230920		ANDA	ANDA216587	Zydus Lifesciences Limited	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
70771-1858_709dd70b-24e1-435f-8373-02e6dd538b2c	70771-1858	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20231113		ANDA	ANDA207382	Zydus Lifesciences Limited	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70780-151_0b606f75-bcef-9046-e063-6294a90a67db	70780-151	HUMAN OTC DRUG	MyTerra Hand Sanitizer Foam NA		Benzalkonium Chloride	SOAP	TOPICAL	20171030		OTC MONOGRAPH DRUG	505G(a)(3)	PortionPac Chemical Corporation	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
70793-008_13e27339-db70-4077-8126-0c5680795864	70793-008	HUMAN OTC DRUG	ZOEY naturals Island Hibiscus HAND SANITIZER		Ethyl Alcohol	SPRAY	TOPICAL	20200309		OTC MONOGRAPH NOT FINAL	part333A	Absolutely Natural, Inc.	ALCOHOL	70	mL/100mL			N	20241231
70793-009_1582528f-3a80-434d-8980-daf64a9ed8b7	70793-009	HUMAN OTC DRUG	ZOEY naturals English Garden HAND SANITIZER		Ethyl Alcohol	SPRAY	TOPICAL	20200309		OTC MONOGRAPH NOT FINAL	part333A	Absolutely Natural	ALCOHOL	70	mL/100mL			N	20241231
70793-010_24075106-163a-4a6f-aade-d98734baf8d5	70793-010	HUMAN OTC DRUG	ZOEY NATURALS DIAPER Cream		Zinc Oxide	CREAM	TOPICAL	20200309		OTC MONOGRAPH FINAL	part347	Absolutely Natural	ZINC OXIDE	15	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70793-011_6cbe224b-00a9-4482-844c-1f0e73912147	70793-011	HUMAN OTC DRUG	Absolutely Natural Rosemary and Mint Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333A	Absolutely Natural, Inc.	ALCOHOL	70	mL/100mL			N	20241231
70793-012_fcae77ba-fa2d-4b6f-909c-cc5e21cda91b	70793-012	HUMAN OTC DRUG	Absolutely Natural Cherry Blossom Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333A	Absolutely Natural, Inc.	ALCOHOL	70	mL/100mL			N	20241231
70793-013_9a34e091-f615-4721-b673-8718b920d5b0	70793-013	HUMAN OTC DRUG	Zoey Naturals Lemon Squeeze Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333A	Absolutely Natural, Inc.	ALCOHOL	70	mL/100mL			N	20241231
70793-020_7bf771c6-5996-45c4-9a21-4937e8cc19fb	70793-020	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 30 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210319	20250222	OTC MONOGRAPH DRUG	M020	Absolutely Natural, Inc.	ZINC OXIDE	18	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
70793-021_d7c8971a-9569-40ee-b923-9d58a799ad81	70793-021	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 15 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210319	20240827	OTC MONOGRAPH DRUG	M020	Absolutely Natural, Inc.	ZINC OXIDE	11	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
70793-022_5c888e4a-5ba4-4b4c-99ea-3be4485a4e89	70793-022	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 8 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210319	20240130	OTC MONOGRAPH DRUG	M020	Absolutely Natural, Inc.	ZINC OXIDE	7	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
70793-032_9cb51afc-874b-4d24-853c-166595d8c171	70793-032	HUMAN OTC DRUG	Zoey naturals Broad Spectrum SPF 50Plus Fragrance Free Sunscreen		Zinc Oxide	LOTION	TOPICAL	20230518		OTC MONOGRAPH FINAL	part352	Absolutely Natural	ZINC OXIDE	24	g/100mL			N	20241231
70793-033_65f39bbc-4e5f-4034-b679-daf4277db3b2	70793-033	HUMAN OTC DRUG	Zoey naturals Broad Spectrum SPF 50 Fragrance Free Sunscreen		Zinc Oxide	STICK	TOPICAL	20230519		OTC MONOGRAPH FINAL	part352	Absolutely Natural	ZINC OXIDE	19	g/100g			N	20241231
70793-034_5471d17b-b5df-4d07-80ea-07396ed77684	70793-034	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 50Plus Sunscreen		Zinc Oxide	LOTION	TOPICAL	20230522		OTC MONOGRAPH FINAL	part352	Absolutely Natural	ZINC OXIDE	24	g/100mL			N	20241231
70793-035_3c4805e1-9e3b-4e48-abeb-e5330da06ed7	70793-035	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 50 Sunscreen		Zinc Oxide	STICK	TOPICAL	20230522		OTC MONOGRAPH FINAL	part352	Absolutely Natural	ZINC OXIDE	19	g/100g			N	20241231
70793-036_118fb2c9-9703-412c-bb0c-65d6899f3ea0	70793-036	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 30 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20230520		OTC MONOGRAPH FINAL	part352	Absolutely Natural	ZINC OXIDE	18	g/100mL			N	20241231
70793-037_2467ddf8-47d8-4d17-8c69-b71cdbebd0ea	70793-037	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 15 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20230520		OTC MONOGRAPH FINAL	part352	Absolutely Natural	ZINC OXIDE	12	g/100mL			N	20241231
70793-038_78e3b975-dc49-4a44-b93a-c2b568af308f	70793-038	HUMAN OTC DRUG	Absolutely Natural Broad Spectrum SPF 8 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20230517		OTC MONOGRAPH FINAL	part352	Absolutely Natural	ZINC OXIDE	8	g/100mL			N	20241231
70797-160_f1ec6f51-1e23-50d9-e053-2a95a90a4cca	70797-160	HUMAN OTC DRUG	Dr. Talbots		Ethyl Alcohol	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Talbots Pharmaceuticals Family Products, LLC.	ALCOHOL	75	mL/100mL			N	20241231
70797-233_c10bb804-816a-63da-e053-2a95a90a8306	70797-233	HUMAN OTC DRUG	Dr. Talbots Vital 12		Calc fluor, Calc phos, Calc sulph, Ferrum phos, Kali mur, Kali phos, Kali sulph, Mag phos, Nat mur, Nat phos, Nat sulph, Silicea, Zinc gluc	TABLET, SOLUBLE	ORAL	20210701		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE; ZINC GLUCONATE	6; 3; 3; 3; 3; 3; 3; 6; 6; 3; 3; 3; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70797-308_c0963200-67de-6349-e053-2a95a90adde1	70797-308	HUMAN OTC DRUG	Dr. Talbots Infant Daily Allergy Relief		Allium cepa, Aralia racemosa, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Luffa operculata, Pulsatilla, Solidago, Natrum muriaticum	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC	ANEMONE PULSATILLA; ARALIA RACEMOSA ROOT; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; ONION; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 12; 12; 12; 12; 6; 12	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
70797-310_cda11a45-6019-dbac-e053-2a95a90a2c1b	70797-310	HUMAN OTC DRUG	Dr. Talbots Gas Colic Relief		Carbo vegetabilis, Chamomilla, Foeniculum vulgare, Lycopodium, Nux moschata, Raphanus sativus, Zingiber officinale, Kali muriaticum, Magnesia phosphorica, Natrum phosphoricum	LIQUID	ORAL	20200720		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC	ACTIVATED CHARCOAL; FENNEL SEED; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; NUTMEG; POTASSIUM CHLORIDE; RADISH; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	12; 12; 12; 30; 12; 12; 12; 6; 12; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
70797-311_cda11fa8-ab3d-bd89-e053-2a95a90a8c0e	70797-311	HUMAN OTC DRUG	Dr. Talbots Tummy Ache Relief		Calendula officinalis, Carbo vegetabilis, Chamomilla, Foeniculum vulgare, Lycopodium, Nux moschata, Zingiber officinale, Kali muriaticum, Magnesia phosphorica, Natrum phosphoricum	LIQUID	ORAL	20200710		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC	ACTIVATED CHARCOAL; CALENDULA OFFICINALIS FLOWERING TOP; FENNEL SEED; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; NUTMEG; POTASSIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	12; 12; 12; 12; 30; 12; 12; 12; 6; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70797-312_cda1180e-7f6a-69b2-e053-2995a90a5015	70797-312	HUMAN OTC DRUG	Dr. Talbots Daily Allergy Relief		Allium cepa, Aralia racemosa, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Luffa operculata, Pulsatilla, Solidago, Natrum muriaticum	LIQUID	ORAL	20200720		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC.	ANEMONE PULSATILLA; ARALIA RACEMOSA ROOT; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; ONION; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 12; 12; 12; 12; 6; 12	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
70797-313_cda11a45-601a-dbac-e053-2a95a90a2c1b	70797-313	HUMAN OTC DRUG	Dr. Talbots Mucus Cold Relief		Eupatorium perf, Hepar sulphuris calcareum, Kali bichromicum, Marrubium vulgare, Phosphorus, Pulsatilla, Rumex crispus, Sambucus nigra, Calcarea sulphurica, Ferrum phosphoricum, Kali muriaticum	LIQUID	ORAL	20200720		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC.	ANEMONE PULSATILLA; CALCIUM SULFATE ANHYDROUS; CALCIUM SULFIDE; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; MARRUBIUM VULGARE; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP	12; 12; 12; 12; 12; 12; 30; 6; 12; 12; 12	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70797-314_cda0f4dc-f551-a6b7-e053-2a95a90a7745	70797-314	HUMAN OTC DRUG	Dr. Talbots Cough Relief		Antimonium tartaricum, Drosera rotundifolia, Ipecacuanha, Phosphorus, Rumex crispus, Spongia Tosta, Sticta pulmonaria, Kali sulphuricum	LIQUID	ORAL	20200720		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC.	ANTIMONY TARTRATE ION; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PHOSPHORUS; POTASSIUM SULFATE; PULMONARIA OFFICINALIS WHOLE; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	12; 12; 12; 12; 6; 12; 12; 12	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70797-315_cda0f5bd-dc31-4faf-e053-2995a90ad4ae	70797-315	HUMAN OTC DRUG	Dr. Talbots Pain Fever Relief		Calendula officinalis, Chamomilla, Echinacea angustifolia, Eupatorium perfoliatum, Hepar sulphuris calcareum, Sulphur, Ferrum phosphoricum, Kali muriaticum	LIQUID	ORAL	20200720		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC.	CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COSMOS SULPHUREUS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; MATRICARIA CHAMOMILLA; POTASSIUM CHLORIDE	12; 12; 12; 12; 12; 12; 12; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70797-316_cda1180e-7f69-69b2-e053-2995a90a5015	70797-316	HUMAN OTC DRUG	Dr. Talbots Pain Inflammation Relief		Arnica, Bellis perennis, Calendula Officinalis, Chamomilla, Coffea Cruda, Hypericum, Millefolium, Ferrum phosphoricum, Kali muriaticum, Magnesia phosphorica	LIQUID	ORAL	20200720		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products, LLC.	ACHILLEA MILLEFOLIUM; ARABICA COFFEE BEAN; ARNICA MONTANA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC; MATRICARIA CHAMOMILLA; POTASSIUM CHLORIDE	12; 12; 12; 12; 12; 12; 12; 6; 12; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS]		N	20241231
70797-317_e9c24994-b936-36e6-e053-2a95a90a78df	70797-317	HUMAN OTC DRUG	Dr Talbots Infant Tummy Ache Relief		Calendula officinalis 12X,Carbo vegetabilis 12X,Lycopodium 30X,Foeniculum vulgare 12X,Nux moschata 12X,Zingiber officinale 12X,Kali muriaticum 6X,Magnesia phosphorica 12X,Natrum phosphoricum 6X	LIQUID	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products,LLC.	ACTIVATED CHARCOAL; CALENDULA OFFICINALIS FLOWERING TOP; FENNEL SEED; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; NUTMEG; POTASSIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	12; 12; 12; 12; 30; 12; 12; 12; 6; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70797-318_eff981fd-5437-7c34-e053-2a95a90a3e8e	70797-318	HUMAN OTC DRUG	Dr Talbots Infant Pain Fever Relief		Calendula officinalis 12X,Chamomilla 12X,Echinacea angustifolia 12X,Eupatorium perfoliatum 12X,Hepar sulphuris calcareum 12X,Sulphur 12X,Ferrum phosphoricum 12X,Kali muriaticum 6X	LIQUID	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products,LLC.	CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COSMOS SULPHUREUS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; MATRICARIA CHAMOMILLA; POTASSIUM CHLORIDE	12; 12; 12; 12; 12; 12; 12; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70797-319_e8902c05-3304-2e0f-e053-2a95a90aa15d	70797-319	HUMAN OTC DRUG	Dr Talbots Infant Cough Relief		Antimonium tartaricum 12X,Drosera rotundifolia 12X,Ipecacuanha 12X,Phosphorus 12X,Rumex crispus 12X,Spongia tosta 12X,Sticta pulmonaria 12X,Kali sulphuricum 6X	LIQUID	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Talbots Pharmaceuticals Family Products, LLC.	ANTIMONY TARTRATE ION; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PHOSPHORUS; PULMONARIA OFFICINALIS WHOLE; RUMEX CRISPUS ROOT; SPONGIA OFFICINALIS SKELETON, ROASTED	12; 12; 12; 12; 12; 12; 12	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL			N	20241231
70797-320_e8917c54-f4c3-3427-e053-2995a90adbf2	70797-320	HUMAN OTC DRUG	Dr Talbots Infant Mucus Cold Relief		Eupatorium perf 12X,Hepar sulphuris calcareum 12X,Kali bichromicum 12X,Marrubium vulgare 12X,Phosphorus 30X,Pulsatilla 12X,Rumex crispus 12X,Sambucus nigra 12X,Calcarea sulphurica 12X,Ferrum phosphoricum 12X	LIQUID	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Talbots Pharmaceuticals Family Products, LLC.	ANEMONE PULSATILLA; CALCIUM SULFATE ANHYDROUS; CALCIUM SULFIDE; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERROSOFERRIC PHOSPHATE; MARRUBIUM VULGARE; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM DICHROMATE; RUMEX CRISPUS ROOT; SAMBUCUS NIGRA FLOWERING TOP	12; 12; 12; 12; 12; 12; 30; 6; 12; 12; 12	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_Q]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70797-321_e892c0cb-03b5-52da-e053-2995a90a0878	70797-321	HUMAN OTC DRUG	Dr Talbots Infant Pain Inflamtion Relief		Arnica 12X,Bellis perennis 12X,Calendula officinalis 12X,Chamomilla 12X,Coffea cruda 12X,Hypericum 12X,Millefolium 12X,Ferrum phosphoricum 12X,Kali muriaticum 6X,Magnesia phosphorica 6X	LIQUID	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Talbots Pharmaceuticals Family Products, LLC.	ARABICA COFFEE BEAN; ARNICA MONTANA; BELLIS PERENNIS; CALENDULA OFFICINALIS FLOWERING TOP; FERROSOFERRIC PHOSPHATE; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; POTASSIUM CHLORIDE	12; 12; 12; 12; 12; 12; 6; 12; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
70797-322_e8bdcc8a-c948-ff5d-e053-2a95a90a3b92	70797-322	HUMAN OTC DRUG	Dr Talbots Infant Daily Allergy Relief		Allium cepa 12X,Aralia racemosa 12X,Euphrasia officinalis 12X,Galphimia glauca 12X,Histaminum hydrochloricum 12X,Luffa operculata 12X,Pulsatilla 12X,Solidago 12X,Natrum muriaticum 6X	LIQUID	ORAL	20220912		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products,LLC.	ANEMONE PULSATILLA; ARALIA RACEMOSA ROOT; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; LUFFA OPERCULATA FRUIT; ONION; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP	12; 12; 12; 12; 12; 12; 12; 6; 12	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vegetable Proteins [CS]		N	20241231
70797-323_e8bee190-04b3-4be6-e053-2a95a90a30a0	70797-323	HUMAN OTC DRUG	Dr Talbots Infgant Gas Colic Relief		Carbo vegetabilis 12X,Chamomilla 12X,Foeniculum vulgare 12X,Lycopodium 30X,Nux moschata 12X,Raphanus sativus 12X,Zingiber officinale 12X,Kali muriaticum 6X,Magnesia phosphorica 12X,Natrum phosphoricum 6X	LIQUID	ORAL	20220928		UNAPPROVED HOMEOPATHIC		Talbot's Pharmaceuticals Family Products,LLC.	ACTIVATED CHARCOAL; FENNEL SEED; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; NUTMEG; POTASSIUM CHLORIDE; RADISH; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	12; 12; 12; 30; 12; 12; 12; 6; 12; 6	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Potassium Compounds [CS], Potassium Salt [EPC], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS]		N	20241231
70803-250_0c5b602d-b977-ffad-e063-6294a90a4eee	70803-250	HUMAN OTC DRUG	ACTIVE ARGAN 365 SPF 30 BROAD SPECTRUM ACTIVATED ARGAN COMPLEX		ZINC OXIDE	OIL	TOPICAL	20190501		OTC MONOGRAPH DRUG	M020	SIBORG LLC	ZINC OXIDE	220	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70807-503_2020e043-14a2-4746-a63e-11dc4dedac97	70807-503	HUMAN PRESCRIPTION DRUG	nifedipine		nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211015		ANDA	ANDA212016	Elite Pharmaceutical Solution, Inc.	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
70809-1902_0ce28f17-7e6a-25df-e063-6294a90ab529	70809-1902	HUMAN OTC DRUG	Complexion Protection Moisturizer SPF		benzophenone, avobenzone, octinoxate, octisalate cream	CREAM	TOPICAL	20190708		OTC MONOGRAPH DRUG	M020	USRX LLC	AVOBENZONE; BENZOPHENONE; OCTINOXATE; OCTISALATE	1; 3.6; 7.5; 5	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
70809-1903_08157f18-635d-3698-e063-6394a90a8867	70809-1903	HUMAN OTC DRUG	Clear Complexion Acne Serum		Benzoyl Peroxide serum	CREAM	TOPICAL	20190708		OTC MONOGRAPH DRUG	M006	USRX LLC	BENZOYL PEROXIDE	7.5	mg/100mL			N	20241231
70809-1906_08157827-a758-1349-e063-6394a90a753d	70809-1906	HUMAN OTC DRUG	ACNE AND BLEMISH CONTROL MASK		SULFER	CREAM	TOPICAL	20200428		OTC MONOGRAPH DRUG	M006	USRX LLC	SULFUR	5	g/100mL			N	20241231
70809-1910_08158b7c-7bcd-b9d4-e063-6294a90ad86e	70809-1910	HUMAN OTC DRUG	Sheer Glow		Zinc Oxide	CREAM	TOPICAL	20010719		OTC MONOGRAPH DRUG	M020	USRX LLC	ZINC OXIDE	11.6	mg/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70809-1912_08157e80-eff8-147b-e063-6394a90aca36	70809-1912	HUMAN OTC DRUG	Complexion Protection Moisturizer SPF		zinc oxide, octisalate	CREAM	TOPICAL	20220401		OTC MONOGRAPH DRUG	M020	USRX LLC	OCTISALATE; ZINC OXIDE	5; 11.6	mg/100mL; mg/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70814-001_f2674285-9e55-c2a3-e053-2995a90a4c0b	70814-001	HUMAN OTC DRUG	MedPride Antiseptic	Alcohol Wipes	Isopropyl Alcohol	CLOTH	TOPICAL	20220810		OTC MONOGRAPH NOT FINAL	part333A	Tongling Lin'Ann Biological Technology Co., Ltd	ALCOHOL	.75	g/1			N	20241231
70839-150_03ab8798-2a41-13ea-e063-6294a90a90b7	70839-150	HUMAN PRESCRIPTION DRUG	Tekturna		aliskiren hemifumarate	TABLET, FILM COATED	ORAL	20070305		NDA	NDA021985	LXO US Inc.	ALISKIREN HEMIFUMARATE	150	mg/1	Renin Inhibitor [EPC], Renin Inhibitors [MoA]		N	20241231
70839-300_03ab8798-2a41-13ea-e063-6294a90a90b7	70839-300	HUMAN PRESCRIPTION DRUG	Tekturna		aliskiren hemifumarate	TABLET, FILM COATED	ORAL	20070305		NDA	NDA021985	LXO US Inc.	ALISKIREN HEMIFUMARATE	300	mg/1	Renin Inhibitor [EPC], Renin Inhibitors [MoA]		N	20241231
70841-0470_0c565eaf-dafa-7154-e063-6394a90a4ddb	70841-0470	HUMAN OTC DRUG	MIMO Anti-bacterial Oats-Avena		Benzalkonium Chloride	SOAP	TOPICAL	20180723	20240510	OTC MONOGRAPH DRUG	505G(a)(3)	C7 Global LLC	BENZALKONIUM CHLORIDE	.1	g/100g			N	
70842-101_3005a09f-04c1-42d2-85c9-3ed861e26c2e	70842-101	HUMAN PRESCRIPTION DRUG	Baxdela		delafloxacin meglumine	TABLET	ORAL	20170619		NDA	NDA208610	Melinta Therapeutics, LLC	DELAFLOXACIN MEGLUMINE	450	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70842-102_3005a09f-04c1-42d2-85c9-3ed861e26c2e	70842-102	HUMAN PRESCRIPTION DRUG	Baxdela		delafloxacin meglumine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170619		NDA	NDA208611	Melinta Therapeutics, LLC	DELAFLOXACIN MEGLUMINE	300	mg/10.5mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70842-110_961c1227-8d45-4e84-a5f5-718dc1b1f319	70842-110	HUMAN PRESCRIPTION DRUG	TOPROL XL		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20230703		NDA	NDA019962	Melinta Therapeutics, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70842-111_961c1227-8d45-4e84-a5f5-718dc1b1f319	70842-111	HUMAN PRESCRIPTION DRUG	TOPROL XL		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20230703		NDA	NDA019962	Melinta Therapeutics, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70842-112_961c1227-8d45-4e84-a5f5-718dc1b1f319	70842-112	HUMAN PRESCRIPTION DRUG	TOPROL XL		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20230703		NDA	NDA019962	Melinta Therapeutics, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70842-113_961c1227-8d45-4e84-a5f5-718dc1b1f319	70842-113	HUMAN PRESCRIPTION DRUG	TOPROL XL		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20230703		NDA	NDA019962	Melinta Therapeutics, LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70842-120_59f040f8-d214-44ac-a873-b9d9bee2509d	70842-120	HUMAN PRESCRIPTION DRUG	VABOMERE		Meropenem-Vaborbactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20171002		NDA	NDA209776	Melinta Therapeutics, LLC	MEROPENEM; VABORBACTAM	1; 1	g/2g; g/2g	Carbapenems [CS], Penem Antibacterial [EPC], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70842-140_14923de6-b8b7-4283-b8a7-53b32df2d9a2	70842-140	HUMAN PRESCRIPTION DRUG	Orbactiv		oritavancin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140901		NDA	NDA206334	Melinta Therapeutics, LLC	ORITAVANCIN	400	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]		N	20241231
70842-160_d3a3c81e-e562-4526-a821-7a236da1de05	70842-160	HUMAN PRESCRIPTION DRUG	Minocin		minocycline hydrochloride	INJECTION	INTRAVENOUS	20130419		NDA	NDA050444	Melinta Therapeutics, LLC	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
70842-225_118241c8-6cba-41af-90f7-97258175710f	70842-225	HUMAN PRESCRIPTION DRUG	Kimyrsa		oritavancin diphosphate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210323		NDA	NDA214155	Melinta Therapeutics, LLC	ORITAVANCIN DIPHOSPHATE	1200	mg/40mL	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]		N	20241231
70842-240_71befa52-0bd0-463a-bfb4-2259f1dba26c	70842-240	HUMAN PRESCRIPTION DRUG	REZZAYO		rezafungin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230609		NDA	NDA217417	Melinta Therapeutics, LLC	REZAFUNGIN	200	mg/1	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
70849-200_3d19523d-7cb5-2f2f-e054-00144ff88e88	70849-200	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE STRONTIUM		esomeprazole strontium	CAPSULE, DELAYED RELEASE	ORAL	20160915		NDA	NDA202342	R2 Pharma, LLC	ESOMEPRAZOLE STRONTIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70849-400_3d19523d-7cb5-2f2f-e054-00144ff88e88	70849-400	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE STRONTIUM		esomeprazole strontium	CAPSULE, DELAYED RELEASE	ORAL	20160915		NDA	NDA202342	R2 Pharma, LLC	ESOMEPRAZOLE STRONTIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
70856-3581_fdf3a261-21ed-f73f-e053-6394a90a487c	70856-3581	HUMAN OTC DRUG	Defense Antifungal Medicated Bar		Tolnaftate	SOAP	TOPICAL	20190201		OTC MONOGRAPH FINAL	M005	Defense Soap LLC	TOLNAFTATE	1	g/100g			N	20241231
70856-3582_fdf408ef-9391-a812-e053-6394a90a0017	70856-3582	HUMAN OTC DRUG	Defense Acne Care 2% Salicylic Acid		Salicylic Acid 2%	SOAP	TOPICAL	20191205		OTC MONOGRAPH FINAL	M006	Defense Soap LLC	SALICYLIC ACID	2	g/100g			N	20241231
70856-3584_0026fe0d-54fa-cd8d-e063-6294a90a1b3c	70856-3584	HUMAN OTC DRUG	Defense 1% Clotrimazole Antifungal Cream		Defense 1% Clotrimazole Antifungal Cream	CREAM	TOPICAL	20231231		OTC MONOGRAPH DRUG	M005	DEFENSE SOAP LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70857-001_d44c2b78-496a-70f3-e053-2a95a90a9ffd	70857-001	HUMAN OTC DRUG	Traulevium		Arnica Montana Radix, Calendula Officinalis, Hamamelis Virginiana, Echinacea, Echinacea Purpurea, Chamomilla, Symphytum Officinale, Bellis Perennis, Hypericum Perforatum, Millefolium, Aconitum Napellus, Belladonna, Mercurius Solubilis, Hepar Sulphuris Calcareum.	OINTMENT	TOPICAL	20161012		UNAPPROVED HOMEOPATHIC		Medical Technology Products, Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	45; 4; 3; 1; 50; 6; 225; 6; 75; 75; 225; 6; 75; 6	mg/50g; [hp_X]/50g; [hp_X]/50g; [hp_X]/50g; mg/50g; [hp_X]/50g; mg/50g; [hp_X]/50g; mg/50g; mg/50g; mg/50g; [hp_X]/50g; mg/50g; [hp_X]/50g			N	20241231
70857-002_d44bff7e-57cc-a6fa-e053-2a95a90a4e04	70857-002	HUMAN OTC DRUG	Traulevium		Belladonna, Arnica Montana Radix, Aconitum Napellus, Chamomilla, Symphytum Officinale, Calendula Officinalis, Hamamelis Virginiana, Millefolium, Hepar Sulphuris Calcareum, Mercurius Solubilis, Hypericum Perforatum, Bellis Perennis, Echinacea Angustifolia, Echinacea Purpurea.	TABLET, CHEWABLE	ORAL	20161003		UNAPPROVED HOMEOPATHIC		Medical Technology Products, Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	3; 3; 3; 4; 2; 8; 2; 8; 2; 2; 2; 3; 3; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
70857-003_d44c5766-13f6-e9cf-e053-2995a90a16b5	70857-003	HUMAN OTC DRUG	TRAULEVIUM	Pain Relief Drops	Arnica Rad, Aconitum Nap, Chamomilla, Belladonna, Symphytum, Bellis, Calendula, Echinacea, Echinacea Purp, Hamamelis, Hypericum, Millefolium, Hepar Sulph Calc, Merc Solub.	LIQUID	ORAL	20161011		UNAPPROVED HOMEOPATHIC		Medical Technology Products, Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA ROOT; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	3; 3; 3; 4; 2; 8; 2; 8; 2; 2; 2; 3; 3; 8	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL			N	20241231
70857-004_d44c63cf-1825-746a-e053-2a95a90adf65	70857-004	HUMAN OTC DRUG	Traulevium	Pain Relief Gel	Arnica Montana, Calendula Officinalis, Hamamelis Virginiana, Echinacea, Echinacea Purpurea, Chamomilla, Symphytum Officinale, Bellis Perennis, Hypericum Perforatum, Millefolium, Aconitum Napellus, Belladonna, Mercurius Solubilis, Hepar Sulphuris Calcareum.	GEL	TOPICAL	20160919		UNAPPROVED HOMEOPATHIC		Medical Technology Products, Inc.	ACHILLEA MILLEFOLIUM; ACONITUM NAPELLUS; ARNICA MONTANA; ATROPA BELLADONNA; BELLIS PERENNIS; CALCIUM SULFIDE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA; ECHINACEA, UNSPECIFIED; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; MERCURIUS SOLUBILIS	.09; 4; 3; 1; .1; 6; .45; 6; .15; .15; .45; 6; .15; 6	g/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g; g/100g; [hp_X]/100g; g/100g; [hp_X]/100g; g/100g; g/100g; g/100g; [hp_X]/100g; g/100g; [hp_X]/100g			N	20241231
70859-004_0c65b039-04db-a2ab-e063-6294a90a6453	70859-004	HUMAN PRESCRIPTION DRUG	NuDiclo TabPak		DICLOFENAC SODIUM, Capsaicin	KIT		20160726		ANDA	ANDA074514	Nucare Pharmaceuticals Inc						N	20241231
70859-054_00b2aee3-487c-56fb-e063-6394a90acac0	70859-054	HUMAN PRESCRIPTION DRUG	NuTriaRX CreamPak		TRIAMCINOLONE ACETONIDE, dimethicone	KIT	TOPICAL	20060928		UNAPPROVED DRUG OTHER		NuCare Pharmaceuticals,Inc.						N	20241231
70859-058_fbec6898-5416-dbce-e053-6294a90af139	70859-058	HUMAN PRESCRIPTION DRUG	NuDiclo SoluPak		diclofenac sodium, capsaicin	KIT		20230208		ANDA	ANDA202769	NuCare Pharmaceuticals,Inc.						N	20241231
70859-059_f5798336-6b1f-1a16-e053-2a95a90aaf12	70859-059	HUMAN PRESCRIPTION DRUG	Mpm Pak		Mpm Pak	KIT		20230224		ANDA	ANDA091178	NuCare Pharmaceuticals,Inc.						N	20241231
70859-060_0259af75-fd9d-f4dc-e063-6294a90a9850	70859-060	HUMAN PRESCRIPTION DRUG	Mpm Pak		Mpm Pak	KIT		20230224		ANDA	ANDA091178	NuCare Pharmaceuticals,Inc.						N	20241231
70859-061_fe1ece0d-a2ab-a24c-e053-6294a90ad53e	70859-061	HUMAN PRESCRIPTION DRUG	Mpm Pak		Mpm Pak	KIT		20230614		ANDA	ANDA091178	NuCare Pharmaceuticals,Inc.						N	20241231
70860-202_d911f27f-726c-47ee-8ba3-c8d6a0132bca	70860-202	HUMAN PRESCRIPTION DRUG	Pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA207352	Athenex Pharmaceutical Division, LLC.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/4.2mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70860-203_d911f27f-726c-47ee-8ba3-c8d6a0132bca	70860-203	HUMAN PRESCRIPTION DRUG	Pemetrexed		pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA207352	Athenex Pharmaceutical Division, LLC.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
70860-228_63614a5d-37f8-4842-ab14-98afc9efb7d3	70860-228	HUMAN PRESCRIPTION DRUG	Melphalan Hydrochloride		melphalan hydrochloride	KIT	INTRAVENOUS	20230901		ANDA	ANDA211463	Athenex Pharmaceutical Division, LLC.						N	20241231
70860-306_e8297459-667e-4b7e-bb45-d673edc471f2	70860-306	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		isoproterenol hydrochloride	INJECTION, SOLUTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20221213	20240930	ANDA	ANDA212189	Athenex Pharmaceutical Division, LLC.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	
70860-407_a96c3507-728b-4f48-9f8d-65067c6a8fbe	70860-407	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20220922	20251231	ANDA	ANDA203521	Athenex Pharmaceutical Division, LLC.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	
70860-454_0379ad5e-68ea-4b50-af16-5d96ea97a28a	70860-454	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20201130		ANDA	ANDA210223	Athenex Pharmaceutical Division, LLC.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
70860-700_9b812eba-3e00-4e5d-8807-6455039e9c4a	70860-700	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170115		ANDA	ANDA204216	Athenex Pharmaceutical Division, LLC.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70860-701_9b812eba-3e00-4e5d-8807-6455039e9c4a	70860-701	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170115		ANDA	ANDA204216	Athenex Pharmaceutical Division, LLC.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70860-785_e1a9e1d6-12c6-44d5-8cec-b923e0d7e171	70860-785	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		palonosetron hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20221001	20250228	ANDA	ANDA202951	Athenex Pharmaceutical Division, LLC.	PALONOSETRON HYDROCHLORIDE	.05	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
70868-810_ed673cf8-bea3-4d5a-9171-3a23ffc696c3	70868-810	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20220718		ANDA	ANDA040751	Key Therapeutics	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
70868-901_187ecd7b-c039-4c5c-a3c2-e7f7bbb02b38	70868-901	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20191226		ANDA	ANDA040489	Key Therapeutics	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70868-910_d07b8fbb-6ec1-4669-b0ea-9e97103a317e	70868-910	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20210101		ANDA	ANDA040489	Key Therapeutics	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70868-920_92114029-091f-4b75-907a-77c2a84dc69b	70868-920	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230717		ANDA	ANDA201270	Key Therapeutics	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70879-824_09d7805e-6571-5fa8-e063-6294a90ac4bb	70879-824	HUMAN OTC DRUG	Advanced Anti Aging Unscented with sunscreen SPF 20		AVOBENZONE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20170503		OTC MONOGRAPH DRUG	M020	Geneva Naturals USA, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 50; 30	mg/g; mg/g; mg/g			N	20241231
70881-100_fed2a655-dafe-434a-9685-5c840469e84e	70881-100	HUMAN OTC DRUG	Sit Clean		Benzalkonium Chloride	CLOTH	TOPICAL	20160823		OTC MONOGRAPH NOT FINAL	part333A	Sit Clean	BENZALKONIUM CHLORIDE	.13	g/g			N	20241231
70882-103_84eceb98-cd51-4392-b808-371bb0bc420d	70882-103	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20150523		ANDA	ANDA075994	Cambridge Therapeutics Technologies, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70882-104_84eceb98-cd51-4392-b808-371bb0bc420d	70882-104	HUMAN PRESCRIPTION DRUG	Lisinopril		lisinopril	TABLET	ORAL	20150523		ANDA	ANDA075994	Cambridge Therapeutics Technologies, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70882-110_84eceb98-cd51-4392-b808-371bb0bc420d	70882-110	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20150523		ANDA	ANDA075994	Cambridge Therapeutics Technologies, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
70882-111_f0063b1e-af9e-474d-96b9-0b3aa1a37ea2	70882-111	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20050823		ANDA	ANDA065189	Cambridge Therapeutics Technologies, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
70882-113_af0ae6a3-1435-40dd-a62a-ce533791a28c	70882-113	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	Cambridge Therapeutics Technologies, LLC	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70882-114_af0ae6a3-1435-40dd-a62a-ce533791a28c	70882-114	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	Cambridge Therapeutics Technologies, LLC	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
70882-117_886eec2f-5b6d-4fce-bc0d-a10e445f041f	70882-117	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Cambridge Therapeutics Technologies, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70882-124_2254915d-44f2-4c8c-9bc9-5929b99eda7f	70882-124	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Cambridge Therapeutics Technologies, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70882-125_61b6dfd4-ea72-40f3-b4cd-0a51e8a810a6	70882-125	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA091184	Cambridge Therapeutics Technologies, LLC	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
70882-128_b30b3f90-b9d8-4110-b0a8-5c18b8969832	70882-128	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Delayed Release	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Cambridge Therapeutics Technologies, LLC	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70882-130_0aa5cb55-934d-4eb1-9c3c-b986053a97da	70882-130	HUMAN PRESCRIPTION DRUG	Metronidazole250 mg	250 mg	Metronidazole	TABLET, FILM COATED	ORAL	20160613		ANDA	ANDA070040	Cambridge Therapeutics Technologies, LLC	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70882-131_1835a76b-e6ee-4e9a-b35d-9c39c6cfcbf3	70882-131	HUMAN PRESCRIPTION DRUG	Metronidazole500 mg	500 mg	Metronidazole	TABLET, FILM COATED	ORAL	20160613		ANDA	ANDA070039	Cambridge Therapeutics Technologies, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
70882-132_6478f769-c2cc-403a-ba3a-17fd73ac84c6	70882-132	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Cambridge Therapeutics Technologies, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70882-133_6478f769-c2cc-403a-ba3a-17fd73ac84c6	70882-133	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Cambridge Therapeutics Technologies, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70884-409_be1bd656-04a4-4961-e053-2a95a90a8e61	70884-409	HUMAN OTC DRUG	Tropic Sport Mineral Sunscreen	SPF 30	Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20190408	20240408	OTC MONOGRAPH NOT FINAL	part352	X3EM Brands LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 8.6	mg/100mg; mg/100mg			N	
70893-0011_0d77c8ef-a4c0-c77b-e063-6294a90a3fc3	70893-0011	HUMAN OTC DRUG	Creomulsion	Cough Medicine Adult Formula	DEXTROMETHORPHAN HYDROBROMIDE	SYRUP	ORAL	20160811		OTC MONOGRAPH DRUG	M012	Socius Care, LLC	DEXTROMETHORPHAN HYDROBROMIDE	20	mg/15mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70893-0012_0d77d531-f801-f7ce-e063-6394a90a0191	70893-0012	HUMAN OTC DRUG	Creomulsion	For Children	DEXTROMETHORPHAN HYDROBROMIDE	SYRUP	ORAL	20160811		OTC MONOGRAPH DRUG	M012	Socius Care, LLC	DEXTROMETHORPHAN HYDROBROMIDE	5	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
70900-202_f53a1288-c619-4103-e053-2a95a90a8904	70900-202	HUMAN OTC DRUG	SUNSHIELD	SPF-30	OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20160804		OTC MONOGRAPH FINAL	part352	CLINICAL CARE SKIN SOLUTIONS, INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	6.9; 3; 4	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
70907-098_09745e88-e706-aa2c-e063-6394a90a954f	70907-098	HUMAN OTC DRUG	NUMB PLUS Maximum Strength Anorectal		LIDOCAINE	GEL	TOPICAL	20201109		OTC MONOGRAPH DRUG	M015	SEENEXT VENTURE LTD	LIDOCAINE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70924-001_0c432d4a-82de-612f-e063-6394a90a2c75	70924-001	HUMAN OTC DRUG	Touchpoint Wipes	Sanitizing Wipes	Benzalkonium Chloride	CLOTH	CUTANEOUS	20160909		OTC MONOGRAPH DRUG	505G(a)(3)	Innocore Sales & Marketing Inc	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
70924-002_0c454b7b-57e1-327e-e063-6394a90a7143	70924-002	HUMAN OTC DRUG	Touchpoint Wipes Fragrance Free	Sanitizing Wipes	Benzalkonium Chloride	CLOTH	CUTANEOUS	20160909		OTC MONOGRAPH DRUG	505G(a)(3)	Innocore Sales & Marketing Inc	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
70924-003_0c45d77c-be65-6414-e063-6394a90a96a1	70924-003	HUMAN OTC DRUG	Touchpoint Hand Sanitizing Wipes Fragrance Free		Benzalkonium Chloride	CLOTH	CUTANEOUS	20200924		OTC MONOGRAPH DRUG	505G(a)(3)	Innocore Sales & Marketing Inc	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
70924-004_0c45b2a0-7faf-a2c6-e063-6294a90a04ff	70924-004	HUMAN OTC DRUG	Touchpoint Biodegradable Sanitizing Wipes		Benzalkonium Chloride	CLOTH	CUTANEOUS	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Innocore Sales & Marketing Inc	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
70924-005_0c45d77c-be75-6414-e063-6394a90a96a1	70924-005	HUMAN OTC DRUG	MaxSaver	Sanitizing Wipes	Benzalkonium Chloride	CLOTH	CUTANEOUS	20230718		OTC MONOGRAPH DRUG	505G(a)(3)	Innocore Sales & Marketing Inc	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
70927-001_0d774b08-e5e4-56c9-e063-6294a90ae8db	70927-001	HUMAN OTC DRUG	EXTERNAL ANALGESIC		camphor, capsicum, menthol	PATCH	TOPICAL	20160825		OTC MONOGRAPH DRUG	M017	Hmong 21	CAMPHOR (SYNTHETIC); CAPSAICIN; MENTHOL	96; .5; 78	mg/g; mg/g; mg/g			N	20241231
70930-107_54430c41-1ab6-4b46-ad84-8280d5972f62	70930-107	HUMAN OTC DRUG	ATOREN PREMIUM HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333E	Natuzen Co.,Ltd.	ALCOHOL	350	g/500mL			N	20241231
70930-108_55e4b0df-d9e2-42a2-a2c1-47cb5d935866	70930-108	HUMAN OTC DRUG	FINE AND CLEAR ADVANCED HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333E	Natuzen Co.,Ltd.	ALCOHOL	42	g/60mL			N	20241231
70930-110_fa60ee38-2225-4147-b3bf-3f9069003939	70930-110	HUMAN OTC DRUG	BENOA PREMIUM HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333E	Natuzen Co.,Ltd.	ALCOHOL	350	mL/500mL			N	20241231
70930-170_031f77d3-1cd5-4fde-8e55-92da56e43484	70930-170	HUMAN OTC DRUG	FINE AND CLEAR ADVANCED HAND SANITIZER		Ethyl alcohol	SPRAY	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333E	Natuzen Co.,Ltd.	ALCOHOL	350	mL/500mL			N	20241231
70934-010_f3a4f7c1-ebd4-549b-e053-2a95a90a2a87	70934-010	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20170309	20240531	ANDA	ANDA077927	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70934-011_f1eeb255-a691-4240-e053-2995a90acd2c	70934-011	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20170309	20240630	ANDA	ANDA077927	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70934-015_d7330cb5-1da2-9eb3-e053-2995a90a19fd	70934-015	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031	20240131	ANDA	ANDA091672	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
70934-016_e296bb79-a52c-7ae8-e053-2995a90a925e	70934-016	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20220627	20240331	ANDA	ANDA091179	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	
70934-019_d83d99fc-af98-c74b-e053-2a95a90aaf0a	70934-019	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20200611	20240731	ANDA	ANDA077206	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-038_ff48f0bd-7144-d34a-e053-6294a90a3c1d	70934-038	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20171031	20250731	ANDA	ANDA065256	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	
70934-040_ff49699c-cf19-13d2-e053-6394a90af079	70934-040	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20171030	20250731	ANDA	ANDA090836	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	
70934-047_f215ddd3-286e-ad07-e053-2995a90a7f18	70934-047	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/ Macrocrystalline		Nitrofurantoin Monohydrate/Macrocrystalline	CAPSULE	ORAL	20171127	20240731	NDA	NDA020064	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	
70934-049_d850757d-b75e-2b73-e053-2a95a90a736c	70934-049	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20171205	20241130	ANDA	ANDA090624	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	
70934-064_ff490c5a-24d8-8756-e053-6394a90a4980	70934-064	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20180221	20240930	ANDA	ANDA065256	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	
70934-071_f14f1d36-f9c8-1669-e053-2995a90a05a3	70934-071	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20180125	20240531	ANDA	ANDA202446	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	
70934-073_d6fa5ff3-ebde-222d-e053-2a95a90a88d5	70934-073	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20191217	20240131	ANDA	ANDA078250	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70934-074_d60a233a-c23f-4e25-e053-2995a90a6889	70934-074	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20180130	20241031	ANDA	ANDA202556	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
70934-075_f14f3ee5-2f4d-cb43-e053-2995a90adfea	70934-075	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20180202	20250131	ANDA	ANDA078925	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
70934-090_f17643ed-e2b7-f8f4-e053-2995a90abc9a	70934-090	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20180321	20250531	ANDA	ANDA078216	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-092_d8a295e4-63ea-984a-e053-2995a90a216f	70934-092	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20180326	20240531	ANDA	ANDA202433	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
70934-093_d244c753-8a4a-c362-e053-2995a90a7e1b	70934-093	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426	20250131	ANDA	ANDA077859	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	
70934-096_e1087ef7-70e1-2457-e053-2995a90a0e17	70934-096	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20180405	20240229	ANDA	ANDA040362	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
70934-098_f19a5b2a-0320-10f0-e053-2a95a90a3392	70934-098	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20180405	20240630	ANDA	ANDA075795	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-102_d7c2b2f0-b705-0bfc-e053-2a95a90a5d0a	70934-102	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20190404	20250630	ANDA	ANDA202038	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
70934-111_d101bc44-8d7d-0481-e053-2995a90a294b	70934-111	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20180516	20240229	ANDA	ANDA077293	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	
70934-122_f18537c2-e413-e1ec-e053-2a95a90a0d7c	70934-122	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20181108	20250731	ANDA	ANDA075185	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70934-125_e39d890c-967f-3e2c-e053-2a95a90aa3f3	70934-125	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220706	20240430	ANDA	ANDA090693	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
70934-135_f1f0165a-aa35-5bb0-e053-2a95a90a726e	70934-135	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20180611	20240131	ANDA	ANDA090564	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	
70934-138_f1ee8851-a383-77c5-e053-2a95a90a626c	70934-138	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20180620	20240131	ANDA	ANDA201451	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
70934-148_f3d115cc-52eb-af38-e053-2a95a90a2b54	70934-148	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20180806	20250831	ANDA	ANDA078539	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
70934-155_d656a108-139b-15f8-e053-2a95a90ad0a2	70934-155	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20181210	20240430	ANDA	ANDA077321	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
70934-170_d60a439a-b853-73af-e053-2995a90a207a	70934-170	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20180919	20240531	ANDA	ANDA202556	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
70934-171_d65667e1-7275-4303-e053-2995a90a0f3e	70934-171	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20180920	20240430	ANDA	ANDA077321	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
70934-181_d61a0f22-291f-5a93-e053-2995a90a9f44	70934-181	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20190121	20240229	ANDA	ANDA091276	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70934-187_d5e28624-a1ec-4833-e053-2a95a90a81df	70934-187	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20200224	20240229	ANDA	ANDA062269	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-188_d83cdf5b-e841-4460-e053-2995a90aa688	70934-188	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20181107	20241130	ANDA	ANDA077206	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-199_f1629845-7641-10b6-e053-2995a90ae98c	70934-199	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20181204	20240930	ANDA	ANDA077829	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70934-216_d6f97aac-8a7e-33c8-e053-2995a90a55a1	70934-216	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20181220	20240731	ANDA	ANDA065061	Denton Pharma, Inc. dba Northwind Pharmaceuticals	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	
70934-238_f1ee8cb0-32d0-a9a9-e053-2a95a90a1061	70934-238	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20190109	20250131	ANDA	ANDA040659	Denton Pharma, Inc. dba Northwind Pharmaceuticals	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
70934-239_d4feec49-8403-1683-e053-2a95a90a8144	70934-239	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20190114	20250331	ANDA	ANDA090083	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
70934-244_d83c4691-785e-d1a0-e053-2995a90ad196	70934-244	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190122	20250430	ANDA	ANDA208898	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
70934-245_d83c4691-785e-d1a0-e053-2995a90ad196	70934-245	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20190122	20250331	ANDA	ANDA208898	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
70934-252_f22bb487-c192-3d62-e053-2a95a90ad72d	70934-252	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20190221	20241031	ANDA	ANDA080704	Denton Pharma, Inc. dba Northwind Pharmaceuticals	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	
70934-255_d5f6a05f-3876-822a-e053-2995a90a19bd	70934-255	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20190122	20240331	ANDA	ANDA077836	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	
70934-264_d73449b9-4962-5122-e053-2995a90abc9d	70934-264	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20190207	20250131	ANDA	ANDA078539	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
70934-280_f057a3e9-ea33-5eae-e053-2a95a90ac0bc	70934-280	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20190213	20240531	ANDA	ANDA204742	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	
70934-291_c8973905-80cb-2372-e053-2a95a90aea08	70934-291	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	20190221	20240131	ANDA	ANDA084122	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
70934-316_f1756152-0021-bdea-e053-2a95a90ae346	70934-316	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20190318	20240831	ANDA	ANDA075593	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	
70934-318_d73449b9-4962-5122-e053-2995a90abc9d	70934-318	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20190313	20250228	ANDA	ANDA078539	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
70934-330_f14f3ee5-2f4c-cb43-e053-2995a90adfea	70934-330	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20190327	20240531	ANDA	ANDA078925	Denton Pharma, Inc. dba Northwind Pharmaceuticals	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
70934-338_c9c3eef0-a491-119d-e053-2995a90a0113	70934-338	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20190404	20240831	ANDA	ANDA077321	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
70934-351_f2045a02-6a66-55bf-e053-2a95a90af73c	70934-351	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20190502	20250831	ANDA	ANDA200981	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
70934-354_e39da38a-1f8d-1303-e053-2995a90aeadc	70934-354	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20190715	20240731	ANDA	ANDA203834	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	
70934-390_dc660d1f-8470-7e56-e053-2995a90af631	70934-390	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20190605	20241031	ANDA	ANDA077739	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
70934-415_cb9482aa-ccda-36e9-e053-2995a90aca82	70934-415	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20190726	20240531	ANDA	ANDA075991	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
70934-418_d813587e-5ec4-662f-e053-2a95a90ac27e	70934-418	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20190805	20241231	ANDA	ANDA076341	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
70934-428_f14f1243-6c84-197b-e053-2995a90a7a87	70934-428	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190813	20240331	ANDA	ANDA202446	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	
70934-429_cb8020b3-57a7-cd67-e053-2995a90accc1	70934-429	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20190813	20240229	ANDA	ANDA208774	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	
70934-442_f1851d69-4b48-13f7-e053-2995a90af2c0	70934-442	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20190917	20241031	ANDA	ANDA208170	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
70934-443_c8e7ecb2-921a-1197-e053-2a95a90a7ab8	70934-443	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20190916	20240131	ANDA	ANDA210733	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
70934-453_ee2699f4-d1d1-4ca2-e053-2995a90a0918	70934-453	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20191017	20240731	ANDA	ANDA077903	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	
70934-461_c2b1a7cb-ca62-dc2b-e053-2995a90a32ed	70934-461	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20191031	20240131	ANDA	ANDA075964	Denton Pharma, Inc. dba Northwind Pharmaceuticals	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	
70934-474_ee88cd77-1b15-d0d2-e053-2995a90af4a9	70934-474	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20191218	20241231	ANDA	ANDA040526	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	
70934-499_f1863271-689c-5279-e053-2995a90a7d1c	70934-499	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20200219	20240229	ANDA	ANDA065053	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-500_d04cb91e-bd7b-d1de-e053-2a95a90a0cce	70934-500	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20200119	20240131	ANDA	ANDA077739	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
70934-544_d8500916-caf6-2622-e053-2995a90ac5f8	70934-544	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20200212	20261231	ANDA	ANDA090624	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	
70934-549_d813021b-31ef-7494-e053-2a95a90ab0f2	70934-549	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20200206	20240430	ANDA	ANDA076341	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
70934-570_d9a67616-5766-5a4d-e053-2995a90a6305	70934-570	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20200225	20240331	ANDA	ANDA077870	Denton Pharma, Inc. dba Northwind Pharmaceuticals	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-571_f19ae5ec-7050-4029-e053-2a95a90a73fb	70934-571	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET, FILM COATED	ORAL	20200226	20240430	ANDA	ANDA086242	Denton Pharma, Inc. dba Northwind Pharmaceuticals	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
70934-594_d8da094e-927d-4e0f-e053-2995a90a4c63	70934-594	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET	ORAL	20200305	20240531	ANDA	ANDA203145	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
70934-603_d7316650-c4f6-2ce6-e053-2995a90ad286	70934-603	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20200305	20240131	ANDA	ANDA203126	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
70934-610_f189414e-6e80-b37d-e053-2a95a90aa748	70934-610	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20200313	20240331	ANDA	ANDA204097	Denton Pharma, Inc. dba Northwind Pharmaceuticals	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70934-627_f1ede694-5861-f672-e053-2995a90ae886	70934-627	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200316	20240131	ANDA	ANDA203835	Denton Pharma, Inc. dba Northwind Pharmaceuticals	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
70934-628_e60fa049-cada-65c6-e053-2995a90a4481	70934-628	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20220805	20250131	ANDA	ANDA090682	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	
70934-629_e7a29027-ae00-3c50-e053-2995a90aba0d	70934-629	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine HCl	TABLET	ORAL	20220811	20250331	ANDA	ANDA204507	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70934-630_d4af8193-5249-64d3-e053-2a95a90ab049	70934-630	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20200318	20241130	ANDA	ANDA078032	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-634_c7062955-792b-3de2-e053-2995a90af012	70934-634	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20200818	20250531	ANDA	ANDA090469	Denton Pharma, Inc. dba Northwind Pharmaceuticals	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
70934-649_f18553fc-f6ee-73d6-e053-2a95a90a2cae	70934-649	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20200402	20251031	ANDA	ANDA085082	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
70934-657_f1ec6441-50af-7764-e053-2995a90a851c	70934-657	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20200407	20240131	ANDA	ANDA203835	Denton Pharma, Inc. dba Northwind Pharmaceuticals	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
70934-666_d3af23c6-4fe1-561d-e053-2995a90a7699	70934-666	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20200415	20241231	ANDA	ANDA075795	Denton Pharma, Inc. dba Northwind Pharmaceuticals	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-675_d0113967-5d31-db35-e053-2a95a90ada42	70934-675	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20200414	20240229	ANDA	ANDA206948	Denton Pharma, Inc. dba Northwind Pharmaceuticals	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	
70934-678_f18537c2-e417-e1ec-e053-2a95a90a0d7c	70934-678	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20200422	20250228	ANDA	ANDA075185	Denton Pharma, Inc. dba Northwind Pharmaceuticals	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70934-682_f185706b-c2b4-61ac-e053-2995a90a982c	70934-682	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20200429	20241031	ANDA	ANDA085223	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
70934-690_d608d942-0e61-4afe-e053-2995a90afdc5	70934-690	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20200430	20240430	ANDA	ANDA090937	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-703_f14edf37-71fd-f3be-e053-2995a90a6070	70934-703	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200515	20240630	ANDA	ANDA202446	Denton Pharma, Inc. dba Northwind Pharmaceuticals	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	
70934-710_d5f166e2-f0cf-dd43-e053-2995a90aad78	70934-710	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20200526	20250430	ANDA	ANDA078619	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-717_a9dcd892-14df-07d6-e053-2a95a90a0ceb	70934-717	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20200519	20241130	ANDA	ANDA077912	Denton Pharma, Inc. dba Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
70934-719_c8975bd7-6dc4-0998-e053-2a95a90a7413	70934-719	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20200521	20250731	ANDA	ANDA200981	Denton Pharma, Inc. dba Northwind Pharmaceuticals	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
70934-726_f19a1de3-9f2e-0527-e053-2995a90a5ede	70934-726	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20200521	20240731	ANDA	ANDA077091	Denton Pharma, Inc. dba Northwind Pharmaceuticals	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-727_f19a379e-32de-81ea-e053-2a95a90aee76	70934-727	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20200521	20240930	ANDA	ANDA077091	Denton Pharma, Inc. dba Northwind Pharmaceuticals	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-736_f3ba0d99-f0cb-0e4a-e053-2a95a90a832a	70934-736	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20200522	20250228	ANDA	ANDA077739	Denton Pharma, Inc. dba Northwind Pharmaceuticals	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
70934-746_d7232933-a250-b187-e053-2995a90a62c5	70934-746	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218	20241031	ANDA	ANDA075927	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
70934-756_de1d004b-f814-03a5-e053-2a95a90a2b58	70934-756	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20200529	20260331	ANDA	ANDA209312	Denton Pharma, Inc. dba Northwind Pharmaceuticals	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
70934-757_cd4fd8f9-7992-c7a2-e053-2a95a90a6db8	70934-757	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	20210928	20250331	ANDA	ANDA085223	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	
70934-761_d8dd99a6-0865-3c5c-e053-2a95a90a8e61	70934-761	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20200529	20240831	ANDA	ANDA078932	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
70934-764_f19b1a89-fc4d-8746-e053-2a95a90aa82c	70934-764	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20200608	20250228	ANDA	ANDA040901	Denton Pharma, Inc. dba Northwind Pharmaceuticals	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	
70934-770_c6256d32-ab43-0c9d-e053-2a95a90a12f0	70934-770	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20210630	20240131	ANDA	ANDA077206	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-796_e729e9bf-8624-afcf-e053-2a95a90a8ce5	70934-796	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20220817	20240831	ANDA	ANDA074726	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
70934-800_da6f0391-dc87-200e-e053-2995a90a0f39	70934-800	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20201022	20240430	ANDA	ANDA075090	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	
70934-808_f1868678-9c16-3c52-e053-2995a90a5825	70934-808	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20201204	20241231	ANDA	ANDA065285	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-809_c9c4f96d-386f-1a9b-e053-2995a90ab6b2	70934-809	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20201208	20250228	ANDA	ANDA090469	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	
70934-810_bb29b03a-36b4-b91d-e053-2995a90a35e7	70934-810	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20210119	20241231	ANDA	ANDA062676	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-827_cf4380fb-90e9-5ce3-e053-2a95a90a64e2	70934-827	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210217	20240331	ANDA	ANDA090858	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
70934-828_c8e7ebd0-f9f5-6ca3-e053-2a95a90ace1c	70934-828	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20210218	20240831	ANDA	ANDA075382	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	
70934-835_f1d83733-9b02-0d6b-e053-2a95a90abe84	70934-835	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20210305	20240930	ANDA	ANDA203646	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
70934-842_c81ebb9d-f6bb-ebc2-e053-2a95a90a323c	70934-842	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20210316	20250430	ANDA	ANDA078216	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-851_f1773d46-06f4-3f6b-e053-2a95a90a281a	70934-851	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20210412	20241031	ANDA	ANDA070925	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	
70934-854_f185ad35-e816-1813-e053-2995a90adbd0	70934-854	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20210423	20250531	NDA AUTHORIZED GENERIC	NDA018602	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	
70934-855_c7ccc099-a523-fdaa-e053-2a95a90ad2ed	70934-855	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20210503	20240930	ANDA	ANDA090937	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-861_c32e1554-af6b-5e69-e053-2995a90a43b6	70934-861	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20120928	20240930	ANDA	ANDA202038	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	
70934-862_d0114d0c-b618-59f5-e053-2a95a90a7474	70934-862	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20210607	20241031	ANDA	ANDA075795	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-865_c50ba5da-9b83-9236-e053-2a95a90acf90	70934-865	HUMAN PRESCRIPTION DRUG	Clindamycin Hydrochloride		Clindamycin Hydrochloride	CAPSULE	ORAL	20210617	20250731	ANDA	ANDA065442	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	
70934-878_e20f574c-de3a-3253-e053-2995a90a2aca	70934-878	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20210806	20240229	ANDA	ANDA206928	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-880_c897c188-a18d-4db3-e053-2995a90af52d	70934-880	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20210802	20240531	ANDA	ANDA080292	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
70934-882_c93a5933-d9fc-3e59-e053-2a95a90ace4d	70934-882	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20210810	20250131	ANDA	ANDA071586	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	
70934-883_c9635f0c-45b9-b5d7-e053-2995a90a4ba8	70934-883	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20210812	20240630	ANDA	ANDA202556	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
70934-884_c9d864fd-24ff-05b2-e053-2995a90a8a1f	70934-884	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210818	20241130	ANDA	ANDA206948	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	
70934-888_f1ea3632-218b-258f-e053-2a95a90af5e0	70934-888	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20210907	20240331	ANDA	ANDA077912	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	
70934-893_e3d9ab6d-8da3-0680-e053-2a95a90aa315	70934-893	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210916	20240331	ANDA	ANDA206948	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	
70934-907_f14b570b-df7d-80d9-e053-2a95a90af434	70934-907	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20211004	20250131	ANDA	ANDA075382	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	
70934-909_f216d9ff-5324-0530-e053-2a95a90a0af3	70934-909	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20211006	20240531	ANDA	ANDA209823	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	
70934-918_f06e527b-159e-29d9-e053-2a95a90aab35	70934-918	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20211104	20240531	ANDA	ANDA209102	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	
70934-919_f1ea7d26-c960-977d-e053-2a95a90a15d4	70934-919	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20211112	20240229	ANDA	ANDA077321	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
70934-920_f14f47c7-30ce-ebc7-e053-2995a90a6a46	70934-920	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20211104	20240229	ANDA	ANDA078925	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
70934-921_f1860ca4-4679-0478-e053-2995a90a39b5	70934-921	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20211104	20240630	ANDA	ANDA075580	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXAZOSIN MESYLATE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	
70934-923_f21868a4-809f-4225-e053-2995a90acefa	70934-923	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20211116	20240531	ANDA	ANDA074726	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
70934-931_f174e1bf-fabf-a225-e053-2a95a90abbbf	70934-931	HUMAN PRESCRIPTION DRUG	Cimetidine		Cimetidine	TABLET, FILM COATED	ORAL	20211124	20240731	ANDA	ANDA074151	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CIMETIDINE	400	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	
70934-933_f199bd2f-6dc9-6d52-e053-2995a90ac06d	70934-933	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20211208	20240531	ANDA	ANDA206402	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
70934-939_f1ed7811-cdcd-23f4-e053-2a95a90af36b	70934-939	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220105	20250228	ANDA	ANDA090083	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	
70934-941_f22ae284-b51b-10e4-e053-2a95a90a06a1	70934-941	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine	TABLET	ORAL	20220112	20240331	ANDA	ANDA078932	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	
70934-944_f06c7406-c4fa-f600-e053-2995a90a9bc3	70934-944	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20220203	20240131	ANDA	ANDA077183	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
70934-945_e546c04d-1aa3-c27e-e053-2995a90a619e	70934-945	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20220209	20250131	ANDA	ANDA090564	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	
70934-947_f229cd16-c565-901e-e053-2995a90afce0	70934-947	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20220203	20240331	ANDA	ANDA077714	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	
70934-948_f2a1e74a-0334-5ad1-e053-2995a90a505d	70934-948	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20220203	20240531	ANDA	ANDA079163	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
70934-949_f185cd03-bd76-384d-e053-2a95a90a9bda	70934-949	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20220209	20240630	ANDA	ANDA079163	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	
70934-950_f199a2cc-ac0e-650a-e053-2995a90aa9cb	70934-950	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20220215	20240630	ANDA	ANDA206402	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
70934-951_f1863e5d-f2b7-2e47-e053-2a95a90af475	70934-951	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20220209	20240630	ANDA	ANDA062676	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-952_f216b61d-ef23-61c3-e053-2a95a90ac5f9	70934-952	HUMAN PRESCRIPTION DRUG	ORPHENADRINE CITRATE		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	20220222	20240430	ANDA	ANDA040284	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	
70934-953_f199bd2f-6dc8-6d52-e053-2995a90ac06d	70934-953	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220222	20240331	ANDA	ANDA090858	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	
70934-957_f186d0e3-4040-21f8-e053-2a95a90ae033	70934-957	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20220307	20240531	ANDA	ANDA202389	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-958_f227cfc0-2002-3c4c-e053-2995a90a641b	70934-958	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20220307	20241031	ANDA	ANDA077670	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	
70934-959_f19a9f34-4cd9-7d16-e053-2a95a90a5872	70934-959	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20220307	20240229	ANDA	ANDA077870	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	GLYBURIDE; METFORMIN HYDROCHLORIDE	2.5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	
70934-962_f19db111-782b-2cf2-e053-2a95a90a5b86	70934-962	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20220324	20260531	ANDA	ANDA087479	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
70934-963_f2159ae7-2c75-d909-e053-2a95a90a61f9	70934-963	HUMAN PRESCRIPTION DRUG	nifedipine		nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220408	20241031	ANDA	ANDA075289	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	
70934-965_e10891a7-9e65-ca14-e053-2995a90afa2f	70934-965	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20220502	20260831	ANDA	ANDA076126	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	
70934-966_f1eeac87-059c-f409-e053-2a95a90a3c75	70934-966	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20220503	20250131	ANDA	ANDA040659	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
70934-967_f148ac1c-49dd-7605-e053-2a95a90aac11	70934-967	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20220516	20240831	ANDA	ANDA202557	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	
70934-968_f18a8545-f194-0b55-e053-2995a90a256d	70934-968	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20220519	20240331	ANDA	ANDA204418	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	FOLIC ACID	1	mg/1			N	
70934-970_e295c653-d082-75b0-e053-2995a90a7db9	70934-970	HUMAN PRESCRIPTION DRUG	Metronidazole		METRONIDAZOLE	TABLET	ORAL	20220526	20251231	ANDA	ANDA205245	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	
70934-972_f1d73916-9e8b-3e53-e053-2a95a90a56a0	70934-972	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20220525	20240831	ANDA	ANDA075522	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
70934-979_f14e93e8-eddf-18bd-e053-2995a90a290b	70934-979	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220609	20241031	ANDA	ANDA204467	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	
70934-981_f19d5e6a-73d7-9fb3-e053-2995a90af1ce	70934-981	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20220616	20250228	ANDA	ANDA204279	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
70934-984_e2c18222-18af-1d46-e053-2a95a90a9cf3	70934-984	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20220701	20240630	ANDA	ANDA203834	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	
70934-987_e39da38a-1f8e-1303-e053-2995a90aeadc	70934-987	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20220706	20251031	ANDA	ANDA062396	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-988_e39dc634-34bf-560a-e053-2a95a90a2d0f	70934-988	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20220707	20240930	ANDA	ANDA075805	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	
70934-989_e39de19c-a2a2-7e84-e053-2a95a90a62b0	70934-989	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20220707	20250131	ANDA	ANDA090548	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	
70934-995_e546d03b-294d-af8c-e053-2995a90a3147	70934-995	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline hyclate	TABLET, COATED	ORAL	20220722	20240831	ANDA	ANDA065095	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-996_e4674ae4-9ac5-2c7b-e053-2995a90a9be7	70934-996	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	CAPSULE	ORAL	20220721	20240731	ANDA	ANDA204234	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
70934-997_e546e157-659a-1e6d-e053-2995a90a94a1	70934-997	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20220721	20241031	ANDA	ANDA071972	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
70936-102_0e0dc370-1b34-b6cc-e063-6294a90a0053	70936-102	HUMAN OTC DRUG	SMART CHOICE INCONTINENCE		ALLANTOIN, DIMETHICONE	CREAM	TOPICAL	20160823		OTC MONOGRAPH DRUG	M016	SMART CHOICE MEDICAL INC.	ALLANTOIN; DIMETHICONE	1.5; 2	g/100g; g/100g	Skin Barrier Activity [PE]		N	20251231
70942-017_d17bea66-5a3c-3aaf-e053-2995a90aca54	70942-017	HUMAN OTC DRUG	Dr. Butler Soothing Incontinence		Petrolatum 36%	SPRAY	TOPICAL	20210726		OTC MONOGRAPH FINAL	part347	Beyond Health P.A.	MINERAL OIL	59.8	g/100g			N	20241231
70942-117_f1daf55d-9133-3341-e053-2a95a90a291f	70942-117	HUMAN OTC DRUG	Dr. Butler Hemorrhoid and Perineal		Mineral Oil 59.8%,Petrolatum 36%	SPRAY	TOPICAL	20210726		OTC MONOGRAPH FINAL	part347	Beyond Health P.A.	MINERAL OIL	59.8	g/100g			N	20241231
70942-121_d92f22a7-c0b6-d8b8-e053-2a95a90a2376	70942-121	HUMAN OTC DRUG	Doctor Butlers Hemorrhoid and Fissure	External Pain Formula	Lidocaine 5%	OINTMENT	TOPICAL	20220301		OTC MONOGRAPH FINAL	part346	Beyond Health, P.A.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70942-135_d2d1c81c-6444-c4b7-e053-2995a90a14d7	70942-135	HUMAN OTC DRUG	Dr. Butler Hemorrhoid Treatment		Phenylephrine Hydrochloride 0.25%, Witch Hazel 50%	SPRAY	TOPICAL	20211210		OTC MONOGRAPH FINAL	part346	Beyond Health P.A.	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	.25; 50	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70942-157_f1d91cd2-6d14-3e7b-e053-2a95a90ab05c	70942-157	HUMAN OTC DRUG	Hand Sanitizer	Dr. Butler	Ethyl Alcohol	GEL	TOPICAL	20200326		OTC MONOGRAPH NOT FINAL	part333E	Beyond Health P.A.	ALCOHOL	62	g/mL			N	20241231
70942-183_d929d4f9-2194-0c4b-e053-2995a90a7435	70942-183	HUMAN OTC DRUG	Doctor Butlers Numb It All Cream		Lidocaine 5%	CREAM	TOPICAL	20220301		OTC MONOGRAPH FINAL	part346	Beyond Health, P.A.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70942-259_f78143d5-4249-1f13-e053-6294a90acf85	70942-259	HUMAN OTC DRUG	Dr Butler Diaper Rash		Dimethicone 1%	CREAM	TOPICAL	20230322		OTC MONOGRAPH FINAL	M016	Beyond Health P.A.	DIMETHICONE 350	1	g/100g			N	20241231
70942-357_f526199e-5c9d-7a3c-e053-2a95a90aa98e	70942-357	HUMAN OTC DRUG	Dr Butlers Hemorrhoid and Fissure PF		Lidocaine 4.00, Phenylephrine Hydrochloride 0.25	OINTMENT	TOPICAL	20230220		OTC MONOGRAPH FINAL	part346	Beyond Health P.A.	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	4; .25	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
70942-517_f1db01ad-6aab-798f-e053-2a95a90ad648	70942-517	HUMAN OTC DRUG	Doctor Butler Hemorrhoid and Fissure	Advanced Formula	Glycerin 37.5%, Lanolin 12.5%, Lidocaine 4%, Zinc Oxide 5%	OINTMENT	TOPICAL	20210920		OTC MONOGRAPH FINAL	part346	Beyond Health, PA	GLYCERIN; LANOLIN; LIDOCAINE; ZINC OXIDE	37.5; 12.5; 4; 5	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
70947-001_017d9df8-d2b1-167b-e063-6294a90a8c66	70947-001	HUMAN OTC DRUG	ETERNAL SPIRIT BEAUTY HAIR PRO ANTI-DANDRUFF		Zinc Pyrithione	SHAMPOO	TOPICAL	20210407		OTC MONOGRAPH FINAL	M032	Worldwide Cosmetics, Inc	PYRITHIONE ZINC	1	g/100mL			N	20241231
70947-010_06bca4b5-bdac-8cb4-e063-6394a90a8938	70947-010	HUMAN OTC DRUG	ETERNAL SPIRIT BEAUTY PAINLESS	PAIN RELIEVING	Menthol, Camphor	CREAM	TOPICAL	20160901		OTC MONOGRAPH DRUG	M017	Worldwide Cosmetics, Inc	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
70947-025_0bc48462-0782-ab4e-e063-6394a90a774e	70947-025	HUMAN OTC DRUG	ETERNAL SPIRIT BEAUTY FUNGI FRESH		Undecylenic Acid	LIQUID	TOPICAL	20161001		OTC MONOGRAPH DRUG	M005	Worldwide Cosmetics, Inc	UNDECYLENIC ACID	25	g/100mL			N	20241231
70947-031_0813ba80-f20f-494e-e063-6394a90a0e7d	70947-031	HUMAN OTC DRUG	ETERNAL SPIRIT BEAUTY PAINLESS WITH CBD 750		Menthol, Camphor	CREAM	TOPICAL	20220522		OTC MONOGRAPH DRUG	M017	Worldwide Cosmetics, Inc	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
70947-103_f3189c90-8606-826f-e053-2a95a90a57cf	70947-103	HUMAN OTC DRUG	ETERNAL SPIRIT BEAUTY PAINLESS WITH CBD OIL 3000		Menthol, Camphor	CREAM	TOPICAL	20220522		OTC MONOGRAPH NOT FINAL	part348	Worldwide Cosmetics, Inc	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
70947-130_0816cc99-cc30-b706-e063-6294a90aecae	70947-130	HUMAN OTC DRUG	ETERNAL SPIRIT BEAUTY PAINLESS WITH CBD 3000		Menthol, Camphor	CREAM	TOPICAL	20220522		OTC MONOGRAPH DRUG	M017	Worldwide Cosmetics, Inc	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
70947-310_f3189c90-8609-826f-e053-2a95a90a57cf	70947-310	HUMAN OTC DRUG	ETERNAL SPIRIT BEAUTY PAINLESS WITH CBD OIL 750		Menthol, Camphor	CREAM	TOPICAL	20220522		OTC MONOGRAPH NOT FINAL	part348	Worldwide Cosmetics, Inc	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
70951-123_0bf2f33a-af98-30a8-e063-6294a90a9349	70951-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20160830		UNAPPROVED MEDICAL GAS		Laurel Medical Supplies, Inc. dba Laurel Medical Solutions	OXYGEN	99	L/100L			N	20241231
70954-005_3a363c29-dbb2-4d7d-baab-c28cef107913	70954-005	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171115		ANDA	ANDA209823	Novitium Pharma LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70954-014_358d888a-c9fe-47ff-b2fb-1322de14eabc	70954-014	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Novitium Pharma LLC	THIOTHIXENE	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
70954-015_358d888a-c9fe-47ff-b2fb-1322de14eabc	70954-015	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Novitium Pharma LLC	THIOTHIXENE	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
70954-016_358d888a-c9fe-47ff-b2fb-1322de14eabc	70954-016	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Novitium Pharma LLC	THIOTHIXENE	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
70954-017_358d888a-c9fe-47ff-b2fb-1322de14eabc	70954-017	HUMAN PRESCRIPTION DRUG	Thiothixene		Thiothixene	CAPSULE	ORAL	20190405		ANDA	ANDA211642	Novitium Pharma LLC	THIOTHIXENE	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
70954-019_8c89194f-977b-4991-aa08-1a5754b10df9	70954-019	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Novitium Pharma LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70954-020_8c89194f-977b-4991-aa08-1a5754b10df9	70954-020	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Novitium Pharma LLC	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70954-021_8c89194f-977b-4991-aa08-1a5754b10df9	70954-021	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Novitium Pharma LLC	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70954-033_a304c648-f1bf-468d-a704-f4d72216f7a0	70954-033	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20191017		ANDA	ANDA210588	ANI Pharmaceuticals, Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70954-034_a304c648-f1bf-468d-a704-f4d72216f7a0	70954-034	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20191017		ANDA	ANDA210588	ANI Pharmaceuticals, Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
70954-036_7d0a148e-294d-4975-9937-5244473f665d	70954-036	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole topical	SOLUTION	TOPICAL	20190218		ANDA	ANDA209815	Novitium Pharma LLC	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
70954-041_baf8ec98-bd0c-4b87-a7ee-813335431b89	70954-041	HUMAN PRESCRIPTION DRUG	Rifabutin		Rifabutin	CAPSULE	ORAL	20211217		ANDA	ANDA215041	Novitium Pharma LLC	RIFABUTIN	150	mg/1	Rifamycin Antimycobacterial [EPC], Rifamycins [CS]		N	20241231
70954-051_ca7073d4-4e4c-48b5-892a-2c33fa54062d	70954-051	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	SUSPENSION	ORAL	20220715		ANDA	ANDA211333	Novitium Pharma LLC	FELBAMATE	600	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70954-056_b4dbe9d5-3ace-4e08-9c5f-83d40aeb9233	70954-056	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20210706		ANDA	ANDA215246	Novitium Pharma LLC	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-057_b0e7f324-399c-44cd-aa1d-edef6005462c	70954-057	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	ANI Pharmaceuticals, Inc.	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-058_b0e7f324-399c-44cd-aa1d-edef6005462c	70954-058	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	ANI Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-059_b0e7f324-399c-44cd-aa1d-edef6005462c	70954-059	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	ANI Pharmaceuticals, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-060_b0e7f324-399c-44cd-aa1d-edef6005462c	70954-060	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	ANI Pharmaceuticals, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-061_b0e7f324-399c-44cd-aa1d-edef6005462c	70954-061	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	ANI Pharmaceuticals, Inc.	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-076_1d5b7ce1-4c18-4ffe-8950-964b2276aa42	70954-076	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	CAPSULE	ORAL	20210310		ANDA	ANDA211398	Novitium Pharma LLC	MELOXICAM	5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70954-077_1d5b7ce1-4c18-4ffe-8950-964b2276aa42	70954-077	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	CAPSULE	ORAL	20210310		ANDA	ANDA211398	Novitium Pharma LLC	MELOXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70954-085_9dce6a48-2f53-4a21-8b9a-736afee9c5f1	70954-085	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20190912		ANDA	ANDA212254	Novitium Pharma LLC	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
70954-135_1efed13c-1c45-48e7-ad3d-c2355f67e6a4	70954-135	HUMAN PRESCRIPTION DRUG	DAPSONE		Dapsone	TABLET	ORAL	20180115		ANDA	ANDA206505	ANI Pharmaceuticals, Inc.	DAPSONE	25	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
70954-136_1efed13c-1c45-48e7-ad3d-c2355f67e6a4	70954-136	HUMAN PRESCRIPTION DRUG	DAPSONE		Dapsone	TABLET	ORAL	20180115		ANDA	ANDA206505	ANI Pharmaceuticals, Inc.	DAPSONE	100	mg/1	Sulfone [EPC], Sulfones [CS]		N	20241231
70954-139_0c3eed37-cba3-44c9-8b74-1e497e09f73a	70954-139	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine Oral Solution	SOLUTION	ORAL	20190814		ANDA	ANDA211676	Novitium Pharma LLC	LEVOCARNITINE	1	g/10mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
70954-140_0c3eed37-cba3-44c9-8b74-1e497e09f73a	70954-140	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine Oral Solution (Suguar Free) 1 g/10 mL	SOLUTION	ORAL	20190814		ANDA	ANDA211676	Novitium Pharma LLC	LEVOCARNITINE	1	g/10mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
70954-148_ef78ff05-8e0f-463a-88cd-ca9a01aed76a	70954-148	HUMAN PRESCRIPTION DRUG	Pyridostigmine		Pyridostigmine bromide oral	SOLUTION	ORAL	20190311		ANDA	ANDA211694	Novitium Pharma LLC	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
70954-151_bbe249ec-e0f6-4745-ae5e-ff2d2f3f64d6	70954-151	HUMAN PRESCRIPTION DRUG	Naproxen Oral Suspension		Naproxen oral	SUSPENSION	ORAL	20210312		ANDA	ANDA211910	Novitium Pharma LLC	NAPROXEN	125	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
70954-157_23835ed6-9802-4fb5-88ef-bef2655db16c	70954-157	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20221216		ANDA	ANDA213730	ANI Pharmaceuticals, Inc.	CLORAZEPATE DIPOTASSIUM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-158_23835ed6-9802-4fb5-88ef-bef2655db16c	70954-158	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20220616		ANDA	ANDA213730	ANI Pharmaceuticals, Inc.	CLORAZEPATE DIPOTASSIUM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-159_23835ed6-9802-4fb5-88ef-bef2655db16c	70954-159	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20220616		ANDA	ANDA213730	ANI Pharmaceuticals, Inc.	CLORAZEPATE DIPOTASSIUM	3.75	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-168_38afc2b0-7d38-4f51-8c70-fd553855e624	70954-168	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil citrate	FOR SUSPENSION	ORAL	20190531		ANDA	ANDA212260	ANI Pharmaceuticals, Inc.	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70954-188_7cac49f8-c8f9-4ded-86b8-5940815bcf23	70954-188	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	SUSPENSION	ORAL	20200713		ANDA	ANDA212252	Novitium Pharma LLC	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
70954-197_0128a879-7185-4b70-b0bb-d108ff1c9542	70954-197	HUMAN PRESCRIPTION DRUG	Potassium chloride		Potassium chloride	FOR SOLUTION	ORAL	20230719		ANDA	ANDA212816	ANI Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1.5	g/1.56g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
70954-200_0e300c02-ed73-4354-9a77-e29d2e6d93b4	70954-200	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220825		ANDA	ANDA215307	Novitium Pharma LLC	DIGOXIN	.0625	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70954-201_0e300c02-ed73-4354-9a77-e29d2e6d93b4	70954-201	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20211122		ANDA	ANDA215307	Novitium Pharma LLC	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70954-202_0e300c02-ed73-4354-9a77-e29d2e6d93b4	70954-202	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20211122		ANDA	ANDA215307	Novitium Pharma LLC	DIGOXIN	.25	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
70954-211_83608c13-509d-448b-8559-5f5e8a9a0d75	70954-211	HUMAN PRESCRIPTION DRUG	TRIHEXYPHENIDYL HYDROCHLORIDE		TRIHEXYPHENIDYL HYDROCHLORIDE	TABLET	ORAL	20190128		ANDA	ANDA040254	Novitium Pharma LLC	TRIHEXYPHENIDYL HYDROCHLORIDE	5	mg/1			N	20241231
70954-212_83608c13-509d-448b-8559-5f5e8a9a0d75	70954-212	HUMAN PRESCRIPTION DRUG	TRIHEXYPHENIDYL HYDROCHLORIDE		TRIHEXYPHENIDYL HYDROCHLORIDE	TABLET	ORAL	20190128		ANDA	ANDA040254	Novitium Pharma LLC	TRIHEXYPHENIDYL HYDROCHLORIDE	2	mg/1			N	20241231
70954-228_5138e347-665b-4dd6-b9f8-12f4a807ed4e	70954-228	HUMAN PRESCRIPTION DRUG	Methsuximide		Methsuximide	CAPSULE	ORAL	20230501		ANDA	ANDA217213	ANI Pharmaceuticals, Inc.	METHSUXIMIDE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
70954-240_76e6ba32-1ed6-4657-aa33-4064b898fd44	70954-240	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	SUSPENSION	ORAL	20221006		ANDA	ANDA214277	ANI Pharmaceuticals, Inc.	CARBAMAZEPINE	100	mg/5mL	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
70954-252_96dbbf53-962b-49a4-a60d-91ae0b9fb9ff	70954-252	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		Fludrocortisone Acetate	TABLET	ORAL	20220602		ANDA	ANDA215279	Novitium Pharma LLC	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
70954-255_c09c4cde-9f6c-4c4f-9d96-18beb5377564	70954-255	HUMAN PRESCRIPTION DRUG	Methyltestosterone		Methyltestosterone	CAPSULE	ORAL	20220218		ANDA	ANDA215270	Novitium Pharma LLC	METHYLTESTOSTERONE	10	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
70954-258_87d97c06-8323-488f-b75b-009c8840c411	70954-258	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	SUSPENSION	ORAL	20220208		ANDA	ANDA214330	ANI Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	200; 40	mg/5mL; mg/5mL	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
70954-261_b0911994-0b36-439d-8247-5d885a899421	70954-261	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	SOLUTION	ORAL	20210423		ANDA	ANDA214721	Novitium Pharma LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
70954-264_81589178-10c9-4806-91eb-54e638d35b8d	70954-264	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	SOLUTION	ORAL	20230524		ANDA	ANDA214512	ANI Pharmaceuticals, Inc.	ALENDRONATE SODIUM	70	mg/75mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
70954-273_6218cbd2-1f7f-40fa-92d2-5d5b0d7fa60b	70954-273	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20210301		ANDA	ANDA214674	Novitium Pharma LLC	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70954-274_6218cbd2-1f7f-40fa-92d2-5d5b0d7fa60b	70954-274	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20210301		ANDA	ANDA214674	Novitium Pharma LLC	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70954-275_6218cbd2-1f7f-40fa-92d2-5d5b0d7fa60b	70954-275	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20210301		ANDA	ANDA214674	Novitium Pharma LLC	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70954-276_6218cbd2-1f7f-40fa-92d2-5d5b0d7fa60b	70954-276	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET	ORAL	20210301		ANDA	ANDA214674	Novitium Pharma LLC	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
70954-310_12e344cb-87c4-44a1-a59a-c6bcaaa6cb2c	70954-310	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	SOLUTION	ORAL	20211102		ANDA	ANDA214102	ANI Pharmaceuticals, Inc.	VALSARTAN	4	mg/mL	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
70954-316_5dd78321-82a9-48a6-9974-d8d27e9785cf	70954-316	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SUSPENSION	ORAL	20210420		ANDA	ANDA215043	ANI Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
70954-319_02316e52-539c-488e-888e-a12f541cb075	70954-319	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	SUSPENSION	ORAL	20210903		ANDA	ANDA215003	ANI Pharmaceuticals, Inc.	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70954-365_235c3c98-4dc2-4b5e-8bdc-f21d18cbb7ac	70954-365	HUMAN PRESCRIPTION DRUG	Phenoxybenzamine Hydrochloride		Phenoxybenzamine Hydrochloride	CAPSULE	ORAL	20220719		ANDA	ANDA215042	Novitium Pharma LLC	PHENOXYBENZAMINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
70954-390_33690cc7-fffc-4620-888d-7f6453fe58c1	70954-390	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20211025		ANDA	ANDA215560	Novitium Pharma LLC	ATENOLOL; CHLORTHALIDONE	50; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70954-391_33690cc7-fffc-4620-888d-7f6453fe58c1	70954-391	HUMAN PRESCRIPTION DRUG	Atenolol and Chlorthalidone		Atenolol and Chlorthalidone	TABLET	ORAL	20211025		ANDA	ANDA215560	Novitium Pharma LLC	ATENOLOL; CHLORTHALIDONE	100; 25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
70954-398_7727b249-ac49-4f6d-9310-9de32c2a03f3	70954-398	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231009		ANDA	ANDA215604	ANI Pharmaceuticals, Inc.	DEXAMETHASONE	.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-399_7727b249-ac49-4f6d-9310-9de32c2a03f3	70954-399	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231009		ANDA	ANDA215604	ANI Pharmaceuticals, Inc.	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-401_7727b249-ac49-4f6d-9310-9de32c2a03f3	70954-401	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220808		ANDA	ANDA215604	ANI Pharmaceuticals, Inc.	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-402_7727b249-ac49-4f6d-9310-9de32c2a03f3	70954-402	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230509		ANDA	ANDA217696	ANI Pharmaceuticals, Inc.	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-403_7727b249-ac49-4f6d-9310-9de32c2a03f3	70954-403	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220808		ANDA	ANDA215604	ANI Pharmaceuticals, Inc.	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-404_7727b249-ac49-4f6d-9310-9de32c2a03f3	70954-404	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220808		ANDA	ANDA215604	ANI Pharmaceuticals, Inc.	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
70954-407_6d8dbaa6-d61a-46ae-a641-f664104f4714	70954-407	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil Citrate	TABLET	ORAL	20230829		ANDA	ANDA216383	ANI Pharmaceuticals, Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70954-408_6d8dbaa6-d61a-46ae-a641-f664104f4714	70954-408	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil Citrate	TABLET	ORAL	20230829		ANDA	ANDA216383	ANI Pharmaceuticals, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70954-409_6d8dbaa6-d61a-46ae-a641-f664104f4714	70954-409	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil Citrate	TABLET	ORAL	20230829		ANDA	ANDA216383	ANI Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70954-412_1e815b31-4689-424c-950a-d8eccd450f52	70954-412	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET	ORAL	20211104		ANDA	ANDA215562	Novitium Pharma LLC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70954-413_1e815b31-4689-424c-950a-d8eccd450f52	70954-413	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET	ORAL	20211104		ANDA	ANDA215562	Novitium Pharma LLC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70954-414_1e815b31-4689-424c-950a-d8eccd450f52	70954-414	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET	ORAL	20211104		ANDA	ANDA215562	Novitium Pharma LLC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
70954-433_1dace1e7-c617-492f-bb0d-141bf4e673db	70954-433	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230306		ANDA	ANDA215949	ANI Pharmaceuticals, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70954-434_1dace1e7-c617-492f-bb0d-141bf4e673db	70954-434	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230306		ANDA	ANDA215949	ANI Pharmaceuticals, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70954-435_1dace1e7-c617-492f-bb0d-141bf4e673db	70954-435	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230306		ANDA	ANDA215949	ANI Pharmaceuticals, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
70954-443_1054ae34-53ea-416c-9065-8af35bde3627	70954-443	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220411		ANDA	ANDA076095	ANI Pharmaceuticals, Inc.	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20251231
70954-444_1054ae34-53ea-416c-9065-8af35bde3627	70954-444	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220411		ANDA	ANDA076095	ANI Pharmaceuticals, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20251231
70954-455_6517d564-ea55-4084-a8ab-34fea548c24e	70954-455	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET	ORAL	20211029		ANDA	ANDA215563	Novitium Pharma LLC	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70954-456_6517d564-ea55-4084-a8ab-34fea548c24e	70954-456	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET	ORAL	20211029		ANDA	ANDA215563	Novitium Pharma LLC	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
70954-480_2a612458-8b9a-4125-a783-44327a8166d9	70954-480	HUMAN PRESCRIPTION DRUG	Estazolam		Estazolam	TABLET	ORAL	20210408		ANDA	ANDA074826	Novitium Pharma LLC	ESTAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-481_2a612458-8b9a-4125-a783-44327a8166d9	70954-481	HUMAN PRESCRIPTION DRUG	Estazolam		Estazolam	TABLET	ORAL	20210408		ANDA	ANDA074826	Novitium Pharma LLC	ESTAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-484_262d8829-728c-48db-b89b-88d13b87e684	70954-484	HUMAN PRESCRIPTION DRUG	Pyrazinamide		Pyrazinamide	TABLET	ORAL	20210511		ANDA	ANDA080157	Novitium Pharma LLC	PYRAZINAMIDE	500	mg/1	Antimycobacterial [EPC]		N	20241231
70954-488_5eda92ac-7993-4d08-877a-6cd6d71f94c6	70954-488	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20220826		ANDA	ANDA216151	ANI Pharmaceuticals, Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
70954-492_fc1468b6-9511-41d5-9192-ec1247b33562	70954-492	HUMAN PRESCRIPTION DRUG	Levocarnitine		Levocarnitine	TABLET	ORAL	20221209		ANDA	ANDA216384	ANI Pharmaceuticals, Inc.	LEVOCARNITINE	330	mg/1	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
70954-496_3b377aff-2d4b-43ea-84c9-8e72c1421b7b	70954-496	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20230417		ANDA	ANDA216385	ANI Pharmaceuticals, Inc.	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
70954-504_e42d99b0-c62e-49d4-b792-1301bb539b92	70954-504	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	CAPSULE	ORAL	20210401		ANDA	ANDA075352	Novitium Pharma LLC	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
70954-508_18a6f29f-7eb8-4aa2-8121-d554c59da191	70954-508	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20210511		ANDA	ANDA074174	ANI Pharmaceuticals, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-509_18a6f29f-7eb8-4aa2-8121-d554c59da191	70954-509	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20210511		ANDA	ANDA074174	ANI Pharmaceuticals, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-510_18a6f29f-7eb8-4aa2-8121-d554c59da191	70954-510	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20210511		ANDA	ANDA074174	ANI Pharmaceuticals, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-511_18a6f29f-7eb8-4aa2-8121-d554c59da191	70954-511	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20210511		ANDA	ANDA074174	ANI Pharmaceuticals, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
70954-518_ffb2d794-2c88-48a2-beff-d01b6fcea51f	70954-518	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	TOPICAL	20220323		ANDA	ANDA216250	Novitium Pharma LLC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
70954-530_ff28c624-906d-459c-8b8c-27cb1a664e12	70954-530	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20230824		ANDA	ANDA217610	ANI Pharmaceuticals, Inc.	ESTRADIOL	.5	mg/.5g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-531_ff28c624-906d-459c-8b8c-27cb1a664e12	70954-531	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20230824		ANDA	ANDA217610	ANI Pharmaceuticals, Inc.	ESTRADIOL	.25	mg/.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-532_ff28c624-906d-459c-8b8c-27cb1a664e12	70954-532	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20230824		ANDA	ANDA217610	ANI Pharmaceuticals, Inc.	ESTRADIOL	.75	mg/.75g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-533_ff28c624-906d-459c-8b8c-27cb1a664e12	70954-533	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20230824		ANDA	ANDA217610	ANI Pharmaceuticals, Inc.	ESTRADIOL	1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-534_ff28c624-906d-459c-8b8c-27cb1a664e12	70954-534	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20230824		ANDA	ANDA217610	ANI Pharmaceuticals, Inc.	ESTRADIOL	1.25	mg/1.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-538_8ab1c887-76fb-44ca-9999-4eefd3778cfc	70954-538	HUMAN PRESCRIPTION DRUG	Tranylcypromine		Tranylcypromine	TABLET	ORAL	20210606		ANDA	ANDA206856	Novitium Pharma LLC	TRANYLCYPROMINE SULFATE	10	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]		N	20241231
70954-541_95a1572c-6109-4d1f-bf92-262015a7654e	70954-541	HUMAN PRESCRIPTION DRUG	Trimethoprim		Trimethoprim	TABLET	ORAL	20221104		ANDA	ANDA216393	Novitium Pharma LLC	TRIMETHOPRIM	100	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
70954-564_3fe899db-a8cd-4a31-88fb-1129be96b4d9	70954-564	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230906		ANDA	ANDA217334	ANI Pharmaceuticals, Inc.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-565_3fe899db-a8cd-4a31-88fb-1129be96b4d9	70954-565	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230906		ANDA	ANDA217334	ANI Pharmaceuticals, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-566_3fe899db-a8cd-4a31-88fb-1129be96b4d9	70954-566	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230906		ANDA	ANDA217334	ANI Pharmaceuticals, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
70954-600_16f23bc4-03a0-4239-bce8-d5b9f6122eba	70954-600	HUMAN PRESCRIPTION DRUG	Fluoxetine Hydrochloride		Fluoxetine Hydrochloride	SOLUTION	ORAL	20221109		ANDA	ANDA216448	ANI Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	20	mg/5mL	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
70954-688_1af7e93e-11bd-4db1-873a-449d5306d98d	70954-688	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220801		ANDA	ANDA216202	ANI Pharmaceuticals, Inc.	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
70954-689_1af7e93e-11bd-4db1-873a-449d5306d98d	70954-689	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20220801		ANDA	ANDA216202	ANI Pharmaceuticals, Inc.	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
70954-804_dd441154-b196-4d4c-bc56-2e37f345ef8d	70954-804	HUMAN PRESCRIPTION DRUG	SOVUNA		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20230915		NDA	NDA214581	ANI Pharmaceuticals, Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
70954-805_dd441154-b196-4d4c-bc56-2e37f345ef8d	70954-805	HUMAN PRESCRIPTION DRUG	SOVUNA		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20230915		NDA	NDA214581	ANI Pharmaceuticals, Inc.	HYDROXYCHLOROQUINE SULFATE	300	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
70954-869_9ea4f191-ddbb-45cf-9e07-022fee9f945d	70954-869	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220719		ANDA	ANDA212722	ANI Pharmaceuticals, Inc.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
70954-870_9ea4f191-ddbb-45cf-9e07-022fee9f945d	70954-870	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, FILM COATED	ORAL	20220719		ANDA	ANDA212722	ANI Pharmaceuticals, Inc.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
70957-0020_0c40eacd-c97c-a1c0-e063-6394a90a383a	70957-0020	HUMAN OTC DRUG	Vitiligo Organics		Cullen corylifolium whole plant, Berberis vulgaris root bark, Nigella sativa seed, Organic coconut oil	OINTMENT	TOPICAL	20160907		UNAPPROVED HOMEOPATHIC		Organic Care Australia Pty LTD	BERBERIS VULGARIS ROOT BARK; CULLEN CORYLIFOLIUM WHOLE; NIGELLA SATIVA SEED	83; 83; 83	mg/125mL; mg/125mL; mg/125mL			N	20241231
70964-0001_91374e7e-c390-4e46-81e2-a69452be6726	70964-0001	HUMAN OTC DRUG	Advance Plus		Carduus Marianus, Cynara Scolymus, Solidago Virgaurea, Taraxacum Officinale, Benzoicum Acidum, Berberis Vulgaris, Bryonia (Alba), Cantharis, Carduus Benedictus, Ceanothus Americanus, Chelidonium Majus, Chionanthus Virginica, Cinchona Officinalis, Dioscorea Villosa, Dolichos Pruriens, Iris Versicolor, Juniperus Communis, Nux Vomica, Ptelea Trifoliata, Uricum Acidum	SPRAY	ORAL	20161208		UNAPPROVED HOMEOPATHIC		VitaminMed, LLC	BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CEANOTHUS AMERICANUS LEAF; CENTAUREA BENEDICTA; CHELIDONIUM MAJUS; CHIONANTHUS VIRGINICUS BARK; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; DIOSCOREA VILLOSA TUBER; IRIS VERSICOLOR ROOT; JUNIPER BERRY; LYTTA VESICATORIA; MILK THISTLE; MUCUNA PRURIENS FRUIT TRICHOME; PTELEA TRIFOLIATA BARK; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; URIC ACID	15; 15; 15; 15; 15; 15; 15; 15; 3; 15; 15; 15; 15; 3; 15; 15; 3; 15; 3; 15	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
70970-006_0e3d3c30-21a1-5e43-e063-6394a90a3566	70970-006	HUMAN OTC DRUG	OHTrust Nano Ion Water		Hydroxide Ions	LIQUID	TOPICAL	20201123		UNAPPROVED DRUG OTHER		Nanoplus Life Biomedical Technology Co. Ltd.	HYDROXIDE ION	.2	g/100mL			N	20251231
70970-007_0c84d2a6-599b-3b44-e063-6294a90ace69	70970-007	HUMAN OTC DRUG	OHTrust Mouth And Nasal Relief		Hydroxide Ions	LIQUID	TOPICAL	20220428		UNAPPROVED DRUG OTHER		Nanoplus Life Biomedical Technology Co. Ltd.	HYDROXIDE ION	.2	g/100mL			N	20241231
70972-1200_eea16075-d119-62d8-e053-2a95a90ad1aa	70972-1200	HUMAN OTC DRUG	Sanitizing Wipes		Benzalkonium chloride	SWAB	TOPICAL	20170404		OTC MONOGRAPH NOT FINAL	part333A	Wipes LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
70975-001_0801d255-e0bd-9e59-e063-6394a90ad9a4	70975-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20160816		NDA	NDA205865	Earlbeck Welding Supplies	OXYGEN	995	mL/L			N	20241231
70975-002_080200ff-2cfe-2dac-e063-6294a90a72dd	70975-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20160816		NDA	NDA205866	Earlbeck Welding Supplies	NITROGEN	995	mL/L			N	20241231
70977-001_0760e2c7-5b1a-31a1-e063-6394a90a0dc7	70977-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20161003		NDA	NDA205865	Geer Gas Corporation	OXYGEN	990	mL/L			N	20241231
70977-003_0760e043-652a-acc6-e063-6294a90a78d4	70977-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20161003		NDA	NDA205866	Geer Gas Corporation	NITROGEN	990	mL/L			N	20241231
70983-001_07016a7e-3dc7-f73a-e063-6394a90ac88f	70983-001	HUMAN OTC DRUG	Chest Comfort		Menthol	SALVE	TOPICAL	20161016		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.	MENTHOL	27.6	mg/g			N	20241231
70983-002_07019db7-7b46-313c-e063-6394a90a106e	70983-002	HUMAN OTC DRUG	Fortify		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.	MENTHOL	24	mg/mL			N	20241231
70983-003_07011cf1-99a6-87ba-e063-6394a90a88d7	70983-003	HUMAN OTC DRUG	Sweet Comfort		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.	MENTHOL	24.56	mg/mL			N	20241231
70983-004_0701c594-d007-451f-e063-6394a90a5819	70983-004	HUMAN OTC DRUG	Pain Release		Menthol	GRANULE	TOPICAL	20161016		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.	MENTHOL	1.6	mg/g			N	20241231
70983-005_07015842-93c4-c0b7-e063-6294a90a7660	70983-005	HUMAN OTC DRUG	Pain Release		Menthol	LIQUID	TOPICAL	20161016		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.	MENTHOL	2.23	mg/mL			N	20241231
70983-006_0701b52f-a52b-4dc9-e063-6294a90a50d7	70983-006	HUMAN OTC DRUG	Pain Release		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.	MENTHOL	17.62	mg/mL			N	20241231
70983-007_07010924-54d3-7e51-e063-6294a90a6907	70983-007	HUMAN OTC DRUG	Pain Release		Menthol	OIL	TOPICAL	20161016		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.	MENTHOL	12.18	mg/mL			N	20241231
70983-008_2e933d8b-a0cf-4e5e-8688-0237bd1425e1	70983-008	HUMAN OTC DRUG	Recovery		Menthol	OINTMENT	TOPICAL	20161016		OTC MONOGRAPH NOT FINAL	part348	Saje Natural Business Inc.	MENTHOL	12.7	mg/g			N	20241231
70983-009_07012039-0be5-74fe-e063-6394a90a8cd2	70983-009	HUMAN OTC DRUG	Trauma Less		Menthol	OINTMENT	TOPICAL	20161016		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.	MENTHOL	12.7	mg/g			N	20241231
70983-010_0701bad5-fc1a-2b1d-e063-6394a90a7570	70983-010	HUMAN OTC DRUG	Pain Release		Menthol	KIT		20161016		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.						N	20241231
70983-012_070143d4-96be-c2d7-e063-6394a90a0d51	70983-012	HUMAN OTC DRUG	Home Farmacy		Menthol	KIT		20161016		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.						N	20241231
70983-013_0700dc1e-d68a-5025-e063-6394a90a6ec6	70983-013	HUMAN OTC DRUG	Pocket Farmacy		Menthol	KIT		20161016		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.						N	20241231
70983-014_0701bad5-fc19-2b1d-e063-6394a90a7570	70983-014	HUMAN OTC DRUG	Pocket Farmacy		Menthol	KIT		20161016		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.						N	20241231
70983-015_07015842-93c5-c0b7-e063-6294a90a7660	70983-015	HUMAN OTC DRUG	Rolling Farmacy		Menthol	KIT		20161016		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.						N	20241231
70983-016_0d5fdd1a-36c8-4103-89b3-0db0b55c9bb3	70983-016	HUMAN OTC DRUG	Comfort and Ease		Menthol	KIT		20161016		OTC MONOGRAPH FINAL	part341	Saje Natural Business Inc.						N	20241231
70983-017_0cf78c45-128b-4144-a1a5-902c632a1d2e	70983-017	HUMAN OTC DRUG	Road to Wellness		Menthol	KIT		20161016		OTC MONOGRAPH NOT FINAL	part348	Saje Natural Business Inc.						N	20241231
70983-018_07014d50-944c-bee5-e063-6294a90aa969	70983-018	HUMAN OTC DRUG	Complete Fortify		Menthol	KIT		20170101		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.						N	20241231
70983-020_0701949f-2bfb-e36f-e063-6394a90ac86e	70983-020	HUMAN OTC DRUG	Traveling Farmacy		Menthol	KIT	TOPICAL	20171101		OTC MONOGRAPH DRUG	M012	Saje Natural Business Inc.						N	20241231
70983-021_07019db7-7b44-313c-e063-6394a90a106e	70983-021	HUMAN OTC DRUG	Sweet cheeks		Zinc oxide	OINTMENT	TOPICAL	20180215		OTC MONOGRAPH DRUG	M016	Saje Natural Business Inc.	ZINC OXIDE	9	g/75g			N	20241231
70983-022_07016a7e-3dc8-f73a-e063-6394a90ac88f	70983-022	HUMAN OTC DRUG	Restoral		Menthol	OINTMENT	TOPICAL	20180201		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.	MENTHOL	.2	g/100g			N	20241231
70983-023_07014d50-944d-bee5-e063-6294a90aa969	70983-023	HUMAN OTC DRUG	Extra Strength		Menthol and Methyl Salicylate	OIL	TOPICAL	20190513		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc.	MENTHOL; METHYL SALICYLATE	94.41; 123.74	mg/mL; mg/mL			N	20241231
70983-024_0700f34f-095b-15cb-e063-6394a90ab2d5	70983-024	HUMAN OTC DRUG	Sun Guard		Zinc Oxide	LOTION	TOPICAL	20190509		OTC MONOGRAPH DRUG	M020	Saje Natural Business Inc	ZINC OXIDE	20	mg/mL			N	20241231
70983-025_07019db7-7b45-313c-e063-6394a90a106e	70983-025	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Saje Natural Business Inc.	ALCOHOL	68	mL/100mL			N	20241231
70983-027_0701b52f-a52c-4dc9-e063-6294a90a50d7	70983-027	HUMAN OTC DRUG	Extra Strength Balm		Capsicum and Menthol	OINTMENT	TOPICAL	20230218		OTC MONOGRAPH DRUG	M017	Saje Natural Business Inc	CAPSICUM; MENTHOL	5000; 2258.75	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
70985-001_0d2e2348-8d39-1ca9-e063-6394a90a881f	70985-001	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20161108		ANDA	ANDA077829	Drug Ocean LLC	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70985-002_0d1c36f6-2a58-53fd-e063-6394a90a99c4	70985-002	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20161108		ANDA	ANDA077829	Drug Ocean LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
70985-005_0d30d9d6-3741-259d-e063-6394a90a651e	70985-005	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA207613	Drug Ocean LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70985-006_0d30d9d6-3741-259d-e063-6394a90a651e	70985-006	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA207613	Drug Ocean LLC	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70985-007_0d30d9d6-3741-259d-e063-6394a90a651e	70985-007	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20200619		ANDA	ANDA207613	Drug Ocean LLC	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
70985-008_0d2e5bb4-3066-32d5-e063-6394a90a0a03	70985-008	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20210426		ANDA	ANDA076639	DRUG OCEAN LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70985-009_0d30d9d6-3740-259d-e063-6394a90a651e	70985-009	HUMAN OTC DRUG	Meclizine HCl		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20210625		OTC MONOGRAPH DRUG	M009	Drug Ocean LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70985-010_0d305bb7-f894-4b45-e063-6294a90ad8ed	70985-010	HUMAN OTC DRUG	Meclizine HCl		MECLIZINE HYDROCHLORIDE CHEWABLE	TABLET, CHEWABLE	ORAL	20220228		OTC MONOGRAPH DRUG	M009	Drug Ocean LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
70985-011_0d2e5bb4-3066-32d5-e063-6394a90a0a03	70985-011	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20210426		ANDA	ANDA076639	DRUG OCEAN LLC	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70985-012_0d2e5bb4-3066-32d5-e063-6394a90a0a03	70985-012	HUMAN PRESCRIPTION DRUG	ciprofloxacin		ciprofloxacin	TABLET	ORAL	20040910		ANDA	ANDA076639	DRUG OCEAN LLC	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
70985-013_0c3cffcf-fe66-2ac9-e063-6394a90a0915	70985-013	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210626		ANDA	ANDA076957	Drug Ocean LLC	FLUCONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70985-014_0c3cffcf-fe66-2ac9-e063-6394a90a0915	70985-014	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210626		ANDA	ANDA076957	Drug Ocean LLC	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70985-015_0c3cffcf-fe66-2ac9-e063-6394a90a0915	70985-015	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210626		ANDA	ANDA076957	Drug Ocean LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70985-016_0c3cffcf-fe66-2ac9-e063-6394a90a0915	70985-016	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210626		ANDA	ANDA076957	Drug Ocean LLC	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
70985-017_082e30ea-4b46-7a5b-e063-6294a90a6d00	70985-017	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210627		ANDA	ANDA214684	DRUG OCEAN LLC	LORATADINE	10	mg/1			N	20241231
70985-019_07ea7ac6-f74b-469a-e063-6394a90ad7bd	70985-019	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20231005		ANDA	ANDA216044	Drug Ocean LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70985-020_07ea7ac6-f74b-469a-e063-6394a90ad7bd	70985-020	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20231005		ANDA	ANDA216044	Drug Ocean LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
70985-021_07eaaf1b-1a87-b57d-e063-6294a90a3421	70985-021	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride	Extended Release	Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20231005		ANDA	ANDA206121	Drug Ocean LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70985-022_0790af46-b330-5036-e063-6294a90ac229	70985-022	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20231004		ANDA	ANDA204721	Drug Ocean LLC	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70985-023_0790af46-b330-5036-e063-6294a90ac229	70985-023	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20231004		ANDA	ANDA204721	Drug Ocean LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
70994-101_0daf31c4-2a2e-59d0-e063-6294a90aec7e	70994-101	HUMAN OTC DRUG	First Aid		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-102_0daf1b85-01a7-5b66-e063-6294a90a0c2d	70994-102	HUMAN OTC DRUG	Pain Relief		Arnica, Menthol Crystals, Cinnamon, Peppermint, Ginger, Rosemary	SALVE	TOPICAL	20160331		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ARNICA MONTANA FLOWER	1	[hp_X]/17g			N	20241231
70994-104_0e84c7df-dbb8-d445-e063-6394a90ab528	70994-104	HUMAN OTC DRUG	First Aid 4pc MIni Stick Kit		Calendula Flowers Chamomile Flowers Elder Flowers Yarrow Flowers Red Clover Flowers Sage Myrrh Plantain St Johns Wort Comfrey Chickweed Arnica Rose Hip Helichrysum	KIT		20191125		UNAPPROVED HOMEOPATHIC		Spry Life LLC						N	20251231
70994-105_0daf317c-adcf-4c3d-e063-6294a90aa8b0	70994-105	HUMAN OTC DRUG	Cold Sore Relief		Stellaria media, Salvia officinalis, Calendula officials, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20190402		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/19.8g; [hp_X]/19.8g; [hp_X]/19.8g; [hp_X]/19.8g; [hp_X]/19.8g; [hp_X]/19.8g; [hp_X]/19.8g; [hp_X]/19.8g			N	20241231
70994-106_0dbc5637-de21-a82d-e063-6294a90a4bc5	70994-106	HUMAN OTC DRUG	Solar Goo		Zinc Oxide, Calendula Officinalis	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	CALENDULA OFFICINALIS FLOWER; ZINC OXIDE	1; 18	[hp_X]/113.4g; g/113.4g			N	20241231
70994-107_0daf35e2-beed-574b-e063-6294a90aa881	70994-107	HUMAN OTC DRUG	Tattoo Care		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-108_0daf1b9c-b64d-5616-e063-6294a90ab3c2	70994-108	HUMAN OTC DRUG	Skin Repair		Rosa canina, Matricaria recutita, Archillea Millefolium	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM; MATRICARIA RECUTITA; ROSA MOSCHATA OIL	.19; .19; 3.06	g/100g; g/100g; g/100g			N	20241231
70994-109_0daf2552-3535-275c-e063-6394a90ab0a0	70994-109	HUMAN OTC DRUG	Free to Breathe		Calendula, Eucalyptus,Peppermint	SALVE	TOPICAL	20200306		UNAPPROVED HOMEOPATHIC		Spry Life LLC	CALENDULA OFFICINALIS FLOWER; EUCALYPTUS GLOBULUS LEAF; MENTHA PIPERITA	1; 1.63; 1.63	[hp_X]/100g; g/100g; g/100g			N	20241231
70994-111_f1ea91e0-5722-f21b-e053-2a95a90aefb9	70994-111	HUMAN OTC DRUG	Dry Skin Salve		Calendula officials Flowers, Chamollia Recutita Flowers, Viola Tricolor Leaf, Sambucus Nigra Flowers, Trifolium Pratense Flowers, Archillea Millefolium	SALVE	TOPICAL	20190401		UNAPPROVED HOMEOPATHIC		Sierra Sage Herbs LLC	ACHILLEA MILLEFOLIUM; CALENDULA OFFICINALIS FLOWER; CHAMOMILE; SAMBUCUS NIGRA FLOWER; TRIFOLIUM PRATENSE FLOWER	1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-202_0daf317c-adce-4c3d-e063-6294a90aa8b0	70994-202	HUMAN OTC DRUG	Foot Care		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-203_0dbc5a3a-170f-d08f-e063-6294a90a50c6	70994-203	HUMAN OTC DRUG	Hand Goo		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-204_0dad0d93-ebff-c354-e063-6294a90a630c	70994-204	HUMAN OTC DRUG	Poison Ivy Care		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-302_0dada80e-dcde-9e4f-e063-6294a90a400e	70994-302	HUMAN OTC DRUG	Animal First Aid		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20190318		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-303_0dad268f-dd35-ec29-e063-6294a90ad1b5	70994-303	HUMAN OTC DRUG	Poultry First Aid		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20190318		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-304_0dada0f0-43be-d7d0-e063-6394a90afe28	70994-304	HUMAN OTC DRUG	Animal Pain Relief		Arnica, Ginger, Rosemary	SALVE	TOPICAL	20190402		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ARNICA MONTANA FLOWER	1	[hp_X]/17g			N	20241231
70994-305_0dad48b2-dc73-0d50-e063-6294a90ac94e	70994-305	HUMAN OTC DRUG	Face Wash		Calendula	OIL	TOPICAL	20190709		UNAPPROVED HOMEOPATHIC		Spry Life LLC	CALENDULA OFFICINALIS FLOWER	1	[hp_X]/133mL			N	20241231
70994-308_0e851341-3b0d-dc79-e063-6394a90afbca	70994-308	HUMAN OTC DRUG	Acne Face Wash		Calendula, Yarrow, Chamomile	OIL	TOPICAL	20220404		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; MATRICARIA RECUTITA FLOWERING TOP	1; 1; 1	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20251231
70994-310_0e85235d-3788-9f6c-e063-6294a90ad320	70994-310	HUMAN OTC DRUG	Acne Roll On		Calendula	OIL	TOPICAL	20220404		UNAPPROVED HOMEOPATHIC		Spry Life LLC	JUNIPER BERRY OIL	1	[hp_X]/100mL			N	20251231
70994-332_a84c17c6-cdd3-2f47-e053-2a95a90a959b	70994-332	HUMAN OTC DRUG	Green Goo Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20200708		OTC MONOGRAPH NOT FINAL	part333A	Sierra Sage Herbs, LLC	ALCOHOL	70	mL/100mL			N	20241231
70994-333_b47c3394-1fd8-6795-e053-2a95a90a2a13	70994-333	HUMAN OTC DRUG	Green Goo Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333A	Sierra Sage Herbs, LLC	ALCOHOL	70	mL/100mL			N	20241231
70994-334_abfae0b1-7d18-6dfc-e053-2a95a90adf2c	70994-334	HUMAN OTC DRUG	Green Goo Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333A	Sierra Sage Herbs, LLC	ALCOHOL	70	mL/100mL			N	20241231
70994-335_b47a0709-8771-d332-e053-2a95a90ab36e	70994-335	HUMAN OTC DRUG	Green Goo Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20200902		OTC MONOGRAPH NOT FINAL	part333A	Sierra Sage Herbs, LLC	ALCOHOL	70	mL/100mL			N	20241231
70994-336_b479725f-7210-bc02-e053-2a95a90aadea	70994-336	HUMAN OTC DRUG	Green Goo Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20201119		OTC MONOGRAPH NOT FINAL	part333A	Sierra Sage Herbs, LLC	ALCOHOL	70	mL/100mL			N	20241231
70994-337_b47888bc-243c-1649-e053-2995a90aca1d	70994-337	HUMAN OTC DRUG	Green Goo Hand Sanitizer		Ethyl Alcohol 70%	GEL	TOPICAL	20201119		OTC MONOGRAPH NOT FINAL	part333A	Sierra Sage Herbs, LLC	ALCOHOL	70	mL/100mL			N	20241231
70994-401_0dad57bb-7cd9-7fbc-e063-6394a90a21d4	70994-401	HUMAN OTC DRUG	Sweet Honey Lip Balm		Zinc Oxide, Calendula officials flowers	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	CALENDULA OFFICINALIS FLOWER; ZINC OXIDE	1; 3.6	[hp_X]/51.7g; g/51.7g			N	20241231
70994-402_0dad48b2-dc6f-0d50-e063-6294a90ac94e	70994-402	HUMAN OTC DRUG	Citrus Zest Lip Balm		Calendula officials flowers	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	CALENDULA OFFICINALIS FLOWER	1	[hp_X]/51.7g			N	20241231
70994-403_0dad3bbd-6386-7bbd-e063-6394a90aed0f	70994-403	HUMAN OTC DRUG	Cool Mint Lip Balm		Calendula officials flowers	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	CALENDULA OFFICINALIS FLOWER	1	[hp_X]/51.7g			N	20241231
70994-501_0dad439a-adfc-767e-e063-6394a90ac2e7	70994-501	HUMAN OTC DRUG	Baby Balm		Calendula officinalis, Chamomilla recutita, Archillea millefolium, Symphytum officinalis, Helianthus annuus	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; CHAMOMILE; SYMPHYTUM OFFICINALE WHOLE	1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-503_0dad0d61-955d-6eb3-e063-6394a90a7fba	70994-503	HUMAN OTC DRUG	Nursing Cream		Calendula officinalis, Chamomilla recutita, Althaea officinalis	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ALTHAEA OFFICINALIS ROOT; CALENDULA OFFICINALIS FLOWER; CHAMOMILE	1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-504_0daf317c-add0-4c3d-e063-6294a90aa8b0	70994-504	HUMAN OTC DRUG	Childrens First Aid		Calendula officials, Stellaria media, St. Johns Wort, Rosemary Oil, Plantago major, Commiphora Myrrha, Comfrey Leaf, Salvia officinalis, Sunflower Oil	SALVE	TOPICAL	20160401		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; COMFREY LEAF; COMMIPHORA MYRRHA WHOLE; PLANTAGO MAJOR; SALVIA OFFICINALIS WHOLE; ST. JOHN'S WORT; STELLARIA MEDIA	1; 1; 1; 1; 1; 1; 1; 1	[hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g; [hp_X]/51.7g			N	20241231
70994-506_0daf568e-1988-7ea9-e063-6294a90a0929	70994-506	HUMAN OTC DRUG	Belly Balm		Rosehip Seed Oil	SALVE	TOPICAL	20190709		UNAPPROVED HOMEOPATHIC		Spry Life LLC	CALENDULA OFFICINALIS FLOWER; ROSA MOSCHATA OIL	1; 3.3	[hp_X]/100g; g/100g			N	20241231
70994-801_0e851341-3b05-dc79-e063-6394a90afbca	70994-801	HUMAN OTC DRUG	Salvacine		Calendula officials, Plantago major, Olea Europaea, Achillea Millefolium	SALVE	TOPICAL	20220829		UNAPPROVED HOMEOPATHIC		Spry Life LLC	ACHILLEA MILLEFOLIUM FLOWER; CALENDULA OFFICINALIS FLOWER; OLEA EUROPAEA LEAF; PLANTAGO MAJOR	1; 1; 1; 1	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20251231
71003-001_ec8baea0-4012-4619-bb68-91cc10cd2fda	71003-001	HUMAN OTC DRUG	Hemorrhoidal	Anesthetic	Glycerin, Phenylephrine Hydrochloride, Pramoxine Hydrochloride, and Petrolatum	CREAM	TOPICAL	20161020		OTC MONOGRAPH FINAL	part346	Purity Products	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	144; 150; 2.5; 10	mg/g; mg/g; mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71014-025_fc9d9ef3-5789-23de-e053-6294a90a6f2f	71014-025	HUMAN OTC DRUG	Vertra Pearl White Face Stick SPF 50		Padimate O, Titanium Dioxide	STICK	TOPICAL	20201216		OTC MONOGRAPH FINAL	M020	Eai-jr 286, Inc	PADIMATE O; TITANIUM DIOXIDE	7; 17	g/100g; g/100g			N	20241231
71014-026_fc9d43a3-d59b-0ee5-e053-6294a90a4539	71014-026	HUMAN OTC DRUG	Vertra S Dorian Kona Gold Signature Face Stick SPF 38		Titanium Dioxide	STICK	TOPICAL	20201218		OTC MONOGRAPH FINAL	M020	Eai-jr 286, Inc	TITANIUM DIOXIDE	23	g/100g			N	20241231
71014-028_fc9d01ba-5947-dde9-e053-6394a90a5fb3	71014-028	HUMAN OTC DRUG	Vertra Ehukai Beige Face Stick SPF 38		Titanium Dioxide	STICK	TOPICAL	20201218		OTC MONOGRAPH FINAL	M020	Eai-jr 286, Inc	TITANIUM DIOXIDE	23	g/100g			N	20241231
71014-029_0974b923-cfe4-7dcc-e063-6294a90aeb1b	71014-029	HUMAN OTC DRUG	VERTRA Premium Suncare SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	SPRAY	TOPICAL	20190221		OTC MONOGRAPH DRUG	M020	Eai-Jr286, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	40; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71014-030_06c30af6-b447-6042-e063-6394a90a6e21	71014-030	HUMAN OTC DRUG	Vertra Coconut Lip Balm Broad Spectrum SPF 15		Zinc Oxide	STICK	TOPICAL	20200206		OTC MONOGRAPH DRUG	M020	Eai-jr 286, Inc	ZINC OXIDE	10.5	g/100g			N	20241231
71014-038_fc88aa8e-a208-0a80-e053-6394a90a5490	71014-038	HUMAN OTC DRUG	Beach Break 2-in-1 Daily Facial Moisturizer Sunscreen SPF 30		Homosalate, Octisalate, Avobenzone, Octocrylene	LOTION	TOPICAL	20220921		OTC MONOGRAPH FINAL	M020	EAI-JR 286	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 5; 2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
71014-090_fc8b57eb-11bf-9204-e053-6294a90afced	71014-090	HUMAN OTC DRUG	Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige		Titanium Dioxide	STICK	TOPICAL	20210127		OTC MONOGRAPH FINAL	M020	EAI-JR 286, Inc.	TITANIUM DIOXIDE	23	g/100g			N	20241231
71014-091_fdf595b6-e105-612d-e053-6294a90aa5e6	71014-091	HUMAN OTC DRUG	Clear Sunscreen Face Stick Sensitive Broad Spectrum SPF 30		Zinc Oxide	STICK	TOPICAL	20220303		OTC MONOGRAPH FINAL	M020	EAI-JR 286, Inc	ZINC OXIDE	20	g/100g			N	20241231
71014-092_fdf595b6-e106-612d-e053-6294a90aa5e6	71014-092	HUMAN OTC DRUG	Clear Sunscreen Face Stick Broad Spectrum SPF 45		Zinc Oxide	STICK	TOPICAL	20220307		OTC MONOGRAPH FINAL	M020	Eai-jr 286, Inc	ZINC OXIDE	22	g/100g			N	20241231
71014-094_fc0f7f01-2ca6-9b72-e053-6394a90aa39a	71014-094	HUMAN OTC DRUG	Coconut Vanilla Body Broad Spectrum SPF 50		Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20230526		OTC MONOGRAPH FINAL	M020	EAI-JR286, Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 8	g/100g; g/100g; g/100g			N	20241231
71018-002_d44c6b5a-0613-71d7-e053-2995a90ac9f7	71018-002	HUMAN OTC DRUG	TH-101		Calc carb, Carbo veg, Chelidonium maj, CoQ10, Fucus, Graphites, Homeopathic glycoprotein complex, Hypothalamus, Kali phos, Lycopodium, Mag phos, Nat mur, Nat phos, Nux vom, Ornithogalum, Phytolacca, Pituitarum, Placenta, Sinapis arv flos, Quercus gland sp, Quercus rob	LIQUID	ORAL	20170508		UNAPPROVED HOMEOPATHIC		Temple Health Nutrition, LLC	ACTIVATED CHARCOAL; ARGININE; BOS TAURUS HYPOTHALAMUS; CHELIDONIUM MAJUS; CYSTEINE; FUCUS VESICULOSUS; GRAPHITE; LEUCINE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ORNITHOGALUM UMBELLATUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM PHOSPHATE, DIBASIC; PROLINE; QUERCUS ROBUR NUT; QUERCUS ROBUR TWIG BARK; SERINE; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; SUCROSE; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; THREONINE; UBIDECARENONE; VALINE	4; 8; 12; 6; 8; 4; 6; 8; 6; 6; 6; 12; 6; 6; 8; 6; 6; 8; 6; 6; 12; 6; 8; 12; 12; 8; 12; 8	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71020-001_d5d18d9a-b2ac-697c-e053-2a95a90a74df	71020-001	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Sante Manufacturing Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71020-003_d5d0dbef-b09a-542b-e053-2a95a90ad350	71020-003	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Sante Manufcaturing Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71020-004_d5d11a03-0b93-29a4-e053-2a95a90a969b	71020-004	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Sante Manufacturing Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71020-005_e4d17b77-f3b3-55e9-e053-2995a90a3863	71020-005	HUMAN OTC DRUG	Antibacterial	2X	Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Sante Manufacturing Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71020-016_d5d1a5d5-a5a8-5b63-e053-2a95a90a63f5	71020-016	HUMAN OTC DRUG	Antibacterial	2X	Benzalkonium Chloride	LIQUID	TOPICAL	20180130		OTC MONOGRAPH NOT FINAL	part333A	Sante Manufacturing Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71020-020_ca189450-0e79-2c0b-e053-2a95a90a279d	71020-020	HUMAN OTC DRUG	Antibacterial	2X Ultra cleansing	Benzalkonium Chloride	LIQUID	TOPICAL	20210821		OTC MONOGRAPH NOT FINAL	part333A	Sante Manufacturing Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71020-030_d5d1bcb7-5895-0aee-e053-2a95a90adfeb	71020-030	HUMAN OTC DRUG	Antibacterial Aqua Clear	2X Ultra	Benzalkonium Chloride	LIQUID	TOPICAL	20161008		OTC MONOGRAPH NOT FINAL	part333A	Sante Manufacturing Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71023-045_fa690ebf-a7af-558f-e053-6294a90a3c75	71023-045	HUMAN OTC DRUG	Afia Alcohol-Free Foaming Hand Sanitizer		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part333A	National Chemical Laboratories, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71023-046_fa1c1c15-c9a6-9d7f-e053-6294a90a9e32	71023-046	HUMAN OTC DRUG	Afia Foaming Anti-Bacterial Hand Cleaner		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part333A	National Chemical Laboratories, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71029-390_07da5ac2-03f6-e68e-e063-6294a90a46ed	71029-390	HUMAN OTC DRUG	Sterile Antibacterial Wound Wash		Benzethonium Chloride	SPRAY	TOPICAL	20170509		OTC MONOGRAPH DRUG	M003	Cosrich Group, Inc.	BENZETHONIUM CHLORIDE	1.3	mg/mL			N	20241231
71034-001_b2b1f979-6a18-ad41-e053-2995a90ad14a	71034-001	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171201		ANDA	ANDA209757	Xiamen LP Pharmaceutical Co., Ltd.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71034-002_c4ddb97d-cba5-9f6b-e053-2a95a90a4956	71034-002	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride	Extended-Release	Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210611		ANDA	ANDA212797	Xiamen LP Pharmaceutical Co., Ltd.	PRAMIPEXOLE DIHYDROCHLORIDE	.375	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71034-003_c4ddb97d-cba5-9f6b-e053-2a95a90a4956	71034-003	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride	Extended-Release	Pramipexole Dihydrochloride	TABLET, EXTENDED RELEASE	ORAL	20210611		ANDA	ANDA212797	Xiamen LP Pharmaceutical Co., Ltd.	PRAMIPEXOLE DIHYDROCHLORIDE	.75	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71042-001_09aa46d5-b8e7-5e76-e063-6394a90a25ce	71042-001	HUMAN OTC DRUG	Curoxen		Olive Extract, Calendula	OINTMENT	TOPICAL	20161021		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	CALENDULA OFFICINALIS FLOWERING TOP; OLEA EUROPAEA FRUIT VOLATILE OIL	3; 2	[hp_X]/14g; [hp_X]/14g			N	20241231
71042-002_09aa46d5-b8e8-5e76-e063-6394a90a25ce	71042-002	HUMAN OTC DRUG	Curoxen Pain Relief		Olive Extract, Calendula, Arnica Montana	OINTMENT	TOPICAL	20170124		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; OLEA EUROPAEA FRUIT VOLATILE OIL	3; 3; 2	[hp_X]/14g; [hp_X]/14g; [hp_X]/14g			N	20241231
71042-003_09aa9421-035a-9cbd-e063-6294a90a0f6a	71042-003	HUMAN OTC DRUG	Curoxen with Vitamin D for Kids		Olive Extract, Calendula, Cholecalciferol	OINTMENT	TOPICAL	20171220		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	CALENDULA OFFICINALIS FLOWERING TOP; CHOLECALCIFEROL; OLEA EUROPAEA FRUIT VOLATILE OIL	3; 3; 2	[hp_X]/14g; [hp_X]/14g; [hp_X]/14g	Vitamin D [CS], Vitamin D [EPC]		N	20241231
71042-004_09aa7c48-78b2-65c6-e063-6294a90ae2ea	71042-004	HUMAN OTC DRUG	Curoxen Oral Care		Olive Extract, Calendula, Clove Oil	OINTMENT	TOPICAL	20171220		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	CALENDULA OFFICINALIS FLOWERING TOP; CLOVE OIL; OLEA EUROPAEA FRUIT VOLATILE OIL	3; 1; 2	[hp_X]/12g; [hp_X]/12g; [hp_X]/12g			N	20241231
71042-007_09aabfa3-df29-a186-e063-6294a90a26f5	71042-007	HUMAN OTC DRUG	FemiClear	Yeast Infection Treatment	Olive Extract, Calendula, Melaleuca	KIT	VAGINAL	20171220		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC						N	20241231
71042-010_09aa38ef-1b47-52ab-e063-6294a90ac12a	71042-010	HUMAN OTC DRUG	FemiClear	Vaginal Itch Relief	Chamomilla, Olive extract	OINTMENT	TOPICAL	20200220		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	CHAMOMILE; OLEA EUROPAEA FRUIT VOLATILE OIL	3; 2	[hp_X]/14g; [hp_X]/14g			N	20241231
71042-011_09aaa33d-d0e1-87b6-e063-6294a90a2597	71042-011	HUMAN OTC DRUG	FemiClear	Yeast Infection Treatment	Calendula, Melaleuca, Oleuropein, Chamomilla	KIT	TOPICAL; VAGINAL	20211112		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC						N	20241231
71042-014_0a973fab-add6-10f0-e063-6294a90ad278	71042-014	HUMAN OTC DRUG	Curoxen Cold Sore Day		Curoxen Cold Sore Day	OINTMENT	TOPICAL	20211202		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	ARNICA MONTANA; LEMON BALM OIL	.1; 1	g/100g; g/100g			N	20241231
71042-020_09aa38ef-1b46-52ab-e063-6294a90ac12a	71042-020	HUMAN OTC DRUG	FemiClear	for Genital Herpes Symptoms	Lemongrass with Olive extract	OINTMENT	TOPICAL	20230717		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	EAST INDIAN LEMONGRASS OIL; OLEA EUROPAEA FRUIT VOLATILE OIL; WILLOW BARK	2; 3; 3	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
71042-020_f2012193-4566-13ae-e053-2995a90aca9d	71042-020	HUMAN OTC DRUG	FemiClear	for Genital Herpes Symptoms	Lemongrass with Olive extract	OINTMENT	TOPICAL	20200701		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	EAST INDIAN LEMONGRASS OIL; OLEA EUROPAEA FRUIT VOLATILE OIL; WILLOW BARK	2; 3; 3	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
71042-021_09aa8ed9-9e40-9817-e063-6394a90aebba	71042-021	HUMAN OTC DRUG	FemiClear	for Genital Herpes Symptoms (Itching and Tingling	Lemongrass with Olive extract	OINTMENT	TOPICAL	20200701		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	EAST INDIAN LEMONGRASS OIL; OLEA EUROPAEA FRUIT VOLATILE OIL	2; 3	[hp_X]/100g; [hp_X]/100g			N	20241231
71042-022_09aa6f68-37c4-827b-e063-6394a90ab840	71042-022	HUMAN OTC DRUG	FemiClear	for Genital Herpes Symptoms (Pain and Burning)	Lemongrass with Olive extract	OINTMENT	TOPICAL	20210303		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	EAST INDIAN LEMONGRASS OIL; OLEA EUROPAEA FRUIT VOLATILE OIL; WILLOW BARK	2; 3; 3	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
71042-023_09aa7c48-78ad-65c6-e063-6294a90ae2ea	71042-023	HUMAN OTC DRUG	HClear for Him	for Genital Herpes Symptoms	Lemongrass with Olive extract	OINTMENT	TOPICAL	20200915		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	EAST INDIAN LEMONGRASS OIL; OLEA EUROPAEA FRUIT VOLATILE OIL; WILLOW BARK	2; 3; 3	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
71042-024_09aa75a2-32af-5f4a-e063-6394a90a94a2	71042-024	HUMAN OTC DRUG	FemiClear Genital Herpes Symptoms	Multisymptom	Lemongrass, Willow Bark extract	OINTMENT	TOPICAL	20220506		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	EAST INDIAN LEMONGRASS OIL; OLEA EUROPAEA FRUIT VOLATILE OIL; WILLOW BARK	2; 3; 3	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
71042-025_078bcc32-8c09-4b31-e063-6294a90a9501	71042-025	HUMAN OTC DRUG	FemiClear Bacterial Vaginosis Symptoms		Thymol with Olive Extract	OINTMENT	TOPICAL	20220601		UNAPPROVED HOMEOPATHIC		Organicare Nature's Science, LLC	OLEA EUROPAEA FRUIT VOLATILE OIL; THYMOL	3; 6	[hp_X]/100g; [hp_X]/100g			N	20241231
71042-026_09aa46e4-0bc5-620e-e063-6394a90a6954	71042-026	HUMAN OTC DRUG	FemiClear Yeast Infection		FemiClear 2 Day Simple	OINTMENT	TOPICAL	20230117		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	CAJUPUT OIL; CALENDULA OFFICINALIS WHOLE	.1; 1	kg/kg; kg/kg			N	20241231
71042-027_078c1caa-6502-a00f-e063-6294a90af1b8	71042-027	HUMAN OTC DRUG	FemiClear Vulva Cream		FemiClear Vulva Cream	CREAM	TOPICAL	20230717		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	MELALEUCA CAJUPUTI LEAF OIL; THYMOL	.0001; .0001	kg/100kg; kg/100kg			N	20241231
71042-028_078c1caa-6501-a00f-e063-6294a90af1b8	71042-028	HUMAN OTC DRUG	FemiClear Infection Protection		Vaginal Cream	CREAM	TOPICAL	20230807		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	MELALEUCA CAJUPUTI WHOLE; THYMOL	.01; .01	g/g; g/g			N	20241231
71042-029_01921c63-299d-0fdb-e063-6294a90af407	71042-029	HUMAN OTC DRUG	FemiClear 2 Day Gentle		2 Day Yeast Infection Gentle	OINTMENT	TOPICAL	20230728		UNAPPROVED HOMEOPATHIC		OrganiCare Nature's Science, LLC	CALENDULA OFFICINALIS WHOLE; MELALEUCA CAJUPUTI WHOLE	.01; .01	g/100g; g/100g			N	20241231
71045-010_7803b863-697d-4d96-911f-5a229bbd8272	71045-010	HUMAN PRESCRIPTION DRUG	Zemdri (plazomicin)		Plazomicin	INJECTION	INTRAVENOUS	20180716		NDA	NDA210303	Achaogen, Inc.	PLAZOMICIN	500	mg/10mL			N	20241231
71047-364_ec975b32-5eb4-3575-e053-2995a90a6780	71047-364	HUMAN OTC DRUG	Alive Prebiotic Balancing Moisturizer SPF 15		ZINC OXIDE	LOTION	TOPICAL	20180914		OTC MONOGRAPH NOT FINAL	part352	Algenist, LLC	ZINC OXIDE	.1365	mg/mL			N	20241231
71049-101_f411ebda-1678-c5d0-e053-2a95a90a890b	71049-101	HUMAN OTC DRUG	TRIPLE ACTION ARTHRITIS		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20161022		OTC MONOGRAPH NOT FINAL	part348	WONG CHARKKEN BILL	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.025; 10; 28	g/100g; g/100g; g/100g			N	20241231
71061-763_09d72d1b-d35e-923b-e063-6394a90a0cfc	71061-763	HUMAN OTC DRUG	Alo Therapeutic Massage		MENTHOL, HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20161110		OTC MONOGRAPH DRUG	M017	CMI Therapy Solutions	HISTAMINE DIHYDROCHLORIDE; MENTHOL	1; 30	mg/mL; mg/mL			N	20241231
71061-764_09d72d1b-d36b-923b-e063-6394a90a0cfc	71061-764	HUMAN OTC DRUG	Alo Therapeutic Massage		MENTHOL, HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20161110		OTC MONOGRAPH DRUG	M017	CMI Therapy Solutions	HISTAMINE DIHYDROCHLORIDE; MENTHOL	1; 30	mg/mL; mg/mL			N	20241231
71061-765_09d769cf-cc55-9fd3-e063-6394a90ac18e	71061-765	HUMAN OTC DRUG	Alo Therapeutic Massage		MENTHOL, HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20161110		OTC MONOGRAPH DRUG	M017	CMI Therapy Solutions	HISTAMINE DIHYDROCHLORIDE; MENTHOL	1; 30	mg/mL; mg/mL			N	20241231
71061-766_09d769cf-cc62-9fd3-e063-6394a90ac18e	71061-766	HUMAN OTC DRUG	Alo Therapeutic Massage		MENTHOL, HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20161110		OTC MONOGRAPH DRUG	M017	CMI Therapy Solutions	HISTAMINE DIHYDROCHLORIDE; MENTHOL	1; 30	mg/mL; mg/mL			N	20241231
71063-001_403dc1ab-6a4d-0e26-e054-00144ff88e88	71063-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part333E	Aiyaya Cloud-Commerce Tech Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
71063-001_40479e2f-b94f-64ca-e054-00144ff88e88	71063-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part333E	Aiyaya Cloud-Commerce Tech Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
71063-001_4047e366-943d-6d4c-e054-00144ff88e88	71063-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part333E	Aiyaya Cloud-Commerce Tech Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
71063-001_404b9b6c-5f42-4039-e054-00144ff8d46c	71063-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part333E	Aiyaya Cloud-Commerce Tech Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
71063-001_404b9b6c-5f51-4039-e054-00144ff8d46c	71063-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part333E	Aiyaya Cloud-Commerce Tech Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
71063-001_404b9b6c-5f60-4039-e054-00144ff8d46c	71063-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part333E	Aiyaya Cloud-Commerce Tech Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
71067-359_097485a4-b59a-a87a-e063-6394a90a8e52	71067-359	HUMAN OTC DRUG	DR. MIKES Ponos Pain Relief Cream Roll-On		HISTAMINE DIHYDROCHLORIDE, MENTHOL	CREAM	TOPICAL	20220829		OTC MONOGRAPH DRUG	M017	Dr. Mike's Vitamins, LLC	HISTAMINE DIHYDROCHLORIDE; MENTHOL	.3; 30	mg/g; mg/g			N	20241231
71070-768_0974579b-6f81-6b47-e063-6294a90a0217	71070-768	HUMAN OTC DRUG	JACKET SPF 50		ZINC OXIDE, OCTINOXATE, OCTISALATE, OCTISALATE	CREAM	TOPICAL	20161118		OTC MONOGRAPH DRUG	M020	Balshi MD Dermaceuticals	OCTINOXATE; OCTISALATE; OXYBENZONE; ZINC OXIDE	75; 50; 50; 75	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71070-868_097478f1-9b29-b749-e063-6394a90a9977	71070-868	HUMAN OTC DRUG	JACKET SPF-50 Broad Spectrum Sunscreen		ZINC OXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20190415		OTC MONOGRAPH DRUG	M020	BALSHI MD DERMACEUTICALS	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71073-308_02da73af-fbae-4bed-e063-6294a90a5f2d	71073-308	HUMAN OTC DRUG	Vita-P Oral and Nasal		Menthol 1%	AEROSOL, SPRAY	TOPICAL	20230811		OTC MONOGRAPH NOT FINAL	part348	Beijing HKKY Medical Tech. Co., Ltd.	MENTHOL	.01	g/g			N	20241231
71080-0003_41025397-b811-4b4f-9dcd-5c979817e473	71080-0003	HUMAN OTC DRUG	LEBODY BU W RENEWAL UP		Niacinamide, Adenosine	CREAM	TOPICAL	20171201		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	ADENOSINE; NIACINAMIDE	.03; 1.6	g/80mL; g/80mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71080-0008_ee29d0ad-5047-49af-b2b9-4a523671ac22	71080-0008	HUMAN OTC DRUG	LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM		Niacinamide, Adenosine	LIQUID	TOPICAL	20190301		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	NIACINAMIDE	.6	g/30mL			N	20241231
71080-0009_8ec2a286-d5a0-4036-9b87-a373200718f4	71080-0009	HUMAN OTC DRUG	LEBODY LAB RENEWAL DUAL EFFECT PEPTIDE SERUM		Niacinamide, Adenosine	LIQUID	TOPICAL	20190301		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	NIACINAMIDE	.6	g/30mL			N	20241231
71080-0010_60615542-310c-495a-a034-9269e47804f1	71080-0010	HUMAN OTC DRUG	LEBODY LAB RENEWAL DUAL EFFECT HYALURONIC SERUM		Niacinamide, Adenosine	LIQUID	TOPICAL	20190301		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	NIACINAMIDE	.6	g/30mL			N	20241231
71080-0011_0ee5183f-eef1-42c5-8f50-852c0b47a03d	71080-0011	HUMAN OTC DRUG	LEBODY LAB RENEWAL DUAL EFFECT 24K GOLD SERUM		Niacinamide, Adenosine	LIQUID	TOPICAL	20190301		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	ADENOSINE; NIACINAMIDE	.012; .6	g/30mL; g/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71080-0012_84fe0bd3-5a31-4cf4-af01-5121a4edeac3	71080-0012	HUMAN OTC DRUG	LEBODY LAB RENEWAL DUAL EFFECT BTX COLLAGEN SERUM		Niacinamide, Adenosine	LIQUID	TOPICAL	20190301		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	ADENOSINE; NIACINAMIDE	.012; .6	g/30mL; g/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71080-0015_991bab91-6cdb-4e03-aef0-093d15ccd5d9	71080-0015	HUMAN OTC DRUG	BIBILIP ALOE CICA DUAL MOISTURIZER		Niacinamide, Adenosine	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	ADENOSINE; NIACINAMIDE	.003; .16	g/8mL; g/8mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71080-0016_f8e4267d-f217-4310-9635-685538ed87f4	71080-0016	HUMAN OTC DRUG	BIBILIP HONEY COCO TOTAL CARE		Niacinamide, Adenosine	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		GTG Wellness Co., Ltd.	ADENOSINE; NIACINAMIDE	.003; .16	g/8mL; g/8mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71080-0030_f13bbf40-665e-4d5e-a470-c5a34b6a5123	71080-0030	HUMAN OTC DRUG	LEBODY FIT BODY MASSAGER		COCONUT	CREAM	TOPICAL	20230301		UNAPPROVED DRUG OTHER		GTG WELLNESS CO., LTD.	COCONUT OIL	.5	g/100mL			N	20241231
71080-0031_3d7d8397-c1e2-40eb-9790-a7c96d69eff0	71080-0031	HUMAN OTC DRUG	LEBODY FACE RENEWAL FACE WATER		Glycerin	GEL	TOPICAL	20230601		UNAPPROVED DRUG OTHER		GTG WELLNESS CO., LTD.	GLYCERIN	8.95	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
71080-0032_44c183e1-80ef-468c-9a90-015406ab1464	71080-0032	HUMAN OTC DRUG	WF FACE FITNESS BTX COLLAGEN SOOTHING		Niacinamide, Adenosine	GEL	TOPICAL	20230601		UNAPPROVED DRUG OTHER		GTG WELLNESS CO., LTD.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71083-0020_f4dd3f8b-2ea0-490b-a29e-2c733b009d01	71083-0020	HUMAN PRESCRIPTION DRUG	NephroScan		SUCCIMER	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220218		NDA	NDA214993	Theragnostics Inc	SUCCIMER	1	mg/1	Lead Chelating Activity [MoA], Lead Chelator [EPC]		N	20241231
71085-001_ad5cd9db-5a28-4323-adec-cabbcda048d4	71085-001	HUMAN PRESCRIPTION DRUG	Lidocaine		LIDOCAINE	OINTMENT	TOPICAL	20161115		ANDA	ANDA086724	IPG Pharmaceuticals, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71085-002_aa6f3401-4aad-43cc-9e01-12ffaf89a0ac	71085-002	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	SOLUTION	TOPICAL	20141126		ANDA	ANDA203818	IPG PHARMACEUTICALS, INC.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71085-003_c4f130b9-1e58-4e59-a01d-65cd423645a3	71085-003	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20160428		ANDA	ANDA206298	IPG PHARMACEUTICALS, INC.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71085-004_4df7d200-5fec-4f32-b32c-06bded188628	71085-004	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20140714		ANDA	ANDA200734	IPG PHARMACEUTICALS, INC.	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71085-005_f4aac2fa-12c4-4711-8219-27db349a8ab2	71085-005	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20161027		ANDA	ANDA071500	IPG PHARMACEUTICALS, INC.	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71085-006_2e9c677b-6737-4198-8b4b-94919ff8754d	71085-006	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	19961231		ANDA	ANDA074799	IPG PHARMACEUTICALS, INC.	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71085-007_6e3c6277-56fb-479f-b5c6-58952bb5410f	71085-007	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		clobetasol propionate	CREAM	TOPICAL	19960708		ANDA	ANDA074249	IPG PHARMACEUTICALS, INC.	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71085-008_ea618ceb-2b37-4885-a3da-16bbf0fa429a	71085-008	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	CREAM	TOPICAL	20021218		ANDA	ANDA075638	IPG PHARMACEUTICALS, INC.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71085-009_b6eaa871-a050-4ee4-99d2-baefe246546f	71085-009	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	CREAM	TOPICAL	19871222		ANDA	ANDA062364	IPG PHARMACEUTICALS, INC.	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
71085-011_a2dbb08e-bfe3-4ed9-a1bc-c00a1e8912e2	71085-011	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	19810817		ANDA	ANDA086724	IPG PHARMACEUTICALS, INC.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71087-001_6a580421-1c8c-45dc-9aee-14d20fd40306	71087-001	HUMAN OTC DRUG	Hand	Sanitizer	ALCOHOL	GEL	TOPICAL	20161201		OTC MONOGRAPH DRUG	M003	CASAD Company, Inc	ALCOHOL	53.5	g/100mL			N	20241231
71087-002_6a580421-1c8c-45dc-9aee-14d20fd40306	71087-002	HUMAN OTC DRUG	Hand	Sanitizer	ALCOHOL	LIQUID	TOPICAL	20161201		OTC MONOGRAPH DRUG	M003	CASAD Company, Inc	ALCOHOL	53.3	g/100mL			N	20241231
71087-105_fa6af8c7-2149-491f-9741-5364207b9d76	71087-105	HUMAN OTC DRUG	Beeswax Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-106_5011b27f-bbf6-47fc-9211-76c14aaf01c8	71087-106	HUMAN OTC DRUG	Spearmint Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-107_51c15bb1-e9b7-44c0-982b-0ce4b1b0ea1e	71087-107	HUMAN OTC DRUG	Cherry Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-108_fe21dd1e-5865-4ee1-8c74-0e2d00286dbe	71087-108	HUMAN OTC DRUG	Iced Pear Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-109_aa22d8e3-0636-4461-90ee-a658dd574ace	71087-109	HUMAN OTC DRUG	Peppermint Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-110_f23db097-44f9-4736-8f90-1e0459977a2f	71087-110	HUMAN OTC DRUG	Pomegranate Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-111_4620c751-2751-425e-8d13-1886bf652c57	71087-111	HUMAN OTC DRUG	Tropical Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-112_133a62df-8655-47c3-a59e-3c7e6e1caf01	71087-112	HUMAN OTC DRUG	Vanilla Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-113_852ddc57-bd6e-46f9-b5f0-e207b7782296	71087-113	HUMAN OTC DRUG	Vanilla Mint Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71087-114_9a1727b7-1114-478f-9dc0-1ebcd03ef987	71087-114	HUMAN OTC DRUG	Wildberry Lip Balm		Lip Balm	STICK	TOPICAL	20220906		OTC MONOGRAPH DRUG	M020	Casad Company Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
71090-001_d30a8795-39d4-51c3-e053-2995a90abcf0	71090-001	HUMAN PRESCRIPTION DRUG	Keveyis		Dichlorphenamide	TABLET	ORAL	20150807	20251023	NDA	NDA011366	Strongbridge US Inc.	DICHLORPHENAMIDE	50	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	
71093-111_c5f1ec3b-405e-4128-882b-43559d5083e5	71093-111	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	ACI Healthcare USA, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-112_c5f1ec3b-405e-4128-882b-43559d5083e5	71093-112	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	ACI Healthcare USA, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-119_49ce7685-667c-420c-b759-9ac675dbabf3	71093-119	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20180301		ANDA	ANDA202075	ACI Healthcare USA, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71093-120_a916797c-381c-4008-b778-19221233ef45	71093-120	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	ACI Healthcare USA, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-121_a916797c-381c-4008-b778-19221233ef45	71093-121	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	ACI Healthcare USA, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-122_a916797c-381c-4008-b778-19221233ef45	71093-122	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	ACI Healthcare USA, Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-123_4500a538-11a2-49a5-9c20-6b1f07b4524b	71093-123	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230930		ANDA	ANDA078042	ACI Healthcare USA, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-124_4500a538-11a2-49a5-9c20-6b1f07b4524b	71093-124	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230930		ANDA	ANDA078042	ACI Healthcare USA, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-125_4500a538-11a2-49a5-9c20-6b1f07b4524b	71093-125	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230930		ANDA	ANDA078042	ACI Healthcare USA, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-126_4500a538-11a2-49a5-9c20-6b1f07b4524b	71093-126	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230930		ANDA	ANDA078042	ACI Healthcare USA, Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-127_a4736add-da84-411f-8e6f-9de67bf467f8	71093-127	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET	ORAL	20210629		ANDA	ANDA078662	ACI Healthcare USA, Inc.	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71093-128_a4736add-da84-411f-8e6f-9de67bf467f8	71093-128	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET	ORAL	20210629		ANDA	ANDA078662	ACI Healthcare USA, Inc.	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71093-129_3f41fc19-b54a-46fd-acbf-b411816bccd5	71093-129	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET	ORAL	20070206		ANDA	ANDA076881	ACI Healthcare USA, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71093-130_3f41fc19-b54a-46fd-acbf-b411816bccd5	71093-130	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET	ORAL	20070206		ANDA	ANDA076881	ACI Healthcare USA, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71093-131_3f41fc19-b54a-46fd-acbf-b411816bccd5	71093-131	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET	ORAL	20070206		ANDA	ANDA076881	ACI Healthcare USA, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71093-132_39bb2259-ba80-4602-b468-a2e0d61f48f6	71093-132	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20180115		ANDA	ANDA203769	ACI Healthcare USA, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71093-133_39bb2259-ba80-4602-b468-a2e0d61f48f6	71093-133	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20180115		ANDA	ANDA203769	ACI Healthcare USA, Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71093-134_39bb2259-ba80-4602-b468-a2e0d61f48f6	71093-134	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20180115		ANDA	ANDA203769	ACI Healthcare USA, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71093-135_8a3515c7-6fc7-4150-a898-23443e4802fd	71093-135	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ACI Healthcare USA, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71093-136_8a3515c7-6fc7-4150-a898-23443e4802fd	71093-136	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ACI Healthcare USA, Inc.	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71093-137_8a3515c7-6fc7-4150-a898-23443e4802fd	71093-137	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ACI Healthcare USA, Inc.	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71093-138_8a3515c7-6fc7-4150-a898-23443e4802fd	71093-138	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ACI Healthcare USA, Inc.	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71093-139_8a3515c7-6fc7-4150-a898-23443e4802fd	71093-139	HUMAN PRESCRIPTION DRUG	Quetiapine	Extended Release	Quetiapine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20171129		ANDA	ANDA209635	ACI Healthcare USA, Inc.	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71093-140_819f2075-6f9c-4e37-8b93-2e1f72bd9206	71093-140	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET, FILM COATED	ORAL	20170208		ANDA	ANDA203550	ACI Healthcare USA, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71093-141_819f2075-6f9c-4e37-8b93-2e1f72bd9206	71093-141	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET, FILM COATED	ORAL	20170208		ANDA	ANDA203550	ACI Healthcare USA, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71093-142_a3904f4f-fe8a-40a5-898b-50743dff2b82	71093-142	HUMAN PRESCRIPTION DRUG	CLOPIDOGREL BISULFATE		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20220701		ANDA	ANDA078004	ACI Healthcare USA, Inc	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
71093-143_08556c0b-5c33-48d7-a554-e43a5075ef04	71093-143	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	SOLUTION	ORAL	20060630		ANDA	ANDA076934	ACI Healthcare USA, Inc.	SERTRALINE HYDROCHLORIDE	20	mg/mL	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71093-144_c3e44750-5c2f-4018-8dbe-ef17fa08dd1e	71093-144	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	SOLUTION	ORAL	20090115		ANDA	ANDA078582	ACI Healthcare USA, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-146_5a93579c-5d45-4662-b39c-8d93b04f52dc	71093-146	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110415		ANDA	ANDA077516	ACI Healthcare USA, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71093-147_5a93579c-5d45-4662-b39c-8d93b04f52dc	71093-147	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110415		ANDA	ANDA077516	ACI Healthcare USA, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71093-148_5a93579c-5d45-4662-b39c-8d93b04f52dc	71093-148	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110415		ANDA	ANDA077516	ACI Healthcare USA, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71093-155_69a3d187-578f-4e49-b8b3-109219a7bdf6	71093-155	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	ACI Healthcare USA, Inc	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71093-156_69a3d187-578f-4e49-b8b3-109219a7bdf6	71093-156	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	ACI Healthcare USA, Inc	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71093-161_8f8a0b4a-31c2-4566-85d5-61d2c0ea9a9b	71093-161	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210503		ANDA	ANDA213603	ACI Healthcare USA, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-162_8f8a0b4a-31c2-4566-85d5-61d2c0ea9a9b	71093-162	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210503		ANDA	ANDA213603	ACI Healthcare USA, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-163_8f8a0b4a-31c2-4566-85d5-61d2c0ea9a9b	71093-163	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20210503		ANDA	ANDA213603	ACI Healthcare USA, Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71093-174_5df20b25-1932-414b-b028-210e839c1c38	71093-174	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA215772	ACI Healthcare USA, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71093-175_77a7e874-29c3-449c-92b3-448023e67197	71093-175	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20230730		ANDA	ANDA215773	ACI Healthcare USA, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71094-0001_ce0797a6-6848-4329-9ced-2b24165f584a	71094-0001	HUMAN OTC DRUG	Tinnistop		Causticum, Cocculus Indicus, Conium Maculatum	TABLET	ORAL	20170117		UNAPPROVED HOMEOPATHIC		Peerless Homeopathic	ANAMIRTA COCCULUS SEED; CAUSTICUM; CONIUM MACULATUM FLOWERING TOP	6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
71094-0002_41303cb2-51b9-4877-a1e0-a215707a7355	71094-0002	HUMAN OTC DRUG	DriNites		Causticum, Equisetum Hyemale, Sepia	TABLET	ORAL	20170913		UNAPPROVED HOMEOPATHIC		Peerless Homeopathic	CAUSTICUM; EQUISETUM HYEMALE; SEPIA OFFICINALIS JUICE	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
71100-001_b4e2c44e-3027-45d1-969c-bd3e6596fcd5	71100-001	HUMAN OTC DRUG	Stout Daily SPF for Men		Sunscreen	LIQUID	TOPICAL	20170301		OTC MONOGRAPH FINAL	part352	Stout Face Care Inc.	ZINC OXIDE	8.82	g/90mL			N	20241231
71101-002_027df3f1-638b-8b75-e063-6394a90ae96a	71101-002	HUMAN OTC DRUG	Healthy Wise Pain Relief Lidocaine Patch		Lidocaine 4%	PATCH	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-200_d6e79113-664e-4b12-e053-2a95a90ad1e4	71101-200	HUMAN OTC DRUG	TheraCare Medicated Chest Rub		Camphor (synthetic), Eucalyptus oil, and Menthol	OINTMENT	TOPICAL	20220101		OTC MONOGRAPH FINAL	part341	Veridian Healthcare	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
71101-201_eb7928eb-82fe-46c4-e053-2a95a90aa268	71101-201	HUMAN OTC DRUG	TheraCare Maximum Strength Oral Pain Relief	Severe	Benzocaine 20%, Benzalkonium Chloride 1%	GEL	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part356	Veridian Healthcare	BENZALKONIUM CHLORIDE; BENZOCAINE	10; 200	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71101-202_f7802194-c16a-6e64-e053-6294a90af471	71101-202	HUMAN OTC DRUG	TheraCare Medicated Chest Rub		camphor, menthol, eucalyptus oil	OINTMENT	TOPICAL	20230301		OTC MONOGRAPH FINAL	part341	Veridian Healthcare	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
71101-205_f202b8ea-9616-7a4b-e053-2a95a90a008d	71101-205	HUMAN OTC DRUG	HealthWise Chest Rub		Camphor (synthetic), Eucalyptus oil, and Menthol	OINTMENT	TOPICAL	20211001		OTC MONOGRAPH FINAL	part341	Veridian Healthcare	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
71101-207_fbbfa780-0e2c-1874-e053-6394a90a5eeb	71101-207	HUMAN OTC DRUG	Caring Mills Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20230501		OTC MONOGRAPH FINAL	part347	Veridian Healthcare	PETROLATUM	100	g/100g			N	20241231
71101-208_d6fb4c2e-51e1-7af4-e053-2995a90a924c	71101-208	HUMAN OTC DRUG	TheraCare Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20220201		OTC MONOGRAPH FINAL	part347	Veridian Healthcare	PETROLATUM	100	g/100g			N	20241231
71101-210_c1609455-76a8-a5ac-e053-2995a90ac405	71101-210	HUMAN OTC DRUG	TheraCare First Aid Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20210401		OTC MONOGRAPH FINAL	part333B	Veridian Healthcare	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71101-211_c18159e9-cad3-0384-e053-2995a90af492	71101-211	HUMAN OTC DRUG	TheraCare Maximum Strength 1% Hydrocortisone		hydrocortisone	CREAM	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71101-212_e5f9109e-3c6c-2311-e053-2995a90af6b1	71101-212	HUMAN OTC DRUG	TheraCare Muscle and Join Pain Relief Cream		Menthol, Methyl Salicylate	CREAM	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 150	mg/g; mg/g			N	20241231
71101-213_f202daac-b896-b07e-e053-2a95a90aa1c2	71101-213	HUMAN OTC DRUG	TheraCare A and D		Lanolin, Petrolatum	OINTMENT	TOPICAL	20210901		OTC MONOGRAPH FINAL	part347	Veridian Healthcare	LANOLIN; PETROLATUM	15.5; 53.4	g/100g; g/100g			N	20241231
71101-215_d8c41944-44a6-11fb-e053-2995a90a11e5	71101-215	HUMAN OTC DRUG	TheraCare Extra Strength Anti-Itch Cream	Itch Stopping	Diphenhydramine Hydrochloride and Zinc Acetate	CREAM	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71101-217_fc714ed3-86f4-5cc3-e053-6394a90a34d9	71101-217	HUMAN OTC DRUG	Theracare Ice Blue Gel	Pain Relieving	Menthol	GEL	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL	20	mg/g			N	20241231
71101-218_d8c32445-eda1-4181-e053-2a95a90a7a5a	71101-218	HUMAN OTC DRUG	TheraCare Pain Relieving Muscle Vanishing Scent		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL, UNSPECIFIED FORM	25	mg/g			N	20241231
71101-800_fbc00052-e98d-e852-e053-6294a90aec0f	71101-800	HUMAN OTC DRUG	Caring Mills Hydrocortisone		hydrocortisone	CREAM	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71101-801_fbd11419-4514-10d7-e053-6394a90ac82b	71101-801	HUMAN OTC DRUG	Caring Mills Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20230501		OTC MONOGRAPH FINAL	part333B	Veridian Healthcare	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71101-904_bbce193c-fc1c-42ce-8399-66b2fede7f5e	71101-904	HUMAN OTC DRUG	2-Count HEAT PATCHES		CAPSAICIN	PATCH	TOPICAL	20181121		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	CAPSAICIN	.25	g/g			N	20241231
71101-907_f6e1ed72-b578-fad9-e053-6394a90a57a3	71101-907	HUMAN OTC DRUG	Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20170601		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
71101-909_f6f3c9c0-d6e4-75a3-e053-6294a90a1965	71101-909	HUMAN OTC DRUG	TheraCare Medicated Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
71101-911_ce647e79-57ee-804b-e053-2995a90afa25	71101-911	HUMAN OTC DRUG	THERA CARE PAIN THERAPY		LIDOCAINE	PATCH	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-913_cdac03ae-d89d-46da-8f13-42628cf1229a	71101-913	HUMAN OTC DRUG	Thera Care Pain Relief Menthol Patchs		MENTHOL	PATCH	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL	5	g/100g			N	20241231
71101-914_ce2ea2f0-bd68-6051-e053-2995a90a31da	71101-914	HUMAN OTC DRUG	HealthWise Lidocaine and Menthol Pain Relief		lidocaine and menthol	PATCH	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-915_ce2897bb-4a4b-1a20-e053-2995a90ae3ac	71101-915	HUMAN OTC DRUG	HealthWise Lidocaine Pain relief		Lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20161001		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-916_aa93d7aa-177a-3c1d-e053-2a95a90a19b9	71101-916	HUMAN OTC DRUG	THERA CARE 24hrs Lidocaine Patch		LIDOCAINE 4%	PATCH	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-917_f161a89b-e71f-2c84-e053-2a95a90a2e66	71101-917	HUMAN OTC DRUG	Caring Mills Relief Patch with Lidocaine		Lidocaine 4%	PATCH	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-918_f93b00e1-06d7-9066-e053-6294a90ae89a	71101-918	HUMAN OTC DRUG	TheraCare Pain Relieving Patch with Lidocaine		Lidocaine	PATCH	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-933_ef18ba0e-e544-469b-e053-2995a90a46d8	71101-933	HUMAN OTC DRUG	TheraCare 4% Lidocaine Cream		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20221201		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71101-934_e2b0342f-90b6-6c80-e053-2995a90add85	71101-934	HUMAN OTC DRUG	TheraCare Antifungal Cream		Tolnaftate	CREAM	TOPICAL	20220601		OTC MONOGRAPH FINAL	part333C	Veridian Healthcare	TOLNAFTATE	10	mg/g			N	20241231
71101-947_ee62e44e-a0a0-2e58-e053-2a95a90abe04	71101-947	HUMAN OTC DRUG	HealthWise Menstrual Pain Relief Patch		MENTHOL	PATCH	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL, UNSPECIFIED FORM	10	g/100g			N	20241231
71101-952_cf47a57c-919d-0356-e053-2995a90acb25	71101-952	HUMAN OTC DRUG	Hot and Cold Medicated Patch		MENTHOL	PATCH	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL	5	g/100g			N	20241231
71101-953_aa84cecb-8b12-c1ca-e053-2995a90a2bbe	71101-953	HUMAN OTC DRUG	Thera Care Hot and Cold Medicated Patch		MENTHOL	PATCH	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL	5	g/100g			N	20241231
71101-954_f1fe7ee0-7b72-3f74-e053-2a95a90a5893	71101-954	HUMAN OTC DRUG	Thera Care Cold Hot Medicated Patch		MENTHOL	PATCH	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part348	Veridian Healthcare	MENTHOL	5	g/100g			N	20241231
71101-962_2389c91b-3487-4a87-9ee7-d4f62d7beb2d	71101-962	HUMAN OTC DRUG	ADVANCE HAND SANITIZER WITH ALOE		ALCOHOL	GEL	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part333E	Veridian Healthcare	ALCOHOL	70	mL/100mL			N	20241231
71104-801_e600c559-32d8-4818-b600-141cc0d74cea	71104-801	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-802_e600c559-32d8-4818-b600-141cc0d74cea	71104-802	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-803_e600c559-32d8-4818-b600-141cc0d74cea	71104-803	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-804_e600c559-32d8-4818-b600-141cc0d74cea	71104-804	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-805_e600c559-32d8-4818-b600-141cc0d74cea	71104-805	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-806_e600c559-32d8-4818-b600-141cc0d74cea	71104-806	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-807_e600c559-32d8-4818-b600-141cc0d74cea	71104-807	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-808_e600c559-32d8-4818-b600-141cc0d74cea	71104-808	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-809_e600c559-32d8-4818-b600-141cc0d74cea	71104-809	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-810_e600c559-32d8-4818-b600-141cc0d74cea	71104-810	PLASMA DERIVATIVE	ELOCTATE		Antihemophilic Factor (Recombinant), Fc Fusion Protein	KIT	INTRAVENOUS	20170906		BLA	BLA125487	Bioverativ Therapeutics Inc.						N	20241231
71104-911_8e642494-8362-4c3a-9062-17b346310e8e	71104-911	PLASMA DERIVATIVE	ALPROLIX		Coagulation Factor IX (Recombinant), Fc Fusion Protein	KIT		20140505		BLA	BLA125444	Bioverativ Therapeutics Inc.						N	20241231
71104-922_8e642494-8362-4c3a-9062-17b346310e8e	71104-922	PLASMA DERIVATIVE	ALPROLIX		Coagulation Factor IX (Recombinant), Fc Fusion Protein	KIT		20140505		BLA	BLA125444	Bioverativ Therapeutics Inc.						N	20241231
71104-933_8e642494-8362-4c3a-9062-17b346310e8e	71104-933	PLASMA DERIVATIVE	ALPROLIX		Coagulation Factor IX (Recombinant), Fc Fusion Protein	KIT		20140505		BLA	BLA125444	Bioverativ Therapeutics Inc.						N	20241231
71104-944_8e642494-8362-4c3a-9062-17b346310e8e	71104-944	PLASMA DERIVATIVE	ALPROLIX		Coagulation Factor IX (Recombinant), Fc Fusion Protein	KIT		20140505		BLA	BLA125444	Bioverativ Therapeutics Inc.						N	20241231
71104-966_8e642494-8362-4c3a-9062-17b346310e8e	71104-966	PLASMA DERIVATIVE	ALPROLIX		Coagulation Factor IX (Recombinant), Fc Fusion Protein	KIT		20140505		BLA	BLA125444	Bioverativ Therapeutics Inc.						N	20241231
71104-977_8e642494-8362-4c3a-9062-17b346310e8e	71104-977	PLASMA DERIVATIVE	ALPROLIX		Coagulation Factor IX (Recombinant), Fc Fusion Protein	KIT		20140505		BLA	BLA125444	Bioverativ Therapeutics Inc.						N	20241231
71104-978_c763ace9-b0c4-4c2c-b631-3350402214e3	71104-978	HUMAN PRESCRIPTION DRUG	ALTUVIIIO		Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl	KIT		20230222		BLA	BLA125771	Bioverativ Therapeutics Inc.						N	20241231
71104-979_c763ace9-b0c4-4c2c-b631-3350402214e3	71104-979	HUMAN PRESCRIPTION DRUG	ALTUVIIIO		Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl	KIT		20230222		BLA	BLA125771	Bioverativ Therapeutics Inc.						N	20241231
71104-981_c763ace9-b0c4-4c2c-b631-3350402214e3	71104-981	HUMAN PRESCRIPTION DRUG	ALTUVIIIO		Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl	KIT		20230222		BLA	BLA125771	Bioverativ Therapeutics Inc.						N	20241231
71104-982_c763ace9-b0c4-4c2c-b631-3350402214e3	71104-982	HUMAN PRESCRIPTION DRUG	ALTUVIIIO		Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl	KIT		20230222		BLA	BLA125771	Bioverativ Therapeutics Inc.						N	20241231
71104-983_c763ace9-b0c4-4c2c-b631-3350402214e3	71104-983	HUMAN PRESCRIPTION DRUG	ALTUVIIIO		Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl	KIT		20230222		BLA	BLA125771	Bioverativ Therapeutics Inc.						N	20241231
71104-984_c763ace9-b0c4-4c2c-b631-3350402214e3	71104-984	HUMAN PRESCRIPTION DRUG	ALTUVIIIO		Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl	KIT		20230222		BLA	BLA125771	Bioverativ Therapeutics Inc.						N	20241231
71105-107_064649c9-cf69-a4c3-e063-6294a90a3624	71105-107	HUMAN OTC DRUG	Redicare Blood Clotting		Blood Clotting Spray	AEROSOL, SPRAY	TOPICAL	20231001		OTC MONOGRAPH NOT FINAL	part348	Redicare LLC	BENZETHONIUM CHLORIDE; LIDOCAINE	170; 3400	mg/85g; mg/85g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71121-010_a768c233-9ed8-4865-bd1a-7fc516f9ff5d	71121-010	HUMAN OTC DRUG	DOCTORCOS Snow White Water GLOW MASK		Dimethicone	CREAM	TOPICAL	20161101		OTC MONOGRAPH FINAL	part347	DOCTORCOS CO., LTD	DIMETHICONE	5.5	g/110mL	Skin Barrier Activity [PE]		N	20241231
71127-1000_8184fbca-ace3-4cab-bfba-218dc5cadfd3	71127-1000	HUMAN PRESCRIPTION DRUG	Sevenfact		Coagulation Factor VIIa Recombinant Human	KIT		20230401		BLA	BLA125641	Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.)						N	20241231
71127-5000_8184fbca-ace3-4cab-bfba-218dc5cadfd3	71127-5000	HUMAN PRESCRIPTION DRUG	Sevenfact		Coagulation Factor VIIa Recombinant Human	KIT		20230401		BLA	BLA125641	Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.)						N	20241231
71130-236_09d769cf-cc6f-9fd3-e063-6394a90ac18e	71130-236	HUMAN OTC DRUG	Miami Beach Body White Gold SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Miami Beach Brands, Corp.	TITANIUM DIOXIDE; ZINC OXIDE	60; 125	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71131-050_09d78f85-d8ee-c97e-e063-6394a90a1c62	71131-050	HUMAN OTC DRUG	Uber Numb		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20171101		OTC MONOGRAPH DRUG	M017	UBERScientific, LLC	LIDOCAINE HYDROCHLORIDE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71131-051_09d8a838-3a74-c010-e063-6294a90aa31a	71131-051	HUMAN OTC DRUG	Uber Numb		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20171101		OTC MONOGRAPH DRUG	M017	UBERScientific, LLC	LIDOCAINE HYDROCHLORIDE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71131-052_07986186-7a16-cd1e-e063-6394a90a5e7e	71131-052	HUMAN OTC DRUG	ADVANCED NUMB Topical Anesthetic		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20180420		OTC MONOGRAPH DRUG	M015	Uber Scientific, LLC	LIDOCAINE HYDROCHLORIDE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71131-100_d43c0bc9-c014-cad8-e053-2a95a90a3315	71131-100	HUMAN OTC DRUG	Kivoria Acne Wash		BENZOYL PEROXIDE	SOAP	TOPICAL	20190401		OTC MONOGRAPH FINAL	part333D	UberScientific, LLC	BENZOYL PEROXIDE	10	g/100g			N	20241231
71131-200_d43c0bc9-c013-cad8-e053-2a95a90a3315	71131-200	HUMAN OTC DRUG	KIVORIA SKIN PROTECTANT		COLLOIDAL OATMEAL	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part347	UBER SCIENTIFIC	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71131-774_09d8af03-eca8-c1e3-e063-6294a90ad4a1	71131-774	HUMAN OTC DRUG	Uber Numb Topical Anesthetic		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20161220		OTC MONOGRAPH DRUG	M015	UberScientific, LLC	LIDOCAINE HYDROCHLORIDE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71131-797_09d8b426-919e-1129-e063-6394a90ae9cd	71131-797	HUMAN OTC DRUG	Uber Numb Topical Anesthetic		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20170223		OTC MONOGRAPH DRUG	M015	UberScientific, LLC	LIDOCAINE HYDROCHLORIDE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71140-0385_ec975b32-5ec3-3575-e053-2995a90a6780	71140-0385	HUMAN OTC DRUG	Perfectly Posh Block it Like its Hot Broad Spectrum	SPF 30	Octisalate, Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part352	Perfectly Posh, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 5; 2.7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
71141-020_71f3fe6e-fe75-4cb0-baa9-61eac5f79c75	71141-020	HUMAN OTC DRUG	Diaper Rash		Zinc oxide	PASTE	TOPICAL	20170605		OTC MONOGRAPH FINAL	part347	Lidl US, LLC	ZINC OXIDE	532	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71141-021_e874203b-8c43-b6b2-e053-2a95a90ad1bf	71141-021	HUMAN OTC DRUG	LIDL		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20210804		OTC MONOGRAPH NOT FINAL	part333E	LIDL US LLC	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
71141-090_08f1b9a9-c74a-2d9a-e063-6294a90a1c00	71141-090	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210330	20250131	OTC MONOGRAPH DRUG	M012	LIDL US LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
71141-095_08f498c3-7b2c-e29b-e063-6294a90ad1ee	71141-095	HUMAN OTC DRUG	Acetaminophen PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20210330	20240831	OTC MONOGRAPH DRUG	M013	LIDL US LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
71141-110_031d6578-9087-fe1e-e063-6394a90a0b15	71141-110	HUMAN OTC DRUG	Cough Drops Honey Lemon with Sugar		Menthol	TABLET	ORAL	20170501		OTC MONOGRAPH DRUG	M012	Lidl US LLC	MENTHOL	7.5	mg/7.5mg			N	20241231
71141-111_031d6578-9087-fe1e-e063-6394a90a0b15	71141-111	HUMAN OTC DRUG	Cough Drops Cherry with Sugar		Menthol	TABLET	ORAL	20170501		OTC MONOGRAPH DRUG	M012	Lidl US LLC	MENTHOL	5.8	mg/5.8mg			N	20241231
71141-112_031d6578-9087-fe1e-e063-6394a90a0b15	71141-112	HUMAN OTC DRUG	Cough Drops Menthol Sugar Free		Menthol	TABLET	ORAL	20170501		OTC MONOGRAPH DRUG	M012	Lidl US LLC	MENTHOL	5.8	mg/5.8mg			N	20241231
71141-114_08f20d0f-5731-52f7-e063-6294a90afaba	71141-114	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20170331	20250831	ANDA	ANDA079174	Lidl US LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
71141-115_ee9dbd09-f086-188f-e053-2a95a90ad582	71141-115	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20170331	20240831	OTC MONOGRAPH NOT FINAL	part343	Lidl US LLC	ACETAMINOPHEN	500	mg/1			N	
71141-132_059bf46f-8a79-486a-995f-5f4e986ea178	71141-132	HUMAN OTC DRUG	Loratadine Allergy Relief		Loratadine	TABLET	ORAL	20170901		ANDA	ANDA076134	LIDL US, LLC	LORATADINE	10	mg/1			N	20241231
71141-133_4cf9e5b8-0be6-4a8b-9ee3-7e7272864279	71141-133	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20170901		ANDA	ANDA077498	LIDL US, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71141-134_b50e40b8-77dc-4710-a434-ad3039ebf94c	71141-134	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate	OINTMENT	TOPICAL	20151215		OTC MONOGRAPH FINAL	part333B	Lidl US, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71141-135_c5c7bd42-d20e-4e8b-930f-f660ac35da10	71141-135	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET	ORAL	20170228	20250228	OTC MONOGRAPH FINAL	part341	Lidl US, LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	
71141-136_6ab72aa6-f207-4894-85ef-3ddcb5499b57	71141-136	HUMAN OTC DRUG	Mucus Relief	DM	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20170228	20250228	OTC MONOGRAPH FINAL	part341	Lidl US, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
71141-137_0d0aade0-001e-499f-b93c-27ca2e3e2e9e	71141-137	HUMAN OTC DRUG	Daytime Cold and Flu	Multi symptom relief	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	LIQUID	ORAL	20170228		OTC MONOGRAPH FINAL	part341	Lidl US, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71141-138_88533acf-c417-4ed3-9c65-ef6818911e99	71141-138	HUMAN OTC DRUG	Cold and Flu	Nighttime Relief	Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20170228	20250228	OTC MONOGRAPH FINAL	part341	Lidl US, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
71141-143_129f68b3-453e-44bc-9ee9-a84030f3e59f	71141-143	HUMAN OTC DRUG	Extra Strength Antacid	Assorted Berries	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20181115		OTC MONOGRAPH FINAL	part331	LIDL US, LLC	CALCIUM CARBONATE	750	mg/1			N	20241231
71141-144_e86ada25-49f3-4ba3-8a04-cd688727d9ec	71141-144	HUMAN OTC DRUG	Lidl Ultra Strength Antacid Calcium Carbonate	Assorted Fruit	Antacid Tablets	TABLET, CHEWABLE	ORAL	20181115		OTC MONOGRAPH FINAL	part331	Lidl US LLC	CALCIUM CARBONATE	1000	mg/1			N	20241231
71141-145_e36a92c7-9ddf-4dc9-ac73-d81363744150	71141-145	HUMAN OTC DRUG	Lidl Orange Smooth Fiber Powder	Naturally and Artificially Flavored	Psyllium Husk	POWDER	ORAL	20181115		OTC MONOGRAPH NOT FINAL	part334	LIDL US, LLC	PSYLLIUM HUSK	3.4	g/12g			N	20241231
71141-146_26e30bbf-23df-46bb-b89d-8bbec25fabd4	71141-146	HUMAN OTC DRUG	LIDL Orange Smooth Fiber Powder Sugar Free	Naturally and Artificially Flavored	Natural Psyllium Husk	POWDER	ORAL	20181115		OTC MONOGRAPH NOT FINAL	part334	LIDL US, LLC	PSYLLIUM HUSK	3.4	g/5.8g			N	20241231
71141-152_58934b3d-7533-4888-ab02-1e4bd1d83a5a	71141-152	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic acid 2%	LOTION	TOPICAL	20170210		OTC MONOGRAPH FINAL	part333D	Lidl US, LLC	SALICYLIC ACID	20.6	mg/mL			N	20241231
71141-155_5f0c8ced-9388-4c91-91e6-d65a343b39f5	71141-155	HUMAN OTC DRUG	Antiseptic Mouthrinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part348	Lidl US, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71141-156_589c167f-4550-48ba-9120-f2f4462549e6	71141-156	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part356	Lidl US, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71141-157_3e7b1649-60cf-469e-93f5-f61cc0e94063	71141-157	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part356	Lidl US, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71141-158_08f17b4d-8ee3-a94f-e063-6394a90a02a0	71141-158	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20190201	20250630	OTC MONOGRAPH DRUG	M013	Lidl USA LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
71141-159_d7f4b8d7-27cc-490f-8ac6-a386404bfd13	71141-159	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH FINAL	part355	Lidl US, LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
71141-160_e0016ed5-d67e-462c-b91c-7953662d7d20	71141-160	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20170209		OTC MONOGRAPH NOT FINAL	part356	Lidl US, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71141-168_ee298d18-1dcd-f7be-e053-2a95a90afcc0	71141-168	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20221123		ANDA	ANDA213420	LIDL US LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71141-169_f81f6b52-92d3-4fe1-e053-6294a90acf8b	71141-169	HUMAN OTC DRUG	Dentalux sensitive		Potassium nitrate, sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210501		OTC MONOGRAPH NOT FINAL	part356	Lidl US LLC	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .243	g/100g; g/100g			N	20241231
71141-170_f81f6d80-0772-16a6-e053-6294a90ab148	71141-170	HUMAN OTC DRUG	Dentalux total care		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210501		OTC MONOGRAPH FINAL	part355	Lidl US LLC	SODIUM FLUORIDE	.243	g/100g			N	20241231
71141-171_f81f6d80-0768-16a6-e053-6294a90ab148	71141-171	HUMAN OTC DRUG	Whitening Plus		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210504		OTC MONOGRAPH FINAL	part355	Lidl US LLC	SODIUM FLUORIDE	.243	g/100g			N	20241231
71141-172_f81f6d80-075b-16a6-e053-6294a90ab148	71141-172	HUMAN OTC DRUG	dentalux kids bubble gum		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210509		OTC MONOGRAPH FINAL	part355	Lidl US LLC	SODIUM FLUORIDE	.243	g/100g			N	20241231
71141-173_f81f6d80-077e-16a6-e053-6294a90ab148	71141-173	HUMAN OTC DRUG	dentalux kids mixed berry		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210509		OTC MONOGRAPH FINAL	part355	Lidl US LLC	SODIUM FLUORIDE	.243	g/100g			N	20241231
71141-174_f81f5efd-c318-e0bf-e053-6394a90aa029	71141-174	HUMAN OTC DRUG	dentalux charcoal		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210630		OTC MONOGRAPH FINAL	part355	Lidl US LLC	SODIUM FLUORIDE	.239	g/100g			N	20241231
71141-175_f81f60fc-6cd1-3b40-e053-6394a90a5cd1	71141-175	HUMAN OTC DRUG	dentalux coconut minerals		sodium fluoride	PASTE, DENTIFRICE	DENTAL	20210630		OTC MONOGRAPH FINAL	part355	Lidl US LLC	SODIUM FLUORIDE	.239	g/100g			N	20241231
71141-176_ee299b7c-d1d3-080f-e053-2a95a90a37b4	71141-176	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, COATED	ORAL	20221123		OTC MONOGRAPH NOT FINAL	part343	LIDL US LLC	ACETAMINOPHEN	500	mg/1			N	20241231
71141-194_08f1de9b-c4d0-e10e-e063-6394a90a5d93	71141-194	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine hydrochloride	TABLET, COATED	ORAL	20210330	20240930	ANDA	ANDA209274	LIDL US LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
71141-245_08f1e954-4e2c-d5de-e063-6394a90a64eb	71141-245	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20210330	20250430	ANDA	ANDA079096	LIDL US LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
71141-294_ea23a5a6-3f35-41bb-e053-2a95a90a1f5c	71141-294	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20221001		ANDA	ANDA209274	LIDL US LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71141-496_b1fffe9f-bfa1-4208-a4c4-f5c6addebd65	71141-496	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20200224		OTC MONOGRAPH FINAL	part347	Lidl US, LLC	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
71141-619_002b9e3c-2f03-4bd6-9ef4-744bfb9c1657	71141-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20200224		OTC MONOGRAPH FINAL	part347	Lidl US, LLC	DIMETHICONE	1.3	kg/100mL	Skin Barrier Activity [PE]		N	20241231
71141-622_b8f7dfb6-18fa-4abe-8b1c-bb2f4af8153a	71141-622	HUMAN OTC DRUG	Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20221115		OTC MONOGRAPH FINAL	part347	Lidl US, LLC	ZINC OXIDE	130	mg/g			N	20241231
71141-849_129adfd5-d267-43e8-a7ad-449006abe56f	71141-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20210628		OTC MONOGRAPH NOT FINAL	part333A	Lidl US, LLC	ALCOHOL	62	mg/mL			N	20241231
71141-943_bc42f2a5-459e-ae70-e053-2a95a90a915a	71141-943	HUMAN OTC DRUG	LIDL Sport SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20140110		OTC MONOGRAPH NOT FINAL	part352	LIDL US LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
71141-944_c704b812-ae75-228a-e053-2a95a90a1c46	71141-944	HUMAN OTC DRUG	LIDL Dry Tanning Oil Sunscreen SPF 15		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20150421		OTC MONOGRAPH NOT FINAL	part352	LIDL US LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
71141-945_e46c53f9-6e27-44cd-e053-2a95a90a110f	71141-945	HUMAN OTC DRUG	CIEN SUN BY LIDL KIDS SUNSCREEN SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210414		OTC MONOGRAPH NOT FINAL	part352	LIDL US LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
71141-946_e46c53f9-6e29-44cd-e053-2a95a90a110f	71141-946	HUMAN OTC DRUG	CIEN SUN BY LIDL SPORT SUNSCREEN SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20170314		OTC MONOGRAPH NOT FINAL	part352	LIDL US LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
71141-947_f7ad3e74-8d2c-2f2e-e053-6294a90af6f0	71141-947	HUMAN OTC DRUG	CIEN SUN BY LIDL KIDS SUNSCREEN SPF 50 PLUS		OCTISALATE, ZINC OXIDE	LOTION	TOPICAL	20210430		OTC MONOGRAPH FINAL	M020	LIDL US LLC	OCTISALATE; ZINC OXIDE	50; 145	mg/mL; mg/mL			N	20241231
71141-948_f7b1bb91-2565-4896-e053-6394a90a5734	71141-948	HUMAN OTC DRUG	Cien SUN by LIDL SPORT Sunscreen Broad Spectrum SPF 30		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20210416		OTC MONOGRAPH FINAL	M020	LIDL US LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
71141-949_f7b28850-540e-5286-e053-6394a90a9eb2	71141-949	HUMAN OTC DRUG	Cien SUN by LIDL SPORT Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20170601		OTC MONOGRAPH FINAL	M020	LIDL US LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
71143-375_c6843202-6ad2-429c-8f73-e4c0a272cab7	71143-375	HUMAN PRESCRIPTION DRUG	XHANCE		fluticasone propionate	SPRAY, METERED	NASAL	20171003		NDA	NDA209022	OptiNose US, Inc.	FLUTICASONE PROPIONATE	93	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71144-0001_a98201e7-4e31-432f-92b0-327334a684e1	71144-0001	HUMAN OTC DRUG	Cold and Flu Relief		Baptisia Tinctoria, Calcarea Sulphurica, Allium Cepa, Calcarea Carbonica, Calcarea Phosphorica, Ferrum Phosphoricum, Kali Muriaticum, Kali Sulphuricum, Silicea, Spongia Tosta, Aconitum Napellus, Arsenicum Album, Dulcamara, Euphrasia Officinalis, Eupatorium Perfoliatum, Gelsemium Sempervirens	SPRAY	ORAL	20170119		UNAPPROVED HOMEOPATHIC		Attuned Matrix, LLC	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; CALCIUM SULFATE ANHYDROUS; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; FERRUM PHOSPHORICUM; GELSEMIUM SEMPERVIRENS ROOT; ONION; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SOLANUM DULCAMARA TOP; SPONGIA OFFICINALIS SKELETON, ROASTED; TRIBASIC CALCIUM PHOSPHATE	12; 12; 3; 6; 12; 12; 8; 12; 8; 8; 8; 8; 8; 12; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS]		N	20241231
71144-0002_63dc49f6-4ff5-433f-80a9-f559806b6efb	71144-0002	HUMAN OTC DRUG	Mens Sports Formula		Agnus Castus, Arnica Montana, Arsenicum Album, Aurum Muriaticum Natronatum, Avena Sativa, Baryta Carbonica, Caladium Seguinum, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Glandula Suprarenalis Suis, Hypophysis Suis, Hypothalamus Suis, Kali Muriaticum, Kali Phosphoricum, Lycopodium Clavatum, Magnesia Phosphorica, Manganum Sulphuricum, Natrum Phosphoricum, Natrum Sulphuricum, Nuphar Luteum, Orchitinum (Suis), Pancreas Suis, Ruta Graveolens, Sabal Serrulata,	SPRAY	ORAL	20230502		UNAPPROVED HOMEOPATHIC		Attuned Matrix, LLC	ARNICA MONTANA WHOLE; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CHASTE TREE FRUIT; DIBASIC POTASSIUM PHOSPHATE; DIEFFENBACHIA SEGUINE WHOLE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE SULFATE; NUPHAR LUTEA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CHLORIDE; RUTA GRAVEOLENS FLOWERING TOP; SAW PALMETTO; SELENIUM; SILICON DIOXIDE; SMILAX ORNATA ROOT; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SODIUM TETRACHLOROAURATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SUS SCROFA TESTICLE; TRIBASIC CALCIUM PHOSPHATE; VERATRUM ALBUM ROOT; ZINC CHLORIDE	8; 12; 12; 12; 12; 6; 6; 6; 6; 5; 12; 12; 6; 12; 12; 6; 3; 12; 12; 6; 6; 6; 12; 13; 13; 6; 12; 6; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71150-786_f112e265-c813-288e-e053-2a95a90ac3d9	71150-786	HUMAN PRESCRIPTION DRUG	Onycho-Med		Miconazole Nitrate, Terbinafine Hcl	KIT	TOPICAL	20190530		UNAPPROVED DRUG OTHER		Medhart Pharmaceuticals, Inc.						N	20241231
71151-003_d94fb558-d963-5c7a-e053-2a95a90a04b4	71151-003	HUMAN PRESCRIPTION DRUG	VALGANCICLOVIR		valganciclovir	FOR SOLUTION	ORAL	20220228		ANDA	ANDA210169	airis PHARMA PVT LTD	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
71151-025_0ef7f20f-a14b-448e-8d10-5e902056b1db	71151-025	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	POWDER, FOR SUSPENSION	ORAL	20230922		ANDA	ANDA213955	airis PHARMA Private Limited	MYCOPHENOLATE MOFETIL	200	mg/mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
71151-030_9d54e7e5-a2b8-46f1-a421-c44335e1587f	71151-030	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20240105		ANDA	ANDA217031	airis PHARMA Private Limited	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
71151-031_9d54e7e5-a2b8-46f1-a421-c44335e1587f	71151-031	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		Mycophenolic Acid	TABLET, DELAYED RELEASE	ORAL	20240105		ANDA	ANDA217031	airis PHARMA Private Limited	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20251231
71160-180_09874a42-626c-b23c-e063-6394a90a889f	71160-180	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20170109		OTC MONOGRAPH DRUG	505G(a)(3)	TEKWELD SOLUTIONS, INC.	ALCOHOL	620	mg/mL			N	20241231
71160-189_0ead8fa4-5c0a-bd80-e063-6294a90ad8e9	71160-189	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20170109		OTC MONOGRAPH DRUG	505G(a)(3)	TEKWELD SOLUTIONS, INC.	ALCOHOL	620	mg/mL			N	20251231
71160-331_0d7021f4-3029-3554-e063-6294a90a64d4	71160-331	HUMAN OTC DRUG	SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	LOTION	TOPICAL	20231220		OTC MONOGRAPH DRUG	M020	Tekweld Solutions, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71160-338_0d7fa814-2190-7a91-e063-6294a90a1fc0	71160-338	HUMAN OTC DRUG	SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	LOTION	TOPICAL	20231220		OTC MONOGRAPH DRUG	M020	Tekweld Solutions, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71162-001_0bc8add0-810a-3d43-e063-6294a90a1bb8	71162-001	HUMAN PRESCRIPTION DRUG	Ammonia N 13		Ammonia N-13	INJECTION	INTRAVENOUS	20181221		ANDA	ANDA210524	Ionetix Corporation	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
71165-011_08a1d3f6-754f-c480-e063-6394a90ae2f0	71165-011	HUMAN OTC DRUG	Freegells Cough Drops Menthol Cherry		MENTHOL	LOZENGE	ORAL	20221001		OTC MONOGRAPH DRUG	M012	Riclan S.A.	MENTHOL	5.8	mg/1			N	20241231
71165-012_08a1d725-5476-d285-e063-6294a90addc0	71165-012	HUMAN OTC DRUG	Freegells Cough Drops Menthol Eucalyptus		MENTHOL	LOZENGE	ORAL	20221001		OTC MONOGRAPH DRUG	M012	Riclan S.A.	MENTHOL	5.4	mg/1			N	20241231
71165-013_08a1dbae-5c73-f0b8-e063-6294a90a44be	71165-013	HUMAN OTC DRUG	Freegells Cough Drops Menthol Honey Lemon		MENTHOL	LOZENGE	ORAL	20221001		OTC MONOGRAPH DRUG	M012	Riclan S.A.	MENTHOL	7.5	mg/1			N	20241231
71165-014_08a1df47-5cbb-bce0-e063-6294a90a4023	71165-014	HUMAN OTC DRUG	Freegells Cough Drops Menthol Strawberry		MENTHOL	LOZENGE	ORAL	20221001		OTC MONOGRAPH DRUG	M012	Riclan S.A.	MENTHOL	2.7	mg/1			N	20241231
71165-171_26755eec-9305-49b3-800d-7a0d03e29d83	71165-171	HUMAN OTC DRUG	Gems	Honey Lemon	Menthol	LOZENGE	ORAL	20210913		OTC MONOGRAPH DRUG	M012	Riclan S.A.	MENTHOL	9	mg/1			N	20241231
71165-172_970f7a8c-d3f2-4131-a2d7-7a1edefa1b1d	71165-172	HUMAN OTC DRUG	Gems	Cherry	Menthol	LOZENGE	ORAL	20210913		OTC MONOGRAPH DRUG	M012	Riclan S.A.	MENTHOL	7	mg/1			N	20241231
71165-173_4bc8f218-78f3-4276-8251-64c700fe77a3	71165-173	HUMAN OTC DRUG	Gems	Menthol Eucalyptus	Menthol	LOZENGE	ORAL	20210913		OTC MONOGRAPH DRUG	M012	Riclan S.A.	MENTHOL	8.4	mg/1			N	20241231
71171-778_09d8a40d-02a3-c265-e063-6294a90a8a0b	71171-778	HUMAN OTC DRUG	ELON Dual Defense Anti Fungal Formula		UNDECYLENIC ACID	LIQUID	TOPICAL	20170102		OTC MONOGRAPH DRUG	M005	Little Giant Holdings LLC	UNDECYLENIC ACID	250	mg/mL			N	20241231
71173-1000_8223be93-b997-01ba-e053-2991aa0acc25	71173-1000	HUMAN OTC DRUG	BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK		Butylene Glycol, Glycerin, Inonotus Obliquus (Mushroom) Extract	LIQUID	TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part347	BUDDATE Co Ltd	BUTYLENE GLYCOL; GLYCERIN; INONOTUS OBLIQUUS FRUITING BODY	6.03; 4; .1	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
71173-2000_82242b4b-fd19-c9b0-e053-2a91aa0a499c	71173-2000	HUMAN OTC DRUG	BUDDATE LOTUS MOISTURE ESSENCE		Glycerin, Niacinamide, Nelumbo Nucifera Flower Extract, Portulaca Oleracea Extract	LIQUID	TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part347	BUDDATE Co Ltd	GLYCERIN; NELUMBO NUCIFERA FLOWER; NIACINAMIDE; PURSLANE	5.93; 1.35; 2; .5	g/100mL; g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
71173-3000_8223be93-b9a1-01ba-e053-2991aa0acc25	71173-3000	HUMAN OTC DRUG	BUDDATE REGES INTENSIVE TREATMENT		Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7	CREAM	TOPICAL	20170101		UNAPPROVED DRUG OTHER		BUDDATE Co Ltd	BUTYLENE GLYCOL; HYDROGENATED COCONUT OIL; PALMITOYL TETRAPEPTIDE-7; PALMITOYL TRIPEPTIDE-1; SHEA BUTTER	5.57; 4; .000006; .000006; 3	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
71179-002_8f11da6c-2f66-42cf-a7f8-d0d80ffafa61	71179-002	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220627		ANDA	ANDA210453	VESPYR BRANDS, INC.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71179-011_0e14a036-7ed4-49d9-b3b0-8086ee314ca6	71179-011	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan HBr		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20220714		ANDA	ANDA206941	VESPYR BRANDS, INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71179-018_04b63c59-22d7-042c-e063-6394a90a6ac6	71179-018	HUMAN OTC DRUG	VIVARIN		caffeine	TABLET	ORAL	20230619		OTC MONOGRAPH DRUG	M011	VESPYR BRANDS, INC.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
71179-024_0cca624d-6867-2baa-e063-6394a90ac44d	71179-024	HUMAN OTC DRUG	CONTAC	COLD FLU DAY	phenylephrine Hydrochloride, acetaminophen	TABLET	ORAL	20221130		OTC MONOGRAPH DRUG	M012	Vespyr Brands, Inc.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	500; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
71179-025_0cdd028b-8f09-2351-e063-6394a90aa0ef	71179-025	HUMAN OTC DRUG	CONTAC	Cold Flu Day Night	Acetaminophen, phenylephrine hydrochloride, chlorpheniramine maleate	KIT	ORAL	20231201		OTC MONOGRAPH DRUG	M012	Vespyr Brands, Inc.						N	20251231
71179-320_01693b98-633d-543e-e063-6394a90a8544	71179-320	HUMAN OTC DRUG	Cold-EEZE Cold Remedy		Zinc Gluconate	LOZENGE	ORAL	20220623		UNAPPROVED HOMEOPATHIC		Vespyr Brands Inc	ZINC GLUCONATE	13.3	mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71179-323_02f6a96b-ef91-59b6-e063-6294a90ab1a9	71179-323	HUMAN OTC DRUG	Cold-EEZE Cold Remedy		Zinc Gluconate, Sambucus Nigra, Avena Sativa L., Rosa Canina, Echinacea Purpurea	LOZENGE	ORAL	20220509		UNAPPROVED HOMEOPATHIC		Vespyr Brands Inc	AVENA SATIVA FLOWERING TOP; ECHINACEA PURPUREA; ROSA CANINA FRUIT; SAMBUCUS NIGRA FLOWER; ZINC GLUCONATE	6.2; 2; 4; 50; 13.3	mg/1; mg/1; mg/1; mg/1; mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71179-324_0326ea5b-3e1b-dee2-e063-6294a90a13b8	71179-324	HUMAN OTC DRUG	Cold-EEZE Cold Remedy		Zinc Gluconate	LOZENGE	ORAL	20220629		UNAPPROVED HOMEOPATHIC		Vespyr Brands Inc	ZINC GLUCONATE	13.3	mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71179-341_05524b80-f6b0-446b-e063-6294a90a7b65	71179-341	HUMAN OTC DRUG	Cold-EEZE Cold Remedy		Zinc Gluconate, Rosa Canina, Echinacea Purpurea	CHEWABLE GEL	ORAL	20230831		UNAPPROVED HOMEOPATHIC		Vespyr Brands Inc	ECHINACEA PURPUREA; ROSA CANINA FRUIT; ZINC GLUCONATE	1; 2; 13.2	mg/1; mg/1; mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71179-342_03e7d098-9c01-2320-e063-6394a90aaa16	71179-342	HUMAN OTC DRUG	Cold-EEZE Cold Remedy		Zinc Gluconate, Sambucus Nigra, Avena Sativa L., Rosa Canina, Echinacea Purpurea	LOZENGE	ORAL	20220629		UNAPPROVED HOMEOPATHIC		Vespyr Brands Inc	AVENA SATIVA FLOWERING TOP; ECHINACEA PURPUREA; ROSA CANINA FRUIT; SAMBUCUS NIGRA FLOWER; ZINC GLUCONATE	6.2; 2; 4; 50; 13.3	mg/1; mg/1; mg/1; mg/1; mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71179-343_fb48a707-44f6-83b3-e053-6394a90a9470	71179-343	HUMAN OTC DRUG	Cold-EEZE Cold Remedy		Zinc Gluconate, Sambucus Nigra, Glycyrrhiza Glabra	LOZENGE	ORAL	20220421		UNAPPROVED HOMEOPATHIC		Vespyr Brands Inc	GLYCYRRHIZA GLABRA; SAMBUCUS NIGRA FLOWER; ZINC GLUCONATE	4.5; 45; 13.3	mg/1; mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71179-350_04b6a230-0817-5388-e063-6394a90ac1cd	71179-350	HUMAN OTC DRUG	Cold-EEZE Cold Remedy	UltraMELT Chews	Zinc Gluconate	TABLET, CHEWABLE	ORAL	20210701		UNAPPROVED HOMEOPATHIC		Vespyr Brands Inc	ZINC GLUCONATE	13.3	mg/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0001_0b58ea7a-0dee-4cd4-e063-6294a90a12fb	71182-0001	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 LIGHT		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0002_0b58f5d5-37bb-da6e-e063-6394a90a804c	71182-0002	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 LIGHT MEDIUM		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0003_0b58faad-cb4c-da64-e063-6394a90a2cab	71182-0003	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 FAIR		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0004_0b58fdc4-200c-6467-e063-6294a90abd33	71182-0004	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 FAIR LIGHT		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0005_0b590070-bf4c-5cc2-e063-6294a90a8e14	71182-0005	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 MEDIUM		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0006_0b58f16f-44ee-d6cf-e063-6394a90a7b56	71182-0006	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 MEDIUM DARK		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0007_0b5902e8-059c-ed12-e063-6394a90a96c6	71182-0007	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 DARK		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0008_0b58f836-25fd-5d03-e063-6294a90a6d8b	71182-0008	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 DARK DEEP		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71182-0009_0b58f538-16b5-6216-e063-6294a90ab387	71182-0009	HUMAN OTC DRUG	Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 DEEP		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Younique, LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71205-001_a287ed41-2a8c-4181-9d55-9994aa9b0769	71205-001	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	19900930		ANDA	ANDA088628	Proficient Rx LP	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71205-002_1bd85e84-ecdb-4e2a-8fcd-cc4c9bca0168	71205-002	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Proficient Rx LP	LEVOFLOXACIN	500	mg/1			N	20241231
71205-003_56227d4b-1b33-412c-9dee-e421fc0d82fc	71205-003	HUMAN PRESCRIPTION DRUG	METOPROLOL TARTRATE		METOPROLOL	TABLET	ORAL	20160731		ANDA	ANDA202871	Proficient Rx LP	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-004_e93bc975-109d-4ac7-9343-5213b15dd160	71205-004	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA091519	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-005_9897ad4f-87a5-40c8-8c79-7638eae42437	71205-005	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-006_781660f1-432b-4f46-9ee3-8c735e5a8bea	71205-006	HUMAN OTC DRUG	TRIPLE ANTIBIOTIC		Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate	OINTMENT	TOPICAL	20110601		OTC MONOGRAPH FINAL	part333B	Proficient Rx LP	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71205-008_d0887230-770f-41c5-8887-83ec83afc378	71205-008	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Proficient Rx LP	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-009_6b7b33dd-b146-4cdf-81c6-3d44668feefd	71205-009	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-012_9c466480-174a-4ddc-a720-76e5d3911f01	71205-012	HUMAN PRESCRIPTION DRUG	TaperDex 6-day		DEXAMETHASONE	TABLET	ORAL	20180119		ANDA	ANDA088237	Proficient Rx LP	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-013_6ef09b56-447c-44c6-a714-298ee1f2c039	71205-013	HUMAN PRESCRIPTION DRUG	TaperDex 12-day		DEXAMETHASONE	TABLET	ORAL	20180119		ANDA	ANDA088237	Proficient Rx LP	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-014_0ac7c0f7-8f34-45f5-9979-2b1c95b3d63f	71205-014	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA205707	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-015_fb1db133-2efe-4418-841b-f86104c50170	71205-015	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-016_0fe3e15b-f736-4d67-abc3-4a0ee506a794	71205-016	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170831		ANDA	ANDA207466	Proficient Rx LP	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
71205-017_a56062ad-d6ec-4335-b902-7ac80cecf3d4	71205-017	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090917		ANDA	ANDA078906	Proficient Rx LP	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71205-018_310c89de-8ded-4c06-8d56-2992165ffa21	71205-018	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20020301		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-019_0c92dc46-6ade-4693-86da-7fa3411efff2	71205-019	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20150713		ANDA	ANDA200958	Proficient Rx LP	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-020_3923b0b2-c0f4-422a-b174-fa0bd0648a59	71205-020	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	Proficient Rx LP	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-021_8b59abf1-d133-4655-b9ba-6b63f102b674	71205-021	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20170302		ANDA	ANDA065211	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-022_c4893485-e865-4537-8bd8-77de435525f8	71205-022	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20060410		ANDA	ANDA077912	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-023_0193ca88-0938-a229-e063-6294a90a4b38	71205-023	HUMAN PRESCRIPTION DRUG	Nitrofurantion Macrocrystals		Nitrofurantion Macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Proficient Rx LP	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71205-024_5914f311-a4d5-4388-8939-d53eb183e612	71205-024	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20170221		ANDA	ANDA207783	Proficient Rx LP	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
71205-025_9a099066-50bb-4651-bce7-5e1dc8e2e5b1	71205-025	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20020901		ANDA	ANDA075948	Proficient Rx LP	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71205-026_7a3de2bf-32a1-465e-ae85-bd7e1ad1b205	71205-026	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	Proficient Rx LP	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-027_9e0658ec-8ba6-4b80-b669-a8904b41fdfb	71205-027	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Proficient Rx LP	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-028_cbf2683a-b8ea-49b3-a0a0-63c69d70f2fb	71205-028	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-029_5e9007b1-3052-4e46-b4e3-28174e3efdfd	71205-029	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Proficient Rx LP	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-030_55d8ea63-038a-4294-9243-ca915460c1a6	71205-030	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20110613		ANDA	ANDA091083	Proficient Rx LP	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-031_013ee364-8c04-4e34-9787-834504e94c72	71205-031	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Proficient Rx LP	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-032_66b45e6d-2ec9-43a9-bbaf-46c0a14fe1a6	71205-032	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20170928		ANDA	ANDA206136	Proficient Rx LP	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-033_dc9e8abc-32e2-46a9-8ad0-bf9e4c0e4695	71205-033	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	20170303		ANDA	ANDA208590	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-034_b27ef9e6-7c67-4af6-aeef-427cbbe017e2	71205-034	HUMAN OTC DRUG	Hydrocortisone	Maximum Strength	Hydrocortisone	OINTMENT	TOPICAL	19980721		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-035_23c32fbb-0d4d-4830-883f-0967c8586247	71205-035	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20050713		ANDA	ANDA065228	Proficient Rx LP	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-036_d8353a21-2ed6-4faa-b0a0-f35aae947ac2	71205-036	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-037_a5f84ed8-8eb7-42c6-a536-f19c1184588b	71205-037	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040749	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-038_11938fb1-5790-4449-b885-a3a34b2c2359	71205-038	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	OINTMENT	TOPICAL	20170303		ANDA	ANDA208590	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-039_4ca84780-9497-4cc3-a5bb-01b7b55ee3e8	71205-039	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE	ORAL	20151102		ANDA	ANDA203118	Proficient Rx LP	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71205-040_dd1d8198-23a2-41d0-8462-6eb7c7eb53aa	71205-040	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		betamethasone valerate	CREAM	TOPICAL	19830831		NDA	NDA018861	Proficient Rx LP	BETAMETHASONE VALERATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-041_b46704f4-8e65-4529-a073-e1d4a2600a12	71205-041	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Proficient Rx LP	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71205-042_da30b7b2-5e23-4513-8c76-867abb256dd8	71205-042	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20160520		ANDA	ANDA201662	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-043_1edd7ce3-5349-48f6-9574-0af4b3437f7b	71205-043	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		dicyclomine hydrochloride	CAPSULE	ORAL	19991103		ANDA	ANDA040319	Proficient Rx LP	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71205-044_633b2d70-e0fa-4589-a224-3d8022884bac	71205-044	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161029		ANDA	ANDA207616	Proficient Rx LP	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-045_0733a90a-9dbf-4cf2-a3b7-3b2dcdc5fbc5	71205-045	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride (XL)		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180108		ANDA	ANDA208652	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-046_091f121a-1432-4ccb-b611-dab9a0f785df	71205-046	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20000504		ANDA	ANDA075429	Proficient Rx LP	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
71205-047_cbf2683a-b8ea-49b3-a0a0-63c69d70f2fb	71205-047	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-048_6db7f218-1343-4b68-b72d-6605f1838e97	71205-048	HUMAN PRESCRIPTION DRUG	Alendronate Sodium		Alendronate Sodium	TABLET	ORAL	20080804		ANDA	ANDA090124	Proficient Rx LP	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
71205-049_7f1180b0-ba8e-497c-a63c-cea5ad7b6306	71205-049	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20150429		ANDA	ANDA203154	Proficient Rx LP	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71205-050_3de04d1d-2c3b-4e08-bdca-658737d018cc	71205-050	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20140813		ANDA	ANDA090715	Proficient Rx LP	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71205-051_eba3cb7b-c393-4fc7-84ae-ee1b0d1ef90d	71205-051	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20071231		ANDA	ANDA076749	Proficient Rx LP	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	3; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20251231
71205-052_5121b2d8-6afb-4875-9922-1444d6e8a465	71205-052	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Proficient Rx LP	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-053_7fadb9ce-34cc-4b19-9470-15e3a64d9c4f	71205-053	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Proficient Rx LP	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-054_466725dd-44bf-4405-9ec6-f7a05a0b63f9	71205-054	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040194	Proficient Rx LP	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-055_4d79a70c-65fe-42e1-b57b-26c9c433e501	71205-055	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151201		ANDA	ANDA204519	Proficient Rx LP	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-056_7fadb9ce-34cc-4b19-9470-15e3a64d9c4f	71205-056	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Proficient Rx LP	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-057_6df0a5e7-318f-4554-895c-0a452db9bc79	71205-057	HUMAN OTC DRUG	Bacitracin		Bacitracin	OINTMENT	TOPICAL	19950110		OTC MONOGRAPH DRUG	M004	Proficient Rx LP	BACITRACIN	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
71205-058_7dd77e34-db22-4496-9150-19d9c37b45b4	71205-058	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	Proficient Rx LP	LEVOFLOXACIN	250	mg/1			N	20241231
71205-059_f716527d-6aaf-458a-9d2a-db3294b3c700	71205-059	HUMAN PRESCRIPTION DRUG	Fexmid		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20180430		ANDA	ANDA071611	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-060_6b4c9ec2-308f-4b60-941c-34a2c7a7882c	71205-060	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	20160705		ANDA	ANDA091432	Proficient Rx LP	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-061_70009d8f-84ce-4f10-a6c5-720b7939efa7	71205-061	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	Proficient Rx LP	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71205-062_d8f31daf-5694-4d1a-babd-bb02b951173a	71205-062	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	SOLUTION	TOPICAL	20141126		ANDA	ANDA203818	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-063_a75326c2-8fa6-4db3-834f-759ea5d81771	71205-063	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20140301		ANDA	ANDA203072	Proficient Rx LP	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-064_20a670b9-5238-4bbc-b23f-b3e56d5b34ab	71205-064	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-065_7cb81f85-9453-48a6-a1dd-ac81e2de0dba	71205-065	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-066_4c4908f6-e4bc-4d1d-90b9-bdabe4512268	71205-066	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20110131		ANDA	ANDA090404	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-067_1d853cad-1e12-4851-83a6-5e346a8285e1	71205-067	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-068_0073dfe4-2772-4fc6-a391-504cd2c4a8fb	71205-068	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	Proficient Rx LP	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-069_353b6b51-4149-4a3a-b0af-a312bdf3be26	71205-069	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA090467	Proficient Rx LP	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-070_1bfa53ed-bcef-4864-81b9-e36a2016a7d4	71205-070	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20060627		ANDA	ANDA076052	Proficient Rx LP	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-071_aeb4debb-b3fc-4b8b-a78d-fbd754ecec58	71205-071	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Proficient Rx LP	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-072_5696b87a-c388-4cd2-b22b-b2861c28d800	71205-072	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20130630		ANDA	ANDA200770	Proficient Rx LP	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71205-073_3d0c235a-ed00-4295-91a1-c0af34ff07a5	71205-073	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	Proficient Rx LP	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
71205-074_12772669-8d4e-4aa0-a911-131638db74fe	71205-074	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20091211		ANDA	ANDA075483	Proficient Rx LP	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71205-075_bdfcb7c8-7269-46a6-aff8-d73b093ee88a	71205-075	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	19851224		NDA AUTHORIZED GENERIC	NDA018998	Proficient Rx LP	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71205-076_fd14cf66-00da-42bc-b08a-29df21a293e7	71205-076	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170322		ANDA	ANDA206556	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-077_646857c5-dccd-4437-93f0-6b3c7529718f	71205-077	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079171	Proficient Rx LP	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-078_300f3b11-59d4-4065-8bfb-e48494bbc407	71205-078	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Proficient Rx LP	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-079_a4f86bef-7df5-4209-bfc3-065a1c5bb297	71205-079	HUMAN OTC DRUG	Good Sense anti diarrheal		Loperamide Hydrochloride	TABLET, FILM COATED	ORAL	20030225		ANDA	ANDA075232	Proficient Rx LP	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
71205-080_f3c3812f-dd34-4869-96c7-91cb4e35bbf7	71205-080	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Proficient Rx LP	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-081_40f55b8c-8674-413a-b58d-f1c8b767d680	71205-081	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Proficient Rx LP	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-082_b40bb16b-4019-4002-8d5e-64c5f887f10b	71205-082	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20160613		ANDA	ANDA203071	Proficient Rx LP	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-083_6eebea17-bc98-49a2-854c-35267194f4c4	71205-083	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121022		ANDA	ANDA088619	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-084_c4f9017b-be83-4e8f-8826-cccd25c33f30	71205-084	HUMAN OTC DRUG	GNP Lubricating Relief		Carboxymethylcellulose Sodium	SOLUTION/ DROPS	OPHTHALMIC	20160930		OTC MONOGRAPH FINAL	part349	Proficient Rx LP	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	5	mg/mL			N	20241231
71205-085_0b4a28ff-6e7e-45ee-a11c-98dd4127b2fb	71205-085	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION/ DROPS	OPHTHALMIC	19980429		ANDA	ANDA074706	Proficient Rx LP	CROMOLYN SODIUM	40	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
71205-086_a2baa928-f954-40a1-a0e7-f7e373f5d3eb	71205-086	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19920201		ANDA	ANDA063181	Proficient Rx LP	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-087_a4ff5eef-8452-42aa-8127-32e3c56c2b2b	71205-087	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	Proficient Rx LP	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-088_ebc2e212-b59d-464c-a0cd-ede59263c5da	71205-088	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA077342	Proficient Rx LP	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-089_f37da7b3-fa10-473c-acab-371529fee8c9	71205-089	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20050606		ANDA	ANDA040611	Proficient Rx LP	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-090_0965a94d-06e5-460f-8edc-d402412da5ee	71205-090	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	Proficient Rx LP	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-091_a6c65fd3-3249-48fc-9196-a756d3d06444	71205-091	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Proficient Rx LP	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71205-092_467be128-2334-4a7b-b7eb-6857ceecd285	71205-092	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20161001		ANDA	ANDA073085	Proficient Rx LP	FLUOCINONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-093_26beeb96-f0b4-4e99-ba9d-3b27c67659dc	71205-093	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20091001		ANDA	ANDA077829	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-094_c38905b1-bc36-4ea2-b272-366c1daf8368	71205-094	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Proficient Rx LP	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-095_5179866d-f336-4e03-85b0-972fbedb6b9e	71205-095	HUMAN PRESCRIPTION DRUG	Labetalol hydrochloride		Labetalol hydrochloride	TABLET, FILM COATED	ORAL	19980803		ANDA	ANDA075133	Proficient Rx LP	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-096_61e32fbc-284e-454d-a0e4-456ec56326ed	71205-096	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Proficient Rx LP	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-097_b112a584-199f-42dd-b6e6-b8fccc63dc85	71205-097	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20000101		ANDA	ANDA085159	Proficient Rx LP	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-098_79466114-113a-472d-bfee-271cf74258ab	71205-098	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20170504		ANDA	ANDA205300	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-099_b3e5541d-43f5-46f5-bd98-09f5afbc1499	71205-099	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Proficient Rx LP	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-100_fd421f26-c475-4559-af71-62c1d91f5927	71205-100	HUMAN OTC DRUG	Aprodine		Pseudoephedrine HCl and Tripolidine	TABLET, FILM COATED	ORAL	19930109		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	60; 2.5	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71205-101_d8d5861a-e24a-4b45-8c72-196492c27271	71205-101	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20170705		ANDA	ANDA207444	Proficient Rx LP	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
71205-102_d81cd77a-fc4d-4fc4-b45d-1d71062a03c6	71205-102	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA090467	Proficient Rx LP	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-103_185894ce-3da6-4a5b-83e6-daeba7b3c362	71205-103	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Proficient Rx LP	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-104_2273afc2-992a-4310-9639-e2bccff1d56a	71205-104	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20110307		ANDA	ANDA078423	Proficient Rx LP	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-105_c7f1508c-9478-4379-9c50-4d5a6b8cdcef	71205-105	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	SHAMPOO, SUSPENSION	TOPICAL	20161001		ANDA	ANDA076942	Proficient Rx LP	KETOCONAZOLE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71205-106_8924a6e9-0d20-4f52-b6e7-b6683ee9eb92	71205-106	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	POWDER	TOPICAL	20140901		ANDA	ANDA065175	Proficient Rx LP	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
71205-107_53f50747-996a-4fc1-aad4-4353834514af	71205-107	HUMAN PRESCRIPTION DRUG	oseltamavir phosphate		oseltamavir phosphate	CAPSULE	ORAL	20170921		ANDA	ANDA207211	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-108_4dcf8fa3-4a4f-49b1-b074-d67b1a82346f	71205-108	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	OINTMENT	TOPICAL	20060804		ANDA	ANDA087385	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-109_77fb2d29-c2fc-4e01-b124-7fb7ddbd533b	71205-109	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron Hydrochloride	SOLUTION	ORAL	20110127		ANDA	ANDA091342	Proficient Rx LP	ONDANSETRON HYDROCHLORIDE	4	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71205-110_4f8063ab-d750-45b5-ae64-410900281562	71205-110	HUMAN OTC DRUG	Infants Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20100511		ANDA	ANDA079058	Proficient Rx LP	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-111_7fef2881-dce5-4746-85bc-edb02e8ea0c5	71205-111	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20090206		ANDA	ANDA078593	Proficient Rx LP	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71205-112_b5be56e1-4e72-405e-aef7-0cd09d5bf0de	71205-112	HUMAN OTC DRUG	LOW DOSE ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20150619		OTC MONOGRAPH DRUG	M013	Proficient Rx LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-115_78139082-90f2-4200-bf95-8a46315597ed	71205-115	HUMAN OTC DRUG	Ketotifen Fumarate		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20071001		ANDA	ANDA077958	Proficient Rx LP	KETOTIFEN FUMARATE	.35	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
71205-116_21d93729-7b00-40f5-8b6d-f23d26b4766b	71205-116	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170115		ANDA	ANDA204216	Proficient Rx LP	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-118_5655db41-00a4-41ec-a253-b6d0d3a22e94	71205-118	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	INJECTION, SUSPENSION	INTRAMUSCULAR	20040914		ANDA	ANDA076553	Proficient Rx LP	MEDROXYPROGESTERONE ACETATE	150	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
71205-119_7f9fddc6-bdba-40a3-8eb0-7d1cd7d9a50f	71205-119	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818		ANDA	ANDA065398	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-120_e9f15be1-e04a-4aaa-b03f-2f9ff0975422	71205-120	HUMAN OTC DRUG	My Choice TM		levonorgestrel	TABLET	ORAL	20180401		ANDA	ANDA202635	Proficient Rx LP	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
71205-121_29b596a0-aa61-4ced-84e8-53011390a19f	71205-121	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	Proficient Rx LP	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-122_5a8c9c91-d6eb-4f0d-bbc7-3ccab08accff	71205-122	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Proficient Rx LP	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-123_a5d8d147-9386-4334-ba38-4052da09ca99	71205-123	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	Proficient Rx LP	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-124_13975027-13af-4ff6-96fe-2c73d24b50a9	71205-124	HUMAN PRESCRIPTION DRUG	triamcinolone acetonide		triamcinolone acetonide	CREAM	TOPICAL	20170417		ANDA	ANDA208848	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-125_68fe7bbf-2dfb-4b9e-86f2-f1eb8e3937a5	71205-125	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-126_fe741fc7-f692-49a0-bf51-04c6a3b2e1bc	71205-126	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	Proficient Rx LP	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-127_ebcef20e-0991-4cd7-b79c-0d1a29b90fed	71205-127	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20101227		ANDA	ANDA077714	Proficient Rx LP	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71205-128_03b5d63d-1c2c-41db-8111-2dcf7e66f010	71205-128	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST	TABLET, CHEWABLE	ORAL	20150813		ANDA	ANDA203328	Proficient Rx LP	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71205-129_3bdf016f-4176-4fd8-aae5-c0806d80daee	71205-129	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	TABLET, FILM COATED	ORAL	19861001		ANDA	ANDA070994	Proficient Rx LP	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71205-132_5650efcf-e609-43b2-868f-03d375fcd7b2	71205-132	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20180116		ANDA	ANDA078722	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-133_ff141990-c712-47cd-ad30-ff1cf4701120	71205-133	HUMAN OTC DRUG	SudoGest		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	19810825		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71205-134_0d25e4f7-07b8-4549-8e21-2a993bbc8f6b	71205-134	HUMAN OTC DRUG	Good Neighbor Pharmacy Artifical Tears Lubricant Eye Drops		Polyvinyl alcohol, Povidone	SOLUTION/ DROPS	INTRAOCULAR	20010129		OTC MONOGRAPH DRUG	M018	Proficient Rx LP	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE, UNSPECIFIED	.5; .6	g/100mL; g/100mL			N	20241231
71205-135_8f7f240b-ae44-495f-81f6-e2f979a1db66	71205-135	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Proficient Rx LP	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-136_61b565d3-ad7d-4ab6-931a-099f2392c9ab	71205-136	HUMAN OTC DRUG	DEBROX		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20120601		OTC MONOGRAPH FINAL	part344	Proficient Rx LP	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
71205-137_d8a112aa-934b-45b2-a18c-6cbb5ffb162c	71205-137	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20160815		ANDA	ANDA206297	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-138_ba14e672-9223-4dfc-87dd-176e4988a9af	71205-138	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium 1.5%		Diclofenac Sodium Topical Solution	SOLUTION	TOPICAL	20171120		ANDA	ANDA202769	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-139_46485412-1ea3-439b-b558-4bfc514ad1b4	71205-139	HUMAN OTC DRUG	Major LiquiTears		Polyvinyl Alcohol	SOLUTION/ DROPS	OPHTHALMIC	20150917		OTC MONOGRAPH FINAL	part349	Proficient Rx LP	POLYVINYL ALCOHOL, UNSPECIFIED	14	mg/mL			N	20241231
71205-140_993feac2-e495-4a5a-838b-721d42dc9b4a	71205-140	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20010209		ANDA	ANDA075665	Proficient Rx LP	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-141_35558fc3-36ae-4d1a-9bd0-404283383955	71205-141	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	Proficient Rx LP	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-142_8d661173-328a-4688-a2ce-65ec211fc928	71205-142	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET	ORAL	20100422		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-143_a1a1941e-0c5f-486e-84d0-321d53061b34	71205-143	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20151210		ANDA	ANDA078279	Proficient Rx LP	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-144_283475ff-3b56-482c-b11b-a20f8a4661d3	71205-144	HUMAN PRESCRIPTION DRUG	drospirenone and ethinyl estradiol		drospirenone and ethinyl estradiol	KIT		20150817		ANDA	ANDA204296	Proficient Rx LP						N	20241231
71205-145_4d2909bd-31fd-4ddc-99b5-2fc99b35f5d4	71205-145	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA203931	Proficient Rx LP	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
71205-146_5857334b-cd0a-47c8-ba29-b8ba367162fa	71205-146	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Proficient Rx LP	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71205-147_5857334b-cd0a-47c8-ba29-b8ba367162fa	71205-147	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Proficient Rx LP	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71205-148_5857334b-cd0a-47c8-ba29-b8ba367162fa	71205-148	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Proficient Rx LP	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71205-149_5b6275ce-603e-4ccf-83dd-1104dbf5c83f	71205-149	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Proficient Rx LP	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-150_7c4088ea-921d-440c-ae1c-c473fc381e50	71205-150	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	Proficient Rx LP	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
71205-151_4d97dda6-6c71-4595-9871-fc85c8e4f73b	71205-151	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	CREAM	TOPICAL	20140203		ANDA	ANDA074139	Proficient Rx LP	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-152_86d7ee5e-ebfd-45ea-a520-b6f65814c3e2	71205-152	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine	TABLET	ORAL	20160627		ANDA	ANDA077533	Proficient Rx LP	TERBINAFINE HYDROCHLORIDE	250	1/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71205-153_f17baf72-5a83-4b63-9ec3-2a3fb64bdd0e	71205-153	HUMAN OTC DRUG	Menthozen		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20181001		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	CAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.375; 50; 200	mg/mL; mg/mL; mg/mL			N	20241231
71205-154_9b2a45c9-c4cc-4fe3-b8a9-1c5891ca953d	71205-154	HUMAN PRESCRIPTION DRUG	Latanoprost		latanoprost	SOLUTION/ DROPS	OPHTHALMIC	20110322		ANDA	ANDA201006	Proficient Rx LP	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
71205-155_877ccf87-4ff7-4fda-961c-edf2e78639bc	71205-155	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121009		ANDA	ANDA088618	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-156_5b923550-fbfa-47d2-8886-dac4bb4a70be	71205-156	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		DOXYCYCLINE HYCLATE	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Proficient Rx LP	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-157_9ee846e2-6191-4e7c-bdbe-86f868eecad6	71205-157	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090123		ANDA	ANDA075410	Proficient Rx LP	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-158_d47fa421-e017-48f1-95a9-c0922cca63d6	71205-158	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207370	Proficient Rx LP	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-159_7cf20748-c6be-4b66-9f17-9455d88c997d	71205-159	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	Proficient Rx LP	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-160_982c815d-046b-47a5-abf7-f8a0c836543e	71205-160	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Proficient Rx LP	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-161_a58f29eb-fe30-469d-89db-eefea2703224	71205-161	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20100315		ANDA	ANDA090510	Proficient Rx LP	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-162_cc58a663-d683-41fb-bf47-1e07ffaa0fe0	71205-162	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	Proficient Rx LP	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-163_d6c5ad7c-b0ec-4db3-aeb7-4ed6e2626557	71205-163	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
71205-164_0df97f57-2593-49af-83ca-138de55289c8	71205-164	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20091001		ANDA	ANDA077829	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-165_dcad7ab6-9cc4-433a-b012-b7300c2dd672	71205-165	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180912		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	500	mg/1			N	20241231
71205-166_2074b620-49aa-4546-8ff0-6018eb961638	71205-166	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	Proficient Rx LP	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-167_5698dd8d-a6fc-4cfd-91a4-c33eee2fa679	71205-167	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	Proficient Rx LP	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-168_bfd7c6f5-24c7-4491-b4f8-d501a2393fec	71205-168	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	Proficient Rx LP	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-169_73ae4ea5-2353-487f-a6f1-04d0077fc551	71205-169	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	Proficient Rx LP	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71205-170_fc4f50b4-4325-477f-93b6-41c76cb1d67f	71205-170	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20161115		ANDA	ANDA200383	Proficient Rx LP						N	20241231
71205-171_a1447d12-32dc-4e06-960e-d4c2f2880fae	71205-171	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20160415		ANDA	ANDA201722	Proficient Rx LP	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71205-172_bfc9129b-05ad-4ae3-b701-73f9cc0ae9e1	71205-172	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA204798	Proficient Rx LP	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-174_bfc9129b-05ad-4ae3-b701-73f9cc0ae9e1	71205-174	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA204798	Proficient Rx LP	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-176_cb9c34dd-eb2e-48da-952b-b28b5683d080	71205-176	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Proficient Rx LP	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-177_aefe01bd-575f-4718-872e-b5d89f4916b5	71205-177	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20030226		ANDA	ANDA065119	Proficient Rx LP	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-178_0fbf8a05-b7b9-47d9-a55c-c2f9bbe50ad4	71205-178	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020129		ANDA	ANDA076001	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-179_9b091850-f016-4642-8926-839511ba4087	71205-179	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Proficient Rx LP	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-180_08f51d35-49e2-4f93-8298-c54065cf021c	71205-180	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170307		ANDA	ANDA077321	Proficient Rx LP	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-181_226845ec-8ddf-4af4-912e-d71d79818165	71205-181	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, FILM COATED	ORAL	20160101		ANDA	ANDA204290	Proficient Rx LP	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71205-183_3139eb2a-bd08-4fc6-bcf0-28e99f234c43	71205-183	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070406		ANDA	ANDA065337	Proficient Rx LP	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-185_0b3b163b-1991-4948-bd2c-727f778b442c	71205-185	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20160919		ANDA	ANDA070175	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-186_17f22c3f-736e-453c-b243-c83e11ea247c	71205-186	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-187_af7f2742-f019-4a23-8f5e-37713e082dba	71205-187	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Proficient Rx LP	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-188_f539a1cd-055f-42ef-92e6-0e222943fcc0	71205-188	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20020130		ANDA	ANDA075452	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-189_d746c647-bf7f-4443-bce5-465209a84d94	71205-189	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, CHEWABLE	ORAL	20120803		ANDA	ANDA200405	Proficient Rx LP	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71205-190_27025f51-5dff-4994-aab0-310895239337	71205-190	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20180720		ANDA	ANDA210138	Proficient Rx LP	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71205-191_0d22421a-357a-4ed4-9be9-53c969ff7846	71205-191	HUMAN PRESCRIPTION DRUG	Norgestimate and Ethinyl Estradiol		Norgestimate and Ethinyl Estradiol	KIT		20110617		ANDA	ANDA200494	Proficient Rx LP						N	20241231
71205-192_3cd63811-b40d-47c5-9c50-c0a30bc68fcc	71205-192	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20151202		ANDA	ANDA078103	Proficient Rx LP	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-193_e3bdc297-e10a-4632-bf0b-5214ffb84e38	71205-193	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	Proficient Rx LP	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-194_30a9e169-3abe-4020-93f5-04ba93ad080c	71205-194	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Proficient Rx LP	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-195_3741e5f0-0c1b-479f-b3a7-3f240cddb98d	71205-195	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Proficient Rx LP	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-196_266594ab-a60f-4dfa-8880-bdc54cebdc75	71205-196	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20170302		ANDA	ANDA065212	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-197_9accf6b7-78b3-4392-b4cd-e3e03fec039c	71205-197	HUMAN OTC DRUG	pseudoephedrine hydrochloride		Pseudoephedrine HCl	TABLET, FILM COATED	ORAL	20081017		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	PSEUDOEPHEDRINE HYDROCHLORIDE	30	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71205-198_7d8ed4bf-6fc8-4021-96d7-bb56f2289124	71205-198	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Proficient Rx LP	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-199_7e11954b-93e7-4984-9560-c52eafc2e2e0	71205-199	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Proficient Rx LP	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-201_9143ab9f-5bc2-4ea6-a33b-01bbc1e880f0	71205-201	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-202_ebe4977e-5a33-4587-8a06-f46c4d5b92bc	71205-202	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Proficient Rx LP	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-203_4d359228-d271-4e40-81ad-e8acf35b224a	71205-203	HUMAN PRESCRIPTION DRUG	PIROXICAM		Piroxicam	CAPSULE	ORAL	20180301		ANDA	ANDA206152	Proficient Rx LP	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-204_e2a1545c-cbc6-4ea0-a462-17ad0f9a59f0	71205-204	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20101126		ANDA	ANDA090229	Proficient Rx LP	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-205_989d7e7a-1918-40f2-a3b1-c637f4a8fad2	71205-205	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-206_2f82dc3e-ad9b-403d-b967-f943819f8476	71205-206	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20180209		ANDA	ANDA208348	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-207_517ed467-a0d0-43ab-99ce-e6a4808800c4	71205-207	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA078336	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-208_5fb68d12-481a-45d4-8fed-1a1acb88f665	71205-208	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	Proficient Rx LP	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71205-209_bc31d44b-7056-43ba-931c-42c3775a5085	71205-209	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20150201		ANDA	ANDA075090	Proficient Rx LP	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-210_1913d2a6-6558-4d2b-bc1e-54cdef6623eb	71205-210	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20130930		ANDA	ANDA202046	Proficient Rx LP	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-211_3a369306-f46b-4a2c-bb6d-484f34bb0c43	71205-211	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate	HFA	Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20190116		NDA	NDA021457	Proficient Rx LP	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-212_8bc42c18-c2ae-4ae7-8102-5a26dbccb39f	71205-212	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Proficient Rx LP	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-213_caf36ae7-7d2e-4058-aa5b-35122c1187ab	71205-213	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20170627		ANDA	ANDA209207	Proficient Rx LP	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-214_79e1cc8f-0005-4913-8ac2-8a9b1d73e171	71205-214	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Proficient Rx LP	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-215_057302f7-9a50-42f4-8f96-ce23f409bc4c	71205-215	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20111101		ANDA	ANDA091240	Proficient Rx LP	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-216_476af655-9fb8-4253-a569-fb3295680838	71205-216	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	POWDER, FOR SUSPENSION	ORAL	20180806		ANDA	ANDA211147	Proficient Rx LP	AZITHROMYCIN DIHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-217_668d5539-1561-457c-9a7c-38784a9b5c66	71205-217	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170811		ANDA	ANDA207405	Proficient Rx LP	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71205-218_562b6948-1bb6-4129-adb1-3b33c4b14d3e	71205-218	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20090921		ANDA	ANDA078895	Proficient Rx LP	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-219_fbf9a8a6-91f7-45c2-8f09-017bf37bb4b4	71205-219	HUMAN OTC DRUG	nasal decongestant		Oxymetazoline HCl	SPRAY	NASAL	20181012		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
71205-220_5d593e03-b6f0-41d0-b7b2-e53d2421a903	71205-220	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA203962	Proficient Rx LP	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-221_aca8c79e-06fa-4919-bc65-a2aff5429fde	71205-221	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-222_aca8c79e-06fa-4919-bc65-a2aff5429fde	71205-222	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-223_600e1f99-3fda-4a12-8041-a4fc6dbced4e	71205-223	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20160630		ANDA	ANDA209047	Proficient Rx LP	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
71205-224_cca0fc04-974d-49a1-8fc9-4e07684fed0a	71205-224	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	Proficient Rx LP	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-225_8c1a4a70-9849-4cb2-9425-5cf5747d4fbc	71205-225	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160829		ANDA	ANDA208191	Proficient Rx LP	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71205-226_61dad858-613a-4add-a885-b63adc2048ba	71205-226	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20110601		ANDA	ANDA091497	Proficient Rx LP	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-227_c256eb0e-ff92-498d-9a9d-820b63126233	71205-227	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	Proficient Rx LP	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-228_08a911c9-3b1b-4404-a770-5bf4d27c7e96	71205-228	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Proficient Rx LP	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-229_b4104f4d-5d3f-4a1e-bc62-208a3c7a688e	71205-229	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Proficient Rx LP	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-230_1c80e622-005d-44f1-a5a9-2e0acd59e485	71205-230	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium		Cromolyn Sodium	SOLUTION/ DROPS	OPHTHALMIC	19990629		ANDA	ANDA075282	Proficient Rx LP	CROMOLYN SODIUM	40	mg/mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
71205-231_bd0158fe-7fca-44c0-9a6c-36fb5c489114	71205-231	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA091448	Proficient Rx LP	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-232_9d727d5c-ed7c-4891-9f0f-8bf86764d40a	71205-232	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine sodium	TABLET	ORAL	20020301		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-233_e394ff4b-4fb0-418c-866f-3e5d95461bfa	71205-233	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Proficient Rx LP	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-234_1d9c3263-38b0-47a4-ba6f-f553254fc442	71205-234	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Proficient Rx LP	LEVOFLOXACIN	750	mg/1			N	20241231
71205-235_5ed33c15-9a4a-4f8b-9d9c-fba2e26e630d	71205-235	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	Proficient Rx LP	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-236_257152f7-f81c-4be1-89ab-6ec7044555ff	71205-236	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Proficient Rx LP	ESZOPICLONE	3	mg/1		CIV	N	20241231
71205-237_98d19b29-166e-42ae-ae3b-1ad981327766	71205-237	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20071001		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-238_0745a72f-4b61-4664-a3ef-30b7e51d4b7b	71205-238	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate Extended-Release Tablet	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20161221		NDA AUTHORIZED GENERIC	NDA018027	Proficient Rx LP	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
71205-239_0ca67162-b529-4986-bf16-a57ca3af0103	71205-239	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085161	Proficient Rx LP	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-240_71aa09de-da41-40e4-8d5c-28cf1da86064	71205-240	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-241_5e27731c-dd23-4d40-9626-d40d8998d38d	71205-241	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140731		ANDA	ANDA203374	Proficient Rx LP	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71205-242_3ac57edc-4bbc-4de2-b070-06df956f947b	71205-242	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-243_c225060d-b6e8-4343-8e4d-b52067f05792	71205-243	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20060320		ANDA	ANDA075677	Proficient Rx LP	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-244_0a3833b4-573a-486f-84ee-dd1737356353	71205-244	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Proficient Rx LP	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71205-245_df5002ba-15f4-4e47-8d2e-1ce041c26944	71205-245	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Proficient Rx LP	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
71205-246_8515db73-8e51-4ff6-b0ae-925490fb815d	71205-246	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180802		ANDA	ANDA207687	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-247_f4ee26ae-8587-4eea-84bb-8e3751a4c21d	71205-247	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-248_a92e4484-0bf2-4390-8cb6-f7f2412206e3	71205-248	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride (XL)		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180108		ANDA	ANDA208652	Proficient Rx LP	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-249_3129e59a-5814-4050-bd80-29f469ca66a2	71205-249	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA078946	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-250_7bc17b89-8e98-45d8-b4d6-50eb822bd5f4	71205-250	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20100719		ANDA	ANDA091359	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71205-251_c4a4ac8c-98fc-420f-b730-ffcc67ebdaa0	71205-251	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA078295	Proficient Rx LP	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71205-252_a0bca6db-e332-4b67-b763-82ba14855bc0	71205-252	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19970212		ANDA	ANDA074869	Proficient Rx LP	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-253_55f728b3-b5c9-427f-a09a-2764663d4175	71205-253	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	PARENTERAL	20180410		ANDA	ANDA207531	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-254_cb494ccb-c59d-4bbb-aab4-6ad8cd020af4	71205-254	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950406		ANDA	ANDA074132	Proficient Rx LP	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-255_1e3a3004-3341-47e3-9961-0f8b966c3d1c	71205-255	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-256_dae145d8-8ae7-4f48-9c1b-191bdebb0d20	71205-256	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		Losartan Potassium and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA091629	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-257_1e2003d4-09a3-4cc8-af3d-93d29b9123c0	71205-257	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Proficient Rx LP	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71205-258_09764c50-8d91-4c74-8d5f-d48f79ecb01c	71205-258	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 160	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-259_545f18f8-d14f-498a-ad60-a08059ca7b4f	71205-259	HUMAN OTC DRUG	Good Neighbor Pharmacy Childrens Allergy		Diphenhydramine Hydrochloride	SOLUTION	ORAL	19890815		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-260_a1e93507-1070-4105-9479-93c14c1f938f	71205-260	HUMAN OTC DRUG	Good Neighbor Pharmacy Earwax Removal Drops		CARBAMIDE PEROXIDE	LIQUID	TOPICAL	20190101		OTC MONOGRAPH DRUG	M014	Proficient Rx LP	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
71205-261_e51f5772-f7d2-448f-83ac-c912fa794ec4	71205-261	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20031201		NDA	NDA021210	Proficient Rx LP	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-262_632fef94-b34c-4c82-8b8a-8e573bad4dd5	71205-262	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate and Salmeterol	DISKUS	fluticasone propionate and salmeterol	POWDER	RESPIRATORY (INHALATION)	20190208		NDA AUTHORIZED GENERIC	NDA021077	Proficient Rx LP	FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE	250; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-263_4119daf0-efea-4ec9-869d-55d9aaf09d0e	71205-263	HUMAN OTC DRUG	Childrens Acetaminophen		Acetaminophen	SUSPENSION	ORAL	20140409		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	160	mg/5mL			N	20241231
71205-264_136dd3de-ea98-49fe-870e-3b06091b521d	71205-264	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-265_e81dd1b8-6a0c-4fc4-afbe-496ed719c048	71205-265	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	OINTMENT	OPHTHALMIC	20140508		ANDA	ANDA062447	Proficient Rx LP	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
71205-266_b7495577-9753-41ff-96cf-8122612928de	71205-266	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065387	Proficient Rx LP	AMOXICILLIN	125	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-267_4224ad27-bb72-4746-86b7-13c648b8223f	71205-267	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA077342	Proficient Rx LP	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-268_cfe4f78a-2bff-4f77-a582-f9027a8eb62e	71205-268	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	Proficient Rx LP	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-269_40f1c753-2918-498e-a8db-acc6514cbdc9	71205-269	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	Proficient Rx LP	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-270_ba23a55b-30dd-4d55-a423-3542524a8efe	71205-270	HUMAN PRESCRIPTION DRUG	Glipizide and Metformin HCl		Glipizide and Metformin HCl	TABLET, FILM COATED	ORAL	20100629		ANDA	ANDA078728	Proficient Rx LP	GLIPIZIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71205-271_614ba5f2-9f66-40c7-b22c-1538492a7995	71205-271	HUMAN PRESCRIPTION DRUG	Desoximetasone		Desoximetasone	CREAM	TOPICAL	20160331		ANDA	ANDA205082	Proficient Rx LP	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-272_716c5abe-6d0e-4cfd-9c37-45a967e136ec	71205-272	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20080311		ANDA	ANDA065470	Proficient Rx LP	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-273_7160086d-21ca-4ca0-9aee-1680c2c4d61c	71205-273	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-274_f215f243-2090-4bb5-8499-321d23b96659	71205-274	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA078295	Proficient Rx LP	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71205-275_c1b9e3e4-cd76-4429-94c9-4ea082f0ad8b	71205-275	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate		Betamethasone Dipropionate	CREAM	TOPICAL	20060928		ANDA	ANDA076592	Proficient Rx LP	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-276_c1db99ba-4b86-4cd4-bf65-d87965ff79f5	71205-276	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	Proficient Rx LP	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71205-277_4f9db4e9-1b45-4c0e-ae3c-068627f5a953	71205-277	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20171223		ANDA	ANDA209234	Proficient Rx LP	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
71205-278_3155a698-8038-4035-a5d5-8b646671ef55	71205-278	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161024		ANDA	ANDA206574	Proficient Rx LP	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71205-279_1b45d342-8e4c-4b95-a08f-c910ef65f335	71205-279	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079172	Proficient Rx LP	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-280_b02f563b-a2cb-42f8-932c-8e307467a300	71205-280	HUMAN PRESCRIPTION DRUG	BusPIRone Hydrochloride		BusPIRone Hydrochloride	TABLET	ORAL	20180703		ANDA	ANDA209696	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71205-281_3acdf264-82c4-4635-bd40-e80e6d8fb3f8	71205-281	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Proficient Rx LP	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-282_3e549d03-823e-4fbe-935a-e9f7de196abc	71205-282	HUMAN OTC DRUG	DOCUZEN		Sennosides 8.6mg and Docusate Sodium 50mg	TABLET	ORAL	20181127		OTC MONOGRAPH DRUG	M007	Proficient Rx LP	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
71205-283_1410a251-cc08-49a0-b4aa-dfd217bca85b	71205-283	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Proficient Rx LP	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-284_4b854ef0-70d6-4b58-9e0f-48868976e069	71205-284	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	Proficient Rx LP	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-285_16891834-bb2f-48b9-9dc4-89ab7c34f1f8	71205-285	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Proficient Rx LP	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-286_bde02c60-5382-4505-b806-ddb2f5f9deab	71205-286	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20140411		ANDA	ANDA078970	Proficient Rx LP	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71205-287_6f7284d1-545e-4691-8a2d-b8a387b36f18	71205-287	HUMAN PRESCRIPTION DRUG	Tri-Lo-Sprintec		Norgestimate and Ethinyl Estradiol	KIT		20151230		ANDA	ANDA076784	Proficient Rx LP						N	20241231
71205-288_f63400e6-c8ea-4a0a-b295-eb33611f3ff2	71205-288	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	19810817		ANDA	ANDA086724	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-289_82f02324-b693-4e8a-95b2-284caa68d414	71205-289	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION	INTRAMUSCULAR	20120501		ANDA	ANDA091244	Proficient Rx LP	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
71205-291_ee865180-23ee-4b72-a56e-30db9551dddc	71205-291	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20171001		ANDA	ANDA207224	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-292_7b3d4e8a-7b85-4504-b5b0-09cc5fa4ba4d	71205-292	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	Proficient Rx LP	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-293_4e6c6c6c-0e4e-49a2-a344-cecf0eb86f75	71205-293	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20121004		ANDA	ANDA200456	Proficient Rx LP	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71205-294_e33be6df-cf54-48ba-b407-16b7b311fdb8	71205-294	HUMAN PRESCRIPTION DRUG	Pravastatin Sodium		Pravastatin Sodium	TABLET	ORAL	20060425		ANDA	ANDA076056	Proficient Rx LP	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-295_9e09d2f6-13f0-4e5e-aea2-e212ade2fcfe	71205-295	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-296_5e336e61-8db7-49fa-9893-2ea1cf60597d	71205-296	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	SOLUTION	OPHTHALMIC	20091105		ANDA	ANDA076583	Proficient Rx LP	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-297_63647c09-e111-4a17-85e7-9f5f1853fad7	71205-297	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20070308		ANDA	ANDA073652	Proficient Rx LP	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71205-298_6c2bf577-88ce-4344-b1ba-b28b5a3d2e86	71205-298	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Proficient Rx LP	PREGABALIN	75	mg/1		CV	N	20241231
71205-300_a797de06-c8be-4417-9bac-137dc4931c8b	71205-300	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20181101		ANDA	ANDA077568	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-301_a3825354-7356-4e03-880f-d510a9019748	71205-301	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20160919		ANDA	ANDA202696	Proficient Rx LP	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-303_911707db-ea86-4df8-b79c-a6122d406ab0	71205-303	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-304_4e9f6266-1c8b-4987-b307-e35191e1b896	71205-304	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	75	mg/1		CV	N	20241231
71205-305_4f09b702-450f-4270-8e1a-2402677095cd	71205-305	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20190101		ANDA	ANDA204883	Proficient Rx LP	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-306_970cf1aa-df52-4cb6-b14a-9811111eb6a3	71205-306	HUMAN OTC DRUG	MEDI-FIRST Non-Aspirin		Acetaminophen	TABLET, COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	325	mg/1			N	20241231
71205-308_ad9d406c-3d6e-4576-99b0-402fcefedc81	71205-308	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20171121		ANDA	ANDA209734	Proficient Rx LP	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71205-309_e39626a8-78f1-4c41-9384-df16361ad209	71205-309	HUMAN PRESCRIPTION DRUG	CIPRODEX		ciprofloxacin and dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20030804		NDA	NDA021537	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-310_a1ac35e1-cad9-49bb-aaaf-0b06db8474cb	71205-310	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20180701		NDA AUTHORIZED GENERIC	NDA022352	Proficient Rx LP	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
71205-311_802394f7-e853-49e0-9812-8b375139c087	71205-311	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Proficient Rx LP	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-312_9e1c17bc-acc1-4088-9509-e985ff3a384f	71205-312	HUMAN OTC DRUG	Coricidin HBP	Cold and Flu	Acetaminophen and Chlorpheniramine maleate	TABLET, FILM COATED	ORAL	20131001		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	325; 2	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-313_6542d443-5a49-4e63-9c2a-aaf099daab07	71205-313	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	Proficient Rx LP	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-314_06b51a94-6ec9-4d8a-b9fc-70547c5ffa88	71205-314	HUMAN OTC DRUG	MEDI-FIRST Non-Aspirin Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	500	mg/1			N	20241231
71205-315_22b06394-9c55-4a5b-b70b-e42b1b2ab474	71205-315	HUMAN OTC DRUG	Medique Diphen		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120101		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-316_d327994a-8748-4c6c-b1c9-21401060bbce	71205-316	HUMAN OTC DRUG	MEDIQUE Diamode		Loperamide Hydrochloride	TABLET	ORAL	20081230		ANDA	ANDA074091	Proficient Rx LP	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
71205-317_2b781a00-5b89-4dff-9294-e97854165efb	71205-317	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Proficient Rx LP	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-318_4858a0d6-c208-4f18-85bb-44b80d8f2874	71205-318	HUMAN OTC DRUG	ASPIRIN 325 MG EC		ASPIRIN	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part343	Proficient Rx LP	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-319_df5371c1-a1d3-4e6d-af7a-17cb46d7653d	71205-319	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA077006	Proficient Rx LP	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-320_63cc7078-2579-49df-8a10-8d5b3b8c169b	71205-320	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	Proficient Rx LP	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71205-322_3e6343ff-ffe8-445c-97bc-9312ed21de44	71205-322	HUMAN OTC DRUG	childrens mapap		Acetaminophen	TABLET, CHEWABLE	ORAL	20050225		OTC MONOGRAPH DRUG	M013	Proficient Rx LP	ACETAMINOPHEN	160	mg/1			N	20241231
71205-323_f2254c8e-9903-4b30-b6c8-0a0be4e4041b	71205-323	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	100	mg/1		CV	N	20241231
71205-325_65ffd6fd-533b-4e39-8fbc-5c65cd88d602	71205-325	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	Proficient Rx LP	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-326_571ff0ce-fc14-461e-840a-eec55effe549	71205-326	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170619		ANDA	ANDA203695	Proficient Rx LP	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
71205-327_fa539f15-b708-425a-83b3-e28e7e20306a	71205-327	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Proficient Rx LP	HYDROCHLOROTHIAZIDE; VALSARTAN	12.5; 80	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-328_710460eb-3821-489b-8255-a975d70d8489	71205-328	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20180228		OTC MONOGRAPH FINAL	part343	Proficient Rx LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-329_12b8ef8f-90ab-4366-9a82-e6164926eb84	71205-329	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71205-330_d7249352-be32-4361-801a-98b4886615f6	71205-330	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Dexamethasone		Neomycin and Polymyxin B Sulfates and Dexamethasone	OINTMENT	OPHTHALMIC	19960221		NDA AUTHORIZED GENERIC	NDA050065	Proficient Rx LP	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71205-331_32686b6d-d8ac-4f0a-831e-f1bbbf2cf640	71205-331	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA204755	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-332_543de8c8-ee2a-4cdc-8968-5fba573d7ebe	71205-332	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040604	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-333_783322e6-a209-401f-9cbe-53e2cdfd6a74	71205-333	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION	OPHTHALMIC	19960405		ANDA	ANDA062196	Proficient Rx LP	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
71205-334_1cdc9d1f-d8eb-40e4-99e6-286c7dbfb986	71205-334	HUMAN OTC DRUG	Menthozen Hydrogel		MENTHOL, CAPSAICIN	PATCH	TOPICAL	20190701		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	CAPSAICIN; MENTHOL, UNSPECIFIED FORM	.3; 40	mg/g; mg/g			N	20241231
71205-335_ddf7c2d7-5daa-4b1f-b325-5590846d6894	71205-335	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-336_423bd774-b131-4d13-b7b7-afc98d6ceeb6	71205-336	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Proficient Rx LP	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-338_4624c58f-8f77-48fa-be0f-fca4010cc8ae	71205-338	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Proficient Rx LP	PREGABALIN	100	mg/1		CV	N	20241231
71205-339_9ec1f150-1c22-45d7-b0b0-d56e659fcf04	71205-339	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	Proficient Rx LP	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71205-340_b613c0a5-6be3-492e-9071-b5677cf4df8f	71205-340	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20071201		ANDA	ANDA087022	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71205-342_e7ccd70a-878a-4d51-a8ea-552c000038a6	71205-342	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	OINTMENT	TOPICAL	20170227		ANDA	ANDA205318	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-343_cdd61dcb-feb4-4c2e-ad54-cfea1a0d9545	71205-343	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-344_9980335c-66da-49de-9880-c06f298c6eb1	71205-344	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130319		ANDA	ANDA202389	Proficient Rx LP	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-345_662f725b-28ea-4dc5-9a67-586eb1b323af	71205-345	HUMAN PRESCRIPTION DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20160629		ANDA	ANDA206306	Proficient Rx LP	OLOPATADINE HYDROCHLORIDE	1.11	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
71205-346_2daad986-907a-4b6c-baae-e465c1bb38f7	71205-346	HUMAN PRESCRIPTION DRUG	brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide		brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide	SYRUP	ORAL	20190206		ANDA	ANDA207676	Proficient Rx LP	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71205-347_b53c68fe-b3a3-4a62-b75b-cb831ef1a81f	71205-347	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71205-348_f687fe54-1e59-45c2-859f-cb3279ed259d	71205-348	HUMAN OTC DRUG	Lidozen		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20190916		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-349_c553117e-c5ed-4247-93c7-01841ac5d5ad	71205-349	HUMAN OTC DRUG	Cold-EEZE		Zinc Gluconate	LOZENGE	ORAL	20180507		UNAPPROVED HOMEOPATHIC		Proficient Rx LP	ZINC GLUCONATE	2	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71205-350_8f22476a-dcca-4603-bf5e-5549a7c9fd0a	71205-350	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Proficient Rx LP	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-351_12ccf2fd-ccf0-4bcf-8eee-e2a16c8b44d6	71205-351	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Proficient Rx LP	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-352_3019762c-d480-4530-a3b2-762b523e7961	71205-352	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Proficient Rx LP	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-353_00a4fc0b-7162-455e-8ed3-56efdbbe182e	71205-353	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Proficient Rx LP	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-354_00a4fc0b-7162-455e-8ed3-56efdbbe182e	71205-354	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Proficient Rx LP	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-355_0ddbf155-487b-4b05-b18b-f4d8b40c746e	71205-355	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Proficient Rx LP	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-356_b8f42c39-b984-478f-a2b8-97209a356960	71205-356	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20251231
71205-357_c18cb763-af0c-4cc2-b7df-520835c91884	71205-357	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180920		ANDA	ANDA072096	Proficient Rx LP	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-358_5761ba46-a046-4deb-93b9-87919fbc17d0	71205-358	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-359_87e6f5db-718e-4e7c-bc9c-e8f519ea57d0	71205-359	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20180209		ANDA	ANDA208348	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-360_87e6f5db-718e-4e7c-bc9c-e8f519ea57d0	71205-360	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20180209		ANDA	ANDA208348	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-361_f2354b0c-dda4-4eb4-93f3-b2d57856a948	71205-361	HUMAN OTC DRUG	My Way		levonorgestrel	TABLET	ORAL	20170425		ANDA	ANDA201446	Proficient Rx LP	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
71205-362_769bce75-57b6-439b-bc76-02be850427e9	71205-362	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	19900101		ANDA	ANDA085162	Proficient Rx LP	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-363_d9a7c7eb-22e1-4361-a708-99f4ed5c3a2c	71205-363	HUMAN OTC DRUG	Virtussin A/C		Codeine phosphate and Guaifenesin	LIQUID	ORAL	20150707		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CV	N	20241231
71205-364_e104fc1b-b0dd-4452-84cb-0b90527f25f8	71205-364	HUMAN PRESCRIPTION DRUG	Betamethasone Valerate		Betamethasone Valerate	OINTMENT	TOPICAL	19851219		ANDA	ANDA070069	Proficient Rx LP	BETAMETHASONE VALERATE	1.2	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-365_faf559f7-a748-4501-8cfb-8924122441f3	71205-365	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20151001		ANDA	ANDA091095	Proficient Rx LP	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71205-366_35b7e5e3-2c66-4441-9cda-9370264d3d3b	71205-366	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20151123		ANDA	ANDA204019	Proficient Rx LP	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71205-367_72b32512-05c7-4113-b0cc-de9c97de2abb	71205-367	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20180716		ANDA	ANDA074978	Proficient Rx LP	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-368_d55d5cbf-532d-4387-a5a8-eb0b3d43e24e	71205-368	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191023		ANDA	ANDA204161	Proficient Rx LP	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-369_61d97d27-06ed-49a4-9514-f02684521d4b	71205-369	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-370_418a1990-bb09-42f7-bc79-7904f724d091	71205-370	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20151001		ANDA	ANDA091095	Proficient Rx LP	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71205-371_32aa3f42-23a1-4867-8228-e6e76cf9f135	71205-371	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20130808		ANDA	ANDA074891	Proficient Rx LP	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-373_7d77dae0-df76-4b7b-9690-713e9a60e3cd	71205-373	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Proficient Rx LP	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-374_172c7feb-7576-4840-b2d4-98628075715f	71205-374	HUMAN PRESCRIPTION DRUG	Meclizine hydrochloride		Meclizine hydrochloride	TABLET	ORAL	20190415		ANDA	ANDA205136	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71205-375_0d89910b-e14d-43cb-b669-8f6789efc781	71205-375	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20171215		ANDA	ANDA086989	Proficient Rx LP	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-377_220da8f7-55dd-4b01-8dad-bb756856202a	71205-377	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	Proficient Rx LP	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71205-379_003c2047-0d19-4a1c-b162-31ef2c319faf	71205-379	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202254	Proficient Rx LP	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-380_eb67d441-028c-49e6-93b4-2be3b6bc9acf	71205-380	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20070507		ANDA	ANDA065259	Proficient Rx LP	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-381_f22e3aef-714b-4014-8d77-83ee03fd1f57	71205-381	HUMAN PRESCRIPTION DRUG	CHANTIX		varenicline tartrate	TABLET, FILM COATED	ORAL	20060510		NDA	NDA021928	Proficient Rx LP	VARENICLINE TARTRATE	1	mg/1	Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
71205-382_ff306327-9953-447b-a338-17fb1143048c	71205-382	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20020301		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-383_66280863-f50b-40f0-b259-df947ebc7b8b	71205-383	HUMAN OTC DRUG	Oxymethazoline HCL		Oxymethazoline HCL	SPRAY	NASAL	20190101		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	OXYMETAZOLINE HYDROCHLORIDE	.05	mg/1	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
71205-384_7fe5e114-9285-4448-a98e-24820b998749	71205-384	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Proficient Rx LP	ESZOPICLONE	1	mg/1		CIV	N	20241231
71205-385_cb3fa2b9-be07-42c8-b617-d1ada36ca132	71205-385	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline	CAPSULE	ORAL	20160628		ANDA	ANDA207289	Proficient Rx LP	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-387_079d1cc7-db71-4327-b73d-e094b345ae05	71205-387	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20031125		ANDA	ANDA075932	Proficient Rx LP	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-388_32aa3f42-23a1-4867-8228-e6e76cf9f135	71205-388	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20130808		ANDA	ANDA074891	Proficient Rx LP	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-389_2dcb6956-3e29-498b-9a87-ccfe08f2a0fb	71205-389	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20150522		ANDA	ANDA091498	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-390_b2f702dc-1c6e-4217-b88a-1cc8a54fbb1c	71205-390	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Proficient Rx LP	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-391_51052f0e-1a07-405a-a962-981ce9439e02	71205-391	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20070609		ANDA	ANDA077309	Proficient Rx LP	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-392_ced62de0-d150-4ff8-a1ab-38ef67c8f061	71205-392	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Proficient Rx LP	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-393_f796fb87-9ffa-4238-a779-5c2268fa41e3	71205-393	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20080131		ANDA	ANDA078619	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-394_4a2be6af-e256-4fa9-bfa9-5300d52cdaf4	71205-394	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181201		ANDA	ANDA210015	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-395_6d84ed87-b643-46e2-96d4-2052f41bd936	71205-395	HUMAN OTC DRUG	ibuprofen		Ibuprofen	SUSPENSION	ORAL	20111117		ANDA	ANDA074937	Proficient Rx LP	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-396_9619e38d-3a8c-49ce-a54d-a633f571d25c	71205-396	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	150	mg/1		CV	N	20241231
71205-397_fdb323be-008d-40c3-91e1-31285bee6ca8	71205-397	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-398_f5520526-1cc5-489f-b142-92f92fec77d3	71205-398	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20170307		ANDA	ANDA207835	Proficient Rx LP	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71205-400_31aa3327-24b2-47cd-a16e-e0727616bc2f	71205-400	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA210420	Proficient Rx LP	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-401_fbe8f179-fe43-43a4-b592-a31f2ec6aede	71205-401	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	Proficient Rx LP	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-402_6258bbaf-4ac0-4621-b95e-e6b032aa0518	71205-402	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA077745	Proficient Rx LP	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-404_26b07048-78ca-46f4-bc10-b78fe387321a	71205-404	HUMAN PRESCRIPTION DRUG	Irbesartan		irbesartan	TABLET, FILM COATED	ORAL	20190903		NDA AUTHORIZED GENERIC	NDA020757	Proficient Rx LP	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-405_b484ae16-7d8d-4be7-9c9a-2b613592eca3	71205-405	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	POWDER, FOR SUSPENSION	ORAL	20071214		ANDA	ANDA065473	Proficient Rx LP	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-406_6ed1bf37-7a09-4b1e-8190-043bacf12429	71205-406	HUMAN OTC DRUG	childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20140409		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	160	mg/5mL			N	20241231
71205-407_e100760e-78a5-42b1-9efb-52a5680737fa	71205-407	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	Proficient Rx LP	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-408_6ae4c40d-f4c1-4ba8-8299-b2527edeff1c	71205-408	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-410_098b27f9-2c4b-4fd0-a4ec-d9213de4181a	71205-410	HUMAN OTC DRUG	Siladryl Allergy Medicine		diphenhydramine hydrochloride	LIQUID	ORAL	19970101		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-411_0f92415d-6d81-4cc1-9a3b-028430951eb8	71205-411	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	TABLET, FILM COATED	ORAL	20071009		ANDA	ANDA077802	Proficient Rx LP	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-412_838d6e8f-37b0-48d3-b701-c4fa32a87b85	71205-412	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Proficient Rx LP	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-413_c08fcb0d-7fff-4d90-aeb8-e912b930bf3d	71205-413	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	OINTMENT	TOPICAL	20080718		ANDA	ANDA076067	Proficient Rx LP	MOMETASONE FUROATE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-416_9feb2d58-035e-458e-a184-3c27d8a66df6	71205-416	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71205-417_ccdb124d-fd56-409a-8615-ae0f675cd8e4	71205-417	HUMAN PRESCRIPTION DRUG	oseltamavir phosphate		oseltamavir phosphate	CAPSULE	ORAL	20170921		ANDA	ANDA207211	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	45	mg/1			N	20241231
71205-418_d16b3ad6-7c3f-4379-b179-b5b6dab29a58	71205-418	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20180927		ANDA	ANDA090141	Proficient Rx LP	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-419_1fbffba8-dcfe-46f7-82c2-352cbd45c439	71205-419	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	Proficient Rx LP	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-420_5a9de529-6f85-467a-97b0-8ce124c31173	71205-420	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20190301		ANDA	ANDA076513	Proficient Rx LP	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-421_8a428fc8-6e40-47cc-abc6-602c3aeb6bc3	71205-421	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	Proficient Rx LP	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-422_ffdf60e8-a414-4675-8e7d-8e90ebab3614	71205-422	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20060619		ANDA	ANDA065325	Proficient Rx LP	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-423_ad34d1da-0c69-45b1-875a-3017d212560f	71205-423	HUMAN OTC DRUG	Good Neighbor Pharmacy Ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20091019		ANDA	ANDA076359	Proficient Rx LP	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-424_d8e60aa5-76e2-4c27-9f03-f6a188be7079	71205-424	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210000	Proficient Rx LP	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-425_91fc4794-1880-460f-86dd-49d8c1e872bc	71205-425	HUMAN OTC DRUG	JUNIOR STRENGTH ADVIL		ibuprofen	TABLET, CHEWABLE	ORAL	20110601		NDA	NDA020944	Proficient Rx LP	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-426_8a05b052-c0ab-4cb1-af99-1d9c65024412	71205-426	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Proficient Rx LP	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
71205-427_79679395-12e4-4440-a9b7-12ffef1ef36c	71205-427	HUMAN PRESCRIPTION DRUG	azithromycin monohydrate		azithromycin monohydrate	TABLET	ORAL	20150818		ANDA	ANDA065398	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-428_254cd89b-86ad-4846-a5d3-5fe66e0d1e81	71205-428	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	Proficient Rx LP	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71205-429_c98eeb63-c896-4417-b0ad-66c4a87efeee	71205-429	HUMAN PRESCRIPTION DRUG	LIDOCAINE		LIDOCAINE	OINTMENT	TOPICAL	20181130		ANDA	ANDA211469	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-430_edcedd16-fe45-4edb-a0f8-55d904a59096	71205-430	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	Proficient Rx LP	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-432_64950943-266b-4fe5-bfc0-643875330c13	71205-432	HUMAN PRESCRIPTION DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	19930831		ANDA	ANDA072640	Proficient Rx LP	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
71205-433_8b9b3ddb-0aac-4b68-8079-d31de791c752	71205-433	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20130603		ANDA	ANDA201507	Proficient Rx LP	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-434_fa8aeb26-bd17-471f-aa37-827321613599	71205-434	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	CREAM	TOPICAL	20150310		OTC MONOGRAPH DRUG	M005	Proficient Rx LP	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
71205-435_4ed61888-4b22-4e11-96e7-f70aa516db4f	71205-435	HUMAN PRESCRIPTION DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	SOLUTION	ORAL	20140501		ANDA	ANDA076601	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-436_ead1e453-af08-4a3b-8379-aa182dff514b	71205-436	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20070326		ANDA	ANDA065378	Proficient Rx LP	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-437_711950c4-1889-4acd-ab76-9a16176ce1e4	71205-437	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin Ointment	OINTMENT	TOPICAL	20171006		ANDA	ANDA209114	Proficient Rx LP	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
71205-438_f70b3add-e332-44cc-86c6-b85164963154	71205-438	HUMAN OTC DRUG	Major Clotrimazole		CLOTRIMAZOLE	CREAM	TOPICAL	20041004		OTC MONOGRAPH FINAL	part333C	Proficient Rx LP	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
71205-439_5d12d209-d2f3-495e-a1de-1c7b496635f9	71205-439	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Proficient Rx LP	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-440_027bd594-6a0a-4e6d-bd3c-4f33fdb4166a	71205-440	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Proficient Rx LP	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-441_539823ee-064c-4094-a74c-b50a07a80bf2	71205-441	HUMAN PRESCRIPTION DRUG	albuterol sulfate		albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200226		ANDA	ANDA203760	Proficient Rx LP	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-442_4b6fae8d-03d4-4816-95a3-1aa0dfaaafea	71205-442	HUMAN OTC DRUG	good sense aspirin		Aspirin	TABLET, CHEWABLE	ORAL	19921104		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-443_ebef6621-2fa3-49b4-b30a-7e5313918ca9	71205-443	HUMAN PRESCRIPTION DRUG	FLUTICASONE		fluticasone propionate	SPRAY, METERED	NASAL	20120109		ANDA	ANDA078492	Proficient Rx LP	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-444_a19e5779-7d1a-4f35-9ab8-9568a18fbd8e	71205-444	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Proficient Rx LP	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71205-445_d0a48dfd-af34-470b-9e1f-7678203e9ae5	71205-445	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20120501		ANDA	ANDA203197	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-446_95331743-477d-4942-aa89-55522fed85e1	71205-446	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-447_9c48f05e-92d9-47de-9ee9-0517640f5ac4	71205-447	HUMAN OTC DRUG	Good Sense Clear Lax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20091007		ANDA	ANDA090685	Proficient Rx LP	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71205-448_8aec894d-5711-4079-b167-240713bf04f2	71205-448	HUMAN PRESCRIPTION DRUG	Plaquenil		Hydroxychloroquine Sulfate	TABLET	ORAL	20130628		NDA	NDA009768	Proficient Rx LP	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
71205-449_91c72454-515f-4966-ad84-a78aba616fb5	71205-449	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		azelastine hydrochloride	SPRAY, METERED	NASAL	20100301		ANDA	ANDA077954	Proficient Rx LP	AZELASTINE HYDROCHLORIDE	137	ug/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-450_7bc185e2-e749-4a24-8550-c2f6d39222d2	71205-450	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		diclofenac sodium	SOLUTION	TOPICAL	20180731		ANDA	ANDA202769	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-451_160cc186-71e9-4166-972c-00077ac99997	71205-451	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20190829		ANDA	ANDA209852	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-452_208cd661-160f-46e4-b9d1-6eaf7bd39ba0	71205-452	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	Proficient Rx LP	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-453_51700a49-0de1-4113-aee8-a57b380cd0d3	71205-453	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	Proficient Rx LP	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-454_a5a3c82e-1d99-4a5e-82c9-2d1f63f4dd6f	71205-454	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		ANDA	ANDA091281	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-455_4fe238eb-0703-4011-bca9-6c376e9b4314	71205-455	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Proficient Rx LP	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-456_c6aae2d7-e737-43f0-b9a9-4fd1d9662f6e	71205-456	HUMAN OTC DRUG	ACETAMINOPHEN 325 MG		ACETAMINOPHEN	TABLET	ORAL	20151101		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	325	mg/1			N	20241231
71205-457_8b2f38ef-0a0c-45cc-88ca-cc086bf80641	71205-457	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Proficient Rx LP	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-458_eff8b514-bb7f-427e-a267-7dee25fff611	71205-458	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, COATED	ORAL	20170424		ANDA	ANDA206763	Proficient Rx LP	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-459_eff8b514-bb7f-427e-a267-7dee25fff611	71205-459	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, COATED	ORAL	20170424		ANDA	ANDA206763	Proficient Rx LP	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-460_cd05bda0-f38f-4ad8-ad0a-f81ed1871843	71205-460	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	Proficient Rx LP	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-461_b327ddff-b501-4861-8b8e-0df044503f77	71205-461	HUMAN OTC DRUG	MEDIQUE APAP Extra Strength		Acetaminophen	TABLET, FILM COATED	ORAL	20081230		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	500	mg/1			N	20241231
71205-462_d2b100bf-cd23-4f3a-8f20-5a31f135cbe4	71205-462	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201090	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-463_77acc237-26cc-4dbd-a211-cad637a0b6ac	71205-463	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-464_8813a8a4-ebbd-4204-88a3-600a92ea9170	71205-464	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	Proficient Rx LP	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-465_293ee809-1b3d-4f31-9d46-ac413f126906	71205-465	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA210497	Proficient Rx LP	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-466_5be02b98-d033-4954-b42c-52fddee8f4ed	71205-466	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141226		ANDA	ANDA202446	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-467_5c5cba7e-33d5-4a93-ad61-ceff43cbd79e	71205-467	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	Proficient Rx LP	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-468_440ba161-845b-407e-a980-0cbd35d2e1cd	71205-468	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-469_cb2a9c90-6e47-41b2-b630-430bddcec7ce	71205-469	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	19980731		ANDA	ANDA075227	Proficient Rx LP	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-470_9bf5fd84-b077-461f-96d2-b3e67247700a	71205-470	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	Proficient Rx LP	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
71205-471_726a6f23-737a-4866-b4ba-b3c18cd2e1ac	71205-471	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Proficient Rx LP	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-472_9a5d6144-7eee-42e1-9ff5-b0822d68568d	71205-472	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20180504		ANDA	ANDA210401	Proficient Rx LP	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-473_1d2a3b34-3e71-4a4b-81ed-4ff35976abc0	71205-473	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20200710		ANDA	ANDA207178	Proficient Rx LP	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-474_4702c59e-202c-4900-9388-f64788cb035c	71205-474	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20110101		ANDA	ANDA078504	Proficient Rx LP	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71205-475_b2f702dc-1c6e-4217-b88a-1cc8a54fbb1c	71205-475	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Proficient Rx LP	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-476_c2d5fe36-08b4-46cc-b6d9-8663f57d56d4	71205-476	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20190919		ANDA	ANDA203646	Proficient Rx LP	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-477_96c761c6-0ba4-4e37-a3e5-4c00762b4a7d	71205-477	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Proficient Rx LP	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
71205-478_76bf2e05-8a22-48ff-9180-c582601932d2	71205-478	HUMAN OTC DRUG	Pharbetol		Acetaminophen	TABLET	ORAL	20060110		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	500	mg/1			N	20241231
71205-479_397db794-027c-4a89-993e-07c208b457a3	71205-479	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20111031		ANDA	ANDA200629	Proficient Rx LP	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-480_41474c73-d053-4e0d-ac8c-095acb9a28d2	71205-480	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Proficient Rx LP	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-481_cc15149e-2921-468f-a145-513b01885a81	71205-481	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Proficient Rx LP	MIRTAZAPINE	15	mg/1			N	20241231
71205-482_2304ba3c-27ed-4666-a08a-84665ee76d65	71205-482	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430		ANDA	ANDA211604	Proficient Rx LP	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71205-483_66af6524-9e2e-41b4-b531-42ff21e350f1	71205-483	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19840701		ANDA	ANDA088496	Proficient Rx LP	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-484_b27e3d0c-4d85-44fa-bd4e-6210e8b5dcab	71205-484	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20171110		ANDA	ANDA205823	Proficient Rx LP	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-485_5ebc3c8b-7e36-4c3c-807a-110b2a21c639	71205-485	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-486_a41237cc-3ead-41aa-bde7-8bc0bb93eafd	71205-486	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Proficient Rx LP	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71205-487_61424fa3-b09a-4267-a208-a7c7c3f69fe5	71205-487	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Proficient Rx LP	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-488_9f327d08-7661-4088-b554-2f9a99a113e7	71205-488	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Proficient Rx LP	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-489_8f7e8906-abfa-49b1-ab57-467f3af0c13e	71205-489	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	POWDER, FOR SUSPENSION	ORAL	20180221		ANDA	ANDA208347	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-490_56da6b01-5580-4adc-b33c-981eaeb4007f	71205-490	HUMAN OTC DRUG	Minoxidil	Regular Strength for Men	Minoxidil	SOLUTION	TOPICAL	19960405		ANDA	ANDA074588	Proficient Rx LP	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71205-491_9f055223-ef07-484e-98b8-5426e8741ec6	71205-491	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	Proficient Rx LP	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-492_2763266d-6b49-4732-b779-79d71b763203	71205-492	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20070702		ANDA	ANDA078297	Proficient Rx LP	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71205-493_db7da29a-36b4-4cdd-a76c-8f140bd5b81b	71205-493	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71205-494_a565aa8c-becb-4fd8-9728-94250812bf37	71205-494	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Proficient Rx LP	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-495_ef143cc7-36f4-430e-9ca2-9a78ee794f88	71205-495	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71205-496_e115f27a-6a7c-498c-b4a1-2d4c5716af22	71205-496	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19920124		ANDA	ANDA073457	Proficient Rx LP	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-498_fcc16d82-43ed-4928-9f4a-42c61af347e7	71205-498	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	Proficient Rx LP	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-499_7429ed84-f690-4cee-9391-f41b9499a444	71205-499	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070175	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-500_f894693b-14d8-4cd5-b9c6-67f3f16333dd	71205-500	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20160701		ANDA	ANDA206498	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-501_dc02ffef-7695-49cb-824c-f9a8f6bc00bc	71205-501	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Proficient Rx LP	OMEPRAZOLE	10	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-502_081d1edf-21a6-4852-bae3-7b285a0f6441	71205-502	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200403		ANDA	ANDA209167	Proficient Rx LP	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-503_31df881c-4b9b-4717-8f76-98b6ca8be644	71205-503	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20190312		ANDA	ANDA210001	Proficient Rx LP	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-504_8ab86beb-3616-414c-92bf-25273a853a9e	71205-504	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-505_facbef5f-e03e-471a-9075-0b4f7f02b2cd	71205-505	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71205-506_3149962f-3daa-456b-867c-dc17b505828f	71205-506	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	Proficient Rx LP	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-507_5f4cb7b3-1b66-479f-9bac-98c8a319e771	71205-507	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Proficient Rx LP	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-509_72c1516f-8a0c-495c-b11f-93bdc574ad21	71205-509	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20130531		ANDA	ANDA078380	Proficient Rx LP	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-510_cc7af14a-ce36-4f1a-80c3-efb483d92f6e	71205-510	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET, COATED	ORAL	20190305		ANDA	ANDA209587	Proficient Rx LP	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
71205-511_d03fd8ae-453f-4b31-b05a-d068f238c8a7	71205-511	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20130513		ANDA	ANDA090867	Proficient Rx LP	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-512_d2f36637-9d33-4514-bec0-81ed87ab79ee	71205-512	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-513_bad8fe65-73c1-4542-8050-720af889905a	71205-513	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Proficient Rx LP	ESZOPICLONE	2	mg/1		CIV	N	20241231
71205-514_dca73902-4c06-4304-a5a4-b289b020cee4	71205-514	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Proficient Rx LP	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-515_dddf9006-4715-487a-b12f-67d56a9e1993	71205-515	HUMAN OTC DRUG	MINTOX MAXIMUM STRENGTH		aluminum hydroxide, magnesium hydroxide, dimethicone	SUSPENSION	ORAL	20110201		OTC MONOGRAPH DRUG	M001	Proficient Rx LP	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/5mL; mg/5mL; mg/5mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71205-516_d1c530da-d15b-4ffc-b2b4-cd1e4dd5e8ee	71205-516	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Proficient Rx LP	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-517_ccda47aa-2aeb-4e29-b140-bb903d516bbf	71205-517	HUMAN OTC DRUG	Tri-Buffered Aspirin		Aspirin	TABLET, FILM COATED	ORAL	19900330		OTC MONOGRAPH DRUG	M013	Proficient Rx LP	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-518_f8be598e-17df-45df-8c0b-13f2e61e4312	71205-518	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Proficient Rx LP	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-519_8a140f7c-4dc7-454d-9ff9-473f4306a649	71205-519	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20180705		ANDA	ANDA207398	Proficient Rx LP	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-520_be1f8d5f-876a-4c16-b504-8812d781e06d	71205-520	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Proficient Rx LP	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-521_e9c2a959-7772-43f4-a097-535c75b917bd	71205-521	HUMAN OTC DRUG	Benadryl		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20080901		OTC MONOGRAPH DRUG	M012	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-522_c5eaa3a9-5aa8-46b0-8cec-639bfb327475	71205-522	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180824		ANDA	ANDA078329	Proficient Rx LP	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-524_c6e4bf5f-f6d6-489e-9286-c30568c601b7	71205-524	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20151106		ANDA	ANDA202894	Proficient Rx LP	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-525_34385a14-d100-4f5f-b3d5-8ee9f1c37ea9	71205-525	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-526_a1d40f02-9c2c-4c1f-a5c1-a8779705992e	71205-526	HUMAN PRESCRIPTION DRUG	ERRIN		NORETHINDRONE	TABLET	ORAL	20180418		ANDA	ANDA076225	Proficient Rx LP	NORETHINDRONE	.35	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20251231
71205-527_ce168c41-a860-45f5-bae8-7b3d9b48d86a	71205-527	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20141101		ANDA	ANDA203854	Proficient Rx LP	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-528_9f01f1ed-3bba-4243-8306-114d90da372b	71205-528	HUMAN PRESCRIPTION DRUG	Narcan		Naloxone Hydrochloride	SPRAY	NASAL	20170124		NDA	NDA208411	Proficient Rx LP	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71205-529_63286201-4b79-45b8-8f48-7e21dadc1408	71205-529	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Proficient Rx LP	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-530_143af59b-1513-46bd-8f77-63c04bdbd07c	71205-530	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Proficient Rx LP	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-531_d085bace-a71e-42d8-919f-7295afd57dad	71205-531	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20160819		ANDA	ANDA204097	Proficient Rx LP	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-532_3b668584-ca03-409b-b016-10c252899d4c	71205-532	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-533_6277f808-3745-48d5-944c-14af994b3690	71205-533	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Proficient Rx LP	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-534_e98f371e-f7fe-4c8f-9491-6eb4c53d43ad	71205-534	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	Proficient Rx LP	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-535_27af792b-276c-453e-98cf-04a9abb2a6b6	71205-535	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	Proficient Rx LP	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71205-536_9aef818d-f549-4ac7-98e9-4bcf4a8eab1f	71205-536	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-537_3ce81e99-e007-4186-8814-4bd44e078141	71205-537	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181207		ANDA	ANDA211495	Proficient Rx LP	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-538_cfac8933-0e28-48e0-92c1-c139cf32bdf3	71205-538	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20160428		ANDA	ANDA206298	Proficient Rx LP	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-539_31fcb983-1e92-4d12-a997-60346b4fff9f	71205-539	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190925		ANDA	ANDA211657	Proficient Rx LP	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-540_31fcb983-1e92-4d12-a997-60346b4fff9f	71205-540	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190925		ANDA	ANDA211657	Proficient Rx LP	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-541_db55bfa9-59e8-40d3-9bc3-4bdadb2eb389	71205-541	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Proficient Rx LP	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-542_310f4dca-236e-4b4c-8b3c-fad143eaf9bf	71205-542	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	Proficient Rx LP	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-543_2daab9ce-0570-4fdf-a7bd-01c3178f8cf3	71205-543	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Proficient Rx LP	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-544_4ecc62bd-49b3-4202-bf5c-91b49c4c2923	71205-544	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Proficient Rx LP	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
71205-545_5112a092-8be2-47d6-81f5-10e632329781	71205-545	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203702	Proficient Rx LP	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-546_ffdcd017-8fc8-4cd2-9319-06e3d2e7f3e9	71205-546	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20141101		ANDA	ANDA077066	Proficient Rx LP	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
71205-548_e389b2f2-4381-4a79-bee8-bde8c9bf7395	71205-548	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-549_30a246a1-08d5-443f-a012-67c0765ac193	71205-549	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20170310		ANDA	ANDA207810	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-550_1c3d16f1-d06e-4a61-b9e2-2d1d1308408c	71205-550	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-551_88ac1a9d-8483-4b29-9fe6-2e60e51f3005	71205-551	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71205-552_7e98952e-9b95-4296-9c23-c0ff4b82b2b7	71205-552	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200130		ANDA	ANDA210986	Proficient Rx LP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-553_ff4b7d77-f5bf-4286-a4a3-9bb13949ad35	71205-553	HUMAN PRESCRIPTION DRUG	cephalexin		Cephalexin	FOR SUSPENSION	ORAL	20170906		ANDA	ANDA065234	Proficient Rx LP	CEPHALEXIN	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-554_3303b423-b270-495b-9360-e43144fcf6f2	71205-554	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Proficient Rx LP	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-555_fa82229f-833e-4ffa-b0a9-148b2ca44ce3	71205-555	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-556_f58c99d0-e792-46b7-a67c-c6b1bce50946	71205-556	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	50	mg/1		CV	N	20241231
71205-557_5ea65f46-b915-486a-93d6-0e352202cf66	71205-557	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20130701		ANDA	ANDA203062	Proficient Rx LP	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71205-558_bff75226-d194-4d64-bcbb-d7d79f5d230e	71205-558	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	Proficient Rx LP	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71205-559_d6525817-bea1-4a4c-bed4-4873ee202cc8	71205-559	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA209333	Proficient Rx LP	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-560_cf4386ba-c62a-4ee8-ab59-1bb2e737a5da	71205-560	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	OINTMENT	TOPICAL	20141128		ANDA	ANDA064054	Proficient Rx LP	GENTAMICIN SULFATE	1	mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
71205-561_a3a77fb3-af3f-4c6f-be7e-8ce349d2a2cc	71205-561	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Proficient Rx LP	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-562_09678d2f-39cd-4821-bcac-3ecdc853f822	71205-562	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-563_17807dbb-9edb-488a-b1ee-d2e4ecc7edb3	71205-563	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Proficient Rx LP	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-564_39d7a8f2-00e7-4629-8e93-7175f047e331	71205-564	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71205-565_64c33202-1fb1-4e0a-ae72-146375fa81aa	71205-565	HUMAN PRESCRIPTION DRUG	bupropion		bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA202304	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-566_191f951e-0a52-4ecf-992a-ea1afffffab8	71205-566	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	20180410		ANDA	ANDA207531	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-567_09678d2f-39cd-4821-bcac-3ecdc853f822	71205-567	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-568_6bf8f35d-c071-44d1-9779-7aa63ede683d	71205-568	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA071523	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71205-569_f234949f-7ee3-4778-9875-4c3ce51e8b38	71205-569	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-570_cabfb3a4-d7d5-4211-b5f7-a89b5f988133	71205-570	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20201224		ANDA	ANDA078895	Proficient Rx LP	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-571_2a876a68-a69a-4cf9-9891-341ecda3b025	71205-571	HUMAN OTC DRUG	hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20110413		OTC MONOGRAPH NOT FINAL	part348	Proficient Rx LP	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-573_493e0baf-6795-4fe0-a9d6-81e035eb8ad6	71205-573	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20040729		ANDA	ANDA076077	Proficient Rx LP	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-574_82b1165a-6f2c-470c-adff-9db816fb0ad4	71205-574	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201008		ANDA	ANDA071524	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71205-575_98364393-50d2-4479-9048-8095cfa7a290	71205-575	HUMAN PRESCRIPTION DRUG	nystatin		nystatin	TABLET, COATED	ORAL	20111031		ANDA	ANDA062474	Proficient Rx LP	NYSTATIN	500000	[USP'U]/1	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
71205-576_e9946b03-ade7-4c74-b94d-78c966bb0c89	71205-576	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20210220		ANDA	ANDA210220	Proficient Rx LP	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-577_d8a5e670-a721-42c1-a384-4efe056f3a65	71205-577	HUMAN PRESCRIPTION DRUG	Bicalutamide		Bicalutamide	TABLET	ORAL	20090706		ANDA	ANDA078917	Proficient Rx LP	BICALUTAMIDE	50	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
71205-578_e95e1c62-32d4-46b8-ab0f-c662b837f9b8	71205-578	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20170817		ANDA	ANDA206261	Proficient Rx LP	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-579_840fbe22-2b9d-40c5-bf0c-30ed391273aa	71205-579	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20141126		ANDA	ANDA203818	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-580_2658be08-1517-4b69-8163-710ce69b74e5	71205-580	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succiate	TABLET, FILM COATED	ORAL	20201122		ANDA	ANDA210281	Proficient Rx LP	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-581_dfa6f802-b9c1-4874-9556-0b88e48bcc58	71205-581	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091166	Proficient Rx LP	ESZOPICLONE	1	mg/1		CIV	N	20241231
71205-582_014ba8d7-7ed3-4d4a-847a-22b65161117e	71205-582	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200121		ANDA	ANDA204216	Proficient Rx LP	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-583_585474af-65d8-4ed1-9793-8439d80212fe	71205-583	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190520		ANDA	ANDA209333	Proficient Rx LP	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-584_1f61dcb1-c108-433a-963c-215cd2239a3e	71205-584	HUMAN OTC DRUG	Good Neighbor Pharmacy Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20130701		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	95	mg/1			N	20241231
71205-585_0a2cc210-ad5e-426f-9ddb-25ab2634820f	71205-585	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20070118		ANDA	ANDA071745	Proficient Rx LP	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71205-586_39cdc974-0387-41dd-946b-4f8b77066ff5	71205-586	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204003	Proficient Rx LP	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-587_e1390a0d-0280-49a5-a2d4-d2e13e9952ca	71205-587	HUMAN PRESCRIPTION DRUG	Letrozole		Letrozole	TABLET, FILM COATED	ORAL	20110603		ANDA	ANDA090289	Proficient Rx LP	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
71205-588_63ed2151-a687-4972-bbe7-f1f1ec060659	71205-588	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070925	Proficient Rx LP	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-589_6c0ead2d-11ee-419c-963f-53481e170b1f	71205-589	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190607		ANDA	ANDA203561	Proficient Rx LP	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-590_0af558f8-6356-45ee-a7fc-8728d7d65d76	71205-590	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-591_ada7b8a5-98f4-454c-b38f-92192d4db33f	71205-591	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	Proficient Rx LP	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-592_0befef0b-102e-4d9b-b451-6ef769a54f2b	71205-592	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20180528		ANDA	ANDA207222	Proficient Rx LP	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71205-593_5f684b27-197e-45f0-b623-83a5fab20b0f	71205-593	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20080724		ANDA	ANDA065329	Proficient Rx LP	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-594_d95f2a2e-a9c8-48b3-86d0-973db8c36eb5	71205-594	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20200110		ANDA	ANDA204216	Proficient Rx LP	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-595_0193d608-f4a8-5a69-e063-6294a90aafe8	71205-595	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20190101		ANDA	ANDA204872	Proficient Rx LP	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-596_fd81606e-c64c-4e10-ab12-39be9a7916e5	71205-596	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Proficient Rx LP	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-597_58d04fa7-f30f-4f9e-834c-f63b2c0431a9	71205-597	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Proficient Rx LP	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-598_f260f7c5-a55b-4294-ae02-2586929e24c9	71205-598	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	50 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	Proficient Rx LP	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-599_c2c51ec3-ffb0-4240-b048-a8e424775a76	71205-599	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	Proficient Rx LP	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-600_c4ab8ed6-6890-4f43-81a3-fad27fb89cad	71205-600	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B sulfate	OINTMENT	TOPICAL	20210524		OTC MONOGRAPH FINAL	part333B	Proficient Rx LP	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71205-601_2459e9eb-fb72-4457-b033-30ae730eace3	71205-601	HUMAN OTC DRUG	Good Sense Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	19930225		OTC MONOGRAPH DRUG	M013	Proficient Rx LP	ACETAMINOPHEN	160	mg/5mL			N	20241231
71205-602_f73fb658-ff2c-4847-a1ee-e551d2776f52	71205-602	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-603_ddba7982-5cbb-4a0f-9425-542cb118e9fa	71205-603	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20170601		ANDA	ANDA204237	Proficient Rx LP	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-604_f49b4e82-120c-4012-b4b3-78c0f89ae8fd	71205-604	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Proficient Rx LP	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-605_2fae3438-3fe9-4f4f-bd89-35fb7050c560	71205-605	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-606_15ddaaca-bd8f-4bf3-8b65-db03ba69cc85	71205-606	HUMAN OTC DRUG	Meclizine HCL 25 mg		Meclizine HCL	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part336	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71205-607_9bcdfff4-8522-4b62-9139-a9aa9e46e633	71205-607	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	Proficient Rx LP	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71205-608_079f7397-045d-4545-b593-4af3434d113f	71205-608	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Proficient Rx LP	PREGABALIN	150	mg/1		CV	N	20241231
71205-609_a126a991-ee66-4221-a2da-6dd916ace3ee	71205-609	HUMAN PRESCRIPTION DRUG	Famciclovir		Famciclovir	TABLET, FILM COATED	ORAL	20120113		ANDA	ANDA201022	Proficient Rx LP	FAMCICLOVIR	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71205-610_23030a80-682e-4757-92bb-4db9f6d2afe6	71205-610	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	Proficient Rx LP	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-611_449c7ca6-7fd4-4728-b330-2a3e261c6693	71205-611	HUMAN OTC DRUG	Banophen		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	19900302		OTC MONOGRAPH DRUG	M012	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-613_d870bdc1-5e26-4153-89e2-f629fef60ad0	71205-613	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190220		ANDA	ANDA212977	Proficient Rx LP	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-614_0221ed96-545d-7ceb-e063-6394a90a528a	71205-614	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Proficient Rx LP	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-615_49763843-7dc9-4416-a2c8-c49f84337322	71205-615	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH DRUG	M012	Proficient Rx LP	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
71205-616_dbf76511-710c-435e-bc2c-834e33fdcd61	71205-616	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Proficient Rx LP	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-617_5d4433aa-fc83-4868-b47f-e9b8674f3b3e	71205-617	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-618_0abc944e-a435-4f77-922d-380e5aab6c5f	71205-618	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20190520		ANDA	ANDA211253	Proficient Rx LP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-619_185f264e-db32-41cd-b90d-519717b97850	71205-619	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-620_474c822b-dc3d-4a55-8159-2b4b799d535b	71205-620	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	SUSPENSION	ORAL	20070813		ANDA	ANDA065358	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-621_4702a3a6-2275-4978-83f9-1298d54ffa6a	71205-621	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Proficient Rx LP	PREGABALIN	75	mg/1		CV	N	20241231
71205-622_003ffb4b-1018-4cf7-af05-0eba0097f9d8	71205-622	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-623_b66fb676-eb26-4bea-b8a6-0767865180c5	71205-623	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20160801		ANDA	ANDA204883	Proficient Rx LP	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-624_20f35f9f-5f3b-4305-b9e4-ab9a8fae9c1d	71205-624	HUMAN OTC DRUG	Codeine-Guaifenesin		Codeine Phosphate and Guaifenesin	SOLUTION	ORAL	20200715		OTC MONOGRAPH FINAL	part341	Proficient Rx LP	CODEINE PHOSPHATE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]	CV	N	20241231
71205-625_10ab10fb-a693-47a4-9739-6bab1f192e9c	71205-625	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20170322		ANDA	ANDA207152	Proficient Rx LP	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-626_55a57d80-6bed-44a3-b3ea-6bb44c34cbfc	71205-626	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Proficient Rx LP	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-627_c17a61e9-5ec5-4807-8ee9-82f07cd4d2d1	71205-627	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-630_59aa7e27-52ed-41c9-8408-0b3b481debfa	71205-630	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20181005		ANDA	ANDA206923	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71205-631_0c969467-9318-4dd2-945e-95ec8092a0fe	71205-631	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	Proficient Rx LP	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-632_a449d609-2233-477e-bdb7-df2c84a1b495	71205-632	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-633_5381d4b2-e743-4ece-9fe3-e2be6eb85711	71205-633	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	OROPHARYNGEAL	20140415		ANDA	ANDA091166	Proficient Rx LP	ESZOPICLONE	3	mg/1		CIV	N	20241231
71205-634_c3f19a52-d462-4fd5-8a28-ce6caac442ae	71205-634	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	Proficient Rx LP	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71205-635_91c30b32-c939-4f18-aa77-1f41d68a29e2	71205-635	HUMAN PRESCRIPTION DRUG	Quinapril		Quinapril	TABLET	ORAL	20070226		ANDA	ANDA077690	Proficient Rx LP	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-636_e72981fd-0d15-473b-8e3d-ee84e3d71c03	71205-636	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-637_ce4deda2-a2d0-47da-9366-a35358dfbcad	71205-637	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Proficient Rx LP	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71205-638_092356cf-c100-4bd5-8a3f-c4b2e66ee462	71205-638	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-639_9cf457c7-9f98-43bc-9ab7-dfea6754ce70	71205-639	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Proficient Rx LP	PREGABALIN	100	mg/1		CV	N	20241231
71205-640_c35273f6-f7d7-4111-ac7c-0f4d0ff11771	71205-640	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium 1.5%		Diclofenac Sodium Topical	SOLUTION	TOPICAL	20210604		ANDA	ANDA204132	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-641_e047d101-9fa6-4f1c-96b4-de88701a5d60	71205-641	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		albuterol sulfate	SOLUTION	RESPIRATORY (INHALATION)	20210611		ANDA	ANDA207857	Proficient Rx LP	ALBUTEROL SULFATE	.83	mg/mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-642_7a6abcab-a753-4c1d-92fb-c134ffc2c0a7	71205-642	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	Proficient Rx LP	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-643_e71f2fad-1fa2-4df1-a09c-d50a60055fc2	71205-643	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-644_fad5d266-a87f-413a-b644-8ebbe93e7534	71205-644	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Proficient Rx LP	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71205-645_d7589ff6-a31c-4bdc-bffc-5e2f3728d184	71205-645	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065211	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-646_d0d8a699-8d2a-469a-b19b-a75ebd1d46f1	71205-646	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Proficient Rx LP	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-647_92e8390b-5173-4aa1-906d-35d2c0eaaaf6	71205-647	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71205-648_d94e8865-d151-4fb1-bacd-f4e43819e3c2	71205-648	HUMAN PRESCRIPTION DRUG	SULINDAC		SULINDAC	TABLET	ORAL	20100125		ANDA	ANDA072711	Proficient Rx LP	SULINDAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-649_1f08d9f0-9863-4f3c-aa05-111d34f85042	71205-649	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-650_2e7093ee-60d8-4b7f-b28d-f415a36ae086	71205-650	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Proficient Rx LP	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-651_f636413f-82e5-446f-94cc-b4841bdedb33	71205-651	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA065063	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-652_4579facb-b225-4108-a5ef-dada926ef7cf	71205-652	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Proficient Rx LP	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-653_86c1f165-af79-4f01-ab61-3bdbce24cd0d	71205-653	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19860710		ANDA	ANDA062676	Proficient Rx LP	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-654_68a4c521-6db0-4e94-9906-96e96e251301	71205-654	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution		Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution	SOLUTION	ORAL	20201005		ANDA	ANDA040649	Proficient Rx LP	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71205-655_ca197216-83f1-470a-9313-d1b923924661	71205-655	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Proficient Rx LP	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-656_68646295-49b2-45ac-bf19-99bb91f7333d	71205-656	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-657_1596fdec-63a2-4501-a78f-42c30e4a672f	71205-657	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20200904		ANDA	ANDA209302	Proficient Rx LP	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-658_f274f5be-72ff-42e5-a4ba-8d1d957375b0	71205-658	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20140113		ANDA	ANDA040596	Proficient Rx LP	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-659_81a69bdf-9a95-4c6c-aa50-6a598e07971d	71205-659	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210802		ANDA	ANDA091310	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-660_c6210466-5feb-45d9-b637-b3f482bc3c2b	71205-660	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71205-661_aa3ab216-372a-4a72-bfd1-88a1ffa31ba3	71205-661	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Proficient Rx LP	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-662_ca7f3bd7-fa5d-441a-9b9b-5329349c3e98	71205-662	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210802		ANDA	ANDA091310	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-663_787724dc-0b4b-4973-852e-c7d722f637b0	71205-663	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Proficient Rx LP	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71205-664_13262ab6-d121-4138-bcff-daf5b8972f83	71205-664	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	Proficient Rx LP	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-665_35f504c3-1cf5-455d-8226-9ffeea606623	71205-665	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	Proficient Rx LP	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-666_26f8f793-fb7a-4327-9441-d8737fe1ff11	71205-666	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20200910		ANDA	ANDA213864	Proficient Rx LP	FENOFIBRATE	54	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71205-667_88f08450-559e-4038-aad1-051e4ab283cf	71205-667	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161220		ANDA	ANDA207138	Proficient Rx LP	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-668_9c21b09e-a1b9-4096-9346-a3fee9c3b7c4	71205-668	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20170124		ANDA	ANDA205008	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71205-669_80a63b2b-96be-423d-abbd-13acc802f6da	71205-669	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Proficient Rx LP	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71205-670_67eacd91-8378-47e7-9bad-1e7b685aa9d4	71205-670	HUMAN OTC DRUG	good sense arthritis pain		diclofenac sodium	GEL	TOPICAL	20200822		ANDA	ANDA211253	Proficient Rx LP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-671_41f58323-3405-499a-a301-dfcc0f6b5a5d	71205-671	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-672_7059a0b2-dd57-4fc1-ac3d-6aead35a4b08	71205-672	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Proficient Rx LP	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-673_8dcaeabf-e7da-4e0c-b6db-0bd425d6506e	71205-673	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-674_90605f94-93e1-43d1-8be7-830e816ac84f	71205-674	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065212	Proficient Rx LP	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71205-675_e8075254-cdfd-44f3-a9c2-1ed913f846ea	71205-675	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	25 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	Proficient Rx LP	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71205-676_c22a625f-f526-477a-85e5-23abe5771284	71205-676	HUMAN PRESCRIPTION DRUG	Ergocalciferol Capsules,		Ergocalciferol Capsules,	CAPSULE	ORAL	20181210		ANDA	ANDA204276	Proficient Rx LP	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71205-677_c7986739-3fc9-4a1d-8dd6-2e11cf1f3610	71205-677	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	75	mg/1		CV	N	20241231
71205-678_e3998083-e3db-4052-9b5b-19d7aaa4e658	71205-678	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-679_d24529e3-e2b4-46d6-81ba-b7da74501792	71205-679	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203661	Proficient Rx LP	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-680_8d264c73-4dd9-4f7c-8a18-f31195cdd013	71205-680	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
71205-681_2f129a3d-f3e6-45b2-9704-3ad171cbd8a5	71205-681	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	Proficient Rx LP	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71205-682_e517e70f-da42-4421-98cc-5a31e84f1d45	71205-682	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxaxin	SOLUTION/ DROPS	AURICULAR (OTIC)	20080317		ANDA	ANDA076616	Proficient Rx LP	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-683_411ed6c7-c5e0-446c-9745-9095404dd0f6	71205-683	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201106		ANDA	ANDA205541	Proficient Rx LP	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-684_e1546b35-cfa8-4808-9652-db1ba675a4e3	71205-684	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Proficient Rx LP	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71205-685_5b684f8f-9610-4449-a213-f70bb4a04b8b	71205-685	HUMAN PRESCRIPTION DRUG	Nortrel 7/7/7	(28 Day Regimen)	Norethindrone and Ethinyl Estradiol	KIT		20030102		ANDA	ANDA075478	Proficient Rx LP						N	20241231
71205-686_52f70c2b-05fa-4bcc-ac3d-60ed60363ca0	71205-686	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-687_eee9439e-0e61-440e-a6d6-a897df41a205	71205-687	HUMAN PRESCRIPTION DRUG	colchicine		colchicine	TABLET	ORAL	20200611		ANDA	ANDA209876	Proficient Rx LP	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
71205-688_58cba3d8-bb57-4e64-a191-dc050904c896	71205-688	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Proficient Rx LP	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71205-689_2b4f125c-338e-479f-8feb-b82324230c65	71205-689	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		sulfacetamide sodium	SOLUTION/ DROPS	OPHTHALMIC	19941228		ANDA	ANDA040066	Proficient Rx LP	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71205-690_8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d	71205-690	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150422		ANDA	ANDA202824	Proficient Rx LP	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71205-691_f76eb9d8-ca7d-4479-bd16-52a57f623b02	71205-691	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Proficient Rx LP	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71205-692_67e384c6-8476-4aad-b967-241335538d56	71205-692	HUMAN PRESCRIPTION DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20181127		ANDA	ANDA210893	Proficient Rx LP	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-694_65311ae9-e440-4650-b1b1-6f4495fda93c	71205-694	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	150	mg/1		CV	N	20241231
71205-695_acb696a8-a74c-4c5d-9ce3-88f67558c2f2	71205-695	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Proficient Rx LP	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-696_137ffe30-ff8b-409d-a719-6be19d4d9522	71205-696	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	50	mg/1		CV	N	20241231
71205-697_dd7672c9-b10f-4ea1-9000-ef3e3faa10db	71205-697	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Proficient Rx LP	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71205-698_b027d9ba-34d3-4f52-b3a8-beb58b1c83d9	71205-698	HUMAN PRESCRIPTION DRUG	hyoscyamine sulfate		hyoscyamine sulfate	TABLET	ORAL	20220126		UNAPPROVED DRUG OTHER		Proficient Rx LP	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
71205-699_47560d98-f4c4-4738-85fe-41cbed09ed59	71205-699	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-700_6a21e112-781e-4bd1-b46c-b4c30bf776f0	71205-700	HUMAN OTC DRUG	Cetirizine Hydrochloride (Allergy)		Cetirizine Hydrochloride	TABLET	ORAL	20150805		ANDA	ANDA090760	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-701_5a4969d2-d569-4d2b-b698-092f07bd055a	71205-701	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Proficient Rx LP	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-702_743d1b73-f47e-4bbf-bb52-45b1e7f17308	71205-702	HUMAN PRESCRIPTION DRUG	amantadine hydrochloride		amantadine hydrochloride	CAPSULE	ORAL	20160804		ANDA	ANDA208278	Proficient Rx LP	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
71205-703_6f917c55-034a-40c5-9011-0e10e94d0eba	71205-703	HUMAN PRESCRIPTION DRUG	Dexamethasone		dexamethasone	TABLET	ORAL	20210628		ANDA	ANDA088481	Proficient Rx LP	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-704_b04fbd67-9ac5-4043-87e9-c3804d1e5d0c	71205-704	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	Proficient Rx LP	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71205-705_582db483-394e-4c00-8522-4041a11696e4	71205-705	HUMAN OTC DRUG	Childrens Cetirizine Hydrochloride	Sugar Free Grape	Cetirizine Hydrochloride	SOLUTION	ORAL	20110908		ANDA	ANDA090182	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-706_ad05cdde-a9e9-4442-80c4-1b02f5ebf6b4	71205-706	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	Proficient Rx LP	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-707_8d529b4c-85fd-4e50-9443-9080825307bf	71205-707	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	SPRAY	NASAL	20220621		ANDA	ANDA211951	Proficient Rx LP	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71205-708_00b7f61b-5173-43e6-a3f9-d2efbda40c19	71205-708	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-709_55b1738c-fa72-4cd1-a8e8-be41b12b593d	71205-709	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20181217		ANDA	ANDA078343	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-710_a25ab5ea-c46d-4562-8f7e-0ccffc2ab069	71205-710	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20050509		ANDA	ANDA065169	Proficient Rx LP	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71205-711_0a8ee5fa-f393-4568-81bd-269f9a4cecd6	71205-711	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20200803		ANDA	ANDA089853	Proficient Rx LP	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-712_a0d22635-0e11-448d-b151-6f6168c65723	71205-712	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA065063	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-713_35203011-d93c-4169-a9cb-90b6d20b146b	71205-713	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Proficient Rx LP	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71205-714_81702f21-3117-49ce-8e9b-2aa2648ba7c3	71205-714	HUMAN PRESCRIPTION DRUG	Risedronate Sodium		Risedronate Sodium	TABLET, FILM COATED	ORAL	20151130		ANDA	ANDA090877	Proficient Rx LP	RISEDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
71205-715_aad2d2f0-c755-4506-9f59-81a6c3439094	71205-715	HUMAN OTC DRUG	Lidozen Gel		LIDOCAINE HYDROCHLORIDE, MENTHOL	GEL	TOPICAL	20220901		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-716_9e9fb921-6b6a-422e-95b6-41d6b9047b80	71205-716	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	SUSPENSION	ORAL	20041208		ANDA	ANDA076925	Proficient Rx LP	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-717_8a85ea77-91ad-4222-9bfe-2ffaf73182e8	71205-717	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20160701		ANDA	ANDA206498	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-718_a6915bb1-c9fb-4580-bbc5-257ce1c1361f	71205-718	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	Proficient Rx LP	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-719_7404ec09-2f3f-4690-91d4-acdfe49ecc00	71205-719	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA065093	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71205-720_7a105ef9-7129-4ce1-bd8d-ae316bf348e2	71205-720	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200403		ANDA	ANDA209167	Proficient Rx LP	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-721_59b623bc-fbdd-4f32-8327-0d600763f429	71205-721	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20200904		ANDA	ANDA209302	Proficient Rx LP	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-722_8ef674ef-82a3-4a2b-8e5e-f8ca2ecccb1e	71205-722	HUMAN OTC DRUG	childrens cetirizine hydrochloride		Cetirizine HCl	SOLUTION	ORAL	20180822		ANDA	ANDA204226	Proficient Rx LP	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-723_b1efcc2c-f71a-463d-9a02-fad7550f31ec	71205-723	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin Cream	CREAM	TOPICAL	20150401		ANDA	ANDA061966	Proficient Rx LP	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
71205-724_09fa1b7f-1911-4bc2-825b-c885a44f5c63	71205-724	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		METOPROLOL SUCCINATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201106		ANDA	ANDA205541	Proficient Rx LP	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-725_f23ac454-8f7d-4c1b-be58-a394c8b0a966	71205-725	HUMAN PRESCRIPTION DRUG	sumatriptan succinate		sumatriptan succinate	TABLET, FILM COATED	ORAL	20090810		ANDA	ANDA078295	Proficient Rx LP	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71205-726_0b0587df-b4bd-4fae-9d79-c71362c0314b	71205-726	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide and Albuterol Sulfate		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20211115		ANDA	ANDA207875	Proficient Rx LP	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-727_b4b0ee6a-d4cf-4f29-b9ff-fd5ffc1ce7e1	71205-727	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210709		ANDA	ANDA214492	Proficient Rx LP	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71205-728_a0ad8200-70c9-4f4f-86c5-4a8c6c9f0223	71205-728	HUMAN PRESCRIPTION DRUG	Levetiracetam	ER	Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210930		ANDA	ANDA205130	Proficient Rx LP	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-729_e56684b6-5548-4447-8d4a-b09443c75cea	71205-729	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Proficient Rx LP	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-730_8bf62cab-8919-4e74-84aa-dc987ca3f431	71205-730	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	LIQUID	ORAL	20210505		OTC MONOGRAPH DRUG	M013	Proficient Rx LP	ACETAMINOPHEN	160	mg/5mL			N	20241231
71205-731_a1b22973-cb9a-473e-a240-112b3e84e97c	71205-731	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20180806		ANDA	ANDA207687	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-732_4ed5342d-7933-406f-93f9-34f45b521ec6	71205-732	HUMAN PRESCRIPTION DRUG	Albuterol sulfate		Albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20200825		ANDA	ANDA209954	Proficient Rx LP	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-733_1d76c6a3-7899-4dec-afcc-2b575dfa6c25	71205-733	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	25	mg/1		CV	N	20241231
71205-734_a72a1311-aa68-4567-ac58-97081f675d73	71205-734	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Proficient Rx LP	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-735_a72a1311-aa68-4567-ac58-97081f675d73	71205-735	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Proficient Rx LP	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-736_a72a1311-aa68-4567-ac58-97081f675d73	71205-736	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Proficient Rx LP	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-738_7c64553b-589c-4e65-a6f0-b2847bbbe8a6	71205-738	HUMAN OTC DRUG	RUGBY ANTIFUNGAL CLOTRIMAZOLE		CLOTRIMAZOLE	CREAM	TOPICAL	20200114		OTC MONOGRAPH FINAL	part333C	Proficient Rx LP	CLOTRIMAZOLE	.01	g/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
71205-739_4a9b4b7f-0441-44d3-86c7-2542ef4b119a	71205-739	HUMAN OTC DRUG	Fexofenadine Hydrochloride		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20220107		ANDA	ANDA212971	Proficient Rx LP	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-740_b67f987f-f0be-423d-b503-8898dd42505e	71205-740	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20200923		ANDA	ANDA203494	Proficient Rx LP	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71205-741_4b37ada5-1f22-46d5-a794-fd1477c0eb9b	71205-741	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Proficient Rx LP	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-742_ad211de8-d236-48aa-bf27-4501eccfffca	71205-742	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	Proficient Rx LP	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71205-743_0fce1aea-5de2-4acb-8a21-2b775c4adb25	71205-743	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150309		ANDA	ANDA075126	Proficient Rx LP	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-744_33d02d85-fb3b-48c1-85db-4be993bfcc96	71205-744	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Proficient Rx LP	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71205-745_4c0346a9-a4b3-4217-9b8c-f08470d3dfb7	71205-745	HUMAN OTC DRUG	Lidozen Patch		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20220901		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-746_5f3dedb9-a500-4e21-8ffa-0d942243c790	71205-746	HUMAN PRESCRIPTION DRUG	Tri-Lo-Mili		Norgestimate and Ethinyl Estradiol	KIT		20161104		ANDA	ANDA205762	Proficient Rx LP						N	20241231
71205-747_b4694451-a13d-484e-92c4-c03a6fcbb511	71205-747	HUMAN OTC DRUG	DICLOFENAC SODIUM		diclofenac sodium topical gel, 1%	GEL	TOPICAL	20200914		ANDA	ANDA210986	Proficient Rx LP	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-748_2efb276a-450e-45ce-a7b7-d38f1a3ca399	71205-748	HUMAN PRESCRIPTION DRUG	TAMSULOSIN HYDROCHLORIDE		TAMSULOSIN HYDROCHLORIDE	CAPSULE	ORAL	20100427		ANDA	ANDA078938	Proficient Rx LP	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71205-749_6b5fe0aa-c74f-42f3-a84a-1cb16009aa80	71205-749	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-751_c4fe84e3-c291-4220-95c1-a2bd02b1e134	71205-751	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	19800107		ANDA	ANDA083177	Proficient Rx LP	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-752_b41335b6-859f-4568-84d2-0d0408415a4e	71205-752	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20160519		ANDA	ANDA206493	Proficient Rx LP	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-753_6a91be8f-70aa-4fa0-9a60-55fdc1b81883	71205-753	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitslopram	TABLET	ORAL	20120910		ANDA	ANDA078169	Proficient Rx LP	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-754_ac93704f-8e33-43ba-8b56-3d61092ff1d9	71205-754	HUMAN PRESCRIPTION DRUG	tadalafil		tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA209250	Proficient Rx LP	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-755_22d9fd96-cad5-4762-9a56-0ff63357ed9e	71205-755	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220524		ANDA	ANDA208412	Proficient Rx LP	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-756_7d33eb18-1504-43fc-b01d-8eb455759eb3	71205-756	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211011		ANDA	ANDA072926	Proficient Rx LP	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-757_637718aa-a453-4acd-a992-590d637b63a3	71205-757	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	20091026		ANDA	ANDA071344	Proficient Rx LP	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71205-758_977886cf-5644-4484-85c5-ff415eb314f9	71205-758	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71205-759_cc2353a0-94ec-4832-b458-1bb3de940a57	71205-759	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215483	Proficient Rx LP	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-760_968353ed-eb79-4f96-9569-3efb220fc388	71205-760	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20070810		ANDA	ANDA078494	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-761_e4009ade-155b-4d28-8a8d-555db68bf8b0	71205-761	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20070810		ANDA	ANDA078494	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-762_3ffa63f2-ea06-4be0-9f59-162c2a9604fc	71205-762	HUMAN OTC DRUG	Meclizine HCL 12.5 mg		Meclizine HCL 12.5 mg	TABLET	ORAL	20151101		OTC MONOGRAPH FINAL	part336	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71205-763_84dba61d-cae2-4f21-9a9e-3088f356f838	71205-763	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Proficient Rx LP	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-764_4eb71151-241a-476e-a495-4a021bc55bda	71205-764	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Proficient Rx LP	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-765_514fcba1-713c-4aeb-be8c-369fcf9b4ffe	71205-765	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-766_1749d731-bc8c-4374-b2a9-7c809c457f56	71205-766	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-767_e31a5901-ef04-4515-bca4-79118a3f3797	71205-767	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20170105		ANDA	ANDA204304	Proficient Rx LP	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71205-770_30263e15-de21-4db4-aceb-59d619909e82	71205-770	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	19950405		ANDA	ANDA074132	Proficient Rx LP	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-771_40b3d1f4-5e9c-4a4f-a2da-b30dc0cb8c12	71205-771	HUMAN OTC DRUG	Menthozen Cream		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20220901		OTC MONOGRAPH DRUG	M017	Proficient Rx LP	CAPSAICIN; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.375; 50; 200	mg/mL; mg/mL; mg/mL			N	20241231
71205-772_67aa6f82-72d2-437f-8c23-4f913640c8f1	71205-772	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Proficient Rx LP	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71205-773_8f687fa6-54eb-4556-8ea6-aafec49a87d1	71205-773	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Proficient Rx LP	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71205-774_35004f84-90ae-45f0-a2ba-653dec507229	71205-774	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160411		ANDA	ANDA205101	Proficient Rx LP	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-775_d5eba477-e255-4d97-9e16-30543c298680	71205-775	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	20061228		ANDA	ANDA065334	Proficient Rx LP	AMOXICILLIN	200	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-776_d3b849a7-219d-4acc-9e29-8f246cb4a7a9	71205-776	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20210330		ANDA	ANDA090513	Proficient Rx LP	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
71205-777_ccc6f2f9-696f-4ef9-bb4c-e0198d957b0b	71205-777	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, FILM COATED	ORAL	20071012		NDA	NDA022145	Proficient Rx LP	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
71205-778_461f2aaa-e091-478e-97c1-27a089db8cdc	71205-778	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA202468	Proficient Rx LP	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71205-779_e12ab052-e3d6-4246-b727-f1e3f9057f09	71205-779	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Proficient Rx LP	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71205-780_b5b47d5b-f953-4e82-99ef-e4e10164095e	71205-780	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	Proficient Rx LP	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-781_fe21daca-ac48-4b46-9cb3-9a69af0c6a84	71205-781	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075511	Proficient Rx LP	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71205-782_3e3de8ea-b96b-456b-9336-69380fd2d058	71205-782	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	Proficient Rx LP	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-783_928ef685-80cb-42a9-a155-3c21c9b1dd67	71205-783	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-784_928ef685-80cb-42a9-a155-3c21c9b1dd67	71205-784	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-785_5e1cc734-5d5c-429e-8b4c-4401a01cfba2	71205-785	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Proficient Rx LP	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71205-786_b91435d1-fb95-4939-8478-84e41f44f732	71205-786	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Proficient Rx LP	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71205-787_4ee828df-873d-4379-9a17-a805d97dfe04	71205-787	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19940816		ANDA	ANDA072096	Proficient Rx LP	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-788_c1f2ccba-62f3-44e7-b06f-dea61eac9e93	71205-788	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Proficient Rx LP	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-789_2da8a709-b31f-4f22-9fcc-11eb60b5e02b	71205-789	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20151104	20281019	ANDA	ANDA202769	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
71205-790_196f7d23-ed90-46c2-ae34-615e6ec1650b	71205-790	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, COATED	ORAL	20170106		ANDA	ANDA207750	Proficient Rx LP	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71205-791_f87b565f-40fc-4615-b58c-60182c8079f3	71205-791	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-792_8201a719-7837-45fb-b991-4fcdbf006d24	71205-792	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	Proficient Rx LP	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-793_3464be28-5bab-4642-9d9b-8b425822dd07	71205-793	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20150115		ANDA	ANDA085182	Proficient Rx LP	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-794_91055555-6967-4b6a-b5c8-5211ec18d2c8	71205-794	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	Proficient Rx LP	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-795_8780c159-8b61-402b-afbe-64f5c85d3886	71205-795	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20200904		ANDA	ANDA209302	Proficient Rx LP	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71205-796_fa2fa2f8-f3a6-4bc0-943c-03dabd0f1581	71205-796	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	Proficient Rx LP	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71205-797_0fb00b77-3fc1-4081-9540-e6a8f8e39008	71205-797	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	Proficient Rx LP	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-798_dad0dd7d-3049-4be4-aaeb-8a1895d55208	71205-798	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	Proficient Rx LP	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-799_864ddd0c-80e5-4b4b-84e9-7d66214464ae	71205-799	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71205-800_57e33bcf-b380-44bb-b96e-3a637af6233a	71205-800	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200203		ANDA	ANDA204161	Proficient Rx LP	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-801_57e33bcf-b380-44bb-b96e-3a637af6233a	71205-801	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20191023		ANDA	ANDA204161	Proficient Rx LP	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71205-802_cd756dc8-6c30-4273-8947-9a3f9b4fc075	71205-802	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium, film coated	TABLET	ORAL	20180618		ANDA	ANDA209912	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-803_9c4fac8e-8744-4378-80af-7887de955a51	71205-803	HUMAN PRESCRIPTION DRUG	Cryselle		Norgestrel and Ethinyl Estradiol	KIT		20020724		ANDA	ANDA075840	Proficient Rx LP						N	20241231
71205-804_3f90b8dd-7234-4428-b896-943d052dd05f	71205-804	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20160407		ANDA	ANDA040903	Proficient Rx LP	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-805_dcb1694a-8451-403c-b848-edb89ba17020	71205-805	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Proficient Rx LP	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-808_22f2294f-352a-4515-87c8-a6ae46e61322	71205-808	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-809_8e686832-1caf-425c-9ca6-7eaade43b6fe	71205-809	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	Proficient Rx LP	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-810_2b902590-982d-43cc-b3a4-52cd9f7edf6f	71205-810	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Proficient Rx LP	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
71205-811_f4da38af-c5bd-4d4a-a6f3-c2933f223809	71205-811	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20160902		ANDA	ANDA206116	Proficient Rx LP	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-812_922388b3-fc1c-46c6-b314-9049bd042df7	71205-812	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71205-813_e018e176-c4ec-42a2-9119-f1278cfa719a	71205-813	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
71205-814_2b9150ea-a876-4511-8d5b-aa72507ef863	71205-814	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	OINTMENT	TOPICAL	20190101		ANDA	ANDA210958	Proficient Rx LP	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-815_3c8c3d2b-9108-40fa-90d9-6ed545cf6549	71205-815	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Proficient Rx LP	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71205-816_a17f03ea-9375-48fe-be32-f8df509f5fba	71205-816	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Proficient Rx LP	PREGABALIN	75	mg/1		CV	N	20241231
71205-817_2c395111-c9c1-483e-a542-58b935ede689	71205-817	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Proficient Rx LP	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71205-818_6ec5b58c-65e9-47ee-b2ac-7d0b395a0630	71205-818	HUMAN PRESCRIPTION DRUG	prednisone		prednisone	TABLET	ORAL	20200624		ANDA	ANDA213386	Proficient Rx LP	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-819_8bd03bb2-3b9b-4707-a9a4-5618ddc3832f	71205-819	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Proficient Rx LP	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-820_76bbea68-52d8-4ba9-a772-0ba75a38f2eb	71205-820	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	Proficient Rx LP	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-821_490a7816-606c-47be-92ee-8af86da0999f	71205-821	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20221205		NDA AUTHORIZED GENERIC	NDA204623	Proficient Rx LP	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-822_0193c0a4-f595-609c-e063-6294a90aaa68	71205-822	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20150724		ANDA	ANDA201807	Proficient Rx LP	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-823_0221f0ce-11e7-171c-e063-6294a90af405	71205-823	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-824_f191b15c-7959-4aa6-a2ef-617cde77c918	71205-824	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Proficient Rx LP	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71205-825_89e3865c-1fe1-4f29-9606-8830df4bbe53	71205-825	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	Proficient Rx LP	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71205-826_85f973e0-93e6-4856-9266-62136acb2532	71205-826	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Proficient Rx LP	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71205-827_645fb912-479c-46de-b99c-4ea341bfd9ba	71205-827	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Proficient Rx LP	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-828_1d438989-6431-4c62-8f24-444475d423a3	71205-828	HUMAN PRESCRIPTION DRUG	FENOPROFEN CALCIUM		FENOPROFEN CALCIUM	CAPSULE	ORAL	20220801		ANDA	ANDA214475	Proficient Rx LP	FENOPROFEN CALCIUM	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-829_8427eee0-955d-4718-b259-73dab56d36d2	71205-829	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070924	Proficient Rx LP	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-830_416ce231-fc8d-4ba0-a1ce-d5e054cf025e	71205-830	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Proficient Rx LP	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71205-831_4aed57d0-99d8-424e-a1c7-0cd8a31a66cf	71205-831	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Proficient Rx LP	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
71205-832_ea61ffd1-0610-4264-b964-00a9f4485d36	71205-832	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Proficient Rx LP	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
71205-834_a368117c-0e80-4dbc-a0a7-9b88dbfeece3	71205-834	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Proficient Rx LP	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
71205-835_39d3b5c1-b374-443e-abf9-3b202bc9abef	71205-835	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71205-836_39d3b5c1-b374-443e-abf9-3b202bc9abef	71205-836	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
71205-837_bc22941e-d2e7-4165-91ea-7239c8b9882d	71205-837	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Proficient Rx LP	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-838_bc22941e-d2e7-4165-91ea-7239c8b9882d	71205-838	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Proficient Rx LP	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-839_bc22941e-d2e7-4165-91ea-7239c8b9882d	71205-839	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Proficient Rx LP	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-840_bc22941e-d2e7-4165-91ea-7239c8b9882d	71205-840	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20220801		ANDA	ANDA215848	Proficient Rx LP	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-841_96322bdc-2183-413b-b7d4-c7192ba7666c	71205-841	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Proficient Rx LP	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-842_96322bdc-2183-413b-b7d4-c7192ba7666c	71205-842	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Proficient Rx LP	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-843_96322bdc-2183-413b-b7d4-c7192ba7666c	71205-843	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Proficient Rx LP	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-844_96322bdc-2183-413b-b7d4-c7192ba7666c	71205-844	HUMAN PRESCRIPTION DRUG	PERPHENAZINE		PERPHENAZINE	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA205056	Proficient Rx LP	PERPHENAZINE	16	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71205-845_6cf88fef-0c82-4d5d-85e8-5896ac013165	71205-845	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	15	mg/1		CIV	N	20241231
71205-846_47b5e7d0-f031-4f6c-a496-c92f9f972f53	71205-846	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
71205-847_47b5e7d0-f031-4f6c-a496-c92f9f972f53	71205-847	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
71205-848_6cf88fef-0c82-4d5d-85e8-5896ac013165	71205-848	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	60	mg/1		CIV	N	20241231
71205-849_47b5e7d0-f031-4f6c-a496-c92f9f972f53	71205-849	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
71205-850_47b5e7d0-f031-4f6c-a496-c92f9f972f53	71205-850	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
71205-851_6cf88fef-0c82-4d5d-85e8-5896ac013165	71205-851	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	100	mg/1		CIV	N	20241231
71205-852_34d3c103-27b8-454b-9f38-c33157c3b6fc	71205-852	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Proficient Rx LP	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
71205-853_45d9b32a-3198-49d5-addf-f077fec50b9c	71205-853	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-854_203cd13e-8c8d-4782-9e5a-2f9d1b20dd42	71205-854	HUMAN PRESCRIPTION DRUG	ACARBOSE		ACARBOSE	TABLET	ORAL	20150201		ANDA	ANDA091343	Proficient Rx LP	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71205-855_203cd13e-8c8d-4782-9e5a-2f9d1b20dd42	71205-855	HUMAN PRESCRIPTION DRUG	ACARBOSE		ACARBOSE	TABLET	ORAL	20150201		ANDA	ANDA091343	Proficient Rx LP	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71205-856_203cd13e-8c8d-4782-9e5a-2f9d1b20dd42	71205-856	HUMAN PRESCRIPTION DRUG	ACARBOSE		ACARBOSE	TABLET	ORAL	20150201		ANDA	ANDA091343	Proficient Rx LP	ACARBOSE	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71205-857_ffd82a69-a64c-4399-8f5d-bddc70cdc3cf	71205-857	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		ANDA	ANDA091281	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-858_ffd82a69-a64c-4399-8f5d-bddc70cdc3cf	71205-858	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190301		ANDA	ANDA091281	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	30	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-859_ef010b85-c2f8-44ca-8042-a10df89dcae3	71205-859	HUMAN PRESCRIPTION DRUG	metformin hydrochloride		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211101		ANDA	ANDA213247	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-860_ef010b85-c2f8-44ca-8042-a10df89dcae3	71205-860	HUMAN PRESCRIPTION DRUG	metformin hydrochloride		metformin hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211101		ANDA	ANDA213247	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-861_9e103cf9-f075-48ba-8913-2e44f9442781	71205-861	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20070419		ANDA	ANDA078214	Proficient Rx LP	DANAZOL	100	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
71205-862_9e103cf9-f075-48ba-8913-2e44f9442781	71205-862	HUMAN PRESCRIPTION DRUG	Danazol		Danazol	CAPSULE	ORAL	20050928		ANDA	ANDA077246	Proficient Rx LP	DANAZOL	200	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]		N	20241231
71205-863_49b9759a-c1b9-4ebe-874b-81fb82a42755	71205-863	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, COATED	ORAL	20211108		ANDA	ANDA207842	Proficient Rx LP	EPLERENONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71205-864_49b9759a-c1b9-4ebe-874b-81fb82a42755	71205-864	HUMAN PRESCRIPTION DRUG	Eplerenone		Eplerenone	TABLET, COATED	ORAL	20211108		ANDA	ANDA207842	Proficient Rx LP	EPLERENONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71205-865_47a851b9-3e7f-4271-a2b8-ce836579729b	71205-865	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20210715		ANDA	ANDA205143	Proficient Rx LP	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
71205-866_47a851b9-3e7f-4271-a2b8-ce836579729b	71205-866	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Misoprostol		Diclofenac Sodium and Misoprostol	TABLET, DELAYED RELEASE	ORAL	20210715		ANDA	ANDA205143	Proficient Rx LP	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
71205-867_278d3fa3-3304-43dc-8a2a-a463c8ae9e9d	71205-867	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210824		ANDA	ANDA211829	Proficient Rx LP	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71205-868_278d3fa3-3304-43dc-8a2a-a463c8ae9e9d	71205-868	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210824		ANDA	ANDA211829	Proficient Rx LP	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71205-869_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-869	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	25	mg/1		CV	N	20241231
71205-870_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-870	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	50	mg/1		CV	N	20241231
71205-871_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-871	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	75	mg/1		CV	N	20241231
71205-872_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-872	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	100	mg/1		CV	N	20241231
71205-873_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-873	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	150	mg/1		CV	N	20241231
71205-874_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-874	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	200	mg/1		CV	N	20241231
71205-875_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-875	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	225	mg/1		CV	N	20241231
71205-876_1815296c-fc89-41c8-9079-ffb947b59b0f	71205-876	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	300	mg/1		CV	N	20241231
71205-877_a704c66b-9765-4219-868d-36e04628fe23	71205-877	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210930		ANDA	ANDA214092	Proficient Rx LP	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
71205-878_a704c66b-9765-4219-868d-36e04628fe23	71205-878	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210930		ANDA	ANDA214092	Proficient Rx LP	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
71205-879_a704c66b-9765-4219-868d-36e04628fe23	71205-879	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210930		ANDA	ANDA214092	Proficient Rx LP	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
71205-880_cb0d9a15-fb02-4393-bdf7-a88dc4b42d6a	71205-880	HUMAN PRESCRIPTION DRUG	Levetiracetam	ER	Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210930		ANDA	ANDA205130	Proficient Rx LP	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-881_cb0d9a15-fb02-4393-bdf7-a88dc4b42d6a	71205-881	HUMAN PRESCRIPTION DRUG	Levetiracetam	ER	Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210930		ANDA	ANDA205130	Proficient Rx LP	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-882_27a10d92-3e03-4881-9b8f-7d0ee57cb744	71205-882	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Proficient Rx LP	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-883_27a10d92-3e03-4881-9b8f-7d0ee57cb744	71205-883	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Proficient Rx LP	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-884_27a10d92-3e03-4881-9b8f-7d0ee57cb744	71205-884	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		METFORMIN HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20171121		ANDA	ANDA203769	Proficient Rx LP	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71205-885_bd2c318d-dbe8-40ee-86fe-b9f604dbf672	71205-885	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210802		ANDA	ANDA091310	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-886_bd2c318d-dbe8-40ee-86fe-b9f604dbf672	71205-886	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20210802		ANDA	ANDA091310	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-887_65edfa43-d933-4390-bec4-b448916e4d5a	71205-887	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-888_a8be3ead-1645-4f63-8683-46e29fdb3041	71205-888	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	CAPSULE	ORAL	20190402		ANDA	ANDA206803	Proficient Rx LP	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
71205-889_d331f550-cbeb-424c-ae6d-1b45dbe3c061	71205-889	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
71205-890_886f2c7d-6a6e-4d73-bbbd-61cff9514a87	71205-890	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	30	mg/1		CIV	N	20241231
71205-891_d331f550-cbeb-424c-ae6d-1b45dbe3c061	71205-891	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
71205-892_d331f550-cbeb-424c-ae6d-1b45dbe3c061	71205-892	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
71205-893_d331f550-cbeb-424c-ae6d-1b45dbe3c061	71205-893	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190521		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
71205-894_d384cafa-d9d7-40b1-a28a-9ac428a3ad51	71205-894	HUMAN PRESCRIPTION DRUG	DIPYRIDAMOLE		DIPYRIDAMOLE	TABLET, FILM COATED	ORAL	20070805		ANDA	ANDA040733	Proficient Rx LP	DIPYRIDAMOLE	25	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-895_d384cafa-d9d7-40b1-a28a-9ac428a3ad51	71205-895	HUMAN PRESCRIPTION DRUG	DIPYRIDAMOLE		DIPYRIDAMOLE	TABLET, FILM COATED	ORAL	20070213		ANDA	ANDA040733	Proficient Rx LP	DIPYRIDAMOLE	50	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-896_d384cafa-d9d7-40b1-a28a-9ac428a3ad51	71205-896	HUMAN PRESCRIPTION DRUG	DIPYRIDAMOLE		DIPYRIDAMOLE	TABLET, FILM COATED	ORAL	20070213		ANDA	ANDA040733	Proficient Rx LP	DIPYRIDAMOLE	75	mg/1	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
71205-897_895c4679-030d-47a8-96b0-394133d04998	71205-897	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20161018		ANDA	ANDA071611	Proficient Rx LP	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71205-898_f5ac6375-7f17-4d27-b13a-b44e73281838	71205-898	HUMAN PRESCRIPTION DRUG	Albuterol		albuterol	TABLET	ORAL	20180629		ANDA	ANDA207046	Proficient Rx LP	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-899_f5ac6375-7f17-4d27-b13a-b44e73281838	71205-899	HUMAN PRESCRIPTION DRUG	Albuterol		albuterol	TABLET	ORAL	20180629		ANDA	ANDA207046	Proficient Rx LP	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71205-900_9c01bd10-78e5-4785-858e-ececd310fb3c	71205-900	HUMAN PRESCRIPTION DRUG	Darifenacin 7.5 mg		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA209571	Proficient Rx LP	DARIFENACIN HYDROBROMIDE	7.5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-901_9c01bd10-78e5-4785-858e-ececd310fb3c	71205-901	HUMAN PRESCRIPTION DRUG	Darifenacin 15 mg		Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20210430		ANDA	ANDA209571	Proficient Rx LP	DARIFENACIN HYDROBROMIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-902_eb911dcf-c635-4133-9d70-db58b6636a97	71205-902	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Proficient Rx LP	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71205-903_eb911dcf-c635-4133-9d70-db58b6636a97	71205-903	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Proficient Rx LP	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71205-904_fac1a712-e714-4137-8604-2ba0f048901c	71205-904	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Proficient Rx LP	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71205-905_fac1a712-e714-4137-8604-2ba0f048901c	71205-905	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Proficient Rx LP	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71205-906_fac1a712-e714-4137-8604-2ba0f048901c	71205-906	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		midodrine hydrochloride	TABLET	ORAL	20201015		ANDA	ANDA207849	Proficient Rx LP	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71205-907_f9c7393f-d347-4ae3-8771-8a3e3615510c	71205-907	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190220		ANDA	ANDA212977	Proficient Rx LP	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-908_349c3831-62bc-4f66-9c19-5185520af6c6	71205-908	HUMAN PRESCRIPTION DRUG	LEUCOVORIN CALCIUM		LEUCOVORIN CALCIUM	TABLET	ORAL	20201116		ANDA	ANDA213929	Proficient Rx LP	LEUCOVORIN CALCIUM	5	mg/1	Folate Analog [EPC], Folic Acid [CS]		N	20241231
71205-909_d6e4b4d5-8bf3-4e39-a1ad-c3ccca5fcab2	71205-909	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	Proficient Rx LP	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
71205-910_be10b430-6ed9-4241-b6d9-818846e80839	71205-910	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200310		ANDA	ANDA211364	Proficient Rx LP	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-911_be10b430-6ed9-4241-b6d9-818846e80839	71205-911	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200310		ANDA	ANDA211364	Proficient Rx LP	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-912_be10b430-6ed9-4241-b6d9-818846e80839	71205-912	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200310		ANDA	ANDA211364	Proficient Rx LP	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71205-913_b78a6505-03e7-4f18-89ef-737f807df7c2	71205-913	HUMAN PRESCRIPTION DRUG	FOLIC ACID		FOLIC ACID	TABLET	ORAL	20090112		ANDA	ANDA040796	Proficient Rx LP	FOLIC ACID	1	mg/1			N	20241231
71205-914_40b473bd-d806-4631-a7ff-58ccc51fd201	71205-914	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Proficient Rx LP	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-915_40b473bd-d806-4631-a7ff-58ccc51fd201	71205-915	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Proficient Rx LP	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71205-916_125ca13e-9784-45be-847a-6fdf9875bd6a	71205-916	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20201221		ANDA	ANDA211735	Proficient Rx LP	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
71205-917_a429ee21-0214-4c69-a264-352ecd758d87	71205-917	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200819		ANDA	ANDA213185	Proficient Rx LP	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-918_c90ef143-aff7-41d6-9171-3e5e7bb6e97e	71205-918	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20201001		ANDA	ANDA213186	Proficient Rx LP	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
71205-920_06c9bc5a-7a0f-483d-bd5c-61768db340bb	71205-920	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Proficient Rx LP	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-921_06c9bc5a-7a0f-483d-bd5c-61768db340bb	71205-921	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Proficient Rx LP	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-922_06c9bc5a-7a0f-483d-bd5c-61768db340bb	71205-922	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Proficient Rx LP	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-923_24995687-1075-4f4b-a198-460fd1f8b7d9	71205-923	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Proficient Rx LP	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-924_24995687-1075-4f4b-a198-460fd1f8b7d9	71205-924	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Proficient Rx LP	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-928_dc28cbd4-d236-4c09-93e9-a6088c0d2b4a	71205-928	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-929_dc28cbd4-d236-4c09-93e9-a6088c0d2b4a	71205-929	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-930_dc28cbd4-d236-4c09-93e9-a6088c0d2b4a	71205-930	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160401		ANDA	ANDA204989	Proficient Rx LP	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-931_26bd4975-008b-4029-b0da-3a75b0f7e0f4	71205-931	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160411		ANDA	ANDA205101	Proficient Rx LP	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-932_26bd4975-008b-4029-b0da-3a75b0f7e0f4	71205-932	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160411		ANDA	ANDA205101	Proficient Rx LP	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71205-933_53c1701c-04cf-4256-9fe0-4c08490e4f30	71205-933	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succiate	TABLET, FILM COATED	ORAL	20201122		ANDA	ANDA210281	Proficient Rx LP	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-934_53c1701c-04cf-4256-9fe0-4c08490e4f30	71205-934	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		solifenacin succinate	TABLET, FILM COATED	ORAL	20201122		ANDA	ANDA210281	Proficient Rx LP	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-935_c8003a86-3d92-4acb-b8b8-fe52835c83f5	71205-935	HUMAN PRESCRIPTION DRUG	Miglitol		Miglitol	TABLET, COATED	ORAL	20210115		ANDA	ANDA203965	Proficient Rx LP	MIGLITOL	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71205-936_c8003a86-3d92-4acb-b8b8-fe52835c83f5	71205-936	HUMAN PRESCRIPTION DRUG	Miglitol		Miglitol	TABLET, COATED	ORAL	20210115		ANDA	ANDA203965	Proficient Rx LP	MIGLITOL	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71205-937_c8003a86-3d92-4acb-b8b8-fe52835c83f5	71205-937	HUMAN PRESCRIPTION DRUG	Miglitol		Miglitol	TABLET, COATED	ORAL	20210115		ANDA	ANDA203965	Proficient Rx LP	MIGLITOL	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71205-938_9f8ee6b8-61e1-478a-90de-57358fdb5905	71205-938	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20200713		ANDA	ANDA211832	Proficient Rx LP	TERBUTALINE SULFATE	2.5	mg/1			N	20241231
71205-939_9f8ee6b8-61e1-478a-90de-57358fdb5905	71205-939	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	TABLET	ORAL	20200713		ANDA	ANDA211832	Proficient Rx LP	TERBUTALINE SULFATE	5	mg/1			N	20241231
71205-940_3b289523-f57e-4424-a3ff-d82aeea7a3a2	71205-940	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	Proficient Rx LP	PROPAFENONE HYDROCHLORIDE	225	mg/1	Antiarrhythmic [EPC]		N	20241231
71205-941_3b289523-f57e-4424-a3ff-d82aeea7a3a2	71205-941	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	Proficient Rx LP	PROPAFENONE HYDROCHLORIDE	325	mg/1	Antiarrhythmic [EPC]		N	20241231
71205-942_3b289523-f57e-4424-a3ff-d82aeea7a3a2	71205-942	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		propafenone	CAPSULE, EXTENDED RELEASE	ORAL	20200713		ANDA	ANDA212928	Proficient Rx LP	PROPAFENONE HYDROCHLORIDE	425	mg/1	Antiarrhythmic [EPC]		N	20241231
71205-943_e9000264-858a-4fcd-af09-21460169305d	71205-943	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	SUSPENSION	ORAL	20150301		ANDA	ANDA203139	Proficient Rx LP	MEGESTROL ACETATE	125	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
71205-944_6de48883-f40b-4aef-83d4-6acb86c1b11e	71205-944	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	Proficient Rx LP	GUANFACINE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-945_6de48883-f40b-4aef-83d4-6acb86c1b11e	71205-945	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	Proficient Rx LP	GUANFACINE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-946_6de48883-f40b-4aef-83d4-6acb86c1b11e	71205-946	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	Proficient Rx LP	GUANFACINE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-947_6de48883-f40b-4aef-83d4-6acb86c1b11e	71205-947	HUMAN PRESCRIPTION DRUG	Guanfacine	Extended-Release	Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20170707		ANDA	ANDA201408	Proficient Rx LP	GUANFACINE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71205-948_b974cd85-fbe8-40e4-89a7-b6c6845172e1	71205-948	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20150301		ANDA	ANDA203104	Proficient Rx LP	DONEPEZIL HYDROCHLORIDE	23	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71205-949_7086101a-d52f-43a3-9fc3-70c2aa9487bf	71205-949	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20200423		ANDA	ANDA207803	Proficient Rx LP	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71205-950_6f3bb5f2-1863-4940-aea3-a67ed756c945	71205-950	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Proficient Rx LP	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71205-951_6f3bb5f2-1863-4940-aea3-a67ed756c945	71205-951	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Proficient Rx LP	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71205-952_6f3bb5f2-1863-4940-aea3-a67ed756c945	71205-952	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Proficient Rx LP	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71205-953_6f3bb5f2-1863-4940-aea3-a67ed756c945	71205-953	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Proficient Rx LP	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71205-954_6f3bb5f2-1863-4940-aea3-a67ed756c945	71205-954	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Proficient Rx LP	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71205-955_6f3bb5f2-1863-4940-aea3-a67ed756c945	71205-955	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Proficient Rx LP	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71205-959_703a7b68-480c-4f73-9f29-ba86ce95eab3	71205-959	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Proficient Rx LP	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-960_703a7b68-480c-4f73-9f29-ba86ce95eab3	71205-960	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Proficient Rx LP	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-961_1a641881-7f74-4619-bb54-5030bdb79fc1	71205-961	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	Proficient Rx LP	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
71205-962_52089539-a130-4592-8449-b5c792020a2c	71205-962	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	CAPSULE	ORAL	20170804		ANDA	ANDA206615	Proficient Rx LP	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
71205-963_ba67d6b0-f638-4264-9bd4-1557223abe83	71205-963	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Proficient Rx LP	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-964_ba67d6b0-f638-4264-9bd4-1557223abe83	71205-964	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Proficient Rx LP	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-965_ba67d6b0-f638-4264-9bd4-1557223abe83	71205-965	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Proficient Rx LP	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71205-966_2622332c-bf61-49c2-92b0-cc7dd09f62ca	71205-966	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate		Sevelamer Carbonate	TABLET, FILM COATED	ORAL	20190930		ANDA	ANDA200959	Proficient Rx LP	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
71205-967_f2be86a1-5401-4b68-a675-95b44c43a5f6	71205-967	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	Proficient Rx LP	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-968_f2be86a1-5401-4b68-a675-95b44c43a5f6	71205-968	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	Proficient Rx LP	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71205-970_8678a3ee-0e2c-4c95-ad2e-83aa601f3238	71205-970	HUMAN OTC DRUG	Senna-S		Sennosides 8.6mg and Docusate Sodium 50mg	TABLET, FILM COATED	ORAL	20181105		OTC MONOGRAPH NOT FINAL	part334	Proficient Rx LP	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
71205-971_492a0004-9824-4df9-ab03-a46953aa4fdb	71205-971	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040627	Proficient Rx LP	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-972_492a0004-9824-4df9-ab03-a46953aa4fdb	71205-972	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040749	Proficient Rx LP	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71205-973_5b4b36dd-da60-47de-a2c1-517a52ab3549	71205-973	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		lidocaine hydrochloride	CREAM	TOPICAL	20190819		UNAPPROVED DRUG OTHER		Proficient Rx LP	LIDOCAINE HYDROCHLORIDE	30	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71205-974_14464dfb-94a5-43a1-923e-d462b7ade131	71205-974	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-975_14464dfb-94a5-43a1-923e-d462b7ade131	71205-975	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-976_43ed7a9a-0aaf-4987-8367-e2490d1b8448	71205-976	HUMAN PRESCRIPTION DRUG	Hydrocortisone Acetate		Hydrocortisone Acetate	SUPPOSITORY	RECTAL	20200205		UNAPPROVED DRUG OTHER		Proficient Rx LP	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71205-977_40ce485f-575c-4c51-8058-83b10a8ddac7	71205-977	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190925		ANDA	ANDA078420	Proficient Rx LP	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-978_40ce485f-575c-4c51-8058-83b10a8ddac7	71205-978	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190925		ANDA	ANDA078420	Proficient Rx LP	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-979_14464dfb-94a5-43a1-923e-d462b7ade131	71205-979	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20190925		ANDA	ANDA204597	Proficient Rx LP	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71205-980_de70d380-0d76-4f67-b64a-dbd848f45620	71205-980	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190607		ANDA	ANDA203561	Proficient Rx LP	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71205-981_c57a5247-126f-480e-8aab-a992be294dc0	71205-981	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20190305		ANDA	ANDA209587	Proficient Rx LP	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
71205-982_9ac60e91-481e-4681-83d6-f0c62114f627	71205-982	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET, FILM COATED	ORAL	20170824		UNAPPROVED DRUG OTHER		Proficient Rx LP	SALSALATE	500	mg/1			N	20241231
71205-983_9ac60e91-481e-4681-83d6-f0c62114f627	71205-983	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET, FILM COATED	ORAL	20170824		UNAPPROVED DRUG OTHER		Proficient Rx LP	SALSALATE	750	mg/1			N	20241231
71205-984_f35ea0c8-7b13-4fe6-9b43-2bbcb916250d	71205-984	HUMAN PRESCRIPTION DRUG	Omeprazole/Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE, GELATIN COATED	ORAL	20180727		ANDA	ANDA207476	Proficient Rx LP	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-985_f35ea0c8-7b13-4fe6-9b43-2bbcb916250d	71205-985	HUMAN PRESCRIPTION DRUG	Omeprazole/Bicarbonate		Omeprazole and Sodium Bicarbonate	CAPSULE, GELATIN COATED	ORAL	20180727		ANDA	ANDA207476	Proficient Rx LP	OMEPRAZOLE; SODIUM BICARBONATE	40; 1100	mg/1; mg/1	Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71205-986_b4c66056-a377-4e1a-8708-283ab85b2fb3	71205-986	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190925		ANDA	ANDA211657	Proficient Rx LP	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-987_b4c66056-a377-4e1a-8708-283ab85b2fb3	71205-987	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190925		ANDA	ANDA211657	Proficient Rx LP	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71205-988_7e56c9c2-6e34-4775-bb35-4a70f6189783	71205-988	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20190919		ANDA	ANDA203646	Proficient Rx LP	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71205-989_1d3ad701-5b69-4cac-a08b-8e694adaf9a1	71205-989	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20200106		ANDA	ANDA207555	Proficient Rx LP	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
71205-990_e07a6489-40fc-4208-b246-6e6b4564f448	71205-990	HUMAN OTC DRUG	Pharbetol		Acetaminophen	TABLET	ORAL	20060110		OTC MONOGRAPH NOT FINAL	part343	Proficient Rx LP	ACETAMINOPHEN	500	mg/1			N	20241231
71205-991_38aee69e-e66f-42b1-814a-551742b1a9cd	71205-991	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Proficient Rx LP	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-992_e637904d-8af6-47fe-b10e-db813d5531bc	71205-992	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Proficient Rx LP	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-993_e637904d-8af6-47fe-b10e-db813d5531bc	71205-993	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Proficient Rx LP	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-994_e637904d-8af6-47fe-b10e-db813d5531bc	71205-994	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Proficient Rx LP	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71205-995_38aee69e-e66f-42b1-814a-551742b1a9cd	71205-995	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Proficient Rx LP	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71205-996_21547c5d-6d3e-41c3-b426-2df82f01fbeb	71205-996	HUMAN PRESCRIPTION DRUG	Potassium chloride extended release		Potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20151211		ANDA	ANDA205993	Proficient Rx LP	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71205-997_1c1b4148-3301-4ab7-8955-667658b4c133	71205-997	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Proficient Rx LP	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71205-998_a4c41d5c-157d-4350-a4b3-b61f9650372d	71205-998	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71205-999_a4c41d5c-157d-4350-a4b3-b61f9650372d	71205-999	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
71207-100_b3e5758e-a314-43fc-aabf-d0c5b9b430be	71207-100	HUMAN OTC DRUG	TriCalm	Hydrogel	Aluminum Acetate	GEL	TOPICAL	20131101		OTC MONOGRAPH FINAL	part347	Modular Thermal Technologies LLC Dba Life Wear Technologies	ALUMINUM ACETATE	2	mg/mL			N	20241231
71207-221_082c6441-be48-4466-e063-6394a90ad500	71207-221	HUMAN OTC DRUG	Tricalm Hydrogel		Aluminum acetate	GEL	TOPICAL	20230102		OTC MONOGRAPH DRUG	M016	MODULAR THERMAL TECHNOLOGIES LLC DBA LIFE WEAR TECHNOLOGIES	ALUMINUM ACETATE	.2	g/100g			N	20241231
71207-461_0a0ae5ba-9fab-45f6-e063-6294a90ad555	71207-461	HUMAN OTC DRUG	Cryomax Cooling		Menthol	GEL	TOPICAL	20230201		OTC MONOGRAPH DRUG	M017	LIFE WEAR TECHNOLOGIES	MENTHOL, (+)-	9.5	g/100g			N	20241231
71209-004_6c578367-5e2d-4c93-bfca-3931966f25b0	71209-004	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20151229		ANDA	ANDA201445	Cadila Pharmaceuticals Limited	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71209-005_9cab01a6-5be4-40ce-91e4-d05df76f7659	71209-005	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20170323		ANDA	ANDA202168	Cadila Pharmaceuticals Limited	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71209-006_9cab01a6-5be4-40ce-91e4-d05df76f7659	71209-006	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20170323		ANDA	ANDA202168	Cadila Pharmaceuticals Limited	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71209-007_fdcdd5ea-a352-4b01-a972-2ed5a82e3a61	71209-007	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20181120		ANDA	ANDA202437	Cadila Pharmaceuticals Limited	FOLIC ACID	1	mg/1			N	20241231
71209-008_b3071718-e27b-4690-88dd-fc58a4fcbf41	71209-008	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20160617		ANDA	ANDA203266	Cadila Pharmaceuticals Limited	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71209-009_54461b9f-3232-47ce-9e73-a26ab1e44702	71209-009	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20140426		ANDA	ANDA203379	Cadila Pharmaceuticals Limited	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71209-010_54461b9f-3232-47ce-9e73-a26ab1e44702	71209-010	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20140426		ANDA	ANDA203379	Cadila Pharmaceuticals Limited	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71209-011_54461b9f-3232-47ce-9e73-a26ab1e44702	71209-011	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20140426		ANDA	ANDA203379	Cadila Pharmaceuticals Limited	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71209-012_862f0b42-695e-4170-983d-cfb848967cf3	71209-012	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20140211		ANDA	ANDA203844	Cadila Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71209-013_862f0b42-695e-4170-983d-cfb848967cf3	71209-013	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20140211		ANDA	ANDA203844	Cadila Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71209-014_862f0b42-695e-4170-983d-cfb848967cf3	71209-014	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20140211		ANDA	ANDA203844	Cadila Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71209-015_862f0b42-695e-4170-983d-cfb848967cf3	71209-015	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20140211		ANDA	ANDA203844	Cadila Pharmaceuticals Limited	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71209-016_4cdbf75c-b17f-4c40-bd7c-7b07668e9659	71209-016	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET	ORAL	20151229		ANDA	ANDA203845	Cadila Pharmaceuticals Limited	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71209-017_4cdbf75c-b17f-4c40-bd7c-7b07668e9659	71209-017	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET	ORAL	20151229		ANDA	ANDA203845	Cadila Pharmaceuticals Limited	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71209-018_4cdbf75c-b17f-4c40-bd7c-7b07668e9659	71209-018	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET	ORAL	20151229		ANDA	ANDA203845	Cadila Pharmaceuticals Limited	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71209-019_e33aac76-604d-43cb-8be4-d58ce3b2b6f8	71209-019	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20170130		ANDA	ANDA204609	Cadila Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71209-020_e33aac76-604d-43cb-8be4-d58ce3b2b6f8	71209-020	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20170130		ANDA	ANDA204609	Cadila Pharmaceuticals Limited	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71209-025_f6bcbdd6-db09-4aeb-8eb0-6eadb8ebdeba	71209-025	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		venlafaxine	TABLET	ORAL	20181203		ANDA	ANDA206250	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	25	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-026_f6bcbdd6-db09-4aeb-8eb0-6eadb8ebdeba	71209-026	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		venlafaxine	TABLET	ORAL	20181203		ANDA	ANDA206250	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-027_f6bcbdd6-db09-4aeb-8eb0-6eadb8ebdeba	71209-027	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		venlafaxine	TABLET	ORAL	20181203		ANDA	ANDA206250	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	50	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-028_f6bcbdd6-db09-4aeb-8eb0-6eadb8ebdeba	71209-028	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		venlafaxine	TABLET	ORAL	20181203		ANDA	ANDA206250	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-029_f6bcbdd6-db09-4aeb-8eb0-6eadb8ebdeba	71209-029	HUMAN PRESCRIPTION DRUG	VENLAFAXINE		venlafaxine	TABLET	ORAL	20181203		ANDA	ANDA206250	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	100	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-030_efa28dcf-77d5-4fb2-b6c0-4939a9bf4766	71209-030	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, COATED	ORAL	20140210		ANDA	ANDA206432	Cadila Pharmaceuticals Limited	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
71209-031_efa28dcf-77d5-4fb2-b6c0-4939a9bf4766	71209-031	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, COATED	ORAL	20140210		ANDA	ANDA206432	Cadila Pharmaceuticals Limited	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
71209-032_492cdacb-ff7d-457f-8747-10004f259a20	71209-032	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	25	mg/1		CV	N	20241231
71209-033_492cdacb-ff7d-457f-8747-10004f259a20	71209-033	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	50	mg/1		CV	N	20241231
71209-034_492cdacb-ff7d-457f-8747-10004f259a20	71209-034	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	75	mg/1		CV	N	20241231
71209-035_492cdacb-ff7d-457f-8747-10004f259a20	71209-035	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	100	mg/1		CV	N	20241231
71209-036_492cdacb-ff7d-457f-8747-10004f259a20	71209-036	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	150	mg/1		CV	N	20241231
71209-037_492cdacb-ff7d-457f-8747-10004f259a20	71209-037	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	200	mg/1		CV	N	20241231
71209-038_492cdacb-ff7d-457f-8747-10004f259a20	71209-038	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	225	mg/1		CV	N	20241231
71209-039_492cdacb-ff7d-457f-8747-10004f259a20	71209-039	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20230713		ANDA	ANDA206452	Cadila Pharmaceuticals Limited	PREGABALIN	300	mg/1		CV	N	20241231
71209-040_e0084be5-c7bb-4ea8-92d1-f8cba0ffea6a	71209-040	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20221215		ANDA	ANDA206993	Cadila Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71209-041_e0084be5-c7bb-4ea8-92d1-f8cba0ffea6a	71209-041	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20221215		ANDA	ANDA206993	Cadila Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71209-042_e0084be5-c7bb-4ea8-92d1-f8cba0ffea6a	71209-042	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20221215		ANDA	ANDA206993	Cadila Pharmaceuticals Limited	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71209-043_d3258367-6db2-4eb6-843f-0f6a143335b3	71209-043	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170324		ANDA	ANDA207453	Cadila Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-044_d3258367-6db2-4eb6-843f-0f6a143335b3	71209-044	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170324		ANDA	ANDA207453	Cadila Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-045_d3258367-6db2-4eb6-843f-0f6a143335b3	71209-045	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170324		ANDA	ANDA207453	Cadila Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-046_d3258367-6db2-4eb6-843f-0f6a143335b3	71209-046	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170324		ANDA	ANDA207453	Cadila Pharmaceuticals Limited	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-047_6c16c48d-a47f-467e-9717-31a7de738b1e	71209-047	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		verapamil hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170527		ANDA	ANDA206173	Cadila Pharmaceuticals Limited	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71209-048_6c16c48d-a47f-467e-9717-31a7de738b1e	71209-048	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		verapamil hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170527		ANDA	ANDA206173	Cadila Pharmaceuticals Limited	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71209-049_a19404d0-fd12-42ab-b469-b8c7d1d5e7eb	71209-049	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150205		ANDA	ANDA208605	Cadila Pharmaceuticals Limited	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71209-050_a19404d0-fd12-42ab-b469-b8c7d1d5e7eb	71209-050	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150205		ANDA	ANDA208605	Cadila Pharmaceuticals Limited	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71209-051_a19404d0-fd12-42ab-b469-b8c7d1d5e7eb	71209-051	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150205		ANDA	ANDA208605	Cadila Pharmaceuticals Limited	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71209-052_26357775-f8c4-496b-8fa5-0f85d47c59c7	71209-052	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20200116		ANDA	ANDA208606	Cadila Pharmaceuticals Limited	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71209-053_26357775-f8c4-496b-8fa5-0f85d47c59c7	71209-053	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20200116		ANDA	ANDA208606	Cadila Pharmaceuticals Limited	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71209-054_a90b33c2-cdd6-4c1d-997f-7663840d6c82	71209-054	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151209		ANDA	ANDA208701	Cadila Pharmaceuticals Limited	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71209-055_a90b33c2-cdd6-4c1d-997f-7663840d6c82	71209-055	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151208		ANDA	ANDA208701	Cadila Pharmaceuticals Limited	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71209-056_a90b33c2-cdd6-4c1d-997f-7663840d6c82	71209-056	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151215		ANDA	ANDA208701	Cadila Pharmaceuticals Limited	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71209-057_a90b33c2-cdd6-4c1d-997f-7663840d6c82	71209-057	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20151215		ANDA	ANDA208701	Cadila Pharmaceuticals Limited	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71209-058_0ab335f1-2089-496b-b65f-02c697f6ee89	71209-058	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Cadila Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71209-059_0ab335f1-2089-496b-b65f-02c697f6ee89	71209-059	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Cadila Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71209-060_0ab335f1-2089-496b-b65f-02c697f6ee89	71209-060	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Cadila Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71209-061_0ab335f1-2089-496b-b65f-02c697f6ee89	71209-061	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Cadila Pharmaceuticals Limited	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71209-062_3a0ace67-c888-489d-ba8b-ec5ef9e2402d	71209-062	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20171229		ANDA	ANDA209794	Cadila Pharmaceuticals Limited	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
71209-063_3a0ace67-c888-489d-ba8b-ec5ef9e2402d	71209-063	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20171229		ANDA	ANDA209794	Cadila Pharmaceuticals Limited	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
71209-064_c938681c-42b4-4628-b186-827292d9e31f	71209-064	HUMAN PRESCRIPTION DRUG	Tizanidine hydrochloride		Tizanidine hydrochloride	CAPSULE	ORAL	20171229		ANDA	ANDA210021	Cadila Pharmaceuticals Limited	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71209-065_c938681c-42b4-4628-b186-827292d9e31f	71209-065	HUMAN PRESCRIPTION DRUG	Tizanidine hydrochloride		Tizanidine hydrochloride	CAPSULE	ORAL	20171229		ANDA	ANDA210021	Cadila Pharmaceuticals Limited	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71209-066_c938681c-42b4-4628-b186-827292d9e31f	71209-066	HUMAN PRESCRIPTION DRUG	Tizanidine hydrochloride		Tizanidine hydrochloride	CAPSULE	ORAL	20171229		ANDA	ANDA210021	Cadila Pharmaceuticals Limited	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71209-073_821c2f70-c608-4f85-bad9-de2179f6477e	71209-073	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20190213		ANDA	ANDA210022	Cadila Pharmaceuticals Limited	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71209-074_821c2f70-c608-4f85-bad9-de2179f6477e	71209-074	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20190213		ANDA	ANDA210022	Cadila Pharmaceuticals Limited	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71209-075_821c2f70-c608-4f85-bad9-de2179f6477e	71209-075	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20190213		ANDA	ANDA210022	Cadila Pharmaceuticals Limited	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71209-076_821c2f70-c608-4f85-bad9-de2179f6477e	71209-076	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20190213		ANDA	ANDA210022	Cadila Pharmaceuticals Limited	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71209-077_821c2f70-c608-4f85-bad9-de2179f6477e	71209-077	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20190213		ANDA	ANDA210022	Cadila Pharmaceuticals Limited	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71209-078_821c2f70-c608-4f85-bad9-de2179f6477e	71209-078	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20190213		ANDA	ANDA210022	Cadila Pharmaceuticals Limited	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71209-082_14d4c334-b49d-4479-a91e-20b7276b4eca	71209-082	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, COATED	ORAL	20171230		ANDA	ANDA211324	Cadila Pharmaceuticals Limited	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71209-083_72d9c230-fb71-4b4b-a4d2-01bf96153ec2	71209-083	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20180529		ANDA	ANDA211325	Cadila Pharmaceuticals Limited	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71209-084_72d9c230-fb71-4b4b-a4d2-01bf96153ec2	71209-084	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20180305		ANDA	ANDA211325	Cadila Pharmaceuticals Limited	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71209-085_72d9c230-fb71-4b4b-a4d2-01bf96153ec2	71209-085	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20180305		ANDA	ANDA211325	Cadila Pharmaceuticals Limited	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71209-087_32b3a6ee-bc86-4e7a-946c-86c78846d6dd	71209-087	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, COATED	ORAL	20180105		ANDA	ANDA211323	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-088_32b3a6ee-bc86-4e7a-946c-86c78846d6dd	71209-088	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, COATED	ORAL	20180105		ANDA	ANDA211323	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-089_32b3a6ee-bc86-4e7a-946c-86c78846d6dd	71209-089	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET, COATED	ORAL	20180105		ANDA	ANDA211323	Cadila Pharmaceuticals Limited	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71209-090_52976064-9b0b-4455-aea9-97f1806e19a9	71209-090	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, COATED	ORAL	20180706		ANDA	ANDA212103	Cadila Pharmaceuticals Limited	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-091_52976064-9b0b-4455-aea9-97f1806e19a9	71209-091	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, COATED	ORAL	20180706		ANDA	ANDA212103	Cadila Pharmaceuticals Limited	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-092_52976064-9b0b-4455-aea9-97f1806e19a9	71209-092	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, COATED	ORAL	20180706		ANDA	ANDA212103	Cadila Pharmaceuticals Limited	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-093_52976064-9b0b-4455-aea9-97f1806e19a9	71209-093	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, COATED	ORAL	20180706		ANDA	ANDA212103	Cadila Pharmaceuticals Limited	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71209-094_eee2ebc5-123b-40b9-ad01-3bf5b1cb5422	71209-094	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200214		ANDA	ANDA212645	Cadila Pharmaceuticals Limited	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71209-095_eee2ebc5-123b-40b9-ad01-3bf5b1cb5422	71209-095	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200214		ANDA	ANDA212645	Cadila Pharmaceuticals Limited	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71209-096_eee2ebc5-123b-40b9-ad01-3bf5b1cb5422	71209-096	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200214		ANDA	ANDA212645	Cadila Pharmaceuticals Limited	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71209-097_93bc4da5-194f-4693-b466-aa5efabc9cb5	71209-097	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, FILM COATED	ORAL	20151229		ANDA	ANDA091656	Cadila Pharmaceuticals Limited	OFLOXACIN	200	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71209-098_93bc4da5-194f-4693-b466-aa5efabc9cb5	71209-098	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, FILM COATED	ORAL	20151229		ANDA	ANDA091656	Cadila Pharmaceuticals Limited	OFLOXACIN	300	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71209-099_93bc4da5-194f-4693-b466-aa5efabc9cb5	71209-099	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, FILM COATED	ORAL	20151229		ANDA	ANDA091656	Cadila Pharmaceuticals Limited	OFLOXACIN	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71209-100_feeef834-a0cb-482c-b5bc-078be4f94e38	71209-100	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20211006		ANDA	ANDA213628	Cadila Pharmaceuticals Limited	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
71209-101_feeef834-a0cb-482c-b5bc-078be4f94e38	71209-101	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20211006		ANDA	ANDA213628	Cadila Pharmaceuticals Limited	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
71209-102_f9139eef-80df-428d-a326-a70cc827f9c9	71209-102	HUMAN PRESCRIPTION DRUG	Erythromycin ethylsuccinate		Erythromycin ethylsuccinate	FOR SUSPENSION	ORAL	20221121		ANDA	ANDA216212	Cadila Pharmaceuticals Limited	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
71209-103_f9139eef-80df-428d-a326-a70cc827f9c9	71209-103	HUMAN PRESCRIPTION DRUG	Erythromycin ethylsuccinate		Erythromycin ethylsuccinate	FOR SUSPENSION	ORAL	20221121		ANDA	ANDA216212	Cadila Pharmaceuticals Limited	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
71209-104_6c16c48d-a47f-467e-9717-31a7de738b1e	71209-104	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		verapamil hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170527		ANDA	ANDA206173	Cadila Pharmaceuticals Limited	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71209-106_1e60dee8-60e4-4be9-9da1-e114bbb4109b	71209-106	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20231201		ANDA	ANDA218045	Cadila Pharmaceuticals Limited	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71209-107_1e60dee8-60e4-4be9-9da1-e114bbb4109b	71209-107	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20231201		ANDA	ANDA218045	Cadila Pharmaceuticals Limited	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71209-108_1e60dee8-60e4-4be9-9da1-e114bbb4109b	71209-108	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20231201		ANDA	ANDA218045	Cadila Pharmaceuticals Limited	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71212-100_f2945104-e3b2-66a0-e053-2995a90a758a	71212-100	HUMAN OTC DRUG	ChemStation E3 Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20170308		OTC MONOGRAPH NOT FINAL	part333E	Chemstation	ALCOHOL	710	g/L			N	20241231
71212-101_f2945104-e3b3-66a0-e053-2995a90a758a	71212-101	HUMAN OTC DRUG	Chemstation HACCP Q E2		Benzalkonium Chloride	LIQUID	TOPICAL	20170308		OTC MONOGRAPH NOT FINAL	part333E	ChemStation	BENZALKONIUM CHLORIDE	1.2	g/L			N	20241231
71212-102_f2945edb-2f71-c7d5-e053-2995a90ad450	71212-102	HUMAN OTC DRUG	Chemstation Q E2		Benzalkonium Chloride	LIQUID	TOPICAL	20170308		OTC MONOGRAPH NOT FINAL	part333E	Chemstation	BENZALKONIUM CHLORIDE	1.2	g/L			N	20241231
71212-103_f2945104-e3b4-66a0-e053-2995a90a758a	71212-103	HUMAN OTC DRUG	Chemstation E2		Chloroxylenol	SOAP	TOPICAL	20170308		OTC MONOGRAPH NOT FINAL	part333E	Chemstation	CHLOROXYLENOL	15	g/L			N	20241231
71217-0047_f3721ffe-99f8-5c45-e053-2995a90a78b8	71217-0047	HUMAN OTC DRUG	Hydrating Treatment Toner		citronellol	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-	.0090402	g/100mL			N	20241231
71217-0048_f3726772-0211-d623-e053-2a95a90a2ce9	71217-0048	HUMAN OTC DRUG	Hydrating extra concentrate serum		citronellol	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-	.00271206	g/100mL			N	20241231
71217-0049_f3735d2a-1a5b-b28d-e053-2995a90a3697	71217-0049	HUMAN OTC DRUG	Hydrating luxurious roseoil		citronellol, geraniol	OIL	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-; GERANIOL	.0090408; .003019675	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71217-0050_f374105d-b286-4f1d-e053-2995a90a926c	71217-0050	HUMAN OTC DRUG	Hydrating all in one concentrate treatment mask		niacinamide, adenosine	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71217-0051_f3ae2d3d-2c48-ad1f-e053-2995a90acfed	71217-0051	HUMAN OTC DRUG	Hydrating all in one glow concentrate ampoule		niacinamide, adenosine	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71217-0052_f37480e6-5c40-7d6c-e053-2a95a90accdc	71217-0052	HUMAN OTC DRUG	Puritying Skin BalanceCream		Hexyl Cinnamal, Limonene	CREAM	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.ALPHA.-HEXYLCINNAMALDEHYDE; LIMONENE, (+)-	.00244785; .001156785	g/100mL; g/100mL			N	20241231
71217-0053_f3752101-b0bd-7ec7-e053-2a95a90adaba	71217-0053	HUMAN OTC DRUG	Purifying centella soothing mask		limonene, linalool	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	LIMONENE, (+)-; LINALOOL, (+/-)-	.00371146; .00109203	g/100g; g/100g			N	20241231
71217-0054_f3757e0b-566b-7539-e053-2995a90a3ff0	71217-0054	HUMAN OTC DRUG	Purifying relief soothing gel essence		citronellol	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-	.0090408	g/100mL			N	20241231
71217-0055_f375ba81-9a97-2c67-e053-2a95a90a061c	71217-0055	HUMAN OTC DRUG	Purifying Balance Soothing Peeling Pad		limonene	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	LIMONENE, (+)-	.00185573	g/100mL			N	20241231
71217-0057_f3fe1a55-90b0-5392-e053-2995a90a2c0c	71217-0057	HUMAN OTC DRUG	Protecting may morning cushion 21		citronellol, geraniol, linalool	POWDER	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-; GERANIOL; LINALOOL, (+/-)-	.03018988; .007430248; .0028142856	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71217-0058_f384fa12-35eb-ac13-e053-2995a90ac33f	71217-0058	HUMAN OTC DRUG	Protecting may morning cushion 21 (refill)		citronellol, geraniol, linalool	POWDER	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-; GERANIOL; LINALOOL, (+/-)-	.03018988; .007430248; .0028142856	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71217-0059_f3850b79-c80c-cba9-e053-2a95a90aa4c2	71217-0059	HUMAN OTC DRUG	Protecting natural shine tone up sun cushion		citronellol, geraniol, linalool	POWDER	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-; GERANIOL; LINALOOL, (+/-)-	.03018988; .007430248; .0028142856	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71217-0060_f3856fda-71d3-2703-e053-2995a90a17a8	71217-0060	HUMAN OTC DRUG	Protecting base suncream		citronellol, geraniol, linalool	CREAM	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71217-0061_f3877ebd-a86b-449b-e053-2995a90a131c	71217-0061	HUMAN OTC DRUG	Protecting tone up and glow B.B		niacinamide, adenosine	CREAM	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71217-0062_f3ae7c36-61b0-7cbe-e053-2995a90a531d	71217-0062	HUMAN OTC DRUG	Boosting apple soothing wash off		pyrus malus fruit extract	GEL	TOPICAL	20230201		UNAPPROVED DRUG OTHER		inthismorning co ltd	APPLE FRUIT OIL	58.69	g/100mL			N	20241231
71217-0063_fe26caf9-8285-cf5d-e053-6394a90a9acc	71217-0063	HUMAN OTC DRUG	Intensive treatment bodycream for mommy to be and all skin		citronellol, geraniol, linalool, limonene	CREAM	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-; GERANIOL; LIMONENE, (+/-)-; LINALOOL, (+/-)-	.0072288108; .003659868; .0330317226; .0123856248	g/100mL; g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71217-0064_f3ad8164-5103-50cc-e053-2995a90a7a43	71217-0064	HUMAN OTC DRUG	Claritying turn over rice perfect oil foam cleanser		oryza sativa (rice) bran oil	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	RICE BRAN OIL	.01	g/100mL			N	20241231
71217-0065_f38cbb93-ef65-0ef6-e053-2a95a90a32cf	71217-0065	HUMAN OTC DRUG	Claritying rice rebalancing cleansing water		Oryza Sativa (Rice) Extract	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	RICE GERM	.0000001	g/100mL			N	20241231
71217-0066_f3990f31-6c15-8690-e053-2995a90abc12	71217-0066	HUMAN OTC DRUG	Claritying rice gently off lip and eye remover		Oryza Sativa (Rice) Extract	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	RICE GERM	.00055	g/100mL			N	20241231
71217-0067_f3a1502c-9e97-2971-e053-2995a90a2b2f	71217-0067	HUMAN OTC DRUG	Hair care scalp volume boostingshampoo		Polygonum Fagopyrum (Buckwheat) Sprout Extract	SHAMPOO	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	RICE GERM	.00055	g/100mL			N	20241231
71217-0068_f3ad2110-0833-7a54-e053-2995a90ad615	71217-0068	HUMAN OTC DRUG	Hair care scalp volume boosting conditioner		Polygonum Fagopyrum (Buckwheat) Sprout Extract	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	BUCKWHEAT	.0003	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
71217-0069_f3adf048-00b5-25b4-e053-2a95a90ad381	71217-0069	HUMAN OTC DRUG	Hair care conditioning Boosting essence		Argania Spinosa Kernel Oil	LIQUID	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	ARGAN OIL	.001	g/100mL			N	20241231
71217-0070_f3e7d5c5-8d6f-38dc-e053-2a95a90a2ef7	71217-0070	HUMAN OTC DRUG	Purifying S.O.S spotgel		limonene	GEL	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	LIMONENE, (+)-	.005016382	g/100mL			N	20241231
71217-0071_fe0cbfa2-e2fd-6377-e053-6294a90a0f74	71217-0071	HUMAN OTC DRUG	Hydrating moisture day and nightcream		citronellol, geraniol	CREAM	TOPICAL	20230115		UNAPPROVED DRUG OTHER		inthismorning co ltd	.BETA.-CITRONELLOL, (R)-; GERANIOL	.0090402; .003019275	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71217-0073_0185f79e-cad3-002e-e063-6294a90a6aaa	71217-0073	HUMAN OTC DRUG	protecting sunny day sun patch		niacinamide, adenosine	LIQUID	TOPICAL	20230701		UNAPPROVED DRUG OTHER		inthismorning co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100g; g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71220-082_026e401e-c02d-4c98-e063-6394a90abb30	71220-082	HUMAN OTC DRUG	innisfree Daily UV Defense Sunscreen		Avobenzone, Homosalate, and Octisalate Lotion	LOTION	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part352	Innisfree Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE	1.25; 3.5; 2.15	g/50mL; g/50mL; g/50mL			N	20241231
71220-083_0b52e695-b6ea-1737-e063-6394a90a67e4	71220-083	HUMAN OTC DRUG	innisfree Matte Priming UV Shield Sunscreen		Octisalate, Titanium dioxide, and Octocrylene Lotion	LOTION	TOPICAL	20200615	20250504	OTC MONOGRAPH DRUG	M020	Innisfree Corporation	OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE	2; 1.25; 1.75	g/50mL; g/50mL; g/50mL			N	
71220-085_091c6a54-b04c-69bc-e063-6394a90ae007	71220-085	HUMAN OTC DRUG	innisfree Daily UV Defense Sunscreen		Avobenzone, Homosalate, and Octisalate Lotion	LOTION	TOPICAL	20230915		OTC MONOGRAPH DRUG	M020	Innisfree Corporation	AVOBENZONE; HOMOSALATE; OCTISALATE	1.25; 3.5; 2.15	g/50mL; g/50mL; g/50mL			N	20241231
71221-333_09d8bb51-cbef-deeb-e063-6394a90a7a60	71221-333	HUMAN OTC DRUG	CoralSafe Broad Spectrum SPF30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Elements Brands	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/L; mg/L	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71221-791_09d8af03-ecb6-c1e3-e063-6294a90ad4a1	71221-791	HUMAN OTC DRUG	Coral Safe SPF-30 Broad Spectrum Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170221		OTC MONOGRAPH DRUG	M020	Elements Brands, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71221-792_09d8c273-4504-2a49-e063-6394a90a3a09	71221-792	HUMAN OTC DRUG	Coral Safe SPF-30 Broad Spectrum Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170221		OTC MONOGRAPH DRUG	M020	Elements Brands, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71221-793_09d8a838-3a80-c010-e063-6294a90aa31a	71221-793	HUMAN OTC DRUG	Tropical Sands SPF-30 Broad Spectrum Sunscreen (Coconut)		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170222		OTC MONOGRAPH DRUG	M020	Elements Brands, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71221-794_09daf79f-48f2-ee9b-e063-6294a90a2833	71221-794	HUMAN OTC DRUG	Tropical Sands, SPF-50 Broad Spectrum Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170222		OTC MONOGRAPH DRUG	M020	Elements Brands, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71221-795_09dafb29-9fba-e3d6-e063-6294a90ad666	71221-795	HUMAN OTC DRUG	Tropical Sands SPF-30 Broad Spectrum Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170221		OTC MONOGRAPH DRUG	M020	Elements Brands, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71221-796_09daf79f-4901-ee9b-e063-6294a90a2833	71221-796	HUMAN OTC DRUG	Tropical Sands SPF-30 Broad Spectrum Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170224		OTC MONOGRAPH DRUG	M020	Elements Brands, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71223-001_0bb582bb-acc0-5f58-e063-6294a90aa88d	71223-001	HUMAN OTC DRUG	Amosan Oral Wound Cleanser		SODIUM PERBORATE MONOHYDRATE	POWDER, FOR SOLUTION	TOPICAL	20171201		OTC MONOGRAPH DRUG	M022	Vintage Brands Limited	SODIUM PERBORATE MONOHYDRATE	1.2	g/1.7g			N	20241231
71223-002_0bb57ed5-7e9e-672d-e063-6294a90afcaf	71223-002	HUMAN OTC DRUG	Amosan Wound Cleanser	Cherry Flavour	SODIUM PERBORATE MONOHYDRATE	POWDER, FOR SOLUTION	ORAL	20190601		OTC MONOGRAPH DRUG	M022	Vintage Brands Limited	SODIUM PERBORATE MONOHYDRATE	1.2	g/1.7g			N	20241231
71225-104_b53ff0ad-525f-4dbb-b3ed-4b028e20cefc	71225-104	HUMAN PRESCRIPTION DRUG	HYDROXYPROGESTERONE CAPROATE		HYDROXYPROGESTERONE CAPROATE	INJECTION	INTRAMUSCULAR	20181228		ANDA	ANDA210618	Slayback Pharma LLC	HYDROXYPROGESTERONE CAPROATE	250	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
71225-105_2e489a75-b05a-49fa-a08a-071d26e1ba30	71225-105	HUMAN PRESCRIPTION DRUG	Hydroxyprogesterone caproate		Hydroxyprogesterone caproate	INJECTION	INTRAMUSCULAR	20190325		ANDA	ANDA210877	Slayback Pharma LLC	HYDROXYPROGESTERONE CAPROATE	250	mg/mL	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
71225-114_dceae0e8-5b3d-4031-a0dc-9c89eb2d0c30	71225-114	HUMAN PRESCRIPTION DRUG	Icatibant		Icatibant	INJECTION	SUBCUTANEOUS	20210128		ANDA	ANDA211501	Slayback Pharma LLC	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
71225-120_b3833b56-d432-479f-b2b0-a07ae1d2c799	71225-120	HUMAN PRESCRIPTION DRUG	VIVIMUSTA		BENDAMUSTINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20221207		NDA	NDA212209	Slayback Pharma LLC	BENDAMUSTINE HYDROCHLORIDE	25	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71225-126_c04838c9-3b1c-46db-b544-e86f10029891	71225-126	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		dexmedetomidine hydrochloride	INJECTION	INTRAVENOUS	20191206		ANDA	ANDA212791	Slayback Pharma LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71225-127_fe8cb916-7dfb-44e5-b190-92484dd3385d	71225-127	HUMAN PRESCRIPTION DRUG	TESTOSTERONE		TESTOSTERONE CYPIONATE	INJECTION, SOLUTION	INTRAMUSCULAR	20220613		NDA	NDA216318	Slayback Pharma LLC	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
71225-130_36292f7e-909d-4907-9a27-d500e401fc75	71225-130	HUMAN PRESCRIPTION DRUG	MERZEE		NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE	KIT		20210216		ANDA	ANDA212706	Slayback Pharma LLC						N	20241231
71225-132_27b03d7a-761e-49f8-bc56-f262ff5259a0	71225-132	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		dexmedetomidine hydrochloride	INJECTION	INTRAVENOUS	20211020		ANDA	ANDA212791	Slayback Pharma LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71225-133_27b03d7a-761e-49f8-bc56-f262ff5259a0	71225-133	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		dexmedetomidine hydrochloride	INJECTION	INTRAVENOUS	20211020		ANDA	ANDA212791	Slayback Pharma LLC	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71225-140_f948e217-c9bb-4ec1-b5fb-864cc14afe4e	71225-140	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	SUSPENSION	ORAL	20230619		ANDA	ANDA217252	Slayback Pharma LLC	BACLOFEN	5	mg/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71227-001_0761d315-121c-41d4-e063-6394a90ae68e	71227-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20151113		NDA	NDA205889	TIMS SOUTH TEXAS LLC	OXYGEN	990	mL/L			N	20241231
71229-101_0906e432-2f37-c2d9-e063-6394a90af9be	71229-101	HUMAN OTC DRUG	PHYTOZINE RINGWORM TREATMENT	MAXIMUM STRENGTH	TOLNAFTATE	OINTMENT	TOPICAL	20190325		OTC MONOGRAPH DRUG	M005	The Sisquoc Healthcare Corporation	TOLNAFTATE	1	g/100g			N	20241231
71229-102_08b96e06-b1aa-af5c-e063-6294a90a086d	71229-102	HUMAN OTC DRUG	FUNGINIX ANTI-FUNGAL TREATMENT		UNDECYLENIC ACID	OINTMENT	TOPICAL	20190325		OTC MONOGRAPH DRUG	M005	The Sisquoc Healthcare Corporation	UNDECYLENIC ACID	10	g/100mL			N	20241231
71229-103_0906fc2c-0620-c21e-e063-6394a90ad75c	71229-103	HUMAN OTC DRUG	FUNGINIX AF		TOLNAFTATE	CREAM	TOPICAL	20190325		OTC MONOGRAPH DRUG	M005	The Sisquoc Healthcare Corporation	TOLNAFTATE	1	g/100g			N	20241231
71229-104_0906f33c-5718-a875-e063-6394a90a9b27	71229-104	HUMAN OTC DRUG	FUNGINIX JOCK ITCH TREATMENT		TOLNAFTATE	CREAM	TOPICAL	20190325		OTC MONOGRAPH DRUG	M005	The Sisquoc Healthcare Corporation	TOLNAFTATE	1	g/100g			N	20241231
71229-105_07ef3ccc-8d3f-c59d-e063-6394a90a411e	71229-105	HUMAN OTC DRUG	WARTICIDE		SALICYLIC ACID	SOLUTION	TOPICAL	20190325		OTC MONOGRAPH DRUG	M028	The Sisquoc Healthcare Corporation	SALICYLIC ACID	10	g/100mL			N	20241231
71233-001_d44ac4b5-2283-712b-e053-2a95a90ae6a0	71233-001	HUMAN OTC DRUG	Detox		Beta vulg, Boldo, Chelidonium maj, Sarsaparilla, Gelsemium, Veratrum alb, Ferrum met, Iodium, Lycopodium, Nux vom, Pulsatilla, Selenium, Thuja occ, Zinc met	LIQUID	ORAL	20170403		UNAPPROVED HOMEOPATHIC		Compass Fat Loss of Glastonbury LLC	BETA VULGARIS; CHELIDONIUM MAJUS; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PULSATILLA VULGARIS; SELENIUM; SMILAX ORNATA ROOT; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	3; 3; 7; 12; 12; 12; 3; 12; 12; 6; 12; 12; 7; 12	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71233-002_61152d26-6f94-4785-ae8f-282e47ac1645	71233-002	HUMAN OTC DRUG	Weight Management		Asclepias vinc, Echinacea, Hypothalamus, Cerebrum suis, Hepar suis, Kidney, Methylcobalamin, Pancreas suis, Stomach suis, AACG-A, AACG-B, Calc carb, Gambogia, Gelsemium, Graphites, Nat mur, Nux vom, Phytolacca, 3-acetyl-7-oxo-dehydroepiandrosterone, ATP, Glucagon, Insulinum, Sarcolacticum ac, Proteus	LIQUID	ORAL	20170403		UNAPPROVED HOMEOPATHIC		Compass Fat Loss of Glastonbury LLC	7-KETO-DEHYDROEPIANDROSTERONE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; BOS TAURUS HYPOTHALAMUS; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA, UNSPECIFIED; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GLUCAGON; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	30; 30; 8; 8; 6; 6; 6; 12; 12; 30; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 12; 8; 8; 8	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Antihypoglycemic Agent [EPC], Cell-mediated Immunity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71238-218_09db034e-7b39-55aa-e063-6394a90a1a3a	71238-218	HUMAN OTC DRUG	L BRI Pure n Natural Deep Clean Toner		SALICYLIC ACID	LIQUID	TOPICAL	20210901		OTC MONOGRAPH DRUG	M006	L'BRI HEALTH AND BEAUTY INC	SALICYLIC ACID	20	mg/mL			N	20241231
71238-326_0974b923-cff4-7dcc-e063-6294a90aeb1b	71238-326	HUMAN OTC DRUG	LBri Pure n Natural SPF 30		ZINC OXIDE	CREAM	TOPICAL	20180501		OTC MONOGRAPH DRUG	M020	L'BRI HEALTH & BEAUTY	ZINC OXIDE	190	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71238-492_0974c990-eafe-73ff-e063-6294a90af414	71238-492	HUMAN OTC DRUG	LBRI STOP THE PAIN Super Aloe Pain Relief Cream		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20230619		OTC MONOGRAPH DRUG	M015	L'BRI HEALTH AND BEAUTY INC	MENTHOL; METHYL SALICYLATE	50; 100	mg/mL; mg/mL			N	20241231
71238-785_09db034e-7b48-55aa-e063-6394a90a1a3a	71238-785	HUMAN OTC DRUG	LBri Pure nNatural Oil Free Moisturizer		OCTINOXATE, AVOBENZONE, OCTISALATE	CREAM	TOPICAL	20170207		OTC MONOGRAPH DRUG	M020	L'Bri Health & Beauty	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 30	mg/mL; mg/mL; mg/mL			N	20241231
71238-847_09db0d9f-aa1f-e3bb-e063-6294a90a046a	71238-847	HUMAN OTC DRUG	LBri Super Aloe Stop The Pain		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20171003		OTC MONOGRAPH DRUG	M017	L'Bris, Pure 'N Natural	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.3; 30; 100	mg/mL; mg/mL; mg/mL			N	20241231
71239-786_09db3fbc-e8be-ccb3-e063-6394a90a8326	71239-786	HUMAN OTC DRUG	Dr. Mercola Broad Spectrum		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170207		OTC MONOGRAPH DRUG	M020	Nature's Health Partner, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 225	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71239-787_09db452d-6f77-5ec1-e063-6294a90a1e14	71239-787	HUMAN OTC DRUG	Dr. Mercola Broad Spectrum		ZINC OXIDE	CREAM	TOPICAL	20170207		OTC MONOGRAPH DRUG	M020	Nature's Health Partner, LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71239-788_09db4862-af3e-5a91-e063-6294a90ad44e	71239-788	HUMAN OTC DRUG	Dr Mercola Broad Spectrum SPF15		ZINC OXIDE	CREAM	TOPICAL	20170207		OTC MONOGRAPH DRUG	M020	Nature's Health Partner, LLC	ZINC OXIDE	95	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71240-240_09be2b97-a392-092d-e063-6394a90af0d9	71240-240	HUMAN OTC DRUG	Nuby Soothing Gel		Soothing Gel	GEL	TOPICAL	20180825		UNAPPROVED HOMEOPATHIC		Ningbo Longwell Baby Products Co Ltd	ARNICA MONTANA ROOT; MATRICARIA RECUTITA; TRIBASIC CALCIUM PHOSPHATE	30; 12; 12	[hp_X]/15g; [hp_X]/15g; [hp_X]/15g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
71240-307_d8a019ac-60bf-8f2c-e053-2a95a90a29ed	71240-307	HUMAN OTC DRUG	Dr. Talbots Oral Comfort Pack		Pain Fever Relief and Soothing Gel	KIT	ORAL; TOPICAL	20200706		UNAPPROVED HOMEOPATHIC		Ningbo Longwell Baby Products Co.,Ltd.						N	20241231
71247-126_b618f615-9674-4aac-9267-0bd76ce94604	71247-126	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA075215	Innogenix, Inc.	LABETALOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71247-127_b618f615-9674-4aac-9267-0bd76ce94604	71247-127	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA075215	Innogenix, Inc.	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71247-130_b618f615-9674-4aac-9267-0bd76ce94604	71247-130	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA075215	Innogenix, Inc.	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71247-150_9dba72ee-b7aa-4f16-bd6d-848ddebcac67	71247-150	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Innogenix, Inc.	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
71247-151_9dba72ee-b7aa-4f16-bd6d-848ddebcac67	71247-151	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Innogenix, Inc.	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
71247-152_9dba72ee-b7aa-4f16-bd6d-848ddebcac67	71247-152	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Innogenix, Inc.	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
71247-153_9dba72ee-b7aa-4f16-bd6d-848ddebcac67	71247-153	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Innogenix, Inc.	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
71247-154_9dba72ee-b7aa-4f16-bd6d-848ddebcac67	71247-154	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Innogenix, Inc.	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
71247-155_9dba72ee-b7aa-4f16-bd6d-848ddebcac67	71247-155	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20210218		ANDA	ANDA071173	Innogenix, Inc.	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
71258-015_bf74c36c-24f8-4073-a024-a43285224302	71258-015	HUMAN PRESCRIPTION DRUG	Azedra		iobenguane I-131	INJECTION, SOLUTION	INTRAVENOUS	20180730		NDA	NDA209607	Progenics Pharmaceuticals, Inc.	IOBENGUANE I-131	15	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
71258-022_be72e718-f45f-41ed-8423-a4d1181d4a2d	71258-022	HUMAN PRESCRIPTION DRUG	PYLARIFY		PIFLUFOLASTAT F-18	INJECTION	INTRAVENOUS	20210526		NDA	NDA214793	Progenics Pharmaceuticals, Inc.	PIFLUFOLASTAT F-18	80	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
71261-001_c61886a3-f5c3-3d95-e053-2995a90ab1d3	71261-001	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Cushion Light		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 131.9	mg/g; mg/g; mg/g			N	20241231
71261-002_c618d489-6321-4176-e053-2995a90ab1e9	71261-002	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Cushion Medium		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 131.9	mg/g; mg/g; mg/g			N	20241231
71261-003_b1ce93c6-d62c-9d1f-e053-2a95a90a67c2	71261-003	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Cushion Medium Deep		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 131.9	mg/g; mg/g; mg/g			N	20241231
71261-008_c618da7d-8502-5b0e-e053-2995a90a6b6d	71261-008	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Cushion Fair Light		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 131.9	mg/g; mg/g; mg/g			N	20241231
71261-011_00dc377c-5e2b-61a7-e063-6294a90adae0	71261-011	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Fair Light		TITANIUM DIOXIDE, OCTINOXATE, Zinc Oxide, OCTISALATE	CREAM	TOPICAL	20200716		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 45; 96; 49	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71261-012_00dc6780-83f1-14cd-e063-6394a90a447b	71261-012	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Light		TITANIUM DIOXIDE, OCTINOXATE, Zinc Oxide, OCTISALATE	CREAM	TOPICAL	20200716		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 45; 96; 49	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71261-013_00df35d3-d80d-dd94-e063-6294a90a1830	71261-013	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Medium		TITANIUM DIOXIDE, OCTINOXATE, Zinc Oxide, OCTISALATE	CREAM	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 45; 96; 49	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71261-014_00dc84ae-83f1-05bb-e063-6294a90a9be9	71261-014	HUMAN OTC DRUG	JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Medium Deep		TITANIUM DIOXIDE, OCTINOXATE, Zinc Oxide, OCTISALATE	CREAM	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 45; 96; 49	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71261-015_b47fd570-8de7-b7a7-e053-2995a90a0b87	71261-015	HUMAN OTC DRUG	JUNGSAEMMOOL Masterclass Radiant Cushion N1 Ivory		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20201119		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 146.3	mg/g; mg/g; mg/g			N	20241231
71261-016_b48027ef-c8a6-4f01-e053-2a95a90afd79	71261-016	HUMAN OTC DRUG	JUNGSAEMMOOL Masterclass Radiant Cushion N2 Vanila		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20201119		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 146.3	mg/g; mg/g; mg/g			N	20241231
71261-017_b4804284-a048-be12-e053-2a95a90a9acc	71261-017	HUMAN OTC DRUG	JUNGSAEMMOOL Masterclass Radiant Cushion Y4 Sand		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20201119		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 146.3	mg/g; mg/g; mg/g			N	20241231
71261-019_bbec26e8-c2da-50d5-e053-2995a90ae027	71261-019	HUMAN OTC DRUG	JUNGSAEMMOOL Masterclass Radiant Cushion N0 Cream		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 146.3	mg/g; mg/g; mg/g			N	20241231
71261-020_bbec4b8a-3175-51ea-e053-2995a90a66a5	71261-020	HUMAN OTC DRUG	JUNGSAEMMOOL Masterclass Radiant Cushion Y5 Honey		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20210222		OTC MONOGRAPH NOT FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 146.3	mg/g; mg/g; mg/g			N	20241231
71261-021_db4c81be-a870-7191-e053-2a95a90a41d4	71261-021	HUMAN OTC DRUG	JUNGSAEMMOOL Skin Nuder Cover Layer Cushion Fair Light		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20220328		OTC MONOGRAPH FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 193.4	mg/g; mg/g; mg/g			N	20241231
71261-022_db4cb48d-fb09-88eb-e053-2a95a90a6f64	71261-022	HUMAN OTC DRUG	JUNGSAEMMOOL Skin Nuder Cover Layer Cushion N-Light		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20220328		OTC MONOGRAPH FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 193.4	mg/g; mg/g; mg/g			N	20241231
71261-023_db4c8e3a-540b-1c7a-e053-2995a90ac420	71261-023	HUMAN OTC DRUG	JUNGSAEMMOOL Skin Nuder Cover Layer Cushion Light		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20220328		OTC MONOGRAPH FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 193.4	mg/g; mg/g; mg/g			N	20241231
71261-024_db4cd901-f1d0-8480-e053-2a95a90afb7a	71261-024	HUMAN OTC DRUG	JUNGSAEMMOOL Skin Nuder Cover Layer Cushion Medium		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20220328		OTC MONOGRAPH FINAL	part352	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 193.4	mg/g; mg/g; mg/g			N	20241231
71261-025_0c3bfea1-f050-9a25-e063-6294a90ae979	71261-025	HUMAN OTC DRUG	JUNGSAEMMOOL Masterclass Glow Base		Octinoxate, Titanium Dioxide, Homosalate, Octisalate	CREAM	TOPICAL	20220801		OTC MONOGRAPH DRUG	M020	Jungsaemmool Beauty Co., Ltd.	HOMOSALATE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	30; 60; 20; 54.7	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71261-026_0d3b677d-9192-56cc-e063-6294a90a1b5b	71261-026	HUMAN OTC DRUG	JUNGSAEMMOOL Skin Nuder Cover Layer Cushion Medium Deep		TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20231223		OTC MONOGRAPH DRUG	M020	Jungsaemmool Beauty Co., Ltd.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	67; 40; 193.4	mg/g; mg/g; mg/g			N	20241231
71262-002_0b6df51f-3181-aaa3-e063-6294a90afc3c	71262-002	HUMAN OTC DRUG	Vitastem		Tetracycline Hydrochloride	OINTMENT	TOPICAL	20161108		OTC MONOGRAPH DRUG	M004	ViaDerma Distribution, Inc.	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
71262-003_0c02e9b6-ff73-c0c7-e063-6294a90adbe3	71262-003	HUMAN OTC DRUG	Vitastem-tetracycline hydrochloride		TETRACYCLINE HYDROCHLORIDE	SPRAY	TOPICAL	20190801		OTC MONOGRAPH DRUG	M004	ViaDerma Distribution, Inc.	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
71262-004_0b6df08e-ce47-b832-e063-6294a90a78ae	71262-004	HUMAN OTC DRUG	Liberdol Analgesic		MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE	LIQUID	TOPICAL	20191001		OTC MONOGRAPH DRUG	M017	ViaDerma Distribution, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/mL; mg/mL; mg/mL			N	20241231
71262-005_0b819764-5234-ae25-e063-6394a90ac73a	71262-005	HUMAN OTC DRUG	Triastem Topical Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20191101		OTC MONOGRAPH DRUG	M004	ViaDerma Distribution, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 5; 5000	mg/mL; mg/mL; U/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71262-006_0b81a020-0873-e454-e063-6294a90a2e03	71262-006	HUMAN OTC DRUG	Prolayed Lidocaine Male Genital Desensitizer		LIDOCAINE	OINTMENT	TOPICAL	20170623		OTC MONOGRAPH DRUG	M017	ViaDerma Distribution, Inc.	LIDOCAINE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71262-007_0b6df296-2efe-e3db-e063-6394a90a9653	71262-007	HUMAN OTC DRUG	Vitastem ULTRA		BACITRACIN ZINC	OINTMENT	TOPICAL	20210601		OTC MONOGRAPH DRUG	M004	ViaDerma Distribution, Inc	BACITRACIN ZINC	500	U/mL	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
71262-008_0b6df7b0-af6a-e3df-e063-6394a90ad193	71262-008	HUMAN OTC DRUG	Liberdol Topical Analgesic		METHYL SALICYLATE, MENTHOL, CAMPHOR (SYNTHETIC)	SPRAY	TOPICAL	20210601		OTC MONOGRAPH DRUG	M017	ViaDerma Distribution, Inc	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	40; 100; 300	mg/mL; mg/mL; mg/mL			N	20241231
71269-040_e885499e-3423-4377-9f0e-0e315677a7b6	71269-040	HUMAN PRESCRIPTION DRUG	Tuxarin		codeine phosphate and chlorpheniramine maleate	TABLET, EXTENDED RELEASE	ORAL	20181015		NDA	NDA206323	Mainpointe Pharmaceuticals	CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE	8; 54.3	mg/1; mg/1	Full Opioid Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC]	CIII	N	20241231
71270-150_c8549dc7-ec86-41d3-9a58-534f18706647	71270-150	HUMAN OTC DRUG	TRADER JOE S MINERAL SUNSCREEN		Zinc Oxide	STICK	TOPICAL	20170225		OTC MONOGRAPH NOT FINAL	part352	Trader Joe's Company	ZINC OXIDE	22	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71270-151_f2e24a99-7818-193d-e053-2a95a90ad40c	71270-151	HUMAN OTC DRUG	TRADER JOES ZINC OXIDE SUNSCREEN	SPF 40	Zinc Oxide	LOTION	TOPICAL	20190227		OTC MONOGRAPH NOT FINAL	part352	Trader Joe's Company	ZINC OXIDE	20.5	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71270-153_081737c8-f0d2-f3a2-e063-6294a90a7a30	71270-153	HUMAN OTC DRUG	TRADER JOES FACE AND BODY SUNSCREEN	SPF 30	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191115		OTC MONOGRAPH DRUG	M020	Trader Joe's Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
71270-154_f218bca5-4b8f-20bd-e053-2995a90afdd8	71270-154	HUMAN OTC DRUG	TRADER JOES SUNSCREEN	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20191115		OTC MONOGRAPH NOT FINAL	part352	Trader Joe's Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
71270-155_f218ba90-17b4-921e-e053-2a95a90a169a	71270-155	HUMAN OTC DRUG	TRADER JOES ZINC OXIDE MINERAL SUNSCREEN	SPF 30	Zinc Oxide	SPRAY	TOPICAL	20200402		OTC MONOGRAPH NOT FINAL	part352	Trader Joe's Company	ZINC OXIDE	15	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71270-156_081737c8-f0ea-f3a2-e063-6294a90a7a30	71270-156	HUMAN OTC DRUG	TRADER JOES DAILY FACIAL SUNSCREEN	SPF 40	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	GEL	TOPICAL	20220327		OTC MONOGRAPH DRUG	M020	Trader Joe's Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 12; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
71270-201_081737c8-f0c3-f3a2-e063-6294a90a7a30	71270-201	HUMAN OTC DRUG	TRADER JOES HAND SANITIZER	GRAPEFRUIT LEMON	ALCOHOL	SPRAY	TOPICAL	20180720		OTC MONOGRAPH DRUG	M003	Trader Joe's Company	ALCOHOL	74	mL/100mL			N	20241231
71270-202_08172089-7829-8a6b-e063-6394a90a8c8a	71270-202	HUMAN OTC DRUG	TRADER JOES HAND SANITIZER	WITH MOISTURIZERS AND VITAMIN E	ALCOHOL	GEL	TOPICAL	20200325		OTC MONOGRAPH DRUG	M003	Trader Joe's Company	ALCOHOL	65	mL/100mL			N	20241231
71270-203_081737c8-f0b8-f3a2-e063-6294a90a7a30	71270-203	HUMAN OTC DRUG	TRADER JOES HAND SANITIZER	LAVENDER	ETHYL ALCOHOL	SPRAY	TOPICAL	20201221		OTC MONOGRAPH DRUG	M003	Trader Joe's Company	ALCOHOL	74	mL/100mL			N	20241231
71270-252_081737c8-f0df-f3a2-e063-6294a90a7a30	71270-252	HUMAN OTC DRUG	TRADER JOES ENRICH MOISTURIZING FACE	BROAD SPECTRUM SPF 15	Octinoxate, Zinc Oxide	LOTION	TOPICAL	20190709		OTC MONOGRAPH DRUG	M020	Trader Joe's Company	OCTINOXATE; ZINC OXIDE	6; 3	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71272-811_09db4862-af4d-5a91-e063-6294a90ad44e	71272-811	HUMAN OTC DRUG	Sunstation All-Natural SPF 30 Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20170228		OTC MONOGRAPH DRUG	M020	Sunstation USA, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71274-170_7cfc3968-6a21-4c48-b72c-01ee71b7e6cf	71274-170	HUMAN PRESCRIPTION DRUG	Joenja		Leniolisib	TABLET, FILM COATED	ORAL	20230329		NDA	NDA217759	Pharming Healthcare Inc.	LENIOLISIB PHOSPHATE	70	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Phosphoinositide 3-Kinase delta Inhibitors [MoA]		N	20241231
71274-350_a742815a-7705-9153-e053-2995a90a562d	71274-350	HUMAN PRESCRIPTION DRUG	Ruconest		c1 esterase inhibitor recombinant	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20180401		BLA	BLA125495	Pharming Healthcare Inc.	CONESTAT ALFA	2100	U/1			N	20241231
71278-005_0a278590-fd16-79e7-e063-6394a90a54f3	71278-005	HUMAN OTC DRUG	Perfect Legs Skin Protector SPF 30		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	CREAM	TOPICAL	20170513		OTC MONOGRAPH DRUG	M020	THIS WORKS PRODUCTS LIMITED	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	16; 16; 8	mg/mL; mg/mL; mg/mL			N	20241231
71278-006_0a277d20-4355-37e6-e063-6394a90a203c	71278-006	HUMAN OTC DRUG	In Transit Skin Defence		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20170517		OTC MONOGRAPH DRUG	M020	THIS WORKS PRODUCTS LIMITED	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	30; 70; 95; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71282-011_e07f0bec-05e9-428e-a50d-13e5ddf9aa9e	71282-011	HUMAN OTC DRUG	4Jointz		Menthol	CREAM	TOPICAL	20170131		OTC MONOGRAPH DRUG	M017	ARP(USA) Pty Ltd	MENTHOL	1.5	g/100g			N	20241231
71284-0001_b2a368fd-8c9a-4bf3-85cd-8d7a782bdbcb	71284-0001	HUMAN OTC DRUG	Gluten Sensitivity Formula		Lycopodium Clavatum, Pulsatilla	CAPSULE	ORAL	20180223	20241217	UNAPPROVED HOMEOPATHIC		Herbs & More of Tulsa	ANEMONE PRATENSIS; LYCOPODIUM CLAVATUM SPORE	12; 12	[hp_X]/1; [hp_X]/1			N	
71287-119_88838c18-3786-48ce-975c-06e1cd63ece4	71287-119	CELLULAR THERAPY	YESCARTA		axicabtagene ciloleucel	SUSPENSION	INTRAVENOUS	20171018		BLA	BLA125643	Kite Pharma, Inc.	AXICABTAGENE CILOLEUCEL	2000000	1/68mL	CD19 Receptor Interactions [MoA], CD19-directed Chimeric Antigen Receptor [EPC], CD19-specific Chimeric Antigen Receptor [CS], Genetically-modified Autologous T Cells [EPC], Increased T Lymphocyte Activation [PE], T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]		N	20251231
71287-219_2d3bc6ab-ff21-46f0-a4c7-1fcc1e4b9e22	71287-219	CELLULAR THERAPY	TECARTUS		brexucabtagene autoleucel	SUSPENSION	INTRAVENOUS	20200724		BLA	BLA125703	Kite Pharma, Inc.	BREXUCABTAGENE AUTOLEUCEL	2000000	1/68mL			N	20241231
71287-220_2d3bc6ab-ff21-46f0-a4c7-1fcc1e4b9e22	71287-220	CELLULAR THERAPY	TECARTUS		brexucabtagene autoleucel	SUSPENSION	INTRAVENOUS	20211001		BLA	BLA125703	Kite Pharma, Inc.	BREXUCABTAGENE AUTOLEUCEL	1000000	1/68mL			N	20241231
71288-003_ed3d8595-3996-4b0c-a550-5609f3d479ed	71288-003	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190729		ANDA	ANDA212287	Meitheal Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71288-005_83e30d31-47ce-4d16-81b0-bfc568e21d89	71288-005	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin sodium and Sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220117		ANDA	ANDA090579	Meitheal Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71288-006_83e30d31-47ce-4d16-81b0-bfc568e21d89	71288-006	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin sodium and Sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220117		ANDA	ANDA090579	Meitheal Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71288-007_f07e7d10-073a-4f11-b334-5084a6d9d2e5	71288-007	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20181217		ANDA	ANDA090578	Meitheal Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	10; 5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71288-016_5d017d3b-63c6-49a0-9ef2-49714549db80	71288-016	HUMAN PRESCRIPTION DRUG	DAPTOMYCIN		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210629		ANDA	ANDA213623	Meitheal Pharmaceuticals Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
71288-016_850ccfab-8bd0-4ca6-acd5-124f856ec336	71288-016	HUMAN PRESCRIPTION DRUG	DAPTOMYCIN		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210629		ANDA	ANDA213623	Meitheal Pharmaceuticals Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
71288-016_e5a3f82f-5774-4016-aea0-0ca0380eebd5	71288-016	HUMAN PRESCRIPTION DRUG	DAPTOMYCIN		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210629		ANDA	ANDA213623	Meitheal Pharmaceuticals Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
71288-017_3c105327-7eb3-4555-b607-6ed8f29b0377	71288-017	HUMAN PRESCRIPTION DRUG	DAPTOMYCIN		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220405		ANDA	ANDA213786	Meitheal Pharmaceuticals Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
71288-017_9f437e13-3f79-40ae-a245-7574931112d0	71288-017	HUMAN PRESCRIPTION DRUG	DAPTOMYCIN		DAPTOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210629		ANDA	ANDA213786	Meitheal Pharmaceuticals Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
71288-019_f09be967-0036-46c3-9766-005ed39d15c8	71288-019	HUMAN PRESCRIPTION DRUG	Tigecycline		Tigecycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210513		ANDA	ANDA214020	Meitheal Pharmaceuticals Inc.	TIGECYCLINE	50	mg/5mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
71288-022_8783ba3b-c343-44ba-9a51-516751993478	71288-022	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220728		ANDA	ANDA215197	Meitheal Pharmaceuticals Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
71288-023_8783ba3b-c343-44ba-9a51-516751993478	71288-023	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220728		ANDA	ANDA215197	Meitheal Pharmaceuticals Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
71288-024_c050d3db-83fa-4e01-a304-db41eb41086a	71288-024	HUMAN PRESCRIPTION DRUG	Vancomycin hydrochloride		Vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220915		ANDA	ANDA215195	Meitheal Pharmaceuticals Inc.	VANCOMYCIN HYDROCHLORIDE	750	mg/15mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
71288-025_b7b203d8-dec6-49c3-a147-2cfb5f38cbb3	71288-025	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220727		ANDA	ANDA215196	Meitheal Pharmaceuticals Inc.	VANCOMYCIN HYDROCHLORIDE	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
71288-026_b7b203d8-dec6-49c3-a147-2cfb5f38cbb3	71288-026	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220727		ANDA	ANDA215196	Meitheal Pharmaceuticals Inc.	VANCOMYCIN HYDROCHLORIDE	10	g/95mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
71288-027_61637e0c-2ce5-4c11-bda9-6079bfcd3250	71288-027	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220509		ANDA	ANDA214516	Meitheal Pharmaceuticals Inc.	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71288-028_0e9e0561-832f-42b8-9e7f-692df6e2c59c	71288-028	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220928		ANDA	ANDA215381	Meitheal Pharmaceuticals Inc.	MICAFUNGIN SODIUM	50	mg/5mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
71288-029_0e9e0561-832f-42b8-9e7f-692df6e2c59c	71288-029	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220928		ANDA	ANDA215381	Meitheal Pharmaceuticals Inc.	MICAFUNGIN SODIUM	100	mg/5mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
71288-031_a620e7ec-6d50-4430-98db-496aae9565b7	71288-031	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin sodium and Sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051129		ANDA	ANDA065222	Meitheal Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71288-032_a620e7ec-6d50-4430-98db-496aae9565b7	71288-032	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin sodium and Sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20051129		ANDA	ANDA065222	Meitheal Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71288-033_595ddbc8-7136-4bc8-9a95-69b6f94fa3fd	71288-033	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin Sodium and Sulbactam Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20061127		ANDA	ANDA065314	Meitheal Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	10; 5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71288-101_e40ef463-a621-42ca-98fa-4a00c2779695	71288-101	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20171001		ANDA	ANDA207325	Meitheal Pharmaceuticals Inc.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20251231
71288-102_f9917f10-8be6-4e83-b4d2-cc1fda074337	71288-102	HUMAN PRESCRIPTION DRUG	Bendamustine		bendamustine HCl	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230605		ANDA	ANDA211001	Meitheal Pharmaceuticals Inc.	BENDAMUSTINE HYDROCHLORIDE	25	mg/5mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-103_f9917f10-8be6-4e83-b4d2-cc1fda074337	71288-103	HUMAN PRESCRIPTION DRUG	Bendamustine		Bendamustine HCl	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230605		ANDA	ANDA211001	Meitheal Pharmaceuticals Inc.	BENDAMUSTINE HYDROCHLORIDE	100	mg/20mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-104_a0d839ca-80eb-4061-a0c4-30e5d94af094	71288-104	HUMAN PRESCRIPTION DRUG	Levoleucovorin		levoleucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190822		ANDA	ANDA211003	Meitheal Pharmaceuticals Inc	LEVOLEUCOVORIN CALCIUM	50	mg/5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
71288-105_17100790-fb82-43cd-80eb-b3e73d918bbd	71288-105	HUMAN PRESCRIPTION DRUG	Levoleucovorin		levoleucovorin calcium	INJECTION, SOLUTION	INTRAVENOUS	20190816		ANDA	ANDA211002	Meitheal Pharmaceuticals Inc.	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20251231
71288-106_ae0d7fba-937e-42d1-b7f5-ae6f7b860bc4	71288-106	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin Sulfate	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20180831		ANDA	ANDA205030	Meitheal Pharmaceuticals Inc.	BLEOMYCIN SULFATE	15	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
71288-107_ae0d7fba-937e-42d1-b7f5-ae6f7b860bc4	71288-107	HUMAN PRESCRIPTION DRUG	Bleomycin		Bleomycin Sulfate	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS	20180831		ANDA	ANDA205030	Meitheal Pharmaceuticals Inc.	BLEOMYCIN SULFATE	30	[USP'U]/1	Cytoprotective Agent [EPC]		N	20241231
71288-108_ba035466-3b01-4e2b-abf5-d876619a2674	71288-108	HUMAN PRESCRIPTION DRUG	Cytarabine		Cytarabine	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20200626		ANDA	ANDA206189	Meitheal Pharmaceuticals Inc.	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-109_1f74972a-b1fc-420b-8448-c81315df389d	71288-109	HUMAN PRESCRIPTION DRUG	Cytarabine		Cytarabine	INJECTION, SOLUTION	INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS	20180717		ANDA	ANDA205696	Meitheal Pharmaceuticals Inc.	CYTARABINE	2	g/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-112_30f168d8-65a3-44d7-971c-462f1ff41d6e	71288-112	HUMAN PRESCRIPTION DRUG	Melphalan hydrochloride		Melphalan hydrochloride	KIT	INTRAVENOUS	20190630		ANDA	ANDA209826	Meitheal Pharmaceuticals Inc.						N	20241231
71288-113_ac076bca-972b-4521-92cc-d49050babc80	71288-113	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181101		ANDA	ANDA091365	Meitheal Pharmaceuticals Inc.	GEMCITABINE HYDROCHLORIDE	200	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-114_ac076bca-972b-4521-92cc-d49050babc80	71288-114	HUMAN PRESCRIPTION DRUG	GEMCITABINE		GEMCITABINE HYDROCHLORIDE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20181101		ANDA	ANDA091365	Meitheal Pharmaceuticals Inc.	GEMCITABINE HYDROCHLORIDE	1	g/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-115_43ffb0fa-6810-49e4-acda-0ef79bfcffcb	71288-115	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20201102		ANDA	ANDA212128	Meitheal Pharmaceuticals Inc.	AZACITIDINE	100	mg/30mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-116_ebe3b619-0e7a-42fc-bb7b-f219b900597b	71288-116	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION, SOLUTION	INTRAVENOUS	20201023		ANDA	ANDA212127	Meitheal Pharmaceuticals Inc.	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-117_b6847fe9-1c9e-44d8-e053-2a95a90ab16f	71288-117	HUMAN PRESCRIPTION DRUG	Gemcitabine		Gemcitabine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201211		ANDA	ANDA212129	Meitheal Pharmaceuticals Inc.	GEMCITABINE HYDROCHLORIDE	38	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-118_ce7feacf-738f-4efa-8e72-88cd95d5373c	71288-118	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220726		ANDA	ANDA212958	Meitheal Pharmaceuticals Inc.	BORTEZOMIB	3.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
71288-119_ba7c29ad-7b66-4950-a309-2de8e56d1a83	71288-119	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210702		ANDA	ANDA212959	Meitheal Pharmaceuticals Inc.	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-126_a0166589-f918-46a3-8da0-a76b25a1ac38	71288-126	HUMAN PRESCRIPTION DRUG	Carmustine		Carmustine	KIT	INTRAVENOUS	20210802		ANDA	ANDA213460	Meitheal Pharmaceuticals Inc.						N	20241231
71288-128_06e3bdb0-c175-4e35-a15e-2779a54004ea	71288-128	HUMAN PRESCRIPTION DRUG	Clofarabine		Clofarabine	INJECTION	INTRAVENOUS	20201023		ANDA	ANDA213461	Meitheal Pharmaceuticals Inc.	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-129_d9bb02eb-3f9e-4932-bdcd-53b5bd6392b6	71288-129	HUMAN PRESCRIPTION DRUG	Dactinomycin		Dactinomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201113		ANDA	ANDA213463	Meitheal Pharmaceuticals Inc.	DACTINOMYCIN	.5	mg/mL	Actinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]		N	20241231
71288-132_a02b7696-e6b3-46c9-9a66-142465157e70	71288-132	HUMAN PRESCRIPTION DRUG	Melphalan hydrochloride		Melphalan hydrochloride	KIT	INTRAVENOUS	20210528		ANDA	ANDA212960	Meitheal Pharmaceuticals Inc.						N	20241231
71288-137_a78f4900-61e4-4e22-bfcb-6b5210c94c57	71288-137	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220908		ANDA	ANDA214505	Meitheal Pharmaceuticals Inc.	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-138_a78f4900-61e4-4e22-bfcb-6b5210c94c57	71288-138	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220908		ANDA	ANDA214505	Meitheal Pharmaceuticals Inc.	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-139_968a3675-c8a8-477c-ad1d-bc8741fa6a6e	71288-139	HUMAN PRESCRIPTION DRUG	MITOMYCIN		MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220906		ANDA	ANDA214504	Meitheal Pharmaceuticals Inc.	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-144_77b41d41-9975-428a-865a-1593d21b3d99	71288-144	HUMAN PRESCRIPTION DRUG	Docetaxel anhydrous		Docetaxel anhydrous	INJECTION, SOLUTION	INTRAVENOUS	20180824		ANDA	ANDA209634	Meitheal Pharmaceuticals Inc	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
71288-145_b369ac27-0118-4e53-be05-c9ba2dbf6875	71288-145	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221213		ANDA	ANDA215479	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEPTAHYDRATE	100	mg/4.2mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-146_b369ac27-0118-4e53-be05-c9ba2dbf6875	71288-146	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221213		ANDA	ANDA215479	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEPTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-147_b369ac27-0118-4e53-be05-c9ba2dbf6875	71288-147	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221213		ANDA	ANDA215479	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEPTAHYDRATE	750	mg/30mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-148_b369ac27-0118-4e53-be05-c9ba2dbf6875	71288-148	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20221213		ANDA	ANDA215479	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEPTAHYDRATE	1	g/40mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-149_3a921f6f-70ef-4af0-a476-267d0d17b862	71288-149	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20171001		ANDA	ANDA207325	Meitheal Pharmaceuticals Inc.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
71288-153_069554af-3994-414e-b43a-8e6c0be2bf49	71288-153	HUMAN PRESCRIPTION DRUG	Azacitidine		Azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20201102		ANDA	ANDA212128	Meitheal Pharmaceuticals Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-155_6d64f3aa-9877-4b73-9766-0080f80c1a40	71288-155	HUMAN PRESCRIPTION DRUG	Plerixafor		Plerixafor	SOLUTION	SUBCUTANEOUS	20230724		ANDA	ANDA215698	Meitheal Pharmaceuticals Inc.	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
71288-156_d75a277e-a2ff-4409-8ef3-34b7fd2198f1	71288-156	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20231226		ANDA	ANDA216037	Meitheal Pharmaceuticals Inc	THIOTEPA	15	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-157_d75a277e-a2ff-4409-8ef3-34b7fd2198f1	71288-157	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20231226		ANDA	ANDA216037	Meitheal Pharmaceuticals Inc	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-158_598cecaa-f38c-451c-a3c8-55d90401b742	71288-158	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION, SOLUTION	INTRAVENOUS	20201023		ANDA	ANDA212127	Meitheal Pharmaceuticals Inc.	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
71288-160_9903254b-7319-4a79-bc1f-4e96df388994	71288-160	HUMAN PRESCRIPTION DRUG	leucovorin calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230719		ANDA	ANDA216590	Meitheal Pharmaceuticals Inc.	LEUCOVORIN CALCIUM	50	mg/5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
71288-161_9903254b-7319-4a79-bc1f-4e96df388994	71288-161	HUMAN PRESCRIPTION DRUG	leucovorin calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230719		ANDA	ANDA216590	Meitheal Pharmaceuticals Inc.	LEUCOVORIN CALCIUM	100	mg/10mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
71288-162_9903254b-7319-4a79-bc1f-4e96df388994	71288-162	HUMAN PRESCRIPTION DRUG	leucovorin calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230719		ANDA	ANDA216590	Meitheal Pharmaceuticals Inc.	LEUCOVORIN CALCIUM	200	mg/20mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
71288-163_9903254b-7319-4a79-bc1f-4e96df388994	71288-163	HUMAN PRESCRIPTION DRUG	leucovorin calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230719		ANDA	ANDA216590	Meitheal Pharmaceuticals Inc.	LEUCOVORIN CALCIUM	350	mg/17.5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
71288-164_9903254b-7319-4a79-bc1f-4e96df388994	71288-164	HUMAN PRESCRIPTION DRUG	leucovorin calcium		leucovorin calcium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230719		ANDA	ANDA216590	Meitheal Pharmaceuticals Inc.	LEUCOVORIN CALCIUM	500	mg/50mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
71288-165_645e4e2a-9429-4e2c-8967-70b6134c9479	71288-165	HUMAN PRESCRIPTION DRUG	Nelarabine		Nelarabine	INJECTION	INTRAVENOUS	20230110		ANDA	ANDA216038	Meitheal Pharmaceuticals Inc	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-166_7e168344-e0c6-4889-b43f-32c704e9726d	71288-166	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA208696	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/10mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-166_b2023705-76a4-4e80-8559-8ed4655854c3	71288-166	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA208696	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/10mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-166_e415f1ca-cbcc-4195-b931-ff0394d9b598	71288-166	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA208696	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	100	mg/10mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-167_7e168344-e0c6-4889-b43f-32c704e9726d	71288-167	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA208696	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/50mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-167_b2023705-76a4-4e80-8559-8ed4655854c3	71288-167	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA208696	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/50mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-167_e415f1ca-cbcc-4195-b931-ff0394d9b598	71288-167	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA208696	Meitheal Pharmaceuticals Inc.	PEMETREXED DISODIUM HEMIPENTAHYDRATE	500	mg/50mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71288-168_038a9b4b-a951-4c8c-be74-00a4a64eedd1	71288-168	HUMAN PRESCRIPTION DRUG	Cytarabine		Cytarabine	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20171109		ANDA	ANDA206190	Meitheal Pharmaceuticals Inc.	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-169_bb497b35-a3a3-43e8-a187-6ad2851acf26	71288-169	HUMAN PRESCRIPTION DRUG	Cytarabine		Cytarabine	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220228		ANDA	ANDA208485	Meitheal Pharmaceuticals Inc.	CYTARABINE	20	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
71288-200_9fb02532-b43c-40c3-adf1-f5071a415e05	71288-200	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20200324		ANDA	ANDA211671	Meitheal Pharmaceuticals Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
71288-201_347eb6ed-dadc-4127-be90-24f65150fbff	71288-201	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20220411		ANDA	ANDA212806	Meitheal Pharmaceuticals Inc.	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
71288-202_c828055a-e911-44e8-bd3a-1b16b2f603db	71288-202	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION, SOLUTION	INTRAVENOUS	20191206		ANDA	ANDA211016	Meitheal Pharmaceuticals Inc.	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
71288-203_63378963-a0c7-469c-a062-a77e481c679c	71288-203	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220127		ANDA	ANDA212803	Meitheal Pharmaceuticals Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71288-303_65f0f72b-691f-4cbb-a5d7-7579a133f457	71288-303	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20200924		ANDA	ANDA214390	Meitheal Pharmaceuticals Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
71288-400_02b32f31-513a-418e-993f-a2d04990392a	71288-400	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211005	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	2000	[USP'U]/2mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-401_5ce1f37b-1c66-4849-9de4-05f790006a49	71288-401	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20200224		ANDA	ANDA211004	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	20000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-402_27fdf70e-fb54-4555-9c43-0566e0b57c1f	71288-402	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-403_27fdf70e-fb54-4555-9c43-0566e0b57c1f	71288-403	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-404_27fdf70e-fb54-4555-9c43-0566e0b57c1f	71288-404	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-405_73435152-3a67-47dd-92f4-fd89bbc499f4	71288-405	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200402		ANDA	ANDA212060	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	5000	[USP'U]/.5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-406_717e8d73-68d1-494b-bc08-3080dd874779	71288-406	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200715		ANDA	ANDA212061	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-407_69319d90-2a3e-4514-9959-b75779280e89	71288-407	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190515		ANDA	ANDA211705	Meitheal Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71288-408_69319d90-2a3e-4514-9959-b75779280e89	71288-408	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190515		ANDA	ANDA211705	Meitheal Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71288-409_a1f0c351-fcb5-4d19-94b1-3317b70be391	71288-409	HUMAN PRESCRIPTION DRUG	Palonosetron Hydrochloride		Palonosetron Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230814		ANDA	ANDA215861	Meitheal Pharmaceuticals Inc.	PALONOSETRON HYDROCHLORIDE	.25	mg/5mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71288-410_7b3fe31e-ec77-4ae9-bdf2-e3e410b005bf	71288-410	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-411_7b3fe31e-ec77-4ae9-bdf2-e3e410b005bf	71288-411	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-414_c229ab19-8e9b-49ee-8d8f-0ed2f12d01b1	71288-414	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210706		ANDA	ANDA212802	Meitheal Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71288-414_e5b7c77c-3071-4a50-9906-6c6302ff62b4	71288-414	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210706		ANDA	ANDA212802	Meitheal Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71288-415_c229ab19-8e9b-49ee-8d8f-0ed2f12d01b1	71288-415	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210706		ANDA	ANDA212802	Meitheal Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71288-415_e5b7c77c-3071-4a50-9906-6c6302ff62b4	71288-415	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210706		ANDA	ANDA212802	Meitheal Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71288-419_62adb621-cc86-4702-8ba2-0fabedf075f4	71288-419	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-420_62adb621-cc86-4702-8ba2-0fabedf075f4	71288-420	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-421_62adb621-cc86-4702-8ba2-0fabedf075f4	71288-421	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-422_62adb621-cc86-4702-8ba2-0fabedf075f4	71288-422	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-423_62adb621-cc86-4702-8ba2-0fabedf075f4	71288-423	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-424_62adb621-cc86-4702-8ba2-0fabedf075f4	71288-424	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-425_62adb621-cc86-4702-8ba2-0fabedf075f4	71288-425	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20190615		ANDA	ANDA211007	Meitheal Pharmaceuticals Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71288-426_c493445a-c6c9-47e7-85ab-f076d4650e12	71288-426	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20220614		ANDA	ANDA214856	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	300	mg/3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-427_2b20b742-4bab-4e5b-9d1b-9a7ca9e0daf7	71288-427	HUMAN PRESCRIPTION DRUG	BIVALIRUDIN		BIVALIRUDIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180716		ANDA	ANDA091602	Meitheal Pharmaceuticals Inc.	BIVALIRUDIN	250	mg/5mL	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
71288-432_97e96e19-e064-4426-8dd7-1f94ae94f29f	71288-432	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-432_d0563190-3b99-4f8e-90b6-cef88259790f	71288-432	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-433_97e96e19-e064-4426-8dd7-1f94ae94f29f	71288-433	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-433_d0563190-3b99-4f8e-90b6-cef88259790f	71288-433	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-434_97e96e19-e064-4426-8dd7-1f94ae94f29f	71288-434	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-434_d0563190-3b99-4f8e-90b6-cef88259790f	71288-434	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-435_97e96e19-e064-4426-8dd7-1f94ae94f29f	71288-435	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-435_d0563190-3b99-4f8e-90b6-cef88259790f	71288-435	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-436_97e96e19-e064-4426-8dd7-1f94ae94f29f	71288-436	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-436_d0563190-3b99-4f8e-90b6-cef88259790f	71288-436	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-437_97e96e19-e064-4426-8dd7-1f94ae94f29f	71288-437	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-437_d0563190-3b99-4f8e-90b6-cef88259790f	71288-437	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-438_97e96e19-e064-4426-8dd7-1f94ae94f29f	71288-438	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-438_d0563190-3b99-4f8e-90b6-cef88259790f	71288-438	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION	SUBCUTANEOUS	20191201		ANDA	ANDA206834	Meitheal Pharmaceuticals Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71288-500_bf415978-8e01-4c77-e053-2995a90a9ea3	71288-500	HUMAN PRESCRIPTION DRUG	neostigmine methylsulfate		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210405		ANDA	ANDA212804	Meitheal Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	.51	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71288-501_bf415978-8e01-4c77-e053-2995a90a9ea3	71288-501	HUMAN PRESCRIPTION DRUG	neostigmine methylsulfate		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210405		ANDA	ANDA212804	Meitheal Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	1.02	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71288-502_71ce47f6-e73e-43bd-a23b-c20879474bf5	71288-502	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20210726		ANDA	ANDA214507	Meitheal Pharmaceuticals Inc.	HALOPERIDOL DECANOATE	50	mg/mL	Typical Antipsychotic [EPC]		N	20241231
71288-503_71ce47f6-e73e-43bd-a23b-c20879474bf5	71288-503	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20210726		ANDA	ANDA214507	Meitheal Pharmaceuticals Inc.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
71288-504_71ce47f6-e73e-43bd-a23b-c20879474bf5	71288-504	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20210726		ANDA	ANDA214507	Meitheal Pharmaceuticals Inc.	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
71288-505_74e25a75-2d63-4f39-b6d0-a73392bd1040	71288-505	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE		DEXMEDETOMIDINE	INJECTION, SOLUTION	INTRAVENOUS	20190118		ANDA	ANDA204843	Meitheal Pharmaceuticals Inc.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71288-554_faf588af-da1d-4c2b-8122-b02e0aa0bddd	71288-554	HUMAN PRESCRIPTION DRUG	Ganirelix Acetate		Ganirelix Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20220606		ANDA	ANDA214996	Meitheal Pharmaceuticals Inc.	GANIRELIX ACETATE	250	ug/.5mL	Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]		N	20241231
71288-555_a72ebf33-8c36-4521-96c5-383dd74984c0	71288-555	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20191121		ANDA	ANDA209714	Meitheal Pharmaceuticals Inc	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71288-600_0a3dd803-c422-4986-b8fe-12232ae0059c	71288-600	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220829		ANDA	ANDA215860	Meitheal Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71288-700_37295b13-65a4-40fa-8d6c-53aeb45e2939	71288-700	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20230508		ANDA	ANDA213453	Meitheal Pharmaceuticals Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-701_d0b1caae-253a-44c2-a7ef-669efca9a9a2	71288-701	HUMAN PRESCRIPTION DRUG	Atracurium Besylate		Atracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20180515		ANDA	ANDA091488	Meitheal Pharmaceuticals Inc.	ATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-702_d0b1caae-253a-44c2-a7ef-669efca9a9a2	71288-702	HUMAN PRESCRIPTION DRUG	Atracurium Besylate		Atracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20180515		ANDA	ANDA091489	Meitheal Pharmaceuticals Inc.	ATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-712_c603acf5-af33-479a-8986-fbceb96ff1e5	71288-712	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20191031		ANDA	ANDA211668	Meitheal Pharmaceuticals Inc.	CISATRACURIUM BESYLATE	10	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-712_d3c597b7-517b-4d79-9fdd-fa88f920111a	71288-712	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20191031		ANDA	ANDA211668	Meitheal Pharmaceuticals Inc.	CISATRACURIUM BESYLATE	10	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-713_c603acf5-af33-479a-8986-fbceb96ff1e5	71288-713	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20191031		ANDA	ANDA211668	Meitheal Pharmaceuticals Inc.	CISATRACURIUM BESYLATE	200	mg/20mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-713_d3c597b7-517b-4d79-9fdd-fa88f920111a	71288-713	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20191031		ANDA	ANDA211668	Meitheal Pharmaceuticals Inc.	CISATRACURIUM BESYLATE	200	mg/20mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-714_c603acf5-af33-479a-8986-fbceb96ff1e5	71288-714	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20191031		ANDA	ANDA211669	Meitheal Pharmaceuticals Inc.	CISATRACURIUM BESYLATE	20	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-714_d3c597b7-517b-4d79-9fdd-fa88f920111a	71288-714	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20191031		ANDA	ANDA211669	Meitheal Pharmaceuticals Inc.	CISATRACURIUM BESYLATE	20	mg/10mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-716_9e2c879f-7485-4071-ad3b-c773985048fc	71288-716	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181217		ANDA	ANDA211504	Meitheal Pharmaceuticals Inc.	METHOCARBAMOL	100	mg/mL	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71288-718_37295b13-65a4-40fa-8d6c-53aeb45e2939	71288-718	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20230508		ANDA	ANDA213453	Meitheal Pharmaceuticals Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-719_18cbd658-029a-4cc4-bd70-9df1cf153dea	71288-719	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20211019		ANDA	ANDA214514	Meitheal Pharmaceuticals Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71288-720_d56233a5-93c0-4828-a18f-28d99e416101	71288-720	HUMAN PRESCRIPTION DRUG	Cisatracurium Besylate		Cisatracurium Besylate	INJECTION, SOLUTION	INTRAVENOUS	20191031		ANDA	ANDA211668	Meitheal Pharmaceuticals Inc.	CISATRACURIUM BESYLATE	10	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71288-723_0949c302-51ce-4fc9-8b99-1df94e693718	71288-723	HUMAN PRESCRIPTION DRUG	bupivacaine hydrochloride		bupivacaine hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20230623		ANDA	ANDA216039	Meitheal Pharmaceuticals Inc	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
71288-726_0949c302-51ce-4fc9-8b99-1df94e693718	71288-726	HUMAN PRESCRIPTION DRUG	bupivacaine hydrochloride		bupivacaine hydrochloride	INJECTION, SOLUTION	PERINEURAL	20230623		ANDA	ANDA216039	Meitheal Pharmaceuticals Inc	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
71288-802_1d64bd9b-5b38-429f-b36c-a3e46c5d2d57	71288-802	HUMAN PRESCRIPTION DRUG	Doxercalciferol		Doxercalciferol	INJECTION, SOLUTION	INTRAVENOUS	20200211		ANDA	ANDA211670	Meitheal Pharmaceuticals Inc.	DOXERCALCIFEROL	4	ug/2mL	Ergocalciferols [CS], Vitamin D2 Analog [EPC]		N	20241231
71288-803_7779ad7f-a903-46b7-ad32-b25ce2c8518c	71288-803	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		Mycophenolate Mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210115		ANDA	ANDA212130	Meitheal Pharmaceuticals Inc.	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
71288-805_1c9d3281-9ee0-4e8c-9d36-7736ada64138	71288-805	HUMAN PRESCRIPTION DRUG	Isosulfan Blue		Isosulfan Blue	INJECTION, SOLUTION	SUBCUTANEOUS	20211103		ANDA	ANDA213130	Meitheal Pharmaceuticals Inc.	ISOSULFAN BLUE	10	mg/mL			N	20241231
71288-806_a4589df5-8c10-4040-ba54-637c518a0e11	71288-806	HUMAN PRESCRIPTION DRUG	Zoledronic Acid		Zoledronic Acid	INJECTION, SOLUTION	INTRAVENOUS	20230605		ANDA	ANDA213371	Meitheal Pharmaceuticals Inc.	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
71288-807_8c63c2aa-de67-4214-99bc-ba483b08d2b5	71288-807	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20180427		ANDA	ANDA210334	Meitheal Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71288-808_80aeb2e2-c42c-454b-a2da-880b0ff9319d	71288-808	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20180427		ANDA	ANDA210333	Meitheal Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71290-813_4a116d5a-332b-68b6-e054-00144ff88e88	71290-813	HUMAN OTC DRUG	Regenpure Precision		MINOXIDIL	LIQUID	TOPICAL	20170304		ANDA	ANDA076239	Salonceuticals, Inc.	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71293-020_eea10c57-a528-9152-e053-2a95a90a0107	71293-020	HUMAN OTC DRUG	Antibacterial Wipes		Benzalkonium chloride	SWAB	TOPICAL	20170316		OTC MONOGRAPH NOT FINAL	part333A	ERC Acquisition, Inc	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71293-021_0c460b4c-621b-fcde-e063-6294a90a82c5	71293-021	HUMAN OTC DRUG	MaxSaver	Sanitizing Wipes	Benzalkonium Chloride	CLOTH	CUTANEOUS	20230718		OTC MONOGRAPH DRUG	505G(a)(3)	ERC ACQUISITION, INC.	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
71297-240_04a2e324-8413-896f-e063-6394a90aaf97	71297-240	HUMAN PRESCRIPTION DRUG	Augmentin		Amoxicillin and Clavulanate Potassium	FOR SUSPENSION	ORAL	20230901		NDA	NDA050575	Allegis Holdings, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	125; 31.25	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
71297-410_06bca4b5-bdb5-8cb4-e063-6394a90a8938	71297-410	HUMAN PRESCRIPTION DRUG	Adapalene Topical Solution		Adapalene Topical Solution	SOLUTION	TOPICAL	20161003		ANDA	ANDA203981	Allegis Holdings LLC	ADAPALENE	1	mg/mL	Retinoid [EPC], Retinoids [CS]		N	20241231
71303-207_03a8d6f3-00f8-5ae3-e063-6294a90a91c2	71303-207	HUMAN OTC DRUG	Foaming Instant Hand Sanitizer		0.13% Benzakonium Chloride	LIQUID	TOPICAL	20170330		OTC MONOGRAPH NOT FINAL	part333E	RJ Schinner	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
71303-213_03a8fa2d-97aa-9f63-e063-6394a90afe68	71303-213	HUMAN OTC DRUG	Foaming Antibacterial Hand Wash		0.13% Benzalkonium Chloride	SOAP	TOPICAL	20170330		OTC MONOGRAPH NOT FINAL	part333E	RJ Schinner	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
71303-683_03a8fa2d-97ab-9f63-e063-6394a90afe68	71303-683	HUMAN OTC DRUG	Foaming Sanitizer		Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20170330		OTC MONOGRAPH NOT FINAL	part333E	RJ Schinner	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
71303-688_03a904f5-0641-f1e2-e063-6294a90af80e	71303-688	HUMAN OTC DRUG	Foaming Hand Sanitizer		Ethyl Alcohol 62%	LIQUID	TOPICAL	20170330		OTC MONOGRAPH NOT FINAL	part333E	RJ Schinner	ALCOHOL	62	mL/100mL			N	20241231
71304-001_0d925332-e035-3109-e063-6294a90af6d2	71304-001	HUMAN OTC DRUG	CU Pain Away Pain Relief		MENTHOL	CREAM	TOPICAL	20170308		OTC MONOGRAPH DRUG	M017	Canadian Unique Health Ltd.	MENTHOL	12.5	mg/g			N	20241231
71308-011_ed045339-cae9-463f-bd65-534f8fa7be2c	71308-011	HUMAN PRESCRIPTION DRUG	OLINVYK		OLICERIDINE	INJECTION, SOLUTION	INTRAVENOUS	20200807		NDA	NDA210730	Trevena, Inc.	OLICERIDINE	1	mg/mL		CII	N	20241231
71308-021_ed045339-cae9-463f-bd65-534f8fa7be2c	71308-021	HUMAN PRESCRIPTION DRUG	OLINVYK		OLICERIDINE	INJECTION, SOLUTION	INTRAVENOUS	20200807		NDA	NDA210730	Trevena, Inc.	OLICERIDINE	2	mg/2mL		CII	N	20241231
71308-301_ed045339-cae9-463f-bd65-534f8fa7be2c	71308-301	HUMAN PRESCRIPTION DRUG	OLINVYK		OLICERIDINE	INJECTION, SOLUTION	INTRAVENOUS	20200807		NDA	NDA210730	Trevena, Inc.	OLICERIDINE	30	mg/30mL		CII	N	20241231
71309-003_f7f18cee-564d-13c4-e053-6294a90ad4a8	71309-003	HUMAN OTC DRUG	Adult Low Dose		Aspirin 81 mg	TABLET, DELAYED RELEASE	ORAL	20160209		OTC MONOGRAPH FINAL	part343	Safrel Pharmaceuticals, LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71309-008_0dd3fe14-f5af-b4c3-e063-6394a90a98a0	71309-008	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 400 mg	TABLET	ORAL	20160413		OTC MONOGRAPH DRUG	M012	Safrel Pharmaceuticals, LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71309-079_0ac07846-5f05-dc4b-e063-6394a90ac8ca	71309-079	HUMAN OTC DRUG	Acetaminophen, Aspirin and Caffeine		Acetaminophen, Aspirin and Caffeine	TABLET	ORAL	20210415		ANDA	ANDA214039	Safrel Pharmaceuticals, LLC.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
71309-090_01c94d0a-30a6-baf4-e063-6394a90a90e3	71309-090	HUMAN OTC DRUG	Fexofenadine HCl		Fexofenadine HCl	TABLET, FILM COATED	ORAL	20221208		ANDA	ANDA204507	Safrel Pharmaceuticals, LLC.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71309-091_f7f18cee-5649-13c4-e053-6294a90ad4a8	71309-091	HUMAN OTC DRUG	Fexofenadine Hydrochloride		Fexofenadine Hydrochloride	TABLET	ORAL	20210103		ANDA	ANDA211075	Safrel Pharmaceuticals, LLC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71309-112_f4ab9fca-5fb1-518a-e053-2a95a90a3420	71309-112	HUMAN OTC DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET, FILM COATED	ORAL	20221028		ANDA	ANDA213513	Safrel Pharmaceuticals LLC	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71309-461_f7f18eb7-a4bc-b7f6-e053-6394a90a0f74	71309-461	HUMAN OTC DRUG	GUAIFENESIN		GUAIFENESIN	TABLET, EXTENDED RELEASE	ORAL	20201218		ANDA	ANDA213420	Safrel Pharmaceuticals, LLC.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71309-601_f4cc6aa7-fa19-1d62-e053-2995a90a59e8	71309-601	HUMAN OTC DRUG	Safrel Cough Relief		DEXTROMETHORPHAN HYDROBROMIDE	CAPSULE, LIQUID FILLED	ORAL	20221028		OTC MONOGRAPH FINAL	part341	Safrel Pharmaceuticals, LLC.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71310-005_0c7c2b9e-b3c4-c447-e063-6294a90a4eeb	71310-005	HUMAN OTC DRUG	Alcohol Prep		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20181111		OTC MONOGRAPH DRUG	M003	Taizhou Kangping Medical Science And Technology Co., Ltd.	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
71310-006_0c86a86e-1d1b-8fa8-e063-6294a90a5963	71310-006	HUMAN OTC DRUG	Antiseptic		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20181111		OTC MONOGRAPH DRUG	505G(a)(3)	Taizhou Kangping Medical Science And Technology Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71310-007_f59620c8-4bb9-473c-e053-2995a90ac391	71310-007	HUMAN OTC DRUG	Antiseptic Wipe		Benzalkonium chloride	CLOTH	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part333E	Taizhou Kangping Medical Science And Technology Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71310-008_fc696cc0-800c-8046-e053-6294a90a7029	71310-008	HUMAN OTC DRUG	ER Alcohol Prep		Isopropyl Alcohol	PATCH	TOPICAL	20230524		OTC MONOGRAPH NOT FINAL	part333A	Taizhou Kangping Medical Science And Technology Co., Ltd.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
71310-009_0e6746c3-d7aa-c617-e063-6294a90a915f	71310-009	HUMAN OTC DRUG	Lightning X Alcohol Prep Pads		Isopropyl Alcohol	PATCH	TOPICAL	20240108		OTC MONOGRAPH DRUG	M003	Taizhou Kangping Medical Science And Technology Co., Ltd.	ISOPROPYL ALCOHOL	70	g/100g			N	20251231
71310-202_d4494c9d-d013-1c0f-e053-2a95a90a0187	71310-202	HUMAN OTC DRUG	Alcohol Prep		Isopropyl Alcohol	PATCH	TOPICAL	20180130	20240530	OTC MONOGRAPH NOT FINAL	part333A	Taizhou Kangping Medical Science And Technology Co., Ltd.	ISOPROPYL ALCOHOL	70	g/100g			N	
71318-111_f7da7dbc-2968-a604-e053-6394a90a0443	71318-111	HUMAN OTC DRUG	Dr Sabharwals		Lidocaine Gel Patch	PATCH	TOPICAL	20230327		OTC MONOGRAPH NOT FINAL	part348	Dr. Sabharwal's Wound Care	LIDOCAINE	84	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71318-112_0407e25d-0c9d-217a-e063-6394a90ad2d3	71318-112	HUMAN OTC DRUG	Lidocaine 4% Gel Patch		Lidocaine 4% Gel Patch	PATCH	TOPICAL	20230810		OTC MONOGRAPH NOT FINAL	part348	Dr. Sabharwal's Wound Care	LIDOCAINE	84	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71321-700_0e77340b-3418-fe13-e063-6294a90a0301	71321-700	HUMAN OTC DRUG	BranTussin DM		Dexbrompheniramine Maleate, Dextromethorphan HBr, Phenylephrine HCl	LIQUID	ORAL	20221014		OTC MONOGRAPH DRUG	M012	Brandywine Pharmaceuticals, LLC	DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 15; 7.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
71321-701_0e775b4a-84df-ff58-e063-6394a90a64f7	71321-701	HUMAN OTC DRUG	Triprolidine HCl Drops		TRIPROLIDINE HYDROCHLORIDE	LIQUID	ORAL	20230308		OTC MONOGRAPH DRUG	M012	Brandywine Pharmaceuticals, LLC	TRIPROLIDINE HYDROCHLORIDE	1.25	mg/2mL			N	20251231
71326-101_06fe9bdc-cb77-8b80-e063-6394a90aa9d3	71326-101	HUMAN OTC DRUG	RHINO LONG POWER		MENTHOL, PANAX GINSENG, GINKGO BILOBA	CREAM	TOPICAL	20170406		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	ASIAN GINSENG; GINKGO; MENTHOL	1; 1; 1	g/100mL; g/100mL; g/100mL			N	20241231
71326-102_06fe92d8-5c82-8e4e-e063-6394a90a7414	71326-102	HUMAN OTC DRUG	PRORINO DELAY		MENTHOL, EUCALYPTUS GLOBULUS, MENTHA ARVENSIS	CREAM	TOPICAL	20180829		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	EUCALYPTUS OIL; MENTHA ARVENSIS LEAF OIL; MENTHOL	.097; .0478; 1	g/100mL; g/100mL; g/100mL			N	20241231
71326-201_06fe88a1-5ee9-653f-e063-6394a90a5cdc	71326-201	HUMAN OTC DRUG	RHINO LONG POWER		MENTHOL, GINKGO BILOBA	SPRAY	TOPICAL	20170406		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	GINKGO; MENTHOL	1; 1	g/100mL; g/100mL			N	20241231
71326-202_06fe77f7-a202-f066-e063-6294a90a7653	71326-202	HUMAN OTC DRUG	PRORINO DELAY		MENTHOL, EUCALYPTUS GLOBULUS, MENTHA ARVENSIS	SPRAY	TOPICAL	20180829		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	EUCALYPTUS OIL; MENTHA ARVENSIS LEAF OIL; MENTHOL	.1; .1; .5	g/100mL; g/100mL; g/100mL			N	20241231
71326-203_06fe6d8f-1960-c1a8-e063-6294a90a81da	71326-203	HUMAN OTC DRUG	V-ACTIV FOR MEN		GINKGO BILOBA, CAPSICUM FRUTESCENS, CAPSICUM ANNUUM	CREAM	TOPICAL	20170406		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	CAPSICUM ANNUUM WHOLE; CAPSICUM FRUTESCENS WHOLE; GINKGO	.1; .1; 1	g/100mL; g/100mL; g/100mL			N	20241231
71326-204_06fe77f7-a1f7-f066-e063-6294a90a7653	71326-204	HUMAN OTC DRUG	V-ACTIV FOR MEN		CAPSICUM FRUTESCENS, CAPSICUM ANNUUM	SPRAY	TOPICAL	20170406		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	CAPSICUM ANNUUM WHOLE; CAPSICUM FRUTESCENS WHOLE	.1; .1	g/100mL; g/100mL			N	20241231
71326-205_06fe88a1-5ede-653f-e063-6394a90a5cdc	71326-205	HUMAN OTC DRUG	V-ACTIV FOR WOMEN		CINNAMOMUM ZEYLANICUM	SPRAY	TOPICAL	20180829		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	CINNAMON LEAF OIL	.1	g/100mL			N	20241231
71326-206_06fe91e2-ae89-7971-e063-6394a90a7571	71326-206	HUMAN OTC DRUG	V-ACTIV FOR WOMEN		CINNAMOMUM ZEYLANICUM	CREAM	TOPICAL	20180829		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	CINNAMON LEAF OIL	.1	g/100mL			N	20241231
71326-207_06fe91e2-ae7e-7971-e063-6394a90a7571	71326-207	HUMAN OTC DRUG	ERO LONG TIME DELAY		EUCALYPTUS GLOBULUS	SPRAY	TOPICAL	20180829		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	EUCALYPTUS OIL	.1	g/100mL			N	20241231
71326-301_06fe8a54-525c-f021-e063-6294a90a7c20	71326-301	HUMAN OTC DRUG	PERFECT BUSTY BOOSTER		CHLORELLA VULGARIS, PCYDONIA OBLONGA, GARCINIA MANGOSTANA	CREAM	TOPICAL	20180830		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	CHLORELLA VULGARIS; CYDONIA OBLONGA SEED; GARCINIA MANGOSTANA FRUIT RIND	.05; .05; .05	g/100mL; g/100mL; g/100mL			N	20241231
71326-302_06fe91e2-ae95-7971-e063-6394a90a7571	71326-302	HUMAN OTC DRUG	PERFECT BUTT BOOSTER		ANEMARRHENA ASPHODELOIDES	CREAM	TOPICAL	20180830		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	ANEMARRHENA ASPHODELOIDES ROOT	.1	g/100mL			N	20241231
71326-303_06fe6d8f-196b-c1a8-e063-6294a90a81da	71326-303	HUMAN OTC DRUG	XXL FOR MEN		ANEMARRHENA ASPHODELOIDES	CREAM	TOPICAL	20180830		UNAPPROVED HOMEOPATHIC		HOT PRODUCTIONS AND VERTRIEBS GMBH	ANEMARRHENA ASPHODELOIDES ROOT	.1	g/100mL			N	20241231
71331-106_f39454be-f1a2-9877-e053-2a95a90a57ec	71331-106	HUMAN OTC DRUG	Anti Dandruff		Salicylic Acid	SHAMPOO	TOPICAL	20200101		OTC MONOGRAPH FINAL	M032	Orange Lab	SALICYLIC ACID	2	g/100g			N	20241231
71331-109_f1f09ca2-53e5-60e7-e053-2995a90aa2e3	71331-109	HUMAN OTC DRUG	A24 Naturalism Sensitive Skin Sunscreen SPF 50		Titanium dioxide and zinc oxide	CREAM	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part352	Orange Lab	TITANIUM DIOXIDE; ZINC OXIDE	2.88; 14.7	g/60g; g/60g			N	20241231
71331-110_f1f09ca2-53e7-60e7-e053-2995a90aa2e3	71331-110	HUMAN OTC DRUG	Enfanti Derma Series 100% Mineral Sun Shield		Titanium dioxide and zinc oxide	CREAM	TOPICAL	20211229		OTC MONOGRAPH NOT FINAL	part352	Orange Lab	TITANIUM DIOXIDE; ZINC OXIDE	2.88; 14.7	g/60g; g/60g			N	20241231
71332-001_4e078ea4-5a66-4a51-af70-24777b4a2d59	71332-001	HUMAN PRESCRIPTION DRUG	TAVALISSE		FOSTAMATINIB	TABLET	ORAL	20180509		NDA	NDA209299	Rigel Pharmaceuticals, Inc.	FOSTAMATINIB	100	mg/1			N	20251231
71332-002_4e078ea4-5a66-4a51-af70-24777b4a2d59	71332-002	HUMAN PRESCRIPTION DRUG	TAVALISSE		FOSTAMATINIB	TABLET	ORAL	20180509		NDA	NDA209299	Rigel Pharmaceuticals, Inc.	FOSTAMATINIB	150	mg/1			N	20251231
71332-005_bef086f5-45c1-443a-9b06-93a445331307	71332-005	HUMAN PRESCRIPTION DRUG	REZLIDHIA		olutasidenib	CAPSULE	ORAL	20221201		NDA	NDA215814	Rigel Pharmaceuticals, Inc.	OLUTASIDENIB	150	mg/1			N	20241231
71334-100_7618e704-4d61-4af1-8a05-1f521db4f309	71334-100	HUMAN PRESCRIPTION DRUG	Tibsovo		ivosidenib	TABLET, FILM COATED	ORAL	20180720	20241130	NDA	NDA211192	Agios Pharmaceuticals, Inc.	IVOSIDENIB	250	mg/1			N	
71334-205_0cf8e1ea-f86d-5bb4-e063-6394a90ab70d	71334-205	HUMAN PRESCRIPTION DRUG	Pyrukynd		mitapivat	TABLET, FILM COATED	ORAL	20220218		NDA	NDA216196	Agios Pharmaceuticals, Inc.	MITAPIVAT	5	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], P-Glycoprotein Inhibitors [MoA], Pyruvate Kinase Activator [EPC], Pyruvate Kinase Activators [MoA], UGT1A1 Inducers [MoA]		N	20241231
71334-210_0cf8e1ea-f86d-5bb4-e063-6394a90ab70d	71334-210	HUMAN PRESCRIPTION DRUG	Pyrukynd		mitapivat	TABLET, FILM COATED	ORAL	20220218		NDA	NDA216196	Agios Pharmaceuticals, Inc.	MITAPIVAT	20	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], P-Glycoprotein Inhibitors [MoA], Pyruvate Kinase Activator [EPC], Pyruvate Kinase Activators [MoA], UGT1A1 Inducers [MoA]		N	20241231
71334-215_0cf8e1ea-f86d-5bb4-e063-6394a90ab70d	71334-215	HUMAN PRESCRIPTION DRUG	Pyrukynd		mitapivat	TABLET, FILM COATED	ORAL	20220218		NDA	NDA216196	Agios Pharmaceuticals, Inc.	MITAPIVAT	50	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], P-Glycoprotein Inhibitors [MoA], Pyruvate Kinase Activator [EPC], Pyruvate Kinase Activators [MoA], UGT1A1 Inducers [MoA]		N	20241231
71334-220_0cf8e1ea-f86d-5bb4-e063-6394a90ab70d	71334-220	HUMAN PRESCRIPTION DRUG	Pyrukynd		mitapivat	TABLET, FILM COATED	ORAL	20220218		NDA	NDA216196	Agios Pharmaceuticals, Inc.	MITAPIVAT	5	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], P-Glycoprotein Inhibitors [MoA], Pyruvate Kinase Activator [EPC], Pyruvate Kinase Activators [MoA], UGT1A1 Inducers [MoA]		N	20241231
71334-225_0cf8e1ea-f86d-5bb4-e063-6394a90ab70d	71334-225	HUMAN PRESCRIPTION DRUG	Pyrukynd		mitapivat	KIT		20220218		NDA	NDA216196	Agios Pharmaceuticals, Inc.						N	20241231
71334-230_0cf8e1ea-f86d-5bb4-e063-6394a90ab70d	71334-230	HUMAN PRESCRIPTION DRUG	Pyrukynd		mitapivat	KIT		20220218		NDA	NDA216196	Agios Pharmaceuticals, Inc.						N	20241231
71335-0007_a1a26248-13d0-4610-9ad5-a9e5434d7f90	71335-0007	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71335-0008_6eb79c92-c2de-4a38-8e71-df95737596fd	71335-0008	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20111001		ANDA	ANDA079163	Bryant Ranch Prepack	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71335-0009_57a75071-96b4-4ba4-bf09-93331c0b105e	71335-0009	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-0013_9ee5dff9-a942-4db2-9c4a-e170de537f2b	71335-0013	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-0014_3d5a3e24-b5d7-4509-8539-f62b30769898	71335-0014	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20120118		ANDA	ANDA091205	Bryant Ranch Prepack	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71335-0015_1f9e6a7d-2a20-4f22-82fa-17b41c8ebde4	71335-0015	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Bryant Ranch Prepack	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0019_5d34959c-8b87-4468-937c-a4f33ae55db2	71335-0019	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20031125	20250731	ANDA	ANDA075932	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	
71335-0022_fc626835-d6e8-bd40-e053-6394a90a51d2	71335-0022	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Bryant Ranch Prepack	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-0024_fc77881a-1bd9-9fa8-e053-6394a90aeb36	71335-0024	HUMAN PRESCRIPTION DRUG	Nitrofurantion		Nitrofurantion	CAPSULE	ORAL	20160415		ANDA	ANDA201722	Bryant Ranch Prepack	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71335-0030_d6a43e62-1926-4660-b4a0-82ea5d0d5b79	71335-0030	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0031_8047b865-7441-4e23-b1d1-7d48a77b8703	71335-0031	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20150810		ANDA	ANDA202765	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-0040_85b7b062-a44c-46d5-b8f3-404bcd61a2f2	71335-0040	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0045_fc9fc4ca-af8a-c6b2-e053-6394a90a6b84	71335-0045	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Bryant Ranch Prepack	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0046_7ac36d7b-edf1-4865-a386-b24346ca513d	71335-0046	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-0049_64c7b894-de22-4c56-9e12-e35eb0b14e57	71335-0049	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride	ER	Diethylpropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111024		ANDA	ANDA091680	Bryant Ranch Prepack	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0051_c74824ac-46e5-491b-b323-efd70f7ad63f	71335-0051	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		GEMFIBROZIL	TABLET	ORAL	20170323		ANDA	ANDA078012	Bryant Ranch Prepack	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71335-0058_bc7e43aa-545e-4e9c-b25f-26a4393ee2a5	71335-0058	HUMAN PRESCRIPTION DRUG	Lansoprazole		lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	Bryant Ranch Prepack	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-0062_65f6bb92-d6cf-4e2e-aa8c-8e7c25dd6fb7	71335-0062	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	Bryant Ranch Prepack	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71335-0067_3aa6328c-0e31-44a8-885e-8b7717e63906	71335-0067	HUMAN PRESCRIPTION DRUG	hydrochlorothiazide		hydrochlorothiazide	CAPSULE	ORAL	20100315		ANDA	ANDA090510	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0069_1d5a650f-ec6f-4d31-b992-b25d7b2d04f9	71335-0069	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Bryant Ranch Prepack	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-0071_44563b18-6fe8-47e2-93bd-9a326eaf9382	71335-0071	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20160613		ANDA	ANDA203071	Bryant Ranch Prepack	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-0074_9aa272e6-5bd9-4a06-873e-e5053911bd17	71335-0074	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	Bryant Ranch Prepack	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
71335-0075_305f6903-96c5-4f4a-9e50-f78669aa966b	71335-0075	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Bryant Ranch Prepack	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0078_fc9d27d0-4035-ad81-e053-6294a90abe93	71335-0078	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Bryant Ranch Prepack	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-0080_27661b2a-5453-4078-8329-10ea715abcef	71335-0080	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel Bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA090540	Bryant Ranch Prepack	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
71335-0082_564bcec0-1a39-4a71-b13a-9144fc645e1b	71335-0082	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0083_1c7ab195-2d22-4021-9af0-f77317695c7c	71335-0083	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0089_6df27092-b075-472f-88f2-ce8564045f77	71335-0089	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Bryant Ranch Prepack	ESZOPICLONE	2	mg/1		CIV	N	20241231
71335-0090_c1c29e18-455d-4321-b993-cbfb812e638c	71335-0090	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20080111		ANDA	ANDA078069	Bryant Ranch Prepack	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0096_dec13c84-ca14-454d-8413-6d482afb0d67	71335-0096	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20150325		ANDA	ANDA078722	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0103_197bd940-b4f6-4b2d-ba2b-e42d8b5057e7	71335-0103	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71335-0107_fc9f928c-6eb7-e844-e053-6294a90a53fa	71335-0107	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	Bryant Ranch Prepack	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0111_48a6769b-5c83-4492-9c98-80f8ebebbf46	71335-0111	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET	ORAL	20091217		ANDA	ANDA090485	Bryant Ranch Prepack	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-0112_fc9f928c-6ea0-e844-e053-6294a90a53fa	71335-0112	HUMAN PRESCRIPTION DRUG	Allopurinol		ALLOPURINOL	TABLET	ORAL	20150429		ANDA	ANDA203154	Bryant Ranch Prepack	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71335-0113_fc6285fa-0144-0cea-e053-6394a90aafba	71335-0113	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Bryant Ranch Prepack	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-0116_6df27092-b075-472f-88f2-ce8564045f77	71335-0116	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	Bryant Ranch Prepack	ESZOPICLONE	3	mg/1		CIV	N	20241231
71335-0120_8dcb81bf-5383-4227-8315-13469ad46a49	71335-0120	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20091215		ANDA	ANDA090702	Bryant Ranch Prepack	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
71335-0126_aabb7d78-64a4-432b-a247-95b767fea183	71335-0126	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	Bryant Ranch Prepack	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0130_dd74ace5-f60e-44bb-a508-a51e6c93bfd2	71335-0130	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Bryant Ranch Prepack	RISPERIDONE	.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0132_33339813-bf8b-4467-9c49-6da474f03076	71335-0132	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, FILM COATED	ORAL	20070727		ANDA	ANDA077851	Bryant Ranch Prepack	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-0141_703af9cd-c96c-4129-bd7f-a5e4973b07a0	71335-0141	HUMAN PRESCRIPTION DRUG	Lamivudine and Zidovudine		Lamivudine and Zidovudine	TABLET	ORAL	20161210		ANDA	ANDA079128	Bryant Ranch Prepack	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
71335-0145_fc734abf-2064-6c02-e053-6394a90a1637	71335-0145	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0149_609cf08a-a8d7-4e20-83e6-05823fb89286	71335-0149	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Bryant Ranch Prepack	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0150_fc6435fa-6962-1d3c-e053-6394a90a4e63	71335-0150	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20101005		ANDA	ANDA090937	Bryant Ranch Prepack	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-0151_dc3c67ad-13e6-4cb8-8da5-301bbfee36bc	71335-0151	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN		TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20051216		ANDA	ANDA077184	Bryant Ranch Prepack	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-0153_fca0506e-4a98-4e55-e053-6294a90a5cf5	71335-0153	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-0154_bff93fd6-ebfb-441a-822e-afe3a2e0fe11	71335-0154	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71335-0155_1c7ab195-2d22-4021-9af0-f77317695c7c	71335-0155	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0158_609cf08a-a8d7-4e20-83e6-05823fb89286	71335-0158	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	Bryant Ranch Prepack	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0161_fc8a8f20-97b2-481e-e053-6394a90a3525	71335-0161	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0165_fd7da43e-35ce-120f-e053-6394a90a2e64	71335-0165	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-0166_f282894d-8b84-4bf3-a10e-2ef9a2b49c3b	71335-0166	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	Bryant Ranch Prepack	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
71335-0167_c22716f8-7409-46e2-947e-b1f10ef78a2f	71335-0167	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA078889	Bryant Ranch Prepack	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0173_85b7b062-a44c-46d5-b8f3-404bcd61a2f2	71335-0173	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141226		ANDA	ANDA202446	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0175_17db9eb2-aafb-4a5a-98df-f733ac5f9f99	71335-0175	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride		Diethylpropion Hydrochloride	TABLET	ORAL	20110718		ANDA	ANDA200177	Bryant Ranch Prepack	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0176_f9b10902-1eea-45f7-aa9c-d2d35f68d526	71335-0176	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Bryant Ranch Prepack	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0180_188733f7-e72a-4217-a2d8-a312cccdc7fc	71335-0180	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Bryant Ranch Prepack	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-0182_0fe9ede8-89a7-4138-9f65-28c4e10f9467	71335-0182	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-0187_1aab7491-76a7-4bd5-953e-f8aeac9293b9	71335-0187	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril	TABLET	ORAL	20160616		ANDA	ANDA077222	Bryant Ranch Prepack	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0192_83748e70-c518-4063-91a9-b1e87aa128fa	71335-0192	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Bryant Ranch Prepack	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0194_05725e50-34b6-49d4-8022-cb204fcf8978	71335-0194	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20040701		ANDA	ANDA076560	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
71335-0202_294bc2d8-de44-4757-8712-6758f099bfb9	71335-0202	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71335-0205_0b074f8b-6330-4b19-b84a-c6946eaaba7b	71335-0205	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Bryant Ranch Prepack	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-0210_d8f504eb-0b96-4bfa-b69f-f8839544e32f	71335-0210	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0222_eee8cb0b-1572-4801-a747-1f46ef9b925c	71335-0222	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71335-0226_49d506c7-5b2c-4be7-8329-8e955df222eb	71335-0226	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Bryant Ranch Prepack	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
71335-0231_937f9913-ef4c-4251-8669-334458e0fd92	71335-0231	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-0232_4e55a728-2703-47ae-a8d2-61247faecebe	71335-0232	HUMAN PRESCRIPTION DRUG	PHENYTOIN SODIUM		PHENYTOIN SODIUM	CAPSULE, EXTENDED RELEASE	ORAL	20061212		ANDA	ANDA040621	Bryant Ranch Prepack	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0233_f0b78f98-d632-40a9-a5aa-317ed5d50338	71335-0233	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-0234_2dae379b-b4bf-4e13-82e5-59ccec22014c	71335-0234	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0236_2a582cd7-cb01-4ec4-bd0a-d43dcd56c31c	71335-0236	HUMAN PRESCRIPTION DRUG	zaleplon		zaleplon	CAPSULE	ORAL	20090505		ANDA	ANDA078989	Bryant Ranch Prepack	ZALEPLON	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], gamma-Aminobutyric Acid A Receptor Agonist [EPC]	CIV	N	20241231
71335-0238_64cbafde-1a25-42aa-a2cc-e1e30a982ab6	71335-0238	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Bryant Ranch Prepack	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0243_1b0d5262-6a3a-4499-b878-2de983a4884e	71335-0243	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20150407		ANDA	ANDA040616	Bryant Ranch Prepack	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-0244_99bc4d0e-37f0-4be4-a7c9-4f9cc083ae7b	71335-0244	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20131108		ANDA	ANDA090678	Bryant Ranch Prepack	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-0246_a5fa17ab-9416-4227-b4ce-b7f9423ce31e	71335-0246	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121022		ANDA	ANDA088619	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-0251_fc9bc685-d2a2-afaa-e053-6394a90a6cfc	71335-0251	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130320		ANDA	ANDA090200	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0255_f6ea33a2-ec65-4b5d-9fb8-d8beb4cc2138	71335-0255	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	Bryant Ranch Prepack	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0260_97c174d9-6e14-44b9-b5a6-c14a05ae3f26	71335-0260	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
71335-0262_ba901b1b-8e05-403d-940d-5539090a7ee8	71335-0262	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Bryant Ranch Prepack	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-0265_f0b78f98-d632-40a9-a5aa-317ed5d50338	71335-0265	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-0266_52fa7362-f665-4d19-b8cf-c8213ef5310b	71335-0266	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE		DILTIAZEM HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20010730		ANDA	ANDA074943	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
71335-0267_b8cacaef-0d8c-4ed5-a49b-23e172a5cde4	71335-0267	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Bryant Ranch Prepack	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-0268_f24f2f99-f6fb-4ead-91ac-bfefcc93c2ed	71335-0268	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20140820		ANDA	ANDA204279	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-0269_fc731fdc-b9af-325f-e053-6294a90a59e4	71335-0269	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20130410		ANDA	ANDA202556	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0273_8717379b-8c97-4e60-9b24-036702e7c180	71335-0273	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Bryant Ranch Prepack	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0278_2073161f-3403-42c3-a7f7-30968de4ae26	71335-0278	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20140516		ANDA	ANDA090455	Bryant Ranch Prepack	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71335-0280_04e709d8-6089-4e98-99ea-bdac2a5eb3d9	71335-0280	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20210527		ANDA	ANDA075090	Bryant Ranch Prepack	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-0286_7bcab2eb-126f-4e34-949a-a7002e06ed12	71335-0286	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Bryant Ranch Prepack	MIRTAZAPINE	15	mg/1			N	20241231
71335-0291_8a153cdd-96af-469f-bb5e-f4586b2f21bf	71335-0291	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20160620		ANDA	ANDA205119	Bryant Ranch Prepack	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-0296_658f2f9e-440b-410d-b681-f14518b63afd	71335-0296	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20170216		ANDA	ANDA207068	Bryant Ranch Prepack	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0299_5bb443d7-ea91-45f0-93ff-c5f3a5567e87	71335-0299	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Bryant Ranch Prepack	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-0302_bce1571e-4981-4e96-935a-4505de11c957	71335-0302	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0303_f0b78f98-d632-40a9-a5aa-317ed5d50338	71335-0303	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-0306_85b7b062-a44c-46d5-b8f3-404bcd61a2f2	71335-0306	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0308_f54265f0-e634-4b0a-b2ef-89f692b74a8f	71335-0308	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Bryant Ranch Prepack	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0309_6a7fd22e-97a9-46b2-b858-cd8535a7cc80	71335-0309	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20170614		ANDA	ANDA202824	Bryant Ranch Prepack	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-0311_320b9b94-a0d8-4dc5-909d-785dd77f572f	71335-0311	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20170707		ANDA	ANDA086727	Bryant Ranch Prepack	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
71335-0320_ae5309e6-331a-473e-b33e-484624b85175	71335-0320	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	Bryant Ranch Prepack	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71335-0321_d9f0749b-cd96-4926-94f9-c81fe5562107	71335-0321	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Bryant Ranch Prepack	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0324_9aa272e6-5bd9-4a06-873e-e5053911bd17	71335-0324	HUMAN PRESCRIPTION DRUG	Phendimetrazine Tartrate		Phendimetrazine Tartrate	TABLET	ORAL	20100915		ANDA	ANDA091042	Bryant Ranch Prepack	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
71335-0325_d2d93e1a-df52-44fd-a60c-02a068bf385c	71335-0325	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Bryant Ranch Prepack	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0326_59131768-c7f8-4eff-80df-38c7f5cf87df	71335-0326	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0332_7bcfbb31-57c4-4494-8670-121ab5a70820	71335-0332	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA075576	Bryant Ranch Prepack	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-0333_e68d0b83-3563-49c4-aff7-e58a80ba8a7f	71335-0333	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Bryant Ranch Prepack	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-0335_629204c0-9a24-46cc-817c-dabbd9e0d3ff	71335-0335	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-0337_b224154a-6d3a-4a67-9939-bda44f9fdb87	71335-0337	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Bryant Ranch Prepack	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0341_7c75603e-150d-4017-ab8e-537e3577d534	71335-0341	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	Bryant Ranch Prepack	LIOTHYRONINE SODIUM	5	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
71335-0344_7a9829c5-4ac1-4856-856c-4c2765c21376	71335-0344	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71335-0345_fcf0a1af-bba3-23a2-e053-6394a90a0513	71335-0345	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Bryant Ranch Prepack	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0349_fc8cb10c-4975-c0bd-e053-6394a90a6fdb	71335-0349	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150422		ANDA	ANDA202824	Bryant Ranch Prepack	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-0350_ea51d624-15dd-4930-8baa-f58948510c04	71335-0350	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0352_a3ef405a-104b-43df-992a-aef81abcf67e	71335-0352	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-0354_faa7635f-47bf-4ab6-a3dd-c1e2b58773d7	71335-0354	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076164	Bryant Ranch Prepack	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0355_fc9ed1ee-1692-9e3f-e053-6294a90a2a5f	71335-0355	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20101222		ANDA	ANDA091276	Bryant Ranch Prepack	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0357_eca6b360-a0e4-4c35-aaae-8a4bf187e678	71335-0357	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0358_10dbdc86-073d-4197-bd36-d2703c8e320a	71335-0358	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	Bryant Ranch Prepack	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
71335-0360_09578b0e-cb8d-473a-9065-57e2b63e10c9	71335-0360	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	Bryant Ranch Prepack	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-0362_fc8d239b-f97c-9a01-e053-6394a90af67d	71335-0362	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	TABLET	ORAL	19900930		ANDA	ANDA070184	Bryant Ranch Prepack	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/1	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
71335-0366_85b7b062-a44c-46d5-b8f3-404bcd61a2f2	71335-0366	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0370_2e30c671-77c1-4fef-b3ac-a6fb4711aefd	71335-0370	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20151222		ANDA	ANDA206530	Bryant Ranch Prepack	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-0371_c4347399-f89a-41f7-84b0-6bc8e7db3edc	71335-0371	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac	GEL	TOPICAL	20160321		ANDA	ANDA208077	Bryant Ranch Prepack	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0377_01ce3728-65ab-40fd-8959-d0fb69fef2e9	71335-0377	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Bryant Ranch Prepack	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0380_8c2bff09-e29b-46ca-b23a-1430829808f8	71335-0380	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20250731	ANDA	ANDA200839	Bryant Ranch Prepack	LEVOFLOXACIN	500	mg/1			N	
71335-0381_45aabe20-10c6-4b99-989a-2b64bd266114	71335-0381	HUMAN PRESCRIPTION DRUG	Fosinopril Sodium		Fosinopril	TABLET	ORAL	20160616		ANDA	ANDA077222	Bryant Ranch Prepack	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0384_435f08cc-aff8-49cf-8e76-72ef8a0a68c3	71335-0384	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20060201		ANDA	ANDA077293	Bryant Ranch Prepack	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71335-0392_f19d31c5-4f28-4ee3-b91b-92dc4fa97278	71335-0392	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-0395_85b7b062-a44c-46d5-b8f3-404bcd61a2f2	71335-0395	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0397_1dcb0621-72e5-4104-bc93-b541f317f39b	71335-0397	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	Bryant Ranch Prepack	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71335-0399_aabb7d78-64a4-432b-a247-95b767fea183	71335-0399	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20030501		ANDA	ANDA076004	Bryant Ranch Prepack	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0402_82aad9bf-b01d-4416-a781-2961d0008937	71335-0402	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-0403_612c69c2-36b5-4c0d-9de1-76816370c37c	71335-0403	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0406_6db54be1-9f9a-4407-80c5-59a5f09e671e	71335-0406	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Bryant Ranch Prepack	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0409_f0ab26be-a69a-456a-852e-840b9c8e117d	71335-0409	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Bryant Ranch Prepack	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-0414_75edd76c-ff40-4a1f-9f7f-8c0b628f8cac	71335-0414	HUMAN PRESCRIPTION DRUG	NP Thyroid 60		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20101111		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	LEVOTHYROXINE; LIOTHYRONINE	38; 9	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
71335-0415_12f949fc-3afe-4a19-b2b6-c27b0e19a271	71335-0415	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0416_bf5f4726-0b8f-4c91-b640-42a1d3c0552c	71335-0416	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71335-0418_3747323c-0497-4cae-b711-9304d2df506f	71335-0418	HUMAN PRESCRIPTION DRUG	LEVOCETIRIZINE DIHYDROCHLORIDE		LEVOCETIRIZINE DIHYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160111		ANDA	ANDA205564	Bryant Ranch Prepack	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-0419_d6a43e62-1926-4660-b4a0-82ea5d0d5b79	71335-0419	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0425_0817caab-8ba3-f9e3-e063-6294a90a9b67	71335-0425	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-0426_1c7ab195-2d22-4021-9af0-f77317695c7c	71335-0426	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0430_fe6c68fe-247b-48de-8df6-30c73f63105d	71335-0430	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	Bryant Ranch Prepack	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
71335-0433_fc9af8c0-6444-7316-e053-6394a90ab738	71335-0433	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20100528		ANDA	ANDA090121	Bryant Ranch Prepack	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71335-0434_23760426-8b87-4ef4-86aa-f8381269b087	71335-0434	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Bryant Ranch Prepack	LEVOFLOXACIN	500	mg/1			N	20241231
71335-0441_ecc9d098-2d04-4636-a062-ee78eb087819	71335-0441	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Bryant Ranch Prepack	MIRTAZAPINE	30	mg/1			N	20241231
71335-0444_fc888abe-fbda-6bda-e053-6294a90af9ed	71335-0444	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071322	Bryant Ranch Prepack	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-0451_e5454571-1da1-4eaa-bb5c-a478ee3aa663	71335-0451	HUMAN PRESCRIPTION DRUG	BENZPHETAMINE HYDROCHLORIDE		benzphetamine hydrochloride	TABLET	ORAL	20100721		ANDA	ANDA090968	Bryant Ranch Prepack	BENZPHETAMINE HYDROCHLORIDE	50	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
71335-0456_300704d3-8dba-4e29-9f03-4191487431c7	71335-0456	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	Bryant Ranch Prepack	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0457_8737247a-5c77-43b5-8cd2-79c74c0ae312	71335-0457	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, COATED	ORAL	20140101		ANDA	ANDA076118	Bryant Ranch Prepack	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-0459_70ed7742-3102-425c-bb6d-b1ed7e6982a0	71335-0459	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Bryant Ranch Prepack	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0461_fdf8dc2e-4127-414b-b9c1-76c237cd8440	71335-0461	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	19961003		ANDA	ANDA074649	Bryant Ranch Prepack	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71335-0464_83a9d3ea-7352-482b-89e1-ec1f1909d432	71335-0464	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20090803		ANDA	ANDA088832	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-0467_fc9cbabd-829a-d480-e053-6394a90ab422	71335-0467	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20150429		ANDA	ANDA203154	Bryant Ranch Prepack	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71335-0469_838acd27-8323-4fe6-ab41-efe5a5dcf0cf	71335-0469	HUMAN PRESCRIPTION DRUG	amantadine hydrochloride		amantadine hydrochloride	CAPSULE	ORAL	20160804		ANDA	ANDA208278	Bryant Ranch Prepack	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
71335-0470_500198f4-7d58-4ca7-af94-da87550a3275	71335-0470	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20060320		ANDA	ANDA075677	Bryant Ranch Prepack	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-0471_e3e9db6a-d009-4197-9353-a946bd37a345	71335-0471	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-0472_564bcec0-1a39-4a71-b13a-9144fc645e1b	71335-0472	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0479_eba5eef7-a593-4e05-8ab1-99a7708397c7	71335-0479	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20061004		ANDA	ANDA077912	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0480_fd15bf11-93b6-5a7b-e053-6394a90adc99	71335-0480	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	Bryant Ranch Prepack	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0481_029b55c3-611e-9971-e063-6394a90a156a	71335-0481	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0483_0d3ec8c9-4703-488b-98c9-1b0935275d78	71335-0483	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20150115		ANDA	ANDA202039	Bryant Ranch Prepack	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-0484_188733f7-e72a-4217-a2d8-a312cccdc7fc	71335-0484	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20070823		ANDA	ANDA078181	Bryant Ranch Prepack	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-0486_e2e2bffc-45ca-42a8-ae95-2a14dd6182b5	71335-0486	HUMAN PRESCRIPTION DRUG	zonisamide		zonisamide	CAPSULE	ORAL	20160713		ANDA	ANDA077869	Bryant Ranch Prepack	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71335-0487_ab760ab7-1242-4fc0-b187-837b936f0a30	71335-0487	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Bryant Ranch Prepack	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0498_b931c0d3-b6f6-401f-9de9-1a459560bd39	71335-0498	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Bryant Ranch Prepack	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0508_629204c0-9a24-46cc-817c-dabbd9e0d3ff	71335-0508	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-0509_2cca2c6c-8dcb-47ab-a840-1cb46be6674b	71335-0509	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-0510_a33b591a-ff05-4e17-9ba7-59f24d8d3176	71335-0510	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0512_fb28b4ff-93df-401f-b4e7-b6c3ec2674a6	71335-0512	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091166	Bryant Ranch Prepack	ESZOPICLONE	2	mg/1		CIV	N	20241231
71335-0513_34a90312-18ce-43a8-b68a-6f2ba4261fa9	71335-0513	HUMAN OTC DRUG	Regular Strength Enteric coated aspirin		Aspirin	TABLET, COATED	ORAL	20000701		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71335-0514_dd8189d6-e479-4e78-812c-523db9c3bdae	71335-0514	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20130411		ANDA	ANDA202717	Bryant Ranch Prepack	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71335-0519_755e9d62-daba-4afa-ba1b-8ad5fad4045a	71335-0519	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	19900930		ANDA	ANDA071655	Bryant Ranch Prepack	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71335-0521_756ee5fa-0da8-4e63-adc4-9f1d81942aa5	71335-0521	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-0524_0ea71997-4939-a72e-e063-6294a90a52da	71335-0524	HUMAN OTC DRUG	Arthritis Pain Reliever		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20020430		ANDA	ANDA076200	Bryant Ranch Prepack	ACETAMINOPHEN	650	mg/1			N	20251231
71335-0526_c7aaaf9a-f499-4347-907d-383c38b5f1e2	71335-0526	HUMAN OTC DRUG	Diphenhydramine HCL		Diphenhydramine HCL	CAPSULE	ORAL	20100127		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-0534_4b246ebf-63ef-4e9e-aa2c-318b00005f84	71335-0534	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Bryant Ranch Prepack	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0536_a2dacb9a-23d1-451f-9aba-61be6725d135	71335-0536	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Bryant Ranch Prepack	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0544_ee05ddc0-ddfa-4071-92c0-c9b01f9a75ce	71335-0544	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20070413		ANDA	ANDA077584	Bryant Ranch Prepack	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0547_1ed0059e-c1d5-4737-add6-8bff8e5e16c0	71335-0547	HUMAN PRESCRIPTION DRUG	Valsartan and Hydrochlorothiazide		Valsartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130419		ANDA	ANDA203145	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0548_f855233b-ef74-4fdc-9fe7-530209a8e3d1	71335-0548	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Bryant Ranch Prepack	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0551_7dba46ef-8cea-4dff-97f5-845518d3851a	71335-0551	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Bryant Ranch Prepack	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-0554_564bcec0-1a39-4a71-b13a-9144fc645e1b	71335-0554	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0564_9cbea15b-829b-4e4b-b89c-558e03513bd9	71335-0564	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040875	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0566_85b7b062-a44c-46d5-b8f3-404bcd61a2f2	71335-0566	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141226		ANDA	ANDA202446	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-0567_75293926-56d9-41ff-9dd6-5e61f969a5e5	71335-0567	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Bryant Ranch Prepack	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-0569_4a505735-fe67-413a-a6a7-df463bf8da23	71335-0569	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20031111		ANDA	ANDA076048	Bryant Ranch Prepack	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-0570_f41904ef-726e-456b-9914-30ae74098f57	71335-0570	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	20150402		ANDA	ANDA065062	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-0574_fb28b4ff-93df-401f-b4e7-b6c3ec2674a6	71335-0574	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091166	Bryant Ranch Prepack	ESZOPICLONE	1	mg/1		CIV	N	20241231
71335-0579_fd901e8d-53ca-6e15-e053-6294a90a4b31	71335-0579	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20101225		NDA AUTHORIZED GENERIC	NDA018602	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	90	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-0581_8a112adf-35d3-4fbf-b23a-2544ae953d61	71335-0581	HUMAN PRESCRIPTION DRUG	Clopidogrel		Clopidogrel	TABLET	ORAL	20121016		ANDA	ANDA202928	Bryant Ranch Prepack	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
71335-0584_7f0d2464-e615-40b6-bb64-dea3bbefb470	71335-0584	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Bryant Ranch Prepack	PRAMIPEXOLE DIHYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-0585_9a0bbd38-a8a5-4d8a-82d2-c7b9ecfa8bab	71335-0585	HUMAN PRESCRIPTION DRUG	Ziprasidone Hydrochloride		Ziprasidone Hydrochloride	CAPSULE	ORAL	20170218		ANDA	ANDA204375	Bryant Ranch Prepack	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0587_d88b1f49-8ea3-43fa-ae34-0cb10ca3a562	71335-0587	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-0593_06dba8fb-989d-4e7c-9e4c-232251e381c3	71335-0593	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Bryant Ranch Prepack	LEVOFLOXACIN	750	mg/1			N	20241231
71335-0595_c8aa01db-b044-462b-af69-bae55087a6a7	71335-0595	HUMAN PRESCRIPTION DRUG	bisoprolol fumarate and hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET	ORAL	20101012		ANDA	ANDA079106	Bryant Ranch Prepack	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0598_6df27092-b075-472f-88f2-ce8564045f77	71335-0598	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Bryant Ranch Prepack	ESZOPICLONE	1	mg/1		CIV	N	20241231
71335-0601_1dcb0621-72e5-4104-bc93-b541f317f39b	71335-0601	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	Bryant Ranch Prepack	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71335-0606_f9bf290d-2693-4169-aab0-0caf3e49b6d3	71335-0606	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0607_fc78bb57-8617-c260-e053-6294a90aadba	71335-0607	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Bryant Ranch Prepack	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0613_a925666f-af51-4ace-85a5-5de390cb8c41	71335-0613	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20150804		ANDA	ANDA204418	Bryant Ranch Prepack	FOLIC ACID	1	mg/1			N	20241231
71335-0617_f128ff41-2ad3-4a5b-a34c-13d6f8940f35	71335-0617	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20170504		ANDA	ANDA208633	Bryant Ranch Prepack	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0618_fc64c052-ae97-1fd5-e053-6394a90ae496	71335-0618	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Bryant Ranch Prepack	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-0622_32a85ae5-2546-483f-a183-168ead487af2	71335-0622	HUMAN OTC DRUG	Aspirin	Low Dose	Aspirin	TABLET, COATED	ORAL	20000701		OTC MONOGRAPH FINAL	part343	Bryant Ranch Prepack	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71335-0623_629204c0-9a24-46cc-817c-dabbd9e0d3ff	71335-0623	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Bryant Ranch Prepack	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-0626_e8c741a1-4965-490f-8f89-5ddef1a1a776	71335-0626	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Bryant Ranch Prepack	RISPERIDONE	1	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0630_41744c05-88e2-4a3c-a166-f2625792482b	71335-0630	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20150525		ANDA	ANDA203047	Bryant Ranch Prepack	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-0632_7ff5b843-e930-4718-804b-c6e0d555b29d	71335-0632	HUMAN OTC DRUG	Stool Softener	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20150131		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM	250	mg/1			N	20241231
71335-0634_2f580fc1-703c-449a-bb1e-7ed78d6cc018	71335-0634	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
71335-0639_aa348cf2-2e1b-486f-9bec-5ccf67879175	71335-0639	HUMAN PRESCRIPTION DRUG	LAMIVUDINE and ZIDOVUDINE		LAMIVUDINE and ZIDOVUDINE	TABLET, FILM COATED	ORAL	20150918		ANDA	ANDA079124	Bryant Ranch Prepack	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
71335-0643_7e6a9719-c345-4c8c-96ed-5f21905e536a	71335-0643	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
71335-0646_46f2ce86-3afb-468e-b738-b43cfc8ac404	71335-0646	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205017	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0648_3f13c7c6-84d0-4128-a7af-cbd3a57042cb	71335-0648	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000228		ANDA	ANDA075492	Bryant Ranch Prepack	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0652_fc731fdc-b9c6-325f-e053-6294a90a59e4	71335-0652	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0653_a29db87b-3f50-40ca-a5ab-406028ff19f0	71335-0653	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate	CAPSULE	ORAL	20020422		ANDA	ANDA075929	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
71335-0655_bede5c6d-846d-4371-947b-1ae2566c8fe2	71335-0655	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	Bryant Ranch Prepack	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-0664_e802776e-5841-4893-b19b-ed3a01a5bb02	71335-0664	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20090817		ANDA	ANDA076921	Bryant Ranch Prepack	MIRTAZAPINE	15	mg/1			N	20241231
71335-0676_c8b51a7a-1b9c-4b09-8e16-4933c245c973	71335-0676	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-0678_9cbea15b-829b-4e4b-b89c-558e03513bd9	71335-0678	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120807		ANDA	ANDA040886	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-0682_034b4afb-e15a-454e-a13a-8a1397856a53	71335-0682	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19920201		ANDA	ANDA063181	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-0684_7d35e0d0-b34b-4593-a5dd-768cd33df370	71335-0684	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170612		ANDA	ANDA208803	Bryant Ranch Prepack	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
71335-0685_6eaf1fe3-8a08-4d0a-b8ad-f25f18ab93e8	71335-0685	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20120911		ANDA	ANDA090939	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0686_c1ed9fa2-3add-4470-822f-278b11271891	71335-0686	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Bryant Ranch Prepack	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-0688_1c471368-6338-4e1e-b93d-8fcb5022a1f5	71335-0688	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040627	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-0690_4be068cc-4c47-48aa-9368-d59dff649f70	71335-0690	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Bryant Ranch Prepack	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0691_510c387b-b8a9-415f-b3fb-af1f7a602f09	71335-0691	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20020901		ANDA	ANDA075948	Bryant Ranch Prepack	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71335-0692_02968188-5c16-180b-e063-6394a90a70c6	71335-0692	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0693_de449fcc-a216-4a3e-ba28-c2aed36842d2	71335-0693	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140731		ANDA	ANDA203374	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71335-0694_e3c76724-8327-4644-9c35-8dfe3af1daf2	71335-0694	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120109		ANDA	ANDA090515	Bryant Ranch Prepack	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0696_1cc047f3-b3d9-4782-9964-e05b8f1a4339	71335-0696	HUMAN PRESCRIPTION DRUG	Labetalol HCl		Labetalol HCl	TABLET, FILM COATED	ORAL	19980804		ANDA	ANDA075113	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0697_273fe481-c4b1-4212-9aa4-feca20eb2baf	71335-0697	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20170808		ANDA	ANDA207761	Bryant Ranch Prepack	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0702_e3c76724-8327-4644-9c35-8dfe3af1daf2	71335-0702	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	Bryant Ranch Prepack	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0705_22b79021-fdc2-45a0-aee8-bf3e9112aedd	71335-0705	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Bryant Ranch Prepack	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71335-0706_9b39a332-9bfd-4077-b367-73d580a76b42	71335-0706	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Bryant Ranch Prepack	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
71335-0707_cce77429-4247-4ead-8766-8c357684d4a4	71335-0707	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-0708_23d2bf71-d94e-4dc2-9a27-921d0c7f1ea7	71335-0708	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Bryant Ranch Prepack	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-0714_6e70ac3e-a755-4656-be55-a412fe9a9dc4	71335-0714	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20131210		ANDA	ANDA076255	Bryant Ranch Prepack	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0720_9f06ac77-2411-4c32-bbed-47cb6dcdbfb9	71335-0720	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-0725_1c471368-6338-4e1e-b93d-8fcb5022a1f5	71335-0725	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040749	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-0726_f21b8db7-bc7f-43c2-80e1-f89304a3c055	71335-0726	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		fosinopirl sodium	TABLET	ORAL	20171001		ANDA	ANDA205670	Bryant Ranch Prepack	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0730_200f66c6-c833-4ffa-bdaa-ec409d90205f	71335-0730	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Bryant Ranch Prepack	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71335-0733_1cc047f3-b3d9-4782-9964-e05b8f1a4339	71335-0733	HUMAN PRESCRIPTION DRUG	Labetalol HCl		Labetalol HCl	TABLET, FILM COATED	ORAL	19980804		ANDA	ANDA075113	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0736_92486bf4-18b1-4f27-836e-3db315aacf6e	71335-0736	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-0738_2ef0bb0f-6168-4d4c-9ede-d940b5afbe4b	71335-0738	HUMAN OTC DRUG	STOOL SOFTNER		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20160301		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM	100	mg/1			N	20241231
71335-0740_42cc7cef-0bbe-4d13-afd9-525b0572428c	71335-0740	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Bryant Ranch Prepack	RISPERIDONE	.25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0741_1d91e4ad-ce12-4b18-abff-c8ec0345a834	71335-0741	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, FILM COATED	ORAL	20170601		ANDA	ANDA076433	Bryant Ranch Prepack	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71335-0742_35b6d3b5-9a08-4a9a-bee2-63135ee5a0da	71335-0742	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Bryant Ranch Prepack	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71335-0743_6aac040c-3be7-4941-ad8f-6c2e22e3b653	71335-0743	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20150814		ANDA	ANDA200981	Bryant Ranch Prepack	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0744_371d22d6-5644-4756-9bce-03fe3f104db0	71335-0744	HUMAN PRESCRIPTION DRUG	nifedipine		nifedipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20000927		ANDA	ANDA075289	Bryant Ranch Prepack	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-0745_9e922d29-12b6-4a9e-85f1-368acea940cf	71335-0745	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-0747_872c7213-8211-4a8a-ad6b-bae596f47011	71335-0747	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0749_2b99a498-a010-4505-827f-f0baa3d7cf16	71335-0749	HUMAN PRESCRIPTION DRUG	Rosuvastatin		Rosuvastatin	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0754_a7f64f32-2cd0-4e44-b791-430751efe4fc	71335-0754	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumentone	TABLET	ORAL	20020225		ANDA	ANDA075280	Bryant Ranch Prepack	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0756_ca16edc5-4810-4243-bd2b-29992cc4b1f8	71335-0756	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20150724		ANDA	ANDA201807	Bryant Ranch Prepack	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0762_37bd4b70-2c16-41b3-9757-52863822d78b	71335-0762	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Bryant Ranch Prepack	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
71335-0766_291dfcdf-7bc5-4313-a533-25c72defdd72	71335-0766	HUMAN PRESCRIPTION DRUG	FOLIC ACID		FOLIC ACID	TABLET	ORAL	20090112		ANDA	ANDA040796	Bryant Ranch Prepack	FOLIC ACID	1	mg/1			N	20241231
71335-0769_46a001ad-977f-447a-ae82-dca366fcf922	71335-0769	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20170406		ANDA	ANDA208963	Bryant Ranch Prepack	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-0771_37fa8916-531b-43e9-ac97-113c6c570ab6	71335-0771	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20000101		ANDA	ANDA085123	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0772_a9bc1e67-05f6-422d-96d8-dd3bb4229e95	71335-0772	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Bryant Ranch Prepack	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0775_e959822e-df83-4abd-99a6-1847aafb11ba	71335-0775	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170427		ANDA	ANDA207662	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-0776_9f06ac77-2411-4c32-bbed-47cb6dcdbfb9	71335-0776	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-0777_fc5f2212-8eb4-e4c8-e053-6394a90a7483	71335-0777	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-0781_a7f64f32-2cd0-4e44-b791-430751efe4fc	71335-0781	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumentone	TABLET	ORAL	20020225		ANDA	ANDA075280	Bryant Ranch Prepack	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0788_737efed5-ff59-4bdc-bc53-a223e6509ae0	71335-0788	HUMAN PRESCRIPTION DRUG	Hyoscyamine	SL	hyoscyamine sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20160415		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
71335-0792_f118d721-590a-4fbd-8433-b1f33c901cb1	71335-0792	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20150202		ANDA	ANDA203034	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71335-0794_8745e26e-a0da-4002-8211-9ff1ab18e29e	71335-0794	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Bryant Ranch Prepack	LEVOFLOXACIN	250	mg/1			N	20241231
71335-0797_3620a3da-02fb-43e1-8952-5a55894b053b	71335-0797	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Bryant Ranch Prepack	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
71335-0800_c1660997-a85d-4743-83f0-0d4cc9829665	71335-0800	HUMAN PRESCRIPTION DRUG	Trimethobenzamide Hydrochloride		Trimethobenzamide Hydrochloride	CAPSULE	ORAL	20110117		ANDA	ANDA076546	Bryant Ranch Prepack	TRIMETHOBENZAMIDE HYDROCHLORIDE	300	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-0808_9c252aee-dfb1-4226-90b5-7477f31f3034	71335-0808	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0815_b638187e-24d5-4c7a-8489-b79e64a2dcfd	71335-0815	HUMAN PRESCRIPTION DRUG	ondansetron		ondansetron hydrochloride	TABLET, FILM COATED	ORAL	20070625		ANDA	ANDA077851	Bryant Ranch Prepack	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-0817_d19ef4d9-873b-4f6b-8130-6afea0653b7e	71335-0817	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20170427		ANDA	ANDA207662	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-0819_fc78db5a-57ed-cd04-e053-6294a90aca53	71335-0819	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Bryant Ranch Prepack	LOVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0821_8f556459-e2b7-4315-bde9-00d8b6ef7477	71335-0821	HUMAN OTC DRUG	Motion-Time	Chewable	Meclizine HCl	TABLET, CHEWABLE	ORAL	20100809		OTC MONOGRAPH FINAL	part336	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	25	mg/251	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-0824_cacdf07a-142b-400b-bac5-bddc457cb8a1	71335-0824	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride (XL)		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180108		ANDA	ANDA208652	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-0827_b9d5a8f5-39f1-425d-93fa-8adf95867fdb	71335-0827	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0828_96951150-51f8-41d7-8886-d2ac5286e54b	71335-0828	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0830_cbf3ec29-66dd-4a92-a951-53a21a3e1c44	71335-0830	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Bryant Ranch Prepack	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
71335-0839_8be22777-9bbe-4d2a-ad16-f2db4185683c	71335-0839	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	EXTENDED RELEASE	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20140820		NDA AUTHORIZED GENERIC	NDA020401	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-0842_fc767667-70ab-0fce-e053-6394a90a9831	71335-0842	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71335-0844_37fa8916-531b-43e9-ac97-113c6c570ab6	71335-0844	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20000101		ANDA	ANDA085159	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0852_fc767667-70ab-0fce-e053-6394a90a9831	71335-0852	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71335-0854_a518664a-2636-475f-824b-81cc1e710c78	71335-0854	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Bryant Ranch Prepack	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-0863_caeadb30-df1d-43b3-b661-5354294102d4	71335-0863	HUMAN PRESCRIPTION DRUG	Nitrofurantoin	(monohydrate/macrocrystals)	Nitrofurantoin monohydrate/macrocrystals	CAPSULE	ORAL	20170525		ANDA	ANDA207372	Bryant Ranch Prepack	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
71335-0867_2f580fc1-703c-449a-bb1e-7ed78d6cc018	71335-0867	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
71335-0868_b20c0add-b781-457e-9529-e6cd6bdc5046	71335-0868	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Bryant Ranch Prepack	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0872_b287c421-4022-448e-9d0d-44d5febcaf40	71335-0872	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20180601		ANDA	ANDA200884	Bryant Ranch Prepack	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71335-0882_fc9fb9dd-6fab-07bf-e053-6294a90ac8da	71335-0882	HUMAN PRESCRIPTION DRUG	Lovastatin		lovastatin	TABLET	ORAL	20071101		ANDA	ANDA078296	Bryant Ranch Prepack	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-0883_73e30786-8309-4943-8ae0-2cb376563217	71335-0883	HUMAN PRESCRIPTION DRUG	Methimazole		Methimazole	TABLET	ORAL	20120115		ANDA	ANDA040734	Bryant Ranch Prepack	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
71335-0890_f9173403-7640-40a6-8b98-f0fe1bdc6c07	71335-0890	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Bryant Ranch Prepack	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-0891_ee881909-c759-4817-a79b-a498e22c4eb8	71335-0891	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20161215		ANDA	ANDA208709	Bryant Ranch Prepack	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71335-0894_fc4d088b-3824-1235-e053-6394a90a5a00	71335-0894	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Bryant Ranch Prepack	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-0897_8f293e26-1ce8-4ad4-a406-c9b67eeca36f	71335-0897	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	Bryant Ranch Prepack	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
71335-0898_c2bae756-7ef4-496b-be8f-c9b788d7a4f8	71335-0898	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET, FILM COATED	ORAL	20161110		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71335-0900_fde8f515-e602-4b77-a4ad-2e829bdaf193	71335-0900	HUMAN PRESCRIPTION DRUG	donepezil hydrochloride		donepezil hydrochloride	TABLET, FILM COATED	ORAL	20111101		ANDA	ANDA200292	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71335-0902_fc63237b-8b6e-72d4-e053-6394a90a110b	71335-0902	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20010131		ANDA	ANDA075845	Bryant Ranch Prepack	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0906_42ac2fc7-21f5-4518-8030-753dfc77a184	71335-0906	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20180528		ANDA	ANDA207222	Bryant Ranch Prepack	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71335-0912_7ad02f23-0012-48cd-ab73-f51acaae3062	71335-0912	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	Bryant Ranch Prepack	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0914_f7208413-1416-5d5e-e053-6394a90aeec9	71335-0914	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-0915_ba3789bf-3ef4-4699-88f1-51574ea61cb6	71335-0915	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-0918_55207f91-899d-4a09-b050-42b592d8bc07	71335-0918	HUMAN PRESCRIPTION DRUG	Terbinafine Hydrochloride		Terbinafine Hydrochloride	TABLET	ORAL	20101227		ANDA	ANDA077714	Bryant Ranch Prepack	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71335-0921_c5d31fa2-ceef-4672-89b3-ab44da8648ab	71335-0921	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0923_b9d5a8f5-39f1-425d-93fa-8adf95867fdb	71335-0923	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-0925_73cc4ed7-0b5e-4813-98e2-d5a960d46e27	71335-0925	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	Bryant Ranch Prepack	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0926_26b43283-8d9a-4d5a-8d6e-e9cbeacee3fe	71335-0926	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Bryant Ranch Prepack	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-0930_fc72e4e3-eb94-6f28-e053-6394a90ae556	71335-0930	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Bryant Ranch Prepack	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-0934_f9173403-7640-40a6-8b98-f0fe1bdc6c07	71335-0934	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Bryant Ranch Prepack	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-0935_a5fa17ab-9416-4227-b4ce-b7f9423ce31e	71335-0935	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121009		ANDA	ANDA088618	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-0936_b20c0add-b781-457e-9529-e6cd6bdc5046	71335-0936	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Bryant Ranch Prepack	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0938_d5fd4345-913c-4236-9dec-1178b63af68b	71335-0938	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19860619		ANDA	ANDA085082	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-0939_20c4c4da-3e8f-49cd-b16e-c2a1b4592f91	71335-0939	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumentone	TABLET	ORAL	20020225		ANDA	ANDA075280	Bryant Ranch Prepack	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0940_c56f1c2a-3e1a-4e1a-9b6c-855351030d80	71335-0940	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20141027		ANDA	ANDA203646	Bryant Ranch Prepack	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-0945_f9173403-7640-40a6-8b98-f0fe1bdc6c07	71335-0945	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Bryant Ranch Prepack	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-0952_c81e4d18-4c33-4f3a-80d0-d452616dd654	71335-0952	HUMAN PRESCRIPTION DRUG	PROCHLORPERAZINE MALEATE		Prochlorperazine maleate	TABLET	ORAL	19980301		ANDA	ANDA040268	Bryant Ranch Prepack	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71335-0953_fc773ed5-3275-9825-e053-6294a90a96c5	71335-0953	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	Bryant Ranch Prepack	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-0954_fc9d8866-3b2c-7fde-e053-6294a90ae8a9	71335-0954	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Bryant Ranch Prepack	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0955_564bcec0-1a39-4a71-b13a-9144fc645e1b	71335-0955	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-0958_cb3b397a-92c0-4c7a-b98d-8da6eb5e521e	71335-0958	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Bryant Ranch Prepack	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0961_a5fa17ab-9416-4227-b4ce-b7f9423ce31e	71335-0961	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20130219		ANDA	ANDA088617	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-0964_d6ac8d5d-a7b2-4221-90cc-531c09d9dc53	71335-0964	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Bryant Ranch Prepack	MIRTAZAPINE	30	mg/1			N	20241231
71335-0968_de510dfd-cf92-4f14-a598-38597b3b5371	71335-0968	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19930923		ANDA	ANDA073449	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-0970_96951150-51f8-41d7-8886-d2ac5286e54b	71335-0970	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-0973_f6ea33a2-ec65-4b5d-9fb8-d8beb4cc2138	71335-0973	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	Bryant Ranch Prepack	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0982_ada3ea44-e396-49f9-a09d-59b17f403e8a	71335-0982	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	Bryant Ranch Prepack	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0989_fd29d4cf-e03f-1d41-e053-6294a90a8ccb	71335-0989	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20070504		ANDA	ANDA040712	Bryant Ranch Prepack	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71335-0992_fc9efc7f-aa54-fc0a-e053-6394a90a81f9	71335-0992	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-0993_c465499f-1fdb-41b6-a9ba-60275273519a	71335-0993	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-0998_029b06a0-5341-5a77-e063-6394a90a7ea2	71335-0998	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-0999_5dfd70fb-a8d5-43fa-83fb-ae8723967a3d	71335-0999	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180823		ANDA	ANDA203281	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1000_ac8d3e70-4d67-458f-8b5b-521caa6c2b56	71335-1000	HUMAN PRESCRIPTION DRUG	DESLORATADINE		DESLORATADINE	TABLET, FILM COATED	ORAL	20130225		ANDA	ANDA078352	Bryant Ranch Prepack	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-1002_e264fb6d-824e-40ff-9dc3-0f6157625b21	71335-1002	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1005_7dde9c19-f947-49da-bcd3-01430780e173	71335-1005	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103	20271031	ANDA	ANDA203814	Bryant Ranch Prepack	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	
71335-1007_1de18a0c-e99c-441c-b5c5-4bae290f87a9	71335-1007	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1010_8e18897d-35f8-4db7-8ddc-ff3e1dfb2978	71335-1010	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1011_d66b2c43-f35c-4936-89f3-5cc9fb87fe87	71335-1011	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1012_07178f05-de42-4231-8b1f-4a976b8b5614	71335-1012	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	TABLET, FILM COATED	ORAL	20060824		ANDA	ANDA077525	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1014_c8e8f195-9180-407f-8b08-93704f2127af	71335-1014	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20180201		ANDA	ANDA209025	Bryant Ranch Prepack	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71335-1016_91df5b29-5db4-442d-b3c8-e3ec53cd99e0	71335-1016	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-1018_07178f05-de42-4231-8b1f-4a976b8b5614	71335-1018	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	TABLET, FILM COATED	ORAL	20060824		ANDA	ANDA077525	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1022_04a466f1-6e78-4e52-a88d-524e0574aa1f	71335-1022	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1026_23338a4f-3886-4308-8f39-d44f9c3eca6e	71335-1026	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1028_272dda1c-852c-460c-9348-0c72d1b4e222	71335-1028	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	Bryant Ranch Prepack	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1030_c516706d-c38f-447a-93b6-608e5ef2bedc	71335-1030	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130319		ANDA	ANDA202389	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1031_26e6e8e4-da36-4f23-baf1-ab9b2d154bb8	71335-1031	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	Bryant Ranch Prepack	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-1033_b9d5a8f5-39f1-425d-93fa-8adf95867fdb	71335-1033	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1041_bdd56179-411f-4970-9e6a-d67d2ffb6692	71335-1041	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1042_26e6e8e4-da36-4f23-baf1-ab9b2d154bb8	71335-1042	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	Bryant Ranch Prepack	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-1043_a2a8a8dc-2a75-4a77-861b-b3f6aa7a6474	71335-1043	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1044_8700c145-ca23-4962-8e2e-89b1603d5ce4	71335-1044	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1045_034b4afb-e15a-454e-a13a-8a1397856a53	71335-1045	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	CAPSULE	ORAL	19930501		ANDA	ANDA063065	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1047_6badcc21-e8d3-4014-97d1-63afd664bcf6	71335-1047	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	Bryant Ranch Prepack	HYDROXYZINE HYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-1050_b38e868e-7d50-45ac-b782-0d96ff53a5c6	71335-1050	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20110222		NDA AUTHORIZED GENERIC	NDA018279	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1051_37d3659f-cf80-4a21-a646-3e0edcda04a7	71335-1051	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Bryant Ranch Prepack	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1053_69b18258-472a-4b9e-bd50-f5d4db0a86c1	71335-1053	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Bryant Ranch Prepack	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-1055_78f0b2ac-a9bf-486c-abf3-b5170ca051fd	71335-1055	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Bryant Ranch Prepack	MIRTAZAPINE	15	mg/1			N	20241231
71335-1056_3710097b-2aba-4a83-a2f2-b616a3ed7193	71335-1056	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Bryant Ranch Prepack	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-1057_fc4f62da-ac9d-fb76-e053-6394a90a2ef6	71335-1057	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20110608		ANDA	ANDA091604	Bryant Ranch Prepack	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-1058_cef1ef27-6965-4aa2-b4f1-9a01e929e937	71335-1058	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214	20260531	ANDA	ANDA086183	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	
71335-1059_2634a3b7-1a57-4f6e-93fa-78e513d0b9b7	71335-1059	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	20180827		ANDA	ANDA040616	Bryant Ranch Prepack	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-1066_3ff92eeb-6fa9-4036-841d-e735f2b93845	71335-1066	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	Bryant Ranch Prepack	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1072_fc72e377-7fc8-1acb-e053-6394a90a4aeb	71335-1072	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1073_3a49476d-08a1-42e1-ae21-589b30a0ca6d	71335-1073	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Bryant Ranch Prepack	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1078_db17ecd2-d39c-4ff1-bc78-911da2bad07e	71335-1078	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1085_fd7eaf0b-8ba0-6192-e053-6294a90a89c2	71335-1085	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Bryant Ranch Prepack	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-1086_fc9d1bd9-f945-7c61-e053-6294a90a3117	71335-1086	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Bryant Ranch Prepack	BENAZEPRIL HYDROCHLORIDE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-1088_4188c3f7-e2f5-4134-8af6-c78a64427e29	71335-1088	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	Bryant Ranch Prepack	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1093_6599b943-d49a-4666-a585-5b17076b8e8e	71335-1093	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1097_04ca597a-0797-4dd7-b85e-9d9bdcad68c3	71335-1097	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130124		ANDA	ANDA077369	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-1098_daab5fef-4e65-4c30-a915-5dd921601106	71335-1098	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1099_e1d36423-2d90-4161-933c-86e83e8c14a5	71335-1099	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1100_280bc774-c765-4e28-b5c8-28ee17d6ab5f	71335-1100	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	Bryant Ranch Prepack	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1102_abda0f13-1d93-4de4-8386-c594827073af	71335-1102	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Bryant Ranch Prepack	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1103_b8984684-5f1c-418b-b68d-da6d19987366	71335-1103	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1105_61b67b02-e739-4538-8543-f7169934a5f1	71335-1105	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71335-1107_9a366fac-a3ee-4ed0-926a-03f50fe853d5	71335-1107	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20180411		ANDA	ANDA209172	Bryant Ranch Prepack	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
71335-1116_5a7c12c7-b931-4ced-95d6-0298c8e45b40	71335-1116	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Bryant Ranch Prepack	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1117_fc9ff849-f9d7-f331-e053-6394a90a8dac	71335-1117	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA075522	Bryant Ranch Prepack	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71335-1120_b8b2eb4c-b8fb-41c4-ba91-c23ba04cd0a5	71335-1120	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	19860513		ANDA	ANDA070176	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1121_6badcc21-e8d3-4014-97d1-63afd664bcf6	71335-1121	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040600	Bryant Ranch Prepack	HYDROXYZINE HYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-1122_14f122c3-47de-4ce8-b65e-0eb7baedf118	71335-1122	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Bryant Ranch Prepack	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
71335-1125_0365b32c-9701-4e6c-8457-8468c1ffd27c	71335-1125	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
71335-1127_74ee0bbc-efe6-4071-9093-be69ba5a1fd5	71335-1127	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20171223		ANDA	ANDA209234	Bryant Ranch Prepack	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
71335-1128_06540a82-d48f-46df-bf2c-04e8332ba9ce	71335-1128	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Bryant Ranch Prepack	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1130_26e6e8e4-da36-4f23-baf1-ab9b2d154bb8	71335-1130	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170424		ANDA	ANDA204720	Bryant Ranch Prepack	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-1131_ea832821-6f5f-4a94-b963-5e305da46245	71335-1131	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20181127		ANDA	ANDA210733	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1132_62073e2b-628c-41c6-8f48-8e6b19c9567b	71335-1132	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1134_fda04907-70de-68d6-e053-6394a90a00d6	71335-1134	HUMAN PRESCRIPTION DRUG	QUINAPRIL		quinapril	TABLET	ORAL	20171110		ANDA	ANDA205823	Bryant Ranch Prepack	QUINAPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-1135_fc777e39-1e68-78b8-e053-6394a90a076c	71335-1135	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20070308		ANDA	ANDA073652	Bryant Ranch Prepack	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71335-1138_69125d8d-aae4-4666-837c-8880ca6815f8	71335-1138	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Bryant Ranch Prepack	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1139_fc9d9ef3-578b-23de-e053-6294a90a6f2f	71335-1139	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20051214		ANDA	ANDA040596	Bryant Ranch Prepack	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71335-1146_fc788dcf-0558-52d2-e053-6294a90a4431	71335-1146	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Bryant Ranch Prepack	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1149_e1941f05-4882-4b06-a67e-f07cfbc3eb2b	71335-1149	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Bryant Ranch Prepack	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71335-1153_940687f1-39e1-4a7d-accf-34b7be42ce51	71335-1153	HUMAN PRESCRIPTION DRUG	Armour Thyroid		THYROID, PORCINE	TABLET	ORAL	19960401		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	THYROID, PORCINE	30	mg/1			N	20241231
71335-1154_29f77e5d-60c5-4355-9083-bf7704ff8735	71335-1154	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE		BUPRENORPHINE	TABLET	SUBLINGUAL	20171025		ANDA	ANDA207276	Bryant Ranch Prepack	BUPRENORPHINE HYDROCHLORIDE	8	mg/1	Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
71335-1157_fc77f0a7-965d-a0e1-e053-6394a90a4fb5	71335-1157	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Bryant Ranch Prepack	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1159_5874f9db-f29d-49b2-bc56-79bb0f1894eb	71335-1159	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate SL		hyoscyamine sulfate	TABLET	SUBLINGUAL	20110519		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
71335-1167_ca63b180-50e1-4902-9bc0-378d0ecdcc8e	71335-1167	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-1168_a0a52280-0a59-4c41-915d-0e69efbbacfb	71335-1168	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Bryant Ranch Prepack	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1169_c63e5e08-817f-4fe2-8cbd-920d52ecfc73	71335-1169	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1173_9b83d250-0b23-45c0-932f-94aea69e50d6	71335-1173	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20120927		ANDA	ANDA202566	Bryant Ranch Prepack	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
71335-1179_99881d63-fad8-46e8-b5e9-6b47696c4c35	71335-1179	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Bryant Ranch Prepack	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
71335-1180_be80102d-eda4-4fef-b1bd-79feaec7d412	71335-1180	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20140411		ANDA	ANDA078970	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71335-1186_ead964e8-ac57-4f64-b64f-cc228bc7b272	71335-1186	HUMAN OTC DRUG	Childrens Mapap		Acetaminophen	TABLET, CHEWABLE	ORAL	20041206		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ACETAMINOPHEN	80	mg/1			N	20241231
71335-1187_16faea05-a191-426e-ac60-c0e955844f94	71335-1187	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1188_c85b525f-9971-4c67-a0ac-7f49f45aaa6a	71335-1188	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-1193_3a3814b0-0cdd-4072-a711-4f611b914180	71335-1193	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20180306		ANDA	ANDA206069	Bryant Ranch Prepack	ARMODAFINIL	150	mg/1		CIV	N	20241231
71335-1197_f6062ec7-0f15-45bd-bccb-f03d6fc87385	71335-1197	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1198_fc89b67e-c1a1-4c34-e053-6394a90a45e4	71335-1198	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1199_7040c389-a46d-4f5c-9b13-c449151cfd1e	71335-1199	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Bryant Ranch Prepack	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1200_afad7386-5f79-4914-8f41-61cf728831a0	71335-1200	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1203_ace944fb-3409-4c5e-a362-d3591891f236	71335-1203	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71335-1208_3f992307-2438-4517-b93a-644159a16da9	71335-1208	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322	20251130	ANDA	ANDA200839	Bryant Ranch Prepack	LEVOFLOXACIN	750	mg/1			N	
71335-1210_b38e868e-7d50-45ac-b782-0d96ff53a5c6	71335-1210	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170601		NDA AUTHORIZED GENERIC	NDA018279	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1213_5d4798d1-87f3-44fc-a6fc-ae748478faa6	71335-1213	HUMAN PRESCRIPTION DRUG	venlafaxine		venlafaxine hydrochloride	TABLET	ORAL	20100407		ANDA	ANDA090555	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1214_548edf87-e18f-4770-b7c1-33a562a9873d	71335-1214	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA210497	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1215_dc78e0fc-fccc-45a2-a33b-2a2eeb5caab9	71335-1215	HUMAN OTC DRUG	MECLIZINE		Meclizine HCl 25mg	TABLET, CHEWABLE	ORAL	20180201		OTC MONOGRAPH FINAL	part336	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-1217_f41df27a-5b13-445b-9c54-0c38e4722dc0	71335-1217	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20160819		ANDA	ANDA204097	Bryant Ranch Prepack	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-1218_4aa44fa5-980d-427b-8b3e-25caf4f35fd9	71335-1218	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Bryant Ranch Prepack	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1219_47a7a0ff-d111-4592-a5e6-9b1b78941ddd	71335-1219	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20151001		ANDA	ANDA207416	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71335-1221_7ff7417c-0a9d-4812-a896-a728ae27a3f3	71335-1221	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Bryant Ranch Prepack	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1223_25662185-7ac5-489e-82fd-378a6cb2d974	71335-1223	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride	Extended-Release	Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20151001		ANDA	ANDA074984	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1225_fd7e1dca-5b7e-37d5-e053-6394a90a5c9b	71335-1225	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20210501		ANDA	ANDA091182	Bryant Ranch Prepack	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-1231_48ddceb6-46b9-43ef-8244-19ee6ce4b8f1	71335-1231	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-1235_2449cfda-21ee-4816-a1b5-9d8f5ce9c660	71335-1235	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Bryant Ranch Prepack	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1238_72d96aa7-bd3d-44e0-98cf-b65a738221d9	71335-1238	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, EXTENDED RELEASE	ORAL	20021106		ANDA	ANDA076201	Bryant Ranch Prepack	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1241_56fa9c49-ae9d-4f26-80b9-38257465e680	71335-1241	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1242_f2ab8c44-59a2-4c4b-abc1-2e6a4e8b2b5c	71335-1242	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20171205		ANDA	ANDA207743	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1243_21b80825-7234-4107-bc86-29abe991233d	71335-1243	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1244_7ccf9f77-5b83-4c00-974a-a04ed67d8248	71335-1244	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	Bryant Ranch Prepack	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1245_0c5d47f0-3a42-46db-b747-d190d382a190	71335-1245	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20131018		ANDA	ANDA091393	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1253_b4aad312-9e2f-48ed-a9ae-2e7544d514a6	71335-1253	HUMAN PRESCRIPTION DRUG	Fexmid		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20180430		ANDA	ANDA071611	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1264_563bc31f-b877-49d3-8630-dcc850dc4107	71335-1264	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Bryant Ranch Prepack	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1266_e1d36423-2d90-4161-933c-86e83e8c14a5	71335-1266	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1268_4478e141-41d3-46db-88f6-f9531089b5e9	71335-1268	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Bryant Ranch Prepack	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1269_d09503ad-c58b-471c-88b1-5b0d796b959b	71335-1269	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1278_61787625-a10a-4608-b091-66530820fd3d	71335-1278	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	Bryant Ranch Prepack	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-1282_b442a77f-fc48-4f18-841a-a3e4418e2f34	71335-1282	HUMAN OTC DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20190101		ANDA	ANDA204872	Bryant Ranch Prepack	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1286_a172b051-67cc-4410-b405-ed484c43c073	71335-1286	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20180720		ANDA	ANDA210138	Bryant Ranch Prepack	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71335-1288_490ede4f-2cc3-42ca-8d33-2d3f80348579	71335-1288	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1289_490ede4f-2cc3-42ca-8d33-2d3f80348579	71335-1289	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1298_a61cfae1-b746-4ba9-af96-7ce345a874b6	71335-1298	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
71335-1303_490ede4f-2cc3-42ca-8d33-2d3f80348579	71335-1303	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1304_0757a85f-a3c4-44c4-bfb0-71aefb441438	71335-1304	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, COATED	ORAL	20170106		ANDA	ANDA207750	Bryant Ranch Prepack	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71335-1307_8f8cfa7f-ced5-4f33-8ceb-3d4027b4e6e9	71335-1307	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20120315		ANDA	ANDA078032	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1308_3a3814b0-0cdd-4072-a711-4f611b914180	71335-1308	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20180306		ANDA	ANDA206069	Bryant Ranch Prepack	ARMODAFINIL	250	mg/1		CIV	N	20241231
71335-1310_6c8eca76-d80c-4331-a5d2-3103bcacec04	71335-1310	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1314_3279cd56-f41b-4da2-bc29-19a7347e298f	71335-1314	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Bryant Ranch Prepack	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-1315_c60c0f9a-e6fe-48b1-bc62-95a3caf9b99f	71335-1315	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170601		NDA AUTHORIZED GENERIC	NDA018279	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1316_4e30527a-9e7c-4e60-881a-aeaa5692a62a	71335-1316	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20160627		ANDA	ANDA062500	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1318_fc8c3780-f226-a2e9-e053-6394a90af113	71335-1318	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20130117		ANDA	ANDA203417	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-1319_338c9eb7-9199-4222-bcb2-336bccd1c836	71335-1319	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-1320_aa935067-2615-49df-8e81-4c462161438c	71335-1320	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	Bryant Ranch Prepack	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1327_bafb1e84-af62-42d7-9e28-61b0a719fcc5	71335-1327	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET, FILM COATED	ORAL	20081119		ANDA	ANDA078542	Bryant Ranch Prepack	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-1329_2e12fdc7-0714-440e-b918-4a080745f10d	71335-1329	HUMAN PRESCRIPTION DRUG	benzonatate		benzonatate	CAPSULE	ORAL	20170322		ANDA	ANDA040627	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-1330_5e8c331a-16fc-4cfe-baa5-d21074a0d334	71335-1330	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1332_6d12b7a3-9c04-4330-a4af-90722e255a36	71335-1332	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Bryant Ranch Prepack	MIRTAZAPINE	45	mg/1			N	20241231
71335-1336_c8b6f75d-679d-42c8-af75-ba25ebec7e30	71335-1336	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1338_570cf492-91f5-4377-b8ee-8502012cd1a1	71335-1338	HUMAN PRESCRIPTION DRUG	venlafaxine hydrochloride		venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA090174	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1340_710bfd61-6f71-4ee1-8034-5226ed7568b7	71335-1340	HUMAN OTC DRUG	ACETAMINOPHEN		ACETAMINOPHEN	TABLET, EXTENDED RELEASE	ORAL	20190701		ANDA	ANDA211544	Bryant Ranch Prepack	ACETAMINOPHEN	650	mg/1			N	20241231
71335-1341_97d0395b-b5bd-45d9-bd2b-a1791a787a5d	71335-1341	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA078518	Bryant Ranch Prepack	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-1343_b7750a8a-fcba-44dd-8ff2-510c3424a495	71335-1343	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
71335-1346_a1105ae1-4c53-43c0-a6de-9a19935ff29e	71335-1346	HUMAN PRESCRIPTION DRUG	rizatriptan benzoate		rizatriptan benzoate	TABLET	ORAL	20140301		ANDA	ANDA203252	Bryant Ranch Prepack	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71335-1347_43a525ac-75a5-467c-bc17-3d5b6c931221	71335-1347	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
71335-1348_07721be0-bda6-4458-8ba9-c5d95fda8ea4	71335-1348	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1352_a861a85d-020d-4386-a833-000af6d7a752	71335-1352	HUMAN PRESCRIPTION DRUG	Rizatriptan		Rizatriptan	TABLET, FILM COATED	ORAL	20140311		ANDA	ANDA203147	Bryant Ranch Prepack	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71335-1357_43a16072-53a6-482f-8589-f130787cf7dc	71335-1357	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Bryant Ranch Prepack	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-1359_fc9db47e-72d4-3e5f-e053-6294a90aa2fd	71335-1359	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		promethazine hydrochloride	TABLET	ORAL	20060731		ANDA	ANDA040712	Bryant Ranch Prepack	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71335-1360_6f29db41-72f8-4eee-b826-d095449170f8	71335-1360	HUMAN PRESCRIPTION DRUG	METHADONE HYDROCHLORIDE		METHADONE HYDROCHLORIDE	TABLET	ORAL	20120116		ANDA	ANDA090635	Bryant Ranch Prepack	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1363_a0a52280-0a59-4c41-915d-0e69efbbacfb	71335-1363	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20180119		ANDA	ANDA204319	Bryant Ranch Prepack	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1365_612171a7-4f72-485d-ba35-b0ad3f17d689	71335-1365	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET, FILM COATED	ORAL	20080522		ANDA	ANDA078212	Bryant Ranch Prepack	BENAZEPRIL HYDROCHLORIDE	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-1375_6dacac8f-2fd2-41f7-a6a7-32f6257fd938	71335-1375	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1380_bc7dfb5c-6c9f-4141-afab-f4c32ba49053	71335-1380	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20020701		ANDA	ANDA076059	Bryant Ranch Prepack	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-1381_aa39326b-7a0d-487d-b170-a0b77f2fa6a2	71335-1381	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20060313		ANDA	ANDA077309	Bryant Ranch Prepack	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-1386_f70e55c0-af15-4175-b8e4-d89d923cce6a	71335-1386	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	Bryant Ranch Prepack	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
71335-1389_2f580fc1-703c-449a-bb1e-7ed78d6cc018	71335-1389	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	19991228		ANDA	ANDA075116	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
71335-1391_fc8d1467-c0df-e5ce-e053-6294a90a42d2	71335-1391	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1394_3af9a0f0-8a7f-4735-85ae-a3427e2f951d	71335-1394	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	Bryant Ranch Prepack	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71335-1395_4a505735-fe67-413a-a6a7-df463bf8da23	71335-1395	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA076048	Bryant Ranch Prepack	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1396_840d6421-5e3e-4933-84fb-e5676439b9a0	71335-1396	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	Bryant Ranch Prepack	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1398_471a68b8-f1a6-4c80-b06a-2fbbbd6a0b62	71335-1398	HUMAN OTC DRUG	Plus Pharma	Pain Reliever,Fever Reducer	ACETAMINOPHEN	TABLET	ORAL	20060327		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ACETAMINOPHEN	325	mg/1			N	20241231
71335-1401_9a479bac-93f9-4459-ada1-34c0a055e5e3	71335-1401	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20181003		ANDA	ANDA210971	Bryant Ranch Prepack	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-1402_a6288e4b-a1d3-49c1-9811-395ca339db6e	71335-1402	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20130801		ANDA	ANDA078963	Bryant Ranch Prepack	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
71335-1407_f2486959-7ee5-4c18-8ccb-8f2df281f403	71335-1407	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	Bryant Ranch Prepack	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1410_81a66469-1c03-486a-bf52-9489a866e866	71335-1410	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1412_1b1f0cb9-3dfe-4a7f-954b-6f253b1c0dfd	71335-1412	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Bryant Ranch Prepack	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71335-1413_b59a0f31-b655-4128-9f50-b9abb8d28d72	71335-1413	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1414_2aab42cc-dec0-4c6c-8e7e-270395b53907	71335-1414	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1417_a52e5f94-aa09-4ae8-91d5-98c37dce1d63	71335-1417	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-1418_e0bc1866-5b3d-4c4d-9308-ac009cb672eb	71335-1418	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-1419_84cafcf3-6d8b-458c-ad8c-0dbe4073aaa5	71335-1419	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-1420_98ef0a02-4048-43b2-bed1-5341feec0903	71335-1420	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1421_aa26885e-2217-4ea5-821a-dfd1f1625076	71335-1421	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1422_6e6390f2-947b-4ad2-9e9b-6c8cdadc0467	71335-1422	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1423_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1423	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1425_90b6bc0f-7b85-4bd4-a0c8-254a881b445e	71335-1425	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180604		ANDA	ANDA205868	Bryant Ranch Prepack	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1428_b1921f9f-2312-4863-a691-20b435ef6a51	71335-1428	HUMAN PRESCRIPTION DRUG	telmisartan		telmisartan	TABLET	ORAL	20160612		ANDA	ANDA205150	Bryant Ranch Prepack	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1431_cf156eaa-cb8f-4a0b-a669-438a7c8f6f6a	71335-1431	HUMAN PRESCRIPTION DRUG	Trandolapril		Trandolapril	TABLET	ORAL	20070612		ANDA	ANDA078438	Bryant Ranch Prepack	TRANDOLAPRIL	2	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-1432_43a6ec6a-f9a5-43cc-b89e-b26b14c54e7c	71335-1432	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20170911		ANDA	ANDA207724	Bryant Ranch Prepack	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71335-1433_a9e35180-5b59-4145-be2d-614ba54442eb	71335-1433	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20060912		ANDA	ANDA077746	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71335-1434_d88b1f49-8ea3-43fa-ae34-0cb10ca3a562	71335-1434	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-1435_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1435	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1437_5b889d54-5134-4b5e-b670-96659edc13d9	71335-1437	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Bryant Ranch Prepack	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1438_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1438	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1444_1a337ab8-e50e-4578-8999-d28ddaff4eed	71335-1444	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-1445_a317b0d6-832a-4564-ac4b-43973355dad0	71335-1445	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1447_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1447	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1451_046b6751-595e-4fd5-96de-d5697238026f	71335-1451	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-1455_e066c4c0-e345-4c9d-9ab7-c357592346d4	71335-1455	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Bryant Ranch Prepack	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1456_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1456	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1457_5ffd139d-17f7-4353-aa5b-7d87f30500cd	71335-1457	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	Bryant Ranch Prepack	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1460_ce50b6f7-832c-43e5-a1dd-928baedc07f3	71335-1460	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, FILM COATED	ORAL	20161012		ANDA	ANDA206384	Bryant Ranch Prepack	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71335-1462_2f213bf7-683c-4e1d-961b-e984539bd22f	71335-1462	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Bryant Ranch Prepack	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1463_06540a82-d48f-46df-bf2c-04e8332ba9ce	71335-1463	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Bryant Ranch Prepack	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1464_fc88eec0-c62e-5d6d-e053-6294a90a13d2	71335-1464	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19840507		ANDA	ANDA062396	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1465_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1465	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1467_fc4cd253-13df-9424-e053-6394a90a35a8	71335-1467	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	Bryant Ranch Prepack	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1468_8fc3132f-7766-4459-8ad9-bfc7e998f9bd	71335-1468	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		ANDA	ANDA204170	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71335-1472_c7bd0186-26f8-4fd8-bd3c-caceaa2480f3	71335-1472	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1477_811ec384-49f7-4bf7-9bfe-6f1fb8577dda	71335-1477	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	Bryant Ranch Prepack	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
71335-1478_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1478	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1479_d81d6e15-9f6e-49d9-9c35-5774c34957f9	71335-1479	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20160314		ANDA	ANDA205115	Bryant Ranch Prepack	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1480_6524f673-ea3d-4705-a0da-6da45f255c58	71335-1480	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		naltrexone hydrochloride	TABLET, FILM COATED	ORAL	20020322		ANDA	ANDA076264	Bryant Ranch Prepack	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71335-1481_046b6751-595e-4fd5-96de-d5697238026f	71335-1481	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-1482_119395d1-b02a-4652-b77c-958c42b3ce64	71335-1482	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1486_4752a2b5-f4a9-4f0f-b9c9-6d97109f6a15	71335-1486	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101220		ANDA	ANDA090365	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-1489_420666e2-bf03-4c46-b885-5151a910e9f5	71335-1489	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Bryant Ranch Prepack	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71335-1491_a3a87aab-8a2e-4116-8717-cc4209abab86	71335-1491	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Bryant Ranch Prepack	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1492_7174b241-eb25-4c0b-aaa7-e74e37b0751c	71335-1492	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1493_022ff2e6-4953-4f02-8ebb-b3fbc10c0c8a	71335-1493	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20050825		ANDA	ANDA065136	Bryant Ranch Prepack	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
71335-1494_fc63689e-e432-ca8f-e053-6394a90a54a2	71335-1494	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171222		ANDA	ANDA209335	Bryant Ranch Prepack	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71335-1495_44b0c4d9-603a-47b6-b0fe-3d2fe08b8b99	71335-1495	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-1496_5ca3f889-cde6-4d22-a320-b4a196ea3d89	71335-1496	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Bryant Ranch Prepack	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1499_a691890d-12cc-477a-bd72-3a6dd058ef3e	71335-1499	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1502_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1502	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1503_840d6421-5e3e-4933-84fb-e5676439b9a0	71335-1503	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	Bryant Ranch Prepack	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1512_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1512	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1513_cfe7a124-6d12-426a-873f-eb583a8decc1	71335-1513	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Bryant Ranch Prepack	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1515_f17beef0-6702-4ae6-8900-079f97bf288d	71335-1515	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Bryant Ranch Prepack	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1516_d3f37948-cf5f-4738-b245-4f8f7975887c	71335-1516	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	Bryant Ranch Prepack	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-1517_840d6421-5e3e-4933-84fb-e5676439b9a0	71335-1517	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	Bryant Ranch Prepack	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1519_04e23616-100f-4f6f-8396-1dcb5bfc0ff7	71335-1519	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Bryant Ranch Prepack	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1520_c0c3ae9b-0e47-4900-8b23-304eb558e3f3	71335-1520	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Bryant Ranch Prepack	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-1522_fc875d4d-ebf9-3497-e053-6394a90a88c9	71335-1522	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20010531		ANDA	ANDA040419	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71335-1524_70e6bcae-2c9a-457f-8ba2-ff4a66859670	71335-1524	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181207		ANDA	ANDA211495	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-1525_d3f37948-cf5f-4738-b245-4f8f7975887c	71335-1525	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	Bryant Ranch Prepack	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-1526_375172b1-6059-4e1b-b7ca-f1ebdf3b3aff	71335-1526	HUMAN PRESCRIPTION DRUG	LETROZOLE		LETROZOLE	TABLET	ORAL	20110604		ANDA	ANDA200161	Bryant Ranch Prepack	LETROZOLE	2.5	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
71335-1528_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1528	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1533_06540a82-d48f-46df-bf2c-04e8332ba9ce	71335-1533	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Bryant Ranch Prepack	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1535_fca00330-ba3f-6c3e-e053-6394a90aee1c	71335-1535	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20100610		ANDA	ANDA077443	Bryant Ranch Prepack	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1538_2b02ea4f-7bea-4725-852e-8bcfedb03e09	71335-1538	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20170811		ANDA	ANDA207405	Bryant Ranch Prepack	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-1539_fc2f78aa-37a2-4658-86fe-187322902a30	71335-1539	HUMAN OTC DRUG	Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20180301		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM	100	mg/1			N	20241231
71335-1541_230e5c20-2f56-4a7b-86ef-97a870757071	71335-1541	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA074299	Bryant Ranch Prepack	INDAPAMIDE	1.25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71335-1542_cacdf07a-142b-400b-bac5-bddc457cb8a1	71335-1542	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride (XL)		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180108		ANDA	ANDA208652	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1544_d0688ddc-031f-4082-946b-b0081614dd0c	71335-1544	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-1545_d88f439e-764d-4285-beae-70ec949f9436	71335-1545	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Bryant Ranch Prepack	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1547_7ccf9f77-5b83-4c00-974a-a04ed67d8248	71335-1547	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	Bryant Ranch Prepack	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1548_fc8cba90-aed9-c167-e053-6394a90a6016	71335-1548	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-1549_fc892c8e-6261-e85c-e053-6394a90a61c2	71335-1549	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1550_b205af94-7091-4776-9429-7e8d30320405	71335-1550	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Bryant Ranch Prepack	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-1551_a40f6960-de12-452e-a112-f7a83d604011	71335-1551	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20180618		ANDA	ANDA203013	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1552_1c7ab195-2d22-4021-9af0-f77317695c7c	71335-1552	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20000508		ANDA	ANDA075520	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-1553_d0688ddc-031f-4082-946b-b0081614dd0c	71335-1553	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-1557_fda6c2bc-0193-e6e3-e053-6394a90a53f8	71335-1557	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-1559_782eff34-6601-4163-8cdf-74991fe64547	71335-1559	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1562_e4df0a73-83bf-4ce6-aa99-91c7b03242ca	71335-1562	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Bryant Ranch Prepack	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1563_7e501fc0-081b-4e64-b2fd-e2193ddb55b6	71335-1563	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-1568_b8579af9-f932-489d-abe4-0e250113b55e	71335-1568	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1572_09863fe3-e1a8-4efe-ac39-adad0bcc1d44	71335-1572	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Bryant Ranch Prepack	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1575_73d68ab4-65d3-4e71-a472-8faf8383f00c	71335-1575	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20181005		ANDA	ANDA206923	Bryant Ranch Prepack	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71335-1580_abda0f13-1d93-4de4-8386-c594827073af	71335-1580	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Bryant Ranch Prepack	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1582_abda0f13-1d93-4de4-8386-c594827073af	71335-1582	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Bryant Ranch Prepack	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1583_6abd4ad4-4989-4403-a971-35dac770b2f4	71335-1583	HUMAN PRESCRIPTION DRUG	ACARBOSE		ACARBOSE	TABLET	ORAL	20150201		ANDA	ANDA091343	Bryant Ranch Prepack	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71335-1589_294bc2d8-de44-4757-8712-6758f099bfb9	71335-1589	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71335-1591_c0929307-25ab-4748-b1a8-fa7096d4c825	71335-1591	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-1594_2eef31a6-f775-43b5-bd03-f35ef5840821	71335-1594	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20160701		ANDA	ANDA075765	Bryant Ranch Prepack	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
71335-1602_4c60d955-177c-497b-8ba4-0672c432083e	71335-1602	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, CHEWABLE	ORAL	20150527		ANDA	ANDA204093	Bryant Ranch Prepack	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71335-1603_7a5a4451-bd05-4f77-9c6c-563119465803	71335-1603	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
71335-1616_984af795-bb5a-4156-b2cd-09707d12b5a2	71335-1616	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20041116		ANDA	ANDA074056	Bryant Ranch Prepack	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1621_bafb1e84-af62-42d7-9e28-61b0a719fcc5	71335-1621	HUMAN PRESCRIPTION DRUG	Ranitidine		Ranitidine	TABLET, FILM COATED	ORAL	20081119		ANDA	ANDA078542	Bryant Ranch Prepack	RANITIDINE HYDROCHLORIDE	300	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-1623_d88f439e-764d-4285-beae-70ec949f9436	71335-1623	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Bryant Ranch Prepack	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1625_63ee98ea-afc8-42dd-a915-ef71500b7c0c	71335-1625	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1626_d88b1f49-8ea3-43fa-ae34-0cb10ca3a562	71335-1626	HUMAN PRESCRIPTION DRUG	ropinirole hydrochloride		ropinirole hydrochloride	TABLET, FILM COATED	ORAL	20110920		ANDA	ANDA078110	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	2	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-1632_d03340ce-c399-479f-956b-7cdb07139219	71335-1632	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	Bryant Ranch Prepack	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71335-1634_763e08a3-1c25-4229-93c8-3cac476a66a6	71335-1634	HUMAN PRESCRIPTION DRUG	Finasteride		finasteride	TABLET, FILM COATED	ORAL	20100528		ANDA	ANDA090121	Bryant Ranch Prepack	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71335-1636_b99f6840-4208-47f8-8291-4f8e301974a4	71335-1636	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20031111		ANDA	ANDA076048	Bryant Ranch Prepack	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1637_21e53fb4-01c2-4ee0-a9fe-09fb50e29917	71335-1637	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1638_68ec1574-866c-495a-a4e9-5631d24b2b04	71335-1638	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103		ANDA	ANDA203814	Bryant Ranch Prepack	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1642_2d901626-71cd-48b1-96cf-5b430762b556	71335-1642	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111123		ANDA	ANDA200834	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1646_c87019f9-85a2-4438-8b1c-950b2676e2d5	71335-1646	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20150915		ANDA	ANDA204165	Bryant Ranch Prepack	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
71335-1647_93e2804c-b4e4-47e5-a379-819b8dce958c	71335-1647	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
71335-1649_42799756-c2b2-4873-9257-257d66a6339c	71335-1649	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20141126		ANDA	ANDA203623	Bryant Ranch Prepack	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1651_b963d0d7-295c-4716-90ec-cc9e62c2de68	71335-1651	HUMAN OTC DRUG	Allergy Relief	Non drowsy	Loratadine	TABLET	ORAL	20191227		ANDA	ANDA075209	Bryant Ranch Prepack	LORATADINE	10	mg/1			N	20241231
71335-1655_dfafd95c-8057-4857-b8e0-5ca61ae1cfc4	71335-1655	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1656_fc9c9a52-4f04-0c9f-e053-6294a90afa0c	71335-1656	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091001		ANDA	ANDA071586	Bryant Ranch Prepack	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71335-1658_a7fb8ba6-c9e7-46fd-a660-441b6d97efc5	71335-1658	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150921		ANDA	ANDA202784	Bryant Ranch Prepack	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1659_c2ec028e-5710-4a4d-98b1-c8eef3b90c13	71335-1659	HUMAN PRESCRIPTION DRUG	Pioglitazone		pioglitazone	TABLET	ORAL	20130301		ANDA	ANDA078670	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
71335-1668_7b05bf8b-12ea-4724-8da3-78520e99f7fe	71335-1668	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine	TABLET	ORAL	20160627		ANDA	ANDA077533	Bryant Ranch Prepack	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71335-1669_b1c97202-48a8-459a-b170-8d3fca9cf210	71335-1669	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Bryant Ranch Prepack	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1670_27df02f3-6b14-4cdb-9a51-e08fb924d1e6	71335-1670	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Bryant Ranch Prepack	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1672_fe264c40-87c4-4a55-818f-8c2a511c9bd2	71335-1672	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20120501		ANDA	ANDA203197	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1673_b48c3f9a-30af-470d-bd52-7dec3d3005aa	71335-1673	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71335-1674_2e9cb8a9-7c66-42df-887b-35feb15e320d	71335-1674	HUMAN OTC DRUG	SENNA-PLUS		Sennosides and Docusate Sodium	TABLET	ORAL	20190501		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
71335-1675_e7f843aa-ad2f-4a60-805a-2e0e2f7d5117	71335-1675	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-1676_ae95316f-0c44-44d2-a95f-0e1a6c55dd97	71335-1676	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-1677_fc437430-d168-42da-85f2-8bf41d99576e	71335-1677	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20200401		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM	250	mg/1			N	20241231
71335-1678_4bb725ef-4484-4f1a-a2b4-471633683660	71335-1678	HUMAN PRESCRIPTION DRUG	Bisoprolol		Bisoprolol fumarate	TABLET, FILM COATED	ORAL	20190620		ANDA	ANDA075474	Bryant Ranch Prepack	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1682_4a578a92-2eda-4094-bdc8-c98badef8545	71335-1682	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20170530		ANDA	ANDA206174	Bryant Ranch Prepack	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1685_a4867e58-df6e-4226-8172-6a4fa68d3961	71335-1685	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20100101		ANDA	ANDA040901	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71335-1686_fda245af-179c-6297-e053-6294a90a935a	71335-1686	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1687_9078ea31-b68a-42f2-aefc-17027b0a5d8b	71335-1687	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Bryant Ranch Prepack	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1691_4ab05220-5522-4465-bce1-dd8ac5856d1b	71335-1691	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol Capsules,	CAPSULE	ORAL	20181210		ANDA	ANDA204276	Bryant Ranch Prepack	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71335-1693_b24081f0-ef55-4057-8513-0974c6f644af	71335-1693	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20200315		ANDA	ANDA213413	Bryant Ranch Prepack	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
71335-1694_08050c36-47d0-ae0b-e063-6294a90ad389	71335-1694	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Bryant Ranch Prepack	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1699_b85d77bc-417a-4a1d-be13-bfefced2d340	71335-1699	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	Bryant Ranch Prepack	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71335-1700_25dd68f4-a844-4608-b4e9-59350b821f19	71335-1700	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170301		ANDA	ANDA204082	Bryant Ranch Prepack	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1701_7e07f60f-fea0-4872-90e8-2fe5459e2fcf	71335-1701	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, COATED	ORAL	20160505		ANDA	ANDA205118	Bryant Ranch Prepack	FENOFIBRATE	48	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71335-1702_08f84212-6dd4-41d6-8c44-a35897eea7cf	71335-1702	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1703_09e3b9f8-d3e1-4b29-b651-9630aded9ffd	71335-1703	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	Bryant Ranch Prepack	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
71335-1704_c5b2b33b-6391-4dfd-9411-fffa3f02870a	71335-1704	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-1705_2be17e48-8258-4f29-914b-7f0fe9ace7a1	71335-1705	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190401		ANDA	ANDA207613	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71335-1710_df649514-e629-474d-8860-4c146a64af2d	71335-1710	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20111201		ANDA	ANDA076477	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1712_cf29d6a7-1e9e-478d-ac01-f178a7de9f7b	71335-1712	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1713_fd64e438-d644-c531-e053-6294a90a703c	71335-1713	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-1714_02a9389c-608e-5a8c-e063-6294a90ab89b	71335-1714	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-1715_8f53d830-2fb0-400c-8f03-f81858280782	71335-1715	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20140328		ANDA	ANDA078193	Bryant Ranch Prepack	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71335-1718_34c14b91-4c8a-457a-ae84-4923c00ada15	71335-1718	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Bryant Ranch Prepack	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-1719_a0ee9ab8-f500-42da-a046-c6184738ce75	71335-1719	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20160803		ANDA	ANDA040197	Bryant Ranch Prepack	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
71335-1721_fc88fb9f-6ab7-9478-e053-6294a90a996c	71335-1721	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Bryant Ranch Prepack	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-1722_26bbc4a1-ce3e-45c2-b1f2-764c9ff68fb5	71335-1722	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20150921		ANDA	ANDA202784	Bryant Ranch Prepack	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1723_b001b97a-a32a-4586-b0b6-c1bb7eab40b4	71335-1723	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20140707		ANDA	ANDA090032	Bryant Ranch Prepack	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1724_d2abd3fa-0134-4000-b9a5-ac5266c76d7d	71335-1724	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890228		ANDA	ANDA072575	Bryant Ranch Prepack	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-1725_86dfae2e-2f82-4807-b68e-270f540c1c9f	71335-1725	HUMAN PRESCRIPTION DRUG	Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate		Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate	TABLET	SUBLINGUAL	20171213		ANDA	ANDA207000	Bryant Ranch Prepack	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
71335-1726_49ba2dac-2f81-47cb-8fe0-2269314c5bda	71335-1726	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-1727_fc9c7b08-e298-aa25-e053-6294a90aca75	71335-1727	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20130115		ANDA	ANDA086988	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1729_507a97b3-b3e4-427f-8d23-205653db2b17	71335-1729	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20190521		ANDA	ANDA210224	Bryant Ranch Prepack	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71335-1730_ba069504-c927-49b1-bcbb-06f097fa1f31	71335-1730	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20200421		ANDA	ANDA207798	Bryant Ranch Prepack	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71335-1731_f33ea165-c213-4cd1-9605-612483ea86e0	71335-1731	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Bryant Ranch Prepack	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-1732_216899e3-38c6-4ac6-9ffc-ec5264ef4246	71335-1732	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
71335-1733_d23071db-2fab-465a-8271-836f70b2f5f2	71335-1733	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1734_5ef450aa-a876-4d1b-a616-84893d6a756e	71335-1734	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1737_bcfaa212-63fe-4140-9672-7a31aa735038	71335-1737	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181207		ANDA	ANDA211495	Bryant Ranch Prepack	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-1738_ba40dbb7-2983-4797-b285-92fdb5b563d7	71335-1738	HUMAN PRESCRIPTION DRUG	colchicine		colchicine	TABLET	ORAL	20200611		ANDA	ANDA209876	Bryant Ranch Prepack	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
71335-1741_08f2fc1e-c84b-4a6c-a6a3-f06f03a6196e	71335-1741	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1742_a02d717a-d009-48b3-8076-670f25b71470	71335-1742	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20170322		ANDA	ANDA207152	Bryant Ranch Prepack	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-1743_fd00105b-dce7-f5dd-e053-6294a90a70b8	71335-1743	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-1747_fdf3e671-7d42-cca8-e053-6294a90a277e	71335-1747	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	19981120		ANDA	ANDA074726	Bryant Ranch Prepack	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1749_2ee8ace5-0b84-4537-8a2b-40c9a3e1a783	71335-1749	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
71335-1751_9fc19a00-64d7-41a0-8252-3b2b2002d6d4	71335-1751	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191002		ANDA	ANDA211177	Bryant Ranch Prepack	PREGABALIN	50	mg/1		CV	N	20241231
71335-1752_fc9dcea2-12ec-2027-e053-6394a90abc44	71335-1752	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71335-1753_57b9bd7c-6404-4667-89a1-bc2c29fa789b	71335-1753	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20200801		ANDA	ANDA210014	Bryant Ranch Prepack	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1754_fbdcf85a-a1a8-41c9-ac40-5220d1ea02e9	71335-1754	HUMAN OTC DRUG	gentle laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20020325		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71335-1756_e4d10350-019b-430a-a9c7-0719b1bc65b6	71335-1756	HUMAN PRESCRIPTION DRUG	FENOFIBRATE		FENOFIBRATE	TABLET	ORAL	20200910		ANDA	ANDA213864	Bryant Ranch Prepack	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71335-1760_db7c29c8-83e0-406e-a115-ffa9db012e53	71335-1760	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Bryant Ranch Prepack	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1762_a458b9e5-c584-4598-83ee-8857f46805e7	71335-1762	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191002		ANDA	ANDA211177	Bryant Ranch Prepack	PREGABALIN	25	mg/1		CV	N	20241231
71335-1764_c7a28890-8998-4664-aa37-ce8ba2e4e392	71335-1764	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20190305		ANDA	ANDA209587	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
71335-1765_08c4d637-4852-482a-a234-aa4f3603f851	71335-1765	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200106		ANDA	ANDA212026	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1767_fda369eb-b3c8-61b8-e053-6394a90aca80	71335-1767	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine		Butalbital, Acetaminophen, and Caffeine	TABLET	ORAL	20190305		ANDA	ANDA209587	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
71335-1768_fd8e8290-39e7-5544-e053-6394a90ab265	71335-1768	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1769_e37fb811-9fe6-4aff-a519-28880529fed1	71335-1769	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA212678	Bryant Ranch Prepack	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1770_b36354a9-ad0c-4e76-88e5-28dbef7cb5c8	71335-1770	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20200701		ANDA	ANDA213063	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-1771_97061aba-0105-438f-95bb-4b1a3e44a19e	71335-1771	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20201008		ANDA	ANDA040081	Bryant Ranch Prepack	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
71335-1772_fc7926d9-d8df-7e09-e053-6394a90a8327	71335-1772	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20200824		ANDA	ANDA213343	Bryant Ranch Prepack	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71335-1773_f401bff5-ecd4-4538-9f7b-4f5a72a13609	71335-1773	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-1775_b7455b5f-bc08-40d8-8880-c0bb64b1f094	71335-1775	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	Bryant Ranch Prepack	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
71335-1776_173421c0-5cd1-4193-a48f-857870734b74	71335-1776	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1777_a26f623f-4916-4cd8-b576-59cf7e437638	71335-1777	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20171211		ANDA	ANDA077342	Bryant Ranch Prepack	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1779_c5e57040-2a19-477f-93dc-d71474e4f7b3	71335-1779	HUMAN PRESCRIPTION DRUG	DIETHYLPROPION HYDROCHLORIDE		DIETHYLPROPION HYDROCHLORIDE	TABLET	ORAL	20101227		ANDA	ANDA201212	Bryant Ranch Prepack	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-1781_0a85b8ba-ab91-40af-9f2a-4c7f5f6067b9	71335-1781	HUMAN PRESCRIPTION DRUG	potassium chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20160726		ANDA	ANDA203562	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1782_fd8ee986-307a-6908-e053-6394a90afdd0	71335-1782	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20180612		ANDA	ANDA091174	Bryant Ranch Prepack	CALCITRIOL	.5	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
71335-1783_e0cd92c5-49e6-4f27-9ba3-699b2ba859cf	71335-1783	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20191226		ANDA	ANDA204058	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-1784_00cffe03-83eb-4e84-84b2-acc8cd923803	71335-1784	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Bryant Ranch Prepack	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-1785_254bf7ea-fed6-4ed5-a868-9c64ce3b8fd5	71335-1785	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20180115		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1786_1819dbea-9186-4da0-9000-2970c7fa9819	71335-1786	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Bryant Ranch Prepack	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-1788_3a97876b-8c5e-4ef1-8005-5fd91c5a1e66	71335-1788	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Bryant Ranch Prepack	PREGABALIN	75	mg/1		CV	N	20241231
71335-1789_5f412300-593e-4f96-a0f3-1b978a8d7875	71335-1789	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Bryant Ranch Prepack	PREGABALIN	100	mg/1		CV	N	20241231
71335-1790_ea41ed89-5bc2-4cdc-a5ae-358deb04ced5	71335-1790	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Bryant Ranch Prepack	PREGABALIN	50	mg/1		CV	N	20241231
71335-1791_2de2d0e0-3511-42d9-bd6d-df9b31bed684	71335-1791	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Bryant Ranch Prepack	PREGABALIN	25	mg/1		CV	N	20241231
71335-1795_fc9b729f-55ba-9df1-e053-6294a90a7d7c	71335-1795	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20171215		ANDA	ANDA086989	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1797_081609c5-fd3c-45d1-e063-6394a90a3e2d	71335-1797	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71335-1799_5f72d21b-d953-4f58-a129-226e5e5b0a81	71335-1799	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-1804_94f649f5-a925-417a-a3e1-31539d968ecd	71335-1804	HUMAN PRESCRIPTION DRUG	CELECOXIB		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	Bryant Ranch Prepack	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1805_ebdf1127-3e12-44ae-a3e2-a30cde4efcb1	71335-1805	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
71335-1810_fc627257-7f59-beb0-e053-6394a90a04f6	71335-1810	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1812_c71d53ce-b8a7-4bd4-948f-728f17556847	71335-1812	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1813_02133840-e871-40b1-88d7-cdb9c5a894c3	71335-1813	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	Bryant Ranch Prepack	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1815_c74cdfbb-a09f-4f4a-856d-379935741b52	71335-1815	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20200801		ANDA	ANDA210014	Bryant Ranch Prepack	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1818_fc8753e5-9ea3-349b-e053-6394a90acd38	71335-1818	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71335-1820_e66cf5f3-d909-40ad-a03d-c0423f41aa23	71335-1820	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180824		ANDA	ANDA203203	Bryant Ranch Prepack	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1822_2fb113af-3fe9-49a3-88f4-414519dd2c18	71335-1822	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Bryant Ranch Prepack	PREGABALIN	200	mg/1		CV	N	20241231
71335-1823_ae768bfd-1faa-4b95-8525-0720bf149f5f	71335-1823	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Bryant Ranch Prepack	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1824_ad1f0082-5632-494c-9d30-7db1d8ebac02	71335-1824	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Bryant Ranch Prepack	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-1825_292ccab7-3f25-449a-99b1-4262db781877	71335-1825	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-1826_2626c411-fe85-4478-b07a-1f1e412b0ab4	71335-1826	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20120927		ANDA	ANDA202910	Bryant Ranch Prepack	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1827_3352b892-88bb-4f05-8c66-80c97e8e43d4	71335-1827	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1828_a6b310a6-e6bb-4f88-ad3e-16d7d9eaf654	71335-1828	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1829_80f21f4f-2bf6-4437-b7d7-9452a14b1e1a	71335-1829	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20190806		ANDA	ANDA211627	Bryant Ranch Prepack	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71335-1833_fc7294b5-6fe8-64ec-e053-6294a90a0cbc	71335-1833	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1834_fc72d905-3556-856d-e053-6294a90ad8d9	71335-1834	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1835_fc7286be-14d0-0896-e053-6394a90a9c9b	71335-1835	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1836_4d8e2da8-b9c3-4b8b-97e1-e24e0d745495	71335-1836	HUMAN PRESCRIPTION DRUG	terbinafine hydrochloride		terbinafine hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA078163	Bryant Ranch Prepack	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71335-1837_e67c2060-2d09-40da-a478-88d9d033ba08	71335-1837	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102		ANDA	ANDA211347	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1838_cbcc7fb0-45a0-45bc-9db7-0517ecddd154	71335-1838	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	Bryant Ranch Prepack	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
71335-1839_402815d4-bfe6-4f9c-a4dd-b272f9c210eb	71335-1839	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Bryant Ranch Prepack	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1840_ad46f585-17db-4c17-ab12-2026dc77caaf	71335-1840	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	TABLET	ORAL	20180701		ANDA	ANDA085588	Bryant Ranch Prepack	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
71335-1842_3563c16b-999c-4ed6-858d-c406195be8ed	71335-1842	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161201		NDA AUTHORIZED GENERIC	NDA021875	Bryant Ranch Prepack	ARMODAFINIL	250	mg/1		CIV	N	20241231
71335-1843_fc627257-7fa2-beb0-e053-6394a90a04f6	71335-1843	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1846_bb7d5fb5-bab9-434e-94cd-4d6555e35ba4	71335-1846	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71335-1847_55bb3efb-4419-4ee8-82a7-413c502ffcba	71335-1847	HUMAN OTC DRUG	Regular Strength Pain Relief		Acetaminophen	TABLET	ORAL	20200401		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ACETAMINOPHEN	325	mg/1			N	20241231
71335-1850_fcf0a1af-bb6c-23a2-e053-6394a90a0513	71335-1850	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Bryant Ranch Prepack	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1851_7ef2972b-1580-4e75-b478-e87f48bee904	71335-1851	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Bryant Ranch Prepack	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1852_bc264025-46b6-45a6-b3e5-9516b9038066	71335-1852	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20150819		ANDA	ANDA203270	Bryant Ranch Prepack	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-1853_0b5e3e91-088c-4ee9-9ed0-431bd8992db6	71335-1853	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20190723		ANDA	ANDA211567	Bryant Ranch Prepack	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
71335-1855_b1f5f5ab-5f4f-4ab5-8d09-d56b91dbf7b0	71335-1855	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Bryant Ranch Prepack	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-1856_722ab62e-0e17-46bb-b170-ac5614ba7fac	71335-1856	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1857_5b99a0ea-fc94-44bd-bd48-5ac5a32c8f8c	71335-1857	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20161201		NDA AUTHORIZED GENERIC	NDA021875	Bryant Ranch Prepack	ARMODAFINIL	150	mg/1		CIV	N	20241231
71335-1858_9bc52e26-1d52-4d68-894a-d3b300f5f090	71335-1858	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE		BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE	TABLET	SUBLINGUAL	20210122		ANDA	ANDA209069	Bryant Ranch Prepack	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
71335-1859_dddfd253-84c8-453f-bdf0-410315ab9145	71335-1859	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20131021	20240131	ANDA	ANDA040644	Bryant Ranch Prepack	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	
71335-1860_c70c9f06-5e78-4ff4-b67e-a024b0e8fc97	71335-1860	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-1861_96b707bf-299f-4504-bf2a-57604d00bb08	71335-1861	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1862_9ea87f54-eb20-4baf-bbd1-d346e1102093	71335-1862	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Bryant Ranch Prepack	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-1863_9dddccbd-8e8d-4128-99f4-a31193b44a18	71335-1863	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20200605		ANDA	ANDA090073	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
71335-1864_1c86a46e-f1da-4960-b42f-fb8f873e11f2	71335-1864	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1866_050b201e-e513-44e2-a8cd-21a642054023	71335-1866	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1867_ed3c3b85-6999-43df-939f-354013938ea4	71335-1867	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
71335-1869_4839e92c-f0cc-4b79-ac75-3c7bdf230d4f	71335-1869	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Bryant Ranch Prepack	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1870_9917d136-1f15-4784-8bdc-971e83b668ef	71335-1870	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102		ANDA	ANDA211347	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1872_fca0506e-4adf-4e55-e053-6294a90a5cf5	71335-1872	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20200115		NDA AUTHORIZED GENERIC	NDA010721	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-1875_554b17b5-690d-4042-be96-5d197804dedd	71335-1875	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Bryant Ranch Prepack	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1876_2311ba27-91a5-40ed-b598-cf481e158704	71335-1876	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20201020		ANDA	ANDA214219	Bryant Ranch Prepack	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1878_cdff99b3-f3e6-4504-9842-207d8af9792a	71335-1878	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Bryant Ranch Prepack	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1879_b8294597-7684-45cf-8e48-dc1a8d85aff9	71335-1879	HUMAN PRESCRIPTION DRUG	ANASTROZOLE		ANASTROZOLE	TABLET	ORAL	20100628		ANDA	ANDA079220	Bryant Ranch Prepack	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
71335-1880_2574a638-6326-420c-a421-79ce8fa2884f	71335-1880	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-1883_940c871a-0eb8-4454-8c3f-e871321f73c5	71335-1883	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20200918		ANDA	ANDA209286	Bryant Ranch Prepack	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71335-1884_0834b994-db3b-487d-a78e-4869e8bc152d	71335-1884	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190326		ANDA	ANDA208934	Bryant Ranch Prepack	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1887_42be4afb-caa4-4ad4-b489-bd42b182ea9c	71335-1887	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110415		ANDA	ANDA077516	Bryant Ranch Prepack	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-1888_fe4fd460-5fdb-440c-b7f4-7a1f27a33e86	71335-1888	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Bryant Ranch Prepack	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1889_15200cab-6cc5-4bf2-a492-ca94fc25e656	71335-1889	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1890_e8228696-db3c-470f-85e8-044929e43b58	71335-1890	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1891_b410c937-f9a1-4089-8ede-265c2dbc32d4	71335-1891	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Bryant Ranch Prepack	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1892_c815097c-e6c6-47c9-b7b6-4412bbc1caf1	71335-1892	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Bryant Ranch Prepack	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1893_8b14770c-9d16-4ea7-9d98-6c57921ce66e	71335-1893	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Bryant Ranch Prepack	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1894_e77d65fb-a575-4188-b3dc-57bce13cc766	71335-1894	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Bryant Ranch Prepack	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1895_dd2fab7f-cdf5-4561-990b-a13d48980014	71335-1895	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Bryant Ranch Prepack	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1896_fef7ca38-625a-4397-9bab-d3b3c9967d07	71335-1896	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-release		Potassium Chloride Extended-release	TABLET	ORAL	20210130		ANDA	ANDA214452	Bryant Ranch Prepack	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1897_932f2821-c78c-472a-bf70-9525fde86137	71335-1897	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1898_fc9ae7e9-e146-3002-e053-6294a90a0a48	71335-1898	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20170105		ANDA	ANDA204304	Bryant Ranch Prepack	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71335-1899_25332d17-7764-432a-bd55-b58415c0f2e3	71335-1899	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20150827		ANDA	ANDA206528	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
71335-1900_79a4ed79-425f-448c-8f92-14f82622af76	71335-1900	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20191120		ANDA	ANDA076368	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71335-1901_fc9c7b08-e26f-aa25-e053-6294a90aca75	71335-1901	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20160523		ANDA	ANDA203482	Bryant Ranch Prepack	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1902_be2e589c-9e89-462a-844a-d3617a68a8d3	71335-1902	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20170215		ANDA	ANDA203266	Bryant Ranch Prepack	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71335-1903_5e383a89-eefe-4482-b45c-c1809bd4f00d	71335-1903	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Bryant Ranch Prepack	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1904_87e95c18-b597-4c78-b645-f8506500caec	71335-1904	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20181011	20240930	ANDA	ANDA210616	Bryant Ranch Prepack	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
71335-1907_5cecc16c-931d-4acd-b164-5ff7d876f641	71335-1907	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	Bryant Ranch Prepack	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-1908_19746c9f-f9af-4181-98c9-fe337206f58c	71335-1908	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20150711		ANDA	ANDA090058	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
71335-1909_a7e76dec-d4c6-400e-8b03-065ed81346af	71335-1909	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1910_fc87d456-5171-76c8-e053-6394a90a7509	71335-1910	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Bryant Ranch Prepack	ENALAPRIL MALEATE	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-1911_cac74d25-4e33-4696-97d5-81fc919de748	71335-1911	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180920		ANDA	ANDA072096	Bryant Ranch Prepack	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1912_3e9d565c-6c80-450b-8986-ece5c71783e0	71335-1912	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202490	Bryant Ranch Prepack	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71335-1913_250d9b7c-59ea-4093-87a7-0d1908d0ec27	71335-1913	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Bryant Ranch Prepack	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71335-1914_fc8abd66-24d1-cd1a-e053-6394a90afa7f	71335-1914	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20190912		ANDA	ANDA212254	Bryant Ranch Prepack	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1915_496b156e-d3fd-4a01-8c47-e782e40bb8a4	71335-1915	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181204		ANDA	ANDA210525	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-1916_7e61a356-817e-4dd1-96fa-05c9972da3ae	71335-1916	HUMAN PRESCRIPTION DRUG	Lamivudine and Zidovudine		Lamivudine and Zidovudine	TABLET	ORAL	20180830		ANDA	ANDA090679	Bryant Ranch Prepack	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
71335-1917_7da2dbe1-dd39-487c-99ee-59ff2fae4eb2	71335-1917	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
71335-1918_fc5ec827-40e5-1403-e053-6394a90a7578	71335-1918	HUMAN PRESCRIPTION DRUG	Captopril		Captopril	TABLET	ORAL	20191213		ANDA	ANDA212809	Bryant Ranch Prepack	CAPTOPRIL	25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-1919_a51bb9b4-3f01-465c-b3d3-3f924c3992f4	71335-1919	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA077633	Bryant Ranch Prepack	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
71335-1920_fd68bf4e-5f21-61f7-e053-6294a90a9185	71335-1920	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil		olmesartan medoxomil	TABLET, FILM COATED	ORAL	20180629		ANDA	ANDA208130	Bryant Ranch Prepack	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-1921_fc76e96e-9ce8-de0f-e053-6294a90a0eb2	71335-1921	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	19910918		ANDA	ANDA072741	Bryant Ranch Prepack	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
71335-1922_624a268f-9baa-4788-bf0b-50e83b62132e	71335-1922	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20150529		ANDA	ANDA203974	Bryant Ranch Prepack	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
71335-1923_7142bcf3-e30c-41ec-824a-a9f4f0041046	71335-1923	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960615		ANDA	ANDA040156	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-1924_8e8143ca-a77b-43a1-9de9-33699c917b19	71335-1924	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71335-1925_cf2bc956-3b43-45df-aec7-74e1d6835aed	71335-1925	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20111031		ANDA	ANDA200629	Bryant Ranch Prepack	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1926_5af7832a-71c0-403d-a77a-166b301a5da0	71335-1926	HUMAN PRESCRIPTION DRUG	PREDNISONE		Prednisone	TABLET	ORAL	20181228		ANDA	ANDA211496	Bryant Ranch Prepack	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-1927_5e7d54d7-0275-4811-80cd-0240495d307a	71335-1927	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20160815		ANDA	ANDA081297	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-1928_2a63d919-c76d-4894-8ebc-51617e2caa71	71335-1928	HUMAN OTC DRUG	Mucus Relief Cough and Congestion DM		Guaifenesin and Dextromethorphan HBr	TABLET	ORAL	20160401		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71335-1929_a0b9b9c7-908e-41fa-b111-dd2416ec148a	71335-1929	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20200924		ANDA	ANDA204991	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1930_dd667412-4391-4c85-9e2e-8bab885206cf	71335-1930	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170217		ANDA	ANDA202330	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
71335-1931_88d7ca47-4207-419b-9d0d-8d944a95e8b1	71335-1931	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		Bisoprolol Fumarate and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20190430		ANDA	ANDA212678	Bryant Ranch Prepack	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1933_ceab6a7a-f1b7-46c0-a2a0-64fddfa70186	71335-1933	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-1934_794c7ac3-af2d-4565-8fd6-d60df7bbf2e9	71335-1934	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	PATCH	CUTANEOUS	20140502		NDA AUTHORIZED GENERIC	NDA020612	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71335-1935_bf117c82-517f-467b-9f75-01595d555b45	71335-1935	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Bryant Ranch Prepack	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1936_9d4ac64a-10a8-4962-9b46-c90641cc0afb	71335-1936	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20120423		ANDA	ANDA202050	Bryant Ranch Prepack	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1937_8b3cf951-7e7f-4789-99bb-84cfe8835b8f	71335-1937	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078251	Bryant Ranch Prepack	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1938_80260ae4-76a2-43fc-aac8-0cb901b5037b	71335-1938	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71335-1939_ccc72b4b-8117-4f02-af49-83e9d71abd39	71335-1939	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-1940_f40fa5ae-6bc8-45ee-85a5-02dbdbe6dc1e	71335-1940	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1943_cbd48de5-1db7-4754-84b4-31c1f2df660f	71335-1943	HUMAN PRESCRIPTION DRUG	Liothyronine sodium		Liothyronine sodium	TABLET	ORAL	20210201		ANDA	ANDA214803	Bryant Ranch Prepack	LIOTHYRONINE SODIUM	25	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
71335-1944_5bed5025-96a3-4df7-ac1c-9d4f37f45a79	71335-1944	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210515		ANDA	ANDA213827	Bryant Ranch Prepack	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71335-1945_52850222-885a-4ecb-b49e-b65b7b85a22d	71335-1945	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1946_7643aa5b-f1c9-4036-93ba-845b8e4f17bd	71335-1946	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate and Benazepril Hydrochloride		Amlodipine Besylate and Benazepril Hydrochloride	CAPSULE	ORAL	20180801		ANDA	ANDA078466	Bryant Ranch Prepack	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-1947_e53b735d-a19c-4172-a86f-9095dfa24288	71335-1947	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1948_8e83ea3d-f3eb-4c76-82bc-ffa976249782	71335-1948	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Bryant Ranch Prepack	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1950_816b9fba-b2a4-41a2-9aee-1a387b832a9f	71335-1950	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20010416		ANDA	ANDA075718	Bryant Ranch Prepack	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-1951_d833624e-bb69-4953-bbfa-db4c503abe89	71335-1951	HUMAN PRESCRIPTION DRUG	metoprolol succinate		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180607		ANDA	ANDA203894	Bryant Ranch Prepack	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1952_f1247810-d7f4-4018-977c-25f8e62f3f84	71335-1952	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20140909		ANDA	ANDA203646	Bryant Ranch Prepack	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-1953_af077cb5-d18b-4be5-9824-8ad1d13da989	71335-1953	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1954_cf222720-e457-484f-b2f8-f6f29dfd4bde	71335-1954	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	Bryant Ranch Prepack	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-1955_d265fea4-a9b7-44e0-a36d-03a15c4adc35	71335-1955	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1956_025f849c-6461-4e8c-badd-9d7f7a03a5b2	71335-1956	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Bryant Ranch Prepack	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1957_d717fd8a-881d-41b5-9d9c-2628e89dc971	71335-1957	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET	ORAL	20160301		NDA AUTHORIZED GENERIC	NDA022430	Bryant Ranch Prepack	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
71335-1958_e52774ce-cbf5-49a6-b3a9-fbea19f0659d	71335-1958	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	19980311		ANDA	ANDA075074	Bryant Ranch Prepack	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-1959_4d737631-cf27-4986-bf11-0b1d52aae996	71335-1959	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-1960_68a033cc-ae05-48e1-99eb-2631fcb70755	71335-1960	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20180725		OTC MONOGRAPH FINAL	part331	Bryant Ranch Prepack	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71335-1961_9bb215d0-276c-4c70-a4f9-f9e20b9f3cdf	71335-1961	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1962_081b5e7c-a504-8d76-e063-6294a90a821f	71335-1962	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-1963_a4bbefb8-48fc-4413-8bad-dd448bcaaef9	71335-1963	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20180504		ANDA	ANDA210394	Bryant Ranch Prepack	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-1964_e03c0004-f4fd-4ae2-a684-3689ab74afe2	71335-1964	HUMAN PRESCRIPTION DRUG	DULOXETINE		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20160120		ANDA	ANDA206653	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1966_7979a077-3ed2-48ef-87cf-595b6896ad73	71335-1966	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1967_09e72ff9-f66c-46be-aae4-ba650a4215a8	71335-1967	HUMAN PRESCRIPTION DRUG	Potassium Citrate		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20200316		ANDA	ANDA212779	Bryant Ranch Prepack	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
71335-1970_694c0138-db90-4f70-b2c4-171037e9e5a8	71335-1970	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-1971_682ae689-d5bc-4c3e-8e1c-b7febaf9cc7f	71335-1971	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20200825		ANDA	ANDA206463	Bryant Ranch Prepack	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71335-1972_a8ecc34e-d850-42d9-8dde-99cc268ef573	71335-1972	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20200710		ANDA	ANDA074255	Bryant Ranch Prepack	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1973_95b3beb0-12bd-4814-85a8-94476cc0b867	71335-1973	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20160803		ANDA	ANDA040197	Bryant Ranch Prepack	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
71335-1975_f99edb6c-fe4f-49d6-8c69-183882eaf5cf	71335-1975	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210105		ANDA	ANDA210014	Bryant Ranch Prepack	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1976_fc734abf-207c-6c02-e053-6394a90a1637	71335-1976	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-1979_f7a8c0bb-1c1d-4de6-9537-3870e1585190	71335-1979	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20140910		ANDA	ANDA202843	Bryant Ranch Prepack	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71335-1980_b9e35222-8a4f-4af6-a422-294f9b3e1b2b	71335-1980	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20190227		ANDA	ANDA207105	Bryant Ranch Prepack	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-1981_bb13d025-697a-4f90-a7d5-8b1b8301901a	71335-1981	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		Tranexamic Acid	TABLET	ORAL	20210701		ANDA	ANDA203256	Bryant Ranch Prepack	TRANEXAMIC ACID	650	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
71335-1982_03ad8e04-90f7-4b06-bff4-46b1e1093b0d	71335-1982	HUMAN PRESCRIPTION DRUG	ropinirole		ropinirole	TABLET, FILM COATED	ORAL	20181017		ANDA	ANDA204022	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-1983_eb33befc-c9d1-4a59-bd5b-971c1769f589	71335-1983	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-1984_5d6b76dd-5560-4334-9e10-3296159e2420	71335-1984	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1985_84684b63-4bba-483c-a253-c67cc80d8276	71335-1985	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20200309		ANDA	ANDA078578	Bryant Ranch Prepack	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71335-1986_b02954ef-d3b9-45ff-ab1f-24d1e3f90a70	71335-1986	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201102		ANDA	ANDA211347	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-1987_c49c28fe-d679-479a-bbd6-ab1c6c09322e	71335-1987	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1988_8beb852a-5429-47db-92d2-000de9741c21	71335-1988	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	Bryant Ranch Prepack	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-1989_45615156-7a74-4046-ad4c-081570c18feb	71335-1989	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20070330		ANDA	ANDA040646	Bryant Ranch Prepack	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-1990_628cefd6-e7bf-4f1a-ade3-bed1c55c9082	71335-1990	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Bryant Ranch Prepack	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71335-1993_f58bc870-b192-4822-aca0-9debdc9eb3d2	71335-1993	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-1994_7fc306a1-3aad-4a51-9bb5-609c90333667	71335-1994	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20191031		ANDA	ANDA070322	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-1995_b403b542-0f14-40de-8fd8-954b63ed8bb8	71335-1995	HUMAN PRESCRIPTION DRUG	montelukast sodium		montelukast sodium	TABLET, FILM COATED	ORAL	20160101		ANDA	ANDA204290	Bryant Ranch Prepack	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71335-1996_78486883-a78e-49b3-a2cc-de2301e808ce	71335-1996	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210120		ANDA	ANDA214603	Bryant Ranch Prepack	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71335-1997_59301efe-24b0-4070-8e16-4a2dc509e2e3	71335-1997	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-1998_5394c860-0097-4b27-92b8-d12b0c4f629c	71335-1998	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-1999_5948299c-0eb0-4808-83d5-02fecfcc00cb	71335-1999	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20170801		ANDA	ANDA208340	Bryant Ranch Prepack	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2002_84840a70-776b-4cc5-ad07-4e075aeb411c	71335-2002	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	OROPHARYNGEAL	20140415		ANDA	ANDA091166	Bryant Ranch Prepack	ESZOPICLONE	3	mg/1		CIV	N	20241231
71335-2004_5e8f71c2-f996-45e5-9c8e-43f9c7cee13d	71335-2004	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2007_48033a95-42e8-4cc9-8048-cd34b2926616	71335-2007	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2008_e0343388-d3d3-4823-b6bd-115222eff6b1	71335-2008	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	TABLET	ORAL	20010710		ANDA	ANDA075902	Bryant Ranch Prepack	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-2009_fc8b10e2-3530-6ae3-e053-6394a90adb2b	71335-2009	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20200803		ANDA	ANDA089853	Bryant Ranch Prepack	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-2010_66746a9b-fde0-4514-a147-13e28931465b	71335-2010	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20181201		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71335-2013_24aceb1f-1a08-4643-ac9d-713874e86ab6	71335-2013	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Bryant Ranch Prepack	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
71335-2014_0344418a-5429-4835-9f2f-0a42638d51bd	71335-2014	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110823		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71335-2016_72a68150-905a-4ecd-a439-1cb925684873	71335-2016	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20130514		ANDA	ANDA202856	Bryant Ranch Prepack	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71335-2017_ac04a1bf-4296-4b0b-b39f-11d23e0246f7	71335-2017	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-2018_f279dc04-756e-4d99-8f0e-3fe36f008ddd	71335-2018	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA211977	Bryant Ranch Prepack	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-2019_67d40b12-ac7b-4e9c-9f54-cf869031964b	71335-2019	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20200903		ANDA	ANDA210628	Bryant Ranch Prepack	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2020_fc8cddba-9153-b09d-e053-6294a90acb89	71335-2020	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20150316		ANDA	ANDA204597	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-2021_e1c77f1a-79d0-4c5d-a011-fd5c8cd59ffe	71335-2021	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71335-2022_02582f1c-4d6b-43b5-9e0b-dded54db8297	71335-2022	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20120817		ANDA	ANDA201146	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71335-2023_335ca76a-0c64-4ce6-8c2b-cbdc12699e12	71335-2023	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	Bryant Ranch Prepack	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2024_fd8c63f6-c697-35b6-e053-6294a90a871b	71335-2024	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		OMEGA-3-ACID ETHYL ESTERS	CAPSULE, LIQUID FILLED	ORAL	20200702		ANDA	ANDA210093	Bryant Ranch Prepack	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
71335-2025_b638c419-55ca-44a1-91c9-eb477f8bd7f6	71335-2025	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	Bryant Ranch Prepack	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71335-2026_419c99fb-aecb-4336-a464-452b01a75896	71335-2026	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	Bryant Ranch Prepack	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2029_fda112a0-3733-78fc-e053-6294a90a9a5d	71335-2029	HUMAN PRESCRIPTION DRUG	Diltiazem HCl CD		Diltiazem Hydrochloride	CAPSULE, COATED, EXTENDED RELEASE	ORAL	20010411		NDA	NDA020062	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	360	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-2031_95a24865-793b-4bcd-b074-e4a22e826769	71335-2031	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20120625		ANDA	ANDA203269	Bryant Ranch Prepack	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71335-2034_cc7a82ac-c4f2-46fd-af3e-be247ee4f3ad	71335-2034	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20200221		ANDA	ANDA208358	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2035_3d131bec-0671-495b-b4d2-1f6e97f7150d	71335-2035	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20170321		ANDA	ANDA206465	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2037_e0487075-9488-4d8a-bada-0b4e7aad99bb	71335-2037	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2038_eedac8b3-3cd0-4ff1-b003-bab063535d68	71335-2038	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2039_9e25399f-96df-4902-9b26-2da47b003ce1	71335-2039	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2040_e2814041-f6eb-461b-ac9e-09b621eec222	71335-2040	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20200602		ANDA	ANDA211977	Bryant Ranch Prepack	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-2041_df847208-8308-4538-a61f-9a4fcfbcfd4e	71335-2041	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-2043_28230ade-ea7a-4fc1-a654-61bc7fe9afc1	71335-2043	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Bryant Ranch Prepack	TEMAZEPAM	22.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2044_0f8b69cf-2ca5-4df4-b0e5-dd03c13d06d7	71335-2044	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20070330		ANDA	ANDA040646	Bryant Ranch Prepack	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2046_1f4f680f-6a86-48ae-a900-3e8213391f0e	71335-2046	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
71335-2047_f49e4782-ac9c-492e-bae4-f35db892126a	71335-2047	HUMAN OTC DRUG	good sense ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19890915		ANDA	ANDA072096	Bryant Ranch Prepack	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2048_db03d8b4-e2ff-47a3-9636-1982b2d08e3a	71335-2048	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2051_04d9b88a-bbf1-4651-bf6f-41ae274d193e	71335-2051	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2053_283f2cd2-92f4-4210-a834-ca84c0b7bdc9	71335-2053	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2054_d1b5a017-f30d-4170-93c1-acf40a8938df	71335-2054	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
71335-2055_79932ffb-eb80-4b06-aaa5-b346c88fc903	71335-2055	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2056_3d3c4a4e-1bbd-4132-821e-23aeeac979b2	71335-2056	HUMAN OTC DRUG	Allergy		Chlorpheniramine Maleate	TABLET	ORAL	19921219		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-2057_65172f8d-232e-4f00-bba8-7dddb1c0c0b2	71335-2057	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2058_325c6924-f918-4c8f-be0a-817e2ce7deef	71335-2058	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130305		ANDA	ANDA202389	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-2059_cceb74be-db69-46f2-beee-f4527e066fa1	71335-2059	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20150828		ANDA	ANDA204310	Bryant Ranch Prepack	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71335-2060_fc9dc59f-8548-8192-e053-6294a90a8670	71335-2060	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20191114		ANDA	ANDA210907	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71335-2061_fc76e109-ffdb-0c14-e053-6394a90a3ae6	71335-2061	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		loperamide hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215579	Bryant Ranch Prepack	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
71335-2062_ab44332a-6f04-4f07-8209-e472206d5707	71335-2062	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		NALTREXONE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20120229		ANDA	ANDA090356	Bryant Ranch Prepack	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71335-2063_37ad438f-c04d-478b-8882-315a34d89628	71335-2063	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2064_fc7809c4-70a2-d0f2-e053-6294a90a2411	71335-2064	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	Bryant Ranch Prepack	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2065_21251452-e7c5-4d25-a922-189ba8740d6c	71335-2065	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET	ORAL	20210629		ANDA	ANDA078662	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71335-2067_0de24c80-65c2-44ee-8909-576f98e9ab5a	71335-2067	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20180507		ANDA	ANDA210347	Bryant Ranch Prepack	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2068_9ad350ec-4ed1-415a-afb6-5f611e7d8f77	71335-2068	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	19940816		ANDA	ANDA072096	Bryant Ranch Prepack	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2069_fdb5c1ce-c42b-8470-e053-6394a90ac23b	71335-2069	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2071_c21b11c1-fad5-4e7d-bb26-981000daaf7c	71335-2071	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20090127		ANDA	ANDA078525	Bryant Ranch Prepack	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
71335-2072_1e72e940-0c13-4856-9da3-888f33f97b7f	71335-2072	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20200213		ANDA	ANDA213412	Bryant Ranch Prepack	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71335-2073_8c0eb390-f204-4192-969b-63983212a817	71335-2073	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71335-2074_cde7dd6d-c987-4034-9488-8b97861f3abd	71335-2074	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20100927		NDA	NDA016620	Bryant Ranch Prepack	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71335-2075_70735550-49a3-41e8-bb70-fb7dbb8b36c8	71335-2075	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20170227		ANDA	ANDA207201	Bryant Ranch Prepack	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-2076_b0f3980d-4810-4ae5-a4ea-11eddb1641f6	71335-2076	HUMAN PRESCRIPTION DRUG	Hydroxyzine pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA086183	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-2077_df974f7d-ae3d-4ca9-b609-a3736e9f46ed	71335-2077	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-2079_fdb67633-f842-8a51-e053-6294a90aace5	71335-2079	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Bryant Ranch Prepack	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2080_601fbcd3-d11d-4638-b4a5-ac841a27a38a	71335-2080	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Bryant Ranch Prepack	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2081_a764c113-34fb-4f9d-837b-ac8c53488b2f	71335-2081	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71335-2082_e3d89233-5f44-483a-bd65-ddb2f96e254c	71335-2082	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride		Pioglitazone Hydrochloride	TABLET	ORAL	20201028		ANDA	ANDA076798	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
71335-2083_fe169942-60b1-45ef-82b2-b9c7da158379	71335-2083	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Bryant Ranch Prepack	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2084_9fa9144b-6a63-4167-90c0-85c261628476	71335-2084	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20131127		ANDA	ANDA202180	Bryant Ranch Prepack	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71335-2085_97e744b2-32cb-4d14-9a90-756989730bdc	71335-2085	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20140411		ANDA	ANDA078970	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71335-2086_fc88eec0-c64e-5d6d-e053-6294a90a13d2	71335-2086	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20220110		ANDA	ANDA207774	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-2088_61d90472-0882-48cb-b848-87cc080caa53	71335-2088	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA209727	Bryant Ranch Prepack	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2089_639aa7bc-c63d-41af-8e39-ea77c76a1b4f	71335-2089	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190614		ANDA	ANDA208783	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
71335-2090_d93ec1ad-27c4-4031-88b8-9a7604da00c4	71335-2090	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201203		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2091_746b1295-24a9-46f9-9032-2d85c0367205	71335-2091	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2092_db2e0d46-5dac-48bd-8aca-4fd5ae1b463b	71335-2092	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-2093_96dfeaaf-19dd-4e56-b435-46f9afe5458f	71335-2093	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET, FILM COATED	ORAL	20110531		ANDA	ANDA090056	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71335-2096_7359324d-778d-4698-b4da-b6c0f48e92d4	71335-2096	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Bryant Ranch Prepack	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-2097_4296bb43-12f6-422c-94b7-ae63c009e32e	71335-2097	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20200812		ANDA	ANDA208921	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
71335-2098_9a3d2a65-29a5-49d1-b090-f904b947fe8b	71335-2098	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20090115		ANDA	ANDA078154	Bryant Ranch Prepack	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2099_cab146b8-2697-4073-a106-931e7a183bf7	71335-2099	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20140301		ANDA	ANDA203072	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2100_fc88fb9f-6a9b-9478-e053-6294a90a996c	71335-2100	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-2101_0f3733ae-9a9f-410b-a07b-df1206650fa7	71335-2101	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA077614	Bryant Ranch Prepack	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2102_b3d343d7-49c2-4528-997c-5bfa8505ab2c	71335-2102	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2103_0da3a5f5-3f1e-4914-b44b-325ef50096c4	71335-2103	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2104_b0ea909c-4c4a-4fcf-8c22-dfba2e3d2994	71335-2104	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2105_26c99b28-4531-434e-b673-5f4bacd0e9b1	71335-2105	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2106_f78225e8-ce96-4757-b790-d482c171631a	71335-2106	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-2108_6fee4080-8eeb-4d43-9f2a-a73a6c0cbe55	71335-2108	HUMAN PRESCRIPTION DRUG	Dexamethasone		dexamethasone	TABLET	ORAL	20210628		ANDA	ANDA088481	Bryant Ranch Prepack	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2110_fc8b8b12-80ca-d4df-e053-6394a90ad437	71335-2110	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-2111_fc76d7e3-6f71-d6c2-e053-6394a90a2f73	71335-2111	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20200925		ANDA	ANDA215001	Bryant Ranch Prepack	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
71335-2112_4024b70b-28b5-485c-869d-2ee443462379	71335-2112	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2113_5616e7d8-7f50-4332-a4eb-1cdeca200009	71335-2113	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20190314		ANDA	ANDA207773	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-2114_fc506a9a-8d99-f22b-e053-6394a90ad6d9	71335-2114	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	Bryant Ranch Prepack	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
71335-2115_d017098c-8956-42f1-b477-51fed32bffcc	71335-2115	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2116_6db75aba-c9ee-4185-82e2-b1bd4b68fc6e	71335-2116	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2117_d2c95738-74cd-4cef-89b8-20d4c5745169	71335-2117	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2118_77a2fcda-9dd5-47bc-b77d-58df41069e20	71335-2118	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2119_0ea3f3bd-6cbc-4e90-9942-4d005d252538	71335-2119	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Bryant Ranch Prepack	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71335-2120_fda30c73-7230-bbca-e053-6294a90ae203	71335-2120	HUMAN PRESCRIPTION DRUG	pilocarpine hydrchloride		pilocarpine hydrchloride	TABLET, FILM COATED	ORAL	20200824		ANDA	ANDA076746	Bryant Ranch Prepack	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
71335-2122_fda1664a-32f0-00f5-e053-6294a90a3492	71335-2122	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2123_b01bf47d-0202-4742-a537-ce09f217616e	71335-2123	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20170825		ANDA	ANDA209838	Bryant Ranch Prepack	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
71335-2125_fbf5baa7-1499-4574-b582-9dd39bcd2339	71335-2125	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Bryant Ranch Prepack	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-2126_1aa823c3-7615-481c-ae22-3432032ed3ee	71335-2126	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20170808		ANDA	ANDA207418	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-2127_9fb29467-4366-4f70-9f7f-72c3acede1e9	71335-2127	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20180215		ANDA	ANDA204901	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2129_e148ea5c-24de-4b3e-bf3b-54185656efae	71335-2129	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20181001		ANDA	ANDA205231	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
71335-2130_bfa62f40-e6f2-4998-8c4f-1aa2ed3b92e9	71335-2130	HUMAN PRESCRIPTION DRUG	Desvenlafaxine		Desvenlafaxine Succinate	TABLET, EXTENDED RELEASE	ORAL	20181128		ANDA	ANDA204003	Bryant Ranch Prepack	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-2131_f5df698d-5ace-41f7-af7d-aca66b73c57b	71335-2131	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20190726		ANDA	ANDA210955	Bryant Ranch Prepack	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2132_5cb5ba49-d959-4e98-8c12-efff26869287	71335-2132	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20190312		ANDA	ANDA210614	Bryant Ranch Prepack	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-2134_02969d86-16dd-d311-e063-6294a90aaf01	71335-2134	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA209727	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2136_f1d92737-780f-4c36-a655-ca478c850a4b	71335-2136	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20220523		ANDA	ANDA215788	Bryant Ranch Prepack	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2137_fca0506e-4abe-4e55-e053-6294a90a5cf5	71335-2137	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20211227		ANDA	ANDA084657	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-2138_1c238d4d-b291-41b5-97d6-08bdbb3f8600	71335-2138	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2141_fc87a6a0-8a4d-acce-e053-6294a90a667e	71335-2141	HUMAN PRESCRIPTION DRUG	Tetracycline Hydrochloride		Tetracycline Hydrochloride	CAPSULE	ORAL	20190118		ANDA	ANDA210662	Bryant Ranch Prepack	TETRACYCLINE HYDROCHLORIDE	500	mg/1	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
71335-2143_fc634fe6-e0f4-713a-e053-6294a90ac9f4	71335-2143	HUMAN PRESCRIPTION DRUG	Torsemide		Torsemide	TABLET	ORAL	20071017		ANDA	ANDA078249	Bryant Ranch Prepack	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71335-2144_90a525a9-b589-4123-9eca-bc12c2021eca	71335-2144	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2145_81c31612-f201-43eb-9709-7a2900bb2792	71335-2145	HUMAN PRESCRIPTION DRUG	Labetalol HCL		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20120724		ANDA	ANDA200908	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2146_e06dc951-8bc5-4dd0-88ff-64d50c23ec37	71335-2146	HUMAN PRESCRIPTION DRUG	Alfuzosin Hydrochloride		Alfuzosin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20111122		ANDA	ANDA079057	Bryant Ranch Prepack	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-2149_fda071c0-096f-4578-e053-6294a90a0772	71335-2149	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20210901		ANDA	ANDA208412	Bryant Ranch Prepack	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2150_488ce94d-bdb2-45f9-b119-215b1ec525fb	71335-2150	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20130708		ANDA	ANDA076008	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
71335-2151_c42a9457-c2f1-4b0b-a954-f67f2ccd1032	71335-2151	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Bryant Ranch Prepack	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2152_0c30c937-a24e-4f12-bebb-eb0d9d2fa8b7	71335-2152	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Bryant Ranch Prepack	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2153_fd79fe73-9b85-8973-e053-6294a90a8cd6	71335-2153	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20050606		ANDA	ANDA040611	Bryant Ranch Prepack	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2154_e630952f-1114-4908-ab2e-8b56e7f6d7c5	71335-2154	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Bryant Ranch Prepack	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2155_08e219cd-0de6-49ba-a526-e02307e5f437	71335-2155	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20210623		ANDA	ANDA203311	Bryant Ranch Prepack	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2156_fc006935-5f28-707a-e053-6294a90aeeb0	71335-2156	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-2157_7c718213-a8e1-46d0-a27a-e9590a3554c9	71335-2157	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Bryant Ranch Prepack	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-2158_fdc24c34-115e-4e23-90fc-2e6737f05d5a	71335-2158	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20141024		ANDA	ANDA090554	Bryant Ranch Prepack	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71335-2160_dbe27720-74ab-4c99-a4aa-fd001919d17a	71335-2160	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20191115		ANDA	ANDA211575	Bryant Ranch Prepack	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2162_b7f45506-6000-4916-aa25-b9766226ad25	71335-2162	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Bryant Ranch Prepack	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-2164_fc78a171-74ad-586d-e053-6294a90af6c5	71335-2164	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Bryant Ranch Prepack	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2167_10ac7883-6220-457b-9e77-70d5636f52d8	71335-2167	HUMAN PRESCRIPTION DRUG	Pramipexole Dihydrochloride		Pramipexole Dihydrochloride	TABLET	ORAL	20101008		ANDA	ANDA090865	Bryant Ranch Prepack	PRAMIPEXOLE DIHYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-2168_f8e0d3a4-3293-4db6-861a-238dd17c9d45	71335-2168	HUMAN PRESCRIPTION DRUG	Irbesartan		Irbesartan	TABLET	ORAL	20160613		ANDA	ANDA203071	Bryant Ranch Prepack	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2169_10871eff-034a-41ec-9f59-2bd2cc7891ef	71335-2169	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210818		ANDA	ANDA211953	Bryant Ranch Prepack	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2171_16f050fb-b3b9-4907-a67c-63642ff31f0e	71335-2171	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190819		ANDA	ANDA212543	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71335-2173_dd8babb8-8394-4d19-acde-91af5e661fc0	71335-2173	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20170820		ANDA	ANDA207882	Bryant Ranch Prepack	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2175_d715d337-b034-4eb8-a569-a9ffadf75ca4	71335-2175	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-2176_68c91671-2ec2-4a5b-8920-192880be67d1	71335-2176	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		Quetiapine fumarate	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA201190	Bryant Ranch Prepack	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-2177_601056fd-b652-4ce6-beaf-b0d48f489743	71335-2177	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20201030		OTC MONOGRAPH FINAL	part336	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-2178_93041a9f-53d9-47b4-96d7-d2b138ea1b06	71335-2178	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET	ORAL	20211029		ANDA	ANDA215563	Bryant Ranch Prepack	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2179_7f9b80e3-3b5e-4117-9f7c-9fda6b67374e	71335-2179	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20220110		ANDA	ANDA207774	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-2180_3bb80282-3088-49f3-9ffd-f8346334113c	71335-2180	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil and Hydrochlorothiazide		Olmesartan Medoxomil and Hydrochlorothiazide	TABLET	ORAL	20201001		ANDA	ANDA208847	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2181_fd90ffc6-a1bf-e02e-e053-6294a90a4e7c	71335-2181	HUMAN PRESCRIPTION DRUG	Megestrol Acetate		Megestrol Acetate	TABLET	ORAL	20220404		ANDA	ANDA072423	Bryant Ranch Prepack	MEGESTROL ACETATE	40	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
71335-2182_8199bdc7-45c8-406d-acc5-3c4b88f7fdc0	71335-2182	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20030306		ANDA	ANDA040330	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-2183_6d48e0ba-6ca4-4fa6-a612-78db6acbd2c4	71335-2183	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCl 200mg		Phenazopyridine Hydrochloride	TABLET	ORAL	20141231		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
71335-2184_2f547f53-1f75-412b-99ac-2406be2d4cf0	71335-2184	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCl 100mg		Phenazopyridine Hydrochloride	TABLET	ORAL	20141231		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71335-2185_ed70665f-c8e1-4263-a937-131e66cf616c	71335-2185	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040604	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-2186_77709852-1778-45c5-8de9-d90820786d80	71335-2186	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA212650	Bryant Ranch Prepack	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
71335-2187_c0538532-e7e9-475c-8598-f88bc06b1779	71335-2187	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19840701		ANDA	ANDA088496	Bryant Ranch Prepack	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71335-2188_e065f520-615b-4d20-9652-1c4a96ff001b	71335-2188	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-2189_f4399979-49db-4889-a029-7e3753ee492a	71335-2189	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20110930		ANDA	ANDA091195	Bryant Ranch Prepack	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
71335-2190_7eeb4059-2482-4380-ba64-c5e5e75485d2	71335-2190	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	Bryant Ranch Prepack	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-2191_4f1b411b-7804-46cf-8e28-d63550e3c9da	71335-2191	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20170820		ANDA	ANDA207882	Bryant Ranch Prepack	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2192_2731692a-2fb7-4b99-bd46-3e430d2b6c4a	71335-2192	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181113		ANDA	ANDA210918	Bryant Ranch Prepack	ISOSORBIDE MONONITRATE	60	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71335-2193_341c39a0-db88-425c-a85d-238e87945e72	71335-2193	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
71335-2194_00d75f8b-1ca0-46a3-8eaa-9a8c0579ab5c	71335-2194	HUMAN PRESCRIPTION DRUG	Isosorbide Mononitrate		Isosorbide Mononitrate	TABLET, EXTENDED RELEASE	ORAL	20181113		ANDA	ANDA210918	Bryant Ranch Prepack	ISOSORBIDE MONONITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71335-2195_cce00f68-85cb-45ef-a365-6b9f4fa51cbf	71335-2195	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2196_fc88872b-c0bf-dc8e-e053-6394a90a182f	71335-2196	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071136	Bryant Ranch Prepack	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2197_fc87fee1-cea7-7c45-e053-6294a90ab88c	71335-2197	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071135	Bryant Ranch Prepack	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2198_7dde13e9-c83d-459d-9c43-d1960c5594fb	71335-2198	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071134	Bryant Ranch Prepack	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2199_73e75fe4-d223-4038-885b-21514f005ce2	71335-2199	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20191212		ANDA	ANDA073556	Bryant Ranch Prepack	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-2200_0016785b-7437-4912-8431-8263f13aad66	71335-2200	HUMAN PRESCRIPTION DRUG	VALSARTAN AND HYDROCHLOROTHIAZIDE		valsartan and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20151031		ANDA	ANDA206083	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; VALSARTAN	25; 320	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2201_07f0321a-bdbe-43cf-8b79-1a354b57d354	71335-2201	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-2202_23850912-f440-4aa8-991e-6523b8a13ef1	71335-2202	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		Spironolactone and Hydrochlorothiazide	TABLET	ORAL	19870702		ANDA	ANDA089534	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-2203_3663060e-b07f-4858-a05c-529219e8e1cd	71335-2203	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71335-2204_4742a01e-13f5-4a92-9382-8687c226c805	71335-2204	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71335-2205_8c23f39e-6044-41e9-bd14-df509e70967c	71335-2205	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71335-2207_1bac88dc-588e-4051-b1d5-516ac21ae839	71335-2207	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71335-2208_17dc20bf-fcf1-4fdd-87c3-208b4bccdb80	71335-2208	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-2209_84c0a1b2-a712-46fb-9715-5b5bbb7b93b6	71335-2209	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-2210_7f228e32-7646-46c8-a517-caf9041df27c	71335-2210	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-2211_886307ce-42b2-47b6-b2cb-d0716f0ab19a	71335-2211	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2212_286e68d4-754d-4900-9365-901ecccac6b0	71335-2212	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230321		ANDA	ANDA217272	Bryant Ranch Prepack	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71335-2213_b1d5891f-5b10-4874-a58e-3b4e997dc7f0	71335-2213	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	Bryant Ranch Prepack	ATORVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2215_d16d72f8-421b-4147-92c2-6f3debce697b	71335-2215	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20210819		ANDA	ANDA215101	Bryant Ranch Prepack	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71335-2216_370392bf-2199-4577-b294-7de59a23b520	71335-2216	HUMAN OTC DRUG	Rugby Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20200901		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71335-2217_b630a80b-1b4a-4e3f-b8e2-3133c6d086a2	71335-2217	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71335-2218_d596269b-696d-4732-9250-a2fa2994a428	71335-2218	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20210422		ANDA	ANDA202068	Bryant Ranch Prepack	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
71335-2219_00e415be-66ba-4650-b558-e743237829ca	71335-2219	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71335-2220_dd0aab88-6149-4c8f-af30-3a6295db2ea2	71335-2220	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	Bryant Ranch Prepack	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2221_5488dfc1-8f40-4f52-ab27-f08e77b8c5c8	71335-2221	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate	TABLET	ORAL	20200130		ANDA	ANDA210454	Bryant Ranch Prepack	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
71335-2222_1c8e2f85-4cfa-4baa-a9c4-4f4764095996	71335-2222	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	Bryant Ranch Prepack	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2223_32ff9d72-eee2-4e70-aa4c-1d8f245c171b	71335-2223	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		chlorthalidone	TABLET	ORAL	20220805		ANDA	ANDA215587	Bryant Ranch Prepack	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71335-2224_7933b827-b127-4ed7-9af8-36ecbaba5d17	71335-2224	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20210517		ANDA	ANDA209882	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-2225_f496ee56-f3f9-4b78-9c74-22a3537d8fe5	71335-2225	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2226_0db99b96-8d64-454d-a50e-80768ab85818	71335-2226	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	TABLET	ORAL	20221214		ANDA	ANDA216736	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-2227_6161a459-ca98-41d3-9e50-9c9458ae1207	71335-2227	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220808		ANDA	ANDA215604	Bryant Ranch Prepack	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2228_88e5b76c-c130-476b-8bb7-9cf161fc0678	71335-2228	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091123		NDA AUTHORIZED GENERIC	NDA019892	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-2229_c7bfeeb0-6af2-44c6-a2c1-26fa6cee6eec	71335-2229	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Bryant Ranch Prepack	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-2230_3b55544f-cdc3-41c7-bac2-2defafcf3e8d	71335-2230	HUMAN OTC DRUG	Geri-kot		SENNOSIDES	TABLET	ORAL	20221201		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	SENNOSIDES	8.6	mg/1			N	20241231
71335-2231_0017b1e3-75e7-4d07-bc93-fabfc1d06aef	71335-2231	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71335-2232_d1a3dcb8-0207-4002-8bf1-5e713b653943	71335-2232	HUMAN PRESCRIPTION DRUG	Citalopram		citalopram	TABLET, FILM COATED	ORAL	20080728		ANDA	ANDA077042	Bryant Ranch Prepack	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-2234_b1096355-2ea6-4116-889d-2c755a4484b8	71335-2234	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
71335-2235_47f88a15-b578-4ca0-9f0a-44884540935a	71335-2235	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Bryant Ranch Prepack	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-2236_d61f0a69-f8b3-4cc3-8c88-dc6b1deeed6d	71335-2236	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	Bryant Ranch Prepack	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-2237_86aa7907-9413-41d8-b2ae-04a0c524b7af	71335-2237	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20230321		ANDA	ANDA078888	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
71335-2238_fae0c46b-9428-4cd0-82e7-2bf40c27c2cf	71335-2238	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-2239_6cbc0b96-441b-4e2d-866d-fd920fadfde6	71335-2239	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	Bryant Ranch Prepack	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2241_ab2d1eb8-c63e-42e5-9e18-9e2fd4801d1c	71335-2241	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2242_694a1ec5-823c-4d1a-bd17-e51a47629745	71335-2242	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	Bryant Ranch Prepack	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71335-2244_b77f45b2-ce63-417b-abdb-e6f807c1ec6c	71335-2244	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol fumarate	TABLET	ORAL	20090921		ANDA	ANDA078635	Bryant Ranch Prepack	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2245_0845de80-4215-480f-81ed-aecaeecaf3e0	71335-2245	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		metformin hydrochloride	TABLET	ORAL	20230119		ANDA	ANDA213320	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-2246_0070aaa8-4b3f-4433-991d-9c1f4aba6411	71335-2246	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	Bryant Ranch Prepack	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71335-2247_797a1809-25a3-4f55-9726-47dc506eee28	71335-2247	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	Bryant Ranch Prepack	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2248_2a567e86-d264-4b4d-89e9-19aa65d2c2df	71335-2248	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Bryant Ranch Prepack	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2252_d7710f3a-7f24-4881-9eb1-779058f0ee10	71335-2252	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Bryant Ranch Prepack	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-2253_dc81a210-c1e1-4674-bcdd-a444b10a4b51	71335-2253	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2254_7d6f0d9a-05d2-4e93-a94e-6ef7cc11563a	71335-2254	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230321		ANDA	ANDA217272	Bryant Ranch Prepack	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
71335-2255_f3e9bbf9-ad43-4ce6-aca0-d7ed0a4499fc	71335-2255	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Bryant Ranch Prepack	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
71335-2256_d9cbc40f-1089-494c-9c58-f0b051a8ccc7	71335-2256	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET, FILM COATED	ORAL	20210329		ANDA	ANDA213652	Bryant Ranch Prepack	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20241231
71335-2257_8f9ef66e-d6b5-4af1-bfd8-0a899f370fee	71335-2257	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-2258_a572bbaf-48b5-4fee-bd9d-49470e8b1bb4	71335-2258	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20210218		ANDA	ANDA207196	Bryant Ranch Prepack	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
71335-2259_610581e0-5d76-4c85-82a3-ff8fd314319b	71335-2259	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA210704	Bryant Ranch Prepack	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2261_b78dd854-2217-4fe5-b1a0-be489ed188a7	71335-2261	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20190823		ANDA	ANDA204313	Bryant Ranch Prepack	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-2262_f41fa778-05da-4301-9b99-4bf1640c4c41	71335-2262	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20061220		ANDA	ANDA077691	Bryant Ranch Prepack	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2263_9e42dac5-9eb6-4111-a297-0b3202086331	71335-2263	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150724		ANDA	ANDA078583	Bryant Ranch Prepack	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-2264_a1db4ac3-1cc1-4c3b-925b-6700f40dab34	71335-2264	HUMAN PRESCRIPTION DRUG	Cevimeline Hydrochloride		Cevimeline Hydrochloride	CAPSULE	ORAL	20130708		ANDA	ANDA091591	Bryant Ranch Prepack	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
71335-2265_b1067cab-e0f9-48ef-996c-d10bd20e28bf	71335-2265	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20220110		ANDA	ANDA077652	Bryant Ranch Prepack	LEVOFLOXACIN	750	mg/1			N	20241231
71335-2266_b9bc9103-8bb5-4ff2-a188-a2ed60d7ef2e	71335-2266	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		clonidine hydrochloride	TABLET	ORAL	20201224		ANDA	ANDA078895	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-2268_a83b2f60-266b-4cbe-afdb-9cb0a2cdf3c5	71335-2268	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	Bryant Ranch Prepack	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-2269_8887b3a4-0310-4537-8427-1cc963160c15	71335-2269	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		Chlorthalidone	TABLET	ORAL	20210331		ANDA	ANDA211320	Bryant Ranch Prepack	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71335-2270_0e3608c9-b97a-4f77-9cd8-d63f6d55cab1	71335-2270	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	TABLET	ORAL	20220629		ANDA	ANDA040864	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
71335-2272_c421e413-0101-4319-9d31-93a666c56692	71335-2272	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen and Caffeine		Butalbital, Acetaminophen and Caffeine	TABLET	ORAL	20220629		ANDA	ANDA040864	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
71335-2273_ab9a1c16-aee1-4076-a70f-d22476070ce3	71335-2273	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20211116		ANDA	ANDA215671	Bryant Ranch Prepack	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-2275_ee34b443-ddc4-4717-9e73-f67f1388017f	71335-2275	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA091491	Bryant Ranch Prepack	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2276_9d31cce6-5110-404a-b8c1-52548d6ef005	71335-2276	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20220110		ANDA	ANDA077652	Bryant Ranch Prepack	LEVOFLOXACIN	500	mg/1			N	20241231
71335-2277_0f5f3827-dcd2-4bf2-808d-9128e07890df	71335-2277	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	Bryant Ranch Prepack	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71335-2278_8b693d3f-cde2-4fee-bad7-ba8343cd46f0	71335-2278	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20120327		ANDA	ANDA201109	Bryant Ranch Prepack	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-2279_89460e99-bf96-4d67-8182-b3cfbab1227b	71335-2279	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2280_a00698e1-8de3-4ab2-83e5-abf5460bf699	71335-2280	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2281_13d23734-efb0-4e76-934d-a8256c7ac58a	71335-2281	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2282_0716c0ac-8bf3-4d34-ae1a-52fe2e6e2cc8	71335-2282	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078858	Bryant Ranch Prepack	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-2283_5b01fa05-d288-47ea-a02f-f27222ce09ff	71335-2283	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		levocetirizine dihydrochloride	TABLET	ORAL	20140909		ANDA	ANDA203646	Bryant Ranch Prepack	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-2284_19fdf724-05f0-43a8-be32-2b9b2e7a8987	71335-2284	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2285_e7ee5b79-25cc-4d4d-9b33-98116057ff75	71335-2285	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2286_2b337dc2-7ace-47b3-a05e-96454c5c9251	71335-2286	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2287_beff3a2d-5733-4edf-ac18-9780e6846e7a	71335-2287	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2288_5d29d108-5d49-4ebf-9f27-3bfd5ffbc7ba	71335-2288	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2289_d45feff0-4a7d-405d-9911-a7bc30606ba2	71335-2289	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2290_b04c14e6-0166-49e3-8e46-fa4f4fe29c3b	71335-2290	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-2291_00e730a2-1db9-4ee8-825b-08c874d77641	71335-2291	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20190501		ANDA	ANDA205096	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-2292_eec1e933-3e7e-4d06-a5fc-34f1eb420611	71335-2292	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2293_fce9081c-66b9-4262-bac6-80d7668d989c	71335-2293	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Bryant Ranch Prepack	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2294_27880452-0625-47d7-b862-3d71ea86074a	71335-2294	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	Bryant Ranch Prepack	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-2295_197571c5-7f51-49b6-8546-bac3576fe859	71335-2295	HUMAN PRESCRIPTION DRUG	Oxaprozin		Oxaprozin	TABLET	ORAL	20010131	20250630	ANDA	ANDA075845	Bryant Ranch Prepack	OXAPROZIN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
71335-2296_deaf90cf-41e5-4173-9914-b564152077be	71335-2296	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205017	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-2297_96d5fa44-cae4-481e-920e-5aea074a3dca	71335-2297	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20170124		ANDA	ANDA205008	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
71335-2298_99763bcf-01be-4276-a58b-8fdb5e9f6159	71335-2298	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-2299_d8e21f57-97e7-466f-b6b5-a3c12d0fb4f4	71335-2299	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-2300_bd5c75b7-82a0-4323-9291-07511b4f8cd4	71335-2300	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-2301_ec3e1e77-594a-415f-94e5-986baf3ba2a4	71335-2301	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71335-2302_de9cf2dc-75c3-4333-954f-e5682094c588	71335-2302	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2303_63c2f4f7-4863-463b-be0e-5ac58f64f9c5	71335-2303	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71335-2304_a5782b92-c056-4c72-b3d1-1dd15d230a5c	71335-2304	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20170601		ANDA	ANDA204237	Bryant Ranch Prepack	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-2305_c6191972-3736-4068-ae3e-0f0157198bfc	71335-2305	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71335-2306_b9906136-3102-42b2-9599-7109a9a41f0f	71335-2306	HUMAN PRESCRIPTION DRUG	Diazepam		diazepam	TABLET	ORAL	19850904		ANDA	ANDA070325	Bryant Ranch Prepack	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-2307_f30b02c3-4e14-4cbd-98d2-4d04e00c77f8	71335-2307	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71335-2308_ea85f3dd-480c-44dd-93e5-cc1b67bdb12d	71335-2308	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET	ORAL	20150831		ANDA	ANDA204821	Bryant Ranch Prepack	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71335-2309_fbf1e034-ee7f-4f4a-84d3-a5ea78fdd363	71335-2309	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Bryant Ranch Prepack	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-2310_7fbd3bf9-01ee-47ff-9b0e-49ebe55b3886	71335-2310	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20230501		ANDA	ANDA215243	Bryant Ranch Prepack	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
71335-2311_35e8bed8-5ae3-4985-9691-e6861194c82d	71335-2311	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	Bryant Ranch Prepack	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-2312_7d7c6d57-bc33-48ea-b392-2d273f953ddf	71335-2312	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-2314_8496a8b2-0d2e-49be-8088-8f46e9227b38	71335-2314	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20100816		ANDA	ANDA202202	Bryant Ranch Prepack	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20251231
71335-2315_f1304b4d-e9e0-4b8b-b232-d21c974302be	71335-2315	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
71335-2316_8ea8e3cc-06f9-4b01-b98a-926ce8c8c376	71335-2316	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230508		ANDA	ANDA040319	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
71335-2317_14a56e92-68a4-4145-ba70-de5731cf044a	71335-2317	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	Bryant Ranch Prepack	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
71335-2318_6cafdf58-ef5b-4b0a-98c5-1c06fad0ef99	71335-2318	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Bryant Ranch Prepack	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
71335-2319_5135e4b9-3646-4afd-9706-f6eb52446f02	71335-2319	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	TABLET	ORAL	20221105		ANDA	ANDA216629	Bryant Ranch Prepack	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20251231
71335-2320_107cc7d3-5048-4057-9c47-4f5370c3518e	71335-2320	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Bryant Ranch Prepack	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20251231
71335-2321_61c19a1d-19bb-4315-80ae-e62260bed9c0	71335-2321	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231019		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20251231
71335-2322_0baf2f26-a737-4de2-837e-67f66f912810	71335-2322	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20110714		ANDA	ANDA075580	Bryant Ranch Prepack	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
71335-2323_545ab7d1-13f0-4f48-8748-69278a192bc3	71335-2323	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231019		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20251231
71335-9602_e2c44468-4b31-4503-9135-e60a99f29e75	71335-9602	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-9604_fc88eec0-c5fb-5d6d-e053-6294a90a13d2	71335-9604	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	Bryant Ranch Prepack	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-9605_6aac450e-491c-41e3-a155-6f6c02f173fc	71335-9605	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-9607_ff1d7383-5600-487f-b66e-4c2eef397eaf	71335-9607	HUMAN PRESCRIPTION DRUG	terazosin		terazosin	CAPSULE	ORAL	20210430		ANDA	ANDA075614	Bryant Ranch Prepack	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-9608_fce8dcc5-d566-407a-90e0-16c2ab53e71a	71335-9608	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	Bryant Ranch Prepack	DOXYCYCLINE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-9609_fdf372cb-a944-46ac-e053-6294a90aec13	71335-9609	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20190701		ANDA	ANDA075757	Bryant Ranch Prepack	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9610_469a01bb-1a94-4ac2-8a59-98b5cb885df5	71335-9610	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20150217		ANDA	ANDA076363	Bryant Ranch Prepack	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
71335-9611_fca00330-ba51-6c3e-e053-6394a90aee1c	71335-9611	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20191121		ANDA	ANDA213136	Bryant Ranch Prepack	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9612_5c400abf-9305-4291-9226-d1b605b4fc38	71335-9612	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride Tablets	TABLET, FILM COATED	ORAL	20181217		ANDA	ANDA078343	Bryant Ranch Prepack	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-9613_fc50bbec-443b-14c8-e053-6294a90a76b5	71335-9613	HUMAN PRESCRIPTION DRUG	carisoprodol		carisoprodol	TABLET	ORAL	20090806		ANDA	ANDA040792	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71335-9614_fc64c052-ae7a-1fd5-e053-6394a90ae496	71335-9614	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20211213		ANDA	ANDA074497	Bryant Ranch Prepack	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-9615_f06a1210-acab-46e0-8251-f03c88421fe5	71335-9615	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220606		ANDA	ANDA216441	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-9616_c33b3739-c7f2-4782-8287-d8ebce04577a	71335-9616	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	TABLET	ORAL	20200801		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71335-9617_0b4f3d2f-d81e-53e3-e063-6294a90a0434	71335-9617	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-9618_58150c54-77d2-4807-8c8c-be5220310c97	71335-9618	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20170731		ANDA	ANDA209047	Bryant Ranch Prepack	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
71335-9619_fc4f62da-acd9-fb76-e053-6394a90a2ef6	71335-9619	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20211227		ANDA	ANDA084657	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-9620_08224c5f-048f-47d2-963e-70afe993cd0b	71335-9620	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200815		ANDA	ANDA209366	Bryant Ranch Prepack	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-9621_fc50b26b-fbb6-1776-e053-6294a90a5129	71335-9621	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	Bryant Ranch Prepack	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71335-9622_01fb22ac-f887-431f-9e3c-b1498b5cee46	71335-9622	HUMAN PRESCRIPTION DRUG	PIROXICAM		Piroxicam	CAPSULE	ORAL	20180301		ANDA	ANDA206152	Bryant Ranch Prepack	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-9623_37a36879-7de0-48c6-bf9a-5d63f45d63a3	71335-9623	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Bryant Ranch Prepack	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-9627_ac9badec-450d-4502-8217-308f916db0f0	71335-9627	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Bryant Ranch Prepack	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-9628_5c4d2506-dcc7-41e9-80c0-25ae483ae86c	71335-9628	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20221025		ANDA	ANDA211064	Bryant Ranch Prepack	FOLIC ACID	1	mg/1			N	20241231
71335-9629_76a9c577-f1e5-4986-9207-8cd5e4c525e9	71335-9629	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20070423		ANDA	ANDA077322	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71335-9630_890165ef-d4a9-40e6-af43-17d074a5fecf	71335-9630	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	Bryant Ranch Prepack	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9631_4629ba57-842d-45ec-8bf9-a1ed10a0a429	71335-9631	HUMAN PRESCRIPTION DRUG	misoprostol		MISOPROSTOL	TABLET	ORAL	20091227		NDA AUTHORIZED GENERIC	NDA019268	Bryant Ranch Prepack	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
71335-9632_7e8ca2e4-1c1e-4565-87a1-cd99437d1dac	71335-9632	HUMAN PRESCRIPTION DRUG	Liothyronine Sodium		Liothyronine Sodium	TABLET	ORAL	20121203		ANDA	ANDA200295	Bryant Ranch Prepack	LIOTHYRONINE SODIUM	50	ug/1	Triiodothyronine [CS], l-Triiodothyronine [EPC]		N	20241231
71335-9633_a4827304-fe6e-4c33-b6f2-67bc325cb129	71335-9633	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9634_fc9f5b1b-f143-056d-e053-6394a90a8842	71335-9634	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20200922		ANDA	ANDA204467	Bryant Ranch Prepack	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71335-9635_432098fd-66f1-4fb6-af5f-01e4e0886947	71335-9635	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9636_dac9c996-cee4-4f7c-851d-e2e7e843a191	71335-9636	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	Bryant Ranch Prepack	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9637_be5c2e44-cbc6-4fcc-973e-6fc942af5796	71335-9637	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9638_08071f48-182b-b5cd-e063-6294a90aaa3a	71335-9638	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71335-9639_9ec9dafd-381b-4964-890f-dfde0169e667	71335-9639	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20220415		ANDA	ANDA210616	Bryant Ranch Prepack	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-9640_9c138105-4463-46ec-b87e-ef41b0faf787	71335-9640	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20180108		ANDA	ANDA207408	Bryant Ranch Prepack	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9641_fc9cc0ba-896b-70f5-e053-6294a90a35bd	71335-9641	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20190312		ANDA	ANDA211820	Bryant Ranch Prepack	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71335-9642_812e5aa7-9a83-40ea-9770-f637a6e90ed4	71335-9642	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	Bryant Ranch Prepack	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9643_f796626f-2d4f-41aa-824d-8566d7718956	71335-9643	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Bryant Ranch Prepack	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-9644_086316dc-3a79-4875-8714-003b96c85dc9	71335-9644	HUMAN OTC DRUG	acetaminophen		Acetaminophen	TABLET	ORAL	20180726		OTC MONOGRAPH NOT FINAL	part343	Bryant Ranch Prepack	ACETAMINOPHEN	500	mg/1			N	20241231
71335-9645_fc4d4b30-6519-8ca1-e053-6394a90ab745	71335-9645	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080610		ANDA	ANDA077626	Bryant Ranch Prepack	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-9646_315ded81-d1e7-49ca-a10a-ee8f124d782b	71335-9646	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	Bryant Ranch Prepack	ATORVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9647_fd914c6f-3944-7dff-e053-6394a90a4ec9	71335-9647	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20191101		ANDA	ANDA040702	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-9648_4cb43f4a-e7bb-4291-a377-cb29f0e48110	71335-9648	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	Bryant Ranch Prepack	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-9649_fc88624a-619d-c16b-e053-6294a90a3467	71335-9649	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20010123		ANDA	ANDA075657	Bryant Ranch Prepack	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-9650_1b57a485-728d-4c50-b78d-954ae87fcdd6	71335-9650	HUMAN PRESCRIPTION DRUG	paroxetine hydrochloride		paroxetine hydrochloride	TABLET, FILM COATED	ORAL	20221114		ANDA	ANDA076968	Bryant Ranch Prepack	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-9651_414969b1-43dd-484e-87d4-a390d50b2966	71335-9651	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Bryant Ranch Prepack	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71335-9652_6c939fb7-9abe-46f8-9a50-1486a2a21fe5	71335-9652	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20180922		ANDA	ANDA090195	Bryant Ranch Prepack	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-9653_32d192d2-3483-4e3e-9d9d-503eb8df46d0	71335-9653	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-9654_08052e8d-9714-d5b6-e063-6394a90ae8e0	71335-9654	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Bryant Ranch Prepack	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-9655_4c5332e8-4c3f-4eb4-973a-bd30f560c8db	71335-9655	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120629		ANDA	ANDA202759	Bryant Ranch Prepack	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-9656_43c971bf-ec28-4c9a-8594-e9987fe77c11	71335-9656	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
71335-9657_ee63aada-fa9e-4399-bfd9-24ba439e382e	71335-9657	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20150714		ANDA	ANDA202112	Bryant Ranch Prepack	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-9658_8e8f905f-8c2b-48ac-b761-f5c310a00df9	71335-9658	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20210422		ANDA	ANDA208708	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-9659_f2270de0-47e3-4465-b5f9-74de3815ddc8	71335-9659	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Bryant Ranch Prepack	ESZOPICLONE	1	mg/1		CIV	N	20241231
71335-9660_d8b332ad-3f17-4e0d-ba73-73797dba4ea6	71335-9660	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Bryant Ranch Prepack	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-9661_c8c09e4a-b28d-426c-b767-d59acdf260f3	71335-9661	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	Bryant Ranch Prepack	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-9662_bad294d7-e142-41cc-a9b0-3cdc4769d932	71335-9662	HUMAN PRESCRIPTION DRUG	MORPHINE SULFATE		MORPHINE SULFATE	TABLET	ORAL	20210211		ANDA	ANDA212451	Bryant Ranch Prepack	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-9663_08062103-9cde-95be-e063-6294a90a7ed7	71335-9663	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	Bryant Ranch Prepack	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-9664_79e0807f-aad8-4470-b0fc-07c79be77873	71335-9664	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	Bryant Ranch Prepack	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
71335-9665_6d948c02-b404-4e2d-8f1e-9913ed879476	71335-9665	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	TABLET, FILM COATED	ORAL	20220926		ANDA	ANDA216275	Bryant Ranch Prepack	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-9666_09b5c419-6f84-4656-b526-3d620c6a8ec4	71335-9666	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Bryant Ranch Prepack	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-9667_2f0ec633-c050-4ad6-bf2f-ea8a34e76b1b	71335-9667	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Bryant Ranch Prepack	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-9668_5ed7751a-3877-4bf0-84c4-6784b34d3e36	71335-9668	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9670_07eabc7b-1960-44e3-b460-24bd6b9a67cf	71335-9670	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71335-9671_2d7a07b0-14d4-430b-b83f-62e6e30bc94f	71335-9671	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	225	mg/1		CV	N	20241231
71335-9672_fc8c4c3a-f16e-b270-e053-6394a90ad28b	71335-9672	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20180417		ANDA	ANDA209013	Bryant Ranch Prepack	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71335-9673_0ecdf21b-3cfa-4623-a438-1cf3f69a6095	71335-9673	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71335-9674_2b832254-e7b8-4d1a-9775-cdcffce01451	71335-9674	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-9675_3765101e-9311-474e-89eb-9e208c671c5a	71335-9675	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-9676_fc9f89df-84d0-c078-e053-6294a90a9a9d	71335-9676	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	19861024		ANDA	ANDA018659	Bryant Ranch Prepack	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71335-9677_a4653803-efd2-4449-b78d-dc7aacaf5466	71335-9677	HUMAN PRESCRIPTION DRUG	terbinafine hydrochloride		terbinafine hydrochloride	TABLET	ORAL	20220128		ANDA	ANDA078163	Bryant Ranch Prepack	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
71335-9678_439d9ce7-ecc1-445e-a15b-a05d79c73eb1	71335-9678	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	Bryant Ranch Prepack	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9679_22af5ef5-8818-47b2-b0fa-f1401aa89e75	71335-9679	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210709		ANDA	ANDA214492	Bryant Ranch Prepack	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71335-9680_5dccd775-9b0f-4802-818f-d4914d3d82d0	71335-9680	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200518		ANDA	ANDA203083	Bryant Ranch Prepack	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9681_bf06137f-b964-46d4-b840-980c513caea5	71335-9681	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077068	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71335-9682_93e3e311-6dac-48ce-9c6c-20e0ae354aa0	71335-9682	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-9683_4e6e3035-562a-4663-bf3d-cb2f755702bb	71335-9683	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200806		ANDA	ANDA076756	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-9684_6569805e-959f-42ed-b32b-2c8e4c20bdf6	71335-9684	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71335-9685_d5885843-a527-41ae-b5f4-94a22960af54	71335-9685	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9686_35cce5c0-2a93-41e7-b3b5-7a3f88b760c6	71335-9686	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE		olmesartan medoxomil and hydrochlorothiazide	TABLET	ORAL	20170424		ANDA	ANDA207804	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	12.5; 40	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-9687_023cbdd4-cb2f-4da0-8b3b-cc9cce0d7d1f	71335-9687	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	Bryant Ranch Prepack	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-9688_10addb28-2102-4a2f-970a-20ef53d4265e	71335-9688	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET, FILM COATED	ORAL	20190103		ANDA	ANDA091347	Bryant Ranch Prepack	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-9689_69ef9434-bb52-46eb-b86b-298cfbb8ca29	71335-9689	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA209057	Bryant Ranch Prepack	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-9690_87a2b610-70a1-4e4e-8c13-5abd6b1bdf1c	71335-9690	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9691_98ef92db-8702-42eb-8584-5f14449624b8	71335-9691	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	200	mg/1		CV	N	20241231
71335-9692_ea7465ab-2e6b-412c-9d5f-96970b6f80e4	71335-9692	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9693_7314235c-0007-4d48-a641-1866850b49ec	71335-9693	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200518		ANDA	ANDA203083	Bryant Ranch Prepack	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9694_2540ec60-940a-4b84-ba12-212fb191d93e	71335-9694	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210528		ANDA	ANDA203306	Bryant Ranch Prepack	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9695_946a0ffb-9ace-4b57-83f3-c8e680d571c3	71335-9695	HUMAN OTC DRUG	lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210729		ANDA	ANDA202319	Bryant Ranch Prepack	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9696_43dd6308-5961-4c36-861d-bba5c5b23c2a	71335-9696	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA209057	Bryant Ranch Prepack	VARDENAFIL HYDROCHLORIDE	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71335-9697_5cb47bfb-b38e-4e1d-87c4-f5f3a0c6aa92	71335-9697	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Bryant Ranch Prepack	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-9698_ec8cdc5e-0977-469d-bd98-c0ed5812b4a9	71335-9698	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	Bryant Ranch Prepack	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
71335-9699_d0c8b99a-ee4d-41b9-b0d6-5a36e48e6dd2	71335-9699	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	200	mg/1		CV	N	20241231
71335-9700_963edcc7-516f-4749-a5e6-edd366334902	71335-9700	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Bryant Ranch Prepack	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71335-9701_63931427-cef8-438a-af45-211b82220c65	71335-9701	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091123		NDA AUTHORIZED GENERIC	NDA019892	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71335-9702_f50ceec7-6602-4336-a624-6b2938610c48	71335-9702	HUMAN PRESCRIPTION DRUG	Atomoxetine		Atomoxetine	CAPSULE	ORAL	20170530		ANDA	ANDA079016	Bryant Ranch Prepack	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71335-9703_c526a852-6b47-4687-b543-f63e7aaf67e7	71335-9703	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		fosinopril sodium	TABLET	ORAL	20171001		ANDA	ANDA205670	Bryant Ranch Prepack	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71335-9704_78aabfb9-d1bf-4a4b-9e0b-d4c97ec5432c	71335-9704	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA077653	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-9705_69da0bf0-b085-4ef5-921a-2b5f40194969	71335-9705	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220907		ANDA	ANDA214654	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71335-9706_afd69df4-2efa-43f1-b587-a482f00c3e80	71335-9706	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20210429		ANDA	ANDA213854	Bryant Ranch Prepack	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9707_0f6be528-843c-4f6b-b78c-fbc3b5a5aeb6	71335-9707	HUMAN PRESCRIPTION DRUG	Carvedilol Phosphate		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA090132	Bryant Ranch Prepack	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9708_f03e1c5c-962f-45f0-b647-e70a3fa6fe5a	71335-9708	HUMAN PRESCRIPTION DRUG	diltiazem hydrochloride		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170928		ANDA	ANDA206534	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
71335-9709_2fd6a3eb-4693-40e1-9c7a-cab96024eafc	71335-9709	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	20230201		ANDA	ANDA217054	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71335-9710_2a22d653-e56c-4c01-9cf9-c1b0246dc328	71335-9710	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210223		ANDA	ANDA213999	Bryant Ranch Prepack	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9711_a7720787-2cb1-40d9-bb9a-406e25d5213d	71335-9711	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9712_6a32d196-c0fa-43a2-ae96-2658b6eb4882	71335-9712	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
71335-9713_f4e26b14-62d9-4be3-960c-d7b2a62a44d7	71335-9713	HUMAN PRESCRIPTION DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210319		ANDA	ANDA213486	Bryant Ranch Prepack	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9714_3463c915-820e-48fd-9267-9474d71222ac	71335-9714	HUMAN PRESCRIPTION DRUG	Sertraline		Sertraline	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077670	Bryant Ranch Prepack	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71335-9715_a950732d-221a-468b-bfe8-9e45aa43d967	71335-9715	HUMAN PRESCRIPTION DRUG	prednisone		PREDNISONE	TABLET	ORAL	20220524		ANDA	ANDA208412	Bryant Ranch Prepack	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71335-9716_d9a21b54-579f-4beb-a1f0-fc81f5af0483	71335-9716	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Bryant Ranch Prepack	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9717_023fa836-2a98-4875-85ee-877d277021e5	71335-9717	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160105		ANDA	ANDA078103	Bryant Ranch Prepack	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9718_312ccb2a-0b32-4486-bca3-a37fa17fec87	71335-9718	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET	ORAL	20191009		ANDA	ANDA211343	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71335-9719_77f3ac18-738e-4bba-942b-9f83dc3243f1	71335-9719	HUMAN PRESCRIPTION DRUG	TIADYLT ER		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20171108		ANDA	ANDA206641	Bryant Ranch Prepack	DILTIAZEM HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71335-9720_1e556f28-6a95-45b3-bb5d-d945d29f30d9	71335-9720	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		Diclofenac Potassium Tablets	TABLET, FILM COATED	ORAL	20220512		ANDA	ANDA215750	Bryant Ranch Prepack	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-9721_91df90e0-73b3-49b9-93a2-5b829caa8a25	71335-9721	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Bryant Ranch Prepack	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
71335-9722_58bc1add-d89b-4604-811f-3bc0534658aa	71335-9722	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71335-9723_040b0256-5bc2-40e0-8f60-c8c0d08b9981	71335-9723	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20220829		ANDA	ANDA214659	Bryant Ranch Prepack	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71335-9724_42e736ab-2451-49bd-ba8b-2a910d281fe3	71335-9724	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-9725_d39c2d5d-535c-44f2-9393-15a5d6114c7a	71335-9725	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20210416		ANDA	ANDA202271	Bryant Ranch Prepack	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
71335-9726_a5b3aa14-0c8e-4e0e-bd2f-5e27358e5149	71335-9726	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20070627		ANDA	ANDA078152	Bryant Ranch Prepack	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71335-9727_fff98446-e1f4-47a5-b098-64b5ea864ac3	71335-9727	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090162	Bryant Ranch Prepack	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-9729_046ebcf2-c5a0-4ea5-83cd-42743940bb61	71335-9729	HUMAN PRESCRIPTION DRUG	acetazolamide		acetazolamide	CAPSULE, EXTENDED RELEASE	ORAL	20211119		ANDA	ANDA207659	Bryant Ranch Prepack	ACETAZOLAMIDE	500	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71335-9730_17a2b36c-22c3-43cf-8dc0-87852dd5fe94	71335-9730	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71335-9731_e8c3da06-c73c-41c7-b6f7-69dad7d24989	71335-9731	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20221115		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM	100	mg/1			N	20241231
71335-9732_cfc63853-77b0-4c21-981e-ddea13fcc09c	71335-9732	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9733_70fac605-bf1a-4ad4-887c-9fd20e46f170	71335-9733	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20181231		ANDA	ANDA209274	Bryant Ranch Prepack	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71335-9734_d3432a82-3b64-4d35-8a47-100f25bf5cca	71335-9734	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-9735_cdd94cde-fb26-4df2-8a64-c2ac6a716fe2	71335-9735	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-9736_6bc33f69-1281-47df-a398-b8316c218d83	71335-9736	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-9737_3cb5e5bd-470d-449f-9023-52547820422d	71335-9737	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71335-9738_612605fe-66ba-43b0-bf0f-fcd04b358d81	71335-9738	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH NOT FINAL	part334	Bryant Ranch Prepack	DOCUSATE SODIUM	250	mg/1			N	20241231
71335-9739_5c46078a-ddce-426b-86c7-6703f1caf39f	71335-9739	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	Bryant Ranch Prepack	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
71335-9740_9ff7719d-2ef3-4db5-9533-8f6f93bb487f	71335-9740	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	300	mg/1		CV	N	20241231
71335-9741_6cc48c88-1650-4e00-a42f-ae16dac4c67a	71335-9741	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20181127		ANDA	ANDA211542	Bryant Ranch Prepack	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-9742_9ed306fc-4226-4b04-a733-8db55ba4ebb8	71335-9742	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA206928	Bryant Ranch Prepack	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71335-9743_ba0ee761-7e2c-49d2-811f-37e06210933d	71335-9743	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		tizanidine hydrochloride	CAPSULE	ORAL	20190320		ANDA	ANDA210267	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-9744_53a718b7-c84e-4b00-887f-783f41226d91	71335-9744	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20121123		ANDA	ANDA091352	Bryant Ranch Prepack	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71335-9745_9cb64f9a-71f2-4d99-9473-9af168c9574d	71335-9745	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Bryant Ranch Prepack	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9746_362387fe-1ee4-45b0-bbf8-54a990402db4	71335-9746	HUMAN OTC DRUG	Acetaminophen		Acetaminophen tablet extended release	TABLET, EXTENDED RELEASE	ORAL	20211004		ANDA	ANDA215486	Bryant Ranch Prepack	ACETAMINOPHEN	650	mg/1			N	20241231
71335-9747_0135b661-071d-4d24-8a54-34a826590a45	71335-9747	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20220414		ANDA	ANDA075468	Bryant Ranch Prepack	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71335-9748_1d7b0086-e245-4363-8039-4925e56677ce	71335-9748	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	Bryant Ranch Prepack	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71335-9749_a58bf99b-6a8c-4c0d-a69d-c86357c44a70	71335-9749	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20190325		ANDA	ANDA207465	Bryant Ranch Prepack	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9750_f95de77e-e4dc-4fd6-8191-63f823a32d03	71335-9750	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71335-9751_364998f2-bf0b-4a82-9afb-1f2a3ac604d3	71335-9751	HUMAN OTC DRUG	Meclizine HCl		MECLIZINE HYDROCHLORIDE CHEWABLE	TABLET, CHEWABLE	ORAL	20220818		OTC MONOGRAPH FINAL	part336	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71335-9752_0b6d123c-b62d-45e3-aa7b-516e85eb8962	71335-9752	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190315		ANDA	ANDA077078	Bryant Ranch Prepack	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71335-9753_97f05adc-a753-48f6-a8c1-7dc1c9284271	71335-9753	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate ER Tablets	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201127		ANDA	ANDA211143	Bryant Ranch Prepack	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9754_be091387-6fea-47c5-8bbc-8a26312a20d9	71335-9754	HUMAN PRESCRIPTION DRUG	INDOMETHACIN		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20090306		ANDA	ANDA079175	Bryant Ranch Prepack	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71335-9755_ac9d8058-e9b0-46df-9173-38894f581f32	71335-9755	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20001116		ANDA	ANDA075643	Bryant Ranch Prepack	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71335-9756_b9ddda4a-9598-451d-abb2-f13f4ba4e67f	71335-9756	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20170526		ANDA	ANDA205236	Bryant Ranch Prepack	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71335-9757_a48c17c0-5631-4bcf-bcba-6a278899ea43	71335-9757	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20230501		ANDA	ANDA091491	Bryant Ranch Prepack	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71335-9758_59b96f64-1d9a-48fa-bf5c-6d153be8532c	71335-9758	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20200904		ANDA	ANDA075521	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71335-9759_6e78ab9d-0fb9-449a-81ed-a2f9324601ed	71335-9759	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210701		ANDA	ANDA214374	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71335-9760_ee230f46-d22c-4953-a9bf-ce974bebc50d	71335-9760	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20211201		ANDA	ANDA215483	Bryant Ranch Prepack	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71335-9761_6fd0b930-d288-43ec-850b-e34083767d74	71335-9761	HUMAN PRESCRIPTION DRUG	ziprasidone hydrochloride		ziprasidone hydrochloride	CAPSULE	ORAL	20120302		ANDA	ANDA077565	Bryant Ranch Prepack	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71335-9762_f9e39663-9241-4103-853d-2de70b4afddc	71335-9762	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-9763_714b454a-810e-452c-b09e-5aa62425bb48	71335-9763	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71335-9764_14333b2e-2e13-424d-819a-b08667725247	71335-9764	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20200709		ANDA	ANDA211421	Bryant Ranch Prepack	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
71336-1000_ffbc20c4-35ca-4779-ab28-57828b566694	71336-1000	HUMAN PRESCRIPTION DRUG	Onpattro		patisiran	INJECTION, LIPID COMPLEX	INTRAVENOUS	20180813		NDA	NDA210922	Alnylam Pharmaceuticals, Inc.	PATISIRAN SODIUM	2	mg/mL	Decreased RNA Integrity [PE], Increased Protein Breakdown [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC], Transthyretin-directed RNA Interaction [EPC]		N	20241231
71336-1001_c47a10ee-f647-4319-85e9-8b7505637bde	71336-1001	HUMAN PRESCRIPTION DRUG	GIVLAARI		givosiran sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20191212		NDA	NDA212194	Alnylam Pharmaceuticals, Inc.	GIVOSIRAN SODIUM	189	mg/mL			N	20241231
71336-1002_0597bb76-a942-459f-93b6-c3612adaf59b	71336-1002	HUMAN PRESCRIPTION DRUG	OXLUMO		lumasiran	INJECTION, SOLUTION	SUBCUTANEOUS	20201123		NDA	NDA214103	Alnylam Pharmaceuticals, Inc.	LUMASIRAN	94.5	mg/.5mL			N	20241231
71336-1003_0a7f82da-c2c4-4e6d-8708-15d128b6a460	71336-1003	HUMAN PRESCRIPTION DRUG	AMVUTTRA		VUTRISIRAN	INJECTION	SUBCUTANEOUS	20220613		NDA	NDA215515	Alnylam Pharmaceuticals, Inc.	VUTRISIRAN	25	mg/.5mL	Decreased RNA Integrity [PE], Increased Protein Breakdown [PE], RNA, Small Interfering [CS], Small Interfering RNA [EPC], Transthyretin-directed RNA Interaction [EPC]		N	20241231
71337-046_2a1e049f-58f9-40e8-b7a6-bcd19ef51f75	71337-046	HUMAN PRESCRIPTION DRUG	DICLOFENAC POTASSIUM		diclofenac potassium, film coated	TABLET	ORAL	20230625		ANDA	ANDA215787	Havix Group Inc d-b-a Aavis Pharmaceuticals	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71338-119_0eb0d276-2eb9-1c8d-e063-6294a90ae9ff	71338-119	HUMAN OTC DRUG	ECOLAB Eye Wash		Purified Water	LIQUID	OPHTHALMIC	20170329		NDA	NDA022305	ECOLAB Food Safety Specialties, Inc.	WATER	.983	mg/mL			N	20251231
71338-121_0eb0e8f6-0ce7-b5a2-e063-6394a90a9010	71338-121	HUMAN OTC DRUG	Ecolab Triple Antibiotic		Bacitracin, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20170320		OTC MONOGRAPH DRUG	M004	Ecolabs Food Safety Specialties, Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
71338-122_0eb0ee0f-b52d-ba62-e063-6394a90a0092	71338-122	HUMAN OTC DRUG	ECOLAB Antiseptic		Benzalkonium Chloride 0.13%	SPRAY	TOPICAL	20170407		OTC MONOGRAPH DRUG	M003	ECOLAB Food Safety and Specialties, Inc.	BENZALKONIUM CHLORIDE	1.3	g/L			N	20251231
71338-123_0eb0f615-09c8-1c8b-e063-6294a90a4c2d	71338-123	HUMAN OTC DRUG	ECOLAB Burn Cream		Benzaalkonium chloride, Lidocaine HCl	CREAM	TOPICAL	20170320		OTC MONOGRAPH DRUG	M003	ECOLAB Food Safety Specialties, Inc.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
71338-124_0eb0ea7e-e08f-b48e-e063-6394a90af874	71338-124	HUMAN OTC DRUG	ECOLAB Hand Sanitizer		Ethyl Alcohol 66.5%	GEL	TOPICAL	20170403		OTC MONOGRAPH DRUG	M003	ECOLAB Food Safety Specialties, Inc.	ALCOHOL	540.26	g/L			N	20251231
71338-137_0eb0f615-09cb-1c8b-e063-6294a90a4c2d	71338-137	HUMAN OTC DRUG	ECOLAB Blood Clotting		Bezethonium Chloride, Lidocaine	AEROSOL, SPRAY	TOPICAL	20170328		OTC MONOGRAPH DRUG	M003	ECOLAB Food Safety Specialties, Inc.	BENZETHONIUM CHLORIDE; LIDOCAINE	170; 3400	mg/85g; mg/85g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
71338-138_0eb10f8f-48e4-550d-e063-6294a90a8475	71338-138	HUMAN OTC DRUG	ECOLAB Burn		Lidocaine HCl 2.0%	SPRAY	TOPICAL	20170323		OTC MONOGRAPH DRUG	M015	ECOLAB Food Safety Specialists, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
71338-140_0eb12028-bb37-c6c0-e063-6394a90a951f	71338-140	HUMAN OTC DRUG	ECOLAB Isopropyl Alcohol		Isopropyl Alcohol	SPRAY	TOPICAL	20170323		OTC MONOGRAPH DRUG	M003	ECOLAB Food Safety Specialties, Inc.	ISOPROPYL ALCOHOL	700	mL/L			N	20251231
71338-141_0eb13769-925c-ce8e-e063-6394a90aea92	71338-141	HUMAN OTC DRUG	ECOLAB Hydrogen Peroxide		Hydrogen Peroxide 3.0%	SPRAY	TOPICAL	20170323		OTC MONOGRAPH DRUG	M022	ECOLAB Food Safety Specialties, Inc.	HYDROGEN PEROXIDE	30	mL/L			N	20251231
71338-225_0eb138d4-71f1-d063-e063-6394a90a1ee4	71338-225	HUMAN OTC DRUG	ECOLAB Antiseptic		Benzalkonium Chloride	LIQUID	TOPICAL	20191101		OTC MONOGRAPH DRUG	M003	Ecolab Food Safety Specialties, Inc.	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20251231
71347-100_d70c1885-739a-3ff1-e053-2a95a90ae9ff	71347-100	HUMAN OTC DRUG	Advance Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20170301		OTC MONOGRAPH NOT FINAL	part356	The Atlanta Dental Supply Company DBA Advanced Dental Products	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71347-101_d65898d5-afc4-29d6-e053-2a95a90adea2	71347-101	HUMAN OTC DRUG	Advance Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20170301		OTC MONOGRAPH NOT FINAL	part356	The Atlanta Dental Supply Company DBA Advanced Dental Products	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71347-102_d6589afb-2d2b-9804-e053-2995a90abf14	71347-102	HUMAN OTC DRUG	Advance Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20170301		OTC MONOGRAPH NOT FINAL	part356	The Atlanta Dental Supply Company DBA Advanced Dental Products	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71347-103_d70c3a4b-f60a-4a89-e053-2995a90a62ce	71347-103	HUMAN OTC DRUG	Advance Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20170301		OTC MONOGRAPH NOT FINAL	part356	The Atlanta Dental Supply Company DBA Advanced Dental Products	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71347-104_d6589afb-2d45-9804-e053-2995a90abf14	71347-104	HUMAN OTC DRUG	Advance Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20170301		OTC MONOGRAPH NOT FINAL	part356	The Atlanta Dental Supply Company DBA Advanced Dental Products	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71347-105_d6589afb-2d51-9804-e053-2995a90abf14	71347-105	HUMAN OTC DRUG	Advance Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20170301		OTC MONOGRAPH NOT FINAL	part356	The Atlanta Dental Supply Company DBA Advanced Dental Products	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71347-210_a94454d8-ee9c-4e5a-bdba-effab8099b57	71347-210	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride and Epinephrine Bitartrate	INJECTION, SOLUTION	SUBCUTANEOUS	20190318		ANDA	ANDA088390	The Atlanta Dental Supply Company DBA Advanced Dental Products	EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE	.01; 20	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71347-500_2cee1e88-dc5f-41f2-8246-ba57387f97ca	71347-500	HUMAN PRESCRIPTION DRUG	TruGuard 5000		Sodium Fluoride Toothpaste	PASTE, DENTIFRICE	ORAL	20230316		UNAPPROVED DRUG OTHER		The Atlanta Dental Supply Company DBA Advanced Dental Products	POTASSIUM NITRATE; SODIUM FLUORIDE	5; 1.1	g/100g; g/100g			N	20241231
71349-070_70fe63d5-58e6-4287-ad3e-f84b66b1feea	71349-070	HUMAN PRESCRIPTION DRUG	YCANTH		Cantharidin	SOLUTION	TOPICAL	20230721		NDA	NDA212905	Verrica Pharmaceuticals Inc.	CANTHARIDIN	3.2	mg/.45mL			N	20241231
71349-999_70fe63d5-58e6-4287-ad3e-f84b66b1feea	71349-999	HUMAN PRESCRIPTION DRUG	YCANTH		Cantharidin	SOLUTION	TOPICAL	20230721		NDA	NDA212905	Verrica Pharmaceuticals Inc.	CANTHARIDIN	3.2	mg/.45mL			N	20241231
71351-021_081218c1-a206-fbf1-e063-6294a90a6e3a	71351-021	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	INTRAVENOUS	20221031		ANDA	ANDA212821	Brookfield Pharmaceuticals, LLC.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71351-022_029f8913-40c8-86e9-e063-6394a90afd56	71351-022	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine hydrochloride	INJECTION	SUBARACHNOID	20221031		ANDA	ANDA212822	Brookfield Pharmaceuticals, LLC.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
71351-023_081218c1-a206-fbf1-e063-6294a90a6e3a	71351-023	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	INTRAVENOUS	20230615		ANDA	ANDA212821	Brookfield Pharmaceuticals, LLC.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71355-219_09db4f55-0153-f22c-e063-6294a90ac06a	71355-219	HUMAN OTC DRUG	PURE HAVEN Face Sunscreen SPF-30		ZINC OXIDE	LOTION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Pure Haven, LLC	ZINC OXIDE	140	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71355-349_09db452d-6f86-5ec1-e063-6294a90a1e14	71355-349	HUMAN OTC DRUG	PURE HAVEN BODY SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20180701		OTC MONOGRAPH DRUG	M020	Pure haven, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71355-819_09db5696-960c-d689-e063-6394a90aeb01	71355-819	HUMAN OTC DRUG	Pure Haven Essentials		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170328		OTC MONOGRAPH DRUG	M020	Pure Haven LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71356-156_097478f1-9b38-b749-e063-6394a90a9977	71356-156	HUMAN OTC DRUG	Human Science Antifungal Foot Care		UNDECYLENIC ACID	LIQUID	TOPICAL	20200614		OTC MONOGRAPH DRUG	M005	HUMAN SCIENCE, LLC	UNDECYLENIC ACID	250	mg/mL			N	20241231
71356-818_09db59ea-79c3-56ef-e063-6294a90a0c4b	71356-818	HUMAN OTC DRUG	Human Science Muscle Pain Relief		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20170328		OTC MONOGRAPH DRUG	M017	Human Science, LLC	MENTHOL; METHYL SALICYLATE	100; 100	mg/mL; mg/mL			N	20241231
71363-100_d658afd2-ce50-2e82-e053-2a95a90a54f1	71363-100	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71363-101_d65909e6-81b6-b592-e053-2a95a90a60a9	71363-101	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71363-102_d65909e6-81c2-b592-e053-2a95a90a60a9	71363-102	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71363-103_d6590cc6-1645-e63d-e053-2a95a90ae85d	71363-103	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71363-104_d6590fda-7898-69aa-e053-2a95a90a54b8	71363-104	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71363-105_d6590cc6-167c-e63d-e053-2a95a90ae85d	71363-105	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71363-106_d658f84f-6528-3ebf-e053-2a95a90a257f	71363-106	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71363-107_d658f84f-6534-3ebf-e053-2a95a90a257f	71363-107	HUMAN OTC DRUG	Astra-dent Topical Anesthetic Gel		Benzocaine	GEL	DENTAL	20160701		OTC MONOGRAPH NOT FINAL	part356	Zag Usa Inc	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71369-020_a5da2f23-d04a-44aa-970c-865d000a49d9	71369-020	HUMAN PRESCRIPTION DRUG	DOPTELET		avatrombopag maleate	TABLET, FILM COATED	ORAL	20180523		NDA	NDA210238	AkaRx, Inc.	AVATROMBOPAG MALEATE	20	mg/1			N	20241231
71376-201_73f8eb7c-c51f-45f5-97eb-5b72418d300b	71376-201	HUMAN PRESCRIPTION DRUG	JORNAY PM	Extended-Release	Methylphenidate Hydrochloride	CAPSULE	ORAL	20190601		NDA	NDA209311	Ironshore Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71376-202_73f8eb7c-c51f-45f5-97eb-5b72418d300b	71376-202	HUMAN PRESCRIPTION DRUG	JORNAY PM	Extended-Release	Methylphenidate Hydrochloride	CAPSULE	ORAL	20190601		NDA	NDA209311	Ironshore Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71376-203_73f8eb7c-c51f-45f5-97eb-5b72418d300b	71376-203	HUMAN PRESCRIPTION DRUG	JORNAY PM	Extended-Release	Methylphenidate Hydrochloride	CAPSULE	ORAL	20190601		NDA	NDA209311	Ironshore Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	60	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71376-204_73f8eb7c-c51f-45f5-97eb-5b72418d300b	71376-204	HUMAN PRESCRIPTION DRUG	JORNAY PM	Extended-Release	Methylphenidate Hydrochloride	CAPSULE	ORAL	20190601		NDA	NDA209311	Ironshore Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	80	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71376-205_73f8eb7c-c51f-45f5-97eb-5b72418d300b	71376-205	HUMAN PRESCRIPTION DRUG	JORNAY PM	Extended-Release	Methylphenidate Hydrochloride	CAPSULE	ORAL	20190601		NDA	NDA209311	Ironshore Pharmaceuticals Inc.	METHYLPHENIDATE HYDROCHLORIDE	100	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71383-014_577a6fed-7e6a-47c6-af44-bcfbc4675126	71383-014	HUMAN OTC DRUG	Deeveeant Numb		Lidocaine	CREAM	TOPICAL	20170430		OTC MONOGRAPH FINAL	part348	Valekista Limited	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71383-024_906c3414-a2c8-4038-9d38-0fd0fbbfdf94	71383-024	HUMAN OTC DRUG	MediNumb		Lidocaine	CREAM	TOPICAL	20170430		OTC MONOGRAPH FINAL	part348	Valekista Limited	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71390-011_e612bcf4-fce1-4b8b-aa7a-a58ad0dce6b2	71390-011	HUMAN PRESCRIPTION DRUG	BYFAVO		remimazolam besylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201006		NDA	NDA212295	Acacia Pharma, Ltd.	REMIMAZOLAM BESYLATE	2.5	mg/mL		CIV	N	20241231
71390-125_3aa09356-e93c-40c1-bb84-547ac93f1388	71390-125	HUMAN PRESCRIPTION DRUG	Barhemsys		Amisulpride	INJECTION, SOLUTION	INTRAVENOUS	20200227		NDA	NDA209510	Acacia Pharma Ltd	AMISULPRIDE	2.5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
71391-123_1460bf1f-c417-471d-ac74-68473bd960d7	71391-123	HUMAN OTC DRUG	Menthol 5%		MENTHOL, UNSPECIFIED FORM	PATCH	TOPICAL	20180301		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences, Private Limited	MENTHOL, UNSPECIFIED FORM	440	mg/1			N	20241231
71391-124_0fd378ac-a5dc-4688-bade-f08cf3152295	71391-124	HUMAN OTC DRUG	Menthol 6.5%		menthol, unspecified form	PATCH	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences, Private Limited	MENTHOL, UNSPECIFIED FORM	910	mg/1			N	20241231
71391-127_3d7db013-d5f0-4742-8e63-ac5195ce3db1	71391-127	HUMAN OTC DRUG	Menthol 5% Hydrogel		MENTHOL, UNSPECIFIED FORM	PATCH	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences, Private Limited	MENTHOL, UNSPECIFIED FORM	600	mg/1			N	20241231
71391-128_b8ee1003-ec8c-4c59-9e02-1cad729e1ef7	71391-128	HUMAN OTC DRUG	Menthol		MENTHOL, UNSPECIFIED FORM	PATCH	TOPICAL	20221115		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences Private Limited	MENTHOL, UNSPECIFIED FORM	105	mg/1			N	20241231
71391-130_92364a28-3e92-4c50-8a70-0122aee5219a	71391-130	HUMAN OTC DRUG	FEMININE PAIN RELIEF		MENTHOL, UNSPECIFIED FORM	PATCH	TOPICAL	20190119		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences, Private Limited	MENTHOL, UNSPECIFIED FORM	200	mg/1			N	20241231
71391-139_d498c290-03b0-40db-a909-706a5842a145	71391-139	HUMAN OTC DRUG	Menthol Camphor Knee		MENTHOL, UNSPECIFIED FORM and CAMPHOR (NATURAL)	PATCH	TOPICAL	20231222		OTC MONOGRAPH DRUG	M017	Unexo Life Sciences Private Limited	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	308; 308	mg/1; mg/1			N	20241231
71391-140_cc93ab8d-e269-44ad-b8b5-e728e68e3021	71391-140	HUMAN OTC DRUG	Menthol Camphor Micro		MENTHOL, UNSPECIFIED FORM and CAMPHOR (NATURAL)	PATCH	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences Private Limited	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	38.22; 38.22	mg/1; mg/1			N	20241231
71391-150_06c4c945-3baf-4e4f-bd0b-3a6a5ff392b2	71391-150	HUMAN OTC DRUG	Lidocaine Pain Relieving		Lidocaine	PATCH	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences Private Limited	LIDOCAINE	344	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71391-151_53d32025-8048-4c6e-8b97-963b67e4f1e1	71391-151	HUMAN OTC DRUG	Pain Relief 4% Lidocaine		Lidocaine	PATCH	TOPICAL	20220815		OTC MONOGRAPH NOT FINAL	part348	Unexo Life Sciences Private Limited	LIDOCAINE	344	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71397-822_09db5d2c-d37b-582f-e063-6294a90ae762	71397-822	HUMAN OTC DRUG	ACNE THERAPY		BENZOYL PEROXIDE	LOTION	TOPICAL	20170420		OTC MONOGRAPH DRUG	M006	menScience Androceuticals, LLC	BENZOYL PEROXIDE	30	mg/g			N	20241231
71399-0021_a778a7f3-39a7-4fe5-88d3-853a16a59727	71399-0021	HUMAN OTC DRUG	MAX relief junior		Acetaminophen	LIQUID	ORAL	20230514		OTC MONOGRAPH NOT FINAL	part343	Akron Pharma Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
71399-0023_8c6097e2-96b6-41e8-8510-964d59c91202	71399-0023	HUMAN OTC DRUG	MAX ALLERGY KIDS		Diphenhydramine HCl	SOLUTION	ORAL	20231115		OTC MONOGRAPH DRUG	M012	Akron Pharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71399-0024_73570cd5-b309-447d-ac71-b3f9d417b918	71399-0024	HUMAN OTC DRUG	MAX Tussin Mucus and Chest Congestion Sugar Free		Guaifenesin	LIQUID	ORAL	20230515		OTC MONOGRAPH FINAL	part341	Akron Pharma Inc.	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71399-0025_fe0787c9-d997-4008-9964-43cdfe5ae406	71399-0025	HUMAN OTC DRUG	MAX Tussin Cough and Chest Congestion DM		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20230515		OTC MONOGRAPH FINAL	part341	Akron Pharma Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71399-0026_aeb5f97d-963c-4cde-8d73-bd5243e0db8e	71399-0026	HUMAN OTC DRUG	MAX Tussin Cough and Chest Congestion DM Sugar Free		Dextromethorphan HBr, Guaifenesin	LIQUID	ORAL	20230515		OTC MONOGRAPH FINAL	part341	Akron Pharma Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71399-0039_63dcff8d-8254-450b-b3d0-e28425784eae	71399-0039	HUMAN OTC DRUG	OneLAX		Docusate Sodium	LIQUID	ORAL	20230804		OTC MONOGRAPH NOT FINAL	part334	Akron Pharma	DOCUSATE SODIUM	50	mg/5mL			N	20241231
71399-0041_95b4c56b-675f-49ce-93bc-bdc1606c4fb6	71399-0041	HUMAN OTC DRUG	TEENY TUMMY	Gas Relief Drops	Simethicone	SUSPENSION	ORAL	20230804		OTC MONOGRAPH FINAL	part332	Akron Pharma	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
71399-0049_640a4f75-dcd4-438f-9859-2d0b476b86a0	71399-0049	HUMAN OTC DRUG	Asper Flex		Lidocaine	CREAM	TOPICAL	20231103		OTC MONOGRAPH DRUG	M017	Akron Pharma Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71399-0050_4419487a-26f7-4df7-8683-6d562faf81af	71399-0050	HUMAN OTC DRUG	RectoProtect		Lidocaine	CREAM	TOPICAL	20231103		OTC MONOGRAPH DRUG	M017	Akron Pharma Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71399-0051_dccdd89a-3709-4754-99e1-805919d1cfe8	71399-0051	HUMAN OTC DRUG	OneLAX	Saline Laxative	Magnesium Citrate	LIQUID	ORAL	20230804		OTC MONOGRAPH NOT FINAL	part334	AKRON PHARMA INC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71399-0054_f1b38b6f-7def-48bd-905a-7f03bf9db4f9	71399-0054	HUMAN OTC DRUG	MAX Tussin Mucus and Chest Congestion		Guaifenesin	LIQUID	ORAL	20231103		OTC MONOGRAPH DRUG	M012	Akron Pharma Inc.	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71399-0110_f35688dd-bb1a-4e4e-89a7-2b0bac069552	71399-0110	HUMAN OTC DRUG	Hemorrhoidal Hygiene pads		witch hazel	SOLUTION	RECTAL	20191025		OTC MONOGRAPH FINAL	part346	Akron Pharma Inc.	WITCH HAZEL	50	g/100mL			N	20241231
71399-0120_30b86201-aa2c-44df-b1ac-bc7009f5a1d0	71399-0120	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	LOTION	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part348	AKRON PHARMA INC	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71399-0122_698f96cc-d240-4aac-be98-1c020355e4e9	71399-0122	HUMAN OTC DRUG	MEDPURA Vitamin A and D	Vitamin A and D	MEDPURA Vitamin A and D	OINTMENT	TOPICAL	20211104		OTC MONOGRAPH FINAL	part347	Akron Pharma Inc.	PETROLATUM	95	g/100g			N	20241231
71399-0125_1180ee01-61eb-4a1b-9c1e-8ca1f5160473	71399-0125	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	LIQUID	ORAL	20191025		OTC MONOGRAPH FINAL	part341	Akron Pharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71399-0160_db7bf2d8-02d1-467f-bce1-549ee48af7f9	71399-0160	HUMAN OTC DRUG	ACETAMINOPHEN		Acetaminophen	ELIXIR	ORAL	20210518		OTC MONOGRAPH NOT FINAL	part343	Akron Pharma Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
71399-0180_f65bd138-874d-4b49-9540-a47188150c3c	71399-0180	HUMAN OTC DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20211105		OTC MONOGRAPH DRUG	M017	AKRON PHARMA INC	HYDROCORTISONE	1	mg/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71399-0245_19cedfa7-7a2f-4f01-9393-f1be0308d584	71399-0245	HUMAN OTC DRUG	Medpura Zinc Oxide 20%		Medpura Zinc Oxide 20%	OINTMENT	TOPICAL	20211104		OTC MONOGRAPH FINAL	part347	Akron Pharma Inc.	ZINC OXIDE	20	g/100g			N	20241231
71399-0480_7aa198ef-f9ce-4890-94ad-6edf94d38dde	71399-0480	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE		SODIUM SULFACETAMIDE	LIQUID	TOPICAL	20190110		UNAPPROVED DRUG OTHER		Akron Pharma Inc	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71399-0482_dcc78222-a461-4137-a2c1-4653d94b6840	71399-0482	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9% - Sulfur 4%		SULFACETAMIDE SODIUM, SULFUR	SUSPENSION	TOPICAL	20201109		UNAPPROVED DRUG OTHER		Akron Pharma Inc.	SULFACETAMIDE SODIUM; SULFUR	90; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71399-0484_a9fd2085-053f-4eb5-928a-e4c28096d362	71399-0484	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9% - Sulfur 4.5% Wash		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20201109		UNAPPROVED DRUG OTHER		Akron Pharma Inc.	SULFACETAMIDE SODIUM; SULFUR	90; 45	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71399-0485_bca3becb-f551-4d7d-96db-e97cc4846cef	71399-0485	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10% and Sulfur 2% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20201109		UNAPPROVED DRUG OTHER		Akron Pharma Inc.	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71399-0486_5d059aa7-3b46-46f4-9d73-adad5498b734	71399-0486	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20201109		UNAPPROVED DRUG OTHER		Akron Pharma Inc.	SULFACETAMIDE SODIUM; SULFUR	9.8; 4.8	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71399-0487_9ba64c38-3ad2-4399-8cd2-666065331575	71399-0487	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 8% and Sulfur 4%		SULFACETAMIDE SODIUM, SULFUR	SUSPENSION	TOPICAL	20201109		UNAPPROVED DRUG OTHER		Akron Pharma Inc.	SULFACETAMIDE SODIUM; SULFUR	80; 40	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71399-0500_e45cf4cc-4187-485f-b7a8-92cc35993f2e	71399-0500	HUMAN OTC DRUG	Clotrimazole		Clotrimazole	SOLUTION	TOPICAL	20170515		OTC MONOGRAPH FINAL	part333C	Akron Pharma Inc	CLOTRIMAZOLE	1	g/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
71399-1599_97bfd8b3-a782-4b4f-8516-48463aa5cdbd	71399-1599	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE		SODIUM SULFACETAMIDE	SHAMPOO	TOPICAL	20200214		UNAPPROVED DRUG OTHER		Akron Pharma Inc	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
71399-2829_56fb50bc-3266-49be-b3b4-6019d7ecfe26	71399-2829	HUMAN OTC DRUG	Dibucaine		Dibucaine	OINTMENT	TOPICAL	20211104		OTC MONOGRAPH FINAL	part346	Akron Pharma Inc.	DIBUCAINE	.28	g/28g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71399-3884_71ba4ef8-57e3-446e-8d0f-ecd766604a94	71399-3884	HUMAN OTC DRUG	ASPERFLEX 24HRS		Lidocaine Patch 4%	PATCH	TOPICAL	20210518		OTC MONOGRAPH NOT FINAL	part348	Akron Pharma Inc.	LIDOCAINE	40	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71399-4439_16ec6c87-0632-4cd4-9ecb-bef923fc3500	71399-4439	HUMAN OTC DRUG	AsperFlex HOT		Camphor, Menthol, Methyl salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20211104		OTC MONOGRAPH NOT FINAL	part348	Akron Pharma Inc.	CAPSICUM; MENTHOL	.025; 1.25	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
71399-4453_32c3fc0a-7237-41d0-ada7-1d4860a27d14	71399-4453	HUMAN OTC DRUG	AsperFlex MAX		Lidocaine 4% with Menthol 1%	PATCH	TOPICAL	20211104		OTC MONOGRAPH NOT FINAL	part348	Akron Pharma Inc.	LIDOCAINE; MENTHOL	240; 60	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71399-4456_f1da1ab6-6feb-4145-ae62-907957d84e63	71399-4456	HUMAN OTC DRUG	AsperFlex		Lidocaine	PATCH	TOPICAL	20211104		OTC MONOGRAPH NOT FINAL	part348	Akron Pharma Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71399-4458_77265a35-9fb8-40a4-a069-12037a505e1d	71399-4458	HUMAN OTC DRUG	AsperFlex Advance		Camphor, Menthol, Methyl salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20211104		OTC MONOGRAPH NOT FINAL	part348	Akron Pharma Inc.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	86.24; 166.92; 278.2	mg/1; mg/1; mg/1			N	20241231
71399-4461_2a890e2e-7156-434e-95b1-9a3b9c03d91a	71399-4461	HUMAN OTC DRUG	AsperFlex Original Maximum Strength		Menthol	PATCH	TOPICAL	20211104		OTC MONOGRAPH NOT FINAL	part348	Akron Pharma Inc.	MENTHOL	210	mg/1			N	20241231
71399-4589_e890628f-f0c1-475d-9e11-07bbdbcc5913	71399-4589	HUMAN OTC DRUG	VAPORX		Camphor (synthetic), Eucalyptus oil, and Menthol	OINTMENT	TOPICAL	20211105		OTC MONOGRAPH FINAL	part341	AKRON PHARMA INC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	.048; .012; .026	g/g; g/g; g/g			N	20241231
71399-5101_14566f13-60c3-4994-90dc-674a8be2f9c8	71399-5101	HUMAN OTC DRUG	HYDROPHOR		HYDROPHOR	OINTMENT	TOPICAL	20210518		OTC MONOGRAPH FINAL	part347	Akron Pharma Inc.	PETROLATUM	42	g/100g			N	20241231
71399-6544_ac5b42b7-854d-40a4-bdde-5345ab594b03	71399-6544	HUMAN OTC DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part348	Akron Pharma Inc.	LIDOCAINE	4	g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71399-6585_a32af723-fd8e-45fd-bcef-d582d922896c	71399-6585	HUMAN OTC DRUG	OneLAX Fiber Therapy	original coarse	Psyllium Husk	POWDER	ORAL	20230101		OTC MONOGRAPH NOT FINAL	part334	Akron Pharma Inc.	PSYLLIUM HUSK	3.4	g/7g			N	20241231
71399-6586_0c923a29-adbd-469e-8d83-e6f8f3fa28e7	71399-6586	HUMAN OTC DRUG	OneLAX Fiber Therapy	original coarse	Psyllium Husk	POWDER	ORAL	20230101		OTC MONOGRAPH NOT FINAL	part334	Akron Pharma Inc.	PSYLLIUM HUSK	3.4	g/7g			N	20241231
71399-6743_feee8437-d7d9-457d-9462-9620e8b3a4f6	71399-6743	HUMAN OTC DRUG	Hydroseptine		Zinc Oxide, Menthol	OINTMENT	TOPICAL	20211105		OTC MONOGRAPH FINAL	part346	AKRON PHARMA INC	MENTHOL; ZINC OXIDE	.44; 20.6	g/100g; g/100g			N	20241231
71399-7889_ba8443ea-0109-4b71-a471-7d0fa021757b	71399-7889	HUMAN OTC DRUG	Magnesium Citrate	Saline Laxative	Magnesium citrate	LIQUID	ORAL	20230102		OTC MONOGRAPH NOT FINAL	part334	AKRON PHARMA INC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71399-8014_618b7382-8bdd-49a8-928b-7a0b545689a2	71399-8014	HUMAN OTC DRUG	ACETAMINOPHEN		Acetaminophen	TABLET	ORAL	20210115		OTC MONOGRAPH NOT FINAL	part343	Akron Pharma Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
71399-8022_705ea9b7-4a0a-42ad-b8a4-aa42f54b6baa	71399-8022	HUMAN OTC DRUG	ACETAMINOPHEN		Acetaminophen	TABLET	ORAL	20210115		OTC MONOGRAPH NOT FINAL	part343	Akron Pharma Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
71399-8024_618b7382-8bdd-49a8-928b-7a0b545689a2	71399-8024	HUMAN OTC DRUG	ACETAMINOPHEN		Acetaminophen	TABLET	ORAL	20210115		OTC MONOGRAPH NOT FINAL	part343	Akron Pharma Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
71399-8026_d89d316b-1d9b-451d-9502-a90a92e5b9bb	71399-8026	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	CAPSULE	ORAL	20210115		OTC MONOGRAPH FINAL	part341	Akron Pharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71399-8028_5dfddb99-208f-4c76-8c59-3c13fd5fe52c	71399-8028	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	CAPSULE	ORAL	20210115		OTC MONOGRAPH FINAL	part341	Akron Pharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71399-8042_bd010bd9-531a-49dd-b4f1-9754af7b577e	71399-8042	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20200909		ANDA	ANDA204507	Akron Pharma Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71399-8237_d24f7b42-94ba-4f56-864b-b423cf1e5efe	71399-8237	HUMAN OTC DRUG	SENNA		SENNA	SYRUP	ORAL	20191025		OTC MONOGRAPH NOT FINAL	part334	Akron Pharma Inc.	SENNOSIDES A AND B	417.12	mg/237mL			N	20241231
71399-8245_55b1f357-372b-48dd-a525-7a7c5e340e8f	71399-8245	HUMAN OTC DRUG	Senna		Sennosides	TABLET, FILM COATED	ORAL	20210510		OTC MONOGRAPH NOT FINAL	part334	Akron Pharma Inc.	SENNOSIDES	8.6	mg/1			N	20241231
71399-8455_5640928b-9bb8-4b1c-9198-f3f5d580c92e	71399-8455	HUMAN PRESCRIPTION DRUG	UREA		UREA	LOTION	TOPICAL	20211101		UNAPPROVED DRUG OTHER		AKRON PHARMA INC	UREA	40	g/100g			N	20241231
71399-8456_2736f925-2e37-417d-9786-202f31c2aeec	71399-8456	HUMAN PRESCRIPTION DRUG	Urea Cream 40%		Urea	CREAM	TOPICAL	20211104		UNAPPROVED DRUG OTHER		Akron Pharma Inc.	UREA	400	mg/g			N	20241231
71399-8460_4041f81d-086f-4825-8b50-0e1254242d84	71399-8460	HUMAN OTC DRUG	OneLAX		BISACODYL	SUPPOSITORY	RECTAL	20211105		OTC MONOGRAPH NOT FINAL	part334	AKRON PHARMA INC	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71399-8627_0bebdf25-4ba1-45b7-b37e-a8c0085de205	71399-8627	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20210512		OTC MONOGRAPH NOT FINAL	part343	Akron Phama	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71399-8659_27a5c104-a914-4bbc-82e1-53921ba5b19f	71399-8659	HUMAN OTC DRUG	fexofenadine hcl		fexofenadine hcl	TABLET, FILM COATED	ORAL	20141226		ANDA	ANDA204507	AKRON PHARMA INC	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71399-9234_164be820-6b36-411b-b37e-c965fb53122b	71399-9234	HUMAN OTC DRUG	MEDPURA Benzoyl Peroxide		Benzoyl Peroxide	LIQUID	TOPICAL	20211104		OTC MONOGRAPH FINAL	part333D	Akron Pharma Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
71399-9236_164be820-6b36-411b-b37e-c965fb53122b	71399-9236	HUMAN OTC DRUG	MEDPURA Benzoyl Peroxide		Benzoyl Peroxide	LIQUID	TOPICAL	20211104		OTC MONOGRAPH FINAL	part333D	Akron Pharma Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
71399-9474_11d3cf69-6243-4de4-bba4-bb519eaf9c73	71399-9474	HUMAN OTC DRUG	MEDPURA Benzoyl Peroxide	Aqueous Base, Acne Treatment Gel	Benzoyl Peroxide	GEL	TOPICAL	20211104		OTC MONOGRAPH FINAL	part333D	Akron Pharma Inc.	BENZOYL PEROXIDE	100	mg/mL			N	20241231
71399-9478_11d3cf69-6243-4de4-bba4-bb519eaf9c73	71399-9478	HUMAN OTC DRUG	MEDPURA Benzoyl Peroxide	Aqueous Base, Acne Treatment Gel	Benzoyl Peroxide	GEL	TOPICAL	20211104		OTC MONOGRAPH FINAL	part333D	Akron Pharma Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
71403-003_d743c06d-1277-4504-803b-5752af09ba03	71403-003	HUMAN PRESCRIPTION DRUG	Rhofade		OXYMETAZOLINE HYDROCHLORIDE	CREAM	TOPICAL	20210118		NDA	NDA208552	EPI Health, LLC	OXYMETAZOLINE HYDROCHLORIDE	1	g/100g	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
71406-105_0d0b0996-208f-e38b-e063-6294a90ae522	71406-105	HUMAN OTC DRUG	Senna		Sennosides 8.6 mg Tablets	TABLET	ORAL	20190830		OTC MONOGRAPH DRUG	M007	AACE PHARMACEUTICALS, INC.	SENNOSIDES	8.6	mg/1			N	20241231
71406-106_0d0b10db-5807-e2f6-e063-6294a90a00db	71406-106	HUMAN OTC DRUG	Senna-S		Docusate Sodium 50 mg Sennosides 8.6 mg	TABLET, FILM COATED	ORAL	20190830		OTC MONOGRAPH DRUG	M007	AACE PHARMACEUTICALS, INC.	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
71406-124_0cf44174-fb1f-bff9-e063-6294a90a8fc0	71406-124	HUMAN OTC DRUG	Lubricant PM		Mineral Oil, White Petrolatum Lubricant Eye Ointment	OINTMENT	OPHTHALMIC	20200319		OTC MONOGRAPH DRUG	M018	AACE PHARMACEUTICALS, INC.	MINERAL OIL; PETROLATUM	425; 573	mg/g; mg/g			N	20241231
71406-128_0d0aff40-5a8a-df0c-e063-6394a90ad752	71406-128	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin Enteric Coated Tablets 81 mg	TABLET, DELAYED RELEASE	ORAL	20210503		OTC MONOGRAPH DRUG	M013	AACE Pharmaceuticals, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71408-001_3b9691fe-bdc9-467e-b2b4-0ab9a2ca87ad	71408-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20171227		NDA	NDA211739	Ineos Pigments ASU LLC	OXYGEN	99	L/100L			N	20241231
71408-003_d780ff96-4551-4fbd-a6d6-1c33713a38f7	71408-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20171227		NDA	NDA211737	Ineos Pigments ASU LLC	NITROGEN	99	L/100L			N	20241231
71409-304_7057d504-679a-5dfe-e053-2991aa0a8093	71409-304	HUMAN OTC DRUG	COLD and FLU RELIEF		COLD and FLU RELIEF	PELLET	ORAL; SUBLINGUAL	20170714		UNAPPROVED HOMEOPATHIC		Clineva Management Services, LLC	ACONITUM NAPELLUS; ALLIUM CEPA WHOLE; ARNICA MONTANA; EUPATORIUM CANNABINUM WHOLE; GELSEMIUM SEMPERVIRENS ROOT; SOLANUM DULCAMARA WHOLE	14; 8; 8; 8; 18; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
71409-311_620e0d1d-b067-2a86-e053-2a91aa0a9bef	71409-311	HUMAN OTC DRUG	Sore Throat Relief		Sore Throat Relief	PELLET	ORAL; SUBLINGUAL	20170718		UNAPPROVED HOMEOPATHIC		Clineva Urgent Care	ACONITUM NAPELLUS; APIS MELLIFERA; ATROPA BELLADONNA; MERCURIUS SOLUBILIS; PHYTOLACCA AMERICANA ROOT; SOLANUM DULCAMARA WHOLE	10; 10; 10; 10; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
71412-110_f5268fa6-37ee-67e1-e053-2a95a90afe40	71412-110	HUMAN OTC DRUG	Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20170526		OTC MONOGRAPH FINAL	part344	R&C Imports LLC	ISOPROPYL ALCOHOL	.7	mL/1			N	20241231
71420-102_f6929d59-87d8-a829-e053-2a95a90ad3fa	71420-102	HUMAN OTC DRUG	M Skin Care Blemish Patches		Salicylic Acid 0.5%	PATCH	TOPICAL	20200701		OTC MONOGRAPH FINAL	part333D	Sales and Product Solutions	SALICYLIC ACID	5	g/1			N	20241231
71420-103_f6929baa-97dd-68a9-e053-2a95a90abdee	71420-103	HUMAN OTC DRUG	Miss Spa Clear Blemish Patches		Salicylic Acid 0.5%	PATCH	TOPICAL	20200701		OTC MONOGRAPH FINAL	part333D	Sales and Product Solutions	SALICYLIC ACID	5	g/1			N	20241231
71421-801_e0c056f3-ebbe-ae17-e053-2995a90ab117	71421-801	HUMAN PRESCRIPTION DRUG	OLIVIA QUIDO BLEMISH ERASER		Hydroquinone	CREAM	TOPICAL	20220504	20270504	UNAPPROVED DRUG OTHER		O Skin Care LLC	HYDROQUINONE	.02	g/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	
71425-030_7a91c9f6-82c3-347a-e053-2a91aa0aab02	71425-030	HUMAN OTC DRUG	Glossier sun glaze gleaming sunscreen oil broad spectrum SPF 30 Water Resistant 40 Min		Glossier sun glaze gleaming sunscreen oil broad spectrum SPF 30 Water Resistant 40 Min	AEROSOL, SPRAY	TOPICAL	20190101		OTC MONOGRAPH FINAL	part352	Glossier Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
71427-213_0949a165-7655-8fc6-e063-6294a90a9cb3	71427-213	HUMAN OTC DRUG	Kong HandiPOD		ALCOHOL	GEL	TOPICAL	20170509		OTC MONOGRAPH DRUG	505G(a)(3)	HANDIPOD LIMITED	ALCOHOL	700	mg/mL			N	20241231
71428-001_0e88c9e2-8dbc-917c-e063-6294a90a6ec9	71428-001	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	SOLUTION	TOPICAL	20180601		ANDA	ANDA209118	Glasshouse Pharmaceuticals Limited Canada	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
71428-002_0e88e5a3-cb33-ca6a-e063-6294a90a9aec	71428-002	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide		Fluocinolone Acetonide	SOLUTION	TOPICAL	20180601		ANDA	ANDA209596	Glasshouse Pharmaceuticals Limited Canada	FLUOCINOLONE ACETONIDE	.1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
71428-003_0e88c0f2-16c1-3684-e063-6394a90a12d0	71428-003	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20190301		ANDA	ANDA209846	Glasshouse Pharmaceuticals Limited Canada	CLINDAMYCIN	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20251231
71428-011_0e88c9e2-8dc2-917c-e063-6294a90a6ec9	71428-011	HUMAN PRESCRIPTION DRUG	Halcinonide		Halcinonide	CREAM	TOPICAL	20211208		ANDA	ANDA214723	Glasshouse Pharmaceuticals Limited Canada	HALCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
71435-0001_0c5cfa6d-c875-7bad-e063-6294a90a1f87	71435-0001	HUMAN OTC DRUG	Milani SPF BFF 30 Primer		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	M020	New Milani Group, LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	30; 73; 30; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71435-0004_0c5d0e48-2faf-0d70-e063-6394a90a97f8	71435-0004	HUMAN OTC DRUG	MILANI MAKE IT LAST SUNSCREEN SETTING SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LIQUID	TOPICAL	20220601		OTC MONOGRAPH DRUG	M020	New Milani Group, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 90; 45; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71435-0005_0c5cff9a-f83a-7fae-e063-6294a90a7737	71435-0005	HUMAN OTC DRUG	MILANI ERASE BASE BLEMISH CONTROL PRIMER Salicylic Acid		SALICYLIC ACID	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M006	New Milani Group, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
71435-8202_ec975f0d-1566-2e3f-e053-2995a90a4241	71435-8202	HUMAN OTC DRUG	Milani Prime Protect SPF 30 Face Primer		Avobenzone, Octinoxate, Octocrylene, and Oxybenzone	CREAM	TOPICAL	20171125		OTC MONOGRAPH NOT FINAL	part352	The Milani Group, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	30; 73; 30; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71436-3025_1282a082-8d14-44e9-9d6d-9bf4158b6403	71436-3025	HUMAN OTC DRUG	Capsaicin		Capsaicin	PATCH	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	ARI BRANDS, LLC	CAPSAICIN	.025	g/100g			N	20241231
71436-3104_2002c004-ba4f-4e1d-8160-bd63bd13bf97	71436-3104	HUMAN OTC DRUG	Lidocaine 4 Percent		Lidocaine	PATCH	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	ARI BRANDS, LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71436-3571_27fac912-0cb1-4cbd-b500-ce1a224cd965	71436-3571	HUMAN PRESCRIPTION DRUG	LM Plus Relief		Lidocaine and Menthol	PATCH	TOPICAL	20230901		UNAPPROVED DRUG OTHER		ARI BRANDS, LLC	LIDOCAINE; MENTHOL	490; 980	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71440-001_df71459e-2e31-8b2e-e053-2a95a90a83a8	71440-001	HUMAN OTC DRUG	Pyrithione Zinc		Pyrithione Zinc	SHAMPOO	TOPICAL	20160307		OTC MONOGRAPH FINAL	part358H	Cosmetic Dermatology Research Institute, LLC.	PYRITHIONE ZINC	2.41	g/237mL			N	20241231
71441-180_4ad98338-8e8d-402c-b5de-b0a8dfba52b0	71441-180	HUMAN OTC DRUG	ONID Wipe		Ethanol	SWAB	TOPICAL	20170628		OTC MONOGRAPH NOT FINAL	part333E	ONID Technology Corp	ALCOHOL	75	mL/100mL			N	20241231
71443-001_987aa9cc-4f7e-442b-b901-a60597a5ad32	71443-001	HUMAN OTC DRUG	QUALITY CHOICE SINGLE SALINE	LAXATIVE	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20170705		OTC MONOGRAPH NOT FINAL	part334	Alcyon Health, LLC.	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
71447-003_c7826d9f-7620-fc9b-e053-2995a90a6dc3	71447-003	HUMAN OTC DRUG	NELLY DEVUYST CLEANSING BIOACNE		SALICYLIC ACID	GEL	TOPICAL	20180526		OTC MONOGRAPH FINAL	part333D	LABORATOIRES DRUIDE INC	SALICYLIC ACID	.7	g/100mL			N	20241231
71447-003_c792053e-56a4-d83a-e053-2a95a90aeda7	71447-003	HUMAN OTC DRUG	NELLY DEVUYST CLEANSING BIOACNE		SALICYLIC ACID	GEL	TOPICAL	20180526		OTC MONOGRAPH FINAL	part333D	LABORATOIRES DRUIDE INC	SALICYLIC ACID	.7	g/100mL			N	20241231
71447-006_c790ed12-fe9e-6619-e053-2a95a90aa45a	71447-006	HUMAN OTC DRUG	NELLY DEVUYST SERUM BIOACNE		Salicylic Acid	LIQUID	TOPICAL	20180420		OTC MONOGRAPH FINAL	part333D	LABORATOIRES DRUIDE INC	SALICYLIC ACID	2	g/100g			N	20241231
71447-008_c791089f-f86f-f1d4-e053-2995a90ad844	71447-008	HUMAN OTC DRUG	NELLY DEVUYST MICELLAR FOAM BIOACNE		SALICYLIC ACID	LIQUID	TOPICAL	20180425		OTC MONOGRAPH FINAL	part333D	LABORATOIRES DRUIDE INC	SALICYLIC ACID	.5	g/100mL			N	20241231
71447-010_c782882f-31dd-6bd9-e053-2995a90aab30	71447-010	HUMAN OTC DRUG	NELLY DEVUYST SALICYLIC ACID COMPLEX BIOACNE		SALICYLIC ACID	LIQUID	TOPICAL	20180724		OTC MONOGRAPH FINAL	part333D	LABORATOIRES DRUIDE INC	SALICYLIC ACID	1	g/100mL			N	20241231
71447-030_ce9fa5a8-dabe-6b55-e053-2995a90ae7c0	71447-030	HUMAN OTC DRUG	NELLY DEVUYST BIO MEDICAL BIOACNE ANTI-REDNESS SERUM 30 mL		COLLOIDAL OATMEAL	CREAM	TOPICAL	20211014		OTC MONOGRAPH FINAL	part347	LABORATOIRES DRUIDE INC	OATMEAL	1.3	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71447-031_d3812629-c85c-3330-e053-2a95a90a6255	71447-031	HUMAN OTC DRUG	NELLY DEVUYST BIOSOLAR COLORLIFT 2 TINTED SUNSCREEN 30 mL	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210426		OTC MONOGRAPH FINAL	part352	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	2; 18.4	g/100g; g/100g			N	20241231
71447-032_d3824e06-097e-4f23-e053-2a95a90a8cc9	71447-032	HUMAN OTC DRUG	NELLY DEVUYST BIOSOLAR COLORLIFT 1 TINTED SUNSCREEN 30 mL	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210426		OTC MONOGRAPH FINAL	part352	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	2; 18.4	g/100g; g/100g			N	20241231
71447-050_d381dc02-015f-ee0d-e053-2995a90a3d39	71447-050	HUMAN OTC DRUG	BIOMI ACTION DE GALA MINERAL SUNSCREEN	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200301		OTC MONOGRAPH FINAL	part352	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	2; 18.4	g/100mL; g/100mL			N	20241231
71447-052_d38259d3-248c-6ae5-e053-2a95a90a8f0e	71447-052	HUMAN OTC DRUG	LANI AND KAI MINERAL SUNSCREEN	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210301		OTC MONOGRAPH FINAL	part352	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	2; 18.4	g/100g; g/100g			N	20241231
71447-055_00e99b98-80d4-6d3e-e063-6394a90aeea4	71447-055	HUMAN OTC DRUG	1926 SINCE DERM ACTE 365 UV SCREEN	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230716		OTC MONOGRAPH FINAL	M020	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	2; 18.4	g/100mL; g/100mL			N	20241231
71447-100_c781ee12-6676-81dc-e053-2995a90adf93	71447-100	HUMAN OTC DRUG	NELLY DEVUYST ORGANIC TRANSPARENT MINERAL SUNSCREEN	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20191001		OTC MONOGRAPH FINAL	part352	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	2; 18.4	g/100g; g/100g			N	20241231
71447-118_d3830ed3-d1f9-783d-e053-2995a90ac65b	71447-118	HUMAN OTC DRUG	DR HOS PAIN AID	5X ACTIVE STRENGTH	Camphor,Menthol	AEROSOL, SPRAY	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	LABORATOIRES DRUIDE INC	CAMPHOR (NATURAL); MENTHOL	3.1; 1.95	g/100mL; g/100mL			N	20241231
71447-120_c791b53a-9252-0d36-e053-2a95a90a4cd2	71447-120	HUMAN OTC DRUG	NELLY DEVUYST ORGANIC SUNSCREEN NATURAL PROTECTION BROAD SPECTRUM	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170612		OTC MONOGRAPH FINAL	part352	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	6.5; 6.3	g/100g; g/100g			N	20241231
71447-121_d382a964-3d0a-9bf6-e053-2a95a90acc39	71447-121	HUMAN OTC DRUG	DR HOS PAIN RELIEF MAXIMUM STRENGTH		Camphor,Menthol	AEROSOL, SPRAY	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	LABORATOIRES DRUIDE INC	MENTHOL	3	g/100mL			N	20241231
71447-130_c780769a-ddf2-bd2d-e053-2995a90a6604	71447-130	HUMAN OTC DRUG	ALASKA BEAUTY FRESH HAND ANTISEPTIC CLEANSER		ETHYL ALCOHOL	GEL	TOPICAL	20200324		OTC MONOGRAPH NOT FINAL	part333E	LABORATOIRES DRUIDE INC	ALCOHOL	60	mL/100mL			N	20241231
71447-150_c7815a74-6ddd-04c4-e053-2a95a90a54b0	71447-150	HUMAN OTC DRUG	ALASKA BEAUTY FRESH HAND ANTISEPTIC CLEANSER		ETHYL ALCOHOL	GEL	TOPICAL	20200324		OTC MONOGRAPH NOT FINAL	part333E	LABORATOIRES DRUIDE INC	ALCOHOL	60	mL/100mL			N	20241231
71447-187_f4b4972c-f9b9-1f25-e053-2995a90a0ca6	71447-187	HUMAN OTC DRUG	DR HO S PAIN RELIEF EXTRA STGHT		Methyl Salicylate,Menthol,Eucalyptus Oil	CREAM	TOPICAL	20230208		OTC MONOGRAPH NOT FINAL	part348	LABORATOIRES DRUIDE INC	EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	1; 15; 30	g/100g; g/100g; g/100g			N	20241231
71447-200_c781b201-bd99-af17-e053-2995a90adf2e	71447-200	HUMAN OTC DRUG	DRUIDE BIOLOVE KIDS MINERAL SUNSCREEN	SPF30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20191216		OTC MONOGRAPH FINAL	part352	LABORATOIRES DRUIDE INC	TITANIUM DIOXIDE; ZINC OXIDE	2; 18.4	g/100g; g/100g			N	20241231
71447-210_c77c9bca-ec21-a86d-e053-2a95a90aa0a3	71447-210	HUMAN OTC DRUG	ALASKA BEAUTY ELEMENTS FRESH HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200422		OTC MONOGRAPH NOT FINAL	part333A	LABORATOIRES DRUIDE INC	ALCOHOL	70	mL/100mL			N	20241231
71447-250_c7819253-bad9-fd65-e053-2a95a90a143f	71447-250	HUMAN OTC DRUG	ALASKA BEAUTY HAND ANTISEPTIC CLEANSER		ETHYL ALCOHOL	GEL	TOPICAL	20200317		OTC MONOGRAPH NOT FINAL	part333E	LABORATOIRES DRUIDE INC	ALCOHOL	60	mL/100mL			N	20241231
71447-251_c7817efa-b695-a6ae-e053-2a95a90a57da	71447-251	HUMAN OTC DRUG	ALASKA BEAUTY FRESH HAND ANTISEPTIC CLEANSER		ETHYL ALCOHOL	GEL	TOPICAL	20200324		OTC MONOGRAPH NOT FINAL	part333E	LABORATOIRES DRUIDE INC	ALCOHOL	60	mL/100mL			N	20241231
71447-252_c77ce430-40ef-4d84-e053-2995a90aa807	71447-252	HUMAN OTC DRUG	ALASKA BEAUTY ELEMENTS FRESH HAND SANITIZER		ISOPROPYL ALCOHOL	SPRAY	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333E	LABORATOIRES DRUIDE INC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
71447-253_c77ca5a5-6b8a-f460-e053-2a95a90ab253	71447-253	HUMAN OTC DRUG	ALASKA BEAUTY ELEMENTS FRESH HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200422		OTC MONOGRAPH NOT FINAL	part333A	LABORATOIRES DRUIDE INC	ALCOHOL	70	mL/100mL			N	20241231
71447-254_c77c61c7-e57f-59b0-e053-2995a90a5598	71447-254	HUMAN OTC DRUG	ALASKA BEAUTY ELEMENTS FRESH HAND SANITIZER		ETHYL ALCOHOL	SPRAY	TOPICAL	20200429		OTC MONOGRAPH NOT FINAL	part333A	LABORATOIRES DRUIDE INC	ALCOHOL	70	mL/100mL			N	20241231
71447-300_c781adda-9e35-c8b2-e053-2995a90afc62	71447-300	HUMAN OTC DRUG	DRUIDE BIOLOVE FOR DIAPER RASH		KAOLIN	PASTE	TOPICAL	20191216		OTC MONOGRAPH FINAL	part347	LABORATOIRES DRUIDE INC	KAOLIN	4	g/100g			N	20241231
71447-400_c77c3c90-017b-f7aa-e053-2995a90a9171	71447-400	HUMAN OTC DRUG	ALASKA BEAUTY ELEMENTS FRESH HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200422		OTC MONOGRAPH NOT FINAL	part333A	LABORATOIRES DRUIDE INC	ALCOHOL	70	mL/100mL			N	20241231
71447-401_c77c2daf-48d2-b7ad-e053-2995a90ac85d	71447-401	HUMAN OTC DRUG	ALASKA BEAUTY ELEMENTS FRESH HAND SANITIZER		ETHYL ALCOHOL	SPRAY	TOPICAL	20200429		OTC MONOGRAPH NOT FINAL	part333A	LABORATOIRES DRUIDE INC	ALCOHOL	70	mL/100mL			N	20241231
71451-001_dc3d1fb9-2926-43fc-b39a-2248e8ce0451	71451-001	HUMAN OTC DRUG	Pro-Enema Single Saline	Laxative	Sodium Phosphate, Dibasic and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	ENEMA	RECTAL	20170606		OTC MONOGRAPH NOT FINAL	part334	Propharma Medical Supplies	SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	7; 19	g/118mL; g/118mL			N	20241231
71453-211_eea14603-7c2b-2f2d-e053-2995a90a0ec8	71453-211	HUMAN OTC DRUG	Cool Comfort		ORGANIC WITCH HAZEL	SWAB	TOPICAL	20171129		OTC MONOGRAPH FINAL	part346	Naticura Inc	WITCH HAZEL	60	g/100g			N	20241231
71475-257_5b016539-e8f2-4def-b707-cad9de03708f	71475-257	HUMAN PRESCRIPTION DRUG	Arakoda		Tafenoquine	TABLET, FILM COATED	ORAL	20180820		NDA	NDA210607	60 Degrees Pharmaceuticals, LLC	TAFENOQUINE	100	mg/1			N	20241231
71481-011_f6421850-a0ff-d275-e053-2a95a90a544a	71481-011	HUMAN OTC DRUG	DGH Antacid Peppermint 500,150ct		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20230308		OTC MONOGRAPH FINAL	part331	BioV Health Inc	CALCIUM CARBONATE	500	mg/1			N	20241231
71481-012_f663921b-abeb-bf81-e053-2a95a90a2e1e	71481-012	HUMAN OTC DRUG	DGH Antacid 1000 Tropical Fruit, 72ct		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20230308		OTC MONOGRAPH FINAL	part331	BioV Health Inc	CALCIUM CARBONATE	1000	mg/1			N	20241231
71481-013_f663921b-abde-bf81-e053-2a95a90a2e1e	71481-013	HUMAN OTC DRUG	Bio V Antacid 1000 Tropical Fruit, 72ct		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20230308		OTC MONOGRAPH FINAL	part331	BioV Health Inc	CALCIUM CARBONATE	1000	mg/1			N	20241231
71481-014_f666bd6a-e1b0-4f0e-e053-2995a90af9fe	71481-014	HUMAN OTC DRUG	Bio V Antacid Peppermint 500, 150ct		CALCIUM CARBONATE	TABLET, CHEWABLE	ORAL	20230308		OTC MONOGRAPH FINAL	part331	BioV Health Inc	CALCIUM CARBONATE	500	mg/1			N	20241231
71489-005_065977ae-1277-8965-e063-6394a90aa4a7	71489-005	HUMAN OTC DRUG	Sani-Com	Pre-Moistened, Multi-Purpose Cleaning Towel	Benzalkonium Chloride	CLOTH	CUTANEOUS	20170721	20250919	OTC MONOGRAPH NOT FINAL	part333E	Celeste Industries Corporation	BENZALKONIUM CHLORIDE	1	mg/1			N	
71489-006_0c3fc787-0b1a-2493-e063-6394a90ae8f9	71489-006	HUMAN OTC DRUG	Sani Luxe Foaming Hand Sanitizer Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	CUTANEOUS	20190128		OTC MONOGRAPH DRUG	505G(a)(3)	Celeste Industries Corporation	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
71489-007_0c416b47-9c14-d2c5-e063-6394a90aaeae	71489-007	HUMAN OTC DRUG	Sani Luxe Hand Sanitizer with Alcohol		ALCOHOL	GEL	CUTANEOUS	20190124		OTC MONOGRAPH DRUG	505G(a)(3)	Celeste Industries Corporation	ALCOHOL	.625	mL/mL			N	20241231
71489-008_0c416f8c-7ba1-d27a-e063-6394a90ae0d7	71489-008	HUMAN OTC DRUG	SaniLuxe Hand Sanitizer Alcohol Free		BENZALKONIUM CHLORIDE	GEL	CUTANEOUS	20190219		OTC MONOGRAPH DRUG	505G(a)(3)	Celeste Industries Corporation	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
71489-009_0c416f8c-7ba8-d27a-e063-6394a90ae0d7	71489-009	HUMAN OTC DRUG	Sani Luxe		ALCOHOL	CLOTH	CUTANEOUS	20210205		OTC MONOGRAPH DRUG	505G(a)(3)	Celeste Industries Corporation	ALCOHOL	.7	mL/mL			N	20241231
71490-001_d363564b-7e52-443d-9bdd-2df1426bd4c5	71490-001	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Lemon		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-002_50e50848-5e05-461d-af2d-b109fee425f1	71490-002	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Kiwi		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-003_2f83a52d-95ca-4d25-86aa-4cf289c64349	71490-003	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Red Fruits		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-005_317f8d26-9cf8-470b-938a-a899117e961c	71490-005	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Marine		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-008_9b538f1c-5b34-4ad6-b75e-52f63f90c161	71490-008	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Green Tea and Cucumber		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-010_de7d095d-adef-489b-ac0c-0abaa5791532	71490-010	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Blue Flowers		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-011_7bc4e11e-659c-442d-a3b6-ed08d65b8608	71490-011	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Passion Flower		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-013_b8a04afa-2d4e-4eb9-be23-d22966686270	71490-013	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Wild Berry		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-015_646c6f42-68c9-4fe8-ba4e-dff90e06867c	71490-015	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Lemon With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-016_6bc3f62d-3bf4-4bbe-8134-0a83e8ab1bfb	71490-016	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Kiwi With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-017_b58e9aa7-3289-4bfa-8883-1ff84e5c2f51	71490-017	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Red Fruits With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-019_32fe4482-4c7c-486f-834c-9da069edebb6	71490-019	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Marine With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-022_465239bf-646c-410e-8316-76e94d9905ef	71490-022	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Green Tea and Cucumber With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-024_3bef23b8-e394-4678-a2ac-fd127594236f	71490-024	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Blue Flowers With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-025_06432f9d-495c-406b-b78f-3681e5a59755	71490-025	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Passion Flower With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-027_e3b092b2-3e1a-49c6-9246-650c959008da	71490-027	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel With Vitamin Beads Wild Berry With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-030_75cfcd86-3d2c-48b7-b94c-ee4dd892a7cc	71490-030	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel with Vitamin Beads Gold With Silicon Holder		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-040_2a7fc943-d6bf-48fc-b83b-74784dda6b15	71490-040	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel FRESH MARACUJA FRAGRANCE		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-041_52e57664-6c32-4c33-a94c-cf45e6b159b5	71490-041	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel FRESH LEMON FRAGRANCE		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-042_06c01aab-459a-4a6f-8a18-46fc188ae3e8	71490-042	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer Gel Fragrance Free		Ethyl alcohol	GEL	TOPICAL	20170918		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71490-059_05db4cd4-ae9d-4a73-a7db-16b3815838cd	71490-059	HUMAN OTC DRUG	HiGeen Antiseptic Hand Sanitizer BLUE FLOWERS		Ethyl alcohol	GEL	TOPICAL	20211210		OTC MONOGRAPH NOT FINAL	part333A	SUKHTIAN-HTM ( HOUSEHOLDS & TOILETRIES MFG.CO)	ALCOHOL	70	mL/100mL			N	20241231
71491-100_0b6dc9f9-4456-e765-e063-6394a90ac6c8	71491-100	HUMAN OTC DRUG	Viabecline		TETRACYCLINE HYDROCHLORIDE	OINTMENT	TOPICAL	20170614		OTC MONOGRAPH DRUG	M004	Accuria, LLC	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
71494-001_0e1083f8-e1c1-6aa0-e063-6294a90af62e	71494-001	HUMAN OTC DRUG	Peace Out Acne		Salicylic Acid	PATCH	TOPICAL	20221011		OTC MONOGRAPH DRUG	M006	Peace Out LLC.	SALICYLIC ACID	.359	mg/1			N	20251231
71494-002_ec19ca6d-9b6e-14c0-e053-2995a90a8e16	71494-002	HUMAN OTC DRUG	Peace Out Acne Day Dot		Salicylic Acid	PATCH	TOPICAL	20221011		OTC MONOGRAPH FINAL	M006	Peace Out Inc.	SALICYLIC ACID	.1575	mg/1			N	20241231
71494-003_0e1052be-4883-43be-e063-6294a90af752	71494-003	HUMAN OTC DRUG	Peace Out Acne Day and Night Duo		Salicylic Acid	KIT	TOPICAL	20221010		OTC MONOGRAPH DRUG	M006	Peace Out LLC.						N	20251231
71494-004_0e1068bb-e2d8-4820-e063-6294a90a9161	71494-004	HUMAN OTC DRUG	Peace Out Acne Day and Night Duo		Salicylic Acid	KIT	TOPICAL	20221010		OTC MONOGRAPH DRUG	M006	Peace Out LLC.						N	20251231
71494-005_ece22db9-fb83-17a7-e053-2995a90a2758	71494-005	HUMAN OTC DRUG	Peace Out Acne Hero Routine		Salicylic Acid	KIT	TOPICAL	20221010		OTC MONOGRAPH FINAL	M006	Peace Out Inc.						N	20241231
71494-006_0e1083f8-e1c0-6aa0-e063-6294a90af62e	71494-006	HUMAN OTC DRUG	Peace Out Acne		Salicylic Acid	PATCH	TOPICAL	20221212		OTC MONOGRAPH DRUG	M006	Peace Out LLC.	SALICYLIC ACID	.359	mg/1			N	20251231
71494-007_0e1066a3-f09e-b1ad-e063-6394a90a4c4b	71494-007	HUMAN OTC DRUG	Peace Out Early Stage Acne Dot		Salicylic Acid	PATCH	TOPICAL	20240109		OTC MONOGRAPH DRUG	M006	Peace Out LLC.	SALICYLIC ACID	.14	mg/1			N	20251231
71494-101_f1ef59c1-1a01-fac9-e053-2995a90a4701	71494-101	HUMAN OTC DRUG	Peace Out Acne		Salicylic Acid	PATCH	TOPICAL	20190603		OTC MONOGRAPH FINAL	part333D	Peace Out Inc.	SALICYLIC ACID	.5	mg/1			N	20241231
71494-102_0e107541-6b49-601a-e063-6294a90a8a0c	71494-102	HUMAN OTC DRUG	Peace Out Acne Serum		Salicylic Acid	LOTION	TOPICAL	20200506		OTC MONOGRAPH DRUG	M006	Peace Out LLC.	SALICYLIC ACID	20	mg/mL			N	20251231
71499-045_09d0fb5b-60d0-bd7b-e063-6394a90a3be5	71499-045	HUMAN OTC DRUG	OLE HENRIKSEN BANANA BRIGHT MINERAL SUNSCREEN	SPF 30	ZINC OXIDE	LOTION	TOPICAL	20230322		OTC MONOGRAPH DRUG	M020	KENDO HOLDINGS INC	ZINC OXIDE	16.32	g/100mL			N	20251231
71499-103_09d0ea9f-ce98-f80e-e063-6294a90a5008	71499-103	HUMAN OTC DRUG	FENTY SKIN HYDRA VIZOR BROAD SPECTRUM MINERAL SPF 15 SUNSCREEN HAND		ZINC OXIDE	CREAM	TOPICAL	20230412		OTC MONOGRAPH DRUG	M020	KENDO HOLDINGS INC	ZINC OXIDE	11	g/100mL			N	20251231
71499-135_09d0fb5b-60c4-bd7b-e063-6394a90a3be5	71499-135	HUMAN OTC DRUG	FENTY SKIN HYDRA VIZOR BROAD SPECTRUM MINERAL SPF 30 SUNSCREEN MOISTURIZER		ZINC OXIDE	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	KENDO HOLDINGS INC	ZINC OXIDE	15.5	g/100mL			N	20251231
71499-220_09d12237-9b5f-f8e4-e063-6294a90ae278	71499-220	HUMAN OTC DRUG	FENTY SKIN HYDRA VIZOR	SPF 30	AVOBENZONE, HOMOSALATE, OCTISALATE	LOTION	TOPICAL	20200823		OTC MONOGRAPH DRUG	M020	KENDO HOLDINGS INC	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 9; 4.5	g/100mL; g/100mL; g/100mL			N	20251231
71501-1901_0c86a86e-1d39-8fa8-e063-6294a90a5963	71501-1901	HUMAN OTC DRUG	Micro Exfoliating Cleanser		Salicylic Acid Soap	LIQUID	TOPICAL	20190101		OTC MONOGRAPH DRUG	M006	Dr. Loretta, LLC	SALICYLIC ACID	20	mg/mL			N	20241231
71501-1902_0c868857-d5b1-9413-e063-6294a90a0bab	71501-1902	HUMAN OTC DRUG	Urban Antioxidant Sunscreen SPF 40		Homosalate, Octisalate, Octocrylene, Zinc Oxyide cream	CREAM	TOPICAL	20190916		OTC MONOGRAPH DRUG	M020	Dr. Loretta, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	80; 50; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71501-1903_fae21e0a-5e42-bffb-e053-6294a90afb9d	71501-1903	HUMAN OTC DRUG	Universal Glow Daily Defense SPF 40		Zinc Oxide	CREAM	TOPICAL	20230501		OTC MONOGRAPH FINAL	M020	Dr. Loretta, LLC	SALICYLIC ACID	170	mg/mL			N	20241231
71511-301_0d07f524-71ba-f90f-e063-6394a90a813d	71511-301	HUMAN PRESCRIPTION DRUG	QDOLO		tramadol hydrochloride	SOLUTION	ORAL	20200911		NDA	NDA214044	Athena Bioscience, LLC	TRAMADOL HYDROCHLORIDE	5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71511-503_dad34ef3-06d2-6355-e053-2995a90aee5f	71511-503	HUMAN PRESCRIPTION DRUG	Nexiclon XR		Clonidine	TABLET, EXTENDED RELEASE	ORAL	20220301		NDA	NDA022500	Athena Bioscience, LLC	CLONIDINE	.17	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71511-701_8ae1c41c-a532-4878-bc44-814b2061fdd3	71511-701	HUMAN PRESCRIPTION DRUG	Naprosyn		Naproxen	SUSPENSION	ORAL	20180101		NDA	NDA018965	Athena Bioscience, LLC	NAPROXEN	125	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71513-105_0b3c8d55-7b68-10e1-e063-6394a90a7186	71513-105	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20210101		OTC MONOGRAPH DRUG	505G(a)(3)	Broder Bros Co.	ALCOHOL	62	mL/100mL			N	20241231
71513-210_0899798b-a3db-0a6b-e063-6394a90a61bd	71513-210	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	Broder Bros Prime Line	ALCOHOL	.62	mL/mL			N	20241231
71513-220_089fb0b8-258f-8500-e063-6394a90aa892	71513-220	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Broder Bros Prime Line	ALCOHOL	.62	mL/mL			N	20241231
71513-302_09ae111c-9389-a8f2-e063-6294a90a1539	71513-302	HUMAN OTC DRUG	Antibacterial Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200101	20240131	OTC MONOGRAPH DRUG	505G(a)(3)	Broder Bros Prime Line	BENZALKONIUM CHLORIDE	.13	g/1			N	
71513-309_0aad8f54-bc18-0f40-e063-6294a90a1513	71513-309	HUMAN OTC DRUG	Alcohol Prep Pad		Alcohol	CLOTH	TOPICAL	20210101	20250905	OTC MONOGRAPH DRUG	505G(a)(3)	Broder Bros Prime Line	ALCOHOL	.7	mL/1			N	
71513-508_0a387641-3b88-38e0-e063-6294a90a81b3	71513-508	HUMAN OTC DRUG	Sunscreen SPF 30		avobenzone, homosalate, octisalate, octocrylene	LOTION	TOPICAL	20210121		OTC MONOGRAPH DRUG	M020	Broder Bros Prime Line	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71513-608_0a3a5fb5-8fcf-beb0-e063-6294a90a0fdf	71513-608	HUMAN OTC DRUG	Lip Balm SPF15		octocrylene, octisalate	STICK	TOPICAL	20210121		OTC MONOGRAPH DRUG	M020	Broder Bros Prime Line	OCTISALATE; OCTOCRYLENE	40; 80	mg/g; mg/g			N	20241231
71513-708_0a360f87-76d0-e6a7-e063-6294a90a07fb	71513-708	HUMAN OTC DRUG	Sunscreen SPF30		avobenzone, homosalate, octisalate, octocrylene	LOTION	TOPICAL	20210101		OTC MONOGRAPH DRUG	M020	Broder Bros Prime Line	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71516-342_09db4f55-0162-f22c-e063-6294a90ac06a	71516-342	HUMAN OTC DRUG	TOTAL RELIEF		HYDROCORTISONE	SHAMPOO	TOPICAL	20220725		OTC MONOGRAPH DRUG	M017	DR. MARDER SKINCARE, LLC	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71521-025_0ce02545-0f52-5073-e063-6394a90a3dc9	71521-025	HUMAN OTC DRUG	Eczema Relief Cream		Colloidal Oatmeal	CREAM	TOPICAL	20210331		OTC MONOGRAPH DRUG	M016	Lavior Pharma Inc	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71521-026_0ce02112-9cc9-cb71-e063-6294a90a0b1d	71521-026	HUMAN OTC DRUG	Diabetic Itch Relief Cream		Colloidal Oatmeal	CREAM	TOPICAL	20210331		OTC MONOGRAPH DRUG	M016	Lavior Pharma Inc	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71521-036_0ce00714-9011-4e8e-e063-6394a90a2833	71521-036	HUMAN OTC DRUG	Diabetic Wound Gel		Allantoin	GEL	TOPICAL	20210331		OTC MONOGRAPH DRUG	M016	Lavior Pharma Inc	ALLANTOIN	1	g/100g			N	20241231
71521-037_0cdf4c0f-e8b9-1539-e063-6294a90aea22	71521-037	HUMAN OTC DRUG	Wound Gel		Allantoin	GEL	TOPICAL	20210331		OTC MONOGRAPH DRUG	M016	Lavior Pharma Inc	ALLANTOIN	.5	g/100g			N	20241231
71521-390_0cdf59eb-fe40-c9bd-e063-6394a90a7817	71521-390	HUMAN OTC DRUG	Diabetic First Aid Gel		Benzalkonium Chloride, Lidocaine Hydrochloride	GEL	TOPICAL	20210331		OTC MONOGRAPH DRUG	M003	Lavior Pharma Inc.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71521-392_0cdfd324-c096-9f61-e063-6294a90adbc9	71521-392	HUMAN OTC DRUG	Diabetic Foot Cream		Dimethicone	CREAM	TOPICAL	20210331		OTC MONOGRAPH DRUG	M016	Lavior Pharma Inc	DIMETHICONE	1	g/100g	Skin Barrier Activity [PE]		N	20241231
71522-834_09db6872-c718-5d77-e063-6294a90af757	71522-834	HUMAN OTC DRUG	Amazonic Natural Sunscreen SPF 30 Broad Spectrum UVA/UVB		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170628		OTC MONOGRAPH DRUG	M020	Amazonic Products	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71523-833_09db6ba6-5806-44a5-e063-6294a90a072f	71523-833	HUMAN OTC DRUG	Debbies Down and Dirty Deep Tissue Joint and Muscle		MENTHOL	CREAM	TOPICAL	20170628		OTC MONOGRAPH DRUG	M017	DD&D Manufacturing Co., Ltd	MENTHOL	100	mg/mL			N	20241231
71527-3492_00367a29-3ebf-b194-e063-6394a90a82b2	71527-3492	HUMAN OTC DRUG	Trulyclear	The One-Step Acne Solution	Salicylic Acid	SOAP	TOPICAL	20170626	20260131	OTC MONOGRAPH FINAL	part333D	RK RESPONSE INC.	SALICYLIC ACID	1	g/100g			N	
71529-835_0974b923-d003-7dcc-e063-6294a90aeb1b	71529-835	HUMAN OTC DRUG	Christina Moss Naturals Natural Sunscreen SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20170629		OTC MONOGRAPH DRUG	M020	Christina Moss Naturals, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71558-590_6234782d-94c1-428b-b34b-c5d0db96d9d7	71558-590	HUMAN PRESCRIPTION DRUG	ARIKAYCE		Amikacin	SUSPENSION	RESPIRATORY (INHALATION)	20181012		NDA	NDA207356	Insmed Incorporated	AMIKACIN	590	mg/8.4mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
71564-001_0e76e634-d940-70ac-e063-6294a90a6ad3	71564-001	HUMAN OTC DRUG	OKeeffes Lip Repair		Avobenzone, Dimethicone, Octinoxate, Octocrylene	STICK	TOPICAL	20180322		OTC MONOGRAPH DRUG	M020	The Gorilla Glue Company/O'Keeffe's Company	AVOBENZONE; DIMETHICONE; OCTINOXATE; OCTOCRYLENE	2.5; 17.5; 6; 2	g/100g; g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20251231
71564-003_f1eba4bb-50a5-32c4-e053-2995a90a161e	71564-003	HUMAN OTC DRUG	OKeeffes Eczema Relief	Hand Cream	Colloidal Oatmeal	CREAM	TOPICAL	20200701		OTC MONOGRAPH FINAL	part347	The Gorilla Glue Company/O'Keeffe's Company	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71564-004_0e76cbc6-8cec-7dc8-e063-6294a90a815a	71564-004	HUMAN OTC DRUG	OKeeffes Eczema Relief	Body Cream	Colloidal Oatmeal	CREAM	TOPICAL	20200701		OTC MONOGRAPH DRUG	M016	The Gorilla Glue Company/O'Keeffe's Company	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
71564-005_f1ebb07f-7c98-414f-e053-2a95a90a083d	71564-005	HUMAN OTC DRUG	OKEEFFES LIP REPAIR	SEAL AND HEAL	Petrolatum	STICK	TOPICAL	20210801		OTC MONOGRAPH FINAL	part347	The Gorilla Glue Company/O'Keeffe's Company	PETROLATUM	30	g/100g			N	20241231
71564-006_0e77166a-8f68-eb67-e063-6394a90a1f12	71564-006	HUMAN OTC DRUG	OKeeffes Healthy Feet		Allantoin, Lidocaine	CREAM	TOPICAL	20220301		OTC MONOGRAPH DRUG	M017	The Gorilla Glue Company/O'Keeffe's Company	ALLANTOIN; LIDOCAINE HYDROCHLORIDE	.5; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
71564-007_0e7705bd-15ff-d906-e063-6394a90a2ee4	71564-007	HUMAN OTC DRUG	OKeeffes Working Hands Eczema Relief	Cream	Colloidal Oatmeal	CREAM	TOPICAL	20220221		OTC MONOGRAPH DRUG	M016	The Gorilla Glue Company/O'Keeffe's Company	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20251231
71564-008_0e7707c5-ca6d-e9fe-e063-6394a90a36e0	71564-008	HUMAN OTC DRUG	Working Hands		Alcohol	LOTION	TOPICAL	20221003		OTC MONOGRAPH DRUG	505G(a)(3)	The Gorilla Glue Company/OKeeffes Company	ALCOHOL	68	mL/100mL			N	20251231
71564-009_0c832380-8c84-e58d-e063-6394a90a46e4	71564-009	HUMAN OTC DRUG	OKeeffes Working Hands Pain Relief	Skin Protectant	allantoin, lidocaine hydrochloride	CREAM	TOPICAL	20231007		OTC MONOGRAPH DRUG	M017	The Gorilla Glue Company/O'Keeffe's Company	ALLANTOIN; LIDOCAINE HYDROCHLORIDE	.5; 4	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71565-040_41a36414-2553-47c7-8a9a-2bed93592e1e	71565-040	HUMAN PRESCRIPTION DRUG	Xipere		triamcinolone acetonide	INJECTION, SUSPENSION	OPHTHALMIC	20211112		NDA	NDA211950	Clearside Biomedical, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71566-100_ea334abe-d8c3-47c5-a09b-3e382f2911dd	71566-100	HUMAN OTC DRUG	Happy Cappy		pyrithione zinc	SHAMPOO	TOPICAL	20171207		OTC MONOGRAPH FINAL	part358H	Pediatric Solutions, LLC	PYRITHIONE ZINC	.0095	g/mL			N	20241231
71569-370_3e26cfcc-8cf7-4b64-814b-72c01f218d1e	71569-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20170711		OTC MONOGRAPH NOT FINAL	part333A	Jubilant, LLC	ALCOHOL	70	mL/100mL			N	20241231
71569-602_e35eb57a-9cc2-460b-9b62-15221b29b864	71569-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20171001		OTC MONOGRAPH NOT FINAL	part334	Jubilant, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71569-664_be3f0860-9b42-4100-8b44-33f46df709ff	71569-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20170403		OTC MONOGRAPH NOT FINAL	part356	Jubilant, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71570-001_8d4b4a14-b632-f2fa-e053-2a95a90a932f	71570-001	HUMAN OTC DRUG	Atopis Eczema Therapy Cream		Colloidal Oatmeal	CREAM	TOPICAL	20190715		OTC MONOGRAPH FINAL	part347	Bionona Limited	OATMEAL	.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71571-121_9f0b6172-d123-4261-a298-f0ec55ab0bf8	71571-121	HUMAN PRESCRIPTION DRUG	Inveltys		loteprednol etabonate	SUSPENSION	TOPICAL	20180822		NDA	NDA210565	ALCON LABORATORIES, INC.	LOTEPREDNOL ETABONATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71571-333_02112af6-eb6e-4ec7-8cd5-cc65dd583390	71571-333	HUMAN PRESCRIPTION DRUG	Eysuvis		loteprednol etabonate	SUSPENSION/ DROPS	OPHTHALMIC	20201118		NDA	NDA210933	ALCON LABORATORIES, INC.	LOTEPREDNOL ETABONATE	2.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71573-102_cdff94ae-4a19-40d1-9e9f-8caa42577394	71573-102	HUMAN OTC DRUG	Prosoria Psoriasis Treatment		Salicylic Acid	GEL	TOPICAL	20171122		OTC MONOGRAPH DRUG	M032	Nuvothera, Inc.	SALICYLIC ACID	1.77	g/59mL			N	20251231
71573-116_b35202c5-6f8b-4013-b720-becfc5fe97db	71573-116	HUMAN OTC DRUG	Prosoria Scalp		Salicylic Acid	LOTION/SHAMPOO	TOPICAL	20220401		OTC MONOGRAPH DRUG	M032	Nuvothera, Inc.	SALICYLIC ACID	1.33	g/74mL			N	20251231
71573-121_6fec05aa-5d44-4667-98f7-c61ac09c6307	71573-121	HUMAN OTC DRUG	Prosoria Medicated		Selenium Sulfide	LOTION/SHAMPOO	TOPICAL	20220401		OTC MONOGRAPH DRUG	M032	Nuvothera, Inc.	SELENIUM SULFIDE	1.77	g/177mL			N	20251231
71574-300_09db59ea-79d1-56ef-e063-6294a90a0c4b	71574-300	HUMAN OTC DRUG	Lidozen		LIDOCAINE HYDROCHLORIDE, MENTHOL	GEL	TOPICAL	20170722		OTC MONOGRAPH DRUG	M017	Village Pharma, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71574-305_0b58273d-93d6-5483-e063-6394a90ad572	71574-305	HUMAN OTC DRUG	Lidozen Gel		LIDOCAINE HYDROCHLORIDE, MENTHOL	GEL	TOPICAL	20220901		OTC MONOGRAPH DRUG	M017	Village Pharma LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71574-500_0b5819ed-d969-869c-e063-6294a90a1e21	71574-500	HUMAN OTC DRUG	Scarzen		DIMETHICONE	LOTION	TOPICAL	20180801		OTC MONOGRAPH DRUG	M016	Village Pharma LLC	DIMETHICONE	50	mg/mL	Skin Barrier Activity [PE]		N	20241231
71574-501_49677e46-cc6f-4f7b-bbe5-c6309aa07ab9	71574-501	HUMAN PRESCRIPTION DRUG	Scarzen		Triamcinolone Acetonide, Dimethicone	KIT		20160511		ANDA	ANDA088042	Village Pharma LLC						N	20241231
71574-600_0b581fa6-e3a9-4dc9-e063-6394a90a9e12	71574-600	HUMAN OTC DRUG	Menthozen		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20181001		OTC MONOGRAPH DRUG	M017	Village Pharma LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.375; 50; 200	mg/mL; mg/mL; mg/mL			N	20241231
71574-601_0b8196c9-4d7e-996e-e063-6294a90a62a0	71574-601	HUMAN OTC DRUG	Menthozen Hydrogel		MENTHOL, CAPSAICIN	PATCH	TOPICAL	20190701		OTC MONOGRAPH DRUG	M017	Village Pharma LLC	CAPSAICIN; MENTHOL	.3; 40	mg/g; mg/g			N	20241231
71574-605_0b582912-eb85-969a-e063-6294a90ab859	71574-605	HUMAN OTC DRUG	Menthozen Cream		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20220901		OTC MONOGRAPH DRUG	M017	Village Pharma LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.375; 50; 200	mg/mL; mg/mL; mg/mL			N	20241231
71574-700_5a0b0f9e-5149-4ac1-b0c6-df7bd1fb1829	71574-700	HUMAN OTC DRUG	DOCUZEN		Sennosides 8.6mg and Docusate Sodium 50mg	TABLET	ORAL	20181127		OTC MONOGRAPH DRUG	M007	Village Pharma	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
71574-711_0b582333-81a1-8a4b-e063-6294a90af19b	71574-711	HUMAN OTC DRUG	Sanizen		ALCOHOL	GEL	TOPICAL	20200413		OTC MONOGRAPH DRUG	505G(a)(3)	Village Pharma, LLC	ALCOHOL	.75	mL/mL			N	20241231
71574-800_0b5824f5-903e-560a-e063-6394a90af9f2	71574-800	HUMAN OTC DRUG	Lidozen		LIDOCAINE HYDROCHLORIDE, MENTHOL	PATCH	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	Village Pharma LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71574-900_0b581dc2-c9a7-4792-e063-6394a90a7db3	71574-900	HUMAN OTC DRUG	Lidozen		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20190916		OTC MONOGRAPH DRUG	M017	Village Pharma, LLC	LIDOCAINE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71574-905_0b582aca-c4d6-93af-e063-6294a90ac526	71574-905	HUMAN OTC DRUG	Lidozen Patch		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20220901		OTC MONOGRAPH DRUG	M017	Village Pharma LLC	LIDOCAINE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71582-001_54a51b82-86b9-4060-b187-5b537a5fcd24	71582-001	HUMAN OTC DRUG	Anti Fungal		Coltrimazole	LIQUID	TOPICAL	20170922		OTC MONOGRAPH DRUG	M005	Guangzhou Ertiantang Pharmaceutical Co.,Ltd	CLOTRIMAZOLE	1	g/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
71584-0101_0d9b708d-702f-1072-e063-6394a90a7f2c	71584-0101	HUMAN OTC DRUG	Alcohol Prep Pad		isopropyl alcohol	SWAB	TOPICAL	20170717		OTC MONOGRAPH DRUG	M003	Guangdong Comfort Medical Products Co., Ltd.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
71584-0107_0c7231d1-4cc2-cde8-e063-6294a90a2b6f	71584-0107	HUMAN OTC DRUG	EYE WASH		EYE WASH	LIQUID	OPHTHALMIC	20170717		OTC MONOGRAPH DRUG	M018	Guangdong Comfort Medical Products Co., Ltd.	WATER	99.1	mL/100mL			N	20241231
71584-0108_f5dd8fa8-0b68-5a30-e053-2995a90ad194	71584-0108	HUMAN OTC DRUG	ANTIBACTERIAL BANDAGES		Benzalkonium Chloride	DRESSING	TOPICAL	20180610		OTC MONOGRAPH NOT FINAL	part333A	Guangdong Comfort Medical Products Co., Ltd.	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
71585-136_08c19c7c-b475-761c-e063-6294a90a0279	71585-136	HUMAN OTC DRUG	Salt and Stone Natural Mineral Sunscreen SPF 30		ZINC OXIDE	LOTION	TOPICAL	20190801		OTC MONOGRAPH DRUG	M020	Salt and Stone LLC	ZINC OXIDE	196	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71585-138_08c19c7c-b466-761c-e063-6294a90a0279	71585-138	HUMAN OTC DRUG	Salt and Stone Tinted Sunscreen SPF 50		ZINC OXIDE	STICK	TOPICAL	20201101		OTC MONOGRAPH DRUG	M020	Salt and Stone LLC	ZINC OXIDE	.2405	g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71585-139_08c19faa-7034-6875-e063-6394a90ae041	71585-139	HUMAN OTC DRUG	Salt and Stone Sunscreen Lip Balm SPF 30		ZINC OXIDE	STICK	TOPICAL	20201123		OTC MONOGRAPH DRUG	M020	Salt and Stone LLC	ZINC OXIDE	.08	g/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71585-141_08c1a8af-2e10-682c-e063-6394a90a8892	71585-141	HUMAN OTC DRUG	Salt and Stone SPF 30 Sunscreen stick		ZINC OXIDE	STICK	TOPICAL	20210922		OTC MONOGRAPH DRUG	M020	Salt and Stone	ZINC OXIDE	225	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71585-143_08c1ad00-de03-625d-e063-6394a90a9357	71585-143	HUMAN OTC DRUG	Salt and Stone Outdoor Voices SPF 50		ZINC OXIDE	STICK	TOPICAL	20230401		OTC MONOGRAPH DRUG	M020	Salt & Stone, Inc.	ZINC OXIDE	240	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71585-144_08c196b2-7262-778c-e063-6294a90a2bd3	71585-144	HUMAN OTC DRUG	Salt and Stone Lightweight Sheer Mineral Sunscreen SPF30		ZINC OXIDE	LOTION	TOPICAL	20230901		OTC MONOGRAPH DRUG	M020	SALT & STONE, INC.	ZINC OXIDE	157	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71592-001_6148c5e0-d631-4d8d-8972-123bedffff66	71592-001	HUMAN OTC DRUG	Antiperspirant Wipe for Women		Aluminum Chlorohydrate	SWAB	TOPICAL	20170718		OTC MONOGRAPH FINAL	part350	FlawlessWipes, LLC	ALUMINUM CHLOROHYDRATE	15	g/100g			N	20241231
71593-101_f1dd2cd5-417b-06c5-e053-2995a90aed79	71593-101	HUMAN OTC DRUG	NIGHTLY FACE TREATMENT - DIMETHICONE		DIMETHICONE	CREAM	TOPICAL	20171206		OTC MONOGRAPH FINAL	part347	ARG LABORATORIES INC	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	20241231
71594-707_faf85f55-9828-79d0-e053-6394a90abc6c	71594-707	HUMAN OTC DRUG	Firstcare Maximum Strength Gas Relief Simethicone 250 mg Anti-gas		Simethicone	TABLET, CHEWABLE	ORAL	20230704		OTC MONOGRAPH FINAL	part332	USpharma Ltd	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
71594-708_faf8b8e9-df2a-87a8-e053-6294a90aca98	71594-708	HUMAN OTC DRUG	FIRSTCARE ALLERGY RELIEF Diphenhydramine HCI, 25 mg Antihistamine		Diphenhydramine HCl	BAR, CHEWABLE	ORAL	20230414		OTC MONOGRAPH FINAL	part341	USpharma Ltd	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71598-015_f2122b79-79a7-45e0-e053-2995a90a3d7c	71598-015	HUMAN OTC DRUG	RoboTablets		Dextromethorphan	TABLET	ORAL	20201015		OTC MONOGRAPH FINAL	part341	DXM Pharmaceutical, Inc	DEXTROMETHORPHAN	30	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71598-100_087ad7ed-ee9c-1136-e063-6294a90ae2d3	71598-100	HUMAN OTC DRUG	RoboHBr Cough SUPPRESSANT		Dextromethorphan Hbr	TABLET	ORAL	20220531		OTC MONOGRAPH DRUG	M012	DXM Pharmaceutical, Inc	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71598-120_0cf37e8d-75f6-6dfb-e063-6294a90a8280	71598-120	HUMAN OTC DRUG	InstaRelief Nighttime Sleep Aid		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20231001		OTC MONOGRAPH DRUG	M010	DXM Pharmacuetical, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/3mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71598-200_0d9409e4-3da7-37d3-e063-6294a90aa775	71598-200	HUMAN OTC DRUG	BupropiDex		DEXTROMETHORPHAN HYDROBROMIDE	TABLET	ORAL	20231201		OTC MONOGRAPH DRUG	M013	DXM Pharmacuetical, Inc.	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
71610-001_888edaa1-a8bd-43da-aa09-6eb5ee7fe515	71610-001	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20170302		ANDA	ANDA065211	Aphena Pharma Solutions - Tennessee, LLC	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
71610-003_bad6eef3-5e26-4e69-8fb1-456528082648	71610-003	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20150501		ANDA	ANDA202038	Aphena Pharma Solutions - Tennessee, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-004_a14e308f-61dd-47d4-bb0f-c69f9704c46b	71610-004	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		temazepam	CAPSULE	ORAL	20100223		NDA	NDA018163	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-005_200bc2b8-3ce5-4382-b613-0785aca729e1	71610-005	HUMAN PRESCRIPTION DRUG	Primidone		primidone	TABLET	ORAL	20050224		ANDA	ANDA040586	Aphena Pharma Solutions - Tennessee, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-006_069eec8b-6cca-435c-9d3f-fbdc75a813a0	71610-006	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, FILM COATED	ORAL	20170824		ANDA	ANDA075977	Aphena Pharma Solutions - Tennessee, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71610-008_ad63049b-9fb2-4b02-8ef4-d3b9aa3fe54b	71610-008	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-009_c3a76330-eefb-4b9d-acbf-571bb6833dff	71610-009	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20170309		ANDA	ANDA076958	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-011_f384e3d8-d9fd-481c-b924-4bf98dfb5bdf	71610-011	HUMAN PRESCRIPTION DRUG	memantine hydrochloride		memantine hydrochloride	TABLET	ORAL	20150401		NDA	NDA021487	Aphena Pharma Solutions - Tennessee, LLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
71610-012_93ad27e7-a3ac-48d3-9dbe-1547c953bcf2	71610-012	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20001204		ANDA	ANDA075269	Aphena Pharma Solutions - Tennessee, LLC	NIFEDIPINE	60	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-013_f112c189-5a07-46a6-b27a-34f5f6da9a47	71610-013	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20110602		NDA AUTHORIZED GENERIC	NDA020699	Aphena Pharma Solutions - Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-014_2c278b34-9004-4bae-a43d-ee454d87b9ba	71610-014	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20170608		ANDA	ANDA083177	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-015_2c278b34-9004-4bae-a43d-ee454d87b9ba	71610-015	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20170608		ANDA	ANDA083177	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-016_a35560e7-0593-4c49-87b1-8971ff6df820	71610-016	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20140731		ANDA	ANDA078048	Aphena Pharma Solutions - Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-017_8527dc6d-ebec-4ba3-91be-59553b69aef6	71610-017	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20170925		NDA AUTHORIZED GENERIC	NDA018333	Aphena Pharma Solutions - Tennessee, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
71610-018_f112c189-5a07-46a6-b27a-34f5f6da9a47	71610-018	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20110602		NDA AUTHORIZED GENERIC	NDA020699	Aphena Pharma Solutions - Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-019_1d7755ac-5480-4614-bc20-beb024ab95f2	71610-019	HUMAN PRESCRIPTION DRUG	LANOXIN		digoxin	TABLET	ORAL	20120930		NDA	NDA020405	Aphena Pharma Solutions - Tennessee, LLC	DIGOXIN	.125	mg/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
71610-020_8b03af98-aba5-409a-9ff9-102f342bbe4a	71610-020	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20091202		ANDA	ANDA078596	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-021_6d839289-f4c6-44d7-a6f5-a4c178766fb2	71610-021	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20160212		ANDA	ANDA089286	Aphena Pharma Solutions - Tennessee, LLC	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71610-022_eb3a5903-a3fa-4071-8e0b-38edfb013464	71610-022	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-023_1c669581-c1d7-40b6-9f07-ddc8d5fcda01	71610-023	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20131018		ANDA	ANDA074869	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-026_f5d86ed6-c804-4fe8-ac6d-adb40336aab3	71610-026	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA202096	Aphena Pharma Solutions - Tennessee, LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71610-027_84b62471-43ba-4761-92cf-17865209c8e2	71610-027	HUMAN PRESCRIPTION DRUG	fenofibrate		fenofibrate	TABLET	ORAL	20140813		ANDA	ANDA090715	Aphena Pharma Solutions - Tennessee, LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
71610-029_c6545c41-a482-4936-be1b-5ad77ee1f1b4	71610-029	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20160212		ANDA	ANDA089286	Aphena Pharma Solutions - Tennessee, LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71610-030_fd96336e-88f7-4dbe-95c3-6af522e39ff8	71610-030	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090129		ANDA	ANDA077567	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-031_0f33ee94-fff3-4ae7-92fc-16f72a983d21	71610-031	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-032_a117c85f-4dfb-46da-99aa-4c4146e78865	71610-032	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20140321		ANDA	ANDA078182	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-033_eda1b520-f0be-457f-9019-a26e715b8896	71610-033	HUMAN PRESCRIPTION DRUG	Mycophenolate Mofetil		mycophenolate mofetil	TABLET, FILM COATED	ORAL	20150106		ANDA	ANDA065521	Aphena Pharma Solutions - Tennessee, LLC	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
71610-034_d18746db-ee0c-4e00-b4b1-dfd10e32d1b3	71610-034	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET	ORAL	20150501		OTC MONOGRAPH FINAL	part343	Aphena Pharma Solutions - Tennessee, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71610-035_f94f454a-2f40-4d6b-8936-57fad107a20b	71610-035	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA	NDA019962	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-036_b294ecc8-3293-48a9-b79f-58ed5969ff43	71610-036	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-037_64560280-1d4e-47ff-a839-3a3bef49e760	71610-037	HUMAN PRESCRIPTION DRUG	Cilostazol		Cilostazol	TABLET	ORAL	20041123		ANDA	ANDA077021	Aphena Pharma Solutions - Tennessee, LLC	CILOSTAZOL	100	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
71610-038_c3184015-df82-4ed5-b174-4e858241622c	71610-038	HUMAN PRESCRIPTION DRUG	TOPROL	XL	Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA	NDA019962	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-039_c2894292-e974-45e8-9955-efadeb645076	71610-039	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-040_23c2dcf4-e2c6-42c9-a016-f507b733a52e	71610-040	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-043_98f8771c-b6c1-4fbe-845f-876cc3cbfe75	71610-043	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150409		ANDA	ANDA075580	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-044_a695e055-6531-4b51-969f-62165d703511	71610-044	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-045_8d3a5be3-6151-4452-ae53-a9f1f69d1979	71610-045	HUMAN PRESCRIPTION DRUG	Risperidone		risperidone	TABLET	ORAL	19931229		NDA	NDA020272	Aphena Pharma Solutions - Tennessee, LLC	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-046_4c4ff07e-b724-4fe0-8d7b-aecd403e429a	71610-046	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20180205		ANDA	ANDA072575	Aphena Pharma Solutions - Tennessee, LLC	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-048_c6a3a867-12d7-4fcb-8261-d53c9189a9fe	71610-048	HUMAN OTC DRUG	CETIRIZINE HYDROCHLORIDE		CETIRIZINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20160622		ANDA	ANDA078317	Aphena Pharma Solutions - Tennessee, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71610-049_780ad204-2238-4c8b-b477-7c93a6b53781	71610-049	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71610-050_79661dad-20cb-47b6-a8b8-7f946189f9b6	71610-050	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-053_29e0719a-c1c4-429b-8544-f1efe06c33fd	71610-053	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, FILM COATED	ORAL	20161012		ANDA	ANDA206384	Aphena Pharma Solutions - Tennessee, LLC	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71610-054_de9c808c-32de-497e-95ce-3c93fa4f3cf1	71610-054	HUMAN OTC DRUG	SENNA		SENNA	TABLET, COATED	ORAL	20150609		OTC MONOGRAPH NOT FINAL	part334	Aphena Pharma Solutions - Tennessee, LLC	SENNOSIDES A AND B	8.6	mg/1			N	20241231
71610-055_9ac260ce-89b0-4218-9215-5e3ba9cba03f	71610-055	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20020816		ANDA	ANDA076070	Aphena Pharma Solutions - Tennessee, LLC	NIFEDIPINE	90	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-056_dc77c275-c420-46bc-863a-cfe7ef2881be	71610-056	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20091203		ANDA	ANDA078406	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-057_4a78f4a9-8b65-456c-9ecb-ebb069e8c00c	71610-057	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170511		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-058_81c8d20a-3679-423a-8916-a1e5dcde0fbf	71610-058	HUMAN OTC DRUG	SENEXON		SENNA	TABLET, COATED	ORAL	20060209		OTC MONOGRAPH NOT FINAL	part334	Aphena Pharma Solutions - Tennessee, LLC	SENNOSIDES A AND B	8.6	mg/1			N	20241231
71610-059_5d754fbf-428a-4871-963b-328fce55e292	71610-059	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-060_6829c3f6-1235-4183-a0e0-3a40042c01e1	71610-060	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20170511		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-061_e3a4b955-4bd0-4353-a436-398f85686242	71610-061	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960918		ANDA	ANDA074569	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-062_dc72ac05-4435-4c84-ab22-2514e65b9fde	71610-062	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20180201		ANDA	ANDA078384	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71610-063_dc72ac05-4435-4c84-ab22-2514e65b9fde	71610-063	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20180201		ANDA	ANDA078384	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71610-064_d16fc908-6343-4c57-a8ab-a8c8c0fed249	71610-064	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091001		ANDA	ANDA071587	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-065_0fd17d3c-5eba-43af-9c72-e97d8dd6623b	71610-065	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20170309		ANDA	ANDA076958	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-066_dc72ac05-4435-4c84-ab22-2514e65b9fde	71610-066	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20180201		ANDA	ANDA078384	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71610-067_dc72ac05-4435-4c84-ab22-2514e65b9fde	71610-067	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20180201		ANDA	ANDA078384	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71610-068_dc9b6499-7a34-4757-86b2-0880f3288048	71610-068	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20150727		ANDA	ANDA074514	Aphena Pharma Solutions - Tennessee, LLC	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-069_cef6341b-bae4-4e08-a609-1afef9307f2e	71610-069	HUMAN PRESCRIPTION DRUG	gabapentin		gabapentin	TABLET, FILM COATED	ORAL	20060824		ANDA	ANDA077525	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-070_c95ab4c6-4665-4554-91fe-98aec928f628	71610-070	HUMAN OTC DRUG	fexofenadine hcl		fexofenadine hcl	TABLET, FILM COATED	ORAL	20180101		ANDA	ANDA204507	Aphena Pharma Solutions - Tennessee, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71610-071_6939056b-1058-44bb-86a0-80bc2e620e81	71610-071	HUMAN PRESCRIPTION DRUG	Lyrica		PREGABALIN	CAPSULE	ORAL	20041230		NDA	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	25	mg/1		CV	N	20241231
71610-072_0ee08c47-adac-4fcb-8824-a7f6fd86cafb	71610-072	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140423		ANDA	ANDA075350	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-074_0e87b445-6112-4dfa-9961-95beb8f7eb82	71610-074	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030909		ANDA	ANDA076214	Aphena Pharma Solutions - Tennessee, LLC	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
71610-078_e0971976-733b-496e-8d1a-93bb656ba57a	71610-078	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-079_2d04438d-30db-4621-aa15-03b25aa283ff	71610-079	HUMAN PRESCRIPTION DRUG	Primidone		primidone	TABLET	ORAL	20180328		ANDA	ANDA040586	Aphena Pharma Solutions - Tennessee, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-080_33dbd974-7f66-410a-a9bc-dc65960a8ecd	71610-080	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-081_56c4b5b6-b49e-4bcf-a25d-ec55fbac531d	71610-081	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Aphena Pharma Solutions - Tennessee, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71610-082_0e463dd4-eab8-4a66-ae70-4832d2394a8c	71610-082	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-083_231334fb-3368-46d4-80a2-737fda561a05	71610-083	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-084_1ab41077-99c0-4270-9a8b-c35e12827342	71610-084	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960910		ANDA	ANDA074569	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-086_c140ca74-1fc8-4a31-a6d1-8b5a346f1ab7	71610-086	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-088_0515dc32-e7fc-4208-9677-ec9dfad018f1	71610-088	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-089_811203d1-e81c-4580-bded-d1fbc0445748	71610-089	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071456	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-090_e8823da8-3545-4630-a3cc-b9dd9aa548d1	71610-090	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20160930		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-092_d05f4e71-95f3-4f22-8b01-b21e5c19e0f2	71610-092	HUMAN PRESCRIPTION DRUG	CITALOPRAM HYDROBROMIDE		CITALOPRAM	TABLET	ORAL	20171110		ANDA	ANDA077534	Aphena Pharma Solutions - Tennessee, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-093_1908d1ea-282d-406d-9875-d5199176b244	71610-093	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20071227		ANDA	ANDA078317	Aphena Pharma Solutions - Tennessee, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71610-095_cd7fa91d-c679-4050-a1b7-3e68b7c49658	71610-095	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20180412		ANDA	ANDA040156	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71610-096_a8dbaba5-a619-41e4-937b-4b7384db1655	71610-096	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71610-098_34de35ef-20f0-4707-9f11-dcf8c4040796	71610-098	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 200 mg	TABLET	ORAL	20160301		OTC MONOGRAPH FINAL	part341	Aphena Pharma Solutions - Tennessee, LLC	GUAIFENESIN	200	mg/1			N	20241231
71610-100_b5d04e06-e889-4ccd-97eb-967ec6e00a6c	71610-100	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	30	mg/1			N	20241231
71610-101_a5b51b65-39a0-4c0f-97c2-8c91700b5f08	71610-101	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-102_c9e366cc-e9b4-4e14-8c40-8daf2fe265ad	71610-102	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET	ORAL	20100802		ANDA	ANDA091426	Aphena Pharma Solutions - Tennessee, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71610-103_f6d59cf3-a7cb-4d70-94c3-0465f32a4ffb	71610-103	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20160222		ANDA	ANDA077056	Aphena Pharma Solutions - Tennessee, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-105_cb4966b5-fc0b-416e-a3d3-9153957afd38	71610-105	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71610-107_54b54e0a-1488-4e0e-bffe-0980faf6f25b	71610-107	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20061020		ANDA	ANDA077836	Aphena Pharma Solutions - Tennessee, LLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71610-108_845bc0be-9869-42e8-b501-09b3ddee754d	71610-108	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL; ORAL	20131010		ANDA	ANDA089776	Aphena Pharma Solutions - Tennessee, LLC	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
71610-109_32ff40df-b3ad-4156-818b-587837737309	71610-109	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Aphena Pharma Solutions - Tennessee, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71610-110_b3e06e81-a608-4bec-9ee6-e7e0085714ca	71610-110	HUMAN PRESCRIPTION DRUG	Doxazosin mesylate		doxazosin mesylate	TABLET	ORAL	20140707		NDA	NDA019668	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-111_c998316d-8c03-4d5a-a57c-3d63398d85de	71610-111	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20110706		ANDA	ANDA040419	Aphena Pharma Solutions - Tennessee, LLC	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71610-112_ac82c8dd-1fbb-4ec1-a126-8eced3452972	71610-112	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Aphena Pharma Solutions - Tennessee, LLC	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-113_22b29541-4f86-41bd-b29d-385327935b24	71610-113	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Aphena Pharma Solutions - Tennessee, LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-114_8826f454-0316-4981-8c28-9bf20cf956f8	71610-114	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	TABLET	ORAL	20020627		ANDA	ANDA076280	Aphena Pharma Solutions - Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71610-115_741ce88a-0753-461f-b456-4d026b540985	71610-115	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20041022		ANDA	ANDA076921	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	15	mg/1			N	20241231
71610-117_610243f6-9761-4cdf-ad1a-0cb65c3d4445	71610-117	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19840911		ANDA	ANDA062505	Aphena Pharma Solutions - Tennessee, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71610-119_864f5aaf-0819-42bb-8bc6-7878a5378986	71610-119	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Aphena Pharma Solutions - Tennessee, LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71610-120_d53bcc2c-29da-459a-b82b-b34d3dee074f	71610-120	HUMAN PRESCRIPTION DRUG	Doxazosin mesylate		doxazosin mesylate	TABLET	ORAL	20140707		NDA	NDA019668	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-121_658b4bb3-7feb-4cd0-85e5-7d6096e601e1	71610-121	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030619		ANDA	ANDA076312	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	15	mg/1			N	20241231
71610-122_3931aebc-69f6-4756-9ca6-72cec3c18be5	71610-122	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20091009		ANDA	ANDA078203	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
71610-124_3bd2577b-8447-4b76-b7f2-aeefbf8abac0	71610-124	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20150202		ANDA	ANDA074069	Aphena Pharma Solutions - Tennessee, LLC	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
71610-125_87014fde-53a6-4199-95b5-8b16357b8bc8	71610-125	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180401		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-126_7face95a-3ced-4b19-8946-6f57fe7bbb3f	71610-126	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-127_2ddf4cb0-6d16-49fa-9267-274ed1643e90	71610-127	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	300	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-128_2ddf4cb0-6d16-49fa-9267-274ed1643e90	71610-128	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-132_64a15efb-fbe4-409a-93e4-dc27c54ac748	71610-132	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20070905		ANDA	ANDA078332	Aphena Pharma Solutions - Tennessee, LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71610-133_5872733a-20c5-48d1-8e27-79d914131f7d	71610-133	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207752	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-134_299592bc-464b-4a36-8ece-fee27da7db8c	71610-134	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	Aphena Pharma Solutions - Tennessee, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-135_87014fde-53a6-4199-95b5-8b16357b8bc8	71610-135	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180401		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-136_2ddf4cb0-6d16-49fa-9267-274ed1643e90	71610-136	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-137_b58c8fbf-c7b3-4b9c-84a9-e19bd76904ac	71610-137	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-138_b58c8fbf-c7b3-4b9c-84a9-e19bd76904ac	71610-138	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-139_78326f5f-e67d-4657-b53f-7a082403a291	71610-139	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE, GELATIN COATED	ORAL	20080211		ANDA	ANDA078391	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-140_2ddf4cb0-6d16-49fa-9267-274ed1643e90	71610-140	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090120	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-141_2ddf4cb0-6d16-49fa-9267-274ed1643e90	71610-141	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20120327		ANDA	ANDA090749	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-142_75f1aa5c-c27e-414b-8c23-32122b472bdd	71610-142	HUMAN PRESCRIPTION DRUG	metolazone		metolazone	TABLET	ORAL	19731127		NDA AUTHORIZED GENERIC	NDA017386	Aphena Pharma Solutions - Tennessee, LLC	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71610-143_5303ff8b-a4cd-4912-be7b-8d3cd9a74cac	71610-143	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-144_f6239345-a673-4d75-98c6-c8e0b1cc18a4	71610-144	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20121018		ANDA	ANDA075269	Aphena Pharma Solutions - Tennessee, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-146_97600ad8-cdf2-4664-83c1-e1deecb26772	71610-146	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-147_14ce0c99-7e67-46ad-b763-99e19e6052c1	71610-147	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-151_4226ed40-0715-4369-87ae-4c2c190fff49	71610-151	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-152_4226ed40-0715-4369-87ae-4c2c190fff49	71610-152	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-153_c783db8d-05dc-4b11-9f6a-bcb821b73cac	71610-153	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150409		ANDA	ANDA075580	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-154_bb1f2e2e-5f5f-4a4b-b44d-07f1e9e15ba8	71610-154	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20130124		ANDA	ANDA078558	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-155_c35e4e9d-906b-4eef-876b-b362108a5ccc	71610-155	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-156_054ab49e-270f-497f-a5ed-a46264e5e282	71610-156	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-157_33511714-8ded-46ee-ae1d-03a536728d31	71610-157	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-158_35ed395e-7b5c-4f66-ab20-28e5b04501f3	71610-158	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20150814		ANDA	ANDA200981	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-159_ed26d6d8-3eab-470a-80ce-d18fabbdfb3a	71610-159	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Aphena Pharma Solutions - Tennessee, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
71610-160_c783db8d-05dc-4b11-9f6a-bcb821b73cac	71610-160	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin	TABLET	ORAL	20150409		ANDA	ANDA075580	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-161_60bab3ba-cbe3-4a97-8a7f-67345d5d38bb	71610-161	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090804		ANDA	ANDA077118	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-162_ed1abfb9-7277-4142-a1f9-3a538bc969ee	71610-162	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20130108		ANDA	ANDA076533	Aphena Pharma Solutions - Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71610-163_505bc442-3fe2-427f-89d9-3057dc391b38	71610-163	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-164_98de55f8-557e-4e9a-b959-03ac0945da0f	71610-164	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Aphena Pharma Solutions - Tennessee, LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71610-165_a80c0ae3-f047-4f97-bddd-0de411fd19ce	71610-165	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71610-166_f3ceca55-470e-4a64-8dfd-a7671f5358e9	71610-166	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20100426		ANDA	ANDA090705	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-167_a03d5407-7fe3-4064-a9cc-bda2f20e1a51	71610-167	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20150728		ANDA	ANDA076416	Aphena Pharma Solutions - Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71610-168_2cff8a5e-1a3e-4a4f-b916-520ce1c15a4d	71610-168	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-169_2cff8a5e-1a3e-4a4f-b916-520ce1c15a4d	71610-169	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-170_2cff8a5e-1a3e-4a4f-b916-520ce1c15a4d	71610-170	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-171_cd8ff64b-8e6e-41cb-b11a-03854c57a9ee	71610-171	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20101006		ANDA	ANDA090083	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-172_47c92eca-9e78-487b-8c63-14588bb16c71	71610-172	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20160201		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71610-173_ffb16d1f-dcec-4aa8-89b4-914087ffd2c6	71610-173	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-174_0cd04c66-6852-4320-add6-5272c3f92dc9	71610-174	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Aphena Pharma Solutions - Tennessee, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-175_8c28eff9-1a6e-4e66-a2b2-7b6feacc6eca	71610-175	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71610-176_79d8c3ce-51ad-42b1-b8d6-e9d067059070	71610-176	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20130124		ANDA	ANDA078558	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-177_75491ff1-aa83-4d04-89ad-1137b2838e7a	71610-177	HUMAN PRESCRIPTION DRUG	Jardiance		Empagliflozin	TABLET, FILM COATED	ORAL	20140801		NDA	NDA204629	Aphena Pharma Solutions - Tennessee, LLC	EMPAGLIFLOZIN	25	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
71610-178_8328a536-b498-4fcb-8a49-19d79fa25f29	71610-178	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20071001		ANDA	ANDA078203	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-179_ffb16d1f-dcec-4aa8-89b4-914087ffd2c6	71610-179	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		warfarin sodium	TABLET	ORAL	20111111		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-180_0be8396c-e02e-46f8-9528-dcfe9f7ab28a	71610-180	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20160519		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-181_8b491e25-af1d-426c-9fc6-8b4c182e701f	71610-181	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180401		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-182_1c7508c2-75cf-41b4-9172-89f4e7054368	71610-182	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20031203		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	MAGNESIUM OXIDE	400	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71610-183_0e7eed66-f0af-469e-ad79-8d442af82177	71610-183	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020301		ANDA	ANDA075022	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71610-184_38f40e37-2e06-4144-953f-9fbbb0e2b2c7	71610-184	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-185_e1f89ae6-021d-4fcd-ad58-27f2be19fd6e	71610-185	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20180913		ANDA	ANDA090705	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-186_3365f4ad-e660-4b09-bff6-c1b8716331fa	71610-186	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-187_4abd6ed8-17d4-44d1-a30e-956ce5cc46e1	71610-187	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-188_33d95ef3-e1a3-44e5-91e6-3e333e272de2	71610-188	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-191_5342e071-7b2f-4231-a73d-8c227f928494	71610-191	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20050407		ANDA	ANDA084903	Aphena Pharma Solutions - Tennessee, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-192_b721f5f7-f18b-4d24-a12d-afaf21d21ea3	71610-192	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-194_f91cc234-c1d7-4d08-bfca-4966770a3339	71610-194	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20091001		ANDA	ANDA071586	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-196_1ee20834-3e0e-4e2a-8f6f-b75350c6cf91	71610-196	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-197_17bbed36-cb0a-4e46-8a4c-234817505566	71610-197	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-198_d4afdf6e-c0e3-4a41-bbc6-4ca79354f9d0	71610-198	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-199_adbae6b7-14fd-4ce0-a7eb-2154805a2a16	71610-199	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-200_540018a9-7f17-4295-9d61-7ce5adce89f7	71610-200	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20161013		ANDA	ANDA077836	Aphena Pharma Solutions - Tennessee, LLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71610-201_463f25a7-5120-4ca4-b572-502598615a09	71610-201	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		DIVALPROEX SODIUM	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090804		ANDA	ANDA078791	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-203_3837aaad-61a9-4f61-ac1a-022302c51d21	71610-203	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20020228		ANDA	ANDA075022	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71610-204_127e7f93-615c-45d1-91a6-98091c1e2d81	71610-204	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-205_4a86282f-831d-4cfe-a814-19a3f544fa85	71610-205	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-206_636c7482-d41f-4a26-a55c-183f4169c148	71610-206	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71610-207_efa818c7-3f30-4f41-9071-71e298ae171d	71610-207	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20140730		ANDA	ANDA091497	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-208_9f977fa3-9302-4338-a22b-a3ac042e82da	71610-208	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20161215		ANDA	ANDA202557	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71610-209_dcd1f50a-a200-48b3-89f7-039081a9e72d	71610-209	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	Aphena Pharma Solutions - Tennessee, LLC	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71610-211_74e2a718-1935-4844-9b06-3e2d168417d5	71610-211	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-212_93ebfb06-61cd-41e0-8c9e-fe5c8e87329e	71610-212	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET	ORAL	20100422		ANDA	ANDA090564	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-213_004c75b3-29f0-4e32-82fe-fec4ce0350d3	71610-213	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20180927		NDA AUTHORIZED GENERIC	NDA021368	Aphena Pharma Solutions - Tennessee, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-214_004c75b3-29f0-4e32-82fe-fec4ce0350d3	71610-214	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20180927		NDA AUTHORIZED GENERIC	NDA021368	Aphena Pharma Solutions - Tennessee, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-215_8829f5bc-538d-4ad6-ad8b-04e28da01924	71610-215	HUMAN PRESCRIPTION DRUG	Rosuvastatin calcium		Rosuvastatin calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA206434	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-216_6a0225f9-61f9-4f17-81b3-e3ccafa7abcd	71610-216	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20160719		ANDA	ANDA079170	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-217_6b2afb94-dcdd-40b9-9d0b-eec36d08e42c	71610-217	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	19960715		ANDA	ANDA040156	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71610-218_492c2d4f-3ba2-4858-bfbb-8ade6b3b7e30	71610-218	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-220_fadba8a4-d8e7-482a-836f-2da4b867eb28	71610-220	HUMAN PRESCRIPTION DRUG	Doxycycline Monohydrate		Doxycycline	CAPSULE	ORAL	20050207		NDA AUTHORIZED GENERIC	NDA050641	Aphena Pharma Solutions - Tennessee, LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
71610-222_d7886733-60dc-49ae-9147-240efccc08bb	71610-222	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-223_516b1961-a47b-4474-a1c1-507ee9d670c0	71610-223	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20181001		ANDA	ANDA208507	Aphena Pharma Solutions - Tennessee, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-224_4e03cfb8-7719-4226-b4a4-10fff49b8390	71610-224	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20110601		ANDA	ANDA091497	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-225_d291bace-88fb-425a-9979-c34f47ee1f43	71610-225	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-228_fb129009-348e-4512-a39f-e36fbf805c86	71610-228	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20130401		ANDA	ANDA091283	Aphena Pharma Solutions - Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71610-229_e2bf4a43-faf3-433b-8f77-8d5d03600845	71610-229	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20170324		ANDA	ANDA203572	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-230_2b6f8229-e650-4b47-8118-810d08a89247	71610-230	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET	ORAL	20101006		ANDA	ANDA090467	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-232_e177d76d-1ef4-4218-9e40-07cdf617857b	71610-232	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207408	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-233_e177d76d-1ef4-4218-9e40-07cdf617857b	71610-233	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207408	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-234_e177d76d-1ef4-4218-9e40-07cdf617857b	71610-234	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20161031		ANDA	ANDA207408	Aphena Pharma Solutions - Tennessee, LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-235_6e0f8f88-2e13-4610-a99f-e544c7560599	71610-235	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20091202		ANDA	ANDA040625	Aphena Pharma Solutions - Tennessee, LLC	FOLIC ACID	1	mg/1			N	20241231
71610-236_51de9fdb-99a3-41a6-a7ef-ec6c5f819088	71610-236	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20090817		ANDA	ANDA077911	Aphena Pharma Solutions - Tennessee, LLC	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71610-237_745ba3af-6e23-40ec-b826-1cdb8c0c36a6	71610-237	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180529		ANDA	ANDA077342	Aphena Pharma Solutions - Tennessee, LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-238_a14457be-2ebb-46db-96dd-ebceb51c077f	71610-238	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20150501		OTC MONOGRAPH NOT FINAL	part343	Aphena Pharma Solutions - Tennessee, LLC	ACETAMINOPHEN	325	mg/1			N	20241231
71610-239_b2a05b13-7cb0-4237-b7ca-24fa35299694	71610-239	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20140627		ANDA	ANDA087479	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71610-240_e9b343fe-c3b5-4dd1-abff-551aa90324f9	71610-240	HUMAN PRESCRIPTION DRUG	ERGOCALCIFEROL		ERGOCALCIFEROL	CAPSULE	ORAL	20090520		ANDA	ANDA040833	Aphena Pharma Solutions - Tennessee, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71610-242_53b25c9f-5a70-4294-9d8a-abcef0b12211	71610-242	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20181001		ANDA	ANDA208507	Aphena Pharma Solutions - Tennessee, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-243_7134cfa5-bee4-48df-9f2c-571b5f555fd7	71610-243	HUMAN PRESCRIPTION DRUG	Paroxetine		paroxetine hydrochloride hemihydrate	TABLET, FILM COATED	ORAL	20080324		ANDA	ANDA078902	Aphena Pharma Solutions - Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	30	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-245_4c668824-7502-4799-8efc-e93581cd75d0	71610-245	HUMAN OTC DRUG	Rugby Travel Sickness	Meclizine HCl, 25 mg Each (Antiemetic)	Meclizine HCl	TABLET, CHEWABLE	ORAL	20140819		OTC MONOGRAPH FINAL	part336	Aphena Pharma Solutions - Tennessee, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71610-246_1ed35e98-e193-4975-917c-86bb64acf404	71610-246	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Aphena Pharma Solutions - Tennessee, LLC	RISPERIDONE	4	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-247_a3c90a47-42cb-44b6-99e0-f027dc45ac2b	71610-247	HUMAN PRESCRIPTION DRUG	Entacapone		Entacapone	TABLET, FILM COATED	ORAL	20140604		NDA AUTHORIZED GENERIC	NDA020796	Aphena Pharma Solutions - Tennessee, LLC	ENTACAPONE	200	mg/1	Catechol O-Methyltransferase Inhibitors [MoA], Catechol-O-Methyltransferase Inhibitor [EPC]		N	20241231
71610-248_b9ce8938-5ddf-4556-84d0-c3d2eb64a734	71610-248	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090121		ANDA	ANDA076048	Aphena Pharma Solutions - Tennessee, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-249_3cb12547-8039-47da-9899-9ac1efb13a87	71610-249	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-250_e41229de-e579-41f7-bfc0-a9fcef4abe0d	71610-250	HUMAN PRESCRIPTION DRUG	simvastatin		simvastatin	TABLET, FILM COATED	ORAL	20080226		ANDA	ANDA078155	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-251_f64dd0e4-d9bf-465c-9e36-2a6ce89651f7	71610-251	HUMAN PRESCRIPTION DRUG	Doxazosin mesylate		doxazosin mesylate	TABLET	ORAL	20140707		NDA	NDA019668	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-253_12e4ee96-a23f-4be5-a378-634cad5c02ee	71610-253	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	19870109		ANDA	ANDA071450	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-254_3c965d39-7948-4e44-bd0c-62edb4501751	71610-254	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170515		ANDA	ANDA204170	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-255_728fd319-96aa-4e54-8338-8d6ae2f90e96	71610-255	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-256_7ef34ca8-1a02-40a3-83a4-4b1dcf3a93d5	71610-256	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180529		ANDA	ANDA077342	Aphena Pharma Solutions - Tennessee, LLC	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-257_66ae500b-25d1-41af-a30c-e6f21a906eb9	71610-257	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20150630		ANDA	ANDA202330	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71610-259_d100ecbc-bf31-4407-a2d6-203a429375c2	71610-259	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20150601		ANDA	ANDA077493	Aphena Pharma Solutions - Tennessee, LLC	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-261_5c6a3e75-f3e2-489a-8582-1328c84b5fd9	71610-261	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-264_734267df-c692-446a-ae8b-47462213b1ba	71610-264	HUMAN PRESCRIPTION DRUG	RISPERIDONE		RISPERIDONE	TABLET	ORAL	20140328		ANDA	ANDA201003	Aphena Pharma Solutions - Tennessee, LLC	RISPERIDONE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-265_c5c78781-b840-4c6b-ad40-968ab2ae25ad	71610-265	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	CAPSULE	ORAL	19740930		ANDA	ANDA084285	Aphena Pharma Solutions - Tennessee, LLC	DICYCLOMINE HYDROCHLORIDE	10	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71610-266_bbf54820-016c-4a8b-b50c-1ce5e26f4c3e	71610-266	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20140503		ANDA	ANDA078888	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71610-267_52da6ae2-944a-4609-a3a0-07cfb06b31a2	71610-267	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20120629		ANDA	ANDA204582	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71610-268_5dfba728-4417-4a75-b194-87feff97aa7b	71610-268	HUMAN PRESCRIPTION DRUG	verapamil hydrochloride		verapamil hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090917		ANDA	ANDA078906	Aphena Pharma Solutions - Tennessee, LLC	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71610-269_a51379dd-c47a-4fcd-aed0-5f19c18bf12c	71610-269	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20180716		ANDA	ANDA073589	Aphena Pharma Solutions - Tennessee, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
71610-270_1ce73ca7-a651-40ea-9629-0e664017b5c8	71610-270	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-271_35c2453d-fbb5-4101-9e04-bd47131d3ada	71610-271	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180529		ANDA	ANDA077342	Aphena Pharma Solutions - Tennessee, LLC	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-272_07f9f5a9-e902-40f5-96c9-f7a232037a4c	71610-272	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20190221		ANDA	ANDA076410	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-273_07f9f5a9-e902-40f5-96c9-f7a232037a4c	71610-273	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20190221		ANDA	ANDA076410	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-274_afec283e-075f-46b5-a927-00434373aa92	71610-274	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20030304		ANDA	ANDA076194	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-275_8205e32a-d524-488b-b591-bc4d697896c1	71610-275	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-276_a675bfd4-aacd-4537-b979-c9612aae3c9b	71610-276	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20170608		ANDA	ANDA040707	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-277_b28dba2b-b19b-469e-98d8-54e87e3800e3	71610-277	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET	ORAL	20171023		ANDA	ANDA209823	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71610-280_5cbc3e43-cf72-4e22-96f3-0de16d3894bf	71610-280	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Aphena Pharma Solutions - Tennessee, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-281_9f6bd1a3-3372-451d-a274-faf0a72e9235	71610-281	HUMAN PRESCRIPTION DRUG	BusPIRone Hydrochloride		BusPIRone Hydrochloride	TABLET	ORAL	20180703		ANDA	ANDA209696	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71610-282_c1ea57cd-ffac-4348-9ccf-40070e7ff8d9	71610-282	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET	ORAL	20101006		ANDA	ANDA090083	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-283_008fb44d-7296-4e3c-a9ad-a6e55b2033a8	71610-283	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210		NDA AUTHORIZED GENERIC	NDA020998	Aphena Pharma Solutions - Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-284_ffdf5578-b8fa-4213-811d-a6701deca3ac	71610-284	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	19810827		NDA	NDA018487	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71610-285_875c85ff-ca13-41b1-bc4e-ca871c3d2cd1	71610-285	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20031219		ANDA	ANDA076732	Aphena Pharma Solutions - Tennessee, LLC	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71610-287_37a5f19e-c2d2-4dde-9aa0-48d70f892e68	71610-287	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Aphena Pharma Solutions - Tennessee, LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71610-288_37a5f19e-c2d2-4dde-9aa0-48d70f892e68	71610-288	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Aphena Pharma Solutions - Tennessee, LLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71610-289_e84f35bd-ac2b-4066-a275-57b1b07aee58	71610-289	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20140602		ANDA	ANDA202419	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-290_544311df-93cf-46bb-9178-7a65deb6e211	71610-290	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Aphena Pharma Solutions - Tennessee, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-291_ab84266e-acad-41f9-ada7-9a54817dd289	71610-291	HUMAN PRESCRIPTION DRUG	BusPIRone Hydrochloride		BusPIRone Hydrochloride	TABLET	ORAL	20180703		ANDA	ANDA209696	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71610-292_1554fdc4-77b0-4483-9cfb-59c004344ff6	71610-292	HUMAN OTC DRUG	Fexofenadine hydrochloride		Fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20150115		ANDA	ANDA202039	Aphena Pharma Solutions - Tennessee, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71610-300_a8ff5402-3a49-4f04-9868-f8b2dff3aa99	71610-300	HUMAN PRESCRIPTION DRUG	Alogliptin		Alogliptin	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022271	Aphena Pharma Solutions - Tennessee, LLC	ALOGLIPTIN BENZOATE	25	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
71610-301_1115445c-a777-44ea-8a2c-660293e4d544	71610-301	HUMAN OTC DRUG	Calcium Carbonate 10 gr (648 mg)	(Antacid)	Calcium Carbonate 10gr (648 mg)	TABLET	ORAL	20190228		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	CALCIUM CARBONATE	648	mg/1			N	20241231
71610-307_4909cb92-6dbf-4ce5-bff9-811a979ba8c5	71610-307	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71610-312_a5e41911-c3cf-4538-9da3-829c49d792ff	71610-312	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113	20240331	ANDA	ANDA077321	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	
71610-313_e4afd760-a8d8-45d3-bd57-9944159828ce	71610-313	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	25	mg/1		CV	N	20241231
71610-314_e4afd760-a8d8-45d3-bd57-9944159828ce	71610-314	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
71610-316_e4afd760-a8d8-45d3-bd57-9944159828ce	71610-316	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
71610-317_e4afd760-a8d8-45d3-bd57-9944159828ce	71610-317	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
71610-318_e4afd760-a8d8-45d3-bd57-9944159828ce	71610-318	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	200	mg/1		CV	N	20241231
71610-319_e4afd760-a8d8-45d3-bd57-9944159828ce	71610-319	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	225	mg/1		CV	N	20241231
71610-320_e4afd760-a8d8-45d3-bd57-9944159828ce	71610-320	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	300	mg/1		CV	N	20241231
71610-328_49d5064f-654b-4a6b-be12-e11523738b04	71610-328	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	300	mg/1		CV	N	20241231
71610-329_49d5064f-654b-4a6b-be12-e11523738b04	71610-329	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
71610-330_49d5064f-654b-4a6b-be12-e11523738b04	71610-330	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	200	mg/1		CV	N	20241231
71610-331_49d5064f-654b-4a6b-be12-e11523738b04	71610-331	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	225	mg/1		CV	N	20241231
71610-332_49d5064f-654b-4a6b-be12-e11523738b04	71610-332	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
71610-333_49d5064f-654b-4a6b-be12-e11523738b04	71610-333	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
71610-339_c8c0bd51-a7c2-4d89-bee2-063cd4da43f3	71610-339	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	19851119		ANDA	ANDA070213	Aphena Pharma Solutions - Tennessee, LLC	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-343_142e9197-d146-48fa-9b27-86cced0fbfba	71610-343	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20190619		ANDA	ANDA074726	Aphena Pharma Solutions - Tennessee, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71610-349_5957b4e7-2e3c-459f-898d-81ee33f3b7fc	71610-349	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190621		NDA	NDA019123	Aphena Pharma Solutions - Tennessee, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71610-350_5f2d411a-1230-4f50-9b6e-53efe829c547	71610-350	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
71610-351_5f2d411a-1230-4f50-9b6e-53efe829c547	71610-351	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	300	mg/1		CV	N	20241231
71610-352_5f2d411a-1230-4f50-9b6e-53efe829c547	71610-352	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
71610-357_5f2d411a-1230-4f50-9b6e-53efe829c547	71610-357	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
71610-358_5f2d411a-1230-4f50-9b6e-53efe829c547	71610-358	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	225	mg/1		CV	N	20241231
71610-361_5f2d411a-1230-4f50-9b6e-53efe829c547	71610-361	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	200	mg/1		CV	N	20241231
71610-365_5f2d411a-1230-4f50-9b6e-53efe829c547	71610-365	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	25	mg/1		CV	N	20241231
71610-368_78d35c58-8484-4268-912a-5677e86782b4	71610-368	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-370_206438fc-a53c-4d5e-afcb-0c85d2be2534	71610-370	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET	ORAL	20101006		ANDA	ANDA090083	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-374_29eb83f5-d92a-4b6f-acf6-3deecf7c4f9f	71610-374	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20190501		ANDA	ANDA204058	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-382_29eb83f5-d92a-4b6f-acf6-3deecf7c4f9f	71610-382	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20190501		ANDA	ANDA204058	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-383_29eb83f5-d92a-4b6f-acf6-3deecf7c4f9f	71610-383	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20190501		ANDA	ANDA204058	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-388_95b6fb77-a8a4-4dc3-bf14-d619feee6f59	71610-388	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20190625		ANDA	ANDA075795	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71610-393_95b6fb77-a8a4-4dc3-bf14-d619feee6f59	71610-393	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20190625		ANDA	ANDA075795	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71610-394_7dee4b0d-3071-4962-82b6-0b0ff220f91a	71610-394	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		oxybutynin chloride	TABLET	ORAL	20190101		ANDA	ANDA210125	Aphena Pharma Solutions - Tennessee, LLC	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71610-395_10b9b8c8-0cfc-47b7-9324-bbd6f2617b5f	71610-395	HUMAN PRESCRIPTION DRUG	Isoniazid		Isoniazid	TABLET	ORAL	19720901		ANDA	ANDA080937	Aphena Pharma Solutions - Tennessee, LLC	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
71610-398_1dff6bc2-aaf7-4003-a970-d18125b491fe	71610-398	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20150522		ANDA	ANDA091498	Aphena Pharma Solutions - Tennessee, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
71610-399_ce00f657-538e-4b73-9126-1cff453be4aa	71610-399	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20160129		ANDA	ANDA078916	Aphena Pharma Solutions - Tennessee, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71610-401_157fe8e5-a477-47eb-adac-6b9ffe571af9	71610-401	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-402_157fe8e5-a477-47eb-adac-6b9ffe571af9	71610-402	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine Hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20131211		ANDA	ANDA090778	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-403_a06859a2-b40c-4955-b797-8c8da1cc8f3d	71610-403	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-404_a93360e6-43f6-4652-a7ef-07087a718258	71610-404	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20190417		ANDA	ANDA208972	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
71610-405_335e56e6-a09f-488d-84dc-06f0b50950df	71610-405	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	Aphena Pharma Solutions - Tennessee, LLC	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71610-406_75ff1aad-8d47-4263-9c2e-29fe43b720e4	71610-406	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-409_fa699b0f-cb02-4a27-b97a-80221ebeabed	71610-409	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140414		ANDA	ANDA091169	Aphena Pharma Solutions - Tennessee, LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
71610-410_c346acec-eaa1-41ee-b0a2-04c99882755c	71610-410	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20180401		ANDA	ANDA205101	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-411_528f271b-fb68-4d6a-b115-607aaabefd0c	71610-411	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	Aphena Pharma Solutions - Tennessee, LLC	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-412_7c318729-6d4b-4a2a-a2fe-155b6513e7d4	71610-412	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20160722		ANDA	ANDA077534	Aphena Pharma Solutions - Tennessee, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-413_fc10ffe3-e320-4a92-9b34-1f56d369691b	71610-413	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20041028		ANDA	ANDA077031	Aphena Pharma Solutions - Tennessee, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-414_409d2d9a-8d54-49ac-8707-a34db699a973	71610-414	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20090610		ANDA	ANDA075682	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-415_d576f84d-990d-40b5-8b52-606ccafe356e	71610-415	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET	ORAL	20101006		ANDA	ANDA090083	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-417_81147c23-9287-4087-8ae7-53731ec9a7ec	71610-417	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 25 mg		losartan potassium	TABLET	ORAL	20181023		ANDA	ANDA201170	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-418_81147c23-9287-4087-8ae7-53731ec9a7ec	71610-418	HUMAN PRESCRIPTION DRUG	Losartan potassium Tablets, 50 mg		losartan potassium	TABLET	ORAL	20181023		ANDA	ANDA201170	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-419_de72ce02-c9dd-4462-aca5-87fb4427c78a	71610-419	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Aphena Pharma Solutions - Tennessee, LLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-421_21d2a6c0-a9bc-4a72-aca2-86a7e840c914	71610-421	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-422_5b7791df-471c-4407-a795-ad43aba3142d	71610-422	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET, FILM COATED	ORAL	20110520		ANDA	ANDA077045	Aphena Pharma Solutions - Tennessee, LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-423_c1e2a0e1-48b7-4481-8ed8-3197bf7d05a2	71610-423	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20181206		ANDA	ANDA076301	Aphena Pharma Solutions - Tennessee, LLC	LORATADINE	10	mg/1			N	20241231
71610-424_674e8116-e236-44a6-92f3-2f33fde550fd	71610-424	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071322	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-425_09b866f0-4435-4d1a-9cc7-c6a5ea487cb0	71610-425	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130321		ANDA	ANDA202389	Aphena Pharma Solutions - Tennessee, LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-426_f44af22b-a99e-4c28-94af-f260bbb6ba0f	71610-426	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-427_b4ce9ce1-55a4-49ef-a63e-c1ec0a5e9467	71610-427	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071136	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-428_437af220-8e2a-4629-899f-a4f7e85db5e7	71610-428	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Aphena Pharma Solutions - Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-430_e80c2151-5bcf-454b-b0ee-94beb3fbb40d	71610-430	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190808		ANDA	ANDA040245	Aphena Pharma Solutions - Tennessee, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71610-431_c0313858-c1ee-40d9-9197-b6059869a430	71610-431	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-433_7c2f1809-97f9-4942-a4f0-5fe016dd709a	71610-433	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET, FILM COATED	ORAL	20190812		NDA AUTHORIZED GENERIC	NDA019839	Aphena Pharma Solutions - Tennessee, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-434_5dd755ce-6ef4-4341-a8e9-cd7d342442ea	71610-434	HUMAN OTC DRUG	Guaifenesin 200mg		Guaifenesin	TABLET	ORAL	20190301		OTC MONOGRAPH FINAL	part341	Aphena Pharma Solutions - Tennessee, LLC	GUAIFENESIN	200	mg/1			N	20241231
71610-435_730d7b7d-3846-47b2-b527-c2bb233f8052	71610-435	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	Aphena Pharma Solutions - Tennessee, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-436_59e3892a-f861-4bec-87ee-63bcdc7c1b64	71610-436	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-438_8c2fd216-d341-4bfb-a25b-6e04602d34bb	71610-438	HUMAN OTC DRUG	Sodium Bicarbonate		sodium bicarbonate	TABLET	ORAL	20170201		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	SODIUM BICARBONATE	650	mg/1			N	20241231
71610-439_ac858720-a7ec-4205-a13b-596c948cde60	71610-439	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA203835	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-440_ac858720-a7ec-4205-a13b-596c948cde60	71610-440	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA203835	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-441_26bddffb-91bc-4305-a698-3df35d7b15d8	71610-441	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20060209		ANDA	ANDA077336	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-443_e8e90401-c593-4009-8954-89cb927d1430	71610-443	HUMAN PRESCRIPTION DRUG	Metoprolol tartrate		Metoprolol tartrate	TABLET	ORAL	20150629		ANDA	ANDA074644	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-444_807fbdcb-66ec-4bf5-9c37-082df44e6b5c	71610-444	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20200501		ANDA	ANDA077241	Aphena Pharma Solutions - Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71610-446_edf4b7c6-f843-4177-ba85-410ad266ba81	71610-446	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20110101		ANDA	ANDA078401	Aphena Pharma Solutions - Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71610-447_f2b2e161-6f49-4a65-970e-017b5c4dcd74	71610-447	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20060209		ANDA	ANDA077336	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-448_c6ed46d9-0050-4c67-9a18-378ab6bf3ab3	71610-448	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-449_6e5cec35-31fa-4db7-a681-cd264ebd6cbf	71610-449	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070923	Aphena Pharma Solutions - Tennessee, LLC	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71610-450_7d2d6969-3ebd-4a87-9e40-407f5d86fd65	71610-450	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET	ORAL	20191111		ANDA	ANDA205414	Aphena Pharma Solutions - Tennessee, LLC	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-451_dd861284-8693-4273-bd3e-451c5c333fc2	71610-451	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Aphena Pharma Solutions - Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71610-452_d28f263b-b7d3-47f4-8d3e-bc2fd5594da4	71610-452	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20200501		ANDA	ANDA078220	Aphena Pharma Solutions - Tennessee, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71610-453_5fb2da10-483f-4431-a408-ffb37dcc06a0	71610-453	HUMAN OTC DRUG	stimulant laxative enteric coated		Bisacodyl	TABLET	ORAL	20000101		OTC MONOGRAPH NOT FINAL	part334	Aphena Pharma Solutions - Tennessee, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71610-454_1b06528a-d7ea-4ae9-b5c1-2cc175af1876	71610-454	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-455_2c6a6719-33e4-44e8-bce6-30c10ae156a6	71610-455	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20040116		ANDA	ANDA076533	Aphena Pharma Solutions - Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
71610-456_b1e690f9-663d-40c1-9803-143678bd96bc	71610-456	HUMAN PRESCRIPTION DRUG	ibuprofen		ibuprofen	TABLET, FILM COATED	ORAL	20161123		ANDA	ANDA202413	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-457_26802a69-e56c-4a63-add0-178b560cce98	71610-457	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE	ER	metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20131101		ANDA	ANDA201991	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-458_6214a8c0-54ca-4c48-984f-9d49088acdab	71610-458	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-459_21fd224c-5c49-4dc0-bbbf-9a124099a7e4	71610-459	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071135	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-460_839fce7f-6e58-459c-bb69-7fbc420e31f1	71610-460	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071134	Aphena Pharma Solutions - Tennessee, LLC	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-461_b5c51223-f994-41aa-8478-ed13dc51a908	71610-461	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Aphena Pharma Solutions - Tennessee, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-462_7499368e-bc27-4934-833c-66da6ebf845c	71610-462	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-465_03a7d931-b0de-41e6-99e0-0d4ff6cb78b8	71610-465	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA203835	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-466_69881114-634b-432c-8d57-e74e2adb1eb5	71610-466	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	Aphena Pharma Solutions - Tennessee, LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
71610-468_e4a50edb-a1aa-436f-9379-63010ae70dae	71610-468	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20130524		ANDA	ANDA091174	Aphena Pharma Solutions - Tennessee, LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
71610-469_d8b9ec72-8206-48b8-a474-660fc685c17d	71610-469	HUMAN PRESCRIPTION DRUG	amlodipine besylate		amlodipine besylate	TABLET	ORAL	20190624		NDA AUTHORIZED GENERIC	NDA019787	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-470_cd18c7ed-b8ed-45a8-accb-f1baa08f0a5b	71610-470	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Aphena Pharma Solutions - Tennessee, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71610-471_b9ef366b-1b6f-4060-a3f0-6c6f5399144e	71610-471	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20070316		ANDA	ANDA040702	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-472_e74a8605-c417-45b6-a098-5046a5e3c446	71610-472	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20170517		ANDA	ANDA206904	Aphena Pharma Solutions - Tennessee, LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71610-473_e1d9d7c7-2690-4fad-9a88-64312b1fd56a	71610-473	HUMAN PRESCRIPTION DRUG	Plaquenil		Hydroxychloroquine Sulfate	TABLET	ORAL	20130628		NDA	NDA009768	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
71610-474_c2c1a3a6-f70e-4b47-85b6-e4d10c110588	71610-474	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Aphena Pharma Solutions - Tennessee, LLC	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
71610-475_a6847321-3e41-463d-92b0-b8186e0269ca	71610-475	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030619		ANDA	ANDA076122	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	15	mg/1			N	20241231
71610-477_9d2796f2-b596-4588-96c8-f99407d3e671	71610-477	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181101		ANDA	ANDA208960	Aphena Pharma Solutions - Tennessee, LLC	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-478_0ff03065-5d3c-4a3e-9a04-207236b7d6f5	71610-478	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200330		ANDA	ANDA075317	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-479_444cd2c3-a0d4-4c73-b74e-284a212f288b	71610-479	HUMAN PRESCRIPTION DRUG	Extended Phenytoin Sodium		Phenytoin Sodium	CAPSULE	ORAL	20200825		ANDA	ANDA040765	Aphena Pharma Solutions - Tennessee, LLC	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-482_5d499a9f-8647-4ede-bb94-ad6f2302d14f	71610-482	HUMAN PRESCRIPTION DRUG	Doxazosin		Doxazosin Mesylate	TABLET	ORAL	20180417		ANDA	ANDA209013	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-483_8d71968c-b273-4b5e-9afd-4f04e10c45cc	71610-483	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-484_8d71968c-b273-4b5e-9afd-4f04e10c45cc	71610-484	HUMAN PRESCRIPTION DRUG	METOPROLOL SUCCINATE		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20180101		NDA AUTHORIZED GENERIC	NDA019962	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-485_875c3303-147e-4bdf-98f2-8355c056e18f	71610-485	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	Aphena Pharma Solutions - Tennessee, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-486_875c3303-147e-4bdf-98f2-8355c056e18f	71610-486	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	Aphena Pharma Solutions - Tennessee, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-487_8be9c177-0bcb-46d8-85e9-ed00e321e040	71610-487	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170217		ANDA	ANDA202330	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
71610-488_2b23f47e-94fc-4aa3-9545-aaa81fdd1400	71610-488	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20070316		ANDA	ANDA040702	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-489_6ffe3e4e-9756-4d21-b5bf-afd5a3b551f6	71610-489	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-490_4d6b79ef-a2c8-4fdb-9b0b-0c050ac22b89	71610-490	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-491_4d6b79ef-a2c8-4fdb-9b0b-0c050ac22b89	71610-491	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-492_875c3303-147e-4bdf-98f2-8355c056e18f	71610-492	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	Aphena Pharma Solutions - Tennessee, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-493_875c3303-147e-4bdf-98f2-8355c056e18f	71610-493	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	Aphena Pharma Solutions - Tennessee, LLC	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-494_543ae21a-60f3-49e2-8bad-b9ee0f412235	71610-494	HUMAN PRESCRIPTION DRUG	Colchicine		Colchicine	TABLET, FILM COATED	ORAL	20200205		ANDA	ANDA210425	Aphena Pharma Solutions - Tennessee, LLC	COLCHICINE	.6	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
71610-495_35580504-c655-4630-8432-b54e6c71218d	71610-495	HUMAN PRESCRIPTION DRUG	Pioglitazone		Pioglitazone	TABLET	ORAL	20130213		ANDA	ANDA200268	Aphena Pharma Solutions - Tennessee, LLC	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
71610-499_349de2f9-ec60-43d7-990a-074c673aa7e3	71610-499	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190923		ANDA	ANDA209215	Aphena Pharma Solutions - Tennessee, LLC	GUAIFENESIN	600	mg/1			N	20241231
71610-500_c5cd8033-06bb-49dc-bbff-fb672f542567	71610-500	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190607		ANDA	ANDA203561	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-501_32ebbdd1-95af-465b-8d01-7382978517ce	71610-501	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20081120		ANDA	ANDA075682	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-502_83880a96-336b-4e03-ac29-a41e62d78f3c	71610-502	HUMAN PRESCRIPTION DRUG	BENZTROPINE MESYLATE		BENZTROPINE MESYLATE	TABLET	ORAL	20121128		ANDA	ANDA090168	Aphena Pharma Solutions - Tennessee, LLC	BENZTROPINE MESYLATE	1	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
71610-503_b23a32b3-7e6b-4b58-be96-303ac3ef069a	71610-503	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200330		ANDA	ANDA075317	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-505_a073904d-242b-43c8-a794-7b64b0fa1bda	71610-505	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200903		ANDA	ANDA078329	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-506_2027b984-d53d-41c0-914b-ff66535e0e51	71610-506	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20080103		ANDA	ANDA040657	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
71610-508_56a14d26-0c09-4a32-bec0-d4fba1003548	71610-508	HUMAN PRESCRIPTION DRUG	Vardenafil Hydrochloride		Vardenafil Hydrochloride	TABLET	ORAL	20181101		ANDA	ANDA209057	Aphena Pharma Solutions - Tennessee, LLC	VARDENAFIL HYDROCHLORIDE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-510_b23a32b3-7e6b-4b58-be96-303ac3ef069a	71610-510	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20200330		ANDA	ANDA075317	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-511_e02c5c89-bea0-4bca-b774-2c9faaec5e73	71610-511	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71610-513_7309a57d-a286-4cde-82fe-5a84f5823572	71610-513	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20081117		ANDA	ANDA071196	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71610-514_7309a57d-a286-4cde-82fe-5a84f5823572	71610-514	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20081117		ANDA	ANDA071258	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71610-515_c729c922-6bc9-4de2-9e95-44a9633e2c33	71610-515	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150522		ANDA	ANDA090061	Aphena Pharma Solutions - Tennessee, LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71610-516_5b74c199-4ea9-4e29-aeb4-57d2db903f12	71610-516	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Aphena Pharma Solutions - Tennessee, LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-518_592f5ce7-4f0c-4fa3-b6d2-7a48e70fbdbe	71610-518	HUMAN PRESCRIPTION DRUG	Ranolazine		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20201027		ANDA	ANDA212781	Aphena Pharma Solutions - Tennessee, LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71610-519_724d0446-c957-4ad7-81a2-685dc46ec67c	71610-519	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20110525		ANDA	ANDA090935	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-520_ab63782b-6982-4cd8-a80f-e8f3da372177	71610-520	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20170105		ANDA	ANDA204304	Aphena Pharma Solutions - Tennessee, LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71610-521_73591ad3-4894-41a5-968a-1955b2a52105	71610-521	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE	ORAL	20060327		ANDA	ANDA076917	Aphena Pharma Solutions - Tennessee, LLC	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
71610-522_dc443031-f5ad-43b3-bc5c-8e7f5a5c0e16	71610-522	HUMAN PRESCRIPTION DRUG	Pioglitazone Hydrochloride		Pioglitazone Hydrochloride	TABLET	ORAL	20130213		ANDA	ANDA200268	Aphena Pharma Solutions - Tennessee, LLC	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
71610-523_622e1f6b-89f8-4ade-ac9f-cebcf8d94aea	71610-523	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20030619		ANDA	ANDA076122	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	30	mg/1			N	20241231
71610-524_4dfb7a20-54ea-4e48-9f0d-03099593073f	71610-524	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene	TABLET	ORAL	20160629		ANDA	ANDA090842	Aphena Pharma Solutions - Tennessee, LLC	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71610-525_732b6511-4b64-4fff-b6c2-4256371f7ba8	71610-525	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201106		ANDA	ANDA071523	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71610-527_5364ce21-e700-4cce-bd59-aadec2a56428	71610-527	HUMAN PRESCRIPTION DRUG	Clopidogrel		clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20120517		ANDA	ANDA076274	Aphena Pharma Solutions - Tennessee, LLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
71610-528_ce757363-1c5a-476b-b373-dd5e7097d56a	71610-528	HUMAN OTC DRUG	Meclizine HCL		Meclizine HCl 25mg Chewable Tablets	TABLET, CHEWABLE	ORAL	20150501		OTC MONOGRAPH FINAL	part336	Aphena Pharma Solutions - Tennessee, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
71610-529_0bfae67d-9034-4ff1-b994-4c4245219a37	71610-529	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201001		ANDA	ANDA071523	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71610-530_732b6511-4b64-4fff-b6c2-4256371f7ba8	71610-530	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201106		ANDA	ANDA071524	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71610-531_b6fb6940-ceb3-4efd-ac81-6a42971012b6	71610-531	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190808		ANDA	ANDA040245	Aphena Pharma Solutions - Tennessee, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71610-532_afa576a9-24b6-40ee-99f6-9126eb884bed	71610-532	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-533_61eefdc5-924c-4798-a8fd-ed8155dd85c0	71610-533	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-534_2b8bb776-9f66-415a-b869-aded0e844450	71610-534	HUMAN PRESCRIPTION DRUG	Escitalopram oxalate		escitalopram	TABLET, FILM COATED	ORAL	20121001		ANDA	ANDA078604	Aphena Pharma Solutions - Tennessee, LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-536_9e5bfd56-544a-417b-97a5-1c3fe45ff979	71610-536	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-537_0bfae67d-9034-4ff1-b994-4c4245219a37	71610-537	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20201008		ANDA	ANDA071524	Aphena Pharma Solutions - Tennessee, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
71610-539_882a3c50-8604-4230-aeb5-9b9df2f02a15	71610-539	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20190522		ANDA	ANDA203245	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-540_11c79cec-987d-4bce-b8ce-ba3edbe60dc6	71610-540	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	Aphena Pharma Solutions - Tennessee, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-541_2f340031-6d65-4f5d-8a70-cd247c832a81	71610-541	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	Aphena Pharma Solutions - Tennessee, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
71610-542_c7a932c0-6588-459a-bbcc-222f304fe61b	71610-542	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20100630		ANDA	ANDA077918	Aphena Pharma Solutions - Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-544_dbe2faa6-75ee-4c6d-9bd9-c91b63851a25	71610-544	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20200217		ANDA	ANDA077927	Aphena Pharma Solutions - Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-545_1ec4ab78-d5f1-4b20-a954-7cf965952c76	71610-545	HUMAN PRESCRIPTION DRUG	Folic acid		Folic Acid	TABLET	ORAL	20190530		ANDA	ANDA090035	Aphena Pharma Solutions - Tennessee, LLC	FOLIC ACID	1	mg/1			N	20241231
71610-547_19cc7ade-51b3-44f2-9bb1-a7a22909af97	71610-547	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20011114		ANDA	ANDA075682	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-549_4352eb55-77a1-48c6-9961-3e2cb065b610	71610-549	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA205236	Aphena Pharma Solutions - Tennessee, LLC	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71610-550_19cc7ade-51b3-44f2-9bb1-a7a22909af97	71610-550	HUMAN PRESCRIPTION DRUG	IBU		Ibuprofen	TABLET	ORAL	20011114		ANDA	ANDA075682	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-552_c1d3e675-06e2-4905-b18c-5ffa0a9428bf	71610-552	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20140516		ANDA	ANDA090455	Aphena Pharma Solutions - Tennessee, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71610-553_41f27cca-3947-46da-8b3d-92dda6601e17	71610-553	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20190220		ANDA	ANDA076301	Aphena Pharma Solutions - Tennessee, LLC	LORATADINE	10	mg/1			N	20241231
71610-554_91ab7bd9-ef80-437c-967b-3f11991c2139	71610-554	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180717		ANDA	ANDA207427	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-555_6294af43-cbbe-4566-9844-e32afc7a5f82	71610-555	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-556_4b804930-cb3d-41eb-b76f-afaff44ba395	71610-556	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040116		ANDA	ANDA076704	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-557_b418ff9e-6e72-4171-915b-4c1ec67c13c3	71610-557	HUMAN PRESCRIPTION DRUG	lithium carbonate		lithium carbonate	CAPSULE	ORAL	20091215		ANDA	ANDA090702	Aphena Pharma Solutions - Tennessee, LLC	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
71610-558_6294af43-cbbe-4566-9844-e32afc7a5f82	71610-558	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-559_4b804930-cb3d-41eb-b76f-afaff44ba395	71610-559	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040116		ANDA	ANDA076704	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-561_4352eb55-77a1-48c6-9961-3e2cb065b610	71610-561	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA205236	Aphena Pharma Solutions - Tennessee, LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71610-562_4352eb55-77a1-48c6-9961-3e2cb065b610	71610-562	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA205236	Aphena Pharma Solutions - Tennessee, LLC	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71610-563_c18bda87-c173-4af7-9517-43568b1b2727	71610-563	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20210211		ANDA	ANDA202843	Aphena Pharma Solutions - Tennessee, LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
71610-564_64f6704f-5cba-4299-b85f-d95bb633f29d	71610-564	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate	Extended-Release	Zolpidem Tartrate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20101203		ANDA	ANDA078148	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-565_4b804930-cb3d-41eb-b76f-afaff44ba395	71610-565	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	TABLET, FILM COATED	ORAL	20040116		ANDA	ANDA076704	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-566_99e98faa-0c9a-4870-aabd-0edece49ff6b	71610-566	HUMAN PRESCRIPTION DRUG	Diphenoxylate hydrochloride and atropine sulfate		Diphenoxylate hydrochloride and Atropine sulfate	TABLET	ORAL	20180831		ANDA	ANDA210571	Aphena Pharma Solutions - Tennessee, LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
71610-567_afa5157f-90d2-4c11-8dd2-4251ab58d3ea	71610-567	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA209744	Aphena Pharma Solutions - Tennessee, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-571_f8a8dd81-4a23-4a7a-9ff5-2684499be0a8	71610-571	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	19890516		ANDA	ANDA072575	Aphena Pharma Solutions - Tennessee, LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-573_94dbe4d4-48d3-41da-bcdf-ffac7505d0ac	71610-573	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-574_1997af85-ab19-433b-9467-e360932e3edf	71610-574	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-575_1997af85-ab19-433b-9467-e360932e3edf	71610-575	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-576_a21c94b7-5512-4999-bb4b-308c6008569c	71610-576	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210415		ANDA	ANDA205794	Aphena Pharma Solutions - Tennessee, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71610-577_0df8f6fc-4e63-401a-b8c5-360f91006687	71610-577	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	19821001		ANDA	ANDA085828	Aphena Pharma Solutions - Tennessee, LLC	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
71610-578_ae39b6bc-4b1a-4db9-b5a1-7195832a1cec	71610-578	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20181027		ANDA	ANDA206145	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-579_2a0b8046-be8b-4599-bd8a-53c0af032852	71610-579	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20210406		ANDA	ANDA074260	Aphena Pharma Solutions - Tennessee, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
71610-580_e66a0da6-9682-4fe2-ac36-0cd8bf98d9ee	71610-580	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Aphena Pharma Solutions - Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-581_8d4b2e53-8d7c-4c86-a25f-8c144a5c542c	71610-581	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA209744	Aphena Pharma Solutions - Tennessee, LLC	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-582_a21c94b7-5512-4999-bb4b-308c6008569c	71610-582	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210415		ANDA	ANDA205794	Aphena Pharma Solutions - Tennessee, LLC	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71610-583_2492146f-a606-419e-b4b5-83bb8d042e46	71610-583	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20200217		ANDA	ANDA077927	Aphena Pharma Solutions - Tennessee, LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-584_b3ea8ff0-0539-46fc-9ab6-aa6e8cb72549	71610-584	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210415		ANDA	ANDA205129	Aphena Pharma Solutions - Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-587_0f023696-fd07-41a2-8f06-bf3472b28de2	71610-587	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180717		ANDA	ANDA207427	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-588_2f083ab0-ee16-4094-97f2-534bf35296d6	71610-588	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-589_3673e690-2fb5-4235-94a8-dd46c7cee8b9	71610-589	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-590_a13f7ad0-b9c2-43c3-88cf-f232eacb2140	71610-590	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	Aphena Pharma Solutions - Tennessee, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-591_705546f2-9f9c-4b26-b5a6-f3d32bc92c60	71610-591	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210604		ANDA	ANDA212517	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-592_705546f2-9f9c-4b26-b5a6-f3d32bc92c60	71610-592	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210604		ANDA	ANDA212517	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-593_3673e690-2fb5-4235-94a8-dd46c7cee8b9	71610-593	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin Sodium	TABLET	ORAL	19990715		ANDA	ANDA040301	Aphena Pharma Solutions - Tennessee, LLC	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
71610-594_2b26376c-c9c8-4d68-aec5-f3aa773fe7f9	71610-594	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-595_2b26376c-c9c8-4d68-aec5-f3aa773fe7f9	71610-595	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-596_828fb9f6-df15-4aaf-9562-c17fe0e32197	71610-596	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
71610-597_b86a9e2f-2e2c-4ca7-b3d7-2615e53ae369	71610-597	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210604		ANDA	ANDA212517	Aphena Pharma Solutions - Tennessee, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-598_0d749d2c-80a9-4bc4-975e-cd9475de438a	71610-598	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	19820101		ANDA	ANDA086988	Aphena Pharma Solutions - Tennessee, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-599_0d749d2c-80a9-4bc4-975e-cd9475de438a	71610-599	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	19820101		ANDA	ANDA086989	Aphena Pharma Solutions - Tennessee, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
71610-600_c21d4b84-cd42-458a-a695-a9d237afaaa6	71610-600	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20170324		ANDA	ANDA203572	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-601_8cfd64d4-38e2-4c2c-97b0-9284da5fe6da	71610-601	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210120		ANDA	ANDA214603	Aphena Pharma Solutions - Tennessee, LLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
71610-602_a7634afa-7ea2-43dd-8fe4-520d827c2725	71610-602	HUMAN PRESCRIPTION DRUG	triamterene and hydrochlorothiazide		triamterene and hydrochlorothiazide	TABLET	ORAL	20180904		ANDA	ANDA208360	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-603_fb3804c0-3aec-487e-8c7f-102df699c1dc	71610-603	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA209744	Aphena Pharma Solutions - Tennessee, LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-604_26f4d74c-2212-4bc2-ad7a-d9cb43a1ea34	71610-604	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
71610-605_be54582f-c05d-4e2f-87fc-56bf6098f410	71610-605	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-606_530e3bfa-2893-4f97-815c-b943e8d2415d	71610-606	HUMAN PRESCRIPTION DRUG	Venlafaxine		Venlafaxine	TABLET	ORAL	20080613		ANDA	ANDA078627	Aphena Pharma Solutions - Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-607_24ffbc01-0a61-4225-8172-25a3ef452b57	71610-607	HUMAN OTC DRUG	Simethicone		Simethicone	TABLET, CHEWABLE	ORAL	20110301		OTC MONOGRAPH FINAL	part332	Aphena Pharma Solutions - Tennessee, LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
71610-608_2d05f5d2-27b7-413b-bd6c-43d3e047e38a	71610-608	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20170217		ANDA	ANDA202330	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
71610-609_ed131a35-eda8-4cdb-a6f0-eae48ea1c59e	71610-609	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-610_ed131a35-eda8-4cdb-a6f0-eae48ea1c59e	71610-610	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-611_ed131a35-eda8-4cdb-a6f0-eae48ea1c59e	71610-611	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-612_7fce9fa4-5381-42ba-a267-46c75292c59a	71610-612	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-613_f3600a2e-5f2c-4af5-a095-36ea99cc82e7	71610-613	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20180731		ANDA	ANDA209313	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-614_e48d1cac-a221-44f5-b2da-7c7a1777e7d7	71610-614	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20200501		ANDA	ANDA077241	Aphena Pharma Solutions - Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71610-615_f4ad952e-eb20-44b8-aff0-f7aac8ec7690	71610-615	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-617_71d51e86-d125-48bc-8c1a-0f08ed9d547e	71610-617	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	Aphena Pharma Solutions - Tennessee, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71610-618_5ffdcd88-4c3c-4cb2-94b8-4092879b7300	71610-618	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
71610-619_5ffdcd88-4c3c-4cb2-94b8-4092879b7300	71610-619	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
71610-620_c7dd30c8-f668-4173-aa7b-8357eb41b207	71610-620	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110425		ANDA	ANDA078552	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-621_bc931d95-28ae-405b-ad93-e1fe0b51eab9	71610-621	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-622_86b78fe2-ccb5-45de-8746-f8bcbcead975	71610-622	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-623_86b78fe2-ccb5-45de-8746-f8bcbcead975	71610-623	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20151217		ANDA	ANDA078034	Aphena Pharma Solutions - Tennessee, LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-624_6224d557-1df2-46fb-bebd-eb8bdf81c897	71610-624	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210601		ANDA	ANDA077321	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-625_cd40268a-d9c7-4fff-be1e-e4b4535efd52	71610-625	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		temazepam	CAPSULE	ORAL	20100223		NDA	NDA018163	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-626_cd40268a-d9c7-4fff-be1e-e4b4535efd52	71610-626	HUMAN PRESCRIPTION DRUG	TEMAZEPAM		temazepam	CAPSULE	ORAL	20100223		NDA	NDA018163	Aphena Pharma Solutions - Tennessee, LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-627_a0e2c947-679d-44ae-80a2-3a6fa06e2441	71610-627	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200903		ANDA	ANDA078329	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-628_ac6242cd-cdb3-48a7-915f-c635e71807cd	71610-628	HUMAN PRESCRIPTION DRUG	Doxazosin		doxazosin	TABLET	ORAL	20211019		NDA AUTHORIZED GENERIC	NDA019668	Aphena Pharma Solutions - Tennessee, LLC	DOXAZOSIN MESYLATE	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-629_fb594a68-2160-4213-948a-02473c64c53c	71610-629	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-630_12e0dcb9-e210-413b-9c77-cdeccd600e82	71610-630	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-631_c5c95e4f-541c-478d-9a40-28813a12969a	71610-631	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-632_91721049-7365-4fbc-8b22-5f6b49fcb828	71610-632	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210120		ANDA	ANDA214422	Aphena Pharma Solutions - Tennessee, LLC	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71610-633_24733c5a-94ea-400b-8e16-62cf696802b1	71610-633	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA090548	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-634_e9231c86-1596-42eb-b1f8-61747c75f030	71610-634	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20220104		ANDA	ANDA076796	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71610-635_e9231c86-1596-42eb-b1f8-61747c75f030	71610-635	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20220104		ANDA	ANDA076796	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71610-636_e9231c86-1596-42eb-b1f8-61747c75f030	71610-636	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20220104		ANDA	ANDA076796	Aphena Pharma Solutions - Tennessee, LLC	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71610-637_5d082e37-f27a-4be2-bf4c-8e1c5bb976af	71610-637	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Aphena Pharma Solutions - Tennessee, LLC	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-638_d7a97460-5f05-45fe-8943-23c7c8f1deef	71610-638	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-639_7aebd188-6319-41ca-950d-352ced2eeb19	71610-639	HUMAN PRESCRIPTION DRUG	Oxazepam		Oxazepam	CAPSULE	ORAL	20210601		ANDA	ANDA071026	Aphena Pharma Solutions - Tennessee, LLC	OXAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-640_210a82b7-8b08-42e6-8a9f-da481485dd4f	71610-640	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20140825		ANDA	ANDA202330	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
71610-641_f649b29f-331d-4208-b878-16e103986fbd	71610-641	HUMAN PRESCRIPTION DRUG	PredniSONE		PredniSONE	TABLET	ORAL	19820101		ANDA	ANDA080352	Aphena Pharma Solutions - Tennessee, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71610-642_2d0c7cc9-b09e-4014-809e-c9e30ab481ca	71610-642	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	Aphena Pharma Solutions - Tennessee, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-643_872fc6c8-cdb2-4056-a5c8-874389bb6605	71610-643	HUMAN PRESCRIPTION DRUG	VARDENAFIL		VARDENAFIL	TABLET, FILM COATED	ORAL	20181031		ANDA	ANDA208960	Aphena Pharma Solutions - Tennessee, LLC	VARDENAFIL HYDROCHLORIDE TRIHYDRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-644_2885c2c3-2f93-4cb1-983d-fd818c71273b	71610-644	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220310		ANDA	ANDA091625	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-645_2885c2c3-2f93-4cb1-983d-fd818c71273b	71610-645	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220310		ANDA	ANDA091625	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-646_2885c2c3-2f93-4cb1-983d-fd818c71273b	71610-646	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220310		ANDA	ANDA091625	Aphena Pharma Solutions - Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-647_188d3827-60b2-4893-a8db-21433377eb1c	71610-647	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET	ORAL	20210507		ANDA	ANDA214092	Aphena Pharma Solutions - Tennessee, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
71610-648_6971060e-f7f3-4055-837d-9c5a16e8ff6d	71610-648	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20200925		ANDA	ANDA215001	Aphena Pharma Solutions - Tennessee, LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
71610-649_b90721af-b67e-4a2e-b05c-a679f5842c0e	71610-649	HUMAN OTC DRUG	SIMETHICONE		Simethicone	TABLET, CHEWABLE	ORAL	20040101		OTC MONOGRAPH FINAL	part332	Aphena Pharma Solutions - Tennessee, LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
71610-650_f65851fe-74aa-46e7-b72e-fe8d7f78deae	71610-650	HUMAN OTC DRUG	Antiflatulent		Simethicone	TABLET, CHEWABLE	ORAL	20211004		OTC MONOGRAPH FINAL	part332	Aphena Pharma Solutions - Tennessee, LLC	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
71610-651_a189f92d-a14a-45be-8f55-4b81fe2dce92	71610-651	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20170209		ANDA	ANDA202825	Aphena Pharma Solutions - Tennessee, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-652_2f692050-7ea1-49b8-a19d-3b0134b7aa2a	71610-652	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220328		ANDA	ANDA078596	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-653_6c0bca16-d681-48d1-a07a-93d9d0f3acef	71610-653	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220501		ANDA	ANDA202882	Aphena Pharma Solutions - Tennessee, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-654_c59e96b8-b58f-412b-91ef-b83269262922	71610-654	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211011		ANDA	ANDA072926	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-655_c59e96b8-b58f-412b-91ef-b83269262922	71610-655	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20210720		ANDA	ANDA072928	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-656_017f87a0-dedf-4942-923b-2bc510e9aafa	71610-656	HUMAN PRESCRIPTION DRUG	FOLIC ACID		folic acid	TABLET	ORAL	20150804		ANDA	ANDA204418	Aphena Pharma Solutions - Tennessee, LLC	FOLIC ACID	1	mg/1			N	20241231
71610-657_a894a6af-5fb0-4bdf-84db-5662ad390737	71610-657	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20061207		ANDA	ANDA077918	Aphena Pharma Solutions - Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71610-658_24bc1717-1cba-4452-a2db-f53e513329b2	71610-658	HUMAN PRESCRIPTION DRUG	Atenolol		atenolol	TABLET	ORAL	19990426		ANDA	ANDA073457	Aphena Pharma Solutions - Tennessee, LLC	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71610-659_269544ac-1dea-4047-87e6-6e04ff951b55	71610-659	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220501		ANDA	ANDA202882	Aphena Pharma Solutions - Tennessee, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-660_70e07130-7d44-48d3-9ad3-f9ea3477ba2e	71610-660	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Aphena Pharma Solutions - Tennessee, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
71610-661_7ecf7f4e-e65c-4dde-9db9-20a170a427c9	71610-661	HUMAN PRESCRIPTION DRUG	Alogliptin		Alogliptin	TABLET, FILM COATED	ORAL	20160408		NDA AUTHORIZED GENERIC	NDA022271	Aphena Pharma Solutions - Tennessee, LLC	ALOGLIPTIN BENZOATE	12.5	mg/1	Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]		N	20241231
71610-662_c42aeca0-6ad0-4382-8d81-077fe3a44ccb	71610-662	HUMAN PRESCRIPTION DRUG	ELIQUIS		apixaban	TABLET, FILM COATED	ORAL	20121228		NDA	NDA202155	Aphena Pharma Solutions - Tennessee, LLC	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
71610-663_4fdb1ed1-f431-46a3-a80d-6177750f5ea3	71610-663	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20201210		ANDA	ANDA212977	Aphena Pharma Solutions - Tennessee, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-664_52e6d4be-7d56-484c-871c-4359f7067273	71610-664	HUMAN PRESCRIPTION DRUG	Carbidopa and levodopa		Carbidopa and levodopa	TABLET	ORAL	20220315		ANDA	ANDA074260	Aphena Pharma Solutions - Tennessee, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
71610-665_1364b6a6-b1c3-49db-80ba-45e060cb4cf5	71610-665	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180531		ANDA	ANDA209735	Aphena Pharma Solutions - Tennessee, LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-666_716a8b04-440a-4112-ab55-ba4ad134e3d8	71610-666	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride	ER	Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180628		ANDA	ANDA207427	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-667_96c283e4-dad6-4cc6-88cf-7c50285ef6a3	71610-667	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-668_737c6102-3cac-4ef5-812b-13e0298c7210	71610-668	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950831		ANDA	ANDA074497	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71610-669_e506a2bd-d302-475f-bc4f-85320d1f6032	71610-669	HUMAN OTC DRUG	Sodium Bicarbonate Antacid		Sodium Bicarbonate	TABLET	ORAL	20150325		OTC MONOGRAPH FINAL	part331	Aphena Pharma Solutions - Tennessee, LLC	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
71610-670_3613ad67-3a05-4718-8c94-ef4c72a58f12	71610-670	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-671_2d778122-9382-4e15-a927-d652112b3606	71610-671	HUMAN PRESCRIPTION DRUG	losartan potassium and hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20170721		ANDA	ANDA204832	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-672_f37e1ca3-ffdc-4b2c-bfe4-975e4121d2c1	71610-672	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20150201		ANDA	ANDA203769	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-673_2e3c04ee-8af6-4b53-88eb-833fdb555094	71610-673	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20190626		ANDA	ANDA090564	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-674_c59e96b8-b58f-412b-91ef-b83269262922	71610-674	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211209		ANDA	ANDA072927	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-675_f4dbdb1b-c31d-4418-abd9-883eef04d5bd	71610-675	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20220701		ANDA	ANDA207178	Aphena Pharma Solutions - Tennessee, LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-676_e28187c8-a987-4806-8652-c28f514db907	71610-676	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20200922		ANDA	ANDA204467	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-677_31933238-b79e-44d1-a237-74f50a8705db	71610-677	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
71610-678_8fc2ce8f-5707-4329-adc7-b1776451e7ea	71610-678	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20150429		ANDA	ANDA203154	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-679_f4dbdb1b-c31d-4418-abd9-883eef04d5bd	71610-679	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20220701		ANDA	ANDA207178	Aphena Pharma Solutions - Tennessee, LLC	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-680_737c6102-3cac-4ef5-812b-13e0298c7210	71610-680	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	19950831		ANDA	ANDA074497	Aphena Pharma Solutions - Tennessee, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71610-681_fe21f4f9-59eb-4885-90b5-c2859a714516	71610-681	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20220301		ANDA	ANDA204467	Aphena Pharma Solutions - Tennessee, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71610-682_cb38eff9-6aab-40c4-9754-7fd9824fa56f	71610-682	HUMAN PRESCRIPTION DRUG	CHLORTHALIDONE		CHLORTHALIDONE	TABLET	ORAL	20221020		ANDA	ANDA210742	Aphena Pharma Solutions - Tennessee, LLC	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
71610-683_7088632f-e68a-40cb-a04f-3321b323a38e	71610-683	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20221024		ANDA	ANDA204597	Aphena Pharma Solutions - Tennessee, LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-684_68e2e6a9-4c93-43ed-ad09-0d20e354c9ea	71610-684	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	19980505		ANDA	ANDA071251	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-685_e12198af-3556-407d-bac7-29b6ea6cc45f	71610-685	HUMAN PRESCRIPTION DRUG	Modafinil		modafinil	TABLET	ORAL	20140203		ANDA	ANDA077667	Aphena Pharma Solutions - Tennessee, LLC	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
71610-686_d26d400a-ed41-4b07-91e3-ff207c4b8381	71610-686	HUMAN PRESCRIPTION DRUG	HydrOXYzine Hydrochloride		HydrOXYzine Hydrochloride	TABLET	ORAL	20091111		ANDA	ANDA040840	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71610-687_a4b2d571-c110-49fb-8eff-688308608ae3	71610-687	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	5 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-688_1d214781-e888-4db5-958c-6716cb30f03d	71610-688	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Aphena Pharma Solutions - Tennessee, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-689_57e2138d-9144-44c7-926e-73810d632cec	71610-689	HUMAN PRESCRIPTION DRUG	Nifedipine		nifedipine	TABLET, EXTENDED RELEASE	ORAL	20160825		ANDA	ANDA202987	Aphena Pharma Solutions - Tennessee, LLC	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-690_d0758929-1cc8-4ac2-807e-969a8c7f6c77	71610-690	HUMAN PRESCRIPTION DRUG	Xarelto		rivaroxaban	TABLET, FILM COATED	ORAL	20110701		NDA	NDA022406	Aphena Pharma Solutions - Tennessee, LLC	RIVAROXABAN	10	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
71610-691_9417d815-3b9a-4f80-93bc-3452217d5fe9	71610-691	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20110425		ANDA	ANDA078552	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-692_48b92534-e189-4b18-906f-8a4abcb776a4	71610-692	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170118		ANDA	ANDA081297	Aphena Pharma Solutions - Tennessee, LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
71610-693_8c268130-91fd-4e37-831d-e4410398666b	71610-693	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230117		ANDA	ANDA214608	Aphena Pharma Solutions - Tennessee, LLC	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-694_8c268130-91fd-4e37-831d-e4410398666b	71610-694	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230117		ANDA	ANDA214608	Aphena Pharma Solutions - Tennessee, LLC	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-695_9b34dd5c-22e5-440d-a552-070aaeeefd55	71610-695	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71610-696_f27967d7-9517-4c95-81a2-29408e707f5a	71610-696	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Aphena Pharma Solutions - Tennessee, LLC	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-697_f8ee7709-8833-4ebb-9dbd-a2d75f6665bf	71610-697	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
71610-698_c97f447e-0233-4a6c-9bed-7dec551aaa95	71610-698	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	20200630		ANDA	ANDA074823	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-699_7088632f-e68a-40cb-a04f-3321b323a38e	71610-699	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20221024		ANDA	ANDA204597	Aphena Pharma Solutions - Tennessee, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
71610-700_23fad7c7-8db8-44c2-9df4-26a05c74c157	71610-700	HUMAN OTC DRUG	Bisacodyl		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20181201		OTC MONOGRAPH NOT FINAL	part334	Aphena Pharma Solutions - Tennessee, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71610-701_7576e78c-5a06-4d83-9f31-bca0a0cfbe87	71610-701	HUMAN PRESCRIPTION DRUG	HYDROXYCHLOROQUINE SULFATE		HYDROXYCHLOROQUINE SULFATE	TABLET	ORAL	20180501		ANDA	ANDA210441	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
71610-702_1b43ca4a-8d47-4085-b50f-b282980f39e3	71610-702	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20220525		ANDA	ANDA077745	Aphena Pharma Solutions - Tennessee, LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
71610-703_ee8718a4-d803-4a58-9c87-06987c7dd356	71610-703	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71610-704_921b4089-8bd5-4081-9251-59b30b01afd9	71610-704	HUMAN PRESCRIPTION DRUG	OMEPRAZOLE		OMEPRAZOLE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20170703		ANDA	ANDA203481	Aphena Pharma Solutions - Tennessee, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71610-706_a5313f88-2d90-4f75-afb8-9dde2a069fa7	71610-706	HUMAN PRESCRIPTION DRUG	Sulfasalazine		Sulfasalazine	TABLET	ORAL	20030701		NDA AUTHORIZED GENERIC	NDA007073	Aphena Pharma Solutions - Tennessee, LLC	SULFASALAZINE	500	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
71610-707_391af5b8-2992-47ad-80dd-9b5c373f7ce4	71610-707	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		divalproex sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090202		ANDA	ANDA077567	Aphena Pharma Solutions - Tennessee, LLC	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71610-708_512751a6-66a2-4ce8-bb22-053853f0300b	71610-708	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Aphena Pharma Solutions - Tennessee, LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
71610-709_20d6175b-0f94-4133-8b95-b8e3a4ef4139	71610-709	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20011217		ANDA	ANDA075551	Aphena Pharma Solutions - Tennessee, LLC	LOVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-710_ee8718a4-d803-4a58-9c87-06987c7dd356	71610-710	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71610-711_ee8718a4-d803-4a58-9c87-06987c7dd356	71610-711	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71610-712_e55a509a-a82e-48d9-94a3-cb86804186cd	71610-712	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	Aphena Pharma Solutions - Tennessee, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
71610-713_f2e7c35d-7c1f-47c3-9879-0ab71aa7a869	71610-713	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	30	mg/1			N	20241231
71610-714_d2906ede-d6cd-449f-83ac-a087b2cec958	71610-714	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		diphenoxylate hydrochloride and atropine sulfate	TABLET	ORAL	20201030		ANDA	ANDA213335	Aphena Pharma Solutions - Tennessee, LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
71610-715_02e1512f-a37e-4a25-82a0-18d8b1af9193	71610-715	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-716_5cf2ccb5-da8a-4a69-9501-11ba0a4cc294	71610-716	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20180209		ANDA	ANDA211064	Aphena Pharma Solutions - Tennessee, LLC	FOLIC ACID	1	mg/1			N	20241231
71610-717_4092fb19-ff2d-4329-aa77-bcc947c6a1a8	71610-717	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20070822		ANDA	ANDA077666	Aphena Pharma Solutions - Tennessee, LLC	MIRTAZAPINE	15	mg/1			N	20241231
71610-719_e55c4611-1f77-4688-9322-f9dd200cdb5a	71610-719	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20210824		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
71610-720_36abefd8-65ef-4ad1-8454-2ac6570b85cd	71610-720	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-721_53cd9821-aed5-4cfe-bcbb-00b71545ea1e	71610-721	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20200204		ANDA	ANDA040362	Aphena Pharma Solutions - Tennessee, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71610-722_6a351e58-9bae-490f-afde-369a851ba74b	71610-722	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20071102		ANDA	ANDA077955	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-723_15689e23-7236-4cfd-8ab4-9b8450b82299	71610-723	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20020926		ANDA	ANDA076140	Aphena Pharma Solutions - Tennessee, LLC	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
71610-724_fa62b406-5269-47dd-8787-8d6dc54e018b	71610-724	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20100427		ANDA	ANDA078225	Aphena Pharma Solutions - Tennessee, LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-726_03a22769-c7ac-496c-80c4-98f76c371987	71610-726	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20060113		ANDA	ANDA077321	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-727_1825c5d6-37dc-4efe-aa05-ec01b2695463	71610-727	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-728_5268667d-cc79-4033-9e1f-6417c8c7d28c	71610-728	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Aphena Pharma Solutions - Tennessee, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71610-729_e36b3cf7-33ab-42da-8eef-2fb77ba06369	71610-729	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719	20250430	NDA AUTHORIZED GENERIC	NDA021446	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	
71610-730_5692f24d-4e5b-4641-9296-215796be21e1	71610-730	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20140411		ANDA	ANDA078970	Aphena Pharma Solutions - Tennessee, LLC	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
71610-731_1825c5d6-37dc-4efe-aa05-ec01b2695463	71610-731	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-732_4f9271e4-d2e6-4456-a890-69d43dcf7496	71610-732	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20221001		ANDA	ANDA076846	Aphena Pharma Solutions - Tennessee, LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
71610-733_f6d2d007-eb94-4227-88d7-76df4b64f6e3	71610-733	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-734_18a18d8e-9c73-4ba6-b05a-b7aae1e82fc4	71610-734	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951229		ANDA	ANDA074112	Aphena Pharma Solutions - Tennessee, LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-735_e5dbdb97-f222-43f5-b261-8e91950377e4	71610-735	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71610-736_0c2b6f3c-0c28-4eff-be0d-cf22961050a3	71610-736	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-737_9f352e62-f8a6-4b97-9d27-a147a3439f71	71610-737	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71610-738_0df2d4c9-cc71-47ff-afb4-e2f49e551d75	71610-738	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Aphena Pharma Solutions - Tennessee, LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-739_42c97e8b-ff25-4a5a-a0b7-5d3154a61c0b	71610-739	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-740_d32116fd-aecc-47f1-b713-9c6d5cca6f82	71610-740	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA078596	Aphena Pharma Solutions - Tennessee, LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71610-741_9f5db76f-349d-4856-b7d9-ded1ab8ca656	71610-741	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170830		ANDA	ANDA075743	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-742_affa2e96-25b1-435b-9668-82dcd7a5777e	71610-742	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Aphena Pharma Solutions - Tennessee, LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
71610-743_b2733a60-855a-4d48-8339-dacb063c2c90	71610-743	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Aphena Pharma Solutions - Tennessee, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71610-744_5866cff8-7c35-4050-a75f-5e235b9d39b2	71610-744	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-745_5866cff8-7c35-4050-a75f-5e235b9d39b2	71610-745	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-746_5866cff8-7c35-4050-a75f-5e235b9d39b2	71610-746	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA205519	Aphena Pharma Solutions - Tennessee, LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
71610-747_04ca77ea-a8b9-43aa-a4d4-89dbd1bdc0c2	71610-747	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	19811214		ANDA	ANDA087479	Aphena Pharma Solutions - Tennessee, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
71610-748_9a8f313b-aada-4f6f-915d-c50f4304cacd	71610-748	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
71610-749_0af09c1a-e64b-4d54-9b26-7e7157208463	71610-749	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	19960918		ANDA	ANDA074569	Aphena Pharma Solutions - Tennessee, LLC	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-750_b68d1558-fe35-4440-9225-d0a5556a04b9	71610-750	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71610-751_b68d1558-fe35-4440-9225-d0a5556a04b9	71610-751	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71610-752_b68d1558-fe35-4440-9225-d0a5556a04b9	71610-752	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	19870714		ANDA	ANDA089399	Aphena Pharma Solutions - Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71610-753_9f1cfdaf-a07f-4f37-9f9c-695cafe6cfee	71610-753	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
71610-754_24954641-a737-4056-89df-792b0d0589d7	71610-754	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	200	mg/1		CV	N	20241231
71610-755_788794cf-21cc-4779-8235-02d190bb5d73	71610-755	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
71610-756_9f1cfdaf-a07f-4f37-9f9c-695cafe6cfee	71610-756	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
71610-757_9f1cfdaf-a07f-4f37-9f9c-695cafe6cfee	71610-757	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
71610-758_43388205-9926-420f-99ca-4882e24a9fad	71610-758	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
71610-759_43388205-9926-420f-99ca-4882e24a9fad	71610-759	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	200	mg/1		CV	N	20241231
71610-760_43388205-9926-420f-99ca-4882e24a9fad	71610-760	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	225	mg/1		CV	N	20241231
71610-761_27a52629-b6f7-4b68-a7ee-01a2175bf236	71610-761	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	Aphena Pharma Solutions - Tennessee, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
71610-762_4472e8c9-ad0a-4681-af7e-cdbe0e736c97	71610-762	HUMAN PRESCRIPTION DRUG	Terazosin Hydrochloride		Terazosin Hydrochloride	CAPSULE	ORAL	19980330		ANDA	ANDA074823	Aphena Pharma Solutions - Tennessee, LLC	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
71610-763_00e54b53-17fb-4504-994d-8aafa70511eb	71610-763	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20010524		ANDA	ANDA084903	Aphena Pharma Solutions - Tennessee, LLC	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
71610-764_0ce0322d-f996-d9e9-e063-6294a90a7386	71610-764	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20231219		ANDA	ANDA076045	Aphena Pharma Solutions - Tennessee, LLC	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71610-765_1d01cd72-b8fb-4066-8c8e-40427ab2d068	71610-765	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Aphena Pharma Solutions - Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20251231
71610-766_0f42d62b-5179-4b4e-ad6a-b718ce03de19	71610-766	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Aphena Pharma Solutions - Tennessee, LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20251231
71610-767_12caf943-5e83-4185-8d53-4b537f26087c	71610-767	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Aphena Pharma Solutions - Tennessee, LLC	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
71611-079_c7c1d47f-6f7a-31cc-e053-2a95a90a1f80	71611-079	HUMAN OTC DRUG	Antibacterial	Modess Basics	Benzalkonium Chloride 0.13%	CREAM	TOPICAL	20210722		OTC MONOGRAPH NOT FINAL	part333E	CLICK PRODUCTS LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71611-080_ca68be95-2ba0-77b5-e053-2995a90af70e	71611-080	HUMAN OTC DRUG	Benzalkonium Chloride	Modess Basics	Antibacterial wash	LIQUID	TOPICAL	20210825		OTC MONOGRAPH NOT FINAL	part333A	Click Products LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71611-127_0723ce51-5875-8a37-e063-6294a90aa69b	71611-127	HUMAN OTC DRUG	Vaporizing Chest Rub		Camphor, Eucalyptus Oil, Menthol	OINTMENT	TOPICAL	20211203		OTC MONOGRAPH DRUG	M012	CLICK PRODUCTS LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
71611-401_0723ce51-5876-8a37-e063-6294a90aa69b	71611-401	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL	70 PERCENT	ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20201125		OTC MONOGRAPH DRUG	M003	MY Sales LLC dba Click Products LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
71611-402_0723cb8b-7d7a-5d1a-e063-6294a90a64fc	71611-402	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL	99 PERCENT	ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20201125		OTC MONOGRAPH DRUG	M003	MY Sales LLC dba Click Products LLC	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
71613-001_7239c6fd-f68a-4f74-ad7c-368f90e3cb4f	71613-001	HUMAN OTC DRUG	Cleansing Wipes		Salicylic Acid	SWAB	TOPICAL	20170728		OTC MONOGRAPH FINAL	part333D	Nextcell Medical	SALICYLIC ACID	2	g/100mL			N	20241231
71614-002_f16cf75f-0e63-510e-e053-2995a90aec97	71614-002	HUMAN OTC DRUG	Parma Anus Skin Premium Cleanser		ALLANTOIN	GEL	TOPICAL	20180827		UNAPPROVED DRUG OTHER		PARMA KOREA.CO.LTD	ALLANTOIN	3	mg/mL			N	20241231
71614-003_f16d1ee4-2169-ea57-e053-2a95a90ad44c	71614-003	HUMAN OTC DRUG	Macoma Senior Premium Cleanser		ALLANTOIN	GEL	TOPICAL	20230104		UNAPPROVED DRUG OTHER		PARMA KOREA.CO.LTD	ALLANTOIN	10	mg/mL			N	20241231
71617-100_075dd6b0-74bf-8030-e063-6294a90a4c3e	71617-100	HUMAN OTC DRUG	CLEARSYNERGY		SALICYLIC ACID	LIQUID	TOPICAL	20170907		OTC MONOGRAPH DRUG	M006	SRL ENTERPRISES LLC	SALICYLIC ACID	.25	g/50mL			N	20241231
71617-102_075de2ba-b23f-8148-e063-6294a90a56b3	71617-102	HUMAN OTC DRUG	ClearSynergy		SALICYLIC ACID	CLOTH	TOPICAL	20200531		OTC MONOGRAPH DRUG	M006	SRL Enterprises, LLC	SALICYLIC ACID	5	mg/mL			N	20241231
71626-101_f538eaaa-1f19-4f02-b744-4749e899b54d	71626-101	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20180530		ANDA	ANDA207867	Medstone Pharma LLC	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71626-102_f538eaaa-1f19-4f02-b744-4749e899b54d	71626-102	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20180530		ANDA	ANDA207867	Medstone Pharma LLC	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71626-502_c534ff05-3d4f-43e5-8b6d-bc7385c94de8	71626-502	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCL	TABLET, COATED	ORAL	20191001	20250131	ANDA	ANDA204097	Medstone Pharma LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
71626-502_da618c87-4310-4ca3-a534-f5142d518c35	71626-502	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCL	TABLET, COATED	ORAL	20191001	20250131	ANDA	ANDA204097	Medstone Pharma LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
71630-147_f3836517-e3ed-5e9e-e053-2a95a90a7af1	71630-147	HUMAN OTC DRUG	doTERRA sun Face Daily Moisturizer		Zinc oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH FINAL	part352	doTERRA International, LLC	ZINC OXIDE	13	g/100g			N	20241231
71630-175_dd308fef-e313-4ced-e053-2995a90a76fd	71630-175	HUMAN OTC DRUG	doTERRA Sun		zinc oxide	STICK	TOPICAL	20220601		OTC MONOGRAPH FINAL	part352	doTERRA International, LLC	ZINC OXIDE	17.6	g/100g			N	20241231
71630-966_dd2fa6a2-2ba9-4333-e053-2a95a90a9790	71630-966	HUMAN OTC DRUG	doTERRA Sun		Zinc Oxide	LOTION	TOPICAL	20220601		OTC MONOGRAPH FINAL	part352	doTERRA International, LLC	ZINC OXIDE	16.3	g/100g			N	20241231
71644-003_08a09a89-ebfc-85a6-e063-6294a90a25ea	71644-003	HUMAN OTC DRUG	Cyberderm	Simply Zinc Ultra	Zinc oxide	LOTION	TOPICAL	20180330		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories Inc.	ZINC OXIDE	25	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-004_f1ffd8e8-c558-43d7-e053-2a95a90a316e	71644-004	HUMAN OTC DRUG	Cyberderm	Every Morning Sun Whip	Zinc oxide, Octinoxate	LOTION	TOPICAL	20180330		OTC MONOGRAPH FINAL	part352	Cyberderm Laboratories Inc.	OCTINOXATE; ZINC OXIDE	7.5; 15	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-005_08a09999-6d66-895c-e063-6294a90a8401	71644-005	HUMAN OTC DRUG	Eleven On the Defense	Sunscreen	Zinc oxide	LOTION	TOPICAL	20200126		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories Inc.	ZINC OXIDE	25	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-006_08a09a89-ebfd-85a6-e063-6294a90a25ea	71644-006	HUMAN OTC DRUG	Eleven Unrivaled Sun Serum		Zinc oxide	LIQUID	TOPICAL	20200126		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	25	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-007_08a08975-caea-576c-e063-6294a90adbcc	71644-007	HUMAN OTC DRUG	Ava Isa Sun Serum		Zinc oxide	LIQUID	TOPICAL	20200311		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	25	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-008_08a09a89-ebfe-85a6-e063-6294a90a25ea	71644-008	HUMAN OTC DRUG	Cyberderm Simply Zinc Lite		Zinc oxide	LOTION	TOPICAL	20200618		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories Inc.	ZINC OXIDE	25	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-009_08a09a89-ebff-85a6-e063-6294a90a25ea	71644-009	HUMAN OTC DRUG	Ava Isa Sun Lip Sun Whip	Clear Sunshine	Zinc oxide	CREAM	TOPICAL	20200618		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-010_08a0c3fb-27c9-336d-e063-6394a90a72ab	71644-010	HUMAN OTC DRUG	Ava Isa Sun Lip Sun Whip	Strawberry Zinnia	Zinc oxide	CREAM	TOPICAL	20200618		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-011_08a0c62c-8aa8-b8e5-e063-6294a90acd18	71644-011	HUMAN OTC DRUG	Ava Isa Sun Lip Sun Whip	Watermelon Lily	Zinc oxide	CREAM	TOPICAL	20200618		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-012_08a0c3fb-27cd-336d-e063-6394a90a72ab	71644-012	HUMAN OTC DRUG	Eleven Perfect Form Tinted Lip Balm	Game Day	Zinc oxide	CREAM	TOPICAL	20200618		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-013_08a0caa2-f04c-e78e-e063-6294a90a9528	71644-013	HUMAN OTC DRUG	Eleven Perfect Form Lip Balm	15 Love	Zinc oxide	CREAM	TOPICAL	20200618		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-014_08a0b6f7-7130-18ab-e063-6394a90a436d	71644-014	HUMAN OTC DRUG	Eleven Perfect Form Tinted Lip Balm	Power Player	Zinc oxide	CREAM	TOPICAL	20200618		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-015_08a0b6f7-7132-18ab-e063-6394a90a436d	71644-015	HUMAN OTC DRUG	Eleven Perfect Form Tinted Lip Balm	Venus	Zinc oxide	CREAM	TOPICAL	20210114		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories inc.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71644-016_0a10c6b4-255d-ba99-e063-6394a90aebaa	71644-016	HUMAN OTC DRUG	Ava Isa	Every Morning	Zinc oxide	LOTION	TOPICAL	20231107		OTC MONOGRAPH DRUG	M020	Cyberderm Laboratories Inc.	ZINC OXIDE	25	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71650-014_86df1fd3-dfe5-4d34-8b03-0261d62eabb6	71650-014	HUMAN OTC DRUG	KeeN Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20201013		OTC MONOGRAPH NOT FINAL	part333A	Global Cosmetics (china) Company Limited	ALCOHOL	750	mL/L			N	20241231
71650-031_3e2acb17-446d-4910-8500-c184c60a7425	71650-031	HUMAN OTC DRUG	MODERN EXPRESSIONS HAND SANITIZER SET		Ethyl alcohol	GEL	TOPICAL	20210712		OTC MONOGRAPH NOT FINAL	part333A	Global Cosmetics (China) Company Limited	ALCOHOL	75	mL/100mL			N	20241231
71654-003_080250a0-64ae-c5ba-e063-6394a90a10c4	71654-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20170830		NDA	NDA205766	SOUTHERN GAS AND SUPPLY, INC. dba Gas and Supply	NITROGEN	995	mL/L			N	20241231
71654-005_08024afc-6236-fcf5-e063-6294a90afbf2	71654-005	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170830		NDA	NDA205767	SOUTHERN GAS AND SUPPLY, INC. dba Gas and Supply	OXYGEN	995	mL/L			N	20241231
71655-103_8bdc1b76-3c74-4a6a-8a82-86a6a09f6c1d	71655-103	HUMAN PRESCRIPTION DRUG	Raxibacumab		raxibacumab	INJECTION	INTRAVENOUS	20121214		BLA	BLA125349	Emergent Manufacturing Operations Baltimore LLC	RAXIBACUMAB	50	mg/mL	Anthrax Protective Antigen-directed Antibody Interactions [MoA], Anthrax Protective Antigen-directed Antibody [EPC]		N	20241231
71656-021_5d3e2d67-6916-4690-9dd0-fbdc3aaba75b	71656-021	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE ORAL	SOLUTION	ORAL	20231005		ANDA	ANDA211648	Saptalis Pharmaceuticals, LLC	POTASSIUM CHLORIDE	1.5	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71656-022_5d3e2d67-6916-4690-9dd0-fbdc3aaba75b	71656-022	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20231005		ANDA	ANDA211648	Saptalis Pharmaceuticals, LLC	POTASSIUM CHLORIDE	3	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71656-042_5de11b51-9f0f-4b8f-a010-e3dbf23c42b8	71656-042	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		triamcinolone acetonide	CREAM	TOPICAL	20230811		ANDA	ANDA040671	Saptalis Pharmaceuticals, LLC.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71662-000_00b40df3-c247-db4a-e063-6394a90a895c	71662-000	HUMAN OTC DRUG	Re-Lieved Lidocaine Patch		Lidocaine Patch 4%	PATCH	TOPICAL	20230717		OTC MONOGRAPH DRUG	M017	Transfer Technology	LIDOCAINE	18	mg/116cm2	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71662-000_00b467be-2d7b-dd8b-e063-6394a90ad862	71662-000	HUMAN OTC DRUG	Re-Lieved Lidocaine Patch		Lidocaine patch 4%	PATCH	TOPICAL	20230723		OTC MONOGRAPH DRUG	M017	Transfer Technology	LIDOCAINE	18	mg/116cm2	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71662-000_019153d9-74bf-658f-e063-6294a90aa2bf	71662-000	HUMAN OTC DRUG	Re-Lieved Lidocaine Patch		Lidocaine Patch 4%	PATCH	TOPICAL	20231102		OTC MONOGRAPH DRUG	M017	Transfer Technology	LIDOCAINE	18	mg/116cm2	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71662-001_ba5cd48c-cd44-2f63-e053-2a95a90a930f	71662-001	HUMAN OTC DRUG	Re-Lieved Lidocaine Patch		Lidocaine Patch 4%	PATCH	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part348	Transfer Technology	LIDOCAINE; MENTHOL, (+)-	4; 1	mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71662-002_e9a894f2-6c07-c159-e053-2a95a90a8a33	71662-002	HUMAN OTC DRUG	Re-Lieved 4% Lidocaine Fabric Tape		Lidocaine 4% Fabric Tape	PATCH	TOPICAL	20220927		OTC MONOGRAPH NOT FINAL	part348	Transfer Technology	LIDOCAINE	18	mg/116cm2	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71662-003_e9ab9a03-b9e4-7317-e053-2995a90a9950	71662-003	HUMAN OTC DRUG	Re-Lieved 3 in 1 Patch		Menthol, Camphor, Methyl Salicylate Patch	PATCH	TOPICAL	20220927		OTC MONOGRAPH NOT FINAL	part348	Transfer Technology	CAMPHOR (SYNTHETIC); MENTHOL, (+)-; METHYL SALICYLATE	3; 6; 10	mg/100mg; mg/100mg; mg/100mg			N	20241231
71665-001_9b03fee7-6174-4362-9b11-d4c069f3eb3d	71665-001	VACCINE	CYFENDUS		Anthrax Vaccine Adsorbed, Adjuvanted	INJECTION, SUSPENSION	INTRAMUSCULAR	20230919		BLA	BLA125761	Emergent Product Development Gaithersburg Inc.	BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS	100	ug/mL	Actively Acquired Immunity [PE], Anthrax Vaccines [Chemical/Ingredient], Live Attenuated Bacillus Anthracis Vaccine [EPC], Vaccines, Attenuated [Chemical/Ingredient]		N	20241231
71665-330_f8b2634b-ccd7-4a42-8db3-26ba9e9627e6	71665-330	VACCINE	ACAM2000		Smallpox (Vaccinia) Vaccine, Live	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	PERCUTANEOUS	20070831		BLA	BLA125158	Emergent Product Development Gaithersburg Inc.	VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN	100000000	[PFU]/mL	Actively Acquired Immunity [PE], Live Vaccinia Virus Vaccine [EPC], Smallpox Vaccine [CS], Vaccines, Live, Unattenuated [CS]		N	20241231
71671-100_f70170ed-1a88-45e8-9ca4-50f203ac8420	71671-100	HUMAN PRESCRIPTION DRUG	Twirla		levonorgestrel/ethinyl estradiol	PATCH	TRANSDERMAL	20200911		NDA	NDA204017	Agile Therapeutics, Inc.	ETHINYL ESTRADIOL; LEVONORGESTREL	2.3; 2.6	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
71679-010_0832faf2-f346-6d0a-e063-6394a90a6ca8	71679-010	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin	TABLET, COATED	ORAL	20110501		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71679-031_08330440-71fa-7252-e063-6294a90a9183	71679-031	HUMAN OTC DRUG	Extra Strenghth Acetaminophen		Acetaminophen	TABLET	ORAL	20170731		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ACETAMINOPHEN	500	mg/1			N	20241231
71679-075_0832ecb0-a6a9-4329-e063-6394a90ac8bc	71679-075	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 400 mg	TABLET	ORAL	20160413		OTC MONOGRAPH DRUG	M012	Health Pharma USA LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71679-104_08d4eee2-dde1-f367-e063-6394a90a3326	71679-104	HUMAN OTC DRUG	Pain Reliever		Aspirin 81 mg	TABLET, DELAYED RELEASE	ORAL	20220121		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71679-106_08d5a43d-182a-fa1b-e063-6294a90a2510	71679-106	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20120512		OTC MONOGRAPH DRUG	M012	Health Pharma USA LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71679-107_08d62962-a646-de73-e063-6394a90a7c46	71679-107	HUMAN OTC DRUG	Extra Strenghth Acetaminophen		Acetaminophen	TABLET	ORAL	20220127		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ACETAMINOPHEN	500	mg/1			N	20241231
71679-110_08da137b-bf5c-886c-e063-6294a90a1da3	71679-110	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl 25 mg	TABLET, COATED	ORAL	20220101		OTC MONOGRAPH DRUG	M010	Health Pharma USA LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71679-111_d60a6772-4667-6b30-e053-2995a90a7516	71679-111	HUMAN OTC DRUG	Pain Relief - Ibuprofen 200 mg		Ibuprofen	TABLET, COATED	ORAL	20220101		ANDA	ANDA079174	Health Pharma USA LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71679-113_08332962-3548-f500-e063-6294a90a9f01	71679-113	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET	ORAL	20220127		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ACETAMINOPHEN; DIPHENHYDRAMINE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71679-115_0b585e3a-34a4-6dc8-e063-6394a90ad4a7	71679-115	HUMAN OTC DRUG	Extra Strength Aspirin		Aspirin	TABLET	ORAL	20231015		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
71679-119_08da137b-bf4d-886c-e063-6294a90a1da3	71679-119	HUMAN OTC DRUG	Mucus Relief		Guaifenesin 400 mg	TABLET	ORAL	20160413		OTC MONOGRAPH DRUG	M012	Health Pharma USA LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71679-125_0832fb7a-5cd1-7026-e063-6294a90a65e2	71679-125	HUMAN OTC DRUG	Extra Strength Headache Relief		Extra Strength Headache Relief	TABLET, COATED	ORAL	20210901		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
71679-127_08343e8a-fabb-79f6-e063-6294a90a4417	71679-127	HUMAN OTC DRUG	Menstrual Complete		Menstrual Complete	TABLET, COATED	ORAL	20210213		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
71679-143_083314e8-c37c-c686-e063-6294a90af8ba	71679-143	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET	ORAL	20160201		OTC MONOGRAPH DRUG	M013	Health Pharma USA LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71679-148_08da11ea-210b-8df3-e063-6294a90a7e8f	71679-148	HUMAN OTC DRUG	Guaifenesin 200mg		Guaifenesin	TABLET	ORAL	20190326		OTC MONOGRAPH DRUG	M012	Health Pharma USA LLC	GUAIFENESIN	200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
71680-001_7207aaa1-1ea3-41c6-ad58-609063012405	71680-001	HUMAN OTC DRUG	Dakota Muscle Relief		MENTHOL, UNSPECIFIED FORM	SPRAY	TOPICAL	20080701		OTC MONOGRAPH NOT FINAL	part348	LaShe Naturals, LLC	MENTHOL, UNSPECIFIED FORM	60	mg/mL			N	20241231
71680-002_143397ce-e7b9-4eb2-8fa2-6b2ce8f088af	71680-002	HUMAN OTC DRUG	Dakota Muscle Relief Roll-On		MENTHOL, UNSPECIFIED FORM	SOLUTION	TOPICAL	20111101		OTC MONOGRAPH NOT FINAL	part348	LaShe Naturals, LLC	MENTHOL, UNSPECIFIED FORM	60	mg/mL			N	20241231
71682-0001_9bff4c2b-6abe-1194-e053-2995a90a2ca5	71682-0001	HUMAN OTC DRUG	MOGUT		Lactobacillus fermentum, Lactobacillus sakei, Leuconostoc holzapfelii, Leuconostoc mesenteroides, Enterococcus faecium	LIQUID	ORAL	20170801		UNAPPROVED DRUG OTHER		COENBIO CO., LTD.	ENTEROCOCCUS FAECIUM; LACTOBACILLUS REUTERI	20; 20	g/100mL; g/100mL			N	20241231
71687-0007_0c517725-86ea-e0df-e063-6294a90ad1e6	71687-0007	HUMAN OTC DRUG	Zapzyt Acne Wash Cleanser		Salicylic Acid	GEL	TOPICAL	20171216		OTC MONOGRAPH DRUG	M006	Focus Consumer Healthcare, LLC	SALICYLIC ACID	2	g/100g			N	20241231
71687-0011_0c513f1d-a242-c3ab-e063-6294a90a59d8	71687-0011	HUMAN OTC DRUG	Zapzyt Acne Treatment Gel		Benzoyl Peroxide	GEL	TOPICAL	20171216		OTC MONOGRAPH DRUG	M006	Focus Consumer Healthcare, LLC	BENZOYL PEROXIDE	10	g/100g			N	20241231
71687-1053_0c531868-c719-7bfe-e063-6394a90ae461	71687-1053	HUMAN OTC DRUG	Benzodent		Benzocaine	CREAM	TOPICAL	20171208		OTC MONOGRAPH DRUG	M017	Focus Consumer Healthcare, LLC	BENZOCAINE	.2	g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71687-2010_0c511266-5f93-a13b-e063-6294a90a01e7	71687-2010	HUMAN OTC DRUG	Blue Star Medicated		camphor	OINTMENT	TOPICAL	20171013		OTC MONOGRAPH DRUG	M017	Focus Consumer Healthcare, LLC	CAMPHOR (SYNTHETIC)	1.24	g/100g			N	20241231
71687-3003_9a755c88-0cf8-8e1a-e053-2a95a90a6150	71687-3003	HUMAN OTC DRUG	Pamprin Multi-Symptom	Maximum Strength	Acetaminophen, Pamabrom, Pyrilamine maleate	TABLET	ORAL	20160601		OTC MONOGRAPH NOT FINAL	part343	Focus Consumer Healthcare, LLC	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
71687-3006_0c509c36-ea0d-7db3-e063-6394a90a6f58	71687-3006	HUMAN OTC DRUG	Pamprin Max Menstrual Pain Relief		Acetaminophen and Aspirin and Caffeine	TABLET, FILM COATED	ORAL	20171018		OTC MONOGRAPH DRUG	M013	Focus Consumer Healthcare, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
71687-3102_a7ba6a1a-4469-3100-e053-2a95a90af325	71687-3102	HUMAN OTC DRUG	Premsyn pms Premenstrual Pain Relief		Acetaminophen and Pamabrom and Pyrilamine maleate	TABLET	ORAL	20171013		OTC MONOGRAPH NOT FINAL	part343	Focus Consumer Healthcare, LLC	ACETAMINOPHEN; PAMABROM; PYRILAMINE MALEATE	500; 25; 15	mg/1; mg/1; mg/1			N	20241231
71687-4000_beeb6043-6548-4fe9-e053-2995a90a5d74	71687-4000	HUMAN OTC DRUG	Herpecin Pain Relief		Allantoin, Benzethonium Chloride, Lidocaine HCl	GEL	TOPICAL	20210611		OTC MONOGRAPH NOT FINAL	part348	Focus Consumer Healthcare, LLC	ALLANTOIN; BENZETHONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE ANHYDROUS	2; .2; 4	g/100g; g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71687-7773_cfbd080f-6bdd-5d7a-e053-2a95a90a52c2	71687-7773	HUMAN OTC DRUG	Herpecin L		Dimethicone and Meradimate and Octinoxate and Octisalate and Oxybenzone	STICK	TOPICAL	20171013		OTC MONOGRAPH NOT FINAL	part352	Focus Consumer Healthcare, LLC	DIMETHICONE; MERADIMATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1; 5; 7.5; 5; 6	g/100g; g/100g; g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
71692-001_f19b3f3c-4411-89ed-e053-2995a90a3981	71692-001	HUMAN OTC DRUG	Tinted Moisturizer SPF 30	SPF 30	Octinoxate, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20170908		OTC MONOGRAPH FINAL	M020	Regi U.S. Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	7.5; 3.5; 3	g/100g; g/100g; g/100g			N	20241231
71692-002_f19b3828-02cd-b8de-e053-2a95a90a8411	71692-002	HUMAN OTC DRUG	Tinted Moisturizer SPF 30	Broad Spectrum	Avobenzone, Homosalate, Octisalate,Octocrylene	CREAM	TOPICAL	20210222		OTC MONOGRAPH FINAL	M020	Regi U.S. Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
71695-200_03a8d733-d4d4-c48f-e063-6294a90a8621	71695-200	HUMAN OTC DRUG	SOFTCIDE		CHLOROXYLENOL	SOAP	TOPICAL	20170410		OTC MONOGRAPH NOT FINAL	part333A	VWR International	CHLOROXYLENOL	.001	mg/100mL			N	20241231
71699-050_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-050	HUMAN PRESCRIPTION DRUG	Xcopri		cenobamate	TABLET, FILM COATED	ORAL	20210430		NDA	NDA212839	SK Life Science, Inc.	CENOBAMATE	50	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], GABA A Receptor Positive Modulators [MoA], Sodium Channel Antagonists [MoA]	CV	N	20241231
71699-100_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-100	HUMAN PRESCRIPTION DRUG	Xcopri		cenobamate	TABLET, FILM COATED	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.	CENOBAMATE	100	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], GABA A Receptor Positive Modulators [MoA], Sodium Channel Antagonists [MoA]	CV	N	20241231
71699-103_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-103	HUMAN PRESCRIPTION DRUG	Xcopri	Maintenance Pack	cenobamate	KIT	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.						N	20241231
71699-104_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-104	HUMAN PRESCRIPTION DRUG	Xcopri	Maintenance Pack	cenobamate	KIT	ORAL	20210430		NDA	NDA212839	SK Life Science, Inc.						N	20241231
71699-150_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-150	HUMAN PRESCRIPTION DRUG	Xcopri		cenobamate	TABLET, FILM COATED	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.	CENOBAMATE	150	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], GABA A Receptor Positive Modulators [MoA], Sodium Channel Antagonists [MoA]	CV	N	20241231
71699-200_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-200	HUMAN PRESCRIPTION DRUG	Xcopri		cenobamate	TABLET, FILM COATED	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.	CENOBAMATE	200	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], GABA A Receptor Positive Modulators [MoA], Sodium Channel Antagonists [MoA]	CV	N	20241231
71699-201_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-201	HUMAN PRESCRIPTION DRUG	Xcopri	Titration Pack	cenobamate	KIT	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.						N	20241231
71699-202_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-202	HUMAN PRESCRIPTION DRUG	Xcopri	Titration Pack	cenobamate	KIT	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.						N	20241231
71699-203_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-203	HUMAN PRESCRIPTION DRUG	Xcopri	Titration Pack	cenobamate	KIT	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.						N	20241231
71699-999_310f6cc8-e2ba-40fb-9b56-ca30d663f2a1	71699-999	HUMAN PRESCRIPTION DRUG	Xcopri	Titration Pack	cenobamate	KIT	ORAL	20200312		NDA	NDA212839	SK Life Science, Inc.						N	20241231
71700-112_0dc0a954-0b29-b397-e063-6394a90ae61d	71700-112	HUMAN OTC DRUG	GETTIK Hair Regrowth Treatment		MINOXIDIL 5%	LIQUID	TOPICAL	20171001		ANDA	ANDA074588	GETTIK International LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71705-050_0b632cb4-6010-7e6f-e063-6394a90a18ce	71705-050	HUMAN PRESCRIPTION DRUG	Moxidectin		Moxidectin	TABLET	ORAL	20191202		NDA	NDA210867	Medicines Development for Global Health	MOXIDECTIN	2	mg/1			N	20241231
71706-060_8487809b-4d24-420e-9955-fcf8109ad190	71706-060	HUMAN OTC DRUG	Benson Bottom Paint		Zinc Oxide	CREAM	TOPICAL	20171001		OTC MONOGRAPH FINAL	part346	Benson's Bottom Paint , Inc	ZINC OXIDE	220	mg/g			N	20241231
71707-011_beda64be-5265-46a6-b001-80ec5f569f09	71707-011	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20171026		NDA	NDA205865	TULSA GAS & GEAR, LLC	OXYGEN	991	mL/L			N	20241231
71707-012_adc43095-04d6-4d8c-bb9b-60ce9b60af2c	71707-012	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20171026		NDA	NDA205866	TULSA GAS & GEAR, LLC	NITROGEN	991	mL/L			N	20241231
71709-110_63699815-ee85-645d-e053-2a91aa0a7c4f	71709-110	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20171114		ANDA	ANDA090564	Metcure Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71709-111_63699815-ee85-645d-e053-2a91aa0a7c4f	71709-111	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20171114		ANDA	ANDA090564	Metcure Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71709-112_63699815-ee85-645d-e053-2a91aa0a7c4f	71709-112	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20171114		ANDA	ANDA090564	Metcure Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
71713-091_19f93b56-e00a-42ee-8255-7d47f10fd273	71713-091	HUMAN OTC DRUG	Minoxidil	5% (For Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20220323		ANDA	ANDA209074	Thirty MADISON, Inc.	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71713-092_f6304d87-c0e7-47fe-ab74-728276791172	71713-092	HUMAN OTC DRUG	keeps minoxidil topical		Minoxidil	AEROSOL, FOAM	TOPICAL	20190723		ANDA	ANDA091344	THIRTY MADISON INC	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71713-093_4e687416-751c-4369-8d89-a4a434ad040c	71713-093	HUMAN OTC DRUG	keeps minoxidil topical		Minoxidil	SOLUTION	TOPICAL	20190531		ANDA	ANDA075598	THIRTY MADISON INC	MINOXIDIL	3	g/60mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71713-094_9a8528df-3cd3-4c85-b7e9-0a0e761d6cbd	71713-094	HUMAN OTC DRUG	minoxidil		minoxidil	SOLUTION	TOPICAL	20220505		ANDA	ANDA075598	THIRTY MADISON INC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71713-096_ecdd4925-db44-f8de-e053-2995a90a83ed	71713-096	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20190612		ANDA	ANDA091643	Thirty Madison Inc	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71713-097_17306f85-843b-443b-bed9-7a185195b671	71713-097	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	SHAMPOO, SUSPENSION	TOPICAL	20050411		ANDA	ANDA076942	THIRTY MADISON INC	KETOCONAZOLE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71713-099_3fe7bdaa-b027-4da9-94ee-550bf28c63e1	71713-099	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET	ORAL	20210322		ANDA	ANDA207750	Thirty Madison Inc	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
71713-100_2b5ac07f-7690-4ca4-95ee-d8369e69d104	71713-100	HUMAN OTC DRUG	sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20220426		OTC MONOGRAPH FINAL	part338	THIRTY MADISON INC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71713-101_2b5817ad-fabf-4d73-bdc0-92867ae1cf64	71713-101	HUMAN OTC DRUG	Cove Migraine Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20190410		ANDA	ANDA075794	THIRTY MADISON INC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
71713-201_b3d11bd8-0ac3-363e-2e46-03fc1366a56a	71713-201	HUMAN OTC DRUG	Omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20190531		ANDA	ANDA207740	Thirty Madison Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71713-202_277a1c13-e5dc-71a8-5d5c-4b853d8870d0	71713-202	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20190531		ANDA	ANDA207673	Thirty Madison Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71713-203_1972bfea-e7a8-9315-8cf1-e0470f90ee52	71713-203	HUMAN OTC DRUG	Ranitidine		Ranitidine	TABLET, COATED	ORAL	20190531		ANDA	ANDA078192	Thirty Madison Inc	RANITIDINE HYDROCHLORIDE	150	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71713-301_98b38ae5-ed68-4ad3-8ea5-4a2753ab19e2	71713-301	HUMAN OTC DRUG	omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20220111		NDA	NDA022032	THIRTY MADISON INC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71713-302_4be5ca83-f8cb-4688-9ffa-06cfd18c02e7	71713-302	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20220204		ANDA	ANDA207193	THIRTY MADISON INC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71713-401_e520eea6-4c61-4e46-9ed8-56b49bbe018d	71713-401	HUMAN OTC DRUG	gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20220104		OTC MONOGRAPH FINAL	part332	THIRTY MADISON INC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
71713-501_6fa7b3d5-c6e5-41cc-a18f-e81f15f95583	71713-501	HUMAN OTC DRUG	anti diarrheal		Loperamide HCl	TABLET, FILM COATED	ORAL	20220104		ANDA	ANDA075232	THIRTY MADISON INC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
71713-701_59887b1c-1add-4fe1-a299-e42a1698088e	71713-701	HUMAN OTC DRUG	heartburn relief		Famotidine	TABLET, FILM COATED	ORAL	20220111		ANDA	ANDA077351	THIRTY MADISON INC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71713-801_355c75c0-c491-4f9e-9136-7f738966f4fc	71713-801	HUMAN OTC DRUG	stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20220104		OTC MONOGRAPH NOT FINAL	part334	THIRTY MADISON INC	DOCUSATE SODIUM	100	mg/1			N	20241231
71714-002_9d9c37ae-e792-48f1-9f90-76f1d35f62c9	71714-002	HUMAN OTC DRUG	Tiege Hanley Daily Moisturizing Acne		SALICYLIC ACID	CREAM	TOPICAL	20180701		OTC MONOGRAPH FINAL	part333D	TIEGE HANLEY,Inc.	SALICYLIC ACID	16	mg/g			N	20241231
71714-020_148be83f-a477-44a2-951a-1389a999f192	71714-020	HUMAN OTC DRUG	Tiege Hanley AM Morning Facial Moisturizer with SPF20		octinoxate, Avobenzone, and octocrylene	LOTION	TOPICAL	20170930		OTC MONOGRAPH FINAL	part352	Tiege hanley	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	25; 55; 20	mg/mL; mg/mL; mg/mL			N	20241231
71715-001_54a39fe1-7a22-4f65-858d-f04c872c1c65	71715-001	HUMAN PRESCRIPTION DRUG	NUZYRA		omadacycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190201		NDA	NDA209817	Paratek Pharmaceuticals, Inc.	OMADACYCLINE	100	mg/5mL	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
71715-002_54a39fe1-7a22-4f65-858d-f04c872c1c65	71715-002	HUMAN PRESCRIPTION DRUG	NUZYRA		omadacycline	TABLET, FILM COATED	ORAL	20190201		NDA	NDA209816	Paratek Pharmaceuticals, Inc.	OMADACYCLINE	150	mg/1	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
71730-000_c3caf0cd-9148-4696-9cb8-ec93cab3f9f5	71730-000	HUMAN OTC DRUG	hims hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20220411		ANDA	ANDA075598	Hims Inc	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71730-009_7f78cafd-185a-48fe-8dc3-4ee410d5ba2c	71730-009	HUMAN OTC DRUG	Hims Delay Wipes		benzocaine wipes	DRESSING	TOPICAL	20210614		OTC MONOGRAPH DRUG	M017	Hims Inc.	BENZOCAINE	70	g/1000g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71730-020_0088cf00-a9a8-bc18-e063-6394a90a7e43	71730-020	HUMAN OTC DRUG	Clear Slate		Zinc Pyrithione	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH FINAL	M032	Hims Inc	PYRITHIONE ZINC	1	g/100mL			N	20241231
71730-023_d5d34755-9956-4782-8b27-4f31d407ff0c	71730-023	HUMAN OTC DRUG	hers hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20220413		ANDA	ANDA075357	Hims Inc	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71730-070_b2c480f5-6156-4aba-b6aa-7e74dd6b783a	71730-070	HUMAN OTC DRUG	HERS Miconazole 3		miconazole nitrate	CREAM	VAGINAL	20190114		ANDA	ANDA091366	Hims Inc	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
71730-101_dca23d1e-37f1-d97c-e053-2a95a90a5010	71730-101	HUMAN OTC DRUG	Dandruff Detox		Pyrithione Zinc	SHAMPOO	TOPICAL	20230214		OTC MONOGRAPH FINAL	M032	HIMS INC	PYRITHIONE ZINC	10	mg/mL			N	20241231
71730-129_93ad4c26-56ca-4f8e-b87a-b20c2fbe61e1	71730-129	HUMAN OTC DRUG	hers hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20210518		ANDA	ANDA091344	Hims Inc	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71730-294_e08ca396-1bb2-4743-a12d-915895cfcc9a	71730-294	HUMAN OTC DRUG	hims hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20210430		ANDA	ANDA091344	Hims Inc	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71730-900_f6545c99-c743-6920-e053-2995a90afb29	71730-900	HUMAN OTC DRUG	hims mineral sunscreen multi-screen		Zinc Oxide	LOTION	TOPICAL	20211004		OTC MONOGRAPH NOT FINAL	part352	HIMS	ZINC OXIDE	132	mg/mL			N	20241231
71730-901_f654546d-e219-581d-e053-2995a90a5baa	71730-901	HUMAN OTC DRUG	hers mineral sunscreen multi-screen		Zinc Oxide	LOTION	TOPICAL	20211004		OTC MONOGRAPH NOT FINAL	part352	HIMS	ZINC OXIDE	132	mg/mL			N	20241231
71731-5111_81dd08f1-47a1-4de6-b0c6-cbeb8f478098	71731-5111	HUMAN PRESCRIPTION DRUG	FOSAPREPITANT		FOSAPREPITANT DIMEGLUMINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210316		ANDA	ANDA212143	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
71731-6121_27feb49a-39d0-417b-bb2b-c2ffb8fb9d80	71731-6121	HUMAN PRESCRIPTION DRUG	Fulvestrant		fulvestrant	INJECTION	INTRAMUSCULAR	20210401		ANDA	ANDA211422	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
71734-106_673c4a82-f8ad-4435-80cb-b0b1357a6303	71734-106	HUMAN OTC DRUG	15pcs Antibactrial Wipes		Alcohol	SWAB	TOPICAL	20211210		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	g/100g			N	20241231
71734-111_7d3a4d29-41e7-4264-9ec9-ab362e2dcbde	71734-111	HUMAN OTC DRUG	FIRSTAR BZK Antiseptic Towelette		benzalkonium chloride	SWAB	TOPICAL	20231115		OTC MONOGRAPH DRUG	M003	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-112_dafbdc68-dc07-4861-a91c-7ec21376e535	71734-112	HUMAN OTC DRUG	FIRSTAR Alcohol Prep Pad		Isopropyl Alcohol	CLOTH	TOPICAL	20231115		OTC MONOGRAPH DRUG	M003	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
71734-113_9a84de84-4fd3-4fd7-8c78-b72b8faf411d	71734-113	HUMAN OTC DRUG	FIRSTAR Sting Relief Pad		Benzocaine	CLOTH	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZOCAINE	6	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71734-201_972b3dde-977d-4b7f-8a01-03797f92087a	71734-201	HUMAN OTC DRUG	Freeman Packaging Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-202_5fc8221b-7d69-45b2-a720-f12ea913f840	71734-202	HUMAN OTC DRUG	Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	.31	mL/mL			N	20241231
71734-203_d3c4da95-60fe-451e-8566-5b87b24c44c9	71734-203	HUMAN OTC DRUG	Hand Wipes		Chlorhexidine Digluconate and BENZETHONIUM CHLORIDE	CLOTH	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZETHONIUM CHLORIDE; CHLORHEXIDINE GLUCONATE	.08; .1	g/g; g/g	Decreased Cell Wall Integrity [PE]		N	20241231
71734-204_7b66fbd8-0469-4370-b7d0-126ab69d4d49	71734-204	HUMAN OTC DRUG	KidzStuff Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20180117		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	g/100g			N	20241231
71734-206_8d61ac4a-e3c6-49a5-988f-7c2dd9dfc16d	71734-206	HUMAN OTC DRUG	Afassco Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20181018		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-210_878a4c5c-f23e-4649-9ee2-9562ec771101	71734-210	HUMAN OTC DRUG	Callington Anti-Bacterial Hand Sanitiser		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20181204		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.05	g/g			N	20241231
71734-212_4744ddbf-e7d3-4c7b-ae04-b11cc6516fb1	71734-212	HUMAN OTC DRUG	CPAP Mask cleaning wipes		Benzethonium Chloride and Benzalkonium Chloride	CLOTH	TOPICAL	20190607		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE; BENZETHONIUM CHLORIDE	.02; .03	g/g; g/g			N	20241231
71734-262_a8caaf5f-f167-4475-a1ae-e90e29cbbb2a	71734-262	HUMAN OTC DRUG	Novo wipe		alcohol	SWAB	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	g/100g			N	20241231
71734-264_d089be07-f64e-46d6-a5ff-b67716728b36	71734-264	HUMAN OTC DRUG	Essential Hand Sanitizer wipe		alcohol	SWAB	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	g/100g			N	20241231
71734-266_50d8bfb1-e496-48ac-813b-5f0a0240f85d	71734-266	HUMAN OTC DRUG	Novo wipe 30 pcs		alcohol	SWAB	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	g/100g			N	20241231
71734-300_245f7a85-1505-4cf0-b939-bd1ab439cdfc	71734-300	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200428		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-301_ddb84a4e-f816-4363-85b5-3b33b73ab938	71734-301	HUMAN OTC DRUG	Joylux Anti Bacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200428		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-302_5e7e3c41-0fcb-4de9-b93b-e2c076c1a682	71734-302	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20200412		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	70	mL/100mL			N	20241231
71734-303_79d52ae6-3818-4224-8670-7ca88cc84e5d	71734-303	HUMAN OTC DRUG	Hand Wipes		benzalkonium chloride	SWAB	TOPICAL	20200605		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-304_fe491efc-eb0e-46ba-88cf-96dd02403580	71734-304	HUMAN OTC DRUG	American Savings Bank Hand Sanitizer		Alcohol	GEL	TOPICAL	20200409		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-306_53ea4875-383e-4452-a076-6e72ad02621e	71734-306	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	mL/100mL			N	20241231
71734-308_dfd31f3f-aefa-4eb3-b533-c737efd9fff6	71734-308	HUMAN OTC DRUG	my medic super Sanitizer with aloe vera		Alcohol	GEL	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-309_adc34e95-4a47-476d-bc1d-e25779fba04f	71734-309	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Alcohol	GEL	TOPICAL	20200502		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-310_11a6e1ee-faf6-41ff-8f3b-9bb5dc3ee4df	71734-310	HUMAN OTC DRUG	Hands Fresh Antiseptic Hand Rub with aloe vera		Alcohol	GEL	TOPICAL	20200418		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	mL/100mL			N	20241231
71734-311_958057d6-034e-46cb-9025-74bee041a274	71734-311	HUMAN OTC DRUG	Bactro Instant hand sanitizer		alcohol	LIQUID	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	mL/100mL			N	20241231
71734-312_664e3037-2af3-4854-947e-a1aa64c81a95	71734-312	HUMAN OTC DRUG	Antibacterial Hnad Sanitizer		alcohol	LIQUID	TOPICAL	20200616		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-313_3fd806a5-e179-4fa0-a07e-32a690ab9011	71734-313	HUMAN OTC DRUG	Bactro Disinfecting wipe		benzalkonium chloride	SWAB	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-318_2eede0b8-27b0-4193-bb02-890ea7bf5405	71734-318	HUMAN OTC DRUG	Safety 1st hand sanitizer		alcohol	LIQUID	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-319_7af2a19c-d9be-4975-b6be-8b973f33ed91	71734-319	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200704		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-322_616e9779-64a4-4e81-99bd-eda059909577	71734-322	HUMAN OTC DRUG	Mykro Max Multi Purpose Disinfecting wipe		benzalkonium chloride	SWAB	TOPICAL	20200731		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-323_5c0cd694-b5ea-4336-abea-750e1c104304	71734-323	HUMAN OTC DRUG	Mykro Max Antibacterial wipes		benzalkonium chloride	SWAB	TOPICAL	20200813		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-324_0ef811c4-e335-4d0d-b7b8-693a97ced210	71734-324	HUMAN OTC DRUG	Sanitize Those Hands 40 Antibacterial Wipes		benzalkonium chloride	SWAB	TOPICAL	20200819		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-326_736d3f10-3d5f-45a5-b8f2-a7ecb347a24c	71734-326	HUMAN OTC DRUG	Alcohol wipes		Alcohol	SWAB	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	g/100g			N	20241231
71734-327_28ca2771-933b-4b12-84bd-93bf3d0bc815	71734-327	HUMAN OTC DRUG	Purenique Hygiene Solutions Alcohol Wipes		Alcohol	SWAB	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	g/100g			N	20241231
71734-328_c718ccff-1bb2-4e70-b1d8-820f55ffb131	71734-328	HUMAN OTC DRUG	Hand Sanitizer		alcohol	LIQUID	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-329_46223c18-270a-4e42-948f-0ece4009cebc	71734-329	HUMAN OTC DRUG	Purenique Hygiene Solutions Hand Sanitizer		alcohol	LIQUID	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
71734-330_da281e53-993b-43df-ab3c-a0c0fbc360d9	71734-330	HUMAN OTC DRUG	Mykro Max Antibacterial wipes		benzalkonium chloride	SWAB	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.1212	g/100g			N	20241231
71734-331_51644c14-2541-4c95-b25f-b07d452c3147	71734-331	HUMAN OTC DRUG	Purenique Hygiene Solutions Antiseptic Wipes		benzalkonium chloride	SWAB	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-332_78916d94-2a9c-4cbe-852c-b527b31ce8a6	71734-332	HUMAN OTC DRUG	Start Clean hand sanitizer		alcohol	LIQUID	TOPICAL	20201007		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	70	mL/100mL			N	20241231
71734-334_80a651a9-3e85-4b21-b98c-d1ca67ed3dae	71734-334	HUMAN OTC DRUG	Dextragel Antiseptic Hand Sanitizer		alcohol	LIQUID	TOPICAL	20201124		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	mL/100mL			N	20241231
71734-340_0798caae-b4ae-421e-ab6a-83882e031798	71734-340	HUMAN OTC DRUG	Keep Going Sting Relief Pad		Benzocaine and Isopropyl Alcohol	CLOTH	TOPICAL	20210706		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZOCAINE; ISOPROPYL ALCOHOL	6; 60	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71734-341_037833d7-b113-408b-a032-e179e6234058	71734-341	HUMAN OTC DRUG	Keep Going Alcohol Prep Pad		Isopropyl Alcohol	CLOTH	TOPICAL	20210706		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
71734-342_505b32ec-25cd-4822-986a-af07d3831d35	71734-342	HUMAN OTC DRUG	Keep Going Hand Sanitizer		alcohol	LIQUID	TOPICAL	20210706		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	62	g/100g			N	20241231
71734-343_155c1799-9c9f-4e91-afed-0cd5ba40c4b0	71734-343	HUMAN OTC DRUG	Keep Going Non Sting Cleaning Wipe		benzalkonium chloride	SWAB	TOPICAL	20210706		OTC MONOGRAPH NOT FINAL	part333A	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
71734-346_8fbf4166-d0c9-4c0e-bf38-f1ee718266bd	71734-346	HUMAN OTC DRUG	Keep Going Hand Sanitizer		alcohol	LIQUID	TOPICAL	20210709		OTC MONOGRAPH NOT FINAL	part333E	JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD.	ALCOHOL	75	g/100g			N	20241231
71740-001_800ff22d-b10c-4cc8-920f-217a4d23563d	71740-001	HUMAN PRESCRIPTION DRUG	Niacor		Niacin	TABLET	ORAL	20000503		ANDA	ANDA040378	Avondale Pharmaceuticals, LLC	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
71741-020_fdf0f91e-6b00-4f86-a54d-92ef9dca0fb8	71741-020	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET	ORAL	20000503		ANDA	ANDA040378	Redmont Pharmaceuticals, LLC	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
71742-0001_33bf81ec-4693-464f-ab65-61cce5756124	71742-0001	HUMAN OTC DRUG	Neuro-Pro	T007	Gaba, L-Dopa, Norepinephrine, Serotonin, Adrenocorticotrophin, Anacardium Orientale, Arsenicum Album, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Hyoscyamus Niger, Lycopodium Clavatum, Stramonium	LIQUID	ORAL	20171018		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	.GAMMA.-AMINOBUTYRIC ACID; ANACARDIUM OCCIDENTALE FRUIT; ARSENIC TRIOXIDE; BARIUM CARBONATE; CORTICOTROPIN; DATURA STRAMONIUM; HYOSCYAMUS NIGER; LEVODOPA; LYCOPODIUM CLAVATUM SPORE; NOREPINEPHRINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SEROTONIN HYDROCHLORIDE; TRIBASIC CALCIUM PHOSPHATE	6; 30; 30; 30; 8; 30; 30; 6; 30; 6; 30; 6; 30	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
71742-0002_8344df86-e3cf-425b-b13d-0e1619dced1e	71742-0002	HUMAN OTC DRUG	Arthri-Joint	T008	Apis Mellifica, Bryonia (Alba), Causticum, Colchicum Autumnale, Kali Carbonicum, Kalmia Latifolia, Ledum Palustre, Pulsatilla (Vulgaris), Rhododendron Chrysanthum, Rhus Tox	LIQUID	ORAL	20171019		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	APIS MELLIFERA; BRYONIA ALBA ROOT; CAUSTICUM; COLCHICUM AUTUMNALE BULB; KALMIA LATIFOLIA LEAF; LEDUM PALUSTRE TWIG; POTASSIUM CARBONATE; PULSATILLA VULGARIS; RHODODENDRON AUREUM LEAF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
71742-0003_07ceb79a-af82-4cc1-89cf-8263c9dea39d	71742-0003	HUMAN OTC DRUG	Vascu-Pro	T009	Cactus Grandiflorus, Hamamelis Virginiana, Valeriana Officinalis, Arteria Suis, Heart (Suis), Arnica Montana, Aurum Metallicum, Baryta Muriatica, Cholesterinum, Lecithin, Magnesia Muriatica, Oxalicum Acidum, Phosphorus	LIQUID	ORAL	20171019		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	ARNICA MONTANA; BARIUM CHLORIDE DIHYDRATE; CHOLESTEROL; GOLD; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; LECITHIN, SOYBEAN; MAGNESIUM CHLORIDE; OXALIC ACID; PHOSPHORUS; PORK HEART; SELENICEREUS GRANDIFLORUS STEM; SUS SCROFA ARTERY; VALERIAN	12; 12; 12; 12; 3; 12; 12; 12; 12; 6; 3; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71742-0004_e568062e-50f9-4442-904a-72e7f33da401	71742-0004	HUMAN OTC DRUG	Female Vitality	T010	Cimicifuga Racemosa, Fucus Vesiculosus, Oophorinum (Suis), Hypophysis Suis, Thyroidinum (Suis), Graphites, Lachesis Mutus, Natrum Muriaticum, Pulsatilla (Pratensis), Sepia	LIQUID	ORAL	20171020		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	ANEMONE PRATENSIS; BLACK COHOSH; FUCUS VESICULOSUS; GRAPHITE; LACHESIS MUTA VENOM; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SUS SCROFA OVARY; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID	12; 3; 3; 12; 12; 12; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
71742-0006_76adb01c-5f32-4d49-abfc-adfbd560d699	71742-0006	HUMAN OTC DRUG	Sleep Well	T012	Arsenicum Album, Avena Sativa, Coffea Cruda, Kali Carbonicum, Magnesia Carbonica, Nux Vomica, Passiflora Incarnata, Sepia, Valeriana Officinalis	LIQUID	ORAL	20171024		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; MAGNESIUM CARBONATE; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM CARBONATE; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; VALERIAN	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71742-0008_55ca2805-9a48-4673-8185-173cddb70edb	71742-0008	HUMAN OTC DRUG	Heavy Metal Detox	T014	Allium Sativum, Avena Sativa, Berberis Vulgaris, Lappa Major, Phytolacca Decandra, Solidago Virgaurea, Lycopodium Clavatum, Nux Vomica, Aluminum Metallicum, Antimonium Crudum, Argentum Metallicum, Arsenicum Album, Aurum Metallicum, Baryta Carbonica, Beryllium Metallicum, Bismuthum Metallicum, Boron, Bromium, Cadmium Metallicum, Cerium Metallicum, Cesium Chloride, Chromium, Cobaltum Metallicum, Cuprum Metallicum, Dysprosium Metallicum, Erbium Metallicum, Europium Metallicum, Ferrum Metallicum	LIQUID	ORAL	20171026		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	ALUMINUM; ANTIMONY TRISULFIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; BISMUTH; BORON; BROMINE; CADMIUM; CERIUM; CESIUM CHLORIDE; CHROMIUM; COBALT; COPPER; DYSPROSIUM; ERBIUM; EUROPIUM; GADOLINIUM; GARLIC; GERMANIUM SESQUIOXIDE; GOLD; HOLMIUM; INDIUM; IRON; LANTHANUM; LEAD; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM; MANGANESE; MERCURIUS SOLUBILIS; MOLYBDENUM; NEODYMIUM OXIDE; NICKEL; NIOBIUM; OSMIUM; PALLADIUM; PHYTOLACCA AMERICANA ROOT; PLATINUM; PRASEODYMIUM; RHODIUM; RUBIDIUM NITRITE; SAMARIUM; SELENIUM; SILVER; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TANTALUM; TERBIUM; THALLIUM; TIN; URANYL NITRATE HEXAHYDRATE; VANADIUM; YTTERBIUM OXIDE; ZINC	12; 12; 3; 12; 3; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 14; 12; 12; 12; 12; 12; 12; 12; 12; 12; 30; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 30; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
71742-0009_5e65d625-8b6c-48af-84c6-f91fdf8cf01d	71742-0009	HUMAN OTC DRUG	Glucose Control	T015	Syzygium Jambolanum, Glandula Suprarenalis Suis, Hydrastis Canadensis, Hypophysis Suis, Pancreas Suis, Phaseolus, Aceticum Acidum, Lacticum Acidum, Phosphoricum Acidum, Phosphorus, Uranium Nitricum	LIQUID	ORAL	20171026		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	ACETIC ACID; GOLDENSEAL; KIDNEY BEAN; LACTIC ACID; PHOSPHORIC ACID; PHOSPHORUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; SUS SCROFA PITUITARY GLAND; SYZYGIUM CUMINI SEED; URANYL NITRATE HEXAHYDRATE	12; 6; 9; 12; 12; 12; 6; 6; 6; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
71742-0010_d950f4c8-16f9-4ea0-9535-884e0c2d7816	71742-0010	HUMAN OTC DRUG	Respiro-Pro	T016	Ammonium Muriaticum, Antimonium Tartaricum, Arsenicum Album, Bryonia (Alba), Calcarea Carbonica, Lobelia Inflata, Natrum Sulphuricum, Phosphorus, Spongia Tosta	LIQUID	ORAL	20171026		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	AMMONIUM CHLORIDE; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; LOBELIA INFLATA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
71742-0012_53f1621b-b6d5-4b35-baf3-1657e67cd5c1	71742-0012	HUMAN OTC DRUG	Spleen-Pro	T018	Spleen (Suis), Arsenicum Album, Carbo Vegetabilis, Ceanothus Americanus, Chininum Sulphuricum, Ignatia Amara, Iodium, Natrum Muriaticum, Nitricum Acidum, Phosphoricum Acidum, Phosphorus	LIQUID	ORAL	20171026		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	ACTIVATED CHARCOAL; ARSENIC TRIOXIDE; CEANOTHUS AMERICANUS LEAF; IODINE; NITRIC ACID; PHOSPHORIC ACID; PHOSPHORUS; QUININE SULFATE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; SUS SCROFA SPLEEN	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC]		N	20241231
71742-0013_7cc99dd9-f722-44e6-a224-a3a40d47af5a	71742-0013	HUMAN OTC DRUG	Thyro-Pro	T019	Fucus Vesiculosus, Spongia Tosta, Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Bromium, Calcarea Carbonica, Iodium, Lachesis Mutus, Pulsatilla (Vulgaris)	LIQUID	ORAL	20171026		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	BROMINE; FUCUS VESICULOSUS; IODINE; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PULSATILLA VULGARIS; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA THYROID	12; 3; 12; 12; 12; 12; 3; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
71742-0014_a7260dff-03f1-4824-bdff-1359f37b58f2	71742-0014	HUMAN OTC DRUG	HGH-Pro	T020	Human Growth Hormone, Hypophysis Suis, Hepar Suis	LIQUID	ORAL	20171031		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	PORK LIVER; SOMATROPIN; SUS SCROFA PITUITARY GLAND	6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Human Growth Hormone [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
71742-0015_de1c8831-eec6-4729-b35f-8c9e1f740f84	71742-0015	HUMAN OTC DRUG	Male Vitality	T021	Damiana, Korean Ginseng, Populus Tremuloides, Nuphar Luteum, Arnica Montana, Carduus Marianus, Galium Aparine, Lactuca Virosa, Caladium Seguinum, Hepar Suis, Orchitinum (Suis), Thymus (Suis), Glandula Suprarenalis Suis, Hypophysis Suis, Thyroidinum (Suis), Testosterone, Phosphoricum Acidum, Thuja Occidentalis	LIQUID	ORAL	20171031		UNAPPROVED HOMEOPATHIC		Guangzhou Renuma Medical Systems Co., Ltd	ARNICA MONTANA WHOLE; ASIAN GINSENG; DIEFFENBACHIA SEGUINE WHOLE; GALIUM APARINE WHOLE; LACTUCA VIROSA WHOLE; MILK THISTLE; NUPHAR LUTEA ROOT; PHOSPHORIC ACID; POPULUS TREMULOIDES BARK; PORK LIVER; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA TESTICLE; SUS SCROFA THYMUS; TESTOSTERONE; THUJA OCCIDENTALIS LEAFY TWIG; THYROID, PORCINE; TURNERA DIFFUSA LEAFY TWIG	3; 1; 6; 3; 3; 3; 2; 200; 1; 6; 12; 12; 6; 6; 30; 200; 12; 1	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
71745-001_0c460b73-a34c-e256-e063-6294a90ad28a	71745-001	HUMAN OTC DRUG	Fragrance Free Sanitizing Wipes		Benzalkonium Chloride	CLOTH	CUTANEOUS	20170925		OTC MONOGRAPH DRUG	505G(a)(3)	GoodEarth Distribution Llc	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
71745-002_0c46351a-6445-0e01-e063-6294a90a1aed	71745-002	HUMAN OTC DRUG	Sanitizing Wipes	Alcohol Free Fragrance Free	Benzalkonium Chloride	CLOTH	CUTANEOUS	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	GoodEarth Distribution Llc	BENZALKONIUM CHLORIDE	1.3	mg/1			N	20241231
71745-331_efcea737-bb31-2e82-e053-2a95a90ac2d3	71745-331	HUMAN OTC DRUG	GoodEarth		Sanitizing Wipes	SWAB	TOPICAL	20200806		OTC MONOGRAPH NOT FINAL	part333A	GOODEARTH DISTRIBUTION LLC	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
71748-101_02fa01c9-b2df-81e8-e063-6394a90a2f44	71748-101	HUMAN OTC DRUG	JON ARES ACNE CONTROL	STEP 1	BENZOYL PEROXIDE	CREAM	TOPICAL	20170930		OTC MONOGRAPH FINAL	M006	DADASHIE ACNE SYSTEM INC	BENZOYL PEROXIDE	5	g/100mL			N	20241231
71748-102_02fa18ea-21eb-d726-e063-6294a90a652b	71748-102	HUMAN OTC DRUG	JON ARES ACNE CONTROL	STEP 2	BENZOYL PEROXIDE	CREAM	TOPICAL	20170930		OTC MONOGRAPH FINAL	M006	DADASHIE ACNE SYSTEM INC	BENZOYL PEROXIDE	10	g/100mL			N	20241231
71748-103_02f9ed76-5e0a-348b-e063-6394a90aa122	71748-103	HUMAN OTC DRUG	JON ARES ACNE CONTROL	MILD	RESORCINIL, SULFUR	CREAM	TOPICAL	20170930		OTC MONOGRAPH FINAL	M006	DADASHIE ACNE SYSTEM INC	RESORCINOL; SULFUR	2; 6	g/100mL; g/100mL			N	20241231
71749-300_cc308f9d-f3f3-48d2-b552-f8efc58d031b	71749-300	HUMAN OTC DRUG	Medt Pad		Isopropyl Alcohol	SWAB	TOPICAL	20160101		OTC MONOGRAPH NOT FINAL	part333A	Carelife (USA) Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
71751-101_949554f3-239d-9b84-e053-2995a90a30a9	71751-101	HUMAN OTC DRUG	Kerstin Florian Multi-Vitamin Day Creme SPF 30		Sunscreen	CREAM	TOPICAL	20191010	20241231	OTC MONOGRAPH FINAL	part352	Kerstin Florian, Inc.	ZINC OXIDE	20.2	g/100g			N	
71753-1054_f9cc86b3-0d22-4c57-a580-731f84769540	71753-1054	HUMAN OTC DRUG	Coxiflu		CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	LIQUID	ORAL	20171004	20250630	UNAPPROVED HOMEOPATHIC		Ratis, LLC	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/mL			N	
71753-1056_15c02a5f-7137-454f-9c00-316fd7921003	71753-1056	HUMAN OTC DRUG	Cold Armor		Allium Cepa, Hydrastis Canadensis, Nux Vomica, Pulsatilla (Pratensis), Ferrum Phosphoricum, Belladonna, Gelsemium Sempervirens, Kali Bichromicum	LIQUID	ORAL	20190923	20250915	UNAPPROVED HOMEOPATHIC		Ratis, LLC	ANEMONE PRATENSIS; ATROPA BELLADONNA; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; ONION; POTASSIUM DICHROMATE; STRYCHNOS NUX-VOMICA SEED	6; 12; 8; 12; 6; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	
71753-1058_59c28082-0bc5-4852-8d0c-efd3d9fe9831	71753-1058	HUMAN OTC DRUG	Virus Defense		Echinacea (Angustifolia), Glycyrrhiza Glabra, Hydrastis Canadensis, aconitum Napellus, Arsenicum Album, Belladonna, Bryonia (Alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Lachesis Mutus, Rhus Tox, Pyrogenium	SPRAY	ORAL	20200422	20250915	UNAPPROVED HOMEOPATHIC		Ratis, LLC	ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GLYCYRRHIZA GLABRA; GOLDENSEAL; LACHESIS MUTA VENOM; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 3; 12; 12; 3; 6; 12; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
71753-1150_4504fe7b-85a6-4932-a172-9af1e3d7bef8	71753-1150	HUMAN OTC DRUG	Influenzinum		Influenzinum (2018-2019)	SPRAY	ORAL	20181101	20240115	UNAPPROVED HOMEOPATHIC		Ratis, LLC	INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)	9; 9; 9; 9	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
71753-1152_ff94c869-5b3e-43a2-8935-9372fb2333fa	71753-1152	HUMAN OTC DRUG	Thymuline		Thymuline	LIQUID	ORAL	20180906	20251201	UNAPPROVED HOMEOPATHIC		Ratis, LLC	NONATHYMULIN	9	[hp_C]/mL			N	
71753-1156_fb97f830-fce0-4a6d-81cf-ae5d2abe5de7	71753-1156	HUMAN OTC DRUG	Cold Armor		Allium Cepa, Hydrastis Canadensis, Pulsatilla (Pratensis), Dulcamara, Nux Vomica, Ferrum Phosphoricum, Gelsemium Sempervirens, Kali Bichromicum	SPRAY	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Ratis, LLC	FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; ONION; POTASSIUM DICHROMATE; PULSATILLA PRATENSIS WHOLE; SOLANUM DULCAMARA TOP; STRYCHNOS NUX-VOMICA SEED	12; 12; 6; 6; 12; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
71753-1258_0c79cb67-2f85-46b2-e063-6294a90aa1f2	71753-1258	HUMAN OTC DRUG	Virus Defense ANNAKARE		aconitum napellus root, arsenic trioxide, baptisia tinctoria whole, bryonia alba root, echinacea angustifolia whole, eupatorium perfoliatum whole, gelsemium sempervirens whole, glycyrrhiza glabra, hydrastis canadensis whole, toxicodendron pubescens leaf	SPRAY	ORAL	20221202		UNAPPROVED HOMEOPATHIC		Ratis, LLC	ACONITUM NAPELLUS ROOT; ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM WHOLE; GELSEMIUM SEMPERVIRENS WHOLE; GLYCYRRHIZA GLABRA; HYDRASTIS CANADENSIS WHOLE; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 3; 12; 12; 3; 6; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71753-1350_2747ee3e-3437-4f23-a184-31f62510876a	71753-1350	HUMAN OTC DRUG	Influenzinum		Influenzinum (2019-2020)	LIQUID	ORAL	20191203	20241213	UNAPPROVED HOMEOPATHIC		Ratis, LLC	INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED)	10; 10; 10	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
71753-1450_0472a0c4-cd8f-4e11-809b-a5d43205c583	71753-1450	HUMAN OTC DRUG	Influenzinum		Influenzinum (2020-2021)	LIQUID	ORAL	20201109	20251125	UNAPPROVED HOMEOPATHIC		Ratis, LLC	INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)	10; 10; 10; 10	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	
71753-2012_53a04308-e36f-420f-88fa-6ebbebaf106c	71753-2012	HUMAN OTC DRUG	Allergy Escape		Allium Cepa, Apis Mellifica, Euphrasia Officinalis, Kali Iodatum, Naphthalinum, Sabadilla, Wyethia Helenoides, Histaminum Hydrochloricum	LIQUID	ORAL	20190410	20250603	UNAPPROVED HOMEOPATHIC		Ratis, LLC	APIS MELLIFERA; EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; NAPHTHALENE; ONION; POTASSIUM IODIDE; SCHOENOCAULON OFFICINALE SEED; WYETHIA HELENIOIDES ROOT	8; 8; 12; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	
71753-2013_56e85885-a836-4a35-af69-831bd90422c7	71753-2013	HUMAN OTC DRUG	Allergy Escape		Allium Cepa, Euphrasia Officinalis, Kali Iodatum, Naphthalinum, Sabadilla, Urtica Urens, Wyethia Helenioides, Histaminum Hydrochloricum	SPRAY	ORAL	20230712		UNAPPROVED HOMEOPATHIC		Ratis, LLC	EUPHRASIA STRICTA; HISTAMINE DIHYDROCHLORIDE; NAPHTHALENE; ONION; POTASSIUM IODIDE; SCHOENOCAULON OFFICINALE SEED; URTICA URENS WHOLE; WYETHIA HELENIOIDES ROOT	8; 12; 8; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
71753-4001_a8612e96-b081-4670-9de0-810bceee06bb	71753-4001	HUMAN OTC DRUG	Peacefuli		Avena Sativa, Humulus Lupulus, Passiflora Incarnata, Kali Phosphoricum, Anacardium Orientale, Argentum Nitricum, Ignatia Amara	SPRAY	ORAL	20200323		UNAPPROVED HOMEOPATHIC		Ratis, LLC	AVENA SATIVA FLOWERING TOP; DIBASIC POTASSIUM PHOSPHATE; HOPS; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORIC ACID; SEMECARPUS ANACARDIUM JUICE; SILVER NITRATE; STRYCHNOS IGNATII SEED	3; 6; 3; 3; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71753-8001_8f978973-3260-45f8-98bc-b98399b30aa2	71753-8001	HUMAN OTC DRUG	Calcarea Fluorica		Calcarea Fluorica	SPRAY	ORAL	20200930		UNAPPROVED HOMEOPATHIC		Ratis, LLC	CALCIUM FLUORIDE	12	[hp_X]/mL			N	20241231
71753-8002_083b9574-04ba-4c68-91b6-5a36993d8e8f	71753-8002	HUMAN OTC DRUG	Calcarea Phosphorica		Calcarea Phosphorica	SPRAY	ORAL	20200930		UNAPPROVED HOMEOPATHIC		Ratis, LLC	TRIBASIC CALCIUM PHOSPHATE	12	[hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
71753-8003_9df27923-add7-4f80-bb1a-a4dea84f4a8f	71753-8003	HUMAN OTC DRUG	Calcarea Sulphurica		Calcarea Sulphurica	SPRAY	ORAL	20201001	20251026	UNAPPROVED HOMEOPATHIC		Ratis, LLC	CALCIUM SULFATE ANHYDROUS	8	[hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
71753-8004_63703d98-9d5b-41bb-8c5d-7ed4a1000e43	71753-8004	HUMAN OTC DRUG	Ferrum Phosphoricum		Ferrum Phosphoricum	SPRAY	ORAL	20201001		UNAPPROVED HOMEOPATHIC		Ratis, LLC	FERROSOFERRIC PHOSPHATE	12	[hp_X]/mL			N	20241231
71753-8005_fe104583-be74-40ea-a8d9-e1843a552893	71753-8005	HUMAN OTC DRUG	Kali Muriaticum		Kali Muriaticum	SPRAY	ORAL	20201001	20251027	UNAPPROVED HOMEOPATHIC		Ratis, LLC	POTASSIUM CHLORIDE	6	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	
71753-8006_7ceb50eb-2adc-465b-a931-bef6ca6af7f7	71753-8006	HUMAN OTC DRUG	Kali Phosphoricum		Kali Phosphoricum	SPRAY	ORAL	20200930		UNAPPROVED HOMEOPATHIC		Ratis, LLC	DIBASIC POTASSIUM PHOSPHATE	6	[hp_X]/mL			N	20241231
71753-8007_755dd085-e530-4320-a574-299151cc654a	71753-8007	HUMAN OTC DRUG	Kali Sulphuricum		Kali Sulphuricum	SPRAY	ORAL	20200930		UNAPPROVED HOMEOPATHIC		Ratis, LLC	POTASSIUM SULFATE	6	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71753-8008_9b278f18-f2f7-4cf3-991e-34caa8ace79c	71753-8008	HUMAN OTC DRUG	Magnesia Phosphorica		Magnesia Phosphorica	SPRAY	ORAL	20200930		UNAPPROVED HOMEOPATHIC		Ratis, LLC	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	12	[hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71753-8009_cef70a76-b116-46d0-9d67-6d4cf6fe74b9	71753-8009	HUMAN OTC DRUG	Natrum Muriaticum		Natrum Muriaticum	SPRAY	ORAL	20200930	20251026	UNAPPROVED HOMEOPATHIC		Ratis, LLC	SODIUM CHLORIDE	6	[hp_X]/mL			N	
71753-8010_f8f8d698-66d8-409e-a9f9-38118cb3fc7a	71753-8010	HUMAN OTC DRUG	Natrum Phosphoricum		Natrum Phosphoricum	SPRAY	ORAL	20200930	20251026	UNAPPROVED HOMEOPATHIC		Ratis, LLC	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_X]/mL			N	
71753-8011_2cc44cf3-5cfb-4a35-a8ea-06831753548a	71753-8011	HUMAN OTC DRUG	Natrum Sulphuricum		Natrum Sulphuricum	SPRAY	ORAL	20200930	20251026	UNAPPROVED HOMEOPATHIC		Ratis, LLC	SODIUM SULFATE	6	[hp_X]/mL			N	
71753-8012_7e565ef2-5239-46c1-854c-4aaf63683a7f	71753-8012	HUMAN OTC DRUG	Silicea		Silicea	SPRAY	ORAL	20200930		UNAPPROVED HOMEOPATHIC		Ratis, LLC	SILICON DIOXIDE	12	[hp_X]/mL			N	20241231
71753-8099_5f471122-6961-4be6-bfce-20cae3e45475	71753-8099	HUMAN OTC DRUG	Cellergy		Calcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Ferrum Phosphoricum, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Magnesia Phosphorica, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Silicea.	LIQUID	ORAL	20191008	20251201	UNAPPROVED HOMEOPATHIC		Ratis, LLC	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
71753-8199_820eaad1-42c5-49da-b9be-664eff0f18bf	71753-8199	HUMAN OTC DRUG	Cellergy		Calcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Ferrum Phosphoricum, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Magnesia Phosphorica, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Silicea.	SPRAY	ORAL	20230807		UNAPPROVED HOMEOPATHIC		Ratis, LLC	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71753-9001_3a9026f0-6678-4ee3-8ab0-7a696be9b3da	71753-9001	HUMAN OTC DRUG	Detox Escort		Aesculus Hippocastanum, Equisetum Hyemale, Fumaria Officinalis, Hydrastis Canadensis, Hydrocotyle Asiatica, Magnesia Muriatica, Oleum Olea Europaea, Passiflora Incarnata, Ribes Nigrum, Solidago Virguarea, Ononis Spinosa	LIQUID	ORAL	20181016	20250610	UNAPPROVED HOMEOPATHIC		Ratis, LLC	BLACK CURRANT; CENTELLA ASIATICA; EQUISETUM HYEMALE; FUMARIA OFFICINALIS FLOWERING TOP; GOLDENSEAL; HORSE CHESTNUT; MAGNESIUM CHLORIDE; OLIVE OIL; ONONIS SPINOSA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Lipid Emulsion [EPC], Lipids [CS], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
71753-9011_8bde6e99-16cb-41df-8e0b-d97826addce1	71753-9011	HUMAN OTC DRUG	Detox Escort		Aesculus Hippocastanum, Equisetum Hyemale, Hydrastis Canadensis, Hydrocotyle Asiatica, Magnesia Muriatica, Linum Usitatissimum, Passiflora Incarnata, Solidago Virgaurea, Thuja Occidentalis, Fumaria Officinalis, Ononis Spinosa	SPRAY	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Ratis, LLC	CENTELLA ASIATICA WHOLE; EQUISETUM HYEMALE WHOLE; FLAX SEED; FUMARIA OFFICINALIS FLOWERING TOP; GOLDENSEAL; HORSE CHESTNUT; MAGNESIUM CHLORIDE; ONONIS SPINOSA WHOLE; PASSIFLORA INCARNATA FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 8; 6; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71754-001_0dd79f13-9d56-36fa-e063-6394a90a0a6f	71754-001	HUMAN PRESCRIPTION DRUG	Certa Dose Epinephrine Convenience Kit		Epinephrine Convenience Kit	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20181126		NDA	NDA204200	CD Acquisitions, LLC						N	20241231
71763-101_b63402fc-3090-464c-89c4-b58203bdcfd5	71763-101	HUMAN OTC DRUG	Mrs. Meyers Clean Day Hand Sanitizer Basil Scent		Alcohol	SOLUTION	TOPICAL	20171101		OTC MONOGRAPH NOT FINAL	part333A	The Caldrea Company	ALCOHOL	.62	mL/mL			N	20241231
71763-201_cd363137-5abe-4a57-9387-d958416a6a9e	71763-201	HUMAN OTC DRUG	Mrs. Meyers Clean Day Hand Sanitizer Lavender Scent		Alcohol	SOLUTION	TOPICAL	20171101		OTC MONOGRAPH NOT FINAL	part333A	The Caldrea Company	ALCOHOL	.62	mL/mL			N	20241231
71766-010_0c603cb7-bdd4-6dfa-e063-6294a90a0e86	71766-010	HUMAN OTC DRUG	ALCOHOL-FREE GYM SANITIZING WIPES		ALCOHOL-FREE GYM SANITIZING WIPES	CLOTH	TOPICAL	20231213		OTC MONOGRAPH DRUG	M003	Hangzhou Linkeweier Daily Chemicals Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
71767-100_0b6532c1-7ebb-b65f-e063-6294a90a4949	71767-100	HUMAN PRESCRIPTION DRUG	FUROSCIX		furosemide injection 80 mg/ 10 mL	INJECTION	SUBCUTANEOUS	20221114		NDA	NDA209988	scPharmaceuticals Inc.	FUROSEMIDE	8	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71770-105_9a8e5e5d-2225-4d17-ae10-287fa1ee0616	71770-105	HUMAN PRESCRIPTION DRUG	Siklos		hydroxyurea	TABLET, FILM COATED	ORAL	20201015		NDA	NDA208843	Medunik	HYDROXYUREA	100	mg/1	Antimetabolite [EPC], Urea [CS]		N	20251231
71770-120_9a8e5e5d-2225-4d17-ae10-287fa1ee0616	71770-120	HUMAN PRESCRIPTION DRUG	Siklos		hydroxyurea	TABLET, FILM COATED	ORAL	20180415		NDA	NDA208843	Medunik	HYDROXYUREA	1000	mg/1	Antimetabolite [EPC], Urea [CS]		N	20251231
71770-200_36fd0ef3-2ee0-427c-9670-f59e2c7b67dc	71770-200	HUMAN PRESCRIPTION DRUG	PHEBURANE		Sodium phenylbutyrate	KIT		20220826		NDA	NDA216513	Medunik USA						N	20241231
71770-210_36fd0ef3-2ee0-427c-9670-f59e2c7b67dc	71770-210	HUMAN PRESCRIPTION DRUG	PHEBURANE		Sodium phenylbutyrate	PELLET	ORAL	20220914		NDA	NDA216513	Medunik USA	SODIUM PHENYLBUTYRATE	483	mg/g	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
71773-050_6dae690a-73ae-42d2-a340-0d1c1f47fc13	71773-050	HUMAN PRESCRIPTION DRUG	Xerava		eravacycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180910		NDA	NDA211109	Tetraphase Pharmaceuticals, Inc.	ERAVACYCLINE DIHYDROCHLORIDE	50	mg/1	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
71773-100_6dae690a-73ae-42d2-a340-0d1c1f47fc13	71773-100	HUMAN PRESCRIPTION DRUG	Xerava		eravacycline	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180910		NDA	NDA211109	Tetraphase Pharmaceuticals, Inc.	ERAVACYCLINE DIHYDROCHLORIDE	100	mg/1	Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]		N	20241231
71776-001_0700d0a1-3b89-10b8-e063-6294a90a819e	71776-001	HUMAN OTC DRUG	FreshKote Preservative Free Lubricant Eye Drops		Povidone, Polyvinyl Alcohol	SOLUTION	OPHTHALMIC	20190313		OTC MONOGRAPH DRUG	M018	Eyevance Pharmaceuticals	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	27; 20	g/1000mL; g/1000mL			N	20241231
71776-005_074ad8b5-641f-e33c-e063-6294a90aca0b	71776-005	HUMAN PRESCRIPTION DRUG	NATACYN		natamycin	SUSPENSION/ DROPS	OPHTHALMIC	20210612		NDA	NDA050514	Eyevance Pharmaceuticals, LLC	NATAMYCIN	50	mg/mL	Polyene Antimicrobial [EPC], Polyenes [CS]		N	20241231
71776-024_074ad03b-95e9-7e53-e063-6394a90a0305	71776-024	HUMAN PRESCRIPTION DRUG	Zerviate		Cetirizine	SOLUTION/ DROPS	OPHTHALMIC	20190219		NDA	NDA208694	Eyevance Pharmaceuticals	CETIRIZINE	2.4	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71776-035_07519d01-5c02-5671-e063-6294a90a25a8	71776-035	HUMAN PRESCRIPTION DRUG	Tobradex ST		tobramycin / dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20210519		NDA	NDA050818	Eyevance Pharmaceuticals, LLC	DEXAMETHASONE; TOBRAMYCIN	.5; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71776-100_0760a31d-934e-56a0-e063-6294a90acb70	71776-100	HUMAN PRESCRIPTION DRUG	Flarex		fluorometholone acetate	SUSPENSION/ DROPS	OPHTHALMIC	20190305		NDA	NDA019079	Eyevance Pharmaceuticals	FLUOROMETHOLONE ACETATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71777-390_5b9e7961-f843-49d8-94b5-a2ce2c9efa46	71777-390	HUMAN PRESCRIPTION DRUG	VITRAKVI		LAROTRECTINIB	CAPSULE	ORAL	20181126		NDA	NDA210861	Loxo Oncology, Inc.	LAROTRECTINIB	25	mg/1	Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]		N	20241231
71777-391_5b9e7961-f843-49d8-94b5-a2ce2c9efa46	71777-391	HUMAN PRESCRIPTION DRUG	VITRAKVI		LAROTRECTINIB	CAPSULE	ORAL	20181126		NDA	NDA210861	Loxo Oncology, Inc.	LAROTRECTINIB	100	mg/1	Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]		N	20241231
71777-392_5b9e7961-f843-49d8-94b5-a2ce2c9efa46	71777-392	HUMAN PRESCRIPTION DRUG	VITRAKVI		LAROTRECTINIB	SOLUTION	ORAL	20181126		NDA	NDA211710	Loxo Oncology, Inc.	LAROTRECTINIB	20	mg/mL	Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]		N	20241231
71778-001_f2027f74-cc9a-4a11-e053-2a95a90aecf3	71778-001	HUMAN OTC DRUG	Vivaiodays Sunscreen with Turmeric		Zinc Oxide	LOTION	TOPICAL	20180215	20241231	OTC MONOGRAPH FINAL	part352	5 SENCO Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
71780-021_ce46b9a2-522c-9bf7-e053-2a95a90a59b8	71780-021	HUMAN OTC DRUG	LaSpa Moisturizing Mineral Sunscreen SPF 30		Zinc Oxide	CREAM	TOPICAL	20211026		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket inc	ZINC OXIDE	200	mg/mL			N	20241231
71780-520_ce14fb1e-93f8-2db9-e053-2995a90aa109	71780-520	HUMAN OTC DRUG	LASPA TINTED MATTE SUNSCREEN SPF 20 LIGHT		ZINC OXIDE	LOTION	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket Inc	ZINC OXIDE	150	mg/g			N	20241231
71780-521_ce14fb1e-93f8-2db9-e053-2995a90aa109	71780-521	HUMAN OTC DRUG	LASPA TINTED MATTE SUNSCREEN SPF 20 GOLDEN		ZINC OXIDE	LOTION	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket Inc	ZINC OXIDE	150	mg/g			N	20241231
71780-522_ce14fb1e-93f8-2db9-e053-2995a90aa109	71780-522	HUMAN OTC DRUG	LASPA TINTED MATTE SUNSCREEN SPF 20 BRONZE		ZINC OXIDE	LOTION	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket Inc	ZINC OXIDE	150	mg/g			N	20241231
71780-523_c572d8c7-fc83-8038-e053-2995a90ad4dc	71780-523	HUMAN OTC DRUG	LASPA DAILY SUN PROTECTION BROAD SPECTRUM MINERAL SUNSCREEN SPF 20		ZINC OXIDE	LOTION	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket Inc	ZINC OXIDE	150	mg/mL			N	20241231
71780-524_ce14fb1e-93f8-2db9-e053-2995a90aa109	71780-524	HUMAN OTC DRUG	LASPA TINTED MATTE SUNSCREEN SPF 20 RICH BROWN		ZINC OXIDE	LOTION	TOPICAL	20211011		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket Inc	ZINC OXIDE	150	mg/g			N	20241231
71780-525_ce14fb1e-93f8-2db9-e053-2995a90aa109	71780-525	HUMAN OTC DRUG	LASPA TINTED MATTE SUNSCREEN SPF 20 DEEP UMBER		ZINC OXIDE	LOTION	TOPICAL	20211011		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket Inc	ZINC OXIDE	150	mg/g			N	20241231
71780-550_c57316fd-956a-79d3-e053-2995a90ab29b	71780-550	HUMAN OTC DRUG	LASPA BROAD SPECTRUM MINERAL SUNSCREEN SPF 50 ULTRA SUN		ZINC OXIDE	STICK	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part352	The Green Cricket Inc	TITANIUM DIOXIDE; ZINC OXIDE	38; 250	mg/g; mg/g			N	20241231
71781-0001_abc6ac3d-e222-4c98-a9cf-1b6dbce52f4a	71781-0001	HUMAN OTC DRUG	Homeoplex A		Aralia Quinquefolia, Avena Sativa, Glandula Suprarenalis Suis, Arsenicum Iodatum, Ignatia Amara, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Zincum Metallicum	LIQUID	ORAL	20171031		UNAPPROVED HOMEOPATHIC		Supplement Clinic, LLC.	AMERICAN GINSENG; ARSENIC TRIIODIDE; AVENA SATIVA FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; ZINC	3; 12; 3; 12; 12; 12; 12; 12; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71781-0002_9f23592b-5e83-47ee-b2b5-b2b255938bc1	71781-0002	HUMAN OTC DRUG	Homeoplex B		Arsenicum Album, Calcarea Carbonica , Ignatia Amara, Kali Carbonicum, Lachesis Mutus, Natrum Muriaticum, Phosphorus, Pulsatilla, Staphysagria	LIQUID	ORAL	20171031		UNAPPROVED HOMEOPATHIC		Supplement Clinic, LLC.	ARSENIC TRIOXIDE; DELPHINIUM STAPHISAGRIA SEED; LACHESIS MUTA VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM CARBONATE; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
71781-0003_b4f1a644-707b-4b5f-b9ae-355e323183b8	71781-0003	HUMAN OTC DRUG	Homeoplex D		Glycerinum, Phytolacca Decandra, Taraxacum Officinale, Arsenicum Album, Nitricum Acidum, Nux Vomica, Petroleum, Phosphoricum Acidum, Phosphorus, Acetylsalicylicum Acidum, Glonoinum, Insulinum (Suis), Lithium Carbonicum, Thyroidinum (Suis), Salicylicum Acidum, Adrenocorticotrophin, Cortisone Aceticum, Eugenol, Stearyl Alcohol, Xylitol, Folliculinum, Benzoicum Acidum, Chlorinum, Potassium Sorbate, Sorbitol, Resorcinum, Benzyl Alcohol, Lacticum Acidum, Isopropyl Palmitate, Boricum Acidum, Aceticum Acidum,	LIQUID	ORAL	20171101		UNAPPROVED HOMEOPATHIC		Supplement Clinic, LLC.	ACETIC ACID; ARSENIC TRIOXIDE; ASPIRIN; BENZOIC ACID; BENZYL ALCOHOL; BORIC ACID; CHLORINE; CORTICOTROPIN; CORTISONE ACETATE; ESTRONE; EUGENOL; GLYCERIN; INSULIN PORK; ISOPROPYL PALMITATE; KEROSENE; LACTIC ACID, DL-; LEAD; LITHIUM CARBONATE; NITRIC ACID; NITROGLYCERIN; PETROLATUM; PHENYLBUTAZONE; PHOSPHORIC ACID; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM SORBATE; RESORCINOL; SALICYLIC ACID; SORBITOL; STEARYL ALCOHOL; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA THYROID; TARAXACUM OFFICINALE; XYLITOL	12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 3; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Mood Stabilizer [EPC], Nitrate Vasodilator [EPC], Nitrates [CS], Nitrogen Binding Agent [EPC], Non-Standardized Chemical Allergen [EPC], Non-Standardized Plant Allergenic Extract [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Pediculicide [EPC], Plant Proteins [CS], Platelet Aggregation Inhibitor [EPC], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
71781-0004_51931414-344f-4ad1-856f-72ba06f03102	71781-0004	HUMAN OTC DRUG	Homeoplex F		Echinacea (Angustifolia), Phytolacca Decandra, Lymph Node (Suis), Conium Maculatum, Ferrum Iodatum, Hepar Sulphuris Calcareum, Kali Muriaticum, Lachesis Mutus, Silicea	LIQUID	ORAL	20171101		UNAPPROVED HOMEOPATHIC		Supplement Clinic, LLC.	CALCIUM SULFIDE; CONIUM MACULATUM FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; FERROUS IODIDE; LACHESIS MUTA VENOM; PHYTOLACCA AMERICANA ROOT; POTASSIUM CHLORIDE; SILICON DIOXIDE; SUS SCROFA LYMPH	12; 12; 3; 12; 12; 3; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71781-0005_1c6495b2-b51b-4b59-866c-f7dd2feee6db	71781-0005	HUMAN OTC DRUG	Homeoplex G		Gentiana Lutea, Arsenicum Album, Cinchona Officinalis, Colocynthis, Nux Vomica, Phosphorus, Small Intestine (Suis)	LIQUID	ORAL	20171101		UNAPPROVED HOMEOPATHIC		Supplement Clinic, LLC.	ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; GENTIANA LUTEA ROOT; PHOSPHORUS; PORK INTESTINE; STRYCHNOS NUX-VOMICA SEED	12; 12; 12; 3; 12; 30; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71781-0006_d33b08fa-aa3b-445d-bd7b-02509835bbec	71781-0006	HUMAN OTC DRUG	Homeoplex L		Beta Vulgaris, Carduus Marianus, Taraxacum Officinale, Cholesterinum, Fel Tauri, Chelidonium Majus, Lycopodium Clavatum, Natrum Sulphuricum, Nux Vomica, Phosphorus	LIQUID	ORAL	20171101		UNAPPROVED HOMEOPATHIC		Supplement Clinic, LLC.	BETA VULGARIS; BOS TAURUS BILE; CHELIDONIUM MAJUS; CHOLESTEROL; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHOSPHORUS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE	3; 6; 12; 6; 12; 3; 12; 12; 12; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71781-0007_8b496fa9-1dd4-4606-becd-4f4414fbd727	71781-0007	HUMAN OTC DRUG	Homeoplex P		Astragalus Membranaceus, Echinacea (Angustifolia), Scrophularia Nodosa, Tabebuia Impetiginosa, Thyroidinum (Suis), Formicum Acidum, Phosphorus, Silicea, Sulphur, Thuja Occidentalis, Aurum Metallicum	LIQUID	ORAL	20171101		UNAPPROVED HOMEOPATHIC		Supplement Clinic, LLC.	ASTRAGALUS PROPINQUUS ROOT; ECHINACEA ANGUSTIFOLIA; FORMIC ACID; GOLD; PHOSPHORUS; SCROPHULARIA NODOSA; SILICON DIOXIDE; SULFUR; SUS SCROFA THYROID; TABEBUIA IMPETIGINOSA BARK; THUJA OCCIDENTALIS LEAFY TWIG	3; 3; 10; 12; 10; 3; 10; 10; 8; 3; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71782-015_f70b54ef-d4e2-3e9f-e053-6394a90a9c79	71782-015	HUMAN OTC DRUG	CANNON BALM		OCTINOXATE, OXYBENZONE	STICK	TOPICAL	20170930	20240401	OTC MONOGRAPH FINAL	part352	DUKE CANNON SUPPLY CO.	OCTINOXATE; OXYBENZONE	1.28; .51	g/17g; g/17g			N	
71782-115_f70a0173-c8bb-da7c-e053-6294a90a67db	71782-115	HUMAN OTC DRUG	CANNON BALM		Octinoxate, Octisalate, Octocrylene, Avobenzone	STICK	TOPICAL	20210507		OTC MONOGRAPH FINAL	M020	DUKE CANNON SUPPLY CO.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.34; 1.105; .85; .255	g/17g; g/17g; g/17g; g/17g			N	20241231
71782-140_f709c4fe-0b52-8f2c-e053-6394a90a6395	71782-140	HUMAN OTC DRUG	CANNON BALM 140		OCTINOXATE, AVOBENZONE, OCTISALATE, OXYBENZONE	STICK	TOPICAL	20170930	20240501	OTC MONOGRAPH FINAL	part352	DUKE CANNON SUPPLY CO.	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	.17; 1.28; .85; .68	g/17g; g/17g; g/17g; g/17g			N	
71782-141_0e8a4258-b8ac-af17-e063-6394a90ac336	71782-141	HUMAN OTC DRUG	CANNON BALM 140		OCTINOXATE, AVOBENZONE, OCTISALATE, OXYBENZONE	STICK	TOPICAL	20210729		OTC MONOGRAPH DRUG	M020	DUKE CANNON SUPPLY CO.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	.51; 1.28; .85; .85; 1.02	g/17g; g/17g; g/17g; g/17g; g/17g			N	20251231
71782-201_0c470c54-6881-d29f-e063-6394a90a522b	71782-201	HUMAN OTC DRUG	Duke Cannon Supply Co. Daily Defense Face Mineral Sunscreen Broad Spectrum SPF 32		Zinc Oxide	LOTION	TOPICAL	20231127		OTC MONOGRAPH DRUG	M020	DUKE CANNON SUPPLY CO.	ZINC OXIDE	150	mg/mL			N	20241231
71784-000_08c155a9-0703-3c59-e063-6294a90a7340	71784-000	HUMAN OTC DRUG	CHUDA		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Premier Ocher LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	30; 150; 75; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71785-1006_b45cbdea-d1be-c16d-e053-2a95a90a821e	71785-1006	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Annora Pharma Private Limited	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71785-1007_b45cbdea-d1be-c16d-e053-2a95a90a821e	71785-1007	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Annora Pharma Private Limited	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71785-1008_b45cbdea-d1be-c16d-e053-2a95a90a821e	71785-1008	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20190708		ANDA	ANDA212277	Annora Pharma Private Limited	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
71788-010_0dd449dc-b5b7-f934-e063-6394a90a8485	71788-010	HUMAN OTC DRUG	Protect U Guard 63% Foaming Hand Sanitizer		ethyl alcohol	LIQUID	TOPICAL	20200801		OTC MONOGRAPH DRUG	M003	Protect U Guard, LLC	ALCOHOL	63	mL/100mL			N	20241231
71788-011_0dd449dc-b5b7-f934-e063-6394a90a8485	71788-011	HUMAN OTC DRUG	Protect U Guard 63% Foaming Hand Sanitizer Lemon		ethyl alcohol	LIQUID	TOPICAL	20200801		OTC MONOGRAPH DRUG	M003	Protect U Guard, LLC	ALCOHOL	63	mL/100mL			N	20241231
71788-012_0dd449dc-b5b7-f934-e063-6394a90a8485	71788-012	HUMAN OTC DRUG	Protect U Guard 63% Foaming Hand Sanitizer Lavender		ethyl alcohol	LIQUID	TOPICAL	20200801		OTC MONOGRAPH DRUG	M003	Protect U Guard, LLC	ALCOHOL	63	mL/100mL			N	20241231
71788-013_0dd449dc-b5b7-f934-e063-6394a90a8485	71788-013	HUMAN OTC DRUG	Protect U Guard 63% Foaming Hand Sanitizer Watermelon		ethyl alcohol	LIQUID	TOPICAL	20200801		OTC MONOGRAPH DRUG	M003	Protect U Guard, LLC	ALCOHOL	63	mL/100mL			N	20241231
71788-014_0dd449dc-b5b7-f934-e063-6394a90a8485	71788-014	HUMAN OTC DRUG	Protect U Guard 63% Foaming Hand Sanitizer Fresh		ethyl alcohol	LIQUID	TOPICAL	20200801		OTC MONOGRAPH DRUG	M003	Protect U Guard, LLC	ALCOHOL	63	mL/100mL			N	20241231
71788-015_0dd449dc-b5b7-f934-e063-6394a90a8485	71788-015	HUMAN OTC DRUG	Protect U Guard 63% Foaming Hand Sanitizer Cotton		ethyl alcohol	LIQUID	TOPICAL	20200801		OTC MONOGRAPH DRUG	M003	Protect U Guard, LLC	ALCOHOL	63	mL/100mL			N	20241231
71788-017_01cf5d7a-5887-e8c6-e063-6294a90ab0d6	71788-017	HUMAN OTC DRUG	Antibacterial		Benzalkonium Chloride	LIQUID	TOPICAL	20211202		OTC MONOGRAPH NOT FINAL	part333A	Protect U Guard LLC	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71788-018_01cf5d7a-5887-e8c6-e063-6294a90ab0d6	71788-018	HUMAN OTC DRUG	Antibacterial Lemon Scent		Benzalkonium Chloride	LIQUID	TOPICAL	20211202		OTC MONOGRAPH NOT FINAL	part333A	Protect U Guard LLC	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71788-019_01cf5d7a-5887-e8c6-e063-6294a90ab0d6	71788-019	HUMAN OTC DRUG	Antibacterial Lavender Scent		Benzalkonium Chloride	LIQUID	TOPICAL	20211202		OTC MONOGRAPH NOT FINAL	part333A	Protect U Guard LLC	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71788-020_01cf5d7a-5887-e8c6-e063-6294a90ab0d6	71788-020	HUMAN OTC DRUG	Antibacterial Watermelon Scent		Benzalkonium Chloride	LIQUID	TOPICAL	20211202		OTC MONOGRAPH NOT FINAL	part333A	Protect U Guard LLC	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71788-021_01cf5d7a-5887-e8c6-e063-6294a90ab0d6	71788-021	HUMAN OTC DRUG	Antibacterial Cotton Scent		Benzalkonium Chloride	LIQUID	TOPICAL	20211202		OTC MONOGRAPH NOT FINAL	part333A	Protect U Guard LLC	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71792-101_0e5e208a-01a8-acda-e063-6394a90aee16	71792-101	HUMAN OTC DRUG	BENZOIL 12HR ACNE TREATMENT		BENZOYL PEROXIDE	LOTION	TOPICAL	20171012		OTC MONOGRAPH DRUG	M006	THE SKINCARE COMPANY, INC.	BENZOYL PEROXIDE	3	g/100mL			N	20251231
71800-009_727a87ee-8629-49f4-8550-bcf670037a8b	71800-009	HUMAN PRESCRIPTION DRUG	Diflorasone Diacetate		Diflorasone Diacetate	OINTMENT	TOPICAL	20180815		ANDA	ANDA075331	Innovida Pharmaceutique Corporation	DIFLORASONE DIACETATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71800-631_cecda053-fb24-b109-e053-2a95a90afaa5	71800-631	HUMAN PRESCRIPTION DRUG	Lidocaine and Tetracaine		Lidocaine and Tetracaine	CREAM	TOPICAL	20170503		NDA AUTHORIZED GENERIC	NDA021717	Innovida Pharmaceutique Corporation	LIDOCAINE; TETRACAINE	70; 70	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
71804-230_09db5696-961b-d689-e063-6394a90aeb01	71804-230	HUMAN OTC DRUG	MD-Acne Body Acne Treatment		BENZOYL PEROXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH DRUG	M006	MD Algorithms Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
71804-232_09e17cf8-9870-a3cc-e063-6394a90a6a00	71804-232	HUMAN OTC DRUG	MD Acne Oil Free SPF 30 Sunscreen		OCTINOXATE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	MD Algorithms Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 50	mg/mL; mg/mL; mg/mL			N	20241231
71804-704_f28be402-cdd3-2b87-e053-2a95a90a9198	71804-704	HUMAN OTC DRUG	MDhair Extra Strength hair regrowth treatment for Men		Minoxidil 5%	SOLUTION	TOPICAL	20210601		ANDA	ANDA076239	MDalgorithms, Inc	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71804-711_f28be97f-66f0-499d-e053-2a95a90a89af	71804-711	HUMAN OTC DRUG	MDhair hair regrowth treatment for women		Minoxidil 2%	SOLUTION	TOPICAL	20210601		ANDA	ANDA078176	MDalgorithms, Inc	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71805-855_09dc09a4-8c6f-1ab6-e063-6394a90a8b1d	71805-855	HUMAN OTC DRUG	TerraFreeze Pain Relief		MENTHOL,METHYL SALICYLATE,HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20171012		OTC MONOGRAPH DRUG	M017	Beyond Derma, LLC	HISTAMINE DIHYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.5; 100; 100	mg/g; mg/g; mg/g			N	20241231
71810-101_0da7759e-9db7-8707-e063-6394a90a0174	71810-101	HUMAN OTC DRUG	WORKMANS FRIEND SUPERIOR BARRIER SKIN		DIMETHICONE	CREAM	TOPICAL	20171130		OTC MONOGRAPH DRUG	M016	SolvChem, Inc.	DIMETHICONE	1	g/100mL	Skin Barrier Activity [PE]		N	20241231
71811-003_01d3b2bb-3945-083e-e063-6394a90a7816	71811-003	HUMAN OTC DRUG	Pain Relieving Lidocaine Patch		Lidocaine	PATCH	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part348	InterMed Laboratories Private Limited	LIDOCAINE	40	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71819-001_a19c5aaf-e90a-fba0-e053-2a95a90a864e	71819-001	HUMAN OTC DRUG	Zinc Therapy		Pyrithione Zinc	SOAP	TOPICAL	20180501		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
71819-002_b29befe4-ae20-29dc-e053-2a95a90aab06	71819-002	HUMAN OTC DRUG	Dermaharmony Seborrheic Dermatitis		Pyrithione Zinc	CREAM	TOPICAL	20190726		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	.25	g/100mL			N	20241231
71819-003_6b650f3d-a243-7a30-e053-2991aa0a777e	71819-003	HUMAN OTC DRUG	Salicylic Acid		Salicylic Acid	SOAP	TOPICAL	20180504		OTC MONOGRAPH FINAL	part333D	D3 Development, Inc.	SALICYLIC ACID	2	g/100g			N	20241231
71819-004_8cb1d526-1ba8-6b02-e053-2a95a90aa1d0	71819-004	HUMAN OTC DRUG	Dermaharmony Sulfur and Salicylic Acid		Salicylic Acid, Sulfur	SOAP	TOPICAL	20190702		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	SALICYLIC ACID; SULFUR	2; 5	g/100g; g/100g			N	20241231
71819-005_a24e188e-3b02-660f-e053-2a95a90aa37c	71819-005	HUMAN OTC DRUG	Dermaharmony Bar	Peppermint	Pyrithione Zinc	SHAMPOO	TOPICAL	20200324		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
71819-006_a1c61da2-7e7b-430a-e053-2995a90ad594	71819-006	HUMAN OTC DRUG	Dermaharmony Sulfur and Salicylic Acid		Salicylic Acid, Sulfur	LIQUID	TOPICAL	20200327		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	SALICYLIC ACID; SULFUR	2; 5	g/100mL; g/100mL			N	20241231
71819-007_8cb1d88d-346d-7cf6-e053-2995a90a1d9a	71819-007	HUMAN OTC DRUG	Zinc Therapy		Pyrithione Zinc	LIQUID	TOPICAL	20180123		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100mL			N	20241231
71819-008_bd72b53c-b22b-40d0-e053-2995a90af9c1	71819-008	HUMAN OTC DRUG	Dermaharmony Face and Body		Pyrithione Zinc	SOAP	TOPICAL	20210315		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
71819-009_af7060a9-986b-500e-e053-2a95a90a6438	71819-009	HUMAN OTC DRUG	Dermaharmony Bar	Peppermint	Salicylic Acid, Sulfur	SHAMPOO	TOPICAL	20201026		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	SALICYLIC ACID; SULFUR	2; 5	g/100g; g/100g			N	20241231
71819-010_b9e765eb-f560-f38a-e053-2a95a90aafd1	71819-010	HUMAN OTC DRUG	Dermaharmony 1% Pyrithione Zinc		Pyrithione Zinc	SOAP	TOPICAL	20210127		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	1	g/100g			N	20241231
71819-011_c7083b69-fed3-d497-e053-2a95a90a1a8c	71819-011	HUMAN OTC DRUG	Dermaharmony 10% Benzoyl Peroxide	Cleansing Bar	Benzoyl Peroxide	SOAP	TOPICAL	20210713		OTC MONOGRAPH FINAL	part333D	D3 Development, Inc.	BENZOYL PEROXIDE	10	g/100g			N	20241231
71819-013_c7ceae0d-3214-1f83-e053-2995a90a60bc	71819-013	HUMAN OTC DRUG	Dermaharmony 5% Benzoyl Peroxide	Cleansing Bar	Benzoyl Peroxide	SOAP	TOPICAL	20210729		OTC MONOGRAPH FINAL	part333D	D3 Development, Inc.	BENZOYL PEROXIDE	5	g/100g			N	20241231
71819-014_c78ead80-a8ef-0b52-e053-2a95a90ab880	71819-014	HUMAN OTC DRUG	Dermaharmony 10% Sulfur		Sulfur	SOAP	TOPICAL	20210720		OTC MONOGRAPH FINAL	part333D	D3 Development, Inc.	SULFUR	10	g/100g			N	20241231
71819-015_c79005d4-0c6e-75d0-e053-2995a90a8314	71819-015	HUMAN OTC DRUG	Dermaharmony 10% Sulfur	with Tea Tree Oil	Sulfur	SOAP	TOPICAL	20210720		OTC MONOGRAPH FINAL	part333D	D3 Development, Inc.	SULFUR	10	g/100g			N	20241231
71819-016_cb442483-b734-01a0-e053-2995a90aaff5	71819-016	HUMAN OTC DRUG	Dermaharmony Zinc Therapy		Pyrithione Zinc	LIQUID	TOPICAL	20210905		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100mL			N	20241231
71819-017_dc7ba02c-bdbe-5136-e053-2995a90ac545	71819-017	HUMAN OTC DRUG	Dermaharmony Pyrithione Zinc	with Shea Butter	Pyrithione Zinc	SOAP	TOPICAL	20220425		OTC MONOGRAPH FINAL	part358H	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
71819-018_e9d5eb14-1841-ae21-e053-2a95a90aa321	71819-018	HUMAN OTC DRUG	Dermaharmony Tea Tree Bar		Pyrithione Zinc	SHAMPOO	TOPICAL	20220929		OTC MONOGRAPH FINAL	M032	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
71819-019_e9d66c9c-5fb0-0a90-e053-2a95a90ab7a4	71819-019	HUMAN OTC DRUG	Dermaharmony Unscented Bar		Pyrithione Zinc	SHAMPOO	TOPICAL	20220929		OTC MONOGRAPH FINAL	M032	D3 Development, Inc.	PYRITHIONE ZINC	2	g/100g			N	20241231
71821-006_d0fb5849-3fc9-11d3-e053-2995a90a5bbc	71821-006	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215556	VKT Pharma Private Limited	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71821-007_d0fb5849-3fc9-11d3-e053-2995a90a5bbc	71821-007	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215556	VKT Pharma Private Limited	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71821-008_d0fb5849-3fc9-11d3-e053-2995a90a5bbc	71821-008	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215556	VKT Pharma Private Limited	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71821-009_d0fb5849-3fc9-11d3-e053-2995a90a5bbc	71821-009	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215556	VKT Pharma Private Limited	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
71825-113_9b442619-dceb-43a2-e053-2a95a90a8513	71825-113	HUMAN OTC DRUG	Cremo Anti-Perspirant Deodorant	Silver Water and Birch	Aluminum Zirconium Tetrachlorohydrex Glycine	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Cremo Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
71825-114_9b444076-7fc1-0cdb-e053-2a95a90acac9	71825-114	HUMAN OTC DRUG	Cremo Anti-Perspirant Deodorant	Sage and Citrus	Aluminum Zirconium Tetrachlorohydrex Glycine	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Cremo Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
71825-115_9b443dd6-69ac-0c42-e053-2a95a90a9d5c	71825-115	HUMAN OTC DRUG	Cremo Anti-Perspirant Deodorant	Reserve Blend	Aluminum Zirconium Tetrachlorohydrex Glycine	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Cremo Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
71825-116_9b43e996-8e64-a2ab-e053-2995a90ac1d5	71825-116	HUMAN OTC DRUG	Cremo Anti-Perspirant Deodorant	Citrus and Mint Leaf	Aluminum Zirconium Tetrachlorohydrex Glycine	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Cremo Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
71825-117_9b43f720-69c1-607d-e053-2a95a90a2531	71825-117	HUMAN OTC DRUG	Cremo Anti-Perspirant Deodorant	Bourbon and Oak	Aluminum Zirconium Tetrachlorohydrex Glycine	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Cremo Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
71825-118_9b43f7a5-e404-5002-e053-2a95a90a6c1b	71825-118	HUMAN OTC DRUG	Cremo Anti-Perspirant Deodorant	Blue Cedar and Cypress	Aluminum Zirconium Tetrachlorohydrex Glycine	STICK	TOPICAL	20200101		OTC MONOGRAPH FINAL	part350	Cremo Company	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	19	g/100g			N	20241231
71825-120_d4ec08df-8f37-8e0d-e053-2a95a90af728	71825-120	HUMAN OTC DRUG	Cremo All-Season Lip Balm SPF 25 Vanilla Mint		Avobenzone, Homosalate, Octisalate, Octocrylene, Petrolatum	OINTMENT	TOPICAL	20220106		OTC MONOGRAPH NOT FINAL	part352	Cremo Company	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; PETROLATUM	3; 10; 5; 8; 40	g/1000g; g/1000g; g/1000g; g/1000g; g/1000g			N	20241231
71831-004_18687c95-4c7a-48fe-80b0-df86117958da	71831-004	HUMAN OTC DRUG	Pranicura 5		GLYCERIN, KAOLIN, CALAMINE, MENTHOL	CREAM	TOPICAL	20211018		OTC MONOGRAPH DRUG	M015	PRANICURA GROUP LLC	GLYCERIN; KAOLIN; MENTHOL; ZINC OXIDE	25; 12.5; 1; 12.5	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
71831-005_8a8a50c0-b8db-423b-9b79-aa3ae73818db	71831-005	HUMAN OTC DRUG	No More Products		GLYCERIN, KAOLIN, CALAMINE, MENTHOL	CREAM	TOPICAL	20230301		OTC MONOGRAPH DRUG	M015	PRANICURA GROUP LLC	GLYCERIN; KAOLIN; MENTHOL; ZINC OXIDE	25; 12.5; 1; 12.5	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
71837-5843_c67e7850-15ba-4170-ab70-7b567daf51bd	71837-5843	HUMAN PRESCRIPTION DRUG	Leukine		SARGRAMOSTIM	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230901		BLA	BLA103362	Partner Therapeutics, Inc.	SARGRAMOSTIM	250	ug/mL	Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
71839-104_f2899d4e-6d6a-482c-9994-5034488a4112	71839-104	HUMAN PRESCRIPTION DRUG	fosaprepitant		fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20191015		ANDA	ANDA212309	BE Pharmaceuticals Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
71839-105_a90a9fa9-dc93-4e87-94fa-e578918ccfce	71839-105	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20190513		ANDA	ANDA212512	BE Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71839-106_a90a9fa9-dc93-4e87-94fa-e578918ccfce	71839-106	HUMAN PRESCRIPTION DRUG	Neostigmine methylsulfate		Neostigmine methylsulfate	INJECTION	INTRAVENOUS	20190513		ANDA	ANDA212512	BE Pharmaceuticals Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71839-107_577b6790-a484-4e8f-a7ca-0d1e2d2a0420	71839-107	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190626		ANDA	ANDA212513	BE Pharmaceuticals Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
71839-108_84aa2283-c18e-442f-9e48-a05a58695769	71839-108	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200820		ANDA	ANDA213425	BE Pharmaceuticals Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
71839-109_5db5abf2-d207-4e03-a5cc-8e31f2fa20c0	71839-109	HUMAN PRESCRIPTION DRUG	enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20230616		ANDA	ANDA214646	BE Pharmaceuticals Inc.	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71839-110_5db5abf2-d207-4e03-a5cc-8e31f2fa20c0	71839-110	HUMAN PRESCRIPTION DRUG	enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20230616		ANDA	ANDA214646	BE Pharmaceuticals Inc.	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71839-111_5db5abf2-d207-4e03-a5cc-8e31f2fa20c0	71839-111	HUMAN PRESCRIPTION DRUG	enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20230616		ANDA	ANDA214646	BE Pharmaceuticals Inc.	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71839-112_5db5abf2-d207-4e03-a5cc-8e31f2fa20c0	71839-112	HUMAN PRESCRIPTION DRUG	enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20230616		ANDA	ANDA214646	BE Pharmaceuticals Inc.	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71839-113_5db5abf2-d207-4e03-a5cc-8e31f2fa20c0	71839-113	HUMAN PRESCRIPTION DRUG	enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20230616		ANDA	ANDA214646	BE Pharmaceuticals Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71839-115_5db5abf2-d207-4e03-a5cc-8e31f2fa20c0	71839-115	HUMAN PRESCRIPTION DRUG	enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20230616		ANDA	ANDA214646	BE Pharmaceuticals Inc.	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71839-116_5db5abf2-d207-4e03-a5cc-8e31f2fa20c0	71839-116	HUMAN PRESCRIPTION DRUG	enoxaparin sodium		enoxaparin sodium	INJECTION	SUBCUTANEOUS	20230616		ANDA	ANDA214646	BE Pharmaceuticals Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
71839-117_893ec8e8-f3d4-4eef-afbc-88ee29b2ba59	71839-117	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20201229		ANDA	ANDA214804	BE Pharmaceuticals Inc.	HEPARIN SODIUM	2000	[USP'U]/2mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71839-118_92e7b0c4-634c-42cd-9559-3a2c1e3b450b	71839-118	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20201229		ANDA	ANDA214839	BE Pharmaceuticals Inc.	HEPARIN SODIUM	5000	[USP'U]/.5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
71839-120_01841345-bed3-458f-8e99-911fbd286512	71839-120	HUMAN PRESCRIPTION DRUG	Sodium Nitroprusside		Sodium Nitroprusside	INJECTION	INTRAVENOUS	20210712		ANDA	ANDA214971	BE Pharmaceuticals Inc.	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
71839-121_200064fa-2d8d-40ac-92a2-cba54deef1c9	71839-121	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220207		ANDA	ANDA216003	BE Pharmaceuticals Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71839-122_129ec9cf-f76a-4fb0-9596-7e162c95c7e0	71839-122	HUMAN PRESCRIPTION DRUG	Pantoprazole sodium		Pantoprazole sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220525		ANDA	ANDA216171	BE Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
71839-123_d9df3900-a8c2-438b-8971-ba11ff91f90b	71839-123	HUMAN PRESCRIPTION DRUG	glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220310		ANDA	ANDA211705	BE Pharmaceuticals Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71839-124_d9df3900-a8c2-438b-8971-ba11ff91f90b	71839-124	HUMAN PRESCRIPTION DRUG	glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220310		ANDA	ANDA211705	BE Pharmaceuticals Inc.	GLYCOPYRROLATE	.4	mg/2mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71839-125_d9df3900-a8c2-438b-8971-ba11ff91f90b	71839-125	HUMAN PRESCRIPTION DRUG	glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220310		ANDA	ANDA211705	BE Pharmaceuticals Inc.	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71839-126_d9df3900-a8c2-438b-8971-ba11ff91f90b	71839-126	HUMAN PRESCRIPTION DRUG	glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220310		ANDA	ANDA211705	BE Pharmaceuticals Inc.	GLYCOPYRROLATE	4	mg/20mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71839-127_fb069778-d16e-40f9-9c02-5496adfcb5d2	71839-127	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20230710		ANDA	ANDA217521	BE Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71839-128_fb069778-d16e-40f9-9c02-5496adfcb5d2	71839-128	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20230710		ANDA	ANDA217521	BE Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71839-129_fb069778-d16e-40f9-9c02-5496adfcb5d2	71839-129	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20230710		ANDA	ANDA217521	BE Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71839-137_8447d4f1-d286-4aa0-a379-a673518da045	71839-137	HUMAN PRESCRIPTION DRUG	CARBOPROST TROMETHAMINE		carboprost tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230511		ANDA	ANDA216882	BE Pharmaceuticals Inc.	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
71839-141_1543ea2b-54ab-4088-a72a-5d71854a2dce	71839-141	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20230712		ANDA	ANDA216234	BE Pharmaceuticals Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71839-142_1543ea2b-54ab-4088-a72a-5d71854a2dce	71839-142	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20230712		ANDA	ANDA216234	BE Pharmaceuticals Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71839-143_c42d425a-094e-4390-b4f9-4bb4b0fbc7d0	71839-143	HUMAN PRESCRIPTION DRUG	Norepinephrine Bitartrate		norepinephrine bitartrate	INJECTION	INTRAVENOUS	20231230		ANDA	ANDA217575	BE Pharmaceuticals Inc.	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
71849-101_0d926b1f-37b6-d222-e063-6394a90a949d	71849-101	HUMAN OTC DRUG	Bonafide Innovations Liquid Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	M003	Bonafide Innovations LLC	ALCOHOL	2.38	kg/3.79L			N	20241231
71852-060_09dc14d7-b6ad-1a86-e063-6394a90a0122	71852-060	HUMAN OTC DRUG	No BS SPF20 Moisturizer		OCTINOXATE, AVOBENZONE, OCTOCRYLENE	CREAM	TOPICAL	20171101		OTC MONOGRAPH DRUG	M020	Product Management LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	30; 55; 20	mg/mL; mg/mL; mg/mL			N	20241231
71852-334_097483fe-a26b-b6fc-e063-6394a90a44dd	71852-334	HUMAN OTC DRUG	NO BS Moisturizer SPF20		OCTINOXATE, OCTISALATE, AVOBENZONE	LOTION	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Product Management, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 50; 30	mg/mL; mg/mL; mg/mL			N	20241231
71853-001_09c29a75-14c4-1335-e063-6394a90a7f27	71853-001	HUMAN OTC DRUG	ElimiShield Clinical Hand Santizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20171102		OTC MONOGRAPH DRUG	505G(a)(3)	Bryson Industries Inc.	BENZALKONIUM CHLORIDE	13	mg/mL			N	20241231
71853-002_09c2a962-02e9-050f-e063-6394a90a6f8a	71853-002	HUMAN OTC DRUG	ElimiShield Sport Body Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20171102		OTC MONOGRAPH DRUG	505G(a)(3)	Bryson Industries Inc.	BENZALKONIUM CHLORIDE	13	mg/mL			N	20241231
71853-004_09c2d3bb-e82a-3015-e063-6394a90aff27	71853-004	HUMAN OTC DRUG	ElimiShield Clinical Care Technology Alcohol-Free Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180122		OTC MONOGRAPH DRUG	505G(a)(3)	Bryson Industries Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71853-005_09c28c59-b8b8-195c-e063-6394a90abbac	71853-005	HUMAN OTC DRUG	ElimiShield Sport Alcohol-Free Full Body Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180122		OTC MONOGRAPH DRUG	505G(a)(3)	Bryson Industries Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71853-006_09c2d98f-43b9-301f-e063-6394a90aff3f	71853-006	HUMAN OTC DRUG	ElimiShield Home and Outdoor Moisturizing Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200901		OTC MONOGRAPH DRUG	505G(a)(3)	Bryson Industries Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71853-007_09c2dbb9-bc5c-b54b-e063-6294a90a9c25	71853-007	HUMAN OTC DRUG	ElimiShield Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200901		OTC MONOGRAPH DRUG	505G(a)(3)	Bryson Industries Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71853-010_09c2c798-648a-fdb4-e063-6394a90ac817	71853-010	HUMAN OTC DRUG	ElimiShield Hunt Core Body Foam for Hunters		BENZALKONIUM CHLORIDE	AEROSOL, FOAM	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Bryson Industries, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71856-070_09dc19d0-24ac-bd12-e063-6294a90ab40f	71856-070	HUMAN OTC DRUG	Arctic Blast Pain Drops		MENTHOL CAMPHOR (NATURAL)	LIQUID	TOPICAL	20171101		OTC MONOGRAPH DRUG	M017	Biostar Nutrition Pte. Ltd.	CAMPHOR (NATURAL); MENTHOL	30; 100	mg/mL; mg/mL			N	20241231
71856-176_09dc0512-bdb5-bdc3-e063-6294a90a03f7	71856-176	HUMAN OTC DRUG	Arctic Blast Pain Releiving		MENTHOL, CAMPHOR (SYNTHETIC)	LIQUID	TOPICAL	20180501		OTC MONOGRAPH DRUG	M017	Nutriomo Labs Pte, Ltd	CAMPHOR (SYNTHETIC); MENTHOL	30; 100	mg/mL; mg/mL			N	20241231
71856-271_09749db1-19ad-799e-e063-6294a90a47eb	71856-271	HUMAN OTC DRUG	N-LABS SOLAR MAX Topical Analgesic		MENTHOL, CAPSAICIN	CREAM	TOPICAL	20220201		OTC MONOGRAPH DRUG	M017	NUTRIOMO LABS PTE. LTD.	CAPSAICIN; MENTHOL	.25; 80	mg/mL; mg/mL			N	20241231
71856-423_09dc19d0-24b9-bd12-e063-6294a90ab40f	71856-423	HUMAN OTC DRUG	7th MANNA PAIN RELIEF DROPS		MENTHOL, CAMPHOR (SYNTHETIC)	LIQUID	TOPICAL	20230925		OTC MONOGRAPH DRUG	M017B	7TH MANNA (USA) PTE. LTD.	CAMPHOR (SYNTHETIC); MENTHOL	30; 100	mg/mL; mg/mL			N	20241231
71858-0005_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0005	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	13	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0010_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0010	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0012_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0012	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	37.5	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0013_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0013	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	44	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0015_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0015	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0017_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0017	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	62.5	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0020_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0020	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0025_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0025	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0030_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0030	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0035_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0035	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0040_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0040	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0045_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0045	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0050_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0050	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0055_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0055	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0060_0b274758-a84c-4e19-e063-6294a90a3b89	71858-0060	HUMAN PRESCRIPTION DRUG	Tirosint		levothyroxine sodium	CAPSULE	ORAL	20181201		NDA	NDA021924	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0105_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0105	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	13	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0110_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0110	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	25	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0112_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0112	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20210701		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	37.5	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0113_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0113	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20210701		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	44	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0115_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0115	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	50	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0117_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0117	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20210701		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	62.5	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0120_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0120	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	75	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0125_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0125	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	88	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0130_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0130	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	100	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0135_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0135	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	112	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0140_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0140	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	125	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0145_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0145	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	137	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0150_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0150	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	150	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0155_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0155	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	175	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0160_0a4370a8-688c-7d96-e063-6294a90a18b8	71858-0160	HUMAN PRESCRIPTION DRUG	Tirosint	SOL	Levothyroxine Sodium	SOLUTION	ORAL	20190301		NDA	NDA206977	IBSA Pharma Inc.	LEVOTHYROXINE SODIUM	200	ug/mL	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
71858-0305_0b72418c-f33d-6338-e063-6394a90a8e0a	71858-0305	HUMAN PRESCRIPTION DRUG	LICART		diclofenac epolamine	SYSTEM	TOPICAL	20200901		NDA	NDA206976	IBSA Pharma Inc.	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71858-0405_e91c51e1-109f-fb8f-e053-2a95a90a725e	71858-0405	HUMAN PRESCRIPTION DRUG	FLECTOR		diclofenac epolamine	SYSTEM	TOPICAL	20201101		NDA	NDA021234	IBSA Pharma Inc.	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71863-109_08f49aef-a4f1-da40-e063-6294a90ab218	71863-109	HUMAN PRESCRIPTION DRUG	Alkindi	Sprinkle	Hydrocortisone	GRANULE	ORAL	20200929		NDA	NDA213876	Eton Pharmaceuticals, Inc.	HYDROCORTISONE	.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71863-110_08f49aef-a4f1-da40-e063-6294a90ab218	71863-110	HUMAN PRESCRIPTION DRUG	Alkindi	Sprinkle	Hydrocortisone	GRANULE	ORAL	20200929		NDA	NDA213876	Eton Pharmaceuticals, Inc.	HYDROCORTISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71863-111_08f49aef-a4f1-da40-e063-6294a90ab218	71863-111	HUMAN PRESCRIPTION DRUG	Alkindi	Sprinkle	Hydrocortisone	GRANULE	ORAL	20200929		NDA	NDA213876	Eton Pharmaceuticals, Inc.	HYDROCORTISONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71863-112_08f49aef-a4f1-da40-e063-6294a90ab218	71863-112	HUMAN PRESCRIPTION DRUG	Alkindi	Sprinkle	Hydrocortisone	GRANULE	ORAL	20200929		NDA	NDA213876	Eton Pharmaceuticals, Inc.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71863-115_0ccb85a5-4b8c-b30a-e063-6294a90a781b	71863-115	HUMAN PRESCRIPTION DRUG	Betaine Anhydrous		Betaine Anhydrous	POWDER, FOR SOLUTION	ORAL	20230201		ANDA	ANDA210508	Eton Pharmaceuticals, Inc.	BETAINE	1	g/g	Methylating Activity [MoA], Methylating Agent [EPC]		N	20241231
71863-202_3508aaf0-b0e3-4aeb-909d-83c13c30a30f	71863-202	HUMAN PRESCRIPTION DRUG	Biorphen		Phenylephrine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20191115		NDA	NDA212909	Eton Pharmaceuticals, Inc.	PHENYLEPHRINE HYDROCHLORIDE	.1	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71863-208_3508aaf0-b0e3-4aeb-909d-83c13c30a30f	71863-208	HUMAN PRESCRIPTION DRUG	Biorphen		Phenylephrine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20191115		NDA	NDA212909	Eton Pharmaceuticals, Inc.	PHENYLEPHRINE HYDROCHLORIDE	.1	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71870-101_ed8dbaa6-e164-e013-e053-2995a90aaa60	71870-101	HUMAN OTC DRUG	Isopropyl Alcohol Wipes		HAND SANITIZER	CLOTH	TOPICAL	20221111		OTC MONOGRAPH NOT FINAL	part333A	WINNER MEDICAL CO., LTD.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
71870-102_f94bfb52-c940-541d-e053-6294a90a2add	71870-102	HUMAN OTC DRUG	75% Isopropyl Alcohol Wipes		HAND SANITIZER	CLOTH	TOPICAL	20230414		OTC MONOGRAPH NOT FINAL	part333A	WINNER MEDICAL CO., LTD.	ISOPROPYL ALCOHOL	75	g/100g			N	20241231
71872-7000_fe91f01c-a089-a2b2-e053-6394a90a79a7	71872-7000	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20080225		ANDA	ANDA077234	Medical Purchasing Solutions, LLC	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7001_fd638baf-af86-a7d0-e053-6394a90ae1ad	71872-7001	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19921101		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7002_eaee9ea4-7c4b-26ce-e053-2995a90acdd9	71872-7002	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	ENDOTRACHEAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20060119		NDA	NDA021146	Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7003_eaee9ea4-7c51-26ce-e053-2995a90acdd9	71872-7003	HUMAN PRESCRIPTION DRUG	Dextrose		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20051202		NDA	NDA019445	Medical Purchasing Solutions, LLC	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
71872-7005_fa45141d-ac30-ca9b-e053-6394a90a5cbb	71872-7005	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		diphenhydramine hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19721127		ANDA	ANDA080817	Medical Purchasing Solutions, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71872-7008_eaeea17c-3d8f-d4eb-e053-2a95a90a9541	71872-7008	HUMAN PRESCRIPTION DRUG	Flumazenil		flumazenil	INJECTION, SOLUTION	INTRAVENOUS	20070101		ANDA	ANDA078527	Medical Purchasing Solutions, LLC	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
71872-7009_fa45551b-cd87-d4cc-e053-6294a90a8829	71872-7009	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Nalxone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19860924		ANDA	ANDA070299	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7010_fd6366f1-0ea4-81a8-e053-6394a90a0b1a	71872-7010	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20160829		ANDA	ANDA208191	Medical Purchasing Solutions, LLC	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71872-7012_fd1a6beb-7da4-5539-e053-6394a90ab391	71872-7012	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170626		ANDA	ANDA207639	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7013_fd1a483b-00df-5124-e053-6394a90a2f3b	71872-7013	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20110921		ANDA	ANDA090963	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7014_fd1a231f-3406-51ef-e053-6394a90abf4e	71872-7014	HUMAN PRESCRIPTION DRUG	Vasostrict		Vasopressin	INJECTION	INTRAVENOUS	20141112		NDA	NDA204485	Medical Purchasin Solutions, LLC	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
71872-7016_fd1a2aa4-0b7f-eee6-e053-6294a90ac4ea	71872-7016	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		NEOSTIGMINE METHYLSULFATE	INJECTION	INTRAVENOUS	20170426		ANDA	ANDA208405	Medical Purchasing Solutions, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71872-7021_fa45551b-cd89-d4cc-e053-6294a90a8829	71872-7021	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151201		ANDA	ANDA206781	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7026_9ce576ca-5e43-8fcc-e053-2995a90a50f2	71872-7026	HUMAN PRESCRIPTION DRUG	Quelicin		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140331		NDA	NDA008845	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7027_fd165c82-ea9b-c943-e053-6294a90a6425	71872-7027	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20010918		ANDA	ANDA065047	Medical Purchasing Solutions, LLC	CEFAZOLIN SODIUM	330	mg/mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71872-7030_fd163116-8854-9366-e053-6394a90a00b5	71872-7030	HUMAN PRESCRIPTION DRUG	Dexmedetomidine hydrochloride		Dexmedetomidine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20161221		ANDA	ANDA204023	Medical Purchasing Solutions, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71872-7031_fd1604d4-5081-7e98-e053-6394a90af8aa	71872-7031	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		Dexmedetomidine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20160317		ANDA	ANDA205867	Medical Purchasing Solutions, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71872-7033_fd026a43-7c6e-6db7-e053-6394a90a33dd	71872-7033	HUMAN PRESCRIPTION DRUG	Nitroglycerin		Nitroglycerin	TABLET	SUBLINGUAL	20170919		ANDA	ANDA206391	Medical Purchasing Solutions, LLC	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71872-7034_fd15b83e-af5c-4e04-e053-6394a90aefd6	71872-7034	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		AMIODARONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20030128		ANDA	ANDA075761	Medical Purchasing Solutions, LLC	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7035_fea51478-1130-3aaa-e053-6394a90a771e	71872-7035	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20110315	20240229	ANDA	ANDA078076	Medical Purchasing Solutions, LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	
71872-7036_00e05dc1-0f7b-2725-e063-6294a90a3493	71872-7036	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	SOLUTION	INTRAVENOUS	20121201		ANDA	ANDA091115	Medical Purchasing Solutions, LLC	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71872-7037_fd021c33-19cc-b7f5-e053-6394a90a9302	71872-7037	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19710101		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7038_fd01fac1-36c1-8788-e053-6294a90aed8d	71872-7038	HUMAN PRESCRIPTION DRUG	Flumazenil		flumazenil	INJECTION, SOLUTION	INTRAVENOUS	20070101		ANDA	ANDA078527	Medical Purchasing Solutions, LLC	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
71872-7040_fd01c91f-e01e-1d2b-e053-6294a90abcd2	71872-7040	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRACARDIAC; INTRAVENOUS	19761201		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7041_81a1a49e-fd8a-59d8-e053-2a91aa0ac3c3	71872-7041	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050616		NDA	NDA018801	Medical Purchasing Solutions, LLC	WATER	1	mL/mL			N	20241231
71872-7043_fcf2bbcb-f21d-037b-e053-6294a90ae915	71872-7043	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20121218		NDA	NDA203826	Medical Purchasing Solutions, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71872-7044_fcf275c4-af8d-b185-e053-6394a90a06b5	71872-7044	HUMAN PRESCRIPTION DRUG	Calcium Chloride		Calcium Chloride	INJECTION	INTRAVENOUS; INTRAVENTRICULAR	19730501		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
71872-7045_fceba9f2-ff61-3fbf-e053-6294a90a3a89	71872-7045	HUMAN PRESCRIPTION DRUG	Calcium Chloride		CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050914		NDA	NDA021117	Medical Purchasing Solutions, LLC	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
71872-7048_fceba9f2-ff13-3fbf-e053-6294a90a3a89	71872-7048	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20160422		NDA	NDA018925	Medical Purchasing Solutions, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7049_fceb7198-5f41-3412-e053-6294a90a7c72	71872-7049	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20150723		ANDA	ANDA205520	Medical Purchasing Solutions, LLC	ESMOLOL HYDROCHLORIDE	100	mg/10mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7050_fceb0a59-469a-f168-e053-6294a90a5fde	71872-7050	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20150629		ANDA	ANDA203110	Medical Purchasing Solutions, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71872-7054_fceb313f-3623-ea34-e053-6294a90ab46d	71872-7054	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20111205		ANDA	ANDA077839	Medical Purchasing Solutions, LLC	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
71872-7057_fceb0798-5014-6e1e-e053-6294a90a3383	71872-7057	HUMAN PRESCRIPTION DRUG	Dextrose		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20050331		NDA	NDA019445	Medical Purchasing Solutions, LLC	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
71872-7059_fceaa3aa-c195-c32b-e053-6394a90a4ac5	71872-7059	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Medical Purchasing Solutions, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71872-7060_fcea8a47-2003-5840-e053-6294a90a341c	71872-7060	HUMAN PRESCRIPTION DRUG	Aminophylline		Aminophylline	INJECTION, SOLUTION	INTRAVENOUS	20050228		ANDA	ANDA087242	Medical Purchasing Solutions, LLC	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
71872-7061_fceaa3aa-c18e-c32b-e053-6394a90a4ac5	71872-7061	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Medical Purchasing Solutions, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7063_fcea91c3-e42b-8991-e053-6394a90a099d	71872-7063	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	INJECTION	INTRAVENOUS	20081217		ANDA	ANDA078538	Medical Purchasing Solutions, LLC	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71872-7064_fcea4371-f2f1-724b-e053-6394a90a6e50	71872-7064	HUMAN PRESCRIPTION DRUG	LIDOCAINE HYDROCHLORIDE		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20051209		ANDA	ANDA040302	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7066_fcea4214-2952-5502-e053-6294a90a7252	71872-7066	HUMAN PRESCRIPTION DRUG	DOPamine Hydrochloride		Dopamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050825		NDA	NDA018132	Medical Purchasing Solutions, LLC	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
71872-7068_fa45b71a-eb4b-e954-e053-6394a90afb7f	71872-7068	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20160526		ANDA	ANDA203711	Medical Purchasing Solutions, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71872-7069_fcea206e-8b74-1482-e053-6294a90a88a8	71872-7069	HUMAN PRESCRIPTION DRUG	Ondansetron		ondansetron hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170101		ANDA	ANDA079224	Medical Purchasing Solutions, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71872-7076_fc600b3b-dab3-eaa0-e053-6394a90a6540	71872-7076	HUMAN PRESCRIPTION DRUG	Metoclopramide		metoclopramide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060202		ANDA	ANDA073118	Medical Purchasing Solutions, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
71872-7077_fc600b3b-dab2-eaa0-e053-6394a90a6540	71872-7077	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Medical Purchasing Solutions, LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71872-7079_0aaca355-f97c-6453-e063-6394a90a07bc	71872-7079	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19750716		ANDA	ANDA084307	Medical Purchasing Solutions, LLC	PHENYTOIN SODIUM	50	mg/mL	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
71872-7080_fc5fc617-c901-4ee6-e053-6294a90aeb43	71872-7080	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	INJECTION	SUBCUTANEOUS	20090520		ANDA	ANDA078630	Medical Purchasing Solutions. LLC	TERBUTALINE SULFATE	1	mg/mL			N	20241231
71872-7083_fc5fb080-bb9e-3283-e053-6394a90aabfb	71872-7083	HUMAN PRESCRIPTION DRUG	BACTERIOSTATIC SODIUM CHLORIDE		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050430		NDA	NDA018800	Medical Purchasing Solutions, LLC	SODIUM CHLORIDE	9	mg/mL			N	20241231
71872-7084_d09f8d06-4c73-2fc6-e053-2a95a90a9b4c	71872-7084	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050228		NDA	NDA018803	Medical Purchasing Solutions, LLC	SODIUM CHLORIDE	9	mg/mL			N	20241231
71872-7085_fc5f7c1f-53da-b350-e053-6394a90a5e75	71872-7085	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Medical Purchasing Solutions, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7086_fc600b6f-0ddf-10ff-e053-6394a90a6ba5	71872-7086	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120201		ANDA	ANDA065499	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7090_febf7e76-1ccc-f4be-e053-6394a90af630	71872-7090	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20110511		ANDA	ANDA040802	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7091_fc5f27d1-15c0-f4e1-e053-6394a90a1517	71872-7091	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19820907		ANDA	ANDA087702	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7092_fc5f11aa-5468-446b-e053-6294a90ae463	71872-7092	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151201		ANDA	ANDA206781	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7093_fc5ee360-8f40-6373-e053-6394a90a3644	71872-7093	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170626		ANDA	ANDA207639	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7094_fc5e985e-2599-a5ed-e053-6394a90a98c2	71872-7094	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170626		ANDA	ANDA207639	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7095_fc5e932d-0841-7ad9-e053-6394a90af784	71872-7095	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050615		ANDA	ANDA088327	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7096_fc5e5df1-f935-b388-e053-6394a90a37ab	71872-7096	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	INJECTION	INTRAVENOUS	20080131		ANDA	ANDA077760	Medical Purchasing Solutions, LLC	PROPRANOLOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7097_fc5e6f2a-e811-0666-e053-6394a90a66a7	71872-7097	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION	INTRAVENOUS	20000601		ANDA	ANDA203449	Medical Purchasing Solutions, LLC	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
71872-7099_fea50da3-bb9f-8545-e053-6394a90a7b3a	71872-7099	HUMAN PRESCRIPTION DRUG	Adenosine		Adenosine	INJECTION, SOLUTION	INTRAVENOUS	20110315	20240630	ANDA	ANDA078076	Medical Purchasing Solutions, LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	
71872-7100_fc5e557b-f3af-c26f-e053-6394a90a17f3	71872-7100	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	19921201		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	ATROPINE SULFATE	1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7102_eaeed597-74f0-3287-e053-2a95a90a3444	71872-7102	HUMAN PRESCRIPTION DRUG	Dextrose		DEXTROSE MONOHYDRATE	INJECTION, SOLUTION	INTRAVENOUS	20051207		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
71872-7107_fc5e2428-7cc4-5cd3-e053-6394a90a7cd2	71872-7107	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA076781	Medical Purchasing Solutions, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71872-7113_0aac32fa-37b8-5520-e063-6394a90a1fe4	71872-7113	HUMAN PRESCRIPTION DRUG	Procainamide Hydrochloride		PROCAINAMIDE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20060308		ANDA	ANDA089069	Medical Purchasing Solutions, LLC	PROCAINAMIDE HYDROCHLORIDE	100	mg/mL	Antiarrhythmic [EPC]		N	20241231
71872-7114_fc5e0914-3e38-0be4-e053-6394a90aee7d	71872-7114	HUMAN PRESCRIPTION DRUG	Nalbuphine Hydrochloride		NALBUPHINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050719		ANDA	ANDA070915	Medical Purchasing Solutions, LLC	NALBUPHINE HYDROCHLORIDE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]		N	20241231
71872-7117_eaeef79e-aef5-4321-e053-2a95a90acece	71872-7117	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20140808		NDA	NDA205029	Medical Purchasing Solutions, LLC	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7120_9ce56894-741e-c9d5-e053-2a95a90ae63e	71872-7120	HUMAN PRESCRIPTION DRUG	Epinephrine		EPINEPHRINE	INJECTION, SOLUTION	ENDOTRACHEAL; INTRACARDIAC; INTRAVENOUS	20051222		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7121_9ce56894-7463-c9d5-e053-2a95a90ae63e	71872-7121	HUMAN PRESCRIPTION DRUG	Aminophylline		Aminophylline	INJECTION, SOLUTION	INTRAVENOUS	20050510		ANDA	ANDA087242	Medical Purchasing Solutions, LLC	AMINOPHYLLINE DIHYDRATE	25	mg/mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
71872-7122_fc5dd4b0-0e31-858e-e053-6394a90a2714	71872-7122	HUMAN PRESCRIPTION DRUG	Dexmedetomidine Hydrochloride		DEXMEDETOMIDINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20150408		ANDA	ANDA202126	Medical Purchasing Solutions, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71872-7123_9ce56830-680a-bc93-e053-2a95a90aecf7	71872-7123	HUMAN PRESCRIPTION DRUG	Clindamycin		clindamycin phosphate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20160603		ANDA	ANDA062800	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
71872-7124_9ce56cdc-356c-1b2d-e053-2995a90ad6bc	71872-7124	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	INJECTION, SOLUTION	INTRAVENOUS	20171102		ANDA	ANDA204205	Medical Purchasin Solutions, LLC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7125_fc5db750-200f-92a2-e053-6294a90a8a60	71872-7125	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050615		ANDA	ANDA088327	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7126_fc50b26b-fbe2-1776-e053-6294a90a5129	71872-7126	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION	INTRAVENOUS	20010601		ANDA	ANDA083173	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7127_fc4d7d56-73bd-9868-e053-6294a90ace42	71872-7127	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140206		ANDA	ANDA202747	Medical Purchasing Solutions, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71872-7128_fc4a79d4-7515-5108-e053-6294a90a6e37	71872-7128	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151201		ANDA	ANDA206781	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7129_fc4d3337-f3c0-d64e-e053-6294a90a75cd	71872-7129	HUMAN PRESCRIPTION DRUG	Bacteriostatic Water		WATER	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050430		NDA	NDA018802	Medical Purchasing Solutions, LLC	WATER	1	mL/mL			N	20241231
71872-7130_9ce58ab7-ba09-f477-e053-2995a90adeae	71872-7130	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		terbutaline sulfate	INJECTION, SOLUTION	SUBCUTANEOUS	20170222		ANDA	ANDA200122	Medical Purchasing Solutions, LLC	TERBUTALINE SULFATE	1	mg/mL			N	20241231
71872-7131_9ce59e9a-1241-4ebf-e053-2995a90aa786	71872-7131	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20170929		ANDA	ANDA204216	Medical Purchasing Solutions, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7132_9ce5a0b7-b4c8-2a77-e053-2995a90a9cfd	71872-7132	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170929		ANDA	ANDA204216	Medical Purchasing Solutions, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7133_fc4a79d4-7514-5108-e053-6294a90a6e37	71872-7133	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20160513		ANDA	ANDA207183	Medical Purchasing Solutions, LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
71872-7134_fc4a52a5-be75-d4b8-e053-6394a90a5e70	71872-7134	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR	20161215		NDA AUTHORIZED GENERIC	NDA019430	Medical Purchasing Solutions, LLC	EPINEPHRINE	.15	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7135_fc4a1996-71c3-fff1-e053-6394a90a2de0	71872-7135	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR	20161215		NDA AUTHORIZED GENERIC	NDA019430	Medical Purchasing Solutions, LLC	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7136_fc4a1996-71bf-fff1-e053-6394a90a2de0	71872-7136	HUMAN PRESCRIPTION DRUG	Esmolol Hydrochloride		Esmolol Hydrochloride	INJECTION	INTRAVENOUS	19861231		NDA	NDA019386	Medical Purchasing Solutions, LLC	ESMOLOL HYDROCHLORIDE	10	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7137_fc49f3bb-25b8-831b-e053-6394a90a5db5	71872-7137	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050712		ANDA	ANDA088299	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7139_fc49f703-5d24-ab36-e053-6294a90a7be3	71872-7139	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20120201		ANDA	ANDA065499	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7140_fbd91eff-2f35-95e9-e053-6294a90aa2cd	71872-7140	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20061226		ANDA	ANDA077541	Medical Purchasing Solutions, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71872-7141_fbd8fbec-88d3-1726-e053-6294a90af96d	71872-7141	HUMAN PRESCRIPTION DRUG	Cefazolin		CEFAZOLIN	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203661	Medical Purchasing Solutions, LLC	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
71872-7142_9ce5ad2c-3b54-78ff-e053-2995a90a514d	71872-7142	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000808		NDA	NDA019316	Medical Purchasing Solutions, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71872-7143_fbd8a68f-6b8e-a80e-e053-6294a90ac0eb	71872-7143	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20170925		ANDA	ANDA209933	Medical Purchasing Solutions, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71872-7144_fbd8ba45-167f-682b-e053-6394a90a0519	71872-7144	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7145_fbd8488b-f04e-fc7f-e053-6394a90a38d5	71872-7145	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA040388	Medical Purchasing Solutions, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71872-7146_9ce5ac17-0d15-4c9f-e053-2995a90ae27a	71872-7146	HUMAN PRESCRIPTION DRUG	Quelicin		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20140331		NDA	NDA008845	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7147_fbd8488b-f01e-fc7f-e053-6394a90a38d5	71872-7147	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7148_81a1022d-6c5a-936b-e053-2991aa0a1e6e	71872-7148	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20180430		ANDA	ANDA208973	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7149_fbd8455e-7d35-e022-e053-6294a90aba6d	71872-7149	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20171025		ANDA	ANDA204550	Medical Purchasing Solutions, LLC	AMIODARONE HYDROCHLORIDE	150	mg/3mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7150_fbd15264-3bd4-015a-e053-6294a90abc6a	71872-7150	HUMAN PRESCRIPTION DRUG	Dexmedetomidine		dexmedetomidine	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20180301		ANDA	ANDA209065	Medical Purchasing Solutions, LLC.	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71872-7151_fbd81e38-4b22-f9ec-e053-6394a90ad658	71872-7151	HUMAN PRESCRIPTION DRUG	Ampicillin		ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180801		ANDA	ANDA090354	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7153_fbd15264-3bc3-015a-e053-6294a90abc6a	71872-7153	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7155_fbd11419-4512-10d7-e053-6394a90ac82b	71872-7155	HUMAN PRESCRIPTION DRUG	Metoprolol		metoprolol tartrate	INJECTION	INTRAVENOUS	20120925		ANDA	ANDA078950	Medical Purchasing Solutions, LLC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7156_fbd11484-90b2-4562-e053-6294a90a10c6	71872-7156	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	19720214		ANDA	ANDA080407	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7157_fbd0bfb6-6192-0bc2-e053-6394a90aa710	71872-7157	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7158_fbd8455e-7d38-e022-e053-6294a90aba6d	71872-7158	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	19720214		ANDA	ANDA080407	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7159_fbc08654-7fbd-6e5a-e053-6394a90a21bf	71872-7159	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20180707		ANDA	ANDA211079	Medical Purchasing Solutions, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71872-7160_fbc05ceb-2e68-3c37-e053-6394a90ac4f4	71872-7160	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20050706		ANDA	ANDA040302	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7161_fbc03cc2-e48a-cf45-e053-6394a90a44b3	71872-7161	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	19750616		ANDA	ANDA084625	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7162_0cf7da8b-6f35-d806-e063-6394a90ad6d9	71872-7162	HUMAN PRESCRIPTION DRUG	Ondansetron		ONDANSETRON	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20081016		ANDA	ANDA077548	Medical Purchasing Solutions, LLC	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71872-7163_fbbf8de0-338f-728d-e053-6294a90a5451	71872-7163	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		amiodarone hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20021014		ANDA	ANDA076217	Medical Purchasing Solutions, LLC	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7164_fbbf4fd1-a825-fc54-e053-6294a90af912	71872-7164	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	19750715		ANDA	ANDA084282	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7165_fbbf2fa2-4db9-8e4a-e053-6394a90a6f76	71872-7165	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19721002		NDA	NDA050441	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7166_fbbf1c9f-000b-1ef4-e053-6294a90abf53	71872-7166	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		SUCCINYLCHOLINE CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20181120		ANDA	ANDA211432	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7167_fbbed43e-dc67-032d-e053-6294a90a4f49	71872-7167	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190410		ANDA	ANDA210231	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7168_fbbf4fd1-a826-fc54-e053-6294a90af912	71872-7168	HUMAN PRESCRIPTION DRUG	Clindamycin		Clindamycin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20171129		ANDA	ANDA204748	Medical Purchasing Solutions, LLC	CLINDAMYCIN	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7169_fbbddf4e-0ab7-44ab-e053-6294a90ae4eb	71872-7169	HUMAN PRESCRIPTION DRUG	Ampicillin		ampicillin sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20180801		ANDA	ANDA090354	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7171_fbbdbacf-afc2-ed3a-e053-6394a90a40b4	71872-7171	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	19750715		ANDA	ANDA084282	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7172_fe91f114-3650-59a5-e053-6294a90a7514	71872-7172	HUMAN PRESCRIPTION DRUG	Auvi-Q		epinephrine	INJECTION, SOLUTION	INTRAMUSCULAR	20121115		NDA	NDA201739	Medical Purchasing Solutions, LLC	EPINEPHRINE	.15	mg/.15mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7173_0141ff31-c242-8ad1-e063-6294a90a229a	71872-7173	HUMAN PRESCRIPTION DRUG	Auvi-Q		epinephrine	INJECTION, SOLUTION	INTRAMUSCULAR	20121115		NDA	NDA201739	Medical Purchasing Solutions, LLC	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7174_fbbda766-12f3-2490-e053-6294a90ac9c6	71872-7174	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190711		ANDA	ANDA210842	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7175_fbbd7904-1352-c9ca-e053-6294a90a4378	71872-7175	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190711		ANDA	ANDA210842	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7176_fbbd3242-b529-7cd0-e053-6394a90aa00d	71872-7176	HUMAN PRESCRIPTION DRUG	Dextrose Monohydrate		Dextrose Monohydrate	INJECTION	PARENTERAL	20000601		UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	DEXTROSE MONOHYDRATE	500	mg/mL			N	20241231
71872-7177_fbbce2ae-1daa-b037-e053-6394a90a3397	71872-7177	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION	PARENTERAL	20010601		ANDA	ANDA072076	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7178_fbbd062c-6f20-ac06-e053-6394a90a529f	71872-7178	HUMAN PRESCRIPTION DRUG	Neostigmine		Neostigmine	INJECTION	INTRAVENOUS	20180904		ANDA	ANDA209135	Medical Purchasing Solutions, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71872-7179_fbbcf473-155c-8551-e053-6294a90af96d	71872-7179	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190722		ANDA	ANDA211334	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	4	mg/20mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7180_fa40e1b9-15f4-2324-e053-6394a90a66ca	71872-7180	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190501		ANDA	ANDA205723	Medical Purchasing Solutions, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71872-7181_fb742ff3-8f1f-32b3-e053-6294a90ae730	71872-7181	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190722		ANDA	ANDA211334	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7182_9c98524b-1543-fe23-e053-2a95a90acc36	71872-7182	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050616		NDA	NDA018801	Medical Purchasing Solutions, LLC	WATER	1	mL/mL			N	20241231
71872-7183_fb5c8bd7-70e5-d657-e053-6394a90a0b58	71872-7183	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20190304		ANDA	ANDA211370	Medical Purchasing Solutions, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7184_fb58a693-8d6c-1280-e053-6294a90ad0b1	71872-7184	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050712		ANDA	ANDA088299	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7185_fb5b6ab1-91ec-02c0-e053-6294a90a660f	71872-7185	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20001018		ANDA	ANDA075784	Medical Purchasing Solutions, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7186_fb5b5273-4dbf-ce6a-e053-6294a90a9b5d	71872-7186	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7187_fb5b3071-8ac3-b2c6-e053-6294a90ae775	71872-7187	HUMAN PRESCRIPTION DRUG	BRIDION		sugammadex	INJECTION, SOLUTION	INTRAVENOUS	20151215		NDA	NDA022225	Medical Purchasing Solutions, LLC	SUGAMMADEX SODIUM	100	mg/mL	gamma-Cyclodextrins [CS]		N	20241231
71872-7189_fb586b87-3e9a-2ed7-e053-6394a90a8ce1	71872-7189	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7190_fb58513d-3635-69ff-e053-6294a90aa492	71872-7190	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203040	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7191_fb582ad8-1756-2041-e053-6294a90a6592	71872-7191	HUMAN PRESCRIPTION DRUG	Clindamycin		Clindamycin Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120515		ANDA	ANDA090108	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7192_fb582ad8-1754-2041-e053-6294a90a6592	71872-7192	HUMAN PRESCRIPTION DRUG	Clindamycin		Clindamycin Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120515		ANDA	ANDA090108	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7193_fb580617-4a22-068d-e053-6294a90a1def	71872-7193	HUMAN PRESCRIPTION DRUG	Calcium Chloride		Calcium Chloride Injection	INJECTION, SOLUTION	INTRAVENOUS	20190822		ANDA	ANDA211553	Medical Purchasing Solutions, LLC	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
71872-7194_fb4bfd14-1e6b-f9fc-e053-6394a90a8d59	71872-7194	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7195_fb4bfd14-1e67-f9fc-e053-6394a90a8d59	71872-7195	HUMAN PRESCRIPTION DRUG	Propranolol		PROPRANOLOL HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20010907		ANDA	ANDA075826	Medical Purchasing Solutions, LLC	PROPRANOLOL HYDROCHLORIDE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7196_fb4bf45a-8a5f-2abc-e053-6294a90a12cc	71872-7196	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190711		ANDA	ANDA210842	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7197_fb4af179-57f4-296b-e053-6294a90a7a82	71872-7197	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19721002		NDA	NDA050441	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7198_fb4adbb5-bf2e-f855-e053-6294a90a8e7b	71872-7198	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20170808		ANDA	ANDA207633	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7199_fb46f35e-f32d-3994-e053-6394a90a8615	71872-7199	HUMAN PRESCRIPTION DRUG	Clindamycin		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	20120515		ANDA	ANDA090109	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7200_fb466c14-9c3e-a395-e053-6294a90a1010	71872-7200	HUMAN PRESCRIPTION DRUG	Cleocin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19721002		NDA	NDA050441	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7201_feb949d8-67ae-6e56-e053-6394a90a7091	71872-7201	HUMAN PRESCRIPTION DRUG	nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20190430	20240531	ANDA	ANDA211604	Medical Purchasing Solutions, LLC	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	
71872-7202_fb465fb4-2feb-6ef9-e053-6394a90a655a	71872-7202	HUMAN PRESCRIPTION DRUG	rocuronium bromide		rocuronium bromide	INJECTION, SOLUTION	INTRAVENOUS	20111220		ANDA	ANDA091458	Medical Purchasing Solutions, LLC	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71872-7203_fb463af6-3dfe-4026-e053-6394a90ad14a	71872-7203	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20200101		ANDA	ANDA211370	Medical Purchasing Solutions, LLC	VERAPAMIL HYDROCHLORIDE	5	mg/2mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7204_fae21111-25f7-bf9a-e053-6294a90ab215	71872-7204	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190306		ANDA	ANDA090354	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	1	g/g	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7205_fad2a3d8-d3cd-9b90-e053-6394a90a519e	71872-7205	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190611		ANDA	ANDA211036	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7206_fad2ccdf-7cda-b25e-e053-6394a90addad	71872-7206	HUMAN PRESCRIPTION DRUG	Flumazenil		Flumazenil	INJECTION	INTRAVENOUS	20171001		ANDA	ANDA076755	Medical Purchasing Solutions, LLC	FLUMAZENIL	.1	mg/mL	Benzodiazepine Antagonist [EPC]		N	20241231
71872-7207_fad2a3d8-d3d1-9b90-e053-6394a90a519e	71872-7207	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION, SOLUTION	INTRAVENOUS	20081201		ANDA	ANDA078519	Medical Purchasing Solutions, LLC	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71872-7208_fad2cfd6-08a1-a491-e053-6394a90a5043	71872-7208	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190320		ANDA	ANDA210927	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7209_fad2cfd6-08a5-a491-e053-6394a90a5043	71872-7209	HUMAN PRESCRIPTION DRUG	adenosine		adenosine	INJECTION	INTRAVENOUS	20180508		ANDA	ANDA078686	Medical Purchasing Solutions, LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
71872-7210_fad2cfd6-08a7-a491-e053-6394a90a5043	71872-7210	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20200101		ANDA	ANDA211370	Medical Purchasing Solutions, LLC	VERAPAMIL HYDROCHLORIDE	5	mg/2mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7212_fa44cbac-1510-e7b7-e053-6294a90aa492	71872-7212	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200103		ANDA	ANDA204216	Medical Purchasing Solutions, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7213_faced894-bb94-3fe2-e053-6294a90a543a	71872-7213	HUMAN PRESCRIPTION DRUG	Ketorolac tromethamine		Ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190318		ANDA	ANDA204216	Medical Purchasing Solutions, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7214_faceeefa-0646-2e48-e053-6394a90a405f	71872-7214	HUMAN PRESCRIPTION DRUG	Dextrose		Dextrose monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20060222		NDA	NDA019445	Medical Purchasing Solutions, LLC	DEXTROSE MONOHYDRATE	250	mg/mL			N	20241231
71872-7215_facf199d-f6dd-926f-e053-6294a90ad1ee	71872-7215	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191104		ANDA	ANDA212456	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7216_fad0da7e-68e5-c873-e053-6294a90a6fac	71872-7216	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151209		ANDA	ANDA062420	Medical Purchasing Solutions, LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
71872-7217_fad3420b-b53f-f7ae-e053-6294a90a200d	71872-7217	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20050430		ANDA	ANDA070590	Medical Purchasing Solutions, LLC	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
71872-7218_fad38944-bb6c-3562-e053-6394a90a3293	71872-7218	HUMAN PRESCRIPTION DRUG	Dexmedetomidine HCl		Dexmedetomidine HCl	INJECTION	INTRAVENOUS	20170426		ANDA	ANDA205046	Medical Purchasing Solutions, LLC	DEXMEDETOMIDINE HYDROCHLORIDE	100	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
71872-7219_fa401361-8e19-c66e-e053-6394a90a30fe	71872-7219	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191015		ANDA	ANDA212455	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7220_fadf58e6-92cd-d87b-e053-6394a90a966f	71872-7220	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20080626		ANDA	ANDA078642	Medical Purchasing Solutions, LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71872-7221_fadf3f94-18fb-1ca3-e053-6294a90adee3	71872-7221	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200115		ANDA	ANDA211589	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7222_fadf4e81-eac7-e407-e053-6394a90a4932	71872-7222	HUMAN PRESCRIPTION DRUG	Calcium Gluconate		Calcium Gluconate	INJECTION, SOLUTION	INTRAVENOUS	20170615		NDA	NDA208418	Medical Purchasing Solutions, LLC	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
71872-7223_0c900ca8-01a4-fa04-e063-6394a90a28fa	71872-7223	HUMAN PRESCRIPTION DRUG	Adrenalin		epinephrine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20130701		NDA	NDA204200	Medical Purchasing Solutions, LLC	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7224_fadf7e0e-24f3-0afc-e053-6394a90a7044	71872-7224	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200909		ANDA	ANDA212612	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7225_fae66e91-be0b-9128-e053-6394a90ac25d	71872-7225	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20070530		ANDA	ANDA077761	Medical Purchasing Solutions, LLC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7226_fae24dde-9951-ff55-e053-6294a90a0946	71872-7226	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	INJECTION, SOLUTION	INTRAVENOUS	20200331		ANDA	ANDA204205	Medical Purchasing Solutions, LLC	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7227_fae67b9a-7ddb-3840-e053-6294a90a9c56	71872-7227	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200610		ANDA	ANDA210246	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7229_b6352e51-468d-6d96-e053-2995a90ade1b	71872-7229	HUMAN PRESCRIPTION DRUG	Magnesium Sulfate		MAGNESIUM SULFATE HEPTAHYDRATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000808		NDA	NDA019316	Medical Purchasing Solutions, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	500	mg/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71872-7230_fae6bd66-8eb7-cf03-e053-6394a90ad143	71872-7230	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin Injection	POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190306		ANDA	ANDA090354	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	2	g/2g	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7231_fae6cee0-57a1-f879-e053-6394a90a1d57	71872-7231	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Medical Purchasing Solutions, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71872-7232_fb3394e0-0f73-b3f1-e053-6394a90a33aa	71872-7232	HUMAN PRESCRIPTION DRUG	SOLU-MEDROL		methylprednisolone sodium succinate	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19590402		NDA	NDA011856	Medical Purchasing Solutions, LLC	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7233_fae6cc7f-7412-91e1-e053-6294a90ae3ce	71872-7233	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7234_f98c46db-ef3d-6632-e053-6394a90a9806	71872-7234	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20200103		ANDA	ANDA204216	Medical Purchasing Solutions, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7235_fb339cb7-08a5-d926-e053-6394a90a6c7f	71872-7235	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	INJECTION	INTRAVENOUS	20010416		ANDA	ANDA075486	Medical Purchasing Solutions, LLC	FAMOTIDINE	10	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
71872-7236_fb32ee8a-091d-2153-e053-6394a90ae9a8	71872-7236	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190503		ANDA	ANDA212174	Medical Purchasing Solutions, LLC	FUROSEMIDE	20	mg/2mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71872-7237_fae6fad6-a46d-1ae8-e053-6394a90a4a97	71872-7237	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200610		ANDA	ANDA210246	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7238_fb332d5d-60b6-69dc-e053-6394a90a1968	71872-7238	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201217		ANDA	ANDA213238	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7239_fae6ed45-7b30-0752-e053-6394a90a3c9b	71872-7239	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190607		ANDA	ANDA210967	Medical Purchasing Solutions, LLC	DEXAMETHASONE SODIUM PHOSPHATE	100	mg/10mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71872-7240_fb3345ac-1c37-35c8-e053-6294a90abc4d	71872-7240	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120510		ANDA	ANDA062772	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7241_facc8cc7-f24d-7f83-e053-6294a90a63f8	71872-7241	HUMAN PRESCRIPTION DRUG	Succinylcholine		Succinylcholine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201007		ANDA	ANDA210698	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7242_fa59581e-a76f-d735-e053-6294a90acd1a	71872-7242	HUMAN PRESCRIPTION DRUG	DIPHENHYDRAMINE HYDROCHLORIDE		DIPHENHYDRAMINE HYDROCHLORIDE	SOLUTION	ORAL	19820210		ANDA	ANDA087513	Medical Purchasing Solutions, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/10mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
71872-7243_fa596101-01ec-c228-e053-6394a90aa48b	71872-7243	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180618		ANDA	ANDA211015	Medical Purchasing Solutions, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7244_fa5960de-b894-25ae-e053-6394a90ac17f	71872-7244	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoroprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20070530		ANDA	ANDA077761	Medical Purchasing Solutions, LLC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7245_eaef17bc-bf14-6157-e053-2a95a90a3910	71872-7245	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20210111		NDA	NDA214652	Medical Purchasing Solutions, LLC	ATROPINE SULFATE	1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7246_fa5960de-b896-25ae-e053-6394a90ac17f	71872-7246	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20210111		NDA	NDA214652	Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7247_bfc9bcd9-4b2f-ce7e-e053-2995a90a6cd1	71872-7247	HUMAN PRESCRIPTION DRUG	SODIUM BICARBONATE		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA202432	Medical Purchasing Solutions, LLC	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
71872-7248_c3f8e83c-4fba-91da-e053-2a95a90abd63	71872-7248	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050228		NDA	NDA018803	Medical Purchasing Solutions, LLC	SODIUM CHLORIDE	9	mg/mL			N	20241231
71872-7249_fa59caf4-b361-c99b-e053-6294a90a69e8	71872-7249	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120510		ANDA	ANDA062772	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7250_fa59ea6e-8bbe-fe7c-e053-6394a90a898a	71872-7250	HUMAN PRESCRIPTION DRUG	EPINEPHRINE		epinephrine	INJECTION, SOLUTION	INTRAVENOUS	20210310		NDA	NDA209359	Medical Purchasing Solutions, LLC	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7251_fa59ea14-5918-f33f-e053-6394a90a2318	71872-7251	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210407		ANDA	ANDA213705	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7252_fa59f46b-6655-17c9-e053-6394a90ace77	71872-7252	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	INTRAVENOUS	20210217		ANDA	ANDA212461	Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7253_fa5a08db-c41a-5503-e053-6294a90a2a5a	71872-7253	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7254_fa5a2f45-6bac-0143-e053-6394a90a7414	71872-7254	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7256_fa3293c2-62ce-33b7-e053-6294a90a7e89	71872-7256	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7257_fa3293c2-62d1-33b7-e053-6294a90a7e89	71872-7257	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20191023		ANDA	ANDA212932	Medical Purchasing Solutions, LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7258_fa5a5cb2-9f38-fbff-e053-6294a90a83a2	71872-7258	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19960701		ANDA	ANDA074524	Medical Purchasing Solutions, LLC	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
71872-7259_fa5a6941-a549-46ad-e053-6294a90a7d24	71872-7259	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200701		ANDA	ANDA211998	Medical Purchasing Solutions, LLC	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71872-7260_facc396f-5544-33fd-e053-6394a90a1d6c	71872-7260	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20071005		ANDA	ANDA071583	Medical Purchasing Solutions, LLC	DIAZEPAM	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71872-7261_fdf784d5-bb7e-78a8-e053-6294a90a32e8	71872-7261	HUMAN OTC DRUG	Ammonia Inhalants		Ammonia Inhalants	INHALANT	RESPIRATORY (INHALATION)	19760214	20251031	UNAPPROVED DRUG OTHER		Medical Purchasing Solutions, LLC	AMMONIA	.05	g/.33mL			N	
71872-7262_fab820e7-cf1b-9086-e053-6294a90adc97	71872-7262	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20190715		ANDA	ANDA091115	Medical Purchasing Solutions, LLC	ROCURONIUM BROMIDE	50	mg/5mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
71872-7263_d162934c-67c8-6e78-e053-2a95a90ac443	71872-7263	HUMAN PRESCRIPTION DRUG	SUCCINYLCHOLINE CHLORIDE		SUCCINYLCHOLINE CHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200831		ANDA	ANDA211432	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7264_facc32bf-5a56-24d8-e053-6394a90a080f	71872-7264	HUMAN PRESCRIPTION DRUG	Vasostrict		Vasopressin	INJECTION	INTRAVENOUS	20141112		NDA	NDA204485	Medical Purchasing Solutions, LLC	VASOPRESSIN, UNSPECIFIED	20	[USP'U]/mL			N	20241231
71872-7265_fab7e8e1-e7e2-586c-e053-6294a90af478	71872-7265	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20140103		ANDA	ANDA204756	Medical Purchasing Solutions, LLC	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
71872-7266_fab7c9bd-f620-0611-e053-6294a90aff45	71872-7266	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION, SOLUTION	INTRAVENOUS	20200723		ANDA	ANDA202494	Medical Purchasing Solutions, LLC	SODIUM BICARBONATE	84	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
71872-7267_fab77b3f-63ed-c96a-e053-6294a90af6e9	71872-7267	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20210107		ANDA	ANDA210696	Medical Purchasing Solutions, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71872-7268_fab75f84-ce38-985f-e053-6294a90a6986	71872-7268	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		HYDRALAZINE HYDROCHLORIDE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20010905		ANDA	ANDA040388	Medical Purchasing Solutions, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71872-7269_fab7b912-fbe9-1572-e053-6294a90a64d2	71872-7269	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20191023		ANDA	ANDA212932	Medical Purchasing Solutions, LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7270_fab744c9-b587-5fa1-e053-6294a90a86af	71872-7270	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	PERINEURAL	20160513		ANDA	ANDA207183	Medical Purchasing Solutions, LLC	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
71872-7271_facbe17e-4696-d5fe-e053-6394a90a8abe	71872-7271	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20220110		ANDA	ANDA213074	Medical Purchasing Solutions, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
71872-7272_facbeb60-fce4-d11a-e053-6294a90aafaf	71872-7272	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200504		ANDA	ANDA213810	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7273_facbdcdc-e758-d7ef-e053-6394a90a7833	71872-7273	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20210922		ANDA	ANDA213318	Medical Purchasing Solutions, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71872-7274_facb9282-cc50-7e82-e053-6294a90af0aa	71872-7274	HUMAN PRESCRIPTION DRUG	HydrALAZINE hydrochloride		HydrALAZINE hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201218		ANDA	ANDA213667	Medical Purchasing Solutions, LLC	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
71872-7275_fabf316e-77fb-94dd-e053-6294a90ae2eb	71872-7275	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201103		ANDA	ANDA214308	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7276_facd3e27-25dd-55ab-e053-6394a90aa8de	71872-7276	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20210614		ANDA	ANDA214579	Medical Purchasing Solutions, LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7277_facb9067-e929-6fd8-e053-6294a90adca4	71872-7277	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20070322		ANDA	ANDA077941	Medical Purchasing Solutions, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71872-7278_facb5297-bc02-ea41-e053-6394a90a840c	71872-7278	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20210421		ANDA	ANDA070017	Medical Purchasing Solutions, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71872-7279_fabf540a-8d5e-bb1c-e053-6394a90a75c2	71872-7279	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201103		ANDA	ANDA214308	Medical Purchasing Solutions, LLC	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
71872-7280_fab6d66b-8b4b-649b-e053-6394a90a44ce	71872-7280	HUMAN PRESCRIPTION DRUG	Ampicillin		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA090583	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7282_ea75f790-621c-3fb6-e053-2995a90af28b	71872-7282	HUMAN PRESCRIPTION DRUG	Dextrose Monohydrate		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20211111		ANDA	ANDA203451	Medical Purchasing Solutions, LLC	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
71872-7283_fab7143c-d976-94a9-e053-6394a90a060c	71872-7283	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20190318		ANDA	ANDA204205	Medical Purchasing Solutions, LLC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71872-7284_fab6c201-bb6d-449d-e053-6394a90ad686	71872-7284	HUMAN PRESCRIPTION DRUG	Clindamycin		Clindamycin Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20120515		ANDA	ANDA090108	Medical Purchasing Solutions, LLC	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
71872-7285_fab6a2d8-d9a4-2f8f-e053-6394a90a22bc	71872-7285	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083312	Medical Purchasing Solutions, LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
71872-7286_fab6b79c-304a-ae35-e053-6294a90aa343	71872-7286	HUMAN PRESCRIPTION DRUG	Ampicillin		AMPICILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210110		ANDA	ANDA090583	Medical Purchasing Solutions, LLC	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
71872-7287_fa2c6f90-b8c9-e03c-e053-6394a90a597f	71872-7287	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170115		ANDA	ANDA204216	Medical Purchasing Solutions, LLC.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7288_fa2c2cff-2110-af95-e053-6294a90adaab	71872-7288	HUMAN PRESCRIPTION DRUG	Ketorolac tromethamine		Ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20190318		ANDA	ANDA204216	Medical Purchasing Solutions, LLC	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71872-7289_fa2c3a4b-691a-09cf-e053-6294a90aebdc	71872-7289	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20170615		ANDA	ANDA208973	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	4	mg/20mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7291_fa1db27f-7f97-61b3-e053-6394a90a875c	71872-7291	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20180618		ANDA	ANDA211015	Medical Purchasing Solutions, LLC	VERAPAMIL HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
71872-7292_fa1d9f8b-9cfc-35d1-e053-6394a90a293e	71872-7292	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200909		ANDA	ANDA212612	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7293_fbd7e438-7ad1-86cc-e053-6394a90aa9d2	71872-7293	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		diltiazem hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20191215		ANDA	ANDA074617	Medical Purchasing Solutions, LLC.	DILTIAZEM HYDROCHLORIDE	5	mg/mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
71872-7294_fa1d9225-c7e1-8f44-e053-6394a90a3984	71872-7294	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION	PARENTERAL	19880401		ANDA	ANDA072076	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7295_fa1d9225-c7df-8f44-e053-6394a90a3984	71872-7295	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140902		ANDA	ANDA203428	Medical Purchasing Solutions, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71872-7296_fa1d55d6-9b8f-40b4-e053-6294a90ac40e	71872-7296	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION, SOLUTION, CONCENTRATE	INTRAMUSCULAR; INTRAVENOUS	20041130		ANDA	ANDA074549	Medical Purchasing Solutions, LLC	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
71872-7297_fa1ca55b-f56c-0d9b-e053-6294a90a258a	71872-7297	HUMAN PRESCRIPTION DRUG	naloxone hydrochloride		naloxone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210129		ANDA	ANDA214785	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7298_fa1c8b84-5f06-0df2-e053-6294a90abc11	71872-7298	HUMAN PRESCRIPTION DRUG	ATROPINE SULFATE		ATROPINE SULFATE	INJECTION	INTRAVENOUS	20210730		ANDA	ANDA212868	Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7299_fa1a4689-9121-afd1-e053-6294a90a44ca	71872-7299	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210114		ANDA	ANDA213279	Medical Purchasing Solutions, LLC	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
71872-7300_f9cc6b27-4398-6f89-e053-6394a90acd4b	71872-7300	HUMAN PRESCRIPTION DRUG	NITROGLYCERIN		NITROGLYCERIN	TABLET	SUBLINGUAL	20221003		ANDA	ANDA211604	Medical Purchasing Solutions, LL	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
71872-7301_fa19aa30-e94d-6f5d-e053-6294a90aaff0	71872-7301	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20051201		ANDA	ANDA083158	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7302_08f5af1d-365f-a97c-e063-6394a90a99ae	71872-7302	HUMAN PRESCRIPTION DRUG	Ephedrine sulfate		Ephedrine sulfate	INJECTION	INTRAVENOUS	20220415		ANDA	ANDA216129	Medical Purchasing Solutions, LLC	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7303_0930ec92-5653-078f-e063-6294a90aad02	71872-7303	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Medical Purhasing Solutions, LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71872-7304_093312a8-528c-d515-e063-6394a90afd8f	71872-7304	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAVENOUS	20230130		NDA	NDA211363	Medical Purchasing Solutions, LLC	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
71872-7305_09333608-55c4-16d3-e063-6294a90a8e03	71872-7305	HUMAN PRESCRIPTION DRUG	Dopamine Hydrochloride		Dopamine Hydrochloride	INJECTION	INTRAVENOUS	20180411		ANDA	ANDA207707	Medical Purchasing Solutions, LLC	DOPAMINE HYDROCHLORIDE	40	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
71872-7306_09337389-136a-2a2e-e063-6294a90a5245	71872-7306	HUMAN PRESCRIPTION DRUG	VASOPRESSIN		VASOPRESSIN	INJECTION	INTRAVENOUS	20220815		ANDA	ANDA214314	Medical Purchasing Solutions, LLC	VASOPRESSIN	20	[USP'U]/mL			N	20241231
71872-7307_0933e8b8-bb81-4330-e063-6394a90a6372	71872-7307	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20200909		ANDA	ANDA212612	Medical Purchasing Solutions, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
71872-7310_09cfad01-259c-fa43-e063-6394a90ad5a1	71872-7310	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA211091	Medical Purchasing Solutions, LLC	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
71872-7311_09cf496c-8177-ebb7-e063-6394a90a745a	71872-7311	HUMAN PRESCRIPTION DRUG	Gentamicin		GENTAMICIN SULFATE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20000810		ANDA	ANDA062366	Medical Purchasing Solutions, LLC	GENTAMICIN SULFATE	40	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
71872-7312_09d086fa-b028-4190-e063-6394a90a763c	71872-7312	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		ATROPINE SULFATE	INJECTION, SOLUTION	INTRAVENOUS	20220802		ANDA	ANDA216120	Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71872-7313_094426f5-3a15-37e5-e063-6394a90aa985	71872-7313	HUMAN PRESCRIPTION DRUG	Cosyntropin		Cosyntropin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120629		ANDA	ANDA202147	Medical Purchasing Solutions, LLC	COSYNTROPIN	.25	mg/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
71872-7314_0a105618-76c2-d2af-e063-6294a90a66ad	71872-7314	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAVENOUS	20140902		ANDA	ANDA203428	Medical Purchasing Solutions, LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
71872-7315_0a3530a7-a2d7-9b20-e063-6394a90ac110	71872-7315	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION; PERINEURAL	20171030		ANDA	ANDA207182	Medical Purchasing Solutions, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71872-7316_0aab02be-9f0a-1b7f-e063-6294a90a7011	71872-7316	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20211201		ANDA	ANDA213561	Medical Purchasing Solutions, LLC	ATROPINE SULFATE	.4	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
71874-080_240148cb-7d42-4043-ada6-7e20dbb03ffd	71874-080	HUMAN OTC DRUG	DAYCON Antibacterial Foaming Hand So ap		Chloroxylenol	LIQUID	TOPICAL	20110228		OTC MONOGRAPH NOT FINAL	part333E	Daycon Products Company, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
71875-080_527de66b-c98a-4606-9ecf-5903c34a4b60	71875-080	HUMAN OTC DRUG	EXTENDED CARE Foaming Antimicrobial Handwash		Chloroxylenol	LIQUID	TOPICAL	20080730		OTC MONOGRAPH NOT FINAL	part333E	TRIPLE A SUPPLIES, INC.	CHLOROXYLENOL	.003	mg/mL			N	20241231
71875-400_6432fddf-ecd4-44ca-a009-fa8cfc86ac91	71875-400	HUMAN OTC DRUG	EXTENDED CARE Antimicrobial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	TRIPLE A SUPPLIES, INC.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
71875-800_f08a44e5-2b73-4fbf-b657-324ffb1000da	71875-800	HUMAN OTC DRUG	EXTENDED CARE Foaming Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20140515		OTC MONOGRAPH NOT FINAL	part333E	TRIPLE A SUPPLIES, INC.	ALCOHOL	.7	mL/mL			N	20241231
71879-001_cb8f6417-27b3-441b-81b8-6b3a1ee87365	71879-001	HUMAN PRESCRIPTION DRUG	Dexycu		dexamethasone	INJECTION, SUSPENSION	INTRAOCULAR	20180522		NDA	NDA208912	EyePoint Pharmaceuticals US, Inc	DEXAMETHASONE	517	ug/.005mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71879-136_0c69de0f-072c-8de5-e063-6294a90a35fe	71879-136	HUMAN PRESCRIPTION DRUG	YUTIQ		fluocinolone acetonide	IMPLANT	INTRAOCULAR	20181012		NDA	NDA210331	EyePoint Pharmaceuticals, Inc	FLUOCINOLONE ACETONIDE	.18	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71881-101_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-101	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 1)	Peanut	POWDER	ORAL	20200131		BLA	BLA125696	Aimmune Therapeutics	PEANUT	3	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
71881-102_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-102	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 2)	Peanut	POWDER	ORAL	20200131		BLA	BLA125696	Aimmune Therapeutics	PEANUT	6	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
71881-103_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-103	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 3)	Peanut	KIT		20200131		BLA	BLA125696	Aimmune Therapeutics						N	20241231
71881-104_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-104	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 4)	Peanut	POWDER	ORAL	20200131		BLA	BLA125696	Aimmune Therapeutics	PEANUT	20	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
71881-105_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-105	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 5)	Peanut	POWDER	ORAL	20200131		BLA	BLA125696	Aimmune Therapeutics	PEANUT	40	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
71881-106_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-106	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 6)	Peanut	POWDER	ORAL	20200131		BLA	BLA125696	Aimmune Therapeutics	PEANUT	80	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
71881-107_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-107	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 7)	Peanut	KIT		20200131		BLA	BLA125696	Aimmune Therapeutics						N	20241231
71881-108_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-108	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 8)	Peanut	KIT		20200131		BLA	BLA125696	Aimmune Therapeutics						N	20241231
71881-109_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-109	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 9)	Peanut	POWDER	ORAL	20200131		BLA	BLA125696	Aimmune Therapeutics	PEANUT	200	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
71881-110_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-110	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 10)	Peanut	KIT		20200131		BLA	BLA125696	Aimmune Therapeutics						N	20241231
71881-111_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-111	HUMAN PRESCRIPTION DRUG	PALFORZIA	(Level 11)	Peanut	POWDER	ORAL	20200131		BLA	BLA125696	Aimmune Therapeutics	PEANUT	300	mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Nut Proteins [EXT]		N	20241231
71881-113_f724158a-5c2e-fa1e-e053-6394a90a5519	71881-113	HUMAN PRESCRIPTION DRUG	PALFORZIA	Initial Dose Escalation	Peanut	KIT		20200131		BLA	BLA125696	Aimmune Therapeutics						N	20241231
71881-400_14249e84-64b4-4b03-9dc4-f3eaa1ca6afc	71881-400	HUMAN PRESCRIPTION DRUG	VOWST		fecal microbiota spores, live-brpk	CAPSULE	ORAL	20230426		BLA	BLA125757	Aimmune Therapeutics, Inc.	DONOR HUMAN STOOL SPORES (ETHANOL TREATED)	30000000	[CFU]/1			N	20241231
71884-006_f2d08bca-f99c-47ae-9060-e3b1cb8bb4d2	71884-006	HUMAN OTC DRUG	Germ Free 24 Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180822		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71884-008_90c2fe42-9216-42ad-8d7d-ca774a7ff49a	71884-008	HUMAN OTC DRUG	Germ Free Topical Antiseptic		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20181201		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71884-009_c1be40ff-341b-46fa-90da-4687768a3e74	71884-009	HUMAN OTC DRUG	My-Shield Sanitizing Body		Benzalkonium Chloride	SPRAY	TOPICAL	20200211		OTC MONOGRAPH NOT FINAL	part333A	ENVIRO SPECIALTY CHEMICALS INC	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71884-010_ffad77e8-f4bd-47ab-b878-bf64fb0a20f5	71884-010	HUMAN OTC DRUG	My-Shield Sanitizing Hand Wipes		Benzalkonium Chloride	SWAB	TOPICAL	20191101		OTC MONOGRAPH NOT FINAL	part333E	ENVIRO SPECIALTY CHEMICALS INC	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
71884-011_e90df761-d0fc-42aa-b3d3-878248a291fd	71884-011	HUMAN OTC DRUG	My-Shield Hand Sanitizer Gel		Benzalkonium Chloride	GEL	TOPICAL	20200526		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
71884-012_4216bb06-c847-4f3e-ac0a-5319d5550ea4	71884-012	HUMAN OTC DRUG	My-Shield Hand Sanitizer		Benzalkonium Chloride	SPRAY	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
71884-013_20f07c2f-1d66-460f-a125-e6170d81c8d2	71884-013	HUMAN OTC DRUG	Pharma care IPA Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20200611		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
71884-015_54c51717-68ff-4c2e-9878-00edcbf34f06	71884-015	HUMAN OTC DRUG	Pharma-Care Skin Preparation Cloths		Benzalkonium chloride	CLOTH	TOPICAL	20200814		OTC MONOGRAPH NOT FINAL	part333E	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
71884-016_7b8ae47e-c120-49e5-84da-f2a22823ef36	71884-016	HUMAN OTC DRUG	Germfree24 Hand Sanitizer		Benzalkonium Chloride	SPRAY	TOPICAL	20201217		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
71884-017_ad03170c-2b8e-4c98-a607-65690e062b05	71884-017	HUMAN OTC DRUG	germfree24 Sanitizing Body-Spray		Benzalkonium Chloride	SPRAY	TOPICAL	20201216		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71884-025_a2e4fc7c-fc14-493a-8c7e-fb695538cd6c	71884-025	HUMAN OTC DRUG	MY-SHIELD TOPICAL ANTISEPTIC		Benzalkonium Chloride	GEL	TOPICAL	20220224		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71884-026_dc7d14d8-cf3d-45a9-bb65-cada8528f452	71884-026	HUMAN OTC DRUG	Germ-Free 24 Sanitizing		Benzalkonium Chloride	SOAP	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
71884-034_5eaaf22d-7c43-4cfb-8e27-79dffe3611aa	71884-034	HUMAN OTC DRUG	TRIPLE SHIELD		Benzalkonium Chloride	SPRAY	TOPICAL	20200826		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
71884-040_bc6c67aa-50a4-4f58-9cb4-411f7df9508f	71884-040	HUMAN OTC DRUG	MY-SHIELD SANITIZING		Benzalkonium Chloride	SOAP	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
71884-101_05d4673e-fbdd-4443-9807-1eb84638eead	71884-101	HUMAN OTC DRUG	NINJA GOLDFISH SANITIZING		Benzalkonium Chloride	SOAP	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333E	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
71884-102_122ce77a-0863-4250-a892-9ee93b6fdcdf	71884-102	HUMAN OTC DRUG	NINJA GOLDFISH SANITIZING BODY		Benzalkonium Chloride	SPRAY	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
71884-103_00ff62a7-0fc4-499f-a790-1866255d391f	71884-103	HUMAN OTC DRUG	NINJA GOLDFISH HAND SANITIZER		Benzalkonium Chloride	SPRAY	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71884-200_5e79eb29-63ff-4c02-b8d0-fa8f7230b884	71884-200	HUMAN OTC DRUG	DOCTOR INKS SANITIZING		Benzalkonium Chloride	SOAP	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part333E	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
71884-201_beb81b1a-b614-4b84-addb-812a37c1d7fd	71884-201	HUMAN OTC DRUG	DOCTOR INKS HAND SANITIZER		Benzalkonium Chloride	LIQUID	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71884-203_52a23faf-b0e7-4710-9312-20c934ba5ded	71884-203	HUMAN OTC DRUG	DOCTOR INKS TOPICAL ANTISEPTIC		Benzalkonium Chloride	GEL	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333A	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71884-204_49f39f47-0fab-4dc4-a06f-06bc1895e816	71884-204	HUMAN OTC DRUG	DOCTOR INK TOPICAL ANTISEPTIC WITH PAIN RELIEF		Benzalkonium Chloride, Lidocaine	GEL	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part348	Enviro Specialty Chemicals Inc	BENZALKONIUM CHLORIDE; LIDOCAINE	1.3; 40	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71888-101_fb35fa5b-c50b-1b94-e053-6394a90a8379	71888-101	HUMAN OTC DRUG	Benzocaine		Benzocaine	GEL	TOPICAL	20170601		OTC MONOGRAPH DRUG	M017	Bellus Medical, LLC	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71888-102_fb360897-c462-de3b-e053-6294a90a6e36	71888-102	HUMAN OTC DRUG	Lidocaine		Lidocaine	GEL	TOPICAL	20170601		OTC MONOGRAPH DRUG	M017	Bellus Medical, LLC	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71888-103_fb35ff9c-6ea7-474a-e053-6394a90ab4cb	71888-103	HUMAN OTC DRUG	Tetracaine		Tetracaine	GEL	TOPICAL	20170601		OTC MONOGRAPH DRUG	M017	Bellus Medical, LLC	TETRACAINE HYDROCHLORIDE	20	mg/1000mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
71888-104_fb35ff9c-6ea6-474a-e053-6394a90ab4cb	71888-104	HUMAN OTC DRUG	Shield		Zinc Oxide	CREAM	TOPICAL	20150501		OTC MONOGRAPH DRUG	M020	Bellus Medical, LLC	ZINC OXIDE	21	g/100mL			N	20241231
71889-350_09dc25cb-c025-39aa-e063-6394a90a99b2	71889-350	HUMAN OTC DRUG	koa protect our ocean life OXYBENZONE FREE Broad Spectrum SPF 30 UVA UVB Protection Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20171118		OTC MONOGRAPH DRUG	M020	Kapa'ihi, Inc	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
71894-120_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-120	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-121_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-121	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-122_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-122	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-123_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-123	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-124_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-124	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-125_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-125	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-126_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-126	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-127_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-127	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-128_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-128	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-129_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-129	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-130_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-130	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-131_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-131	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-132_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-132	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-133_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-133	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-134_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-134	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-135_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-135	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-136_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-136	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-137_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-137	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-138_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-138	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-139_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-139	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-140_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-140	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-141_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-141	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-142_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-142	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-143_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-143	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-144_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-144	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-145_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-145	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-146_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-146	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-147_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-147	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-148_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-148	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-149_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-149	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-150_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-150	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-151_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-151	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-152_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-152	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-153_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-153	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-154_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-154	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-155_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-155	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71894-156_b3aa4bb6-1096-458a-b2dc-8deb5197721d	71894-156	HUMAN PRESCRIPTION DRUG	Zolgensma		onasemnogene abeparvovec-xioi	KIT		20190524		BLA	BLA125694	Novartis Gene Therapies, Inc.						N	20241231
71896-051_5e062bff-a04e-47fe-b7a5-f4eaf1f50019	71896-051	HUMAN OTC DRUG	RENOWN Antimicrobial So ap		Chloroxylenol	LIQUID	TOPICAL	20120801		OTC MONOGRAPH NOT FINAL	part333E	Interline Brands, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
71896-081_921f416f-29cf-470e-9029-82b0fa8cfa4f	71896-081	HUMAN OTC DRUG	RENOWN Antibacterial Foam Cleanser		Chloroxylenol	LIQUID	TOPICAL	20120731		OTC MONOGRAPH NOT FINAL	part333E	Interline Brands, Inc.	CHLOROXYLENOL	.003	mg/mL			N	20241231
71896-400_fc66a314-3904-4a4f-895c-65cb0cee9f08	71896-400	HUMAN OTC DRUG	RENOWN Antibacterial Plum Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Interline Brands, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
71896-701_3b1ec74c-c658-4d7c-ae15-5753f83d12fe	71896-701	HUMAN OTC DRUG	Hand Sanitizer	Fragrance Free	Ethyl Alcohol	SOLUTION	TOPICAL	20160602		OTC MONOGRAPH NOT FINAL	part333A	Interline Brands, Inc	ALCOHOL	70	mg/mL			N	20241231
71897-022_75fe568f-cf3d-4891-bdb2-9515b42d3918	71897-022	HUMAN OTC DRUG	Hand wash		Benzalkonium chloride	SOAP	TOPICAL	20180123		OTC MONOGRAPH NOT FINAL	part333A	Veritiv Operating Company	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71897-114_af857f6d-7294-4ccf-870b-d649ef3a5eea	71897-114	HUMAN OTC DRUG	Reliable Brand Powered by PURELL Antimicrobial Fragrance Free Foam CB10 1.2L		Benzalkonium Chloride	LIQUID	TOPICAL	20231205		OTC MONOGRAPH DRUG	505G(a)(3)	Veritiv Operating Company	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
71897-118_2d5bf30e-bdc7-491d-8864-583b77959709	71897-118	HUMAN OTC DRUG	Foaming Hand Sanitizer		Benzalkonium Chloride	LOTION	TOPICAL	20200105		OTC MONOGRAPH NOT FINAL	part333A	VERITIV OPERATING COMPANY	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71897-370_8ff6f7e6-d72e-4991-8a42-ed1b87317fef	71897-370	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	19920424		OTC MONOGRAPH NOT FINAL	part333A	VERITIV OPERATING COMPANY	ALCOHOL	616	mg/100mL			N	20241231
71897-401_2418a2ef-0272-47dc-a2c5-da3e19212493	71897-401	HUMAN OTC DRUG	Reliable Luxury Foam Antimicrobial Handwash Citrus Floral Scent		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Veritiv Operating Company	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
71897-456_d775efa4-921c-410d-b3fc-108ebda9448f	71897-456	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200106		OTC MONOGRAPH NOT FINAL	part333A	VERITIV OPERATING COMPANY	ALCOHOL	70	mL/100mL			N	20241231
71897-523_97fce862-ae5f-48d2-b1b7-4ec425d30ffb	71897-523	HUMAN OTC DRUG	Reliable Hand So ap Antibacterial Plum		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20180615		OTC MONOGRAPH NOT FINAL	part333E	Veritiv Operating Company	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
71897-566_a2f29c1c-c72b-4898-9388-10e5c6c63e84	71897-566	HUMAN OTC DRUG	Reliable E2 Luxury Foam Handwash		CHLOROXYLENOL	LIQUID	TOPICAL	20190915		OTC MONOGRAPH NOT FINAL	part333E	Veritiv Operating Company	CHLOROXYLENOL	.5	mg/100mL			N	20241231
71897-575_97be8400-b90c-4dd1-9265-70c5a0555ae5	71897-575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20191220		OTC MONOGRAPH NOT FINAL	part333A	Veritiv Operating Company	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
71897-610_6511055e-24ed-4808-8b03-ad2034ba1ac3	71897-610	HUMAN OTC DRUG	Reliable Brand Powered by PURELL Antimicrobial Scented Foam CB10 1.2L		Benzalkonium Chloride	LIQUID	TOPICAL	20231205		OTC MONOGRAPH DRUG	505G(a)(3)	Veritiv Operating Company	BENZALKONIUM CHLORIDE	.5	mg/100mL			N	20241231
71899-067_7ebc91e4-0236-4ce5-a792-1fc81a3ddc67	71899-067	HUMAN OTC DRUG	Hairitage Power Punch Anti-Dandruff Pre-Wash Booster		Salicylic Acid	LIQUID	TOPICAL	20230324		OTC MONOGRAPH FINAL	part333D	Maesa, LLC.	SALICYLIC ACID	3	mg/118mL			N	20241231
71899-068_617f3e1c-cafa-4202-a795-52190e23faec	71899-068	HUMAN OTC DRUG	Hairitage Wash It Away Anti-Dandruff for Dry, Flaky Scalp		Selenium Sulfide	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	part358H	Maesa, LLC.	SELENIUM SULFIDE	.1	g/mL			N	20241231
71899-069_b701d90f-e811-4adb-8d83-ad25e48e8214	71899-069	HUMAN OTC DRUG	Hairitage Wash It Away Anti-Dandruff for Oily, Flaky Scalp		Selenium Sulfide	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	part358H	Maesa, LLC.	SELENIUM SULFIDE	1	mg/384mL			N	20241231
71904-100_72a170d0-4aa4-4290-873f-57ba771f71a9	71904-100	HUMAN PRESCRIPTION DRUG	Galafold		migalastat hydrochloride	CAPSULE	ORAL	20180810		NDA	NDA208623	Amicus Therapeutics US, LLC	MIGALASTAT HYDROCHLORIDE	123	mg/1			N	20241231
71904-200_1ef2779f-6d2a-426a-9cce-b14a4bcf1e9a	71904-200	HUMAN PRESCRIPTION DRUG	POMBILITI	ATGA	cipaglucosidase alfa-atga	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231011		BLA	BLA761204	AMICUS THERAPEUTICS US, LLC	CIPAGLUCOSIDASE ALFA	105	mg/1			N	20241231
71904-300_608208ec-6d30-4796-9d61-fed1159b8b38	71904-300	HUMAN PRESCRIPTION DRUG	OPFOLDA		miglustat	CAPSULE	ORAL	20231011		NDA	NDA215211	AMICUS THERAPEUTICS US, LLC	MIGLUSTAT	65	mg/1	Glucosylceramide Synthase Inhibitor [EPC], Glucosylceramide Synthase Inhibitors [MoA]		N	20241231
71906-051_90a2e701-55e6-4755-a8ae-0eb053cd5eb1	71906-051	HUMAN OTC DRUG	BOARDWALK Antibacterial Ltion So ap		Chloroxylenol	LIQUID	TOPICAL	20030315		OTC MONOGRAPH NOT FINAL	part333E	Essendant Co.	CHLOROXYLENOL	.003	mg/mL			N	20241231
71906-080_cbe81e3f-6fc6-40bf-969a-2b6d63614a85	71906-080	HUMAN OTC DRUG	BOARDWALK Antibacterial Foam Handwash		Chloroxylenol	LIQUID	TOPICAL	20111001		OTC MONOGRAPH NOT FINAL	part333E	Essendant Co.	CHLOROXYLENOL	.003	mg/mL			N	20241231
71906-700_a2b1d7db-9394-4cb0-92ef-accc05a46f24	71906-700	HUMAN OTC DRUG	BOARDWALK Hand Sanitizer		alcohol	GEL	TOPICAL	20150830		OTC MONOGRAPH NOT FINAL	part333E	Essendant Co.	ALCOHOL	.7	mL/mL			N	20241231
71906-701_09d2a2c7-d9a4-6c89-e063-6394a90a0756	71906-701	HUMAN OTC DRUG	Antibacterial Hand Refill		PMCX	SOAP	TOPICAL	20220211		OTC MONOGRAPH DRUG	505G(a)(3)	Essendant Co.	CHLOROXYLENOL	1	g/L			N	20241231
71906-713_05b9cba9-9880-443f-ab7f-a5690cb86385	71906-713	HUMAN OTC DRUG	dishwashing		chloroxylenol	LIQUID	TOPICAL	20191214		OTC MONOGRAPH NOT FINAL	part333A	ESSENDANT CO.	CHLOROXYLENOL	3	mg/mL			N	20241231
71907-114_627232b2-c67e-46c6-b87d-ee4f99e5832f	71907-114	HUMAN OTC DRUG	Victoria Bay Antimicrobial Foam Handwash 1200 mL		Benzalkonium Chloride	LIQUID	TOPICAL	20231205		OTC MONOGRAPH DRUG	505G(a)(3)	Dade Paper & Bag, LLC	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
71907-201_09d27d77-e985-67c7-e063-6394a90a129c	71907-201	HUMAN OTC DRUG	Antibacterial Foam		PCMX, Hand Soap	SOAP	TOPICAL	20230203		OTC MONOGRAPH DRUG	505G(a)(3)	Dade Paper & Bag, LLC	CHLOROXYLENOL	.1	g/L			N	20241231
71907-301_0e21211d-e996-03c8-e063-6394a90a0492	71907-301	HUMAN OTC DRUG	Victoria Bay Anti-Bacterial Hand		PMCX	SOAP	TOPICAL	20210813		OTC MONOGRAPH DRUG	505G(a)(3)	Dade Paper & Bag, LLC	CHLOROXYLENOL	1	g/L			N	20251231
71907-400_60b41f5e-1790-4c4a-8415-1119c6979e53	71907-400	HUMAN OTC DRUG	Victoria Bay Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Dade Paper & Bag, LLC	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
71907-701_09d2a2c7-d9a5-6c89-e063-6394a90a0756	71907-701	HUMAN OTC DRUG	Victoria Bay Soft Touch Antibacterial		PCMX	SOAP	TOPICAL	20210630		OTC MONOGRAPH DRUG	505G(a)(3)	Dade Paper & Bag, LLC	CHLOROXYLENOL	1	g/L			N	20241231
71908-400_dc76afbb-0207-4ddb-97ad-fe5def96449b	71908-400	HUMAN OTC DRUG	SMART Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Southeastern Paper Group, Inc.	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
71912-521_36616925-5cd8-4e75-8df7-b78c210c10fa	71912-521	HUMAN OTC DRUG	ADVANTAGE CHEMICAL Premium Antibacterial Foaming Hand So ap		CHLOROXYLENOL	LIQUID	TOPICAL	20150415		OTC MONOGRAPH NOT FINAL	part333E	Advantage Chemical, Inc.	CHLOROXYLENOL	.005	mg/mL			N	20241231
71917-001_d60993ab-eae6-4307-9318-69c3449f3a53	71917-001	HUMAN OTC DRUG	Cirlutone		Camphor	OINTMENT	TOPICAL	20171206		OTC MONOGRAPH NOT FINAL	part348	Herbal Health LLC	CAMPHOR (SYNTHETIC)	.6	g/100g			N	20241231
71918-001_a11aafa4-46dd-49a2-899d-7232fd51db54	71918-001	HUMAN OTC DRUG	Timing Pain Savior Cool Herbal Patch		Menthol, Methyl Salicylate	PATCH	TOPICAL	20180120		OTC MONOGRAPH DRUG	M017	Timing Pharmaceutical Co., Ltd PABP Branch	MENTHOL; METHYL SALICYLATE	4; .5	g/100g; g/100g			N	20241231
71918-002_35750316-bbd1-468c-b764-f4dfaff14a9d	71918-002	HUMAN OTC DRUG	Timing Pain Savior Fragrant Ginger Patch		Menthol, Methyl Salicylate	PATCH	TOPICAL	20180120		OTC MONOGRAPH DRUG	M017	Timing Pharmaceutical Co., Ltd PABP Branch	MENTHOL; METHYL SALICYLATE	2; 2	g/100g; g/100g			N	20241231
71919-034_ecf7b735-9258-4039-82d3-ee1ae9c5ba9f	71919-034	HUMAN OTC DRUG	Alumina		ALUMINUM OXIDE	LIQUID	ORAL	20100429		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ALUMINUM OXIDE	30	[hp_C]/mL			N	20241231
71919-420_dae7d21a-9f20-89ac-e053-2995a90ae203	71919-420	HUMAN OTC DRUG	Lithium bromatum		LITHIUM BROMIDE	LIQUID	ORAL	20110727		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LITHIUM BROMIDE	30	[hp_C]/mL	Mood Stabilizer [EPC]		N	20241231
71919-563_7e5abe5e-f7f2-6c38-e053-2a91aa0aa9b4	71919-563	HUMAN OTC DRUG	Pulsatilla nuttalliana		ANEMONE PATENS	LIQUID	ORAL	20101208		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANEMONE PATENS	30	[hp_C]/mL			N	20241231
71919-596_0acbe15c-5af6-4ba3-99ac-fd4f69fc2ca0	71919-596	HUMAN OTC DRUG	Sabadilla		SCHOENOCAULON OFFICINALE SEED	LIQUID	ORAL	20100112		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SCHOENOCAULON OFFICINALE SEED	30	[hp_C]/mL			N	20241231
71919-597_42b543d0-478f-4d13-aab2-3b79d088301c	71919-597	HUMAN OTC DRUG	Sabal serrulata		SAW PALMETTO	LIQUID	ORAL	20100514		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SAW PALMETTO	30	[hp_C]/mL			N	20241231
71919-598_a6608634-a5d8-4d29-8ead-59995576afe5	71919-598	HUMAN OTC DRUG	Sabina		JUNIPERUS SABINA LEAFY TWIG	LIQUID	ORAL	20091008		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	JUNIPERUS SABINA LEAFY TWIG	30	[hp_C]/mL			N	20241231
71919-599_89580bfa-b28b-4663-adb0-4e909fea30e4	71919-599	HUMAN OTC DRUG	Saccharinum		SACCHARIN	LIQUID	ORAL	20100930		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SACCHARIN	30	[hp_C]/mL			N	20241231
71919-600_dea37cad-d0c4-409c-b900-bfff1e33d245	71919-600	HUMAN OTC DRUG	Saccharum lactis		LACTOSE, UNSPECIFIED FORM	LIQUID	ORAL	20100811		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LACTOSE, UNSPECIFIED FORM	30	[hp_C]/mL			N	20241231
71919-601_c2504498-d090-4e27-a5ed-e7db6f90abe4	71919-601	HUMAN OTC DRUG	Saccharum officinale		SUCROSE	LIQUID	ORAL	20101116		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SUCROSE	30	[hp_C]/mL			N	20241231
71919-603_a12fdd29-c66b-4b14-8cc1-9f00c6160993	71919-603	HUMAN OTC DRUG	Salix nigra		SALIX NIGRA BARK	LIQUID	ORAL	20101007		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SALIX NIGRA BARK	30	[hp_C]/mL			N	20241231
71919-604_42d25f2b-d911-4770-85f9-8e4207a45f75	71919-604	HUMAN OTC DRUG	Salvia officinalis		SAGE	LIQUID	ORAL	20091016		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SAGE	30	[hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71919-607_02f7aa96-045d-48d1-8339-b872699c787e	71919-607	HUMAN OTC DRUG	Sanguinarinum nitricum		SANGUINARINE NITRATE	LIQUID	ORAL	20100504		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SANGUINARINE NITRATE	30	[hp_C]/mL			N	20241231
71919-609_4836327c-0068-4d76-b5f9-06d5b5d093bc	71919-609	HUMAN OTC DRUG	Santoninum		SANTONIN	LIQUID	ORAL	20100316		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SANTONIN	30	[hp_C]/mL			N	20241231
71919-610_e1b7fdd5-191d-45b3-ab06-73a015813a27	71919-610	HUMAN OTC DRUG	Saponaria officinalis		SAPONARIA OFFICINALIS ROOT	LIQUID	ORAL	20100316		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SAPONARIA OFFICINALIS ROOT	30	[hp_C]/mL			N	20241231
71919-612_452fa54b-175a-4e4c-8b1d-6f9ade3d2a7b	71919-612	HUMAN OTC DRUG	Sarracenia purpurea		SARRACENIA PURPUREA	LIQUID	ORAL	20091106		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SARRACENIA PURPUREA	30	[hp_C]/mL			N	20241231
71919-613_735a066e-b4b5-4e3c-954b-5a7fd9d75d8b	71919-613	HUMAN OTC DRUG	Sarsaparilla		SMILAX ORNATA ROOT	LIQUID	ORAL	20100504		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SMILAX ORNATA ROOT	30	[hp_C]/mL			N	20241231
71919-614_7220898d-c136-4366-84d2-d01e06bd3227	71919-614	HUMAN OTC DRUG	Scilla maritima		DRIMIA MARITIMA BULB	LIQUID	ORAL	20090408		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DRIMIA MARITIMA BULB	30	[hp_C]/mL			N	20241231
71919-615_6f39c4f8-7f7a-427e-9baf-4dafe231d104	71919-615	HUMAN OTC DRUG	Scolopendra		SCOLOPENDRA SUBSPINIPES	LIQUID	ORAL	20101019		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SCOLOPENDRA SUBSPINIPES	30	[hp_C]/mL			N	20241231
71919-616_d1b770cd-b652-4d8f-9f0f-0b3393aeb9da	71919-616	HUMAN OTC DRUG	Scrophularia nodosa		SCROPHULARIA NODOSA	LIQUID	ORAL	20091231		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SCROPHULARIA NODOSA	30	[hp_C]/mL			N	20241231
71919-617_fff6427d-8a1e-4de4-9653-12a59321c1e6	71919-617	HUMAN OTC DRUG	Scutellaria lateriflora		SCUTELLARIA LATERIFLORA	LIQUID	ORAL	20100401		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SCUTELLARIA LATERIFLORA	30	[hp_C]/mL			N	20241231
71919-618_e7f74039-fcce-4e02-9e98-582e891b8225	71919-618	HUMAN OTC DRUG	Secale cornutum		CLAVICEPS PURPUREA SCLEROTIUM	LIQUID	ORAL	20091210		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CLAVICEPS PURPUREA SCLEROTIUM	30	[hp_C]/mL			N	20241231
71919-619_3cfcfa22-047e-4a18-98bc-a13c7f08e387	71919-619	HUMAN OTC DRUG	Sedum acre		SEDUM ACRE	LIQUID	ORAL	20091210		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SEDUM ACRE	30	[hp_C]/mL			N	20241231
71919-620_50763b0e-ab3e-4c84-b54d-99f3f5a3b9d6	71919-620	HUMAN OTC DRUG	Selenium metallicum		SELENIUM	LIQUID	ORAL	20100409		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SELENIUM	30	[hp_C]/mL			N	20241231
71919-622_dd667f97-92b3-4d51-bb34-ce9a63ac88a8	71919-622	HUMAN OTC DRUG	Sempervivum tectorum		SEMPERVIVUM TECTORUM LEAF	LIQUID	ORAL	20090603		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SEMPERVIVUM TECTORUM LEAF	30	[hp_C]/mL			N	20241231
71919-623_f7b72fad-5612-41ca-b784-e48d6a407c07	71919-623	HUMAN OTC DRUG	Senecio aureus		PACKERA AUREA	LIQUID	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PACKERA AUREA	30	[hp_C]/mL			N	20241231
71919-624_1d1ddfac-41ae-45d5-8dff-ca47132cc745	71919-624	HUMAN OTC DRUG	Senega officinalis		POLYGALA SENEGA ROOT	LIQUID	ORAL	20100312		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POLYGALA SENEGA ROOT	30	[hp_C]/mL			N	20241231
71919-625_b96fb7ee-9b2d-4382-901c-e78e1ca2ea2f	71919-625	HUMAN OTC DRUG	Senna		SENNA LEAF	LIQUID	ORAL	20100203		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SENNA LEAF	30	[hp_C]/mL			N	20241231
71919-626_eb175c10-da62-41f3-b3f8-82ebd07e92d4	71919-626	HUMAN OTC DRUG	Sepia		SEPIA OFFICINALIS JUICE	LIQUID	ORAL	20091112		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SEPIA OFFICINALIS JUICE	30	[hp_C]/mL			N	20241231
71919-627_0100a357-3a47-43f1-a3cd-f44b194e0a0f	71919-627	HUMAN OTC DRUG	Serum anguillae		ANGUILLA ROSTRATA BLOOD SERUM	LIQUID	ORAL	20091021		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANGUILLA ROSTRATA BLOOD SERUM	30	[hp_C]/mL			N	20241231
71919-629_79b53b5d-bf73-4f3f-bf0a-51d80c014aca	71919-629	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	LIQUID	ORAL	20100114		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SILICON DIOXIDE	30	[hp_C]/mL			N	20241231
71919-631_507a937e-9bf8-40b8-8e7c-b6d5b42761fc	71919-631	HUMAN OTC DRUG	Sinapis nigra		BLACK MUSTARD SEED	LIQUID	ORAL	20091028		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BLACK MUSTARD SEED	30	[hp_C]/mL			N	20241231
71919-633_319978ff-5ca4-40bf-9eca-0020a59a1891	71919-633	HUMAN OTC DRUG	Solanum nigrum		SOLANUM NIGRUM WHOLE	LIQUID	ORAL	20090612		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SOLANUM NIGRUM WHOLE	30	[hp_C]/mL			N	20241231
71919-634_99af3b33-9b88-457b-82a3-1f354dd0a7b4	71919-634	HUMAN OTC DRUG	Solanum tuberosum		SOLANUM TUBEROSUM	LIQUID	ORAL	20090512		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SOLANUM TUBEROSUM	30	[hp_C]/mL			N	20241231
71919-637_93c8f413-06a7-418e-a2a0-83abd5942cf1	71919-637	HUMAN OTC DRUG	Spiraea ulmaria		FILIPENDULA ULMARIA ROOT	LIQUID	ORAL	20100621		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	FILIPENDULA ULMARIA ROOT	30	[hp_C]/mL			N	20241231
71919-638_661b8afa-df5c-4348-868d-79cf9cee61c8	71919-638	HUMAN OTC DRUG	Spiranthes autumnalis		SPIRANTHES SPIRALIS ROOT	LIQUID	ORAL	20090105		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SPIRANTHES SPIRALIS ROOT	30	[hp_C]/mL			N	20241231
71919-639_d9e69439-23ae-4401-b546-e64392c774c0	71919-639	HUMAN OTC DRUG	Spongia tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	LIQUID	ORAL	20091120		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_C]/mL			N	20241231
71919-640_118b623e-7c13-4a0e-9674-fae3562fef3f	71919-640	HUMAN OTC DRUG	Stannum iodatum		STANNOUS IODIDE	LIQUID	ORAL	20100212		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STANNOUS IODIDE	30	[hp_C]/mL			N	20241231
71919-641_fa672a2e-5ca6-4b00-bc7d-0d4bff2dfec4	71919-641	HUMAN OTC DRUG	Stannum metallicum		TIN	LIQUID	ORAL	20100615		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	TIN	30	[hp_C]/mL			N	20241231
71919-642_72484377-94e6-4f69-acd2-d1864209e642	71919-642	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	LIQUID	ORAL	20091016		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DELPHINIUM STAPHISAGRIA SEED	30	[hp_C]/mL			N	20241231
71919-643_c29b6674-2579-4b50-9051-4eeaabf27881	71919-643	HUMAN OTC DRUG	Stellaria media		STELLARIA MEDIA	LIQUID	ORAL	20100908		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	STELLARIA MEDIA	30	[hp_C]/mL			N	20241231
71919-758_de35d3e6-ecea-1971-e053-2a95a90a6940	71919-758	HUMAN OTC DRUG	Valeriana Officinalis Kit Refill		VALERIAN	PELLET	ORAL	20220504		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	VALERIAN	200	[hp_C]/1			N	20241231
71919-759_de49cd4b-cc15-89dc-e053-2995a90a6a13	71919-759	HUMAN OTC DRUG	Aesculus Hipp Kit Refill		HORSE CHESTNUT	PELLET	ORAL	20220505		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HORSE CHESTNUT	200	[hp_C]/1			N	20241231
71919-760_dea9a4c0-4a29-9a55-e053-2a95a90a6ba3	71919-760	HUMAN OTC DRUG	Hamamelis Virginiana Kit Refill		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	200	[hp_C]/1			N	20241231
71919-761_deaad1e2-cdd3-c952-e053-2a95a90a3383	71919-761	HUMAN OTC DRUG	Drosera Rotundifolia Kit Refill		DROSERA ROTUNDIFOLIA	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	DROSERA ROTUNDIFOLIA	200	[hp_C]/1			N	20241231
71919-762_deab272a-6e6f-26b4-e053-2995a90aa410	71919-762	HUMAN OTC DRUG	Berberis Vulgaris Kit Refill		BERBERIS VULGARIS ROOT BARK	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BERBERIS VULGARIS ROOT BARK	200	[hp_C]/1			N	20241231
71919-763_deac4e46-21af-23c2-e053-2a95a90a0e27	71919-763	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GOLDENSEAL	200	[hp_C]/1			N	20241231
71919-764_deac68b1-3d5d-d589-e053-2a95a90a6528	71919-764	HUMAN OTC DRUG	Sarsaparilla Kit Refill		SARSAPARILLA ROOT	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	SMILAX ORNATA ROOT	200	[hp_C]/1			N	20241231
71919-765_deacf8d2-fd4c-f4c2-e053-2a95a90a7e7a	71919-765	HUMAN OTC DRUG	Baptisia Tinctoria Kit Refill		BAPTISIA TINCTORIA ROOT	PELLET	ORAL	20220510		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BAPTISIA TINCTORIA ROOT	200	[hp_C]/1			N	20241231
71919-766_dfdac28b-8cd7-7dc1-e053-2a95a90a4e9f	71919-766	HUMAN OTC DRUG	Eupatorium Perf Kit Refill		Eupatorium Perfoliatum Flowering Top	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	EUPATORIUM PERFOLIATUM FLOWERING TOP	200	[hp_C]/1			N	20241231
71919-767_dfdb0223-14dc-f2d7-e053-2a95a90a4728	71919-767	HUMAN OTC DRUG	Cimicifuga Racemosa Kit Refill		BLACK COHOSH	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BLACK COHOSH	200	[hp_C]/1			N	20241231
71919-768_dfdb36c8-895d-5e32-e053-2995a90adf6f	71919-768	HUMAN OTC DRUG	Hydrastis canadensis		GOLDENSEAL	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GOLDENSEAL	30	[hp_C]/1			N	20241231
71919-769_dfdb7bfb-40c5-87c4-e053-2995a90a46d2	71919-769	HUMAN OTC DRUG	Kali Carbonicum Kit Refill		POTASSIUM CARBONATE	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM CARBONATE	200	[hp_C]/1			N	20241231
71919-770_dfdbf612-b34a-23c4-e053-2a95a90a8ed9	71919-770	HUMAN OTC DRUG	Petroleum Kit Refill		KEROSENE	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	KEROSENE	200	[hp_C]/1			N	20241231
71919-771_dfdc172b-78ab-15f9-e053-2995a90ac419	71919-771	HUMAN OTC DRUG	Podophyllum Pelt Kit Refill		PODOPHYLLUM	PELLET	ORAL	20220525		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PODOPHYLLUM	200	[hp_C]/1			N	20241231
71919-772_e1182c7b-e080-3f2f-e053-2a95a90a7d14	71919-772	HUMAN OTC DRUG	30C and 200C Homeopathic Remedy Kit		50 Remedy Kit	KIT	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products						N	20241231
71919-773_e11a6519-07a5-6c08-e053-2a95a90a3526	71919-773	HUMAN OTC DRUG	Bellis Perennis Kit Refill		BELLIS PERENNIS	PELLET	ORAL	20220610		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	BELLIS PERENNIS	200	[hp_C]/1			N	20241231
71919-774_e3501273-a8cd-c7a1-e053-2995a90af846	71919-774	HUMAN OTC DRUG	Passiflora incarnata Kit Refill		Passiflora Incarnata Flowering Top	PELLET	ORAL	20220708		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PASSIFLORA INCARNATA FLOWERING TOP	30	[hp_C]/1			N	20241231
71919-775_e3b4c4a2-e91f-4c39-e053-2995a90aefe8	71919-775	HUMAN OTC DRUG	Passiflora incarnata Kit Refill		Passiflora Incarnata Flowering Top	PELLET	ORAL	20220713		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PASSIFLORA INCARNATA FLOWERING TOP	200	[hp_C]/1			N	20241231
71919-777_e958ba7d-dbd2-518e-e053-2995a90a0faf	71919-777	HUMAN OTC DRUG	Kali Phosphoricum Kit Refill		POTASSIUM PHOSPHATE, DIBASIC	PELLET	ORAL	20220923		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM PHOSPHATE, DIBASIC	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71919-798_05438719-05c6-5a91-e063-6294a90aae5d	71919-798	HUMAN OTC DRUG	Camphora Kit Refill		CAMPHORA	PELLET	ORAL	20230913		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAMPHOR (NATURAL)	30	[hp_C]/1			N	20241231
71919-799_0551bc2c-6e0d-99d1-e063-6294a90aa3af	71919-799	HUMAN OTC DRUG	Camphora Kit Refill		CAMPHORA	PELLET	ORAL	20230914		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAMPHOR (NATURAL)	200	[hp_C]/1			N	20241231
71919-800_066df766-b1f6-83df-e063-6394a90aa588	71919-800	HUMAN OTC DRUG	WHP Colds and Cough		ACONITUM NAPELLUS - ARSENIC TRIOXIDE - BRYONIA ALBA ROOT - PULSATILLA VULGARIS - STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71919-801_0670e4b8-34bd-5c31-e063-6394a90a6718	71919-801	HUMAN OTC DRUG	WHP Flu like Symptoms		Bryonia Alba Root - Gelsemium Sempervirens Root - Toxicodendron Pubescens Leaf - Arsenic Trioxide Strychnos - Nux-Vomica Seed	PELLET	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; GELSEMIUM SEMPERVIRENS ROOT; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71919-802_06820c5e-3318-58d3-e063-6294a90ad81e	71919-802	HUMAN OTC DRUG	WHP Sinus Congestion		GOLDENSEAL - POTASSIUM DICHROMATE - PULSATILLA VULGARIS	PELLET	ORAL	20230929		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	GOLDENSEAL; POTASSIUM DICHROMATE; PULSATILLA VULGARIS	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
71919-803_06d15d06-c7f0-8e85-e063-6294a90ab2a2	71919-803	HUMAN OTC DRUG	WHP Sleeplessness		Arsenic Trioxide - Arabic Coffee Bean - Lachesis Muta Venom - Passiflora Incarnata Flowering Top	PELLET	ORAL	20231003		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; LACHESIS MUTA VENOM; PASSIFLORA INCARNATA FLOWERING TOP	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71919-804_06d25564-4c7f-0b3a-e063-6294a90a38bf	71919-804	HUMAN OTC DRUG	WHP Headache		ATROPA BELLADONNA - BRYONIA ALBA ROOT - SODIUM CHLORIDE - STRYCHNOS NUX-VOMICA SEED	PELLET	ORAL	20231003		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ATROPA BELLADONNA; BRYONIA ALBA ROOT; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71919-805_06d2bf97-d514-7c04-e063-6394a90af4ed	71919-805	HUMAN OTC DRUG	WHP Smoking		ARABICA COFFEE BEAN - STRYCHNOS NUX-VOMICA SEED - DELPHINIUM STAPHISAGRIA SEED	PELLET	ORAL	20231003		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARABICA COFFEE BEAN; DELPHINIUM STAPHISAGRIA SEED; STRYCHNOS NUX-VOMICA SEED	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71919-806_06d446a8-2fc1-fea1-e063-6394a90a835e	71919-806	HUMAN OTC DRUG	WHP Fungus		KEROSENE - SULFUR - THUJA OCCIDENTALIS LEAFY	PELLET	ORAL	20231003		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	KEROSENE; SULFUR; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
71919-807_06d4d93a-eb7a-99a3-e063-6394a90a8ed7	71919-807	HUMAN OTC DRUG	WHP Hay Fever		Onion - Arsenic Trioxide - Gelsemium Sempervirens Root - Strychnos Nux-Vomica Seed	PELLET	ORAL	20231003		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; GELSEMIUM SEMPERVIRENS ROOT; ONION; STRYCHNOS NUX-VOMICA SEED	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
71919-808_06d5e51f-78ac-72c7-e063-6394a90a9ab1	71919-808	HUMAN OTC DRUG	WHP Hot Flashes		LACHESIS MUTA VENOM - PULSATILLA VULGARIS - SEPIA OFFICINALIS JUICE - SULFUR	PELLET	ORAL	20231003		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	LACHESIS MUTA VENOM; PULSATILLA VULGARIS; SEPIA OFFICINALIS JUICE; SULFUR	6; 6; 12; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
71919-809_06e4315a-2ffb-a0f8-e063-6394a90a7fa0	71919-809	HUMAN OTC DRUG	WHP Stress		Arsenic Trioxide - Dibasic Potassium Phosphate - Passiflora Incarnata Flowering Top - Delphinium Staphisagria Seed	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; DELPHINIUM STAPHISAGRIA SEED; PASSIFLORA INCARNATA FLOWERING TOP; POTASSIUM PHOSPHATE, DIBASIC	6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
71919-810_06e54e78-9697-3e62-e063-6294a90a7b93	71919-810	HUMAN OTC DRUG	WHP Stomach Disorders		Arsenic Trioxide - Ipecac - Strychnos Nux-Vomica - Pulsatilla Vulgaris - Sulfur	PELLET	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ARSENIC TRIOXIDE; IPECAC; PULSATILLA VULGARIS; STRYCHNOS NUX-VOMICA SEED; SULFUR	6; 6; 6; 6; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71919-811_0876d0ba-0e06-61c5-e063-6294a90aba7e	71919-811	HUMAN OTC DRUG	Camphora		CAMPHOR (NATURAL)	PELLET	ORAL	20231024		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CAMPHOR (NATURAL)	30	[hp_C]/1			N	20241231
71919-812_0991d9cc-1908-9209-e063-6394a90aec7b	71919-812	HUMAN OTC DRUG	Antimonium Crudum Kit Refill		ANTIMONY TRISULFIDE	PELLET	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ANTIMONY TRISULFIDE	200	[hp_C]/1			N	20241231
71919-813_099204b8-3820-5f8c-e063-6294a90ada72	71919-813	HUMAN OTC DRUG	Kali Muriaticum Kit Refill		POTASSIUM CHLORIDE	PELLET	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	POTASSIUM CHLORIDE	200	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
71919-814_099251f6-be56-e136-e063-6394a90a94c7	71919-814	HUMAN OTC DRUG	Phosphoricum Acidum Kit Refill		PHOSPHORIC ACID	PELLET	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	PHOSPHORIC ACID	200	[hp_C]/1			N	20241231
71919-815_0992f3aa-3250-20e7-e063-6394a90a367f	71919-815	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CHELIDONIUM MAJUS	200	[hp_C]/1			N	20241231
71919-816_09952af1-9e59-4615-e063-6394a90a00f3	71919-816	HUMAN OTC DRUG	Chelidonium majus		CHELIDONIUM MAJUS	PELLET	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	CHELIDONIUM MAJUS	30	[hp_C]/1			N	20241231
71919-817_0995e648-9f2f-9d3f-e063-6394a90ab072	71919-817	HUMAN OTC DRUG	Helleborus niger		HELLEBORUS NIGER ROOT	PELLET	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HELLEBORUS NIGER ROOT	30	[hp_C]/1			N	20241231
71919-818_0996d446-1c36-f98f-e063-6394a90af8b8	71919-818	HUMAN OTC DRUG	Helleborus niger		HELLEBORUS NIGER ROOT	PELLET	ORAL	20231107		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	HELLEBORUS NIGER ROOT	200	[hp_C]/1			N	20241231
71919-819_09a60d62-a47a-0f02-e063-6294a90a6d39	71919-819	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	20231108		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ALLYLTHIOUREA	30	[hp_C]/1			N	20241231
71919-820_09a6bf06-ea86-5aee-e063-6294a90a3bb2	71919-820	HUMAN OTC DRUG	Thiosinaminum		ALLYLTHIOUREA	PELLET	ORAL	20231108		UNAPPROVED HOMEOPATHIC		Washington Homeopathic Products	ALLYLTHIOUREA	200	[hp_C]/1			N	20241231
71921-162_ccbb860e-6367-5114-e053-2a95a90abfb9	71921-162	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	Florida Pharmaceutical Products, LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71921-163_ccbb860e-6367-5114-e053-2a95a90abfb9	71921-163	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	Florida Pharmaceutical Products, LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71921-164_ccbb860e-6367-5114-e053-2a95a90abfb9	71921-164	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	Florida Pharmaceutical Products, LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71921-165_ccbb860e-6367-5114-e053-2a95a90abfb9	71921-165	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	Florida Pharmaceutical Products, LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71921-166_ccbb860e-6367-5114-e053-2a95a90abfb9	71921-166	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	Florida Pharmaceutical Products, LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
71921-170_d0b56323-49ef-f239-e053-2a95a90ae766	71921-170	HUMAN PRESCRIPTION DRUG	Sumatriptan		sumatriptan	SPRAY	NASAL	20210515		ANDA	ANDA208967	Florida Pharmaceutical Products, LLC.	SUMATRIPTAN	20	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
71921-177_f8b632d6-dbe5-e56a-e053-6394a90a3597	71921-177	HUMAN PRESCRIPTION DRUG	Abiraterone acetate		Abiraterone acetate	TABLET, FILM COATED	ORAL	20230410		ANDA	ANDA215086	Florida Pharmaceutical Products, LLC	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
71921-178_38b4b689-c306-42a0-9df6-5b125314aaab	71921-178	HUMAN PRESCRIPTION DRUG	abiraterone acetate		abiraterone acetate	TABLET	ORAL	20220815		ANDA	ANDA212462	Florida Pharmaceutical Products, LLC.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
71921-180_ce75cfd9-b711-cdbb-e053-2a95a90a277c	71921-180	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	Florida Pharmaceutical Products, LLC	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71921-181_ce75cfd9-b711-cdbb-e053-2a95a90a277c	71921-181	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	Florida Pharmaceutical Products, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71921-182_ce75cfd9-b711-cdbb-e053-2a95a90a277c	71921-182	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA071268	Florida Pharmaceutical Products, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
71921-185_d94b0f88-bcff-4797-b317-b95ecd982a62	71921-185	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate		Brimonidine Tartrate	SOLUTION/ DROPS	OPHTHALMIC	20220115		ANDA	ANDA091691	Florida Pharmaceutical Products, LLC	BRIMONIDINE TARTRATE	2	mg/mg	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71921-188_0b25c3d0-6cf7-cce0-e063-6294a90a8ea9	71921-188	HUMAN PRESCRIPTION DRUG	Brimonidine tartrate and Timolol maleate		Brimonidine tartrate and Timolol maleate	SOLUTION	OPHTHALMIC	20231123		ANDA	ANDA201949	Florida Pharmaceutical Products, LLC	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
71921-190_fe86c929-95ed-1849-e053-6294a90a897d	71921-190	HUMAN PRESCRIPTION DRUG	Exemestane		Exemestane	TABLET, FILM COATED	ORAL	20210115		ANDA	ANDA213547	Florida Pharmaceutical Products, LLC	EXEMESTANE	25	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
71921-194_b94f9be0-8dc2-0340-e053-2995a90adfc2	71921-194	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20210226		ANDA	ANDA212106	Florida Pharmaceutical Products, LLC	ENTECAVIR	.5	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
71921-195_b94f9be0-8dc2-0340-e053-2995a90adfc2	71921-195	HUMAN PRESCRIPTION DRUG	Entecavir		Entecavir	TABLET	ORAL	20210226		ANDA	ANDA212106	Florida Pharmaceutical Products, LLC	ENTECAVIR	1	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
71921-210_cc6c4939-7908-439c-b1b8-6b52e826c7a5	71921-210	HUMAN PRESCRIPTION DRUG	Valganciclovir		Valganciclovir	POWDER, FOR SOLUTION	ORAL	20230701		ANDA	ANDA216317	Florida Pharmaceutical Products, LLC	VALGANCICLOVIR	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
71921-214_8ff0de99-272e-4e68-9caf-69f3f146ac29	71921-214	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230731		ANDA	ANDA202112	Florida Pharmaceutical Products, LLC	GLIMEPIRIDE	1	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71921-215_8ff0de99-272e-4e68-9caf-69f3f146ac29	71921-215	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230731		ANDA	ANDA202112	Florida Pharmaceutical Products, LLC	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71921-216_8ff0de99-272e-4e68-9caf-69f3f146ac29	71921-216	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230731		ANDA	ANDA202112	Florida Pharmaceutical Products, LLC	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
71921-220_602f1d26-5679-41b9-a63f-f062f87bac73	71921-220	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230921		ANDA	ANDA208308	Florida Pharmaceutical Products, LLC	LACOSAMIDE	50	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
71921-221_602f1d26-5679-41b9-a63f-f062f87bac73	71921-221	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230921		ANDA	ANDA208308	Florida Pharmaceutical Products, LLC	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
71921-222_602f1d26-5679-41b9-a63f-f062f87bac73	71921-222	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230921		ANDA	ANDA208308	Florida Pharmaceutical Products, LLC	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
71921-223_602f1d26-5679-41b9-a63f-f062f87bac73	71921-223	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	TABLET	ORAL	20230921		ANDA	ANDA208308	Florida Pharmaceutical Products, LLC	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
71921-226_02d89d37-cbca-4e06-83ef-2a10f988f1ea	71921-226	HUMAN PRESCRIPTION DRUG	DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE		dorzolamide hydrochloride timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20230816		ANDA	ANDA202054	Florida Pharmaceutical Products, LLC	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71921-240_3dcd374e-562b-4788-bc2a-cccc72a95d8b	71921-240	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20231031		ANDA	ANDA204467	Florida Pharmaceutical Products, LLC	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71921-242_3dcd374e-562b-4788-bc2a-cccc72a95d8b	71921-242	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20231031		ANDA	ANDA204467	Florida Pharmaceutical Products, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
71922-100_d691da56-baa8-c47a-e053-2995a90a2ba2	71922-100	HUMAN OTC DRUG	Candee Caine Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	American Medical & Hospital Supply Co., Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71922-101_d691ce56-7177-dea6-e053-2995a90a3fc6	71922-101	HUMAN OTC DRUG	Candee Caine Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	American Medical & Hospital Supply Co., Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71922-102_d691da56-bab4-c47a-e053-2995a90a2ba2	71922-102	HUMAN OTC DRUG	Candee Caine Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	American Medical & Hospital Supply Co., Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71922-103_d691bcc9-5cbd-3e63-e053-2995a90add5a	71922-103	HUMAN OTC DRUG	Candee Caine Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	American Medical & Hospital Supply Co., Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71922-104_d691da56-bac0-c47a-e053-2995a90a2ba2	71922-104	HUMAN OTC DRUG	Candee Caine Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	American Medical & Hospital Supply Co., Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71922-105_d691e241-9287-482a-e053-2a95a90a18bb	71922-105	HUMAN OTC DRUG	Candee Caine Topical Anesthetic		Benzocaine	GEL	DENTAL	20130701		OTC MONOGRAPH NOT FINAL	part356	American Medical & Hospital Supply Co., Inc.	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
71925-301_0e218d0e-1efe-6f5e-e063-6394a90afde7	71925-301	HUMAN OTC DRUG	Anti-Bacterial Hand		PCMX	SOAP	TOPICAL	20210817		OTC MONOGRAPH DRUG	505G(a)(3)	Pollock Investments Inc	CHLOROXYLENOL	1	g/L			N	20251231
71925-400_29e21d6c-20cc-4a14-a713-52a3d6ea8e71	71925-400	HUMAN OTC DRUG	RADIANCE Antibacterial Plum Foam Handwash		Benzalkonium Chloride	LIQUID	TOPICAL	20170430		OTC MONOGRAPH NOT FINAL	part333E	Pollock Investments Incorporated	BENZALKONIUM CHLORIDE	.005	mg/mL			N	20241231
71927-001_600b618b-183b-18f6-e053-2a91aa0ae7ff	71927-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20171211		OTC MONOGRAPH NOT FINAL	part333E	Orazen Inc	ALCOHOL	62	mL/100mL			N	20241231
71927-001_aa8466b7-a7d2-2383-e053-2a95a90acd6b	71927-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Orazen Inc	ALCOHOL	62	mL/100mL			N	20241231
71927-005_7e8f4517-c995-8797-e053-2991aa0a4f58	71927-005	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190107		OTC MONOGRAPH NOT FINAL	part333E	Orazen Inc	ALCOHOL	62	mL/100mL			N	20241231
71927-006_873c2601-931a-b87b-e053-2991aa0aea7a	71927-006	HUMAN OTC DRUG	Mouthwash		Menthol, Methyl salicylate, Thymol	LIQUID	ORAL	20190422		OTC MONOGRAPH NOT FINAL	part356	Orazen Inc	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
71927-007_98b90d27-eb54-3c45-e053-2995a90ab0b3	71927-007	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20191203		OTC MONOGRAPH NOT FINAL	part333E	Orazen Inc	ALCOHOL	62	mL/100mL			N	20241231
71927-008_9ae42862-f732-9d67-e053-2a95a90af955	71927-008	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20191231		OTC MONOGRAPH NOT FINAL	part333E	Orazen Inc	ALCOHOL	62	mL/100mL			N	20241231
71927-009_a47a303a-7ee9-2759-e053-2995a90a4960	71927-009	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333E	Orazen Inc.	ALCOHOL	70	mL/100mL			N	20241231
71927-017_f4e42755-1f02-36dc-e053-2995a90a8b87	71927-017	HUMAN OTC DRUG	MEDI-FIRST		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230217		OTC MONOGRAPH FINAL	part333B	Orazen Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71927-017_f4e4854a-ee02-df72-e053-2995a90aa8ea	71927-017	HUMAN OTC DRUG	MEDI-FIRST		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230217		OTC MONOGRAPH FINAL	part333B	Orazen Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71927-017_f4e4d0a4-b90d-99b0-e053-2995a90ab423	71927-017	HUMAN OTC DRUG	MEDI-FIRST		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230217		OTC MONOGRAPH FINAL	part333B	Orazen Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71927-018_f4e65624-f426-3552-e053-2995a90ae616	71927-018	HUMAN OTC DRUG	MEDI-FIRST		HYDROCORTISONE ACETATE	CREAM	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part348	Orazen Inc	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71927-018_f4e7135e-042f-9862-e053-2a95a90aec08	71927-018	HUMAN OTC DRUG	MEDI-FIRST		HYDROCORTISONE ACETATE	CREAM	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part348	Orazen Inc	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71927-018_f4e72b36-c687-3f02-e053-2a95a90a075e	71927-018	HUMAN OTC DRUG	MEDI-FIRST		HYDROCORTISONE ACETATE	CREAM	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part348	Orazen Inc	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
71927-019_f508434f-5949-7134-e053-2a95a90a03d7	71927-019	HUMAN OTC DRUG	MEDI-FIRST		Benzalkonium Chloride, Lidocaine	CREAM	TOPICAL	20230220		OTC MONOGRAPH NOT FINAL	part348	Orazen Inc	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71927-019_f5230137-32dd-0479-e053-2995a90a56f2	71927-019	HUMAN OTC DRUG	MEDI-FIRST		Benzalkonium Chloride, Lidocaine	CREAM	TOPICAL	20230220		OTC MONOGRAPH NOT FINAL	part348	Orazen Inc	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
71927-020_ecddaa3b-e190-1c74-e053-2995a90ad86a	71927-020	HUMAN OTC DRUG	Medicated Chest Rub		Camphor, Menthol, Eucalyptus Oil	CREAM	TOPICAL	20220214		OTC MONOGRAPH FINAL	part341	Orazen Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
71927-021_0814f4b9-3a5b-e425-e063-6394a90ad662	71927-021	HUMAN OTC DRUG	Lil Drug Store Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20231018		OTC MONOGRAPH DRUG	M004	ORAZEN INC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71927-022_0814bc6d-5515-8353-e063-6394a90a0e16	71927-022	HUMAN OTC DRUG	Circle K Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20231018		OTC MONOGRAPH DRUG	M004	ORAZEN INC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
71927-102_02d3b8d7-921c-daed-e063-6294a90a5db6	71927-102	HUMAN OTC DRUG	Orazen		SODIUM MONOFLUOROPHOSPHATE	PASTE	DENTAL	20230401		OTC MONOGRAPH NOT FINAL	part356	Orazen Inc	SODIUM MONOFLUOROPHOSPHATE	.1	g/100g			N	20241231
71930-008_1af50e25-cbd6-41d5-bcc2-ff23cc854d96	71930-008	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20200130		ANDA	ANDA211556	Eywa Pharma Inc	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71930-009_1af50e25-cbd6-41d5-bcc2-ff23cc854d96	71930-009	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20200130		ANDA	ANDA211556	Eywa Pharma Inc	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
71930-015_eb12dd32-f22b-4134-9146-98befe0fb7dc	71930-015	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20200205		ANDA	ANDA212452	Eywa Pharma Inc	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
71930-016_d4e8ed08-f426-4fdb-9dd3-d46730e9f81b	71930-016	HUMAN PRESCRIPTION DRUG	Quinidine gluconate		Quinidine gluonate	TABLET, EXTENDED RELEASE	ORAL	20220320		ANDA	ANDA212589	Eywa Pharma Inc	QUINIDINE GLUCONATE	324	mg/1	Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
71930-017_13d17c94-b480-4c55-b45a-0302e9d6a6cc	71930-017	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20180711		ANDA	ANDA077851	Eywa Pharma Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71930-018_13d17c94-b480-4c55-b45a-0302e9d6a6cc	71930-018	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET	ORAL	20180711		ANDA	ANDA077851	Eywa Pharma Inc.	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
71930-019_8617f887-26cb-48b5-ab9b-2b45f0fabc6e	71930-019	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Eywa Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71930-020_8617f887-26cb-48b5-ab9b-2b45f0fabc6e	71930-020	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Eywa Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71930-021_8617f887-26cb-48b5-ab9b-2b45f0fabc6e	71930-021	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Eywa Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71930-022_85f53ea3-a6ab-4ab9-961c-5bf126a873d8	71930-022	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20190301		ANDA	ANDA207511	Eywa Pharma Inc	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71930-023_22934938-f9bb-42a2-9141-ea936d77feb3	71930-023	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone hydrochloride	SOLUTION	ORAL	20180601		ANDA	ANDA209897	Eywa Pharma Inc	OXYCODONE HYDROCHLORIDE	20	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71930-024_2ec047c6-e9ea-4093-bb03-1b3f80fb2a13	71930-024	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20190329		ANDA	ANDA210139	Eywa Pharma Inc	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71930-025_2ec047c6-e9ea-4093-bb03-1b3f80fb2a13	71930-025	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20190329		ANDA	ANDA210139	Eywa Pharma Inc	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
71930-026_8a4b2d13-d1c9-416f-95fd-f7d7b7970bb5	71930-026	HUMAN PRESCRIPTION DRUG	Brompheniramine maleate, pseudoephedrine hydrochloride,		Brompheniramine maleate, pseudoephedrine hydrochloride,	SYRUP	ORAL	20200626		ANDA	ANDA211170	Eywa Pharma Inc	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
71930-027_5ab6fc05-d708-4f00-9336-33a541bf0c87	71930-027	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	SOLUTION	ORAL	20190408		ANDA	ANDA211023	Eywa Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/15mL; mg/15mL	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71930-035_5fdcf3db-a10a-4e6b-a476-31d04cee1464	71930-035	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA207863	Eywa Pharma Inc	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71930-036_5fdcf3db-a10a-4e6b-a476-31d04cee1464	71930-036	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA207863	Eywa Pharma Inc	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71930-037_5fdcf3db-a10a-4e6b-a476-31d04cee1464	71930-037	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20190524		ANDA	ANDA207863	Eywa Pharma Inc	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
71930-042_fc2380af-9a70-4e55-9c5f-18a3ddd5bfce	71930-042	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20190617		ANDA	ANDA207509	Eywa Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71930-043_fc2380af-9a70-4e55-9c5f-18a3ddd5bfce	71930-043	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20190617		ANDA	ANDA207509	Eywa Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71930-044_fc2380af-9a70-4e55-9c5f-18a3ddd5bfce	71930-044	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20190617		ANDA	ANDA207509	Eywa Pharma Inc	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
71930-045_ba4b1358-6435-425a-afd8-fd3c31c2a8af	71930-045	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Eywa Pharma Inc	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71930-046_ba4b1358-6435-425a-afd8-fd3c31c2a8af	71930-046	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Eywa Pharma Inc	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71930-047_ba4b1358-6435-425a-afd8-fd3c31c2a8af	71930-047	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		oxycodone and acetaminophen	TABLET	ORAL	20190601		ANDA	ANDA207510	Eywa Pharma Inc	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
71930-054_58628a31-d262-492a-b6c8-31725aa428ab	71930-054	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Eywa Pharma Inc	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 15	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71930-055_58628a31-d262-492a-b6c8-31725aa428ab	71930-055	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Eywa Pharma Inc	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71930-056_58628a31-d262-492a-b6c8-31725aa428ab	71930-056	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Eywa Pharma Inc	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
71930-072_fe788fd8-8083-4201-af83-010af795d108	71930-072	HUMAN PRESCRIPTION DRUG	Carbamazepine	ER	Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20211015		ANDA	ANDA212948	Eywa Pharma Inc	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71930-073_fe788fd8-8083-4201-af83-010af795d108	71930-073	HUMAN PRESCRIPTION DRUG	Carbamazepine	ER	Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20211015		ANDA	ANDA212948	Eywa Pharma Inc	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71930-074_fe788fd8-8083-4201-af83-010af795d108	71930-074	HUMAN PRESCRIPTION DRUG	Carbamazepine	ER	Carbamazepine	TABLET, EXTENDED RELEASE	ORAL	20211015		ANDA	ANDA212948	Eywa Pharma Inc	CARBAMAZEPINE	400	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
71953-0001_e793581d-f746-4253-b9be-59994c75f955	71953-0001	HUMAN OTC DRUG	Supreme		Abrotanum, Anacardium Orientale, Arsenicum Album, Baryta Muriatica, Helleborus Niger, Ignatia Amara, Lycopodium Clavatum, Nicotinamidum, Secale Cornutum, Thymus (Bovine), Thyroidinum (Bovine), Calcarea Carbonica, Calcarea Phosphorica, Hypothalamus Suis, Pituitarum Posterium (Bovine), Silicea	LIQUID	ORAL	20180517		UNAPPROVED HOMEOPATHIC		BOUARI GROUP, LLC dba WEIGHT LOSS COMPANY, THE	ANACARDIUM OCCIDENTALE FRUIT; ARSENIC TRIOXIDE; ARTEMISIA ABROTANUM FLOWERING TOP; BARIUM CHLORIDE DIHYDRATE; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS THYMUS; CLAVICEPS PURPUREA SCLEROTIUM; HELLEBORUS NIGER ROOT; LYCOPODIUM CLAVATUM SPORE; NIACINAMIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; STRYCHNOS IGNATII SEED; SUS SCROFA HYPOTHALAMUS; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6; 6; 8; 6; 6; 6; 6; 6; 8; 8; 6; 8; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
71954-729_d44c8873-88ab-30c5-e053-2995a90a5170	71954-729	HUMAN PRESCRIPTION DRUG	Healthy Start Weight and Appetite Support		Aceticum Acidum, Anacardium Orientale, Baryta Iodata, Calcarea Carbonica, Capsicum Annum, Fucus Vesiculosus, Graphites, Natrum Sulphuricum, Phytolacca Decandra, Stannum Metallicum, Thyrdoidinum, Zinum Metallicum	LIQUID	ORAL	20180501		UNAPPROVED HOMEOPATHIC		WELL BODY CONCEPTS LLC	ACETIC ACID; BARIUM IODIDE; CAPSICUM; FUCUS VESICULOSUS; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SEMECARPUS ANACARDIUM JUICE; SODIUM SULFATE; THYROID, UNSPECIFIED; TIN; ZINC	10; 12; 12; 5; 12; 12; 7; 12; 12; 12; 12; 12	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
71970-324_09dc1ca0-5299-a077-e063-6294a90a77b7	71970-324	HUMAN OTC DRUG	DERMA SANTE Anti Eczema Cream		OATMEAL	CREAM	TOPICAL	20220701		OTC MONOGRAPH DRUG	M016	Hope Science Inc.	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
71971-6001_d08bfe9c-f29e-4ffd-b779-26b9e8cfcea0	71971-6001	HUMAN OTC DRUG	Real Relief		Eriodictyon californicum, Histaminum, Ipecacuanha, Lobelia inflata, Sambucus nigra, Solidago virgaurea	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ERIODICTYON CALIFORNICUM LEAF; HISTAMINE DIHYDROCHLORIDE; IPECAC; LOBELIA INFLATA; SAMBUCUS NIGRA FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP	8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
71971-6002_0da99696-b23d-4565-be15-d92a3fe6d439	71971-6002	HUMAN OTC DRUG	Real Relief		Chamomila, Coffea Cruda, Eriodictyon californicum, Histaminum, Ipecacuanha, Lobelia inflata, Sambucus nigra, Solidago virgaurea	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARABICA COFFEE BEAN; ERIODICTYON CALIFORNICUM LEAF; HISTAMINE DIHYDROCHLORIDE; IPECAC; LOBELIA INFLATA; MATRICARIA CHAMOMILLA; SAMBUCUS NIGRA FLOWERING TOP; SOLIDAGO VIRGAUREA FLOWERING TOP	8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71971-6030_4064be78-c5a6-4b5f-9879-7092234c952f	71971-6030	HUMAN OTC DRUG	Real Relief		Allium cepa, Aralia racemosa, Arsenicum album, Cuprum metallicum, Euphrasia officinalis, Nux vomica, Sabadilla, Sticta pulmonaria	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARALIA RACEMOSA ROOT; ARSENIC TRIOXIDE; COPPER; EUPHRASIA STRICTA; LOBARIA PULMONARIA; ONION; SCHOENOCAULON OFFICINALE SEED; STRYCHNOS NUX-VOMICA SEED	8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
71971-6032_86edcbd4-9489-43ce-9a68-b00c9b2932e8	71971-6032	HUMAN OTC DRUG	Real Relief		Arnica montana, Bryonia, Causticum, Cinchona officinalis, Dulcamara, Hydrastis canadensis, Kali bromatum, Sulphur	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARNICA MONTANA; BRYONIA ALBA ROOT; CAUSTICUM; CINCHONA OFFICINALIS BARK; GOLDENSEAL; POTASSIUM BROMIDE; SOLANUM DULCAMARA TOP; SULFUR	8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
71971-6036_c5ccba80-a910-4b3f-b5c4-2e72cd685a10	71971-6036	HUMAN OTC DRUG	Real Relief		Apis Mellifica, Arnica Montana, Benzoicum Acidum, Causticum, Colchicum Autumnale, Natrum Carbonicum	TABLET	ORAL	20200101		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	APIS MELLIFERA; ARNICA MONTANA; BENZOIC ACID; CAUSTICUM; COLCHICUM AUTUMNALE BULB; SODIUM CARBONATE	8; 8; 8; 8; 8; 8	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Ammonium Ion Binding Activity [MoA], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
71971-6105_f31bc870-b06d-8ec1-e053-2a95a90a27df	71971-6105	HUMAN OTC DRUG	Kids Relief Cough and Cold Syrup Combo Pack Daytime Formula and Nighttime Formula		drosera rotundifolia flowering top, arnica montana, bryonia alba whole, ipecacuanha, cetraria islandica subsp. islandica, cochineal, corallium rubrum whole, stannum metallicum, chamomilla, coffea cruda	KIT		20220901		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc						N	20241231
71971-6155_f31bd21e-9d84-c225-e053-2a95a90a691c	71971-6155	HUMAN OTC DRUG	Real Relief Natural Wellness Cough and Cold Syrup Combo Pack Daytime Formula and Nighttime Formula		drosera rotundifolia flowering top, arnica montana, bryonia alba whole, ipecacuanha (ipecac), cetraria islandica subsp. islandica, cochineal (coccus cacti), corallium rubrum whole, stannum metallicum (tin), chamomilla (german chamomille), coffea cruda (coffee)	KIT		20220901		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc						N	20241231
71971-9021_bf3bb366-1d16-4aa8-b065-f66f22180b5b	71971-9021	HUMAN OTC DRUG	Kids Relief		Arsenicum Album, Kali Phosphoricum, Mercuris Solubilis, Natrum Sulphuricum, Hepar Sulphuris Calcareum, Arum Triphyllum	LIQUID	ORAL	20190801		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARISAEMA TRIPHYLLUM ROOT; ARSENIC TRIOXIDE; CALCIUM SULFIDE; DIBASIC POTASSIUM PHOSPHATE; MERCURIUS SOLUBILIS; SODIUM SULFATE	8; 8; 8; 8; 8; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
71971-9042_ec97a8da-436c-e7e0-e053-2a95a90a7b7f	71971-9042	HUMAN OTC DRUG	Real Relief Natural Wellness Calming Syrup		asafoetida, strychnos ignatii seed (ignatia amara), valeriana officinalis whole (valeriana officinalis), oat bran (avena sativa), silver nitrate (argentum nitricum), hyoscyamus niger, paeonia officinalis root (paeonia officinalis), datura stramonium, anamirta cocculus whole (cocculus indicus)	LIQUID	ORAL	20220901		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ANAMIRTA COCCULUS WHOLE; DATURA STRAMONIUM; FERULA ASSA-FOETIDA RESIN; HYOSCYAMUS NIGER; OAT BRAN; PAEONIA OFFICINALIS ROOT; SILVER NITRATE; STRYCHNOS IGNATII SEED; VALERIANA OFFICINALIS WHOLE	8; 8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
71971-9060_cb5c8a1b-fa0f-4f18-bc34-028c9d46401f	71971-9060	HUMAN OTC DRUG	Kids Relief	Teething Oral Liquid	chamomilla, arnica montana, borax, hypericum perforatum liquid	LIQUID	ORAL	20170303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARNICA MONTANA; HYPERICUM PERFORATUM; MATRICARIA RECUTITA; SODIUM BORATE	5; 5; 5; 5	[hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL			N	20241231
71971-9062_99a6d316-6fd0-40a6-8e19-8a80f41d767c	71971-9062	HUMAN OTC DRUG	Kids Relief		ANAS BARBARIAE HEPATIS ET CORDIS	LIQUID	ORAL	20170303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/25mL			N	20241231
71971-9066_27e95caf-7afc-437c-b7c0-05f6df793fbc	71971-9066	HUMAN OTC DRUG	Kids Relief		PULSATILLA, ALLIUM CEPA, ARSENICUM ALBUM, NUX VOMICA, EUPHRASIA OFFINALIS, SABADILLA, ARALIA RACEMOSA, CUPRUM METALLICUM	LIQUID	ORAL	20190726		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ANEMONE PULSATILLA; ARALIA RACEMOSA ROOT; ARSENIC TRIOXIDE; COPPER; EUPHRASIA STRICTA; ONION; SCHOENOCAULON OFFICINALE SEED; STRYCHNOS NUX-VOMICA SEED	8; 6; 8; 8; 6; 6; 6; 6	[hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
71971-9077_89e04889-f92f-41d0-9e45-a5eddb46453f	71971-9077	HUMAN OTC DRUG	Kids Relief		PULSATILLA, ALLIUM CEPA, ARSENICUM ALBUM, NUX VOMICA, EUPHRASIA OFFINALIS, SABADILLA, STICTA PULMONARIA, ARAILA RACEMOSA, CUPRUM METALLICUM	LIQUID	ORAL	20170303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ANEMONE PULSATILLA; ARALIA RACEMOSA ROOT; ARSENIC TRIOXIDE; COPPER; EUPHRASIA STRICTA; LOBARIA PULMONARIA; ONION; SCHOENOCAULON OFFICINALE SEED; STRYCHNOS NUX-VOMICA SEED	8; 6; 8; 8; 6; 6; 6; 6; 6	[hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
71971-9083_3c6169c7-d8f8-4cbe-adf3-efedd55bc0ee	71971-9083	HUMAN OTC DRUG	Kids Relief		COLOCYNTHIS, MAGNESIA PHOSPHORICA, CHAMOMILLA, DIOSCOREA VILLOSA	LIQUID	ORAL	20170303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	CITRULLUS COLOCYNTHIS FRUIT PULP; DIOSCOREA VILLOSA TUBER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA	6; 6; 6; 6	[hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
71971-9104_93a1a99e-bfd0-4818-92b9-b64f2c775f05	71971-9104	HUMAN OTC DRUG	Kids Relief		Asafoetida, Ignatia amara, Valeriana officinalis, Avena sativa, Argentum nitricum, Hyoscyamus niger, Paeonia officinalis, Stramonium, Cocculus indicus	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ANAMIRTA COCCULUS WHOLE; ASAFETIDA; DATURA STRAMONIUM; HYOSCYAMUS NIGER; OAT BRAN; PAEONIA OFFICINALIS ROOT; SILVER NITRATE; STRYCHNOS IGNATII SEED; VALERIANA OFFICINALIS WHOLE	8; 8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
71971-9121_a4663cc3-7fac-43e9-949b-4fe627aa2998	71971-9121	HUMAN OTC DRUG	Kids Relief		DROSERA, ARNICA MONTANA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; COCHINEAL; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; TIN	3; 3; 1; 3; 3; 1; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL			N	20241231
71971-9151_1cb513cf-ca7d-4501-845a-ae052103c866	71971-9151	HUMAN OTC DRUG	Kids Relief		DROSERA, ARNICA MONTANA, BRYONIA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CHAMOMILLA, COFFEE CRUDEA	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71971-9185_b63b9290-bf12-4f63-9521-33b901c4339d	71971-9185	HUMAN OTC DRUG	Real Relief		DROSERA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PROTORTONIA CACTI; TIN	3; 3; 1; 3; 1; 3; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL			N	20241231
71971-9204_fe047742-2f8f-476b-a842-3378be6b60fd	71971-9204	HUMAN OTC DRUG	Real Relief		DROSERA, ARNICA MONTANA, BRYONIA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CAMOMILLA, COFFEA CRUDEA	LIQUID	ORAL	20180303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71971-9214_8d5c1881-2344-4dab-a301-915416fd75ae	71971-9214	HUMAN OTC DRUG	Kids Relief		FERRUM PHOSPHORICUM, CAPSICUM ANNUUM, PYROGENIUM, ARSENICUM ALBUM	LIQUID	ORAL	20170303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARSENIC TRIOXIDE; CAPSICUM; FERRUM PHOSPHORICUM; RANCID BEEF	30; 30; 30; 30	[hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
71971-9216_6e89611d-2738-4c6b-b0d2-57f6e79885ab	71971-9216	HUMAN OTC DRUG	Kids Relief		ARNICA MONTANA, FERRUM PHOSPHORICUM, HYPERICUM PERFORATUM, THUJA OCCIDENTALIS, LEDUM PALUSTRE	LIQUID	ORAL	20170303		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARNICA MONTANA; FERRUM PHOSPHORICUM; HYPERICUM PERFORATUM; RHODODENDRON TOMENTOSUM LEAFY TWIG; THUJA OCCIDENTALIS LEAFY TWIG	8; 8; 8; 8; 8	[hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL; [hp_X]/25mL			N	20241231
71971-9899_01f2c5cc-e3bd-4550-8d86-c2fab316179c	71971-9899	HUMAN OTC DRUG	Real Relief		DROSERA, ARNICA MONTANA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CAMOMILLA, COFFEA CRUDEA	LIQUID	ORAL	20180503		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71971-9999_ee1654f2-9006-4794-af29-87f56472648d	71971-9999	HUMAN OTC DRUG	Kids Relief		DROSERA, ARNICA MONTANA, BRYONIA, IPECACUANHA, CETRARIA ISLANDICA, COCCUS CACTI, CORALLIUM RUBRUM, STANNUM METALLICUM, CAMOMILLA, COFFEA CRUDEA	LIQUID	ORAL	20180503		UNAPPROVED HOMEOPATHIC		Homeolab International (Canada) inc	ARABICA COFFEE BEAN; ARNICA MONTANA; BRYONIA ALBA WHOLE; CETRARIA ISLANDICA SUBSP. ISLANDICA; CHAMOMILE; CORALLIUM RUBRUM WHOLE; DROSERA ROTUNDIFOLIA FLOWERING TOP; IPECAC; PROTORTONIA CACTI; TIN	4; 3; 3; 1; 4; 3; 1; 3; 3; 3	[hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL; [hp_C]/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
71977-125_09dc19d0-24c9-bd12-e063-6294a90ab40f	71977-125	HUMAN OTC DRUG	BRAZILIAN MENTHOL Pain Relieving Roll On		MENTHOL	CREAM	TOPICAL	20171227		OTC MONOGRAPH DRUG	M017	DDR Product, LLC	MENTHOL	100	mg/mL			N	20241231
71977-126_09dc14d7-b6bc-1a86-e063-6394a90a0122	71977-126	HUMAN OTC DRUG	BRAZILIAN MENTHOL Pain Relieving		MENTHOL	CREAM	TOPICAL	20171227		OTC MONOGRAPH DRUG	M017	DDR Product, LLC	MENTHOL	100	mg/mL			N	20241231
71981-001_39e193f0-1484-49f9-b162-c64f0a8cb158	71981-001	HUMAN PRESCRIPTION DRUG	OXERVATE		cenegermin-bkbj	KIT		20181126		BLA	BLA761094	Domp farmaceutici S.p.A.						N	20241231
71981-020_39e193f0-1484-49f9-b162-c64f0a8cb158	71981-020	HUMAN PRESCRIPTION DRUG	OXERVATE		cenegermin-bkbj	SOLUTION/ DROPS	OPHTHALMIC	20181126		BLA	BLA761094	Domp farmaceutici S.p.A.	CENEGERMIN	20	ug/mL	Nerve Growth Factor [CS], Recombinant Human Nerve Growth Factor [EPC]		N	20241231
71987-000_efcf4345-6ecf-88f7-e053-2a95a90a3c1c	71987-000	HUMAN OTC DRUG	Complexion Protection		Titanium Dioxide	CREAM	TOPICAL	20180109	20241231	OTC MONOGRAPH NOT FINAL	part352	Hale Comeceuticals	TITANIUM DIOXIDE	75	mg/mL			N	
71987-001_efcf5a31-7511-d233-e053-2a95a90a9c52	71987-001	HUMAN OTC DRUG	Complexion Protection Moisturizing Sunscreen		Titanium Dioxide	CREAM	TOPICAL	20180109	20241231	OTC MONOGRAPH NOT FINAL	part352	Hale Comeceuticals	TITANIUM DIOXIDE	75	mg/mL			N	
71987-002_efcf6ed4-baaf-89e4-e053-2995a90a1ac3	71987-002	HUMAN OTC DRUG	Complexion Perfection BB		Titanium Dioxide	CREAM	TOPICAL	20180109	20241231	OTC MONOGRAPH NOT FINAL	part352	Hale Comeceuticals	TITANIUM DIOXIDE	50	mg/mL			N	
71987-007_efcf7ca9-a38f-323a-e053-2995a90a83fc	71987-007	HUMAN OTC DRUG	Hale Cosmeceuticals Complexion Perfection Sunscreen SPF 20		TITANIUM DIOXIDE	CREAM	TOPICAL	20201201	20241231	OTC MONOGRAPH NOT FINAL	part352	Hale Cosmeceuticals, Inc.	TITANIUM DIOXIDE	50	mg/mL			N	
71987-008_efcf8feb-77cf-389d-e053-2a95a90a7232	71987-008	HUMAN OTC DRUG	Hale Cosmeceuticals Complexion Protection Sunscreen SPF 35		TITANIUM DIOXIDE	CREAM	TOPICAL	20201201	20241231	OTC MONOGRAPH NOT FINAL	part352	Hale Cosmeceuticals, Inc.	TITANIUM DIOXIDE	75	mg/mL			N	
71987-009_ed231fc9-06df-261b-e053-2a95a90a063c	71987-009	HUMAN OTC DRUG	Surya Natural Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220301	20241231	OTC MONOGRAPH NOT FINAL	part352	Hale Cosmeceuticals	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
71990-001_0da81704-5063-b397-e063-6394a90a1afb	71990-001	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20120315		OTC MONOGRAPH DRUG	505G(a)(3)	Arcadia Beauty Labs LLC	WITCH HAZEL	86	g/100mL			N	20241231
71992-154_086318bd-5067-477e-e063-6294a90ab2dd	71992-154	HUMAN OTC DRUG	ALKA SELTZER PLUS Cold Day and Night Effervescent		ASPIRIN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE BITARTRATE	TABLET	ORAL	20180702		OTC MONOGRAPH DRUG	M012	Sincronia Logistica, S.A. de C.V.	ASPIRIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE BITARTRATE	325; 10; 7.8	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
71993-265_f54d4963-a0cc-1099-e053-2995a90a9230	71993-265	HUMAN PRESCRIPTION DRUG	Quazepam		Quazepam	TABLET	ORAL	20180320		NDA AUTHORIZED GENERIC	NDA018708	Atland Pharmaceuticals, LLC	QUAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
71993-304_0e7bbce6-3af0-962f-e063-6394a90a9482	71993-304	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate, Aspirin and Caffeine		Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20220318		ANDA	ANDA075141	Atland Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	385; 30; 25	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Muscle Relaxant [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20251231
71993-307_fe86c929-95df-1849-e053-6294a90a897d	71993-307	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate, Aspirin and Caffeine		Orphenadrine Citrate, Aspirin and Caffeine	TABLET	ORAL	20230301		ANDA	ANDA075141	Atland Pharmaceuticals, LLC	ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE	770; 60; 50	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Muscle Relaxant [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
71995-002_eea0af44-5a28-7d11-e053-2995a90a32c1	71995-002	HUMAN OTC DRUG	2xl Mega Roll sanitizing wipes 2300 count megaroll		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20140121		OTC MONOGRAPH NOT FINAL	part333E	2XL Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
71995-020_f1885673-34a1-8061-e053-2995a90af03b	71995-020	HUMAN OTC DRUG	2XL Mega Rolls Sanitizing Wipes		Benzalkonium chloride	SWAB	TOPICAL	20170316		OTC MONOGRAPH NOT FINAL	part333A	2xl Corporation	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
72000-030_772b4b36-4627-4087-8a16-c1ed771939c4	72000-030	HUMAN PRESCRIPTION DRUG	Citric Buffered Normal Saline		anhydrous citric acid	INJECTION, SOLUTION	INTRAVENOUS	20190909		NDA	NDA211673	Nabriva Therapeutics US, Inc.	ANHYDROUS CITRIC ACID	166	mg/270mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72000-110_772b4b36-4627-4087-8a16-c1ed771939c4	72000-110	HUMAN PRESCRIPTION DRUG	Xenleta		lefamulin acetate	TABLET, COATED	ORAL	20190909		NDA	NDA211672	Nabriva Therapeutics US, Inc.	LEFAMULIN ACETATE	600	mg/1			N	20241231
72000-120_772b4b36-4627-4087-8a16-c1ed771939c4	72000-120	HUMAN PRESCRIPTION DRUG	Xenleta		lefamulin acetate	INJECTION, SOLUTION	INTRAVENOUS	20190909		NDA	NDA211673	Nabriva Therapeutics US, Inc.	LEFAMULIN ACETATE	150	mg/15mL			N	20241231
72000-310_6b3f7c1e-f936-4651-9cfe-43f1634a00c9	72000-310	HUMAN PRESCRIPTION DRUG	SIVEXTRO		tedizolid phosphate	TABLET, FILM COATED	ORAL	20140620		NDA	NDA205435	Nabriva Therapeutics US, Inc.	TEDIZOLID PHOSPHATE	200	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]		N	20241231
72024-488_69fedabc-0840-448d-bc5e-7712f0d9ac59	72024-488	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride 0.13%	LIQUID	TOPICAL	20180527		OTC MONOGRAPH NOT FINAL	part333A	Fastenal	BENZALKONIUM CHLORIDE	1.313	mg/mL			N	20241231
72024-770_d2a28d92-b898-4a1e-818b-a4fa6a752322	72024-770	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20180103		OTC MONOGRAPH NOT FINAL	part333A	Fastenal	ALCOHOL	70	mL/100mL			N	20241231
72028-045_b4401c40-d27c-4a82-9c17-dac9c771a6ec	72028-045	HUMAN PRESCRIPTION DRUG	Wakix		PITOLISANT HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190814		NDA	NDA211150	Harmony Biosciences, LLC	PITOLISANT HYDROCHLORIDE	4.45	mg/1			N	20241231
72028-178_b4401c40-d27c-4a82-9c17-dac9c771a6ec	72028-178	HUMAN PRESCRIPTION DRUG	Wakix		PITOLISANT HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190814		NDA	NDA211150	Harmony Biosciences, LLC	PITOLISANT HYDROCHLORIDE	17.8	mg/1			N	20241231
72030-001_c397db61-3e12-40d6-8d94-60a756edb2ec	72030-001	HUMAN OTC DRUG	YINCHIAO		ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE	TABLET, COATED	ORAL	20180118		OTC MONOGRAPH FINAL	part341	ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	60; .667	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72030-002_992db9b6-e8a8-4efa-a19f-8a76cccda813	72030-002	HUMAN OTC DRUG	GANMAOLING		ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE	TABLET	ORAL	20181126		OTC MONOGRAPH FINAL	part341	ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	60; .667	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72033-100_0c68588e-1f46-bbd9-e063-6294a90ae976	72033-100	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Wild Watermelon		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-101_0c78d401-5e33-4dad-e063-6394a90ab5d1	72033-101	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Aloe You		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-102_0c792b3c-069f-3275-e063-6394a90aeb96	72033-102	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Berry Bliss		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-103_0c7949f5-76bc-dc7b-e063-6294a90ad180	72033-103	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Blue Sandalwood		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-104_0c7941ed-1704-efb3-e063-6294a90a73d1	72033-104	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Citrus Grove		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-105_0c796241-249b-f7be-e063-6294a90ae419	72033-105	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Frosted Mint		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-106_0c7940fa-0e57-90f3-e063-6394a90a344f	72033-106	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Lemon Lime Spritz		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-107_0c79613a-4ca2-9815-e063-6394a90a7460	72033-107	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Pure Lavender		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-108_0c79792b-5981-9c99-e063-6394a90ab883	72033-108	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Rainwater		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-109_0c797dbc-06f3-fce7-e063-6294a90a1995	72033-109	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Unscented		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-110_0c797dbc-0702-fce7-e063-6294a90a1995	72033-110	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Beach Coco		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-111_0c797863-65b2-17dc-e063-6294a90a493f	72033-111	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Velvet Peach		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-112_0c7979b5-3e9d-89f1-e063-6394a90a3e90	72033-112	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Applelicious		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-113_0c79903b-e2fb-a1d8-e063-6394a90af606	72033-113	HUMAN OTC DRUG	Touchland Glow Mist Hand Sanitizer Rosewater		Alcohol	SPRAY	TOPICAL	20220411		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-114_0c799ce2-040b-21fe-e063-6294a90ab3f9	72033-114	HUMAN OTC DRUG	Touchland Power Mist Hand Sanitizer Vanilla Blossom		Alcohol	SPRAY	TOPICAL	20220101		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-118_0da7f382-45e1-a658-e063-6394a90ac057	72033-118	HUMAN OTC DRUG	Touchland Power Mist Hydrating Hand Sanitizer		ALCOHOL	KIT		20231015		OTC MONOGRAPH DRUG	505G(a)(3)	TOUCHLAND LLC						N	20241231
72033-120_0c798050-d1b3-1ff8-e063-6294a90a416f	72033-120	HUMAN OTC DRUG	Touchland BlackPink Blue Sandalwood Power Mist		Alcohol	SPRAY	TOPICAL	20230608		OTC MONOGRAPH DRUG	505G(a)(3)	Touchland LLC	ALCOHOL	.7	mL/mL			N	20241231
72033-216_0d97ff82-3dc0-bf00-e063-6394a90a6045	72033-216	HUMAN OTC DRUG	Touchland Power Mist Hydrating Hand Sanitizer Mango Passion		ALCOHOL	SPRAY	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	TOUCHLAND LLC	ALCOHOL	70	mL/100mL			N	20241231
72033-217_0d97e205-68a0-c08e-e063-6294a90aa7b9	72033-217	HUMAN OTC DRUG	Touchland Gentle Mist Ultra Soothing Hand Lily of The Valley		ALCOHOL	SPRAY	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	TOUCHLAND LLC	ALCOHOL	70	mg/100mL			N	20241231
72033-406_d711ff0c-325a-18de-e053-2a95a90ad67c	72033-406	HUMAN OTC DRUG	HAND SANITIZER	70%	ETHYL ALCOHOL	SPRAY	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part333A	Touchland LLC	ALCOHOL	70	mL/100mL			N	20241231
72033-407_d1cbbc2d-eb4f-1ac7-e053-2a95a90a37b0	72033-407	HUMAN OTC DRUG	HAND SANITIZER	70%	ETHYL ALCOHOL	SPRAY	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part333A	TOUCHLAND LLC	ALCOHOL	70	mL/100mL			N	20241231
72033-408_0c79c89d-12ec-30ed-e063-6294a90ada5b	72033-408	HUMAN OTC DRUG	HAND SANITIZER		ETHYL ALCOHOL	SOLUTION	TOPICAL	20220509		OTC MONOGRAPH DRUG	505G(a)(3)	TOUCHLAND LLC	ALCOHOL	67	mL/100mL			N	20241231
72036-002_b11b3408-e720-43ba-a9a1-ded604118170	72036-002	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20190904		OTC MONOGRAPH NOT FINAL	part334	Harris Teeter	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72036-008_d9a48bc1-2dc2-4cff-9659-3add3495f6a1	72036-008	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	Harris Teeter	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
72036-009_646362b0-778f-4019-8f73-1974e7cceddb	72036-009	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Harris Teeter	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
72036-018_93df8585-cde2-5f1f-e053-2995a90ac049	72036-018	HUMAN OTC DRUG	ASPIRIN		ASPIRIN	TABLET, COATED	ORAL	20141001		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72036-019_94975a7b-682b-bb85-e053-2a95a90acac2	72036-019	HUMAN OTC DRUG	Somnitabs		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20111006		OTC MONOGRAPH FINAL	part338	HARRIS TEETER	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-020_94974a0e-1ca4-bcc0-e053-2a95a90aede7	72036-020	HUMAN OTC DRUG	Stay Awake		CAFFEINE	TABLET	ORAL	20111006		OTC MONOGRAPH FINAL	part340	Harris Teeter	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
72036-026_9c38ff5c-68d6-47e1-afc4-03c3fcd72a3d	72036-026	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20160426		ANDA	ANDA206531	Harris Teeter	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72036-034_089fe8ce-36ac-3132-e063-6294a90a85b2	72036-034	HUMAN OTC DRUG	menthol cough drops		Menthol	LOZENGE	ORAL	20171213		OTC MONOGRAPH DRUG	M012	Harris Teeter	MENTHOL	5.4	mg/1			N	20241231
72036-036_08a0077a-68c1-310c-e063-6394a90a8e27	72036-036	HUMAN OTC DRUG	honey lemon cough drops		Menthol	LOZENGE	ORAL	20171214		OTC MONOGRAPH DRUG	M012	Harris Teeter	MENTHOL	7.5	mg/1			N	20241231
72036-069_1e9e3464-60ec-4092-b8ed-c8f2b1376aa9	72036-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20090209		OTC MONOGRAPH FINAL	part347	Harris Teeter	PETROLATUM	1	g/g			N	20241231
72036-072_dcd6f45e-c581-470e-b1f2-57a7bed4f2fc	72036-072	HUMAN OTC DRUG	Antiseptic Mouth Rinse		EUCALYPTOL	MOUTHWASH	ORAL	20090815		OTC MONOGRAPH NOT FINAL	part348	HARRIS TEETER	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72036-080_94a960d7-fcb5-0fa4-e053-2a95a90a7537	72036-080	HUMAN OTC DRUG	Aspirin 81mg		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20111001		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72036-090_94977e3b-271a-7944-e053-2a95a90a8c68	72036-090	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20120806		OTC MONOGRAPH FINAL	part341	Harris Teeter	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-091_949794c3-bed6-c1db-e053-2995a90af13f	72036-091	HUMAN OTC DRUG	Rest Simply		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20111006		OTC MONOGRAPH FINAL	part338	Harris Teeter	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-092_93df472f-7923-60d9-e053-2a95a90a5faa	72036-092	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20111201		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ACETAMINOPHEN	500	mg/1			N	20241231
72036-095_93df472f-7937-60d9-e053-2a95a90a5faa	72036-095	HUMAN OTC DRUG	pain relief PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20111001		OTC MONOGRAPH FINAL	part341	HARRIS TEETER	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-098_93df2f8d-6221-3604-e053-2995a90ae48b	72036-098	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20130601		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ACETAMINOPHEN	500	mg/1			N	20241231
72036-100_93defe58-3f27-6736-e053-2995a90a5116	72036-100	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20130601		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ACETAMINOPHEN	325	mg/1			N	20241231
72036-104_93df353d-b622-daf4-e053-2995a90ac9d1	72036-104	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20111201		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ACETAMINOPHEN	500	mg/1			N	20241231
72036-109_9497dc3a-200f-4653-e053-2995a90a3670	72036-109	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20120723		ANDA	ANDA079174	Harris Teeter	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72036-110_9497dc3a-2025-4653-e053-2995a90a3670	72036-110	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20120723		ANDA	ANDA079174	Harris Teeter	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72036-113_949851b2-e663-d51c-e053-2995a90ae1e9	72036-113	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20120806		OTC MONOGRAPH FINAL	part341	Harris Teeter	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-119_d0710896-eea6-3b81-e053-2a95a90ac0c6	72036-119	HUMAN OTC DRUG	Sinus Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160816		OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-131_94988a6a-101b-6f98-e053-2a95a90a5545	72036-131	HUMAN OTC DRUG	Congestion PE		PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20130611		OTC MONOGRAPH FINAL	part341	Harris Teeter	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-138_ee298d18-1db5-f7be-e053-2a95a90afcc0	72036-138	HUMAN OTC DRUG	Cold Max		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160816		OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-144_94989d62-3868-200e-e053-2a95a90a3e44	72036-144	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20111201		ANDA	ANDA079096	Harris Teeter	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72036-145_94988a6a-1091-6f98-e053-2a95a90a5545	72036-145	HUMAN OTC DRUG	Naproxen Sodium		NAPROXEN SODIUM	TABLET, COATED	ORAL	20111201		ANDA	ANDA079096	Harris Teeter	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72036-146_9498c762-ffe4-cc0d-e053-2995a90abf90	72036-146	HUMAN OTC DRUG	Aspirin		ASPIRIN	TABLET, DELAYED RELEASE	ORAL	20111006		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72036-153_799cbcf8-9fbe-4ad5-be23-18342665893f	72036-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH DRUG	M032	Harris Teeter	PYRITHIONE ZINC	10	mg/mL			N	20241231
72036-155_d0710896-eebc-3b81-e053-2a95a90ac0c6	72036-155	HUMAN OTC DRUG	Cold Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160816		OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-167_bccb6000-f238-68d6-e053-2995a90a6b69	72036-167	HUMAN OTC DRUG	Mucus Relief Sinus Severe Congestion and Pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210204		OTC MONOGRAPH FINAL	part341	HARRIS TEETER	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-170_f30a0103-2213-7b36-e053-2995a90ac6bf	72036-170	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20140606		OTC MONOGRAPH NOT FINAL	part343	Harris Teeter	ACETAMINOPHEN	500	mg/1			N	20241231
72036-171_ee9d5c6b-5957-19f4-e053-2a95a90ad69e	72036-171	HUMAN OTC DRUG	Acetaminophen PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20140606		OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-174_e8b862f1-1c8e-c98b-e053-2995a90ac4d1	72036-174	HUMAN OTC DRUG	Pressure Pain Cold		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20160816	20240930	OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
72036-175_d0710896-eed3-3b81-e053-2a95a90ac0c6	72036-175	HUMAN OTC DRUG	Cold Head Congestion Severe		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20170411		OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-181_95111d97-4e16-6beb-e053-2995a90a5ae7	72036-181	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20141028		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72036-185_949851b2-e64d-d51c-e053-2995a90ae1e9	72036-185	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20170724		ANDA	ANDA079205	Harris Teeter	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72036-186_d0710896-eeea-3b81-e053-2a95a90ac0c6	72036-186	HUMAN OTC DRUG	Cold Flu Severe Day Night		Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	KIT		20190923		OTC MONOGRAPH FINAL	part341	Harris Teeter						N	20241231
72036-191_ee298d18-1da3-f7be-e053-2a95a90afcc0	72036-191	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20220805		ANDA	ANDA211075	HARRIS TEETER	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-193_c11dbffc-c6b2-a259-e053-2a95a90a9f31	72036-193	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20210125		ANDA	ANDA210722	HARRIS TEETER	LORATADINE	10	mg/1			N	20241231
72036-194_08f15d4b-b676-acec-e063-6394a90aa778	72036-194	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20210125		ANDA	ANDA209274	HARRIS TEETER	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-199_ee298717-eb66-ca61-e053-2995a90a13bf	72036-199	HUMAN OTC DRUG	Mucus Relief Sinus Pressure Pain and Cough		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220805		OTC MONOGRAPH FINAL	part341	HARRIS TEETER	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-200_c11dbffc-c6c4-a259-e053-2a95a90a9f31	72036-200	HUMAN OTC DRUG	8HR Arthritis Pain		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20210428		ANDA	ANDA211544	HARRIS TEETER	ACETAMINOPHEN	650	mg/1			N	20241231
72036-205_cb692b83-6fdf-5924-e053-2a95a90a41a1	72036-205	HUMAN OTC DRUG	Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20210906		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72036-211_d07104c9-e97c-69f7-e053-2a95a90a0723	72036-211	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20191213		ANDA	ANDA202312	Harris Teeter	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72036-212_d0710ce3-bf81-b983-e053-2995a90a7107	72036-212	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20191213		ANDA	ANDA202312	Harris Teeter	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72036-213_e20d995d-8bc4-405d-b0ab-d3fd29d6d1cb	72036-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20090514		OTC MONOGRAPH FINAL	part355	HARRIS TEETER, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72036-252_cb69a48a-8074-0697-e053-2995a90a9e60	72036-252	HUMAN OTC DRUG	Adult Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20210906		OTC MONOGRAPH NOT FINAL	part343	HARRIS TEETER	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72036-274_ee298d18-1d8c-f7be-e053-2a95a90afcc0	72036-274	HUMAN OTC DRUG	Head Congestion plus Flu Severe PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20220708		OTC MONOGRAPH FINAL	part341	HARRIS TEETER	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-292_dcf43332-b5b8-1f7b-e053-2995a90a658f	72036-292	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20210906		ANDA	ANDA211075	HARRIS TEETER	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-297_efb77a77-ec54-458e-e053-2995a90acb05	72036-297	HUMAN OTC DRUG	Mucus Relief Cold Flu and Sore Throat		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210129		OTC MONOGRAPH FINAL	part341	HARRIS TEETER	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-298_efb77a52-7f03-2039-e053-2995a90a757c	72036-298	HUMAN OTC DRUG	Mucus Relief Cold and Flu All in One		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20210201		OTC MONOGRAPH FINAL	part341	HARRIS TEETER	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-305_092d4d23-379b-2281-e063-6294a90aa7e9	72036-305	HUMAN OTC DRUG	Migraine Relief		ACETAMINOPHEN, ASPIRIN and CAFFEINE	TABLET	ORAL	20230830		ANDA	ANDA214039	HARRIS TEETER	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
72036-320_d0710ce3-bf98-b983-e053-2995a90a7107	72036-320	HUMAN OTC DRUG	Sinus Pressure plus Pain PE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200619		OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-323_d0710896-ef13-3b81-e053-2a95a90ac0c6	72036-323	HUMAN OTC DRUG	Sinus plus Headache		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200619		OTC MONOGRAPH FINAL	part341	Harris Teeter	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72036-370_c0f92aa6-69c7-4ba6-acfd-5f2a37171e9f	72036-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20140717		OTC MONOGRAPH NOT FINAL	part333A	Harris Teeter, LLC	ALCOHOL	70	mL/100mL			N	20241231
72036-439_2b2e8f62-d6cc-49b1-847c-55dbb1882606	72036-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20140718		OTC MONOGRAPH NOT FINAL	part333A	Harris Teeter	ALCOHOL	70	mL/100mL			N	20241231
72036-521_b6db8cd6-ea7c-4958-bd6f-b43ce9a818bc	72036-521	HUMAN OTC DRUG	Harris Teeter Allergy Relief		diphenhydramine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220119		OTC MONOGRAPH FINAL	part341	Harris Teeter	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72036-576_5146241b-4d3f-4d21-a019-cc13588ecb17	72036-576	HUMAN OTC DRUG	Oral Antivavity		Sodium fluoride	MOUTHWASH	ORAL	20150108		OTC MONOGRAPH FINAL	part355	HARRIS TEETER, LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
72036-664_ec2ee761-6fde-489f-8d57-bbb016defe91	72036-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19921001		OTC MONOGRAPH NOT FINAL	part356	HARRIS TEETER	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72036-714_334a66f5-9701-43fd-8d03-68d019632a23	72036-714	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211202		OTC MONOGRAPH FINAL	part352	HARRIS TEETER, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.3; 101; 50.5; 101	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72036-727_5be37094-5764-4aa9-aef8-e3623b6917e4	72036-727	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20171121		OTC MONOGRAPH FINAL	part352	HARRIS TEETER, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	30; 150; 50; 60	mg/g; mg/g; mg/g; mg/g			N	20241231
72036-730_882fcafa-d6ea-4bc9-ad57-5e980d9c5c3a	72036-730	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20171129		OTC MONOGRAPH FINAL	part352	HARRIS TEETER, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 150; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
72036-764_69ceea69-bdb2-47be-8c5f-73f17266664c	72036-764	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	HARRIS TEETER, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 117; 45; 45; 54	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72036-801_89774566-baf6-4de4-8197-bf5a661fdccd	72036-801	HUMAN OTC DRUG	Harris Teeter Spring Fresh Body Wash		Benzalkonium Chloride	LIQUID	TOPICAL	20180725		OTC MONOGRAPH NOT FINAL	part333E	Harris Teeter	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
72036-804_e0bb511f-97c8-453f-ae1e-5960d5d06ec4	72036-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20231213		OTC MONOGRAPH DRUG	M003	HARRIS TEETER	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
72036-810_0c7f2c81-d224-8f23-e063-6394a90a93d7	72036-810	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20231214		OTC MONOGRAPH DRUG	M003	HARRIS TEETER	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
72036-871_6eac4048-826f-4ce5-ab38-68a7da2f94b2	72036-871	HUMAN OTC DRUG	Hydrogen Peroxide		Hydrogen Peroxide	SOLUTION	TOPICAL	20231213		OTC MONOGRAPH DRUG	M003	HARRIS TEETER	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
72036-907_eff82df2-8e52-6af8-e053-2995a90aa30e	72036-907	HUMAN OTC DRUG	Pain Relief Patches		CAMPHOR, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Harris Teeter	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
72036-911_eff83055-16a3-7531-e053-2995a90a52b8	72036-911	HUMAN OTC DRUG	PAIN RELIEF PATCHES		LIDOCAINE	PATCH	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Harris Teeter	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72036-914_70140282-0521-4fd6-828c-51a66bbd4474	72036-914	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	HARRIS TEETER	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72036-920_a35b48c2-8491-457d-adac-a8a9acf0a935	72036-920	HUMAN OTC DRUG	sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	HARRIS TEETER	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 120; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72036-926_9b2a10fc-7b2f-4849-b41f-86256b236558	72036-926	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210521		OTC MONOGRAPH FINAL	part352	HARRIS TEETER	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	mg/g; mg/g; mg/g; mg/g			N	20241231
72036-929_ef1520a1-a99e-4474-ac9f-2ca11da4d559	72036-929	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20200718		OTC MONOGRAPH FINAL	part352	Harris Teeter	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
72036-938_c27faae8-414e-4425-b92d-5ed42a69c3aa	72036-938	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20200718		OTC MONOGRAPH FINAL	part352	Harris Teeter	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
72036-939_93d062b4-7325-4fc9-97a8-0ea359a0cfc4	72036-939	HUMAN OTC DRUG	Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231121		OTC MONOGRAPH DRUG	M020	HARRIS TEETER	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
72036-940_7c331131-4195-4647-ac35-dc5e9b47327e	72036-940	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231121		OTC MONOGRAPH DRUG	M020	HARRIS TEETER	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
72036-941_69e45ab6-7a8b-4166-8a5d-54871a4b46e5	72036-941	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230905		OTC MONOGRAPH FINAL	part352	HARRIS TEETER	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
72036-952_ef574886-f8df-f69e-e053-2a95a90ac443	72036-952	HUMAN OTC DRUG	Hot and Cold Medicated Patch		MENTHOL	PATCH	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Harris Teeter	MENTHOL	5	g/100g			N	20241231
72036-980_62d9a672-5103-4e25-826e-bf3ce36da4d6	72036-980	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin and Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20170317		ANDA	ANDA206941	Harris Teeter	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72036-981_ca9797c6-5708-4d45-bd1a-c670077e1a0b	72036-981	HUMAN OTC DRUG	Omeprazole		OMEPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20200916		ANDA	ANDA207891	HARRIS TEETER	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72036-982_97ef0c76-1b40-4263-9ec0-eba9a9f3d454	72036-982	HUMAN OTC DRUG	Esomeprazole		Esomeprazole Magnesium	TABLET	ORAL	20210303		ANDA	ANDA212866	HARRIS TEETER	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72037-135_097485a4-b5ac-a87a-e063-6394a90a8e52	72037-135	HUMAN OTC DRUG	AcuPlus Pain Relief		MENTHOL	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M017	Innovations for Wellness, LLC	MENTHOL	35	mg/mL			N	20241231
72037-136_0974c990-eb0f-73ff-e063-6294a90af414	72037-136	HUMAN OTC DRUG	AcuPlus Advanced Therapy for Pain and Recovery		MENTHOL	SOLUTION	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	INNOVATIONS FOR WELLNESS, LLC	MENTHOL	35	mg/mL			N	20241231
72043-0495_ec9934f6-f6c9-011e-e053-2995a90af7c6	72043-0495	HUMAN OTC DRUG	Elta MD Skincare UV Stick Broad Spectrum	SPF50	Zinc Oxide	STICK	TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part352	CP Skin Health Group, Inc	ZINC OXIDE	22	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2256_4a5f8f4a-27b8-47d6-8d7c-3e6a67094bab	72043-2256	HUMAN OTC DRUG	EltaMD UV Luminous		titanium dioxide, zinc oxide sunscreen	LOTION	TOPICAL	20201209		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc	TITANIUM DIOXIDE; ZINC OXIDE	72; 90	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2269_634cafd9-4141-47db-a841-2aa6b4212e48	72043-2269	HUMAN OTC DRUG	EltaMD UV Daily Tinted SPF40		zinc oxide and octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; ZINC OXIDE	75; 90	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2277_2ca96e6f-3b91-405f-995f-469ef825be85	72043-2277	HUMAN OTC DRUG	EltaMD Laser Balm		petrolatum skin protectant	OINTMENT	TOPICAL	20180110		OTC MONOGRAPH DRUG	M016	CP Skin Health Group, Inc	PETROLATUM	600	g/1000g			N	20241231
72043-2282_f02d3f5a-a4cf-48fc-a5b6-8b6d0bd307f7	72043-2282	HUMAN OTC DRUG	EltaMD UV Shield SPF45		zinc oxide and octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; ZINC OXIDE	75; 90	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2283_e2128d85-4b31-4aa8-b9cc-8f15d61f6b34	72043-2283	HUMAN OTC DRUG	EltaMD UV Facial SPF30 Plus		zinc oxide and octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; ZINC OXIDE	75; 70	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2286_5c68c391-3efe-435b-858e-4e581035211b	72043-2286	HUMAN OTC DRUG	EltaMD UV SPF 30 Plus		zinc oxide and octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; ZINC OXIDE	75; 70	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2287_701de5bb-7054-40c9-82d5-ab98d84ff03a	72043-2287	HUMAN OTC DRUG	EltaMD UV Sport SPF50		zinc oxide, octinoxate and octisalate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 90	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2289_8611073b-3ec7-41b3-8f00-53df19c0d881	72043-2289	HUMAN OTC DRUG	EltaMD UV Daily SPF40		zinc oxide and octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; ZINC OXIDE	75; 90	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2500_b9a47572-3530-4051-8644-5656accda6d3	72043-2500	HUMAN OTC DRUG	EltaMD UV Clear SPF46		Zinc oxide and Octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; ZINC OXIDE	75; 90	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2510_2f6446c3-33b0-4122-ad65-d9d9b5d36de7	72043-2510	HUMAN OTC DRUG	EltaMD UV Lip Balm SPF31		zinc oxide and octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health, Inc	OCTINOXATE; ZINC OXIDE	75; 50	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2512_55842f08-6909-40a6-95c5-7848a2bd178c	72043-2512	HUMAN OTC DRUG	EltaMD UV Elements SPF44		zinc oxide and titanium dioxide sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc	TITANIUM DIOXIDE; ZINC OXIDE	55; 100	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2519_38625f9d-801a-4728-95fa-975ed85dd164	72043-2519	HUMAN OTC DRUG	EltaMD Skincare UV AOX Elements SPF50 Tinted		titanium dioxide, zinc oxide sunscreen	LOTION	TOPICAL	20231114		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc	TITANIUM DIOXIDE; ZINC OXIDE	44; 135	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2520_e196f0db-f021-438a-b0d0-e33b1997546b	72043-2520	HUMAN OTC DRUG	EltaMD UV Clear Tinted SPF46		zinc oxide and octinoxate sunscreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTINOXATE; ZINC OXIDE	75; 90	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2563_8a66097c-9f42-4c0c-abc4-dc22b27624b6	72043-2563	HUMAN OTC DRUG	EltaMD UV Sheer		zinc oxide and octocrylene sunscreen	CREAM	TOPICAL	20201030		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	OCTOCRYLENE; ZINC OXIDE	100; 150	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2578_6e5791ac-2a4b-458c-bd5e-e34dc048c801	72043-2578	HUMAN OTC DRUG	EltaMD UV Physical SPF41		zinc oxide and titanium dioxide sunscrreen	LOTION	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	70; 90	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2582_5c7f807e-6162-4489-9a6b-d4ce6429fc0f	72043-2582	HUMAN OTC DRUG	EltaMD UV Pure SPF47		zinc oxide and titanium dioxide sunscreen	CREAM	TOPICAL	20180110		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	55; 100	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2600_3c3c0d5a-342d-4a67-bed9-40dcd39f3869	72043-2600	HUMAN OTC DRUG	EltaMD UV Active		zinc oxide, titanium dioxide sunscreen	CREAM	TOPICAL	20200203		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	40; 190	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2630_0b47e422-6079-4d8a-b504-2ab11dd2f73b	72043-2630	HUMAN OTC DRUG	EltaMD UV Restore		titanium dioxide, zinc oxide sunscreen	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc	TITANIUM DIOXIDE; ZINC OXIDE	20; 150	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2640_f65880d5-2ea9-4743-8c0b-e439998d3e99	72043-2640	HUMAN OTC DRUG	EltaMD UV Restore Tinted		titanium dioxide and zinc oxide sunscreen	LOTION	TOPICAL	20200915		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	20; 150	g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-2671_11e2901b-dcb2-4c9b-8b18-2affe55ca370	72043-2671	HUMAN OTC DRUG	EltaMD UV AOX Mist		Zinc oxide sunscreen	SPRAY	TOPICAL	20230331		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc	ZINC OXIDE	14	g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72043-4341_0c7bc973-252a-8337-e063-6394a90ac325	72043-4341	HUMAN OTC DRUG	Elta MD		Zinc Oxide	SPRAY	TOPICAL	20231214		OTC MONOGRAPH DRUG	M020	CP Skin Health Group, Inc.	ZINC OXIDE	14	g/100g			N	20241231
72053-000_0b6dc9f9-4461-e765-e063-6394a90ac6c8	72053-000	HUMAN OTC DRUG	Tetracycline 3 percent a First Aid Antibiotic		TETRACYCLINE HYDROCHLORIDE	OINTMENT	TOPICAL	20180401		OTC MONOGRAPH DRUG	M004	Patient Focused Tele-Health, LLC	TETRACYCLINE HYDROCHLORIDE	30	mg/g	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
72053-002_0b6de7f3-1004-b75b-e063-6294a90af1f5	72053-002	HUMAN OTC DRUG	APT T3X Tetracycline Hydrochloride First Aid Antibiotic		TETRACYCLINE HYDROCHLORIDE	OINTMENT	TOPICAL	20200901		OTC MONOGRAPH DRUG	M004	Patient Focused Tele-Health, LLC	TETRACYCLINE HYDROCHLORIDE	30	mg/g	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
72060-110_88c2147f-7048-46cf-b24d-26af24eaad98	72060-110	HUMAN PRESCRIPTION DRUG	CAPLYTA		lumateperone	CAPSULE	ORAL	20220809		NDA	NDA209500	Intra-Cellular Therapies, Inc	LUMATEPERONE	10.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72060-121_88c2147f-7048-46cf-b24d-26af24eaad98	72060-121	HUMAN PRESCRIPTION DRUG	CAPLYTA		lumateperone	CAPSULE	ORAL	20220809		NDA	NDA209500	Intra-Cellular Therapies, Inc	LUMATEPERONE	21	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72060-142_88c2147f-7048-46cf-b24d-26af24eaad98	72060-142	HUMAN PRESCRIPTION DRUG	CAPLYTA		lumateperone	CAPSULE	ORAL	20200201		NDA	NDA209500	Intra-Cellular Therapies, Inc	LUMATEPERONE	42	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72064-110_aefcc620-a610-413b-92aa-74009a5ac68b	72064-110	HUMAN PRESCRIPTION DRUG	Ayvakit		avapritinib	TABLET, FILM COATED	ORAL	20200109		NDA	NDA212608	Blueprint Medicines Corporation	AVAPRITINIB	100	mg/1	Bile Salt Export Pump Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]		N	20241231
72064-120_aefcc620-a610-413b-92aa-74009a5ac68b	72064-120	HUMAN PRESCRIPTION DRUG	Ayvakit		avapritinib	TABLET, FILM COATED	ORAL	20200109		NDA	NDA212608	Blueprint Medicines Corporation	AVAPRITINIB	200	mg/1	Bile Salt Export Pump Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]		N	20241231
72064-125_aefcc620-a610-413b-92aa-74009a5ac68b	72064-125	HUMAN PRESCRIPTION DRUG	Ayvakit		avapritinib	TABLET, FILM COATED	ORAL	20200109		NDA	NDA212608	Blueprint Medicines Corporation	AVAPRITINIB	25	mg/1	Bile Salt Export Pump Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]		N	20241231
72064-130_aefcc620-a610-413b-92aa-74009a5ac68b	72064-130	HUMAN PRESCRIPTION DRUG	Ayvakit		avapritinib	TABLET, FILM COATED	ORAL	20200109		NDA	NDA212608	Blueprint Medicines Corporation	AVAPRITINIB	300	mg/1	Bile Salt Export Pump Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]		N	20241231
72064-150_aefcc620-a610-413b-92aa-74009a5ac68b	72064-150	HUMAN PRESCRIPTION DRUG	Ayvakit		avapritinib	TABLET, FILM COATED	ORAL	20200109		NDA	NDA212608	Blueprint Medicines Corporation	AVAPRITINIB	50	mg/1	Bile Salt Export Pump Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Tyrosine Kinase Inhibitors [MoA]		N	20241231
72065-001_2ef26931-0c6d-420b-aa2d-eacea77aa9d4	72065-001	HUMAN PRESCRIPTION DRUG	Keveyis		Dichlorphenamide	TABLET	ORAL	20211213		NDA	NDA011366	Xeris Pharmaceuticals, Inc.	DICHLORPHENAMIDE	50	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72065-002_88984313-c5df-4328-b79a-0b2644a913ad	72065-002	HUMAN PRESCRIPTION DRUG	Dichlorphenamide		Dichlorphenamide	TABLET	ORAL	20230310		NDA AUTHORIZED GENERIC	NDA011366	Xeris Pharmaceuticals, Inc.	DICHLORPHENAMIDE	50	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72065-003_b35f3799-2981-4cd2-b021-65dc50b4d0a9	72065-003	HUMAN PRESCRIPTION DRUG	Recorlev		Levoketoconazole	TABLET	ORAL	20211230		NDA	NDA214133	Xeris Pharmaceuticals, Inc.	LEVOKETOCONAZOLE	150	mg/1	Cortisol Synthesis Inhibitor [EPC], Cytochrome P450 11A1 Inhibitors [MoA], Cytochrome P450 11B1 Inhibitors [MoA], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72065-120_263b455f-1592-4246-be80-161dd6cc3ebc	72065-120	HUMAN PRESCRIPTION DRUG	Gvoke HypoPen	0.5 mg Auto-Injector	glucagon injection, solution	INJECTION, SOLUTION	SUBCUTANEOUS	20190910		NDA	NDA212097	Xeris Pharmaceuticals, Inc.	GLUCAGON	.5	mg/.1mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20251231
72065-121_263b455f-1592-4246-be80-161dd6cc3ebc	72065-121	HUMAN PRESCRIPTION DRUG	Gvoke HypoPen	1 mg Auto-Injector	glucagon injection, solution	INJECTION, SOLUTION	SUBCUTANEOUS	20190910		NDA	NDA212097	Xeris Pharmaceuticals, Inc.	GLUCAGON	1	mg/.2mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20251231
72065-131_263b455f-1592-4246-be80-161dd6cc3ebc	72065-131	HUMAN PRESCRIPTION DRUG	Gvoke PFS	1 mg Pre-filled Syringe	glucagon injection, solution	INJECTION, SOLUTION	SUBCUTANEOUS	20190910		NDA	NDA212097	Xeris Pharmaceuticals, Inc.	GLUCAGON	1	mg/.2mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20251231
72065-140_263b455f-1592-4246-be80-161dd6cc3ebc	72065-140	HUMAN PRESCRIPTION DRUG	Gvoke Kit		glucagon injection, solution	INJECTION, SOLUTION	SUBCUTANEOUS	20211011		NDA	NDA212097	Xeris Pharmaceuticals, Inc.	GLUCAGON	1	mg/.2mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20251231
72065-141_263b455f-1592-4246-be80-161dd6cc3ebc	72065-141	HUMAN PRESCRIPTION DRUG	Gvoke Kit	Vial	glucagon injection, solution	INJECTION, SOLUTION	SUBCUTANEOUS	20211011		NDA	NDA212097	Xeris Pharmaceuticals, Inc.	GLUCAGON	1	mg/.2mL	Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]		N	20251231
72078-002_f55bd465-c5b2-4542-8765-00480fd6043d	72078-002	HUMAN PRESCRIPTION DRUG	Norepinephrine bitartrate		Norepinephrine bitartrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20201204		ANDA	ANDA211242	Mylan Institutional LLC	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
72078-025_7af20acf-ba9f-4387-9729-85d3c137f41e	72078-025	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20210401		ANDA	ANDA203258	Mylan Institutional LLC	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
72078-026_7af20acf-ba9f-4387-9729-85d3c137f41e	72078-026	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20201120		ANDA	ANDA203258	Mylan Institutional LLC	EPTIFIBATIDE	.75	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
72078-027_7af20acf-ba9f-4387-9729-85d3c137f41e	72078-027	HUMAN PRESCRIPTION DRUG	Eptifibatide		eptifibatide	INJECTION, SOLUTION	INTRAVENOUS	20210401		ANDA	ANDA203258	Mylan Institutional LLC	EPTIFIBATIDE	2	mg/mL	Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]		N	20241231
72078-033_c1c149fe-9095-4b2a-a21f-7af3212e0254	72078-033	HUMAN PRESCRIPTION DRUG	adenosine		adenosine	INJECTION	INTRAVENOUS	20220406		ANDA	ANDA078686	Mylan Institutional LLC	ADENOSINE	3	mg/mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
72078-034_a7f48ee2-9d40-4858-8d80-512acba3fe0a	72078-034	HUMAN PRESCRIPTION DRUG	Ultiva		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230621		NDA	NDA020630	Mylan Institutional LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72078-035_a7f48ee2-9d40-4858-8d80-512acba3fe0a	72078-035	HUMAN PRESCRIPTION DRUG	Ultiva		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230918		NDA	NDA020630	Mylan Institutional LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72078-036_a7f48ee2-9d40-4858-8d80-512acba3fe0a	72078-036	HUMAN PRESCRIPTION DRUG	Ultiva		Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230621		NDA	NDA020630	Mylan Institutional LLC	REMIFENTANIL HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72078-038_fddf56ea-530f-41aa-a913-f2557527fb12	72078-038	HUMAN PRESCRIPTION DRUG	Miacalcin		calcitonin salmon	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220616		NDA	NDA017808	Mylan Institutional LLC	CALCITONIN SALMON	200	[USP'U]/mL	Calcitonin [CS], Calcitonin [EPC]		N	20241231
72078-039_abb73bfc-a3a0-4c75-8920-da09e0b006d3	72078-039	HUMAN PRESCRIPTION DRUG	Miacalcin		calcitonin salmon	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220718		NDA	NDA017808	Mylan Institutional LLC	CALCITONIN SALMON	200	[USP'U]/mL	Calcitonin [CS], Calcitonin [EPC]		N	20241231
72078-040_8f647874-d9fc-4d8f-98e4-3bf4693e3766	72078-040	HUMAN PRESCRIPTION DRUG	Docetaxel		DOCETAXEL ANHYDROUS	INJECTION, SOLUTION	INTRAVENOUS	20220803		ANDA	ANDA210848	Mylan Institutional LLC	DOCETAXEL ANHYDROUS	10	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
72078-046_b1ba4016-d9a2-423b-814e-9f8a1209efaf	72078-046	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		amiodarone hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230609		ANDA	ANDA076217	Mylan Institutional LLC	AMIODARONE HYDROCHLORIDE	50	mg/mL	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72085-145_0a3b743f-7239-8cf5-e063-6294a90aecb2	72085-145	HUMAN OTC DRUG	Totally Fun After Sun		Lidocaine HCL	GEL	TOPICAL	20180301		OTC MONOGRAPH DRUG	M017	MJ Products Association, LLC	LIDOCAINE HYDROCHLORIDE	15	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72085-146_0a3b74cc-622a-6dbd-e063-6294a90aab55	72085-146	HUMAN OTC DRUG	Beach Gypsy SPF-30		Octinoxate, Octocrylene, Octisalate, Avobenzone	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 75; 40; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
72085-147_0a3e30fc-6f91-b9d7-e063-6294a90a8f99	72085-147	HUMAN OTC DRUG	Sea Star Sparkle SPF-50 MANGO-TANGO		Octinoxate, Octisalate, Octocrylene, Zinc Oxide	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	OCTINOXATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	75; 50; 50; 50	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-148_09dc43ef-0b0e-4949-e063-6394a90ab2f9	72085-148	HUMAN OTC DRUG	Sea Star Sparkle SPF-50 PARTY CAKE		Octinoxate, Octisalate, Octocrylene, Zinc Oxide	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	OCTINOXATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	75; 50; 50; 50	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-149_09dc4870-a244-48af-e063-6394a90aa79e	72085-149	HUMAN OTC DRUG	Sea Star Sparkle SPF-50 VERY BERRY		Octinoxate, Octisalate, Octocrylene, Zinc Oxide	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	OCTINOXATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	75; 50; 50; 50	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-150_09dc4870-a254-48af-e063-6394a90aa79e	72085-150	HUMAN OTC DRUG	Glamour Camper SPF-50		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 170	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-151_09dc25cb-c034-39aa-e063-6394a90a99b2	72085-151	HUMAN OTC DRUG	Scout SPF-50		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20180301		OTC MONOGRAPH DRUG	M017	MJ Products Association, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 170	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-307_097478f1-9b4a-b749-e063-6394a90a9977	72085-307	HUMAN OTC DRUG	SEA STAR SPARKLE SPF 50 Glitter Sunscreen Cotton Candy		HOMOSALATE, OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20200810		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-308_097478f1-9b5a-b749-e063-6394a90a9977	72085-308	HUMAN OTC DRUG	SEA STAR SPARKLE SPF 50 Glitter Sunscreen Cotton Candy		HOMOSALATE, OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20200810		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 50; 40	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-309_09749db1-19bf-799e-e063-6294a90a47eb	72085-309	HUMAN OTC DRUG	SEA STAR SPARKLE SPF 50 Glitter Sunscreen Coco Lime		HOMOSALATE, OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20200810		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-311_097483fe-a27a-b6fc-e063-6394a90a44dd	72085-311	HUMAN OTC DRUG	SEA STAR SPARKLE SPF 50 Glitter Sunscreen Coco Lime		HOMOSALATE, OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20200810		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 50; 40	mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72085-312_0974b923-d014-7dcc-e063-6294a90aeb1b	72085-312	HUMAN OTC DRUG	BEACH GYPSY Glitter Sunscreen SPF 30		OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20200810		OTC MONOGRAPH DRUG	M020	MJ Products Association, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 75; 40; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72086-010_086354ef-915b-ef86-e063-6294a90a3ecd	72086-010	HUMAN OTC DRUG	Hemopropin Hemorrhoidal		LANOLIN, PETROLATUM	OINTMENT	TOPICAL	20180701		OTC MONOGRAPH DRUG	M015	Apipharma d.o.o	LANOLIN; PETROLATUM	17.76; 71.2	g/100g; g/100g			N	20241231
72089-307_5c51299b-82cb-416d-aeb4-c0ff2826a6cb	72089-307	HUMAN PRESCRIPTION DRUG	GIMOTI		METOCLOPRAMIDE HYDROCHLORIDE	SPRAY	NASAL	20200619		NDA	NDA209388	Evoke Pharma, Inc.	METOCLOPRAMIDE HYDROCHLORIDE	15	mg/.07mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
72090-001_49b40d3d-c235-426e-a4a5-6e3519aafbb9	72090-001	HUMAN OTC DRUG	Aspirin Pain reliver		Aspirin	TABLET	ORAL	20210517		OTC MONOGRAPH DRUG	M013	Pioneer Life Sciences, LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72090-004_0fef6908-3f13-43d8-a144-e7a93ee79920	72090-004	HUMAN OTC DRUG	Tension Headache Relief		ACETAMINOPHEN, CAFFEINE	TABLET	ORAL	20200803		OTC MONOGRAPH DRUG	M013	Pioneer Life Sciences, LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
72090-005_fadd8bfb-e853-4869-b6bf-cd5a314a9727	72090-005	HUMAN OTC DRUG	Gencare DayTime Cold and Flu Softgel		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20231208		OTC MONOGRAPH DRUG	M012	Pioneer Life Sciences, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72090-007_efc10276-c367-4891-9dca-d526a39e602c	72090-007	HUMAN OTC DRUG	GenCare Headache Relief		ACETAMINOPHEN, Aspirin, Caffeine	TABLET	ORAL	20200803		OTC MONOGRAPH DRUG	M013	Pioneer Life Sciences, LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
72090-008_a36f81c9-7bdd-4acd-891b-703427d0c20c	72090-008	HUMAN OTC DRUG	ACETAMINOPHEN 500 MG		ACETAMINOPHEN	TABLET	ORAL	20230511		OTC MONOGRAPH NOT FINAL	part343	Pioneer Life Sciences, LLC	ACETAMINOPHEN	500	mg/1			N	20241231
72090-010_a5a04189-d5c2-44e6-a552-a07a1897e75b	72090-010	HUMAN OTC DRUG	FEXOFENADINE HYDROCHLORIDE		FEXOFENADINE HYDROCHLORIDE	TABLET	ORAL	20231207		ANDA	ANDA210137	Pioneer Life Sciences, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72090-010_b1a97357-d982-455c-a725-a15300bbc0f7	72090-010	HUMAN OTC DRUG	FEXOFENADINE HYDROCHLORIDE		FEXOFENADINE HYDROCHLORIDE	TABLET	ORAL	20230811		ANDA	ANDA210137	Pioneer Life Sciences, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72090-020_57110250-d5cb-400c-b352-c9f9e26dadeb	72090-020	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl 25 mg	TABLET	ORAL	20200629		OTC MONOGRAPH DRUG	M010	Pioneer Life Sciences, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72090-021_e9caa2f9-738a-4545-92c3-91ee86741b8f	72090-021	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl 25 mg	TABLET	ORAL	20200629		OTC MONOGRAPH DRUG	M012	Pioneer Life Sciences, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72090-028_4642090f-9b1b-47ce-8b72-bfa842dac580	72090-028	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20231026		ANDA	ANDA077829	Pioneer Life Sciences, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72090-029_54ae6336-bddf-49fe-a1fe-471a2ecfed99	72090-029	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine HCl 25 mg	TABLET	ORAL	20231025		OTC MONOGRAPH DRUG	M012	Pioneer Life Sciences, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72090-030_b8534c5d-072a-46e6-96b5-4563aa310a40	72090-030	HUMAN OTC DRUG	Senna-S		Senna-S	TABLET	ORAL	20200629		OTC MONOGRAPH NOT FINAL	part334	Pioneer Life Sciences, LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
72090-031_dfa82c65-f6db-4911-9e87-37e3472f1bfa	72090-031	HUMAN OTC DRUG	Senna Natural Relief		Senna Natural Relief	TABLET	ORAL	20200803		OTC MONOGRAPH NOT FINAL	part334	Pioneer Life Sciences, LLC	SENNOSIDES	8.6	mg/1			N	20241231
72090-059_5c2cb40d-35fa-403f-a58b-d217228c571d	72090-059	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	TABLET	ORAL	20200921		ANDA	ANDA209274	Pioneer Life Sciences, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72094-001_d7ada5d1-e824-76e8-e053-2a95a90a6605	72094-001	HUMAN OTC DRUG	HylaTears		Eye Drops	LIQUID	OPHTHALMIC	20180212		OTC MONOGRAPH FINAL	part349	Hyalogic LLC	HYPROMELLOSE 2910 (4000 MPA.S)	3	mg/10mL			N	20241231
72096-101_ff24177f-753e-b35d-e053-6394a90ab16f	72096-101	HUMAN OTC DRUG	Hawaiian Natural Zinc Sunscreen SPF 50		Zinc Oxide	LOTION	TOPICAL	20180210		OTC MONOGRAPH FINAL	part352	Kokua Sun Care	ZINC OXIDE	25	g/100g			N	20241231
72096-102_f9a12dac-2fd1-798f-e053-6394a90aa784	72096-102	HUMAN OTC DRUG	Hawaiian Natural Zinc Sunscreen Broad Spectrum Tinted SPF 30		Zinc Oxide	CREAM	TOPICAL	20230418		OTC MONOGRAPH FINAL	M020	Kokua Sun Care	ZINC OXIDE	18	g/100mL			N	20241231
72098-001_0c86a86e-1d43-8fa8-e063-6294a90a5963	72098-001	HUMAN OTC DRUG	Resting Beach Face SPF30 Anti-Pollution Sunscreen Serum		Butyl Methoxydibenzoylmethane, Homosalate, Octyl Salicylate, Octocrylene	CREAM	TOPICAL	20200309		OTC MONOGRAPH DRUG	M020	Everyday Group Limted	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 40; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72098-002_0c86d49a-27c4-7f18-e063-6394a90ad534	72098-002	HUMAN OTC DRUG	Oh My Bod SPF50 Antioxidant Infused Dry Touch Sunscreen		Butyl Methoxydibenzoylmethane, Homosalate, Octocrylene, Octyl Salicylate	CREAM	TOPICAL	20200309		OTC MONOGRAPH DRUG	M020	Everyday Group Limted	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72098-004_09c2d4fa-e9ec-318b-e063-6394a90a6d51	72098-004	HUMAN OTC DRUG	Big Mood SPF 30 Milky Lip Balm		ZINC OXIDE	STICK	TOPICAL	20211201		OTC MONOGRAPH DRUG	M020	Everyday Group Limited	ZINC OXIDE	80	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72098-005_0c86cec5-078a-ade6-e063-6294a90afac0	72098-005	HUMAN OTC DRUG	Oh My Bod SPF 50 sunscreen		HOMOSALATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	LOTION	TOPICAL	20211201		OTC MONOGRAPH DRUG	M020	EVERYDAY GROUP LIMITED	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72098-006_0c86d49a-27d3-7f18-e063-6394a90ad534	72098-006	HUMAN OTC DRUG	Everydayhumans Rose from above SPF 35 sunscreen base		ZINC OXIDE	LOTION	TOPICAL	20220415		OTC MONOGRAPH DRUG	M020	EVERYDAY GROUP LIMITED	ZINC OXIDE	157	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72098-007_0c86d49a-27e2-7f18-e063-6394a90ad534	72098-007	HUMAN OTC DRUG	Sun Glazed SPF 30 Sunscreen Glow Oil		AVOBENZONE, HOMOSALATE, OCTOCRYLENE	OIL	TOPICAL	20230401		OTC MONOGRAPH DRUG	M020	EVERYDAY GROUP LIMITED	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 80	mg/mL; mg/mL; mg/mL			N	20241231
72098-009_0c86bd59-1f25-763f-e063-6394a90af4f1	72098-009	HUMAN OTC DRUG	Good Times SPF 50 Sunscreen		HOMOSALATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	SPRAY	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	EVERYDAY GROUP LIMITED	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72101-419_09dc64a4-8580-ddca-e063-6294a90ab8f1	72101-419	HUMAN OTC DRUG	BLUE MONARCH Tinted SPF-50 (Rose Gold)		ZINC OXIDE	CREAM	TOPICAL	20230807		OTC MONOGRAPH DRUG	M020	Blue Monarch, LLC	ZINC OXIDE	180	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72104-062_1e57d819-15cc-4504-9aa2-80ffa1625c22	72104-062	HUMAN OTC DRUG	Truffoire Truffle Brightening		Octinoxate, Homosalate, Octisalate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20210727		OTC MONOGRAPH NOT FINAL	part352	Lionesse USA, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5.2; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
72104-362_a9042f37-f2ba-4d79-ab8c-af2c3c88167d	72104-362	HUMAN OTC DRUG	Nova Bright Skin SPF 30		Octinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone	CREAM	TOPICAL	20160901		OTC MONOGRAPH NOT FINAL	part352	Lionesse USA, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
72104-588_2983f95e-786c-42ba-84e8-0b139021af76	72104-588	HUMAN OTC DRUG	Orchidee Double Defense Skin Shield		Octinoxate, Homosalate, Octisalate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20210827		OTC MONOGRAPH NOT FINAL	part352	Lionesse USA, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
72104-589_4760bc42-7bd7-419b-9063-86574b743d49	72104-589	HUMAN OTC DRUG	Introstem Stem Cell Active Defense		Octinoxate, Homosalate, Octisalate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20210727		OTC MONOGRAPH NOT FINAL	part352	Lionesse USA, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
72104-890_7d96fcd4-584b-43bc-a308-a22984b20123	72104-890	HUMAN OTC DRUG	Voupre Age Defense		Octinoxate, Homosalate, Octisalate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20210727		OTC MONOGRAPH NOT FINAL	part352	Lionesse USA, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
72104-926_d9557a6c-78e9-4b01-8a4b-e0eceb511c4e	72104-926	HUMAN OTC DRUG	CB Multi-Active Moisturizer with SPF 30		Octinoxate, Homosalate, Octisalate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20230630		OTC MONOGRAPH NOT FINAL	part352	Lionesse USA, Inc.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
72113-102_f6f54ce2-7dd4-fb15-e053-6294a90a5dc6	72113-102	HUMAN OTC DRUG	Evereden Premium Mineral Sunscreen SPF 30		Zinc Oxide	LOTION	TOPICAL	20210419		OTC MONOGRAPH FINAL	part352	Eden Brands Inc	ZINC OXIDE	188	mg/g			N	20241231
72113-103_f6f551ab-5fb7-9364-e053-6394a90ad83b	72113-103	HUMAN OTC DRUG	Evereden Botanical Facial Sunscreen SPF 30		Zinc Oxide	LOTION	TOPICAL	20210419		OTC MONOGRAPH FINAL	part352	Eden Brands Inc	ZINC OXIDE	188	mg/g			N	20241231
72113-104_f6f56143-ea73-af87-e053-6394a90ae346	72113-104	HUMAN OTC DRUG	Evereden Multi-purpose Healing Balm		Glycerin	JELLY	TOPICAL	20211122		OTC MONOGRAPH FINAL	part346	Eden Brands Inc	GLYCERIN	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72113-106_f6f55fee-17fc-1cbb-e053-6294a90a7263	72113-106	HUMAN OTC DRUG	Evereden Healing Eczema Treatment		Colloidal Oatmeal	CREAM	TOPICAL	20220201		OTC MONOGRAPH FINAL	part347	Eden Brands, Inc.	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72113-107_082bf765-c945-3716-e063-6294a90a34dc	72113-107	HUMAN OTC DRUG	Evereden SPF50 Premium Mineral Sunscreen		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20220118		OTC MONOGRAPH DRUG	M020	Eden Brands Inc	TITANIUM DIOXIDE; ZINC OXIDE	3.7; 14	g/100mL; g/100mL			N	20241231
72113-108_fbfcdf64-6e05-1261-e053-6394a90aa97a	72113-108	HUMAN OTC DRUG	Evereden SPF20 Protective Mineral Face Cream		Zinc Oxide	CREAM	TOPICAL	20230301		OTC MONOGRAPH FINAL	part352	Eden Brands Inc	ZINC OXIDE	115	mg/g			N	20241231
72119-006_0c5f5bd8-6fa1-bb44-e063-6294a90ae830	72119-006	HUMAN OTC DRUG	Dry Original Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231213		OTC MONOGRAPH DRUG	M019	BLUE SEA AEROSOL & DAILY CARE CO., LTD.	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
72119-007_0c7231d1-4cc1-cde8-e063-6294a90a2b6f	72119-007	HUMAN OTC DRUG	Dry Cooling Essence 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231213		OTC MONOGRAPH DRUG	M019	BLUE SEA AEROSOL & DAILY CARE CO., LTD.	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
72119-008_0c729c2b-47c5-09d9-e063-6294a90afb01	72119-008	HUMAN OTC DRUG	Dry Orignal Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231212		OTC MONOGRAPH DRUG	M019	BLUE SEA AEROSOL & DAILY CARE CO., LTD	ALUMINUM CHLOROHYDRATE	20.2	g/100g			N	20241231
72119-009_0c88f1cf-4006-07f4-e063-6294a90a8e87	72119-009	HUMAN OTC DRUG	Dry Sweat Shield 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231212		OTC MONOGRAPH DRUG	M019	BLUE SEA AEROSOL & DAILY CARE CO., LTD.	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
72119-010_0cbfe8e3-0672-42a4-e063-6394a90a9ea2	72119-010	HUMAN OTC DRUG	Dry Shower Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231218		OTC MONOGRAPH DRUG	M019	BLUE SEA AEROSOL & DAILY CARE CO., LTD.	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
72119-011_0cc00fb9-5631-46a9-e063-6394a90a2305	72119-011	HUMAN OTC DRUG	Dry Shower Fresh 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231218		OTC MONOGRAPH DRUG	M019	BLUE SEA AEROSOL & DAILY CARE CO., LTD.	ALUMINUM CHLOROHYDRATE	23.3	g/100g			N	20241231
72119-012_0cc06b0c-affe-5d5d-e063-6294a90a1032	72119-012	HUMAN OTC DRUG	Dry Sweat Shield 3.5oz		Aluminum Chlorohydrate	AEROSOL, SPRAY	TOPICAL	20231218		OTC MONOGRAPH DRUG	M019	BLUE SEA AEROSOL & DAILY CARE CO., LTD.	ALUMINUM CHLOROHYDRATE	24.5	g/100g			N	20241231
72123-002_d5ddc9a0-2d2b-22e6-e053-2995a90a00d5	72123-002	HUMAN OTC DRUG	Brillia		Lapine S-100 Immune Globulin 12 hpC, 30 hpC, 50 hpC	PILL	ORAL	20180119		UNAPPROVED HOMEOPATHIC		Hadaf LLC	LAPINE S-100 IMMUNE GLOBULIN	50	[hp_C]/1			N	20241231
72123-003_d5de47f1-998a-3c92-e053-2a95a90adf32	72123-003	HUMAN OTC DRUG	Brillia	Adult	Lapine S-100 Immune Globulin 12 hpC, 30 hpC, 200 hpC	PILL	ORAL	20180119		UNAPPROVED HOMEOPATHIC		Hadaf LLC	LAPINE S-100 IMMUNE GLOBULIN	12	[hp_C]/1			N	20241231
72123-006_d5e20d53-a765-5fb4-e053-2995a90a08c5	72123-006	HUMAN OTC DRUG	Brillia Health Cold-Flu Recovery		Lapine Histamine Immune Globulin (12C, 30C, 50C), Lapine Interferon Gamma Immune Globulin (12C, 30C, 50C), Lapine CD4 Immune Globulin (12C, 30C, 50C)	TABLET	ORAL	20200731		UNAPPROVED HOMEOPATHIC		Hadaf LLC	LAPINE CD4 IMMUNE GLOBULIN; LAPINE HISTAMINE IMMUNE GLOBULIN; LAPINE INTERFERON GAMMA IMMUNE GLOBULIN	12; 12; 12	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
72123-007_d5e19d12-636d-2149-e053-2995a90a7be6	72123-007	HUMAN OTC DRUG	Brillia Health Cough Control		Lapine Bradykinin Immune Globulin (12C, 30C, 50C), Lapine Morphine Immune Globulin (12C, 30C, 50C), Lapine Histamine Immune Globulin (12C, 30C, 50C)	TABLET	ORAL	20200731		UNAPPROVED HOMEOPATHIC		Hadaf LLC	LAPINE BRADYKININ IMMUNE GLOBULIN; LAPINE HISTAMINE IMMUNE GLOBULIN; LAPINE MORPHINE IMMUNE GLOBULIN	12; 12; 12	[hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
72126-007_14be3820-eafc-42a9-b3dd-d4b0e6e57557	72126-007	HUMAN PRESCRIPTION DRUG	Tegsedi		inotersen	INJECTION, SOLUTION	SUBCUTANEOUS	20181005		NDA	NDA211172	Akcea Therapeutics, Inc.	INOTERSEN SODIUM	284	mg/1.5mL	Antisense Oligonucleotide [EPC], Decreased RNA Integrity [PE], Increased Protein Breakdown [PE], Oligonucleotides, Antisense [CS], Transthyretin-directed RNA Interaction [EPC]		N	20241231
72127-0801_ad706dcf-4872-4ed5-8150-33b6b8ee2c7d	72127-0801	HUMAN OTC DRUG	Forticept Antifungal Foot Cream		Clotrimazole	CREAM	TOPICAL	20200412		OTC MONOGRAPH FINAL	part333C	Lidan, Inc.	CLOTRIMAZOLE	.01	kg/kg	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72127-0803_1a6ffa10-df5f-417f-b379-e89d63b72026	72127-0803	HUMAN OTC DRUG	Forticept Wounds and Burns Hydrogel		BENZETHONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20200506		OTC MONOGRAPH NOT FINAL	part348	Lidan, inc.	BENZETHONIUM CHLORIDE; LIDOCAINE	.001; .04	kg/kg; kg/kg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72127-0805_dd45b843-0486-4678-962d-2cc697afd6de	72127-0805	HUMAN OTC DRUG	Forticept HP Antiseptic Wound Cleanser		Benzalkonium Chloride, Allamtoin	SPRAY	TOPICAL	20200412		OTC MONOGRAPH NOT FINAL	part333A	Lidan, inc.	ALLANTOIN; BENZALKONIUM CHLORIDE	.003; .002	kg/kg; kg/kg			N	20241231
72127-0806_1e9e88bd-6c86-4bee-a332-fef7ee156e53	72127-0806	HUMAN OTC DRUG	Forticept Antifungal Foot Gel		Clotrimazole	GEL	TOPICAL	20200412		OTC MONOGRAPH FINAL	part333C	Lidan, Inc.	CLOTRIMAZOLE	.01	kg/kg	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72127-0807_5d4bc3d9-0563-45e9-aec2-61ccc39977d1	72127-0807	HUMAN OTC DRUG	Forticept HP Antiseptic Wound Cleanser		Benzalkonium Chloride, Allantoin	SPRAY	TOPICAL	20200412		OTC MONOGRAPH NOT FINAL	part333A	Lidan, inc.	ALLANTOIN; BENZALKONIUM CHLORIDE	.003; .002	kg/kg; kg/kg			N	20241231
72127-0901_6af707c4-f5c8-4d3c-8ddf-ddc9ce494dd6	72127-0901	HUMAN OTC DRUG	Forticept Antimicrobial Hydrogel Wound Dressing		Benzethonium Chloride, Thymol	GEL	TOPICAL	20220220		OTC MONOGRAPH NOT FINAL	part333A	Lidan, Inc	BENZETHONIUM CHLORIDE; THYMOL	1; 1	g/1000g; g/1000g			N	20241231
72133-100_69c11c21-e210-779d-e053-2a91aa0a0ba6	72133-100	HUMAN OTC DRUG	Personal CARE	Vaporizing Chestrub	Camphor Menthol Eucalyptus Oil	OINTMENT	TOPICAL	20180409		OTC MONOGRAPH FINAL	part341	Delta Brands & Products LLC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
72133-210_6a37570e-c42d-d091-e053-2991aa0acbb9	72133-210	HUMAN OTC DRUG	Personal CARE	ICE COLD ANALGESIC	Menthol	GEL	TOPICAL	20180402		OTC MONOGRAPH NOT FINAL	part348	Delta Brands & Products LLC	MENTHOL	1.25	g/100g			N	20241231
72133-321_69c1fbc0-825c-1e44-e053-2a91aa0a44c5	72133-321	HUMAN OTC DRUG	Baby LOVE Personal CARE	Diaper Rash	Zinc Oxide	CREAM	TOPICAL	20180409		OTC MONOGRAPH FINAL	part347	Delta Brands & Products LLC	ZINC OXIDE	13	g/100g			N	20241231
72134-008_66ada4f8-c5a9-49f1-848f-e172416892a1	72134-008	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20220211		ANDA	ANDA213336	Agnitio Inc.	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
72137-555_066da7f4-1c15-ac76-e063-6394a90ae680	72137-555	HUMAN OTC DRUG	1ST MEDXPATCH	WITH LIDOCAINE 4%	LIDOCAINE, CAPSAICIN, MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20180315		OTC MONOGRAPH NOT FINAL	part348	1ST MEDX LLC	CAPSAICIN; LIDOCAINE; MENTHOL; METHYL SALICYLATE	.025; 4; 5; 20	g/1; g/1; g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72143-211_350ad5db-85fe-4b8d-a107-15caa120e115	72143-211	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20180420		ANDA	ANDA062269	JG Pharma Inc.	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72143-221_7ffa4ed7-b304-4e08-a732-b1d23d26f720	72143-221	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		minocycline hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200420	20240331	NDA	NDA201922	JG Pharma, Inc.	MINOCYCLINE HYDROCHLORIDE	45	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
72143-222_7ffa4ed7-b304-4e08-a732-b1d23d26f720	72143-222	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		minocycline hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200420	20240331	NDA	NDA201922	JG Pharma, Inc.	MINOCYCLINE HYDROCHLORIDE	90	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
72143-223_7ffa4ed7-b304-4e08-a732-b1d23d26f720	72143-223	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		minocycline hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20200420	20240331	NDA	NDA201922	JG Pharma, Inc.	MINOCYCLINE HYDROCHLORIDE	135	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
72143-233_ac89a282-9fe8-4ce5-be3b-898831e265e0	72143-233	HUMAN PRESCRIPTION DRUG	ACCUTANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20210111	20240131	ANDA	ANDA202099	JG Pharma Inc.	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	
72143-251_3ab8537d-7d59-4534-a51f-407a71d80d9c	72143-251	HUMAN PRESCRIPTION DRUG	ACCUTANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20220801		ANDA	ANDA202099	JG Pharma Inc.	ISOTRETINOIN	10	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
72143-252_3ab8537d-7d59-4534-a51f-407a71d80d9c	72143-252	HUMAN PRESCRIPTION DRUG	ACCUTANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20220801		ANDA	ANDA202099	JG Pharma Inc.	ISOTRETINOIN	20	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
72143-253_3ab8537d-7d59-4534-a51f-407a71d80d9c	72143-253	HUMAN PRESCRIPTION DRUG	ACCUTANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20220801		ANDA	ANDA202099	JG Pharma Inc.	ISOTRETINOIN	30	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
72143-254_3ab8537d-7d59-4534-a51f-407a71d80d9c	72143-254	HUMAN PRESCRIPTION DRUG	ACCUTANE		ISOTRETINOIN	CAPSULE, GELATIN COATED	ORAL	20220801		ANDA	ANDA202099	JG Pharma Inc.	ISOTRETINOIN	40	mg/1	Retinoid [EPC], Retinoids [CS]		N	20241231
72143-311_92db3719-055b-4dde-a36c-b07bc89c6d7f	72143-311	HUMAN PRESCRIPTION DRUG	Sulconazole Nitrate		Sulconazole Nitrate	CREAM	TOPICAL	20200204		NDA	NDA018737	JG Pharma	SULCONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72143-321_fc60cb89-7eba-463c-91b9-1b21cd8637a5	72143-321	HUMAN PRESCRIPTION DRUG	Sulconazole Nitrate		Sulconazole Nitrate	SOLUTION	TOPICAL	20200224		NDA	NDA018738	JG Pharma Inc.	SULCONAZOLE NITRATE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72146-002_6fc028df-324a-46b5-e053-2a91aa0aef23	72146-002	HUMAN OTC DRUG	GLOBAL CARE 15OZ ORIGINAL ANTIBACTERIAL HAND		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	CHLOROXYLENOL	.3	g/100mL			N	20241231
72146-003_701484f3-fce1-3ef8-e053-2991aa0a6ca9	72146-003	HUMAN OTC DRUG	GLOBAL CARE 7.5OZ ANTIBACTERIAL HAND SWEETPEA ORCHID		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	CHLOROXYLENOL	.3	g/100mL			N	20241231
72146-004_70142046-b6fb-0653-e053-2a91aa0a8b2d	72146-004	HUMAN OTC DRUG	GLOBAL CARE 7.5OZ ANTIBACTERIAL HAND CUCUMBER MELON		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	CHLOROXYLENOL	.3	g/100mL			N	20241231
72146-005_6e5a801f-2b0b-67bf-e053-2a91aa0afb8b	72146-005	HUMAN OTC DRUG	GLOBAL CARE 2 PACK HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	ALCOHOL	62	mL/100mL			N	20241231
72146-006_6e1e7333-fbcc-22ae-e053-2a91aa0a6710	72146-006	HUMAN OTC DRUG	GLOBAL CARE INSTANT 8OZ HAND SANITIZER - ORIGINAL		ALCOHOL	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Target Price, Inc	ALCOHOL	62	mL/100mL			N	20241231
72146-007_6e085d13-6874-bec0-e053-2a91aa0af08e	72146-007	HUMAN OTC DRUG	GLOBAL CARE INSTANT HAND SANITIZER 1.8OZ		ALCOHOL	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	ALCOHOL	62	mL/100mL			N	20241231
72146-008_6f71833b-d8ba-7f5a-e053-2a91aa0a1b82	72146-008	HUMAN OTC DRUG	GLOBAL CARE 4OZ VAPOR RUB		menthol, camphor, eucalyptus oil	OINTMENT	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	TARGET PRICE, INC	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
72146-009_6f71833b-d8cf-7f5a-e053-2a91aa0a1b82	72146-009	HUMAN OTC DRUG	GLOBAL CARE ICE COLD ANALGESIC		menthol	OINTMENT	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	TARGET PRICE, INC	MENTHOL	1	g/100g			N	20241231
72146-010_6f74108d-a23c-7870-e053-2a91aa0afdba	72146-010	HUMAN OTC DRUG	GLOBAL HOME CARE 19OZ ANTIBACTERIAL DISH DETERGENT		CHLOROXYLENON	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	CHLOROXYLENOL	.3	g/100mL			N	20241231
72146-011_7011f5c1-21e3-07ce-e053-2991aa0a4293	72146-011	HUMAN OTC DRUG	GLOBAL CARE 7.5OZ ORIGINAL ANTIBACTERIAL HAND		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	CHLOROXYLENOL	.3	g/100mL			N	20241231
72146-012_83e09805-1049-ecd7-e053-2991aa0abb3b	72146-012	HUMAN OTC DRUG	GLOBAL HOME CARE 19OZ LEMON ANTIBACTERIAL DISH DETERGENT		CHLOROXYLENOL	LIQUID	TOPICAL	20190331		OTC MONOGRAPH NOT FINAL	part333E	TARGET PRICE, INC	CHLOROXYLENOL	.3	g/100mL			N	20241231
72146-013_a50d52f3-6f9d-bfc9-e053-2995a90a0d9b	72146-013	HUMAN OTC DRUG	GLOBAL CARE LEMON ZEST ANTIBACTERIAL FOAMING HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-014_a52e9bf7-b9e6-280f-e053-2a95a90a7aa8	72146-014	HUMAN OTC DRUG	GLOBAL CARE OCEAN MIST ANTIBACTERIAL FOAMING HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-015_a6a013f1-8fc7-28a1-e053-2a95a90ac95e	72146-015	HUMAN OTC DRUG	GLOBAL CARE INSTANT HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	ALCOHOL	62	mL/100mL			N	20241231
72146-016_a69ffe66-e210-fbb2-e053-2995a90a1fdc	72146-016	HUMAN OTC DRUG	GLOBAL CARE INSTANT HAND SANITIZER 2OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	ALCOHOL	62	mL/100mL			N	20241231
72146-017_a6b0c9a8-f974-0821-e053-2a95a90a9454	72146-017	HUMAN OTC DRUG	GLOBAL CARE INSTANT HAND SANITIZER 16OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	ALCOHOL	62	mL/100mL			N	20241231
72146-018_a8aa52bd-3710-b7f9-e053-2995a90a62fd	72146-018	HUMAN OTC DRUG	GLOBAL CARE GOLD ANTIBACTERIAL HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-019_aec5707c-5e26-6179-e053-2a95a90a8831	72146-019	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND LAVENDER CHAMOMILE		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-021_aec5fa82-4be3-c700-e053-2995a90ab942	72146-021	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND GEORGIA PEACH		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-022_aec5707c-5e2b-6179-e053-2a95a90a8831	72146-022	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND VANILLA BEAN		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-023_aec638f3-313a-64d1-e053-2995a90a080a	72146-023	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND CHERRY BLOSSOM		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-024_aec6773f-e74c-46e1-e053-2995a90acab3	72146-024	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND ALOE VERA		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-026_bb9949f1-83d7-39a0-e053-2995a90ab25b	72146-026	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND SWEET PEA ORCHID		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-027_aec751b1-9e4e-574b-e053-2995a90a4d29	72146-027	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND ORIGINAL		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72146-028_bba7da88-9fed-6270-e053-2a95a90a4fe3	72146-028	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND CUCUMBER MELON		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	TARGET PRICE, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72152-547_8115acb4-4050-4778-b516-e21ef742d451	72152-547	HUMAN PRESCRIPTION DRUG	Zulresso		brexanolone	INJECTION, SOLUTION	INTRAVENOUS	20190617		NDA	NDA211371	Sage Therapeutics, Inc.	BREXANOLONE	5	mg/mL		CIV	N	20241231
72156-002_0c43c36d-43c0-d627-e063-6294a90a8872	72156-002	HUMAN OTC DRUG	WATERMELON GLOW NIACINAMIDE SUNSCREEN		Homosalate, Octisalate, Octocrylene, and Zinc Oxide	LOTION	TOPICAL	20220222		OTC MONOGRAPH DRUG	M020	Aramara Beauty	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	85; 50; 85; 121	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72162-1035_64347ae8-d628-4834-8cf4-4dc202675ac7	72162-1035	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide		Irbesartan and Hydrochlorothiazide	TABLET, FILM COATED	ORAL	20130124		ANDA	ANDA077369	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5; 150	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72162-1059_6e4271db-f791-421e-8abd-65feddded931	72162-1059	HUMAN PRESCRIPTION DRUG	Alprazolam	Extended Release	Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20070312		ANDA	ANDA078056	Bryant Ranch Prepack	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72162-1077_5912cfd5-c3e7-41e0-93cd-f051f6446e3f	72162-1077	HUMAN PRESCRIPTION DRUG	Dicyclomine Hydrochloride		Dicyclomine Hydrochloride	TABLET	ORAL	19990226		ANDA	ANDA040230	Bryant Ranch Prepack	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72162-1078_f0657f4c-8f10-449e-b6bc-b66650c5580c	72162-1078	HUMAN PRESCRIPTION DRUG	Pilocarpine Hydrochloride		Pilocarpine Hydrochloride	TABLET, FILM COATED	ORAL	20051014		ANDA	ANDA077220	Bryant Ranch Prepack	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
72162-1079_814cfbd9-6f0d-4060-9b49-f3e856d883cd	72162-1079	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20070701		ANDA	ANDA078220	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72162-1080_fe56c0db-1ac9-4c6c-a238-1b46b6586e7e	72162-1080	HUMAN PRESCRIPTION DRUG	Baclofen		baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	Bryant Ranch Prepack	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72162-1081_df37826e-a4e3-428c-9ec5-66d2bf2513cf	72162-1081	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	2	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1082_a0f37d48-d182-4f70-adaa-ba973ad391c0	72162-1082	HUMAN PRESCRIPTION DRUG	Hydromorphone Hydrochloride		Hydromorphone Hydrochloride	TABLET	ORAL	20091209		ANDA	ANDA077471	Bryant Ranch Prepack	HYDROMORPHONE HYDROCHLORIDE	4	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1084_36d42d5e-39d0-4eae-8580-373d2d3c5cd0	72162-1084	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20111209		ANDA	ANDA201407	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72162-1085_f065b12c-b219-41a4-a385-a0525cae1c61	72162-1085	HUMAN PRESCRIPTION DRUG	Methadone Hydrocloride	dye-free, sugar-free, unflavored	methadone hydrochloride	CONCENTRATE	ORAL	20201102		ANDA	ANDA212093	Bryant Ranch Prepack	METHADONE HYDROCHLORIDE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1086_b48907d5-f288-41f3-b160-ed26c05290aa	72162-1086	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, EXTENDED RELEASE	ORAL	20021106		ANDA	ANDA076201	Bryant Ranch Prepack	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1087_0a0413d9-598f-4d5a-a444-e7198a455c51	72162-1087	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200525		ANDA	ANDA212901	Bryant Ranch Prepack	AMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1088_fc42a446-346f-483b-9f63-d0d20a98d480	72162-1088	HUMAN PRESCRIPTION DRUG	AMPHETAMINE SULFATE		amphetamine sulfate	TABLET	ORAL	20200525		ANDA	ANDA212901	Bryant Ranch Prepack	AMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1089_e2c3a496-9960-4eec-896f-eb7bf41ba23e	72162-1089	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	TABLET	ORAL	20191226		ANDA	ANDA209193	Bryant Ranch Prepack	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72162-1090_30c237e5-b8ea-4ca6-bd83-b7e4a7afcb3e	72162-1090	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72162-1091_726c2b08-3378-4562-b698-8b88ad3956a4	72162-1091	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72162-1092_b5c08080-34f5-4a93-a7e9-8d3cc163c331	72162-1092	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72162-1093_dd56c6b5-cb1b-4809-b99e-7ad67588163d	72162-1093	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72162-1094_52f652d7-0c79-4394-a984-55bb652f2e7d	72162-1094	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20200803		NDA AUTHORIZED GENERIC	NDA021342	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72162-1098_6bb8701b-84a2-45ce-ae75-32a871981b2e	72162-1098	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	ORAL	20070227		ANDA	ANDA040710	Bryant Ranch Prepack	LIDOCAINE HYDROCHLORIDE ANHYDROUS	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72162-1106_7e439538-b17a-48fd-8d28-82c39de47ad5	72162-1106	HUMAN PRESCRIPTION DRUG	Trospium Chloride	ER	Trospium Chloride	CAPSULE, EXTENDED RELEASE	ORAL	20130607		ANDA	ANDA201291	Bryant Ranch Prepack	TROSPIUM CHLORIDE	60	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72162-1107_85dab5b6-bd1c-4ffa-94e1-f317d529b123	72162-1107	HUMAN PRESCRIPTION DRUG	Clindamycin Palmitate Hydrochloride		Clindamycin Palmitate Hydrochloride	GRANULE, FOR SOLUTION	ORAL	20100121		ANDA	ANDA090902	Bryant Ranch Prepack	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72162-1108_56de5c43-dd07-43f8-9239-b78384e5d535	72162-1108	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	TABLET, FILM COATED	ORAL	20101117		ANDA	ANDA091573	Bryant Ranch Prepack	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72162-1109_f9324142-58b0-448d-b37d-f0f7025d02c3	72162-1109	HUMAN PRESCRIPTION DRUG	Midazolam Hydrochloride		Midazolam Hydrochloride	SYRUP	ORAL	20050502		ANDA	ANDA076379	Bryant Ranch Prepack	MIDAZOLAM HYDROCHLORIDE	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72162-1112_0413c98c-b609-6d8a-e063-6394a90a70aa	72162-1112	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20130809		ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	.5	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
72162-1113_fcf0901e-8e27-45d3-b6f9-47509f159311	72162-1113	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20140122	20250131	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	1	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	
72162-1114_0413c98c-b630-6d8a-e063-6394a90a70aa	72162-1114	HUMAN PRESCRIPTION DRUG	Repaglinide		REPAGLINIDE	TABLET	ORAL	20140122	20240531	ANDA	ANDA201189	Bryant Ranch Prepack	REPAGLINIDE	2	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	
72162-1118_2e6a892a-b520-4b93-aab4-7d77a4edfeeb	72162-1118	HUMAN PRESCRIPTION DRUG	pilocarpine hydrchloride		pilocarpine hydrchloride	TABLET, FILM COATED	ORAL	20200824		ANDA	ANDA076746	Bryant Ranch Prepack	PILOCARPINE HYDROCHLORIDE	5	mg/1	Cholinergic Agonists [MoA], Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
72162-1123_955e02a8-56f9-456e-95f1-8a9aedd3e695	72162-1123	HUMAN PRESCRIPTION DRUG	Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide		Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide	SYRUP	ORAL	20150206		ANDA	ANDA205292	Bryant Ranch Prepack	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	2; 10; 30	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
72162-1149_03c5f284-4f59-a14a-e063-6394a90a894e	72162-1149	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Bryant Ranch Prepack	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72162-1150_03c65ec1-fb9f-d82e-e063-6394a90a24f7	72162-1150	HUMAN PRESCRIPTION DRUG	Allopurinol		allopurinol	TABLET	ORAL	20030627		ANDA	ANDA075798	Bryant Ranch Prepack	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72162-1152_e6f4c6ba-3a78-4ae3-8907-ffb525da5057	72162-1152	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20050830		ANDA	ANDA077156	Bryant Ranch Prepack	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72162-1154_0cd274ca-3c17-4d18-b7d2-31edd8f2c9cf	72162-1154	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20220317		ANDA	ANDA040715	Bryant Ranch Prepack	BENZTROPINE MESYLATE	2	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	20241231
72162-1155_13a0ead6-bcd5-40e3-890e-c471b42fa12a	72162-1155	HUMAN PRESCRIPTION DRUG	Benztropine Mesylate		benztropine mesylate	TABLET	ORAL	20170515	20240531	ANDA	ANDA204713	Bryant Ranch Prepack	BENZTROPINE MESYLATE	.5	mg/1	Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]		N	
72162-1158_11dbb480-9f25-4185-a41f-512c0ecab534	72162-1158	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20090331		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72162-1159_9ad2cf8e-eb11-41b6-b54f-fdd0b86a0fad	72162-1159	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72162-1160_ed9ee5b6-5cf9-45bb-b321-74c902baf333	72162-1160	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20111215		ANDA	ANDA200815	Bryant Ranch Prepack	FELODIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72162-1161_ef688580-523e-40e5-b0a5-b92b78b3cbc6	72162-1161	HUMAN PRESCRIPTION DRUG	MethylPREDNISolone		methylprednisolone	TABLET	ORAL	19981222		ANDA	ANDA040183	Bryant Ranch Prepack	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1162_49296d69-d0c0-440b-9563-7bb9ea4c90e1	72162-1162	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72162-1163_baac14ec-3afe-4921-a123-5801a1ec6b63	72162-1163	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	4	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72162-1164_cb0252ff-97d4-4246-8281-a392e267de0f	72162-1164	HUMAN PRESCRIPTION DRUG	Perphenazine		perphenazine	TABLET, FILM COATED	ORAL	19981231		ANDA	ANDA040226	Bryant Ranch Prepack	PERPHENAZINE	8	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72162-1166_c0a83e34-4fcb-4c6d-a416-77cf30a0f4de	72162-1166	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20020301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
72162-1167_5ff2435a-c0e6-49e0-a9da-0d36eb7d9c5c	72162-1167	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20011201		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
72162-1169_04141f31-2d31-f604-e063-6394a90a5f5b	72162-1169	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20041221		ANDA	ANDA040584	Bryant Ranch Prepack	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1170_0414ce83-ac75-1049-e063-6294a90a1945	72162-1170	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20041221		ANDA	ANDA040581	Bryant Ranch Prepack	PREDNISONE	2.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1171_b1dc2688-4fa6-4d40-8b07-b8c38a18c1c7	72162-1171	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1172_041463a4-b0ba-0596-e063-6394a90a1f33	72162-1172	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20020712		ANDA	ANDA040256	Bryant Ranch Prepack	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1175_754126db-9371-4c77-80a8-45c86accf5a2	72162-1175	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1176_7421645d-b23f-4cfa-8545-6c37012911a9	72162-1176	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1177_72661e92-405e-48b0-b282-11ae04486ce9	72162-1177	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1178_89c95e75-c288-49aa-9952-7bee5a5912bd	72162-1178	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1179_a5ba421d-98db-4c08-9d47-2b1214fc640c	72162-1179	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1218_03c546f9-e16e-bee3-e063-6394a90a0564	72162-1218	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612		ANDA	ANDA077284	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72162-1219_03c52b18-17ee-ceb3-e063-6394a90aa0c6	72162-1219	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20070612		ANDA	ANDA077284	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72162-1227_d7ecb669-c8bd-468b-8c15-426e2a925e62	72162-1227	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1228_f2f76dc9-ac41-48f3-8adb-03e91595e63e	72162-1228	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205017	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1229_d4c6fc19-1ebf-4084-b56b-808af4b6df70	72162-1229	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20170124		ANDA	ANDA205008	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1230_9d311d64-3bd2-4e6e-90ce-dbf3c56963ac	72162-1230	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE		sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124		ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1	meq/g			N	20241231
72162-1231_50eb81e6-02da-4a0f-8f82-270da46da456	72162-1231	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1232_2cf89fe3-c69b-4358-a1d4-8cd2586c9c32	72162-1232	HUMAN PRESCRIPTION DRUG	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE		butalbital, acetaminophen and caffeine	CAPSULE	ORAL	20170110		ANDA	ANDA207118	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
72162-1233_1c4b00b3-89ff-48fd-9959-13ad775c0dca	72162-1233	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA210059	Bryant Ranch Prepack	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1234_dec5df57-54a7-456e-9ef7-515a78610b63	72162-1234	HUMAN PRESCRIPTION DRUG	DEXTROAMPHETAMINE SULFATE		dextroamphetamine sulfate	TABLET	ORAL	20180704		ANDA	ANDA210059	Bryant Ranch Prepack	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1237_60301774-0c03-4eab-8c94-57500ebda3a2	72162-1237	HUMAN PRESCRIPTION DRUG	Chlordiazepoxide Hydrochloride and Clidinium Bromide		Chlordiazepoxide Hydrochloride and Clidinium Bromide	CAPSULE	ORAL	20200709		ANDA	ANDA211421	Bryant Ranch Prepack	CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE	5; 2.5	mg/1; mg/1	Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]	CIV	N	20241231
72162-1262_8aad59b3-9d20-422a-9b0d-03a1d7a1c3a4	72162-1262	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	CAPSULE	ORAL	20180101		ANDA	ANDA208516	Bryant Ranch Prepack	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
72162-1265_0308bc99-4ace-43f0-9d40-cfef627ad1a8	72162-1265	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
72162-1267_6c4b37ca-c911-4d20-88fd-5d4d8d7c6214	72162-1267	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20201101		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
72162-1268_df23532c-cce6-45ca-97f5-19feca861877	72162-1268	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	LIQUID	ORAL	20200901		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	20	mg/5mL		CIV	N	20241231
72162-1273_165384be-9637-4103-902b-7ec552d6d8eb	72162-1273	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate Ointment USP, 0.05%	OINTMENT	TOPICAL	20191118		ANDA	ANDA211295	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1275_2141751f-e23c-40b7-a5d4-1696ea2ff8cf	72162-1275	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20190928		ANDA	ANDA207741	Bryant Ranch Prepack	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
72162-1277_d713ebf4-6b8a-44ed-9fc2-0e1b34f6bb5f	72162-1277	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	TABLET, EXTENDED RELEASE	ORAL	20141101		ANDA	ANDA203126	Bryant Ranch Prepack	NIFEDIPINE	30	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72162-1278_6309d872-9545-4710-85fe-fa76da046ff1	72162-1278	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72162-1279_1fdd1b1f-7033-41f1-83fe-1689cdb9042c	72162-1279	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20141006		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-1283_99b4f905-7d1c-42ac-a2ab-2470d3570954	72162-1283	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	extended-release	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20150306		ANDA	ANDA091632	Bryant Ranch Prepack	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE	8; 10	mg/5mL; mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-1287_ebeb71fc-35d9-40f2-a617-dee4f06e0f6e	72162-1287	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160407		ANDA	ANDA202214	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-1296_b3be263a-6ce0-42f9-9c62-0c88fb750f78	72162-1296	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20161024		ANDA	ANDA206574	Bryant Ranch Prepack	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
72162-1299_ffdc4e1a-d139-49c1-a4ff-37f70034ce90	72162-1299	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1300_80f2ac4b-8ce3-4561-8226-e35a833a5a3e	72162-1300	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Bryant Ranch Prepack	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1302_d6f980f3-fcef-45c0-913d-cde244e50934	72162-1302	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20150724		ANDA	ANDA201807	Bryant Ranch Prepack	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1309_a057c45a-badd-4f27-bb78-b765df773fe3	72162-1309	HUMAN PRESCRIPTION DRUG	Albendazole	200 mg	Albendazole	TABLET, FILM COATED	ORAL	20181215		ANDA	ANDA210011	Bryant Ranch Prepack	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
72162-1310_774e24ef-b517-4346-9c90-c74cde9d8f06	72162-1310	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20190225		ANDA	ANDA207420	Bryant Ranch Prepack	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
72162-1316_01c4f415-1f2d-413b-8696-85aec7791fac	72162-1316	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20190222		ANDA	ANDA211518	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72162-1326_a7e8a233-a46a-46c6-898f-b68e983a0d67	72162-1326	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Bryant Ranch Prepack	FLUCYTOSINE	250	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
72162-1327_34be165c-e6bc-4f4a-840e-46abccb267a1	72162-1327	HUMAN PRESCRIPTION DRUG	Flucytosine		Flucytosine	CAPSULE	ORAL	20170726		NDA AUTHORIZED GENERIC	NDA017001	Bryant Ranch Prepack	FLUCYTOSINE	500	mg/1	Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]		N	20241231
72162-1329_0428273f-9cf0-c4fa-e063-6294a90ae594	72162-1329	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL SODIUM	65	mg/mL		CIV	N	20241231
72162-1330_3da39379-bd05-4e63-81ec-9edd5cbee15e	72162-1330	HUMAN PRESCRIPTION DRUG	Phenobarbital Sodium		Phenobarbital Sodium	INJECTION	INTRAMUSCULAR	20200205		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL SODIUM	130	mg/mL		CIV	N	20241231
72162-1332_09936a3d-b1e2-4c02-8f5c-07144213a0bc	72162-1332	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040600	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72162-1333_78a05ed6-ca77-483d-bf6e-8a9155da91f0	72162-1333	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040602	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72162-1334_fdad4260-f6df-484a-b833-2c75214fa109	72162-1334	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1335_1494c2d1-0f76-4c30-b2a7-acd9bfd33355	72162-1335	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1336_c2d8a59c-0200-4fca-8970-b0b28b0bbdce	72162-1336	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1337_42d746c3-1a23-497e-be8f-7c55a49c8cc2	72162-1337	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20140908		ANDA	ANDA091490	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1341_80b652d9-9567-428a-978c-dd0a2cd6441f	72162-1341	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-1342_753bc843-b1fc-4e22-996f-9fb1658d96fa	72162-1342	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-1356_9b0cd8fd-63ad-40b6-9b4c-215365b1f122	72162-1356	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20020329		ANDA	ANDA040412	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72162-1358_226f10f7-5901-48cf-915a-3fa95589244a	72162-1358	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Bryant Ranch Prepack	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72162-1361_e959fd06-a804-409d-b545-bed5ba0f12ea	72162-1361	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	Bryant Ranch Prepack	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72162-1364_bc7b574d-002f-4daf-a134-3e98e76bcd0c	72162-1364	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	Bryant Ranch Prepack	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72162-1367_f678a238-9b57-4a36-a99c-0bf46c1219f5	72162-1367	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180215		ANDA	ANDA209757	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-1383_c3ab7ed5-70c4-40d6-807a-002f4ef7b66e	72162-1383	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	OINTMENT	TOPICAL	20060613		ANDA	ANDA085027	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1390_4eaf0dd3-28f0-4d8e-936d-5118bdd6edaa	72162-1390	HUMAN PRESCRIPTION DRUG	olopatadine hydrochloride		Olopatadine Hydrochloride	SPRAY	NASAL	20170614		ANDA	ANDA202853	Bryant Ranch Prepack	OLOPATADINE HYDROCHLORIDE	665	ug/1	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
72162-1391_7fe1979d-4bd9-4aad-befc-e6c41957c1c6	72162-1391	HUMAN PRESCRIPTION DRUG	diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20181127		ANDA	ANDA210893	Bryant Ranch Prepack	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1392_539d6967-2a14-4c0c-b33d-36fb90682830	72162-1392	HUMAN PRESCRIPTION DRUG	Mometasone Furoate		Mometasone Furoate	SOLUTION	TOPICAL	20081211		ANDA	ANDA077180	Bryant Ranch Prepack	MOMETASONE FUROATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1399_a2e2f237-1138-464a-9c64-e0e42a15bf1e	72162-1399	HUMAN PRESCRIPTION DRUG	hydrocortisone acetate pramoxine hcl		hydrocortisone acetate pramoxine hcl	CREAM	TOPICAL	20100413		ANDA	ANDA085368	Bryant Ranch Prepack	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	1; 1	g/100g; g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1402_e7666378-33e9-462d-a5a8-d356cd2163f6	72162-1402	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	CREAM	TOPICAL	20060913		ANDA	ANDA076793	Bryant Ranch Prepack	FLUTICASONE PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1406_b8f5f056-2527-4b61-86e1-590f392d6f13	72162-1406	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	SUSPENSION	TOPICAL	20061229		ANDA	ANDA077676	Bryant Ranch Prepack	CICLOPIROX OLAMINE	7.7	mg/100mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
72162-1410_912c0ffe-8346-426e-82f6-3588a0d8471d	72162-1410	HUMAN PRESCRIPTION DRUG	Econazole Nitrate		Econazole Nitrate	CREAM	TOPICAL	20060808		ANDA	ANDA076479	Bryant Ranch Prepack	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72162-1413_8c670756-f8c1-4bea-9eda-6b9e569debbe	72162-1413	HUMAN PRESCRIPTION DRUG	Ammonium Lactate		Ammonium Lactate	CREAM	TOPICAL	20060816		ANDA	ANDA075774	Bryant Ranch Prepack	AMMONIUM LACTATE	12	g/100g	Acidifying Activity [MoA]		N	20241231
72162-1414_712f089c-dd9a-4221-9d8c-9809d773ff12	72162-1414	HUMAN PRESCRIPTION DRUG	desoximetasone		Desoximetasone	OINTMENT	TOPICAL	20150514		ANDA	ANDA077770	Bryant Ranch Prepack	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1419_e8c33323-2824-4b02-84a6-d24d4e08cf17	72162-1419	HUMAN PRESCRIPTION DRUG	Scopolamine Trandermal System		scolopamine transdermal system	PATCH, EXTENDED RELEASE	TRANSDERMAL	20170613		ANDA	ANDA078830	Bryant Ranch Prepack	SCOPOLAMINE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20251231
72162-1424_38cb0ddb-5227-4066-9b07-a1feececf7a3	72162-1424	HUMAN PRESCRIPTION DRUG	levocetirizine dihydrochloride		Levocetirizine dihydrochloride	SOLUTION	ORAL	20111107		ANDA	ANDA091263	Bryant Ranch Prepack	LEVOCETIRIZINE DIHYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72162-1426_0dfc1bea-c618-4599-9a39-9416b88c2e5f	72162-1426	HUMAN PRESCRIPTION DRUG	testosterone		testosterone	GEL	TOPICAL	20181012		ANDA	ANDA204268	Bryant Ranch Prepack	TESTOSTERONE	16.2	mg/g	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
72162-1428_28dfa3c0-be9b-4fbe-8245-8dc49e628b33	72162-1428	HUMAN PRESCRIPTION DRUG	Calcipotriene and Betamethasone Dipropionate		Calcipotriene, Betamethasone Dipropionate	OINTMENT	TOPICAL	20200130		ANDA	ANDA200174	Bryant Ranch Prepack	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	.643; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
72162-1438_4a44570f-3e35-470b-8b81-6ac605eb1ba6	72162-1438	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol propionate	GEL	TOPICAL	20080730		ANDA	ANDA075027	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1439_f3f324b5-23ff-4171-b94f-db557655691b	72162-1439	HUMAN PRESCRIPTION DRUG	Flurandrenolide		Flurandrenolide	LOTION	TOPICAL	20161006		ANDA	ANDA207133	Bryant Ranch Prepack	FLURANDRENOLIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1444_04a760c9-4888-4649-8162-9767d06d8a43	72162-1444	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	GEL	TOPICAL	20080612		ANDA	ANDA063211	Bryant Ranch Prepack	ERYTHROMYCIN	20	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
72162-1446_511efea2-62e5-4b56-a3c1-9abff251834a	72162-1446	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Bryant Ranch Prepack	GALANTAMINE HYDROBROMIDE	8	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72162-1447_dbf3b05e-d43c-4d4a-b176-2db147a70ecd	72162-1447	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Bryant Ranch Prepack	GALANTAMINE HYDROBROMIDE	16	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72162-1448_61e307ef-0037-4097-bafd-84bf5e7a9dae	72162-1448	HUMAN PRESCRIPTION DRUG	Galantamine Hydrobromide		Galantamine Hydrobromide	CAPSULE, EXTENDED RELEASE	ORAL	20110209		ANDA	ANDA090178	Bryant Ranch Prepack	GALANTAMINE HYDROBROMIDE	24	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72162-1458_f028ba37-d4c2-43f2-b811-e7ba38bce735	72162-1458	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72162-1460_306d1f8f-e945-4531-b1a4-b82a38cf470c	72162-1460	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
72162-1462_729d7626-cb52-4105-a0fa-b6ecba3a8847	72162-1462	HUMAN PRESCRIPTION DRUG	levothyroxine sodium		levothyroxine sodium	TABLET	ORAL	20190507		NDA	NDA021116	Bryant Ranch Prepack	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20251231
72162-1472_04139ecf-5357-091b-e063-6394a90a44b3	72162-1472	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1473_03c6aa0d-c9b0-bb11-e063-6394a90a3423	72162-1473	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1477_ea5de5f7-67b3-4a6e-8de6-643f9c5284c6	72162-1477	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Bryant Ranch Prepack	GLYCOPYRROLATE	1	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72162-1478_84c15a00-04ac-4406-89aa-78d4048bc785	72162-1478	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		glycopyrrolate	TABLET	ORAL	20060926		ANDA	ANDA040653	Bryant Ranch Prepack	GLYCOPYRROLATE	2	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72162-1485_cc985325-f831-4f1a-8111-2ce9fce02a96	72162-1485	HUMAN PRESCRIPTION DRUG	Doxylamine Succinate and Pyridoxine Hydrochloride		Doxylamine Succinate and Pyridoxine Hydrochloride, Delayed release Tablets 10 mg/10 mg	TABLET, DELAYED RELEASE	ORAL	20191219		ANDA	ANDA208518	Bryant Ranch Prepack	DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE	10; 10	mg/1; mg/1	Analogs/Derivatives [Chemical/Ingredient], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
72162-1488_03462333-cf10-4cab-825c-34c8238c7ef1	72162-1488	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1489_b9755d1c-5e36-441b-8646-6a906b1cd662	72162-1489	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071826	Bryant Ranch Prepack	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72162-1490_04276eed-6d51-6906-e063-6294a90a5a06	72162-1490	HUMAN PRESCRIPTION DRUG	Minoxidil		Minoxidil	TABLET	ORAL	19881114		ANDA	ANDA071839	Bryant Ranch Prepack	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72162-1493_04131b2a-e85e-db96-e063-6294a90a6cd1	72162-1493	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	25	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1494_fceae5a4-c99c-437f-8874-d7ebe9378e3b	72162-1494	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72162-1495_69fb683e-2ff5-4a53-af97-b5b87f8dfa94	72162-1495	HUMAN PRESCRIPTION DRUG	fluoxetine hydrochloride		fluoxetine hydrochloride	TABLET, COATED	ORAL	20160822		ANDA	ANDA203836	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72162-1496_04133bc1-b028-47ea-e063-6394a90ac870	72162-1496	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	35	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1497_9974d620-d55a-44ec-9202-fe552286d921	72162-1497	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Bryant Ranch Prepack	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
72162-1498_e75f30cd-3f50-4779-a480-24def4cf0e00	72162-1498	HUMAN PRESCRIPTION DRUG	dantrolene sodium		dantrolene sodium	CAPSULE	ORAL	20160328		NDA AUTHORIZED GENERIC	NDA017443	Bryant Ranch Prepack	DANTROLENE SODIUM	50	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
72162-1500_03c5e9e8-b761-76aa-e063-6394a90aea71	72162-1500	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Bryant Ranch Prepack	URSODIOL	250	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72162-1501_03c69677-9bd4-f698-e063-6294a90aa7c4	72162-1501	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	TABLET, FILM COATED	ORAL	20130801		ANDA	ANDA202540	Bryant Ranch Prepack	URSODIOL	500	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72162-1502_03c69c0e-b38d-6356-e063-6394a90a293b	72162-1502	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20131119		ANDA	ANDA078992	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1503_0413601a-dbff-8773-e063-6394a90abd1d	72162-1503	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride	Extended-Release	Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20131119		ANDA	ANDA078992	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1504_cf7f5e91-db59-472d-aff1-d7d2650a8cef	72162-1504	HUMAN PRESCRIPTION DRUG	Cholestyramine		cholestyramine	POWDER, FOR SUSPENSION	ORAL	20050915		ANDA	ANDA077204	Bryant Ranch Prepack	CHOLESTYRAMINE	4	g/9g	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
72162-1506_0415ee03-30e8-e975-e063-6294a90abf3c	72162-1506	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	TABLET, FILM COATED	ORAL	20171116		ANDA	ANDA209419	Bryant Ranch Prepack	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72162-1507_0413a689-7ddc-1817-e063-6394a90adce3	72162-1507	HUMAN PRESCRIPTION DRUG	Dexmethylphenidate Hydrochloride		Dexmethylphenidate Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20170105		ANDA	ANDA202842	Bryant Ranch Prepack	DEXMETHYLPHENIDATE HYDROCHLORIDE	40	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1510_061d25d1-2ade-44ab-aa27-7cb4c3fab99f	72162-1510	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Bryant Ranch Prepack	CANDESARTAN CILEXETIL	4	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72162-1511_4936ab77-a09f-4813-b89e-7a3ac00f0e7c	72162-1511	HUMAN PRESCRIPTION DRUG	Candesartan cilexetil		Candesartan cilexetil	TABLET	ORAL	20130521		NDA AUTHORIZED GENERIC	NDA020838	Bryant Ranch Prepack	CANDESARTAN CILEXETIL	8	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72162-1514_5791116d-281e-4854-8a44-cbca13c51e59	72162-1514	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Bryant Ranch Prepack	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 12.5; 20	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72162-1515_f1f7f2f7-401b-44b6-b3cf-0f116da04ab8	72162-1515	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Bryant Ranch Prepack	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	5; 25; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72162-1516_c31747cc-3f8e-41ec-94ea-ebd8a31b0449	72162-1516	HUMAN PRESCRIPTION DRUG	olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide		olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide	TABLET, FILM COATED	ORAL	20161026		ANDA	ANDA206137	Bryant Ranch Prepack	AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL	10; 12.5; 40	mg/1; mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72162-1517_c4296ad6-f454-4e6e-bf0b-2c1fc5d7271e	72162-1517	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20181029		ANDA	ANDA207169	Bryant Ranch Prepack	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
72162-1526_58587963-95be-4dec-ad76-6482563a3697	72162-1526	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20170412		ANDA	ANDA207479	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72162-1541_393dc15a-d185-450e-9b2c-e29ea0a39cf7	72162-1541	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	25	mg/1		CV	N	20241231
72162-1542_1dc765fe-717d-41b9-99cd-6748551c8ebf	72162-1542	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	50	mg/1		CV	N	20241231
72162-1543_0c505dc3-c418-44d7-ab16-02736d66282d	72162-1543	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	75	mg/1		CV	N	20241231
72162-1544_b009b637-211e-497e-bb5d-f0063e816fc4	72162-1544	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	100	mg/1		CV	N	20241231
72162-1545_856bd55d-abd6-41c1-b65d-38707433f356	72162-1545	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	150	mg/1		CV	N	20241231
72162-1546_9ed95242-c995-4f4b-9a04-ebc67c26acfb	72162-1546	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	200	mg/1		CV	N	20241231
72162-1547_493ed97c-821c-4b1d-a92f-a7541c24a4c6	72162-1547	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	225	mg/1		CV	N	20241231
72162-1548_7275a89f-b903-44e6-9299-d133da4d2beb	72162-1548	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Bryant Ranch Prepack	PREGABALIN	300	mg/1		CV	N	20241231
72162-1560_d1c4e262-5707-467c-8cea-c241a4603841	72162-1560	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20150810		ANDA	ANDA202765	Bryant Ranch Prepack	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72162-1561_53206ffd-e35d-420d-85f2-ba3688c33fb6	72162-1561	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20170907		ANDA	ANDA202765	Bryant Ranch Prepack	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72162-1562_d7c5de39-2416-4cc7-8b34-5283df8aaca1	72162-1562	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1563_7864ea84-46b5-4271-ab3d-193499b97368	72162-1563	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20110415		ANDA	ANDA075517	Bryant Ranch Prepack	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72162-1564_dd41a16c-2aad-4470-b525-c90d3ddea54f	72162-1564	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1565_3a8c9ec8-7941-4d0f-8169-053d8b167bb4	72162-1565	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20120217		ANDA	ANDA202248	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1566_a3b74230-f1bf-4ab3-934d-fb9f43cfae3d	72162-1566	HUMAN PRESCRIPTION DRUG	Naltrexone Hydrochloride		Naltrexone Hydrochloride	TABLET, FILM COATED	ORAL	20130923		ANDA	ANDA075274	Bryant Ranch Prepack	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
72162-1569_0ce84910-58f4-4a8d-ace5-e3a9c5b81865	72162-1569	HUMAN PRESCRIPTION DRUG	Salsalate		Salsalate	TABLET	ORAL	20141001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SALSALATE	750	mg/1			N	20241231
72162-1571_95ea9194-0adb-4723-bfdb-adf413f3002d	72162-1571	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
72162-1572_180e9cd1-6cc6-48cd-8f56-d06abcd76531	72162-1572	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
72162-1574_0a8da9a0-7071-4636-8dbe-51f983b4901e	72162-1574	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20141124		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
72162-1581_0427e1fa-ccf5-265f-e063-6394a90a26c7	72162-1581	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	15	mg/1		CIV	N	20241231
72162-1582_0e6eb3a1-f9ab-453f-ace9-d7fa4a1464c5	72162-1582	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	30	mg/1		CIV	N	20241231
72162-1583_0428273f-9cd4-c4fa-e063-6294a90ae594	72162-1583	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	60	mg/1		CIV	N	20241231
72162-1584_04275a50-1692-9977-e063-6294a90a7efe	72162-1584	HUMAN PRESCRIPTION DRUG	Phenobarbital		phenobarbital	TABLET	ORAL	20200301		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	PHENOBARBITAL	100	mg/1		CIV	N	20241231
72162-1591_03a06df6-2878-4b43-a71d-6ba5891c920c	72162-1591	HUMAN PRESCRIPTION DRUG	Butalbital, Acetaminophen, Caffeine and Codeine Phosphate		Butalbital, Acetaminophen, Caffeine and Codeine Phosphate	CAPSULE	ORAL	20040701		ANDA	ANDA076560	Bryant Ranch Prepack	ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE	325; 50; 40; 30	mg/1; mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS]	CIII	N	20241231
72162-1600_6490ab81-42c8-4a49-b39b-42c35942ff44	72162-1600	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20180521		ANDA	ANDA203088	Bryant Ranch Prepack	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72162-1602_4ae52eeb-eab2-40d8-ad67-41b68789134d	72162-1602	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	60	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1604_1f687dd8-62f7-4412-83cc-693d47d9c15a	72162-1604	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1605_6d5a6a9b-693f-4e88-bbdc-371fc430d3a8	72162-1605	HUMAN PRESCRIPTION DRUG	propranolol hydrochloride		propranolol hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20130311		ANDA	ANDA078703	Bryant Ranch Prepack	PROPRANOLOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1608_8a3d78ee-9fea-4875-9c71-8d09e842ab43	72162-1608	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Bryant Ranch Prepack	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72162-1624_87ff2b4d-2584-4721-814b-01b7afc101fb	72162-1624	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72162-1625_37152b1e-3904-4e71-a2ac-e0bfa0683401	72162-1625	HUMAN PRESCRIPTION DRUG	Spironolactone and Hydrochlorothiazide		Spironolactone and Hydrochlorothiazide	TABLET	ORAL	19870702		ANDA	ANDA089534	Bryant Ranch Prepack	HYDROCHLOROTHIAZIDE; SPIRONOLACTONE	25; 25	mg/1; mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72162-1626_81f265fe-1259-4c78-8db5-39843f33ba8d	72162-1626	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72162-1627_4d5c5f42-440a-4577-a7c8-3cfe9e6d1e01	72162-1627	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Bryant Ranch Prepack	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72162-1628_2d187f9c-8c57-472f-91e3-fbb22c93b9a3	72162-1628	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20130812		ANDA	ANDA040526	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-1639_53386747-10e4-48e2-9ab0-e4bfe4eddfa5	72162-1639	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Bryant Ranch Prepack	MIRTAZAPINE	15	mg/1			N	20241231
72162-1640_13721c6c-541a-48a4-88d1-4fc4c84bc3e4	72162-1640	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET	ORAL	20040422		ANDA	ANDA076541	Bryant Ranch Prepack	MIRTAZAPINE	30	mg/1			N	20241231
72162-1641_22f61022-d96e-4e23-aacf-768f014220c8	72162-1641	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-1642_34f8bd8c-ed22-48f6-8f93-68d10353e23a	72162-1642	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	Bryant Ranch Prepack	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-1646_1e2e5da5-f9aa-4074-9594-bdecfc1e5e86	72162-1646	HUMAN PRESCRIPTION DRUG	Phenytoin Sodium		Phenytoin Sodium	CAPSULE, EXTENDED RELEASE	ORAL	20170724		ANDA	ANDA040684	Bryant Ranch Prepack	PHENYTOIN SODIUM	100	mg/1	Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-1652_ee4aef29-a1ea-4cb5-9cf5-c293108168c0	72162-1652	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	.25	mg/1			N	20241231
72162-1653_5d0cae5d-4cf4-4fa5-96cc-23f218a056ce	72162-1653	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	.5	mg/1			N	20241231
72162-1654_6652adaa-ace4-44cd-a794-b27b794c17f3	72162-1654	HUMAN PRESCRIPTION DRUG	Sodium Fluoride Chewable		Sodium Fluoride	TABLET	ORAL	20180817		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SODIUM FLUORIDE	1	mg/1			N	20241231
72162-1666_3f28114a-c7da-4151-9324-3ceb21aacca8	72162-1666	HUMAN PRESCRIPTION DRUG	Selenium Sulfide		selenium sulfide	SHAMPOO	TOPICAL	20150601		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SELENIUM SULFIDE	22.5	mg/mL			N	20241231
72162-1670_5c8cba29-93b6-45f2-a811-7c0e233ef941	72162-1670	HUMAN OTC DRUG	Guaifenesin and Dextromethorphan Hydrobromide		Guaifenesin and Dextromethorphan Hydrobromide	SYRUP	ORAL	20160614		OTC MONOGRAPH FINAL	part341	Bryant Ranch Prepack	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72162-1674_4112d5e5-fbd4-4006-98b6-b1e7c21327ca	72162-1674	HUMAN OTC DRUG	M-Dryl		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20190801		OTC MONOGRAPH DRUG	M012	Bryant Ranch Prepack	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
72162-1675_1563516e-45c6-4536-bd3a-83ad0ab22bdd	72162-1675	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1676_b99a327d-0fed-4058-9346-b0cfd4523048	72162-1676	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1677_78ca2b6b-d7a7-4b4a-a1ed-ec922594ebd4	72162-1677	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20191122		ANDA	ANDA075215	Bryant Ranch Prepack	LABETALOL	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-1679_269519d3-126d-46de-9cf9-20d7338b9305	72162-1679	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-1680_e3f3d721-5607-491a-9205-114e41d3dc67	72162-1680	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-1681_1187df09-da7d-439d-84d9-56ecd9c95ee1	72162-1681	HUMAN PRESCRIPTION DRUG	Clonidine Hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20200701		ANDA	ANDA202297	Bryant Ranch Prepack	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-1687_bc171e14-6c33-4f05-82d7-42235a507bdd	72162-1687	HUMAN PRESCRIPTION DRUG	Haloperidol		Haloperidol	TABLET	ORAL	20191125		ANDA	ANDA071173	Bryant Ranch Prepack	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
72162-1690_5d7595a6-9998-4d70-af1b-7f7ca2a67a31	72162-1690	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrochloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Bryant Ranch Prepack	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
72162-1702_391463c0-2407-45f6-8f93-77f586484f4a	72162-1702	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Bryant Ranch Prepack	TERAZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72162-1704_6aa44677-3c44-4ffd-bab7-6630e7d818d5	72162-1704	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	CAPSULE	ORAL	20060320		ANDA	ANDA075677	Bryant Ranch Prepack	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72162-1706_5203af59-bfc1-4b23-80fb-294905a7323d	72162-1706	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-1707_a64fee20-c43e-4a6e-ac4c-44a17989387d	72162-1707	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-1711_b249ccfc-44cc-4dda-84cd-2ae1074e0bbf	72162-1711	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-1712_5d10adef-24d9-46b7-b9b6-1bb963113070	72162-1712	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20120529		ANDA	ANDA090548	Bryant Ranch Prepack	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-1724_0bd1d0e2-36dc-47f7-84d1-493feff8a1a7	72162-1724	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20060313		ANDA	ANDA077309	Bryant Ranch Prepack	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72162-1728_0427617b-2627-8707-e063-6394a90a6386	72162-1728	HUMAN PRESCRIPTION DRUG	ENDOCET		Oxycodone and Acetaminophen	TABLET	ORAL	20030306		ANDA	ANDA040330	Bryant Ranch Prepack	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1733_d0365acc-8003-47b3-bf63-2798b79bba6e	72162-1733	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1734_433cf2f2-f0fc-4bbf-a2a4-d20005d24a49	72162-1734	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	Delayed Release	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Bryant Ranch Prepack	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1735_fad51927-4121-432f-8c3c-f935a38b821a	72162-1735	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20091022		ANDA	ANDA075382	Bryant Ranch Prepack	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72162-1737_350b6c46-976f-420b-bce3-3305bb35648b	72162-1737	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	Bryant Ranch Prepack	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72162-1739_42b9ca25-c4c0-47a9-9910-33c0f3fcf6c7	72162-1739	HUMAN PRESCRIPTION DRUG	Lovastatin		Lovastatin	TABLET	ORAL	20021125		ANDA	ANDA075991	Bryant Ranch Prepack	LOVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-1741_b89a98f7-2851-43fc-84ee-9134d75c6f87	72162-1741	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	Bryant Ranch Prepack	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72162-1743_f8aff965-1631-4065-8bc3-00cf2b7d43c6	72162-1743	HUMAN PRESCRIPTION DRUG	Felodipine		Felodipine	TABLET, FILM COATED	ORAL	20201012		ANDA	ANDA204800	Bryant Ranch Prepack	FELODIPINE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72162-1746_fcbf73d6-c0c4-4112-9230-293c1da10868	72162-1746	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	Bryant Ranch Prepack	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72162-1747_467eaca7-2673-41bf-9063-e99432622f68	72162-1747	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20101222		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	1.25; 2.5	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
72162-1748_0415ff20-880c-8aab-e063-6294a90aaf75	72162-1748	HUMAN PRESCRIPTION DRUG	Esterified Estrogens and Methyltestosterone		Esterified Estrogens and Methyltestosterone	TABLET	ORAL	20101222		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE	.625; 1.25	mg/1; mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
72162-1749_8e81198a-8120-4944-adfd-9e0b76b936b8	72162-1749	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	SOLUTION	ORAL	20151013		ANDA	ANDA204979	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	5	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1750_08bfdcba-7d6b-49de-bf79-a8f059b6c74c	72162-1750	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide	SOLUTION	ORAL	20150518		ANDA	ANDA071402	Bryant Ranch Prepack	METOCLOPRAMIDE HYDROCHLORIDE	5	mg/5mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
72162-1751_d9aa58c9-f62c-4552-95cf-8d54fa519ba8	72162-1751	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1753_ef99f213-69e6-48f1-ab61-6a5f5fea2425	72162-1753	HUMAN PRESCRIPTION DRUG	Propafenone Hydrochloride		Propafenone Hydrochloride	TABLET, COATED	ORAL	20150331		ANDA	ANDA076550	Bryant Ranch Prepack	PROPAFENONE HYDROCHLORIDE	300	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1756_b0777445-46c9-4341-b9b5-17b04e4fb72b	72162-1756	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150309		ANDA	ANDA075126	Bryant Ranch Prepack	ETODOLAC	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1757_95f7ca43-d954-43ef-ab05-ae97b70bbbbd	72162-1757	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	CAPSULE	ORAL	20150201		ANDA	ANDA075126	Bryant Ranch Prepack	ETODOLAC	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1760_c2b58e2f-ffff-4287-af69-7c9dfaa30618	72162-1760	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	Bryant Ranch Prepack	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1761_322a4d6f-c1d1-499f-94d0-e47e6e3dc96e	72162-1761	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	Bryant Ranch Prepack	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1762_fdea8afc-3244-4f97-9a64-6a8e2551c7e4	72162-1762	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		Flecainide Acetate Tablet	TABLET	ORAL	20151228		ANDA	ANDA075882	Bryant Ranch Prepack	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1763_58b928ce-7a5e-4c6c-8b8f-ea97a58742ca	72162-1763	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160401		ANDA	ANDA080706	Bryant Ranch Prepack	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1764_46637de0-194d-478d-b441-8378887cb6fc	72162-1764	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20160401		ANDA	ANDA080706	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1766_da7671a4-2348-46c8-8475-7092e7b999c5	72162-1766	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA074299	Bryant Ranch Prepack	INDAPAMIDE	1.25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72162-1767_6faac85c-b2ff-4d97-9208-7dfd66c219d0	72162-1767	HUMAN PRESCRIPTION DRUG	Indapamide		Indapamide	TABLET, FILM COATED	ORAL	20170424		ANDA	ANDA074299	Bryant Ranch Prepack	INDAPAMIDE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72162-1770_6764f27f-137e-42ae-be0d-efe9eec25ba5	72162-1770	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20180904		ANDA	ANDA202284	Bryant Ranch Prepack	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-1771_3fe1c43d-1751-4611-8fe5-3750f501c862	72162-1771	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20180904		ANDA	ANDA202284	Bryant Ranch Prepack	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-1775_06df93d3-7d4e-41e0-ae36-d5c667e13c27	72162-1775	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	POWDER, FOR SOLUTION	ORAL	20190909		ANDA	ANDA061667	Bryant Ranch Prepack	VANCOMYCIN HYDROCHLORIDE	250	mg/5mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
72162-1782_7df98d6f-0687-48a9-861b-c86b4fa64861	72162-1782	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1783_f1803dfb-b7b7-46f4-a06f-1f5f4fd1a007	72162-1783	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1784_140f171b-416e-4798-a732-1480043a5559	72162-1784	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Bryant Ranch Prepack	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
72162-1786_246d4100-e94b-4288-a7ad-ec950c346de3	72162-1786	HUMAN PRESCRIPTION DRUG	Potassium Chloride Extended-Release		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20191120		ANDA	ANDA076368	Bryant Ranch Prepack	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72162-1789_b8f98652-2ba9-451d-bc7f-5fd8a74b00c4	72162-1789	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1790_6214d204-5325-4bd3-9701-e2e65861e16c	72162-1790	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1791_3448d6ef-c3f8-4b47-a878-0221a604c824	72162-1791	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1792_15b7047c-7e5d-4a5e-9e9f-90b9317b09c6	72162-1792	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1793_6ead3165-0229-4ee5-9a98-28dc8c0aac28	72162-1793	HUMAN PRESCRIPTION DRUG	Morphine sulfate		morphine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20120511		ANDA	ANDA078761	Bryant Ranch Prepack	MORPHINE SULFATE	60	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1799_0a9ba425-d552-4266-8562-3f2942a584b4	72162-1799	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET, EXTENDED RELEASE	ORAL	20180817		ANDA	ANDA205689	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-1802_0414ff5d-a4cc-74ef-e063-6294a90ab407	72162-1802	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220314		ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	5	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
72162-1803_0415a027-ff1c-cdf3-e063-6294a90a5ba4	72162-1803	HUMAN PRESCRIPTION DRUG	Methimazole		methimazole	TABLET	ORAL	20220314		ANDA	ANDA040350	Bryant Ranch Prepack	METHIMAZOLE	10	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
72162-1805_6f7c466b-e390-434c-afdd-fa2a6f0af56e	72162-1805	HUMAN PRESCRIPTION DRUG	PROCTOZONE-HC		hydrocortisone 2.5%	CREAM	TOPICAL	20150803		ANDA	ANDA040879	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1806_89777742-6553-403a-8635-072f667410b0	72162-1806	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	AEROSOL, SPRAY	TOPICAL	20170908		ANDA	ANDA206786	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.147	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1807_4827f85c-0142-412e-8447-bb4552d09596	72162-1807	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		Clobetasol Propionate	CREAM	TOPICAL	20190131		ANDA	ANDA211401	Bryant Ranch Prepack	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1808_69dc2d24-c19b-438f-ac9a-bee2bc4447e8	72162-1808	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	Bryant Ranch Prepack	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72162-1809_9a7fa137-cd05-4442-8df7-2f17abaa700d	72162-1809	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN PALMITATE HYDROCHLORIDE	(Pediatric)	CLINDAMYCIN PALMITATE HYDROCHLORIDE	GRANULE, FOR SOLUTION	ORAL	20120911		ANDA	ANDA201821	Bryant Ranch Prepack	CLINDAMYCIN PALMITATE HYDROCHLORIDE	75	mg/5mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72162-1811_8e64d1ce-1026-4901-b895-5cd705a43a89	72162-1811	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1812_0109dcbe-86dd-407d-b7ab-6b05068436fd	72162-1812	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone	TABLET	ORAL	20121030		ANDA	ANDA203638	Bryant Ranch Prepack	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72162-1813_0675168c-57a8-4795-8aa5-772a42150168	72162-1813	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20091124		ANDA	ANDA078428	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-1815_f9015508-9bf1-429b-a50f-eefbbd5b4ca2	72162-1815	HUMAN PRESCRIPTION DRUG	Nitrofurantoin	(monohydrate/macrocrystals)	Nitrofurantoin monohydrate/macrocrystals	CAPSULE	ORAL	20170525		ANDA	ANDA207372	Bryant Ranch Prepack	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
72162-1816_ea0f1205-c572-429b-ae69-01e6b88a1075	72162-1816	HUMAN PRESCRIPTION DRUG	Benazepril Hydrochloride		Benazepril Hydrochloride	TABLET	ORAL	20100202		ANDA	ANDA076820	Bryant Ranch Prepack	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
72162-1825_78141f4e-cdab-41e7-b447-21e79d5d2dd7	72162-1825	HUMAN PRESCRIPTION DRUG	temazepam		temazepam	CAPSULE	ORAL	19870421		ANDA	ANDA071457	Bryant Ranch Prepack	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
72162-1832_d4889845-86e6-44cb-b775-7d0402870755	72162-1832	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	CREAM	TOPICAL	20120401		ANDA	ANDA088042	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-1833_0415a027-ff3a-cdf3-e063-6294a90a5ba4	72162-1833	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20120604		ANDA	ANDA090836	Bryant Ranch Prepack	CEPHALEXIN	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72162-1840_042765e5-bd0f-8224-e063-6394a90a141b	72162-1840	HUMAN PRESCRIPTION DRUG	Minocycline Hydrochloride		Minocycline Hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20160930		ANDA	ANDA204453	Bryant Ranch Prepack	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72162-1846_04157527-47ac-35e9-e063-6394a90a4096	72162-1846	HUMAN PRESCRIPTION DRUG	Colesevelam HCL		Colesevelam HCL	TABLET, FILM COATED	ORAL	20181006		ANDA	ANDA209038	Bryant Ranch Prepack	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
72162-1878_30d0e442-83fa-4082-a5c4-cc43a42496f2	72162-1878	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA AUTHORIZED GENERIC	NDA018651	Bryant Ranch Prepack	DRONABINOL	2.5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
72162-1879_872faecb-6e20-433f-8dbe-a405e681c156	72162-1879	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA AUTHORIZED GENERIC	NDA018651	Bryant Ranch Prepack	DRONABINOL	5	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
72162-1880_0702b03e-d161-4305-ba74-cd0920c23fdf	72162-1880	HUMAN PRESCRIPTION DRUG	Dronabinol		Dronabinol	CAPSULE	ORAL	20210303		NDA AUTHORIZED GENERIC	NDA018651	Bryant Ranch Prepack	DRONABINOL	10	mg/1	Cannabinoid [EPC], Cannabinoids [CS]	CIII	N	20241231
72162-1908_b14c9945-fd73-48e0-af82-302ccf0184ff	72162-1908	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20210527		ANDA	ANDA075090	Bryant Ranch Prepack	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72162-1915_46a035a7-36a4-46c1-a8fc-2521940aa623	72162-1915	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160816		ANDA	ANDA202539	Bryant Ranch Prepack	PARICALCITOL	1	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
72162-1916_c90a43a1-5f05-4cc1-ad36-62bd3606601d	72162-1916	HUMAN PRESCRIPTION DRUG	Paricalcitol		Paricalcitol	CAPSULE	ORAL	20160816		ANDA	ANDA202539	Bryant Ranch Prepack	PARICALCITOL	2	ug/1	Ergocalciferols [CS], Vitamin D Analog [EPC], Vitamin D2 Analog [EPC]		N	20241231
72162-1917_7c180d4c-79ad-40fe-8195-4f2752bbe071	72162-1917	HUMAN PRESCRIPTION DRUG	Valproic Acid		Valproic Acid	CAPSULE, LIQUID FILLED	ORAL	20160715		ANDA	ANDA073484	Bryant Ranch Prepack	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72162-1918_78728b32-756f-4b3d-93f5-f71fba4789ff	72162-1918	HUMAN PRESCRIPTION DRUG	Ergocalciferol		Ergocalciferol	CAPSULE, LIQUID FILLED	ORAL	20160615		ANDA	ANDA080704	Bryant Ranch Prepack	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
72162-1920_6a18943d-16ea-4df7-a2fb-498565914cdc	72162-1920	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE, LIQUID FILLED	ORAL	20180612		ANDA	ANDA091174	Bryant Ranch Prepack	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
72162-1925_1f612038-2249-42be-8957-83d440b000e8	72162-1925	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
72162-1926_17933209-7d39-48d9-a1bb-ea1225d20b40	72162-1926	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
72162-1927_e07ea1a1-8d55-49a5-877e-53cbd182d3c8	72162-1927	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200501		ANDA	ANDA078302	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
72162-1929_170f47fc-0f20-4ba8-b0e3-aede5d20c457	72162-1929	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Bryant Ranch Prepack	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72162-1930_92de5b81-cde8-4b8c-a217-48d5c61178e3	72162-1930	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Bryant Ranch Prepack	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72162-1931_f326c909-3704-4f19-8d29-a76e90568286	72162-1931	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72162-1932_0768944f-00c5-47d2-a239-93e575c545d4	72162-1932	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72162-1935_b699ef28-be91-44f9-a12f-10c329d964e2	72162-1935	HUMAN PRESCRIPTION DRUG	EC-NAPROXEN		naproxen	TABLET, DELAYED RELEASE	ORAL	20181015		NDA	NDA020067	Bryant Ranch Prepack	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-1939_51e502c9-5761-4bdf-933b-372169555e69	72162-1939	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
72162-1940_5262f3f6-d5a6-4350-83d8-2ee415f0169a	72162-1940	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
72162-1941_11fb20e6-62ca-4bbf-82a3-2234f341c322	72162-1941	HUMAN PRESCRIPTION DRUG	Hyoscyamine Sulfate		Hyoscyamine Sulfate	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	HYOSCYAMINE SULFATE	.125	mg/1			N	20241231
72162-1951_5c5ec748-d519-4ace-8f2f-a24fda02126a	72162-1951	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20210201		ANDA	ANDA209869	Bryant Ranch Prepack	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-1977_af5d94d4-108b-43c0-872d-b6615d98d40b	72162-1977	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20200301		ANDA	ANDA211767	Bryant Ranch Prepack	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72162-1978_1e1f6df5-739b-4346-a2e9-a86316e801f6	72162-1978	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20201113		ANDA	ANDA214282	Bryant Ranch Prepack	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72162-1982_2ff1da74-bb60-4476-a2c4-088373b8f83b	72162-1982	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
72162-1983_367a08ed-9634-4667-ae2a-23f5e69de3d2	72162-1983	HUMAN PRESCRIPTION DRUG	Zolpidem		Zolpidem Tartrate	TABLET	ORAL	20200924		ANDA	ANDA077214	Bryant Ranch Prepack	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
72162-1988_b57c0641-2a7c-48b2-9eb7-e8fcdd0a653c	72162-1988	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20200205		ANDA	ANDA212452	Bryant Ranch Prepack	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72162-1989_09db9245-1255-40bd-b190-b0d6caec39c4	72162-1989	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-1991_960ac7e1-4dbd-43a7-b4e1-490c5f0cc529	72162-1991	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20180713		ANDA	ANDA210211	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-1992_46c06284-c97a-407b-bdaf-d0a99a75bae3	72162-1992	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20190329		ANDA	ANDA210139	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-1996_191d1cc7-cb24-4c9e-9d8f-928d66e81f15	72162-1996	HUMAN PRESCRIPTION DRUG	hydrocodone bitartrate and acetaminophen		hydrocodone bitartrate and acetaminophen	TABLET	ORAL	20190617		ANDA	ANDA207509	Bryant Ranch Prepack	ACETAMINOPHEN; HYDROCODONE BITARTRATE	300; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72162-2001_08ad0e3b-2288-4e30-86b6-d33afc4cf05e	72162-2001	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
72162-2002_33b896b6-330c-4a97-a200-d4607f647d68	72162-2002	HUMAN PRESCRIPTION DRUG	ACETAMINOPHEN AND CODEINE PHOSPHATE		acetaminophen and codeine phosphate	TABLET	ORAL	20190802		ANDA	ANDA211610	Bryant Ranch Prepack	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
72162-2017_7f2795a1-bac1-4a51-8518-77dce29dfd9c	72162-2017	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	CAPSULE	ORAL	20071201		ANDA	ANDA087022	Bryant Ranch Prepack	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72162-2018_c2fe1af2-09e6-4f15-ba0b-8ead6b4bc86a	72162-2018	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		hydrocortisone	TABLET	ORAL	20070330		ANDA	ANDA040646	Bryant Ranch Prepack	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-2019_2c523a1b-be4f-4c81-89f6-068e8ae98f26	72162-2019	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20140407		ANDA	ANDA091159	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2020_7bcd8a7e-9fd9-4c6e-beb9-b1c7f1b57b57	72162-2020	HUMAN PRESCRIPTION DRUG	ORPHENADRINE CITRATE		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	Bryant Ranch Prepack	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72162-2021_c3004d72-8ed0-43d6-a31a-e24ce02fd0bc	72162-2021	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	CAPSULE, EXTENDED RELEASE	ORAL	20120323		ANDA	ANDA078986	Bryant Ranch Prepack	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72162-2022_631c40bf-b5ed-4b6b-80cf-e498315649bb	72162-2022	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	25	mg/1		CV	N	20241231
72162-2023_61666355-4ab9-4a98-895e-86863a310748	72162-2023	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	50	mg/1		CV	N	20241231
72162-2024_cf836edc-2363-4c8b-bf31-0f09ce69a18b	72162-2024	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	75	mg/1		CV	N	20241231
72162-2025_c1a5e437-7a7d-405c-bea6-c23ec3127dec	72162-2025	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	100	mg/1		CV	N	20241231
72162-2026_cf074af6-e9c4-4a90-b158-62850ce31c1a	72162-2026	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	150	mg/1		CV	N	20241231
72162-2027_29a2acc9-4c5d-4e5e-8796-6ce5f6e181d4	72162-2027	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	200	mg/1		CV	N	20241231
72162-2028_822f4929-7d7e-45d1-a060-c0d83c63fc36	72162-2028	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	225	mg/1		CV	N	20241231
72162-2029_dfaad17f-fcf7-4d33-a92c-5aef837d8035	72162-2029	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-2030_acff9c3d-f1c6-4936-b32f-bc18966def12	72162-2030	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-2031_5a879840-8626-4c60-ba9f-bf3e3fe00db0	72162-2031	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20160902		ANDA	ANDA206116	Bryant Ranch Prepack	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-2032_09548ab7-c77f-4b66-b004-384c91434520	72162-2032	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Bryant Ranch Prepack	ESTRADIOL	.025	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72162-2033_ab59ae96-f177-4752-b090-c73c0e9d0e5a	72162-2033	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Bryant Ranch Prepack	ESTRADIOL	.0375	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72162-2034_48183865-16c7-41a7-b926-74f00e8e01e6	72162-2034	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Bryant Ranch Prepack	ESTRADIOL	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72162-2035_5b972068-ee16-4b78-b0af-10bbb44f858e	72162-2035	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Bryant Ranch Prepack	ESTRADIOL	.075	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72162-2036_fe7eef03-f7ff-49ce-b4dd-de33c5cff89a	72162-2036	HUMAN PRESCRIPTION DRUG	DOTTI		Estradiol	PATCH, EXTENDED RELEASE	TRANSDERMAL	20190204		ANDA	ANDA211293	Bryant Ranch Prepack	ESTRADIOL	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72162-2037_9fb2a0d3-9829-4a85-800a-6b52fc66683b	72162-2037	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	SOLUTION	ORAL	20150313		ANDA	ANDA079059	Bryant Ranch Prepack	RISPERIDONE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
72162-2038_a0145c96-9513-4a9f-806c-3b5cdf4eb29d	72162-2038	HUMAN PRESCRIPTION DRUG	Theophylline		Theophylline	SOLUTION	ORAL	20120802		ANDA	ANDA091586	Bryant Ranch Prepack	THEOPHYLLINE ANHYDROUS	80	mg/15mL	Methylxanthine [EPC], Xanthines [CS]		N	20241231
72162-2039_8737be6d-ef32-43f8-b595-c5da17552c1e	72162-2039	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Dextromethorphan Hydrobromide		Promethazine Hydrochloride and Dextromethorphan Hydrobromide	SOLUTION	ORAL	20140131		ANDA	ANDA091687	Bryant Ranch Prepack	DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE	15; 6.25	mg/5mL; mg/5mL	Phenothiazine [EPC], Phenothiazines [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72162-2040_8786bde0-beb8-4a0a-9ff1-dfb277f35d44	72162-2040	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20150304		ANDA	ANDA091601	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2041_ca027dbb-bc05-459f-8e30-9ed375e6d66f	72162-2041	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	SOLUTION	ORAL	20150304		ANDA	ANDA091601	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	10	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2042_6a773791-1552-4f95-b5ad-afb1e1f3175b	72162-2042	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride and Codeine Phosphate		Promethazine Hydrochloride and Codeine Phosphate	SOLUTION	ORAL	20180312		ANDA	ANDA200386	Bryant Ranch Prepack	CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE	10; 6.25	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]	CV	N	20241231
72162-2043_9d8eb096-ecbd-48b8-a5c2-8bd9f1ad656e	72162-2043	HUMAN PRESCRIPTION DRUG	Dextroamphetamine		Dextroamphetamine	SOLUTION	ORAL	20130531		ANDA	ANDA203644	Bryant Ranch Prepack	DEXTROAMPHETAMINE SULFATE	5	mg/5mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2044_206296be-2b0a-43af-8927-d8189d0af96d	72162-2044	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		Phendimetrazine Tartrate	TABLET	ORAL	20121120		ANDA	ANDA040762	Bryant Ranch Prepack	PHENDIMETRAZINE TARTRATE	35	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
72162-2045_fb832a78-2979-433e-bf57-f99dc9e4d4ad	72162-2045	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Bryant Ranch Prepack	DANTROLENE SODIUM	25	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
72162-2046_12d2dc9a-f3c7-4a01-8294-7dc7ce285b24	72162-2046	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Bryant Ranch Prepack	DANTROLENE SODIUM	50	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
72162-2047_f06929dd-4265-46ee-848b-bf96e9782124	72162-2047	HUMAN PRESCRIPTION DRUG	Dantrolene Sodium		dantrolene sodium	CAPSULE	ORAL	20051026		ANDA	ANDA076686	Bryant Ranch Prepack	DANTROLENE SODIUM	100	mg/1	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
72162-2048_f0cea0e3-45fd-45f7-9ccc-51d1aab86301	72162-2048	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2049_7c8cfbf6-d2da-42dc-92e1-e7792bc591a9	72162-2049	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2050_49c41831-bac9-48f0-8791-972d1d22f41e	72162-2050	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2051_fd843766-7870-489d-a8ca-04736aa72b36	72162-2051	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.125; 3.125; 3.125; 3.125	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2052_09755346-4e4d-4fd1-a534-73400afd605e	72162-2052	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2053_fca80382-cd8a-4ae6-b150-45af596bd8d5	72162-2053	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2054_030290fa-fbf4-4a77-ba53-4ffd7c6fc3fe	72162-2054	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20221229		ANDA	ANDA211352	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2055_4d6450ab-c45b-419a-abe8-3417dc21f6b0	72162-2055	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2056_97aadaab-414b-47f0-943f-11c991dfe8b8	72162-2056	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2057_cd6beb57-c465-4411-b961-94016108c689	72162-2057	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2058_8c0e5527-79c8-4f12-9a15-c62e44319646	72162-2058	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2059_22a1f7c6-ed18-429f-ae1a-9a842ebbf9e3	72162-2059	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	6.25; 6.25; 6.25; 6.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2060_3f454032-8665-4404-bdf8-0f77de047c31	72162-2060	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	CAPSULE, EXTENDED RELEASE	ORAL	20191216		ANDA	ANDA212037	Bryant Ranch Prepack	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2061_a449698f-871d-4572-afdb-4b292acb78fe	72162-2061	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20111121		ANDA	ANDA077361	Bryant Ranch Prepack	TRIMIPRAMINE MALEATE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72162-2062_5407dfce-2ed0-48cd-af63-9a7d68545626	72162-2062	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20111121		ANDA	ANDA077361	Bryant Ranch Prepack	TRIMIPRAMINE MALEATE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72162-2063_fd16e507-23d3-4b55-88f6-d09b70e4fe33	72162-2063	HUMAN PRESCRIPTION DRUG	Trimipramine Maleate		Trimipramine Maleate	CAPSULE	ORAL	20111021		ANDA	ANDA077361	Bryant Ranch Prepack	TRIMIPRAMINE MALEATE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72162-2064_2ed36787-dd7a-45a5-9404-06ccbee7f37b	72162-2064	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		ALBUTEROL SULFATE	SYRUP	ORAL	20190906		ANDA	ANDA212197	Bryant Ranch Prepack	ALBUTEROL SULFATE	2	mg/5mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
72162-2065_a0cba336-0083-495d-bef9-cf9b2af8d6ae	72162-2065	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	SOLUTION	ORAL	20190919		ANDA	ANDA212423	Bryant Ranch Prepack	CYPROHEPTADINE HYDROCHLORIDE	2	mg/5mL			N	20241231
72162-2066_0128ca37-2085-42c9-98e8-b2f09e537f4e	72162-2066	HUMAN PRESCRIPTION DRUG	CYPROHEPTADINE HYDROCHLORIDE		CYPROHEPTADINE HYDROCHLORIDE	TABLET	ORAL	20210224		ANDA	ANDA212491	Bryant Ranch Prepack	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20241231
72162-2067_0f4d6dd3-dbbf-4e43-b21b-bc45460c0573	72162-2067	HUMAN PRESCRIPTION DRUG	Halobetasol Propionate		Halobetasol Propionate	OINTMENT	TOPICAL	20201006		ANDA	ANDA213560	Bryant Ranch Prepack	HALOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-2068_ffc6dd71-9334-4e57-b071-2f96c2b2fca3	72162-2068	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20210420		ANDA	ANDA212695	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72162-2069_f74381a6-6e39-4f51-8165-a05eb55a8c13	72162-2069	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	LOTION	TOPICAL	20200701		ANDA	ANDA213559	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	.25	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-2070_07e7a514-42e4-445b-b87d-528b1f6aaca4	72162-2070	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	LOTION	TOPICAL	20200701		ANDA	ANDA213559	Bryant Ranch Prepack	TRIAMCINOLONE ACETONIDE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-2071_462a5ca2-0edd-402e-b94d-468c31982cee	72162-2071	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	SOLUTION	ORAL	20210712		ANDA	ANDA213890	Bryant Ranch Prepack	PROMETHAZINE HYDROCHLORIDE	6.25	mg/5mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72162-2072_6fb904a6-4b74-4eb4-b2ff-ea281897352d	72162-2072	HUMAN PRESCRIPTION DRUG	PROPYLTHIOURACIL		PROPYLTHIOURACIL	TABLET	ORAL	20210318		ANDA	ANDA080154	Bryant Ranch Prepack	PROPYLTHIOURACIL	50	mg/1	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]		N	20241231
72162-2073_9b6fed2b-325d-4892-9aab-056967882c57	72162-2073	HUMAN OTC DRUG	CETIRIZINE HYDROCHLORIDE		CETIRIZINE HYDROCHLORIDE	SOLUTION	ORAL	20221015		ANDA	ANDA212266	Bryant Ranch Prepack	CETIRIZINE HYDROCHLORIDE	1	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72162-2074_0eac69b9-110e-4e7a-bfbd-7fd40a40f5ea	72162-2074	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN AND BENZOYL PEROXIDE		clindamycin and benzoyl peroxide	KIT		20150922		ANDA	ANDA202440	Bryant Ranch Prepack						N	20241231
72162-2075_28099a78-1de0-4e79-a6bb-8e630cfe319b	72162-2075	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	SOLUTION	TOPICAL	20111219		ANDA	ANDA063038	Bryant Ranch Prepack	ERYTHROMYCIN	20	mg/mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
72162-2076_541d2200-cc21-4df7-ba10-10c7001cf031	72162-2076	HUMAN PRESCRIPTION DRUG	Ciclopirox		Ciclopirox	SOLUTION	TOPICAL	20070919		ANDA	ANDA077623	Bryant Ranch Prepack	CICLOPIROX	80	mg/mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
72162-2077_9eaee68a-ae1a-4b51-89cd-353a0c4a3253	72162-2077	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Benzoyl Peroxide		Clindamycin Phosphate, Benzoyl Peroxide	GEL	TOPICAL	20190912		ANDA	ANDA205397	Bryant Ranch Prepack	BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE	25; 10	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72162-2081_005d9f18-702c-4193-bd95-274bee7236b9	72162-2081	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Bryant Ranch Prepack	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
72162-2082_308a5c8b-e02d-4660-8dd6-2df0dfd0414b	72162-2082	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Bryant Ranch Prepack	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
72162-2083_09dcc8a8-2973-42a3-b0da-0ab1ffdbb959	72162-2083	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Bryant Ranch Prepack	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
72162-2084_67786dd2-6b4e-42d8-ae81-19aa648f0a92	72162-2084	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20150810		ANDA	ANDA206297	Bryant Ranch Prepack	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72162-2085_b545f084-ccff-4a2e-8f30-ba24a947b6c9	72162-2085	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20200825		ANDA	ANDA206463	Bryant Ranch Prepack	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72162-2086_2c094f42-15da-45db-b1f0-9677177b4809	72162-2086	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20140407		ANDA	ANDA091159	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2087_2875b24d-9ec2-48dc-a24a-3c03739b5445	72162-2087	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20140407		ANDA	ANDA091159	Bryant Ranch Prepack	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72162-2088_bec95c4f-665a-4524-bebe-728ba79c16e3	72162-2088	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		Oxcarbazepine	SUSPENSION	ORAL	20120604		ANDA	ANDA202961	Bryant Ranch Prepack	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-2089_79c12221-060d-46bc-a916-880d5cbfce21	72162-2089	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Bryant Ranch Prepack	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-2090_09148b0c-5c69-4320-bb42-b99409e1fedb	72162-2090	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Bryant Ranch Prepack	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-2091_6ef7e19a-40b7-47d1-a652-a4ca871687fa	72162-2091	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Bryant Ranch Prepack	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	10; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-2092_6b0e718b-72d9-48ab-b3dd-19f2a769a032	72162-2092	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Bryant Ranch Prepack	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 10	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-2093_e53b2331-e645-40a1-8483-f5458a95feb2	72162-2093	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Bryant Ranch Prepack	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 20	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-2094_2bbff1ab-5aac-41a2-b28b-77185385a904	72162-2094	HUMAN PRESCRIPTION DRUG	Amlodipine and Atorvastatin		Amlodipine and Atorvastatin	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA205199	Bryant Ranch Prepack	AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE	5; 40	mg/1; mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-2095_bc5dae5d-22fb-438c-8eac-35156a9ad462	72162-2095	HUMAN PRESCRIPTION DRUG	Balsalazide Disodium		Balsalazide Disodium	CAPSULE	ORAL	20071228		ANDA	ANDA077883	Bryant Ranch Prepack	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
72162-2096_1bbec292-7a15-422f-86b6-4ff2551e3d43	72162-2096	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution		Brimonidine Tartrate and Timolol Maleate	SOLUTION	OPHTHALMIC	20221019		ANDA	ANDA091442	Bryant Ranch Prepack	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
72162-2097_572e4f62-2c8d-4073-9d6e-49db1ed46440	72162-2097	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72162-2098_41283cea-9309-4cfd-a0c4-66ac6457aa83	72162-2098	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	Bryant Ranch Prepack	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72162-2099_6c59ec37-8e11-4ea2-8f35-24ad0b1279f2	72162-2099	HUMAN PRESCRIPTION DRUG	Butorphanol Tartrate		Butorphanol Tartrate	SPRAY	NASAL	20021204		ANDA	ANDA075499	Bryant Ranch Prepack	BUTORPHANOL TARTRATE	10	mg/mL	Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]	CIV	N	20241231
72162-2100_1bc7d7d2-6ce7-4215-9e6d-3d8424c37636	72162-2100	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20220922		ANDA	ANDA215566	Bryant Ranch Prepack	CLORAZEPATE DIPOTASSIUM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72162-2101_5d381b6b-56f7-47de-947f-5008b87d9bff	72162-2101	HUMAN PRESCRIPTION DRUG	Desmopressin Acetate		desmopressin acetate	TABLET	ORAL	20060307		ANDA	ANDA077414	Bryant Ranch Prepack	DESMOPRESSIN ACETATE	.2	mg/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
72162-2102_457fb6bf-0eb6-46ed-96ae-5b5593306dae	72162-2102	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Bryant Ranch Prepack	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72162-2103_2efc1264-cd10-41f0-9ffc-1ae6c6061d7a	72162-2103	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	Bryant Ranch Prepack	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72162-2104_946c7208-701b-4e80-83cd-b20489c7a3f7	72162-2104	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-2105_8c308dda-e7d6-4db7-ad82-52dc53f2a269	72162-2105	HUMAN PRESCRIPTION DRUG	Guanfacine extended-release		guanfacine	TABLET, EXTENDED RELEASE	ORAL	20181003		ANDA	ANDA205430	Bryant Ranch Prepack	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72162-2106_1742c6e3-5fcb-4b1a-96be-b4418630eed4	72162-2106	HUMAN PRESCRIPTION DRUG	ICATIBANT		icatibant acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20210415		ANDA	ANDA212081	Bryant Ranch Prepack	ICATIBANT ACETATE	30	mg/3mL	Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA]		N	20241231
72162-2107_09abd9e8-a790-470b-bfe6-84a6b90adf33	72162-2107	HUMAN PRESCRIPTION DRUG	Moxifloxacin		moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20170701		ANDA	ANDA090080	Bryant Ranch Prepack	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72162-2108_68f319cd-1d79-488d-a29c-a0deee851105	72162-2108	HUMAN PRESCRIPTION DRUG	Ofloxacin		ofloxacin	SOLUTION	OPHTHALMIC	20190301		ANDA	ANDA076513	Bryant Ranch Prepack	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72162-2109_6fd73c9b-3b5b-44eb-8204-b1a2335ef95a	72162-2109	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Bryant Ranch Prepack	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72162-2110_1a79c912-e902-4a3f-ada6-7e103a9b3193	72162-2110	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20120423		ANDA	ANDA090798	Bryant Ranch Prepack	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72162-2111_e01b257c-d899-40ee-8b46-b672bd473c88	72162-2111	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20140930		ANDA	ANDA090973	Bryant Ranch Prepack	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
72162-2112_b3413c62-495a-45f4-a32d-c65c1dfa0802	72162-2112	HUMAN PRESCRIPTION DRUG	Penicillamine		Penicillamine	CAPSULE	ORAL	20200626		ANDA	ANDA213310	Bryant Ranch Prepack	PENICILLAMINE	250	mg/1	Antirheumatic Agent [EPC]		N	20241231
72162-2113_e8b5f64d-fdce-4460-824a-fc51d983a2a2	72162-2113	HUMAN PRESCRIPTION DRUG	PENTOXIFYLLINE		PENTOXIFYLLINE	TABLET, EXTENDED RELEASE	ORAL	19990610		ANDA	ANDA075191	Bryant Ranch Prepack	PENTOXIFYLLINE	400	mg/1	Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]		N	20241231
72162-2114_623f0111-0829-4a67-afb6-ff4bdc05ca76	72162-2114	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	Bryant Ranch Prepack	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72162-2115_71eb02c6-a6c3-4c5e-828c-b8b3cff124fd	72162-2115	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Bryant Ranch Prepack	PREGABALIN	300	mg/1		CV	N	20241231
72162-2116_b41aea2d-979c-48e1-a39e-60b47653b4e5	72162-2116	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72162-2117_276cf9b0-5bcc-49de-b687-69a5522f3458	72162-2117	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72162-2118_589c9e0f-0d70-40b0-99c2-e842cc686f84	72162-2118	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20030201		ANDA	ANDA076140	Bryant Ranch Prepack	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72162-2119_cfb9ebc5-4268-4d5b-a5db-1078913644bf	72162-2119	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210120		ANDA	ANDA214603	Bryant Ranch Prepack	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
72162-2120_29ad8572-bd95-44f4-a554-307431397d2d	72162-2120	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Bryant Ranch Prepack	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72162-2121_f22f9988-78e9-4600-9376-55c79e35445c	72162-2121	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Bryant Ranch Prepack	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72162-2122_4ee28ca5-549e-4bcf-b77f-9fe341a6631b	72162-2122	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	Bryant Ranch Prepack	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72162-2127_12f8f431-4e52-4da2-9d29-29b19919d590	72162-2127	HUMAN PRESCRIPTION DRUG	Azelastine hydrochloride and Fluticasone propionate		Azelastine hydrochloride and Fluticasone propionate	SPRAY, METERED	NASAL	20200302		ANDA	ANDA207712	Bryant Ranch Prepack	AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE	137; 50	ug/1; ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72162-2128_b292fa22-c05c-48b2-9c01-85df023ffcae	72162-2128	HUMAN PRESCRIPTION DRUG	Calcitonin Salmon		Calcitonin Salmon	SPRAY, METERED	NASAL	20081209		ANDA	ANDA076396	Bryant Ranch Prepack	CALCITONIN SALMON	200	[iU]/1	Calcitonin [CS], Calcitonin [EPC]		N	20241231
72162-2129_a1e66b1f-d142-4057-8b1f-ab8852e2be30	72162-2129	HUMAN PRESCRIPTION DRUG	DESMOPRESSIN ACETATE		DESMOPRESSIN ACETATE	SPRAY	NASAL	20201130		ANDA	ANDA076703	Bryant Ranch Prepack	DESMOPRESSIN ACETATE	10	ug/1	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
72162-2132_85467051-7eeb-4ead-b2ad-1e90fe50b34e	72162-2132	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Bryant Ranch Prepack	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72162-2133_7dbbb7ec-f74a-49c3-8a97-92e9988da826	72162-2133	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20220805		ANDA	ANDA212878	Bryant Ranch Prepack	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72162-2134_deceb103-0c69-4dea-8c7b-92f50e8b872b	72162-2134	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20220805		ANDA	ANDA212875	Bryant Ranch Prepack	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72162-2135_fd9d4f22-3611-48d8-bcec-b6bb04e30d02	72162-2135	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	CREAM	TOPICAL	20170615		ANDA	ANDA075264	Bryant Ranch Prepack	TRETINOIN	.25	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
72162-2136_92b4aea8-02bd-42ad-9283-48705f7a2b6a	72162-2136	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET	ORAL	20210629		ANDA	ANDA078662	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72162-2137_3fe02a9a-5669-4c94-880b-512b3b81b8d0	72162-2137	HUMAN PRESCRIPTION DRUG	Donepezil Hydrochloride		Donepezil Hydrochloride	TABLET	ORAL	20210629		ANDA	ANDA078662	Bryant Ranch Prepack	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72162-2138_a4923880-ef29-4fc1-97f1-9377ddf57418	72162-2138	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-2139_a748e9eb-d46d-47ef-bb79-5b72078e8f36	72162-2139	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-2140_5734a653-53ce-4850-9c6d-c426d9899846	72162-2140	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	Bryant Ranch Prepack	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-2141_8b6e731b-e52c-4a2d-8fba-c994d9f015d3	72162-2141	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Bryant Ranch Prepack	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-2142_11e02a31-1049-4394-bbe9-6eb593aa8e00	72162-2142	HUMAN PRESCRIPTION DRUG	Gabapentin		GABAPENTIN	TABLET, FILM COATED	ORAL	20140111		ANDA	ANDA203244	Bryant Ranch Prepack	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72162-2143_0b496d6c-b45d-49f7-a32b-8913fef91546	72162-2143	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY	NASAL	20031105		ANDA	ANDA076664	Bryant Ranch Prepack	IPRATROPIUM BROMIDE	21	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72162-2144_615cf38d-092a-4ed8-a75a-dfd1384f15af	72162-2144	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SPRAY	NASAL	20031105		ANDA	ANDA076598	Bryant Ranch Prepack	IPRATROPIUM BROMIDE	42	ug/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72162-2145_58759ee9-29d7-4b3e-8b95-d4857eeffadd	72162-2145	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	19900930		ANDA	ANDA062702	Bryant Ranch Prepack	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72162-2146_c7b12686-fc8d-496d-86b1-cdc7cda111cf	72162-2146	HUMAN PRESCRIPTION DRUG	fluocinonide		fluocinonide	SOLUTION	TOPICAL	19950227		ANDA	ANDA072934	Bryant Ranch Prepack	FLUOCINONIDE	.5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-2147_e1d1616f-a099-43d4-ba18-9d04b17b301b	72162-2147	HUMAN PRESCRIPTION DRUG	clindamycin phosphate		clindamycin phosphate	LOTION	TOPICAL	20020131		ANDA	ANDA065067	Bryant Ranch Prepack	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72162-2148_bac70d70-49e4-444c-af43-49eac58d7a99	72162-2148	HUMAN PRESCRIPTION DRUG	Pacerone		Amiodarone Hydrochloride	TABLET	ORAL	20101115		ANDA	ANDA075135	Bryant Ranch Prepack	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72162-2149_28ad1ec2-6253-400b-8a82-ba85994a49ec	72162-2149	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20190307		ANDA	ANDA080292	Bryant Ranch Prepack	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-2150_221eb6a5-7e95-4219-9d19-9415d4578a38	72162-2150	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	19810203		ANDA	ANDA040424	Bryant Ranch Prepack	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72162-2151_2d3f3959-77b9-418f-9e9a-eccb0501dadf	72162-2151	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		abiraterone acetate	TABLET, FILM COATED	ORAL	20201214		ANDA	ANDA208446	Bryant Ranch Prepack	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
72162-2152_797ce897-04ec-461a-a733-f3afe7658ebc	72162-2152	HUMAN PRESCRIPTION DRUG	Fenofibrate		fenofibrate	TABLET, FILM COATED	ORAL	20091222		ANDA	ANDA076520	Bryant Ranch Prepack	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
72162-2154_ba53c1a1-0bc1-444f-9dc8-fbd07df724d0	72162-2154	HUMAN PRESCRIPTION DRUG	NALTREXONE HYDROCHLORIDE		naltrexone hydrochloride	TABLET, FILM COATED	ORAL	20020322		ANDA	ANDA076264	Bryant Ranch Prepack	NALTREXONE HYDROCHLORIDE	50	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
72162-2158_18123135-e777-4378-b2b4-acbbf8e9a281	72162-2158	HUMAN PRESCRIPTION DRUG	TRETINOIN		tretinoin	CREAM	TOPICAL	20170426		ANDA	ANDA075265	Bryant Ranch Prepack	TRETINOIN	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
72162-2159_71adf84e-3467-4ef3-9156-72524d92ae6b	72162-2159	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	TOPICAL	20130701		ANDA	ANDA090903	Bryant Ranch Prepack	METRONIDAZOLE	10	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72162-2160_ce490345-782c-48fa-b608-b02c6cd1d9de	72162-2160	HUMAN PRESCRIPTION DRUG	Calcipotriene		Calcipotriene	CREAM	TOPICAL	20120727		ANDA	ANDA200935	Bryant Ranch Prepack	CALCIPOTRIENE	.05	mg/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
72162-2161_139cc3b9-c35f-4724-a954-3818bf9216a0	72162-2161	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20201026		ANDA	ANDA213815	Bryant Ranch Prepack	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
72162-2165_ef7feab3-8be2-48fc-9884-8c5ea98c29aa	72162-2165	HUMAN PRESCRIPTION DRUG	Proctosol-HC		Hydrocortisone	CREAM	TOPICAL	20050428		ANDA	ANDA088799	Bryant Ranch Prepack	HYDROCORTISONE	25	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72162-2166_dccae2c2-a35c-4bd6-8d02-02e150bcfa0a	72162-2166	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20090714		ANDA	ANDA090037	Bryant Ranch Prepack	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-2167_b2cc26b2-1108-4186-943c-9b9f200cbc28	72162-2167	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20150331		ANDA	ANDA040604	Bryant Ranch Prepack	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72162-2168_ebdd40ad-00e7-46e8-bad8-47c8f62c98d3	72162-2168	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20100716		ANDA	ANDA075517	Bryant Ranch Prepack	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72162-2169_8d67f7ec-a03b-4bf7-9cd6-b31c1a27e82c	72162-2169	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20190722		ANDA	ANDA091693	Bryant Ranch Prepack	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
72162-2170_69d90731-598d-4cfa-93f3-b9641d385d9f	72162-2170	HUMAN PRESCRIPTION DRUG	Fenofibrate		FENOFIBRATE	TABLET, FILM COATED	ORAL	20200131		ANDA	ANDA210670	Bryant Ranch Prepack	FENOFIBRATE	160	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
72162-2171_61521c4b-0a38-4e6a-9ce7-7f55f56661e2	72162-2171	HUMAN PRESCRIPTION DRUG	Permethrin		Permethrin	CREAM	TOPICAL	20060811		ANDA	ANDA076369	Bryant Ranch Prepack	PERMETHRIN	50	mg/g	Pyrethrins [CS], Pyrethroid [EPC]		N	20241231
72162-2174_2a3d5064-e336-459f-b0dc-28e50256b32e	72162-2174	HUMAN PRESCRIPTION DRUG	Methotrexate		Methotrexate Sodium	TABLET	ORAL	20171110		ANDA	ANDA201749	Bryant Ranch Prepack	METHOTREXATE SODIUM	2.5	mg/1	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
72162-2175_0dcdc9d4-9431-4710-8153-467d87798748	72162-2175	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	Bryant Ranch Prepack	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72162-2176_98aba35d-89dd-4131-9713-ca3952802767	72162-2176	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA212650	Bryant Ranch Prepack	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
72162-2177_134a42de-4b00-48ab-bd5e-8061b1ee3ff5	72162-2177	HUMAN PRESCRIPTION DRUG	Bisoprolol		Bisoprolol fumarate	TABLET, FILM COATED	ORAL	20190620		ANDA	ANDA075474	Bryant Ranch Prepack	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-2178_0e4349d6-3206-414b-8669-ba6418b45113	72162-2178	HUMAN PRESCRIPTION DRUG	Clotrimazole Topical Solution USP, 1%		Clotrimazole Topical Solution USP, 1%	SOLUTION	TOPICAL	20190725		ANDA	ANDA212281	Bryant Ranch Prepack	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72162-2182_5edad2a6-17f5-462d-a015-88b65acd2d7f	72162-2182	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Bryant Ranch Prepack	TERAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72162-2183_f9207674-ed52-47b9-b675-ce98abbab9a8	72162-2183	HUMAN PRESCRIPTION DRUG	Terazosin		Terazosin Hydrochloride	CAPSULE	ORAL	20041220		ANDA	ANDA075317	Bryant Ranch Prepack	TERAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72162-2184_2d368eee-4a07-4885-a62d-868ed570e307	72162-2184	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride and Timolol Maleate		Dorzolamide Hydrochloride and Timolol Maleate	SOLUTION	OPHTHALMIC	20100102		ANDA	ANDA090604	Bryant Ranch Prepack	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-2185_dac7c3d4-11cb-4bec-bb4f-b381f97d2175	72162-2185	HUMAN PRESCRIPTION DRUG	Timolol GFS		timolol maleate	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	19981224		NDA	NDA020963	Bryant Ranch Prepack	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-2186_e3e5516d-4892-41da-860c-aed90d582028	72162-2186	HUMAN PRESCRIPTION DRUG	doxycycline hyclate		doxycycline hyclate	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Bryant Ranch Prepack	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72162-2187_f881471f-7964-417d-b532-347965d5003f	72162-2187	HUMAN PRESCRIPTION DRUG	Potassium Citrate		potassium citrate	TABLET	ORAL	20131223		NDA AUTHORIZED GENERIC	NDA019071	Bryant Ranch Prepack	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72162-2188_f8f55a27-96c4-4821-8160-3e4c9e350602	72162-2188	HUMAN PRESCRIPTION DRUG	SODIUM SULFACETAMIDE AND SULFUR		sodium sulfacetamide, sulfur	LOTION	TOPICAL	20110415		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM; SULFUR	90; 45	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
72162-2189_1dd47f22-4b85-47f0-a77b-1b115de74692	72162-2189	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide, Sulfur		SULFACETAMIDE SODIUM, SULFUR	EMULSION	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM; SULFUR	100; 20	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
72162-2190_69548a67-432d-4b29-b75b-ad4505cf9755	72162-2190	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM, SULFUR		SULFACETAMIDE SODIUM, SULFUR	EMULSION	TOPICAL	20110915		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
72162-2192_19ce6319-70d3-4777-b057-94622d23502b	72162-2192	HUMAN PRESCRIPTION DRUG	UREA		UREA	CREAM	TOPICAL	20180315		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	400	mg/g			N	20241231
72162-2193_78f6b350-9ca5-47e2-9486-3ccd66b75bee	72162-2193	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20211005		ANDA	ANDA214091	Bryant Ranch Prepack	CARBIDOPA; LEVODOPA	50; 200	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
72162-2194_e1628e16-ce5d-45cf-848e-90ab56094c42	72162-2194	HUMAN PRESCRIPTION DRUG	Carbidopa and Levodopa		Carbidopa and Levodopa	TABLET, EXTENDED RELEASE	ORAL	20211005		ANDA	ANDA214091	Bryant Ranch Prepack	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
72162-2195_ebad853f-d83c-40df-8418-c68ccb392e6f	72162-2195	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Bryant Ranch Prepack	BUMETANIDE	.5	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72162-2196_8c8ef80d-5af1-485a-9e9c-4e92beef3734	72162-2196	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Bryant Ranch Prepack	BUMETANIDE	1	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72162-2197_5e494f24-6b56-410e-b39e-df0e2af10502	72162-2197	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	TABLET	ORAL	19961121		ANDA	ANDA074700	Bryant Ranch Prepack	BUMETANIDE	2	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72162-2198_7f87cc13-2308-42f1-ac72-62001ddd2328	72162-2198	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20190726		ANDA	ANDA210955	Bryant Ranch Prepack	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72162-2199_c461477c-ba9b-418d-99e2-a5bedd3e994a	72162-2199	HUMAN PRESCRIPTION DRUG	Buspirone hydrochloride		Buspirone hydrochloride	TABLET	ORAL	20230321		ANDA	ANDA078888	Bryant Ranch Prepack	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
72162-2200_8b049ebc-b842-4f07-ac6f-eb4bf350240a	72162-2200	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA079229	Bryant Ranch Prepack	ROPINIROLE HYDROCHLORIDE	.5	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
72162-2201_584621b7-07b3-45c9-8e3d-8f21391cf3f1	72162-2201	HUMAN PRESCRIPTION DRUG	BRINZOLAMIDE		brinzolamide	SUSPENSION/ DROPS	OPHTHALMIC	20231010		ANDA	ANDA211914	Bryant Ranch Prepack	BRINZOLAMIDE	10	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
72162-2202_a39d0349-4ac5-4d43-8170-e770c22f7670	72162-2202	HUMAN PRESCRIPTION DRUG	TAZAROTENE		tazarotene	GEL	TOPICAL	20230605		ANDA	ANDA213079	Bryant Ranch Prepack	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
72162-2203_cf40f616-a8ed-4a77-98d2-959d864b373b	72162-2203	HUMAN PRESCRIPTION DRUG	Urea Cream 40 Percent		Urea	CREAM	TOPICAL	20231031		UNAPPROVED DRUG OTHER		Bryant Ranch Prepack	UREA	400	mg/g			N	20241231
72162-2204_9262cc6e-b3d1-497e-8e34-eeeef227cdd5	72162-2204	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085785	Bryant Ranch Prepack	TRIFLUOPERAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
72162-2205_39161b62-ff99-4ca1-99cf-b4476980f139	72162-2205	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085788	Bryant Ranch Prepack	TRIFLUOPERAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
72162-2206_49b69e65-918a-4524-84a3-4e3b6d002516	72162-2206	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085786	Bryant Ranch Prepack	TRIFLUOPERAZINE HYDROCHLORIDE	2	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
72162-2207_3726d581-c83b-4eaa-b4ec-415152249f4d	72162-2207	HUMAN PRESCRIPTION DRUG	Trifluoperazine Hydrochloride		Trifluoperazine Hydrochloride	TABLET, FILM COATED	ORAL	19811120		ANDA	ANDA085789	Bryant Ranch Prepack	TRIFLUOPERAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20251231
72162-2208_55aa3d72-be35-4b1d-9a44-f217329e573c	72162-2208	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20200814		ANDA	ANDA213358	Bryant Ranch Prepack	TAMOXIFEN CITRATE	10	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20251231
72162-2209_b78898be-5983-4297-88c3-ce1369c51542	72162-2209	HUMAN PRESCRIPTION DRUG	Tamoxifen Citrate		Tamoxifen Citrate	TABLET, FILM COATED	ORAL	20200814		ANDA	ANDA213358	Bryant Ranch Prepack	TAMOXIFEN CITRATE	20	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20251231
72162-2210_761e2c53-aac2-46ae-8634-4e5d8f04ca8c	72162-2210	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020315		ANDA	ANDA065064	Bryant Ranch Prepack	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20251231
72162-2211_b7c0feb0-7163-4ac1-ac82-08771c22e00e	72162-2211	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20020314		ANDA	ANDA065063	Bryant Ranch Prepack	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20251231
72162-2212_0ae0a458-0119-486c-a658-698a6b7a3695	72162-2212	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20150915		ANDA	ANDA204165	Bryant Ranch Prepack	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20251231
72162-2213_989dae8c-5fd6-4df1-bd3a-43a31abc7615	72162-2213	HUMAN PRESCRIPTION DRUG	MESALAMINE		mesalamine	TABLET, DELAYED RELEASE	ORAL	20230603		ANDA	ANDA217337	Bryant Ranch Prepack	MESALAMINE	1.2	g/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20251231
72162-2214_f2ffd057-f79c-4337-9647-a9779b305b79	72162-2214	HUMAN PRESCRIPTION DRUG	Dexlansoprazole		Dexlansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221122		ANDA	ANDA202294	Bryant Ranch Prepack	DEXLANSOPRAZOLE	60	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
72162-2215_0dbcf947-6edf-445a-b6b2-e1e76b9d78a8	72162-2215	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20211213		ANDA	ANDA074497	Bryant Ranch Prepack	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20251231
72162-2216_a0de8320-488d-4cd2-b976-68067f7222fe	72162-2216	HUMAN PRESCRIPTION DRUG	lisdexamfetamine dimesylate		lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825		ANDA	ANDA214547	Bryant Ranch Prepack	LISDEXAMFETAMINE DIMESYLATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20251231
72162-2217_566e638b-1851-45e0-b04e-9c547be44c27	72162-2217	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	Bryant Ranch Prepack	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20251231
72162-2218_9a67ef83-a5ef-42b4-a591-12cd03661b6a	72162-2218	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230126		ANDA	ANDA201962	Bryant Ranch Prepack	VARENICLINE TARTRATE	.5	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20251231
72162-2219_ed1af2c2-4bbc-4ea9-882f-ae635c7e295a	72162-2219	HUMAN PRESCRIPTION DRUG	VARENICLINE		VARENICLINE	TABLET, FILM COATED	ORAL	20230126		ANDA	ANDA201962	Bryant Ranch Prepack	VARENICLINE TARTRATE	1	mg/1	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20251231
72162-2220_30c594bc-5a53-44ba-9f2b-ab6bdc637032	72162-2220	HUMAN PRESCRIPTION DRUG	ZAFEMY		Norelgestromin and Ethinyl Estradiol	PATCH	TRANSDERMAL	20200628		ANDA	ANDA213950	Bryant Ranch Prepack	ETHINYL ESTRADIOL; NORELGESTROMIN	35; 150	ug/d; ug/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20251231
72164-000_ebe74164-255c-60e3-e053-2a95a90adb64	72164-000	HUMAN OTC DRUG	Twilight Peppermint with Vanilla and Lavender		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE	DENTAL	20180518		OTC MONOGRAPH NOT FINAL	part356	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.4	mg/g; mg/g			N	20241231
72164-001_ebe7cc38-e054-1d14-e053-2a95a90aad8f	72164-001	HUMAN OTC DRUG	Early Bird Wintergreen and Peppermint		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE	DENTAL	20180518		OTC MONOGRAPH NOT FINAL	part356	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.4	mg/g; mg/g			N	20241231
72164-002_0d0042ce-c0c7-bd55-e063-6294a90a6bec	72164-002	HUMAN OTC DRUG	Twice Science and Wellness Calming Vanilla Lavender Mint		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE, DENTIFRICE	TOPICAL	20200930		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.4	mg/g; mg/g			N	20241231
72164-003_0d0042ce-c0d4-bd55-e063-6294a90a6bec	72164-003	HUMAN OTC DRUG	Twice Science and Wellness Invigorating Wintergreen and Peppermint		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE, DENTIFRICE	TOPICAL	20200930		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.4	mg/g; mg/g			N	20241231
72164-004_0d004edb-7e81-05a6-e063-6394a90a6ca8	72164-004	HUMAN OTC DRUG	Twice Science Wellness Cooling Spearmint Eucalyptus		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20210102		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.5	mg/g; mg/g			N	20241231
72164-005_0d0b8a06-8584-2cfe-e063-6294a90af7a0	72164-005	HUMAN OTC DRUG	Wintergreen Peppermint		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220301		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.5	mg/g; mg/g			N	20241231
72164-006_0d0b8e90-2068-1c76-e063-6394a90af668	72164-006	HUMAN OTC DRUG	Spearmint Eucalyptus		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220301		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.5	mg/g; mg/g			N	20241231
72164-007_0d0b7898-9322-11d2-e063-6394a90aac0c	72164-007	HUMAN OTC DRUG	Vanilla Lavender Mint		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20220301		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 1.5	mg/g; mg/g			N	20241231
72164-100_0d0042ce-c0e1-bd55-e063-6294a90a6bec	72164-100	HUMAN OTC DRUG	The Duo		POTASSIUM NITRATE, SODIUM FLUORIDE	KIT		20180914		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.						N	20241231
72164-101_0d002185-d46e-d439-e063-6294a90ac30e	72164-101	HUMAN OTC DRUG	4 Pack		POTASSIUM NITRATE, SODIUM FLUORIDE	KIT		20180914		OTC MONOGRAPH DRUG	M022	Smiletwice, Inc.						N	20241231
72164-102_0d0042ce-c0b8-bd55-e063-6294a90a6bec	72164-102	HUMAN OTC DRUG	Mini Duo		POTASSIUM NITRATE, SODIUM FLUORIDE	KIT		20200301		OTC MONOGRAPH DRUG	part355B	Smiletwice, Inc.						N	20241231
72169-510_43239654-eb2e-4c04-b86d-37ef8ae5fe61	72169-510	HUMAN OTC DRUG	Look At Me Expert Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333E	Youngwon Costech Co.,ltd.	ALCOHOL	350	mL/500mL			N	20241231
72169-520_dc5ad9ba-b1cc-45ca-8595-978e6e13c261	72169-520	HUMAN OTC DRUG	LOOK AT ME INVISIBLE ACNE		Salicylic Acid	PATCH	TOPICAL	20210801		OTC MONOGRAPH FINAL	part333D	Youngwon Costech Co.,ltd.	SALICYLIC ACID	.005	g/1			N	20241231
72169-530_c4cdf26e-6c60-4fe5-a203-e0d777b03b05	72169-530	HUMAN OTC DRUG	LOOK AT ME INVISIBLE ACNE		Salicylic Acid	PATCH	TOPICAL	20220401		OTC MONOGRAPH FINAL	part333D	Youngwon Costech Co.,ltd.	SALICYLIC ACID	.005	g/1			N	20241231
72169-540_1c0d97a2-72fe-40cd-bea0-39d85aeaebc1	72169-540	HUMAN OTC DRUG	DONT BE SHY ACNE		Salicylic Acid	PATCH	TOPICAL	20230801		OTC MONOGRAPH FINAL	part333D	Youngwon Costech Co.,ltd.	SALICYLIC ACID	.005	g/1			N	20241231
72172-001_eff39617-fb01-331e-e053-2995a90a1c76	72172-001	HUMAN OTC DRUG	Common Sense		Alcohol	LIQUID	TOPICAL	20180815		OTC MONOGRAPH NOT FINAL	part333E	Microbe Solutions, LLC	ALCOHOL	62	mL/100mL			N	20241231
72177-180_e99b21f7-5d92-95da-e053-2995a90a944a	72177-180	HUMAN OTC DRUG	Handi-Kleen Antibacterial	Foaming Hand Wash	Chloroxylenol	LIQUID	TOPICAL	20210203	20240726	OTC MONOGRAPH NOT FINAL	part333E	Diamond Chemical Co. Inc.	CHLOROXYLENOL	.3	g/100mL			N	
72184-001_c88df38f-6f33-3e76-e053-2995a90a468f	72184-001	HUMAN OTC DRUG	Theresienol MD Skin Protectant		Lanolin	LIQUID	TOPICAL	20180326	20250731	OTC MONOGRAPH FINAL	part347	Fordee Group, LLC	LANOLIN	12.5	g/100mL			N	
72187-0101_8195fa6c-91ac-4fe6-af1b-33881aae7e4c	72187-0101	HUMAN PRESCRIPTION DRUG	ORSERDU		Elacestrant	TABLET, FILM COATED	ORAL	20230127		NDA	NDA217639	Stemline Therapeutics, Inc.	ELACESTRANT	86	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72187-0102_8195fa6c-91ac-4fe6-af1b-33881aae7e4c	72187-0102	HUMAN PRESCRIPTION DRUG	ORSERDU		Elacestrant	TABLET, FILM COATED	ORAL	20230127		NDA	NDA217639	Stemline Therapeutics, Inc.	ELACESTRANT	345	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72187-0401_fb0fe1fc-42ab-4a79-a73d-7f2999af9786	72187-0401	HUMAN PRESCRIPTION DRUG	Elzonris		tagraxofusp	INJECTION, SOLUTION	INTRAVENOUS	20190118		BLA	BLA761116	Stemline Therapeutics, Inc.	TAGRAXOFUSP	1000	ug/mL	CD123 Interaction [EPC], CD123 Interactions [MoA], Cytotoxin [EPC], Cytotoxins [CS]		N	20241231
72188-170_09dc681e-2348-4213-e063-6394a90a41e1	72188-170	HUMAN OTC DRUG	MAXOCAINE PAIN RELIEVING ROLL-ON		LIDOCAINE HYDROCHLORIDE, MENTHOL	LIQUID	TOPICAL	20180301		OTC MONOGRAPH DRUG	M017	Prime Commerce, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72188-188_09dc64a4-8591-ddca-e063-6294a90ab8f1	72188-188	HUMAN OTC DRUG	MAXOCAINE Lidocaine Hemp Oil Topical Analgesic		LIDOCAINE HYDROCHLORIDE	SOLUTION	TOPICAL	20210424		OTC MONOGRAPH DRUG	M017	Prime Commerce, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-004_8b9f7474-8d8a-b3e6-e053-2995a90aeddb	72189-004	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20190618		ANDA	ANDA077538	Direct_RX	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-006_ff1fa994-def7-e3d4-e053-6294a90ad8be	72189-006	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20190625		ANDA	ANDA062396	Direct_Rx	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72189-008_cbe5e01e-67c6-f8a2-e053-2995a90a0d15	72189-008	HUMAN PRESCRIPTION DRUG	Methylpred DP		Methylpred DP	TABLET	ORAL	20190626		ANDA	ANDA040194	Direct_Rx	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-009_ff1fce6b-be5f-ecf3-e053-6394a90ac765	72189-009	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20190626		ANDA	ANDA201507	Direct_Rx	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72189-012_ff328439-b70e-9387-e053-6294a90a45cb	72189-012	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20190717		ANDA	ANDA091629	Direct_Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-015_e9d30cc4-3615-659d-e053-2a95a90a1b94	72189-015	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	TABLET, FILM COATED	ORAL	20190724		ANDA	ANDA207398	Direct_Rx	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72189-019_8efaf0a6-955b-f74d-e053-2a95a90ab339	72189-019	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190731		ANDA	ANDA208677	Direct_Rx	PREGABALIN	50	mg/1		CV	N	20241231
72189-019_8efb49b4-27ea-a1a1-e053-2a95a90ae5b8	72189-019	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190731		ANDA	ANDA208677	Direct_Rx	PREGABALIN	50	mg/1		CV	N	20241231
72189-019_d167de93-2576-2c0c-e053-2995a90a81c9	72189-019	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190731		ANDA	ANDA208677	Direct_Rx	PREGABALIN	50	mg/1		CV	N	20241231
72189-021_eac5541f-ab31-6513-e053-2a95a90a3aef	72189-021	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190730		ANDA	ANDA208677	Direct_Rx	PREGABALIN	75	mg/1		CV	N	20241231
72189-027_ff1fd705-a152-4a34-e053-6394a90a02ef	72189-027	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20191002		ANDA	ANDA210733	Direct_Rx	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72189-031_92fce88e-9fe0-43a8-e053-2995a90a5867	72189-031	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20190920		ANDA	ANDA200292	Direct_Rx	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72189-031_93dd96a4-3a75-ea7e-e053-2a95a90ab0a4	72189-031	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191001		ANDA	ANDA200292	Direct_Rx	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72189-031_ca90724d-86f5-8353-e053-2a95a90af420	72189-031	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191001		ANDA	ANDA200292	Direct_Rx	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72189-033_ffbfa36e-650e-8b35-e053-6394a90a9dfb	72189-033	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190905		ANDA	ANDA209743	Direct_Rx	PREGABALIN	100	mg/1		CV	N	20241231
72189-037_ff44e969-fc65-ac2d-e053-6294a90a25bb	72189-037	HUMAN PRESCRIPTION DRUG	VALACYCLOVIR HYDROCHLORIDE		VALACYCLOVIR HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20191118		ANDA	ANDA201506	DIRECT RX	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72189-039_d103ac3e-c8dc-4546-e053-2995a90aa0f5	72189-039	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	CREAM	TOPICAL	20191001		ANDA	ANDA088042	Direct_Rx	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-043_cc1f06ae-3fc2-714c-e053-2995a90ac865	72189-043	HUMAN PRESCRIPTION DRUG	CEFDINIR		CEFDINIR	POWDER, FOR SUSPENSION	ORAL	20191125		ANDA	ANDA065259	DIRECT RX	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-045_ffbfa36e-650e-8b35-e053-6394a90a9dfb	72189-045	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20201201		ANDA	ANDA209743	Direct_Rx	PREGABALIN	225	mg/1		CV	N	20241231
72189-051_ff44e969-fc65-ac2d-e053-6294a90a25bb	72189-051	HUMAN PRESCRIPTION DRUG	VALACYCLOVIR		VALACYCLOVIR	TABLET, FILM COATED	ORAL	20200617		ANDA	ANDA203047	DIRECT RX	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72189-057_ff320bb1-b703-3618-e053-6394a90a2795	72189-057	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20191108		ANDA	ANDA202304	DIRECT RX	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72189-059_fea92dde-d87f-5799-e053-6394a90ad1ee	72189-059	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20191111		ANDA	ANDA076341	DIRECT RX	PRAVASTATIN SODIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-060_fea92dde-d87f-5799-e053-6394a90ad1ee	72189-060	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20191111		ANDA	ANDA076341	DIRECT RX	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-061_fea92dde-d87f-5799-e053-6394a90ad1ee	72189-061	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20191111		ANDA	ANDA076341	DIRECT RX	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-063_a835b697-2bec-1ba8-e053-2995a90a470c	72189-063	HUMAN PRESCRIPTION DRUG	LAMOTRIGINE		LAMOTRIGINE	TABLET	ORAL	20200616		ANDA	ANDA090170	DIRECT RX	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72189-064_eac55694-f21f-1f19-e053-2995a90ab603	72189-064	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200617		ANDA	ANDA090295	direct rx	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72189-065_ff1fc9a9-3741-66a2-e053-6294a90a79f0	72189-065	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN		ROSUVASTATIN	TABLET, FILM COATED	ORAL	20191210		ANDA	ANDA208898	DIRECT RX	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-067_e9d2facc-c0e7-cf6a-e053-2995a90a7ebe	72189-067	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE HYDROCHLORIDE	CAPSULE	ORAL	20200107		ANDA	ANDA078619	DIRECT RX	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-069_eac578bf-ccec-e432-e053-2995a90af957	72189-069	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET, FILM COATED	ORAL	20200617		ANDA	ANDA202659	DIRECT RX	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72189-070_a825166c-fac3-06b1-e053-2995a90a58cf	72189-070	HUMAN PRESCRIPTION DRUG	GLIPIZIDE ER		glipizide	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200615		ANDA	ANDA076467	DIRECT RX	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72189-071_ff1fc41a-e7b1-476e-e053-6394a90a9f6e	72189-071	HUMAN PRESCRIPTION DRUG	PHENTERMINE HYDROCHLORIDE		PHENTERMINE HYDROCHLORIDE	CAPSULE	ORAL	20200617		ANDA	ANDA087022	direct rx	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72189-072_ff32e332-8830-e529-e053-6394a90acd5d	72189-072	HUMAN PRESCRIPTION DRUG	NABUMETONE		NABUMETONE	TABLET	ORAL	20200618		ANDA	ANDA078420	direct rx	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-073_ff32e332-8815-e529-e053-6394a90acd5d	72189-073	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20200730		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-074_a834d1cf-72fd-93bf-e053-2995a90a6191	72189-074	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	TABLET	ORAL	20200616		ANDA	ANDA070217	DIRECT RX	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72189-075_cc1d8eb6-4958-1878-e053-2a95a90a83d4	72189-075	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		DICLOFENAC SODIUM	SOLUTION	TOPICAL	20200515		ANDA	ANDA206116	DIRECT RX	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-080_ff1fddae-16ca-c822-e053-6394a90acc0a	72189-080	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200513		ANDA	ANDA208170	DIRECT RX	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72189-081_e8bc02a8-3a58-b609-e053-2995a90a27fb	72189-081	HUMAN PRESCRIPTION DRUG	CLONAZEPAM		CLONAZEPAM	TABLET	ORAL	20200615		ANDA	ANDA077856	DIRECT RX	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-082_c42fea0c-d80e-061c-e053-2995a90a9b8d	72189-082	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200616		ANDA	ANDA078243	DIRECT RX	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-084_a18a3f7e-7255-56c0-e053-2a95a90a7036	72189-084	HUMAN PRESCRIPTION DRUG	IMIQUIMOD		IMIQUIMOD	CREAM	TOPICAL	20200323		ANDA	ANDA078837	DIRECT RX	IMIQUIMOD	12.5	mg/.25g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
72189-086_e9a9a8f9-476c-af4c-e053-2a95a90a1e50	72189-086	HUMAN PRESCRIPTION DRUG	Lidothol Gel		Lidothol Gel	GEL	TOPICAL	20220927		UNAPPROVED DRUG OTHER		Direct_Rx	LIDOCAINE HYDROCHLORIDE; MENTHOL	4.5; 5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-087_e9d3271f-0be2-5d04-e053-2995a90aaf84	72189-087	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	TABLET, FILM COATED	ORAL	20200615		ANDA	ANDA207370	DIRECT RX	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72189-088_e9d3271f-0be2-5d04-e053-2995a90aaf84	72189-088	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	TABLET, FILM COATED	ORAL	20200618		ANDA	ANDA210001	DIRECT RX	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72189-089_e9d3271f-0be2-5d04-e053-2995a90aaf84	72189-089	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN DIHYDRATE		AZITHROMYCIN DIHYDRATE	TABLET, FILM COATED	ORAL	20201015		ANDA	ANDA208250	DIRECT RX	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72189-090_ed9d1765-4166-fd20-e053-2995a90a3e06	72189-090	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN DIHYDRATE		AZITHROMYCIN DIHYDRATE	TABLET, FILM COATED	ORAL	20200522		ANDA	ANDA208249	DIRECT RX	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72189-092_a5b47f89-ed36-31de-e053-2a95a90a5554	72189-092	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA200651	DIRECT RX	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-093_e9d3271f-0be2-5d04-e053-2995a90aaf84	72189-093	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA210000	DIRECT RX	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72189-094_0879b292-9b37-b225-e063-6394a90a3800	72189-094	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20200615		ANDA	ANDA091393	DIRECT RX	OXYCODONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-095_0879b292-9b37-b225-e063-6394a90a3800	72189-095	HUMAN PRESCRIPTION DRUG	OXYCODONE HYDROCHLORIDE		OXYCODONE HYDROCHLORIDE	TABLET	ORAL	20200615		ANDA	ANDA204021	DIRECT RX	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-096_a5b5da65-a4d6-1bd5-e053-2a95a90a6a60	72189-096	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200515		ANDA	ANDA203835	DIRECT RX	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-097_ff200d6f-f4a5-23f4-e053-6294a90a74e2	72189-097	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220927		ANDA	ANDA203835	Direct_Rx	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-098_ff328439-b70e-9387-e053-6294a90a45cb	72189-098	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20200612		ANDA	ANDA077157	Direct_Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-099_a7e47d14-b54c-168c-e053-2a95a90a083e	72189-099	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20200610		ANDA	ANDA091124	DIRECT RX	ESZOPICLONE	1	mg/1		CIV	N	20241231
72189-100_c42fea0c-d80e-061c-e053-2995a90a9b8d	72189-100	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200513		ANDA	ANDA091497	DIRECT RX	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-101_a512d34c-8165-0c04-e053-2995a90a1942	72189-101	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200507		ANDA	ANDA091281	DIRECT RX	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72189-102_d31f75dc-1261-3d92-e053-2995a90afb56	72189-102	HUMAN PRESCRIPTION DRUG	TORSEMIDE		TORSEMIDE	TABLET	ORAL	20200511		ANDA	ANDA079234	Direct_Rx	TORSEMIDE	10	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72189-103_ff200d6f-f4a6-23f4-e053-6294a90a74e2	72189-103	HUMAN PRESCRIPTION DRUG	CEFADROXIL		CEFADROXIL	CAPSULE	ORAL	20200612		ANDA	ANDA065352	DIRECT RX	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-104_a7e6d256-7227-3334-e053-2995a90aa96d	72189-104	HUMAN PRESCRIPTION DRUG	DESIPRAMINE HYDROCHLORIDE		DESIPRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200612		ANDA	ANDA072099	DIRECT RX	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-105_a7e8d5a3-b0db-1d70-e053-2a95a90aa435	72189-105	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		PIOGLITAZONE	TABLET	ORAL	20200612		ANDA	ANDA200268	DIRECT RX	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
72189-106_ff1fc9a9-3741-66a2-e053-6294a90a79f0	72189-106	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN CALCIUM		ROSUVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20200612		ANDA	ANDA208898	DIRECT RX	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-107_ff32e332-8815-e529-e053-6394a90acd5d	72189-107	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20200518		ANDA	ANDA209713	DIRECT RX	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-108_a7d04d6c-3f01-dc69-e053-2a95a90aa2b0	72189-108	HUMAN PRESCRIPTION DRUG	OFLOXACIN OTIC		OFLOXACIN	SOLUTION	AURICULAR (OTIC)	20200608		ANDA	ANDA076527	DIRECT RX	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-109_ff3217ae-c972-18c8-e053-6394a90a18d2	72189-109	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200612		ANDA	ANDA090007	DIRECT RX	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-110_ff1fd97c-af51-dffb-e053-6294a90a2039	72189-110	HUMAN PRESCRIPTION DRUG	BENAZEPRIL HYDROCHLORIDE		BENAZEPRIL HYDROCHLORIDE	TABLET, COATED	ORAL	20200612		ANDA	ANDA076118	DIRECT RX	BENAZEPRIL HYDROCHLORIDE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
72189-111_ff1fddae-16d2-c822-e053-6394a90acc0a	72189-111	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		ciprofloxacin hydrochloride	TABLET, FILM COATED	ORAL	20200612		ANDA	ANDA077859	DIRECT RX	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72189-112_ff2036e8-3e1f-afb4-e053-6294a90a7767	72189-112	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		pantoprazole	TABLET, DELAYED RELEASE	ORAL	20200612		ANDA	ANDA202882	DIRECT RX	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72189-113_ff3217ae-c972-18c8-e053-6394a90a18d2	72189-113	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20201015		ANDA	ANDA090007	DIRECT RX	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-115_ffbfa36e-650e-8b35-e053-6394a90a9dfb	72189-115	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20200722		ANDA	ANDA209743	Direct_Rx	PREGABALIN	25	mg/1		CV	N	20241231
72189-116_b57d3c1e-e370-5255-e053-2a95a90ada83	72189-116	HUMAN PRESCRIPTION DRUG	CILOSTAZOL		CILOSTAZOL	TABLET	ORAL	20201202		ANDA	ANDA077027	direct rx	CILOSTAZOL	50	mg/1	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
72189-117_b57cf33b-e0be-54e9-e053-2a95a90a5a6a	72189-117	HUMAN PRESCRIPTION DRUG	DOXAZOSIN		DOXAZOSIN	TABLET	ORAL	20201202		ANDA	ANDA202824	direct rx	DOXAZOSIN MESYLATE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72189-119_fea92dde-d87f-5799-e053-6394a90ad1ee	72189-119	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20200729		ANDA	ANDA076341	DIRECT RX	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-121_ff44e969-fc5e-ac2d-e053-6294a90a25bb	72189-121	HUMAN PRESCRIPTION DRUG	ALPRAZOLAM		ALPRAZOLAM	TABLET	ORAL	20200810		ANDA	ANDA207507	Direct Rx	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-122_ff3232c0-8f19-d00d-e053-6294a90ae743	72189-122	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		SERTRALINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20200729		ANDA	ANDA077206	DIRECT RX	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-123_ff3217ae-c976-18c8-e053-6394a90a18d2	72189-123	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20200810		ANDA	ANDA204590	Direct Rx	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-124_ff320bb1-b703-3618-e053-6394a90a2795	72189-124	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200814		ANDA	ANDA210497	DIRECT RX	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72189-126_fae2d00b-29f5-9312-e053-6294a90ad015	72189-126	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		RIZATRIPTAN BENZOATE	TABLET	ORAL	20201111		ANDA	ANDA203252	direct rx	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-127_b56dffde-1335-f5a0-e053-2a95a90a717c	72189-127	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE HYCLATE		DOXYCYCLINE HYCLATE	TABLET, FILM COATED	ORAL	20201201		ANDA	ANDA062505	direct rx	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72189-128_b3d7cc9c-c2c2-b394-e053-2a95a90a1dd8	72189-128	HUMAN PRESCRIPTION DRUG	LIDOTHOL		lidocaine, menthol	PATCH	TOPICAL	20201111		UNAPPROVED DRUG OTHER		direct rx	LIDOCAINE; MENTHOL	4.5; 5	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-129_ff328439-b70e-9387-e053-6294a90a45cb	72189-129	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20201015		ANDA	ANDA201845	Direct_Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-130_b3d6d2a8-97c5-5bad-e053-2a95a90a155d	72189-130	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET	ORAL	20201111		ANDA	ANDA071655	direct rx	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72189-131_b3d6d2a8-97c5-5bad-e053-2a95a90a155d	72189-131	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201111		ANDA	ANDA207138	direct rx	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72189-132_ada3be87-2cde-75f7-e053-2995a90aa95b	72189-132	HUMAN PRESCRIPTION DRUG	OXYBUTYNIN CHLORIDE		OXYBUTYNIN CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20200824		ANDA	ANDA207138	DIRECT RX	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72189-133_cbe63572-330d-8d3e-e053-2995a90a70b3	72189-133	HUMAN PRESCRIPTION DRUG	ARMODAFINIL		ARMODAFINIL	TABLET	ORAL	20201015		ANDA	ANDA206069	direct rx	ARMODAFINIL	250	mg/1		CIV	N	20241231
72189-134_ff320bb1-b703-3618-e053-6394a90a2795	72189-134	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201015		ANDA	ANDA210497	DIRECT RX	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72189-135_ff32a9e7-076c-8df9-e053-6394a90a94cf	72189-135	HUMAN PRESCRIPTION DRUG	ATENOLOL		ATENOLOL	TABLET	ORAL	20201202		ANDA	ANDA077443	direct rx	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72189-136_ff325b59-5d44-6277-e053-6294a90ae5db	72189-136	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20201015		ANDA	ANDA091416	DIRECT RX	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-137_ff3284d1-e726-93bf-e053-6294a90aaf4e	72189-137	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		OLMESARTAN MEDOXOMIL	TABLET, FILM COATED	ORAL	20201202		ANDA	ANDA207662	direct rx	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-138_ff3284d1-e726-93bf-e053-6294a90aaf4e	72189-138	HUMAN PRESCRIPTION DRUG	OLMESARTAN MEDOXOMIL		OLMESARTAN MEDOXOMIL	TABLET, FILM COATED	ORAL	20201202		ANDA	ANDA207662	direct rx	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-139_ff328439-b70e-9387-e053-6294a90a45cb	72189-139	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20201202		ANDA	ANDA201845	Direct_Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-140_ca4dede2-bc8a-1ab8-e053-2995a90a49ba	72189-140	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20210824		ANDA	ANDA208963	direct rx	FLUCONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72189-141_e9d2befa-c6d7-e3bf-e053-2995a90ad40a	72189-141	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET	ORAL	20201015		ANDA	ANDA078916	direct rx	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72189-142_06833e54-0dfb-dd3d-e063-6394a90a32a0	72189-142	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		RABEPRAZOLE SODIUM	TABLET, DELAYED RELEASE	ORAL	20201015		ANDA	ANDA205761	DIRECT RX	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72189-143_ca4dede2-bc8a-1ab8-e053-2995a90a49ba	72189-143	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20201112		ANDA	ANDA076658	direct rx	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72189-145_b3ee8325-bcb3-43fd-e053-2a95a90a08c8	72189-145	HUMAN PRESCRIPTION DRUG	TADALAFIL		TADALAFIL	TABLET	ORAL	20201112		ANDA	ANDA209654	direct rx	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72189-146_ff32a9e7-076c-8df9-e053-6394a90a94cf	72189-146	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20220125		ANDA	ANDA073457	direct rx	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72189-147_d65668e9-b95b-2d15-e053-2995a90a007d	72189-147	HUMAN PRESCRIPTION DRUG	desvenlafaxine		desvenlafaxine succinate	TABLET, EXTENDED RELEASE	ORAL	20201112		ANDA	ANDA204003	DIRECT RX	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72189-149_ca4dede2-bc8a-1ab8-e053-2995a90a49ba	72189-149	HUMAN PRESCRIPTION DRUG	fluconazole		fluconazole	TABLET	ORAL	20201111		ANDA	ANDA208963	direct rx	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72189-150_eac55694-f21f-1f19-e053-2995a90ab603	72189-150	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201014		ANDA	ANDA078321	direct rx	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72189-151_b3ee3b05-8741-cd17-e053-2a95a90a6e28	72189-151	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20201112		ANDA	ANDA075657	direct rx	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
72189-152_b3c757de-1cc0-61f5-e053-2995a90accfc	72189-152	HUMAN PRESCRIPTION DRUG	atenolol		atenolol	TABLET	ORAL	20201110		ANDA	ANDA077443	direct rx	ATENOLOL	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72189-153_b336438f-7952-d3b7-e053-2995a90a4d69	72189-153	HUMAN PRESCRIPTION DRUG	RAMELTEON		RAMELTEON	TABLET	ORAL	20201103		ANDA	ANDA211567	DIRECT RX	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
72189-154_ff32aea4-fbf5-3905-e053-6394a90ae09c	72189-154	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20201110		ANDA	ANDA200503	DIRECT RX	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72189-155_ff32e332-8815-e529-e053-6394a90acd5d	72189-155	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20201201		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-156_b4777cf6-0fef-6cbc-e053-2995a90aca5f	72189-156	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20201119		ANDA	ANDA090894	Direct Rx	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
72189-157_b56dd9c8-1bcb-21e3-e053-2995a90a3e6e	72189-157	HUMAN PRESCRIPTION DRUG	CARBAMAZEPINE		CARBAMAZEPINE	TABLET	ORAL	20201201		ANDA	ANDA207798	direct rx	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72189-158_ff3217ae-c972-18c8-e053-6394a90a18d2	72189-158	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	TABLET, FILM COATED	ORAL	20201201		ANDA	ANDA203244	DIRECT RX	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-159_ff32e332-8815-e529-e053-6394a90acd5d	72189-159	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20201201		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-160_ff32e332-8815-e529-e053-6394a90acd5d	72189-160	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20201201		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-161_b56cdaee-6188-c763-e053-2995a90acc3f	72189-161	HUMAN PRESCRIPTION DRUG	DOXEPIN HYDROCHLORIDE		DOXEPIN HYDROCHLORIDE	CAPSULE	ORAL	20201201		ANDA	ANDA213063	direct rx	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-162_c9397a25-8fec-48d0-e053-2a95a90ab495	72189-162	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20210112		ANDA	ANDA078925	DIRECT RX	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72189-163_ff32e332-8815-e529-e053-6394a90acd5d	72189-163	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20210108		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-164_ffbfa36e-650e-8b35-e053-6394a90a9dfb	72189-164	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20210112		ANDA	ANDA209743	Direct_Rx	PREGABALIN	300	mg/1		CV	N	20241231
72189-165_c3b988ee-eff5-4578-e053-2995a90a1fcb	72189-165	HUMAN PRESCRIPTION DRUG	LIDOCAINE		LIDOCAINE	OINTMENT	TOPICAL	20210108		ANDA	ANDA086724	DIRECT RX	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-167_ff328439-b70e-9387-e053-6294a90a45cb	72189-167	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET	ORAL	20210108		ANDA	ANDA078245	Direct_Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-168_c3b988ee-eff5-4578-e053-2995a90a1fcb	72189-168	HUMAN PRESCRIPTION DRUG	LIDOCAINE		LIDOCAINE	OINTMENT	TOPICAL	20210112		ANDA	ANDA207810	DIRECT RX	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-169_06833e54-0dfb-dd3d-e063-6394a90a32a0	72189-169	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		RABEPRAZOLE SODIUM	TABLET, DELAYED RELEASE	ORAL	20210114		ANDA	ANDA208644	DIRECT RX	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72189-173_ff32e332-8815-e529-e053-6394a90acd5d	72189-173	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20210209		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-174_ff32e332-8815-e529-e053-6394a90acd5d	72189-174	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20210209		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-175_ff32cbb2-79ed-9158-e053-6394a90ac357	72189-175	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20210209		ANDA	ANDA202557	DIRECT RX	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
72189-176_0514f788-1ae8-9239-e063-6294a90a8ac2	72189-176	HUMAN PRESCRIPTION DRUG	PROMETHAZINE HYDROCHLORIDE		PROMETHAZINE HYDROCHLORIDE	TABLET	ORAL	20210209		ANDA	ANDA040596	DIRECT RX	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72189-177_bae90e1e-0b15-6e0e-e053-2a95a90af54e	72189-177	HUMAN PRESCRIPTION DRUG	NORTRIPTYLINE HYDROCHLORIDE		NORTRIPTYLINE HYDROCHLORIDE	CAPSULE	ORAL	20210209		ANDA	ANDA073556	DIRECT RX	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-178_ff3217ae-c972-18c8-e053-6394a90a18d2	72189-178	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	TABLET	ORAL	20210208		ANDA	ANDA205101	DIRECT RX	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-179_ff32f599-b9ca-6acc-e053-6394a90a8037	72189-179	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN		NITROFURANTOIN	CAPSULE	ORAL	20220118		ANDA	ANDA077066	Directrx	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
72189-180_bc189ce2-3f11-260d-e053-2a95a90ae808	72189-180	HUMAN PRESCRIPTION DRUG	KETOCONAZOLE		KETOCONAZOLE	TABLET	ORAL	20210224		ANDA	ANDA075912	Direct Rx	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72189-182_bbf26437-c9b5-d8e6-e053-2a95a90a0062	72189-182	HUMAN PRESCRIPTION DRUG	CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE		CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE	CREAM	TOPICAL	20210223		ANDA	ANDA202894	Direct Rx	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-183_bfc81113-5ec2-d799-e053-2a95a90afbdf	72189-183	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20210224		ANDA	ANDA040197	Direct Rx	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72189-184_ff32e332-8830-e529-e053-6394a90acd5d	72189-184	HUMAN PRESCRIPTION DRUG	NABUMETONE		NABUMETONE	TABLET	ORAL	20210511		ANDA	ANDA078420	direct rx	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-185_cc1f06ae-3fc2-714c-e053-2995a90ac865	72189-185	HUMAN PRESCRIPTION DRUG	CEFDINIR		CEFDINIR	POWDER, FOR SUSPENSION	ORAL	20210412		ANDA	ANDA065473	DIRECT RX	CEFDINIR	125	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-186_cc1f06ae-3fc2-714c-e053-2995a90ac865	72189-186	HUMAN PRESCRIPTION DRUG	CEFDINIR		CEFDINIR	POWDER, FOR SUSPENSION	ORAL	20210412		ANDA	ANDA065473	DIRECT RX	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-189_c3f35f80-e4af-95f5-e053-2995a90a1b64	72189-189	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		CLINDAMYCIN HYDROCHLORIDE	CAPSULE	ORAL	20210604		ANDA	ANDA207402	DIRECT RX	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS]		N	20241231
72189-190_fa2c35e8-9da0-3124-e053-6394a90a68e4	72189-190	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	TABLET, FILM COATED	ORAL	20210607		ANDA	ANDA090515	DIRECT RX	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-191_cc0e654d-1eab-7d17-e053-2995a90ab1db	72189-191	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20210915		ANDA	ANDA209037	DirectRx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72189-192_ff331e8f-7603-e825-e053-6294a90af20a	72189-192	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20210603		ANDA	ANDA206948	DIRECT RX	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72189-194_ff331e8f-7603-e825-e053-6294a90af20a	72189-194	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20210330		ANDA	ANDA206948	DIRECT RX	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72189-198_bfc81113-5ec2-d799-e053-2a95a90afbdf	72189-198	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20210412		ANDA	ANDA040197	Direct Rx	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72189-199_bfcb0849-6d9c-7705-e053-2a95a90a6541	72189-199	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20210412		ANDA	ANDA204418	DIRECT RX	FOLIC ACID	1	mg/1			N	20241231
72189-200_ff32cbb2-79ed-9158-e053-6394a90ac357	72189-200	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20210412		ANDA	ANDA202330	DIRECT RX	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
72189-201_cc1de234-dc56-24fe-e053-2a95a90a0eb1	72189-201	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20210413		ANDA	ANDA202910	direct rx	IRBESARTAN	75	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-202_c3dff64f-4669-f157-e053-2995a90a97cd	72189-202	HUMAN PRESCRIPTION DRUG	NP THYROID 60		levothyroxine liothyronine	TABLET	ORAL	20210603		UNAPPROVED DRUG OTHER		DIRECT RX	LEVOTHYROXINE; LIOTHYRONINE	38; 9	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
72189-203_c3dda0a4-b429-f3e7-e053-2995a90ad106	72189-203	HUMAN PRESCRIPTION DRUG	PHENTERMINE HYDROCHLORIDE		PHENTERMINE HYDROCHLORIDE	TABLET	ORAL	20210603		ANDA	ANDA203068	DIRECT RX	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72189-204_c3df223b-6571-dbb1-e053-2995a90aa438	72189-204	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20210603		ANDA	ANDA211285	direct rx	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
72189-205_cc1de234-dc56-24fe-e053-2a95a90a0eb1	72189-205	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20210421		ANDA	ANDA202910	direct rx	IRBESARTAN	150	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-206_ff32e332-8815-e529-e053-6394a90acd5d	72189-206	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20210603		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-207_cbe55082-3a93-3997-e053-2a95a90a8e8e	72189-207	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET	ORAL	20210603		ANDA	ANDA075805	direct rx	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72189-209_c583b93e-c941-2e9b-e053-2a95a90a1b08	72189-209	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE		HYDROCORTISONE	CREAM	TOPICAL	20210517		ANDA	ANDA087795	DIRECT RX	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-210_c186d1ff-64de-bfcb-e053-2a95a90af800	72189-210	HUMAN PRESCRIPTION DRUG	WARFARIN SODIUM		WARFARIN SODIUM	TABLET	ORAL	20210504		ANDA	ANDA090935	DIRECT RX	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
72189-211_c3b988ee-eff5-4578-e053-2995a90a1fcb	72189-211	HUMAN PRESCRIPTION DRUG	LIDOCAINE		LIDOCAINE	OINTMENT	TOPICAL	20210507		ANDA	ANDA086724	DIRECT RX	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-213_ff44e969-fc5e-ac2d-e053-6294a90a25bb	72189-213	HUMAN PRESCRIPTION DRUG	ALPRAZOLAM		ALPRAZOLAM	TABLET	ORAL	20210527		ANDA	ANDA207507	Direct Rx	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-215_ea62a66e-d45e-11be-e053-2a95a90a7801	72189-215	HUMAN PRESCRIPTION DRUG	Junel FE		Junel FE	TABLET	ORAL	20211006		ANDA	ANDA076380	Direct_Rx	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	20; 1	ug/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
72189-216_c20f803c-e966-9dd8-e053-2995a90a92ba	72189-216	HUMAN PRESCRIPTION DRUG	PRIMIDONE		PRIMIDONE	TABLET	ORAL	20210511		ANDA	ANDA040586	DIRECT RX	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-217_c3df223b-6571-dbb1-e053-2995a90aa438	72189-217	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20210527		ANDA	ANDA211285	direct rx	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
72189-218_c3dff64f-4669-f157-e053-2995a90a97cd	72189-218	HUMAN PRESCRIPTION DRUG	NP THYROID		levothyroxine, liothyronine	TABLET	ORAL	20210511		UNAPPROVED DRUG OTHER		DIRECT RX	LEVOTHYROXINE; LIOTHYRONINE	19; 4.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
72189-219_ff453210-700a-2085-e053-6294a90aa8df	72189-219	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20210526		ANDA	ANDA203769	direct rx	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72189-220_ff453210-700a-2085-e053-6294a90aa8df	72189-220	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20210527		ANDA	ANDA203769	direct rx	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72189-221_ff453210-700a-2085-e053-6294a90aa8df	72189-221	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET	ORAL	20210601		ANDA	ANDA203769	direct rx	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72189-222_d160b5f9-4265-9337-e053-2a95a90ae2c6	72189-222	HUMAN PRESCRIPTION DRUG	ROPINIROLE		ROPINIROLE	TABLET, FILM COATED	ORAL	20210520		ANDA	ANDA204022	DIRECT RX	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
72189-223_c2d834e6-7b39-d266-e053-2995a90a27ef	72189-223	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, CHEWABLE	ORAL	20210521		ANDA	ANDA204093	DIRECT RX	MONTELUKAST	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
72189-226_d1248466-7422-784e-e053-2995a90a0d08	72189-226	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20210601		ANDA	ANDA076477	DIRECT RX	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-227_c3b48cb3-6285-f293-e053-2995a90a5200	72189-227	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20210601		ANDA	ANDA212689	DIRECT RX	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
72189-229_fa2c35e8-9da0-3124-e053-6394a90a68e4	72189-229	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	TABLET, FILM COATED	ORAL	20210601		ANDA	ANDA090515	DIRECT RX	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-230_c3f23bc3-595c-28e5-e053-2a95a90a9c2c	72189-230	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		ZOLPIDEM TARTRATE	TABLET, EXTENDED RELEASE	ORAL	20210604		ANDA	ANDA078970	DIRECT RX	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
72189-231_ffbfd97f-39d7-c26f-e053-6294a90abc5a	72189-231	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20210604		ANDA	ANDA090796	DIRECT RX	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-232_ff44e969-fc65-ac2d-e053-6294a90a25bb	72189-232	HUMAN PRESCRIPTION DRUG	ACYCLOVIR		ACYCLOVIR	TABLET	ORAL	20210913		ANDA	ANDA075382	DIRECT RX	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72189-234_d1243811-c096-53f9-e053-2995a90abd74	72189-234	HUMAN PRESCRIPTION DRUG	SUCRALFATE		SUCRALFATE	TABLET	ORAL	20210618		ANDA	ANDA070848	DIRECT RX	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
72189-235_ff45738f-5a97-9d64-e053-6294a90a6a20	72189-235	HUMAN PRESCRIPTION DRUG	Buspirone Hcl		Buspirone Hcl	TABLET	ORAL	20220316		ANDA	ANDA210907	Direct Rx	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
72189-239_d1248466-7422-784e-e053-2995a90a0d08	72189-239	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET	ORAL	20210920		ANDA	ANDA204991	DIRECT RX	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-240_ff44e969-fc5e-ac2d-e053-6294a90a25bb	72189-240	HUMAN PRESCRIPTION DRUG	ALPRAZOLAM		ALPRAZOLAM	TABLET	ORAL	20210916		ANDA	ANDA207507	Direct Rx	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-241_ffbfa36e-650e-8b35-e053-6394a90a9dfb	72189-241	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20210723		ANDA	ANDA208677	Direct_Rx	PREGABALIN	200	mg/1		CV	N	20241231
72189-242_d20242e7-264c-18a2-e053-2995a90aeb7b	72189-242	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	TABLET, FILM COATED	ORAL	20210723		ANDA	ANDA075593	direct rx	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-243_c7cf55e2-f638-e2d9-e053-2995a90a6270	72189-243	HUMAN PRESCRIPTION DRUG	TERBINAFINE		TERBINAFINE	TABLET	ORAL	20210723		ANDA	ANDA078297	direct rx	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
72189-246_cc330c63-1bb0-210d-e053-2995a90a2545	72189-246	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20210708		ANDA	ANDA210525	DIRECT RX	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-248_c7cf9276-4b4d-10b2-e053-2995a90a3738	72189-248	HUMAN PRESCRIPTION DRUG	DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE		DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE	CAPSULE, EXTENDED RELEASE	ORAL	20210723		NDA AUTHORIZED GENERIC	NDA020401	direct rx	DILTIAZEM HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
72189-249_c7d013b7-0a68-0953-e053-2a95a90ac47c	72189-249	HUMAN PRESCRIPTION DRUG	COLCHICINE		COLCHICINE	TABLET, FILM COATED	ORAL	20210723		NDA	NDA022352	direct rx	COLCHICINE	.6	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
72189-250_ff32e332-8815-e529-e053-6394a90acd5d	72189-250	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20210723		NDA	NDA021116	DIRECT RX	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-251_ffbfa36e-650e-8b35-e053-6394a90a9dfb	72189-251	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20210723		ANDA	ANDA208677	Direct_Rx	PREGABALIN	300	mg/1		CV	N	20241231
72189-253_ca683656-16a7-9602-e053-2a95a90aa895	72189-253	HUMAN PRESCRIPTION DRUG	PHENTERMINE HYDROCHLORIDE		PHENTERMINE HYDROCHLORIDE	CAPSULE	ORAL	20210825		ANDA	ANDA205019	DirectRx	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72189-254_cc7140de-a206-f675-e053-2995a90ac22b	72189-254	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE		DEXAMETHASONE	TABLET	ORAL	20210920		ANDA	ANDA084612	Direct Rx	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-255_0879b292-9b37-b225-e063-6394a90a3800	72189-255	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20210810		ANDA	ANDA207510	DIRECT RX	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-256_0879b292-9b37-b225-e063-6394a90a3800	72189-256	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20210810		ANDA	ANDA207510	DIRECT RX	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-257_ffc026bd-495e-46c6-e053-6394a90a6300	72189-257	HUMAN PRESCRIPTION DRUG	OXYCODONE AND ACETAMINOPHEN		OXYCODONE AND ACETAMINOPHEN	TABLET	ORAL	20210824		ANDA	ANDA207510	DirectRx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-258_fae2d00b-29f5-9312-e053-6294a90ad015	72189-258	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		RIZATRIPTAN BENZOATE	TABLET	ORAL	20210810		ANDA	ANDA202490	direct rx	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-259_cc1f06ae-3fc2-714c-e053-2995a90ac865	72189-259	HUMAN PRESCRIPTION DRUG	CEFDINIR		CEFDINIR	POWDER, FOR SUSPENSION	ORAL	20210913		ANDA	ANDA210534	DIRECT RX	CEFDINIR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-261_cbe63572-330d-8d3e-e053-2995a90a70b3	72189-261	HUMAN PRESCRIPTION DRUG	ARMODAFINIL		ARMODAFINIL	TABLET	ORAL	20210913		NDA AUTHORIZED GENERIC	NDA021875	direct rx	ARMODAFINIL	250	mg/1		CIV	N	20241231
72189-262_cc716dab-b536-8b51-e053-2995a90a8f16	72189-262	HUMAN PRESCRIPTION DRUG	CLOBETASOL PROPIONATE		CLOBETASOL PROPIONATE	CREAM	TOPICAL	20210920		ANDA	ANDA212982	DIRECT RX	CLOBETASOL PROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-263_cbe5e01e-67cb-f8a2-e053-2995a90a0d15	72189-263	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		HYDROCHLOROTHIAZIDE	TABLET	ORAL	20210913		ANDA	ANDA202556	DIRECT RX	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-264_cbe5e01e-67c6-f8a2-e053-2995a90a0d15	72189-264	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20210913		ANDA	ANDA204072	Direct_Rx	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-265_cb1b3ed1-6e69-08e2-e053-2995a90a68c4	72189-265	HUMAN PRESCRIPTION DRUG	DONEPEZIL HYDROCHLORIDE		DONEPEZIL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210903		ANDA	ANDA200292	DirectRx	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72189-266_ffbfd97f-39d7-c26f-e053-6294a90abc5a	72189-266	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20210916		ANDA	ANDA090796	DIRECT RX	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-267_cc1e3db1-1345-59df-e053-2995a90a8ffc	72189-267	HUMAN PRESCRIPTION DRUG	VALPROIC ACID		VALPROIC ACID	CAPSULE	ORAL	20210916		ANDA	ANDA207611	Direct_Rx	VALPROIC ACID	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72189-269_ffbfa36e-650e-8b35-e053-6394a90a9dfb	72189-269	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20210916		ANDA	ANDA208677	Direct_Rx	PREGABALIN	25	mg/1		CV	N	20241231
72189-270_cc1de234-dc56-24fe-e053-2a95a90a0eb1	72189-270	HUMAN PRESCRIPTION DRUG	IRBESARTAN		IRBESARTAN	TABLET	ORAL	20210916		ANDA	ANDA202910	direct rx	IRBESARTAN	300	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-273_cc1d8eb6-4958-1878-e053-2a95a90a83d4	72189-273	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		DICLOFENAC SODIUM	SOLUTION	TOPICAL	20210916		ANDA	ANDA204132	DIRECT RX	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-275_cc330c63-1bb0-210d-e053-2995a90a2545	72189-275	HUMAN PRESCRIPTION DRUG	PREDNISONE		PREDNISONE	TABLET	ORAL	20210917		ANDA	ANDA211495	DIRECT RX	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-277_d103ac3e-c8dc-4546-e053-2995a90aa0f5	72189-277	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		TRIAMCINOLONE ACETONIDE	CREAM	TOPICAL	20210930		ANDA	ANDA209535	Direct_Rx	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-278_d1039c0b-1956-b3e4-e053-2a95a90a0837	72189-278	HUMAN PRESCRIPTION DRUG	NYSTATIN		NYSTATIN	CREAM	ORAL; TOPICAL	20210930		ANDA	ANDA064022	DIRECT RX	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
72189-280_0c41e3a6-4386-e05b-e063-6394a90a5dad	72189-280	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20211007		ANDA	ANDA213324	DirectRx	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72189-281_ffc0012e-5270-89e0-e053-6294a90ab519	72189-281	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		AMOXICILLIN AND CLAVULANATE POTASSIUM	TABLET, FILM COATED	ORAL	20211007		ANDA	ANDA065064	DirectRx	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72189-282_d1608ffd-2bbf-a006-e053-2a95a90a291d	72189-282	HUMAN PRESCRIPTION DRUG	ENALAPRIL MALEATE		ENALAPRIL MALEATE	TABLET	ORAL	20211019		ANDA	ANDA075483	DirectRx	ENALAPRIL MALEATE	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
72189-283_ffc026bd-4962-46c6-e053-6394a90a6300	72189-283	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		CYCLOBENZAPRINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20211019		ANDA	ANDA208170	DirectRx	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72189-284_fd11db2d-3649-9bd6-e053-6394a90ade0b	72189-284	HUMAN PRESCRIPTION DRUG	METHOCARBAMOL		METHOCARBAMOL	TABLET	ORAL	20211019		ANDA	ANDA040489	DirectRx	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72189-285_d124c443-a2ec-7984-e053-2995a90ad7cd	72189-285	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		AMOXICILLIN	POWDER, FOR SUSPENSION	ORAL	20211021		ANDA	ANDA065334	DirectRx	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72189-288_cf477eeb-c29f-331c-e053-2995a90a95bb	72189-288	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20211026		ANDA	ANDA091629	DirectRx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-289_d1ed9593-a588-55bb-e053-2995a90a8a9a	72189-289	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20211129		ANDA	ANDA202289	DirectRx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-290_d1ee193e-bf79-3134-e053-2a95a90a65d2	72189-290	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20211129		ANDA	ANDA202289	DirectRx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-291_d076309f-313b-1c71-e053-2995a90a7bb7	72189-291	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET	ORAL	20211110		ANDA	ANDA213853	DirectRX	ATORVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-292_d05f6e91-07a5-658b-e053-2995a90af360	72189-292	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		PIOGLITAZONE HYDROCHLORIDE	TABLET	ORAL	20211109		ANDA	ANDA200044	DirectRx	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
72189-293_d06fe500-4969-ba97-e053-2995a90ab1f6	72189-293	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE		PIOGLITAZONE	TABLET	ORAL	20211110		ANDA	ANDA200044	DirectRX	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
72189-294_d0839a2d-35f2-1f14-e053-2995a90ad549	72189-294	HUMAN PRESCRIPTION DRUG	MEMANTINE HYDROCHLORIDE		MEMANTINE HYDROCHLORIDE	TABLET	ORAL	20211111		ANDA	ANDA090961	DirectRx	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
72189-295_d160d04b-2082-9008-e053-2995a90a6721	72189-295	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET	ORAL	20211122		ANDA	ANDA204991	DirectRx	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-297_d2021060-94d8-3e1d-e053-2995a90a10ee	72189-297	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20211130		ANDA	ANDA202289	DirectRx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-298_030fb30e-1398-c964-e063-6394a90a4c23	72189-298	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20211129		ANDA	ANDA210394	DirectRx	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72189-299_0cf3484e-3d3c-edc9-e063-6294a90a8c4a	72189-299	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20211202		ANDA	ANDA065136	DirectRx	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
72189-300_d23e359d-6d13-38f6-e053-2a95a90a0a88	72189-300	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	TABLET, FILM COATED	ORAL	20211203		ANDA	ANDA076558	DirectRx	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-301_df498577-46cd-b389-e053-2a95a90a711e	72189-301	HUMAN PRESCRIPTION DRUG	PHENTERMINE HYDROCHLORIDE		PHENTERMINE HYDROCHLORIDE	TABLET	ORAL	20211206		ANDA	ANDA040876	DirectRx	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72189-302_db709a98-70ca-11a2-e053-2995a90af78d	72189-302	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		MECLIZINE HYDROCHLORIDE	TABLET	ORAL	20211206		NDA AUTHORIZED GENERIC	NDA010721	DirectRx	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
72189-303_d358499d-5ebc-75b2-e053-2a95a90a4223	72189-303	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20211217		ANDA	ANDA203835	DirectRx	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-304_d358eb18-f4d1-e9ba-e053-2a95a90a435d	72189-304	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20211217		ANDA	ANDA076558	DirectRx	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-306_d732a4c4-c0bc-a72f-e053-2995a90a3fad	72189-306	HUMAN PRESCRIPTION DRUG	Metronidazole Topical Cream		Metronidazole Topical Cream	CREAM	TOPICAL	20220118		NDA AUTHORIZED GENERIC	NDA020531	DirectRx	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72189-307_d44e23db-381b-cfc3-e053-2995a90a13c8	72189-307	HUMAN PRESCRIPTION DRUG	DIETHYLPROPION HYDROCHLORIDE ER		DIETHYLPROPION HYDROCHLORIDE ER	TABLET, EXTENDED RELEASE	ORAL	20211229		ANDA	ANDA091680	Directrx	DIETHYLPROPION HYDROCHLORIDE	75	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72189-308_e5e84e60-433b-460d-e053-2a95a90ad152	72189-308	HUMAN PRESCRIPTION DRUG	CEFDINIR		CEFDINIR	CAPSULE	ORAL	20220202		ANDA	ANDA210220	DirectRx	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-309_d44efada-eee3-747e-e053-2995a90af561	72189-309	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20211229		ANDA	ANDA202446	DirectRx	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-310_ffc05799-7862-7c4f-e053-6394a90abd09	72189-310	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20220117		ANDA	ANDA040188	Directrx	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
72189-311_ffc06cbd-7826-ad07-e053-6294a90af300	72189-311	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, COATED	ORAL	20220112		ANDA	ANDA208708	DirectRx	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72189-312_d67e2df4-4095-4f5a-e053-2a95a90ae4aa	72189-312	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20220126		ANDA	ANDA204131	DirectRx	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
72189-313_daf88e71-a164-3ab8-e053-2a95a90a89d3	72189-313	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20220117		ANDA	ANDA205101	Directrx	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-314_d564d91e-303a-c120-e053-2995a90ae6db	72189-314	HUMAN PRESCRIPTION DRUG	AZITHROMYCIN		AZITHROMYCIN	POWDER, FOR SUSPENSION	ORAL	20220112		ANDA	ANDA207531	DirectRx	AZITHROMYCIN MONOHYDRATE	200	mg/5mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72189-315_fd1696a5-3199-80c7-e053-6394a90a5da0	72189-315	HUMAN PRESCRIPTION DRUG	HYDROXYZINE PAMOATE		HYDROXYZINE PAMOATE	CAPSULE	ORAL	20220120		ANDA	ANDA040156	DirectRx	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72189-316_d60560d5-8e53-099d-e053-2a95a90a20af	72189-316	HUMAN PRESCRIPTION DRUG	RIZATRIPTAN BENZOATE		RIZATRIPTAN BENZOATE	TABLET	ORAL	20220120		ANDA	ANDA203269	Direct Rx	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-317_ffc06cbd-7827-ad07-e053-6294a90af300	72189-317	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET	ORAL	20220119		ANDA	ANDA077459	DirectRx	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-318_f6003241-59b9-1c87-e053-2a95a90a7dbe	72189-318	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20220119		ANDA	ANDA211977	Direct Rx	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72189-319_d5f215d4-9aa4-2ecf-e053-2995a90a2e89	72189-319	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		DICLOFENAC SODIUM	SOLUTION	TOPICAL	20220119		ANDA	ANDA203818	DirectRx	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-320_d5e00bad-abb5-63ad-e053-2a95a90a5abb	72189-320	HUMAN PRESCRIPTION DRUG	NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE		neomycin sulfate, polymyxin b sulfate and dexamethasone suspension/ drops	SUSPENSION/ DROPS	TOPICAL	20220118		ANDA	ANDA064135	DirectRx	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72189-321_d771e69b-7d9c-13fa-e053-2995a90ac161	72189-321	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN		MOXIFLOXACIN	SOLUTION/ DROPS	OPHTHALMIC	20220207		ANDA	ANDA202867	Direct Rx	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-322_ffc0c4b1-3477-46f0-e053-6294a90a57ab	72189-322	HUMAN PRESCRIPTION DRUG	PROPRANOLOL HYDROCHLORIDE		PROPRANOLOL HYDROCHLORIDE	TABLET	ORAL	20220211		ANDA	ANDA070322	Direct Rx	PROPRANOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72189-323_d88a22f4-2f62-17f2-e053-2995a90acd14	72189-323	HUMAN PRESCRIPTION DRUG	CIPROFLOXACIN		CIPROFLOXACIN	TABLET, COATED	ORAL	20220221		ANDA	ANDA208921	Direct Rx	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-324_ffc1a52d-2741-3c51-e053-6294a90ab586	72189-324	HUMAN PRESCRIPTION DRUG	IBUPROFEN		IBUPROFEN	TABLET, FILM COATED	ORAL	20220221		ANDA	ANDA090796	Direct Rx	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-325_d93e4358-f855-289a-e053-2a95a90ac001	72189-325	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20220216		ANDA	ANDA204901	Direct Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-326_da34054a-f467-5ff3-e053-2995a90a1a29	72189-326	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20220221		ANDA	ANDA204901	Direct Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-327_d838e918-2464-79f6-e053-2a95a90a948d	72189-327	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE		LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	TABLET, FILM COATED	ORAL	20220217		ANDA	ANDA204901	Direct Rx	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-328_dd02a245-8bbc-befe-e053-2995a90afc7c	72189-328	HUMAN PRESCRIPTION DRUG	PREGABALIN		pregabalin	CAPSULE	ORAL	20220221		ANDA	ANDA208677	Direct Rx	PREGABALIN	225	mg/1		CV	N	20241231
72189-330_d92e9eaf-3a7a-76d7-e053-2995a90ae28d	72189-330	HUMAN PRESCRIPTION DRUG	TRIAMCINOLONE ACETONIDE		triamcinolone acetonide cream	CREAM	TOPICAL	20220301		ANDA	ANDA086413	Direct Rx	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-331_d9a2f92d-e9e5-5d24-e053-2a95a90a6e42	72189-331	HUMAN PRESCRIPTION DRUG	COLCHICINE		COLCHICINE	TABLET	ORAL	20220301		ANDA	ANDA209876	Direct Rx	COLCHICINE	.6	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
72189-332_d95279d9-6e2b-0bd6-e053-2a95a90a447d	72189-332	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20220303		ANDA	ANDA212199	Direct Rx	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-333_d956063a-ef49-faca-e053-2995a90a0291	72189-333	HUMAN PRESCRIPTION DRUG	HYDROXYZINE HYDROCHLORIDE		HYDROXYZINE HYDROCHLORIDE	TABLET	ORAL	20220303		ANDA	ANDA204279	Direct Rx	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72189-334_d9b6a460-6378-76d0-e053-2995a90a3d05	72189-334	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN		MOXIFLOXACIN	SOLUTION/ DROPS	OPHTHALMIC	20220308		ANDA	ANDA202916	Direct Rx	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-335_d9a589b4-bd33-0e45-e053-2a95a90ae67d	72189-335	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	SOLUTION	OPHTHALMIC	20220307		ANDA	ANDA203410	Direct Rx	KETOROLAC TROMETHAMINE	5	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-336_f6003033-dd84-0c03-e053-2995a90a1da7	72189-336	HUMAN PRESCRIPTION DRUG	DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE		DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE	TABLET	ORAL	20220307		ANDA	ANDA213413	Direct Rx	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
72189-338_ffc1465a-4d9a-96f3-e053-6294a90af88b	72189-338	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20220321		ANDA	ANDA202801	DirectRx	LEVOFLOXACIN	750	mg/1			N	20241231
72189-339_dbea45c2-e167-b557-e053-2995a90a7643	72189-339	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	TABLET, FILM COATED	ORAL	20220405		ANDA	ANDA077794	DirectRx	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-340_fadff612-3613-137c-e053-6294a90af08f	72189-340	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20220328		ANDA	ANDA201504	Direct Rx	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-341_db489d19-150a-c979-e053-2a95a90a4410	72189-341	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate ODT		Rizatriptan Benzoate ODT	TABLET, ORALLY DISINTEGRATING	ORAL	20220328		ANDA	ANDA203062	Direct Rx	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-342_db886cfe-ea24-50c9-e053-2995a90a4d10	72189-342	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20220331		ANDA	ANDA077253	Direct Rx	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72189-343_ffc1465a-4d9d-96f3-e053-6294a90af88b	72189-343	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20220330		ANDA	ANDA211487	Direct Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72189-344_dd049eb3-7094-3311-e053-2995a90a8792	72189-344	HUMAN PRESCRIPTION DRUG	CARTIA XT		diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20220406		ANDA	ANDA074752	DirectRx	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
72189-346_dd032289-acef-49fc-e053-2a95a90a5999	72189-346	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		LEVOTHYROXINE SODIUM	TABLET	ORAL	20220419		ANDA	ANDA212399	Direct Rx	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72189-347_dda3d864-2f33-758f-e053-2995a90a6182	72189-347	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20220414		ANDA	ANDA205229	Direct Rx	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
72189-348_ffc17297-4639-7cc8-e053-6394a90a244b	72189-348	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20220426		ANDA	ANDA211487	DirectRx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72189-349_ffc1d0e3-c498-d62c-e053-6294a90abb4e	72189-349	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE SR		BUPROPION HYDROCHLORIDE SR	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220422		ANDA	ANDA205794	DirectRx	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72189-350_fa56b439-893e-003e-e053-6294a90a865b	72189-350	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20230427		ANDA	ANDA210347	Direct_Rx	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-351_ffc1ab7e-5956-222e-e053-6294a90a6926	72189-351	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20220429		ANDA	ANDA203572	DirectRx	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-352_e8bc037f-681d-7e7a-e053-2a95a90a532b	72189-352	HUMAN PRESCRIPTION DRUG	Hydrocodone APAP		Hydrocodone APAP	TABLET	ORAL	20220510		ANDA	ANDA211487	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72189-353_df629bf0-e6c0-602b-e053-2995a90aac0e	72189-353	HUMAN PRESCRIPTION DRUG	ARMODAFINIL		ARMODAFINIL	TABLET	ORAL	20220429		NDA AUTHORIZED GENERIC	NDA021875	DirectRx	ARMODAFINIL	200	mg/1		CIV	N	20241231
72189-355_df6292d8-e993-5bd5-e053-2995a90ac823	72189-355	HUMAN PRESCRIPTION DRUG	Doxepin HCL		Doxepin HCL	CAPSULE	ORAL	20220510		ANDA	ANDA213063	Direct_Rx	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-356_deab1d3e-75a0-480e-e053-2995a90a0a75	72189-356	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20220510		ANDA	ANDA211627	Direct_Rx	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72189-357_ffc1ab7e-595a-222e-e053-6294a90a6926	72189-357	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20220518		ANDA	ANDA207419	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-358_dfef600c-bcec-fbc9-e053-2a95a90ae6c0	72189-358	HUMAN PRESCRIPTION DRUG	Doxycycline Monohydrate		Doxycycline Monohydrate	CAPSULE	ORAL	20220526		ANDA	ANDA065053	Direct_Rx	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72189-359_e1a5bc32-f9a1-6b33-e053-2995a90ab9ac	72189-359	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate Opth Solution		Gentamicin Sulfate Opth Solution	SOLUTION/ DROPS	OPHTHALMIC	20220617		ANDA	ANDA064048	Direct_Rx	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
72189-360_e0f3aacf-df5e-dad7-e053-2995a90ac5eb	72189-360	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20220608		ANDA	ANDA205129	DirectRx	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-362_e4a3383a-7b31-25b7-e053-2995a90a341b	72189-362	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL ER		Cyclobenzaprine HCL ER	CAPSULE, EXTENDED RELEASE	ORAL	20220725		NDA	NDA021777	Direct_Rx	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72189-363_ffc207a4-9805-d8ee-e053-6294a90ab131	72189-363	HUMAN PRESCRIPTION DRUG	Venlafaxine HCL ER		Venlafaxine HCL ER	CAPSULE, EXTENDED RELEASE	ORAL	20220622		ANDA	ANDA200834	Direct_Rx	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72189-364_e1fb0b51-4f8b-965d-e053-2a95a90ad936	72189-364	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20220621		ANDA	ANDA204022	Direct_Rx	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
72189-365_e4a2996e-2bfb-376f-e053-2995a90a0ed1	72189-365	HUMAN PRESCRIPTION DRUG	Phentermine HCL C-IV		Phentermine HCL C-IV	CAPSULE	ORAL	20220725		ANDA	ANDA205019	Direct_Rx	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72189-366_e4ce9d50-9787-2233-e053-2a95a90a276f	72189-366	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20220727		ANDA	ANDA201504	Direct_Rx	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-367_e5bd9918-b074-c50b-e053-2a95a90aaeb7	72189-367	HUMAN PRESCRIPTION DRUG	Amoxicillin/Clav Pot Oral Susp		Amoxicillin/Clav Pot Oral Susp	POWDER, FOR SUSPENSION	ORAL	20220808		ANDA	ANDA201090	Direct_Rx	AMOXICILLIN; CLAVULANATE POTASSIUM	400; 57	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72189-368_e55b61de-1bd2-46b6-e053-2a95a90acf0d	72189-368	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20220728		ANDA	ANDA207419	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-369_f68cb317-9f75-2be2-e053-2995a90a504f	72189-369	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20220803		ANDA	ANDA212650	Direct_Rx	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
72189-371_0c00914f-63f3-8eb1-e063-6294a90a1b3b	72189-371	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20220810		ANDA	ANDA210616	Direct_Rx	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-372_e5e766e3-ef76-4100-e053-2995a90a510f	72189-372	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20220810		ANDA	ANDA078227	Direct_Rx	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
72189-373_e64c3b3b-d5e8-6d46-e053-2a95a90a1b64	72189-373	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20220815		ANDA	ANDA207662	Direct_Rx	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72189-374_e64b78d8-79df-337b-e053-2a95a90a4861	72189-374	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20220815		ANDA	ANDA077634	Direct_Rx	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72189-375_ffc1d0e3-c49e-d62c-e053-6294a90abb4e	72189-375	HUMAN PRESCRIPTION DRUG	Oxycodone/APAP		Oxycodone/APAP	TABLET	ORAL	20220909		ANDA	ANDA201278	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-376_e78e50c0-36db-528e-e053-2995a90a3d80	72189-376	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine Phosphate		Acetaminophen and Codeine Phosphate	TABLET	ORAL	20220831		ANDA	ANDA040419	Direct_Rx	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 60	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
72189-379_e8cb5afb-80f4-030b-e053-2a95a90ad182	72189-379	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Gel		Diclofenac Sodium Gel	GEL	TOPICAL	20220908		ANDA	ANDA208301	Direct_Rx	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-380_e87c6908-4e10-eb8a-e053-2a95a90acbd7	72189-380	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate ER		Metoprolol Succinate ER	TABLET, EXTENDED RELEASE	ORAL	20220912		ANDA	ANDA207206	Direct_Rx	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72189-381_039a0f22-5209-ce60-e063-6294a90a83a3	72189-381	HUMAN PRESCRIPTION DRUG	Esomeprazole DR		Esomeprazole DR	CAPSULE, DELAYED RELEASE	ORAL	20220913		ANDA	ANDA211977	Direct_Rx	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72189-382_e8a7c995-e474-ca87-e053-2995a90a5b80	72189-382	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET, FILM COATED	ORAL	20220914		ANDA	ANDA207152	Direct_Rx	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72189-383_e90cb7f5-5e9a-fbf3-e053-2995a90a70aa	72189-383	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20220919		ANDA	ANDA084613	Direct_Rx	DEXAMETHASONE	.75	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-384_eb3be630-4fe4-723d-e053-2a95a90a6b71	72189-384	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220919		ANDA	ANDA213603	Direct_Rx	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-385_eca52304-2251-afdf-e053-2995a90a3797	72189-385	HUMAN PRESCRIPTION DRUG	Amoxil		Amoxicillin Oral Susp	POWDER, FOR SUSPENSION	ORAL	20221021		ANDA	ANDA065325	DirectRx	AMOXICILLIN	400	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72189-386_ed0ce38e-b598-9e8f-e053-2995a90a2341	72189-386	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20221012		ANDA	ANDA040792	Direct_Rx	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
72189-387_eb503f1f-cd3b-ab76-e053-2995a90ab1c8	72189-387	HUMAN PRESCRIPTION DRUG	Lidocaine Patch		Lidocaine Patch	PATCH	TOPICAL	20221018		ANDA	ANDA206463	Direct_Rx	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-388_00edbed0-998f-a9fb-e063-6394a90ada4a	72189-388	HUMAN PRESCRIPTION DRUG	Doxepin HCL		Doxepin HCL	CAPSULE	ORAL	20221019		ANDA	ANDA215483	Direct_Rx	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-389_ed0b9acc-1330-64c0-e053-2995a90a198c	72189-389	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL ER		Cyclobenzaprine HCL ER	CAPSULE, EXTENDED RELEASE	ORAL	20221109		NDA AUTHORIZED GENERIC	NDA021777	Direct_Rx	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72189-390_ed0c3c4f-d0a9-26b5-e053-2a95a90ad06f	72189-390	HUMAN PRESCRIPTION DRUG	Diclona Gel		Diclona Gel	GEL	TOPICAL	20221109		UNAPPROVED DRUG OTHER		Direct_Rx	DICLOFENAC SODIUM; LIDOCAINE	.01; .045	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Antiarrhythmic [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-391_ed9d2290-9ada-ecff-e053-2a95a90a5fd6	72189-391	HUMAN PRESCRIPTION DRUG	Desipramine HCL		Desipramine HCL	TABLET	ORAL	20221116		ANDA	ANDA204963	Direct_Rx	DESIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-392_f0590a6a-a9c7-c5f2-e053-2995a90a9d4f	72189-392	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20221116		ANDA	ANDA204989	Direct_Rx	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-394_f19b1104-ff5b-061b-e053-2995a90a8659	72189-394	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20221116		ANDA	ANDA214957	Direct_Rx	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-395_f63e7de7-7406-0ca6-e053-2995a90a23df	72189-395	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Monohydrate/Macrocrystal		Nitrofurantoin Monohydrate/Macrocrystal	CAPSULE	ORAL	20221122		ANDA	ANDA208516	Direct_Rx	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
72189-396_08b4f203-186d-0882-e063-6294a90a7409	72189-396	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20221122		ANDA	ANDA077443	Direct_Rx	ATENOLOL	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72189-397_ee151649-b52b-0a51-e053-2a95a90a6c35	72189-397	HUMAN PRESCRIPTION DRUG	Percocet		Oxycodone/APAP	TABLET	ORAL	20221122		ANDA	ANDA201278	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-398_f63e8b75-8afc-726f-e053-2a95a90a9ef9	72189-398	HUMAN PRESCRIPTION DRUG	Oxycodone/APAP		Oxycodone/APAP	TABLET	ORAL	20221122		ANDA	ANDA201278	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-399_f758ab37-3b21-4a7a-e053-6394a90a1f5b	72189-399	HUMAN PRESCRIPTION DRUG	Norco		Hydrocodone/APAP	TABLET	ORAL	20221123		ANDA	ANDA040400	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72189-400_0816f132-ccdd-f3e6-e063-6394a90a88c3	72189-400	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20221205		ANDA	ANDA071136	Direct_Rx	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-401_f63e967a-bb5a-1fe5-e053-2a95a90a829e	72189-401	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20221205		ANDA	ANDA071135	Direct_Rx	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-402_eec705f7-123b-7926-e053-2a95a90af46d	72189-402	HUMAN PRESCRIPTION DRUG	Phenergan		Promethazine HCL	TABLET	ORAL	20221201		ANDA	ANDA040596	Direct_Rx	PROMETHAZINE HYDROCHLORIDE	12.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72189-403_f63e9477-8015-070b-e053-2a95a90a0d5f	72189-403	HUMAN PRESCRIPTION DRUG	Emtricitabine/TDF		Emtricitabine/TDF	TABLET, FILM COATED	ORAL	20221205		ANDA	ANDA090513	Direct_Rx	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
72189-404_f63e845e-fb3a-93ce-e053-2995a90a3f5d	72189-404	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20221213		ANDA	ANDA078284	Direct_Rx	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-405_f63ea94f-d28e-30d8-e053-2995a90a7aaf	72189-405	HUMAN PRESCRIPTION DRUG	WARFARIN SODIUM		WARFARIN SODIUM	TABLET	ORAL	20221215		ANDA	ANDA202202	Direct_Rx	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
72189-406_004a68ba-5034-ad48-e063-6394a90a61c3	72189-406	HUMAN PRESCRIPTION DRUG	HYDROCODONE/APAP		HYDROCODONE/APAP	TABLET	ORAL	20221215		ANDA	ANDA040405	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72189-407_09d2875a-c3d6-6749-e063-6394a90acba7	72189-407	HUMAN PRESCRIPTION DRUG	Hydrocodone/APAP		Hydrocodone/APAP	TABLET	ORAL	20221228		ANDA	ANDA040409	Direct_Rx	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72189-408_f1857ac0-806d-4a7e-e053-2995a90abbc0	72189-408	HUMAN PRESCRIPTION DRUG	Mycostatin		Nystatin	CREAM	TOPICAL	20230105		ANDA	ANDA062225	Direct_Rx	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
72189-409_f5b191a9-9b9e-1d59-e053-2995a90a794c	72189-409	HUMAN PRESCRIPTION DRUG	Diltiazem HCL ER		Diltiazem HCL ER	CAPSULE, EXTENDED RELEASE	ORAL	20230110		ANDA	ANDA208783	Direct_Rx	DILTIAZEM HYDROCHLORIDE	300	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]		N	20241231
72189-410_f2121338-9587-161d-e053-2995a90af908	72189-410	HUMAN PRESCRIPTION DRUG	Amitza		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230112		ANDA	ANDA209920	Direct_Rx	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
72189-412_f6001d44-e57a-9267-e053-2a95a90aace2	72189-412	HUMAN PRESCRIPTION DRUG	Amantadine HCL		Amantadine HCL	CAPSULE	ORAL	20230118		ANDA	ANDA209047	Direct_Rx	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
72189-414_fbd294a3-5cf6-fcf8-e053-6294a90aaaa9	72189-414	HUMAN PRESCRIPTION DRUG	Venlafaxine HCL ER		Venlafaxine HCL ER	CAPSULE, EXTENDED RELEASE	ORAL	20230126		ANDA	ANDA200834	Direct_Rx	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72189-415_f37db328-bb82-9df9-e053-2a95a90a6f43	72189-415	HUMAN PRESCRIPTION DRUG	ANASTROZOLE		ANASTROZOLE	TABLET	ORAL	20230130		ANDA	ANDA090568	Direct_Rx	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
72189-416_f3a9982a-015b-1134-e053-2a95a90ad2d4	72189-416	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20230201		ANDA	ANDA090135	Direct_Rx	ROPINIROLE HYDROCHLORIDE	.25	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
72189-417_f3bd5852-8e44-6b5d-e053-2995a90a194f	72189-417	HUMAN PRESCRIPTION DRUG	ALLOPURINOL		ALLOPURINOL	TABLET	ORAL	20230202		ANDA	ANDA204467	Direct_Rx	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72189-418_f910a7da-f03e-1ecd-e053-6294a90a2bb9	72189-418	HUMAN PRESCRIPTION DRUG	MONTELUKAST SODIUM		MONTELUKAST SODIUM	TABLET, FILM COATED	ORAL	20230202		ANDA	ANDA202843	Direct_Rx	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
72189-419_febd2287-ad54-7ac5-e053-6394a90af470	72189-419	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230206		ANDA	ANDA206943	Direct_Rx	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-420_ffc1f165-6d53-ba77-e053-6394a90a77a3	72189-420	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HCL		AMITRIPTYLINE HCL	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA214548	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-421_ffc1d0e3-c49f-d62c-e053-6294a90abb4e	72189-421	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230207		ANDA	ANDA078103	Direct_Rx	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-422_f422aaa8-3ccf-5989-e053-2a95a90a5205	72189-422	HUMAN PRESCRIPTION DRUG	Ketoconazole Cream		Ketoconazole Cream	CREAM	TOPICAL	20230207		ANDA	ANDA212443	Direct_Rx	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72189-423_fe0267f1-2142-9fac-e053-6294a90ad6f3	72189-423	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20230208		ANDA	ANDA065434	Direct_Rx	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-424_f435d670-8800-f226-e053-2a95a90ac0ee	72189-424	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20230208		ANDA	ANDA078032	Direct_Rx	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-425_f7569d66-9b32-9918-e053-6394a90a8302	72189-425	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20230213		ANDA	ANDA212517	Direct_Rx	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-426_013ce907-de92-9a2c-e063-6394a90a0585	72189-426	HUMAN PRESCRIPTION DRUG	Oxycodone/APAP		Oxycodone/APAP	TABLET	ORAL	20230221		ANDA	ANDA040545	Direct_Rx	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72189-427_fd169dd8-709d-b6b4-e053-6394a90a3a6f	72189-427	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA078103	Direct_Rx	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-428_f5dc1e67-63a0-5476-e053-2995a90a4210	72189-428	HUMAN PRESCRIPTION DRUG	Ketoconazole		Ketoconazole	TABLET	ORAL	20230301		ANDA	ANDA075319	Direct_Rx	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72189-429_f5f0fecb-949d-3998-e053-2a95a90aac8c	72189-429	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20230302		ANDA	ANDA074415	Direct_Rx	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
72189-430_051503cb-3e9c-75bf-e063-6394a90ac7ca	72189-430	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230303		ANDA	ANDA208412	Direct_Rx	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-431_f832903e-7662-ea13-e053-6394a90a621d	72189-431	HUMAN PRESCRIPTION DRUG	Amitriptyline HCL		Amitriptyline HCL	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA214548	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-432_f6f53342-3884-4e3f-e053-6394a90aec08	72189-432	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA078295	Direct_Rx	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-433_f6f54227-1fd3-c4f8-e053-6294a90a5b17	72189-433	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA078295	Direct_Rx	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-434_f7f50ee3-b945-fd20-e053-6294a90a2be9	72189-434	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET	ORAL	20230313		ANDA	ANDA204041	Direct_Rx	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-435_f7f54d9e-a356-6d05-e053-6294a90a4cb6	72189-435	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET	ORAL	20230313		ANDA	ANDA204041	Direct_Rx	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-436_f754e1b8-cd5a-7034-e053-6394a90aee13	72189-436	HUMAN PRESCRIPTION DRUG	Prazosin HCL		Prazosin HCL	CAPSULE	ORAL	20230313		ANDA	ANDA215697	Direct_Rx	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72189-437_f7f52a3a-de06-9458-e053-6394a90ae543	72189-437	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20230313		ANDA	ANDA211820	Direct_Rx	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72189-438_fe0857c2-dc7b-6da2-e053-6394a90af766	72189-438	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET	ORAL	20230313		ANDA	ANDA090939	Direct_Rx	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-439_f7e255be-5d84-5f0e-e053-6294a90a420e	72189-439	HUMAN PRESCRIPTION DRUG	Eletriptan HBR		Eletriptan HBR	TABLET, FILM COATED	ORAL	20230314		ANDA	ANDA205186	Direct_Rx	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-440_020666b0-c52a-bbd8-e063-6294a90aed7e	72189-440	HUMAN PRESCRIPTION DRUG	Amitriptyline HCL		Amitriptyline HCL	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA214548	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-441_f6dc9bbc-3332-b422-e053-6394a90af9a1	72189-441	HUMAN PRESCRIPTION DRUG	Butal/APAP/Caff		Butal/APAP/Caff	TABLET	ORAL	20230314		ANDA	ANDA200243	Direct_Rx	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	325; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
72189-442_fb2ea28a-c889-eba4-e053-6394a90aa413	72189-442	HUMAN PRESCRIPTION DRUG	Alprazolam C-IV		Alprazolam C-IV	TABLET	ORAL	20230314		ANDA	ANDA203346	Direct_Rx	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-443_f808c127-91f5-34e5-e053-6294a90ac9c4	72189-443	HUMAN PRESCRIPTION DRUG	Alprazolam C-IV		Alprazolam C-IV	TABLET	ORAL	20230314		ANDA	ANDA203346	Direct_Rx	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-444_f6dc463b-3602-48c0-e053-6294a90a2d77	72189-444	HUMAN PRESCRIPTION DRUG	Amitriptyline HCL		Amitriptyline HCL	TABLET, FILM COATED	ORAL	20230314		ANDA	ANDA214548	Direct_Rx	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72189-445_fd25cf82-1b3a-d6ef-e053-6294a90ac6a8	72189-445	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20230314		ANDA	ANDA065392	Direct_Rx	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-446_f6de1d2b-b10f-2e9a-e053-6394a90a735d	72189-446	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20230314		ANDA	ANDA201504	Direct_Rx	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-447_f7f55580-8d85-b70e-e053-6294a90a145d	72189-447	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET, FILM COATED	ORAL	20230320		ANDA	ANDA203147	Direct_Rx	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-448_f8732912-8bc7-5150-e053-6294a90afbab	72189-448	HUMAN PRESCRIPTION DRUG	Buspirone HCL		Buspirone HCL	TABLET	ORAL	20230317		ANDA	ANDA210907	Direct_Rx	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
72189-449_f75aabf8-f4a2-acd1-e053-6294a90ab9a6	72189-449	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20230320		ANDA	ANDA078032	Direct_Rx	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-450_f77cfdd0-847e-4edd-e053-6394a90a91b7	72189-450	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230322		ANDA	ANDA203346	Direct_Rx	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-451_f81e3858-f01f-1df6-e053-6394a90aef4f	72189-451	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20230330		ANDA	ANDA078032	Direct_Rx	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-452_f7aa095f-590d-98e3-e053-6394a90ad972	72189-452	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20230324		ANDA	ANDA078103	Direct_Rx	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72189-453_f8328cd4-1784-b819-e053-6294a90a96f2	72189-453	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230324		ANDA	ANDA202112	Direct_Rx	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72189-454_f80b0b95-f4db-2d6c-e053-6294a90acf92	72189-454	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230329		ANDA	ANDA203818	Direct_Rx	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-455_f81d9b82-587a-3c0a-e053-6294a90ac23e	72189-455	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230330		ANDA	ANDA201519	Direct_Rx	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-456_f823bc23-27f4-2397-e053-6294a90a365a	72189-456	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230330		ANDA	ANDA205064	Direct_Rx	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-457_f820ad7d-3c89-4a4f-e053-6294a90aef7b	72189-457	HUMAN PRESCRIPTION DRUG	Bupropion HCL		Bupropion HCL	TABLET, FILM COATED	ORAL	20230330		ANDA	ANDA076143	Direct_Rx	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72189-458_f83219c9-8082-fe55-e053-6394a90aa924	72189-458	HUMAN PRESCRIPTION DRUG	Buspirone HCL		Buspirone HCL	TABLET	ORAL	20230331		ANDA	ANDA202330	Direct_Rx	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
72189-459_f86f185b-4acc-43b5-e053-6394a90a681c	72189-459	HUMAN PRESCRIPTION DRUG	Divalproex Sodium ER		Divalproex Sodium ER	TABLET, EXTENDED RELEASE	ORAL	20230403		ANDA	ANDA209286	Direct_Rx	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72189-460_f8998c1c-c35a-6f01-e053-6294a90aebf4	72189-460	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230405		ANDA	ANDA204989	Direct_Rx	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-462_f988aa11-60f0-411e-e053-6294a90a522a	72189-462	HUMAN PRESCRIPTION DRUG	Potassium Chloride ER		Potassium Chloride ER	TABLET, EXTENDED RELEASE	ORAL	20230417		ANDA	ANDA203562	Direct_Rx	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72189-463_f98c49a3-e6bc-7fc7-e053-6394a90a9062	72189-463	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20230417		ANDA	ANDA065228	Direct_Rx	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72189-464_facd329b-1926-61df-e053-6294a90ab738	72189-464	HUMAN PRESCRIPTION DRUG	Armodafinil		Armodafinil	TABLET	ORAL	20230503		ANDA	ANDA206069	Direct_Rx	ARMODAFINIL	50	mg/1		CIV	N	20241231
72189-465_face6c19-3dda-b188-e053-6294a90a62d0	72189-465	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230503		ANDA	ANDA091388	Direct_Rx	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-466_facdb9a9-6130-e59a-e053-6394a90a1fa7	72189-466	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230503		ANDA	ANDA207105	Direct_Rx	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-467_faccacb7-65f2-cb00-e053-6394a90a9fcb	72189-467	HUMAN PRESCRIPTION DRUG	Lamotrigine ER		Lamotrigine ER	TABLET, EXTENDED RELEASE	ORAL	20230503		ANDA	ANDA207763	Direct_Rx	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
72189-468_fade983c-81fc-df94-e053-6394a90a7560	72189-468	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230504		ANDA	ANDA215604	Direct_Rx	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-469_fae2df3c-2299-a3e1-e053-6294a90aeac4	72189-469	HUMAN PRESCRIPTION DRUG	Guanfacine ER		Guanfacine ER	TABLET, EXTENDED RELEASE	ORAL	20230504		ANDA	ANDA205430	Direct_Rx	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72189-470_fb6db16d-3769-631b-e053-6294a90a1cee	72189-470	HUMAN PRESCRIPTION DRUG	Prazosin HCL		Prazosin HCL	CAPSULE	ORAL	20230511		ANDA	ANDA215697	Direct_Rx	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72189-471_03fd5810-c38c-f0a2-e063-6394a90aebcb	72189-471	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20230515		ANDA	ANDA214957	Direct_Rx	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-472_fc4d4b14-1eec-0fba-e053-6394a90a738e	72189-472	HUMAN PRESCRIPTION DRUG	Ofloxacin Ophth Soln		Ofloxacin Ophth Soln	SOLUTION/ DROPS	OPHTHALMIC	20230522		ANDA	ANDA215886	Direct_Rx	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-473_fc0c9cfe-998c-d22a-e053-6294a90afa42	72189-473	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Gel		Diclofenac Sodium Gel	GEL	TOPICAL	20230519		ANDA	ANDA212351	Direct_Rx	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-475_fc75869c-cd6c-44a3-e053-6294a90a699e	72189-475	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230524		ANDA	ANDA077856	Direct_Rx	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72189-476_fcea91c3-e429-8991-e053-6394a90a099d	72189-476	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230530		ANDA	ANDA207105	Direct_Rx	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-477_fceb9f47-8da8-7138-e053-6294a90a5558	72189-477	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20230530		ANDA	ANDA091388	Direct_Rx	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-478_fcec190f-b866-c5d3-e053-6394a90a7e45	72189-478	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20230530		ANDA	ANDA202862	Direct_Rx	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-479_fd257bd4-bbf1-64ec-e053-6394a90a43ee	72189-479	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Gel		Diclofenac Sodium Gel	GEL	TOPICAL	20230530		ANDA	ANDA210986	Direct_Rx	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-480_ff5d43ec-7df0-231e-e053-6394a90a935c	72189-480	HUMAN PRESCRIPTION DRUG	Hydroxyzine Pamoate		Hydroxyzine Pamoate	CAPSULE	ORAL	20230530		ANDA	ANDA086183	Direct_Rx	HYDROXYZINE PAMOATE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72189-481_fd11db2d-364e-9bd6-e053-6394a90ade0b	72189-481	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate ER		Quetiapine Fumarate ER	TABLET, EXTENDED RELEASE	ORAL	20230601		ANDA	ANDA090681	Direct_Rx	QUETIAPINE FUMARATE	150	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-482_fd12e3cb-8b9c-4ea0-e053-6294a90a4e7a	72189-482	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate ER		Quetiapine Fumarate ER	TABLET, EXTENDED RELEASE	ORAL	20230601		ANDA	ANDA090681	Direct_Rx	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-483_fd17163f-a309-5c9a-e053-6294a90a2ae6	72189-483	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate ER		Quetiapine Fumarate ER	TABLET, EXTENDED RELEASE	ORAL	20230601		ANDA	ANDA090681	Direct_Rx	QUETIAPINE FUMARATE	400	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-484_fd169dd8-70a1-b6b4-e053-6394a90a3a6f	72189-484	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA213815	Direct_Rx	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
72189-485_08b5ae67-70cf-1fe8-e063-6294a90a3f20	72189-485	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20230602		ANDA	ANDA202759	Direct_Rx	GLIMEPIRIDE	2	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72189-486_fd268952-e5c1-75ba-e053-6294a90a7410	72189-486	HUMAN PRESCRIPTION DRUG	Promethazine/Codeine		Promethazine/Codeine	SOLUTION	ORAL	20230602		ANDA	ANDA200386	Direct_Rx	CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE	10; 6.25	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS]	CV	N	20241231
72189-487_fd664927-db64-a1af-e053-6294a90a9048	72189-487	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCL		Phenazopyridine HCL	TABLET	ORAL	20230605		UNAPPROVED DRUG OTHER		Direct_Rx	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
72189-488_fd8a640a-b5cb-f0a7-e053-6394a90ad603	72189-488	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230607		ANDA	ANDA211697	Direct_Rx	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-489_fd8eb82e-52e0-c368-e053-6294a90ac6b0	72189-489	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230607		ANDA	ANDA208412	Direct_Rx	PREDNISONE	50	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-490_fda35d37-f36b-efc8-e053-6294a90a2bb8	72189-490	HUMAN PRESCRIPTION DRUG	Olfoxacin Otic Soln		Olfoxacin Otic Soln	SOLUTION	AURICULAR (OTIC)	20230608		ANDA	ANDA216130	Direct_Rx	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72189-492_fea936a5-fdec-e4fb-e053-6294a90a8995	72189-492	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20230621		ANDA	ANDA077584	Direct_Rx	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-493_feb8692a-9c09-0d5c-e053-6394a90a904b	72189-493	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230622		ANDA	ANDA210958	Direct_Rx	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-494_febd4b37-603a-5522-e053-6394a90a855f	72189-494	HUMAN PRESCRIPTION DRUG	Ropinirole		Ropinirole	TABLET, FILM COATED	ORAL	20230622		ANDA	ANDA079229	Direct_Rx	ROPINIROLE HYDROCHLORIDE	1	mg/1	Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]		N	20241231
72189-495_ffc2e9b4-1f10-220c-e053-6294a90a6d75	72189-495	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230705		ANDA	ANDA040750	Direct_Rx	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72189-496_00ee4acc-fde1-5504-e063-6294a90aabd0	72189-496	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230706		ANDA	ANDA040750	Direct_Rx	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72189-497_ffd2f3f5-c7c9-0028-e053-6394a90aaf17	72189-497	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20230706		ANDA	ANDA040750	Direct_Rx	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72189-498_0026d74b-7a6c-66ce-e063-6294a90a0ffa	72189-498	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Topical Sol		Diclofenac Sodium Topical Sol	SOLUTION	TOPICAL	20230710		NDA AUTHORIZED GENERIC	NDA204623	Direct_Rx	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-499_00725e5b-694d-b9e1-e063-6294a90a4182	72189-499	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230714		ANDA	ANDA206498	Direct_Rx	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72189-500_013cd34b-2440-c2e0-e063-6394a90a87d6	72189-500	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230724		ANDA	ANDA209654	Direct_Rx	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72189-502_030fb750-e38a-5d1f-e063-6294a90a8b84	72189-502	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230727		ANDA	ANDA040275	Direct_Rx	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72189-503_02069e43-5246-20dc-e063-6294a90a9dcd	72189-503	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20230803		ANDA	ANDA040268	Direct_Rx	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72189-504_020632f4-5e8b-f4a0-e063-6294a90a6301	72189-504	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20230803		ANDA	ANDA209102	Direct_Rx	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72189-505_0259db51-e200-6e7a-e063-6394a90abace	72189-505	HUMAN PRESCRIPTION DRUG	Fluoxetine HCL		Fluoxetine HCL	CAPSULE	ORAL	20230807		ANDA	ANDA204597	Direct_Rx	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72189-506_02566385-46f4-255a-e063-6294a90a1d1c	72189-506	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20230807		ANDA	ANDA065352	Direct_Rx	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72189-507_05ca5354-63c2-0308-e063-6294a90a0d4d	72189-507	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20230817		ANDA	ANDA214129	Direct_Rx	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72189-508_032135ee-7bca-5cdf-e063-6394a90ad9a2	72189-508	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20230817		ANDA	ANDA040275	Direct_Rx	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72189-509_06456968-fe7f-2c27-e063-6294a90af3ea	72189-509	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Topical Solution		Diclofenac Sodium Topical Solution	SOLUTION	TOPICAL	20230824		NDA AUTHORIZED GENERIC	NDA204623	Direct_Rx	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-510_03c449a1-9b41-a7da-e063-6394a90a984e	72189-510	HUMAN PRESCRIPTION DRUG	Levetiracetam ER		Levetiracetam ER	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20230825		ANDA	ANDA203468	Direct_Rx	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-511_044d7898-4ab7-a0b3-e063-6294a90acdba	72189-511	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230901		ANDA	ANDA215604	Direct_Rx	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-512_066acc57-af58-4b62-e063-6394a90a2b94	72189-512	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20230911		ANDA	ANDA202490	Direct_Rx	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-513_05156717-fe1c-22f1-e063-6394a90a3d10	72189-513	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20230911		ANDA	ANDA040907	Direct_Rx	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72189-514_0515ceaa-7d18-c92f-e063-6294a90a044e	72189-514	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium DR		Pantoprazole Sodium DR	TABLET, DELAYED RELEASE	ORAL	20230911		ANDA	ANDA202882	Direct_Rx	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72189-515_091c0bed-7edb-e897-e063-6294a90ae2d5	72189-515	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCL		Phenazopyridine HCL	TABLET	ORAL	20230914		UNAPPROVED DRUG OTHER		Direct_Rx	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
72189-516_06f8f4b9-528a-2d59-e063-6294a90a7209	72189-516	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20231005		ANDA	ANDA077731	Direct_Rx	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72189-517_077134d1-427e-6235-e063-6394a90abcf6	72189-517	HUMAN PRESCRIPTION DRUG	Eletriptan HBR		Eletriptan HBR	TABLET, FILM COATED	ORAL	20231011		ANDA	ANDA210708	Direct_Rx	ELETRIPTAN HYDROBROMIDE	40	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72189-518_08901233-7d37-e5d9-e063-6394a90af33d	72189-518	HUMAN PRESCRIPTION DRUG	Clotrimazole/Betameth		Clotrimazole/Betameth	CREAM	TOPICAL	20231025		ANDA	ANDA076002	Direct_Rx	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-519_0917ef53-2648-b54b-e063-6294a90a4211	72189-519	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate ER		Quetiapine Fumarate ER	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231101		ANDA	ANDA209635	Direct_Rx	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-520_094498f2-11da-2a05-e063-6294a90ab2e1	72189-520	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20231103		ANDA	ANDA203245	Direct_Rx	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72189-521_09a7af47-423b-1e8b-e063-6394a90a99ef	72189-521	HUMAN PRESCRIPTION DRUG	Tramadol HCL ER		Tramadol HCL ER	TABLET, EXTENDED RELEASE	ORAL	20231108		ANDA	ANDA200503	Direct_Rx	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72189-522_0a4a90f7-b324-ef0f-e063-6394a90a8ba0	72189-522	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231116		UNAPPROVED DRUG OTHER		DirectRx	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
72189-523_0a0db8e7-8475-3d08-e063-6294a90af3f5	72189-523	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231113		ANDA	ANDA217696	Direct_Rx	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72189-524_0b286fd1-817a-d87a-e063-6294a90a2f23	72189-524	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20231127		ANDA	ANDA207099	Direct_Rx	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72189-525_0b784f21-fc03-6542-e063-6294a90a285e	72189-525	HUMAN PRESCRIPTION DRUG	Risperidone		Risperidone	TABLET	ORAL	20231201		ANDA	ANDA201003	Direct_Rx	RISPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72189-526_0c3c67cf-a8a3-fdad-e063-6394a90a43cb	72189-526	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	CAPSULE	ORAL	20231206		ANDA	ANDA210267	Direct_Rx	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72189-527_0c41977f-8dae-1d26-e063-6294a90a9b22	72189-527	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20231211		ANDA	ANDA206116	Direct_Rx	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72189-529_0c7d1f99-dfe1-7041-e063-6294a90a9705	72189-529	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20231214		ANDA	ANDA203245	Direct_Rx	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72189-530_0e34badf-c887-08c1-e063-6294a90aeefd	72189-530	HUMAN PRESCRIPTION DRUG	Phenazopyridine HCL		Phenazopyridine HCL	TABLET	ORAL	20240105		UNAPPROVED DRUG OTHER		Direct Rx	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20251231
72189-531_0e24e7cb-194a-6686-e063-6394a90a4760	72189-531	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET	ORAL	20240104		ANDA	ANDA213853	Direct_Rx	ATORVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
72189-533_0ead9074-3479-7c3d-e063-6394a90a9d27	72189-533	HUMAN PRESCRIPTION DRUG	Doxepin HCL		Doxepin HCL	CAPSULE	ORAL	20240111		ANDA	ANDA212624	Direct_Rx	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
72190-0001_60ad61f0-97ad-42cb-ab73-b9ff6ed00302	72190-0001	HUMAN OTC DRUG	Metalock		Passiflora Incarnata, Chamomilla, Valeriana Officinalis, Fucus Officinalis, Agnus Castus, Kali Phosphoricum, Natrum Muriaticum, Nux Vomica, Phytolacca Decandra, Chelidonium Majus, Lycopodium Clavatum, Pituitarum Posterium (Bovine), Adrenocorticotrophin, Thyroidinum (Bovine), Thyroidinum (Ovine), Calcarea Carbonica, Carbo Vegetabilis, Magnesia Phosphorica, Natrum Phosphoricum, Ubidecarenonum, Graphites, Hypophysis Suis, Hypothalamus (Bovine), Placenta Totalis Suis, Argentum Nitricum, Berberis Vulgaris,	LIQUID	ORAL	20190404	20240418	UNAPPROVED HOMEOPATHIC		Real Health Medical, LLC	ACTIVATED CHARCOAL; AESCULUS HIPPOCASTANUM FLOWER; AGRIMONIA EUPATORIA FLOWER; ANEMONE PULSATILLA; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; BOS TAURUS PITUITARY GLAND, POSTERIOR; BRYONIA ALBA ROOT; CASTANEA SATIVA LEAF; CENTAURIUM ERYTHRAEA FLOWER; CERATOSTIGMA WILLMOTTIANUM FLOWER; CHASTE TREE FRUIT; CHELIDONIUM MAJUS; CORTICOTROPIN; DATURA STRAMONIUM; DIBASIC POTASSIUM PHOSPHATE; DIGITALIS; FUCUS VESICULOSUS; GRAPHITE; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA CHAMOMILLA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; SCUTELLARIA LATERIFLORA; SEMECARPUS ANACARDIUM JUICE; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SODIUM CARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; THYROID, BOVINE; THYROID, OVINE; TOXICODENDRON PUBESCENS LEAF; UBIDECARENONE; VALERIAN	12; 9; 6; 20; 20; 12; 10; 20; 6; 9; 6; 6; 6; 10; 20; 6; 20; 4; 12; 20; 6; 12; 3; 12; 3; 6; 20; 20; 200; 20; 20; 20; 6; 12; 20; 6; 12; 12; 10; 1; 20; 12; 3	[hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
72197-001_fb49a6db-2e15-6514-e053-6294a90a3310	72197-001	HUMAN OTC DRUG	Pharmacys Prescription Analgesic Gel		Menthol	GEL	TOPICAL	20180831		OTC MONOGRAPH FINAL	part346	American Consumer Products Corp	MENTHOL	1	g/100g			N	20241231
72197-007_c9eeafc8-9671-c935-e053-2995a90abe7e	72197-007	HUMAN OTC DRUG	Pharmacys Prescription Vapor Rub		MENTHOL	GEL	TOPICAL	20180928		OTC MONOGRAPH FINAL	part341	American Consumer Products Corp	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
72197-009_a8c6ef84-b073-72ee-e053-2995a90aa111	72197-009	HUMAN OTC DRUG	Sanitaxe Antibacterial		Benzalkonium Chloride	GEL	TOPICAL	20200630		OTC MONOGRAPH NOT FINAL	part333E	American Consumer Products Corp	BENZALKONIUM CHLORIDE	.26	g/100mL			N	20241231
72197-011_7a048607-f4c4-6724-e053-2a91aa0ab6f2	72197-011	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION 8OZ HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20190501		OTC MONOGRAPH NOT FINAL	part333A	American Consumer Products Corp	ALCOHOL	62	mL/100mL			N	20241231
72197-017_c28df5b9-7b7b-959d-e053-2a95a90a89d5	72197-017	HUMAN OTC DRUG	2.5OZ EverDry Antiperspirant Invisible		Aluminum Chlorohydrate Gel	STICK	TOPICAL	20190917		OTC MONOGRAPH FINAL	part350	American Consumer Products Corp	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
72197-032_a9cc16fa-b2e4-2358-e053-2a95a90ab2a5	72197-032	HUMAN OTC DRUG	SANITAXE 27 OZ INSTANT HAND SANITIZER WITH ALOE VERA		Alcohol	GEL	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part333A	American Consumer Products Corp	ALCOHOL	62	mL/100mL			N	20241231
72197-033_adbcc0e6-5c1a-4281-e053-2a95a90a94dc	72197-033	HUMAN OTC DRUG	Sanitaxe Antibacterial		Benzalkonium Chloride	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	American Consumer Products Corp	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72197-044_c4d29ee7-6893-27e0-e053-2a95a90a3166	72197-044	HUMAN OTC DRUG	Pharmacys Prescription Petroleum Jelly		Petrolatum	GEL	TOPICAL	20210615		OTC MONOGRAPH FINAL	part347	American Consumer Products Corp	PETROLATUM	99.9	g/100g			N	20241231
72197-045_c4eb36ca-ff82-629c-e053-2a95a90a51e5	72197-045	HUMAN OTC DRUG	Pharmacys Prescription Petroleum Jelly		Petrolatum	GEL	TOPICAL	20210616		OTC MONOGRAPH FINAL	part347	American Consumer Products Corp	PETROLATUM	99.9	g/100g			N	20241231
72198-0001_b19c9d39-029b-4d16-91de-086966a9710f	72198-0001	HUMAN OTC DRUG	Metabolism Manager		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus Suis, Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gambogia, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, 7-oxo-dehydroepiandrosterone-3Beta-acetate (7-KETO), Adenosinum Triphosphoricum Dinatrum, Glucagon, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20180411		UNAPPROVED HOMEOPATHIC		Healthsource of New England LLC	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GLUCAGON; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH; VINCETOXICUM HIRUNDINARIA ROOT	30; 30; 8; 8; 6; 12; 12; 30; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Antihypoglycemic Agent [EPC], Cell-mediated Immunity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
72198-0003_7f262a98-cd45-401e-9d21-105d95d7d9d2	72198-0003	HUMAN OTC DRUG	Metabolic Detox		Beta Vulgaris, Boldo, Chelidonium Majus, Sarsaparilla (Smilax Regelii), Gelsemium Sempervirens, Veratrum Album, Ferrum Metallicum, Iodium, Lycopodium Clavatum, Nux Vomica, Pulsatilla (Vulgaris), Selenium Metallicum, Thuja Occidentalis, Zincum Metallicum	LIQUID	ORAL	20181018		UNAPPROVED HOMEOPATHIC		Healthsource of New England LLC	BETA VULGARIS; CHELIDONIUM MAJUS; GELSEMIUM SEMPERVIRENS ROOT; IODINE; IRON; LYCOPODIUM CLAVATUM SPORE; PEUMUS BOLDUS LEAF; PULSATILLA VULGARIS; SARSAPARILLA; SELENIUM; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; VERATRUM ALBUM ROOT; ZINC	3; 3; 8; 12; 12; 12; 3; 12; 6; 12; 12; 12; 8; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
72198-0004_25d079e3-6290-49ec-946c-5593225d5465	72198-0004	HUMAN OTC DRUG	Metabolism Manager		Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus Suis, Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gambogia, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, 7-oxo-dehydroepiandrosterone-3Beta-acetate (7-KETO), Adenosinum Triphosphoricum Dinatrum, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20190722		UNAPPROVED HOMEOPATHIC		Healthsource of New England LLC	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH; VINCETOXICUM HIRUNDINARIA ROOT	30; 30; 8; 8; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
72201-1009_faeb1956-d83a-105f-e053-6394a90a7a45	72201-1009	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220923		ANDA	ANDA216413	Aspiro Pharma Limited	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
72202-026_0b3aee54-c9f0-08de-e063-6394a90a4ea5	72202-026	HUMAN OTC DRUG	Zogics Instant Hand Sanitizer Hydrating Gel		Alcohol	GEL	TOPICAL	20200227		OTC MONOGRAPH DRUG	505G(a)(3)	Zogics, LLC	ALCOHOL	60	mL/100mL			N	20241231
72202-200_eea1704f-9b9d-9f9e-e053-2a95a90a1d57	72202-200	HUMAN OTC DRUG	Sanitizing Wipes		Benzalkonium chloride	SWAB	TOPICAL	20180402		OTC MONOGRAPH NOT FINAL	part333A	Zogics, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
72203-001_4f3374cd-fda8-4045-97a0-3d45acb892cc	72203-001	HUMAN OTC DRUG	Hydraboost Moisturizer SPF 30		Avobenzone, Homosalate, Octisalate, and Octocrylene	LOTION	TOPICAL	20180520		OTC MONOGRAPH FINAL	part352	Bluemercury	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72203-005_71932fa9-ca28-480b-b0c4-aba3f3a83a0f	72203-005	HUMAN OTC DRUG	COVER plus CORRECT/TINTED MOISTURIZER	CC CRM FAIR	Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	CREAM	TOPICAL	20150820		OTC MONOGRAPH FINAL	part352	Bluemercury	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	75; 50; 30; 67.4	mg/g; mg/g; mg/g; mg/g			N	20241231
72203-006_71932fa9-ca28-480b-b0c4-aba3f3a83a0f	72203-006	HUMAN OTC DRUG	COVER plus CORRECT/TINTED MOISTURIZER	CC CRM LIGHT	Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	CREAM	TOPICAL	20150820		OTC MONOGRAPH FINAL	part352	Bluemercury	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	75; 50; 30; 67.4	mg/g; mg/g; mg/g; mg/g			N	20241231
72203-007_71932fa9-ca28-480b-b0c4-aba3f3a83a0f	72203-007	HUMAN OTC DRUG	COVER plus CORRECT/TINTED MOISTURIZER	CC CRM MED	Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	CREAM	TOPICAL	20150820		OTC MONOGRAPH FINAL	part352	Bluemercury	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	75; 50; 30; 67.4	mg/g; mg/g; mg/g; mg/g			N	20241231
72203-008_71932fa9-ca28-480b-b0c4-aba3f3a83a0f	72203-008	HUMAN OTC DRUG	COVER plus CORRECT/TINTED MOISTURIZER	CC CRM MED/DEEP	Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	CREAM	TOPICAL	20150820		OTC MONOGRAPH FINAL	part352	Bluemercury	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	75; 50; 30; 67.4	mg/g; mg/g; mg/g; mg/g			N	20241231
72203-009_71932fa9-ca28-480b-b0c4-aba3f3a83a0f	72203-009	HUMAN OTC DRUG	COVER plus CORRECT/TINTED MOISTURIZER	CC CRM PORCELAIN	Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	CREAM	TOPICAL	20150820		OTC MONOGRAPH FINAL	part352	Bluemercury	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	75; 50; 30; 67.4	mg/g; mg/g; mg/g; mg/g			N	20241231
72203-010_71932fa9-ca28-480b-b0c4-aba3f3a83a0f	72203-010	HUMAN OTC DRUG	COVER plus CORRECT/TINTED MOISTURIZER	CC CRM GOLDEN LIGHT	Octinoxate, Octisalate, Oxybenzone, and Titanium Dioxide	CREAM	TOPICAL	20150820		OTC MONOGRAPH FINAL	part352	Bluemercury	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	75; 50; 30; 67.4	mg/g; mg/g; mg/g; mg/g			N	20241231
72203-016_81d1ee7e-2b38-4759-9a3b-7fea8741bec2	72203-016	HUMAN OTC DRUG	Perfect Sunscreen SPF 50 Sheer Mineral		Zinc Oxide	LOTION	TOPICAL	20220415		OTC MONOGRAPH FINAL	part352	Bluemercury, Inc.	ZINC OXIDE	.12	g/mL			N	20241231
72203-017_41b075a5-cb84-4909-82d0-d4e68e250482	72203-017	HUMAN OTC DRUG	Perfect Sunscreen Tinted Mineral SPF50		Zinc Oxide	LOTION	TOPICAL	20220415		OTC MONOGRAPH FINAL	part352	Bluemercury, Inc.	ZINC OXIDE	.12	g/mL			N	20241231
72203-018_9adb1539-3553-422c-9f30-b92766a93b34	72203-018	HUMAN OTC DRUG	Hydraboost Body Sunscreen SPF 30		HOMOSALATE, OCTISALATE, and AVOBENZONE	LOTION	TOPICAL	20230415		OTC MONOGRAPH FINAL	part352	Bluemercury	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
72204-002_07ecad62-3c24-b42d-e063-6294a90aee2a	72204-002	HUMAN OTC DRUG	PATCHOLOGY BREAKOUT BOX 3-IN-1 ACNE TREATMENT		SALICYLIC ACID	KIT		20190603		OTC MONOGRAPH DRUG	M006	Iontera, Inc						N	20241231
72205-001_79a88ea4-ddf4-4ee9-acc2-91047ce636d5	72205-001	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride Tablets, 400 mg		Moxifloxacin Hydrochloride Tablets, 400 mg	TABLET, FILM COATED	ORAL	20180721		ANDA	ANDA208682	Novadoz Pharmaceuticals LLC	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72205-002_6fc8cae8-aa7d-4957-9604-d725d97a754d	72205-002	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Novadoz Pharmaceuticals LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-003_6fc8cae8-aa7d-4957-9604-d725d97a754d	72205-003	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Novadoz Pharmaceuticals LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-004_6fc8cae8-aa7d-4957-9604-d725d97a754d	72205-004	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Novadoz Pharmaceuticals LLC	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-005_6fc8cae8-aa7d-4957-9604-d725d97a754d	72205-005	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Novadoz Pharmaceuticals LLC	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-006_9f76322a-af62-4a08-892c-65f6d7f62483	72205-006	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20180721		ANDA	ANDA209365	Novadoz Pharmaceuticals LLC	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72205-007_9f76322a-af62-4a08-892c-65f6d7f62483	72205-007	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET, FILM COATED	ORAL	20180721		ANDA	ANDA209365	Novadoz Pharmaceuticals LLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72205-008_da623cb5-cd76-4236-87ad-212e25349fcd	72205-008	HUMAN PRESCRIPTION DRUG	Trientine hydrochloride		Trientine hydrochloride	CAPSULE	ORAL	20190522		ANDA	ANDA211134	Novadoz Pharmaceuticals LLC	TRIENTINE HYDROCHLORIDE	250	mg/1	Metal Chelating Activity [MoA], Metal Chelator [EPC]		N	20241231
72205-009_3f84ebe8-9db0-4334-984d-1bb4996c4339	72205-009	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181203		ANDA	ANDA210687	Novadoz Pharmaceuticals LLC	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72205-010_3f84ebe8-9db0-4334-984d-1bb4996c4339	72205-010	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181203		ANDA	ANDA210687	Novadoz Pharmaceuticals LLC	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72205-011_9052621a-b793-4c86-937b-b87dcf7133fe	72205-011	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	25	mg/1		CV	N	20241231
72205-012_9052621a-b793-4c86-937b-b87dcf7133fe	72205-012	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	50	mg/1		CV	N	20241231
72205-013_9052621a-b793-4c86-937b-b87dcf7133fe	72205-013	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	75	mg/1		CV	N	20241231
72205-014_9052621a-b793-4c86-937b-b87dcf7133fe	72205-014	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	100	mg/1		CV	N	20241231
72205-015_9052621a-b793-4c86-937b-b87dcf7133fe	72205-015	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	150	mg/1		CV	N	20241231
72205-016_9052621a-b793-4c86-937b-b87dcf7133fe	72205-016	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	200	mg/1		CV	N	20241231
72205-017_9052621a-b793-4c86-937b-b87dcf7133fe	72205-017	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	225	mg/1		CV	N	20241231
72205-018_9052621a-b793-4c86-937b-b87dcf7133fe	72205-018	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Novadoz Pharmaceuticals LLC	PREGABALIN	300	mg/1		CV	N	20241231
72205-019_614ff447-7e5f-4ea6-ba85-ec1f6497b360	72205-019	HUMAN PRESCRIPTION DRUG	valganciclovir hydrochloride		valganciclovir hydrochloride	FOR SOLUTION	ORAL	20220217		ANDA	ANDA210169	Novadoz Pharmaceuticals LLC	VALGANCICLOVIR HYDROCHLORIDE	50	mg/mL	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]		N	20241231
72205-020_eaccb7fc-2098-43d1-a64e-759b8d4c35c2	72205-020	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET	ORAL	20190520		ANDA	ANDA210688	Novadoz Pharmaceuticals LLC	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72205-021_eaccb7fc-2098-43d1-a64e-759b8d4c35c2	72205-021	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET	ORAL	20190520		ANDA	ANDA210688	Novadoz Pharmaceuticals LLC	SOLIFENACIN SUCCINATE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72205-022_59a4d692-b815-42a1-86d7-a61cf56787ce	72205-022	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Novadoz Pharmaceuticals LLC	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-023_59a4d692-b815-42a1-86d7-a61cf56787ce	72205-023	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Novadoz Pharmaceuticals LLC	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-024_59a4d692-b815-42a1-86d7-a61cf56787ce	72205-024	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Novadoz Pharmaceuticals LLC	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-025_59a4d692-b815-42a1-86d7-a61cf56787ce	72205-025	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	Novadoz Pharmaceuticals LLC	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-026_444f0992-1860-4369-9e86-69a9cf788171	72205-026	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190905		ANDA	ANDA209965	Novadoz Pharmaceuticals LLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
72205-027_6fc8cae8-aa7d-4957-9604-d725d97a754d	72205-027	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20171122		ANDA	ANDA208898	Novadoz Pharmaceuticals LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72205-028_076514fb-8843-46a7-898d-7cf05955cf74	72205-028	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	Novadoz Pharmaceuticals LLC	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72205-029_076514fb-8843-46a7-898d-7cf05955cf74	72205-029	HUMAN PRESCRIPTION DRUG	Febuxostat		Febuxostat	TABLET, FILM COATED	ORAL	20191230		ANDA	ANDA210461	Novadoz Pharmaceuticals LLC	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72205-030_aa63adb8-ffa0-421a-b37b-1b98bfb1394b	72205-030	HUMAN PRESCRIPTION DRUG	Abiraterone		Abiraterone acetate	TABLET	ORAL	20190710		ANDA	ANDA210686	Novadoz Pharmaceuticals LLC	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
72205-031_414e2f5c-5d05-41b7-9c24-fc7be0ba974e	72205-031	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190828		ANDA	ANDA212265	Novadoz Pharmaceuticals LLC	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72205-034_b9a0ca8c-593c-48e8-b2a7-d30d5f6e6a9b	72205-034	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	SOLUTION	ORAL	20231222		ANDA	ANDA215379	Novadoz Pharmaceuticals LLC	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
72205-036_2ca9d834-97c7-48db-a6ad-cdf530063b05	72205-036	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200302		ANDA	ANDA212265	Novadoz Pharmaceuticals LLC	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72205-037_1ec4c05d-7fba-4c02-a3bf-4343a8a421d5	72205-037	HUMAN PRESCRIPTION DRUG	levetiracetam		levetiracetam	SOLUTION	ORAL	20220716		ANDA	ANDA214757	Novadoz Pharmaceuticals LLC	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-039_feb8626e-9d88-4a06-919f-f8169a69814b	72205-039	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200612		ANDA	ANDA213220	Novadoz Pharmaceuticals LLC	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
72205-040_feb8626e-9d88-4a06-919f-f8169a69814b	72205-040	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200612		ANDA	ANDA213220	Novadoz Pharmaceuticals LLC	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
72205-041_feb8626e-9d88-4a06-919f-f8169a69814b	72205-041	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20200612		ANDA	ANDA213220	Novadoz Pharmaceuticals LLC	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
72205-042_aa08b037-16b8-405c-b730-23c6bd127db8	72205-042	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20200825		ANDA	ANDA212544	Novadoz Pharmaceuticals LLC	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
72205-043_aa08b037-16b8-405c-b730-23c6bd127db8	72205-043	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20200825		ANDA	ANDA212544	Novadoz Pharmaceuticals LLC	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
72205-044_aa08b037-16b8-405c-b730-23c6bd127db8	72205-044	HUMAN PRESCRIPTION DRUG	Oseltamivir phosphate		Oseltamivir phosphate	CAPSULE	ORAL	20200825		ANDA	ANDA212544	Novadoz Pharmaceuticals LLC	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
72205-045_b702dcc9-dd0e-4386-b1e2-f20562fd2ad9	72205-045	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20200201		ANDA	ANDA213049	Novadoz Pharmaceuticals LLC	THIOTEPA	15	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72205-046_b702dcc9-dd0e-4386-b1e2-f20562fd2ad9	72205-046	HUMAN PRESCRIPTION DRUG	Thiotepa		Thiotepa	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRACAVITARY; INTRAVENOUS; INTRAVESICAL	20200201		ANDA	ANDA213049	Novadoz Pharmaceuticals LLC	THIOTEPA	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72205-047_cf5bb37f-5386-47d3-8cec-d48253d359f6	72205-047	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20220610		ANDA	ANDA213404	Novadoz Pharmaceuticals LLC	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
72205-048_cf5bb37f-5386-47d3-8cec-d48253d359f6	72205-048	HUMAN PRESCRIPTION DRUG	CLOBAZAM		CLOBAZAM	TABLET	ORAL	20220610		ANDA	ANDA213404	Novadoz Pharmaceuticals LLC	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
72205-049_9d58cbb6-d3e8-4b56-a3f5-d2619db3b618	72205-049	HUMAN PRESCRIPTION DRUG	Aminocaproic acid		Aminocaproic acid	TABLET	ORAL	20201210		ANDA	ANDA212938	Novadoz Pharmaceuticals LLC	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
72205-050_e897546b-4136-4cb5-a262-d94cf3fa3298	72205-050	HUMAN PRESCRIPTION DRUG	toremifene citrate		toremifene citrate	TABLET	ORAL	20200902		ANDA	ANDA212818	Novadoz Pharmaceuticals LLC	TOREMIFENE CITRATE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
72205-051_594f7aab-b336-4d6d-b702-a33346c69645	72205-051	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET	ORAL	20210224		ANDA	ANDA213435	Novadoz Pharmaceuticals LLC	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
72205-052_96086fd8-8fa3-4a2b-ac12-fe1a3ad4f384	72205-052	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	TABLET	ORAL	20230405		ANDA	ANDA214823	Novadoz Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72205-053_96086fd8-8fa3-4a2b-ac12-fe1a3ad4f384	72205-053	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	TABLET	ORAL	20230405		ANDA	ANDA214823	Novadoz Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72205-054_1e6b36b2-3c8b-4ac4-827e-d6f00d999032	72205-054	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200512		ANDA	ANDA209965	Novadoz Pharmaceuticals LLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
72205-059_18b327c1-19c9-4e33-ae02-de7cc900149c	72205-059	HUMAN PRESCRIPTION DRUG	sildenafil citrate		sildenafil citrate	POWDER, FOR SUSPENSION	ORAL	20220214		ANDA	ANDA214641	Novadoz Pharmaceuticals LLC	SILDENAFIL CITRATE	10	mg/mL	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72205-060_9c924083-1934-4fc5-b2ec-fbb618dcfdb1	72205-060	HUMAN PRESCRIPTION DRUG	oseltamivir phosphate		oseltamivir phosphate	POWDER, FOR SUSPENSION	ORAL	20220506		ANDA	ANDA215313	Novadoz Pharmaceuticals LLC	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
72205-061_4e1bf850-d616-4ff3-b62a-2057dddc3dfe	72205-061	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20200826		ANDA	ANDA213434	Novadoz Pharmaceuticals LLC	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
72205-062_4e1bf850-d616-4ff3-b62a-2057dddc3dfe	72205-062	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20200826		ANDA	ANDA213434	Novadoz Pharmaceuticals LLC	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
72205-063_4e1bf850-d616-4ff3-b62a-2057dddc3dfe	72205-063	HUMAN PRESCRIPTION DRUG	Paclitaxel		Paclitaxel	INJECTION, SOLUTION	INTRAVENOUS	20200826		ANDA	ANDA213434	Novadoz Pharmaceuticals LLC	PACLITAXEL	6	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
72205-064_3a474e06-fb00-40cb-aa3a-6edad43c2c0a	72205-064	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20221118		ANDA	ANDA216004	Novadoz Pharmaceuticals LLC	HALOPERIDOL	.5	mg/1	Typical Antipsychotic [EPC]		N	20241231
72205-065_3a474e06-fb00-40cb-aa3a-6edad43c2c0a	72205-065	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20221118		ANDA	ANDA216004	Novadoz Pharmaceuticals LLC	HALOPERIDOL	1	mg/1	Typical Antipsychotic [EPC]		N	20241231
72205-066_3a474e06-fb00-40cb-aa3a-6edad43c2c0a	72205-066	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20221118		ANDA	ANDA216004	Novadoz Pharmaceuticals LLC	HALOPERIDOL	2	mg/1	Typical Antipsychotic [EPC]		N	20241231
72205-067_3a474e06-fb00-40cb-aa3a-6edad43c2c0a	72205-067	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20221118		ANDA	ANDA216004	Novadoz Pharmaceuticals LLC	HALOPERIDOL	5	mg/1	Typical Antipsychotic [EPC]		N	20241231
72205-068_3a474e06-fb00-40cb-aa3a-6edad43c2c0a	72205-068	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20221118		ANDA	ANDA216004	Novadoz Pharmaceuticals LLC	HALOPERIDOL	10	mg/1	Typical Antipsychotic [EPC]		N	20241231
72205-069_3a474e06-fb00-40cb-aa3a-6edad43c2c0a	72205-069	HUMAN PRESCRIPTION DRUG	HALOPERIDOL		HALOPERIDOL	TABLET	ORAL	20221118		ANDA	ANDA216004	Novadoz Pharmaceuticals LLC	HALOPERIDOL	20	mg/1	Typical Antipsychotic [EPC]		N	20241231
72205-072_381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d	72205-072	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	Novadoz Pharmaceuticals LLC	DROXIDOPA	100	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
72205-073_381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d	72205-073	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	Novadoz Pharmaceuticals LLC	DROXIDOPA	200	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
72205-074_381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d	72205-074	HUMAN PRESCRIPTION DRUG	Droxidopa		Droxidopa	CAPSULE	ORAL	20210219		ANDA	ANDA211741	Novadoz Pharmaceuticals LLC	DROXIDOPA	300	mg/1	Catecholamines [CS], Increased Blood Pressure [PE]		N	20241231
72205-075_b2ff1a76-b564-4235-8275-89005d9c4a24	72205-075	HUMAN PRESCRIPTION DRUG	Deferasorox		Deferasirox	GRANULE	ORAL	20210318		ANDA	ANDA214650	Novadoz Pharmaceuticals LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
72205-076_b2ff1a76-b564-4235-8275-89005d9c4a24	72205-076	HUMAN PRESCRIPTION DRUG	Deferasorox		Deferasirox	GRANULE	ORAL	20210318		ANDA	ANDA214650	Novadoz Pharmaceuticals LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
72205-077_f6aa5977-97c8-4a56-8e35-d9ab5cc24369	72205-077	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213226	Novadoz Pharmaceuticals LLC	PREGABALIN	82.5	mg/1		CV	N	20241231
72205-078_f6aa5977-97c8-4a56-8e35-d9ab5cc24369	72205-078	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213226	Novadoz Pharmaceuticals LLC	PREGABALIN	165	mg/1		CV	N	20241231
72205-079_f6aa5977-97c8-4a56-8e35-d9ab5cc24369	72205-079	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210413		ANDA	ANDA213226	Novadoz Pharmaceuticals LLC	PREGABALIN	330	mg/1		CV	N	20241231
72205-080_4cff04f5-3693-4d87-a9f8-a2b195e3d26e	72205-080	HUMAN PRESCRIPTION DRUG	Erlotinib Hydrochloride		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA214366	Novadoz Pharmaceuticals LLC	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72205-081_4cff04f5-3693-4d87-a9f8-a2b195e3d26e	72205-081	HUMAN PRESCRIPTION DRUG	Erlotinib Hydrochloride		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA214366	Novadoz Pharmaceuticals LLC	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72205-082_4cff04f5-3693-4d87-a9f8-a2b195e3d26e	72205-082	HUMAN PRESCRIPTION DRUG	Erlotinib Hydrochloride		Erlotinib Hydrochloride	TABLET, FILM COATED	ORAL	20210511		ANDA	ANDA214366	Novadoz Pharmaceuticals LLC	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72205-083_a7343abe-b2b0-4e5a-907b-532a8e16dfcb	72205-083	HUMAN PRESCRIPTION DRUG	Fosaprepitant		Fosaprepitant	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200512		ANDA	ANDA209965	Novadoz Pharmaceuticals LLC	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
72205-084_7c034fe0-cdac-49e1-8e39-592846ea3bec	72205-084	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211123		ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	2	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-085_7c034fe0-cdac-49e1-8e39-592846ea3bec	72205-085	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211123		ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	4	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-086_7c034fe0-cdac-49e1-8e39-592846ea3bec	72205-086	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211123		ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	12	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-087_7c034fe0-cdac-49e1-8e39-592846ea3bec	72205-087	HUMAN PRESCRIPTION DRUG	Tiagabine Hydrochloride		Tiagabine Hydrochloride	TABLET	ORAL	20211123		ANDA	ANDA214816	Novadoz Pharmaceuticals LLC	TIAGABINE HYDROCHLORIDE	16	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-088_2b1f0144-65d8-451f-8054-6be1675f102c	72205-088	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220627		ANDA	ANDA215113	Novadoz Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72205-089_2b1f0144-65d8-451f-8054-6be1675f102c	72205-089	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220627		ANDA	ANDA215113	Novadoz Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72205-090_2b1f0144-65d8-451f-8054-6be1675f102c	72205-090	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220627		ANDA	ANDA215113	Novadoz Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72205-091_2b1f0144-65d8-451f-8054-6be1675f102c	72205-091	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220627		ANDA	ANDA215113	Novadoz Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72205-092_2b1f0144-65d8-451f-8054-6be1675f102c	72205-092	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20220627		ANDA	ANDA215113	Novadoz Pharmaceuticals LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72205-093_082d818a-4f4e-4675-98c6-91db0294e63c	72205-093	HUMAN PRESCRIPTION DRUG	Vigabatrin		vigabatrin	FOR SOLUTION	ORAL	20220907		ANDA	ANDA215363	Novadoz Pharmaceuticals LLC	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20241231
72205-094_1c4450a1-6c05-4b45-a733-c19b4e861970	72205-094	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20221007		ANDA	ANDA214815	Novadoz Pharmaceuticals LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-095_1c4450a1-6c05-4b45-a733-c19b4e861970	72205-095	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20221007		ANDA	ANDA214815	Novadoz Pharmaceuticals LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-096_1c4450a1-6c05-4b45-a733-c19b4e861970	72205-096	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20221007		ANDA	ANDA214815	Novadoz Pharmaceuticals LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-097_1c4450a1-6c05-4b45-a733-c19b4e861970	72205-097	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20221007		ANDA	ANDA214815	Novadoz Pharmaceuticals LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-098_0bed477f-b228-4f8d-a956-f192b1329ea0	72205-098	HUMAN PRESCRIPTION DRUG	Pyridostigmine Bromide		Pyridostigmine Bromide	SOLUTION	ORAL	20230921		ANDA	ANDA216512	Novadoz Pharmaceuticals LLC	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72205-099_580c1ec1-c1f5-45f6-89b7-3be25c07a0e5	72205-099	HUMAN PRESCRIPTION DRUG	sirolimus		sirolimus	SOLUTION	ORAL	20230119		ANDA	ANDA216728	Novadoz Pharmaceuticals LLC	SIROLIMUS	1	mg/mL	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
72205-100_8d7ba627-cf3f-4b94-aee8-8b44cc9400be	72205-100	HUMAN PRESCRIPTION DRUG	Fluphenazine Decanoate		Fluphenazine Decanoate	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20231102		ANDA	ANDA215365	Novadoz Pharmaceuticals LLC	FLUPHENAZINE DECANOATE	25	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-101_387edfd4-be85-41cd-8a6d-14e6a022b5a9	72205-101	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220806		ANDA	ANDA215364	Novadoz Pharmaceuticals LLC	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72205-102_387edfd4-be85-41cd-8a6d-14e6a022b5a9	72205-102	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220806		ANDA	ANDA215364	Novadoz Pharmaceuticals LLC	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72205-104_315ce03f-d9f8-4f3a-9e83-922747430c23	72205-104	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, SUGAR COATED	ORAL	20220209		ANDA	ANDA214827	Novadoz Pharmaceuticals LLC	CHLORPROMAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-105_315ce03f-d9f8-4f3a-9e83-922747430c23	72205-105	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, SUGAR COATED	ORAL	20220209		ANDA	ANDA214827	Novadoz Pharmaceuticals LLC	CHLORPROMAZINE HYDROCHLORIDE	50	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-106_315ce03f-d9f8-4f3a-9e83-922747430c23	72205-106	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, SUGAR COATED	ORAL	20220209		ANDA	ANDA214827	Novadoz Pharmaceuticals LLC	CHLORPROMAZINE HYDROCHLORIDE	100	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-107_315ce03f-d9f8-4f3a-9e83-922747430c23	72205-107	HUMAN PRESCRIPTION DRUG	Chlorpromazine Hydrochloride		Chlorpromazine Hydrochloride	TABLET, SUGAR COATED	ORAL	20220209		ANDA	ANDA214827	Novadoz Pharmaceuticals LLC	CHLORPROMAZINE HYDROCHLORIDE	200	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-112_83ce71b9-28eb-4074-b1e7-192ed254c529	72205-112	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20230911		ANDA	ANDA217189	Novadoz Pharmaceuticals LLC	FLUPHENAZINE HYDROCHLORIDE	1	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-113_83ce71b9-28eb-4074-b1e7-192ed254c529	72205-113	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20230911		ANDA	ANDA217189	Novadoz Pharmaceuticals LLC	FLUPHENAZINE HYDROCHLORIDE	2.5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-114_83ce71b9-28eb-4074-b1e7-192ed254c529	72205-114	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20230911		ANDA	ANDA217189	Novadoz Pharmaceuticals LLC	FLUPHENAZINE HYDROCHLORIDE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-115_83ce71b9-28eb-4074-b1e7-192ed254c529	72205-115	HUMAN PRESCRIPTION DRUG	Fluphenazine Hydrochloride		Fluphenazine Hydrochloride	TABLET, FILM COATED	ORAL	20230911		ANDA	ANDA217189	Novadoz Pharmaceuticals LLC	FLUPHENAZINE HYDROCHLORIDE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72205-120_484e8d8f-be40-46f8-a509-d1bbdbbd2981	72205-120	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20221115		ANDA	ANDA215980	Novadoz Pharmaceuticals LLC	LEVETIRACETAM	500	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72205-130_92ce12f1-eae0-4c83-9a4e-a5181e08fa92	72205-130	HUMAN PRESCRIPTION DRUG	TOLVAPTAN		TOLVAPTAN	TABLET	ORAL	20230621		ANDA	ANDA216949	Novadoz Pharmaceuticals LLC	TOLVAPTAN	15	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
72205-131_92ce12f1-eae0-4c83-9a4e-a5181e08fa92	72205-131	HUMAN PRESCRIPTION DRUG	TOLVAPTAN		TOLVAPTAN	TABLET	ORAL	20230621		ANDA	ANDA216949	Novadoz Pharmaceuticals LLC	TOLVAPTAN	30	mg/1	Vasopressin V2 Receptor Antagonist [EPC], Vasopressin V2 Receptor Antagonists [MoA]		N	20241231
72205-141_5edb843a-66ed-4950-9ed0-393e6a5d7c99	72205-141	HUMAN PRESCRIPTION DRUG	Losartan potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA217396	Novadoz Pharmaceuticals LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72205-142_5edb843a-66ed-4950-9ed0-393e6a5d7c99	72205-142	HUMAN PRESCRIPTION DRUG	Losartan potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA217396	Novadoz Pharmaceuticals LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72205-143_5edb843a-66ed-4950-9ed0-393e6a5d7c99	72205-143	HUMAN PRESCRIPTION DRUG	Losartan potassium		Losartan potassium	TABLET, FILM COATED	ORAL	20230814		ANDA	ANDA217396	Novadoz Pharmaceuticals LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72205-170_3efa1e5e-5a14-4724-a2ca-25702f10faed	72205-170	HUMAN PRESCRIPTION DRUG	Acyclovir suspension		Acyclovir	SUSPENSION	ORAL	20230309		ANDA	ANDA217393	Novadoz Pharmaceuticals LLC	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72205-176_b2ff1a76-b564-4235-8275-89005d9c4a24	72205-176	HUMAN PRESCRIPTION DRUG	Deferasorox		Deferasirox	GRANULE	ORAL	20220521		ANDA	ANDA214650	Novadoz Pharmaceuticals LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	20241231
72205-180_1172bc4e-1700-402f-8262-97f05bac0d09	72205-180	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220519		ANDA	ANDA216171	Novadoz Pharmaceuticals LLC	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72205-181_6c681651-2bca-4b56-8a30-d642e8d9610e	72205-181	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET, FILM COATED	ORAL	20220907		ANDA	ANDA212772	Novadoz Pharmaceuticals LLC	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
72205-182_6c681651-2bca-4b56-8a30-d642e8d9610e	72205-182	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	TABLET, FILM COATED	ORAL	20220907		ANDA	ANDA212772	Novadoz Pharmaceuticals LLC	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
72205-183_d41340c2-7fe8-42b2-aaa5-c9f9b0e9b50e	72205-183	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20220726		ANDA	ANDA209622	Novadoz Pharmaceuticals LLC	BORTEZOMIB	3.5	mg/3.5mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
72205-184_ea6e0136-75b2-4793-9500-04e6658a0a73	72205-184	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231128		ANDA	ANDA215389	Novadoz Pharmaceuticals LLC	DARUNAVIR	600	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
72205-185_ea6e0136-75b2-4793-9500-04e6658a0a73	72205-185	HUMAN PRESCRIPTION DRUG	Darunavir		Darunavir	TABLET, FILM COATED	ORAL	20231128		ANDA	ANDA215389	Novadoz Pharmaceuticals LLC	DARUNAVIR	800	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC]		N	20241231
72205-198_e6e28c8c-f793-41f3-aaeb-7bf412660288	72205-198	HUMAN PRESCRIPTION DRUG	Carmustine		Carmustine	KIT		20230511		ANDA	ANDA214814	Novadoz Pharmaceuticals LLC						N	20241231
72205-200_4d25f69c-58b7-4e2a-b835-4d0c76a83c7c	72205-200	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20220907		ANDA	ANDA208256	Novadoz Pharmaceuticals LLC	ROFLUMILAST	500	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
72205-201_4d25f69c-58b7-4e2a-b835-4d0c76a83c7c	72205-201	HUMAN PRESCRIPTION DRUG	Roflumilast		Roflumilast	TABLET	ORAL	20220907		ANDA	ANDA208256	Novadoz Pharmaceuticals LLC	ROFLUMILAST	250	ug/1	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
72205-205_90b35a26-ab65-4c39-b97f-55c8c0e34b0b	72205-205	HUMAN PRESCRIPTION DRUG	ziprasidone mesylate		ziprasidone mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20220915		ANDA	ANDA216091	Novadoz Pharmaceuticals LLC	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
72205-207_4f969224-a9f0-4089-84d6-a15664ea7bfe	72205-207	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	Novadoz Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72205-208_4f969224-a9f0-4089-84d6-a15664ea7bfe	72205-208	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	Novadoz Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72205-209_4f969224-a9f0-4089-84d6-a15664ea7bfe	72205-209	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	Novadoz Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72205-210_4f969224-a9f0-4089-84d6-a15664ea7bfe	72205-210	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	Novadoz Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72205-211_4f969224-a9f0-4089-84d6-a15664ea7bfe	72205-211	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230209		ANDA	ANDA208037	Novadoz Pharmaceuticals LLC	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72205-220_a024081a-e131-4e88-967d-40155651a945	72205-220	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	INJECTION	INTRAVENOUS	20230209		ANDA	ANDA215979	Novadoz Pharmaceuticals LLC	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
72205-249_f26effc5-2a22-441f-91ac-e131ee1c9886	72205-249	HUMAN PRESCRIPTION DRUG	Plerixafor		Plerixafor	INJECTION, SOLUTION	SUBCUTANEOUS	20230725		ANDA	ANDA211901	Novadoz Pharmaceuticals LLC	PLERIXAFOR	24	mg/1.2mL	Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]		N	20241231
72205-260_c3e167cd-7f56-45eb-80df-a60fa1392e57	72205-260	HUMAN PRESCRIPTION DRUG	vilazodone hydrochloride		vilazodone hydrochloride	TABLET	ORAL	20230707		ANDA	ANDA208228	Novadoz Pharmaceuticals LLC	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
72205-261_c3e167cd-7f56-45eb-80df-a60fa1392e57	72205-261	HUMAN PRESCRIPTION DRUG	vilazodone hydrochloride		vilazodone hydrochloride	TABLET	ORAL	20230707		ANDA	ANDA208228	Novadoz Pharmaceuticals LLC	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
72205-262_c3e167cd-7f56-45eb-80df-a60fa1392e57	72205-262	HUMAN PRESCRIPTION DRUG	vilazodone hydrochloride		vilazodone hydrochloride	TABLET	ORAL	20230707		ANDA	ANDA208228	Novadoz Pharmaceuticals LLC	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
72205-286_9d58cbb6-d3e8-4b56-a3f5-d2619db3b618	72205-286	HUMAN PRESCRIPTION DRUG	Aminocaproic acid		Aminocaproic acid	TABLET	ORAL	20230913		ANDA	ANDA212938	Novadoz Pharmaceuticals LLC	AMINOCAPROIC ACID	1000	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
72208-211_ee9cf44c-6c93-228c-e053-2995a90a86f1	72208-211	HUMAN OTC DRUG	The Ordinary Salicylic Acid 2% Solution		Salicylic Acid	LIQUID	TOPICAL	20220115		OTC MONOGRAPH FINAL	M006	Deciem	SALICYLIC ACID	20	mg/mL			N	20241231
72209-001_0d0d4155-0c41-8d60-e063-6294a90a7cea	72209-001	HUMAN OTC DRUG	Chemical Free Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20190501		OTC MONOGRAPH DRUG	M020	Herban Roots, LLC	ZINC OXIDE	145.7	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72211-004_cfd2a317-e0e9-622f-e053-2a95a90af3a7	72211-004	HUMAN OTC DRUG	PEPPLUS WRINKLE EYE		Adenosine	CREAM	TOPICAL	20180409		UNAPPROVED DRUG OTHER		Picobio Co., Ltd	ADENOSINE	.012	g/30g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
72211-008_cfd2b14c-c149-2134-e053-2a95a90ab8b0	72211-008	HUMAN OTC DRUG	PEPPLUS SPECIAL SKIN CARE LIFTING PROGRAM		Copper Tripeptide-1, Nicotinoyl dipeptide-230, sh-polypeptide-10, Hexapeptide-67 Palmitate, Camellia Sinensis Leaf Extract	KIT		20211102		UNAPPROVED DRUG OTHER		Picobio Co., Ltd.						N	20241231
72211-009_cf833a8b-63c7-5ede-e053-2995a90ae43d	72211-009	HUMAN OTC DRUG	PEPPLUS SPECIAL CARE		Pyrithione Zinc, Panthenol, Niacinamide, Biotin	SHAMPOO	TOPICAL	20200113		UNAPPROVED DRUG OTHER		Picobio Co., Ltd	BIOTIN; NIACINAMIDE; PANTHENOL; PYRITHIONE ZINC	.18; .9; 1.5; 2.88	mg/300mL; mg/300mL; mg/300mL; mg/300mL			N	20241231
72211-010_cfd2b75e-011d-4e1a-e053-2a95a90a3d6b	72211-010	HUMAN OTC DRUG	PEPPLUS LIFTING ESSENCE		DIMETHICONE	CREAM	TOPICAL	20211102		UNAPPROVED DRUG OTHER		Picobio Co., Ltd	DIMETHICONE	1.5	g/100mL	Skin Barrier Activity [PE]		N	20241231
72211-011_cfd2e467-e47c-499d-e053-2a95a90abacc	72211-011	HUMAN OTC DRUG	PEPPLUS WRINKLE		Dimethicone	CREAM	TOPICAL	20211102		UNAPPROVED DRUG OTHER		Picobio Co., Ltd	DIMETHICONE	1.675	g/50g	Skin Barrier Activity [PE]		N	20241231
72222-224_d71a5a70-f0e4-45cc-8227-407f577d1fb6	72222-224	HUMAN OTC DRUG	Remedy Nails		Undecylenic Acid	LOTION	TOPICAL	20180601		OTC MONOGRAPH FINAL	part333C	Adwill Labs Inc	UNDECYLENIC ACID	85	mg/mL			N	20241231
72224-000_4fec21e4-a21b-4f7a-ac58-c8f8e0df21e7	72224-000	HUMAN OTC DRUG	lucy nicotine		nicotine polacrilex	LOZENGE	ORAL	20210129		ANDA	ANDA203690	Lucy Goods, INC.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72224-017_9beb48d2-0d37-467d-a151-468fc08210d2	72224-017	HUMAN OTC DRUG	Lucy nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20190506		ANDA	ANDA203690	Lucy Goods, INC.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72224-870_7af35ea8-a5ed-4424-b1c4-4e4ff7902046	72224-870	HUMAN OTC DRUG	lucy nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210129		ANDA	ANDA203690	Lucy Goods, INC.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72226-305_09dc4870-a264-48af-e063-6394a90aa79e	72226-305	HUMAN OTC DRUG	GOLD ICE Pain Relief		MENTHOL	CREAM	TOPICAL	20200801		OTC MONOGRAPH DRUG	M017	Eden's Answers, Inc.	MENTHOL	62.5	mg/mL			N	20241231
72234-457_220dba72-7664-4aa8-ad24-fe210cb27b28	72234-457	HUMAN OTC DRUG	Foaming Instant Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20180529		OTC MONOGRAPH NOT FINAL	part333E	Pro Source Distributors, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
72234-876_ebb6760d-3da4-4c83-af67-120c2c736ef9	72234-876	HUMAN OTC DRUG	High Foaming Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20180419		OTC MONOGRAPH NOT FINAL	part333E	Pro Source Distributors, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
72235-5838_c4957958-b317-4d2b-ab23-9876d5a83163	72235-5838	HUMAN OTC DRUG	Lubracane		Lubracane	GEL	TOPICAL	20180115		OTC MONOGRAPH FINAL	part341	Ozeion LLC	MENTHOL	.24	mg/mL			N	20241231
72237-101_0aa4ad93-ecc2-41b6-9668-ad45f3f32c61	72237-101	HUMAN PRESCRIPTION DRUG	XPOVIO		selinexor	TABLET, FILM COATED	ORAL	20190710		NDA	NDA212306	Karyopharm Therapeutics Inc.	SELINEXOR	20	mg/1			N	20241231
72237-102_0aa4ad93-ecc2-41b6-9668-ad45f3f32c61	72237-102	HUMAN PRESCRIPTION DRUG	XPOVIO		selinexor	TABLET, FILM COATED	ORAL	20210519		NDA	NDA212306	Karyopharm Therapeutics Inc.	SELINEXOR	40	mg/1			N	20241231
72237-103_0aa4ad93-ecc2-41b6-9668-ad45f3f32c61	72237-103	HUMAN PRESCRIPTION DRUG	XPOVIO		selinexor	TABLET, FILM COATED	ORAL	20210519		NDA	NDA212306	Karyopharm Therapeutics Inc.	SELINEXOR	50	mg/1			N	20241231
72237-104_0aa4ad93-ecc2-41b6-9668-ad45f3f32c61	72237-104	HUMAN PRESCRIPTION DRUG	XPOVIO		selinexor	TABLET, FILM COATED	ORAL	20210519		NDA	NDA212306	Karyopharm Therapeutics Inc.	SELINEXOR	60	mg/1			N	20241231
72238-001_ff3672dc-85db-d231-e053-6394a90a6633	72238-001	HUMAN OTC DRUG	Vamousse Lice Treatment		Pediculicide	AEROSOL, FOAM	TOPICAL	20181001		UNAPPROVED HOMEOPATHIC		Alliance Pharma Inc.	SODIUM CHLORIDE	2	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
72238-002_00b1c544-9ae4-215b-e063-6394a90a28a1	72238-002	HUMAN OTC DRUG	Vamousse Lice Defense		Pediculicide	SHAMPOO	TOPICAL	20180702		UNAPPROVED HOMEOPATHIC		Alliance Pharma Inc.	EUCALYPTUS GLOBULUS LEAF; SODIUM CHLORIDE	2; 2	[hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
72238-002_ff367bb3-b305-9053-e053-6394a90a8d07	72238-002	HUMAN OTC DRUG	Vamousse Lice Defense		Pediculicide	SHAMPOO	TOPICAL	20190821		UNAPPROVED HOMEOPATHIC		Alliance Pharma Inc.	EUCALYPTUS GLOBULUS LEAF; SODIUM CHLORIDE	2; 2	[hp_X]/mL; [hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
72238-003_ff3672dc-85ee-d231-e053-6394a90a6633	72238-003	HUMAN OTC DRUG	Vamousse Lice Treatment Complete Kit		sodium chloride and eucalyptus globulus leaf	AEROSOL, FOAM	TOPICAL	20190823		UNAPPROVED HOMEOPATHIC		Alliance Pharma Inc.	SODIUM CHLORIDE	2	[hp_X]/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
72238-004_00b0ae89-7396-0bf8-e063-6394a90a0c67	72238-004	HUMAN OTC DRUG	Vamousse Lice Defense		Eucalyptus globulus, Natrum muriaticum	SHAMPOO	TOPICAL	20210501		UNAPPROVED HOMEOPATHIC		Alliance Pharma Inc.	EUCALYPTUS GLOBULUS LEAF; SODIUM CHLORIDE	2; 2	[hp_X]/mL; [hp_X]/mL			N	20241231
72238-005_005f2272-a1fe-687d-e063-6394a90accdb	72238-005	HUMAN OTC DRUG	Vamousse Pro Total Lice Emergency Kit		Pediculicide	KIT	TOPICAL	20230510		UNAPPROVED HOMEOPATHIC		Alliance Pharma Inc.						N	20241231
72241-002_af81465b-5f49-4eeb-8122-ef7fe5d90ddc	72241-002	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, COATED	ORAL	20210819		ANDA	ANDA206432	Modavar Pharmaceuticals LLC	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
72241-003_af81465b-5f49-4eeb-8122-ef7fe5d90ddc	72241-003	HUMAN PRESCRIPTION DRUG	Nateglinide		Nateglinide	TABLET, COATED	ORAL	20210819		ANDA	ANDA206432	Modavar Pharmaceuticals LLC	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
72241-004_a456bc34-0c79-44f4-9119-50028a978f5f	72241-004	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET	ORAL	20151229		ANDA	ANDA203845	Modavar Pharmaceuticals LLC	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72241-005_a456bc34-0c79-44f4-9119-50028a978f5f	72241-005	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET	ORAL	20151229		ANDA	ANDA203845	Modavar Pharmaceuticals LLC	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72241-006_a456bc34-0c79-44f4-9119-50028a978f5f	72241-006	HUMAN PRESCRIPTION DRUG	HYDRALAZINE HYDROCHLORIDE		hydralazine hydrochloride	TABLET	ORAL	20151229		ANDA	ANDA203845	Modavar Pharmaceuticals LLC	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72241-007_05b0781b-50e2-4311-bde0-430b96e2ef8e	72241-007	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20210908		ANDA	ANDA206993	Modavar Pharmaceuticals LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72241-008_05b0781b-50e2-4311-bde0-430b96e2ef8e	72241-008	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20210908		ANDA	ANDA206993	Modavar Pharmaceuticals LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72241-009_05b0781b-50e2-4311-bde0-430b96e2ef8e	72241-009	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20210908		ANDA	ANDA206993	Modavar Pharmaceuticals LLC	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72241-010_f0db29f5-28da-4165-94f8-24727b6b71e5	72241-010	HUMAN PRESCRIPTION DRUG	Raloxifene hydrochloride		Raloxifene hydrochloride	TABLET, COATED	ORAL	20171230		ANDA	ANDA211324	Modavar Pharmaceuticals LLC	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
72241-011_27f32649-68c4-4f16-abaf-35cba6ac6b75	72241-011	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20211005		ANDA	ANDA203844	Modavar Pharmaceuticals LLC	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72241-012_27f32649-68c4-4f16-abaf-35cba6ac6b75	72241-012	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20211005		ANDA	ANDA203844	Modavar Pharmaceuticals LLC	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72241-013_27f32649-68c4-4f16-abaf-35cba6ac6b75	72241-013	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20211005		ANDA	ANDA203844	Modavar Pharmaceuticals LLC	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72241-014_27f32649-68c4-4f16-abaf-35cba6ac6b75	72241-014	HUMAN PRESCRIPTION DRUG	Rivastigmine Tartrate		Rivastigmine Tartrate	CAPSULE	ORAL	20211005		ANDA	ANDA203844	Modavar Pharmaceuticals LLC	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72241-015_2d61b730-b379-49e1-877a-d14c92ab5b23	72241-015	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150205		ANDA	ANDA208605	Modavar Pharmaceuticals LLC	TELMISARTAN	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72241-016_2d61b730-b379-49e1-877a-d14c92ab5b23	72241-016	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150205		ANDA	ANDA208605	Modavar Pharmaceuticals LLC	TELMISARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72241-017_2d61b730-b379-49e1-877a-d14c92ab5b23	72241-017	HUMAN PRESCRIPTION DRUG	Telmisartan		Telmisartan	TABLET	ORAL	20150205		ANDA	ANDA208605	Modavar Pharmaceuticals LLC	TELMISARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72241-020_dcbb7521-8205-4083-b3cc-79be5f89972f	72241-020	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20200116		ANDA	ANDA208606	Modavar Pharmaceuticals LLC	BUPROPION HYDROCHLORIDE	75	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72241-021_dcbb7521-8205-4083-b3cc-79be5f89972f	72241-021	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20200116		ANDA	ANDA208606	Modavar Pharmaceuticals LLC	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72241-022_f3a62ac7-5261-4c04-98b3-82b87ac821bf	72241-022	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210820		ANDA	ANDA208701	Modavar Pharmaceuticals LLC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72241-023_f3a62ac7-5261-4c04-98b3-82b87ac821bf	72241-023	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210823		ANDA	ANDA208701	Modavar Pharmaceuticals LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72241-024_f3a62ac7-5261-4c04-98b3-82b87ac821bf	72241-024	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210823		ANDA	ANDA208701	Modavar Pharmaceuticals LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72241-025_f3a62ac7-5261-4c04-98b3-82b87ac821bf	72241-025	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210823		ANDA	ANDA208701	Modavar Pharmaceuticals LLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72241-026_ea578b6a-2897-45b9-8757-a2d9caf34459	72241-026	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20210818		ANDA	ANDA202168	Modavar Pharmaceuticals LLC	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72241-027_ea578b6a-2897-45b9-8757-a2d9caf34459	72241-027	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20210818		ANDA	ANDA202168	Modavar Pharmaceuticals LLC	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72241-028_01c32aff-63a6-4048-b408-ded7e5d9b9da	72241-028	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20210818		ANDA	ANDA201445	Modavar Pharmaceuticals LLC	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72241-029_a44e8986-7f53-4862-a1a3-86cced69594e	72241-029	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211020		ANDA	ANDA212645	Modavar Pharmaceuticals LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	12.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72241-030_a44e8986-7f53-4862-a1a3-86cced69594e	72241-030	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211020		ANDA	ANDA212645	Modavar Pharmaceuticals LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	25	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72241-031_a44e8986-7f53-4862-a1a3-86cced69594e	72241-031	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211020		ANDA	ANDA212645	Modavar Pharmaceuticals LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	37.5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72241-032_53d2f49b-b0b8-46fc-b80d-1ac3756e7e7c	72241-032	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Modavar Pharmaceuticals LLC	NEBIVOLOL HYDROCHLORIDE	2.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72241-033_53d2f49b-b0b8-46fc-b80d-1ac3756e7e7c	72241-033	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Modavar Pharmaceuticals LLC	NEBIVOLOL HYDROCHLORIDE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72241-034_53d2f49b-b0b8-46fc-b80d-1ac3756e7e7c	72241-034	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Modavar Pharmaceuticals LLC	NEBIVOLOL HYDROCHLORIDE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72241-035_53d2f49b-b0b8-46fc-b80d-1ac3756e7e7c	72241-035	HUMAN PRESCRIPTION DRUG	Nebivolol		Nebivolol	TABLET	ORAL	20171229		ANDA	ANDA208717	Modavar Pharmaceuticals LLC	NEBIVOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72241-036_eb7928f4-e0c7-4f23-a1a8-934d82f5eca4	72241-036	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20210731		ANDA	ANDA213628	Modavar Pharmaceuticals LLC	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
72241-037_eb7928f4-e0c7-4f23-a1a8-934d82f5eca4	72241-037	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20210731		ANDA	ANDA213628	Modavar Pharmaceuticals LLC	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
72241-038_7ebf5b06-fdd3-4120-93f2-d31def5bf104	72241-038	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20211005		ANDA	ANDA203379	Modavar Pharmaceuticals LLC	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72241-039_7ebf5b06-fdd3-4120-93f2-d31def5bf104	72241-039	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20211005		ANDA	ANDA203379	Modavar Pharmaceuticals LLC	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72241-040_7ebf5b06-fdd3-4120-93f2-d31def5bf104	72241-040	HUMAN PRESCRIPTION DRUG	Glyburide		Glyburide	TABLET	ORAL	20211005		ANDA	ANDA203379	Modavar Pharmaceuticals LLC	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72241-041_f8288ccd-6c66-415e-a06b-758971afe9a0	72241-041	HUMAN PRESCRIPTION DRUG	Tizanidine hydrochloride		Tizanidine hydrochloride	CAPSULE	ORAL	20171229		ANDA	ANDA210021	Modavar Pharmaceuticals LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72241-042_f8288ccd-6c66-415e-a06b-758971afe9a0	72241-042	HUMAN PRESCRIPTION DRUG	Tizanidine hydrochloride		Tizanidine hydrochloride	CAPSULE	ORAL	20171229		ANDA	ANDA210021	Modavar Pharmaceuticals LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72241-043_f8288ccd-6c66-415e-a06b-758971afe9a0	72241-043	HUMAN PRESCRIPTION DRUG	Tizanidine hydrochloride		Tizanidine hydrochloride	CAPSULE	ORAL	20171229		ANDA	ANDA210021	Modavar Pharmaceuticals LLC	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72241-050_f1dbb47b-a3bd-472b-b565-053e5db411eb	72241-050	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20181120		ANDA	ANDA202437	Modavar Pharmaceuticals LLC	FOLIC ACID	1	mg/1			N	20241231
72241-051_f0943b4e-6bdc-48c1-8ecd-39cf732e16f5	72241-051	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20230227		ANDA	ANDA210022	Modavar Pharmaceuticals LLC	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72241-052_f0943b4e-6bdc-48c1-8ecd-39cf732e16f5	72241-052	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20230227		ANDA	ANDA210022	Modavar Pharmaceuticals LLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72241-053_f0943b4e-6bdc-48c1-8ecd-39cf732e16f5	72241-053	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20230227		ANDA	ANDA210022	Modavar Pharmaceuticals LLC	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72241-054_f0943b4e-6bdc-48c1-8ecd-39cf732e16f5	72241-054	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20230227		ANDA	ANDA210022	Modavar Pharmaceuticals LLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72241-055_f0943b4e-6bdc-48c1-8ecd-39cf732e16f5	72241-055	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20230227		ANDA	ANDA210022	Modavar Pharmaceuticals LLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72241-056_f0943b4e-6bdc-48c1-8ecd-39cf732e16f5	72241-056	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET	ORAL	20230227		ANDA	ANDA210022	Modavar Pharmaceuticals LLC	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72245-193_0e837595-e684-5b0f-e063-6394a90a425f	72245-193	HUMAN PRESCRIPTION DRUG	Nalocet		oxycodone and acetaminophen	TABLET	ORAL	20180523		ANDA	ANDA040608	Forte Bio-Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
72245-648_0e837595-e685-5b0f-e063-6394a90a425f	72245-648	HUMAN PRESCRIPTION DRUG	Prolate		oxycodone hydrochloride and acetaminophen	SOLUTION	ORAL	20200301		ANDA	ANDA202142	Forte Bio-Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 10	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
72245-681_0e837595-e683-5b0f-e063-6394a90a425f	72245-681	HUMAN PRESCRIPTION DRUG	Prolate		oxycodone and acetaminophen	TABLET	ORAL	20200217		ANDA	ANDA040608	Forte Bio-Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
72245-682_0e837595-e683-5b0f-e063-6394a90a425f	72245-682	HUMAN PRESCRIPTION DRUG	Prolate		oxycodone and acetaminophen	TABLET	ORAL	20200217		ANDA	ANDA040608	Forte Bio-Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
72245-683_0e837595-e683-5b0f-e063-6394a90a425f	72245-683	HUMAN PRESCRIPTION DRUG	Prolate		oxycodone and acetaminophen	TABLET	ORAL	20200217		ANDA	ANDA040608	Forte Bio-Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
72246-112_b9e9ab5b-aff7-e8cf-e053-2995a90a93f5	72246-112	HUMAN OTC DRUG	Dr. Ds Super 7 Pain Relief		menthyl salicylate and menthol	CREAM	TOPICAL	20190904		OTC MONOGRAPH NOT FINAL	part348	Promedx Innovations Inc	MENTHOL; MENTHYL SALICYLATE, (+/-)-	20; 100	mg/mL; mg/mL			N	20241231
72247-106_0437ce83-7482-c84e-e063-6394a90ac189	72247-106	HUMAN OTC DRUG	CURODONT REPAIR FLUORIDE PLUS		SODIUM FLUORIDE	SPONGE	ORAL	20230827		OTC MONOGRAPH FINAL	part355	CREDENTIS AG	SODIUM MONOFLUOROPHOSPHATE	.02	g/100mL			N	20241231
72247-107_04377fa2-7d06-503b-e063-6394a90a0a42	72247-107	HUMAN OTC DRUG	CURODONT PROTECT		STANNOUS FLUORIDE	PASTE, DENTIFRICE	ORAL	20230827		OTC MONOGRAPH FINAL	part355	CREDENTIS AG	STANNOUS FLUORIDE	.14	g/100g			N	20241231
72250-0001_c5e682fd-dce8-446d-9198-36799f82b4e0	72250-0001	HUMAN OTC DRUG	Metabolic Support		Fucus Vesiculosus, Agnus Castus, Chelidonium Majus, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phytolacca Decandra, Kali Phosphoricum, Magnesia Phosphorica, Carbo Vegetabilis, Graphites, Calcarea Carbonica, Natrum Phosphoricum, Hypophysis Suis, Placenta Totalis Suis, Thyroidinum (Suis)	LIQUID	ORAL	20180531		UNAPPROVED HOMEOPATHIC		BodyLogicMD of Fort Lauderdale	ACTIVATED CHARCOAL; CHASTE TREE; CHELIDONIUM MAJUS; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA THYROID	10; 6; 6; 8; 4; 10; 6; 8; 12; 6; 6; 12; 6; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72251-001_075e7765-6b6e-d7a0-e063-6294a90a5c99	72251-001	HUMAN OTC DRUG	Neova DNA Damage Control - Silc Sheer	Broad Spectrum SPF 40	Octinoxate, Titanium Dioxide, Zinc Oxide	EMULSION	TOPICAL	20121008		OTC MONOGRAPH DRUG	M020	Pharma Cosmetics	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 3; 9	g/100mL; g/100mL; g/100mL			N	20241231
72251-002_075ea4f1-908c-3bd3-e063-6394a90a1cb7	72251-002	HUMAN OTC DRUG	Neova DNA Damage Control - Everyday	Broad Spectrum SPF 44	Octinoxate, Octisalate, Zinc Oxide	EMULSION	TOPICAL	20121008		OTC MONOGRAPH DRUG	M020	PHARMA COSMETICS, INC	OCTINOXATE; OCTISALATE; ZINC OXIDE	6.5; 2.5; 8.5	g/100mL; g/100mL; g/100mL			N	20241231
72251-003_075ea91f-7b56-1c8b-e063-6294a90aa765	72251-003	HUMAN OTC DRUG	Neova DNA Damage Control - Active	Broad Spectrum SPF 43	Octinoxate, Zinc Oxide	CREAM	TOPICAL	20121008		OTC MONOGRAPH DRUG	M020	PHARMA COSMETICS, INC	OCTINOXATE; ZINC OXIDE	7.5; 9	g/100mL; g/100mL			N	20241231
72252-505_d4304577-0d16-4b10-bce1-c72f81ab2cbc	72252-505	HUMAN PRESCRIPTION DRUG	Valtoco		diazepam	SPRAY	NASAL	20200110		NDA	NDA211635	Neurelis, Inc	DIAZEPAM	5	mg/.1mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72252-510_d4304577-0d16-4b10-bce1-c72f81ab2cbc	72252-510	HUMAN PRESCRIPTION DRUG	Valtoco		diazepam	SPRAY	NASAL	20200110		NDA	NDA211635	Neurelis, Inc	DIAZEPAM	10	mg/.1mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72252-515_d4304577-0d16-4b10-bce1-c72f81ab2cbc	72252-515	HUMAN PRESCRIPTION DRUG	Valtoco		diazepam	SPRAY	NASAL	20200110		NDA	NDA211635	Neurelis, Inc	DIAZEPAM	7.5	mg/.1mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72252-520_d4304577-0d16-4b10-bce1-c72f81ab2cbc	72252-520	HUMAN PRESCRIPTION DRUG	Valtoco		diazepam	SPRAY	NASAL	20200110		NDA	NDA211635	Neurelis, Inc	DIAZEPAM	10	mg/.1mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72266-101_e15ad0ae-009a-ea57-e053-2995a90a0ab5	72266-101	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane for Injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190318		ANDA	ANDA207321	Fosun Pharma USA Inc.	DEXRAZOXANE HYDROCHLORIDE	500	mg/50mL	Cytoprotective Agent [EPC]		N	20241231
72266-102_aa0db1d0-cf62-ec8f-e053-2995a90af7d1	72266-102	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	20190402		ANDA	ANDA090699	Fosun Pharma USA Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72266-103_aa0db1d0-cf62-ec8f-e053-2995a90af7d1	72266-103	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	20190402		ANDA	ANDA090699	Fosun Pharma USA Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72266-103_bd8b283f-c281-6682-e053-2a95a90ad608	72266-103	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	20210331		ANDA	ANDA090699	Fosun Pharma USA Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72266-106_debdc54f-5ba6-4090-e053-2a95a90a5692	72266-106	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190402		ANDA	ANDA207092	Fosun Pharma USA Inc.	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
72266-107_debdc54f-5ba6-4090-e053-2a95a90a5692	72266-107	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		Caspofungin Acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190402		ANDA	ANDA207092	Fosun Pharma USA Inc.	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
72266-108_f4c48f34-ebdd-cb2b-e053-2995a90ad691	72266-108	HUMAN PRESCRIPTION DRUG	CLOFARABINE		CLOFARABINE	INJECTION	INTRAVENOUS	20190819		ANDA	ANDA207831	Fosun Pharma USA Inc.	CLOFARABINE	1	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72266-118_fe80793a-f46b-428c-e053-6394a90ad6a5	72266-118	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230623		ANDA	ANDA204216	FOSUN PHARMA USA INC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72266-119_fe80793a-f46b-428c-e053-6394a90ad6a5	72266-119	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20230623		ANDA	ANDA204216	FOSUN PHARMA USA INC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72266-120_ebf1c3d5-e699-68bb-e053-2a95a90a9b5a	72266-120	HUMAN PRESCRIPTION DRUG	Levoleucovorin		Levoleucovorin	INJECTION	INTRAVENOUS	20190625		ANDA	ANDA210892	Fosun Pharma USA Inc.	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
72266-121_ebf1c3d5-e699-68bb-e053-2a95a90a9b5a	72266-121	HUMAN PRESCRIPTION DRUG	Levoleucovorin		Levoleucovorin	INJECTION	INTRAVENOUS	20190625		ANDA	ANDA210892	Fosun Pharma USA Inc.	LEVOLEUCOVORIN CALCIUM	10	mg/mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
72266-122_d71e8982-f3fc-689c-e053-2a95a90aee08	72266-122	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20190318		ANDA	ANDA204205	FOSUN PHARMA USA INC	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72266-123_f392d44e-e879-cfed-e053-2a95a90af28b	72266-123	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190402		ANDA	ANDA079224	Fosun Pharma USA Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
72266-124_f392d44e-e879-cfed-e053-2a95a90af28b	72266-124	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20190402		ANDA	ANDA090648	Fosun Pharma USA Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
72266-125_8a719215-d0a0-42fb-e053-2a95a90a60da	72266-125	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20190215		ANDA	ANDA207325	Fosun Pharma USA Inc.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
72266-126_8a719215-d0a0-42fb-e053-2a95a90a60da	72266-126	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20190215		ANDA	ANDA207325	Fosun Pharma USA Inc.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
72266-127_ebf1c110-23ba-57ea-e053-2995a90a802b	72266-127	HUMAN PRESCRIPTION DRUG	DICYCLOMINE HYDROCHLORIDE		Dicyclomine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR	20191230		ANDA	ANDA210979	Fosun Pharma USA Inc.	DICYCLOMINE HYDROCHLORIDE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72266-128_ebf1c110-23bb-57ea-e053-2995a90a802b	72266-128	HUMAN PRESCRIPTION DRUG	Melphalan hydrochloride		Melphalan hydrochloride	KIT		20190923		ANDA	ANDA209826	Fosun Pharma USA Inc						N	20241231
72266-131_f2792f5b-872a-2da9-e053-2995a90a3126	72266-131	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210104		ANDA	ANDA211099	Fosun Pharma USA Inc.	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72266-132_0e7b64bf-41fd-498c-e063-6394a90a8fcb	72266-132	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20221116		ANDA	ANDA077087	Fosun Pharma USA Inc.	LEFLUNOMIDE	10	mg/1	Antirheumatic Agent [EPC]		N	20251231
72266-133_0e7b64bf-41fd-498c-e063-6394a90a8fcb	72266-133	HUMAN PRESCRIPTION DRUG	Leflunomide		Leflunomide	TABLET	ORAL	20221116		ANDA	ANDA077087	Fosun Pharma USA Inc.	LEFLUNOMIDE	20	mg/1	Antirheumatic Agent [EPC]		N	20251231
72266-139_e109c3d3-6567-77b6-e053-2995a90a54ac	72266-139	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20200810		ANDA	ANDA210126	Fosun Pharma USA Inc.	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
72266-140_e109c3d3-6567-77b6-e053-2995a90a54ac	72266-140	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20200810		ANDA	ANDA210126	Fosun Pharma USA Inc.	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
72266-141_a0fb8538-b5db-2780-e053-2995a90ab90d	72266-141	HUMAN PRESCRIPTION DRUG	Azelastine Hydrochloride		Azelastine Hydrochloride	SOLUTION/ DROPS	INTRAOCULAR	20200908		ANDA	ANDA210092	Fosun Pharma USA Inc	AZELASTINE HYDROCHLORIDE	.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72266-142_a6403ae1-d4f7-d923-e053-2995a90a1c8c	72266-142	HUMAN PRESCRIPTION DRUG	BROMFENAC		Bromfenac	SOLUTION/ DROPS	OPHTHALMIC	20200706		ANDA	ANDA211029	Fosun Pharma USA Inc.	BROMFENAC SODIUM	.9	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72266-146_ebf1cb62-5180-704f-e053-2a95a90a0ccf	72266-146	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate Injection	SOLUTION	INTRAVENOUS	20190903		ANDA	ANDA209058	Fosun Pharma USA Inc	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72266-147_ebf1cb62-5180-704f-e053-2a95a90a0ccf	72266-147	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate Injection	SOLUTION	INTRAVENOUS	20190903		ANDA	ANDA209058	Fosun Pharma USA Inc	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72266-152_fd914c6f-3942-7dff-e053-6394a90a4ec9	72266-152	HUMAN PRESCRIPTION DRUG	Zoledronic acid		Zoledronic acid	INJECTION	INTRAVENOUS	20170612		ANDA	ANDA209578	FOSUN PHARMA USA INC	ZOLEDRONIC ACID	5	mg/100mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
72266-158_a6401839-81a8-e2dc-e053-2995a90a2df2	72266-158	HUMAN PRESCRIPTION DRUG	Moxifloxacin Ophthalmic Solution		Moxifloxacin Ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200824		ANDA	ANDA208778	Fosun Pharma USA Inc.	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72266-159_ee010fd8-bb46-a658-e053-2a95a90a0c2e	72266-159	HUMAN PRESCRIPTION DRUG	Ertapenem		Ertapenem Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20211101		ANDA	ANDA212040	Fosun Pharma USA Inc	ERTAPENEM SODIUM	1	g/1	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
72266-160_aa9a89eb-4ecd-b79f-e053-2995a90af0eb	72266-160	HUMAN PRESCRIPTION DRUG	Ziprasidone Mesylate		Ziprasidone Mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20200615		ANDA	ANDA211908	Fosun Pharma USA Inc.	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
72266-160_b28a4f4e-b315-6319-e053-2995a90a28d1	72266-160	HUMAN PRESCRIPTION DRUG	Ziprasidone Mesylate		Ziprasidone Mesylate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20201027		ANDA	ANDA211908	Fosun Pharma USA Inc.	ZIPRASIDONE MESYLATE	20	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
72266-161_0e7b38b9-5be6-1fad-e063-6294a90a36e3	72266-161	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20200330		ANDA	ANDA207325	FOSUN PHARMA USA INC.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20251231
72266-162_0e7b38b9-5be6-1fad-e063-6294a90a36e3	72266-162	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20200330		ANDA	ANDA207325	FOSUN PHARMA USA INC.	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20251231
72266-163_f1ebfd06-d6b2-3742-e053-2a95a90a1dd2	72266-163	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210811		ANDA	ANDA211189	Fosun Pharma USA Inc	TOBRAMYCIN SULFATE	1.2	g/30mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
72266-196_cc22a28a-fc22-2239-e053-2995a90ad0e7	72266-196	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20211101		ANDA	ANDA212628	FOSUN PHARMA USA INC	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
72266-197_ef173162-1290-ce7d-e053-2995a90afc28	72266-197	HUMAN PRESCRIPTION DRUG	Dorzolamide Hydrochloride		Dorzolamide Hydrochloride	SOLUTION	OPHTHALMIC	20230123		ANDA	ANDA215660	FOSUN PHARMA USA INC	DORZOLAMIDE HYDROCHLORIDE	20	mg/mL	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]		N	20241231
72266-199_f6cc1b3c-0332-de25-e053-6294a90a2a7e	72266-199	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution		Timolol Maleate Ophthalmic Gel Forming Solution	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20220624		ANDA	ANDA214645	FOSUN PHARMA USA INC	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72266-200_f6cc1b3c-0332-de25-e053-6294a90a2a7e	72266-200	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution		Timolol Maleate Ophthalmic Gel Forming Solution	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20230315		ANDA	ANDA214645	FOSUN PHARMA USA INC	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72266-204_fae8c785-258a-1d69-e053-6394a90afc8b	72266-204	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230501		ANDA	ANDA214107	FOSUN PHARMA USA INC	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72266-234_fe80793a-f46b-428c-e053-6394a90ad6a5	72266-234	HUMAN PRESCRIPTION DRUG	ketorolac tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230623		ANDA	ANDA204216	FOSUN PHARMA USA INC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72266-235_e15ad0ae-009a-ea57-e053-2995a90a0ab5	72266-235	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane for Injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211101		ANDA	ANDA207321	Fosun Pharma USA Inc.	DEXRAZOXANE HYDROCHLORIDE	250	mg/25mL	Cytoprotective Agent [EPC]		N	20241231
72266-236_cee1f36f-6c28-620c-e053-2a95a90ac4db	72266-236	HUMAN PRESCRIPTION DRUG	Sodium Phenylacetate and Sodium Benzoate		Sodium Phenylacetate and Sodium Benzoate	INJECTION	INTRAVENOUS	20211114		NDA	NDA215025	FOSUN PHARMA USA INC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
72266-237_fa3fcfdd-b00b-91f5-e053-6394a90a0bb3	72266-237	HUMAN PRESCRIPTION DRUG	DOXYCYCLINE		DOXYCYCLINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230412		ANDA	ANDA215583	FOSUN PHARMA USA INC	DOXYCYCLINE HYCLATE	100	mg/10mL	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72266-241_e109c3d3-6567-77b6-e053-2995a90a54ac	72266-241	HUMAN PRESCRIPTION DRUG	Bimatoprost		Bimatoprost	SOLUTION/ DROPS	OPHTHALMIC	20220303		ANDA	ANDA210126	Fosun Pharma USA Inc.	BIMATOPROST	.3	mg/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
72266-242_f5b049c5-0e47-55c6-e053-2a95a90a6851	72266-242	HUMAN PRESCRIPTION DRUG	Lacosamide		Lacosamide	INJECTION	INTRAVENOUS	20221115		ANDA	ANDA215628	Fosun Pharma USA	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
72266-243_e6718dc6-ebc8-570b-e053-2a95a90a86ba	72266-243	HUMAN PRESCRIPTION DRUG	Bortezomib		bortezomib	INJECTION	INTRAVENOUS	20220823		NDA	NDA215331	FOSUN PHARMA USA INC	BORTEZOMIB	1	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
72266-244_e6718dc6-ebc8-570b-e053-2a95a90a86ba	72266-244	HUMAN PRESCRIPTION DRUG	Bortezomib		bortezomib	INJECTION	INTRAVENOUS	20220823		NDA	NDA215331	FOSUN PHARMA USA INC	BORTEZOMIB	2.5	mg/1	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
72266-247_fc10509a-d2b2-5d1e-e053-6394a90ab0dd	72266-247	HUMAN PRESCRIPTION DRUG	Sodium Phenylacetate and Sodium Benzoate		Sodium Phenylacetate and Sodium Benzoate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220818		ANDA	ANDA208521	FOSUN PHARMA USA INC	SODIUM BENZOATE; SODIUM PHENYLACETATE	100; 100	mg/mL; mg/mL	Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]		N	20241231
72266-248_efbc18a5-4c7a-104c-e053-2995a90a99f9	72266-248	HUMAN PRESCRIPTION DRUG	Sincalide		Sincalide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230109		NDA	NDA210850	FOSUN PHARMA USA INC	SINCALIDE	5	ug/5mL	Cholecystokinin Analog [EPC], Cholecystokinin [CS]		N	20241231
72266-249_fd663b0e-4789-7a45-e053-6294a90a8d11	72266-249	HUMAN PRESCRIPTION DRUG	POLYMYXIN B		POLYMYXIN B SULFATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC	20160610		ANDA	ANDA207322	FOSUN PHARMA USA INC	POLYMYXIN B SULFATE	500000	[USP'U]/1	Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72266-251_febc12e3-e53e-b3ba-e053-6294a90ae2c9	72266-251	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	INJECTION	INTRAVENOUS	20230620		ANDA	ANDA211030	FOSUN PHARMA USA INC	CALCITRIOL	1	ug/mL	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
72266-252_0219ee77-eb38-b81f-e063-6394a90a5ca4	72266-252	HUMAN PRESCRIPTION DRUG	CISPLATIN		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20230811		ANDA	ANDA207323	FOSUN PHARMA USA INC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
72266-253_0219ee77-eb38-b81f-e063-6394a90a5ca4	72266-253	HUMAN PRESCRIPTION DRUG	CISPLATIN		Cisplatin	INJECTION, SOLUTION	INTRAVENOUS	20230811		ANDA	ANDA207323	FOSUN PHARMA USA INC	CISPLATIN	1	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
72276-001_080297ff-a3e3-398b-e063-6394a90a2f28	72276-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20180705		NDA	NDA205889	MITCHELL WELDING SUPPLY	OXYGEN	990	mL/L			N	20241231
72276-002_0802bcb4-fca4-2397-e063-6294a90a2862	72276-002	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20180705		NDA	NDA209989	MITCHELL WELDING SUPPLY	NITROUS OXIDE	990	mL/L			N	20241231
72276-003_0802a852-5adc-f1cc-e063-6294a90a199f	72276-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20191210		NDA	NDA205766	MITCHELL WELDING SUPPLY	NITROGEN	990	mL/L			N	20241231
72277-0001_f650e162-6d2c-46b6-800d-1454d2ce0eae	72277-0001	HUMAN OTC DRUG	Herplex		Anatherum Muricatum, Clematis Erecta, Mezereum, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox, Thuja Occidentalis, Natrum Muriaticum, Sepia	TABLET	ORAL	20180503	20240128	UNAPPROVED HOMEOPATHIC		Prime Time Solutions, Inc.	CHRYSOPOGON ZIZANIOIDES ROOT; CLEMATIS RECTA FLOWERING TOP; DAPHNE MEZEREUM BARK; PHYTOLACCA AMERICANA ROOT; RANUNCULUS BULBOSUS; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 30; 30; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
72287-310_9ceaceed-1674-4e6d-8baf-44c4693549b3	72287-310	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20180627		ANDA	ANDA065253	AMELLA PHARMA, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72288-001_6d94823a-375e-49dc-9114-1a4bb1301aab	72288-001	HUMAN OTC DRUG	Basic Care Loperamide Hydrochloride and Simethicone		loperamide hydrochloride, simethicone	TABLET	ORAL	20200624		ANDA	ANDA209837	Amazon.com Services LLC	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
72288-002_882ce8ac-077e-41da-b957-714fa21773bb	72288-002	HUMAN OTC DRUG	basic care daytime severe cold and flu nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20210204		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-003_bbeb84ae-c98f-422e-9770-e44961af593f	72288-003	HUMAN OTC DRUG	Basic Care Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210731		ANDA	ANDA206393	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-004_04edc52c-53e5-476c-827f-3304818f03a7	72288-004	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20180425		OTC MONOGRAPH DRUG	M021	Amazon. com Services LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72288-005_6f313afd-807c-451d-a471-5e15691fb517	72288-005	HUMAN OTC DRUG	Sunburn Relief Gel		Lidocaine HCl	GEL	TOPICAL	20180831		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	LIDOCAINE HYDROCHLORIDE	5.05	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72288-007_c3e987c5-7ca1-4514-aa0a-6668ff2937c5	72288-007	HUMAN OTC DRUG	basic care all day allergy		Cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220104		ANDA	ANDA207235	Amazon.com Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-009_2c13b399-4e6d-4315-94da-7db3dc5b2803	72288-009	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20211123		OTC MONOGRAPH NOT FINAL	part333A	Amazon.com Services LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
72288-012_db2288d9-0c32-40c0-a567-576a1a467970	72288-012	HUMAN OTC DRUG	Clean Apple		Pyrithione zinc	SHAMPOO	TOPICAL	20180501		OTC MONOGRAPH FINAL	part358H	Amazon.Com Services LLC	PYRITHIONE ZINC	1	g/mL			N	20241231
72288-020_b89aabab-39d1-4c5a-b291-8554495ae568	72288-020	HUMAN OTC DRUG	basic care clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20221128		ANDA	ANDA090685	Amazon.com Services LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72288-022_906f7c61-fc1f-4f93-b581-ee576c0a00e6	72288-022	HUMAN OTC DRUG	basic care acid reducer		Cimetidine	TABLET, FILM COATED	ORAL	20220109		ANDA	ANDA075285	Amazon.com Services LLC	CIMETIDINE	200	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72288-023_fac15e76-409d-4998-b365-7d36af01ca58	72288-023	HUMAN OTC DRUG	basic care omeprazole		Omeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230222		ANDA	ANDA216096	Amazon.com Services LLC	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-029_b32bbc4a-9771-42b5-9abe-766e1707cfcb	72288-029	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210617		ANDA	ANDA076775	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-047_28b529d0-2ffe-4451-8b12-23358a6a4b98	72288-047	HUMAN OTC DRUG	basic care omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220429		NDA	NDA022032	Amazon.com Services LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-049_0c4cf108-c21c-41c2-b0bb-5519a3345db5	72288-049	HUMAN OTC DRUG	Basic Care Eye		Polyethylene Glycol, Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20210812		OTC MONOGRAPH FINAL	part349	Amazon.com Services LLC	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
72288-050_23cb3002-3b75-48a4-9292-01daf72ee746	72288-050	HUMAN OTC DRUG	basic care ibuprofen pm		diphenhydramine citrate, ibuprofen	TABLET, FILM COATED	ORAL	20210430		ANDA	ANDA079113	Amazon.com Services LLC	DIPHENHYDRAMINE CITRATE; IBUPROFEN	38; 200	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-052_19676ec7-f49b-4f0e-93cb-2edf9afd31ba	72288-052	HUMAN OTC DRUG	basic care nighttime sleep aid		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210304		OTC MONOGRAPH FINAL	part338	Amazon.com Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-056_a51bf39e-556b-4dcc-a6f5-7c0a894efd1a	72288-056	HUMAN OTC DRUG	basic care nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20201228		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-057_9480367b-7eb3-46f1-a93f-81ce2dab1071	72288-057	HUMAN OTC DRUG	basic care infants ibuprofen		ibuprofen	SUSPENSION	ORAL	20211008		ANDA	ANDA075217	Amazon.com Services LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-067_c159b18d-0d6e-409f-8b2b-e8f28cd85633	72288-067	HUMAN OTC DRUG	basic care first aid antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20210614		OTC MONOGRAPH FINAL	part333B	Amazon.com Services LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72288-069_9284479e-5cc1-4e0c-8208-d28df69730f4	72288-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20180425		OTC MONOGRAPH FINAL	part347	Amazon.com Services LLC	PETROLATUM	1	g/g			N	20241231
72288-070_e1457c13-6d35-41b2-b1e8-7e82b647a0c7	72288-070	HUMAN OTC DRUG	basic care miconazole 3		miconazole nitrate	CREAM	VAGINAL	20210715		ANDA	ANDA091366	Amazon.com Services LLC	MICONAZOLE NITRATE	40	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72288-072_182b9ef8-a9fe-42d5-aac8-e93f3601c827	72288-072	HUMAN OTC DRUG	Antiseptic Mouthrinse		Eucalyptol, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20181105		OTC MONOGRAPH NOT FINAL	part348	Amazon.Com Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-077_a3889ffb-e234-4b9c-9559-c17a71a55a29	72288-077	HUMAN OTC DRUG	Basic Care Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210823		ANDA	ANDA203690	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-089_5d185c6d-d547-4a54-a35f-cc6082997284	72288-089	HUMAN OTC DRUG	basic care allergy relief		Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210503		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-094_617f3717-9345-44aa-a9c2-24be1ea7b307	72288-094	HUMAN OTC DRUG	Basic Care Sinus PE		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20210610		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-104_d5699130-fc61-e323-e053-2995a90aeba5	72288-104	HUMAN OTC DRUG	Solimo	Sport Sunscreen SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 20; 40	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
72288-105_5bcfa90a-a5aa-4889-9ce6-21eb93af42c2	72288-105	HUMAN OTC DRUG	Basic Care Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20210720		OTC MONOGRAPH DRUG	M013	Amazon.com Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
72288-108_d61d1edf-1a38-04ca-e053-2995a90aeda4	72288-108	HUMAN OTC DRUG	Solimo	Kids Sunscreen SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180502		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
72288-110_b1092318-3ab7-3d4a-e053-2a95a90a06a0	72288-110	HUMAN OTC DRUG	Solimo	General Protection Sunscreen SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180502		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
72288-111_06aa3c8d-96d2-4058-9274-9cc4e3f64eff	72288-111	HUMAN OTC DRUG	basic care levonorgestrel		levonorgestrel	TABLET	ORAL	20221219		ANDA	ANDA202334	Amazon.com Services LLC	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
72288-112_475f8687-20fc-48fd-88d0-0bb175a1e635	72288-112	HUMAN OTC DRUG	Basic Care Eye		tetrahydrozoline hcl, zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20210722		OTC MONOGRAPH FINAL	part349	Amazon.com Services LLC	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM	.5; 2.5	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72288-116_b1090f8f-6ca4-0da0-e053-2995a90a2045	72288-116	HUMAN OTC DRUG	Solimo	Sport Sunscreen SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	AEROSOL, SPRAY	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 40; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
72288-119_398c4e86-69e4-4534-8fff-e73f6d31f044	72288-119	HUMAN OTC DRUG	basic care allergy relief nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20210222		ANDA	ANDA207957	Amazon.com Services LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72288-123_e272c1a6-46c3-4b0b-9e7f-79161bbe2be7	72288-123	HUMAN OTC DRUG	Basic Care Omeprazole		omeprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20210819		NDA	NDA209400	Amazon.com Services LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-124_e3a609b4-be67-4197-84c1-80a0ed9971fb	72288-124	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210318		ANDA	ANDA090711	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-129_ffe3d18b-86c9-4784-9b27-255232d3a589	72288-129	HUMAN OTC DRUG	basic care hair regrowth treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20201214		ANDA	ANDA091344	Amazon.com Services LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72288-130_aef35870-9cbb-4b85-8a1b-e45bcda17c5e	72288-130	HUMAN OTC DRUG	Basic Care Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20200328		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
72288-131_8ec1bd70-b89c-49c2-a27a-b95326c67829	72288-131	HUMAN OTC DRUG	basic care ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200722		ANDA	ANDA203599	Amazon.com Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-141_f8ec65fc-4574-4cd0-a209-36cbc7aed81f	72288-141	HUMAN OTC DRUG	basic care acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20200618		ANDA	ANDA075400	Amazon.com Services LLC	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72288-151_46cb302a-cdb7-4b7b-bc2b-c3b093b99314	72288-151	HUMAN OTC DRUG	basic care heartburn prevention		famotidine	TABLET, FILM COATED	ORAL	20220105		ANDA	ANDA077351	Amazon.com Services LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72288-153_aaed4712-10ff-424f-84cc-0532366a83d7	72288-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20180501		OTC MONOGRAPH FINAL	part358H	Amazon.Com Services LLC	PYRITHIONE ZINC	1	mg/mL			N	20241231
72288-166_d0f29b6f-d65a-4535-9635-d0bfbfb71cd5	72288-166	HUMAN OTC DRUG	basic care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20211123		ANDA	ANDA074937	Amazon.com Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-170_8544e051-d6d8-4817-8b22-4ed86ac8bc3c	72288-170	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210107		ANDA	ANDA076789	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-171_e60dfa7b-ba5b-482b-a446-7f9075952aec	72288-171	HUMAN OTC DRUG	basic care lidocaine		lidocaine	KIT		20210318		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC						N	20241231
72288-175_1ce291dc-2871-4abc-94f3-144e93314188	72288-175	HUMAN OTC DRUG	basic care childrens pain and fever		Acetaminophen	SUSPENSION	ORAL	20210304		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
72288-180_dc2c9808-97eb-4345-b5d3-5b4e3dca2e8c	72288-180	HUMAN OTC DRUG	Petrolatum		Petrolatum	OINTMENT	TOPICAL	20180425		OTC MONOGRAPH FINAL	part347	Amazon.com Services LLC	PETROLATUM	410	mg/g			N	20241231
72288-186_2a1a44ce-a58b-4035-a751-5a6a2950f631	72288-186	HUMAN OTC DRUG	basic care nighttime sleep aid		Diphenhydramine HCl	SOLUTION	ORAL	20210806		OTC MONOGRAPH FINAL	part338	Amazon.com Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-188_fe675174-fc95-4dd7-bd39-c209c6ce0f6c	72288-188	HUMAN OTC DRUG	Basic Care Hemorrhoidal		mineral oil, petrolatum, phenylephrine HCl	OINTMENT	RECTAL	20210714		OTC MONOGRAPH FINAL	part346	Amazon.com Services LLC	MINERAL OIL; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14; 74.9; .25	g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-189_55e3026b-370c-407c-9eb7-b59a7a2f1f3f	72288-189	HUMAN OTC DRUG	basic care nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20220121		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-190_47561b44-572e-4ca0-b91c-db0706131363	72288-190	HUMAN OTC DRUG	Basic Care Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210809		ANDA	ANDA090711	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-191_f65ab142-fa29-4cbc-a81c-fd32cf2c639e	72288-191	HUMAN OTC DRUG	basic care daytime severe cold and flu nighttime severe cold cough and flu		acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride, diphenhydramine hydrochloride	KIT		20230531		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-194_c3f1857c-2561-43fd-8fb6-abb3f5c94aee	72288-194	HUMAN OTC DRUG	basic care acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20201006		ANDA	ANDA077351	Amazon.com Services LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72288-196_0986b3e1-e44d-5243-e063-6294a90a09dc	72288-196	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20210614		OTC MONOGRAPH DRUG	M003	Amazon Services LLC	ALCOHOL	.84	mL/1.2mL			N	20241231
72288-199_fd06ee22-3b92-412a-86d6-76bcabf29841	72288-199	HUMAN OTC DRUG	Basic Care Miconazole		Miconazole nitrate	KIT		20210820		ANDA	ANDA079114	Amazon.com Services LLC						N	20241231
72288-200_c22c9880-ed0e-48a7-a30e-41f0aed5a212	72288-200	HUMAN OTC DRUG	Basic Care Allergy Relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20200831		ANDA	ANDA076011	Amazon.com Services LLC	LORATADINE	10	mg/1			N	20241231
72288-202_ecffad75-d883-4428-843e-e49cd30e35dd	72288-202	HUMAN OTC DRUG	basic care hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20210827		ANDA	ANDA075357	Amazon.com Services LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72288-203_b1093a9f-5229-948f-e053-2a95a90a90be	72288-203	HUMAN OTC DRUG	Solimo	Sport SPF 30 Sunscreen	Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20180502		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	18; 70; 50	mg/mL; mg/mL; mg/mL			N	20241231
72288-204_b1093755-32fa-2379-e053-2995a90a4b90	72288-204	HUMAN OTC DRUG	Solimo	Sport SPF 50 Sunscreen	Avobenzone, Homosalate, Octocrylene	LOTION	TOPICAL	20180502		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
72288-205_3dcf33bd-5d33-4ab3-b9a3-9c7e79c96d92	72288-205	HUMAN OTC DRUG	Therapeutic T Plus		Coal Tar	SHAMPOO	TOPICAL	20180425		OTC MONOGRAPH FINAL	part358H	Amazon.com Services LLC	COAL TAR	25	mg/mL			N	20241231
72288-206_0e80918a-a3cb-4617-9384-53283532ddc4	72288-206	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210517		ANDA	ANDA078325	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-208_b1093755-3309-2379-e053-2995a90a4b90	72288-208	HUMAN OTC DRUG	Solimo	General Protection SPF 50 Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20180502		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-209_b17dfa30-d019-c529-e053-2995a90a4e28	72288-209	HUMAN OTC DRUG	SOLIMO SPORT SPF 50 BROAD SPECTRUM SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
72288-210_e3de73ee-bc93-ba40-e053-2a95a90a8f8f	72288-210	HUMAN OTC DRUG	SOLIMO KIDS SPF 50 BROAD SPECTRUM SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
72288-211_c731a433-458c-4cc7-e053-2995a90a2a91	72288-211	HUMAN OTC DRUG	Solimo Ultra Light Sunscreen Broad Spectrum SPF 70		Avobenzone, Homosalate,Octisalate,Octocrylene,Oxybenzone	STICK	TOPICAL	20161206		OTC MONOGRAPH NOT FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 30	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
72288-212_a63c718c-bddf-49d2-9f2d-655eb16b22c0	72288-212	HUMAN OTC DRUG	Isopropyl		Isopropyl Alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH NOT FINAL	part333A	AMAZON.COM SERVICES LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
72288-213_2991151b-692c-4baf-b19d-f1eca0d7044e	72288-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20180424		OTC MONOGRAPH FINAL	part355	Amazon.com Services LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72288-218_9b426d17-7aea-43fa-bdfe-a0138283aa46	72288-218	HUMAN OTC DRUG	Clear Anti Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20180501		OTC MONOGRAPH FINAL	part347	Amazon.Com Services LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72288-219_257c3217-5f70-4e94-92d9-d4ef309f7611	72288-219	HUMAN OTC DRUG	basic care mucus dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210806		ANDA	ANDA207602	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-223_ebf2ad10-e6ab-4542-b7c6-84af9d2832eb	72288-223	HUMAN OTC DRUG	basic care nicotine		nicotine polacrilex	LOZENGE	ORAL	20210506		ANDA	ANDA203690	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-224_732edad8-9a3f-4ce0-a323-c8bffa4acb5f	72288-224	HUMAN OTC DRUG	basic care loperamide hydrochloride		Loperamide HCl	TABLET, FILM COATED	ORAL	20210216		ANDA	ANDA075232	Amazon.com Services LLC	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
72288-229_f36ba753-12bb-4396-923d-05925788e50e	72288-229	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20190322		OTC MONOGRAPH FINAL	part333D	Amazon.com Services LLC	BENZOYL PEROXIDE	100	mg/g			N	20241231
72288-231_06c0be42-cdae-5216-e063-6294a90a438b	72288-231	HUMAN OTC DRUG	Basic Care Cherry Cough Drops		Menthol	LOZENGE	ORAL	20210419		OTC MONOGRAPH FINAL	part341	Amazon.com	MENTHOL	5.8	mg/1			N	20241231
72288-232_06c0e63c-1d6a-166c-e063-6394a90ad3a6	72288-232	HUMAN OTC DRUG	Basic Care Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20210422		OTC MONOGRAPH FINAL	part341	Amazon.com	MENTHOL	7.5	mg/1			N	20241231
72288-233_06c0e63c-1d6b-166c-e063-6394a90ad3a6	72288-233	HUMAN OTC DRUG	Basic Care SF Menthol Cough Drops		Menthol	LOZENGE	ORAL	20210422		OTC MONOGRAPH FINAL	part341	Amazon.com	MENTHOL	5.8	mg/1			N	20241231
72288-234_06c0e63c-1d6c-166c-e063-6394a90ad3a6	72288-234	HUMAN OTC DRUG	Basic Care Antacid Fruit Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20210805		OTC MONOGRAPH FINAL	part331	Amazon.com	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
72288-235_06c0fe9a-92b7-1679-e063-6394a90a4bf8	72288-235	HUMAN OTC DRUG	Basic Care Berry Antacid HBG		Calcium carbonate	TABLET, CHEWABLE	ORAL	20210805		OTC MONOGRAPH FINAL	part331	Amazon.com	CALCIUM CARBONATE; DIMETHICONE	750; 80	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Skin Barrier Activity [PE]		N	20241231
72288-236_06c0c130-0bf9-e4fc-e063-6394a90a0493	72288-236	HUMAN OTC DRUG	Basic Care SF Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20211029		OTC MONOGRAPH FINAL	part341	Amazon.com	MENTHOL	7.6	mg/1			N	20241231
72288-241_fe965a15-7789-4ea5-b33e-2d3513409e1a	72288-241	HUMAN OTC DRUG	basic care allergy relief		levocetirizine dihydrochloride	TABLET, FILM COATED	ORAL	20201029		ANDA	ANDA211983	Amazon.com Services LLC	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-247_2f6bebf1-81f1-439c-bc25-5c037be5593c	72288-247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20170827		OTC MONOGRAPH FINAL	part347	Amazon.Com Services LLC	PETROLATUM	340	mg/100g			N	20241231
72288-248_fe0a622e-1acc-4225-85d1-2c9a461294b7	72288-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	CREAM	TOPICAL	20180424		OTC MONOGRAPH FINAL	part341	Amazon.com Service LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	kg/100g; kg/100g; kg/100g			N	20241231
72288-251_c91709fd-f59c-4fd8-88c4-510f6b4caa23	72288-251	HUMAN OTC DRUG	basic care arthritis		Trolamine Salicylate	CREAM	TOPICAL	20210405		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	TROLAMINE SALICYLATE	10	g/100g			N	20241231
72288-252_c8c38311-be7d-48ed-8e18-a804ebc4f90c	72288-252	HUMAN OTC DRUG	basic care headache relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20211006		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
72288-253_0b70ed66-376b-45c6-87b0-04e472592c87	72288-253	HUMAN OTC DRUG	basic care first aid antibiotic and burn relief		bacitracin zinc, neomycin sulfate, polymyxin b sulfate, pramoxine hydrochloride	OINTMENT	TOPICAL	20210721		OTC MONOGRAPH FINAL	part333B	Amazon.com Services LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72288-255_ef3d3359-06e3-4554-bd18-bf19591295cc	72288-255	HUMAN OTC DRUG	basic care infants ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20210430		ANDA	ANDA075217	Amazon.com Services LLC	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-264_3b34b392-9d02-406c-9b76-01dfb405a869	72288-264	HUMAN OTC DRUG	Daily Acne Control Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20180425		OTC MONOGRAPH FINAL	part333D	Amazon.com Services LLC	BENZOYL PEROXIDE	104	mg/10g			N	20241231
72288-279_9cd3cb35-4f43-460a-97c6-2549486def86	72288-279	HUMAN OTC DRUG	Benzalkonium chloride		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20180425		OTC MONOGRAPH NOT FINAL	part333A	Amazon.com Services LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
72288-281_686f3520-b285-4381-a776-40f346192355	72288-281	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20020315		OTC MONOGRAPH FINAL	part358H	AMAZON.COM SERVICES LLC	PYRITHIONE ZINC	10.4	mg/mL			N	20241231
72288-292_92fab7b2-eabb-4e73-bc7d-6acc913aa312	72288-292	HUMAN OTC DRUG	Basic Care Nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20210810		ANDA	ANDA206394	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-293_fa248543-1c47-430a-b498-50efb523d0c5	72288-293	HUMAN OTC DRUG	basic care tussin dm max		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20201210		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-294_76bf3364-6b89-41a5-a903-a276aa59c105	72288-294	HUMAN OTC DRUG	Basic Care Hair Regrowth Treatment		Minoxidil	AEROSOL, FOAM	TOPICAL	20210914		ANDA	ANDA091344	Amazon.com Services LLC	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72288-295_02f85a9d-e401-4604-8ccf-9f13b0d84ebd	72288-295	HUMAN OTC DRUG	basic care migraine relief		acetaminophen, aspirin, caffeine	TABLET, FILM COATED	ORAL	20220721		ANDA	ANDA075794	Amazon.com Services LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
72288-298_ca339682-ad63-4580-a252-1f464d64d2cf	72288-298	HUMAN OTC DRUG	basic care mucus er		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210114		ANDA	ANDA078912	Amazon.com Services LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
72288-299_a72b6cf4-2c95-42a9-bd6e-8044f87986ef	72288-299	HUMAN OTC DRUG	Multi-Action Antiseptic		CETYLPYRIDINIUM CHLORIDE	RINSE	ORAL	20180425		OTC MONOGRAPH NOT FINAL	part356	Amazon.com Services LLC	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
72288-300_8c1bf22a-2d18-4575-8a3d-1f14521d9052	72288-300	HUMAN OTC DRUG	basic care acetaminophen		Acetaminophen	TABLET, FILM COATED	ORAL	20210503		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
72288-301_a005894d-6d4a-4089-982b-7d09191598e8	72288-301	HUMAN OTC DRUG	basic care lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20200924		ANDA	ANDA202319	Amazon.com Services LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-303_289f02d4-ffad-4a53-b090-633e170e0956	72288-303	HUMAN OTC DRUG	Basic Care Severe Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	POWDER, FOR SOLUTION	ORAL	20210811		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	500; 20; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-304_206a79b2-95ad-4a51-b766-9a59dfd5bed8	72288-304	HUMAN OTC DRUG	basic care nasal		oxymetazoline hydrochloride	SPRAY	NASAL	20210709		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
72288-310_1bd608d9-75b3-4ffa-8937-85b6c2d57825	72288-310	HUMAN OTC DRUG	basic care naproxen sodium pm		diphenhydramine hydrochloride, naproxen sodium	TABLET, FILM COATED	ORAL	20210810		ANDA	ANDA208499	Amazon.com Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-311_2fc07c98-e937-4c0c-941c-786edd6347bb	72288-311	HUMAN OTC DRUG	basic care ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220228		ANDA	ANDA072096	Amazon.com Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-318_c522433e-d7b7-437c-bcf6-c472eb2bc388	72288-318	HUMAN OTC DRUG	Original Antiseptic		EUCALYPTOL, Menthol, Methyl salicylate, Thymol	MOUTHWASH	ORAL	20180501		OTC MONOGRAPH NOT FINAL	part356	Amazon.Com Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-321_8193363b-ea3e-415d-8940-5d58be9fe3cf	72288-321	HUMAN OTC DRUG	Basic Care Dual Action Complete		famotidine, calcium carbonate and magnesium hydroxide	TABLET, CHEWABLE	ORAL	20200613		ANDA	ANDA077355	Amazon.com Services LLC	CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE	800; 10; 165	mg/1; mg/1; mg/1	Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72288-326_dbb14a26-9a8d-40cd-96ae-8017b2c48575	72288-326	HUMAN OTC DRUG	Tartar Control Plus		eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20180424		OTC MONOGRAPH NOT FINAL	part356	Amazon.com Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-329_0829b878-8bb7-4881-b22b-c51c7c027f5c	72288-329	HUMAN OTC DRUG	basic care acid reducer		famotidine	TABLET, FILM COATED	ORAL	20220106		ANDA	ANDA077351	Amazon.com Services LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72288-330_4da23634-30da-4a70-904d-41964a491f4d	72288-330	HUMAN OTC DRUG	Basic Care Childrens All Day Allergy		Cetirizine HCl	SOLUTION	ORAL	20210809		ANDA	ANDA204226	Amazon.com Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-331_afd4db72-4386-453a-945b-36cae595c5e2	72288-331	HUMAN OTC DRUG	Basic Care Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210715		ANDA	ANDA074661	Amazon.com Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-333_438e52a2-cccd-4dc8-8123-e623c33fa1ab	72288-333	HUMAN OTC DRUG	basic care childrens allergy relief nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20211220		ANDA	ANDA207957	Amazon.com Services LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72288-335_3f0daedb-ecac-46ff-aae1-1a7ac24b2d15	72288-335	HUMAN OTC DRUG	basic care nighttime cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate	SOLUTION	ORAL	20210731		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-336_6ea372c0-4e49-42c8-b227-ffcde516cde9	72288-336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20180521		OTC MONOGRAPH FINAL	part347	Amazon.Com Services LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	8.6; 10; 20	mg/mL; mg/mL; mg/mL			N	20241231
72288-338_bc028f85-dc46-4b77-8c57-2420ca323dd5	72288-338	HUMAN OTC DRUG	daily moisturizer		Octinoxate, Octisalate	LOTION	TOPICAL	20180426		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/mL; mg/mL; mg/mL			N	20241231
72288-343_b16d733d-1fa0-49a7-9887-8d5e105067b9	72288-343	HUMAN OTC DRUG	basic care lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210622		ANDA	ANDA202319	Amazon.com Services LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-344_6b500780-f45c-477c-8371-3b60e3305000	72288-344	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210507		ANDA	ANDA077007	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-352_81732bdc-af9d-4890-aab9-3306276d04a3	72288-352	HUMAN OTC DRUG	Basic Care Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210118		ANDA	ANDA078547	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-353_280e7b4f-3d2c-46c9-b498-ac4ecca76b4b	72288-353	HUMAN OTC DRUG	Body Wash		Salicylic Acid	GEL	TOPICAL	20180422		OTC MONOGRAPH FINAL	part333D	Amazon.com Services LLC	SALICYLIC ACID	25	mg/mL			N	20241231
72288-357_89196afa-eb97-4408-8613-1e8c91f6c039	72288-357	HUMAN OTC DRUG	basic care daytime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20201210		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-359_d1d3611a-6554-4056-96a0-50bcce8ce06f	72288-359	HUMAN OTC DRUG	basic care tussin dm		Dextromethorphan HBr, Guaifenesin	SOLUTION	ORAL	20210806		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/10mL; mg/10mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-361_5f5387d9-c36b-49c6-a9c8-41f9b6fa804f	72288-361	HUMAN OTC DRUG	Basic Care Lidocaine		Lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20220103		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	LIDOCAINE	560	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72288-368_86f76b75-7091-40f7-98ee-c61e3e447a22	72288-368	HUMAN OTC DRUG	basic care naproxen sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20200518		ANDA	ANDA074661	Amazon.com Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-369_0959dfcc-5a05-4849-aa62-ffb0feec3ed9	72288-369	HUMAN OTC DRUG	Basic Care Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20210824		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72288-370_976ddd62-4f83-4199-b368-3e3c7c2fc315	72288-370	HUMAN OTC DRUG	Advanced		Ethyl Alcohol	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Amazon.Com Services LLC	ALCOHOL	70	mL/100mL			N	20241231
72288-374_c3a82920-990b-45e6-b53c-dce4371f7a59	72288-374	HUMAN OTC DRUG	basic care migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210208		ANDA	ANDA075794	Amazon.com Services LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
72288-379_4785ca4a-8f1e-4201-aad2-4ed51b32389c	72288-379	HUMAN OTC DRUG	basic care childrens allergy relief		Diphenhydramine HCl	SOLUTION	ORAL	20201110		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-384_09929e66-3681-41a8-a30b-511aba8f748a	72288-384	HUMAN OTC DRUG	basic care cough dm		dextromethorphan polistirex	SUSPENSION	ORAL	20210809		ANDA	ANDA091135	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-386_8b4af4d3-365e-43d7-9eef-30088a8e0eb1	72288-386	HUMAN OTC DRUG	amazon basics advanced blemish spot treatment	Acne medication	Salicylic Acid	LOTION	TOPICAL	20230828		OTC MONOGRAPH FINAL	part333D	AMAZON.COM SERVICES LLC	SALICYLIC ACID	20	mg/mL			N	20241231
72288-388_96e018e2-e0b5-4802-a4a1-73a73d574082	72288-388	HUMAN OTC DRUG	basic care no drip nasal		Oxymetazoline Hydrochloride	SPRAY	NASAL	20201001		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
72288-397_659cb89c-3900-48aa-96e2-43157d8d17af	72288-397	HUMAN OTC DRUG	Vaporizing		Camphor	INHALANT	RESPIRATORY (INHALATION)	20190601		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	CAMPHOR (SYNTHETIC)	62	mg/mL			N	20241231
72288-401_ade1c8fb-1f39-419b-ac5d-a416dcd0e2a4	72288-401	HUMAN OTC DRUG	basic care omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20201015		NDA	NDA022032	Amazon.com Services LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-403_20b612de-4977-4baf-a3fb-66d116353dca	72288-403	HUMAN OTC DRUG	basic care acetaminophen		Acetaminophen	TABLET	ORAL	20220510		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	325	mg/1			N	20241231
72288-411_36de155a-75d8-471a-be42-56bf64a7b39a	72288-411	HUMAN OTC DRUG	basic care all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20200615		ANDA	ANDA078336	Amazon.com Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-413_c2c4e3f3-74af-4a90-be2c-5c3cd846bdfa	72288-413	HUMAN OTC DRUG	basic care lidocaine		Lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20210318		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	LIDOCAINE	960	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72288-416_c20ccdf3-f847-4bbc-b50b-f638d2553889	72288-416	HUMAN OTC DRUG	Basic Care Aspirin		aspirin	TABLET, FILM COATED	ORAL	20210316		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72288-419_b705d963-e4a0-40f0-a7cb-988f91b317be	72288-419	HUMAN OTC DRUG	basic care childrens mucus relief		Dextromethorphan hbr, Guaifenesin	SOLUTION	ORAL	20210720		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-422_5938c595-8227-4e8d-b713-d4d8977add62	72288-422	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20210809		ANDA	ANDA078326	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-426_0484dbe9-37a6-4b98-b29a-3c006205c94d	72288-426	HUMAN OTC DRUG	basic care tioconazole		Tioconazole	OINTMENT	VAGINAL	20210727		ANDA	ANDA075915	Amazon.com Services LLC	TIOCONAZOLE	6.5	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72288-428_d1c7ff4f-e28f-43aa-9a0c-ca7c6cf8b898	72288-428	HUMAN OTC DRUG	basic care gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20220203		OTC MONOGRAPH FINAL	part332	Amazon.com Services LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
72288-434_fe829ce0-3033-49d9-8710-f4df4d3935ef	72288-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20180425		OTC MONOGRAPH NOT FINAL	part356	Amazon.com Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-435_e1f74033-8afc-4150-8aa0-f4aec53439be	72288-435	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Amazon.Com Services LLC	ALCOHOL	616	mg/mL			N	20241231
72288-436_c0ea46cc-7ea3-4ec5-a311-f6ca7684a5d2	72288-436	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20180521		OTC MONOGRAPH FINAL	part347	Amazon.Com Services LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
72288-437_64a0084a-e29e-4c1a-8704-13a3e1238f76	72288-437	HUMAN OTC DRUG	basic care acetaminophen pm		Acetaminophen, Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210811		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-439_9abe0638-8789-40d8-b265-957bff475df5	72288-439	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20180501		OTC MONOGRAPH FINAL	part355	AMAZON.COM SERVICES LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72288-441_935141b7-6dee-4383-aa2f-6b6483416314	72288-441	HUMAN OTC DRUG	Basic Care Sleep Aid		Doxylamine succinate	TABLET	ORAL	20200602		ANDA	ANDA040167	Amazon.com Services LLC	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72288-442_f72110fa-3077-40e3-bf36-24f9610ba1cb	72288-442	HUMAN OTC DRUG	basic care nicotine		Nicotine polacrilex	GUM, CHEWING	ORAL	20201210		ANDA	ANDA091354	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-443_416afea6-9436-4bbb-821b-fbb2e5611d75	72288-443	HUMAN OTC DRUG	Basic Care Nasal Allergy		Triamcinolone acetonide	SPRAY, METERED	NASAL	20210726		ANDA	ANDA078104	Amazon.com Services LLC	TRIAMCINOLONE ACETONIDE	55	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72288-446_47385d98-c789-47d1-9864-36b930be8699	72288-446	HUMAN OTC DRUG	Basic Care Allergy Relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20200312		ANDA	ANDA202538	Amazon.com Services LLC	LORATADINE	10	mg/1			N	20241231
72288-450_b498ec15-6d98-4cd7-bf79-5229b6161661	72288-450	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20180509		OTC MONOGRAPH NOT FINAL	part333E	Amazon.Com Services LLC	POVIDONE-IODINE	10	mg/mL			N	20241231
72288-451_08acfdfe-8651-4b56-8425-cc38ad035595	72288-451	HUMAN OTC DRUG	Basic Care Allergy Relief		loratadine	TABLET, ORALLY DISINTEGRATING	ORAL	20210304		ANDA	ANDA076011	Amazon.com Services LLC	LORATADINE	10	mg/1			N	20241231
72288-456_ce201a5a-46b8-4095-a09f-a61708357c24	72288-456	HUMAN OTC DRUG	Basic Care Nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20200611		ANDA	ANDA076777	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-459_e52b886d-e108-4fdf-ab3b-0ea4f812d34e	72288-459	HUMAN OTC DRUG	basic care nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20210114		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-461_d53cb3f1-6689-40dd-bdea-fad3a841d482	72288-461	HUMAN OTC DRUG	Basic Care Childrens Ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20200827		ANDA	ANDA076359	Amazon.com Services LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-463_f69eb325-e351-4ee3-b42d-5217195b2c6c	72288-463	HUMAN OTC DRUG	basic care tussin cf severe		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230510		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-467_0ad7071f-0355-48b6-8e11-a839e0e37d3b	72288-467	HUMAN OTC DRUG	basic care aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20210226		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72288-475_e32a86d9-e992-4212-b503-dcda524672a2	72288-475	HUMAN OTC DRUG	basic care childrens all day allergy		Cetirizine HCl	SOLUTION	ORAL	20210107		ANDA	ANDA204226	Amazon.com Services LLC	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-479_8e8dc342-a0e3-4f90-adfc-7a9b7d075ad2	72288-479	HUMAN OTC DRUG	basic care allergy relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20200728		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-482_1fe7c672-fedd-4e3c-978a-7e9202930e0a	72288-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20180501		OTC MONOGRAPH FINAL	part355	Amazon.Com Services LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
72288-484_1cb10523-a381-47e9-88ef-a695eb16b9f5	72288-484	HUMAN OTC DRUG	basic care acetaminophen		Acetaminophen	TABLET	ORAL	20200415		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
72288-486_b332aeeb-bc92-44db-86b0-d871d438833c	72288-486	HUMAN OTC DRUG	basic care stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20200714		OTC MONOGRAPH NOT FINAL	part334	Amazon.com Services LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
72288-489_70383bf7-6215-40fb-8051-88de3a852d31	72288-489	HUMAN OTC DRUG	Basic Care Naproxen Sodium		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220211		ANDA	ANDA074661	Amazon.com Services LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-492_793d93fa-0b0a-4601-b4c1-a71a45978382	72288-492	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20220111		ANDA	ANDA077007	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-494_55854072-79a6-48b3-a4bd-8941f404949a	72288-494	HUMAN OTC DRUG	basic care cough dm		dextromethorphan polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20210304		ANDA	ANDA091135	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-496_7dcfa7e2-9470-48cb-965a-662513ccf0b4	72288-496	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20180425		OTC MONOGRAPH FINAL	part347	Amazon.com Services LLC	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
72288-499_2f25aa1d-686e-4b52-b5d7-11ff68aa7fc2	72288-499	HUMAN OTC DRUG	basic care clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20200622		ANDA	ANDA090685	Amazon.com Services LLC	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72288-500_5c7ffe4f-7951-4526-a904-c1f95c23af37	72288-500	HUMAN OTC DRUG	basic care ibuprofen		ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20211014		ANDA	ANDA203599	Amazon.com Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-502_cf8894ec-90f7-476a-ae42-080ca5602009	72288-502	HUMAN OTC DRUG	basic care daytime severe cold and flu nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20210805		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-503_3cf1c5cd-a35d-4fc6-a4d2-24f93ea6db66	72288-503	HUMAN OTC DRUG	Complete Beauty		octinoxate, zinc oxide	LOTION	TOPICAL	20180425		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	OCTINOXATE; ZINC OXIDE	60; 30	mg/mL; mg/mL			N	20241231
72288-509_9582d831-2347-465c-af54-99ce27f4effb	72288-509	HUMAN OTC DRUG	basic care nicotine		nicotine polacrilex	LOZENGE	ORAL	20230720		ANDA	ANDA077007	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-511_90f40330-46a6-44cf-9b09-6f791c9b210b	72288-511	HUMAN OTC DRUG	basic care childrens allergy relief		Loratadine	SOLUTION	ORAL	20210511		ANDA	ANDA075728	Amazon.com Services LLC	LORATADINE	5	mg/5mL			N	20241231
72288-515_77c7fe17-bafd-421c-bb6d-9a91b522bee7	72288-515	HUMAN OTC DRUG	basic care daytime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20220422		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-517_c54134e3-81b2-4ee6-8b7c-25b17b0c56c1	72288-517	HUMAN OTC DRUG	basic care ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211201		ANDA	ANDA077349	Amazon.com Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-521_18e5eed7-d3be-4559-93ca-b40ee26c7bd8	72288-521	HUMAN OTC DRUG	basic care childrens ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20200903		ANDA	ANDA076359	Amazon.com Services LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-523_bb43ac18-d77e-4eea-9e4c-ba3fc1144445	72288-523	HUMAN OTC DRUG	basic care daytime nighttime severe cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride,Guaifenesin	KIT		20220812		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-525_09c2d90b-b47f-31ff-e063-6394a90a7c20	72288-525	HUMAN OTC DRUG	Solimo Repairing Treatment For Acne Prone Skin		BENZOYL PEROXIDE	LIQUID	TOPICAL	20200730		OTC MONOGRAPH DRUG	M006	Amazon.com Services LLC	BENZOYL PEROXIDE	25	mg/mL			N	20241231
72288-526_09c28e4c-cee5-8f33-e063-6294a90a580e	72288-526	HUMAN OTC DRUG	Solimo Renewing Cleanser For Acne Prone Skin		BENZOYL PEROXIDE	LIQUID	TOPICAL	20200730		OTC MONOGRAPH DRUG	M006	Amazon.com Services LLC	BENZOYL PEROXIDE	25	mg/mL			N	20241231
72288-532_bbec8a64-a1ca-412e-84d9-9c5a0bedb2c3	72288-532	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20201029		ANDA	ANDA076779	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-544_f23b6105-5aee-4191-8d17-13b2376ad02d	72288-544	HUMAN OTC DRUG	basic care acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210810		ANDA	ANDA075077	Amazon.com Services LLC	ACETAMINOPHEN	650	mg/1			N	20241231
72288-566_c862e462-9cef-4471-b0d3-63936b3f5898	72288-566	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20090105		OTC MONOGRAPH FINAL	part347	AMAZON.COM SERVICES LLC	PETROLATUM	1	g/g			N	20241231
72288-575_1dcaf953-d03b-46be-a654-72d6d70e1d7b	72288-575	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20180425		OTC MONOGRAPH NOT FINAL	part333A	Amozon.com Services LLC	BENZALKONIUM CHLORIDE	.999	mg/mL			N	20241231
72288-576_353aaa81-dafe-4d2b-b753-22c740ad054f	72288-576	HUMAN OTC DRUG	Oral Antivavity		Sodium fluoride	MOUTHWASH	ORAL	20180501		OTC MONOGRAPH FINAL	part355	Amazon.Com Services LLC	SODIUM FLUORIDE	10.41	mg/mL			N	20241231
72288-577_1324b035-2f65-4da1-b576-9a1c672a04cf	72288-577	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230712		ANDA	ANDA206393	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-580_b25c633b-fa42-40f6-b49e-8f0a0afebceb	72288-580	HUMAN OTC DRUG	basic care daytime cold and flu nighttime cold and flu		Acetaminophen, dextromethorphan HBr, doxylamine succinate, phenylephrine HCl	KIT		20210826		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-590_fd30f035-6807-496f-ae72-2cc647d77db1	72288-590	HUMAN OTC DRUG	basic care infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20210121		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
72288-597_d55e7783-9721-441a-ab89-70e79d040ab7	72288-597	HUMAN OTC DRUG	basic care daytime severe cold and flu nighttime severe cold and flu		acetaminophen, dextromethorphan HBr, doxylamine succinate, guaifenesin, phenylephrine HCl	KIT		20210311		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-599_62808dc2-9939-4a5e-bc99-e9c02dfed914	72288-599	HUMAN OTC DRUG	basic care nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20220125		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-601_5b3db6d8-44aa-4a3d-82eb-2f06af814a91	72288-601	HUMAN OTC DRUG	basic care nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20220422		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-602_6cb29501-c2ff-4e4f-a0d4-009ac65a5989	72288-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part334	Amazon.Com Services LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72288-603_91d8a383-2046-4222-a203-556ffd9c583f	72288-603	HUMAN OTC DRUG	basic care daytime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20210222		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-604_b8132898-36f1-4368-a18c-441319a428a1	72288-604	HUMAN OTC DRUG	basic care ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200511		ANDA	ANDA072096	Amazon.com Services LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-612_9a66fc01-8476-45a6-92bd-595ef38dcc1f	72288-612	HUMAN OTC DRUG	basic care allergy relief		Loratadine	TABLET	ORAL	20200422		ANDA	ANDA076301	Amazon.com Services LLC	LORATADINE	10	mg/1			N	20241231
72288-619_bf1dc4ac-d2c5-4cf9-8b06-3663c62776e5	72288-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20180425		OTC MONOGRAPH FINAL	part347	Amazon.com Services LLC	DIMETHICONE	13	mg/g	Skin Barrier Activity [PE]		N	20241231
72288-631_5844c5fc-56c6-48b3-a002-02b10410d16a	72288-631	HUMAN OTC DRUG	basic care tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220722		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-633_ffbd0ae2-abab-4a13-a0cb-26c9f55432ec	72288-633	HUMAN OTC DRUG	antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20170415		OTC MONOGRAPH NOT FINAL	part333A	Amazon.com Services, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
72288-634_bb2faa3e-e31d-41dd-a2f9-0e24104042ba	72288-634	HUMAN OTC DRUG	basic care acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220211		ANDA	ANDA075077	Amazon.com Services LLC	ACETAMINOPHEN	650	mg/1			N	20241231
72288-639_ac8e1bda-0257-4641-bd6b-34bc6916d28e	72288-639	HUMAN OTC DRUG	basic care nighttime severe cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride	SOLUTION	ORAL	20210826		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-642_1c8e6c98-24a7-4aca-8f6b-ff9ecb0d4791	72288-642	HUMAN OTC DRUG	basic care nicotine		nicotine polacrilex	LOZENGE	ORAL	20210429		ANDA	ANDA203690	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-645_dda3ead3-bf4b-4a1d-96b1-4f23fd2ea8d3	72288-645	HUMAN OTC DRUG	basic care loperamide hydrochloride		loperamide HCl	SOLUTION	ORAL	20210121		ANDA	ANDA091292	Amazon.com Services LLC	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
72288-648_6acb085b-6acc-4420-8324-42d20ea777ac	72288-648	HUMAN OTC DRUG	basic care nasal		Phenylephrine hydrochloride	SPRAY	NASAL	20210709		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-650_bb560851-9ea3-4e85-9053-0a4f57c67b66	72288-650	HUMAN OTC DRUG	basic care mucus er max		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210811		ANDA	ANDA213420	Amazon.com Services LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
72288-656_a6fd7397-ce7f-4497-90cf-68ee626cdaba	72288-656	HUMAN OTC DRUG	Basic Care Daytime Cold and Flu		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20210120		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-657_bad5b208-4122-4644-acc6-bff49831fcf4	72288-657	HUMAN OTC DRUG	basic care gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20220422		OTC MONOGRAPH FINAL	part332	Amazon.com Services LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
72288-660_dd12a91a-2ff5-4f67-88b1-f5037524fa05	72288-660	HUMAN OTC DRUG	basic care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20210812		ANDA	ANDA074937	Amazon.com Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-664_1c60c87a-1488-4bc2-995d-e3530f87e539	72288-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20180501		OTC MONOGRAPH NOT FINAL	part356	Amazon.Com Services LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-668_7cd464b9-cd3d-4688-9322-a483f8767eb9	72288-668	HUMAN OTC DRUG	basic care night time cough		Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20211217		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	30; 12.5	mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-671_8c65f3f4-6831-4ded-a69d-215f0f91547b	72288-671	HUMAN OTC DRUG	basic care lidocaine		lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20210318		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	LIDOCAINE	960	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72288-679_d33f3533-a7c5-4628-b5d4-71b4f14f2023	72288-679	HUMAN OTC DRUG	Basic Care First Aid Antibiotic		Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl	OINTMENT	TOPICAL	20210812		OTC MONOGRAPH FINAL	part333B	Amazon.com Services LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72288-680_fda98d03-fc3e-4e56-804b-a06247e573e4	72288-680	HUMAN OTC DRUG	Basic Care Eye		dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20210722		OTC MONOGRAPH FINAL	part349	Amazon.com Services LLC	DEXTRAN 70; POLYETHYLENE GLYCOL 400; POVIDONE, UNSPECIFIED; TETRAHYDROZOLINE HYDROCHLORIDE	1; 10; 10; .5	mg/mL; mg/mL; mg/mL; mg/mL	Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC]		N	20241231
72288-685_56d4a5be-41b3-4063-afc5-6e19def22a75	72288-685	HUMAN OTC DRUG	basic care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20211210		ANDA	ANDA074937	Amazon.com Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-700_0b115351-318c-4bd9-935c-704a09bcdf52	72288-700	HUMAN OTC DRUG	basic care esomeprazole magnesium		esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200615		ANDA	ANDA207193	Amazon.com Services Inc.	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-701_5f180f3e-266d-4185-8f29-7c3c216b7c3c	72288-701	HUMAN OTC DRUG	basic care hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20220512		ANDA	ANDA075357	Amazon.com Services LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72288-703_b15eb271-7842-495b-aa0f-9b20def86dc1	72288-703	HUMAN OTC DRUG	basic care no drip nasal		Oxymetazoline hydrochloride	SPRAY	NASAL	20210517		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
72288-714_3cfc64eb-da87-46b0-b333-5fb0dd435ca1	72288-714	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190831		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30.3; 101; 50.5; 101	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-721_ffb62016-75d9-4c39-b359-065e6b4c3291	72288-721	HUMAN OTC DRUG	basic care nighttime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20201210		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-723_43c0dd73-913d-452c-a22e-1063cc12253f	72288-723	HUMAN OTC DRUG	basic care tussin cf severe		Acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20210304		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-732_b0315d2a-d4eb-4a52-9dc5-45fb4028e346	72288-732	HUMAN OTC DRUG	basic care omeprazole and sodium bicarbonate		Omeprazole, sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20210722		ANDA	ANDA201361	Amazon.com Services LLC	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-733_7c7d155a-0c54-41cc-9302-6860b739c279	72288-733	HUMAN OTC DRUG	basic care daytime nighttime cold and flu		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20210503		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-734_4fbac5c3-3429-4887-a275-c3e1badbdce5	72288-734	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210610		ANDA	ANDA203690	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-747_a6fa6101-2e01-40be-8d85-4cf03d122ce8	72288-747	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl, Menthol	GEL	TOPICAL	20180517		OTC MONOGRAPH NOT FINAL	part348	Amazon	LIDOCAINE HYDROCHLORIDE; MENTHOL	7; 2	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72288-750_ac483c87-f2ed-4bf3-8d7c-6d25008267ce	72288-750	HUMAN OTC DRUG	Basic Care Lidocaine		LIDOCAINE	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20210812		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	LIDOCAINE	560	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72288-758_9099d1d9-45ff-49d7-911b-ae53dcdebe08	72288-758	HUMAN OTC DRUG	basic care loperamide hydrochloride		Loperamide hydrochloride	SUSPENSION	ORAL	20201221		ANDA	ANDA091292	Amazon.com Services LLC	LOPERAMIDE HYDROCHLORIDE	1	mg/7.5mL	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
72288-760_9e5c6025-7362-46fb-8328-070a962f0c2d	72288-760	HUMAN OTC DRUG	Sheer Touch Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Amazon.Com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 28; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-763_cfbe0e30-ed09-43e3-9a82-9187f88559b8	72288-763	HUMAN OTC DRUG	basic care childrens ibuprofen		ibuprofen	TABLET, CHEWABLE	ORAL	20210811		ANDA	ANDA076359	Amazon.com Services LLC	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-764_952b5c0d-34b8-4dbd-85ed-fec9b406f070	72288-764	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	AMAZON.COM SERVICES LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 117; 45; 45; 54	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-766_2777d722-87e9-456e-af2d-f7c25b576032	72288-766	HUMAN OTC DRUG	basic care infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20201210		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
72288-792_c5433325-87aa-4330-bbe7-854384682000	72288-792	HUMAN OTC DRUG	Sheer Touch Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part352	Amazon.Com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 80; 50; 40; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-798_927dd74e-c646-4726-9edb-8b45f01ff63b	72288-798	HUMAN OTC DRUG	basic care hair regrowth treatment		minoxidil	SOLUTION	TOPICAL	20220415		ANDA	ANDA075598	Amazon.com Services LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72288-800_9b969a52-251f-4db3-988c-eaa87d8142b9	72288-800	HUMAN OTC DRUG	basic care hemorrhoidal		cocoa butter, phenylephrine HCl	SUPPOSITORY	RECTAL	20220501		OTC MONOGRAPH FINAL	part346	Amazon.com Services LLC	COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE	2211; 6.5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-804_3e51caf5-094d-4717-a2cf-d4b3f9d20882	72288-804	HUMAN OTC DRUG	basic care daytime severe cold and flu nighttime severe cold and flu		Acetaminophen, dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl	KIT		20210513		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC						N	20241231
72288-808_d53b5ba3-b9b9-4fdf-acc2-607584abcad8	72288-808	HUMAN OTC DRUG	basic care nicotine		nicotine polacrilex	LOZENGE	ORAL	20210806		ANDA	ANDA203690	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-810_a32fc687-02a3-4a46-b06b-168ff38dd835	72288-810	HUMAN OTC DRUG	70% Isopropyl Alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Amazon.Com Services LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
72288-811_b0a02b44-eb1e-40d1-bdc6-c43f61ec7e30	72288-811	HUMAN OTC DRUG	basic care nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230616		ANDA	ANDA206394	Amazon.com Services LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-812_ac01ad52-483a-4cce-9279-51ceecada9b9	72288-812	HUMAN OTC DRUG	basic care mucus dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210709		ANDA	ANDA207602	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-816_d39bbd1c-fba8-4691-aec9-5a536eab1f38	72288-816	HUMAN OTC DRUG	Dandruff		Selenium sulfide	SHAMPOO	TOPICAL	20121209		OTC MONOGRAPH FINAL	part358H	AMAZON.COM SERVICES LLC	SELENIUM SULFIDE	10	mg/mL			N	20241231
72288-821_4ce28ab1-3dab-41dd-afbf-b24911ced7f7	72288-821	HUMAN OTC DRUG	Acne Scrub		Salicylic Acid	GEL	TOPICAL	20180425		OTC MONOGRAPH FINAL	part333D	Amazon.com Services LLC	SALICYLIC ACID	20	mg/mL			N	20241231
72288-822_ae5b7cf2-c273-8f1f-e053-2a95a90aa171	72288-822	HUMAN OTC DRUG	BELEI OILFREE FACIAL CLEANSING WIPES		SALICYLIC ACID	SOLUTION	TOPICAL	20190301		OTC MONOGRAPH FINAL	part333D	Amazon.com Services LLC	SALICYLIC ACID	2	g/100mL			N	20241231
72288-825_4a828083-f5a9-46c3-a07a-3d151f155025	72288-825	HUMAN OTC DRUG	Basic Care Miconazole 7		Miconazole nitrate	CREAM	VAGINAL	20210813		ANDA	ANDA074760	Amazon.com Services LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72288-826_6a1005b3-4f3f-49f2-b412-942d2da1fc0f	72288-826	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20210104		OTC MONOGRAPH DRUG	505G(a)(3)	Amazon.com Services LLC	ALCOHOL	62	mL/100mL			N	20241231
72288-829_f39feec2-54fb-47d4-9b45-08f75e92117e	72288-829	HUMAN OTC DRUG	basic care lansoprazole		Lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	ORAL	20210809		NDA	NDA208025	Amazon.com Services LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-831_972ac02d-a179-4c53-9966-0ec25123707f	72288-831	HUMAN OTC DRUG	Mineral oil		Mineral Oil	OIL	ORAL	20180501		OTC MONOGRAPH NOT FINAL	part334	Amazon.Com Services LLC	MINERAL OIL	1	mg/mL			N	20241231
72288-839_c4866306-d575-4ce2-aa58-29ba21a10d53	72288-839	HUMAN OTC DRUG	basic care childrens mucus relief		dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20210531		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-845_f3e99613-4470-49af-839c-80a802bbc04e	72288-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20180501		OTC MONOGRAPH FINAL	part344	Amazon.Com Services LLC	ISOPROPYL ALCOHOL	924	mg/mL			N	20241231
72288-847_d78bcf54-8667-4631-b9b6-259ceba22484	72288-847	HUMAN OTC DRUG	basic care allergy		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20210816		ANDA	ANDA212971	Amazon.com Services LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-849_0f53d24a-33aa-4b3e-a20f-5de556bc461f	72288-849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20200420		OTC MONOGRAPH DRUG	505(a)(3)	Amazon.com Services LLC	ALCOHOL	62	mL/100mL			N	20241231
72288-850_857df2d2-bc55-42a2-a294-f638ec36732a	72288-850	HUMAN OTC DRUG	Therapeutic		Coal Tar	SHAMPOO	TOPICAL	20180425		OTC MONOGRAPH FINAL	part358H	Amazon.com Services LLC	COAL TAR	1.02	mg/mL			N	20241231
72288-852_2738116f-4837-49d5-9ab7-3fbeec89886f	72288-852	HUMAN OTC DRUG	amazon basics acne foaming cleanser	Acne Treatment	BENZOYL PEROXIDE	LOTION	TOPICAL	20230726		OTC MONOGRAPH FINAL	part333D	AMAZON.COM SERVICES LLC	BENZOYL PEROXIDE	40	mg/mL			N	20241231
72288-861_b3020210-4ff5-489a-abd3-d7104de5402a	72288-861	HUMAN OTC DRUG	Oil Free Moisturizer		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20180501		OTC MONOGRAPH FINAL	part352	Amazon.Com Services LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30.6; 76.5; 51	mg/mL; mg/mL; mg/mL			N	20241231
72288-862_8aca1cec-4c3b-40a9-84bd-0725b9d71978	72288-862	HUMAN OTC DRUG	amazon basics acne blackhead clearing scrub	Acne Treatment	Salicylic Acid	LOTION	TOPICAL	20230724		OTC MONOGRAPH FINAL	part333D	AMAZON.COM SERVICES LLC	SALICYLIC ACID	20	mg/g			N	20241231
72288-864_4462cc03-8145-403f-b15c-735bd9c8d37e	72288-864	HUMAN OTC DRUG	50% Isopropyl Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Amazon.Com Services LLC	ISOPROPYL ALCOHOL	500	mg/mL			N	20241231
72288-870_6a603918-2d04-4331-9fe2-2be1f69c94c2	72288-870	HUMAN OTC DRUG	basic care arthritis pain		diclofenac sodium	GEL	TOPICAL	20210709		ANDA	ANDA211253	Amazon.com Services LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-871_0963877c-97d1-4764-b8f9-1f9c841f6a55	72288-871	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Amazon.Com Services LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
72288-873_349ea84d-47ad-4c23-9930-e71508486bb3	72288-873	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20200511		ANDA	ANDA077007	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-875_82fba257-0c4c-453d-87de-26d608d7fc33	72288-875	HUMAN OTC DRUG	Salicylic Acid		Astringent	LIQUID	TOPICAL	20181019		OTC MONOGRAPH FINAL	part333D	AMAZON.COM SERVICES LLC	SALICYLIC ACID	5	mg/mL			N	20241231
72288-876_5c2c5919-09b4-4d04-b6b5-880c189375f2	72288-876	HUMAN OTC DRUG	Ethyl Rubbing Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333A	Amazon.Com Services LLC	ALCOHOL	70	mL/100mL			N	20241231
72288-878_2047cf7b-7423-4fea-8b1a-4cd79c725d0b	72288-878	HUMAN OTC DRUG	basic care hydrocortisone		Hydrocortisone	LOTION	TOPICAL	20211217		OTC MONOGRAPH DRUG	M017	Amazon.com Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72288-897_3b804894-a65b-4939-96d6-17335d3f9cff	72288-897	HUMAN OTC DRUG	basic care childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20200701		ANDA	ANDA074937	Amazon.com Services LLC	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72288-898_ce88d99d-0ec2-411d-837d-cb602c04fec5	72288-898	HUMAN OTC DRUG	basic care esomeprazole magnesium		Esomeprazole	CAPSULE, DELAYED RELEASE	ORAL	20200722		ANDA	ANDA207193	Amazon.com Services LLC	ESOMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-899_71d6ca67-f8d3-451b-b45d-b493fe8b1c82	72288-899	HUMAN OTC DRUG	basic care childrens cough dm		Dextromethorphan polistirex	SUSPENSION	ORAL	20210318		ANDA	ANDA091135	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-901_e2c83874-aa95-477a-9cfd-cecfd776ba0e	72288-901	HUMAN OTC DRUG	Basic Care Childrens Allergy Relief		loratadine	TABLET, CHEWABLE	ORAL	20210812		ANDA	ANDA210033	Amazon.com Services LLC	LORATADINE	5	mg/1			N	20241231
72288-904_9d6652c6-059c-4602-9fe6-2e04aba95c59	72288-904	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20180501		OTC MONOGRAPH DRUG	M003	Amazon.Com Services LLC	ISOPROPYL ALCOHOL	.91	mg/mL			N	20241231
72288-911_347d3c88-c11f-4422-8533-18c80807875b	72288-911	HUMAN OTC DRUG	Everyday Clean		Pyrithione zinc	SHAMPOO	TOPICAL	20180501		OTC MONOGRAPH FINAL	part358H	Amazon.Com Services LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72288-914_c65e8f25-038c-4c5e-958b-f38a38331d57	72288-914	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-915_cf33ee04-e3b6-48bb-b22c-1f1348103f58	72288-915	HUMAN OTC DRUG	basic care omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20201203		NDA	NDA022032	Amazon.com Services LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72288-920_111e4702-911e-4dc1-a71a-0c4975272f85	72288-920	HUMAN OTC DRUG	sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 120; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-922_657e8ff7-2280-49c3-bdca-ab0bb8f2ebf6	72288-922	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH FINAL	part347	Amazon.Com Services LLC	WITCH HAZEL	855	mg/mL			N	20241231
72288-924_5adcf059-7b9b-4fca-b427-a3549d4d3295	72288-924	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-932_0d7f34b3-94f7-43c3-e063-6294a90ab512	72288-932	HUMAN OTC DRUG	Sheer Touch Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
72288-933_0d805ace-ef7b-4bf9-e063-6394a90a56b8	72288-933	HUMAN OTC DRUG	Sheer Touch Sunscreen SPF 55		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
72288-939_0d83a263-357a-55bc-e063-6394a90a6986	72288-939	HUMAN OTC DRUG	Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
72288-940_0d83fa7f-d294-7d3c-e063-6294a90aa441	72288-940	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
72288-943_a03720f1-d5e1-49e0-8cb3-26fc7e1c8ed2	72288-943	HUMAN OTC DRUG	basic care daytime severe cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20220330		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-946_de1c0d4b-eb32-4a9c-a437-2bd7c68cb908	72288-946	HUMAN OTC DRUG	basic care infants pain and fever		Acetaminophen	SUSPENSION	ORAL	20220505		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
72288-947_053139ce-2f9d-459a-af27-9feed500d134	72288-947	HUMAN OTC DRUG	Oil Free Acne Wash		Salicylic Acid 2%	LOTION	TOPICAL	20141120		OTC MONOGRAPH FINAL	part333D	AMAZON.COM SERVICES LLC	SALICYLIC ACID	20	mg/mL			N	20241231
72288-949_62d7f1bc-3951-4f84-bd32-491ffe0d131c	72288-949	HUMAN OTC DRUG	basic care lidocaine		lidocaine	KIT		20210318		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC						N	20241231
72288-950_00666c17-e813-4526-8068-87bc1ea3e303	72288-950	HUMAN OTC DRUG	baby		Sunscreen	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72288-952_d882c490-e6ef-488c-8334-bfd612b28eb2	72288-952	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	SPRAY	TOPICAL	20180501		OTC MONOGRAPH FINAL	part352	Amazon.Com Services LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30.9; 133.9; 51.5; 72.1; 41.2	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
72288-953_27e3471e-bc4b-4cc6-9128-5509236d8e1a	72288-953	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20180501		OTC MONOGRAPH FINAL	part358H	Amazon.Com Services LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72288-955_75d3dfbb-1d8f-41b5-a09c-7fa06e44d364	72288-955	HUMAN OTC DRUG	Amazon Basics Acne Wash	Acne treatment	Salicylic Acid	LIQUID	TOPICAL	20230510		OTC MONOGRAPH FINAL	part333D	Amazon.com Services LLC	SALICYLIC ACID	20	mg/mL			N	20241231
72288-957_2ce82de4-768b-4b16-9869-e831fbe9846d	72288-957	HUMAN OTC DRUG	basic care nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20210806		ANDA	ANDA203690	Amazon.com Services LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72288-958_9fe3ad85-7150-4f4a-a569-a269ec0b47c1	72288-958	HUMAN OTC DRUG	basic care childrens cough dm		dextromethorphan polistirex	SUSPENSION	ORAL	20210720		ANDA	ANDA091135	Amazon.com Services LLC	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72288-959_d56590ed-f051-4061-af03-0deab7368bd2	72288-959	HUMAN OTC DRUG	Basic Care Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20210720		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
72288-964_7b9afda5-2df5-4553-a344-067617643cbe	72288-964	HUMAN OTC DRUG	Basic Care severe cold and cough		Acetaminophen, Diphenhydramine hydrochloride, Phenylephrine hydrochloride	POWDER, FOR SOLUTION	ORAL	20210720		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-965_bebba069-c002-4d56-87ef-a63381cc3415	72288-965	HUMAN OTC DRUG	Colloidal oatmeal		Colloidal oatmeal	CREAM	TOPICAL	20180425		OTC MONOGRAPH FINAL	part347	Amazon.com Services LLC	OATMEAL	10.4	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72288-973_5e3837d3-d656-4f42-920c-810dd25a0ef6	72288-973	HUMAN OTC DRUG	basic care hydrocortisone		hydrocortisone	CREAM	TOPICAL	20221024		OTC MONOGRAPH NOT FINAL	part348	Amazon.com Services LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72288-975_a03a39cf-9ed9-40eb-8e91-7ae96041de53	72288-975	HUMAN OTC DRUG	basic care acetaminophen		Acetaminophen	TABLET	ORAL	20210722		OTC MONOGRAPH NOT FINAL	part343	Amazon.com Services LLC	ACETAMINOPHEN	500	mg/1			N	20241231
72288-980_a00b0bd4-48e8-4691-b370-4f2cb87556a3	72288-980	HUMAN OTC DRUG	basic care all day allergy		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220308		ANDA	ANDA213105	Amazon.com Services LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72288-987_d5f1540a-5cba-47a7-a7ba-cd98e1d9ad2c	72288-987	HUMAN OTC DRUG	basic care childrens cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20210121		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-994_ef73080e-9f48-4bec-9e09-dbd09c06c62d	72288-994	HUMAN OTC DRUG	Basic Care Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20210903		OTC MONOGRAPH FINAL	part341	Amazon.com Services LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72288-995_f9b05944-bb34-44b0-8761-0c51fd6ba813	72288-995	HUMAN OTC DRUG	Daily Facial Moisturizer		Octinoxate, Octisalate, Avobenzone	LOTION	TOPICAL	20170225		OTC MONOGRAPH FINAL	part352	Amazon.com Services LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30.6; 76.5; 51	mg/mL; mg/mL; mg/mL			N	20241231
72296-010_d8df491f-d0ec-43f8-b401-b7e051f5005c	72296-010	HUMAN OTC DRUG	TULA acne clearing and tone correcting gel		TULA acne clearing and tone correcting gel	LIQUID	TOPICAL	20221226		OTC MONOGRAPH FINAL	part333D	Tula Life LLC	SALICYLIC ACID	2	g/100g			N	20241231
72296-030_8f52e66b-0a13-4335-a541-e29bf27b2529	72296-030	HUMAN OTC DRUG	TULA Skincare Keep it Clear Acne Foam Cleanser		TULA Skincare Keep it Clear Acne Foam Cleanser	LIQUID	TOPICAL	20221226		OTC MONOGRAPH FINAL	part333D	Tula Life LLC	SALICYLIC ACID	2	g/100g			N	20241231
72296-090_18b09abb-947b-4ff5-a748-28a14588d350	72296-090	HUMAN OTC DRUG	Acne All-Star 3-in-1 Acne Cleanser, Mask and Spot Treatment		Sulfur Lotion	LIQUID	TOPICAL	20220725		OTC MONOGRAPH FINAL	part333D	Tula Life LLC	SULFUR	.03	g/g			N	20241231
72296-101_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-101	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Very Light Neutral	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-102_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-102	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Very Light Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-103_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-103	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Very Light Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-104_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-104	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-105_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-105	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light Neutral	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-106_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-106	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-107_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-107	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light Neutral-Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-108_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-108	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light-Medium Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-109_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-109	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light-Medium Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-110_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-110	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light-Medium Olive	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-111_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-111	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Light-Medium Neutral	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-112_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-112	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Medium Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-113_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-113	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Medium Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-114_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-114	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Medium Neutral	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-115_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-115	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Medium Neutral-Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-116_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-116	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Medium-Tan Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-117_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-117	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Medium-Tan Neutral	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-118_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-118	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Medium-Tan Olive	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-119_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-119	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Tan Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-120_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-120	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Tan Neutral-Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-121_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-121	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Tan Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-122_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-122	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Tan Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-123_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-123	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Tan-Deep Olive	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-124_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-124	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Tan-Deep Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-125_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-125	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Tan-Deep Neutral	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-126_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-126	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Deep Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-127_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-127	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Deep Neutral-Warm	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-128_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-128	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Deep Neutral-Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-129_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-129	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Deep Cool	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-130_bbe47d64-abbe-42a7-82a2-9a7f84f28dca	72296-130	HUMAN OTC DRUG	TULA Radiant Skin Brightening Serum Skin Tint Sunscreen Broad Spectrum SPF 30	Deep Neutral	Avobenzone, Octisalate Serum	LIQUID	TOPICAL	20220801		OTC MONOGRAPH FINAL	part352	Tula Life LLC	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
72296-201_f485c51a-b148-7b2b-e053-2995a90a876d	72296-201	HUMAN OTC DRUG	TULA Ultimate Sun Serum PentaPeptide Sunscreen	Broad Spectrum SPF 50	Sunscreen Serum	LIQUID	TOPICAL	20230212		OTC MONOGRAPH FINAL	M020	Tula Life LLC	TITANIUM DIOXIDE; ZINC OXIDE	6; 5.0076	g/100mL; g/100mL			N	20241231
72296-902_f477354b-265a-e520-e053-2a95a90a2560	72296-902	HUMAN OTC DRUG	TULA Skincare Acne Heroes Acne-Clearing Routine		Acne-Clearing Routine Kit	KIT	TOPICAL	20230212		OTC MONOGRAPH FINAL	M006	TULA Life LLC						N	20241231
72296-906_f481cd10-fe54-1cb6-e053-2a95a90a0516	72296-906	HUMAN OTC DRUG	TULA Skincare Clear Skin Starters Travel-size Acne and Blemish Fighting Kit		Acne and Blemish Fighting Kit	KIT	TOPICAL	20230214		OTC MONOGRAPH FINAL	M006	TULA Life LLC						N	20241231
72296-910_f6f7d369-64f1-0ed9-e053-6294a90a40fa	72296-910	HUMAN OTC DRUG	TULA Everyday Glow Exclusive Best Selling Essentials Kit		Everyday Glow Essential Kit	KIT	TOPICAL	20230316		OTC MONOGRAPH FINAL	M020	TULA Life LLC						N	20241231
72299-011_08aaa759-3e7f-ec9c-e063-6294a90a4719	72299-011	HUMAN OTC DRUG	The Humble Co Anticavity Mouthwash Fresh Mint		SODIUM FLUORIDE	RINSE	ORAL	20191201		OTC MONOGRAPH DRUG	M021	The Humble Company North America Inc	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72299-019_08aaadea-deca-2120-e063-6294a90ae460	72299-019	HUMAN OTC DRUG	The Humble Co. Anticavity FRESH MINT		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20210901		OTC MONOGRAPH DRUG	M021	The Humble Company North America, Inc	SODIUM FLUORIDE	1.5	mg/g			N	20241231
72299-021_090d4133-3435-57a8-e063-6294a90a6f30	72299-021	HUMAN OTC DRUG	Humble Brush Bamboo with FRESH MINT FLOURIDE		SODIUM FLUORIDE	KIT		20210901		OTC MONOGRAPH DRUG	M021	The Humble Company North America Inc						N	20241231
72299-024_08aaa759-3e71-ec9c-e063-6294a90a4719	72299-024	HUMAN OTC DRUG	The Humble Co. Kit		SODIUM FLUORIDE	KIT		20220201		OTC MONOGRAPH DRUG	M021	The Humble Company North America Inc						N	20241231
72301-595_7f7323c9-a2c0-49f8-915f-439fd59cfe5a	72301-595	HUMAN PRESCRIPTION DRUG	Jeuveau		Prabotulinum Toxin Type A	POWDER	INTRAMUSCULAR	20190213		BLA	BLA761085	Evolus, Inc.	BOTULINUM TOXIN TYPE A	100	[USP'U]/1	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
72304-005_68e74e3d-3fe8-43a3-8550-01e5231ac5f5	72304-005	HUMAN OTC DRUG	Midway Select Topical Anesthetic		Benzocaine	GEL	DENTAL	20180601	20250118	OTC MONOGRAPH NOT FINAL	part356	Midway Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
72304-006_6a275c1f-73c7-4c0f-9dce-b425be186183	72304-006	HUMAN OTC DRUG	Midway Select Topical Anesthetic		Benzocaine	GEL	DENTAL	20180601	20250120	OTC MONOGRAPH NOT FINAL	part356	Midway Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
72304-007_b4b48fce-29c5-4c14-85c9-0d4eb02fe8f4	72304-007	HUMAN OTC DRUG	Midway Select Topical Anesthetic		Benzocaine	GEL	DENTAL	20180601	20241115	OTC MONOGRAPH NOT FINAL	part356	Midway Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
72304-008_d56281d8-e976-45a5-8677-915a7ac96d52	72304-008	HUMAN OTC DRUG	Midway Select Topical Anesthetic		Benzocaine	GEL	DENTAL	20180601	20250419	OTC MONOGRAPH NOT FINAL	part356	Midway Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
72304-009_d786583c-52c9-4c80-a1a5-3f2707113f6c	72304-009	HUMAN OTC DRUG	Midway Select Topical Anesthetic		Benzocaine	GEL	DENTAL	20180601	20250421	NDA AUTHORIZED GENERIC	NDA022466	Midway Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
72304-010_ae42f967-4320-44db-8d86-3c8112f28202	72304-010	HUMAN OTC DRUG	Midway Select Topical Anesthetic		Benzocaine	GEL	DENTAL	20180601	20250127	OTC MONOGRAPH NOT FINAL	part356	Midway Dental Supply, LLC	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
72304-015_46609c3a-d809-4745-bee7-ac6d77792794	72304-015	HUMAN PRESCRIPTION DRUG	Articaine Hydrochloride and Epinephrine		ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	SUBMUCOSAL	20210426	20240601	NDA	NDA022466	Midway Dental Supply, LLC	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; 10	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
72304-016_46609c3a-d809-4745-bee7-ac6d77792794	72304-016	HUMAN PRESCRIPTION DRUG	Articaine Hydrochloride and Epinephrine		ARTICAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE	INJECTION, SOLUTION	SUBMUCOSAL	20210426	20240601	NDA	NDA022466	Midway Dental Supply, LLC	ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE	40; 5	mg/mL; ug/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
72305-025_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-025	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-050_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-050	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-075_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-075	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-088_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-088	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-100_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-100	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-112_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-112	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-125_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-125	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-137_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-137	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-150_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-150	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-175_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-175	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72305-200_58e5597f-72d0-45b5-a66a-81a4f10d83e1	72305-200	HUMAN PRESCRIPTION DRUG	EUTHYROX		levothyroxine sodium	TABLET	ORAL	20181017		NDA	NDA021292	Provell Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72308-025_0c840173-0518-5ce4-e063-6394a90ae78c	72308-025	HUMAN OTC DRUG	Germ Out Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200815		OTC MONOGRAPH DRUG	505G(a)(3)	Flex Beauty Labs LLC	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
72308-036_0c864236-9d48-38e4-e063-6394a90aa4ec	72308-036	HUMAN OTC DRUG	Visibly Clean Antibacterial Wet Wipes Blue Sage Lime		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200915		OTC MONOGRAPH DRUG	505G(a)(3)	Flex Beauty Labs LLC	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
72308-037_0c864f2d-7b1f-370e-e063-6394a90ae1a4	72308-037	HUMAN OTC DRUG	Visibly Clean Antibacterial Wet Wipes Strawberry Tart		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200915		OTC MONOGRAPH DRUG	505G(a)(3)	Flex Beauty Labs LLC	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
72308-038_0c864f2d-7b2f-370e-e063-6394a90ae1a4	72308-038	HUMAN OTC DRUG	Visibly Clean Antibacterial Wet Wipes Fresh Lemonade		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200915		OTC MONOGRAPH DRUG	505G(a)(3)	Flex Beauty Labs LLC	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
72319-005_06e9fbb6-77c8-997b-e063-6394a90ad4f3	72319-005	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20200430		ANDA	ANDA212650	i3 Pharmaceuticals, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
72319-006_e9806820-4106-4204-8ac2-53e590a866ab	72319-006	HUMAN PRESCRIPTION DRUG	Selegiline Hydrochloride		Selegiline Hydrochloride	TABLET	ORAL	20211215		ANDA	ANDA074672	i3 Pharmaceuticals, LLC	SELEGILINE HYDROCHLORIDE	5	mg/1	Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor [EPC], Monoamine Oxidase-B Inhibitors [MoA]		N	20241231
72319-018_07741df0-3ffb-82bd-e063-6394a90a2259	72319-018	HUMAN PRESCRIPTION DRUG	Guanfacine		Gaunfacine	TABLET	ORAL	20231108		ANDA	ANDA216828	i3 Pharmaceuticals, LLC	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72319-019_07741df0-3ffb-82bd-e063-6394a90a2259	72319-019	HUMAN PRESCRIPTION DRUG	Guanfacine		Gaunfacine	TABLET	ORAL	20231108		ANDA	ANDA216828	i3 Pharmaceuticals, LLC	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72319-021_163908d8-6b41-4e68-b14c-76faa57c7ac0	72319-021	HUMAN PRESCRIPTION DRUG	RANOLAZINE		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220615		ANDA	ANDA213517	i3 Pharmaceuticals, LLC	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72319-022_163908d8-6b41-4e68-b14c-76faa57c7ac0	72319-022	HUMAN PRESCRIPTION DRUG	RANOLAZINE		RANOLAZINE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220615		ANDA	ANDA213517	i3 Pharmaceuticals, LLC	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72319-023_05196c9c-fb44-616c-e063-6394a90a6377	72319-023	HUMAN PRESCRIPTION DRUG	Posaconazole		Posaconazole	TABLET, DELAYED RELEASE	ORAL	20230915		ANDA	ANDA216488	i3 Pharmaceuticals, LLC	POSACONAZOLE	100	mg/1	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72319-024_0416607a-fd74-87e3-e063-6294a90ae6b5	72319-024	HUMAN PRESCRIPTION DRUG	Maraviroc		Maraviroc	TABLET, FILM COATED	ORAL	20230915		ANDA	ANDA217114	i3 Pharmaceuticals, LLC	MARAVIROC	150	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
72319-025_0416607a-fd74-87e3-e063-6294a90ae6b5	72319-025	HUMAN PRESCRIPTION DRUG	Maraviroc		Maraviroc	TABLET, FILM COATED	ORAL	20230915		ANDA	ANDA217114	i3 Pharmaceuticals, LLC	MARAVIROC	300	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
72319-168_7fc76bc9-380c-4b26-8a3e-b5f6ac956618	72319-168	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20200916		ANDA	ANDA212053	i3 Pharmaceuticals, LLC	CHLORZOXAZONE	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72319-169_7fc76bc9-380c-4b26-8a3e-b5f6ac956618	72319-169	HUMAN PRESCRIPTION DRUG	CHLORZOXAZONE		CHLORZOXAZONE	TABLET	ORAL	20200916		ANDA	ANDA212053	i3 Pharmaceuticals, LLC	CHLORZOXAZONE	375	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72326-8001_d174dd33-15a2-0f7c-e053-2995a90a9fee	72326-8001	HUMAN OTC DRUG	MINTBLAST		SODIUM FLUORIDE	PASTE	DENTAL	20180526		OTC MONOGRAPH NOT FINAL	part356	YOUNG PS ACQUISITION, LLC	SODIUM FLUORIDE	2.43	mg/g			N	20241231
72326-8002_07d5baa5-6b43-e0fa-e063-6394a90a9565	72326-8002	HUMAN OTC DRUG	Plak Smacker Anti Cavity Fluoride		Sodium Fluoride	PASTE	DENTAL	20180527		OTC MONOGRAPH DRUG	M021	YOUNG PS ACQUISITION, LLC	SODIUM FLUORIDE	1.4	mg/g			N	20241231
72326-8003_0863c813-ed44-cf81-e063-6294a90ab427	72326-8003	HUMAN OTC DRUG	Plak Smacker GREAT WHITE SHARK		Sodium Fluoride	PASTE	DENTAL	20180527		OTC MONOGRAPH DRUG	M021	YOUNG PS ACQUISITION, LLC	SODIUM FLUORIDE	1.4	mg/g			N	20241231
72330-052_d30aeaa6-3420-401c-e053-2a95a90a8fe9	72330-052	HUMAN OTC DRUG	THEFACESHOP Cushion CC SPF 50 Apricot Beige	Oil-Free	Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
72330-053_d30aeaa6-3424-401c-e053-2a95a90a8fe9	72330-053	HUMAN OTC DRUG	THEFACESHOP Cushion CC SPF 50 Natural Beige	Oil-Free	Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
72330-062_d30b06a7-b8b9-2619-e053-2995a90a814c	72330-062	HUMAN OTC DRUG	THEFACESHOP Cushion CC Total Cover SPF 50 Apricot Beige		Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
72330-063_d30afd94-8bce-01bc-e053-2a95a90afb49	72330-063	HUMAN OTC DRUG	THEFACESHOP Cushion CC Total Cover SPF 50 Natural Beige		Ensulizole, Titanium Dioxide	POWDER	TOPICAL	20210204		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
72330-195_d30b156a-b9b2-499b-e053-2a95a90ada6a	72330-195	HUMAN OTC DRUG	THEFACESHOP Natural Sun Oil-Free Sunscreen Broad Spectrum SPF 50		Ensulizole, Octinoxate, Octisalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	1.75; 3.5; 2.25; 2.285; 5.825	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-196_d30b156a-b9b8-499b-e053-2a95a90ada6a	72330-196	HUMAN OTC DRUG	THEFACESHOP Natural Sun Long Lasting Sunscreen Broad Spectrum SPF 50		Ensulizole, Octinoxate, Octisalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	1.75; 3.5; 2.25; 2.285; 5.825	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-301_0a64627b-1a48-e33c-e063-6394a90a638b	72330-301	HUMAN OTC DRUG	Dominas Dark Spot UV Defense Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	fmg Co.Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-501_d6dcdb14-f361-65e3-e053-2a95a90acba2	72330-501	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-502_d6de8140-29cd-efd1-e053-2a95a90ab393	72330-502	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE ACTIVE FACE AND BODY PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-503_02e64be2-d48e-4668-e063-6394a90a51f0	72330-503	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230714		OTC MONOGRAPH FINAL	M020	fmg Co.Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-510_d6de99f5-5659-8a6e-e053-2995a90ad973	72330-510	HUMAN OTC DRUG	ISA KNOX LXNEW PLATINUM SCULPTING DAY BROAD SPECTRUM SPF 30 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 7; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-511_f114e45c-6c32-2382-e053-2995a90ac754	72330-511	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY MINERAL FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		Zinc Oxide	CREAM	TOPICAL	20221201		OTC MONOGRAPH FINAL	M020	fmg Co.Ltd	ZINC OXIDE	15.52	g/50mL			N	20241231
72330-512_02e5eb03-05a3-c55c-e063-6394a90ae076	72330-512	HUMAN OTC DRUG	ISA KNOX ANEW SOLAIRE EVERYDAY MINERAL FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN		ZINC OXIDE	CREAM	TOPICAL	20230714		OTC MONOGRAPH FINAL	M020	fmg Co.Ltd	ZINC OXIDE	15.52	g/50mL			N	20241231
72330-600_d3078dd2-ae9d-d81a-e053-2a95a90a47bf	72330-600	HUMAN OTC DRUG	OHUI Ultimate Cover CC Cushion Compact 01 Light Beige		Titanium Dioxide	POWDER	TOPICAL	20160125		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
72330-601_d307b366-b9b7-1d68-e053-2995a90af94e	72330-601	HUMAN OTC DRUG	OHUI Ultimate Cover CC Cushion Compact 02 Natural Beige		Titanium Dioxide	POWDER	TOPICAL	20160125		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; TITANIUM DIOXIDE	.405; .819	g/15g; g/15g			N	20241231
72330-650_f8377a86-3d75-e2af-e053-6294a90a0b6c	72330-650	HUMAN OTC DRUG	O HUI DAY SHIELD PERFECT SUN BLACK BROAD SPECTRUM SPF 50 SUNSCREEN		Octisalate, Octocrylene, Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230331		OTC MONOGRAPH FINAL	M020	fmg Co.Ltd	OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	2.5; 4; 1.53; 8.73	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-710_02e64046-687e-449e-e063-6294a90a6c32	72330-710	HUMAN OTC DRUG	belif The true cream aqua bomb sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20230808		OTC MONOGRAPH FINAL	M020	fmg Co.Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-710_d67faeb3-0b74-5b6e-e053-2a95a90aac2b	72330-710	HUMAN OTC DRUG	belif The true cream aqua bomb sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20220126		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 9; 4.5; 9	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72330-800_d31f4e71-ad05-d2df-e053-2a95a90a7e24	72330-800	HUMAN OTC DRUG	Babience KIDS Sunscreen pinkfong BABY SHARK SPF 50		Ensulizole, Octinoxate, Octisalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part352	fmg Co.Ltd	ENSULIZOLE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	1.75; 3.5; 2.25; 2.285; 5.825	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
72333-001_2ac35af3-5037-49d4-a118-c87866abf861	72333-001	HUMAN PRESCRIPTION DRUG	Ammonia N 13		Ammonia N 13	INJECTION	INTRAVENOUS	20200909		ANDA	ANDA211740	University of Wisconsin System	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
72336-064_ffd1c048-c170-7a9e-e053-6294a90ac00c	72336-064	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET	ORAL	20020124		ANDA	ANDA075972	LifSa Drugs, LLC	METFORMIN HYDROCHLORIDE	625	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72336-910_dd4cbd3f-572e-400b-8fe7-98d537557b80	72336-910	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	SOLUTION	ORAL	20220404		ANDA	ANDA214102	Lifsa Drugs LLC	VALSARTAN	4	mg/mL	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72338-100_d0687ba7-a598-4409-8459-0204bcb6d9f3	72338-100	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180604		ANDA	ANDA211899	Waverley Pharma Inc	PEMETREXED DISODIUM HEPTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
72338-101_d0687ba7-a598-4409-8459-0204bcb6d9f3	72338-101	HUMAN PRESCRIPTION DRUG	Pemetrexed		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180604		ANDA	ANDA211899	Waverley Pharma Inc	PEMETREXED DISODIUM HEPTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20251231
72342-020_ac2d54c9-1de3-4567-879a-49713f40b700	72342-020	HUMAN OTC DRUG	Pain Relieving Cooling		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	MENTHOL, UNSPECIFIED FORM	3	g/100g			N	20241231
72342-030_a41b71da-a328-4ab0-8c8f-89a67592bee9	72342-030	HUMAN OTC DRUG	Pain Relieving Warming Balm		Methyl Salicylate and Menthol, Unspecified Form	GEL	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	1.25; 10	g/100g; g/100g			N	20241231
72342-040_14d7ca72-419b-4116-a972-928ea590c34e	72342-040	HUMAN OTC DRUG	Pain Relieving		CAMPHOR (NATURAL)	LINIMENT	TOPICAL	20230515		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL)	3.5	g/100mL			N	20241231
72342-050_85485b7d-b40f-447a-b242-38f6a8baa7b1	72342-050	HUMAN OTC DRUG	Pain Relieving Liniment		Camphor (Natural) and Menthol, Unspecified Form	SPRAY	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3.5; 2.5	g/100mL; g/100mL			N	20241231
72342-060_a1d56a82-034f-4a85-9793-b87201dafb29	72342-060	HUMAN OTC DRUG	Pain Relieving	Petro Carbo	Phenol	SALVE	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	PHENOL	1.5	g/100g			N	20241231
72342-080_1b90f6ac-d42a-4bf0-8850-2ff350ccb877	72342-080	HUMAN OTC DRUG	White Cream		CAMPHOR (NATURAL) and Turpentine Oil	LINIMENT	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL); TURPENTINE OIL	3; 9	g/100mL; g/100mL			N	20241231
72342-100_72d99a1e-aef9-4a6b-8c90-adaaab009872	72342-100	HUMAN OTC DRUG	Pain Relief	Cooling, Extra Strength	MENTHOL, UNSPECIFIED FORM	PATCH	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	MENTHOL, UNSPECIFIED FORM	105	mg/1			N	20241231
72342-110_bcacebb7-80dd-4117-a171-0e3fbe78bf84	72342-110	HUMAN OTC DRUG	Pain Relief	Extra Strength, Cooling	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20201215		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	MENTHOL, UNSPECIFIED FORM	6	g/100g			N	20241231
72342-120_9664d70d-0ff1-45ad-9539-2ea07ae96c3f	72342-120	HUMAN OTC DRUG	Pain Relief Roll On	Extra Strength, Cooling	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20201215		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	MENTHOL, UNSPECIFIED FORM	6	g/100g			N	20241231
72342-130_d439d7fe-3363-4a75-b30b-5723f4e4dd42	72342-130	HUMAN OTC DRUG	Pain Relief	Extra Strength, Cooling	MENTHOL, UNSPECIFIED FORM	AEROSOL, SPRAY	TOPICAL	20201215		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	MENTHOL, UNSPECIFIED FORM	6	g/100mL			N	20241231
72342-180_c95bdcc4-19ef-4756-af64-30d6d3ded4b5	72342-180	HUMAN OTC DRUG	Pain Relief	Muscle	Camphor (Natural)	AEROSOL, SPRAY	TOPICAL	20201215		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL)	1.5	g/100mL			N	20241231
72342-190_3249d53d-2143-4461-9b9d-88943c53d032	72342-190	HUMAN OTC DRUG	Pain Relief Roll-On	Muscle	Camphor (Natural)	GEL	TOPICAL	20201215		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL)	1.5	g/100g			N	20241231
72342-200_a18a1eeb-e9f3-4918-9416-ef642547fe80	72342-200	HUMAN OTC DRUG	Pain Relief	Muscle	Camphor (Natural)	LOTION	TOPICAL	20201215		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL)	1.5	g/100g			N	20241231
72342-210_80e891af-9856-4521-943c-74c0d2e10204	72342-210	HUMAN OTC DRUG	Pain Relief	Muscle Relief	Camphor (Natural)	PATCH	TOPICAL	20210315		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL)	280	mg/1			N	20241231
72342-220_d4c861ed-7d24-4557-9319-801f7a657298	72342-220	HUMAN OTC DRUG	Menthol Camphor Cough Suppressant Topical Analgesic Rub		CAMPHOR (NATURAL) and MENTHOL, UNSPECIFIED FORM	OINTMENT	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part348	J.R. Watkins, LLC.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	5.3; 2.8	g/100g; g/100g			N	20241231
72342-230_3414823d-9695-489d-8c81-269946f256e7	72342-230	HUMAN OTC DRUG	Menthol Camphor Vapor Rub		CAMPHOR (NATURAL) and MENTHOL, UNSPECIFIED FORM	OINTMENT	TOPICAL	20230821		OTC MONOGRAPH FINAL	part341	J.R. Watkins, LLC.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	5.3; 2.8	g/100g; g/100g			N	20241231
72343-001_07100573-509e-53cf-e063-6394a90a92db	72343-001	HUMAN PRESCRIPTION DRUG	Nitrous Oxide		Nitrous Oxide	GAS	RESPIRATORY (INHALATION)	20000101		NDA	NDA206009	Nitrous Oxide of Canada	NITROUS OXIDE	900	mL/L			N	20241231
72344-100_f1ea03d5-e2ed-a1c1-e053-2a95a90ae755	72344-100	HUMAN OTC DRUG	Surface Sun Sheer Touch SPF 50 Sunscreen		Avobenzone, Humosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211217		OTC MONOGRAPH NOT FINAL	part352	Surface Products Corp	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72344-101_f1ea032b-0274-cfd1-e053-2995a90a837b	72344-101	HUMAN OTC DRUG	Surface Sun Sheer Touch SPF30 Sunscreen		Avobenzone, Humosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211217		OTC MONOGRAPH NOT FINAL	part352	Surface Products Corp	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72344-102_f1e9e2b0-c0e9-3e51-e053-2995a90a3895	72344-102	HUMAN OTC DRUG	Surface Sun Dry Touch SPF 50 Sunscreen		Avobenzone, Humosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211217		OTC MONOGRAPH NOT FINAL	part352	Surface Products Corp	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72344-103_f1e9f9e2-fcf1-61d2-e053-2995a90af59d	72344-103	HUMAN OTC DRUG	Surface Sun Dry Touch SPF 30 Sunscreen		Avobenzone, Humosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20211217		OTC MONOGRAPH NOT FINAL	part352	Surface Products Corp	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72344-104_f1e9ff44-1029-b90f-e053-2995a90ad751	72344-104	HUMAN OTC DRUG	Surface Dry Touch SPF 30 Sunscreen		Octocrylene, Avobenzone, Homosalate	LOTION	TOPICAL	20211220		OTC MONOGRAPH NOT FINAL	part352	Surface Products Corp	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 6	g/100mL; g/100mL; g/100mL			N	20241231
72344-105_f1e9ff44-1028-b90f-e053-2995a90ad751	72344-105	HUMAN OTC DRUG	Surface Sheer Touch SPF 50 Sunscreen		Octocrylene, Avobenzone, Homosalate	LOTION	TOPICAL	20211220		OTC MONOGRAPH NOT FINAL	part352	Surface Products Corp	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 6	g/100mL; g/100mL; g/100mL			N	20241231
72346-010_eb1dc942-6ab1-4cc2-942e-3395527edb3a	72346-010	HUMAN OTC DRUG	MediF Tooth		SILICON DIOXIDE, ALCLOXA	PASTE, DENTIFRICE	TOPICAL	20180501		UNAPPROVED DRUG OTHER		MEDIF CO.,LTD	ALCLOXA; SILICON DIOXIDE	.06; 18.2	g/130g; g/130g			N	20241231
72346-100_229f45c9-d0c3-4fb4-83cb-a4964f4b4bf5	72346-100	HUMAN OTC DRUG	Medi i Tooth		Sodium Monofluorophosphate	PASTE, DENTIFRICE	ORAL	20200801		OTC MONOGRAPH FINAL	part355	MEDIF CO.,LTD	SODIUM MONOFLUOROPHOSPHATE	.26	g/70g			N	20241231
72346-110_8866028c-e5a6-4dca-a095-81321d7997cd	72346-110	HUMAN OTC DRUG	Medi W Tooth		Hydrogen Peroxide Solution, Colloidal Silicon Dioxide	PASTE, DENTIFRICE	ORAL	20200801		UNAPPROVED DRUG OTHER		MEDIF CO.,LTD	HYDROGEN PEROXIDE; SILICON DIOXIDE	2.35; 7.7	g/110g; g/110g			N	20241231
72346-120_4b01d8d9-7429-4981-93d7-38ead4d82135	72346-120	HUMAN OTC DRUG	MEDIF WHITE TOOTH		Hydrated Silica, Aluminium Chlorohydrate, Allantoinate	PASTE, DENTIFRICE	ORAL	20201001		UNAPPROVED DRUG OTHER		MEDIF CO.,LTD	ALLANTOIN; ALUMINUM CHLOROHYDRATE; HYDRATED SILICA	.65; .65; 16.9	g/130g; g/130g; g/130g			N	20241231
72349-0001_a56d1db4-fd63-4b4c-9a9a-b134a5c2915b	72349-0001	HUMAN OTC DRUG	Benefit Plus Drops		Kidney (Suis), Abrotanum, Anacardium Orientale, Baryta Muriatica, Calcarea Carbonica, Calcarea Phosphorica, Glandula Suprarenalis Suis, Graphites, Helleborus Niger, Hepar Suis, Hypothalamus Suis, Ignatia Amara, Lycopodium Clavatum, Secale Cornutum, Silicea, Thymus (Suis), Thyroidinum (Suis)	LIQUID	ORAL	20180817		UNAPPROVED HOMEOPATHIC		Gulf Coast Wellness Center	ARTEMISIA ABROTANUM FLOWERING TOP; BARIUM CHLORIDE DIHYDRATE; CLAVICEPS PURPUREA SCLEROTIUM; GRAPHITE; HELLEBORUS NIGER ROOT; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK KIDNEY; PORK LIVER; SEMECARPUS ANACARDIUM JUICE; SILICON DIOXIDE; STRYCHNOS IGNATII SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA THYMUS; THYROID, PORCINE; TRIBASIC CALCIUM PHOSPHATE	8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
72356-101_59ac784b-80ea-4b7a-a007-563048e08fa0	72356-101	HUMAN PRESCRIPTION DRUG	AMZEEQ		Minocycline	AEROSOL, FOAM	TOPICAL	20200102	20240331	NDA	NDA212379	Journey Medical Corporation	MINOCYCLINE HYDROCHLORIDE	40	mg/g	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	
72356-103_4a338f8a-b749-4d69-b8aa-1b1b5ebb77b8	72356-103	HUMAN PRESCRIPTION DRUG	ZILXI		Minocycline	AEROSOL, FOAM	TOPICAL	20201001		NDA	NDA213690	Journey Medical Corporation	MINOCYCLINE HYDROCHLORIDE	15	mg/g	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72358-101_0bb43095-e397-3c27-e063-6294a90a4089	72358-101	HUMAN OTC DRUG	PR		Menthol	LOTION	TOPICAL	20181101		OTC MONOGRAPH DRUG	M017	Amphp, Inc	MENTHOL	.5	g/100g			N	20241231
72359-001_26f0ef6d-b23f-4069-b10a-0326b146032d	72359-001	HUMAN PRESCRIPTION DRUG	RETHYMIC		allogenic thymocyte-depleted thymus tissue-agdc	IMPLANT	INTRAMUSCULAR	20211008		BLA	BLA125685	Sumitomo Pharma America, Inc.	ALLOGENEIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC	22000	mm/1			N	20241231
72363-006_d9e2cfe3-a65e-2637-e053-2a95a90afc56	72363-006	HUMAN OTC DRUG	Germproof		Argentum Metallicum	GEL	TOPICAL	20220314	20250314	UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	1	g/28.5g			N	
72363-010_00c6fcd0-a1cb-f6a7-e063-6394a90afdd4	72363-010	HUMAN OTC DRUG	SilvaPlex Throat		Argentum Metalicum	SPRAY	TOPICAL	20230801		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.0003	g/236g			N	20241231
72363-011_00d7ae49-4024-16eb-e063-6294a90afc55	72363-011	HUMAN OTC DRUG	SilvaPlex Throat		Argentum Metalicum	SPRAY	TOPICAL	20230801		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.0006	g/473g			N	20241231
72363-012_05a53d3f-29b1-f08c-e063-6394a90ad6bc	72363-012	HUMAN OTC DRUG	SilvaPlex Wound Gel		Wound Gel	GEL	TOPICAL	20220324	20250324	UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	5.9	g/118g			N	
72363-013_05b69dba-6017-2a7d-e063-6294a90aecf1	72363-013	HUMAN OTC DRUG	PetSilver Wound Gel with Hemp Oil		Wound Gel	GEL	TOPICAL	20220328	20250328	UNAPPROVED HOMEOPATHIC		Ag Essence	SILVER	5.895	g/118g			N	
72363-014_05b6700a-af8e-eb81-e063-6394a90a5a3c	72363-014	HUMAN OTC DRUG	VA Harvest Silver Wound Gel for Pets		Silver Wound Gel	GEL	TOPICAL	20220329	20250329	UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	5.895	g/118g			N	
72363-015_0a483bdc-f8df-c2db-e063-6394a90ad373	72363-015	HUMAN OTC DRUG	SilvaPlex Wound		Argentum Metallicum	SPRAY	TOPICAL	20231206		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.047	g/236g			N	20241231
72363-016_0c66a2e5-e3b6-bc1b-e063-6294a90af1df	72363-016	HUMAN OTC DRUG	PetSilver Wound 2		Argentum Metalicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.00175	g/59g			N	20241231
72363-017_0c7940fa-0e55-90f3-e063-6394a90a344f	72363-017	HUMAN OTC DRUG	PetSilver Wound 4		Argentum Metallicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.0035	g/118g			N	20241231
72363-018_0c79d23d-ab12-a626-e063-6394a90afeb5	72363-018	HUMAN OTC DRUG	PetSilver Wound 8		Argentum Metallicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.007	g/237g			N	20241231
72363-019_0c7a29f4-ee1f-80c0-e063-6294a90aac9a	72363-019	HUMAN OTC DRUG	Petsilver Wound 12		Argentum Metallicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.0105	g/355g			N	20241231
72363-021_0c7ae60a-7f0b-45d0-e063-6394a90a9032	72363-021	HUMAN OTC DRUG	PetSilver Teeth and Gum		Argentum Metallicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.0035	g/118g			N	20241231
72363-023_0c7be4df-1169-8c01-e063-6394a90aa8f3	72363-023	HUMAN OTC DRUG	PetSilver Ear Wash 4		Argentum Metallicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.0035	g/118g			N	20241231
72363-024_0c7c4ca1-5b00-0b76-e063-6294a90af03d	72363-024	HUMAN OTC DRUG	PetSilver Ear Wash 8		Argentum Metallicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.007	g/237g			N	20241231
72363-025_0d058e8e-557a-030b-e063-6394a90a973e	72363-025	HUMAN OTC DRUG	PetSilver Wound 16		Argentum Metallicum	SPRAY	TOPICAL	20240101		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.014	g/473g			N	20241231
72363-027_0e234f11-403b-ea1f-e063-6394a90a9958	72363-027	HUMAN OTC DRUG	PetSilver Wound For Chickens and Birds		Argentum Metallicum	SPRAY	TOPICAL	20240104		UNAPPROVED HOMEOPATHIC		AG Essence	SILVER	.0105	g/355g			N	20251231
72379-544_c953c3a0-230f-4891-9a96-af36dbba20ca	72379-544	HUMAN OTC DRUG	Germ A Stat		CHLOROXYLENOL	SOAP	TOPICAL	20180621		OTC MONOGRAPH NOT FINAL	part333E	Warsaw Chemical Holdings, LLC	CHLOROXYLENOL	3	mg/mL			N	20241231
72379-876_d6790020-61e8-4af1-87da-32bd76fecd41	72379-876	HUMAN OTC DRUG	Mango Select High Foaming Antiseptic Hand and Body Wash 6876		CHLOROXYLENOL	SOAP	TOPICAL	20180618		OTC MONOGRAPH NOT FINAL	part333E	Warsaw Chemical Holding, LLC	CHLOROXYLENOL	3	mg/mL			N	20241231
72381-103_f461455c-16d3-70b6-e053-2a95a90abb8e	72381-103	HUMAN OTC DRUG	Eczema Therapy		Colloidal Oatmeal	CREAM	TOPICAL	20180611		OTC MONOGRAPH FINAL	part347	Hamilton Therapeutics, Inc.	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72384-751_3c391ac6-8faa-46ea-b4f0-5ca1b0dc68e5	72384-751	HUMAN PRESCRIPTION DRUG	Stendra		avanafil	TABLET	ORAL	20131227		NDA	NDA202276	Metuchen Pharmaceuticals, LLC	AVANAFIL	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72384-752_3c391ac6-8faa-46ea-b4f0-5ca1b0dc68e5	72384-752	HUMAN PRESCRIPTION DRUG	Stendra		avanafil	TABLET	ORAL	20131227		NDA	NDA202276	Metuchen Pharmaceuticals, LLC	AVANAFIL	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72384-753_3c391ac6-8faa-46ea-b4f0-5ca1b0dc68e5	72384-753	HUMAN PRESCRIPTION DRUG	Stendra		avanafil	TABLET	ORAL	20131227		NDA	NDA202276	Metuchen Pharmaceuticals, LLC	AVANAFIL	200	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72385-001_0c025ef1-0040-f5b6-e063-6294a90a087b	72385-001	HUMAN PRESCRIPTION DRUG	GENOSYL		nitric oxide	GAS	RESPIRATORY (INHALATION)	20191220		NDA	NDA202860	VERO BIOTECH, INC.	NITRIC OXIDE	.98	mg/L	Vasodilation [PE], Vasodilator [EPC]		N	20241231
72385-002_9eeb3c1b-e325-4708-babd-c6d366416572	72385-002	HUMAN PRESCRIPTION DRUG	GENOSYL		nitric oxide	GAS	RESPIRATORY (INHALATION)	20221228		NDA	NDA202860	VERO BIOTECH, INC.	NITRIC OXIDE	.98	mg/L	Vasodilation [PE], Vasodilator [EPC]		N	20241231
72393-203_dc7a6bfe-6fc7-e7a4-e053-2a95a90a8330	72393-203	HUMAN OTC DRUG	Workvie		Lidocaine HCL, Menthol	CREAM	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part348	Marketites LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72393-204_dc7a2254-dd03-d0a2-e053-2a95a90a65ea	72393-204	HUMAN OTC DRUG	Aromalief Lidocaine Roll On		Lidocaine HCL, Menthol	LOTION	TOPICAL	20220406		OTC MONOGRAPH NOT FINAL	part348	Marketites LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72393-301_f1e89565-9daf-5016-e053-2995a90a711d	72393-301	HUMAN OTC DRUG	Aromalief Pain Relief Cream Orange Ginger		Menthol	LOTION	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part348	Marketites LLC	MENTHOL	1	g/100g			N	20241231
72393-302_f1e8cb7c-d00b-126c-e053-2995a90a6f47	72393-302	HUMAN OTC DRUG	Aromalief Calming Pain Relief Cream Lavender		Menthol	LOTION	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part348	Marketites LLC	MENTHOL	1	g/100g			N	20241231
72393-306_f1e89a0e-d75a-968c-e053-2995a90abdd9	72393-306	HUMAN OTC DRUG	Aromalief Soothing Pain Relief Cream Spearmint		Menthol	LOTION	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	Marketites LLC	MENTHOL	1	g/100g			N	20241231
72407-404_0b533d30-fa79-a0b0-e063-6294a90a15df	72407-404	HUMAN OTC DRUG	PURLISSE AGELESS GLOW BB	SPF 40	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20221228		OTC MONOGRAPH DRUG	M020	Pur-Lisse Beauty, LLC	TITANIUM DIOXIDE; ZINC OXIDE	9.95; 7	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72407-406_0b5339c2-6cf2-9f97-e063-6294a90a961c	72407-406	HUMAN OTC DRUG	PURLISSE YOUTH GLOW CC	SPF 50	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20221228		OTC MONOGRAPH DRUG	M020	Pur-Lisse Beauty, LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 7	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72407-407_0b5333cf-e50a-970d-e063-6294a90af7b5	72407-407	HUMAN OTC DRUG	PURLISSE RADIANT GLOW ILLUMINATING BB	SPF 30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20221228		OTC MONOGRAPH DRUG	M020	Pur-Lisse Beauty, LLC	TITANIUM DIOXIDE; ZINC OXIDE	5.4; 3.5	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72407-408_0b533927-c4af-9975-e063-6294a90a836c	72407-408	HUMAN OTC DRUG	PURLISSE PERFECT GLOW BB	SPF 30	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200606		OTC MONOGRAPH DRUG	M020	Pur-Lisse Beauty, LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.4; 7	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72414-000_ecb3c837-e762-5651-e053-2995a90a6093	72414-000	HUMAN OTC DRUG	Radiance Superbe Day Cream Translucent		Ensulizole, Octocrylene, Titanium dioxide, Zinc Oxide	CREAM	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part352	Haute Custom Beauty	ENSULIZOLE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4; 6; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
72414-002_ecb3c837-e762-5651-e053-2995a90a6093	72414-002	HUMAN OTC DRUG	Radiance Superbe Day Cream Neutral Light		Ensulizole, Octocrylene, Titanium dioxide, Zinc Oxide	CREAM	TOPICAL	20211228		OTC MONOGRAPH NOT FINAL	part352	Haute Custom Beauty	ENSULIZOLE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4; 6; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
72414-003_ecb3c837-e762-5651-e053-2995a90a6093	72414-003	HUMAN OTC DRUG	Radiance Superbe Day Cream Neutral Medium		Ensulizole, Octocrylene, Titanium dioxide, Zinc Oxide	CREAM	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part352	Haute Custom Beauty	ENSULIZOLE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4; 6; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
72414-004_ecb3c837-e762-5651-e053-2995a90a6093	72414-004	HUMAN OTC DRUG	Radiance Superbe Day Cream Neutral Caramel		Ensulizole, Octocrylene, Titanium dioxide, Zinc Oxide	CREAM	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part352	Haute Custom Beauty	ENSULIZOLE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4; 6; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
72414-005_ecb3c837-e762-5651-e053-2995a90a6093	72414-005	HUMAN OTC DRUG	Radiance Superbe Day Cream Neutral Tan		Ensulizole, Octocrylene, Titanium dioxide, Zinc Oxide	CREAM	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part352	Haute Custom Beauty	ENSULIZOLE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4; 6; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
72414-006_ecb3c837-e762-5651-e053-2995a90a6093	72414-006	HUMAN OTC DRUG	Radiance Superbe Day Cream Neutral Bronze		Ensulizole, Octocrylene, Titanium dioxide, Zinc Oxide	CREAM	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part352	Haute Custom Beauty	ENSULIZOLE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4; 6; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
72414-007_03339124-dd00-328e-e063-6394a90a68dc	72414-007	HUMAN OTC DRUG	NECK DECOLLETE HAND ARM DAY REPARATIVE HYDRATION RESCUE AND REPROGRAM BROAD SPECTRUM SPF 35 SUNSCREEN		Neck and Decollete Day	CREAM	TOPICAL	20230818		OTC MONOGRAPH NOT FINAL	part352	Haute Custom Beauty	ENSULIZOLE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	4; 6; 2.4; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
72425-201_70ef2040-bdc5-462e-9c6e-19c67b9d3617	72425-201	HUMAN OTC DRUG	Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20191202		OTC MONOGRAPH DRUG	M017	SanaMax Plus LLC	MENTHOL	1.25	g/100g			N	20241231
72425-210_fb6dca14-0a5e-420e-a402-8cba9b7eb17f	72425-210	HUMAN OTC DRUG	SanaMax Menthol Pain Relief Cream	CBD	MENTHOL	CREAM	TOPICAL	20220531		OTC MONOGRAPH DRUG	M017	SanaMax Plus LLC	MENTHOL	4	g/100mL			N	20241231
72426-118_77158886-4ee6-4972-b622-4b471e179172	72426-118	HUMAN PRESCRIPTION DRUG	Nexletol		Bempedoic Acid	TABLET, FILM COATED	ORAL	20200306		NDA	NDA211616	Esperion Therapeutics, Inc.	BEMPEDOIC ACID	180	mg/1	Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC], Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]		N	20241231
72426-818_eec27ac3-c444-4088-9fc0-d75e24913695	72426-818	HUMAN PRESCRIPTION DRUG	Nexlizet		Bempedoic Acid and Ezetimibe	TABLET, FILM COATED	ORAL	20200309		NDA	NDA211617	Esperion Therapeutics, Inc.	BEMPEDOIC ACID; EZETIMIBE	180; 10	mg/1; mg/1	Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC], Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA], Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
72427-3116_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3116	HUMAN OTC DRUG	Lolleez Variety Pack Box		Pectin	LOZENGE	ORAL	20220317		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-3121_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3121	HUMAN OTC DRUG	Lolleez Variety Pack 21		Pectin	LOZENGE	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-3195_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3195	HUMAN OTC DRUG	Lolleez Variety Pack		Pectin	LOZENGE	ORAL	20181008		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-3295_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3295	HUMAN OTC DRUG	Lolleez Watermelon		Pectin	LOZENGE	ORAL	20181008		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-3395_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3395	HUMAN OTC DRUG	Lolleez Strawberry		Pectin	LOZENGE	ORAL	20181008		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-3495_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3495	HUMAN OTC DRUG	Lolleez Orange Mango		Pectin	LOZENGE	ORAL	20181008		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-3515_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3515	HUMAN OTC DRUG	Lolleez Mixed Berry		Pectin	LOZENGE	ORAL	20190807		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-3610_052c7231-24db-44c8-e063-6394a90ae1a9	72427-3610	HUMAN OTC DRUG	Lolleez Mixed Berry Box		Pectin	LOZENGE	ORAL	20210106		OTC MONOGRAPH NOT FINAL	part356	BFY LLC	PECTIN	11.5	mg/7g			N	20241231
72427-6010_052c7231-24db-44c8-e063-6394a90ae1a9	72427-6010	HUMAN OTC DRUG	Tumeez Variety Pack		Calcium Carbonate	LOZENGE	ORAL	20190621		OTC MONOGRAPH FINAL	part331	BFY LLC	CALCIUM CARBONATE	200	mg/7g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
72427-6020_052c7231-24db-44c8-e063-6394a90ae1a9	72427-6020	HUMAN OTC DRUG	Tumeez Variety Pack Box		Calcium Carbonate	LOZENGE	ORAL	20220317		OTC MONOGRAPH FINAL	part331	BFY LLC	CALCIUM CARBONATE	200	mg/7g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
72429-0001_47cf4a8a-d9ad-456e-9080-f8925a226a52	72429-0001	HUMAN OTC DRUG	Ear Pain MD		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20220124		OTC MONOGRAPH DRUG	M017	Eosera, Inc	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
72429-0002_47cf4a8a-d9ad-456e-9080-f8925a226a52	72429-0002	HUMAN OTC DRUG	Ear Pain MD for Kids		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20220124		OTC MONOGRAPH DRUG	M017	Eosera, Inc	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
72430-003_f41e145c-8962-2782-e053-2995a90a5f81	72430-003	HUMAN OTC DRUG	MUCILIN	SF	Psyllium (Ispaghula) husk	POWDER	ORAL	20200115		OTC MONOGRAPH NOT FINAL	part334	Paradigm Pharmaceuticals Inc	PSYLLIUM HUSK	3.5	g/5g			N	20241231
72430-004_f41e145c-896f-2782-e053-2995a90a5f81	72430-004	HUMAN OTC DRUG	MUCILIN		Psyllium (Ispaghula) husk	POWDER	ORAL	20200115		OTC MONOGRAPH NOT FINAL	part334	Paradigm Pharmaceuticals Inc	PSYLLIUM HUSK	2.45	g/5g			N	20241231
72446-002_f3960301-56aa-4ecf-e053-2a95a90a3060	72446-002	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20180831		OTC MONOGRAPH FINAL	part358F	Hudson Health LLC	SALICYLIC ACID	40	mg/181			N	20241231
72446-003_003c36c3-c2dc-01f2-e063-6294a90a0bc5	72446-003	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20180831		OTC MONOGRAPH FINAL	part358F	Hudson Health LLC	SALICYLIC ACID	40	mg/41			N	20241231
72446-004_f395e7b9-4c49-5590-e053-2995a90aa57c	72446-004	HUMAN OTC DRUG	Undecylenic Acid		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20180901		OTC MONOGRAPH FINAL	part333C	Hudson Health LLC	UNDECYLENIC ACID	7.5	g/30g			N	20241231
72446-005_f3960301-5698-4ecf-e053-2a95a90a3060	72446-005	HUMAN OTC DRUG	Salicylic Acid		Medicated Corn Removers	PATCH	TOPICAL	20180901		OTC MONOGRAPH NOT FINAL	part333A	Hudson Health LLC	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.2; .75	mg/9mL; mg/9mL			N	20241231
72446-006_f3960301-56a8-4ecf-e053-2a95a90a3060	72446-006	HUMAN OTC DRUG	Salicylic Acid		Liquid Wart Remover	LIQUID	TOPICAL	20180901		OTC MONOGRAPH FINAL	part358F	Hudson Health LLC	SALICYLIC ACID	.17	mg/9mL			N	20241231
72446-007_f39609e6-ddb2-bbea-e053-2995a90a437e	72446-007	HUMAN OTC DRUG	Miconazole Nitrate		Anti-fungal Powder Miconazole Nitrate Talc Free	POWDER	TOPICAL	20180901		OTC MONOGRAPH FINAL	part333C	Hudson Health LLC	MICONAZOLE NITRATE	1.42	g/71g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72446-008_0a24908f-0fd8-ee04-e063-6394a90a26a4	72446-008	HUMAN OTC DRUG	Maximum Strength Wart Remover Strips		One Step Wart Remover	PLASTER	TOPICAL	20180901	20240131	OTC MONOGRAPH DRUG	M028	Hudson Health LLC	SALICYLIC ACID	40	mg/141			N	
72446-009_f3960488-5c6d-3f13-e053-2995a90a9ebf	72446-009	HUMAN OTC DRUG	Salicylic Acid		Medicated Plantar Wart Remover	PATCH	TOPICAL	20180901		OTC MONOGRAPH FINAL	part358B	Hudson Health LLC	SALICYLIC ACID	40	mg/241			N	20241231
72446-010_f3960030-0352-230b-e053-2995a90a764e	72446-010	HUMAN OTC DRUG	Salicylic Acid		Corn and Callus Remover Kit	LIQUID	TOPICAL	20180901		OTC MONOGRAPH FINAL	part358F	Hudson Health LLC	SALICYLIC ACID	.17	mg/9.8mL			N	20241231
72446-011_f3960edb-bf46-68f8-e053-2a95a90a2c4f	72446-011	HUMAN OTC DRUG	Tolnaftate		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20210521		OTC MONOGRAPH FINAL	part333C	Hudson Health LLC	TOLNAFTATE	.3	g/30mL			N	20241231
72449-100_09874a42-627a-b23c-e063-6394a90a889f	72449-100	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200630		OTC MONOGRAPH DRUG	505G(a)(3)	LS PROMOTIONS INC.	ALCOHOL	.62	mL/mL			N	20241231
72449-100_b6083405-9b47-4d2c-e053-2995a90ad9ef	72449-100	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200323		OTC MONOGRAPH NOT FINAL	part333E	LS Promotions Inc.	ALCOHOL	.62	mL/mL			N	20241231
72449-102_a5111ff2-163f-a210-e053-2a95a90ae11b	72449-102	HUMAN OTC DRUG	Hand Sanitizer Gel		Hand Sanitizer Gel	GEL	TOPICAL	20200507		OTC MONOGRAPH NOT FINAL	part333E	LS Promotions Inc.	ALCOHOL	70	mL/100mL			N	20241231
72449-200_c4bbc742-9fb2-14e3-e053-2995a90ac478	72449-200	HUMAN OTC DRUG	Lip Balm		Lip Balm	LIPSTICK	TOPICAL	20210614		OTC MONOGRAPH FINAL	part352	LS Promotions Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.09; .28; .21; .06	g/4.25g; g/4.25g; g/4.25g; g/4.25g			N	20241231
72454-0030_19fe0534-f5f0-4610-8b2a-79b5ca2e332e	72454-0030	HUMAN OTC DRUG	Skinnies SPF30 Sungel		Sunscreen	GEL	TOPICAL	20180718		OTC MONOGRAPH DRUG	M020	Skinnies USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 30; 100	g/1000g; g/1000g; g/1000g; g/1000g			N	20241231
72455-001_5d6e19ca-3038-4b69-8aa7-e4e03fe8da98	72455-001	HUMAN OTC DRUG	All Natural Eye Patch		Menthol	PATCH	TOPICAL	20180724		OTC MONOGRAPH DRUG	M017	Tianjin Oculax Biotech Inc	MENTHOL	2.5	mg/100mg			N	20241231
72457-003_0761fa74-8bfd-54e2-e063-6294a90a6b12	72457-003	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20181101		NDA	NDA212314	UCG Georgia, LLC	OXYGEN	990	mL/L			N	20241231
72457-005_07620560-f134-8a16-e063-6294a90aacea	72457-005	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20181101		NDA	NDA212315	UCG Georgia, LLC	NITROGEN	995	mL/L			N	20241231
72459-010_0c868857-d5a3-9413-e063-6294a90a0bab	72459-010	HUMAN OTC DRUG	OP First Aid Series Alcohol Prep Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20201103		OTC MONOGRAPH DRUG	M003	Yiwu Ori-Power Medtech Co., Ltd.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
72459-011_0c86a86e-1d29-8fa8-e063-6294a90a5963	72459-011	HUMAN OTC DRUG	OP First Aid Series Antiseptic Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201103		OTC MONOGRAPH DRUG	505G(a)(3)	Yiwu Ori-Power Medtech Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
72459-012_0c86d49a-27b6-7f18-e063-6394a90ad534	72459-012	HUMAN OTC DRUG	OP First Aid Series Povidone Iodine Prep Pad		POVIDONE-IODINE	CLOTH	TOPICAL	20201103		OTC MONOGRAPH DRUG	505G(a)(3)	Yiwu Ori-Power Medtech Co.,Ltd.	POVIDONE-IODINE	100	mg/mL			N	20241231
72459-013_0c86980d-ee8f-96f8-e063-6294a90a42a6	72459-013	HUMAN OTC DRUG	OP First Aid Series Insect Sting Relief Pad		BENZOCAINE, ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20201103		OTC MONOGRAPH DRUG	M017	Yiwu Ori-Power Medtech Co.,Ltd.	BENZOCAINE; ISOPROPYL ALCOHOL	60; .6	mg/mL; mL/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72459-101_03f3c281-542c-6fca-e063-6394a90abec5	72459-101	HUMAN OTC DRUG	Burn		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part348	Yiwu Ori-Power Medtech Co., Ltd.	LIDOCAINE HYDROCHLORIDE	20	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72459-102_03f3cc7a-e356-ef78-e063-6294a90a806b	72459-102	HUMAN OTC DRUG	OP Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230828		OTC MONOGRAPH FINAL	part333B	Yiwu Ori-Power Medtech Co., Ltd.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72465-600_097478f1-9b6a-b749-e063-6394a90a9977	72465-600	HUMAN OTC DRUG	INSTA RELIEF DM		LIDOCAINE HYDROCHLORIDE, MENTHOL	CREAM	TOPICAL	20180705		OTC MONOGRAPH DRUG	M017	DM LAB CORP	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72475-001_0eafaedb-7531-65bd-e063-6294a90a1f95	72475-001	HUMAN OTC DRUG	Cardon		Avobenzone, Homosalate, Octyl Salicylate	LOTION	TOPICAL	20180809		OTC MONOGRAPH DRUG	M020	Cardon, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE	2.5; 7; 4.3	g/100mL; g/100mL; g/100mL			N	20251231
72476-001_693dd5a7-bca5-49f0-9455-7b8e8f99c565	72476-001	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	RETAIL BUSINESS SERVICES, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-002_47bcae1a-5ef4-4fa0-8099-26c0dfd35f74	72476-002	HUMAN OTC DRUG	citroma		Magnesium Citrate	LIQUID	ORAL	20180218		OTC MONOGRAPH NOT FINAL	part334	Retail Business Services, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-004_edc2ab65-237e-7bcf-e053-2a95a90a5ebc	72476-004	HUMAN OTC DRUG	Careone Amber		Benzalkonium Chloride	SOAP	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333E	Retail Business Services, LLC	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
72476-005_13753836-1022-428b-9bfd-b979f180951b	72476-005	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	MOUTHWASH	ORAL	20050912		OTC MONOGRAPH FINAL	part355	RETAIL BUSINESS SERVICES , LLC	SODIUM FLUORIDE	1	mg/mL			N	20241231
72476-011_997f1656-4636-91d1-e053-2a95a90adbdf	72476-011	HUMAN OTC DRUG	CareOne Itchy Relief Eye Drops 15mL		Tetrahydrozoline HCI, Zinc sulfate	LIQUID	OPHTHALMIC	20191029		OTC MONOGRAPH FINAL	part349	Retail Business Services, LLC.	TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	.05; .25	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72476-012_0d37dad1-219b-7c25-e063-6394a90a7eb7	72476-012	HUMAN OTC DRUG	CareOne Maximum Redness Relief Eye Drops		Glycerin, Naphazoline HCI	SOLUTION/ DROPS	OPHTHALMIC	20200112		OTC MONOGRAPH DRUG	M018	Retail Business Services, LLC	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.5; .03	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72476-015_29f8acdc-9eaf-4180-8d9f-55d3f4b267cd	72476-015	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20150407		OTC MONOGRAPH FINAL	part344	retail Business Services, LLC	ISOPROPYL ALCOHOL	613	mg/mL			N	20241231
72476-017_1f5cf5ce-364c-40cd-ba45-6a8c4835c3a2	72476-017	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	20100811		OTC MONOGRAPH NOT FINAL	part334	RETAIL BUSINESS SERVICES, LLC.	CASTOR OIL	1	g/mL			N	20241231
72476-019_cdc0a023-65a0-4ec8-a4bb-44a0043c5f5e	72476-019	HUMAN OTC DRUG	Careone Extra Strength Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20211013		OTC MONOGRAPH FINAL	part332	Retail Business Services, LLC.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
72476-020_e52c97e2-3e06-47ec-8b69-9efbbf55ff3a	72476-020	HUMAN OTC DRUG	careone acid reducer		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20211214		ANDA	ANDA202319	Retail Business Services, LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72476-022_0d0aa687-9c61-4437-9bc8-85988736a510	72476-022	HUMAN OTC DRUG	Careone Regular Strength Calcium Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20211012		OTC MONOGRAPH FINAL	part331	Retail Business Services, LLC.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
72476-024_5f1de15d-0244-4f6c-a72e-7a369e4cae51	72476-024	HUMAN OTC DRUG	Oral Sore Antiseptic		Hydrogen Peroxide, Menthol	LIQUID	ORAL	20230113		OTC MONOGRAPH NOT FINAL	part356	RETAIL BUSINESS SERVICES , LLC	HYDROGEN PEROXIDE; MENTHOL	15; 1	mg/mL; mg/mL			N	20241231
72476-025_ee15211c-489f-2dd7-e053-2995a90a888c	72476-025	HUMAN OTC DRUG	Careone Medicated Dandruff		Selenium Sulfide	SHAMPOO	TOPICAL	20210826		OTC MONOGRAPH FINAL	part358H	Retail Business Services, LLC	SELENIUM SULFIDE	10	mg/mL			N	20241231
72476-026_cb6e12cc-4b88-4046-a9fc-2dbe4bca965e	72476-026	HUMAN OTC DRUG	Careone Regular Strength calcium Antacid		Calcium carbonate	TABLET, CHEWABLE	ORAL	20211013		OTC MONOGRAPH FINAL	part331	Retail Business Services, LLC.	CALCIUM CARBONATE	500	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
72476-034_18a7dde5-7c8b-4f92-9f3d-98ce3693e488	72476-034	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	LIQUID	ORAL	20190630	20250630	OTC MONOGRAPH FINAL	part341	Care One (Retail Business Services, LLC.)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
72476-038_0d37dad1-219c-7c25-e063-6394a90a7eb7	72476-038	HUMAN OTC DRUG	CareOne Artificial Tears Eye Drops 15mL		Polyvinyl alcohol, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20191029		OTC MONOGRAPH DRUG	M018	Retail Business Services, LLC	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
72476-041_62a9fff5-5485-4890-b854-450a9a1d4ee0	72476-041	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	DOCUSATE SODIUM	100	mg/1			N	20241231
72476-044_0e728618-bca7-52b2-e063-6394a90a0830	72476-044	HUMAN OTC DRUG	Medicated Apricot Scrub		Salicylic acid	GEL	TOPICAL	20101214		OTC MONOGRAPH DRUG	M006	Retail Business Services, LLC	SALICYLIC ACID	19.8	mg/g			N	20251231
72476-050_e890438a-0686-4a5a-90bc-3b10d3055456	72476-050	HUMAN OTC DRUG	First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20180509		OTC MONOGRAPH NOT FINAL	part333E	RETAIL BUSINESS SERVICES, LLC	POVIDONE-IODINE	10	mg/mL			N	20241231
72476-063_a8d1f2df-9706-4bd5-9915-a05f42372b81	72476-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	20130206		OTC MONOGRAPH FINAL	part347	Retail Business Services, LLC	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/mL; mg/mL			N	20241231
72476-064_e3d08c78-89a2-4185-8e6f-07fbdc018254	72476-064	HUMAN OTC DRUG	Allergy Relief		Cetirizine HCl	CAPSULE	ORAL	20180430		ANDA	ANDA213105	Care One (Retail Business Services, LLC.)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-102_af106cce-5feb-4fd9-e053-2a95a90aa378	72476-102	HUMAN OTC DRUG	STAY AWAKE		CAFFEINE	TABLET	ORAL	20200801		OTC MONOGRAPH FINAL	part340	RETAIL BUSINESS SERVICES , LLC.	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
72476-104_092d4d23-3773-2281-e063-6294a90aa7e9	72476-104	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, COATED	ORAL	20230120		OTC MONOGRAPH DRUG	M013	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN	500	mg/1			N	20241231
72476-107_67296594-89ca-4145-8976-c1f123fb58c8	72476-107	HUMAN OTC DRUG	Stool Softener Laxative		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20230430		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	DOCUSATE SODIUM	100	mg/1			N	20241231
72476-109_bccade3a-2047-f668-e053-2995a90a5c32	72476-109	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200201		ANDA	ANDA079174	RETAIL BUSINESS SERVICES , LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-110_af106c99-05b3-21b9-e053-2995a90ab96c	72476-110	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200201		ANDA	ANDA079174	RETAIL BUSINESS SERVICES , LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-111_af106c99-059e-21b9-e053-2995a90ab96c	72476-111	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20200201		ANDA	ANDA202312	RETAIL BUSINESS SERVICES , LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-112_af105d01-a14b-3c0a-e053-2995a90afae2	72476-112	HUMAN OTC DRUG	IBUPROFEN		Ibuprofen	TABLET, COATED	ORAL	20200201		ANDA	ANDA202312	RETAIL BUSINESS SERVICES , LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-113_af105d01-a139-3c0a-e053-2995a90afae2	72476-113	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE	ORAL	20200801		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-117_e3a5c30a-9f7b-49de-83be-f6d37c9090d4	72476-117	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalat, Octocrylene	LOTION	TOPICAL	20211130		OTC MONOGRAPH FINAL	part352	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 1000	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-119_bccb82a5-f591-400e-e053-2995a90ae57b	72476-119	HUMAN OTC DRUG	SINUS SEVRE		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-120_092d5783-2759-5ae8-e063-6394a90ac1c0	72476-120	HUMAN OTC DRUG	Sinus Pressure plus Pain PE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230120		OTC MONOGRAPH DRUG	M012	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-123_efb78d7b-f205-985b-e053-2995a90aac52	72476-123	HUMAN OTC DRUG	SINUS AND HEADACHE		ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-128_cf22b0e0-1ffd-1af2-e053-2a95a90ad084	72476-128	HUMAN OTC DRUG	Allergy MultiSymptom		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20201021		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-131_0c6a3ec0-14c2-c01a-e063-6294a90a76a2	72476-131	HUMAN OTC DRUG	Acetaminophen and Ibuprofen (NSAID)		Acetaminophen and Ibuprofen (NSAID)	TABLET	ORAL	20230720		ANDA	ANDA216592	RETAIL BUSINESS SERVICES,LLC	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-150_cd37bbc7-d990-410d-8367-8aa4187ef6b0	72476-150	HUMAN OTC DRUG	careone acid relief		famotidine	TABLET, FILM COATED	ORAL	20220603		ANDA	ANDA077351	Retail Business Services, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72476-153_c34f69a3-cbff-4895-a857-21d25986b7a5	72476-153	HUMAN OTC DRUG	Everyday Clean Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH DRUG	M032	Retail Business Services, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72476-163_bccb4af5-8d42-5b8f-e053-2995a90a44dd	72476-163	HUMAN OTC DRUG	Cold and Flu Severe		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC. (	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-167_c6f2b5c1-d67f-c884-e053-2a95a90ae0b6	72476-167	HUMAN OTC DRUG	Severe Congestion and Pain		ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20191001		OTC MONOGRAPH FINAL	part341	Retail Business Services , LLC.	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-174_ebddd617-3e06-18a5-e053-2995a90a3d16	72476-174	HUMAN OTC DRUG	HEAD CONGESTION PLUS FLU SEVERE PE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221025		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 100; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-185_0c6a0cf2-dead-d5ac-e063-6394a90a3b3f	72476-185	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200819		ANDA	ANDA211544	RETAIL BUSINESS SERVICES,LLC.	ACETAMINOPHEN	650	mg/1			N	20241231
72476-186_0c6a3840-ca79-ec15-e063-6394a90a4ffb	72476-186	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20190819		ANDA	ANDA211544	RETAIL BUSINESS SERVICES,LLC.	ACETAMINOPHEN	650	mg/1			N	20241231
72476-192_cf22d677-c125-1721-e053-2a95a90a1c3e	72476-192	HUMAN OTC DRUG	ALLERGY RELIEF		Fexofenadine Hydrochloride	TABLET	ORAL	20210714		ANDA	ANDA211075	RETAIL BUSINESS SERVICES , LLC.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-194_c6f31728-fdb8-f78d-e053-2a95a90a253e	72476-194	HUMAN OTC DRUG	ALLERGY RELIEF		Cetirizine hydrochloride	TABLET, COATED	ORAL	20200701		ANDA	ANDA209274	RETAIL BUSINESS SERVICES , LLC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-197_efb78d7b-f206-985b-e053-2995a90aac52	72476-197	HUMAN OTC DRUG	COLD FLU AND SORE THROAT		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-198_efb78e1c-469a-5afe-e053-2a95a90a23ce	72476-198	HUMAN OTC DRUG	COLD AND FLU ALL IN ONE		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20200801		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-204_0c7de326-a1ea-43d7-86ee-60c252f6d0b4	72476-204	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20100310		OTC MONOGRAPH FINAL	part355	Retail Business Services, LLC	SODIUM FLUORIDE	.5	mg/mL			N	20241231
72476-205_cb69256f-a9e0-1172-e053-2a95a90ab58d	72476-205	HUMAN OTC DRUG	Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20210906		OTC MONOGRAPH NOT FINAL	part343	RETAIL BUSINESS SERVICES , LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72476-210_af5de8ac-c8fe-4d6b-9d32-24fc7c54249c	72476-210	HUMAN OTC DRUG	Care One Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20190920		UNAPPROVED DRUG OTHER		Retail Business Services , LLC.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
72476-212_000692be-22ea-4a3f-8eb7-aaa35b10b939	72476-212	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20211007		ANDA	ANDA208077	Care One (Retail Business Services, LLC.)	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-213_c8d473cc-ea7c-4a12-b760-a23a94755499	72476-213	HUMAN OTC DRUG	Anticavity Fluoride Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20100524		OTC MONOGRAPH FINAL	part355	Retail Business Services, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72476-218_c167042e-1896-4c33-93b6-9c1375880455	72476-218	HUMAN OTC DRUG	Clear Anti-Itch		Pramoxine HCl, Zinc acetate	LOTION	TOPICAL	20160322		OTC MONOGRAPH NOT FINAL	part347	Retail Business Services, LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72476-239_ebdddcec-f5c1-51fe-e053-2995a90a6167	72476-239	HUMAN OTC DRUG	Cold Max Nighttime		ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	TABLET, COATED	ORAL	20221025		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 10; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-247_c9cb2e28-442b-4ea4-ad15-4f252853ee73	72476-247	HUMAN OTC DRUG	Advanced Healing		Petrolatum	OINTMENT	TOPICAL	20221219		OTC MONOGRAPH FINAL	part347	Retail Business Services, LLC	PETROLATUM	410	mg/g			N	20241231
72476-248_bab341d1-7960-44bc-ac5f-1c4664f42a79	72476-248	HUMAN OTC DRUG	Chest Rub		Camphor, Eucalyptus Oil, Menthol	CREAM	TOPICAL	20090112		OTC MONOGRAPH FINAL	part341	Retail Business Services, LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	kg/100g; kg/100g; kg/100g			N	20241231
72476-252_cb697032-b3de-500b-e053-2995a90a6b2c	72476-252	HUMAN OTC DRUG	LOW DOSE ASPIRIN		ASPIRIN	TABLET, CHEWABLE	ORAL	20210906		OTC MONOGRAPH NOT FINAL	part343	RETAIL BUSINESS SERVICES , LLC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72476-253_87e76c0e-c15a-471d-a14e-45a8a71d08f2	72476-253	HUMAN OTC DRUG	Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20180501		OTC MONOGRAPH DRUG	M032	Retail Business Services, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72476-263_4114ae72-9b52-4567-b703-53ee8e69ee2b	72476-263	HUMAN OTC DRUG	Aspirin	Low Dose Safety Coated	Aspirin	TABLET, COATED	ORAL	20210917		OTC MONOGRAPH FINAL	part343	Care One (Retail Business Services, LLC.)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72476-281_e5d2cdfb-12bb-4638-9ca1-9162b0d94bba	72476-281	HUMAN OTC DRUG	Dry Scalp Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20231102		OTC MONOGRAPH DRUG	M032	RETAIL BUSINESS SERVICES , LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72476-295_b75951f7-bcaf-4662-bcd4-ce20273c6c18	72476-295	HUMAN OTC DRUG	Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20111006		OTC MONOGRAPH NOT FINAL	part348	Retail Business Services, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	kg/100L; kg/100L	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-296_77ec1919-78f3-4bda-bef2-6effcad0d914	72476-296	HUMAN OTC DRUG	Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20090605		OTC MONOGRAPH DRUG	M032	Retail Business Services, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72476-299_ec1b7ccf-0824-4bf2-b925-2f80ce455ca6	72476-299	HUMAN OTC DRUG	careone acid relief		famotidine	TABLET, FILM COATED	ORAL	20220603		ANDA	ANDA077351	Retail Business Services, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72476-311_c0baec0d-dbae-483b-952c-9947cd71c208	72476-311	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	19950215		OTC MONOGRAPH DRUG	M032	Retail Business Services, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72476-318_12d53d19-cb3b-43c3-9315-3e1fda1bdc1a	72476-318	HUMAN OTC DRUG	Antiseptic Mouth Rinse		Eucalyptol, Menthol, Methyl Salicylate, Thymol	MOUTHWASH	ORAL	19890313		OTC MONOGRAPH NOT FINAL	part356	Retail Business Services, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-358_0c695bcc-fbef-9abd-e063-6394a90ab388	72476-358	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200726		ANDA	ANDA202312	RETAIL BUSINESS SERVICES,LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-362_70885f58-18e6-46a2-93eb-2183b7d8e8cb	72476-362	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20230103		OTC MONOGRAPH DRUG	M032	Retail Business Services, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
72476-365_0c680cee-b66d-2d47-e063-6394a90a7934	72476-365	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200726		ANDA	ANDA079174	RETAIL BUSINESS SERVICES,LLC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-366_0c681d4f-33f8-3928-e063-6394a90a1924	72476-366	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200726		ANDA	ANDA079174	Retail Business Services, LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-370_42d3fa72-71dd-4e90-8ddf-57a2a6a36e67	72476-370	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20210104		OTC MONOGRAPH NOT FINAL	part333A	Retail Business Services, LLC	ALCOHOL	70	mL/100mL			N	20241231
72476-412_632d77de-9792-40f9-a523-815088ee987f	72476-412	HUMAN OTC DRUG	Maximum Strength Cold Sore Treatment		Maximum Strength Cold Sore Treatment	GEL	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part333E	Retail Business Services, LLC	CAMPHOR (SYNTHETIC); MENTHOL; PETROLATUM; PHENOL	30; 10; 892; 15	mg/g; mg/g; mg/g; mg/g			N	20241231
72476-425_5914d6b6-6c46-4897-b22c-a7800d86a385	72476-425	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20190630	20241231	OTC MONOGRAPH FINAL	part335	Care One (Retail Business Services, LLC.)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	
72476-434_2462692e-4a9f-4095-9c1a-aa6eb8b39aa6	72476-434	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130906		OTC MONOGRAPH NOT FINAL	part356	Retail Business Services, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-435_69e671a5-1136-44f7-acaf-79ccc718cb2e	72476-435	HUMAN OTC DRUG	Anticavity		Sodium fluoride	MOUTHWASH	ORAL	20150601		OTC MONOGRAPH FINAL	part355	RETAIL BUSINESS SERVICES, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72476-439_a38d015d-b11c-4c97-9c9d-76434d6b6462	72476-439	HUMAN OTC DRUG	Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20210104		OTC MONOGRAPH NOT FINAL	part333A	Retail Business Services	ALCOHOL	70	mL/100mL			N	20241231
72476-473_1b2066c5-4b44-4f88-9b32-6a4c9cae5c96	72476-473	HUMAN OTC DRUG	careone omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220603		NDA	NDA022032	Retail Business Services, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72476-482_4f7fd6d2-b98f-49cd-8b61-d99528b4e891	72476-482	HUMAN OTC DRUG	Alcohol-Free Anticavity		Sodium fluoride	LIQUID	ORAL	20130201		OTC MONOGRAPH FINAL	part355	Retail Business Services, LLC	SODIUM FLUORIDE	.1	mg/mL			N	20241231
72476-492_7647f893-702f-486f-92d4-5b7cccd2d714	72476-492	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20201127		ANDA	ANDA208754	Care One (Retail Business Services, LLC.)	DOCOSANOL	100	mg/g			N	20241231
72476-500_855f7fd6-0c28-4eea-8c9d-466d79782133	72476-500	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20171016		ANDA	ANDA209339	Retail Business Services, LLC.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72476-503_c8173d42-f900-4527-aa56-472d1177a9bc	72476-503	HUMAN OTC DRUG	Antacid Antigas		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20210526		OTC MONOGRAPH FINAL	part331	Retail Business Services, LLC.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-509_74823298-d24a-4ffe-8446-1661305372b2	72476-509	HUMAN OTC DRUG	Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20211021		OTC MONOGRAPH FINAL	part331	Retail Business Services, LLC.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	400; 40; 400	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-516_ce2edc57-e550-4aa9-bbfe-37933913c9eb	72476-516	HUMAN OTC DRUG	Antacid		aluminum hydroxide, magnesium hydroxide, simethicone	LIQUID	ORAL	20210527		OTC MONOGRAPH FINAL	part331	Retail Business Services, LLC.	ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDE	800; 80; 800	mg/10mL; mg/10mL; mg/10mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-558_36e5da08-b62b-47af-b13e-1394e6054c81	72476-558	HUMAN OTC DRUG	Tartar control plus		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20230113		OTC MONOGRAPH NOT FINAL	part356	RETAIL BUSINESS SERVICES , LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-592_a6ca22eb-9f06-4489-a4fa-b3ee495c6b15	72476-592	HUMAN OTC DRUG	Tartar Control Plus		eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20130906		OTC MONOGRAPH NOT FINAL	part356	Retail Business Services	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-602_d659ec7c-0393-4a54-9d6d-5902173bcca6	72476-602	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20150506		OTC MONOGRAPH NOT FINAL	part334	Retail Business Services, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-612_44c8de10-50bb-432e-9ce4-51d7e883d48b	72476-612	HUMAN OTC DRUG	2 in 1 Dandruff		Pyrithione zinc	SHAMPOO	TOPICAL	20161206		OTC MONOGRAPH DRUG	M032	Retail Business Services, LLC	PYRITHIONE ZINC	1	g/mL			N	20241231
72476-619_47bfdfe6-2f8b-4c65-ac6c-66a9d1c7543b	72476-619	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20120915		OTC MONOGRAPH FINAL	part347	Retail Business Services, LLC	DIMETHICONE	13	mg/mL	Skin Barrier Activity [PE]		N	20241231
72476-623_4f85d968-dae7-479c-869e-6e79021de97c	72476-623	HUMAN OTC DRUG	careone allergy relief		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20221012		ANDA	ANDA213105	Retail Business Services, LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-630_de77a4d7-c626-427b-9e08-433896e395d1	72476-630	HUMAN OTC DRUG	careone tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220713		OTC MONOGRAPH FINAL	part341	Retail Business Services, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72476-642_f8fd7ea6-6785-40a4-8de1-9320f48c79cb	72476-642	HUMAN OTC DRUG	Stomach Relief	Ultra	Bismuth subsalicylate	LIQUID	ORAL	20190630	20250131	OTC MONOGRAPH FINAL	part335	Care One (Retail Business Services, LLC.)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	
72476-661_13ffb00b-7c6f-47aa-bc82-2402d121a758	72476-661	HUMAN OTC DRUG	Careone Milk of magnesia Original	Milk of Magnesia Original	Magnesium hydroxide	LIQUID	ORAL	20220427		OTC MONOGRAPH NOT FINAL	part334	Retail Business Services, LLC.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-664_d7c622a9-ae3c-4de7-9ec1-9b0205a718fd	72476-664	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	19920915		OTC MONOGRAPH DRUG	505G(a)(3)	Retail Business Services, LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-665_b50ce99e-b532-46e8-8140-98844b48a6ea	72476-665	HUMAN OTC DRUG	CareOne Milk of Magnesia Cherry		Magnesium hydroxide	LIQUID	ORAL	20220422		OTC MONOGRAPH NOT FINAL	part334	Retail Business Services, LLC.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-724_82c1acea-58ce-4a82-b348-763256f41b9f	72476-724	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part335	Care One (Retail Business Services, LLC.)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
72476-733_049f3b20-a010-4763-bc51-ad23c78738db	72476-733	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20210723		ANDA	ANDA209692	Care One (Retail Business Services, LLC.)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72476-734_5615e45c-82f5-4b61-9f0d-6728e5f8d1df	72476-734	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20191129		ANDA	ANDA209692	Care One (Retail Business Services, LLC.)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72476-736_74cc6383-aa3a-497e-a8c0-756113c8393e	72476-736	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH DRUG	M008	Care One (Retail Business Services, LLC.)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
72476-737_6f8be061-2793-464f-a406-6fddff4aa263	72476-737	HUMAN OTC DRUG	Stomach Relief	Ultra Strength	Bismuth subsalicylate	LIQUID	ORAL	20191227		OTC MONOGRAPH FINAL	part335	Care One (Retail Business Services, LLC.)	BISMUTH SUBSALICYLATE	525	mg/15mL	Bismuth [CS], Bismuth [EPC]		N	20241231
72476-745_28bfbd83-e7ad-462d-9f38-1bf78343540b	72476-745	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20201127		ANDA	ANDA206568	Care One (Retail Business Services, LLC.)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-747_c490f5f8-1f7c-45af-b022-1d85010be8fd	72476-747	HUMAN OTC DRUG	Aloe Vera Gel		Lidocaine HCl, Menthol	GEL	TOPICAL	20211124		OTC MONOGRAPH NOT FINAL	part348	Retail Business Services, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	7; 2	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72476-748_b25f7998-cc7e-48ee-bf37-c666aca95a4e	72476-748	HUMAN OTC DRUG	Naproxen Sodium		Naproxen Sodium	CAPSULE, LIQUID FILLED	ORAL	20210430		ANDA	ANDA208363	Care One (Retail Business Services, LLC.)	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-764_0c69a53d-bf13-6d7e-e063-6294a90a534c	72476-764	HUMAN OTC DRUG	Cetirizine Hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20200421		ANDA	ANDA209274	RETAIL BUSINESS SERVICES,LLC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-804_ebc0366f-995b-43e2-9feb-3bde5765281e	72476-804	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20150308		OTC MONOGRAPH NOT FINAL	part333A	Retail Business Services, LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
72476-810_189a748a-4fb4-4076-8e12-0403752e1f6c	72476-810	HUMAN OTC DRUG	70%		Isopropyl alcohol	LIQUID	TOPICAL	20130430		OTC MONOGRAPH NOT FINAL	part333A	Retail Business Services, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
72476-816_35aa6609-9271-447a-b2bf-314d1e388163	72476-816	HUMAN OTC DRUG	Dandruff		Selenium sulfide	SHAMPOO	TOPICAL	20210818		OTC MONOGRAPH FINAL	part358H	Retail Business Services, LLC	SELENIUM SULFIDE	10	mg/mL			N	20241231
72476-838_0c801757-f335-cd4d-e063-6294a90a433b	72476-838	HUMAN OTC DRUG	CareOne Earwax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20200101		OTC MONOGRAPH DRUG	M014	Retail Business Services, LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
72476-843_86134c96-ce20-45b7-a418-c0096fc673f6	72476-843	HUMAN OTC DRUG	Ibuprofen minis		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20200630		ANDA	ANDA206568	Care One (Retail Business Services, LLC.)	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72476-847_4679cef1-6a61-4814-9013-b631d7ced002	72476-847	HUMAN OTC DRUG	careone allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20211226		ANDA	ANDA212971	Retail Business Services, LLC	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-848_135ab6ee-39b8-4b9b-92e0-29ea27f3ef0d	72476-848	HUMAN OTC DRUG	Multi-Symptom Cold and Flu	DayTime	Acetaminophen, Dextromethorphan HBr, Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part341	Care One (Retail Business Services, LLC.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-849_0b63075a-0402-4521-a7b9-e51bd508f902	72476-849	HUMAN OTC DRUG	Nighttime Cold and Flu Relief	Multi Symptom	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE	CAPSULE, LIQUID FILLED	ORAL	20190930	20240930	OTC MONOGRAPH FINAL	part341	Care One (Retail Business Services, LLC.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	
72476-850_2205b4e6-d4ef-4f41-9a6f-c646d351fa9c	72476-850	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	KIT		20190930		OTC MONOGRAPH FINAL	part341	Care One (Retail Business Services, LLC.)						N	20241231
72476-851_bca27f6a-d1b1-1d6a-e053-2995a90a37b5	72476-851	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20210402		ANDA	ANDA209995	Retail Business Services, LLC.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
72476-852_3de497ac-ef3e-4eb0-88e3-723394770274	72476-852	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20210506		ANDA	ANDA204812	Retail Business Services, LLC.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
72476-853_a91524b6-47bc-42ed-ac18-876c9516767c	72476-853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210326		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	DOCUSATE SODIUM	100	mg/1			N	20241231
72476-855_d17db7e6-991c-4484-a2b7-7ea1e93d0100	72476-855	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20200630		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
72476-860_bfd223e6-f9bd-4da8-8806-c7f96714e56d	72476-860	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	CAPSULE	ORAL	20191227		OTC MONOGRAPH FINAL	part338	Care One (Retail Business Services, LLC.)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-862_dede23a8-eccf-4742-b73a-33ac3a6efe58	72476-862	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE	ORAL	20200802		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	DOCUSATE SODIUM	100	mg/1			N	20241231
72476-867_9ab3490b-1b93-4914-b36b-ae17e941cbdb	72476-867	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20210528		OTC MONOGRAPH FINAL	part343	Care One (Retail Business Services, LLC.)	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72476-871_e16b275c-8fa1-465c-bbf9-9abc218362c0	72476-871	HUMAN OTC DRUG	Care One Chest Congestion Relief	DM	Dextromethorphan Hydrobromide / Guaifenesin	TABLET	ORAL	20210809		OTC MONOGRAPH FINAL	part341	RETAIL BUSINESS SERVICES , LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72476-875_f6d096f7-5838-4ed8-b53a-52d218ff6016	72476-875	HUMAN OTC DRUG	Senna Laxative		Sennosides	TABLET	ORAL	20211105		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	SENNOSIDES	8.6	mg/1			N	20241231
72476-877_518a65f6-deff-4020-8a4a-e57ac03157e9	72476-877	HUMAN OTC DRUG	Mineral Oil		Mineral Oil	LIQUID	ORAL; TOPICAL	20180709		OTC MONOGRAPH NOT FINAL	part334	Retail Business Services	MINERAL OIL	999	mg/mL			N	20241231
72476-878_e23db7b7-909e-4019-bb58-3a8aa5465cf0	72476-878	HUMAN OTC DRUG	Stool Softener	Plus Stimulant Laxative	docusate sodium and sennosides	TABLET	ORAL	20200630		OTC MONOGRAPH DRUG	M007	Care One (Retail Business Services, LLC.)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
72476-882_9bf27a2c-3123-4eab-b414-7bde5ed3718b	72476-882	HUMAN OTC DRUG	Senna Laxative		SENNOSIDES	TABLET	ORAL	20211105		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	SENNOSIDES	8.6	mg/1			N	20241231
72476-883_581f53b8-15dc-4a0b-ab44-6b59f786466d	72476-883	HUMAN OTC DRUG	Senna S Orange		Docusate Sodium Sennosides	TABLET	ORAL	20190930		OTC MONOGRAPH NOT FINAL	part334	Care One (Retail Business Services, LLC.)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
72476-897_11a4be4d-5ab8-459b-a9bd-f376ec43831f	72476-897	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20190930		OTC MONOGRAPH FINAL	part347	Care One (Retail Business Services, LLC.)	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
72476-898_9bcc9ed4-4a8b-490d-99ac-759c9227b754	72476-898	HUMAN OTC DRUG	Daytime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCL	CAPSULE, LIQUID FILLED	ORAL	20191129		OTC MONOGRAPH FINAL	part341	Care One (Retail Business Services, LLC.)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72476-901_a58840ce-0f08-4e59-a884-fb51b640a823	72476-901	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20190930		OTC MONOGRAPH FINAL	part341	Care One (Retail Business Services, LLC.)						N	20241231
72476-916_1f740cb0-af83-4e64-b504-1a4c7667319f	72476-916	HUMAN OTC DRUG	Nighttime Sleep Aid	Maximum Strength	Diphenhydramine HCl	CAPSULE	ORAL	20191227		OTC MONOGRAPH FINAL	part338	Care One (Retail Business Services, LLC.)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72476-922_ca6bd819-d850-4d5d-b213-c27f8f858749	72476-922	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20200630		ANDA	ANDA208754	Care One (Retail Business Services, LLC.)	DOCOSANOL	100	mg/g			N	20241231
72476-924_b4f5d09c-3a21-4256-a3c3-b7cd8b60ec19	72476-924	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211201		OTC MONOGRAPH FINAL	part352	RETAIL BUSINESS SERVICES , LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 1000; 202.5; 640	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-926_03d98704-58e8-4234-9a04-9e57d70337f2	72476-926	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201028		OTC MONOGRAPH FINAL	part352	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
72476-929_5a841a7e-78d4-42a5-906f-2bcd7caba1fe	72476-929	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210106		OTC MONOGRAPH FINAL	part352	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
72476-934_0d80da16-e09e-a4f6-e063-6294a90a5e18	72476-934	HUMAN OTC DRUG	Sheer Touch Sunscreen SPF 100		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	MM020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-935_0d81a340-7e72-12ad-e063-6294a90abbf8	72476-935	HUMAN OTC DRUG	Sheer Touch Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231107		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-938_cfb37cc9-6ad5-41bb-a699-d83f2073fe01	72476-938	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210118		OTC MONOGRAPH FINAL	part352	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
72476-939_0d8379f2-3692-3e64-e063-6294a90a8488	72476-939	HUMAN OTC DRUG	Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-940_0d85306d-351c-bbb2-e063-6394a90a4050	72476-940	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-941_0ccedf12-88aa-9a0e-e063-6294a90a3a5f	72476-941	HUMAN OTC DRUG	Sport Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231218		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
72476-942_01533fb7-6d5a-4e89-9575-182e7fd28920	72476-942	HUMAN OTC DRUG	Hydrogen Peroxide		HYDROGEN PEROXIDE	SOLUTION	TOPICAL	20111210		OTC MONOGRAPH NOT FINAL	part333A	Retail Bsiness Services, LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
72476-943_0ccf5ed7-0381-e3d5-e063-6294a90ad9db	72476-943	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231218		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
72476-946_0ce45244-49cb-d4ce-e063-6394a90aa0a1	72476-946	HUMAN OTC DRUG	Sport Sunscreen SPF 70		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231219		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
72476-947_0ce45244-49dc-d4ce-e063-6394a90aa0a1	72476-947	HUMAN OTC DRUG	Sunscreen for Babies SPF 50		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231219		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-948_a60df2ef-585c-40e1-8ed0-3ff3aceb6ca9	72476-948	HUMAN OTC DRUG	Broad Spectrum Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
72476-949_1c537330-3829-4c9e-9c04-8912f0226f6f	72476-949	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231002		OTC MONOGRAPH FINAL	part352	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
72476-950_32d487f7-3fdd-4f2d-b8ef-0fcb501f280c	72476-950	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate, Octocrylene		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20190908		OTC MONOGRAPH FINAL	part352	RETAIL BUSINESS SERVICES, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72476-951_eb3b822d-42f5-4243-a530-0fc521dad9e4	72476-951	HUMAN OTC DRUG	Sunscreen		Sunscreen	LOTION	TOPICAL	20230929		OTC MONOGRAPH FINAL	part352	RETAIL BUSINESS SERVICES , LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-954_0ce44ead-ebbe-85de-e063-6394a90a2968	72476-954	HUMAN OTC DRUG	Moisturizing Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231219		OTC MONOGRAPH DRUG	M020	Retail Business Service, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-955_0ce43eb7-e77c-3d6e-e063-6294a90acaab	72476-955	HUMAN OTC DRUG	Moisturizing Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20231219		OTC MONOGRAPH DRUG	M020	RETAIL BUSINESS SERVICES , LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
72476-956_0ce45244-49ec-d4ce-e063-6394a90aa0a1	72476-956	HUMAN OTC DRUG	Sport Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231109		OTC MONOGRAPH DRUG	M020	RETAIL BUSINESS SERVICES , LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
72476-959_653cd187-d195-490c-af9d-4765a1522a0d	72476-959	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210118		OTC MONOGRAPH FINAL	part352	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
72476-960_fab92744-47ce-24d2-e053-6394a90ab03b	72476-960	HUMAN OTC DRUG	Womens Gentle Laxative		Bisacodyl	TABLET, DELAYED RELEASE	ORAL	20220803		OTC MONOGRAPH NOT FINAL	part334	RETAIL BUSINESS SERVICES, LLC	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72476-961_dd568961-1ef8-4c14-8114-01789d80cf52	72476-961	HUMAN OTC DRUG	Sunscreen for Kids SPF 50		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231108		OTC MONOGRAPH DRUG	M020	Retail Business Services, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
72476-965_440a49b7-f2e3-4151-8871-b505f1caeadf	72476-965	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Care One (Retail Business Services, LLC.)	DOCOSANOL	100	mg/g			N	20241231
72476-971_6779331a-c2f3-4883-9a66-1e0baa3abd1b	72476-971	HUMAN OTC DRUG	Anticavity		Sodium Fluoride	RINSE	ORAL	20221208		OTC MONOGRAPH FINAL	part355	RETAIL BUSINESS SERVICES, LLC	SODIUM FLUORIDE	.2	mg/mL			N	20241231
72476-978_fbfb3ab0-8cc4-4a60-abe5-fc98d496b103	72476-978	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate,Otisalate, Octocrylene	SPRAY	TOPICAL	20230105		OTC MONOGRAPH FINAL	part352	RETAIL BUSINESS SERVICES , LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 10	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
72481-101_c3dd60dd-f281-2d25-e053-2a95a90a260c	72481-101	HUMAN OTC DRUG	LactiGo		MENTHOL	GEL	TOPICAL	20190321		OTC MONOGRAPH NOT FINAL	part348	LactiGo, Inc.	MENTHOL, UNSPECIFIED FORM	12.5	mg/mL			N	20241231
72482-100_8dbc8c92-e63c-43cf-8584-333d8b53ddde	72482-100	HUMAN PRESCRIPTION DRUG	Vonjo		Pacritinib	CAPSULE	ORAL	20220228		NDA	NDA208712	CTI BioPharma Corp.	PACRITINIB	100	mg/1			N	20241231
72484-095_fdb47a5e-80c9-8b0f-e053-6394a90a2668	72484-095	HUMAN OTC DRUG	Minoxidil	Extra Strength for Men	Minoxidil	SOLUTION	TOPICAL	20200508		ANDA	ANDA076239	Roman Health Ventures Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72484-097_0551cb89-1a84-b1cf-e063-6294a90abb73	72484-097	HUMAN OTC DRUG	Minoxidil	Extra Strength for Men	Minoxidil	SPRAY	TOPICAL	20240101		ANDA	ANDA076239	Roman Health Ventures Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72484-433_fdb451eb-12c2-b33c-e053-6394a90aac9b	72484-433	HUMAN OTC DRUG	Roman Swipes		Benzocaine	LIQUID	TOPICAL	20190110		OTC MONOGRAPH FINAL	part348	Roman Health Ventures Inc.	BENZOCAINE	4	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72485-101_d949ac61-1864-4cf8-9b51-738b29952cc2	72485-101	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190501		ANDA	ANDA205723	Armas Pharmaceuticals Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72485-104_2cd4c6d2-3786-4e00-abd0-0d62d2c18e0a	72485-104	HUMAN PRESCRIPTION DRUG	CAFFEINE CITRATE		Caffeine Citrate	INJECTION	INTRAVENOUS	20200101		ANDA	ANDA207400	Armas Pharmaceuticals Inc.	CAFFEINE CITRATE	60	mg/3mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
72485-105_e2df76e1-9850-4469-a3c0-43d2a8cfeba3	72485-105	HUMAN PRESCRIPTION DRUG	SODIUM NITROPRUSSIDE		SODIUM NITROPRUSSIDE	INJECTION	INTRAVENOUS	20200327		ANDA	ANDA209352	Armas Pharmaceuticals Inc.	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
72485-106_19255a4c-a8da-4e24-9633-16b9e3fc1f89	72485-106	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM		LEVETIRACETAM	INJECTION	INTRAVENOUS	20210114		ANDA	ANDA211954	Armas Pharmaceuticals Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72485-107_49a3cee3-011b-4a23-a732-b5ec1c02c590	72485-107	HUMAN PRESCRIPTION DRUG	TRANEXAMIC ACID		TRANEXAMIC ACID	INJECTION	INTRAVENOUS	20210611		ANDA	ANDA206713	Armas Pharmaceuticals Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
72485-108_065dae38-a47b-4d8c-b067-d45ebd1eee99	72485-108	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20200101		ANDA	ANDA211370	Armas Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	5	mg/2mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72485-109_e0530bba-ed48-45e7-ad3e-5d2b3f16a04f	72485-109	HUMAN PRESCRIPTION DRUG	Verapamil Hydrochloride		Verapamil Hydrochloride	INJECTION	INTRAVENOUS	20200101		ANDA	ANDA211370	Armas Pharmaceuticals Inc.	VERAPAMIL HYDROCHLORIDE	10	mg/4mL	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72485-110_492b9f6d-ad36-4fd7-a3d5-b6cb4a8f01cc	72485-110	HUMAN PRESCRIPTION DRUG	Caffeine Citrate Oral Solution		Caffeine Citrate	SOLUTION	ORAL	20200301		ANDA	ANDA213202	Armas Pharmaceuticals Inc.	CAFFEINE CITRATE	60	mg/3mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
72485-113_f62c3ef7-c8bd-4517-8ca9-b22829516dbf	72485-113	HUMAN PRESCRIPTION DRUG	Isoproterenol Hydrochloride		Isoproterenol Hydrochloride	INJECTION	INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210806		ANDA	ANDA210845	Armas Pharmaceuticals Inc.	ISOPROTERENOL HYDROCHLORIDE	.2	mg/mL	Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]		N	20241231
72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0	72485-114	HUMAN PRESCRIPTION DRUG	Lincomycin		Lincomycin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230505		ANDA	ANDA215082	Armas Pharmaceuticals Inc.	LINCOMYCIN HYDROCHLORIDE	600	mg/2mL			N	20241231
72485-115_2b18b782-a0a7-4072-b573-e66de82eae06	72485-115	HUMAN PRESCRIPTION DRUG	Lincomycin		Lincomycin	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230505		ANDA	ANDA215082	Armas Pharmaceuticals Inc.	LINCOMYCIN HYDROCHLORIDE	3000	mg/10mL			N	20241231
72485-201_e0429a55-e69e-4d8b-9498-46c52b696642	72485-201	HUMAN PRESCRIPTION DRUG	AZACITIDINE		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20180910		ANDA	ANDA207518	Armas Pharmaceuticals Inc.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72485-202_f3d17411-8424-4c6d-b244-47f125f17f31	72485-202	HUMAN PRESCRIPTION DRUG	Imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA208302	Armas Pharmaceuticals Inc.	IMATINIB MESYLATE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72485-203_2e636646-af84-4711-84b4-9092bb51ca8a	72485-203	HUMAN PRESCRIPTION DRUG	Imatinib mesylate	400 mg	imatinib mesylate	TABLET, FILM COATED	ORAL	20190315		ANDA	ANDA208302	Armas Pharmaceuticals Inc.	IMATINIB MESYLATE	400	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72485-204_680dac89-d210-4eb8-a955-bf40e652c546	72485-204	HUMAN PRESCRIPTION DRUG	Capecitabine 150mg		Capecitabine	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA207456	Armas Pharmaceuticals Inc.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72485-205_dad6f70f-70c9-4152-bd36-9cb3537239da	72485-205	HUMAN PRESCRIPTION DRUG	Capecitabine 500mg		Capecitabine	TABLET, FILM COATED	ORAL	20190301		ANDA	ANDA207456	Armas Pharmaceuticals Inc.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72485-210_ae29e15b-df07-403f-8d07-f99e3ce501e7	72485-210	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION, SOLUTION	INTRAVENOUS	20190601		ANDA	ANDA210931	Armas Pharmaceuticals Inc.	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72485-211_2c48b1cc-14b4-4de2-9cea-58a89cf32147	72485-211	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride	40 mg/2 mL	Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20190401		ANDA	ANDA208718	Armas Pharmaceuticals Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
72485-212_e1309129-c950-48ba-b8af-a952d5b3bed3	72485-212	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride	100 mg/5 mL	Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20190401		ANDA	ANDA208718	Armas Pharmaceuticals Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
72485-213_16bc41f7-c83f-473e-bf17-9e6328cecb4b	72485-213	HUMAN PRESCRIPTION DRUG	Irinotecan Hydrochloride		Irinotecan Hydrochloride	INJECTION	INTRAVENOUS	20200904		ANDA	ANDA208718	Armas Pharmaceuticals Inc.	IRINOTECAN HYDROCHLORIDE	20	mg/mL	Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]		N	20241231
72485-214_029d2385-81d6-4bca-9472-c884d3fd7e24	72485-214	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA210327	Armas Pharmaceuticals Inc.	DOCETAXEL	20	mg/mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
72485-215_8c30c9d6-97ac-42b0-a5dc-97f56e94c3bb	72485-215	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA210327	Armas Pharmaceuticals Inc.	DOCETAXEL	80	mg/4mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
72485-216_10308491-d534-4e9f-9fcc-8d8a3eda213d	72485-216	HUMAN PRESCRIPTION DRUG	Docetaxel		Docetaxel	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA210327	Armas Pharmaceuticals Inc.	DOCETAXEL	160	mg/8mL	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]		N	20241231
72485-217_35e3a161-752e-4479-b27c-3dc8efd3ca9e	72485-217	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib hydrochloride	TABLET, FILM COATED	ORAL	20191106		ANDA	ANDA211960	Armas Pharmaceuticals Inc.	ERLOTINIB HYDROCHLORIDE	25	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72485-218_bc4532f4-6a0a-4fd1-a630-8b524c02c7aa	72485-218	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib hydrochloride	TABLET, FILM COATED	ORAL	20191106		ANDA	ANDA211960	Armas Pharmaceuticals Inc.	ERLOTINIB HYDROCHLORIDE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72485-219_e7a350dc-b9b0-4650-9cb6-2948162a8e04	72485-219	HUMAN PRESCRIPTION DRUG	Erlotinib		Erlotinib hydrochloride	TABLET, FILM COATED	ORAL	20191106		ANDA	ANDA211960	Armas Pharmaceuticals Inc.	ERLOTINIB HYDROCHLORIDE	150	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72485-221_52a15e83-e33d-42e7-9270-636b5b59d63b	72485-221	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA210991	Armas Pharmaceuticals Inc.	GEMCITABINE HYDROCHLORIDE	200	mg/5.26mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72485-222_3f1b1931-04c8-45ba-afbb-4daf5e05a69f	72485-222	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA210991	Armas Pharmaceuticals Inc.	GEMCITABINE HYDROCHLORIDE	1	g/26.3mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72485-223_470dbc2b-c18a-403d-b815-3c6e296a7f41	72485-223	HUMAN PRESCRIPTION DRUG	Gemcitabine		GEMCITABINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20200115		ANDA	ANDA210991	Armas Pharmaceuticals Inc.	GEMCITABINE HYDROCHLORIDE	2	g/52.6mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72485-305_cd9bd8bb-ec7d-47dd-81e2-0cf2f134f828	72485-305	HUMAN PRESCRIPTION DRUG	SODIUM NITROPRUSSIDE		SODIUM NITROPRUSSIDE	INJECTION	INTRAVENOUS	20210915		ANDA	ANDA209352	Armas Pharmaceuticals Inc.	SODIUM NITROPRUSSIDE	50	mg/2mL	Vasodilation [PE], Vasodilator [EPC]		N	20241231
72485-403_0e17af82-18e4-8503-e063-6394a90a4e5a	72485-403	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20220414		ANDA	ANDA065458	Armas Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20251231
72485-404_0e184b84-e246-9f3a-e063-6394a90a9087	72485-404	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin and Tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; PARENTERAL	20220414		ANDA	ANDA065458	Armas Pharmaceuticals Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20251231
72485-405_090fe986-0ab2-c9a6-e063-6394a90ab171	72485-405	HUMAN PRESCRIPTION DRUG	NAFCILLIN SODIUM		NAFCILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231101		ANDA	ANDA200002	Armas Pharmaceuticals Inc.	NAFCILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72485-406_090fe986-0ab2-c9a6-e063-6394a90ab171	72485-406	HUMAN PRESCRIPTION DRUG	NAFCILLIN SODIUM		NAFCILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231101		ANDA	ANDA200002	Armas Pharmaceuticals Inc.	NAFCILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72485-409_0e186c32-67ad-af94-e063-6394a90a7203	72485-409	HUMAN PRESCRIPTION DRUG	Oxacillin		Oxacillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220921		ANDA	ANDA091486	Armas Pharmaceuticals Inc.	OXACILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
72485-411_0251fe30-65ad-120d-e063-6394a90a64c5	72485-411	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION	INTRAVENOUS	20230810		ANDA	ANDA216154	ARMAS PHARMACEUTICALS INC	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
72485-412_0251fe30-65ad-120d-e063-6394a90a64c5	72485-412	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION	INTRAVENOUS	20230531		ANDA	ANDA216154	ARMAS PHARMACEUTICALS INC	MEROPENEM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
72485-415_ffcd3d1d-7bc9-9047-e053-6294a90af9c0	72485-415	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230706		ANDA	ANDA216390	ARMAS PHARMACEUTICALS INC	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
72485-416_00ff2bd5-ac23-bdc0-e063-6394a90aaa54	72485-416	HUMAN PRESCRIPTION DRUG	Ampicillin Sodium and Sulbactam Sodium		ampicillin sodium, sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230721		ANDA	ANDA201024	Armas Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72485-417_00ff2bd5-ac23-bdc0-e063-6394a90aaa54	72485-417	HUMAN PRESCRIPTION DRUG	Ampicillin Sodium and Sulbactam Sodium		ampicillin sodium, sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230425		ANDA	ANDA201024	Armas Pharmaceuticals Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72485-421_09c7d2d2-6b69-53fd-e063-6294a90aefe7	72485-421	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231110		ANDA	ANDA201025	Armas Pharmaceuticals Inc.	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72485-422_09c7d2d2-6b69-53fd-e063-6294a90aefe7	72485-422	HUMAN PRESCRIPTION DRUG	Ampicillin sodium		Ampicillin Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230425		ANDA	ANDA201025	Armas Pharmaceuticals Inc.	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72485-501_fde1e354-4f15-4ade-9ae3-db2ba67e0431	72485-501	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20230405		ANDA	ANDA214380	Armas Pharmaceuticals Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
72485-502_fde1e354-4f15-4ade-9ae3-db2ba67e0431	72485-502	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20230405		ANDA	ANDA214380	Armas Pharmaceuticals Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
72485-503_fde1e354-4f15-4ade-9ae3-db2ba67e0431	72485-503	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20230405		ANDA	ANDA214380	Armas Pharmaceuticals Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
72485-504_16c02d53-fd3f-4fd7-abbe-f1358ea0891f	72485-504	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20230328		ANDA	ANDA213318	Armas Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72485-505_16c02d53-fd3f-4fd7-abbe-f1358ea0891f	72485-505	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20230328		ANDA	ANDA213318	Armas Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	50	mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72485-506_16c02d53-fd3f-4fd7-abbe-f1358ea0891f	72485-506	HUMAN PRESCRIPTION DRUG	PHENYLEPHRINE HYDROCHLORIDE		PHENYLEPHRINE HYDROCHLORIDE	INJECTION	INTRAVENOUS	20230328		ANDA	ANDA213318	Armas Pharmaceuticals Inc.	PHENYLEPHRINE HYDROCHLORIDE	100	mg/10mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72485-507_9ecbf165-bd2e-4bc1-a52c-1f40d1c2bbd9	72485-507	HUMAN PRESCRIPTION DRUG	Thiamine		Thiamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230522		ANDA	ANDA215692	Armas Pharmaceuticals Inc.	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
72485-508_75467058-da52-48fa-8d4e-e1025ec7d461	72485-508	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20231218		ANDA	ANDA215028	Armas Pharmaceuticals Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72485-509_75467058-da52-48fa-8d4e-e1025ec7d461	72485-509	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION, SOLUTION	INTRAVENOUS	20231218		ANDA	ANDA215028	Armas Pharmaceuticals Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72485-602_220e5038-9335-4480-959e-e1e393f9cc77	72485-602	HUMAN PRESCRIPTION DRUG	Timolol maleate		Timolol maleate	SOLUTION	OPHTHALMIC	20230508		ANDA	ANDA217195	Armas Pharmaceuticals, Inc.	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72485-613_086cc6db-b800-dc8f-e063-6294a90a4196	72485-613	HUMAN PRESCRIPTION DRUG	Ofloxacin		Ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20231014		ANDA	ANDA076407	ARMAS PHARMACEUTICALS INC.	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72485-617_cd02d900-5bfc-494b-a588-8f6098fe058e	72485-617	HUMAN OTC DRUG	Ketotifen Fumarate Ophthalmic Solution		Ketotifen Fumarate	SOLUTION/ DROPS	OPHTHALMIC	20231009		ANDA	ANDA077958	Armas Pharmaceuticals Inc.	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20251231
72485-625_0a5b0305-9f16-b6a0-e063-6294a90aef9a	72485-625	HUMAN PRESCRIPTION DRUG	Ciprofloxacin and dexamethasone		Ciprofloxacin and dexamethasone	SUSPENSION/ DROPS	AURICULAR (OTIC)	20231101		ANDA	ANDA215768	ARMAS PHARMACEUTICALS INC.	CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE	3; 1	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72485-630_0919fa30-ff66-f021-e063-6394a90ae4bb	72485-630	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		Loteprednol Etabonate	GEL	OPHTHALMIC	20231025		ANDA	ANDA212080	ARMAS PHARMACEUTICALS INC.	LOTEPREDNOL ETABONATE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72485-634_094755f0-b19a-62e3-e063-6294a90aa90f	72485-634	HUMAN PRESCRIPTION DRUG	Brimonidine Tartrate/Timolol Maleate		Brimonidine Tartrate and Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20231103		ANDA	ANDA201949	ARMAS PHARMACEUTICALS INC	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
72485-649_08a05c09-5f0e-dca3-e063-6294a90a1bc1	72485-649	HUMAN PRESCRIPTION DRUG	Bromfenac		Bromfenac	SOLUTION/ DROPS	OPHTHALMIC	20231026		ANDA	ANDA203395	ARMAS PHARMACEUTICALS INC.	BROMFENAC SODIUM	1.035	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72485-653_087cc5f6-3b6f-de90-e063-6294a90a8379	72485-653	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		Loteprednol Etabonate	SUSPENSION/ DROPS	OPHTHALMIC	20231024		ANDA	ANDA215933	ARMAS PHARMACEUTICALS INC.	LOTEPREDNOL ETABONATE	2	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72485-665_08a09440-b505-b2c9-e063-6394a90a0d76	72485-665	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		Loteprednol Etabonate	SUSPENSION/ DROPS	OPHTHALMIC	20231026		ANDA	ANDA207609	ARMAS PHARMACEUTICALS INC.	LOTEPREDNOL ETABONATE	5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72485-670_086299e1-e483-5e65-e063-6394a90a29fb	72485-670	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	20231018		ANDA	ANDA064030	ARMAS PHARMACEUTICALS INC.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
72490-010_091e4ba8-63d9-35c0-e063-6394a90a5b68	72490-010	HUMAN OTC DRUG	Nufabrx Foot/Ankle Sleeve		Capsaicin	CLOTH	TOPICAL	20200511		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.12	g/100g			N	20241231
72490-012_091e16e5-43f3-1d0e-e063-6394a90a5872	72490-012	HUMAN OTC DRUG	Nufabrx Knee Sleeve		Capsaicin	CLOTH	TOPICAL	20200511		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.15	g/100g			N	20241231
72490-013_091e2b1e-3b1d-2a08-e063-6294a90aab80	72490-013	HUMAN OTC DRUG	Nufabrx Arm Sleeve		Capsaicin	CLOTH	TOPICAL	20200522		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.2	g/100g			N	20241231
72490-014_091e228a-ab0e-1994-e063-6394a90a4d55	72490-014	HUMAN OTC DRUG	Nufabrx Hand/Wrist Sleeve		Capsaicin	CLOTH	TOPICAL	20200511		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.23	g/100g			N	20241231
72490-018_091df982-42d9-07f8-e063-6394a90ae8af	72490-018	HUMAN OTC DRUG	Nufabrx Lower Leg Sleeve		Capsaicin	CLOTH	TOPICAL	20210114		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.18	g/100g			N	20241231
72490-019_091e523d-4bcb-3949-e063-6394a90ac9c0	72490-019	HUMAN OTC DRUG	Nufabrx Calf Sleeve		Capsaicin	CLOTH	TOPICAL	20210315		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.16	g/100g			N	20241231
72490-021_09d004ba-518a-2a21-e063-6394a90acba5	72490-021	HUMAN OTC DRUG	Nufabrx Calf Sleeve		Capsaicin	CLOTH	TOPICAL	20210326		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.16	g/100g			N	20241231
72490-022_09d01443-6a7e-29ef-e063-6394a90a7927	72490-022	HUMAN OTC DRUG	Nufabrx Lower Leg Sleeve XS/S		Capsaicin	CLOTH	TOPICAL	20210326		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.19	g/100g			N	20241231
72490-023_09d01443-6a7e-29ef-e063-6394a90a7927	72490-023	HUMAN OTC DRUG	Nufabrx Lower Leg Sleeve M/L		Capsaicin	CLOTH	TOPICAL	20210326		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.19	g/100g			N	20241231
72490-024_09d01443-6a7e-29ef-e063-6394a90a7927	72490-024	HUMAN OTC DRUG	Nufabrx Lower Leg Sleeve XL/XXL		Capsaicin	CLOTH	TOPICAL	20210326		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.19	g/100g			N	20241231
72490-025_09d01cac-c585-6157-e063-6294a90aefee	72490-025	HUMAN OTC DRUG	Nufabrx Knee Sleeve		Capsaicin	CLOTH	TOPICAL	20210329		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.18	g/100g			N	20241231
72490-026_09d01cac-c585-6157-e063-6294a90aefee	72490-026	HUMAN OTC DRUG	Nufabrx Knee Sleeve		Capsaicin	CLOTH	TOPICAL	20210329		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.18	g/100g			N	20241231
72490-027_09d01cac-c585-6157-e063-6294a90aefee	72490-027	HUMAN OTC DRUG	Nufabrx Knee Sleeve		Capsaicin	CLOTH	TOPICAL	20210329		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.18	g/100g			N	20241231
72490-028_09d04007-8759-7e8a-e063-6294a90a7acb	72490-028	HUMAN OTC DRUG	Nufabrx Arm Sleeve		Capsaicin	CLOTH	TOPICAL	20210408		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.2	g/100g			N	20241231
72490-029_09d04007-8759-7e8a-e063-6294a90a7acb	72490-029	HUMAN OTC DRUG	Nufabrx Arm Sleeve		Capsaicin	CLOTH	TOPICAL	20210408		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.2	g/100g			N	20241231
72490-030_09d04007-8759-7e8a-e063-6294a90a7acb	72490-030	HUMAN OTC DRUG	Nufabrx Arm Sleeve		Capsaicin	CLOTH	TOPICAL	20210408		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.2	g/100g			N	20241231
72490-032_09cfad01-25a2-fa43-e063-6394a90ad5a1	72490-032	HUMAN OTC DRUG	Nufabrx Wrist Sleeve		Capsaicin	CLOTH	TOPICAL	20210325		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.23	g/100g			N	20241231
72490-033_09d025bd-f78f-5776-e063-6294a90afd3b	72490-033	HUMAN OTC DRUG	Nufabrx Ankle Sleeve		Capsaicin	CLOTH	TOPICAL	20210326		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.12	g/100g			N	20241231
72490-034_091dedb2-bc14-0146-e063-6394a90af46f	72490-034	HUMAN OTC DRUG	Nufabrx Neck Wrap		Capsaicin	CLOTH	TOPICAL	20220609		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.19	g/100g			N	20241231
72490-035_091e4354-ef4c-2d79-e063-6394a90a08ef	72490-035	HUMAN OTC DRUG	Nufabrx Back Wrap		Capsaicin	CLOTH	TOPICAL	20220729		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.14	g/100g			N	20241231
72490-036_01cbd8f0-e599-7416-e063-6294a90a8147	72490-036	HUMAN OTC DRUG	Nufabrx Medicine Infused Socks		Capsaicin	CLOTH	TOPICAL	20230719		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.11	g/100g			N	20241231
72490-037_09d03482-2cec-378c-e063-6394a90a9a62	72490-037	HUMAN OTC DRUG	Nufabrx Medicine Infused Socks		Capsaicin	CLOTH	TOPICAL	20230719		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.12	g/100g			N	20241231
72490-039_08f74fa2-ef7a-3a35-e063-6394a90a636c	72490-039	HUMAN OTC DRUG	Nufabrx Medicine Infused Ankle Sleeve		Capsaicin	CLOTH	TOPICAL	20230719		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.19	g/100g			N	20241231
72490-100_0a9ba161-8b41-bcc5-e063-6294a90ad347	72490-100	HUMAN OTC DRUG	Nufabrx Rx Clothing Pain Relief Socks		Capsaicin	CLOTH	TOPICAL	20231120		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.17	g/100g			N	20241231
72490-101_0b52cc7a-b17a-4546-e063-6294a90ae6aa	72490-101	HUMAN OTC DRUG	Nufabrx Rx Clothing Pain Relief Socks		Capsaicin	CLOTH	TOPICAL	20231129		OTC MONOGRAPH DRUG	M017	Nufabrx LLC	CAPSAICIN	.17	g/100g			N	20241231
72493-103_c7838eec-38c2-4b99-b590-d396658313b9	72493-103	HUMAN PRESCRIPTION DRUG	JELMYTO		mitomycin	KIT		20200501		NDA	NDA211728	UroGen Pharma, Inc.						N	20241231
72495-201_ec049f8b-0303-7d58-e053-2995a90a6c0c	72495-201	HUMAN PRESCRIPTION DRUG	Femring		estradiol acetate	RING	VAGINAL	20181210		NDA	NDA021367	Millicent US, Inc.	ESTRADIOL ACETATE	.05	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72495-202_ec049f8b-0303-7d58-e053-2995a90a6c0c	72495-202	HUMAN PRESCRIPTION DRUG	Femring		estradiol acetate	RING	VAGINAL	20181210		NDA	NDA021367	Millicent US, Inc.	ESTRADIOL ACETATE	.1	mg/d	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72495-401_f277c0eb-453c-8d7d-e053-2995a90a20df	72495-401	HUMAN PRESCRIPTION DRUG	Intrarosa		Prasterone	INSERT	VAGINAL	20201101		NDA	NDA208470	Millicent US, Inc.	PRASTERONE	6.5	mg/1			N	20241231
72495-501_f277c0eb-453c-8d7d-e053-2995a90a20df	72495-501	HUMAN PRESCRIPTION DRUG	Intrarosa		Prasterone	INSERT	VAGINAL	20201101		NDA	NDA208470	Millicent US, Inc.	PRASTERONE	6.5	mg/1			N	20241231
72496-1037_0c6bb744-7c7c-fb85-e063-6294a90a8b76	72496-1037	HUMAN OTC DRUG	ScalpProtectionSpray		Scalp Protection Spray	SPRAY	TOPICAL	20210201		OTC MONOGRAPH DRUG	M020	Naturich Labs	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.5; 6; 5; 7	g/100g; g/100g; g/100g; g/100g			N	20241231
72496-1111_f7e769a3-f2ec-1ed7-e053-6294a90a91c6	72496-1111	HUMAN OTC DRUG	NLI GBB Hand Sanitizer Fragrance		Hand Sanitizer	SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1114_f929eebf-6619-dd0a-e053-6294a90a38fd	72496-1114	HUMAN OTC DRUG	Germaphobe Black Tea Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1115_f929f942-2fa4-ea42-e053-6294a90a3658	72496-1115	HUMAN OTC DRUG	Germaphobe Crisp Pine Hand Sanitizer		Hand Sanitizer	SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1117_f92a0b82-32c8-085b-e053-6294a90af82c	72496-1117	HUMAN OTC DRUG	GC Hand Sanitizer Gel Lavender		Hand Sanitizer	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1119_fc4d4e13-1bf5-03c6-e053-6294a90a3399	72496-1119	HUMAN OTC DRUG	GC Hand Sanitizer Lavender		Hand Sanitizer spray	SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1120_f92a1121-e29f-d0d5-e053-6394a90add01	72496-1120	HUMAN OTC DRUG	GC Holiday Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1122_f92a12e0-1e80-0a74-e053-6294a90a8cc2	72496-1122	HUMAN OTC DRUG	GC Jeremiah Brent Hand Sanitizer		Hand sanitizer	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1124_f8778a48-48aa-3361-e053-6294a90a7a2d	72496-1124	HUMAN OTC DRUG	C Kids Hand Sanitizer Gel Wacky Watermelon		Hand Sanitizer	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich	ALCOHOL	62	mL/100mL			N	20241231
72496-1125_f92a12e0-1e84-0a74-e053-6294a90a8cc2	72496-1125	HUMAN OTC DRUG	GIR The Guardian Gel Sanitize		hand sanitizer	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1127_f92a12e0-1e86-0a74-e053-6294a90a8cc2	72496-1127	HUMAN OTC DRUG	Summer Fridays Hand sanitizer		Hand Sanitizer	SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs	ALCOHOL	65	mL/100mL			N	20241231
72496-1130_fc630aac-9895-e3c1-e053-6394a90af178	72496-1130	HUMAN OTC DRUG	HandSanitizerGelBloodOrange		GC-Hand Sanitizer Gel-Blood Orange	GEL	TOPICAL	20200121		OTC MONOGRAPH NOT FINAL	part333A	Naturich Labs, Inc	ALCOHOL	62	mL/100mL			N	20241231
72496-2469_0e7660ec-ac80-78f8-e063-6394a90ae05a	72496-2469	HUMAN OTC DRUG	SanitizerSpray		Hand Sanitizer Spray	LIQUID	TOPICAL	20200511		OTC MONOGRAPH DRUG	M003	Naturich Cosmetique Labs	ALCOHOL	65	mL/100mL			N	20251231
72496-2471_0e7691d1-1c3f-8021-e063-6394a90adec2	72496-2471	HUMAN OTC DRUG	GelSanitizerLav		Hand Sanitizer Gel - Lavender	LIQUID	TOPICAL	20200515		OTC MONOGRAPH DRUG	M003	Naturich Cosmetique Labs	ALCOHOL	65	mL/100mL			N	20251231
72511-400_224993ce-474c-470e-be8d-9e02cafa1924	72511-400	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230131		BLA	BLA761024	Amgen USA Inc.	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
72511-482_224993ce-474c-470e-be8d-9e02cafa1924	72511-482	HUMAN PRESCRIPTION DRUG	AMJEVITA		adalimumab-atto	INJECTION	SUBCUTANEOUS	20230814		BLA	BLA761024	Amgen USA Inc.	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
72511-750_6a32f6c9-7e54-467d-99c6-e5b396375d37	72511-750	HUMAN PRESCRIPTION DRUG	REPATHA		Evolocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20181009		BLA	BLA125522	Amgen USA Inc.	EVOLOCUMAB	140	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
72511-760_6a32f6c9-7e54-467d-99c6-e5b396375d37	72511-760	HUMAN PRESCRIPTION DRUG	REPATHA		Evolocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20181009		BLA	BLA125522	Amgen USA Inc.	EVOLOCUMAB	140	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
72511-770_6a32f6c9-7e54-467d-99c6-e5b396375d37	72511-770	HUMAN PRESCRIPTION DRUG	REPATHA		Evolocumab	KIT		20181009		BLA	BLA125522	Amgen USA Inc.						N	20241231
72512-928_5ac32254-fa18-42ba-a5bd-c34a58dabb84	72512-928	HUMAN PRESCRIPTION DRUG	Qutenza		capsaicin	KIT		20181030		NDA	NDA022395	Averitas Pharma Inc						N	20241231
72512-929_5ac32254-fa18-42ba-a5bd-c34a58dabb84	72512-929	HUMAN PRESCRIPTION DRUG	Qutenza		capsaicin	KIT		20181030		NDA	NDA022395	Averitas Pharma Inc						N	20241231
72512-930_5ac32254-fa18-42ba-a5bd-c34a58dabb84	72512-930	HUMAN PRESCRIPTION DRUG	Qutenza		capsaicin	KIT		20210325		NDA	NDA022395	Averitas Pharma Inc						N	20241231
72513-000_0cf46158-a125-f7af-e063-6294a90af36a	72513-000	HUMAN OTC DRUG	Microsure Hand Sanitizer		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20200720		OTC MONOGRAPH DRUG	M016	Strategia Project Management, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
72513-100_0cf497fd-d12f-dbe9-e063-6394a90a8d71	72513-100	HUMAN OTC DRUG	Microsure Wound Care		Benzalkonium Chloride.	LIQUID	TOPICAL	20180828		OTC MONOGRAPH DRUG	M003	Strategia Project Management, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72513-200_0cf46e3d-9b2b-c091-e063-6394a90aa8ad	72513-200	HUMAN OTC DRUG	8HD Hand and Skin Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201216		OTC MONOGRAPH DRUG	M016	Strategia Project Management, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72513-300_0cf4318f-67f3-ce24-e063-6294a90a6080	72513-300	HUMAN OTC DRUG	Microsure Hand and Skin Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201221		OTC MONOGRAPH DRUG	M016	Strategia Project Management, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
72516-011_b2089df4-ef8a-40ff-e053-2995a90a03e0	72516-011	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019		ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5; 7.5; 7.5; 7.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72516-012_b2089df4-ef8a-40ff-e053-2995a90a03e0	72516-012	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019		ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5; 5; 5; 5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72516-013_b2089df4-ef8a-40ff-e053-2995a90a03e0	72516-013	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019		ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75; 3.75; 3.75; 3.75	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72516-014_b2089df4-ef8a-40ff-e053-2995a90a03e0	72516-014	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019		ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5; 2.5; 2.5; 2.5	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72516-015_b2089df4-ef8a-40ff-e053-2995a90a03e0	72516-015	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019		ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875; 1.875; 1.875; 1.875	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72516-016_b2089df4-ef8a-40ff-e053-2995a90a03e0	72516-016	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate		Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019		ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25; 1.25; 1.25; 1.25	mg/1; mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]	CII	N	20241231
72516-024_e6894d2b-727f-4cef-a0ba-ab408584fee9	72516-024	HUMAN PRESCRIPTION DRUG	Papaverine Hydrochloride		Papaverine Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20210201		UNAPPROVED DRUG OTHER		Oryza Pharmaceuticals Inc.	PAPAVERINE HYDROCHLORIDE	30	mg/mL			N	20241231
72516-030_f988875d-c328-42c4-87ca-ef31688bf55e	72516-030	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	Oryza Pharmaceuticals, Inc	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72516-031_f988875d-c328-42c4-87ca-ef31688bf55e	72516-031	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	Oryza Pharmaceuticals, Inc	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72516-032_f988875d-c328-42c4-87ca-ef31688bf55e	72516-032	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	Oryza Pharmaceuticals, Inc	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72516-033_f988875d-c328-42c4-87ca-ef31688bf55e	72516-033	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	Oryza Pharmaceuticals, Inc	METOPROLOL TARTRATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72518-001_0d95c359-2432-781f-e063-6294a90a7a1a	72518-001	HUMAN OTC DRUG	TriClara		Benzalkonium Chloride	LIQUID	TOPICAL	20190514		OTC MONOGRAPH DRUG	505G(a)(3)	Nightingale Pharmaceuticals, Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
72520-001_493339b8-694f-4736-829b-b0ea025890e3	72520-001	HUMAN OTC DRUG	NuValu Epsom Salt		Magnesium sulfate (heptahydrate)	GRANULE	ORAL	20181130		OTC MONOGRAPH NOT FINAL	part334	J C SALES	MAGNESIUM SULFATE HEPTAHYDRATE	100	g/100g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72520-002_b31e5327-6f2b-4e35-8015-c41b2cb4691b	72520-002	HUMAN OTC DRUG	NuValu Epsom Salt		Magnesium sulfate (heptahydrate)	GRANULE	ORAL	20181130		OTC MONOGRAPH NOT FINAL	part334	J C SALES	MAGNESIUM SULFATE HEPTAHYDRATE	100	g/100g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72520-101_7aafbe30-6a1c-fdc8-e053-2991aa0aaae2	72520-101	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ALOE VERA		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-102_7b13f708-2a5a-320b-e053-2a91aa0ac88c	72520-102	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ORIGINAL		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-103_7b28058c-da5b-a98c-e053-2a91aa0ad0cd	72520-103	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ORIGINAL		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-104_7b2acfed-39d3-6d72-e053-2991aa0abebc	72520-104	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ORIGINAL 8OZ		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-105_7b39c6c1-5d76-6e47-e053-2991aa0a39fe	72520-105	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER LAVENDER 8OZ		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-106_7b3c742e-dcb1-bf71-e053-2991aa0a2b55	72520-106	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ALOE VERA 8OZ		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-107_7ac43799-9020-4dca-e053-2a91aa0a31a6	72520-107	HUMAN OTC DRUG	NUVALU 100 PURE PETROLEUM		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	JC SALES	PETROLATUM	100	g/100g			N	20241231
72520-108_7b3ca7df-588d-1d69-e053-2a91aa0aa259	72520-108	HUMAN OTC DRUG	NUVALU PETROLEUM BABY FRESH SCENT		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	JC SALES	PETROLATUM	99.9	g/100g			N	20241231
72520-109_7b3d6dc2-e31b-619d-e053-2a91aa0a4d1d	72520-109	HUMAN OTC DRUG	NUVALU PETROLEUM BABY FRESH SCENT		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	JC SALES	PETROLATUM	99.9	g/100g			N	20241231
72520-110_7b3d6dc2-e321-619d-e053-2a91aa0a4d1d	72520-110	HUMAN OTC DRUG	NUVALU PETROLEUM COCOA BUTTER		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	JC SALES	PETROLATUM	99.9	g/100g			N	20241231
72520-111_7b3d5da1-f909-186c-e053-2991aa0a6b91	72520-111	HUMAN OTC DRUG	NUVALU VAPORIZING CHEST RUB		camphor, eucalyptus oil, menthol	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part348	JC SALES	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
72520-112_7b4dcca8-dc9a-0bc5-e053-2991aa0a7582	72520-112	HUMAN OTC DRUG	NUVALU ICE THERAPY MENTHOL PAIN RELIEVING		menthol	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part348	JC SALES	MENTHOL	1	g/100g			N	20241231
72520-116_bd4f5868-07f2-4fb5-e053-2995a90a41d9	72520-116	HUMAN OTC DRUG	NUVALU HAND SANITIZER SWEET PEA PINK 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-117_bd4f7b5e-1a8d-46c3-e053-2995a90a2767	72520-117	HUMAN OTC DRUG	NUVALU HAND SANITIZER SWEET PEA BLUE 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-118_bd4ed746-f760-890a-e053-2a95a90a128c	72520-118	HUMAN OTC DRUG	NUVALU HAND SANITIZER GUAVA BURST 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-119_bd8fbc31-b916-8c0f-e053-2995a90a3a7e	72520-119	HUMAN OTC DRUG	NUVALU HAND SANITIZER VIOLET MIST 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-120_bd9051b5-8159-4132-e053-2995a90a0089	72520-120	HUMAN OTC DRUG	NUVALU HAND SANITIZER ALOHA PINA COLADA 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	JC SALES	ALCOHOL	70	mL/100mL			N	20241231
72520-121_0b58fdc4-201a-6467-e063-6294a90abd33	72520-121	HUMAN OTC DRUG	NUVALU CREAMY PETROLEUM		PETROLATUM	JELLY	TOPICAL	20231101		OTC MONOGRAPH DRUG	M016	JC SALES	PETROLATUM	30	g/100g			N	20241231
72521-001_f2258c7d-4acd-2570-e053-2995a90a76f2	72521-001	HUMAN OTC DRUG	STOP SPOT		SALICYLIC ACID	GEL	TOPICAL	20210701		OTC MONOGRAPH FINAL	part333D	Clearly Pte Ltd	SALICYLIC ACID	2	g/100mL			N	20241231
72522-103_08b4af19-3977-477f-e063-6294a90a5a4a	72522-103	HUMAN OTC DRUG	Capsiva		Capsicum Annuum, Arnica Montana	GEL	TOPICAL	20220506		UNAPPROVED HOMEOPATHIC		ANESIS LIFE, LLC	ARNICA MONTANA; CAPSICUM	1; 1	[hp_X]/84g; [hp_X]/84g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
72522-104_08b4af19-3927-477f-e063-6294a90a5a4a	72522-104	HUMAN OTC DRUG	Capsiva		Capsicum Annuum, Arnica Montana	GEL	TOPICAL	20220506		UNAPPROVED HOMEOPATHIC		ANESIS LIFE, LLC	ARNICA MONTANA; CAPSICUM	1; 1	[hp_X]/88.7mL; [hp_X]/88.7mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
72524-005_04da142e-9763-3fb9-e063-6294a90a8596	72524-005	HUMAN OTC DRUG	AY BENDITO - THERMOACTIVE		Camphor, Menthol	LOTION	TOPICAL	20190318		OTC MONOGRAPH NOT FINAL	part348	AY BENDITO - THERMOACTIVE LOTION	CAMPHOR (NATURAL); MENTHOL	6; 4	g/100g; g/100g			N	20241231
72524-009_04b1d0b2-0b28-72c9-e063-6294a90a0c26	72524-009	HUMAN OTC DRUG	AY BENDITO - CBD		CAMPHOR, MENTHOL	GEL	TOPICAL	20230908		OTC MONOGRAPH NOT FINAL	part348	AY BENDITO INTERNATIONAL, INC	CAMPHOR (SYNTHETIC); MENTHOL	6; 4	g/100g; g/100g			N	20241231
72524-010_01552450-6740-4299-e063-6394a90af610	72524-010	HUMAN OTC DRUG	AY BENDITO - THERMOACTIVE		Camphor, Menthol	LOTION	TOPICAL	20180917		OTC MONOGRAPH NOT FINAL	part348	AY BENDITO INT'L THERMO ANALGETICS ROLL-ON	CAMPHOR (NATURAL); MENTHOL	6; 4	g/100g; g/100g			N	20241231
72524-604_01555a8f-63f3-68e9-e063-6394a90aa2c3	72524-604	HUMAN OTC DRUG	AY BENDITO - THERMOACTIVE		CAMPHOR, MENTHOL	GEL	TOPICAL	20210122		OTC MONOGRAPH NOT FINAL	part348	AY BENDITO INTERNATIONAL, INC	CAMPHOR (NATURAL); MENTHOL, (+)-	6; 4	g/100g; g/100g			N	20241231
72524-640_0162c891-ba32-a78f-e063-6394a90a156c	72524-640	HUMAN OTC DRUG	AY BENDITO - PAIN RELIEF		CAMPHOR, MENTHOL	CREAM	TOPICAL	20210122		OTC MONOGRAPH NOT FINAL	part348	AY BENDITO INTERNATIONAL, INC	CAMPHOR (NATURAL); MENTHOL, (+)-	6; 4	g/100g; g/100g			N	20241231
72524-641_016365e2-65b0-6df9-e063-6394a90a9d57	72524-641	HUMAN OTC DRUG	AY BENDITO - THERMOACTIVE		CAMPHOR, MENTHOL	CREAM	TOPICAL	20210122		OTC MONOGRAPH NOT FINAL	part348	AY BENDITO INTERNATIONAL, INC	CAMPHOR (NATURAL); MENTHOL, (+)-	6; 4	g/100g; g/100g			N	20241231
72526-101_f6cce071-0f16-4975-bb8c-a910b8046622	72526-101	HUMAN PRESCRIPTION DRUG	Rykindo	extended-release microspheres	Risperidone	KIT		20230620		NDA	NDA212849	Shandong Luye Pharmaceutical Co., Ltd.						N	20241231
72526-102_f6cce071-0f16-4975-bb8c-a910b8046622	72526-102	HUMAN PRESCRIPTION DRUG	Rykindo	extended-release microspheres	Risperidone	KIT		20230620		NDA	NDA212849	Shandong Luye Pharmaceutical Co., Ltd.						N	20241231
72526-103_f6cce071-0f16-4975-bb8c-a910b8046622	72526-103	HUMAN PRESCRIPTION DRUG	Rykindo	extended-release microspheres	Risperidone	KIT		20230620		NDA	NDA212849	Shandong Luye Pharmaceutical Co., Ltd.						N	20241231
72526-104_f6cce071-0f16-4975-bb8c-a910b8046622	72526-104	HUMAN PRESCRIPTION DRUG	Rykindo	extended-release microspheres	Risperidone	KIT		20230620		NDA	NDA212849	Shandong Luye Pharmaceutical Co., Ltd.						N	20241231
72528-141_e714abd6-846a-c43a-e053-2995a90a6956	72528-141	HUMAN OTC DRUG	Skin Cleanser		Chloroxylenol	SOAP	TOPICAL	20220825		OTC MONOGRAPH NOT FINAL	part333A	West Coast Paper Company	CHLOROXYLENOL	3.75	mg/mL			N	20241231
72536-0920_ef08cfcf-460d-4dc8-ad6d-e806a167a5f8	72536-0920	HUMAN PRESCRIPTION DRUG	Indium In 111 Oxyquinoline		Indium In-111 Oxyquinoline	LIQUID	INTRAVENOUS	20190927		ANDA	ANDA202586	BWXT Medical Ltd.	INDIUM IN-111 OXYQUINOLINE	1	mCi/mL			N	20241231
72542-200_36d8d106-be31-41c1-b280-5cecb69b6cfc	72542-200	HUMAN PRESCRIPTION DRUG	OLPRUVA		sodium phenylbutyrate	KIT	ORAL	20221222		NDA	NDA214860	Acer Therapeutics Inc.						N	20241231
72542-300_36d8d106-be31-41c1-b280-5cecb69b6cfc	72542-300	HUMAN PRESCRIPTION DRUG	OLPRUVA		sodium phenylbutyrate	KIT	ORAL	20221222		NDA	NDA214860	Acer Therapeutics Inc.						N	20241231
72542-400_36d8d106-be31-41c1-b280-5cecb69b6cfc	72542-400	HUMAN PRESCRIPTION DRUG	OLPRUVA		sodium phenylbutyrate	KIT	ORAL	20221222		NDA	NDA214860	Acer Therapeutics Inc.						N	20241231
72542-500_36d8d106-be31-41c1-b280-5cecb69b6cfc	72542-500	HUMAN PRESCRIPTION DRUG	OLPRUVA		sodium phenylbutyrate	KIT	ORAL	20221222		NDA	NDA214860	Acer Therapeutics Inc.						N	20241231
72542-600_36d8d106-be31-41c1-b280-5cecb69b6cfc	72542-600	HUMAN PRESCRIPTION DRUG	OLPRUVA		sodium phenylbutyrate	KIT	ORAL	20221222		NDA	NDA214860	Acer Therapeutics Inc.						N	20241231
72542-667_36d8d106-be31-41c1-b280-5cecb69b6cfc	72542-667	HUMAN PRESCRIPTION DRUG	OLPRUVA		sodium phenylbutyrate	KIT	ORAL	20221222		NDA	NDA214860	Acer Therapeutics Inc.						N	20241231
72559-001_e4a9e3a2-d7bc-31cb-e053-2995a90ab996	72559-001	HUMAN OTC DRUG	Curist Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20190605		ANDA	ANDA209215	Little Pharma, Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
72559-002_731157e5-7c83-4893-93da-ddf292c77245	72559-002	HUMAN OTC DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20170517		ANDA	ANDA208150	Little Pharma, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72559-003_f53920db-bcca-678a-e053-2a95a90a59d0	72559-003	HUMAN OTC DRUG	Curist Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20190626		ANDA	ANDA209274	Little Pharma, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72559-008_e4aa014b-f3f4-18ad-e053-2a95a90a13b7	72559-008	HUMAN OTC DRUG	Curist Pain Relief		Acetaminophen	TABLET	ORAL	20200407		OTC MONOGRAPH NOT FINAL	part343	Little Pharma, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
72559-010_e4a9ed33-1893-6101-e053-2a95a90ad383	72559-010	HUMAN OTC DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20201219		ANDA	ANDA210593	Little Pharma, Inc.	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72559-011_e4a9ed33-18a7-6101-e053-2a95a90ad383	72559-011	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20210323		ANDA	ANDA212866	LITTLE PHARMA, INC.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72559-012_e4a9e3a2-d7e2-31cb-e053-2995a90ab996	72559-012	HUMAN OTC DRUG	Curist Lidocaine Numbing Relief		Lidocaine	CREAM	TOPICAL	20210414		OTC MONOGRAPH FINAL	part346	Little Pharma, Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72559-013_feabf140-e287-dcd5-e053-6394a90a2917	72559-013	HUMAN OTC DRUG	Curist Mucus Relief	Maximum Strength	Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210723		ANDA	ANDA213420	Little Pharma, Inc.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
72559-014_3e313404-f5c3-404c-9ad3-613ef88618e3	72559-014	HUMAN OTC DRUG	omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20200715		ANDA	ANDA207891	Little Pharma, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72559-015_e6380880-529a-0826-e053-2a95a90a1942	72559-015	HUMAN OTC DRUG	Curist Acne Relief		Adapalene	GEL	TOPICAL	20220815		ANDA	ANDA091314	Little Pharma, Inc.	ADAPALENE	.1	g/100g	Retinoid [EPC], Retinoids [CS]		N	20241231
72559-016_e4aa0700-697f-76be-e053-2995a90a18a4	72559-016	HUMAN OTC DRUG	Curist Lidocaine	Maximum Strength	Lidocaine	PATCH	TOPICAL	20220124		OTC MONOGRAPH NOT FINAL	part348	Little Pharma, Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72559-017_feabf140-e286-dcd5-e053-6394a90a2917	72559-017	HUMAN OTC DRUG	Curist Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220221		ANDA	ANDA213420	Little Pharma, Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
72559-018_e4aa0700-6991-76be-e053-2995a90a18a4	72559-018	HUMAN OTC DRUG	Curist Hemorrhoid Relief		Lidocaine	CREAM	TOPICAL	20220120		OTC MONOGRAPH FINAL	part346	Little Pharma, Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72559-019_e4aa0af2-7a6a-69a7-e053-2a95a90a181b	72559-019	HUMAN OTC DRUG	Curist Gas Relief	Maximum Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20220407		OTC MONOGRAPH FINAL	part332	Little Pharma, Inc.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
72559-020_02ab1d25-cdd3-79e8-e063-6394a90ab1ab	72559-020	HUMAN OTC DRUG	Curist Arthritis Relief		Diclofenac Sodium	GEL	TOPICAL	20220815		ANDA	ANDA210986	Little Pharma, Inc.	DICLOFENAC SODIUM	1	g/100g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72559-021_feabf6fd-6a9e-90c8-e053-6394a90a92cb	72559-021	HUMAN OTC DRUG	Curist Allergy Relief		Levocetirizine dihydrochloride 5 mg	TABLET	ORAL	20230124		ANDA	ANDA213513	Little Pharma, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72559-022_e46b913e-588c-6883-e053-2995a90a855f	72559-022	HUMAN OTC DRUG	Curist Medicated Wipes	Maximum Strength	Witch Hazel	CLOTH	TOPICAL	20220901		OTC MONOGRAPH FINAL	M015	LITTLE PHARMA, INC.	WITCH HAZEL	50	g/100mL			N	20241231
72559-023_fb5de395-e105-ce2b-e053-6394a90af802	72559-023	HUMAN OTC DRUG	curist lidocaine can		Lidocaine Spray	AEROSOL, SPRAY	TOPICAL	20230510		OTC MONOGRAPH FINAL	M015	Little Pharma, Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72559-024_f6ce4eac-27e4-c9b1-e053-6394a90ac061	72559-024	HUMAN OTC DRUG	Curist Lidocaine Relief		Lidocaine 5%	CREAM	TOPICAL	20230223		OTC MONOGRAPH FINAL	M015	Little Pharma, Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72559-025_e574c1ce-f661-4bcb-e053-2995a90a1dba	72559-025	HUMAN OTC DRUG	Curist Lidocaine Patch	Maximum Strength	Lidocaine	PATCH	TOPICAL	20210804		OTC MONOGRAPH NOT FINAL	part348	Little Pharma, Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72559-027_f8228938-b5e4-0fa8-e053-6294a90a1d7c	72559-027	HUMAN OTC DRUG	Curist Allergy Relief		Fexofenadine Hydrochloride 180 mg	TABLET	ORAL	20230330		ANDA	ANDA204507	Little Pharma, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72559-028_04c75e93-b1f5-2546-e063-6394a90af0e1	72559-028	HUMAN OTC DRUG	Curist Hives Relief		Fexofenadine Hydrochloride 180 mg	TABLET	ORAL	20230907		ANDA	ANDA204507	Little Pharma, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72559-033_0c53cf0f-7683-a422-e063-6394a90ab764	72559-033	HUMAN OTC DRUG	Curist Allergy Relief		Loratadine 10 mg	TABLET	ORAL	20231212		ANDA	ANDA210722	Little Pharma, Inc.	LORATADINE	10	mg/1			N	20241231
72562-103_f201ef0f-6207-33d2-e053-2a95a90a8a95	72562-103	HUMAN OTC DRUG	Tommie Copper Pain Relief	Maximum Strength	Trolamine Salicylate 10%	CREAM	TOPICAL	20201214		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
72562-105_f201ec4f-8ba4-0997-e053-2a95a90aa19b	72562-105	HUMAN OTC DRUG	Tommie Copper Pain Relief Roller		Camphor 3.5%, Menthol 3.5%	LIQUID	TOPICAL	20201130		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.5; 3.5	g/100g; g/100g			N	20241231
72562-121_f201ef0f-6204-33d2-e053-2a95a90a8a95	72562-121	HUMAN OTC DRUG	Copperlife Pain Relief Liquid		Menthol 16%	SPRAY	TOPICAL	20210810		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	MENTHOL	16	g/100g			N	20241231
72562-123_f1db8929-9b99-0d6e-e053-2995a90a817f	72562-123	HUMAN OTC DRUG	Copperlife Pain Relief		Trolamine Salicylate 10%	CREAM	TOPICAL	20210811		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
72562-125_f1db8ba7-30ee-151c-e053-2995a90a4ea4	72562-125	HUMAN OTC DRUG	Tommie Copper Pain Relief Roller		Camphor 3.5%, Menthol 3.5%	LIQUID	TOPICAL	20201218		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.5; 3.5	g/100mL; g/100mL			N	20241231
72562-167_f1db89cb-4a58-1461-e053-2995a90a6d0e	72562-167	HUMAN OTC DRUG	Pain Relief Liquid Roller		Camphor 3.5%, Menthol 3.5%	LIQUID	TOPICAL	20210819		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.5; 3.5	g/100g; g/100g			N	20241231
72562-211_f1db7db2-5fd5-40c1-e053-2995a90a5986	72562-211	HUMAN OTC DRUG	Copperlife Foot		Dimethicone 1%	CREAM	TOPICAL	20210908		OTC MONOGRAPH FINAL	part347	Tommie Copper, Inc.	DIMETHICONE	1	g/100g	Skin Barrier Activity [PE]		N	20241231
72562-222_f1db8929-9b94-0d6e-e053-2995a90a817f	72562-222	HUMAN OTC DRUG	Tommie Copper Foot		Dimethicone 1%	CREAM	TOPICAL	20210819		OTC MONOGRAPH FINAL	part347	Tommie Copper, Inc.	DIMETHICONE	1	g/100g	Skin Barrier Activity [PE]		N	20241231
72562-223_f1db8ba7-30eb-151c-e053-2995a90a4ea4	72562-223	HUMAN OTC DRUG	Tommie Copper Pain Relief		Trolamine Salicylate 10%	CREAM	TOPICAL	20210819		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
72562-910_f201fcdb-2c05-5618-e053-2a95a90aee2a	72562-910	HUMAN OTC DRUG	Tommie Copper Pain Relief		Menthol 16%	SPRAY	TOPICAL	20201130		OTC MONOGRAPH NOT FINAL	part348	Tommie Copper, Inc.	MENTHOL	16	g/100g			N	20241231
72572-014_073f1ee6-aeb6-4823-ad20-2fb70a7903ad	72572-014	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		albuterol sulfate	INHALANT	RESPIRATORY (INHALATION)	20210607		ANDA	ANDA209959	Civica Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
72572-015_eca54466-0ed1-4cb0-9ca4-e484706235e4	72572-015	HUMAN PRESCRIPTION DRUG	Aminocaproic Acid		Aminocaproic Acid	INJECTION, SOLUTION	INTRAVENOUS	20201029		ANDA	ANDA071192	Civica, Inc.	AMINOCAPROIC ACID	250	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
72572-016_3fda9296-88a9-4d7f-9ab8-5c526b01330a	72572-016	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201201		ANDA	ANDA062719	Civica, Inc.	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72572-017_3fda9296-88a9-4d7f-9ab8-5c526b01330a	72572-017	HUMAN PRESCRIPTION DRUG	AMPICILLIN		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201201		ANDA	ANDA062797	Civica, Inc.	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72572-021_29b2046c-a9eb-4dac-8322-20ff4a6c1f73	72572-021	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA090579	Civica, Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72572-022_29b2046c-a9eb-4dac-8322-20ff4a6c1f73	72572-022	HUMAN PRESCRIPTION DRUG	Ampicillin and Sulbactam		Ampicillin and Sulbactam	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220110		ANDA	ANDA090579	Civica, Inc.	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72572-035_19a4afc5-151d-4d3c-bfef-48aa8797d695	72572-035	HUMAN PRESCRIPTION DRUG	bivalirudin		bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201221		NDA AUTHORIZED GENERIC	NDA020873	Civica, Inc.	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
72572-040_fee7772b-da97-4671-a532-553d74a49d36	72572-040	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220307		ANDA	ANDA079196	Civica, Inc.	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72572-041_fee7772b-da97-4671-a532-553d74a49d36	72572-041	HUMAN PRESCRIPTION DRUG	Bumetanide		Bumetanide	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220307		ANDA	ANDA079196	Civica, Inc.	BUMETANIDE	.25	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72572-050_1b5ca3e0-ce08-4e11-9385-9ec22e5abb5b	72572-050	HUMAN PRESCRIPTION DRUG	Acetaminophen		acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20221110		ANDA	ANDA204052	Civica, Inc.	ACETAMINOPHEN	10	mg/mL			N	20241231
72572-052_81d3217a-4aa5-4454-bb57-fb1cf8bb4734	72572-052	HUMAN PRESCRIPTION DRUG	Calcium Chloride		CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20210402		ANDA	ANDA209088	Civica, Inc.	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
72572-055_d49bdd4d-0740-4c1d-9058-8abfd5d3430e	72572-055	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220301		ANDA	ANDA065047	Civica, Inc.	CEFAZOLIN SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72572-056_77cfa8c7-af08-4ae8-80a6-1e6780a17d65	72572-056	HUMAN PRESCRIPTION DRUG	Cefazolin		Cefazolin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220301		ANDA	ANDA065143	Civica, Inc.	CEFAZOLIN SODIUM	10	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72572-061_d3543906-2d4c-459f-8f12-c81cf6cb03d6	72572-061	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200301		ANDA	ANDA065342	Civica, Inc.	CEFTRIAXONE SODIUM	1	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72572-062_d3543906-2d4c-459f-8f12-c81cf6cb03d6	72572-062	HUMAN PRESCRIPTION DRUG	Ceftriaxone		Ceftriaxone	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200301		ANDA	ANDA065342	Civica, Inc.	CEFTRIAXONE SODIUM	2	g/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72572-066_53ba2304-1898-49f0-9422-ff3c8761de23	72572-066	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20221221		ANDA	ANDA200159	Civica, Inc.	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72572-067_f5a1c3fa-fc2b-4084-b5bc-786c092a3212	72572-067	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20221221		ANDA	ANDA200154	Civica, Inc.	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72572-074_e40b6e7f-1d37-4d0a-ace3-e5accc461e02	72572-074	HUMAN PRESCRIPTION DRUG	Clindamycin in 5 Percent Dextrose		Clindamycin in 5 Percent Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20220113		ANDA	ANDA201692	Civica, Inc.	CLINDAMYCIN	12	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72572-076_e40b6e7f-1d37-4d0a-ace3-e5accc461e02	72572-076	HUMAN PRESCRIPTION DRUG	Clindamycin in 5 Percent Dextrose		Clindamycin in 5 Percent Dextrose	INJECTION, SOLUTION	INTRAVENOUS	20220113		ANDA	ANDA201692	Civica, Inc.	CLINDAMYCIN	18	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72572-083_763f1271-58f3-4130-bbee-0ca550f6b714	72572-083	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Civica, Inc.	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72572-085_763f1271-58f3-4130-bbee-0ca550f6b714	72572-085	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Civica, Inc.	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72572-087_763f1271-58f3-4130-bbee-0ca550f6b714	72572-087	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20080521		ANDA	ANDA040745	Civica, Inc.	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72572-100_95e6032f-9b8e-46e7-8df1-3be984fd5613	72572-100	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190903		NDA	NDA209949	Civica, Inc.	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
72572-102_eca0ec1b-b9f1-45f3-a805-42c5337c943f	72572-102	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190820		ANDA	ANDA206005	Civica, Inc.	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
72572-120_72c454ba-73fd-49df-8fd8-19c3f21e28c1	72572-120	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20191113		ANDA	ANDA084282	Civica, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72572-122_72c454ba-73fd-49df-8fd8-19c3f21e28c1	72572-122	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191113		ANDA	ANDA087702	Civica, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72572-127_fb0759f3-818c-4e6e-9aa7-ac94f7d59de8	72572-127	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		dexmedetomidine hydrochloride	INJECTION	INTRAVENOUS	20210823		ANDA	ANDA212791	CIVICA, INC.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
72572-128_fb0759f3-818c-4e6e-9aa7-ac94f7d59de8	72572-128	HUMAN PRESCRIPTION DRUG	DEXMEDETOMIDINE HYDROCHLORIDE		dexmedetomidine hydrochloride	INJECTION	INTRAVENOUS	20210823		ANDA	ANDA212791	CIVICA, INC.	DEXMEDETOMIDINE HYDROCHLORIDE	4	ug/mL	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
72572-140_581c7e2c-ca0d-43b2-8acc-29a12fb70733	72572-140	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20191201		ANDA	ANDA210363	Civica, Inc.	DIAZEPAM	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72572-150_5cb4b67b-3d20-45de-9d29-d70cb4da1b74	72572-150	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20210329		ANDA	ANDA209784	Civica, Inc.	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
72572-151_c864cde1-7508-482d-8cca-7e03fc870c00	72572-151	HUMAN PRESCRIPTION DRUG	Ephedrine Sulfate		Ephedrine Sulfate	INJECTION	INTRAVENOUS	20210823		ANDA	ANDA212932	Civica, Inc.	EPHEDRINE SULFATE	50	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
72572-160_cdea71c3-0ef9-4232-a80c-84975ca939c5	72572-160	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION	INTRAVENOUS	20220301		ANDA	ANDA202354	Civica, Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72572-161_cdea71c3-0ef9-4232-a80c-84975ca939c5	72572-161	HUMAN PRESCRIPTION DRUG	Etomidate		Etomidate	INJECTION	INTRAVENOUS	20220301		ANDA	ANDA202354	Civica, Inc.	ETOMIDATE	2	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72572-170_14d2e804-ae7e-4a95-baa7-1dcd09b4cfee	72572-170	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191210		NDA	NDA019101	Civica, Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72572-171_14d2e804-ae7e-4a95-baa7-1dcd09b4cfee	72572-171	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191210		NDA	NDA019101	Civica, Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72572-172_14d2e804-ae7e-4a95-baa7-1dcd09b4cfee	72572-172	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAVENOUS	20201007		NDA	NDA019101	Civica, Inc.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72572-190_2834d65f-e387-467c-a7cc-65a6ff2cf2f4	72572-190	HUMAN PRESCRIPTION DRUG	FUROSEMIDE		furosemide	INJECTION, SOLUTION	INTRAVENOUS	20220923		ANDA	ANDA202747	Civica, Inc.	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72572-225_4605bea0-172d-4eac-b510-0395189a99ff	72572-225	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191210		ANDA	ANDA090963	Civica, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72572-226_956a3401-de57-425e-8ba8-3675301fc509	72572-226	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210131		ANDA	ANDA089335	Civica, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72572-250_50e23992-d4e3-4252-815a-3370c57a8b30	72572-250	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20191115		NDA	NDA017037	Civica, Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
72572-255_50e23992-d4e3-4252-815a-3370c57a8b30	72572-255	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20191115		NDA	NDA017037	Civica, Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
72572-265_eccec6fe-57be-4d86-bfc7-94b694b63204	72572-265	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201029		ANDA	ANDA040136	Civica, Inc.	HYDRALAZINE HYDROCHLORIDE	20	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72572-320_bd267da4-d343-44b3-9e46-e25731e179bb	72572-320	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191205		ANDA	ANDA074524	Civica, Inc.	KETAMINE HYDROCHLORIDE	50	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
72572-321_bd267da4-d343-44b3-9e46-e25731e179bb	72572-321	HUMAN PRESCRIPTION DRUG	Ketamine Hydrochloride		Ketamine Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191205		ANDA	ANDA074524	Civica, Inc.	KETAMINE HYDROCHLORIDE	100	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]	CIII	N	20241231
72572-350_30e5d832-b1f2-4371-9f7d-53a7668890b3	72572-350	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION	INTRAVENOUS	20191121		ANDA	ANDA075303	Civica, Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72572-354_2a2c6b34-37e2-407d-b434-c2656a2ec364	72572-354	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230325		ANDA	ANDA209900	Civica, Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72572-355_2a2c6b34-37e2-407d-b434-c2656a2ec364	72572-355	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230325		ANDA	ANDA209900	Civica, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72572-360_8214778d-a95f-4004-80b1-81a9d67d0307	72572-360	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	INJECTION	INTRAVENOUS	20221201		ANDA	ANDA090981	Civica, Inc.	LEVETIRACETAM	100	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72572-370_96bb2aff-0ee8-46cc-9273-9a7cd714b464	72572-370	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20191210		ANDA	ANDA084625	Civica, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72572-372_96bb2aff-0ee8-46cc-9273-9a7cd714b464	72572-372	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20191210		ANDA	ANDA084625	Civica, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72572-380_4b66b887-9825-4a33-9eb8-d483666e8b88	72572-380	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20201207		NDA	NDA018140	Civica, Inc.	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72572-415_0e17040f-06bc-538c-e063-6294a90a5995	72572-415	HUMAN PRESCRIPTION DRUG	MEROPENEM		MEROPENEM	INJECTION	INTRAVENOUS	20200923		ANDA	ANDA206086	Civica, Inc	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20251231
72572-416_0e17040f-06bc-538c-e063-6294a90a5995	72572-416	HUMAN PRESCRIPTION DRUG	MEROPENEM		MEROPENEM	INJECTION	INTRAVENOUS	20200923		ANDA	ANDA206086	Civica, Inc	MEROPENEM	1	g/30mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20251231
72572-420_f3905ff4-81db-4fd5-9a90-51446ff6b93f	72572-420	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoroprolol Tartrate	INJECTION, SOLUTION	INTRAVENOUS	20191210		ANDA	ANDA077761	Civica, Inc.	METOPROLOL TARTRATE	5	mg/5mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72572-427_01ad2081-0a06-4eeb-940b-db59b0725597	72572-427	HUMAN PRESCRIPTION DRUG	Micafungin		Micafungin sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210206	20251231	ANDA	ANDA211713	Civica, Inc.	MICAFUNGIN SODIUM	100	mg/1	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	
72572-430_14453411-72d4-4a5b-8f25-fe7472ef8686	72572-430	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191210		ANDA	ANDA075243	Civica, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72572-432_14453411-72d4-4a5b-8f25-fe7472ef8686	72572-432	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191210		ANDA	ANDA075243	Civica, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72572-440_2c713d80-8bbf-436d-815b-95033fb839b7	72572-440	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION	INTRAVENOUS	20191111		ANDA	ANDA205758	Civica, Inc.	MORPHINE SULFATE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72572-450_2d750fb1-591f-47fd-b148-fc5e9b5a9486	72572-450	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Nalxone Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20191111		ANDA	ANDA070299	Civica, Inc.	NALOXONE HYDROCHLORIDE	.4	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
72572-460_993286a1-6f76-459c-b18b-f4ade0526c43	72572-460	HUMAN PRESCRIPTION DRUG	neostigmine methylsulfate		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20190513		ANDA	ANDA212512	Civica Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72572-461_993286a1-6f76-459c-b18b-f4ade0526c43	72572-461	HUMAN PRESCRIPTION DRUG	neostigmine methylsulfate		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20190513		ANDA	ANDA212512	Civica Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72572-462_e1fdbd7f-432c-4e13-b4c7-0ba524092b6c	72572-462	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20200416		ANDA	ANDA207042	Civica, Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72572-470_fba70df6-5d37-4a12-bce3-e6fb1b0c72b2	72572-470	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		nicardipine hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20201029		ANDA	ANDA090534	Civica, Inc.	NICARDIPINE HYDROCHLORIDE	2.5	mg/mL	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72572-481_c190b37f-ee4a-43ca-b9c6-dbe7a73771b0	72572-481	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		Norepinephrine Bitartrate	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210312		ANDA	ANDA211359	Civica, Inc.	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
72572-520_0c34b5a6-e21b-41e7-8e7b-61a9706b67e0	72572-520	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191118		ANDA	ANDA077541	Civica, Inc.	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
72572-550_c9111d39-4f16-4e33-890e-d9aaa6b6dfe0	72572-550	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20201115		ANDA	ANDA090296	Civica, Inc.	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72572-570_e8388f3b-845a-427e-a45c-fa46b49a5040	72572-570	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20201202		NDA	NDA203826	Civica, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72572-571_e8388f3b-845a-427e-a45c-fa46b49a5040	72572-571	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		Phenylephrine Hydrochloride	INJECTION	INTRAVENOUS	20201202		NDA	NDA203826	Civica, Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72572-573_4c1d7685-9d8a-43f6-ba1b-1e7fd4f27aad	72572-573	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		piperacillin sodium and tazobactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20201201		ANDA	ANDA065523	Civica, Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72572-574_4c1d7685-9d8a-43f6-ba1b-1e7fd4f27aad	72572-574	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		piperacillin sodium and tazobactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20210101		ANDA	ANDA065523	Civica, Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72572-575_2919e37d-528c-413a-aad3-eb5d116718ae	72572-575	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220120		ANDA	ANDA212287	Civica, Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72572-576_2919e37d-528c-413a-aad3-eb5d116718ae	72572-576	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220120		ANDA	ANDA212287	Civica, Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72572-577_2919e37d-528c-413a-aad3-eb5d116718ae	72572-577	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin Sodium and Tazobactam Sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220120		ANDA	ANDA212287	Civica, Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72572-580_4a5b1035-44f6-4855-b353-f7b8b49cc6b0	72572-580	HUMAN PRESCRIPTION DRUG	Prochlorperazine Edisylate		Prochlorperazine Edisylate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20191118		ANDA	ANDA089903	Civica, Inc.	PROCHLORPERAZINE EDISYLATE	5	mg/mL	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72572-590_59e709a4-fd66-439b-a45a-6d3254d1665d	72572-590	HUMAN PRESCRIPTION DRUG	Propofol		Propofol	INJECTION, EMULSION	INTRAVENOUS	20210716		ANDA	ANDA205576	Civica, Inc	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72572-601_59e709a4-fd66-439b-a45a-6d3254d1665d	72572-601	HUMAN PRESCRIPTION DRUG	Propofol		Propofol	INJECTION, EMULSION	INTRAVENOUS	20210716		ANDA	ANDA205576	Civica, Inc	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72572-612_59e709a4-fd66-439b-a45a-6d3254d1665d	72572-612	HUMAN PRESCRIPTION DRUG	Propofol		Propofol	INJECTION, EMULSION	INTRAVENOUS	20210716		ANDA	ANDA205576	Civica, Inc	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
72572-650_03bc8c3c-5da4-4ff3-83f4-e78026656117	72572-650	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20201216		ANDA	ANDA204679	Civica, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72572-651_03bc8c3c-5da4-4ff3-83f4-e78026656117	72572-651	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		Rocuronium Bromide	INJECTION	INTRAVENOUS	20201216		ANDA	ANDA204679	Civica, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72572-707_3965d2a7-e66f-4510-9fe6-431ff20bea11	72572-707	HUMAN PRESCRIPTION DRUG	Ropivacaine Hydrochloride		Ropivacaine Hydrochloride	INJECTION	EPIDURAL; INFILTRATION; PERINEURAL	20220919		ANDA	ANDA212808	Civica, Inc.	ROPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
72572-740_98efb401-5361-41ff-979a-6857768a144c	72572-740	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA211091	Civica	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20251231
72572-747_54c5a74f-9e9d-49cb-b263-7fffe486def7	72572-747	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20220223		ANDA	ANDA206369	Civica, Inc.	WATER	1	mL/mL			N	20241231
72572-750_3bd5488f-6286-4567-b76c-af61880daaef	72572-750	HUMAN PRESCRIPTION DRUG	Anectine		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; PARENTERAL	20201211		NDA	NDA008453	Civica, Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
72572-801_a44fa817-9955-4e31-8626-39b9c84999a7	72572-801	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190702		ANDA	ANDA204107	Civica, Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
72572-803_4d41d3bd-076a-4bf1-826d-53ad7c2e43ff	72572-803	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190710		ANDA	ANDA204125	Civica, Inc.	VANCOMYCIN HYDROCHLORIDE	5	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
72572-805_4d41d3bd-076a-4bf1-826d-53ad7c2e43ff	72572-805	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		Vancomycin Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190710		ANDA	ANDA204125	Civica, Inc.	VANCOMYCIN HYDROCHLORIDE	10	g/100mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
72572-875_c8a168b1-e3e5-4729-9c9c-fb014bb20563	72572-875	HUMAN PRESCRIPTION DRUG	Voriconazole		Voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230401		ANDA	ANDA090862	Civica, Inc.	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72574-001_51e5d7b3-8899-42f5-adc8-929d780f1e3b	72574-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20180701		NDA	NDA205849	Biomedics Systems, Inc.	OXYGEN	99	L/100L			N	20241231
72578-001_d199706f-debb-4ee5-b172-6d67718fc1d3	72578-001	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20190314		ANDA	ANDA207773	Viona Pharmaceuticals Inc	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72578-002_553474fa-ce7b-4934-84bd-54e89dfbc064	72578-002	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	CAPSULE	ORAL	20190823		ANDA	ANDA204313	Viona Pharmaceuticals Inc	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72578-003_2dee57d8-27d7-481c-b1c9-21375e258a1b	72578-003	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Viona Pharmaceuticals Inc	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
72578-004_2dee57d8-27d7-481c-b1c9-21375e258a1b	72578-004	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET	ORAL	20190228		ANDA	ANDA090961	Viona Pharmaceuticals Inc	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
72578-005_452d2687-49ff-4734-8799-a4a5264cc584	72578-005	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20190215		ANDA	ANDA209966	Viona Pharmaceuticals Inc	MODAFINIL	100	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
72578-006_452d2687-49ff-4734-8799-a4a5264cc584	72578-006	HUMAN PRESCRIPTION DRUG	Modafinil		Modafinil	TABLET	ORAL	20190215		ANDA	ANDA209966	Viona Pharmaceuticals Inc	MODAFINIL	200	mg/1	Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE], Sympathomimetic-like Agent [EPC]	CIV	N	20241231
72578-007_e83cf454-b1cf-4695-8cf4-1d0a16c915a9	72578-007	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	Viona Pharmaceuticals Inc	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72578-008_e83cf454-b1cf-4695-8cf4-1d0a16c915a9	72578-008	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	Viona Pharmaceuticals Inc	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72578-012_c7ab9252-2acc-4172-aa67-376072d72e38	72578-012	HUMAN PRESCRIPTION DRUG	clopidogrel		clopidogrel	TABLET, FILM COATED	ORAL	20190808		ANDA	ANDA201686	Viona Pharmaceuticals Inc	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
72578-019_59a26e95-6ed5-4648-9bf6-f0189e4f1c32	72578-019	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE	ORAL	20190415		ANDA	ANDA204373	Viona Pharmaceuticals Inc	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
72578-035_ca52a4c2-f8fd-4395-a307-3c1ec9c3cf7f	72578-035	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190315		ANDA	ANDA077060	Viona Pharmaceuticals Inc	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72578-036_ca52a4c2-f8fd-4395-a307-3c1ec9c3cf7f	72578-036	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190315		ANDA	ANDA077078	Viona Pharmaceuticals Inc	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72578-038_d6fd6a5f-0a70-49e8-aee2-5586006869b8	72578-038	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20190620		ANDA	ANDA090403	Viona Pharmaceuticals Inc	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72578-039_d6fd6a5f-0a70-49e8-aee2-5586006869b8	72578-039	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20190620		ANDA	ANDA090403	Viona Pharmaceuticals Inc	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72578-040_ae95556a-06c3-4e0e-9b9e-562ae444579c	72578-040	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20220704		ANDA	ANDA077625	Viona Pharmaceuticals Inc	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72578-041_ae95556a-06c3-4e0e-9b9e-562ae444579c	72578-041	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20220704		ANDA	ANDA077625	Viona Pharmaceuticals Inc	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72578-042_ae95556a-06c3-4e0e-9b9e-562ae444579c	72578-042	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20220704		ANDA	ANDA077625	Viona Pharmaceuticals Inc	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72578-054_067c94b6-7574-46ad-ac24-d33b9a1d0a57	72578-054	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20220110		ANDA	ANDA207774	Viona Pharmaceuticals Inc	DOXYCYCLINE HYCLATE	50	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72578-055_067c94b6-7574-46ad-ac24-d33b9a1d0a57	72578-055	HUMAN PRESCRIPTION DRUG	Doxycycline hyclate		Doxycycline hyclate	CAPSULE	ORAL	20220110		ANDA	ANDA207774	Viona Pharmaceuticals Inc	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72578-056_d66a589d-eb0f-47e6-9d90-da34938b5641	72578-056	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20200303		ANDA	ANDA208970	Viona Pharmaceuticals Inc	FELBAMATE	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72578-057_d66a589d-eb0f-47e6-9d90-da34938b5641	72578-057	HUMAN PRESCRIPTION DRUG	Felbamate		Felbamate	TABLET	ORAL	20200303		ANDA	ANDA208970	Viona Pharmaceuticals Inc	FELBAMATE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72578-062_11925a0a-4715-4c67-83ba-34dd14690b34	72578-062	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET	ORAL	20190416		ANDA	ANDA206747	Viona Pharmaceuticals Inc	VORICONAZOLE	50	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72578-063_11925a0a-4715-4c67-83ba-34dd14690b34	72578-063	HUMAN PRESCRIPTION DRUG	voriconazole		voriconazole	TABLET	ORAL	20190416		ANDA	ANDA206747	Viona Pharmaceuticals Inc	VORICONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72578-064_2c72dbc3-5385-4706-b5fd-841d4b70a26f	72578-064	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA210188	Viona Pharmaceuticals Inc	RANOLAZINE	500	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72578-065_2c72dbc3-5385-4706-b5fd-841d4b70a26f	72578-065	HUMAN PRESCRIPTION DRUG	Ranolazine		Ranolazine	TABLET, EXTENDED RELEASE	ORAL	20190910		ANDA	ANDA210188	Viona Pharmaceuticals Inc	RANOLAZINE	1000	mg/1	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72578-066_81e93b62-553c-4553-9f0e-44f06293ae7d	72578-066	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20200221		ANDA	ANDA204189	Viona Pharmaceuticals Inc	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
72578-081_50be7e37-3381-49ff-afe2-ca6a50245bf8	72578-081	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20230520		ANDA	ANDA215705	Viona Pharmaceuticals Inc	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
72578-082_ccf3671e-924e-466b-932e-f8e7ebacd4a4	72578-082	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	OINTMENT	TOPICAL	20200608		ANDA	ANDA205974	Viona Pharmaceuticals Inc	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72578-084_c9998922-ba46-4484-8acb-b7ad39ec4acf	72578-084	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		Clindamycin Phosphate	SOLUTION	TOPICAL	20200615		ANDA	ANDA208767	Viona Pharmaceuticals Inc	CLINDAMYCIN PHOSPHATE	10	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72578-085_7dbc5596-df6a-4fe3-98ff-27b2bb960b7a	72578-085	HUMAN PRESCRIPTION DRUG	Clobetasol Propionate		Clobetasol Propionate	LOTION	TOPICAL	20200430		ANDA	ANDA205249	Viona Pharmaceuticals Inc	CLOBETASOL PROPIONATE	.05	g/100mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72578-086_cdbd7fe9-4eb5-407c-8466-000b675c101a	72578-086	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20200617		ANDA	ANDA210198	Viona Pharmaceuticals Inc	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72578-087_289f3db8-a73f-4141-8c35-5b3c53b9a16c	72578-087	HUMAN PRESCRIPTION DRUG	FLUOCINONIDE		FLUOCINONIDE	CREAM	TOPICAL	20200430		ANDA	ANDA208989	Viona Pharmaceuticals Inc	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72578-088_1a3aab5b-5427-414c-a40f-ed4ea70da502	72578-088	HUMAN PRESCRIPTION DRUG	Nystatin and Triamcinolone Acetonide		Nystatin and Triamcinolone Acetonide	OINTMENT	TOPICAL	20200624		ANDA	ANDA207764	Viona Pharmaceuticals Inc	NYSTATIN; TRIAMCINOLONE ACETONIDE	100000; 1	[USP'U]/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
72578-089_3d917a6c-4e9a-4c45-9e79-caf91f8b11b0	72578-089	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	OINTMENT	TOPICAL	20200624		ANDA	ANDA207767	Viona Pharmaceuticals Inc	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
72578-090_ba702c00-5dc6-4545-bde9-ff7dbb7fd1a7	72578-090	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20200221		ANDA	ANDA208358	Viona Pharmaceuticals Inc	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72578-091_af1f6394-c7b7-41be-bf5e-d0cc7f0da19b	72578-091	HUMAN PRESCRIPTION DRUG	desoximetasone		desoximetasone	CREAM	TOPICAL	20200831		ANDA	ANDA205620	Viona Pharmaceuticals Inc	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72578-092_bdebb301-fd1a-4f14-ba27-c3a0e5bfd0b1	72578-092	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac sodium	LIQUID	TOPICAL	20200720		ANDA	ANDA206411	Viona Pharmaceuticals Inc	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72578-093_48e480f9-2c41-4fd3-909b-a2490d7a1509	72578-093	HUMAN PRESCRIPTION DRUG	betamethasone dipropionate		betamethasone dipropionate	OINTMENT	TOPICAL	20200720		ANDA	ANDA214048	Viona Pharmaceuticals Inc	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72578-095_a4b291f3-d49c-4ff0-b79d-dba724f45037	72578-095	HUMAN PRESCRIPTION DRUG	desoximetasone		desoximetasone	OINTMENT	TOPICAL	20201023		ANDA	ANDA205206	Viona Pharmaceuticals Inc	DESOXIMETASONE	2.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72578-096_c1813e2d-81a1-4db6-80a3-12c265d1e8f5	72578-096	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20210304		ANDA	ANDA208187	Viona Pharmaceuticals Inc	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72578-097_c1813e2d-81a1-4db6-80a3-12c265d1e8f5	72578-097	HUMAN PRESCRIPTION DRUG	tizanidine		tizanidine	TABLET	ORAL	20210304		ANDA	ANDA208187	Viona Pharmaceuticals Inc	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72578-098_1e751b41-167b-4844-a3a6-ff1a84ec0cad	72578-098	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20220110		ANDA	ANDA077652	Viona Pharmaceuticals Inc	LEVOFLOXACIN	250	mg/1			N	20241231
72578-099_1e751b41-167b-4844-a3a6-ff1a84ec0cad	72578-099	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20220110		ANDA	ANDA077652	Viona Pharmaceuticals Inc	LEVOFLOXACIN	500	mg/1			N	20241231
72578-100_1e751b41-167b-4844-a3a6-ff1a84ec0cad	72578-100	HUMAN PRESCRIPTION DRUG	levofloxacin		levofloxacin	TABLET, FILM COATED	ORAL	20220110		ANDA	ANDA077652	Viona Pharmaceuticals Inc	LEVOFLOXACIN	750	mg/1			N	20241231
72578-101_e5163268-e28b-4318-a502-308e66e8ef38	72578-101	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CREAM	TOPICAL	20230303		ANDA	ANDA206770	Viona Pharmaceuticals Inc	ACYCLOVIR	50	mg/g	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72578-102_bef61005-9f0d-4d08-b60c-1ec794840468	72578-102	HUMAN PRESCRIPTION DRUG	Tavaborole		Tavaborole	SOLUTION	TOPICAL	20230424		ANDA	ANDA212294	Viona Pharmaceuticals Inc	TAVABOROLE	43.5	mg/mL	Boron Compounds [CS], Oxaborole Antifungal [EPC], Protein Synthesis Inhibitors [MoA]		N	20241231
72578-103_ea816266-a6cc-4461-93fc-32f762b3db45	72578-103	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20220807		ANDA	ANDA205798	Viona Pharmaceuticals Inc.	MIRTAZAPINE	15	mg/1			N	20241231
72578-104_ea816266-a6cc-4461-93fc-32f762b3db45	72578-104	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20220807		ANDA	ANDA205798	Viona Pharmaceuticals Inc.	MIRTAZAPINE	30	mg/1			N	20241231
72578-105_ea816266-a6cc-4461-93fc-32f762b3db45	72578-105	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20220807		ANDA	ANDA205798	Viona Pharmaceuticals Inc.	MIRTAZAPINE	45	mg/1			N	20241231
72578-106_dca7f9f0-185a-4042-a54e-4355c329db6c	72578-106	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220720		ANDA	ANDA090165	Viona Pharmaceuticals Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72578-107_dca7f9f0-185a-4042-a54e-4355c329db6c	72578-107	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220720		ANDA	ANDA090165	Viona Pharmaceuticals Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72578-111_d47ca4c0-7783-43d1-a951-5adca27ea13c	72578-111	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA215680	Viona Pharmaceuticals Inc	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72578-112_d47ca4c0-7783-43d1-a951-5adca27ea13c	72578-112	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20220915		ANDA	ANDA215680	Viona Pharmaceuticals Inc	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72578-113_550e6ac5-3ece-461f-a9c5-2e4050a5eabb	72578-113	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA215666	Viona Pharmaceuticals Inc	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
72578-114_550e6ac5-3ece-461f-a9c5-2e4050a5eabb	72578-114	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA215666	Viona Pharmaceuticals Inc	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
72578-115_550e6ac5-3ece-461f-a9c5-2e4050a5eabb	72578-115	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate and Hydrochlorothiazide		bisoprolol fumarate and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA215666	Viona Pharmaceuticals Inc	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10; 6.25	mg/1; mg/1	Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]		N	20251231
72578-118_76fd5ef0-c06b-4f17-8607-89255693bffd	72578-118	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	GEL	TOPICAL	20230920		ANDA	ANDA216587	Viona Pharmaceuticals Inc	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72578-119_a3a51e80-afaf-42e7-b3e0-863f32314e3b	72578-119	HUMAN PRESCRIPTION DRUG	Adapalene and benzoyl peroxide		Adapalene and benzoyl peroxide	GEL	TOPICAL	20220606		ANDA	ANDA214553	Viona Pharmaceuticals Inc	ADAPALENE; BENZOYL PEROXIDE	3; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
72578-120_3cf43bff-d768-4fce-ba11-4a9135f8d116	72578-120	HUMAN PRESCRIPTION DRUG	ivermectin		ivermectin	CREAM	TOPICAL	20230610		ANDA	ANDA215210	Viona Pharmaceuticals Inc	IVERMECTIN	10	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
72578-125_e02b7585-27db-4f92-a018-4ed89374da48	72578-125	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20200915		ANDA	ANDA208988	Viona Pharmaceuticals Inc	ZIPRASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72578-126_e02b7585-27db-4f92-a018-4ed89374da48	72578-126	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20200915		ANDA	ANDA208988	Viona Pharmaceuticals Inc	ZIPRASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72578-127_e02b7585-27db-4f92-a018-4ed89374da48	72578-127	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20200915		ANDA	ANDA208988	Viona Pharmaceuticals Inc	ZIPRASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72578-128_e02b7585-27db-4f92-a018-4ed89374da48	72578-128	HUMAN PRESCRIPTION DRUG	Ziprasidone		Ziprasidone	CAPSULE	ORAL	20200915		ANDA	ANDA208988	Viona Pharmaceuticals Inc	ZIPRASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72578-129_3d32ce01-d498-47d9-b589-3b2b8c741524	72578-129	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	CREAM	TOPICAL	20230531		ANDA	ANDA217128	Viona Pharmaceuticals Inc	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72578-136_082ca5b7-ccb9-4096-a363-a188d6f51586	72578-136	HUMAN PRESCRIPTION DRUG	febuxostat		febuxostat	TABLET	ORAL	20230331		ANDA	ANDA205443	Viona Pharmaceuticals Inc	FEBUXOSTAT	40	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72578-137_082ca5b7-ccb9-4096-a363-a188d6f51586	72578-137	HUMAN PRESCRIPTION DRUG	febuxostat		febuxostat	TABLET	ORAL	20230331		ANDA	ANDA205443	Viona Pharmaceuticals Inc	FEBUXOSTAT	80	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
72578-138_50a14097-cb3f-4064-97d8-2a662c5a4ad0	72578-138	HUMAN PRESCRIPTION DRUG	Loperamide hydrochloride		Loperamide hydrochloride	CAPSULE	ORAL	20230625		ANDA	ANDA217471	Viona Pharmaceuticals Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
72578-149_c087a4a4-dd45-4b06-8b7c-76be61a8c063	72578-149	HUMAN PRESCRIPTION DRUG	acetaZOLAMIDE		acetaZOLAMIDE	TABLET	ORAL	20230715		ANDA	ANDA211069	Viona Pharmaceuticals Inc	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72578-150_c087a4a4-dd45-4b06-8b7c-76be61a8c063	72578-150	HUMAN PRESCRIPTION DRUG	acetaZOLAMIDE		acetaZOLAMIDE	TABLET	ORAL	20230715		ANDA	ANDA211069	Viona Pharmaceuticals Inc	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72579-011_0d82275f-673a-e1a3-e063-6394a90ad12e	72579-011	HUMAN PRESCRIPTION DRUG	BRUKINSA		zanubrutinib	CAPSULE	ORAL	20191114		NDA	NDA213217	BEIGENE USA, INC.	ZANUBRUTINIB	80	mg/1	Bruton's Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
72587-001_0bf1202d-1d5a-7707-e063-6394a90a8ce4	72587-001	HUMAN OTC DRUG	Cycle		Menthol	PATCH	TOPICAL	20211206		OTC MONOGRAPH DRUG	M017	La Mend, Inc.	MENTHOL	5	g/100g			N	20241231
72587-002_0c41fe43-5ef1-fecc-e063-6394a90a12fc	72587-002	HUMAN OTC DRUG	Relief		Menthol	PATCH	TOPICAL	20220415		OTC MONOGRAPH DRUG	M017	La Mend, Inc.	MENTHOL	5	g/100g			N	20241231
72587-111_0cfc848e-8d8e-5d64-e063-6394a90a920a	72587-111	HUMAN OTC DRUG	Soothe		Capsaicin, Menthol	PATCH	TOPICAL	20181001	20240331	OTC MONOGRAPH DRUG	M017	La Mend, Inc.	CAPSAICIN; MENTHOL, UNSPECIFIED FORM	.25; 5	g/100g; g/100g			N	
72592-001_b7b1d8fd-5c9b-6624-e053-2a95a90a6d06	72592-001	HUMAN OTC DRUG	Everyday Coverage Tinted Sunscreen - Extra Light Tint		Zinc Oxide	CREAM	TOPICAL	20100901		OTC MONOGRAPH FINAL	part352	MV Advanced	ZINC OXIDE	200	mg/mL			N	20241231
72592-002_b7b2ac3d-2cc7-c485-e053-2995a90a8763	72592-002	HUMAN OTC DRUG	Everyday Coverage Tinted Sunscreen - Light Tint		Zinc Oxide	CREAM	TOPICAL	20100901		OTC MONOGRAPH FINAL	part352	MV Advanced	ZINC OXIDE	200	mg/mL			N	20241231
72592-003_b7b2bb89-7305-c487-e053-2995a90a8332	72592-003	HUMAN OTC DRUG	Everyday Coverage Tinted Sunscreen - Medium Tint		Zinc Oxide	CREAM	TOPICAL	20100901		OTC MONOGRAPH FINAL	part352	MV Advanced	ZINC OXIDE	200	mg/mL			N	20241231
72594-1090_02ac4acc-581c-1b83-e063-6294a90a97eb	72594-1090	HUMAN OTC DRUG	Mencaine		Lidocaine, Menthol	PATCH	TOPICAL	20221108		OTC MONOGRAPH NOT FINAL	part348	Neptune Products	LIDOCAINE; MENTHOL	4.5; 5	mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72594-1846_0c7d382a-b977-6159-e063-6294a90a886f	72594-1846	HUMAN OTC DRUG	Neptune Ice		Lidocaine, Menthol, Camphor, and Dimethicone Gel	GEL	TOPICAL	20181010		OTC MONOGRAPH DRUG	M017	Neptune Products L.L.C.	CAMPHOR (NATURAL); DIMETHICONE; LIDOCAINE; MENTHOL	.0291; .0291; .0388; .0097	g/mL; g/mL; g/mL; g/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Skin Barrier Activity [PE]		N	20241231
72602-002_0811a11e-61f3-e41f-e063-6294a90ad210	72602-002	HUMAN OTC DRUG	Mentho patch	cool	Menthol	PATCH	TOPICAL	20180920		OTC MONOGRAPH DRUG	M017	THE EGYPTIAN SAUDI CO FOR MEDICAL MANUFACTURING MASCOMID	MENTHOL	15	mg/g			N	20241231
72602-003_0811a627-4524-86c7-e063-6394a90a5d60	72602-003	HUMAN OTC DRUG	Tempo cool		Menthol	PATCH	TOPICAL	20180920		OTC MONOGRAPH DRUG	M017	The Egyptian Saudi Co. For Medical Manufacturing (Masco-Mid) S.A.E	CAMPHOR (NATURAL); MENTHOL	1; 3	mg/g; mg/g			N	20241231
72602-004_0811aad4-5c73-362d-e063-6294a90ad550	72602-004	HUMAN OTC DRUG	Menthopatch	Hot	Menthol , Capsicum extract	PATCH	TOPICAL	20181025		OTC MONOGRAPH DRUG	M017	THE EGYPTIAN SAUDI CO FOR MEDICAL MANUFACTURING MASCOMID	CAPSICUM; MENTHOL	50; 40	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
72603-101_016df506-49f2-4cab-80d2-01a60ef78370	72603-101	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20190617		ANDA	ANDA207325	NorthStar Rx LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
72603-103_b7246b0b-cd55-4364-b4e1-9b0c0efd696e	72603-103	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20190529		ANDA	ANDA203263	NorthStar RxLLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
72603-104_c626e123-2692-43a1-8c3e-3af9ca2f117d	72603-104	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20190510		ANDA	ANDA210046	NorthStar RxLLC	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72603-105_c7bfe1f1-6131-4da2-9180-fc1b46dcf1fb	72603-105	HUMAN PRESCRIPTION DRUG	Fulvestrant		Fulvestrant	INJECTION	INTRAMUSCULAR	20191121		ANDA	ANDA209714	NorthStar Rx LLC	FULVESTRANT	50	mg/mL	Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]		N	20241231
72603-107_1abbe952-58bc-4dbc-b06a-fb79167bcd66	72603-107	HUMAN PRESCRIPTION DRUG	Decitabine		Decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200817		ANDA	ANDA212265	Northstar Rx LLC	DECITABINE	50	mg/10mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72603-110_d344c9ba-435e-4ea9-83b2-4685f3dc3495	72603-110	HUMAN PRESCRIPTION DRUG	abiraterone acetate		abiraterone acetate	TABLET	ORAL	20220307		ANDA	ANDA209227	NORTHSTAR RX LLC	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20251231
72603-111_d344c9ba-435e-4ea9-83b2-4685f3dc3495	72603-111	HUMAN PRESCRIPTION DRUG	abiraterone acetate		abiraterone acetate	TABLET	ORAL	20220519		ANDA	ANDA209227	NORTHSTAR RX LLC	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20251231
72603-112_63a51923-6870-4c5d-a751-aca2980eb62f	72603-112	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20221024		ANDA	ANDA075731	NORTHSTAR RX LLC	CLORAZEPATE DIPOTASSIUM	3.75	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72603-113_63a51923-6870-4c5d-a751-aca2980eb62f	72603-113	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20221024		ANDA	ANDA075731	NORTHSTAR RX LLC	CLORAZEPATE DIPOTASSIUM	7.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72603-114_63a51923-6870-4c5d-a751-aca2980eb62f	72603-114	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20221024		ANDA	ANDA075731	NORTHSTAR RX LLC	CLORAZEPATE DIPOTASSIUM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72603-115_d26ad47b-f3ef-45d6-b39d-f64929a54489	72603-115	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20130430		ANDA	ANDA202433	NorthStar Rx LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72603-116_ee4b1a3b-acfb-5229-e053-2a95a90a04bb	72603-116	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20230301		ANDA	ANDA074550	NorthStar RxLLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72603-117_ee4b1a3b-acfb-5229-e053-2a95a90a04bb	72603-117	HUMAN PRESCRIPTION DRUG	Glipizide		glipizide	TABLET	ORAL	20230301		ANDA	ANDA074550	NorthStar RxLLC	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72603-118_dd10c9a1-a7af-b51f-4317-ee2290f19a85	72603-118	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20220913		ANDA	ANDA090048	NorthStar RxLLC	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
72603-119_dd10c9a1-a7af-b51f-4317-ee2290f19a85	72603-119	HUMAN PRESCRIPTION DRUG	Memantine		Memantine	TABLET	ORAL	20220913		ANDA	ANDA090048	NorthStar RxLLC	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
72603-120_0393d333-5166-4b2e-9fc6-91b2f1781998	72603-120	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101		ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72603-121_0393d333-5166-4b2e-9fc6-91b2f1781998	72603-121	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101		ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72603-122_0393d333-5166-4b2e-9fc6-91b2f1781998	72603-122	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101		ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72603-123_0393d333-5166-4b2e-9fc6-91b2f1781998	72603-123	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101		ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	150	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72603-124_0393d333-5166-4b2e-9fc6-91b2f1781998	72603-124	HUMAN PRESCRIPTION DRUG	TOPIRAMATE		topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20230101		ANDA	ANDA210278	NorthStar RxLLC	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72603-125_eed3aa6f-1e31-e063-e053-2a95a90a286e	72603-125	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET	ORAL	20230201		ANDA	ANDA208209	NorthStar RxLLC	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
72603-126_eed3aa6f-1e31-e063-e053-2a95a90a286e	72603-126	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET	ORAL	20230201		ANDA	ANDA208209	NorthStar RxLLC	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
72603-127_eed3aa6f-1e31-e063-e053-2a95a90a286e	72603-127	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET	ORAL	20230201		ANDA	ANDA208209	NorthStar RxLLC	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
72603-128_e6f21248-e12b-4d74-a573-52b189338de2	72603-128	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20220829		ANDA	ANDA215860	Northstar Rx LLC	PANTOPRAZOLE SODIUM	40	mg/10mL	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72603-129_757a9559-dad4-4397-93ac-d81fbaf92754	72603-129	HUMAN PRESCRIPTION DRUG	Icosapent Ethyl		Icosapent Ethyl	CAPSULE	ORAL	20201104		ANDA	ANDA209457	Northstar Rx LLC	ICOSAPENT ETHYL	1	g/1			N	20241231
72603-130_d9cc5e83-13c7-40a5-86d3-29216f7f55fe	72603-130	HUMAN PRESCRIPTION DRUG	DOFETILIDE		DOFETILIDE	CAPSULE	ORAL	20230207		ANDA	ANDA210466	NorthStar RxLLC	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
72603-131_d9cc5e83-13c7-40a5-86d3-29216f7f55fe	72603-131	HUMAN PRESCRIPTION DRUG	DOFETILIDE		DOFETILIDE	CAPSULE	ORAL	20230207		ANDA	ANDA210466	NorthStar RxLLC	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
72603-132_d9cc5e83-13c7-40a5-86d3-29216f7f55fe	72603-132	HUMAN PRESCRIPTION DRUG	DOFETILIDE		DOFETILIDE	CAPSULE	ORAL	20230207		ANDA	ANDA210466	NorthStar RxLLC	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
72603-133_a6640585-8264-4da8-bc2b-d6caa046d8e8	72603-133	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAVENOUS	20230201		ANDA	ANDA203428	NorthStar Rx LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72603-134_ffaeea5c-aa86-4a43-bacf-89a9c6293282	72603-134	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	NorthStar Rx LLC	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72603-135_ffaeea5c-aa86-4a43-bacf-89a9c6293282	72603-135	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	NorthStar Rx LLC	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72603-136_ffaeea5c-aa86-4a43-bacf-89a9c6293282	72603-136	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	20191213		ANDA	ANDA202187	NorthStar Rx LLC	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72603-139_f4790075-a740-4550-9d4c-69a00dac354c	72603-139	HUMAN PRESCRIPTION DRUG	Thiamine		Thiamine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230420		ANDA	ANDA215692	NorthStar Rx LLC	THIAMINE HYDROCHLORIDE	100	mg/mL			N	20241231
72603-140_1e90c155-29a4-4c16-abe3-df24ac091b17	72603-140	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		Lacosamide	INJECTION	INTRAVENOUS	20230313		ANDA	ANDA209465	Northstar Rx LLC.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
72603-141_2c846d12-405c-6236-1e68-c45dc1c91149	72603-141	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	INJECTION	SUBCUTANEOUS	20230613		ANDA	ANDA090495	NorthStar Rx LLC	SUMATRIPTAN SUCCINATE	6	mg/.5mL	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72603-142_01a4f287-b051-8294-9038-17eaf0121fe0	72603-142	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA090617	Northstar Rx LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72603-143_01a4f287-b051-8294-9038-17eaf0121fe0	72603-143	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA090617	Northstar Rx LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72603-144_abb2bc59-5e73-199a-377f-e0ab03d8efd6	72603-144	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA078889	Northstar Rx LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72603-145_abb2bc59-5e73-199a-377f-e0ab03d8efd6	72603-145	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA078889	Northstar Rx LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72603-146_a2d07ec0-3718-40eb-9d0a-79c557c486b9	72603-146	HUMAN PRESCRIPTION DRUG	Labetalol Hydrochloride		Labetalol Hydrochloride	INJECTION, SOLUTION	INTRAVENOUS	20230428		ANDA	ANDA214533	NorthStar Rx LLC	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72603-147_f9aa5759-84d0-be13-e053-6294a90af8c3	72603-147	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230418		ANDA	ANDA216445	NorthStar RxLLC	DAPTOMYCIN	350	mg/7mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
72603-148_a229a42a-4d1b-45df-aa77-71f44e0921ee	72603-148	HUMAN PRESCRIPTION DRUG	sevelamer hydrochloride		sevelamer hydrochloride	TABLET, FILM COATED	ORAL	20230523		ANDA	ANDA204724	NorthStar RxLLC	SEVELAMER HYDROCHLORIDE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
72603-149_81840aec-96fd-4af2-bd10-3f38d068f39a	72603-149	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20240108		ANDA	ANDA202210	NorthStar RxLLC	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
72603-150_81840aec-96fd-4af2-bd10-3f38d068f39a	72603-150	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20240108		ANDA	ANDA202210	NorthStar RxLLC	ESCITALOPRAM OXALATE	10	mg/21	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
72603-151_81840aec-96fd-4af2-bd10-3f38d068f39a	72603-151	HUMAN PRESCRIPTION DRUG	Escitalopram Oxalate		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20240108		ANDA	ANDA202210	NorthStar RxLLC	ESCITALOPRAM OXALATE	20	mg/21	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
72603-152_f9aa5b99-344b-ab3f-e053-6294a90ade3a	72603-152	HUMAN PRESCRIPTION DRUG	Daptomycin		Daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230418		ANDA	ANDA216413	NorthStar RxLLC	DAPTOMYCIN	500	mg/10mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
72603-153_bdfb7f14-ad9c-4901-844b-aacfbb4429c3	72603-153	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230708		ANDA	ANDA217789	NorthStar Rx LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72603-154_ea3259d5-36ee-4ac9-b849-9625626e2187	72603-154	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20230705		ANDA	ANDA202862	NorthStar RxLLC	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72603-155_ea3259d5-36ee-4ac9-b849-9625626e2187	72603-155	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	NorthStar RxLLC	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72603-156_ea3259d5-36ee-4ac9-b849-9625626e2187	72603-156	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20230705		ANDA	ANDA202862	NorthStar RxLLC	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72603-157_ea3259d5-36ee-4ac9-b849-9625626e2187	72603-157	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20230705		ANDA	ANDA202862	NorthStar RxLLC	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72603-158_ea3259d5-36ee-4ac9-b849-9625626e2187	72603-158	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	NorthStar RxLLC	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72603-159_ea3259d5-36ee-4ac9-b849-9625626e2187	72603-159	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20230705		ANDA	ANDA202862	NorthStar RxLLC	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72603-161_bdfb7f14-ad9c-4901-844b-aacfbb4429c3	72603-161	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230708		ANDA	ANDA217789	NorthStar Rx LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72603-162_1e9cae2e-e3bf-9a9d-22cc-c4a037e47409	72603-162	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution 0.25%		Timolol Maleate Ophthalmic Gel Forming Solution 0.25%	SOLUTION/ DROPS	OPHTHALMIC	20230814		ANDA	ANDA215733	NorthStar RxLLC	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72603-163_1e9cae2e-e3bf-9a9d-22cc-c4a037e47409	72603-163	HUMAN PRESCRIPTION DRUG	Timolol Maleate Ophthalmic Gel Forming Solution 0.5%		Timolol Maleate Ophthalmic Gel Forming Solution 0.5%	SOLUTION/ DROPS	OPHTHALMIC	20230814		ANDA	ANDA215733	NorthStar RxLLC	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72603-164_adfa045e-ce4b-4195-962f-1c3165667119	72603-164	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	OINTMENT	TOPICAL	20230907		ANDA	ANDA074254	NORTHSTAR RX LLC	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72603-165_03f5e601-6572-08bb-e063-6294a90ac155	72603-165	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	NorthStar RxLLC	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
72603-166_042586b3-4d4a-c5ae-e063-6394a90aaa7c	72603-166	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20230830		ANDA	ANDA040001	NorthStar Rx LLC	METHAZOLAMIDE	25	mg/1			N	20241231
72603-167_042586b3-4d4a-c5ae-e063-6394a90aaa7c	72603-167	HUMAN PRESCRIPTION DRUG	Methazolamide		Methazolamide	TABLET	ORAL	20230830		ANDA	ANDA040001	NorthStar Rx LLC	METHAZOLAMIDE	50	mg/1			N	20241231
72603-168_04bf8a28-8d50-d2a5-e063-6394a90a259d	72603-168	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20230830		ANDA	ANDA216202	Northstar Rx LLC	PROCHLORPERAZINE MALEATE	5	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72603-169_04bf8a28-8d50-d2a5-e063-6394a90a259d	72603-169	HUMAN PRESCRIPTION DRUG	Prochlorperazine Maleate		Prochlorperazine Maleate	TABLET	ORAL	20230907		ANDA	ANDA216202	Northstar Rx LLC	PROCHLORPERAZINE MALEATE	10	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
72603-170_04ad6ba3-6782-b5df-e063-6294a90a7e6e	72603-170	HUMAN PRESCRIPTION DRUG	Fludrocortisone Acetate		Fludrocortisone Acetate	TABLET	ORAL	20230907		ANDA	ANDA215279	NorthStar Rx LLC	FLUDROCORTISONE ACETATE	.1	mg/1			N	20241231
72603-171_04aaf2b3-3610-056f-e063-6394a90a91df	72603-171	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	POWDER, FOR SUSPENSION	ORAL	20230907		ANDA	ANDA215043	NorthStar Rx LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72603-173_075aadb3-292e-af29-e063-6394a90a6999	72603-173	HUMAN PRESCRIPTION DRUG	Acetaminophen		Acetaminophen	INJECTION, SOLUTION	INTRAVENOUS	20231101		ANDA	ANDA216617	NorthStar RxLLC	ACETAMINOPHEN	10	mg/mL			N	20241231
72603-175_03f5e601-6572-08bb-e063-6294a90ac155	72603-175	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	NorthStar RxLLC	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
72603-176_04af5933-be7c-3d9e-e063-6294a90a2710	72603-176	HUMAN PRESCRIPTION DRUG	Nitrofurantoin		Nitrofurantoin	SUSPENSION	ORAL	20230907		ANDA	ANDA216385	NorthStar Rx LLC	NITROFURANTOIN	25	mg/5mL	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
72603-177_57338853-6995-de1e-62ca-be5505c8d656	72603-177	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20231215		ANDA	ANDA077619	NorthStar RxLLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
72603-178_57338853-6995-de1e-62ca-be5505c8d656	72603-178	HUMAN PRESCRIPTION DRUG	Pantoprazole		Pantoprazole	TABLET, DELAYED RELEASE	ORAL	20231215		ANDA	ANDA077619	NorthStar RxLLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20251231
72603-180_fd398152-b428-4dca-8478-b691b909ee0e	72603-180	HUMAN PRESCRIPTION DRUG	NOREPINEPHRINE BITARTRATE		norepinephrine bitartrate	INJECTION	INTRAVENOUS	20231201		ANDA	ANDA217575	NorthStar Rx LLC	NOREPINEPHRINE BITARTRATE	1	mg/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
72603-181_075ca296-d5cc-1898-e063-6394a90acd13	72603-181	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR	20231016		ANDA	ANDA217466	NorthStar RxLLC	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]		N	20241231
72603-182_3dfb2c77-98f5-4810-a491-b0b0198bd9c1	72603-182	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20231201		ANDA	ANDA217272	NorthStar RxLLC	NITROFURANTOIN	25	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
72603-183_3dfb2c77-98f5-4810-a491-b0b0198bd9c1	72603-183	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20231201		ANDA	ANDA217272	NorthStar RxLLC	NITROFURANTOIN	50	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
72603-184_3dfb2c77-98f5-4810-a491-b0b0198bd9c1	72603-184	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20231201		ANDA	ANDA217272	NorthStar RxLLC	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
72603-185_03f5e601-6572-08bb-e063-6294a90ac155	72603-185	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	NorthStar RxLLC	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
72603-186_1831737e-5035-4daf-9924-5a29ebb6b433	72603-186	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin otic	SOLUTION	AURICULAR (OTIC)	20231201		ANDA	ANDA216130	NorthStar RxLLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72603-187_0a088b24-f327-cb17-e063-6294a90ac234	72603-187	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230807		ANDA	ANDA215604	NorthStar Rx LLC	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72603-188_0a088b24-f327-cb17-e063-6294a90ac234	72603-188	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230807		ANDA	ANDA217696	NorthStar Rx LLC	DEXAMETHASONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72603-189_0a088b24-f327-cb17-e063-6294a90ac234	72603-189	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230807		ANDA	ANDA215604	NorthStar Rx LLC	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72603-190_0a088b24-f327-cb17-e063-6294a90ac234	72603-190	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230807		ANDA	ANDA215604	NorthStar Rx LLC	DEXAMETHASONE	6	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72603-191_0bad959e-817e-3055-e063-6294a90a7646	72603-191	HUMAN PRESCRIPTION DRUG	sapropterin dihydrochloride		sapropterin dihydrochloride	TABLET	ORAL	20231201		ANDA	ANDA215534	NorthStar RxLLC	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
72603-192_190472a6-29f4-4b58-8436-faeacd608459	72603-192	HUMAN PRESCRIPTION DRUG	ofloxacin		ofloxacin	SOLUTION/ DROPS	OPHTHALMIC	20231201		ANDA	ANDA215886	NorthStar RxLLC	OFLOXACIN	3	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72603-193_0bada422-a189-3871-e063-6294a90a0008	72603-193	HUMAN PRESCRIPTION DRUG	Sapropterin dihydrochloride		Sapropterin dihydrochloride	POWDER, FOR SOLUTION	ORAL	20231201		ANDA	ANDA215420	NorthStar RxLLC	SAPROPTERIN DIHYDROCHLORIDE	100	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
72603-194_0bada422-a189-3871-e063-6294a90a0008	72603-194	HUMAN PRESCRIPTION DRUG	Sapropterin dihydrochloride		Sapropterin dihydrochloride	POWDER, FOR SOLUTION	ORAL	20231201		ANDA	ANDA215420	NorthStar RxLLC	SAPROPTERIN DIHYDROCHLORIDE	500	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]		N	20241231
72603-195_03f5e601-6572-08bb-e063-6294a90ac155	72603-195	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	NorthStar RxLLC	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
72603-196_1080bf1e-86d4-4f7a-9b1b-2823a389dbcc	72603-196	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20231201		ANDA	ANDA217357	NorthStar RxLLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
72603-198_5499e3f9-5d5d-4eeb-a859-62cc967d468f	72603-198	HUMAN PRESCRIPTION DRUG	Zoledronic acid		Zoledronic acid	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20231101		ANDA	ANDA201783	NORTHSTAR RX LLC	ZOLEDRONIC ACID	4	mg/5mL	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
72603-200_b7246b0b-cd55-4364-b4e1-9b0c0efd696e	72603-200	HUMAN PRESCRIPTION DRUG	Doxorubicin Hydrochloride		Doxorubicin Hydrochloride	INJECTABLE, LIPOSOMAL	INTRAVENOUS	20190529		ANDA	ANDA203263	NorthStar RxLLC	DOXORUBICIN HYDROCHLORIDE	2	mg/mL	Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]		N	20241231
72603-205_03f5e601-6572-08bb-e063-6294a90ac155	72603-205	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	NorthStar RxLLC	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
72603-206_b5e33ee2-f766-41d6-8a4b-7b4f0e961bf4	72603-206	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20150916		ANDA	ANDA202726	NorthStar Rx LLC	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
72603-212_0a088b24-f327-cb17-e063-6294a90ac234	72603-212	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231113		ANDA	ANDA215604	NorthStar Rx LLC	DEXAMETHASONE	.5	mg/.5mg	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72603-213_0a088b24-f327-cb17-e063-6294a90ac234	72603-213	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20231113		ANDA	ANDA215604	NorthStar Rx LLC	DEXAMETHASONE	.75	mg/.75mg	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72603-215_03f5e601-6572-08bb-e063-6294a90ac155	72603-215	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	NorthStar RxLLC	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
72603-225_03f5e601-6572-08bb-e063-6294a90ac155	72603-225	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	NorthStar RxLLC	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
72603-230_ed190e9b-7af6-4d59-897a-ed47975ad97b	72603-230	HUMAN PRESCRIPTION DRUG	Haloperidol Decanoate		Haloperidol Decanoate	INJECTION	INTRAMUSCULAR	20231201		ANDA	ANDA216730	NorthStar RxLLC	HALOPERIDOL DECANOATE	100	mg/mL	Typical Antipsychotic [EPC]		N	20241231
72603-240_0e96ff8a-6847-1ba0-e063-6294a90a8c62	72603-240	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	SOLUTION	ORAL	20240110		ANDA	ANDA213698	NorthStar RxLLC	GLYCOPYRROLATE	1	mg/5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20251231
72603-241_0c89dad5-58c5-0c96-e063-6294a90a1006	72603-241	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20231218		ANDA	ANDA217610	NorthStar Rx LLC	ESTRADIOL	.25	mg/.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
72603-242_0c89dad5-58c5-0c96-e063-6294a90a1006	72603-242	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20231218		ANDA	ANDA217610	NorthStar Rx LLC	ESTRADIOL	.5	mg/.5g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
72603-243_0c89dad5-58c5-0c96-e063-6294a90a1006	72603-243	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20231218		ANDA	ANDA217610	NorthStar Rx LLC	ESTRADIOL	.75	mg/.75g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
72603-244_0c89dad5-58c5-0c96-e063-6294a90a1006	72603-244	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20231218		ANDA	ANDA217610	NorthStar Rx LLC	ESTRADIOL	1	mg/g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
72603-245_0c89dad5-58c5-0c96-e063-6294a90a1006	72603-245	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	GEL	TOPICAL	20231218		ANDA	ANDA217610	NorthStar Rx LLC	ESTRADIOL	1.25	mg/1.25g	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
72603-251_a6640585-8264-4da8-bc2b-d6caa046d8e8	72603-251	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAVENOUS	20230201		ANDA	ANDA203428	NorthStar Rx LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72603-301_016df506-49f2-4cab-80d2-01a60ef78370	72603-301	HUMAN PRESCRIPTION DRUG	Oxaliplatin		Oxaliplatin	INJECTION, SOLUTION	INTRAVENOUS	20190617		ANDA	ANDA207325	NorthStar Rx LLC	OXALIPLATIN	5	mg/mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
72603-326_c626e123-2692-43a1-8c3e-3af9ca2f117d	72603-326	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20190510		ANDA	ANDA210046	NorthStar RxLLC	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72603-344_0cf2cd13-08b0-05cb-e063-6394a90ad325	72603-344	HUMAN PRESCRIPTION DRUG	Leuprolide Acetate		Leuprolide Acetate	KIT		20230115		ANDA	ANDA213829	NorthStar RxLLC						N	20241231
72603-411_c626e123-2692-43a1-8c3e-3af9ca2f117d	72603-411	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		Cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20190510		ANDA	ANDA210046	NorthStar RxLLC	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72603-474_a6640585-8264-4da8-bc2b-d6caa046d8e8	72603-474	HUMAN PRESCRIPTION DRUG	Furosemide		Furosemide	INJECTION, SOLUTION	INTRAVENOUS	20230201		ANDA	ANDA203428	NorthStar Rx LLC	FUROSEMIDE	10	mg/mL	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72606-003_19cd2331-75e7-4fb1-a439-d4524a9bd68f	72606-003	HUMAN PRESCRIPTION DRUG	Clobazam		clobazam	TABLET	ORAL	20210121		ANDA	ANDA211959	CELLTRION USA, INC.	CLOBAZAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
72606-004_19cd2331-75e7-4fb1-a439-d4524a9bd68f	72606-004	HUMAN PRESCRIPTION DRUG	Clobazam		clobazam	TABLET	ORAL	20210121		ANDA	ANDA211959	CELLTRION USA, INC.	CLOBAZAM	20	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]	CIV	N	20241231
72606-011_d58b28c8-9a47-4869-92c5-a55895ec1605	72606-011	HUMAN PRESCRIPTION DRUG	Vegzelma		bevacizumab-adcd	INJECTION, SOLUTION	INTRAVENOUS	20230403		BLA	BLA761268	CELLTRION USA, Inc.	BEVACIZUMAB	100	mg/4mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
72606-012_d58b28c8-9a47-4869-92c5-a55895ec1605	72606-012	HUMAN PRESCRIPTION DRUG	Vegzelma		bevacizumab-adcd	INJECTION, SOLUTION	INTRAVENOUS	20230403		BLA	BLA761268	CELLTRION USA, Inc.	BEVACIZUMAB	400	mg/16mL	Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]		N	20241231
72606-022_844d5d61-baed-44ee-afc2-5dd8174c54ca	72606-022	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab-aaty	INJECTION	SUBCUTANEOUS	20231130		BLA	BLA761219	CELLTRION USA, Inc.	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
72606-023_098ca14c-c9b4-46a4-8f4d-543840c6e1a5	72606-023	HUMAN PRESCRIPTION DRUG	Yuflyma		adalimumab	INJECTION	SUBCUTANEOUS	20230929		BLA	BLA761219	CELLTRION USA, Inc.	ADALIMUMAB	80	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20251231
72606-024_098ca14c-c9b4-46a4-8f4d-543840c6e1a5	72606-024	HUMAN PRESCRIPTION DRUG	Yuflyma		adalimumab	INJECTION	SUBCUTANEOUS	20230929		BLA	BLA761219	CELLTRION USA, Inc.	ADALIMUMAB	20	mg/.2mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20251231
72606-030_098ca14c-c9b4-46a4-8f4d-543840c6e1a5	72606-030	HUMAN PRESCRIPTION DRUG	Yuflyma		adalimumab	INJECTION	SUBCUTANEOUS	20230523		BLA	BLA761219	CELLTRION USA, Inc.	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20251231
72606-039_098ca14c-c9b4-46a4-8f4d-543840c6e1a5	72606-039	HUMAN PRESCRIPTION DRUG	Yuflyma		adalimumab	KIT		20230929		BLA	BLA761219	CELLTRION USA, Inc.						N	20251231
72606-040_844d5d61-baed-44ee-afc2-5dd8174c54ca	72606-040	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab-aaty	INJECTION	SUBCUTANEOUS	20231130		BLA	BLA761219	CELLTRION USA, Inc.	ADALIMUMAB	80	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
72606-041_844d5d61-baed-44ee-afc2-5dd8174c54ca	72606-041	HUMAN PRESCRIPTION DRUG	Adalimumab		adalimumab-aaty	INJECTION	SUBCUTANEOUS	20231130		BLA	BLA761219	CELLTRION USA, Inc.	ADALIMUMAB	20	mg/.2mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
72606-046_098ca14c-c9b4-46a4-8f4d-543840c6e1a5	72606-046	HUMAN PRESCRIPTION DRUG	Yuflyma		adalimumab	KIT		20230929		BLA	BLA761219	CELLTRION USA, Inc.						N	20251231
72606-514_c46fb7ce-bb2c-48ef-84ac-9da1a7fec412	72606-514	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20200605		ANDA	ANDA090073	CELLTRION USA, INC.	MEMANTINE HYDROCHLORIDE	5	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
72606-515_c46fb7ce-bb2c-48ef-84ac-9da1a7fec412	72606-515	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride		Memantine Hydrochloride	TABLET, FILM COATED	ORAL	20200605		ANDA	ANDA090073	CELLTRION USA, INC.	MEMANTINE HYDROCHLORIDE	10	mg/1	N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]		N	20241231
72606-554_e38150f6-257d-415d-b90c-09f30f083612	72606-554	HUMAN PRESCRIPTION DRUG	Capecitabine 150mg		Capecitabine	TABLET, FILM COATED	ORAL	20191106		ANDA	ANDA207456	CELLTRION USA, INC.	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72606-555_e38150f6-257d-415d-b90c-09f30f083612	72606-555	HUMAN PRESCRIPTION DRUG	Capecitabine 500mg		CAPECITABINE	TABLET, FILM COATED	ORAL	20191106		ANDA	ANDA207456	CELLTRION USA, INC.	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72606-556_49f943af-2ff6-4a87-aabc-1786db9d4ff1	72606-556	HUMAN PRESCRIPTION DRUG	Imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20191106		ANDA	ANDA208302	CELLTRION USA, INC.	IMATINIB MESYLATE	100	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72606-557_49f943af-2ff6-4a87-aabc-1786db9d4ff1	72606-557	HUMAN PRESCRIPTION DRUG	Imatinib mesylate		imatinib mesylate	TABLET, FILM COATED	ORAL	20191106		ANDA	ANDA208302	CELLTRION USA, INC.	IMATINIB MESYLATE	400	mg/1	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]		N	20241231
72606-558_1542236d-9049-4a6b-8956-c53d38f8520c	72606-558	HUMAN PRESCRIPTION DRUG	AZACITIDINE		azacitidine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20200106		ANDA	ANDA207518	CELLTRION USA, INC.	AZACITIDINE	100	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
72606-559_63ede55c-8326-4a52-a873-f46ce8427ae6	72606-559	HUMAN PRESCRIPTION DRUG	Busulfan		Busulfan	INJECTION	INTRAVENOUS	20191201		ANDA	ANDA210931	CELLTRION USA, INC.	BUSULFAN	6	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72606-566_2765ab03-f2d2-4e68-a704-c1c45505b50a	72606-566	HUMAN PRESCRIPTION DRUG	Abiraterone acetate		Abiraterone acetate	TABLET	ORAL	20200107		ANDA	ANDA212462	CELLTRION USA, INC.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
72606-567_0ebb714e-0792-47af-9194-67bc50d2705e	72606-567	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20200605		ANDA	ANDA206973	CELLTRION USA, INC.	ZOLMITRIPTAN	2.5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72606-568_0ebb714e-0792-47af-9194-67bc50d2705e	72606-568	HUMAN PRESCRIPTION DRUG	Zolmitriptan		Zolmitriptan	TABLET, FILM COATED	ORAL	20200605		ANDA	ANDA206973	CELLTRION USA, INC.	ZOLMITRIPTAN	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
72606-573_2765ab03-f2d2-4e68-a704-c1c45505b50a	72606-573	HUMAN PRESCRIPTION DRUG	Abiraterone acetate		Abiraterone acetate	TABLET	ORAL	20210722		ANDA	ANDA212462	CELLTRION USA, INC.	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
72607-100_6656919b-73f1-4d41-9da9-944e72f0356d	72607-100	HUMAN PRESCRIPTION DRUG	TAZVERIK		tazemetostat	TABLET, FILM COATED	ORAL	20200123		NDA	NDA211723	Epizyme, Inc.	TAZEMETOSTAT HYDROBROMIDE	200	mg/1	Methyltransferase Inhibitor [EPC], Methyltransferase Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]		N	20241231
72611-634_4ffd5cec-03a6-4531-b8d5-b6e262ee4e3a	72611-634	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	ALMAJECT, INC.	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72611-639_4ffd5cec-03a6-4531-b8d5-b6e262ee4e3a	72611-639	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	ALMAJECT, INC.	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72611-642_4ffd5cec-03a6-4531-b8d5-b6e262ee4e3a	72611-642	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	ALMAJECT, INC.	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72611-645_4ffd5cec-03a6-4531-b8d5-b6e262ee4e3a	72611-645	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	INJECTION, SOLUTION	INTRAVENOUS	19721002		NDA	NDA050441	ALMAJECT, INC.	CLINDAMYCIN PHOSPHATE	150	mg/mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72611-700_8ff7d1ad-8146-8207-d467-e9c7cfdd12f2	72611-700	HUMAN PRESCRIPTION DRUG	caspofungin acetate		caspofungin acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200331		ANDA	ANDA207092	Almaject, Inc.	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
72611-702_8ff7d1ad-8146-8207-d467-e9c7cfdd12f2	72611-702	HUMAN PRESCRIPTION DRUG	Caspofungin Acetate		caspofungin acetate	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200331		ANDA	ANDA207092	Almaject, Inc.	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
72611-716_ce8b4e89-8e2c-5cde-2a20-df21fac07d57	72611-716	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane for Injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200901		ANDA	ANDA207321	Almaject, Inc.	DEXRAZOXANE HYDROCHLORIDE	500	mg/50mL	Cytoprotective Agent [EPC]		N	20241231
72611-716_e961ed48-b0cf-5604-d38c-285e0b8df548	72611-716	HUMAN PRESCRIPTION DRUG	Dexrazoxane		Dexrazoxane for Injection	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220601		ANDA	ANDA207321	Almaject, Inc.	DEXRAZOXANE HYDROCHLORIDE	500	mg/50mL	Cytoprotective Agent [EPC]		N	20241231
72611-719_38ddbbb7-f1ce-daba-cf1c-8761f9c5c3ef	72611-719	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200201		ANDA	ANDA204216	Almaject, Inc.	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72611-722_38ddbbb7-f1ce-daba-cf1c-8761f9c5c3ef	72611-722	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200121		ANDA	ANDA204216	Almaject, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72611-725_38ddbbb7-f1ce-daba-cf1c-8761f9c5c3ef	72611-725	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20200110		ANDA	ANDA204216	Almaject, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72611-734_70b3be52-4485-fa01-222e-e251837ff0de	72611-734	HUMAN PRESCRIPTION DRUG	labetalol hydrochloride		labetalol hydrochloride	INJECTION	INTRAVENOUS	20200601		ANDA	ANDA090699	Almaject, Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72611-738_70b3be52-4485-fa01-222e-e251837ff0de	72611-738	HUMAN PRESCRIPTION DRUG	labetalol hydrochloride		labetalol hydrochloride	INJECTION	INTRAVENOUS	20200601		ANDA	ANDA090699	Almaject, Inc.	LABETALOL HYDROCHLORIDE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72611-740_4a307739-5ec2-dbba-3c45-9d60b4e8cd37	72611-740	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		metoprolol tartrate	INJECTION, SOLUTION	INTRAVENOUS	20200331		ANDA	ANDA204205	Almaject, Inc.	METOPROLOL TARTRATE	1	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72611-741_87807c1e-c3b9-8c88-40df-684e805e47bc	72611-741	HUMAN PRESCRIPTION DRUG	midazolam		midazolam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200414		ANDA	ANDA090696	Almaject, Inc.	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72611-749_c40ab914-ed64-1f31-1826-932cb9464220	72611-749	HUMAN PRESCRIPTION DRUG	midazolam		midazolam	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200414		ANDA	ANDA090850	Almaject, Inc.	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72611-756_c4a69f20-f855-cae9-2341-247b5f7513ff	72611-756	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		rocuronium bromide	INJECTION	INTRAVENOUS	20200327		ANDA	ANDA205656	Almaject, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72611-757_c4a69f20-f855-cae9-2341-247b5f7513ff	72611-757	HUMAN PRESCRIPTION DRUG	Rocuronium Bromide		rocuronium bromide	INJECTION	INTRAVENOUS	20200327		ANDA	ANDA205656	Almaject, Inc.	ROCURONIUM BROMIDE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72611-760_e0f15db3-e0a6-1130-35bd-a3fa7dedfe94	72611-760	HUMAN PRESCRIPTION DRUG	Tranexamic Acid		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20210301		ANDA	ANDA207239	Almaject, Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
72611-761_a5934623-7861-a65d-ae66-708e9520cbb1	72611-761	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200508		ANDA	ANDA205694	Almaject, Inc.	VANCOMYCIN HYDROCHLORIDE	500	mg/10mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
72611-765_a5934623-7861-a65d-ae66-708e9520cbb1	72611-765	HUMAN PRESCRIPTION DRUG	Vancomycin Hydrochloride		vancomycin hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200508		ANDA	ANDA205694	Almaject, Inc.	VANCOMYCIN HYDROCHLORIDE	1	g/20mL	Glycopeptide Antibacterial [EPC], Glycopeptides [CS]		N	20241231
72611-779_023930ae-e5a6-4561-1266-c337efbbc2f6	72611-779	HUMAN PRESCRIPTION DRUG	melphalan hydrochloride		melphalan hydrochloride	KIT		20190518		ANDA	ANDA204817	Almaject, Inc.						N	20241231
72611-785_43d87a8b-7237-64cd-165f-09894680db15	72611-785	HUMAN PRESCRIPTION DRUG	Temsirolimus		Temsirolimus Injection	KIT		20200508		ANDA	ANDA207383	Almaject, Inc.						N	20241231
72611-860_0c3a3ef5-d364-8311-9d9e-f0097acdb82e	72611-860	HUMAN PRESCRIPTION DRUG	ACETYLCYSTEINE		ACETYLCYSTEINE	INJECTION	INTRAVENOUS	20221017		ANDA	ANDA215620	Almaject, Inc.	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
72611-874_974ac1a4-cb88-6339-5b65-0d50108df695	72611-874	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20230703		ANDA	ANDA207320	Almaject, Inc.	REGADENOSON	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
72614-265_0974736c-8d20-767b-e063-6294a90a5abe	72614-265	HUMAN OTC DRUG	CANNA NUMB Roll On		LIDOCAINE HYDROCHLORIDE, MENTHOL	LIQUID	TOPICAL	20181001		OTC MONOGRAPH DRUG	M017	Hempagenix, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72618-3000_2324b31a-d161-463e-9c3a-b4b611fd3de1	72618-3000	HUMAN PRESCRIPTION DRUG	NURTEC ODT		rimegepant sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20200305		NDA	NDA212728	Pfizer Laboratories Div Pfizer Inc	RIMEGEPANT SULFATE	75	mg/1	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
72618-3001_2324b31a-d161-463e-9c3a-b4b611fd3de1	72618-3001	HUMAN PRESCRIPTION DRUG	NURTEC ODT		rimegepant sulfate	TABLET, ORALLY DISINTEGRATING	ORAL	20200305		NDA	NDA212728	Pfizer Laboratories Div Pfizer Inc	RIMEGEPANT SULFATE	75	mg/1	Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]		N	20241231
72622-001_bf3915d9-4097-47df-8de3-f47340b75298	72622-001	HUMAN OTC DRUG	Clinicians Complex		Sulfur	LOTION	TOPICAL	20181101		OTC MONOGRAPH FINAL	part333D	SkinSx.com, Inc.	SULFUR	100	mg/g			N	20241231
72625-130_9f6fa49b-3aaf-48ab-aba2-ac74f6cbb6cc	72625-130	HUMAN OTC DRUG	Ultra Vedic		Feminine Pain Relief	PATCH	TOPICAL	20190301		OTC MONOGRAPH NOT FINAL	part348	Pharmaneek, Inc.	MENTHOL, UNSPECIFIED FORM	200	mg/1			N	20241231
72626-2601_a90fc9bb-7020-4121-9682-35731d3ce975	72626-2601	HUMAN PRESCRIPTION DRUG	Ledipasvir and Sofosbuvir		Ledipasvir and Sofosbuvir	TABLET, FILM COATED	ORAL	20190101		NDA AUTHORIZED GENERIC	NDA205834	Asegua Therapeutics LLC	LEDIPASVIR; SOFOSBUVIR	90; 400	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Nucleoside Analog [EXT], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
72626-2701_f259fb14-e171-4f3e-b275-e79748375ce0	72626-2701	HUMAN PRESCRIPTION DRUG	Sofosbuvir and Velpatasvir		Velpatasvir and Sofosbuvir	TABLET, FILM COATED	ORAL	20181114		NDA AUTHORIZED GENERIC	NDA208341	Asegua Therapeutics LLC	SOFOSBUVIR; VELPATASVIR	400; 100	mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]		N	20241231
72628-102_b8f55136-bcbe-496e-e053-2a95a90aff0e	72628-102	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	PASTILLE	ORAL	20190309		OTC MONOGRAPH FINAL	part341	Boston Nutraceutical Production SL	MENTHOL	7.6	mg/1			N	20241231
72628-103_b8f56ed6-7e3b-0293-e053-2a95a90a8e1c	72628-103	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	PASTILLE	ORAL	20190326		OTC MONOGRAPH FINAL	part341	Boston Nutraceutical Production SL	MENTHOL	7.6	mg/1			N	20241231
72628-104_b8f51ddc-c64a-24be-e053-2995a90a79b8	72628-104	HUMAN OTC DRUG	Black Cherry Cough Drops		Menthol	PASTILLE	ORAL	20190326		OTC MONOGRAPH FINAL	part341	Boston Nutraceutical Production SL	MENTHOL	5.8	mg/1			N	20241231
72628-105_b8f51795-2016-f2da-e053-2a95a90af7de	72628-105	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	PASTILLE	ORAL	20190326		OTC MONOGRAPH FINAL	part341	Boston Nutraceutical Production SL	MENTHOL	5.8	mg/1			N	20241231
72628-106_b8f51795-2015-f2da-e053-2a95a90af7de	72628-106	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	PASTILLE	ORAL	20190326		OTC MONOGRAPH FINAL	part341	Boston Nutraceutical Production SL	MENTHOL	5.8	mg/1			N	20241231
72628-107_a706ed57-ef38-6e5d-e053-2995a90a59f7	72628-107	HUMAN OTC DRUG	Natural Herbal Cough Drops		Menthol	PASTILLE	ORAL	20200601		OTC MONOGRAPH FINAL	part341	BOSTON NUTRACEUTICAL PRODUCTION, S.L	MENTHOL	4.8	mg/1			N	20241231
72628-108_f405e91c-247b-72ba-e053-2995a90a70da	72628-108	HUMAN OTC DRUG	Menthol Vapor Cough Drops		Menthol	PASTILLE	ORAL	20200601		OTC MONOGRAPH FINAL	part341	BOSTON NUTRACEUTICAL PRODUCTION, S.L	MENTHOL	20	mg/1			N	20241231
72628-109_b8f48a47-6872-f7ed-e053-2995a90a16f3	72628-109	HUMAN OTC DRUG	Honey Lemon Cough Drops		Menthol	PASTILLE	ORAL	20190326		OTC MONOGRAPH FINAL	part341	Boston Nutraceutical Production SL	MENTHOL	7.6	mg/1			N	20241231
72628-111_f405cbd1-b54c-6e4c-e053-2a95a90a8a4f	72628-111	HUMAN OTC DRUG	Natural Herbal Cough Drops		Menthol	PASTILLE	ORAL	20210512		OTC MONOGRAPH FINAL	part341	BOSTON NUTRACEUTICAL PRODUCTION, S.L	MENTHOL	4.8	mg/1			N	20241231
72630-030_e25994c4-c617-4eb9-999a-822d846670bb	72630-030	HUMAN OTC DRUG	DR.PLINUS ZERO TROUBLE		Gluconolactone, Epigallocatechin Gallatyl Glucoside, Madecassoside	PATCH	TOPICAL	20210501		UNAPPROVED DRUG OTHER		S Skin Co., Ltd.	EPIGALLOCATECHIN GALLATYL GLUCOSIDE; GLUCONOLACTONE; MADECASSOSIDE	.0007; .029; .00001	mg/1.4mg; mg/1.4mg; mg/1.4mg	Calculi Dissolution Agent [EPC], Irrigation [MoA]		N	20241231
72638-001_b96b78f9-de91-cbf6-e053-2995a90a8893	72638-001	HUMAN OTC DRUG	Metabolic Reset		Aceticum Acidum, Anacardium Orientale, Baryta Iodata, Calcarea Carbonica, Capsicum Annum, Focus Versiculosus, Graphites, Natrum Sulphuricum, Phytolacca Decandra, Stannum Metallicum, Thyroidinum, Zincum Metallicum	LIQUID	ORAL	20190701		UNAPPROVED HOMEOPATHIC		Hanoun, Andrew Functional Medicine Inc.	ACETIC ACID; BARIUM IODIDE; CAPSICUM; FUCUS VESICULOSUS; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; SEMECARPUS ANACARDIUM JUICE; SODIUM SULFIDE NONAHYDRATE; THYROID, UNSPECIFIED; TIN; ZINC	10; 12; 14; 5; 14; 14; 7; 14; 14; 12; 16; 14	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
72641-001_bfb0250b-a218-4edc-817a-849af07c006b	72641-001	HUMAN PRESCRIPTION DRUG	Clotrimazole Topical Solution USP, 1%		Clotrimazole Topical Solution USP, 1%	SOLUTION	TOPICAL	20190725		ANDA	ANDA212281	Tasman Pharma Inc.	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72641-002_f3d208ca-3397-49d4-860a-772d5bb0695c	72641-002	HUMAN PRESCRIPTION DRUG	Fluocinolone Acetonide Oil, 0.01% (Ear Drops)		Fluocinolone Acetonide Oil, 0.01% (Ear Drops)	OIL	AURICULAR (OTIC)	20210205		ANDA	ANDA213264	Tasman Pharma Inc.	FLUOCINOLONE ACETONIDE	.11	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72641-004_f726b3fc-5483-4120-bdd5-9c44e1f4b5de	72641-004	HUMAN PRESCRIPTION DRUG	Betamethasone Dipropionate USP, 0.05%		Betamethasone Dipropionate USP, 0.05%	OINTMENT	TOPICAL	20220218		ANDA	ANDA215186	Tasman Pharma Inc.	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72641-005_d6ee378a-9542-4f67-9d7c-6d7a98ec2fe2	72641-005	HUMAN PRESCRIPTION DRUG	Ketoconazole Cream, 2%		Ketoconazole Cream, 2%	CREAM	TOPICAL	20211117		ANDA	ANDA215185	Tasman Pharma Inc.	KETOCONAZOLE	20	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72644-633_af727835-980e-5af0-e053-2a95a90a5ad7	72644-633	HUMAN OTC DRUG	DayTime Moisturizer		Salicylic Acid	LOTION	TOPICAL	20200916		OTC MONOGRAPH FINAL	part358H	SGII, INC	SALICYLIC ACID	1	g/100g			N	20241231
72644-634_af74baf6-c8c3-3a58-e053-2a95a90a669e	72644-634	HUMAN OTC DRUG	3 in 1 Cleanser		Salicylic Acid	LIQUID	TOPICAL	20200916		OTC MONOGRAPH FINAL	part358H	SGII, INC.	SALICYLIC ACID	1	g/100g			N	20241231
72644-635_af741928-c852-4c2a-e053-2995a90a7c1d	72644-635	HUMAN OTC DRUG	Evening Moisturizer		Salicylic Acid	CREAM	TOPICAL	20200916		OTC MONOGRAPH FINAL	part358H	SGII, INC.	SALICYLIC ACID	1	g/100g			N	20241231
72644-636_d2948dc8-0769-7dcc-e053-2995a90a10d9	72644-636	HUMAN OTC DRUG	Spot On Treatment		Benzyl Peroxide	LOTION	TOPICAL	20200916		OTC MONOGRAPH FINAL	part333D	SGII, INC	BENZOYL PEROXIDE	10	g/100g			N	20241231
72644-637_bde71227-297c-36f0-e053-2995a90ab9ee	72644-637	HUMAN OTC DRUG	Senegence Hand Sanitizer		Alcohol 70%	LIQUID	TOPICAL	20201005		OTC MONOGRAPH NOT FINAL	part333A	SGII, Inc	ALCOHOL	140	mL/200mL			N	20241231
72647-330_d61ffa19-149f-4402-884a-4d16becb80ba	72647-330	HUMAN PRESCRIPTION DRUG	Pyrimethamine		pyrimethamine	TABLET	ORAL	20200313		NDA AUTHORIZED GENERIC	NDA008578	OAKRUM PHARMA, LLC	PYRIMETHAMINE	25	mg/1	Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
72647-331_95478ba5-65bc-4f31-b596-6417bed6f66c	72647-331	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		methylprednisolone	TABLET	ORAL	20191112	20240131	ANDA	ANDA212262	OAKRUM PHARMA, LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
72647-371_b170a73b-628d-4c59-b837-768812fbdd6c	72647-371	HUMAN PRESCRIPTION DRUG	Deferasirox Oral Granules		deferasirox	GRANULE	ORAL	20210309	20240131	ANDA	ANDA214559	OAKRUM PHARMA, LLC	DEFERASIROX	90	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	
72647-372_b170a73b-628d-4c59-b837-768812fbdd6c	72647-372	HUMAN PRESCRIPTION DRUG	Deferasirox Oral Granules		deferasirox	GRANULE	ORAL	20210309	20240131	ANDA	ANDA214559	OAKRUM PHARMA, LLC	DEFERASIROX	180	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	
72647-373_b170a73b-628d-4c59-b837-768812fbdd6c	72647-373	HUMAN PRESCRIPTION DRUG	Deferasirox Oral Granules		deferasirox	GRANULE	ORAL	20210309	20240131	ANDA	ANDA214559	OAKRUM PHARMA, LLC	DEFERASIROX	360	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]		N	
72647-900_acce10dd-c8fa-4457-b3ed-d716c9978e29	72647-900	HUMAN PRESCRIPTION DRUG	Betaine Anhydrous for Oral Solution		Betaine Anhydrous	FOR SOLUTION	ORAL	20220203	20240430	ANDA	ANDA214864	OAKRUM PHARMA, LLC	BETAINE	1	g/g	Methylating Activity [MoA], Methylating Agent [EPC]		N	
72654-001_0d771f4d-fd0d-cd5d-e063-6394a90a0720	72654-001	HUMAN OTC DRUG	Fungus Master Antifungal Treatment		MICONAZOLE NITRATE	LOTION	TOPICAL	20191101		OTC MONOGRAPH DRUG	M005	Ebanel Laboratories, Inc	MICONAZOLE NITRATE	20	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72654-002_0d77230e-fbf0-c95e-e063-6394a90ab484	72654-002	HUMAN OTC DRUG	Hemorrhoid Master		LIDOCAINE, PHENYLEPHRINE	OINTMENT	TOPICAL	20191101		OTC MONOGRAPH DRUG	M017	Ebanel Laboratories, Inc	LIDOCAINE; PHENYLEPHRINE	40; 2.5	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72657-102_ff452c34-eeee-4b6a-b177-e2b767e2c9d5	72657-102	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20230101		ANDA	ANDA091314	GLENMARK THERAPEUTICS INC., USA	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
72657-108_b0dd498e-5624-43a5-952d-3222c040513a	72657-108	HUMAN OTC DRUG	SheWise		Levonorgestrel	TABLET	ORAL	20220729		ANDA	ANDA207044	GLENMARK THERAPEUTICS INC., USA	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20251231
72657-109_4488b3e5-6a6d-49ce-a578-da53b406aa5c	72657-109	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20220113		ANDA	ANDA077654	Glenmark Therapeutics Inc., USA	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72657-110_4488b3e5-6a6d-49ce-a578-da53b406aa5c	72657-110	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20220113		ANDA	ANDA077654	Glenmark Therapeutics Inc., USA	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72657-111_4488b3e5-6a6d-49ce-a578-da53b406aa5c	72657-111	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20220113		ANDA	ANDA077654	Glenmark Therapeutics Inc., USA	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72657-112_ee1f9ca9-3c23-4662-8194-68ec5ea7a6bd	72657-112	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA215822	GLENMARK THERAPEUTICS INC., USA	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
72657-113_ee1f9ca9-3c23-4662-8194-68ec5ea7a6bd	72657-113	HUMAN OTC DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20220601		ANDA	ANDA215822	GLENMARK THERAPEUTICS INC., USA	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20251231
72657-123_07567b80-d8a1-41c0-95e4-33afa584bbc4	72657-123	HUMAN OTC DRUG	Levonorgestrel		Levonorgestrel	TABLET	ORAL	20230209		ANDA	ANDA207044	GLENMARK THERAPEUTICS INC., USA	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
72657-124_4744704a-027c-4925-9d57-99b4434fc946	72657-124	HUMAN OTC DRUG	esomeprazole magnesium		esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230822		ANDA	ANDA216349	GLENMARK THERAPEUTICS INC., USA	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72658-0808_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0808	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	25	mg/1		CV	N	20241231
72658-0809_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0809	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	50	mg/1		CV	N	20241231
72658-0810_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0810	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	75	mg/1		CV	N	20241231
72658-0811_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0811	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	100	mg/1		CV	N	20241231
72658-0812_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0812	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	150	mg/1		CV	N	20241231
72658-0813_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0813	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	225	mg/1		CV	N	20241231
72658-0814_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0814	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	300	mg/1		CV	N	20241231
72658-0849_026461ad-5290-8a9d-e063-6394a90a83b5	72658-0849	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220404		ANDA	ANDA212988	Eskayef Pharmaceuticals Limited	PREGABALIN	200	mg/1		CV	N	20241231
72660-001_0a235a45-bec8-83d1-e063-6394a90a800d	72660-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091028		UNAPPROVED MEDICAL GAS		Medical Equipment Solutions Inc dba Pur Air Products	OXYGEN	99	L/100L			N	20241231
72661-123_06d33b7f-6a4c-472f-e063-6294a90a7624	72661-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130531		UNAPPROVED MEDICAL GAS		CareLinc Medical Equipment	OXYGEN	99	L/100L			N	20241231
72662-123_0d82275f-6735-e1a3-e063-6394a90ad12e	72662-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100825		UNAPPROVED MEDICAL GAS		Verio Healthcare, Inc.	OXYGEN	99	L/100L			N	20241231
72663-069_a3d11002-6082-4737-95a0-d3ecd4a0c194	72663-069	HUMAN OTC DRUG	Welly Calm Balm		Anti Itch Cream	CREAM	TOPICAL	20190209		OTC MONOGRAPH FINAL	part347	Welly Health PBC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72663-111_d4772db9-a478-2095-e053-2a95a90a82c0	72663-111	HUMAN OTC DRUG	Antiseptic		alcohol	GEL	TOPICAL	20190225		OTC MONOGRAPH NOT FINAL	part333E	Welly Health PCB	ALCOHOL	666	mg/mL			N	20241231
72663-112_d4779541-f4dc-ed29-e053-2a95a90a89e0	72663-112	HUMAN OTC DRUG	Welly Clean Hands		alcohol	GEL	TOPICAL	20190827		OTC MONOGRAPH NOT FINAL	part333A	Welly Health PBC	ALCOHOL	66.5	mL/100mL			N	20241231
72663-155_0cf1abd1-278d-4f5c-99d3-252b41ff0aae	72663-155	HUMAN OTC DRUG	Welly Itch Fix		Hydrocortisone Anti Itch Cream	CREAM	TOPICAL	20190222		OTC MONOGRAPH NOT FINAL	part348	Welly Health PBC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72663-161_023cafb4-3709-43d4-8e78-b8eb1eaef4ee	72663-161	HUMAN OTC DRUG	Welly Bravery Triple Antibiotic with Pain Relief		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine HCL	OINTMENT	TOPICAL	20190131		OTC MONOGRAPH FINAL	part333B	Welly Health PBC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72663-162_aa14bfb5-5dbe-448a-b6ed-4b5fcdcd7e4e	72663-162	HUMAN OTC DRUG	Welly Bravery Triple Antibiotic		Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate	OINTMENT	TOPICAL	20110123		OTC MONOGRAPH FINAL	part333B	Welly Health PBC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72663-493_ccecee2e-8dc5-4d0a-9bbe-a38da57be80e	72663-493	HUMAN OTC DRUG	Itch Fixer		hydrocortisone	CREAM	TOPICAL	20211001		OTC MONOGRAPH NOT FINAL	part348	Welly Health PBC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72663-560_d476fb97-dda2-7a4c-e053-2a95a90a39a2	72663-560	HUMAN OTC DRUG	Antibiotic		bacitracin zinc, neomycin sulfate, polymyxin b sulfate	OINTMENT	TOPICAL	20190225		OTC MONOGRAPH FINAL	part333B	Welly Health PBC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	6; 3.5; .77	mg/mL; mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72663-561_d477bcd9-0c60-a423-e053-2a95a90ac022	72663-561	HUMAN OTC DRUG	Welly Bravery Balm		bacitracin zinc, neomycin sulfate, polymyxin b sulfate	OINTMENT	TOPICAL	20190906		OTC MONOGRAPH FINAL	part333B	Welly Health PBC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72663-636_93060ba2-beda-451c-bd24-70408a09711b	72663-636	HUMAN OTC DRUG	Bump and Bruise Reliever		MENTHOL	CREAM	TOPICAL	20220301		OTC MONOGRAPH NOT FINAL	part348	Welly Health PBC	MENTHOL, UNSPECIFIED FORM	1.5	g/100g			N	20241231
72664-211_05f81151-3c12-9235-e063-6294a90af890	72664-211	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20200630		ANDA	ANDA212856	VGYAAN Pharmaceuticals LLC	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72664-212_05f81151-3c12-9235-e063-6294a90af890	72664-212	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20200630		ANDA	ANDA212856	VGYAAN Pharmaceuticals LLC	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72664-213_05f81151-3c12-9235-e063-6294a90af890	72664-213	HUMAN PRESCRIPTION DRUG	NADOLOL		NADOLOL	TABLET	ORAL	20200630		ANDA	ANDA212856	VGYAAN Pharmaceuticals LLC	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72664-214_05f77230-a0af-366f-e063-6294a90a70c7	72664-214	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20210701		ANDA	ANDA213221	VGYAAN Pharmaceuticals LLC	CLOMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72664-215_05f77230-a0af-366f-e063-6294a90a70c7	72664-215	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20210701		ANDA	ANDA213221	VGYAAN Pharmaceuticals LLC	CLOMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72664-216_05f77230-a0af-366f-e063-6294a90a70c7	72664-216	HUMAN PRESCRIPTION DRUG	Clomipramine Hydrochloride		Clomipramine Hydrochloride	CAPSULE	ORAL	20210701		ANDA	ANDA213221	VGYAAN Pharmaceuticals LLC	CLOMIPRAMINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72664-217_062ebe65-b4e7-2fb9-e063-6294a90a5caa	72664-217	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20201025		ANDA	ANDA214329	VGYAAN Pharmaceuticals LLC	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72664-218_05f0f9ee-9f24-be46-e063-6294a90a037a	72664-218	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20201119		ANDA	ANDA214328	VGYAAN Pharmaceuticals LLC	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72664-227_05f10272-9976-b4f6-e063-6294a90a0092	72664-227	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211130		ANDA	ANDA215629	VGYAAN Pharmaceuticals LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72664-228_05f10272-9976-b4f6-e063-6294a90a0092	72664-228	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20211130		ANDA	ANDA215629	VGYAAN Pharmaceuticals LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72664-229_06f10c20-8274-cef9-e063-6294a90aed71	72664-229	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20210731		ANDA	ANDA215323	VGYAAN Pharmaceuticals LLC	DOFETILIDE	.125	mg/1	Antiarrhythmic [EPC]		N	20241231
72664-230_06f10c20-8274-cef9-e063-6294a90aed71	72664-230	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20210731		ANDA	ANDA215323	VGYAAN Pharmaceuticals LLC	DOFETILIDE	.25	mg/1	Antiarrhythmic [EPC]		N	20241231
72664-231_06f10c20-8274-cef9-e063-6294a90aed71	72664-231	HUMAN PRESCRIPTION DRUG	Dofetilide		Dofetilide	CAPSULE	ORAL	20210731		ANDA	ANDA215323	VGYAAN Pharmaceuticals LLC	DOFETILIDE	.5	mg/1	Antiarrhythmic [EPC]		N	20241231
72664-611_06472efa-d14f-d303-e063-6394a90a596b	72664-611	HUMAN PRESCRIPTION DRUG	Leuprolide Acetate		Leuprolide Acetate	KIT		20201025		ANDA	ANDA213829	VGYAAN Pharmaceuticals LLC						N	20241231
72667-008_f1ec87b6-3897-1d10-e053-2995a90a053d	72667-008	HUMAN OTC DRUG	MyDerm		Lidocaine	GEL	TOPICAL	20190226		OTC MONOGRAPH NOT FINAL	part348	Inspec Solutions LLC.	LIDOCAINE HYDROCHLORIDE	.5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72667-019_f1ec46e5-eea5-d623-e053-2a95a90a13c3	72667-019	HUMAN OTC DRUG	MyDerm Bite Relief		Benzocaine	OINTMENT	TOPICAL	20211214		OTC MONOGRAPH NOT FINAL	part348	Inspec Solutions LLC.	BENZOCAINE	5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72667-020_f1ec46e5-eeb1-d623-e053-2a95a90a13c3	72667-020	HUMAN OTC DRUG	myDerm Cooling Menthol Pain Relief with 50 Percent More Menthol		Menthol	SPRAY	TOPICAL	20211227		OTC MONOGRAPH NOT FINAL	part348	Inspec Solutions LLC	MENTHOL	15.75	g/100mL			N	20241231
72667-021_f1ec1402-5ac2-61ec-e053-2a95a90a2e4c	72667-021	HUMAN OTC DRUG	myDerm Cooling Menthol Pain Relief with 50 Percent More Menthol		Menthol	GEL	TOPICAL	20211227		OTC MONOGRAPH NOT FINAL	part348	Inspec Solutions LLC.	MENTHOL	6	g/100mL			N	20241231
72667-022_f1ec39f0-2786-2676-e053-2a95a90a5fde	72667-022	HUMAN OTC DRUG	myDerm Cooling Menthol Pain Relief Roll-On with 50 Percent More Menthol		Menthol	GEL	TOPICAL	20211227		OTC MONOGRAPH NOT FINAL	part348	Inspec Solutions LLC.	MENTHOL	6	g/100mL			N	20241231
72667-058_f14da33b-2eb0-dc2c-e053-2a95a90a3203	72667-058	HUMAN OTC DRUG	myDerm Numbing Roll-On		Inspec Solutions LLC	CREAM	TOPICAL	20230102		OTC MONOGRAPH NOT FINAL	part348	Inspec Solutions LLC.	LIDOCAINE HYDROCHLORIDE	5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72667-060_f1613a86-05af-161e-e053-2995a90a3426	72667-060	HUMAN OTC DRUG	Hawaiian Blend Essential Zinc SPF 30		Zinc Oxide, Titanium Dioxide	AEROSOL	TOPICAL	20230103		OTC MONOGRAPH NOT FINAL	part352	Inspec Solutions LLC.	TITANIUM DIOXIDE; ZINC OXIDE	4; 19.5	g/100g; g/100g			N	20241231
72667-061_f161544b-40da-6c22-e053-2995a90ad846	72667-061	HUMAN OTC DRUG	Hawaiian Blend Extreme Zinc SPF 50		Zinc Oxide, Titanium Dioxide	AEROSOL	TOPICAL	20230103		OTC MONOGRAPH NOT FINAL	part352	Inspec Solutions LLC.	TITANIUM DIOXIDE; ZINC OXIDE	4; 19.5	g/100g; g/100g			N	20241231
72667-062_f161c099-7e1b-56b7-e053-2995a90ae1d0	72667-062	HUMAN OTC DRUG	Hawaiian Blend Sensitive Zinc SPF 50		Zinc Oxide, Titanium Dioxide	AEROSOL	TOPICAL	20230103		OTC MONOGRAPH NOT FINAL	part352	Inspec Solutions LLC.	TITANIUM DIOXIDE; ZINC OXIDE	4; 19.5	g/100g; g/100g			N	20241231
72667-063_f161e151-4f9b-2fbc-e053-2a95a90a5437	72667-063	HUMAN OTC DRUG	Hawaiian Blend Extreme Zinc SPF 30		Zinc Oxide, Titanium Dioxide	AEROSOL	TOPICAL	20230103		OTC MONOGRAPH NOT FINAL	part352	Inspec Solutions LLC.	TITANIUM DIOXIDE; ZINC OXIDE	4; 19.5	g/100g; g/100g			N	20241231
72667-064_f163c9e7-39d1-3610-e053-2995a90a0990	72667-064	HUMAN OTC DRUG	Sport IQ Pain Relief		Menthol	CREAM	TOPICAL	20230103		OTC MONOGRAPH NOT FINAL	part348	Inspec Solutions LLC.	MENTHOL	8	g/100g			N	20241231
72670-001_716a40f6-e5af-4fa8-9954-d4ea3829a674	72670-001	HUMAN OTC DRUG	LILAS Feminine Pain Relief Patch		MENTHOL	PATCH	TOPICAL	20190318		OTC MONOGRAPH NOT FINAL	part348	Lilas Wellness, Inc.	MENTHOL, UNSPECIFIED FORM	200	mg/1			N	20241231
72670-002_26fa692d-8bff-4c2c-a77f-8a4312da2678	72670-002	HUMAN OTC DRUG	LILAS Knee Pain Relief Patch		Menthol, Camphor	PATCH	TOPICAL	20231212		OTC MONOGRAPH DRUG	M017	Lilas Wellness, Inc.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	308; 308	mg/1; mg/1			N	20241231
72671-100_0e8f99e7-186c-a77d-e063-6394a90a2b1b	72671-100	HUMAN OTC DRUG	ForPro Professional Collection Alcohol-Free Foaming Instant Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20200324		OTC MONOGRAPH DRUG	M003	Sani-care Salon Products, Inc.	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20251231
72677-551_7edce787-91e3-4b7d-9800-66711a5c096f	72677-551	HUMAN PRESCRIPTION DRUG	UPLIZNA		Inebilizumab	INJECTION	INTRAVENOUS	20200611		BLA	BLA761142	Viela Bio, Inc.	INEBILIZUMAB	10	mg/mL			N	20241231
72683-001_b5eace4d-3cf8-0b66-e053-2995a90a20ba	72683-001	HUMAN OTC DRUG	WellHeal		Aesculus Hipp, Calendula Off, Equisetum Arv, Symphytum Off, Salix Alba, Stellaria Med, Mezereum Off, Uritca Urens, Althaea Off, Hamamelis Vir	CREAM	TOPICAL	20190318		UNAPPROVED HOMEOPATHIC		Proximity Capital Partners LLC dba Asutra	ALTHAEA OFFICINALIS ROOT; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; DAPHNE MEZEREUM BARK; EQUISETUM ARVENSE TOP; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; SALIX ALBA BARK; STELLARIA MEDIA; URTICA URENS	3; 3; 3; 3; 3; 3; 3; 3; 3; 3	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g			N	20241231
72683-002_b5eb8560-647f-f1f3-e053-2995a90a8781	72683-002	HUMAN OTC DRUG	Ease Your Pain		Menthol	CREAM	TOPICAL	20190121		OTC MONOGRAPH NOT FINAL	part348	Proximity Capital Partners LLC dba Asutra	MENTHOL	4	g/100g			N	20241231
72683-003_a95a11d7-a2af-6654-e053-2a95a90a802c	72683-003	HUMAN OTC DRUG	Melt Pain Away		Capsaicin	CREAM	TOPICAL	20200415		OTC MONOGRAPH NOT FINAL	part348	Proximity Capital Partners LLC dba Asutra	CAPSAICIN	.025	g/100g			N	20241231
72683-005_c12369dd-8306-edaf-e053-2995a90a0d3d	72683-005	HUMAN OTC DRUG	Relieve Your Pain		Menthol	CREAM	TOPICAL	20210429		OTC MONOGRAPH NOT FINAL	part348	Proximity Capital Partners LLC dba Asutra	MENTHOL	10	g/100g			N	20241231
72683-006_0c3f4b09-fe73-0ce3-e063-6394a90a798a	72683-006	HUMAN OTC DRUG	SprayPain Away		Capsaicin	SPRAY	TOPICAL	20210630		OTC MONOGRAPH DRUG	M017	Proximity Capital Partners LLC dba Asutra	CAPSAICIN	.025	g/100g			N	20241231
72683-008_ebc9630f-6d8c-e4f0-e053-2995a90a0b49	72683-008	HUMAN OTC DRUG	Recovery Roll-On		Menthol, Camphor	GEL	TOPICAL	20221017		OTC MONOGRAPH NOT FINAL	part348	PROXIMITY CAPITAL PARTNERS LLC DBA ASUTRA	CAMPHOR (NATURAL); MENTHOL	5; 5	g/100mL; g/100mL			N	20241231
72684-006_d8729131-5ce6-4e9c-bbb1-1dfd5a9fca0b	72684-006	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	TABLET	ORAL	20221021		ANDA	ANDA216407	ATNAHS PHARMA US LIMITED	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72692-123_082b4007-6e98-77ce-e063-6294a90a3a49	72692-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20181128		UNAPPROVED MEDICAL GAS		Alpine Medical, LLC	OXYGEN	99	L/100L			N	20241231
72694-515_ffe80517-c3ca-462a-9c38-573a3c724bcb	72694-515	HUMAN PRESCRIPTION DRUG	asparlas		calaspargase pegol	INJECTION, SOLUTION	INTRAVENOUS	20190927		BLA	BLA761102	Servier Pharmaceuticals LLC	CALASPARGASE PEGOL	750	U/mL	Asparaginase [CS], Asparagine-specific Enzyme [EPC]		N	20241231
72694-617_e41af141-5e59-46f0-b6d3-56c57f59ee70	72694-617	HUMAN PRESCRIPTION DRUG	TIBSOVO		ivosidenib	TABLET, FILM COATED	ORAL	20211019		NDA	NDA211192	Servier Pharmaceutical LLC	IVOSIDENIB	250	mg/1	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Isocitrate Dehydrogenase 1 Inhibitor [EPC], Isocitrate Dehydrogenase 1 Inhibitors [MoA]		N	20241231
72694-954_e968db89-a041-41f8-baa4-a93b419eb46c	72694-954	HUMAN PRESCRIPTION DRUG	ONCASPAR		Pegaspargase	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200102		BLA	BLA103411	Servier Pharmaceuticals LLC	PEGASPARGASE	750	[iU]/mL	Asparaginase [CS], Asparagine-specific Enzyme [EPC]		N	20241231
72697-0001_08ac039f-1920-e1ea-e063-6294a90a9329	72697-0001	HUMAN OTC DRUG	in2itiv Hand Sanitizer 70 Alcohol Antiseptic		ALCOHOL	LIQUID	TOPICAL	20200510		OTC MONOGRAPH DRUG	505G(a)(3)	Redi-2-PaQ Home Products	ALCOHOL	.7	mL/mL			N	20241231
72697-0003_08ac0c08-4f18-507d-e063-6294a90a5abf	72697-0003	HUMAN OTC DRUG	in2itiv SPF30 Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210501		OTC MONOGRAPH DRUG	M020	Redi-2-PaQ Home Products	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72697-0004_08ac10bd-fedb-04bb-e063-6394a90a4d37	72697-0004	HUMAN OTC DRUG	in2itiv 2 Hand Sanitizer Alcohol Antiseptic		ALCOHOL	GEL	TOPICAL	20220801		OTC MONOGRAPH DRUG	505G(a)(3)	Redi-2-Paq Home Products, LLC	ALCOHOL	.75	mL/mL			N	20241231
72697-0005_08ac15a9-96fd-2ed0-e063-6394a90a4196	72697-0005	HUMAN OTC DRUG	in2itiv 2 Hand Sanitizer Alcohol Antiseptic		ALCOHOL	LIQUID	TOPICAL	20220801		OTC MONOGRAPH DRUG	505G(a)(3)	Redi-2-Paq Home Products, LLC	ALCOHOL	.75	mL/mL			N	20241231
72698-305_f380f1f1-c892-2c59-e053-2a95a90a4e2d	72698-305	HUMAN OTC DRUG	ART OF SPORT ANTIPERSPIRANT VICTORY		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191205		OTC MONOGRAPH FINAL	M019	AOS GROUP INC, THE	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
72698-405_f380f1f1-c895-2c59-e053-2a95a90a4e2d	72698-405	HUMAN OTC DRUG	ART OF SPORT ANTIPERSPIRANT COMPETE		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191205		OTC MONOGRAPH FINAL	M019	AOS GROUP INC, THE	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
72698-505_f380f3c1-a7b6-0c2d-e053-2995a90a4ea8	72698-505	HUMAN OTC DRUG	ART OF SPORT ANTIPERSPIRANT RISE		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20191205		OTC MONOGRAPH FINAL	M019	AOS GROUP INC, THE	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
72698-605_f380eb3f-95a6-b73a-e053-2a95a90ae102	72698-605	HUMAN OTC DRUG	ART OF SPORT ANTIPERSPIRANT DEFY		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20220117		OTC MONOGRAPH FINAL	M019	AOS GROUP INC, THE	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15.2	g/100g			N	20241231
72698-711_f3811a9b-ebc1-4bb8-e053-2a95a90a8f38	72698-711	HUMAN OTC DRUG	Art of Sport Anti Dandruff Victory		Pyrithione Zinc	SHAMPOO	TOPICAL	20191212		OTC MONOGRAPH FINAL	part358H	AOS GROUP INC, THE	PYRITHIONE ZINC	100	g/mL			N	20241231
72698-811_f3810744-c0e2-4d27-e053-2995a90a943d	72698-811	HUMAN OTC DRUG	Art of Sport Anti Dandruff Compete		Pyrithione Zinc	SHAMPOO	TOPICAL	20191212		OTC MONOGRAPH FINAL	M032	AOS GROUP INC, THE	PYRITHIONE ZINC	100	g/mL			N	20241231
72701-102_f655d8d8-cc78-713b-e053-2995a90af916	72701-102	HUMAN OTC DRUG	Conlax		Bisacodyl	SUPPOSITORY	RECTAL	20181216		OTC MONOGRAPH NOT FINAL	part334	Bliss GVS Pharma Limited	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
72701-110_f63f294a-b1ca-6be8-e053-2995a90a6808	72701-110	HUMAN OTC DRUG	Bliss GVS Hemorrhoidal		Hard Fat, Phenylephrine HCl	SUPPOSITORY	RECTAL	20190513		OTC MONOGRAPH FINAL	M015	Bliss GVS Pharma Limited	HARD FAT; PHENYLEPHRINE HYDROCHLORIDE	2493.75; 6.25	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72701-111_fceea303-2ea1-10e9-e053-6294a90a5492	72701-111	HUMAN OTC DRUG	BLISS GVS HEMORRHOIDAL		phenylephrine hcl	SUPPOSITORY	RECTAL	20230525		OTC MONOGRAPH FINAL	M015	Bliss GVS Pharma Limited	PHENYLEPHRINE HYDROCHLORIDE	6.25	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72704-105_ecf39f76-7354-4ab8-a551-0dbbfb074bff	72704-105	HUMAN OTC DRUG	Clarifying Detox Mask with Green Tea plus Sulfur	Acne Treatment Mask	Sulfur	CREAM	TOPICAL	20190601		OTC MONOGRAPH FINAL	part333D	Lancer Skincare LLC.	SULFUR	3	g/100mL			N	20241231
72704-108_92b3e58b-fde2-40bc-9cf6-3f3aea097788	72704-108	HUMAN OTC DRUG	Sheer Fluid Sun Shield	Broad Spectrum SPF 30	Octinoxate and Zinc Oxide	LIQUID	TOPICAL	20161101		OTC MONOGRAPH NOT FINAL	part352	Lancer Skincare LLC.	OCTINOXATE; ZINC OXIDE	7.5; 17.1	g/100mL; g/100mL			N	20241231
72704-129_1decc807-6919-498c-89d1-4c048c3bf3e0	72704-129	HUMAN OTC DRUG	Clarifying Spot with Sulfur plus Green Clay	Acne Medication	Sulfur	SOLUTION	TOPICAL	20211015		OTC MONOGRAPH FINAL	part333D	Lancer Skincare LLC.	SULFUR	10	g/100mL			N	20241231
72705-100_318362c9-92b4-4be0-a1da-9fa2975cb9fc	72705-100	HUMAN OTC DRUG	frida mom Perineal Cooling Pad Liners		Witch Hazel	CLOTH	TOPICAL	20190501		OTC MONOGRAPH FINAL	part346	Fridababy, LLC	WITCH HAZEL	.5	g/1			N	20241231
72705-124_0cdf002b-72f7-a399-e063-6294a90a7e02	72705-124	HUMAN OTC DRUG	Fridababy Children Pain and Fever Acetaminophen 160mg per 5mL vial 10ct		Acetaminophen 160mg per 5mL	SOLUTION	ORAL	20220816	20240831	OTC MONOGRAPH DRUG	M013	Fridababy LLC	ACETAMINOPHEN	160	mg/5mL			N	
72705-125_0cdef68f-49bf-c3f7-e063-6394a90a9e04	72705-125	HUMAN OTC DRUG	Fridababy Children Allergy Relief Diphenhydramine HCl 12.5mg per 5mL vial , 15ct		Diphenhydramine HCl 12.5mg / 5mL	SOLUTION	ORAL	20220816	20240731	OTC MONOGRAPH DRUG	M012	Fridababy LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
72705-150_6031417c-a7a7-4c80-8af8-cc0adbdcbdd0	72705-150	HUMAN OTC DRUG	frida mom Perineal Healing		Witch Hazel	AEROSOL, FOAM	TOPICAL	20190501		OTC MONOGRAPH FINAL	part346	Fridababy, LLC	WITCH HAZEL	.5	g/g			N	20241231
72705-200_20c46c26-ffd1-4aa5-9e63-b1ad1814327e	72705-200	HUMAN OTC DRUG	frida mom Postpartum Recovery Essentials		Witch Hazel	KIT		20190501		OTC MONOGRAPH FINAL	part346	Fridababy, LLC						N	20241231
72705-251_6eb56d87-2690-469c-8901-89030fed550f	72705-251	HUMAN OTC DRUG	frida mom Labor and Delivery Plus Postpartum Recovery		Witch Hazel	KIT		20190501		OTC MONOGRAPH FINAL	part346	Fridababy, LLC						N	20241231
72705-420_070e75a5-e032-6aae-e063-6394a90a7387	72705-420	HUMAN OTC DRUG	Perineal Cooling Pad Liners		Frida Mom Perineal Cooling Pad Liners	SWAB	TOPICAL	20230115		OTC MONOGRAPH DRUG	M015	Fridababy, LLC	WITCH HAZEL	50	g/100g			N	20241231
72706-123_09cdcd1c-1024-2b63-e063-6294a90af899	72706-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100723		UNAPPROVED MEDICAL GAS		Carroll Apothecary, Inc. dba Home Care Medical Equipment	OXYGEN	99	L/100L			N	20241231
72707-029_ae73b4f4-97e4-8245-e053-2995a90ac430	72707-029	HUMAN OTC DRUG	Anti-Bacterial HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200904		OTC MONOGRAPH NOT FINAL	part333E	DISNEY DESTINATIONS,LLC	ALCOHOL	63	mL/100mL			N	20241231
72714-405_8d6f6486-0445-4f7f-b6f5-c8aaf20708d6	72714-405	HUMAN OTC DRUG	Aspirin 81mg Enteric coated	Delayed Release	Aspirin	TABLET, COATED	ORAL	20211215		OTC MONOGRAPH DRUG	M013	Dr. Wayne's	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72715-001_b5c9776c-f051-4f34-9be8-c8641057dc9c	72715-001	HUMAN OTC DRUG	Thumb Thumb No Thumb		Saccharum off.	GEL	TOPICAL	20190412		UNAPPROVED HOMEOPATHIC		Beautiful Day Organics, LLC	SACCHARUM OFFICINARUM WHOLE	6	[hp_X]/58g			N	20241231
72718-123_0d82275f-67a4-e1a3-e063-6394a90ad12e	72718-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20170509		UNAPPROVED MEDICAL GAS		Surgimed Corporation	OXYGEN	99	L/100L			N	20241231
72723-123_078ae1f5-9b33-384a-e063-6394a90a915a	72723-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20070917		UNAPPROVED MEDICAL GAS		Liberty Oxygen and Homecare, Inc. dba Liberty Oxygen and Home Care, Inc.	OXYGEN	99	L/100L			N	20241231
72724-001_7e08cd86-7ae5-7d12-e053-2991aa0a4cba	72724-001	HUMAN OTC DRUG	WaxRx Ear Wax Removal Aid Drops		Carbamide Peroxide	LIQUID	AURICULAR (OTIC)	20181212		OTC MONOGRAPH FINAL	part344	DOCTOR EASY MEDICAL PRODUCTS, LLC	CARBAMIDE PEROXIDE	6.5	g/100mL			N	20241231
72727-0001_9ca2ecd8-3b80-439e-949f-dd20d42a2886	72727-0001	HUMAN OTC DRUG	Alcohol Prep Pad-Large		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20190320		OTC MONOGRAPH NOT FINAL	part333A	Global Biomedical Technologies, LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
72728-004_cef7d296-299f-5c20-e053-2a95a90a289b	72728-004	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer Hand Sanitizer	LIQUID	TOPICAL	20200601	20240129	OTC MONOGRAPH NOT FINAL	part333A	A2Z Products, LLC	ALCOHOL	75	mL/100mL			N	
72728-005_cef79fd1-d0ae-41a9-e053-2995a90ad184	72728-005	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20201215	20240129	OTC MONOGRAPH NOT FINAL	part333A	A2Z Products, LLC	ALCOHOL	.62	mL/1			N	
72733-5901_9f6bfdfc-2991-4bd3-85c8-0f0c446f6d1d	72733-5901	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20190215		BLA	BLA125559	Sanofi US Corporation	ALIROCUMAB	75	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
72733-5902_9f6bfdfc-2991-4bd3-85c8-0f0c446f6d1d	72733-5902	HUMAN PRESCRIPTION DRUG	Praluent		alirocumab	INJECTION, SOLUTION	SUBCUTANEOUS	20190215		BLA	BLA125559	Sanofi US Corporation	ALIROCUMAB	150	mg/mL	Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]		N	20241231
72739-001_076363c9-6aa2-4ff9-e063-6394a90a714c	72739-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Walnut Medical Services	OXYGEN	99	L/100L			N	20241231
72740-123_0981fec6-145a-3929-e063-6394a90a0bba	72740-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19951220		UNAPPROVED MEDICAL GAS		Seattle Children's Hospital	OXYGEN	99	L/100L			N	20241231
72744-433_09135640-d8a9-790c-e063-6294a90a8fce	72744-433	HUMAN OTC DRUG	COOL BREEZE Pain Relief		MENTHOL	GEL	TOPICAL	20231113		OTC MONOGRAPH DRUG	M017	COOL BREEZE US LLC	MENTHOL	51	mg/mL			N	20241231
72745-100_7d3ab893-7bb8-f6d6-e053-2a91aa0a51f3	72745-100	HUMAN OTC DRUG	Dynamic Eyewash		Water	SOLUTION	OPHTHALMIC	20181217		NDA	NDA022305	Dynamic Safety International	WATER	929	g/946mL			N	20241231
72745-101_7d3af8da-fdf3-9cb2-e053-2a91aa0a8dc6	72745-101	HUMAN OTC DRUG	Dynamic Eyewash with Eyecup		Water	SOLUTION	OPHTHALMIC	20181217		NDA	NDA022305	Dynamic Safety International	WATER	929	g/946mL			N	20241231
72746-0001_06e7248d-e6b5-eaac-e063-6394a90aceb3	72746-0001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20080720		UNAPPROVED MEDICAL GAS		Scheffe Warehouse dba Scheffe RX, Inc.	OXYGEN	99	L/100L			N	20241231
72749-001_33506b50-b6dc-43d2-b582-16d8144af4b3	72749-001	HUMAN OTC DRUG	PainFix Relief		MENTHOL	GEL	TOPICAL	20190201		OTC MONOGRAPH DRUG	M017	PainFix LLC	MENTHOL, UNSPECIFIED FORM	50	mg/g			N	20241231
72749-008_114c8733-c818-49ac-8c1c-8b1c87db6bce	72749-008	HUMAN OTC DRUG	PainFix Restore		Menthol	PATCH	TOPICAL	20220107		OTC MONOGRAPH NOT FINAL	part348	PainFix LLC	MENTHOL, UNSPECIFIED FORM	70	mg/g			N	20241231
72751-0301_d21c275e-697d-e95e-e053-2a95a90ad633	72751-0301	HUMAN OTC DRUG	Zilactin	Early Relief Cold Sore	benzyl alcohol	GEL	TOPICAL	20050630		OTC MONOGRAPH NOT FINAL	part356	Applied Laboratories, Inc.	BENZYL ALCOHOL	.1	g/g	Pediculicide [EPC]		N	20241231
72751-0302_d21c544c-39da-0bb8-e053-2995a90ac6a2	72751-0302	HUMAN OTC DRUG	Zilactin-B		benzocaine	GEL	TOPICAL	20050629		OTC MONOGRAPH NOT FINAL	part356	Applied Laboratories, Inc.	BENZOCAINE	.1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72753-001_07fe5988-225e-2cd9-e063-6294a90a1794	72753-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141121		UNAPPROVED MEDICAL GAS		High Desert Respiratory	OXYGEN	99	L/100L			N	20241231
72755-123_092cde94-cb63-d209-e063-6294a90ae90e	72755-123	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19951220		UNAPPROVED MEDICAL GAS		Integrated HomeCare Services	OXYGEN	99	L/100L			N	20241231
72764-001_f28be15d-27af-563f-e053-2995a90aef6f	72764-001	HUMAN OTC DRUG	GROW GIRL		MINOXIDIL	SOLUTION	TOPICAL	20190208		ANDA	ANDA078176	Brandable, Inc.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72764-002_f28be15d-27ae-563f-e053-2995a90aef6f	72764-002	HUMAN OTC DRUG	GOOD GUY Mens Hair Regrowth Treatment		Minoxidil	SOLUTION	TOPICAL	20190207		ANDA	ANDA076239	Brandable, Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72766-001_fa2c8dc3-f6e1-3122-e053-6394a90a95fa	72766-001	HUMAN OTC DRUG	PROVIDONE-IODINE PREP PADS		POVIDONE-IODINE PREP PADS	CLOTH	TOPICAL	20190215		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co, LTD	POVIDONE-IODINE	10	mg/1			N	20241231
72766-002_fa2cc6fd-dbfd-4aeb-e053-6294a90a8ed8	72766-002	HUMAN OTC DRUG	Sterile Alcohol Prep Pads		Sterile Alcohol Prep Pads	SWAB	TOPICAL	20181215		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co., Ltd.	ISOPROPYL ALCOHOL	.7	mL/1			N	20241231
72766-003_fa2d0d08-5c4d-3bdf-e053-6394a90a4474	72766-003	HUMAN OTC DRUG	Benzalkonium Chloride Towelette		Benzalkonium Chloride Towelette	SWAB	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/1			N	20241231
72766-006_fa1aa1ba-7110-8458-e053-6394a90a8d1b	72766-006	HUMAN OTC DRUG	Alcohol prep pad		Alcohol prep pad	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co., Ltd.	ISOPROPYL ALCOHOL	70	g/1001			N	20241231
72766-016_05302e97-3d9a-c5be-e063-6394a90ab689	72766-016	HUMAN OTC DRUG	EVERLIT SURVIVAL ALCOHOL PAD		Alcohol Prep Pad	CLOTH	TOPICAL	20230929		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co., Ltd.	ISOPROPYL ALCOHOL	.34	g/1			N	20241231
72766-017_056ff89f-2120-1aba-e063-6394a90a4072	72766-017	HUMAN OTC DRUG	Everlit Survival Sting Relief Pad		Sting Relief	CLOTH	TOPICAL	20230929		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co., Ltd.	BENZOCAINE; ISOPROPYL ALCOHOL	.34; 8	g/1; g/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72766-018_05702e77-d912-75e6-e063-6294a90aebbe	72766-018	HUMAN OTC DRUG	EVERLIT SURVIVAL IODINE PREP PADS		POVIDONE-IODINE PREP PADS	CLOTH	TOPICAL	20230929		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co, LTD	POVIDONE-IODINE	.54	g/1			N	20241231
72766-019_0570529f-e11c-a54c-e063-6394a90a0b36	72766-019	HUMAN OTC DRUG	Everlit Survival Antiseptic Wipe		Antiseptic Wipe	CLOTH	TOPICAL	20230929		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co., Ltd.	BENZALKONIUM CHLORIDE	1.22	g/1			N	20241231
72766-020_095897a4-bb36-ca21-e063-6394a90a8397	72766-020	HUMAN OTC DRUG	KENTEX Alcohol Prep Pad		Alcohol Prep Pad	CLOTH	TOPICAL	20231115		OTC MONOGRAPH DRUG	M003	Yangzhou Suxiang Medical Instrument Co., Ltd.	ISOPROPYL ALCOHOL	.273	g/1			N	20241231
72766-021_095990b5-4154-bce2-e063-6294a90a31b1	72766-021	HUMAN OTC DRUG	KENTEX Alcohol Prep Pad		Alcohol Prep Pad	CLOTH	TOPICAL	20231115		OTC MONOGRAPH DRUG	M003	Yangzhou Suxiang Medical Instrument Co., Ltd.	ISOPROPYL ALCOHOL	.567	g/1			N	20241231
72766-022_0d0bbcad-1309-2b12-e063-6394a90a9927	72766-022	HUMAN OTC DRUG	Earth Essentials Antibacterial Hand Wipes		BZK Disinfectant Wipe	CLOTH	TOPICAL	20231226		OTC MONOGRAPH DRUG	M003	Yangzhou Suxiang Medical Instrument Co., Ltd.	BENZALKONIUM CHLORIDE	154	g/1			N	20241231
72766-023_0d0c72cf-cbe4-6398-e063-6394a90a3ae8	72766-023	HUMAN OTC DRUG	Earth Essentials Antibacterial Hand Wipes		BZK Disinfectant Wipe	CLOTH	TOPICAL	20231226		OTC MONOGRAPH DRUG	M003	Yangzhou Suxiang Medical Instrument Co., Ltd.	BENZALKONIUM CHLORIDE	3.5	g/1			N	20241231
72766-024_0d0ce687-031c-bfa9-e063-6394a90af94e	72766-024	HUMAN OTC DRUG	Earth Essentials Antibacterial Hand Wipes Unscented		BZK Disinfectant Wipe	CLOTH	TOPICAL	20231226		OTC MONOGRAPH DRUG	M003	Yangzhou Suxiang Medical Instrument Co., Ltd.	BENZALKONIUM CHLORIDE	70	g/1			N	20241231
72766-101_028687ea-857a-c94f-e063-6394a90a6f07	72766-101	HUMAN OTC DRUG	Sterile Alcohol Prep Pads		Sterile Alcohol Prep Pads	SWAB	TOPICAL	20200907		OTC MONOGRAPH NOT FINAL	part333A	Yangzhou Suxiang Medical Instrument Co., Ltd.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
72769-101_b5c90354-6b1a-411b-8f51-08ab3ba1e136	72769-101	HUMAN PRESCRIPTION DRUG	Orladeyo		Berotralstat hydrochloride	CAPSULE	ORAL	20201204		NDA	NDA214094	BioCryst Pharmaceuticals Inc.	BEROTRALSTAT HYDROCHLORIDE	150	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kallikrein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]		N	20241231
72769-102_b5c90354-6b1a-411b-8f51-08ab3ba1e136	72769-102	HUMAN PRESCRIPTION DRUG	Orladeyo		Berotralstat hydrochloride	CAPSULE	ORAL	20201204		NDA	NDA214094	BioCryst Pharmaceuticals Inc.	BEROTRALSTAT HYDROCHLORIDE	110	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kallikrein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Plasma Kallikrein Inhibitor [EPC]		N	20241231
72769-181_5334c729-b8ee-4d46-bca7-1f3486c52ab7	72769-181	HUMAN PRESCRIPTION DRUG	Rapivab		peramivir	SOLUTION	INTRAVENOUS	20141220		NDA	NDA206426	BioCryst Pharmaceuticals, Inc.	PERAMIVIR	600	mg/60mL			N	20241231
72773-001_0c7f04af-9fde-b1c4-e063-6294a90afd70	72773-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190130		UNAPPROVED MEDICAL GAS		O2 Depot, LLC	OXYGEN	99	L/100L			N	20241231
72779-100_e7dfe524-438c-45e8-b652-fa625f72bc79	72779-100	HUMAN OTC DRUG	Instaflex Pain Relief Cream		Menthol	CREAM	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part348	Adaptive Health, LLC	MENTHOL	12.5	mg/g			N	20241231
72782-102_09814f89-baf2-ffaa-e063-6394a90a3f99	72782-102	HUMAN OTC DRUG	YENSA SKIN ON SKIN BC FOUNDATION	SPF 40 SUNSCREEN (ALL SHADES)	TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210129		OTC MONOGRAPH DRUG	M020	YENSA LLC	TITANIUM DIOXIDE; ZINC OXIDE	2.8; 7	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72784-101_00f8f736-76e8-e38e-e063-6394a90a5bf8	72784-101	HUMAN OTC DRUG	Saint		Cough Spray	LIQUID	RESPIRATORY (INHALATION)	20230720		OTC MONOGRAPH FINAL	part341	Saint Medicine, Inc.	MENTHOL	3.2	g/100mL			N	20241231
72785-0001_2c7f5efb-48f9-42f3-885c-7012660019e3	72785-0001	HUMAN PRESCRIPTION DRUG	Ranitidine Hydrochloride		ranitidine hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20190221		ANDA	ANDA091534	Zydus Lifesciences Limited	RANITIDINE HYDROCHLORIDE	25	mg/mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72785-0008_1b257332-a1a5-406e-86e4-283580657dc6	72785-0008	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20200212		ANDA	ANDA212171	Zydus Lifesciences Limited	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72785-0009_1b257332-a1a5-406e-86e4-283580657dc6	72785-0009	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20200212		ANDA	ANDA212171	Zydus Lifesciences Limited	CISATRACURIUM BESYLATE	10	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72785-0011_edbc4b0d-92ea-48b7-a7d7-406c82d40221	72785-0011	HUMAN PRESCRIPTION DRUG	cisatracurium besylate		cisatracurium besylate	INJECTION	INTRAVENOUS	20201105		ANDA	ANDA213527	Zydus Lifesciences Limited	CISATRACURIUM BESYLATE	2	mg/mL	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
72786-101_e27a3e07-438e-49d3-aae3-095e9379c7b4	72786-101	HUMAN PRESCRIPTION DRUG	OXBRYTA		Voxelotor	TABLET, FILM COATED	ORAL	20191125		NDA	NDA213137	Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.	VOXELOTOR	500	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Hemoglobin S Polymerization Inhibitor [EPC], Hemoglobin S Polymerization Inhibitors [MoA]		N	20241231
72786-102_e27a3e07-438e-49d3-aae3-095e9379c7b4	72786-102	HUMAN PRESCRIPTION DRUG	OXBRYTA		Voxelotor	TABLET, FILM COATED	ORAL	20191125		NDA	NDA213137	Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.	VOXELOTOR	300	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Hemoglobin S Polymerization Inhibitor [EPC], Hemoglobin S Polymerization Inhibitors [MoA]		N	20241231
72786-111_e27a3e07-438e-49d3-aae3-095e9379c7b4	72786-111	HUMAN PRESCRIPTION DRUG	OXBRYTA		Voxelotor	TABLET, FOR SUSPENSION	ORAL	20211217		NDA	NDA216157	Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.	VOXELOTOR	300	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Hemoglobin S Polymerization Inhibitor [EPC], Hemoglobin S Polymerization Inhibitors [MoA]		N	20241231
72789-003_05f98f21-12f2-5d8e-e063-6294a90a2681	72789-003	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET, DELAYED RELEASE	ORAL	20160705		ANDA	ANDA091432	PD-Rx Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-004_02e381a2-b496-6828-e063-6294a90a39e1	72789-004	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20141215		ANDA	ANDA090278	PD-Rx Pharmaceuticals, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-005_05f99647-e76f-abfe-e063-6294a90a0bc2	72789-005	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET, FILM COATED	ORAL	20140601		ANDA	ANDA203458	PD-Rx Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72789-007_08f02263-911d-16e5-e063-6394a90a63f6	72789-007	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161201		ANDA	ANDA079067	PD-Rx Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72789-008_068491e6-0512-9383-e063-6294a90acebf	72789-008	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	PD-Rx Pharmaceuticals, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
72789-009_05f98f21-12f5-5d8e-e063-6294a90a2681	72789-009	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE EXTENDED RELEASE		METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20160512		ANDA	ANDA090295	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72789-010_f22cb66f-cb06-7fcb-e053-2a95a90aa293	72789-010	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20180206		ANDA	ANDA204106	PD-Rx Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-011_05f98f21-12f6-5d8e-e063-6294a90a2681	72789-011	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20161201		ANDA	ANDA079067	PD-Rx Pharmaceuticals, Inc.	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72789-012_f93b9f48-d0eb-8af4-e053-6394a90afa28	72789-012	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	PD-Rx Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-013_fda364ed-67c0-2525-e053-6294a90a1efe	72789-013	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-014_fda4b7a4-f040-c280-e053-6394a90a0046	72789-014	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	PD-Rx Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72789-016_f22cbbfa-dfae-9a0e-e053-2a95a90a4469	72789-016	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190808		ANDA	ANDA040245	PD-Rx Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
72789-018_f88758b3-67f7-8892-e053-6394a90a6abc	72789-018	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	PD-Rx Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
72789-019_f22cc7eb-9f1e-47a4-e053-2995a90add7d	72789-019	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20190808		ANDA	ANDA040245	PD-Rx Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
72789-021_09a7141e-5877-df3c-e063-6394a90a9962	72789-021	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	PD-Rx Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-022_0a1f2eba-4119-82ae-e063-6394a90a4b27	72789-022	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	PD-Rx Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-023_05f98f21-12f7-5d8e-e063-6294a90a2681	72789-023	HUMAN PRESCRIPTION DRUG	Levocetirizine Dihydrochloride		Levocetirizine Dihydrochloride	TABLET	ORAL	20120629		ANDA	ANDA091264	PD-Rx Pharmaceuticals, Inc.	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72789-024_02e37321-00ba-46eb-e063-6294a90ae560	72789-024	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	PD-Rx Pharmaceuticals, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
72789-025_fda53e8a-6e89-9dce-e053-6394a90a3644	72789-025	HUMAN PRESCRIPTION DRUG	BENZONATATE		BENZONATATE	CAPSULE	ORAL	20180501		ANDA	ANDA040682	PD-Rx Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72789-027_fdb3ce77-6b5d-9acf-e053-6394a90a86a3	72789-027	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET	ORAL	20010416		ANDA	ANDA075805	PD-Rx Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72789-028_fdb3db79-dfd4-4051-e053-6394a90a5320	72789-028	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170831		ANDA	ANDA207466	PD-Rx Pharmaceuticals, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-029_0bdc15a3-34e9-c2d0-e063-6294a90abb59	72789-029	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-030_f22cd652-f298-d46a-e053-2a95a90a5796	72789-030	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	20	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72789-032_f22ce168-c446-0d4a-e053-2a95a90a7621	72789-032	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72789-033_f22ce8c0-0657-396f-e053-2a95a90ad11d	72789-033	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	80	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72789-034_f8874fd6-9a6c-c6b9-e053-6294a90afb7d	72789-034	HUMAN PRESCRIPTION DRUG	Ondansetron Hydrochloride		Ondansetron Hydrochloride	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	PD-Rx Pharmaceuticals, Inc.	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
72789-035_fbc19790-00ad-17de-e053-6394a90afcd1	72789-035	HUMAN PRESCRIPTION DRUG	Cefuroxime axetil		Cefuroxime axetil	TABLET, FILM COATED	ORAL	20101201		ANDA	ANDA065496	PD-Rx Pharmaceuticals, Inc.	CEFUROXIME AXETIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72789-036_0bdcb1fc-f6db-5184-e063-6294a90a6aa3	72789-036	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-037_05f960df-d977-1e1f-e063-6394a90a816e	72789-037	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN HYDROCHLORIDE		moxifloxacin hydrochloride	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA202632	PD-Rx Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-038_05f92489-92b6-eb5f-e063-6394a90ad2fb	72789-038	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN HYDROCHLORIDE		moxifloxacin hydrochloride	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA202632	PD-Rx Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-039_06be1d04-c8d8-4bc5-e063-6394a90a8008	72789-039	HUMAN OTC DRUG	Adult Low Dose Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20070112		OTC MONOGRAPH DRUG	M013	PD-Rx Pharmaceuticals, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
72789-040_fe4577fa-39e3-ccad-e053-6294a90a9ee4	72789-040	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	PD-Rx Pharmaceuticals, Inc.	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-041_f8876df6-63ad-d9e8-e053-6294a90a192b	72789-041	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	PD-Rx Pharmaceuticals, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-042_02e3d114-e95e-5e74-e063-6394a90a8410	72789-042	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709	20251031	ANDA	ANDA207507	PD-Rx Pharmaceuticals, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	
72789-043_05f998b7-a799-4637-e063-6394a90a0b9d	72789-043	HUMAN PRESCRIPTION DRUG	Medroxyprogesterone Acetate		Medroxyprogesterone Acetate	TABLET	ORAL	19961204		ANDA	ANDA040159	PD-Rx Pharmaceuticals, Inc.	MEDROXYPROGESTERONE ACETATE	2.5	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
72789-044_0569805a-9ffe-34da-e063-6294a90a694b	72789-044	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20150819		ANDA	ANDA203835	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-045_f22d143d-1578-8de3-e053-2a95a90a4b58	72789-045	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20171120		ANDA	ANDA209734	PD-Rx Pharmaceuticals, Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72789-046_f8877d27-32fc-ade7-e053-6394a90abe9e	72789-046	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-047_063123cd-7f31-2331-e063-6394a90aec1c	72789-047	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-048_f22ce8c0-067c-396f-e053-2a95a90ad11d	72789-048	HUMAN PRESCRIPTION DRUG	Glimepiride		Glimepiride	TABLET	ORAL	20120101		ANDA	ANDA077911	PD-Rx Pharmaceuticals, Inc.	GLIMEPIRIDE	4	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72789-049_fe464b9c-f4af-0f7d-e053-6394a90a6dcb	72789-049	HUMAN PRESCRIPTION DRUG	oxybutynin chloride		oxybutynin chloride	TABLET, EXTENDED RELEASE	ORAL	20161220		ANDA	ANDA207138	PD-Rx Pharmaceuticals, Inc.	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72789-051_06311e45-7195-a60d-e063-6294a90a95ec	72789-051	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	19990917	20240229	ANDA	ANDA075463	PD-Rx Pharmaceuticals, Inc.	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
72789-052_0996cbde-0215-ee6b-e063-6394a90a4820	72789-052	HUMAN PRESCRIPTION DRUG	KETOCONAZOLE		KETOCONAZOLE	TABLET	ORAL	20180626		ANDA	ANDA210457	PD-Rx Pharmaceuticals, Inc.	KETOCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72789-054_fdb507a5-01ce-0689-e053-6394a90a860a	72789-054	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	PD-Rx Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72789-055_0631402a-9b20-501b-e063-6394a90a7064	72789-055	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-056_00761aa3-3e36-1730-e063-6394a90afd0c	72789-056	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200102		ANDA	ANDA208864	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	600	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72789-057_0e76d80a-2d11-e4c4-e063-6294a90aeac2	72789-057	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200102		ANDA	ANDA208864	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
72789-057_0e76e917-55bd-d7b3-e063-6394a90afc95	72789-057	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200102		ANDA	ANDA208864	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
72789-058_0b289dcf-38ac-6553-e063-6394a90aae57	72789-058	HUMAN PRESCRIPTION DRUG	Calcitriol		Calcitriol	CAPSULE	ORAL	20060327		ANDA	ANDA076917	PD-Rx Pharmaceuticals, Inc.	CALCITRIOL	.25	ug/1	Cholecalciferol [CS], Vitamin D3 Analog [EPC]		N	20241231
72789-059_068491e6-0515-9383-e063-6294a90acebf	72789-059	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72789-061_fdb644a3-3f8a-841a-e053-6394a90a59d8	72789-061	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20080107		ANDA	ANDA065434	PD-Rx Pharmaceuticals, Inc.	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72789-063_063096f3-1034-99ab-e063-6294a90ab7cf	72789-063	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72789-064_063157cd-1cd1-4e2a-e063-6394a90ab056	72789-064	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	PD-Rx Pharmaceuticals, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
72789-065_fdb69be9-daca-6ddd-e053-6394a90a7b11	72789-065	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20091010		ANDA	ANDA076126	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-066_0568ab9a-ca0b-a305-e063-6394a90a35b8	72789-066	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72789-067_09971e58-7995-2725-e063-6294a90acb77	72789-067	HUMAN PRESCRIPTION DRUG	ESZOPICLONE		ESZOPICLONE	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	PD-Rx Pharmaceuticals, Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
72789-070_030ed323-cbbd-7507-e063-6394a90a3c53	72789-070	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, FILM COATED	ORAL	20060117		ANDA	ANDA076143	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72789-071_030efd44-9b54-b8d4-e063-6394a90a1340	72789-071	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET	ORAL	20071018		ANDA	ANDA078216	PD-Rx Pharmaceuticals, Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-072_0631585d-3b5d-3922-e063-6294a90a8898	72789-072	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	19860513		ANDA	ANDA070791	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-073_063163ca-25d7-6156-e063-6294a90a949f	72789-073	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-079_05685c5c-1afa-cabc-e063-6294a90ad6d5	72789-079	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20200311		ANDA	ANDA071525	PD-Rx Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
72789-080_063163ca-25d8-6156-e063-6294a90a949f	72789-080	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride Tablets, 400 mg		Moxifloxacin Hydrochloride Tablets, 400 mg	TABLET, FILM COATED	ORAL	20180721		ANDA	ANDA208682	PD-Rx Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-081_f8397444-0c1d-2364-e053-6294a90aac20	72789-081	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72789-082_0566c019-3aa8-2613-e063-6394a90a3d97	72789-082	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine besylate	TABLET	ORAL	20101020		ANDA	ANDA078925	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72789-084_0566c26f-276a-a811-e063-6394a90ade26	72789-084	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	PD-Rx Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-085_06315aa0-db36-611d-e063-6294a90ae563	72789-085	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
72789-086_062f732d-ba3f-17ed-e063-6294a90afcfa	72789-086	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110120		ANDA	ANDA078281	PD-Rx Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72789-088_fdb73c66-5d26-464a-e053-6394a90a4229	72789-088	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-089_09302760-34fb-b8b0-e063-6394a90adc4e	72789-089	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	PD-Rx Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-090_06318bbd-9c06-921f-e063-6294a90a9077	72789-090	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181203		ANDA	ANDA210687	PD-Rx Pharmaceuticals, Inc.	SILODOSIN	8	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72789-091_f8878e7b-2b02-bf6b-e053-6394a90af362	72789-091	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	PD-Rx Pharmaceuticals, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72789-092_0334cef7-edeb-65ed-e063-6394a90af77e	72789-092	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-093_f2689794-5417-4bf1-e053-2995a90ac272	72789-093	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20170512		ANDA	ANDA077321	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72789-097_063311c1-e5fd-731b-e063-6394a90ab3e5	72789-097	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20080417		ANDA	ANDA078321	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72789-098_fe45a6e4-40f2-161c-e053-6294a90a9880	72789-098	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	PD-Rx Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72789-099_0631d415-6d37-2877-e063-6294a90a9c82	72789-099	HUMAN PRESCRIPTION DRUG	Pindolol		pindolol	TABLET	ORAL	20200201		ANDA	ANDA211712	PD-Rx Pharmaceuticals, Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-100_0631d415-6d37-2877-e063-6294a90a9c82	72789-100	HUMAN PRESCRIPTION DRUG	Pindolol		pindolol	TABLET	ORAL	20200201		ANDA	ANDA211712	PD-Rx Pharmaceuticals, Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-101_0631dc59-461f-8f2d-e063-6294a90a1a7b	72789-101	HUMAN PRESCRIPTION DRUG	LISINOPRIL		Lisinopril	TABLET	ORAL	20111101		ANDA	ANDA076180	PD-Rx Pharmaceuticals, Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72789-102_0e76db01-181a-6a4e-e063-6294a90a6e32	72789-102	HUMAN PRESCRIPTION DRUG	Cyproheptadine Hydrochloride		Cyproheptadine Hydrochloride	TABLET	ORAL	20200301		ANDA	ANDA206676	PD-Rx Pharmaceuticals, Inc.	CYPROHEPTADINE HYDROCHLORIDE	4	mg/1			N	20251231
72789-103_09974c47-482c-2103-e063-6394a90a4343	72789-103	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA202659	PD-Rx Pharmaceuticals, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72789-105_0b289c7d-e7fa-2c20-e063-6394a90a89b1	72789-105	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride		Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180717		ANDA	ANDA207427	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72789-106_0b289c7d-e7fa-2c20-e063-6394a90a89b1	72789-106	HUMAN PRESCRIPTION DRUG	Metformin hydrochloride	ER	Metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180628		ANDA	ANDA207427	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72789-107_0631d099-0abf-621a-e063-6294a90a36ac	72789-107	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20191001		ANDA	ANDA207206	PD-Rx Pharmaceuticals, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-108_f8395dc9-53ae-0c35-e053-6294a90a6035	72789-108	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72789-110_0631d5e5-9da5-bcb7-e063-6394a90a62de	72789-110	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	PD-Rx Pharmaceuticals, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-111_0631dc59-4620-8f2d-e063-6294a90a1a7b	72789-111	HUMAN PRESCRIPTION DRUG	misoprostol		MISOPROSTOL	TABLET	ORAL	20091227		NDA AUTHORIZED GENERIC	NDA019268	PD-Rx Pharmaceuticals, Inc.	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
72789-112_f8399515-a166-d537-e053-6394a90a9973	72789-112	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72789-115_0631f0ca-cb04-49ea-e063-6294a90a1a26	72789-115	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-117_0631f506-5714-3229-e063-6294a90a4e4c	72789-117	HUMAN PRESCRIPTION DRUG	Diethylpropion Hydrochloride		Diethylpropion Hydrochloride	TABLET	ORAL	20110718		ANDA	ANDA200177	PD-Rx Pharmaceuticals, Inc.	DIETHYLPROPION HYDROCHLORIDE	25	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72789-118_f268c1c1-0984-6c1c-e053-2995a90aacc1	72789-118	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72789-120_0631d415-6d3d-2877-e063-6294a90a9c82	72789-120	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20180830		ANDA	ANDA210081	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72789-121_0631d5e5-9da6-bcb7-e063-6394a90a62de	72789-121	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20120725		ANDA	ANDA091667	PD-Rx Pharmaceuticals, Inc.	MISOPROSTOL	100	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
72789-122_0632aa0a-3d3a-374f-e063-6394a90a52c4	72789-122	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20180924		ANDA	ANDA208774	PD-Rx Pharmaceuticals, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-123_0632af86-7ddc-55b8-e063-6294a90aa6a8	72789-123	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20151230		ANDA	ANDA090007	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-124_f29147c8-4ac3-3e85-e053-2a95a90a9a19	72789-124	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72789-125_f29147c8-4ac3-3e85-e053-2a95a90a9a19	72789-125	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	750	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
72789-127_fbfcc5e3-bd36-3305-e053-6394a90a7c2e	72789-127	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20121016		ANDA	ANDA078926	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-129_f2916b24-007e-4f92-e053-2995a90aac09	72789-129	HUMAN PRESCRIPTION DRUG	AZATHIOPRINE		Azathioprine	TABLET	ORAL	20150202		ANDA	ANDA074069	PD-Rx Pharmaceuticals, Inc.	AZATHIOPRINE	50	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]		N	20241231
72789-130_fa1bd716-e695-1bee-e053-6294a90a9f8e	72789-130	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20020925		ANDA	ANDA075795	PD-Rx Pharmaceuticals, Inc.	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72789-131_0bdcd623-71ec-5ab8-e063-6294a90acbd9	72789-131	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20080507		ANDA	ANDA078470	PD-Rx Pharmaceuticals, Inc.	ACARBOSE	25	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
72789-132_0bdcd623-71ec-5ab8-e063-6294a90acbd9	72789-132	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20080507		ANDA	ANDA078470	PD-Rx Pharmaceuticals, Inc.	ACARBOSE	50	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
72789-133_0bdcd623-71ec-5ab8-e063-6294a90acbd9	72789-133	HUMAN PRESCRIPTION DRUG	Acarbose		Acarbose	TABLET	ORAL	20080507		ANDA	ANDA078470	PD-Rx Pharmaceuticals, Inc.	ACARBOSE	100	mg/1	alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]		N	20241231
72789-134_05f92b70-2d16-1bcf-e063-6294a90aba07	72789-134	HUMAN OTC DRUG	Chlorpheniramine Maleate 4 mg		Chlorpheniramine Maleate	TABLET	ORAL	20151101		OTC MONOGRAPH DRUG	M012	PD-Rx Pharmaceuticals, Inc.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72789-135_0632abb2-518b-7c34-e063-6394a90a2318	72789-135	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	PD-Rx Pharmaceuticals, Inc.	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72789-136_0632abb2-518b-7c34-e063-6394a90a2318	72789-136	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	PD-Rx Pharmaceuticals, Inc.	SOTALOL HYDROCHLORIDE	240	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72789-137_0632abb2-518b-7c34-e063-6394a90a2318	72789-137	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	PD-Rx Pharmaceuticals, Inc.	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72789-138_0632abb2-518b-7c34-e063-6394a90a2318	72789-138	HUMAN PRESCRIPTION DRUG	Sotalol Hydrochloride		Sotalol Hydrochloride	TABLET	ORAL	20200724		ANDA	ANDA075563	PD-Rx Pharmaceuticals, Inc.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
72789-139_0bdc5a82-2d09-04d9-e063-6294a90a625a	72789-139	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	PD-Rx Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
72789-140_0bdc5a82-2d09-04d9-e063-6294a90a625a	72789-140	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	PD-Rx Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
72789-141_0bdc5a82-2d09-04d9-e063-6294a90a625a	72789-141	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	PD-Rx Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
72789-142_0bdc5a82-2d09-04d9-e063-6294a90a625a	72789-142	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200501		ANDA	ANDA078302	PD-Rx Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
72789-143_01f57fe0-c57e-b82d-e063-6394a90ad8b8	72789-143	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	PD-Rx Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-144_fd00105b-dd14-f5dd-e053-6294a90a70b8	72789-144	HUMAN PRESCRIPTION DRUG	Atenolol		Atenolol	TABLET	ORAL	20051008		ANDA	ANDA076900	PD-Rx Pharmaceuticals, Inc.	ATENOLOL	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-145_0632aa0a-3d3c-374f-e063-6394a90a52c4	72789-145	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20191001		ANDA	ANDA207206	PD-Rx Pharmaceuticals, Inc.	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-146_f887b71b-4fe9-e182-e053-6394a90a48b3	72789-146	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20080429		ANDA	ANDA065435	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-147_0334f532-811e-b825-e063-6294a90ab4fc	72789-147	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20160823		ANDA	ANDA203824	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72789-149_f291a06f-dae6-181c-e053-2995a90a7eee	72789-149	HUMAN PRESCRIPTION DRUG	Balsalazide Disodium		Balsalazide Disodium	CAPSULE	ORAL	20071228		ANDA	ANDA077806	PD-Rx Pharmaceuticals, Inc.	BALSALAZIDE DISODIUM	750	mg/1	Aminosalicylate [EPC], Aminosalicylic Acids [CS]		N	20241231
72789-151_00294627-d89c-e68b-e063-6294a90aee47	72789-151	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	PD-Rx Pharmaceuticals, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-152_ff226eef-057e-e518-e053-6394a90a96e8	72789-152	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20101008		ANDA	ANDA090515	PD-Rx Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-153_0a1eceaf-d666-78eb-e063-6394a90a3923	72789-153	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET, FILM COATED	ORAL	20190208		ANDA	ANDA211933	PD-Rx Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-154_0a4a4b43-c237-3a20-e063-6294a90a739a	72789-154	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	PD-Rx Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
72789-155_021f197d-c736-29f7-e063-6294a90aee3d	72789-155	HUMAN PRESCRIPTION DRUG	Omeprazole		omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20090123		ANDA	ANDA075410	PD-Rx Pharmaceuticals, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72789-156_0633084a-add3-8df0-e063-6294a90a237a	72789-156	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	PD-Rx Pharmaceuticals, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72789-157_fbd60eb3-113c-bdd7-e053-6294a90a26b6	72789-157	HUMAN PRESCRIPTION DRUG	Furosemide		furosemide	TABLET	ORAL	20040326		ANDA	ANDA076796	PD-Rx Pharmaceuticals, Inc.	FUROSEMIDE	40	mg/1	Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]		N	20241231
72789-158_021f32a8-4946-3e41-e063-6394a90a4ef0	72789-158	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20180420		ANDA	ANDA205794	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72789-161_042817f9-6760-056a-e063-6394a90a2d97	72789-161	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20110718		ANDA	ANDA076341	PD-Rx Pharmaceuticals, Inc.	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-162_093046b6-bb71-3239-e063-6294a90af6a8	72789-162	HUMAN PRESCRIPTION DRUG	Losartan Potassium and Hydrochlorothiazide		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20121030		ANDA	ANDA201845	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72789-163_f2b4b0fc-f472-4d6a-e053-2995a90a0480	72789-163	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	25 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-164_f2b4b0fc-f472-4d6a-e053-2995a90a0480	72789-164	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	50 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-165_f2b4b0fc-f472-4d6a-e053-2995a90a0480	72789-165	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	100 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-166_05f8e581-b62c-8636-e063-6294a90a92c8	72789-166	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000501		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	DOCUSATE SODIUM	250	mg/1			N	20241231
72789-167_0634159a-17a6-cba2-e063-6394a90a4799	72789-167	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	PD-Rx Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72789-168_f8739649-cb94-14ec-e053-6394a90a9bf9	72789-168	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	PD-Rx Pharmaceuticals, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
72789-169_063422ae-4356-01ce-e063-6294a90a5151	72789-169	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208249	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72789-170_063422ae-4357-01ce-e063-6294a90a5151	72789-170	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	PD-Rx Pharmaceuticals, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
72789-171_039e7fdc-b641-f77d-e063-6294a90ae35f	72789-171	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20041028		ANDA	ANDA076832	PD-Rx Pharmaceuticals, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
72789-171_0b293129-7212-ac60-e063-6294a90ae92f	72789-171	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET, EXTENDED RELEASE	ORAL	20041028		ANDA	ANDA076832	PD-Rx Pharmaceuticals, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
72789-172_f49a7dc7-77ba-3911-e053-2a95a90ad55c	72789-172	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19870128		NDA	NDA017812	PD-Rx Pharmaceuticals, Inc.	LITHIUM CARBONATE	600	mg/1	Mood Stabilizer [EPC]		N	20241231
72789-173_f49a7dc7-77f6-3911-e053-2a95a90ad55c	72789-173	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	CAPSULE, GELATIN COATED	ORAL	19801126		NDA	NDA017812	PD-Rx Pharmaceuticals, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
72789-174_f49a9e84-4baa-068e-e053-2a95a90a6e4d	72789-174	HUMAN PRESCRIPTION DRUG	Lithium Carbonate		Lithium Carbonate	TABLET	ORAL	19820129		NDA	NDA018558	PD-Rx Pharmaceuticals, Inc.	LITHIUM CARBONATE	300	mg/1	Mood Stabilizer [EPC]		N	20241231
72789-175_0633a947-b7a1-0588-e063-6294a90aa848	72789-175	HUMAN PRESCRIPTION DRUG	Adipex-P		Phentermine Hydrochloride	TABLET	ORAL	20201208		ANDA	ANDA085128	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72789-176_fbd606e2-06d9-9b1d-e053-6294a90a664c	72789-176	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	CAPSULE	ORAL	20190114		ANDA	ANDA203561	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	12.5	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72789-177_0192ea0c-9a13-dcc6-e063-6294a90ab6a4	72789-177	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	PD-Rx Pharmaceuticals, Inc.	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-177_0e76f0d9-0ac0-e097-e063-6394a90adba2	72789-177	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	PD-Rx Pharmaceuticals, Inc.	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
72789-178_0192ea0c-9a13-dcc6-e063-6294a90ab6a4	72789-178	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	PD-Rx Pharmaceuticals, Inc.	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-178_0e76f0d9-0ac0-e097-e063-6394a90adba2	72789-178	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20210222		ANDA	ANDA040586	PD-Rx Pharmaceuticals, Inc.	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
72789-179_0634351f-fae1-a8e3-e063-6294a90a3b60	72789-179	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	50 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-180_f888f934-4fbb-f08f-e053-6294a90ace39	72789-180	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	PD-Rx Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72789-181_07ffc7b1-97b5-09ba-e063-6294a90a521c	72789-181	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	PD-Rx Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
72789-182_0e77166a-8fb2-eb67-e063-6394a90a1f12	72789-182	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	PD-Rx Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20251231
72789-183_fa1b7586-fb27-5e37-e053-6394a90aa92d	72789-183	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20090921		ANDA	ANDA071251	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72789-184_030befb3-9867-57dc-e063-6394a90a6027	72789-184	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	PD-Rx Pharmaceuticals, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72789-185_fe077d49-1c89-29d8-e053-6394a90aa31e	72789-185	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-186_fe077d49-1c89-29d8-e053-6394a90aa31e	72789-186	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-187_fe077d49-1c89-29d8-e053-6394a90aa31e	72789-187	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-189_0633084a-add4-8df0-e063-6294a90a237a	72789-189	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72789-190_fc10e25f-edc1-4dd1-e053-6294a90a53f6	72789-190	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20200120		ANDA	ANDA040188	PD-Rx Pharmaceuticals, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
72789-191_0335184e-abb7-e8c6-e063-6394a90a2d2d	72789-191	HUMAN OTC DRUG	ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20180920		ANDA	ANDA072096	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-192_09302760-34f9-b8b0-e063-6394a90adc4e	72789-192	HUMAN PRESCRIPTION DRUG	Metformin HCl		Metformin HCl	TABLET	ORAL	20170206		ANDA	ANDA090564	PD-Rx Pharmaceuticals, Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
72789-193_0634159a-17aa-cba2-e063-6394a90a4799	72789-193	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-194_06343ab5-e5f1-dd22-e063-6294a90a27d8	72789-194	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20130319		ANDA	ANDA202389	PD-Rx Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-195_06343ef1-058a-5bde-e063-6294a90a6147	72789-195	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20190223		ANDA	ANDA206560	PD-Rx Pharmaceuticals, Inc.	METRONIDAZOLE	250	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
72789-196_f6e158c9-9d02-13e9-e053-6394a90a1843	72789-196	HUMAN OTC DRUG	Fexofenadine HCL		Fexofenadine HCL	TABLET	ORAL	20190218		ANDA	ANDA204097	PD-Rx Pharmaceuticals, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72789-197_fe080226-12e7-5bf8-e053-6294a90ae6eb	72789-197	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	PD-Rx Pharmaceuticals, Inc.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-198_021f9235-d9c7-7255-e063-6294a90ac3e6	72789-198	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-199_0bdcf009-4dd8-e3d1-e063-6394a90ace29	72789-199	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-200_fe18a1df-acba-d253-e053-6394a90a074e	72789-200	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-201_09975ec8-8fe3-36d9-e063-6394a90a09bc	72789-201	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-202_0062fb43-38a3-902a-e063-6294a90ad500	72789-202	HUMAN PRESCRIPTION DRUG	Potassium citrate		Potassium citrate	TABLET, EXTENDED RELEASE	ORAL	20210301		ANDA	ANDA214426	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72789-203_0062fb43-38a3-902a-e063-6294a90ad500	72789-203	HUMAN PRESCRIPTION DRUG	Potassium citrate		potassium citrate	TABLET, EXTENDED RELEASE	ORAL	20210301		ANDA	ANDA214426	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72789-204_0062fb43-38a3-902a-e063-6294a90ad500	72789-204	HUMAN PRESCRIPTION DRUG	Potassium citrate		Potassium citrate	TABLET, EXTENDED RELEASE	ORAL	20210301		ANDA	ANDA214426	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72789-205_062f87d5-d214-2a74-e063-6394a90a13ce	72789-205	HUMAN PRESCRIPTION DRUG	Ursodiol		Ursodiol	CAPSULE	ORAL	20200205		ANDA	ANDA212452	PD-Rx Pharmaceuticals, Inc.	URSODIOL	300	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72789-206_fbd53122-0526-9baa-e053-6294a90a5399	72789-206	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	PD-Rx Pharmaceuticals, Inc.	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
72789-207_f889064a-1651-0039-e053-6294a90ae985	72789-207	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	PD-Rx Pharmaceuticals, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
72789-208_06349cd4-9200-0e2b-e063-6394a90a433a	72789-208	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20110308		ANDA	ANDA200272	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72789-209_0bb2c2fd-7a68-ec40-e063-6294a90a8967	72789-209	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20210422		ANDA	ANDA078423	PD-Rx Pharmaceuticals, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72789-210_f49aa3f1-5d44-5f11-e053-2995a90abe8c	72789-210	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20180507		ANDA	ANDA210347	PD-Rx Pharmaceuticals, Inc.	PIROXICAM	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-211_f49aa3f1-5d44-5f11-e053-2995a90abe8c	72789-211	HUMAN PRESCRIPTION DRUG	Piroxicam		Piroxicam	CAPSULE	ORAL	20180507		ANDA	ANDA210347	PD-Rx Pharmaceuticals, Inc.	PIROXICAM	20	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-212_fe43e2f5-0ed5-b163-e053-6394a90a327d	72789-212	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-213_06348ed6-e295-6b48-e063-6294a90a4074	72789-213	HUMAN PRESCRIPTION DRUG	Abiraterone		Abiraterone acetate	TABLET	ORAL	20181123		ANDA	ANDA208339	PD-Rx Pharmaceuticals, Inc.	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
72789-216_0322ef5c-632f-d1e6-e063-6294a90a417a	72789-216	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121009		ANDA	ANDA088618	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72789-217_fe19c10f-eff5-4dee-e053-6394a90a1ed2	72789-217	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-218_05671a95-d30e-be61-e063-6394a90a1e66	72789-218	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20200821		ANDA	ANDA078329	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-219_fe45a6e4-40f4-161c-e053-6294a90a9880	72789-219	HUMAN PRESCRIPTION DRUG	Nifedipine		Nifedipine	CAPSULE	ORAL	20101207		ANDA	ANDA202644	PD-Rx Pharmaceuticals, Inc.	NIFEDIPINE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
72789-220_fbd4edbf-bc8d-dabf-e053-6294a90aa684	72789-220	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20190327		ANDA	ANDA211603	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-221_0634e2f1-9c88-b84c-e063-6294a90a3895	72789-221	HUMAN PRESCRIPTION DRUG	Fluvoxamine Maleate		Fluvoxamine Maleate	TABLET	ORAL	20010710		ANDA	ANDA075902	PD-Rx Pharmaceuticals, Inc.	FLUVOXAMINE MALEATE	100	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-222_0b2953bf-dd22-c837-e063-6294a90af125	72789-222	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-223_0b2953bf-dd22-c837-e063-6294a90af125	72789-223	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-224_f49ac99c-97c8-4941-e053-2995a90a11ca	72789-224	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, COATED	ORAL	20060329		ANDA	ANDA065255	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-225_0e7729de-1047-e578-e063-6394a90a7de6	72789-225	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20251231
72789-226_04b5039e-e52d-930a-e063-6394a90a2219	72789-226	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211209		ANDA	ANDA072927	PD-Rx Pharmaceuticals, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-227_f889231a-b25f-2ec4-e053-6294a90a6018	72789-227	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20211222		ANDA	ANDA207029	PD-Rx Pharmaceuticals, Inc.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72789-228_f889231a-b25f-2ec4-e053-6294a90a6018	72789-228	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20211222		ANDA	ANDA207029	PD-Rx Pharmaceuticals, Inc.	HYDROCORTISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72789-229_f889231a-b25f-2ec4-e053-6294a90a6018	72789-229	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20211222		ANDA	ANDA207029	PD-Rx Pharmaceuticals, Inc.	HYDROCORTISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72789-230_f8893d7b-84ed-77ca-e053-6294a90aca9c	72789-230	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	PD-Rx Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72789-231_06349548-79c7-894b-e063-6294a90afe69	72789-231	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	PD-Rx Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72789-232_f93ba0a4-9354-a0d3-e053-6294a90a82b6	72789-232	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20181221		ANDA	ANDA206948	PD-Rx Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72789-233_06349e4c-2cca-df3f-e063-6294a90af67b	72789-233	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	TABLET, FILM COATED	ORAL	20140305		ANDA	ANDA076938	PD-Rx Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-234_06349548-79c8-894b-e063-6294a90afe69	72789-234	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	PD-Rx Pharmaceuticals, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
72789-235_fa1bbb69-298f-94a6-e053-6394a90ab9b0	72789-235	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	PD-Rx Pharmaceuticals, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72789-236_04b4fc90-576a-fb7b-e063-6294a90a4722	72789-236	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20211011		ANDA	ANDA072926	PD-Rx Pharmaceuticals, Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-237_0634e06b-b9d5-8b16-e063-6294a90a144d	72789-237	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20200130		ANDA	ANDA211556	PD-Rx Pharmaceuticals, Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72789-238_0634e06b-b9d5-8b16-e063-6294a90a144d	72789-238	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20200130		ANDA	ANDA211556	PD-Rx Pharmaceuticals, Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72789-239_fe45b3e0-b0b7-152a-e053-6394a90ad808	72789-239	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20200511		ANDA	ANDA212861	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72789-240_0634fc46-019b-6bab-e063-6394a90a428e	72789-240	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20200801		ANDA	ANDA040751	PD-Rx Pharmaceuticals, Inc.	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-241_06c1a044-cb6e-be06-e063-6294a90a6687	72789-241	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180912		OTC MONOGRAPH DRUG	M013	PD-Rx Pharmaceuticals, Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
72789-242_fe08fb0c-007d-40a7-e053-6294a90acac9	72789-242	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	PD-Rx Pharmaceuticals, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
72789-243_0634fc46-019b-6bab-e063-6394a90a428e	72789-243	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20200801		ANDA	ANDA040751	PD-Rx Pharmaceuticals, Inc.	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-244_0634fc46-019b-6bab-e063-6394a90a428e	72789-244	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET	ORAL	20200801		ANDA	ANDA040751	PD-Rx Pharmaceuticals, Inc.	IMIPRAMINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-245_0775a04a-4612-87d2-e063-6394a90a9f1f	72789-245	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-246_f49bba2c-29e0-fdea-e053-2a95a90acd9d	72789-246	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20211108		ANDA	ANDA214289	PD-Rx Pharmaceuticals, Inc.	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72789-247_f49bba2c-29e0-fdea-e053-2a95a90acd9d	72789-247	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20211108		ANDA	ANDA214289	PD-Rx Pharmaceuticals, Inc.	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72789-248_f839821f-34c0-93fb-e053-6394a90affe9	72789-248	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	750	mg/1			N	20241231
72789-249_063506e4-f2c5-5f90-e063-6294a90a2b61	72789-249	HUMAN PRESCRIPTION DRUG	VITAMIN D		ergocalciferol	CAPSULE	ORAL	20140516		ANDA	ANDA090455	PD-Rx Pharmaceuticals, Inc.	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
72789-250_06c1c1ef-4024-7e97-e063-6294a90a5723	72789-250	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20201030		OTC MONOGRAPH DRUG	M009	PD-Rx Pharmaceuticals, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
72789-251_f19e4d5d-56c6-27f1-e053-2995a90ae0c6	72789-251	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72789-252_06350f23-db33-be5a-e063-6394a90ad897	72789-252	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	PD-Rx Pharmaceuticals, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
72789-253_0a1f2074-d581-5fbc-e063-6294a90a2456	72789-253	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET	ORAL	20160823		ANDA	ANDA203824	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
72789-254_039ca779-eae7-4172-e063-6394a90a9598	72789-254	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-254_fe1bcf0c-6223-252c-e053-6294a90a8da4	72789-254	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20070301		ANDA	ANDA065291	PD-Rx Pharmaceuticals, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-255_0635683b-880c-0cd4-e063-6394a90ab73e	72789-255	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20120328		ANDA	ANDA202152	PD-Rx Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72789-256_06359122-6076-7c3a-e063-6294a90a784f	72789-256	HUMAN PRESCRIPTION DRUG	Clorazepate Dipotassium		Clorazepate Dipotassium	TABLET	ORAL	20000427		ANDA	ANDA075731	PD-Rx Pharmaceuticals, Inc.	CLORAZEPATE DIPOTASSIUM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-257_04b542c2-7a62-edec-e063-6394a90aca94	72789-257	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20140301		ANDA	ANDA078490	PD-Rx Pharmaceuticals, Inc.	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72789-258_fe457894-44dd-6666-e053-6394a90ac247	72789-258	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20150528		ANDA	ANDA204446	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-259_fa19bc13-30b3-bca7-e053-6394a90a838b	72789-259	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201203		ANDA	ANDA205129	PD-Rx Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-260_0e7707c5-ca6a-e9fe-e063-6394a90a36e0	72789-260	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	2.5 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
72789-261_0e7707c5-ca6a-e9fe-e063-6394a90a36e0	72789-261	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	5 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
72789-262_0e7707c5-ca6a-e9fe-e063-6394a90a36e0	72789-262	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE	10 mg	AMLODIPINE BESYLATE	TABLET	ORAL	20211001		ANDA	ANDA078414	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
72789-263_0bb527d4-6abc-a98b-e063-6394a90af3a0	72789-263	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	PD-Rx Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72789-264_04b542c2-7aa4-edec-e063-6394a90aca94	72789-264	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	PD-Rx Pharmaceuticals, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72789-265_f49cde3c-60f0-0e9a-e053-2a95a90a2be4	72789-265	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20111024		ANDA	ANDA091265	PD-Rx Pharmaceuticals, Inc.	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72789-266_f8872437-a837-9096-e053-6294a90a3260	72789-266	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	PD-Rx Pharmaceuticals, Inc.	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72789-267_06c1eb9b-2ed5-1bc3-e063-6394a90a00c2	72789-267	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20210311		OTC MONOGRAPH DRUG	M013	PD-Rx Pharmaceuticals, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
72789-268_fbfcf75f-75be-979c-e053-6394a90a610e	72789-268	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	PD-Rx Pharmaceuticals, Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72789-269_01f5ac08-36b7-b000-e063-6294a90a80c6	72789-269	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20121022		ANDA	ANDA088619	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72789-270_f88973cb-0323-8b77-e053-6294a90aee2b	72789-270	HUMAN PRESCRIPTION DRUG	Nitrofurantoin Macrocrystals		Nitrofurantoin Macrocrystals	CAPSULE	ORAL	20070308		ANDA	ANDA073652	PD-Rx Pharmaceuticals, Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
72789-271_01f57fe0-c57f-b82d-e063-6394a90ad8b8	72789-271	HUMAN PRESCRIPTION DRUG	Hydroxyzine Hydrochloride		Hydroxyzine Hydrochloride	TABLET, FILM COATED	ORAL	20130219		ANDA	ANDA088617	PD-Rx Pharmaceuticals, Inc.	HYDROXYZINE DIHYDROCHLORIDE	10	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
72789-272_fcffd390-8073-406c-e053-6294a90a54bf	72789-272	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	PD-Rx Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72789-273_fe1ce099-b849-32d1-e053-6294a90a0a91	72789-273	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-274_06c1eb1f-0057-1942-e063-6294a90a27f4	72789-274	HUMAN OTC DRUG	Docusate Sodium		DOCUSATE SODIUM	CAPSULE	ORAL	20200228		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
72789-275_0b296833-55d8-fe37-e063-6394a90a8a62	72789-275	HUMAN PRESCRIPTION DRUG	Glyburide and Metformin Hydrochloride		Glyburide and Metformin Hydrochloride	TABLET, FILM COATED	ORAL	20071114		ANDA	ANDA077870	PD-Rx Pharmaceuticals, Inc.	GLYBURIDE; METFORMIN HYDROCHLORIDE	5; 500	mg/1; mg/1	Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72789-276_0bb3e1a3-e209-e0c8-e063-6294a90af301	72789-276	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19860710		ANDA	ANDA062677	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-277_0e76f0d9-0ac9-e097-e063-6394a90adba2	72789-277	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19860710		ANDA	ANDA062676	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20251231
72789-278_0a1f0b71-663c-7e4e-e063-6394a90a1ef3	72789-278	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	19951214		ANDA	ANDA072709	PD-Rx Pharmaceuticals, Inc.	MINOXIDIL	2.5	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72789-279_0635c5a7-63df-af00-e063-6294a90aa5e1	72789-279	HUMAN PRESCRIPTION DRUG	MINOXIDIL		minoxidil	TABLET	ORAL	19951214		ANDA	ANDA072709	PD-Rx Pharmaceuticals, Inc.	MINOXIDIL	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72789-280_0635bee1-78e5-49b3-e063-6394a90ad40c	72789-280	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		propranolol hydrochloride	TABLET	ORAL	20100621		ANDA	ANDA070221	PD-Rx Pharmaceuticals, Inc.	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-281_0635c2c4-5f2d-a3b4-e063-6394a90a12a9	72789-281	HUMAN PRESCRIPTION DRUG	valsartan		valsartan	TABLET	ORAL	20150105		ANDA	ANDA203536	PD-Rx Pharmaceuticals, Inc.	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-282_fe464b9c-f4ae-0f7d-e053-6394a90a6dcb	72789-282	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM	25 mg	LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20191009		ANDA	ANDA090382	PD-Rx Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72789-283_06c1eb9b-2ef3-1bc3-e063-6394a90a00c2	72789-283	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET	ORAL	20200801		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	SENNOSIDES A AND B	8.6	mg/1			N	20241231
72789-284_0eb3fe42-4ed7-8fe9-e063-6294a90a5032	72789-284	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20120910		ANDA	ANDA090617	PD-Rx Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
72789-285_0e772402-6cf3-8c75-e063-6294a90a5c45	72789-285	HUMAN PRESCRIPTION DRUG	Amlodipine and Benazepril Hydrochloride		Amlodipine and Benazepril Hydrochloride	CAPSULE	ORAL	20120905		ANDA	ANDA202239	PD-Rx Pharmaceuticals, Inc.	AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE	10; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
72789-286_04b5542b-fdf0-5b6d-e063-6294a90aaeb2	72789-286	HUMAN PRESCRIPTION DRUG	Divalproex sodium		Divalproex sodium	TABLET, EXTENDED RELEASE	ORAL	20200918		ANDA	ANDA209286	PD-Rx Pharmaceuticals, Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72789-287_06359122-607b-7c3a-e063-6294a90a784f	72789-287	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	PD-Rx Pharmaceuticals, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
72789-288_f8ffe76d-f80c-24eb-e053-6394a90a9b0e	72789-288	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		PD-Rx Pharmaceuticals, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
72789-289_0b386304-8d4c-da72-e063-6294a90ad239	72789-289	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	PD-Rx Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72789-290_0b38b4b8-8c8d-bff2-e063-6394a90a9f75	72789-290	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	PD-Rx Pharmaceuticals, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72789-291_0a1f38b6-4e19-9ba9-e063-6394a90ac482	72789-291	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	PD-Rx Pharmaceuticals, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72789-292_062ffd88-2018-3c4d-e063-6394a90a5cf9	72789-292	HUMAN PRESCRIPTION DRUG	Spironolactone		Spironolactone	TABLET, COATED	ORAL	20210104		ANDA	ANDA040750	PD-Rx Pharmaceuticals, Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
72789-293_f201a00c-1b98-abfc-e053-2995a90a3a5c	72789-293	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	19940127		ANDA	ANDA074063	PD-Rx Pharmaceuticals, Inc.	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-294_f20092e7-25ec-54c1-e053-2a95a90aadbe	72789-294	HUMAN PRESCRIPTION DRUG	Pindolol		Pindolol	TABLET	ORAL	19940127		ANDA	ANDA074063	PD-Rx Pharmaceuticals, Inc.	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72789-295_06c1eaf8-cbe7-2af7-e063-6294a90a863e	72789-295	HUMAN OTC DRUG	Docusate Sodium		DOCUSATE SODIUM	CAPSULE	ORAL	20210528		OTC MONOGRAPH DRUG	M007	PD-Rx Pharmaceuticals, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
72789-296_017f5147-aa4e-392e-e063-6294a90a3c78	72789-296	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20200925		ANDA	ANDA087059	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72789-297_f88973cb-0324-8b77-e053-6294a90aee2b	72789-297	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201210		ANDA	ANDA212399	PD-Rx Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72789-298_f3a8a0b0-6c79-f728-e053-2995a90a3e88	72789-298	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19860710		ANDA	ANDA062676	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-299_09977109-e715-38b1-e063-6394a90a6142	72789-299	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	PD-Rx Pharmaceuticals, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72789-300_0566dcd6-02f0-a3ef-e063-6394a90ae932	72789-300	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220411		ANDA	ANDA076095	PD-Rx Pharmaceuticals, Inc.	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
72789-301_f8871409-07ec-3a07-e053-6394a90afa42	72789-301	HUMAN PRESCRIPTION DRUG	BUPROPION HYDROCHLORIDE		BUPROPION HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20181108		ANDA	ANDA210497	PD-Rx Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
72789-302_04b5c3be-cb51-7106-e063-6394a90a602e	72789-302	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-303_fbd5de64-0e5e-4cc2-e053-6294a90a4cee	72789-303	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	PD-Rx Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72789-304_f8fd9496-4e5d-3162-e053-6394a90ad524	72789-304	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20160219		ANDA	ANDA078103	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-305_fe465b9a-f9e6-2a9b-e053-6394a90afed3	72789-305	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	PD-Rx Pharmaceuticals, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-306_f87299ad-d55d-eb7a-e053-6394a90a4135	72789-306	HUMAN PRESCRIPTION DRUG	Montelukast Sodium		Montelukast Sodium	TABLET, FILM COATED	ORAL	20120803		ANDA	ANDA202468	PD-Rx Pharmaceuticals, Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
72789-307_fe1d8d05-f545-072d-e053-6394a90aa37f	72789-307	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	PD-Rx Pharmaceuticals, Inc.	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-308_0a1f3256-dc58-91b7-e063-6394a90a0de4	72789-308	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-308_f7099d5e-63bb-5b82-e053-6394a90a3a5e	72789-308	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	CAPSULE	ORAL	20001226		ANDA	ANDA065053	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-309_09a7136c-d35a-6d30-e063-6294a90ab07f	72789-309	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20050513		ANDA	ANDA065134	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	20	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-310_f6f51c72-37a4-33f8-e053-6394a90a7aca	72789-310	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	CAPSULE	ORAL	20150302		ANDA	ANDA201748	PD-Rx Pharmaceuticals, Inc.	FENOFIBRATE	130	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
72789-311_003aa46c-a162-8c9e-e063-6294a90a4931	72789-311	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram Oxalate	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA090432	PD-Rx Pharmaceuticals, Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-312_fa2a8fac-5278-6d0d-e053-6294a90a1865	72789-312	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	PD-Rx Pharmaceuticals, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72789-313_01cf8ba0-20f2-be6a-e063-6394a90a65b4	72789-313	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	PD-Rx Pharmaceuticals, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-314_fe1dc06a-0b18-85f4-e053-6394a90a1f21	72789-314	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	PD-Rx Pharmaceuticals, Inc.	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-315_fe1db493-aecb-0331-e053-6394a90ab628	72789-315	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20180215		ANDA	ANDA077856	PD-Rx Pharmaceuticals, Inc.	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-316_f8fd8863-24ab-28e4-e053-6294a90aaf3d	72789-316	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070614		ANDA	ANDA078103	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-317_06c2144d-239d-3b9d-e063-6394a90a5666	72789-317	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE	ORAL	20220414		OTC MONOGRAPH DRUG	M012	PD-Rx Pharmaceuticals, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72789-318_f886f501-1168-1e7e-e053-6394a90a20b8	72789-318	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	PD-Rx Pharmaceuticals, Inc.	ENALAPRIL MALEATE	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
72789-319_0cceeb5c-3f52-cca0-e063-6394a90a3b95	72789-319	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	19860710		ANDA	ANDA062677	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72789-320_f9a011ea-9e08-126c-e053-6394a90a844a	72789-320	HUMAN PRESCRIPTION DRUG	SIMVASTATIN		SIMVASTATIN	TABLET, FILM COATED	ORAL	20070612		ANDA	ANDA078103	PD-Rx Pharmaceuticals, Inc.	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
72789-321_0a36a405-49ca-28d1-e063-6294a90ae102	72789-321	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	PD-Rx Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-323_0e9e6d9a-5b6a-f1d9-e063-6394a90a2bf0	72789-323	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	PD-Rx Pharmaceuticals, Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20251231
72789-324_0997c35c-de8b-89c8-e063-6294a90a7843	72789-324	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20230401		ANDA	ANDA215556	PD-RX Pharmaceuticals, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72789-325_0cf2cf97-05af-9c9e-e063-6294a90a6ac0	72789-325	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	PD-Rx Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72789-326_0cf2cf97-05af-9c9e-e063-6294a90a6ac0	72789-326	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	PD-Rx Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72789-327_fdf4fe8b-6c10-78c6-e053-6294a90aa318	72789-327	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20031211		ANDA	ANDA076416	PD-Rx Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72789-328_fdf4f2ce-e22f-d79c-e053-6394a90a3df6	72789-328	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	PD-Rx Pharmaceuticals, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-329_fe304bc1-e74c-d206-e053-6294a90a0930	72789-329	HUMAN PRESCRIPTION DRUG	Enalapril Maleate		Enalapril Maleate	TABLET	ORAL	20220424		ANDA	ANDA213273	PD-Rx Pharmaceuticals, Inc.	ENALAPRIL MALEATE	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]		N	20241231
72789-330_04c86719-59bd-4b29-e063-6394a90ae4ba	72789-330	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-331_0257be1f-2e79-bd8c-e063-6294a90a76ad	72789-331	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20211104		ANDA	ANDA215767	PD-Rx Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72789-332_019149e5-ac1b-067c-e063-6294a90a71dd	72789-332	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		buspirone hydrochloride	TABLET	ORAL	20200727		ANDA	ANDA075388	PD-Rx Pharmaceuticals, Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
72789-333_04c6f39e-2c3b-c0c6-e063-6394a90a1f76	72789-333	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-334_04c6f39e-2c3b-c0c6-e063-6394a90a1f76	72789-334	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-335_04c6f39e-2c3b-c0c6-e063-6394a90a1f76	72789-335	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-336_04c6f39e-2c3b-c0c6-e063-6394a90a1f76	72789-336	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-337_04c6f39e-2c3b-c0c6-e063-6394a90a1f76	72789-337	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20210501		ANDA	ANDA213474	PD-Rx Pharmaceuticals, Inc.	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72789-338_01f5ac08-36b4-b000-e063-6294a90a80c6	72789-338	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	PD-Rx Pharmaceuticals, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72789-339_0179ac3b-f435-96d8-e063-6294a90a9457	72789-339	HUMAN PRESCRIPTION DRUG	LORAZEPAM		LORAZEPAM	TABLET	ORAL	20170324		ANDA	ANDA203572	PD-Rx Pharmaceuticals, Inc.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-340_03fdc530-ff2e-424d-e063-6394a90a2243	72789-340	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20230321		ANDA	ANDA217272	PD-Rx Pharmaceuticals, Inc.	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
72789-341_01e352a7-24f6-d380-e063-6394a90acc5e	72789-341	HUMAN PRESCRIPTION DRUG	Olanzapine		Olanzapine	TABLET, FILM COATED	ORAL	20140822		ANDA	ANDA202862	PD-Rx Pharmaceuticals, Inc.	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72789-342_0450c5cc-a604-1e48-e063-6294a90a7bf9	72789-342	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET, COATED	ORAL	20100627		ANDA	ANDA078921	PD-Rx Pharmaceuticals, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
72789-343_030e4b42-1870-28d2-e063-6294a90ac226	72789-343	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA078336	PD-Rx Pharmaceuticals, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72789-343_03c0a599-0718-10ef-e063-6394a90a9698	72789-343	HUMAN OTC DRUG	cetirizine hydrochloride		Cetirizine Hydrochloride	TABLET	ORAL	20071227		ANDA	ANDA078336	PD-Rx Pharmaceuticals, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72789-344_056a5aec-4951-cc3e-e063-6294a90ad3e1	72789-344	HUMAN PRESCRIPTION DRUG	tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20230401		ANDA	ANDA215556	PD-Rx Pharmaceuticals, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72789-345_025b09be-86f7-ca78-e063-6294a90ac624	72789-345	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	TABLET, FILM COATED	ORAL	20220708		ANDA	ANDA215630	PD-Rx Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72789-346_02f75c76-1451-d23e-e063-6294a90a0db8	72789-346	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20070206		ANDA	ANDA077206	PD-Rx Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72789-347_039e434c-1a8a-0a99-e063-6294a90af412	72789-347	HUMAN OTC DRUG	Loratadine	antihistamine	Loratadine	TABLET	ORAL	20081015		ANDA	ANDA076301	PD-Rx Pharmaceuticals, Inc.	LORATADINE	10	mg/1			N	20241231
72789-348_0410c7a2-bb81-aafd-e063-6394a90a92a5	72789-348	HUMAN PRESCRIPTION DRUG	TROSPIUM CHLORIDE		TROSPIUM CHLORIDE	TABLET, FILM COATED	ORAL	20101117		ANDA	ANDA091573	PD-Rx Pharmaceuticals, Inc.	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72789-349_03244cff-442c-609f-e063-6294a90a8b6c	72789-349	HUMAN PRESCRIPTION DRUG	Triazolam		Triazolam	TABLET	ORAL	20201020		ANDA	ANDA214219	PD-Rx Pharmaceuticals, Inc.	TRIAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-350_05685c5c-1ab1-cabc-e063-6294a90ad6d5	72789-350	HUMAN PRESCRIPTION DRUG	Moxifloxacin Hydrochloride		Moxifloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20140304		ANDA	ANDA202632	PD-Rx Pharmaceuticals, Inc.	MOXIFLOXACIN HYDROCHLORIDE	400	mg/1	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-351_05f52877-e748-b08d-e063-6294a90a0a3a	72789-351	HUMAN PRESCRIPTION DRUG	SILODOSIN		SILODOSIN	CAPSULE	ORAL	20181210		ANDA	ANDA210626	PD-Rx Pharmaceuticals, Inc.	SILODOSIN	4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
72789-352_074fb18b-27cd-5691-e063-6294a90a813e	72789-352	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160421		ANDA	ANDA205606	PD-Rx Pharmaceuticals, Inc.	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72789-353_0803d298-8a96-ebee-e063-6394a90aecc7	72789-353	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	PD-Rx Pharmaceuticals, Inc.	DIVALPROEX SODIUM	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72789-354_07ec5d59-1de8-896e-e063-6294a90afd04	72789-354	HUMAN PRESCRIPTION DRUG	Divalproex Sodium		Divalproex Sodium	TABLET, DELAYED RELEASE	ORAL	20080729		ANDA	ANDA078597	PD-Rx Pharmaceuticals, Inc.	DIVALPROEX SODIUM	500	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
72789-355_0b38b9fd-6463-25fb-e063-6294a90a2b00	72789-355	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20231026		ANDA	ANDA076045	PD-Rx Pharmaceuticals, Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-356_0b38b9fd-6463-25fb-e063-6294a90a2b00	72789-356	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20231026		ANDA	ANDA076045	PD-Rx Pharmaceuticals, Inc.	LORAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-357_0b38b9fd-6463-25fb-e063-6294a90a2b00	72789-357	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20231026		ANDA	ANDA076045	PD-Rx Pharmaceuticals, Inc.	LORAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72789-358_0bb3df93-cf59-fecd-e063-6294a90a2b51	72789-358	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20231027		ANDA	ANDA089286	PD-Rx Pharmaceuticals, Inc.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72789-359_0bb3df93-cf59-fecd-e063-6294a90a2b51	72789-359	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20231027		ANDA	ANDA089286	PD-Rx Pharmaceuticals, Inc.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72789-360_07fe6290-0b45-e485-e063-6394a90ab359	72789-360	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	19971028		ANDA	ANDA040197	PD-Rx Pharmaceuticals, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
72789-361_08a27b6e-ad58-85b3-e063-6294a90afc74	72789-361	HUMAN PRESCRIPTION DRUG	Tenofovir Disoproxil Fumarate		Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20231026		ANDA	ANDA090636	PD-Rx Pharmaceuticals, Inc.	TENOFOVIR DISOPROXIL FUMARATE	300	mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]		N	20241231
72789-362_0a33560b-92a1-fa1a-e063-6294a90a3cad	72789-362	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine	TABLET	ORAL	20110201		UNAPPROVED DRUG OTHER		PD-Rx Pharmaceuticals, Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
72789-363_0d821c56-3d07-e0d6-e063-6394a90a6723	72789-363	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72789-364_0eb3b67d-b7ee-7468-e063-6294a90aa636	72789-364	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	PD-Rx Pharmaceuticals, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
72789-365_0d940a57-45d0-0d82-e063-6294a90a8343	72789-365	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20231114		ANDA	ANDA076368	PD-Rx Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	20	meq/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72789-366_0c4177a2-5bab-d262-e063-6394a90a90e5	72789-366	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20131011		ANDA	ANDA090549	PD-Rx Pharmaceuticals, Inc.	PENICILLIN V POTASSIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
72789-367_0c67d9af-4da8-2e09-e063-6394a90a60fe	72789-367	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	PD-Rx Pharmaceuticals, Inc.	LEVOFLOXACIN	500	mg/1			N	20241231
72789-368_0c570733-e2df-6dea-e063-6294a90a9e68	72789-368	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	PD-Rx Pharmaceuticals, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
72789-369_0d971568-f89d-4ff5-e063-6294a90aa108	72789-369	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	19860710		ANDA	ANDA062676	PD-Rx Pharmaceuticals, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
72793-100_23bdbae2-2f37-4315-a8f0-58d6d8a08193	72793-100	HUMAN OTC DRUG	Mountain Ice	Pain Relief	Menthol	GEL	TOPICAL	20190528		OTC MONOGRAPH DRUG	M017	Mountainside Medical Equipment, Inc.	MENTHOL, UNSPECIFIED FORM	5	g/100mL			N	20241231
72793-201_bd0c20f7-a163-43b2-bf69-93496063f8e0	72793-201	HUMAN OTC DRUG	Mountain Ice Sports Recovery		Menthol	GEL	TOPICAL	20221101		OTC MONOGRAPH DRUG	M017	Mountainside Medical Equipment, Inc.	MENTHOL, UNSPECIFIED FORM	6	g/100mL			N	20241231
72793-300_a505d391-23b5-413e-a354-50cde3323d0f	72793-300	HUMAN OTC DRUG	Mountain Ice Advanced Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200914		OTC MONOGRAPH DRUG	M003	Mountainside Medical Equipment, Inc.	ALCOHOL	72	mL/100mL			N	20251231
72793-400_53a8fe84-88a9-4b57-bc3f-73dce0f94721	72793-400	HUMAN OTC DRUG	Mountain Ice Eczema		Colloidal Oatmeal	CREAM	TOPICAL	20210218		OTC MONOGRAPH DRUG	M016	Mountainside Medical Equipment, Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72797-001_9d64ab72-8d84-4481-9135-69e00bf0658b	72797-001	HUMAN OTC DRUG	BobBarker antibacterial wrapped body		Benzethonium Chloride	SOAP	TOPICAL	20230113		OTC MONOGRAPH NOT FINAL	part333E	Yangzhou H&R Plastic Daily Chemical Co., Ltd.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20241231
72805-120_3e70f61f-fbdb-46ff-a507-ca0ef8ecf2d0	72805-120	HUMAN OTC DRUG	Luster Premium White	AM/PM	Sodium Fluoride and Sodium Monofluorophosphate	KIT		20180401		OTC MONOGRAPH FINAL	part355	French Transit, Ltd.						N	20241231
72805-130_d0154c38-0b82-4cd7-a5a6-418c821ad0df	72805-130	HUMAN OTC DRUG	Luster Premium White	Now	Sodium Fluoride	PASTE	DENTAL	20180401		OTC MONOGRAPH FINAL	part355	French Transit, Ltd.	SODIUM FLUORIDE	.24	g/100g			N	20241231
72805-140_bf1e7c8d-bb4b-481d-b464-f25ebb8f202d	72805-140	HUMAN OTC DRUG	Luster Premium White	Power White Pro	Sodium Monofluorophosphate	PASTE	DENTAL	20180401		OTC MONOGRAPH FINAL	part355	French Transit, Ltd.	SODIUM MONOFLUOROPHOSPHATE	.88	g/100g			N	20241231
72805-150_bf1e7c8d-bb4b-481d-b464-f25ebb8f202d	72805-150	HUMAN OTC DRUG	Luster Premium White	Power White Pro	Sodium Monofluorophosphate	PASTE	DENTAL	20180401		OTC MONOGRAPH FINAL	part355	French Transit, Ltd.	SODIUM MONOFLUOROPHOSPHATE	.88	g/100g			N	20241231
72808-001_0d98d98e-141e-4acf-e063-6294a90ad2a8	72808-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000110		UNAPPROVED MEDICAL GAS		East Coast Oxygen	OXYGEN	99	L/100L			N	20241231
72811-000_0c5ccc0a-d8a6-fd03-e063-6394a90a3ebc	72811-000	HUMAN OTC DRUG	111MedCo 2% Salicylic Acid Cleansing Bar		SALICYLIC ACID	SOAP	TOPICAL	20220701		OTC MONOGRAPH DRUG	M006	111MedCo LLC	SALICYLIC ACID	20	mg/g			N	20241231
72811-001_0c5cbcce-9208-e712-e063-6394a90a2e18	72811-001	HUMAN OTC DRUG	111MedCo 6% Sulfur Skin Cleansing Bar		SULFUR	SOAP	TOPICAL	20230906		OTC MONOGRAPH DRUG	M006	111MedCo LLC	SULFUR	60	mg/g			N	20241231
72811-002_0a9b3755-c0d0-4282-e063-6394a90a0c08	72811-002	HUMAN OTC DRUG	111MedCo Medicated Bar 2 Pyrithione Zinc		PYRITHIONE ZINC	SOAP	TOPICAL	20231001		OTC MONOGRAPH DRUG	M032	111MedCo LLC	PYRITHIONE ZINC	20	mg/g			N	20241231
72811-137_0c5ce71d-4764-65bd-e063-6294a90ad6da	72811-137	HUMAN OTC DRUG	111 Medco Benzoyl Peroxide		Benzoyl Peroxide	SOAP	TOPICAL	20190402		OTC MONOGRAPH DRUG	M006	111 Medco	BENZOYL PEROXIDE	100	mg/g			N	20241231
72812-143_e6086c01-d711-4e3d-9fb8-a15982f7c9d0	72812-143	HUMAN OTC DRUG	Earth Mama Baby Face Mineral Sunscreen SPF 40		Zinc Oxide	CREAM	TOPICAL	20190401		OTC MONOGRAPH FINAL	part352	Earth Mama Angel Baby, LLC	ZINC OXIDE	220	mg/g			N	20241231
72812-144_d26801bc-0293-41ea-b85d-f3d94934b062	72812-144	HUMAN OTC DRUG	Earth Mama Baby Mineral Sunscreen SPF 40		Zinc Oxide	CREAM	TOPICAL	20190401		OTC MONOGRAPH FINAL	part352	Earth Mama Angel Baby, LLC	ZINC OXIDE	250	mg/g			N	20241231
72812-148_70671953-b9fd-4bd2-928e-87d52606ac29	72812-148	HUMAN OTC DRUG	Earth Mama Kids Uber-Sensitive Mineral Sunscreen SPF 40		Zinc Oxide	CREAM	TOPICAL	20190401	20250731	OTC MONOGRAPH FINAL	M020	Earth Mama Angel Baby, LLC	ZINC OXIDE	250	mg/g			N	
72812-149_85e7930a-d592-4fd9-bccf-91c3d72bb2bf	72812-149	HUMAN OTC DRUG	Earth Mama Lady Face Mineral Sunscreen - Light/Medium Tint Broad Spectrum SPF 40		Zinc Oxide	STICK	TOPICAL	20200605		OTC MONOGRAPH FINAL	part352	Earth Mama Angel Baby LLC	ZINC OXIDE	22	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72812-150_3e66deb9-20a3-4393-b012-36f6c01e8955	72812-150	HUMAN OTC DRUG	Earth Mama Lady Face Mineral Sunscreen - Medium/Dark Tint Broad Spectrum	SPF 40	Zinc Oxide	STICK	TOPICAL	20200605		OTC MONOGRAPH FINAL	part352	Earth Mama Angel Baby LLC	ZINC OXIDE	22	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72812-151_75fd6214-1fb4-4f8d-bf71-39d03006e51f	72812-151	HUMAN OTC DRUG	Earth Mama Eczema Cream		Colloidal Oatmeal	CREAM	TOPICAL	20210101		OTC MONOGRAPH FINAL	part347	Earth Mama Angel Baby, LLC	OATMEAL	50	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72812-152_146f1d76-d7f9-4998-a1a6-2afbb8c6a128	72812-152	HUMAN OTC DRUG	Tinted Mineral Sunscreen Broad Spectrum SPF 25		Zinc Oxide	LOTION	TOPICAL	20200801		OTC MONOGRAPH FINAL	part352	Earth Mama Angel Baby, LLC	ZINC OXIDE	200	mg/g			N	20241231
72812-153_8d6ab42c-fe47-4ce8-9c71-ab852d0fe59e	72812-153	HUMAN OTC DRUG	Tinted Mineral Sunscreen Broad Spectrum SPF 40		Zinc Oxide	LOTION	TOPICAL	20200901		OTC MONOGRAPH FINAL	part352	Earth Mama Angel Baby, LLC	ZINC OXIDE	250	mg/g			N	20241231
72812-154_f5610e14-58b0-464c-a33f-0270535363c8	72812-154	HUMAN OTC DRUG	earth mama UBER-SENSITIVE MINERAL Sunscreen SPF 40		Zinc Oxide	LOTION	TOPICAL	20230912		OTC MONOGRAPH FINAL	M020	Earth Mama Angel Baby, LLC	ZINC OXIDE	250	mg/g			N	20241231
72814-001_d27ff50f-5203-cba9-e053-2995a90a0a51	72814-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020130		UNAPPROVED MEDICAL GAS		RFJ & G Incorporated dba M4 Oxygen Service	OXYGEN	99	L/100L			N	20241231
72816-000_0d6d638d-dda3-3362-e063-6394a90a91ab	72816-000	HUMAN OTC DRUG	Mamisan Pain Relieving		LIDOCAINE HYDROCHLORIDE, MENTHOL	OINTMENT	TOPICAL	20230605		OTC MONOGRAPH DRUG	M017	PLANTIMEX DISTRIBUTORS INC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72816-001_0d6d2af4-b01b-4364-e063-6394a90aa990	72816-001	HUMAN OTC DRUG	Mamisan Pain Relieving Cream Lidocaine Plus Menthol		LIDOCAINE HYDROCHLORIDE, MENTHOL	CREAM	TOPICAL	20230619		OTC MONOGRAPH DRUG	M017	PLANTIMEX DISTRIBUTORS INC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72817-001_0aadd43a-a225-4f78-e063-6394a90a1499	72817-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20000201		UNAPPROVED MEDICAL GAS		All About Pediatrics, LLC	OXYGEN	99	L/100L			N	20241231
72819-151_f1eb3570-4aa2-340c-e053-2a95a90aced9	72819-151	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, FILM COATED	ORAL	20210915		ANDA	ANDA075463	Archis Pharma LLC	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72819-152_05e37cd7-f0c4-3bde-e063-6294a90a2acf	72819-152	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220311		ANDA	ANDA202670	Archis Pharma LLC	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72819-152_fd60f15a-95d0-b4ae-e053-6394a90a355c	72819-152	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220425		ANDA	ANDA202670	Archis Pharma LLC	MITOMYCIN	5	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72819-153_fd60f15a-95d0-b4ae-e053-6394a90a355c	72819-153	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220425		ANDA	ANDA202670	Archis Pharma LLC	MITOMYCIN	20	mg/40mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72819-154_fd60f15a-95d0-b4ae-e053-6394a90a355c	72819-154	HUMAN PRESCRIPTION DRUG	Mitomycin		Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20220425		ANDA	ANDA203386	Archis Pharma LLC	MITOMYCIN	40	mg/80mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72819-155_05dc6c98-f0e0-0459-e063-6294a90aa181	72819-155	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		mycophenilic acid	TABLET, DELAYED RELEASE	ORAL	20220221		ANDA	ANDA091248	Archis Pharma LLC	MYCOPHENOLIC ACID	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72819-156_05dc6c98-f0e0-0459-e063-6294a90aa181	72819-156	HUMAN PRESCRIPTION DRUG	Mycophenolic Acid		mycophenilic acid	TABLET, DELAYED RELEASE	ORAL	20220221		ANDA	ANDA091248	Archis Pharma LLC	MYCOPHENOLIC ACID	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72819-157_066acc57-af5a-4b62-e063-6394a90a2b94	72819-157	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220531		ANDA	ANDA203802	Archis Pharma LLC	PALIPERIDONE	1.5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72819-158_066acc57-af5a-4b62-e063-6394a90a2b94	72819-158	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220531		ANDA	ANDA203802	Archis Pharma LLC	PALIPERIDONE	3	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72819-159_066acc57-af5a-4b62-e063-6394a90a2b94	72819-159	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220531		ANDA	ANDA203802	Archis Pharma LLC	PALIPERIDONE	6	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72819-160_066acc57-af5a-4b62-e063-6394a90a2b94	72819-160	HUMAN PRESCRIPTION DRUG	Paliperidone		paliperidone	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220531		ANDA	ANDA203802	Archis Pharma LLC	PALIPERIDONE	9	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72819-161_0e1f91fa-a035-857e-e063-6394a90a68c9	72819-161	HUMAN PRESCRIPTION DRUG	Doxepin		Doxepin	TABLET, FILM COATED	ORAL	20220221		ANDA	ANDA202337	Archis Pharma LLC	DOXEPIN HYDROCHLORIDE	3	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
72819-162_0e1f91fa-a035-857e-e063-6394a90a68c9	72819-162	HUMAN PRESCRIPTION DRUG	Doxepin		Doxepin	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA202337	Archis Pharma LLC	DOXEPIN HYDROCHLORIDE	6	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
72819-181_0037a1a4-d769-2567-e063-6394a90a721c	72819-181	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, COATED	ORAL	20220901		ANDA	ANDA205347	Archis Pharma LLC	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72819-182_0037a1a4-d769-2567-e063-6394a90a721c	72819-182	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, COATED	ORAL	20220901		ANDA	ANDA205347	Archis Pharma LLC	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72819-183_0037a1a4-d769-2567-e063-6394a90a721c	72819-183	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, COATED	ORAL	20220901		ANDA	ANDA205347	Archis Pharma LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72819-184_0037a1a4-d769-2567-e063-6394a90a721c	72819-184	HUMAN PRESCRIPTION DRUG	Valsartan		valsartan	TABLET, COATED	ORAL	20220901		ANDA	ANDA205347	Archis Pharma LLC	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72819-185_05dbf49e-73b7-3190-e063-6394a90a1a64	72819-185	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET	ORAL	20220901		ANDA	ANDA212135	Archis Pharma LLC	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
72819-186_05dbf49e-73b7-3190-e063-6394a90a1a64	72819-186	HUMAN PRESCRIPTION DRUG	imatinib mesylate		imatinib mesylate	TABLET	ORAL	20220901		ANDA	ANDA212135	Archis Pharma LLC	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
72823-301_27e27f85-2304-4afe-82b4-3e236099bb0e	72823-301	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate For Oral Suspension		Sevelamer Carbonate For Oral Suspension	POWDER, FOR SUSPENSION	ORAL	20230302		ANDA	ANDA217319	Hangzhou Anprime Biopharm Co., Ltd.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
72823-302_27e27f85-2304-4afe-82b4-3e236099bb0e	72823-302	HUMAN PRESCRIPTION DRUG	Sevelamer Carbonate For Oral Suspension		Sevelamer Carbonate For Oral Suspension	POWDER, FOR SUSPENSION	ORAL	20230302		ANDA	ANDA217319	Hangzhou Anprime Biopharm Co., Ltd.	SEVELAMER CARBONATE	2400	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
72826-101_806ad904-35cf-46f6-b9bb-1aa282c80866	72826-101	HUMAN OTC DRUG	Flexilon		methyl salicylate, menthol, camphor	CREAM	TOPICAL	20201110		OTC MONOGRAPH NOT FINAL	part348	Semprae Laboratories Inc	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	4; 7.5; 10	g/100g; g/100g; g/100g			N	20241231
72827-100_de1ab8fc-1d03-4477-97d1-5387697a14a1	72827-100	HUMAN OTC DRUG	Matys Organic Baby Eczema Relief		Sulphur	OINTMENT	TOPICAL	20190218		UNAPPROVED HOMEOPATHIC		Matys Healthy Products Llc	SULFUR	7	[hp_X]/142g			N	20241231
72827-101_483af208-4ce7-4252-8971-9f99251d3871	72827-101	HUMAN OTC DRUG	Matys Organic Baby Diaper Rash Relief		Calendula	OINTMENT	TOPICAL	20190218		UNAPPROVED HOMEOPATHIC		Matys Healthy Products Llc	CALENDULA OFFICINALIS FLOWERING TOP	3	[hp_X]/284g			N	20241231
72827-102_0281ddb9-17af-438d-94b6-c91bbf7f8581	72827-102	HUMAN OTC DRUG	MATYS Baby DIAPER RASH RELIEF		Zinc Oxide	OINTMENT	TOPICAL	20210601		OTC MONOGRAPH FINAL	part347	Matys Healthy Products LLC	ZINC OXIDE	1	g/100g			N	20241231
72827-103_d8c8c49b-c914-4af8-a283-5a8637c2ca43	72827-103	HUMAN OTC DRUG	MATYS Baby ECZEMA RELIEF		Colloidal Oatmeal	OINTMENT	TOPICAL	20210601		OTC MONOGRAPH FINAL	part347	Matys Healthy Products LLC	OATMEAL	.1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72829-010_4c3f963c-e963-44ac-af35-a815a1460985	72829-010	HUMAN PRESCRIPTION DRUG	Imcivree		setmelanotide	SOLUTION	SUBCUTANEOUS	20201214		NDA	NDA213793	Rhythm Pharmaceuticals, Inc	SETMELANOTIDE	10	mg/mL	Melanocortin 4 Receptor Agonist [EPC], Melanocortin 4 Receptor Agonists [MoA]		N	20241231
72830-261_08c1a8af-2e39-682c-e063-6394a90a8892	72830-261	HUMAN OTC DRUG	Green Defense Broad Spectrum SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20200531		OTC MONOGRAPH DRUG	M020	Farmacy	TITANIUM DIOXIDE; ZINC OXIDE	24; 58.2	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72830-265_08c1b333-9b69-90d9-e063-6394a90a52fd	72830-265	HUMAN OTC DRUG	Green Defense daily mineral sunscreen Broad Spectrum SPF 30		ZINC OXIDE	LOTION	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	Farmacy Beauty LLC	ZINC OXIDE	182.3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72835-201_1093b649-b7b1-42de-bf49-db430f9be733	72835-201	HUMAN PRESCRIPTION DRUG	Varophen		Diclofenac Sodium and Menthol, Methyl salicylate	KIT		20190603		ANDA	ANDA202027	V2 Pharma, LLC						N	20241231
72835-202_037a4b6d-c798-44e9-af8f-aa6a431228cb	72835-202	HUMAN PRESCRIPTION DRUG	Fenovar		Diclofenac Sodium and Menthol, Methyl salicylate	KIT		20220121		UNAPPROVED DRUG OTHER		V2 Pharma, LLC						N	20241231
72835-302_6737e798-61e1-47cc-a05b-85c81602d88e	72835-302	HUMAN PRESCRIPTION DRUG	Podiatrole		Ketoconazole 2% and Urea 20%	KIT		20230106		UNAPPROVED DRUG OTHER		V2 Pharma, LLC						N	20241231
72835-501_21b37e4f-7ff5-4462-aa5c-85b7aae2441b	72835-501	HUMAN PRESCRIPTION DRUG	LMR Plus		Lidocaine	KIT		20190603		ANDA	ANDA200675	V2 Pharma, LLC						N	20241231
72835-502_5f05d80c-6e1b-40ee-9d91-0f8b2b65e8b2	72835-502	HUMAN PRESCRIPTION DRUG	Elemar Patch		Lidocaine	KIT		20220222		UNAPPROVED DRUG OTHER		V2 Pharma, LLC						N	20241231
72835-601_6508f6db-0e5e-46c7-a596-4bb5222a4d3d	72835-601	HUMAN PRESCRIPTION DRUG	Quinixil		Mometasone Furoate and Dimethicone	KIT		20190603		ANDA	ANDA076216	V2 Pharma, LLC						N	20241231
72835-602_ad348698-0878-46dc-a453-06abf5815929	72835-602	HUMAN PRESCRIPTION DRUG	Lefluniclo		Leflunomide and Diclofenac Sodium Gel	KIT		20230111		UNAPPROVED DRUG OTHER		V2 Pharma, LLC						N	20241231
72835-701_148b05e3-f467-463f-8813-6ecb2bef9bc5	72835-701	HUMAN PRESCRIPTION DRUG	Inflatherm		Diclofenac Sodium and Menthol / Camphor Gel	KIT		20190603		ANDA	ANDA074514	V2 Pharma, LLC						N	20241231
72835-802_069a1f99-3ffa-4a83-a466-1d4bcd18643d	72835-802	HUMAN PRESCRIPTION DRUG	Duloxicaine		Duloxetine and Lidocaine	KIT		20230123		UNAPPROVED DRUG OTHER		V2 Pharma, LLC						N	20241231
72835-902_99c15fb7-07fe-491c-b3a1-21324747ad23	72835-902	HUMAN PRESCRIPTION DRUG	Trionex		Calcipotriene Cream, 0.005% and Transparent Dressing	KIT		20230113		UNAPPROVED DRUG OTHER		V2 Pharma, LLC						N	20241231
72838-0360_09c727e0-0190-4b43-e063-6394a90abe69	72838-0360	HUMAN OTC DRUG	Povidone Iodine Swabsticks 4 Triple		POVIDONE-IODINE	SWAB	TOPICAL	20220130		OTC MONOGRAPH DRUG	505G(a)(3)	Amsino healthcare (USA) inc.	POVIDONE-IODINE	100	mg/g			N	20241231
72839-013_fda2afaf-3ccf-92b3-e053-6394a90a7493	72839-013	HUMAN OTC DRUG	DCH Calaspray Itch Relief		Pramoxine HCl 1%, Zinc Acetate 0.1%	SPRAY	TOPICAL	20210218		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	1; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72839-014_ff32cbb2-79ea-9158-e053-6394a90ac357	72839-014	HUMAN OTC DRUG	DCH Nerve Pain Relief Roll-On		Lidocaine HCl 4%, Menthol 1%	GEL	TOPICAL	20230530		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-021_ffd7be08-050f-dfcb-e053-6394a90ad286	72839-021	HUMAN OTC DRUG	DCH Burn Relief		Lidocaine, 0.5%	SPRAY	TOPICAL	20211224		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs	LIDOCAINE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-026_fda0d359-9604-8b38-e053-6294a90a7b88	72839-026	HUMAN OTC DRUG	DCH Arthritis Pain Relief Roll-On		Capsaisin 0.1%	GEL	TOPICAL	20230120		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	CAPSAICIN	.1	g/100g			N	20241231
72839-031_ff49ee63-6a88-c7a7-e053-6294a90a77a3	72839-031	HUMAN OTC DRUG	DCH Pain Relieving		Menthol 2%	GEL	TOPICAL	20210812		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	MENTHOL	2	g/100g			N	20241231
72839-069_dcf2f52b-2294-58e5-e053-2995a90a7fd8	72839-069	HUMAN OTC DRUG	Warrior Chiggerex Relief		Benzocaine 10%	CREAM	TOPICAL	20200814		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	BENZOCAINE	10	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72839-071_fc10cbc3-fc1c-ae09-e053-6394a90ac8f3	72839-071	HUMAN OTC DRUG	Warrior Rectal Care		Lidocaine 4%, Phenylephrine Hydrochloride 0.25%	OINTMENT	TOPICAL	20230123		OTC MONOGRAPH FINAL	part346	Derma Care Research Labs	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	4; .25	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72839-083_fb5b55a6-caa1-e7ee-e053-6294a90a3190	72839-083	HUMAN OTC DRUG	Aruba Sun SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20211125		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-087_fda35d37-f36d-efc8-e053-6294a90a2bb8	72839-087	HUMAN OTC DRUG	DCH Pain Relief Roll-On		Lidocaine HCl 4%	GEL	TOPICAL	20220421		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-093_f28c9a8d-2ed0-0e8e-e053-2a95a90aaf1a	72839-093	HUMAN OTC DRUG	Habana SPF 70 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-096_fc749882-2e1f-cad3-e053-6294a90a33ca	72839-096	HUMAN OTC DRUG	DCH Labs Antifungal Jock		Miconazole Nitrate 2%	POWDER	TOPICAL	20220114		OTC MONOGRAPH FINAL	M005	Derma Care Research Labs, LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72839-097_00edbc64-9d33-5751-e063-6294a90a400b	72839-097	HUMAN OTC DRUG	DCH Scar		Allantoin 0.5%	GEL	TOPICAL	20211005		OTC MONOGRAPH FINAL	part347	Derma Care Research Labs, LLC	ALLANTOIN	.5	g/100g			N	20241231
72839-101_d35d7720-44cd-3624-e053-2995a90a7fb4	72839-101	HUMAN OTC DRUG	DCH Labs Cool and Heat Roll-On		Menthol 16%	LIQUID	TOPICAL	20211216		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	MENTHOL	16	g/100g			N	20241231
72839-102_e945f9df-0aee-469c-e053-2995a90ab6aa	72839-102	HUMAN OTC DRUG	Pavin SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20220711		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-108_dd80e560-6468-2166-e053-2995a90a88a8	72839-108	HUMAN OTC DRUG	Warrior Pain Relief Roll-On	Maximum Strength	Lidocaine HCl 4%	GEL	TOPICAL	20200814		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-114_0dfb66d6-5b7d-638f-e063-6294a90a2331	72839-114	HUMAN OTC DRUG	Coral Isle SPF 50 Mineral Sunscreen		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230523		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4.5; 4	g/100g; g/100g			N	20251231
72839-119_d53ff8f5-0b07-1e8b-e053-2a95a90ab924	72839-119	HUMAN OTC DRUG	Black Girl Sunscreen SPF 50 Kids		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20220110		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-121_d438be95-0f87-69d7-e053-2995a90a982e	72839-121	HUMAN OTC DRUG	Black Girl Sunscreen SPF 30		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 8%	SPRAY	TOPICAL	20220103		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-129_ff323282-612d-eaf8-e053-6394a90ab779	72839-129	HUMAN OTC DRUG	DCH Cool and Heat		Menthol 16%	SPRAY	TOPICAL	20210212		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	MENTHOL	16	g/100g			N	20241231
72839-131_db6085a7-8415-a4bb-e053-2995a90a35dc	72839-131	HUMAN OTC DRUG	Habana SPF 30 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 8%	SPRAY	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-132_0411f5e3-03d3-c512-e063-6394a90a37d3	72839-132	HUMAN OTC DRUG	Bamboobies Diaper Rash		Zinc Oxide 15%	SPRAY	TOPICAL	20230309		OTC MONOGRAPH FINAL	M016	Derma Care Research Labs, LLC	ZINC OXIDE	15	g/100mL			N	20241231
72839-135_043cadde-ba08-7c77-e063-6394a90abee6	72839-135	HUMAN OTC DRUG	Fresh Coast SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20220526		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-137_0e367a46-f4df-15da-e063-6394a90a849c	72839-137	HUMAN OTC DRUG	Aruba Sun SPF 30 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 6%	LOTION	TOPICAL	20211125		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs,LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 6	g/100g; g/100g; g/100g; g/100g			N	20251231
72839-138_051b68f9-5d6a-3cd7-e063-6394a90aeb35	72839-138	HUMAN OTC DRUG	Bee Bald Smooth Plus Daily Moisturizer SPF 30 Sunscreen		Avobenzone 3%, Homosalate 10%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 6%	LOTION	TOPICAL	20220124		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	3; 10; 5; 2.7; 6	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72839-141_f5d8a4f8-cbcc-d11d-e053-2995a90a2662	72839-141	HUMAN OTC DRUG	Rectal Care Cream	Revivol	Lidocaine 5%	CREAM	TOPICAL	20200326		OTC MONOGRAPH FINAL	part346	Derma Care Research Labs	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-145_fb34b0d3-ccc1-305e-e053-6394a90a231d	72839-145	HUMAN OTC DRUG	Dr Goldsons Pain		Menthol 8%, Methyl Salicylate 30%	CREAM	TOPICAL	20210921		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	MENTHOL; METHYL SALICYLATE	8; 30	g/100g; g/100g			N	20241231
72839-147_dd06af3c-5451-9759-e053-2a95a90afc21	72839-147	HUMAN OTC DRUG	Warrior Pain Relieving		Camphor 4%, Menthol 10%, Methyl Salicylate 30%	SPRAY	TOPICAL	20190809		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	4; 10; 30	g/100g; g/100g; g/100g			N	20241231
72839-151_05e4706b-1954-aba8-e063-6294a90a29c7	72839-151	HUMAN OTC DRUG	SPF 50 Sunscreen Unfragranced		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20230523		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-159_f28c6d70-f9d2-ed4b-e053-2a95a90ac1cd	72839-159	HUMAN OTC DRUG	SPF 50 Sunscreen	Rocky Mountain	Avobenzone 3%, Homosalate 10%, Octocrylene 6%	LOTION	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 6	g/100mL; g/100mL; g/100mL			N	20241231
72839-165_0a9b61ac-4f47-8399-e063-6394a90a43fe	72839-165	HUMAN OTC DRUG	SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230523		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-167_0aad5ced-f355-e294-e063-6394a90aa8d5	72839-167	HUMAN OTC DRUG	SPF 70 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230523		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-173_ffd70a31-7d0d-d2d0-e053-6394a90a8674	72839-173	HUMAN OTC DRUG	DCH Numbing Relief		Lidocaine 5%	SPRAY	TOPICAL	20230130		OTC MONOGRAPH FINAL	M015	Derma Care Research Labs, LLC	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-183_f1db427b-72d6-3dd8-e053-2a95a90a37b8	72839-183	HUMAN OTC DRUG	Rubber Ducky SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72839-185_ec6efa4b-dcbf-1c2b-e053-2995a90ae043	72839-185	HUMAN OTC DRUG	Warrior Burn Relief Aloe	Maximum Strength	Lidocaine HCl 4%	GEL	TOPICAL	20220725		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-193_dafc5532-a7bd-5558-e053-2995a90aec68	72839-193	HUMAN OTC DRUG	Habana Brisa SPF 70 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72839-201_db6193ee-c63b-a9aa-e053-2995a90a0ee7	72839-201	HUMAN OTC DRUG	Habana SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-203_db4a0668-8edc-b1c2-e053-2995a90a02ab	72839-203	HUMAN OTC DRUG	Habana Brisa SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72839-213_013f48b9-913e-b283-e063-6394a90abd73	72839-213	HUMAN OTC DRUG	Warrior Arthritis Relief		Trolamin Salicylate 10%	CREAM	TOPICAL	20230421		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	TROLAMINE SALICYLATE	10	g/100g			N	20241231
72839-214_ff31e515-5781-b77d-e053-6394a90af6b9	72839-214	HUMAN OTC DRUG	DCH Arthritis Relief		Trolamin Salicylate 10%	CREAM	TOPICAL	20211020		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	TROLAMINE SALICYLATE	10	g/100g			N	20241231
72839-215_db0d6dec-d0ed-6160-e053-2a95a90a2c6e	72839-215	HUMAN OTC DRUG	Habana Brisa SPF 30 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 6%	LOTION	TOPICAL	20220131		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72839-217_0050701f-4394-3f01-e063-6394a90a4e0e	72839-217	HUMAN OTC DRUG	DCH Hemorrhoidal		Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%	CREAM	TOPICAL	20230512		OTC MONOGRAPH FINAL	M015	Derma Care Research Labs, LLC	GLYCERIN; LIDOCAINE; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14.4; 5; 15; .25	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72839-218_fbd5b488-1922-e9b7-e053-6294a90aba70	72839-218	HUMAN OTC DRUG	Moshe Numbing Hemorrhoidal		Lidocaine 5%	CREAM	TOPICAL	20230123		OTC MONOGRAPH FINAL	M015	Derma Care Research Labs	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-223_00db480a-e511-a64d-e063-6394a90a4695	72839-223	HUMAN OTC DRUG	DCH Nerve Pain Relief		Lidocaine 4%, Menthol 1%	SPRAY	TOPICAL	20230324		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-226_00efda74-d433-04be-e063-6294a90a6d98	72839-226	HUMAN OTC DRUG	DCH Pain Relief		Lidocaine 4%	SPRAY	TOPICAL	20210610		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-247_fc61847b-cb62-97b1-e053-6394a90ae1b9	72839-247	HUMAN OTC DRUG	Rod and Rifle SPF 50 Sunscreen		Avobenzone 3%, Homosalate 10%, Octocrylene 6%	LOTION	TOPICAL	20220519		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 6	g/100mL; g/100mL; g/100mL			N	20241231
72839-263_00eef84c-a72f-3343-e063-6294a90aa4d8	72839-263	HUMAN OTC DRUG	DCH Rapid Relief Hemorrhoidal		Lidocaine 5%, Phenylephrine Hydrochloride 0.25%	SPRAY	TOPICAL	20230224		OTC MONOGRAPH FINAL	part346	Derma Care Research Labs	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	5; .25	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72839-265_a05d5e07-ae4a-38cc-e053-2a95a90abced	72839-265	HUMAN OTC DRUG	Formula 2 Skin Care		Lidocaine 5%	CREAM	TOPICAL	20200309		OTC MONOGRAPH FINAL	part346	Derma Care Research Labs	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-289_f8730f9c-43c2-f4d3-e053-6294a90a1809	72839-289	HUMAN OTC DRUG	Caribbean Breeze SPF 30 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 8%	SPRAY	TOPICAL	20221212		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-291_f8735925-dcb1-6723-e053-6294a90a51f4	72839-291	HUMAN OTC DRUG	Caribbean Breeze SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20221212		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-293_f873c125-86b9-3d1d-e053-6394a90a6bcf	72839-293	HUMAN OTC DRUG	Caribbean Breeze SPF 70 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20221212		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-295_0140cf68-b6a1-4378-e063-6394a90afee8	72839-295	HUMAN OTC DRUG	Revivol Hemorrhoid and Fissure		Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%	CREAM	TOPICAL	20230512		OTC MONOGRAPH FINAL	M015	Derma Care Research Labs, LLC	GLYCERIN; LIDOCAINE; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14.4; 5; 15; .25	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72839-297_00ed3175-c3b9-6545-e063-6394a90acfd1	72839-297	HUMAN OTC DRUG	DCH Cooling Pain Relief		Menthol 4%	GEL	TOPICAL	20221111		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	MENTHOL	4	g/100mL			N	20241231
72839-310_0aadc378-dc35-9a37-e063-6294a90ad49e	72839-310	HUMAN OTC DRUG	SPF 70 Kids Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230523		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-343_fd9fe09f-3aea-c5f5-e053-6394a90ad691	72839-343	HUMAN OTC DRUG	Pain, Burn, and Itch Relief		Benzocaine 20%, Menthol 0.5%	SPRAY	TOPICAL	20230130		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	BENZOCAINE; MENTHOL	20; .5	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72839-361_00dd70f3-ecc2-33ba-e063-6294a90a4f32	72839-361	HUMAN OTC DRUG	DCH Pain Relief		Lidocaine HCl 4%	CREAM	TOPICAL	20210810		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-371_e9ae2682-59b5-e796-e053-2995a90af921	72839-371	HUMAN OTC DRUG	Flexigen		Menthol 1.25%	CREAM	TOPICAL	20220711		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	MENTHOL	1.25	g/100mL			N	20241231
72839-389_0aacafca-baf6-9a22-e063-6394a90a2ca9	72839-389	HUMAN OTC DRUG	SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230523		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-391_f886a02f-c042-b281-e053-6294a90af746	72839-391	HUMAN OTC DRUG	Australian Sands SPF 50 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20221012		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-413_fbd0ec60-61aa-c17f-e053-6394a90a961b	72839-413	HUMAN OTC DRUG	Dermatool Hemorrhoidal		Glycerin 14.4%, Lidocaine 5%, Petrolatum 15%, Phenylephrine HCl 0.25%	CREAM	TOPICAL	20230510		OTC MONOGRAPH FINAL	M015	Derma Care Research Labs, LLC	GLYCERIN; LIDOCAINE; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE	14.4; 5; 15; .25	g/100g; g/100g; g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72839-507_013d6107-e3b1-0264-e063-6394a90ae1e2	72839-507	HUMAN OTC DRUG	Novonail Solution		Tolnaftate 1%	LIQUID	TOPICAL	20200311		OTC MONOGRAPH FINAL	M005	Derma Care Research Labs, LLC	TOLNAFTATE	1	g/100mL			N	20241231
72839-510_fbc1a55e-b995-4962-e053-6394a90a13ba	72839-510	HUMAN OTC DRUG	Dermatool Fungal Nail Treatment		Tolnaftate 1%	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	M005	Derma Care Research Labs, LLC	TOLNAFTATE	1	g/100mL			N	20241231
72839-515_043b447c-4518-37ce-e063-6394a90a7197	72839-515	HUMAN OTC DRUG	Rubber Ducky SPF 50 Unfragranced Sunscreen		Avobenzone 3%, Homosalate 10%, Octocrylene 6%	LOTION	TOPICAL	20230510		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	3; 10; 6	g/100g; g/100g; g/100g			N	20241231
72839-543_f28cefac-e495-5465-e053-2a95a90a99f3	72839-543	HUMAN OTC DRUG	SPF 50 Sunscreen	Rocky Mountain	Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	SPRAY	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72839-547_0aae69f1-66c0-a199-e063-6394a90a3d75	72839-547	HUMAN OTC DRUG	SPF 60 Mineral Sunscreen		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20230523		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs, LLC	TITANIUM DIOXIDE; ZINC OXIDE	6; 4.6	g/100g; g/100g			N	20241231
72839-605_d680b6f6-e1a8-47a4-e053-2a95a90ae3b0	72839-605	HUMAN OTC DRUG	Dr. Throwers SPF 30 Face and Body Sunscreen		Avobenzone 3%, Homosalate 12%, Octisalate 5%, Octocrylene 3%	LOTION	TOPICAL	20210928		OTC MONOGRAPH NOT FINAL	part352	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 12; 5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-611_d692e7e2-11c6-7b4a-e053-2a95a90ae17b	72839-611	HUMAN OTC DRUG	Dr Throwers Oily Skin Facial Astringent		Salicylic Acid 2%	LIQUID	TOPICAL	20210928		OTC MONOGRAPH FINAL	part333D	Derma Care Research Labs, LLC	SALICYLIC ACID	2	g/100g			N	20241231
72839-613_d6e59f75-cd3e-3fc4-e053-2a95a90abf4c	72839-613	HUMAN OTC DRUG	Dr Throwers Oily Skin Facial Cleanser		Salicylic Acid 2%	LIQUID	TOPICAL	20210928		OTC MONOGRAPH FINAL	part333D	Derma Care Research Labs, LLC	SALICYLIC ACID	2	g/100g			N	20241231
72839-639_00dcdae0-c745-8402-e063-6294a90a12f8	72839-639	HUMAN OTC DRUG	DCH Cooling Pain Relief		Menthol 10.5%	SPRAY	TOPICAL	20210524		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	MENTHOL	10.5	g/100g			N	20241231
72839-647_ec6e9a5b-c61e-a385-e053-2995a90ac936	72839-647	HUMAN OTC DRUG	Warrior First Aid Anti Itch		Diphenhydramine HCl 2%, Zinc Acetate 0.1%	SPRAY	TOPICAL	20220725		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72839-915_09ab318a-a6ca-eb9a-e063-6394a90ab602	72839-915	HUMAN OTC DRUG	Aruba Sun SPF 70 Sunscreen		Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%	LOTION	TOPICAL	20221215		OTC MONOGRAPH DRUG	M020	Derma Care Research Labs, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
72839-955_ff227154-cf3a-9796-e053-6294a90a5535	72839-955	HUMAN OTC DRUG	DCH Burn Relief		Lidocaine HCl	GEL	TOPICAL	20210311		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	LIDOCAINE HYDROCHLORIDE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72839-961_f1dbbe36-c2c8-6708-e053-2a95a90a1090	72839-961	HUMAN OTC DRUG	Warrior Antifungal Foot		Miconazole Nitrate 2%	POWDER	TOPICAL	20210202		OTC MONOGRAPH FINAL	part333C	Derma Care Research Labs, LLC	MICONAZOLE NITRATE	2	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
72839-987_f1dba692-7a60-99bb-e053-2a95a90a1ef1	72839-987	HUMAN OTC DRUG	Outback Pain Relief		Camphor 6%, Menthol 16%	CREAM	TOPICAL	20210513		OTC MONOGRAPH NOT FINAL	part348	Derma Care Research Labs, LLC	CAMPHOR (SYNTHETIC); MENTHOL	6; 16	g/100g; g/100g			N	20241231
72841-205_3282ba9c-b98c-43c7-b326-2d6c74268d64	72841-205	HUMAN OTC DRUG	TreeActiv Spot Treatment		SULFUR	PASTE	TOPICAL	20230405		OTC MONOGRAPH FINAL	part333D	Leiluna LLC	SULFUR	30	mg/mL			N	20241231
72841-301_c24223ad-f9c5-4c27-b938-5b76754b2aff	72841-301	HUMAN OTC DRUG	TreeActiv Advanced Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH NOT FINAL	part333A	Leiluna LLC	ALCOHOL	70	mL/100mL			N	20241231
72843-101_81bce60c-9786-74f5-e053-2a91aa0ade0d	72843-101	HUMAN PRESCRIPTION DRUG	Terbutaline Sulfate		Terbutaline Sulfate	INJECTION	SUBCUTANEOUS	20141215		ANDA	ANDA200122	UBI Pharma Inc.	TERBUTALINE SULFATE	1	mg/mL			N	20241231
72843-434_cd961d6c-beed-d6a3-e053-2a95a90a5b86	72843-434	HUMAN PRESCRIPTION DRUG	CASPOFUNGIN ACETATE		CASPOFUNGIN ACETATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211001		ANDA	ANDA211263	UBI Pharma Inc.	CASPOFUNGIN ACETATE	5	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
72843-440_edb71a95-6e27-ef14-e053-2a95a90a17c4	72843-440	HUMAN PRESCRIPTION DRUG	DESMOPRESSIN ACETATE		DESMOPRESSIN ACETATE	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20200917		ANDA	ANDA210223	UBI Pharma Inc.	DESMOPRESSIN ACETATE	40	ug/10mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
72843-441_f6d4306e-841e-a0b5-e053-6394a90a6124	72843-441	HUMAN PRESCRIPTION DRUG	Voriconazole		voriconazole	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200831		ANDA	ANDA211264	UBI Pharma Inc.	VORICONAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
72843-459_07e248ae-20fa-5d04-e063-6294a90acec0	72843-459	HUMAN PRESCRIPTION DRUG	DESMOPRESSIN ACETATE		DESMOPRESSIN ACETATE	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20200214		ANDA	ANDA210218	UBI Pharma Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
72843-461_edb71a95-6e27-ef14-e053-2a95a90a17c4	72843-461	HUMAN PRESCRIPTION DRUG	DESMOPRESSIN ACETATE		DESMOPRESSIN ACETATE	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20200917		ANDA	ANDA210223	UBI Pharma Inc.	DESMOPRESSIN ACETATE	4	ug/mL	Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]		N	20241231
72843-533_cd961d6c-beed-d6a3-e053-2a95a90a5b86	72843-533	HUMAN PRESCRIPTION DRUG	CASPOFUNGIN ACETATE		CASPOFUNGIN ACETATE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211001		ANDA	ANDA211263	UBI Pharma Inc.	CASPOFUNGIN ACETATE	7	mg/mL	Echinocandin Antifungal [EPC], Lipopeptides [CS]		N	20241231
72845-000_090d6a60-bb3f-b449-e063-6394a90a47a3	72845-000	HUMAN OTC DRUG	Colgate 5g Toothbrush Kit		SODIUM MONOFLUOROPHOSPHATE	KIT		20210119		OTC MONOGRAPH DRUG	M021	Wuhan Jinshengyuan Textiles Manufacturing Co., Ltd.						N	20241231
72847-316_e5064721-5529-4cd6-a53e-dbc2df496adf	72847-316	HUMAN OTC DRUG	CAPZIX		Capsaicin	CREAM	TOPICAL	20190719		OTC MONOGRAPH NOT FINAL	part348	Toprail Chp Llc.	CAPSAICIN	.001	g/g			N	20241231
72852-585_d72e8fda-71cd-44a8-8f98-270c6c83cf2a	72852-585	HUMAN OTC DRUG	Insta Clean Foam Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20190204		OTC MONOGRAPH NOT FINAL	part333E	Alan Environmental Product Inc.	ALCOHOL	.62	mL/mL			N	20241231
72854-126_fd914c6f-38eb-7dff-e053-6394a90a4ec9	72854-126	HUMAN OTC DRUG	Mucinex Fast-Max Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210726		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-127_4c5bb65e-88c4-4cc0-992a-0b073d71aa54	72854-127	HUMAN OTC DRUG	Mucinex Fast-Max Cold, Flu and Sore Throat	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210726		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-128_6f3f53f9-ccf2-49cd-b790-6bc5736cbd78	72854-128	HUMAN OTC DRUG	Mucinex Fast-Max Congestion and Headache	Maximum Strength	ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210726		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-129_fe320fcf-fb20-6d2a-e053-6394a90a2cd9	72854-129	HUMAN OTC DRUG	Mucinex Fast-Max Day Cold and Flu and Night Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Doxylamine Succinate, and Phenylephrine Hydrochloride	KIT		20210726		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
72854-133_0b651193-0483-af85-e063-6394a90a8cb0	72854-133	HUMAN OTC DRUG	Mucinex Fast-Max Cold and Flu Arctic Burst	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	SOLUTION	ORAL	20210701	20240910	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
72854-134_0b653d17-1bf5-a8bd-e063-6294a90a78f2	72854-134	HUMAN OTC DRUG	Mucinex Fast-Max Severe Congestion and Cough Arctic Burst	Maximum Strength	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20210701	20250515	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
72854-135_0b65287a-963d-b4ed-e063-6394a90aa521	72854-135	HUMAN OTC DRUG	Mucinex Fast-Max Cold and Flu Arctic Burst and Nightshift Severe Cold and Flu Arctic Burst		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Triprolidine Hydrochloride	KIT		20210601	20250515	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC						N	
72854-136_021c3ffe-da06-6faf-e063-6394a90a4551	72854-136	HUMAN OTC DRUG	Mucinex Cold and Flu		Acetaminophen, Guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20220701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; GUAIFENESIN	325; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
72854-137_021c1620-cdd1-8bd9-e063-6294a90a848c	72854-137	HUMAN OTC DRUG	Mucinex Cough Chest Congestion		Dextromethorphan HBr, Guaifenesin	CAPSULE, LIQUID FILLED	ORAL	20220701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72854-138_fda752e4-c5ef-dfa7-e053-6394a90a7c58	72854-138	HUMAN OTC DRUG	Mucinex Fast-Max Kickstart Severe Cold and Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride	SOLUTION	ORAL	20230501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-139_fdb70793-5dd2-0455-e053-6394a90ac621	72854-139	HUMAN OTC DRUG	MUCINEX FAST MAX Liquid Cold and Flu Kickstart and MUCINEX Nightshift Kickstart		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI, Triprolidine HCI	KIT		20230501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
72854-140_fdb5c8b7-241e-dab3-e053-6394a90a7316	72854-140	HUMAN OTC DRUG	Mucinex Night Time Severe Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE	SOLUTION	ORAL	20230501		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-144_fe44a71e-034a-174b-e053-6394a90ac0fc	72854-144	HUMAN OTC DRUG	Mucinex Fast-Max Day Cold and Flu and Night Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Doxylamine Succinate, and Phenylephrine Hydrochloride	KIT		20230614		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
72854-202_34118748-221b-406c-b202-8ac1b037539a	72854-202	HUMAN OTC DRUG	Mucinex Sinus-Max Pressure, Pain and Cough	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210726		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-203_29681bff-70ad-4bb1-9339-728051a39eea	72854-203	HUMAN OTC DRUG	Mucinex Sinus-Max Severe Congestion and Pain	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, and Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20210726		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-233_fda420fa-f5fd-312e-e053-6394a90a2b81	72854-233	HUMAN OTC DRUG	Mucinex Nightshift Cold and Flu	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, and triprolidine hydrochloride	TABLET, COATED	ORAL	20210701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	325; 10; 1.25	mg/1; mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72854-234_07621dc9-9ae8-1c1e-e063-6294a90a88f3	72854-234	HUMAN OTC DRUG	Mucinex Nightshift Severe Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	TABLET, COATED	ORAL	20210701		OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	325; 10; 5; 1.25	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-240_fda4a906-a659-08e9-e053-6294a90a2a63	72854-240	HUMAN OTC DRUG	Mucinex Nightshift Sinus	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	TABLET, COATED	ORAL	20210701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	325; 10; 5; 1.25	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72854-241_fda4d249-997e-97e3-e053-6394a90a579f	72854-241	HUMAN OTC DRUG	Mucinex Fast-Max Day Cold and Flu and Mucinex Nightshift Night Severe Cold and Flu	Maximum Strength	acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, and triprolidine hydrochloride	KIT		20210701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
72854-242_fda4e199-492a-bf92-e053-6394a90aed40	72854-242	HUMAN OTC DRUG	Mucinex Fast-Max Day Severe Congestion and Cough and Mucinex Nightshift Night Cold and Flu	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, and Triprolidine Hydrochloride	KIT		20210701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
72854-243_fda4ebe2-4199-e980-e053-6394a90a8d60	72854-243	HUMAN OTC DRUG	Mucinex Sinus-Max Day Pressure, Pain and Cough and Mucinex Nightshift Night Sinus	Maximum Strength	Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Triprolidine Hydrochloride	KIT		20210701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC						N	20241231
72854-250_0b657cec-8e69-f125-e063-6394a90a75a0	72854-250	HUMAN OTC DRUG	Mucinex Nightshift Severe Cold and Flu Arctic Burst		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE	SOLUTION	ORAL	20210701	20250515	OTC MONOGRAPH DRUG	M012	RB Health (US) LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 10; 2.5	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	
72854-261_9cafe349-407c-4f34-9825-03f4abcaf1c2	72854-261	HUMAN OTC DRUG	MUCINEX INSTASOOTHE	SORE THROAT PLUS SOOTHING COMFORT	HEXYLRESORCINOL	LOZENGE	ORAL	20210701		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	HEXYLRESORCINOL	2.4	mg/1			N	20241231
72854-262_6a5d7ea1-a5cb-41bc-bcca-54f581f819d2	72854-262	HUMAN OTC DRUG	MUCINEX INSTASOOTHE	SORE THROAT PLUS PAIN RELIEF	Hexylresorcinol	LOZENGE	ORAL	20220701		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	HEXYLRESORCINOL	2	mg/1			N	20241231
72854-263_8b2a3599-ea97-4eaf-bf5c-20eef840bda6	72854-263	HUMAN OTC DRUG	MUCINEX INSTASOOTHE	SORE THROAT PLUS COUGH RELIEF	DEXTROMETHORPHAN HYDROBROMIDE and HEXYLRESORCINOL	LOZENGE	ORAL	20210701		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE; HEXYLRESORCINOL	5; 2	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72854-265_49503b64-761f-4d3c-84fc-acd896feb8c6	72854-265	HUMAN OTC DRUG	MUCINEX INSTASOOTHE	SORE THROAT PLUS PAIN RELIEF	BENZOCAINE and Menthol, Unspecified Form	SPRAY	ORAL	20210701		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	7; 1	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72854-266_f7a6ed6d-2b72-b9a2-e053-6394a90a04ef	72854-266	HUMAN OTC DRUG	Mucinex Insta soothe	Sore Throat Winter Fresh	BENZOCAINE and Menthol, Unspecified Form	SPRAY	ORAL	20230601		OTC MONOGRAPH NOT FINAL	part356	RB Health (US) LLC	BENZOCAINE; MENTHOL, UNSPECIFIED FORM	5; 2	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72854-351_f8b0b67b-e5b6-85b9-e053-6394a90a5778	72854-351	HUMAN OTC DRUG	Delsym Cough		Dextromethorphan Hydrobromide	TABLET	ORAL	20210701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72854-352_7738b019-5d8a-4cff-be3f-2645e391306c	72854-352	HUMAN OTC DRUG	DELSYM	NO MESS VAPOR ROLL ON	camphor (natural), eucalyptus oil, and menthol, unspecified form	OINTMENT	TOPICAL	20220701		OTC MONOGRAPH FINAL	part341	RB Health (US) LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	53; 13; 28	mg/g; mg/g; mg/g			N	20241231
72854-683_11fed0f0-a201-4afe-8e84-964620a55c7c	72854-683	HUMAN OTC DRUG	KY Duration for Him		Benzocaine	GEL	TOPICAL	20200901		OTC MONOGRAPH FINAL	part348	RB Health (US) LLC	BENZOCAINE	7	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72855-100_087b5a9e-3157-abc7-e063-6394a90a554b	72855-100	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Adhexpharma	RIVASTIGMINE	4.6	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72855-101_087b5a9e-3157-abc7-e063-6394a90a554b	72855-101	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Adhexpharma	RIVASTIGMINE	9.5	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72855-102_087b5a9e-3157-abc7-e063-6394a90a554b	72855-102	HUMAN PRESCRIPTION DRUG	Rivastigmine Transdermal System		Rivastigmine	PATCH, EXTENDED RELEASE	TRANSDERMAL	20191219		ANDA	ANDA209063	Adhexpharma	RIVASTIGMINE	13.3	mg/24h	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
72862-001_0b3c8488-81ec-608b-e063-6294a90a6c88	72862-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190130		UNAPPROVED MEDICAL GAS		Affordable Transport Inc.	OXYGEN	99	L/100L			N	20241231
72863-109_fdb7ecd2-c4c9-90b6-e053-6294a90a69b1	72863-109	HUMAN OTC DRUG	Rael Beauty Miracle Clear Complete Acne Serum		Salicylic Acid	EMULSION	TOPICAL	20240101		OTC MONOGRAPH FINAL	M006	Rael, Inc.	SALICYLIC ACID	15	mg/mL			N	20241231
72864-562_be1b9d48-35cf-6308-e053-2a95a90afbc0	72864-562	HUMAN PRESCRIPTION DRUG	OLIVIA QUIDO FIRM and FADE I		hydrocortisone, hydroquinone, tretinoin	CREAM	TOPICAL	20190909	20241231	UNAPPROVED DRUG OTHER		O Skin Pharmaceutical Corporation	HYDROCORTISONE; HYDROQUINONE; TRETINOIN	.01; .08; .001	g/g; g/g; g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Retinoid [EPC], Retinoids [CS]		N	
72864-563_be1bb3be-3038-6e08-e053-2995a90a6995	72864-563	HUMAN PRESCRIPTION DRUG	OLIVIA QUIDO FIRM and FADE II		hydrocortisone, hydroquinone, tretinoin	CREAM	TOPICAL	20190909	20241231	UNAPPROVED DRUG OTHER		O Skin Pharmaceutical Corporation	HYDROCORTISONE; HYDROQUINONE; TRETINOIN	.01; .06; .001	g/g; g/g; g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Retinoid [EPC], Retinoids [CS]		N	
72865-101_f26fd1e1-7c9e-b45b-e053-2995a90a162d	72865-101	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA202659	XLCARE Pharmaceuticals INC.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72865-102_f26fd1e1-7c9e-b45b-e053-2995a90a162d	72865-102	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA202659	XLCARE Pharmaceuticals INC.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72865-103_f26fd1e1-7c9e-b45b-e053-2995a90a162d	72865-103	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190801		ANDA	ANDA202659	XLCARE Pharmaceuticals INC.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72865-105_f26fd814-a6cb-4749-e053-2a95a90a26fb	72865-105	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20190710		ANDA	ANDA203623	XLCare Pharmaceuticals, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72865-109_fe42cdff-62f7-4209-b953-1f4d13ba4195	72865-109	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20200227		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 2.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-110_fe42cdff-62f7-4209-b953-1f4d13ba4195	72865-110	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20200227		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-111_fe42cdff-62f7-4209-b953-1f4d13ba4195	72865-111	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20200227		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-112_fe42cdff-62f7-4209-b953-1f4d13ba4195	72865-112	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20200227		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-113_e95ef7d6-3a21-4846-b1fd-f15a87675304	72865-113	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-114_e95ef7d6-3a21-4846-b1fd-f15a87675304	72865-114	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-115_e95ef7d6-3a21-4846-b1fd-f15a87675304	72865-115	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-116_e95ef7d6-3a21-4846-b1fd-f15a87675304	72865-116	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20170411		ANDA	ANDA207419	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-117_ff2c1e5b-32ee-4c36-bf70-6aa9df252b01	72865-117	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20200217		ANDA	ANDA211518	XLCare Pharmaceuticals, Inc.	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72865-118_ff2c1e5b-32ee-4c36-bf70-6aa9df252b01	72865-118	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20200217		ANDA	ANDA211518	XLCare Pharmaceuticals, Inc.	BENZONATATE	150	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72865-119_ff2c1e5b-32ee-4c36-bf70-6aa9df252b01	72865-119	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20200217		ANDA	ANDA211518	XLCare Pharmaceuticals, Inc.	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
72865-120_ecea9406-f092-4953-93e8-92b3c26a57bf	72865-120	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20190103		ANDA	ANDA211228	XLCare Pharmaceuticals, Inc	METHADONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-121_ecea9406-f092-4953-93e8-92b3c26a57bf	72865-121	HUMAN PRESCRIPTION DRUG	Methadone Hydrochloride		Methadone Hydrochloride	TABLET	ORAL	20190103		ANDA	ANDA211228	XLCare Pharmaceuticals, Inc	METHADONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-122_0a38c200-2e90-42b8-97e8-e5b64a7078e0	72865-122	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20200226		ANDA	ANDA207416	XLCare Pharmaceuticals Inc	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-123_0a38c200-2e90-42b8-97e8-e5b64a7078e0	72865-123	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20200226		ANDA	ANDA207416	XLCare Pharmaceuticals Inc	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-124_0a38c200-2e90-42b8-97e8-e5b64a7078e0	72865-124	HUMAN PRESCRIPTION DRUG	METHYLPHENIDATE HYDROCHLORIDE		METHYLPHENIDATE HYDROCHLORIDE	TABLET	ORAL	20200226		ANDA	ANDA207416	XLCare Pharmaceuticals Inc	METHYLPHENIDATE HYDROCHLORIDE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-125_96784c11-8f1f-4073-9691-1a1627c79a61	72865-125	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	XLCare Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-126_96784c11-8f1f-4073-9691-1a1627c79a61	72865-126	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	XLCare Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-127_96784c11-8f1f-4073-9691-1a1627c79a61	72865-127	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, CHEWABLE	ORAL	20180301		ANDA	ANDA210354	XLCare Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-128_6261bbcf-f814-4219-9954-8f4662cfa9d9	72865-128	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20200225		ANDA	ANDA207418	XLCare Pharmaceuticals, Inc	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-129_6261bbcf-f814-4219-9954-8f4662cfa9d9	72865-129	HUMAN PRESCRIPTION DRUG	Oxycodone Hydrochloride		Oxycodone Hydrochloride	TABLET	ORAL	20200225		ANDA	ANDA207418	XLCare Pharmaceuticals, Inc	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-130_4fdf3b7e-f6ff-4d78-a928-c9d47c5bc9d9	72865-130	HUMAN PRESCRIPTION DRUG	OXYMORPHONE HYDROCHLORIDE		OXYMORPHONE HYDROCHLORIDE	TABLET	ORAL	20200506		ANDA	ANDA210175	XLCare Pharmaceuticals, Inc.	OXYMORPHONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-131_4fdf3b7e-f6ff-4d78-a928-c9d47c5bc9d9	72865-131	HUMAN PRESCRIPTION DRUG	OXYMORPHONE HYDROCHLORIDE		OXYMORPHONE HYDROCHLORIDE	TABLET	ORAL	20200506		ANDA	ANDA210175	XLCare Pharmaceuticals, Inc.	OXYMORPHONE HYDROCHLORIDE	10	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-133_f0d4af9c-1d16-4405-ac11-6c412af320eb	72865-133	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200224		ANDA	ANDA211009	XLCare Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	18	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-134_f0d4af9c-1d16-4405-ac11-6c412af320eb	72865-134	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200224		ANDA	ANDA211009	XLCare Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	27	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-135_f0d4af9c-1d16-4405-ac11-6c412af320eb	72865-135	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200224		ANDA	ANDA211009	XLCare Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	36	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-136_f0d4af9c-1d16-4405-ac11-6c412af320eb	72865-136	HUMAN PRESCRIPTION DRUG	Methylphenidate Hydrochloride		Methylphenidate Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200224		ANDA	ANDA211009	XLCare Pharmaceuticals, Inc.	METHYLPHENIDATE HYDROCHLORIDE	54	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
72865-137_95fd3aa2-33b0-4e24-b930-3c501a4164b7	72865-137	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20200217		ANDA	ANDA077927	XLCare Pharmaceuticals, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72865-138_95fd3aa2-33b0-4e24-b930-3c501a4164b7	72865-138	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20200217		ANDA	ANDA077927	XLCare Pharmaceuticals, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72865-139_74f8b700-c6a0-406f-ade2-14615adefab5	72865-139	HUMAN PRESCRIPTION DRUG	Omega-3-acid ethyl esters		Omega-3-acid ethyl esters	CAPSULE, LIQUID FILLED	ORAL	20200217		ANDA	ANDA207420	XLCare Pharmaceuticals, Inc.	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
72865-140_64c4cfd9-a320-49f6-ae29-ed9a1f1e3789	72865-140	HUMAN PRESCRIPTION DRUG	Dutasteride		Dutasteride	CAPSULE, LIQUID FILLED	ORAL	20200309		ANDA	ANDA206574	XLCare Pharmaceuticals, Inc.	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
72865-141_f26f9307-2adc-692c-e053-2995a90a83a3	72865-141	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA203835	XLCare Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72865-142_f26f9307-2adc-692c-e053-2995a90a83a3	72865-142	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA203835	XLCare Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72865-143_f26f9307-2adc-692c-e053-2995a90a83a3	72865-143	HUMAN PRESCRIPTION DRUG	LOSARTAN POTASSIUM		LOSARTAN POTASSIUM	TABLET, FILM COATED	ORAL	20200313		ANDA	ANDA203835	XLCare Pharmaceuticals, Inc.	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
72865-144_f26f80c3-6ad3-2c78-e053-2995a90a7783	72865-144	HUMAN PRESCRIPTION DRUG	LAMIVUDINE AND ZIDOVUDINE		lamivudine and zidovudine	TABLET, FILM COATED	ORAL	20200417		ANDA	ANDA203259	XLCare Pharmaceuticals, Inc	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
72865-148_f26f7451-69b2-99d7-e053-2a95a90af7a1	72865-148	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20210727		ANDA	ANDA091240	XLCare Pharmaceuticals Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72865-149_f26f7451-69b2-99d7-e053-2a95a90af7a1	72865-149	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20210727		ANDA	ANDA091240	XLCare Pharmaceuticals Inc.	INDOMETHACIN	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72865-150_f26f3bd0-cfac-0d57-e053-2995a90aa96a	72865-150	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20210216		ANDA	ANDA209403	XLCare Pharmaceuticals Inc.	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
72865-151_f26f3bd0-cfac-0d57-e053-2995a90aa96a	72865-151	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20210216		ANDA	ANDA209403	XLCare Pharmaceuticals Inc.	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
72865-152_f26f3bd0-cfac-0d57-e053-2995a90aa96a	72865-152	HUMAN PRESCRIPTION DRUG	Cinacalcet		Cinacalcet	TABLET, FILM COATED	ORAL	20210216		ANDA	ANDA209403	XLCare Pharmaceuticals Inc.	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
72865-153_f26f3784-b822-9efd-e053-2a95a90ab6ee	72865-153	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201120		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-154_f26f3784-b822-9efd-e053-2a95a90ab6ee	72865-154	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201120		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-155_f26f3784-b822-9efd-e053-2a95a90ab6ee	72865-155	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201120		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-156_f26f3784-b822-9efd-e053-2a95a90ab6ee	72865-156	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201120		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-157_f26f3784-b822-9efd-e053-2a95a90ab6ee	72865-157	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201120		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-158_f26f3784-b822-9efd-e053-2a95a90ab6ee	72865-158	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20201120		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-167_f26efe20-afb4-390a-e053-2a95a90ae396	72865-167	HUMAN PRESCRIPTION DRUG	Abacavir		Abacavir	TABLET	ORAL	20210528		ANDA	ANDA091560	XLCare Pharmaceuticals Inc.	ABACAVIR SULFATE	300	mg/1	Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
72865-168_73ce3fb5-5848-4987-98ab-cb0345b2d077	72865-168	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	XLCare Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	8	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-169_73ce3fb5-5848-4987-98ab-cb0345b2d077	72865-169	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	XLCare Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	12	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-170_73ce3fb5-5848-4987-98ab-cb0345b2d077	72865-170	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	XLCare Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	16	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-171_73ce3fb5-5848-4987-98ab-cb0345b2d077	72865-171	HUMAN PRESCRIPTION DRUG	hydromorphone hydrochloride		hydromorphone hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200924		ANDA	ANDA212133	XLCare Pharmaceuticals, Inc.	HYDROMORPHONE HYDROCHLORIDE	32	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72865-172_f21e4fb1-352d-7105-e053-2995a90a0588	72865-172	HUMAN PRESCRIPTION DRUG	EFAVIRENZ		EFAVIRENZ	TABLET, FILM COATED	ORAL	20210529		ANDA	ANDA078886	XLCare Pharmaceuticals Inc.	EFAVIRENZ	600	mg/1	Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
72865-175_f26fa301-e121-03c1-e053-2a95a90ab2e1	72865-175	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20210211		ANDA	ANDA202843	XLCare Pharmaceuticals Inc.	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
72865-180_a45172c6-a7a6-46f3-bfc4-a7b12eac07c5	72865-180	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20210105		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-181_a45172c6-a7a6-46f3-bfc4-a7b12eac07c5	72865-181	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20210105		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-182_a45172c6-a7a6-46f3-bfc4-a7b12eac07c5	72865-182	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20210105		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-183_a45172c6-a7a6-46f3-bfc4-a7b12eac07c5	72865-183	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20210105		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-184_a45172c6-a7a6-46f3-bfc4-a7b12eac07c5	72865-184	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20210105		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-185_a45172c6-a7a6-46f3-bfc4-a7b12eac07c5	72865-185	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20210105		ANDA	ANDA205064	XLCare Pharmaceuticals, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
72865-186_418dc670-97c2-4103-b924-aed5242e9417	72865-186	HUMAN PRESCRIPTION DRUG	GEMFIBROZIL		Gemfibrozil	TABLET	ORAL	20210120		ANDA	ANDA214603	XLCare Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
72865-187_f26f8c25-d3f8-532f-e053-2a95a90a1450	72865-187	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20210415		ANDA	ANDA090515	XLCare Pharmaceuticals Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-188_f26f8c25-d3f8-532f-e053-2a95a90a1450	72865-188	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20210415		ANDA	ANDA090515	XLCare Pharmaceuticals Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-189_f26f8c25-d3f8-532f-e053-2a95a90a1450	72865-189	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20210415		ANDA	ANDA090515	XLCare Pharmaceuticals Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-190_f26f8c25-d3f8-532f-e053-2a95a90a1450	72865-190	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20210415		ANDA	ANDA090515	XLCare Pharmaceuticals Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-191_7809b770-e255-4e34-b38f-90a0d51eeaea	72865-191	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210225		ANDA	ANDA214420	XLCare Pharmaceuticals, Inc.	POTASSIUM CITRATE	5	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72865-192_7809b770-e255-4e34-b38f-90a0d51eeaea	72865-192	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	XLCare Pharmaceuticals, Inc.	POTASSIUM CITRATE	10	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72865-193_7809b770-e255-4e34-b38f-90a0d51eeaea	72865-193	HUMAN PRESCRIPTION DRUG	POTASSIUM CITRATE		Potassium Citrate	TABLET, EXTENDED RELEASE	ORAL	20210215		ANDA	ANDA214420	XLCare Pharmaceuticals, Inc.	POTASSIUM CITRATE	15	meq/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
72865-194_1e5407b7-9d6a-4c64-8674-2cba50adb5ce	72865-194	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20210304		ANDA	ANDA214422	XLCare Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72865-195_1e5407b7-9d6a-4c64-8674-2cba50adb5ce	72865-195	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210304		ANDA	ANDA214422	XLCare Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72865-196_1e5407b7-9d6a-4c64-8674-2cba50adb5ce	72865-196	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		Potassium Chloride	TABLET, EXTENDED RELEASE	ORAL	20210120		ANDA	ANDA214422	XLCare Pharmaceuticals, Inc.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72865-197_2cdc9267-9619-474a-abe4-a0b85ac3fb2d	72865-197	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA214419	XLCare Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72865-198_2cdc9267-9619-474a-abe4-a0b85ac3fb2d	72865-198	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA214419	XLCare Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72865-199_2cdc9267-9619-474a-abe4-a0b85ac3fb2d	72865-199	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA214419	XLCare Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72865-200_2cdc9267-9619-474a-abe4-a0b85ac3fb2d	72865-200	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		venlafaxine	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA214419	XLCare Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72865-201_4533550e-d20a-4329-b5ab-fb7542ce0be9	72865-201	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20200227		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 2.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-202_4533550e-d20a-4329-b5ab-fb7542ce0be9	72865-202	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20200227		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-203_4533550e-d20a-4329-b5ab-fb7542ce0be9	72865-203	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20200227		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-204_4533550e-d20a-4329-b5ab-fb7542ce0be9	72865-204	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20181108		ANDA	ANDA211487	XLCare Pharmaceuticals, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
72865-205_918e3fe6-8b38-4ec8-accb-09b2d82ff404	72865-205	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	XLCare Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72865-206_918e3fe6-8b38-4ec8-accb-09b2d82ff404	72865-206	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	XLCare Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72865-207_918e3fe6-8b38-4ec8-accb-09b2d82ff404	72865-207	HUMAN PRESCRIPTION DRUG	SERTRALINE HYDROCHLORIDE		sertraline hydrochloride	TABLET	ORAL	20210503		ANDA	ANDA214790	XLCare Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
72865-208_c008ecb6-970d-4ac9-9402-e21e8d9d76b2	72865-208	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	XLCare Pharmaceuticals Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72865-209_c008ecb6-970d-4ac9-9402-e21e8d9d76b2	72865-209	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	XLCare Pharmaceuticals Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72865-210_c008ecb6-970d-4ac9-9402-e21e8d9d76b2	72865-210	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	XLCare Pharmaceuticals Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72865-211_c008ecb6-970d-4ac9-9402-e21e8d9d76b2	72865-211	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	XLCare Pharmaceuticals Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72865-212_c008ecb6-970d-4ac9-9402-e21e8d9d76b2	72865-212	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	XLCare Pharmaceuticals Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72865-213_c008ecb6-970d-4ac9-9402-e21e8d9d76b2	72865-213	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20210817		ANDA	ANDA075903	XLCare Pharmaceuticals Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
72865-214_b37fe9a5-6465-4518-823d-5d369a4c7793	72865-214	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		Famotidine	TABLET, FILM COATED	ORAL	20211015		ANDA	ANDA215689	XLCare Pharmaceuticals, Inc.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72865-215_b37fe9a5-6465-4518-823d-5d369a4c7793	72865-215	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		Famotidine	TABLET, FILM COATED	ORAL	20211015		ANDA	ANDA215689	XLCare Pharmaceuticals, Inc.	FAMOTIDINE	40	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
72865-229_f26fc428-a419-1008-e053-2a95a90a83fc	72865-229	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220501		ANDA	ANDA202882	XLCare Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72865-230_f26fc428-a419-1008-e053-2a95a90a83fc	72865-230	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220501		ANDA	ANDA202882	XLCare Pharmaceuticals Inc.	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72865-231_00498e1e-2c96-4932-e063-6294a90abfc4	72865-231	HUMAN PRESCRIPTION DRUG	Maraviroc		Maraviroc	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA203347	XLCare Pharmaceuticals Inc.	MARAVIROC	150	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
72865-232_00498e1e-2c96-4932-e063-6294a90abfc4	72865-232	HUMAN PRESCRIPTION DRUG	Maraviroc		Maraviroc	TABLET, FILM COATED	ORAL	20230601		ANDA	ANDA203347	XLCare Pharmaceuticals Inc.	MARAVIROC	300	mg/1	CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]		N	20241231
72865-235_f3394cab-e834-326c-e053-2a95a90af10e	72865-235	HUMAN PRESCRIPTION DRUG	LACOSAMIDE		LACOSAMIDE	INJECTION	INTRAVENOUS	20230125		ANDA	ANDA216335	XLCare Pharmaceuticals Inc.	LACOSAMIDE	10	mg/mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
72865-236_16376b6d-2936-4208-ab94-3e0969dce769	72865-236	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.025	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-237_16376b6d-2936-4208-ab94-3e0969dce769	72865-237	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.05	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-238_16376b6d-2936-4208-ab94-3e0969dce769	72865-238	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.075	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-239_16376b6d-2936-4208-ab94-3e0969dce769	72865-239	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.088	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-240_16376b6d-2936-4208-ab94-3e0969dce769	72865-240	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.1	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-241_16376b6d-2936-4208-ab94-3e0969dce769	72865-241	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.112	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-242_16376b6d-2936-4208-ab94-3e0969dce769	72865-242	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.125	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-243_16376b6d-2936-4208-ab94-3e0969dce769	72865-243	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.137	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-244_16376b6d-2936-4208-ab94-3e0969dce769	72865-244	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.15	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-245_16376b6d-2936-4208-ab94-3e0969dce769	72865-245	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.175	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-246_16376b6d-2936-4208-ab94-3e0969dce769	72865-246	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.2	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-247_16376b6d-2936-4208-ab94-3e0969dce769	72865-247	HUMAN PRESCRIPTION DRUG	LEVOTHYROXINE SODIUM		levothyroxine sodium	TABLET	ORAL	20230118		ANDA	ANDA215259	XLCare Pharmaceuticals, Inc.	LEVOTHYROXINE SODIUM	.3	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
72865-252_a18e77ed-ed0b-4ea3-959d-e7923d453d0c	72865-252	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	XLCare Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-253_a18e77ed-ed0b-4ea3-959d-e7923d453d0c	72865-253	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	XLCare Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-254_a18e77ed-ed0b-4ea3-959d-e7923d453d0c	72865-254	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	CAPSULE	ORAL	20210510		ANDA	ANDA214956	XLCare Pharmaceuticals, Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-255_800c60ab-e34e-496f-b813-d805c88d8e64	72865-255	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	XLCare Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72865-256_800c60ab-e34e-496f-b813-d805c88d8e64	72865-256	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	XLCare Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72866-000_ee9f9dcd-3c87-b18d-e053-2a95a90a449a	72866-000	HUMAN OTC DRUG	Hand Sanitizer, Hello Sunshine		ALCOHOL	GEL	TOPICAL	20190301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-001_ee9fbfd4-aad6-5189-e053-2a95a90a4ff2	72866-001	HUMAN OTC DRUG	Hand Sanitizer, Flower Power		ALCOHOL	GEL	TOPICAL	20190301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-002_ee9fb4b0-a45f-04c6-e053-2a95a90afa0e	72866-002	HUMAN OTC DRUG	Hand Sanitizer, Namaste		ALCOHOL	GEL	TOPICAL	20190301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-003_ee9fefd8-0532-99e0-e053-2a95a90a93dd	72866-003	HUMAN OTC DRUG	Hand Sanitizer, Unicorn Edition		ALCOHOL	GEL	TOPICAL	20190301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-004_b4cb62d4-a1d0-30d1-e053-2995a90ad0ad	72866-004	HUMAN OTC DRUG	Hand Sanitizer, Cross the lime		ALCOHOL	GEL	TOPICAL	20190301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-005_eea02438-3b58-2899-e053-2995a90a7bdf	72866-005	HUMAN OTC DRUG	Hand Sanitizer, Mystic Fruits		ALCOHOL	GEL	TOPICAL	20190301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-006_eea03ab1-61f1-566c-e053-2a95a90aad9e	72866-006	HUMAN OTC DRUG	Hand Sanitizer, Coco Rico		ALCOHOL	GEL	TOPICAL	20200301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-007_eea04c44-6203-89a8-e053-2a95a90ae562	72866-007	HUMAN OTC DRUG	Hand Sanitizer, Dolce Vita		ALCOHOL	GEL	TOPICAL	20200301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-008_eea03ab1-61f2-566c-e053-2a95a90aad9e	72866-008	HUMAN OTC DRUG	Hand Sanitizer, Into The Wild		ALCOHOL	GEL	TOPICAL	20200301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-009_eea07c75-2fed-2cae-e053-2a95a90a08b0	72866-009	HUMAN OTC DRUG	Hand Sanitizer, Glitter Fever		ALCOHOL	GEL	TOPICAL	20200301	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	670	mg/mL			N	
72866-010_eea0755b-e10e-6af2-e053-2995a90a3400	72866-010	HUMAN OTC DRUG	HAND SANITIZER Cherie Cherry		ALCOHOL	GEL	TOPICAL	20200801	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	.67	mL/mL			N	
72866-011_ee9fc539-255a-3a50-e053-2995a90a1a54	72866-011	HUMAN OTC DRUG	Magic Pouch		ALCOHOL	KIT		20201015	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation						N	
72866-012_ee9e0b0e-ad3f-c86b-e053-2a95a90a0732	72866-012	HUMAN OTC DRUG	Merci Handy Hand Sanitizer Self-Love		ALCOHOL	GEL	TOPICAL	20201201	20250630	OTC MONOGRAPH NOT FINAL	part333E	MERCI HANDY CORPORATION	ALCOHOL	.67	mL/mL			N	
72866-013_ee9fa14d-4793-1232-e053-2995a90aed3c	72866-013	HUMAN OTC DRUG	Merci Handy Rainbowtiful Hand Sanitizer		ALCOHOL	KIT		20210101	20250630	OTC MONOGRAPH NOT FINAL	part333E	MERCI HANDY CORPORATION						N	
72866-014_ee9e34b9-275d-3477-e053-2995a90a0091	72866-014	HUMAN OTC DRUG	Merci Handy Hand Sanitizer SAGE and TEA TREE Purifying		ALCOHOL	SPRAY	TOPICAL	20200101	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corp	ALCOHOL	.7	mL/mL			N	
72866-015_ee9e1f7f-d462-1538-e053-2a95a90a7efc	72866-015	HUMAN OTC DRUG	Merci Handy Hand Sanitizer Orange and Peppermint Energizing		ALCOHOL	SPRAY	TOPICAL	20200101	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corp	ALCOHOL	.7	mL/mL			N	
72866-016_ee9e1f7f-d466-1538-e053-2a95a90a7efc	72866-016	HUMAN OTC DRUG	Merci Handy Hand Sanitizer Lavender and Eucalyptus Relaxing		ALCOHOL	SPRAY	TOPICAL	20200101	20250630	OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corp	ALCOHOL	.7	mL/mL			N	
72866-101_82718bf3-1a15-f201-e053-2a91aa0a4ccd	72866-101	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	67	mL/100mL			N	20241231
72866-102_8289a38f-3c05-1214-e053-2a91aa0a0bc4	72866-102	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	67	mL/100mL			N	20241231
72866-103_828a836d-dab8-e387-e053-2991aa0a7261	72866-103	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	67	mL/100mL			N	20241231
72866-104_828a836d-dacb-e387-e053-2991aa0a7261	72866-104	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	67	mL/100mL			N	20241231
72866-105_828a836d-dacf-e387-e053-2991aa0a7261	72866-105	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	67	mL/100mL			N	20241231
72866-106_82918ec4-78db-618b-e053-2a91aa0a41c6	72866-106	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190218		OTC MONOGRAPH NOT FINAL	part333E	Merci Handy Corporation	ALCOHOL	67	mL/100mL			N	20241231
72874-001_7425cda4-f7cf-4c57-b06a-15b9573578bc	72874-001	HUMAN PRESCRIPTION DRUG	CERIANNA		Fluoroestradiol F 18	INJECTION	INTRAVENOUS	20200520		NDA	NDA212155	GE Healthcare Inc.	FLUOROESTRADIOL F-18	100	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
72876-007_09dc75e1-1a89-f3b6-e063-6294a90ac272	72876-007	HUMAN OTC DRUG	Arthmed Topical Analgesic		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20181220		OTC MONOGRAPH DRUG	M017	Fusion Health and Vitality	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.25; 100; 150	mg/mL; mg/mL; mg/mL			N	20241231
72882-094_04c4dc43-730e-447e-b96c-25481971723b	72882-094	HUMAN OTC DRUG	Minoxidil	Extra Strength for Men	Minoxidil	SOLUTION	TOPICAL	20200521		ANDA	ANDA075518	Mens LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
72887-143_c28d41e2-14c2-4401-87ab-49b32239caba	72887-143	HUMAN PRESCRIPTION DRUG	Ursodiol 200 mg		Ursodiol	CAPSULE	ORAL	20211118		ANDA	ANDA205789	FH2 Pharma LLC	URSODIOL	200	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72887-144_c28d41e2-14c2-4401-87ab-49b32239caba	72887-144	HUMAN PRESCRIPTION DRUG	Ursodiol 400 mg		Ursodiol	CAPSULE	ORAL	20211118		ANDA	ANDA205789	FH2 Pharma LLC	URSODIOL	400	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
72887-160_5bc26249-4e9b-4870-a696-99779c90dc27	72887-160	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		GLYCOPYRROLATE	TABLET	ORAL	20211129		ANDA	ANDA091522	FH2 Pharma LLC	GLYCOPYRROLATE	1.5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72887-193_fa570597-2943-f861-e053-6294a90ad9c1	72887-193	HUMAN PRESCRIPTION DRUG	oxycodone and acetaminophen		oxycodone and acetaminophen	TABLET	ORAL	20190603		ANDA	ANDA040608	FH2 Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 2.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72887-648_facf11e0-8fff-754c-e053-6394a90af918	72887-648	HUMAN PRESCRIPTION DRUG	oxycodone hydrochloride and acetaminophen		oxycodone hydrochloride and acetaminophen	SOLUTION	ORAL	20200301		ANDA	ANDA202142	FH2 Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 10	mg/5mL; mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72887-681_fa570597-2943-f861-e053-6294a90ad9c1	72887-681	HUMAN PRESCRIPTION DRUG	oxycodone and acetaminophen		oxycodone and acetaminophen tablets	TABLET	ORAL	20200925		ANDA	ANDA040608	FH2 Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72887-682_fa570597-2943-f861-e053-6294a90ad9c1	72887-682	HUMAN PRESCRIPTION DRUG	oxycodone and acetaminophen		oxycodone and acetaminophen	TABLET	ORAL	20210302		ANDA	ANDA040608	FH2 Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 7.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72887-683_fa570597-2943-f861-e053-6294a90ad9c1	72887-683	HUMAN PRESCRIPTION DRUG	oxycodone and acetaminophen		oxycodone and acetaminophen tablets	TABLET	ORAL	20200701		ANDA	ANDA040608	FH2 Pharma LLC	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	300; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
72888-001_b2c8558c-f355-5ba9-e053-2995a90adb24	72888-001	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20200527		ANDA	ANDA213798	Advagen Pharma Limited	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72888-002_b2c8558c-f355-5ba9-e053-2995a90adb24	72888-002	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20200527		ANDA	ANDA213798	Advagen Pharma Limited	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72888-003_b2c8558c-f355-5ba9-e053-2995a90adb24	72888-003	HUMAN PRESCRIPTION DRUG	tizanidine hydrochloride		tizanidine hydrochloride	CAPSULE	ORAL	20200527		ANDA	ANDA213798	Advagen Pharma Limited	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72888-004_e655d13a-7b74-63d5-e053-2a95a90abe8f	72888-004	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Advagen Pharma Limited	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-005_e655d13a-7b74-63d5-e053-2a95a90abe8f	72888-005	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Advagen Pharma Limited	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-006_e655d13a-7b74-63d5-e053-2a95a90abe8f	72888-006	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Advagen Pharma Limited	METOPROLOL TARTRATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-008_0b3979a2-eff9-3965-e063-6394a90a73af	72888-008	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20200224		ANDA	ANDA208708	Advagen Pharma Limited	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72888-009_ffa4e3dc-9e52-dc9d-e053-6294a90a59b3	72888-009	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	Advagen Pharma Limited	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72888-010_ffa4e3dc-9e52-dc9d-e053-6294a90a59b3	72888-010	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	Advagen Pharma Limited	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72888-011_ffa4e3dc-9e52-dc9d-e053-6294a90a59b3	72888-011	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20180401		ANDA	ANDA209102	Advagen Pharma Limited	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72888-012_d1ff27a2-a8c1-424a-e053-2995a90a3bac	72888-012	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Advagen Pharma Limited	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72888-013_d1ff27a2-a8c1-424a-e053-2995a90a3bac	72888-013	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Advagen Pharma Limited	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72888-014_d1ff27a2-a8c1-424a-e053-2995a90a3bac	72888-014	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Advagen Pharma Limited	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
72888-015_d0530f0d-ce7d-09f9-e053-2a95a90a3b7c	72888-015	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20210617		ANDA	ANDA204882	Advagen Pharma Ltd	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72888-016_d0530f0d-ce7d-09f9-e053-2a95a90a3b7c	72888-016	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20210617		ANDA	ANDA204882	Advagen Pharma Ltd	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72888-017_d0530f0d-ce7d-09f9-e053-2a95a90a3b7c	72888-017	HUMAN PRESCRIPTION DRUG	SILDENAFIL		sildenafil	TABLET, FILM COATED	ORAL	20210617		ANDA	ANDA204882	Advagen Pharma Ltd	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72888-018_bfe8ca8c-c1f7-cd2c-e053-2995a90aba8f	72888-018	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20160801		ANDA	ANDA204883	Advagen Pharma Ltd	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
72888-023_e655d13a-7b74-63d5-e053-2a95a90abe8f	72888-023	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Advagen Pharma Limited	METOPROLOL TARTRATE	75	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-024_f63c33cd-2aed-646e-e053-2995a90a4f59	72888-024	HUMAN PRESCRIPTION DRUG	Potassium Chloride		Potassium Chloride	POWDER, FOR SOLUTION	ORAL	20220324		ANDA	ANDA214108	Advagen Pharma Limited	POTASSIUM CHLORIDE	1.5	g/1.58g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-025_f63c5768-f68c-5318-e053-2a95a90a2dcf	72888-025	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211029		ANDA	ANDA078625	Advagen Pharma Limited	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
72888-026_f63c5768-f68c-5318-e053-2a95a90a2dcf	72888-026	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211029		ANDA	ANDA078625	Advagen Pharma Limited	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
72888-027_f63c5768-f68c-5318-e053-2a95a90a2dcf	72888-027	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211029		ANDA	ANDA078625	Advagen Pharma Limited	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
72888-028_f63c5768-f68c-5318-e053-2a95a90a2dcf	72888-028	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20211029		ANDA	ANDA078625	Advagen Pharma Limited	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
72888-029_b021e919-4cb9-09f4-e053-2a95a90a4327	72888-029	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20200910		ANDA	ANDA214280	Advagen Pharma Limited	LORATADINE	10	mg/1			N	20241231
72888-030_d9ec6364-feae-1bc5-e053-2995a90a1fd8	72888-030	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20201027		ANDA	ANDA214415	Advagen Pharma Limited	OXYBUTYNIN CHLORIDE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72888-031_d9ec6364-feae-1bc5-e053-2995a90a1fd8	72888-031	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20201027		ANDA	ANDA214415	Advagen Pharma Limited	OXYBUTYNIN CHLORIDE	10	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72888-032_d9ec6364-feae-1bc5-e053-2995a90a1fd8	72888-032	HUMAN PRESCRIPTION DRUG	Oxybutynin Chloride		Oxybutynin Chloride	TABLET, EXTENDED RELEASE	ORAL	20201027		ANDA	ANDA214415	Advagen Pharma Limited	OXYBUTYNIN CHLORIDE	15	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
72888-033_d124ff30-7360-4446-e053-2995a90af5ff	72888-033	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20200521		ANDA	ANDA212044	Advagen Pharma Limited	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
72888-034_c9c39fa9-e682-1aac-e053-2995a90aa2f9	72888-034	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	Advagen Pharma Ltd	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
72888-035_c9c39fa9-e682-1aac-e053-2995a90aa2f9	72888-035	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	Advagen Pharma Ltd	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
72888-036_c9c39fa9-e682-1aac-e053-2995a90aa2f9	72888-036	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	Advagen Pharma Ltd	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
72888-037_c9c39fa9-e682-1aac-e053-2995a90aa2f9	72888-037	HUMAN PRESCRIPTION DRUG	CARVEDILOL		CARVEDILOL	TABLET, FILM COATED	ORAL	20210729		ANDA	ANDA078165	Advagen Pharma Ltd	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
72888-039_bfee5768-6164-52f7-e053-2995a90aeeb1	72888-039	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20200309		ANDA	ANDA078578	Advagen Pharma Limited	AMIODARONE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72888-041_0d4725ca-f356-0e63-e063-6294a90ad283	72888-041	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20220113		ANDA	ANDA214656	Advagen Pharma Limited	POTASSIUM CHLORIDE	20	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-042_0d4725ca-f356-0e63-e063-6294a90ad283	72888-042	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20220113		ANDA	ANDA214656	Advagen Pharma Limited	POTASSIUM CHLORIDE	40	meq/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-045_f2007fb7-e460-bd91-e053-2995a90aad16	72888-045	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20220628		ANDA	ANDA214896	Advagen Pharma Limited	PRIMIDONE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-046_f2007fb7-e460-bd91-e053-2995a90aad16	72888-046	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20220628		ANDA	ANDA214896	Advagen Pharma Limited	PRIMIDONE	250	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-047_ca978199-e02f-6021-e053-2a95a90a74ed	72888-047	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20210819		ANDA	ANDA215101	Advagen Pharma Ltd	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72888-048_ca978199-e02f-6021-e053-2a95a90a74ed	72888-048	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20210819		ANDA	ANDA215101	Advagen Pharma Ltd	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
72888-049_fac73c6c-11e2-54dc-e053-6394a90a9b28	72888-049	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA215249	Advagen Pharma Ltd.	PREGABALIN	82.5	mg/1		CV	N	20241231
72888-050_fac73c6c-11e2-54dc-e053-6394a90a9b28	72888-050	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA215249	Advagen Pharma Ltd.	PREGABALIN	165	mg/1		CV	N	20241231
72888-051_fac73c6c-11e2-54dc-e053-6394a90a9b28	72888-051	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220322		ANDA	ANDA215249	Advagen Pharma Ltd.	PREGABALIN	330	mg/1		CV	N	20241231
72888-052_eb384a51-9f9a-cb5e-e053-2995a90a0b42	72888-052	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20210820		ANDA	ANDA215184	Advagen Pharma Limited	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72888-053_eb384a51-9f9a-cb5e-e053-2995a90a0b42	72888-053	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20210820		ANDA	ANDA215184	Advagen Pharma Limited	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72888-054_eb384a51-9f9a-cb5e-e053-2995a90a0b42	72888-054	HUMAN PRESCRIPTION DRUG	METOLAZONE		METOLAZONE	TABLET	ORAL	20210820		ANDA	ANDA215184	Advagen Pharma Limited	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
72888-059_c21fd23e-f152-c2ea-e053-2a95a90a3735	72888-059	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20170601		ANDA	ANDA204237	Advagen Pharma Limited	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
72888-060_bfee5768-6164-52f7-e053-2995a90aeeb1	72888-060	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20200821		ANDA	ANDA078578	Advagen Pharma Limited	AMIODARONE HYDROCHLORIDE	100	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72888-061_bfee5768-6164-52f7-e053-2995a90aeeb1	72888-061	HUMAN PRESCRIPTION DRUG	Amiodarone Hydrochloride		Amiodarone Hydrochloride	TABLET	ORAL	20200821		ANDA	ANDA078578	Advagen Pharma Limited	AMIODARONE HYDROCHLORIDE	400	mg/1	Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72888-062_f29ccd06-ec7a-6c00-e053-2a95a90a4dde	72888-062	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20200904		ANDA	ANDA075521	Advagen Pharma Ltd	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
72888-063_f29ccd06-ec7a-6c00-e053-2a95a90a4dde	72888-063	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20210316		ANDA	ANDA075521	Advagen Pharma Ltd	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
72888-064_f29ccd06-ec7a-6c00-e053-2a95a90a4dde	72888-064	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20200904		ANDA	ANDA075521	Advagen Pharma Ltd	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
72888-065_f29ccd06-ec7a-6c00-e053-2a95a90a4dde	72888-065	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20200904		ANDA	ANDA075521	Advagen Pharma Ltd	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
72888-066_f29ccd06-ec7a-6c00-e053-2a95a90a4dde	72888-066	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20210316		ANDA	ANDA075521	Advagen Pharma Ltd	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
72888-067_ffa4d939-026c-0998-e053-6394a90ac12a	72888-067	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230501		ANDA	ANDA215376	Advagen Pharma Ltd	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72888-068_ffa4d939-026c-0998-e053-6394a90ac12a	72888-068	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230501		ANDA	ANDA215376	Advagen Pharma Ltd	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72888-069_ffa4d939-026c-0998-e053-6394a90ac12a	72888-069	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230501		ANDA	ANDA215376	Advagen Pharma Ltd	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72888-070_ffa4d939-026c-0998-e053-6394a90ac12a	72888-070	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230501		ANDA	ANDA215376	Advagen Pharma Ltd	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72888-071_ffa4d939-026c-0998-e053-6394a90ac12a	72888-071	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230501		ANDA	ANDA215376	Advagen Pharma Ltd	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72888-072_ffa4d939-026c-0998-e053-6394a90ac12a	72888-072	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230501		ANDA	ANDA215376	Advagen Pharma Ltd	AMITRIPTYLINE HYDROCHLORIDE	150	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
72888-073_d729157a-d50c-73e4-e053-2a95a90afd14	72888-073	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20201219		ANDA	ANDA075229	Advagen Pharma Ltd	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72888-074_0d816f60-bd1f-02a7-e063-6294a90a0789	72888-074	HUMAN PRESCRIPTION DRUG	OXCARBAZEPINE		OXCARBAZEPINE	SUSPENSION	ORAL	20220831		ANDA	ANDA215726	Advagen Pharma Ltd	OXCARBAZEPINE	300	mg/5mL	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-075_e5263a4a-31e6-6881-e053-2a95a90a7b1e	72888-075	HUMAN PRESCRIPTION DRUG	Potassium chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220725		ANDA	ANDA215725	Advagen Pharma Ltd	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-076_e5263a4a-31e6-6881-e053-2a95a90a7b1e	72888-076	HUMAN PRESCRIPTION DRUG	Potassium chloride		Potassium Chloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220725		ANDA	ANDA215725	Advagen Pharma Ltd	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-079_0d8120a6-a16d-c732-e063-6294a90a52aa	72888-079	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	SUSPENSION	ORAL	20220818		ANDA	ANDA215724	Advagen Pharma Limited	ACYCLOVIR	200	mg/5mL	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
72888-080_0b3979a2-eff9-3965-e063-6394a90a73af	72888-080	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20230724		ANDA	ANDA208708	Advagen Pharma Limited	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72888-081_e3aad1bf-29df-3d9e-e053-2a95a90a21e2	72888-081	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	Advagen Pharma Ltd	ISOSORBIDE DINITRATE	5	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-082_e3aad1bf-29df-3d9e-e053-2a95a90a21e2	72888-082	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	Advagen Pharma Ltd	ISOSORBIDE DINITRATE	10	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-083_e3aad1bf-29df-3d9e-e053-2a95a90a21e2	72888-083	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	Advagen Pharma Ltd	ISOSORBIDE DINITRATE	20	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-084_e3aad1bf-29df-3d9e-e053-2a95a90a21e2	72888-084	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	Advagen Pharma Ltd	ISOSORBIDE DINITRATE	30	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-085_e3aad1bf-29df-3d9e-e053-2a95a90a21e2	72888-085	HUMAN PRESCRIPTION DRUG	ISOSORBIDE DINITRATE		isosorbide dinitrate	TABLET	ORAL	20220708		ANDA	ANDA215723	Advagen Pharma Ltd	ISOSORBIDE DINITRATE	40	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-086_d729157a-d50c-73e4-e053-2a95a90afd14	72888-086	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20210316		ANDA	ANDA075229	Advagen Pharma Ltd	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72888-087_49dc6901-70d3-4e74-82e7-dd8b90310a9e	72888-087	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		oxcarbazepine	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA077747	Advagen Pharma Limited	OXCARBAZEPINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-088_49dc6901-70d3-4e74-82e7-dd8b90310a9e	72888-088	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		oxcarbazepine	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA077747	Advagen Pharma Limited	OXCARBAZEPINE	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-089_49dc6901-70d3-4e74-82e7-dd8b90310a9e	72888-089	HUMAN PRESCRIPTION DRUG	Oxcarbazepine		oxcarbazepine	TABLET, FILM COATED	ORAL	20230602		ANDA	ANDA077747	Advagen Pharma Limited	OXCARBAZEPINE	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-092_eabf4dea-96e8-4477-e053-2995a90a8b12	72888-092	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20001116		ANDA	ANDA075643	Advagen Pharma Ltd	BISOPROLOL FUMARATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-093_eabf4dea-96e8-4477-e053-2995a90a8b12	72888-093	HUMAN PRESCRIPTION DRUG	Bisoprolol Fumarate		Bisoprolol Fumarate	TABLET, FILM COATED	ORAL	20001116		ANDA	ANDA075643	Advagen Pharma Ltd	BISOPROLOL FUMARATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-094_d8d4cdb5-4e4f-1cd6-e053-2a95a90a711b	72888-094	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20220223		ANDA	ANDA216211	Advagen Pharma Ltd	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72888-095_d8d4cdb5-4e4f-1cd6-e053-2a95a90a711b	72888-095	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20220223		ANDA	ANDA216211	Advagen Pharma Ltd	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
72888-096_ffbd246d-7dde-08b9-e053-6294a90a2d95	72888-096	HUMAN PRESCRIPTION DRUG	Dihydroergotamine mesylate		Dihydroergotamine mesylate	SPRAY	NASAL	20230623		ANDA	ANDA216881	Advagen Pharma Ltd	DIHYDROERGOTAMINE MESYLATE	4	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
72888-097_ffa769eb-0d3f-06c8-e053-6394a90a1fdc	72888-097	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20230616		ANDA	ANDA216321	Advagen Pharma Ltd.	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-098_ffa769eb-0d3f-06c8-e053-6394a90a1fdc	72888-098	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20230616		ANDA	ANDA216321	Advagen Pharma Ltd.	POTASSIUM CHLORIDE	1125	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-099_ffa769eb-0d3f-06c8-e053-6394a90a1fdc	72888-099	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20230616		ANDA	ANDA216321	Advagen Pharma Ltd.	POTASSIUM CHLORIDE	1500	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
72888-100_0d80f3f8-8185-7c70-e063-6294a90af493	72888-100	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	SOLUTION	ORAL	20221027		ANDA	ANDA216351	Advagen Pharma Ltd	ARIPIPRAZOLE	1	mg/mL	Atypical Antipsychotic [EPC]		N	20241231
72888-101_e655d13a-7b74-63d5-e053-2a95a90abe8f	72888-101	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20181201		ANDA	ANDA200981	Advagen Pharma Limited	METOPROLOL TARTRATE	37.5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-104_0d47d8f7-0106-6111-e063-6294a90a55d0	72888-104	HUMAN PRESCRIPTION DRUG	Gabapentin		gabapentin	SOLUTION	ORAL	20230118		ANDA	ANDA216492	Advagen Pharma Ltd	GABAPENTIN	250	mg/5mL	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-106_f225fba2-3ed1-1cc8-e053-2995a90a9733	72888-106	HUMAN PRESCRIPTION DRUG	Carbidopa-levodopa		carbidopa and levodopa	TABLET	ORAL	20210729		ANDA	ANDA216505	Advagen Pharma Ltd.,	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
72888-107_f225fba2-3ed1-1cc8-e053-2995a90a9733	72888-107	HUMAN PRESCRIPTION DRUG	Carbidopa-levodopa		carbidopa and levodopa	TABLET	ORAL	20210729		ANDA	ANDA216505	Advagen Pharma Ltd.,	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733	72888-108	HUMAN PRESCRIPTION DRUG	Carbidopa-levodopa		carbidopa and levodopa	TABLET	ORAL	20210729		ANDA	ANDA216505	Advagen Pharma Ltd.,	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
72888-109_06683bda-a854-5a80-e063-6294a90a3fdf	72888-109	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20230511		ANDA	ANDA216548	Advagen Pharma Ltd	DICLOFENAC SODIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72888-110_06683bda-a854-5a80-e063-6294a90a3fdf	72888-110	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20230511		ANDA	ANDA216548	Advagen Pharma Ltd	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72888-111_06683bda-a854-5a80-e063-6294a90a3fdf	72888-111	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20230511		ANDA	ANDA216548	Advagen Pharma Ltd	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72888-112_cc2d4c1a-89e7-621d-e053-2a95a90adf89	72888-112	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190819		ANDA	ANDA212543	Advagen Pharma Limited	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
72888-113_cc2d4c1a-89e7-621d-e053-2a95a90adf89	72888-113	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190819		ANDA	ANDA212543	Advagen Pharma Limited	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
72888-114_cc2d4c1a-89e7-621d-e053-2a95a90adf89	72888-114	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20190819		ANDA	ANDA212543	Advagen Pharma Limited	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
72888-115_076b60e7-5901-02a0-e063-6294a90a2587	72888-115	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20231003		ANDA	ANDA214874	Advagen Pharma Limited	GLIPIZIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72888-116_076b60e7-5901-02a0-e063-6294a90a2587	72888-116	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20231003		ANDA	ANDA214874	Advagen Pharma Limited	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72888-117_076b60e7-5901-02a0-e063-6294a90a2587	72888-117	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET	ORAL	20231003		ANDA	ANDA214874	Advagen Pharma Limited	GLIPIZIDE	10	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
72888-118_fac9903a-6fb9-3fe7-e053-6394a90a1a72	72888-118	HUMAN PRESCRIPTION DRUG	CEVIMELINE HYDROCHLORIDE		CEVIMELINE HYDROCHLORIDE	CAPSULE	ORAL	20230406		ANDA	ANDA216682	Advagen Pharma Ltd	CEVIMELINE HYDROCHLORIDE	30	mg/1	Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]		N	20241231
72888-119_f28714bb-3267-c227-e053-2995a90a453f	72888-119	HUMAN PRESCRIPTION DRUG	Dicyclomine hydrochloride		Dicyclomine hydrochloride	TABLET	ORAL	20221214		ANDA	ANDA216736	Advagen Pharma Ltd.,	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
72888-120_cfe54378-537f-73c3-e053-2995a90a27a9	72888-120	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210818		ANDA	ANDA211953	Advagen Pharma Ltd	LABETALOL HYDROCHLORIDE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-121_cfe54378-537f-73c3-e053-2995a90a27a9	72888-121	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210818		ANDA	ANDA211953	Advagen Pharma Ltd	LABETALOL HYDROCHLORIDE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-122_cfe54378-537f-73c3-e053-2995a90a27a9	72888-122	HUMAN PRESCRIPTION DRUG	LABETALOL HYDROCHLORIDE		Labetalol Hydrochloride	TABLET, FILM COATED	ORAL	20210818		ANDA	ANDA211953	Advagen Pharma Ltd	LABETALOL HYDROCHLORIDE	300	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
72888-123_085ebeaa-a0f4-b744-e063-6394a90a4d2f	72888-123	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20231017		ANDA	ANDA216762	Advagen Pharma Ltd	GUANFACINE HYDROCHLORIDE	1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72888-124_085ebeaa-a0f4-b744-e063-6394a90a4d2f	72888-124	HUMAN PRESCRIPTION DRUG	Guanfacine		Guanfacine	TABLET	ORAL	20231017		ANDA	ANDA216762	Advagen Pharma Ltd	GUANFACINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
72888-125_fe0267f1-2120-9fac-e053-6294a90ad6f3	72888-125	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		Lidocaine hydrochloride	SOLUTION	ORAL; TOPICAL	20230328		ANDA	ANDA216780	Advagen Pharma Ltd	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72888-130_f865b735-c983-0ce7-e053-6394a90a9a50	72888-130	HUMAN PRESCRIPTION DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE	ORAL	20230126		ANDA	ANDA216876	Advagen Pharma Ltd.,	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
72888-131_eacea548-d95b-6a0f-e053-2a95a90a03af	72888-131	HUMAN PRESCRIPTION DRUG	Gabapentin		gabapentin	TABLET	ORAL	20220922		ANDA	ANDA077661	Advagen Pharma Ltd	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-132_eacea548-d95b-6a0f-e053-2a95a90a03af	72888-132	HUMAN PRESCRIPTION DRUG	Gabapentin		gabapentin	TABLET	ORAL	20220922		ANDA	ANDA077661	Advagen Pharma Ltd	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-138_06562ef8-c11b-7975-e063-6394a90a722a	72888-138	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20210503		ANDA	ANDA209779	Advagen Pharma Ltd	NITROGLYCERIN	.3	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-139_06562ef8-c11b-7975-e063-6394a90a722a	72888-139	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20210503		ANDA	ANDA209779	Advagen Pharma Ltd	NITROGLYCERIN	.4	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-140_06562ef8-c11b-7975-e063-6394a90a722a	72888-140	HUMAN PRESCRIPTION DRUG	Nitroglycerin		nitroglycerin	TABLET	SUBLINGUAL	20210503		ANDA	ANDA209779	Advagen Pharma Ltd	NITROGLYCERIN	.6	mg/1	Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]		N	20241231
72888-143_0cddab65-5933-5be8-e063-6394a90a20b2	72888-143	HUMAN PRESCRIPTION DRUG	DESVENLAFAXINE		DESVENLAFAXINE	TABLET, EXTENDED RELEASE	ORAL	20220131		ANDA	ANDA204028	Advagen Pharma Ltd	DESVENLAFAXINE SUCCINATE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72888-144_0cddab65-5933-5be8-e063-6394a90a20b2	72888-144	HUMAN PRESCRIPTION DRUG	DESVENLAFAXINE		DESVENLAFAXINE	TABLET, EXTENDED RELEASE	ORAL	20220131		ANDA	ANDA204028	Advagen Pharma Ltd	DESVENLAFAXINE SUCCINATE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72888-145_f63c33cd-2b1b-646e-e053-2995a90a4f59	72888-145	HUMAN PRESCRIPTION DRUG	BACLOFEN		Baclofen	INJECTION	INTRATHECAL	20230222		ANDA	ANDA217324	Advagen Pharma Limited	BACLOFEN	500	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72888-146_f63c33cd-2b1b-646e-e053-2995a90a4f59	72888-146	HUMAN PRESCRIPTION DRUG	BACLOFEN		Baclofen	INJECTION	INTRATHECAL	20230222		ANDA	ANDA217324	Advagen Pharma Limited	BACLOFEN	1000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72888-147_f63c33cd-2b1b-646e-e053-2995a90a4f59	72888-147	HUMAN PRESCRIPTION DRUG	BACLOFEN		Baclofen	INJECTION	INTRATHECAL	20230222		ANDA	ANDA217324	Advagen Pharma Limited	BACLOFEN	2000	ug/mL	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
72888-152_f2261f75-a525-5bdc-e053-2a95a90aed79	72888-152	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20220414		ANDA	ANDA075468	Advagen Pharma Ltd	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72888-153_f2261f75-a525-5bdc-e053-2a95a90aed79	72888-153	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20220414		ANDA	ANDA075468	Advagen Pharma Ltd	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72888-154_f2261f75-a525-5bdc-e053-2a95a90aed79	72888-154	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20220414		ANDA	ANDA075468	Advagen Pharma Ltd	CLONAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
72888-157_05ef9fb3-35e1-0bac-e063-6294a90aacd6	72888-157	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	SOLUTION	ORAL	20220614		ANDA	ANDA217731	Advagen Pharma Ltd	NORTRIPTYLINE HYDROCHLORIDE	10	mg/5mL	Tricyclic Antidepressant [EPC]		N	20241231
72888-160_f2007fb7-e460-bd91-e053-2995a90aad16	72888-160	HUMAN PRESCRIPTION DRUG	Primidone		Primidone	TABLET	ORAL	20220628		ANDA	ANDA214896	Advagen Pharma Limited	PRIMIDONE	125	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
72888-162_0b3979a2-eff9-3965-e063-6394a90a73af	72888-162	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20231128		ANDA	ANDA208708	Advagen Pharma Limited	TRAMADOL HYDROCHLORIDE	25	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
72888-172_03bf22bc-626c-eaf3-e063-6394a90a1e3a	72888-172	HUMAN PRESCRIPTION DRUG	Lithium		Lithium	SOLUTION	ORAL	20221109		ANDA	ANDA218036	Advagen Pharma Ltd	LITHIUM CITRATE	8	meq/5mL	Mood Stabilizer [EPC]		N	20241231
72888-175_0cddab65-5933-5be8-e063-6394a90a20b2	72888-175	HUMAN PRESCRIPTION DRUG	DESVENLAFAXINE		DESVENLAFAXINE	TABLET, EXTENDED RELEASE	ORAL	20220131		ANDA	ANDA204028	Advagen Pharma Ltd	DESVENLAFAXINE SUCCINATE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72888-179_4c5ee1a9-59ff-4340-9993-487a34d12e91	72888-179	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200320		ANDA	ANDA203332	Advagen Pharma Ltd.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72888-180_4c5ee1a9-59ff-4340-9993-487a34d12e91	72888-180	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200320		ANDA	ANDA203332	Advagen Pharma Ltd.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72888-181_4c5ee1a9-59ff-4340-9993-487a34d12e91	72888-181	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE	ORAL	20200320		ANDA	ANDA203332	Advagen Pharma Ltd.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
72888-185_62dce3b0-81ad-4ba5-87d7-c841f5c06719	72888-185	HUMAN PRESCRIPTION DRUG	MYCOPHENOLATE MOFETIL		MYCOPHENOLATE MOFETIL	TABLET	ORAL	20230801		ANDA	ANDA212087	Advagen Pharma Limited	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72888-186_fa622dd8-8c65-8e19-e053-6294a90a23cc	72888-186	HUMAN OTC DRUG	Nicotine Mini		Nicotine Polacrilex	LOZENGE	ORAL	20230414		ANDA	ANDA208875	Advagen Pharma Limited	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72888-187_fa622dd8-8c65-8e19-e053-6294a90a23cc	72888-187	HUMAN OTC DRUG	Nicotine Mini		Nicotine Polacrilex	LOZENGE	ORAL	20230414		ANDA	ANDA208875	Advagen Pharma Limited	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
72888-192_62dce3b0-81ad-4ba5-87d7-c841f5c06719	72888-192	HUMAN PRESCRIPTION DRUG	MYCOPHENOLATE MOFETIL		MYCOPHENOLATE MOFETIL	CAPSULE	ORAL	20230801		ANDA	ANDA210181	Advagen Pharma Limited	MYCOPHENOLATE MOFETIL	250	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72888-199_8eaa9257-7fe9-4b5c-8de6-3c8f68901627	72888-199	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20231110		ANDA	ANDA211173	Advagen Pharma Limited	MYCOPHENOLATE SODIUM	180	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72888-200_8eaa9257-7fe9-4b5c-8de6-3c8f68901627	72888-200	HUMAN PRESCRIPTION DRUG	mycophenolic acid		mycophenolic acid	TABLET, DELAYED RELEASE	ORAL	20231110		ANDA	ANDA211173	Advagen Pharma Limited	MYCOPHENOLATE SODIUM	360	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
72893-001_4dd3db2d-aa56-4952-bcad-70fa22e8e93c	72893-001	HUMAN PRESCRIPTION DRUG	EVOMELA		Melphalan	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160331		NDA	NDA207155	Acrotech Biopharma Inc	MELPHALAN HYDROCHLORIDE	50	mg/10mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
72893-002_33fb62b0-3206-4132-87c7-d348aa5ef770	72893-002	HUMAN PRESCRIPTION DRUG	Beleodaq		Belinostat	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20140721		NDA	NDA206256	Acrotech Biopharma Inc	BELINOSTAT	500	mg/10mL	Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA]		N	20241231
72893-003_993134b8-c368-49c6-b6ca-565a35a26ec5	72893-003	HUMAN PRESCRIPTION DRUG	Folotyn		pralatrexate	INJECTION	INTRAVENOUS	20090924		NDA	NDA022468	Acrotech Biopharma Inc	PRALATREXATE	20	mg/mL	Folate Analog Metabolic Inhibitor [EPC]		N	20241231
72893-004_6a3d45b5-0736-44fa-8039-a1c1ff392a50	72893-004	HUMAN PRESCRIPTION DRUG	KHAPZORY		levoleucovorin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190102		NDA	NDA211226	Acrotech Biopharma Inc	LEVOLEUCOVORIN DISODIUM	175	mg/3.5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
72893-005_993134b8-c368-49c6-b6ca-565a35a26ec5	72893-005	HUMAN PRESCRIPTION DRUG	Folotyn		pralatrexate	INJECTION	INTRAVENOUS	20090924		NDA	NDA022468	Acrotech Biopharma Inc	PRALATREXATE	40	mg/2mL	Folate Analog Metabolic Inhibitor [EPC]		N	20241231
72893-007_c1ec6e37-45bb-4cda-a821-464552c48982	72893-007	HUMAN PRESCRIPTION DRUG	Zevalin		ibritumomab tiuxetan	KIT		20020219		BLA	BLA125019	Acrotech Biopharma Inc						N	20241231
72893-009_c1e3b82a-8c60-45eb-976b-3e33f42710e2	72893-009	HUMAN PRESCRIPTION DRUG	Fusilev		levoleucovorin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20080815		NDA	NDA020140	Acrotech Biopharma Inc	LEVOLEUCOVORIN CALCIUM	50	mg/5mL	Folate Analog [EPC], Folic Acid [CS]		N	20241231
72894-003_ed24547f-87a6-3b47-e053-2a95a90a40f3	72894-003	HUMAN OTC DRUG	NUORI MINERAL DEFENCE SUNSCREEN SPF 30		ZINC OXIDE	CREAM	TOPICAL	20190601		OTC MONOGRAPH NOT FINAL	part352	NUORI ApS	ZINC OXIDE	230	mg/mL			N	20241231
72897-001_0a5dc368-f031-8eee-e063-6394a90a45fe	72897-001	HUMAN OTC DRUG	Amour CBD		Pain Relief Cream	CREAM	TOPICAL	20191025		OTC MONOGRAPH DRUG	M017	SVD Premium Products	LIDOCAINE HYDROCHLORIDE	4	mg/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
72903-853_73674b49-1932-4e06-aef7-f37c0d50d121	72903-853	HUMAN PRESCRIPTION DRUG	ELAHERE		mirvetuximab soravtansine	INJECTION, SOLUTION	INTRAVENOUS	20221114		BLA	BLA761310	ImmunoGen, Inc.	MIRVETUXIMAB SORAVTANSINE	100	mg/20mL			N	20241231
72908-001_07ed730c-fd31-be99-e063-6294a90a3048	72908-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141001		UNAPPROVED MEDICAL GAS		CBJ Development Co.	OXYGEN	99	L/100L			N	20241231
72909-014_0975098e-6ef7-9b89-e063-6294a90a8f42	72909-014	HUMAN OTC DRUG	IRELIEV ROLL ON COOL PAIN RELIEF		MENTHOL	GEL	TOPICAL	20190220		OTC MONOGRAPH DRUG	M017	Excel Health, Inc	MENTHOL	60	mg/mL			N	20241231
72909-015_0974b923-d026-7dcc-e063-6294a90aeb1b	72909-015	HUMAN OTC DRUG	PlayMakar Roll On Cool Pain Relief		MENTHOL	GEL	TOPICAL	20190220		OTC MONOGRAPH DRUG	M017	PlayMakar Inc.	MENTHOL	60	mg/mL			N	20241231
72919-420_f80225f4-fe62-4807-8369-7cf33e0161dd	72919-420	HUMAN PRESCRIPTION DRUG	Niacin		Niacin	TABLET	ORAL	20000503		ANDA	ANDA040378	Emerald Therapeutics, LLC	NIACIN	500	mg/1	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
72919-549_b1da7022-1876-4413-8115-5d39c32bc7c3	72919-549	HUMAN PRESCRIPTION DRUG	Diflorasone Diacetate		Diflorasone Diacetate	CREAM	TOPICAL	20000424		ANDA	ANDA075508	Emerald Therapeutics, LLC	DIFLORASONE DIACETATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
72921-001_0d856c35-3d43-1b6c-e063-6294a90a13d7	72921-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20141001		UNAPPROVED MEDICAL GAS		Stone Company Management, Inc. dba SCM True Air Technologies, Inc.	OXYGEN	99	L/100L			N	20241231
72924-001_07b54aae-aa6c-0a6b-e063-6394a90a84e9	72924-001	HUMAN OTC DRUG	Kollourion Eyesalve Eyewash		Purified Water 98.3%	SOLUTION	OPHTHALMIC	20201201		OTC MONOGRAPH DRUG	M018	Miracle Eye Pharmaceuticals	WATER	929	g/946mL			N	20241231
72927-805_81537956-fe44-4175-bbcf-eb0aa383dc86	72927-805	HUMAN OTC DRUG	IBUPROFEN		IBUPROFEN	TABLET, COATED	ORAL	20190910		ANDA	ANDA207052	Strides Consumer LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
72927-904_16e3e03c-1a4e-42b4-ae92-0a6373b77e71	72927-904	HUMAN OTC DRUG	Jointflex		Jointflex	CREAM	TOPICAL	20190802		OTC MONOGRAPH NOT FINAL	part348	Strides Consumer LLC	CAMPHOR (SYNTHETIC)	3.2	g/100g			N	20241231
72927-944_484d0f89-5f66-4b58-bc49-75c87ef52a3a	72927-944	HUMAN OTC DRUG	Jointflex		Camphor	CREAM	TOPICAL	20200309		OTC MONOGRAPH NOT FINAL	part348	Strides Consumer LLC	CAMPHOR (SYNTHETIC)	3.2	g/100g			N	20241231
72927-976_5aba2ed8-89ca-4c60-8fb8-a3fcc469dc2e	72927-976	HUMAN OTC DRUG	Jointflex		Camphor	CREAM	TOPICAL	20210601		OTC MONOGRAPH NOT FINAL	part348	Strides Consumer LLC	CAMPHOR (SYNTHETIC)	3.2	g/100g			N	20241231
72932-001_8956add6-1d5e-37d3-e053-2a95a90a185c	72932-001	HUMAN OTC DRUG	Zonsen Alcohol Prep Pad		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part333E	Wuhan Zonsen Medical Products Co., Ltd.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
72932-002_8956add6-1d6f-37d3-e053-2a95a90a185c	72932-002	HUMAN OTC DRUG	Zonsen BZK Antiseptic		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part333A	Wuhan Zonsen Medical Products Co., Ltd.	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
72932-003_89569a9d-d57a-f72d-e053-2a95a90aa9b9	72932-003	HUMAN OTC DRUG	Zonsen Povidone-Iodine Prep Pad		POVIDONE-IODINE	SWAB	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part333E	Wuhan Zonsen Medical Products Co., Ltd.	POVIDONE-IODINE	100	mg/mL			N	20241231
72932-004_8956add6-1d7f-37d3-e053-2a95a90a185c	72932-004	HUMAN OTC DRUG	Zonsen Sting Relief Pad		ISOPROPYL ALCOHOL, BENZOCAINE	SWAB	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part333A	Wuhan Zonsen Medical Products Co., Ltd.	BENZOCAINE; ISOPROPYL ALCOHOL	60; .7	mg/mL; mL/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72935-001_08684937-d58b-79cf-e063-6394a90ad589	72935-001	HUMAN OTC DRUG	Neora	Complexion Clearing	Salicylic acid	SWAB	TOPICAL	20190501		OTC MONOGRAPH DRUG	M006	Neora, LLC	SALICYLIC ACID	.5	g/100mL			N	20241231
72935-002_0869c630-4da9-213c-e063-6394a90a3825	72935-002	HUMAN OTC DRUG	Neora	Age IQ Invisi-Bloc Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20190501		OTC MONOGRAPH DRUG	M020	Neora, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9.5; 5; 2.6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72935-003_08698eda-076f-5919-e063-6294a90a1fa2	72935-003	HUMAN OTC DRUG	Neora	Age IQ Invisi-Bloc Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Neora, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 9.5; 5	g/100mL; g/100mL; g/100mL			N	20241231
72936-010_fbd19ef4-84b0-d058-e053-6294a90aa84c	72936-010	HUMAN OTC DRUG	Higher Education Spring Break Oil-Free Broad-Spectrum Sunscreen SPF 30		Higher Education Spring Break Oil-Free Broad-Spectrum Sunscreen SPF 30	LOTION	TOPICAL	20210621		OTC MONOGRAPH FINAL	M020	Higher Education Skincare, LLC	OCTINOXATE; OCTISALATE; ZINC OXIDE	6.9; 3; 4	g/100g; g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72936-030_eac604f3-6789-0b64-e053-2a95a90a63b7	72936-030	HUMAN OTC DRUG	Higher Education Rush Clear Complexion Wipes With 2% Salicylic Acid		Higher Education Rush Clear Complexion Wipes With 2% Salicylic Acid	LIQUID	TOPICAL	20190309		OTC MONOGRAPH FINAL	part333D	Higher Education Skincare, LLC	SALICYLIC ACID	2	g/100g			N	20241231
72936-777_ef5aa9cb-24aa-acb4-e053-2a95a90a7b7c	72936-777	HUMAN OTC DRUG	SPF15 sunscreen lip balm		avobenzone, octinoxate, octisalate, octocrylene	LIPSTICK	TOPICAL	20210401		OTC MONOGRAPH FINAL	part352	HIGHER EDUCATION SKINCARE, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
72937-001_f034fa18-e676-30d0-e053-2a95a90a67cc	72937-001	HUMAN OTC DRUG	GREEN FARM POTENT THERMAL RELIEF		METHYL SALICYLATE	STICK	TOPICAL	20221219		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	METHYL SALICYLATE	10	g/100mL			N	20241231
72937-006_05de454d-857a-ce4d-e063-6394a90a2d1d	72937-006	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	GEL	TOPICAL	20200922		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR, (-)-; MENTHOL	2; 6	g/100g; g/100g			N	20241231
72937-006_fed14164-3ff7-ca67-e053-6294a90a0117	72937-006	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	GEL	TOPICAL	20200922		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR, (-)-; MENTHOL	2; 6	g/100g; g/100g			N	20241231
72937-010_05b8c42f-48f8-62ea-e063-6394a90a8b32	72937-010	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20190524		OTC MONOGRAPH NOT FINAL	part348	SUNSET PAIN RELIEF	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
72937-011_e79d0000-bdcd-b51a-e053-2a95a90a9e71	72937-011	HUMAN OTC DRUG	SUNSET PAIN RELIEF - COOLING RELIEF		MENTHOL	STICK	TOPICAL	20220908		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	MENTHOL	10	g/100mL			N	20241231
72937-026_ef167336-8a71-eca1-e053-2995a90aeeee	72937-026	HUMAN OTC DRUG	GREEN FARM POTENT COOLING RELIEF		MENTHOL, CAMPHOR	GEL	TOPICAL	20221205		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (SYNTHETIC); MENTHOL	2; 6	g/100mL; g/100mL			N	20241231
72937-040_ef15ad44-6dc4-0c85-e053-2a95a90a6f10	72937-040	HUMAN OTC DRUG	KANGAROO CBD PAIN RELIEVING		MENTHOL	GEL	TOPICAL	20221205		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	MENTHOL	4	g/100g			N	20241231
72937-062_eeda53d4-9b8c-525d-e053-2a95a90a078c	72937-062	HUMAN OTC DRUG	KANGAROO CBD COOLING PAIN RELIEF		MENTHOL, CAMPHOR	GEL	TOPICAL	20221129		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (SYNTHETIC); MENTHOL	2; 6	g/100mL; g/100mL			N	20241231
72937-101_f0350e31-ad28-a160-e053-2a95a90a84bb	72937-101	HUMAN OTC DRUG	GREEN FARM COOLING PAIN RELIEF		MENTHOL	STICK	TOPICAL	20221219		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	MENTHOL	10	g/100mL			N	20241231
72937-103_ef1b0e5c-86a1-611d-e053-2995a90ab4a4	72937-103	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20201002		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL	3; 10	g/100g; g/100g			N	20241231
72937-103_ef2b8ef1-2055-48a9-e053-2a95a90a2af4	72937-103	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20201005		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL	3; 10	g/100g; g/100g			N	20241231
72937-103_ef2bddbe-d32f-72df-e053-2a95a90a83a3	72937-103	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20201005		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL	3; 10	g/100g; g/100g			N	20241231
72937-110_e82d3ed4-2373-0fb9-e053-2a95a90a1043	72937-110	HUMAN OTC DRUG	SUNSET PAIN RELIEF - HEATING RELIEF		METHYL SALICYLATE	STICK	TOPICAL	20220908		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	METHYL SALICYLATE	10	g/100mL			N	20241231
72937-118_eeda8feb-1227-5974-e053-2a95a90afe84	72937-118	HUMAN OTC DRUG	KANGAROO CBD HEATING PAIN RELIEF		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20221129		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	MENTHOL; METHYL SALICYLATE	9.8; 17.6	g/100mL; g/100mL			N	20241231
72937-180_05df95b5-e63f-13ab-e063-6394a90ab8ea	72937-180	HUMAN OTC DRUG	HEATING PAIN RELIEF		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20230915		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	MENTHOL; METHYL SALICYLATE	9.8; 17.6	g/100mL; g/100mL			N	20241231
72937-180_ff06d68f-d674-d097-e053-6294a90a7e5f	72937-180	HUMAN OTC DRUG	HEATING PAIN RELIEF		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20230525		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	MENTHOL; METHYL SALICYLATE	9.8; 17.6	g/100mL; g/100mL			N	20241231
72937-300_0bd81050-6c2c-3b29-e063-6394a90a0454	72937-300	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20200204		OTC MONOGRAPH DRUG	M017	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20251231
72937-300_fecfeaf1-05e0-ee9f-e053-6394a90ac8ad	72937-300	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20200204		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
72937-301_efcc2313-d56a-73f1-e053-2a95a90a8733	72937-301	HUMAN OTC DRUG	KANGAROO CBD PAIN RELIEF		MENTHOL, CAMPHOR	CREAM	TOPICAL	20221201		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL	3; 10	g/100g; g/100g			N	20241231
72937-310_05b87b34-5169-dfbb-e063-6394a90a0104	72937-310	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20210304		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL	3; 10	g/100g; g/100g			N	20241231
72937-310_e39e0c2b-925b-8a42-e053-2995a90a7943	72937-310	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20210304		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR (NATURAL); MENTHOL	3; 10	g/100g; g/100g			N	20241231
72937-444_ef2c551c-5288-4c9e-e053-2995a90a5da1	72937-444	HUMAN OTC DRUG	GREEN FARM - CBD INFUSED PAIN RELIEF		MENTHOL	GEL	TOPICAL	20201005		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	MENTHOL	4	g/100g			N	20241231
72937-600_ef42103b-f1f3-14e4-e053-2995a90a817f	72937-600	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	GEL	TOPICAL	20200922		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR, (-)-; MENTHOL	2; 6	g/100g; g/100g			N	20241231
72937-600_ef422b09-c8b8-25ec-e053-2995a90a14ff	72937-600	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	GEL	TOPICAL	20200922		OTC MONOGRAPH NOT FINAL	part348	SUNSET NOVELTIES, INC	CAMPHOR, (-)-; MENTHOL	2; 6	g/100g; g/100g			N	20241231
72937-811_09cd5d4f-462a-0544-e063-6294a90a6296	72937-811	HUMAN OTC DRUG	GREEN FARM POTENT THERMAL RELIEF		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20221202		OTC MONOGRAPH DRUG	M017	SUNSET NOVELTIES, INC	MENTHOL; METHYL SALICYLATE	9.8; 17.6	g/100mL; g/100mL			N	20241231
72940-0001_0d579dd1-e3f3-4b24-8fc2-1afc39705db6	72940-0001	HUMAN OTC DRUG	2 Transform		Fucus Vesiculosus, Chelidonium Majus, Kali Phosphoricum, Lycopodium Clavatum, Natrum Muriaticum, Quercus Glandium Spiritus, Quercus Robur, Nux Vomica, Phytolacca Decandra, Ornithogalum Umbellatum, Agnus Castus, Berberis Aquifolium, Berberis Vulgaris, Saccharum Officinale, Solidago Virgaurea, Calcarea Carbonica, Carbo Vegetabilis, Magnesia Phosphorica, Natrum Phosphoricum, Sinapis Arvensis, Flos, Ubidecarenonum, Graphites, Hypophysis Suis, Placenta Totalis Suis, Hypothalamus (Bovine)	LIQUID	ORAL	20190513	20250114	UNAPPROVED HOMEOPATHIC		2 Transform	ACTIVATED CHARCOAL; BERBERIS AQUIFOLIUM ROOT BARK; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; CHASTE TREE FRUIT; CHELIDONIUM MAJUS; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ORNITHOGALUM UMBELLATUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; QUERCUS ROBUR NUT; QUERCUS ROBUR TWIG BARK; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUCROSE; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; UBIDECARENONE	12; 8; 8; 16; 8; 6; 6; 4; 12; 6; 12; 8; 12; 6; 6; 6; 12; 6; 12; 8; 6; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
72940-0002_e5876807-8522-4634-a499-7d08b46336aa	72940-0002	HUMAN OTC DRUG	2 Transform		Fucus Vesiculosus, Chelidonium Majus, Kali Phosphoricum, Lycopodium Clavatum, Natrum Muriaticum, Quercus Glandium Spiritus, Quercus Robur, Nux Vomica, Phytolacca Decandra, Ornithogalum Umbellatum, Agnus Castus, Berberis Aquifolium, Berberis Vulgaris, Saccharum Officinale, Solidago Virgaurea, Calcarea Carbonica, Carbo Vegetabilis, Magnesia Phosphorica, Natrum Phosphoricum, Sinapis Arvensis, Flos, Ubidecarenonum, Graphites, Hypophysis Suis, Placenta Totalis Suis, Hypothalamus (Bovine)	LIQUID	ORAL	20200303	20250122	UNAPPROVED HOMEOPATHIC		2 Transform	ACTIVATED CHARCOAL; BERBERIS AQUIFOLIUM ROOT BARK; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; CHASTE TREE FRUIT; CHELIDONIUM MAJUS; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ORNITHOGALUM UMBELLATUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; QUERCUS ROBUR NUT; QUERCUS ROBUR TWIG BARK; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUCROSE; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; UBIDECARENONE	12; 8; 8; 16; 8; 6; 6; 4; 12; 6; 12; 8; 12; 6; 6; 6; 12; 6; 12; 8; 6; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
72944-0001_f44aa8d1-7c2f-cbbe-e053-2995a90ab3c2	72944-0001	HUMAN OTC DRUG	Kenaf wet wipe		ALLANTOIN	LIQUID	TOPICAL	20170409		UNAPPROVED DRUG OTHER		MEDICELL BIO CO., Ltd.	ALLANTOIN	.05	g/100g			N	20241231
72944-0002_f44ab989-c61c-1831-e053-2995a90adc8e	72944-0002	HUMAN OTC DRUG	Kenaf wet wipe kids		ALLANTOIN	LIQUID	TOPICAL	20170409		UNAPPROVED DRUG OTHER		MEDICELL BIO CO., Ltd.	ALLANTOIN	.05	g/100g			N	20241231
72944-0004_f441ea6c-bc9c-0c4f-e053-2995a90af39d	72944-0004	HUMAN OTC DRUG	Kenaf wet wipe kids		ALLANTOIN	LIQUID	TOPICAL	20170409		UNAPPROVED DRUG OTHER		MEDICELL BIO CO., Ltd.	ALLANTOIN	.05	g/100g			N	20241231
72951-130_fbaca8d2-0fc0-4d9f-b01f-c45495cbcfab	72951-130	HUMAN OTC DRUG	ExoSCRT Scalp Care HRLV		Biotin	POWDER	TOPICAL	20211001		UNAPPROVED DRUG OTHER		Exocobio Inc.	BIOTIN	.01	mg/20mg			N	20241231
72951-140_e6fc9c12-c747-4770-af57-63fc6703cd37	72951-140	HUMAN OTC DRUG	ExoSCRT Derma Signal SRLV Vial 1. Lyophilized		Leucine, Isoleucine	POWDER	TOPICAL	20211001		UNAPPROVED DRUG OTHER		Exocobio Inc.	ISOLEUCINE; LEUCINE	.01; .01	mg/20mg; mg/20mg			N	20241231
72951-150_bd03506e-ac56-463a-ad07-d4059e8343a8	72951-150	HUMAN OTC DRUG	ExoSCRT Derma Signal SRLV Vial 2. Diluent		Leucine, Isoleucine	LIQUID	TOPICAL	20211001		UNAPPROVED DRUG OTHER		Exocobio Inc.	ISOLEUCINE; LEUCINE	.0025; .0025	g/5mL; g/5mL			N	20241231
72956-100_6fc57379-41ef-485d-8a34-9cc69eac5c19	72956-100	HUMAN OTC DRUG	Weis SIMPLY GREAT ADVANCED Hand Sanitizer WITH VITAMINS E and B5		Ethanol	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Weis Markets, Inc.	ALCOHOL	75	mL/100mL			N	20241231
72957-001_28ef1bb5-0d0c-4a3f-8ccd-636e86ad362e	72957-001	HUMAN OTC DRUG	Acne Control Serum		Benzoyl Peroxide	LOTION	TOPICAL	20200123		OTC MONOGRAPH FINAL	part333D	Private Label Skin Care	BENZOYL PEROXIDE	5	g/100g			N	20241231
72957-002_e5e73204-7d18-4032-a3ca-6b671759ee3e	72957-002	HUMAN OTC DRUG	Sheer Defense Tinted SPF 46		Zinc oxide, Octinoxate	CREAM	TOPICAL	20200127		OTC MONOGRAPH NOT FINAL	part352	Private Label Skin Care	OCTINOXATE; ZINC OXIDE	7.5; 12	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72957-003_f3d469ba-75ce-4732-a0b5-5cd3cd64dbd6	72957-003	HUMAN OTC DRUG	Clear Defense SPF 45		Zinc Oxide, Octinoxate	CREAM	TOPICAL	20200127		OTC MONOGRAPH NOT FINAL	part352	Private Label Skin Care	OCTINOXATE; ZINC OXIDE	7.5; 12	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72957-005_edfa75dd-329d-43c9-bfd6-ee42fba7e418	72957-005	HUMAN OTC DRUG	Purely Physical SPF 47		Zinc Oxide, Titanium Dioxide	CREAM	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Private Label Skin Care	TITANIUM DIOXIDE; ZINC OXIDE	5.5; 10	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72957-006_91714b86-bc18-4e56-ba95-c3dd4a313a0b	72957-006	HUMAN OTC DRUG	HA Physical Tint SPF 44		Zinc oxide, Titanium Dioxide	CREAM	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part352	Private Label Skin Care	TITANIUM DIOXIDE; ZINC OXIDE	5.5; 10	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72959-005_d3760a63-28a6-4a12-923f-1c3e9fd5e06f	72959-005	HUMAN OTC DRUG	RectiBiom Hemorrhoid Relief		RectiBiom Suppositories	SUPPOSITORY	RECTAL	20230315		OTC MONOGRAPH FINAL	part346	Biom Pharmaceutical Corporation	HARD FAT; PHENYLEPHRINE HYDROCHLORIDE	88.44; .25	g/1; g/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
72960-112_4d7afe1d-492b-4ade-8d79-272f9d578883	72960-112	HUMAN PRESCRIPTION DRUG	DAXXIFY		botulinum toxin type A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR	20220920		BLA	BLA761127	Revance Therapeutics, Inc.	BOTULINUM TOXIN TYPE A	100	U/1.2mL	Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC]		N	20241231
72962-101_0635330b-8894-e407-e063-6394a90aa4de	72962-101	HUMAN OTC DRUG	ETHICAL ZINC NATURAL CLEAR ZINC SUNSCREEN	SPF-50	ZINC OXIDE	LOTION	TOPICAL	20170829		OTC MONOGRAPH NOT FINAL	part352	ETHICAL ZINC PTY LTD	ZINC OXIDE	22	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72962-102_063555e9-f885-7d22-e063-6294a90a2e3d	72962-102	HUMAN OTC DRUG	ETHICAL ZINC DAILY WEAR LIGHT SUNSCREEN	SPF-50	ZINC OXIDE	LOTION	TOPICAL	20201212		OTC MONOGRAPH NOT FINAL	part352	ETHICAL ZINC PTY LTD	ZINC OXIDE	22.7	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72962-103_063230d0-7c6a-77d9-e063-6294a90a7b34	72962-103	HUMAN OTC DRUG	ETHICAL ZINC DAILY WEAR TINTED FACIAL SUNSCREEN	DARK TINT SPF-50	ZINC OXIDE	LOTION	TOPICAL	20230728		OTC MONOGRAPH FINAL	M020	ETHICAL ZINC PTY LTD	ZINC OXIDE	22.7	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72962-104_06325690-ea73-8425-e063-6394a90a28ae	72962-104	HUMAN OTC DRUG	ETHICAL ZINC DAILY WEAR TINTED FACIAL SUNSCREEN	LIGHT TINT SPF-50	ZINC OXIDE	LOTION	TOPICAL	20230728		OTC MONOGRAPH FINAL	M020	ETHICAL ZINC PTY LTD	ZINC OXIDE	22.7	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72968-0002_8b30ab9a-b623-48b7-a020-d105c7966b42	72968-0002	HUMAN OTC DRUG	Herplex		Anatherum Muricatum, Clematis Erecta, Mezereum, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox, Thuja Occidentalis, Natrum Muriaticum, Sepia	TABLET	ORAL	20190418	20261228	UNAPPROVED HOMEOPATHIC		Nashco Products LLC	CHRYSOPOGON ZIZANIOIDES ROOT; CLEMATIS RECTA FLOWERING TOP; DAPHNE MEZEREUM BARK; PHYTOLACCA AMERICANA ROOT; RANUNCULUS BULBOSUS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 30; 30; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	
72968-0004_1d44a27d-7870-4a51-88ec-195c547bbad0	72968-0004	HUMAN OTC DRUG	Herplex		Anatherum Muricatum, Clematis Erecta, Mezereum, Phytolacca Decandra, Ranunculus Bulbosus, Rhus Tox, Thuja Occidentalis, Natrum Muriaticum, Sepia	TABLET	ORAL	20220830		UNAPPROVED HOMEOPATHIC		Nashco Products LLC	CHRYSOPOGON ZIZANIOIDES ROOT; CLEMATIS RECTA FLOWERING TOP; DAPHNE MEZEREUM BARK; PHYTOLACCA AMERICANA ROOT; RANUNCULUS BULBOSUS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 12; 12; 30; 30; 12; 12	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
72972-001_0a7b9f23-0baa-a4bc-e063-6294a90a1657	72972-001	HUMAN OTC DRUG	Optase		glycerin	SPRAY	OPHTHALMIC	20190422		OTC MONOGRAPH DRUG	M018	Scope Health Inc	GLYCERIN	1	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72972-002_0a7b9f23-0bab-a4bc-e063-6294a90a1657	72972-002	HUMAN OTC DRUG	Optase		glycerin	SOLUTION/ DROPS	OPHTHALMIC	20200214		OTC MONOGRAPH DRUG	M018	Scope Health Inc	GLYCERIN	2	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72972-003_0a7b9976-52be-aa20-e063-6294a90ac5db	72972-003	HUMAN OTC DRUG	Optase		white petrolatum, lanolin	OINTMENT	OPHTHALMIC	20210505		OTC MONOGRAPH DRUG	M018	Scope Health Inc	LANOLIN; PETROLATUM	.06; .9	g/g; g/g			N	20241231
72972-004_0a7b8f8b-115a-842d-e063-6394a90ae3c6	72972-004	HUMAN OTC DRUG	Optase		glycerin	SOLUTION/ DROPS	OPHTHALMIC	20220222		OTC MONOGRAPH DRUG	M018	Scope Health Inc	GLYCERIN	9	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72972-005_0a7b8968-f55d-85db-e063-6394a90a6e09	72972-005	HUMAN OTC DRUG	Optase		glycerin	SOLUTION/ DROPS	OPHTHALMIC	20230210		OTC MONOGRAPH DRUG	M018	Scope Health Inc	GLYCERIN	.25	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72972-006_0a7b7ced-34ed-7921-e063-6294a90a78ea	72972-006	HUMAN OTC DRUG	Optase Allegro		hydroxyethyl cellulose	SOLUTION/ DROPS	OPHTHALMIC	20230323		OTC MONOGRAPH DRUG	M018	Scope Health Inc	HYDROXYETHYL CELLULOSE (140 CPS AT 5%)	.35	mg/mL			N	20241231
72973-001_07610e87-e108-c8e2-e063-6294a90a4b39	72973-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190318		NDA	NDA205849	HOWARDS MEDICAL LLC	OXYGEN	990	mL/L			N	20241231
72974-120_2ec7524a-0548-48eb-b59b-09fbe985f8ea	72974-120	HUMAN PRESCRIPTION DRUG	Orgovyx		relugolix	TABLET, FILM COATED	ORAL	20201218		NDA	NDA214621	Sumitomo Pharma America, Inc	RELUGOLIX	120	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
72974-415_450384fa-4960-4f5b-8c7d-3ed6360dd1d3	72974-415	HUMAN PRESCRIPTION DRUG	Myfembree		relugolix, estradiol hemihydrate, and norethindrone acetate	TABLET, FILM COATED	ORAL	20210526		NDA	NDA214846	Sumitomo Pharma America, Inc	ESTRADIOL HEMIHYDRATE; NORETHINDRONE ACETATE; RELUGOLIX	1; .5; 40	mg/1; mg/1; mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
72975-277_09dc4870-a274-48af-e063-6394a90aa79e	72975-277	HUMAN OTC DRUG	FITGLOW Vita Shield Hyaluronic Primer SPF-30		ZINC OXIDE	CREAM	TOPICAL	20220221		OTC MONOGRAPH DRUG	M020	FITGLOW BEAUTY LLC	ZINC OXIDE	140	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
72976-001_a8232f85-74b8-09e0-e053-2a95a90abe1e	72976-001	HUMAN OTC DRUG	70% Isopropyl Rubbing Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	SZY Holdings, LLC dba EverReady First Aid	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
72976-010_f3a58268-0f5c-3de2-e053-2995a90abb32	72976-010	HUMAN OTC DRUG	Sting Relief Wipe		Benzocaine and Isopropyl Alcohol	SWAB	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part333A	EVER READY FIRST AID	BENZOCAINE; ISOPROPYL ALCOHOL	60; 600	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
72976-011_f3b06b6e-f2e2-0750-e053-2995a90abc36	72976-011	HUMAN OTC DRUG	Povidone Iodine Wipe		Povidone-Iodine	SWAB	TOPICAL	20230202		OTC MONOGRAPH FINAL	part333C	Ever Ready First Aid	POVIDONE-IODINE	10	mg/100mL			N	20241231
72976-012_fd24ca71-3b09-952d-e053-6394a90a1639	72976-012	HUMAN OTC DRUG	ER Alcohol Prep		Isopropyl Alcohol	PATCH	TOPICAL	20230524		OTC MONOGRAPH NOT FINAL	part333A	EVER READY FIRST AID	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
72976-016_0eb447a9-efbe-c9f9-e063-6294a90ae08e	72976-016	HUMAN OTC DRUG	ER Hand Sanitizer Packets		ALCOHOL	GEL	TOPICAL	20231014		OTC MONOGRAPH DRUG	M005	EVER READY FIRST AID	ALCOHOL	75	mL/100mL			N	20251231
72976-017_0eb46f57-a383-c64a-e063-6294a90a5800	72976-017	HUMAN OTC DRUG	ER Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20240111		OTC MONOGRAPH DRUG	M004	EVER READY FIRST AID	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
72976-563_cce5a886-c59e-4080-b3b5-65a6fc70cd07	72976-563	HUMAN OTC DRUG	Ever Ready Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20211022		OTC MONOGRAPH FINAL	part333B	Ever Ready	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
72983-500_0df0dfde-1f52-4769-e063-6394a90a2f92	72983-500	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20210519		ANDA	ANDA212795	Tenshi Kaizen Pvt Ltd	LORATADINE	5	mg/1			N	20251231
72983-501_0df121d3-d784-620c-e063-6294a90acdab	72983-501	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210519		ANDA	ANDA213294	Tenshi Kaizen Pvt Ltd	LORATADINE	10	mg/1			N	20251231
72985-001_138a8040-2111-4380-9f9a-2b743b0d2ba2	72985-001	HUMAN OTC DRUG	Dry Eye Formula Lubricant Eye Drops		glycerin propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20201102		OTC MONOGRAPH FINAL	part349	Eye Essentials LLC	GLYCERIN; PROPYLENE GLYCOL	3; 10	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72986-001_0aafd90f-4172-8b00-e063-6394a90a909b	72986-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20080720		UNAPPROVED MEDICAL GAS		Family Enterprises LLC dba Preferred Cylinder Services	OXYGEN	99	L/100L			N	20241231
72987-001_0bdd9005-2c94-0df3-e063-6394a90ae2b4	72987-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100830		UNAPPROVED MEDICAL GAS		Accurate Healthcare, Inc.	OXYGEN	99	L/100L			N	20241231
72988-0002_ba7bff06-9174-4aa7-e053-2995a90a5e07	72988-0002	HUMAN OTC DRUG	AMULDY S		glycerin	LIQUID	TOPICAL	20190323		OTC MONOGRAPH NOT FINAL	part347	Lydia Co., Ltd.	GLYCERIN	8	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
72988-0005_c5cd92d6-2be7-73c6-e053-2995a90a3ea3	72988-0005	HUMAN OTC DRUG	MOSQUITO BUG OFF		DIETHYLTOLUAMIDE	LIQUID	TOPICAL	20190323		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	DIETHYLTOLUAMIDE	10	g/100mL			N	20241231
72988-0007_ffc8f035-939b-481a-e053-6294a90a5b61	72988-0007	HUMAN OTC DRUG	Hot Pap Cataplasma		Methyl salicylate, vanillyl nonylamide	PATCH	TRANSDERMAL	20190329		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	METHYL SALICYLATE; NONIVAMIDE	58.3; 5	mg/13.4g; mg/13.4g			N	20241231
72988-0008_d5d1291f-189b-2843-e053-2995a90a657c	72988-0008	HUMAN OTC DRUG	Cool Pap Cataplasma		Methyl salicylate, l-menthol, dl-camphor, mentha oil, thymol	PATCH	TRANSDERMAL	20190323		OTC MONOGRAPH NOT FINAL	part348	Lydia Co., Ltd.	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE; PEPPERMINT OIL; THYMOL	122.5; 17.5; 262.5; 87.5; 17.5	mg/17.5g; mg/17.5g; mg/17.5g; mg/17.5g; mg/17.5g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72988-0010_0ca8aa27-d06b-cbe4-e063-6394a90a629f	72988-0010	HUMAN OTC DRUG	LAXATIVES RUBILAX		psyllium huskpowder	GRANULE	ORAL	20190422		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	PSYLLIUM HUSK; SENNA PODS	2168; 496	mg/3.5g; mg/3.5g			N	20241231
72988-0011_0ca8ac22-aaab-9d25-e063-6294a90a4541	72988-0011	HUMAN OTC DRUG	BAENOSIN		platycodon root, licorice, jujube, peony root	CAPSULE	ORAL	20190422		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	GINGER; JUJUBE FRUIT; LICORICE; PAEONIA LACTIFLORA ROOT; PLATYCODON GRANDIFLORUM ROOT; PONCIRUS TRIFOLIATA FRUIT	.5; .5; .5; .5; .67; .5	g/1; g/1; g/1; g/1; g/1; g/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72988-0012_0ca8ac22-aaac-9d25-e063-6294a90a4541	72988-0012	HUMAN OTC DRUG	YOBISIN		rehmannia root, angelica gigas root	TABLET	ORAL	20190422		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	AKEBIA STEM; ALISMA PLANTAGO-AQUATICA ROOT; ANGELICA GIGAS ROOT; CHINESE CINNAMON; FORSYTHIA SUSPENSA FRUIT; GINGER; LICORICE; PLANTAGO SEED; REHMANNIA GLUTINOSA ROOT; RHUBARB; SCUTELLARIA BAICALENSIS ROOT	416.7; 250; 416.7; 16.7; 16.7; 16.7; 125; 250; 416.7; 16.7; 250	mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS]		N	20241231
72988-0013_c5c92ffd-bf92-09d4-e053-2a95a90a2497	72988-0013	HUMAN OTC DRUG	CO COOL		menthol, peppermint oil, pinus pumilio branch/leaf oil	LIQUID	NASAL	20190822		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	MENTHOL; PEPPERMINT OIL; PINE NEEDLE OIL (PINUS MUGO)	.06; .01; .01	g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
72988-0023_ffcaeaef-e521-a583-e053-6294a90abf8f	72988-0023	HUMAN OTC DRUG	AMULDY SPORTS gel		menthol, methyl salicylate, camphor, salicylic acid	LIQUID	TOPICAL	20200424		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	CAMPHOR OIL; MENTHOL; METHYL SALICYLATE; SALICYLIC ACID	.05; 2.5; .3; .03	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
72988-0024_a4a921e5-d8e3-6743-e053-2995a90afb31	72988-0024	HUMAN OTC DRUG	Hand and Care Clear Gel		alcohol	GEL	TOPICAL	20200502		OTC MONOGRAPH NOT FINAL	part333A	Lydia Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
72988-0025_d01859d1-8355-fe47-e053-2a95a90a5795	72988-0025	HUMAN OTC DRUG	ZENOL MILD HOT		Methyl salicylate, vanillyl nonylamide	PATCH	TRANSDERMAL	20211001		OTC MONOGRAPH NOT FINAL	part348	Lydia Co., Ltd.	METHYL SALICYLATE; NONIVAMIDE	105; 1.75	mg/14g; mg/14g			N	20241231
72988-0026_ffcad475-c7fb-fb65-e053-6294a90a7e12	72988-0026	HUMAN OTC DRUG	ZENOL COOL		Methyl salicylate, l-menthol	PATCH	TRANSDERMAL	20211001		OTC MONOGRAPH NOT FINAL	part348	Lydia Co., Ltd.	LEVOMENTHOL; METHYL SALICYLATE	140; 160	mg/6.8g; mg/6.8g			N	20241231
72988-0027_d0b20c56-de2b-1489-e053-2995a90a6a06	72988-0027	HUMAN OTC DRUG	NOCOLD-F		ACETAMINOPHENE. CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE	LIQUID	ORAL	20211114		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE	200; 2.5; 15	mg/30mL; mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
72988-0028_ffb6c041-03a7-c6c1-e053-6394a90a8194	72988-0028	HUMAN OTC DRUG	ANTIPHLAMINE		L-Menthol, L-Camphor, Methyl Salicylate	LOTION	TOPICAL	20220102		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	CAMPHOR, (-)-; LEVOMENTHOL; METHYL SALICYLATE	59; 8; 46	mg/g; mg/g; mg/g			N	20241231
72988-0029_e0bb7903-d8c5-2bff-e053-2a95a90a0773	72988-0029	HUMAN OTC DRUG	CHUNGWIDAN-F		cinnamon, nutmeg	LIQUID	ORAL	20220606		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	CINNAMON; NUTMEG	500; 300	mg/30mL; mg/30mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
72988-0030_e9eb354f-e61d-6a3a-e053-2995a90ae200	72988-0030	HUMAN OTC DRUG	Metarivin Soln. 0.1%		Xylometazoline Hydrochloride	LIQUID	NASAL	20220930		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	XYLOMETAZOLINE HYDROCHLORIDE	1	mg/mL			N	20241231
72988-0031_ffcab802-a76f-e425-e053-6294a90acf76	72988-0031	HUMAN OTC DRUG	Mentholatum		Methyl Salicylate, DL-Menthol	LOTION	TOPICAL	20220930		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	MENTHOL; METHYL SALICYLATE	60; 200	mg/g; mg/g			N	20241231
72988-0032_001bec55-6d03-2e8e-e063-6394a90ab5b7	72988-0032	HUMAN OTC DRUG	New Hanbang Col Cap		Acetaminophen, Caffeine Anhydrous,	TABLET	ORAL	20220930		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	ACETAMINOPHEN; CAFFEINE	150; 12.5	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
72988-0033_ffc8ccb8-929d-8a6f-e053-6294a90ae29b	72988-0033	HUMAN OTC DRUG	NOCOLD-S		Acetaminophen, CHLORPHENIRAMINE MALEATE	LIQUID	ORAL	20230123		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	200; 2.5	mg/20mL; mg/20mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
72988-0034_f2e9f62e-22fb-9555-e053-2995a90ae44b	72988-0034	HUMAN OTC DRUG	NOVOMINSYRUP		Caffeine Anhydrous, Meclizine Hydrochloride Hydrate, Pyridoxine Hydrochloride	LIQUID	ORAL	20230123		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	CAFFEINE; MECLIZINE HYDROCHLORIDE; PYRIDOXINE HYDROCHLORIDE	20; 25; 5	mg/6mL; mg/6mL; mg/6mL	Analogs/Derivatives [Chemical/Ingredient], Antiemetic [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Emesis Suppression [PE], Methylxanthine [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Xanthines [CS]		N	20241231
72988-0035_001d54ef-148b-e55a-e063-6294a90a7c40	72988-0035	HUMAN OTC DRUG	ALBOTHYL		Policresulen Solution	LIQUID	ORAL	20230123		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	POLICRESULEN	720	mg/g			N	20241231
72988-0036_0278e810-7614-f9e0-e063-6394a90a3198	72988-0036	HUMAN OTC DRUG	GEWORIN		Acetaminophen, Isopropylantipyrine	TABLET	ORAL	20230211		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	ACETAMINOPHEN; PROPYPHENAZONE	300; 150	mg/1; mg/1			N	20241231
72988-0037_f468dee0-c460-9f28-e053-2a95a90a9834	72988-0037	HUMAN OTC DRUG	EASYDERM BAND		pine resin	PATCH	TOPICAL	20230123		UNAPPROVED DRUG OTHER		Lydia Co., Ltd.	PINUS HALEPENSIS RESIN	.57	mg/100mg			N	20241231
72989-372_1382cb5e-d6bc-40d9-887d-4128ee6f8256	72989-372	HUMAN PRESCRIPTION DRUG	Prometrium		Progesterone	CAPSULE	ORAL	20221101		NDA	NDA019781	Acertis Pharmaceuticals, LLC	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
72989-373_1382cb5e-d6bc-40d9-887d-4128ee6f8256	72989-373	HUMAN PRESCRIPTION DRUG	Prometrium		Progesterone	CAPSULE	ORAL	20221101		NDA	NDA019781	Acertis Pharmaceuticals, LLC	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
72989-409_2066873e-a83d-42ad-827b-a8087288555e	72989-409	HUMAN PRESCRIPTION DRUG	PHENDIMETRAZINE TARTRATE		PHENDIMETRAZINE TARTRATE	CAPSULE, EXTENDED RELEASE	ORAL	20221101		NDA	NDA018074	Acertis Pharmaceuticals, LLC	PHENDIMETRAZINE TARTRATE	105	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIII	N	20241231
72990-103_21f18326-17f1-4cf1-af64-1607543c16e3	72990-103	HUMAN PRESCRIPTION DRUG	DEFENCATH		taurolidine and heparin	SOLUTION	INTRALUMINAL	20231115		NDA	NDA214520	CorMedix Inc.	HEPARIN; TAUROLIDINE	3000; 40.5	[USP'U]/3mL; mg/3mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
72990-105_21f18326-17f1-4cf1-af64-1607543c16e3	72990-105	HUMAN PRESCRIPTION DRUG	DEFENCATH		taurolidine and heparin	SOLUTION	INTRALUMINAL	20231115		NDA	NDA214520	CorMedix Inc.	HEPARIN; TAUROLIDINE	5000; 67.5	[USP'U]/5mL; mg/5mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
72995-001_0a97a9f7-b6b4-29ff-e063-6394a90aae56	72995-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091012		UNAPPROVED MEDICAL GAS		GenVentures, Inc dba Genesis Home Medical Equipment	OXYGEN	99	L/100L			N	20241231
72998-850_ba47cb44-824b-454b-8921-5f57d7c236cd	72998-850	HUMAN PRESCRIPTION DRUG	OMEGA-3-ACID ETHYL ESTERS		OMEGA-3-ACID ETHYL ESTERS	CAPSULE	ORAL	20210501		ANDA	ANDA212504	KD Pharma USA, Inc.	OMEGA-3-ACID ETHYL ESTERS	1	g/1	Fatty Acids, Omega-3 [CS], Omega-3 Fatty Acid [EPC]		N	20241231
73001-005_616b904f-62f4-4309-a7f4-088d436b7287	73001-005	HUMAN OTC DRUG	LIGHT HEARTED BROAD SPECTRUM SPF 30 SUNSCREEN		Octisalate, Octocrylene, Zinc oxide	LOTION	TOPICAL	20210416		OTC MONOGRAPH NOT FINAL	part352	Sunday Riley Modern Skincare, LLC	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	5; 3.5; 16.32	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73001-305_f6a90db2-c6d2-442b-9240-cb419c4ec77b	73001-305	HUMAN OTC DRUG	SUNDAY RILEY SATURN SULFUR ACNE SPOT TREATMENT MASK		Sulfur	CREAM	TOPICAL	20200831		OTC MONOGRAPH FINAL	part333D	Sunday Riley Modern Skincare, LLC	SULFUR	.1	g/mL			N	20241231
73001-340_e56d0e94-99aa-45ba-ac95-4f88a83e476f	73001-340	HUMAN OTC DRUG	SUNDAY RILEY SULFUR ACNE TREATMENT MASK		Sulfur	CREAM	TOPICAL	20170108		OTC MONOGRAPH FINAL	part333D	Sunday Riley Modern Skincare, LLC	SULFUR	.1	g/mL			N	20241231
73001-430_6b3c80eb-f3d4-46f7-87ab-e015225b9467	73001-430	HUMAN OTC DRUG	SUNDAY RILEY ultra-clarifying ACNE TREATMENT FACE		Salicylic Acid	OIL	TOPICAL	20170401		OTC MONOGRAPH FINAL	part333D	Sunday Riley Modern Skincare, LLC	SALICYLIC ACID	15	mg/mL			N	20241231
73001-460_3bbccf3b-91fd-47d0-a9e9-fbd85d1ebb58	73001-460	HUMAN OTC DRUG	SUNDAY RILEY U.F.O Acne Treatment Face Oil		Salicylic Acid	OIL	TOPICAL	20170430		OTC MONOGRAPH FINAL	part333D	Sunday Riley Modern Skincare, LLC	SALICYLIC ACID	15	mg/mL			N	20241231
73002-131_0de5b56f-e1b0-9787-e063-6394a90a3559	73002-131	HUMAN OTC DRUG	PAIN RELIEF CAFFEINE AND SNAKE VENOM		Caffeine (Coffeinum) 6X, Cobra venom (Naja naja) 5X, Moccasin venom (A.piscivorus) 7X	SPRAY	ORAL	20200901		UNAPPROVED HOMEOPATHIC		Green Earth Health Inc.	AGKISTRODON PISCIVORUS VENOM; CAFFEINE; NAJA NAJA VENOM	6; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20251231
73002-142_0d7f16c2-cd6e-b640-e063-6394a90aa53e	73002-142	HUMAN OTC DRUG	PAIN RELIEF MENTHOL AND SNAKE VENOM		cobra venom (Naja naja) 2X, menthol (Mentholum) Tinc, moccasin venom (A.piscivorus) 4X	GEL	TOPICAL	20200901		UNAPPROVED HOMEOPATHIC		Green Earth Health Inc.	AGKISTRODON PISCIVORUS VENOM; MENTHOL, (+)-; NAJA NAJA VENOM	.001; 1; .1	mg/mL; mg/mL; mg/mL			N	20251231
73002-222_0d7f16c2-cd78-b640-e063-6394a90aa53e	73002-222	HUMAN OTC DRUG	PAIN RELIEF SNAKE VENOM AND HEMP		cobra venom (Naja naja) 2X, hemp extract (Cannabis sativa) 1X, moccasin venom (A.piscivorus) 4X	LOTION	TOPICAL	20200901		UNAPPROVED HOMEOPATHIC		Green Earth Health Inc.	AGKISTRODON PISCIVORUS VENOM; CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP; NAJA NAJA VENOM	.001; 15.7; .1	mg/mL; mg/mL; mg/mL			N	20251231
73002-231_0d7f090d-991f-a5f4-e063-6394a90ac8a9	73002-231	HUMAN OTC DRUG	PAIN RELIEF SNAKE VENOM AND HEMP		Cobra venom (Naja naja) 4X, Hemp extract (Cannabis sativa) 2X, Moccasin venom (A.piscivorus) 6X	LIQUID	ORAL	20200915		UNAPPROVED HOMEOPATHIC		Green Earth Health Inc.	AGKISTRODON PISCIVORUS VENOM; CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP; NAJA NAJA VENOM	6; 2; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20251231
73002-332_0d7f1b8b-349e-bdb2-e063-6294a90a751c	73002-332	HUMAN OTC DRUG	PAIN RELIEF ARNICA AND HEMP		arnica (A. montana) Tinc, hemp extract (Cannabis sativa) 1X	LOTION	TOPICAL	20200901		UNAPPROVED HOMEOPATHIC		Green Earth Health Inc.	ARNICA MONTANA FLOWER; CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP	70; 15.7	mg/mL; mg/mL			N	20251231
73002-342_0d7f16c2-cd83-b640-e063-6394a90aa53e	73002-342	HUMAN OTC DRUG	PAIN RELIEF MENTHOL AND HEMP		hemp extract (Cannabis sativa) 1X, menthol (Mentholum) Tinc.	LOTION	TOPICAL	20200901		UNAPPROVED HOMEOPATHIC		Green Earth Health Inc.	CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP; LEVOMENTHOL	15.7; 10	mg/mL; mg/mL			N	20251231
73002-351_0d7f16c2-cd8e-b640-e063-6394a90aa53e	73002-351	HUMAN OTC DRUG	PAIN RELIEF CAFFEINE AND HEMP		Caffeine (Coffeinum) 6X, Hemp extract (Cannabis sativa) 2X	LIQUID	ORAL	20200901		UNAPPROVED HOMEOPATHIC		Green Earth Health Inc.	CAFFEINE CITRATE; CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP	6; 2	[hp_X]/mL; [hp_X]/mL	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20251231
73002-713_0d7fa814-2186-7a91-e063-6294a90a1fc0	73002-713	HUMAN OTC DRUG	MDFARMA COLD and FLU RELIEF		ATROPINE, NAJA NAJA VENOM, MAGNESIUM CHLORIDE, POTASSIUM HYDROXIDE	SPRAY	NASAL	20200923		UNAPPROVED DRUG OTHER		Green Earth Health Inc.	ATROPINE; MAGNESIUM CHLORIDE; NAJA NAJA VENOM; POTASSIUM HYDROXIDE	5; 5; 5; 7	[hp_X]/.2mL; [hp_X]/.2mL; [hp_X]/.2mL; [hp_X]/.2mL	Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20251231
73008-001_0d962ead-ddab-d232-e063-6294a90a7a6b	73008-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20120724		UNAPPROVED MEDICAL GAS		Tennessee Medical Equipment Inc	OXYGEN	99	L/100L			N	20241231
73010-127_09dc7f08-9210-435a-e063-6394a90a8dca	73010-127	HUMAN OTC DRUG	HUMANE Acne Spot Treatment		BENZOYL PEROXIDE	GEL	TOPICAL	20210301		OTC MONOGRAPH DRUG	M006	Apprendista, LLC	BENZOYL PEROXIDE	50	mg/mL			N	20241231
73010-900_097502bf-7222-dd2b-e063-6394a90a7520	73010-900	HUMAN OTC DRUG	HUMANE ACNE WASH		BENZOYL PEROXIDE	LIQUID	TOPICAL	20190401		OTC MONOGRAPH DRUG	M006	Apprendista, LLC	BENZOYL PEROXIDE	100	mg/mL			N	20241231
73012-001_088d81b1-12e8-ff5b-e063-6294a90ad4bf	73012-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	19930701		UNAPPROVED MEDICAL GAS		Med-Ox Supply	OXYGEN	99	L/100L			N	20241231
73015-001_0c708699-3cf6-284c-e063-6394a90a85be	73015-001	HUMAN OTC DRUG	Antibacterial Wet Wipes		benzalkonium chloride	SWAB	TOPICAL	20160806		OTC MONOGRAPH DRUG	M003	HangZhou YangYi Daily Cosmetics Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73017-3111_48114bd0-2d25-4d74-aca7-a05fdf5c6ae1	73017-3111	HUMAN OTC DRUG	Eyeganics Organic Tears		Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20190513		OTC MONOGRAPH DRUG	M018	Eyeganics LLC	GLYCERIN	2	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
73024-399_f888fdac-363a-23fa-e053-6394a90a9e86	73024-399	HUMAN OTC DRUG	Optimel Manuka Dry Eye Drops		Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20190719		OTC MONOGRAPH FINAL	part349	Melcare Biomedical Pty Ltd	GLYCERIN	2	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
73024-429_f88909d1-f11c-05cc-e053-6294a90a7602	73024-429	HUMAN OTC DRUG	Optimel Manuka Forte Eye Gel		Glycerin	GEL	OPHTHALMIC	20190719		OTC MONOGRAPH FINAL	part349	Melcare Biomedical Pty Ltd	GLYCERIN	2	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
73025-160_0b57bb80-8682-3850-e063-6294a90a4dcb	73025-160	HUMAN OTC DRUG	Spatherapy Antibacterial Berry		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-161_0b57a607-7df5-10f8-e063-6394a90a81e3	73025-161	HUMAN OTC DRUG	Spatherapy Antibacterial Cherry		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-162_0b57b92a-0816-1a79-e063-6294a90a1364	73025-162	HUMAN OTC DRUG	Spatherapy Antibacterial Citrus		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-163_0b57bb80-8668-3850-e063-6294a90a4dcb	73025-163	HUMAN OTC DRUG	Spatherapy Antibacterial Peach		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-164_0b57a10f-de7d-240d-e063-6294a90a9f3b	73025-164	HUMAN OTC DRUG	Spatherapy Antibacterial Pineapple		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-165_0b57a36b-e118-047c-e063-6394a90a16e8	73025-165	HUMAN OTC DRUG	Spatherapy Antibacterial Watermelon		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-166_0b57c9b0-cee1-4968-e063-6294a90a6e01	73025-166	HUMAN OTC DRUG	Spatherapy Antibacterial Cherry Blossom		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-167_0b57c8de-43af-2d1d-e063-6294a90a11b9	73025-167	HUMAN OTC DRUG	Spatherapy Antibacterial Cucumber Aloe		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-168_0b57ab95-2936-09b7-e063-6394a90a20be	73025-168	HUMAN OTC DRUG	Spatherapy Antibacterial Eucalyptus Mint		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-169_0b57bd72-ba6f-19b2-e063-6394a90a0116	73025-169	HUMAN OTC DRUG	Spatherapy Antibacterial French Lavender		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-170_0b57b2db-194c-3702-e063-6294a90a7d17	73025-170	HUMAN OTC DRUG	Spatherapy Antibacterial Lemon Citrus		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73025-171_0b57bf3d-e6d6-1b17-e063-6394a90a9ac9	73025-171	HUMAN OTC DRUG	Spatherapy Antibacterial Vanilla Coconut		ALCOHOL	GEL	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Shalom International Corp	ALCOHOL	62	mL/100mL			N	20241231
73027-215_f6f149ea-384b-2718-e053-6394a90a25de	73027-215	HUMAN OTC DRUG	Sumikkogurashi Aloe Vera Scented		Alcohol	GEL	TOPICAL	20210524		OTC MONOGRAPH NOT FINAL	part333A	JIANGSU HANHE DAILY CHEMICALS CO., LTD.	ALCOHOL	75	mL/100mL			N	20241231
73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0	73027-216	HUMAN OTC DRUG	Rilakkuma Aloe Vera Scented		Alcohol	GEL	TOPICAL	20210524		OTC MONOGRAPH NOT FINAL	part333A	JIANGSU HANHE DAILY CHEMICALS CO., LTD.	ALCOHOL	75	mL/100mL			N	20241231
73030-020_eea25a60-2d70-2aec-e053-2a95a90a2d75	73030-020	HUMAN OTC DRUG	Trip Wipes		Benzalkonium chloride	SWAB	TOPICAL	20190415		OTC MONOGRAPH NOT FINAL	part333A	DETROIT WICK	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73033-007_f2697b08-0866-1d5d-e053-2a95a90a3e95	73033-007	HUMAN OTC DRUG	Omeza Skin Protectant Gel		Cod Liver Oil	GEL	TOPICAL	20221121		OTC MONOGRAPH FINAL	M016	Omeza LLC	COD LIVER OIL	14.24	g/100mL			N	20241231
73037-001_0c8f22fa-65e2-2c97-e063-6294a90ae68c	73037-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091008		UNAPPROVED MEDICAL GAS		The Medical Store, Inc.	OXYGEN	99	L/100L			N	20241231
73039-001_0bf31114-1aa4-2361-e063-6394a90a4750	73039-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130531		UNAPPROVED MEDICAL GAS		AxisCare Health Logistics, Inc.	OXYGEN	99	L/100L			N	20241231
73042-201_5b8f4535-cb6d-46c9-b9fc-b86df5792555	73042-201	HUMAN PRESCRIPTION DRUG	DANYELZA		Naxitamab	INJECTION	INTRAVENOUS	20201125		BLA	BLA761171	Y-mAbs Therapeutics, Inc.	NAXITAMAB	40	mg/10mL	Glycolipid Disialoganglioside-directed Antibody Interactions [MoA], Glycolipid Disialoganglioside-directed Antibody [EPC]		N	20241231
73043-021_80c24d8c-3e87-4eb5-a349-17c55c62d70d	73043-021	HUMAN PRESCRIPTION DRUG	Succinylcholine Chloride		Succinylcholine Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210312		ANDA	ANDA214491	Devatis, Inc.	SUCCINYLCHOLINE CHLORIDE	20	mg/mL	Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]		N	20241231
73044-102_082bf31b-f917-4af1-e063-6394a90a7fa8	73044-102	HUMAN OTC DRUG	KT Recovery Plus Pain Relief Gel		camphor, menthol	GEL	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	KT Health LLC	CAMPHOR (NATURAL); MENTHOL	50; 50	mg/mL; mg/mL			N	20241231
73044-103_f76e09aa-d86c-92ae-e053-6294a90a6451	73044-103	HUMAN OTC DRUG	KT Recovery Plus Pain Relief Gel		camphor, menthol	GEL	TOPICAL	20230415		OTC MONOGRAPH NOT FINAL	part348	KT Health LLC	CAMPHOR (NATURAL); MENTHOL	5; 5	g/100mL; g/100mL			N	20241231
73044-104_05ce3c3e-7f9b-94d3-e063-6394a90a9e9c	73044-104	HUMAN OTC DRUG	KT RECOVER MAGNESIUM		MENTHOL	CREAM	TOPICAL	20230912		OTC MONOGRAPH NOT FINAL	part348	KT Health LLC	MENTHOL	2	g/100g			N	20241231
73044-105_05ce1c0e-14e9-6a31-e063-6294a90a3f11	73044-105	HUMAN OTC DRUG	KT ACTIVATE MAGNESIUM ARNICA		ARNICA MONTANA WHOLE	CREAM	TOPICAL	20230912		UNAPPROVED HOMEOPATHIC		KT Health LLC	ARNICA MONTANA WHOLE	5	g/100g			N	20241231
73046-124_0ccaa5aa-56a4-449e-e063-6394a90a273e	73046-124	HUMAN OTC DRUG	Smooth AF		TOLNAFTATE	CLOTH	TOPICAL	20190711		OTC MONOGRAPH DRUG	M005	Pelli Skin Co.,LLC.	TOLNAFTATE	1	g/100g			N	20241231
73046-613_0ccb6189-ee17-62c6-e063-6294a90ad05b	73046-613	HUMAN OTC DRUG	Smooth AF		TOLNAFTATE	CLOTH	TOPICAL	20190711		OTC MONOGRAPH DRUG	M005	Pelli Skin Co.,LLC.	TOLNAFTATE	1	g/100g			N	20241231
73048-000_c4422161-474d-c082-e053-2995a90adffc	73048-000	HUMAN OTC DRUG	Zen Sports Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20151015		OTC MONOGRAPH NOT FINAL	part348	Zen Enterprises LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 8; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
73048-001_c4422161-474e-c082-e053-2995a90adffc	73048-001	HUMAN OTC DRUG	Zen Hemp Balm		camphor, eucalyptus oil, menthol, methyl salicylate	CREAM	TOPICAL	20190422		OTC MONOGRAPH NOT FINAL	part348	Zen Enterprises LLC	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL; METHYL SALICYLATE	11; 10; 8; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
73048-002_ad3d557b-7200-7ab0-e053-2995a90acd6e	73048-002	HUMAN OTC DRUG	Zen Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Zen Enterprises	ALCOHOL	70	mL/100mL			N	20241231
73048-003_ad3d6735-d3ff-3fed-e053-2995a90a7d36	73048-003	HUMAN OTC DRUG	Sycuan Casino Resort Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Zen Enterprises	ALCOHOL	70	mL/100mL			N	20241231
73051-0754_0a963bca-efc3-8a5f-e063-6394a90aeae3	73051-0754	HUMAN OTC DRUG	Orthocare		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL; ORAL	20190417		OTC MONOGRAPH DRUG	M021	Orthosciences, Inc.	SODIUM FLUORIDE	2.4	mg/g			N	20241231
73054-101_f8104a02-dacc-bfc6-e053-6294a90a61db	73054-101	HUMAN OTC DRUG	SOLARA SUNCARE - CLEAN FREAK	SPF-30 UNSCENTED	ZINC OXIDE	LOTION	TOPICAL	20190706		OTC MONOGRAPH NOT FINAL	part352	SOLARA SUNCARE, INC.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-102_f3d11c9e-2ed9-c7ab-e053-2a95a90afca8	73054-102	HUMAN OTC DRUG	SOLARA SUNCARE - CLEAN FREAK	SPF-30 NATURALLY SCENTED	ZINC OXIDE	LOTION	TOPICAL	20190706		OTC MONOGRAPH NOT FINAL	part352	SOLARA SUNCARE, INC.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-103_f810438c-ac8d-a572-e053-6394a90a363e	73054-103	HUMAN OTC DRUG	SOLARA SUNCARE - GLOW GETTER	SPF-30 NATURALLY SCENTED	ZINC OXIDE	LOTION	TOPICAL	20190706		OTC MONOGRAPH NOT FINAL	part352	SOLARA SUNCARE, INC.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-104_f810438c-ac8e-a572-e053-6394a90a363e	73054-104	HUMAN OTC DRUG	SOLARA SUNCARE - POUT PROTECTOR	SPF-15	ZINC OXIDE	CREAM	TOPICAL	20190706		OTC MONOGRAPH NOT FINAL	part352	SOLARA SUNCARE, INC.	ZINC OXIDE	11	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-105_f8104e20-a934-52bc-e053-6294a90ab15d	73054-105	HUMAN OTC DRUG	SOLARA SUNCARE - TIME TRAVELER	SPF-30 UNSCENTED	ZINC OXIDE	LOTION	TOPICAL	20190706		OTC MONOGRAPH NOT FINAL	part352	SOLARA SUNCARE, INC.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-107_f3d0ccbd-2706-5207-e053-2995a90aad9d	73054-107	HUMAN OTC DRUG	MINERAL DEFENSE SPORT ANTIOXIDANT FACE SUNSCREEN	SPF-50	ZINC OXIDE	LOTION	TOPICAL	20211017		OTC MONOGRAPH FINAL	M020	SOLARA SUNCARE, INC.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-108_f3d0a993-46aa-6c57-e053-2a95a90adf73	73054-108	HUMAN OTC DRUG	MINERAL DEFENSE SPORT CERAMIDE	SPF-30	ZINC OXIDE	STICK	TOPICAL	20211017		OTC MONOGRAPH FINAL	M020	SOLARA SUNCARE, INC.	ZINC OXIDE	20	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-109_f810843b-5a4c-6cbc-e053-6294a90ac9e3	73054-109	HUMAN OTC DRUG	SOLARA SUNCARE - GO MINERAL DEFENSE SPORT SUPERFRUIT VITAMIN C PLUS ALOE SHEER SUNSCREEN MIST	SPF-30 UNSCENTED	ZINC OXIDE	SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	M020	SOLARA SUNCARE, INC.	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-116_fd03c357-b19e-c2b2-e053-6294a90abe2e	73054-116	HUMAN OTC DRUG	Go Daily Defense Soothing Mineral Face Sunscreen	SPF-30	ZINC OXIDE	LOTION	TOPICAL	20211017		OTC MONOGRAPH FINAL	M020	SOLARA SUNCARE, INC.	ZINC OXIDE	19	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-120_f43854ac-3d49-5979-e053-2995a90a1a2e	73054-120	HUMAN OTC DRUG	SOLARA SUNCARE - FORTUNE TELLER	SPF-30	ZINC OXIDE	LOTION	TOPICAL	20190706		OTC MONOGRAPH NOT FINAL	part352	SOLARA SUNCARE, INC.	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73054-126_f4386210-df1a-d431-e053-2995a90a0e75	73054-126	HUMAN OTC DRUG	GUARDIAN ANGEL SUPER PEPTIDE SUNSCREEN MILK	SPF-50	ZINC OXIDE	LOTION	TOPICAL	20211017		OTC MONOGRAPH NOT FINAL	part352	SOLARA SUNCARE, INC.	ZINC OXIDE	12	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73055-001_078bd3e2-5706-d418-e063-6394a90afe9f	73055-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20130411		UNAPPROVED MEDICAL GAS		West Healthcare Solutions, Inc dba Mercy Plaza Respiratory & Medical Supply	OXYGEN	99	L/100L			N	20241231
73057-346_d6e77117-3ea8-0bd5-e053-2a95a90aa4dc	73057-346	HUMAN OTC DRUG	Pharbechlor		Chlorpheniramine Maleate 4mg	TABLET	ORAL	20190701		OTC MONOGRAPH FINAL	part341	Ulai Health LLC	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73057-347_d6e6f5ff-9bbf-2920-e053-2a95a90a21d8	73057-347	HUMAN OTC DRUG	PHARBEDRYL		Diphenhydramine HCl 50mg	CAPSULE	ORAL	20190702		OTC MONOGRAPH FINAL	part341	Ulai Health LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73057-348_d6e70a10-c94f-d82b-e053-2a95a90acfba	73057-348	HUMAN OTC DRUG	Allergy Relief 25 mg		Diphenhydramine HCl 25mg	CAPSULE	ORAL	20190701		OTC MONOGRAPH FINAL	part341	Ulai Health LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73057-350_d6e73a52-b71b-3943-e053-2995a90abd39	73057-350	HUMAN OTC DRUG	Pharbetol		Acetaminophen 500mg	TABLET, COATED	ORAL	20190708		OTC MONOGRAPH NOT FINAL	part343	Ulai Health LLC	ACETAMINOPHEN	500	mg/1			N	20241231
73057-352_d6e761d5-7742-a025-e053-2a95a90a871c	73057-352	HUMAN OTC DRUG	ACETAMINOPHEN PM		Acetaminophen 500mg / Diphenhydramine HCl 25mg	TABLET, FILM COATED	ORAL	20190708		OTC MONOGRAPH NOT FINAL	part343	Ulai Health LLC	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73057-353_d6e77117-3eb9-0bd5-e053-2a95a90aa4dc	73057-353	HUMAN OTC DRUG	Pharbetol		Acetaminophen 325 mg	TABLET	ORAL	20190708		OTC MONOGRAPH NOT FINAL	part343	Ulai Health LLC	ACETAMINOPHEN	325	mg/1			N	20241231
73057-356_d6e77117-3e96-0bd5-e053-2a95a90aa4dc	73057-356	HUMAN OTC DRUG	Safety Coated Aspirin 81 mg Low Dose		Aspirin 81mg	TABLET, DELAYED RELEASE	ORAL	20190628		OTC MONOGRAPH FINAL	part343	Ulai Health LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
73057-358_d6e6ff9c-dd59-7544-e053-2995a90ac6f4	73057-358	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCl 25 mg	TABLET	ORAL	20190702		OTC MONOGRAPH FINAL	part338	Ulai Health LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73057-363_d6e70a10-c960-d82b-e053-2a95a90acfba	73057-363	HUMAN OTC DRUG	Senna-Tabs		Senna 8.6mg	TABLET, FILM COATED	ORAL	20190710		OTC MONOGRAPH NOT FINAL	part334	Ulai Health LLC	SENNOSIDES	8.6	mg/1			N	20241231
73057-365_d6e72936-43e1-f5a0-e053-2995a90a07fa	73057-365	HUMAN OTC DRUG	Aspirin Regular Strength		Aspirin 325mg	TABLET	ORAL	20190628		OTC MONOGRAPH FINAL	part343	Ulai Health LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
73057-376_d6e70a10-c93d-d82b-e053-2a95a90acfba	73057-376	HUMAN OTC DRUG	Pharbetol		Acetaminophen 500mg	TABLET	ORAL	20190708		OTC MONOGRAPH NOT FINAL	part343	Ulai Health LLC	ACETAMINOPHEN	500	mg/1			N	20241231
73057-377_d6e6a7b3-e68a-6248-e053-2995a90a9c7a	73057-377	HUMAN OTC DRUG	Calcium Carbonate 10 gr (648 mg)	(Antacid)	Calcium Carbonate 10gr (648 mg)	TABLET	ORAL	20190701		OTC MONOGRAPH FINAL	part331	Ulai Health LLC	CALCIUM CARBONATE	648	mg/1			N	20241231
73057-378_d6e6ff9c-dd6b-7544-e053-2995a90ac6f4	73057-378	HUMAN OTC DRUG	Senna-S		Sennosides 8.6mg and Docusate Sodium 50mg	TABLET, FILM COATED	ORAL	20190710		OTC MONOGRAPH NOT FINAL	part334	Ulai Health LLC	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
73057-379_d6e72936-43f2-f5a0-e053-2995a90a07fa	73057-379	HUMAN OTC DRUG	Pharbinex		Guaifenesin 400mg	TABLET	ORAL	20190626		OTC MONOGRAPH FINAL	part341	Ulai Health LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
73057-381_d6e72920-8910-0f78-e053-2a95a90a672b	73057-381	HUMAN OTC DRUG	Pharbinex-DM		Guaifenesin 400mg and Dextromethorphan HBr 20mg	TABLET	ORAL	20190718		OTC MONOGRAPH FINAL	part341	Ulai Health LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
73057-386_d6e7750a-1bab-ba9b-e053-2a95a90acc4b	73057-386	HUMAN OTC DRUG	MECLIZINE		Meclizine HCl 12.5mg	TABLET	ORAL	20190708		OTC MONOGRAPH FINAL	part336	Ulai Health LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
73057-389_d6e72936-4449-f5a0-e053-2995a90a07fa	73057-389	HUMAN OTC DRUG	Pharbinex-PE		GUAIFENESIN 400mg and PHENYLEPHRINE HCL 10MG	TABLET, COATED	ORAL	20190718		OTC MONOGRAPH FINAL	part341	Ulai Health LLC	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	400; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
73059-001_0bde79a3-26b4-e0d2-e063-6294a90ac663	73059-001	HUMAN PRESCRIPTION DRUG	ACCRUFER		Ferric Maltol	CAPSULE	ORAL	20210701		NDA	NDA212320	Shield TX (UK) Ltd	FERRIC MALTOL	30	mg/1	Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
73060-001_f6f78f0b-5546-35ed-e053-6394a90a3250	73060-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20120125		UNAPPROVED MEDICAL GAS		Florida Oxygen & Transfilling Inc.	OXYGEN	99	L/100L			N	20241231
73061-000_0b6e0cdc-69a0-fbab-e063-6294a90a9436	73061-000	HUMAN OTC DRUG	Hemopropin Extra Strength Hemorrhoidal		LANOLIN, PETROLATUM	OINTMENT	RECTAL; TOPICAL	20200310		OTC MONOGRAPH DRUG	M015	Apipharmausa, LLC	LANOLIN; PETROLATUM	177.6; 712	mg/g; mg/g			N	20241231
73061-003_0b6e0aaa-f5a1-00e5-e063-6394a90a0d21	73061-003	HUMAN OTC DRUG	Kapsin		CAMPHOR (SYNTHETIC), CAPSAICIN	OINTMENT	TOPICAL	20200904		OTC MONOGRAPH DRUG	M017	Apipharmausa, LLC	CAMPHOR (SYNTHETIC); CAPSAICIN	31.6; .3	mg/g; mg/g			N	20241231
73062-032_0a59627b-cad3-b9b2-e063-6394a90a2f7f	73062-032	HUMAN OTC DRUG	Inofoam Antibacterial Foaming Hand Wash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20231120		OTC MONOGRAPH DRUG	505G(a)(3)	Avro Enterprises, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73062-033_0a5ec655-d06c-cb78-e063-6294a90aee74	73062-033	HUMAN OTC DRUG	Inofoam Antibacterial Foaming Hand Wash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20231120		OTC MONOGRAPH DRUG	505G(a)(3)	Avro Enterprises, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73062-055_08bfe1ce-49d1-3165-e063-6394a90a0375	73062-055	HUMAN OTC DRUG	Inoderm Style Antibacterial		CHLOROXYLENOL	LIQUID	TOPICAL	20230316		OTC MONOGRAPH DRUG	505G(a)(3)	Avro Enterprises LLC	CHLOROXYLENOL	3	mg/.001L			N	20241231
73062-135_f27996c1-1f82-1b5a-e053-2995a90a254e	73062-135	HUMAN OTC DRUG	Puresan Hand Sanitizing		Alcohol	GEL	TOPICAL	20210820	20240711	OTC MONOGRAPH NOT FINAL	part333E	Avro Enterprises LLC	ALCOHOL	70	mL/100mL			N	
73062-400_eea15c27-66c9-470e-e053-2995a90a8dff	73062-400	HUMAN OTC DRUG	Benzalkonium Chloride		Dual Action Antibacterial Wipes	CLOTH	TOPICAL	20211026		OTC MONOGRAPH NOT FINAL	part333A	Avro Enterprises LLC	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
73062-401_eea16075-d0d4-62d8-e053-2a95a90ad1aa	73062-401	HUMAN OTC DRUG	Benzalkonium Chloride		Dual Action Antimicrobial Wipes	CLOTH	TOPICAL	20211026		OTC MONOGRAPH NOT FINAL	part333A	Avro Enterprises LLC	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
73062-408_f27977ed-9611-3c5b-e053-2995a90a419d	73062-408	HUMAN OTC DRUG	Puresan Antibacterial Liquid		Chloroxylenol	LIQUID	TOPICAL	20210820	20240626	OTC MONOGRAPH NOT FINAL	part333E	Avro Enterprises LLC	CHLOROXYLENOL	.3	g/100mL			N	
73062-511_f27988e1-47f7-be4c-e053-2a95a90ab398	73062-511	HUMAN OTC DRUG	Puresan Antibacterial Foaming Hand Wash		Chloroxylenol	LIQUID	TOPICAL	20210820	20240720	OTC MONOGRAPH NOT FINAL	part333E	Avro Enterprises LLC	CHLOROXYLENOL	.3	g/100mL			N	
73062-523_08bff442-7d38-56d5-e063-6394a90a6477	73062-523	HUMAN OTC DRUG	Inoderm Choice Antibacterial		CHLOROXYLENOL	LIQUID	TOPICAL	20230414		OTC MONOGRAPH DRUG	505G(a)(3)	Avro Enterprises LLC	CHLOROXYLENOL	3	mg/mL			N	20241231
73063-035_b5f26edd-82c2-4680-be7a-0c4ed150302c	73063-035	HUMAN PRESCRIPTION DRUG	RELYVRIO		sodium phenylbutyrate/taurursodiol	POWDER, FOR SUSPENSION	ORAL	20220929		NDA	NDA216660	Amylyx Pharmaceuticals Inc	SODIUM PHENYLBUTYRATE; TAURURSODIOL DIHYDRATE	3; 1	g/1; g/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20251231
73065-0008_fa0ab7bf-406a-4c67-e053-6394a90ae7d7	73065-0008	HUMAN OTC DRUG	Hea YanToothpaste		precipitated calcium carbonate, aluminum chlorohydroxy allantoinate, aminocaproic acid, dibasic calcium phosphate hydrate	PASTE, DENTIFRICE	DENTAL	20230424		UNAPPROVED DRUG OTHER		WOORI LIFE & HEALTH	ALCLOXA; AMINOCAPROIC ACID; CALCIUM CARBONATE; DIBASIC CALCIUM PHOSPHATE DIHYDRATE	.09; .09; 37; .09	g/100g; g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Decreased Fibrinolysis [PE], Increased Coagulation Factor Activity [PE]		N	20241231
73065-0009_fa856208-e7a7-043d-e053-6294a90a4ed9	73065-0009	HUMAN OTC DRUG	ToothpasteToothpaste (Aqua mint flavor)		Hydrogen peroxide, Tocopheryl acetate, silicon dioxide	PASTE, DENTIFRICE	DENTAL	20230424		UNAPPROVED DRUG OTHER		WOORI LIFE & HEALTH	.ALPHA.-TOCOPHEROL ACETATE; HYDROGEN PEROXIDE; SILICON DIOXIDE	.2; 2.14; 7	g/100mL; g/100mL; g/100mL			N	20241231
73065-0010_fac0d318-fd4b-b2ce-e053-6394a90ad95c	73065-0010	HUMAN OTC DRUG	ToothpasteToothpaste (Pineapple mint flavor)		Hydrogen peroxide, Tocopheryl acetate, silicon dioxide	PASTE, DENTIFRICE	DENTAL	20230424		UNAPPROVED DRUG OTHER		WOORI LIFE & HEALTH	.ALPHA.-TOCOPHEROL ACETATE; HYDROGEN PEROXIDE; SILICON DIOXIDE	.2; 2.14; 7	g/100mL; g/100mL; g/100mL			N	20241231
73067-870_097502bf-7230-dd2b-e063-6394a90a7520	73067-870	HUMAN OTC DRUG	NERVE REVERSE PAIN RELIEF		MENTHOL	CREAM	TOPICAL	20190415		OTC MONOGRAPH DRUG	M017	Pogue Medical Services	MENTHOL	40	mg/mL			N	20241231
73070-100_393af9a3-df9a-40b2-a5e6-bfa5434a2552	73070-100	HUMAN PRESCRIPTION DRUG	Insulin Aspart		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	Novo Nordisk Pharma, Inc.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73070-102_393af9a3-df9a-40b2-a5e6-bfa5434a2552	73070-102	HUMAN PRESCRIPTION DRUG	Insulin Aspart		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20010827		BLA	BLA020986	Novo Nordisk Pharma, Inc.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73070-103_393af9a3-df9a-40b2-a5e6-bfa5434a2552	73070-103	HUMAN PRESCRIPTION DRUG	Insulin Aspart		insulin aspart	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20030122		BLA	BLA020986	Novo Nordisk Pharma, Inc.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73070-200_ec67820c-4008-4894-b933-34b28704221d	73070-200	HUMAN PRESCRIPTION DRUG	Insulin Aspart Protamine and Insulin Aspart	Mix 70/30	insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20011101		BLA	BLA021172	Novo Nordisk Pharma, Inc.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73070-203_ec67820c-4008-4894-b933-34b28704221d	73070-203	HUMAN PRESCRIPTION DRUG	Insulin Aspart Protamine and Insulin Aspart	Mix 70/30	insulin aspart	INJECTION, SUSPENSION	SUBCUTANEOUS	20020911		BLA	BLA021172	Novo Nordisk Pharma, Inc.	INSULIN ASPART	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73070-400_c1be283d-4b1d-4996-b2a7-4488dbff3037	73070-400	HUMAN PRESCRIPTION DRUG	Insulin Degludec		insulin degludec	INJECTION, SOLUTION	SUBCUTANEOUS	20220701		BLA	BLA203314	Novo Nordisk Pharma, Inc.	INSULIN DEGLUDEC	100	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73070-403_c1be283d-4b1d-4996-b2a7-4488dbff3037	73070-403	HUMAN PRESCRIPTION DRUG	Insulin Degludec		insulin degludec	INJECTION, SOLUTION	SUBCUTANEOUS	20220701		BLA	BLA203314	Novo Nordisk Pharma, Inc.	INSULIN DEGLUDEC	100	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73070-503_c1be283d-4b1d-4996-b2a7-4488dbff3037	73070-503	HUMAN PRESCRIPTION DRUG	Insulin Degludec		insulin degludec	INJECTION, SOLUTION	SUBCUTANEOUS	20220701		BLA	BLA203314	Novo Nordisk Pharma, Inc.	INSULIN DEGLUDEC	200	U/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
73075-001_075f82e3-915a-6342-e063-6394a90a93cc	73075-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100111		UNAPPROVED MEDICAL GAS		Isla Home Infusion	OXYGEN	99	L/100L			N	20241231
73076-107_0c85a6e9-ce8a-2903-e063-6294a90ad28b	73076-107	HUMAN OTC DRUG	iShancare Folliculitis Cream		Folliculitis Cream	CREAM	TOPICAL	20221215		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73076-108_07fb5f3e-5c28-0c2f-e063-6394a90a2923	73076-108	HUMAN OTC DRUG	LMNOOP Folliculitis Treatment Cream		LMNOOP Folliculitis Treatment Cream	CREAM	TOPICAL	20231018		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73076-109_07e623b1-cd18-b319-e063-6394a90a0160	73076-109	HUMAN OTC DRUG	LMNOOP Feminine Antibacterial Cream		LMNOOP Feminine Antibacterial Cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73076-110_07e66f7a-4447-727c-e063-6394a90a7068	73076-110	HUMAN OTC DRUG	LMNOOP Seborrheic Dermatitis Treatment		LMNOOP Seborrheic Dermatitis Treatment	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73076-111_07e623b1-cd07-b319-e063-6394a90a0160	73076-111	HUMAN OTC DRUG	LMNOOP Itch Relief Cream		LMNOOP Itch Relief Cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73076-112_07e6f0d8-216d-15ef-e063-6294a90ade1e	73076-112	HUMAN OTC DRUG	LMNOOP Psoriasis Treatment Cream		Psoriasis Treatment Cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	SALICYLIC ACID	2	g/100g			N	20241231
73076-113_07e71be6-9183-87f9-e063-6294a90af026	73076-113	HUMAN OTC DRUG	lmnoop serious antifungal cream		lmnoop serious antifungal cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73076-115_07e5c48d-54d9-c6b8-e063-6394a90a7a6b	73076-115	HUMAN OTC DRUG	lmnoop jock itch cream		lmnoop jock itch cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73076-116_07e56891-f606-2233-e063-6394a90a9bcd	73076-116	HUMAN OTC DRUG	lmnoop tinea treatment		lmnoop tinea treatment	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73076-118_07e6537e-62f5-f102-e063-6394a90ab1d6	73076-118	HUMAN OTC DRUG	ishancare feminine ttch relief		LMNOOP Feminine Itch Relief	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73076-119_07e618b9-7474-7613-e063-6394a90a7d0f	73076-119	HUMAN OTC DRUG	iShancare Seborrheic Dermatitis Cream		iShancare Seborrheic Dermatitis Cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73076-120_07e5e393-d2b0-a4e5-e063-6394a90aec9b	73076-120	HUMAN OTC DRUG	iShancare Anti-itch Cream		iShancare Anti-itch Cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73076-121_07e697e3-042d-0cfc-e063-6394a90add8d	73076-121	HUMAN OTC DRUG	iShanCare Psoriasis Relief Cream		Psoriasis Relief Cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	SALICYLIC ACID	2	g/100g			N	20241231
73076-123_0c8cf87f-6024-8c09-e063-6294a90a3de5	73076-123	HUMAN OTC DRUG	ishancare anti-fungal treatment		ishancare anti-fungal treatment	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73076-125_07e67720-4734-c363-e063-6394a90ae9a2	73076-125	HUMAN OTC DRUG	ishancare jock itch treatment		ishancare jock itch treatment	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73076-126_0d02d443-43e7-2812-e063-6394a90a34ce	73076-126	HUMAN OTC DRUG	ringworm treatment		iShancare ringworm treatment	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73076-127_07e56bc4-ba64-3617-e063-6294a90a45b3	73076-127	HUMAN OTC DRUG	ishancare eczema cream		ishancare eczema cream	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73076-131_0d0323fe-99a0-e57b-e063-6294a90a8f21	73076-131	HUMAN OTC DRUG	iShanCare Rosacea Treatment Cream		Rosacea Treatment Cream	CREAM	TOPICAL	20231221		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73076-135_0d12c3c1-13c3-c912-e063-6394a90a4c4e	73076-135	HUMAN OTC DRUG	iShanCare Mens Cream		Mens Cream	CREAM	TOPICAL	20231221		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73076-136_0d12d45a-4c0a-d31b-e063-6394a90a11bd	73076-136	HUMAN OTC DRUG	LMNOOP Intimate Skin Cream		Intimate Skin Cream	CREAM	TOPICAL	20231221		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73076-137_0d04dd04-5968-d315-e063-6294a90a943d	73076-137	HUMAN OTC DRUG	LMNOOP Rosacea Cream		Rosacea Cream	CREAM	TOPICAL	20231221		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73076-138_0d151419-18cc-46e3-e063-6294a90a7719	73076-138	HUMAN OTC DRUG	ishancare Feminine Itch Protect		Feminine Itch Protect	CREAM	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Shenzhen Ishan Technology Co., Ltd	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73077-010_b7f09611-0c5e-43bb-8dee-900634076dc9	73077-010	HUMAN PRESCRIPTION DRUG	PEDMARK		SODIUM THIOSULFATE	INJECTION, SOLUTION	INTRAVENOUS	20221003		NDA	NDA212937	Fennec Pharmaceuticals Inc.	SODIUM THIOSULFATE	12.5	g/100mL			N	20241231
73078-001_09cd8ca7-afef-2081-e063-6294a90a1f4f	73078-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100111		UNAPPROVED MEDICAL GAS		Professional Medical Supply	OXYGEN	99	L/100L			N	20241231
73079-050_2db30f3a-1f45-448f-ae87-ade4805df70a	73079-050	HUMAN PRESCRIPTION DRUG	Zokinvy		lonafarnib	CAPSULE	ORAL	20201120		NDA	NDA213969	Eiger BioPharmaceuticals, Inc.	LONAFARNIB	50	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Farnesyltransferase Inhibitor [EPC], Farnesyltransferase Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
73079-075_2db30f3a-1f45-448f-ae87-ade4805df70a	73079-075	HUMAN PRESCRIPTION DRUG	Zokinvy		lonafarnib	CAPSULE	ORAL	20201120		NDA	NDA213969	Eiger BioPharmaceuticals, Inc.	LONAFARNIB	75	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Farnesyltransferase Inhibitor [EPC], Farnesyltransferase Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
73082-010_70c37150-654e-46d8-8931-e2e395f4bceb	73082-010	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20191005		ANDA	ANDA213628	Orange Pharmaceuticals USA LLC	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
73082-020_70c37150-654e-46d8-8931-e2e395f4bceb	73082-020	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20191005		ANDA	ANDA213628	Orange Pharmaceuticals USA LLC	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
73087-001_08028904-49c9-1659-e063-6394a90a9573	73087-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190612		NDA	NDA206023	KENRIC INC dba Trinity Medical Supplies	OXYGEN	990	mL/L			N	20241231
73089-081_f1883355-2371-2a05-e053-2a95a90a278d	73089-081	HUMAN OTC DRUG	VAZALORE		Aspirin	CAPSULE	ORAL	20210805		NDA	NDA203697	PLx Pharma Inc	ASPIRIN	81	mg/81mg	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
73089-325_f1883355-2372-2a05-e053-2a95a90a278d	73089-325	HUMAN OTC DRUG	VAZALORE		aspirin	CAPSULE	ORAL	20210805		NDA	NDA203697	PLx Pharma Inc	ASPIRIN	325	mg/325mg	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
73093-001_0ce312a1-c5d4-44cf-e063-6394a90a22d3	73093-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20121031		UNAPPROVED MEDICAL GAS		Dusara Corporation dba UniversalMed Supply	OXYGEN	99	L/100L			N	20241231
73095-085_09751799-662b-ec58-e063-6394a90aea39	73095-085	HUMAN OTC DRUG	BEAST HYDRATING FACE SPF-20		OCTOCRYLENE, OCTISALATE, AVOBENZONE	LOTION	TOPICAL	20190501		OTC MONOGRAPH DRUG	M020	Small Batch Beauty, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
73095-385_09dc82c6-e291-c731-e063-6294a90ad5ef	73095-385	HUMAN OTC DRUG	BEAST SPIT and POLISH FACE SPF-20		OCTOCRYLENE, OCTISALATE, AVOBENZONE	LOTION	TOPICAL	20210110		OTC MONOGRAPH DRUG	M020	Small Batch Beauty, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
73096-741_f0ec5c76-3352-d633-e053-2995a90a05fd	73096-741	HUMAN OTC DRUG	CBDMEDIC Active Sport Pain Relief		Camphor and Menthol	STICK	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	100; 150	mg/g; mg/g			N	20241231
73096-742_f0ec5f47-2f9b-0558-e053-2a95a90aa7ca	73096-742	HUMAN OTC DRUG	CBDMEDIC Active Sport Pain Relief		Camphor and Menthol	OINTMENT	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	100; 150	mg/g; mg/g			N	20241231
73096-743_f0ec783e-e0d7-7a8f-e053-2a95a90a582a	73096-743	HUMAN OTC DRUG	CBDMEDIC Arthritis Aches and Pain Relief		Camphor and Menthol	OINTMENT	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	100; 100	mg/g; mg/g			N	20241231
73096-744_f0ec8751-fabe-8204-e053-2a95a90a00f5	73096-744	HUMAN OTC DRUG	CBDMEDIC Arthritis Aches and Pain Relief		Menthol	CREAM	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	MENTHOL	40	mg/g			N	20241231
73096-745_f0ec8751-facc-8204-e053-2a95a90a00f5	73096-745	HUMAN OTC DRUG	CBDMEDIC Back and Neck Pain Relief		Camphor and Menthol	OINTMENT	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	100; 150	mg/g; mg/g			N	20241231
73096-746_f0ec9c26-29aa-e096-e053-2a95a90a85eb	73096-746	HUMAN OTC DRUG	CBDMEDIC Foot and Ankle Pain Relief		Camphor and Menthol	OINTMENT	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	100; 150	mg/g; mg/g			N	20241231
73096-747_f0eca582-022d-f8b1-e053-2995a90a5613	73096-747	HUMAN OTC DRUG	CBDMEDIC Foot and Ankle Pain Relief		Camphor and Menthol	STICK	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	100; 150	mg/g; mg/g			N	20241231
73096-748_f0eca06a-ee14-4513-e053-2995a90ac661	73096-748	HUMAN OTC DRUG	CBDMEDIC Muscle and Joint Pain Relief		Camphor and Menthol	SPRAY	TOPICAL	20190701		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	31; 100	mg/mL; mg/mL			N	20241231
73096-749_f0ecb90e-fbbd-a39e-e053-2995a90a087c	73096-749	HUMAN OTC DRUG	CBDMEDIC Muscle and Joint Pain Relief		Camphor and Menthol	OINTMENT	TOPICAL	20190701		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	100; 150	mg/g; mg/g			N	20241231
73096-750_f0ecc494-590d-5303-e053-2a95a90a66d5	73096-750	HUMAN OTC DRUG	CBDMEDIC Massage Therapy Pain Relief		Camphor and Menthol	OIL	TOPICAL	20190701		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	31; 40	mg/mL; mg/mL			N	20241231
73096-751_f0ecc494-590e-5303-e053-2a95a90a66d5	73096-751	HUMAN OTC DRUG	CBDMEDIC Eczema Therapy		Colloidal Oatmeal	OINTMENT	TOPICAL	20190901		OTC MONOGRAPH FINAL	part347	ABACUS HEALTH PRODUCTS, INC.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73096-755_f0eaabeb-686a-dde7-e053-2995a90aa725	73096-755	HUMAN OTC DRUG	CBD Clinic Relax Massage		Camphor	CREAM	TOPICAL	20191215		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL)	5	g/100g			N	20241231
73096-757_f0eaf190-b53f-735b-e053-2995a90ade8a	73096-757	HUMAN OTC DRUG	CBD Clinic Revive Massage		Menthol, Camphor	CREAM	TOPICAL	20191215		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	5; 5	g/100g; g/100g			N	20241231
73096-758_f0eb37a5-b85b-2df2-e053-2995a90ad2bf	73096-758	HUMAN OTC DRUG	CBD Clinic Revive Massage		Menthol, Camphor	OIL	TOPICAL	20191215		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	4; 4	g/100mL; g/100mL			N	20241231
73096-759_f0eb36fa-f406-3911-e053-2a95a90a6f8c	73096-759	HUMAN OTC DRUG	CBD Clinic Ultimate Massage		Menthol, Camphor	OINTMENT	TOPICAL	20191115		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	11; 16	g/100g; g/100g			N	20241231
73096-760_f0eb4b27-c6d7-f553-e053-2a95a90ab486	73096-760	HUMAN OTC DRUG	CBD Clinic Ultimate Massage		Menthol, Camphor	OIL	TOPICAL	20191115		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	5; 10	g/100mL; g/100mL			N	20241231
73096-761_f0ea9360-709e-2125-e053-2a95a90af7a3	73096-761	HUMAN OTC DRUG	CBD Clinic Pain Relief - Level 1		Lidocaine HCL	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73096-762_f0eb6c1f-cc9e-8290-e053-2a95a90adbe7	73096-762	HUMAN OTC DRUG	CBD Clinic Pain Relief - Level 2		Camphor	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL)	3	g/100g			N	20241231
73096-763_f0e9ac7c-a83c-2e05-e053-2a95a90a33f1	73096-763	HUMAN OTC DRUG	CBD Clinic Pain Relief - Level 3		Menthol	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	MENTHOL	4	g/100g			N	20241231
73096-764_f0eba1dd-cf3f-8e6c-e053-2a95a90a474b	73096-764	HUMAN OTC DRUG	CBD Clinic Pain Relief - Level 4		Menthol, Camphor	OINTMENT	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	5; 7	g/100g; g/100g			N	20241231
73096-765_f0e9db11-f8d0-bef0-e053-2a95a90aaefb	73096-765	HUMAN OTC DRUG	CBD Clinic Pain Relief - Level 5		Menthol, Camphor	OINTMENT	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	11; 16	g/100g; g/100g			N	20241231
73096-766_f0ebc1c6-93fc-efd6-e053-2995a90a25bb	73096-766	HUMAN OTC DRUG	CBD Clinic Pain Relief - Level 5		Menthol, Camphor	STICK	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	ABACUS HEALTH PRODUCTS, INC.	CAMPHOR (NATURAL); MENTHOL	11; 16	g/100g; g/100g			N	20241231
73096-767_f0eccc8a-2ea3-063e-e053-2a95a90a18f7	73096-767	HUMAN OTC DRUG	CBDMEDIC Acne Treatment		Salicylic Acid	CREAM	TOPICAL	20190701		OTC MONOGRAPH FINAL	part333D	ABACUS HEALTH PRODUCTS, INC.	SALICYLIC ACID	10	mg/g			N	20241231
73102-062_09751799-663a-ec58-e063-6394a90aea39	73102-062	HUMAN OTC DRUG	MINTED LEAF Cold Therapy Relief with CBD and Menthol		MENTHOL	CREAM	TOPICAL	20190801		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	MENTHOL	100	mg/g			N	20241231
73102-063_097502bf-723d-dd2b-e063-6394a90a7520	73102-063	HUMAN OTC DRUG	MINTED LEAF Cold Therapy Relief with CBD and Menthol		MENTHOL	GEL	TOPICAL	20190801		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	MENTHOL	40	mg/g			N	20241231
73102-064_097502bf-724b-dd2b-e063-6394a90a7520	73102-064	HUMAN OTC DRUG	MINTED LEAF Cold Therapy Foot Relief with CBD and Menthol		MENTHOL	GEL	TOPICAL	20190801		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	MENTHOL	160	mg/g			N	20241231
73102-065_097502bf-725d-dd2b-e063-6394a90a7520	73102-065	HUMAN OTC DRUG	MINTED LEAF Cold Therapy Relief with CBD and Menthol Roll On		MENTHOL	CREAM	TOPICAL	20190801		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	MENTHOL	40	mg/mL			N	20241231
73102-114_09dc82c6-e2a0-c731-e063-6294a90ad5ef	73102-114	HUMAN OTC DRUG	Minted Leaf Cold Therapy Pain Relief		MENTHOL	CREAM	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	MENTHOL	100	mg/mL			N	20241231
73102-115_0975230a-86da-cc07-e063-6294a90a3873	73102-115	HUMAN OTC DRUG	Minted Leaf Cold Therapy Pain Relief		MENTHOL	GEL	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	MENTHOL	40	mg/mL			N	20241231
73102-116_097502bf-726e-dd2b-e063-6394a90a7520	73102-116	HUMAN OTC DRUG	Minted Leaf Cold Therapy Pain Relief Roll-On		MENTHOL	SOLUTION	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	MENTHOL	40	mg/mL			N	20241231
73102-117_0975230a-86e8-cc07-e063-6294a90a3873	73102-117	HUMAN OTC DRUG	Minted Leaf Heat Therapy Relief Roll-On		CAPSAICIN	SOLUTION	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	CAPSAICIN	.25	mg/mL			N	20241231
73102-118_09751fc7-6649-c196-e063-6294a90a4a57	73102-118	HUMAN OTC DRUG	Minted Leaf Odorless Pain Relief		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20190501		OTC MONOGRAPH DRUG	M017	MMG Consumer Brands, LLC	HISTAMINE DIHYDROCHLORIDE	.3	mg/mL			N	20241231
73105-003_06f9af75-c5fe-d37b-e063-6394a90a4f6c	73105-003	HUMAN OTC DRUG	GLADSKIN ECZEMACT ECZEMA		COLLOIDAL OATMEAL	CREAM	TOPICAL	20231005		OTC MONOGRAPH DRUG	M016	Micreos North America, Inc.	OATMEAL	.2	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73107-105_a431f6fe-3723-4e74-a741-7c8f05c90196	73107-105	HUMAN OTC DRUG	KONIX Alcohol Antiseptic Hand Rub		KONIX Alcohol Antiseptic Hand Rub	SOLUTION	TOPICAL	20200512		OTC MONOGRAPH NOT FINAL	part333A	TURKUAZ SAGLIK HIZMETLERI MEDIKAL TEMIZLIK KIMYASAL URUNLER SANAYI VE TICARET AS	ALCOHOL	70	mL/100mL			N	20241231
73116-215_e7c8f6bf-6c16-4a6e-93c8-e7241b160aa8	73116-215	HUMAN PRESCRIPTION DRUG	COPIKTRA		duvelisib	CAPSULE	ORAL	20180925		NDA	NDA211155	Secura Bio, Inc.	DUVELISIB	15	mg/1			N	20241231
73116-225_e7c8f6bf-6c16-4a6e-93c8-e7241b160aa8	73116-225	HUMAN PRESCRIPTION DRUG	COPIKTRA		duvelisib	CAPSULE	ORAL	20180925		NDA	NDA211155	Secura Bio, Inc.	DUVELISIB	25	mg/1			N	20241231
73117-111_f92616af-6e4c-a8cd-e053-6294a90a29b7	73117-111	HUMAN OTC DRUG	Cleanse Right Ear Wax Drops		Ear Wax Drops	LIQUID	IRRIGATION	20220907		OTC MONOGRAPH FINAL	M014	Blue Echo Care	CARBAMIDE PEROXIDE	.065	g/mL			N	20241231
73122-061_f1ee7415-4adb-0ea6-e053-2995a90ab073	73122-061	HUMAN OTC DRUG	RVR90 Brighten		Zinc Oxide	KIT	TOPICAL	20211115		OTC MONOGRAPH FINAL	part352	Ultraceuticals US, LLC						N	20241231
73122-063_f1ee79a6-d462-79a7-e053-2a95a90a327d	73122-063	HUMAN OTC DRUG	RVR90 Hydrating		Zinc Oxide	KIT	TOPICAL	20211220		OTC MONOGRAPH FINAL	part352	Ultraceuticals US, LLC						N	20241231
73122-065_f552334c-2f3f-27a4-e053-2995a90a6495	73122-065	HUMAN OTC DRUG	RVR90 Firm		Zinc Oxide	KIT		20220103		OTC MONOGRAPH FINAL	part352	Ultraceuticals US, LLC						N	20241231
73122-067_f5524981-b2d7-715e-e053-2995a90a747b	73122-067	HUMAN OTC DRUG	RVR90 Refine and Perfect		Zinc Oxide	KIT	TOPICAL	20211220		OTC MONOGRAPH FINAL	part352	Ultraceuticals US, LLC						N	20241231
73122-069_f5617d06-2e60-498b-e053-2995a90ae1e5	73122-069	HUMAN OTC DRUG	RVR90 Retexturize		Zinc Oxide	KIT		20220103		OTC MONOGRAPH FINAL	M020	Ultraceuticals US, LLC						N	20241231
73122-071_04514f59-79cc-57e6-e063-6294a90aa644	73122-071	HUMAN OTC DRUG	RVR90 Clear		Zinc Oxide	KIT	TOPICAL	20220103		OTC MONOGRAPH FINAL	M020	Ultraceuticals US, LLC						N	20241231
73126-001_dd93bd82-d52e-2136-e053-2a95a90afe7a	73126-001	HUMAN OTC DRUG	HEMP THE POINT		Eucalyptus Globulus, Menthol	OIL	TOPICAL	20190703	20240420	OTC MONOGRAPH NOT FINAL	part348	Lab-Clean, Inc	EUCALYPTUS GUM; MENTHOL	20; 20	mg/g; mg/g			N	
73126-002_dd937274-7fb4-2339-e053-2a95a90a74eb	73126-002	HUMAN OTC DRUG	BAYES Alcohol free Hydrating Hand Sanitizer		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20200321	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-003_dd93c206-8f4c-5b2b-e053-2995a90a995a	73126-003	HUMAN OTC DRUG	BEEKMAN 1802 HAPPY PLACE Hand Sanitizer		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20200401	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-004_dd93bcee-fbf8-1430-e053-2a95a90a4637	73126-004	HUMAN OTC DRUG	Nellies Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200409	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-005_dd937274-7fbf-2339-e053-2a95a90a74eb	73126-005	HUMAN OTC DRUG	Nellies Baby Lavender		Benzalkonium Chloride	LIQUID	TOPICAL	20200522	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-006_dd93bcee-fc03-1430-e053-2a95a90a4637	73126-006	HUMAN OTC DRUG	Nellies Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20200522	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-007_dd93c992-b1f6-66da-e053-2a95a90ae2c4	73126-007	HUMAN OTC DRUG	Nellies Hand Sanitizer eucalyptus		Benzalkonium Chloride	LIQUID	TOPICAL	20200522	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-008_dd93dd2c-7397-3a63-e053-2995a90a1a76	73126-008	HUMAN OTC DRUG	BAYES Alcohol Free Hydrating Hand Sanitizer Eucalyptus Lavender		benzalkonium chloride	LIQUID	TOPICAL	20200527	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-009_dd93db0a-1646-23b9-e053-2995a90a1635	73126-009	HUMAN OTC DRUG	ELS EVERYBODY LOVES ANTIMICROBIAL HAND WASH		Benzalkonium Chloride	LIQUID	TOPICAL	20200601	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-010_dd93d53d-5495-b47c-e053-2a95a90a2a05	73126-010	HUMAN OTC DRUG	SPA SENSE ANTIBACTERIAL HAND WASH		Benzalkonium Chloride	LIQUID	TOPICAL	20200601	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-011_dd93eb70-1aa0-4039-e053-2995a90a5074	73126-011	HUMAN OTC DRUG	ELS EVERYBODY LOVES HAND SANITIZER - EUCALYPTUS LAVENDER		Benzalkonium Chloride	LIQUID	TOPICAL	20200611	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-012_dd93f75e-9f90-e2b4-e053-2a95a90ab3d3	73126-012	HUMAN OTC DRUG	SPA SENSE HAND SANITIZER Eucalyptus Lavender		Benzalkonium Chloride	LIQUID	TOPICAL	20200611	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-013_dd93f845-7038-e6ad-e053-2995a90a45c7	73126-013	HUMAN OTC DRUG	Sume Apothecary Alcohol Free Hand Sanitizer Lavender and White Sage		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200709	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-014_dd93f845-7042-e6ad-e053-2995a90a45c7	73126-014	HUMAN OTC DRUG	Sume Apothecary Alcohol Free Hand Sanitizer Fresh		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200709	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-015_dd940558-0187-6958-e053-2995a90aab13	73126-015	HUMAN OTC DRUG	But First Be Clean Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-016_dd94038c-b500-dfa5-e053-2a95a90a917e	73126-016	HUMAN OTC DRUG	But First Be Clean Alcohol Free Hand Sanitizer Eucalyptus Lavender		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-017_dd93f845-704d-e6ad-e053-2995a90a45c7	73126-017	HUMAN OTC DRUG	But First Be Clean Alcohol Free Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-018_dd9406ee-178a-0ae4-e053-2995a90aa35e	73126-018	HUMAN OTC DRUG	ELS EVERYBODY LOVES ANTIMICROBIAL HAND WASH		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-019_dd94162d-9c49-9b9a-e053-2995a90af841	73126-019	HUMAN OTC DRUG	Social Grace Alcohol Free Hand Sanitizer Eucalyptus Lavender		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-020_dd94162d-9c56-9b9a-e053-2995a90af841	73126-020	HUMAN OTC DRUG	Spa Sense Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-021_dd94162d-9c65-9b9a-e053-2995a90af841	73126-021	HUMAN OTC DRUG	Spa Sense Antibacterial Hand Wash Eucalyptus Aloe		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-022_dd941925-0341-3be6-e053-2995a90ad7df	73126-022	HUMAN OTC DRUG	Spa Sense Antibacterial Hand Wash Lavender		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-023_dd942843-3c64-475b-e053-2995a90a6872	73126-023	HUMAN OTC DRUG	ELS2 Everybody Loves Alcohol Free Hand Sanitizer - Bamboo, Coconut, Sea Salt		Benzalkonium Chloride	LIQUID	TOPICAL	20200723	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-024_dd942843-3c6e-475b-e053-2995a90a6872	73126-024	HUMAN OTC DRUG	ELS2 Everybody Loves Alcohol Free Hand Sanitizer - Holy Basil, Eucalyptus, Lavender		Benzalkonium Chloride	LIQUID	TOPICAL	20200723	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-025_dd942843-3c78-475b-e053-2995a90a6872	73126-025	HUMAN OTC DRUG	SPA SENSE Antibacterial Hand Wash-Lavender		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200901	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-026_dd9432cf-938c-6a97-e053-2a95a90acfce	73126-026	HUMAN OTC DRUG	SPA SENSE Antibacterial Hand Wash-Eucalyptus Aloe		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200901	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-027_dd9432cf-939a-6a97-e053-2a95a90acfce	73126-027	HUMAN OTC DRUG	Hutch AND Waldo Hand Sanitizer-Lavender, Clary Sage, Eucalyptus		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200901	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-028_dd943829-35cb-6e5b-e053-2995a90a60a4	73126-028	HUMAN OTC DRUG	Shock Doctor Hand Sanitizer- Eucalyptus		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200901	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-029_dd943d58-5847-a418-e053-2995a90a7474	73126-029	HUMAN OTC DRUG	The Home Edit Antibacterial Hand Wash-Unscented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201001	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73126-030_dd944506-1da0-402b-e053-2a95a90a3430	73126-030	HUMAN OTC DRUG	The Home Edit Hand Sanitizer-Unscented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201001	20240420	OTC MONOGRAPH NOT FINAL	part333A	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-031_dd944506-1dab-402b-e053-2a95a90a3430	73126-031	HUMAN OTC DRUG	Dewzi Alcohol Free Hand Sanitizer Fragrance Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210210	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-032_dd944506-1db6-402b-e053-2a95a90a3430	73126-032	HUMAN OTC DRUG	Truth Antibacterial Foaming Hand Wash - Unscented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210304	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
73126-033_dd944506-1dcc-402b-e053-2a95a90a3430	73126-033	HUMAN OTC DRUG	Truth Alcohol Free Hand Sanitizer - Lavender Eucalyptus		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210304	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
73126-034_dd944e02-8ce6-72e4-e053-2a95a90ae2fe	73126-034	HUMAN OTC DRUG	Truth Alcohol Free Hand Sanitizer - Unscented		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210304	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
73126-035_dd9446b3-13bc-5e13-e053-2a95a90a73b2	73126-035	HUMAN OTC DRUG	BAYES Alcohol Free Foaming Hand Sanitizer Fragrance Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210611	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-036_dd9453da-9201-44f0-e053-2995a90a3e03	73126-036	HUMAN OTC DRUG	BAYES Alcohol Free Foaming Hand Sanitizer Eucalyptus Lavender		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210611	20240420	OTC MONOGRAPH NOT FINAL	part333E	LAB-CLEAN, INC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
73126-037_dd943c17-9ed7-e1ba-e053-2a95a90a684c	73126-037	HUMAN OTC DRUG	MUSE APOTHECARY HEMP RITUAL ROLL ON		eucalyptus gum, menthol	CREAM	TOPICAL	20211124	20240420	OTC MONOGRAPH NOT FINAL	part348	LAB-CLEAN, INC	EUCALYPTUS GLOBULUS LEAF; MENTHOL	20; 20	mg/g; mg/g			N	
73128-614_38003ce2-d541-42fd-b0ac-9d66025633ac	73128-614	HUMAN OTC DRUG	TRIPLE CARE plus ARNICA	ANALGESIC - RECOVERY	Methyl Salicylate, CAMPHOR (SYNTHETIC), and Menthol, Unspecified form	CREAM	TOPICAL	20191001		OTC MONOGRAPH DRUG	M017	Paloven, Inc.	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	4.968; 4.968; 12.42	g/82.8g; g/82.8g; g/82.8g			N	20241231
73130-001_b96adee0-168c-7058-e053-2995a90a756d	73130-001	HUMAN OTC DRUG	MD Post Care		Arnica montana, Calendula officinalis, Carduus marianus, Graphites, Hypericum perforatum, Staphysagria, Thiosinaminum, Vitamin K1	SPRAY	ORAL	20190724		UNAPPROVED HOMEOPATHIC		Bottled Science, Inc.	ALLYLTHIOUREA; ARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; GRAPHITE; HYPERICUM PERFORATUM; MILK THISTLE; PHYTONADIONE	6; 30; 6; 30; 6; 30; 3; 3	[hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_X]/25mL; [hp_X]/25mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
73130-002_364967de-9ae9-4cb6-9527-df25f653259d	73130-002	HUMAN OTC DRUG	Skinade MD INsupport		Apis Mellifica, Arnica Montana, Bellis Perenis, Calendula Officinalis, Ledum Palustre, Natrum Sulphuricum, Staphysagria	SPRAY	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Bottled Science, Inc.	APIS MELLIFERA; ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; CALENDULA OFFICINALIS FLOWER; DELPHINIUM STAPHISAGRIA SEED; LEDUM PALUSTRE WHOLE; SODIUM SULFATE	30; 30; 30; 30; 30; 30; 30	[hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL; [hp_C]/25mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
73132-001_f1f03ab2-ee8c-5b3c-e053-2a95a90aaa55	73132-001	HUMAN OTC DRUG	Green Compass Reduce Topical Pain		Camphor, Menthol, Methyl Salicylate	CREAM	TOPICAL	20190724		OTC MONOGRAPH NOT FINAL	part348	Green Compass, Inc.	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	3; 10; 10	g/100mL; g/100mL; g/100mL			N	20241231
73132-003_f1f0305f-0054-08ad-e053-2995a90aa371	73132-003	HUMAN OTC DRUG	Green Compass Reduce Roll-On Pain Relief		Menthol	LIQUID	TOPICAL	20201203		OTC MONOGRAPH NOT FINAL	part348	Green Compass, Inc.	MENTHOL, UNSPECIFIED FORM	5	g/100mL			N	20241231
73132-004_0a0b8b6b-f10a-ba12-e063-6294a90ab977	73132-004	HUMAN OTC DRUG	Green Compass Reduce Pain Relief		Camphor, Menthol, Methyl Salicylate	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Green Compass, Inc.	CAMPHOR (NATURAL); MENTHOL; METHYL SALICYLATE	3.1; 10; 10	g/100mL; g/100mL; g/100mL			N	20241231
73132-005_0a0bfe4a-53ba-5b7c-e063-6394a90a23ec	73132-005	HUMAN OTC DRUG	Green Compass Reduce Pain Relief with Menthol		Menthol	GEL	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Green Compass, Inc.	MENTHOL, UNSPECIFIED FORM	5	g/100mL			N	20241231
73141-001_addbf328-1531-40cc-b40c-b10df5911f9a	73141-001	HUMAN OTC DRUG	LUBRICATING EYE DROPS		Carboxymethylcellulose Sodium	LIQUID	OPHTHALMIC	20191004		OTC MONOGRAPH FINAL	part349	A2A Integrated Pharmaceuticals, LLC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	5	mg/mL			N	20241231
73141-180_0d9834cf-e6b3-c128-e063-6294a90ab53e	73141-180	HUMAN OTC DRUG	A2A Hand Sanitizer		Alcohol	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	M003	A2A INTEGRATED PHARMACEUTICALS, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
73141-190_0d981dc6-7d5e-bdc7-e063-6394a90a5b73	73141-190	HUMAN OTC DRUG	Next Home Hand Sanitizer Gel		Isopropyl Alcohol 70% Next Home Hand Sanitizer Gel	GEL	TOPICAL	20200801		OTC MONOGRAPH DRUG	M003	A2A Integrated Pharmaceuticals, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
73141-221_f305e9d7-341b-45f6-e053-2a95a90a2d69	73141-221	HUMAN PRESCRIPTION DRUG	Nystatin Cream		NYSTATIN	CREAM	TOPICAL	20230118		ANDA	ANDA207733	A2A Integrated Pharmaceuticals, LLC	NYSTATIN	100000	[USP'U]/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
73141-225_0d9489a5-0703-a095-e063-6294a90a75e2	73141-225	HUMAN OTC DRUG	A2A Anti-Fungal Powder		Miconazole nitrate 2%	POWDER	TOPICAL	20211001		OTC MONOGRAPH DRUG	M005	A2A Integrated Pharmaceuticals, LLC	MICONAZOLE NITRATE	1.7	g/85g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73143-002_f183f9bf-558b-4a99-e053-2995a90a0878	73143-002	HUMAN OTC DRUG	Auebliss		Lidocaine	CREAM	TOPICAL	20230105		OTC MONOGRAPH NOT FINAL	part348	Jag Alliance, LLC	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73145-001_b3e0fbc3-4ec7-4bf4-e053-2a95a90ae2d6	73145-001	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201111		OTC MONOGRAPH NOT FINAL	part333E	ASC Marketing Ltd.	ALCOHOL	70	mL/100mL			N	20241231
73145-002_b3e0eb97-bace-4953-e053-2995a90a571b	73145-002	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201111		OTC MONOGRAPH NOT FINAL	part333E	ASC Marketing Ltd.	ALCOHOL	70	mL/100mL			N	20241231
73145-003_0b6e0023-a810-dcd8-e063-6394a90a52ae	73145-003	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201119		OTC MONOGRAPH DRUG	505G(a)(3)	ASC Marketing LTD	ALCOHOL	.7	mL/mL			N	20241231
73145-004_0b6e0202-cde6-d783-e063-6394a90a3bf2	73145-004	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201119		OTC MONOGRAPH DRUG	505G(a)(3)	ASC Marketing LTD	ALCOHOL	.7	mL/mL			N	20241231
73145-005_b3caa9c8-67e4-c737-e053-2a95a90a8970	73145-005	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201111		OTC MONOGRAPH NOT FINAL	part333E	ASC Marketing Ltd.	ALCOHOL	70	mL/100mL			N	20241231
73145-007_0b6dc42e-c0ac-b6cf-e063-6294a90aef5b	73145-007	HUMAN OTC DRUG	AZX Wellness Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201121		OTC MONOGRAPH DRUG	505G(a)(3)	ASC Marketing LTD	ALCOHOL	.8	mL/mL			N	20241231
73145-008_b41d75da-55f2-a244-e053-2a95a90a976e	73145-008	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333E	ASC Marketing Ltd.	ALCOHOL	70	mL/100mL			N	20241231
73145-009_b42ec656-25fd-3580-e053-2995a90a3181	73145-009	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333E	ASC Marketing Ltd.	ALCOHOL	70	mL/100mL			N	20241231
73145-010_0b6df08e-ce56-b832-e063-6294a90a78ae	73145-010	HUMAN OTC DRUG	Instant Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20201121		OTC MONOGRAPH DRUG	505G(a)(3)	ASC Marketing LTD	ALCOHOL	.7	mL/mL			N	20241231
73145-012_0b6e0202-cdf3-d783-e063-6394a90a3bf2	73145-012	HUMAN OTC DRUG	AZX Wellness Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210322		OTC MONOGRAPH DRUG	505G(a)(3)	ASC Marketing LTD	ALCOHOL	70	mL/100mL			N	20241231
73147-8273_2b0cb99e-f6cb-412d-9784-49fa5653ead8	73147-8273	HUMAN OTC DRUG	DOCUSATE SODIUM		DOCUSATE SODIUM	CAPSULE	ORAL	20231010		OTC MONOGRAPH DRUG	M007	Cellchem Pharmaceutical Inc	DOCUSATE SODIUM	100	mg/1			N	20241231
73150-150_f2a493dd-3d7e-5ecf-e053-2995a90abe22	73150-150	HUMAN PRESCRIPTION DRUG	BRIUMVI		ublituximab	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20221228		BLA	BLA761238	TG Therapeutics, Inc.	UBLITUXIMAB	150	mg/6mL			N	20241231
73152-026_f796abc7-9348-ad5f-e053-6294a90a92cb	73152-026	HUMAN PRESCRIPTION DRUG	Tolterodine Tartrate		Tolterodine Tartrate	TABLET	ORAL	20200803		ANDA	ANDA210775	Athem LLC	TOLTERODINE TARTRATE	1	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
73152-027_f796abc7-9348-ad5f-e053-6294a90a92cb	73152-027	HUMAN PRESCRIPTION DRUG	Tolterodine Tartarate		Tolterodine Tartarate	TABLET	ORAL	20200803		ANDA	ANDA210775	Athem LLC	TOLTERODINE TARTRATE	2	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
73152-028_f795dd02-2910-d691-e053-6294a90a88e0	73152-028	HUMAN PRESCRIPTION DRUG	Pryidostigmine Bromide		Pyridostigmine Bromide	SOLUTION	ORAL	20210225		ANDA	ANDA208797	Athem LLC	PYRIDOSTIGMINE BROMIDE	60	mg/5mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
73152-029_d9bb4169-103d-dd54-e053-2995a90a1df7	73152-029	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	TABLET	ORAL	20220114		ANDA	ANDA207556	Athem LLC	TIMOLOL MALEATE	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
73152-030_d9bb4169-103d-dd54-e053-2995a90a1df7	73152-030	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	TABLET	ORAL	20220114		ANDA	ANDA207556	Athem LLC	TIMOLOL MALEATE	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
73152-031_d9bb4169-103d-dd54-e053-2995a90a1df7	73152-031	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	TABLET	ORAL	20220114		ANDA	ANDA207556	Athem LLC	TIMOLOL MALEATE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
73152-076_f76bf2f7-1753-7656-e053-6394a90a8d22	73152-076	HUMAN PRESCRIPTION DRUG	Amantadine Hydrochloride		Amantadine Hydrochloride	CAPSULE	ORAL	20210219		ANDA	ANDA210129	ATHEM LLC	AMANTADINE HYDROCHLORIDE	100	mg/1	Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]		N	20241231
73152-141_f792b9a4-efd6-8663-e053-6394a90a6e9d	73152-141	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20210215		ANDA	ANDA211064	Athem	FOLIC ACID	1	mg/1			N	20241231
73153-900_1107bed2-4fa1-4953-b193-7d882c61f897	73153-900	CELLULAR THERAPY	BREYANZI		Lisocabtagene maraleucel	KIT		20210205		BLA	BLA125714	Juno Therapeutics, Inc.						N	20241231
73154-050_a81dd9be-17ba-4a21-b731-340ea72e0386	73154-050	HUMAN PRESCRIPTION DRUG	IBSRELA		tenapanor hydrochloride	TABLET	ORAL	20190912		NDA	NDA211801	Ardelyx, Inc.	TENAPANOR HYDROCHLORIDE	53.2	mg/1			N	20241231
73154-110_2443bb1b-63e8-4b35-a9e1-d4a393c2ede5	73154-110	HUMAN PRESCRIPTION DRUG	XPHOZAH 10 mg		Tenapanor	TABLET, FILM COATED	ORAL	20231017		NDA	NDA213931	Ardelyx, Inc.	TENAPANOR	10.6	mg/1	Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], Sodium-Hydrogen Exchanger 3 Inhibitor [EPC], Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]		N	20241231
73154-120_2443bb1b-63e8-4b35-a9e1-d4a393c2ede5	73154-120	HUMAN PRESCRIPTION DRUG	XPHOZAH 20 mg		Tenapanor	TABLET, FILM COATED	ORAL	20231017		NDA	NDA213931	Ardelyx, Inc.	TENAPANOR	21.3	mg/1	Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], Sodium-Hydrogen Exchanger 3 Inhibitor [EPC], Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]		N	20241231
73154-130_2443bb1b-63e8-4b35-a9e1-d4a393c2ede5	73154-130	HUMAN PRESCRIPTION DRUG	XPHOZAH 30 mg		Tenapanor	TABLET, FILM COATED	ORAL	20231017		NDA	NDA213931	Ardelyx, Inc.	TENAPANOR	31.9	mg/1	Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA], Sodium-Hydrogen Exchanger 3 Inhibitor [EPC], Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]		N	20241231
73162-0001_09ad71e3-a245-4ebe-921e-5cccf2692b3e	73162-0001	HUMAN OTC DRUG	Fat Loss Activation Complex		Fucus Vesiculosus, Kali Carbonicum, Agave Americana, Capsicum Annuum, Phytolacca Decandra, Aurum Metallicum, Calcarea Carbonica, Ferrum Metallicum, Graphites	LIQUID	ORAL	20200226	20250226	UNAPPROVED HOMEOPATHIC		Health Masters LLC	AGAVE AMERICANA LEAF; CAPSICUM; FUCUS VESICULOSUS; GOLD; GRAPHITE; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE	4; 4; 2; 8; 8; 8; 8; 4; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	
73162-0004_72ab052d-a89b-482b-989e-b754918bb79e	73162-0004	HUMAN OTC DRUG	Fat Loss Activation Complex		Fucus Vesiculosus, Kali Carbonicum, Asafoetida, Capsicum Annuum, Phytolacca Decandra, Aurum Metallicum, Calcarea Carbonica, Ferrum Metallicum, Graphites	LIQUID	ORAL	20230406		UNAPPROVED HOMEOPATHIC		Health Masters LLC	CAPSICUM; FERULA ASSA-FOETIDA RESIN; FUCUS VESICULOSUS; GOLD; GRAPHITE; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE	4; 4; 2; 8; 8; 8; 8; 4; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vegetable Proteins [CS]		N	20241231
73168-004_09751fc7-6657-c196-e063-6294a90a4a57	73168-004	HUMAN OTC DRUG	URIFLEX Fast Acting Analgesic Pain Relief		MENTHOL	CREAM	TOPICAL	20190520		OTC MONOGRAPH DRUG	M017	Rejuvica LLC	MENTHOL	45	mg/mL			N	20241231
73169-001_21d4e110-1a32-48ea-bf79-b64036d9b0b3	73169-001	HUMAN OTC DRUG	NO MORE NOSEBLEED		Oxymetazoline Hydrochloride	LIQUID	TOPICAL	20190608		OTC MONOGRAPH FINAL	part341	DR. FRIEDMAN'S NO MORE NOSEBLEED KIT INC.	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
73179-250_fb80f4b4-159e-484c-e053-6294a90af892	73179-250	HUMAN PRESCRIPTION DRUG	SKYCLARYS		omaveloxolone	CAPSULE	ORAL	20230228		NDA	NDA216718	Reata Pharmaceuticals, Inc.	OMAVELOXOLONE	50	mg/1			N	20241231
73180-005_f1ed8384-83d7-6f2a-e053-2a95a90ab08f	73180-005	HUMAN OTC DRUG	QR PAIN		Analgesic	CREAM	TOPICAL	20191201		OTC MONOGRAPH NOT FINAL	part348	MARYHELENE ENTERPRISES INC	MANNITOL; MENTHOL	30; 1.25	g/100g; g/100g	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
73180-075_f1edf5e5-632a-5e8b-e053-2995a90acd28	73180-075	HUMAN OTC DRUG	QR PAIN		Analgesic	CREAM	TOPICAL	20190801		OTC MONOGRAPH NOT FINAL	part348	MARYHELENE ENTERPRISES INC	MANNITOL; MENTHOL	30; 1.25	g/100g; g/100g	Increased Diuresis [PE], Osmotic Activity [MoA], Osmotic Diuretic [EPC]		N	20241231
73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85	73191-325	HUMAN OTC DRUG	Lavelier Divine Day Defense Broad Spectrum SPF 30		Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20190801		OTC MONOGRAPH NOT FINAL	part352	Florida Private Labeling LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5.2; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
73191-588_b0190322-7578-4c23-a68c-f6fe196379fa	73191-588	HUMAN OTC DRUG	Noella 24K Aged Defense SPF 30 Broad Spectrum		Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone	CREAM	TOPICAL	20210727		OTC MONOGRAPH NOT FINAL	part352	Florida Private Labeling LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OXYBENZONE	1.5; 6.2; 7.4; 5; 3.1	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
73200-191_09dc681e-2356-4213-e063-6394a90a41e1	73200-191	HUMAN OTC DRUG	BADASS BOTANICALS Hemp Pain Relief		MENTHOL	CREAM	TOPICAL	20191130		OTC MONOGRAPH DRUG	M017	Frontier Sales, LLC	MENTHOL	25	mg/mL			N	20241231
73207-101_b87c6225-a814-4e10-84fd-ebf19ce2f413	73207-101	HUMAN PRESCRIPTION DRUG	QINLOCK		Ripretinib	TABLET	ORAL	20200515		NDA	NDA213973	Deciphera Pharmaceuticals, LLC	RIPRETINIB	50	mg/1	Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA], Stem Cell Factor (KIT) Receptor Inhibitors [MoA]		N	20241231
73208-580_935a1618-36de-4b50-b8bc-f9800a3ffa53	73208-580	HUMAN OTC DRUG	Sal de Uvas Picot		Citric Acid monohydrate and Sodium bicarbonate	GRANULE, EFFERVESCENT	ORAL	20220107		OTC MONOGRAPH FINAL	part331	RB Health Mexico, S.A. de C.V.	CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE	1948.5; 2485	mg/1; mg/1	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
73214-001_f1e96716-1fa1-51b5-e053-2a95a90a774d	73214-001	HUMAN OTC DRUG	Carpal Comfort		Benzyl Alchohol, Lidocaine HCI	CREAM	TOPICAL	20190710		OTC MONOGRAPH NOT FINAL	part348	Comfort Lab, LP	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	10; 4	mg/100mL; mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
73234-037_082a45fa-5595-1572-e063-6294a90af378	73234-037	HUMAN OTC DRUG	UNITED Asutra TC Kit Colgate		SODIUM MONOFLUOROPHOSPHATE	KIT		20230807		OTC MONOGRAPH DRUG	M021	MING FAI ENTERPRISE (CAMBODIA) CO., LTD						N	20241231
73237-001_f1e96716-1fa0-51b5-e053-2a95a90a774d	73237-001	HUMAN OTC DRUG	AXELOFEIN		Minoxidil 2%	SOLUTION/ DROPS	TOPICAL	20190710		ANDA	ANDA078176	TRILOGIC, LTD	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73237-002_f1e96883-af8d-3cb9-e053-2995a90abee2	73237-002	HUMAN OTC DRUG	AZELOMAX FORTE		Minoxidil 5%	SOLUTION/ DROPS	TOPICAL	20190710		ANDA	ANDA076239	TRILOGIC LTD	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73238-002_074d566d-5a0e-c9cf-e063-6394a90ae68e	73238-002	HUMAN OTC DRUG	Skineez		Menthol, Retinol	CLOTH	TOPICAL	20230927		OTC MONOGRAPH DRUG	M016	CAUSE FOR CHANGE LLC	MENTHOL; VITAMIN A	.05; .01	g/4.66g; g/4.66g	Vitamin A [CS], Vitamin A [EPC]		N	20241231
73240-904_ff49699c-ceda-13d2-e053-6394a90af079	73240-904	HUMAN OTC DRUG	SUNMED pain freeze		MENTHOL	SPRAY	TOPICAL	20230629		OTC MONOGRAPH NOT FINAL	part348	Sunflora Inc.	MENTHOL	6	g/100mL			N	20241231
73243-045_09dc75e1-1a97-f3b6-e063-6294a90ac272	73243-045	HUMAN OTC DRUG	YOU-V SPF-30 Broad Spectrum Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20190722		OTC MONOGRAPH DRUG	M020	YouV, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 35	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73246-001_6a02afc9-1a33-4309-a020-0fdf0c4e3236	73246-001	HUMAN OTC DRUG	Touch Acne Treatment	Benzoyl Peroxide	Benzoyl Peroxide	GEL	TOPICAL	20190726		OTC MONOGRAPH FINAL	part333D	Diractions Capital LLC	BENZOYL PEROXIDE	25	mg/g			N	20241231
73246-002_301ad8ed-10c0-4fb3-b762-462779eec535	73246-002	HUMAN OTC DRUG	Touch Anti-Aging SPF 30 Moisturizer		Zinc Oxide, Octinoxate, and Octisalate	CREAM	TOPICAL	20200304		OTC MONOGRAPH NOT FINAL	part352	Diractions Capital LLC	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 70	mg/mL; mg/mL; mg/mL			N	20241231
73253-0001_d14ce413-93d5-461c-9332-2fcca7eb2672	73253-0001	HUMAN OTC DRUG	MFL	20/40	Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Cerebrum Suis, Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), AACG-A, AACG-B, Calcarea Carbonica, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, Gambogia, 7-Oxo-Dehydroepiandrosterone 3-Acetate, Adenosinum Triphosphoricum Dinatrum, Insulinum (Suis), Sarcolacticum Acidum, Proteus (Vulgaris)	LIQUID	ORAL	20191010	20241007	UNAPPROVED HOMEOPATHIC		Mass Fatloss Com	7-OXODEHYDROEPIANDROSTERONE 3-ACETATE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	30; 30; 8; 8; 6; 6; 14; 12; 12; 30; 30; 8; 12; 12; 8; 8; 30; 12; 8; 6; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
73254-310_09acadb7-c0a2-d753-e063-6294a90af9a9	73254-310	HUMAN PRESCRIPTION DRUG	ExEm Foam		Air Polymer-Type A Intrauterine Foam	KIT	INTRAUTERINE	20201016		NDA	NDA212279	GISKIT PHARMA B.V.						N	20241231
73266-001_082bbf1d-efff-b904-e063-6294a90a28ce	73266-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20090926		UNAPPROVED MEDICAL GAS		One Home Medical Equipment, LLC	OXYGEN	99	L/100L			N	20241231
73274-001_c29e2c3a-9ec9-0b62-e053-2a95a90ac69c	73274-001	HUMAN OTC DRUG	My Cycles BFF		Black Cohosh, Blue Cohosh, Calcium Carbonate, Chamomile, Graphites, High Cranberry, Poke Root, Potassium Carbonate, Potassium Hydrate, Sodium Chloride, Sulfur, Wind Flower	TABLET, CHEWABLE	ORAL	20210518		UNAPPROVED HOMEOPATHIC		Knockout Remedy, LLC	BLACK COHOSH; CALCIUM CARBONATE; CAULOPHYLLUM THALICTROIDES ROOT; CHAMOMILE; GRAPHITE; PHYTOLACCA AMERICANA ROOT; POTASSIUM CARBONATE; POTASSIUM HYDROXIDE; PULSATILLA VULGARIS; SODIUM CHLORIDE; SULFUR; VIBURNUM OPULUS ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
73277-001_f1e96883-af8e-3cb9-e053-2995a90abee2	73277-001	HUMAN OTC DRUG	Shapiro MD 5% Minoxidil Hair Regrowth Treatment for Men		Minoxidil	SOLUTION	TOPICAL	20190728		ANDA	ANDA076239	CONVERSION LABS PR, LLC	MINOXIDIL	5	mg/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73277-002_f1e96883-af8f-3cb9-e053-2995a90abee2	73277-002	HUMAN OTC DRUG	Shapriero 2% Hair Regrowth Treatment for Women		Minoxidil	SOLUTION	TOPICAL	20190728		ANDA	ANDA078176	CONVERSION LABS PR, LLC	MINOXIDIL	2	mg/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73278-202_f9b38271-4d8c-a628-e053-6394a90ac853	73278-202	HUMAN OTC DRUG	Holus Relief Gel, 1.7 oz		Menthol, Camphor	GEL	TOPICAL	20230424		OTC MONOGRAPH NOT FINAL	part348	Nemadji Management, LLC	CAMPHOR OIL; MENTHOL, UNSPECIFIED FORM	.4; 3.9	g/100g; g/100g			N	20241231
73278-210_f9b1210d-e8c1-2863-e053-6394a90a27c4	73278-210	HUMAN OTC DRUG	Holus Relief Cream		MENTHOL, CAMPHOR	CREAM	TOPICAL	20230424		OTC MONOGRAPH NOT FINAL	part348	Nemadji Management, LLC	CAMPHOR OIL; MENTHOL, UNSPECIFIED FORM	.4; 3.9	g/100g; g/100g			N	20241231
73282-0001_0cce708a-2111-53e4-e063-6294a90a9128	73282-0001	HUMAN OTC DRUG	Colic Calm		Carbo Vegetabilis, Carum Carvi, Chamomilla, Foeniculum Vulgare, Melissa Officinalis, Mentha Piperita, Prunus Spinosa, Zingiber Officinale	LIQUID	ORAL	20190830	20250331	UNAPPROVED HOMEOPATHIC		CalmCo LLC	ACTIVATED CHARCOAL; CARAWAY SEED; CHAMOMILE; FENNEL SEED; GINGER; MELISSA OFFICINALIS; MENTHA PIPERITA; PRUNUS SPINOSA FLOWER BUD	1; 3; 3; 3; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	
73282-0003_0cde7ea1-af76-a447-e063-6394a90ada20	73282-0003	HUMAN OTC DRUG	Colic Calm Plus		Aloe, Asafoetida, Carbo Vegetabilis, Carum Carvi, Chamomilla, Cinchona Officinalis, Foeniculum Vulgare, Magnesia Phosphorica, Melissa Officinalis, Mentha Piperita, Prunus Spinosa, Zingiber Officinale	LIQUID	ORAL	20190830	20250531	UNAPPROVED HOMEOPATHIC		CalmCo LLC	ACTIVATED CHARCOAL; ALOE; CARAWAY OIL; CHAMOMILE; CINCHONA OFFICINALIS BARK; FENNEL SEED; FERULA ASSA-FOETIDA RESIN; GINGER; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MELISSA OFFICINALIS; MENTHA PIPERITA; PRUNUS SPINOSA FLOWER BUD	1; 8; 3; 3; 3; 3; 3; 3; 8; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	
73282-0005_fd6759e7-ea24-ff5f-e053-6294a90a265b	73282-0005	HUMAN OTC DRUG	Tummy Calm		Carbo Vegetabilis, Chamomilla, Lycopodium Clavatum, Nux Moschata, Passiflora Incarnata, Raphanus Sativus, sarsaparilla (Smilax Regelii), Zingiber Officinale	LIQUID	ORAL	20211027		UNAPPROVED HOMEOPATHIC		CalmCo LLC	ACTIVATED CHARCOAL; GINGER; LYCOPODIUM CLAVATUM SPORE; MATRICARIA CHAMOMILLA WHOLE; NUTMEG; PASSIFLORA INCARNATA FLOWERING TOP; RADISH; SMILAX ORNATA ROOT	1; 3; 3; 3; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
73282-0011_0cdea24e-9736-6fc1-e063-6294a90afca9	73282-0011	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen 160mg/5mL	SOLUTION	ORAL	20210806		OTC MONOGRAPH DRUG	M013	Calmco LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-0012_0c94060a-bddd-6ceb-e063-6394a90a745f	73282-0012	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine Hydrochloride	SOLUTION	ORAL	20210806		OTC MONOGRAPH DRUG	M012	CalmCo LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73282-0013_0c94833f-4c25-dbe1-e063-6294a90a3592	73282-0013	HUMAN OTC DRUG	DrKids Childrens Cough and Chest Congestion DM		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	SOLUTION	ORAL	20231215		OTC MONOGRAPH DRUG	M012	CalmCo LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
73282-0115_0cdea24e-9736-6fc1-e063-6294a90afca9	73282-0115	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen 160mg/5mL	SOLUTION	ORAL	20210806		OTC MONOGRAPH DRUG	M013	Calmco LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-0125_010235de-82fd-17f7-e063-6294a90abcd3	73282-0125	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine 12.5mg/5mL	SOLUTION	ORAL	20220101		OTC MONOGRAPH FINAL	part341	CalmCo LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73282-0164_0102eaa5-3cd0-0477-e063-6394a90a6037	73282-0164	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SOLUTION	ORAL	20220201		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-1164_0102812b-dae9-9cce-e063-6294a90ab555	73282-1164	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SOLUTION	ORAL	20220201		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-1254_01403355-5b22-c8e5-e063-6394a90a2810	73282-1254	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCL 12.5mg/5mL	SOLUTION	ORAL	20220101		OTC MONOGRAPH FINAL	part341	CalmCo LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73282-2016_01407e3f-6554-f319-e063-6294a90a19ca	73282-2016	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen 160mg/5mL	SOLUTION	ORAL	20221116		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-2116_010235de-82f7-17f7-e063-6294a90abcd3	73282-2116	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen 160mg/5mL	SOLUTION	ORAL	20220501		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-2160_010235d6-a5c9-9ee4-e063-6294a90a5719	73282-2160	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen 160mg/5mL	SOLUTION	ORAL	20220805		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-2164_01407e3f-6552-f319-e063-6294a90a19ca	73282-2164	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen 160mg/5mL	SOLUTION	ORAL	20220901		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73282-2480_ff4b0528-39a1-80d5-e053-6394a90a8a83	73282-2480	HUMAN OTC DRUG	DrKids Childrens Pain and Fever		Acetaminophen 80mg/piece	BAR, CHEWABLE	ORAL	20230701		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	80	mg/1			N	20241231
73282-2518_0c534cbd-40e7-8af0-e063-6394a90a5605	73282-2518	HUMAN OTC DRUG	CalmCo Sleep Aid Gummy Bite		diphenhydramine HCl	BAR, CHEWABLE	ORAL	20231212		OTC MONOGRAPH DRUG	M010	CalmCo LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73282-2520_08288825-0f39-b6a3-e063-6394a90aa358	73282-2520	HUMAN OTC DRUG	Adult Allergy Relief		CalmCo Allergy Relief	BAR, CHEWABLE	ORAL	20231020		OTC MONOGRAPH DRUG	M012	CalmCo	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73282-3164_0141d76f-b558-8936-e063-6394a90a93b7	73282-3164	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen 160mg/5mL	SOLUTION	ORAL	20220901		OTC MONOGRAPH NOT FINAL	part343	CalmCo LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
73284-508_07ff16a6-0454-e062-e063-6294a90aa027	73284-508	HUMAN OTC DRUG	Valmont Daily Veil. Moisturizing Face Fluid Mineral Sunscreen		Zinc Oxide	CREAM	TOPICAL	20240107		OTC MONOGRAPH DRUG	M020	Innovation Labs, Inc.	ZINC OXIDE	175	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73287-001_d3b389fe-d7b8-14c4-e053-2995a90ac37d	73287-001	HUMAN OTC DRUG	Hempvana	Pain Relief	Trolamine Salicylate	CREAM	TOPICAL	20190110		OTC MONOGRAPH NOT FINAL	part348	Telebrands Corp	TROLAMINE SALICYLATE	10	g/100g			N	20241231
73287-004_c71ab94e-b7a8-6180-e053-2a95a90af6a0	73287-004	HUMAN OTC DRUG	Hempvana Cold As Ice	Pain Relief	Menthol	GEL	TOPICAL	20190611		OTC MONOGRAPH NOT FINAL	part348	Telebrands Corp	MENTHOL	8	mg/100mL			N	20241231
73287-005_976a43ad-a7d8-78fb-e053-2a95a90a2343	73287-005	HUMAN OTC DRUG	Hempvana Cold As Ice	Pain Relief Gel-Patch	Menthol	PATCH	TOPICAL	20191115		OTC MONOGRAPH NOT FINAL	part348	Telebrands Corp	MENTHOL	5	g/100g			N	20241231
73287-012_a9e103f2-7790-e49b-e053-2a95a90aa8b7	73287-012	HUMAN OTC DRUG	Hempvana Cold as Ice Gel		Menthol	GEL	TOPICAL	20200707		OTC MONOGRAPH NOT FINAL	part348	Telebrands Corp	MENTHOL	8	mg/100mL			N	20241231
73287-014_c22cf1a5-0d5e-5ea5-e053-2995a90a333b	73287-014	HUMAN OTC DRUG	Hempvana Ultra Strength Pain Relief Gel - Arthritis		Menthol 8%	GEL	TOPICAL	20210512		OTC MONOGRAPH NOT FINAL	part348	Telebrands Corp	MENTHOL	8	g/8g			N	20241231
73287-016_c315e185-df06-5de0-e053-2995a90acf37	73287-016	HUMAN OTC DRUG	Hempvana Ultra Strength Pain Relief Cream		Lidocaine 4%	CREAM	TOPICAL	20210524		OTC MONOGRAPH NOT FINAL	part348	Telebrands Corp	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73287-020_049f0569-f237-e930-e063-6294a90aaeed	73287-020	HUMAN OTC DRUG	Hempvana Knee Bird Ultra Strength Pain Relief		Lidocaine, Menthol	PATCH	TOPICAL	20220114		OTC MONOGRAPH NOT FINAL	part348	TELEBRANDS CORP	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73287-021_d58da6c5-47a7-b8a8-e053-2995a90a7ce7	73287-021	HUMAN OTC DRUG	Hempvana Maximum Strength Pain Relief - Platinum		Trolamine salicylate	CREAM	TOPICAL	20220114		OTC MONOGRAPH NOT FINAL	part348	TELEBRANDS CORP	TROLAMINE SALICYLATE	10	g/100g			N	20241231
73287-022_d91a0fad-a38d-1580-e053-2a95a90ad268	73287-022	HUMAN OTC DRUG	Hempvana Maximum Strength Pain Relief		Trolamine Salicylate	LOTION	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part348	TELEBRANDS CORP	TROLAMINE SALICYLATE	10	g/100g			N	20241231
73287-023_d91b2e09-550f-4968-e053-2995a90ae323	73287-023	HUMAN OTC DRUG	Ultra Strength Pain Relief Gel		Menthol	LOTION	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part348	TELEBRANDS CORP	MENTHOL	8	g/100g			N	20241231
73287-024_d91ba9b1-0840-32e9-e053-2a95a90a9bd1	73287-024	HUMAN OTC DRUG	Hempvana Ultra Strength Pain Relief		Lidocaine	LOTION	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part348	TELEBRANDS CORP	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73287-025_e0027b82-087a-da3c-e053-2995a90a3f0c	73287-025	HUMAN OTC DRUG	Hempvana Knee Bird Ultra Strength Pain Relief		Lidocaine, Menthol	PATCH	TOPICAL	20220519		OTC MONOGRAPH NOT FINAL	part348	TELEBRANDS CORP	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73287-026_f525075a-d7ef-dad0-e053-2a95a90a6f3f	73287-026	HUMAN OTC DRUG	Hempvana Maximum Strength Pain Relief Topical Anesthetic		Lidocaine	CREAM	TOPICAL	20230217		OTC MONOGRAPH FINAL	M015	Telebrands Corp	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73287-027_f93a1ed0-5047-0355-e053-6294a90a6a90	73287-027	HUMAN OTC DRUG	Hempvana Ultra Pain Relief - Nerve Relief		Arnica montana, Aconitum napellus, Hypericum perforatum, Ledum palustre, Magnesia phosphorica, Secale cornutum, Silicea	CREAM	TOPICAL	20230412		UNAPPROVED HOMEOPATHIC		TELEBRANDS CORP	ACONITUM NAPELLUS; ARNICA MONTANA; CLAVICEPS PURPUREA SCLEROTIUM; HYPERICUM PERFORATUM; LEDUM PALUSTRE WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SILICON DIOXIDE	12; 12; 12; 12; 12; 12; 12	[hp_X]/85g; [hp_X]/85g; [hp_X]/85g; [hp_X]/85g; [hp_X]/85g; [hp_X]/85g; [hp_X]/85g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
73287-028_042cdf33-f9cb-2928-e063-6294a90a3f5e	73287-028	HUMAN OTC DRUG	Hemorrhoid Pain Relief		Lidocaine	CREAM	TOPICAL	20230829		OTC MONOGRAPH FINAL	M015	Telebrands Corp	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73288-001_f5e3d10a-cb51-57d3-e053-2995a90a1612	73288-001	HUMAN OTC DRUG	Alcohol Prep Pads		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20190818		OTC MONOGRAPH NOT FINAL	part333A	NINGBO TIANBO FIRST AID PRODUCT CO., LTD.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
73288-002_f5e3b559-fb72-2152-e053-2995a90a9858	73288-002	HUMAN OTC DRUG	Povidone Iodine Prep Pad		POVIDONE-IODINE	SOLUTION	TOPICAL	20190819		OTC MONOGRAPH FINAL	part333C	NINGBO TIANBO FIRST AID PRODUCT CO., LTD.	POVIDONE-IODINE	1	g/100g			N	20241231
73288-003_f5e3cb73-272f-1e54-e053-2995a90a8e98	73288-003	HUMAN OTC DRUG	BZK Antiseptic Swab		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20190829		OTC MONOGRAPH NOT FINAL	part333A	NINGBO TIANBO FIRST AID PRODUCT CO., LTD.	BENZALKONIUM CHLORIDE	.4	g/100mL			N	20241231
73288-004_f5e3cb73-272e-1e54-e053-2995a90a8e98	73288-004	HUMAN OTC DRUG	Sting Relief Prep Pad		BENZOCAINE	SOLUTION	TOPICAL	20190818		OTC MONOGRAPH NOT FINAL	part348	NINGBO TIANBO FIRST AID PRODUCT CO., LTD.	BENZOCAINE	10	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
73288-005_f5e3cdcf-9729-911d-e053-2995a90aa9c2	73288-005	HUMAN OTC DRUG	First Aid Antibiotic		BACITRACIN ZINC	OINTMENT	TOPICAL	20191001		OTC MONOGRAPH FINAL	part333B	NINGBO TIANBO FIRST AID PRODUCT CO., LTD.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
73289-0060_f1da053e-9d8f-68ee-e053-2995a90a9882	73289-0060	HUMAN PRESCRIPTION DRUG	Formoterol Fumarate		formoterol fumarate dihydrate	SOLUTION	RESPIRATORY (INHALATION)	20221215		ANDA	ANDA216486	Aucta Pharmaceuticals, Inc	FORMOTEROL FUMARATE	.02	mg/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
73289-0063_0d087b93-b0a2-5cf9-e063-6294a90aa058	73289-0063	HUMAN PRESCRIPTION DRUG	MOTPOLY XR		lacosamide	CAPSULE, EXTENDED RELEASE	ORAL	20230505		NDA	NDA216185	Aucta Pharmaceuticals, Inc.	LACOSAMIDE	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
73289-0064_0d087b93-b0a2-5cf9-e063-6294a90aa058	73289-0064	HUMAN PRESCRIPTION DRUG	MOTPOLY XR		lacosamide	CAPSULE, EXTENDED RELEASE	ORAL	20230505		NDA	NDA216185	Aucta Pharmaceuticals, Inc.	LACOSAMIDE	150	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
73289-0065_0d087b93-b0a2-5cf9-e063-6294a90aa058	73289-0065	HUMAN PRESCRIPTION DRUG	MOTPOLY XR		lacosamide	CAPSULE, EXTENDED RELEASE	ORAL	20230505		NDA	NDA216185	Aucta Pharmaceuticals, Inc.	LACOSAMIDE	200	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]	CV	N	20241231
73291-0003_eff3083e-17e2-9144-e053-2995a90ab85c	73291-0003	HUMAN OTC DRUG	sunbetter Broad Spectrum SPF 75 Sunscreen Tone Smart		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part352	SKINBETTER SCIENCE LLC	TITANIUM DIOXIDE; ZINC OXIDE	35; 100	mg/mL; mg/mL			N	20241231
73291-0004_eff2da45-99c6-af4e-e053-2a95a90afed1	73291-0004	HUMAN OTC DRUG	sunbetter Broad Spectrum SPF 70 Sunscreen Sheer		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part352	SKINBETTER SCIENCE LLC	TITANIUM DIOXIDE; ZINC OXIDE	36; 100	mg/mL; mg/mL			N	20241231
73292-011_660fd183-2dc3-4e7c-9695-6105573165c9	73292-011	HUMAN PRESCRIPTION DRUG	Viltepso		viltolarsen	INJECTION, SOLUTION	INTRAVENOUS	20200813		NDA	NDA212154	NS Pharma, Inc.	VILTOLARSEN	250	mg/1			N	20241231
73293-0001_0a4f9566-6c88-1e27-e063-6394a90acaf8	73293-0001	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	INTRAVENOUS	20200507		ANDA	ANDA212821	Huons Co., Ltd.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73293-0002_04cff7aa-3be2-fea3-e063-6394a90aa57a	73293-0002	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine hydrochloride	INJECTION	SUBARACHNOID	20191230		ANDA	ANDA212822	Huons Co., Ltd.	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
73293-0003_0a4f9566-6c88-1e27-e063-6394a90acaf8	73293-0003	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	INTRAVENOUS	20230615		ANDA	ANDA212821	Huons Co., Ltd.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73294-005_09dc4870-a286-48af-e063-6394a90aa79e	73294-005	HUMAN OTC DRUG	RUBBING DOTS NATURAL COOL PAIN RELIEF		MENTHOL	CREAM	TOPICAL	20200521		OTC MONOGRAPH DRUG	M017	Awesome Trading, LLC	MENTHOL	50	mg/mL			N	20241231
73300-0001_15151b9b-eee9-4d06-8027-ff425174dcaf	73300-0001	HUMAN OTC DRUG	Muscles		Hypericum Perforatum, Ruta Graveolens, Arnica Montana	GEL	TOPICAL	20190930		UNAPPROVED HOMEOPATHIC		Spirit Homeopathy LLC	ARNICA MONTANA; HYPERICUM PERFORATUM; RUTA GRAVEOLENS FLOWERING TOP	30; 6; 12	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
73302-201_9b5b78ea-3d72-4078-acc0-b58f59b03a16	73302-201	HUMAN OTC DRUG	Mederma Advanced Scar		Allantoin	GEL	TOPICAL	20131101		OTC MONOGRAPH DRUG	M016	HRA PHARMA AMERICA, INC.	ALLANTOIN	5	mg/g			N	20241231
73302-202_0bb4b095-da3b-4a45-a08a-89b359a9a9d0	73302-202	HUMAN OTC DRUG	Mederma for Kids		Allantoin	GEL	TOPICAL	20201001		OTC MONOGRAPH DRUG	M016	HRA PHARMA AMERICA, INC.	ALLANTOIN	1	g/100g			N	20241231
73302-203_a57c4d76-da44-4b12-bc2d-67eca9ccd9c1	73302-203	HUMAN OTC DRUG	Mederma PM		Dimethicone	CREAM	TOPICAL	20201001		OTC MONOGRAPH DRUG	M016	HRA PHARMA AMERICA, INC.	DIMETHICONE	20	mg/g	Skin Barrier Activity [PE]		N	20241231
73302-204_1fa5acb8-7152-4e9c-89ed-5d1fd5db3b93	73302-204	HUMAN OTC DRUG	Mederma Stretch Marks Therapy		dimethicone	CREAM	TOPICAL	20201001		OTC MONOGRAPH DRUG	M016	HRA PHARMA AMERICA, INC.	DIMETHICONE	2	g/100g	Skin Barrier Activity [PE]		N	20241231
73302-205_385104bf-02e0-4938-aeb1-9b705baa7bf1	73302-205	HUMAN OTC DRUG	Mederma Scar Cream		AVOBENZONE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20210820		OTC MONOGRAPH DRUG	M020	HRA PHARMA AMERICA, INC.	AVOBENZONE; OCTOCRYLENE; OXYBENZONE	30; 100; 60	mg/g; mg/g; mg/g			N	20241231
73302-456_92f32308-14b2-466f-a600-dab9449f44e8	73302-456	HUMAN PRESCRIPTION DRUG	Ella		ulipristal acetate	TABLET	ORAL	20200511		NDA	NDA022474	HRA PHARMA AMERICA, INC.	ULIPRISTAL ACETATE	30	mg/1	Progesterone Agonist/Antagonist [EPC], Selective Progesterone Receptor Modulators [MoA]		N	20241231
73306-1139_ed4a9844-f20c-da5d-e053-2995a90adc09	73306-1139	HUMAN OTC DRUG	DEO PEDICO ABOVE NEYMAR JR MEN		DEO PEDICO ABOVE NEYMAR JR MEN	AEROSOL, SPRAY	TOPICAL	20221112		OTC MONOGRAPH FINAL	M005	BASTON INDUSTRIA DE AEROSSOIS LTDA	FARNESOL	3	mg/100g			N	20241231
73306-1140_f4c33db5-ad9f-43a6-e053-2995a90a2e87	73306-1140	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE ONE BY SPORT MEN		ANTIPERSPIRANT ABOVE ONE BY SPORT MEN	AEROSOL, SPRAY	TOPICAL	20230215		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM CHLOROHYDRATE	100	g/100g			N	20241231
73306-1141_f4c2f82f-db8b-9dfb-e053-2995a90ae679	73306-1141	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE ONE BY PASSION WOMEN		ANTIPERSPIRANT ABOVE ONE BY PASSION WOMEN	AEROSOL, SPRAY	TOPICAL	20230215		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM CHLOROHYDRATE	16	g/100g			N	20241231
73306-1142_f4c0292e-7b11-2b3e-e053-2995a90ac707	73306-1142	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE ONE BY LOVE WOMEN		ANTIPERSPIRANT ABOVE ONE BY LOVE WOMEN	AEROSOL, SPRAY	TOPICAL	20230215		OTC MONOGRAPH FINAL	M019	Baston Indstria de Aerossis Ltda	ALUMINUM CHLOROHYDRATE	16	g/100g			N	20241231
73306-1143_f4c3df0a-d16f-0f1f-e053-2995a90a87d8	73306-1143	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE DERMACLINICAL WOMEN		ANTIPERSPIRANT ABOVE DERMACLINICAL WOMEN	AEROSOL, SPRAY	TOPICAL	20230216		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
73306-1144_f4d5c354-9100-8af7-e053-2a95a90ab0b9	73306-1144	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE DERMACLINICAL MEN		ANTIPERSPIRANT ABOVE DERMACLINICAL MEN	AEROSOL, SPRAY	TOPICAL	20230216		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
73306-1148_f5736421-4924-13e3-e053-2a95a90a17fb	73306-1148	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE DERMACLINICAL UNSCENTED		ANTIPERSPIRANT ABOVE DERMACLINICAL UNSCENTED	AEROSOL, SPRAY	TOPICAL	20230224		OTC MONOGRAPH FINAL	M019	BASTON IDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	16	g/100g			N	20241231
73306-1150_f6534fb5-9c5c-544f-e053-2a95a90a9dd0	73306-1150	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE ONE BY ENERGY MEN		ANTIPERSPIRANT ABOVE ONE BY ENERGY MEN	AEROSOL, SPRAY	TOPICAL	20230307		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM CHLOROHYDRATE	16	g/100g			N	20241231
73306-1151_f6535c56-9a64-c054-e053-2a95a90a2e23	73306-1151	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE ONE BY MOVING WOMEN		ANTIPERSPIRANT ABOVE ONE BY MOVING WOMEN	AEROSOL, SPRAY	TOPICAL	20230307		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM CHLOROHYDRATE	16	g/100g			N	20241231
73306-1153_f681af20-2a78-037d-e053-2a95a90a9d31	73306-1153	HUMAN OTC DRUG	Above foot Protect Neymar Jr Unissex		Above foot Protect Neymar Jr Unissex	AEROSOL, SPRAY	TOPICAL	20230309		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	FARNESOL	3	mg/100g			N	20241231
73306-1156_fe8f7ad4-2a5b-ae30-e053-6394a90acb98	73306-1156	HUMAN OTC DRUG	ABOVE EXTREME MEN MOVEMENT 72 HOURS		ABOVE EXTREME MEN MOVEMENT 72 HOURS	AEROSOL, SPRAY	TOPICAL	20230620		OTC MONOGRAPH FINAL	M01	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	19	mg/90g			N	20241231
73306-1157_fe8f7ad4-2a5d-ae30-e053-6394a90acb98	73306-1157	HUMAN OTC DRUG	ABOVE EXTREME MEN SPORT 72 HOURS		ABOVE EXTREME MEN SPORT 72 HOURS	AEROSOL, SPRAY	TOPICAL	20230620		OTC MONOGRAPH FINAL	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	19	mg/90g			N	20241231
73306-1160_013d6133-cf6f-9c15-e063-6294a90a53e7	73306-1160	HUMAN OTC DRUG	Above Mouthwash Antiseptic		Above Mouthwash Antiseptic	MOUTHWASH	BUCCAL; DENTAL	20230724		OTC MONOGRAPH FINAL	M021	BASTON INDUSTRIA DE AEROSSOIS LTDA	CETYLPYRIDINIUM CHLORIDE; MENTHOL; METHYL SALICYLATE	.075; .3; .25	mg/500g; mg/500g; mg/500g			N	20241231
73306-1161_02f37e55-72fc-532b-e063-6394a90ab0c3	73306-1161	HUMAN OTC DRUG	ABOVE INTIMATE LIQUIDSOAP		ABOVE INTIMATE	LIQUID	TOPICAL	20230815		OTC MONOGRAPH FINAL	M003	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALOE	.01	mg/250g			N	20241231
73306-1162_0981aed6-600d-a86f-e063-6294a90a0f90	73306-1162	HUMAN OTC DRUG	ANTIPERSPIRANT ABOVE EXTREME SUN MEN		ANTIPERSPIRANT ABOVE EXTREME SUN MEN	AEROSOL, SPRAY	TOPICAL	20231106		OTC MONOGRAPH DRUG	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	19	mg/90g			N	20241231
73306-1164_0cd1b36a-a073-a1db-e063-6294a90a5994	73306-1164	HUMAN OTC DRUG	ABOVE NBA MEN WOOD BREEZE ANTIPERSPIRANT DEODORANT 72H		ABOVE NBA MEN WOOD BREEZE ANTIPERSPIRANT DEODORANT 72H	AEROSOL, SPRAY	TOPICAL	20231218		OTC MONOGRAPH DRUG	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	19.2	mg/100g			N	20241231
73306-1165_0cddfada-92de-fbcc-e063-6294a90a4f59	73306-1165	HUMAN OTC DRUG	ABOVE NBA WOMEN SPORT PLUS ANTIPERSPIRANT DEODORANT 72H		ABOVE NBA WOMEN SPORT PLUS ANTIPERSPIRANT DEODORANT 72H	AEROSOL, SPRAY	TOPICAL	20231219		OTC MONOGRAPH DRUG	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	19.2	mg/100g			N	20241231
73306-1166_0cde4f09-9bd3-4241-e063-6294a90a6853	73306-1166	HUMAN OTC DRUG	ABOVE NBA MEN TEAMS ANTIPERSPIRANT DEODORANT 72H		ABOVE NBA MEN TEAMS ANTIPERSPIRANT DEODORANT 72H	AEROSOL, SPRAY	TOPICAL	20231219		OTC MONOGRAPH DRUG	M019	BASTON INDUSTRIA DE AEROSSOIS LTDA	ALUMINUM SESQUICHLOROHYDRATE	19.2	mg/100g			N	20241231
73308-358_725f493e-b206-4fa1-935c-8410a5a16353	73308-358	HUMAN PRESCRIPTION DRUG	Clemastine Fumarate		Clemastine Fumarate	SYRUP	ORAL	20210209		ANDA	ANDA073399	Ayurax, LLC	CLEMASTINE FUMARATE	.67	mg/5mL			N	20241231
73308-403_affe8774-57df-4fa0-8b55-31df97fe641d	73308-403	HUMAN PRESCRIPTION DRUG	Oxaprozin		oxaprozin	CAPSULE	ORAL	20231114		NDA	NDA217927	Ayurax, LLC	OXAPROZIN	300	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
73308-407_5116108a-0ca6-4027-98cc-5451afef6483	73308-407	HUMAN PRESCRIPTION DRUG	Amcinonide		amcinonide	OINTMENT	TOPICAL	20230501		ANDA	ANDA076096	Ayurax, LLC	AMCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73311-140_0cdffcc2-4c64-b7fc-e063-6294a90a5fd9	73311-140	HUMAN OTC DRUG	TaurImmune Fatigue		ABIES NIGRA, ALOE SOCOTRINA, ARNICA MONTANA, CACTUS GRANDIFLORA, CALCAREA CARBONICA, LYCOPODIUM CLAVATUM, TAUROXICUM	PELLET	SUBLINGUAL	20191209		UNAPPROVED HOMEOPATHIC		CureImmune	ALOE; ARNICA MONTANA; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PICEA MARIANA RESIN; SELENICEREUS GRANDIFLORUS STEM; ZINC CARBOBENZOXY-.BETA.-ALANYLTAURINATE	6; 6; 6; 8; 6; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
73311-141_0cdff8a6-4863-4a19-e063-6394a90a94bc	73311-141	HUMAN OTC DRUG	Taurox Immune Support		ABIES NIGRA, ALOE SOCOTRINA, ARNICA MONTANA, CACTUS GRANDIFLORA, CALCAREA CARBONICA, LYCOPODIUM CLAVATUM, TAUROXICUM	PELLET	SUBLINGUAL	20191209		UNAPPROVED HOMEOPATHIC		CureImmune	ALOE; ARNICA MONTANA; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PICEA MARIANA RESIN; SELENICEREUS GRANDIFLORUS STEM; ZINC CARBOBENZOXY-.BETA.-ALANYLTAURINATE	6; 6; 6; 8; 6; 6; 4	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
73313-075_09dc94a7-aabf-f8c4-e063-6294a90adeee	73313-075	HUMAN OTC DRUG	SUGAR BRANDS Rescue Pain Relief and Recovery		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20190820		OTC MONOGRAPH DRUG	M017	Sugar Brands, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73318-1040_f26fd1e1-7ce2-b45b-e053-2995a90a162d	73318-1040	HUMAN OTC DRUG	Salicylic Acid Pimple Patches		Acne Patches with Salicylic Acid	PATCH	TOPICAL	20230117		OTC MONOGRAPH FINAL	part333D	Skin PS Brands	SALICYLIC ACID	5	mg/g			N	20241231
73318-4320_0cddc686-dbc1-ed43-e063-6294a90adca6	73318-4320	HUMAN OTC DRUG	Resurfacing acne swipes		Salicylic Acid	SWAB	TOPICAL	20191201		OTC MONOGRAPH DRUG	M006	SKIN PS Brands	SALICYLIC ACID	.02	mg/mL			N	20241231
73318-7001_fc0484cd-83e1-c272-e053-6294a90a6c45	73318-7001	HUMAN OTC DRUG	Salicylic Acid Cleanser		Exfoliating and Clarifying Face Wash	GEL	TOPICAL	20230701		OTC MONOGRAPH FINAL	M006	Skin PS Brands	SALICYLIC ACID	5	mg/g			N	20241231
73318-7002_feb0eebc-4952-975c-e053-6394a90aceea	73318-7002	HUMAN OTC DRUG	BP Acne Spot Treatment		Acne Spot Treatment	LOTION	TOPICAL	20230622		OTC MONOGRAPH FINAL	M006	Skin PS Brands	BENZOYL PEROXIDE	100	mg/g			N	20241231
73318-7003_0c575296-6e5b-b622-e063-6294a90a1657	73318-7003	HUMAN OTC DRUG	SA Acne Spot Treatment		Acne Spot Treatment	LOTION	TOPICAL	20230705		OTC MONOGRAPH DRUG	M006	Skin PS Brands	SALICYLIC ACID	20	mg/g			N	20241231
73318-7004_02601602-badd-f18d-e063-6394a90a4006	73318-7004	HUMAN OTC DRUG	AHA/BHA Swipes		Resurfacing Treatment Pads	SWAB	TOPICAL	20230701		OTC MONOGRAPH FINAL	M006	SKIN PS Brands	SALICYLIC ACID	2	g/100mL			N	20241231
73318-7005_0754f853-293b-d2fc-e063-6394a90af3bb	73318-7005	HUMAN OTC DRUG	BP Body Wash		Body Wash	GEL	TOPICAL	20230701		OTC MONOGRAPH DRUG	M006	Skin PS Brands	BENZOYL PEROXIDE	50	mg/g			N	20241231
73318-7006_0792f477-d45f-76f5-e063-6294a90a5426	73318-7006	HUMAN OTC DRUG	Benzoyl Peroxide Acne		Acne Lotion	LOTION	TOPICAL	20230701		OTC MONOGRAPH DRUG	M006	Skin PS Brands	BENZOYL PEROXIDE	25	mg/g			N	20241231
73318-7007_099ddba5-8e35-1e11-e063-6294a90af4c0	73318-7007	HUMAN OTC DRUG	Body Acne Treatment		Body Spray	SPRAY	TOPICAL	20230801		OTC MONOGRAPH DRUG	M006	Skin PS Brands	SALICYLIC ACID	20	mg/g			N	20241231
73320-001_21dc3dc4-c5a7-4075-95e9-64668dc205d8	73320-001	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210701		ANDA	ANDA214374	Kartha Pharmaceuticals, Inc.	BACLOFEN	5	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
73320-002_21dc3dc4-c5a7-4075-95e9-64668dc205d8	73320-002	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210701		ANDA	ANDA214374	Kartha Pharmaceuticals, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
73320-003_21dc3dc4-c5a7-4075-95e9-64668dc205d8	73320-003	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210701		ANDA	ANDA214374	Kartha Pharmaceuticals, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
73324-090_09dc97bc-a588-66ac-e063-6394a90ac78a	73324-090	HUMAN OTC DRUG	Aloe Coal 02 Conditioner		PYRITHIONE ZINC	LIQUID	TOPICAL	20190826		OTC MONOGRAPH DRUG	M032	T. SPRUILL, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
73324-091_09dc9d5d-a40b-0968-e063-6294a90a7e38	73324-091	HUMAN OTC DRUG	Aloe Coal 01		PYRITHIONE ZINC	LIQUID	TOPICAL	20190826		OTC MONOGRAPH DRUG	M032	T. SPRUILL, LLC	PYRITHIONE ZINC	10	mg/mL			N	20241231
73326-001_912eeb87-03ab-dbb6-e053-2a95a90ab90c	73326-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20190828		OTC MONOGRAPH NOT FINAL	part333E	Jacent Strategic Merchandising, LLC.	ALCOHOL	62	mL/100mL			N	20241231
73336-075_dff76a29-8827-4ba4-8ee8-27921744748a	73336-075	HUMAN PRESCRIPTION DRUG	GEMTESA		vibegron	TABLET, FILM COATED	ORAL	20201229		NDA	NDA213006	Sumitomo Pharma America, Inc.	VIBEGRON	75	mg/1	Adrenergic beta3-Agonists [MoA], beta3-Adrenergic Agonist [EPC]		N	20251231
73341-001_087972ab-146e-3a62-e063-6394a90acf46	73341-001	HUMAN OTC DRUG	BLT Skin Cream		Benzocaine, Lidocaine, Tetracaine	CREAM	TOPICAL	20200204		OTC MONOGRAPH DRUG	M017	M2B Pharma LLC	BENZOCAINE; LIDOCAINE; TETRACAINE	.2; .04; .01	g/g; g/g; g/g	Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
73350-105_09751fc7-6664-c196-e063-6294a90a4a57	73350-105	HUMAN OTC DRUG	VIE NATURELLE ACNE BODY		BENZOYL PEROXIDE	LIQUID	TOPICAL	20190805		OTC MONOGRAPH DRUG	M006	TNT PRO SERIES	BENZOYL PEROXIDE	25	mg/mL			N	20241231
73352-086_70d7a233-33eb-4973-a4c3-404adbe00eb7	73352-086	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20230217		ANDA	ANDA075229	Trifluent Pharma LLC	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
73352-095_a3546a08-a892-46f3-8226-db5a4ffab118	73352-095	HUMAN PRESCRIPTION DRUG	diclofenac potassium		diclofenac potassium	CAPSULE, LIQUID FILLED	ORAL	20220520		ANDA	ANDA210078	Trifluent Pharma LLC	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
73352-107_2e5e9d43-0740-494f-95de-803be99201a1	73352-107	HUMAN PRESCRIPTION DRUG	SALICYLIC ACID		SALICYLIC ACID	OINTMENT	TOPICAL	20220215	20250701	UNAPPROVED DRUG OTHER		Trifluent Pharma LLC	SALICYLIC ACID	30	mg/g			N	
73352-520_b947f7ae-c91f-49d3-9090-e316efb535f7	73352-520	HUMAN OTC DRUG	Tridergel		Benzalkonium Chloride	GEL	TOPICAL	20231211		OTC MONOGRAPH DRUG	M005	Trifluent Pharma LLC	BENZALKONIUM CHLORIDE	.001	g/mL			N	20241231
73352-550_a598f6b3-33d1-468d-a530-6f0c61c08324	73352-550	HUMAN OTC DRUG	Tripenicol S		Undecylenic acid	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	M005	Trifluent Pharma LLC	UNDECYLENIC ACID	.25	g/mL			N	20241231
73352-555_539c076b-2340-4941-a17c-7c29fd20d5b6	73352-555	HUMAN OTC DRUG	Tripenicol C		Undecylenic Acid	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M005	Trifluent Pharma LLC	UNDECYLENIC ACID	.13	g/mL			N	20241231
73352-560_8370b883-ba80-44ba-845f-98fa9adfb2f3	73352-560	HUMAN OTC DRUG	Tritolnacide S		Tolnaftate	SOLUTION	TOPICAL	20231211		OTC MONOGRAPH DRUG	M005	Trifluent Pharma LLC	TOLNAFTATE	.01	g/mL			N	20241231
73352-565_9f81a6a5-194d-49ac-95f5-4b18d1533cf1	73352-565	HUMAN OTC DRUG	Trifena		DICLOFENAC SODIUM, LIDOCAINE, and MENTHOL, (plus)minus	PATCH	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Trifluent Pharma LLC	DICLOFENAC SODIUM; LIDOCAINE; MENTHOL, (+)-	.012; .04; .05	g/1; g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Antiarrhythmic [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
73358-241_d1a19222-e215-46df-a6d4-eebbf1297085	73358-241	HUMAN OTC DRUG	Curae		Levonorgestrel	TABLET	ORAL	20230301		ANDA	ANDA202380	Curae Pharma360 Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
73358-911_962fb10f-2419-4aef-9966-ab5c27c46f3b	73358-911	HUMAN OTC DRUG	Levonorgestrel		Levonorgestrel	TABLET	ORAL	20221017		ANDA	ANDA202380	Curae Pharma360 Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
73359-001_f1e95bc6-e988-ec93-e053-2a95a90a0a50	73359-001	HUMAN OTC DRUG	Club Roots - Topical Solution Hair Regrowth Treatment		Minoxidil 5%	SOLUTION	TOPICAL	20190911		ANDA	ANDA076239	Roots Hair Club, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73359-002_f1e962be-e772-cd46-e053-2995a90a1c83	73359-002	HUMAN OTC DRUG	Roots Professional - Topical Solution Hair Regrowth Treatment		Minoxidil 5%	SOLUTION	TOPICAL	20190911		ANDA	ANDA076239	Roots Hair Club, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73368-150_0d0bf359-08e9-3937-e063-6394a90a11ea	73368-150	HUMAN OTC DRUG	Luminess SPF30 Suncreen Setting Powder		Zinc Oxide,Titanium Dioxide	POWDER	TOPICAL	20200801		OTC MONOGRAPH DRUG	M020	Kinetics Derma Beauty, L.L.C	TITANIUM DIOXIDE; ZINC OXIDE	.012; .0375	g/.15g; g/.15g			N	20241231
73369-0001_06c47318-c42e-e56e-e063-6394a90a086f	73369-0001	HUMAN OTC DRUG	Green Screen SPF 32 Original Sunscreen		Zinc Oxide	CREAM	TOPICAL	20130117		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-0002_06c4cc4e-27d3-37b8-e063-6394a90a2b1b	73369-0002	HUMAN OTC DRUG	Green Screen SPF 31 Neutral Sunscreen		Zinc Oxide	CREAM	TOPICAL	20130111		OTC MONOGRAPH FINAL	part352	Kabana Skin Care LLC	ZINC OXIDE	25	g/100g			N	20241231
73369-0003_06c4640a-ee46-5d1a-e063-6394a90ad254	73369-0003	HUMAN OTC DRUG	Green Screen SPF 31 Peach Sunscreen		Zinc Oxide	CREAM	TOPICAL	20130111		OTC MONOGRAPH FINAL	part352	Kabana Skin Care LLC	ZINC OXIDE	25	g/100g			N	20241231
73369-0004_06c4ab0b-2038-c8fa-e063-6294a90a73af	73369-0004	HUMAN OTC DRUG	Green Screen SPF 31 Nude Sunscreen		Zinc Oxide	CREAM	TOPICAL	20130111		OTC MONOGRAPH FINAL	part352	Kabana Skin Care LLC	ZINC OXIDE	25	g/100g			N	20241231
73369-0005_06c4b5d5-8496-d318-e063-6394a90adb08	73369-0005	HUMAN OTC DRUG	Green Screen SPF 31 Bronze Sunscreen		Zinc Oxide	CREAM	TOPICAL	20130111		OTC MONOGRAPH FINAL	part352	Kabana Skin Care LLC	ZINC OXIDE	25	g/100g			N	20241231
73369-0006_06c4cc42-a218-3949-e063-6394a90a665e	73369-0006	HUMAN OTC DRUG	Green Screen D SPF 35 Sunscreen		Zinc Oxide	CREAM	TOPICAL	20120420		OTC MONOGRAPH FINAL	part352	Kabana Skin Care LLC	ZINC OXIDE	25	g/100g			N	20241231
73369-0007_06c4cc4e-27d4-37b8-e063-6394a90a2b1b	73369-0007	HUMAN OTC DRUG	Bali Bloc SPF 30 Vanilla Sunscreen		Zinc Oxide	CREAM	TOPICAL	20151228		OTC MONOGRAPH FINAL	part352	Kabana Skin Care LLC	ZINC OXIDE	25	g/100g			N	20241231
73369-0008_06c47318-c430-e56e-e063-6394a90a086f	73369-0008	HUMAN OTC DRUG	Bali Bloc SPF 30 Cocoa Sunscreen		Zinc Oxide	CREAM	TOPICAL	20141008		OTC MONOGRAPH FINAL	part352	Kabana Skin Care LLC	ZINC OXIDE	25	g/100g			N	20241231
73369-0009_06c47318-c42c-e56e-e063-6394a90a086f	73369-0009	HUMAN OTC DRUG	C19 Antimicrobial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200403		OTC MONOGRAPH NOT FINAL	part333A	Kabana Skin Care LLC	ALCOHOL	64.7	g/100g			N	20241231
73369-0010_06c47318-c42b-e56e-e063-6394a90a086f	73369-0010	HUMAN OTC DRUG	Astral Organica Hand Sanitizer		Hand Santizer	GEL	TOPICAL	20200802		OTC MONOGRAPH NOT FINAL	part333A	Kabana Skin Care	ALCOHOL	64.7	g/100g			N	20241231
73369-1001_06c4ab0b-2039-c8fa-e063-6294a90a73af	73369-1001	HUMAN OTC DRUG	Be Natural Organics Broad Spectrum Tint Free SPF 30		Zinc Oxide	CREAM	TOPICAL	20140415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1002_06c47318-c42d-e56e-e063-6394a90a086f	73369-1002	HUMAN OTC DRUG	Be Natural Organics Broad Spectrum Nude Tint SPF 30		Zinc Oxide	CREAM	TOPICAL	20140415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1003_06c4cb25-e5b0-f84c-e063-6394a90af11e	73369-1003	HUMAN OTC DRUG	Be Natural Organics Broad Spectrum Tan Tint SPF 30 73369-1003		Zinc Oxide	CREAM	TOPICAL	20140415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1201_06c4ab0b-203a-c8fa-e063-6294a90a73af	73369-1201	HUMAN OTC DRUG	Waxhead Skin Nourishing Tinted Sunscreen SPF 31		Sunscreen	CREAM	TOPICAL	20160415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1202_06c4640a-ee44-5d1a-e063-6394a90ad254	73369-1202	HUMAN OTC DRUG	Waxhead Skin Nourishing Tinted Plus Sunscreen SPF 31		Sunscreen	CREAM	TOPICAL	20160415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1203_06c4cc4e-27d1-37b8-e063-6394a90a2b1b	73369-1203	HUMAN OTC DRUG	Waxhead Skin Nourishing Sunscreen SPF 32		Sunscreen	CREAM	TOPICAL	20160415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1204_06c4ab0b-2037-c8fa-e063-6294a90a73af	73369-1204	HUMAN OTC DRUG	Waxhead Baby Sunscreen SPF 35		Sunscreen	CREAM	TOPICAL	20160415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1205_06c47318-c42f-e56e-e063-6394a90a086f	73369-1205	HUMAN OTC DRUG	Waxhead Zinc Oxide Sunscreen SPF 30		Zinc Oxide	CREAM	TOPICAL	20160415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1206_06c4cc42-a217-3949-e063-6394a90a665e	73369-1206	HUMAN OTC DRUG	Waxhead Tinted Zinc Oxide Sunscreen SPF 30		ZINC OXIDE	CREAM	TOPICAL	20160415		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1401_06c4cc4e-27d2-37b8-e063-6394a90a2b1b	73369-1401	HUMAN OTC DRUG	Erins Faces Mineral SPF 32 Sunscreen		Zinc Oxide Sunscreen	CREAM	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1501_06c4b5d5-8499-d318-e063-6394a90adb08	73369-1501	HUMAN OTC DRUG	Sensible SPF 32 Mineral Sunscreen		Zinc Oxide	CREAM	TOPICAL	20220401		OTC MONOGRAPH FINAL	part352	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73369-1601_06c47ba9-1b42-8349-e063-6294a90a7d86	73369-1601	HUMAN OTC DRUG	In Your Face Mineral Tint SPF 31		Zinc Oxide	CREAM	TOPICAL	20230714		OTC MONOGRAPH FINAL	M020	Kabana Skin Care	ZINC OXIDE	25	g/100g			N	20241231
73371-048_09dcb032-1239-67ba-e063-6394a90a6a27	73371-048	HUMAN OTC DRUG	CLEAN REMEDIES CR PAIN RELIEF		MENTHOL	CREAM	TOPICAL	20190910		OTC MONOGRAPH DRUG	M017	Clean Remedies, LLC	MENTHOL	20	mg/g			N	20241231
73372-0116_07d969bf-dbe9-1f05-e063-6294a90a0a28	73372-0116	HUMAN PRESCRIPTION DRUG	SCENESSE		afamelanotide	IMPLANT	SUBCUTANEOUS	20191231		NDA	NDA210797	CLINUVEL INC.	AFAMELANOTIDE	16	mg/16mg			N	20241231
73375-7800_ba810846-95da-4880-a687-dd0863b7c15f	73375-7800	HUMAN OTC DRUG	Instant Hand Sanitizer		alcohol	GEL	TOPICAL	20191014		OTC MONOGRAPH NOT FINAL	part333A	Essential Dental Systems Inc.	ALCOHOL	665	mL/L			N	20241231
73376-001_0e7604d4-4181-6453-e063-6394a90a515e	73376-001	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, DELAYED RELEASE	ORAL	20220810		OTC MONOGRAPH DRUG	M013	INVAHEALTH INC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20251231
73376-003_0e7604d4-4193-6453-e063-6394a90a515e	73376-003	HUMAN OTC DRUG	Diphenhydramine HCl		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20220728		OTC MONOGRAPH DRUG	M012	INVAHEALTH INC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/25mg	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
73381-001_eeda94de-45f9-695e-e053-2a95a90a953b	73381-001	HUMAN OTC DRUG	Pore Release 2 Salicylic Acid Acne Treatment		SALICYLIC ACID	LIQUID	TOPICAL	20221201	20241121	OTC MONOGRAPH FINAL	part333D	Hero Cosmetics, Inc.	SALICYLIC ACID	20	mg/mL			N	
73381-003_eedad2ce-69c6-7a56-e053-2995a90adebf	73381-003	HUMAN OTC DRUG	Pimple Correct 2% Salicylic Acid Acne Treatment		SALICYLIC ACID	GEL	TOPICAL	20221201	20240914	OTC MONOGRAPH FINAL	M006	Hero Cosmetics, Inc.	SALICYLIC ACID	20	mg/mL			N	
73381-004_eeda1f01-a83d-99aa-e053-2a95a90a6386	73381-004	HUMAN OTC DRUG	Force Shield Superbeam Sunscreen Broad Spectrum SPF 30 Apricot		ZINC OXIDE	CREAM	TOPICAL	20221201	20241102	OTC MONOGRAPH NOT FINAL	part352	Hero Cosmetics Inc.	ZINC OXIDE	175.3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
73381-505_08c18533-78b3-577d-e063-6294a90a28e6	73381-505	HUMAN OTC DRUG	Hero Force Shield SPF 30		ZINC OXIDE	CREAM	TOPICAL	20210601		OTC MONOGRAPH DRUG	M020	Hero Cosmetics, Inc.	ZINC OXIDE	175.3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73381-506_eeda0d78-dd5b-6396-e053-2995a90a17c3	73381-506	HUMAN OTC DRUG	Hero Force Shield SPF 30		ZINC OXIDE	CREAM	TOPICAL	20210601	20241024	OTC MONOGRAPH NOT FINAL	part352	Hero Cosmetics, Inc.	ZINC OXIDE	175.3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
73382-185_09dc94a7-aacd-f8c4-e063-6294a90adeee	73382-185	HUMAN OTC DRUG	NATURES CRAFT LIDOCAINE Male Genital Desensitizer		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20210405		OTC MONOGRAPH DRUG	M017	Natures Design Products LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73386-005_ed71d84c-320a-5f44-e053-2a95a90a85d0	73386-005	HUMAN OTC DRUG	SANAR - ARNICA ROLL ON		Camphor	GEL	TOPICAL	20210927		OTC MONOGRAPH NOT FINAL	part348	SANVALL ENTERPRISES, INC	CAMPHOR (SYNTHETIC)	1	g/100mL			N	20241231
73399-001_8884d1f0-cace-4c1c-86cb-d344962a164e	73399-001	HUMAN OTC DRUG	Formula 1		ATP, Adeps suillus, Adrenal cortex suis, Alpha ketoglutaricum acidum, Cerebrum suis, Coenzyme A, Colon suis, Duodenum suis, Fel suis, Fel tauri, Fumaricum acidum, Glandula thyreoidea suis, Hepar suis, Hypothalamus suis, lleum suis, Jejunum suis, Malicum acidum, Methylglyoxal, Oxalaldehyde, Pancreas suis, Pituitary gland suis, Ventriculus	LIQUID	ORAL	20200129		UNAPPROVED HOMEOPATHIC		20Lighter, LLC.	ADENOSINE TRIPHOSPHATE; BOS TAURUS BILE; BOS TAURUS HYPOTHALAMUS; COENZYME A; FUMARIC ACID; GLYOXAL; LARD; PORK LIVER; PYRUVALDEHYDE; SUS SCROFA CEREBRUM; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA PANCREAS; THYROID, PORCINE	30; 30; 30; 30; 60; 60; 30; 30; 60; 30; 30; 30; 30; 30	[hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL			N	20241231
73399-002_bb4c2923-7ed8-4e17-a8ae-e0653d166589	73399-002	HUMAN OTC DRUG	Formula 2		Agnus Castus, Alpha lipoicum acidum, Androsterone 1 DHEA, Calcarea carbonica,Cinchona officinalis, Cynara Scolymus, Dopamine Hydrochloride, Hydrastis canadensis, Lycopodium clavatum, Oxytocin acetate, Quercetin, Sarcolacticum, Serotonin, Ignatia amara, Tiliroside, Ubiquinone, Valeriana Officinalis,	LIQUID	ORAL	20200130		UNAPPROVED HOMEOPATHIC		20Lighter, LLC.	ALPHA LIPOIC ACID; ANDROSTERONE; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; CYNARA SCOLYMUS LEAF; GOLDENSEAL; LACTIC ACID, L-; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; QUERCETIN; SEROTONIN; STRYCHNOS IGNATII SEED; TILIROSIDE; UBIDECARENONE; VALERIAN	30; 30; 60; 30; 60; 30; 30; 30; 30; 30; 30; 30; 30; 30; 60	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
73408-030_0293f337-e4d3-e77a-e063-6394a90a9040	73408-030	HUMAN OTC DRUG	Crane Safety Antiseptic		benzalkonium chloride	SWAB	TOPICAL	20200117	20251101	OTC MONOGRAPH NOT FINAL	part333A	Crane Safety LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
73408-031_0293d3f0-47e0-a6a2-e063-6394a90a975f	73408-031	HUMAN OTC DRUG	Crane Safety Alcohol Wipes		isopropyl alcohol	SWAB	TOPICAL	20200117	20251031	OTC MONOGRAPH NOT FINAL	part333A	Crane Safety LLC	ISOPROPYL ALCOHOL	.7	mL/1			N	
73408-032_f537c81d-1fdd-3e0f-e053-2a95a90a6c2b	73408-032	HUMAN OTC DRUG	Thompson Antiseptic		benzalkonium chloride	SWAB	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part333A	Thompson	BENZALKONIUM CHLORIDE	1.33	mg/mL			N	20241231
73408-033_f539db3b-f30a-6a60-e053-2a95a90a5a9b	73408-033	HUMAN OTC DRUG	Thompson Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part333A	Thompson	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
73408-034_0c009ed0-23b9-e4b3-e063-6394a90a723d	73408-034	HUMAN OTC DRUG	Thompson Antiseptic		benzalkonium chloride	SWAB	TOPICAL	20231205		OTC MONOGRAPH DRUG	M003	Thompson	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73408-174_f837c31f-24e6-a8df-e053-6394a90a0b36	73408-174	HUMAN OTC DRUG	Thompson Extra Strength Non-Aspirin		Acetaminophen	TABLET	ORAL	20230501		OTC MONOGRAPH NOT FINAL	part343	Thompson	ACETAMINOPHEN	500	mg/1			N	20241231
73408-406_e221bbce-83e0-0f03-e053-2995a90abca5	73408-406	HUMAN OTC DRUG	Crane Safety Bismuth		bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20200117	20241129	OTC MONOGRAPH FINAL	part335	Crane Safety LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	
73408-407_da58fbf1-1f8b-4841-e053-2a95a90a7293	73408-407	HUMAN OTC DRUG	Thompson Chewable Bismuth Tabs		bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20210811		OTC MONOGRAPH FINAL	part335	Thompson Safety LLC	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
73408-511_f1eeb255-a68f-4240-e053-2995a90acd2c	73408-511	HUMAN OTC DRUG	Crane Safety Hand Sanitizer		alcohol gel	GEL	TOPICAL	20200117	20240430	OTC MONOGRAPH NOT FINAL	part333E	Crane Safety LLC	ALCOHOL	540.26	g/L			N	
73408-616_02e6d7d6-3bc8-d3f7-e063-6394a90a89d1	73408-616	HUMAN OTC DRUG	Crane Safety Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200117		OTC MONOGRAPH FINAL	part343	Crane Safety, LLC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
73408-620_02e6d7d6-3bc8-d3f7-e063-6394a90a89d1	73408-620	HUMAN OTC DRUG	Crane Safety Aspirin		Aspirin	TABLET, COATED	ORAL	20210210	20240401	OTC MONOGRAPH NOT FINAL	part343	Crane Safety, LLC.	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
73408-633_f8359e5a-ab30-d9ac-e053-6394a90a2c86	73408-633	HUMAN OTC DRUG	Crane Safety Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20200117	20241201	OTC MONOGRAPH NOT FINAL	part348	Crane Safety LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
73408-804_f837c31f-24e6-a8df-e053-6394a90a0b36	73408-804	HUMAN OTC DRUG	Thompson Extra Strength Non-Aspirin		Acetaminophen	TABLET	ORAL	20230501		OTC MONOGRAPH NOT FINAL	part343	Thompson	ACETAMINOPHEN	500	mg/1			N	20241231
73408-815_df4d7d88-af71-3b2e-e053-2a95a90a512b	73408-815	HUMAN OTC DRUG	Thompson Cherry Cough Drops		Menthol	LOZENGE	ORAL	20210811		OTC MONOGRAPH FINAL	part341	Thompson Safety LLC	MENTHOL	7.6	mg/1			N	20241231
73408-904_f8353375-14d7-f52f-e053-6294a90a5ae9	73408-904	HUMAN OTC DRUG	Crane Safety XS Non-Aspirin		Acetaminophen 500 mg	TABLET, FILM COATED	ORAL	20200117		OTC MONOGRAPH NOT FINAL	part343	Crane Safety LLC	ACETAMINOPHEN	500	mg/1			N	20241231
73408-911_ffe66650-24c5-0bec-e053-6294a90ae535	73408-911	HUMAN OTC DRUG	Crane Safety XS Pain Relief		acetaminophen, aspirin, salicylamide and caffeine	TABLET	ORAL	20200117	20240301	OTC MONOGRAPH NOT FINAL	part343	Crane Safety LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE	110; 162; 32.4; 152	mg/1; mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	
73408-915_d6692a88-331d-71f2-e053-2a95a90a6f4c	73408-915	HUMAN OTC DRUG	Crane Safety Cherry Cough Drops		MENTHOL	LOZENGE	ORAL	20200117	20240930	OTC MONOGRAPH FINAL	part341	Crane Safety LLC	MENTHOL	7.6	mg/1			N	
73408-920_f833b7f8-17e0-b244-e053-6294a90a8d03	73408-920	HUMAN OTC DRUG	Crane Safety Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20200117	20240531	OTC MONOGRAPH FINAL	part331	Crane Safety LLC	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	
73408-921_f834cb08-7b91-cf71-e053-6294a90a5465	73408-921	HUMAN OTC DRUG	Thompson Antacid		calcium carbonate	TABLET, CHEWABLE	ORAL	20220502		OTC MONOGRAPH FINAL	part331	Thompson	CALCIUM CARBONATE	420	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
73408-929_f8373995-156c-853b-e053-6394a90a52b6	73408-929	HUMAN OTC DRUG	Thompson Triple Antibiotic		bacitracin zinc, polymyxin B sulfate, neomycin sulfate	OINTMENT	TOPICAL	20220801	20250901	OTC MONOGRAPH FINAL	part333B	Thompson	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
73408-930_f8372b56-3cfc-065e-e053-6294a90ad714	73408-930	HUMAN OTC DRUG	Crane Safety Triple Antibiotic		bacitracin zinc, neomycin sulfate, polymyxin b sulfate	OINTMENT	TOPICAL	20210601	20250901	OTC MONOGRAPH FINAL	part333B	Crane Safety LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
73408-933_f8359e5a-ab30-d9ac-e053-6394a90a2c86	73408-933	HUMAN OTC DRUG	Crane Safety Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20200117		OTC MONOGRAPH NOT FINAL	part348	Crane Safety LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73408-934_f8372b56-3cfc-065e-e053-6294a90ad714	73408-934	HUMAN OTC DRUG	Crane Safety Triple Antibiotic		bacitracin zinc, neomycin sulfate, polymyxin b sulfate	OINTMENT	TOPICAL	20200117		OTC MONOGRAPH FINAL	part333B	Crane Safety LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
73408-981_f8740314-7e20-815e-e053-6294a90a6eae	73408-981	HUMAN OTC DRUG	Thompson Hydrocortisone 1%		Hydrocortisone	CREAM	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part348	Thompson	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
73408-983_f883c4cb-c32d-76e3-e053-6294a90aa4fc	73408-983	HUMAN OTC DRUG	Thompson Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20230501		OTC MONOGRAPH FINAL	part333B	Thompson	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
73408-990_da558771-b2aa-c35d-e053-2995a90a7f30	73408-990	HUMAN OTC DRUG	Crane Safety Sinus Decongestant		phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20200117		OTC MONOGRAPH FINAL	part341	Crane Safety LLC	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
73410-001_d24f8595-2231-4f15-ac2b-9148ec453324	73410-001	HUMAN PRESCRIPTION DRUG	Ammonia N 13		Ammonia N 13	INJECTION	INTRAVENOUS	20191106		ANDA	ANDA204465	Decatur Memorial Hospital	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
73410-003_1f47e93e-12b5-42df-a196-a32f2980ccf0	73410-003	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F 18	INJECTION	INTRAVENOUS	20191106		ANDA	ANDA204463	Decatur Memorial Hospital	FLUDEOXYGLUCOSE F-18	20	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
73410-004_e817ab8b-ba2c-4226-b37f-c6d75e4d94cd	73410-004	HUMAN PRESCRIPTION DRUG	Choline C 11		Choline C 11	INJECTION	INTRAVENOUS	20191106		ANDA	ANDA206319	Decatur Memorial Hospital	CHOLINE C-11	4	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
73414-065_fa7980a3-9add-48f8-829b-23808b0c7f4e	73414-065	HUMAN OTC DRUG	VIROCCINUM		VIROCCINUM	PELLET	ORAL	20210801		UNAPPROVED HOMEOPATHIC		Seaway Pharma Inc.	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
73418-100_0190eeaf-c5a1-3253-e063-6294a90a43c4	73418-100	HUMAN OTC DRUG	Baby Mineral Sunscreen SPF55		Zinc Oxide	LOTION	TOPICAL	20230728		OTC MONOGRAPH FINAL	M020	Hello Bello	ZINC OXIDE	200	mg/g			N	20241231
73418-101_0191b2e4-bcc6-541a-e063-6294a90a0e78	73418-101	HUMAN OTC DRUG	Baby Mineral Sunscreen Probiotics SPF55		Zinc Oxide	LOTION	TOPICAL	20230728		OTC MONOGRAPH FINAL	M020	Hello Bello	ZINC OXIDE	200	mg/g			N	20241231
73418-102_01cc205b-a346-262a-e063-6394a90a955c	73418-102	HUMAN OTC DRUG	Mineral Sunscreen SPF 50		Zinc Oxide	LOTION	TOPICAL	20230730		OTC MONOGRAPH FINAL	M020	Hello Bello	ZINC OXIDE	200	mg/g			N	20241231
73418-103_01cc4ea0-e3df-32f1-e063-6394a90a1375	73418-103	HUMAN OTC DRUG	Kids Face and Body Sunscreen SPF 50		Zinc Oxide	STICK	TOPICAL	20230930		OTC MONOGRAPH FINAL	M020	Hello Bello	ZINC OXIDE	210	mg/g			N	20241231
73418-104_01cc4ea0-e3e1-32f1-e063-6394a90a1375	73418-104	HUMAN OTC DRUG	Mineral Sunscreen SPF30		Zinc Oxide	SPRAY	TOPICAL	20230930		OTC MONOGRAPH FINAL	M020	Hello Bello	ZINC OXIDE	140	mg/g			N	20241231
73418-105_01cc554b-9242-d891-e063-6394a90a8450	73418-105	HUMAN OTC DRUG	Kids Mineral Sunscreen SPF50		Sunscreen	SPRAY	TOPICAL	20230913		OTC MONOGRAPH FINAL	M020	Hello Bello	TITANIUM DIOXIDE; ZINC OXIDE	34; 160	mg/g; mg/g			N	20241231
73418-200_01cc51ab-2221-41ec-e063-6394a90a7b8d	73418-200	HUMAN OTC DRUG	Hand Sanitizer Gel		Alcohol	GEL	TOPICAL	20231030		OTC MONOGRAPH DRUG	M003	Hello Bello	ALCOHOL	75	mL/L			N	20241231
73418-201_01cc4ea0-e3e3-32f1-e063-6394a90a1375	73418-201	HUMAN OTC DRUG	Hand Sanitizer Apple Blossom		Alcohol	SPRAY	TOPICAL	20230926		OTC MONOGRAPH NOT FINAL	part333A	Hello Bello	ALCOHOL	.625	mL/mL			N	20241231
73418-300_01cc78d6-7949-97c4-e063-6394a90a1708	73418-300	HUMAN OTC DRUG	Diaper Rash Cream		Zinc Oxide	CREAM	TOPICAL	20231013		OTC MONOGRAPH DRUG	M016	Hello Bello	ZINC OXIDE	400	mg/g			N	20241231
73418-747_234adbde-5ac6-433f-8d82-6197652749e5	73418-747	HUMAN OTC DRUG	Allergies	MY CHILD NEEDS HELP WITH	Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20191025		OTC MONOGRAPH DRUG	M012	Unconditional Love	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73419-0001_00ab968d-bcd3-1104-e063-6394a90a8dcd	73419-0001	HUMAN OTC DRUG	Puttisu		Titanium dioxide, Zinc Oxide	LIQUID	TOPICAL	20200306		OTC MONOGRAPH FINAL	part352	Jellycup, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	9.7; 5.95	g/100mL; g/100mL			N	20241231
73421-0052_eedfd248-254d-2c60-e053-2a95a90a44f1	73421-0052	HUMAN OTC DRUG	BACTOFLAM		Apis mel, Arsenicum alb, Baptisia, Belladonna, Echinacea, Ferrum phos, Rhus tox	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA, UNSPECIFIED; FERROSOFERRIC PHOSPHATE; TOXICODENDRON PUBESCENS LEAF	12; 12; 12; 3; 3; 12; 12	[hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
73421-0526_eedfd248-253f-2c60-e053-2a95a90a44f1	73421-0526	HUMAN OTC DRUG	MET TOX		Arsenicum alb, Avena, Berberis vulg, Lycopodium, Nat mur, Nux vom, Phytolacca, Rhamnus frang, Solidago, Trifolium prat	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; FRANGULA ALNUS BARK; LYCOPODIUM CLAVATUM SPORE; PHYTOLACCA AMERICANA ROOT; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; TRIFOLIUM PRATENSE FLOWER	12; 3; 3; 3; 12; 3; 12; 3; 12; 3	[hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
73421-1027_eedfd248-255d-2c60-e053-2a95a90a44f1	73421-1027	HUMAN OTC DRUG	VIREX		Arsenicum alb, Baptisia, Belladonna, Echinacea, Eupatorium perf, Gelsemium, Lycopodium, , Nux vom, Phosphoricum ac, Phosphorus, Pyrogenium, Rhus tox	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARSENIC TRIOXIDE; ATROPA BELLADONNA; BAPTISIA TINCTORIA ROOT; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; RANCID BEEF; STRYCHNOS NUX-VOMICA SEED; TOXICODENDRON PUBESCENS LEAF	12; 12; 3; 3; 12; 12; 12; 12; 12; 30; 12; 30	[hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
73421-2208_eedfe71b-5afe-2700-e053-2a95a90a28df	73421-2208	HUMAN OTC DRUG	Whole System Eep		Belladonna, Berber vulg, Causticum, Ceanothus, Chelidonium maj, Cinchona, Coffea cruda, Condurango, Graphites, Hydrastis, Ignatia, Lilium, Lycopodium, , Merc corros, Nux vom, Pancreas, Scrophularia nodosa, Senna, Spongia, Zinc met	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARABICA COFFEE BEAN; ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; CAUSTICUM; CEANOTHUS AMERICANUS LEAF; CHELIDONIUM MAJUS WHOLE; CINCHONA BARK; GOLDENSEAL; GRAPHITE; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; MARSDENIA CONDURANGO BARK; MERCURIC CHLORIDE; SCROPHULARIA NODOSA WHOLE; SENNA LEAF; SPONGIA OFFICINALIS SKELETON, ROASTED; STRYCHNOS IGNATII SEED; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PANCREAS; ZINC	1; 1; 12; 1; 6; 3; 1; 5; 1; 1; 12; 3; 12; 15; 3; 6; 200; 1; 12; 1	[hp_M]/29.6mL; [hp_M]/29.6mL; [hp_X]/29.6mL; [hp_M]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_M]/29.6mL; [hp_X]/29.6mL; [hp_M]/29.6mL; [hp_M]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_M]/29.6mL; [hp_X]/29.6mL; [hp_M]/29.6mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Seed Storage Proteins [CS]		N	20241231
73421-2968_8f247064-6e68-4aa2-8337-20221b433ab1	73421-2968	HUMAN OTC DRUG	TOTAL FLU CLD 1		Arsenicum alb, Baptisia, Bryonia, Causticum, Cinchona, Dulcamara, Echinacea purp, Eucalyptus, Eupatorium perf, Gelsemium, Influenzinum, Lachesis, Phytolacca, Rhus tox, Sarcolacticum ac, Sulphur, Wyethia, Anas barbariae	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		White Manufacturing Inc. DBA Micro-West	ARSENIC TRIOXIDE; BAPTISIA TINCTORIA ROOT; BRYONIA ALBA ROOT; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CAUSTICUM; CINCHONA BARK; ECHINACEA PURPUREA; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS; LACHESIS MUTA VENOM; LACTIC ACID, L-; PHYTOLACCA AMERICANA ROOT; SOLANUM DULCAMARA TOP; SULFUR; TOXICODENDRON PUBESCENS LEAF; WYETHIA HELENIOIDES ROOT	10; 10; 10; 35; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_C]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL; [hp_X]/29.6mL			N	20241231
73422-001_06e5f9d1-98ba-987e-e063-6394a90a88f3	73422-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20051215		UNAPPROVED MEDICAL GAS		American Medical Inc	OXYGEN	99	L/100L			N	20241231
73423-002_0c49a83c-cdf7-3f85-e063-6294a90a34e1	73423-002	HUMAN OTC DRUG	CBD CRYOTHERAPY PAIN RELIEF		MENTHOL	GEL	TOPICAL	20201217	20250430	OTC MONOGRAPH DRUG	M017	Global Widget, LLC	MENTHOL	40	mg/g			N	
73423-003_0c49c820-5cff-e750-e063-6394a90ab42c	73423-003	HUMAN OTC DRUG	CBD Pain Freeze Shrink		MENTHOL	GEL	TOPICAL	20201215	20250930	OTC MONOGRAPH DRUG	M017	Global Widget, LLC	MENTHOL	40	mg/g			N	
73423-005_0c498828-e0d8-d65a-e063-6394a90a1488	73423-005	HUMAN OTC DRUG	CBD Cryotherapy Pain Relief Roll-On		MENTHOL	GEL	TOPICAL	20201211	20251130	OTC MONOGRAPH DRUG	M017	Global Widget, LLC	MENTHOL	40	mg/mL			N	
73423-006_0c49be2b-2d35-e698-e063-6394a90ac994	73423-006	HUMAN OTC DRUG	CBD Pain Freeze Roll-On		MENTHOL	GEL	TOPICAL	20201215	20251130	OTC MONOGRAPH DRUG	M017	Global Widget, LLC	MENTHOL	40	mg/mL			N	
73423-011_0c498f35-7619-32fe-e063-6294a90a266c	73423-011	HUMAN OTC DRUG	Relieve Well Pain Relief		Menthol and Camphor	GEL	TOPICAL	20220215	20240229	OTC MONOGRAPH DRUG	M017	Global Widget, LLC	CAMPHOR (SYNTHETIC); MENTHOL	2; 4	g/100g; g/100g			N	
73432-002_1987db76-7ea4-4769-8ee3-955213090424	73432-002	HUMAN OTC DRUG	OSEA Blemish Balm		Salicylic Acid	CREAM	TOPICAL	20231001		OTC MONOGRAPH FINAL	part333D	OSEA International, LLC	SALICYLIC ACID	1	mg/100mL			N	20241231
73434-001_e952e319-e06c-4e0c-ad3b-ee29363f0c08	73434-001	HUMAN OTC DRUG	Face Plus Scalp Invisible Daily SPF 30 Broad Spectrum		AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	GEL	TOPICAL	20200105		OTC MONOGRAPH FINAL	part352	Mantl	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 28	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
73436-2859_056c2ecb-4a90-669d-e063-6294a90a90ba	73436-2859	HUMAN OTC DRUG	Morning After Pill		levonorgestrel	TABLET	ORAL	20231001		ANDA	ANDA202380	Cadence Health Inc	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
73441-800_48bfd4d5-3670-436d-8dcd-f5674c7ce3dd	73441-800	CELLULAR THERAPY	OMISIRGE		omidubicel-onlv	KIT		20230501		BLA	BLA125738	Gamida Cell Inc.						N	20241231
73442-0001_96b7b864-2571-8570-e053-2995a90a176b	73442-0001	HUMAN OTC DRUG	FUCIDIN		Sodium Fusidate	OINTMENT	TOPICAL	20191008		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	FUSIDATE SODIUM	20	mg/g			N	20241231
73442-0002_96e0edc5-2505-b9e2-e053-2a95a90a266c	73442-0002	HUMAN OTC DRUG	INSADOL		Corn sterilized quantitative extract (beta sitosterol)	TABLET	ORAL	20191008		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	.BETA.-SITOSTEROL	35	mg/1			N	20241231
73442-0003_96e0edc5-2513-b9e2-e053-2a95a90a266c	73442-0003	HUMAN OTC DRUG	GELFOS-M		Aluminum Phosphate, Colloidal, Magnesium Hydroxide, Simethicone	LIQUID	ORAL	20191008		OTC MONOGRAPH FINAL	part331	I World Pharmaceutical Co., Ltd.	ALUMINUM PHOSPHATE; DIMETHICONE; MAGNESIUM HYDROXIDE	12.38; 40; 400	g/20g; mg/20g; mg/20g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
73442-0004_96e108f1-a167-302b-e053-2a95a90a23c3	73442-0004	HUMAN OTC DRUG	MADECASSOL		Neomycin Sulfate, Titrated Ext. of Centella Asiatica	OINTMENT	TOPICAL	20191008		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	CENTELLA ASIATICA; NEOMYCIN SULFATE	10; 3.5	mg/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
73442-0005_96e0edc5-251f-b9e2-e053-2a95a90a266c	73442-0005	HUMAN OTC DRUG	YOUNGGAKSAN		Apricot Kernel, Powdered Glycyrrhiza, Powdered Platycodon Root, Powdered Senega	POWDER	ORAL	20191008		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	APRICOT KERNEL OIL; GLYCYRRHIZIN; PLATYCODON GRANDIFLORUS ROOT; POLYGALA SENEGA ROOT	.83; 8.3; 11.7; .5	mg/.3g; mg/.3g; mg/.3g; mg/.3g			N	20241231
73442-0006_96e0edc5-2521-b9e2-e053-2a95a90a266c	73442-0006	HUMAN OTC DRUG	YOUNGGAKSAN		Apricot Kernel, Powdered Glycyrrhiza, Powdered Platycodon Root, Powdered Senega	POWDER	ORAL	20191008		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	APRICOT KERNEL OIL; GLYCYRRHIZIN; PLATYCODON GRANDIFLORUS ROOT; POLYGALA SENEGA ROOT	.83; 8.3; 11.7; .5	mg/.3g; mg/.3g; mg/.3g; mg/.3g			N	20241231
73442-0007_96e0da52-66dc-5c3f-e053-2a95a90a6d8c	73442-0007	HUMAN OTC DRUG	Baekcho-DS		Licorice Ext	SYRUP	ORAL	20190323		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	LICORICE	10	g/mL			N	20241231
73442-0008_96e3f948-ab3c-81e9-e053-2a95a90a7a12	73442-0008	HUMAN OTC DRUG	SSANGBI TANG		galgeun-tang extract	LIQUID	ORAL	20191008		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	GINGER; PERILLA FRUTESCENS LEAF; PUERARIA MONTANA VAR. LOBATA WHOLE	1.121; 1.121; 2.242	g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73442-0009_96e441ab-d3a1-2259-e053-2a95a90a9abd	73442-0009	HUMAN OTC DRUG	SSANGGI TANG		ssanghwa extract	LIQUID	ORAL	20191008		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	ASTRAGALUS GUMMIFER ROOT; LIGUSTICUM SINENSE SUBSP. CHUANXIONG ROOT; PAEONIA LACTIFLORA ROOT; REHMANNIA GLUTINOSA ROOT	.4845; .627; .9785; .6745	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73442-0010_aed8b1c6-1208-1499-e053-2a95a90a5dde	73442-0010	HUMAN OTC DRUG	ANTIPHLAMINE		L-Menthol, L-Camphor, Methyl Salicylate	PATCH	TOPICAL	20200909		OTC MONOGRAPH NOT FINAL	part348	I World Pharmaceutical Co., Ltd.	CAMPHOR, (-)-; LEVOMENTHOL; METHYL SALICYLATE	59; 8; 46	mg/g; mg/g; mg/g			N	20241231
73442-0011_af640819-1188-3254-e053-2995a90a2957	73442-0011	HUMAN OTC DRUG	MaekMunDong Tang Extract		jujube, acetaminophen, chlorheniramine maleate	GRANULE	ORAL	20200916		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; JUJUBE FRUIT	.05; .00067; 1	g/3g; g/3g; g/3g	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73442-0012_af68fb1a-def6-0bd5-e053-2995a90af056	73442-0012	HUMAN OTC DRUG	SoCheongRyong Tang Extract		ginger, chlorheniramine maleate, dextromethorphan hydrobromide	GRANULE	ORAL	20200916		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; GINGER	.00087; .00515; 1	g/3g; g/3g; g/3g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
73442-0013_af68634f-eb0b-64e7-e053-2a95a90a5df2	73442-0013	HUMAN OTC DRUG	JEGAMSAN Extract		lonicera flower, acetaminophen, dextromethorphan hydromide	GRANULE	ORAL	20200916		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; LONICERA CAPRIFOLIUM FLOWER	.07; .00525; 1.42	g/3g; g/3g; g/3g	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
73442-0014_af69d604-180d-702f-e053-2a95a90a2ae4	73442-0014	HUMAN OTC DRUG	PEDOXAN Extract		citrus unshiu peel, saposhnikovia root, acetaminophen, dextromethorphan hydrobromide	GRANULE	ORAL	20200916		UNAPPROVED DRUG OTHER		I World Pharmaceutical Co., Ltd.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; SAPOSHNIKOVIA DIVARICATA ROOT; TANGERINE	.06; .00425; 1; 1	g/3g; g/3g; g/3g; g/3g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
73453-003_0dc7bda4-7a8c-9041-e063-6294a90a5157	73453-003	HUMAN OTC DRUG	Even and Clear Cleanser		SALICYLIC ACID	LIQUID	TOPICAL	20140615		OTC MONOGRAPH DRUG	M006	Ambi Enterprises LLC	SALICYLIC ACID	5	mg/mL			N	20241231
73453-073_0d84b299-cd17-de3b-e063-6294a90a6717	73453-073	HUMAN OTC DRUG	AMBI SKINCARE Even and Clear Daily Facial Moisturizer SPF 30		OCTISALATE, OCTOCRYLENE, AVOBENZONE	CREAM	TOPICAL	20191101		OTC MONOGRAPH DRUG	M020	AMBI Enterprises LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
73453-143_09751799-664e-ec58-e063-6394a90aea39	73453-143	HUMAN OTC DRUG	AMBI Soothing Hand sanitizer		ALCOHOL	GEL	TOPICAL	20200520		OTC MONOGRAPH DRUG	505G(a)(3)	AMBI Enterprises, llc	ALCOHOL	.7	mL/mL			N	20241231
73453-166_0d849e47-671b-a7b6-e063-6394a90af811	73453-166	HUMAN OTC DRUG	AMBI Even and Clear Exfoliating Wash Acne Treatment		SALICYLIC ACID	GEL	TOPICAL	20200713		OTC MONOGRAPH DRUG	M006	AMBI ENTERPRISES, LLC	SALICYLIC ACID	15	mg/g			N	20241231
73453-233_0d849e47-670a-a7b6-e063-6394a90af811	73453-233	HUMAN OTC DRUG	AMBI Even and Clear Facial Moisturizer SPF-30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20210925		OTC MONOGRAPH DRUG	M020	AMBI Enterprises LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
73455-011_880b7e4c-d962-466f-a29e-76d03df93f72	73455-011	HUMAN OTC DRUG	Mineral Tinted Face Sunscreen SPF 30 - Light/ Medium		zinc oxide and titanium dioxide	CREAM	TOPICAL	20190415		OTC MONOGRAPH FINAL	part352	Unsun Cosmetics	TITANIUM DIOXIDE; ZINC OXIDE	.055; .065	g/mL; g/mL			N	20241231
73455-111_880b7e4c-d962-466f-a29e-76d03df93f72	73455-111	HUMAN OTC DRUG	Mineral Tinted Face Sunscreen SPF 30 - Medium/ Dark		zinc oxide and titanium dioxide	CREAM	TOPICAL	20190415		OTC MONOGRAPH FINAL	part352	Unsun Cosmetics	TITANIUM DIOXIDE; ZINC OXIDE	.055; .065	g/mL; g/mL			N	20241231
73462-101_771900a0-4eee-4197-9051-ffe0fdc0f1d4	73462-101	HUMAN PRESCRIPTION DRUG	COSELA		trilaciclib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210212		NDA	NDA214200	G1 Therapeutics, Inc.	TRILACICLIB DIHYDROCHLORIDE	300	mg/20mL	Cyclin-dependent Kinase 4 Inhibitors [MoA], Cyclin-dependent Kinase 6 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
73464-001_eca759ee-4199-2762-e053-2a95a90aed5a	73464-001	HUMAN OTC DRUG	NU CALMAR		undecylenic acid	CREAM	TOPICAL	20200129		OTC MONOGRAPH FINAL	part333C	Nu Calmar Pty Ltd	UNDECYLENIC ACID	200	mg/mL			N	20241231
73466-0007_d4950ac9-8c06-989a-e053-2995a90ac6b7	73466-0007	HUMAN OTC DRUG	Aewajin HasuoShampoo		menthol, salicylic acid, panthenol	SHAMPOO	TOPICAL	20220102		UNAPPROVED DRUG OTHER		MISOCOS	MENTHOL; PANTHENOL; SALICYLIC ACID	.3; .2; .25	g/100mL; g/100mL; g/100mL			N	20241231
73466-0008_f8b4d197-211f-f967-e053-6294a90a2d7f	73466-0008	HUMAN OTC DRUG	Fantastic LightCream		Hydrogenated Polydecene,Niacinamide	CREAM	TOPICAL	20230407		UNAPPROVED DRUG OTHER		MISOCOS	NIACINAMIDE	.3	g/100mL			N	20241231
73466-0009_07cc44d5-6ef3-fa21-e063-6394a90ad22d	73466-0009	HUMAN OTC DRUG	ko7 Herbal MedicatedSoap		Sodium palm kernelate, Panax Ginseng Root Extract	SOAP	TOPICAL	20231016		UNAPPROVED DRUG OTHER		MISOCOS	PANAX GINSENG ROOT OIL	.3	g/100g			N	20241231
73469-0062_07430582-0db4-a750-e063-6294a90a7be4	73469-0062	HUMAN OTC DRUG	Scholls Wellness Company LLC	Ingrown Toenail	Sodium Sulfide	GEL	TOPICAL	20210101		OTC MONOGRAPH DRUG	M029	Scholls Wellness Company LLC	SODIUM SULFIDE	1	g/100g			N	20241231
73469-0691_0d11e0f2-d822-7b89-e063-6294a90a39ff	73469-0691	HUMAN OTC DRUG	Dr. Scholls Instant Cool Athletes foot treatment with Menthol		TOLNAFTATE	SPRAY	TOPICAL	20220310		OTC MONOGRAPH DRUG	M005	Scholl's Wellness Company	TOLNAFTATE	10	mg/g			N	20241231
73469-1192_07432d7b-c54b-6d72-e063-6394a90aa435	73469-1192	HUMAN OTC DRUG	Wart Remover		Salicylic Acid	LIQUID	TOPICAL	20230531		OTC MONOGRAPH DRUG	M028	Scholls Wellness Company LLC	SALICYLIC ACID	1.7	mg/10mL			N	20241231
73469-2053_5ec5f1c8-7188-42fd-bb1f-ae1ff38f3bab	73469-2053	HUMAN OTC DRUG	Diclofenac sodium		Diclofenac	GEL	TOPICAL	20201030		ANDA	ANDA208077	Scholl's Wellness Company	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
73469-6321_fc9f1fc5-e256-6ddb-e053-6294a90a2fc2	73469-6321	HUMAN OTC DRUG	One Step Wart Removers		Salicylic acid	DISC	TOPICAL	20230523		OTC MONOGRAPH FINAL	M028	Scholls Wellness Company LLC	SALICYLIC ACID	.4	g/g			N	20241231
73469-6331_fc9f34e2-e492-b2f7-e053-6294a90a4427	73469-6331	HUMAN OTC DRUG	Plantar Wart Removers		Salicylic acid	DISC	TOPICAL	20230523		OTC MONOGRAPH FINAL	M028	Scholls Wellness Company LLC	SALICYLIC ACID	.4	g/g			N	20241231
73469-6421_fc9f0fe9-daf4-a64d-e053-6394a90ab749	73469-6421	HUMAN OTC DRUG	Clear Away Wart Removers		Salicylic acid	DISC	TOPICAL	20191101		OTC MONOGRAPH FINAL	M028	Scholls Wellness Company LLC	SALICYLIC ACID	.4	g/g			N	20241231
73469-7214_02e22480-8c3e-1fea-e063-6294a90a0d16	73469-7214	HUMAN OTC DRUG	Scholls Wellness Company LLC	Ingrown Toenail	Sodium Sulfide	GEL	TOPICAL	20210101		OTC MONOGRAPH FINAL	part358D	Scholls Wellness Company LLC	SODIUM SULFIDE	1	g/10g			N	20241231
73473-300_022f463a-c5bb-4252-bce4-dde798c21dc5	73473-300	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	GEL	TOPICAL	20230813		ANDA	ANDA211872	Solaris Pharma Corporation	CLINDAMYCIN PHOSPHATE	10	mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
73473-302_e3079b78-4de1-4188-91f2-8d4b640d5d31	73473-302	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate		clindamycin phosphate	GEL	TOPICAL	20210814		ANDA	ANDA212842	Solaris Pharma Corporation	CLINDAMYCIN PHOSPHATE	1	g/10mL	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
73473-303_612c73db-7cb6-4ae6-94fa-97c7c9ec49c6	73473-303	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	GEL	VAGINAL	20211018		ANDA	ANDA213648	Solaris Pharma Corporation	METRONIDAZOLE	7.5	mg/g	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
73473-306_9d909114-026b-44a8-af8e-82c787b6b584	73473-306	HUMAN PRESCRIPTION DRUG	Clindamycin Phosphate and Tretinoin		clindamycin phosphate and tretinoin	GEL	TOPICAL	20231019		ANDA	ANDA212845	Solaris Pharma Corporation	CLINDAMYCIN PHOSPHATE; TRETINOIN	10; .25	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE], Retinoid [EPC], Retinoids [CS]		N	20241231
73473-309_aa11ee21-0fa2-4a1a-a1cb-d171cf71e649	73473-309	HUMAN PRESCRIPTION DRUG	Tazarotene		Tazarotene	GEL	CUTANEOUS	20230801		ANDA	ANDA213644	Solaris Pharma Corporation	TAZAROTENE	.5	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
73473-310_aa11ee21-0fa2-4a1a-a1cb-d171cf71e649	73473-310	HUMAN PRESCRIPTION DRUG	Tazarotene		Tazarotene	GEL	CUTANEOUS	20230801		ANDA	ANDA213644	Solaris Pharma Corporation	TAZAROTENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
73473-901_f430c5d9-ae83-3314-e053-2a95a90af04c	73473-901	HUMAN PRESCRIPTION DRUG	Neomycin Sulfate		Neomycin Sulfate	TABLET	ORAL	20230601		ANDA	ANDA065220	Solaris Pharma Corporation	NEOMYCIN SULFATE	500	mg/1	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
73474-0001_9a7b1e74-b8b0-449c-e053-2995a90a349e	73474-0001	HUMAN OTC DRUG	HM-B (EDIBLE VINEGAR)		titanium oxide	LIQUID	ORAL	20191225		UNAPPROVED DRUG OTHER		DEMAND SERVICE, CO., LTD.	TITANIUM DIOXIDE	2	g/100mL			N	20241231
73475-3041_eda70bcd-00e6-4196-9826-00ef3cd2b26b	73475-3041	HUMAN PRESCRIPTION DRUG	VYVGART		EFGARTIGIMOD ALFA	INJECTION	INTRAVENOUS	20211217		BLA	BLA761195	argenx US	EFGARTIGIMOD ALFA	20	mg/mL	Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]		N	20241231
73475-3102_b7cba729-876e-44e3-b497-cb77da05806f	73475-3102	HUMAN PRESCRIPTION DRUG	VYVGART Hytrulo		efgartigimod alfa and hyaluronidase (human recombinant)	INJECTION, SOLUTION	SUBCUTANEOUS	20230620		BLA	BLA761304	argenx US	EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT)	180; 2000	mg/mL; U/mL	Endoglycosidase [EPC], Glycoside Hydrolases [CS], Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]		N	20241231
73479-029_0cef86b0-d095-07bb-e063-6394a90a079d	73479-029	HUMAN OTC DRUG	NotaQuenSAN		PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM, PENICILLIUM GLABRUM	SPRAY	NASAL	20191206		UNAPPROVED HOMEOPATHIC		sanPharmacy Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM	4; 4	[hp_X]/10mL; [hp_X]/10mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
73479-030_0cef9562-2614-f56b-e063-6394a90a4ba5	73479-030	HUMAN OTC DRUG	NotaSAN		PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	CAPSULE	ORAL	20191209		UNAPPROVED HOMEOPATHIC		sanPharmacy Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	4	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
73479-032_0cef99dd-6278-c838-e063-6294a90a0bca	73479-032	HUMAN OTC DRUG	NotaSAN		PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	SOLUTION/ DROPS	ORAL	20191206		UNAPPROVED HOMEOPATHIC		sanPharmacy Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	4	[hp_X]/10mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
73479-033_0cef8956-184b-bc15-e063-6294a90adfef	73479-033	HUMAN OTC DRUG	NotaSAN		PENICILLIUM NOTATUM (CHRYSOGENUM)	SUPPOSITORY	RECTAL	20231012		UNAPPROVED HOMEOPATHIC		sanPharmacy Inc	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	3	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
73479-035_0cef9562-2613-f56b-e063-6394a90a4ba5	73479-035	HUMAN OTC DRUG	QuentaSAN		PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	CAPSULE	ORAL	20191209		UNAPPROVED HOMEOPATHIC		sanPharmacy Inc.	PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM	4	[hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
73479-036_0cef9562-2610-f56b-e063-6394a90a4ba5	73479-036	HUMAN OTC DRUG	QuentaSAN		PENICILLIUM GLABRUM	SOLUTION/ DROPS	ORAL	20231012		UNAPPROVED HOMEOPATHIC		sanPharmacy Inc.	PENICILLIUM GLABRUM	4	[hp_X]/10mL			N	20241231
73479-038_0cef86b0-d094-07bb-e063-6394a90a079d	73479-038	HUMAN OTC DRUG	QuentaSAN		PENICILLIUM GLABRUM	SUPPOSITORY	RECTAL	20231012		UNAPPROVED HOMEOPATHIC		sanPharmacy Inc.	PENICILLIUM GLABRUM	3	[hp_X]/1			N	20241231
73487-001_f7660553-8330-499d-84a9-bb507ce1108a	73487-001	HUMAN OTC DRUG	Kroger Antibacterial Green Apple Hand		Chloroxylenol	SOAP	TOPICAL	20190401		OTC MONOGRAPH DRUG	505G(a)(3)	Korex Chicago LLC	CHLOROXYLENOL	.3	g/100mL			N	20241231
73487-003_d2cd7e83-e2a5-4ca7-9d85-4670a47de115	73487-003	HUMAN OTC DRUG	Radiance Antibacterial Green Apple Scent Hand		Chloroxylenol	SOAP	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	Korex Chicago LLC	CHLOROXYLENOL	.3	g/100mL			N	20241231
73487-004_2a5d2142-9187-4951-bf91-4e46d4b49969	73487-004	HUMAN OTC DRUG	Radiance Antibacterial Citrus Scent Hand		Chloroxylenol	SOAP	TOPICAL	20200101		OTC MONOGRAPH DRUG	505G(a)(3)	Korex Chicago LLC	CHLOROXYLENOL	.3	g/100mL			N	20241231
73487-005_8871ed1c-62c0-47d4-8dac-15e0d296e3cf	73487-005	HUMAN OTC DRUG	CHECK THIS OUT DISHSOAP ORANGE SCENT		CHLOROXYLENOL	SOAP	TOPICAL	20201006	20240630	OTC MONOGRAPH NOT FINAL	part333A	Korex Chicago Llc	CHLOROXYLENOL	.1	g/100mL			N	
73487-006_4342dd98-741b-4454-9e39-8fe5713c69c4	73487-006	HUMAN OTC DRUG	Kroger ANTIBACTERIAL Orange Scent HAND		Chloroxylenol	SOAP	TOPICAL	20220601	20250201	OTC MONOGRAPH DRUG	505G(a)(3)	Korex Chicago LLC	CHLOROXYLENOL	.3	g/100mL			N	
73487-007_e9e461ff-5dcd-45ab-a737-f7181897930b	73487-007	HUMAN OTC DRUG	smart way orange scent dish		Chloroxylenol	SOAP	TOPICAL	20220810		OTC MONOGRAPH NOT FINAL	part333A	Korex Chicago LLC	CHLOROXYLENOL	.1	g/100mL			N	20241231
73488-001_0760b970-1afe-dbf1-e063-6394a90a9eec	73488-001	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20200602		NDA	NDA205866	ENCORE WELDING AND INDUSTRIAL SUPPLY LLC	NITROGEN	990	mL/L			N	20241231
73491-627_937e4697-541c-45d1-a27f-4132b963ff88	73491-627	HUMAN PRESCRIPTION DRUG	RYZNEUTA		efbemalenograstim alfa-vuxw	INJECTION	SUBCUTANEOUS	20231123		BLA	BLA761134	Evive Biotechnology Singapore PTE. LTD.	EFBEMALENOGRASTIM ALFA	20	mg/mL	Colony-Stimulating Factors [CS], Leukocyte Growth Factor [EPC]		N	20241231
73492-711_0c38b320-8988-7d06-e063-6294a90acf14	73492-711	HUMAN OTC DRUG	Ultra Strength Pain Relief Balm		CAMPHOR, MENTHOL	OINTMENT	TOPICAL	20220127		OTC MONOGRAPH DRUG	M017	ALAINA HEALTHCARE PRIVATE LIMITED	CAMPHOR (SYNTHETIC); MENTHOL	110; 110	mg/g; mg/g			N	20241231
73492-712_0c35d3b5-59ea-8063-e063-6394a90a66a9	73492-712	HUMAN OTC DRUG	Hemorrhoid Relief Cream		Lidocaine 5% Anorectal	CREAM	TOPICAL	20220128		OTC MONOGRAPH DRUG	M015	ALAINA HEALTHCARE PRIVATE LIMITED	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73492-715_0c38b320-8979-7d06-e063-6294a90acf14	73492-715	HUMAN OTC DRUG	Severe Nasal		oxymetazoline hydrochloride 0.05%	SPRAY	NASAL	20230915		OTC MONOGRAPH DRUG	M012	ALAINA HEALTHCARE PRIVATE LIMITED	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
73492-716_0c38e48d-035e-a948-e063-6294a90a00a1	73492-716	HUMAN OTC DRUG	Vaporizing Rub		Camphor, Eucalyptus Oil and Menthol	OINTMENT	TOPICAL	20230718		OTC MONOGRAPH DRUG	M012	ALAINA HEALTHCARE PRIVATE LIMITED	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	2.4; .6; 1.3	g/50g; g/50g; g/50g			N	20241231
73492-717_0c71967e-16fc-4d7b-e063-6294a90a943d	73492-717	HUMAN OTC DRUG	Oral pain relief		benzocaine	GEL	ORAL	20231208		OTC MONOGRAPH DRUG	M022	ALAINA HEALTHCARE PRIVATE LIMITED	BENZOCAINE	.2	g/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
73496-003_41cb0ded-1f7f-4147-acd4-afbdd18c7b26	73496-003	HUMAN OTC DRUG	ROC MULTI CORREXION 5 IN 1 CHEST, NECK AND FACE SUNSCREEN BROAD SPECTRUM SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part352	ROC Skincare	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 40; 40; 20	mg/g; mg/g; mg/g; mg/g			N	20241231
73496-004_0cf91b40-9e4a-6a45-e063-6394a90a73ae	73496-004	HUMAN OTC DRUG	ROC RETINOL CORREXION WRINKLE CORRECT DAILY MOISTURIZER SPF 30		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20210402		OTC MONOGRAPH DRUG	M020	Roc Skincare	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	mg/100mL; mg/100mL; mg/100mL			N	20241231
73496-005_0d0c348b-9c06-4f7e-e063-6394a90ad997	73496-005	HUMAN OTC DRUG	ROC MULTI CORREXION HYDRATE AND PLUMP DAILY MOISTURISER SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210405		OTC MONOGRAPH DRUG	M020	Roc Skincare	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
73496-007_0d0d4a7a-a69c-d15e-e063-6394a90a24aa	73496-007	HUMAN OTC DRUG	ROC MULTI CORREXION EVEN TONE LIFT DAILY MOISTURIZER SPF30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230101		OTC MONOGRAPH DRUG	M020	Roc Skincare	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 4; 4; 2	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
73496-010_0d0e22c7-e191-1b54-e063-6394a90a72e6	73496-010	HUMAN OTC DRUG	RoC Multi Correxion Revive and Glow Moisturizer SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	RoC Skincare	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73496-011_0cf8cb8c-91b2-36c8-e063-6294a90a0e82	73496-011	HUMAN OTC DRUG	RoC Barrier Renew AM Moisturizer SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	RoC Skincare	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 5.5; 4.5; 4	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73498-021_0cdefed6-6444-c34c-e063-6394a90a4099	73498-021	HUMAN OTC DRUG	Natures Willow Balm		Menthol	CREAM	TOPICAL	20210128		OTC MONOGRAPH DRUG	M017	WB VENTURES LLC	MENTHOL	30	mg/g			N	20241231
73498-022_0ce3186c-8ad9-852a-e063-6294a90a7a28	73498-022	HUMAN OTC DRUG	Natures Willow Bug Bite Balm		Menthol	CREAM	TOPICAL	20210128		OTC MONOGRAPH DRUG	M017	WB Ventures LLC	MENTHOL	10	mg/g			N	20241231
73498-023_0ce0934d-81de-76be-e063-6394a90aad1a	73498-023	HUMAN OTC DRUG	Natures Willow Balm Pain Relieving Patch		Harpagophytum Procumbens, Arnica Montana, Boswellia Serrata, Salix Alba	PATCH	TOPICAL	20210421		UNAPPROVED HOMEOPATHIC		WB Ventures LLC	ARNICA MONTANA FLOWER; HARPAGOPHYTUM PROCUMBENS ROOT; INDIAN FRANKINCENSE; SALIX ALBA BARK	3; 19; 1; .5	mg/1; mg/1; mg/1; mg/1			N	20241231
73498-024_0ce01a78-6f33-501e-e063-6394a90a0589	73498-024	HUMAN OTC DRUG	Natures Willow Itch Relief		Menthol	LOTION	TOPICAL	20210330	20240630	OTC MONOGRAPH DRUG	M017	WB Ventures LLC	MENTHOL	5	mg/g			N	
73498-025_0cdee317-4b8a-be0a-e063-6394a90abc6b	73498-025	HUMAN OTC DRUG	Natures Willow Bug Bite Patch		Calendula, Salix Alba	PATCH	TOPICAL	20211208	20241130	UNAPPROVED HOMEOPATHIC		WB Ventures LLC	CALENDULA OFFICINALIS FLOWER; SALIX ALBA BARK	.002; .004	mg/1; mg/1			N	
73498-026_0ce13ead-fc35-b1e6-e063-6394a90a3d67	73498-026	HUMAN OTC DRUG	Natures Willow Balm Pain Relief XL Patch		Harpagophytum Procumbens, Arnica Montana, Boswellia Serrata, Salix Alba	PATCH	TOPICAL	20231229		UNAPPROVED HOMEOPATHIC		WB Ventures LLC	ARNICA MONTANA FLOWER; HARPAGOPHYTUM PROCUMBENS ROOT; INDIAN FRANKINCENSE; SALIX ALBA BARK	3; 19; 1; .5	mg/1; mg/1; mg/1; mg/1			N	20241231
73498-028_0ce31b5d-4402-460c-e063-6394a90ab558	73498-028	HUMAN OTC DRUG	Natures Willow Balm Itch Relief Cream		Menthol	CREAM	TOPICAL	20231229		OTC MONOGRAPH DRUG	M017	WB Ventures LLC	MENTHOL	10	mg/g			N	20241231
73499-001_22617d3b-9736-472b-bc08-1ce53fe151aa	73499-001	HUMAN PRESCRIPTION DRUG	Wynzora		Calcipotriene and Betamethasone dipropionate	CREAM	TOPICAL	20210630		NDA	NDA213422	MC2 Therapeutics Ltd	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE	64; 50	mg/g; ug/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
73503-007_0d0ed130-0851-4fac-e063-6394a90ac1dc	73503-007	HUMAN OTC DRUG	Tazarodex	Plaque Psoriasis and Acne	TAZAROTENE	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M032	PSODEX USA INC	TAZAROTENE	.1	g/100mL	Retinoid [EPC], Retinoids [CS]		N	20241231
73503-008_0d0ec3bf-47e4-3390-e063-6394a90a38b8	73503-008	HUMAN OTC DRUG	Acne Therapy	Moisturizing	Salicylic Acid	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M006	PSODEX USA INC	SALICYLIC ACID	1.5	g/100mL			N	20241231
73503-009_0db01f99-4bf4-ee38-e063-6294a90afba9	73503-009	HUMAN OTC DRUG	Rosacea Therapy	Moisturizing	Azelaic Acid, Tranexamic Acid	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M006	PSODEX USA INC	AZELAIC ACID; TRANEXAMIC ACID	5; 1	g/100mL; g/100mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE], Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	20241231
73503-010_0d0ecf5b-0eaf-55c7-e063-6294a90ad69e	73503-010	HUMAN OTC DRUG	Seborrheic Dermatitis	Therapy	salicylic acid, pyrithione zinc	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M032	PSODEX USA INC	PYRITHIONE ZINC; SALICYLIC ACID	1; 1.5	g/100mL; g/100mL			N	20241231
73503-011_0d0e86c3-de38-3e1f-e063-6394a90a5b13	73503-011	HUMAN OTC DRUG	PSO THERA	Scalp Psoriasis	Tazaratone	SHAMPOO	TOPICAL	20240101		OTC MONOGRAPH DRUG	M032	PSODEX USA INC	TAZAROTENE	.05	g/100mL	Retinoid [EPC], Retinoids [CS]		N	20241231
73503-012_0d0e86c3-de25-3e1f-e063-6394a90a5b13	73503-012	HUMAN OTC DRUG	Anti Dandruff	Intensive Therapy	Selenium Sulfide, Zinc Pyrithione, Salicylic Acid	SHAMPOO	TOPICAL	20240101		OTC MONOGRAPH DRUG	M032	PSODEX USA INC	PYRITHIONE ZINC; SALICYLIC ACID; SELENIUM SULFIDE	1; 1; 1	g/100mL; g/100mL; g/100mL			N	20241231
73503-013_0d0e8dea-e6de-3e60-e063-6294a90aa7d4	73503-013	HUMAN OTC DRUG	Acne Therapy	Bar	sulfur	SOAP	TOPICAL	20240101		OTC MONOGRAPH DRUG	M006	PSODEX USA INC	SULFUR	3	g/100g			N	20241231
73509-010_8ed4635f-48b2-489e-8c2e-80929226ad56	73509-010	HUMAN OTC DRUG	by selected reinforce day serum		Adenosine	LIQUID	TOPICAL	20191201		UNAPPROVED DRUG OTHER		Garam Of Nature	ADENOSINE	.02	g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73509-020_e8ef5ba0-c2ab-4249-ae42-bc39c249d41d	73509-020	HUMAN OTC DRUG	by selected anti wrinkle day serum		Adenosine	LIQUID	TOPICAL	20191201		UNAPPROVED DRUG OTHER		Garam Of Nature	ADENOSINE	.02	g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73509-030_2fad653d-b362-4f9b-9cea-2e43d71eb751	73509-030	HUMAN OTC DRUG	by selected hyaluron day serum		Niacinamide	LIQUID	TOPICAL	20191201		UNAPPROVED DRUG OTHER		Garam Of Nature	NIACINAMIDE	1	g/50mL			N	20241231
73509-040_152a5bdc-29d7-4891-9be6-37042687845d	73509-040	HUMAN OTC DRUG	by Selected Repair Vitality		NIACINAMIDE, ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		Garam Of Nature	ADENOSINE; NIACINAMIDE	.02; 1	g/50mL; g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73509-050_4583c1dc-5c2d-4794-bce0-75962fdd4a9b	73509-050	HUMAN OTC DRUG	by Selected Daily Broad Spectrum Sunscreen		Ethylhexyl Methoxycinnamate, Ethylhexyl Salicylate	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		Garam Of Nature	OCTINOXATE; OCTISALATE	3.5; 2	g/50mL; g/50mL			N	20241231
73509-090_f239d0ae-b851-482e-b6ee-0c237133d202	73509-090	HUMAN OTC DRUG	by Selected Recovering Almighty		ADENOSINE	CREAM	TOPICAL	20220401		UNAPPROVED DRUG OTHER		Garam Of Nature	ADENOSINE	.04	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73513-323_b517ba94-1341-41ad-a4aa-d9516efec6bd	73513-323	HUMAN OTC DRUG	Topwin Speedy Enema		Glycerin	ENEMA	RECTAL	20200528		OTC MONOGRAPH DRUG	M007	Health Chemical Pharmaceutical Co., Ltd	GLYCERIN	3	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
73517-111_f333dfe6-1cfd-2a50-e053-2995a90aff5e	73517-111	HUMAN OTC DRUG	Olika Ultra Hydrating Hand Sanitizer Fragrance Free		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-121_f3341894-02a1-0998-e053-2995a90aef68	73517-121	HUMAN OTC DRUG	Olika Ultra Hydrating Hand Sanitizer Fragrance Free		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-127_f334252a-f003-3876-e053-2a95a90acd3d	73517-127	HUMAN OTC DRUG	Biossance Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	70	mL/100mL			N	20241231
73517-212_f3342dcd-165c-3e13-e053-2a95a90a28f5	73517-212	HUMAN OTC DRUG	OLIKA Hydrating Hand Sanitizer- Orange Blossom		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-345_f334308b-0e8b-894e-e053-2995a90a683f	73517-345	HUMAN OTC DRUG	OLIKA Hydrating Hand Sanitizer- Mint Citrus		ALCOHOL	GEL	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-353_f3343345-b939-9319-e053-2995a90ab104	73517-353	HUMAN OTC DRUG	OLIKA Hydrating Hand Sanitizer- Mint Citrus		ALCOHOL	GEL	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-381_ec976a81-09f3-6fb6-e053-2995a90a46e2	73517-381	HUMAN OTC DRUG	Biossance Squalane Moisturizer	SPF30	Zinc Oxide	LOTION	TOPICAL	20200601		OTC MONOGRAPH FINAL	M020	Amyris, Inc	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73517-382_ec975c9d-a14e-db6c-e053-2995a90a9e8f	73517-382	HUMAN OTC DRUG	Pipette Mineral Sunscreen Broad Spectrum	SPF50	Zinc Oxide	LOTION	TOPICAL	20200601		OTC MONOGRAPH FINAL	M020	Amyris, Inc	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73517-425_ec9769f6-68e7-7c92-e053-2a95a90a0bf6	73517-425	HUMAN OTC DRUG	Eczema		Colloidal Oatmeal	LOTION	TOPICAL	20210201		OTC MONOGRAPH FINAL	M016	Amyris, Inc	OATMEAL	1	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
73517-427_ec977a5f-7f93-2ccd-e053-2a95a90aa6fc	73517-427	HUMAN OTC DRUG	Pipette Diaper Rash		Zinc Oxide	CREAM	TOPICAL	20210201		OTC MONOGRAPH FINAL	M016	Amyris, Inc	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73517-494_f3343345-b93a-9319-e053-2995a90ab104	73517-494	HUMAN OTC DRUG	OLIKA Hydrating Hand Sanitizer- Lavender		ALCOHOL	GEL	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-501_f2f6c217-5c45-7b5c-e053-2995a90a50f1	73517-501	HUMAN OTC DRUG	Rose Inc. Solar Power Luminous Serum	SPF30	Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH FINAL	M020	Amyris, Inc	ZINC OXIDE	14	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73517-676_f334308b-0e8c-894e-e053-2995a90a683f	73517-676	HUMAN OTC DRUG	OLIKA Hydrating Hand Sanitizer- Cucumber Basil		ALCOHOL	GEL	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-767_f33450f5-b28b-a6cc-e053-2a95a90ab10c	73517-767	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-767_f334543a-ac57-cd87-e053-2a95a90a987c	73517-767	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-767_f334543a-ac58-cd87-e053-2a95a90a987c	73517-767	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-767_f33478b6-cf62-2366-e053-2a95a90ab659	73517-767	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73517-878_f3344b30-b98f-72d8-e053-2a95a90a95bc	73517-878	HUMAN OTC DRUG	OLIKA Hydrating Hand Sanitizer- Cucumber Basil		ALCOHOL	GEL	TOPICAL	20210901		OTC MONOGRAPH NOT FINAL	part333A	Amyris, Inc	ALCOHOL	65	mL/100mL			N	20241231
73519-001_0c0e8f59-0e22-854a-e063-6294a90a7663	73519-001	HUMAN OTC DRUG	BABYSONS		DEXPANTHENOL	OINTMENT	TOPICAL	20200615		OTC MONOGRAPH DRUG	M016	Laboratorios Quimica Son's, S.A. de C.V	DEXPANTHENOL	50	mg/g			N	20241231
73521-030_0c54ac73-09d0-41a4-9846-fa77f7f187f1	73521-030	HUMAN PRESCRIPTION DRUG	Tyrvaya		varenicline	SPRAY	NASAL	20211020		NDA	NDA213978	Oyster Point Pharma	VARENICLINE TARTRATE	.03	mg/.05mL	Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]		N	20241231
73526-002_6f8c1a05-f763-404a-990f-635e18a95738	73526-002	HUMAN OTC DRUG	SORARESAL		Salicylic Acid	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	M032	Summer Herbal Inc.	SALICYLIC ACID	2	g/100g			N	20241231
73527-0001_0b6a912d-0982-03b4-e063-6394a90a3348	73527-0001	HUMAN OTC DRUG	ONETOOTHCLINIC TOOTH		Silicon Dioxide, Tocopherol Acetate, Sodium Pyrophosphate	PASTE	DENTAL	20191114		UNAPPROVED DRUG OTHER		CONE MEDICAL Co., Ltd.	ALPHA-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM PYROPHOSPHATE	.1; 14; .5	g/100g; g/100g; g/100g			N	20241231
73527-0002_0b6a924d-37a7-08f3-e063-6294a90afe5f	73527-0002	HUMAN OTC DRUG	ONETOOTH CLINIC TOOTH		Silicon Dioxide, Tocopherol Acetate, Tetrasodium Pyrophosphate	PASTE	DENTAL	20210301		UNAPPROVED DRUG OTHER		CONE MEDICAL Co., Ltd.	ALPHA-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM PYROPHOSPHATE	.1; 14; .5	g/100g; g/100g; g/100g			N	20241231
73527-0003_0b6a93a4-de9a-0768-e063-6394a90afe77	73527-0003	HUMAN OTC DRUG	MIMIBO PREMIUM TOOTH		Silicon Dioxide, Tocopherol Acetate, Tetrasodium Pyrophosphate	PASTE, DENTIFRICE	DENTAL	20210401		UNAPPROVED DRUG OTHER		CONE MEDICAL Co., Ltd.	.ALPHA.-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM PYROPHOSPHATE	.1; 14; .5	g/100g; g/100g; g/100g			N	20241231
73527-0004_0b6a94d1-d0cb-145c-e063-6294a90a27e2	73527-0004	HUMAN OTC DRUG	MIMIBO PREMIUM TOOTH		Silicon Dioxide, Tocopherol Acetate, Tetrasodium Pyrophosphate	PASTE, DENTIFRICE	DENTAL	20210401		UNAPPROVED DRUG OTHER		CONE MEDICAL Co., Ltd.	.ALPHA.-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM PYROPHOSPHATE	.1; 14; .5	g/100g; g/100g; g/100g			N	20241231
73528-100_eacc0b70-1a69-ca6a-e053-2995a90afd2b	73528-100	HUMAN OTC DRUG	Balancing		Zinc Pyrithione	SHAMPOO	TOPICAL	20200201		OTC MONOGRAPH FINAL	part358H	Zero Flakes Given, LLC.	PYRITHIONE ZINC	1	g/100mL			N	20241231
73528-400_eacafe04-8ce9-5069-e053-2995a90a46a1	73528-400	HUMAN OTC DRUG	Treatment		Zinc Pyrithione	CREAM	TOPICAL	20200201		OTC MONOGRAPH FINAL	part358H	Zero Flakes Given, LLC.	PYRITHIONE ZINC	.125	g/100mL			N	20241231
73535-208_3e360b52-bf17-4064-8c61-64efb8772e0d	73535-208	HUMAN PRESCRIPTION DRUG	MONJUVI		Tafasitamab-cxix	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200805		BLA	BLA761163	MorphoSys US Inc.	TAFASITAMAB	200	mg/5mL			N	20241231
73539-001_a81d737d-e5c7-4823-968a-726d49ea3f7b	73539-001	CELLULAR THERAPY	LANTIDRA		DONISLECEL	SOLUTION	INTRAVASCULAR	20230628		BLA	BLA125734	CellTrans Inc.	DONISLECEL	5000	[arb'U]/400mL			N	20241231
73541-000_06f1ca45-396d-fa74-e063-6394a90a87fc	73541-000	HUMAN OTC DRUG	Reef Repair SPF 50	Suncream	Zinc Oxide, 25%	CREAM	TOPICAL	20191227		OTC MONOGRAPH DRUG	M020	Alive 2 Dive Company Limited	ZINC OXIDE	25	g/100mL			N	20241231
73541-001_06f1d4e6-807e-8d5d-e063-6294a90a827d	73541-001	HUMAN OTC DRUG	Reef Repair SPF 30	Suncream	Zinc Oxide, 20%	CREAM	TOPICAL	20191227		OTC MONOGRAPH DRUG	M020	Alive 2 Dive Company Limited	ZINC OXIDE	20	g/100mL			N	20241231
73543-001_0bdd78c5-378a-082a-e063-6294a90aedea	73543-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091223		UNAPPROVED MEDICAL GAS		SAKRX, LLC dba Kohll's RX	OXYGEN	99	L/100L			N	20241231
73544-001_0bb190fe-7187-d4d8-e063-6294a90a8938	73544-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091223		UNAPPROVED MEDICAL GAS		MasVida Health Care Solutions, LLC	OXYGEN	99	L/100L			N	20241231
73554-1111_0d1b475e-5782-2bd1-e063-6294a90a7311	73554-1111	CELLULAR THERAPY	Lyfgenia		lovotibeglogene autotemcel	SUSPENSION	INTRAVENOUS	20231208		BLA	BLA125788	bluebird bio, Inc.	LOVOTIBEGLOGENE AUTOTEMCEL	20000000	1/20mL			N	20241231
73554-2111_3b27cff8-97db-4002-86a8-e4b454312728	73554-2111	CELLULAR THERAPY	Skysona		elivaldogene autotemcel	SUSPENSION	INTRAVENOUS	20220916		BLA	BLA125755	bluebird bio, Inc.	ELIVALDOGENE AUTOTEMCEL	30000000	1/1			N	20241231
73554-3111_1f4166d5-1256-4c4d-b974-6afbab410b31	73554-3111	CELLULAR THERAPY	Zynteglo		betibeglogene autotemcel	SUSPENSION	INTRAVENOUS	20220817		BLA	BLA125717	bluebird bio, Inc.	BETIBEGLOGENE AUTOTEMCEL	20000000	1/1			N	20241231
73556-168_75d372f7-9f5f-4552-bc06-0e534dae00c7	73556-168	HUMAN PRESCRIPTION DRUG	TAVNEOS		avacopan	CAPSULE	ORAL	20211018		NDA	NDA214487	ChemoCentryx, Inc.	AVACOPAN	10	mg/1	Complement 5a Receptor Antagonist [EPC], Complement 5a Receptor Antagonists [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
73557-130_f78d7170-41b3-0379-e053-6294a90afd63	73557-130	HUMAN OTC DRUG	Elastic Relief Strip		Menthol	PATCH	TOPICAL	20221230		OTC MONOGRAPH NOT FINAL	part348	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	MENTHOL	.056	g/g			N	20241231
73557-131_0e6a09cc-7987-f851-e063-6294a90aff67	73557-131	HUMAN OTC DRUG	MENTHOL PAIN RELIEF Gel-Patch		Menthol	PATCH	TOPICAL	20240109		OTC MONOGRAPH DRUG	M017	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	MENTHOL	.05	g/g			N	20251231
73557-133_f790c967-3ffb-fca9-e053-6294a90a731b	73557-133	HUMAN OTC DRUG	OVERNIGHT RELIEF Gel-Patch		Menthol	PATCH	TOPICAL	20221230		OTC MONOGRAPH NOT FINAL	part348	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	MENTHOL	.05	g/g			N	20241231
73557-157_0e6bacb9-400e-b6d8-e063-6294a90a8feb	73557-157	HUMAN OTC DRUG	Pain Relieving Gel-Patch		Lidocaine	PATCH	TOPICAL	20221230		OTC MONOGRAPH DRUG	M017	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	LIDOCAINE	.04	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
73557-158_fd0d4646-4b5f-3fe8-e053-6394a90ad6c4	73557-158	HUMAN OTC DRUG	Pain Relieving Gel-Patch		Lidocaine	PATCH	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part348	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	LIDOCAINE	.04	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73557-172_0e6bad85-9997-d523-e063-6294a90ae069	73557-172	HUMAN OTC DRUG	PAIN RELIEF Gel-Patch		Lidocaine and Menthol	PATCH	TOPICAL	20221230		OTC MONOGRAPH DRUG	M017	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	LIDOCAINE; MENTHOL	.04; .01	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
73557-180_f19a9a9d-cd42-229e-e053-2a95a90a9584	73557-180	HUMAN OTC DRUG	Pain Relieving Gel-Patch		Capsaicin	PATCH	TOPICAL	20221230		OTC MONOGRAPH NOT FINAL	part348	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	CAPSAICIN	.00025	g/g			N	20241231
73557-323_f0bec1d4-2e19-4519-e053-2a95a90a1bbb	73557-323	HUMAN OTC DRUG	PAIN RELIEF Gel-Tube		Menthol	GEL	TOPICAL	20221228		OTC MONOGRAPH NOT FINAL	part348	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	MENTHOL	.04	g/mL			N	20241231
73557-333_f0bc2a14-6bdb-428c-e053-2995a90a4ced	73557-333	HUMAN OTC DRUG	PAIN RELIEF Gel-Roll On		Menthol	GEL	TOPICAL	20221228		OTC MONOGRAPH NOT FINAL	part348	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	MENTHOL	.04	g/mL			N	20241231
73557-373_f0bc2a14-6bd4-428c-e053-2995a90a4ced	73557-373	HUMAN OTC DRUG	PAIN RELIEF Gel-Roll On		Lidocaine and Menthol	GEL	TOPICAL	20221222		OTC MONOGRAPH NOT FINAL	part348	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	LIDOCAINE; MENTHOL	.04; .01	g/mL; g/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73557-575_05b08163-e42d-45b0-e063-6394a90ab429	73557-575	HUMAN OTC DRUG	Sunscreen-Lotion		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20230913		OTC MONOGRAPH FINAL	M020	Shanghai Chuangshi Medical Technology (Group) Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	.037; .14	g/g; g/g			N	20241231
73562-104_add89bad-4329-42e0-b164-f1e7bc293fdc	73562-104	HUMAN PRESCRIPTION DRUG	Viokace		Pancrelipase	TABLET	ORAL	20210301		BLA	BLA022542	Aimmune Therapeutics, Inc	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	39150; 10440; 39150	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-110_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-110	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20210101		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	42000; 10000; 32000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-111_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-111	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20201201		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	63000; 15000; 47000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-112_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-112	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20201201		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	84000; 20000; 63000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-113_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-113	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20210101		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	14000; 3000; 10000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-114_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-114	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20201101		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	168000; 40000; 126000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-115_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-115	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20210101		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	24000; 5000; 17000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-116_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-116	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20201101		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	105000; 25000; 79000	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-117_ced6785c-6d88-45c2-ade0-0c21b60f39fa	73562-117	HUMAN PRESCRIPTION DRUG	Zenpep		pancrelipase lipase, pancrelipase protease, pancrelipase amylase	CAPSULE, DELAYED RELEASE	ORAL	20201101		BLA	BLA022210	Aimmune Therapeutics, Inc.	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	252600; 60000; 189600	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73562-208_add89bad-4329-42e0-b164-f1e7bc293fdc	73562-208	HUMAN PRESCRIPTION DRUG	Viokace		Pancrelipase	TABLET	ORAL	20210301		BLA	BLA022542	Aimmune Therapeutics, Inc	PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE	78300; 20880; 78300	[USP'U]/1; [USP'U]/1; [USP'U]/1			N	20241231
73563-011_d1ff5e22-6219-404c-9a2f-b9862dba0c36	73563-011	HUMAN OTC DRUG	Sunscreen with Aloe Vera SPF 30		Octinoxate, Octisalate, and Oxybenzone	LOTION	TOPICAL	20200201		OTC MONOGRAPH FINAL	part352	Body One Products, Inc.	OCTINOXATE; OCTISALATE; OXYBENZONE	75; 50; 60	mg/mL; mg/mL; mg/mL			N	20241231
73563-335_006d3b91-f3ef-4711-ba62-1321a70e5000	73563-335	HUMAN OTC DRUG	Hilton SPF 30 Mineral Sunscreen		Zinc Oxide	CREAM	CUTANEOUS	20230801		OTC MONOGRAPH NOT FINAL	part352	Body One, LLC	ZINC OXIDE	21.6	g/100mL			N	20241231
73563-638_006d3b91-f3ef-4711-ba62-1321a70e5000	73563-638	HUMAN OTC DRUG	Orior SPF 30 Mineral Sunscreen		Zinc Oxide	CREAM	CUTANEOUS	20230801		OTC MONOGRAPH NOT FINAL	part352	Body One, LLC	ZINC OXIDE	21.6	g/100mL			N	20241231
73567-001_0d773c0d-7a28-d567-e063-6394a90a9c54	73567-001	HUMAN OTC DRUG	EXTERNAL ANALGESIC		CAMPHOR (SYNTHETIC), CAPSICUM, MENTHOL	PATCH	TOPICAL	20200401		OTC MONOGRAPH DRUG	M017	Zhengzhou Daohe Medical Technology Co.,Ltd	CAMPHOR (SYNTHETIC); CAPSICUM; MENTHOL	96; .5; 78	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
73570-001_ad68adab-ec03-4d5d-b38e-322d1cc578cb	73570-001	HUMAN OTC DRUG	Doctor Os Diaper Balm		Zinc Oxide	OINTMENT	TOPICAL	20200214		OTC MONOGRAPH FINAL	part347	Dr. O's Dermabalm, Llc	ZINC OXIDE	30	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73572-002_09cca94c-cafb-1c88-e063-6294a90a90e5	73572-002	HUMAN OTC DRUG	Personalized Day Moisturizer with SPF		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200301		OTC MONOGRAPH DRUG	M020	Proven Skincare	TITANIUM DIOXIDE; ZINC OXIDE	20; 10	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73572-003_09cca59b-e10d-a52d-e063-6294a90a076b	73572-003	HUMAN OTC DRUG	Personalized Day Moisturizer with SPF		ZINC OXIDE	CREAM	TOPICAL	20200301		OTC MONOGRAPH DRUG	M020	Proven Skincare	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73572-004_09cccc31-4580-e72e-e063-6394a90ab35a	73572-004	HUMAN OTC DRUG	Proven Personalized Day Moisturizer With SPF 50		ZINC OXIDE	CREAM	TOPICAL	20210214		OTC MONOGRAPH DRUG	M020	Proven Skincare	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73572-007_09cc9eb2-c5b1-d6fa-e063-6394a90a4ea2	73572-007	HUMAN OTC DRUG	Personalized Day Moisturizer with SPF 50		ZINC OXIDE	CREAM	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Proven Skincare	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73575-009_e9b6e7d9-0dee-4669-a6f7-627cd94af7b2	73575-009	HUMAN PRESCRIPTION DRUG	Pliaglis		lidocaine and tetracaine	CREAM	TOPICAL	20200124		NDA	NDA021717	Oba Pharmaceuticals, Inc.	LIDOCAINE; TETRACAINE	70; 70	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
73581-001_0197e24f-8cb1-bfbe-e063-6394a90a93fd	73581-001	HUMAN OTC DRUG	Pain Relieving Lidocaine Patch		Lidocaine	PATCH	TOPICAL	20200917		OTC MONOGRAPH NOT FINAL	part348	YYBA CORP	LIDOCAINE	40	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73581-011_0e13a9d0-d559-95a8-e063-6294a90a72ff	73581-011	HUMAN OTC DRUG	ALLERGY RELIEF		FEXOFENADINE HYDROCHLORIDE	TABLET	ORAL	20210325		ANDA	ANDA204507	YYBA CORP	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
73581-013_5f3f8962-43e1-417d-bf06-6dd656eb5c60	73581-013	HUMAN OTC DRUG	Esomeprazole		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20230308		ANDA	ANDA212866	YYBA CORP	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
73581-020_6f8bb858-3540-447e-a75b-86596b753ec3	73581-020	HUMAN OTC DRUG	Allergy Relief Diphenhydramine HCL 50 MG		Diphenhydramine HCL	CAPSULE	ORAL	20230801		OTC MONOGRAPH FINAL	part341	YYBA Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73581-101_ae2e0cfe-f5ab-d20f-e053-2995a90a5237	73581-101	HUMAN OTC DRUG	WELMATE Anti Diarrheal Loperamide HCl		LOPERAMIDE HYDROCHLORIDE	TABLET	ORAL	20200822		ANDA	ANDA076497	YYBA CORP	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
73581-102_ec6b87f1-e600-21c2-e053-2a95a90ab76d	73581-102	HUMAN OTC DRUG	WELMATE Anti Diarrheal Loperamide HCl Softgels		LOPERAMIDE HYDROCHLORIDE	CAPSULE	ORAL	20200822		NDA	NDA021855	YYBA CORP	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
73581-103_0e13664c-b409-d2fa-e063-6394a90a2d33	73581-103	HUMAN OTC DRUG	ALLERGY RELIEF		FEXOFENADINE HYDROCHLORIDE	TABLET	ORAL	20200630		ANDA	ANDA204507	YYBA CORP	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
73581-104_0e135981-faca-f255-e063-6394a90ae356	73581-104	HUMAN OTC DRUG	Diclofenac Sodium Topical	1%	Diclofenac Sodium	GEL	TOPICAL	20230831		ANDA	ANDA210986	YYBA CORP	DICLOFENAC SODIUM	1	mg/100g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
73581-105_0e135981-faae-f255-e063-6394a90ae356	73581-105	HUMAN OTC DRUG	Lidocaine Numbing Cream		Lidocaine	CREAM	TOPICAL	20201113		OTC MONOGRAPH DRUG	M017	YYBA Corp	LIDOCAINE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20251231
73581-105_387e2e36-2ddd-4015-97de-a2a62088b40f	73581-105	HUMAN OTC DRUG	Lidocaine Numbing Cream		Lidocaine	CREAM	TOPICAL	20220617		OTC MONOGRAPH DRUG	M	Yyba Corp	LIDOCAINE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73581-107_0e138cd5-2c08-ffff-e063-6394a90a0b72	73581-107	HUMAN OTC DRUG	PINRID		PYRANTEL PAMOATE	TABLET	ORAL	20210402		OTC MONOGRAPH DRUG	M031	YYBA CORP	PYRANTEL PAMOATE	250	mg/1			N	20251231
73581-201_600c2aad-ce4c-406b-91c6-a365199ec58a	73581-201	HUMAN OTC DRUG	ALLERGY RELIEF		LEVOCETIRIZINE DIHYDROCHLORIDE	TABLET	ORAL	20200630		ANDA	ANDA213513	YYBA CORP	LEVOCETIRIZINE DIHYDROCHLORIDE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73581-202_0e13664c-b422-d2fa-e063-6394a90a2d33	73581-202	HUMAN OTC DRUG	CETIRIZINE HYDROCHLORIDE	10 MG	CETIRIZINE HYDROCHLORIDE	TABLET	ORAL	20210616		ANDA	ANDA209274	YYBA CORP	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
73581-203_0e1383b5-910b-fabb-e063-6394a90a0a30	73581-203	HUMAN OTC DRUG	ALLERGY RELIEF	10mg	LORATADINE	TABLET	ORAL	20210728		ANDA	ANDA208314	YYBA CORP	LORATADINE	10	mg/1			N	20251231
73581-204_0e13a1f1-87bb-b26e-e063-6294a90a87f8	73581-204	HUMAN OTC DRUG	NASAL DECONGESTANT PE	10mg	PHENYLPHRINE HCL	TABLET	ORAL	20210803		OTC MONOGRAPH DRUG	M012	YYBA CORP	PHENYLEPHRINE HYDROCHLORIDE	25	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20251231
73581-205_f201a684-1c47-ded4-e053-2995a90a853e	73581-205	HUMAN OTC DRUG	SLEEP AID	25mg	DOXYLAMINE SUCCINATE	TABLET	ORAL	20210803		ANDA	ANDA040564	YYBA CORP	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
73581-210_cc5f372c-2a7c-47f0-b324-d0cf2c363279	73581-210	HUMAN OTC DRUG	Butenafine Hydrochloride		Butenafine Hydrochloride	CREAM	TOPICAL	20231012		ANDA	ANDA205181	YYBA CORP	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
73581-214_a9cc0bf4-02f6-4c7a-bf84-770d56bafb4a	73581-214	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20231015		ANDA	ANDA215940	YYBA CORP	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
73581-230_0e135981-fabe-f255-e063-6394a90ae356	73581-230	HUMAN OTC DRUG	LORATADINE ALLERGY RELIEF	10mg	LORATADINE	TABLET	ORAL	20220415		ANDA	ANDA210722	YYBA CORP	LORATADINE	10	mg/1			N	20251231
73581-301_f201a2bd-92bd-b4ac-e053-2a95a90af713	73581-301	HUMAN OTC DRUG	GAS RELIEF	EXTRA STRENGTH	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20210920		OTC MONOGRAPH FINAL	part332	YYBA CORP	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
73581-401_0e1352bf-9971-edc9-e063-6394a90adc7d	73581-401	HUMAN OTC DRUG	MUCUS RELIEF	GUAIFENESIN EXTENDED-RELEASE 600 mg	GUAIFENESIN	TABLET	ORAL	20220302		ANDA	ANDA213420	YYBA CORP	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
73581-402_0e136ad4-0fa9-8639-e063-6294a90aa9c7	73581-402	HUMAN OTC DRUG	MUCUS RELIEF	GUAIFENESIN EXTENDED-RELEASE 1200 mg	GUAIFENESIN	TABLET	ORAL	20220302		ANDA	ANDA213420	YYBA CORP	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
73581-404_0e1383b5-90ff-fabb-e063-6394a90a0a30	73581-404	HUMAN OTC DRUG	MUCUS RELIEF - DM	MAXIMUM STRENGTH	Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20230525		ANDA	ANDA206941	YYBA CORP	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
73581-909_0e137aa6-12f6-9487-e063-6294a90a4dd9	73581-909	HUMAN OTC DRUG	Urinary Pain Relief		Phenazopyridine Hydrochloride	TABLET	ORAL	20200910		UNAPPROVED DRUG OTHER		YYBA CORP	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20251231
73581-911_e8bc96bc-7878-4906-e053-2a95a90ae6ba	73581-911	HUMAN OTC DRUG	Welmate Lidocaine Pain Relieving Patch		Lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20211101		OTC MONOGRAPH NOT FINAL	part348	Yyba Corporation	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73582-0002_f5626988-a23f-44ea-e053-2a95a90a6bd0	73582-0002	HUMAN OTC DRUG	BONBLISSITY HAND SANITIZING WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20200602		OTC MONOGRAPH NOT FINAL	part333E	BONBLISS BEAUTY, INC.	BENZALKONIUM CHLORIDE	.01	g/g			N	20241231
73586-102_05ea9eea-3d53-3778-e063-6294a90ad8ac	73586-102	HUMAN OTC DRUG	DAYDREAM CUSHION	CLOUD DREAM	Avobenzone, Homosalate, Octisalate, Titanium Dioxide	CREAM	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part352	EM Cosmetics LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE	1.5; 8; 3; 12.6	g/100g; g/100g; g/100g; g/100g			N	20241231
73586-103_05ea9eea-3d5f-3778-e063-6294a90ad8ac	73586-103	HUMAN OTC DRUG	DAYDREAM CUSHION	GENTLE LIGHT	Avobenzone, Homosalate, Octisalate, Titanium Dioxide	CREAM	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part352	EM Cosmetics LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE	1.5; 8; 3; 11.8	g/100g; g/100g; g/100g; g/100g			N	20241231
73586-104_05eab4a0-c729-7298-e063-6294a90a8ba2	73586-104	HUMAN OTC DRUG	DAYDREAM CUSHION	MAGIC DREAM	Avobenzone, Homosalate, Octisalate, Titanium Dioxide	CREAM	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part352	EM Cosmetics LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE	1.5; 8; 3; 8.3	g/100g; g/100g; g/100g; g/100g			N	20241231
73586-105_05eab4a0-c735-7298-e063-6294a90a8ba2	73586-105	HUMAN OTC DRUG	DAYDREAM CUSHION	SUMMER HUE	Avobenzone, Homosalate, Octisalate, Titanium Dioxide	CREAM	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part352	EM Cosmetics LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE	1.5; 8; 3; 8.4	g/100g; g/100g; g/100g; g/100g			N	20241231
73586-106_05ea81bc-3f9b-4482-e063-6394a90adade	73586-106	HUMAN OTC DRUG	DAYDREAM CUSHION	SWEET SECRET	Avobenzone, Homosalate, Octisalate, Titanium Dioxide	CREAM	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part352	EM Cosmetics LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE	1.5; 8; 3; 10.9	g/100g; g/100g; g/100g; g/100g			N	20241231
73586-107_05eaca2b-0c78-ddfa-e063-6294a90a5f72	73586-107	HUMAN OTC DRUG	DAYDREAM CUSHION	WARM DUSK	Avobenzone, Homosalate, Octisalate, Titanium Dioxide	CREAM	TOPICAL	20201006		OTC MONOGRAPH NOT FINAL	part352	EM Cosmetics LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE	1.5; 8; 3; 8.3	g/100g; g/100g; g/100g; g/100g			N	20241231
73590-0001_9d2a82d1-5ebc-751b-e053-2995a90a1dd0	73590-0001	HUMAN OTC DRUG	THE SKINHOUSE WHITE TIGHTENINGCREAM		niacinamide	CREAM	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0002_9d2b6397-b630-1144-e053-2995a90af80d	73590-0002	HUMAN OTC DRUG	THE SKINHOUSE WHITE TIGHTENINGEMULSION		niacinamide	EMULSION	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0003_9d50f2b9-1952-0292-e053-2995a90aad81	73590-0003	HUMAN OTC DRUG	THE SKINHOUSE WHITE TIGHTENING SERUM		niacinamide	LIQUID	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0004_9d51e2d9-15de-258b-e053-2995a90a6e85	73590-0004	HUMAN OTC DRUG	THE SKINHOUSE WHITE TIGHTENING TONER		niacinamide	LIQUID	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0005_9d5231bf-fd71-1298-e053-2a95a90ae00e	73590-0005	HUMAN OTC DRUG	THE SKINHOUSE WRINKLE SUPREMECREAM		panax ginseng extract	CREAM	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ASIAN GINSENG	.5	g/100mL			N	20241231
73590-0006_9d526616-5b33-9195-e053-2995a90a59bb	73590-0006	HUMAN OTC DRUG	THE SKINHOUSE WRINKLE SUPREMEEMULSION		Panax Ginseng Root Extract	EMULSION	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ASIAN GINSENG	.5	g/100mL			N	20241231
73590-0007_9d52b294-d589-c782-e053-2a95a90ab66b	73590-0007	HUMAN OTC DRUG	THE SKINHOUSE WRINKLE SUPREME SERUM		panax ginseng extract	LIQUID	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ASIAN GINSENG	.5	g/100mL			N	20241231
73590-0008_9d530096-d5ba-5c06-e053-2995a90a60d9	73590-0008	HUMAN OTC DRUG	THE SKINHOUSE WRINKLE SUPREME TONER		Panax Ginseng Root Extract	LIQUID	TOPICAL	20200122		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ASIAN GINSENG	.5	g/100mL			N	20241231
73590-0009_a04f12bb-b383-e6b4-e053-2995a90a3434	73590-0009	HUMAN OTC DRUG	THE SKINHOUSE Rose Heaven Toner		Rose Extract, Rosa Canina Fruit Oil, PaeoniaLactiflora Bark/Sap Extract, Leontopodium Alpinum extract, Adenosine, Niacinamide	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; LEONTOPODIUM ALPINUM FLOWER; NIACINAMIDE; PAEONIA LACTIFLORA WHOLE; ROSA CANINA FRUIT; ROSA CANINA FRUIT OIL	.04; .1; 2; .1; .5; .5	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0010_2932cbff-eab7-4614-b610-996e01330068	73590-0010	HUMAN OTC DRUG	Black Snail CollagenCream		Snail Secretion Filtrate, collagen	CREAM	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	SNAIL, UNSPECIFIED	60	g/100mL			N	20241231
73590-0011_a0c9f7e8-63ca-6962-e053-2a95a90ae722	73590-0011	HUMAN OTC DRUG	Black Snail Collagen EyeCream		Snail Secretion Filtrate, collagen	CREAM	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	SNAIL, UNSPECIFIED	60	g/100mL			N	20241231
73590-0012_a0ca377b-08a3-e50e-e053-2a95a90acb44	73590-0012	HUMAN OTC DRUG	Black Snail CollagenEmulsion		Snail Secretion Filtrate, collagen	EMULSION	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	SNAIL, UNSPECIFIED	60	g/100mL			N	20241231
73590-0013_a0ca7991-8382-94cf-e053-2995a90a2022	73590-0013	HUMAN OTC DRUG	Black Snail Collagen Serum		Snail Secretion Filtrate, collagen	LIQUID	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	SNAIL, UNSPECIFIED	60	g/100mL			N	20241231
73590-0014_a0caa16a-8e93-7ecb-e053-2995a90afcbd	73590-0014	HUMAN OTC DRUG	Black Snail Collagen Toner		Snail Secretion Filtrate, collagen	LIQUID	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	SNAIL, UNSPECIFIED	60	g/100mL			N	20241231
73590-0015_a0cabb39-c306-0be1-e053-2a95a90ade71	73590-0015	HUMAN OTC DRUG	VITA C BRIGHTCREAM		niacinamide	CREAM	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0016_a0ca6689-d4a5-207e-e053-2995a90aad6b	73590-0016	HUMAN OTC DRUG	Vita C Bright EyeCream		niacinamide	CREAM	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0017_a0cb9fce-a03f-05d3-e053-2a95a90a69e9	73590-0017	HUMAN OTC DRUG	Vita C Bright Serum		niacinamide	LIQUID	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0018_a0cbc39d-9e3d-cc8b-e053-2a95a90a5492	73590-0018	HUMAN OTC DRUG	Vita C Bright Toner		niacinamide	LIQUID	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0019_a0cc3b6a-c6ab-8410-e053-2995a90ae5e9	73590-0019	HUMAN OTC DRUG	THE SKIN HOUSE EGF COLLAGEN AMPOULE		Hydrolyzed Collagen (GLYCYRRHIZINATE DIPOTASSIUM)	LIQUID	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	GLYCYRRHIZINATE DIPOTASSIUM	.1	g/100mL			N	20241231
73590-0020_a103df89-0437-f1d9-e053-2995a90a1dca	73590-0020	HUMAN OTC DRUG	THE SKIN HOUSE HYALURONIC 6000 AMPOULE		Sodium Hyaluronate	LIQUID	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	HYALURONATE SODIUM	6	g/100mL			N	20241231
73590-0021_a104325b-f104-cded-e053-2a95a90a6dca	73590-0021	HUMAN OTC DRUG	THE SKIN HOUSE SNAIL MUCIN 5000 AMPOULE		Snail Secretion Filtrate	LIQUID	TOPICAL	20200314		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	SNAIL, UNSPECIFIED	.1	g/100mL			N	20241231
73590-0022_a21bb0c4-aca1-4bb2-e053-2a95a90aa9a5	73590-0022	HUMAN OTC DRUG	THE SKIN HOUSE Rose HeavenCream		Adenosine, Niacinamide	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0023_a21b8148-1279-79a0-e053-2995a90a34a0	73590-0023	HUMAN OTC DRUG	THE SKIN HOUSE ROSE HEAVEN		Adenosine, Niacinamide	EMULSION	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0024_a21c72f8-0100-0971-e053-2995a90a2f97	73590-0024	HUMAN OTC DRUG	THE SKIN HOUSE ROSE HEAVEN SERUM		Adenosine, Niacinamide	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0025_a21cbd15-1305-2e59-e053-2a95a90abbcc	73590-0025	HUMAN OTC DRUG	THE SKIN HOUSE Vital BrightCream		Niacinamide	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0026_a21d0a60-7a0d-f7fa-e053-2a95a90a262c	73590-0026	HUMAN OTC DRUG	THE SKIN HOUSE Vital Bright Emulsion		Niacinamide	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	1	g/100mL			N	20241231
73590-0027_a21d3c87-0a80-2e15-e053-2a95a90aee69	73590-0027	HUMAN OTC DRUG	THE SKIN HOUSE Vital Bright EyeCream		Niacinamide	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0028_a21d7c1c-801d-0f92-e053-2995a90a9781	73590-0028	HUMAN OTC DRUG	THE SKIN HOUSE Vital BrightSerum		Niacinamide	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0029_a21da4f3-db5e-896c-e053-2995a90a38ab	73590-0029	HUMAN OTC DRUG	THE SKIN HOUSE Vital Bright Toner		Niacinamide	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0031_a21f14df-a276-3791-e053-2a95a90a6b59	73590-0031	HUMAN OTC DRUG	THE SKIN HOUSE Wrinkle CollagenEmulsion		adenosine	EMULSION	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0032_a58e41a9-486a-6a1e-e053-2a95a90aff9b	73590-0032	HUMAN OTC DRUG	THE SKIN HOUSE Wrinkle Snail SystemCream		adenosine	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0033_a21fa53d-f7af-071c-e053-2995a90adbb7	73590-0033	HUMAN OTC DRUG	THE SKIN HOUSE Wrinkle SystemCream		adenosine	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0034_a2211d4f-4412-18bf-e053-2995a90a4494	73590-0034	HUMAN OTC DRUG	THE SKIN HOUSE Wrinkle System Essence		adenosine	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0035_a2220aa2-953b-7b63-e053-2a95a90a6382	73590-0035	HUMAN OTC DRUG	THE SKIN HOUSE Wrinkle System EyeCream		adenosine	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0036_a226a635-42cd-7a0e-e053-2a95a90afa68	73590-0036	HUMAN OTC DRUG	THE SKIN HOUSE Wrinkle Collagen Toner		adenosine	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0037_a48dae76-df80-d22d-e053-2995a90a1155	73590-0037	HUMAN OTC DRUG	SFERANGS COLLAGEN RECHARGING SERUM		adenosine	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0038_a227604a-2aa5-f37e-e053-2995a90a0d85	73590-0038	HUMAN OTC DRUG	SFERANGS COLLAGEN RECHARGING		adenosine	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0039_a48d8432-9330-5ae3-e053-2995a90ac028	73590-0039	HUMAN OTC DRUG	SFERANGS COLLAGEN RECHARGING TONER		adenosine	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0040_a22c5ad3-9911-45df-e053-2995a90a2d13	73590-0040	HUMAN OTC DRUG	SFERANGS COLLAGEN SYNERGY AMPOULE		adenosine	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0041_a22c6db2-bdf8-6227-e053-2a95a90a14f1	73590-0041	HUMAN OTC DRUG	SFERANGS VITA C CAPSULEBOOSTER		niacinamide	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
73590-0045_a22ca66a-44ec-efcc-e053-2995a90a027c	73590-0045	HUMAN OTC DRUG	XYCOS PINK COLLAGEN		adenosine, niacinamide	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0046_a22d3cc9-ea70-a594-e053-2995a90abe6c	73590-0046	HUMAN OTC DRUG	XYCOS PINK COLLAGEN SERUM		adenosine, niacinamide	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0047_a22d5d31-4c3e-651c-e053-2a95a90ae541	73590-0047	HUMAN OTC DRUG	XYCOS PINK COLLAGEN TONER		adenosine, niacinamide	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0048_a2c155de-ff56-80b0-e053-2995a90af41b	73590-0048	HUMAN OTC DRUG	THE SKIN HOUSE WRINKLE COLLAGEN AMPOULE		adenosine	LIQUID	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0049_a2c151e1-3a85-8639-e053-2a95a90a86db	73590-0049	HUMAN OTC DRUG	THE SKIN HOUSE ROSE HeavenEmulsion		Adenosine, Niacinamide	EMULSION	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0050_a2c19f6e-80d1-8178-e053-2995a90a1a89	73590-0050	HUMAN OTC DRUG	THE SKIN HOUSE Vital BrightEmulsion		Niacinamide	EMULSION	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	1	g/100mL			N	20241231
73590-0051_a48defb1-0979-c261-e053-2995a90af75f	73590-0051	HUMAN OTC DRUG	SFERANGS COLLAGEN RECHARGINGCREAM		adenosine	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0052_a37811f9-7dfb-40f4-e053-2a95a90aa1f6	73590-0052	HUMAN OTC DRUG	XYCOS PINK COLLAGENCREAM		adenosine, niacinamide	CREAM	TOPICAL	20200308		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0053_aeb29f2c-d1e9-981d-e053-2a95a90a2047	73590-0053	HUMAN OTC DRUG	AP II NeckCream		adenosine, niacinamide	CREAM	TOPICAL	20200907		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0054_aeb32a08-92cc-5a48-e053-2a95a90aa05e	73590-0054	HUMAN OTC DRUG	MULTI FUNCTION SLEEPING PACK		adenosine	LIQUID	TOPICAL	20200907		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0061_822b1bd6-5d7a-41b4-bdd9-2e95eea84c40	73590-0061	HUMAN OTC DRUG	VITA SNAIL		NIACINAMIDE, ADENOSINE	CREAM	TOPICAL	20210301		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.02; 1	g/50mL; g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0070_bc55cc95-4181-4456-9318-334742ed4dc3	73590-0070	HUMAN OTC DRUG	COXIR INTENSIVE EGF PEPTIDE MASK PACK		NIACINAMIDE, ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.03; 1.6	g/80mL; g/80mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0071_6a55c458-0a4e-4dc0-8878-ed0164061d93	73590-0071	HUMAN OTC DRUG	COXIR INTENSIVE EGF PEPTIDE		NIACINAMIDE, ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.02; 1	g/50mL; g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0072_9f3c92eb-5820-46c6-bcc6-109ef6e0f60b	73590-0072	HUMAN OTC DRUG	COXIR INTENSIVE EGF PEPTIDE		NIACINAMIDE, ADENOSINE	EMULSION	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0073_4c2a01bc-c624-4feb-a024-e83aa1a5fefe	73590-0073	HUMAN OTC DRUG	COXIR INTENSIVE EGF PEPTIDE SERUM		NIACINAMIDE, ADENOSINE	LIQUID	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.02; 1	g/50mL; g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0074_206c4a1d-4d70-406f-a7a0-f90bdeabd39d	73590-0074	HUMAN OTC DRUG	COXIR INTENSIVE EGF PEPTIDE TONER		NIACINAMIDE, ADENOSINE	LIQUID	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.06; 3	g/150mL; g/150mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0075_e0ed71f8-9fcc-4604-83e7-4c83389aa83f	73590-0075	HUMAN OTC DRUG	THE SKINHOUSE ALOE SOOTHING VITAMIN		NIACINAMIDE	GEL	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	NIACINAMIDE	1	g/50mL			N	20241231
73590-0076_47496618-e7e9-4796-b7f4-197fdd31d005	73590-0076	HUMAN OTC DRUG	THE SKINHOUSE BLACK SNAIL WRINKLE		ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.02	g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0077_60ac4e26-e91e-4213-b586-49e291ee0863	73590-0077	HUMAN OTC DRUG	THE SKINHOUSE GREEN TEA COLLAGEN		ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.02	g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0078_ca38055e-3545-4d85-bd06-fb0096f6d534	73590-0078	HUMAN OTC DRUG	THE SKINHOUSE REAL SNAIL WRINKLE FREE		ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.01	g/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0079_4e84dd95-1ae3-4ea3-a1fa-51cb4a62d731	73590-0079	HUMAN OTC DRUG	THE SKINHOUSE WRINKLE COLLAGEN		ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.02	g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0080_953fffc5-e956-47a2-b748-ab494904a40b	73590-0080	HUMAN OTC DRUG	THE SKINHOUSE WRINKLE COLLAGEN FREE SPOT		ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.01	g/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0081_92e0bb18-470f-4317-8640-16d2437ff8f2	73590-0081	HUMAN OTC DRUG	THE SKINHOUSE WRINKLE EYE PLUS		ADENOSINE	CREAM	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE	.01	g/30mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73590-0082_7dc9ae24-7853-481b-a600-528db0b1d23a	73590-0082	HUMAN OTC DRUG	THE SKINHOUSE VITA SNAIL FIRST ESSENSE		NIACINAMIDE, ADENOSINE	LIQUID	TOPICAL	20210701		UNAPPROVED DRUG OTHER		NOKSIBCHO cosmetic Co., Ltd.	ADENOSINE; NIACINAMIDE	.06; 3	g/150mL; g/150mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73597-004_d9a93ed3-9413-66c2-e053-2a95a90a32c8	73597-004	HUMAN OTC DRUG	Basic Essentials Astringent		Salicylic Acid	LIQUID	TOPICAL	20200730		OTC MONOGRAPH FINAL	part333D	Mission Series Inc. dpa Prestige Beauty Care	SALICYLIC ACID	.05	g/100mL			N	20241231
73597-012_a903c855-8679-4f14-e053-2a95a90a5333	73597-012	HUMAN OTC DRUG	Royal Creamy Petroleum Jelly		Petrolatum Jelly	JELLY	TOPICAL	20200630		OTC MONOGRAPH FINAL	part347	Mission Series Inc. dba Prestige Beauty Care	PETROLATUM	30	g/100g			N	20241231
73597-014_aca24d5e-42ef-1606-e053-2a95a90ab4e6	73597-014	HUMAN OTC DRUG	Royal Creamy Petroleum Jelly Cocoa Butter		Petrolatum Jelly	JELLY	TOPICAL	20200811		OTC MONOGRAPH FINAL	part347	Mission Series Inc. dba Prestige Beauty Care	PETROLATUM	30	g/100g			N	20241231
73597-020_f54fee69-ee13-fef8-e053-2a95a90a6a32	73597-020	HUMAN OTC DRUG	Royal Dandruff Dry Scalp		Pyrithione Zinc	SHAMPOO	TOPICAL	20230501		OTC MONOGRAPH FINAL	part358H	Mission Series Inc. dba Prestige Beauty Care	PYRITHIONE ZINC	1	g/100g			N	20241231
73597-021_f53f3b18-93d9-6e6a-e053-2995a90af3d9	73597-021	HUMAN OTC DRUG	Basic Essentials Astringent		Salicylic Acid	SOLUTION	TOPICAL	20230501		OTC MONOGRAPH FINAL	M006	Mission Series Inc. dpa Prestige Beauty Care	SALICYLIC ACID	.05	g/100mL			N	20241231
73597-022_ff30514b-435f-cd8a-e053-6294a90a4e7a	73597-022	HUMAN OTC DRUG	Basic Essential Oil Free Acne Wash		Salicyclic Acid	LIQUID	TOPICAL	20230315		OTC MONOGRAPH FINAL	part358H	Mission Series Inc. dba Prestige Beauty Care	SALICYLIC ACID	2	g/100mL			N	20241231
73597-026_00d7203d-fdb7-951c-e063-6394a90ae46b	73597-026	HUMAN OTC DRUG	Royal Dandruff Dry Scalp Care		Pyrithione Zinc	SHAMPOO	TOPICAL	20230315		OTC MONOGRAPH FINAL	part358H	Mission Series Inc. dba Prestige Beauty Care	PYRITHIONE ZINC	1	g/100mL			N	20241231
73603-000_0b6e1256-1229-0317-e063-6394a90ab48b	73603-000	HUMAN OTC DRUG	Comforte Menstrual Cramp Relief Cream		MENTHOL	CREAM	TOPICAL	20230201		OTC MONOGRAPH DRUG	M017	PMS4PMS LLC	MENTHOL	40	mg/g			N	20241231
73604-914_2aa52095-8da8-4ff8-83a4-556c65f8f9ce	73604-914	HUMAN PRESCRIPTION DRUG	Arcalyst		rilonacept	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20080227		BLA	BLA125249	Kiniksa Pharmaceuticals (UK), Ltd.	RILONACEPT	160	mg/2mL			N	20241231
73606-010_2670b0cf-059f-4575-b2ee-402393e1e5df	73606-010	HUMAN PRESCRIPTION DRUG	Empaveli		Pegcetacoplan	INJECTION, SOLUTION	SUBCUTANEOUS	20210514		NDA	NDA215014	Apellis Pharmaceuticals, Inc.	PEGCETACOPLAN	1080	mg/20mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
73606-020_cea46b9d-cc72-4f97-9413-461a7f79a723	73606-020	HUMAN PRESCRIPTION DRUG	Syfovre		Pegcetacoplan	INJECTION, SOLUTION	INTRAVITREAL	20230217		NDA	NDA217171	Apellis Pharmaceuticals, Inc.	PEGCETACOPLAN	15	mg/.1mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
73607-011_1034b728-0598-43f5-a083-158b8ff85db0	73607-011	HUMAN PRESCRIPTION DRUG	Artesunate		Artesunate	KIT		20201211		NDA	NDA213036	Amivas, Inc						N	20241231
73609-220_09dcbf50-7ff4-08aa-e063-6294a90ad7bc	73609-220	HUMAN OTC DRUG	SEVEN MINERALS Skin Friendly SPF 30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200203		OTC MONOGRAPH DRUG	M020	Seven Minerals NA LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
73609-221_09e2089e-a6e9-9d2f-e063-6394a90a2282	73609-221	HUMAN OTC DRUG	SEVEN MINERALS Skin Friendly SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20200203		OTC MONOGRAPH DRUG	M020	Seven Minerals NA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
73611-300_96a21827-46ee-4299-88ee-1b983e3e5e43	73611-300	HUMAN PRESCRIPTION DRUG	Qwo		collagenase clostridium histolyticum-aaes	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRALESIONAL	20210201	20250131	BLA	BLA761146	Endo Aesthetics LLC	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	.23	mg/mL	Collagen-specific Enzyme [EPC], Collagenases [Chemical/Ingredient]		N	
73612-200_9ecae5d1-0a7f-44dd-a50f-9489cfd441a9	73612-200	HUMAN PRESCRIPTION DRUG	StrataGraft		allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat	CELLULAR SHEET	TOPICAL	20210615		BLA	BLA125730	Stratatech Corporation	VIABLE AND METABOLICALLY ACTIVE ALLOGENEIC HUMAN NIKS KERATINOCYTES AND HUMAN DERMAL FIBROBLASTS CELLULARIZED LAYERED SCAFFOLD	1	cm2/cm2			N	20241231
73612-201_9ecae5d1-0a7f-44dd-a50f-9489cfd441a9	73612-201	HUMAN PRESCRIPTION DRUG	StrataGraft		allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat	CELLULAR SHEET	TOPICAL	20210615		BLA	BLA125730	Stratatech Corporation	VIABLE AND METABOLICALLY ACTIVE ALLOGENEIC HUMAN NIKS KERATINOCYTES AND HUMAN DERMAL FIBROBLASTS CELLULARIZED LAYERED SCAFFOLD	1	cm2/cm2			N	20241231
73616-208_0925694b-8908-4d77-a25a-e5090dc840ef	73616-208	HUMAN OTC DRUG	Hemp Pain Balm	Sacred Pain Balm	.ALPHA.,.ALPHA.-DIBROMO-D-CAMPHOR and MENTHOL, UNSPECIFIED FORM	OINTMENT	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	Sacred Enterprises LLC	.ALPHA.,.ALPHA.-DIBROMO-D-CAMPHOR; MENTHOL, UNSPECIFIED FORM	1; 6	g/100g; g/100g			N	20241231
73616-210_677d07f8-f160-486f-8308-71175e56b240	73616-210	HUMAN OTC DRUG	Hemp Pain		MENTHOL, UNSPECIFIED FORM and Methyl Salicylate	LOTION	TOPICAL	20190901		OTC MONOGRAPH NOT FINAL	part348	Sacred Enterprises, LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	2; 6	mg/100mL; mg/100mL			N	20241231
73620-001_b9498f65-2bd9-fe13-e053-2995a90ad25f	73620-001	HUMAN OTC DRUG	Tenacious	Ergodyne	SPF 50 Sunscreen Lotion	LOTION	TOPICAL	20200213		OTC MONOGRAPH NOT FINAL	part352	Tenacious Holdings, Inc.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 60	mg/mL; mg/mL; mg/mL			N	20241231
73620-002_f13f9a06-8772-a15f-e053-2995a90a28c9	73620-002	HUMAN OTC DRUG	Tenacious	Ergodyne	KREWD Clear SPF 50 Continuous Spray	AEROSOL, SPRAY	TOPICAL	20200214		OTC MONOGRAPH NOT FINAL	part352	Tenacious Holdings, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
73620-004_f565d0c6-eac7-58a6-e053-2995a90a9bb0	73620-004	HUMAN OTC DRUG	Tenacious Ergodyne KREWD SPF 50 Sunscreen Stick		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20200214		OTC MONOGRAPH FINAL	M020	Tenacious Holdings, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
73624-424_e6cdd6c3-3611-4ced-9cd6-6642718999de	73624-424	HUMAN PRESCRIPTION DRUG	Indocyanine Green		Indocyanine Green and Water	KIT		20210401		ANDA	ANDA040811	Olympus America, Inc.						N	20241231
73625-111_8ec4ee8e-12bb-4e9e-bc7c-ac49ee8ad1b4	73625-111	CELLULAR THERAPY	CAMZYOS		mavacamten	CAPSULE, GELATIN COATED	ORAL	20220428		NDA	NDA214998	Myokardia, Inc.	MAVACAMTEN	2.5	mg/1			N	20241231
73625-112_8ec4ee8e-12bb-4e9e-bc7c-ac49ee8ad1b4	73625-112	CELLULAR THERAPY	CAMZYOS		mavacamten	CAPSULE, GELATIN COATED	ORAL	20220428		NDA	NDA214998	Myokardia, Inc.	MAVACAMTEN	5	mg/1			N	20241231
73625-113_8ec4ee8e-12bb-4e9e-bc7c-ac49ee8ad1b4	73625-113	CELLULAR THERAPY	CAMZYOS		mavacamten	CAPSULE, GELATIN COATED	ORAL	20220428		NDA	NDA214998	Myokardia, Inc.	MAVACAMTEN	10	mg/1			N	20241231
73625-114_8ec4ee8e-12bb-4e9e-bc7c-ac49ee8ad1b4	73625-114	CELLULAR THERAPY	CAMZYOS		mavacamten	CAPSULE, GELATIN COATED	ORAL	20220428		NDA	NDA214998	Myokardia, Inc.	MAVACAMTEN	15	mg/1			N	20241231
73628-001_f1e95bc6-e989-ec93-e053-2a95a90a0a50	73628-001	HUMAN OTC DRUG	ScalpMED for Men - VITADIL-5A Hair Regrowth Treatment		Minoxidil 5%	SOLUTION	TOPICAL	20200217		ANDA	ANDA076239	Celmatrix Technologies, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73628-002_f1e96fe0-0674-26a8-e053-2a95a90ae60b	73628-002	HUMAN OTC DRUG	ScalpMED for Women - Vitadil-2A Hair Regrowth Treatment 2%		Minoxidil 2%	SOLUTION	TOPICAL	20200217		ANDA	ANDA078176	Celmatrix Technologies, LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73629-001_d56f3af9-92ae-1525-e053-2a95a90aceb0	73629-001	HUMAN OTC DRUG	DIPHENHYDRAMINE HYDROCHLORIDE 50mg		DIPHENHYDRAMINE HYDROCHLORIDE 50mg	CAPSULE, LIQUID FILLED	ORAL	20200921		OTC MONOGRAPH FINAL	part338	AMZ789 LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73629-002_fcc354ce-eb3c-6a00-e053-6294a90a4ecd	73629-002	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210501		OTC MONOGRAPH FINAL	part332	AMZ789 LLC	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
73629-003_db71197e-d634-644d-e053-2a95a90a261d	73629-003	HUMAN OTC DRUG	LORATADINE		LORATADINE	TABLET	ORAL	20220330		ANDA	ANDA210722	AMZ789 LLC	LORATADINE	10	mg/1			N	20241231
73629-005_e2175022-de7e-17cd-e053-2995a90aa144	73629-005	HUMAN OTC DRUG	DEXTROMETHORPHAN HBR 15 MG		DEXTROMETHORPHAN HBR 15 MG	CAPSULE, LIQUID FILLED	ORAL	20220501		OTC MONOGRAPH FINAL	part341	AMZ789 LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
73629-006_fcc2ef8b-9182-2c59-e053-6394a90adcc1	73629-006	HUMAN OTC DRUG	Simethicone 250mg		Simethicone 250mg	CAPSULE, LIQUID FILLED	ORAL	20221201		OTC MONOGRAPH FINAL	M002	AMZ789 LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
73630-001_f1e964cb-33ed-61b4-e053-2a95a90a7183	73630-001	HUMAN OTC DRUG	RIZE Hair Regrowth Treatment for Men 5%		Minoxidil 5%	SPRAY	TOPICAL	20200217		ANDA	ANDA076239	Rize Health, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
73635-1219_08b44c4c-7ee8-2f50-e063-6294a90a939f	73635-1219	HUMAN OTC DRUG	Gentian Violet	Anti-Infective	Gentian Violet 1%	LIQUID	TOPICAL	20210329		OTC MONOGRAPH DRUG	M003	Germa Products, LLC	GENTIAN VIOLET	10	mg/mL			N	20241231
73635-1220_08b42cdc-cdd8-be9b-e063-6294a90a5466	73635-1220	HUMAN OTC DRUG	Salicylic Iodine (Iodo Salicilico)	First Aid Antiseptic	Iodine 2%	LIQUID	TOPICAL	20210329		OTC MONOGRAPH DRUG	M003	Germa Products, LLC	IODINE	20	mg/mL			N	20241231
73635-1221_08b3d4a7-dd5d-c541-e063-6294a90a4fd3	73635-1221	HUMAN OTC DRUG	Iodine Tincture (IODO)	First Aid Antiseptic	Iodine 2%	LIQUID	TOPICAL	20210329		OTC MONOGRAPH DRUG	M003	Germa Products, LLC	IODINE	20	mg/mL			N	20241231
73635-1222_0804f50f-8ef8-3d34-e063-6394a90a5910	73635-1222	HUMAN OTC DRUG	Iodo Blanco (Iodine Tincture Decolorized)	First Aid Antiseptic	Iodine 2%	LIQUID	TOPICAL	20210329		OTC MONOGRAPH DRUG	M003	Germa Products, LLC	IODINE	20	mg/mL			N	20241231
73635-1223_08064f5b-0d1a-7203-e063-6294a90af82a	73635-1223	HUMAN OTC DRUG	Mercurochrome	First Aid Antiseptic	Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20210329		OTC MONOGRAPH DRUG	M003	Germa Products, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73635-1224_08055503-9fd1-1aba-e063-6394a90a0de6	73635-1224	HUMAN OTC DRUG	Merthiolate Tincture	First Aid Antiseptic	Benzalkonium Chloride 0.13%	LIQUID	TOPICAL	20210329		OTC MONOGRAPH DRUG	M003	Germa Products, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73635-5800_091b57c6-f9b0-6a51-e063-6294a90a403f	73635-5800	HUMAN OTC DRUG	Germa Linimento Ubre Plus		Methyl Salicylate 10%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	METHYL SALICYLATE	100	mg/mL			N	20241231
73635-5801_08160c0e-5a4e-1d7b-e063-6394a90aed8e	73635-5801	HUMAN OTC DRUG	Germa Vapozol	Chest-Rub	Menthol	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	MENTHOL	18	mg/mL			N	20241231
73635-5802_08157e2c-2c73-1487-e063-6394a90a1092	73635-5802	HUMAN OTC DRUG	Germa Gel del Artico		Menthol 1%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	MENTHOL, UNSPECIFIED FORM	10	mg/mL			N	20241231
73635-5803_081757dd-3a77-2449-e063-6394a90a9c56	73635-5803	HUMAN OTC DRUG	Germa Manteca Ubre Plus (YELLOW)		Methyl Salicylate 10%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	METHYL SALICYLATE	100	mg/mL			N	20241231
73635-5804_08173bad-d2a4-d916-e063-6394a90a609f	73635-5804	HUMAN OTC DRUG	Germa Manteca Ubre Plus (RED)		Methyl Salicylate 10%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	METHYL SALICYLATE	100	mg/mL			N	20241231
73635-5805_0814f567-cda7-8d8e-e063-6294a90af37e	73635-5805	HUMAN OTC DRUG	Germa Manteca Ubre Plus (TIN)		Methyl Salicylate 10%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M014	Germa Products, LLC	METHYL SALICYLATE	100	mg/mL			N	20241231
73635-5806_0816bd3e-365f-cf68-e063-6394a90aa661	73635-5806	HUMAN OTC DRUG	Germa Linimento Ubre Plus (Roll-On)		Methyl Salicylate 10%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	METHYL SALICYLATE	100	mg/mL			N	20241231
73635-5807_08028540-8079-ca20-e063-6394a90a80e8	73635-5807	HUMAN OTC DRUG	Germa Ubre Mastitis		Methyl Salicylate 2%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M014	Germa Products, LLC	METHYL SALICYLATE	20	mg/mL			N	20241231
73635-5808_0817588e-1ac6-24e3-e063-6394a90ac6ba	73635-5808	HUMAN OTC DRUG	Germa Snake Oil Bee Venom		Methyl Salicylate 10%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	METHYL SALICYLATE	100	mg/mL			N	20241231
73635-5809_0816d917-897f-184e-e063-6394a90aeee8	73635-5809	HUMAN OTC DRUG	Germa Camphor	Analgesic	Camphor 10%	OINTMENT	TOPICAL	20190329		OTC MONOGRAPH DRUG	M017	Germa Products, LLC	CAMPHOR (SYNTHETIC)	100	mg/mL			N	20241231
73635-5810_08b2b99b-a0f8-fad5-e063-6294a90aa592	73635-5810	HUMAN OTC DRUG	Verruguin Liquid Wart Remover		Salisylic Acid 17%	LIQUID	TOPICAL	20190329		OTC MONOGRAPH DRUG	M028	Germa Products, LLC	SALICYLIC ACID	170	mg/mL			N	20241231
73635-5811_08b2f233-b976-2b12-e063-6394a90af677	73635-5811	HUMAN OTC DRUG	Quita Callos Corn and Callus Remover		Salisylic Acid 17%	LIQUID	TOPICAL	20190329		OTC MONOGRAPH DRUG	M030	Germa Products, LLC	SALICYLIC ACID	170	mg/mL			N	20241231
73635-7101_fb444f58-062c-a742-e053-6394a90acfb1	73635-7101	HUMAN OTC DRUG	Anesgerm LA MUELA	Fast Pain Relief	Benzocaine 20%	LIQUID	TOPICAL	20190329		OTC MONOGRAPH FINAL	part348	Germa Products, LLC	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
73635-7102_08173bad-d29d-d916-e063-6394a90a609f	73635-7102	HUMAN OTC DRUG	Aftaseptic	Instant Pain Relief	Salisylic Acid 1%	LIQUID	TOPICAL	20190329		OTC MONOGRAPH DRUG	M022	Germa Products, LLC	SALICYLIC ACID	10	mg/mL			N	20241231
73638-901_d7f4061b-0ffd-4b57-a6bd-c7cedfd61854	73638-901	HUMAN OTC DRUG	Niravi 24 Hours Lidocaine 4 % Patch		Lidocaine	PATCH	TOPICAL	20210630		OTC MONOGRAPH NOT FINAL	part348	Sparsha Pharma USA, Inc.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73645-0001_f327ced8-cce8-abbf-e053-2a95a90ad931	73645-0001	HUMAN OTC DRUG	PHYTONCIDE ESSENTIAL		phytoncide	OIL	TOPICAL	20200222		UNAPPROVED DRUG OTHER		DONGYANG SPECIAL WOOD CORPORATION	CHAMAECYPARIS OBTUSA WOOD OIL	99.9	g/100mL			N	20241231
73645-0002_abd90219-27a3-a0b2-e053-2a95a90a3cbe	73645-0002	HUMAN OTC DRUG	COVID-19 STERILIZING		phytoncide	OIL	TOPICAL	20200802		UNAPPROVED DRUG OTHER		DONGYANG SPECIAL WOOD CORPORATION	CHAMAECYPARIS OBTUSA WOOD OIL	99.9	g/100mL			N	20241231
73645-0003_f327e843-5392-760e-e053-2995a90a5fec	73645-0003	HUMAN OTC DRUG	COVID-19 STERILIZING AGENT		phytoncide	OIL	TOPICAL	20200809		UNAPPROVED DRUG OTHER		DONGYANG SPECIAL WOOD CORPORATION	CHAMAECYPARIS OBTUSA WOOD OIL	99.9	g/100mL			N	20241231
73647-004_f6538e47-0684-7340-e053-2a95a90a173e	73647-004	HUMAN OTC DRUG	JUST CBD ROLL-ON COOLING		MENTHOL	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	MENTHOL	4	g/100mL			N	20241231
73647-026_f66476d5-036c-0b1c-e053-2a95a90a0a07	73647-026	HUMAN OTC DRUG	JUST CBD - CBD AND THC ULTRA RELIEF		MENTHOL, CAMPHOR	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	CAMPHOR (SYNTHETIC); MENTHOL	2; 6	g/100g; g/100g			N	20241231
73647-040_f65455d7-04aa-6217-e053-2995a90a7c90	73647-040	HUMAN OTC DRUG	JUST CBD ROLL-ON WARMING		CAMPHOR	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	CAMPHOR (NATURAL)	4	g/100mL			N	20241231
73647-041_f65455d7-04aa-6217-e053-2995a90a7c90	73647-041	HUMAN OTC DRUG	JUST CBD ROLL-ON WARMING		CAMPHOR	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	CAMPHOR (NATURAL)	4	g/100mL			N	20241231
73647-042_02e64046-687f-449e-e063-6294a90a6c32	73647-042	HUMAN OTC DRUG	JUST CBD RELIEF SOOTHING		LIDOCAINE HCL	CREAM	TOPICAL	20230426		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73647-062_f66476d5-036c-0b1c-e053-2a95a90a0a07	73647-062	HUMAN OTC DRUG	JUST CBD - CBD AND THC ULTRA RELIEF		MENTHOL, CAMPHOR	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	CAMPHOR (SYNTHETIC); MENTHOL	2; 6	g/100g; g/100g			N	20241231
73647-103_0abecd71-3dbd-0625-e063-6394a90a1990	73647-103	HUMAN OTC DRUG	JUST CBD SOOTHING		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231220		OTC MONOGRAPH DRUG	M017	Just Brands LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	3; 10	g/100mL; g/100mL			N	20241231
73647-206_f65327b3-9c98-58f3-e053-2995a90a3f55	73647-206	HUMAN OTC DRUG	JUST CBD ULTRA RELIEF		MENTHOL, CAMPHOR	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	CAMPHOR (SYNTHETIC); MENTHOL	2; 6	g/100mL; g/100mL			N	20241231
73647-400_f6538e47-0684-7340-e053-2a95a90a173e	73647-400	HUMAN OTC DRUG	JUST CBD ROLL-ON COOLING		MENTHOL	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	MENTHOL	4	g/100mL			N	20241231
73647-602_f65327b3-9c98-58f3-e053-2995a90a3f55	73647-602	HUMAN OTC DRUG	JUST CBD ULTRA RELIEF		MENTHOL, CAMPHOR	GEL	TOPICAL	20230314		OTC MONOGRAPH NOT FINAL	part348	Just Brands LLC	CAMPHOR (SYNTHETIC); MENTHOL	2; 6	g/100mL; g/100mL			N	20241231
73650-316_0250988e-2402-4088-9ee7-b7176d10d489	73650-316	HUMAN PRESCRIPTION DRUG	TZIELD		teplizumab-mzwv	INJECTION	INTRAVENOUS	20221117		BLA	BLA761183	Provention Bio, Inc.	TEPLIZUMAB	1	mg/mL			N	20251231
73653-211_0cbfdca6-de92-3e69-e063-6394a90a8f1d	73653-211	HUMAN OTC DRUG	Dentemp Canker Cover		Canker Cover	TABLET, EXTENDED RELEASE	ORAL; TOPICAL	20200220		OTC MONOGRAPH DRUG	M022	DOC Brands	MENTHOL	2.5	mg/150mg			N	20241231
73653-212_0cc00879-c4ab-417a-e063-6394a90a256d	73653-212	HUMAN OTC DRUG	Dentemp Canker Cover		Canker Cover	TABLET, EXTENDED RELEASE	ORAL; TOPICAL	20230202		OTC MONOGRAPH DRUG	M022	DOC Brands	MENTHOL	2.5	mg/1			N	20241231
73655-010_54dbd8ea-a54c-41c4-8394-f7baf1f786c4	73655-010	HUMAN OTC DRUG	CELONIA SIGNATURE BIO AMPOULE		Niacinamide, Adenosine	LIQUID	TOPICAL	20200201		UNAPPROVED DRUG OTHER		Celino Inc.	ADENOSINE; NIACINAMIDE	.014; .7	g/35mL; g/35mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73655-020_f0ae76c2-2662-4aa1-9d61-2dd30ffee8c8	73655-020	HUMAN OTC DRUG	CELONIA SIGNATURE BIO		Niacinamide, Adenosine	CREAM	TOPICAL	20200201		UNAPPROVED DRUG OTHER		Celino Inc.	ADENOSINE; NIACINAMIDE	.02; 1	g/50mL; g/50mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73655-030_e3075617-20b8-4e5d-8927-631bbef8e8f7	73655-030	HUMAN OTC DRUG	CELONIA SIGNATURE BIO ESSENCE TONER		Niacinamide, Adenosine	LIQUID	TOPICAL	20200201		UNAPPROVED DRUG OTHER		Celino Inc.	ADENOSINE; NIACINAMIDE	.06; 3	g/150mL; g/150mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73655-040_06246803-5e82-494e-8f5b-d224a9cda7c6	73655-040	HUMAN OTC DRUG	CELONIA SIGNATURE BIO EYE		Niacinamide, Adenosine	CREAM	TOPICAL	20200201		UNAPPROVED DRUG OTHER		Celino Inc.	ADENOSINE; NIACINAMIDE	.008; .4	g/20mL; g/20mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73655-050_36dd3d4d-3123-4e9a-92d5-5f343e777bf8	73655-050	HUMAN OTC DRUG	CELONIA SIGNATURE BIO SHEET MASK		Niacinamide, Adenosine	PATCH	TOPICAL	20200201		UNAPPROVED DRUG OTHER		Celino Inc.	ADENOSINE; NIACINAMIDE	.01; .64	g/32mL; g/32mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73655-070_359e42a3-86f4-4c5d-a1d5-68ea4cecf838	73655-070	HUMAN OTC DRUG	NGF 574H HAIR TONIC		Panthenol	LIQUID	TOPICAL	20200201		UNAPPROVED DRUG OTHER		Celino Inc.	PANTHENOL	.5	g/50mL			N	20241231
73655-080_8e344524-535d-4c6f-8bb4-d74611180f4b	73655-080	HUMAN OTC DRUG	CELONIA SIGNATURE BIO CUSHION PACT PINK IVORY		Titanium Dioxide	POWDER	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Celino Inc.	TITANIUM DIOXIDE	2.1	g/14g			N	20241231
73655-090_3bcd8375-6e4c-440a-aad4-c002fce3740b	73655-090	HUMAN OTC DRUG	CELONIA SIGNATURE BIO TONE UP SUN BLOCK		Homosalate, Octisalate, Titanium Dioxide, Avobenzone	CREAM	TOPICAL	20200201		OTC MONOGRAPH NOT FINAL	part352	Celino Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; TITANIUM DIOXIDE	1.5; 5; 2.5; 2.13	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
73655-100_775e178e-17e6-43ab-b13e-733928070e81	73655-100	HUMAN OTC DRUG	574H Cell Care		Zinc Pyrithione, Panthenol, Niacinamide, Biotin	SHAMPOO	TOPICAL	20200601		UNAPPROVED DRUG OTHER		Celino Inc.	BIOTIN; NIACINAMIDE; PANTHENOL; PYRITHIONE ZINC	.18; .9; 1.5; 3	g/300mL; g/300mL; g/300mL; g/300mL			N	20241231
73655-110_8a82bfb9-0e2b-4a0a-a658-8b1dfabe3001	73655-110	HUMAN OTC DRUG	CELONIA BIO HOME SOLUTION CONCENTRATED SKIN BOOSTER REJUVENATION		NIACINAMIDE, ADENOSINE	LIQUID	TOPICAL	20210401		UNAPPROVED DRUG OTHER		Celino Inc.	ADENOSINE; NIACINAMIDE	.004; .2	g/10mL; g/10mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73655-120_dba41dff-6b9f-4250-bd22-a15037709520	73655-120	HUMAN OTC DRUG	NGF37 hUCB BOOST		NIACINAMIDE, ADENOSINE	LIQUID	TOPICAL	20211001		UNAPPROVED DRUG OTHER		Celino Inc.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73655-130_a65f68b2-ac2a-4344-a25c-913110c8c76c	73655-130	HUMAN OTC DRUG	NGF 574H HAIR		Panthenol	SOLUTION	TOPICAL	20211001		UNAPPROVED DRUG OTHER		Celino Inc.	PANTHENOL	1	g/100mL			N	20241231
73656-003_08ac2c32-bf07-449e-e063-6294a90a873c	73656-003	HUMAN OTC DRUG	WHITE GLO MICELLAR		SODIUM MONOFLUOROPHOSPHATE	KIT		20200215		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-005_08ac039f-1933-e1ea-e063-6294a90a9329	73656-005	HUMAN OTC DRUG	WHITE GLO BIO-ENZYME		SODIUM MONOFLUOROPHOSPHATE	KIT		20200215		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-007_08ac308c-857a-75f0-e063-6294a90ad469	73656-007	HUMAN OTC DRUG	WHITE GLO PROFESSIONAL CHOICE		SODIUM MONOFLUOROPHOSPHATE	KIT		20200215		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-009_08ac10bd-feed-04bb-e063-6394a90a4d37	73656-009	HUMAN OTC DRUG	WHITE GLO CHARCOAL		SODIUM MONOFLUOROPHOSPHATE	KIT		20200316		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-011_090d36cf-3d1d-6485-e063-6294a90a4e19	73656-011	HUMAN OTC DRUG	WHITE GLO CHARCOAL SENSITIVE		POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE	KIT		20200316		OTC MONOGRAPH DRUG	M022	WHITE GLO USA INC						N	20241231
73656-013_08ac2c32-bf14-449e-e063-6294a90a873c	73656-013	HUMAN OTC DRUG	White Glo Maximum White Charcoal		SODIUM MONOFLUOROPHOSPHATE	KIT		20211101		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-015_08ac4020-ee76-2fcd-e063-6394a90aaee2	73656-015	HUMAN OTC DRUG	White Glo Instant White		SODIUM MONOFLUOROPHOSPHATE	KIT		20211101		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-017_08ac449b-f183-8aa0-e063-6394a90ab16f	73656-017	HUMAN OTC DRUG	White Glo Mouthwash Protection		SODIUM MONOFLUOROPHOSPHATE	KIT		20211101		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-019_0989136e-4d3e-64fb-e063-6394a90a7106	73656-019	HUMAN OTC DRUG	White Glo Professional White AntiCavity		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	TOPICAL	20230820		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC	SODIUM FLUORIDE	1	mg/g			N	20241231
73656-020_0ba9b650-d66c-f327-e063-6394a90ab5d5	73656-020	HUMAN OTC DRUG	White Glo Activated Charcoal Twin Pack		SODIUM FLUORIDE	KIT		20231019		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73656-024_0c914bf5-accd-5312-e063-6394a90a38ce	73656-024	HUMAN OTC DRUG	White Glo Professional Choice Twin Pack		SODIUM FLUORIDE	KIT		20231019		OTC MONOGRAPH DRUG	M021	WHITE GLO USA INC						N	20241231
73665-102_07f1b23c-20a8-e774-e063-6294a90a3c65	73665-102	HUMAN OTC DRUG	KARI GRAN ESSENTIAL SPF	SPF 30	ZINC OXIDE	SOLUTION	TOPICAL	20231016		OTC MONOGRAPH DRUG	M020	KARI GRAN	ZINC OXIDE	18	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73666-0500_8400ab7d-8e55-4c92-b2cd-d201eaa122ae	73666-0500	HUMAN OTC DRUG	DR.CHOIS TOOTHPASTE CARE PLUS		Silica, Tetrasodium Pyrophosphate, Tocopheryl Acetate	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	.ALPHA.-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM PYROPHOSPHATE	.1; 14; .5	g/100g; g/100g; g/100g			N	20241231
73666-0510_323d9f14-813d-4d8b-95d3-caaa61d28471	73666-0510	HUMAN OTC DRUG	DR.CHOIS TOOTHPASTE CARE		Silica, Tetrasodium Pyrophosphate, Tocopheryl Acetate	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	.ALPHA.-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM PYROPHOSPHATE	.1; 14; .5	g/100g; g/100g; g/100g			N	20241231
73666-0520_b1ce8ab1-3187-476b-845e-5f5bafec253e	73666-0520	HUMAN OTC DRUG	DR.CHOIS TOOTHPASTE FRESH		Silica, Sodium Monofluorophosphate, Tetrasodium Pyrophosphate, Tocopheryl Acetate	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	.ALPHA.-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	.2; 17; .76; .5	g/100g; g/100g; g/100g; g/100g			N	20241231
73666-0530_cc8b1c75-ba2c-48e8-870a-499fa31b4310	73666-0530	HUMAN OTC DRUG	DR.CHOIS TOOTHPASTE STEP ONE BABIES		Hydrated Silica, Tocopheryl Acetate	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	.ALPHA.-TOCOPHEROL ACETATE; HYDRATED SILICA	.1; 13	g/100g; g/100g			N	20241231
73666-0540_957d3343-476a-48e2-a913-74a39615ba61	73666-0540	HUMAN OTC DRUG	DR.CHOIS TOOTHPASTE STEP TWO KIDS		Hydrated Silica, Calcium Glycerophosphate, Sodium Fluoride, Tocopheryl Acetate	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	.ALPHA.-TOCOPHEROL ACETATE; CALCIUM GLYCEROPHOSPHATE; HYDRATED SILICA; SODIUM FLUORIDE	.1; .13; 13; .11	g/100g; g/100g; g/100g; g/100g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
73666-0550_bd8a7618-235f-4dc4-b9a1-3bc59f71fb46	73666-0550	HUMAN OTC DRUG	TID Clean Align		Sodium Chloride	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	SODIUM CHLORIDE	.7	g/100mL			N	20241231
73666-0560_77d4a67e-4524-410a-8bda-b791075f3fc9	73666-0560	HUMAN OTC DRUG	TID Clean Care		Sodium Chloride	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	SODIUM CHLORIDE	.7	g/100mL			N	20241231
73666-0570_6d7ed13b-325f-4155-ac4f-ab1643a665ab	73666-0570	HUMAN OTC DRUG	TID Clean Dent		Sodium Chloride	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	SODIUM CHLORIDE	.7	g/100mL			N	20241231
73666-0580_6bfc37e2-f79b-42ae-8269-d832a2e4c5ec	73666-0580	HUMAN OTC DRUG	TID Clean Plant		Sodium Chloride	PASTE, DENTIFRICE	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Doctor Choi`s Korea Co., LTD.	SODIUM CHLORIDE	.7	g/100mL			N	20241231
73669-012_f9bf6820-2a0f-896e-e053-6394a90ae14c	73669-012	HUMAN OTC DRUG	Unidental All CareToothpaste		Sodium monofluorophosphate, Cetylpyridinium chloride, Potassium nitrate	PASTE, DENTIFRICE	DENTAL	20230420		UNAPPROVED DRUG OTHER		Unimed Pharmaceuticals, Inc.	CETYLPYRIDINIUM CHLORIDE; POTASSIUM NITRATE; SODIUM MONOFLUOROPHOSPHATE	.3; 3.75; .76	g/100g; g/100g; g/100g			N	20241231
73669-013_fb601788-7251-8f58-e053-6294a90ac548	73669-013	HUMAN OTC DRUG	Sysfol Eye Drops		Polyethylene Glycol 400, Propylene Glycol	LIQUID	OPHTHALMIC	20230420		UNAPPROVED DRUG OTHER		Unimed Pharmaceuticals, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
73670-049_09752095-fe0d-c6de-e063-6294a90a88dd	73670-049	HUMAN OTC DRUG	NAELI Day Moisturizer SPF 30		OCTISALATE, OCTOCRYLENE, AVOBENZONE	LOTION	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Alli LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
73676-116_f8203d54-cd3e-314d-e053-6394a90ac10d	73676-116	HUMAN OTC DRUG	Airy sunstick smooting bar		homosalate,octocrylene,octisalate,avobenzone	STICK	TOPICAL	20230531		OTC MONOGRAPH FINAL	M020	FOURCOMPANY CO., LTD.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9.5; 4.5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
73678-100_fa45141d-ac33-ca9b-e053-6394a90a5cbb	73678-100	HUMAN OTC DRUG	Natural Aspirin plus Lemon and Honey Dietary Supplement		Aspirin	KIT	ORAL	20230425		UNAPPROVED DRUG OTHER		Applied Biological Laboratories Inc.						N	20241231
73678-102_fa6a220e-2a7f-4712-e053-6294a90ab2f9	73678-102	HUMAN OTC DRUG	Natural Aspirin plus Tart Cherry Dietary Supplement		Aspirin	KIT	ORAL	20230425		UNAPPROVED DRUG OTHER		Applied Biological Laboratories Inc.						N	20241231
73678-103_fa6a35ad-3431-0147-e053-6394a90ae529	73678-103	HUMAN OTC DRUG	Natural Aspirin plus Immune Supporting Dietary Supplement		Aspirin	KIT	ORAL	20230425		UNAPPROVED DRUG OTHER		Applied Biological Laboratories Inc.						N	20241231
73678-160_0c918986-e983-70b6-e063-6394a90a7fec	73678-160	HUMAN OTC DRUG	Biovanta Double Action		Acetylsalicylic Acid	SPRAY	ORAL	20200815	20241231	OTC MONOGRAPH DRUG	M013	Applied Biological Laboratories Inc.	ASPIRIN	6	mg/.1mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
73678-360_f336086f-b576-42ea-e053-2995a90a5095	73678-360	HUMAN OTC DRUG	Biovanta Trip Action Lemon and Honey		Acetylsalicylic Acid, menthol	LOZENGE	ORAL	20200801		OTC MONOGRAPH FINAL	part341	Applied Biological Laboratories Inc.	ASPIRIN; MENTHOL	6; 5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
73678-460_d6581d7b-711b-f9e6-e053-2995a90aa0c0	73678-460	HUMAN OTC DRUG	Biovanta Trip Action Tart Cherry and Honey		Acetylsalicylic Acid, menthol	LOZENGE	ORAL	20200815		OTC MONOGRAPH FINAL	part341	Applied Biological Laboratories Inc.	ASPIRIN; MENTHOL	6; 5	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
73683-101_0eac28b6-a2c9-f1d6-e063-6294a90a5060	73683-101	HUMAN PRESCRIPTION DRUG	HYFTOR		sirolimus	GEL	TOPICAL	20220323		NDA	NDA213478	Nobelpharma America, LLC	SIROLIMUS	2	mg/g	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20251231
73687-062_9c9dd555-72d5-40c9-99ab-df10d532ed89	73687-062	HUMAN PRESCRIPTION DRUG	UPNEEQ		Oxymetazoline hydrochloride ophthalmic	SOLUTION/ DROPS	OPHTHALMIC	20200821		NDA	NDA212520	RVL Pharmaceuticals, Inc.	OXYMETAZOLINE HYDROCHLORIDE	1	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
73690-024_090dcb6e-fd2f-4c72-ab31-24643cb1102a	73690-024	HUMAN OTC DRUG	Keep the Peace Acne-Calming Cream Cleanser		Salicylic Acid	RINSE	TOPICAL	20200701		OTC MONOGRAPH DRUG	M006	Offspring Beauty Co. / Versed	SALICYLIC ACID	15	mg/mL			N	20251231
73690-026_945db8b7-c7fb-4b26-835a-9fb9ab3d2f8c	73690-026	HUMAN OTC DRUG	Game Over Acne Drying Treatment		Sulfur	CREAM	TOPICAL	20200701		OTC MONOGRAPH DRUG	M006	Offspring Beauty Co.	SULFUR	100	mg/mL			N	20251231
73690-028_fb80ee62-0480-68d5-e053-6294a90a3aa6	73690-028	HUMAN OTC DRUG	Versed SPF 30 Replenishing Body Mineral		Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH FINAL	M020	Offspring Beauty Co.	ZINC OXIDE	17.6	g/100mL			N	20241231
73691-047_09752095-fe1c-c6de-e063-6294a90a88dd	73691-047	HUMAN OTC DRUG	OUTER REEF MINERAL SUNSCREEN SPF 30		TITANIUM DIOXIDE	CREAM	TOPICAL	20200310		OTC MONOGRAPH DRUG	M020	Coral Reef Park Co., Inc.	TITANIUM DIOXIDE	80	mg/mL			N	20241231
73691-296_09e204c1-4284-c24c-e063-6394a90aef68	73691-296	HUMAN OTC DRUG	OUTER REEF Reef Safe (WR) Broad Spectrum SPF 30		TITANIUM DIOXIDE	CREAM	TOPICAL	20220606		OTC MONOGRAPH DRUG	M020	Coral Reef Park Co., Inc.	TITANIUM DIOXIDE	80	mg/mL			N	20241231
73698-281_097502bf-727c-dd2b-e063-6394a90a7520	73698-281	HUMAN OTC DRUG	SCLERA CARE Topical Anesthetic Gel		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20220321		OTC MONOGRAPH DRUG	M017	ScleraCare, LLC	LIDOCAINE HYDROCHLORIDE	30	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73703-124_079c68e7-7fd4-9bb9-e063-6394a90a5f8e	73703-124	HUMAN OTC DRUG	TotalDry Sensitive Wash		Benzethonium Chloride	SPRAY	TOPICAL	20200601		UNAPPROVED DRUG OTHER		Secure Personal Care Products LLC	BENZETHONIUM CHLORIDE	.001212	g/mL			N	20241231
73703-127_08728008-f5a7-2efa-e063-6294a90aed7c	73703-127	HUMAN OTC DRUG	secure personal care products alcohol wipes		alcohol wipes	CLOTH	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Secure Personal Care Products LLC	ALCOHOL; BENZALKONIUM CHLORIDE	75; .05	g/100g; g/100g			N	20241231
73712-113_9d499d81-f689-490d-9f92-ea685c3622af	73712-113	HUMAN OTC DRUG	Uqora Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20200429		UNAPPROVED DRUG OTHER		Uqora Inc	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
73712-500_ebde96d2-e1f3-26b1-e053-2a95a90a2fb1	73712-500	HUMAN OTC DRUG	All-In-One UTI Emergency Kit		Methenamine, Sodium Salicylate, and Phenazopyridine Hydrochloride	KIT		20221017		UNAPPROVED DRUG OTHER		UQORA INC						N	20241231
73715-005_f1f3fb63-7ef9-95d2-e053-2995a90a4c0d	73715-005	HUMAN OTC DRUG	Diclofenac Sodium Topical Gel, 1%		Diclofenac Sodium Topical Gel, 1% (NSAID)	GEL	TOPICAL	20210831		ANDA	ANDA210986	Mohnark Pharmaceuticals Inc.	DICLOFENAC SODIUM	1	g/100g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
73716-001_f0d2e221-00f4-584d-e053-2995a90aace3	73716-001	HUMAN OTC DRUG	BiopHresh		Kreosotum 6C, Nitricum Acidum 6C, Thuja Occidentalis 6C, Pulsatilla Vulgaris 6C, Sepia Officinalis 6C	SUPPOSITORY	VAGINAL	20200417		UNAPPROVED HOMEOPATHIC		Good Clean Love, Inc.	NITRIC ACID; PULSATILLA VULGARIS; SEPIA OFFICINALIS WHOLE; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	6; 6; 6; 6; 6	[hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g; [hp_C]/g			N	20241231
73716-003_e5fc72e0-46a2-6b49-e053-2995a90af1c0	73716-003	HUMAN OTC DRUG	Relief Gel		Lidocaine HCL	GEL	TOPICAL	20220408		OTC MONOGRAPH NOT FINAL	part348	Good Clean Love, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
73731-082_09e20200-844e-8895-e063-6294a90a9f90	73731-082	HUMAN OTC DRUG	MALIE ORGANICS REEF SAFE SUNSCREEN SPF-30		HOMOSALATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20200320		OTC MONOGRAPH DRUG	M020	Malie, Inc.	HOMOSALATE; OCTISALATE; ZINC OXIDE	100; 50; 50	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73731-083_09e2208a-9175-e219-e063-6394a90a7f63	73731-083	HUMAN OTC DRUG	MALIE ORGANICS REEF SAFE SUNSCREEN SPF-50		HOMOSALATE, OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20200320		OTC MONOGRAPH DRUG	M020	Malie, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	100; 50; 80; 50	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
73736-115_25c19433-d7b3-479a-a02d-c7c6be293972	73736-115	HUMAN OTC DRUG	Dr. Rainer s Vaginal Cream		Miconazole Nitrate	CREAM	TOPICAL	20200323		OTC MONOGRAPH FINAL	part333C	Plexoris Health Care Products, Llc	MICONAZOLE NITRATE	2	g/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
73737-436_00276890-59ba-d927-e063-6394a90ae7fd	73737-436	HUMAN OTC DRUG	Push Clean		Benzalkonium Chloride	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	pushclean technology plastik sanayi ve ticaret limited sirketi	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73737-436_0027848c-f22f-5532-e063-6294a90a5213	73737-436	HUMAN OTC DRUG	Push Clean		Benzalkonium Chloride	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	pushclean technology plastik sanayi ve ticaret limited sirketi	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73744-258_3b0cda42-907a-46d3-a27f-1db0bbefa8b3	73744-258	HUMAN OTC DRUG	FancyClean Antiseptic Hand Sanitizer		Ethyl alcohol	LIQUID	TOPICAL	20200827	20240513	OTC MONOGRAPH NOT FINAL	part333A	Fancyheat Corporation	ALCOHOL	80	L/100L			N	
73744-267_8ea6296b-bbdd-49a1-b6b0-052afea390a5	73744-267	HUMAN OTC DRUG	FANCYCLEAN ANTISEPTIC HAND SANITIZER		Ethyl Alcohol	GEL	TOPICAL	20200319	20240513	OTC MONOGRAPH NOT FINAL	part333A	Fancyheat Corporation	ALCOHOL	70	L/100L			N	
73744-268_353a8668-4edc-4ab4-be43-34cc4f3ccb63	73744-268	HUMAN OTC DRUG	FANCYCLEAN ANTISEPTIC HAND SANITIZER		Ethyl Alcohol	GEL	TOPICAL	20200327	20240513	OTC MONOGRAPH NOT FINAL	part333A	Fancyheat Corporation	ALCOHOL	70	L/100L			N	
73744-269_d6641dfd-643f-4449-8fce-306b24921f17	73744-269	HUMAN OTC DRUG	Fancy Clean antiseptic hand sanitizer		Isopropyl Alcohol	GEL	TOPICAL	20200323	20240513	OTC MONOGRAPH NOT FINAL	part333A	Fancyheat Corporation	ISOPROPYL ALCOHOL	70	L/100L			N	
73760-001_da91e9a2-2c65-61e0-e053-2a95a90a20a4	73760-001	HUMAN OTC DRUG	Antibacterial Wet wipes		Benzalkonium Chloride	SWAB	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Easyclean Daily Chemical Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73760-002_da91cfef-14f5-4508-e053-2a95a90ab127	73760-002	HUMAN OTC DRUG	Househould Cleaning Wipes		Benzalkonium Chloride	SWAB	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Easyclean Daily Chemical Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73760-003_da91ceda-fd0e-1bf7-e053-2a95a90a5f91	73760-003	HUMAN OTC DRUG	Alcohol Wet Wipes		Alcohol	CLOTH	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Easyclean Daily Chemical Co., Ltd.	ALCOHOL	70	g/100g			N	20241231
73760-004_da91c464-4199-3a59-e053-2a95a90a2dc4	73760-004	HUMAN OTC DRUG	Antibacterial Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Easyclean Daily Chemical Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73760-005_da91aca5-2c62-0d5e-e053-2a95a90a0e06	73760-005	HUMAN OTC DRUG	Antibacterial Wet wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200628		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Easyclean Daily Chemical Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73760-008_e9196cff-ad2b-2b85-e053-2a95a90a76a8	73760-008	HUMAN OTC DRUG	Antibacterial Wet wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20220922		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Easyclean Daily Chemical Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73763-265_0105156b-4391-d588-e063-6294a90a1535	73763-265	HUMAN OTC DRUG	Wow EZ Finishes Hand Sanitizer		ALCOHOL HAND SANITIZER	GEL	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Aquagenics Technologies	ALCOHOL	70	mL/100mL			N	20241231
73763-365_01052336-5073-ded5-e063-6294a90a5055	73763-365	HUMAN OTC DRUG	Safe Choice Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Aquagenics Technologies	ALCOHOL	70	mL/100mL			N	20241231
73763-460_0104b7d4-7cd2-cc68-e063-6394a90acfe5	73763-460	HUMAN OTC DRUG	Natural House Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333A	Aquagenics Technologies	ALCOHOL	70	mL/100mL			N	20241231
73763-465_0104fe6b-2645-8503-e063-6294a90a8060	73763-465	HUMAN OTC DRUG	Sanitect Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333A	Aquagenics Technologies	ALCOHOL	70	mL/100mL			N	20241231
73763-466_0105156b-438f-d588-e063-6294a90a1535	73763-466	HUMAN OTC DRUG	Sanitect Antibacterial Hand		Benzalkonium Chloride Soap	SOAP	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333E	Aquagenics Technologies	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
73763-470_0105156b-4390-d588-e063-6294a90a1535	73763-470	HUMAN OTC DRUG	Sanitect Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	Aquagenics Technologies	ALCOHOL	80	mL/100mL			N	20241231
73763-475_01051ea1-9713-4420-e063-6394a90a1c62	73763-475	HUMAN OTC DRUG	Infinity Shields Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200413		OTC MONOGRAPH NOT FINAL	part333A	Aquagenics Technologies Inc	ALCOHOL	70	mL/100mL			N	20241231
73769-200_fa1cd3aa-6fd7-2a2c-e053-6294a90aa976	73769-200	HUMAN OTC DRUG	NMNQuil		Nighttime Sleep Aid	CAPSULE	ORAL	20230426		OTC MONOGRAPH FINAL	M010	NATURE'S FUSIONS, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
73769-300_0bde56be-8690-d1cd-e063-6294a90abe45	73769-300	HUMAN OTC DRUG	Potassium Iodide		Potassium Iodide Tablet	TABLET	ORAL	20230401		UNAPPROVED HOMEOPATHIC		Nature's Fusions, Llc	POTASSIUM IODIDE	65	mg/1			N	20241231
73769-301_0bf3ceba-d770-adc3-e063-6294a90a06b9	73769-301	HUMAN OTC DRUG	Potassium Iodide		Potassium Iodide	CAPSULE	ORAL	20230401		UNAPPROVED HOMEOPATHIC		NATURE'S FUSIONS, LLC	POTASSIUM IODIDE	65	mg/1			N	20241231
73779-916_19fd4e28-8ba4-49f5-90b1-6fdcbd971d23	73779-916	HUMAN OTC DRUG	CleanShot Sanitizing Alcohol Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20201015	20241031	OTC MONOGRAPH NOT FINAL	part333A	CIC Coatings, LLC	ISOPROPYL ALCOHOL	75	mL/100mL			N	
73782-688_f1e9e2b0-c0e8-3e51-e053-2995a90a3895	73782-688	HUMAN OTC DRUG	Alcohol Sanitizer		Foaming Alcohol Sanitizer	SOLUTION	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333A	Chemco Corporation	ALCOHOL	62	mL/100mL			N	20241231
73788-002_d8bf30df-8c5f-289b-e053-2a95a90a4992	73788-002	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-003_d8bf82f1-6a0b-0a11-e053-2a95a90ae837	73788-003	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-004_d8bf87fe-2d1c-cceb-e053-2a95a90aea54	73788-004	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-100_d8bf21b4-aebe-39a4-e053-2995a90a7b58	73788-100	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-101_d8bf87fe-2d1d-cceb-e053-2a95a90aea54	73788-101	HUMAN OTC DRUG	Hand Sanitizer Gel		Ethyl Alcohol	GEL	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
73788-102_d8bf95f2-8ca7-cb1f-e053-2a95a90adbd3	73788-102	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-103_d8bf9af7-5a4f-eb84-e053-2a95a90ae88a	73788-103	HUMAN OTC DRUG	CLEANHANDS		Benzalkonium chloride	SOAP	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73788-104_d8bfc992-222c-4f07-e053-2995a90aa560	73788-104	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-105_d8c04259-4369-1471-e053-2995a90a06e6	73788-105	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-106_d8bfc992-222d-4f07-e053-2995a90aa560	73788-106	HUMAN OTC DRUG	SIMONIZ SaniClean		Benzalkonium chloride	SOAP	TOPICAL	20200715		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73788-107_d8bfdd5d-1f51-4bab-e053-2995a90ac085	73788-107	HUMAN OTC DRUG	U.S. Legal Support Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200812		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-108_d8bfff1e-e11e-0f20-e053-2a95a90a832b	73788-108	HUMAN OTC DRUG	CLEANHANDS		Benzalkonium chloride	SOAP	TOPICAL	20200825		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73788-109_d8c02211-1ce3-5a89-e053-2995a90a6990	73788-109	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20201101		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73788-110_d8c027c5-4a09-835f-e053-2995a90a1e57	73788-110	HUMAN OTC DRUG	hand sanitizer		Ethyl Alcohol	GEL	TOPICAL	20210415		OTC MONOGRAPH NOT FINAL	part333E	Hangzhou Huiji Biotechnology Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
73789-0442_86515173-a1d8-49fa-b8bf-6a99cd20bd4e	73789-0442	HUMAN OTC DRUG	HOBBY ANTIBACTERIAL HANDWASH		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201023		OTC MONOGRAPH NOT FINAL	part333E	Hobi Kozmetik Imalat Sanayi Ve Ticaret Anonim Sirketi	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
73789-8038_a1b14cb9-c4d1-ed3b-e053-2995a90a0e66	73789-8038	HUMAN OTC DRUG	hobby wash		PARACHLOROMETAXYLENOL	LIQUID	TOPICAL	20170801		OTC MONOGRAPH NOT FINAL	part333E	Hobi Kozmetik Imalat Sanayi Ve Ticaret Anonim Sirketi	CHLOROXYLENOL	.003	mg/mL			N	20241231
73795-001_fc600b6f-0dd2-10ff-e053-6394a90a6ba5	73795-001	HUMAN OTC DRUG	Medi Defense mPulse Hand Sanitizer		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333E	CLEARSTREAM TECHNOLOGIES, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
73796-110_09874a42-6288-b23c-e063-6394a90a889f	73796-110	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Prostock LLC	ALCOHOL	.62	mL/mL			N	20241231
73796-110_0c53824b-1b8d-a3f8-e063-6394a90aacb7	73796-110	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200321		OTC MONOGRAPH DRUG	505G(a)(3)	Prostock LLC.	ALCOHOL	.62	mL/mL			N	20241231
73796-111_09875ee3-5ea6-ac09-e063-6394a90ae4c7	73796-111	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Prostock LLC	ALCOHOL	.62	mL/mL			N	20241231
73796-112_098725d4-ed85-891b-e063-6294a90a051e	73796-112	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200321		OTC MONOGRAPH DRUG	505G(a)(3)	Prostock LLC	ALCOHOL	.62	mL/mL			N	20241231
73796-114_09875d00-a8d6-8128-e063-6294a90aa548	73796-114	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200321		OTC MONOGRAPH DRUG	505G(a)(3)	Prostock LLC	ALCOHOL	.62	mL/mL			N	20241231
73796-119_09876f3d-693c-c403-e063-6394a90a502a	73796-119	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	Prostock LLC	ALCOHOL	.62	mL/mL			N	20241231
73814-986_07673c14-231e-9292-e063-6394a90aff2d	73814-986	HUMAN PRESCRIPTION DRUG	TECHNEGAS		Kit for the preparation of technetium Tc 99m-labeled carbon inhalation aerosol	AEROSOL	RESPIRATORY (INHALATION)	20230929		NDA	NDA022335	Cyclomedica Australia Pty Limited	GRAPHITE	1.25	g/1			N	20241231
73819-0015_140d8384-fab6-48cf-9c86-ebb7f2b8e2a0	73819-0015	HUMAN OTC DRUG	innerpink Feminine Spot		Niacinamide, Adenosine	CREAM	TOPICAL	20230401		UNAPPROVED DRUG OTHER		GuStar Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100g; g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
73833-000_f186ca5a-fffc-bfe4-e053-2995a90ab684	73833-000	HUMAN OTC DRUG	Sanit Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200324	20251231	OTC MONOGRAPH NOT FINAL	part333E	Unified Solutions for Cleaning Inc	ALCOHOL	.7	L/L			N	
73833-001_f1870a6f-cbe7-2908-e053-2995a90ab848	73833-001	HUMAN OTC DRUG	Sanit Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200527	20251231	OTC MONOGRAPH NOT FINAL	part333E	Unified Solutions for Cleaning Inc	ALCOHOL	.7	mL/mL			N	
73833-003_f1872f81-964c-283e-e053-2a95a90a565d	73833-003	HUMAN OTC DRUG	Sanit Hand Sanitizer Advanced Formula		ALCOHOL	GEL	TOPICAL	20200805	20251231	OTC MONOGRAPH NOT FINAL	part333E	Unified Solutions for Cleaning Inc	ALCOHOL	.7	mL/mL			N	
73833-004_f1875a4f-fc43-cb91-e053-2995a90addeb	73833-004	HUMAN OTC DRUG	Sanit Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200805	20251231	OTC MONOGRAPH NOT FINAL	part333E	Unified Solutions for Cleaning Inc	ALCOHOL	.7	mL/mL			N	
73857-003_fad6c76f-db96-445e-9318-6496e83da930	73857-003	HUMAN OTC DRUG	Theorie Antimicrobial Hand WASH		Benzalkonium Chloride	SOAP	TOPICAL	20200414		OTC MONOGRAPH NOT FINAL	part333E	Dynastis, LLC	BENZALKONIUM CHLORIDE	.0013	kg/kg			N	20241231
73869-101_f54f947b-37f2-1bd4-e053-2a95a90a7bd8	73869-101	HUMAN OTC DRUG	FORTO Antiseptic Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200402		OTC MONOGRAPH NOT FINAL	part333A	Master Paints & Chemical Corp	ALCOHOL	605.7	mg/mL			N	20241231
73869-102_f54f9c1f-9850-25a5-e053-2995a90a444f	73869-102	HUMAN OTC DRUG	Forto	Isopropyl Alcohol 70%	Isopropyl Alcohol	LIQUID	TOPICAL	20200921		OTC MONOGRAPH NOT FINAL	part333A	Master Paints & Chemical Corp	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
73898-001_0e8d5cf6-3f9e-e847-e063-6294a90a634b	73898-001	HUMAN OTC DRUG	Noshinku Bergamot Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20190325		OTC MONOGRAPH DRUG	M003	Noshinku	ALCOHOL	62.5	mL/100mL			N	20251231
73898-002_0e7729de-104b-e578-e063-6394a90a7de6	73898-002	HUMAN OTC DRUG	Noshinku Eucalyptus Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20201207		OTC MONOGRAPH DRUG	M003	Noshinku	ALCOHOL	70	mL/100mL			N	20251231
73898-003_0e771c1f-5982-e177-e063-6394a90a0b89	73898-003	HUMAN OTC DRUG	Noshinku Lavender Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20201207		OTC MONOGRAPH DRUG	M003	Noshinku	ALCOHOL	70	mL/100mL			N	20251231
73898-005_0e8d5cf6-3f9f-e847-e063-6294a90a634b	73898-005	HUMAN OTC DRUG	Nourishing Hand Sanitizer	Spice	ALCOHOL	SOLUTION	TOPICAL	20190325		OTC MONOGRAPH DRUG	M003	Noshinku	ALCOHOL	70	mL/100mL			N	20251231
73898-006_0e8d6239-dc98-ddba-e063-6394a90a0e3f	73898-006	HUMAN OTC DRUG	Nourishing Hand Sanitizer	Limon	ALCOHOL	SOLUTION	TOPICAL	20190325		OTC MONOGRAPH DRUG	M003	Noshinku	ALCOHOL	70	mL/100mL			N	20251231
73898-007_0e8d6877-a9a6-ca0d-e063-6394a90ab929	73898-007	HUMAN OTC DRUG	Nourishing Hand Sanitizer	Vetiver	ALCOHOL	SOLUTION	TOPICAL	20190325		OTC MONOGRAPH DRUG	M003	Noshinku	ALCOHOL	70	mL/100mL			N	20251231
73926-753_0c66b525-7708-cc97-e063-6394a90a2496	73926-753	HUMAN OTC DRUG	EcoChoice Sterno Hand Sanitizer Lemon Zest		Alcohol	SOLUTION	TOPICAL	20231130		OTC MONOGRAPH DRUG	M003	STERNO PRODUCTS, LLC	ALCOHOL	70	mL/100mL			N	20241231
73926-754_0c66abd2-b8ab-9b9f-e063-6394a90ad3b7	73926-754	HUMAN OTC DRUG	EcoChoice Sterno Hand Sanitizer Clean and Fresh		Alcohol	SOLUTION	TOPICAL	20231130		OTC MONOGRAPH DRUG	M003	STERNO PRODUCTS, LLC	ALCOHOL	70	mL/100mL			N	20241231
73928-001_b3c68f3c-f871-4af1-a732-3189513283c7	73928-001	HUMAN OTC DRUG	LOCKE TEDDY		Alcohol antiseptic	GEL	TOPICAL	20200326		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO.,LTD	ALCOHOL	75	mL/100mL			N	20241231
73928-002_c5483584-9841-4c22-9375-2e6730f12af1	73928-002	HUMAN OTC DRUG	HAND SANITIZER		ALCHOHOL	LIQUID	TOPICAL	20200519		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	ALCOHOL	75	mL/100mL			N	20241231
73928-003_29958342-62c1-4f36-81f7-3d63f9cc6269	73928-003	HUMAN OTC DRUG	Clean Simple Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200525		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	ALCOHOL	75	mL/100mL			N	20241231
73928-004_69fad6d3-b404-49d1-8531-3ba3684c5927	73928-004	HUMAN OTC DRUG	Pure care hand sanitizer		Alcohol	GEL	TOPICAL	20200526		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	ALCOHOL	75	mL/100mL			N	20241231
73928-005_8ed133fd-41b4-4247-beb2-be1c31427f07	73928-005	HUMAN OTC DRUG	livWell		Alcohol	GEL	TOPICAL	20200622		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	ALCOHOL	75	mL/100mL			N	20241231
73928-006_90113709-f2ec-4539-b004-e8e364eb7897	73928-006	HUMAN OTC DRUG	Locke Teddy		Alcohol	SWAB	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	ALCOHOL	75	mL/100mL			N	20241231
73928-007_efaf69cd-1e9e-4916-91f2-78d6aa8865f5	73928-007	HUMAN OTC DRUG	Anthem Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200727		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	ALCOHOL	75	mL/100mL			N	20241231
73928-010_b3cde609-7d63-2ac7-e053-2a95a90a26b3	73928-010	HUMAN OTC DRUG	SPF50 Sunscreen		Sunscreen	CREAM	TOPICAL	20201110		OTC MONOGRAPH NOT FINAL	part352	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	HOMOSALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE; ZINC OXIDE	10; 9.8; 2; 8; 3	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73928-011_bec5811d-b130-6632-e053-2995a90a708c	73928-011	HUMAN OTC DRUG	LOCKE TEDDY Foaming Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20210323		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
73928-012_bb277d77-6cdf-bb64-e053-2a95a90a848b	73928-012	HUMAN OTC DRUG	HANDOUT protection hand sanitizer		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part333A	KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
73928-100_2416b68a-8463-4681-93d1-ca07257d49bc	73928-100	HUMAN OTC DRUG	Dermasil DrySkin		DIMETHICONE	LOTION	TOPICAL	20230714		OTC MONOGRAPH FINAL	part347	Kingkey MBC Life Technology Group Co., Ltd.	DIMETHICONE	.01	g/mL	Skin Barrier Activity [PE]		N	20241231
73928-101_174e201c-8f17-4a04-8a3e-22133282ffc9	73928-101	HUMAN OTC DRUG	DERMASIL ADVANCED		DIMETHICONE	LOTION	TOPICAL	20230717		OTC MONOGRAPH FINAL	part347	Kingkey MBC Life Technology Group Co., Ltd.	DIMETHICONE	.01	g/mL	Skin Barrier Activity [PE]		N	20241231
73931-001_5b386c5a-8137-4e60-961e-6833a87cb18f	73931-001	HUMAN OTC DRUG	I-Softto Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20190730		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-002_48f3fcd4-8c64-49f0-8dc9-b7635f65a4b7	73931-002	HUMAN OTC DRUG	I-Softto Alcohol Disinfectant		Alcohol	SOLUTION	TOPICAL	20200328		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-003_bac9675e-701c-47e0-969b-01ddc81c51c0	73931-003	HUMAN OTC DRUG	kekangbei Instant hand Sanitizer		Alcohol	GEL	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-004_ff95f30b-4da6-43c2-89c8-02f524bbc444	73931-004	HUMAN OTC DRUG	kekangbei Alcohol Disinfectant		Alcohol	SOLUTION	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-005_3825438b-73d0-41e6-a1de-c28413b45c3a	73931-005	HUMAN OTC DRUG	I-Softto Instant hand Sanitizer		Alcohol	GEL	TOPICAL	20200623		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-006_7b0005b3-feed-46bf-8af5-5508c3813b27	73931-006	HUMAN OTC DRUG	Lifebuoy Hand Sanitizer		Alcohol	GEL	TOPICAL	20200507		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-008_7093d244-67ac-4ae9-be49-dbc9de6b8b8a	73931-008	HUMAN OTC DRUG	One Drop Care Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	80	mL/100mL			N	20241231
73931-010_f38dbd1e-e119-4a46-85c7-97b561146332	73931-010	HUMAN OTC DRUG	Asepso Sani Care Alcohol Sanitizer		Alcohol	GEL	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-012_2a023364-4f07-4bf9-b69b-ee351451b632	73931-012	HUMAN OTC DRUG	One Drop Care Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	80	mL/100mL			N	20241231
73931-014_94d39baa-391a-4d5c-b687-0cbfdc9dce02	73931-014	HUMAN OTC DRUG	Asepso Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200704		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	72	mL/100mL			N	20241231
73931-015_cc6df326-255b-467b-abaf-df4687dffb18	73931-015	HUMAN OTC DRUG	Lifebuoy Hand Sanitizer		Alcohol	GEL	TOPICAL	20200827		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-016_a084b642-3789-4e71-b61e-4404feda5013	73931-016	HUMAN OTC DRUG	Lifebuoy Hand Sanitizer Professional		Alcohol	GEL	TOPICAL	20200827		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-017_9d07c9fe-8958-4e5f-a24c-0c072b02ce04	73931-017	HUMAN OTC DRUG	Suave Hand Sanitizer Professional		Alcohol	GEL	TOPICAL	20200827		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73931-018_042334fa-f7db-404c-91c2-3860c7c86a88	73931-018	HUMAN OTC DRUG	Suave Hand Sanitizer		Alcohol	GEL	TOPICAL	20200827		OTC MONOGRAPH NOT FINAL	part333E	Guangdong Essence Daily Chemical Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
73943-945_d27d8c2c-f4b2-2eb3-e053-2a95a90aad5c	73943-945	HUMAN OTC DRUG	Han-San Gel		Han-San Gel	GEL	TOPICAL	20200324		OTC MONOGRAPH NOT FINAL	part333A	Rite-Kem Incorporated	ALCOHOL	70	mL/100mL			N	20241231
73943-946_d27d8c2c-f4b2-2eb3-e053-2a95a90aad5c	73943-946	HUMAN OTC DRUG	Han-San Topical		Han-San Topical	LIQUID	TOPICAL	20200324		OTC MONOGRAPH NOT FINAL	part333A	Rite-Kem Incorporated	ALCOHOL	70	mL/100mL			N	20241231
73943-947_d27d8c2c-f4b2-2eb3-e053-2a95a90aad5c	73943-947	HUMAN OTC DRUG	Han-San Topical 80		Han-San Topical 80	LIQUID	TOPICAL	20200324		OTC MONOGRAPH NOT FINAL	part333A	Rite-Kem Incorporated	ALCOHOL	80	mL/100mL			N	20241231
73943-949_d27d8c2c-f4b2-2eb3-e053-2a95a90aad5c	73943-949	HUMAN OTC DRUG	Han-San Gel with Aloe		Alcohol	GEL	TOPICAL	20210315		OTC MONOGRAPH NOT FINAL	part333A	Rite-Kem Incorporated	ALCOHOL	70	mL/100mL			N	20241231
73943-950_f1eb2d67-0d8e-1472-e053-2a95a90a9d62	73943-950	HUMAN OTC DRUG	Soft Wet Wipes		Soft Wet Wipes	LIQUID	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part333A	Rite-Kem Incorporated	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
73943-951_f1eb1393-6149-d040-e053-2995a90a3626	73943-951	HUMAN OTC DRUG	Klean-Them Hand Scrubbing Towels		Klean-Them Hand Scrubbing Towels	LIQUID	TOPICAL	20210517		OTC MONOGRAPH NOT FINAL	part333A	Rite-Kem Incorporated	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
73943-952_d27d8c2c-f4b2-2eb3-e053-2a95a90aad5c	73943-952	HUMAN OTC DRUG	SOBER-SAN		SOBER-SAN	LIQUID	TOPICAL	20200315		OTC MONOGRAPH NOT FINAL	part333A	Rite-Kem Incorporated	ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE (C12-C16)	.1	g/100mL			N	20241231
73950-001_a651dcde-31cd-b5c7-e053-2995a90ae8ab	73950-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200523		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-002_a682549c-48ee-62d9-e053-2a95a90aca62	73950-002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200523		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-003_a6acd1d9-4fb5-692a-e053-2a95a90a5697	73950-003	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-004_a682cddb-a4db-2ef3-e053-2a95a90ab303	73950-004	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200526		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-005_a6834411-e106-eea2-e053-2995a90a7fd1	73950-005	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200526		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-006_a683bf41-78e7-448b-e053-2a95a90a2de6	73950-006	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200526		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-007_a684339f-6b67-090e-e053-2a95a90a056a	73950-007	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200526		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-008_a684d6b1-1f77-4151-e053-2a95a90aa981	73950-008	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200526		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-052_a3cae279-9fb8-c13a-e053-2995a90af208	73950-052	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73950-053_a3cd0f3e-90ef-95c7-e053-2995a90a6b1b	73950-053	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333E	MINISO DEPOT CA, INC.	ALCOHOL	62	mL/100mL			N	20241231
73964-032_f27781af-b584-293f-e053-2a95a90a843f	73964-032	HUMAN OTC DRUG	LESS EVERY TONE SPF 30		Zinc Oxide	LOTION	TOPICAL	20220922		OTC MONOGRAPH FINAL	part346	Happy Farm Botanicals, Inc.	ZINC OXIDE	17	g/100g			N	20241231
73978-001_a217f7ae-f38f-841c-e053-2995a90acea1	73978-001	HUMAN OTC DRUG	b.clean hand sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Marque of Brands Americas, LLC	ALCOHOL	60	mL/100mL			N	20241231
73978-002_a22af71e-6273-9a66-e053-2995a90a6414	73978-002	HUMAN OTC DRUG	b.clean hand sanitizer (foam)		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Marque of Brands Americas, LLC	BENZALKONIUM CHLORIDE	.25	g/100mL			N	20241231
73978-003_a5b6452f-961e-efd3-e053-2995a90a71cc	73978-003	HUMAN OTC DRUG	b.clean hand sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Marque of Brands Americas, LLC	ALCOHOL	70	mL/100mL			N	20241231
73978-004_ba88a7db-90d2-168a-e053-2a95a90ae173	73978-004	HUMAN OTC DRUG	b.tan Sun Safe AF Face	SPF 70	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210211		OTC MONOGRAPH FINAL	part352	Marque of Brands Americas, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73978-005_bb15b4c6-99c8-2b7f-e053-2a95a90a6da9	73978-005	HUMAN OTC DRUG	b.tan Tropic Like Its Hot	SPF 15	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210211		OTC MONOGRAPH NOT FINAL	part352	Marque of Brands Americas, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 6; 5; 8	mg/100g; mg/100g; mg/100g; mg/100g			N	20241231
73978-006_bdadedbb-f385-3d0f-e053-2a95a90ab801	73978-006	HUMAN OTC DRUG	b.tan Sun Safe AF	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210316		OTC MONOGRAPH FINAL	part352	Marque of Brands Americas, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73978-007_bdbc0e6d-6d30-9dcf-e053-2995a90aa37e	73978-007	HUMAN OTC DRUG	b.tan Sun Safe AF	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210317		OTC MONOGRAPH FINAL	part352	Marque of Brands Americas, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
73978-008_bdbc9edd-de15-718f-e053-2995a90a1f5a	73978-008	HUMAN OTC DRUG	b.tan SPF is Your BFF	SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210317		OTC MONOGRAPH FINAL	part352	Marque of Brands Americas, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73978-009_bdc073be-01ba-6467-e053-2995a90ac8d5	73978-009	HUMAN OTC DRUG	b.tan Beach Please	SPF 7	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210317		OTC MONOGRAPH NOT FINAL	part352	Marque of Brands Americas, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 6; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
73978-010_d8ca4f78-b155-4799-e053-2995a90ade95	73978-010	HUMAN OTC DRUG	b.tan SPF is Your BFF	SPF 30	Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220224		OTC MONOGRAPH FINAL	part352	Marque of Brands Americas, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
74026-004_e65dedfe-81f4-4481-e053-2a95a90a6d86	74026-004	HUMAN OTC DRUG	Advanced Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200623	20240211	OTC MONOGRAPH NOT FINAL	part333E	Maple Mountain Co-Packers LLC	ALCOHOL	.8	mL/mL			N	
74047-002_0c370f5d-320c-174e-e063-6394a90a3e64	74047-002	HUMAN OTC DRUG	Alcohol Hand Sanitizer		Alcohol Hand Sanitizer	GEL	TOPICAL	20200416		OTC MONOGRAPH DRUG	M003	Shantou Kangjie Daily Chemical Industry Co.,Ltd	ALCOHOL	75	mL/100mL			N	20241231
74047-003_fff2fe2f-198c-f85f-e053-6294a90a54f5	74047-003	HUMAN OTC DRUG	Denatured Alcohol		Ethanol	LIQUID	TOPICAL	20230606		OTC MONOGRAPH NOT FINAL	part333A	Shantou Kangjie Daily Chemical Industry Co.,Ltd	ALCOHOL	75	mL/100mL			N	20241231
74047-010_0c37e8a0-b5fa-2c1f-e063-6294a90a5d34	74047-010	HUMAN OTC DRUG	Re-Mover By The Fifteenth 15inc		Re-Mover By The Fifteenth 15inc	LIQUID	TOPICAL	20231211		UNAPPROVED DRUG OTHER		Shantou Kangjie Daily Chemical Industry Co.,Ltd.	ALCOHOL	75	mL/100mL			N	20241231
74094-002_f28ddf64-5f46-414a-e053-2a95a90a9b6c	74094-002	HUMAN OTC DRUG	Marshall Toothache Drops		Eugenol 85% (Clove Oil 2% v/v)	SOLUTION/ DROPS	DENTAL	20210517		OTC MONOGRAPH NOT FINAL	part356	Yashvire LLC	EUGENOL	17	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
74103-001_be399016-d960-a12a-e053-2995a90a2d46	74103-001	HUMAN OTC DRUG	fisherbrand Alcohol Prep Pad Sterile		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20201229		OTC MONOGRAPH NOT FINAL	part333A	FISHER SCIENTIFIC CHEMICAL DIVISION	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
74139-444_c7bb4ad9-ec76-486b-e053-2a95a90ae8cf	74139-444	HUMAN OTC DRUG	Hygiene Hero		Super Mist Multi-purpose Organic Hand Sanitizer	LIQUID	TOPICAL	20200330	20250330	OTC MONOGRAPH NOT FINAL	part333A	Berry White Inc	ALCOHOL	75	mL/100mL			N	
74154-012_42226631-28e1-4e34-bffc-aaa7190e438b	74154-012	HUMAN OTC DRUG	Kiss My Face Bare Naked 30 Mineral Sunscreen		titanium dioxide	SPRAY	TOPICAL	20220218		OTC MONOGRAPH NOT FINAL	part352	Windmill Health Products, LLC	TITANIUM DIOXIDE	.078	mg/mL			N	20241231
74154-013_28a7acfd-488d-4cee-a2de-431c14c0b762	74154-013	HUMAN OTC DRUG	Kiss My Face Kids 30 Mineral Sunscreen		Titanium Dioxide	SPRAY	TOPICAL	20220225		OTC MONOGRAPH NOT FINAL	part352	Windmill Health Products, LLC	TITANIUM DIOXIDE	78	mg/mL			N	20241231
74154-014_0a00e743-5e0a-4334-84e2-7dd4c07d06c2	74154-014	HUMAN OTC DRUG	Kiss My Face Kids Fluoride - Berry Smart		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20220218		OTC MONOGRAPH FINAL	part355	Windmill Health Products, LLC	SODIUM MONOFLUOROPHOSPHATE	7.6	mg/g			N	20241231
74154-015_c856117d-0466-4bf6-b1d0-0b6b0602d10e	74154-015	HUMAN OTC DRUG	Kiss My Face Sensitive Fluoride-Free Whitening - Citrus Mint		Potassium Nitrate	PASTE, DENTIFRICE	DENTAL	20220218		OTC MONOGRAPH NOT FINAL	part356	Windmill Health Products, LLC	POTASSIUM NITRATE	.05	g/g			N	20241231
74154-016_61819350-ff9c-4db5-a59d-af816a286500	74154-016	HUMAN OTC DRUG	Kiss My Face Cool Sport 30 Mineral Sunscreen		Titanium Dioxide	SPRAY	TOPICAL	20220222		OTC MONOGRAPH NOT FINAL	part352	Windmill Health Products, LLC	TITANIUM DIOXIDE	78	mg/mL			N	20241231
74154-317_09e2089e-a6fa-9d2f-e063-6394a90a2282	74154-317	HUMAN OTC DRUG	KISS MY FACE SPF-50 Baby Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220214		OTC MONOGRAPH DRUG	M020	WINDMILL HEALTH PRODUCTS LLC	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
74154-318_09e2089e-a70b-9d2f-e063-6394a90a2282	74154-318	HUMAN OTC DRUG	KISS MY FACE SPF-50 Daily Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220214		OTC MONOGRAPH DRUG	M020	WINDMILL HEALTH PRODUCTS LLC	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
74154-319_09e2089e-a71c-9d2f-e063-6394a90a2282	74154-319	HUMAN OTC DRUG	KISS MY FACE SPF-50 Face Factor Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220214		OTC MONOGRAPH DRUG	M020	WINDMILL HEALTH PRODUCTS LLC	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
74157-007_075c49d1-a6b8-d976-e063-6394a90a21d4	74157-007	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20210920		ANDA	ANDA075229	INA Pharmaceutics Inc	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
74157-095_0c5042a2-cf2d-1888-e063-6294a90a5a62	74157-095	HUMAN PRESCRIPTION DRUG	diclofenac potassium		diclofenac potassium	CAPSULE, LIQUID FILLED	ORAL	20220520		ANDA	ANDA210078	INA Pharmaceutics Inc.	DICLOFENAC POTASSIUM	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
74177-003_08968558-c322-da57-e063-6394a90a8f21	74177-003	HUMAN OTC DRUG	Lavender Hand Sanitizer Girl		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-004_08968b1b-154e-480e-e063-6294a90a5414	74177-004	HUMAN OTC DRUG	Peppermint Hand Sanitizer Girl		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-005_08968433-3b5b-1ee5-e063-6294a90aeddd	74177-005	HUMAN OTC DRUG	Watermelon Hand Sanitizer Girl		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-006_0896c4d1-6ab6-2552-e063-6294a90a69b9	74177-006	HUMAN OTC DRUG	Cherry Hand Sanitizer Boy		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-007_0896ba3c-9ee1-2fc2-e063-6394a90a2d29	74177-007	HUMAN OTC DRUG	Lemonade Hand Sanitizer Boy		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-010_08968b1b-1541-480e-e063-6294a90a5414	74177-010	HUMAN OTC DRUG	PEPPERMINT HAND SANITIZER boy		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-021_08979f64-b260-9491-e063-6294a90a5fa7	74177-021	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200425		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-022_0897c92f-ad36-a897-e063-6394a90af29c	74177-022	HUMAN OTC DRUG	BUBBLE GUM HAND SANITIZER boy		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	g/g			N	20241231
74177-023_0897b5ff-ca95-5ed5-e063-6294a90a92ee	74177-023	HUMAN OTC DRUG	BUBBLE GUM HAND SANITIZER girl		ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	g/g			N	20241231
74177-024_0897b9cc-48fb-571f-e063-6294a90a6ca5	74177-024	HUMAN OTC DRUG	Hibiscus ROSE HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200513		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-025_0897a8a2-111f-bf07-e063-6294a90a37eb	74177-025	HUMAN OTC DRUG	Lavender ALOE HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200513		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-026_0897ac32-8721-c027-e063-6294a90a3985	74177-026	HUMAN OTC DRUG	Natural ALOE HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200513		OTC MONOGRAPH DRUG	505G(a)(3)	K7 Design Group Inc.	ALCOHOL	.62	mL/mL			N	20241231
74177-031_0897bdf3-a452-ae95-e063-6294a90a565e	74177-031	HUMAN OTC DRUG	berry blast scent hand sanitizer		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	ALCOHOL	.62	mL/mL			N	20241231
74177-032_08978b6c-5954-e65d-e063-6294a90a722e	74177-032	HUMAN OTC DRUG	bubble gum scent hand sanitizer		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	ALCOHOL	.62	mL/mL			N	20241231
74177-033_08979f64-b27c-9491-e063-6294a90a5fa7	74177-033	HUMAN OTC DRUG	citrus crush scent hand sanitizer panda		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	ALCOHOL	.62	mL/mL			N	20241231
74177-034_0897ccca-fa0a-873f-e063-6394a90a59ab	74177-034	HUMAN OTC DRUG	citrus crush scent hand sanitizer robot		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	ALCOHOL	.62	mL/mL			N	20241231
74177-035_0897d0cd-b2aa-e371-e063-6394a90a5300	74177-035	HUMAN OTC DRUG	lemon lime scent hand sanitizer		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	ALCOHOL	.62	mL/mL			N	20241231
74177-036_0897b5ff-caa2-5ed5-e063-6294a90a92ee	74177-036	HUMAN OTC DRUG	vanilla frosting scent hand sanitizer		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	ALCOHOL	.62	mL/mL			N	20241231
74177-040_0897c92f-ad28-a897-e063-6394a90af29c	74177-040	HUMAN OTC DRUG	Mountain Air Scent FOAMING HAND SANITIZER		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210124		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
74177-041_0897b5ff-cab0-5ed5-e063-6294a90a92ee	74177-041	HUMAN OTC DRUG	Pine and Honey Scent FOAMING HAND SANITIZER		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210124		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
74177-042_0897d0cd-b2b8-e371-e063-6394a90a5300	74177-042	HUMAN OTC DRUG	Simply Lavender Scent FOAMING HAND SANITIZER		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210124		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
74177-043_0897b5ff-cacc-5ed5-e063-6294a90a92ee	74177-043	HUMAN OTC DRUG	Vanilla Coconut Scent FOAMING HAND SANITIZER		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210124		OTC MONOGRAPH DRUG	505G(a)(3)	K7 DESIGN GROUP INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
74201-004_a9bbcc7a-692e-6f32-e053-2a95a90ac19a	74201-004	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part333E	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
74201-016_0718038b-35b3-5ffc-e063-6394a90ab398	74201-016	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200508		OTC MONOGRAPH DRUG	M003	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
74201-020_ae5e8903-a185-7f2c-e053-2995a90a98bf	74201-020	HUMAN OTC DRUG	INTCO Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200903		OTC MONOGRAPH NOT FINAL	part333E	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	75	mL/100mL			N	20241231
74201-033_a62082b5-4c14-7939-e053-2995a90a75c7	74201-033	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200521		OTC MONOGRAPH NOT FINAL	part333E	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
74201-102_a9bc462e-614d-a3dc-e053-2a95a90aed70	74201-102	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200706		OTC MONOGRAPH NOT FINAL	part333E	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
74201-108_a64ff4e1-d59a-8508-e053-2995a90aa098	74201-108	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200525		OTC MONOGRAPH NOT FINAL	part333E	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
74201-338_ae5f9d87-d193-51cd-e053-2a95a90a7d24	74201-338	HUMAN OTC DRUG	INTCO Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200903		OTC MONOGRAPH NOT FINAL	part333E	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	75	mL/100mL			N	20241231
74201-845_ae6162de-19c8-43ae-e053-2a95a90a5848	74201-845	HUMAN OTC DRUG	INTCO Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200903		OTC MONOGRAPH NOT FINAL	part333E	Jiangsu Intco Medical Products Co Ltd	ALCOHOL	75	mL/100mL			N	20241231
74213-381_754e7ed4-aba0-4ccd-a23e-b0f9f4444cee	74213-381	HUMAN OTC DRUG	CROSSCO ANTISEPTIC HAND SANITIZER		Ethyl alcohol	SOLUTION	TOPICAL	20200402		OTC MONOGRAPH NOT FINAL	part333A	Max Chemical, Inc.	ALCOHOL	70	mL/100mL			N	20241231
74213-382_14b47a0d-97fb-4360-bd0e-176a10e28fdd	74213-382	HUMAN OTC DRUG	CROSSCO		Isopropyl alcohol	SOLUTION	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333A	Max Chemical, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
74242-102_aac95898-1206-fc8f-e053-2995a90a429c	74242-102	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333E	Kem Krest LLC	ALCOHOL	62	mL/100mL			N	20241231
74242-110_aae8ad23-ee08-23e2-e053-2995a90afcd4	74242-110	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333E	Kem Krest LLC	ALCOHOL	62	mL/100mL			N	20241231
74242-134_aae8d1fd-39dd-53fb-e053-2995a90a28ce	74242-134	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333E	Kem Krest LLC	ALCOHOL	62	mL/100mL			N	20241231
74242-169_aae8d1fd-39da-53fb-e053-2995a90a28ce	74242-169	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333E	Kem Krest LLC	ALCOHOL	62	mL/100mL			N	20241231
74246-102_0cd072a4-ff3c-647b-e063-6394a90ab62a	74246-102	HUMAN OTC DRUG	Aura Cacia Hand Sanitizer	Lavender	Alcohol	SOLUTION	TOPICAL	20200610	20251106	OTC MONOGRAPH DRUG	505G(a)(3)	Frontier Co-op	ALCOHOL	80	mL/100mL			N	
74246-103_0cf79d4b-8751-eaaa-e063-6294a90a1e6d	74246-103	HUMAN OTC DRUG	Aura Cacia Hand Sanitizer	Tea Tree Citrus	Alcohol	SOLUTION	TOPICAL	20200611	20251112	OTC MONOGRAPH DRUG	505G(a)(3)	Frontier Co-op	ALCOHOL	80	mL/100mL			N	
74246-104_0cf79b4d-c1c2-2268-e063-6294a90a1239	74246-104	HUMAN OTC DRUG	Aura Cacia Hand Sanitizer	Unscented	Alcohol	SOLUTION	TOPICAL	20200611	20250522	OTC MONOGRAPH DRUG	505G(a)(3)	Frontier Co-op	ALCOHOL	80	mL/100mL			N	
74274-001_6ae1f06f-0c7b-43d0-bb21-567bcd3c8917	74274-001	HUMAN OTC DRUG	Frozen II HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-002_101c4dc6-1d4f-4246-b7e6-feaf3e907657	74274-002	HUMAN OTC DRUG	star wars HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-003_663d1a0c-aa09-4d9c-98d2-ad9583348b3d	74274-003	HUMAN OTC DRUG	mickey mouse HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-004_e6ce17f2-1d5d-4038-a59a-1654b11a4e46	74274-004	HUMAN OTC DRUG	minnie mouse HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-005_e900b48d-2320-4a56-bd18-e31d561a6e57	74274-005	HUMAN OTC DRUG	Instant Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	65	mL/100mL			N	20241231
74274-006_384fa8df-9f0e-445b-80ef-0cb8f97c1603	74274-006	HUMAN OTC DRUG	AmphiSept Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200413		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
74274-007_58e73f91-d760-4381-aa62-360b7101602a	74274-007	HUMAN OTC DRUG	Traveltime Instant Hand Sanitizer	Soothing Aloe and Vitamin E	Alcohol	SOLUTION	TOPICAL	20200418		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	65	mL/100mL			N	20241231
74274-008_3f3f8f5e-1028-4d46-8e40-9d34f99868c2	74274-008	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200418		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
74274-009_5e6ca6c1-3f22-4978-bd82-878c1d5f39cb	74274-009	HUMAN OTC DRUG	90013 Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200418		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-010_c594eaa6-d399-4524-9226-43fc5b360fb5	74274-010	HUMAN OTC DRUG	Magnet Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
74274-011_ce5f7974-3b7e-41ae-a69f-1d6df5dfd5da	74274-011	HUMAN OTC DRUG	Stay Safe HAND SANITIZER		Alcohol	SOLUTION	TOPICAL	20200609		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	65	mL/100mL			N	20241231
74274-012_65dd614e-0616-4f5d-954d-06ab206d4f68	74274-012	HUMAN OTC DRUG	Travelers Hand Sanitizers		Alcohol	SOLUTION	TOPICAL	20200429		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	65	mL/100mL			N	20241231
74274-014_5979013e-a643-4cc2-9670-6fb37938ffeb	74274-014	HUMAN OTC DRUG	cabeau Sanitizer To Go		Alcohol	GEL	TOPICAL	20200507		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	70	mL/100mL			N	20241231
74274-016_372b0fd5-c229-4da1-82f9-850dea95039e	74274-016	HUMAN OTC DRUG	Assorted Scented Hand Sanitizers		Alcohol	SPRAY	TOPICAL	20200522		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
74274-018_4e1ec414-c784-4d5a-a55f-d8029f86e4a1	74274-018	HUMAN OTC DRUG	Centricity/STAR Products Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	70	mL/100mL			N	20241231
74274-022_19b7f3f4-2e52-41a2-a44c-fa28c5045db8	74274-022	HUMAN OTC DRUG	MARVEL Spider-Man HAND SANITIZER With Case		Alcohol	GEL	TOPICAL	20201007		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-023_8385fd74-dbb9-4f75-9ec3-27c4c78cfd60	74274-023	HUMAN OTC DRUG	MARVEL Avengers HAND SANITIZER With Case		Alcohol	GEL	TOPICAL	20201007		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-116_1b939b8b-8ab8-4a7d-804e-1e0db9f0305c	74274-116	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200413		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
74274-118_c931db21-510f-4500-b2d4-9b1eab30a373	74274-118	HUMAN OTC DRUG	Doordash Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200413		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-120_05f4fae0-bed8-4b27-ad4a-4fa146c8d922	74274-120	HUMAN OTC DRUG	Peannuts Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20201203		OTC MONOGRAPH NOT FINAL	part333E	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	mL/100mL			N	20241231
74274-200_ae5f8a72-1505-1429-e053-2995a90a46e2	74274-200	HUMAN OTC DRUG	90013 Hand Sanitizer		90013 Hand Sanitizer	GEL	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part333A	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	68	g/112mL			N	20241231
74274-201_ae51a8ca-e292-0ca0-e053-2995a90a10cf	74274-201	HUMAN OTC DRUG	90018 Sanitizer Pen		90018 Sanitizer Pen	SPRAY	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part333A	Huizhou Bliss Commodity Co., Ltd	ALCOHOL	75	g/117mL			N	20241231
74301-001_0c43c36d-43a8-d627-e063-6294a90a8872	74301-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100830		UNAPPROVED MEDICAL GAS		Medwiser, Inc.	OXYGEN	99	L/100L			N	20241231
74307-002_ed760956-4a42-af0d-e053-2995a90a8a66	74307-002	HUMAN OTC DRUG	Underarm Antiperspirant Daily Use Mandarin Scent		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20200423		OTC MONOGRAPH FINAL	part350	Clutch Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
74307-009_ed75fb5f-a408-59f5-e053-2995a90a9370	74307-009	HUMAN OTC DRUG	Underarm Antiperspirant Daily Use Fresh Linen Scent		Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20211019		OTC MONOGRAPH FINAL	part350	Clutch Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
74307-010_d78ad43a-c226-0629-e053-2a95a90a3781	74307-010	HUMAN OTC DRUG	Underarm Antiperspirant PM Wipes Clean Lavender Scent		Aluminum Zirconium Tetrachlorohydrex GLY	SOLUTION	TOPICAL	20210315		OTC MONOGRAPH FINAL	part350	Clutch Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
74307-011_d7896c6c-e78f-b038-e053-2995a90ae976	74307-011	HUMAN OTC DRUG	On-the-go Underarm Antiperspirant Wipes		Aluminum Chlorohydrate	SOLUTION	TOPICAL	20190205		OTC MONOGRAPH FINAL	part350	Clutch Inc	ALUMINUM CHLOROHYDRATE	15	g/100g			N	20241231
74332-003_e99b282e-0753-c895-e053-2a95a90a8af6	74332-003	HUMAN OTC DRUG	Encore Instant Hand Sanitizing		Alcohol	GEL	TOPICAL	20210826	20240307	OTC MONOGRAPH NOT FINAL	part333E	Encore Industrial Products, LLC	ALCOHOL	70	mL/100mL			N	
74340-0001_a45994ad-f434-0e29-e053-2a95a90a2ec4	74340-0001	HUMAN OTC DRUG	Pine Phytoncide Antiseptic Solution		Pinus Densiflora Extract	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		Jungwon Company	PINUS DENSIFLORA WHOLE	20	g/100mL			N	20241231
74340-0002_a459aedc-421e-8146-e053-2a95a90ad99e	74340-0002	HUMAN OTC DRUG	JungWon Pine Antibiosis Wet Wipes		Pinus Densiflora Extract	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		Jungwon Company	PINUS DENSIFLORA WHOLE	.65	g/100g			N	20241231
74355-321_fc9b7fb5-8db3-9deb-e053-6294a90a04e8	74355-321	HUMAN OTC DRUG	Unpaste		Zero waste fluoride cinnamon tooth tabs	TABLET, CHEWABLE	DENTAL	20230501		OTC MONOGRAPH FINAL	part355	Avespan LLC	SODIUM FLUORIDE	.62	mg/1			N	20241231
74355-322_fc9b9ef5-6b2b-8377-e053-6394a90ad03e	74355-322	HUMAN OTC DRUG	Unpaste		Zero waste fluoride mint tooth tabs	TABLET, CHEWABLE	DENTAL	20230501		OTC MONOGRAPH FINAL	part355	Avespan LLC	SODIUM FLUORIDE	.62	mg/1			N	20241231
74401-400_f26529f0-a495-afc5-e053-2a95a90ae4c3	74401-400	HUMAN OTC DRUG	Volu-Sol Moisturizing Hand Sanitizer		ALCOHOL	LOTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Volu-Sol	ALCOHOL	540.7	mg/mL			N	20241231
74401-500_f2654be7-ce60-6690-e053-2a95a90a8787	74401-500	HUMAN OTC DRUG	Moisturizing Foam Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Volu-Sol	ALCOHOL	74.3	mL/100mL			N	20241231
74401-700_f2656a6e-3486-61b9-e053-2a95a90a6456	74401-700	HUMAN OTC DRUG	Sanitizer Solution, Formulation One		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Volu-Sol	ALCOHOL	80	mL/100mL			N	20241231
74419-350_814a6b78-ae54-4c79-8176-1ce47b450218	74419-350	HUMAN OTC DRUG	Benchmark Shield		Ethyl Alcohol	LIQUID	TOPICAL	20200330	20240229	OTC MONOGRAPH NOT FINAL	part333A	Benchmark Industrial Supply, Llc	ALCOHOL	62	mL/100mL			N	
74419-750_6ee30114-97a3-4077-9fb4-76b8fcf01faa	74419-750	HUMAN OTC DRUG	BENCHMARK SHIELD ALCOHOL WIPES		Ethyl Alcohol	SWAB	TOPICAL	20200423	20240331	OTC MONOGRAPH NOT FINAL	part333A	Benchmark Industrial Supply, Llc	ALCOHOL	75	mL/100mL			N	
74419-775_a6878b29-621a-467c-8672-bf0a05c62b65	74419-775	HUMAN OTC DRUG	Shield		Ethyl Alcohol	CLOTH	TOPICAL	20200811	20240331	OTC MONOGRAPH NOT FINAL	part333A	Benchmark Industrial Inc.	ALCOHOL	75	mL/100mL			N	
74472-101_0c5fa852-12ce-20c4-e063-6294a90a913c	74472-101	HUMAN OTC DRUG	SOME BY MI AHA BHA PHA 30 DAYS MIRACLE ACNE CLEAR FOAM		SOME BY MI AHA BHA PHA 30 DAYS MIRACLE ACNE CLEAR FOAM	CREAM	TOPICAL	20231205		OTC MONOGRAPH DRUG	M006	PERENNEBELL Co., Ltd.	SALICYLIC ACID	.5	g/100g			N	20241231
74472-102_0c5f5889-d15a-0506-e063-6294a90ab0cc	74472-102	HUMAN OTC DRUG	SOME BY MI AHA BHA PHA 30 DAYS MIRACLE ACNE BODY CLEANSER		SOME BY MI AHA BHA PHA 30 DAYS MIRACLE ACNE BODY CLEANSER	CREAM	TOPICAL	20231205		OTC MONOGRAPH DRUG	M006	PERENNEBELL Co., Ltd.	SALICYLIC ACID	2	g/400g			N	20241231
74472-235_0e1a2e69-4d97-a066-e063-6394a90ad450	74472-235	HUMAN OTC DRUG	SOME BY MI V10 HYAL AIR FIT SUNSCREEN		sunscreent	CREAM	TOPICAL	20230731		OTC MONOGRAPH DRUG	M020	PERENNEBELL	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8.7	g/50mL; g/50mL; g/50mL; g/50mL			N	20251231
74474-103_c4932210-5ba9-3043-e053-2a95a90a8f29	74474-103	HUMAN OTC DRUG	Terravitals LoBak		Chamomilla, Phosphorus, Platinum Metallicum, Ruta Graveolens, Veratrum Album	PELLET	ORAL	20210615		UNAPPROVED HOMEOPATHIC		Terravitals LLC	CHAMOMILE; PHOSPHORUS; PLATINUM; RUTA GRAVEOLENS FLOWERING TOP; VERATRUM ALBUM ROOT	6; 30; 30; 6; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
74474-105_c59d8201-64a3-13ed-e053-2995a90a1b2a	74474-105	HUMAN OTC DRUG	Terravitals MidBak		Chamomile,RutaGraveolens,Zinc,VeratrumAlbum	PELLET	ORAL	20210626		UNAPPROVED HOMEOPATHIC		Terravitals LLC	CHAMOMILE; RUTA GRAVEOLENS FLOWERING TOP; VERATRUM ALBUM ROOT; ZINC	6; 6; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
74474-107_c756f288-693b-15c8-e053-2a95a90acd14	74474-107	HUMAN OTC DRUG	Terravitals BakNek		Antimonium crudum, Antimonium tartaricum, Arnica montana, Cuprum metallicum, Lycopodium clavatum	PELLET	ORAL	20210419		UNAPPROVED HOMEOPATHIC		Terravitals LLC	ANTIMONY POTASSIUM TARTRATE; ANTIMONY TRISULFIDE; ARNICA MONTANA WHOLE; COPPER; LYCOPODIUM CLAVATUM SPORE	8; 8; 30; 8; 6	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
74474-202_e6b46591-2de1-0d32-e053-2a95a90a3b8c	74474-202	HUMAN OTC DRUG	Terravitals SinuPure		Agaricus mus, Absinthium,Berberis vulgaris, Nitricum acidum, Urtica Urens	PELLET	ORAL	20220821		UNAPPROVED HOMEOPATHIC		Terravitals LLC	AMANITA MUSCARIA FRUITING BODY; BERBERIS VULGARIS ROOT BARK; NITRIC ACID; URTICA URENS; WORMWOOD	30; 30; 30; 30; 12	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
74474-401_c99c6e14-f6e6-45ca-e053-2995a90ab0dd	74474-401	HUMAN OTC DRUG	Terravitals BakNek		Zincum metallicum, Lecithinum	PELLET	ORAL	20210815		UNAPPROVED HOMEOPATHIC		Terravitals LLC	LECITHIN, SOYBEAN; ZINC	30; 30	[hp_C]/1; [hp_C]/1			N	20241231
74474-501_ea78fa5c-4f2f-5008-e053-2995a90ad4ed	74474-501	HUMAN OTC DRUG	Terravitals Migryx		Antimon tart, Mag phos, Selenium, Silicea, Zinc met	PELLET	ORAL	20221007		UNAPPROVED HOMEOPATHIC		Terravitals LLC	ANTIMONY POTASSIUM TARTRATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SELENIUM; SILICON DIOXIDE; ZINC	8; 30; 6; 30; 8	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
74496-9751_f1efbede-1212-4d12-e053-2995a90a0d82	74496-9751	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Hans Manufacturer Inc.	ALCOHOL	75	mL/100mL			N	20241231
74527-022_ecffdaa1-85ce-4114-9815-d90ae7ec3258	74527-022	HUMAN PRESCRIPTION DRUG	MARGENZA		margetuximab-cmkb	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20210115		BLA	BLA761150	MacroGenics, Inc	MARGETUXIMAB	25	mg/mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
74528-020_556071dc-02b2-4d9b-9ed3-44343e0f2432	74528-020	HUMAN PRESCRIPTION DRUG	BYLVAY		odevixibat	CAPSULE, COATED PELLETS	ORAL	20210720		NDA	NDA215498	Albireo Pharma, Inc.	ODEVIXIBAT	200	ug/1	Ileal Bile Acid Transporter Inhibitor [EPC], Ileal Bile Acid Transporter Inhibitors [MoA]		N	20241231
74528-040_556071dc-02b2-4d9b-9ed3-44343e0f2432	74528-040	HUMAN PRESCRIPTION DRUG	BYLVAY		odevixibat	CAPSULE, COATED PELLETS	ORAL	20210720		NDA	NDA215498	Albireo Pharma, Inc.	ODEVIXIBAT	400	ug/1	Ileal Bile Acid Transporter Inhibitor [EPC], Ileal Bile Acid Transporter Inhibitors [MoA]		N	20241231
74528-060_556071dc-02b2-4d9b-9ed3-44343e0f2432	74528-060	HUMAN PRESCRIPTION DRUG	BYLVAY		odevixibat	CAPSULE, COATED PELLETS	ORAL	20210720		NDA	NDA215498	Albireo Pharma, Inc.	ODEVIXIBAT	600	ug/1	Ileal Bile Acid Transporter Inhibitor [EPC], Ileal Bile Acid Transporter Inhibitors [MoA]		N	20241231
74528-120_556071dc-02b2-4d9b-9ed3-44343e0f2432	74528-120	HUMAN PRESCRIPTION DRUG	BYLVAY		odevixibat	CAPSULE, COATED PELLETS	ORAL	20210720		NDA	NDA215498	Albireo Pharma, Inc.	ODEVIXIBAT	1200	ug/1	Ileal Bile Acid Transporter Inhibitor [EPC], Ileal Bile Acid Transporter Inhibitors [MoA]		N	20241231
74530-021_d4a2010c-6c37-75fa-e053-2995a90a7af2	74530-021	HUMAN OTC DRUG	Disney Frozen II Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Best Brand Consumers Products, Inc.	ALCOHOL	68	mL/100mL			N	20241231
74530-022_d4a2010c-6c38-75fa-e053-2995a90a7af2	74530-022	HUMAN OTC DRUG	Star War MANDALORIAN Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Best Brand Consumers Products, Inc.	ALCOHOL	68	mL/100mL			N	20241231
74530-023_d4a2010c-6c36-75fa-e053-2995a90a7af2	74530-023	HUMAN OTC DRUG	Disney Mickey Mouse Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Best Brand Consumers Products, Inc.	ALCOHOL	68	mL/100mL			N	20241231
74530-024_d4a20988-9c13-0b7d-e053-2995a90a36fe	74530-024	HUMAN OTC DRUG	Disney Minnie Mouse Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Best Brand Consumers Products, Inc.	ALCOHOL	68	mL/100mL			N	20241231
74530-044_d4a1f5db-135e-c6a1-e053-2995a90ad204	74530-044	HUMAN OTC DRUG	Marvel Spiderman Hand Sanitizer With Case		Alcohol	SOLUTION	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333A	Best Brand Consumers Products, Inc.	ALCOHOL	68	mL/100mL			N	20241231
74530-045_d4a1f08d-7611-d445-e053-2a95a90a2de5	74530-045	HUMAN OTC DRUG	Marvel Avengers Hand Sanitizer With Case		Alcohol	SOLUTION	TOPICAL	20200925		OTC MONOGRAPH NOT FINAL	part333A	Best Brand Consumers Products, Inc.	ALCOHOL	68	mL/100mL			N	20241231
74530-057_d4a1e3c0-528b-8517-e053-2a95a90afc07	74530-057	HUMAN OTC DRUG	DISNEY Stitch Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20210908		OTC MONOGRAPH NOT FINAL	part333A	Best Brand Consumers Products, Inc.	ALCOHOL	68	mL/100mL			N	20241231
74545-001_08c09aa5-83ea-dacf-e063-6394a90a325d	74545-001	HUMAN OTC DRUG	Palmero Healthcare Foaming Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200617		OTC MONOGRAPH DRUG	505G(a)(3)	Palmero Healthcare	ALCOHOL	.62	mL/mL			N	20241231
74545-002_08c1157e-e2c5-2809-e063-6394a90acf48	74545-002	HUMAN OTC DRUG	Palmero Healthcare Discide XRA Hand Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20201115		OTC MONOGRAPH DRUG	505G(a)(3)	Palmero Healthcare, LLC	ALCOHOL	.7	mL/mL			N	20241231
74548-016_08634f11-3d6a-9bdc-e063-6294a90a101b	74548-016	HUMAN OTC DRUG	Aulani Disney Resort and Spa Hawaii Alcohol Wet Wipe		ALCOHOL	CLOTH	TOPICAL	20210423		OTC MONOGRAPH DRUG	505G(a)(3)	MING FAI ENTERPRISE INTERNATIONAL CO., LTD	ALCOHOL	72	mL/100mL			N	20241231
74550-0001_2c91abe8-a950-427d-9528-77d0e8ce40c0	74550-0001	HUMAN OTC DRUG	Ultra Slim 30		Fucus Vesiculosus, Cysteinum, Nicotinamidum, Alpha-Lipoicum Acidum, Antimonium Crudum, Chromium Sulphuricum, Gambogia, Anacardium Orientale, Graphites	LIQUID	ORAL	20201022		UNAPPROVED HOMEOPATHIC		Healthy Habits Management Company Inc.	ALPHA LIPOIC ACID; ANTIMONY TRISULFIDE; CHROMIC SULFATE PENTADECAHYDRATE; CYSTEINE; FUCUS VESICULOSUS; GAMBOGE; GRAPHITE; NIACINAMIDE; SEMECARPUS ANACARDIUM JUICE	12; 12; 12; 6; 3; 12; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
74553-000_c69afb50-4f1b-4e37-bacf-67f4ef8b13d1	74553-000	HUMAN OTC DRUG	OKAY HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200327		OTC MONOGRAPH NOT FINAL	part333E	XTREME TOOLS INTERNATIONAL, INC	ALCOHOL	.7	mL/mL			N	20241231
74553-001_b0fdfe63-fee9-9f79-e053-2a95a90ac30f	74553-001	HUMAN OTC DRUG	Anti-Perspirant Deodorant		Aluminium zirconium tetrachlorohydrex gly	LIQUID	TOPICAL	20201006		OTC MONOGRAPH FINAL	part350	Xtreme Tools International, Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	15	g/100mL			N	20241231
74553-002_b0fd7fae-1270-34f3-e053-2995a90a3093	74553-002	HUMAN OTC DRUG	BABY Diaper Rash		zinc oxide	CREAM	TOPICAL	20201006		OTC MONOGRAPH FINAL	part347	Xtreme Tools International, Inc	ZINC OXIDE	17	g/100g			N	20241231
74553-003_b1bc4938-e945-2ba0-e053-2995a90a08bf	74553-003	HUMAN OTC DRUG	DANDRUFF		Pyrithione zinc	SHAMPOO	TOPICAL	20201006		OTC MONOGRAPH FINAL	part358H	Xtreme Tools International, Inc	PYRITHIONE ZINC	2	g/100mL			N	20241231
74553-004_b1bc6ef9-fb4b-3f60-e053-2a95a90adfe1	74553-004	HUMAN OTC DRUG	MEDICATED LIP BALM		Dimethicone, Oxybenzone, and 2-Ethylhexyl Dimethyl PABA	CREAM	TOPICAL	20201014		OTC MONOGRAPH FINAL	part347	Xtreme Tools International, Inc	DIMETHICONE; OXYBENZONE; PADIMATE O	2; 2.5; 6.6	g/100g; g/100g; g/100g	Skin Barrier Activity [PE]		N	20241231
74553-005_b4eb8841-196f-133a-e053-2a95a90a9400	74553-005	HUMAN OTC DRUG	FOOT SOAK		Menthol, Methyl Salicylate	CRYSTAL	TOPICAL	20201125		OTC MONOGRAPH NOT FINAL	part348	Xtreme Tools International, Inc	MENTHOL; METHYL SALICYLATE	5; 5	g/100g; g/100g			N	20241231
74553-006_ae540ef8-b67f-43db-b0a1-86716135f27f	74553-006	HUMAN OTC DRUG	OKAY Nourishing Peppermint Scrub and Mask		Salicylic Acid	CREAM	TOPICAL	20210421		OTC MONOGRAPH FINAL	part333D	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100g			N	20241231
74553-007_06e5b6ce-839c-40cd-b138-586c2bfd951f	74553-007	HUMAN OTC DRUG	OKAY Blemish Control Apricot Scrub		Salicylic Acid	CREAM	TOPICAL	20210421		OTC MONOGRAPH FINAL	part333D	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100g			N	20241231
74553-008_dd9cea94-8222-4f10-9dd2-f893a44bd57b	74553-008	HUMAN OTC DRUG	Okay Womens Aluminium Free Deodorant Stick		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20210514		OTC MONOGRAPH FINAL	part350	Xtreme Tools International, Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
74553-009_6d518258-6753-4aff-98c0-b585b23cb5dd	74553-009	HUMAN OTC DRUG	Okay Womens Antiperspirant Roll on Deodorant		Aluminum Chlorohydrate	LIQUID	TOPICAL	20210607		OTC MONOGRAPH FINAL	part350	Xtreme Tools International, Inc	ALUMINUM CHLOROHYDRATE	15	g/100g			N	20241231
74553-010_0e75c034-da03-4fa7-9346-f400b5a8f730	74553-010	HUMAN OTC DRUG	Okay Mens Aluminium Free Deodorant Stick		Aluminum Zirconium Tetrachlorohydrex GLY	STICK	TOPICAL	20210514		OTC MONOGRAPH FINAL	part350	Xtreme Tools International, Inc	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	20	g/100g			N	20241231
74553-011_170d7ebe-97af-4480-ab9e-ea01560dd775	74553-011	HUMAN OTC DRUG	Okay Mens Antiperspirant RollOn Deodorant		Aluminum Chlorohydrate	LIQUID	TOPICAL	20210607		OTC MONOGRAPH FINAL	part350	Xtreme Tools International, Inc	ALUMINUM CHLOROHYDRATE	15	g/100g			N	20241231
74553-012_464741ff-9009-4bce-9f14-2f45cb5cdcb4	74553-012	HUMAN OTC DRUG	Salicylic Acid Acne Treatment		Salicylic Acid	SOAP	TOPICAL	20230911		OTC MONOGRAPH FINAL	M006	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100g			N	20241231
74553-013_a37e56e0-8a7b-4cdf-b661-ecc049e74743	74553-013	HUMAN OTC DRUG	SULFUR ACNE TREATMENT		SULFUR	SOAP	TOPICAL	20230912		OTC MONOGRAPH FINAL	M006	Xtreme Tools International, Inc	SULFUR	10	g/100g			N	20241231
74553-014_1722015f-bd34-497e-be05-b37f1d04bed1	74553-014	HUMAN OTC DRUG	OKAY Facial Serum		Salicylic Acid	GEL	TOPICAL	20230911		OTC MONOGRAPH FINAL	M006	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
74553-015_001926ff-b22b-406c-aa75-a09f000a176d	74553-015	HUMAN OTC DRUG	OKAY Facial Wash		Salicylic Acid	GEL	TOPICAL	20230911		OTC MONOGRAPH FINAL	M006	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
74553-016_f50148b7-003b-469b-9494-17f669e9d969	74553-016	HUMAN OTC DRUG	OKAY Facial Scrub		Salicylic Acid	GEL	TOPICAL	20230911		OTC MONOGRAPH FINAL	M006	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100g			N	20241231
74553-017_f8d1bc9f-55df-4ff6-ad30-9c8fad374558	74553-017	HUMAN OTC DRUG	OKAY Facial Toner		Salicylic Acid	LIQUID	TOPICAL	20230911		OTC MONOGRAPH FINAL	M006	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
74553-018_e0e65340-45ce-4ffb-8468-d53a259c9159	74553-018	HUMAN OTC DRUG	OKAY Body Wash		Salicylic Acid	GEL	TOPICAL	20230911		OTC MONOGRAPH FINAL	M006	Xtreme Tools International, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
74587-0001_ddd11c6c-b30d-49aa-9669-dc411b9f1927	74587-0001	HUMAN OTC DRUG	Prostate Relief		Sarsaparilla (Smilax Regelii), Thuja Occidentalis, Cantharis	LIQUID	ORAL	20201002		UNAPPROVED HOMEOPATHIC		Feel Good Pets LLC	LYTTA VESICATORIA; SMILAX ORNATA ROOT; THUJA OCCIDENTALIS LEAFY TWIG	200; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
74621-001_f47a17c5-29f4-bffa-e053-2a95a90a8099	74621-001	HUMAN OTC DRUG	75% alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200405		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74621-006_f47a1f19-23e9-5f95-e053-2a95a90a093d	74621-006	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Benzalkonium chloride	GEL	TOPICAL	20200523		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
74621-007_f47a1f19-23ea-5f95-e053-2a95a90a093d	74621-007	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Benzalkonium chloride	GEL	TOPICAL	20200523		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
74621-009_f47a320f-f6a3-e9cc-e053-2995a90a05da	74621-009	HUMAN OTC DRUG	CLEACE Alcohol disinfectant		Alcohol	LIQUID	TOPICAL	20200531		OTC MONOGRAPH NOT FINAL	part333A	AOGRAND INTERNATIONAL TRADE CORPORATION	ALCOHOL	75	mL/100mL			N	20241231
74621-011_f47a320f-f6a4-e9cc-e053-2995a90a05da	74621-011	HUMAN OTC DRUG	CLEACE 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200711		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74621-013_f47a5131-b833-624a-e053-2995a90ae205	74621-013	HUMAN OTC DRUG	CLEACE 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200813		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74621-014_f47a5131-b834-624a-e053-2995a90ae205	74621-014	HUMAN OTC DRUG	CLEACE 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200823		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	750	mL/L			N	20241231
74621-015_f47a5131-b835-624a-e053-2995a90ae205	74621-015	HUMAN OTC DRUG	CLEACE Alcohol disinfectant		ALCOHOL	LIQUID	TOPICAL	20200823		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74621-016_f47a5c01-5f6c-465e-e053-2a95a90a5465	74621-016	HUMAN OTC DRUG	KNOCK OUT 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200830		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74621-021_f47a5131-b836-624a-e053-2995a90ae205	74621-021	HUMAN OTC DRUG	Cleanly N5 Sanitizer wipes 20pcs		ALCOHOL	CLOTH	TOPICAL	20201017		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100g			N	20241231
74621-022_f47a62a5-9c7f-5d99-e053-2a95a90acce4	74621-022	HUMAN OTC DRUG	CLEACE 75% Ethyl Alcohol Sanitizer Wipes		ALCOHOL	CLOTH	TOPICAL	20201020		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100g			N	20241231
74621-023_f47a62a5-9c80-5d99-e053-2a95a90acce4	74621-023	HUMAN OTC DRUG	CLEACE 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20201024		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74621-024_f47a62a5-9c81-5d99-e053-2a95a90acce4	74621-024	HUMAN OTC DRUG	CLEACE 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20201024		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74621-028_f47a62a5-9c82-5d99-e053-2a95a90acce4	74621-028	HUMAN OTC DRUG	CLEACE 75% Ethyl Alcohol Antiseptic Hand Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100g			N	20241231
74621-029_f47a6de2-cef7-67ad-e053-2995a90a82eb	74621-029	HUMAN OTC DRUG	Cleace 75% Alcohol Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	Aogrand International Trade Corporation	ALCOHOL	75	mL/100mL			N	20241231
74640-010_0896e861-a79a-2dd8-e063-6294a90aaa3c	74640-010	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH DRUG	505G(a)(3)	Gordon Industries	ALCOHOL	.75	mL/mL			N	20241231
74641-000_0896762b-88d3-8966-e063-6394a90a1b88	74641-000	HUMAN OTC DRUG	Slight Scent Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200408		OTC MONOGRAPH DRUG	505G(a)(3)	Sobe Promos LLC	ALCOHOL	.62	mL/mL			N	20241231
74642-000_08966e8c-8a45-4808-e063-6294a90afddf	74642-000	HUMAN OTC DRUG	Artnaturals Scent Free Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200408		OTC MONOGRAPH DRUG	505G(a)(3)	Virgin Scent Inc	ALCOHOL	.65	mL/mL			N	20241231
74642-001_f48f3cce-4996-182a-e053-2995a90a9055	74642-001	HUMAN OTC DRUG	65% alcohol hand sanitizer (no water)		ALCOHOL	GEL	TOPICAL	20200418		OTC MONOGRAPH NOT FINAL	part333A	Virgin Scent Inc.	ALCOHOL	65	mL/100mL			N	20241231
74676-5902_5585cc1d-63b5-4625-6308-460d02ee914f	74676-5902	HUMAN PRESCRIPTION DRUG	Trelstar		triptorelin pamoate	KIT		20000615		NDA	NDA020715	Verity Pharmaceuticals Inc.						N	20241231
74676-5904_5585cc1d-63b5-4625-6308-460d02ee914f	74676-5904	HUMAN PRESCRIPTION DRUG	Trelstar		triptorelin pamoate	KIT		20010629		NDA	NDA021288	Verity Pharmaceuticals Inc.						N	20241231
74676-5906_5585cc1d-63b5-4625-6308-460d02ee914f	74676-5906	HUMAN PRESCRIPTION DRUG	Trelstar		triptorelin pamoate	KIT		20100311		NDA	NDA022437	Verity Pharmaceuticals Inc.						N	20241231
74680-101_0c53454c-bb58-96b3-e063-6394a90a7417	74680-101	HUMAN OTC DRUG	Germ Away		Anti-microbial Wipe	CLOTH	TOPICAL	20200528		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
74680-102_0c5321c3-802f-779d-e063-6394a90a9183	74680-102	HUMAN OTC DRUG	Germ-Away		Anti-microbial	CLOTH	TOPICAL	20200611		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
74680-103_0c5321c3-8032-779d-e063-6394a90a9183	74680-103	HUMAN OTC DRUG	Germ-Away		Anti-microbial	CLOTH	TOPICAL	20200611		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
74680-104_0c53454c-bb57-96b3-e063-6394a90a7417	74680-104	HUMAN OTC DRUG	Germ-Away		Anti-microbial	CLOTH	TOPICAL	20200611		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
74680-107_0c5327cb-af91-7daf-e063-6394a90a8718	74680-107	HUMAN OTC DRUG	Germ-Away		Anti-microbial	CLOTH	TOPICAL	20200611		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1	mg/g			N	20241231
74680-108_0c531a6a-365c-7632-e063-6394a90a0eb2	74680-108	HUMAN OTC DRUG	Germ-Away		antibacterial hand wipe	CLOTH	TOPICAL	20200824		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
74680-110_0c53454c-bb56-96b3-e063-6394a90a7417	74680-110	HUMAN OTC DRUG	Germ-Away		anti-microbial	CLOTH	TOPICAL	20200612		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1	mg/g			N	20241231
74680-111_0c5321c3-8030-779d-e063-6394a90a9183	74680-111	HUMAN OTC DRUG	Germ-Away		antibacterial	CLOTH	TOPICAL	20200824		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1	mg/g			N	20241231
74680-112_0c535178-dd65-87cb-e063-6394a90ab1b3	74680-112	HUMAN OTC DRUG	Germ-Away		Anti-bacterial	CLOTH	TOPICAL	20200825		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1	mg/g			N	20241231
74680-200_0c531cba-b96d-2655-e063-6294a90acabd	74680-200	HUMAN OTC DRUG	Wipex		Anti-microbial Wipe	CLOTH	TOPICAL	20200525		OTC MONOGRAPH DRUG	M003	UNICO International Trading Corp.	BENZALKONIUM CHLORIDE	1	mg/g			N	20241231
74680-200_0c5321c3-802e-779d-e063-6394a90a9183	74680-200	HUMAN OTC DRUG	Wipex		Anti-microbial wipe	CLOTH	TOPICAL	20200527		OTC MONOGRAPH DRUG	M003	Unico International Trading Corp	BENZALKONIUM CHLORIDE	1	mg/g			N	20241231
74683-1000_05f48e44-e62d-3bd6-e063-6294a90a1376	74683-1000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200424	20240630	OTC MONOGRAPH NOT FINAL	part333A	Horizon Tool Inc.	ALCOHOL	73	mL/100mL			N	
74683-2001_05f48e44-e62d-3bd6-e063-6294a90a1376	74683-2001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20230731		OTC MONOGRAPH NOT FINAL	part333A	Horizon Tool Inc.	ALCOHOL	80	mL/100mL			N	20241231
74683-3000_05f48e44-e62d-3bd6-e063-6294a90a1376	74683-3000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200717	20240630	OTC MONOGRAPH NOT FINAL	part333A	Horizon Tool Inc.	ALCOHOL	73	mL/100mL			N	
74683-5000_05f48e44-e62d-3bd6-e063-6294a90a1376	74683-5000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201111	20240630	OTC MONOGRAPH NOT FINAL	part333A	Horizon Tool Inc.	ALCOHOL	715.4	mL/1021.95mL			N	
74683-5001_05f48e44-e62d-3bd6-e063-6294a90a1376	74683-5001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20230623		OTC MONOGRAPH NOT FINAL	part333A	Horizon Tool Inc.	ALCOHOL	715.4	mL/1021.95mL			N	20241231
74683-6000_05f48e44-e62d-3bd6-e063-6294a90a1376	74683-6000	HUMAN OTC DRUG	E2 hand wash		E2 Sanitizing Hand Soap	SOAP	TOPICAL	20221018		OTC MONOGRAPH NOT FINAL	part333A	Horizon Tool Inc.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
74683-6200_05f48e44-e62d-3bd6-e063-6294a90a1376	74683-6200	HUMAN OTC DRUG	E2 hand wash		E2 Sanitizing Hand Soap	SOAP	TOPICAL	20230103		OTC MONOGRAPH NOT FINAL	part333A	Horizon Tool Inc.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
74690-001_0c0e5035-f169-4f24-e063-6294a90aaa45	74690-001	HUMAN OTC DRUG	Dr. C. Tuna Sunscreen SPF30 Broad Spectrum		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, HOMOSALATE	LOTION	TOPICAL	20200601		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	15; 70; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
74690-002_0c0e3045-2deb-2316-e063-6394a90a4f94	74690-002	HUMAN OTC DRUG	Dr. C. Tuna Sun 6 SPF Tan and Care Carrot		OCTINOXATE	OIL	TOPICAL	20200108		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	OCTINOXATE	35	mg/mL			N	20241231
74690-003_0c0e2a83-4a0c-009f-e063-6394a90a250f	74690-003	HUMAN OTC DRUG	Dr. C. Tuna Lumi Radiance Brightening		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	CREAM	TOPICAL	20200108		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 60; 55	mg/mL; mg/mL; mg/mL			N	20241231
74690-004_0c0e5035-f179-4f24-e063-6294a90aaa45	74690-004	HUMAN OTC DRUG	Dr. C. Tuna Antibacterial Waterless Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200615		OTC MONOGRAPH DRUG	505G(a)(3)	Farmasi US LLC	ALCOHOL	70	mL/100mL			N	20241231
74690-005_0c0e20d7-5491-801c-e063-6294a90ab84f	74690-005	HUMAN OTC DRUG	Dr. C. Tuna Antibacterial Hand Wash		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200615		OTC MONOGRAPH DRUG	505G(a)(3)	Farmasi US LLC	BENZALKONIUM CHLORIDE	1.2	mg/mL			N	20241231
74690-006_0c0e3045-2df9-2316-e063-6394a90a4f94	74690-006	HUMAN OTC DRUG	Dr. C. Tuna Sunscreen 50 SPF UVA UVB Protection Face and Body Sun		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, HOMOSALATE	LOTION	TOPICAL	20200108		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	25; 80; 65; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
74690-007_09723345-85d6-2e38-e063-6294a90afbcd	74690-007	HUMAN OTC DRUG	Dr. C. Tuna Antibacterial Liquid Hand Sanitizer Lemon		ALCOHOL	LIQUID	TOPICAL	20201201		OTC MONOGRAPH DRUG	505G(a)(3)	Farmasi US LLC	ALCOHOL	.8	mL/mL			N	20241231
74690-008_0973365b-3496-8024-e063-6294a90a60c8	74690-008	HUMAN OTC DRUG	Eurofresh Whitening		SODIUM FLUORIDE	PASTE, DENTIFRICE	TOPICAL	20201201		OTC MONOGRAPH DRUG	M021	Farmasi US LLC	SODIUM FLUORIDE	1.08	mg/g			N	20241231
74690-009_09733cf3-4b2b-1f7a-e063-6394a90a5c2d	74690-009	HUMAN OTC DRUG	Dr. C. Tuna Acne Pore Purifying Toner		SALICYLIC ACID	LIQUID	TOPICAL	20210120		OTC MONOGRAPH DRUG	M006	Farmasi US LLC	SALICYLIC ACID	5	mg/mL			N	20241231
74690-010_09733cf3-4b3b-1f7a-e063-6394a90a5c2d	74690-010	HUMAN OTC DRUG	Dr. C. Tuna Acne Clear Complexion Cleanser		SALICYLIC ACID	GEL	TOPICAL	20210120		OTC MONOGRAPH DRUG	M006	Farmasi US LLC	SALICYLIC ACID	20	mg/mL			N	20241231
74690-011_09735173-2608-39fd-e063-6394a90aa6cf	74690-011	HUMAN OTC DRUG	Dr. C. Tuna Acne Blemish Control Serum		SALICYLIC ACID	LIQUID	TOPICAL	20210120		OTC MONOGRAPH DRUG	M006	Farmasi US LLC	SALICYLIC ACID	10	mg/mL			N	20241231
74690-012_09734a55-efb4-3b22-e063-6394a90ad2d2	74690-012	HUMAN OTC DRUG	Farmasi Whitening		SODIUM FLUORIDE	PASTE, DENTIFRICE	DENTAL	20210415		OTC MONOGRAPH DRUG	M021	Farmasi US LLC	SODIUM FLUORIDE	1.5	mg/g			N	20241231
74690-013_09735b00-e28e-ab1f-e063-6294a90a81ea	74690-013	HUMAN OTC DRUG	Dr. C. Tuna Lumi Radiance Brightening Cream		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	CREAM	TOPICAL	20210725		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	20; 60; 55	mg/mL; mg/mL; mg/mL			N	20241231
74690-014_09735fbf-7779-ca3f-e063-6294a90a9f94	74690-014	HUMAN OTC DRUG	Dr. C. Tuna Sun Bronzing Oil SPF 6		OCTINOXATE	OIL	TOPICAL	20210725		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	OCTINOXATE	35	mg/mL			N	20241231
74690-015_09735b2f-2ae4-ca91-e063-6294a90a210a	74690-015	HUMAN OTC DRUG	Dr. C. Tuna Sun Face and Body SPF 50		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, HOMOSALATE	LOTION	TOPICAL	20210725		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	25; 80; 65; 90	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
74690-016_097353b6-41d7-cea1-e063-6294a90aea19	74690-016	HUMAN OTC DRUG	Dr. C. Tuna Resurface Essential Day Cream		HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AVOBENZONE	CREAM	TOPICAL	20210725		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	20; 70; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
74690-020_097353b6-41e6-cea1-e063-6294a90aea19	74690-020	HUMAN OTC DRUG	Dr C Tuna Sun protector lip balm SPF 15		HOMOSALATE, OCTINOXATE	CREAM	TOPICAL	20220105		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	HOMOSALATE; OCTINOXATE	44.5; 34.5	mg/mL; mg/mL			N	20241231
74690-021_09735b2f-2af6-ca91-e063-6294a90a210a	74690-021	HUMAN OTC DRUG	Dr. C. Tuna Acne Clear Complexion Cleanser		SALICYLIC ACID	KIT		20210815		OTC MONOGRAPH DRUG	M006	Farmasi US LLC						N	20241231
74690-023_09735b00-e2b5-ab1f-e063-6294a90a81ea	74690-023	HUMAN OTC DRUG	Dr. C. Tuna Lumi Radiance Brightening Cream 22 SPF		OCTOCRYLENE, OCTINOXATE, AVOBENZONE	KIT		20210815		OTC MONOGRAPH DRUG	M020	Farmasi US LLC						N	20241231
74690-025_09734a55-efd6-3b22-e063-6394a90ad2d2	74690-025	HUMAN OTC DRUG	Dr. C. Tuna Resurface Essential Day Cream SPF 30		HOMOSALATE, OCTINOXATE, OCTOCRYLENE, AVOBENZONE	KIT		20210815		OTC MONOGRAPH DRUG	M020	Farmasi US LLC						N	20241231
74690-030_0c0e2a83-4a19-009f-e063-6394a90a250f	74690-030	HUMAN OTC DRUG	Dr. C. TUNA SUN PROTECTOR LIP BALM SPF 15		HOMOSALATE, OCTINOXATE	CREAM	TOPICAL	20220105		OTC MONOGRAPH DRUG	M020	FARMASI US LLC	HOMOSALATE; OCTINOXATE	44.5; 34.5	mg/mL; mg/mL			N	20241231
74690-040_09734a55-efe4-3b22-e063-6394a90ad2d2	74690-040	HUMAN OTC DRUG	Farmasi BB Beauty Balm Cream SPF 15- 01 Light		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	35	mg/mL			N	20241231
74690-041_09735aeb-7420-4078-e063-6394a90a065d	74690-041	HUMAN OTC DRUG	Farmasi BB Beauty Balm Cream SPF 15- 02 Light to Medium		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	35	mg/mL			N	20241231
74690-042_09738b82-8e00-7e4c-e063-6294a90a4dd0	74690-042	HUMAN OTC DRUG	Farmasi BB Beauty Balm Cream SPF 15- 03 Medium		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	35	mg/mL			N	20241231
74690-043_097353b6-4208-cea1-e063-6294a90aea19	74690-043	HUMAN OTC DRUG	Farmasi BB Beauty Balm Cream SPF 15- 04 Medium to Tan		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	35	mg/mL			N	20241231
74690-044_097362c3-b1b2-404b-e063-6394a90a1361	74690-044	HUMAN OTC DRUG	Farmasi BB Beauty Balm Cream SPF 15- 05 Tan		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	35	mg/mL			N	20241231
74690-045_09735b2f-2b3d-ca91-e063-6294a90a210a	74690-045	HUMAN OTC DRUG	Farmasi BB Beauty Balm Cream SPF 15- 06 Deep		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	35	mg/mL			N	20241231
74690-046_097362c3-b1c2-404b-e063-6394a90a1361	74690-046	HUMAN OTC DRUG	Farmasi CC Color Control Cream SPF 25		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	40	mg/mL			N	20241231
74690-047_097362c3-b1d2-404b-e063-6394a90a1361	74690-047	HUMAN OTC DRUG	Farmasi CC Color Control Cream SPF 25- 02 Light to Medium		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	40	mg/mL			N	20241231
74690-048_0973aae6-55a3-5f1a-e063-6394a90a9848	74690-048	HUMAN OTC DRUG	Farmasi CC Color Control Cream SPF 25- 03 Medium		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	40	mg/mL			N	20241231
74690-049_09738b82-8e31-7e4c-e063-6294a90a4dd0	74690-049	HUMAN OTC DRUG	Farmasi CC Color Control Cream SPF 25- 04 Medium to Tan		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	40	mg/mL			N	20241231
74690-050_09738b82-8e41-7e4c-e063-6294a90a4dd0	74690-050	HUMAN OTC DRUG	Farmasi CC Color Control Cream SPF 25- 05 Tan		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	40	mg/mL			N	20241231
74690-051_0973b548-7ae1-5b98-e063-6394a90af208	74690-051	HUMAN OTC DRUG	Farmasi CC Color Control Cream SPF 25- 06 Deep		TITANIUM DIOXIDE	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M020	Farmasi US LLC	TITANIUM DIOXIDE	40	mg/mL			N	20241231
74695-823_e3a11f7b-9608-a1d3-e053-2995a90aca2b	74695-823	HUMAN PRESCRIPTION DRUG	VIVJOA		oteseconazole	CAPSULE	ORAL	20220711		NDA	NDA215888	Mycovia Pharmaceuticals, Inc.	OTESECONAZOLE	150	mg/1			N	20241231
74707-010_08968111-3888-2035-e063-6294a90a1f7f	74707-010	HUMAN OTC DRUG	Antiseptic Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200513		OTC MONOGRAPH DRUG	505G(a)(3)	Virus Protection Systems,LLC	ALCOHOL	.75	mL/mL			N	20241231
74709-001_a1c09b7a-cd49-4772-9cec-701216522e12	74709-001	HUMAN PRESCRIPTION DRUG	OXYGEN		OXYGEN	GAS	RESPIRATORY (INHALATION)	20200501		UNAPPROVED MEDICAL GAS		Air Liquide Canada Inc	OXYGEN	992	mL/L			N	20241231
74709-002_88d7c5bc-4217-4c4e-9d87-113d582665bd	74709-002	HUMAN PRESCRIPTION DRUG	NITROGEN		NITROGEN	GAS	RESPIRATORY (INHALATION)	20200501		UNAPPROVED MEDICAL GAS		Air Liquide Canada Inc	NITROGEN	992	mL/L			N	20241231
74712-000_08966536-82bc-2006-e063-6294a90a243c	74712-000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200410		OTC MONOGRAPH DRUG	505G(a)(3)	In Designs Global LLC	ALCOHOL	.62	mL/mL			N	20241231
74721-0070_f32104dd-1c8c-5890-e053-2995a90a73ef	74721-0070	HUMAN OTC DRUG	MODUGA camellia hair bar		Sodium Cocoyl Isethionate	SOAP	TOPICAL	20210726		UNAPPROVED DRUG OTHER		S-ONE PHARMACEUTICAL INC	SODIUM COCOYL ISETHIONATE	76.5	g/100g			N	20241231
74721-0080_f4cb5060-9fad-3223-e053-2995a90ac212	74721-0080	HUMAN OTC DRUG	MODUGA woody hair bar		Sodium Cocoyl Isethionate	SOAP	TOPICAL	20210726		UNAPPROVED DRUG OTHER		S-ONE PHARMACEUTICAL INC	SODIUM COCOYL ISETHIONATE	76.5	g/100g			N	20241231
74721-0090_f321118b-fe05-18b0-e053-2995a90af007	74721-0090	HUMAN OTC DRUG	Incredible Saintete DishclothSoap		Sodium Cocoyl Isethionate	SOAP	TOPICAL	20220613		UNAPPROVED DRUG OTHER		S-ONE PHARMACEUTICAL INC	SODIUM COCOYL ISETHIONATE	76.5	g/100g			N	20241231
74721-0100_f4cb9791-5d02-efb1-e053-2a95a90ae5f2	74721-0100	HUMAN OTC DRUG	SSEUG SSAGCREAM		Xanthium Strumarium Fruit Extract, Canavalia Gladiata Extract	CREAM	TOPICAL	20220722		UNAPPROVED DRUG OTHER		S-ONE PHARMACEUTICAL INC	CANAVALIA GLADIATA WHOLE; XANTHIUM STRUMARIUM FRUIT	5; 10	g/100mL; g/100mL			N	20241231
74724-0001_a3266598-98b9-3f4c-e053-2a95a90a8295	74724-0001	HUMAN OTC DRUG	K.Boeun Hand Sanitizer		Alcohol	GEL	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	K.Boeun Pharmaceutical Co.,Ltd.	ALCOHOL	70	g/100mL			N	20241231
74724-0002_a326e481-3816-9135-e053-2995a90a0d23	74724-0002	HUMAN OTC DRUG	K.Boeun Hand Sanitizer		Alcohol	GEL	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	K.Boeun Pharmaceutical Co.,Ltd.	ALCOHOL	70	g/100mL			N	20241231
74724-0003_a5ad49bb-1a57-3e4d-e053-2a95a90a745b	74724-0003	HUMAN OTC DRUG	DNATURE HAND SANITIZER		Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	K.Boeun Pharmaceutical Co.,Ltd.	ALCOHOL	70	g/100mL			N	20241231
74724-0004_bc22ffee-f75e-47c3-e053-2995a90ac5a6	74724-0004	HUMAN OTC DRUG	K.Doctor Clean Ethanol for Disinfection		Alcohol	LIQUID	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part333A	K.Boeun Pharmaceutical Co.,Ltd.	ALCOHOL	83	g/100mL			N	20241231
74724-0010_a69aa6ef-be28-a4ad-e053-2a95a90aeefb	74724-0010	HUMAN OTC DRUG	Kosette Salt Tooth		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20200501		OTC MONOGRAPH FINAL	part355	K.Boeun Pharmaceutical Co.,Ltd.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
74724-0011_a69ac6f6-aa42-07ab-e053-2a95a90a5b3a	74724-0011	HUMAN OTC DRUG	Kosette Salt Tooth		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	DENTAL	20200501		OTC MONOGRAPH FINAL	part355	K.Boeun Pharmaceutical Co.,Ltd.	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	20241231
74724-0015_af545c24-f82c-a23e-e053-2995a90abde5	74724-0015	HUMAN OTC DRUG	Glancure Tooth		Sodium monofluorophosphate	PASTE	DENTAL	20200901		OTC MONOGRAPH FINAL	part355	K.Boeun Pharmaceutical Co.,Ltd.	SODIUM MONOFLUOROPHOSPHATE	.35	g/100g			N	20241231
74724-0020_b3ce86fe-6461-7a10-e053-2995a90a5400	74724-0020	HUMAN OTC DRUG	SALTRAIN CLEAN BREATH		Sodium Fluoride	MOUTHWASH	DENTAL	20201101		OTC MONOGRAPH FINAL	part355	K.Boeun Pharmaceutical Co.,Ltd.	SODIUM FLUORIDE	.02	g/100mL			N	20241231
74724-0021_b3cecaf6-4e27-7266-e053-2995a90a5da2	74724-0021	HUMAN OTC DRUG	SALTRAIN TOOTH		Sodium Monofluorophosphate	PASTE	DENTAL	20201101		OTC MONOGRAPH FINAL	part355	K.Boeun Pharmaceutical Co.,Ltd.	SODIUM MONOFLUOROPHOSPHATE	.4	g/100g			N	20241231
74724-0022_b8d5fdd1-f76f-2f6f-e053-2995a90a366e	74724-0022	HUMAN OTC DRUG	CLEAN BREATH TOOTH		Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20210101		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; CALCIUM CARBONATE; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	.06; .06; 36; .07	g/100g; g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Decreased Fibrinolysis [PE], Increased Coagulation Factor Activity [PE]		N	20241231
74724-0024_c31fe7eb-abed-ec18-e053-2a95a90aab84	74724-0024	HUMAN OTC DRUG	CLEAN BREATH TOOTH		Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20210501		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; CALCIUM CARBONATE; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	.06; .06; 36; .07	g/100g; g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Decreased Fibrinolysis [PE], Increased Coagulation Factor Activity [PE]		N	20241231
74724-0025_c3225686-d56e-123f-e053-2a95a90acf57	74724-0025	HUMAN OTC DRUG	SALTRAIN TOOTH		Sodium monofluorophosphate, Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20210501		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; CALCIUM CARBONATE; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM MONOFLUOROPHOSPHATE	.06; .06; 36; .07; .4	g/100g; g/100g; g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Decreased Fibrinolysis [PE], Increased Coagulation Factor Activity [PE]		N	20241231
74724-0026_c3232d0d-a662-8c60-e053-2a95a90ad46b	74724-0026	HUMAN OTC DRUG	GREENSALTRAIN TOOTH		Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20210501		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; SILICON DIOXIDE	.05; .05; 13.5	g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
74724-0027_c3325628-d300-a0b8-e053-2995a90a9bd5	74724-0027	HUMAN OTC DRUG	GREENSALTRAIN TOOTH		Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20210501		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; SILICON DIOXIDE	.05; .05; 13.5	g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
74724-0028_d1feeb95-7f4c-c8de-e053-2995a90aea5e	74724-0028	HUMAN OTC DRUG	CLEAN BREATH TOOTH		Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20211130		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; CALCIUM CARBONATE; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	.06; .06; 36; .07	g/100g; g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Decreased Fibrinolysis [PE], Increased Coagulation Factor Activity [PE]		N	20241231
74724-0029_d1ff388e-5d6d-8141-e053-2995a90a233c	74724-0029	HUMAN OTC DRUG	SALTRAIN TOOTH		Sodium monofluorophosphate, Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20211130		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; CALCIUM CARBONATE; CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM MONOFLUOROPHOSPHATE	.06; .06; 36; .07; .4	g/100g; g/100g; g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Decreased Fibrinolysis [PE], Increased Coagulation Factor Activity [PE]		N	20241231
74724-0030_d1ff1294-d8f2-390b-e053-2995a90a3477	74724-0030	HUMAN OTC DRUG	GREENSALTRAIN TOOTH		Precipitated Calcium Carbonate, Dibasic Calcium Phosphate, Aminocaproic Acid, Aluminium Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	DENTAL	20211130		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	ALCLOXA; AMINOCAPROIC ACID; SILICON DIOXIDE	.05; .05; 13.5	g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
74724-0031_f126e30f-5f3a-7bf9-e053-2a95a90a265d	74724-0031	HUMAN OTC DRUG	SALTRAIN LTOOTHPASTE		sodium chloride, Precipitated Calcium Carbonate	PASTE, DENTIFRICE	DENTAL	20230101		UNAPPROVED DRUG OTHER		K.Boeun Pharmaceutical Co.,Ltd.	CALCIUM CARBONATE; SODIUM CHLORIDE	33; 3	g/100g; g/100g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
74725-100_07891d62-3958-4976-e063-6294a90a1644	74725-100	HUMAN PRESCRIPTION DRUG	ILLUCCIX		Kit for the preparation of gallium Ga 68 gozetotide injection	KIT	INTRAVENOUS	20211217		NDA	NDA214032	Telix Pharmaceuticals (US) Inc.						N	20241231
74744-005_0744e82a-924c-743f-e063-6294a90ad30a	74744-005	HUMAN OTC DRUG	QSYH Hypochlorite Disinfectant		QSYH Hypochlorite Disinfectant	LIQUID	TOPICAL	20200426		UNAPPROVED DRUG OTHER		Weihai Medison Medical Equipment Co., Ltd	HYPOCHLOROUS ACID	.006	g/100mL			N	20241231
74781-010_05f3c9e6-447a-3507-e063-6294a90a36d5	74781-010	HUMAN OTC DRUG	GLOBAL KERATIN - ANTI-DANDRUFF		Zinc Pyrithione	SHAMPOO	TOPICAL	20200430		OTC MONOGRAPH FINAL	M032	Tibolli LLC	PYRITHIONE ZINC	1	g/100g			N	20241231
74787-1801_fb5acf80-7a1c-31d5-e053-6294a90abba2	74787-1801	HUMAN OTC DRUG	CannaSerene Hot and Cold CBD Cream		Hot and Cold Cream	CREAM	TOPICAL	20220614	20250120	OTC MONOGRAPH NOT FINAL	part348	BioSerene Inc.	MENTHOL; METHYL SALICYLATE	10; 4	g/100mL; g/100mL			N	
74787-1901_fb71db58-d321-9dbe-e053-6294a90aeb6a	74787-1901	HUMAN OTC DRUG	ExaltHemp Hot and Cold Pain Cream		Hot and Cold Pain Cream	CREAM	TOPICAL	20220623	20250120	OTC MONOGRAPH NOT FINAL	part348	BioSerene Inc.	MENTHOL; METHYL SALICYLATE	10; 4	g/100mL; g/100mL			N	
74795-001_0d823038-6654-79a1-e063-6294a90ab827	74795-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20200407		UNAPPROVED MEDICAL GAS		Palmetto Oxygen, LLC	OXYGEN	99	L/100L			N	20241231
74810-725_0d7774df-5638-96af-e063-6294a90aee99	74810-725	HUMAN OTC DRUG	Clean Revolution Foaming Hand Sanitizer Refill Supply Container - Gentle and Aloe Enriched - ELIMINATES 99.9% Germs - 70% Ethanol - Ready To Use		ALCOHOL	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	505G(a)(3)	Replenish Bottling LLC	ALCOHOL	70	mL/100mL			N	20241231
74810-726_0d777a5f-7e0b-e47e-e063-6394a90a3104	74810-726	HUMAN OTC DRUG	Clean Revolution Hand Sanitizer Refill Supply Container - Gentle and Aloe Enriched - ELIMINATES 99.9% Germs - 70% Ethanol - Ready To Use		ALCOHOL	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	505G(a)(3)	Replenish Bottling LLC	ALCOHOL	70	mL/100mL			N	20241231
74810-727_0d7774df-5639-96af-e063-6294a90aee99	74810-727	HUMAN OTC DRUG	Clean Revolution Anti-Bacterial Foaming Hand Refill Supply Container - Anti-Bacterial - ELIMINATES 99.9% Germs - Ready To Use - Fresh Orange		BENZETHONIUM CHLORIDE	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	505G(a)(3)	Replenish Bottling LLC	BENZETHONIUM CHLORIDE	1.3	mg/mL			N	20241231
74810-728_0d773c0d-7a2c-d567-e063-6394a90a9c54	74810-728	HUMAN OTC DRUG	Clean Revolution Anti-Bacterial Hand Refill Supply Container - Anti-Bacterial - ELIMINATES 99.9% Germs - Ready To Use - Fresh Orange		BENZETHONIUM CHLORIDE	LIQUID	TOPICAL	20230601		OTC MONOGRAPH DRUG	505G(a)(3)	Replenish Bottling LLC	BENZETHONIUM CHLORIDE	1.3	mg/mL			N	20241231
74830-001_01f448ac-d541-0452-e063-6294a90aaa51	74830-001	HUMAN OTC DRUG	70 Isopropyl Alcohol First Aid Antiseptic		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333E	Economy Polymers and Chemicals	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
74830-001_f89b29af-b69c-91d6-e053-6294a90a7a9d	74830-001	HUMAN OTC DRUG	70 Isopropyl Alcohol First Aid Antiseptic		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333E	Economy Polymers and Chemicals	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
74830-546_f89cd0a8-052e-abce-e053-6294a90a2d66	74830-546	HUMAN OTC DRUG	PureGel Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Economy Polymers and Chemicals	ALCOHOL	.7	mL/mL			N	20241231
74830-546_f915d665-b15c-e5d5-e053-6294a90aeeb6	74830-546	HUMAN OTC DRUG	PureGel Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200331		OTC MONOGRAPH NOT FINAL	part333E	Economy Polymers and Chemicals	ALCOHOL	.7	mL/mL			N	20241231
74866-414_00bf0083-4ef5-76ef-e063-6294a90a9907	74866-414	HUMAN OTC DRUG	SUAVECITO 5% Minoxidil Solution		MINOXIDIL	LIQUID	TOPICAL	20230731		ANDA	ANDA076239	SUAVECITO, INC.	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
74869-524_f2a0632a-d6e8-101f-e053-2995a90ac6a9	74869-524	HUMAN OTC DRUG	Purgo AF Gel		benzalkonium chloride	GEL	TOPICAL	20201009	20240127	OTC MONOGRAPH NOT FINAL	part333E	Environmental Manufacturing Solutions, LLC.	BENZALKONIUM CHLORIDE	.1274	g/100g			N	
74876-656_9d481de8-ae0c-49a4-9f64-2afe939b0d29	74876-656	HUMAN OTC DRUG	ALCOHOL ANTISEPTIC HAND SANITIZER		Alcohol	GEL	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	Custom Quest, Inc.	ALCOHOL	70	mL/100mL			N	20241231
74911-001_0d82275f-6736-e1a3-e063-6394a90ad12e	74911-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20200407		UNAPPROVED MEDICAL GAS		Ogles Oxygen, LLC	OXYGEN	99	L/100L			N	20241231
74932-320_8a25df0d-a71a-428c-a6d9-cf03b5248564	74932-320	HUMAN OTC DRUG	FA Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200601		OTC MONOGRAPH DRUG	M003	HLB CO.,LTD_Healthcare	ALCOHOL	70	mL/100mL			N	20241231
74932-340_15bdc632-f40d-435c-bc17-71d0e4caf125	74932-340	HUMAN OTC DRUG	FA Alcohol swab		Isopropyl Alcohol	CLOTH	TOPICAL	20200601		OTC MONOGRAPH DRUG	M003	HLB CO.,LTD_Healthcare	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
74932-400_c6574336-b0a8-4651-8fd3-e33854638004	74932-400	HUMAN OTC DRUG	FA Hand Sanitizer Liquid 70		Alcohol	SPRAY	TOPICAL	20200401		OTC MONOGRAPH DRUG	M003	HLB CO.,LTD_Healthcare	ALCOHOL	70	mL/100mL			N	20241231
74932-410_7274df30-a739-4cae-b819-1c071fc146cb	74932-410	HUMAN OTC DRUG	CareSens Alcohol prep pads		Isopropyl Alcohol	CLOTH	TOPICAL	20231001		OTC MONOGRAPH DRUG	M003	HLB CO.,LTD_Healthcare	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
74955-020_03eba6bb-13c7-4ff5-93fb-ad5d96ea944f	74955-020	HUMAN OTC DRUG	Breeze Hand Sanitizer With Vitamin E and Aloe Vera		Ethyl Alcohol	GEL	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	COSMOLIVE KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
74955-021_f9746d17-2094-4224-ad83-9ef3a898c271	74955-021	HUMAN OTC DRUG	BREEZE ANTIBACTERIAL WET WIPES 60 PCS		Benzalkonium Chloride	CLOTH	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part333A	COSMOLIVE KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
74955-027_c207678e-f366-4848-b107-9f07890b39d0	74955-027	HUMAN OTC DRUG	BREEZE	70% ALCOHOL ANTIBACTERIAL WIPES	Ethyl alcohol	CLOTH	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	COSMOLIVE KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	ALCOHOL	70	g/100g			N	20241231
74955-030_acdb4d73-9829-4459-aa13-e4069102548c	74955-030	HUMAN OTC DRUG	BREEZE ANTIBACTERIAL HANDSOAP PINK ORCHID AND COCONUT		Benzalkonium Chloride	LIQUID	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333E	COSMOLIVE KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
74955-031_ef139aac-8c5e-44fe-ab4c-bdc1017a2d5f	74955-031	HUMAN OTC DRUG	BREEZE ANTIBACTERIAL HANDSOAP LAVENDER AND JASMINE		Benzalkonium chloride	LIQUID	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333E	COSMOLIVE KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
74955-032_60b2e8f1-3134-4d49-ae29-fcdc9c43422e	74955-032	HUMAN OTC DRUG	BREEZE ANTIBACTERIAL HANDSOAP CHAMOMILE AND ALOE VERA		Benzalkonium chloride	LIQUID	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333E	COSMOLIVE KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
74955-033_f99bc9ac-d68c-411b-ae62-128b35a8a9bf	74955-033	HUMAN OTC DRUG	BREEZE ANTIBACTERIAL HANDSOAP BERRY MIXTURE		Benzalkonium chloride	LIQUID	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333E	COSMOLIVE KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
74966-002_a7be7965-afa2-902e-e053-2995a90a4111	74966-002	HUMAN OTC DRUG	Cleanse-AF Hand Sanitizer		Benzalkonium chloride	LIQUID	TOPICAL	20200603		OTC MONOGRAPH NOT FINAL	part333A	California Prison Industry Authority	BENZALKONIUM CHLORIDE	.1	mg/100mL			N	20241231
74966-003_a79886d5-c882-a28e-e053-2a95a90aa432	74966-003	HUMAN OTC DRUG	Cleanse Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200603		OTC MONOGRAPH NOT FINAL	part333A	California Prison Industry Authority	ALCOHOL	62	mL/100mL			N	20241231
74966-004_c3fc6abd-6d9e-6954-e053-2a95a90ad9d1	74966-004	HUMAN OTC DRUG	Cleanse-AF Hand Sanitizer		Benzalkonium chloride	LIQUID	TOPICAL	20210604		OTC MONOGRAPH NOT FINAL	part333A	California Prison Industry Authority	BENZALKONIUM CHLORIDE	.1	mg/100mL			N	20241231
74979-001_f449de15-1b8d-171f-e053-2a95a90a2e37	74979-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333E	Robert Gordon Ind. Ltd.	ALCOHOL	.75	mL/mL			N	20241231
74979-002_f449efc9-f40a-bdee-e053-2995a90a89f7	74979-002	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333E	Robert Gordon Ind. Ltd.	ALCOHOL	.75	mL/mL			N	20241231
74979-003_f4499f62-eee2-620c-e053-2995a90a10d2	74979-003	HUMAN OTC DRUG	Welkin Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200821		OTC MONOGRAPH NOT FINAL	part333E	Robert Gordon Ind. Ltd.	ALCOHOL	.7	mL/mL			N	20241231
74979-006_f7e66dcd-8f27-b52c-e053-6294a90a0433	74979-006	HUMAN OTC DRUG	Alcohol Wet Wipes		ALCOHOL	CLOTH	TOPICAL	20200820		OTC MONOGRAPH NOT FINAL	part333E	Robert Gordon Ind. Ltd.	ALCOHOL	.75	mL/mL			N	20241231
75021-002_f48ec7a8-42c6-88be-e053-2995a90ac849	75021-002	HUMAN OTC DRUG	70% alcohol hand sanitizer (no water)		ALCOHOL	GEL	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	D Zone Imports, Llc	ALCOHOL	70	mL/100mL			N	20241231
75042-001_f3991ccd-2451-e192-e053-2a95a90a80f4	75042-001	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part333A	Solevy Co.	ALCOHOL	75	mL/100mL			N	20241231
75052-001_ff95ea89-9206-e536-e053-6294a90ae178	75052-001	VACCINE	PREHEVBRIO		Hepatitis B Vaccine (Recombinant)	INJECTION, SUSPENSION	INTRAMUSCULAR	20220302		BLA	BLA125737	VBI Vaccines (Delaware) Inc.	RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM L/SCI-B-VAC); RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM M/SCI-B-VAC); RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM S/SCI-B-VAC)	.6; 1.1; 10	ug/mL; ug/mL; ug/mL			N	20241231
75053-0002_4dc08759-2b09-49f9-bc57-d89370b4e980	75053-0002	HUMAN OTC DRUG	Lymphocil		Phytolacca Decandra, Arsenicum Iodatum, Agraphis Nutans, Apium Graveolens, Eriodictyon Californicum, Allium Sativum, Erigeron Canadensis, Euonymus Atropurpureus, Aconitum Lycoctonum, Aethiops Antimonialis, Euonymus Europaeus, Absinthium, Apis Mellifica, Causticum, Sanguinaria Canadensis, Uva Ursi, Capsicum Annuum	LIQUID	ORAL	20200629		UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	ACONITUM LYCOCTONUM WHOLE; APIS MELLIFERA; ARCTOSTAPHYLOS UVA-URSI LEAF; ARSENIC TRIIODIDE; CAPSICUM; CAUSTICUM; CELERY SEED; ERIGERON CANADENSIS WHOLE; ERIODICTYON CALIFORNICUM LEAF; EUONYMUS ATROPURPUREUS BRANCH BARK/ROOT BARK; EUONYMUS EUROPAEUS SEED; GARLIC; HYACINTHOIDES NON-SCRIPTA WHOLE; MERCURIC SULFIDE; PHYTOLACCA AMERICANA ROOT; SANGUINARIA CANADENSIS ROOT; WORMWOOD	9; 30; 30; 12; 30; 30; 3; 6; 3; 6; 9; 6; 12; 9; 4; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
75053-0003_59f4c666-2a91-4015-ad88-779ce50a314e	75053-0003	HUMAN OTC DRUG	Celltem		Carbo Vegetabilis, Anilinum, Radium Bromatum, Millefolium, Medulla Ossis Suis, RNA, DNA, Methylene Blue, Abrotanum, Calcarea Oxalica, Conium Maculatum, Euphorbia Corollata, Euphorbium Officinarum	LIQUID	ORAL	20210503		UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	ACHILLEA MILLEFOLIUM WHOLE; ACTIVATED CHARCOAL; ANILINE; ARTEMISIA ABROTANUM FLOWERING TOP; CALCIUM OXALATE MONOHYDRATE; CONIUM MACULATUM FLOWERING TOP; EUPHORBIA COROLLATA ROOT; EUPHORBIA RESINIFERA RESIN; HERRING SPERM DNA; METHYLENE BLUE; RADIUM BROMIDE; SACCHAROMYCES CEREVISIAE RNA; SUS SCROFA BONE MARROW	13; 9; 9; 200; 200; 200; 200; 200; 6; 9; 12; 5; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
75053-0005_c1b284c5-17c0-41aa-a6dc-9702ed0a9fca	75053-0005	HUMAN OTC DRUG	Cerebellutem		Causticum, Absinthium, Ranunculus Glacialis, Theridion, Heloderma, Picrotoxinum, Succinum, Helleborus Niger	LIQUID	ORAL	20210419		UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	AMBER; CAUSTICUM; HELLEBORUS NIGER ROOT; HELODERMA HORRIDUM VENOM; PICROTOXIN; RANUNCULUS GLACIALIS WHOLE; THERIDION CURASSAVICUM; WORMWOOD	30; 5; 30; 12; 16; 10; 10; 6	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
75053-0007_792c57ab-3c06-420b-9cec-9456f7f1dc4b	75053-0007	HUMAN OTC DRUG	Influenseg		Galphimia Glauca, Causticum, Eupatorium Perfoliatum, Ipecacuanha, Aconitum Napellus, Kali Bichromicum, Avena Sativa, Influenzinum (2020 2021), Lobelia Purpurescens, Anas Barbariae, Hepatis ET Cordis Extractum, Echinacea (Angustifolia), Canchalagua	LIQUID	ORAL	20210504	20260312	UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	ACONITUM NAPELLUS WHOLE; AVENA SATIVA FLOWERING TOP; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CAUSTICUM; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; POTASSIUM DICHROMATE; PRATIA PURPURASCENS; ZELTNERA VENUSTA WHOLE FLOWERING	9; 12; 16; 6; 3; 6; 4; 12; 12; 12; 12; 6; 9; 16; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	
75053-0008_630e60d9-29b6-4a78-a13c-24593d5fe171	75053-0008	HUMAN OTC DRUG	Apnetem		Phosphoricum Acidum, Alumen, Phosphorus, Senega Officinalis, Adenosinum Cyclophosphoricum, Antimonium Tartaricum, Grindelia, Sabadilla, Alumina, Cuprum Metallicum, Sanguinarinum Nitricum, Silicea, Lachesis Mutus, Rheum (Palmatum), Zincum Metallicum, Lycopodium Clavatum, Manganum Phosphoricum, Antipyrinum, Coenzyme A	LIQUID	ORAL	20210518		UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	ADENOSINE CYCLIC PHOSPHATE; ALUMINUM OXIDE; ANTIMONY POTASSIUM TARTRATE; ANTIPYRINE; COENZYME A; COPPER; GRINDELIA HIRSUTULA FLOWERING TOP; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MANGANESE PHOSPHATE, DIBASIC; PHOSPHORIC ACID; PHOSPHORUS; POLYGALA SENEGA ROOT; POTASSIUM ALUM; RHEUM PALMATUM ROOT; SANGUINARINE NITRATE; SCHOENOCAULON OFFICINALE SEED; SILICON DIOXIDE; ZINC	9; 12; 9; 18; 12; 12; 9; 12; 13; 15; 6; 9; 9; 6; 12; 12; 9; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]		N	20241231
75053-0009_cead9f57-84ad-4705-8e9c-31a0ab6d2ddc	75053-0009	HUMAN OTC DRUG	Oxaltem		Berberis Vulgaris, Oxalicum Acidum, Sanguinaria Canadensis, Chimaphila Umbellata, Calcarea Fluorica, Calcarea Silicata, Uricum Acidum, Calcarea Phosphorica, Parathormonum, Pyridoxinum Hydrochloricum	LIQUID	ORAL	20220131		UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	BERBERIS VULGARIS ROOT BARK; CALCIUM FLUORIDE; CALCIUM SILICATE; CHIMAPHILA UMBELLATA WHOLE; OXALIC ACID; PARATHYROID HORMONE; PYRIDOXINE HYDROCHLORIDE; SANGUINARIA CANADENSIS WHOLE; TRIBASIC CALCIUM PHOSPHATE; URIC ACID	6; 12; 12; 9; 6; 9; 12; 9; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Parathyroid Hormone [CS], Parathyroid Hormone [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
75053-0010_e343956a-60cc-4473-929d-39b034ffc6ca	75053-0010	HUMAN OTC DRUG	Hypothaltem		Eupatorium Perfoliatum, Berberis Vulgaris, Mentha Pulegium, Moschus, Benzinum, Sepia, Baryta Carbonica, Glandula Suprarenalis Suis, Hypophysis Suis, Hypothalamus Suis, Thyroidinum (Suis), Pyridoxinum Hydrochloricum, Gelsemium Sempervirens, Natrum Carbonicum, Nux Vomica, Staphysagria	LIQUID	ORAL	20210511		UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	BARIUM CARBONATE; BENZENE; BERBERIS VULGARIS ROOT BARK; DELPHINIUM STAPHISAGRIA SEED; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; MENTHA PULEGIUM WHOLE; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; PYRIDOXINE HYDROCHLORIDE; SEPIA OFFICINALIS JUICE; SODIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA ADRENAL GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND; THYROID, UNSPECIFIED	12; 9; 9; 30; 6; 30; 9; 9; 12; 9; 30; 30; 7; 7; 7; 7	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
75053-0011_df11f289-cd1d-4b8f-90da-3a00ae452e82	75053-0011	HUMAN OTC DRUG	Influenseg		Galphimia Glauca, Causticum, Eupatorium Perfoliatum, Ipecacuanha, Aconitum Napellus, Kali Bichromicum, Avena Sativa, Influenzinum (2021-2022), Lobelia Purpurescens, Anas Barbariae, Hepatis ET Cordis Extractum, Echinacea (Angustifolia), Canchalagua	LIQUID	ORAL	20220620		UNAPPROVED HOMEOPATHIC		Nucleic Products, LLC	ACONITUM NAPELLUS WHOLE; AVENA SATIVA FLOWERING TOP; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; CAUSTICUM; ECHINACEA ANGUSTIFOLIA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; GALPHIMIA GLAUCA FLOWERING TOP; INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED); IPECAC; POTASSIUM DICHROMATE; PRATIA PURPURASCENS; ZELTNERA VENUSTA WHOLE FLOWERING	9; 12; 16; 6; 3; 6; 4; 12; 12; 12; 12; 6; 9; 16; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
75065-017_e739d916-df68-4ef5-bc66-e06c24f0ab86	75065-017	HUMAN OTC DRUG	Made By Dentists, Inc. Whitening		SODIUM FLUORIDE	PASTE	DENTAL	20230124		OTC MONOGRAPH FINAL	part355	Made By Dentists, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
75065-018_f382f93e-601b-88f8-e053-2a95a90ac2eb	75065-018	HUMAN OTC DRUG	Made By Dentists, Inc. Total Care		SODIUM FLUORIDE	PASTE	DENTAL	20230124		OTC MONOGRAPH FINAL	part355	Made By Dentists, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
75065-019_f3834bf9-126a-5d0d-e053-2995a90a9f93	75065-019	HUMAN OTC DRUG	Made By Dentists, Inc. Rebuilding		POTASSIUM NITRATE, SODIUM FLUORIDE	PASTE	DENTAL	20230124		OTC MONOGRAPH NOT FINAL	part356	Made By Dentists, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
75065-020_4407654d-697d-4693-9bd3-c637c04638e2	75065-020	HUMAN OTC DRUG	Made By Dentists, Inc. Alien Blood		SODIUM FLUORIDE	PASTE	DENTAL	20230124		OTC MONOGRAPH FINAL	part355	Made By Dentists, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
75065-021_081585a8-0440-b3a5-e063-6294a90a737d	75065-021	HUMAN OTC DRUG	Made By Dentists, Inc. Monster Slime		SODIUM FLUORIDE	PASTE	DENTAL	20230124		OTC MONOGRAPH DRUG	M021	Made By Dentists, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
75065-022_081595a1-aa50-2a79-e063-6394a90aa5b9	75065-022	HUMAN OTC DRUG	Made By Dentists, Inc. EyeBall Juice		SODIUM FLUORIDE	PASTE	DENTAL	20230124		OTC MONOGRAPH DRUG	M021	Made By Dentists, Inc.	SODIUM FLUORIDE	.24	g/100g			N	20241231
75071-002_f605f98c-0aee-d808-e053-2995a90ae9bb	75071-002	HUMAN OTC DRUG	Eco Lips Mint Sunscreen Lip Balm	SPF 15	Octinoxate, Oxybenzone	STICK	TOPICAL	20170101	20240401	OTC MONOGRAPH FINAL	part352	Eco Lips. Inc.	OCTINOXATE; OXYBENZONE	7.5; 3	g/100g; g/100g			N	
75071-003_f605f4f8-156a-bbc4-e053-2995a90a8118	75071-003	HUMAN OTC DRUG	Eco Lips Berry Sunscreen Lip Balm	SPF 15	Octinoxate, Oxybenzone	STICK	TOPICAL	20170101	20240401	OTC MONOGRAPH FINAL	part352	Eco Lips. Inc.	OCTINOXATE; OXYBENZONE	7.5; 3	g/100g; g/100g			N	
75071-004_e5e8834b-af09-758a-e053-2a95a90a4304	75071-004	HUMAN OTC DRUG	Eco Lips Zinc Sunscreen Lip Balm	Broad Spectrum SPF 15 Coconut Vanilla	Zinc oxide	STICK	TOPICAL	20210401		OTC MONOGRAPH FINAL	M020	Eco Lips. Inc.	ZINC OXIDE	20	g/100g			N	20241231
75071-005_e5e84e60-433a-460d-e053-2a95a90ad152	75071-005	HUMAN OTC DRUG	Eco Lips PlantPod Sunscreen Lip Balm Berry	SPF 15	Avobenzone, Octinoxate, Octisalate, Octocrylene	STICK	TOPICAL	20220301		OTC MONOGRAPH FINAL	M020	Eco Lips. Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
75071-006_e64c4a2d-134d-999a-e053-2a95a90a64ee	75071-006	HUMAN OTC DRUG	Eco Lips PlantPod Sunscreen Lip Balm Mint	SPF 15	Avobenzone, Octinoxate, Octisalate, Octocrylene	STICK	TOPICAL	20220301		OTC MONOGRAPH FINAL	M020	Eco Lips. Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	3; 7.5; 5; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
75071-007_fd8e8539-8830-6c1a-e053-6294a90a9d73	75071-007	HUMAN OTC DRUG	Eco Lips PlantPod Sunscreen Lip Balm Sport	SPF 30	Avobenzone, Octinoxate, Octisalate, Oxybenzone	STICK	TOPICAL	20220301		OTC MONOGRAPH FINAL	M020	Eco Lips. Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	3; 7.5; 5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
75071-008_fd8ec002-7ecd-6906-e053-6394a90a6f6c	75071-008	HUMAN OTC DRUG	Eco Lips PlantPod Sunscreen Lip Balm Vanilla	SPF 30	Avobenzone, Octinoxate, Octisalate, Oxybenzone	STICK	TOPICAL	20230331		OTC MONOGRAPH FINAL	M020	Eco Lips. Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	3; 7.5; 5; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
75071-010_fc4c25d6-610a-dfd8-e053-6394a90a4e91	75071-010	HUMAN OTC DRUG	Eco Lips Menthol Medicated Lip Balm		Menthol	STICK	TOPICAL	20230605		OTC MONOGRAPH NOT FINAL	part348	Eco Lips, Inc.	MENTHOL	.0425	g/4.25g			N	20241231
75071-415_febae05d-ff17-c63c-e053-6394a90a4161	75071-415	HUMAN OTC DRUG	Eco Lips Zinc SPF 30 Broad Spectrum Sunscreen Unscented		Zinc Oxide	LOTION	TOPICAL	20230601		OTC MONOGRAPH FINAL	M020	Eco Lips, Inc.	ZINC OXIDE	15.7	g/100mL			N	20241231
75087-074_09e2089e-a72d-9d2f-e063-6394a90a2282	75087-074	HUMAN OTC DRUG	ONCODERM Rx Mineral Sunscreen SPF-30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200417		OTC MONOGRAPH DRUG	M020	Oncoderm, LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75109-001_d5871ab7-796d-ad6d-e053-2995a90ab2e6	75109-001	HUMAN OTC DRUG	Antibacterial wipes		Benzalkonium Chloride	SWAB	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75109-003_d5879726-e436-0109-e053-2a95a90af120	75109-003	HUMAN OTC DRUG	Wet Wipe		Alcohol	SWAB	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
75109-004_d587a7d3-b6db-4748-e053-2995a90a1172	75109-004	HUMAN OTC DRUG	Wet Wipe		Isopropyl Alcohol	SWAB	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
75109-005_d587a3a5-0d8b-56fd-e053-2a95a90a7725	75109-005	HUMAN OTC DRUG	Wet Wipe		Alcohol	CLOTH	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
75109-501_d58749b6-f7bc-4e6b-e053-2995a90ae3c3	75109-501	HUMAN OTC DRUG	Antibacterial wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75109-502_d5870da1-386f-3527-e053-2995a90a7e6d	75109-502	HUMAN OTC DRUG	Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
75109-503_d5870da1-3870-3527-e053-2995a90a7e6d	75109-503	HUMAN OTC DRUG	Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20200620		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
75109-504_d5873b92-2a55-cb36-e053-2995a90aef93	75109-504	HUMAN OTC DRUG	Antibacterial wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200621		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	BENZALKONIUM CHLORIDE	.3	g/100g			N	20241231
75109-512_d5877990-9eb3-474d-e053-2995a90aa842	75109-512	HUMAN OTC DRUG	Digcare Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
75109-519_b80ab7ae-34c9-4766-e053-2a95a90abe55	75109-519	HUMAN OTC DRUG	Bamboo sanitizing wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20201230		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
75109-520_d58703cb-067f-dba6-e053-2a95a90a128f	75109-520	HUMAN OTC DRUG	50ct Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
75109-521_f20e29c0-2b66-15b8-e053-2a95a90af458	75109-521	HUMAN OTC DRUG	Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20210309		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
75109-522_f20e3bb7-0c35-aca0-e053-2a95a90a423b	75109-522	HUMAN OTC DRUG	Antibacterial Eco Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20210309		OTC MONOGRAPH NOT FINAL	part333A	Kangna (Zhejiang) Medical Supplies Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75115-467_09453bf6-92cd-4aa6-e063-6294a90a62b2	75115-467	HUMAN OTC DRUG	Instant Hand Sanitizer Citrus		ALCOHOL	GEL	TOPICAL	20200608		OTC MONOGRAPH DRUG	505G(a)(3)	Soapbox Soaps LLC	ALCOHOL	70	mL/100mL			N	20241231
75124-0001_adfeccac-a851-8cb6-e053-2995a90ac488	75124-0001	HUMAN OTC DRUG	PURE O2-S F		chlorine dioxide	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		Pure O2	CHLORINE DIOXIDE	.005	g/100mL			N	20241231
75124-0002_adfee65d-2c7c-0781-e053-2995a90a43db	75124-0002	HUMAN OTC DRUG	PURE O2 Pack-Solid		sodium chlorite	POWDER	TOPICAL	20200401		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	23	g/100g			N	20241231
75124-0003_0a4eb0be-cd45-6702-e063-6294a90ab9a3	75124-0003	HUMAN OTC DRUG	PURE O2STICK		sodium chlorite	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	5	g/100g			N	20241231
75124-0004_0a4eb0be-cd46-6702-e063-6294a90ab9a3	75124-0004	HUMAN OTC DRUG	EasyStick		sodium chlorite	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	5	g/100g			N	20241231
75124-0005_0a4e3811-94d7-57dd-e063-6394a90af493	75124-0005	HUMAN OTC DRUG	Doctor GuardStick		sodium chlorite	LIQUID	TOPICAL	20200401		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	5	g/100g			N	20241231
75124-0006_a492a053-5919-58fa-e053-2a95a90aba0b	75124-0006	HUMAN OTC DRUG	V Doctor pure chlorine dioxide		sodium chlorite	POWDER	TOPICAL	20200501		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	23	g/100g			N	20241231
75124-0007_a4920675-d3f3-218e-e053-2a95a90a6346	75124-0007	HUMAN OTC DRUG	PURE O2 S		Chlorine Dioxide(ClO2)	LIQUID	TOPICAL	20200501		UNAPPROVED DRUG OTHER		Pure O2	CHLORINE DIOXIDE	.005	g/100mL			N	20241231
75124-0008_0a4eb2ef-b05b-8d1a-e063-6394a90aa3b8	75124-0008	HUMAN OTC DRUG	iSTICK		sodium chlorite	LIQUID	TOPICAL	20200601		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	5	g/100g			N	20241231
75124-0009_0a4ec641-f746-afa2-e063-6294a90a35f0	75124-0009	HUMAN OTC DRUG	NARYN CARE Stick		sodium chlorite	LIQUID	TOPICAL	20200601		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	5	g/100g			N	20241231
75124-0010_acde31eb-b011-5f00-e053-2a95a90a36eb	75124-0010	HUMAN OTC DRUG	QVE - S		sodium chlorite	POWDER	TOPICAL	20200815		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	23	g/100g			N	20241231
75124-0011_c0289ea3-c593-0760-e053-2a95a90a0cfd	75124-0011	HUMAN OTC DRUG	D.PRO Pack Solid		sodium chlorite	POWDER	TOPICAL	20210417		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	23	g/100g			N	20241231
75124-0012_c0293cb2-be63-25bb-e053-2995a90a9d6a	75124-0012	HUMAN OTC DRUG	DEFENDER SIGNATURE		sodium chlorite	POWDER	TOPICAL	20210417		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	23	g/100g			N	20241231
75124-0013_c02915ef-e7fd-4811-e053-2a95a90a9770	75124-0013	HUMAN OTC DRUG	DEFENDERSTICK		sodium chlorite	LIQUID	TOPICAL	20210417		UNAPPROVED DRUG OTHER		Pure O2	SODIUM CHLORITE	5	g/100g			N	20241231
75127-001_d8c11442-87ab-b691-e053-2a95a90afb87	75127-001	HUMAN OTC DRUG	HAND SANITIZING WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20200421		OTC MONOGRAPH NOT FINAL	part333A	Jurong Dongfa General Merchandise Co Ltd	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75127-002_d8c117af-226d-0df8-e053-2a95a90ad81d	75127-002	HUMAN OTC DRUG	Germisept Antibacterial Alcohol		ALCOHOL	CLOTH	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333E	Jurong Dongfa General Merchandise Co., Ltd.	ALCOHOL	.75	mL/mL			N	20241231
75127-004_d8c11e15-b942-7123-e053-2a95a90a814a	75127-004	HUMAN OTC DRUG	HAND SANITIZING WIPES		ALCOHOL	CLOTH	TOPICAL	20201010		OTC MONOGRAPH NOT FINAL	part333E	Jurong Dongfa General Merchandise Co., Ltd.	ALCOHOL	.7	mL/mL			N	20241231
75127-005_d8c117af-226f-0df8-e053-2a95a90ad81d	75127-005	HUMAN OTC DRUG	HAND SANITIZING WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20201020		OTC MONOGRAPH NOT FINAL	part333A	Jurong Dongfa General Merchandise Co Ltd	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75127-006_d8c11e15-b943-7123-e053-2a95a90a814a	75127-006	HUMAN OTC DRUG	HAND SANITIZING WIPES		ALCOHOL	CLOTH	TOPICAL	20201010		OTC MONOGRAPH NOT FINAL	part333E	Jurong Dongfa General Merchandise Co., Ltd.	ALCOHOL	.659	mL/mL			N	20241231
75127-007_d8c11e15-b946-7123-e053-2a95a90a814a	75127-007	HUMAN OTC DRUG	HAND SANITIZING WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20201020		OTC MONOGRAPH NOT FINAL	part333A	Jurong Dongfa General Merchandise Co Ltd	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75127-104_f0537334-089c-5013-e053-2a95a90a741e	75127-104	HUMAN OTC DRUG	Germisept Antibacterial Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20221220		OTC MONOGRAPH NOT FINAL	part333E	Jurong Dongfa General Merchandise Co., Ltd.	ALCOHOL	.75	mL/g			N	20241231
75204-075_0cfe05cb-524b-369d-e063-6394a90a1b8f	75204-075	HUMAN OTC DRUG	DispoTouch	Sanitizer	Alcohol	GEL	TOPICAL	20200510		OTC MONOGRAPH DRUG	505G(a)(3)	Martinni Beauty Inc	ALCOHOL	75	mL/100mL			N	20241231
75205-258_dc485b60-c7bf-4717-9d95-337483ed3138	75205-258	HUMAN OTC DRUG	GJ CHEMICAL ANTISEPTIC HAND SANITIZER		Alcohol	LIQUID	TOPICAL	20200630	20240513	OTC MONOGRAPH NOT FINAL	part333A	G. J. Chemical Co.	ALCOHOL	80	L/100L			N	
75205-259_0b6921ba-2a6d-4435-96da-480184414248	75205-259	HUMAN OTC DRUG	GJ CHEMICAL ANTISEPTIC HAND SANITIZER		Isopropyl Alcohol	SPRAY	TOPICAL	20200630	20240513	OTC MONOGRAPH NOT FINAL	part333A	G. J. Chemical Co.	ISOPROPYL ALCOHOL	75	L/100L			N	
75248-000_08968111-3879-2035-e063-6294a90a1f7f	75248-000	HUMAN OTC DRUG	Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200410		OTC MONOGRAPH DRUG	505G(a)(3)	ICARCOVER INC.	ALCOHOL	.65	mL/mL			N	20241231
75249-003_a95a978b-467e-44f8-e053-2a95a90afb81	75249-003	HUMAN OTC DRUG	Melt Pain Away		Capsaicin	CREAM	TOPICAL	20200415		OTC MONOGRAPH NOT FINAL	part348	SOLITEINT Kozmetikum gyarto es forgalmazo termelo es kereskedelmi Korlatolt Felelossegu Tarsasag	CAPSAICIN	.025	g/100g			N	20241231
75249-005_d7c78f30-1c22-1dbb-e053-2995a90a4f64	75249-005	HUMAN OTC DRUG	Relieve Your Pain		Menthol	CREAM	TOPICAL	20210429		OTC MONOGRAPH NOT FINAL	part348	SOLITEINT Kozmetikum gyarto es forgalmazo, termelo es kereskedelmi Korlatolt Felelossegu Tarsasag	MENTHOL	10	g/100g			N	20241231
75249-006_0c3f4425-d177-c35f-e063-6294a90ad946	75249-006	HUMAN OTC DRUG	SprayPain Away		Capsaicin	SPRAY	TOPICAL	20210630		OTC MONOGRAPH DRUG	M017	SOLITEINT Kozmetikum gyarto es forgalmazo, termelo es kereskedelmi Korlatolt Felelossegu Tarsasag	CAPSAICIN	.025	g/100g			N	20241231
75249-008_f49967e5-ad7f-4c2b-e053-2995a90aed72	75249-008	HUMAN OTC DRUG	Recovery Roll-On		Menthol, Camphor	GEL	TOPICAL	20221017		OTC MONOGRAPH NOT FINAL	part348	SOLITEINT KOZMETIKUM GYARTO ES FORGALMAZO TERMELO ES KERESKEDELMI KORLATOLT FELELOSSEGU TARSASAG	CAMPHOR (NATURAL); MENTHOL	5; 5	g/100mL; g/100mL			N	20241231
75262-002_b85dfd5e-99ef-4858-9e61-ed6909cd6e2b	75262-002	HUMAN OTC DRUG	Platinum Hand Sanitizer with Aloe Vera		Alcohol	GEL	TOPICAL	20200513		OTC MONOGRAPH NOT FINAL	part333E	ZheJiang Eshine Cosmetic Co Ltd	ALCOHOL	75	mL/100mL			N	20241231
75262-004_7bdf567f-1e38-4df9-8c95-a2084d25bc98	75262-004	HUMAN OTC DRUG	Signature Care Hand Sanitizer Aloe Vera		Alcohol	SPRAY	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333E	ZheJiang Eshine Cosmetic Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
75262-005_f4eba93f-d3b3-44fe-bb9e-2ab640b974b4	75262-005	HUMAN OTC DRUG	Signature Care Hand Sanitizer Chamomile Scented		Alcohol	SPRAY	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333E	ZheJiang Eshine Cosmetic Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
75262-006_f3d95119-5a13-49ff-b8c3-9fd52b14b692	75262-006	HUMAN OTC DRUG	Signature Care Advanced Hand Sanitizer with Aloe		Alcohol	LIQUID	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333E	ZheJiang Eshine Cosmetic Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
75262-008_c7272189-9339-48e4-a461-a4dd2eee0177	75262-008	HUMAN OTC DRUG	Signature Care Advanced Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200710		OTC MONOGRAPH NOT FINAL	part333E	ZheJiang Eshine Cosmetic Co Ltd	ALCOHOL	70	mL/100mL			N	20241231
75262-201_3fcbfdba-6cff-45ca-bece-96d336b37c1f	75262-201	HUMAN OTC DRUG	Instant Hand Sanitizizer Wipes		ALCOHOL	SWAB	TOPICAL	20220703		OTC MONOGRAPH NOT FINAL	part333A	ZheJiang Eshine Cosmetic Co Ltd	ALCOHOL	70	g/100g			N	20241231
75269-004_0872a405-7c27-9d1a-e063-6394a90a0545	75269-004	HUMAN OTC DRUG	ALCOHOL DISINFECTING CLEANING WIPES		ALCOHOL WIPES	CLOTH	TOPICAL	20201106		OTC MONOGRAPH DRUG	505G(a)(3)	LINGHAI ZHANWANG BIOTECHNOLOGY CO.,LTD.	ALCOHOL	75	mL/100mL			N	20241231
75269-006_0872cdfa-de00-f061-e063-6294a90aa5e6	75269-006	HUMAN OTC DRUG	75% Alcohol Disinfectant Cleaning Wipes		75% Alcohol Disinfectant Cleaning Wipes	CLOTH	TOPICAL	20201124		OTC MONOGRAPH DRUG	505G(a)(3)	LINGHAI ZHANWANG BIOTECHNOLOGY CO.,LTD.	ALCOHOL	75	mL/100mL			N	20241231
75269-007_0872e0b5-ab69-193c-e063-6394a90ac629	75269-007	HUMAN OTC DRUG	FRST1 ALCOHOL WIPES		ALCOHOL WIPES	CLOTH	TOPICAL	20201126		OTC MONOGRAPH DRUG	505G(a)(3)	LINGHAI ZHANWANG BIOTECHNOLOGY CO.,LTD.	ALCOHOL	75	mL/100mL			N	20241231
75269-008_08734311-1c3c-3ae4-e063-6394a90a6afa	75269-008	HUMAN OTC DRUG	Anti-Bacterial Disinfectant Cleaning Wipes		Anti-Bacterial Disinfectant Cleaning Wipes	CLOTH	TOPICAL	20201124		OTC MONOGRAPH DRUG	505G(a)(3)	LINGHAI ZHANWANG BIOTECHNOLOGY CO.,LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75269-011_087395e0-95de-1e9d-e063-6394a90a09dd	75269-011	HUMAN OTC DRUG	Hand Sanitizer Wipes		Hand Sanitizer Wipes	CLOTH	TOPICAL	20201213		OTC MONOGRAPH DRUG	505G(a)(3)	LINGHAI ZHANWANG BIOTECHNOLOGY CO.,LTD.	ALCOHOL	75	mL/100mL			N	20241231
75269-013_0871d4ab-6708-8174-e063-6294a90acb03	75269-013	HUMAN OTC DRUG	alcohol wipes		alcohol wipes	CLOTH	TOPICAL	20200327		OTC MONOGRAPH DRUG	505G(a)(3)	LINGHAI ZHANWANG BIOTECHNOLOGY CO.,LTD.	ALCOHOL	75	mL/100mL			N	20241231
75269-014_08725365-b385-b5e1-e063-6394a90ac331	75269-014	HUMAN OTC DRUG	Mioszzi SANITARY WIPES		Sanitary Wipes	CLOTH	TOPICAL	20200602		OTC MONOGRAPH DRUG	505G(a)(3)	LINGHAI ZHANWANG BIOTECHNOLOGY CO.,LTD.	BENZALKONIUM CHLORIDE	.04	g/100g			N	20241231
75353-002_00bd40ec-eb7d-7bf5-e063-6294a90a2d85	75353-002	HUMAN OTC DRUG	CLEAN ANTISEPTIC HAND SANITIZER wipes		Ethyl Alcohol	CLOTH	TOPICAL	20200811		OTC MONOGRAPH NOT FINAL	part333A	Raw Office Inc, The	ALCOHOL	75	mL/100mL			N	20241231
75356-0001_b2a267d8-7b5c-9529-e053-2a95a90aa119	75356-0001	HUMAN OTC DRUG	Bebesup Hand Sanitizer(Ethanol)		ALCOHOL	GEL	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	AJ Co., Ltd.	ALCOHOL	155	mL/250mL			N	20241231
75356-0002_b2a26cc2-227f-86a3-e053-2a95a90a0128	75356-0002	HUMAN OTC DRUG	Bebesup Hand Sanitizer(Ethanol)		ALCOHOL	GEL	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	AJ Co., Ltd.	ALCOHOL	310	mL/500mL			N	20241231
75356-0004_ad35fa25-0f01-37e1-e053-2a95a90ac6f4	75356-0004	HUMAN OTC DRUG	SANIPRO DISINFECTANT WIPES		Benzalkonium Chloride	LIQUID	TOPICAL	20200808		OTC MONOGRAPH NOT FINAL	part333A	AJ Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
75356-0005_b12101d5-9242-13e4-e053-2995a90a5c7c	75356-0005	HUMAN OTC DRUG	SANIPRO DISINFECTANT WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20200808		OTC MONOGRAPH NOT FINAL	part333A	AJ Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
75356-0006_bd2877f4-d6d7-452a-e053-2995a90afac6	75356-0006	HUMAN OTC DRUG	Olje Antibacterial Wipes		Benzalkonium Chloride	SWAB	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	AJ Co., Ltd.	BENZALKONIUM CHLORIDE	.4	g/407g			N	20241231
75356-0007_bdb2dfed-8088-6c50-e053-2a95a90a637b	75356-0007	HUMAN OTC DRUG	Gentle Beast Antibacterial Wipes		Benzalkonium Chloride	SWAB	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	AJ Co., Ltd.	BENZALKONIUM CHLORIDE	.3	g/337g			N	20241231
75356-0008_bdb36b01-f424-8fc7-e053-2995a90a429b	75356-0008	HUMAN OTC DRUG	Gentle Beast Antiseptic Wipes		Isopropyl Alcohol	SWAB	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	AJ Co., Ltd.	ISOPROPYL ALCOHOL	75	g/100g			N	20241231
75357-201_0c4a0d9d-416b-0b11-e063-6394a90acda7	75357-201	HUMAN OTC DRUG	ARAM Hand Sanitizing Wipe		Alcohol	LIQUID	TOPICAL	20200428		OTC MONOGRAPH DRUG	505G(a)(3)	Aram Cosmetic Co., Ltd	ALCOHOL	70	g/100g			N	20241231
75360-1125_0ce04f31-95fa-4ebe-e063-6394a90a7832	75360-1125	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200401		OTC MONOGRAPH DRUG	505G(a)(3)	Hemani International	ALCOHOL	80	mL/100mL			N	20241231
75447-200_7f7aec44-7ea7-4d79-adad-e7d646122abd	75447-200	HUMAN OTC DRUG	OPTIMAL Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20200609		OTC MONOGRAPH NOT FINAL	part333A	Optisource International Inc.	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
75447-224_8bb1a4db-00a3-4435-900e-6a565d232629	75447-224	HUMAN OTC DRUG	Foaming Hand		Benzalkonium Chloride	LOTION	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	OptiSource International, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
75473-001_bca6e13a-a9c2-1bac-e053-2a95a90a9b37	75473-001	HUMAN OTC DRUG	Q SMART SPA GERMINATOR ANTI-BACTERIAL		ISOPROPYL ALCOHOL	SPRAY	TOPICAL	20210303		OTC MONOGRAPH NOT FINAL	part333A	ART OF BEAUTY COMPANY INC.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
75473-444_ad6575ef-9dc6-755f-e053-2995a90a4daa	75473-444	HUMAN OTC DRUG	ZOYA HAND SANITIZER		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20200416		OTC MONOGRAPH NOT FINAL	part333A	ART OF BEAUTY COMPANY INC.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
75488-123_a58a5482-b549-6654-e053-2a95a90a6ae6	75488-123	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200330	20240531	OTC MONOGRAPH NOT FINAL	part333A	Maser Industries, LLC	ALCOHOL	80	mL/100mL			N	
75523-101_a3464e73-8394-06e0-e053-2995a90ab236	75523-101	HUMAN OTC DRUG	Derm Assure Hand Sanitizer Aloe and Grapefruit		Ethyl Alcohol	GEL	TOPICAL	20200414	20240430	OTC MONOGRAPH NOT FINAL	part333A	PROJECT CHEMISTRY, INC.	ALCOHOL	62	mL/100mL			N	
75523-200_08c2eeef-4b80-4434-e063-6394a90afd14	75523-200	HUMAN OTC DRUG	Barrier Balm		Skin Protectant	OINTMENT	TOPICAL	20221019		OTC MONOGRAPH DRUG	M016	PROJECT CHEMISTRY, INC.	ZINC OXIDE	15	g/100g			N	20241231
75532-001_f463841d-aa9a-70b9-e053-2995a90a88f2	75532-001	HUMAN OTC DRUG	75% Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200421		OTC MONOGRAPH NOT FINAL	part333A	Shandong Retouch Wash And Sterilize Technology Co.,ltd.	ALCOHOL	75	mL/100mL			N	20241231
75532-002_f4638d67-9c7e-0f74-e053-2a95a90acae3	75532-002	HUMAN OTC DRUG	75% Alcohol		ALCOHOL	LIQUID	TOPICAL	20200421		OTC MONOGRAPH NOT FINAL	part333A	Shandong Retouch Wash And Sterilize Technology Co.,ltd.	ALCOHOL	75	mL/100mL			N	20241231
75540-436_f515af7e-6ac6-40f2-e053-2995a90a3674	75540-436	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital, Inc.	ALCOHOL	73	mL/100mL			N	20241231
75540-436_f515af7e-6ac7-40f2-e053-2995a90a3674	75540-436	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital, Inc.	ALCOHOL	73	mL/100mL			N	20241231
75540-436_f515b5c6-dec3-6bc0-e053-2a95a90a46ab	75540-436	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital, Inc.	ALCOHOL	73	mL/100mL			N	20241231
75540-436_f515b5c6-dec4-6bc0-e053-2a95a90a46ab	75540-436	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital, Inc.	ALCOHOL	73	mL/100mL			N	20241231
75540-436_f515e7b8-2548-4d49-e053-2a95a90a889e	75540-436	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital, Inc.	ALCOHOL	73	mL/100mL			N	20241231
75540-528_f1a01bba-46bc-af4e-e053-2a95a90a0f67	75540-528	HUMAN OTC DRUG	Hyalolex Hand Sanitizer with Lavender and Zinc		ALCOHOL	LIQUID	TOPICAL	20200420		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital	ALCOHOL	70	mL/100mL			N	20241231
75540-528_f5162013-3d8a-a7b7-e053-2995a90aa3d1	75540-528	HUMAN OTC DRUG	Hyalolex Hand Sanitizer with Lavender and Zinc		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital Inc	ALCOHOL	70	mL/100mL			N	20241231
75540-536_f515d306-37a1-669b-e053-2a95a90a8134	75540-536	HUMAN OTC DRUG	Hyalolex Hand Sanitizer with Lemon and Zinc		ALCOHOL	SOLUTION	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333E	India Globalization Capital	ALCOHOL	70	mL/100mL			N	20241231
75540-941_f515d306-37ab-669b-e053-2a95a90a8134	75540-941	HUMAN OTC DRUG	Hyalolex Antiseptic Hand Rub		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital Inc	ALCOHOL	80	mL/100mL			N	20241231
75540-941_f515dc38-eedb-20a7-e053-2995a90a2a88	75540-941	HUMAN OTC DRUG	Hyalolex Antiseptic Hand Rub		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital Inc	ALCOHOL	80	mL/100mL			N	20241231
75540-941_f515dc38-eedd-20a7-e053-2995a90a2a88	75540-941	HUMAN OTC DRUG	Hyalolex Antiseptic Hand Rub		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital Inc	ALCOHOL	80	mL/100mL			N	20241231
75540-941_f515dc38-eede-20a7-e053-2995a90a2a88	75540-941	HUMAN OTC DRUG	Hyalolex Antiseptic Hand Rub		ALCOHOL	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital Inc	ALCOHOL	80	mL/100mL			N	20241231
75540-946_f51586b8-c83c-8277-e053-2a95a90a50b5	75540-946	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20200427		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital, Inc.	ALCOHOL	80	mL/100mL			N	20241231
75540-946_f515d306-379b-669b-e053-2a95a90a8134	75540-946	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital Inc	ALCOHOL	80	mL/100mL			N	20241231
75540-946_f515d306-379c-669b-e053-2a95a90a8134	75540-946	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital Inc	ALCOHOL	80	mL/100mL			N	20241231
75540-946_f515e7b8-2547-4d49-e053-2a95a90a889e	75540-946	HUMAN OTC DRUG	Hyalolex Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	India Globalization Capital Inc	ALCOHOL	80	mL/100mL			N	20241231
75560-276_f1ec1cd7-3eea-27bf-e053-2a95a90a3db0	75560-276	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	LIQUID	TOPICAL	20201231		OTC MONOGRAPH NOT FINAL	part333A	Accelerated Speed Dynamics, Inc	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
75568-004_08aa9221-ffc1-277e-e063-6294a90aa372	75568-004	HUMAN OTC DRUG	Careland Lidocaine 4 Pain Relieving Gel-Patches		LIDOCAINE	PATCH	TOPICAL	20230406		OTC MONOGRAPH DRUG	M017	Planet (Anhui) Pharmaceutical Co., Ltd.	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
75568-013_0989aad0-14cb-b1a4-e063-6394a90a5d2a	75568-013	HUMAN OTC DRUG	Careland Lidocaine 4 plus menthol pain relieving gel-patches with border for knee		MENTHOL, LAUROCAPRAM	PATCH	TOPICAL	20230810		OTC MONOGRAPH DRUG	M017	Planet (Anhui) Pharmaceutical Co., Ltd.	LIDOCAINE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
75568-014_09898669-28a3-e17b-e063-6294a90a45c7	75568-014	HUMAN OTC DRUG	Careland Lidocaine 4 Plus Menthol Pain Relieving Gel Patches for back, neck shoulders knees and elbows with border		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20230810		OTC MONOGRAPH DRUG	M017	Planet (Anhui) Pharmaceutical Co., Ltd.	LIDOCAINE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
75568-015_09b970f3-aac9-4a5a-e063-6294a90af72d	75568-015	HUMAN OTC DRUG	Careland Triple Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20231030		OTC MONOGRAPH DRUG	M004	Planet (Anhui) Pharmaceutical Co., Ltd.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[CFU]/g; mg/g; [CFU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
75617-001_f48f4a03-3d77-158e-e053-2a95a90a5188	75617-001	HUMAN OTC DRUG	75% alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200420		OTC MONOGRAPH NOT FINAL	part333A	JASPERS GLOBAL MANUFACTURING INC	ALCOHOL	7.5	mg/mL			N	20241231
75617-002_f48f636b-2136-e5a3-e053-2995a90a04d8	75617-002	HUMAN OTC DRUG	75% alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200523		OTC MONOGRAPH NOT FINAL	part333A	JASPERS GLOBAL MANUFACTURING INC	ALCOHOL	75	mL/100mL			N	20241231
75617-003_f48f9e01-12d5-17af-e053-2a95a90ab949	75617-003	HUMAN OTC DRUG	Joby instant hand sanitrizer		Alcohol	GEL	TOPICAL	20200524		OTC MONOGRAPH NOT FINAL	part333A	JASPERS GLOBAL MANUFACTURING INC	ALCOHOL	75	mL/100mL			N	20241231
75622-222_09a0ab56-e5be-3ff0-e063-6294a90a14ac	75622-222	HUMAN OTC DRUG	VILOE		Hand Sanitizer Wipes	CLOTH	TOPICAL	20201009		OTC MONOGRAPH DRUG	M003	Henan Yeesain Health Technology Co., Ltd.	ALCOHOL	.75	mL/1			N	20241231
75622-633_099f7445-2a1c-8957-e063-6394a90aa1b6	75622-633	HUMAN OTC DRUG	DEYO		Disinfecting Wet Wipes	CLOTH	TOPICAL	20200501		OTC MONOGRAPH DRUG	M003	Henan Yeesain Health Technology Co., Ltd.	ALCOHOL	.75	mL/1			N	20241231
75622-655_099f7445-2a1b-8957-e063-6394a90aa1b6	75622-655	HUMAN OTC DRUG	DEEYEO		Sanitizing Flushable Wipes	CLOTH	TOPICAL	20230223		OTC MONOGRAPH DRUG	M003	Henan Yeesain Health Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
75626-001_0c6c5678-e986-b822-e063-6394a90ac88b	75626-001	HUMAN PRESCRIPTION DRUG	LUPKYNIS		Voclosporin	CAPSULE	ORAL	20210122		NDA	NDA213716	Aurinia Pharma U.S., Inc.	VOCLOSPORIN	7.9	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
75632-876_f28e98e1-bcb6-2899-e053-2995a90ada11	75632-876	HUMAN OTC DRUG	Freshands Premium Foamy Antibacterial Handsoap 6876		CHLOROXYLENOL	SOAP	TOPICAL	20230104		OTC MONOGRAPH NOT FINAL	part333E	Consolidated Chemicals, LLC	CHLOROXYLENOL	3	mg/mL			N	20241231
75638-009_f759e757-b69e-04f0-e053-6294a90a5a09	75638-009	HUMAN OTC DRUG	Doctor Hoys Arnica Boost Recovery		ARNICA MONTANA	GEL	TOPICAL	20230301		UNAPPROVED HOMEOPATHIC		Dynamic Blending Specialists, Inc.	ARNICA MONTANA	50	mg/mL			N	20241231
75638-010_0d0d2163-f953-ccff-e063-6394a90a5d60	75638-010	HUMAN OTC DRUG	Doctor Hoys Pain Relief Gel		MENTHOL, CAMPHOR (SYNTHETIC)	GEL	TOPICAL	20230301		OTC MONOGRAPH DRUG	M017	Dynamic Blending Specialists, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	50; 50	mg/mL; mg/mL			N	20241231
75638-011_0d0d4a7a-a68c-d15e-e063-6394a90a24aa	75638-011	HUMAN OTC DRUG	Doctor Hoys Pain Relief Gel Roll-On		MENTHOL, CAMPHOR (SYNTHETIC)	GEL	TOPICAL	20230301		OTC MONOGRAPH DRUG	M017	Dynamic Blending Specialists, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	50; 50	mg/mL; mg/mL			N	20241231
75644-001_d5e06243-b963-7810-e053-2a95a90a7cf5	75644-001	HUMAN OTC DRUG	HUUREKA SANITIZER		HYPOCHLOROUS ACID	LIQUID	TOPICAL	20200501		UNAPPROVED DRUG OTHER		KEWS CORPORATION	HYPOCHLOROUS ACID	.007	mg/mL			N	20241231
75644-002_d5e06bd1-95be-0276-e053-2995a90abda2	75644-002	HUMAN OTC DRUG	AbsoClean-S Sanitizing Mist		HYPOCHLOROUS ACID	LIQUID	TOPICAL	20200430		UNAPPROVED DRUG OTHER		KEWS CORPORATION	HYPOCHLOROUS ACID	.006	mg/mL			N	20241231
75644-003_d5e073ac-61a8-226a-e053-2a95a90a3db0	75644-003	HUMAN OTC DRUG	BELSON ALCOHOL FREE HAND SANIZITER		HYPOCHLOROUS ACID	LIQUID	TOPICAL	20200619		UNAPPROVED DRUG OTHER		KEWS CORPORATION	HYPOCHLOROUS ACID	.007	mg/mL			N	20241231
75670-001_d8c0d4f2-21df-1609-e053-2995a90aed15	75670-001	HUMAN OTC DRUG	SANITIZING WIPES		BENZALKONIUM CHLORIDE,Didecyldimonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .15	g/100g; g/100g			N	20241231
75670-002_d8c0dac8-72cb-9255-e053-2a95a90a7ff7	75670-002	HUMAN OTC DRUG	SANITIZING WIPES		BENZALKONIUM CHLORIDE,Didecyldimonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .15	g/100g; g/100g			N	20241231
75670-003_d8c0d4f2-21e0-1609-e053-2995a90aed15	75670-003	HUMAN OTC DRUG	SANITIZING WIPES		BENZALKONIUM CHLORIDE,Didecyldimonium Chloride	CLOTH	TOPICAL	20200609		OTC MONOGRAPH NOT FINAL	part333A	SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .15	g/100g; g/100g			N	20241231
75670-004_d8c0dac8-72cc-9255-e053-2a95a90a7ff7	75670-004	HUMAN OTC DRUG	Hand Sanitizing Wipes 80CT		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200812		OTC MONOGRAPH NOT FINAL	part333A	SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
75670-005_d8c0ebae-3649-8ee8-e053-2a95a90ae9bb	75670-005	HUMAN OTC DRUG	Alcohol-free Hand sanitizing wipes 800CT		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200815		OTC MONOGRAPH NOT FINAL	part333A	SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
75670-010_ef5d3884-9b29-8563-e053-2a95a90aeb1a	75670-010	HUMAN OTC DRUG	30 soft wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH NOT FINAL	part333A	SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .15	g/100g; g/100g			N	20241231
75670-011_ef869dea-50d5-be48-e053-2995a90a78c7	75670-011	HUMAN OTC DRUG	60 soft wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH NOT FINAL	part333A	SHANGHAI SANJUN GENERAL MERCHANDISE CO., LTD.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .15	g/100g; g/100g			N	20241231
75690-001_f48f6b74-edb0-98cb-e053-2a95a90a5c7b	75690-001	HUMAN OTC DRUG	75% alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200421		OTC MONOGRAPH NOT FINAL	part333A	Pinnacle Brands LLC	ALCOHOL	75	mL/100mL			N	20241231
75712-001_08a1ea95-478e-f314-e063-6294a90a0f37	75712-001	HUMAN OTC DRUG	DG Health Cough Drops Assorted Flavors		MENTHOL	KIT		20210701		OTC MONOGRAPH DRUG	M012	Dollar General Corporation						N	20241231
75712-005_08a1ade1-5663-7393-e063-6394a90a158d	75712-005	HUMAN OTC DRUG	DG Health Cough Drops Cherry Flavor		MENTHOL	LOZENGE	TOPICAL	20210701		OTC MONOGRAPH DRUG	M012	Dollar General Corporation	MENTHOL	5.8	mg/1			N	20241231
75712-006_0bf27dfd-0d50-de8f-e063-6394a90a0178	75712-006	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220715		ANDA	ANDA079129	DOLLAR GENERAL CORPORATION	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
75712-007_0bf27dfd-0d51-de8f-e063-6394a90a0178	75712-007	HUMAN OTC DRUG	Maximum Strength Non Drowsy Daytime Severe Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20230328		OTC MONOGRAPH DRUG	M012	DOLGENCORP, INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
75712-010_0bf2680a-32cf-b0d9-e063-6294a90a3333	75712-010	HUMAN OTC DRUG	Non Drowsy Daytime and Nighttime Cold and Flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20230427		OTC MONOGRAPH DRUG	M012	DOLGENCORP, INC.						N	20241231
75712-015_ffe8d471-ab5e-b9f8-e053-6294a90ab91a	75712-015	HUMAN OTC DRUG	Cough Drops Dollar General Honey Lemon 30ct		MENTHOL	LOZENGE	ORAL	20230707		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	7.5	mg/1			N	20241231
75712-016_ffe93f9a-b09e-eed0-e053-6394a90a30c9	75712-016	HUMAN OTC DRUG	Menthol Drops Dollar General Severe Honey Lemon 45ct		MENTHOL	LOZENGE	ORAL	20230707		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	20	mg/1			N	20241231
75712-017_ff21b81d-ef65-18d9-e053-6394a90a147f	75712-017	HUMAN OTC DRUG	Cough Drops Dollar General Menthol 30ct		MENTHOL	LOZENGE	ORAL	20230721		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	5.4	mg/1			N	20241231
75712-018_ff21cb2f-fbfb-cddd-e053-6294a90a8bdf	75712-018	HUMAN OTC DRUG	Cough Drops Dollar General Cherry 30ct		MENTHOL	LOZENGE	ORAL	20230721		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	5.8	mg/1			N	20241231
75712-020_ff21c9fc-2f5e-a024-e053-6394a90a04c4	75712-020	HUMAN OTC DRUG	Cough Drops Dollar General Honey Lemon 200ct		MENTHOL	LOZENGE	ORAL	20230721		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	7.5	mg/1			N	20241231
75712-021_ff21cb2f-fc13-cddd-e053-6294a90a8bdf	75712-021	HUMAN OTC DRUG	Cough Drops Dollar General Menthol 80ct		MENTHOL	LOZENGE	ORAL	20230721		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	5.4	mg/1			N	20241231
75712-022_ff3718a6-f55c-70aa-e053-6294a90a541e	75712-022	HUMAN OTC DRUG	Cough Drops Dollar General Strawberry 30ct		MENTHOL	LOZENGE	ORAL	20230721		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	2.7	mg/1			N	20241231
75712-023_00b088b3-1069-ffb4-e063-6394a90af51b	75712-023	HUMAN OTC DRUG	Cough Drops Dollar General Menthol 160ct		MENTHOL	LOZENGE	ORAL	20230714		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	5.4	mg/1			N	20241231
75712-024_00c4bb18-795c-e6d7-e063-6394a90a4388	75712-024	HUMAN OTC DRUG	Menthol Drops Dollar General Severe 45ct		MENTHOL	LOZENGE	ORAL	20230714		OTC MONOGRAPH FINAL	part341	Dollar General Corporation	MENTHOL	20	mg/1			N	20241231
75712-116_33a1d07c-dca7-48bc-ac48-12e486a6c296	75712-116	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220817		OTC MONOGRAPH FINAL	part352	DOLLAR GENERAL CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
75712-200_f41d9da6-8185-250e-e053-2995a90ae870	75712-200	HUMAN OTC DRUG	DG Health	Maximum Strength Pain Relieving Cleansing	Benzalkonium Cl, Lidocaine HCl	SPRAY	TOPICAL	20220211		OTC MONOGRAPH NOT FINAL	part333A	Dollar General Corporation	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 40	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
75712-301_5c0fd2e6-1c99-4f3f-8127-1b3bd72d91ac	75712-301	HUMAN OTC DRUG	DG Health Earwax Removal kit		Carbamide Peroxide 6.5%	SOLUTION/ DROPS	TOPICAL	20231101		OTC MONOGRAPH DRUG	M014	DOLLAR GENERAL CORPORATION	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
75712-470_d9f4fcf5-4fc6-4231-942c-23759bf8e589	75712-470	HUMAN OTC DRUG	Pyrithione zinc		Pyrithione zinc	SHAMPOO	TOPICAL	20230925		OTC MONOGRAPH FINAL	part358H	OLD EAST MAIN CO.	PYRITHIONE ZINC	10	mg/mL			N	20241231
75712-496_efba5966-c6e0-4113-b807-71cec373e620	75712-496	HUMAN OTC DRUG	Daily Moisturizing		Dimethicone	LOTION	TOPICAL	20230118		OTC MONOGRAPH FINAL	part347	Dollar General Corporation	DIMETHICONE	12	mg/g	Skin Barrier Activity [PE]		N	20241231
75712-805_041174e2-7ff6-a293-e063-6294a90a2c4d	75712-805	HUMAN OTC DRUG	Dollar General		isopropyl alcohol	SWAB	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part333A	Dollar General Corporation	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
75712-849_6008d292-b156-43e8-ba90-4207293787a5	75712-849	HUMAN OTC DRUG	Ethyl Alcohol		Ethyl Alcohol	LIQUID	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part333A	DOLLAR GENERAL CORPORATION	ALCOHOL	62	mL/100mL			N	20241231
75712-934_4d9f1900-c749-4182-b57b-a6d4459b2db8	75712-934	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230825		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
75712-935_1f3e5543-dcb2-46c9-895d-6958c08ffd0f	75712-935	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230801		OTC MONOGRAPH FINAL	part352	DOLLAR GENERAL CORPORATION	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
75712-938_59f33187-4c23-41f3-be6e-e5e15b8b430d	75712-938	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230906		OTC MONOGRAPH FINAL	part352	OLD EAST MAIN CO.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
75712-940_a677b23e-11b4-4366-84e5-46c78199169c	75712-940	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230824		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
75712-941_383f4932-7a9b-42b7-ad1c-900df878842e	75712-941	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230905		OTC MONOGRAPH FINAL	part352	Old East Main CO.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
75712-943_8e1e5819-9162-45ce-97a5-ae29f47ed073	75712-943	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230929		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
75712-944_dd4e5fe5-7622-4d22-af14-6876a9e286ba	75712-944	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230808		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
75712-946_04caa6de-8df2-4a7b-84ab-e24da51fa381	75712-946	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230824		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
75712-947_130f99c0-dc21-4b23-a77e-52ae0bc82d33	75712-947	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230831		OTC MONOGRAPH FINAL	part352	Old East Main CO.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
75712-954_f437da1f-4847-4990-94e0-966865ed4946	75712-954	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230824		OTC MONOGRAPH FINAL	part352	Old East Main Co.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
75742-008_f20208a0-334a-d06a-e053-2995a90aa04d	75742-008	HUMAN OTC DRUG	PFA		ETHYL ALCOHOL	GEL	TOPICAL	20210302		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-018_f6bf5c5a-4955-4030-e053-6394a90a9cba	75742-018	HUMAN OTC DRUG	American Red Cross 70% Ethyl Alcohol Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20230313		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd	ALCOHOL	70	mL/100mL			N	20241231
75742-019_03f890f7-da35-a788-e063-6294a90add2a	75742-019	HUMAN OTC DRUG	Hand sanitizer 8oz with vitamin E		Ethyl Alcohol 70%	LIQUID	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-020_04064c4d-e80f-28ff-e063-6394a90a3983	75742-020	HUMAN OTC DRUG	Hand sanitizer 8oz with aloe vera		Ethyl Alcohol 70%	LIQUID	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-021_040615da-f3fe-a838-e063-6394a90a7700	75742-021	HUMAN OTC DRUG	Hand sanitizer 16.9oz with vitamin E		Ethyl Alcohol 70%	LIQUID	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-022_04fe5d74-d3d9-6468-e063-6394a90aff29	75742-022	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk with aloe vera		Ethyl Alcohol 70%	GEL	TOPICAL	20230910		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-024_04fe378d-ee1f-ad52-e063-6294a90ae146	75742-024	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk lemon		Ethyl Alcohol 70%	GEL	TOPICAL	20230910		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-025_05204984-f14c-c666-e063-6394a90a1ee4	75742-025	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk lavender		Ethyl Alcohol 70%	GEL	TOPICAL	20230910		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-026_06dcf8dc-0832-475e-e063-6394a90a9fef	75742-026	HUMAN OTC DRUG	Hand sanitizer 1.8oz with extra clip original		Ethyl Alcohol	GEL	TOPICAL	20231004		OTC MONOGRAPH DRUG	M003	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-027_06dd2427-097d-b0fa-e063-6294a90a4f82	75742-027	HUMAN OTC DRUG	Hand sanitizer 2oz 2pk original		Ethyl Alcohol	GEL	TOPICAL	20231004		OTC MONOGRAPH DRUG	M003	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75742-028_0c73f4f5-2b1e-84ae-e063-6394a90a5d7b	75742-028	HUMAN OTC DRUG	ALCOHOL ANTISEPTIC HAND SANITIZER ANTIBACTERIAL		ALCOHOL	GEL	TOPICAL	20231214		OTC MONOGRAPH DRUG	M003	Zhejiang Guoyao Jingyue Aerosol Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
75765-040_204ff820-8498-4c21-8166-a96c9429466f	75765-040	HUMAN OTC DRUG	Chung Sol Disinfection Ethanol		ALCOHOL	SPRAY	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333E	Samhyun pharma	ALCOHOL	249	mL/100mL			N	20241231
75771-006_6bea625c-7dc1-4d3f-b2d2-ec6825ba30a2	75771-006	HUMAN OTC DRUG	NISC MEGA Hand Sanitizer Gel		Ethyl alcohol	GEL	TOPICAL	20200430		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL	75	mL/100mL			N	20241231
75771-101_4cf0c101-1e0a-48cb-8c84-5024ef032499	75771-101	HUMAN OTC DRUG	NISC Pure 50%	Rubbing Alcohol	Isopropyl Alcohol	LIQUID	TOPICAL	20210308		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
75771-120_0b791954-23b5-4dcc-a772-b81b0f6e9a99	75771-120	HUMAN OTC DRUG	NISC Pure 50% with Wintergreen and Glycerin	Rubbing Alcohol	Isopropyl Alcohol	LIQUID	TOPICAL	20210308		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
75771-231_31db69f7-a111-4a0e-bfc0-a0377fe0efc1	75771-231	HUMAN OTC DRUG	NISC MEGA Hand Sanitizer Gel		ALCOHOL	GEL	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL	75	mL/100mL			N	20241231
75771-232_f1a500e0-ee72-4dc5-b8c4-dbc55799ff32	75771-232	HUMAN OTC DRUG	NISC MEGA DISINFECTION		Ethyl Alcohol	SPRAY	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL	75	mL/100mL			N	20241231
75771-235_c623c448-527c-4002-aae5-a5f4e56bf16b	75771-235	HUMAN OTC DRUG	NISC PURE DISINFECTION		Ethyl Alcohol	SPRAY	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL	75	mL/100mL			N	20241231
75771-241_15d5d5c4-b628-4bc9-b6f6-3de85bd9dfe4	75771-241	HUMAN OTC DRUG	NISC Pure Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL	75	mL/100mL			N	20241231
75771-242_b66f0d37-0a75-442d-85df-de503a50d5f1	75771-242	HUMAN OTC DRUG	NISC Pure Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL	75	mL/100mL			N	20241231
75771-243_2bd8df58-8a56-4974-be12-d94ba6f3f151	75771-243	HUMAN OTC DRUG	NISC Pure Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL	75	mL/100mL			N	20241231
75771-444_3745ec6c-0c15-407a-9337-8083474bd880	75771-444	HUMAN OTC DRUG	NISC Pure 70%	Rubbing Alcohol	Isopropyl Alcohol	LIQUID	TOPICAL	20210308		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
75771-555_6831ebe6-da23-439b-954e-354c420cca4f	75771-555	HUMAN OTC DRUG	NISC Pure 90%	Rubbing Alcohol	Isopropyl Alcohol	LIQUID	TOPICAL	20210308		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ISOPROPYL ALCOHOL	90	mL/100mL			N	20241231
75771-888_bbcd9e7f-0a2a-4cb8-b21b-a5954e62992f	75771-888	HUMAN OTC DRUG	NISC MEGA	Rubbing Alcohol	Ethyl Alcohol, Isopropyl Alcohol	LIQUID	TOPICAL	20210107		OTC MONOGRAPH NOT FINAL	part333A	NOWREZ & ISMAIL SHUKRI COMPANY	ALCOHOL; ISOPROPYL ALCOHOL	35; 35	mL/100mL; mL/100mL			N	20241231
75786-223_ff336f7c-aaca-a24e-e053-6394a90ae766	75786-223	HUMAN OTC DRUG	All Good Mineral Sport Sunscreen Butter		Zinc Oxide	OINTMENT	TOPICAL	20220201		OTC MONOGRAPH FINAL	M020	Elemental Herbs, Inc.	ZINC OXIDE	25	g/100g			N	20241231
75786-224_fe1ce099-b886-32d1-e053-6294a90a0a91	75786-224	HUMAN OTC DRUG	All Good Coconut SPF 20 Zinc Oxide Lip Balm		Zinc Oxide	STICK	TOPICAL	20140108		OTC MONOGRAPH FINAL	M020	Elemental Herbs, Inc.	ZINC OXIDE	8	g/100g			N	20241231
75786-226_fe2c64c4-9da5-622d-e053-6394a90aea13	75786-226	HUMAN OTC DRUG	All Good Tinted Mineral Sunscreen Butter SPF 50		Zinc Oxide	OINTMENT	TOPICAL	20210513		OTC MONOGRAPH FINAL	M020	Elemental Herbs, Inc.	ZINC OXIDE	25	g/100g			N	20241231
75786-228_fe92b1e2-94a5-33ed-e053-6294a90a3b5f	75786-228	HUMAN OTC DRUG	All Good Mineral Sport Sunscreen Butter Stick SPF 50		Zinc Oxide	OINTMENT	TOPICAL	20160425		OTC MONOGRAPH FINAL	M020	Elemental Herbs, Inc.	ZINC OXIDE	25	g/100g			N	20241231
75786-230_feb94fd7-6728-6fb1-e053-6394a90a2af1	75786-230	HUMAN OTC DRUG	All Good kids mineral sunscreen butter stick SPF 50		Zinc Oxide	OINTMENT	TOPICAL	20160425		OTC MONOGRAPH FINAL	M020	Elemental Herbs, Inc.	ZINC OXIDE	25	g/100g			N	20241231
75786-234_fa6c43f8-b1cb-03d5-e053-6294a90a220a	75786-234	HUMAN OTC DRUG	All Good Unscented Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	Elemental Herbs, Inc.	ALCOHOL	62	mL/100mL			N	20241231
75786-236_fa6be16e-ad0f-91ea-e053-6394a90a720e	75786-236	HUMAN OTC DRUG	Grove Blood Orange Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20170801		OTC MONOGRAPH NOT FINAL	part333A	Elemental Herbs, Inc.	ALCOHOL	62	mL/100mL			N	20241231
75786-237_ff5e7c82-5c95-86d2-e053-6294a90adae2	75786-237	HUMAN OTC DRUG	Grove Blood Orange Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20190701		OTC MONOGRAPH NOT FINAL	part333A	Elemental Herbs, Inc.	ALCOHOL	62	mL/100mL			N	20241231
75786-336_f9cb4df1-2232-24ec-e053-6394a90affd3	75786-336	HUMAN OTC DRUG	All Good Rose Geranium Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Elemental Herbs, Inc.	ALCOHOL	62	mL/100mL			N	20241231
75786-337_f9dc343f-edad-5acd-e053-6294a90a8bbd	75786-337	HUMAN OTC DRUG	All Good Lavender Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Elemental Herbs, Inc.	ALCOHOL	62	mL/100mL			N	20241231
75788-115_0b74c7e7-5f82-6243-e063-6294a90a9d08	75788-115	HUMAN PRESCRIPTION DRUG	BREXAFEMME		ibrexafungerp	TABLET, FILM COATED	ORAL	20210701		NDA	NDA214900	SCYNEXIS, INC.	IBREXAFUNGERP CITRATE	150	mg/1	Glucan Synthase Inhibitors [MoA], Triterpenes [CS], Triterpenoid Antifungal [EPC]		N	20241231
75796-002_08c16579-fb7e-5c01-e063-6294a90af226	75796-002	HUMAN OTC DRUG	Light Medium Tinted Drops		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20200601		OTC MONOGRAPH DRUG	M020	Make2Give LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75796-003_08c16579-fb8c-5c01-e063-6294a90af226	75796-003	HUMAN OTC DRUG	Sheer Face		ZINC OXIDE	LOTION	TOPICAL	20200601		OTC MONOGRAPH DRUG	M020	Make2Give LLC	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75796-008_08c16a38-625e-e15a-e063-6394a90abb96	75796-008	HUMAN OTC DRUG	Fair Light Tinted Drops		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20230101		OTC MONOGRAPH DRUG	M020	Make2Give LLC	TITANIUM DIOXIDE; ZINC OXIDE	90; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75796-009_08c183af-2e9b-1e0b-e063-6294a90ab37b	75796-009	HUMAN OTC DRUG	My day screen Tinted drops Mini 30 SPF Fair Light		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20230101		OTC MONOGRAPH DRUG	M020	Make2Give LLC	TITANIUM DIOXIDE; ZINC OXIDE	90; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75796-010_08c163c7-b6c1-57f2-e063-6294a90ac409	75796-010	HUMAN OTC DRUG	My day screen Tinted drops Mini 30 SPF Light Medium		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20230101		OTC MONOGRAPH DRUG	M020	Make2Give LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75796-017_08c183af-2ea9-1e0b-e063-6294a90ab37b	75796-017	HUMAN OTC DRUG	Tinted Body Screen Medium Bronze		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230101		OTC MONOGRAPH DRUG	M020	Make2Give LLC	TITANIUM DIOXIDE; ZINC OXIDE	65; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75796-018_08c16579-fb6e-5c01-e063-6294a90af226	75796-018	HUMAN OTC DRUG	My Day Screen Tinted Body Screen Mini Medium Bronze		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230201		OTC MONOGRAPH DRUG	M020	Make2Give LLC	TITANIUM DIOXIDE; ZINC OXIDE	65; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75801-999_fe602eee-2357-5b8d-e053-6394a90a719b	75801-999	HUMAN OTC DRUG	Clensil		ALCOHOL	GEL	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333A	EZEL KOZMETIK ITH. VE IHR. TIC. VE SAN. A.S.	ALCOHOL	71.5	mL/100mL			N	20241231
75826-107_e764053d-4fd1-ea36-e053-2995a90a4ea9	75826-107	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20220430		ANDA	ANDA211362	Winder Laboratories LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20241231
75826-114_e0537551-5536-d23c-e053-2995a90af439	75826-114	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20151223		UNAPPROVED DRUG OTHER		Winder Laboratories, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
75826-115_e0537551-5536-d23c-e053-2995a90af439	75826-115	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20151123		UNAPPROVED DRUG OTHER		Winder Laboratories, LLC	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
75826-118_9af244ce-8841-4443-e053-2995a90af4e3	75826-118	HUMAN PRESCRIPTION DRUG	Phenohytro		PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE	TABLET	ORAL	20160229		UNAPPROVED DRUG OTHER		Winder Laboratories, LLC	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/1; mg/1; mg/1; mg/1	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
75826-120_dabda9d0-19c6-519e-e053-2a95a90adb5e	75826-120	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20211206		ANDA	ANDA212160	Winder Laboratories LLC	DEXTROAMPHETAMINE SULFATE	2.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
75826-121_dabda9d0-19c6-519e-e053-2a95a90adb5e	75826-121	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20211206		ANDA	ANDA212160	Winder Laboratories LLC	DEXTROAMPHETAMINE SULFATE	5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
75826-122_dabda9d0-19c6-519e-e053-2a95a90adb5e	75826-122	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20211206		ANDA	ANDA212160	Winder Laboratories LLC	DEXTROAMPHETAMINE SULFATE	7.5	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
75826-123_dabda9d0-19c6-519e-e053-2a95a90adb5e	75826-123	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20211206		ANDA	ANDA212160	Winder Laboratories LLC	DEXTROAMPHETAMINE SULFATE	10	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
75826-124_dabda9d0-19c6-519e-e053-2a95a90adb5e	75826-124	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20211206		ANDA	ANDA212160	Winder Laboratories LLC	DEXTROAMPHETAMINE SULFATE	15	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
75826-125_dabda9d0-19c6-519e-e053-2a95a90adb5e	75826-125	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20211206		ANDA	ANDA212160	Winder Laboratories LLC	DEXTROAMPHETAMINE SULFATE	20	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
75826-126_dabda9d0-19c6-519e-e053-2a95a90adb5e	75826-126	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Sulfate		Dextroamphetamine Sulfate	TABLET	ORAL	20211206		ANDA	ANDA212160	Winder Laboratories LLC	DEXTROAMPHETAMINE SULFATE	30	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]	CII	N	20241231
75826-127_82aba447-e388-4d5e-9499-1e030f43f3b9	75826-127	HUMAN PRESCRIPTION DRUG	Phenohytro		Phenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide	ELIXIR	ORAL	20180625		UNAPPROVED DRUG OTHER		Winder Laboratories LLC	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
75826-128_82aba447-e388-4d5e-9499-1e030f43f3b9	75826-128	HUMAN PRESCRIPTION DRUG	Phenohytro		Phenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide	ELIXIR	ORAL	20180625		UNAPPROVED DRUG OTHER		Winder Laboratories LLC	ATROPINE SULFATE; HYOSCYAMINE SULFATE; PHENOBARBITAL; SCOPOLAMINE HYDROBROMIDE	.0194; .1037; 16.2; .0065	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Anticholinergic [EPC], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CIV	N	20241231
75826-129_d92a72eb-7139-71ae-e053-2a95a90a938d	75826-129	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20190515		ANDA	ANDA211454	Winder Laboratories LLC	MORPHINE SULFATE	10	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
75826-130_d92a72eb-7139-71ae-e053-2a95a90a938d	75826-130	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20190515		ANDA	ANDA211454	Winder Laboratories LLC	MORPHINE SULFATE	20	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
75826-131_d92a72eb-7139-71ae-e053-2a95a90a938d	75826-131	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	SOLUTION	ORAL	20190515		ANDA	ANDA211454	Winder Laboratories LLC	MORPHINE SULFATE	100	mg/5mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
75826-136_e053b26d-dbad-d075-e053-2995a90afc77	75826-136	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	15	mg/1		CIV	N	20241231
75826-137_e053b26d-dbad-d075-e053-2995a90afc77	75826-137	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190611		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	16.2	mg/1		CIV	N	20241231
75826-138_e053b26d-dbad-d075-e053-2995a90afc77	75826-138	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	30	mg/1		CIV	N	20241231
75826-139_e053b26d-dbad-d075-e053-2995a90afc77	75826-139	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190611		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	32.4	mg/1		CIV	N	20241231
75826-140_e053b26d-dbad-d075-e053-2995a90afc77	75826-140	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	60	mg/1		CIV	N	20241231
75826-141_e053b26d-dbad-d075-e053-2995a90afc77	75826-141	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190611		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	64.8	mg/1		CIV	N	20241231
75826-142_e053b26d-dbad-d075-e053-2995a90afc77	75826-142	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20190611		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	97.2	mg/1		CIV	N	20241231
75826-143_e053b26d-dbad-d075-e053-2995a90afc77	75826-143	HUMAN PRESCRIPTION DRUG	Phenobarbital		Phenobarbital	TABLET	ORAL	20181001		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	PHENOBARBITAL	100	mg/1		CIV	N	20241231
75826-163_0df8f1aa-f3f0-9f59-e063-6294a90a0666	75826-163	HUMAN PRESCRIPTION DRUG	Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20240101		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	SODIUM FLUORIDE	.25	mg/1			N	20251231
75826-164_0df8f1aa-f3f0-9f59-e063-6294a90a0666	75826-164	HUMAN PRESCRIPTION DRUG	Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20240101		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	SODIUM FLUORIDE	.5	mg/1			N	20251231
75826-165_0df8f1aa-f3f0-9f59-e063-6294a90a0666	75826-165	HUMAN PRESCRIPTION DRUG	Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20240101		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	SODIUM FLUORIDE	1	mg/1			N	20251231
75826-169_0ba78004-b7ed-1fe3-e063-6394a90ad761	75826-169	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20231201		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	.ALPHA.-TOCOPHEROL; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A	13.5; 24; 10; 4.5; 500; 13.5; 1.05; 1.2; 36; .25; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
75826-170_0ba78004-b7ed-1fe3-e063-6394a90ad761	75826-170	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20231201		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	.ALPHA.-TOCOPHEROL; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A	13.5; 24; 10; 4.5; 500; 13.5; 1.05; 1.2; 36; .5; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
75826-171_0ba78004-b7ed-1fe3-e063-6394a90ad761	75826-171	HUMAN PRESCRIPTION DRUG	Multivitamin with Fluoride		Sodium Fluoride	TABLET, CHEWABLE	ORAL	20231201		UNAPPROVED DRUG OTHER		WINDER LABORATORIES, LLC	.ALPHA.-TOCOPHEROL; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; SODIUM FLUORIDE; THIAMINE MONONITRATE; VITAMIN A	13.5; 24; 10; 4.5; 500; 13.5; 1.05; 1.2; 36; 1; 1.05; 750	mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
75828-001_08f48a0e-57df-370a-e063-6394a90a49c5	75828-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20020130		UNAPPROVED MEDICAL GAS		Pure-Ox, LLC	OXYGEN	99	L/100L			N	20241231
75833-601_2685e427-20bd-46f5-85a9-85dac091ea36	75833-601	HUMAN PRESCRIPTION DRUG	Hepzato Kit		melphalan hydrochloride injection, powder, lyophilized, for solution	KIT	INTRA-ARTERIAL	20231204		NDA	NDA201848	Delcath Systems, Inc.						N	20241231
75834-109_0cf065ec-f94a-4361-e063-6294a90a14ae	75834-109	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20180528		ANDA	ANDA207222	Nivagen Pharmaceuticals, INC.	CHLORTHALIDONE	25	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
75834-110_0cf065ec-f94a-4361-e063-6294a90a14ae	75834-110	HUMAN PRESCRIPTION DRUG	Chlorthalidone		Chlorthalidone	TABLET	ORAL	20180528		ANDA	ANDA207222	Nivagen Pharmaceuticals, INC.	CHLORTHALIDONE	50	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
75834-112_67a823b3-3e2d-4483-98e5-99fbddc0c8f5	75834-112	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, COATED	ORAL	20160715		ANDA	ANDA091656	Nivagen Pharmaceuticals, Inc.	OFLOXACIN	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
75834-115_ce9b07a1-54f8-46d8-a8e1-c606e2c65c01	75834-115	HUMAN PRESCRIPTION DRUG	Drospirenone and Ethinyl Estradiol		Drospirenone and Ethinyl Estradiol	KIT		20171101		ANDA	ANDA202015	Nivagen Pharmaceuticals, Inc.						N	20241231
75834-116_d14eb5b4-a0d0-4793-b41b-ab31bf2f16c5	75834-116	HUMAN PRESCRIPTION DRUG	Drospirenone and ethinyl estradiol		Drospirenone and ethinyl estradiol	KIT		20170815		ANDA	ANDA202016	Nivagen Pharmaceuticals, Inc.						N	20241231
75834-119_67a823b3-3e2d-4483-98e5-99fbddc0c8f5	75834-119	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, COATED	ORAL	20160715		ANDA	ANDA091656	Nivagen Pharmaceuticals, Inc.	OFLOXACIN	300	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
75834-120_67a823b3-3e2d-4483-98e5-99fbddc0c8f5	75834-120	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, COATED	ORAL	20160715		ANDA	ANDA091656	Nivagen Pharmaceuticals, Inc.	OFLOXACIN	200	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
75834-122_d14fe0b4-4772-45ee-b0d9-6ea50e5c9733	75834-122	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20161015		ANDA	ANDA202168	Nivagen Pharmaceuticals, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
75834-123_d14fe0b4-4772-45ee-b0d9-6ea50e5c9733	75834-123	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20161015		ANDA	ANDA202168	Nivagen Pharmaceuticals, Inc.	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
75834-124_bdd7c1ab-7f2d-43b5-9ff7-238aa1b9576f	75834-124	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20161015		ANDA	ANDA201445	Nivagen Pharmaceuticals, Inc.	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
75834-126_379fe677-a8e7-4bfe-abcf-85283768c27b	75834-126	HUMAN PRESCRIPTION DRUG	Hydralazine		HYDRALAZINE HYDROCHLORIDE	TABLET	ORAL	20170215		ANDA	ANDA203845	Nivagen Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
75834-127_379fe677-a8e7-4bfe-abcf-85283768c27b	75834-127	HUMAN PRESCRIPTION DRUG	Hydralazine		HYDRALAZINE HYDROCHLORIDE	TABLET	ORAL	20170215		ANDA	ANDA203845	Nivagen Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
75834-128_379fe677-a8e7-4bfe-abcf-85283768c27b	75834-128	HUMAN PRESCRIPTION DRUG	Hydralazine		HYDRALAZINE HYDROCHLORIDE	TABLET	ORAL	20170215		ANDA	ANDA203845	Nivagen Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
75834-129_4ffa902e-2cf8-4160-ba1e-f27e48b8e502	75834-129	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20161125		ANDA	ANDA203435	Nivagen Pharmaceuticals, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.0025; .5	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
75834-130_4ffa902e-2cf8-4160-ba1e-f27e48b8e502	75834-130	HUMAN PRESCRIPTION DRUG	Norethindrone Acetate and Ethinyl Estradiol		Norethindrone Acetate and Ethinyl Estradiol	TABLET	ORAL	20161125		ANDA	ANDA203435	Nivagen Pharmaceuticals, Inc.	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	.005; 1	mg/1; mg/1	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
75834-131_46c22ec0-5ec6-472c-a8cf-b89c27dc6448	75834-131	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET	ORAL	20170215		ANDA	ANDA203266	Nivagen Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
75834-132_9db23336-458a-46a6-a676-1702497a1891	75834-132	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20211207		ANDA	ANDA213328	Nivagen Pharmaceuticals, Inc.	TEMOZOLOMIDE	5	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
75834-133_e272f7d1-d782-4ff1-919c-784c91ee024d	75834-133	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20170904		ANDA	ANDA203844	Nivagen Pharmaceuticals, Inc.	RIVASTIGMINE TARTRATE	1.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
75834-134_e272f7d1-d782-4ff1-919c-784c91ee024d	75834-134	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20170904		ANDA	ANDA203844	Nivagen Pharmaceuticals, Inc.	RIVASTIGMINE TARTRATE	3	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
75834-135_e272f7d1-d782-4ff1-919c-784c91ee024d	75834-135	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20170904		ANDA	ANDA203844	Nivagen Pharmaceuticals, Inc.	RIVASTIGMINE TARTRATE	4.5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
75834-136_e272f7d1-d782-4ff1-919c-784c91ee024d	75834-136	HUMAN PRESCRIPTION DRUG	RIVASTIGMINE TARTRATE		RIVASTIGMINE TARTRATE	CAPSULE	ORAL	20170904		ANDA	ANDA203844	Nivagen Pharmaceuticals, Inc.	RIVASTIGMINE TARTRATE	6	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
75834-141_079c90d4-1c7d-a567-e063-6394a90a45d8	75834-141	HUMAN OTC DRUG	Lidocaine		Lidocaine	CREAM	TOPICAL	20161215		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
75834-142_9db23336-458a-46a6-a676-1702497a1891	75834-142	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20211207		ANDA	ANDA213328	Nivagen Pharmaceuticals, Inc.	TEMOZOLOMIDE	20	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
75834-143_9db23336-458a-46a6-a676-1702497a1891	75834-143	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20211207		ANDA	ANDA213328	Nivagen Pharmaceuticals, Inc.	TEMOZOLOMIDE	100	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
75834-144_9db23336-458a-46a6-a676-1702497a1891	75834-144	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20211207		ANDA	ANDA213328	Nivagen Pharmaceuticals, Inc.	TEMOZOLOMIDE	140	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
75834-145_9db23336-458a-46a6-a676-1702497a1891	75834-145	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20211207		ANDA	ANDA213328	Nivagen Pharmaceuticals, Inc.	TEMOZOLOMIDE	180	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
75834-146_9db23336-458a-46a6-a676-1702497a1891	75834-146	HUMAN PRESCRIPTION DRUG	temozolomide		temozolomide	CAPSULE	ORAL	20211207		ANDA	ANDA213328	Nivagen Pharmaceuticals, Inc.	TEMOZOLOMIDE	250	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
75834-147_fe395d7c-ccaa-4f49-a902-70a9f6fce571	75834-147	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE ACETATE		HYDROCORTISONE ACETATE	SUPPOSITORY	RECTAL	20200515		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	HYDROCORTISONE ACETATE	25	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
75834-148_1e43460d-ed31-4faf-83f2-96d7ca7fe6ec	75834-148	HUMAN PRESCRIPTION DRUG	Fluoxetine		FLUOXETINE HYDROCHLORIDE	TABLET	ORAL	20171211		ANDA	ANDA209695	Nivagen Pharmaceuticals, Inc.	FLUOXETINE HYDROCHLORIDE	60	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
75834-149_2dcffb9b-454f-49a0-bb77-f43a8429687d	75834-149	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20221121		ANDA	ANDA212627	Nivagen Pharmaceuticals, Inc.	NEOSTIGMINE METHYLSULFATE	.5	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
75834-150_2dcffb9b-454f-49a0-bb77-f43a8429687d	75834-150	HUMAN PRESCRIPTION DRUG	NEOSTIGMINE METHYLSULFATE		neostigmine methylsulfate	INJECTION	INTRAVENOUS	20221121		ANDA	ANDA212627	Nivagen Pharmaceuticals, Inc.	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
75834-152_0275e19f-3ee7-008b-e063-6294a90a27eb	75834-152	HUMAN PRESCRIPTION DRUG	colesevelam hydrochloride		colesevelam hydrochloride	TABLET, COATED	ORAL	20201204		ANDA	ANDA212050	Nivagen Pharmaceuticals, Inc.	COLESEVELAM HYDROCHLORIDE	625	mg/1	Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]		N	20241231
75834-158_ebbb0dad-ab4d-4d6c-aebb-d65e2dd08c28	75834-158	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	Nivagen Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	180	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
75834-159_ebbb0dad-ab4d-4d6c-aebb-d65e2dd08c28	75834-159	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20190515		ANDA	ANDA206173	Nivagen Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	240	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
75834-170_c0fffe6a-f964-4a71-aac8-ca5d675e2168	75834-170	HUMAN OTC DRUG	NIVAGEN ZINC OXIDE		ZINC OXIDE	OINTMENT	TOPICAL	20180510		OTC MONOGRAPH FINAL	part347	Nivagen Pharmaceuticals, Inc.	ZINC OXIDE	200	mg/g			N	20241231
75834-171_b99af4e6-74c3-4a4f-85f2-6dcc0a759449	75834-171	HUMAN PRESCRIPTION DRUG	calcium gluconate		calcium gluconate	INJECTION, SOLUTION	INTRAVENOUS	20221024		ANDA	ANDA213071	Nivagen Pharmaceuticals, Inc.	CALCIUM GLUCONATE MONOHYDRATE	98	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
75834-190_e20c2038-e61d-4c04-8b35-f2ff37a1b8d5	75834-190	HUMAN PRESCRIPTION DRUG	DECITABINE		decitabine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20201217		ANDA	ANDA212117	Nivagen Pharmaceuticals, Inc.	DECITABINE	50	mg/20mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
75834-193_29803114-1d00-4e06-9a14-b75895c85f5a	75834-193	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211025		ANDA	ANDA212591	Nivagen Pharmaceuticals, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
75834-194_29803114-1d00-4e06-9a14-b75895c85f5a	75834-194	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211025		ANDA	ANDA212591	Nivagen Pharmaceuticals, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
75834-195_29803114-1d00-4e06-9a14-b75895c85f5a	75834-195	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211025		ANDA	ANDA212591	Nivagen Pharmaceuticals, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
75834-196_29803114-1d00-4e06-9a14-b75895c85f5a	75834-196	HUMAN PRESCRIPTION DRUG	GLYCOPYRROLATE		glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20211025		ANDA	ANDA212591	Nivagen Pharmaceuticals, Inc.	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
75834-197_53ac723b-1f67-47e5-b560-6589342a27d8	75834-197	HUMAN PRESCRIPTION DRUG	HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE		PRAMOXINE HYDROCHLORIDE and HYDROCORTISONE ACETATE	CREAM	TOPICAL	20190429		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals Inc.	HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE	25; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
75834-199_991170ff-e65c-421f-b7f0-95f78e459844	75834-199	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, COATED	ORAL	20190125		ANDA	ANDA091656	Nivagen Pharmaceuticals, Inc.	OFLOXACIN	200	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
75834-200_991170ff-e65c-421f-b7f0-95f78e459844	75834-200	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, COATED	ORAL	20190125		ANDA	ANDA091656	Nivagen Pharmaceuticals, Inc.	OFLOXACIN	300	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
75834-201_991170ff-e65c-421f-b7f0-95f78e459844	75834-201	HUMAN PRESCRIPTION DRUG	OFLOXACIN		OFLOXACIN	TABLET, COATED	ORAL	20190125		ANDA	ANDA091656	Nivagen Pharmaceuticals, Inc.	OFLOXACIN	400	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
75834-202_757b12d9-8efb-49ca-b8f7-7884535ca011	75834-202	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20190125		ANDA	ANDA203379	Nivagen Pharmaceuticals, Inc.	GLYBURIDE	1.25	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
75834-203_757b12d9-8efb-49ca-b8f7-7884535ca011	75834-203	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20190125		ANDA	ANDA203379	Nivagen Pharmaceuticals, Inc.	GLYBURIDE	2.5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
75834-204_757b12d9-8efb-49ca-b8f7-7884535ca011	75834-204	HUMAN PRESCRIPTION DRUG	GLYBURIDE		GLYBURIDE	TABLET	ORAL	20190125		ANDA	ANDA203379	Nivagen Pharmaceuticals, Inc.	GLYBURIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
75834-205_4b5b12e1-59db-4ec2-a2be-9b60abc79ebf	75834-205	HUMAN PRESCRIPTION DRUG	NATEGLINIDE		NATEGLINIDE	TABLET, COATED	ORAL	20190925		ANDA	ANDA206432	Nivagen Pharmaceuticals, Inc.	NATEGLINIDE	60	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
75834-206_4b5b12e1-59db-4ec2-a2be-9b60abc79ebf	75834-206	HUMAN PRESCRIPTION DRUG	NATEGLINIDE		NATEGLINIDE	TABLET, COATED	ORAL	20190925		ANDA	ANDA206432	Nivagen Pharmaceuticals, Inc.	NATEGLINIDE	120	mg/1	Glinide [EPC], Potassium Channel Antagonists [MoA]		N	20241231
75834-207_359eaf8b-a8f7-4493-ba61-98e106bcc3d5	75834-207	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		TIZANIDINE HYDROCHLORIDE	CAPSULE	ORAL	20190926		ANDA	ANDA210021	Nivagen Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
75834-208_359eaf8b-a8f7-4493-ba61-98e106bcc3d5	75834-208	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		TIZANIDINE HYDROCHLORIDE	CAPSULE	ORAL	20190926		ANDA	ANDA210021	Nivagen Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
75834-209_359eaf8b-a8f7-4493-ba61-98e106bcc3d5	75834-209	HUMAN PRESCRIPTION DRUG	TIZANIDINE HYDROCHLORIDE		TIZANIDINE HYDROCHLORIDE	CAPSULE	ORAL	20190926		ANDA	ANDA210021	Nivagen Pharmaceuticals, Inc.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
75834-217_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238	75834-217	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190906		ANDA	ANDA211323	Nivagen Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
75834-218_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238	75834-218	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190906		ANDA	ANDA211323	Nivagen Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
75834-219_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238	75834-219	HUMAN PRESCRIPTION DRUG	VENLAFAXINE HYDROCHLORIDE		VENLAFAXINE HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20190906		ANDA	ANDA211323	Nivagen Pharmaceuticals, Inc.	VENLAFAXINE HYDROCHLORIDE	225	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
75834-220_0cf0a237-2a65-5cae-e063-6294a90a91f7	75834-220	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20200421		ANDA	ANDA207798	NIVAGEN PHARMACEUTICALS, INC.	CARBAMAZEPINE	100	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
75834-221_0cf0a237-2a65-5cae-e063-6294a90a91f7	75834-221	HUMAN PRESCRIPTION DRUG	Carbamazepine		Carbamazepine	TABLET	ORAL	20200421		ANDA	ANDA207798	NIVAGEN PHARMACEUTICALS, INC.	CARBAMAZEPINE	200	mg/1	Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
75834-236_0cf12688-3f4b-8571-e063-6394a90abca2	75834-236	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20200903		ANDA	ANDA210628	NIVAGEN PHARMACEUTICALS, INC.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
75834-237_0cf12688-3f4b-8571-e063-6394a90abca2	75834-237	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20200903		ANDA	ANDA210628	NIVAGEN PHARMACEUTICALS, INC.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
75834-238_0cf12688-3f4b-8571-e063-6394a90abca2	75834-238	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20200903		ANDA	ANDA210628	NIVAGEN PHARMACEUTICALS, INC.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
75834-239_0cf12688-3f4b-8571-e063-6394a90abca2	75834-239	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20200903		ANDA	ANDA210628	NIVAGEN PHARMACEUTICALS, INC.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
75834-240_0cf0c12a-c9b3-658d-e063-6294a90a1a32	75834-240	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20200904		ANDA	ANDA209302	NIVAGEN PHARMACEUTICALS, INC.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
75834-241_0cf0c12a-c9b3-658d-e063-6294a90a1a32	75834-241	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20200904		ANDA	ANDA209302	NIVAGEN PHARMACEUTICALS, INC.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
75834-242_7fd2f23e-f993-46cb-b564-54458729759a	75834-242	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20210715		ANDA	ANDA213628	Nivagen Pharmaceuticals, Inc.	ERYTHROMYCIN	250	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
75834-243_7fd2f23e-f993-46cb-b564-54458729759a	75834-243	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	TABLET, FILM COATED	ORAL	20210715		ANDA	ANDA213628	Nivagen Pharmaceuticals, Inc.	ERYTHROMYCIN	500	mg/1	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
75834-245_fb43800c-896d-4333-8854-37e4d14c7390	75834-245	HUMAN PRESCRIPTION DRUG	Levetiracetam Extended Release		Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200916		ANDA	ANDA201464	Nivagen Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
75834-246_fb43800c-896d-4333-8854-37e4d14c7390	75834-246	HUMAN PRESCRIPTION DRUG	Levetiracetam Extended Release		Levetiracetam	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20200916		ANDA	ANDA201464	Nivagen Pharmaceuticals, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
75834-247_0cf08823-fb54-56bc-e063-6394a90ab359	75834-247	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA211298	NIVAGEN PHARMACEUTICALS, INC.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
75834-248_0cf08823-fb54-56bc-e063-6394a90ab359	75834-248	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA211298	NIVAGEN PHARMACEUTICALS, INC.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
75834-249_0cf08823-fb54-56bc-e063-6394a90ab359	75834-249	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA211298	NIVAGEN PHARMACEUTICALS, INC.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
75834-250_0cf08823-fb54-56bc-e063-6394a90ab359	75834-250	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA211298	NIVAGEN PHARMACEUTICALS, INC.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
75834-255_0c732159-8fb2-35c5-e063-6394a90af246	75834-255	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	NIVAGEN PHARMACEUTICALS, INC.	ATORVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
75834-256_0c732159-8fb2-35c5-e063-6394a90af246	75834-256	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	NIVAGEN PHARMACEUTICALS, INC.	ATORVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
75834-257_0c732159-8fb2-35c5-e063-6394a90af246	75834-257	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	NIVAGEN PHARMACEUTICALS, INC.	ATORVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
75834-258_0c732159-8fb2-35c5-e063-6394a90af246	75834-258	HUMAN PRESCRIPTION DRUG	Atorvastatin calcium		Atorvastatin calcium	TABLET	ORAL	20200826		ANDA	ANDA213853	NIVAGEN PHARMACEUTICALS, INC.	ATORVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
75834-264_ec6c28fc-0909-4a33-818c-77ead8538bcc	75834-264	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Misoprostol		diclofenac sodium and misoprostol	TABLET, DELAYED RELEASE	ORAL	20210715		ANDA	ANDA205143	Nivagen Pharmaceuticals, Inc.	DICLOFENAC SODIUM; MISOPROSTOL	50; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
75834-265_ec6c28fc-0909-4a33-818c-77ead8538bcc	75834-265	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium Misoprostol		diclofenac sodium and misoprostol	TABLET, DELAYED RELEASE	ORAL	20210715		ANDA	ANDA205143	Nivagen Pharmaceuticals, Inc.	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
75834-266_5bad7053-8f63-45fc-adb0-88c628fa039b	75834-266	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210215		ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
75834-267_5bad7053-8f63-45fc-adb0-88c628fa039b	75834-267	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210215		ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
75834-268_5bad7053-8f63-45fc-adb0-88c628fa039b	75834-268	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210215		ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
75834-269_5bad7053-8f63-45fc-adb0-88c628fa039b	75834-269	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210215		ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
75834-270_5bad7053-8f63-45fc-adb0-88c628fa039b	75834-270	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20210215		ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	30	mg/1			N	20241231
75834-272_0cf0c12a-c9b3-658d-e063-6294a90a1a32	75834-272	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20210616		ANDA	ANDA209302	NIVAGEN PHARMACEUTICALS, INC.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
75834-273_5b89a3bb-e3bb-421d-89f7-f180e01a1b4d	75834-273	HUMAN PRESCRIPTION DRUG	Albuterol		albuterol sulfate	TABLET	ORAL	20210121		ANDA	ANDA210948	Nivagen Pharmaceuticals Inc	ALBUTEROL SULFATE	2	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
75834-274_5b89a3bb-e3bb-421d-89f7-f180e01a1b4d	75834-274	HUMAN PRESCRIPTION DRUG	Albuterol		albuterol sulfate	TABLET	ORAL	20210121		ANDA	ANDA210948	Nivagen Pharmaceuticals Inc	ALBUTEROL SULFATE	4	mg/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
75834-280_62e50e38-f41a-4dc9-96e8-37a7c677bec5	75834-280	HUMAN PRESCRIPTION DRUG	POTASSIUM IODIDE		POTASSIUM IODIDE	SOLUTION	ORAL	20211229		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	POTASSIUM IODIDE	1	g/mL			N	20241231
75834-290_0175a6b8-51dd-44d3-e063-6394a90a2f03	75834-290	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA203028	Nivagen Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
75834-291_0175a6b8-51dd-44d3-e063-6394a90a2f03	75834-291	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA203028	Nivagen Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
75834-292_01740be9-3731-2dd7-e063-6294a90a2b7a	75834-292	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA203699	Nivagen Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
75834-293_01740be9-3731-2dd7-e063-6294a90a2b7a	75834-293	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20210226		ANDA	ANDA203699	Nivagen Pharmaceuticals, Inc.	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
75834-294_46f74c4f-10fc-44cf-aec4-d113f49149bc	75834-294	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	SUSPENSION	ORAL	20230201		ANDA	ANDA216212	Nivagen Pharmaceuticals, Inc.	ERYTHROMYCIN ETHYLSUCCINATE	400	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
75834-295_46f74c4f-10fc-44cf-aec4-d113f49149bc	75834-295	HUMAN PRESCRIPTION DRUG	Erythromycin Ethylsuccinate		Erythromycin Ethylsuccinate	SUSPENSION	ORAL	20230201		ANDA	ANDA216212	Nivagen Pharmaceuticals, Inc.	ERYTHROMYCIN ETHYLSUCCINATE	200	mg/5mL	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
75834-296_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-296	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
75834-297_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-297	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
75834-298_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-298	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
75834-299_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-299	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
75834-300_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-300	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
75834-301_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-301	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
75834-302_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-302	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	225	mg/1		CV	N	20241231
75834-303_3b93005b-dd76-4271-9b3c-f2f047285f13	75834-303	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20220714		ANDA	ANDA212988	Nivagen Pharmaceuticals, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
75834-310_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-310	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	15	mg/1			N	20241231
75834-311_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-311	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	30	mg/1			N	20241231
75834-312_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-312	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	60	mg/1			N	20241231
75834-313_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-313	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	90	mg/1			N	20241231
75834-314_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-314	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	120	mg/1			N	20241231
75834-315_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-315	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	180	mg/1			N	20241231
75834-316_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-316	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	240	mg/1			N	20241231
75834-317_1cce3de8-0aa9-4f05-9104-a84b7d91dd68	75834-317	HUMAN PRESCRIPTION DRUG	Niva Thyroid		thyroid, porcine	TABLET	ORAL	20230724		UNAPPROVED DRUG OTHER		Nivagen Pharmaceuticals, Inc.	THYROID	300	mg/1			N	20241231
75834-320_ebbb0dad-ab4d-4d6c-aebb-d65e2dd08c28	75834-320	HUMAN PRESCRIPTION DRUG	VERAPAMIL HYDROCHLORIDE		VERAPAMIL HYDROCHLORIDE	TABLET	ORAL	20230102		ANDA	ANDA206173	Nivagen Pharmaceuticals, Inc.	VERAPAMIL HYDROCHLORIDE	120	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
75834-323_da6dc42d-1ae6-45ff-8a81-20a7135f8d17	75834-323	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20231207		ANDA	ANDA217205	Nivagen Pharmaceuticals, Inc.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
75834-500_a85b9b37-34f0-4a0d-e053-2995a90ab1ce	75834-500	HUMAN PRESCRIPTION DRUG	METFORMIN HYDROCHLORIDE	ER	metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20131101		ANDA	ANDA201991	Nivagen Pharmaceuticals Inc	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
75849-301_e0089b62-e19a-4ab7-a2f0-a8e9a70ff2e8	75849-301	HUMAN OTC DRUG	Valtrum Topical Analgesic Roll On		SALICYLIC ACID MENTHOL CAMPHOR (NATURAL)	GEL	TOPICAL	20190301		OTC MONOGRAPH DRUG	M017	LABORATORIOS QUANTIUM LLC	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	3; 3; 10	g/100g; g/100g; g/100g			N	20241231
75849-304_1a272d1e-a955-40ff-a40d-008b0c9eebdb	75849-304	HUMAN OTC DRUG	Valtrum Aerobic Sports		SALICYLIC ACID MENTHOL CAMPHOR (NATURAL)	GEL	TOPICAL	20190301		OTC MONOGRAPH DRUG	M017	LABORATORIOS QUANTIUM LLC	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	3; 3; 10	g/100g; g/100g; g/100g			N	20241231
75854-343_1bdbe782-d27b-425b-b48b-c2d08daee019	75854-343	HUMAN PRESCRIPTION DRUG	Nicomide		niacinamide, zinc glycinate, folic acid, cupric oxide, selenium and chromium	TABLET	ORAL	20141208		UNAPPROVED DRUG OTHER		Avion Pharmaceuticals, LLC	CHROMIUM; CUPRIC OXIDE; FOLIC ACID; NIACINAMIDE; SELENIUM; ZINC GLYCINATE	100; 2; 500; 750; 50; 27	ug/1; mg/1; ug/1; mg/1; ug/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
75854-602_0ca934cf-a654-435c-ad1e-73fd7c563318	75854-602	HUMAN PRESCRIPTION DRUG	Balcoltra		levonorgestrel and ethinyl estradiol	KIT		20180410		NDA	NDA208612	Avion Pharmaceuticals						N	20241231
75854-701_9f706f14-3c75-4967-b6af-1f9c559a5720	75854-701	HUMAN PRESCRIPTION DRUG	Dhivy		Carbidopa Levodopa	TABLET	ORAL	20220210		NDA	NDA214869	Avion Pharmaceuticals, LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
75907-069_8630467c-de24-9d2e-ac96-ce9afeaca9b1	75907-069	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20231117		ANDA	ANDA073556	Dr. Reddy's Laboratories Inc.	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
75907-070_8630467c-de24-9d2e-ac96-ce9afeaca9b1	75907-070	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20231117		ANDA	ANDA073556	Dr. Reddy's Laboratories Inc.	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
75907-071_8630467c-de24-9d2e-ac96-ce9afeaca9b1	75907-071	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20231117		ANDA	ANDA073556	Dr. Reddy's Laboratories Inc.	NORTRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
75907-072_8630467c-de24-9d2e-ac96-ce9afeaca9b1	75907-072	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20231117		ANDA	ANDA073556	Dr. Reddy's Laboratories Inc.	NORTRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
75907-097_cefb1fd9-768f-c7a4-b9b1-ab7faaa67308	75907-097	HUMAN OTC DRUG	Loperamide Hydrochloride		Loperamide Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20211022		ANDA	ANDA213070	Dr. Reddy's Laboratories Inc.	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
75907-119_a40c48e8-93c4-8b65-6b4d-a6d236e39c38	75907-119	HUMAN OTC DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	TABLET, DELAYED RELEASE	ORAL	20231230		ANDA	ANDA211571	Dr. Reddys Laboratories Inc	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
75913-113_cf85b16b-e523-0fd2-e053-2a95a90a129d	75913-113	HUMAN PRESCRIPTION DRUG	Ammonia N 13		NH3N13	INJECTION	INTRAVENOUS	20120320		ANDA	ANDA204506	Washington University School of Medicine	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
75913-647_cf858070-65a1-61fd-e053-2995a90a6b86	75913-647	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F 18	INJECTION	INTRAVENOUS	20110102		ANDA	ANDA203935	Washington University School of Medicine	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
75920-0464_0daa059c-59cd-268d-e063-6294a90a0c61	75920-0464	HUMAN OTC DRUG	Blowfish		Aspirin, Caffeine	TABLET, EFFERVESCENT	ORAL	20110723		OTC MONOGRAPH DRUG	M013	Rally Labs LLC	ASPIRIN; CAFFEINE	500; 60	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
75929-027_0c6dd669-1ac5-3edc-e063-6294a90a9909	75929-027	HUMAN PRESCRIPTION DRUG	Juxtapid		lomitapide mesylate	CAPSULE	ORAL	20130103		NDA	NDA203858	Pharma Packaging Solutions, LLC dba Tjoapack LLC	LOMITAPIDE MESYLATE	20	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Microsomal Triglyceride Transfer Protein Inhibitor [EPC], Microsomal Triglyceride Transfer Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
75929-057_01f97b31-d7d9-3533-e063-6294a90a9ed1	75929-057	HUMAN PRESCRIPTION DRUG	Hyoscyamine	ER	hyoscyamine sulfate	TABLET, EXTENDED RELEASE	ORAL	20160501		UNAPPROVED DRUG OTHER		Pharma Packaging Solutions, LLC dba Tjopack LLC	HYOSCYAMINE SULFATE	.375	mg/1			N	20241231
75929-109_02e47dfc-ae18-d0e4-e063-6294a90a69a9	75929-109	HUMAN OTC DRUG	Boron		Boron	PELLET	ORAL	20220503		UNAPPROVED HOMEOPATHIC		Pharma Packaging Solutions, LLC dba Tjoapack LLC	BORON	30	[hp_C]/1			N	20241231
75929-110_02e460fb-6bea-601e-e063-6294a90a5887	75929-110	HUMAN OTC DRUG	SinEcch		Arnica montana	CAPSULE	ORAL	20190507		UNAPPROVED HOMEOPATHIC		Pharma Packaging Solutions, LLC dba Tjoapack LLC	ARNICA MONTANA	1	[hp_M]/[hp_M]			N	20241231
75929-172_0c6dd669-1ac5-3edc-e063-6294a90a9909	75929-172	HUMAN PRESCRIPTION DRUG	Juxtapid		lomitapide mesylate	CAPSULE	ORAL	20130103		NDA	NDA203858	Pharma Packaging Solutions, LLC dba Tjoapack LLC	LOMITAPIDE MESYLATE	30	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Microsomal Triglyceride Transfer Protein Inhibitor [EPC], Microsomal Triglyceride Transfer Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
75929-184_f6054728-85bc-eaf8-e053-2a95a90ad74f	75929-184	HUMAN PRESCRIPTION DRUG	Albendazole		Albendazole	TABLET	ORAL	20200819		ANDA	ANDA211117	Pharma Packaging Solutions, LLC dba Tjoapack LLC	ALBENDAZOLE	200	mg/1	Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]		N	20241231
75930-001_08b3d4a7-dd5e-c541-e063-6294a90a4fd3	75930-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110214		UNAPPROVED MEDICAL GAS		SG Homecare, Inc.	OXYGEN	99	L/100L			N	20241231
75936-111_eb7f0eb3-546b-3284-e053-2995a90a7f5d	75936-111	HUMAN OTC DRUG	City Sunscreen serum Broad Spectrum SPF 30	Supergoop	Homosalate, Octisalate, Avobenzene, Octocrylene	CREAM	TOPICAL	20101207		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4; 2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-136_ffac2489-e0ec-a769-e053-6294a90adf2a	75936-136	HUMAN OTC DRUG	Daily Dose Vitamin C and Broad Spectrum SPF 40 Serum		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20200908		OTC MONOGRAPH FINAL	part352	Supergoop LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-143_f8dbd89b-b077-d4cd-e053-6294a90a61c4	75936-143	HUMAN OTC DRUG	Healthy Glow Sunless Tan Broad Spectrum SPF 40		Avobenzone, Homosalate, Octinoxate, Octisalate	LOTION	TOPICAL	20180102		OTC MONOGRAPH FINAL	M020	Supergoop LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	2; 10; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-149_00242727-5d14-5ab1-e063-6394a90ac6ba	75936-149	HUMAN OTC DRUG	Bright-eyed 100% mineral Eye Cream Broad Spectrum Sunscreen SPF 40		Zinc Oxide	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	14.4	g/100mL			N	20241231
75936-151_00243efc-1d40-a0eb-e063-6394a90ab40e	75936-151	HUMAN OTC DRUG	Hand Screen Broad Spectrum Sunscreen SPF 40		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20191112		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
75936-152_00243efc-1d42-a0eb-e063-6394a90ab40e	75936-152	HUMAN OTC DRUG	Glow Oil Broad Spectrum Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20191112		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-154_ec0762ca-ebbc-12fb-e053-2995a90ab106	75936-154	HUMAN OTC DRUG	PLAY Antioxidant Body Mist SPF 50 With Vitamin C		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20200117		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.8; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-155_0b394c93-2825-1c18-e063-6394a90a7f0c	75936-155	HUMAN OTC DRUG	Play SPF 30 Lip Shield Strawberry		Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20201001		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
75936-156_ec0791af-aa9b-9b8e-e053-2a95a90aca5f	75936-156	HUMAN OTC DRUG	PLAY SPF 30 Lip Shield Coconut		Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20201002		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
75936-157_0c7e6efe-4bcf-5581-e063-6394a90ae213	75936-157	HUMAN OTC DRUG	Glow Stick Broad Spectrum SPF 50		AVOBENZONE, OCTISALATE, OCTOCRYLENE	STICK	TOPICAL	20180103		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100g; g/100g; g/100g			N	20241231
75936-158_ec081910-67ac-3629-e053-2995a90a65f2	75936-158	HUMAN OTC DRUG	Ounce by Ounce Broad Spectrum Sunscreen SPF 30		Zinc Oxide	LOTION	TOPICAL	20210826		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	15.7	g/100mL			N	20241231
75936-164_00243efc-1d43-a0eb-e063-6394a90ab40e	75936-164	HUMAN OTC DRUG	Unseen Sunscreen Broad Spectrum SPF 40		Avobenzone, Homosalate, Octinoxate, Octisalate	CREAM	TOPICAL	20171010		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 5; 4	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-165_ec086008-dc9a-b030-e053-2a95a90aa88c	75936-165	HUMAN OTC DRUG	Play Antioxidant Body Mist WIth Vitamin C Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20200117		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.4; 9.8; 4.9; 5.7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-166_eb479a2f-836d-c15c-e053-2995a90a22e5	75936-166	HUMAN OTC DRUG	(Re) Setting 100% mineral Powder Light Broad Spectrum SPF 35		Zinc Oxide	POWDER	TOPICAL	20200908		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	24.7	g/100g			N	20241231
75936-167_eb4785e6-0fa6-69b2-e053-2995a90a353f	75936-167	HUMAN OTC DRUG	(RE) Setting 100% Mineral Powder Medium Broad Spectrum Sunscreen SPF 35		Zinc Oxide	POWDER	TOPICAL	20200908		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	24.7	g/100g			N	20241231
75936-168_eb479db5-450e-27a2-e053-2a95a90a4310	75936-168	HUMAN OTC DRUG	(Re) Setting 100% mineral Powder Deep Broad Spectrum SPF 35		Zinc Oxide	POWDER	TOPICAL	20200914		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	24.7	g/100g			N	20241231
75936-169_eb4785e6-0fa5-69b2-e053-2995a90a353f	75936-169	HUMAN OTC DRUG	(RE) Setting 100% Mineral Powder Translucent Broad Spectrum Sunscreen SPF 35		Zinc Oxide	POWDER	TOPICAL	20200908		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	24.7	g/100g			N	20241231
75936-175_ec08a129-8923-6b5a-e053-2995a90a5d4a	75936-175	HUMAN OTC DRUG	Play Mineral Broad Spectrum SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20190516		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	2; 24	g/100mL; g/100mL			N	20241231
75936-210_00243efc-1d44-a0eb-e063-6394a90ab40e	75936-210	HUMAN OTC DRUG	Everyday Sunscreen with Sunflower Extract Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate	CREAM	TOPICAL	20190212		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	g/100mL; g/100mL; g/100mL			N	20241231
75936-212_eac3b1b0-6bf2-f549-e053-2a95a90ac25d	75936-212	HUMAN OTC DRUG	100% Mineral Body Mist With Green Tea Extract Broad Spectrum SPF 50		Titanium dioxide, Zinc Oxide	LIQUID	TOPICAL	20200501		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	10; 12	g/100mL; g/100mL			N	20241231
75936-214_eb6c3131-2603-1409-e053-2a95a90af329	75936-214	HUMAN OTC DRUG	Poof 100% Mineral Part Powder SPF 35		Zinc Oxide	POWDER	TOPICAL	20200601		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	24.7	g/100g			N	20241231
75936-216_00246f6f-a98b-e2c3-e063-6394a90aa27d	75936-216	HUMAN OTC DRUG	Glow Screen SPF 40		Avobenzone, Octisalate, Octocylene	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 10	g/100mL; g/100mL; g/100mL			N	20241231
75936-217_0024a9f1-4d65-4591-e063-6394a90a9ede	75936-217	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 100C		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-218_0024a9f1-4d66-4591-e063-6394a90a9ede	75936-218	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 105N		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-219_0024a56b-46fd-c44e-e063-6294a90abd52	75936-219	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 110C		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-220_0024a534-22fd-3568-e063-6294a90a637f	75936-220	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 206W		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-223_ebca053c-c526-79b2-e053-2a95a90a8cf5	75936-223	HUMAN OTC DRUG	Zinc Screen Broad Spectrum Sunscreen SPF 40		Zinc Oxide	LOTION	TOPICAL	20190430		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	13	g/100mL			N	20241231
75936-224_0024a56b-46fc-c44e-e063-6294a90abd52	75936-224	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 215N		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-225_0037f7b6-d5e4-79ec-e063-6394a90a5891	75936-225	HUMAN OTC DRUG	Play Lip Balm with Acai Broad Spectrum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	STICK	TOPICAL	20200227		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-226_0037fc84-2880-79ee-e063-6394a90afa8a	75936-226	HUMAN OTC DRUG	Play Lip Balm Broad Spectrum SPF 30 with Mint		Avobenzone, Homosalate, Octisalate,	STICK	TOPICAL	20200228		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-227_ec570747-610d-9a9e-e053-2a95a90aa6bb	75936-227	HUMAN OTC DRUG	Play Body Mousse with Blue Sea Kale Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate	CREAM	TOPICAL	20200402		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 15; 5	g/100mL; g/100mL; g/100mL			N	20241231
75936-228_0024a56b-46fb-c44e-e063-6294a90abd52	75936-228	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 226W		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-229_0024a534-22fc-3568-e063-6294a90a637f	75936-229	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 230C		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-230_0024a56b-46f9-c44e-e063-6294a90abd52	75936-230	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 306W		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-231_0024a534-22fb-3568-e063-6294a90a637f	75936-231	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 315N		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-232_0024a534-22fa-3568-e063-6294a90a637f	75936-232	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 326W		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-233_0024a9f1-4d60-4591-e063-6394a90a9ede	75936-233	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 336W		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-234_0024a9f1-4d6c-4591-e063-6394a90a9ede	75936-234	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 346W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-236_00383c6d-2e53-391e-e063-6394a90a25b1	75936-236	HUMAN OTC DRUG	Play Everyday Sunscreen SPF 50 with Sunflower Extract		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20200101		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-237_0024d77c-9c6a-503d-e063-6294a90a3171	75936-237	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 400C		Titanium Dioxide, zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-238_0024a9f1-4d6b-4591-e063-6394a90a9ede	75936-238	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 416W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200528		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-239_0024a9f1-4d6a-4591-e063-6394a90a9ede	75936-239	HUMAN OTC DRUG	CC Screen 100% Mineral CC Cream Broad Spectrum SPF 50 426W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200521		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	4; 20	g/100mL; g/100mL			N	20241231
75936-250_0c7f1dcd-1268-bff4-e063-6294a90a74b4	75936-250	HUMAN OTC DRUG	Sunnyscreen SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20190401		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	3.4; 23.8	g/100mL; g/100mL			N	20241231
75936-252_ec0be7c6-8f41-9c89-e053-2995a90ab120	75936-252	HUMAN OTC DRUG	Sunnyscreen SPF 50		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20190402		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	10; 12	g/100mL; g/100mL			N	20241231
75936-257_00383aa5-1310-f75f-e063-6294a90ab305	75936-257	HUMAN OTC DRUG	Lip Screen Broad Spectrum SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	LIQUID	TOPICAL	20200422		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-281_0c7ddb7b-8d6f-f4ef-e063-6294a90acbb4	75936-281	HUMAN OTC DRUG	Mineral Mattescreen SPF 40		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20210518		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	1.3; 17.4	g/100mL; g/100mL			N	20241231
75936-301_00383ccc-6627-e449-e063-6294a90aae11	75936-301	HUMAN OTC DRUG	Shimmershade Broad Spectrum SPF 30 First Light		Octisalate, Zinc Oxide	CREAM	TOPICAL	20190123		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	OCTISALATE; ZINC OXIDE	5; 20	g/100g; g/100g			N	20241231
75936-302_00383c6d-2e54-391e-e063-6394a90a25b1	75936-302	HUMAN OTC DRUG	Shimmershade Broad Spectrum Sunscreen SPF 30 Golden Hour		Octisalate, Zinc Oxide	CREAM	TOPICAL	20190124		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	OCTISALATE; ZINC OXIDE	5; 20	g/100g; g/100g			N	20241231
75936-303_00383c6d-2e54-391e-e063-6394a90a25b1	75936-303	HUMAN OTC DRUG	Shimmershade Broad Spectrum Sunscreen SPF 30 Day Dream		Octisalate, Zinc Oxide	CREAM	TOPICAL	20190124		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	OCTISALATE; ZINC OXIDE	5; 20	g/100g; g/100g			N	20241231
75936-304_00383c6d-2e54-391e-e063-6394a90a25b1	75936-304	HUMAN OTC DRUG	Shimmershade Broad Spectrum Sunscreen SPF 30 Sunset		Octisalate, Zinc Oxide	CREAM	TOPICAL	20190124		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	OCTISALATE; ZINC OXIDE	5; 20	g/100g; g/100g			N	20241231
75936-305_eb5dcbf3-ad43-472a-e053-2a95a90a41ba	75936-305	HUMAN OTC DRUG	Mineral Sheer Screen Broad Spectrum Sunscreen SPF 30		Zinc Oxide	LOTION	TOPICAL	20210112		OTC MONOGRAPH FINAL	part352	Supergoop LLC	ZINC OXIDE	17.5	g/100mL			N	20241231
75936-306_eb7f867b-fd45-3612-e053-2995a90a9dda	75936-306	HUMAN OTC DRUG	Daily Dose Hydra-Ceramide Boost Broad Spectrum Sunscreen SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20210826		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 9; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-350_eb5d427d-8f9d-f885-e053-2995a90a81b9	75936-350	HUMAN OTC DRUG	Glow Screen Body Broad Spectrum Sunscreen SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20210120		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-354_de0c153a-2fcb-3a3c-e053-2995a90a59d4	75936-354	HUMAN OTC DRUG	Defense Refresh (Re)Setting Mist SPF 40		Avobenzone, Homosalate , Octisalate, Octocrylene	LIQUID	TOPICAL	20210120		OTC MONOGRAPH FINAL	part352	Supergoop LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-360_eb6941cf-882a-7479-e053-2995a90af4ef	75936-360	HUMAN OTC DRUG	Every. Single. Face. Watery SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211111		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 5; 9	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-361_eaf5c020-1204-52e6-e053-2a95a90a3b3b	75936-361	HUMAN OTC DRUG	(Re)Setting Refreshing Mist SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20220105		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-362_eac9a511-3bb8-0f13-e053-2a95a90a7af8	75936-362	HUMAN OTC DRUG	100% Mineral Broad Spectrum Sunscreen SPF 50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220204		OTC MONOGRAPH FINAL	part352	Supergoop LLC	TITANIUM DIOXIDE; ZINC OXIDE	2.3; 17.9	g/100mL; g/100mL			N	20241231
75936-363_eadbb333-51b4-1047-e053-2a95a90aafc3	75936-363	HUMAN OTC DRUG	100% Mineral Broad Spectrum Sunscreen SPF 30		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220204		OTC MONOGRAPH FINAL	part352	Supergoop LLC	ZINC OXIDE	16	g/100mL			N	20241231
75936-410_00383ccc-662a-e449-e063-6294a90aae11	75936-410	HUMAN OTC DRUG	SPF Bestsellers Starter Kit		Avobenzone, Homosalate, Octisalate, Octocrylene	KIT		20210924		OTC MONOGRAPH FINAL	part352	Supergoop, LLC						N	20241231
75936-506_eb9340a4-e57d-70fc-e053-2995a90a8991	75936-506	HUMAN OTC DRUG	SuperScreen Daily Moisturizer Broad Spectrum SPF 40		Avobenzone,Homosalate, Octisalate	LOTION	TOPICAL	20181201		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE	8; 8; 5	g/100mL; g/100mL; g/100mL			N	20241231
75936-510_eac4d65a-01a8-4a14-e053-2995a90aac0e	75936-510	HUMAN OTC DRUG	Mineral Sunscreen SPF 30		Zinc Oxide	SPRAY	TOPICAL	20170515		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	12	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75936-512_0df8da49-e163-7690-e063-6294a90a8088	75936-512	HUMAN OTC DRUG	Cloud 9 100% Mineral Sun Balm Broad Spectrum Sunscreen SPF 40		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20200820		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	1.14; 20.4	g/100g; g/100g			N	20251231
75936-514_f334ab8b-94b0-5dea-e053-2995a90ac6fd	75936-514	HUMAN OTC DRUG	HEALTHY GLOW SUNLESS TAN BROAD SPECTRUM SUNSCREEN	SPF 40	Avobenzone, Homosalate, Octinoxate, Octisalate	SPRAY	TOPICAL	20230126		OTC MONOGRAPH FINAL	M020	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	2; 10; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-601_0c69e908-40cb-9491-e063-6294a90a5420	75936-601	HUMAN OTC DRUG	Supergoop Glow Screen SPF 40	Shade 2 Golden Hour	Broad Spectrum Sunscreen	CREAM	TOPICAL	20211220		OTC MONOGRAPH DRUG	M020	Supergoop LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4; 5; 8	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
75936-602_db12a89f-5ff0-1b2a-e053-2a95a90a56f9	75936-602	HUMAN OTC DRUG	Lip Screen Sheer SPF 30		OCTOCRYLENE, AVOBENZONE, HOMOSALATE, OCTISALATE	LIPSTICK	TOPICAL	20220325		OTC MONOGRAPH FINAL	part352	Supergoop LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 5; 9	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
75936-603_eb556291-8de6-6bc4-e053-2a95a90a1494	75936-603	HUMAN OTC DRUG	(Glow)Setting 100% Mineral Powder SPF 35		ZINC OXIDE	POWDER	TOPICAL	20221018		OTC MONOGRAPH FINAL	M020	Supergoop, LLC	ZINC OXIDE	24.9	g/100g			N	20241231
75936-604_eb5bbc70-dbe0-06a8-e053-2995a90a66c1	75936-604	HUMAN OTC DRUG	Daily Dose Bioretinol Mineral SPF 40		Zinc Oxide	LIQUID	TOPICAL	20221018		OTC MONOGRAPH FINAL	M020	Supergoop, LLC	ZINC OXIDE	16.5	g/100mL			N	20241231
75936-605_ec1c30bd-76e2-9d00-e053-2a95a90a1759	75936-605	HUMAN OTC DRUG	Unseen Sunscreen Body SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20221028		OTC MONOGRAPH FINAL	M020	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-606_003895b4-0e3b-d200-e063-6394a90a1a23	75936-606	HUMAN OTC DRUG	Glowscreen SPF 40 - Dawn		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230315		OTC MONOGRAPH FINAL	M020	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-608_f7e493da-8fc7-191d-e053-6294a90aa483	75936-608	HUMAN OTC DRUG	Glowscreen SPF 40 -Sunset		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230301		OTC MONOGRAPH FINAL	M020	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-610_ee9e7841-eb11-5939-e053-2995a90ac175	75936-610	HUMAN OTC DRUG	Mineral SPF Starter Kit		Titanium Dioxide, Zinc Oxide	KIT		20230101		OTC MONOGRAPH FINAL	M020	Supergoop, LLC						N	20241231
75936-615_f93dfa13-ff19-ee38-e053-6394a90aea46	75936-615	HUMAN OTC DRUG	Lipshade SPF 30 Hey Yall		Zinc Oxide	LIPSTICK	TOPICAL	20230413		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	17.5	g/100g			N	20241231
75936-616_f93dfa13-ff19-ee38-e053-6394a90aea46	75936-616	HUMAN OTC DRUG	Lipshade SPF 30 High Five		Zinc Oxide	LIPSTICK	TOPICAL	20230413		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	17.5	g/100g			N	20241231
75936-617_f93dfa13-ff19-ee38-e053-6394a90aea46	75936-617	HUMAN OTC DRUG	Lipshade SPF 30 Love You More		Zinc Oxide	LIPSTICK	TOPICAL	20230413		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	17.5	g/100g			N	20241231
75936-618_f93dfa13-ff19-ee38-e053-6394a90aea46	75936-618	HUMAN OTC DRUG	Lipshade SPF 30 Lucky Me		Zinc Oxide	LIPSTICK	TOPICAL	20230413		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	17.5	g/100g			N	20241231
75936-619_f93dfa13-ff19-ee38-e053-6394a90aea46	75936-619	HUMAN OTC DRUG	Lipshade SPF 30 Obsessed		Zinc Oxide	LIPSTICK	TOPICAL	20230413		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	ZINC OXIDE	17.5	g/100g			N	20241231
75936-620_ff0e4e97-8f02-bd36-e053-6394a90a47ae	75936-620	HUMAN OTC DRUG	Superscreen Hydrating Daily Cream SPF 40		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20230626		OTC MONOGRAPH FINAL	part352	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 6; 5; 1.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-621_004df4e5-dbaa-6030-e063-6394a90a76d3	75936-621	HUMAN OTC DRUG	Triple Prep SPF 40		Avobenzone, Octisalate, Octocrylene, Homosalate	LOTION	TOPICAL	20230712		OTC MONOGRAPH FINAL	M020	Supergoop, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
75936-622_0801287f-0df6-4303-e063-6394a90a503b	75936-622	HUMAN OTC DRUG	ProtecTINT 10N		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-623_08671d39-3be3-d666-e063-6294a90a6207	75936-623	HUMAN OTC DRUG	Mineral Unseen Sunscreen SPF 40		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20231023		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	TITANIUM DIOXIDE; ZINC OXIDE	1.33; 17.68	g/100mL; g/100mL			N	20241231
75936-624_0801287f-0df6-4303-e063-6394a90a503b	75936-624	HUMAN OTC DRUG	ProtecTINT 14N		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-625_0801287f-0df6-4303-e063-6394a90a503b	75936-625	HUMAN OTC DRUG	ProtecTINT 20C		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-626_0801287f-0df6-4303-e063-6394a90a503b	75936-626	HUMAN OTC DRUG	ProtecTINT 22W		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-627_0801287f-0df6-4303-e063-6394a90a503b	75936-627	HUMAN OTC DRUG	ProtecTINT 24N		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-628_0801287f-0df6-4303-e063-6394a90a503b	75936-628	HUMAN OTC DRUG	ProtecTINT 26W		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-629_0801287f-0df6-4303-e063-6394a90a503b	75936-629	HUMAN OTC DRUG	ProtecTINT 30W		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-630_0801287f-0df6-4303-e063-6394a90a503b	75936-630	HUMAN OTC DRUG	ProtecTINT 32N		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-631_0801287f-0df6-4303-e063-6394a90a503b	75936-631	HUMAN OTC DRUG	ProtecTINT 34C		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-632_0801287f-0df6-4303-e063-6394a90a503b	75936-632	HUMAN OTC DRUG	ProtecTINT 40W		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-633_0801287f-0df6-4303-e063-6394a90a503b	75936-633	HUMAN OTC DRUG	ProtecTINT 42C		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-634_0801287f-0df6-4303-e063-6394a90a503b	75936-634	HUMAN OTC DRUG	ProtecTINT 46N		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-635_0801287f-0df6-4303-e063-6394a90a503b	75936-635	HUMAN OTC DRUG	ProtecTINT 52N		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-636_0801287f-0df6-4303-e063-6394a90a503b	75936-636	HUMAN OTC DRUG	ProtecTINT 58W		Homosalate, Octisalate, Zinc Oxide	CREAM	TOPICAL	20231122		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	7; 5; 13.58	g/100mL; g/100mL; g/100mL			N	20241231
75936-637_0beed72e-51e0-d15a-e063-6394a90af559	75936-637	HUMAN OTC DRUG	Mineral Sheer Stick		Zinc Oxide	STICK	TOPICAL	20231213		OTC MONOGRAPH DRUG	M020	Supergoop, LLC	ZINC OXIDE	16	g/100g			N	20241231
75940-171_6c7c7bed-7527-44ce-9616-f155db2e4753	75940-171	HUMAN OTC DRUG	Herklin		Piperonyl butoxide and Pyrethrum extract	SHAMPOO	TOPICAL	20171029		OTC MONOGRAPH FINAL	part358G	MarcusUSA	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	40; .033	mg/mL; mg/mL			N	20241231
75940-192_3fbdf14a-eb00-4fd1-b00e-01f8354f04cb	75940-192	HUMAN OTC DRUG	Herklin Lice Treatment		Piperonyl butoxide, Pyrethrum extract	SHAMPOO	TOPICAL	20180716		OTC MONOGRAPH FINAL	part358G	MarcasUSA LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
75981-063_b1476ee2-5437-40b4-9954-6b0ef27a3547	75981-063	HUMAN OTC DRUG	Calamine		FERRIC OXIDE RED	LOTION	TOPICAL	19920915		OTC MONOGRAPH DRUG	M016	Perrigo Direct, Inc.	FERRIC OXIDE RED; ZINC OXIDE	8; 8	mg/mL; mg/mL			N	20241231
75981-069_6d4ea6ab-823f-4048-bcf8-2dbb176b9a7a	75981-069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	19920615		OTC MONOGRAPH FINAL	part347	Perrigo Direct, Inc.	PETROLATUM	1	g/g			N	20241231
75981-370_c3913133-6e96-492e-b30a-a83fea62e478	75981-370	HUMAN OTC DRUG	Advanced		Ethyl Alcohol	GEL	TOPICAL	20120920		OTC MONOGRAPH NOT FINAL	part333A	Perrigo Direct, Inc	ALCOHOL	70	mL/100mL			N	20241231
75981-909_63dfbd79-5a38-4a50-a1f5-5dd2f0863544	75981-909	HUMAN OTC DRUG	Beauty Hydrating		Octinoxate, Zinc Oxide	LOTION	TOPICAL	20061108		OTC MONOGRAPH NOT FINAL	part352	Geiss, Destin + Dunn, Inc	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
75983-008_a7bd9e62-6841-524e-e053-2a95a90af7b9	75983-008	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70%		Isopropyl Alcohol	LIQUID	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part333A	First Aid Research Corp.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
75987-010_3eae7ae8-f4f3-4cab-8f44-d48b524d3138	75987-010	HUMAN PRESCRIPTION DRUG	DUEXIS		Ibuprofen and Famotidine	TABLET, COATED	ORAL	20111205	20250831	NDA	NDA022519	Horizon Therapeutics USA, Inc.	FAMOTIDINE; IBUPROFEN	26.6; 800	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
75987-020_96a17428-b512-4fd9-a64d-50160d22aaaa	75987-020	HUMAN PRESCRIPTION DRUG	RAYOS		prednisone	TABLET, DELAYED RELEASE	ORAL	20120727		NDA	NDA202020	Horizon Therapeutics USA, Inc.	PREDNISONE	1	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
75987-021_96a17428-b512-4fd9-a64d-50160d22aaaa	75987-021	HUMAN PRESCRIPTION DRUG	RAYOS		prednisone	TABLET, DELAYED RELEASE	ORAL	20120727		NDA	NDA202020	Horizon Therapeutics USA, Inc.	PREDNISONE	2	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
75987-022_96a17428-b512-4fd9-a64d-50160d22aaaa	75987-022	HUMAN PRESCRIPTION DRUG	RAYOS		prednisone	TABLET, DELAYED RELEASE	ORAL	20120727		NDA	NDA202020	Horizon Therapeutics USA, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
75987-030_500596e1-ef8d-4845-ad4c-1de8fd0ec0a1	75987-030	HUMAN PRESCRIPTION DRUG	Vimovo		Naproxen and Esomeprazole Magnesium	TABLET, DELAYED RELEASE	ORAL	20100706		NDA	NDA022511	Horizon Therapeutics USA, Inc.	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 500	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
75987-031_500596e1-ef8d-4845-ad4c-1de8fd0ec0a1	75987-031	HUMAN PRESCRIPTION DRUG	Vimovo		Naproxen and Esomeprazole Magnesium	TABLET, DELAYED RELEASE	ORAL	20100706		NDA	NDA022511	Horizon Therapeutics USA, Inc.	ESOMEPRAZOLE MAGNESIUM; NAPROXEN	20; 375	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
75987-040_e720bcad-48f2-4af3-a895-c1a119c8d423	75987-040	HUMAN PRESCRIPTION DRUG	Pennsaid		diclofenac sodium	SOLUTION	TOPICAL	20140203	20260731	NDA	NDA204623	Horizon Therapeutics USA, Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
75987-050_1e0214e6-fd39-4eec-a65d-3122f98b2c6e	75987-050	HUMAN PRESCRIPTION DRUG	Ravicti		glycerol phenylbutyrate	LIQUID	ORAL	20130228		NDA	NDA203284	Horizon Therapeutics USA, Inc.	GLYCEROL PHENYLBUTYRATE	1.1	g/mL			N	20241231
75987-060_fc7c51c0-ed77-459c-8dad-aabeb9d863d2	75987-060	HUMAN PRESCRIPTION DRUG	BUPHENYL		sodium phenylbutyrate	TABLET	ORAL	19960513		NDA	NDA020572	Horizon Therapeutics USA, Inc.	SODIUM PHENYLBUTYRATE	500	mg/1	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
75987-070_fc7c51c0-ed77-459c-8dad-aabeb9d863d2	75987-070	HUMAN PRESCRIPTION DRUG	Buphenyl		sodium phenylbutyrate	POWDER	ORAL	19960430		NDA	NDA020573	Horizon Therapeutics USA, Inc.	SODIUM PHENYLBUTYRATE	.94	g/g	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
75987-080_5cd1b348-e083-4b70-855b-eb440e5b4b57	75987-080	HUMAN PRESCRIPTION DRUG	Krystexxa		pegloticase	INJECTION, SOLUTION	INTRAVENOUS	20100914		BLA	BLA125293	Horizon Therapeutics USA, Inc.	PEGLOTICASE	8	mg/mL	Urate Oxidase [CS], Uric Acid-specific Enzyme [EPC]		N	20241231
75987-100_e1483d82-8f0b-418b-bd27-6b0bab353f53	75987-100	HUMAN PRESCRIPTION DRUG	PROCYSBI		Cysteamine bitartrate	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130430		NDA	NDA203389	Horizon Therapeutics USA, Inc.	CYSTEAMINE BITARTRATE	25	mg/1	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
75987-101_e1483d82-8f0b-418b-bd27-6b0bab353f53	75987-101	HUMAN PRESCRIPTION DRUG	PROCYSBI		Cysteamine bitartrate	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20130430		NDA	NDA203389	Horizon Therapeutics USA, Inc.	CYSTEAMINE BITARTRATE	75	mg/1	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
75987-111_10c38fa8-bbf3-40e5-83dc-bc105723a442	75987-111	HUMAN PRESCRIPTION DRUG	ACTIMMUNE		Interferon gamma-1b	INJECTION, SOLUTION	SUBCUTANEOUS	20131201		BLA	BLA103836	Horizon Therapeutics USA, Inc.	INTERFERON GAMMA-1B	100	ug/.5mL	Interferon gamma [EPC], Interferon-gamma [CS]		N	20241231
75987-130_8d1559f0-64a5-4c69-8818-c31f248c9b5f	75987-130	HUMAN PRESCRIPTION DRUG	TEPEZZA		teprotumumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200121		BLA	BLA761143	Horizon Therapeutics USA, Inc.	TEPROTUMUMAB	500	mg/1	Insulin-like Growth Factor-1 Receptor Inhibitor [EPC], Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]		N	20241231
75987-140_e1483d82-8f0b-418b-bd27-6b0bab353f53	75987-140	HUMAN PRESCRIPTION DRUG	PROCYSBI		Cysteamine bitartrate	GRANULE, DELAYED RELEASE	ORAL	20200214		NDA	NDA213491	Horizon Therapeutics USA, Inc.	CYSTEAMINE BITARTRATE	75	mg/1	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
75987-145_e1483d82-8f0b-418b-bd27-6b0bab353f53	75987-145	HUMAN PRESCRIPTION DRUG	PROCYSBI		Cysteamine bitartrate	GRANULE, DELAYED RELEASE	ORAL	20200214		NDA	NDA213491	Horizon Therapeutics USA, Inc.	CYSTEAMINE BITARTRATE	300	mg/1	Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA]		N	20241231
75987-150_9798b7eb-ddc0-4efb-8f92-bf6a82dbf269	75987-150	HUMAN PRESCRIPTION DRUG	UPLIZNA		Inebilizumab	INJECTION	INTRAVENOUS	20200611		BLA	BLA761142	Horizon Therapeutics USA, Inc.	INEBILIZUMAB	10	mg/mL	CD19-directed Antibody Interactions [MoA], CD19-directed Cytolytic Antibody [EPC]		N	20241231
75990-457_ee9d0554-864d-44d9-e053-2a95a90ac816	75990-457	HUMAN OTC DRUG	Secure Hand Sanitizer		BENZEALKONIUM CHLORIDE	LIQUID	TOPICAL	20200605		OTC MONOGRAPH NOT FINAL	part333E	Certus Medical, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
75990-605_eeb15c36-2fc6-1d6d-e053-2995a90aa4b3	75990-605	HUMAN OTC DRUG	Recens		ALCOHOL	GEL	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333E	Certus Medical, Inc.	ALCOHOL	.7	mL/mL			N	20241231
75990-739_e5d05269-6696-a1a2-e053-2995a90aea45	75990-739	HUMAN OTC DRUG	Florens Antiseptic Handsoap		CHLOROXYLENOL	SOAP	TOPICAL	20220824		OTC MONOGRAPH NOT FINAL	part333E	Certus Medical, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
75990-783_d2d39adf-db42-4f23-961f-e4c858df34b3	75990-783	HUMAN OTC DRUG	Recens Hand Sanitizer Wipes		ALCOHOL	CLOTH	TOPICAL	20110923		OTC MONOGRAPH NOT FINAL	part333E	Certus Medical, Inc.	ALCOHOL	620	mg/g			N	20241231
75990-914_ea49da65-ae5f-bfde-e053-2a95a90adef2	75990-914	HUMAN OTC DRUG	Satin Foam High Foaming Antiseptic Hand Wash		CHLOROXYLENOL	SOAP	TOPICAL	20221005		OTC MONOGRAPH NOT FINAL	part333E	Certus Medical, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
75990-968_ea3864c4-d9b7-364d-e053-2995a90aba1a	75990-968	HUMAN OTC DRUG	Recens Foam		ALCOHOL	LIQUID	TOPICAL	20221004		OTC MONOGRAPH NOT FINAL	part333E	Certus Medical, Inc.	ALCOHOL	.7	mL/mL			N	20241231
76018-100_09e20d45-bfaf-e303-e063-6394a90a445f	76018-100	HUMAN OTC DRUG	Arth Arrest		METHYL NICOTINATE, CAPSAICIN	CREAM	TOPICAL	20110211		OTC MONOGRAPH DRUG	M017	Key 2 Health, Inc.	CAPSAICIN; METHYL NICOTINATE	.025; .5	g/100g; g/100g	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
76020-100_09751799-665e-ec58-e063-6394a90aea39	76020-100	HUMAN OTC DRUG	HomeHealth Antifungal		TOLNAFTATE	LOTION	TOPICAL	20110214		OTC MONOGRAPH DRUG	M005	Home Health	TOLNAFTATE	10	mg/mL			N	20241231
76020-200_09751799-666d-ec58-e063-6394a90aea39	76020-200	HUMAN OTC DRUG	Home Health Everclean Antidandruff		SALICYLIC ACID	SHAMPOO	TOPICAL	20110214		OTC MONOGRAPH DRUG	M032	Home Health	SALICYLIC ACID	1.8	g/100mL			N	20241231
76020-300_09759b68-4bf3-c41f-e063-6294a90a62a4	76020-300	HUMAN OTC DRUG	Home Health Psoriasis Medicated Scalp and Body Wash		SALICYLIC ACID	LIQUID	TOPICAL	20110212		OTC MONOGRAPH DRUG	M032	Home Health	SALICYLIC ACID	2	g/100mL			N	20241231
76038-404_f5dc9661-fa30-f1e1-e053-2995a90ab892	76038-404	HUMAN OTC DRUG	KENDA CARE INSTANT HAND SANITIZER	70 PERCENT	ETHYL ALCOHOL	GEL	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part333E	MICRO CONNECTION ENTERPRISES INC	ALCOHOL	70	mL/100mL			N	20241231
76045-001_e7017885-3716-474c-bfc4-cda89069132c	76045-001	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20141003		ANDA	ANDA203460	Fresenius Kabi USA, LLC	MIDAZOLAM HYDROCHLORIDE	2	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76045-002_e7017885-3716-474c-bfc4-cda89069132c	76045-002	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20141003		ANDA	ANDA203460	Fresenius Kabi USA, LLC	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76045-003_e7017885-3716-474c-bfc4-cda89069132c	76045-003	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20141003		ANDA	ANDA203460	Fresenius Kabi USA, LLC	MIDAZOLAM HYDROCHLORIDE	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76045-004_37b9ad12-9117-471a-9362-e0a5e7031a1e	76045-004	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi, USA LLC	MORPHINE SULFATE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-004_9f4a86d2-5469-4bf2-b854-34b160feac04	76045-004	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76045-005_37b9ad12-9117-471a-9362-e0a5e7031a1e	76045-005	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi, USA LLC	MORPHINE SULFATE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-005_9f4a86d2-5469-4bf2-b854-34b160feac04	76045-005	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	4	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76045-006_37b9ad12-9117-471a-9362-e0a5e7031a1e	76045-006	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi, USA LLC	MORPHINE SULFATE	5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-006_9f4a86d2-5469-4bf2-b854-34b160feac04	76045-006	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	5	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76045-007_37b9ad12-9117-471a-9362-e0a5e7031a1e	76045-007	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi, USA LLC	MORPHINE SULFATE	8	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-007_9f4a86d2-5469-4bf2-b854-34b160feac04	76045-007	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	8	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76045-008_37b9ad12-9117-471a-9362-e0a5e7031a1e	76045-008	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi, USA LLC	MORPHINE SULFATE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-008_9f4a86d2-5469-4bf2-b854-34b160feac04	76045-008	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20131030		NDA	NDA204223	Fresenius Kabi USA, LLC	MORPHINE SULFATE	10	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76045-009_d2fe0d3b-8eb6-4e54-8418-642f330abbf7	76045-009	HUMAN PRESCRIPTION DRUG	Dilaudid		Hydromorphone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20181204		NDA	NDA019034	Fresenius Kabi USA, LLC	HYDROMORPHONE HYDROCHLORIDE	1	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-010_d2fe0d3b-8eb6-4e54-8418-642f330abbf7	76045-010	HUMAN PRESCRIPTION DRUG	Dilaudid		Hydromorphone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20161216		NDA	NDA019034	Fresenius Kabi USA, LLC	HYDROMORPHONE HYDROCHLORIDE	2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-023_2d066d8f-6b6f-4cf8-ae9a-b77fe8b2398a	76045-023	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20220421		NDA	NDA214919	Fresenius Kabi USA, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
76045-101_4a411ded-d608-41d3-bb26-67d5d5d3c9b5	76045-101	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130503		ANDA	ANDA091392	Fresenius Kabi USA, LLC	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/2mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
76045-102_7ac2810d-c4c6-42de-8ea6-cb84002ae1e7	76045-102	HUMAN PRESCRIPTION DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130326		ANDA	ANDA091526	Fresenius Kabi USA, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76045-103_b71a45e3-2b90-4199-b88b-fef27cb394fc	76045-103	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151210		ANDA	ANDA202253	Fresenius Kabi USA, LLC	ONDANSETRON HYDROCHLORIDE	4	mg/2mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
76045-104_0dab642d-7fcf-4301-8ac9-10e64a040c6b	76045-104	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151102		ANDA	ANDA203242	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76045-105_0dab642d-7fcf-4301-8ac9-10e64a040c6b	76045-105	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20151102		ANDA	ANDA203242	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76045-106_916ef348-1e5b-40b4-9d12-508fc2ce567c	76045-106	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20151030		ANDA	ANDA203129	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76045-107_0dab642d-7fcf-4301-8ac9-10e64a040c6b	76045-107	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20151102		ANDA	ANDA203242	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76045-108_151a54ec-f7e5-4e6d-9810-cbfa75a16a22	76045-108	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20160610		ANDA	ANDA206552	Fresenius Kabi USA, LLC	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
76045-109_636f2f86-1cf7-43c3-94ca-f6a42756ada0	76045-109	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS	20180706		ANDA	ANDA209192	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76045-121_d2fe0d3b-8eb6-4e54-8418-642f330abbf7	76045-121	HUMAN PRESCRIPTION DRUG	Dilaudid		Hydromorphone hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20161216		NDA	NDA019034	Fresenius Kabi USA, LLC	HYDROMORPHONE HYDROCHLORIDE	.2	mg/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20251231
76045-203_d8f5e3e4-34e3-4e52-b76d-69e210e649d5	76045-203	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20180725		ANDA	ANDA209024	Fresenius Kabi USA, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
76045-204_710cd250-847e-4da1-8488-1708fd9eb610	76045-204	HUMAN PRESCRIPTION DRUG	Diazepam		DIAZEPAM	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20221110		ANDA	ANDA214745	Fresenius Kabi USA, LLC	DIAZEPAM	10	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76045-206_d8f5e3e4-34e3-4e52-b76d-69e210e649d5	76045-206	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201030		ANDA	ANDA209024	Fresenius Kabi USA, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
76045-208_d8f5e3e4-34e3-4e52-b76d-69e210e649d5	76045-208	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20201030		ANDA	ANDA209024	Fresenius Kabi USA, LLC	GLYCOPYRROLATE	.2	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
76045-209_0dab642d-7fcf-4301-8ac9-10e64a040c6b	76045-209	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20200901		ANDA	ANDA203242	Fresenius Kabi USA, LLC	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76045-210_bb59f9e1-0d67-4c51-85e5-b09199464b91	76045-210	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20201130		ANDA	ANDA203129	Fresenius Kabi USA, LLC	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76045-211_e7017885-3716-474c-bfc4-cda89069132c	76045-211	HUMAN PRESCRIPTION DRUG	Midazolam		Midazolam Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210416		ANDA	ANDA203460	Fresenius Kabi USA, LLC	MIDAZOLAM HYDROCHLORIDE	2	mg/2mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76045-213_4a411ded-d608-41d3-bb26-67d5d5d3c9b5	76045-213	HUMAN PRESCRIPTION DRUG	Metoclopramide		Metoclopramide Hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20130503		ANDA	ANDA091392	Fresenius Kabi USA, LLC	METOCLOPRAMIDE HYDROCHLORIDE	10	mg/2mL	Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]		N	20241231
76045-214_13bcbf72-e861-475e-9bc4-db78498caba0	76045-214	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20180918		NDA	NDA203629	Fresenius Kabi USA, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
76045-216_b71a45e3-2b90-4199-b88b-fef27cb394fc	76045-216	HUMAN PRESCRIPTION DRUG	ONDANSETRON		ONDANSETRON HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20220531		ANDA	ANDA202253	Fresenius Kabi USA, LLC	ONDANSETRON HYDROCHLORIDE	4	mg/2mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
76045-383_13bcbf72-e861-475e-9bc4-db78498caba0	76045-383	HUMAN PRESCRIPTION DRUG	Neostigmine Methylsulfate		Neostigmine Methylsulfate	INJECTION, SOLUTION	INTRAVENOUS	20180918		NDA	NDA203629	Fresenius Kabi USA, LLC	NEOSTIGMINE METHYLSULFATE	1	mg/mL	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
76045-737_740165fb-1e22-44ae-bc3e-3b66a6862c1a	76045-737	HUMAN PRESCRIPTION DRUG	Haloperidol		haloperidol lactate	INJECTION, SOLUTION	INTRAMUSCULAR	20190701		ANDA	ANDA210356	Fresenius Kabi USA, LLC	HALOPERIDOL LACTATE	5	mg/mL	Typical Antipsychotic [EPC]		N	20241231
76069-100_0975eb87-fa94-1621-e063-6394a90a9880	76069-100	HUMAN OTC DRUG	Arth RX Topical Analgesic		METHYL NICOTINATE, CAPSAICIN	LOTION	TOPICAL	20110212		OTC MONOGRAPH DRUG	M017	HCD Sales	CAPSAICIN; METHYL NICOTINATE	.025; .5	g/100g; g/100g	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
76075-101_703533f9-fc6c-4d67-bc41-40f99fb2e0df	76075-101	HUMAN PRESCRIPTION DRUG	KYPROLIS		carfilzomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20120720		NDA	NDA202714	Onyx Pharmaceuticals, Inc.	CARFILZOMIB	60	mg/30mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
76075-102_703533f9-fc6c-4d67-bc41-40f99fb2e0df	76075-102	HUMAN PRESCRIPTION DRUG	KYPROLIS		carfilzomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20160715		NDA	NDA202714	Onyx Pharmaceuticals, Inc.	CARFILZOMIB	30	mg/15mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
76075-103_703533f9-fc6c-4d67-bc41-40f99fb2e0df	76075-103	HUMAN PRESCRIPTION DRUG	KYPROLIS		carfilzomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180523		NDA	NDA202714	Onyx Pharmaceuticals, Inc.	CARFILZOMIB	10	mg/5mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
76091-002_fd6c803a-bd1c-4596-b192-81d7b0b0bcde	76091-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20190101		NDA	NDA206023	Support Medical Systems, Inc.	OXYGEN	99	L/100L			N	20241231
76095-010_eb00f3b1-ba62-57ff-e053-2995a90a4787	76095-010	HUMAN OTC DRUG	Cold Medicine	XL3 FORTE	Acetaminophen Chlorpheniramine Maleate Phenylepherine Hydrochloride	TABLET	ORAL	20170801		OTC MONOGRAPH FINAL	M012	MIDWAY IMPORTING INC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76095-011_e41b9beb-e275-5c02-e053-2995a90ad0f8	76095-011	HUMAN OTC DRUG	Cold Medicine	XL3	Acetaminophen Chlorpheniramine Maleate Phenylepherine Hydrochloride	TABLET	ORAL	20220627		OTC MONOGRAPH FINAL	part341	Midway Importing, Inc.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 2; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76095-012_eb00ebef-f821-3abb-e053-2995a90ac9b7	76095-012	HUMAN OTC DRUG	Mucus Relief Xpect		Guaifensin, Dextromethorphan	TABLET	ORAL	20210517		OTC MONOGRAPH FINAL	M012	Midway Importing Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76102-029_09e235ab-ce1a-ad20-e063-6294a90a90a3	76102-029	HUMAN OTC DRUG	Bakers Best Arthritis Pain Relief with Hemp Seed		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20190708		OTC MONOGRAPH DRUG	M017	Baker's Best Health Products, LLC	HISTAMINE DIHYDROCHLORIDE	.3	mg/g			N	20241231
76102-030_09e2382c-480d-e207-e063-6394a90a3997	76102-030	HUMAN OTC DRUG	Bakers Best Arthritis Pain Relief		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20190708		OTC MONOGRAPH DRUG	M017	Baker's Best Health Products, LLC	HISTAMINE DIHYDROCHLORIDE	.3	mg/g			N	20241231
76102-031_0975bb48-2470-e8bd-e063-6394a90ae8d9	76102-031	HUMAN OTC DRUG	Bakers Best Maximum Strength Pain Relief		LIDOCAINE HYDROCHLORIDE, MENTHOL	CREAM	TOPICAL	20190708		OTC MONOGRAPH DRUG	M017	Baker's Best Health Products, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76102-329_097603dc-2280-2bef-e063-6294a90a1bdd	76102-329	HUMAN OTC DRUG	BAKERS BEST Arthritis Pain Relief Cream with Hemp and Lavender		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20220116		OTC MONOGRAPH DRUG	M017	BAKER'S BEST HEALTH PRODUCTS, INC.	HISTAMINE DIHYDROCHLORIDE	.3	mg/g			N	20241231
76102-389_0975c654-f32e-1c35-e063-6394a90a0ba2	76102-389	HUMAN OTC DRUG	BAKERS BEST Pain Relief with Pure Hemp Seed Oil		LIDOCAINE HYDROCHLORIDE, MENTHOL	CREAM	TOPICAL	20230203		OTC MONOGRAPH DRUG	M017	BAKER'S BEST HEALTH PRODUCTS, INC.	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76117-001_97b756b2-7fa2-fc74-e053-2995a90a4588	76117-001	HUMAN OTC DRUG	Rycontuss	Cherry Flavor	CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20110531		OTC MONOGRAPH FINAL	part341	Okendpharma, Inc.	CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76123-121_0a533dba-d9b9-22dd-e063-6294a90aa5aa	76123-121	HUMAN OTC DRUG	School Health Sterile Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20120503		OTC MONOGRAPH DRUG	M003	School Health Corporation	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
76123-200_51733cbf-04a6-46e1-b704-9dd158723183	76123-200	HUMAN OTC DRUG	School Health Alcohol-free Hand Sanitizer Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221031		OTC MONOGRAPH NOT FINAL	part333A	School Health Corporation	BENZALKONIUM CHLORIDE	.1	g/1			N	20241231
76125-150_5e5c130a-693b-47f9-b44a-3d8f9cde3f98	76125-150	PLASMA DERIVATIVE	KEDRAB		HUMAN RABIES VIRUS IMMUNE GLOBULIN	INJECTION, SOLUTION	INTRAMUSCULAR	20171108		BLA	BLA125613	Kedrion Biopharma Inc.	HUMAN RABIES VIRUS IMMUNE GLOBULIN	150	[iU]/mL			N	20241231
76125-250_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-250	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT		19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-253_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-253	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-256_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-256	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-257_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-257	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-258_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-258	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-259_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-259	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-661_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-661	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-662_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-662	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-663_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-663	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-665_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-665	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-667_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-667	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT		19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-668_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-668	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-672_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-672	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT		19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-674_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-674	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-675_39b47b35-753a-47ca-aa93-3ec34e28b599	76125-675	PLASMA DERIVATIVE	Koate		Antihemophilic Factor (Human)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-676_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-676	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-678_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-678	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-679_703c908c-e602-4a36-9b58-1ba7206d18ea	76125-679	PLASMA DERIVATIVE	Koate		ANTIHEMOPHILIC FACTOR (HUMAN)	KIT	INTRAVENOUS	19990520		BLA	BLA101130	KEDRION BIOPHARMA, INC.						N	20241231
76125-790_2b3f8934-dbf3-45c0-89c1-616385112b80	76125-790	PLASMA DERIVATIVE	Albuked		Albumin (Human)	SOLUTION	INTRAVENOUS	19760826		BLA	BLA101138	KEDRION BIOPHARMA, INC.	ALBUMIN HUMAN	2.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
76125-791_0d86d9cc-a63a-4905-9620-deb24eed170e	76125-791	PLASMA DERIVATIVE	Albuked		Albumin (Human)	SOLUTION	INTRAVENOUS	19810728		BLA	BLA101138	KEDRION BIOPHARMA, INC.	ALBUMIN HUMAN	10	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
76125-792_b3da7fba-1de6-4ec3-bf9c-63ef9e041278	76125-792	PLASMA DERIVATIVE	Albuked		Albumin (Human)	SOLUTION	INTRAVENOUS	19421021		BLA	BLA101138	KEDRION BIOPHARMA, INC.	ALBUMIN HUMAN	5	g/20mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
76125-900_a7b621b8-b33b-4ece-b7ba-7d63f8ec7018	76125-900	PLASMA DERIVATIVE	GAMMAKED		Immune Globulin (Human)	INJECTION	INTRAVENOUS; SUBCUTANEOUS	20101013		BLA	BLA125046	KEDRION BIOPHARMA, INC.	HUMAN IMMUNOGLOBULIN G	10	g/100mL	Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]		N	20241231
76128-155_a7f07012-d2d3-45b0-b8b6-818a3fc06fff	76128-155	HUMAN PRESCRIPTION DRUG	Photofrin		Porfimer Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	19951227		NDA	NDA020451	Pinnacle Biologics, Inc.	PORFIMER SODIUM	75	mg/31.8mL	Photoabsorption [MoA], Photoactivated Radical Generator [EPC], Photosensitizing Activity [PE]		N	20241231
76138-112_039b79f9-840c-4172-b3e5-125718458c42	76138-112	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Ethyl alcohol	SPRAY	TOPICAL	20160102		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties Inc	ALCOHOL	62	mL/100mL			N	20241231
76138-112_e102d240-ae6d-46b3-bb94-557dbd093f95	76138-112	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Ethyl alcohol	SPRAY	TOPICAL	20160102		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties Inc	ALCOHOL	62	mL/100mL			N	20241231
76138-113_43712caa-6e33-4cbf-879d-0079ecb1a5fb	76138-113	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160102		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties Inc	ALCOHOL	62	mL/100mL			N	20241231
76138-113_7a07c9fc-a557-495b-8942-598fdb91e17a	76138-113	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20160102		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties Inc	ALCOHOL	62	mL/100mL			N	20241231
76138-113_e5e29f5a-2a45-47c9-8a16-fcab01c761a5	76138-113	HUMAN OTC DRUG	ANTISEPTIC HAND SANITIZER		Ethyl Alcohol	GEL	TOPICAL	20160102		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties Inc	ALCOHOL	62	mL/100mL			N	20241231
76138-113_ff6a8a9f-f1b8-4ffc-b021-ea9a16d91b19	76138-113	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20160102		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties Inc	ALCOHOL	62	mL/100mL			N	20241231
76138-114_c46eb906-ee2d-4617-bc87-310b3e0ee84b	76138-114	HUMAN OTC DRUG	Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20160102		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties Inc	ALCOHOL	62	mL/100mL			N	20241231
76138-116_ec19a705-4f69-4bc8-a569-400672108326	76138-116	HUMAN OTC DRUG	5406 hand sanitizer		Ethyl alcohol	GEL	TOPICAL	20180711		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties	ALCOHOL	62	mL/100mL			N	20241231
76138-117_210602d1-a762-4e78-bb8a-5d996ade7181	76138-117	HUMAN OTC DRUG	5253 hand sanitizer		Ethyl alcohol	GEL	TOPICAL	20180716		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties	ALCOHOL	62	mL/100mL			N	20241231
76138-120_dbf006f9-7ac0-4f9e-a2fb-263353ab3f3f	76138-120	HUMAN OTC DRUG	5259 HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20190425		OTC MONOGRAPH NOT FINAL	part333A	Innovation Specialties	ALCOHOL	62	mL/100mL			N	20241231
76138-219_6744266a-f0f5-482f-87f8-274fde0b956e	76138-219	HUMAN OTC DRUG	5281 SUNSCREEN		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20220510		OTC MONOGRAPH FINAL	part352	Innovation Specialties	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76138-220_90e098cc-45b5-490b-badd-5d870f60707a	76138-220	HUMAN OTC DRUG	5298 SUNSCREEN		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20220510		OTC MONOGRAPH FINAL	part352	Innovation Specialties	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76138-221_77e045ff-b147-494c-8ca0-56d037a89931	76138-221	HUMAN OTC DRUG	5299 SUNSCREEN		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20220510		OTC MONOGRAPH FINAL	part352	Innovation Specialties	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76138-222_72479495-f756-4bcd-8ffd-4800fe5e7c27	76138-222	HUMAN OTC DRUG	5283 Sunscreen		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Innovation Specialties	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76138-223_af850957-4fbb-4e00-884a-fe3618db03bd	76138-223	HUMAN OTC DRUG	5407 Sunscreen		Avobenzone, Homosalate, Octocrylene, Octisalate	LOTION	TOPICAL	20231031		OTC MONOGRAPH DRUG	M020	Innovation Specialties	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76144-000_0c5b797d-1b54-4a3e-e063-6394a90a9d6d	76144-000	HUMAN OTC DRUG	PAULAS CHOICE HYDRALIGHT SHINE-FREE DAILY MINERAL COMPLEX Broad Spectrum SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20130411		OTC MONOGRAPH DRUG	M020	Paula's Choice, Inc	TITANIUM DIOXIDE; ZINC OXIDE	23.2; 60	mg/mL; mg/mL			N	20241231
76147-123_0c5b6cd3-e1b5-5a83-e063-6394a90aa65c	76147-123	HUMAN OTC DRUG	StriVectin-SH NIA-114 UVA UVB Shields SPF 30		HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20110406		OTC MONOGRAPH DRUG	M020	StriVectin Operating Company Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 75; 50; 26; 20	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76147-230_06d1650d-74d1-d159-e063-6394a90a2a12	76147-230	HUMAN OTC DRUG	StriVectin Advanced Retinol Day Moisturizer Broad Spectrum SPF30		Avobenzone, Octinoxate, Octisalate, Octocrylene, Oxybenzone	CREAM	TOPICAL	20150407	20241130	OTC MONOGRAPH DRUG	M020	StriVectin Operating Company, Inc.	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 75; 50; 27; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	
76147-232_06d2fc91-dbd3-b44f-e063-6394a90a7b9f	76147-232	HUMAN OTC DRUG	StriVectin Advanced SPF Full Screen	Illuminating	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191204		OTC MONOGRAPH DRUG	M020	StriVectin Operating Company, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 4.5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76147-233_06bdcb1d-8d42-f233-e063-6394a90a9b18	76147-233	HUMAN OTC DRUG	StriVectin Advanced SPF Full Screen	Vanishing Tint	ZINC OXIDE	LOTION	TOPICAL	20191204		OTC MONOGRAPH DRUG	M020	StriVectin Operating Company, Inc.	ZINC OXIDE	16	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76147-234_06bdb03b-3406-c4b9-e063-6394a90ad3e3	76147-234	HUMAN OTC DRUG	StriVectin Advanced SPF Full Screen	Clear Finish	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20191204		OTC MONOGRAPH DRUG	M020	StriVectin Operating Company, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 9; 4.5; 8.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76147-235_06bd9bd7-d81e-8203-e063-6294a90a6c1e	76147-235	HUMAN OTC DRUG	StriVectin multi-action Super-C SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20210422		OTC MONOGRAPH DRUG	M020	StriVectin Operating Company, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 4.5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76147-236_06d1650d-74df-d159-e063-6394a90a2a12	76147-236	HUMAN OTC DRUG	StriVectin Advanced Retinol Daily Repair Moisturizer	SPF30	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211031		OTC MONOGRAPH DRUG	M020	StriVectin Operating Company, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.7; 6.3; 4.05; 9	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76147-240_06bdc935-3483-9a20-e063-6294a90a1d1f	76147-240	HUMAN OTC DRUG	StriVectin ANTI-WRINKLE GLOWFECTOR	SPF 30	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20221111		OTC MONOGRAPH DRUG	M020	StriVectin Operating Company, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 7; 4.5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76147-301_06bedb97-d7d2-ea46-e063-6394a90a8696	76147-301	HUMAN OTC DRUG	MULTI-ACTION CLEAR - ACNE CLEARING TREATMENT	2% SALICYLIC ACID	SALICYLIC ACID	LOTION	TOPICAL	20230109		OTC MONOGRAPH DRUG	M006	StriVectin Operating Company, Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
76150-261_f643e4b7-b8e5-35ee-e053-2a95a90a9879	76150-261	HUMAN OTC DRUG	Habit	SPF 41	Facial	SPRAY	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part352	Bell International Laboratories, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.8; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76150-271_04b92c08-1092-3f9a-e063-6394a90a0be5	76150-271	HUMAN OTC DRUG	Hand Savior Radiance Boosting Serum		Hand Sanitizer	LIQUID	TOPICAL	20210226		OTC MONOGRAPH NOT FINAL	part333A	Bell International Laboratories, Inc	ALCOHOL	60	mL/100mL			N	20241231
76150-293_f6440282-4633-f9d2-e053-2995a90afbe2	76150-293	HUMAN OTC DRUG	Sunlight Daily Facial	SPF 30	Sunscreen	LOTION	TOPICAL	20210414		OTC MONOGRAPH NOT FINAL	part352	Bell International Laboratories, Inc	ZINC OXIDE	12.5	g/100mL			N	20241231
76151-105_0c5b6a69-0a76-0f46-e063-6294a90a4fca	76151-105	HUMAN OTC DRUG	Oil-Free Daily Hydration SPF 15		OCTINOXATE, AVOBENZONE	CREAM	TOPICAL	20110416		OTC MONOGRAPH DRUG	M020	Boscia LLC	AVOBENZONE; OCTINOXATE	30; 50	mg/mL; mg/mL			N	20241231
76151-106_0c5b74ab-a044-2667-e063-6294a90a757e	76151-106	HUMAN OTC DRUG	Boscia Daily Hydration SPF 15 Broad Spectrum For Normal To Oily Skin		AVOBENZONE, OCTINOXATE	CREAM	TOPICAL	20121108		OTC MONOGRAPH DRUG	M020	Boscia LLC	AVOBENZONE; OCTINOXATE	30; 60	mg/mL; mg/mL			N	20241231
76151-207_0c5b797d-1b65-4a3e-e063-6394a90a9d6d	76151-207	HUMAN OTC DRUG	Restorative Day Moisture SPF 15		OCTINOXATE, AVOBENZONE	CREAM	TOPICAL	20110416		OTC MONOGRAPH DRUG	M020	Boscia LLC	AVOBENZONE; OCTINOXATE	30; 50	mg/mL; mg/mL			N	20241231
76151-210_0c5b6cd3-e1c0-5a83-e063-6394a90aa65c	76151-210	HUMAN OTC DRUG	Boscia BB SPF 27 PA		TITANIUM DIOXIDE	CREAM	TOPICAL	20110511		OTC MONOGRAPH DRUG	M020	Boscia LLC	TITANIUM DIOXIDE	6.4	g/100g			N	20241231
76151-211_0c5b74ab-a056-2667-e063-6294a90a757e	76151-211	HUMAN OTC DRUG	Boscia BB Broad Spectrum SPF 27 PA Self Adjusting Shade		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20121107		OTC MONOGRAPH DRUG	M020	Boscia LLC	TITANIUM DIOXIDE; ZINC OXIDE	10.02; .97	g/100g; g/100g			N	20241231
76151-217_0c5b74ab-a067-2667-e063-6294a90a757e	76151-217	HUMAN OTC DRUG	Boscia Restorative Day Moisture Broad Spectrum SPF 15 For Dry Skin		AVOBENZONE, OCTINOXATE	CREAM	TOPICAL	20121116		OTC MONOGRAPH DRUG	M020	Boscia LLC	AVOBENZONE; OCTINOXATE	30; 65	mg/mL; mg/mL			N	20241231
76151-221_0c5b770a-fe23-17be-e063-6294a90a40a0	76151-221	HUMAN OTC DRUG	Boscia BB BRONZE Broad Spectrum SPF 27 PA Self-Adjusting Shade		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20121107		OTC MONOGRAPH DRUG	M020	Boscia LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.55; .98	g/100g; g/100g			N	20241231
76151-231_0c5b904e-58bc-3a41-e063-6294a90a5d88	76151-231	HUMAN OTC DRUG	Boscia B.B. LIGHT Broad Spectrum SPF 27 PA Self-Adjusting Shade		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20121106		OTC MONOGRAPH DRUG	M020	Boscia LLC	TITANIUM DIOXIDE; ZINC OXIDE	11.25; .98	g/100g; g/100g			N	20241231
76151-241_0c5ba509-8b32-1fa2-e063-6294a90a5e1b	76151-241	HUMAN OTC DRUG	Boscia Daily Defense Sunscreen Broad Spectrum SPF 50 PA		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20121107		OTC MONOGRAPH DRUG	M020	Boscia LLC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	7.25; 5.742; 4.75	g/100g; g/100g; g/100g			N	20241231
76151-251_0c5b770a-fe35-17be-e063-6294a90a40a0	76151-251	HUMAN OTC DRUG	Boscia Self-Defense Vital Antioxidant Moisture Broad Spectrum SPF 30		AVOBENZONE, OCTINOXATE	CREAM	TOPICAL	20121103		OTC MONOGRAPH DRUG	M020	Boscia LLC	AVOBENZONE; OCTINOXATE	30; 75	mg/mL; mg/mL			N	20241231
76151-261_0c5b904e-58ce-3a41-e063-6294a90a5d88	76151-261	HUMAN OTC DRUG	Boscia All In One B.B. Eye Brightener Broad Spectrum SPF 20		TITANIUM DIOXIDE	CREAM	TOPICAL	20140410		OTC MONOGRAPH DRUG	M020	Boscia LLC	TITANIUM DIOXIDE	6.45	g/100g			N	20241231
76159-001_0c5bad81-0936-4f66-e063-6294a90a48d9	76159-001	HUMAN OTC DRUG	3LAB PERFECT BB SPF 40 Broad Spectrum 01		TITANIUM DIOXIDE	CREAM	TOPICAL	20130110		OTC MONOGRAPH DRUG	M020	3LAB, Inc	TITANIUM DIOXIDE	121.6	mg/mL			N	20241231
76159-002_0c5bb478-7c63-4a3d-e063-6294a90a1000	76159-002	HUMAN OTC DRUG	3LAB PERFECT BB SPF 40 Broad Spectrum 02		TITANIUM DIOXIDE	CREAM	TOPICAL	20130110		OTC MONOGRAPH DRUG	M020	3LAB, Inc	TITANIUM DIOXIDE	121.6	mg/mL			N	20241231
76159-003_0c5bad81-0947-4f66-e063-6294a90a48d9	76159-003	HUMAN OTC DRUG	3LAB PERFECT BB SPF 40 Broad Spectrum 03		TITANIUM DIOXIDE	CREAM	TOPICAL	20130110		OTC MONOGRAPH DRUG	M020	3LAB, Inc	TITANIUM DIOXIDE	77.2	mg/mL			N	20241231
76159-004_0c5baaf8-ed44-5c24-e063-6394a90a9f3c	76159-004	HUMAN OTC DRUG	3LAB Aqua BB SPF 40 BROAD SPECTRUM 01		TITANIUM DIOXIDE	CREAM	TOPICAL	20131118		OTC MONOGRAPH DRUG	M020	3LAB, Inc.	TITANIUM DIOXIDE	78.6	mg/mL			N	20241231
76159-005_0c5baaf8-ed53-5c24-e063-6394a90a9f3c	76159-005	HUMAN OTC DRUG	3LAB Aqua BB SPF 40 BROAD SPECTRUM 02		TITANIUM DIOXIDE	CREAM	TOPICAL	20131118		OTC MONOGRAPH DRUG	M020	3LAB, Inc.	TITANIUM DIOXIDE	78.6	mg/mL			N	20241231
76159-006_0c5b797d-1b79-4a3e-e063-6394a90a9d6d	76159-006	HUMAN OTC DRUG	3LAB Aqua BB SPF 40 BROAD SPECTRUM 03		TITANIUM DIOXIDE	CREAM	TOPICAL	20131118		OTC MONOGRAPH DRUG	M020	3LAB, Inc.	TITANIUM DIOXIDE	78.6	mg/mL			N	20241231
76159-124_0c5b86f1-c32e-510a-e063-6394a90a0b56	76159-124	HUMAN OTC DRUG	3LAB Hydra Day SPF 20 Broad Spectrum Water-Based Sunscreen		OCTINOXATE, OCTISALATE, AVOBENZONE	CREAM	TOPICAL	20121015		OTC MONOGRAPH DRUG	M020	3LAB, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE	2; 75; 46	mg/mL; mg/mL; mg/mL			N	20241231
76159-234_0c5b86f1-c33f-510a-e063-6394a90a0b56	76159-234	HUMAN OTC DRUG	3LAB PERFECT Lite Sunscreen SPF 30 Broad Spectrum		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20110415		OTC MONOGRAPH DRUG	M020	3LAB, Inc	TITANIUM DIOXIDE; ZINC OXIDE	24.8; 60	mg/mL; mg/mL			N	20241231
76159-345_0c5bb478-7c78-4a3d-e063-6294a90a1000	76159-345	HUMAN OTC DRUG	3LAB PERFECT Sunscreen SPF 50 Plus Broad Spectrum		HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE	CREAM	TOPICAL	20110421		OTC MONOGRAPH DRUG	M020	3LAB, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76162-000_e433441a-55ae-464c-a722-044931911f37	76162-000	HUMAN OTC DRUG	topcare tussin cf max		Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride	SOLUTION	ORAL	20230322		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-001_cfa0f68a-3278-47da-80b3-64e17d97fa35	76162-001	HUMAN OTC DRUG	Topcare Stomach Relief	Original Strength	Bismuth subsalicylate	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M008	TopCo Associates, LLC	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
76162-002_64df3a52-8279-458b-9d0d-4f600dc8b879	76162-002	HUMAN OTC DRUG	Topcare Stay Awake	Maximum Strength	Caffeine	TABLET, COATED	ORAL	20140701		OTC MONOGRAPH DRUG	M011	TopCo Associates, LLC	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
76162-004_bf64ce65-6978-4634-bd02-ab1389acf47d	76162-004	HUMAN OTC DRUG	Mucus Relief	Immediate Release	Guaifenesin 400mg	TABLET	ORAL	20141223		OTC MONOGRAPH DRUG	M012	TopCo Associates, LLC	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
76162-005_422029e7-9273-4087-887e-df2aff2ad676	76162-005	HUMAN OTC DRUG	Senna Lax		Sennosides 8.6mg	TABLET	ORAL	20140701		OTC MONOGRAPH DRUG	M007	TopCo Associates, LLC	SENNOSIDES	8.6	mg/1			N	20241231
76162-006_8d7c4d0b-d04c-4423-ba3a-dd93c58b2a9b	76162-006	HUMAN OTC DRUG	Topcare Stool Softener		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20150410		OTC MONOGRAPH DRUG	M007	TopCo Associates, LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
76162-007_d56a3a99-9bd6-68cc-e053-2a95a90a34fd	76162-007	HUMAN OTC DRUG	TopCare Pain Relief Patch		Lidocaine, Menthol	PATCH	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part348	Topco Associates LLC	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76162-008_4a6451db-f202-4efd-8fb8-e55d9a9179d8	76162-008	HUMAN OTC DRUG	Mucus Relief DM		Mucus Relief DM	TABLET	ORAL	20221031		OTC MONOGRAPH DRUG	M012	TopCo Associates, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76162-010_efcf22c9-2293-4630-e053-2995a90ab11d	76162-010	HUMAN OTC DRUG	Sugar Free Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	MENTHOL	5.8	mg/1			N	20241231
76162-011_eff0b0ae-c044-6ea2-e053-2995a90a897d	76162-011	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	MENTHOL	5.4	mg/1			N	20241231
76162-012_eff0f6e5-80a2-3558-e053-2995a90aa916	76162-012	HUMAN OTC DRUG	Sugar Free Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	MENTHOL	5.8	mg/1			N	20241231
76162-014_eff16b9d-4290-bf10-e053-2995a90a3e6d	76162-014	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	MENTHOL	5.8	mg/1			N	20241231
76162-016_eff1bab6-50f8-7a26-e053-2a95a90a1adb	76162-016	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	MENTHOL	5.8	mg/1			N	20241231
76162-018_eff6617b-4d32-d7da-e053-2995a90a5dc1	76162-018	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	MENTHOL	5.8	mg/1			N	20241231
76162-022_37c964b5-3477-497c-b5f9-537e60571bfe	76162-022	HUMAN OTC DRUG	Topcare Ultra Strength Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20220105		OTC MONOGRAPH FINAL	part335	Topco Associates, LLC	BISMUTH SUBSALICYLATE	525	mg/15mL			N	20241231
76162-023_10acef5c-96f0-49f2-a227-fd1e4152778b	76162-023	HUMAN OTC DRUG	Topcare Stomach Relief		Bismuth subsalicylate	LIQUID	ORAL	20210105		OTC MONOGRAPH FINAL	part335	Topco Associates, LLC	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
76162-024_fdf75b2b-135c-4c4e-e053-6394a90afe66	76162-024	HUMAN OTC DRUG	Honey Lemon Menthol Cough Drops		Honey Lemon Menthol	PASTILLE	ORAL	20230608		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	MENTHOL	7.5	mg/1			N	20241231
76162-025_06d2b7e1-88de-6dd2-e063-6394a90ad3b8	76162-025	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH DRUG	M012	Topco Associates LLC	MENTHOL	7.5	mg/1			N	20241231
76162-026_b08572e7-e4b1-41fe-bc12-ed0c3300a906	76162-026	HUMAN OTC DRUG	Nite Time Cold and Flu Relief		Nite Time Cold and Flu Relief	CAPSULE, LIQUID FILLED	ORAL	20231101		OTC MONOGRAPH DRUG	M012	TopCo Associates, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76162-027_0945c807-b07d-d8f6-e063-6394a90a80f5	76162-027	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH DRUG	M012	Topco Associates LLC	MENTHOL	7.5	mg/1			N	20241231
76162-028_096bbcb9-84df-22a5-e063-6294a90a4204	76162-028	HUMAN OTC DRUG	Sugar Free Cough Drops		Menthol	PASTILLE	ORAL	20221214		OTC MONOGRAPH DRUG	M012	Topco Associates LLC	MENTHOL	7.6	mg/1			N	20241231
76162-029_c91cb020-17b4-407a-a5f2-3acb6e485cbf	76162-029	HUMAN OTC DRUG	Epsom Salt		Magnesium Sulfate	GRANULE, FOR SOLUTION	ORAL; TOPICAL	20211201		OTC MONOGRAPH NOT FINAL	part334	TOPCO Associates, LLC	MAGNESIUM SULFATE HEPTAHYDRATE	1	g/g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76162-040_c0246f0f-953e-45ca-9fa2-f90a60752c07	76162-040	HUMAN OTC DRUG	Mucus Relief Severe Congestion and Cough		Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20230810		OTC MONOGRAPH DRUG	M012	TOPCO ASSOCIATES LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	20; 400; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-050_74605f6c-bcd7-4dcc-96c3-cd0ab773a764	76162-050	HUMAN OTC DRUG	Mucus Relief Cold, Flu and Sore Throat		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20230811		OTC MONOGRAPH DRUG	M012	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-065_97e61aee-34b7-468d-b3ea-6d796d4365da	76162-065	HUMAN OTC DRUG	Daytime Cold and Flu Relief		Daytime Cold and Flu Relief	CAPSULE, LIQUID FILLED	ORAL	20231103		OTC MONOGRAPH DRUG	M012	TopCo Associates, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-079_52489f8a-1a4a-4a53-996f-264a13494beb	76162-079	HUMAN OTC DRUG	Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20221229		OTC MONOGRAPH DRUG	M013	TOPCO ASSOCIATES LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
76162-088_fc73450d-6767-4409-8d50-80811908faab	76162-088	HUMAN OTC DRUG	Iodine Tincture		Iodine Tincture	SOLUTION/ DROPS	TOPICAL	20220915		OTC MONOGRAPH NOT FINAL	part333A	Topco associates LLC	IODINE	20	mg/mL			N	20241231
76162-089_0d38267e-cdf8-a2c0-e063-6394a90ab84c	76162-089	HUMAN OTC DRUG	TopCare Health Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20221017		OTC MONOGRAPH DRUG	M018	Topcare Associates LLC	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
76162-114_07a16bf2-d35b-458d-ae0c-c8752330acfe	76162-114	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20231130		ANDA	ANDA090962	Topco Associates	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
76162-123_827dc022-69fb-4066-88c1-f9166e5395b4	76162-123	HUMAN OTC DRUG	Topcare mucus er		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20220929		ANDA	ANDA078912	Topco Associates LLC	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
76162-124_3f57c587-ba9c-46c0-ac4c-39243bb4d3e4	76162-124	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20090804		OTC MONOGRAPH NOT FINAL	part356	TOPCO ASSOCIATES LLC	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76162-127_563a9951-0d40-448b-bf0d-8f6d905087d0	76162-127	HUMAN OTC DRUG	Topcare Extra Strength Antacid Assorted Fruit	Extra Strength Antacid Assorted Fruit	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220427		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
76162-128_0aefbd70-4103-410c-83b2-f7baa0b80ddd	76162-128	HUMAN OTC DRUG	TopCare Extra Strength Antacid	Extra Strength Antacid Assorted Berry	Calcium carbonate	TABLET, CHEWABLE	ORAL	20220428		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
76162-129_dd038b15-2ecb-4ee2-b356-db6d87c2f01b	76162-129	HUMAN OTC DRUG	TopCare Ultra Strength Antacid Assorted Fruit		Calcium carbonate	TABLET, CHEWABLE	ORAL	20220426		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
76162-130_9e6d29f4-f1ec-4cc9-8387-47ea8e034a4e	76162-130	HUMAN OTC DRUG	TopCare Ultra Strength Antacid Assorted Berry		Calcium carbonate	TABLET, CHEWABLE	ORAL	20220426		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
76162-131_fb434059-7b6e-42e0-acfa-db9879f6a4e4	76162-131	HUMAN OTC DRUG	Topcare Ultra Strength Antacid Peppermint		Calcium carbonate	TABLET, CHEWABLE	ORAL	20220425		OTC MONOGRAPH FINAL	part331	Topco Associates, LLC	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
76162-134_4dc7a573-e010-4f89-a540-bb3bd6116b8e	76162-134	HUMAN OTC DRUG	topcare allergy		mometasone furoate monohydrate	SPRAY	NASAL	20230328		NDA	NDA215712	Topco Associates LLC	MOMETASONE FUROATE MONOHYDRATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76162-142_04e4db94-b659-4638-bf24-789208c20830	76162-142	HUMAN OTC DRUG	TopCare EXTRA STRENGTH Headache Relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20231109		OTC MONOGRAPH DRUG	505G(a)(3)	Topco Associates LLC	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
76162-171_fadf4e81-eac3-e407-e053-6394a90a4932	76162-171	HUMAN OTC DRUG	Topco Associates		Selenium Sulfide	SHAMPOO	TOPICAL	20230504		OTC MONOGRAPH FINAL	M032	Topco Associates	SELENIUM SULFIDE	10	mg/mL			N	20241231
76162-180_5d5565af-f998-489d-9442-a33ec6679d95	76162-180	HUMAN OTC DRUG	TopCare Cold and Hot Pain Relieving	Analgesic	LIDOCAINE HYDROCHLORIDE and MENTHOL, UNSPECIFIED FORM	CREAM	TOPICAL	20220524		OTC MONOGRAPH NOT FINAL	part348	Topco Associates, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76162-190_360bf638-e439-4ca2-b6e5-ccb26eb6bbbd	76162-190	HUMAN OTC DRUG	TopCare Therapeutic Anti-Dandruff	Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis	Coal Tar	SHAMPOO	TOPICAL	20220831		OTC MONOGRAPH FINAL	part358H	Topco Associates, LLC	COAL TAR	5	mg/mL			N	20241231
76162-200_e5b3b657-44e1-4734-b6ec-465aed634533	76162-200	HUMAN OTC DRUG	Nighttime Sleep Aid		Diphenhydramine HCl	SOLUTION	ORAL	20230111		OTC MONOGRAPH DRUG	M010	TOPCO ASSOCIATES LLC	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76162-202_2cbc98b4-58c7-4a0d-af1f-e9e7b3e03c11	76162-202	HUMAN OTC DRUG	topcare nite time cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230703		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-229_da8ae325-0353-4c0a-bc48-b226b7e8c215	76162-229	HUMAN OTC DRUG	Acne Treatment		Benzoyl peroxide	GEL	TOPICAL	20220823		OTC MONOGRAPH FINAL	part333D	Topco associates LLC	BENZOYL PEROXIDE	1	mg/g			N	20241231
76162-253_0be04ad2-e1b6-d3fb-e063-6394a90ab8e5	76162-253	HUMAN OTC DRUG	Topcare Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20231101		OTC MONOGRAPH DRUG	M031	Topco Associates, LLC	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
76162-255_0bf3a910-e715-3cb9-e063-6394a90a0d8e	76162-255	HUMAN OTC DRUG	Topcare Complete Lice Treatment Kit		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20231001		OTC MONOGRAPH DRUG	M031	Topco Associates, LLC						N	20241231
76162-264_bf521f53-c3ea-40ec-8da9-70958f4627ec	76162-264	HUMAN OTC DRUG	Daily Acne Control Cleanser		Benzoyl peroxide	CREAM	TOPICAL	20220809		OTC MONOGRAPH FINAL	part333D	Topco Associates LLC	BENZOYL PEROXIDE	104	mg/10g			N	20241231
76162-294_db448090-79eb-4c1d-ae79-74ba43a9ad8d	76162-294	HUMAN OTC DRUG	Childrens Mucus Relief Cough	Cherry Liquid	Dextromethorphan HBr, Guaifensin	LIQUID	ORAL	20220418		OTC MONOGRAPH FINAL	part341	Topco Associates	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76162-300_8a5a69da-3a67-4ecc-97d1-39ffea001485	76162-300	HUMAN OTC DRUG	topcare acid reducer		famotidine	TABLET, FILM COATED	ORAL	20220925		ANDA	ANDA077351	Topco Associates LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
76162-326_09d66546-85e2-27f4-e063-6394a90a4c33	76162-326	HUMAN OTC DRUG	Topcare 70 Isopropyl Alcohol Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20150810		OTC MONOGRAPH DRUG	M003	Topco Associates LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
76162-327_09d64076-c0f0-fb0e-e063-6394a90aa4d5	76162-327	HUMAN OTC DRUG	Topcare 3 Hydrogen Peroxide Wipes		HYDROGEN PEROXIDE	CLOTH	TOPICAL	20200901		OTC MONOGRAPH DRUG	M003	Topco Associates LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
76162-336_f05447b7-b071-4b6f-abfa-b3736a6e52da	76162-336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20090521		OTC MONOGRAPH FINAL	part347	Topco associates LLC	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 80	mg/mL; mg/mL			N	20241231
76162-403_25aba504-b4ce-473d-862b-c878189a50a9	76162-403	HUMAN OTC DRUG	Topcare Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20230630		ANDA	ANDA077007	Topco Associates LLC	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
76162-404_06d34085-d5bc-561b-e063-6294a90a8865	76162-404	HUMAN OTC DRUG	TopCare Cherry Antacid Soft Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220426		OTC MONOGRAPH FINAL	part331	TopCo	CALCIUM CARBONATE	1177	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76162-405_08f56c9e-9220-4e48-e063-6294a90a56db	76162-405	HUMAN OTC DRUG	TopCare Lime and Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220429		OTC MONOGRAPH DRUG	M001	TopCo	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76162-470_ce295874-4fda-4aaa-8373-6b0ad3a1de1b	76162-470	HUMAN OTC DRUG	topcare omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220922		NDA	NDA022032	Topco Associates LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
76162-500_071976ba-8f1e-44cc-b5a0-3baea96da12d	76162-500	HUMAN OTC DRUG	topcare day time cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-501_45a4d44d-ba32-4aec-8eaf-9665cb6fb08b	76162-501	HUMAN OTC DRUG	topcare dual action		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230306		ANDA	ANDA214836	Topco Associates LLC	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76162-523_587dfac2-f276-4f77-a36e-69ad14331bf5	76162-523	HUMAN OTC DRUG	Topcare Mucus ER		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20220909		ANDA	ANDA213420	Topco Associates LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
76162-567_c6a34d34-a8ba-43b9-ad38-cb1894dbc763	76162-567	HUMAN OTC DRUG	Antispetic		Eucalyptol, menthol, methyl salicylate, thymol	MOUTHWASH	ORAL	20211220		OTC MONOGRAPH NOT FINAL	part356	Topco	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76162-576_e02c42a7-295f-4424-9a64-191978bb865f	76162-576	HUMAN OTC DRUG	Oral Antivavity		Sodium fluoride	MOUTHWASH	ORAL	20220404		OTC MONOGRAPH FINAL	part355	Topco	SODIUM FLUORIDE	10.41	mg/mL			N	20241231
76162-600_fc6f9d8a-4072-484b-8296-580d61192f09	76162-600	HUMAN OTC DRUG	topcare tussin dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220511		OTC MONOGRAPH FINAL	part341	Topco Associates LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76162-700_ca6eca25-9077-44c5-9ccf-e7f381107e84	76162-700	HUMAN OTC DRUG	topcare nicotine		nicotine polacrilex	LOZENGE	ORAL	20230608		ANDA	ANDA077007	Topco Associates LLC	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
76162-720_0c06dc59-fccf-f09b-e063-6394a90a3629	76162-720	HUMAN OTC DRUG	NON-DROWSY DAYTIME Cold and Flu Max Softgels MAXIMUM STRENGTH		Acetaminophen, Dextromethorphan hydrobromide, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220420		OTC MONOGRAPH DRUG	M012	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-732_0c070058-9e21-cc8c-e063-6394a90ad801	76162-732	HUMAN OTC DRUG	NIGHTTIME Cold and Flu Max Softgels MAXIMUM STRENGTH		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220420		OTC MONOGRAPH DRUG	M012	TOPCO ASSOCIATES LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-733_0c06e3d2-447f-f4b5-e063-6394a90a0608	76162-733	HUMAN OTC DRUG	Gas Relief		simethicone softgels	CAPSULE, LIQUID FILLED	ORAL	20220708		OTC MONOGRAPH DRUG	M002	Topco Associates LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
76162-761_3f762d73-3e90-467a-a3b7-0b7f6479096d	76162-761	HUMAN OTC DRUG	Topcare Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210720		OTC MONOGRAPH NOT FINAL	part334	TOPCO ASSOCIATES LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
76162-764_34a11108-7d23-406c-a1f2-eb49cfed8de7	76162-764	HUMAN OTC DRUG	Topcare Stool Softener	laxative	DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210720		OTC MONOGRAPH NOT FINAL	part334	TOPCO ASSOCIATES LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
76162-773_d47efe47-c430-444d-ac8c-4f48b307ffec	76162-773	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, FILM COATED	ORAL	20220618		OTC MONOGRAPH DRUG	505G(a)(3)	TOPCO ASSOCIATES LLC	SENNOSIDES	25	mg/1			N	20241231
76162-777_da35f73f-284d-4bdf-a11f-dd15a7641a41	76162-777	HUMAN OTC DRUG	Topcare Stool Softener		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210720		OTC MONOGRAPH NOT FINAL	part334	TOPCO ASSOCIATES LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
76162-801_784ad93e-f3b9-48a8-beff-e2aae8b5e147	76162-801	HUMAN OTC DRUG	topcare mucus d		guaifenesin and pseudoephedrine hydrochloride	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20230816		ANDA	ANDA214407	Topco Associates LLC	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
76162-809_0d7ffc64-5322-ba5d-e063-6294a90a6cac	76162-809	HUMAN OTC DRUG	Alcohol Prep		Isopropyl Alcohol	SWAB	TOPICAL	20110713	20261231	OTC MONOGRAPH DRUG	M003	Topco Associates	ISOPROPYL ALCOHOL	70	mL/100mL			N	
76162-810_03708e08-0188-b83d-e063-6394a90a50e6	76162-810	HUMAN OTC DRUG	TopCo		isopropyl alcohol	SWAB	TOPICAL	20210101	20240229	OTC MONOGRAPH NOT FINAL	part333A	Topco Associates	ISOPROPYL ALCOHOL	70	mL/100mL			N	
76162-811_ce37a50d-23c0-44b6-ac20-a59183987bcc	76162-811	HUMAN OTC DRUG	TopCare Day Time SEVERE Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20231103		OTC MONOGRAPH DRUG	M012	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-812_7d17a6f4-b731-46c2-810f-6e3768e59e9c	76162-812	HUMAN OTC DRUG	TopCare Nite Time SEVERE Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20231103		OTC MONOGRAPH DRUG	M012	Topco Associates LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76162-818_df63f2f7-3cd4-4761-825a-a8ae403c8a7e	76162-818	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Topco Associates	DOCOSANOL	100	mg/g			N	20241231
76162-822_be35c0e5-4193-45a7-afb8-ccc306f367e5	76162-822	HUMAN OTC DRUG	Witch Hazel		WITCH HAZEL	LIQUID	TOPICAL	20190308		OTC MONOGRAPH FINAL	part347	TOPCO ASSOCIATES LLC	WITCH HAZEL	860	mg/mL			N	20241231
76162-823_1cf9fc29-a15e-4aa0-b169-7eab1ff6d123	76162-823	HUMAN OTC DRUG	Cold and Flu Severe Daytime/Nighttime		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride, Doxylamine succinate	KIT		20231103		OTC MONOGRAPH DRUG	M012	Topco Associates LLC						N	20241231
76162-824_d2f3ebc3-248b-4545-921b-d58debd5f06a	76162-824	HUMAN OTC DRUG	MAXIMUM STRENGTH Sinus Relief		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride, Doxylamine succinate	KIT		20231225		OTC MONOGRAPH DRUG	M012	Topco Associates LLC						N	20251231
76162-836_0c7ffed4-7f2b-0946-e063-6394a90aef39	76162-836	HUMAN OTC DRUG	TopCare Earwax Removal Drops		CARBAMIDE PEROXIDE	SOLUTION/ DROPS	AURICULAR (OTIC)	20150601		OTC MONOGRAPH DRUG	M014	Topco Associates LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20241231
76162-845_e97b757b-b8e3-482f-ba2f-b398d05fbfc3	76162-845	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20190308		OTC MONOGRAPH FINAL	part344	TOPCO ASSOCIATES LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
76162-894_0e542945-db53-4f33-add7-59036d9b4762	76162-894	HUMAN OTC DRUG	Gel Cooling Pain Relief		Menthol	GEL	TOPICAL	20210624		OTC MONOGRAPH NOT FINAL	part348	Topco	MENTHOL	160	mg/mL			N	20241231
76162-900_db7e591e-9cbf-49c9-acbd-92110b979388	76162-900	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20220121		ANDA	ANDA208754	Topco Associates	DOCOSANOL	100	mg/g			N	20241231
76162-980_70d059f6-78db-4094-a90b-0720618b67b5	76162-980	HUMAN OTC DRUG	Low Dose Aspirin		Aspirin	TABLET, COATED	ORAL	20230801		OTC MONOGRAPH FINAL	part343	Topco Associates	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
76168-015_6c311047-4bf2-44ad-e053-2a91aa0ad047	76168-015	HUMAN OTC DRUG	Sleep Aid		diphenhydramine hydrochloride	TABLET, FILM COATED	ORAL	20180514		OTC MONOGRAPH FINAL	part338	Velocity Pharma LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76168-056_58ee90a2-07a9-2253-e053-2a91aa0ad9cf	76168-056	HUMAN OTC DRUG	NightTime Cold and Flu		Acetaminophen,Dextromethorphan,Doxylamine	CAPSULE, LIQUID FILLED	ORAL	20140501		OTC MONOGRAPH FINAL	part341	Velocity Pharma	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76168-065_6cbc010f-0449-cb45-e053-2a91aa0a1ec6	76168-065	HUMAN OTC DRUG	Nightime Sleep Aid		Diphenhydramine	CAPSULE, LIQUID FILLED	ORAL	20140331		OTC MONOGRAPH FINAL	part341	Velocity Pharma	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76168-119_6c30260f-b9e7-58c3-e053-2991aa0a818c	76168-119	HUMAN OTC DRUG	Pain Relief PM		Acetaminophen PM	TABLET	ORAL	20121205		OTC MONOGRAPH NOT FINAL	part343	Velocity Pharma	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76168-120_6c311047-4be7-44ad-e053-2a91aa0ad047	76168-120	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20180514		OTC MONOGRAPH NOT FINAL	part343	Velocity Pharma LLC	ACETAMINOPHEN	500	mg/1			N	20241231
76168-121_6c30ec6a-4c24-d604-e053-2a91aa0ac869	76168-121	HUMAN OTC DRUG	Allergy		Diphenhydramine Hydrochloride	TABLET	ORAL	20180514		OTC MONOGRAPH FINAL	part341	Velocity Pharma LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76168-502_0941531f-a2b2-2dcb-e063-6294a90aa78e	76168-502	HUMAN OTC DRUG	Lubricant Drops		propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20211111		OTC MONOGRAPH DRUG	M018	VELOCITY PHARMA	PROPYLENE GLYCOL	.06	mg/mL			N	20241231
76176-010_7e714214-20d7-356c-e053-2a91aa0ab7f5	76176-010	HUMAN OTC DRUG	SANITAXE INSTANT HAND SANITIZER WITH ALOE VERA 27 FL OZ		Ethyl Alcohol	GEL	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-011_d77966b1-2ee3-0a08-e053-2a95a90a499c	76176-011	HUMAN OTC DRUG	LUCKY ANTIPERSPIRANT DEODORANT SPRING FRESH		aluminum chlorohydrate	STICK	TOPICAL	20170101		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
76176-012_d779d278-f6cf-07ad-e053-2a95a90a64af	76176-012	HUMAN OTC DRUG	LUCKY ANTIPERSPIRANT DEODORANT FRESH COMFORT		aluminum chlorohydrate	STICK	TOPICAL	20170101		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
76176-014_d77a0955-d366-6096-e053-2a95a90a8185	76176-014	HUMAN OTC DRUG	LUCKY ANTIPERSPIRANT DEODORANT EXTREME ENERGY		aluminum chlorohydrate	STICK	TOPICAL	20170101		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
76176-015_d77b8fd3-fa0e-8275-e053-2995a90a2998	76176-015	HUMAN OTC DRUG	CLARISSE ANTIPERSPIRANT DEODORANRT		aluminum chlorohydrate	STICK	TOPICAL	20170101		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
76176-016_d77c8185-f916-b6c5-e053-2995a90a100e	76176-016	HUMAN OTC DRUG	CLARISSE ANTIPERSPIRANT DEODORANRT CHERRY BLOSSOM		aluminum chlorohydrate	STICK	TOPICAL	20170101		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
76176-031_605d26d2-ace6-0d33-e053-2a91aa0af154	76176-031	HUMAN OTC DRUG	2PK 2OZ HAND SANITIIZER-ALOE VERA		2OZ HAND SANITIZER	LIQUID	TOPICAL	20170401		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/1			N	20241231
76176-032_6cc48bd5-ef11-ce02-e053-2a91aa0afdde	76176-032	HUMAN OTC DRUG	8OZ HAND SANITIZER WITH PUMP		8OZ HAND SANITIZER	GEL	TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/1			N	20241231
76176-033_64fdd4c0-f44d-0df4-e053-2991aa0a4af1	76176-033	HUMAN OTC DRUG	1.8OZ HAND SANITIZER WITH CLIP -ASSORTED		ethyl alcohol	GEL	TOPICAL	20170101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/1			N	20241231
76176-034_6cc42772-fae8-5780-e053-2a91aa0a8bf8	76176-034	HUMAN OTC DRUG	QC 2OZ INSTANT HAND SANITIZER (ORIGINAL)		ALCOHOL	GEL	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-035_6cd9900f-5ab7-3c4e-e053-2a91aa0a5e51	76176-035	HUMAN OTC DRUG	QC 8OZ INSTANT HAND SANITIZER (ORIGINAL)		ALCOHOL	GEL	TOPICAL	20171009		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-036_6cedc0c4-6d62-db32-e053-2991aa0a72f6	76176-036	HUMAN OTC DRUG	UNTRA DRY ANTI-PERSPIRANT and DEODORANT -COOL BLAST		aluminum chlorohydrate gel	STICK	TOPICAL	20160101		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	1	g/100g			N	20241231
76176-037_6b9ade26-005c-23d0-e053-2991aa0a647f	76176-037	HUMAN OTC DRUG	INVISIBLE SOLID ANTI-PERSPIRANT and DEODORANT		aluminum chlorohydrate gel	STICK	TOPICAL	20160101		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	1	g/100g			N	20241231
76176-041_64209f02-bdfe-eee8-e053-2991aa0ab2d6	76176-041	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	PEACH DREAM	antibacterial hand soap benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-042_747ba742-142b-3b08-e053-2991aa0a3226	76176-042	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	LAVENDER BOUQUET	benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-043_747bb668-13c9-389d-e053-2991aa0af25e	76176-043	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	TROPICAL BEACH	benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-044_751b96ae-5693-2c34-e053-2991aa0a0dfa	76176-044	HUMAN OTC DRUG	ANTIBACTERIAL HANDWASH	BERRY MEDLEY	benzalkonium chloride	LIQUID	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-045_760be0f2-b5b3-b22a-e053-2991aa0a90d5	76176-045	HUMAN OTC DRUG	U ICE COLD		menthol	OINTMENT	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd.	CAMPHOR, (-)-; MENTHOL	.5; 1	g/100g; g/100g			N	20241231
76176-050_64855372-7291-7e20-e053-2a91aa0afd43	76176-050	HUMAN OTC DRUG	ADRIANA CLIP ON HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-051_64855372-72a3-7e20-e053-2a91aa0afd43	76176-051	HUMAN OTC DRUG	ADRIANA 8OZ HAND SANITIZER -ORIGINAL		ALCOHOL	GEL	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-052_64846eb3-a011-dfb3-e053-2991aa0aebd7	76176-052	HUMAN OTC DRUG	ADRIANA 8OZ HAND SANITIZER - ALOE VERA		ALCOHOL	GEL	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-053_64ae4032-789a-975a-e053-2a91aa0ab092	76176-053	HUMAN OTC DRUG	ADRIANA 12OZ HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-054_6cdb9ce3-e6aa-2848-e053-2a91aa0ad04c	76176-054	HUMAN OTC DRUG	ADRIANA 12OZ HAND SANITIZER -ALOE VERA		ALCOHOL	GEL	TOPICAL	20180131		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-056_7aaede8e-9e91-57bb-e053-2a91aa0a3d26	76176-056	HUMAN OTC DRUG	MAXIM ICE COLD ANALGESIC		menthol	OINTMENT	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd.	MENTHOL	1	g/100g			N	20241231
76176-057_aa623723-91da-05f0-e053-2995a90a4c00	76176-057	HUMAN OTC DRUG	HAND SANITIZER 16OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-058_aa61afd8-988a-1927-e053-2995a90ab43e	76176-058	HUMAN OTC DRUG	HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-060_ebc34409-3e02-deff-e053-2995a90af98d	76176-060	HUMAN OTC DRUG	HAND SANITIZER ANTIBACTERIAL WITH MOISTURIZERS AND VITAMIN E 1.8OZ		ALCOHOL	GEL	TOPICAL	20180401		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-061_ebc34633-f2b6-b47e-e053-2a95a90a372c	76176-061	HUMAN OTC DRUG	HAND SANITIZER ANTIBACTERIAL WITH MOISTURIZERS AND ALOE 8OZ		ALCOHOL	GEL	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-063_ebc33e4a-aff6-a326-e053-2a95a90a08c1	76176-063	HUMAN OTC DRUG	OATMEAL		dimethicone	LOTION	TOPICAL	20190401		OTC MONOGRAPH FINAL	part347	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD	DIMETHICONE	1	g/100g	Skin Barrier Activity [PE]		N	20241231
76176-064_a6b3e856-d3cc-d192-e053-2995a90aeeff	76176-064	HUMAN OTC DRUG	GOLD ANTIBACTERIAL HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-065_adb109f6-7ca6-80d7-e053-2a95a90ae3b9	76176-065	HUMAN OTC DRUG	PETROLEUM ORIGINAL		WHITE PETROLATUM	JELLY	TOPICAL	20200801		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	100	g/100g			N	20241231
76176-066_ad61ac93-a9ac-3626-e053-2a95a90a88bc	76176-066	HUMAN OTC DRUG	ICE COLD ANALGESIC		MENTHOL	GEL	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part348	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	MENTHOL	1	g/100g			N	20241231
76176-067_adc5c353-573c-57cf-e053-2995a90a0ffd	76176-067	HUMAN OTC DRUG	VAPORIZING CHEST RUB		camphor,menthol	GEL	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	4.7; 1	g/100g; g/100g			N	20241231
76176-071_6df1ea82-0e07-6d2e-e053-2991aa0aeb2e	76176-071	HUMAN OTC DRUG	PHARMACY PRESCRIPTION 1.8OZ HAND SANITIZER - ORIGINAL SCENT		ALCOHOL	GEL	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-072_6e0a49ca-33fa-42df-e053-2991aa0ac158	76176-072	HUMAN OTC DRUG	PHARMACY PRESCRIPTION 1.8OZ HAND SANITIZER - SWEET PEACH		ALCOHOL	GEL	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-073_6e0aab12-92be-8443-e053-2a91aa0a061c	76176-073	HUMAN OTC DRUG	PHARMACY PRESCRIPTION 1.8OZ HAND SANITIZER - CUCUMBER MELON		ALCOHOL	GEL	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-074_6e1c0edb-1985-6b60-e053-2991aa0a61d0	76176-074	HUMAN OTC DRUG	PHARMACY PRESCRIPTION 1.8OZ HAND SANITIZER - SWEET PEA		ALCOHOL	GEL	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-081_700f9b72-2cec-8fa2-e053-2991aa0a0026	76176-081	HUMAN OTC DRUG	GLOBAL CARE 15OZ GOLD ANTIBACTERIAL HAND		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd	CHLOROXYLENOL	.3	g/100mL			N	20241231
76176-082_6fc54c96-d75a-160d-e053-2991aa0ac011	76176-082	HUMAN OTC DRUG	GLOBAL CARE 15OZ ORIGINAL ANTIBACTERIAL HAND		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd	CHLOROXYLENOL	.3	g/100mL			N	20241231
76176-083_70136107-dff0-9adf-e053-2991aa0a9959	76176-083	HUMAN OTC DRUG	GLOBAL CARE 7.5OZ ANTIBACTERIAL HAND SWEETPEA ORCHID		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd	CHLOROXYLENOL	.3	g/100mL			N	20241231
76176-084_70140e11-33f4-2240-e053-2991aa0a0480	76176-084	HUMAN OTC DRUG	GLOBAL CARE 7.5OZ ANTIBACTERIAL HAND CUCUMBER MELON		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd.	CHLOROXYLENOL	.3	g/100mL			N	20241231
76176-085_6e1e7333-fbd3-22ae-e053-2a91aa0a6710	76176-085	HUMAN OTC DRUG	GLOBAL CARE 2 PACK HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-086_6e0945fd-c6d4-46f9-e053-2991aa0a0a1c	76176-086	HUMAN OTC DRUG	GLOBAL CARE 8OZ HAND SANITIZER -ORIGINAL		ALCOHOL	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO.,LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-087_6cdc0fd5-907c-47af-e053-2991aa0a4fe7	76176-087	HUMAN OTC DRUG	CLOBAL CARE INSTANT HAND SANITIZER 1.8OZ		ALCOHOL	GEL	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-088_6f85a8af-145e-08c9-e053-2991aa0ad8be	76176-088	HUMAN OTC DRUG	GLOBAL CARE 4OZ VAPOR RUB		menthol, camphor, eucalyptus oil	OINTMENT	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
76176-089_6fc492a0-a62d-934a-e053-2991aa0a8aa0	76176-089	HUMAN OTC DRUG	GLOBAL CARE ICE COLD ANALGESIC		menthol	OINTMENT	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd	MENTHOL	1	g/100g			N	20241231
76176-090_6fc492a0-a644-934a-e053-2991aa0a8aa0	76176-090	HUMAN OTC DRUG	GLOBAL HOME CARE 19OZ ANTIBACTERIAL DISH DETERGENT		CHLOROXYLENON	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd.	CHLOROXYLENOL	.3	g/100mL			N	20241231
76176-091_7011f5c1-21d5-07ce-e053-2991aa0a4293	76176-091	HUMAN OTC DRUG	GLOBAL CARE 7.5OZ ORIGINAL ANTIBACTERIAL HAND		CHLOROXYLENOL	LIQUID	TOPICAL	20180501		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd	CHLOROXYLENOL	.3	g/100mL			N	20241231
76176-092_83e206a0-df05-628d-e053-2991aa0a1e63	76176-092	HUMAN OTC DRUG	GLOBAL HOME CARE 19OZ LEMON ANTIBACTERIAL DISH DETERGENT		CHLOROXYLENOL	LIQUID	TOPICAL	20190331		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd.	CHLOROXYLENOL	.3	g/100mL			N	20241231
76176-093_a52fd018-72dc-15be-e053-2a95a90a4450	76176-093	HUMAN OTC DRUG	GLOBAL CARE LEMON ZEST ANTIBACTERIAL FOAMING HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-094_a5308866-7a43-42ab-e053-2995a90aefee	76176-094	HUMAN OTC DRUG	GLOBAL CARE OCEAN MIST ANTIBACTERIAL FOAMING HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-095_a68b4864-ad60-5408-e053-2a95a90a344b	76176-095	HUMAN OTC DRUG	INSTANT HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-096_a69f7b56-ef66-5bc2-e053-2a95a90a2634	76176-096	HUMAN OTC DRUG	INSTANT HAND SANITIZER 2OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-097_a69fde9e-c856-4e49-e053-2995a90a8590	76176-097	HUMAN OTC DRUG	INSTANT HAND SANITIZER 16OZ		Ethyl Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-098_a844d3fe-e03b-b5fb-e053-2a95a90ab0a5	76176-098	HUMAN OTC DRUG	GLOBAL CARE GOLD ANTIBACTERIAL HAND		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-099_acbb30ed-f3c6-1754-e053-2995a90a231b	76176-099	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND LAVENDER CHAMOMILE		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-110_7c421fab-6cab-3aad-e053-2a91aa0ab60f	76176-110	HUMAN OTC DRUG	BEING WELL HAND SANITIZER 2 PACK		Ethyl Alcohol	GEL	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-111_7982c043-29fb-1018-e053-2991aa0ab41c	76176-111	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION HYDROGEN PEROXIDE		hydrogen peroxide	LIQUID	TOPICAL	20180831		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
76176-112_76ac3da9-a44d-265c-e053-2a91aa0a9752	76176-112	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION VAPOR RUB		menthol	GEL	TOPICAL	20180801		OTC MONOGRAPH FINAL	part341	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
76176-113_77135be8-93fe-9f5e-e053-2991aa0a093b	76176-113	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION ICE COLD ANALGESIC		menthol	OINTMENT	TOPICAL	20180801		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd.	MENTHOL	1	g/100g			N	20241231
76176-114_7bda9dd7-42ab-a366-e053-2991aa0a817d	76176-114	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION HAND SANITIZER 2OZ		Ethyl Alcohol	GEL	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-115_7bde104d-2a54-321a-e053-2a91aa0a8e11	76176-115	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-116_7bdd7646-79e4-eb04-e053-2991aa0a0fb9	76176-116	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION PETROLEUM SKIN PROTECTANT		WHITE PETROLATUM	JELLY	TOPICAL	20181001		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	100	g/100g			N	20241231
76176-117_7bdd7646-79fe-eb04-e053-2991aa0a0fb9	76176-117	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION PETROLEUM BABY FRESH SCENT		WHITE PETROLATUM	JELLY	TOPICAL	20181001		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	99.9	g/100g			N	20241231
76176-118_86ca5f10-e46b-8064-e053-2a91aa0ac285	76176-118	HUMAN OTC DRUG	SANITAXE ANTIBACTERIAL AMBER HAND		Chloroxylenol	LIQUID	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	CHLOROXYLENOL	.1	g/100mL			N	20241231
76176-119_868d29c5-b040-91fc-e053-2a91aa0a608f	76176-119	HUMAN OTC DRUG	SANITAXE INSTANT HAND SANITIZER WITH ALOE VERA 27 FL OZ		Ethyl Alcohol	GEL	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-120_ebc30a3e-c936-7167-e053-2a95a90a2042	76176-120	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20181001		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-121_ebc3115c-6eea-e8c3-e053-2995a90a22b3	76176-121	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION CREAMY PETROLEUM UNSCENTED		PETROLATUM	JELLY	TOPICAL	20200101		OTC MONOGRAPH FINAL	part347	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	PETROLATUM	30	g/100g			N	20241231
76176-122_ebc33e4a-aff5-a326-e053-2a95a90a08c1	76176-122	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION CREAMY PETROLEUM COCOA BUTTER		PETROLATUM	JELLY	TOPICAL	20200101		OTC MONOGRAPH FINAL	part347	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	PETROLATUM	30	g/100g			N	20241231
76176-123_aeca6a85-5fda-94b2-e053-2995a90a22bc	76176-123	HUMAN OTC DRUG	SANITAXE INSTANT HAND SANITIZER WITH ALOE VERA 27 FL OZ		Ethyl Alcohol	GEL	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-124_af511208-bae0-501d-e053-2a95a90aeae9	76176-124	HUMAN OTC DRUG	SANITAXE ANTIBACTERIAL AMBER HAND 27 FL OZ		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20150101		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-125_b3e18c4b-a0e7-36bf-e053-2a95a90ad1b8	76176-125	HUMAN OTC DRUG	ULTRA DRY ANTI-PERSPIRANT AND DEODORANT COOL BLAST		aluminum chlorohydrate	STICK	TOPICAL	20201001		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
76176-126_b45ea74c-90fe-a048-e053-2a95a90a57ae	76176-126	HUMAN OTC DRUG	INVISIBLE SOLID ANTI-PERSPIRANT AND DEODORANT		aluminum chlorohydrate	STICK	TOPICAL	20201001		OTC MONOGRAPH FINAL	part350	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
76176-127_b8bf4662-f582-1321-e053-2995a90ad362	76176-127	HUMAN OTC DRUG	BEING WELL HAND SANITIZER 2 PACK		Ethyl Alcohol	GEL	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-128_d6138877-77ab-5336-e053-2995a90a028f	76176-128	HUMAN OTC DRUG	PHARMACYS PRESCRIPTION 8 OZ ACNE CONTROL		SALICYLIC ACID	LIQUID	TOPICAL	20210101		OTC MONOGRAPH FINAL	part333D	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	SALICYLIC ACID	5	mg/100mL			N	20241231
76176-151_aeb75417-5b0f-1d7d-e053-2995a90a37f6	76176-151	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND LAVENDER CHAMOMILE		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-152_aeb68fff-1095-be9c-e053-2995a90a895e	76176-152	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND VANILLA BEAN		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-153_aeb6d9d2-0231-1340-e053-2995a90a6f88	76176-153	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND GEORGIA PEACH		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-154_aeb75201-f267-a5f1-e053-2995a90ae919	76176-154	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND CHERRY BLOSSOM		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-155_aec3eb9c-bddf-0045-e053-2995a90a798a	76176-155	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND ALOE VERA		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-156_aec431f2-bf1a-5992-e053-2a95a90a78e7	76176-156	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND ORIGINAL		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-157_bba8a4d9-6be7-2213-e053-2a95a90aefcd	76176-157	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND SWEET PEA ORCHID		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-158_bbbfbf29-267c-4852-e053-2a95a90a6cdb	76176-158	HUMAN OTC DRUG	GLOBAL CARE ANTIBACTERIAL HAND CUCUMBER MELON		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200801		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76176-191_a196646f-b58c-8526-e053-2995a90abb36	76176-191	HUMAN OTC DRUG	ISLAMIC RELIEF HAND SANITIZER 2OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-192_a1a537d5-f195-18c1-e053-2a95a90a0afc	76176-192	HUMAN OTC DRUG	ISLAMIC RELIEF HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-193_a1ab8bbc-d12d-7668-e053-2a95a90ab60e	76176-193	HUMAN OTC DRUG	ISLAMIC RELIEF HAND SANITIZER 16OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-194_a25bd0f0-6fb0-45e7-e053-2a95a90a36ca	76176-194	HUMAN OTC DRUG	GRANDWAY HAND SANITIZER 1.8OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-195_a1bce9c4-df1c-4d08-e053-2a95a90a76f8	76176-195	HUMAN OTC DRUG	GRANDWAY HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-196_a24b40cc-fe1c-c456-e053-2a95a90aa0fc	76176-196	HUMAN OTC DRUG	GRANDWAY HAND SANITIZER 2OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-197_a20fdcf9-36b2-381c-e053-2a95a90a9e45	76176-197	HUMAN OTC DRUG	GRANDWAY HAND SANITIZER 16OZ		Ethyl Alcohol	GEL	TOPICAL	20200301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	62	mL/100mL			N	20241231
76176-201_fbf4b14a-c5d1-283b-e053-6294a90abee1	76176-201	HUMAN OTC DRUG	URBAN WASH DANDRUFF		pyrithione zinc	SHAMPOO	TOPICAL	20230501		OTC MONOGRAPH FINAL	M032	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PYRITHIONE ZINC	.3	g/100mL			N	20241231
76176-202_33101c62-fa70-2c69-e054-00144ff8d46c	76176-202	HUMAN OTC DRUG	Le Vital Sweet Pea		ethyl alcohol	GEL	TOPICAL	20150723		OTC MONOGRAPH NOT FINAL	part333E	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	g/100g			N	20241231
76176-203_076dcc74-1f9f-a55c-e063-6294a90a3c76	76176-203	HUMAN OTC DRUG	ANTI-PERSPIRANT DEODORANT SPORT		Aluminum Zironium Tetrachlorohydrex GLY	STICK	TOPICAL	20230101		OTC MONOGRAPH DRUG	M019	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	8.6	g/100g			N	20241231
76176-204_07f5dddd-1fbb-1609-e063-6394a90ab7ff	76176-204	HUMAN OTC DRUG	DANDRUFF		pyrithione zinc	SHAMPOO	TOPICAL	20230501		OTC MONOGRAPH DRUG	M032	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	PYRITHIONE ZINC	.3	g/100mL			N	20241231
76176-205_07f5ed5b-3b5b-133a-e063-6294a90ae160	76176-205	HUMAN OTC DRUG	PETROLEUM		PETROLATUM	JELLY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M016	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	WHITE PETROLATUM	100	g/100g			N	20241231
76176-206_07f5dddd-1fbc-1609-e063-6394a90ab7ff	76176-206	HUMAN OTC DRUG	ARCTIC ICE		MENTHOL	GEL	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	MENTHOL	1.25	g/100g			N	20241231
76176-211_7aff8b67-446c-1d19-e053-2991aa0a2c34	76176-211	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ALOE VERA		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-212_7b4fc1c0-4ea7-f047-e053-2a91aa0a1246	76176-212	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ORIGINAL		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-213_7b500bf6-c528-7863-e053-2991aa0ada66	76176-213	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ORIGINAL		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-214_7b500bf6-c539-7863-e053-2991aa0ada66	76176-214	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ORIGINAL 8OZ		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-215_7b50b2e2-1b87-618a-e053-2991aa0a4a57	76176-215	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER LAVENDER 8OZ		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-216_7b50ff0b-4162-1428-e053-2991aa0aa844	76176-216	HUMAN OTC DRUG	NUVALU INSTANT HAND SANITIZER ALOE VERA 8OZ		ETHYL ALCOHOL	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-217_7b50ff0b-416f-1428-e053-2991aa0aa844	76176-217	HUMAN OTC DRUG	NUVALU 100 PURE PETROLEUM		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	100	g/100g			N	20241231
76176-218_7b50b2e2-1bad-618a-e053-2991aa0a4a57	76176-218	HUMAN OTC DRUG	NUVALU PETROLEUM BABY FRESH SCENT		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	99.9	g/100g			N	20241231
76176-219_7b8e0b85-84b6-410b-e053-2991aa0a3d48	76176-219	HUMAN OTC DRUG	NUVALU PETROLEUM BABY FRESH SCENT		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	99.9	g/100g			N	20241231
76176-220_7b8ee331-4830-f0bf-e053-2991aa0a13ea	76176-220	HUMAN OTC DRUG	NUVALU PETROLEUM COCOA BUTTER		WHITE PETROLATUM	JELLY	TOPICAL	20181101		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	99.9	g/100g			N	20241231
76176-221_7b8e0b85-84c2-410b-e053-2991aa0a3d48	76176-221	HUMAN OTC DRUG	NUVALU VAPORIZING CHEST RUB		camphor, eucalyptus oil, menthol	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
76176-222_7b8ee331-4847-f0bf-e053-2991aa0a13ea	76176-222	HUMAN OTC DRUG	NUVALU ICE THERAPY MENTHOL PAIN RELIEVING		menthol	GEL	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd.	MENTHOL	1	g/100g			N	20241231
76176-225_bd5022ed-a094-e79b-e053-2a95a90a81fc	76176-225	HUMAN OTC DRUG	NUVALU HAND SANITIZER SWEET PEA PINK 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-226_bd530bf6-bd97-7958-e053-2a95a90a2f22	76176-226	HUMAN OTC DRUG	NUVALU HAND SANITIZER SWEET PEA BLUE 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
76176-227_be5817eb-b5f3-47b2-e053-2a95a90a2be0	76176-227	HUMAN OTC DRUG	NUVALU HAND SANITIZER GUAVA BURST 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	70	mL/100mL			N	20241231
76176-228_be58c8bc-a610-34df-e053-2995a90a818e	76176-228	HUMAN OTC DRUG	NUVALU HAND SANITIZER VIOLET MIST 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	70	mL/100mL			N	20241231
76176-229_be58f20d-c3d8-6736-e053-2a95a90a1c12	76176-229	HUMAN OTC DRUG	NUVALU HAND SANITIZER ALOHA PINA COLADA 1OZ		ETHYL ALCOHOL	GEL	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333A	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	ALCOHOL	70	mL/100mL			N	20241231
76176-230_0bcf3a8a-e6d9-28b6-e063-6394a90a0662	76176-230	HUMAN OTC DRUG	NUVALU CREAMY PETROLEUM		PETROLATUM	JELLY	TOPICAL	20231101		OTC MONOGRAPH DRUG	M016	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	PETROLATUM	30	g/100g			N	20241231
76176-251_d69f3880-1f7d-dad4-e053-2a95a90a50e3	76176-251	HUMAN OTC DRUG	ARCTIC ICE PAIN RELIEVING		MENTHOL	GEL	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part348	Ningbo Liyuan Daily Chemical Products Co., Ltd.	MENTHOL	2	g/100g			N	20241231
76176-252_d6a142cf-5f14-3282-e053-2a95a90a13ed	76176-252	HUMAN OTC DRUG	MED AID CHEST RUB		camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20120101		OTC MONOGRAPH FINAL	part341	Ningbo Liyuan Daily Chemical Products Co., Ltd.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 1.25	g/100g; g/100g; g/100g			N	20241231
76176-301_83c850c5-8f3e-482c-895e-a5d52f95d5f2	76176-301	HUMAN OTC DRUG	MELLOW HAND SANITIZER (ALOE AND VITAMIN E)		ALCOHOL	GEL	TOPICAL	20170616		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-302_156258ed-f67d-4e27-b051-b6db62d86053	76176-302	HUMAN OTC DRUG	MELLOW HAND SANITIZER (ORIGINAL)	WITH MOISTURIZER AND VITAMIN E	ALCOHOL	GEL	TOPICAL	20170616		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-304_a5b3bdfe-cadd-0c00-e053-2995a90ac0bd	76176-304	HUMAN OTC DRUG	Blue Devil Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200511		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-330_a5f06b3d-e84c-9520-e053-2a95a90ab0d0	76176-330	HUMAN OTC DRUG	Hand Rx Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200511		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
76176-351_b057f83a-2c94-057f-e053-2995a90a9d03	76176-351	HUMAN OTC DRUG	ROYAL CREAMY PETROLEUM		PETROLATUM	JELLY	TOPICAL	20200901		OTC MONOGRAPH FINAL	part347	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	PETROLATUM	30	g/100g			N	20241231
76176-352_b05d1a0e-1d63-7fae-e053-2a95a90a8210	76176-352	HUMAN OTC DRUG	ROYAL CREAMY PETROLEUM COCOA SCENT		PETROLATUM	JELLY	TOPICAL	20200901		OTC MONOGRAPH FINAL	part347	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	PETROLATUM	30	g/100g			N	20241231
76176-353_b05d6d76-5a46-1d16-e053-2995a90ad7f2	76176-353	HUMAN OTC DRUG	BASIC ESSENTIALS ASTRINGENT		SALICYLIC ACID	LIQUID	TOPICAL	20200901		OTC MONOGRAPH FINAL	part333D	NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.	SALICYLIC ACID	5	mg/100mL			N	20241231
76176-361_c69441d7-f9c5-5f9e-e053-2995a90a273e	76176-361	HUMAN OTC DRUG	U COCOA BUTTER PETROLEUM		PETROLATUM	JELLY	TOPICAL	20190101		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	30	g/100g			N	20241231
76176-362_d77d331a-8051-a4cb-e053-2995a90ab0ea	76176-362	HUMAN OTC DRUG	U NOURISHING VITAMIN E PETROLEUM		PETROLATUM	JELLY	TOPICAL	20190101		OTC MONOGRAPH FINAL	part347	Ningbo Liyuan Daily Chemical Products Co., Ltd.	PETROLATUM	30	g/100g			N	20241231
76176-562_64ff385b-4472-88b3-e053-2991aa0a46e5	76176-562	HUMAN OTC DRUG	2PACK 2OZ HAND SANITIZER- CLASSIC		HAND SANITIZER	LIQUID	TOPICAL	20170802		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co.,Ltd.	ALCOHOL	62	mL/1			N	20241231
76176-563_65002b01-e20c-7f49-e053-2991aa0ad772	76176-563	HUMAN OTC DRUG	8OZ INSTANT HAND SANITIZER LAVENDER		HAND SANITIZER	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/1			N	20241231
76176-564_650fa284-5821-588f-e053-2991aa0a9a0e	76176-564	HUMAN OTC DRUG	8OZ HAND SANITIZER W/PUMP ALOE VERA		HAND SANITIZER	LIQUID	TOPICAL	20170201		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	ALCOHOL	70	mL/1			N	20241231
76176-860_6cb24fc2-67ff-27f4-e053-2991aa0a544b	76176-860	HUMAN OTC DRUG	16OZ HYDORGEN PEROXIDE		HYDORGEN PEROXIDE	LIQUID	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Liyuan Daily Chemical Products Co., Ltd.	HYDROGEN PEROXIDE	3	mL/1			N	20241231
76179-025_27037958-0529-4374-bf3d-e74da80a04dc	76179-025	PLASMA DERIVATIVE	KEDBUMIN		Albumin (Human)	INJECTION, SOLUTION	INTRAVENOUS	20110915		BLA	BLA125384	Kedrion S.p.A	ALBUMIN HUMAN	12.5	g/50mL	Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]		N	20241231
76184-0100_d17048f2-a358-4255-aa4c-7622f85dac0a	76184-0100	HUMAN OTC DRUG	DERMASIL ADVANCED		DIMETHICONE	LOTION	TOPICAL	20170830	20241231	OTC MONOGRAPH DRUG	M016	Fantasia Beauty LLC	DIMETHICONE	.01	g/mL	Skin Barrier Activity [PE]		N	
76184-0101_1a3cf28d-d515-4216-9536-beafbaa52874	76184-0101	HUMAN OTC DRUG	DERMASIL DRYSKIN		DIMETHICONE	LOTION	TOPICAL	20170830		OTC MONOGRAPH DRUG	M016	Fantasia Beauty LLC	DIMETHICONE	.01	g/mL	Skin Barrier Activity [PE]		N	20241231
76184-1000_089fe0e3-7be1-ae6c-e063-6394a90a8d3d	76184-1000	HUMAN OTC DRUG	RIPE RASPBERRY HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20201227		OTC MONOGRAPH DRUG	505G(a)(3)	Fantasia Accessories, Ltd.	ALCOHOL	.62	mL/mL			N	20241231
76187-762_0c5bc967-946b-52f5-e063-6394a90ac07e	76187-762	HUMAN OTC DRUG	Ageless Pain Relief		METHYL SALICYLATE, MENTHOL	CREAM	TOPICAL	20110423		OTC MONOGRAPH DRUG	M017	Isagenix International, LLC	MENTHOL; METHYL SALICYLATE	70; 140	mg/mL; mg/mL			N	20241231
76187-850_0c5b86f1-c352-510a-e063-6394a90a0b56	76187-850	HUMAN OTC DRUG	Isa SunGuard SPF 30		ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20110526		OTC MONOGRAPH DRUG	M020	Isagenix International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	23; 60	mg/mL; mg/mL			N	20241231
76187-860_0c7bcb76-01a0-875e-e063-6394a90ad780	76187-860	HUMAN OTC DRUG	Rejuvity moisturizing day cream BROAD SPECTRUM SPF 15 SUNSCREEN		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20130523		OTC MONOGRAPH DRUG	M020	Isagenix International, LLC	TITANIUM DIOXIDE; ZINC OXIDE	10; 65	mg/mL; mg/mL			N	20241231
76204-010_0cf35a21-493e-f028-e063-6294a90a6b3e	76204-010	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate Inhalation Solution		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20220104		ANDA	ANDA214531	Ritedose Pharmaceuticals, LLC	ALBUTEROL SULFATE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76204-011_0cf35a21-493e-f028-e063-6294a90a6b3e	76204-011	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate Inhalation Solution		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20220104		ANDA	ANDA214531	Ritedose Pharmaceuticals, LLC	ALBUTEROL SULFATE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76204-025_0cf3795c-5626-7acb-e063-6394a90a3a2c	76204-025	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium Oral Solution (Concentrate)		Cromolyn Sodium Oral Solution (Concentrate)	SOLUTION, CONCENTRATE	ORAL	20211201		ANDA	ANDA209264	Ritedose Pharmaceuticals, LLC	CROMOLYN SODIUM	100	mg/5mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
76204-026_0cf362f1-2a32-f966-e063-6294a90a5871	76204-026	HUMAN PRESCRIPTION DRUG	Arformoterol Tartrate Inhalation Solution		Arformoterol Tartrate Inhalation Solution	SOLUTION	RESPIRATORY (INHALATION)	20230227		ANDA	ANDA214736	Ritedose Pharmaceuticals, LLC	ARFORMOTEROL TARTRATE	15	ug/2mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76204-028_027df98e-8a9d-0254-e063-6294a90a350f	76204-028	HUMAN PRESCRIPTION DRUG	Cromolyn Sodium Inhalation Solution		Cromolyn Sodium Inhalation Solution	SOLUTION	RESPIRATORY (INHALATION)	20211201		ANDA	ANDA209453	Ritedose Pharmaceuticals, LLC	CROMOLYN SODIUM	20	mg/2mL	Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]		N	20241231
76204-100_0cf35356-36b3-3c83-e063-6394a90a3527	76204-100	HUMAN PRESCRIPTION DRUG	Ipratropium Bromide		Ipratropium Bromide	SOLUTION	RESPIRATORY (INHALATION)	20110201		ANDA	ANDA075693	Ritedose Pharmaceuticals, LLC	IPRATROPIUM BROMIDE	.5	mg/2.5mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
76204-200_0cf3529c-ed52-ea6f-e063-6294a90afeed	76204-200	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20111205		ANDA	ANDA077839	Ritedose Pharmaceuticals, LLC	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76204-600_0cf34c25-4f31-329a-e063-6394a90a928a	76204-600	HUMAN PRESCRIPTION DRUG	IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE		Ipratropium Bromide and Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	20121015		ANDA	ANDA202496	Ritedose Pharmaceuticals, LLC	ALBUTEROL SULFATE; IPRATROPIUM BROMIDE	2.5; .5	mg/3mL; mg/3mL	Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76204-700_0cf37834-6265-6135-e063-6294a90a2bfd	76204-700	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Ritedose Pharmaceuticals, LLC	LEVALBUTEROL HYDROCHLORIDE	.31	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76204-800_0cf37834-6265-6135-e063-6294a90a2bfd	76204-800	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Ritedose Pharmaceuticals, LLC	LEVALBUTEROL HYDROCHLORIDE	.63	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76204-900_0cf37834-6265-6135-e063-6294a90a2bfd	76204-900	HUMAN PRESCRIPTION DRUG	Levalbuterol		Levalbuterol Hydrochloride	SOLUTION	RESPIRATORY (INHALATION)	20160322		ANDA	ANDA203653	Ritedose Pharmaceuticals, LLC	LEVALBUTEROL HYDROCHLORIDE	1.25	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76209-001_088574b4-dedb-9dc1-e063-6294a90a74e3	76209-001	HUMAN OTC DRUG	Shopping Annuity Brand Premium Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20210217		OTC MONOGRAPH DRUG	M020	Market America, Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76209-123_0c5b74ab-a079-2667-e063-6294a90a757e	76209-123	HUMAN OTC DRUG	Cellular Laboratories De-Aging Sunscreen Broad Spectrum SPF 50 Plus		HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE	CREAM	TOPICAL	20110503		OTC MONOGRAPH DRUG	M020	Market America	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76209-234_0c5bb478-7c87-4a3d-e063-6294a90a1000	76209-234	HUMAN OTC DRUG	De-Aging Moisturizing Day Creme With Sunscreen SPF 20		OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE	CREAM	TOPICAL	20110608		OTC MONOGRAPH DRUG	M020	Market America	OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE	75; 30; 30; 4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76209-301_f4374397-7725-3b06-e053-2a95a90a6a89	76209-301	HUMAN OTC DRUG	Lumiere de Vie Daily Brightening Broad Spectrum SPF 50		Lumiere de Vie Daily Brightening Broad Spectrum SPF 50	LOTION	TOPICAL	20200127		OTC MONOGRAPH FINAL	part352	Market America	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
76209-401_ea8c4193-83d9-72fe-e053-2a95a90a29e2	76209-401	HUMAN OTC DRUG	Motives Liquid Powder Mineral Foundation SPF 15		Motives Liquid Powder Mineral Foundation SPF 15	CREAM	TOPICAL	20200928		OTC MONOGRAPH NOT FINAL	part352	Market America	TITANIUM DIOXIDE; ZINC OXIDE	6; 3	g/100g; g/100g			N	20241231
76209-567_b3ce3eb0-5d8d-4539-a0d9-d6cc5df4f509	76209-567	HUMAN OTC DRUG	Cannabicool Pain Relieving Lidocaine Roll-On		Lidocaine HCL	GEL	TOPICAL	20190801		OTC MONOGRAPH NOT FINAL	part348	Market America, Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76229-123_0c5babd5-2026-0faf-e063-6294a90aa1e1	76229-123	HUMAN OTC DRUG	Likewise Hand Moisturizer - Sun Protectant SPF 50		OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20110620		OTC MONOGRAPH DRUG	M020	Likewise Incorporated	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 111.6	mg/mL; mg/mL; mg/mL			N	20241231
76229-234_0c5be140-80db-1501-e063-6294a90a3faf	76229-234	HUMAN OTC DRUG	Likewise Facial Moisturizer - Sun Protectant SPF 50 Oily Skin		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20110620		OTC MONOGRAPH DRUG	M020	Likewise Incorporated	TITANIUM DIOXIDE; ZINC OXIDE	65; 66.5	mg/mL; mg/mL			N	20241231
76229-345_0c5ba509-8b44-1fa2-e063-6294a90a5e1b	76229-345	HUMAN OTC DRUG	Likewise Facial Moisturizer - Sun Protectant SPF 50 Normal to Oily Skin		OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20110620		OTC MONOGRAPH DRUG	M020	Likewise Incorporated	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 111.6	mg/mL; mg/mL; mg/mL			N	20241231
76229-456_0c5baaf8-ed62-5c24-e063-6394a90a9f3c	76229-456	HUMAN OTC DRUG	Likewise Facial Moisturizer - Sun Protectant SPF 50 Normal to Dry Skin		OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20110514		OTC MONOGRAPH DRUG	M020	Likewise Incorporated	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 50; 111.6	mg/mL; mg/mL; mg/mL			N	20241231
76230-727_f52253fa-6db9-ace6-e053-2995a90a2ffa	76230-727	HUMAN OTC DRUG	Everyday Facial Moisturizer And Sunscreen SPF 20		ZINC OXIDE	CREAM	TOPICAL	20110609		OTC MONOGRAPH FINAL	part352	714 Essentials LTD	ZINC OXIDE	163.2	mg/mL			N	20241231
76243-338_b6a6cd72-279a-637f-e053-2995a90af3c6	76243-338	HUMAN OTC DRUG	INSTANT HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201217		OTC MONOGRAPH NOT FINAL	part333E	Dgl Group Ltd.	ALCOHOL	75	mL/100mL			N	20241231
76250-140_f32d1600-1e4f-642e-e053-2a95a90ad1bf	76250-140	HUMAN OTC DRUG	Problend Hand Sanitizer Gel		Ethanol	GEL	TOPICAL	20230125		OTC MONOGRAPH NOT FINAL	part333A	Seatex, LLC	ALCOHOL	70	mL/70mL			N	20241231
76277-122_c6a6571a-d56f-dff9-e053-2995a90a081f	76277-122	HUMAN OTC DRUG	ActivMend		Arnica Montana, Hypericum Perforatum, Ledum Palustre, Rhus Toxicodendron, Ruta Graveolens, Natrum Muraticum	PATCH	TOPICAL	20210209		UNAPPROVED HOMEOPATHIC		Cearna, Inc.	ARNICA MONTANA; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; RUTA GRAVEOLENS FLOWERING TOP; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF	1; 1; 1; 1; 2; 1	[hp_M]/g; [hp_M]/g; [hp_M]/g; [hp_M]/g; [hp_C]/g; [hp_M]/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76277-123_f1eb77a2-687c-1cc4-e053-2a95a90a8009	76277-123	HUMAN OTC DRUG	ActivMend Pro		Arnica Montana, Hypericum Perforatum, Ledum Palustre, Rhus toxicodendron, Ruta graveolens	PATCH	TOPICAL	20210209		UNAPPROVED HOMEOPATHIC		Cearna, Inc.	ARNICA MONTANA; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; RUTA GRAVEOLENS FLOWERING TOP; TOXICODENDRON PUBESCENS LEAF	50; 50; 50; 50; 50	[hp_M]/g; [hp_M]/g; [hp_M]/g; [hp_M]/g; [hp_M]/g			N	20241231
76281-128_a8a680c3-06f3-40ce-aec1-2790435b9c76	76281-128	HUMAN OTC DRUG	Childrens Ibuprofen Oral Suspension	Dye free	IBUPROFEN	SUSPENSION	ORAL	20200930		ANDA	ANDA210602	AptaPharma Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76281-304_2fc9865d-66d5-4fb0-9ea8-82f5981b6562	76281-304	HUMAN OTC DRUG	XL-3 Day Time		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL	LIQUID	ORAL	20180101		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76281-305_95f58511-c4d4-4a9d-b8be-ba0b464f2e59	76281-305	HUMAN OTC DRUG	XL-3 Xtreme		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20180101		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76281-306_2fc9865d-66d5-4fb0-9ea8-82f5981b6562	76281-306	HUMAN OTC DRUG	XL-3 Day Time		ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL	LIQUID	ORAL	20180901		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76281-307_95f58511-c4d4-4a9d-b8be-ba0b464f2e59	76281-307	HUMAN OTC DRUG	XL-3 Xtreme		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20180901		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76281-501_cb6b6620-c09c-4a6c-b243-a04cb59768ba	76281-501	HUMAN OTC DRUG	Nite-Time	COLD/FLU Medicine	ACETAMINOPHEN	LIQUID	ORAL	20180309		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76281-502_48306b6d-5226-48fa-beef-9db9df844a1c	76281-502	HUMAN OTC DRUG	Nite-Time	COLD/FLU Medicine Cherry	ACETAMINOPHEN	LIQUID	ORAL	20180101		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76281-503_5b440237-78c8-458a-b365-8b77ae10fdd3	76281-503	HUMAN OTC DRUG	TUSSIN COUGH	EXPECTORANT COUGH SUPRESSANT DM	DEXTROMETHORPHAN HYDROBROMIDE	LIQUID	ORAL	20200930		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76281-504_9560bce8-d705-4882-87cf-fde3c283513f	76281-504	HUMAN OTC DRUG	TUSSIN CF		DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE	LIQUID	ORAL	20200930		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	10; 100; 5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76281-505_e5ea2a3e-b957-4469-b0ee-b0c5af3cb417	76281-505	HUMAN OTC DRUG	Childrens Allergy		DIPHENHYDRAMINE HYDROCHLORIDE	LIQUID	ORAL	20200930		OTC MONOGRAPH DRUG	M012	AptaPharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76281-507_fcb17b85-ea1d-4390-9e7d-634179472862	76281-507	HUMAN OTC DRUG	Tussin Expectorant		GUAIFENESIN	LIQUID	ORAL	20200930		OTC MONOGRAPH DRUG	M012	AptaPharma, Inc.	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
76281-522_f1654da1-64f7-4c2b-9201-3a7af430ba37	76281-522	HUMAN OTC DRUG	Nighttime Sleep-Aid	Non-Habit Forming	Diphenhydramine HCI	LIQUID	ORAL	20180101		OTC MONOGRAPH DRUG	M017	AptaPharma Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76281-525_9ba5a534-67e1-48bb-8e57-8b3283564e43	76281-525	HUMAN OTC DRUG	Childrens Pain and Fever		ACETAMINOPHEN	SUSPENSION	ORAL	20130821		OTC MONOGRAPH NOT FINAL	part343	AptaPharma Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
76281-526_7b3806ae-eaa1-4d66-89d0-1c983571d02b	76281-526	HUMAN OTC DRUG	Childrens Pain and Fever		ACETAMINOPHEN	SUSPENSION	ORAL	20130821		OTC MONOGRAPH DRUG	M013	AptaPharma Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
76281-537_0e43e21f-d421-4a57-9056-85b2f73aadd8	76281-537	HUMAN OTC DRUG	Stomach Relief - Regular Strength		BISMUTH SUBSALICYLATE	LIQUID	ORAL	20181001		OTC MONOGRAPH DRUG	M008	AptaPharma Inc.	BISMUTH SUBSALICYLATE	525	mg/30mL			N	20241231
76281-538_e1c9aa00-c943-4589-8f0b-92ec76d91897	76281-538	HUMAN OTC DRUG	Stomach Relief - Maximum Strength		BISMUTH SUBSALICYLATE	LIQUID	ORAL	20181001		OTC MONOGRAPH DRUG	M008	AptaPharma Inc.	BISMUTH SUBSALICYLATE	1050	mg/30mL			N	20241231
76281-558_22de45fb-431e-41c3-aafc-f9d8655dc60a	76281-558	HUMAN OTC DRUG	Stomach Relief, Maximum Strength		BISMUTH SUBSALICYLATE	SUSPENSION	ORAL	20200930		OTC MONOGRAPH DRUG	M008	AptaPharma Inc.	BISMUTH SUBSALICYLATE	1050	mg/30mL			N	20241231
76282-044_ae9e2824-8741-4973-b349-a18ce05cb334	76282-044	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Exelan Pharmaceuticals, Inc.	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-045_ae9e2824-8741-4973-b349-a18ce05cb334	76282-045	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Exelan Pharmaceuticals, Inc.	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-046_ae9e2824-8741-4973-b349-a18ce05cb334	76282-046	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Exelan Pharmaceuticals, Inc.	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-047_ae9e2824-8741-4973-b349-a18ce05cb334	76282-047	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Exelan Pharmaceuticals, Inc.	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-048_ae9e2824-8741-4973-b349-a18ce05cb334	76282-048	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Exelan Pharmaceuticals, Inc.	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-049_ae9e2824-8741-4973-b349-a18ce05cb334	76282-049	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20150428		ANDA	ANDA205064	Exelan Pharmaceuticals, Inc.	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-115_9d9239ba-eadd-45f3-a528-f9e2f7e2db04	76282-115	HUMAN PRESCRIPTION DRUG	Lamivudine and Zidovudine		Lamivudine and Zidovudine	TABLET, FILM COATED	ORAL	20150429		ANDA	ANDA203259	Exelan Pharmaceuticals Inc.	LAMIVUDINE; ZIDOVUDINE	150; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]		N	20241231
76282-152_d0aae8af-6204-4dd6-8c05-8137d46a5bb6	76282-152	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20150414		ANDA	ANDA077927	Exelan Pharmaceuticals Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-153_d0aae8af-6204-4dd6-8c05-8137d46a5bb6	76282-153	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20150414		ANDA	ANDA077927	Exelan Pharmaceuticals Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-154_3a2fd599-143e-4dc4-b22c-e08f8b16a19e	76282-154	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20160830		ANDA	ANDA040907	Exelan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	25	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
76282-155_3a2fd599-143e-4dc4-b22c-e08f8b16a19e	76282-155	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20160830		ANDA	ANDA040907	Exelan Pharmaceuticals Inc.	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
76282-200_ed121c1b-359c-471e-913c-4afdf9102c34	76282-200	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		Fosinopril sodium	TABLET	ORAL	20050621		ANDA	ANDA077222	Exelan Pharmaceuticals, Inc.	FOSINOPRIL SODIUM	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-201_ed121c1b-359c-471e-913c-4afdf9102c34	76282-201	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		Fosinopril sodium	TABLET	ORAL	20050621		ANDA	ANDA077222	Exelan Pharmaceuticals, Inc.	FOSINOPRIL SODIUM	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-202_ed121c1b-359c-471e-913c-4afdf9102c34	76282-202	HUMAN PRESCRIPTION DRUG	Fosinopril sodium		Fosinopril sodium	TABLET	ORAL	20050621		ANDA	ANDA077222	Exelan Pharmaceuticals, Inc.	FOSINOPRIL SODIUM	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-208_34b5aecd-39db-43ea-ab05-ca67548d247e	76282-208	HUMAN PRESCRIPTION DRUG	CITALOPRAM HYDROBROMIDE		CITALOPRAM	TABLET	ORAL	20121001		ANDA	ANDA077534	Exelan Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-209_dc86cdd6-0a8a-4e5c-b3c4-8b05388af862	76282-209	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine	TABLET	ORAL	20120425		ANDA	ANDA077533	Exelan Pharmaceuticals Inc.	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
76282-212_5c34aa64-3f25-4d6e-8fbb-98aa3688f72d	76282-212	HUMAN PRESCRIPTION DRUG	SERTRALINE		Sertraline	TABLET, FILM COATED	ORAL	20120820		ANDA	ANDA077397	Exelan Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	25	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-213_5c34aa64-3f25-4d6e-8fbb-98aa3688f72d	76282-213	HUMAN PRESCRIPTION DRUG	SERTRALINE		Sertraline	TABLET, FILM COATED	ORAL	20120820		ANDA	ANDA077397	Exelan Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-214_5c34aa64-3f25-4d6e-8fbb-98aa3688f72d	76282-214	HUMAN PRESCRIPTION DRUG	SERTRALINE		Sertraline	TABLET, FILM COATED	ORAL	20120820		ANDA	ANDA077397	Exelan Pharmaceuticals, Inc.	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-225_9d0b053e-d825-4af2-b923-35d7709da23e	76282-225	HUMAN PRESCRIPTION DRUG	Gemfibrozil		Gemfibrozil	TABLET, FILM COATED	ORAL	20061020		ANDA	ANDA077836	Exelan Pharmaceuticals, Inc.	GEMFIBROZIL	600	mg/1	PPAR alpha [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]		N	20241231
76282-226_5b700833-52ca-46ef-8874-67b56595db24	76282-226	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210315		ANDA	ANDA077869	Exelan Pharmaceuticals, Inc.	ZONISAMIDE	25	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
76282-227_5b700833-52ca-46ef-8874-67b56595db24	76282-227	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20210315		ANDA	ANDA077869	Exelan Pharmaceuticals, Inc.	ZONISAMIDE	50	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
76282-228_5b700833-52ca-46ef-8874-67b56595db24	76282-228	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20060705		ANDA	ANDA077869	Exelan Pharmaceuticals, Inc.	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
76282-237_44d49d27-9fc5-42f5-9366-be150a8d47ea	76282-237	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20071102		ANDA	ANDA077955	Exelan Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76282-238_44d49d27-9fc5-42f5-9366-be150a8d47ea	76282-238	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20071102		ANDA	ANDA077955	Exelan Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76282-239_44d49d27-9fc5-42f5-9366-be150a8d47ea	76282-239	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20071102		ANDA	ANDA077955	Exelan Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76282-246_b044e723-e969-45fa-a4e6-159bfb65267a	76282-246	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078234	Exelan Pharmaceuticals, Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-247_b044e723-e969-45fa-a4e6-159bfb65267a	76282-247	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078234	Exelan Pharmaceuticals, Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-248_b044e723-e969-45fa-a4e6-159bfb65267a	76282-248	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET	ORAL	20090115		ANDA	ANDA078234	Exelan Pharmaceuticals, Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-249_9fe14cf1-e191-4ab7-9a80-eda059c3bd38	76282-249	HUMAN PRESCRIPTION DRUG	Escitalopram oxalate		escitalopram	TABLET, FILM COATED	ORAL	20121001		ANDA	ANDA078604	Exelan Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-250_9fe14cf1-e191-4ab7-9a80-eda059c3bd38	76282-250	HUMAN PRESCRIPTION DRUG	Escitalopram oxalate		escitalopram	TABLET, FILM COATED	ORAL	20121001		ANDA	ANDA078604	Exelan Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-251_9fe14cf1-e191-4ab7-9a80-eda059c3bd38	76282-251	HUMAN PRESCRIPTION DRUG	Escitalopram oxalate		escitalopram	TABLET, FILM COATED	ORAL	20121001		ANDA	ANDA078604	Exelan Pharmaceuticals Inc.	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-256_7238f870-72f1-4e67-9c88-5125522971da	76282-256	HUMAN PRESCRIPTION DRUG	Raloxifene Hydrochloride		Raloxifene Hydrochloride	TABLET, FILM COATED	ORAL	20141112		ANDA	ANDA090842	Exelan Pharmaceuticals, Inc.	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]		N	20241231
76282-257_766c8abb-8497-43f1-8839-dd6c1753c5a7	76282-257	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20150414		ANDA	ANDA078671	Exelan Pharmaceuticals Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-258_766c8abb-8497-43f1-8839-dd6c1753c5a7	76282-258	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20150414		ANDA	ANDA078671	Exelan Pharmaceuticals Inc.	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-278_2095e91a-c59b-401f-b177-207c6666cf0a	76282-278	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	EXELAN PHARMACEUTICALS INC.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-279_2095e91a-c59b-401f-b177-207c6666cf0a	76282-279	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	EXELAN PHARMACEUTICALS INC.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-280_2095e91a-c59b-401f-b177-207c6666cf0a	76282-280	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	EXELAN PHARMACEUTICALS INC.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-281_2095e91a-c59b-401f-b177-207c6666cf0a	76282-281	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20200907		ANDA	ANDA079162	EXELAN PHARMACEUTICALS INC.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-302_f4c39ed7-45e5-400b-a68e-d9a9970c4300	76282-302	HUMAN PRESCRIPTION DRUG	Alfuzosin hydrochloride		Alfuzosin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20121002		ANDA	ANDA090284	Exelan Pharmaceuticals Inc.	ALFUZOSIN HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
76282-309_f313fc00-1f7a-40ea-9d61-29c4bfba2426	76282-309	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20160520		ANDA	ANDA090255	Exelan Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
76282-310_f313fc00-1f7a-40ea-9d61-29c4bfba2426	76282-310	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20160520		ANDA	ANDA090255	Exelan Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
76282-311_f313fc00-1f7a-40ea-9d61-29c4bfba2426	76282-311	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20160520		ANDA	ANDA090255	Exelan Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
76282-312_f313fc00-1f7a-40ea-9d61-29c4bfba2426	76282-312	HUMAN PRESCRIPTION DRUG	HydrALAZINE Hydrochloride		HydrALAZINE Hydrochloride	TABLET	ORAL	20160520		ANDA	ANDA090255	Exelan Pharmaceuticals Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
76282-321_923f7861-e4d8-4b87-8587-fc075b561653	76282-321	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20100426		ANDA	ANDA090705	Exelan Pharmaceuticals, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-323_923f7861-e4d8-4b87-8587-fc075b561653	76282-323	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20100426		ANDA	ANDA090705	Exelan Pharmaceuticals, Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-327_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-327	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	1	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-328_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-328	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	2	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-329_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-329	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	2.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-330_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-330	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	3	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-331_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-331	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	4	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-332_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-332	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-333_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-333	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	6	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-334_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-334	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	7.5	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-335_45e85c4e-ae91-4cf3-bd98-1d5b5aecc7c5	76282-335	HUMAN PRESCRIPTION DRUG	Warfarin Sodium		Warfarin	TABLET	ORAL	20150408		ANDA	ANDA090935	Exelan Pharmaceuticals Inc.	WARFARIN SODIUM	10	mg/1	Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]		N	20241231
76282-336_0631f266-1c3c-430c-ad8b-66e89161f861	76282-336	HUMAN PRESCRIPTION DRUG	Trospium Chloride		Trospium Chloride	TABLET, FILM COATED	ORAL	20170711		ANDA	ANDA091688	Exelan Pharmaceuticals Inc.	TROSPIUM CHLORIDE	20	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
76282-340_509fffe2-2bab-4ae4-8c53-520e1c5eff68	76282-340	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20160610		ANDA	ANDA091305	Exelan Pharmaceuticals, Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-341_509fffe2-2bab-4ae4-8c53-520e1c5eff68	76282-341	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20160610		ANDA	ANDA091305	Exelan Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-342_509fffe2-2bab-4ae4-8c53-520e1c5eff68	76282-342	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20160610		ANDA	ANDA091305	Exelan Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-347_ce5d3fc0-a9d2-41e1-ba2c-3a5ad72cc491	76282-347	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20200727		ANDA	ANDA203455	Exelan Pharmaceuticals Inc.	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
76282-348_ce5d3fc0-a9d2-41e1-ba2c-3a5ad72cc491	76282-348	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20200727		ANDA	ANDA203455	Exelan Pharmaceuticals Inc.	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
76282-349_ce5d3fc0-a9d2-41e1-ba2c-3a5ad72cc491	76282-349	HUMAN PRESCRIPTION DRUG	Nadolol		Nadolol	TABLET	ORAL	20200727		ANDA	ANDA203455	Exelan Pharmaceuticals Inc.	NADOLOL	80	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
76282-377_b22d0aaf-0636-492b-981f-6c220640c1cd	76282-377	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20140414		ANDA	ANDA203135	EXELAN PHARMACEUTICALS, INC.	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
76282-405_20a38b18-352b-47a6-b640-091b42db10aa	76282-405	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	TABLET, FILM COATED	ORAL	20121102		ANDA	ANDA202764	Exelan Pharmaceuticals Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-406_20a38b18-352b-47a6-b640-091b42db10aa	76282-406	HUMAN PRESCRIPTION DRUG	GABAPENTIN		gabapentin	TABLET, FILM COATED	ORAL	20121102		ANDA	ANDA202764	Exelan Pharmaceuticals Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-407_531e94a5-1e37-446c-879a-bafeedf64bd5	76282-407	HUMAN PRESCRIPTION DRUG	Sevelamer carbonate		SEVELAMER CARBONATE	TABLET, FILM COATED	ORAL	20171108		ANDA	ANDA203860	Exelan Pharmaceuticals Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76282-412_6e0d44f6-d0c0-4db5-b0ea-8f52dd2e5613	76282-412	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20150522		ANDA	ANDA090061	Exelan Pharmaceuticals Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
76282-417_3e79fbc7-ef6e-4f2f-99a3-7ae3c1e1eec7	76282-417	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20170322		ANDA	ANDA203508	Exelan Pharmaceuticals Inc.	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-418_3e79fbc7-ef6e-4f2f-99a3-7ae3c1e1eec7	76282-418	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20170322		ANDA	ANDA203508	Exelan Pharmaceuticals Inc.	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-419_3e79fbc7-ef6e-4f2f-99a3-7ae3c1e1eec7	76282-419	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20170322		ANDA	ANDA203508	Exelan Pharmaceuticals Inc.	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-420_3e79fbc7-ef6e-4f2f-99a3-7ae3c1e1eec7	76282-420	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20170322		ANDA	ANDA203508	Exelan Pharmaceuticals Inc.	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-421_3e79fbc7-ef6e-4f2f-99a3-7ae3c1e1eec7	76282-421	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20170322		ANDA	ANDA203508	Exelan Pharmaceuticals Inc.	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-422_3e79fbc7-ef6e-4f2f-99a3-7ae3c1e1eec7	76282-422	HUMAN PRESCRIPTION DRUG	lisinopril		lisinopril	TABLET	ORAL	20170322		ANDA	ANDA203508	Exelan Pharmaceuticals Inc.	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-446_7f4a4f31-58b0-4fe1-bd11-ba5a6ac4f26c	76282-446	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20190501		ANDA	ANDA204058	Exelan Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
76282-447_7f4a4f31-58b0-4fe1-bd11-ba5a6ac4f26c	76282-447	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20190501		ANDA	ANDA204058	Exelan Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
76282-448_7f4a4f31-58b0-4fe1-bd11-ba5a6ac4f26c	76282-448	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20190501		ANDA	ANDA204058	Exelan Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE; LISINOPRIL	25; 20	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
76282-476_4596226a-8cac-466e-b0b9-6415c3b79dd0	76282-476	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20220125		ANDA	ANDA206868	Exelan Pharmaceuticals, Inc.	LANTHANUM CARBONATE	500	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76282-477_4596226a-8cac-466e-b0b9-6415c3b79dd0	76282-477	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20220125		ANDA	ANDA206868	Exelan Pharmaceuticals, Inc.	LANTHANUM CARBONATE	750	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76282-478_4596226a-8cac-466e-b0b9-6415c3b79dd0	76282-478	HUMAN PRESCRIPTION DRUG	Lanthanum carbonate		LANTHANUM CARBONATE	TABLET, CHEWABLE	ORAL	20220125		ANDA	ANDA206868	Exelan Pharmaceuticals, Inc.	LANTHANUM CARBONATE	1000	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76282-480_9fff6e28-19e0-43ad-85c8-57d111b990bb	76282-480	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190201		ANDA	ANDA206556	Exelan Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
76282-481_9fff6e28-19e0-43ad-85c8-57d111b990bb	76282-481	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20170612		ANDA	ANDA206556	Exelan Pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
76282-507_17a72ab9-cae7-43c3-9913-fff5e038970b	76282-507	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20220315		ANDA	ANDA206367	Exelan Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76282-508_17a72ab9-cae7-43c3-9913-fff5e038970b	76282-508	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20220315		ANDA	ANDA206367	Exelan Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76282-509_17a72ab9-cae7-43c3-9913-fff5e038970b	76282-509	HUMAN PRESCRIPTION DRUG	Amlodipine besylate		Amlodipine besylate	TABLET	ORAL	20220315		ANDA	ANDA206367	Exelan Pharmaceuticals, Inc.	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76282-522_a361733d-1de2-403c-aada-13f035ffb15b	76282-522	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Exelan Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-523_a361733d-1de2-403c-aada-13f035ffb15b	76282-523	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Exelan Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	40	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-524_a361733d-1de2-403c-aada-13f035ffb15b	76282-524	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Exelan Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	80	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-525_a361733d-1de2-403c-aada-13f035ffb15b	76282-525	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Exelan Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	120	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-534_a361733d-1de2-403c-aada-13f035ffb15b	76282-534	HUMAN PRESCRIPTION DRUG	Lurasidone Hydrochloride		Lurasidone Hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA208028	Exelan Pharmaceuticals Inc.	LURASIDONE HYDROCHLORIDE	60	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76282-544_87cf38e6-ebcd-4ef8-8c4c-13aa0c413257	76282-544	HUMAN PRESCRIPTION DRUG	Vilazodone Hydrochloride		Vilazodone Hydrochloride	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA208200	Exelan Pharmaceuticals Inc.	VILAZODONE HYDROCHLORIDE	10	mg/1			N	20241231
76282-545_87cf38e6-ebcd-4ef8-8c4c-13aa0c413257	76282-545	HUMAN PRESCRIPTION DRUG	Vilazodone hydrochloride		Vilazodone hydrochloride	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA208200	Exelan Pharmaceuticals Inc.	VILAZODONE HYDROCHLORIDE	20	mg/1			N	20241231
76282-546_87cf38e6-ebcd-4ef8-8c4c-13aa0c413257	76282-546	HUMAN PRESCRIPTION DRUG	Vilazodone hydrochloride		Vilazodone hydrochloride	TABLET, FILM COATED	ORAL	20221201		ANDA	ANDA208200	Exelan Pharmaceuticals Inc.	VILAZODONE HYDROCHLORIDE	40	mg/1			N	20241231
76282-568_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-568	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	25	mg/1		CV	N	20241231
76282-569_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-569	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	50	mg/1		CV	N	20241231
76282-570_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-570	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	75	mg/1		CV	N	20241231
76282-571_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-571	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	100	mg/1		CV	N	20241231
76282-572_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-572	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	150	mg/1		CV	N	20241231
76282-573_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-573	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	200	mg/1		CV	N	20241231
76282-574_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-574	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	225	mg/1		CV	N	20241231
76282-575_ffea406a-d87e-46a3-a5b2-2a2cddff0b3b	76282-575	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA211384	Exelan Pharmaceuticals Inc.	PREGABALIN	300	mg/1		CV	N	20241231
76282-627_923f7861-e4d8-4b87-8587-fc075b561653	76282-627	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20180913		ANDA	ANDA090705	Exelan Pharmaceuticals, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-628_34b5aecd-39db-43ea-ab05-ca67548d247e	76282-628	HUMAN PRESCRIPTION DRUG	CITALOPRAM HYDROBROMIDE		CITALOPRAM	TABLET	ORAL	20171110		ANDA	ANDA077534	Exelan Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-629_34b5aecd-39db-43ea-ab05-ca67548d247e	76282-629	HUMAN PRESCRIPTION DRUG	CITALOPRAM HYDROBROMIDE		CITALOPRAM	TABLET	ORAL	20171110		ANDA	ANDA077534	Exelan Pharmaceuticals Inc.	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
76282-640_c53a81a4-fad8-4587-ac13-cc4de968485e	76282-640	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20190417		ANDA	ANDA205710	Exelan Pharmaceuticals, Inc.	BUDESONIDE	.25	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76282-641_c53a81a4-fad8-4587-ac13-cc4de968485e	76282-641	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20190417		ANDA	ANDA205710	Exelan Pharmaceuticals, Inc.	BUDESONIDE	.5	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76282-642_c53a81a4-fad8-4587-ac13-cc4de968485e	76282-642	HUMAN PRESCRIPTION DRUG	Budesonide	Inhalation Suspension	Budesonide	INHALANT	ORAL	20190419		ANDA	ANDA205710	Exelan Pharmaceuticals, Inc.	BUDESONIDE	1	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76282-643_2feb2e90-dc79-4542-87c5-42653c624704	76282-643	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20220701		ANDA	ANDA207178	Exelan Pharmaceuticals, Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76282-644_2feb2e90-dc79-4542-87c5-42653c624704	76282-644	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20220701		ANDA	ANDA207178	Exelan Pharmaceuticals, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76282-645_2feb2e90-dc79-4542-87c5-42653c624704	76282-645	HUMAN PRESCRIPTION DRUG	SILDENAFIL		SILDENAFIL	TABLET	ORAL	20220701		ANDA	ANDA207178	Exelan Pharmaceuticals, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76282-663_b7bac1be-2e94-461b-b0e3-51a8f881f831	76282-663	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20191018		ANDA	ANDA209903	EXELAN PHARMACEUTICALS INC.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-664_831095de-d22d-496d-834c-c4505e639c87	76282-664	HUMAN PRESCRIPTION DRUG	Sevelamer carbonate		SEVELAMER CARBONATE	TABLET, FILM COATED	ORAL	20171026		ANDA	ANDA203860	Exelan Pharmaceuticals Inc.	SEVELAMER CARBONATE	800	mg/1	Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76282-670_37481fc5-771f-4dc7-aa06-6913ab75d485	76282-670	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Exelan Pharmaceuticals, Inc.	RAMIPRIL	1.25	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-671_37481fc5-771f-4dc7-aa06-6913ab75d485	76282-671	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Exelan Pharmaceuticals, Inc.	RAMIPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-672_37481fc5-771f-4dc7-aa06-6913ab75d485	76282-672	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Exelan Pharmaceuticals, Inc.	RAMIPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-673_37481fc5-771f-4dc7-aa06-6913ab75d485	76282-673	HUMAN PRESCRIPTION DRUG	Ramipril		Ramipril	CAPSULE	ORAL	20080618		ANDA	ANDA077900	Exelan Pharmaceuticals, Inc.	RAMIPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-674_d4eda09a-6371-49ea-bc20-054b55e432e4	76282-674	HUMAN PRESCRIPTION DRUG	CINACALCET		CINACALCET	TABLET	ORAL	20200414		ANDA	ANDA208915	EXELAN PHARMACEUTICALS INC.	CINACALCET HYDROCHLORIDE	30	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
76282-675_d4eda09a-6371-49ea-bc20-054b55e432e4	76282-675	HUMAN PRESCRIPTION DRUG	CINACALCET		CINACALCET	TABLET	ORAL	20200414		ANDA	ANDA208915	EXELAN PHARMACEUTICALS INC.	CINACALCET HYDROCHLORIDE	60	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
76282-676_d4eda09a-6371-49ea-bc20-054b55e432e4	76282-676	HUMAN PRESCRIPTION DRUG	CINACALCET		CINACALCET	TABLET	ORAL	20200414		ANDA	ANDA208915	EXELAN PHARMACEUTICALS INC.	CINACALCET HYDROCHLORIDE	90	mg/1	Calcium-sensing Receptor Agonist [EPC], Increased Calcium-sensing Receptor Sensitivity [MoA]		N	20241231
76282-677_09bb7f3f-5d80-4f4b-b681-4878830cd971	76282-677	HUMAN PRESCRIPTION DRUG	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE		EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	TABLET, FILM COATED	ORAL	20210406		ANDA	ANDA090958	Exelan Pharmaceuticals, Inc.	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
76282-679_3449ab68-28d3-42f5-8d34-329bf6fa0e6b	76282-679	HUMAN PRESCRIPTION DRUG	ALBUTEROL SULFATE		albuterol sulfate	INHALANT	RESPIRATORY (INHALATION)	20211004		ANDA	ANDA209959	Exelan Pharmaceuticals, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76282-681_2012c7a8-8aa7-4c18-a8c3-fe74d74ac873	76282-681	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20210202		ANDA	ANDA076768	EXELAN PHARMACEUTICALS INC.	ALENDRONATE SODIUM	35	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
76282-682_2012c7a8-8aa7-4c18-a8c3-fe74d74ac873	76282-682	HUMAN PRESCRIPTION DRUG	ALENDRONATE SODIUM		Alendronate sodium	TABLET	ORAL	20210202		ANDA	ANDA076768	EXELAN PHARMACEUTICALS INC.	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
76282-697_4814da57-b841-4be1-8011-f9c06d3e1fbf	76282-697	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Exelan Pharmaceuticals, Inc.	LENALIDOMIDE	5	mg/1	Thalidomide Analog [EPC]		N	20241231
76282-698_4814da57-b841-4be1-8011-f9c06d3e1fbf	76282-698	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Exelan Pharmaceuticals, Inc.	LENALIDOMIDE	10	mg/1	Thalidomide Analog [EPC]		N	20241231
76282-699_4814da57-b841-4be1-8011-f9c06d3e1fbf	76282-699	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Exelan Pharmaceuticals, Inc.	LENALIDOMIDE	15	mg/1	Thalidomide Analog [EPC]		N	20241231
76282-701_4814da57-b841-4be1-8011-f9c06d3e1fbf	76282-701	HUMAN PRESCRIPTION DRUG	lenalidomide		lenalidomide	CAPSULE	ORAL	20220906		ANDA	ANDA210435	Exelan Pharmaceuticals, Inc.	LENALIDOMIDE	25	mg/1	Thalidomide Analog [EPC]		N	20241231
76282-702_06b669de-f1f1-4754-9cec-1f51a1198a3a	76282-702	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	CAPSULE	ORAL	20231201		ANDA	ANDA217467	Exelan Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76282-703_06b669de-f1f1-4754-9cec-1f51a1198a3a	76282-703	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	CAPSULE	ORAL	20231201		ANDA	ANDA217467	Exelan Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76282-704_06b669de-f1f1-4754-9cec-1f51a1198a3a	76282-704	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	CAPSULE	ORAL	20231201		ANDA	ANDA217467	Exelan Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76282-706_cc3b53de-378a-4460-a7f6-c214e0896afb	76282-706	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Exelan Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-707_cc3b53de-378a-4460-a7f6-c214e0896afb	76282-707	HUMAN PRESCRIPTION DRUG	GABAPENTIN		Gabapentin	TABLET	ORAL	20211001		ANDA	ANDA214957	Exelan Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76282-712_86b2f46c-a7d2-42f3-bf16-aefe0b57f5f7	76282-712	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220310		ANDA	ANDA091625	EXELAN PHARMACEUTICALS, INC.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-713_86b2f46c-a7d2-42f3-bf16-aefe0b57f5f7	76282-713	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220310		ANDA	ANDA091625	EXELAN PHARMACEUTICALS, INC.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-714_86b2f46c-a7d2-42f3-bf16-aefe0b57f5f7	76282-714	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220310		ANDA	ANDA091625	EXELAN PHARMACEUTICALS, INC.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76282-715_2696c9c1-fdbb-4135-862e-ab4cd18ad2aa	76282-715	HUMAN PRESCRIPTION DRUG	PIRFENIDONE		PIRFENIDONE	CAPSULE	ORAL	20220802		ANDA	ANDA212077	EXELAN PHARMACEUTICALS INC.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
76282-716_3449172d-fe07-4924-ad05-89b854600aeb	76282-716	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220802		ANDA	ANDA212078	EXELAN PHARMACEUTICALS INC.	PIRFENIDONE	801	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
76282-717_3449172d-fe07-4924-ad05-89b854600aeb	76282-717	HUMAN PRESCRIPTION DRUG	Pirfenidone		Pirfenidone	TABLET, COATED	ORAL	20220802		ANDA	ANDA212078	EXELAN PHARMACEUTICALS INC.	PIRFENIDONE	267	mg/1	Pyridone [EPC], Pyridones [CS]		N	20241231
76282-721_f3388e9a-2c36-de8d-e053-2a95a90aa213	76282-721	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230117		ANDA	ANDA214608	Exelan Pharmaceuticals	PRAZOSIN HYDROCHLORIDE	1	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
76282-722_f3388e9a-2c36-de8d-e053-2a95a90aa213	76282-722	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230117		ANDA	ANDA214608	Exelan Pharmaceuticals	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
76282-723_f3388e9a-2c36-de8d-e053-2a95a90aa213	76282-723	HUMAN PRESCRIPTION DRUG	Prazosin Hydrochloride		Prazosin Hydrochloride	CAPSULE	ORAL	20230117		ANDA	ANDA214608	Exelan Pharmaceuticals	PRAZOSIN HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
76282-728_e5eb4355-a956-464b-ac7e-7f54acefcf85	76282-728	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Exelan Pharmaceuticals, Inc	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-729_e5eb4355-a956-464b-ac7e-7f54acefcf85	76282-729	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Exelan Pharmaceuticals, Inc	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-730_e5eb4355-a956-464b-ac7e-7f54acefcf85	76282-730	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Exelan Pharmaceuticals, Inc	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-731_e5eb4355-a956-464b-ac7e-7f54acefcf85	76282-731	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Exelan Pharmaceuticals, Inc	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-732_e5eb4355-a956-464b-ac7e-7f54acefcf85	76282-732	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Exelan Pharmaceuticals, Inc	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-733_e5eb4355-a956-464b-ac7e-7f54acefcf85	76282-733	HUMAN PRESCRIPTION DRUG	LISINOPRIL		LISINOPRIL	TABLET	ORAL	20230407		ANDA	ANDA076102	Exelan Pharmaceuticals, Inc	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
76282-739_b9fa33ae-039e-4192-bda0-7797932d2653	76282-739	HUMAN PRESCRIPTION DRUG	OSELTAMIVIR PHOSPHATE		OSELTAMIVIR PHOSPHATE	FOR SUSPENSION	ORAL	20231201		ANDA	ANDA212858	Exelan Pharmaceuticals, Inc.	OSELTAMIVIR PHOSPHATE	6	mg/mL	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76282-740_1c09ec9b-5913-42d4-92e2-34d26682556a	76282-740	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	TABLET	ORAL	20231201		ANDA	ANDA213329	Exelan Pharmaceuticals, Inc.	PHYTONADIONE	5	mg/1	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20251231
76287-876_4e75e0ef-1b5a-4ef0-927c-63c3b650ee09	76287-876	HUMAN OTC DRUG	FresHands Instant Foaming Antiseptic Hand and Body Wash		CHLOROXYLENOL	SOAP	TOPICAL	20170104		OTC MONOGRAPH NOT FINAL	part333E	Spa Concepts, Inc.	CHLOROXYLENOL	3	mg/mL			N	20241231
76293-015_c18980de-f1aa-715d-e053-2a95a90ad9b1	76293-015	HUMAN OTC DRUG	Avail Body with Sunscreen		Homosalate, Octocrylene, Octisalate, and Avobenzone	LOTION	TOPICAL	20141104		OTC MONOGRAPH NOT FINAL	part352	Emeis Cosmetics Pty Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1050; 3500; 1750; 2800	mg/35g; mg/35g; mg/35g; mg/35g			N	20241231
76293-055_b3eacc5d-a7a4-0f0d-e053-2a95a90aa4de	76293-055	HUMAN OTC DRUG	Avail Facial Sunscreen SPF 25		Homosalate, Octocrylene, Octisalate, Avobenzone	LOTION	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part352	Emeis Cosmetics Pty Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 40; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
76293-372_ccabd647-ecde-7230-e053-2a95a90a7a96	76293-372	HUMAN OTC DRUG	Sage and Zinc Facial Hydrating SPF15		Zinc Oxide	LOTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Emeis Cosmetics Pty Ltd	ZINC OXIDE	195	mg/g			N	20241231
76297-001_dfbc89fc-dc3f-450c-bb42-cf1295dca50b	76297-001	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAVENOUS	20170525		ANDA	ANDA207956	LABORATORIOS GRIFOLS SA	SODIUM CHLORIDE	9	g/1000mL			N	20241231
76297-006_968c3a2e-d855-41a5-a687-8415af956f3a	76297-006	HUMAN PRESCRIPTION DRUG	Anticoagulant Sodium Citrate		Trisodium Citrate Dihydrate	SOLUTION	EXTRACORPOREAL	20191025		ANDA	BA125697	LABORATORIOS GRIFOLS SA	TRISODIUM CITRATE DIHYDRATE	40	mg/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
76305-300_0a95b0e6-05bd-0854-e063-6394a90a5140	76305-300	HUMAN OTC DRUG	China-Gel	Topical Pain Reliever	Menthol and Camohor (synthetic)	CREAM	TOPICAL	20000819		OTC MONOGRAPH DRUG	M017	China-Gel, LLC	CAMPHOR (SYNTHETIC); MENTHOL	30; 50	mg/g; mg/g			N	20241231
76305-301_0a95be8a-1de7-92e5-e063-6294a90a174c	76305-301	HUMAN OTC DRUG	China-Gel	Topical Pain Reliever	Menthol and Camohor (synthetic)	CREAM	TOPICAL	20150401		OTC MONOGRAPH DRUG	M017	China-Gel, LLC	CAMPHOR (SYNTHETIC); MENTHOL	30; 50	mg/g; mg/g			N	20241231
76305-302_0a95dad6-f638-d8e2-e063-6294a90a47d3	76305-302	HUMAN OTC DRUG	Aulief	Topical Pain Reliever	Menthol and Camohor	CREAM	TOPICAL	20190514		OTC MONOGRAPH DRUG	M017	China-Gel, LLC	CAMPHOR (NATURAL); MENTHOL	30; 50	mg/g; mg/g			N	20241231
76305-402_0a0d563e-f71b-b11c-e063-6294a90ababb	76305-402	HUMAN OTC DRUG	China-Gel		Menthol and Camohor (synthetic)	CREAM	TOPICAL	20220211		OTC MONOGRAPH DRUG	M017	China-Gel, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	30; 50	mg/g; mg/g			N	20241231
76309-100_0daad4cd-1075-bcca-e063-6394a90ab8cf	76309-100	HUMAN OTC DRUG	SnugZ SPF 30 Soy Lip Balm		SPF 30 Soy Lip Balm	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SnugZ/USA, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.14; .23; .37	g/4.67g; g/4.67g; g/4.67g			N	20251231
76309-200_0daab837-6094-b472-e063-6394a90a360f	76309-200	HUMAN OTC DRUG	SnugZ SPF 15 Beeswax Lip Balm		SPF 15 Beeswax Lip Balm	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SnugZ/USA, LLC	AVOBENZONE; OCTINOXATE	.09; .35	g/4.67g; g/4.67g			N	20251231
76309-250_0daacdd3-b8fc-bea3-e063-6394a90a8a24	76309-250	HUMAN OTC DRUG	SnugZ SPF 15 Flavored Beeswax Lip Balm		SPF 15 Flavored Beeswax Lip Balm	STICK	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SnugZ/USA, LLC	AVOBENZONE; OCTINOXATE	.09; .35	g/4.67g; g/4.67g			N	20251231
76309-301_0ddbdc6c-020c-b1a3-e063-6394a90ada62	76309-301	HUMAN OTC DRUG	SnugZ Hand Sanitizer Gel		Hand Sanitizer Gel	GEL	TOPICAL	20180101		OTC MONOGRAPH DRUG	M003	SnugZ/USA, LLC	ALCOHOL	70	mL/100mL			N	20241231
76309-351_0daab837-6095-b472-e063-6394a90a360f	76309-351	HUMAN OTC DRUG	SnugZ Beaded Hand Sanitizer Gel		Beaded Hand Sanitizer Gel	GEL	TOPICAL	20180101		OTC MONOGRAPH DRUG	M003	SnugZ/USA, LLC	ALCOHOL	70	mL/100mL			N	20241231
76309-400_0daa9134-2f9e-8cf1-e063-6294a90a1f7b	76309-400	HUMAN OTC DRUG	SnugZ SPF 30 Broad Spectrum Sunscreen		SPF 30 Broad Spectrum Sunscreen	LOTION	TOPICAL	20180101		OTC MONOGRAPH DRUG	M020	SnugZ/USA, LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	.000714; .00198; .0018	mg/28mL; mg/28mL; mg/28mL			N	20251231
76309-451_0daacdd3-b8fd-bea3-e063-6394a90a8a24	76309-451	HUMAN OTC DRUG	SnugZ Hand Sanitizing Spry		Hand Sanitizer Spray	SPRAY	TOPICAL	20190101		OTC MONOGRAPH DRUG	M003	SnugZ/USA, LLC	ALCOHOL	70	mL/100mL			N	20241231
76309-525_0daad028-4168-b080-e063-6294a90a14b7	76309-525	HUMAN OTC DRUG	SnugZ SPF 50 Sunscreen Spry		SPF 50 Sunscreen Spray	SPRAY	TOPICAL	20190601		OTC MONOGRAPH DRUG	M020	SnugZ USA	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.84; 4.2; 1.4; 2.8	g/28mL; g/28mL; g/28mL; g/28mL			N	20251231
76309-551_0daad476-bd26-bd5d-e063-6394a90ac74a	76309-551	HUMAN OTC DRUG	SnugZ SPF 50 Broad Spectrum Sunscreen		SPF 50 Broad Spectrum Sunscreen	LOTION	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	SnugZ/USA, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2.7; 6.7; 4.5; 4.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
76310-017_26e61d61-cc06-49d2-ab32-e4da8ae7a6aa	76310-017	HUMAN PRESCRIPTION DRUG	Ethyol		amifostine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200101		NDA	NDA020221	Clinigen Limited	AMIFOSTINE	500	mg/10mL	Cytoprotective Agent [EPC], Free Radical Scavenging Activity [MoA]		N	20241231
76310-022_7032fe1c-0860-4bd1-bee9-245f3a825dee	76310-022	HUMAN PRESCRIPTION DRUG	Proleukin		aldesleukin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19920505		BLA	BLA103293	Clinigen Limited	ALDESLEUKIN	1.1	mg/mL	Increased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interleukin-2 [CS], Lymphocyte Growth Factor [EPC]		N	20241231
76310-024_6b533566-4390-4017-a686-42db9b43f835	76310-024	HUMAN PRESCRIPTION DRUG	Foscavir		foscarnet sodium	INJECTION, SOLUTION	INTRAVENOUS	20140401		NDA	NDA020068	Clinigen Limited	FOSCARNET SODIUM	24	mg/mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
76310-024_ab62dd50-b9f2-4ce7-bad3-4832336160d1	76310-024	HUMAN PRESCRIPTION DRUG	Foscavir		FOSCARNET SODIUM	INJECTION, SOLUTION	INTRAVENOUS	20210406		NDA	NDA020068	Clinigen Limited	FOSCARNET SODIUM	24	mg/mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
76310-024_bd1b879e-f5cf-4a72-9be8-bc3ad54e4845	76310-024	HUMAN PRESCRIPTION DRUG	Foscavir		foscarnet sodium	INJECTION, SOLUTION	INTRAVENOUS	20120709		NDA	NDA020068	Clinigen Limited	FOSCARNET SODIUM	24	mg/mL	Chelating Activity [MoA], DNA Polymerase Inhibitors [MoA], Pyrophosphate Analog DNA Polymerase Inhibitor [EPC], Pyrophosphate Analog [EXT]		N	20241231
76314-002_0b58f5d5-37db-da6e-e063-6394a90a804c	76314-002	HUMAN OTC DRUG	FixMySkin Healing Balm Fragrance-Free		HYDROCORTISONE	OINTMENT	TOPICAL	20091231		OTC MONOGRAPH DRUG	M017	Lovely Skin, Inc.	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76314-003_0b58f836-2617-5d03-e063-6294a90a6d8b	76314-003	HUMAN OTC DRUG	FixMySkin Healing Balm Unflavored		HYDROCORTISONE	OINTMENT	TOPICAL	20111117		OTC MONOGRAPH DRUG	M017	Lovely Skin, Inc.	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76314-004_0b58fdc4-2027-6467-e063-6294a90abd33	76314-004	HUMAN OTC DRUG	FixMySkin Healing Balm Vanilla Flavor		HYDROCORTISONE	OINTMENT	TOPICAL	20111117		OTC MONOGRAPH DRUG	M017	Lovely Skin, Inc.	HYDROCORTISONE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76315-1052_777cdecd-a8fa-4109-bdb5-5ab383c06d17	76315-1052	HUMAN OTC DRUG	Bac-Off		Foaming Hand Sanitizer	AEROSOL, FOAM	TOPICAL	20220815		OTC MONOGRAPH DRUG	M	DeVere Company, Inc.	BENZALKONIUM CHLORIDE	100	g/100L			N	20251231
76318-334_d6019460-717e-4285-9582-06646e8f778a	76318-334	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F-18	INJECTION, SOLUTION	INTRAVENOUS	20111030		ANDA	ANDA204333	Massachusetts General Hospital	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
76318-643_483561c7-747d-40a7-8ed7-134eac3da69c	76318-643	HUMAN PRESCRIPTION DRUG	Ammonia N 13		ammonia n-13	INJECTION, SOLUTION	INTRAVENOUS	20160203		ANDA	ANDA207025	Massachusetts General Hospital	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
76326-001_289f1038-12cd-4ca1-91f0-38e1b3563e77	76326-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose	F18	Fludeoxyglucose F18	INJECTION	INTRAVENOUS	20150717		ANDA	ANDA204531	The Regents of the University of Michigan	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
76328-100_fe980cd8-fb02-4042-881e-cdf30fbf2d6d	76328-100	HUMAN OTC DRUG	Ancient Secrets	Breathe Again	Sodium Chloride	AEROSOL, SPRAY	NASAL	20110815		OTC MONOGRAPH FINAL	part349	LOTUS BRANDS, INC.	SODIUM CHLORIDE	20	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76328-221_fff6588e-b4c0-4a0d-bdef-8bcb1b5630e4	76328-221	HUMAN OTC DRUG	EcoDent Ultimate Essential Mouthcare	Spicy-Cool Cinnamon	SODIUM BICARBONATE	LIQUID	ORAL	20130601		OTC MONOGRAPH NOT FINAL	part356	Lotus Brands, Inc.	SODIUM BICARBONATE	25	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76328-223_774a2cef-b101-4dd4-be22-a070e87a2a6e	76328-223	HUMAN OTC DRUG	EcoDent Ultimate Essential Mouthcare	Sparkling Clean Mint	SODIUM BICARBONATE	LIQUID	ORAL	20130601		OTC MONOGRAPH NOT FINAL	part356	Lotus Brands, Inc.	SODIUM BICARBONATE	25	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76329-1240_6ae3bac4-5a2a-47ff-b613-2014518a8365	76329-1240	HUMAN PRESCRIPTION DRUG	Phytonadione		Phytonadione	INJECTION, EMULSION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20030418		ANDA	ANDA083722	International Medication Systems, Limited	PHYTONADIONE	1	mg/.5mL	Increased Prothrombin Activity [PE], Reversed Anticoagulation Activity [PE], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC]		N	20241231
76329-1469_9b970090-1b9f-48c8-997d-0cc5e87579ad	76329-1469	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION	PARENTERAL	19880401		ANDA	ANDA072076	International Medication Systems, Limited	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
76329-1912_15b3760b-a073-4480-a7f5-01ed5524db31	76329-1912	HUMAN PRESCRIPTION DRUG	Morphine Sulfate		Morphine Sulfate	INJECTION	INTRAVENOUS	20220120		ANDA	ANDA202861	International Medication Systems, Limited	MORPHINE SULFATE	1	mg/30mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76329-3011_51e08341-a68e-4116-b17b-a006a807b4d6	76329-3011	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	19790807		ANDA	ANDA086283	International Medication Systems, Limited	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76329-3012_51e08341-a68e-4116-b17b-a006a807b4d6	76329-3012	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	19790807		ANDA	ANDA086283	International Medication Systems, Limited	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76329-3013_51e08341-a68e-4116-b17b-a006a807b4d6	76329-3013	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	19790807		ANDA	ANDA086283	International Medication Systems, Limited	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76329-3015_51e08341-a68e-4116-b17b-a006a807b4d6	76329-3015	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	JELLY	TOPICAL	19790807		ANDA	ANDA086283	International Medication Systems, Limited	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76329-3301_872f0955-2da1-49c0-8b21-8f48115ef533	76329-3301	HUMAN PRESCRIPTION DRUG	Dextrose Monohydrate		Dextrose Monohydrate	INJECTION	PARENTERAL	20000601		UNAPPROVED DRUG OTHER		International Medication Systems, Limited	DEXTROSE MONOHYDRATE	500	mg/mL			N	20241231
76329-3302_45b366a9-6c0c-4643-9951-4ff880b29c83	76329-3302	HUMAN PRESCRIPTION DRUG	Dextrose Monohydrate		Dextrose Monohydrate	INJECTION, SOLUTION	INTRAVENOUS	20211111		ANDA	ANDA203451	International Medication Systems, Limited	DEXTROSE MONOHYDRATE	25	g/50mL			N	20241231
76329-3304_40d52b3b-b94f-4c8d-a07e-7473410dc130	76329-3304	HUMAN PRESCRIPTION DRUG	Calcium Chloride		Calcium Chloride	INJECTION	INTRAVENOUS; INTRAVENTRICULAR	20180708		ANDA	ANDA203477	International Medication Systems, Limited	CALCIUM CHLORIDE	100	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76329-3316_e6e743c3-bb1e-4d6d-853b-b975dc9f1d79	76329-3316	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRACARDIAC; INTRAVENOUS	19761201		UNAPPROVED DRUG OTHER		International Medication Systems, Limited	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
76329-3318_60d11fad-22ff-4b96-9d0c-ec94dbd586d6	76329-3318	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAVENOUS	20230130		NDA	NDA211363	International Medication Systems, Limited	EPINEPHRINE	.1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
76329-3321_350f0b8b-7ae6-4b31-8aa3-2178f5c869d7	76329-3321	HUMAN PRESCRIPTION DRUG	Regadenoson		Regadenoson	INJECTION, SOLUTION	INTRAVENOUS	20230420		ANDA	ANDA214252	International Medication Systems, Limited	REGADENOSON ANHYDROUS	.08	mg/mL	Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]		N	20241231
76329-3340_afe410bb-2a70-448e-b69e-bee4416e31e8	76329-3340	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	INJECTION	INTRAVENOUS	20210217		ANDA	ANDA212461	International Medication Systems, Limited	ATROPINE SULFATE	.1	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
76329-3352_74a86dc7-0929-40d0-9661-9f9063a8fd7d	76329-3352	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		Sodium Bicarbonate	INJECTION	INTRAVENOUS	20000601		ANDA	ANDA203449	International Medication Systems, Limited	SODIUM BICARBONATE	84	mg/mL			N	20241231
76329-3369_9b970090-1b9f-48c8-997d-0cc5e87579ad	76329-3369	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION	PARENTERAL	20010601		ANDA	ANDA072076	International Medication Systems, Limited	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
76329-3390_3d910bb6-792f-41f3-8b28-b33bcbec5ccb	76329-3390	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION	INTRAVENOUS	20010601		ANDA	ANDA083173	International Medication Systems, Limited	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76329-3399_f3adde99-01db-4dee-a59d-9434cbb88495	76329-3399	HUMAN PRESCRIPTION DRUG	Procainamide Hydrochloride		Procainamide Hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20161221		ANDA	ANDA088636	International Medication Systems, Limited	PROCAINAMIDE HYDROCHLORIDE	100	mg/mL	Antiarrhythmic [EPC]		N	20241231
76329-3469_2ab20a74-a067-4d43-84fb-fe331192c34b	76329-3469	HUMAN PRESCRIPTION DRUG	Naloxone Hydrochloride		Naloxone Hydrochloride	INJECTION	PARENTERAL	20160728		ANDA	ANDA072076	International Medication Systems, Limited	NALOXONE HYDROCHLORIDE	1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
76329-6300_8e30c3dd-67a2-4973-9325-1765b95c047d	76329-6300	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	TOPICAL	20120619		ANDA	ANDA086364	International Medication Systems, Limited	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76329-8261_ac83af71-9706-477f-8d49-01dc8553a052	76329-8261	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20121201		ANDA	ANDA076150	International Medication Systems, Limited	LORAZEPAM	2	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76329-9060_28514b47-96db-46ec-bfd9-f5772967810e	76329-9060	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20200519		ANDA	ANDA211880	International Medication Systems, Limited	EPINEPHRINE	1	mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
76333-170_09ffa1bb-23fb-a399-e063-6294a90a7ccd	76333-170	HUMAN PRESCRIPTION DRUG	Ezetimibe		Ezetimibe	TABLET	ORAL	20220630		ANDA	ANDA215693	Orient Pharma Co., Ltd.	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
76336-080_cad08567-e091-4732-b53b-ae18b7b8a022	76336-080	HUMAN PRESCRIPTION DRUG	Lysodren		mitotane	TABLET	ORAL	19781015		NDA	NDA016885	HRA Pharma Rare Diseases	MITOTANE	500	mg/1	Cytochrome P450 3A4 Inducers [MoA]		N	20241231
76336-455_72aae5c8-f14e-4439-8b5e-5b67abd20fad	76336-455	HUMAN PRESCRIPTION DRUG	Metopirone		Metyrapone	CAPSULE, GELATIN COATED	ORAL	19620125		NDA	NDA012911	HRA Pharma Rare Diseases	METYRAPONE	250	mg/1	Adrenal Steroid Synthesis Inhibitor [EPC], Adrenal Steroid Synthesis Inhibitors [MoA]		N	20241231
76344-8005_f1ec9ba8-a023-63c2-e053-2a95a90a72c6	76344-8005	HUMAN OTC DRUG	Rejuve Sunscreen 100		Inc Oxide,Octinoxate,Octisalate,Homosalate,Titanium Dioxide	CREAM	TOPICAL	20201201		OTC MONOGRAPH FINAL	part352	HUMEX,INC.	HOMOSALATE; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	3; 6; 4; 2; 9	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
76344-8006_f1ecb705-b0ce-b58d-e053-2a95a90a6d0f	76344-8006	HUMAN OTC DRUG	Mild Care Suncream		Zinc Oxide	CREAM	TOPICAL	20210101		OTC MONOGRAPH FINAL	part352	HUMEX,INC.	ZINC OXIDE	15.44	g/100mL			N	20241231
76346-073_d0d82f40-83f0-4433-876b-ef28628f2e05	76346-073	HUMAN PRESCRIPTION DRUG	Korlym		Mifepristone	TABLET	ORAL	20120217		NDA	NDA202107	Corcept Therapeutics Incorporated	MIFEPRISTONE	300	mg/1	Progestational Hormone Receptor Antagonists [MoA], Progestin Antagonist [EPC]		N	20241231
76348-401_97f7d5fa-d798-2927-e053-2995a90ac35c	76348-401	HUMAN OTC DRUG	Molecular AF		tolnaftate	OIL	TOPICAL	20110701		OTC MONOGRAPH FINAL	M005	Renu Laboratories, Inc.	TOLNAFTATE	.01	mg/mL			N	20241231
76348-402_d5c9e15b-7e83-d9a5-e053-2995a90a9725	76348-402	HUMAN OTC DRUG	Molecular AF Molecular Cream		Molecular AF Molecular Cream	CREAM	TOPICAL	20150331		OTC MONOGRAPH FINAL	part333C	Renu Laboratories, Inc.	MICONAZOLE NITRATE	.3	g/14g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
76348-403_f43797ed-74e5-a541-e053-2995a90acf88	76348-403	HUMAN OTC DRUG	ROOVEMAG Magnesium Soothing Warming Cream		Arnica Montana, Hamamelis Virginiana, Magnesia Sulphurica	CREAM	TOPICAL	20230301		UNAPPROVED HOMEOPATHIC		RENU LABORATORIES, INC.	ARNICA MONTANA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; MAGNESIUM SULFATE HEPTAHYDRATE	.6; .6; .12	g/60g; g/60g; g/60g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76348-404_f7a8dfa2-28a4-6070-e053-6394a90a83ce	76348-404	HUMAN OTC DRUG	RooveMag Magnesium Soothing Cream Lavender		Arnica, Witch Hazel, Magnesium Sulfate	CREAM	TOPICAL	20230424		UNAPPROVED HOMEOPATHIC		RENU LABORATORIES, INC.	ARNICA MONTANA FLOWER; MAGNESIUM SULFATE ANHYDROUS; WITCH HAZEL	.6; .12; .6	g/60g; g/60g; g/60g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76348-405_d5e3426d-5eb7-e8be-e053-2a95a90a0637	76348-405	HUMAN OTC DRUG	Renu Laboratories Drying		Acne Drying Lotion	SUSPENSION	TOPICAL	20150406		OTC MONOGRAPH FINAL	part333D	Renu Laboratories, Inc.	SULFUR	1.4	g/14g			N	20241231
76348-409_d57c1168-4500-cece-e053-2995a90a27e7	76348-409	HUMAN OTC DRUG	Dr. Canuso foot repair serum		Tolnaftate serum	LOTION	TOPICAL	20150820		OTC MONOGRAPH FINAL	part333C	Renu Laboratories, Inc.	TOLNAFTATE	.3	g/28g			N	20241231
76348-410_d57c0e4a-ee73-e438-e053-2a95a90aeda5	76348-410	HUMAN OTC DRUG	Dr CANUSO fungal nail eraser		Tolnaftate Oil	OIL	TOPICAL	20150811		OTC MONOGRAPH FINAL	part333C	Renu Laboratories, Inc.	TOLNAFTATE	.3	g/28g			N	20241231
76348-413_d59016b8-ff44-e40d-e053-2995a90ab47f	76348-413	HUMAN OTC DRUG	Margarite Zinc Cream		Zinc Cream	CREAM	TOPICAL	20151013		OTC MONOGRAPH FINAL	part333D	Renu Laboratories, Inc.	SULFUR	1.12	g/28g			N	20241231
76348-414_d5794985-97b6-3b24-e053-2a95a90a5a92	76348-414	HUMAN OTC DRUG	ARCTIC HEAT		Menthol, Methyl Salicylate	CREAM	TOPICAL	20150917		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL; METHYL SALICYLATE	2.24; 11.2	g/112g; g/112g			N	20241231
76348-450_d5c9e15b-7e88-d9a5-e053-2995a90a9725	76348-450	HUMAN OTC DRUG	Renu Laboratories Acne Sulphur L		Acne Sulfur Lotion	SUSPENSION	TOPICAL	20150416		OTC MONOGRAPH FINAL	part333D	Renu Laboratories, Inc.	SULFUR	1.4	g/14g			N	20241231
76348-454_d57c916b-de5f-93c6-e053-2a95a90a380c	76348-454	HUMAN OTC DRUG	Elevate Heating Therapy TWIST UP		Menthol cream	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	2.8	g/56g			N	20241231
76348-455_d57c7fee-52fb-613c-e053-2a95a90a458f	76348-455	HUMAN OTC DRUG	ELEVATE CBD HEATING THERAPY		MENTHOL	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	5.6	g/112g			N	20241231
76348-456_d57c85bc-4eb0-3fc9-e053-2a95a90a3917	76348-456	HUMAN OTC DRUG	elevate COOLING THERAPY TWIST UP		Menthol	CREAM	TOPICAL	20191001		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL	2.8	g/56g			N	20241231
76348-458_d57c85bc-4eb2-3fc9-e053-2a95a90a3917	76348-458	HUMAN OTC DRUG	elevate HEATING THERAPY		Menthol	CREAM	TOPICAL	20191104		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL	2.8	g/56g			N	20241231
76348-480_d5c9e83d-60d4-fb9c-e053-2995a90a9731	76348-480	HUMAN OTC DRUG	Natural Relief 1222		Bryonia 6x, Rhus Toxicodendron 6x	LOTION	TOPICAL	20200220		UNAPPROVED HOMEOPATHIC		RENU LABORATORIES, INC.	BRYONIA ALBA ROOT; TOXICODENDRON PUBESCENS LEAF	2.24; 2.24	g/224g; g/224g			N	20241231
76348-481_e15775a3-833d-14ae-e053-2995a90a5ece	76348-481	HUMAN OTC DRUG	SOLID ROOTS ROLL-ON RELIEF		Menthol 3 percent	LIQUID	TOPICAL	20220613		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	.84	g/28g			N	20241231
76348-500_d5e34b76-c7db-8ed6-e053-2a95a90aca00	76348-500	HUMAN OTC DRUG	Renu Laboratories Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Renu Laboratories, Inc.	ALCOHOL	44.8	g/56g			N	20241231
76348-501_d5e35248-298b-d332-e053-2995a90a2afe	76348-501	HUMAN OTC DRUG	Renu Laboratories Isopropyl Alcohol 75% Hand Sanitizer		Isopropyl Alcohol	SPRAY	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Renu Laboratories, Inc.	ISOPROPYL ALCOHOL	42	g/56g			N	20241231
76348-505_03372376-ef07-943d-e063-6394a90a52ee	76348-505	HUMAN OTC DRUG	Bae Sciences Menthol Muscle Rub		Menthol Muscle Rub	LOTION	TOPICAL	20230821		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL	5	g/95g			N	20241231
76348-510_f3f7702e-f3d0-3333-e053-2995a90ac5ad	76348-510	HUMAN OTC DRUG	Mag 5 PT Cooling Formula Recovery Cream		Menthol	CREAM	TOPICAL	20190319		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	22.7	g/454g			N	20241231
76348-511_f3f8260e-6e69-1576-e053-2995a90aa586	76348-511	HUMAN OTC DRUG	MAG 5 PT WARMING FORMULA		Menthol	CREAM	TOPICAL	20190319		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	5.6	g/112g			N	20241231
76348-580_d5c9dd2c-b8ec-1406-e053-2995a90a0287	76348-580	HUMAN OTC DRUG	pediadermics eczema 3		Colloidal Oatmeal, Dimethicone	CREAM	TOPICAL	20201001		OTC MONOGRAPH FINAL	part347	Renu Laboratories, Inc.	DIMETHICONE; OATMEAL	3.36; .168	g/168g; g/168g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Skin Barrier Activity [PE]		N	20241231
76348-581_d58ff26e-132f-0c82-e053-2995a90a0c33	76348-581	HUMAN OTC DRUG	Herbal Healers Menthol Warming Roll On		Menthol	LIQUID	TOPICAL	20201012		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL	4.2	g/84g			N	20241231
76348-585_da840bf6-ed64-bafc-e053-2a95a90a92d5	76348-585	HUMAN OTC DRUG	PEDIADERMICS ECZEMA 2		Hydrocortisone	SPRAY	TOPICAL	20220318		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	HYDROCORTISONE	1.12	g/112g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76348-598_f95329c2-a7e1-a85f-e053-6394a90ae68f	76348-598	HUMAN OTC DRUG	Impact Melanoma SPF 30		ZINC OXIDE	LOTION	TOPICAL	20230417		OTC MONOGRAPH NOT FINAL	part352	RENU LABORATORIES, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 10; 12.5; 17.5	g/1000g; g/1000g; g/1000g; g/1000g			N	20241231
76348-640_c24fff8a-fb22-6d6b-e053-2995a90a1831	76348-640	HUMAN OTC DRUG	PAIN THERAPY		Menthol, Methyl Salicylate	CREAM	TOPICAL	20210514		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL; METHYL SALICYLATE	2.24; 11.2	g/112g; g/112g			N	20241231
76348-640_c29c1aea-5e8c-61fd-e053-2995a90a9b22	76348-640	HUMAN OTC DRUG	PAIN THERAPY		Menthol, Methyl Salicylate	CREAM	TOPICAL	20210514		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL; METHYL SALICYLATE	2.24; 11.2	g/112g; g/112g			N	20241231
76348-650_c8c251e1-ab0c-edba-e053-2995a90abfd4	76348-650	HUMAN OTC DRUG	KidZGoo Natural Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210730		OTC MONOGRAPH NOT FINAL	part352	RENU LABORATORIES, INC.	ZINC OXIDE	98.56	g/448g			N	20241231
76348-660_c94fd093-a09e-f4e8-e053-2995a90ad861	76348-660	HUMAN OTC DRUG	OP 6 MENTHOL WARMING ROLL ON		MENTHOL	LIQUID	TOPICAL	20210802		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	4.2	g/84g			N	20241231
76348-670_c9b2e269-9d3c-acc7-e053-2a95a90a0806	76348-670	HUMAN OTC DRUG	OP 6 MENTHOL COOLING ROLL ON		MENTHOL	LIQUID	TOPICAL	20210802		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	4.2	g/84g			N	20241231
76348-675_c9b48a9e-d6a0-65a7-e053-2995a90a0baf	76348-675	HUMAN OTC DRUG	Bright Guard Sport SPF		ZINC SPF	LOTION	TOPICAL	20210701		OTC MONOGRAPH NOT FINAL	part352	RENU LABORATORIES, INC.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	70; 10; 12.5; 17.5	g/1000g; g/1000g; g/1000g; g/1000g			N	20241231
76348-676_e7035fcd-6895-3360-e053-2a95a90a6f1d	76348-676	HUMAN OTC DRUG	Bright Guard Natural SPF 30		Zinc Oxide	LOTION	TOPICAL	20220824		OTC MONOGRAPH FINAL	M020	Renu Laboratories, Inc.	ZINC OXIDE	209	g/950g			N	20241231
76348-680_cbab04af-2d76-5360-e053-2a95a90a245d	76348-680	HUMAN OTC DRUG	op6 Menthol Cooling Pain Cream		Menthol	CREAM	TOPICAL	20210910		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL	5.6	g/112g			N	20241231
76348-681_cbfbc90f-a4bf-1372-e053-2995a90a0880	76348-681	HUMAN OTC DRUG	op6 Menthol Warming Pain Cream		Menthol	CREAM	TOPICAL	20210914		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL	5.6	g/112g			N	20241231
76348-685_08f56c9e-921d-4e48-e063-6294a90a56db	76348-685	HUMAN OTC DRUG	Clear Reflection Complexion Acne Treatment Serum		Salicylic Acid 2%	GEL	TOPICAL	20231030		OTC MONOGRAPH DRUG	M006	Renu Laboratories, Inc.	SALICYLIC ACID	1.04	g/52mL			N	20241231
76348-690_cc35681c-69f7-4830-e053-2995a90a2dc4	76348-690	HUMAN OTC DRUG	Just Chill Pain Relief		Menthol 5 percent	LIQUID	TOPICAL	20210920		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	1.4	g/28g			N	20241231
76348-695_cc850426-c0a1-c9a9-e053-2995a90aa799	76348-695	HUMAN OTC DRUG	Just ADD HEAT Pain Relief		Menthol 5 percent	LIQUID	TOPICAL	20210921		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	1.4	g/28g			N	20241231
76348-720_e4e298ee-f3d5-dea7-e053-2a95a90a0560	76348-720	HUMAN OTC DRUG	DermaRad Relief		Lidocaine Emulsion	EMULSION	TOPICAL	20220103		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	ALLANTOIN; LIDOCAINE	1.18; 4.72	g/118mL; g/118mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76348-725_ddcf1c2e-2f68-44d7-e053-2a95a90a812b	76348-725	HUMAN OTC DRUG	Calm and Correct Serum with Lidocaine		Lidocaine 3 percent	LIQUID	TOPICAL	20220802		OTC MONOGRAPH FINAL	M015	Renu Laboratories, Inc.	LIDOCAINE	1.5	g/50mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76348-800_cd38dce6-2664-bfce-e053-2995a90a63bf	76348-800	HUMAN OTC DRUG	Mars Wellness Mg PLUS Pain Cream		Arnica, Magnesium Sulphurica, Witch Hazel	CREAM	TOPICAL	20210910		UNAPPROVED HOMEOPATHIC		Renu Laboratories, Inc.	ARNICA MONTANA; MAGNESIUM SULFATE ANHYDROUS; WITCH HAZEL	1.12; 2.24; 1.12	g/112g; g/112g; g/112g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76348-804_fc8bcde9-26e9-a35f-e053-6394a90a3300	76348-804	HUMAN OTC DRUG	HEALING TREE CALMING ANTI-ITCH		Hydrocortisone	CREAM	TOPICAL	20230526		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	HYDROCORTISONE	.59	mg/59mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76348-810_dae7673c-4353-b9d7-e053-2995a90a96da	76348-810	HUMAN OTC DRUG	MARS WELLNESS MAGNESIUM		MENTHOL	SPRAY	TOPICAL	20220323		UNAPPROVED HOMEOPATHIC		RENU LABORATORIES, INC.	ARNICA MONTANA; MAGNESIUM SULFATE, UNSPECIFIED; WITCH HAZEL	1.12; .12; .11	g/112g; g/112g; g/112g	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76348-825_0427bbc9-f4c1-0eb6-e063-6294a90a7199	76348-825	HUMAN OTC DRUG	Baby Mantra Diaper Cream		Zinc Oxide 10%	OINTMENT	TOPICAL	20240103		OTC MONOGRAPH DRUG	M016	Renu Laboratories, Inc.	ZINC OXIDE	10	g/100mL			N	20251231
76348-890_02e3dd2c-45d9-9419-e063-6294a90a2206	76348-890	HUMAN OTC DRUG	ADARA Acne 911 Drying		Acne Drying Lotion	SUSPENSION	TOPICAL	20230814		OTC MONOGRAPH DRUG	M006	Renu Laboratories, Inc.	SULFUR	1.4	g/14g			N	20241231
76348-900_d04e5e54-6b8b-c7cb-e053-2a95a90aaf6e	76348-900	HUMAN OTC DRUG	Inspiration Academy Menthol Cooling Pain Cream		Menthol 5 percent	CREAM	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part348	Renu Laboratories, Inc.	MENTHOL	5.6	g/112g			N	20241231
76348-950_d590047a-9516-fac2-e053-2995a90ae161	76348-950	HUMAN OTC DRUG	INSPIRATION ACADEMY MENTHOL COOLING ROLL ON		MENTHOL	LIQUID	TOPICAL	20211011		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	4.2	g/84g			N	20241231
76348-960_d8df7f63-d44a-bc4d-e053-2995a90a3f7c	76348-960	HUMAN OTC DRUG	INKED SCIENCE LIDOCAINE 4 Percent		Lidocaine HCL	CREAM	TOPICAL	20201020		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	LIDOCAINE HYDROCHLORIDE	2.24	g/56g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76348-970_e5d6490d-34cf-19ac-e053-2995a90ab24b	76348-970	HUMAN OTC DRUG	DermaRad Relief Post Radiation Calming		Lidocaine 3 percent	LIQUID	TOPICAL	20220808		OTC MONOGRAPH FINAL	M015	Renu Laboratories, Inc.	LIDOCAINE	1.5	g/50mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76348-990_f1875a4f-fc47-cb91-e053-2995a90addeb	76348-990	HUMAN OTC DRUG	FLAWLESS NAILS		Tolnaftate	SOLUTION	TOPICAL	20230403		OTC MONOGRAPH FINAL	M005	RENU LABORATORIES, INC.	TOLNAFTATE	1	g/100mL			N	20241231
76348-995_f1877b83-30fd-7c8f-e053-2a95a90a7d1b	76348-995	HUMAN OTC DRUG	Nail Renu		Tolnaftate 1%	SOLUTION	TOPICAL	20230322		OTC MONOGRAPH FINAL	M005	RENU LABORATORIES, INC.	TOLNAFTATE	1	g/100mL			N	20241231
76348-996_fa2f9539-b704-a00b-e053-6394a90ae309	76348-996	HUMAN OTC DRUG	SUGARLOAF ORGANICS MENTHOL REVIVE		Menthol	CREAM	TOPICAL	20230425		OTC MONOGRAPH NOT FINAL	part348	RENU LABORATORIES, INC.	MENTHOL	5.9	g/118mL			N	20241231
76348-997_003d6dd9-f806-3185-e063-6394a90afc94	76348-997	HUMAN OTC DRUG	NAIL RENU Antifungal		Miconazole Nitrate 2%	CREAM	TOPICAL	20230717		OTC MONOGRAPH FINAL	M005	RENU LABORATORIES, INC.	MICONAZOLE NITRATE	.6	g/28g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
76348-998_06820449-1fe1-0e7d-e063-6294a90aad52	76348-998	HUMAN OTC DRUG	STEEL CITY GREATS MENTHOL REVIVE		Menthol	CREAM	TOPICAL	20230907		OTC MONOGRAPH DRUG	M017	RENU LABORATORIES, INC.	MENTHOL	5.9	g/118mL			N	20241231
76349-001_0802760c-cc0b-8290-e063-6294a90a71e9	76349-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20110701		NDA	NDA205767	Southern Gas and Supply LLC	OXYGEN	995	mL/L			N	20241231
76349-002_08025a83-212c-c949-e063-6394a90a52bc	76349-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20111101		NDA	NDA205766	Southern Gas & Supply LLC	NITROGEN	995	mL/L			N	20241231
76354-120_0a276d4e-4adf-2437-e063-6294a90aae21	76354-120	HUMAN OTC DRUG	Naturium Sulfur Spot Treatment 8%		Sulfur	LIQUID	TOPICAL	20220617		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SULFUR	80	mg/mL			N	20241231
76354-121_0a4a2ef0-8dd9-d16a-e063-6394a90a1f44	76354-121	HUMAN OTC DRUG	Naturium Encapsulated Salicylic Acid Moisturizer 0.75%		Salicylic Acid	LOTION	TOPICAL	20220617		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SALICYLIC ACID	7.5	mg/g			N	20241231
76354-122_0a27dd57-ee5b-4c88-e063-6294a90a61f1	76354-122	HUMAN OTC DRUG	Naturium Salicylic Acid Serum 2%		Salicylic Acid	LIQUID	TOPICAL	20220617		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
76354-123_0a2790b7-0908-7c14-e063-6394a90a8b30	76354-123	HUMAN OTC DRUG	Naturium Benzoyl Peroxide Cleanser 5%		Benzoyl Peroxide	CREAM	TOPICAL	20220617		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	BENZOYL PEROXIDE	50	mg/mL			N	20241231
76354-124_0a3dc8fe-4227-85fa-e063-6294a90ad359	76354-124	HUMAN OTC DRUG	Naturium Salicylic Acid Body 2%		Salicylic Acid	AEROSOL, SPRAY	TOPICAL	20221201		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
76354-125_0a3dc999-cfd8-85ae-e063-6294a90aca95	76354-125	HUMAN OTC DRUG	Naturium UV Reflect Antioxidant SPF 50		Homosalate, Octisalate, Avobenzone	LOTION	TOPICAL	20230410		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
76354-130_0d850e8c-b842-bfae-e063-6394a90aa534	76354-130	HUMAN OTC DRUG	Naturium Dew-Glow Moisturizer SPF 50		Homosalate, Octisalate, Avobenzone	LOTION	TOPICAL	20221024		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
76354-131_0d860c0b-68bf-fcb9-e063-6294a90abbae	76354-131	HUMAN OTC DRUG	Naturium Dew Glow Tinted Moisturizer SPF50		Homosalate, Octisalate, Avobenzone	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	g/50mL; g/50mL; g/50mL			N	20241231
76354-132_0d86d1ac-58ed-6f97-e063-6294a90a3bf6	76354-132	HUMAN OTC DRUG	Naturium Dew Glow Tinted Moisturizer SPF50-medium		Homosalate, Octisalate, Avobenzone	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	g/50mL; g/50mL; g/50mL			N	20241231
76354-133_0d869813-3632-5b6a-e063-6294a90a6d1d	76354-133	HUMAN OTC DRUG	Naturium Dew Glow Tinted Moisturizer SPF50-deep		Homosalate, Octisalate, Avobenzone	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	g/50mL; g/50mL; g/50mL			N	20241231
76354-194_098738da-208b-8b6a-e063-6294a90ae6e2	76354-194	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	e.l.f. Cosmetics, Inc	ALCOHOL	.62	mL/mL			N	20241231
76354-210_09876f3d-694b-c403-e063-6394a90a502a	76354-210	HUMAN OTC DRUG	ELF Blemish Control Face Primer Clear		SALICYLIC ACID	CREAM	TOPICAL	20170817		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
76354-412_09877a6d-6fbc-c7cc-e063-6394a90a0b18	76354-412	HUMAN OTC DRUG	Acne Fighting Putty Primer		SALICYLIC ACID	CREAM	TOPICAL	20210220		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SALICYLIC ACID	18	mg/g			N	20241231
76354-413_0987eb55-6e21-ce4a-e063-6294a90a1c30	76354-413	HUMAN OTC DRUG	Acne Spot Treatment		SALICYLIC ACID	LIQUID	TOPICAL	20210901		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SALICYLIC ACID	18	mg/mL			N	20241231
76354-414_098847c6-ba8d-f79c-e063-6294a90a3046	76354-414	HUMAN OTC DRUG	Acne Fighting Spot Gel		SALICYLIC ACID	GEL	TOPICAL	20220225		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SALICYLIC ACID	10	mg/mL			N	20241231
76354-415_0c534cbd-40f2-8af0-e063-6394a90a5605	76354-415	HUMAN OTC DRUG	Acne Clarifying Cleanser		SALICYLIC ACID	LIQUID	TOPICAL	20220225		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc.	SALICYLIC ACID	10	mg/mL			N	20241231
76354-416_098847c6-bab3-f79c-e063-6294a90a3046	76354-416	HUMAN OTC DRUG	Acne Calming Water Cream		SALICYLIC ACID	CREAM	TOPICAL	20220225		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc.	SALICYLIC ACID	10	mg/mL			N	20241231
76354-417_098847c6-ba9a-f79c-e063-6294a90a3046	76354-417	HUMAN OTC DRUG	Blemish Control Basics Kit		SALICYLIC ACID	KIT		20220225		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc						N	20241231
76354-418_0988517f-b298-1902-e063-6394a90a901a	76354-418	HUMAN OTC DRUG	e.l.f Skin Acne-Treating Body Mist		SALICYLIC ACID	LIQUID	TOPICAL	20230415		OTC MONOGRAPH DRUG	M006	e.l.f. Cosmetics, Inc	SALICYLIC ACID	20	mg/mL			N	20241231
76354-441_09885453-3278-1e5a-e063-6294a90aba07	76354-441	HUMAN OTC DRUG	e.l.f. Holy Hydration Face Cream SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20210220		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 70	mg/g; mg/g; mg/g; mg/g			N	20241231
76354-442_09883a8c-44a9-f566-e063-6294a90a320d	76354-442	HUMAN OTC DRUG	KEYS SOULCARE DAILY MOISTURIZER BROAD SPECTRUM SPF30 SUNSCREEN		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20220430		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76354-443_09885963-226f-20c5-e063-6294a90ab59d	76354-443	HUMAN OTC DRUG	e.l.f Whoa Glow Broad Spectrum SPF30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20220915		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76354-443_0c53c3b6-1eea-972a-e063-6394a90afd03	76354-443	HUMAN OTC DRUG	e.l.f Whoa Glow Broad Spectrum SPF30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20220915		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76354-444_09885c7d-8386-1e5c-e063-6294a90a66c7	76354-444	HUMAN OTC DRUG	e.l.f Invisible Sunscreen SPF 35		AVOBENZONE, OCTISALATE, OCTOCRYLENE, HOMOSALATE	CREAM	TOPICAL	20230215		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76354-445_0988517f-b2a5-1902-e063-6394a90a901a	76354-445	HUMAN OTC DRUG	Whoa Glow broad spectrum spf 30 sunscreen Sheer Bronze shimmer		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230515		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76354-446_098861b7-9294-2289-e063-6394a90a2edb	76354-446	HUMAN OTC DRUG	Whoa Glow broad spectrum spf 30 sunscreen Sheer Champagne shimmer sunlight		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230515		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76354-450_09886422-4451-1e78-e063-6394a90a07a8	76354-450	HUMAN OTC DRUG	BB SPF20		OCTINOXATE, OCTISALATE, OXYBENZONE	CREAM	TOPICAL	20191020		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; OCTISALATE; OXYBENZONE	60; 40; 35	mg/mL; mg/mL; mg/mL			N	20241231
76354-470_09886654-551a-184d-e063-6394a90a80ff	76354-470	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 1C		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-471_098861b7-92a4-2289-e063-6394a90a2edb	76354-471	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 2w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-472_09885453-3288-1e5a-e063-6294a90aba07	76354-472	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 4W		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-473_09886d69-cb3b-1498-e063-6294a90a50f8	76354-473	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 6w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-474_09886fc5-b38d-2b12-e063-6394a90a3e21	76354-474	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 9w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-475_09885453-3298-1e5a-e063-6294a90aba07	76354-475	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 10w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-476_09886654-552a-184d-e063-6394a90a80ff	76354-476	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 11w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-477_09885c7d-8399-1e5c-e063-6294a90a66c7	76354-477	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 12w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-478_09886fc5-b39d-2b12-e063-6394a90a3e21	76354-478	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 13w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-479_09887b61-27e3-fa00-e063-6394a90aeb58	76354-479	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 14w		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-480_09887b61-27f3-fa00-e063-6394a90aeb58	76354-480	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 3N		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-481_09887b61-2803-fa00-e063-6394a90aeb58	76354-481	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 5N		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-482_09885963-2280-20c5-e063-6294a90ab59d	76354-482	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 7N		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-483_09886fc5-b3ad-2b12-e063-6394a90a3e21	76354-483	HUMAN OTC DRUG	Well People Bio Tint SPF 30 Sunscreen 8N		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-490_09886fc5-b3bd-2b12-e063-6394a90a3e21	76354-490	HUMAN OTC DRUG	Well People Lip Butter SPF 15 Sunscreen NATURAL		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	100	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-491_09886fc5-b3cd-2b12-e063-6394a90a3e21	76354-491	HUMAN OTC DRUG	Well People Lip Butter SPF 15 Sunscreen WINE		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	100	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-492_09885c7d-83a9-1e5c-e063-6294a90a66c7	76354-492	HUMAN OTC DRUG	Well People Lip Butter SPF 15 Sunscreen PEACH		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	100	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-493_09885453-32a8-1e5a-e063-6294a90aba07	76354-493	HUMAN OTC DRUG	Well People Lip Butter SPF 15 Sunscreen AFTERGLOW		ZINC OXIDE	CREAM	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	ZINC OXIDE	100	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-601_098861b7-92b4-2289-e063-6394a90a2edb	76354-601	HUMAN OTC DRUG	ELF Porcelain ACNE Fighting Foundation		SALICYLIC ACID	CREAM	TOPICAL	20150809		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
76354-602_09885963-2290-20c5-e063-6294a90ab59d	76354-602	HUMAN OTC DRUG	ELF Buff ACNE Fighting Foundation		SALICYLIC ACID	CREAM	TOPICAL	20151010		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
76354-603_09885c7d-83b9-1e5c-e063-6294a90a66c7	76354-603	HUMAN OTC DRUG	ELF Beige ACNE Fighting Foundation		SALICYLIC ACID	CREAM	TOPICAL	20151010		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
76354-604_09886fc5-b3dd-2b12-e063-6394a90a3e21	76354-604	HUMAN OTC DRUG	ELF Sand ACNE Fighting Foundation		SALICYLIC ACID	CREAM	TOPICAL	20150809		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
76354-616_09886422-4460-1e78-e063-6394a90a07a8	76354-616	HUMAN OTC DRUG	ELF ACNE Fighting Spot Gel with Aloe Clear		SALICYLIC ACID	GEL	TOPICAL	20151020		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	1	g/100mL			N	20241231
76354-624_09889827-2487-3c32-e063-6394a90a2d4b	76354-624	HUMAN OTC DRUG	ELF Clear Blemish Control Face Primer		SALICYLIC ACID	CREAM	TOPICAL	20151010		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	2	g/100mL			N	20241231
76354-627_09889827-2493-3c32-e063-6394a90a2d4b	76354-627	HUMAN OTC DRUG	ELF Oil free flawless Finish SPF 15 Sunscreen Foundation Buff		OCTISALATE	CREAM	TOPICAL	20160104		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTISALATE; TITANIUM DIOXIDE	2; 5.5	g/100mL; g/100mL			N	20241231
76354-631_098861b7-92c0-2289-e063-6394a90a2edb	76354-631	HUMAN OTC DRUG	ELF Flawless Finish Foundation Oil Free SPF 15 Sunscreen Light Ivory		TITANIUM DIOXIDE	CREAM	TOPICAL	20170526		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE	4; 3; 4.45	g/100mL; g/100mL; g/100mL			N	20241231
76354-650_09887b61-2813-fa00-e063-6394a90aeb58	76354-650	HUMAN OTC DRUG	Glow Radiant Moisturizer SPF 15		OCTINOXATE, OCTOCRYLENE, OCTISALATE, OXYBENZONE, AVOBENZONE	CREAM	TOPICAL	20181001		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	25; 71; 45; 38; 28	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76354-705_0988c059-f642-4181-e063-6394a90a2b76	76354-705	HUMAN OTC DRUG	ELF ACNE Fighting Foundation Caramel		SALICYLIC ACID	CREAM	TOPICAL	20150809		OTC MONOGRAPH DRUG	M032	e.l.f. Cosmetics, Inc	SALICYLIC ACID	.5	g/100mL			N	20241231
76354-770_0988c414-9a21-4c61-e063-6394a90a9c85	76354-770	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Fair 100 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-771_09889827-249f-3c32-e063-6394a90a2d4b	76354-771	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Fair 120 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-772_0988c829-1314-3f39-e063-6394a90a8f57	76354-772	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Fair 125 C		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-773_0988c414-9a31-4c61-e063-6394a90a9c85	76354-773	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Fair 140 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-774_0988c059-f64e-4181-e063-6394a90a2b76	76354-774	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Fair 150 C		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-775_0988c829-1324-3f39-e063-6394a90a8f57	76354-775	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Light 205 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-776_09889827-24af-3c32-e063-6394a90a2d4b	76354-776	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Light 210 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-777_0988c414-9a41-4c61-e063-6394a90a9c85	76354-777	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Light 240 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-778_09889827-24bf-3c32-e063-6394a90a2d4b	76354-778	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Light 250 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-779_0988c829-1334-3f39-e063-6394a90a8f57	76354-779	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Light 280 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-780_0988c829-1344-3f39-e063-6394a90a8f57	76354-780	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Medium 310 C		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-781_0988c829-1355-3f39-e063-6394a90a8f57	76354-781	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Medium 330 W		ZINC OXIDE, TITAZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENENIUM DIOXIDE, HOMOSALATE, OCTISALATE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-782_0988d28c-fd43-61e0-e063-6294a90af3c0	76354-782	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Medium 355 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-783_0988e993-f756-60d9-e063-6294a90a19c8	76354-783	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Medium 370 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-784_0988e993-f766-60d9-e063-6294a90a19c8	76354-784	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Medium 375 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-785_0988c414-9a53-4c61-e063-6394a90a9c85	76354-785	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Tan 400 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-786_0988c414-9a63-4c61-e063-6394a90a9c85	76354-786	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Tan 415 C		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-787_0988d28c-fd53-61e0-e063-6294a90af3c0	76354-787	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Tan 425 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-788_0988d078-d998-385a-e063-6294a90a1d09	76354-788	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Tan 450 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-789_0988c414-9a73-4c61-e063-6394a90a9c85	76354-789	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Tan 460 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-790_0988d078-d9a8-385a-e063-6294a90a1d09	76354-790	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Deep 500 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-791_0988e993-f776-60d9-e063-6294a90a19c8	76354-791	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Deep 510 C		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-792_0988fd2f-8311-5795-e063-6394a90a871a	76354-792	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Deep 530 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-793_0988fd2f-8321-5795-e063-6394a90a871a	76354-793	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Deep 540 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-794_0989111d-fec1-5abb-e063-6394a90a94c2	76354-794	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Deep 560 C		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-795_0989142a-978e-63f6-e063-6394a90a47a0	76354-795	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Rich 610 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-796_09890742-72f1-73b6-e063-6294a90a9590	76354-796	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Rich 620 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-797_09891759-b180-6a81-e063-6394a90a2f89	76354-797	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Rich 640 W		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-798_0988fd2f-8341-5795-e063-6394a90a871a	76354-798	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Rich 650 C		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-799_09894522-5671-4c5e-e063-6394a90a1b29	76354-799	HUMAN OTC DRUG	Hydrating Camo CC Cream SPF30 Rich 660 N		ZINC OXIDE, TITANIUM DIOXIDE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230815		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc.	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 45; 30; 60; 63	mg/g; mg/g; mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-864_09894522-5681-4c5e-e063-6394a90a1b29	76354-864	HUMAN OTC DRUG	Camo CC SPF 30 Light 205 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-865_0989136e-4d4b-64fb-e063-6394a90a7106	76354-865	HUMAN OTC DRUG	Camo CC SPF 30 Light 250 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-866_09894522-5691-4c5e-e063-6394a90a1b29	76354-866	HUMAN OTC DRUG	Camo CC SPF 30 Medium 370 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-867_0989568f-a28f-c4b7-e063-6294a90a2cfb	76354-867	HUMAN OTC DRUG	Camo CC SPF 30 Tan 400 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-868_0989568f-a29f-c4b7-e063-6294a90a2cfb	76354-868	HUMAN OTC DRUG	Camo CC SPF 30 Tan 460 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-869_0989111d-fed1-5abb-e063-6394a90a94c2	76354-869	HUMAN OTC DRUG	Camo CC SPF 30 Deep 530 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-870_098ac085-1cc6-72d4-e063-6394a90ad9e1	76354-870	HUMAN OTC DRUG	Camo CC SPF 30 Rich 610 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-871_098ac61b-b1c9-82f6-e063-6394a90ae63d	76354-871	HUMAN OTC DRUG	Camo CC SPF 30 Rich 650 C		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-872_098acc26-e840-800c-e063-6394a90ad7ac	76354-872	HUMAN OTC DRUG	Camo CC SPF 30 Fair 100 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-873_098ac085-1cd6-72d4-e063-6394a90ad9e1	76354-873	HUMAN OTC DRUG	Camo CC SPF 30 Fair 125 C		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-910_098acc26-e850-800c-e063-6394a90ad7ac	76354-910	HUMAN OTC DRUG	Camo CC Cream SPF30 Fair 120 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-911_098acc26-e860-800c-e063-6394a90ad7ac	76354-911	HUMAN OTC DRUG	Camo CC Cream SPF30 Fair 140 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-912_098ac085-1ce6-72d4-e063-6394a90ad9e1	76354-912	HUMAN OTC DRUG	Camo CC Cream SPF30 Fair 150 C		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-913_098ae043-35b3-860d-e063-6394a90abf6f	76354-913	HUMAN OTC DRUG	Camo CC Cream SPF30 Light 210 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-914_098ae043-35c3-860d-e063-6394a90abf6f	76354-914	HUMAN OTC DRUG	Camo CC Cream SPF30 Light 240 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-915_098ae843-99bc-ccbe-e063-6294a90a03e0	76354-915	HUMAN OTC DRUG	Camo CC Cream SPF30 Light 280 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-916_098ae843-99cc-ccbe-e063-6294a90a03e0	76354-916	HUMAN OTC DRUG	Camo CC Cream SPF30 Medium 310 C		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-917_098acc26-e870-800c-e063-6394a90ad7ac	76354-917	HUMAN OTC DRUG	Camo CC Cream SPF30 Medium 330 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-918_098af367-729a-320b-e063-6394a90a6088	76354-918	HUMAN OTC DRUG	Camo CC Cream SPF30 Medium 355 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-919_098ae043-35d5-860d-e063-6394a90abf6f	76354-919	HUMAN OTC DRUG	Camo CC Cream SPF30 Medium 375 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-920_098af971-5bc4-e81d-e063-6294a90a6010	76354-920	HUMAN OTC DRUG	Camo CC Cream SPF30 Tan 415 C		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-921_098afe7e-c8b9-cce4-e063-6294a90aeae8	76354-921	HUMAN OTC DRUG	Camo CC Cream SPF30 Tan 425 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-922_098af971-5bd4-e81d-e063-6294a90a6010	76354-922	HUMAN OTC DRUG	Camo CC Cream SPF30 Tan 450 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-923_098aff0b-563c-8d38-e063-6394a90a6d15	76354-923	HUMAN OTC DRUG	Camo CC Cream SPF30 Deep 500 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-924_098b088a-8f27-9eae-e063-6394a90a42a1	76354-924	HUMAN OTC DRUG	Camo CC Cream SPF30 Deep 510 C		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-925_098b0d3b-6622-8ee6-e063-6394a90ae8a0	76354-925	HUMAN OTC DRUG	Camo CC Cream SPF30 Deep 540 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-926_098af971-5be4-e81d-e063-6294a90a6010	76354-926	HUMAN OTC DRUG	Camo CC Cream SPF30 Deep 560 C		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-927_098b1bfa-330c-f3bc-e063-6294a90a76cd	76354-927	HUMAN OTC DRUG	Camo CC Cream SPF30 Rich 620 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-928_098b22bd-3a45-a351-e063-6394a90aae67	76354-928	HUMAN OTC DRUG	Camo CC Cream SPF30 Rich 640 W		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76354-929_098b26f5-5401-a57b-e063-6394a90ae20f	76354-929	HUMAN OTC DRUG	Camo CC Cream SPF30 Rich 660 N		OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M020	e.l.f. Cosmetics, Inc	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	75; 44.5; 137.2	mg/g; mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76357-175_43940664-f1da-476b-82ab-49a913fe58a6	76357-175	HUMAN OTC DRUG	SmartMouth Premium Action	SmartMouth Advanced Clinical Formula (ACF)	Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20180201		OTC MONOGRAPH FINAL	part355	Triumph Pharmaceuticals Inc.	SODIUM MONOFLUOROPHOSPHATE	10.21	g/96.4g			N	20241231
76357-210_5a827ba3-98b7-4993-83fb-a0a2d8c0713a	76357-210	HUMAN OTC DRUG	SmartMouth	Clinical Gum and Plaque Formula	Cetylpyridinium Chloride	KIT		20201202		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals Inc.						N	20241231
76357-211_5a827ba3-98b7-4993-83fb-a0a2d8c0713a	76357-211	HUMAN OTC DRUG	SmartMouth	Clinical Gum and Plaque Formula	Cetylpyridinium Chloride	KIT		20230101		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals Inc.						N	20241231
76357-230_5008b055-cd52-4cb1-bb98-700050415f94	76357-230	HUMAN OTC DRUG	SmartMouth Advance Clinical DDS Formula Mint		CETYLPYRIDINIUM CHLORIDE	KIT		20191201		OTC MONOGRAPH NOT FINAL	part356	Triumph Pharmaceuticals, Inc.						N	20241231
76357-250_5a827ba3-98b7-4993-83fb-a0a2d8c0713a	76357-250	HUMAN OTC DRUG	SmartMouth	Clinical Gum and Plaque Formula	Cetylpyridinium Chloride	KIT		20150928		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals Inc.						N	20241231
76357-255_5a827ba3-98b7-4993-83fb-a0a2d8c0713a	76357-255	HUMAN OTC DRUG	SmartMouth	Clinical Gum and Plaque Formula	Cetylpyridinium Chloride	KIT		20180201		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals Inc.						N	20241231
76357-285_d9300784-e2ae-423c-9f58-152259b1fc99	76357-285	HUMAN OTC DRUG	SmartMouth Mouthwash	Clinical DDS Formula	Cetylpyridinium Chloride	KIT		20181001		OTC MONOGRAPH NOT FINAL	part356	Triumph Pharmaceuticals Inc.						N	20241231
76357-409_1459a9d3-0005-4d84-ad38-67465672feb9	76357-409	HUMAN OTC DRUG	SmartMouth	Mouth Sore Zinc Activated Formula	MENTHOL, UNSPECIFIED FORM	KIT		20220101		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals Inc.						N	20241231
76357-410_1459a9d3-0005-4d84-ad38-67465672feb9	76357-410	HUMAN OTC DRUG	SmartMouth	Mouth Sore Zinc Activated Formula	MENTHOL, UNSPECIFIED FORM	KIT		20230101		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals Inc.						N	20241231
76357-411_1459a9d3-0005-4d84-ad38-67465672feb9	76357-411	HUMAN OTC DRUG	SmartMouth	Mouth Sore Zinc Activated Formula	MENTHOL, UNSPECIFIED FORM	KIT		20220101		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals Inc.						N	20241231
76357-509_4dfc40ce-65f4-4a7c-806c-884d58ad9eaf	76357-509	HUMAN OTC DRUG	SmartMouth	SmartMouth Gum Health Zinc Activated Formula	Cetylpyridinium Chloride	KIT		20240101		OTC MONOGRAPH DRUG	M022	Triumph Pharmaceuticals, Inc.						N	20241231
76370-0001_0b292e81-8f41-e0e4-e063-6394a90a2436	76370-0001	HUMAN OTC DRUG	Tazza		Benzalkonium Chloride	CLOTH	TOPICAL	20131101		OTC MONOGRAPH DRUG	505G(a)(3)	Tazza Brands East Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76370-0004_0b2953bf-dd21-c837-e063-6294a90af125	76370-0004	HUMAN OTC DRUG	Tazza		Ethanol	CLOTH	TOPICAL	20160802		OTC MONOGRAPH DRUG	505G(a)(3)	Tazza Brands East Inc.	ALCOHOL	70	mL/100mL			N	20241231
76370-0005_0b294ba0-5ed8-e34c-e063-6294a90aaf09	76370-0005	HUMAN OTC DRUG	Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20170117		OTC MONOGRAPH DRUG	505G(a)(3)	Tazza Brands East Inc.	ALCOHOL	70	mL/100mL			N	20241231
76370-0006_df4cd50c-454f-34c2-e053-2a95a90a3b6c	76370-0006	HUMAN OTC DRUG	Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20170117		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76370-0007_df4cd4b6-b3f4-22d1-e053-2a95a90a2961	76370-0007	HUMAN OTC DRUG	Tazza	Gym Wipes	Benzalkonium Chloride	CLOTH	TOPICAL	20181127		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East Inc.	BENZALKONIUM CHLORIDE	.0062	g/1			N	20241231
76370-0008_0b294e1a-d6e6-e2fd-e063-6394a90a05c4	76370-0008	HUMAN OTC DRUG	Tazza-X Hand Sanitizing Wipes		Ethanol	CLOTH	TOPICAL	20200904		OTC MONOGRAPH DRUG	505G(a)(3)	Tazza Brands East Inc.	ALCOHOL	70	mL/100mL			N	20241231
76370-0009_df397097-6bc4-735d-e053-2a95a90a3744	76370-0009	HUMAN OTC DRUG	Tazza		Benzalkonium Chloride	CLOTH	TOPICAL	20201024		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76370-0010_df4cf1b8-93e6-a4af-e053-2a95a90ac69a	76370-0010	HUMAN OTC DRUG	Tazza-X Extreme Hand Sanitizing Wipes		Ethanol	CLOTH	TOPICAL	20201127		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East Inc.	ALCOHOL	70	mL/100mL			N	20241231
76370-0012_0b295c57-1ad9-f603-e063-6394a90a868d	76370-0012	HUMAN OTC DRUG	Tazza Antiseptic Hand Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20210529		OTC MONOGRAPH DRUG	505G(a)(3)	Tazza Brands East Inc.	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
76370-0013_df4d0107-c35a-7bcf-e053-2a95a90ae832	76370-0013	HUMAN OTC DRUG	Tazza		Benzalkonium Chloride	CLOTH	TOPICAL	20210609		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76370-0016_d6832e54-8257-66b5-e053-2995a90a7c8d	76370-0016	HUMAN OTC DRUG	Tazza Antiseptic Hand Sanitizing Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20220211		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76370-0017_e117ebe5-de97-d650-e053-2a95a90a1fe1	76370-0017	HUMAN OTC DRUG	Tazza Hand Sanitizer	Gym Wipes	Benzalkonium Chloride	CLOTH	TOPICAL	20220610		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76370-0018_e1189ae7-3889-23d0-e053-2a95a90a29ad	76370-0018	HUMAN OTC DRUG	Tazza Antiseptic Hand Sanitizing Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20220610		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76370-0019_e4e20984-abb0-5bdd-e053-2a95a90a356b	76370-0019	HUMAN OTC DRUG	Tazza Antiseptic Hand Sanitizing Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20220728		OTC MONOGRAPH NOT FINAL	part333E	Tazza Brands East, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76376-618_efa30b82-7631-41be-abc9-73a2931d4328	76376-618	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F-18	INJECTION, SOLUTION	INTRAVENOUS	20111114		ANDA	ANDA203771	Hamamatsu/Queens PET Imaging Center, LLC	FLUDEOXYGLUCOSE F-18	100	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
76378-011_b4b97458-19b5-3dc2-e053-2995a90a2e73	76378-011	HUMAN OTC DRUG	Servo Stat-Foam		Alcohol	LIQUID	TOPICAL	20110201		OTC MONOGRAPH NOT FINAL	part333A	Enzyme Solutions, Inc.	ALCOHOL	62	mL/100mL			N	20241231
76378-015_0aad8f5e-dff8-279a-e063-6394a90a5d11	76378-015	HUMAN OTC DRUG	Servo-Stat		Alcohol	GEL	TOPICAL	20110201		OTC MONOGRAPH DRUG	505G(a)(3)	Enzyme Solutions, Inc.	ALCOHOL	62	mL/100mL			N	20241231
76378-017_d65d4642-de26-4369-bdd1-65684de5cb50	76378-017	HUMAN OTC DRUG	Servo-Stat P		Chloroxylenol	LIQUID	TOPICAL	20110201		OTC MONOGRAPH NOT FINAL	part333A	Enzyme Solutions, Inc.	CHLOROXYLENOL	.6	g/100mL			N	20241231
76378-021_343e1899-f6ef-485e-8c77-1fe72106a7ce	76378-021	HUMAN OTC DRUG	Servo-Stat P Antiseptic Hand Wash		Chloroxylenol	LIQUID	TOPICAL	20181214		OTC MONOGRAPH NOT FINAL	part333A	Enzyme Solutions, Inc.	CHLOROXYLENOL	.6	g/100mL			N	20241231
76378-022_85314c64-462e-4519-a6d8-c9381a15abf4	76378-022	HUMAN OTC DRUG	Servo-Stat P Foam Antiseptic Hand Wash		Chloroxylenol	LIQUID	TOPICAL	20181214		OTC MONOGRAPH NOT FINAL	part333A	Enzyme Solutions, Inc.	CHLOROXYLENOL	.6	g/100mL			N	20241231
76378-023_a5728eef-dd91-6d45-e053-2a95a90a31ce	76378-023	HUMAN OTC DRUG	Servo Stat BAC		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200512		OTC MONOGRAPH NOT FINAL	part333A	Enzyme Solutions, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
76381-725_e65d0847-666b-4420-9f84-6c65df29e501	76381-725	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BIPSO GmbH	IOMEPROL	510	mg/mL			N	20241231
76381-730_e65d0847-666b-4420-9f84-6c65df29e501	76381-730	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BIPSO GmbH	IOMEPROL	612	mg/mL			N	20241231
76381-735_e65d0847-666b-4420-9f84-6c65df29e501	76381-735	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BIPSO GmbH	IOMEPROL	714	mg/mL			N	20241231
76381-740_e65d0847-666b-4420-9f84-6c65df29e501	76381-740	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BIPSO GmbH	IOMEPROL	816	mg/mL			N	20241231
76381-930_e65d0847-666b-4420-9f84-6c65df29e501	76381-930	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BIPSO GmbH	IOMEPROL	612	mg/mL			N	20241231
76381-935_e65d0847-666b-4420-9f84-6c65df29e501	76381-935	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BIPSO GmbH	IOMEPROL	714	mg/mL			N	20241231
76381-940_e65d0847-666b-4420-9f84-6c65df29e501	76381-940	HUMAN PRESCRIPTION DRUG	Iomeron		Iomeprol Injection	INJECTION, SOLUTION	INTRAVASCULAR	20220701		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		BIPSO GmbH	IOMEPROL	816	mg/mL			N	20241231
76383-033_a6d85e6d-6a7d-789d-e053-2a95a90afc10	76383-033	HUMAN OTC DRUG	disney princess floral scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC Group limit	ALCOHOL	62	g/100mL			N	
76383-034_a6d85f16-3471-350d-e053-2995a90a4e5b	76383-034	HUMAN OTC DRUG	disney princess Cherry blossom scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-035_a6d8b434-f7b4-5b5d-e053-2995a90aeb1b	76383-035	HUMAN OTC DRUG	disney princess floral scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-036_a6d8e296-21db-1836-e053-2995a90aa1d5	76383-036	HUMAN OTC DRUG	Frozen vanilla scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-037_a6d8b434-f7b5-5b5d-e053-2995a90aeb1b	76383-037	HUMAN OTC DRUG	Frozen lavender scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-038_a6d94d62-857a-6f6d-e053-2a95a90abf2c	76383-038	HUMAN OTC DRUG	Frozen orange blossom scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-039_a6d9a79a-49f0-43c9-e053-2a95a90ad1e4	76383-039	HUMAN OTC DRUG	Jojo blueberry scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-040_a6d9e010-5357-fbbe-e053-2a95a90a0ec2	76383-040	HUMAN OTC DRUG	Jojo grape scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-041_a6da0393-a009-05cb-e053-2a95a90a822d	76383-041	HUMAN OTC DRUG	Jojo strawberry scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-042_a6da53b2-fbf2-f8e3-e053-2995a90aeb47	76383-042	HUMAN OTC DRUG	My little pony grape scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-043_a6da8971-41f1-b662-e053-2995a90ad9dd	76383-043	HUMAN OTC DRUG	My little pony blueberry scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-044_a6daada8-9c1e-61e9-e053-2995a90a0edc	76383-044	HUMAN OTC DRUG	My little pony strawberry scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-045_a6dae779-97cf-4a92-e053-2995a90a12a9	76383-045	HUMAN OTC DRUG	spongebob bubble gum scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC Group limit	ALCOHOL	62	g/100mL			N	
76383-046_a6db3ba7-eaae-5747-e053-2a95a90a2d20	76383-046	HUMAN OTC DRUG	Spongebob bubble gum scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-047_a6db55d3-fb87-e897-e053-2a95a90a1fcd	76383-047	HUMAN OTC DRUG	Trolls cherry scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-048_a6dbb765-5976-1544-e053-2995a90a45f1	76383-048	HUMAN OTC DRUG	Trolls raspberry scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76383-049_a6dbe749-2816-2f1e-e053-2a95a90a7f96	76383-049	HUMAN OTC DRUG	Trolls grape scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC Group limit	ALCOHOL	62	g/100mL			N	
76383-050_a6dc168e-1ccb-2034-e053-2a95a90af365	76383-050	HUMAN OTC DRUG	Trolls strawberry scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	BBC GROUP limit	ALCOHOL	62	g/100mL			N	
76385-100_d3251434-3554-4bdf-874c-f84801e49609	76385-100	HUMAN PRESCRIPTION DRUG	METHSCOPOLAMINE BROMIDE		methscopolamine bromide	TABLET	ORAL	20131001		ANDA	ANDA200602	BAYSHORE PHARMACEUTICALS LLC	METHSCOPOLAMINE BROMIDE	2.5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
76385-101_d3251434-3554-4bdf-874c-f84801e49609	76385-101	HUMAN PRESCRIPTION DRUG	METHSCOPOLAMINE BROMIDE		methscopolamine bromide	TABLET	ORAL	20131001		ANDA	ANDA200602	BAYSHORE PHARMACEUTICALS LLC	METHSCOPOLAMINE BROMIDE	5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
76385-102_6b56e67f-8e04-4efd-a12a-4c82596f3adc	76385-102	HUMAN PRESCRIPTION DRUG	Primaquine Phosphate		Primaquine Phosphate	TABLET	ORAL	20140801		ANDA	ANDA204476	Bayshore Pharmaceuticals, LLC	PRIMAQUINE PHOSPHATE	15	mg/1	Antimalarial [EPC]		N	20251231
76385-106_ca50459a-8472-4a04-bae3-51f27113c37d	76385-106	HUMAN OTC DRUG	Ketotifen Fumarate		Ketotifen Fumarate	SOLUTION	OPHTHALMIC	20211015		ANDA	ANDA204059	Bayshore Pharmaceuticals, LLC	KETOTIFEN FUMARATE	.25	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
76385-107_00b51542-bb7b-4d80-9849-4f560a96d669	76385-107	HUMAN PRESCRIPTION DRUG	Diphenoxylate Hydrochloride and Atropine Sulfate		Diphenoxylate Hydrochloride and Atropine Sulfate	TABLET	ORAL	20190515		ANDA	ANDA210819	Bayshore Pharmaceuticals, LLC	ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE	.025; 2.5	mg/1; mg/1	Anticholinergic [EPC], Antidiarrheal [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]	CV	N	20251231
76385-110_169edf1c-826c-4153-a26f-155cad96b3ea	76385-110	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	Bayshore Pharmaceuticals LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
76385-111_169edf1c-826c-4153-a26f-155cad96b3ea	76385-111	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	Bayshore Pharmaceuticals LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
76385-112_169edf1c-826c-4153-a26f-155cad96b3ea	76385-112	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	Bayshore Pharmaceuticals LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
76385-113_169edf1c-826c-4153-a26f-155cad96b3ea	76385-113	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20161001		ANDA	ANDA078384	Bayshore Pharmaceuticals LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20251231
76385-118_b154adac-fe09-429e-babd-a44c615200d7	76385-118	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA210704	Bayshore Pharmaceuticals, LLC	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76385-119_b154adac-fe09-429e-babd-a44c615200d7	76385-119	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20210801		ANDA	ANDA210704	Bayshore Pharmaceuticals, LLC	ETODOLAC	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76385-131_d80318b4-f9bf-4ac4-ab31-cac1478a3af9	76385-131	HUMAN PRESCRIPTION DRUG	Pindolol		pindolol	TABLET	ORAL	20200201		ANDA	ANDA211712	Bayshore Pharmaceuticals LLC	PINDOLOL	5	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
76385-132_d80318b4-f9bf-4ac4-ab31-cac1478a3af9	76385-132	HUMAN PRESCRIPTION DRUG	Pindolol		pindolol	TABLET	ORAL	20200201		ANDA	ANDA211712	Bayshore Pharmaceuticals LLC	PINDOLOL	10	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
76385-136_3efe711b-1d5e-49f3-a70b-0b5cc027857d	76385-136	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210330		ANDA	ANDA214799	Bayshore Pharmaceuticals LLC	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
76385-137_3efe711b-1d5e-49f3-a70b-0b5cc027857d	76385-137	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210330		ANDA	ANDA214799	Bayshore Pharmaceuticals LLC	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
76385-138_3efe711b-1d5e-49f3-a70b-0b5cc027857d	76385-138	HUMAN PRESCRIPTION DRUG	Metolazone		Metolazone	TABLET	ORAL	20210330		ANDA	ANDA214799	Bayshore Pharmaceuticals LLC	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
76385-142_fd0b69cf-23b8-6b35-e053-6394a90a7e47	76385-142	HUMAN PRESCRIPTION DRUG	Chloroquine phosphate		Chloroquine phosphate	TABLET, FILM COATED	ORAL	20200415		ANDA	ANDA090610	Bayshore Pharmaceuticals LLC	CHLOROQUINE PHOSPHATE	250	mg/1	Antimalarial [EPC]		N	20241231
76385-144_74dbedae-8fba-4357-b3fe-e9c8572dcc94	76385-144	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20200508		ANDA	ANDA040766	Bayshore Pharmaceuticals LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
76385-145_d6378aa3-785e-4c2b-867b-db0fa23f3d15	76385-145	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20240111		ANDA	ANDA210683	Bayshore Pharmaceuticals LLC	FLECAINIDE ACETATE	50	mg/1	Antiarrhythmic [EPC]		N	20251231
76385-146_d6378aa3-785e-4c2b-867b-db0fa23f3d15	76385-146	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20240111		ANDA	ANDA210683	Bayshore Pharmaceuticals LLC	FLECAINIDE ACETATE	100	mg/1	Antiarrhythmic [EPC]		N	20251231
76385-147_d6378aa3-785e-4c2b-867b-db0fa23f3d15	76385-147	HUMAN PRESCRIPTION DRUG	Flecainide Acetate		flecainide acetate	TABLET	ORAL	20240111		ANDA	ANDA210683	Bayshore Pharmaceuticals LLC	FLECAINIDE ACETATE	150	mg/1	Antiarrhythmic [EPC]		N	20251231
76388-880_f88aebf9-c2b4-4389-bff1-d59a9ebe0875	76388-880	HUMAN PRESCRIPTION DRUG	TABLOID		thioguanine	TABLET	ORAL	20130312	20250331	NDA	NDA012429	Aspen Global Inc.	THIOGUANINE	40	mg/1	Antimetabolite [EPC]		N	
76394-2642_eec8a589-3cee-b71c-e053-2995a90a3a5f	76394-2642	HUMAN PRESCRIPTION DRUG	Gallium Ga-68 PSMA-11		GALLIUM GA-68 GOZETOTIDE	INJECTION, SOLUTION	INTRAVENOUS	20201209		NDA	NDA212642	UCLA Biomedical Cyclotron	GALLIUM GA-68 GOZETOTIDE	5	mCi/mL	Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]		N	20241231
76394-3811_eec89f5e-783b-d6ac-e053-2a95a90abdc4	76394-3811	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F 18	INJECTION	INTRAVENOUS	20130627		ANDA	ANDA203811	University of California, Los Angeles	FLUDEOXYGLUCOSE F-18	40	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
76394-3812_eec8ab18-2b7f-1dd6-e053-2995a90a701c	76394-3812	HUMAN PRESCRIPTION DRUG	Ammonia N 13		AMMONIA N-13	INJECTION	INTRAVENOUS	20130627		ANDA	ANDA203812	University of California, Los Angeles	AMMONIA N-13	37.5	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
76398-009_06f8c5e9-5c61-8ba6-e063-6294a90ae72c	76398-009	HUMAN OTC DRUG	TRACELESS TOUCH FOUNDATION BROAD SPECTRUM SPF 45 REFILL CUSHION COMPACT		titanium dioxide and zinc oxide	CREAM	TOPICAL	20190301		OTC MONOGRAPH DRUG	M020	TOM FORD BEAUTY DIST	TITANIUM DIOXIDE; ZINC OXIDE	7.6; 5.1	g/100g; g/100g			N	20241231
76398-010_06f87aba-f8db-872d-e063-6294a90aee3c	76398-010	HUMAN OTC DRUG	TOM FORD SHADE AND ILLUMINATE SOFT RADIANCE FOUNDATION BROAD SPECTRUM SPF 50		ENSULIZOLE, OCTINOXATE, OCTISALATE, and ZINC OXIDE	LIQUID	TOPICAL	20191010		OTC MONOGRAPH DRUG	M020	TOM FORD BEAUTY DIST	ENSULIZOLE; OCTINOXATE; OCTISALATE; ZINC OXIDE	27; 67; 45; 38	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
76398-011_0d07e34e-983e-f68e-e063-6394a90a51d8	76398-011	HUMAN OTC DRUG	TOM FORD SHADE AND ILLUMINATE FOUNDATION BROAD SPECTRUM SPF 45 SOFT RADIANCE CUSHION COMPACT REFILL		OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE	CREAM	TOPICAL	20191115		OTC MONOGRAPH DRUG	M020	TOM FORD BEAUTY DIST	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	7; 7.6; 3.6	g/100g; g/100g; g/100g			N	20241231
76398-012_0d080c44-bd64-0c5f-e063-6294a90a9078	76398-012	HUMAN OTC DRUG	TOM FORD SOLEIL GLOW TINTED MOISTURIZER BROAD SPECTRUM SPF 15		OCTINOXATE and TITANIUM DIOXIDE	LIQUID	TOPICAL	20200221		OTC MONOGRAPH DRUG	M020	TOM FORD BEAUTY DIST	OCTINOXATE; TITANIUM DIOXIDE	75; 29	mg/mL; mg/mL			N	20241231
76398-013_0b782b71-11a2-56d4-e063-6394a90a7676	76398-013	HUMAN OTC DRUG	SHADE and ILLUMINATE SOFT RAD PRMR SPF		OCTINOXATE,OCTISALATE,ZINC OXIDE	CREAM	TOPICAL	20221014		OTC MONOGRAPH DRUG	M020	TOM FORD BEAUTY DIST	OCTINOXATE; OCTISALATE; ZINC OXIDE	67; 45; 100	mg/mL; mg/mL; mg/mL			N	20241231
76402-402_44fe57b0-1187-4a69-9856-3c19df614c54	76402-402	HUMAN OTC DRUG	Hillyard Instant Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20120321		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	ALCOHOL	62	mL/100mL			N	20241231
76402-403_a066bd4e-8f1d-4dfe-8754-fc7fd5ae48f9	76402-403	HUMAN OTC DRUG	Hillyard Alcohol Free Foaming Instant Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20120229		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
76402-405_f3e3768b-7cc8-400a-be77-49867b2058fb	76402-405	HUMAN OTC DRUG	Juniper Breeze Foaming Antimicrobial		Benzalkonium Chloride	LIQUID	TOPICAL	20200301	20240601	OTC MONOGRAPH DRUG	M003	Hillyard GMP	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
76402-408_d2b2581d-0e45-4b4d-8610-248bf9d2bf75	76402-408	HUMAN OTC DRUG	Hillyard Citrus Fresh Antimicrobial Foaming		Chloroxylenol	LIQUID	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	CHLOROXYLENOL	.5	g/100mL			N	20241231
76402-410_00769ef0-54c6-4696-88b4-c0af5c4e4d2b	76402-410	HUMAN OTC DRUG	Hillyard Foaming Instant Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20120207		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	ALCOHOL	62	mL/100mL			N	20241231
76402-418_5bfe1246-7367-4b13-ae46-9d87339be3a9	76402-418	HUMAN OTC DRUG	Juniper Breeze Liquid Antimicrobial		Benzalkonium Chloride	LIQUID	TOPICAL	20200301	20240601	OTC MONOGRAPH DRUG	M003	Hillyard GMP	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
76402-419_81148442-6ee2-4655-85e4-27c2753c5c27	76402-419	HUMAN OTC DRUG	Hillyard E2 Food Industry Foaming		Benzalkonium Chloride	LIQUID	TOPICAL	20150901		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76402-420_086b7f58-59f3-429e-a2d8-8a5ffed0f820	76402-420	HUMAN OTC DRUG	Citrus Fresh Foaming Antimicrobial		Benzalkonium Chloride	LIQUID	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76402-421_8abcace0-08b7-45ea-8f4f-cc74417db58a	76402-421	HUMAN OTC DRUG	Citrus Fresh Liquid Antimicrobial		Benzalkonium Chloride	LIQUID	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
76402-422_f9e6a877-c3f1-4215-9030-4230908a881a	76402-422	HUMAN OTC DRUG	Instant Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333E	Hillyard GMP	ALCOHOL	62	mL/100mL			N	20241231
76420-003_ae617f95-addf-cee4-e053-2995a90a08ba	76420-003	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, FILM COATED	ORAL	20051109		ANDA	ANDA065256	Asclemed USA, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-004_ead05b62-3efd-ee20-e053-2a95a90ab610	76420-004	HUMAN PRESCRIPTION DRUG	Anastrozole		Anastrozole	TABLET	ORAL	20100622		ANDA	ANDA090568	Asclemed USA, Inc.	ANASTROZOLE	1	mg/1	Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA]		N	20241231
76420-005_ae61a16a-506a-9c59-e053-2995a90a4704	76420-005	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA204755	Asclemed USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
76420-006_04472220-f8c1-1f1a-e063-6294a90a2bb2	76420-006	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065225	Asclemed USA, Inc.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
76420-007_ead06a22-6d5a-f9bb-e053-2a95a90aa12a	76420-007	HUMAN PRESCRIPTION DRUG	Betamethasone Sodium Phosphate and Betamethasone Acetate		Betamethasone Sodium Phosphate and Betamethasone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR	20100428		ANDA	ANDA090747	Asclemed USA, Inc.	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
76420-008_ead08199-44c1-c795-e053-2995a90a7e08	76420-008	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL	20131105		ANDA	ANDA203895	Asclemed USA, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
76420-009_045987eb-8735-65e2-e063-6394a90a9699	76420-009	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Asclemed USA, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-010_eb84c1e9-a96f-21ed-e053-2995a90a6646	76420-010	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20170928		ANDA	ANDA078722	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-011_e5e2bf99-21f7-4962-e053-2a95a90a836d	76420-011	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-012_ead0dde9-f4f4-9f9b-e053-2a95a90ac6e5	76420-012	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20160902		ANDA	ANDA206116	Asclemed USA, Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-014_ead11d10-7482-8d9b-e053-2a95a90a2c68	76420-014	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140423		ANDA	ANDA075350	Asclemed USA, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-015_ead11d10-7482-8d9b-e053-2a95a90a2c68	76420-015	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20140403		ANDA	ANDA075350	Asclemed USA, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-018_a2dc1141-204b-3c3a-e053-2995a90a4230	76420-018	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	20131105		ANDA	ANDA203895	Asclemed USA, Inc.	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
76420-019_a73bd6a8-be64-4e54-e053-2a95a90a88a7	76420-019	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20180116		ANDA	ANDA078722	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-020_a7b785f9-4f75-92ed-e053-2995a90a9fa5	76420-020	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20171205		ANDA	ANDA090705	Asclemed USA, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-021_ead12b79-385c-4dee-e053-2a95a90ac9da	76420-021	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Asclemed USA, Inc.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
76420-021_ead13f84-431f-7125-e053-2995a90a9bd2	76420-021	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Asclemed USA, Inc.	ESTRADIOL	.5	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
76420-022_ead12b79-385c-4dee-e053-2a95a90ac9da	76420-022	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Asclemed USA, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
76420-022_ead13f84-431f-7125-e053-2995a90a9bd2	76420-022	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Asclemed USA, Inc.	ESTRADIOL	1	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
76420-023_ead12b79-385c-4dee-e053-2a95a90ac9da	76420-023	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Asclemed USA, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
76420-023_ead13f84-431f-7125-e053-2995a90a9bd2	76420-023	HUMAN PRESCRIPTION DRUG	ESTRADIOL		ESTRADIOL	TABLET	ORAL	20170410		ANDA	ANDA040275	Asclemed USA, Inc.	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
76420-024_a8441690-b15e-a057-e053-2995a90af272	76420-024	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Asclemed USA, Inc.	ESZOPICLONE	2	mg/1		CIV	N	20241231
76420-025_a843b00f-4da3-1901-e053-2a95a90affae	76420-025	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20131121		ANDA	ANDA200936	Asclemed USA, Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-026_a8441690-b15e-a057-e053-2995a90af272	76420-026	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Asclemed USA, Inc.	ESZOPICLONE	1	mg/1		CIV	N	20241231
76420-027_a8441690-b15e-a057-e053-2995a90af272	76420-027	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	Asclemed USA, Inc.	ESZOPICLONE	3	mg/1		CIV	N	20241231
76420-028_ead13f84-4320-7125-e053-2995a90a9bd2	76420-028	HUMAN PRESCRIPTION DRUG	Hydrocortisone		hydrocortisone	TABLET	ORAL	20130220		NDA AUTHORIZED GENERIC	NDA008697	Asclemed USA, Inc.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-029_ead13cff-b9d2-cdc1-e053-2a95a90adf09	76420-029	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20150724		ANDA	ANDA201807	Asclemed USA, Inc.	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-030_e4ec0115-3fdf-8c05-e053-2995a90a8353	76420-030	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-031_a8e5cbe9-22a7-4051-e053-2995a90a93f7	76420-031	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20170707		ANDA	ANDA207029	Asclemed USA, Inc.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-032_04ab174a-3ae9-2b8e-e063-6394a90a1df5	76420-032	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	Asclemed USA, Inc.	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-033_f5f82b93-a80e-3ab8-e053-2995a90a68f5	76420-033	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-034_e436e361-d938-7d6d-e053-2995a90a10e4	76420-034	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	Asclemed USA, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-035_e436e361-d965-7d6d-e053-2995a90a10e4	76420-035	HUMAN PRESCRIPTION DRUG	cephalexin		cephalexin	CAPSULE	ORAL	20080118		ANDA	ANDA065248	Asclemed USA, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-036_a8447430-59fb-86a4-e053-2a95a90ad3a7	76420-036	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20120312		ANDA	ANDA040911	Asclemed USA, Inc.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-037_ead14e8e-059a-1ebb-e053-2995a90a78b3	76420-037	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20130915		ANDA	ANDA200675	Asclemed USA, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-038_07ceb8e0-957d-8c2c-e063-6294a90afa1d	76420-038	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20220708		OTC MONOGRAPH DRUG	M017	Asclemed USA, Inc.	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-038_07cebfba-4f3a-882f-e063-6294a90ac460	76420-038	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20140101		OTC MONOGRAPH DRUG	M017	Asclemed USA, Inc.	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-039_0459a811-26c5-25f1-e063-6394a90a3c61	76420-039	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Asclemed USA, Inc.	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-040_ead159e0-3579-29c9-e053-2a95a90a77ad	76420-040	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Asclemed USA, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-041_ead14e8e-059c-1ebb-e053-2995a90a78b3	76420-041	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	19971031		ANDA	ANDA040189	Asclemed USA, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-042_ead160e6-aba4-ca0a-e053-2a95a90ab964	76420-042	HUMAN PRESCRIPTION DRUG	NAPROXEN		NAPROXEN	TABLET	ORAL	20160706		ANDA	ANDA091416	Asclemed USA, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-043_ea430998-90ab-4135-e053-2a95a90acc12	76420-043	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Asclemed USA, Inc.	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-044_c4dbc73a-82cc-e635-e053-2a95a90a4fc5	76420-044	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		DOXYCYCLINE HYCLATE	CAPSULE	ORAL	19840911		ANDA	ANDA062500	Asclemed USA, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
76420-045_ae77a7d7-f644-7b8f-e053-2a95a90a23e5	76420-045	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Asclemed USA, Inc.	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
76420-046_ae7775dd-3ddd-58b8-e053-2995a90ad046	76420-046	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20190701		ANDA	ANDA208250	Asclemed USA, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
76420-047_e35b53ce-ead2-6007-e053-2995a90a7f25	76420-047	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Asclemed USA, Inc.	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-050_b01ced44-7b5d-5716-e053-2995a90a1263	76420-050	HUMAN PRESCRIPTION DRUG	acyclovir		acyclovir	TABLET	ORAL	20070609		ANDA	ANDA077309	Asclemed USA, Inc.	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
76420-051_b21449e8-c203-520d-e053-2995a90ad298	76420-051	HUMAN PRESCRIPTION DRUG	Clarithromycin		Clarithromycin	TABLET	ORAL	20050825		ANDA	ANDA065136	Asclemed USA, Inc.	CLARITHROMYCIN	500	mg/1	Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]		N	20241231
76420-052_b21440a7-8193-47fc-e053-2995a90ae2f3	76420-052	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	Asclemed USA, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-053_b26ab5c7-62e8-3fc4-e053-2a95a90abb45	76420-053	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Asclemed USA, Inc.	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
76420-054_b26a83fd-322b-d988-e053-2a95a90a35e3	76420-054	HUMAN PRESCRIPTION DRUG	Metoprolol Tartrate		Metoprolol Tartrate	TABLET, FILM COATED	ORAL	20070911		ANDA	ANDA077739	Asclemed USA, Inc.	METOPROLOL TARTRATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
76420-055_ead271f5-d9a9-fa00-e053-2a95a90a0ea4	76420-055	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Asclemed USA, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
76420-056_b2c9498d-28af-3ee5-e053-2a95a90af167	76420-056	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Asclemed USA, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
76420-057_ead26ce5-33db-58dc-e053-2995a90a06c6	76420-057	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		Phentermine Hydrochloride	TABLET	ORAL	20050415		ANDA	ANDA040555	Asclemed USA, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
76420-058_ead2bd7f-b5e3-3c69-e053-2995a90adf37	76420-058	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20170911		ANDA	ANDA207724	Asclemed USA, Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-059_ead2bd7f-b5e3-3c69-e053-2995a90adf37	76420-059	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20170911		ANDA	ANDA207724	Asclemed USA, Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-060_b1aea89e-52fb-b32e-e053-2995a90a032b	76420-060	HUMAN PRESCRIPTION DRUG	Rifampin		Rifampin	CAPSULE	ORAL	19970528		ANDA	ANDA064150	Asclemed USA, Inc.	RIFAMPIN	300	mg/1	Rifamycin Antibacterial [EPC], Rifamycins [CS]		N	20241231
76420-061_e785ec65-b5e8-693c-e053-2995a90aa9e7	76420-061	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20140103		ANDA	ANDA203814	Asclemed USA, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-062_06c94882-1323-c834-e063-6394a90a2d75	76420-062	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Asclemed USA, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
76420-063_06c94882-1323-c834-e063-6394a90a2d75	76420-063	HUMAN PRESCRIPTION DRUG	Spironolactone		spironolactone	TABLET, FILM COATED	ORAL	20170602		ANDA	ANDA203512	Asclemed USA, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
76420-064_ae77a5c0-a27b-770c-e053-2a95a90a6a96	76420-064	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Asclemed USA, Inc.	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
76420-065_ead2c72c-bd9f-2f0c-e053-2995a90af3cb	76420-065	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		testosterone cypionate	INJECTION	INTRAMUSCULAR	20190531		ANDA	ANDA206368	Asclemed USA, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
76420-066_b26a7261-c68e-834b-e053-2a95a90a1f7d	76420-066	HUMAN PRESCRIPTION DRUG	clonidine hydrochloride		Clonidine Hydrochloride	TABLET	ORAL	20160503		ANDA	ANDA091368	Asclemed USA, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
76420-067_ade999a8-168a-32d1-e053-2a95a90ac173	76420-067	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Asclemed USA, Inc.	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-068_ade999a8-168a-32d1-e053-2a95a90ac173	76420-068	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Asclemed USA, Inc.	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-069_ade999a8-168a-32d1-e053-2a95a90ac173	76420-069	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Asclemed USA, Inc.	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-072_ead2c72c-bda1-2f0c-e053-2995a90af3cb	76420-072	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20181026		ANDA	ANDA211285	Asclemed USA, Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-073_ead2c72c-bda1-2f0c-e053-2995a90af3cb	76420-073	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20181026		ANDA	ANDA211285	Asclemed USA, Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-074_ead2d1fe-f89c-ee3a-e053-2995a90ac920	76420-074	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20130701		ANDA	ANDA090060	Asclemed USA, Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
76420-075_ead2d6e4-62f5-3b3c-e053-2a95a90a4ccd	76420-075	HUMAN PRESCRIPTION DRUG	cyanocobalamin		cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20151211		ANDA	ANDA206503	Asclemed USA, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
76420-076_ead2d6e4-62f6-3b3c-e053-2a95a90a4ccd	76420-076	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		Sulfacetamide Sodium	SOLUTION	OPHTHALMIC	20030325		ANDA	ANDA089560	Asclemed USA, Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
76420-077_ead2db1e-54b5-fa3c-e053-2a95a90a1b97	76420-077	HUMAN PRESCRIPTION DRUG	DEXAMETHASONE SODIUM PHOSPHATE		DEXAMETHASONE SODIUM PHOSPHATE	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20200211		ANDA	ANDA206781	Asclemed USA, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-078_ead2d6e4-62f7-3b3c-e053-2a95a90a4ccd	76420-078	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL	19750616		ANDA	ANDA084625	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-079_ead2e17d-c777-57a3-e053-2995a90af78b	76420-079	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203040	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-080_a2dc0a04-7bb0-b275-e053-2995a90a1004	76420-080	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-081_ead30b86-564f-7e78-e053-2a95a90ab41c	76420-081	HUMAN PRESCRIPTION DRUG	Depo-Medrol		methylprednisolone acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	19590528		NDA	NDA011757	Asclemed USA, Inc.	METHYLPREDNISOLONE ACETATE	80	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-082_b8e8faa1-b124-450e-e053-2995a90aeace	76420-082	HUMAN PRESCRIPTION DRUG	Sterile Water		WATER	INJECTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050616		NDA	NDA018801	Asclemed USA, Inc.	WATER	1	mL/mL			N	20241231
76420-083_b8e8faa1-b133-450e-e053-2995a90aeace	76420-083	HUMAN PRESCRIPTION DRUG	Sodium Chloride		Sodium Chloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20050228		NDA	NDA018803	Asclemed USA, Inc.	SODIUM CHLORIDE	9	mg/mL			N	20241231
76420-084_ead317e5-93f1-fd8d-e053-2995a90adbf6	76420-084	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20050708		ANDA	ANDA080408	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-085_a4f97750-d5aa-8236-e053-2995a90a1854	76420-085	HUMAN PRESCRIPTION DRUG	KENALOG-40		TRIAMCINOLONE ACETONIDE	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20090601		NDA	NDA014901	Asclemed USA, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-087_b1c30e22-3079-11d3-e053-2a95a90a00bf	76420-087	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	SOLUTION	RESPIRATORY (INHALATION)	19970917		ANDA	ANDA074880	Asclemed USA, Inc.	ALBUTEROL SULFATE	2.5	mg/3mL	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76420-088_0cdb4881-c3c2-9edf-e063-6394a90a5cac	76420-088	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate	HFA	Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20190116		NDA	NDA021457	Asclemed USA, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76420-089_b26a17f3-e137-3c74-e053-2a95a90af65b	76420-089	HUMAN PRESCRIPTION DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION/ DROPS	OPHTHALMIC	20151207		ANDA	ANDA206306	Asclemed USA, Inc.	OLOPATADINE HYDROCHLORIDE	1.11	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
76420-090_b26a1d2a-bf50-4787-e053-2a95a90a951b	76420-090	HUMAN PRESCRIPTION DRUG	Sulfacetamide Sodium		sulfacetamide sodium	SOLUTION/ DROPS	OPHTHALMIC	19941228		ANDA	ANDA040066	Asclemed USA, Inc.	SULFACETAMIDE SODIUM	100	mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
76420-091_b269742f-932d-73f2-e053-2a95a90a3761	76420-091	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200130		ANDA	ANDA210986	Asclemed USA, Inc.	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-092_b2696acf-8175-16fb-e053-2a95a90aa378	76420-092	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION/ DROPS	OPHTHALMIC	20170628		ANDA	ANDA207444	Asclemed USA, Inc.	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
76420-093_b26ec84b-1af1-b04d-e053-2a95a90a8c78	76420-093	HUMAN PRESCRIPTION DRUG	Sumatriptan Succinate		Sumatriptan Succinate	TABLET	ORAL	20091117		ANDA	ANDA076847	Asclemed USA, Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
76420-095_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-095	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
76420-096_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-096	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
76420-097_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-097	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
76420-098_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-098	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
76420-099_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-099	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
76420-100_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-100	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
76420-101_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-101	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	225	mg/1		CV	N	20241231
76420-102_ead3b1c9-5c7d-457b-e053-2995a90a71ef	76420-102	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Asclemed USA, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
76420-103_b2dde53b-af58-ce44-e053-2a95a90a8fe0	76420-103	HUMAN PRESCRIPTION DRUG	Acetaminophen and Codeine		Acetaminophen and Codeine	TABLET	ORAL	20080529		ANDA	ANDA040779	Asclemed USA, Inc.	ACETAMINOPHEN; CODEINE PHOSPHATE	300; 30	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIII	N	20241231
76420-104_b2ddcdd0-72c2-99df-e053-2a95a90a8818	76420-104	HUMAN PRESCRIPTION DRUG	Neomycin and Polymyxin B Sulfates and Hydrocortisone		Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone	SOLUTION/ DROPS	AURICULAR (OTIC)	19951229		ANDA	ANDA064053	Asclemed USA, Inc.	HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	10; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
76420-105_b2ddcdd0-7229-99df-e053-2a95a90a8818	76420-105	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN		TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN	TABLET, FILM COATED	ORAL	20121215		ANDA	ANDA201952	Asclemed USA, Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-106_ead40f72-3d3e-1c2b-e053-2995a90ad35b	76420-106	HUMAN PRESCRIPTION DRUG	Fluticasone Propionate		Fluticasone Propionate	SPRAY, METERED	NASAL	20080116		ANDA	ANDA077570	Asclemed USA, Inc.	FLUTICASONE PROPIONATE	50	ug/.1g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-107_a8f5a654-c183-044b-e053-2995a90af261	76420-107	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium		Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20170217		ANDA	ANDA205761	Asclemed USA, Inc.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
76420-108_b2ddcdd0-7292-99df-e053-2a95a90a8818	76420-108	HUMAN PRESCRIPTION DRUG	Phentermine hydrochloride		phentermine hydrochloride	TABLET	ORAL	20170124		ANDA	ANDA205008	Asclemed USA, Inc.	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
76420-110_bf9ab34f-28af-24f9-e053-2a95a90a3627	76420-110	HUMAN PRESCRIPTION DRUG	Hydrocortisone		Hydrocortisone	TABLET	ORAL	20200925		ANDA	ANDA207029	Asclemed USA, Inc.	HYDROCORTISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-111_c6976242-83a1-4644-e053-2995a90a0904	76420-111	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		CYANOCOBALAMIN	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20001018		ANDA	ANDA080557	Asclemed USA, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
76420-112_c6979c55-d3e2-7094-e053-2a95a90a77b6	76420-112	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Asclemed USA, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-117_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-117	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	25	mg/1		CV	N	20241231
76420-118_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-118	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
76420-119_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-119	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
76420-120_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-120	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
76420-121_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-121	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
76420-122_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-122	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	200	mg/1		CV	N	20241231
76420-123_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-123	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	225	mg/1		CV	N	20241231
76420-124_a8e4e23f-490f-7ebc-e053-2a95a90af171	76420-124	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Asclemed USA, Inc.	PREGABALIN	300	mg/1		CV	N	20241231
76420-125_c92d68a6-8340-63e3-e053-2a95a90ae9c3	76420-125	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20160701		ANDA	ANDA206498	Asclemed USA, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-126_d6b1a441-d2cb-e481-e053-2995a90abf78	76420-126	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20190327		ANDA	ANDA209167	Asclemed USA, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-127_add5be5e-957e-fe25-e053-2995a90a6927	76420-127	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20150522		ANDA	ANDA091498	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-128_b3ba247a-da42-b643-e053-2a95a90aa969	76420-128	HUMAN PRESCRIPTION DRUG	mupirocin		Mupirocin	OINTMENT	TOPICAL	20091030		ANDA	ANDA065123	Asclemed USA, Inc.	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
76420-129_b2c9498d-2899-3ee5-e053-2a95a90af167	76420-129	HUMAN PRESCRIPTION DRUG	Lactated Ringers		SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, and CALCIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20190624		NDA	NDA017641	Asclemed USA, Inc.	CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE	20; 30; 600; 310	mg/100mL; mg/100mL; mg/100mL; mg/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
76420-130_b2ddcdd0-726a-99df-e053-2a95a90a8818	76420-130	HUMAN PRESCRIPTION DRUG	MECLIZINE HYDROCHLORIDE		Meclizine Hydrocloride	TABLET	ORAL	20100604		ANDA	ANDA040659	Asclemed USA, Inc.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
76420-131_b32f75c1-1ea5-112b-e053-2995a90ae0c7	76420-131	HUMAN PRESCRIPTION DRUG	Lidocaine		lidocaine	OINTMENT	TOPICAL	20170227		ANDA	ANDA205318	Asclemed USA, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-132_b2dde8d1-d0df-d7c2-e053-2995a90a2ed3	76420-132	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20160913		ANDA	ANDA208301	Asclemed USA, Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-133_ead3cd2c-c412-f612-e053-2995a90a63e0	76420-133	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Asclemed USA, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
76420-134_b965985a-9568-58f3-e053-2995a90a008c	76420-134	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION/ DROPS	TRANSDERMAL	20150820		ANDA	ANDA204132	Asclemed USA, Inc.	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-136_ca9b9e11-ae8f-f35e-e053-2a95a90a8762	76420-136	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Asclemed USA, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76420-137_d96467a9-dbc5-20ab-e053-2a95a90addb8	76420-137	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION	OPHTHALMIC	19960405		ANDA	ANDA062196	Asclemed USA, Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
76420-138_d964632f-4590-9500-e053-2995a90a992d	76420-138	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	TABLET, COATED	ORAL	20060329		ANDA	ANDA065255	Asclemed USA, Inc.	AMOXICILLIN	875	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-144_0831f4f6-1154-c740-e063-6294a90a33ef	76420-144	HUMAN OTC DRUG	Zylotrol Maximum Pain Patch		Lidocaine 4%, Menthol 1%	PATCH	TOPICAL	20210730		OTC MONOGRAPH DRUG	505G(a)(3)	ASCLEMED USA INC.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-145_07cebfba-4f3b-882f-e063-6294a90ac460	76420-145	HUMAN OTC DRUG	Zylotrol		Lidocaine HCl 4%, Menthol 1%	GEL	TOPICAL	20220612		OTC MONOGRAPH DRUG	M017	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-146_0831e9d4-03f8-c1ed-e063-6294a90aed67	76420-146	HUMAN OTC DRUG	Centipaine for Pain Control		Lidocaine 4%, Menthol 1%	PATCH	TOPICAL	20211223		OTC MONOGRAPH DRUG	505G(a)(3)	ASCLEMED USA INC.	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-148_e49badcf-439d-5511-e053-2995a90a14bf	76420-148	HUMAN PRESCRIPTION DRUG	Indomethacin		Indomethacin	CAPSULE	ORAL	20160519		ANDA	ANDA091240	Asclemed USA, Inc.	INDOMETHACIN	25	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-149_e425b6aa-1427-785f-e053-2a95a90a4350	76420-149	HUMAN PRESCRIPTION DRUG	LIDOTHOL		LIDOCAINE, MENTHOL	PATCH	TOPICAL	20150616		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LIDOCAINE; MENTHOL	4.5; 5	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-151_d5d43200-9843-10c3-e053-2995a90ad355	76420-151	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20131105		ANDA	ANDA203687	Asclemed USA, Inc.	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
76420-154_c8288d05-1cf2-2623-e053-2995a90a906f	76420-154	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20071030		ANDA	ANDA078341	Asclemed USA, Inc.	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
76420-164_d964ddff-cfca-92ad-e053-2995a90a6568	76420-164	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20201120		ANDA	ANDA077253	Asclemed USA, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
76420-182_b19b2211-34a8-759d-e053-2a95a90af002	76420-182	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20111101		ANDA	ANDA090170	Asclemed USA, Inc.	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]		N	20241231
76420-183_b41444ca-246e-b54e-e053-2a95a90ae0e7	76420-183	HUMAN PRESCRIPTION DRUG	Dicloxacillin Sodium		Dicloxacillin Sodium	CAPSULE	ORAL	19900930		ANDA	ANDA062286	Asclemed USA, Inc.	DICLOXACILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-184_eada7d08-38b8-4c19-e053-2995a90ae3ac	76420-184	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		KETOROLAC TROMETHAMINE	INJECTION, SOLUTION	INTRAMUSCULAR	20151030		ANDA	ANDA074802	Asclemed USA, Inc.	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-185_b4ea9bea-3f7b-4dc9-e053-2a95a90ae557	76420-185	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	20110511		ANDA	ANDA040803	Asclemed USA, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-188_ead5985f-7585-52ae-e053-2a95a90affce	76420-188	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20181127		ANDA	ANDA090589	Asclemed USA, Inc.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
76420-190_d9ae8e58-9ae8-7234-e053-2a95a90a3112	76420-190	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	SOLUTION	OROPHARYNGEAL	20070227		ANDA	ANDA040708	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-192_d19616e7-f7df-d290-e053-2995a90ae266	76420-192	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19940930		ANDA	ANDA064076	Asclemed USA, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-193_bda4563a-3fa1-a76b-e053-2995a90a304c	76420-193	HUMAN PRESCRIPTION DRUG	METHYLPREDNISOLONE		METHYLPREDNISOLONE	TABLET	ORAL	20180514		ANDA	ANDA204072	Asclemed USA, Inc.	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-195_e9294cf2-886b-1f04-e053-2995a90a3984	76420-195	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20050406		ANDA	ANDA077066	Asclemed USA, Inc.	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
76420-196_d1fbbd69-37b7-7ae4-e053-2a95a90a8398	76420-196	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19940729		ANDA	ANDA064067	Asclemed USA, Inc.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
76420-202_fab215a4-0e6e-767a-e053-6294a90a89ed	76420-202	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20010323		ANDA	ANDA065061	Asclemed USA, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
76420-203_d1fbb852-8bda-7a0e-e053-2a95a90a2d8e	76420-203	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	CREAM	TOPICAL	20180519		ANDA	ANDA209535	Asclemed USA, Inc.	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-204_d1fbb852-8bc5-7a0e-e053-2a95a90a2d8e	76420-204	HUMAN PRESCRIPTION DRUG	PREDNISOLONE ACETATE		prednisolone acetate	SUSPENSION/ DROPS	OPHTHALMIC	19970819		NDA AUTHORIZED GENERIC	NDA017011	Asclemed USA, Inc.	PREDNISOLONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-205_f9440001-dea9-2d5c-e053-6394a90aeb4d	76420-205	HUMAN PRESCRIPTION DRUG	tramadol hydrochloride		tramadol hydrochloride	TABLET	ORAL	20020622		ANDA	ANDA075964	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-208_d9c1d5d3-ee58-76e3-e053-2995a90ae559	76420-208	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	20110504		NDA	NDA018578	Asclemed USA, Inc.	SILVER SULFADIAZINE	10	g/1000g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
76420-209_de3d43dc-ba4c-e233-e053-2995a90ac632	76420-209	HUMAN PRESCRIPTION DRUG	Oxycodone and Acetaminophen		Oxycodone and Acetaminophen	TABLET	ORAL	20140828		ANDA	ANDA201278	Asclemed USA, Inc.	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325; 10	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
76420-210_d9ae8825-f28b-ba4e-e053-2995a90a4487	76420-210	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Asclemed USA, Inc.	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-212_d9ae93e7-f4a8-1df3-e053-2a95a90ae5b1	76420-212	HUMAN PRESCRIPTION DRUG	Erythromycin		Erythromycin	OINTMENT	OPHTHALMIC	19960718		ANDA	ANDA064030	Asclemed USA, Inc.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
76420-213_d9ae8825-f2f1-ba4e-e053-2995a90a4487	76420-213	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20051114		ANDA	ANDA065211	Asclemed USA, Inc.	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
76420-214_d9b54ffb-864f-1ca8-e053-2995a90a5144	76420-214	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA076558	Asclemed USA, Inc.	CIPROFLOXACIN HYDROCHLORIDE	250	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
76420-215_dea38bcd-012c-0949-e053-2a95a90a8f7b	76420-215	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Asclemed USA, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
76420-217_00388f2a-013b-518d-e063-6294a90af1a0	76420-217	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Asclemed USA, Inc.	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
76420-219_afe29f04-a566-757b-e053-2995a90a47a0	76420-219	HUMAN PRESCRIPTION DRUG	Ropidex		Dexamethasone Sodium Phosphate, Ropivacaine Hydrochloride, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRAVENOUS; PERINEURAL; TOPICAL	20190610		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-220_df6aa318-eae8-608c-e053-2995a90a0d27	76420-220	HUMAN PRESCRIPTION DRUG	Triloan SUIK		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20090601		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-221_e824474c-f378-a1c2-e053-2995a90a0bed	76420-221	HUMAN PRESCRIPTION DRUG	Pregabalin		pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Asclemed USA, Inc.	PREGABALIN	75	mg/1		CV	N	20241231
76420-222_0e7fdebd-8ab4-024a-e063-6394a90afec3	76420-222	HUMAN PRESCRIPTION DRUG	Triloan II SUIK		Triamcinolone Acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20090601		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
76420-223_e347fcb2-dbe0-193d-e053-2995a90a4784	76420-223	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20170601		ANDA	ANDA204237	Asclemed USA, Inc.	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
76420-224_07ceb8e0-9580-8c2c-e063-6294a90afa1d	76420-224	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin	TABLET, COATED	ORAL	20201001		OTC MONOGRAPH DRUG	M013	Asclemed USA, Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
76420-225_07cec8ef-ecca-ac49-e063-6294a90a6083	76420-225	HUMAN OTC DRUG	Docusate Sodium		Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20000101		OTC MONOGRAPH DRUG	M007	Asclemed USA, Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
76420-226_e4c45fb9-821e-45cb-e053-2995a90ae263	76420-226	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	Asclemed USA, Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
76420-227_e4c45fb9-821e-45cb-e053-2995a90ae263	76420-227	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium delayed release capsules	CAPSULE, COATED PELLETS	ORAL	20210227		ANDA	ANDA210559	Asclemed USA, Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
76420-228_0e7fc7ed-8e8f-3778-e063-6294a90aecb7	76420-228	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	Asclemed USA, Inc.	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
76420-229_0e7fc7ed-8e8f-3778-e063-6294a90aecb7	76420-229	HUMAN PRESCRIPTION DRUG	Tizanidine		Tizanidine	TABLET	ORAL	20020703		ANDA	ANDA076286	Asclemed USA, Inc.	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20251231
76420-230_01491362-9a55-d75a-e063-6294a90a8402	76420-230	HUMAN PRESCRIPTION DRUG	Marvona SUIK		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20090908		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
76420-231_e347f58a-9fc4-7e64-e053-2a95a90a528b	76420-231	HUMAN PRESCRIPTION DRUG	Tizanidne hydrochloride		Tizanidne Hydrochloride	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Asclemed USA, Inc.	TIZANIDINE HYDROCHLORIDE	6	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
76420-232_e49bafe5-839d-17b7-e053-2a95a90a64d9	76420-232	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Asclemed USA, Inc.	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
76420-233_e5e2bf99-2205-4962-e053-2a95a90a836d	76420-233	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Asclemed USA, Inc.	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
76420-234_e35b53ce-ead2-6007-e053-2995a90a7f25	76420-234	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Asclemed USA, Inc.	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-235_e347fcb2-dba9-193d-e053-2995a90a4784	76420-235	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Asclemed USA, Inc.	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-236_e347f58a-9f2f-7e64-e053-2a95a90a528b	76420-236	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Asclemed USA, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-237_e49b93ea-4940-7ab0-e053-2a95a90a539b	76420-237	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Asclemed USA, Inc.	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
76420-238_e49b93ea-4940-7ab0-e053-2a95a90a539b	76420-238	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Asclemed USA, Inc.	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
76420-239_e49b93ea-4940-7ab0-e053-2a95a90a539b	76420-239	HUMAN PRESCRIPTION DRUG	AMITRIPTYLINE HYDROCHLORIDE		AMITRIPTYLINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Asclemed USA, Inc.	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
76420-240_ead42ac0-5d53-308b-e053-2a95a90a6407	76420-240	HUMAN PRESCRIPTION DRUG	Betaloan SUIK		Betamethasone Sodium Phosphate and Betamethasone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR	20100428		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
76420-241_e49b9670-2c04-bd09-e053-2a95a90a989e	76420-241	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	Asclemed USA, Inc.	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
76420-242_e49b9670-2c04-bd09-e053-2a95a90a989e	76420-242	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20210713		ANDA	ANDA214099	Asclemed USA, Inc.	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
76420-243_e67ea944-997f-03d6-e053-2a95a90a9a6e	76420-243	HUMAN PRESCRIPTION DRUG	celecoxib		celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Asclemed USA, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-244_e49bb4f0-8b07-c774-e053-2a95a90acff7	76420-244	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-245_e49bb4f0-8b07-c774-e053-2a95a90acff7	76420-245	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-246_e49bb4f0-8b07-c774-e053-2a95a90acff7	76420-246	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-247_e824474c-f378-a1c2-e053-2995a90a0bed	76420-247	HUMAN PRESCRIPTION DRUG	Pregabalin		pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Asclemed USA, Inc.	PREGABALIN	50	mg/1		CV	N	20241231
76420-248_e824474c-f378-a1c2-e053-2995a90a0bed	76420-248	HUMAN PRESCRIPTION DRUG	Pregabalin		pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Asclemed USA, Inc.	PREGABALIN	100	mg/1		CV	N	20241231
76420-249_e824474c-f378-a1c2-e053-2995a90a0bed	76420-249	HUMAN PRESCRIPTION DRUG	Pregabalin		pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Asclemed USA, Inc.	PREGABALIN	150	mg/1		CV	N	20241231
76420-250_ccbb4bb7-0312-2fe2-e053-2995a90addb2	76420-250	HUMAN PRESCRIPTION DRUG	Toronova SUIK		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19970605		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-251_00388f2a-013b-518d-e063-6294a90af1a0	76420-251	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Asclemed USA, Inc.	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
76420-252_ccbb860e-6318-5114-e053-2a95a90abfb9	76420-252	HUMAN PRESCRIPTION DRUG	Toronova II SUIK		Ketorolac Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	19970605		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-253_e837dbef-8ea9-e5cb-e053-2995a90a8ec8	76420-253	HUMAN PRESCRIPTION DRUG	Lidothol		LIDOCAINE HCl, MENTHOL	GEL	TOPICAL	20190401		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL	4.5; 5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-254_e425b6aa-1415-785f-e053-2a95a90a4350	76420-254	HUMAN PRESCRIPTION DRUG	Gentamicin Sulfate		Gentamicin Sulfate	SOLUTION/ DROPS	OPHTHALMIC	19940511		ANDA	ANDA064048	Asclemed USA, Inc.	GENTAMICIN SULFATE	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
76420-256_e425b6aa-1438-785f-e053-2a95a90a4350	76420-256	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine hydrochloride		Cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-257_e436e361-d992-7d6d-e053-2995a90a10e4	76420-257	HUMAN PRESCRIPTION DRUG	Hydrocodone Bitartrate and Acetaminophen		Hydrocodone Bitartrate and Acetaminophen	TABLET	ORAL	20160412		ANDA	ANDA202991	Asclemed USA, Inc.	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
76420-258_e45e33db-d043-f2c9-e053-2a95a90ab76f	76420-258	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Asclemed USA, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-259_e6556af1-c426-5e24-e053-2995a90ae528	76420-259	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Asclemed USA, Inc.	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-260_efecfdf4-cb57-34bb-e053-2995a90a37a5	76420-260	HUMAN PRESCRIPTION DRUG	Medroloan SUIK		Methylprednisolone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20160629		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-261_e709b84d-fa7d-3f23-e053-2995a90aacd3	76420-261	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20160519		ANDA	ANDA206493	Asclemed USA, Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-262_efecfdf4-cb6c-34bb-e053-2995a90a37a5	76420-262	HUMAN PRESCRIPTION DRUG	Medroloan II SUIK		Methylprednisolone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20160629		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	METHYLPREDNISOLONE ACETATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-263_e5e2bf99-2205-4962-e053-2a95a90a836d	76420-263	HUMAN PRESCRIPTION DRUG	ZOLPIDEM TARTRATE		zolpidem tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Asclemed USA, Inc.	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
76420-264_045b551a-c273-2f52-e063-6294a90ab21b	76420-264	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Asclemed USA, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-265_e89c4c80-d10f-2a48-e053-2995a90a5d58	76420-265	HUMAN PRESCRIPTION DRUG	CYCLOBENZAPRINE HYDROCHLORIDE		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-267_ffca6765-4ed7-292d-e053-6394a90a39f2	76420-267	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210412		ANDA	ANDA205229	Asclemed USA, Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-268_e7bfa09d-7e18-d2bf-e053-2995a90a9145	76420-268	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-269_e7bfa09d-7e18-d2bf-e053-2995a90a9145	76420-269	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-270_a843b00f-4db5-1901-e053-2a95a90affae	76420-270	HUMAN PRESCRIPTION DRUG	DMT SUIK		Dexamethasone Sodium Phosphate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20030529		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-271_e7bfa09d-7e18-d2bf-e053-2995a90a9145	76420-271	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20210720		ANDA	ANDA071611	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-272_e7aa72fc-eb56-e9e2-e053-2a95a90a2df2	76420-272	HUMAN PRESCRIPTION DRUG	Ketorolac tromethamine		Ketorolac tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20190318		ANDA	ANDA204216	Asclemed USA, Inc.	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-273_e80fc4b5-cf91-6430-e053-2995a90a8128	76420-273	HUMAN PRESCRIPTION DRUG	CIPRO	HC	ciprofloxacin hydrochloride and hydrocortisone	SUSPENSION/ DROPS	AURICULAR (OTIC)	19990315		NDA	NDA020805	Asclemed USA, Inc.	CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE	2; 10	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
76420-275_e83802ce-a8c7-e6a6-e053-2995a90a5256	76420-275	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	GEL	TOPICAL	20160428		ANDA	ANDA206298	Asclemed USA, Inc.	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-276_e838b0d0-6869-8c20-e053-2a95a90a4d11	76420-276	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Asclemed USA, Inc.	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-278_e838b0d0-6869-8c20-e053-2a95a90a4d11	76420-278	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Asclemed USA, Inc.	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-279_e838b0d0-6869-8c20-e053-2a95a90a4d11	76420-279	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Asclemed USA, Inc.	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-280_e838b0d0-6869-8c20-e053-2a95a90a4d11	76420-280	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140612		ANDA	ANDA076343	Asclemed USA, Inc.	TOPIRAMATE	200	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-281_e8bb17c7-a664-6cfb-e053-2995a90af31f	76420-281	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Asclemed USA, Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-282_e8bb17c7-a664-6cfb-e053-2995a90af31f	76420-282	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210108		ANDA	ANDA205229	Asclemed USA, Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-283_e8c7a94e-8d26-886a-e053-2995a90a1ad8	76420-283	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070925	Asclemed USA, Inc.	CLONIDINE HYDROCHLORIDE	.1	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
76420-285_e8c7a94e-8d26-886a-e053-2995a90a1ad8	76420-285	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070924	Asclemed USA, Inc.	CLONIDINE HYDROCHLORIDE	.2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
76420-286_e8c7a94e-8d26-886a-e053-2995a90a1ad8	76420-286	HUMAN PRESCRIPTION DRUG	Clonidine hydrochloride		Clonidine hydrochloride	TABLET	ORAL	20170601		ANDA	ANDA070923	Asclemed USA, Inc.	CLONIDINE HYDROCHLORIDE	.3	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
76420-287_e9294cf2-8837-1f04-e053-2995a90a3984	76420-287	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	Asclemed USA, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-288_e9294cf2-8837-1f04-e053-2995a90a3984	76420-288	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	Asclemed USA, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-289_e950e1ff-a794-4179-e053-2995a90acd95	76420-289	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Asclemed USA, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76420-290_e950e1ff-a794-4179-e053-2995a90acd95	76420-290	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Asclemed USA, Inc.	OSELTAMIVIR PHOSPHATE	45	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76420-291_e950e1ff-a794-4179-e053-2995a90acd95	76420-291	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Asclemed USA, Inc.	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76420-306_f56bf11d-8422-56b8-e053-2a95a90ae40f	76420-306	HUMAN PRESCRIPTION DRUG	Hyronan		Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; TOPICAL	20201115		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-313_7bf5d114-7d2e-7284-e053-2a91aa0a638a	76420-313	HUMAN PRESCRIPTION DRUG	Cadira Compliant Blood Stat		Lidocaine / Prilocaine	CREAM	TOPICAL	20030827		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
76420-351_7d77ecf6-5731-d43e-e053-2991aa0af0db	76420-351	HUMAN PRESCRIPTION DRUG	Eha		Lidocaine Hydrochloride	LOTION	TOPICAL	20160607		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE	4	g/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-372_07ceca92-2158-8829-e063-6294a90a8c97	76420-372	HUMAN OTC DRUG	Aphen		acetaminophen	TABLET	ORAL	20200904		OTC MONOGRAPH DRUG	M013	Asclemed USA, Inc.	ACETAMINOPHEN	325	mg/1			N	20241231
76420-450_07cec8ef-ecc9-ac49-e063-6294a90a6083	76420-450	HUMAN OTC DRUG	Calypxo Pain Relief		Methyl Salicylate, Menthol	CREAM	TOPICAL	20140115		OTC MONOGRAPH DRUG	M017	Asclemed USA, Inc	MENTHOL; METHYL SALICYLATE	3; 10	g/100g; g/100g			N	20241231
76420-494_ea435212-caf8-164b-e053-2a95a90a0bf6	76420-494	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20201217		ANDA	ANDA213592	Asclemed USA, Inc.	ZOLPIDEM TARTRATE	6.25	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
76420-496_ea435212-caf8-164b-e053-2a95a90a0bf6	76420-496	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, EXTENDED RELEASE	ORAL	20201217		ANDA	ANDA213592	Asclemed USA, Inc.	ZOLPIDEM TARTRATE	12.5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
76420-497_eaa81374-5d2c-60d1-e053-2a95a90af8ea	76420-497	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160204		ANDA	ANDA205101	Asclemed USA, Inc.	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-498_eacf382a-98ac-e3ad-e053-2995a90a44e8	76420-498	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Asclemed USA, Inc.	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
76420-499_eacf382a-98ac-e3ad-e053-2995a90a44e8	76420-499	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Asclemed USA, Inc.	SUMATRIPTAN SUCCINATE	25	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
76420-500_eacf382a-98ac-e3ad-e053-2995a90a44e8	76420-500	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan Succinate	TABLET	ORAL	20090817		ANDA	ANDA078327	Asclemed USA, Inc.	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
76420-501_eb09cb41-7bbe-ea9e-e053-2995a90a8443	76420-501	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20200501		ANDA	ANDA065063	Asclemed USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
76420-503_eb09cb41-7bbe-ea9e-e053-2995a90a8443	76420-503	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA065189	Asclemed USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
76420-507_eb09cb41-7bbe-ea9e-e053-2995a90a8443	76420-507	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20151101		ANDA	ANDA065064	Asclemed USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
76420-508_ec75f13d-67a5-ddb2-e053-2a95a90a1b69	76420-508	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20051109		ANDA	ANDA065271	Asclemed USA, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-509_0cad6c91-0fe0-91c8-e063-6394a90a3fe8	76420-509	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20140714		ANDA	ANDA200734	Asclemed USA, Inc.	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-520_00f9a0d8-a64c-b119-e063-6394a90ac19b	76420-520	HUMAN PRESCRIPTION DRUG	Physicians EZ Use M-pred		Methylprednisolone Acetate, Bupivacaine Hydrochloride, Povidone-Iodine	KIT	EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE; TOPICAL	20130530		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-524_dd88dc31-b527-0390-e053-2a95a90abd08	76420-524	HUMAN PRESCRIPTION DRUG	Physician EZ Use Joint Tunnel and Trigger Kit		AMMONIA, LIDOCAINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE	KIT		20130701		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-527_afe47753-75fb-2c7d-e053-2a95a90a4bc8	76420-527	HUMAN PRESCRIPTION DRUG	Physicians EZ Use B-12 Compliance		Physicians EZ Use B-12 Compliance	KIT	INTRAMUSCULAR; SUBCUTANEOUS; TOPICAL	20001018		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-529_efb3276f-d284-59b5-e053-2a95a90ab9fb	76420-529	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065096	Asclemed USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
76420-530_efb3276f-d261-59b5-e053-2a95a90ab9fb	76420-530	HUMAN PRESCRIPTION DRUG	Fluocinonide		Fluocinonide	CREAM	TOPICAL	20180731		ANDA	ANDA211111	Asclemed USA, Inc.	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-531_f104fd15-0d76-3db4-e053-2995a90a1a88	76420-531	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20211130		ANDA	ANDA207085	Asclemed USA, Inc.	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
76420-532_f9c74a0c-ae33-1cd2-e053-6394a90aae62	76420-532	HUMAN PRESCRIPTION DRUG	Enoxiluv Kit		Enoxaparin Sodium, Isopropyl Alcohol	KIT	SUBCUTANEOUS; TOPICAL	20230208		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-533_f231a9aa-cc76-88a9-e053-2995a90aafb2	76420-533	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071321	Asclemed USA, Inc.	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76420-534_f33905ee-0218-1314-e053-2a95a90a25c7	76420-534	HUMAN PRESCRIPTION DRUG	BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE		BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE	TABLET	SUBLINGUAL	20210122		ANDA	ANDA209069	Asclemed USA, Inc.	BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE	8; 2	mg/1; mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]	CIII	N	20241231
76420-535_f5442f5e-af25-9d75-e053-2995a90a15e4	76420-535	HUMAN OTC DRUG	Hibiclens		Chlorhexidine Gluconate	SOLUTION	TOPICAL	19760917		NDA	NDA017768	Asclemed USA, Inc.	CHLORHEXIDINE GLUCONATE	213	g/1000mL	Decreased Cell Wall Integrity [PE]		N	20241231
76420-536_f4ca3781-8aec-9696-e053-2a95a90adf9f	76420-536	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-537_f4ca3781-8aec-9696-e053-2a95a90adf9f	76420-537	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-538_f4ca3781-8aec-9696-e053-2a95a90adf9f	76420-538	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Asclemed USA, Inc.	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-540_f5e688fe-a3a6-70a5-e053-2a95a90a2889	76420-540	HUMAN PRESCRIPTION DRUG	Lidocaine Hydrochloride		Lidocaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20130314		ANDA	ANDA203082	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-541_f7777037-65b9-9411-e053-6294a90a37eb	76420-541	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	Asclemed USA, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-542_f7777037-65b9-9411-e053-6294a90a37eb	76420-542	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	Asclemed USA, Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-543_f7777037-65b9-9411-e053-6294a90a37eb	76420-543	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	Asclemed USA, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-544_f7777037-65b9-9411-e053-6294a90a37eb	76420-544	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20200219		ANDA	ANDA208934	Asclemed USA, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-545_f7278cd0-99b5-9e8e-e053-6294a90a66e7	76420-545	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	19900930		ANDA	ANDA061926	Asclemed USA, Inc.	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-550_f7dc716f-969d-0bf4-e053-6294a90a9698	76420-550	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20160701		ANDA	ANDA206498	Asclemed USA, Inc.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-551_f7f0bf23-1272-256a-e053-6294a90a40ee	76420-551	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Asclemed USA, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-552_f7f0bf23-1272-256a-e053-6294a90a40ee	76420-552	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Asclemed USA, Inc.	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-553_f7f0bf23-1272-256a-e053-6294a90a40ee	76420-553	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Asclemed USA, Inc.	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-554_f7f0bf23-1272-256a-e053-6294a90a40ee	76420-554	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20190326		ANDA	ANDA209654	Asclemed USA, Inc.	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-555_f87f3d2b-033d-ea7a-e053-6394a90ac766	76420-555	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE	19750715		ANDA	ANDA084282	Asclemed USA, Inc.	DEXAMETHASONE SODIUM PHOSPHATE	4	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
76420-556_f8b9eb31-4486-7638-e053-6394a90aee92	76420-556	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET	ORAL	19860723		ANDA	ANDA089424	Asclemed USA, Inc.	SPIRONOLACTONE	25	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
76420-557_f8b9eb31-4486-7638-e053-6394a90aee92	76420-557	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Asclemed USA, Inc.	SPIRONOLACTONE	50	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
76420-558_f8b9eb31-4486-7638-e053-6394a90aee92	76420-558	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE		SPIRONOLACTONE	TABLET, FILM COATED	ORAL	19860723		ANDA	ANDA089424	Asclemed USA, Inc.	SPIRONOLACTONE	100	mg/1	Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]		N	20241231
76420-560_07ced67e-5c3d-6a20-e063-6294a90af548	76420-560	HUMAN OTC DRUG	ZYLOTROL PAIN RELIEVING		Lidocaine HCl, Menthol	CREAM	TOPICAL	20221229		OTC MONOGRAPH DRUG	M017	Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-561_028b204a-e3a0-ea94-e063-6294a90ad70e	76420-561	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20210211		ANDA	ANDA204842	Asclemed USA, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
76420-562_fad74c54-802a-300b-e053-6294a90a2af9	76420-562	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	Asclemed USA, Inc.	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
76420-563_fb50d332-1618-2b63-e053-6394a90ad585	76420-563	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Asclemed USA, Inc.	SILDENAFIL CITRATE	25	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-564_fb50d332-1618-2b63-e053-6394a90ad585	76420-564	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Asclemed USA, Inc.	SILDENAFIL CITRATE	50	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-565_fb50d332-1618-2b63-e053-6394a90ad585	76420-565	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Asclemed USA, Inc.	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-568_fbc96c09-340c-aa6b-e053-6294a90ae779	76420-568	HUMAN PRESCRIPTION DRUG	NP Thyroid 60		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20101111		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LEVOTHYROXINE; LIOTHYRONINE	38; 9	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
76420-569_fbc97068-7495-5269-e053-6294a90abbeb	76420-569	HUMAN PRESCRIPTION DRUG	NP Thyroid 90		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20110203		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LEVOTHYROXINE; LIOTHYRONINE	57; 13.5	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
76420-570_fbc96c09-33f1-aa6b-e053-6294a90ae779	76420-570	HUMAN PRESCRIPTION DRUG	NP Thyroid 120		LEVOTHYROXINE, LIOTHYRONINE	TABLET	ORAL	20170612		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LEVOTHYROXINE; LIOTHYRONINE	76; 18	ug/1; ug/1	Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]		N	20241231
76420-573_fe4d14a5-07d5-9345-e053-6294a90a78b2	76420-573	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	POWDER, FOR SUSPENSION	ORAL	19900930		ANDA	ANDA061931	Asclemed USA, Inc.	AMOXICILLIN	250	mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
76420-574_ffca6765-4ed7-292d-e053-6394a90a39f2	76420-574	HUMAN PRESCRIPTION DRUG	Progesterone		Progesterone	CAPSULE	ORAL	20210412		ANDA	ANDA205229	Asclemed USA, Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-575_0706e837-6b65-31c5-e063-6294a90a85e5	76420-575	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Asclemed USA, Inc.	IBUPROFEN	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-576_0706e837-6b65-31c5-e063-6294a90a85e5	76420-576	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Asclemed USA, Inc.	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-577_0706e837-6b65-31c5-e063-6294a90a85e5	76420-577	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20200508		ANDA	ANDA213794	Asclemed USA, Inc.	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-578_01ecac9a-6037-2746-e063-6294a90a9c67	76420-578	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20221205		NDA AUTHORIZED GENERIC	NDA204623	Asclemed USA, Inc.	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-579_02772bd6-36ba-d64e-e063-6294a90ab039	76420-579	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		BUPIVACAINE HYDROCHLORIDE	INJECTION, SOLUTION	EPIDURAL; INTRACAUDAL; PERINEURAL	20051122		ANDA	ANDA070584	Asclemed USA, Inc.	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
76420-580_032f47f4-4310-7979-e063-6294a90a4a7b	76420-580	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	Asclemed USA, Inc.	PROGESTERONE	200	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-581_0831d32f-b4cd-6e8b-e063-6294a90a38b8	76420-581	HUMAN OTC DRUG	ZYLOTROL MAXIMUM PAIN		lidocaine 4%, menthol 1%	PATCH	TOPICAL	20221223		OTC MONOGRAPH DRUG	505G(a)(3)	Asclemed USA, Inc.	LIDOCAINE; MENTHOL	.12; .03	g/3g; g/3g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-582_032f47f4-4310-7979-e063-6294a90a4a7b	76420-582	HUMAN PRESCRIPTION DRUG	PROGESTERONE		PROGESTERONE	CAPSULE	ORAL	20181128		ANDA	ANDA200900	Asclemed USA, Inc.	PROGESTERONE	100	mg/1	Progesterone [CS], Progesterone [EPC]		N	20241231
76420-583_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-583	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	100	mg/1		CV	N	20251231
76420-584_040d1b88-235a-aa09-e063-6394a90adbad	76420-584	HUMAN PRESCRIPTION DRUG	EPIPEN		epinephrine	INJECTION	INTRAMUSCULAR	19871222		NDA	NDA019430	Asclemed USA, Inc.	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
76420-585_04472220-f8f9-1f1a-e063-6294a90a2bb2	76420-585	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Asclemed USA, Inc.	PHENTERMINE HYDROCHLORIDE	15	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
76420-586_04472220-f8f9-1f1a-e063-6294a90a2bb2	76420-586	HUMAN PRESCRIPTION DRUG	Phentermine Hydrochloride		phentermine hydrochloride	CAPSULE	ORAL	20170124		ANDA	ANDA205019	Asclemed USA, Inc.	PHENTERMINE HYDROCHLORIDE	30	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
76420-587_044738e8-265d-d820-e063-6394a90a9e68	76420-587	HUMAN PRESCRIPTION DRUG	FLUCONAZOLE		FLUCONAZOLE	TABLET	ORAL	20040729		ANDA	ANDA076665	Asclemed USA, Inc.	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
76420-588_045968a3-3bad-28cf-e063-6394a90a4fe1	76420-588	HUMAN PRESCRIPTION DRUG	ciprofloxacin		Ciprofloxacin	SOLUTION	OPHTHALMIC	20181101		ANDA	ANDA077568	Asclemed USA, Inc.	CIPROFLOXACIN HYDROCHLORIDE	3	mg/mL	Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20241231
76420-589_04472220-f8c1-1f1a-e063-6294a90a2bb2	76420-589	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20060106		ANDA	ANDA065223	Asclemed USA, Inc.	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
76420-592_044738e8-2630-d820-e063-6394a90a9e68	76420-592	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Asclemed USA, Inc.	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-593_044738e8-2630-d820-e063-6394a90a9e68	76420-593	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20120604		ANDA	ANDA090836	Asclemed USA, Inc.	CEPHALEXIN	333	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-594_044738e8-2630-d820-e063-6394a90a9e68	76420-594	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110120		ANDA	ANDA090836	Asclemed USA, Inc.	CEPHALEXIN	250	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-595_044738e8-2630-d820-e063-6394a90a9e68	76420-595	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20120604		ANDA	ANDA090836	Asclemed USA, Inc.	CEPHALEXIN	750	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-596_045b6441-f12b-f2b4-e063-6394a90ad0ac	76420-596	HUMAN PRESCRIPTION DRUG	Ceftriaxone Sodium		Ceftriaxone Sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20170630		ANDA	ANDA203702	Asclemed USA, Inc.	CEFTRIAXONE SODIUM	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
76420-597_045b5851-b429-0639-e063-6394a90aa208	76420-597	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20181005		ANDA	ANDA209421	Asclemed USA, Inc.	OSELTAMIVIR PHOSPHATE	75	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
76420-598_045ce619-2c60-e219-e063-6294a90a8cd5	76420-598	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		diclofenac sodium	TABLET, FILM COATED	ORAL	20220926		ANDA	ANDA216275	Asclemed USA, Inc.	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-599_04ab2bbb-1be5-1bfc-e063-6394a90a103e	76420-599	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20080926		ANDA	ANDA078643	Asclemed USA, Inc.	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-600_04ab174a-3abc-2b8e-e063-6394a90a1df5	76420-600	HUMAN PRESCRIPTION DRUG	Valacyclovir Hydrochloride		Valacyclovir Hydrochloride	TABLET, FILM COATED	ORAL	20100524		ANDA	ANDA090682	Asclemed USA, Inc.	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
76420-607_04ab2de4-f463-1b52-e063-6394a90a5fc6	76420-607	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20120120		ANDA	ANDA091568	Asclemed USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
76420-608_04ab2de4-f498-1b52-e063-6394a90a5fc6	76420-608	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20021031		ANDA	ANDA065101	Asclemed USA, Inc.	AMOXICILLIN; CLAVULANATE POTASSIUM	500; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
76420-612_0523a539-bb30-676e-e063-6394a90af39b	76420-612	HUMAN PRESCRIPTION DRUG	erythromycin		erythromycin	OINTMENT	OPHTHALMIC	20140508		ANDA	ANDA062447	Asclemed USA, Inc.	ERYTHROMYCIN	5	mg/g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
76420-613_05373fec-0f63-7fd4-e063-6394a90af72d	76420-613	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20121106		ANDA	ANDA091479	Asclemed USA, Inc.	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-614_054ad3e6-3c9c-e6d2-e063-6294a90ab46f	76420-614	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Asclemed USA, Inc.	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
76420-615_054ad3e6-3c9c-e6d2-e063-6294a90ab46f	76420-615	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Asclemed USA, Inc.	CLINDAMYCIN HYDROCHLORIDE	75	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
76420-616_054ad3e6-3c9c-e6d2-e063-6294a90ab46f	76420-616	HUMAN PRESCRIPTION DRUG	CLINDAMYCIN HYDROCHLORIDE		Clindamycin hydrochloride	CAPSULE	ORAL	20190107		ANDA	ANDA207402	Asclemed USA, Inc.	CLINDAMYCIN HYDROCHLORIDE	150	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
76420-617_068d23f0-3994-f3d5-e063-6394a90ae9a4	76420-617	HUMAN PRESCRIPTION DRUG	GABAPENTIN		GABAPENTIN	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Asclemed USA, Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76420-618_06c9643e-5491-13c4-e063-6394a90aa3e1	76420-618	HUMAN PRESCRIPTION DRUG	Cyanocobalamin		Cyanocobalamin	INJECTION	INTRAMUSCULAR; SUBCUTANEOUS	20220803		ANDA	ANDA215417	Asclemed USA, Inc.	CYANOCOBALAMIN	1000	ug/mL	Vitamin B 12 [CS], Vitamin B12 [EPC]		N	20241231
76420-619_06f2293c-2cf4-70d4-e063-6394a90a3a56	76420-619	HUMAN PRESCRIPTION DRUG	Ivermectin		Ivermectin	TABLET	ORAL	20141115		ANDA	ANDA204154	Asclemed USA, Inc.	IVERMECTIN	3	mg/1	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
76420-621_06f23716-6fa8-7294-e063-6394a90a0db9	76420-621	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20190120		ANDA	ANDA207394	Asclemed USA, Inc.	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
76420-622_07064ca3-dc6a-0927-e063-6294a90aac46	76420-622	HUMAN PRESCRIPTION DRUG	Pro-C-Dure 6 Kit		kenalog	KIT	INTRA-ARTICULAR; INTRAMUSCULAR	20150817		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-623_0988d28c-fd62-61e0-e063-6294a90af3c0	76420-623	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Asclemed USA, Inc.	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-624_eb109dc4-36fe-42b2-e053-2a95a90a16c4	76420-624	HUMAN PRESCRIPTION DRUG	Physician EZ Use Joint Tunnel and Trigger Kit II		LIDOCAINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE	KIT		20211223		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-626_07e39b36-491f-3269-e063-6394a90aff40	76420-626	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Asclemed USA, Inc.	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-627_07f76fa9-dba3-997b-e063-6294a90a6dd5	76420-627	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	Asclemed USA, Inc.	NAPROXEN SODIUM	550	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-628_0b2fcb56-d9fa-e9f6-e063-6294a90a2f8e	76420-628	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET	ORAL	20190723		ANDA	ANDA211567	Asclemed USA, Inc.	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
76420-630_07f772a8-08d9-f37e-e063-6294a90a430c	76420-630	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Asclemed USA, Inc.	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-631_07f772a8-08d9-f37e-e063-6294a90a430c	76420-631	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20110601		ANDA	ANDA200834	Asclemed USA, Inc.	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-632_07f772a8-08d9-f37e-e063-6294a90a430c	76420-632	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111123		ANDA	ANDA200834	Asclemed USA, Inc.	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-633_0988d28c-fd62-61e0-e063-6294a90af3c0	76420-633	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Asclemed USA, Inc.	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-634_0988d28c-fd62-61e0-e063-6294a90af3c0	76420-634	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Asclemed USA, Inc.	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-636_0988d28c-fd62-61e0-e063-6294a90af3c0	76420-636	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20190325		ANDA	ANDA208706	Asclemed USA, Inc.	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
76420-637_07f76fa9-dba3-997b-e063-6294a90a6dd5	76420-637	HUMAN PRESCRIPTION DRUG	Naproxen Sodium		Naproxen Sodium	TABLET	ORAL	20191030		ANDA	ANDA212199	Asclemed USA, Inc.	NAPROXEN SODIUM	275	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
76420-638_07e39b36-491f-3269-e063-6394a90aff40	76420-638	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Asclemed USA, Inc.	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
76420-641_7bf5d114-7d46-7284-e053-2a91aa0a638a	76420-641	HUMAN PRESCRIPTION DRUG	LIDO BDK		Lidocaine, Prilocaine	CREAM	TOPICAL	20030827		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
76420-642_091085d0-280b-a5cc-e063-6294a90a78ce	76420-642	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20191008		ANDA	ANDA207244	Asclemed USA, Inc.	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
76420-643_091085d0-27cf-a5cc-e063-6294a90a78ce	76420-643	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine Sulfate		Hydroxychloroquine Sulfate	TABLET, FILM COATED	ORAL	20190905		ANDA	ANDA210959	Asclemed USA, Inc.	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
76420-644_0c5d5420-c6cf-0d61-e063-6394a90aea41	76420-644	HUMAN PRESCRIPTION DRUG	Trubrexa		lidocaine and capsaicin	PATCH	TRANSDERMAL	20231003		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	CAPSAICIN; LIDOCAINE	.00025; .0475	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-645_0aa2a70c-f281-4165-e063-6294a90ace32	76420-645	HUMAN PRESCRIPTION DRUG	Testosterone Cypionate		Testosterone Cypionate	INJECTION, SOLUTION	INTRAMUSCULAR	20071221		ANDA	ANDA040530	Asclemed USA, Inc.	TESTOSTERONE CYPIONATE	200	mg/mL	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
76420-646_0b44d519-3a0a-614d-e063-6294a90ab9b0	76420-646	HUMAN PRESCRIPTION DRUG	CARISOPRODOL		CARISOPRODOL	TABLET	ORAL	20140127		ANDA	ANDA203374	Asclemed USA, Inc.	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
76420-647_0b44d6cf-d204-741a-e063-6294a90a05ff	76420-647	HUMAN PRESCRIPTION DRUG	Lorazepam		Lorazepam	TABLET	ORAL	20230516		ANDA	ANDA078203	Asclemed USA, Inc.	LORAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
76420-648_0c0cf76f-2d99-45ef-e063-6394a90a9fef	76420-648	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20171211		ANDA	ANDA205253	Asclemed USA, Inc.	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
76420-649_0dc7bda4-7a99-9041-e063-6294a90a5157	76420-649	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20220411		ANDA	ANDA210000	Asclemed USA, Inc.	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20251231
76420-650_8dc7c66d-b497-4d17-8766-7f49ecd36d0d	76420-650	HUMAN PRESCRIPTION DRUG	Testone CIK		Testosterone Cypionate, Alcohol	KIT		20071221		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-651_0e42e402-85e4-30a1-e063-6394a90a142c	76420-651	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Asclemed USA, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-652_0e42e402-85e4-30a1-e063-6394a90a142c	76420-652	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Asclemed USA, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-653_0e42e402-85e4-30a1-e063-6394a90a142c	76420-653	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Asclemed USA, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-654_0e42e402-85e4-30a1-e063-6394a90a142c	76420-654	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET, EXTENDED RELEASE	ORAL	20110607		ANDA	ANDA090871	Asclemed USA, Inc.	ALPRAZOLAM	3	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-656_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-656	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	50	mg/1		CV	N	20251231
76420-657_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-657	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	75	mg/1		CV	N	20251231
76420-658_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-658	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	150	mg/1		CV	N	20251231
76420-659_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-659	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	200	mg/1		CV	N	20251231
76420-660_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-660	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	225	mg/1		CV	N	20251231
76420-661_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-661	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	300	mg/1		CV	N	20251231
76420-662_0e7fc116-92a5-1b8e-e063-6294a90a1aed	76420-662	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20220620		ANDA	ANDA211685	Asclemed USA, Inc.	PREGABALIN	25	mg/1		CV	N	20251231
76420-663_0ea9692e-7d75-80f3-e063-6294a90ad6f9	76420-663	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Asclemed USA, Inc.	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-664_0ea9692e-7d75-80f3-e063-6294a90ad6f9	76420-664	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Asclemed USA, Inc.	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-665_0ea9692e-7d75-80f3-e063-6294a90ad6f9	76420-665	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Asclemed USA, Inc.	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-666_0ea9692e-7d75-80f3-e063-6294a90ad6f9	76420-666	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Asclemed USA, Inc.	ALPRAZOLAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20251231
76420-715_02db6c14-f841-85bd-e063-6294a90a3bf9	76420-715	HUMAN PRESCRIPTION DRUG	Accucaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION	20160201		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
76420-720_00f9adce-cdec-5fb5-e063-6394a90a6cb4	76420-720	HUMAN PRESCRIPTION DRUG	Bupivilog Kit		marcaine, kenalog, povidone iodine	KIT	EPIDURAL; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL	20140204		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-730_00f9a62b-3a76-8658-e063-6394a90a2055	76420-730	HUMAN PRESCRIPTION DRUG	Marlido Kit		marcaine, lidocaine, povidone iodine	KIT	EPIDURAL; INFILTRATION; TOPICAL	20140204		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-735_efebeeed-8243-083c-e053-2a95a90a4f66	76420-735	HUMAN PRESCRIPTION DRUG	Marlido 25 Kit		Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; TOPICAL	20090908		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-740_00f9adce-ce5e-5fb5-e063-6394a90a6cb4	76420-740	HUMAN PRESCRIPTION DRUG	MLK F1 Kit		marcaine, lidocaine, kenalog, povidone iodine	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRAMUSCULAR	20140116		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-742_00f9b947-7fe2-ae97-e063-6394a90a9cc5	76420-742	HUMAN PRESCRIPTION DRUG	MLK Kit F2		marcaine, lidocaine, kenalog, povidone iodine	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL	20180510		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-743_00f9bbc6-fbc0-321e-e063-6394a90aa2d5	76420-743	HUMAN PRESCRIPTION DRUG	MLK F3 Kit		marcaine, lidocaine, kenalog, povidone iodine	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL	20140204		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-744_00f9bbc6-fc58-321e-e063-6394a90aa2d5	76420-744	HUMAN PRESCRIPTION DRUG	MLK F4 Kit		Triamcinolone Acetonide, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL	20090601		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-750_efdaefa1-4eb9-8284-e053-2a95a90a35df	76420-750	HUMAN PRESCRIPTION DRUG	Dyural 40 Kit		Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Sodium Chloride, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE; SUBCUTANEOUS; TOPICAL	20140725		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-755_f053778a-beeb-4ff8-e053-2a95a90abe68	76420-755	HUMAN PRESCRIPTION DRUG	Dyural 80 Kit		Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Sodium Chloride, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE; SUBCUTANEOUS; TOPICAL	20140801		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-760_c361fd47-daf9-1322-e053-2a95a90ae3f9	76420-760	HUMAN PRESCRIPTION DRUG	Lidolog Kit		lidocaine, kenalog, povidone iodine	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL	20180510		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-765_af084941-87c8-34a6-e053-2995a90af785	76420-765	HUMAN PRESCRIPTION DRUG	Betalido Kit		Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Povidine Iodine	KIT	INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; PERINEURAL; TOPICAL	20140613		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-766_afe47fde-074d-2644-e053-2a95a90af04e	76420-766	HUMAN PRESCRIPTION DRUG	DoubleDex Kit		Dexamethasone Sodium Phosphate, Povidine Iodine	KIT	INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20140725		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-767_dd88deca-8064-4aa0-e053-2a95a90aa246	76420-767	HUMAN PRESCRIPTION DRUG	Dexlido Kit		Dexamethasone Sodium Phosphate, Lidocaine Hydrochloride, Povidine Iodine	KIT	INFILTRATION; INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20140725		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-769_efdc15d7-beba-2ee8-e053-2995a90aa80c	76420-769	HUMAN PRESCRIPTION DRUG	Dexlido-M Kit		Dexamethasone Sodium Phosphate, Lidocaine Hydrochloride, maricaine, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20140725		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-771_dd88deca-80bb-4aa0-e053-2a95a90aa246	76420-771	HUMAN PRESCRIPTION DRUG	Ketorocaine L Kit		Ketorolac Tromethamine, Lidocaine Hydrochloride, Povidine Iodine	KIT	INFILTRATION; INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20140815		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-772_efebfe84-b23b-05bc-e053-2a95a90aa668	76420-772	HUMAN PRESCRIPTION DRUG	Ketorocaine LM Kit		Ketorolac Tromethamine, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20140811		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-775_efed04fc-aa53-1484-e053-2a95a90ab8c7	76420-775	HUMAN PRESCRIPTION DRUG	Dyural L Kit		Methylprednisolone Acetate, Lidocaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol	KIT	INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE; TOPICAL	20140815		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-780_efecf75d-f945-7f73-e053-2a95a90a0256	76420-780	HUMAN PRESCRIPTION DRUG	Multi-Specialty Kit		Depo-Medrol, Lidocaine, Isopropyl Alcohol	KIT	INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE; TOPICAL	20140206		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-782_efebfe84-b3d9-05bc-e053-2a95a90aa668	76420-782	HUMAN PRESCRIPTION DRUG	Marbeta L Kit		Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; TOPICAL	20100428		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-785_efebfe84-b326-05bc-e053-2a95a90aa668	76420-785	HUMAN PRESCRIPTION DRUG	Marbeta 25 Kit		Betamethasone Sodium Phosphate and Betamethasone Acetate, Bupivacaine Hydrochloride, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; TOPICAL	20100428		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-795_efdc15d7-bf6d-2ee8-e053-2995a90aa80c	76420-795	HUMAN PRESCRIPTION DRUG	Dyural LM Kit		Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE; TOPICAL	20140821		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-796_efdc0036-fb4f-369b-e053-2a95a90aa50f	76420-796	HUMAN PRESCRIPTION DRUG	Dyural 80-LM		Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE; SUBCUTANEOUS; TOPICAL	20220111		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-810_efebfe84-b4b2-05bc-e053-2a95a90aa668	76420-810	HUMAN PRESCRIPTION DRUG	Mardex 25 Kit		Dexamethasone Sodium Phosphate, Bupivacaine Hydrochloride, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20140821		UNAPPROVED DRUG OTHER		Asclemed USA, Inc.						N	20241231
76420-947_07cec02c-17d3-145d-e063-6294a90a0fb3	76420-947	HUMAN OTC DRUG	EXOTEN-C		METHYL SALICYLATE, MENTHOL, CAPSAICIN	LOTION	TOPICAL	20170210		OTC MONOGRAPH DRUG	M017	Asclemed USA, Inc.	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.025; 10; 20	g/100g; g/100g; g/100g			N	20241231
76420-983_d5db9e70-d7a4-462d-e053-2995a90a32be	76420-983	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride and Acetaminophen		Tramadol Hydrochloride and Acetaminophen	TABLET	ORAL	20091217		ANDA	ANDA090485	Asclemed USA, Inc.	ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE	325; 37.5	mg/1; mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
76420-999_07ceca92-2157-8829-e063-6294a90a8c97	76420-999	HUMAN OTC DRUG	Calypxo HP Pain Relief		Methyl Salicylate, Menthol	CREAM	TOPICAL	20201210		OTC MONOGRAPH DRUG	M017	Asclemed USA, Inc	MENTHOL; METHYL SALICYLATE	10; 15	g/100g; g/100g			N	20241231
76431-105_9404d970-ee07-43d7-8fa8-30e45b08087b	76431-105	HUMAN PRESCRIPTION DRUG	Juxtapid		lomitapide mesylate	CAPSULE	ORAL	20130103		NDA	NDA203858	Amryt Pharmaceuticals DAC	LOMITAPIDE MESYLATE	5	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Microsomal Triglyceride Transfer Protein Inhibitor [EPC], Microsomal Triglyceride Transfer Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
76431-110_9404d970-ee07-43d7-8fa8-30e45b08087b	76431-110	HUMAN PRESCRIPTION DRUG	Juxtapid		lomitapide mesylate	CAPSULE	ORAL	20130103		NDA	NDA203858	Amryt Pharmaceuticals DAC	LOMITAPIDE MESYLATE	10	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Microsomal Triglyceride Transfer Protein Inhibitor [EPC], Microsomal Triglyceride Transfer Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
76431-120_9404d970-ee07-43d7-8fa8-30e45b08087b	76431-120	HUMAN PRESCRIPTION DRUG	Juxtapid		lomitapide mesylate	CAPSULE	ORAL	20130103		NDA	NDA203858	Amryt Pharmaceuticals DAC	LOMITAPIDE MESYLATE	20	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Microsomal Triglyceride Transfer Protein Inhibitor [EPC], Microsomal Triglyceride Transfer Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
76431-130_9404d970-ee07-43d7-8fa8-30e45b08087b	76431-130	HUMAN PRESCRIPTION DRUG	Juxtapid		lomitapide mesylate	CAPSULE	ORAL	20130103		NDA	NDA203858	Amryt Pharmaceuticals DAC	LOMITAPIDE MESYLATE	30	mg/1	Cytochrome P450 3A4 Inhibitors [MoA], Microsomal Triglyceride Transfer Protein Inhibitor [EPC], Microsomal Triglyceride Transfer Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
76431-210_d02c8a27-7501-4b03-bf87-43f4948f11a5	76431-210	HUMAN PRESCRIPTION DRUG	Myalept		metreleptin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20150305		BLA	BLA125390	Amryt Pharmaceuticals DAC	METRELEPTIN	11.3	mg/2.2mL	Analogs/Derivatives [Chemical/Ingredient], Leptin Analog [EPC], Leptin [Chemical/Ingredient]		N	20241231
76436-127_0d338580-a3c3-0112-e063-6394a90a985d	76436-127	HUMAN OTC DRUG	Sof Skin Vaporizing Chest Rub and Cough Suppressant		Menthol and Camphor and Eucalyptus Oil	GEL	TOPICAL	20100310		OTC MONOGRAPH DRUG	M012	Viny Health and Beauty Inc	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	5.31; 1.13; 2.26	g/113g; g/113g; g/113g			N	20241231
76436-140_0d33121a-43f2-9db1-e063-6294a90aa5cf	76436-140	HUMAN OTC DRUG	ICY BLUE		Menthol	GEL	TOPICAL	20100310		OTC MONOGRAPH DRUG	M017	Viny Health and Beauty Inc	MENTHOL	1	g/100g			N	20241231
76436-304_0d3346a9-dc86-b239-e063-6294a90ad1f9	76436-304	HUMAN OTC DRUG	RUBBING ALCOHOL	70 PERCENT with Wintergreen	ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20141203		OTC MONOGRAPH DRUG	M003	Viny Health and Beauty Products Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
76436-306_0d32c6de-abea-a69e-e063-6394a90a8774	76436-306	HUMAN OTC DRUG	RUBBING ALCOHOL	99 PERCENT	ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20141203		OTC MONOGRAPH DRUG	M003	Viny Health and Beauty Products Inc	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
76436-312_0d32c6de-abdf-a69e-e063-6394a90a8774	76436-312	HUMAN OTC DRUG	99 PERCENT ISOPROPYL RUBBING ALCOHOL	with Wintergreen Oil	ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20141203		OTC MONOGRAPH DRUG	M003	Viny Health and Beauty Products Inc	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
76441-909_203deaf1-2712-4604-bc81-8dc793596f5d	76441-909	HUMAN OTC DRUG	Lice-Nil LICE AND EGGS ELIMINATOR Oil		AZADIRACHTA INDICA	OIL	TOPICAL	20170801		UNAPPROVED HOMEOPATHIC		Sujanil Chemo Industries	AZADIRACHTA INDICA SEED OIL	1	[hp_X]/100mL			N	20241231
76445-0055_d43f258b-d9d3-579b-e053-2995a90a2a34	76445-0055	HUMAN OTC DRUG	Clear-N-Smooth		Antiperspirant/Deodorant - Ultrafresh	LOTION	TOPICAL	19920102		OTC MONOGRAPH FINAL	part350	Hawknad Manufacturing Industries	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	16	g/100g			N	20241231
76445-0091_f1f4876f-dda3-dd9a-e053-2a95a90a4636	76445-0091	HUMAN OTC DRUG	Clear-N-Smooth		Acne-Pimple Medication	LOTION	TOPICAL	19920102		OTC MONOGRAPH FINAL	part333D	Hawknad Manufacturing Industries, Inc.	SALICYLIC ACID	.01	g/g			N	20241231
76445-2175_d43f54d6-01d6-64f7-e053-2995a90a1459	76445-2175	HUMAN OTC DRUG	Clear-N-Smooth		Antiperspirant/Deodorant - Perpetual	LOTION	TOPICAL	19920102		OTC MONOGRAPH FINAL	part350	Hawknad Manufacturing Industries	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	16	g/100g			N	20241231
76446-041_fb607af5-6249-44a5-8c0f-b109f24a4753	76446-041	HUMAN OTC DRUG	anna lotan Premium BB Cream SPF46 Pale Beige		Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20230915		OTC MONOGRAPH FINAL	M020	Anna Lotan Ltd	OCTINOXATE; TITANIUM DIOXIDE	6.99; 16	g/100mL; g/100mL			N	20241231
76446-042_c7124d57-47ba-4b12-a34d-5d0a51f52474	76446-042	HUMAN OTC DRUG	anna lotan Premium BB Cream SPF46 Natural Beige		Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20230915		OTC MONOGRAPH FINAL	M020	Anna Lotan Ltd	OCTINOXATE; TITANIUM DIOXIDE	6.99; 16	g/100mL; g/100mL			N	20241231
76446-043_80016b2e-83a8-4757-85df-984d2c73de35	76446-043	HUMAN OTC DRUG	anna lotan Premium BB Cream SPF46 Medium Beige		Titanium Dioxide, Octinoxate	CREAM	TOPICAL	20230915		OTC MONOGRAPH FINAL	M020	Anna Lotan Ltd	OCTINOXATE; TITANIUM DIOXIDE	6.99; 16	g/100mL; g/100mL			N	20241231
76446-300_174ada27-cae8-46b3-b6dd-b001befab1f7	76446-300	HUMAN OTC DRUG	Anna Lotan Lightly Tinted Mineral Day Cream Broad Spectrum SPF 30		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220525		OTC MONOGRAPH FINAL	part352	Anna Lotan Ltd	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
76446-648_af45f6f0-b764-4d36-8d31-e3884c19eb3a	76446-648	HUMAN OTC DRUG	Rosease By Anna Lotan Gentle Daytime Broad Spectrum SPF 30		Octinoxate, Zinc Oxide	CREAM	TOPICAL	20220525		OTC MONOGRAPH FINAL	part352	Anna Lotan Ltd	OCTINOXATE; ZINC OXIDE	7.5; 10	g/100mL; g/100mL			N	20241231
76457-001_0b5850de-34f4-b95e-e063-6294a90affe1	76457-001	HUMAN OTC DRUG	Aluminum hydroxide and Magnesium carbonate		ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE	TABLET, CHEWABLE	ORAL	20180209		OTC MONOGRAPH DRUG	M001	Simpex Pharma Pvt. Ltd	ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE	160; 105	mg/1; mg/1			N	20241231
76457-002_0b586170-9b5f-74dc-e063-6394a90aa09b	76457-002	HUMAN OTC DRUG	diphenhydramine hydrochloride		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20180209		OTC MONOGRAPH DRUG	M012	Simpex Pharma Pvt. Ltd	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
76457-003_0b586450-2c14-70e7-e063-6394a90a5f33	76457-003	HUMAN OTC DRUG	SIMPEX Bisacodyl laxative		BISACODYL	TABLET, COATED	ORAL	20180209		OTC MONOGRAPH DRUG	M007	Simpex Pharma Pvt. Ltd	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76457-004_0b586737-4616-db6e-e063-6294a90a6135	76457-004	HUMAN OTC DRUG	SIMPEX Guaifenesin		GUAIFENESIN	TABLET	ORAL	20180209		OTC MONOGRAPH DRUG	M012	Simpex Pharma Pvt. Ltd	GUAIFENESIN	400	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
76458-301_0c8f2edd-e15a-3709-e063-6294a90a3b7b	76458-301	HUMAN OTC DRUG	Light Day Sunscreen SPF 37		AVOBENZONE, OCTINOXATE, OCTOCRYLENE	LOTION	TOPICAL	20200214		OTC MONOGRAPH DRUG	M020	Circadia by Dr Pugliese, Inc.	AVOBENZONE; OCTINOXATE; OCTOCRYLENE	30; 75; 28	mg/mL; mg/mL; mg/mL			N	20241231
76458-333_0c86a86e-1d0e-8fa8-e063-6294a90a5963	76458-333	HUMAN OTC DRUG	Nighttime Control		Benzoyl Peroxide	LOTION	TOPICAL	20120715		OTC MONOGRAPH DRUG	M006	Circadia by Dr Pugliese, Inc.	BENZOYL PEROXIDE	50	mg/mL			N	20241231
76458-400_0c8f6687-e666-c08c-e063-6394a90a3921	76458-400	HUMAN OTC DRUG	Hand Sanitizer Isopropyl Alcohol Antiseptic 75		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20200406		OTC MONOGRAPH DRUG	505G(a)(3)	Circadia by Dr Pugliese, Inc.	ISOPROPYL ALCOHOL	.75	mL/mL			N	20241231
76458-401_0d1ad873-78fa-d26e-e063-6294a90a3712	76458-401	HUMAN OTC DRUG	Circadia Circa-Shield Mineral Sunscreen SPF 30		ZINC OXIDE	CREAM	TOPICAL	20231231		OTC MONOGRAPH DRUG	M020	Circadia by Dr Pugliese, Inc.	ZINC OXIDE	173	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
76472-1123_054155d2-62fd-04ac-e063-6294a90a380f	76472-1123	HUMAN OTC DRUG	ACONITUM NAPELLUS		ACONITUM NAPELLUS	PELLET	SUBLINGUAL	20111212		UNAPPROVED HOMEOPATHIC		SEVENE USA	ACONITUM NAPELLUS	30	[hp_C]/1			N	20241231
76472-1124_05414779-f606-8fa7-e063-6394a90aa034	76472-1124	HUMAN OTC DRUG	Allium Cepa		Allium Cepa	PELLET	SUBLINGUAL	20111120		UNAPPROVED HOMEOPATHIC		SEVENE USA	ONION	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
76472-1125_054157a2-aef9-2b56-e063-6294a90a9382	76472-1125	HUMAN OTC DRUG	APIS MELLIFERA		APIS MELLIFERA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	APIS MELLIFERA	30	[hp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
76472-1126_054155d2-62fc-04ac-e063-6294a90a380f	76472-1126	HUMAN OTC DRUG	Argentum Nitricum		SILVER NITRATE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	SILVER NITRATE	30	[hp_C]/1			N	20241231
76472-1127_05412012-6c66-28e0-e063-6394a90a8f89	76472-1127	HUMAN OTC DRUG	Arnica 12c		ARNICA MONTANA	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARNICA MONTANA	12	[hp_C]/1			N	20241231
76472-1128_05414a66-83f2-8f96-e063-6394a90a81c5	76472-1128	HUMAN OTC DRUG	ARNICA MONTANA		ARNICA MONTANA	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARNICA MONTANA	200	[kp_C]/1			N	20241231
76472-1129_05414a66-83f1-8f96-e063-6394a90a81c5	76472-1129	HUMAN OTC DRUG	ARNICA 30C		ARNICA MONTANA	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARNICA MONTANA	30	[hp_C]/1			N	20241231
76472-1130_05414a66-83f0-8f96-e063-6394a90a81c5	76472-1130	HUMAN OTC DRUG	ARNICA		ARNICA MONTANA	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARNICA MONTANA	30	[hp_X]/1			N	20241231
76472-1131_05412b91-c1ef-c947-e063-6294a90acd17	76472-1131	HUMAN OTC DRUG	Arnica 6c		ARNICA MONTANA	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARNICA MONTANA	6	[hp_C]/1			N	20241231
76472-1132_05412a27-1cc4-b001-e063-6294a90a1b47	76472-1132	HUMAN OTC DRUG	Arsenicum Album 30c		ARSENIC TRIOXIDE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARSENIC TRIOXIDE	30	[hp_C]/1			N	20241231
76472-1133_05414a66-83ef-8f96-e063-6394a90a81c5	76472-1133	HUMAN OTC DRUG	Belladonna		ATROPA BELLADONNA	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ATROPA BELLADONNA	30	[hp_C]/1			N	20241231
76472-1134_05414a66-83ee-8f96-e063-6394a90a81c5	76472-1134	HUMAN OTC DRUG	Borax		SODIUM BORATE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	SODIUM BORATE	30	[hp_C]/1			N	20241231
76472-1135_05412b91-c1ee-c947-e063-6294a90acd17	76472-1135	HUMAN OTC DRUG	Bryonia Alba 30c		BRYONIA ALBA ROOT	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	BRYONIA ALBA ROOT	30	[hp_C]/1			N	20241231
76472-1136_05414779-f604-8fa7-e063-6394a90aa034	76472-1136	HUMAN OTC DRUG	Calcarea Carbonic 30c		OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	OYSTER SHELL CALCIUM CARBONATE, CRUDE	30	[hp_C]/1			N	20241231
76472-1137_05412b91-c1ed-c947-e063-6294a90acd17	76472-1137	HUMAN OTC DRUG	Calcarea Sulphurica 30c		CALCIUM SULFATE ANHYDROUS	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	CALCIUM SULFATE ANHYDROUS	30	[hp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76472-1138_05412b91-c1ec-c947-e063-6294a90acd17	76472-1138	HUMAN OTC DRUG	Cantharis 30c		LYTTA VESICATORIA	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	LYTTA VESICATORIA	30	[hp_C]/1			N	20241231
76472-1139_05411a51-a497-96fd-e063-6294a90ae37b	76472-1139	HUMAN OTC DRUG	Carbo Vegetabilis 30c		ACTIVATED CHARCOAL	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	ACTIVATED CHARCOAL	30	[hp_C]/1			N	20241231
76472-1140_05412b91-c1eb-c947-e063-6294a90acd17	76472-1140	HUMAN OTC DRUG	Chamomilla 30c		MATRICARIA RECUTITA	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	MATRICARIA RECUTITA	30	[hp_C]/1			N	20241231
76472-1141_05412012-6c65-28e0-e063-6394a90a8f89	76472-1141	HUMAN OTC DRUG	Coffea Cruda 30c		ARABICA COFFEE BEAN	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARABICA COFFEE BEAN	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
76472-1142_05412012-6c64-28e0-e063-6394a90a8f89	76472-1142	HUMAN OTC DRUG	Gelsemium Sempervirens 30c		Gelsemium Sempervirens Root	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	GELSEMIUM SEMPERVIRENS ROOT	30	[hp_C]/1			N	20241231
76472-1143_05412b91-c1ea-c947-e063-6294a90acd17	76472-1143	HUMAN OTC DRUG	Hamamelis Virginiana 30c		HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	30	[hp_C]/1			N	20241231
76472-1144_05412b91-c1d6-c947-e063-6294a90acd17	76472-1144	HUMAN OTC DRUG	Hepar Sulphuris Calcareum 30c		CALCIUM SULFIDE	PELLET	SUBGINGIVAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	CALCIUM SULFIDE	30	[hp_C]/1			N	20241231
76472-1145_05412b91-c1d5-c947-e063-6294a90acd17	76472-1145	HUMAN OTC DRUG	Histaminum Hydrochloricum		HISTAMINE DIHYDROCHLORIDE	PELLET	SUBLINGUAL	20111201		UNAPPROVED HOMEOPATHIC		SEVENE USA	HISTAMINE DIHYDROCHLORIDE	30	[hp_C]/1			N	20241231
76472-1146_05412b91-c1d4-c947-e063-6294a90acd17	76472-1146	HUMAN OTC DRUG	HYDRASTIS CANADENSIS		GOLDENSEAL	PELLET	SUBLINGUAL	20111115		UNAPPROVED HOMEOPATHIC		SEVENE USA	GOLDENSEAL	30	[hp_C]/1			N	20241231
76472-1147_05411a51-a494-96fd-e063-6294a90ae37b	76472-1147	HUMAN OTC DRUG	Hypericum Perforatum 30c		HYPERICUM PERFORATUM	PELLET	SUBLINGUAL	20111115		UNAPPROVED HOMEOPATHIC		SEVENE USA	HYPERICUM PERFORATUM	30	[hp_C]/1			N	20241231
76472-1148_05412b91-c1d3-c947-e063-6294a90acd17	76472-1148	HUMAN OTC DRUG	Ignatia Amara 30c		STRYCHNOS IGNATII SEED	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	STRYCHNOS IGNATII SEED	30	[hp_C]/1			N	20241231
76472-1149_0540fc81-7bdf-76e8-e063-6294a90a411b	76472-1149	HUMAN OTC DRUG	Kali Bichromicum 30c		POTASSIUM DICHROMATE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	POTASSIUM DICHROMATE	30	[hp_C]/1			N	20241231
76472-1150_05412012-6c61-28e0-e063-6394a90a8f89	76472-1150	HUMAN OTC DRUG	Lachesis Mutus		LACHESIS MUTA VENOM	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	LACHESIS MUTA VENOM	30	[hp_C]/1			N	20241231
76472-1151_05411a51-a493-96fd-e063-6294a90ae37b	76472-1151	HUMAN OTC DRUG	Ledum Palustre 30c		LEDUM PALUSTRE TWIG	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	LEDUM PALUSTRE TWIG	30	[hp_C]/1			N	20241231
76472-1152_05412343-2f00-031c-e063-6394a90ab004	76472-1152	HUMAN OTC DRUG	Lycopodium Clavatum		LYCOPODIUM CLAVATUM SPORE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	LYCOPODIUM CLAVATUM SPORE	30	[hp_C]/1			N	20241231
76472-1153_05412a70-9fc9-21dc-e063-6394a90a73f8	76472-1153	HUMAN OTC DRUG	Mercurius Solubilis		MERCURIUS SOLUBILIS	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	MERCURIUS SOLUBILIS	30	[hp_C]/1			N	20241231
76472-1154_05411a51-a492-96fd-e063-6294a90ae37b	76472-1154	HUMAN OTC DRUG	Natrum Muriaticum		SODIUM CHLORIDE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	SODIUM CHLORIDE	30	[hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76472-1155_05412343-2eff-031c-e063-6394a90ab004	76472-1155	HUMAN OTC DRUG	Nux Vomica		STRYCHNOS NUX-VOMICA SEED	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	STRYCHNOS NUX-VOMICA SEED	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
76472-1156_05412a70-9fc8-21dc-e063-6394a90a73f8	76472-1156	HUMAN OTC DRUG	Phosphorus		PHOSPHORUS	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	PHOSPHORUS	30	[hp_C]/1			N	20241231
76472-1157_05411ba7-541d-792e-e063-6294a90ac8a4	76472-1157	HUMAN OTC DRUG	Phytolacca Decandra		PHYTOLACCA AMERICANA ROOT	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	PHYTOLACCA AMERICANA ROOT	30	[hp_C]/1			N	20241231
76472-1158_05412012-6c60-28e0-e063-6394a90a8f89	76472-1158	HUMAN OTC DRUG	Pulsatilla		PULSATILLA VULGARIS	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	PULSATILLA VULGARIS	30	[hp_C]/1			N	20241231
76472-1159_0540fc81-7bdd-76e8-e063-6294a90a411b	76472-1159	HUMAN OTC DRUG	Rhus Toxicodendron		TOXICODENDRON PUBESCENS LEAF	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	TOXICODENDRON PUBESCENS LEAF	30	[hp_C]/1			N	20241231
76472-1160_05412343-2efe-031c-e063-6394a90ab004	76472-1160	HUMAN OTC DRUG	Ruta Graveolens		RUTA GRAVEOLENS	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	RUTA GRAVEOLENS FLOWERING TOP	30	[hp_C]/1			N	20241231
76472-1161_05411a51-a491-96fd-e063-6294a90ae37b	76472-1161	HUMAN OTC DRUG	Sepia 30c		SEPIA OFFICINALIS JUICE	PELLET	SUBLINGUAL	20111108		UNAPPROVED HOMEOPATHIC		SEVENE USA	SEPIA OFFICINALIS JUICE	30	[hp_C]/1			N	20241231
76472-1162_05412012-6c5f-28e0-e063-6394a90a8f89	76472-1162	HUMAN OTC DRUG	Silicea		SILICON DIOXIDE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	SILICON DIOXIDE	30	[hp_C]/1			N	20241231
76472-1163_05411cb2-8635-21c2-e063-6394a90aacee	76472-1163	HUMAN OTC DRUG	Spongia Tosta		SPONGIA OFFICINALIS SKELETON, ROASTED	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	SPONGIA OFFICINALIS SKELETON, ROASTED	30	[hp_C]/1			N	20241231
76472-1164_05411ba7-541c-792e-e063-6294a90ac8a4	76472-1164	HUMAN OTC DRUG	Staphysagria		DELPHINIUM STAPHISAGRIA SEED	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	DELPHINIUM STAPHISAGRIA SEED	30	[hp_C]/1			N	20241231
76472-1165_05411cb2-8634-21c2-e063-6394a90aacee	76472-1165	HUMAN OTC DRUG	SULPHUR		SULFUR	PELLET	SUBLINGUAL	20111115		UNAPPROVED HOMEOPATHIC		SEVENE USA	SULFUR	30	[hp_C]/1			N	20241231
76472-1166_05411a51-a490-96fd-e063-6294a90ae37b	76472-1166	HUMAN OTC DRUG	Symphytum Officinale		COMFREY ROOT	PELLET	SUBLINGUAL	20111115		UNAPPROVED HOMEOPATHIC		SEVENE USA	COMFREY ROOT	30	[hp_C]/1			N	20241231
76472-1167_0540fc81-7bdc-76e8-e063-6294a90a411b	76472-1167	HUMAN OTC DRUG	Thuja Occidentalis		THUJA OCCIDENTALIS LEAFY TWIG	PELLET	SUBLINGUAL	20111115		UNAPPROVED HOMEOPATHIC		SEVENE USA	THUJA OCCIDENTALIS LEAFY TWIG	30	[hp_C]/1			N	20241231
76472-3001_0541c98b-f6d7-077d-e063-6294a90afc09	76472-3001	HUMAN OTC DRUG	Allium Cepa	200ck	Allium Cepa	PELLET	SUBLINGUAL	20111120		UNAPPROVED HOMEOPATHIC		SEVENE USA	ONION	200	[kp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
76472-3002_0865f7a8-981e-d382-e063-6394a90a4ec6	76472-3002	HUMAN OTC DRUG	APIS MELLIFICA 200CK		APIS MELLIFICA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	APIS MELLIFERA	200	[kp_C]/1	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
76472-3003_0541ca6c-a426-48b1-e063-6394a90a8d6c	76472-3003	HUMAN OTC DRUG	Argentum Nitricum	200ck	SILVER NITRATE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	SILVER NITRATE	200	[kp_C]/1			N	20241231
76472-3004_03890907-8f77-e6e6-e063-6394a90aa291	76472-3004	HUMAN OTC DRUG	Arsenicum Album	200ck	ARSENIC TRIOXIDE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARSENIC TRIOXIDE	200	[kp_C]/1			N	20241231
76472-3005_0541a3c4-b9f4-1792-e063-6394a90ac52f	76472-3005	HUMAN OTC DRUG	Belladonna	200ck	ATROPA BELLADONNA	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	ATROPA BELLADONNA	200	[kp_C]/1			N	20241231
76472-3006_0541b937-e0ca-cf87-e063-6294a90a03b1	76472-3006	HUMAN OTC DRUG	Borax	200ck	SODIUM BORATE	PELLET	SUBLINGUAL	20111130		UNAPPROVED HOMEOPATHIC		SEVENE USA	SODIUM BORATE	200	[kp_C]/1			N	20241231
76472-3007_0541becd-61c7-31f9-e063-6394a90acade	76472-3007	HUMAN OTC DRUG	Bryonia Alba	200ck	BRYONIA ALBA ROOT	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	BRYONIA ALBA ROOT	200	[kp_C]/1			N	20241231
76472-3008_05419d5e-f918-99ba-e063-6294a90a5b96	76472-3008	HUMAN OTC DRUG	Calcarea Carbonic	200ck	OYSTER SHELL CALCIUM CARBONATE, CRUDE	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	OYSTER SHELL CALCIUM CARBONATE, CRUDE	200	[kp_C]/1			N	20241231
76472-3009_05419d5e-f917-99ba-e063-6294a90a5b96	76472-3009	HUMAN OTC DRUG	Calcarea Sulphurica	200ck	CALCIUM SULFATE ANHYDROUS	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	CALCIUM SULFATE ANHYDROUS	200	[kp_C]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76472-3010_0541becd-61c6-31f9-e063-6394a90acade	76472-3010	HUMAN OTC DRUG	Cantharis	200ck	LYTTA VESICATORIA	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	LYTTA VESICATORIA	200	[kp_C]/1			N	20241231
76472-3011_0541be35-cec2-f490-e063-6294a90a091e	76472-3011	HUMAN OTC DRUG	Carbo Vegetabilis	200ck	ACTIVATED CHARCOAL	PELLET	SUBLINGUAL	20111122		UNAPPROVED HOMEOPATHIC		SEVENE USA	ACTIVATED CHARCOAL	200	[kp_C]/1			N	20241231
76472-3012_0541aea2-da2b-b6de-e063-6294a90aa11e	76472-3012	HUMAN OTC DRUG	Chamomilla	200ck	MATRICARIA RECUTITA	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	MATRICARIA RECUTITA	200	[kp_C]/1			N	20241231
76472-3013_05419d5e-f915-99ba-e063-6294a90a5b96	76472-3013	HUMAN OTC DRUG	Coffea Cruda	200ck	ARABICA COFFEE BEAN	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARABICA COFFEE BEAN	200	[kp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
76472-3014_0541a3c4-b9f3-1792-e063-6394a90ac52f	76472-3014	HUMAN OTC DRUG	Gelsemium Sempervirens	200ck	Gelsemium Sempervirens Root	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	GELSEMIUM SEMPERVIRENS ROOT	200	[kp_C]/1			N	20241231
76472-3015_0541b937-e0c9-cf87-e063-6294a90a03b1	76472-3015	HUMAN OTC DRUG	Hamamelis Virginiana	200ck	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	PELLET	SUBLINGUAL	20111124		UNAPPROVED HOMEOPATHIC		SEVENE USA	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	200	[kp_C]/1			N	20241231
76472-3016_05418133-95c9-ea56-e063-6394a90a2a6e	76472-3016	HUMAN OTC DRUG	Hepar Sulphuris Calcareum	200ck	Hepar Sulphuris Calcareum	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	CALCIUM SULFIDE	200	[kp_C]/1			N	20241231
76472-3017_05419d5e-f914-99ba-e063-6294a90a5b96	76472-3017	HUMAN OTC DRUG	Histaminum Hydrochloricum	200ck	Histaminum Hydrochloricum	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	HISTAMINE DIHYDROCHLORIDE	200	[kp_C]/1			N	20241231
76472-3018_05418455-014a-71ff-e063-6294a90a0c94	76472-3018	HUMAN OTC DRUG	HYDRASTIS CANADENSIS	200ck	HYDRASTIS CANADENSIS	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	GOLDENSEAL	200	[kp_C]/1			N	20241231
76472-3019_05418133-95c8-ea56-e063-6394a90a2a6e	76472-3019	HUMAN OTC DRUG	Hypericum Perforatum	200ck	Hypericum Perforatum	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	HYPERICUM PERFORATUM WHOLE	200	[kp_C]/1			N	20241231
76472-3020_054188fc-e7e0-eafd-e063-6394a90a5e4d	76472-3020	HUMAN OTC DRUG	Ignatia Amara	200ck	Ignatia Amara	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	STRYCHNOS IGNATII SEED	200	[kp_C]/1			N	20241231
76472-3021_05418455-0148-71ff-e063-6294a90a0c94	76472-3021	HUMAN OTC DRUG	KALI BICHROMICUM	200ck	KALI BICHROMICUM	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	POTASSIUM DICHROMATE	200	[kp_C]/1			N	20241231
76472-3022_0541a3c4-b9f2-1792-e063-6394a90ac52f	76472-3022	HUMAN OTC DRUG	LACHESIS MUTUS	200ck	LACHESIS MUTUS	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	LACHESIS MUTA VENOM	200	[kp_C]/1			N	20241231
76472-3023_05415f80-889d-465a-e063-6294a90aae8b	76472-3023	HUMAN OTC DRUG	Ledum Palustre	200ck	Ledum Palustre	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	RHODODENDRON TOMENTOSUM LEAFY TWIG	200	[kp_C]/1			N	20241231
76472-3024_054171ad-bf79-d268-e063-6394a90a6395	76472-3024	HUMAN OTC DRUG	Lycopodium Clavatum	200ck	Lycopodium Clavatum	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	LYCOPODIUM CLAVATUM SPORE	200	[kp_C]/1			N	20241231
76472-3025_05418133-95c5-ea56-e063-6394a90a2a6e	76472-3025	HUMAN OTC DRUG	Mercurius Solubilis	200ck	Mercurius Solubilis	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	MERCURIUS SOLUBILIS	200	[kp_C]/1			N	20241231
76472-3026_05418133-95c4-ea56-e063-6394a90a2a6e	76472-3026	HUMAN OTC DRUG	NATRUM MURIATICUM	200ck	NATRUM MURIATICUM	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	SODIUM CHLORIDE	200	[kp_C]/1			N	20241231
76472-3027_05418455-0147-71ff-e063-6294a90a0c94	76472-3027	HUMAN OTC DRUG	NUX VOMICA	200ck	NUX VOMICA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	STRYCHNOS NUX-VOMICA SEED	200	[kp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
76472-3028_0541a3c4-b9f1-1792-e063-6394a90ac52f	76472-3028	HUMAN OTC DRUG	Phosphorus	200ck	Phosphorus	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	PHOSPHORUS	200	[kp_C]/1			N	20241231
76472-3029_05415e6b-1559-b870-e063-6394a90a1b05	76472-3029	HUMAN OTC DRUG	PHYTOLACCA DECANDRA	200ck	PHYTOLACCA DECANDRA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	PHYTOLACCA AMERICANA ROOT	200	[kp_C]/1			N	20241231
76472-3030_054171ad-bf77-d268-e063-6394a90a6395	76472-3030	HUMAN OTC DRUG	Pulsatilla	200ck	Pulsatilla	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	PULSATILLA ALPINA WHOLE	200	[kp_C]/1			N	20241231
76472-3031_0541a3c4-b9f0-1792-e063-6394a90ac52f	76472-3031	HUMAN OTC DRUG	Rhus Toxicodendron	200ck	Rhus Toxicodendron	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	TOXICODENDRON PUBESCENS LEAF	200	[kp_C]/1			N	20241231
76472-3032_054188fc-e7de-eafd-e063-6394a90a5e4d	76472-3032	HUMAN OTC DRUG	RUTA GRAVEOLENS	200ck	RUTA GRAVEOLENS	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	RUTA GRAVEOLENS FLOWERING TOP	200	[kp_C]/1			N	20241231
76472-3033_05418133-95c2-ea56-e063-6394a90a2a6e	76472-3033	HUMAN OTC DRUG	SEPIA	200ck	SEPIA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	SEPIA OFFICINALIS JUICE	200	[kp_C]/1			N	20241231
76472-3034_05418455-0145-71ff-e063-6294a90a0c94	76472-3034	HUMAN OTC DRUG	SILICEA	200ck	SILICEA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	SILICON DIOXIDE	200	[kp_C]/1			N	20241231
76472-3035_054155d2-6308-04ac-e063-6294a90a380f	76472-3035	HUMAN OTC DRUG	SPONGIA TOSTA	200ck	SPONGIA TOSTA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	SPONGIA OFFICINALIS SKELETON, ROASTED	200	[kp_C]/1			N	20241231
76472-3036_05418133-95c1-ea56-e063-6394a90a2a6e	76472-3036	HUMAN OTC DRUG	STAPHYSAGRIA	200ck	STAPHYSAGRIA	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	DELPHINIUM STAPHISAGRIA SEED	200	[kp_C]/1			N	20241231
76472-3037_054188fc-e7dd-eafd-e063-6394a90a5e4d	76472-3037	HUMAN OTC DRUG	SULPHUR	200ck	SULPHUR	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	SULFUR	200	[kp_C]/1			N	20241231
76472-3038_05418455-0143-71ff-e063-6294a90a0c94	76472-3038	HUMAN OTC DRUG	SYMPHYTUM OFFICINALE	200ck	SYMPHYTUM OFFICINALE	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	COMFREY ROOT	200	[kp_C]/1			N	20241231
76472-3039_05418455-0142-71ff-e063-6294a90a0c94	76472-3039	HUMAN OTC DRUG	THUJA OCCIDENTALIS	200ck	THUJA OCCIDENTALIS	PELLET	SUBLINGUAL	20111123		UNAPPROVED HOMEOPATHIC		SEVENE USA	THUJA OCCIDENTALIS BARK	200	[kp_C]/1			N	20241231
76472-4040_0632a7fd-8fac-822a-e063-6294a90a4001	76472-4040	HUMAN OTC DRUG	CAUSTICUM	30c	CAUSTICUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CAUSTICUM	30	[hp_C]/1			N	20241231
76472-4041_0632bfcf-eb09-d160-e063-6294a90a6e36	76472-4041	HUMAN OTC DRUG	CHELIDONIUM MAJUS	30c	CHELIDONIUM MAJUS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CHELIDONIUM MAJUS	30	[hp_C]/1			N	20241231
76472-4042_0632a7fd-8fad-822a-e063-6294a90a4001	76472-4042	HUMAN OTC DRUG	CINA	30C	CINA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARTEMISIA CINA FLOWER	200	[hp_C]/1			N	20241231
76472-4043_0632af86-7de0-55b8-e063-6294a90aa6a8	76472-4043	HUMAN OTC DRUG	CINCHONA OFFICINALIS	30C	CINCHONA OFFICINALIS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CINCHONA OFFICINALIS WHOLE	30	[hp_C]/1			N	20241231
76472-4044_0632abb2-518e-7c34-e063-6394a90a2318	76472-4044	HUMAN OTC DRUG	COCCULUS INDICUS	30c	COCCULUS INDICUS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	ANAMIRTA COCCULUS SEED	30	[hp_C]/1			N	20241231
76472-4045_0632b1c3-15e3-50d8-e063-6394a90aaf71	76472-4045	HUMAN OTC DRUG	COLOCYNTHIS	30C	COLOCYNTHIS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CITRULLUS COLOCYNTHIS FRUIT PULP	30	[hp_C]/1			N	20241231
76472-4046_0632a7fd-8faa-822a-e063-6294a90a4001	76472-4046	HUMAN OTC DRUG	CUPRUM METALLICUM	30C	CUPRUM METALLICUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	COPPER	30	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
76472-4047_0632abb2-518d-7c34-e063-6394a90a2318	76472-4047	HUMAN OTC DRUG	DROSERA	30C	DROSERA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	DROSERA ANGLICA	30	[hp_C]/1			N	20241231
76472-4048_0632b1c3-15e0-50d8-e063-6394a90aaf71	76472-4048	HUMAN OTC DRUG	DULCAMARA	30C	DULCAMARA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	SOLANUM DULCAMARA TOP	30	[hp_C]/1			N	20241231
76472-4049_0632d36f-df5f-7cf1-e063-6294a90a1203	76472-4049	HUMAN OTC DRUG	EUPHRASIA OFFICINALIS	30C	EUPHRASIA OFFICINALIS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	EUPHRASIA STRICTA	30	[hp_C]/1			N	20241231
76472-4050_0632a7fd-8fab-822a-e063-6294a90a4001	76472-4050	HUMAN OTC DRUG	URTICA URENS	30C	URTICA URENS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	URTICA URENS	30	[hp_C]/1			N	20241231
76472-4051_0632bfcf-eb07-d160-e063-6294a90a6e36	76472-4051	HUMAN OTC DRUG	IPECACUANHA	30C	IPECACUANHA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	IPECAC	30	[hp_C]/1			N	20241231
76472-4052_0632d36f-df5c-7cf1-e063-6294a90a1203	76472-4052	HUMAN OTC DRUG	MEZEREUM	30C	MEZEREUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	DAPHNE MEZEREUM BARK	30	[hp_C]/1			N	20241231
76472-4053_0632c290-96a6-d3c8-e063-6394a90aa990	76472-4053	HUMAN OTC DRUG	SABINA	30C	SABINA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	JUNIPERUS SABINA LEAFY TWIG	30	[hp_C]/1			N	20241231
76472-4054_0632abb2-518c-7c34-e063-6394a90a2318	76472-4054	HUMAN OTC DRUG	TABACUM	30C	TABACUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	TOBACCO LEAF	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
76472-4055_0632bfcf-eb06-d160-e063-6294a90a6e36	76472-4055	HUMAN OTC DRUG	ZINCUM METALLICUM	30c	ZINCUM METALLICUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	ZINC	30	[hp_C]/1			N	20241231
76472-4072_0541becd-61c8-31f9-e063-6394a90acade	76472-4072	HUMAN OTC DRUG	CAUSTICUM	200ck	CAUSTICUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CAUSTICUM	200	[hp_C]/1			N	20241231
76472-4073_0632b1c3-15e6-50d8-e063-6394a90aaf71	76472-4073	HUMAN OTC DRUG	CHELIDONIUM MAJUS	200CK	CHELIDONIUM MAJUS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CHELIDONIUM MAJUS	200	[hp_C]/1			N	20241231
76472-4074_05419d5e-f919-99ba-e063-6294a90a5b96	76472-4074	HUMAN OTC DRUG	CINA	200CK	CINA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	ARTEMISIA CINA FLOWER	200	[hp_C]/1			N	20241231
76472-4075_0632c290-96a5-d3c8-e063-6394a90aa990	76472-4075	HUMAN OTC DRUG	CINCHONA OFFICINALIS	200CK	CINCHONA OFFICINALIS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CINCHONA OFFICINALIS WHOLE	200	[hp_C]/1			N	20241231
76472-4076_0632d36f-df5d-7cf1-e063-6294a90a1203	76472-4076	HUMAN OTC DRUG	COCCULUS INDICUS	200CK	COCCULUS INDICUS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	ANAMIRTA COCCULUS SEED	200	[hp_C]/1			N	20241231
76472-4077_0541be35-cec7-f490-e063-6294a90a091e	76472-4077	HUMAN OTC DRUG	COLOCYNTHIS	200CK	COLOCYNTHIS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	CITRULLUS COLOCYNTHIS FRUIT PULP	200	[hp_C]/1			N	20241231
76472-4078_0632c746-82ab-73c5-e063-6394a90a8f28	76472-4078	HUMAN OTC DRUG	CUPRUM METALLICUM	200CK	CUPRUM METALLICUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	COPPER	30	[hp_C]/1	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
76472-4079_0541ca6c-a427-48b1-e063-6394a90a8d6c	76472-4079	HUMAN OTC DRUG	DROSERA	200CK	DROSERA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	DROSERA ANGLICA	200	[hp_C]/1			N	20241231
76472-4080_0541aea2-da2e-b6de-e063-6294a90aa11e	76472-4080	HUMAN OTC DRUG	DULCAMARA	200	DULCAMARA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	SOLANUM DULCAMARA TOP	200	[hp_C]/1			N	20241231
76472-4081_0541be35-cec8-f490-e063-6294a90a091e	76472-4081	HUMAN OTC DRUG	EUPHRASIA OFFICINALIS	200CK	EUPHRASIA OFFICINALIS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	EUPHRASIA STRICTA	200	[hp_C]/1			N	20241231
76472-4082_0541ca6c-a428-48b1-e063-6394a90a8d6c	76472-4082	HUMAN OTC DRUG	URTICA URENS	200CK	URTICA URENS	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	URTICA URENS	30	[hp_C]/1			N	20241231
76472-4083_0632af86-7dde-55b8-e063-6294a90aa6a8	76472-4083	HUMAN OTC DRUG	IPECACUANHA	200CK	IPECACUANHA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	IPECAC	200	[hp_C]/1			N	20241231
76472-4084_0632c290-96a4-d3c8-e063-6394a90aa990	76472-4084	HUMAN OTC DRUG	MEZEREUM	200CK	MEZEREUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	DAPHNE MEZEREUM BARK	200	[hp_C]/1			N	20241231
76472-4085_0632bfcf-eb05-d160-e063-6294a90a6e36	76472-4085	HUMAN OTC DRUG	SABINA	200CK	SABINA	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	JUNIPERUS SABINA LEAFY TWIG	30	[hp_C]/1			N	20241231
76472-4086_0541be35-cec9-f490-e063-6294a90a091e	76472-4086	HUMAN OTC DRUG	TABACUM	200CK	TABACUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	TOBACCO LEAF	30	[hp_C]/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
76472-4087_0632af86-7ddf-55b8-e063-6294a90aa6a8	76472-4087	HUMAN OTC DRUG	ZINCUM METALLICUM	200CK	ZINCUM METALLICUM	PELLET	SUBLINGUAL	20220708		UNAPPROVED HOMEOPATHIC		SEVENE USA	ZINC	30	[hp_C]/1			N	20241231
76472-4088_0632f49c-891d-3ac2-e063-6294a90a29ec	76472-4088	HUMAN OTC DRUG	CALCAREA FLUORICA	6X	CALCAREA FLUORICA	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	CALCIUM FLUORIDE	6	[hp_X]/1			N	20241231
76472-4089_0632d458-d329-ade4-e063-6294a90af3ba	76472-4089	HUMAN OTC DRUG	CALCAREA PHOSPHORICA	6X	CALCAREA PHOSPHORICA	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	TRIBASIC CALCIUM PHOSPHATE	6	[hp_X]/1			N	20241231
76472-4090_0632c746-82ad-73c5-e063-6394a90a8f28	76472-4090	HUMAN OTC DRUG	CALCAREA SULPHURICA	6X	CALCAREA SULPHURICA	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	CALCIUM SULFATE ANHYDROUS	6	[hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76472-4091_0632d458-d327-ade4-e063-6294a90af3ba	76472-4091	HUMAN OTC DRUG	FERRUM PHOSPHORICUM	6X	FERRUM PHOSPHORICUM	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	FERROSOFERRIC PHOSPHATE	6	[hp_X]/1			N	20241231
76472-4092_0632c746-82ae-73c5-e063-6394a90a8f28	76472-4092	HUMAN OTC DRUG	KALI MURIATICUM	6X	KALI MURIATICUM	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	POTASSIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
76472-4093_0632d458-d32b-ade4-e063-6294a90af3ba	76472-4093	HUMAN OTC DRUG	KALI PHOSPHORICUM	6X	KALI PHOSPHORICUM	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	DIBASIC POTASSIUM PHOSPHATE	6	[hp_X]/1			N	20241231
76472-4094_0632d458-d32a-ade4-e063-6294a90af3ba	76472-4094	HUMAN OTC DRUG	KALI SULPHURICUM	6X	KALI SULPHURICUM	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	POTASSIUM SULFATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76472-4095_0632d36f-df61-7cf1-e063-6294a90a1203	76472-4095	HUMAN OTC DRUG	Magnesia Phosphorica	6X	Magnesia Phosphorica	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	6	[hp_X]/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76472-4096_0632ead6-efb0-55be-e063-6294a90a9e37	76472-4096	HUMAN OTC DRUG	Natrum Muriaticum	6X	SODIUM CHLORIDE	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	SODIUM CHLORIDE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76472-4097_0632d36f-df60-7cf1-e063-6294a90a1203	76472-4097	HUMAN OTC DRUG	Natrum Phosphoricum	6X	Natrum Phosphoricum	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	6	[hp_X]/1			N	20241231
76472-4098_0632d458-d328-ade4-e063-6294a90af3ba	76472-4098	HUMAN OTC DRUG	Natrum Sulphuricum	6X	SODIUM SULFATE	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	SODIUM SULFATE	6	[hp_X]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
76472-4099_0540fc81-7bdb-76e8-e063-6294a90a411b	76472-4099	HUMAN OTC DRUG	SILICEA	6X	SILICEA	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	SILICON DIOXIDE	6	[hp_X]/1			N	20241231
76472-4100_08f29feb-ecb9-2efa-e063-6394a90a9eb2	76472-4100	HUMAN OTC DRUG	12 CELL SALTS COMPLEX		CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, FERRUM PHOSPHORICUM, KALI MURIATICUM, KALI PHOSPHORICUM, KALI SULPHURICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, SILICEA	PELLET	SUBLINGUAL	20230626		UNAPPROVED HOMEOPATHIC		SEVENE USA	CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
76478-015_2fb716bd-40ab-4f38-9d83-fa725d6baef9	76478-015	HUMAN PRESCRIPTION DRUG	Atropine		Atropine Sulfate	SOLUTION/ DROPS	OPHTHALMIC	20220502		NDA AUTHORIZED GENERIC	NDA206289	Akorn	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
76478-501_05af1063-ce0d-485f-a569-3345f6e1b761	76478-501	HUMAN PRESCRIPTION DRUG	Nembutal Sodium		pentobarbital sodium	INJECTION	INTRAMUSCULAR; INTRAVENOUS	19730919		ANDA	ANDA083246	Akron	PENTOBARBITAL SODIUM	50	mg/mL		CII	N	20241231
76483-023_9f718442-a70e-4f30-8a1e-456392400ec0	76483-023	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20220715		ANDA	ANDA205347	SQUARE PHARMACEUTICALS LIMITED	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
76483-024_9f718442-a70e-4f30-8a1e-456392400ec0	76483-024	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20220715		ANDA	ANDA205347	SQUARE PHARMACEUTICALS LIMITED	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
76483-025_9f718442-a70e-4f30-8a1e-456392400ec0	76483-025	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20220715		ANDA	ANDA205347	SQUARE PHARMACEUTICALS LIMITED	VALSARTAN	320	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
76483-026_9f718442-a70e-4f30-8a1e-456392400ec0	76483-026	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET	ORAL	20220715		ANDA	ANDA205347	SQUARE PHARMACEUTICALS LIMITED	VALSARTAN	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
76483-042_2b705cc7-7286-4acb-a3e7-95c65fc90bc3	76483-042	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200131		ANDA	ANDA209366	SQUARE PHARMACEUTICALS LIMITED	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
76483-047_2b705cc7-7286-4acb-a3e7-95c65fc90bc3	76483-047	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20200131		ANDA	ANDA209366	SQUARE PHARMACEUTICALS LIMITED	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
76483-086_6561c80c-48b4-4318-a28c-7cca27cd2885	76483-086	HUMAN PRESCRIPTION DRUG	Calcium Acetate		Calcium Acetate	CAPSULE	ORAL	20230531		ANDA	ANDA217205	SQUARE PHARMACEUTICALS LIMITED	CALCIUM ACETATE	667	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
76483-087_8373b728-5040-4651-aac5-36c539d8269a	76483-087	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20230731		ANDA	ANDA217555	SQUARE PHARMACEUTICALS LIMITED	NICARDIPINE HYDROCHLORIDE	20	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76483-088_8373b728-5040-4651-aac5-36c539d8269a	76483-088	HUMAN PRESCRIPTION DRUG	Nicardipine Hydrochloride		Nicardipine Hydrochloride	CAPSULE	ORAL	20230731		ANDA	ANDA217555	SQUARE PHARMACEUTICALS LIMITED	NICARDIPINE HYDROCHLORIDE	30	mg/1	Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
76483-100_d7622fbb-a43c-46db-bde4-d05ed7bff185	76483-100	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220720		ANDA	ANDA090165	SQUARE PHARMACEUTICALS LIMITED	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76483-101_d7622fbb-a43c-46db-bde4-d05ed7bff185	76483-101	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220720		ANDA	ANDA090165	SQUARE PHARMACEUTICALS LIMITED	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76483-102_d7622fbb-a43c-46db-bde4-d05ed7bff185	76483-102	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220720		ANDA	ANDA090165	SQUARE PHARMACEUTICALS LIMITED	ARIPIPRAZOLE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76483-103_d7622fbb-a43c-46db-bde4-d05ed7bff185	76483-103	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET, ORALLY DISINTEGRATING	ORAL	20220720		ANDA	ANDA090165	SQUARE PHARMACEUTICALS LIMITED	ARIPIPRAZOLE	30	mg/1	Atypical Antipsychotic [EPC]		N	20241231
76483-110_d6b98cf3-2e20-47c1-bb31-e8dd31f67cdf	76483-110	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20221115		ANDA	ANDA205798	SQUARE PHARMACEUTICALS LIMITED	MIRTAZAPINE	15	mg/1			N	20241231
76483-111_d6b98cf3-2e20-47c1-bb31-e8dd31f67cdf	76483-111	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20221115		ANDA	ANDA205798	SQUARE PHARMACEUTICALS LIMITED	MIRTAZAPINE	30	mg/1			N	20241231
76483-112_d6b98cf3-2e20-47c1-bb31-e8dd31f67cdf	76483-112	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, ORALLY DISINTEGRATING	ORAL	20221115		ANDA	ANDA205798	SQUARE PHARMACEUTICALS LIMITED	MIRTAZAPINE	45	mg/1			N	20241231
76485-1114_f3551124-0e93-1ed3-e053-2995a90af043	76485-1114	HUMAN OTC DRUG	Rimmel London Lasting Finish 25 HR Foundation SPF 20		Octinoxate	CREAM	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	Rimmel	OCTINOXATE	2.5	g/100mL			N	20241231
76489-001_eb63d261-e74f-f8fa-e053-2a95a90a538a	76489-001	CELLULAR THERAPY	HemaCord		HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL	INJECTION	INTRAVENOUS	20111110		BLA	BLA125397	New York Blood Center	HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL	500000000	1/25mL	Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC], Cells, Allogeneic [EXT], Hematopoietic Stem Cells [CS]		N	20241231
76494-528_bf716ab6-d438-4a19-8193-dbc05b4eabad	76494-528	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Prinston Pharmaceutical Inc.	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76494-529_bf716ab6-d438-4a19-8193-dbc05b4eabad	76494-529	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Prinston Pharmaceutical Inc.	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76494-530_bf716ab6-d438-4a19-8193-dbc05b4eabad	76494-530	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Prinston Pharmaceutical Inc.	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76494-531_bf716ab6-d438-4a19-8193-dbc05b4eabad	76494-531	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20120911		ANDA	ANDA078106	Prinston Pharmaceutical Inc.	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
76557-000_f5502537-0617-8e83-e053-2a95a90a0234	76557-000	HUMAN OTC DRUG	Juniper Clean Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	KYNC Design LLC	ALCOHOL	70	mL/100mL			N	20241231
76557-012_0bde23af-4667-7cd8-e063-6294a90aa81d	76557-012	HUMAN OTC DRUG	JuniperCleanDishSoap Juniper		DISHWASHING DETERGENT JUNIPER FOREST	LIQUID	CUTANEOUS; TOPICAL	20231230		OTC MONOGRAPH DRUG	505G(a)(3)	KYNC DESIGN LLC	CHLOROXYLENOL	.2	g/100g			N	20241231
76557-013_0bde23af-4667-7cd8-e063-6294a90aa81d	76557-013	HUMAN OTC DRUG	JuniperCleanDishSoap Apple		DISHWASHING DETERGENT	LIQUID	CUTANEOUS; TOPICAL	20231230		OTC MONOGRAPH DRUG	505G(a)(3)	KYNC DESIGN LLC	CHLOROXYLENOL	.2	g/100g			N	20241231
76557-014_0bde23af-4667-7cd8-e063-6294a90aa81d	76557-014	HUMAN OTC DRUG	JuniperCleanDishSoap Lemon		DISHWASHING DETERGENT	LIQUID	CUTANEOUS; TOPICAL	20231230		OTC MONOGRAPH DRUG	505G(a)(3)	KYNC DESIGN LLC	CHLOROXYLENOL	.2	g/100g			N	20241231
76557-015_0befe1f8-16a1-2256-e063-6394a90a6680	76557-015	HUMAN OTC DRUG	JuniperClean Lavender		Juniper Clean Hand Soap Lavender	LIQUID	TOPICAL	20231230		OTC MONOGRAPH DRUG	505G(a)(3)	KYNC Design LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
76557-016_0befe1f8-16a1-2256-e063-6394a90a6680	76557-016	HUMAN OTC DRUG	JuniperClean Jasmine		Juniper Clean Hand Soap Jasmine	LIQUID	TOPICAL	20231230		OTC MONOGRAPH DRUG	505G(a)(3)	KYNC Design LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
76557-017_0befe1f8-16a1-2256-e063-6394a90a6680	76557-017	HUMAN OTC DRUG	JuniperClean Rose		Juniper Clean Hand Soap Rose	LIQUID	TOPICAL	20231230		OTC MONOGRAPH DRUG	505G(a)(3)	KYNC Design LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
76557-050_fe1ab4d1-cdf4-8303-e053-6294a90a0cac	76557-050	HUMAN OTC DRUG	CaseysDishwashingSoap		DISHWASHING DETERGENT JUNIPER FOREST	LIQUID	CUTANEOUS; TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333E	KYNC DESIGN LLC	CHLOROXYLENOL	.2	g/100g			N	20241231
76557-051_fe1aaead-8e27-e1d4-e053-6394a90a96f4	76557-051	HUMAN OTC DRUG	CaseysLavender		Caseys Hand Soap Lavender Scent	LIQUID	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	KYNC Design LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
76571-313_47369b75-9168-4fe1-8c45-35849240915f	76571-313	HUMAN OTC DRUG	TRIVITA QPR		MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20200401		OTC MONOGRAPH NOT FINAL	part348	TriVita, Inc.	MENTHOL, UNSPECIFIED FORM	8.5	g/100mL			N	20241231
76600-3071_f1f079b7-6220-19a4-e053-2995a90a471f	76600-3071	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	LIQUID	TOPICAL	20200420		OTC MONOGRAPH NOT FINAL	part333A	AVO TECH INTERNATIONAL INC.	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
76618-001_f48f6b74-edb2-98cb-e053-2a95a90a5c7b	76618-001	HUMAN OTC DRUG	70% alcohol hand sanitizer (no water)		ALCOHOL	GEL	TOPICAL	20200422		OTC MONOGRAPH NOT FINAL	part333A	Star USA Imports Inc	ALCOHOL	70	mL/100mL			N	20241231
76626-001_da3cc1f9-f8b7-4f64-9d6c-da1139103bac	76626-001	HUMAN OTC DRUG	Essentials Hand Sanitizer		Alcohol	GEL	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333A	MCRL Overseas Printing Inc	ALCOHOL	75	mL/100mL			N	20241231
76626-002_e1a51e29-2a33-4a60-8c07-aa370395f6b3	76626-002	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333A	MCRL Overseas Printing Inc	ALCOHOL	70	mL/100mL			N	20241231
76626-003_f7988004-9d06-4205-91f4-411263ca492a	76626-003	HUMAN OTC DRUG	Essentials Hand Sanitizer		Alcohol	GEL	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333A	MCRL Overseas Printing Inc	ALCOHOL	70	mL/100mL			N	20241231
76626-004_7d983a53-1d43-4a3b-82e0-162939651054	76626-004	HUMAN OTC DRUG	CareCom Hand Sanitizer		Alcohol	GEL	TOPICAL	20200417		OTC MONOGRAPH NOT FINAL	part333A	MCRL Overseas Printing Inc	ALCOHOL	75	mL/100mL			N	20241231
76635-001_0acdf86a-e37b-af03-e063-6294a90a8a9e	76635-001	HUMAN OTC DRUG	Antibacterial Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.2	g/100g			N	20241231
76635-002_0acddd98-6d57-7b7b-e063-6294a90a5245	76635-002	HUMAN OTC DRUG	GOLDESSENCE DISINFECTING WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.3	g/100g			N	20241231
76635-003_0acdca13-a904-8589-e063-6294a90ab6b7	76635-003	HUMAN OTC DRUG	Hand sanitizer		Alcohol	GEL	TOPICAL	20200430		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	ALCOHOL	66	mL/100mL			N	20241231
76635-004_0acdea45-e605-a527-e063-6294a90aea76	76635-004	HUMAN OTC DRUG	Antibacterial Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200516		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
76635-005_0acddafb-f985-6929-e063-6394a90ab016	76635-005	HUMAN OTC DRUG	NUVOMED Antibacterial Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200523		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.3	g/100g			N	20241231
76635-006_0acddafb-f988-6929-e063-6394a90ab016	76635-006	HUMAN OTC DRUG	GOLDESSENCE Antibacterial Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200528		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.3	g/100g			N	20241231
76635-007_0acdfa67-2dd0-ac71-e063-6294a90a49ee	76635-007	HUMAN OTC DRUG	Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200619		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.14	g/100g			N	20241231
76635-008_0acdf86a-e37a-af03-e063-6294a90a8a9e	76635-008	HUMAN OTC DRUG	disinpro ANTIBACTERIAL WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20200819		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.2	g/100g			N	20241231
76635-009_0acdfa5b-3cea-b19c-e063-6294a90a4553	76635-009	HUMAN OTC DRUG	ANTIBACTERIAL WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20200829		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.2	g/100g			N	20241231
76635-120_0acdfa67-2dd1-ac71-e063-6294a90a49ee	76635-120	HUMAN OTC DRUG	JULEP antibacterial sanitizing wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200811		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.2	g/100g			N	20241231
76635-121_0ace12a1-1aad-ae79-e063-6394a90ae030	76635-121	HUMAN OTC DRUG	JULEP antibacterial sanitizing wipe		Benzalkonium Chloride	CLOTH	TOPICAL	20200923		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.2	g/100g			N	20241231
76635-220_0acdea45-e606-a527-e063-6294a90aea76	76635-220	HUMAN OTC DRUG	LAURA GELLER antibacterial hand sanitizing wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200811		OTC MONOGRAPH DRUG	505G(a)(3)	Hangzhou Glamcos Biotech CO.,LTD	BENZALKONIUM CHLORIDE	.2	g/100g			N	20241231
76670-0010_5a079a2d-e194-47ae-b8b2-a9b6d7e8ec07	76670-0010	HUMAN OTC DRUG	DOCTRUST DOUBLEX Tooth		Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20211001		OTC MONOGRAPH DRUG	M021	DOCSMEDI OralBiome Co., Ltd.	SODIUM FLUORIDE	.22	g/100g			N	20241231
76670-0011_bd44c9c0-0d99-4a1d-a717-76b2b54bc3a1	76670-0011	HUMAN OTC DRUG	DOCTRUST ONE S Tooth		Sodium fluoride, Dental type silica, Potassium nirate	PASTE, DENTIFRICE	DENTAL	20211201		UNAPPROVED DRUG OTHER		DOCSMEDI OralBiome Co., Ltd.	POTASSIUM NITRATE; SILICON DIOXIDE; SODIUM FLUORIDE	5; 17.5; .02	g/100g; g/100g; g/100g			N	20241231
76670-0012_096b3e0b-4d7c-4033-bac2-1a2950db915e	76670-0012	HUMAN OTC DRUG	Double X CONCENTRATED		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20220102		OTC MONOGRAPH DRUG	M021	DOCSMEDI OralBiome Co., Ltd.	CETYLPYRIDINIUM CHLORIDE	2.3	g/100mL			N	20241231
76670-0013_776eb860-125c-4c6f-a2c3-6f722e657717	76670-0013	HUMAN OTC DRUG	Cool sense Care Plus		Sodium fluoride	MOUTHWASH	DENTAL	20221201		OTC MONOGRAPH DRUG	M021	DOCSMEDI OralBiome Co., Ltd.	SODIUM FLUORIDE	.05	g/100mL			N	20241231
76670-0014_90ad77d8-c0d4-4649-92b9-41ebb6ec561d	76670-0014	HUMAN OTC DRUG	DOCTRUST K Tooth		Silicon dioxide, Sodium monofluorophosphate	GEL, DENTIFRICE	DENTAL	20221201		UNAPPROVED DRUG OTHER		DOCSMEDI OralBiome Co., Ltd.	SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE	16; .74	g/100g; g/100g			N	20241231
76670-0015_f26cffd8-9a76-43d8-8fe0-5a3a3f5792f2	76670-0015	HUMAN OTC DRUG	COOL SENSE STICK GARGLE		Cetylpyridinium Chloride	LIQUID	DENTAL	20230201		UNAPPROVED DRUG OTHER		DOCSMEDI OralBiome Co., Ltd.	CETYLPYRIDINIUM CHLORIDE	.05	g/100mL			N	20241231
76679-002_a3ff6a9c-12ce-62aa-e053-2a95a90a50bd	76679-002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333E	Angel Ride Inc.	ALCOHOL	75	mL/100mL			N	20241231
76679-008_a4002d2b-69e3-5c30-e053-2a95a90a3be2	76679-008	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333E	Angel Ride Inc.	ALCOHOL	75	mL/100mL			N	20241231
76679-016_a4005511-f9db-1a6e-e053-2a95a90a7472	76679-016	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333E	Angel Ride Inc.	ALCOHOL	75	mL/100mL			N	20241231
76702-122_6b9e4ce7-b973-40bf-8835-12c8766dbc25	76702-122	HUMAN OTC DRUG	Hand-Aid		ALCOHOL	GEL	TOPICAL	20200827		OTC MONOGRAPH NOT FINAL	part333E	Play On Products	ALCOHOL	.7	mL/mL			N	20241231
76702-665_aa445ead-c081-4543-983e-f85e1a3a98e9	76702-665	HUMAN OTC DRUG	PARKERS SANI SPRITZ II		ALCOHOL	LIQUID	TOPICAL	20200424		OTC MONOGRAPH NOT FINAL	part333E	Play On Products	ALCOHOL	.7	mL/mL			N	20241231
76702-738_5667486a-c07c-49ee-9223-748a583ade34	76702-738	HUMAN OTC DRUG	PARKERS SANI SPRITZ		ALCOHOL	LIQUID	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333E	Play On Products	ALCOHOL	.7	mL/mL			N	20241231
76743-001_a78fe644-db28-5874-e053-2a95a90a2ad2	76743-001	HUMAN OTC DRUG	My little pony cotton candy scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	Jinhua Magic color Cosmetic Co., Ltd	ALCOHOL	62	g/100mL			N	
76743-002_a7b3b837-a6e5-9c69-e053-2a95a90a6b66	76743-002	HUMAN OTC DRUG	Cotton candy scented hand sanitizer	01	alochol	LIQUID	TOPICAL	20200526	20240531	OTC MONOGRAPH NOT FINAL	part333A	Jinhua Magic color Cosmetic Co., Ltd	ALCOHOL	70	g/100mL			N	
76801-972_f2185744-0c04-08ef-e053-2995a90aa0d6	76801-972	HUMAN OTC DRUG	Eagle Wipes Hand Sanitizing Wipes with Aloe Vera		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200428		OTC MONOGRAPH NOT FINAL	part333A	TEXAS RAGTIME INC	BENZALKONIUM CHLORIDE	.0013	g/g			N	20241231
76835-001_f1f023c3-420d-5c71-e053-2995a90a1908	76835-001	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Siebert Inc	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
76835-002_f1f01b41-eeb5-09b1-e053-2a95a90a1c40	76835-002	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Siebert Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
76864-100_e2877488-3537-cba2-e053-2995a90a6005	76864-100	HUMAN OTC DRUG	Intestinomicina		Loperamide HCI, Simethicone	CAPSULE	ORAL	20180704		ANDA	ANDA214541	Procaps S.A. de C.V.	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
76864-208_03ff71a0-697f-60ee-e063-6394a90abbb8	76864-208	HUMAN OTC DRUG	BACZOL COLD MEDICINE		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCl	SYRUP	ORAL	20200525		OTC MONOGRAPH FINAL	part341	Procaps S.A. de C.V.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	250; 4; 10; 10	mg/5mL; mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76864-209_03ff88e3-61a2-0828-e063-6294a90ab37b	76864-209	HUMAN OTC DRUG	BACZOL EXPECTORANT		GUAIFENESIN, PHENYLEPHRINE HCl	SYRUP	ORAL	20210603		OTC MONOGRAPH FINAL	part341	Procaps S.A. de C.V.	GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	200; 5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
76864-221_0b66a67f-3b55-e7ed-e063-6294a90a2f32	76864-221	HUMAN OTC DRUG	Baczol	Expectorant	Dextromethorphan, Guaifenesin	LIQUID	ORAL	20231201		OTC MONOGRAPH DRUG	M012	Procaps S.A. de C.V.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/10mL; mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
76866-001_afb7045e-6f00-e70e-e053-2995a90a6709	76866-001	HUMAN OTC DRUG	PEANUTS Hand Sanitizer with Aloe		ETHYL ALCOHOL	GEL	TOPICAL	20200918		OTC MONOGRAPH NOT FINAL	part333E	2 Market Llc	ALCOHOL	63	mL/100mL			N	20241231
76866-002_afc78e75-b787-3c43-e053-2995a90a78eb	76866-002	HUMAN OTC DRUG	PEANUTS Hand Sanitizer with Aloe		ETHYL ALCOHOL	GEL	TOPICAL	20200918		OTC MONOGRAPH NOT FINAL	part333E	2 Market Llc	ALCOHOL	63	mL/100mL			N	20241231
76866-004_afc7ccb8-b21f-4398-e053-2995a90a69a2	76866-004	HUMAN OTC DRUG	PEANUTS Hand Sanitizer with Aloe		ETHYL ALCOHOL	GEL	TOPICAL	20200918		OTC MONOGRAPH NOT FINAL	part333E	2 Market Llc	ALCOHOL	63	mL/100mL			N	20241231
76866-005_afc7ddc4-24c0-0e8d-e053-2a95a90ab707	76866-005	HUMAN OTC DRUG	PEANUTS Hand Sanitizer with Aloe		ETHYL ALCOHOL	GEL	TOPICAL	20200918		OTC MONOGRAPH NOT FINAL	part333E	2 Market Llc	ALCOHOL	63	mL/100mL			N	20241231
76884-0001_a56c9207-36d5-cc50-e053-2a95a90ad920	76884-0001	HUMAN OTC DRUG	Dr. Daddys Hand Sanitizer		Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	TB Healthcare Co., Ltd.	ALCOHOL	350	mL/500mL			N	20241231
76884-0002_a56d09ed-e171-c3d6-e053-2995a90ad615	76884-0002	HUMAN OTC DRUG	Dr. Daddys Hand Sanitizer		Alcohol	GEL	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	TB Healthcare Co., Ltd.	ALCOHOL	42	mL/60mL			N	20241231
76884-0003_b663cd60-75dd-6bc5-e053-2995a90a9477	76884-0003	HUMAN OTC DRUG	Dr. DADDYS Tooth		Dental Type Silica, Tetrasodium Pyrophosphate	PASTE, DENTIFRICE	DENTAL	20201201		UNAPPROVED DRUG OTHER		TB Healthcare Co., Ltd.	SILICON DIOXIDE; SODIUM PYROPHOSPHATE	14; .5	g/100g; g/100g			N	20241231
76884-0007_dc077785-b781-96ca-e053-2a95a90ab566	76884-0007	HUMAN OTC DRUG	Dr.DADDYS Junior Toothpaste(Mint flavor)		Tetrasodium Pyrophosphate, Sodium monofluorophosphate, dental type silica	PASTE, DENTIFRICE	DENTAL	20220226		UNAPPROVED DRUG OTHER		TB Healthcare Co., Ltd.	SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	15; .758; .5	g/100g; g/100g; g/100g			N	20241231
76884-0008_d8f2fb71-63ed-c03e-e053-2a95a90a45f9	76884-0008	HUMAN OTC DRUG	Dr. DADDYS Junior Toothpaste(Green grape)		Tetrasodium Pyrophosphate, Sodium monofluorophosphate, dental type silica	PASTE, DENTIFRICE	DENTAL	20220226		UNAPPROVED DRUG OTHER		TB Healthcare Co., Ltd.	SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	15; .758; .5	g/100g; g/100g; g/100g			N	20241231
76884-0010_ce355c0b-db24-0c9c-e053-2995a90a46e9	76884-0010	HUMAN OTC DRUG	Dr. DADDYS Kids Tooth		Dental Type Silica, SODIUM PYROPHOSPHATE, Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20210101		UNAPPROVED DRUG OTHER		TB Healthcare Co., Ltd.	SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	13; .36; .5	g/100g; g/100g; g/100g			N	20241231
76884-0011_ce35c6a3-aca8-e0b5-e053-2a95a90a6a5d	76884-0011	HUMAN OTC DRUG	Dr. DADDYS Kids Toothpaste(Raspberry flavor)		Dental Type Silica, Tetrasodium Pyrophosphate, Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20210920		UNAPPROVED DRUG OTHER		TB Healthcare Co., Ltd.	SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	14; .36; .5	g/100g; g/100g; g/100g			N	20241231
76884-0012_dc82bc61-67a2-3808-e053-2a95a90ae465	76884-0012	HUMAN OTC DRUG	Dr. DADDYS GumToothpaste		Silicon dioxide, Tetrasodium Pyrophosphate, Tocopherol Acetate, Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20211106		UNAPPROVED DRUG OTHER		TB Healthcare Co., Ltd.	.ALPHA.-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	.2; 17; .76; .5	g/100g; g/100g; g/100g; g/100g			N	20241231
76892-001_0897c92f-ad19-a897-e063-6394a90af29c	76892-001	HUMAN OTC DRUG	Hand Sanitizer Alcohol Hand		ALCOHOL	GEL	TOPICAL	20200513		OTC MONOGRAPH DRUG	505G(a)(3)	Design International Group	ALCOHOL	.75	mL/mL			N	20241231
76906-001_b60090b2-c10b-87e5-e053-2a95a90a588b	76906-001	HUMAN OTC DRUG	Wet Wipe		Alcohol	SWAB	TOPICAL	20200204		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang BeiTao Hygienic Products Co., Ltd.	ALCOHOL	70	g/100g			N	20241231
76906-002_ab7bb914-c40a-cab4-e053-2a95a90a3643	76906-002	HUMAN OTC DRUG	Wet Wipe		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200321		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang BeiTao Hygienic Products Co.,Ltd	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
76906-005_a6ac9856-e0d6-ebe6-e053-2995a90a266e	76906-005	HUMAN OTC DRUG	Baby Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang BeiTao Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
76906-006_ae86e396-5a8c-5449-e053-2995a90aa46f	76906-006	HUMAN OTC DRUG	Wet Wipe		Alcohol	CLOTH	TOPICAL	20200527		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang BeiTao Hygienic Products Co., Ltd.	ALCOHOL	75	g/100mL			N	20241231
76906-007_b14b86b1-cae8-db43-e053-2995a90af3ac	76906-007	HUMAN OTC DRUG	Wet Wipe		Alcohol	SWAB	TOPICAL	20201010		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang BeiTao Hygienic Products Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
76914-222_a593076a-84ba-ff04-e053-2995a90a77d5	76914-222	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200509		OTC MONOGRAPH NOT FINAL	part333A	Tropical Green Organics	ALCOHOL	70	mL/100mL			N	20241231
76939-541_f436f5b6-f2fd-ff6e-e053-2995a90a2f7d	76939-541	HUMAN OTC DRUG	Aktive Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part333A	NVIP LLC	ALCOHOL	80	mL/100mL			N	20241231
76961-101_ff5e76e2-1ca1-57e2-e053-6394a90a38a4	76961-101	HUMAN PRESCRIPTION DRUG	Rolvedon		eflapegrastim-xnst	INJECTION, SOLUTION	SUBCUTANEOUS	20221018		BLA	BLA761148	Spectrum Pharmaceuticals, Inc.	EFLAPEGRASTIM	13.2	mg/.6mL			N	20241231
76964-101_ef74ae55-a41a-f6b9-e053-2a95a90a6752	76964-101	HUMAN OTC DRUG	Dexclusive Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	TAT KIMYA SABUN VE GLISERIN SANAYI VE TICARET ANONIM SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
76964-102_ef758b3c-9f20-c5c6-e053-2995a90a5ac2	76964-102	HUMAN OTC DRUG	Dex Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	TAT KIMYA SABUN VE GLISERIN SANAYI VE TICARET ANONIM SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
76964-200_e43b6212-edcc-35bf-e053-2995a90a0ab1	76964-200	HUMAN OTC DRUG	Antibacterial Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200603		OTC MONOGRAPH NOT FINAL	part333A	TAT KIMYA SABUN VE GLISERIN SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
76973-071_0975bb48-247e-e8bd-e063-6394a90ae8d9	76973-071	HUMAN OTC DRUG	EmoniNail Antifungal		UNDECYLENIC ACID	LIQUID	TOPICAL	20200501		OTC MONOGRAPH DRUG	M005	GG Healthworks Inc.	UNDECYLENIC ACID	100	mg/mL			N	20241231
76982-3865_081542bc-4151-9f36-e063-6394a90a66c1	76982-3865	HUMAN OTC DRUG	Linstol Refreshing and Cleansing Towelette		Alcohol	CLOTH	TOPICAL	20200520		OTC MONOGRAPH DRUG	505G(a)(3)	Linstol USA, LLC	ALCOHOL	4	mL/1			N	20241231
77006-001_d5680ca0-cd0a-b448-e053-2a95a90ac4a2	77006-001	HUMAN OTC DRUG	WeClean Hand Sanitizer Gel - Eucalyptus		ALCOHOL	LIQUID	TOPICAL	20200508		OTC MONOGRAPH NOT FINAL	part333A	WeCoolToys, Inc.	ALCOHOL	58.36	g/100mL			N	20241231
77006-002_d5660167-b2f1-9293-e053-2995a90a4ed2	77006-002	HUMAN OTC DRUG	WeClean Foam Hand Sanitizer Eucalyptus		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	WeCool Toys, Inc.	BENZALKONIUM CHLORIDE	200	mg/100mL			N	20241231
77006-003_d566106e-d113-05fd-e053-2995a90ac1e8	77006-003	HUMAN OTC DRUG	We Clean Hand Sanitizer Gel - Tea Tree		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	58.36	g/100mL			N	20241231
77006-004_d566079d-a66b-061f-e053-2995a90aad1a	77006-004	HUMAN OTC DRUG	WeClean Hand Sanitizer Unscented		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	59.7	g/100mL			N	20241231
77006-005_d567f420-ae5d-ebcf-e053-2a95a90ac78a	77006-005	HUMAN OTC DRUG	CrazyCleanz Hand Sanitizer Strawberry		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	58.36	g/100mL			N	20241231
77006-006_d567f420-ae5c-ebcf-e053-2a95a90ac78a	77006-006	HUMAN OTC DRUG	Crazy Cleanz Hand Sanitizer - Frosted Strawberry		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	58.36	g/100mL			N	20241231
77006-007_d567c7e9-f21b-1793-e053-2995a90ad0dd	77006-007	HUMAN OTC DRUG	Crazy Cleanz Hand Sanitizer - Vanilla Swirl		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	58.36	g/100mL			N	20241231
77006-010_d567dd4d-e402-12ab-e053-2995a90aaf19	77006-010	HUMAN OTC DRUG	Crazy Cleanz Foaming Hand Sanitizer - Eucalyptus		Benzalkonium Chloride	LIQUID	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333E	WeCool Toys, Inc.	BENZALKONIUM CHLORIDE	200	mg/100mL			N	20241231
77006-011_d56820d9-17ee-40d4-e053-2995a90ac47d	77006-011	HUMAN OTC DRUG	Crazy Cleanz Hand Sanitizer - Unscented		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	59.7	g/100mL			N	20241231
77006-012_d567f782-8498-178f-e053-2995a90ad2e8	77006-012	HUMAN OTC DRUG	Crazy Clean Hand Sanitizer - Blue Raspberry		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	58.36	g/100mL			N	20241231
77006-013_d5660475-f5c5-c05b-e053-2995a90a6fd4	77006-013	HUMAN OTC DRUG	Crazy Clean Hand Sanitizer - Berry Swirl		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys, Inc.	ALCOHOL	58.36	g/100mL			N	20241231
77006-020_d566106e-d10f-05fd-e053-2995a90ac1e8	77006-020	HUMAN OTC DRUG	WeClean Gel Hand Sanitizer Eucalyptus		ALCOHOL	GEL	TOPICAL	20200723		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-025_d567dd4d-e409-12ab-e053-2995a90aaf19	77006-025	HUMAN OTC DRUG	Crazy Cleanz Hand wipes Lemon scent		Benzalkonium chloride	CLOTH	TOPICAL	20200618		OTC MONOGRAPH NOT FINAL	part333E	WeCool Toys, Inc.	BENZALKONIUM CHLORIDE	200	mg/100mL			N	20241231
77006-030_d567f782-84a1-178f-e053-2995a90ad2e8	77006-030	HUMAN OTC DRUG	WeClean Hand Sanitizer Pumpkin Swirl		Alcohol	LIQUID	TOPICAL	20200626		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-031_d567d693-9dfc-f51a-e053-2995a90a304b	77006-031	HUMAN OTC DRUG	We Clean Hand Sanitizer Roasted Marshmallow		Alcohol	LIQUID	TOPICAL	20200626		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-032_d567fda8-9d15-1a2a-e053-2995a90aaf51	77006-032	HUMAN OTC DRUG	We Clean Hand Sanitizer Apple Cider		ALCOHOL	LIQUID	TOPICAL	20200626		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-033_d567fda8-9d14-1a2a-e053-2995a90aaf51	77006-033	HUMAN OTC DRUG	We Clean Hand Sanitizer Fall Chai		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-034_d567d693-9dfb-f51a-e053-2995a90a304b	77006-034	HUMAN OTC DRUG	We Clean Hand Sanitizer Caramel Apple		Alcohol	LIQUID	TOPICAL	20200626		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-035_d567f782-84a0-178f-e053-2995a90ad2e8	77006-035	HUMAN OTC DRUG	We Clean Hand Sanitizer Candy Corn		ALCOHOL	LIQUID	TOPICAL	20200626		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-060_d567c7e9-f218-1793-e053-2995a90ad0dd	77006-060	HUMAN OTC DRUG	WeClean Hand Sanitizer - Lemon Scent		Alcohol	LIQUID	TOPICAL	20200911		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77006-061_d567d005-edca-3c62-e053-2995a90ac042	77006-061	HUMAN OTC DRUG	WeClean Hand Sanitizer - Orange Apple Scent		ALCOHOL	LIQUID	TOPICAL	20200911		OTC MONOGRAPH NOT FINAL	part333A	WeCool Toys	ALCOHOL	58.36	g/100mL			N	20241231
77008-2298_f5801a69-7a3c-cab1-e053-2a95a90a48fd	77008-2298	HUMAN OTC DRUG	Manna DD Tea (Detox and Diet Tea)		Allium hookeri	LIQUID	ORAL	20230224	20240223	UNAPPROVED DRUG OTHER		BIOHERB Co., Ltd.	ALLIUM HOOKERI WHOLE	10	g/100g			N	
77008-3194_f802e6d0-b45f-c427-e053-6394a90a02e9	77008-3194	HUMAN OTC DRUG	BEVERHILL Micro-Biome Scalp Cooling Essence (Prevention of hair loss, Trouble scalp treatment, Treatment of itching)		Undaria Pinnatifida Extract, Camellia Sinensis Leaf Extract, Morus Alba Bark Extract, Pinus Densiflora Leaf Extract, Artemisia Vulgaris Extract, Sesamum Indicum Seed Extract, Sodium Benzoate	SHAMPOO	TOPICAL	20230328	20240327	UNAPPROVED DRUG OTHER		BIOHERB Co., Ltd.	ALCOHOL; ARTEMISIA VULGARIS WHOLE; CAMELLIA SINENSIS WHOLE; MORUS ALBA BARK; PINUS DENSIFLORA LEAF; SESAMUM INDICUM WHOLE; SODIUM BENZOATE; UNDARIA PINNATIFIDA	20; 1.793; 2.608; 1.793; 1.793; 1.793; .0815; 2.608	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	
77008-4285_0042be44-1b4d-a011-e063-6394a90a3b29	77008-4285	HUMAN OTC DRUG	CHI. JOA (Anti-inflammatory effect, antibacterial effect, stomatitis improvement, plaque removal)		sea salt, bamboo salt, lactobacillus powder	POWDER	TOPICAL	20230711	20240710	UNAPPROVED DRUG OTHER		BIOHERB Co., Ltd.	CINNAMON; LEVOMENTHOL; MENTHOL; MYRRH; PEAR; PEPPERMINT; SEA SALT; SILICON DIOXIDE; SORBITOL; XYLITOL	1; 1; 1; 1; 1; 1; 47; 1; 1; 1	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	
77008-5714_f77252b0-e806-edd6-e053-6294a90ac76c	77008-5714	HUMAN OTC DRUG	Hankki ssog Pre-Biome Shake (Detox and Diet, Body Change)		Dietary fiber, Cellulose fiber, Probiotic	POWDER	TOPICAL	20230224	20240223	UNAPPROVED DRUG OTHER		BIOHERB Co., Ltd.	COTTON FIBER; LACTIC ACID; PEA FIBER	5; 10; 5	g/100g; g/100g; g/100g	Acidifying Activity [MoA], Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Fiber Allergenic Extract [EPC], Plant Proteins [CS]		N	
77015-100_f1ef623e-b33f-fd91-e053-2995a90ae888	77015-100	HUMAN OTC DRUG	SOLDANIZER	DN-723	BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part333A	3VETS LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
77015-420_f1ef6c22-d797-291d-e053-2995a90a6d10	77015-420	HUMAN OTC DRUG	SOLDAMIST	DN-420	BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20210120		OTC MONOGRAPH NOT FINAL	part333A	3VETS LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
77039-010_d583459d-3d93-a86e-e053-2a95a90a2216	77039-010	HUMAN OTC DRUG	70% Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20220112		OTC MONOGRAPH NOT FINAL	part333A	IDO PHARM	ISOPROPYL ALCOHOL	70	g/100mL			N	20241231
77039-020_ddee409f-51a9-3a4c-e053-2995a90af3d9	77039-020	HUMAN OTC DRUG	IDO DISINFECTION ETHANOL		Isopropyl Alcohol	LIQUID	TOPICAL	20220501		OTC MONOGRAPH NOT FINAL	part333A	IDO PHARM	ISOPROPYL ALCOHOL	83	mL/100mL			N	20241231
77039-021_e0704322-164c-6141-e053-2a95a90aba30	77039-021	HUMAN OTC DRUG	IDO DISINFECTION TISSUE		Isopropyl Alcohol	LIQUID	TOPICAL	20220602		UNAPPROVED DRUG OTHER		IDO PHARM	ISOPROPYL ALCOHOL	83	mL/100g			N	20241231
77039-022_e564ff75-3918-f52f-e053-2a95a90a30e0	77039-022	HUMAN OTC DRUG	IDO DISINFECTION ETHANOL		ethanol	LIQUID	TOPICAL	20220501		OTC MONOGRAPH NOT FINAL	part333A	IDO PHARM	ALCOHOL	83	mL/100mL			N	20241231
77039-023_04aaccef-0a94-5232-e063-6394a90aeaed	77039-023	HUMAN OTC DRUG	PolleySwab		alcohol	LIQUID	NASAL	20230503		OTC MONOGRAPH NOT FINAL	part333A	IDO PHARM	ALCOHOL	65	mL/100g			N	20241231
77039-024_0301ba8b-1b24-1831-e063-6394a90a03b9	77039-024	HUMAN OTC DRUG	AWAS ALCOHOLSPRAY		alcohol	SPRAY	TOPICAL	20230816		OTC MONOGRAPH NOT FINAL	part333A	IDO PHARM	ALCOHOL	83	mL/100mL			N	20241231
77039-025_06249d90-279f-6dc9-e063-6394a90a7f57	77039-025	HUMAN OTC DRUG	IDO SWABA		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20230919		OTC MONOGRAPH NOT FINAL	part333A	IDO PHARM	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
77039-026_05c44516-71a5-da08-e063-6294a90aee99	77039-026	HUMAN OTC DRUG	SaniiSwab		isopropyl alcohol	LIQUID	NASAL	20230920		OTC MONOGRAPH NOT FINAL	part333A	IDO PHARM	ISOPROPYL ALCOHOL	70	mL/100g			N	20241231
77049-0013_f469f1e5-24b1-8ade-e053-2995a90a3028	77049-0013	HUMAN OTC DRUG	The Fact Hair Care Scalp Booster Ampoule		L-menthol, Salicylic acid, Dexpanthenol	LIQUID	TOPICAL	20230211		UNAPPROVED DRUG OTHER		Interkos Co.,Ltd.	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.2; .3; .25	g/100mL; g/100mL; g/100mL			N	20241231
77052-010_074d2952-be59-9e5c-e063-6394a90a0692	77052-010	HUMAN PRESCRIPTION DRUG	Ala-Scalp		Hydrocortisone	LOTION	TOPICAL	20200724		ANDA	ANDA083231	Derm Ventures LLC	HYDROCORTISONE	20	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
77129-000_08a251f6-627c-d24a-e063-6394a90a3b3e	77129-000	HUMAN OTC DRUG	INSTANT FREE HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200510		OTC MONOGRAPH DRUG	505G(a)(3)	Travel Retail Global Inc	ALCOHOL	.75	mL/mL			N	20241231
77129-001_0905a832-fda0-67bd-e063-6294a90a77cd	77129-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Travel Retail Global Inc.	ALCOHOL	.75	mL/mL			N	20241231
77133-000_08a1a1e3-05d8-5508-e063-6294a90a8fa0	77133-000	HUMAN OTC DRUG	Alcohol Prep Pads		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20200630		OTC MONOGRAPH DRUG	505G(a)(3)	ALCOVE BRANDS	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
77133-001_08a1a1e3-05c8-5508-e063-6294a90a8fa0	77133-001	HUMAN OTC DRUG	Fight wipes		ALCOHOL	CLOTH	TOPICAL	20201224		OTC MONOGRAPH DRUG	505G(a)(3)	ALCOVE BRANDS	ALCOHOL	.75	mL/mL			N	20241231
77133-002_08a19eaa-f1a4-2467-e063-6294a90adb7d	77133-002	HUMAN OTC DRUG	O Well sanitizing hand wipes		ALCOHOL	CLOTH	TOPICAL	20201224		OTC MONOGRAPH DRUG	505G(a)(3)	ALCOVE BRANDS	ALCOHOL	.75	mL/mL			N	20241231
77211-001_d83bac79-8334-4470-e053-2a95a90a956a	77211-001	HUMAN OTC DRUG	HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200501	20240831	OTC MONOGRAPH NOT FINAL	part333A	Reusable Bag Solutions Inc.	ALCOHOL	70	mL/100mL			N	
77267-001_0aa45255-267b-fa2f-e063-6394a90aee7b	77267-001	HUMAN OTC DRUG	IPA Wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20200509		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
77267-002_0aa3f80d-b5a9-743c-e063-6294a90a00a1	77267-002	HUMAN OTC DRUG	Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20200510		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	ALCOHOL	.75	mL/mL			N	20241231
77267-003_0aa441d8-a28e-a678-e063-6294a90a698e	77267-003	HUMAN OTC DRUG	Hand Antibacterial Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200511		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77267-004_0aa48c94-f80e-ec03-e063-6294a90afecb	77267-004	HUMAN OTC DRUG	Anti-Bacterial Hand Sanitizer Gel		Ethyl Alcohol	GEL	TOPICAL	20200523		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	ALCOHOL	75	mL/100mL			N	20241231
77267-005_0aa459ec-0658-c126-e063-6294a90ad9e8	77267-005	HUMAN OTC DRUG	Eyelids Wipes		Benzoic Acid	CLOTH	TOPICAL	20200928		UNAPPROVED DRUG OTHER		NingboRiwayIndustrialCo.,Ltd.	BENZOIC ACID	.1	g/100g	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
77267-006_0aa45019-2ad9-343d-e063-6394a90a4f27	77267-006	HUMAN OTC DRUG	Adhesive Remover Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20201017		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	ISOPROPYL ALCOHOL	1	mL/100mL			N	20241231
77267-007_0aa44bac-b7d2-d56c-e063-6394a90ab4cd	77267-007	HUMAN OTC DRUG	Saline Wipes		Sodium chloride	CLOTH	TOPICAL	20201017		UNAPPROVED DRUG OTHER		NingboRiwayIndustrialCo.,Ltd.	SODIUM CHLORIDE	.9	g/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
77267-008_63a7aad9-c0bb-48d5-9959-4ff9ae359217	77267-008	HUMAN OTC DRUG	Premium Nature Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	Ningbo Riway Daily Commodity Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
77267-009_0aa3d78f-4659-d56a-e063-6394a90a7322	77267-009	HUMAN OTC DRUG	Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221014		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77267-010_0aa3f80d-b5a2-743c-e063-6294a90a00a1	77267-010	HUMAN OTC DRUG	Himmy Pet BathWipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
77267-011_0aa3fa26-562c-4da8-e063-6294a90a4974	77267-011	HUMAN OTC DRUG	Himmy Pet BathWipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
77267-012_0aa3f80d-b5a1-743c-e063-6294a90a00a1	77267-012	HUMAN OTC DRUG	Himmy Pet BathWipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
77267-013_0aa3f80d-b59f-743c-e063-6294a90a00a1	77267-013	HUMAN OTC DRUG	Mega Body Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.08	g/100g			N	20241231
77267-014_08ae7c40-7d47-0f0d-e063-6394a90a45ea	77267-014	HUMAN OTC DRUG	Mega Body Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.08	g/100g			N	20241231
77267-015_0aa3e431-6bd6-2a3e-e063-6294a90abbe0	77267-015	HUMAN OTC DRUG	Mega Body Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221208		OTC MONOGRAPH DRUG	505G(a)(3)	NingboRiwayIndustrialCo.,Ltd.	BENZALKONIUM CHLORIDE	.08	g/100g			N	20241231
77313-875_f1f10bf0-ec06-3da0-e053-2995a90a1b40	77313-875	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	SPRAY	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333A	Boss (Huizhou) Medical & Health Products Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
77313-975_f1f131cc-fe1a-66e3-e053-2a95a90a87e4	77313-975	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200514		OTC MONOGRAPH NOT FINAL	part333A	Boss (Huizhou) Medical & Health Products Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
77333-827_f6e60297-848b-8d15-e053-6294a90ad16d	77333-827	HUMAN OTC DRUG	Sodium Bicarbonate	10 GR. (650 MG)	Sodium Bicarbonate	TABLET	ORAL	20230314		OTC MONOGRAPH NOT FINAL	part334	Gendose Pharmaceuticals, LLC	SODIUM BICARBONATE	650	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
77333-844_ff376144-28a2-8811-e053-6394a90aa995	77333-844	HUMAN OTC DRUG	SODIUM CHLORIDE	1 GRAM	SODIUM CHLORIDE	TABLET	ORAL	20200515		OTC MONOGRAPH FINAL	part349	Gendose Pharmaceuticals, LLC	SODIUM CHLORIDE	1	g/1			N	20241231
77338-100_fbd4bf16-e141-9ecd-e053-6294a90a5b2c	77338-100	HUMAN OTC DRUG	ASTONEA Burn Cream		Lidocaine	CREAM	TOPICAL	20230516		OTC MONOGRAPH NOT FINAL	part348	ASTONEA LABS PRIVATE LIMITED	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
77338-101_f216106d-2254-fc25-e053-2a95a90aeff8	77338-101	HUMAN OTC DRUG	Petrolatum Jelly		Petrolatum	JELLY	TOPICAL	20161011		OTC MONOGRAPH FINAL	part347	ASTONEA LABS PRIVATE LIMITED	PETROLATUM	99.9	g/100g			N	20241231
77338-103_ffe99ffd-d3ba-8e4e-e053-6294a90a9895	77338-103	HUMAN OTC DRUG	Aloe Vera Petrolatum Jelly		Petrolatum	JELLY	TOPICAL	20230612		OTC MONOGRAPH FINAL	part347	ASTONEA LABS PRIVATE LIMITED	PETROLATUM	99.35	g/100g			N	20241231
77338-211_f215e9e2-af7a-acbd-e053-2995a90abf8f	77338-211	HUMAN OTC DRUG	ASTONEA PETROLATUM		PETROLATUM	OINTMENT	TOPICAL	20130205		OTC MONOGRAPH FINAL	part347	ASTONEA LABS PRIVATE LIMITED	PETROLATUM	1	g/g			N	20241231
77358-201_399a2395-a185-4687-87cb-9122c2104a13	77358-201	HUMAN OTC DRUG	Bluevado Sunfix		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20211201		OTC MONOGRAPH DRUG	M020	Magic Blue, LLC	TITANIUM DIOXIDE; ZINC OXIDE	2.8; 8.2	g/100mL; g/100mL			N	20251231
77365-005_0ffcb228-f498-40ec-9f02-aaa9e707d430	77365-005	HUMAN OTC DRUG	Buildable Blur CC Broad Spectrum SPF 40 Sunscreen		Homosalate, Octisalate, and Zinc Oxide	CREAM	TOPICAL	20220907		OTC MONOGRAPH FINAL	part352	Thrive Causemetics	HOMOSALATE; OCTISALATE; ZINC OXIDE	90; 45; 78	mg/mL; mg/mL; mg/mL			N	20241231
77365-006_e6bbd894-d11f-4b95-8c6d-10523d243261	77365-006	HUMAN OTC DRUG	Filtered Effects Protecting Primer Broad Spectrum SPF 37 Sunscreen Water Resistant (80 minutes)		Avobenzone, Homosalate, and Octisalate	GEL	TOPICAL	20230419		OTC MONOGRAPH FINAL	part352	Thrive Causemetics	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
77365-007_f925fd1e-42f2-4cce-b94a-31e333e39176	77365-007	HUMAN OTC DRUG	SUNPROOF NOURISHING LIP BALM Broad Spectrum SPF 24 Sunscreen FRESH MINT		Avobenzone, Homosalate, and Octisalate	LIPSTICK	TOPICAL	20230419		OTC MONOGRAPH FINAL	part352	Thrive Causemetics	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
77365-008_8213c8bb-fae4-4d16-bb91-aad6940ec6b5	77365-008	HUMAN OTC DRUG	SUNPROOF NOURISHING LIP BALM Broad Spectrum SPF 24 Sunscreen TANGERINE		Avobenzone, Homosalate, and Octisalate	LIPSTICK	TOPICAL	20230419		OTC MONOGRAPH FINAL	part352	Thrive Causemetics	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
77394-103_06d47045-9650-cbe4-e063-6294a90a71f7	77394-103	HUMAN OTC DRUG	LATHER - LAVENDER HAND SANITIZING WIPES	WITH MOISTURIZING ALOE	ETHYL ALCOHOL	SOLUTION	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	Lather, Inc.	ALCOHOL	6.5	mL/1			N	20241231
77394-202_06d49422-3f8c-f930-e063-6294a90a27eb	77394-202	HUMAN OTC DRUG	LATHER- DAILY DEFENSE MINERAL SPF 50		ZINC OXIDE	CREAM	TOPICAL	20210428		OTC MONOGRAPH NOT FINAL	part352	Lather, Inc.	ZINC OXIDE	21	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
77435-002_7e77f767-18bf-4986-be44-77876bfc66cb	77435-002	HUMAN OTC DRUG	MaxEnergy Health Care Alcohol Wipes		ALCOHOL	SWAB	TOPICAL	20200506		OTC MONOGRAPH NOT FINAL	part333A	Haining Baihe Sanitary Products Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
77435-004_fb8b020c-7e11-4aae-b85b-30b7522f24ec	77435-004	HUMAN OTC DRUG	NuvoMed Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	BENZALKONIUM CHLORIDE	.3	g/100g			N	20241231
77435-006_343a4b1b-17bb-4815-aca9-c8d8c126a26d	77435-006	HUMAN OTC DRUG	Alcohol Wipes		ALCOHOL	SWAB	TOPICAL	20200512		OTC MONOGRAPH NOT FINAL	part333A	Haining Baihe Sanitary Products Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
77435-010_6461a1e7-7203-4a7e-a484-d091539dc460	77435-010	HUMAN OTC DRUG	Disinfectant Wipes		ALCOHOL	SWAB	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-012_f339af67-9a17-435c-b6e1-afeec39db26a	77435-012	HUMAN OTC DRUG	Alcohol Wipes		ALCOHOL	SWAB	TOPICAL	20200628		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-016_7601b8d3-6473-47a4-b7dd-de0df3beb3c6	77435-016	HUMAN OTC DRUG	Handy Antibac Antiseptic Hand Sanitizng Wipes		ALCOHOL	CLOTH	TOPICAL	20200812		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-018_f4662d4e-8eea-4be6-8b8e-042301b8a95d	77435-018	HUMAN OTC DRUG	Handy Antibac Antiseptic Hand Sanitizng Wipes		ALCOHOL	CLOTH	TOPICAL	20200812		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-020_1bb7491c-49da-4613-9590-8c327a1cbce3	77435-020	HUMAN OTC DRUG	Antibacterial Wipes		BENZALKONIUM wipes	CLOTH	TOPICAL	20210107		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77435-021_e43822f9-e26d-47d6-9ae9-178bff84c3f1	77435-021	HUMAN OTC DRUG	Antibacterial Wipes		BENZALKONIUM wipes	CLOTH	TOPICAL	20210107		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77435-022_bd28bdfb-d6a0-421e-8b3f-ce6ae5e6eb26	77435-022	HUMAN OTC DRUG	Wet Wipes		ALCOHOL wipes	CLOTH	TOPICAL	20210117		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	62	g/100g			N	20241231
77435-023_7e25f8ec-876a-4c7f-8ab6-3d6c77d00393	77435-023	HUMAN OTC DRUG	Hand Sanitizing Wipes		ALCOHOL wipes	CLOTH	TOPICAL	20210329		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-101_d3712e0f-5632-432d-9a13-8dfa95a4c3c2	77435-101	HUMAN OTC DRUG	Handy antibac Antiseptic Hand Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20200628		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-103_e9715f73-49fd-46ab-b6c1-dc0cfc88b28b	77435-103	HUMAN OTC DRUG	Alcohol Wipes		ALCOHOL	SWAB	TOPICAL	20200628		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-104_24f1eee5-5b10-420b-a65a-ad5d0e879f79	77435-104	HUMAN OTC DRUG	Sanitizing Wipes		ALCOHOL	SWAB	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-106_22e88f8c-f687-40e0-8558-f0f14e506dd8	77435-106	HUMAN OTC DRUG	Procure Products Hand Sanitizing Wipes		ALCOHOL	SWAB	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-108_aca67e59-f404-4cf5-aa8f-4e2767360d8a	77435-108	HUMAN OTC DRUG	Contractor Engineered Tough Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200727		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	BENZALKONIUM CHLORIDE	.15	g/100g			N	20241231
77435-109_9b28720a-7317-4f98-8c1a-410d2e566879	77435-109	HUMAN OTC DRUG	groovi beauty spring RAIN hand sanitizing wipes		ALCOHOL	SWAB	TOPICAL	20200728		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-111_13a41e07-7e58-4b75-8ce0-f6c833dc9c8f	77435-111	HUMAN OTC DRUG	Wet Wipes		ALCOHOL	SWAB	TOPICAL	20200728		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	70	g/100g			N	20241231
77435-112_6a0b43d1-75bf-498c-b85c-856d1450b8c9	77435-112	HUMAN OTC DRUG	Disinfecting Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200728		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	BENZALKONIUM CHLORIDE	.08	g/100g			N	20241231
77435-114_a6cc182b-6e44-4c9a-a69d-73d1d4c095c3	77435-114	HUMAN OTC DRUG	Disinfectant Wipes for hand sanitizing		ALCOHOL	SWAB	TOPICAL	20200805		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	ALCOHOL	75	g/100g			N	20241231
77435-220_f622d6f7-fe29-41a8-984b-3f59783de657	77435-220	HUMAN OTC DRUG	Antiseptic Wipes		BENZALKONIUM wipes	CLOTH	TOPICAL	20211030		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77435-221_84cd25a2-683b-4e5f-8f44-6210020d5b0b	77435-221	HUMAN OTC DRUG	Antiseptic Wipes		BENZALKONIUM wipes	CLOTH	TOPICAL	20211030		OTC MONOGRAPH NOT FINAL	part333A	HAINING LILY CLEANING PRODUCTS CO., LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77446-000_08979f64-b26e-9491-e063-6294a90a5fa7	77446-000	HUMAN OTC DRUG	PARASOL HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200510		OTC MONOGRAPH DRUG	505G(a)(3)	We've Got Chemistry LLC	ALCOHOL	.62	mL/mL			N	20241231
77446-001_0897bdf3-a460-ae95-e063-6294a90a565e	77446-001	HUMAN OTC DRUG	PARASOL SCENT-FREE HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200905		OTC MONOGRAPH DRUG	505G(a)(3)	We've Got Chemistry LLC	ALCOHOL	.75	mL/mL			N	20241231
77462-010_08c0d47d-ca70-479a-e063-6394a90aaf32	77462-010	HUMAN OTC DRUG	Hygienic Instant Hand Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20200825		OTC MONOGRAPH DRUG	505G(a)(3)	SORA KOZMETIK SANAYI TICARET ANONIM SIRKETI	ALCOHOL	.75	mL/mL			N	20241231
77462-011_08c0e473-cdee-04e7-e063-6294a90a891f	77462-011	HUMAN OTC DRUG	Instant Hand Sanitizing Gel		ALCOHOL	GEL	TOPICAL	20200825		OTC MONOGRAPH DRUG	505G(a)(3)	SORA KOZMETIK SANAYI TICARET ANONIM SIRKETI	ALCOHOL	.7	mL/mL			N	20241231
77462-012_08c09aa5-8414-dacf-e063-6394a90a325d	77462-012	HUMAN OTC DRUG	Instant Sanitizing Gel		ALCOHOL	GEL	TOPICAL	20200825		OTC MONOGRAPH DRUG	505G(a)(3)	SORA KOZMETIK SANAYI TICARET ANONIM SIRKETI	ALCOHOL	.7	mL/mL			N	20241231
77465-001_d59a4036-ddeb-f174-e053-2995a90a4bec	77465-001	HUMAN OTC DRUG	Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20200512		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Youquan Care Products Technology Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
77465-002_d599f0b3-e144-c954-e053-2995a90a3383	77465-002	HUMAN OTC DRUG	Antibacterial Hand Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Youquan Care Products Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77465-003_d599f0b3-e145-c954-e053-2995a90a3383	77465-003	HUMAN OTC DRUG	Disney Frozen II Antibacterial Hand Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Youquan Care Products Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77465-004_d599f0b3-e146-c954-e053-2995a90a3383	77465-004	HUMAN OTC DRUG	Disney Mickey And Friends Antibacterial Hand Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Youquan Care Products Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77465-005_d599ed43-7540-ee2b-e053-2a95a90a61ab	77465-005	HUMAN OTC DRUG	Disney Princess Antibacterial Hand Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20210125		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Youquan Care Products Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77478-455_f1ed895e-4636-e678-e053-2995a90aa08b	77478-455	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	TJP Labs Inc	ALCOHOL	70	mL/100mL			N	20241231
77512-002_a5e3fd2e-5bdf-110c-e053-2a95a90a59e0	77512-002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333E	Inkwell Global Marketing Corp.	ALCOHOL	75	mL/100mL			N	20241231
77512-008_a5e82bef-58e4-08ff-e053-2995a90a6c33	77512-008	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333E	Inkwell Global Marketing Corp.	ALCOHOL	75	mL/100mL			N	20241231
77513-006_e1e5c588-d9e8-33b7-e053-2995a90ae634	77513-006	HUMAN OTC DRUG	Lafco New York Hand Sanitizer Chamomile Lavender		ALCOHOL	GEL	TOPICAL	20210301	20240319	OTC MONOGRAPH NOT FINAL	part333E	GFL SA	ALCOHOL	73.2	mL/100mL			N	
77513-007_e1e66d97-d1a1-41fe-e053-2995a90ae883	77513-007	HUMAN OTC DRUG	Lafco New York Hand Sanitizer Champagne		ALCOHOL	GEL	TOPICAL	20210301	20240319	OTC MONOGRAPH NOT FINAL	part333E	GFL SA	ALCOHOL	73.2	mL/100mL			N	
77513-008_f9c798d0-d0a3-b1dd-e053-6394a90a3438	77513-008	HUMAN OTC DRUG	LAFCO Hand Sanitizer Blue Mercury Grapefruit Lavender Cucumber		ALCOHOL	GEL	TOPICAL	20210401	20241203	OTC MONOGRAPH NOT FINAL	part333E	GFL SA	ALCOHOL	73.2	mL/100mL			N	
77513-009_e1e6f3a6-1327-2975-e053-2a95a90aff8e	77513-009	HUMAN OTC DRUG	Antiseptic Wipe Gel for Life		ALCOHOL	CLOTH	TOPICAL	20210601	20241220	OTC MONOGRAPH NOT FINAL	part333E	GFL SA	ALCOHOL	73.2	mL/100mL			N	
77513-010_e1e726c4-fc38-f008-e053-2a95a90acb11	77513-010	HUMAN OTC DRUG	Antiseptic Hand Sanitizer Gel for Life		ALCOHOL	GEL	TOPICAL	20210801	20241222	OTC MONOGRAPH NOT FINAL	part333E	GFL SA	ALCOHOL	73.3	mL/100mL			N	
77530-725_c4a41e43-8ce2-47d6-9ff6-241d50411b6a	77530-725	HUMAN PRESCRIPTION DRUG	Trudhesa		Dihydroergotamine mesylate	SPRAY, METERED	NASAL	20210924		NDA	NDA213436	Impel Pharmaceuticals Inc.	DIHYDROERGOTAMINE MESYLATE	4	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
77556-580_0eb3f8fa-0f66-8f8a-e063-6294a90aea6c	77556-580	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200430		OTC MONOGRAPH DRUG	M003	Astera International LLC	ALCOHOL	80	mL/100mL			N	20251231
77573-001_0e2cfc15-605c-76aa-e063-6394a90a9bf1	77573-001	HUMAN OTC DRUG	MIAOYUE Instant Hand Sanitizer		Alcohol	GEL	TOPICAL	20200514		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	ALCOHOL	65	mL/100mL			N	20251231
77573-002_0e2d1926-f1f2-8462-e063-6394a90aa350	77573-002	HUMAN OTC DRUG	Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200703		OTC MONOGRAPH DRUG	M005	JIANGSU AIMEILI COSMETIC CO.,LTD	ALCOHOL	75	mL/100mL			N	20251231
77573-003_0e2cfc15-605b-76aa-e063-6394a90a9bf1	77573-003	HUMAN OTC DRUG	TERRA PURE Spa Collection Fresh Aloe Hand Sanitizer Paraben and Gluten Free		Alcohol	SOLUTION	TOPICAL	20200825		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	ALCOHOL	70	mL/100mL			N	20251231
77573-004_0e2d1237-968b-83ad-e063-6394a90a7a80	77573-004	HUMAN OTC DRUG	TERRA PURE Spa Collection Fresh Aloe Hand Sanitizer Fragrance Free		Alcohol	SOLUTION	TOPICAL	20200825		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	ALCOHOL	70	mL/100mL			N	20251231
77573-005_0e2d0ca0-b396-772a-e063-6394a90a7f73	77573-005	HUMAN OTC DRUG	TERRA PURE Spa Collection Fresh Aloe Foaming Hand Sanitizer Fragrance Free		Alcohol	SOLUTION	TOPICAL	20200915		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	ALCOHOL	70	mL/100mL			N	20251231
77573-006_0e2cf0e2-4031-541a-e063-6294a90a72ef	77573-006	HUMAN OTC DRUG	TERRA PURE Spa Collection Fresh Aloe Hand Sanitizer Moisturizing Formula with Organic Aloe and Vitamin E		Alcohol	SOLUTION	TOPICAL	20200915		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	ALCOHOL	70	mL/100mL			N	20251231
77573-007_0e2ce3fa-3100-5516-e063-6294a90a45bf	77573-007	HUMAN OTC DRUG	Charm Tex Lightly Scented Antibacterial		Alcohol	SOAP	TOPICAL	20201027		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20251231
77573-009_0e2c8b78-8fc5-56f0-e063-6394a90aad04	77573-009	HUMAN OTC DRUG	Charm Tex 3 IN 1 Antibacterial Shave Gel Body Wash		BENZETHONIUM CHLORIDE	LOTION/SHAMPOO	TOPICAL	20210314		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20251231
77573-010_0e2cf0e2-402f-541a-e063-6294a90a72ef	77573-010	HUMAN OTC DRUG	Amerfresh Antibacterial Unwrapped		Alcohol	SOAP	TOPICAL	20220723		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20251231
77573-011_0e2cf0e2-4030-541a-e063-6294a90a72ef	77573-011	HUMAN OTC DRUG	Charm-Tex FLUORIDE		SODIUM MONOFLUOROPHOSPHATE	PASTE, DENTIFRICE	TOPICAL	20220710		OTC MONOGRAPH DRUG	M021	Jiangsu Aimeili Cosmetic Co.,Ltd.	SODIUM MONOFLUOROPHOSPHATE	.1	g/100g			N	20251231
77573-012_0e2cfc15-6059-76aa-e063-6394a90a9bf1	77573-012	HUMAN OTC DRUG	Charm-Tex FLUORIDE Gel		SODIUM FLUORIDE	PASTE, DENTIFRICE	TOPICAL	20220710		OTC MONOGRAPH DRUG	M021	Jiangsu Aimeili Cosmetic Co.,Ltd.	SODIUM FLUORIDE	.1	g/100g			N	20251231
77573-013_0e2cf0e2-402e-541a-e063-6294a90a72ef	77573-013	HUMAN OTC DRUG	GeriGentle Aloe Dry Anti Perspirant Deodorant Body		Aluminum chlorohydrate	SPRAY	TOPICAL	20221020		OTC MONOGRAPH DRUG	M019	Jiangsu Aimeili Cosmetic Co., Ltd.	ALUMINUM CHLOROHYDRATE	.13	g/g			N	20251231
77573-014_0e2ccbb3-ea2f-5123-e063-6394a90a4e02	77573-014	HUMAN OTC DRUG	GeriGentle Aloe Dry Anti Perspirant Deodorant Roll On		Aluminum chlorohydrate	LIQUID	TOPICAL	20221020		OTC MONOGRAPH DRUG	M019	Jiangsu Aimeili Cosmetic Co., Ltd.	ALUMINUM CHLOROHYDRATE	.1	g/g			N	20251231
77573-015_0e2ce70f-530c-429f-e063-6394a90abc48	77573-015	HUMAN OTC DRUG	Amerfresh Antibacterial Deodorant		Alcohol	SOAP	TOPICAL	20221021		OTC MONOGRAPH DRUG	M005	Jiangsu Aimeili Cosmetic Co.,Ltd.	BENZETHONIUM CHLORIDE	.1	g/100g			N	20251231
77578-001_d5cfa326-4bdd-2829-e053-2995a90a3a2c	77578-001	HUMAN OTC DRUG	BACTEDA		ALCOHOL	GEL	TOPICAL	20220117		OTC MONOGRAPH NOT FINAL	part333A	Nutraze, S.C de R.L. de C.V.	ALCOHOL	75	mL/100mL			N	20241231
77578-003_d5cfa326-4bde-2829-e053-2995a90a3a2c	77578-003	HUMAN OTC DRUG	Sanitizer		Alcohol, citric acid	LIQUID	TOPICAL	20220117		OTC MONOGRAPH NOT FINAL	part333A	Nutraze, S.C de R.L. de C.V.	ALCOHOL	80	mL/100mL			N	20241231
77617-001_295a1c46-365f-4bc5-98f8-ae293262279b	77617-001	HUMAN OTC DRUG	Healthy Hands Foaming Hand Sanitizer		N/A	LIQUID	TOPICAL	20180923		UNAPPROVED DRUG OTHER		Maintex	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
77617-002_d3704330-c03b-4bf5-8068-76fc39e08559	77617-002	HUMAN OTC DRUG	Premium Protection Antibacterial Hand		Benzalkonium Chloride	LIQUID	TOPICAL	20180415		UNAPPROVED DRUG OTHER		Maintex	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20241231
77617-004_a704157c-6f65-4c61-891c-82a00dae1dba	77617-004	HUMAN OTC DRUG	Butler Clean Hands		Benzalkonium Chloride	LIQUID	TOPICAL	20200103		UNAPPROVED DRUG OTHER		Maintex	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20241231
77617-009_00760767-d7fc-46cb-a576-7f34abb017cb	77617-009	HUMAN OTC DRUG	Fresh Hands		Benzalkonium Chloride	LIQUID	TOPICAL	20180916		UNAPPROVED DRUG OTHER		Maintex	BENZALKONIUM CHLORIDE	13	kg/100kg			N	20241231
77617-012_ee190424-455e-4ce8-bb38-a6edfad67c27	77617-012	HUMAN OTC DRUG	MAGICSHINE ANTIBACTERIAL FOAMING HAND		Benzalkonium Chloride	LIQUID	TOPICAL	20180918		UNAPPROVED DRUG OTHER		Maintex	BENZALKONIUM CHLORIDE	.13	g/.1L			N	20241231
77617-017_29bce53c-245f-429b-b12e-8f2cf837a142	77617-017	HUMAN OTC DRUG	Champion Ultra Clean		Chloroxylenol	LIQUID	TOPICAL	20200206		UNAPPROVED DRUG OTHER		Maintex	CHLOROXYLENOL	.3	kg/100kg			N	20251231
77629-130_a62ceb50-0dff-37de-e053-2995a90a80ce	77629-130	HUMAN OTC DRUG	Fortera360 Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333E	Pocket Nurse	ALCOHOL	.7	mL/mL			N	20241231
77629-131_a7a4eebf-a995-6443-e053-2a95a90aff4b	77629-131	HUMAN OTC DRUG	HAND SANITIZER 8OZ		Ethyl Alcohol	GEL	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Pocket Nurse Enterprises, Inc.	ALCOHOL	70	mL/100mL			N	20241231
77632-123_ffc656d7-263c-927a-e053-6394a90ac580	77632-123	HUMAN OTC DRUG	Blackwork		Numbing Spray	SPRAY	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part348	Private Label Productions LLC	LIDOCAINE HYDROCHLORIDE	5	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
77632-124_ff9de62e-b92a-059d-e053-6394a90a8b15	77632-124	HUMAN OTC DRUG	Blackwork		Foaming Lidocaine Wash	LIQUID	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part348	Private Label Productions LLC	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.06; 5	mg/100mL; mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
77632-125_ffd479cd-3419-0b67-e053-6394a90a30c1	77632-125	HUMAN OTC DRUG	CALEXOTICS Fuck Sauce Anal		Numbing Lubricant	GEL	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part348	Private Label Productions LLC	LIDOCAINE HYDROCHLORIDE	3.5	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
77632-126_fff2c971-2fe4-1f6e-e053-6394a90a90c4	77632-126	HUMAN OTC DRUG	Optimum Rock Hard Cream		Cream Desensitizer	CREAM	TOPICAL	20230531		OTC MONOGRAPH NOT FINAL	part348	Private Label Productions LLC	BENZOCAINE	7.5	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
77643-201_0294318f-0b38-2efe-e063-6294a90a187c	77643-201	HUMAN OTC DRUG	REJUV REJUVENATING		Aquilaria Malaccensis, Piper Umbellatum, Piper Auritum, Leontopodium Nivale Subsp. Alpinum	CREAM	TOPICAL	20230810		UNAPPROVED HOMEOPATHIC		Rabusta Coffee and Trading LLC	AQUILARIA MALACCENSIS WHOLE; LEONTOPODIUM NIVALE SUBSP. ALPINUM WHOLE; PIPER AURITUM WHOLE; PIPER UMBELLATUM WHOLE	1; 5; 5; 5	[hp_X]/100g; [hp_X]/100g; [hp_X]/100g; [hp_X]/100g			N	20241231
77658-001_0d0a1a6f-604c-2d77-e063-6294a90ab898	77658-001	HUMAN OTC DRUG	Isopropyl alcohol 75%		Alcohol	CLOTH	TOPICAL	20200511		OTC MONOGRAPH DRUG	M003	JUDITH ADORE TOBY LLC	ISOPROPYL ALCOHOL	7.5	mL/1			N	20241231
77658-002_0d0a22e9-2829-3c9c-e063-6294a90ad06f	77658-002	HUMAN OTC DRUG	CLEAN BUDDIES		Isopropyl Alcohol 75%	CLOTH	TOPICAL	20210108		OTC MONOGRAPH DRUG	M003	JUDITH ADORE TOBY LLC	ISOPROPYL ALCOHOL	7.5	mL/1			N	20241231
77661-001_0e842bf8-2da3-a25a-e063-6394a90aa965	77661-001	HUMAN OTC DRUG	FLYGIENE Nourishing Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200521		OTC MONOGRAPH DRUG	M003	FLYGIENE LLC	ALCOHOL	70	mL/100mL			N	20251231
77661-030_f1ea2168-7984-dac9-e053-2a95a90a5133	77661-030	HUMAN OTC DRUG	FLYGIENE Alcohol Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part333A	FLYGIENE LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
77665-104_0e66af91-e0b2-827f-e063-6294a90a9847	77665-104	HUMAN OTC DRUG	Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20230718		UNAPPROVED DRUG OTHER		Guangzhou Baihua Co., Ltd.	ALCOHOL	75	mL/100mL			N	20251231
77677-001_2744ceab-4d59-4cad-bfc3-ccb05b9ea7bf	77677-001	HUMAN OTC DRUG	SONO Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20200617		UNAPPROVED DRUG OTHER		Advanced Ultrasound Solutions Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77677-013_fbc01f5d-ad84-5da3-e053-6294a90a3786	77677-013	HUMAN OTC DRUG	Hand Wipes		Benzalkonium chloride	SWAB	TOPICAL	20200515		OTC MONOGRAPH NOT FINAL	part333A	Advanced Ultrasound Solutions Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
77678-002_a89d023c-5e54-9a12-e053-2995a90a6de9	77678-002	HUMAN OTC DRUG	HyLanson Antiseptic Wipes 75 Alcohol 60mmX80mm		ALCOHOL	CLOTH	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333E	Hebei Zihan Textile Co., Ltd	ALCOHOL	.75	mL/mL			N	20241231
77678-003_a89d42a5-0648-ef13-e053-2995a90ae42c	77678-003	HUMAN OTC DRUG	HyLanson Alcohol Wipes 13cmX19cm		ALCOHOL	CLOTH	TOPICAL	20200528		OTC MONOGRAPH NOT FINAL	part333E	Hebei Zihan Textile Co., Ltd	ALCOHOL	.75	mL/mL			N	20241231
77678-004_a89d4c89-8f12-3075-e053-2a95a90a4d8e	77678-004	HUMAN OTC DRUG	HyLanson Alcohol Wipes 5.9inX7.9in		ALCOHOL	CLOTH	TOPICAL	20200530		OTC MONOGRAPH NOT FINAL	part333E	Hebei Zihan Textile Co., Ltd	ALCOHOL	.75	mL/mL			N	20241231
77693-010_0899cafe-905e-8a8e-e063-6394a90a1f0e	77693-010	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200818		OTC MONOGRAPH DRUG	505G(a)(3)	BeSafe Industries LLC	ALCOHOL	.65	mL/mL			N	20241231
77710-001_0c8c7342-db0c-9e03-e063-6394a90a4796	77710-001	HUMAN OTC DRUG	ANTIBACTERIAL HAND SANITIZING		ALCOHOL	GEL	TOPICAL	20200507		OTC MONOGRAPH DRUG	M003	Grupo Rodeh S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
77714-001_c8979cef-c661-0e2b-e053-2a95a90ab6a1	77714-001	HUMAN OTC DRUG	Hand Sanitizer	GERM-EZE	ALCOHOL	AEROSOL, SPRAY	TOPICAL	20200328		OTC MONOGRAPH NOT FINAL	part333A	Bullfrog Brands, LLC	ALCOHOL	70	mg/100g			N	20241231
77714-002_0a105552-86f1-8f36-e063-6394a90a4fdf	77714-002	HUMAN OTC DRUG	Bull Frog SPF 50		Avobenzone 3.00% Homosalate 15.00% Octisalate 5.00% Octocrylene 10.00%	GEL	TOPICAL	20210808		OTC MONOGRAPH DRUG	M020	Bullfrog Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
77714-003_d6226877-8f28-136a-e053-2995a90acf3e	77714-003	HUMAN OTC DRUG	Sunscreen and insect repellent	Bull frog	SPF 50	AEROSOL, SPRAY	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bullfrog Brands, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 100; 75; 50; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
77714-005_d65d15a6-0a33-1203-e053-2995a90aa6c5	77714-005	HUMAN OTC DRUG	Sunscreen and insect repellent	Bull frog	SPF 50	SOLUTION	TOPICAL	20220119		OTC MONOGRAPH NOT FINAL	part352	Bullfrog Brands, LLC	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 100; 75; 50; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
77714-006_f706f90c-eb7a-2201-e053-6394a90a2ce4	77714-006	HUMAN OTC DRUG	Bull Frog SPF 50 Quik with Water Armor Tech		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20220301		OTC MONOGRAPH FINAL	M020	BULLFROG BRANDS, LLC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
77714-007_0a0f996a-3e25-2381-e063-6394a90aad12	77714-007	HUMAN OTC DRUG	Bull Frog SPF 50 Mosquito Coast Sunscreen Plus Inspect Repellent		AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE	AEROSOL, SPRAY	TOPICAL	20220426		OTC MONOGRAPH DRUG	M020	BULLFROG BRANDS, LLC.	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	30; 100; 75; 50; 50	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
77714-008_f70816a3-cc05-b000-e053-6294a90a0fae	77714-008	HUMAN OTC DRUG	Bull Frog SPF 50 Quik with Water Armor Tech		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20230215		OTC MONOGRAPH FINAL	M020	BULLFROG BRANDS, LLC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 50	mg/g; mg/g; mg/g; mg/g			N	20241231
77720-016_b7e2e277-352f-edb9-e053-2995a90aaf2a	77720-016	HUMAN OTC DRUG	CLEANZE HAND SANITIZING		ethyl alcohol	GEL	TOPICAL	20201230		OTC MONOGRAPH NOT FINAL	part333A	Skaffles Group Limited Liability Company	ALCOHOL	71	mL/100mL			N	20241231
77725-003_fe21ff0a-a893-4849-a9fc-25338598fe53	77725-003	HUMAN OTC DRUG	QUALITY CHOICE INSTANT HAND SANITIZER		Ethyl alcohol	GEL	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part333A	L.e.d. Cosmetics, Inc.	ALCOHOL	70	mL/100mL			N	20241231
77725-004_ff704918-9e16-4ce5-a9c8-63e04f5dc9d2	77725-004	HUMAN OTC DRUG	QUALITY CHOICE INSTANT HAND SANITIZER		Ethyl alcohol	GEL	TOPICAL	20200804		OTC MONOGRAPH NOT FINAL	part333A	L.e.d. Cosmetics, Inc.	ALCOHOL	70	mL/100mL			N	20241231
77771-113_ec1a01fe-54da-21df-e053-2a95a90a0561	77771-113	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20221024		ANDA	ANDA204597	RADHA PHARMACEUTICALS, INC.	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
77771-114_ec1a01fe-54da-21df-e053-2a95a90a0561	77771-114	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20221024		ANDA	ANDA204597	RADHA PHARMACEUTICALS, INC.	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
77771-115_ec1a01fe-54da-21df-e053-2a95a90a0561	77771-115	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20221024		ANDA	ANDA204597	RADHA PHARMACEUTICALS, INC.	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
77771-121_09ac9273-240e-b149-e063-6394a90a20cb	77771-121	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA204165	RADHA PHARMACEUTICALS, INC.	CLOPIDOGREL BISULFATE	300	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
77771-124_09ac9273-240e-b149-e063-6394a90a20cb	77771-124	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA204165	RADHA PHARMACEUTICALS, INC.	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
77771-144_ec921e21-db6b-db77-e053-2a95a90a5781	77771-144	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221026		ANDA	ANDA207479	RADHA PHARMACEUTICALS, INC.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
77771-145_ec921e21-db6b-db77-e053-2a95a90a5781	77771-145	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221026		ANDA	ANDA207479	RADHA PHARMACEUTICALS, INC.	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
77771-156_ec976645-a01f-558e-e053-2995a90a66e5	77771-156	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210415		ANDA	ANDA205129	Radha Pharmaceuticals, Inc.	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
77771-157_ec976645-a01f-558e-e053-2995a90a66e5	77771-157	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210415		ANDA	ANDA205129	Radha Pharmaceuticals, Inc.	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
77771-158_ec976645-a01f-558e-e053-2995a90a66e5	77771-158	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210415		ANDA	ANDA205129	Radha Pharmaceuticals, Inc.	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
77771-159_ec976645-a01f-558e-e053-2995a90a66e5	77771-159	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20210415		ANDA	ANDA205129	Radha Pharmaceuticals, Inc.	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
77771-174_f70a0849-6537-f475-e053-6394a90a71b2	77771-174	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210415		ANDA	ANDA205794	Radha Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	100	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
77771-175_f70a0849-6537-f475-e053-6394a90a71b2	77771-175	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210415		ANDA	ANDA205794	Radha Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
77771-176_f70a0849-6537-f475-e053-6394a90a71b2	77771-176	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20210415		ANDA	ANDA205794	Radha Pharmaceuticals, Inc.	BUPROPION HYDROCHLORIDE	200	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
77771-177_09c266af-ce9f-e4a5-e063-6394a90a28c4	77771-177	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20231103		ANDA	ANDA205101	Radha Pharmaceuticals, Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
77771-178_09c266af-ce9f-e4a5-e063-6394a90a28c4	77771-178	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20231103		ANDA	ANDA205101	Radha Pharmaceuticals, Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
77771-182_bd5f421e-db2b-6f83-e053-2a95a90ab05e	77771-182	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA205236	Radha Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	10	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
77771-183_bd5f421e-db2b-6f83-e053-2a95a90ab05e	77771-183	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA205236	Radha Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	25	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
77771-184_bd5f421e-db2b-6f83-e053-2a95a90ab05e	77771-184	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA205236	Radha Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	50	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
77771-185_bd5f421e-db2b-6f83-e053-2a95a90ab05e	77771-185	HUMAN PRESCRIPTION DRUG	Hydralazine Hydrochloride		Hydralazine Hydrochloride	TABLET	ORAL	20210304		ANDA	ANDA205236	Radha Pharmaceuticals, Inc.	HYDRALAZINE HYDROCHLORIDE	100	mg/1	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
77771-434_09abd331-76e6-4d67-e063-6394a90ae75d	77771-434	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210604		ANDA	ANDA212517	Radha Pharmaceuticals, Inc.	NAPROXEN	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
77771-435_09abd331-76e6-4d67-e063-6394a90ae75d	77771-435	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210604		ANDA	ANDA212517	Radha Pharmaceuticals, Inc.	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
77771-436_09abd331-76e6-4d67-e063-6394a90ae75d	77771-436	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20210604		ANDA	ANDA212517	Radha Pharmaceuticals, Inc.	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
77771-451_03218a9c-aab1-3e5d-e063-6394a90a5136	77771-451	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA205519	Radha Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
77771-452_03218a9c-aab1-3e5d-e063-6394a90a5136	77771-452	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA205519	Radha Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
77771-453_03218a9c-aab1-3e5d-e063-6394a90a5136	77771-453	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA205519	Radha Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
77771-454_03218a9c-aab1-3e5d-e063-6394a90a5136	77771-454	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20230810		ANDA	ANDA205519	Radha Pharmaceuticals, Inc.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
77790-022_0e2466fb-cb1d-5181-e063-6394a90a8883	77790-022	HUMAN OTC DRUG	Vista Gonio Eye Lubricant		Hypromellose Ophthalmic Solution	SOLUTION	OPHTHALMIC	20230701		UNAPPROVED DRUG OTHER		Red Wedding LLC	HYPROMELLOSE 2208 (100 MPA.S)	25	mg/15mL			N	20251231
77808-001_0d7e6cd9-85d5-5a42-e063-6394a90acb4f	77808-001	HUMAN OTC DRUG	Physicians Group Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200515		OTC MONOGRAPH DRUG	505G(a)(3)	Physicians Group, L.L.C.	ALCOHOL	.75	mL/mL			N	20241231
77808-002_0d773e41-50c9-7c54-e063-6294a90aff1f	77808-002	HUMAN OTC DRUG	Physicians Group Hand Sanitizer Gel		ALCOHOL	GEL	TOPICAL	20200714		OTC MONOGRAPH DRUG	505G(a)(3)	Physicians Group LLC	ALCOHOL	.7	mL/mL			N	20241231
77808-003_0d776fde-72f5-dab1-e063-6394a90a89bf	77808-003	HUMAN OTC DRUG	Physicians Group Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200907		OTC MONOGRAPH DRUG	505G(a)(3)	Physicians Group LLC	ALCOHOL	.7	mL/mL			N	20241231
77824-001_0c065361-870b-b9c7-e063-6294a90a4a22	77824-001	HUMAN OTC DRUG	Dodys Wipes		Antiseptic Hand Sanitizer Wipes	CLOTH	TOPICAL	20230626		OTC MONOGRAPH DRUG	505G(a)(3)	Betone SA de CV	BENZALKONIUM CHLORIDE	.13	mg/1			N	20241231
77827-100_0d0d5824-1688-a063-e063-6294a90aa025	77827-100	HUMAN OTC DRUG	70% Isopropanol wipes		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20210201		OTC MONOGRAPH DRUG	M003	Tianjin Lantian Bishui Technology Co,. Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
77908-005_f187cc92-7d1a-0627-e053-2995a90a71a1	77908-005	HUMAN OTC DRUG	ABC Supplies Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210105	20251231	OTC MONOGRAPH NOT FINAL	part333E	ABC Technical Solutions, Inc.	ALCOHOL	.7	mL/mL			N	
77922-0625_c8bae7c7-3923-7c60-e053-2a95a90a1a10	77922-0625	HUMAN OTC DRUG	Bay Rum Valle Verde		Alcohol 40%	LIQUID	TOPICAL	20200824	20250115	OTC MONOGRAPH NOT FINAL	part333A	Vialen SRL	ALCOHOL	40	mL/100mL			N	
77931-0001_2367d5e6-eac1-4fb8-8891-0b9ef2d77d68	77931-0001	HUMAN OTC DRUG	Drop20		Fucus Vesiculosus, Chelidonium Majus, Kali Phosphoricum, Lycopodium Clavatum, Natrum Muriaticum, Quercus Glandium Spiritus, Quercus Robur, Nux Vomica, Phytolacca Decandra, Ornithogalum Umbellatum, Agnus Castus, Berberis Aquifolium, Berberis Vulgaris, Saccharum Officinale, Solidago Virgaurea, Calcarea Carbonica, Carbo Vegetabilis, Magnesia Phosphorica, Natrum Phosphoricum, Sinapis Arvensis, Flos, Ubidecarenonum, Graphites, Hypophysis Suis, Placenta Totalis Suis, Hypothalamus (Bovine)	LIQUID	ORAL	20200817		UNAPPROVED HOMEOPATHIC		Pick Enterprises Corp	ACTIVATED CHARCOAL; BERBERIS AQUIFOLIUM ROOT BARK; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; CHASTE TREE FRUIT; CHELIDONIUM MAJUS WHOLE; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ORNITHOGALUM UMBELLATUM WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; QUERCUS ROBUR NUT; QUERCUS ROBUR TWIG BARK; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUCROSE; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; UBIDECARENONE	12; 8; 8; 16; 8; 6; 6; 4; 12; 6; 12; 8; 12; 6; 6; 6; 12; 6; 12; 8; 6; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
77932-001_dafd1e53-7cf4-c301-e053-2995a90a7ff7	77932-001	HUMAN OTC DRUG	Oriox Cool Breath Oral Rinse Mild		sodium benzoate	LIQUID	TOPICAL	20220325		UNAPPROVED DRUG OTHER		LCC LTD	SODIUM BENZOATE	.3	g/100mL	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
77932-002_db7f3ca2-da55-1eea-e053-2995a90acc2c	77932-002	HUMAN OTC DRUG	Oriox Cool Breath Oral Rinse Mild		allantoin	LIQUID	TOPICAL	20220331		UNAPPROVED DRUG OTHER		LCC LTD	ALLANTOIN	.1	g/100mL			N	20241231
77932-003_f9929526-a27d-8724-e053-6294a90ad854	77932-003	HUMAN OTC DRUG	Sol Mouthwash		allantoin	LIQUID	DENTAL	20230418		UNAPPROVED DRUG OTHER		LCC LTD	ALLANTOIN	.2	g/100mL			N	20241231
77935-505_f541bb94-4f78-963c-e053-2a95a90afdbb	77935-505	HUMAN OTC DRUG	NORO-X Foaming HandSoap		O-CYMEN-5-OL	SOAP	TOPICAL	20221227		UNAPPROVED DRUG OTHER		BIO3S Co.,Ltd.	O-CYMEN-5-OL	.095	g/100mL			N	20241231
77935-506_f541bb94-4f77-963c-e053-2a95a90afdbb	77935-506	HUMAN OTC DRUG	NORO-X Foaming HandSoap		O-CYMEN-5-OL	SOAP	TOPICAL	20221227		UNAPPROVED DRUG OTHER		BIO3S Co.,Ltd.	O-CYMEN-5-OL	.095	g/100mL			N	20241231
77935-507_f543b2fd-dff2-170f-e053-2a95a90a9ea6	77935-507	HUMAN OTC DRUG	NORO-X Foaming HandSoap		O-CYMEN-5-OL	SOAP	TOPICAL	20221227		UNAPPROVED DRUG OTHER		BIO3S Co.,Ltd.	O-CYMEN-5-OL	.095	g/100mL			N	20241231
77935-508_f54384f2-77cb-b1d6-e053-2a95a90aa06b	77935-508	HUMAN OTC DRUG	NORO-X Foaming HandSoap		O-CYMEN-5-OL	SOAP	TOPICAL	20221227		UNAPPROVED DRUG OTHER		BIO3S Co.,Ltd.	O-CYMEN-5-OL	.095	g/100mL			N	20241231
77939-000_0c5d1b7f-98f6-0628-e063-6394a90a9147	77939-000	HUMAN OTC DRUG	XPRO Antiseptic Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200515		OTC MONOGRAPH DRUG	505G(a)(3)	Savone SA	ALCOHOL	.7	mL/mL			N	20241231
77964-002_d8f899d3-f2fd-23d0-e053-2995a90a5cdf	77964-002	HUMAN OTC DRUG	FOASU Pink Y s MOISTURIZING MIST		niacinamide, adenosine	LIQUID	TOPICAL	20220227		UNAPPROVED DRUG OTHER		HANSCOS Co.,Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
77964-003_d8f9ca3e-74f8-e5d5-e053-2995a90a0b81	77964-003	HUMAN OTC DRUG	FOASU JIN MOISTURIZING ESSENCE		niacinamide, adenosine	LIQUID	TOPICAL	20220227		UNAPPROVED DRUG OTHER		HANSCOS Co.,Ltd.	ADENOSINE; NIACINAMIDE	.04; 3	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
77964-004_d8fa269e-18ac-0889-e053-2995a90a31ab	77964-004	HUMAN OTC DRUG	FOASU Pink Y s RecoveryCream		niacinamide, adenosine	CREAM	TOPICAL	20220227		UNAPPROVED DRUG OTHER		HANSCOS Co.,Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
77964-005_d8fa5b99-b9ab-fb14-e053-2a95a90a74d9	77964-005	HUMAN OTC DRUG	FOASU JIN POWDERWASH		allantoin, panthenol	POWDER	TOPICAL	20220227		UNAPPROVED DRUG OTHER		HANSCOS Co.,Ltd.	ALLANTOIN; PANTHENOL	.1; .01	g/100g; g/100g			N	20241231
77964-006_d8faaf8e-180e-4255-e053-2a95a90aab32	77964-006	HUMAN OTC DRUG	FOASU Pink Y s Collagen Moisturizing Mask		niacinamide, adenosine	LIQUID	TOPICAL	20220227		UNAPPROVED DRUG OTHER		HANSCOS Co.,Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
77975-001_f154605c-5015-05bb-e053-2995a90a5fc7	77975-001	HUMAN OTC DRUG	FREE WASH SANITIZER		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Guangzhou Tingcai Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
77975-010_03a3bfad-d707-519e-e063-6294a90abaf1	77975-010	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20221229		OTC MONOGRAPH NOT FINAL	part333A	Guangzhou Tingcai Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
77975-011_f6323ecf-9509-d3b9-e053-2995a90adbf0	77975-011	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20230306		OTC MONOGRAPH NOT FINAL	part333A	Guangzhou Tingcai Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
77975-012_0b6f29f2-4a05-5ded-e063-6394a90ab582	77975-012	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20231201		OTC MONOGRAPH DRUG	M003	Guangzhou Tingcai Cosmetic Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
77975-025_054cf62d-5831-1983-e063-6394a90ad42e	77975-025	HUMAN OTC DRUG	hand sanitizer gel		ETHYL ALCOHOL	GEL	TOPICAL	20230914		OTC MONOGRAPH NOT FINAL	part333E	Guangzhou Tingcai Cosmetic Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
78003-140_d5ccc62d-3d96-650c-e053-2a95a90a5e17	78003-140	HUMAN OTC DRUG	HydrAphex		HydrAphex	SOLUTION	TOPICAL	20120601	20290131	OTC MONOGRAPH NOT FINAL	part333A	Aphex Biocleanse Systems, Inc	BENZALKONIUM CHLORIDE	.0013	g/mL			N	
78028-001_d5983300-ccab-b9c9-e053-2a95a90a471d	78028-001	HUMAN OTC DRUG	HAND SANITIZING WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200518		OTC MONOGRAPH NOT FINAL	part333A	Dalian Daxin Nonwoven Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.3	g/100g			N	20241231
78028-002_d5983300-ccac-b9c9-e053-2a95a90a471d	78028-002	HUMAN OTC DRUG	Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20200520		OTC MONOGRAPH NOT FINAL	part333A	Dalian Daxin Nonwoven Technology Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
78028-003_d5983e19-5986-2a64-e053-2a95a90a4333	78028-003	HUMAN OTC DRUG	Disinfectant Wipes		Alcohol	CLOTH	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part333A	Dalian Daxin Nonwoven Technology Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
78028-005_ee09f180-98bb-f94f-e053-2995a90ac9b3	78028-005	HUMAN OTC DRUG	WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part333A	Dalian Daxin Nonwoven Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78028-331_efce8a68-858d-30d6-e053-2a95a90af648	78028-331	HUMAN OTC DRUG	Sanitizing Wipes		Wipes	SWAB	TOPICAL	20200916		OTC MONOGRAPH NOT FINAL	part333A	Dalian Da Xin Nonwoven Technology Co.,Ltd	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
78041-0023_ad647f6e-ddd6-6fdf-e053-2995a90ac14c	78041-0023	HUMAN OTC DRUG	Servo Stat BAC		Benzalkonium Chloride	LIQUID	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Fusion Chemcial	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
78058-001_09b09277-5371-e81b-e063-6294a90a6ddd	78058-001	HUMAN OTC DRUG	75% alcohol wipes		ALCOHOL	CLOTH	TOPICAL	20200518		OTC MONOGRAPH DRUG	505G(a)(3)	Guangzhou Mengting Biotechnology Co., Ltd.	ALCOHOL	.75	mL/1			N	20241231
78060-001_cdc6c4b3-fa5a-5791-e053-2a95a90ad70c	78060-001	HUMAN OTC DRUG	Hypex Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333A	Jordan Chemical Industries Co. LTD	ALCOHOL	63	g/100g			N	20241231
78128-101_a6c87751-c6b6-44d3-e053-2a95a90ae32b	78128-101	HUMAN OTC DRUG	JUC Sterilization Wipes		Wipes	CLOTH	TOPICAL	20200527		OTC MONOGRAPH NOT FINAL	part333E	NMS Technologies Co., Ltd.	BENZALKONIUM CHLORIDE	8	mg/1			N	20241231
78128-201_a6a3db31-b457-427c-e053-2a95a90a58cf	78128-201	HUMAN OTC DRUG	JUC RINSEFREE ANTI MICROBIAL HAND SANITIZER		Hand Sanitizer	LIQUID	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333E	NMS Technologies Co., Ltd.	BENZALKONIUM CHLORIDE	750	mg/250mL			N	20241231
78149-002_ff68b3c8-b730-4625-aba3-f2b0cc793880	78149-002	HUMAN OTC DRUG	Hynaut Alcohol Prep Pad		Alcohol	CLOTH	TOPICAL	20200623		OTC MONOGRAPH DRUG	505G(a)(3)	Qingdao Hainuo Biological Engineering Co., Ltd.	ALCOHOL	70	mL/100g			N	20241231
78149-201_9452d936-f720-483e-86d5-565b20af3ba3	78149-201	HUMAN OTC DRUG	Alcohol Prep Pads		Alcohol Prep Pads	SWAB	EXTRACORPOREAL; TOPICAL	20200520		OTC MONOGRAPH DRUG	505G(a)(3)	Qingdao Hainuo Biological Engineering Co., Ltd.	ISOPROPYL ALCOHOL	75	g/100g			N	20241231
78149-205_bb6812ef-8272-41a7-b1a1-3d522813b5e3	78149-205	HUMAN OTC DRUG	Pain Relief Cream		Pain Relief Cream	SOLUTION	TOPICAL	20220906		UNAPPROVED DRUG OTHER		QINGDAO HAINUO BIOLOGICAL ENGINEERING CO., LTD.	MENTHOL	2	g/100g			N	20241231
78151-020_80c164f6-8bda-4ea7-b5ff-ddbed2dc6959	78151-020	HUMAN OTC DRUG	Karl and Hans Botanic Jasmine		Sodium Monofluorophosphate	PASTE, DENTIFRICE	TOPICAL	20220501		OTC MONOGRAPH FINAL	part355	PIGEON CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.74	g/100g			N	20241231
78151-030_9b557bc7-f6ef-4e34-831e-927be2e44163	78151-030	HUMAN OTC DRUG	Karl and Hans Botanic Double Mint		Sodium Monofluorophosphate	PASTE, DENTIFRICE	TOPICAL	20220501		OTC MONOGRAPH FINAL	part355	PIGEON CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.74	g/100g			N	20241231
78161-001_0c86cec5-079a-ade6-e063-6294a90afac0	78161-001	HUMAN OTC DRUG	Jack N Jill Unicorn Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	ALCOHOL	.62	mL/mL			N	20241231
78161-002_0c87128e-44fa-f8de-e063-6294a90aa23d	78161-002	HUMAN OTC DRUG	Jack N Jill Unicorn Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78161-003_0c87143d-2857-0d1d-e063-6294a90a8a66	78161-003	HUMAN OTC DRUG	Jack N Jill Bunny Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	ALCOHOL	.62	mL/mL			N	20241231
78161-004_0c87143d-2863-0d1d-e063-6294a90a8a66	78161-004	HUMAN OTC DRUG	Jack N Jill Bunny Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78161-005_0c86cec5-07a6-ade6-e063-6294a90afac0	78161-005	HUMAN OTC DRUG	Jack N Jill Monkey Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	ALCOHOL	.62	mL/mL			N	20241231
78161-006_0c86bd59-1f34-763f-e063-6394a90af4f1	78161-006	HUMAN OTC DRUG	Jack N Jill Monkey Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78161-007_0c87143d-286f-0d1d-e063-6294a90a8a66	78161-007	HUMAN OTC DRUG	Jack N Jill Dino Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	ALCOHOL	.62	mL/mL			N	20241231
78161-008_0c870cce-24db-9f40-e063-6394a90a0c76	78161-008	HUMAN OTC DRUG	Jack N Jill Dino Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78161-009_0c86d49a-2801-7f18-e063-6394a90ad534	78161-009	HUMAN OTC DRUG	Jack N Jill Koala Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	ALCOHOL	.62	mL/mL			N	20241231
78161-010_0c87143d-287b-0d1d-e063-6294a90a8a66	78161-010	HUMAN OTC DRUG	Jack N Jill Koala Hand Sanitizer		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	Jack & Jill Operations Pty Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78206-111_de289485-6104-4b5b-94a7-fbfe9d6bee96	78206-111	HUMAN PRESCRIPTION DRUG	ASMANEX HFA		MOMETASONE FUROATE	AEROSOL	RESPIRATORY (INHALATION)	20210601		NDA	NDA205641	Organon LLC	MOMETASONE FUROATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
78206-112_de289485-6104-4b5b-94a7-fbfe9d6bee96	78206-112	HUMAN PRESCRIPTION DRUG	ASMANEX HFA		MOMETASONE FUROATE	AEROSOL	RESPIRATORY (INHALATION)	20210601		NDA	NDA205641	Organon LLC	MOMETASONE FUROATE	100	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
78206-113_de289485-6104-4b5b-94a7-fbfe9d6bee96	78206-113	HUMAN PRESCRIPTION DRUG	ASMANEX HFA		MOMETASONE FUROATE	AEROSOL	RESPIRATORY (INHALATION)	20210601		NDA	NDA205641	Organon LLC	MOMETASONE FUROATE	200	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
78206-114_102a53d9-414a-4632-990a-dd4caca8002c	78206-114	HUMAN PRESCRIPTION DRUG	ASMANEX		Mometasone Furoate	INHALANT	RESPIRATORY (INHALATION)	20210601		NDA	NDA021067	Organon LLC	MOMETASONE FUROATE	220	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
78206-115_102a53d9-414a-4632-990a-dd4caca8002c	78206-115	HUMAN PRESCRIPTION DRUG	ASMANEX		Mometasone Furoate	INHALANT	RESPIRATORY (INHALATION)	20210601		NDA	NDA021067	Organon LLC	MOMETASONE FUROATE	110	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
78206-118_501138c6-f3e1-4c97-84e0-ff0e72f5b9a4	78206-118	HUMAN PRESCRIPTION DRUG	CELESTONE SOLUSPAN		Betamethasone Acetate and Betamethasone Sodium Phosphate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE	20210601		NDA	NDA014602	Organon LLC	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
78206-119_6e9abbb4-b77c-4a3e-b1be-fb3dc04ef98f	78206-119	HUMAN PRESCRIPTION DRUG	Clarinex		Desloratadine	TABLET, FILM COATED	ORAL	20210601		NDA	NDA021165	Organon LLC	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
78206-120_c0730420-ac3b-4a84-a69a-04bd7a654901	78206-120	HUMAN PRESCRIPTION DRUG	CLARINEX-D 12 HOUR		desloratadine and pseudoephedrine sulfate	TABLET, EXTENDED RELEASE	ORAL	20210601		NDA	NDA021313	Organon LLC	DESLORATADINE; PSEUDOEPHEDRINE SULFATE	2.5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
78206-121_f9954e71-93c2-4276-b2d7-e2e91108aa07	78206-121	HUMAN PRESCRIPTION DRUG	COZAAR		losartan potassium	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020386	Organon LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
78206-122_f9954e71-93c2-4276-b2d7-e2e91108aa07	78206-122	HUMAN PRESCRIPTION DRUG	COZAAR		losartan potassium	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020386	Organon LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
78206-123_f9954e71-93c2-4276-b2d7-e2e91108aa07	78206-123	HUMAN PRESCRIPTION DRUG	COZAAR		losartan potassium	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020386	Organon LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
78206-124_24d396ad-d6b2-4fd3-a314-98bb1316cc9b	78206-124	HUMAN PRESCRIPTION DRUG	DIPROLENE		betamethasone dipropionate	OINTMENT	TOPICAL	20210601		NDA	NDA018741	Organon LLC	BETAMETHASONE DIPROPIONATE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
78206-125_e1839e0b-347d-4ec5-80c9-52aeb21163a6	78206-125	HUMAN PRESCRIPTION DRUG	Dulera		mometasone furoate and formoterol fumarate dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20210601		NDA	NDA022518	Organon LLC	FORMOTEROL FUMARATE; MOMETASONE FUROATE	5; 50	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
78206-126_e1839e0b-347d-4ec5-80c9-52aeb21163a6	78206-126	HUMAN PRESCRIPTION DRUG	Dulera		mometasone furoate and formoterol fumarate dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20210601		NDA	NDA022518	Organon LLC	FORMOTEROL FUMARATE; MOMETASONE FUROATE	5; 200	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
78206-127_e1839e0b-347d-4ec5-80c9-52aeb21163a6	78206-127	HUMAN PRESCRIPTION DRUG	Dulera		mometasone furoate and formoterol fumarate dihydrate	AEROSOL	RESPIRATORY (INHALATION)	20210601		NDA	NDA022518	Organon LLC	FORMOTEROL FUMARATE; MOMETASONE FUROATE	5; 100	ug/1; ug/1	Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]		N	20241231
78206-129_78928fe1-46dd-4ad7-b57a-4f2e9449660a	78206-129	HUMAN PRESCRIPTION DRUG	Follistim AQ		follitropin	INJECTION, SOLUTION	SUBCUTANEOUS	20230724		BLA	BLA021211	Organon LLC	FOLLITROPIN	300	[iU]/.36mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
78206-130_78928fe1-46dd-4ad7-b57a-4f2e9449660a	78206-130	HUMAN PRESCRIPTION DRUG	Follistim AQ		follitropin	INJECTION, SOLUTION	SUBCUTANEOUS	20230724		BLA	BLA021211	Organon LLC	FOLLITROPIN	600	[iU]/.72mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
78206-131_78928fe1-46dd-4ad7-b57a-4f2e9449660a	78206-131	HUMAN PRESCRIPTION DRUG	Follistim AQ		follitropin	INJECTION, SOLUTION	SUBCUTANEOUS	20230724		BLA	BLA021211	Organon LLC	FOLLITROPIN	900	[iU]/1.08mL	Gonadotropin [EPC], Gonadotropins [CS]		N	20241231
78206-135_4e13d0ec-c0cc-45dc-8c94-415bf9960111	78206-135	HUMAN PRESCRIPTION DRUG	FOSAMAX		alendronate sodium	TABLET	ORAL	20210601		NDA	NDA020560	Organon LLC	ALENDRONATE SODIUM	70	mg/1	Bisphosphonate [EPC], Diphosphonates [CS]		N	20241231
78206-136_587e47f6-6e25-4379-8263-9fc44f72718e	78206-136	HUMAN PRESCRIPTION DRUG	FOSAMAX PLUS D		ALENDRONATE SODIUM and CHOLECALCIFEROL	TABLET	ORAL	20210601		NDA	NDA021762	Organon LLC	ALENDRONATE SODIUM; CHOLECALCIFEROL	70; 5600	mg/1; [iU]/1	Bisphosphonate [EPC], Diphosphonates [CS], Vitamin D [CS], Vitamin D [EPC]		N	20241231
78206-137_587e47f6-6e25-4379-8263-9fc44f72718e	78206-137	HUMAN PRESCRIPTION DRUG	FOSAMAX PLUS D		ALENDRONATE SODIUM and CHOLECALCIFEROL	TABLET	ORAL	20210601		NDA	NDA021762	Organon LLC	ALENDRONATE SODIUM; CHOLECALCIFEROL	70; 2800	mg/1; [iU]/1	Bisphosphonate [EPC], Diphosphonates [CS], Vitamin D [CS], Vitamin D [EPC]		N	20241231
78206-138_53b5d334-57a8-400f-8d65-a7a7520db94d	78206-138	HUMAN PRESCRIPTION DRUG	Ganirelix Acetate		Ganirelix Acetate	INJECTION, SOLUTION	SUBCUTANEOUS	20210601		NDA	NDA021057	Organon LLC	GANIRELIX ACETATE	250	ug/.5mL	Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA]		N	20241231
78206-139_523001d3-24b4-4b24-8b40-47799b751880	78206-139	HUMAN PRESCRIPTION DRUG	HYZAAR		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020387	Organon LLC	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 50	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
78206-140_523001d3-24b4-4b24-8b40-47799b751880	78206-140	HUMAN PRESCRIPTION DRUG	HYZAAR		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020387	Organon LLC	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	12.5; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
78206-141_523001d3-24b4-4b24-8b40-47799b751880	78206-141	HUMAN PRESCRIPTION DRUG	HYZAAR		losartan potassium and hydrochlorothiazide	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020387	Organon LLC	HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM	25; 100	mg/1; mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
78206-142_de376dab-ae25-4825-9c3b-fd0e3688e41e	78206-142	HUMAN PRESCRIPTION DRUG	MAXALT		rizatriptan benzoate	TABLET	ORAL	20210601		NDA	NDA020864	Organon LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
78206-143_de376dab-ae25-4825-9c3b-fd0e3688e41e	78206-143	HUMAN PRESCRIPTION DRUG	MAXALT-MLT		rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING	ORAL	20210601		NDA	NDA020865	Organon LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
78206-145_5889e52e-1ba6-44d7-a377-315a3c5e0bca	78206-145	HUMAN PRESCRIPTION DRUG	Nexplanon		etonogestrel	IMPLANT	SUBCUTANEOUS	20210601		NDA	NDA021529	Organon LLC	ETONOGESTREL	68	mg/1	Progesterone Congeners [CS], Progestin [EPC]		N	20241231
78206-146_7f4bf16b-ca66-4dc9-ac24-0b68eae15cfe	78206-146	HUMAN PRESCRIPTION DRUG	NuvaRing		etonogestrel and ethinyl estradiol	INSERT, EXTENDED RELEASE	VAGINAL	20210601		NDA	NDA021187	Organon LLC	ETHINYL ESTRADIOL; ETONOGESTREL	.015; .12	mg/d; mg/d	Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]		N	20241231
78206-147_ad98aa3b-8438-40df-9a42-f034962edec5	78206-147	HUMAN PRESCRIPTION DRUG	Ontruzant		trastuzumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210601		BLA	BLA761100	Organon LLC	TRASTUZUMAB	150	mg/1	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
78206-148_ad98aa3b-8438-40df-9a42-f034962edec5	78206-148	HUMAN PRESCRIPTION DRUG	Ontruzant		Ontruzant	KIT	INTRAVENOUS	20210601		BLA	BLA761100	Organon LLC						N	20241231
78206-150_6bb1d695-fd2a-491e-bb06-c9356eb60a12	78206-150	HUMAN PRESCRIPTION DRUG	Pregnyl		CHORIOGONADOTROPIN ALFA	KIT		20230602		BLA	BLA017692	Organon LLC						N	20241231
78206-152_808952d8-5232-448b-adf4-2ff3b389e7fd	78206-152	HUMAN PRESCRIPTION DRUG	PROPECIA		finasteride	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020788	Organon LLC	FINASTERIDE	1	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
78206-153_6a38f242-f951-4165-b640-8af695fded77	78206-153	HUMAN PRESCRIPTION DRUG	PROSCAR		FINASTERIDE	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020180	Organon LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
78206-156_9ca37cbe-04af-433a-940a-326169418b9d	78206-156	HUMAN PRESCRIPTION DRUG	REMERONSOLTAB		MIRTAZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210601		NDA	NDA021208	Organon LLC	MIRTAZAPINE	15	mg/1			N	20241231
78206-158_9ca37cbe-04af-433a-940a-326169418b9d	78206-158	HUMAN PRESCRIPTION DRUG	REMERONSOLTAB		MIRTAZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210601		NDA	NDA021208	Organon LLC	MIRTAZAPINE	30	mg/1			N	20241231
78206-159_9ca37cbe-04af-433a-940a-326169418b9d	78206-159	HUMAN PRESCRIPTION DRUG	REMERONSOLTAB		MIRTAZAPINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210601		NDA	NDA021208	Organon LLC	MIRTAZAPINE	45	mg/1			N	20241231
78206-160_9ca37cbe-04af-433a-940a-326169418b9d	78206-160	HUMAN PRESCRIPTION DRUG	REMERON		MIRTAZAPINE	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020415	Organon LLC	MIRTAZAPINE	15	mg/1			N	20241231
78206-161_9ca37cbe-04af-433a-940a-326169418b9d	78206-161	HUMAN PRESCRIPTION DRUG	REMERON		MIRTAZAPINE	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020415	Organon LLC	MIRTAZAPINE	30	mg/1			N	20241231
78206-162_7437432c-e2d3-4be0-847d-fdcd176ce304	78206-162	HUMAN PRESCRIPTION DRUG	Renflexis		infliximab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20170421		BLA	BLA761054	Organon LLC	INFLIXIMAB	100	mg/1	Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20251231
78206-166_6c5fd48a-693a-442c-b0f9-80da97b467e9	78206-166	HUMAN PRESCRIPTION DRUG	SINEMET		carbidopa and levodopa	TABLET	ORAL	20210601		NDA	NDA017555	Organon LLC	CARBIDOPA; LEVODOPA	10; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
78206-167_6c5fd48a-693a-442c-b0f9-80da97b467e9	78206-167	HUMAN PRESCRIPTION DRUG	SINEMET		carbidopa and levodopa	TABLET	ORAL	20210601		NDA	NDA017555	Organon LLC	CARBIDOPA; LEVODOPA	25; 250	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
78206-168_6c5fd48a-693a-442c-b0f9-80da97b467e9	78206-168	HUMAN PRESCRIPTION DRUG	SINEMET		carbidopa and levodopa	TABLET	ORAL	20210601		NDA	NDA017555	Organon LLC	CARBIDOPA; LEVODOPA	25; 100	mg/1; mg/1	Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]		N	20241231
78206-170_3436ade9-e29b-44aa-9fae-af1effd1b24c	78206-170	HUMAN PRESCRIPTION DRUG	SINGULAIR		montelukast sodium	TABLET, CHEWABLE	ORAL	20210601		NDA	NDA020830	Organon LLC	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
78206-171_3436ade9-e29b-44aa-9fae-af1effd1b24c	78206-171	HUMAN PRESCRIPTION DRUG	SINGULAIR		montelukast sodium	GRANULE	ORAL	20210601		NDA	NDA021409	Organon LLC	MONTELUKAST SODIUM	4	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
78206-172_3436ade9-e29b-44aa-9fae-af1effd1b24c	78206-172	HUMAN PRESCRIPTION DRUG	SINGULAIR		montelukast sodium	TABLET, FILM COATED	ORAL	20210601		NDA	NDA020829	Organon LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
78206-173_3436ade9-e29b-44aa-9fae-af1effd1b24c	78206-173	HUMAN PRESCRIPTION DRUG	SINGULAIR		montelukast sodium	TABLET, CHEWABLE	ORAL	20210601		NDA	NDA020830	Organon LLC	MONTELUKAST SODIUM	5	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
78206-174_a5b011e5-bb5e-4c3e-90ee-2c040c3420f1	78206-174	HUMAN PRESCRIPTION DRUG	VYTORIN		ezetimibe and simvastatin	TABLET	ORAL	20210601		NDA	NDA021687	Organon LLC	EZETIMIBE; SIMVASTATIN	10; 10	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
78206-175_a5b011e5-bb5e-4c3e-90ee-2c040c3420f1	78206-175	HUMAN PRESCRIPTION DRUG	VYTORIN		ezetimibe and simvastatin	TABLET	ORAL	20210601		NDA	NDA021687	Organon LLC	EZETIMIBE; SIMVASTATIN	10; 20	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
78206-176_a5b011e5-bb5e-4c3e-90ee-2c040c3420f1	78206-176	HUMAN PRESCRIPTION DRUG	VYTORIN		ezetimibe and simvastatin	TABLET	ORAL	20210601		NDA	NDA021687	Organon LLC	EZETIMIBE; SIMVASTATIN	10; 40	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
78206-177_a5b011e5-bb5e-4c3e-90ee-2c040c3420f1	78206-177	HUMAN PRESCRIPTION DRUG	VYTORIN		ezetimibe and simvastatin	TABLET	ORAL	20210601		NDA	NDA021687	Organon LLC	EZETIMIBE; SIMVASTATIN	10; 80	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
78206-178_47ff35a3-9f50-43ba-91ee-5aa9409b171a	78206-178	HUMAN PRESCRIPTION DRUG	Zetia		Ezetimibe	TABLET	ORAL	20210601		NDA	NDA021445	Organon LLC	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
78206-180_89d94832-f179-44ac-aafa-e9490a78e343	78206-180	HUMAN PRESCRIPTION DRUG	ZOCOR		SIMVASTATIN	TABLET, FILM COATED	ORAL	20210601		NDA	NDA019766	Organon LLC	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
78206-181_89d94832-f179-44ac-aafa-e9490a78e343	78206-181	HUMAN PRESCRIPTION DRUG	ZOCOR		SIMVASTATIN	TABLET, FILM COATED	ORAL	20210601		NDA	NDA019766	Organon LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
78206-182_89d94832-f179-44ac-aafa-e9490a78e343	78206-182	HUMAN PRESCRIPTION DRUG	ZOCOR		SIMVASTATIN	TABLET, FILM COATED	ORAL	20210601		NDA	NDA019766	Organon LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
78206-183_943ee6ac-e3cf-4552-a468-01c9b11d7c47	78206-183	HUMAN PRESCRIPTION DRUG	Hadlima		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	Organon LLC	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
78206-184_943ee6ac-e3cf-4552-a468-01c9b11d7c47	78206-184	HUMAN PRESCRIPTION DRUG	Hadlima		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	Organon LLC	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
78206-185_943ee6ac-e3cf-4552-a468-01c9b11d7c47	78206-185	HUMAN PRESCRIPTION DRUG	Hadlima		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	Organon LLC	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
78206-186_943ee6ac-e3cf-4552-a468-01c9b11d7c47	78206-186	HUMAN PRESCRIPTION DRUG	Hadlima		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	Organon LLC	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
78206-187_943ee6ac-e3cf-4552-a468-01c9b11d7c47	78206-187	HUMAN PRESCRIPTION DRUG	Hadlima		adalimumab-bwwd	SOLUTION	SUBCUTANEOUS	20230701		BLA	BLA761059	Organon LLC	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
78206-188_6e9abbb4-b77c-4a3e-b1be-fb3dc04ef98f	78206-188	HUMAN PRESCRIPTION DRUG	Clarinex		Desloratadine	TABLET, FILM COATED	ORAL	20220823		NDA	NDA021165	Organon LLC	DESLORATADINE	5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
78206-189_838a1921-7a81-4dca-9847-c581ec3d976f	78206-189	HUMAN PRESCRIPTION DRUG	XACIATO		clindamycin phosphate	GEL	VAGINAL	20231013		NDA	NDA215650	Organon LLC	CLINDAMYCIN PHOSPHATE	100	mg/5g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
78209-000_086354ef-916a-ef86-e063-6294a90a3ecd	78209-000	HUMAN OTC DRUG	Fortaderm Antiseptic Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Forta Lab, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
78229-005_09ae8abf-69fb-e85f-e063-6294a90ab79c	78229-005	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200828		OTC MONOGRAPH DRUG	505G(a)(3)	Beauty Partners LLC	ALCOHOL	.72	mL/mL			N	20241231
78245-101_eb665069-0d05-c524-e053-2a95a90aeab2	78245-101	HUMAN OTC DRUG	Decon7 Antiseptic Foaming Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20211122	20240328	OTC MONOGRAPH NOT FINAL	part333A	Decon7 Systems, LLC	BENZALKONIUM CHLORIDE	1	mg/mL			N	
78245-201_07d75da3-0cce-5609-e063-6294a90a3d81	78245-201	HUMAN OTC DRUG	Decon7 Antiseptic Foaming Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20211122		OTC MONOGRAPH DRUG	505G(a)(3)	Decon7 Systems, LLC	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
78246-153_09760958-f943-2465-e063-6294a90a0278	78246-153	HUMAN OTC DRUG	REVIVE SCIENCE Natural Hemp Pain Relief Rub		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20200510		OTC MONOGRAPH DRUG	M017	REVIVE SCIENCE, llc	HISTAMINE DIHYDROCHLORIDE	.3	mg/mL			N	20241231
78280-302_c2a02768-396b-4a05-905d-bae1a7dd9a4e	78280-302	HUMAN OTC DRUG	KeriCure Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	Kericure Inc.	ALCOHOL	70	mL/100mL			N	20241231
78280-303_04ee0e29-7bf7-40f9-a366-86d3f685b3ee	78280-303	HUMAN OTC DRUG	KeriCure Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	Kericure Inc.	ALCOHOL	70	mL/100mL			N	20241231
78280-304_ea0976ed-3358-4d5a-8257-cf3802cd2143	78280-304	HUMAN OTC DRUG	KeriCure Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part333A	Kericure Inc.	ALCOHOL	70	mL/100mL			N	20241231
78280-305_2b3e940f-9b4e-4133-825c-25854525bcfa	78280-305	HUMAN OTC DRUG	KeriCure Fabric and Hand Sanitizer		Isopropyl Alcohol	SPRAY	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Kericure Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78280-306_c7d1f79b-ec71-4b74-9d8d-fb05243e4045	78280-306	HUMAN OTC DRUG	KeriCure Fabric and Hand Sanitizer		Isopropyl Alcohol	SPRAY	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Kericure Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78280-401_1d3cbfc1-4ead-4e5d-93df-3d79f7a052fa	78280-401	HUMAN OTC DRUG	KeriCleanz ANTISEPTIC		Hydrogen Peroxide	SPRAY	TOPICAL	20231011		OTC MONOGRAPH DRUG	M003	Kericure Inc.	HYDROGEN PEROXIDE	1	mL/100mL			N	20241231
78280-703_8441af88-cb3c-456c-bb47-ae0b2ce7235e	78280-703	HUMAN OTC DRUG	Advanced Seal Barrier plus Pain Relief		Lidocaine	SPRAY	TOPICAL	20200410		OTC MONOGRAPH NOT FINAL	part348	Kericure Inc.	LIDOCAINE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
78280-712_beb6867d-20fd-4a42-b4bf-af98c5ca7c85	78280-712	HUMAN OTC DRUG	Natural Seal Itch Relief for Kids		Lidocaine	SPRAY	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part348	Kericure Inc.	LIDOCAINE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
78308-007_0e775a95-3ba5-f934-e063-6394a90a314f	78308-007	HUMAN OTC DRUG	Recover CBD Pro		Menthol	GEL	TOPICAL	20200720		OTC MONOGRAPH DRUG	M017	VRB Labs, LLC	MENTHOL, UNSPECIFIED FORM	85	mg/mL			N	20251231
78311-080_06c0fe9a-92b6-1679-e063-6394a90a4bf8	78311-080	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	Integrated Green Force, LLC	ALCOHOL	80	mL/100mL			N	20241231
78311-090_f0e804f0-ae9f-760b-e053-2995a90a4c6d	78311-090	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200615		OTC MONOGRAPH NOT FINAL	part333A	Integrated Green Force, LLC	ALCOHOL	80	mL/100mL			N	20241231
78317-000_0973b548-7af1-5b98-e063-6394a90af208	78317-000	HUMAN OTC DRUG	DR. C Tuna Sunscreen 30 SPF Broad Spectrum Face and body		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, HOMOSALATE	CREAM	TOPICAL	20200601		OTC MONOGRAPH DRUG	M020	TAN-ALIZE KOZMETIK VE TEMIZLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	15; 70; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
78317-027_0973c689-82d4-6348-e063-6394a90accb4	78317-027	HUMAN OTC DRUG	Dr.C.Tuna Sun Face Cream SPF50		AVOBENZONE, OCTINOXATE, HOMOSALATE, OCTOCRYLENE	CREAM	TOPICAL	20231003		OTC MONOGRAPH DRUG	M020	Tan Alize Kozmetik ve Temizlik Urunleri Sanayi ve Ticaret Anonim Sirketi	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	29.5; 99.5; 74.5; 61.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
78317-036_0973c7d8-bd79-e83b-e063-6294a90acf55	78317-036	HUMAN OTC DRUG	Dr.C.Tuna Sun Body SPF50		AVOBENZONE, OCTINOXATE, HOMOSALATE, OCTOCRYLENE	CREAM	TOPICAL	20231003		OTC MONOGRAPH DRUG	M020	Tan Alize Kozmetik ve Temizlik Urunleri Sanayi ve Ticaret Anonim Sirketi	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	29.5; 97.9; 73.5; 61.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
78317-052_0831d32f-b4be-6e8b-e063-6294a90a38b8	78317-052	HUMAN OTC DRUG	Farmasi BB Cream LIGHT to MEDIUM 02		TITANIUM DIOXIDE	CREAM	TOPICAL	20230109		OTC MONOGRAPH DRUG	M020	TAN ALIZE KOZMETIK VE TEMIZLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI	TITANIUM DIOXIDE	35	mg/mL			N	20241231
78317-053_08668261-5065-2450-e063-6394a90a315c	78317-053	HUMAN OTC DRUG	Farmasi CC Cream LIGHT to MEDIUM 02		TITANIUM DIOXIDE	CREAM	TOPICAL	20230109		OTC MONOGRAPH DRUG	M020	TAN ALIZE KOZMETIK VE TEMIZLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI	TITANIUM DIOXIDE	40	mg/mL			N	20241231
78317-054_0866960e-e0cf-74d6-e063-6394a90a36b3	78317-054	HUMAN OTC DRUG	Farmasi BB Cream- MEDIUM 03		TITANIUM DIOXIDE	CREAM	TOPICAL	20230109		OTC MONOGRAPH DRUG	M020	TAN ALIZE KOZMETIK VE TEMIZLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI	TITANIUM DIOXIDE	35	mg/mL			N	20241231
78317-055_08668261-5075-2450-e063-6394a90a315c	78317-055	HUMAN OTC DRUG	Farmasi CC Cream- MEDIUM 03		TITANIUM DIOXIDE	CREAM	TOPICAL	20230109		OTC MONOGRAPH DRUG	M020	TAN ALIZE KOZMETIK VE TEMIZLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI	TITANIUM DIOXIDE	40	mg/mL			N	20241231
78317-056_0973ce0d-48d1-5977-e063-6394a90ad88e	78317-056	HUMAN OTC DRUG	Farmasi BB		AVOBENZONE, OCTINOXATE, HOMOSALATE, OCTOCRYLENE	CREAM	TOPICAL	20231003		OTC MONOGRAPH DRUG	M020	TAN ALIZE KOZMETIK VE TEMIZLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE	29.5; 97.9; 73.5; 61.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
78396-002_a6bf5d67-d875-77e9-e053-2a95a90a4402	78396-002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333E	B Holding Group LLC	ALCOHOL	62	mL/100mL			N	20241231
78398-008_a6c043ce-83ca-46c8-e053-2995a90a11e5	78398-008	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333E	SentryPPE, Inc.	ALCOHOL	62	mL/100mL			N	20241231
78398-169_a6c0b772-8af4-64ce-e053-2995a90a34ab	78398-169	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333E	SentryPPE, Inc.	ALCOHOL	62	mL/100mL			N	20241231
78405-001_0c63c2ca-44ea-93b0-e063-6394a90a303e	78405-001	HUMAN OTC DRUG	75 Alcohol Antiseptic Wipes		ALCOHOL	CLOTH	TOPICAL	20200501		OTC MONOGRAPH DRUG	505G(a)(3)	WATERMARK LIMITED	ALCOHOL	.75	mL/mL			N	20241231
78434-100_576df427-f9eb-4f3f-a5d0-ee443a6ea797	78434-100	HUMAN OTC DRUG	ACCURATE LABS ANTISEPTIC HAND SANITIZER		Ethyl alcohol	GEL	TOPICAL	20200601	20250630	OTC MONOGRAPH NOT FINAL	part333A	Accurate Labs, LLC	ALCOHOL	80	L/100L			N	
78434-110_6d26614f-a7d8-42ad-acce-039dd56f0fa0	78434-110	HUMAN OTC DRUG	ACCURATE LABS ANTISEPTIC HAND SANITIZER		Ethyl alcohol	LIQUID	TOPICAL	20200601	20250630	OTC MONOGRAPH NOT FINAL	part333A	Accurate Labs, LLC	ALCOHOL	80	L/100L			N	
78440-009_bd5e96af-2a23-6e3c-e053-2995a90a3956	78440-009	HUMAN OTC DRUG	RUBBING ALCOHOL		Alcohol	LIQUID	TOPICAL	20210312		OTC MONOGRAPH NOT FINAL	part333A	INTERNATIONAL GENERAL TRADING CORP	ISOPROPYL ALCOHOL	50	mL/100mL			N	20241231
78440-010_bd5ee961-1d56-0d9d-e053-2a95a90a6010	78440-010	HUMAN OTC DRUG	RUBBING ALCOHOL		ALCOHOL	LIQUID	TOPICAL	20210312		OTC MONOGRAPH NOT FINAL	part333A	INTERNATIONAL GENERAL TRADING CORP	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78495-001_ae86e396-5a8f-5449-e053-2995a90aa46f	78495-001	HUMAN OTC DRUG	HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200904		OTC MONOGRAPH NOT FINAL	part333E	Ultra Distributors Inc	ALCOHOL	62	mL/100mL			N	20241231
78495-002_ae878ac6-3f68-ce74-e053-2995a90a0700	78495-002	HUMAN OTC DRUG	HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20200904		OTC MONOGRAPH NOT FINAL	part333E	Ultra Distributors Inc	ALCOHOL	62	mL/100mL			N	20241231
78495-003_b57e1019-479f-1783-e053-2995a90aa9be	78495-003	HUMAN OTC DRUG	Cars Petroleum		White Petrolatum	JELLY	TOPICAL	20201201		OTC MONOGRAPH FINAL	part347	Ultra Distributors Inc.	PETROLATUM	100	g/100g			N	20241231
78495-004_b57e105c-c2aa-1812-e053-2995a90a37f5	78495-004	HUMAN OTC DRUG	Princess Petroleum		White Petrolatum	JELLY	TOPICAL	20201201		OTC MONOGRAPH FINAL	part347	Ultra Distributors Inc.	PETROLATUM	100	g/100g			N	20241231
78495-008_a72843fc-0efb-5fa0-e053-2a95a90a6416	78495-008	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200603		OTC MONOGRAPH NOT FINAL	part333E	Ultra Distributors Inc.	ALCOHOL	70	mL/100mL			N	20241231
78495-102_b6c88941-9983-3a37-e053-2995a90a8a5a	78495-102	HUMAN OTC DRUG	MEDI-FIRST First Aid Antiseptic		ISOPROPYL ALCOHOL	SPRAY	TOPICAL	20201219		OTC MONOGRAPH NOT FINAL	part333E	Ultra Distributors Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78495-112_b6e5b0c1-b30c-6d44-e053-2a95a90a33e7	78495-112	HUMAN OTC DRUG	GREEN GUARD First Aid Antiseptic		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20201219		OTC MONOGRAPH NOT FINAL	part333A	Ultra Distributors Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78495-122_b6efcc2c-7409-111e-e053-2a95a90a411c	78495-122	HUMAN OTC DRUG	MEDI-FIRST First Aid Antiseptic		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20201219		OTC MONOGRAPH NOT FINAL	part333A	Ultra Distributors Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78495-132_b6f10314-0e41-c0d4-e053-2a95a90a270a	78495-132	HUMAN OTC DRUG	GREEN GUARD Topical Pain Relief		Lidocaine HCI	SPRAY	TOPICAL	20201219		OTC MONOGRAPH NOT FINAL	part348	Ultra Distributors Inc	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
78495-142_b6f288f7-9ae4-215e-e053-2a95a90aedf6	78495-142	HUMAN OTC DRUG	MEDI-FIRST Topical Analgesic		Lidocaine HCI	SPRAY	TOPICAL	20201219		OTC MONOGRAPH NOT FINAL	part348	Ultra Distributors Inc	LIDOCAINE HYDROCHLORIDE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
78495-152_b6f6a986-a160-ec0a-e053-2995a90a99f2	78495-152	HUMAN OTC DRUG	GREEN GUARD First Aid Antiseptic		HYDROGEN PEROXIDE	SPRAY	TOPICAL	20201219		OTC MONOGRAPH NOT FINAL	part333A	Ultra Distributors Inc	HYDROGEN PEROXIDE	30	mL/L			N	20241231
78495-162_b6f7b346-3d6a-5953-e053-2995a90a878f	78495-162	HUMAN OTC DRUG	MEDI-FIRST First Aid Antiseptic		HYDROGEN PEROXIDE	SPRAY	TOPICAL	20201219		OTC MONOGRAPH NOT FINAL	part333A	Ultra Distributors Inc	HYDROGEN PEROXIDE	30	mL/L			N	20241231
78495-169_a7288b90-f6df-6066-e053-2995a90a6ce6	78495-169	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200603		OTC MONOGRAPH NOT FINAL	part333E	Ultra Distributors Inc.	ALCOHOL	70	mL/100mL			N	20241231
78506-010_2eec5eaf-2e1d-4e18-abad-5c18e8539418	78506-010	HUMAN OTC DRUG	Clean Disinfectant Wipes		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333E	Clean One Co., Ltd.	BENZALKONIUM CHLORIDE	.14	g/100g			N	20241231
78518-001_f0e82e1f-7f74-2b0b-e053-2a95a90a1745	78518-001	HUMAN OTC DRUG	Monat Sun Veil Sunscreen Broad Spectrum SPF 30		Zinc Oxide	LOTION	TOPICAL	20200803		OTC MONOGRAPH NOT FINAL	part352	Monat Global Corp.	ZINC OXIDE	150	mg/mL			N	20241231
78518-002_0bddaa1e-0d9c-13d2-e063-6394a90a7932	78518-002	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH DRUG	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20251231
78518-003_0bddd6d1-34d8-2327-e063-6394a90a7ae4	78518-003	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH DRUG	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20251231
78518-004_0bddbb71-fa3e-0eac-e063-6394a90a851d	78518-004	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH DRUG	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20251231
78518-005_0bddcccd-fd51-1358-e063-6394a90a09a9	78518-005	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH DRUG	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20251231
78518-006_02a9fa38-e1f6-6b43-e063-6294a90a7575	78518-006	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH FINAL	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20241231
78518-007_02aa057b-ae72-f34e-e063-6394a90a371c	78518-007	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH FINAL	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20241231
78518-008_02a9d065-675d-e8d9-e063-6394a90a3db5	78518-008	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH FINAL	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20241231
78518-009_02a9fa38-e1f3-6b43-e063-6294a90a7575	78518-009	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH FINAL	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20241231
78518-010_0bddacdb-6b6d-1142-e063-6394a90ae230	78518-010	HUMAN OTC DRUG	Cream		ZINC OXIDE	CREAM	TOPICAL	20220912		OTC MONOGRAPH DRUG	M020	MONAT GLOBAL CORP	ZINC OXIDE	18.8	mg/100mg			N	20251231
78518-011_f54d0bad-65ce-4281-e053-2a95a90a9e52	78518-011	HUMAN OTC DRUG	ACNE CLEANSER		SALYCILIC ACID	GEL	TOPICAL	20230404		OTC MONOGRAPH FINAL	M006	MONAT GLOBAL CORP	SALICYLIC ACID	2	mg/100mg			N	20241231
78518-012_0bdd94a6-91f4-f115-e063-6294a90a96f0	78518-012	HUMAN OTC DRUG	ACNE Moisturizer		SALYCILIC ACID	CREAM	TOPICAL	20230404		OTC MONOGRAPH DRUG	M006	MONAT GLOBAL CORP	SALICYLIC ACID	2	mg/100mg			N	20251231
78518-013_f8700864-81e8-62eb-e053-6394a90a4aeb	78518-013	HUMAN OTC DRUG	Acne Spot Treatment		BENZOYL PEROXIDE	CREAM	TOPICAL	20230404		OTC MONOGRAPH FINAL	M006	MONAT GLOBAL CORP	BENZOYL PEROXIDE	5	mg/100mg			N	20241231
78518-295_f76eb53e-643e-52cf-e053-6394a90a6e8f	78518-295	HUMAN OTC DRUG	Monat Acne Treatment		Benzoyl Peroxide	CREAM	TOPICAL	20230321		OTC MONOGRAPH FINAL	part333D	Monat Global Corp	BENZOYL PEROXIDE	5	g/100mL			N	20241231
78527-003_c28d8fe8-c150-556f-e053-2995a90a1125	78527-003	HUMAN OTC DRUG	NOTAFLU Lemon Oil Nasal		LEMON	SPRAY	TOPICAL	20130916		UNAPPROVED HOMEOPATHIC		RAPHA HEALTH NETWORK INTERNATIONAL	LEMON OIL	1	[hp_X]/mL			N	20241231
78536-009_034019c4-ed45-ac68-e063-6294a90a33c7	78536-009	HUMAN OTC DRUG	70% Isopropyl Alcohol Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20230820		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Yiwu Mingou Biotechnology Co., Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78536-010_04220712-9ceb-17ff-e063-6294a90ac4d5	78536-010	HUMAN OTC DRUG	CARING MILL ALCOHOL PREP PADS		Isopropyl Alcohol	CLOTH	TOPICAL	20230829		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Yiwu Mingou Biotechnology Co., Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78564-000_0c83cb14-c7e2-3b79-e063-6394a90a4d77	78564-000	HUMAN OTC DRUG	Bittol Anti-Bacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200710		OTC MONOGRAPH DRUG	505G(a)(3)	Taha Kimya Kozmetik Ve Tuketim Urunleri Sanayi Pazarlama Limited Sirketi	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
78564-001_0c862b27-06a5-2268-e063-6394a90a28cf	78564-001	HUMAN OTC DRUG	Bittol Anti-Bacterial Hand Gel		ALCOHOL	GEL	TOPICAL	20200814		OTC MONOGRAPH DRUG	505G(a)(3)	Taha Kimya Kozmetik Ve Tuketim Urunleri Sanayi Pazarlama Limited Sirketi	ALCOHOL	.7	mL/mL			N	20241231
78564-002_0c864f2d-7b3f-370e-e063-6394a90ae1a4	78564-002	HUMAN OTC DRUG	Bittol Anti-Bacterial Liquid		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200920		OTC MONOGRAPH DRUG	505G(a)(3)	Taha Kimya Kozmetik Ve Tuketim Urunleri Sanayi Pazarlama Limited Sirketi	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78564-003_0c8655bc-439e-2b67-e063-6394a90aafa3	78564-003	HUMAN OTC DRUG	Bittol Anti-Bacterial Hygienic Hand Cleaning Liquid		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200920		OTC MONOGRAPH DRUG	505G(a)(3)	Taha Kimya Kozmetik Ve Tuketim Urunleri Sanayi Pazarlama Limited Sirketi	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
78564-004_0c863e4e-1b07-6315-e063-6294a90a9034	78564-004	HUMAN OTC DRUG	Bittol Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20201101		OTC MONOGRAPH DRUG	505G(a)(3)	Taha Kimya Kozmetik Ve Tuketim Urunleri Sanayi Pazarlama Limited Sirketi	ALCOHOL	.75	g/g			N	20241231
78564-006_fd18fa65-0b6a-6acc-e053-6294a90ab896	78564-006	HUMAN OTC DRUG	Wet wipes	Ten	Benzalkonium Chloride	CLOTH	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	TAHA KIMYA KOZMETIK VE TUKETIM URUNLERI SANAYI PAZARLAMA ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.13	mg/1001			N	20241231
78573-002_f187d890-3909-8614-e053-2a95a90ab91d	78573-002	HUMAN OTC DRUG	Jermee Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200519	20251231	OTC MONOGRAPH NOT FINAL	part333E	Jermee Inc	ALCOHOL	.7	mL/mL			N	
78587-000_0c5d1392-34fa-098b-e063-6394a90a95d6	78587-000	HUMAN OTC DRUG	Omni Fresh by Facela Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200701		OTC MONOGRAPH DRUG	505G(a)(3)	Industrias Facela SA de CV	ALCOHOL	.75	mL/mL			N	20241231
78589-233_ed34d728-0276-e209-e053-2995a90a93ff	78589-233	HUMAN OTC DRUG	Mirakel Pain and Itch Relief		Benzocaine 20%, Resorcinol 3%	CREAM	TOPICAL	20220711		OTC MONOGRAPH NOT FINAL	part348	Sanvio, Inc.	BENZOCAINE; RESORCINOL	20; 3	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
78594-000_febd4b37-5ff3-5522-e053-6394a90a855f	78594-000	HUMAN OTC DRUG	Tend Anticavity		SODIUM MONOFLUOROPHOSPHATE	GEL	TOPICAL	20220101		OTC MONOGRAPH FINAL	part355	Tend, LLC	SODIUM MONOFLUOROPHOSPHATE	1.3	mg/g			N	20241231
78602-002_a7268ae4-4943-99d1-e053-2995a90a4684	78602-002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200603		OTC MONOGRAPH NOT FINAL	part333E	Three Square Market, Inc	ALCOHOL	62	mL/100mL			N	20241231
78604-646_3f54e374-3eef-4e66-8d52-aace004432c5	78604-646	HUMAN OTC DRUG	CAL-SHINE ANTISEPTIC HAND SANITIZER		Isopropyl alcohol	LIQUID	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part333A	California Shine Construction	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
78611-4146_943dd9da-e90b-42e9-be5e-b657d68a22ad	78611-4146	HUMAN OTC DRUG	Nuria Defend Matte Finish Daily Moisturizer Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20210315		OTC MONOGRAPH FINAL	part352	Small World Brands	TITANIUM DIOXIDE; ZINC OXIDE	16.5; 110	mg/mL; mg/mL			N	20241231
78615-001_f48fa482-28a2-307f-e053-2995a90a3bca	78615-001	HUMAN OTC DRUG	75% alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200531		OTC MONOGRAPH NOT FINAL	part333A	Narwhal, Inc.	ALCOHOL	75	mL/100mL			N	20241231
78630-202_06c7f7dc-b18e-f249-e063-6294a90ac2a0	78630-202	HUMAN OTC DRUG	SKYMO Hand Sanitizer		Isopropyl Alcohol	LIQUID	TOPICAL	20200605		OTC MONOGRAPH DRUG	M014	SKYMO	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78630-202_06c8a6e4-7d75-bd3c-e063-6394a90a44de	78630-202	HUMAN OTC DRUG	SKYMO Hand Sanitizer		Isopropyl Alcohol	LIQUID	TOPICAL	20200330		OTC MONOGRAPH DRUG	M014	SKYMO	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78641-207_03a8fa2d-97ac-9f63-e063-6394a90afe68	78641-207	HUMAN OTC DRUG	Foaming Instant Hand Sanitizer		Benzalkonium Chloride	SOLUTION	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333E	Global Equipment Company	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
78641-213_03a91ad5-cb3a-beac-e063-6294a90a7976	78641-213	HUMAN OTC DRUG	Foaming Antibacterial Hand Wash		Benzalkonium Chloride	SOLUTION	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333E	Global Equipment Company	BENZALKONIUM CHLORIDE	.013	mg/mL			N	20241231
78641-688_03a8fa2d-97ad-9f63-e063-6394a90afe68	78641-688	HUMAN OTC DRUG	Foaming Alcohol Hand Sanitizer		Ethyl Alcohol	SOLUTION	TOPICAL	20200316		OTC MONOGRAPH NOT FINAL	part333A	Global Equipment Company	ALCOHOL	62	mL/100mL			N	20241231
78641-785_c4f713eb-44bc-1f55-e053-2a95a90af3fa	78641-785	HUMAN OTC DRUG	Eyewash Station Additive Concentrate		Chlorhexidine gluconate and Propylene Glycol	LIQUID	OPHTHALMIC	20210305		OTC MONOGRAPH NOT FINAL	part349	Global Equipment Company	CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL	145.6; 280	kg/2800L; kg/2800L	Decreased Cell Wall Integrity [PE]		N	20241231
78641-786_c4f783d3-b047-ab39-e053-2995a90ab6f3	78641-786	HUMAN OTC DRUG	Eyewash		Eyewash	SOLUTION	OPHTHALMIC	20210617		NDA	NDA022305	Global Equipment Company	WATER	465	mL/473mL			N	20241231
78663-102_0942d1fe-062f-62fd-e063-6394a90a871e	78663-102	HUMAN OTC DRUG	DERMADIVE ULTRACARE - TETRAID		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20230807		OTC MONOGRAPH DRUG	M003	Releaf Technologies LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
78663-201_0980999b-e892-3453-e063-6294a90a2e60	78663-201	HUMAN OTC DRUG	THERABLAST	MAXIMUM RELIEF	LIDOCAINE, MENTHOL	LOTION	TOPICAL	20231106		OTC MONOGRAPH DRUG	M017	Releaf Technologies LLC	LIDOCAINE; MENTHOL	4; 1	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
78663-211_09c0c2e2-4b2c-0066-e063-6394a90acfdb	78663-211	HUMAN OTC DRUG	ReleafPEAK HemCare	MAXIMUM RELIEF	LIDOCAINE, MENTHOL	LOTION	TOPICAL	20231109		OTC MONOGRAPH DRUG	M015	Releaf Technologies LLC	LIDOCAINE; MENTHOL	4; 1	g/100mL; g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
78670-003_12725182-c78c-43f3-8a0e-3943446ee3b6	78670-003	HUMAN PRESCRIPTION DRUG	Revonto		dantrolene sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210409		ANDA	ANDA078378	USWM, LLC	DANTROLENE SODIUM	20	mg/60mL	Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]		N	20241231
78670-050_0df35cf0-1630-403e-b051-7212027f1f26	78670-050	HUMAN PRESCRIPTION DRUG	Lucemyra		lofexidine hydrochloride	TABLET, FILM COATED	ORAL	20210209		NDA	NDA209229	USWM, LLC	LOFEXIDINE HYDROCHLORIDE	.2	mg/1			N	20241231
78670-100_554ff400-ee50-4318-abda-dcb1f8aabf24	78670-100	HUMAN PRESCRIPTION DRUG	Corgard		nadolol	TABLET	ORAL	20220201	20240930	NDA	NDA018063	USWM, LLC	NADOLOL	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
78670-101_554ff400-ee50-4318-abda-dcb1f8aabf24	78670-101	HUMAN PRESCRIPTION DRUG	Corgard		nadolol	TABLET	ORAL	20220201	20241031	NDA	NDA018063	USWM, LLC	NADOLOL	40	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	
78670-140_98dc3cf1-2f05-4619-a6df-6c46c16e7af1	78670-140	HUMAN PRESCRIPTION DRUG	Zimhi		NALOXONE HYDROCHLORIDE	INJECTION, SOLUTION	INTRAMUSCULAR; SUBCUTANEOUS	20220331		NDA	NDA212854	USWM, LLC	NALOXONE HYDROCHLORIDE	5	mg/.5mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
78674-100_a7a774ee-7eb4-43d2-8ae5-ec26ed25b6bd	78674-100	HUMAN OTC DRUG	bioPURE Shield		Benzalkonium Chloride	LIQUID	TOPICAL	20200722		OTC MONOGRAPH NOT FINAL	part333A	Biopure Services Llc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
78691-009_0d964c7c-4d8b-e478-e063-6294a90a4f2e	78691-009	HUMAN OTC DRUG	BioPure Antibacterial Hand Wipes Benzalkonium Chloride 0.12% - 250 Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200920		OTC MONOGRAPH DRUG	505G(a)(3)	QUEST USA CORP.	BENZALKONIUM CHLORIDE	1.2	mg/mL			N	20241231
78691-017_0d6ad995-97a6-1801-e063-6394a90a8e6c	78691-017	HUMAN OTC DRUG	Biopure Antibacterial Hand Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20230115		OTC MONOGRAPH DRUG	505G(a)(3)	Quest USA Corp	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78691-021_0b595b30-1fdd-3bbc-e063-6394a90a1059	78691-021	HUMAN OTC DRUG	Biopure 3 Hydrogen Peroxide		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20230629		OTC MONOGRAPH DRUG	M003	Quest USA Corp	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
78691-022_0b595825-9d52-cf63-e063-6294a90a142f	78691-022	HUMAN OTC DRUG	Biopure Anti-bacterial Hand Wipes Fresh Morning Breeze Scent		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230807		OTC MONOGRAPH DRUG	505G(a)(3)	Quest USA Corp	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78691-023_0b58fdc4-2045-6467-e063-6294a90abd33	78691-023	HUMAN OTC DRUG	Biopure Anti-bacterial Hand Wipes Honey Wildflower Scent		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230807		OTC MONOGRAPH DRUG	505G(a)(3)	Quest USA Corp	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78691-024_0b593f64-2f43-606b-e063-6294a90a66b5	78691-024	HUMAN OTC DRUG	Biopure Pocket Size Singles Fresh Breeze Scent		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20230807		OTC MONOGRAPH DRUG	505G(a)(3)	Quest USA Corp	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78691-025_0e9a2d67-b763-a1ff-e063-6394a90a3076	78691-025	HUMAN OTC DRUG	Biopure alcohol prep pads 70 isopropyl		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20231218		OTC MONOGRAPH DRUG	M003	Quest USA Corp	ISOPROPYL ALCOHOL	70	mL/100mL			N	20251231
78691-140_0d6ad995-97a7-1801-e063-6394a90a8e6c	78691-140	HUMAN OTC DRUG	Benzalkonium Chloride		Antibacterial Hand Wipes	CLOTH	TOPICAL	20220304		OTC MONOGRAPH DRUG	M003	Quest USA Corp	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
78702-000_aa94426d-eac8-3df0-e053-2a95a90ab8d3	78702-000	HUMAN OTC DRUG	Pulezza Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333E	Tastek LLC	ALCOHOL	.75	mL/mL			N	20241231
78702-002_a96ba2e0-5b38-1f89-e053-2a95a90af593	78702-002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part333E	Tastek LLC	ALCOHOL	75	mL/100mL			N	20241231
78702-008_a96d20c9-749e-49e6-e053-2a95a90a32b7	78702-008	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part333E	Tastek LLC	ALCOHOL	75	mL/100mL			N	20241231
78702-169_a96d9834-5103-ba21-e053-2995a90a4cc3	78702-169	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part333E	Tastek LLC	ALCOHOL	75	mL/100mL			N	20241231
78702-335_a96e0990-52b9-2b8f-e053-2995a90a8eae	78702-335	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part333E	Tastek LLC	ALCOHOL	75	mL/100mL			N	20241231
78713-000_0898be5e-2a0f-7c7f-e063-6294a90ac297	78713-000	HUMAN OTC DRUG	ANTI BACTERIAL HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200718		OTC MONOGRAPH DRUG	505G(a)(3)	MiWorld Accesories LLC	ALCOHOL	.75	mL/mL			N	20241231
78714-001_6862a859-c498-4540-aade-4f982e528fbe	78714-001	HUMAN PRESCRIPTION DRUG	FLUDEOXYGLUCOSE F-18		FLUDEOXYGLUCOSE F-18	INJECTION	INTRAVENOUS	20200131		ANDA	ANDA204385	Barbara Ann Karmanos Cancer Hospital	FLUDEOXYGLUCOSE F-18	300	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
78724-002_92b36d4e-48ae-4d1f-85ad-1939af22a5f5	78724-002	HUMAN OTC DRUG	Rosewill Hygiene Wipes		ALCOHOL	SWAB	TOPICAL	20200604		OTC MONOGRAPH NOT FINAL	part333A	Jiebao Daily Chemical (Xiangxi)Co.,Ltd	ALCOHOL	75	g/100g			N	20241231
78724-004_490a8c15-6dfd-4c77-925e-dfe43c46455d	78724-004	HUMAN OTC DRUG	WBM CARE Alcohol cleaning wet wipes		ALCOHOL	SWAB	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333A	Jiebao Daily Chemical (Xiangxi)Co.,Ltd	ALCOHOL	75	g/100g			N	20241231
78724-006_8a5d0389-9bad-4dc7-9f33-2a1795d3a7e7	78724-006	HUMAN OTC DRUG	Alcohol Wipes		ALCOHOL	SWAB	TOPICAL	20200731		OTC MONOGRAPH NOT FINAL	part333A	Jiebao Daily Chemical (Xiangxi)Co.,Ltd	ALCOHOL	75	g/100g			N	20241231
78724-008_16ea284a-6805-4f0c-87b4-dde050e2c1f9	78724-008	HUMAN OTC DRUG	antiseptic hand wipes		POLYAMINOPROPYL BIGUANIDE, BENZALKONIUM and CETYLPYRIDINIUM	SWAB	TOPICAL	20200604		OTC MONOGRAPH NOT FINAL	part333A	Jiebao Daily Chemical (Xiangxi)Co.,Ltd	BENZALKONIUM CHLORIDE; CETYLPYRIDINIUM CHLORIDE; POLYAMINOPROPYL BIGUANIDE	2; 1; 15	mg/g; mg/g; mg/g			N	20241231
78724-010_0e9423eb-aa0a-4edc-91f7-32e8a844f757	78724-010	HUMAN OTC DRUG	UNITED CleanPlus Sanitizing Wipe		ISOPROPYL ALCOHOL	SWAB	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333A	Jiebao Daily Chemical (Xiangxi)Co.,Ltd	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
78724-104_c0d8ecc7-8a0a-4e63-bc2a-c3b0cdbe7887	78724-104	HUMAN OTC DRUG	WBM Care Wet Wipes		Benzalkonium Chloride	SWAB	TOPICAL	20211210		OTC MONOGRAPH NOT FINAL	part333A	Jiebao Daily Chemical (Xiangxi)Co.,Ltd	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78732-001_a746cef4-1fb5-45cf-e053-2995a90a02c8	78732-001	HUMAN OTC DRUG	Throat Coat	Sweet Orange Fennel	Menthol	LOZENGE	ORAL	20200604		OTC MONOGRAPH FINAL	part341	Traditional Medicinals, Inc.	MENTHOL, UNSPECIFIED FORM	6	mg/4.2g			N	20241231
78732-002_08a7f1c4-6c0a-c290-e063-6294a90a0369	78732-002	HUMAN OTC DRUG	Throat Coat	Eucalyptus Mint	Menthol	LOZENGE	ORAL	20200604		OTC MONOGRAPH DRUG	M012	Traditional Medicinals, Inc.	MENTHOL, UNSPECIFIED FORM	6	mg/4.2g			N	20241231
78732-100_08a85288-36ce-bb5d-e063-6394a90a880e	78732-100	HUMAN OTC DRUG	Throat Coat	Lemon Ginger Echinacea	Pectin	LOZENGE	ORAL	20200604		OTC MONOGRAPH DRUG	M022	Traditional Medicinals, Inc.	PECTIN	5	mg/4.2g			N	20241231
78733-111_09a07003-0b4b-f3fc-e063-6394a90ace20	78733-111	HUMAN OTC DRUG	VILOE		Hand Sanitizer Wipes	CLOTH	TOPICAL	20201009		OTC MONOGRAPH DRUG	M003	Sonora Corporation	ALCOHOL	.75	mL/1			N	20241231
78740-004_053eb0b1-d021-a9d2-e063-6294a90a4182	78740-004	HUMAN OTC DRUG	Ivresse Sanitizer Disinfectant		ALCOHOL	SPRAY	TOPICAL	20200811	20250401	OTC MONOGRAPH NOT FINAL	part333E	Ivresse Internacional, S.A. de C.V.	ALCOHOL	.94	mL/mL			N	
78768-001_0897ac32-872e-c027-e063-6294a90a3985	78768-001	HUMAN OTC DRUG	BEAUTANIQ BEAUTY HAND SANITIZER		ALCOHOL	SPRAY	TOPICAL	20200612		OTC MONOGRAPH DRUG	505G(a)(3)	CROP BEAUTY GROUP INC.	ALCOHOL	.62	mL/mL			N	20241231
78768-002_0897ccca-fa1b-873f-e063-6394a90a59ab	78768-002	HUMAN OTC DRUG	FINEAPPLE Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	CROP BEAUTY GROUP INC.	ALCOHOL	.62	mL/mL			N	20241231
78768-003_0897e3ac-f97d-e1a4-e063-6294a90a93d5	78768-003	HUMAN OTC DRUG	MELON DOLLAR Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200607		OTC MONOGRAPH DRUG	505G(a)(3)	CROP BEAUTY GROUP INC.	ALCOHOL	.62	mL/mL			N	20241231
78768-004_0897b5ff-cabe-5ed5-e063-6294a90a92ee	78768-004	HUMAN OTC DRUG	knDR SANITIZER		ALCOHOL	GEL	TOPICAL	20200612		OTC MONOGRAPH DRUG	505G(a)(3)	CROP BEAUTY GROUP INC.	ALCOHOL	.62	mL/mL			N	20241231
78784-002_f5640112-4f7a-f7f3-e053-2995a90a2acc	78784-002	HUMAN OTC DRUG	Instant Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200613		OTC MONOGRAPH NOT FINAL	part333E	GUANGZHOU SLUJ SPECIAL CHEMICAL CO., LTD	ALCOHOL	.75	mL/mL			N	20241231
78784-003_f564219f-2b76-47b2-e053-2a95a90a68eb	78784-003	HUMAN OTC DRUG	Antibacterial Hand Lavender Sage		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333E	GUANGZHOU SLUJ SPECIAL CHEMICAL CO., LTD	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
78785-002_f1e9d36d-986f-085e-e053-2995a90a2937	78785-002	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		ALCOHOL	LIQUID	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	Pure Syncore LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
78789-000_d2bcce93-595b-28eb-e053-2a95a90a13a5	78789-000	HUMAN OTC DRUG	Mad Beauty Best Friend Hand Sanitizer Poppy Temptation		ALCOHOL	SPRAY	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-001_d2bd1177-f51e-1108-e053-2995a90a55f1	78789-001	HUMAN OTC DRUG	Disney Villains Ursula Hand Sanitizer, Deep Aqua		ALCOHOL	GEL	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-002_d2b8505a-27d9-d4d3-e053-2a95a90a568d	78789-002	HUMAN OTC DRUG	Disney Villains Maleficent Hand Sanitizer, Dark Fruits		ALCOHOL	GEL	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-003_d2b7be17-1b01-1151-e053-2a95a90a8081	78789-003	HUMAN OTC DRUG	Disney Villains Cruella Hand Sanitizer Black Coconut		ALCOHOL	GEL	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-004_d2b8b693-a3fe-23b0-e053-2995a90acfc8	78789-004	HUMAN OTC DRUG	Disney Villains Evil Queen Hand Sanitizer, Poison Apple		ALCOHOL	GEL	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-005_d2b82468-917c-335e-e053-2a95a90a4991	78789-005	HUMAN OTC DRUG	Mad Beauty Llama Queen Hand Sanitizer, Cherry		ALCOHOL	SPRAY	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-006_d2cc4e8c-7b1b-56d7-e053-2995a90a195a	78789-006	HUMAN OTC DRUG	Mad Beauty Llama Queen Hand Sanitizer, Strawberry		ALCOHOL	SPRAY	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-007_d2b8dba7-2041-792c-e053-2995a90a1f7c	78789-007	HUMAN OTC DRUG	Mad Beauty Llama Queen Hand Sanitizer, Vanilla		ALCOHOL	SPRAY	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-008_d2a7a819-699d-95b7-e053-2995a90a7606	78789-008	HUMAN OTC DRUG	Mad Beauty Pom Pom Moisturising Hand Sanitizer, Wild Berries		ALCOHOL	GEL	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-009_d2bcb87a-9e6c-1a32-e053-2995a90a6ce7	78789-009	HUMAN OTC DRUG	Mad Beauty Pom Pom Moisturising Hand Sanitizer, Fresh Apples		ALCOHOL	GEL	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-010_d2bccaf6-b3d9-78af-e053-2a95a90a682f	78789-010	HUMAN OTC DRUG	Mad Beauty Pom Pom Moisturising Hand Sanitizer, Sweet Watermelon		ALCOHOL	GEL	TOPICAL	20200701	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-011_d2a8918a-37f5-86f6-e053-2a95a90a3361	78789-011	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean HOW YOU DOIN Coconut		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.62	mL/mL			N	
78789-012_d2cc461f-0977-9e17-e053-2995a90afa82	78789-012	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean ON A BREAK Pear		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.62	mL/mL			N	
78789-013_d2bc8a60-6b11-144e-e053-2995a90a459a	78789-013	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean WE KNOW Grapefruit		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.62	mL/mL			N	
78789-014_d2a8835e-20da-69f8-e053-2995a90a5017	78789-014	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean OH MY GOD Peach		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.62	mL/mL			N	
78789-015_d2a99db8-46be-01b0-e053-2995a90ad9c0	78789-015	HUMAN OTC DRUG	I Love Xmas Penguin Moisturizing Hand Sanitizer Winter Berry		ALCOHOL	SPRAY	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-016_d2b7b5e6-35a7-d534-e053-2995a90a3689	78789-016	HUMAN OTC DRUG	I Love Xmas Polar Bear Moisturizing Hand Sanitizer Marshmallow		ALCOHOL	SPRAY	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-017_d2bcce93-595e-28eb-e053-2a95a90a13a5	78789-017	HUMAN OTC DRUG	I Love Xmas Reindeer Moisturizing Hand Sanitizer, Clementine		ALCOHOL	SPRAY	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-018_d2b86b09-9ed7-4e31-e053-2995a90a4af3	78789-018	HUMAN OTC DRUG	Splash of Silver Moisturizing Hand Sanitizer TONKA BEAN and MYRRH		ALCOHOL	SPRAY	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-019_d2bceace-de35-46c3-e053-2a95a90a58ec	78789-019	HUMAN OTC DRUG	Splash of Silver Moisturizing Hand Sanitizer PEONY JASMINE		ALCOHOL	SPRAY	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-020_d2cc2734-b3d3-65b7-e053-2a95a90a09f9	78789-020	HUMAN OTC DRUG	Splash of Silver Moisturizing Hand Sanitizer, SOFT ROSE and OUD		ALCOHOL	SPRAY	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-021_d2b84ca0-0dc7-81f4-e053-2995a90ad406	78789-021	HUMAN OTC DRUG	Disney Dalmatians Moisturizing Hand Sanitizer, VANILLA		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-022_d2bd42f0-da34-5134-e053-2995a90a0dc0	78789-022	HUMAN OTC DRUG	Disney Bambi Moisturizing Hand Sanitizer MELON		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-023_d2b7a2f1-0ac0-4b39-e053-2a95a90a88be	78789-023	HUMAN OTC DRUG	Disney Dumbo Moisturizing Hand Sanitizer COCONUT		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-024_d2a80087-3244-90c2-e053-2995a90a7576	78789-024	HUMAN OTC DRUG	Disney Marie Moisturizing Hand Sanitizer, STRAWBERRY		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-025_d2bd01b1-7065-3c3f-e053-2995a90a562c	78789-025	HUMAN OTC DRUG	Warner Friends Moisturizing Hand Sanitizer Peach		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.62	mL/mL			N	
78789-026_d2cc2734-b3d5-65b7-e053-2a95a90a09f9	78789-026	HUMAN OTC DRUG	Warner Friends Moisturizing Hand Sanitizer Apple		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.62	mL/mL			N	
78789-027_d2b813de-53e1-73d7-e053-2a95a90ad5bc	78789-027	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Sweet Marshmallow		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-028_d2bb414c-ffe6-ec3e-e053-2a95a90a0e8a	78789-028	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Candy Cane		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-029_d2b83917-1201-242d-e053-2995a90a8de2	78789-029	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Spiced Apple		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-030_d2bd1eeb-70ec-1d98-e053-2a95a90a98f6	78789-030	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Winter Pear		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-031_d2b8dfba-d939-216f-e053-2a95a90a67e8	78789-031	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Frosted Berries		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-032_d2b7fe90-dbc0-1dda-e053-2995a90ac4e2	78789-032	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Strawberry		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-033_d2bd2bf8-7162-9e31-e053-2a95a90a478a	78789-033	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Coconut		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-034_d2cbb2b0-7793-01a7-e053-2995a90a33ea	78789-034	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Blackcurrant		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-035_d2bb5092-2b42-77d3-e053-2a95a90a3d4b	78789-035	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Vanilla		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-036_d2cc05d7-2d1c-612e-e053-2a95a90ae194	78789-036	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Vanilla		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-037_d2cbf516-4966-2ca2-e053-2995a90a9992	78789-037	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Marshmallow		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-038_d2b8ae2c-c0a3-5ddd-e053-2995a90a19c8	78789-038	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Cranberry		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-039_d2a7f39e-1852-8e38-e053-2a95a90a55c8	78789-039	HUMAN OTC DRUG	Mad Beauty Hand Sanitizer Spiced Apple		ALCOHOL	GEL	TOPICAL	20200720	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-040_d2cb96c3-1a5e-08b5-e053-2995a90afba0	78789-040	HUMAN OTC DRUG	Best Mom Moisturizing Hand Sanitizer, Peony and Cherry Blossom		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-041_d2a84157-c1b6-681f-e053-2a95a90a724e	78789-041	HUMAN OTC DRUG	Best Sister Moisturizing Hand Sanitizer, Tuberose and Jasmine		ALCOHOL	SPRAY	TOPICAL	20200820	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-042_d2bd5cac-18d8-f321-e053-2a95a90a24ab	78789-042	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean, HOW U DOIN Coconut		ALCOHOL	GEL	TOPICAL	20200109	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-043_d2bd7382-2b7c-6448-e053-2a95a90aa578	78789-043	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean OH MY GOD Peach		ALCOHOL	GEL	TOPICAL	20200109	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-044_d2b87fad-769b-3757-e053-2a95a90a8211	78789-044	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean, WE WERE ON A BREAK, Apple		ALCOHOL	GEL	TOPICAL	20200109	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-045_d2cc4d36-df8f-55e3-e053-2995a90a3019	78789-045	HUMAN OTC DRUG	Warner Friends Sanitizer Clip and Clean, WE KNOW, Strawberry		ALCOHOL	GEL	TOPICAL	20200109	20241231	OTC MONOGRAPH NOT FINAL	part333E	Mad Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-046_d2cb96c3-1a5d-08b5-e053-2995a90afba0	78789-046	HUMAN OTC DRUG	All Hands Raspberry and Honeydew Moisturizing Hand Cleansing Gel with Alcohol		ALCOHOL	GEL	TOPICAL	20201030	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-047_d2bd5cac-18d3-f321-e053-2a95a90a24ab	78789-047	HUMAN OTC DRUG	All Hands Zingy Pineapple and Lime Moisturizing Hand Cleansing Gel with Alcohol		ALCOHOL	GEL	TOPICAL	20201030	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-048_d2bd8825-c161-e7ff-e053-2a95a90a3c1c	78789-048	HUMAN OTC DRUG	All Hands Lychee and Asian Pear Moisturizing Hand Cleansing Gel with Alcohol		ALCOHOL	GEL	TOPICAL	20201030	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-049_d2b7e0c8-65fa-6bb8-e053-2995a90aa032	78789-049	HUMAN OTC DRUG	Looney Tunes Moisturizing Hand Cleanser with Alcohol Aqua		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-050_d2cbdd6c-79c5-0726-e053-2a95a90a4651	78789-050	HUMAN OTC DRUG	Looney Tunes Moisturizing Hand Cleanser with Alcohol Rose		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-051_d2bca514-72ac-5588-e053-2a95a90a11c9	78789-051	HUMAN OTC DRUG	Looney Tunes Moisturizing Hand Cleanser with Alcohol Sweet Pea		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-052_d2a9635e-5584-2761-e053-2995a90a9a31	78789-052	HUMAN OTC DRUG	Looney Tunes Moisturizing Hand Cleanser with Alcohol Pearl		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-053_d2cbb246-40fa-0e90-e053-2995a90a9a5a	78789-053	HUMAN OTC DRUG	DC Robin Moisturizing Hand Cleanser with Alcohol Amber and Ginseng		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-054_d2a96bf7-b8fc-65bd-e053-2995a90af869	78789-054	HUMAN OTC DRUG	DC Wonder Woman Moisturizing Hand Cleanser with Alcohol Jasmine and Indigo		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-055_d2bd9858-0005-33cc-e053-2995a90a900d	78789-055	HUMAN OTC DRUG	DC Superman Moisturizing Hand Cleanser with Alcohol Aqua		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-056_d2b8912f-d09d-4dc0-e053-2a95a90a33c4	78789-056	HUMAN OTC DRUG	DC Batman Moisturizing Hand Cleanser with Alcohol Dark Forest		ALCOHOL	GEL	TOPICAL	20201115	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-057_d2cc1314-c4cb-ae9f-e053-2995a90a4e80	78789-057	HUMAN OTC DRUG	Mickey and Friends Moisturising Hand Cleanser with Alcohol Aqua		ALCOHOL	GEL	TOPICAL	20200201	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-058_d2a80c8a-21c3-1bc4-e053-2995a90aa1d6	78789-058	HUMAN OTC DRUG	Mickey and Friends Moisturising Hand Cleanser with Alcohol Lavender		ALCOHOL	GEL	TOPICAL	20200201	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-059_d2b8aeb1-5e96-088f-e053-2a95a90a01d4	78789-059	HUMAN OTC DRUG	Mickey and Friends Moisturising Hand Cleanser with Alcohol Amber and Ginseng		ALCOHOL	GEL	TOPICAL	20200201	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78789-060_d2a80c8a-21c6-1bc4-e053-2995a90aa1d6	78789-060	HUMAN OTC DRUG	Mickey and Friends Moisturising Hand Cleanser with Alcohol Soft Rose		ALCOHOL	GEL	TOPICAL	20200201	20241231	OTC MONOGRAPH NOT FINAL	part333E	MAD Beauty USA LLC	ALCOHOL	.69	mL/mL			N	
78803-101_0d877d88-6f84-9d03-e063-6294a90a9f30	78803-101	HUMAN OTC DRUG	HAND SANITIZER WIPE		ETHYL ALCOHOL	SOLUTION	TOPICAL	20200611		OTC MONOGRAPH DRUG	M003	Mayti LLC	ALCOHOL	7	mL/1			N	20241231
78823-001_33886ac6-1ce0-4641-941e-cf53eec01ce2	78823-001	HUMAN OTC DRUG	HAMMER WIPES		BENZALKONIUM CHLORIDE and didecyldimonium chloride	SWAB	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .2	g/100g; g/100g			N	20241231
78823-002_02101515-6ee8-443e-b46c-33fd5cbd0b15	78823-002	HUMAN OTC DRUG	Keep Clean Surface Cleaning Wipes		BENZALKONIUM CHLORIDE and didecyldimonium chloride	SWAB	TOPICAL	20200506		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .2	1/100g; g/100g			N	20241231
78823-004_fe8aa615-4a0b-487c-9a8a-d022f5005155	78823-004	HUMAN OTC DRUG	COMCAST Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200609		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.135	1/100g			N	20241231
78823-006_31068991-2348-447d-929c-2011b6efe549	78823-006	HUMAN OTC DRUG	KLX Antibaterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
78823-008_545485d3-2d72-4cd7-8584-c56e48f27744	78823-008	HUMAN OTC DRUG	Premium Nature Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
78823-009_28ac1ee6-963a-437e-9e60-abb180cecbe5	78823-009	HUMAN OTC DRUG	Sipa Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200625		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78823-010_c007c64e-c3e8-4414-bd00-d3eabbdcf337	78823-010	HUMAN OTC DRUG	Kleen Freak Disinfecting Wipes		BENZALKONIUM CHLORIDE and didecyldimonium chloride	SWAB	TOPICAL	20200506		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .2	g/100g; g/100g			N	20241231
78823-014_6f3c2d6b-19b5-45bb-a19a-4f8b0daaf637	78823-014	HUMAN OTC DRUG	WSINC Disinfecting Wipes		BENZALKONIUM CHLORIDE and didecyldimonium chloride	SWAB	TOPICAL	20200506		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .2	g/100g; g/100g			N	20241231
78823-015_580ad587-d05c-49dd-8f95-6da740d1d36c	78823-015	HUMAN OTC DRUG	WDC Antibacterial Wipes		BENZALKONIUM CHLORIDE and didecyldimonium chloride	SWAB	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .2	g/100g; g/100g			N	20241231
78823-016_65583722-b34e-41bc-9516-c509aec87c9e	78823-016	HUMAN OTC DRUG	WDC Antibacterial Travel Wipes		Alcohol and BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	6; .1	g/100g; g/100g			N	20241231
78823-018_ce4578b6-e8ef-43f9-80c5-7baaa89d7dd9	78823-018	HUMAN OTC DRUG	NovaGreen Antibacterial Wipes		BENZALKONIUM CHLORIDE And ALCOHOL	SWAB	TOPICAL	20200707		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	4; .13	g/100g; g/100g			N	20241231
78823-020_5b6eb425-2ed5-4ae8-a71b-adbf31330a9e	78823-020	HUMAN OTC DRUG	NovaGreen Antibacterial Wipes		BENZALKONIUM CHLORIDE and ALCOHOL	SWAB	TOPICAL	20200717		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	4; .1	g/100g; g/100g			N	20241231
78823-022_e10f43b9-4d06-4c73-8c47-455625640193	78823-022	HUMAN OTC DRUG	Oriental Antibacterial Wipes		BENZALKONIUM CHLORIDE and DIDECYLDIMONIUM CHLORIDE	SWAB	TOPICAL	20200727		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.1; .2	g/100g; g/100g			N	20241231
78823-024_b6c4470b-17d5-446d-9c20-8b979801e8d2	78823-024	HUMAN OTC DRUG	FAMOLOGY Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200612		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
78823-026_c9234f3a-48a6-4a9d-be54-de7959860ed5	78823-026	HUMAN OTC DRUG	Full Circle PPE Antibacterial Wipes		BENZALKONIUM CHLORIDE and ALCOHOL	SWAB	TOPICAL	20200804		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	4; .13	g/100g; g/100g			N	20241231
78823-028_9bc51c31-24cf-471f-b974-540ed9eef0ad	78823-028	HUMAN OTC DRUG	TMD INDUSTRIAL Disinfecting Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200804		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.135	g/100g			N	20241231
78823-030_f5ee69ac-2817-4b44-ba30-5577b1937d8d	78823-030	HUMAN OTC DRUG	Wipe All-purpose Wipes Lemon Scent		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200804		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
78823-031_1acf3ce6-574e-4d22-ac87-2e3c0193d69d	78823-031	HUMAN OTC DRUG	Wipe All-purpose wipes fresh lemon scent		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200804		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
78823-032_6ffaa265-4d58-40bd-8cef-89b48a82faf3	78823-032	HUMAN OTC DRUG	Wipe All-Purpose Wipes Fresh Lemon Scent		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200804		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
78823-034_d4a27655-d840-43be-ba35-e29628c669fe	78823-034	HUMAN OTC DRUG	Nova Green Antibacterial wipes		BENZALKONIUM CHLORIDE and ALCOHOL	SWAB	TOPICAL	20200717		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	4; .1	g/100g; g/100g			N	20241231
78823-035_731e56d9-93c1-4f4d-a8f3-b37e94033b40	78823-035	HUMAN OTC DRUG	Nova Green Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200821		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78823-036_f18a387c-b504-4f05-97d1-5e3c8c6abbc6	78823-036	HUMAN OTC DRUG	Kleen Freak Disinfecting Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
78823-037_86a8f1b9-f721-4cb5-9da7-444dbab348e9	78823-037	HUMAN OTC DRUG	Kleen Freak Disinfecting Wipes		BENZALKONIUM CHLORIDE and alcohol	SWAB	TOPICAL	20200828		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	4; .1	g/100g; g/100g			N	20241231
78823-038_ee6b6890-8f8c-48d4-8483-8387aec61fd3	78823-038	HUMAN OTC DRUG	Free Planet Antibacterial Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20200831		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78823-039_4c153d3c-6e18-430f-b30a-5ae30a665b62	78823-039	HUMAN OTC DRUG	Nova Green Antibacterial wipes		BENZALKONIUM CHLORIDE and Alcohol	SWAB	TOPICAL	20200904		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	4; .1	g/100g; g/100g			N	20241231
78823-040_956a3879-52ed-4843-b0df-ee2c1063c063	78823-040	HUMAN OTC DRUG	COMCAST Antibacterial Wipes Lemon Scent		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20201116		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.135	g/100g			N	20241231
78823-050_fcf0b172-cbd9-42e4-83d3-940d3ab898bb	78823-050	HUMAN OTC DRUG	SIPA HAND SANITIZING WIPES		BENZALKONIUM CHLORIDE And ALCOHOL	SWAB	TOPICAL	20230718		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	ALCOHOL; BENZALKONIUM CHLORIDE	4; .13	g/100g; g/100g			N	20241231
78823-051_30923a84-4a93-4330-90ae-647338395d04	78823-051	HUMAN OTC DRUG	SIPA HAND SANITIZING WIPES		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20230718		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Ruolin Hygienic Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78824-625_0e0f039e-054e-7963-e063-6294a90a1de1	78824-625	HUMAN OTC DRUG	ISOPROPYL RUBBING ALCOHOL 70%		ALCOHOL	LIQUID	TOPICAL	20200303		OTC MONOGRAPH DRUG	505G(a)(3)	Artesanales P.R. LLC	ISOPROPYL ALCOHOL	70	mL/99mL			N	20251231
78828-222_dc195491-c6e4-49fa-9380-875b4cd6862c	78828-222	HUMAN OTC DRUG	LOEWS HOTELS Antiseptic Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20230911		OTC MONOGRAPH DRUG	505G(a)(3)	Carretta USA, Inc	ALCOHOL	75	mL/100mL			N	20241231
78863-1010_091e1fc8-4e17-4739-b67e-95bbd23a0ac9	78863-1010	HUMAN OTC DRUG	Brush and Go	All Skin types	Titanium Dioxide, Octinoxate, Octocrylene, Octisalate, Avobenzone, and Oxybenzone	POWDER	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part352	Noon Aesthetics M.R. Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	.075; .236; .135; .225; .075; 1.25	g/5g; g/5g; g/5g; g/5g; g/5g; g/5g			N	20241231
78863-1011_091e1fc8-4e17-4739-b67e-95bbd23a0ac9	78863-1011	HUMAN OTC DRUG	Brush and Go	All Skin types Matte Finish Tone 1	Titanium Dioxide, Octinoxate, Octocrylene, Octisalate, Avobenzone, and Oxybenzone	POWDER	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Noon Aesthetics M.R. Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	.075; .236; .135; .225; .075; 1.25	g/5g; g/5g; g/5g; g/5g; g/5g; g/5g			N	20241231
78863-1012_c6b01881-4177-452a-95f7-d27cb2eb8512	78863-1012	HUMAN OTC DRUG	Brush and Go	Oily Problematic Skin	Titanium Dioxide, Octinoxate, Octocrylene, Octisalate, Avobenzone, and Oxybenzone	POWDER	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part352	Noon Aesthetics M.R. Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	.075; .236; .135; .225; .075; 1.25	g/5g; g/5g; g/5g; g/5g; g/5g; g/5g			N	20241231
78863-1013_091e1fc8-4e17-4739-b67e-95bbd23a0ac9	78863-1013	HUMAN OTC DRUG	Brush and Go	All Skin types Matte Finish Tone 2	Titanium Dioxide, Octinoxate, Octocrylene, Octisalate, Avobenzone, and Oxybenzone	POWDER	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Noon Aesthetics M.R. Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	.075; .236; .135; .225; .075; 1.25	g/5g; g/5g; g/5g; g/5g; g/5g; g/5g			N	20241231
78863-1016_c6b01881-4177-452a-95f7-d27cb2eb8512	78863-1016	HUMAN OTC DRUG	Brush and Go	Oily Problematic Skin Matte Finish Tone 1	Titanium Dioxide, Octinoxate, Octocrylene, Octisalate, Avobenzone, and Oxybenzone	POWDER	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Noon Aesthetics M.R. Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	.075; .236; .135; .225; .075; 1.25	g/5g; g/5g; g/5g; g/5g; g/5g; g/5g			N	20241231
78863-1017_c6b01881-4177-452a-95f7-d27cb2eb8512	78863-1017	HUMAN OTC DRUG	Brush and Go	Oily Problematic Skin Matte Finish Tone 2	Titanium Dioxide, Octinoxate, Octocrylene, Octisalate, Avobenzone, and Oxybenzone	POWDER	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Noon Aesthetics M.R. Ltd	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE	.075; .236; .135; .225; .075; 1.25	g/5g; g/5g; g/5g; g/5g; g/5g; g/5g			N	20241231
78863-1040_d8a988e2-267a-4f33-8d35-b3ddb0ab43fb	78863-1040	HUMAN OTC DRUG	Double Fight		Salicylic Acid and Benzoyl Peroxide	KIT		20200105		OTC MONOGRAPH FINAL	part333D	Noon Aesthetics M.R. Ltd						N	20241231
78863-1220_5ae1e2d1-2b4e-45ba-b9d1-a4687aea8c15	78863-1220	HUMAN OTC DRUG	AcNe solution		Salicylic Acid	CREAM	TOPICAL	20200501		OTC MONOGRAPH FINAL	part333D	Noon Aesthetics M.R. Ltd	SALICYLIC ACID	.15	g/30g			N	20241231
78863-1270_1fca675a-85d1-4e2a-b47e-ab8aa5f82444	78863-1270	HUMAN OTC DRUG	DeFlame		ALLANTOIN	CREAM	TOPICAL	20231001		OTC MONOGRAPH FINAL	part352	Noon Aesthetics M.R. Ltd	ALLANTOIN	5	mg/mL			N	20241231
78863-2600_43bf98c2-9ea3-4494-8a1f-41e018df42ae	78863-2600	HUMAN OTC DRUG	NOON Post Procedure Program		ALLANTOIN, TITANIUM DIOXIDE, OCTOCRYLENE, and AVOBENZONE	KIT		20231001		OTC MONOGRAPH DRUG	M016	Noon Aesthetics M.R. Ltd						N	20241231
78863-2700_735fe2f6-eaf3-4705-8515-b26bd90d0ffd	78863-2700	HUMAN OTC DRUG	NOON Cartessa Accelerate Program		ALLANTOIN, TITANIUM DIOXIDE, OCTOCRYLENE, and AVOBENZONE	KIT		20231001		OTC MONOGRAPH DRUG	M016	Noon Aesthetics M.R. Ltd						N	20241231
78868-002_f20894aa-5e8f-1222-e053-2995a90a2cc5	78868-002	HUMAN OTC DRUG	ROADPRO Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Xiamen Wally Bath Manufacture Co., Ltd	ALCOHOL	70	mL/100mL			N	20241231
78868-003_f20894aa-5e8d-1222-e053-2995a90a2cc5	78868-003	HUMAN OTC DRUG	ROADPRO Hand Sanitizer-Spray		ALCOHOL	SPRAY	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Xiamen Wally Bath Manufacture Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
78868-004_f2087b6f-1c54-5d7d-e053-2a95a90a3f22	78868-004	HUMAN OTC DRUG	ROADPRO Hand Sanitizer Foaming		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Xiamen Wally Bath Manufacture Co., Ltd	ALCOHOL	70	mL/100mL			N	20241231
78868-006_f2085bce-fc3d-2a1c-e053-2995a90a985c	78868-006	HUMAN OTC DRUG	helpmate Hand Sanitizer		ALCOHOL Denat.	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Xiamen Wally Bath Manufacture Co., Ltd	ALCOHOL	70	mL/100mL			N	20241231
78868-007_f2085bce-fc3e-2a1c-e053-2995a90a985c	78868-007	HUMAN OTC DRUG	Simply BLISS ANTI-BACTERIAL HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Xiamen Wally Bath Manufacture Co., Ltd	ALCOHOL	70	mL/100mL			N	20241231
78868-011_fc94efd9-3b44-60ae-e053-6294a90ae65b	78868-011	HUMAN OTC DRUG	eco harbor Hand Sanitizing Mist		Ethyl Alcohol	SPRAY	TOPICAL	20230526		OTC MONOGRAPH NOT FINAL	part333A	Xiamen Wally Bath Manufacture Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
78882-101_f1a81af3-6a3f-2e9e-e053-2995a90a80b8	78882-101	HUMAN OTC DRUG	sanitizing alcohol free wipe		Benzalkonium Chloride	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Hangzhou Boyiqing Hygiene Products Co., Ltd.	BENZALKONIUM CHLORIDE	3.79	mg/1			N	20241231
78890-001_06e944e8-71fd-9fe9-e063-6294a90a8c37	78890-001	HUMAN OTC DRUG	Non-Alcohol Foaming Hand Wash		BENZALKONIUM CHLORIDE 0.10%	LIQUID	TOPICAL	20200622		OTC MONOGRAPH DRUG	M003	Arkansas Correctional Industries	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
78915-000_f5646880-2f9f-0245-e053-2995a90a4572	78915-000	HUMAN OTC DRUG	Hand Sanitizer With Glycerin and Aloe Vera		ALCOHOL	GEL	TOPICAL	20200826		OTC MONOGRAPH NOT FINAL	part333E	TV Direct LLC	ALCOHOL	.75	mL/mL			N	20241231
78915-001_f5646880-2fa0-0245-e053-2995a90a4572	78915-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200818		OTC MONOGRAPH NOT FINAL	part333E	TV Direct LLC	ALCOHOL	.75	mL/mL			N	20241231
78927-003_0aa48c94-f80c-ec03-e063-6294a90afecb	78927-003	HUMAN OTC DRUG	Multi-purpose Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200613		OTC MONOGRAPH DRUG	505G(a)(3)	NUVOMED,INC.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78927-005_0aa45255-267e-fa2f-e063-6394a90aee7b	78927-005	HUMAN OTC DRUG	Multi-purpose Alcohol Wipes		Isopropyl alcohol	CLOTH	TOPICAL	20200902		OTC MONOGRAPH DRUG	505G(a)(3)	NUVOMED,INC.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
78969-001_a81c8951-f257-3924-e053-2a95a90ad935	78969-001	HUMAN OTC DRUG	Alcohol Antiseptic 80%	Hand Sanitizer	Alcohol Antiseptic 80%	LIQUID	TOPICAL	20200701	20240701	OTC MONOGRAPH NOT FINAL	part333A	Strickerchemie GmbH	ALCOHOL	80	mL/100mL			N	
78970-161_09e235ab-ce28-ad20-e063-6294a90a90a3	78970-161	HUMAN OTC DRUG	Dr PAINES Pain Relief		MENTHOL	CREAM	TOPICAL	20200620		OTC MONOGRAPH DRUG	M017	DOCTOR PAINE'S MEDICAL, LLC	MENTHOL	50	mg/g			N	20241231
78982-001_0812e131-e790-1c50-e063-6394a90adabe	78982-001	HUMAN OTC DRUG	Klean Freak		Benzalkonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH DRUG	M003	KLEAN FREAK, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78982-002_0812f78e-c6af-658d-e063-6394a90a11c7	78982-002	HUMAN OTC DRUG	Klean Freak		Benzalkonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH DRUG	M003	KLEAN FREAK, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78982-003_0812fb62-d075-8305-e063-6394a90a7d4d	78982-003	HUMAN OTC DRUG	Klean Freak		Benzalkonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH DRUG	M003	KLEAN FREAK, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78982-004_0812f908-117f-66f3-e063-6394a90a0798	78982-004	HUMAN OTC DRUG	Klean Freak		Benzalkonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH DRUG	M003	KLEAN FREAK, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78982-005_0813031f-45b4-66bf-e063-6394a90ac948	78982-005	HUMAN OTC DRUG	Klean Freak		Benzalkonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH DRUG	M003	KLEAN FREAK, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78982-006_0813070e-df4c-4b53-e063-6294a90a6f22	78982-006	HUMAN OTC DRUG	Klean Freak		Benzalkonium Chloride	CLOTH	TOPICAL	20200520		OTC MONOGRAPH DRUG	M003	KLEAN FREAK, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
78983-101_f4d51157-cb63-84d6-e053-2a95a90aadb0	78983-101	HUMAN OTC DRUG	Glucosamine Cream EXTRA STRENGTH		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20220908		OTC MONOGRAPH NOT FINAL	part348	IDEAZ, LLC	HISTAMINE DIHYDROCHLORIDE	.05	g/100g			N	20241231
78994-002_e443a011-58c4-2a04-e053-2995a90aec82	78994-002	HUMAN OTC DRUG	PurLif Tek		Alcohol	GEL	TOPICAL	20210302		OTC MONOGRAPH NOT FINAL	part333E	RFH BioTek Inc.	ALCOHOL	70	mL/100mL			N	20241231
78994-070_e443b0d5-be7f-59c9-e053-2a95a90a28fe	78994-070	HUMAN OTC DRUG	Hand Sanitizer gel		Alcohol	GEL	TOPICAL	20200617		OTC MONOGRAPH NOT FINAL	part333E	RFH BioTek Inc.	ALCOHOL	70	mL/100mL			N	20241231
78999-007_f45cbf6d-5fbd-52a3-e053-2995a90a66a1	78999-007	HUMAN OTC DRUG	MIST		SALICYLIC ACID	LIQUID	TOPICAL	20210309		OTC MONOGRAPH FINAL	part333D	CLEAN SKIN CLUB	SALICYLIC ACID	.5	mg/100mg			N	20241231
79016-101_060c3255-c9b5-adb9-e063-6394a90a689b	79016-101	HUMAN OTC DRUG	OPS 70 PERCENT ALCOHOL FOAMING SKIN SANITIZER		ETHYL ALCOHOL	SOLUTION	TOPICAL	20211108		OTC MONOGRAPH NOT FINAL	part333A	Archer Manufacturing, Inc.	ALCOHOL	70	mL/100mL			N	20241231
79016-102_06be0175-7bd1-1796-e063-6394a90a987e	79016-102	HUMAN OTC DRUG	BLACK OPS 70 PERCENT ALCOHOL FOAMING SKIN SANITIZER		ETHYL ALCOHOL	SOLUTION	TOPICAL	20211215		OTC MONOGRAPH NOT FINAL	part333A	Archer Manufacturing, Inc.	ALCOHOL	70	mL/100mL			N	20241231
79016-103_060c3b86-51b3-e26d-e063-6294a90a7f94	79016-103	HUMAN OTC DRUG	BLACK OPS AB ANTIBACTERIAL FOAMING		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20211215		OTC MONOGRAPH NOT FINAL	part333A	Archer Manufacturing, Inc.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
79016-104_05f503e8-7f18-eaf0-e063-6294a90ac80a	79016-104	HUMAN OTC DRUG	BLACK OPS INSTANT HAND SANITIZER		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20211215		OTC MONOGRAPH NOT FINAL	part333A	Archer Manufacturing, Inc.	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
79016-105_060c3255-c9b3-adb9-e063-6394a90a689b	79016-105	HUMAN OTC DRUG	OPS INSTANT HAND SANITIZER		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20211215		OTC MONOGRAPH NOT FINAL	part333A	Archer Manufacturing, Inc.	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
79016-140_060c3482-7292-669d-e063-6294a90a4a0e	79016-140	HUMAN OTC DRUG	OPS AB ANTIBACTERIAL FOAMING		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333E	Archer Manufacturing, Inc.	BENZALKONIUM CHLORIDE	.0013	mg/mL			N	20241231
79016-141_060c3255-c9b4-adb9-e063-6394a90a689b	79016-141	HUMAN OTC DRUG	OPS RANCH HAND ANTIBACTERIAL FOAMING		CHLOROXYLENOL	SOAP	TOPICAL	20220215		OTC MONOGRAPH NOT FINAL	part333A	Archer Manufacturing, Inc.	CHLOROXYLENOL	.45	g/100mL			N	20241231
79021-001_08bdfe4d-89f2-695d-e063-6394a90a08d8	79021-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200630		OTC MONOGRAPH DRUG	505G(a)(3)	Positive Promotions Inc.	ALCOHOL	.62	mL/mL			N	20241231
79021-003_d1f12bbd-2716-512e-e053-2a95a90aa54e	79021-003	HUMAN OTC DRUG	Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333E	Positive Promotions Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79021-007_08bf1e7b-8230-ed12-e063-6294a90a676f	79021-007	HUMAN OTC DRUG	Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201001		OTC MONOGRAPH DRUG	505G(a)(3)	Positive Promotions Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79021-009_08be23e2-6de3-166d-e063-6394a90aedab	79021-009	HUMAN OTC DRUG	Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200601		OTC MONOGRAPH DRUG	505G(a)(3)	Positive Promotions Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
79021-010_08bf2247-51f5-5a01-e063-6394a90a1138	79021-010	HUMAN OTC DRUG	SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	SPRAY	TOPICAL	20230101		OTC MONOGRAPH DRUG	M020	Positive Promotions Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79035-001_0bf14d3c-ebd5-878e-e063-6394a90a5ee2	79035-001	HUMAN OTC DRUG	TSONG Anti Bacterial Foaming Hand Wash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200605		OTC MONOGRAPH DRUG	505G(a)(3)	Tianjin Power-Long Packaging Technology Development Co.,Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79035-002_0863632c-c1ab-aab8-e063-6394a90adc89	79035-002	HUMAN OTC DRUG	TSONG Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200605		OTC MONOGRAPH DRUG	505G(a)(3)	Tianjin Power-Long Packaging Technology Development Co.,Ltd.	ALCOHOL	.7	mL/mL			N	20241231
79035-003_086318bd-508b-477e-e063-6294a90ab2dd	79035-003	HUMAN OTC DRUG	TSONG Anti Bacterial Hand Wash		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200605		OTC MONOGRAPH DRUG	505G(a)(3)	Tianjin Power-Long Packaging Technology Development Co.,Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79043-180_039eaa3c-6bca-a89c-e063-6294a90af455	79043-180	HUMAN PRESCRIPTION DRUG	Clenia Plus	Sodium Sulfacetamide - Sulfur	sulfacetamide sodium and sulfur	SUSPENSION	TOPICAL	20210310		UNAPPROVED DRUG OTHER		Scite Pharma, LLC	SULFACETAMIDE SODIUM; SULFUR	90; 42.5	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
79043-338_fd8a0d15-56ce-2683-e053-6294a90ad942	79043-338	HUMAN PRESCRIPTION DRUG	UrNeva		methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, hyoscyamine sulfate	CAPSULE	ORAL	20230522		UNAPPROVED DRUG OTHER		Scite Pharma, LLC	HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.12; 120; 10.8; 36.2; 40.8	mg/1; mg/1; mg/1; mg/1; mg/1	Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]		N	20241231
79043-410_fd8a0661-a0a8-892b-e053-6394a90af82d	79043-410	HUMAN PRESCRIPTION DRUG	hydrocort		Hydrocortisone Lotion Kit	KIT	TOPICAL	20230610		UNAPPROVED DRUG OTHER		Scite Pharma						N	20241231
79043-980_0074d398-aef4-8ca7-e063-6394a90aeeb3	79043-980	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide and Sulfur		SULFACETAMIDE SODIUM and SULFUR	SUSPENSION	TOPICAL	20220422	20240401	UNAPPROVED DRUG OTHER		Scite Pharma, LLC	SULFACETAMIDE SODIUM; SULFUR	90; 42.5	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	
79067-004_003e98b4-c97d-4464-e063-6294a90adc35	79067-004	HUMAN OTC DRUG	Sanikit		Hand Sanitizer Gel	GEL	TOPICAL	20230920		OTC MONOGRAPH NOT FINAL	part333A	Renopac, S.A. de C.V.	ALCOHOL	70	mL/100mL			N	20241231
79096-032_cfe3debe-13a6-4500-b6f0-b00df18bd629	79096-032	HUMAN OTC DRUG	BIOTOP PROFESSIONAL 02 Eco Dandruff		Salicylic acid	SHAMPOO	TOPICAL	20230105		OTC MONOGRAPH FINAL	part358H	G.V. COSMETICS LTD	SALICYLIC ACID	2	g/100mL			N	20241231
79096-033_4e1acbdb-18f6-4e25-b213-4c2290da9383	79096-033	HUMAN OTC DRUG	BIOTOP PROFESSIONAL 02 Eco Dandruff		Salicylic acid	SOLUTION	TOPICAL	20230116		OTC MONOGRAPH FINAL	part358H	G.V. COSMETICS LTD	SALICYLIC ACID	1.8	g/100mL			N	20241231
79116-000_f2b6fbd5-10f5-8879-e053-2a95a90a9ba9	79116-000	HUMAN OTC DRUG	Naked X Restore Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333E	Essations Inc.	ALCOHOL	.7	mL/mL			N	20241231
79163-347_f654546d-e21a-581d-e053-2995a90a5baa	79163-347	HUMAN OTC DRUG	ELEVEN BY VENUS WILLIAMS GAME SET MATCH BODY		Zinc Oxide	LOTION	TOPICAL	20220421		OTC MONOGRAPH NOT FINAL	part352	Eco-Chic LLC	ZINC OXIDE	105	mg/mL			N	20241231
79163-386_f6545c99-c744-6920-e053-2995a90afb29	79163-386	HUMAN OTC DRUG	ELEVEN BY VENUS WILLIAMS ACE THE DAY Face		Zinc Oxide	LOTION	TOPICAL	20220505		OTC MONOGRAPH NOT FINAL	part352	Eco-Chic LLC	ZINC OXIDE	110	mg/mL			N	20241231
79163-399_f6541d38-3524-9c03-e053-2995a90a8c34	79163-399	HUMAN OTC DRUG	ELEVEN UNRIVALED SERUM		Zinc Oxide	LOTION	TOPICAL	20221101		OTC MONOGRAPH NOT FINAL	part352	Eco Chic, LLC	ZINC OXIDE	110	mg/mL			N	20241231
79165-777_f1fac06e-3a29-4f21-aec5-6afbdc9e8a8d	79165-777	HUMAN OTC DRUG	ALTA ANTIBACTERIAL HAND WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200701		OTC MONOGRAPH NOT FINAL	part333A	Alta Sales Inc	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
79179-0738_07d4a3b1-35b4-f76b-e063-6394a90aa455	79179-0738	HUMAN OTC DRUG	Hand Sanitizer		RAWGANIC Organic Alcohol Hand Wipes	SWAB	TOPICAL	20201207		UNAPPROVED DRUG OTHER		Pearmine Health Ltd	ALCOHOL	77.5	mL/125mL			N	20241231
79203-001_d77c7c9e-edce-a011-e053-2995a90a3ce6	79203-001	HUMAN OTC DRUG	Dynamic Hand Sanitizing Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200725		OTC MONOGRAPH NOT FINAL	part333A	Milky Way International Trading Corp	BENZALKONIUM CHLORIDE	.3	g/100g			N	20241231
79214-157_0975bb48-248e-e8bd-e063-6394a90ae8d9	79214-157	HUMAN OTC DRUG	GOLD MOUNTAIN BEAUTY Collagen Broad Spectrum SPF 30		OCTINOXATE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20200610		OTC MONOGRAPH DRUG	M020	TT Fitness, Inc	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 30; 30	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79216-159_097603dc-228f-2bef-e063-6294a90a1bdd	79216-159	HUMAN OTC DRUG	HAVASU HEMP Soothing Pain Relief Rub		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20200501		OTC MONOGRAPH DRUG	M017	Havasu Nutrition LLC	HISTAMINE DIHYDROCHLORIDE	.3	mg/mL			N	20241231
79218-000_0b6e16ef-e003-e9d4-e063-6394a90abe37	79218-000	HUMAN OTC DRUG	Anistem		TETRACYCLINE HYDROCHLORIDE	SPRAY	TOPICAL	20200701		OTC MONOGRAPH DRUG	M004	MATRIX MIXOLOGY, INC	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
79218-001_0b6e190a-d192-f957-e063-6294a90a8cfe	79218-001	HUMAN OTC DRUG	Prolayed		LIDOCAINE	SPRAY	TOPICAL	20200701		OTC MONOGRAPH DRUG	M017	MATRIX MIXOLOGY, INC	LIDOCAINE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79218-002_0b81a8db-d1d4-bd3e-e063-6394a90a7780	79218-002	HUMAN OTC DRUG	MeaStem First Aid and Antibiotic		TETRACYCLINE HYDROCHLORIDE	SPRAY	TOPICAL	20201231		OTC MONOGRAPH DRUG	M004	MATRIX MIXOLOGY, INC	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
79218-003_0b81a5a3-ca89-cbef-e063-6394a90a3376	79218-003	HUMAN OTC DRUG	DeeDol Topical Analgesic		METHYL SALICYLATE, MENTHOL, CAMPHOR (SYNTHETIC)	SPRAY	TOPICAL	20201231		OTC MONOGRAPH DRUG	M017	MATRIX MIXOLOGY, INC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	40; 100; 300	mg/mL; mg/mL; mg/mL			N	20241231
79228-0000_0d0d2fbf-6dae-7240-e063-6294a90acb2f	79228-0000	HUMAN OTC DRUG	Natural Hydrating Shield SPF 30		ZINC OXIDE	CREAM	TOPICAL	20200112		OTC MONOGRAPH DRUG	M020	Group Fourteen Operations Pty Limited	ZINC OXIDE	195	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79257-098_e351a0d8-2130-64e3-e053-2a95a90aa29a	79257-098	HUMAN OTC DRUG	NL Germs-Away		ALCOHOL	GEL	TOPICAL	20200330	20241231	OTC MONOGRAPH NOT FINAL	part333A	Nu-Life Labs	ALCOHOL	80	mL/100mL			N	
79258-141_d9681642-2377-93f3-e053-2a95a90aa5c0	79258-141	HUMAN OTC DRUG	Individual AntibacterialLotion Skin Cleanser		Chloroxylenol	SOAP	TOPICAL	20220302		OTC MONOGRAPH NOT FINAL	part333A	Brady Industries Inc.	CHLOROXYLENOL	3.75	mg/mL			N	20241231
79258-717_d9686c5c-e47a-425d-e053-2995a90a50a2	79258-717	HUMAN OTC DRUG	Individual Free and Clear Foaming Antibacterial Skin Cleanser		Chloroxylenol	SOAP	TOPICAL	20220302		OTC MONOGRAPH NOT FINAL	part333E	Brady Industries Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79258-751_da33421b-dc7d-6ce8-e053-2995a90ab500	79258-751	HUMAN OTC DRUG	Individual Free and Clear Foaming Antibacterial Skin Cleanser		Benzalkonium Chloride	SOAP	TOPICAL	20220302		OTC MONOGRAPH NOT FINAL	part333E	Brady Industries Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79258-795_da33b6af-9355-14ab-e053-2a95a90a53de	79258-795	HUMAN OTC DRUG	Individual Free and Clear Foaming Antibacterial Skin Cleanser		Benzalkonium Chloride	SOAP	TOPICAL	20220302		OTC MONOGRAPH NOT FINAL	part333E	Brady Industries Inc.	DEHYDRATED ALCOHOL	.7	mg/mL			N	20241231
79265-5608_088bacc1-0191-4745-e063-6394a90a67c0	79265-5608	HUMAN OTC DRUG	Babo Botanicals Sensitive Baby Mineral Sunscreen SPF50		Zinc Oxide	STICK	TOPICAL	20231025		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	ZINC OXIDE	197	mg/g			N	20241231
79265-7708_08f04326-7fb6-6106-e063-6294a90a7848	79265-7708	HUMAN OTC DRUG	Babo Botanicals Sheer Zinc Mineral Sunscreen SPF30		Zinc Oxide	LOTION	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	ZINC OXIDE	160	mg/mL			N	20241231
79265-7778_e2112975-7199-9141-e053-2a95a90ad62c	79265-7778	HUMAN OTC DRUG	Babo Botanicals Super Shield Mineral Sunscreen SPF50		Zinc Oxide	LOTION	TOPICAL	20231027		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc	ZINC OXIDE	200	mg/mL			N	20241231
79265-7908_08f10c8d-2da2-bc7f-e063-6294a90aed61	79265-7908	HUMAN OTC DRUG	Babo Botanicals Sheer Zinc Mineral Sunscreen SPF30		Zinc Oxide	SPRAY	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	ZINC OXIDE	120	mg/mL			N	20241231
79265-7978_08f0164e-20dc-520a-e063-6294a90acf81	79265-7978	HUMAN OTC DRUG	Babo Botanicals Super Shield Mineral Sunscreen SPF50		Zinc Oxide, Titanium Dioxide	AEROSOL, SPRAY	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	43; 147	mg/mL; mg/mL			N	20241231
79265-8061_0867303a-d32d-921f-e063-6394a90a3fbe	79265-8061	HUMAN OTC DRUG	Babo Botanicals Daily Sheer Fluid Mineral Sunscreen SPF 50		Zinc Oxide	LOTION	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	ZINC OXIDE	206	mg/mL			N	20241231
79265-8063_086d7297-abf1-f29d-e063-6294a90afb73	79265-8063	HUMAN OTC DRUG	Babo Botanicals Daily Sheer Fluid Tinted Mineral Sunscreen SPF 50		Zinc Oxide	LOTION	TOPICAL	20220301		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	ZINC OXIDE	206	mg/mL			N	20241231
79265-8065_ed79dde0-24fa-030c-e053-2a95a90a2e97	79265-8065	HUMAN OTC DRUG	Babo Baby Face Mineral Sunscreen		Mineral Sunscreen	STICK	TOPICAL	20201101		OTC MONOGRAPH FINAL	M020	Babo Botanicals, Inc.	ZINC OXIDE	20.267	g/100g			N	20241231
79265-8068_ceae1d5f-8a14-645c-e053-2a95a90a88f5	79265-8068	HUMAN OTC DRUG	SPF 50 Tinted Face Mineral Fragrance Free Sunscreen		Mineral Sunscreen	STICK	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc.	ZINC OXIDE	20.2115	g/100g			N	20241231
79265-8072_d6a4ec9c-459e-6860-e053-2a95a90aeac3	79265-8072	HUMAN OTC DRUG	Babo Botanicals SPF 30 Daily Sheer Tinted Sunscreen - Natural Glow		Mineral Sunscreen	LOTION	TOPICAL	20200724		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	3000; 3000	mg/100mL; mg/100mL			N	20241231
79265-8075_d6a4fd8b-4f57-5a6d-e053-2a95a90a4200	79265-8075	HUMAN OTC DRUG	Babo SPF 30 Clear Zinc Fragrance Free Sport		Mineral Sunscreen	STICK	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc.	ZINC OXIDE	15.326	g/100g			N	20241231
79265-8077_d6e49ade-65e7-49ae-e053-2995a90af74b	79265-8077	HUMAN OTC DRUG	Babo SPF 30 Clear Zinc Fragrance Free		Mineral Sunscreen	LOTION	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc.	ZINC OXIDE	16	g/100mL			N	20241231
79265-8078_f8ae2909-c730-aa41-e053-6394a90a8967	79265-8078	HUMAN OTC DRUG	Babo Botanicals Daily Sheer Mineral Sunscreen SPF 40		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20230301		OTC MONOGRAPH FINAL	M020	Babo Botanicals, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	19; 157	mg/mL; mg/mL			N	20241231
79265-8097_edfe52ae-c7e7-2ed6-e053-2995a90aa58b	79265-8097	HUMAN OTC DRUG	Babo SPF 30 Sheer Zinc Sunscreen		Mineral Sunscreen	SPRAY	TOPICAL	20201101		OTC MONOGRAPH FINAL	M020	Babo Botanicals, Inc.	ZINC OXIDE	12.222	g/100mL			N	20241231
79265-8098_d6e49931-8520-fa3b-e053-2a95a90aa23e	79265-8098	HUMAN OTC DRUG	SPF 50 Super Shield Sport Sunscreen		Mineral Sunscreen	STICK	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc.	ZINC OXIDE	17.363	g/100g			N	20241231
79265-8566_08671d39-3be0-d666-e063-6294a90a6207	79265-8566	HUMAN OTC DRUG	Babo Fragrance Free Diaper Cream		Zinc Oxide	CREAM	TOPICAL	20200826		OTC MONOGRAPH DRUG	M016	Babo Botanicals, Inc.	ZINC OXIDE	25	g/100g			N	20241231
79265-8576_08651e5c-9236-0d03-e063-6294a90a21fc	79265-8576	HUMAN OTC DRUG	Babo Botanicals Sensitive Baby Fragrance Free Diaper Rash		Zinc Oxide	SPRAY	TOPICAL	20220201		OTC MONOGRAPH DRUG	M016	Babo Botanicals, Inc.	ZINC OXIDE	206	mg/mL			N	20241231
79265-8578_ceb608aa-24c2-5138-e053-2995a90a8d42	79265-8578	HUMAN OTC DRUG	Baby Skin Mineral Sunscreen		Mineral Sunscreen	LOTION	TOPICAL	20200826		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc.	ZINC OXIDE	20	g/100mL			N	20241231
79265-8579_d6e498f8-c40f-9c7f-e053-2a95a90a9c67	79265-8579	HUMAN OTC DRUG	Babo Baby Skin Mineral Sunscreen FF		Mineral Sunscreen	SPRAY	TOPICAL	20201101		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc.	ZINC OXIDE	14.5	g/100mL			N	20241231
79265-8655_0865929f-e8c6-3f68-e063-6294a90ac71c	79265-8655	HUMAN OTC DRUG	Babo Botanicals Sensitive Baby Healing		Colloidal Oatmeal	OINTMENT	TOPICAL	20231023		OTC MONOGRAPH DRUG	M016	Babo Botanicals, Inc.	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
79265-8708_ee004474-bec9-52c7-e053-2995a90ae89a	79265-8708	HUMAN OTC DRUG	Babo Botanicals Daily Sheer Mineral Sunscreen SPF 40		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20230301		OTC MONOGRAPH FINAL	M020	Babo Botanicals, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	59; 33	mg/mL; mg/mL			N	20241231
79265-8758_08a16eed-ba04-b1fa-e063-6294a90a6615	79265-8758	HUMAN OTC DRUG	Babo Botanicals Sensitive Baby Mineral Sunscreen SPF50		Zinc Oxide	LOTION	TOPICAL	20231026		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	ZINC OXIDE	200	mg/mL			N	20241231
79265-8775_f8b1f14d-29bc-0792-e053-6394a90a87ba	79265-8775	HUMAN OTC DRUG	Babo Botanicals Swim and Sport Mineral Sunscreen SPF 30		Zinc Oxide	SPRAY	TOPICAL	20230402		OTC MONOGRAPH FINAL	M020	Babo Botanicals, Inc.	ZINC OXIDE	145	mg/mL			N	20241231
79265-8776_f8b272f6-8725-de1d-e053-6294a90a7b1e	79265-8776	HUMAN OTC DRUG	Babo Botanicals Swim and Sport Mineral Sunscreen Balm SPF 50		Zinc Oxide	SALVE	TOPICAL	20230402		OTC MONOGRAPH FINAL	M020	Babo Botanicals, Inc.	ZINC OXIDE	245	mg/g			N	20241231
79265-8777_ceae1d5f-8a0e-645c-e053-2a95a90a88f5	79265-8777	HUMAN OTC DRUG	Babo SPF 50 Sheer Mineral Sensitive Gentle		Mineral Sunscreen	LOTION	TOPICAL	20201201		OTC MONOGRAPH FINAL	part352	Babo Botanicals, Inc	ZINC OXIDE	20	g/100mL			N	20241231
79265-8908_e3ca6f03-1c7d-e116-e053-2995a90ad317	79265-8908	HUMAN OTC DRUG	Babo Botanicals Super Shield Sport Sunscreen SPF 50		ZINC OXIDE	STICK	TOPICAL	20220901		OTC MONOGRAPH FINAL	M020	Babo Botanicals, Inc.	ZINC OXIDE	197	mg/g			N	20241231
79265-9758_08a348a0-00a1-4f33-e063-6394a90ad6ed	79265-9758	HUMAN OTC DRUG	Babo Botanicals Sensitive Baby Mineral Sunscreen SPF30		Zinc Oxide	SPRAY	TOPICAL	20231026		OTC MONOGRAPH DRUG	M020	Babo Botanicals, Inc.	ZINC OXIDE	145	mg/mL			N	20241231
79266-001_0e78cb95-f918-de0a-e063-6294a90a523f	79266-001	HUMAN OTC DRUG	HAND SANITIZER		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20200701		OTC MONOGRAPH DRUG	505G(a)(3)	University of Pittsburgh	ISOPROPYL ALCOHOL	70	mL/100mL			N	20251231
79287-0000_b1f5ad10-071e-402d-a6b4-8c562bc19844	79287-0000	HUMAN OTC DRUG	Larkly SPF30 Mineral Powder Face Sunscreen		Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20200710		OTC MONOGRAPH FINAL	part352	LARKLY, LLC	TITANIUM DIOXIDE; ZINC OXIDE	.212; .15	kg/kg; kg/kg	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79288-001_f60d3bbd-d94f-ab8c-e053-2995a90a01ef	79288-001	HUMAN OTC DRUG	Disinfecting Wipes		ALCOHOL	CLOTH	TOPICAL	20200624		OTC MONOGRAPH NOT FINAL	part333A	Xiamen Yiukin Paper Products Co.,ltd	ALCOHOL	75	mL/100g			N	20241231
79324-000_08c19faa-7025-6875-e063-6394a90ae041	79324-000	HUMAN OTC DRUG	Hand Sanitizer 70 Alcohol		ALCOHOL	GEL	TOPICAL	20200718		OTC MONOGRAPH DRUG	505G(a)(3)	Servi Quim de Monterrey, S.A. de C.V.	ALCOHOL	.7	mL/mL			N	20241231
79346-101_06684ecc-fa98-4f75-a590-f9a31161f49b	79346-101	HUMAN OTC DRUG	Dr. Hess Hand Sanitizer		Alcohol	GEL	TOPICAL	20200701	20241214	OTC MONOGRAPH DRUG	M003	Dr. Hess Wellness Corp.	ALCOHOL	70	mL/100mL			N	
79356-201_0d9cfef6-886e-72e2-e063-6394a90adc30	79356-201	HUMAN OTC DRUG	Daily SPF Facial SunscreenLotion Broad Spectrum SPF 32		Zinc Oxide	CREAM	TOPICAL	20201103		OTC MONOGRAPH DRUG	M020	Onekind.25	ZINC OXIDE	210	mg/g			N	20241231
79356-202_0d9d0a52-84f0-1808-e063-6294a90a3b5e	79356-202	HUMAN OTC DRUG	silk SPF facial sunscreen fluid hybrid broad spectrum SPF 30 UVA/UVB		Zinc Oxide and Homosalate	CREAM	TOPICAL	20220201		OTC MONOGRAPH DRUG	M020	OneKind.25	HOMOSALATE; ZINC OXIDE	10; 10.5	g/100g; g/100g			N	20241231
79356-203_0d9d19aa-c756-9ad4-e063-6394a90a79e9	79356-203	HUMAN OTC DRUG	Tinted Lip Shield		Zinc oxide and Homosalate	CREAM	TOPICAL	20220325		OTC MONOGRAPH DRUG	M020	OneKind.25	HOMOSALATE; ZINC OXIDE	8; 5.6	g/100g; g/100g			N	20241231
79356-210_0d9ce63d-5553-d02f-e063-6294a90a716c	79356-210	HUMAN OTC DRUG	Cocokind postbiotic acne serum		Salicylic Acid 1.5%	LIQUID	TOPICAL	20220110		OTC MONOGRAPH DRUG	M006	Onekind.25	SALICYLIC ACID	1.5	g/100mL			N	20241231
79364-0932_11b330c8-e9fa-4ae4-a1cd-a63463855e5b	79364-0932	HUMAN OTC DRUG	BiteMD External Analgesic First Aid Antiseptic		Benzocaine, Camphor (Synthetic), and Phenol	LIQUID	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part348	United Industries Corporation	BENZOCAINE; CAMPHOR (SYNTHETIC); PHENOL	.0524; .03144; .01572	mg/mL; mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
79378-110_926e8d5f-ab82-4ea4-a14a-2f1ad528b908	79378-110	HUMAN PRESCRIPTION DRUG	Livmarli		maralixibat chloride	SOLUTION	ORAL	20210929		NDA	NDA214662	Mirum Pharmaceuticals Inc.	MARALIXIBAT CHLORIDE	9.5	mg/mL	Ileal Bile Acid Transporter Inhibitor [EPC], Ileal Bile Acid Transporter Inhibitors [MoA], Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]		N	20241231
79395-003_a347832b-d162-45ea-bace-7b566d93a7de	79395-003	HUMAN OTC DRUG	CHILDRENS IBUPROFEN		Ibuprofen	SUSPENSION	ORAL	20200801		ANDA	ANDA209179	Chalkboard Health	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79395-011_ac121e46-43d6-4cb5-a466-05e2ac4b2fe0	79395-011	HUMAN OTC DRUG	Cold and Flu	Severe Night	Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl	SOLUTION	ORAL	20200826		OTC MONOGRAPH DRUG	M012	Chalkboard Health Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	650; 25; 10	mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79395-282_d31c31d4-4ae4-421e-94d6-e131a3805332	79395-282	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20200922		OTC MONOGRAPH DRUG	M013	Chalkboard Health Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
79395-527_7863afd0-cb4d-41a9-b283-8bb299fa1154	79395-527	HUMAN OTC DRUG	Head Congestion		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20200820		OTC MONOGRAPH DRUG	M012	Chalkboard Health Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79396-000_0898ae01-4ba4-74ee-e063-6394a90a1e58	79396-000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200523		OTC MONOGRAPH DRUG	505G(a)(3)	BOZZANO Group	ALCOHOL	.65	mL/mL			N	20241231
79396-001_089eb04e-03b8-78fe-e063-6394a90a5918	79396-001	HUMAN OTC DRUG	SANITIZER		ALCOHOL	SPRAY	TOPICAL	20201021		OTC MONOGRAPH DRUG	505G(a)(3)	BOZZANO Group	ALCOHOL	.7	mL/mL			N	20241231
79401-000_08990fd0-6f68-25b3-e063-6294a90adcaa	79401-000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	ORR Safety Corporation	ALCOHOL	.75	mL/mL			N	20241231
79401-001_08991727-7cb5-018a-e063-6394a90ab089	79401-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200618		OTC MONOGRAPH DRUG	505G(a)(3)	ORR Safety Corporation	ALCOHOL	.75	mL/mL			N	20241231
79401-002_0898be5e-2a1f-7c7f-e063-6294a90ac297	79401-002	HUMAN OTC DRUG	SFT1 Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20210113		OTC MONOGRAPH DRUG	505G(a)(3)	ORR Safety	ALCOHOL	.75	mL/mL			N	20241231
79403-791_0cf56469-01ab-11ae-e063-6394a90af77b	79403-791	HUMAN PRESCRIPTION DRUG	Pall Sterile Cord Blood Collection Unit		Sterile Cord Blood Collection Unit	SOLUTION	INTRAVENOUS	20110316		NDA	BN800222	Global Life Sciences Solutions USA LLC	CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE	.114; .893; .921; .0078	g/35mL; g/35mL; g/35mL; g/35mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
79421-001_acc2997a-6f4c-1540-e053-2a95a90a98b4	79421-001	HUMAN OTC DRUG	American Hand Sanitizer		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20170518		OTC MONOGRAPH NOT FINAL	part333A	American Hand Sanitizer, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
79421-002_acc3f45d-2a83-53c5-e053-2995a90afb40	79421-002	HUMAN OTC DRUG	American Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20170518		OTC MONOGRAPH NOT FINAL	part333A	American Hand Sanitizer, LLC	BENZALKONIUM CHLORIDE	1.3	g/mL			N	20241231
79432-000_09ce2f4e-4b6b-7516-e063-6394a90aa28e	79432-000	HUMAN OTC DRUG	MediClean Sanitizing		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Industrias Maqun, S.A. de C.V.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79432-001_09ce39b5-3de4-80d6-e063-6294a90afef4	79432-001	HUMAN OTC DRUG	Mediclean Sanitizing Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200820		OTC MONOGRAPH DRUG	505G(a)(3)	Industrias Maqun, S.A. de C.V.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79468-001_09ce7e86-3b9d-8e30-e063-6394a90a2d55	79468-001	HUMAN OTC DRUG	Skin Cottage 70 Percent Ethyl Alcohol Antiseptic Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201015		OTC MONOGRAPH DRUG	505G(a)(3)	KEN-RICH CHEMICAL PRODUCTION SDN. BHD.	ALCOHOL	.7	mL/mL			N	20241231
79481-0000_b01ced91-1f39-4a83-913e-65eba0701f77	79481-0000	HUMAN OTC DRUG	Beauty Hydrating		Homosalate, Zinc Oxide	LOTION	TOPICAL	20200602		OTC MONOGRAPH NOT FINAL	part352	Meijer	OCTINOXATE; ZINC OXIDE	61.2; 30.6	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79481-0001_92ec9617-b43c-4755-a279-6e3b20c4d604	79481-0001	HUMAN OTC DRUG	daily moisturizer		Avbenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20200602		OTC MONOGRAPH FINAL	part352	Meijer Distribution, INC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0002_9e958636-8569-4ffe-93f8-6da6ff96b62c	79481-0002	HUMAN OTC DRUG	Antibacterial Hand Wash		Benzalkonium chloride	SOAP	TOPICAL	20200602		OTC MONOGRAPH NOT FINAL	part333A	Meijer	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79481-0003_aa7f9bc8-0d57-5dde-e053-2a95a90af0e7	79481-0003	HUMAN OTC DRUG	Meijer Lidocaine Pain Relief Patch Assortment Large		LIDOCAINE	PATCH	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-0004_ab83ae57-86d0-9c68-e053-2995a90a89d3	79481-0004	HUMAN OTC DRUG	Meijer Lidocaine Pain Relief Patch Assortment Medium		LIDOCAINE	PATCH	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-0005_ab860012-1fcb-0fab-e053-2a95a90af782	79481-0005	HUMAN OTC DRUG	Meijer Lidocaine Pain Relief Patch Assortment Small		LIDOCAINE	PATCH	TOPICAL	20190101		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-0006_0192aaf4-a14f-9f23-e063-6294a90aa56c	79481-0006	HUMAN OTC DRUG	Meijer Maximum Strength Vagicaine		Benzocaine, Resorcinol	CREAM	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	BENZOCAINE; RESORCINOL	5.6; .84	g/28g; g/28g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
79481-0007_f54df2ac-48b8-1dde-e053-2995a90a61a9	79481-0007	HUMAN OTC DRUG	Meijer Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20230201		OTC MONOGRAPH FINAL	M016	Meijer Distribution, Inc	PETROLATUM	100	g/100g			N	20241231
79481-0008_5702d4c9-289c-41fa-9492-8d8313192b1a	79481-0008	HUMAN OTC DRUG	Sensitive Whitening Tooth-paste		Potassium nitrate, Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20201224		OTC MONOGRAPH NOT FINAL	part356	Meijer, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.43	mg/g; mg/g			N	20241231
79481-0009_1e5d5112-3913-4f59-9d59-5a7370a9b064	79481-0009	HUMAN OTC DRUG	Sensitive Mint Tooth-paste		Potassium nitrate, Sodium fluoride	PASTE, DENTIFRICE	DENTAL	20201224		OTC MONOGRAPH NOT FINAL	part356	Meijer, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	50; 2.43	mg/g; mg/g			N	20241231
79481-0010_21673420-cd77-42ba-818c-33a0a337e5c7	79481-0010	HUMAN OTC DRUG	Meijer First Aid Antiseptic		alcohol	CLOTH	TOPICAL	20220301	20240301	OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution Inc.	ALCOHOL	70	mL/100mL			N	
79481-0011_fe4b7176-fda5-4eed-ad9e-fa0e154e9cca	79481-0011	HUMAN OTC DRUG	Infants Gas relief		Simethicone	SOLUTION/ DROPS	ORAL	20220118		OTC MONOGRAPH FINAL	part332	Meijer, Inc.	DIMETHICONE	20	mg/.3mL	Skin Barrier Activity [PE]		N	20241231
79481-0014_f202615d-9600-f0b2-e053-2a95a90aaea8	79481-0014	HUMAN OTC DRUG	Clotrimazole 1%		Clotrimazole	CREAM	TOPICAL	20210420		OTC MONOGRAPH FINAL	part333C	Meijer	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
79481-0015_f2026976-ae4a-a6ea-e053-2a95a90ae6ac	79481-0015	HUMAN OTC DRUG	Antifungal Cream Tolnaftate 1%		Tolnaftate	CREAM	TOPICAL	20210512		OTC MONOGRAPH FINAL	part333C	Meijer	TOLNAFTATE	1	g/100g			N	20241231
79481-0016_f202600b-ca3a-f1c9-e053-2a95a90ab17e	79481-0016	HUMAN OTC DRUG	Triple antibiotic and pain relief		Bacitracin,Neomycin,Polymyxin, Pramoxine	OINTMENT	TOPICAL	20210625		OTC MONOGRAPH FINAL	part333B	Meijer	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
79481-0017_f2026c57-f03f-0dc5-e053-2a95a90ade8b	79481-0017	HUMAN OTC DRUG	Triple antibiotic and pain itch scar		Bacitracin,Neomycin,Polymyxin, Pramoxine	OINTMENT	TOPICAL	20210715		OTC MONOGRAPH FINAL	part333B	Meijer	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[USP'U]/g; mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
79481-0019_91013d5e-2d97-4064-bf2c-92b051154d6c	79481-0019	HUMAN OTC DRUG	Meijer Pain Relieving Max Strength with Lavender Essential Oil	Analgesic	LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20210430		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-0020_0c669cd4-d4a1-76d9-e063-6394a90a9304	79481-0020	HUMAN OTC DRUG	Meijer Whole Care with Fluoride		Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20201229	20250901	OTC MONOGRAPH DRUG	M021	Meijer	SODIUM MONOFLUOROPHOSPHATE	.76	g/100g			N	
79481-0021_ba608d34-4d4f-f4ec-e053-2995a90ac632	79481-0021	HUMAN OTC DRUG	MEIJER LIDOCAINE PAIN RELIEF BACK AND LARGE AREAS		LIDOCAINE	PATCH	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-0022_b33cb276-ebb0-4b2a-8c48-a23b198e3c9c	79481-0022	HUMAN OTC DRUG	Meijer Maximum Strength Foaming Acne Face Wash	Acne Medication	BENZOYL PEROXIDE	LOTION	TOPICAL	20211101		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	BENZOYL PEROXIDE	100	mg/g			N	20241231
79481-0023_c87779a7-805d-4f83-84b8-377b74e296aa	79481-0023	HUMAN OTC DRUG	Meijer Acne Foaming Cleanser	Acne Treatment	Benzoyl Peroxide	CREAM	TOPICAL	20211101		OTC MONOGRAPH FINAL	part333D	Meijer Distribution, INC	BENZOYL PEROXIDE	40	mg/mL			N	20241231
79481-0025_de6c1d3b-8381-4da3-ac62-3c3aad4293a2	79481-0025	HUMAN OTC DRUG	SUNSCREEN		Avobenzone, Homosalate, Octisalat, Octocrylene	LOTION	TOPICAL	20211130		OTC MONOGRAPH FINAL	part352	Meijer	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 1000	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79481-0026_0c064a69-ed9c-bc0e-e063-6394a90a3650	79481-0026	HUMAN OTC DRUG	DAYTIME COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20220912		OTC MONOGRAPH DRUG	M012	MEIJER, INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79481-0027_0c065361-870d-b9c7-e063-6294a90a4a22	79481-0027	HUMAN OTC DRUG	Nightime Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20220915		OTC MONOGRAPH DRUG	M012	Meijer, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79481-0030_0c068849-08ed-ca22-e063-6394a90ac04d	79481-0030	HUMAN OTC DRUG	Cold and Flu Non Drowsy Daytime and Nighttime		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20220919		OTC MONOGRAPH DRUG	M012	Meijer, Inc.						N	20241231
79481-0031_0e76286e-b433-865a-e063-6294a90ac761	79481-0031	HUMAN OTC DRUG	Meijer		Complete First Aid Kit	KIT	TOPICAL	20230101		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution, Inc.						N	20251231
79481-0032_fa196002-0c27-f8d0-e053-6394a90ae839	79481-0032	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230424		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc.	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79481-0033_fa196002-0c28-f8d0-e053-6394a90ae839	79481-0033	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230424		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79481-0034_fa18f1a9-7a6d-856e-e053-6294a90aeafa	79481-0034	HUMAN OTC DRUG	Magnesium Citrate		Magnesium Citrate	LIQUID	ORAL	20230424		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79481-0035_0c06ad03-860f-23d9-e063-6294a90ae32d	79481-0035	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20230501		OTC MONOGRAPH DRUG	M012	Meijer, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79481-0036_0c06c855-3cb3-5470-e063-6294a90a6639	79481-0036	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20230501		OTC MONOGRAPH DRUG	M012	Meijer, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79481-0037_0c7ce612-2d23-d25b-e063-6394a90a2f67	79481-0037	HUMAN OTC DRUG	Ultra Strength Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20231214		OTC MONOGRAPH DRUG	M002	Meijer Distribution Inc.	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
79481-0038_200bdea4-760a-4276-b247-d3f57f92e4ad	79481-0038	HUMAN OTC DRUG	meijer Sensitive EXTRA WHITENING		Potassium Nitrate, Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230921		OTC MONOGRAPH FINAL	M022	Meijer, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
79481-0039_8dfbe386-c135-4c1f-a490-71458b0ba834	79481-0039	HUMAN OTC DRUG	meijer Sensitive FRESH MINT		Potassium Nitrate, Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230922		OTC MONOGRAPH FINAL	M022	Meijer, Inc.	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .24	g/100g; g/100g			N	20241231
79481-0045_c1d14009-ee9b-4b72-8a1c-495aa3092f73	79481-0045	HUMAN OTC DRUG	pain relief	EXTRA STRENGTH	Acetaminophen	SOLUTION	ORAL	20210414		OTC MONOGRAPH DRUG	M013	Meijer Distribution, Inc.	ACETAMINOPHEN	1000	mg/30mL			N	20241231
79481-0049_092d20d2-159c-35fb-e063-6394a90a972e	79481-0049	HUMAN OTC DRUG	Meijer		isopropyl alcohol	SWAB	TOPICAL	20210801		OTC MONOGRAPH DRUG	M003	Meijer Distribution Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
79481-0051_761e52f3-91fb-49bd-ad68-3599a26a7a53	79481-0051	HUMAN OTC DRUG	Meijer Pain Relieving	analgesic	CAMPHOR (SYNTHETIC) and MENTHOL, UNSPECIFIED FORM	LOTION	TOPICAL	20221205		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	55; 160	mg/g; mg/g			N	20241231
79481-0055_734f3ad3-0aba-43d9-a5fb-1870b6a8f1f2	79481-0055	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210811		OTC MONOGRAPH FINAL	part352	Meijer	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
79481-0061_77a11f0a-d2ce-40b7-8c19-011d6665d18b	79481-0061	HUMAN OTC DRUG	Omeprazole		Omeprazole	CAPSULE	ORAL	20201201		ANDA	ANDA210593	Meijer Distribution Inc.	OMEPRAZOLE MAGNESIUM	20.6	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
79481-0063_9bc6d61f-afe9-4bd1-abb2-79ca7f4d7872	79481-0063	HUMAN OTC DRUG	adult cough and chest congestion		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220610		OTC MONOGRAPH FINAL	part341	Meijer, Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79481-0065_46990e21-8c4c-4bc2-91e8-350aced1ceff	79481-0065	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20230707		ANDA	ANDA212385	Meijer Distribution Inc.	DOCOSANOL	100	mg/g			N	20241231
79481-0066_0d38267e-cdf9-a2c0-e063-6394a90ab84c	79481-0066	HUMAN OTC DRUG	Meijer Lubricant Eye Drops		Carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20201108		OTC MONOGRAPH DRUG	M018	Meijer Distribution, Inc.	CARBOXYMETHYLCELLULOSE SODIUM	.5	g/100mL			N	20241231
79481-0070_9cab7f71-5553-41d8-9003-3b394792597e	79481-0070	HUMAN OTC DRUG	hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20211229		ANDA	ANDA075357	Meijer, Inc.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
79481-0075_66c5853b-2afd-449c-91e8-5f15723fde46	79481-0075	HUMAN OTC DRUG	24 hr omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220525		NDA	NDA022032	Meijer, Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
79481-0080_0b57cdd0-d6e0-4e06-e063-6294a90a5af5	79481-0080	HUMAN OTC DRUG	Peppermint hand sanitizer gel		ALCOHOL	CLOTH	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution, Inc.	ALCOHOL	62	mL/100mL			N	20241231
79481-0081_0b57c548-c691-2de2-e063-6294a90a2b31	79481-0081	HUMAN OTC DRUG	Meijer Wet wipes antibacterial hand wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79481-0082_0b57bb80-8675-3850-e063-6294a90a4dcb	79481-0082	HUMAN OTC DRUG	Cinnamon apple hand sanitizer gel		ALCOHOL	CLOTH	TOPICAL	20230912		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer Distribution, Inc	ALCOHOL	62	mL/100mL			N	20241231
79481-0084_f4e26369-e585-4683-a647-d0b8432de8c0	79481-0084	HUMAN OTC DRUG	Meijer Pain Lidocaine Plus Relieving	Analgesic	BENZYL ALCOHOL and LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20230126		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	BENZYL ALCOHOL; LIDOCAINE HYDROCHLORIDE	100; 40	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Pediculicide [EPC]		N	20241231
79481-0086_0bf3b0d9-4ad1-38ca-e063-6394a90a897a	79481-0086	HUMAN OTC DRUG	Butenafine Hydrochloride		Butenafine Hydrochloride	CREAM	TOPICAL	20231130		ANDA	ANDA205181	MEIJER DISTRIBUTION INC	BUTENAFINE HYDROCHLORIDE	10	mg/g	Benzylamine Antifungal [EPC], Benzylamines [CS]		N	20241231
79481-0090_eaca4afa-20f3-4839-bf96-b4e864521af2	79481-0090	HUMAN OTC DRUG	clearlax		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20230113		ANDA	ANDA090685	Meijer, Inc.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79481-0096_449ce181-a7a6-4525-be98-85c43a0cb933	79481-0096	HUMAN OTC DRUG	sleep aid ultra		Doxylamine Succinate	TABLET	ORAL	20220729		ANDA	ANDA040167	Meijer, Inc.	DOXYLAMINE SUCCINATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
79481-0100_2858ef51-85b8-4117-b3fb-b73ef94fe0f4	79481-0100	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230615		ANDA	ANDA206394	Meijer, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79481-0103_d538d813-42d7-4016-92df-f580714e957b	79481-0103	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230623		ANDA	ANDA206393	Meijer, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79481-0112_1f44c8d3-0911-4e3d-b734-6a71c0b2a0b1	79481-0112	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	Meijer Distribution Inc.	DOCOSANOL	100	mg/g			N	20241231
79481-0119_9200cccd-7ce9-499e-bd47-d495ca25ec37	79481-0119	HUMAN OTC DRUG	mucus D		guaifenesin and pseudoephedrine hydrochloride	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20230822		ANDA	ANDA214407	Meijer, Inc.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	1200; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
79481-0183_0c6a6d0f-c8b2-feb8-e063-6394a90ae405	79481-0183	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230717		ANDA	ANDA211544	MEIJER DISTRIBUTION INC	ACETAMINOPHEN	650	mg/1			N	20241231
79481-0184_0c6a5156-2494-f98e-e063-6394a90aedba	79481-0184	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20230717		ANDA	ANDA211544	MEIJER, INC.	ACETAMINOPHEN	650	mg/1			N	20241231
79481-0201_cc4c89dc-081a-44b5-babe-8ddd39a163f6	79481-0201	HUMAN OTC DRUG	Anticavity Rinse		Sodium Fluoride	MOUTHWASH	ORAL	20210714		OTC MONOGRAPH DRUG	M021	Meijer Distribution, Inc.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
79481-0227_4292b4af-d9ce-4e21-a2f3-923c2524331e	79481-0227	HUMAN OTC DRUG	All Day Moisture		Homosalate, Zinc Oxide	LOTION	TOPICAL	20221221		OTC MONOGRAPH FINAL	part352	Meijer Distribution, Inc.	HOMOSALATE; ZINC OXIDE	50; 30	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79481-0238_1bbebe25-3f80-40bc-b001-625ab553dae9	79481-0238	HUMAN OTC DRUG	oil-free moisturizer		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20200315		OTC MONOGRAPH FINAL	part352	Meijer Distribution, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0250_0d3808a3-511d-756d-e063-6294a90a02d0	79481-0250	HUMAN OTC DRUG	Meijer Multi-Symptom Relief		polyethylene glycol 400, tetrahydrozoline HCl, zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20230109		OTC MONOGRAPH DRUG	M018	Meijer, Inc.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	1; .05; .25	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79481-0300_118050cf-fb2d-49cf-a245-5f2636e0d128	79481-0300	HUMAN OTC DRUG	Levmetamfetamine		Levmetamfetamine	INHALANT	NASAL	20230929		OTC MONOGRAPH FINAL	part341	Meijer, Inc.	LEVMETAMFETAMINE	50	mg/1			N	20241231
79481-0319_689acccf-1037-4e0e-a5b6-353faec3ef8c	79481-0319	HUMAN OTC DRUG	anti itch		Hydrocortisone	CREAM	TOPICAL	20210323		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79481-0336_d876e0c9-72a0-4954-92ae-4281d0e5da2d	79481-0336	HUMAN OTC DRUG	Calamine		Calamine, Pramoxine HCl	LOTION	TOPICAL	20090617		OTC MONOGRAPH FINAL	part347	Meijer Distribution	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE	80; 10	mg/mL; mg/mL			N	20241231
79481-0392_29ec2a02-5ddc-4404-a6d9-bc3ee9c63d50	79481-0392	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20211221		ANDA	ANDA075139	Meijer Distribution, Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79481-0446_e34653df-cb50-41a2-9910-9c860c0eef03	79481-0446	HUMAN OTC DRUG	allergy relief		Loratadine	CAPSULE, LIQUID FILLED	ORAL	20200714		ANDA	ANDA202538	Meijer, Inc.	LORATADINE	10	mg/1			N	20241231
79481-0471_6658bd8c-30a8-42e0-aa96-6953b9193d33	79481-0471	HUMAN OTC DRUG	anti itch		hydrocortisone	OINTMENT	TOPICAL	20210505		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79481-0500_dd74396e-e53d-65b6-e053-2a95a90a2464	79481-0500	HUMAN OTC DRUG	Soft Tip Neti Pot Sinus wash	Meijer	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		Meijer, Inc.						N	20241231
79481-0501_dd7452b4-9421-240d-e053-2995a90a9235	79481-0501	HUMAN OTC DRUG	Soft Tip Squeeze bottle Sinus Wash	Meijer	SODIUM BICARBONATE, SODIUM CHLORIDE	KIT	NASAL	20220109		UNAPPROVED DRUG OTHER		Meijer, Inc.						N	20241231
79481-0502_effed7e4-def0-7322-e053-2995a90acc5f	79481-0502	HUMAN OTC DRUG	Sinus Wash Saline Refills	Meijer	SODIUM BICARBONATE, SODIUM CHLORIDE	POWDER, FOR SOLUTION	NASAL	20220108		UNAPPROVED DRUG OTHER		Meijer, Inc.	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC]		N	20241231
79481-0503_d5b62f57-f964-414b-9a54-03e58404d11e	79481-0503	HUMAN OTC DRUG	dual pain reliever		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230921		ANDA	ANDA214836	Meijer, Inc.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79481-0505_030f218c-4481-9e91-e063-6394a90a2808	79481-0505	HUMAN OTC DRUG	Antifungal Athletes Foot		Miconazole Nitrate	AEROSOL, POWDER	TOPICAL	20230816		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
79481-0591_0e8bd3f4-19de-1924-e063-6294a90a6ada	79481-0591	HUMAN OTC DRUG	Tolnaftate		Meijer Athletes Foot Liquid Spray	AEROSOL, SPRAY	TOPICAL	20220311		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc.	TOLNAFTATE	1.5	g/150g			N	20251231
79481-0592_0e8a830a-1c3e-cad5-e063-6294a90a1399	79481-0592	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20220311		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc.	TOLNAFTATE	1.3	g/130g			N	20251231
79481-0593_0e8ae45f-79d2-d34e-e063-6394a90a4cea	79481-0593	HUMAN OTC DRUG	Medicated Callus Removers		Salicylic Acid	PATCH	TOPICAL	20230222		OTC MONOGRAPH DRUG	M030	Meijer Distribution Inc.	SALICYLIC ACID	40	mg/41			N	20251231
79481-0594_f8360793-bde5-e43d-e053-6394a90ae7fd	79481-0594	HUMAN OTC DRUG	Clear Corn Remover Strips		Salicylic Acid	PATCH	TOPICAL	20230331		OTC MONOGRAPH FINAL	part358F	MEIJER DISTRIBUTION, INC.	SALICYLIC ACID	40	mg/121			N	20241231
79481-0595_f836a879-6aa2-23fb-e053-6394a90a03ba	79481-0595	HUMAN OTC DRUG	Clear Wart Remover Strips		Salicylic Acid	PATCH	TOPICAL	20230331		OTC MONOGRAPH FINAL	part358F	MEIJER DISTRIBUTION, INC.	SALICYLIC ACID	40	mg/121			N	20241231
79481-0598_02f9ef9d-fdb4-0140-e063-6394a90ae5dd	79481-0598	HUMAN OTC DRUG	Extra Strength Itch Relief		Diphenhydramine HCl and Zinc Acetate	SPRAY	TOPICAL	20230815		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	20; 1	mg/g; mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79481-0599_030f218c-4474-9e91-e063-6394a90a2808	79481-0599	HUMAN OTC DRUG	Antifungal Miconazole Liquid Continuous		Miconazole Nitrate	AEROSOL, SPRAY	TOPICAL	20230816		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
79481-0601_7865dd02-beb5-4a7b-9e32-f9cf2809b776	79481-0601	HUMAN OTC DRUG	nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230803		ANDA	ANDA206393	Meijer, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79481-0602_030f218c-4476-9e91-e063-6394a90a2808	79481-0602	HUMAN OTC DRUG	Jock Itch		Miconazole Nitrate	AEROSOL, SPRAY	TOPICAL	20200801		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc.	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
79481-0604_0338e099-95f5-9b53-e063-6394a90a3346	79481-0604	HUMAN OTC DRUG	AntiFungal Liquid Maximum Strength		Tolnaftate	LIQUID	TOPICAL	20230816		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc.	TOLNAFTATE	10	mg/mL			N	20241231
79481-0606_051bd780-5f93-0d03-e063-6294a90ad604	79481-0606	HUMAN OTC DRUG	Liquid Bandage		Benzethonium chloride Plus Dyclonine hydrochloride	LIQUID	TOPICAL	20230818		OTC MONOGRAPH NOT FINAL	part333A	Meijer Distribution Inc	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	2; 7.5	mg/mL; mg/mL			N	20241231
79481-0607_0eb3c5c9-f140-d91d-e063-6394a90ac18b	79481-0607	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20230818		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc.	TOLNAFTATE	10	mg/g			N	20251231
79481-0608_223d3d6c-0dfc-4ce2-b297-7dd3524e145b	79481-0608	HUMAN OTC DRUG	Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20201228		OTC MONOGRAPH DRUG	M002	Meijer Distribution, Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
79481-0609_039a2036-54af-cf28-e063-6294a90a8ce6	79481-0609	HUMAN OTC DRUG	Medicated Callus Removers		Salicylic Acid	PATCH	TOPICAL	20230222		OTC MONOGRAPH FINAL	part358F	Meijer Distribution Inc.	SALICYLIC ACID	400	mg/g			N	20241231
79481-0610_02ab80da-6970-130f-e063-6394a90aba25	79481-0610	HUMAN OTC DRUG	4x Medicated Severe Toothache and Gum Gel		Benzalkonium chloride	GEL	ORAL	20191120		OTC MONOGRAPH NOT FINAL	part356	Meijer	BENZALKONIUM CHLORIDE; BENZOCAINE; MENTHOL; ZINC CHLORIDE	.13; 20; .5; .15	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
79481-0611_039b824e-341d-9845-e063-6294a90a5a88	79481-0611	HUMAN OTC DRUG	Medicated Callus Removers Extra Thick		Salicylic acid	PATCH	TOPICAL	20170101		OTC MONOGRAPH FINAL	part358F	Meijer Distribution Inc	SALICYLIC ACID	400	mg/g			N	20241231
79481-0612_052a61fa-7f22-3def-e063-6394a90ab5b9	79481-0612	HUMAN OTC DRUG	Liquid Corn and Callus Remover		Salicylic Acid	LIQUID	TOPICAL	20150716		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	170	mg/mL			N	20241231
79481-0614_03c34886-ae5a-cc1d-e063-6294a90a412e	79481-0614	HUMAN OTC DRUG	Liquid Wart Remover		Salicylic Acid	LIQUID	TOPICAL	20230825		OTC MONOGRAPH FINAL	part358F	Meijer Distribution Inc	SALICYLIC ACID	170	mg/mL			N	20241231
79481-0615_03c4ab8f-7182-914c-e063-6394a90aee27	79481-0615	HUMAN OTC DRUG	Calamine Plus		Calamine Plus Pramoxine HCL	AEROSOL, SPRAY	TOPICAL	20230825		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc.	FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	5; 10; 79.5	mg/g; mg/g; mg/g			N	20241231
79481-0616_04266b35-28d0-9fb3-e063-6294a90a54b9	79481-0616	HUMAN OTC DRUG	Wart Remover Gel		Salicylic Acid	GEL	TOPICAL	20230827		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	170	mg/g			N	20241231
79481-0617_03f23203-9903-753a-e063-6294a90aacbe	79481-0617	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	SPRAY	TOPICAL	20230827		OTC MONOGRAPH FINAL	part347	Meijer Distribution Inc	WITCH HAZEL	860	mg/g			N	20241231
79481-0618_03f23203-9904-753a-e063-6294a90aacbe	79481-0618	HUMAN OTC DRUG	Hydrocortisone Continuous		Hydrocortisone	AEROSOL, SPRAY	TOPICAL	20230827		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79481-0619_03f29b61-2b8d-9344-e063-6294a90a5476	79481-0619	HUMAN OTC DRUG	Medicated Plantar Wart Remover		Salicylic Acid	PATCH	TOPICAL	20230828		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	400	mg/g			N	20241231
79481-0620_03fc974a-38d3-0a95-e063-6394a90a4073	79481-0620	HUMAN OTC DRUG	Wart Removers		Salicylic Acid	PATCH	TOPICAL	20230828		OTC MONOGRAPH FINAL	part358B	Meijer Distribution Inc	SALICYLIC ACID	400	mg/g			N	20241231
79481-0621_052ea282-da58-888e-e063-6394a90ad149	79481-0621	HUMAN OTC DRUG	Anti-fungal Powder Miconazole Nitrate		Miconazole Nitrate	POWDER	TOPICAL	20230828		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
79481-0622_03fd2680-0041-aa8c-e063-6294a90a090f	79481-0622	HUMAN OTC DRUG	Foot Odor Control Powder		Tolnaftate	AEROSOL, SPRAY	TOPICAL	20230828		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc	TOLNAFTATE	10	mg/g			N	20241231
79481-0623_04234853-9e54-52ed-e063-6294a90a44d5	79481-0623	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20230818		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc.	TOLNAFTATE	10	mg/g			N	20241231
79481-0625_0399b36b-e967-6448-e063-6394a90a4898	79481-0625	HUMAN OTC DRUG	Tolnaftate		Meijer Athletes Foot Liquid	AEROSOL, SPRAY	TOPICAL	20230823		OTC MONOGRAPH FINAL	part333C	Meijer Distribution Inc.	TOLNAFTATE	10	mg/g			N	20241231
79481-0635_20a6adab-61a3-4841-a601-911aecf02188	79481-0635	HUMAN OTC DRUG	Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20201228		OTC MONOGRAPH DRUG	M002	Meijer Distribution, Inc.	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
79481-0639_f1773a09-cd14-bc3b-e053-2995a90a683b	79481-0639	HUMAN OTC DRUG	Meijer Pain Relief		Menthol 10.5%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Meijer	MENTHOL	10.5	g/100g			N	20241231
79481-0647_09a7136c-d359-6d30-e063-6294a90ab07f	79481-0647	HUMAN OTC DRUG	Milk of Magnesia mint		Magnesium hydroxide	SUSPENSION	ORAL	20210201		OTC MONOGRAPH DRUG	M007	Meijer, Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79481-0648_09a70f75-c690-e4ef-e063-6394a90ac2c2	79481-0648	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20210201		OTC MONOGRAPH DRUG	M007	Meijer, Inc.	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79481-0660_0b3ebe28-cb69-6998-e063-6394a90a4c4e	79481-0660	HUMAN OTC DRUG	Maximum Strength Antifungal Liquid		Tolnaftate	LIQUID	TOPICAL	20230504		OTC MONOGRAPH DRUG	M005	Meijer Distribution Inc	TOLNAFTATE	10	mg/mL			N	20241231
79481-0701_08a2505b-b723-8c29-e063-6294a90a850e	79481-0701	HUMAN OTC DRUG	Meijer Allergy Relief Diphenhydramine HCl, 25 mg Antihistamine		Diphenhydramine HCl	BAR, CHEWABLE	ORAL	20231211		OTC MONOGRAPH DRUG	M012	MEIJER DISTRIBUTION, INC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79481-0782_89758c03-8be2-46d2-88e9-63d9fd6229a3	79481-0782	HUMAN OTC DRUG	Castor Oil		Castor Oil	LIQUID	ORAL	20230310		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution, Inc.	CASTOR OIL	1000	mg/mL			N	20241231
79481-0784_33bda808-6ba2-40e0-b881-b67b6f63bb3e	79481-0784	HUMAN OTC DRUG	Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20170222		OTC MONOGRAPH NOT FINAL	part333A	MEIJER	ALCOHOL	63	mL/100mL			N	20241231
79481-0809_aef51505-f339-4f1c-a249-230dcd9b2b27	79481-0809	HUMAN OTC DRUG	first aid antibiotic and pain relief		Neomycin, Polymyxin B, Pramoxine HCl	CREAM	TOPICAL	20210420		OTC MONOGRAPH FINAL	part333B	Meijer Distribution Inc	NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	3.5; 10000; 10	mg/g; [USP'U]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
79481-0826_c24df3af-7e02-4c31-8717-45252523a55d	79481-0826	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20210114		OTC MONOGRAPH NOT FINAL	part333A	Meijer	ALCOHOL	62	mL/100mL			N	20241231
79481-0847_560a847d-0e9a-4e98-902f-851335469996	79481-0847	HUMAN OTC DRUG	allergy relief		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20211006		ANDA	ANDA212971	Meijer, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79481-0849_f9e1365c-a6f8-4efb-b0a5-ff3fa37d8a21	79481-0849	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20201220		OTC MONOGRAPH DRUG	505G(a)(3)	Meijer	ALCOHOL	62	mL/100mL			N	20241231
79481-0853_1da3f0c5-6942-4281-ba2f-796965ab1144	79481-0853	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20210430		OTC MONOGRAPH NOT FINAL	part334	Meijer Distribution Inc.	DOCUSATE SODIUM	100	mg/1			N	20241231
79481-0860_16d1f48c-9307-43a1-a2a7-2e1168321d98	79481-0860	HUMAN OTC DRUG	Sennosides		Sennosides	TABLET, CHEWABLE	ORAL	20230915		OTC MONOGRAPH NOT FINAL	part334	Meijer, Inc.	SENNOSIDES	15	mg/1			N	20241231
79481-0894_a20522b9-526e-4fb4-b119-422e0c3d2b67	79481-0894	HUMAN OTC DRUG	Gel Cooling Pain Relief		Menthol	GEL	TOPICAL	20200215		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution	MENTHOL	40	mg/mL			N	20241231
79481-0900_faf83a88-450c-4aa1-8c9e-e8d21228ba6a	79481-0900	HUMAN OTC DRUG	Antigingivitis/Antiplaque		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20231108		OTC MONOGRAPH DRUG	M505G(a)(3)	Meijer Distribution, INC	CETYLPYRIDINIUM CHLORIDE	.7	mg/mL			N	20241231
79481-0914_0ebb7964-0479-40cb-a5e4-9a95d7209976	79481-0914	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210315		OTC MONOGRAPH FINAL	part352	Meijer	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 1000; 250; 360	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79481-0920_c6f4e76a-0f9c-425e-a213-f17478219d7b	79481-0920	HUMAN OTC DRUG	sheer		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210315		OTC MONOGRAPH FINAL	part352	Meijer	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 1440; 250; 1000	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79481-0932_990aeabb-aee7-460e-8126-9241f84eb1aa	79481-0932	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230807		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0933_4f4c7bbf-8e45-4e78-81ed-e40bb90f55fd	79481-0933	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230725		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0934_1f082c69-55b8-42ad-a8b6-5fa7bf6d7e3a	79481-0934	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230807		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0936_e16c3fa7-372b-4a91-9ddc-944d9460a5dd	79481-0936	HUMAN OTC DRUG	Sheer Touch Sunscreen Mist SPF 100		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	Meijer Distribution	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 150; 50	mg/g; mg/g; mg/g			N	20241231
79481-0938_689ddc3a-04de-419c-830a-a59862eed491	79481-0938	HUMAN OTC DRUG	sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210127		OTC MONOGRAPH FINAL	part352	Meijer	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	90; 2250; 250; 640	g/g; g/g; g/g; g/g			N	20241231
79481-0939_11d839a4-1f10-4a79-98c9-d85cea36d3d1	79481-0939	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230807		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0941_36fc0fb1-51ed-46f5-8caf-2292a71aa1ac	79481-0941	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230808		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
79481-0943_6ef76149-a05d-4924-9de2-e82fd318d96f	79481-0943	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230808		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
79481-0948_3ad45cde-6627-42bf-8d79-fc9418c6a059	79481-0948	HUMAN OTC DRUG	Broad Spectrum Sunscreen SPF 30		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20231030		OTC MONOGRAPH DRUG	M020	Meijer Distribution	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
79481-0949_4f3883a2-0e6c-4f1a-8ec8-56a40aca75f8	79481-0949	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	SPRAY	TOPICAL	20230808		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/g; mg/g; mg/g			N	20241231
79481-0951_8f747174-c3de-413c-a014-c3b17cb2a9c9	79481-0951	HUMAN OTC DRUG	Avbenzone, Homosalate, Octisalate		Avbenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230828		OTC MONOGRAPH FINAL	part352	Meijer Distribution, INC	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0953_36044e46-7803-44e9-966b-b2a07dccec5d	79481-0953	HUMAN OTC DRUG	Antigingivitis/Antiplaque		Cetylpyridinium Chloride	MOUTHWASH	ORAL	20231108		OTC MONOGRAPH DRUG	M505G(a)(3)	Meijer Distribution, INC	CETYLPYRIDINIUM CHLORIDE	.5	mg/mL			N	20241231
79481-0954_acaf08fd-9d4f-401a-8ea2-47ae59489da3	79481-0954	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230828		OTC MONOGRAPH FINAL	part352	Meijer Distribution	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-0960_f56615c8-36fd-4f63-a5b1-6f776e6166c4	79481-0960	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20210104		OTC MONOGRAPH FINAL	part347	Meijer	PETROLATUM	1	g/g			N	20241231
79481-0973_d5a51adc-87b6-4d09-b774-41668286af5a	79481-0973	HUMAN OTC DRUG	anti itch		hydrocortisone	CREAM	TOPICAL	20210428		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79481-0981_0c710841-aa72-4e1a-a7cc-1e3a4d4b8f38	79481-0981	HUMAN OTC DRUG	24 hour allergy		cetirizine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220308		ANDA	ANDA213105	Meijer, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79481-0989_f17784bc-7d47-a071-e053-2a95a90ae9c4	79481-0989	HUMAN OTC DRUG	Meijer Pain Relief		Lidocaine 4%	LIQUID	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Meijer	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-1000_16bbbb47-152b-42f2-aed2-6c325a3941fd	79481-1000	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	Meijer	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
79481-1001_40115ffa-9be6-430c-9fd9-e530686c9ab9	79481-1001	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Meijer	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
79481-1002_495db9d0-1034-4254-9eb3-fd5bb2dd2218	79481-1002	HUMAN OTC DRUG	Guaifenesin and Pseudoephedrine HCl		Guaifenesin and Pseudoephedrine HCl	TABLET, EXTENDED RELEASE	ORAL	20210715		ANDA	ANDA213203	Meijer	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
79481-1087_f31b11ed-2ffa-5cfc-e053-2a95a90af2ca	79481-1087	HUMAN OTC DRUG	Meijer Pain Relief		Lidocaine HCl 4%	GEL	TOPICAL	20210831		OTC MONOGRAPH NOT FINAL	part348	Meijer	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-1100_a4d8b48b-2c72-4f58-b131-937abacdd258	79481-1100	HUMAN OTC DRUG	nicotine		nicotine polacrilex	LOZENGE	ORAL	20230823		ANDA	ANDA077007	Meijer, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79481-1123_fbd47e4b-ad8b-45ec-91d0-7cb9f3139925	79481-1123	HUMAN OTC DRUG	nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20230615		ANDA	ANDA077007	Meijer, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79481-1140_497c53f6-f8c6-45ba-9d58-6262c5024ce2	79481-1140	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20231004		ANDA	ANDA090962	Meijer Distribution Inc.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
79481-1220_632c60f3-514f-44a1-822f-294a446fc668	79481-1220	HUMAN OTC DRUG	Meijer Ultra Strength Pain Relieving	Topical Analgesic	CAMPHOR (SYNTHETIC), MENTHOL, UNSPECIFIED FORM, and Methyl Salicylate	CREAM	TOPICAL	20201130		OTC MONOGRAPH NOT FINAL	part348	Meijer Distribution, INC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	40; 100; 300	mg/g; mg/g; mg/g			N	20241231
79481-1295_f177bb72-cd53-f875-e053-2a95a90a0bf5	79481-1295	HUMAN OTC DRUG	Meijer Scar Gel		Allantoin 0.5%	GEL	TOPICAL	20210331		OTC MONOGRAPH FINAL	part347	Meijer	ALLANTOIN	.5	g/100g			N	20241231
79481-1297_f1f023c3-420f-5c71-e053-2995a90a1908	79481-1297	HUMAN OTC DRUG	Meijer Scar Gel		Allantoin 0.5%	GEL	TOPICAL	20210720		OTC MONOGRAPH FINAL	part347	Meijer	ALLANTOIN	.5	g/100g			N	20241231
79481-1613_039d9204-2c88-d40b-e063-6394a90a0798	79481-1613	HUMAN OTC DRUG	Medicated Corn Removers		Salicylic Acid	PATCH	TOPICAL	20230825		OTC MONOGRAPH FINAL	part358F	Meijer Distribution Inc	SALICYLIC ACID	400	mg/g			N	20241231
79481-2183_f177bd61-2c21-9e15-e053-2a95a90a409d	79481-2183	HUMAN OTC DRUG	Meijer Burn Relief		Lidocaine 0.5%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Meijer	LIDOCAINE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79481-2530_0191b2e4-bcaf-541a-e063-6294a90a0e78	79481-2530	HUMAN OTC DRUG	Meijer Lice Killing		Piperonyl Butoxide, Pyrethrum Extract	SHAMPOO	TOPICAL	20230901		OTC MONOGRAPH DRUG	M031	Meijer, Inc.	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	4; .33	g/100mL; g/100mL			N	20241231
79481-2550_0bf02103-479b-379b-e063-6394a90ad38a	79481-2550	HUMAN OTC DRUG	Meijer Complete Lice Treatment Kit		Piperonyl butoxide, Pyrethrum extract	KIT	TOPICAL	20201209		OTC MONOGRAPH DRUG	M031	Meijer, Inc.						N	20241231
79481-2800_c1b4a6cb-0aca-4ce6-a711-24a35b21a690	79481-2800	HUMAN OTC DRUG	vapor ice daytime and nitetime cold and flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride,Guaifenesin	KIT		20210923		OTC MONOGRAPH FINAL	part341	Meijer, Inc.						N	20241231
79481-4534_25458382-3651-4eb2-84a2-1ac795b11a5f	79481-4534	HUMAN OTC DRUG	Sinus PE Congestion	Daytime Nighttime	Diphenhydramine HCl, Phenylephrine HCl	KIT		20230705		OTC MONOGRAPH DRUG	M012	Meijer Distribution, Inc.						N	20241231
79481-5100_5297a2f1-790a-4f0f-ae53-5f5d8f8f7bf3	79481-5100	HUMAN OTC DRUG	daytime cold flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH DRUG	M012	Meijer, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79481-5129_f177916c-167d-6b91-e053-2995a90ad808	79481-5129	HUMAN OTC DRUG	Meijer Cold and Hot Pain Relieving		Menthol 16%	SPRAY	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part348	Meijer	MENTHOL	16	g/100g			N	20241231
79481-5200_8a96a0b4-06fe-48a5-be25-be2ab7979ee0	79481-5200	HUMAN OTC DRUG	daytime cold and flu nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, doxylamine succinate	KIT		20210821		OTC MONOGRAPH FINAL	part341	Meijer Distribution Inc						N	20241231
79481-5660_0e802a4b-f514-064d-e063-6394a90a5c2e	79481-5660	HUMAN OTC DRUG	Meijer 3 Hydrogen Peroxide Wipes		HYDROGEN PEROXIDE	CLOTH	TOPICAL	20240101		OTC MONOGRAPH DRUG	M003	Meijer, Inc.	HYDROGEN PEROXIDE	30	mg/g			N	20251231
79481-5670_0e802a4b-f524-064d-e063-6394a90a5c2e	79481-5670	HUMAN OTC DRUG	Meijer 70 Isopropyl Alcohol Wipes First Aid Antiseptic		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20240101		OTC MONOGRAPH DRUG	M003	Meijer, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20251231
79481-6300_4cc27b78-5e6d-4993-a851-9e6af32620fa	79481-6300	HUMAN OTC DRUG	Meijer Adult Severe Multi-Symptom Cough Cold Flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	LIQUID	ORAL	20230331		OTC MONOGRAPH FINAL	part341	MEIJER DISTRIBUTION INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/20mL; mg/20mL; mg/20mL; mg/20mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79481-6921_f7cc9b50-8199-4df7-97a7-b09358f2931b	79481-6921	HUMAN OTC DRUG	Meijer Nitetime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	SOLUTION	ORAL	20230331		OTC MONOGRAPH FINAL	part341	MEIJER DISTRIBUTION INC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79481-7430_f6a23be6-0313-4c23-afb7-576666b80e21	79481-7430	HUMAN OTC DRUG	Meijer Adult Mucus Plus	chest congestion	Guaifenesin	SYRUP	ORAL	20230331		OTC MONOGRAPH FINAL	part341	MEIJER DISTRIBUTION, INC	GUAIFENESIN	200	mg/10mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
79481-7470_9121804a-e5eb-46a2-a4a7-cc625be846d1	79481-7470	HUMAN OTC DRUG	Meijer Children Cough and Chest Congestion DM	Grape Flavor	Dextromethorphan HBr and Guaifenesin	LIQUID	ORAL	20230331		OTC MONOGRAPH FINAL	part341	MEIJER DISTRIBUTION INC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79481-8223_db8bdbdb-cd3d-0e05-e053-2a95a90ad7be	79481-8223	HUMAN OTC DRUG	Meijer Maximum Strength Anti-itch Cream wiith Aloe		Hydrocortisone	CREAM	TOPICAL	20200731		OTC MONOGRAPH NOT FINAL	part348	MEIJER, INC.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79481-8224_db8bdbdb-cd3e-0e05-e053-2a95a90ad7be	79481-8224	HUMAN OTC DRUG	Meijer Maximum Strength Anti-itch Cream with Aloe		Hydrocortisone	CREAM	TOPICAL	20200807		OTC MONOGRAPH NOT FINAL	part348	MEIJER, INC.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79481-8229_efe78e44-bc2b-4006-e053-2a95a90a45fa	79481-8229	HUMAN OTC DRUG	Meijer Antifungal Tolnaftate Cream		Tolnaftate	CREAM	TOPICAL	20200716		OTC MONOGRAPH FINAL	part333C	MEIJER, INC.	TOLNAFTATE	10	mg/g			N	20241231
79481-8999_0f17a573-209c-40d7-9e49-a5037e123888	79481-8999	HUMAN OTC DRUG	nitetime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH DRUG	M012	Meijer, Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79481-9069_97efa661-6a29-460b-a4cb-5eb89f451858	79481-9069	HUMAN OTC DRUG	Petroleum		White Petrolatum	JELLY	TOPICAL	20200821		OTC MONOGRAPH FINAL	part347	MEIJER	PETROLATUM	100	g/100g			N	20241231
79481-9220_24cf279a-8048-4946-8496-3ee12fbe99aa	79481-9220	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20220527		ANDA	ANDA208754	Meijer Distribution Inc.	DOCOSANOL	100	mg/g			N	20241231
79481-9400_6b5acccd-8d67-4339-b917-3c109cc4bb21	79481-9400	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate		Avobenzone, Homosalate, Octisalate	LOTION	TOPICAL	20230807		OTC MONOGRAPH FINAL	part352	Meijer, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 120; 50	mg/mL; mg/mL; mg/mL			N	20241231
79481-9402_4c5db31d-0877-4b86-b3ab-240e1a6682a4	79481-9402	HUMAN OTC DRUG	Avobenzone, Homosalate, Octisalate, Octocrylene		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230605		OTC MONOGRAPH FINAL	part352	Meijer Distribution	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79481-9471_9cd81c57-1570-4398-aa1b-86544a1b7a57	79481-9471	HUMAN OTC DRUG	Alcohol		Alcohol	LIQUID	TOPICAL	20190210		OTC MONOGRAPH NOT FINAL	part333A	MEIJER	ALCOHOL	62	mL/100mL			N	20241231
79481-9633_38227f53-1c44-4ccb-a12d-fc9a1fb2ab0d	79481-9633	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride 0.13%	SOAP	TOPICAL	20160226		OTC MONOGRAPH NOT FINAL	part333A	MEIJER	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79481-9730_5875f10d-5d2b-481b-9c46-b3c671cd8bbb	79481-9730	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20171213		OTC MONOGRAPH FINAL	part352	MEIJER	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	20; 150; 50; 40	mg/g; mg/g; mg/g; mg/g			N	20241231
79481-9764_e2534208-28d4-40f7-b6f8-0798e04ddb75	79481-9764	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20160112		OTC MONOGRAPH FINAL	part352	MEIJER	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 117; 45; 45; 54	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79481-9787_6d936cef-d2ee-4e46-b404-778b701f46c8	79481-9787	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Oxybenzone	SPRAY	TOPICAL	20170807		OTC MONOGRAPH FINAL	part352	MEIJER	AVOBENZONE; HOMOSALATE; OCTISALATE; OXYBENZONE	30; 150; 50; 60	mg/g; mg/g; mg/g; mg/g			N	20241231
79481-9924_5e36b1ff-7a43-4e65-ae16-a7d826af1e65	79481-9924	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211201		OTC MONOGRAPH FINAL	part352	MEIJER	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79481-9926_c5ccb1e5-50ce-432e-8583-89deeae06233	79481-9926	HUMAN OTC DRUG	Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20201028		OTC MONOGRAPH FINAL	part352	MEIJER	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 80	mg/g; mg/g; mg/g; mg/g			N	20241231
79481-9965_13f64e96-b988-4963-bb0b-a51c97d90d56	79481-9965	HUMAN OTC DRUG	Colloidal oatmeal		Colloidal oatmeal	CREAM	TOPICAL	20200624		OTC MONOGRAPH FINAL	part347	MEIJER	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
79501-502_c7426607-7a37-1d46-e053-2995a90aee9a	79501-502	HUMAN OTC DRUG	EUZ-Clean		Alcohol	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	EUROZONE TRADING PARTNERS LIMITED LIABILITY COMPANY	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
79503-101_11f69253-f62c-48ad-8614-5da7015366c4	79503-101	HUMAN OTC DRUG	ARTIFICIAL TEARS LUBRICANT EYE DROPS		CARBOXYMETHYLCELLULOSE SODIUM	SOLUTION/ DROPS	OPHTHALMIC	20201122	20250301	OTC MONOGRAPH DRUG	M018	Ezricare Llc	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	10	mg/mL			N	
79503-103_90838075-1bd2-4c22-b31e-fb4393ec2b48	79503-103	HUMAN OTC DRUG	Hydrocortisone 1%		Hydrocortisone Acetate	OINTMENT	TOPICAL	20210819	20250701	OTC MONOGRAPH DRUG	M017	Ezricare Llc	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
79503-105_fe3d0c53-d146-42ac-a550-a1d321dc88fc	79503-105	HUMAN OTC DRUG	Clotrimazole Cream 1%		Clotrimazole	CREAM	TOPICAL	20210819	20250701	OTC MONOGRAPH DRUG	M005	Ezricare Llc	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
79503-106_74714e6a-ccd9-46d4-9027-bd13eb29b897	79503-106	HUMAN OTC DRUG	Miconazole Nitrate Cream 2%		Miconazole Nitrate	CREAM	TOPICAL	20210819	20250701	OTC MONOGRAPH DRUG	M005	Ezricare Llc	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	
79503-107_b9dbb52f-4ca4-4519-8e15-f2133c9519c9	79503-107	HUMAN OTC DRUG	Bacitracin Zinc		Bacitracin Zinc	OINTMENT	TOPICAL	20210819	20250701	OTC MONOGRAPH DRUG	M004	Ezricare Llc	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	
79503-108_f511b6b3-0601-4a64-97b0-41dfa9a435dd	79503-108	HUMAN OTC DRUG	Triple Antibiotic		Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate	OINTMENT	TOPICAL	20210901	20250701	OTC MONOGRAPH DRUG	M004	Ezricare Llc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	
79503-202_101309fd-ad8d-4923-b12a-8f139cb94be9	79503-202	HUMAN OTC DRUG	Hydrocortisone Cream 1% with Aloe Vera		Hydrocortisone	CREAM	TOPICAL	20210601	20250701	OTC MONOGRAPH DRUG	M017	Ezricare Llc	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	
79506-100_22399241-cbbd-4248-b8ba-628fe4101534	79506-100	HUMAN OTC DRUG	DETROX	DETRODERM HAND AND SKIN ANTISEPTIC	Isopropyl Alcohol	LIQUID	TOPICAL	20200630		OTC MONOGRAPH NOT FINAL	part333A	DETRO HEALTHCARE KIMYA SANAYI ANONIM SIRKETI	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
79506-101_1505a698-a6ca-4a2a-bbf3-f727322f1a1f	79506-101	HUMAN OTC DRUG	DETROX	DETRODERM Gel HAND AND SKIN ANTISEPTIC	Isopropyl Alcohol	GEL	TOPICAL	20200630		OTC MONOGRAPH NOT FINAL	part333A	DETRO HEALTHCARE KIMYA SANAYI ANONIM SIRKETI	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
79506-102_97f4cb01-1c90-484a-8c81-8b630412c345	79506-102	HUMAN OTC DRUG	DETRODERM SOFT HAND AND SKIN ANTISEPTIC		Alcohol	LIQUID	TOPICAL	20210415		OTC MONOGRAPH NOT FINAL	part333A	DETRO HEALTHCARE KIMYA SANAYI ANONIM SIRKETI	ALCOHOL	80	mL/100mL			N	20241231
79506-103_a92d86fa-7667-4406-8145-d37782bbbe26	79506-103	HUMAN OTC DRUG	DETRODERM SOFT geL HAND AND SKIN ANTISEPTIC		Alcohol	GEL	TOPICAL	20210415		OTC MONOGRAPH NOT FINAL	part333A	DETRO HEALTHCARE KIMYA SANAYI ANONIM SIRKETI	ALCOHOL	80	mL/100mL			N	20241231
79524-000_089944c7-69ea-2b30-e063-6394a90a11ba	79524-000	HUMAN OTC DRUG	Instant HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200722		OTC MONOGRAPH DRUG	505G(a)(3)	Xact Xpressions	ALCOHOL	.75	mL/mL			N	20241231
79530-003_0aa49205-0a9b-8ae4-e063-6394a90a5475	79530-003	HUMAN OTC DRUG	Hand Antibacterial Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200711		OTC MONOGRAPH DRUG	505G(a)(3)	Namco Manufacturing INC.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
79531-003_aa1e8b9d-08fc-a415-e053-2995a90a6c9f	79531-003	HUMAN OTC DRUG	Multi-purpose Antibacterial Wet Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200711		OTC MONOGRAPH NOT FINAL	part333A	Supreme Premium Products,Inc.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
79539-101_08223e51-f19f-768b-e063-6394a90a4178	79539-101	HUMAN OTC DRUG	Alcohol Formula Sanitizing Hand Wipes		Alcohol and Glycerol	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	Shandong Yayun Sanitary Products Co., Ltd.	ALCOHOL	1	mL/1			N	20241231
79539-201_0822b9fd-67f8-b9c3-e063-6294a90a092b	79539-201	HUMAN OTC DRUG	Instant Hand Sanitizeing Wipe		Isopropanol and Compound double-stranded quaternary ammonium salts	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	Shandong Yayun Sanitary Products Co., Ltd.	BENZALKONIUM CHLORIDE	1.2	g/1			N	20241231
79539-301_08230a88-b052-8c20-e063-6394a90aaea3	79539-301	HUMAN OTC DRUG	75%ALCOHOL WIPES		ALCOHOL	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	Shandong Yayun Sanitary Products Co., Ltd.	ALCOHOL	1	mL/1			N	20241231
79539-401_08235c97-4709-2d1f-e063-6294a90acc62	79539-401	HUMAN OTC DRUG	Baby Wipes		Propylene Glycol	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	Shandong Yayun Sanitary Products Co., Ltd.	PROPYLENE GLYCOL	1	g/1			N	20241231
79539-501_08239e85-eb3f-c257-e063-6394a90a5274	79539-501	HUMAN OTC DRUG	75% alcohol wipes		ALCOHOL	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	Shandong Yayun Sanitary Products Co., Ltd.	ALCOHOL	1	mL/1			N	20241231
79539-601_08241d0b-695b-e7c5-e063-6394a90a91f3	79539-601	HUMAN OTC DRUG	Instant Hand Sanitizeing Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201121		OTC MONOGRAPH DRUG	M003	Shandong Yayun Sanitary Products Co., Ltd.	BENZALKONIUM CHLORIDE	.05	mg/1001			N	20241231
79542-201_0d8c8187-20b2-54ec-e063-6394a90ac5a0	79542-201	HUMAN OTC DRUG	Mi Deurium Antibacterial Wet Wipes		Glyceryl laurate	LIQUID	TOPICAL	20200710		UNAPPROVED DRUG OTHER		SEOJEON CO., LTD	GLYCERYL LAURATE	10	g/100g			N	20241231
79546-201_fbcb11fb-dcb3-ee80-e053-6294a90ac8d9	79546-201	HUMAN OTC DRUG	MOCHEASU ALOPECIA-Shampoo		Zinc Pyrithione, Salicylic Acid	SHAMPOO	TOPICAL	20200711		OTC MONOGRAPH FINAL	M032	Somi T Na Co., Ltd	PYRITHIONE ZINC; SALICYLIC ACID	.3; .2	g/100mL; g/100mL			N	20241231
79561-000_0ccfe939-f2cd-4119-e063-6294a90a2312	79561-000	HUMAN OTC DRUG	Sterlomax Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	47.2	mL/59mL			N	20241231
79561-001_0ccfeffc-5814-4580-e063-6294a90a3b79	79561-001	HUMAN OTC DRUG	Sterlomax Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	188.8	mL/236mL			N	20241231
79561-002_0ccfe45f-2181-27e3-e063-6294a90a984d	79561-002	HUMAN OTC DRUG	Sterlomax Hand Sanitizer Professional		ALCOHOL	SOLUTION	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	80	mL/100mL			N	20241231
79561-003_0ccff397-b397-433e-e063-6294a90a6a40	79561-003	HUMAN OTC DRUG	Sterlomax Hand Sanitizer Professional		ALCOHOL	SOLUTION	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	400	mL/500mL			N	20241231
79561-004_0ccfe45f-2182-27e3-e063-6294a90a984d	79561-004	HUMAN OTC DRUG	Sterlomax Hand Sanitizer Professional		ALCOHOL	SOLUTION	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	4	L/5L			N	20241231
79561-005_0ccfe45f-2183-27e3-e063-6294a90a984d	79561-005	HUMAN OTC DRUG	Sterlomax Hand Sanitizer Professional		ALCOHOL	SOLUTION	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	3.024	L/3.78L			N	20241231
79561-008_0ccfe788-9684-211b-e063-6394a90a6100	79561-008	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
79561-009_0ccff037-bb9a-45d6-e063-6294a90ae6a6	79561-009	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ISOPROPYL ALCOHOL	375	mL/500mL			N	20241231
79561-010_0ccfe788-9685-211b-e063-6394a90a6100	79561-010	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	SOLUTION	TOPICAL	20200330		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ISOPROPYL ALCOHOL	3.75	L/5L			N	20241231
79561-011_0ccfe788-9687-211b-e063-6394a90a6100	79561-011	HUMAN OTC DRUG	Hand Sanitizer		Isopropyl Alcohol	SOLUTION	TOPICAL	20200721		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ISOPROPYL ALCOHOL	2.835	L/3.78L			N	20241231
79561-012_0ccff037-bb9b-45d6-e063-6294a90ae6a6	79561-012	HUMAN OTC DRUG	Sterlomax Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	47.2	mL/59mL			N	20241231
79561-013_0ccfe939-f2cf-4119-e063-6294a90a2312	79561-013	HUMAN OTC DRUG	Sterlomax Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200720		OTC MONOGRAPH DRUG	505G(a)(3)	Natures Only Inc.	ALCOHOL	188.8	mL/236mL			N	20241231
79577-7000_fcd992d8-d97c-85f2-e053-6394a90a7c8b	79577-7000	HUMAN OTC DRUG	DERMATOLOGICAL		BUTYLATED HYDROXYTOLUENE	SOAP	TOPICAL	20230504		OTC MONOGRAPH NOT FINAL	part333A	PROMAQUILA DE COCULA, S.A. DE C.V.	ALCOHOL; BUTYLATED HYDROXYTOLUENE	.001; .001	g/g; g/g			N	20241231
79587-100_0a4f2ee3-07f0-0445-e063-6394a90a6499	79587-100	HUMAN OTC DRUG	Raloy Pharma Hand Sanitizer Gel		ALCOHOL	GEL	TOPICAL	20200727	20240401	OTC MONOGRAPH DRUG	M003	Raloy Lubricantes, S.A. de C.V.	ALCOHOL	75	mL/100mL			N	
79587-200_0a4f31fc-4ebe-fd4b-e063-6394a90aafee	79587-200	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200330	20240401	OTC MONOGRAPH DRUG	M003	Raloy Lubricantes, S.A. de C.V.	ALCOHOL	80	mL/100mL			N	
79596-005_0370680d-aeef-d212-e063-6394a90aa8db	79596-005	HUMAN OTC DRUG	TOO FACED HANGOVER GOOD TO GO SPF 25 BROAD SPECTRUM MOISTURIZER		AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE	LOTION	TOPICAL	20190615		OTC MONOGRAPH FINAL	M020	TOO FACED COSMETICS LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 80; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79596-006_f1785b65-5aea-3b20-e053-2a95a90ad930	79596-006	HUMAN OTC DRUG	BORN THIS WAY HEALTHY GLOW SPF30		OCTINOXATE,TITANIUM DIOXIDE,ZINC OXIDE	EMULSION	TOPICAL	20230112		OTC MONOGRAPH FINAL	M020	TOO FACED COSMETICS LLC	OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	50; 31; 22	mg/mL; mg/mL; mg/mL			N	20241231
79618-001_f060cee9-5395-7126-e053-2995a90afbf1	79618-001	HUMAN OTC DRUG	Alcohol Wipe		ALCOHOL	CLOTH	TOPICAL	20201031		OTC MONOGRAPH NOT FINAL	part333A	YAHON ENTERPRISE CO.,LTD	ALCOHOL	75	mL/1001			N	20241231
79618-001_f060cee9-5396-7126-e053-2995a90afbf1	79618-001	HUMAN OTC DRUG	Alcohol Wipe		ALCOHOL	CLOTH	TOPICAL	20200711		OTC MONOGRAPH NOT FINAL	part333A	YAHON ENTERPRISE CO.,LTD	ALCOHOL	75	mL/1001			N	20241231
79618-001_f060da42-8dea-5f8d-e053-2a95a90ac38b	79618-001	HUMAN OTC DRUG	Alcohol Wipe		ALCOHOL	CLOTH	TOPICAL	20200711		OTC MONOGRAPH NOT FINAL	part333A	YAHON ENTERPRISE CO.,LTD	ALCOHOL	75	mL/1001			N	20241231
79618-001_f060da42-8deb-5f8d-e053-2a95a90ac38b	79618-001	HUMAN OTC DRUG	Alcohol Wipe		ALCOHOL	CLOTH	TOPICAL	20200711		OTC MONOGRAPH NOT FINAL	part333A	YAHON ENTERPRISE CO.,LTD	ALCOHOL	75	mL/1001			N	20241231
79618-001_f060db92-7755-3a9b-e053-2995a90a6d51	79618-001	HUMAN OTC DRUG	Alcohol Wipe		ALCOHOL	CLOTH	TOPICAL	20200711		OTC MONOGRAPH NOT FINAL	part333A	YAHON ENTERPRISE CO.,LTD	ALCOHOL	75	mL/1001			N	20241231
79618-001_f060dcfc-722b-96aa-e053-2a95a90a0709	79618-001	HUMAN OTC DRUG	Alcohol Wipe		ALCOHOL	CLOTH	TOPICAL	20200711		OTC MONOGRAPH NOT FINAL	part333A	YAHON ENTERPRISE CO.,LTD	ALCOHOL	75	mL/1001			N	20241231
79618-001_f060e027-fae0-791e-e053-2995a90a944d	79618-001	HUMAN OTC DRUG	Alcohol Wipe		ALCOHOL	CLOTH	TOPICAL	20200721		OTC MONOGRAPH NOT FINAL	part333A	YAHON ENTERPRISE CO.,LTD	ALCOHOL	75	mL/1001			N	20241231
79622-010_179ef983-ea03-496a-be62-7ce509cea793	79622-010	HUMAN PRESCRIPTION DRUG	Tembexa		Brincidofovir	TABLET, FILM COATED	ORAL	20220420		NDA	NDA214461	Chimerix, Inc.	BRINCIDOFOVIR	100	mg/1			N	20241231
79622-012_2f140fb3-5828-484b-b006-529b7f31c036	79622-012	HUMAN PRESCRIPTION DRUG	Tembexa		Brincidofovir	SUSPENSION	ORAL	20220420		NDA	NDA214460	Chimerix, Inc.	BRINCIDOFOVIR	10	mg/mL			N	20241231
79625-001_fa540a8c-f2b1-4f90-be96-9b08bb201663	79625-001	HUMAN OTC DRUG	JLo Beauty That Big Screen Broad Spectrum SPF 30 Moisturizer		Homosalate, Octisalate, and Zinc Oxide	CREAM	TOPICAL	20210401		OTC MONOGRAPH DRUG	M020	Ascendant Beauty LLC	HOMOSALATE; OCTISALATE; ZINC OXIDE	150; 50; 30	mg/mL; mg/mL; mg/mL			N	20241231
79631-000_0899cafe-9050-8a8e-e063-6394a90a1f0e	79631-000	HUMAN OTC DRUG	HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200718		OTC MONOGRAPH DRUG	505G(a)(3)	Andaz Group LLC	ALCOHOL	.75	mL/mL			N	20241231
79643-001_075f048f-70ba-971f-e063-6394a90a3108	79643-001	HUMAN OTC DRUG	Lidocanna		LIDOCAINE	PATCH	TOPICAL	20200629		OTC MONOGRAPH DRUG	M017	PHARMACURE, INC.	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79643-002_f6c907a3-9627-f893-e053-6294a90a31af	79643-002	HUMAN PRESCRIPTION DRUG	Capsaicin		Capsaicin	PATCH	TOPICAL	20210202		UNAPPROVED DRUG OTHER		PHARMACURE, INC.	CAPSAICIN	.025	g/100g			N	20241231
79643-003_f6c901e2-a565-df63-e053-6294a90a7aaa	79643-003	HUMAN OTC DRUG	Methyl Salicylate		Methyl Salicylate	PATCH	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part348	PHARMACURE, INC.	METHYL SALICYLATE	100	mg/1000mg			N	20241231
79662-001_f55092be-6bd0-c13d-e053-2a95a90a45cb	79662-001	HUMAN OTC DRUG	Rain Renewal Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20200918		OTC MONOGRAPH FINAL	part349	Rain Eye Drops, LLC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
79662-002_0a5f2fa9-3a78-ec8a-e063-6294a90aa869	79662-002	HUMAN OTC DRUG	Rain Renewal Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20210215		OTC MONOGRAPH DRUG	M018	Rain Eye Drops, LLC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
79662-002_0a5f5aa5-a98a-83d4-e063-6394a90ac015	79662-002	HUMAN OTC DRUG	Rain Renewal Eye Drops		carboxymethylcellulose sodium	SOLUTION/ DROPS	OPHTHALMIC	20200918		OTC MONOGRAPH DRUG	M018	Rain Eye Drops, LLC	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	.5	g/100mL			N	20241231
79672-613_08a53274-1299-4099-8fff-052a5ccdad0b	79672-613	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170525		ANDA	ANDA207956	Nextgen Pharmaceuticals LLC	SODIUM CHLORIDE	9	g/1000mL			N	20241231
79672-825_900434b9-beb1-4c1d-9265-7185b38e3b6e	79672-825	HUMAN PRESCRIPTION DRUG	Oxaliplatin		OXALIPLATIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200701		ANDA	ANDA204616	Nextgen Pharmaceuticals LLC	OXALIPLATIN	50	mg/10mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
79672-826_900434b9-beb1-4c1d-9265-7185b38e3b6e	79672-826	HUMAN PRESCRIPTION DRUG	Oxaliplatin		OXALIPLATIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20200701		ANDA	ANDA204616	Nextgen Pharmaceuticals LLC	OXALIPLATIN	100	mg/20mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
79680-002_ad8561f9-c673-4d57-bb2f-0fdd1d53ccbf	79680-002	HUMAN OTC DRUG	Saiveroy Alcohol Wipes		ALCOHOL	SWAB	TOPICAL	20200728		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Saiveroy Cleaning Products Co., LTD.	ALCOHOL	75	g/100g			N	20241231
79680-004_bd3be23a-a9b0-4d4c-9d7f-a695a3ef19a1	79680-004	HUMAN OTC DRUG	Saiveroy Alcohol Disinfectant Wipes		ALCOHOL	SWAB	TOPICAL	20200728		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Saiveroy Cleaning Products Co., LTD.	ALCOHOL	75	g/100g			N	20241231
79680-006_dd0fd877-99a5-498b-9f09-d16009830506	79680-006	HUMAN OTC DRUG	LIFECARE Antibacterial Sanitizing Wet Wipes		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20201104		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Saiveroy Cleaning Products Co., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
79680-008_40390652-c23a-4195-b1a2-f5e43489f829	79680-008	HUMAN OTC DRUG	LIFEGUARD DISINFECTING WIPES		BENZALKONIUM CHLORIDE	SWAB	TOPICAL	20201207		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Saiveroy Cleaning Products Co., LTD.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
79705-002_ee26f5f8-cd7f-60fb-e053-2a95a90a877a	79705-002	HUMAN OTC DRUG	BIG WIPES Multi-Purpose		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200831	20251031	OTC MONOGRAPH NOT FINAL	part333A	Sycamore USA Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
79705-003_ee270a38-0ec5-0b44-e053-2a95a90a2ba5	79705-003	HUMAN OTC DRUG	BIG WIPES Heavy Duty		Benzalkonium Chloride	CLOTH	TOPICAL	20200828	20251031	OTC MONOGRAPH NOT FINAL	part333A	Sycamore USA Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
79734-010_ab3c93b6-7bf3-9c27-e053-2a95a90a2b9c	79734-010	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200723		OTC MONOGRAPH NOT FINAL	part333E	Callington Inc.	ALCOHOL	62	mL/100mL			N	20241231
79734-034_ab129fca-2caa-62b8-e053-2a95a90af288	79734-034	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200723		OTC MONOGRAPH NOT FINAL	part333E	Callington Inc.	ALCOHOL	62	mL/100mL			N	20241231
79739-7097_9004cf80-5ded-482e-89ca-841fcd89f778	79739-7097	HUMAN PRESCRIPTION DRUG	Glycopyrrolate		Glycopyrrolate	TABLET	ORAL	20120312		ANDA	ANDA091522	LGM PHARMA SOLUTIONS, LLC	GLYCOPYRROLATE	1.5	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
79739-7121_c32a8220-2b23-4186-82ed-1d994075104b	79739-7121	HUMAN PRESCRIPTION DRUG	Chenodiol		Chenodiol	TABLET, FILM COATED	ORAL	20091022		ANDA	ANDA091019	LGM PHARMA SOLUTIONS, LLC	CHENODIOL	250	mg/1			N	20241231
79740-006_f1e1e29b-c1eb-3eb3-e053-2a95a90af2da	79740-006	HUMAN OTC DRUG	TIDL Sport Plant Powered		TIDL Sport Plant Powered Spray	SPRAY	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part348	ANTHOS GROUP, INC, THE	MENTHOL	10.5	g/100mL			N	20241231
79740-007_f1e21048-6b49-df20-e053-2a95a90ae667	79740-007	HUMAN OTC DRUG	Hemp Powered		Menthol 10.5%	SPRAY	TOPICAL	20210623		OTC MONOGRAPH NOT FINAL	part348	The Anthos Group	MENTHOL	10.5	g/100mL			N	20241231
79740-012_0baa3842-79e3-9735-e063-6294a90ab4ea	79740-012	HUMAN OTC DRUG	Tidl Full Body Pain Relief Cryotherapy Spray.		Full Body Pain Relief Cryotherapy Spray.	LIQUID	TOPICAL	20231203		OTC MONOGRAPH DRUG	M017	The Anthos Group, Inc	MENTHOL	10.5	g/100mL			N	20241231
79747-004_dc388063-f337-4686-8288-0eb3b3295eca	79747-004	HUMAN OTC DRUG	SPF 50 Sunscreen Stick		Zinc Oxide	STICK	TOPICAL	20210210		OTC MONOGRAPH NOT FINAL	part352	ELEEO Brands LLC	ZINC OXIDE	200	mg/g			N	20241231
79747-200_813275da-0edb-4bba-b0a4-bca9822b39bf	79747-200	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part333A	ElEEO Brands LLC	ALCOHOL	3.56	mL/mL			N	20241231
79753-007_f654b976-ecb5-1304-e053-2a95a90a8c74	79753-007	HUMAN OTC DRUG	Baby Bare Republic Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20201026		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	ZINC OXIDE	12	mg/mL			N	20241231
79753-009_7a1f9caf-7887-4f00-80f6-5f74db74c4ef	79753-009	HUMAN OTC DRUG	Baby Bare Republic Mineral Sunscreen SoftStick SPF 50		ZINC OXIDE	STICK	TOPICAL	20210303		OTC MONOGRAPH DRUG	M020	COOLA LLC	ZINC OXIDE	17.9	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-013_bcd2579d-f696-2459-e053-2a95a90abcff	79753-013	HUMAN OTC DRUG	COOLA BARE REPUBLIC CLEARSCREEN SPF30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 15	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79753-014_f14b0125-626b-c2c7-e053-2995a90a2161	79753-014	HUMAN OTC DRUG	COOLA BARE REPUBLIC CLEARSCREEN SPF50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79753-015_e013ac7e-9756-4d2c-8173-0ef7d53ad729	79753-015	HUMAN OTC DRUG	COOLA Classic Body Sunscreen SPF 70 - Peach Blossom		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20210208		OTC MONOGRAPH DRUG	M020	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 4.9; 7.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79753-018_20808356-02e6-4e90-8228-085e5b2f2ee0	79753-018	HUMAN OTC DRUG	COOLA Liplux Hydrating Oil SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	OIL	TOPICAL	20201222		OTC MONOGRAPH DRUG	M020	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 4; 4; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79753-020_1cc9aa13-9722-40c4-b356-c18a20fd432d	79753-020	HUMAN OTC DRUG	COOLA Full Spectrum 360 Refreshing Water Cream SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20210208		OTC MONOGRAPH DRUG	M020	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 3; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79753-021_f14d0b44-0fc5-9633-e053-2a95a90afa6d	79753-021	HUMAN OTC DRUG	COOLA BARE REPUBLIC CLEARSCREEN SPF100		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211021		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79753-022_f150431c-0c0a-a23e-e053-2a95a90ab8e0	79753-022	HUMAN OTC DRUG	COOLA BARE REPUBLIC CLEARSCREEN SPF100		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211021		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79753-023_f14d70a5-3044-77db-e053-2a95a90a2a86	79753-023	HUMAN OTC DRUG	COOLA BARE REPUBLIC CLEARSCREEN SUNSCREEN SPF100		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210923		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
79753-026_8246c27d-f27a-4a31-9e5a-7ebd44ce81ef	79753-026	HUMAN OTC DRUG	Bare Republic Big Adventure Stick SPF 70		TITANIUM DIOXIDE 3.5% ZINC OXIDE 16.9%	STICK	TOPICAL	20220201		OTC MONOGRAPH DRUG	M020	COOLA	TITANIUM DIOXIDE; ZINC OXIDE	3.5; 16.9	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-029_bbf15e58-c161-d599-e053-2a95a90a0696	79753-029	HUMAN OTC DRUG	COOLA BARE REPUBLIC MINERAL SPORT SPF50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20181101		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	TITANIUM DIOXIDE; ZINC OXIDE	29; 78	mg/mL; mg/mL			N	20241231
79753-030_ba9df08b-08ea-f8c6-e053-2a95a90a9233	79753-030	HUMAN OTC DRUG	COOLA BARE HANDS BY BARE REPUBLIC HAND SANITIZER		ALCOHOL	SPRAY	TOPICAL	20200610		OTC MONOGRAPH NOT FINAL	part333A	COOLA, LLC	ALCOHOL	70	mg/mL			N	20241231
79753-032_baadc174-19ed-4d2b-b5be-67b9bcc855ef	79753-032	HUMAN OTC DRUG	Mineral Sunscreen Stick SPF 50	Fragrance-Free	ZINC OXIDE	STICK	TOPICAL	20230116		OTC MONOGRAPH FINAL	part352	COOLA LLC	ZINC OXIDE	13.63	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-033_f883266a-063d-3323-e053-6294a90ab696	79753-033	HUMAN OTC DRUG	Coola	SPF 50 Classic	Sunscreen Face Mist	SPRAY	TOPICAL	20211102		OTC MONOGRAPH NOT FINAL	part352	COOLA LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.9; 4.9; 9.5	g/100mL; g/100mL; g/100mL			N	20241231
79753-035_391c57fe-bf3f-4af1-9130-2e1559e443e8	79753-035	HUMAN OTC DRUG	Refreshing Water Hydration Stick	SPF 50	AVOBENZONE OCTISALATE HOMOSALATE OCTOCRYLENE	STICK	TOPICAL	20230116		OTC MONOGRAPH FINAL	part352	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.5; 3.5; 2.15; 5	g/100g; g/100g; g/100g; g/100g			N	20241231
79753-039_0c6bbbd7-dc84-a232-e063-6394a90a5acb	79753-039	HUMAN OTC DRUG	ScalpHair MistSunscreen SPF30		COOLA ScalpHair Mist Organic Sunscreen SPF30	SPRAY	TOPICAL	20191001		OTC MONOGRAPH DRUG	M020	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.5; 3.6; 3; 4.2	g/60mL; g/60mL; g/60mL; g/60mL			N	20241231
79753-040_fd8d8777-b375-001a-e053-6394a90ab66a	79753-040	HUMAN OTC DRUG	COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20190601		OTC MONOGRAPH FINAL	M020	COOLA, LLC	TITANIUM DIOXIDE; ZINC OXIDE	35; 72.5	mg/mL; mg/mL			N	20241231
79753-041_2afb4f90-07f2-4b17-afb2-7d57e211ab6b	79753-041	HUMAN OTC DRUG	Coola Bare Republic Mineral Face-Lotion	SPF 70	TITANIUM DIOXIDE 3.5% ZINC OXIDE 15.8%	LOTION	TOPICAL	20200501		OTC MONOGRAPH DRUG	M020	COOLA LLC	TITANIUM DIOXIDE; ZINC OXIDE	3.5; 15.8	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-042_84b18d74-d0ed-434c-8cf2-75e6a6eb94b8	79753-042	HUMAN OTC DRUG	Coola Bare Republic Mineral Body Gel-Lotion	SPF 30	ZINC OXIDE 18.2%	LOTION	TOPICAL	20200302		OTC MONOGRAPH DRUG	M020	COOLA LLC	ZINC OXIDE	18.2	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-043_fda9b242-5ad3-4e79-90c0-91fa01523771	79753-043	HUMAN OTC DRUG	Coola Bare Republic Mineral Face Gel-Lotion	SPF 30	ZINC OXIDE 18.2%	LOTION	TOPICAL	20200302		OTC MONOGRAPH DRUG	M020	COOLA LLC	ZINC OXIDE	18.2	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-044_883e9824-5d48-41d4-bb0a-6872124f39d4	79753-044	HUMAN OTC DRUG	Sheer Matte SPF 30		ZINC OXIDE 10.5%	LOTION	TOPICAL	20220201		OTC MONOGRAPH DRUG	M020	COOLA	ZINC OXIDE	10.5	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-045_cfeaf245-41af-644d-e053-2995a90a4a34	79753-045	HUMAN OTC DRUG	COOLA CLASSIC SUNSCREEN FRAGRANCE FREE		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20180101		OTC MONOGRAPH NOT FINAL	part352	COOLA, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79753-053_fafa1bcd-516e-8ecd-e053-6394a90a77e2	79753-053	HUMAN OTC DRUG	COOLA Mineral Body SPF 30 Tropical Coconut		Zinc Oxide	LOTION	TOPICAL	20191101		OTC MONOGRAPH FINAL	M020	COOLA, LLC	ZINC OXIDE	14.2	g/100mL			N	20241231
79753-069_194167a2-0ac9-497c-a984-cfe4542abc29	79753-069	HUMAN OTC DRUG	Bare Republic Mineral SPF 50		ZINC OXIDE	STICK	TOPICAL	20230116		OTC MONOGRAPH FINAL	part352	COOLA LLC	ZINC OXIDE	17.9	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-070_01e221ba-9bce-4d69-b576-de96d6074b44	79753-070	HUMAN OTC DRUG	COOLA Mineral Sun Silk Creme Sunscreen	SPF 30	ZINC OXIDE	LOTION	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part352	COOLA LLC	ZINC OXIDE	158	mg/mL			N	20241231
79753-073_c2df38eb-16ee-4f72-9ba5-4d9579c590a2	79753-073	HUMAN OTC DRUG	COOLA CLASSIC FACE SUNSCREEN Cucumber Broad Spectrum	SPF 30	AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	part352	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.75; 2.5; 1.5; 3.75	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79753-074_1c53bea8-c68b-4202-b4fb-df01111e882f	79753-074	HUMAN OTC DRUG	COOLA Classic Face Sunscreen Fragrance-Free	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	part352	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	17.5; 50; 20; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79753-075_07213063-d2ae-49fc-af7a-73f741395e31	79753-075	HUMAN OTC DRUG	COOLA CLASSIC BODY SUNSCREEN Guava Mango Broad Spectrum	SPF 50	AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	part352	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.75; 5; 2; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79753-076_701e4bf8-2d1e-463f-ac70-fff4fe0331fb	79753-076	HUMAN OTC DRUG	COOLA Classic Body Sunscreen Tropical Coconut	SPF 30	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230201		OTC MONOGRAPH FINAL	part352	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	17.5; 22.5; 15; 37.5	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79753-078_6ac723d3-9a33-44db-810b-f86f231c8107	79753-078	HUMAN OTC DRUG	Mineral Sun Silk Moisturizer Sunscreen	SPF 30	ZINC OXIDE 13.5%	CREAM	TOPICAL	20230201		OTC MONOGRAPH FINAL	part352	COOLA LLC	ZINC OXIDE	135	mg/mL			N	20241231
79753-079_4c6d2b61-9129-414e-b706-73b01a934e51	79753-079	HUMAN OTC DRUG	COOLA Refreshing Water Mist SPF 18		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part352	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 10; 5; 5.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79753-080_9c0ac914-f34b-4c53-9062-2bf74ce987b0	79753-080	HUMAN OTC DRUG	COOLA Clear Skin Oil-Free Moisturizer SPF 30		Zinc Oxide Sunscreen	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	COOLA LLC	ZINC OXIDE	14.7	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79753-081_03562bd0-c7c8-496b-a80f-d3ab665cff54	79753-081	HUMAN OTC DRUG	COOLA Refreshing Water Plumping Gel Serum SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	COOLA LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 6; 5; 7	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79790-000_0b6e3a15-d5e1-1cab-e063-6294a90a8fd3	79790-000	HUMAN OTC DRUG	Tetracyte Topical		TETRACYCLINE HYDROCHLORIDE	OINTMENT	TOPICAL	20200701		OTC MONOGRAPH DRUG	M004	WOUNDS PROS, LLC	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
79790-001_0b6e2e9a-a928-0d1c-e063-6394a90aa411	79790-001	HUMAN OTC DRUG	Tetracyte Topical		TETRACYCLINE HYDROCHLORIDE	SPRAY	TOPICAL	20200701		OTC MONOGRAPH DRUG	M004	WOUNDS PROS, LLC	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
79794-110_f2184b0f-d130-9460-e053-2995a90acc4b	79794-110	HUMAN OTC DRUG	BIOPURE 1400CT ANTI BACTERIAL HAND WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20230113		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Furuisen Spunlaced Nonwovens Co., Ltd.	BENZALKONIUM CHLORIDE	.12	g/1001			N	20241231
79794-111_fdadef7a-1b7f-5bf5-e053-6294a90ae9e9	79794-111	HUMAN OTC DRUG	HYDROGEN PEROXIDE		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20230609		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Furuisen Spunlaced Nonwovens Co., Ltd.	HYDROGEN PEROXIDE	3	g/100g			N	20241231
79794-112_042149c9-a207-8462-e063-6394a90a7252	79794-112	HUMAN OTC DRUG	BIOPURE 1600CT ANTIBACTERIAL HAND WIPES		Benzalkonium Chloride	PATCH	TOPICAL	20230830		OTC MONOGRAPH NOT FINAL	part333E	Zhejiang Furuisen Spunlaced Nonwovens Co., Ltd.	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
79802-200_c08b4209-c9d8-436e-8d5a-884b29983550	79802-200	HUMAN PRESCRIPTION DRUG	Rezurock		belumosudil	TABLET	ORAL	20210716		NDA	NDA214783	Kadmon Pharmaceuticals, LLC	BELUMOSUDIL	200	mg/1			N	20241231
79804-032_0b508c1c-5435-5a82-e063-6294a90ab8c6	79804-032	HUMAN OTC DRUG	Ninjacof Cotton Candy Flavor- 16 oz		antitussive and antihistamine	LIQUID	ORAL	20211217		OTC MONOGRAPH DRUG	M012	Eagle Labs Inc.	CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE	12.5; 12.5	mg/5mL; mg/5mL			N	20241231
79832-401_f1fda07f-e1f7-2be6-e053-2995a90a4c05	79832-401	HUMAN OTC DRUG	Kleen Start Hand Sanitizer		Benzalkonium chloride	LIQUID	TOPICAL	20210201	20241231	OTC MONOGRAPH NOT FINAL	part333A	BioSyn Inc	BENZALKONIUM CHLORIDE	.0013	g/L			N	
79835-701_08dc49b6-b10a-9e0a-e063-6394a90aec2e	79835-701	HUMAN OTC DRUG	Lemyn Organics Medical-Grade Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201006		OTC MONOGRAPH DRUG	M003	Lemyn LLC	ALCOHOL	70	mL/100mL			N	20241231
79849-001_e2856928-dcda-36c5-e053-2a95a90ae4b1	79849-001	HUMAN OTC DRUG	Dynamic Drying		Calamine 15% and Zinc Oxide 2%	LOTION	TOPICAL	20200701	20240610	OTC MONOGRAPH FINAL	part347	Guangzhou Xiran Cosmetics Co.,Ltd	ZINC OXIDE	170	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	
79885-001_08f4921c-1409-d756-e063-6294a90a746f	79885-001	HUMAN OTC DRUG	Top of Texas Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200701		OTC MONOGRAPH DRUG	M003	Top Shelf Industries Operating, LTD	ALCOHOL	70	mL/100mL			N	20241231
79903-000_2517db24-3263-45e7-aed0-7d955d198c96	79903-000	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA204812	Wal-Mart Stores, Inc.	OLOPATADINE HYDROCHLORIDE	1	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]		N	20241231
79903-001_0c3d13c1-95fd-4bf6-ac9d-cf0b801b8568	79903-001	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Wal-Mart Stores, Inc.	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
79903-002_4779d76d-591c-468d-ad85-d2290c0a583a	79903-002	HUMAN OTC DRUG	Equate Mens Bold Scent 2 in 1 Dandruff SH and COND	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20201105		OTC MONOGRAPH FINAL	part358H	Wal-Mart Stores, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
79903-003_6aa6daaa-172e-4b4a-b52c-e7836a6c1d1c	79903-003	HUMAN OTC DRUG	Equate Mens Ultra Sport 2 in 1 Dandruff SH and COND	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20201105		OTC MONOGRAPH FINAL	part358H	Wal-Mart Stores, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
79903-004_27c69231-ba49-42a5-921a-456f5ab2a273	79903-004	HUMAN OTC DRUG	Equate Soft and Smooth 2 in 1 Dandruff SH and COND	Anti-Dandruff	Pyrithione Zinc	SHAMPOO	TOPICAL	20201105		OTC MONOGRAPH FINAL	part358H	Wal-Mart Stores, Inc.	PYRITHIONE ZINC	10	mg/mL			N	20241231
79903-005_43dbf861-15a0-4a1f-95a7-359586092784	79903-005	HUMAN OTC DRUG	All Day Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20201022		ANDA	ANDA204872	WALMART INC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79903-006_0d1c36f6-2a5f-53fd-e063-6394a90a99c4	79903-006	HUMAN OTC DRUG	Equate Cool and Heat Pain Relieving Liquid		Cool and Heat Pain Relief	LIQUID	TOPICAL	20200817		OTC MONOGRAPH DRUG	M017	Walmart, Inc.	MENTHOL	16	mg/100mL			N	20241231
79903-007_f0f2c680-ac99-af33-e053-2a95a90a68cc	79903-007	HUMAN OTC DRUG	Tanning Sunscreen UVB Protection Dry Oil	Equate	Avobenzone, Homosalate, Octisalate	AEROSOL, SPRAY	TOPICAL	20200831		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE	20; 100; 50	mg/g; mg/g; mg/g			N	20241231
79903-008_0ea6e88f-9c1d-1fe5-e063-6394a90ae867	79903-008	HUMAN OTC DRUG	DYE-FREE CHILDRENS LORATADINE		LORATADINE	TABLET, CHEWABLE	ORAL	20210101		ANDA	ANDA210088	WAL-MART STORES, INC	LORATADINE	5	mg/1			N	20251231
79903-009_65af4249-d64e-4841-a46e-2c94c7367677	79903-009	HUMAN OTC DRUG	Stool Softener Laxative		Docusate sodium, Sennosides	TABLET	ORAL	20201231		OTC MONOGRAPH NOT FINAL	part334	WALMART INC. (see also Equate)	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
79903-011_f6cc6056-7479-4fd7-934a-2cd84a28032c	79903-011	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20210601		ANDA	ANDA208754	WALMART INC. (see also Equate)	DOCOSANOL	100	mg/g			N	20241231
79903-012_0d383700-e254-881f-e063-6294a90a347c	79903-012	HUMAN OTC DRUG	Equate Redness and Dry Eye Relief Eye Drops		Glycerin, Naphazoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20201212		OTC MONOGRAPH DRUG	M018	Wal-Mart Stores, Inc.	GLYCERIN; NAPHAZOLINE HYDROCHLORIDE	.25; .012	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
79903-013_c24c3326-99da-4c7d-aecc-7b4a8ac3f04e	79903-013	HUMAN OTC DRUG	equate omeprazole and sodium bicarbonate		Omeprazole, sodium bicarbonate	CAPSULE, GELATIN COATED	ORAL	20210430		ANDA	ANDA201361	Wal-Mart Stores Inc	OMEPRAZOLE; SODIUM BICARBONATE	20; 1100	mg/1; mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
79903-014_f31ee57f-cc25-5811-e053-2a95a90ac22d	79903-014	HUMAN OTC DRUG	Miconazole Nitrate		Athletes Foot Powder Spray Talc Free	AEROSOL, POWDER	TOPICAL	20210301		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc	MICONAZOLE NITRATE	2.6	g/130g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
79903-015_f31ed84d-7bb5-db54-e053-2a95a90a2f89	79903-015	HUMAN OTC DRUG	Tolnaftate		Antifungal Liquid Spray	AEROSOL, SPRAY	TOPICAL	20210301		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc	TOLNAFTATE	1.5	g/150g			N	20241231
79903-016_f31ec594-5f2f-87a8-e053-2a95a90ada3f	79903-016	HUMAN OTC DRUG	Tolnafate		Tolnaftate Powder Spray	AEROSOL, SPRAY	TOPICAL	20210301		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc	TOLNAFTATE	1.3	g/130g			N	20241231
79903-017_c8d6d924-2a36-fe6c-e053-2995a90ac773	79903-017	HUMAN OTC DRUG	Walmart Equate Beauty Ultra Light Sunscreen Broad Spectrum SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 70	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-019_c8d55407-73b2-9c5e-e053-2a95a90a3095	79903-019	HUMAN OTC DRUG	WALMART EQUATE BEAUTY ULTRA LIGHT SUNSCREEN SPF 100		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	LOTION	TOPICAL	20201008		OTC MONOGRAPH NOT FINAL	part352	WAL-MART STORES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 150; 50; 100; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-020_8b491f85-3549-49e8-b24b-59515aa54cfb	79903-020	HUMAN OTC DRUG	Simethicone		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20201218		OTC MONOGRAPH FINAL	part332	WALMART INC.	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20241231
79903-021_06c39159-81ae-49b9-86da-912689802a21	79903-021	HUMAN OTC DRUG	Equate Cold Therapy Pain Relieving	Analgesic	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20201228		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores, Inc.	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
79903-022_57494ca6-619e-4aad-82cf-83d380042057	79903-022	HUMAN OTC DRUG	Equate Cold Therapy Pain Relieving Roll-on	Analgesic	MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20210114		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores, Inc.	MENTHOL, UNSPECIFIED FORM	40	mg/mL			N	20241231
79903-025_f2f21c02-a2bf-689c-e053-2a95a90a2166	79903-025	HUMAN OTC DRUG	Gum Detoxify		Stannous fluoride	PASTE, DENTIFRICE	DENTAL	20210701		OTC MONOGRAPH FINAL	part355	Walmart	STANNOUS FLUORIDE	.454	g/100g			N	20241231
79903-032_0bdebf2e-36f6-0c58-e063-6294a90a251c	79903-032	HUMAN OTC DRUG	EXTRA STRENGTH ACETAMINOPHEN		ACETAMINOPHEN	TABLET	ORAL	20210105		OTC MONOGRAPH DRUG	M013	Wal-Mart Stores Inc	ACETAMINOPHEN	500	mg/1			N	20241231
79903-033_629ee11a-efc0-4eb6-b826-bb6a7f1352e9	79903-033	HUMAN OTC DRUG	Anticavity		Sodium fluoride	RINSE	ORAL	20201119		OTC MONOGRAPH FINAL	part355	Wal-Mart	SODIUM FLUORIDE	.5	mg/mL			N	20241231
79903-037_eb2a46e0-74ec-4ed5-a383-d0a3a0fb73c7	79903-037	HUMAN OTC DRUG	Sunburn Relief		Lidocaine HCl 0.5%	GEL	TOPICAL	20201223		OTC MONOGRAPH NOT FINAL	part348	WALMART INC.	LIDOCAINE HYDROCHLORIDE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79903-038_b9bdcc3c-d47e-db7d-e053-2995a90a87d2	79903-038	HUMAN OTC DRUG	Equate Lidocaine Cool and Heat		Lidocaine 4% plus Menthol 1%	PATCH	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part348	Walmart Stores Inc	LIDOCAINE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79903-039_bd95a7b5-2ce6-9499-e053-2a95a90a7332	79903-039	HUMAN OTC DRUG	Equate Pain Relief Patch Camphor/Menthol/Salicylate		Camphor, Menthol, Methyl salicylate	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20210101		OTC MONOGRAPH NOT FINAL	part348	Walmart Stores Inc	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/100g; g/100g; g/100g			N	20241231
79903-042_06e6817e-6306-54eb-e063-6394a90a3444	79903-042	HUMAN OTC DRUG	Equate Benz-Dex Cough and Throat Lozenges		Benzocaine	LOZENGE	ORAL	20210423		OTC MONOGRAPH NOT FINAL	part356	Walmart	BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE	7.5; 5	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79903-046_f438fff4-83a7-132c-e053-2995a90ae812	79903-046	HUMAN OTC DRUG	Equate Black Elderberry Cold and Flu Relief		bryonia, gelsemium sempervirens, sambucus nigra, sulphur, zincum gluconicum	TABLET, ORALLY DISINTEGRATING	ORAL	20210622		UNAPPROVED HOMEOPATHIC		WAL-MART STORES INC	SAMBUCUS NIGRA FLOWERING TOP	3	[hp_X]/1			N	20241231
79903-047_f438fff4-83a8-132c-e053-2995a90ae812	79903-047	HUMAN OTC DRUG	Equate Non-Drowsy Flu Relief		cairina moschata heart/liver autolysate pellet	TABLET	ORAL	20210624		UNAPPROVED HOMEOPATHIC		WAL-MART STORES INC	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
79903-050_e103fd7e-9c07-435e-8a98-bf2836908dae	79903-050	HUMAN OTC DRUG	Pain Reliever PM		Acetaminophen, Diphenhydramine HCl	TABLET, COATED	ORAL	20210212		OTC MONOGRAPH DRUG	M013	WALMART INC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-053_0bdee309-31f3-7fe4-e063-6394a90ae280	79903-053	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEVER PM		ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20210113		OTC MONOGRAPH DRUG	M013	WALMART INC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-054_f7069f81-2d3c-4f0b-a94d-d5422b4bffed	79903-054	HUMAN OTC DRUG	Zinc cold Remedy	Non Drowsy	Zincum Gluconicum	TABLET	ORAL	20210106		UNAPPROVED HOMEOPATHIC		WALMART STORES INC	ZINC GLUCONATE	1	[hp_X]/1	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79903-055_f31ee607-043e-24d0-e053-2a95a90ada24	79903-055	HUMAN OTC DRUG	Tolnaftate		Anti-Fungal Liquid Maximum Strength	LIQUID	TOPICAL	20210316		OTC MONOGRAPH FINAL	part333C	Wal-Mart Stores, Inc.	TOLNAFTATE	.3	g/30mL			N	20241231
79903-056_0bdf2856-a96d-7e38-e063-6394a90a6ef5	79903-056	HUMAN OTC DRUG	ALLERGY RELIEF		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, FILM COATED	ORAL	20210128		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-057_0bdef627-38b5-7fac-e063-6394a90afa0c	79903-057	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20210128		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-058_f7f72d47-2d17-4316-8cdb-e1800332df80	79903-058	HUMAN OTC DRUG	SPF Beauty		SPF Beauty	LOTION	TOPICAL	20210520		OTC MONOGRAPH FINAL	part352	Wal-Mart Stores, Inc.	HOMOSALATE; ZINC OXIDE	50; 30	mg/mL; mg/mL			N	20241231
79903-059_4cbed341-adb2-4648-895c-9fd18d8caaf4	79903-059	HUMAN OTC DRUG	SPF Moisturizer		SPF Moisturizer	LOTION	TOPICAL	20210520		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
79903-061_cef6d274-d516-4d5f-8a22-9f05e904aef9	79903-061	HUMAN OTC DRUG	Equate Acne Wash	Acne medication	Benzoyl Peroxide	CREAM	TOPICAL	20210430		OTC MONOGRAPH FINAL	part333D	Wal-Mart Stores, Inc.	BENZOYL PEROXIDE	100	mg/g			N	20241231
79903-064_0bdee259-a5c3-7554-e063-6394a90a1b1f	79903-064	HUMAN OTC DRUG	Vegetable Laxative		SENNOSIDES	TABLET	ORAL	20210224		OTC MONOGRAPH DRUG	M007	Wal-Mart Stores Inc	SENNOSIDES	8.6	mg/1			N	20241231
79903-065_1ceed839-93d0-4124-9fb8-63fbb97b75ac	79903-065	HUMAN OTC DRUG	equate mucus relief dm		dextromethorphan hydrobromide, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20210623		ANDA	ANDA207602	Wal-Mart Stores Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30; 600	mg/1; mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79903-068_a2d1c879-24e1-4844-8c6d-1c87fee63674	79903-068	HUMAN OTC DRUG	equate lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210720		ANDA	ANDA202319	WALMART INC.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
79903-071_de8f3990-61d6-4584-bcf5-419667d68495	79903-071	HUMAN OTC DRUG	Equate Allergy Relief		Fluticasone propionate	SPRAY, METERED	NASAL	20210818		ANDA	ANDA207957	WALMART INC.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79903-072_fd67b4d2-e71d-4145-bf69-437d0aa86cd3	79903-072	HUMAN OTC DRUG	equate hair regrowth treatment		Minoxidil	SOLUTION	TOPICAL	20211208		ANDA	ANDA075357	WALMART INC.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
79903-073_a463d362-7fcd-4d72-a38c-25b566496f6f	79903-073	HUMAN OTC DRUG	Stool Softener Laxative	Extra Strength	Docusate Sodium	CAPSULE, LIQUID FILLED	ORAL	20210625		OTC MONOGRAPH NOT FINAL	part334	WALMART INC. (see also Equate)	DOCUSATE SODIUM	250	mg/1			N	20241231
79903-074_32e86cca-0a7c-4154-b178-23a29af96975	79903-074	HUMAN OTC DRUG	Allergy Relief		Chlorpheniramine maleate	TABLET	ORAL	20210901		OTC MONOGRAPH DRUG	M012	WALMART INC.	CHLORPHENIRAMINE MALEATE	4	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-075_f4200aec-7d61-42b9-88d3-a3bd1c249f6e	79903-075	HUMAN OTC DRUG	Sinus PE and Allergy		Chlorpheniramine Maleate, Phenylephrine HCl	TABLET	ORAL	20210901		OTC MONOGRAPH DRUG	M012	WALMART INC.	CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	4; 10	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-076_0fa4b08c-c7eb-49b5-9edb-be65749cd035	79903-076	HUMAN OTC DRUG	Sinus Congestion PE		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210831		OTC MONOGRAPH DRUG	M012	WALMART INC.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-082_f32dc2c2-e68b-ec1f-e053-2a95a90afe1f	79903-082	HUMAN OTC DRUG	Equate Repair and Protect		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20210923		OTC MONOGRAPH FINAL	part355	Walmart	STANNOUS FLUORIDE	.454	g/100g			N	20241231
79903-083_0beed72e-51dc-d15a-e063-6394a90af559	79903-083	HUMAN OTC DRUG	NIGHTTIME SLEEP AID		DIPHENHYDRAMINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210622		OTC MONOGRAPH DRUG	M010	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-084_c0deca1e-4095-45b7-92f0-12e6163b8afb	79903-084	HUMAN OTC DRUG	All Day Allergy		Cetirizine HCl	CAPSULE	ORAL	20211230		ANDA	ANDA213105	WALMART INC. (see also Equate)	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-085_f44d83ca-2d46-57b8-e053-2995a90a082e	79903-085	HUMAN OTC DRUG	Equate Sunscreen Tanning Oil With Coconut Oil SPF 6		Avobenzone, Homosalate	SPRAY	TOPICAL	20211115		OTC MONOGRAPH FINAL	M020	WAL-MART STORES INC.	AVOBENZONE; HOMOSALATE	5; 40	mg/mL; mg/mL			N	20241231
79903-086_f4110049-5f12-1620-e053-2a95a90a4faa	79903-086	HUMAN OTC DRUG	Equate Sunscreen for All Skin Tones SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20211215		OTC MONOGRAPH NOT FINAL	part352	Wal-Mart Stores Inc	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 45; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-087_e65b605a-8b62-430a-b43f-33a536e10e6e	79903-087	HUMAN OTC DRUG	Equate Therapeutic Dandruff Original Strength	Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis	COAL TAR	SHAMPOO	TOPICAL	20220316		OTC MONOGRAPH DRUG	M032	Walmart Inc.	COAL TAR	5	mg/mL			N	20241231
79903-088_a5de5b76-8667-4ea7-b134-22db47846d03	79903-088	HUMAN OTC DRUG	Equate Therapeutic Dandruff Extra Strength	Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis	coal tar	SHAMPOO	TOPICAL	20220314		OTC MONOGRAPH DRUG	M032	Walmart Inc.	COAL TAR	10	mg/mL			N	20241231
79903-089_f480d97f-d8c6-4068-b24f-d6572077be47	79903-089	HUMAN OTC DRUG	Equate Stomach Relief		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20211217		OTC MONOGRAPH FINAL	part335	Wal-Mart Stores, Inc.	BISMUTH SUBSALICYLATE	262	mg/1			N	20241231
79903-090_b9559631-d448-4075-9e4b-d03f0307e85e	79903-090	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20211015		ANDA	ANDA211075	WALMART INC. (see also Equate)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-091_941fd935-e4da-4ce2-8942-1807aa59eb3b	79903-091	HUMAN OTC DRUG	Equate Hydrocortisone	Topical	Hydrocortisone	CREAM	TOPICAL	20211117		OTC MONOGRAPH NOT FINAL	part348	WalMart	HYDROCORTISONE	.01	g/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79903-092_6f3bad1f-4134-4fda-bf02-9ce1f61d7d1d	79903-092	HUMAN OTC DRUG	Equate Hydrocortisone		Hydrocortisone	CREAM	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part348	WalMart	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79903-093_bdac1eef-82d4-444f-b0f1-449b01b0a0dc	79903-093	HUMAN OTC DRUG	Equate Antibiotic Plus Pain, Itch, Scar Relief		bacitracin zinc, neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride	CREAM	TOPICAL	20211118		OTC MONOGRAPH FINAL	part333B	WalMart	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	500; 3.5; 10000; 10	[iU]/g; mg/g; [iU]/g; mg/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
79903-094_0dd7c659-d4e0-4616-e063-6394a90a059d	79903-094	HUMAN OTC DRUG	Equate Yeast Relief		Candida Albicans, Wood Creosote, Sodium Chloride, and Sulfur	TABLET	ORAL	20220304		UNAPPROVED HOMEOPATHIC		WAL-MART STORES INC	CANDIDA ALBICANS; SODIUM CHLORIDE; SULFUR; WOOD CREOSOTE	30; 12; 12; 30	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
79903-095_e770bdb2-3662-4538-8199-fe4a4059c720	79903-095	HUMAN OTC DRUG	equate adult cough and chest congestion dm		dextromethorphan hydrobromide, guaifenesin	SOLUTION	ORAL	20220617		OTC MONOGRAPH FINAL	part341	WALMART INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 200	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79903-096_78864e9c-cfc9-4fa4-aee3-2e73d3d03dd4	79903-096	HUMAN OTC DRUG	Laxative		Sennosides	TABLET, FILM COATED	ORAL	20211221		OTC MONOGRAPH DRUG	505G(a)(3)	WALMART INC.	SENNOSIDES	25	mg/1			N	20241231
79903-097_ebf3e2eb-0b5c-4419-8f3a-5b9809757b66	79903-097	HUMAN OTC DRUG	Benzalkonium Chloride		Benzalkonium Chloride	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79903-098_5593c1df-b3c5-4fac-9508-ad7b2b3554ec	79903-098	HUMAN OTC DRUG	All Day Back and Muscle Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220117		ANDA	ANDA204872	WALMART INC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79903-099_c0017758-618e-4421-8333-62c26ef61e05	79903-099	HUMAN OTC DRUG	Nighttime Pain Reliever plus Sleep Aid		Acetaminophen, Diphenhydramine HCl	SOLUTION	ORAL	20220112		OTC MONOGRAPH DRUG	M013	WALMART INC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	1000; 50	mg/30mL; mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20251231
79903-100_0dd77edd-daca-5c2d-e063-6294a90aadca	79903-100	HUMAN OTC DRUG	Equate Muscle Cramp and Spasm Relief		MAGNESIUM SULFATE HEPTAHYDRATE	LIQUID	TOPICAL	20220419		UNAPPROVED HOMEOPATHIC		Walmart, inc	MAGNESIUM SULFATE HEPTAHYDRATE	6	[hp_X]/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79903-101_012bcc52-fb21-4b53-9bed-aa144d6d9ee3	79903-101	HUMAN OTC DRUG	euqate nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20220111		ANDA	ANDA077007	WALMART INC.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79903-102_f8f8e805-9fa6-4faa-abf5-e889f0a506e2	79903-102	HUMAN OTC DRUG	equate Extra Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20211220		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	750	mg/1			N	20241231
79903-103_e81e487c-d161-44ec-a0ad-c8af59553e86	79903-103	HUMAN OTC DRUG	Ultra Strength Antacid	Assorted Fruit	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20211220		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	1000	mg/1			N	20241231
79903-104_2272c43d-db85-4b86-b29b-d8ca20d6de5a	79903-104	HUMAN OTC DRUG	equate nicotine		nicotine polacrilex	LOZENGE	ORAL	20220511		ANDA	ANDA203690	WALMART INC.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79903-107_59d01f72-4575-48e2-b914-b6a6456ca7d2	79903-107	HUMAN OTC DRUG	equate pain reliever		Acetaminophen	TABLET	ORAL	20220325		OTC MONOGRAPH NOT FINAL	part343	WALMART INC.	ACETAMINOPHEN	500	mg/1			N	20241231
79903-108_60b1b119-09e5-23d7-1feb-19b79d303e7d	79903-108	HUMAN OTC DRUG	Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride		Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220331		ANDA	ANDA215434	Wal-mart Stores, Inc.	FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	60; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
79903-112_83cb730b-0e75-4820-a67c-110f3b47b2af	79903-112	HUMAN OTC DRUG	equate omeprazole		Omeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20221130		ANDA	ANDA216096	WALMART INC.	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
79903-113_dcfe8e94-9c88-464e-9a80-3baa9c4755d9	79903-113	HUMAN OTC DRUG	equate omeprazole		omeprazole	TABLET, DELAYED RELEASE	ORAL	20220727		NDA	NDA022032	WALMART INC.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
79903-114_c5c13378-3c08-415f-8ab4-8a18d6300ca8	79903-114	HUMAN OTC DRUG	Equate ClearLAX		Polyethylene Glycol 3350	POWDER, FOR SOLUTION	ORAL	20220831		ANDA	ANDA090685	WALMART INC.	POLYETHYLENE GLYCOL 3350	17	g/17g	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79903-115_f38f8a8f-3292-4fe5-b83f-ffd634196d42	79903-115	HUMAN OTC DRUG	equate famotidine		famotidine	TABLET, FILM COATED	ORAL	20220802		ANDA	ANDA077351	WALMART INC.	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
79903-116_a4d5dd69-22cf-4d00-b539-133886c09e37	79903-116	HUMAN OTC DRUG	Anti-Diarrheal/Anti-Gas Multi-Symptom Relief		Loperamide Hydrochloride 2mg, Simethicone 125mg	TABLET	ORAL	20220715		ANDA	ANDA214541	Wal-Mart Stores, Inc.	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
79903-117_b644ae1f-a099-43d2-b8b0-11407d89879c	79903-117	HUMAN OTC DRUG	Equate Odor-Free Therapy Arthritis	Analgesic	Trolamine Salicylate	CREAM	TOPICAL	20190401		OTC MONOGRAPH NOT FINAL	part348	Wal-Mart Stores, Inc.	TROLAMINE SALICYLATE	100	mg/g			N	20241231
79903-118_b953f1fa-0afb-4b01-abbd-7adf3d765470	79903-118	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20220318		ANDA	ANDA208754	WALMART INC.	DOCOSANOL	100	mg/g			N	20241231
79903-119_213ebf87-aa35-4539-a1eb-c0f5a06485f2	79903-119	HUMAN OTC DRUG	Cold and Flu	Nighttime	Acetaminophen, Dextromethorphan HBr, Triprolidine HCl	SOLUTION	ORAL	20220503		OTC MONOGRAPH DRUG	M012	WALMART INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; TRIPROLIDINE HYDROCHLORIDE	650; 20; 2.5	mg/20mL; mg/20mL; mg/20mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79903-120_81ab22f2-1081-498f-ba61-a59e5325908e	79903-120	HUMAN OTC DRUG	Cold and Flu HBP		Acetaminophen, Chlorpheniramine maleate	TABLET, FILM COATED	ORAL	20220414		OTC MONOGRAPH DRUG	M012	WALMART INC.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE	325; 2	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-121_e41e15cf-3284-426e-9e81-d60c39fb2996	79903-121	HUMAN OTC DRUG	Equate SPF 15 Lip Balm		Avobenzone, Octinoxate, Petrolatum	STICK	TOPICAL	20220620		OTC MONOGRAPH NOT FINAL	part352	Walmart	AVOBENZONE; OCTINOXATE; PETROLATUM	30; 75; 423	mg/g; mg/g; mg/g			N	20241231
79903-122_5a6a6b27-ac99-4c96-bae2-dde1944fe546	79903-122	HUMAN OTC DRUG	equate nighttime cold and flu		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH FINAL	part341	WALMART INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-123_b11d4f97-44d0-42bb-a288-72c58c4e82d6	79903-123	HUMAN OTC DRUG	equate cold and flu		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	SOLUTION	ORAL	20230630		OTC MONOGRAPH FINAL	part341	WALMART INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/15mL; mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-124_7e31ea24-c051-4cb3-8a94-c139820b4df3	79903-124	HUMAN OTC DRUG	GUAIFENESIN		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20220428		ANDA	ANDA209254	Walmart Stores, Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
79903-125_0d5f6e14-5e42-494b-be1f-a46731007a0d	79903-125	HUMAN OTC DRUG	equate mucus d		guaifenesin and pseudoephedrine hydrochloride	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20221001		ANDA	ANDA214407	WALMART INC.	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE	600; 60	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]		N	20241231
79903-126_7b7b8cce-ede6-47c6-91c8-88fd94cb292d	79903-126	HUMAN OTC DRUG	equate allergy relief d nasal decongestant		Cetirizine hydrochloride, Pseudoephedrine hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221001		ANDA	ANDA210719	WALMART INC.	CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]		N	20241231
79903-127_d8e229b1-330a-4227-9bbe-e564fc3fb896	79903-127	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20220701		ANDA	ANDA207868	WALMART INC. (see also Equate)	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79903-128_c8e52227-cd3f-43e3-9717-3280551e1109	79903-128	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20220701		ANDA	ANDA207868	WALMART INC. (see also Equate)	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79903-130_0bdef51d-5d1f-812b-e063-6394a90a9e21	79903-130	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	TABLET, FILM COATED	ORAL	20220617		OTC MONOGRAPH DRUG	M013	WAL-MART STORES INC	ACETAMINOPHEN	325	mg/1			N	20241231
79903-131_0d383700-e255-881f-e063-6294a90a347c	79903-131	HUMAN OTC DRUG	Equate Lubricant Eye Drops		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20220720		OTC MONOGRAPH DRUG	M018	Walmart, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
79903-132_f33dc836-c138-4a72-a7d5-dd7b4a96193b	79903-132	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET, EXTENDED RELEASE	ORAL	20220726		ANDA	ANDA207229	WALMART INC.	ACETAMINOPHEN	650	mg/1			N	20241231
79903-133_0bdd2b40-8b6b-f0fa-e063-6394a90a1ecf	79903-133	HUMAN OTC DRUG	Equate Health Non Drowsy DAY Cold and Flu Plus and NIGHTTIME Cold and Flu Plus		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20220811		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc						N	20241231
79903-134_0bde2d80-0560-36db-e063-6394a90aee4a	79903-134	HUMAN OTC DRUG	NIGHTTIME SEVERE COLD AND FLU		ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, and PHENYLEPHRINE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20220804		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-135_ffede19a-06e3-61c7-e053-6394a90ac77b	79903-135	HUMAN OTC DRUG	Equate		Vaporizing Steam Liquid	LIQUID	RESPIRATORY (INHALATION)	20230101		OTC MONOGRAPH FINAL	part341	Walmart Inc.	CAMPHOR (SYNTHETIC)	6.23	g/10mL			N	20241231
79903-137_0c6ad431-4d8e-131c-e063-6394a90a2395	79903-137	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	TABLET	ORAL	20221129		ANDA	ANDA211544	WAL-MART STORES INC	ACETAMINOPHEN	650	mg/1			N	20241231
79903-138_e4ccc482-3259-ec0d-e053-2a95a90a9ceb	79903-138	HUMAN OTC DRUG	Equate Beauty		Salicylic Acid	SOAP	TOPICAL	20220719		OTC MONOGRAPH FINAL	M006	WALMART INC.	SALICYLIC ACID	2000	mg/100mL			N	20241231
79903-139_e4e3226e-61f4-2264-e053-2a95a90a8e78	79903-139	HUMAN OTC DRUG	Equate Beauty		Salicylic Acid	SOAP	TOPICAL	20220719		OTC MONOGRAPH FINAL	M006	WALMART INC	SALICYLIC ACID	2000	mg/100mL			N	20241231
79903-143_ed3796ee-3079-e850-e053-2a95a90a318a	79903-143	HUMAN OTC DRUG	Equate		Ethyl Alcohol	GEL	TOPICAL	20221111		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores Inc.	ALCOHOL	700	mg/mL			N	20241231
79903-144_ed63bd55-9420-9785-e053-2995a90a5952	79903-144	HUMAN OTC DRUG	Equate		Ethyl Alcohol	GEL	TOPICAL	20221113		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores Inc.	ALCOHOL	700	mg/mL			N	20241231
79903-146_e46afe8a-6ca0-4f95-8406-c9ddafe2cbde	79903-146	HUMAN OTC DRUG	Severe Congestion and Cough, Cold and Flu	Daytime, Nighttime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, Triprolidine HCl	KIT		20221222		OTC MONOGRAPH DRUG	M012	WALMART INC.						N	20241231
79903-148_a166280f-8c84-4256-92e0-ada9deb3846d	79903-148	HUMAN OTC DRUG	equate pain reliever		Acetaminophen, Ibuprofen	TABLET, FILM COATED	ORAL	20230308		ANDA	ANDA214836	WALMART INC.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79903-151_04fbe093-df3b-47a7-a7b3-23a70f43d411	79903-151	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	LIQUID	ORAL	20221230		OTC MONOGRAPH NOT FINAL	part356	WALMART INC. (see also Equate)	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-152_15c5fa45-f32e-45c8-b3df-f0a10fc603bd	79903-152	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	LIQUID	ORAL	20221230		OTC MONOGRAPH NOT FINAL	part356	WALMART INC. (see also Equate)	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-153_3e090b80-d546-4617-b782-78c10a1f6371	79903-153	HUMAN OTC DRUG	Antiseptic		Eucalyptol, Menthol, Methyl Salicylate, Thymol	LIQUID	ORAL	20221230		OTC MONOGRAPH NOT FINAL	part356	WALMART INC. (see also Equate)	EUCALYPTOL; MENTHOL; METHYL SALICYLATE; THYMOL	.92; .42; .6; .64	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-154_47fbdef2-5745-41a6-a59f-2cfa7c4fecfb	79903-154	HUMAN OTC DRUG	Ivermectin		Ivermectin	LOTION	TOPICAL	20221227		ANDA	ANDA210720	WALMART INC.	IVERMECTIN	5	mg/g	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
79903-155_fb59c3f5-c600-4acf-a6e3-8a00a0e20eb7	79903-155	HUMAN OTC DRUG	Sinus and Headache		Acetaminophen, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20050726		OTC MONOGRAPH DRUG	M012	WALMART INC.	ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE	325; 5	mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-156_07d7bfa6-27e6-409f-9261-2b70678f9ae1	79903-156	HUMAN OTC DRUG	All Day Allergy Relief		Loratadine	TABLET	ORAL	20221130		ANDA	ANDA075209	WALMART INC. (see also Equate)	LORATADINE	10	mg/1			N	20241231
79903-157_0d383ddb-8684-63da-e063-6394a90a3da9	79903-157	HUMAN OTC DRUG	Equate Artificial Tears		Polyvinyl alcohol, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20230216		OTC MONOGRAPH DRUG	M018	Walmart, Inc.	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	.5; .6	g/100mL; g/100mL			N	20241231
79903-158_0d3842c0-149b-b681-e063-6394a90a52ed	79903-158	HUMAN OTC DRUG	Equate Original Eye Drops		Tetrahydrozoline HCl	SOLUTION/ DROPS	OPHTHALMIC	20230215		OTC MONOGRAPH DRUG	M018	Walmart, Inc.	TETRAHYDROZOLINE HYDROCHLORIDE	.05	g/100mL			N	20241231
79903-159_0d383ddb-8685-63da-e063-6394a90a3da9	79903-159	HUMAN OTC DRUG	Equate Multi-Symptom Relief Eye Drops		Polyethylene glycol 400,Tetrahydrozoline HCl, Zinc sulfate	SOLUTION/ DROPS	OPHTHALMIC	20230214		OTC MONOGRAPH DRUG	M018	Walmart, Inc.	POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE	1; .05; .25	g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79903-160_58db6965-8fe5-4a42-bf28-869acf3d6a4c	79903-160	HUMAN OTC DRUG	equate nicotine		nicotine polacrilex	LOZENGE	ORAL	20220511		ANDA	ANDA203690	WALMART INC.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79903-161_947c001e-1bfb-4a3b-9b53-644e56602bd8	79903-161	HUMAN OTC DRUG	Walmart Pain Relief Powder		Aspirin and Caffeine	POWDER	ORAL	20210325		OTC MONOGRAPH NOT FINAL	part343	Walmart	ASPIRIN; CAFFEINE	845; 65	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
79903-162_0bddf750-3195-6dc9-e063-6294a90a014a	79903-162	HUMAN OTC DRUG	Maximum Strength Non Drowsy Daytime Severe Cold and Flu		Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20221024		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-163_a500301e-4163-4f23-8242-ae7d33569851	79903-163	HUMAN OTC DRUG	Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20160914		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79903-164_9abbbef4-8374-4bd1-9893-6099d726c1dd	79903-164	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride	SOAP	TOPICAL	20221215		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79903-165_97e46e2e-104d-4d6e-9798-a02621338208	79903-165	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride	SOAP	TOPICAL	20221215		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.,	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79903-166_80742f77-94cd-456d-876a-53f68c26be25	79903-166	HUMAN OTC DRUG	Moisturizing Antibacterial		Benzalkonium chloride	SOAP	TOPICAL	20131101		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79903-167_d674811b-69f5-4241-ac47-aa3d06cef311	79903-167	HUMAN OTC DRUG	Benzalkonium Chloride		Benzalkonium Chloride	GEL	TOPICAL	20211118		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
79903-168_0450dcc9-3fad-e2c2-e063-6294a90af60b	79903-168	HUMAN OTC DRUG	HYDRATION PF		Polyethylene Glycol 400 and Propylene Glycol	SOLUTION/ DROPS	OPHTHALMIC	20230901		OTC MONOGRAPH FINAL	part349	Walmart	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	4; 3	mg/mL; mg/mL			N	20241231
79903-170_7a384935-12d2-43fb-9fbf-604a7b4d3cc6	79903-170	HUMAN OTC DRUG	Stool Softener Laxative		DOCUSATE SODIUM	CAPSULE, LIQUID FILLED	ORAL	20230215		OTC MONOGRAPH NOT FINAL	part334	WALMART INC. (see also Equate)	DOCUSATE SODIUM	100	mg/1			N	20241231
79903-172_8198973a-3fc0-4d25-8029-d373314b43ca	79903-172	HUMAN OTC DRUG	Pain Reliever		Acetaminophen	SUSPENSION	ORAL	20221230		OTC MONOGRAPH NOT FINAL	part343	WALMART INC. (see also Equate)	ACETAMINOPHEN	160	mg/5mL			N	20241231
79903-173_731facd9-aaa8-4540-ba28-fea443c85381	79903-173	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate	LIQUID	ORAL	20221230		OTC MONOGRAPH FINAL	part341	WALMART INC. (see also Equate)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79903-174_49cd754b-2a7a-49bf-9470-de7a0138c8c6	79903-174	HUMAN OTC DRUG	equate pain reliever		acetaminophen	TABLET, FILM COATED	ORAL	20230111		OTC MONOGRAPH DRUG	M013	WALMART INC.	ACETAMINOPHEN	500	mg/1			N	20241231
79903-175_7413f8a2-2076-44d5-84fc-1bf8096e6ab1	79903-175	HUMAN OTC DRUG	Allergy Relief	childrens	Diphenhydramine HCl	SOLUTION	ORAL	20230608		OTC MONOGRAPH DRUG	M012	WALMART INC.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-176_3b12a99c-80cf-421d-8434-4694b8051419	79903-176	HUMAN OTC DRUG	Multi-Symptom Cold	childrens	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20230609		OTC MONOGRAPH DRUG	M012	WALMART INC.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-177_02f0618d-95d0-4c5d-ac00-850d07fd006e	79903-177	HUMAN OTC DRUG	Nausea Relief		Meclizine HCl	TABLET	ORAL	20230516		OTC MONOGRAPH DRUG	M009	WALMART INC.	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
79903-178_0cd00569-e2aa-514a-e063-6294a90a4951	79903-178	HUMAN OTC DRUG	GENTLE LAXATIVE		BISACODYL	TABLET, DELAYED RELEASE	ORAL	20221227		OTC MONOGRAPH DRUG	M007	Wal-Mart Stores Inc	BISACODYL	5	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79903-179_5201c568-fb9a-41d8-9d0c-9a6735bcf841	79903-179	HUMAN OTC DRUG	Mucus Relief Cold and Flu	Daytime Nighttime	Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20230213		OTC MONOGRAPH DRUG	M012	WALMART INC.						N	20241231
79903-182_ad49b333-a8d2-4355-b2af-641b38ba8ddf	79903-182	HUMAN OTC DRUG	equate nicotine		nicotine polacrilex	LOZENGE	ORAL	20230607		ANDA	ANDA077007	WALMART INC.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
79903-183_fac0f334-ce26-9226-e053-6294a90a4301	79903-183	HUMAN OTC DRUG	Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20230501		OTC MONOGRAPH FINAL	M016	Walmart INC	WHITE PETROLATUM	100	g/100g			N	20241231
79903-185_003a229c-b015-e9f3-e063-6294a90aa5ed	79903-185	HUMAN OTC DRUG	Equate SF Menthol Cough Drops		Menthol	LOZENGE	ORAL	20230711		OTC MONOGRAPH FINAL	part341	WalMart	MENTHOL	5.8	mg/1			N	20241231
79903-187_f544455d-fdc5-454c-e053-2995a90a9bd9	79903-187	HUMAN OTC DRUG	Walmart Equate Beauty Ultra Light Sunscreen SPF 55		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20171213		OTC MONOGRAPH FINAL	M020	WAL-MART STORES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 30; 70; 60	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-188_f5441092-5d64-6f62-e053-2995a90ad15f	79903-188	HUMAN OTC DRUG	Walmart Equate Ultra Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone	LOTION	TOPICAL	20171108		OTC MONOGRAPH FINAL	M020	WAL-MART STORES INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 130; 50; 70; 40	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79903-189_6f7ac0a4-2ff9-402e-8e5c-62d782fd1cbe	79903-189	HUMAN OTC DRUG	Childrens Allergy Relief		Diphenhydramine HCl	TABLET, CHEWABLE	ORAL	20230630		OTC MONOGRAPH DRUG	M012	WALMART INC.	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-190_44c0b345-e338-48b8-9b94-59be5067e61b	79903-190	HUMAN OTC DRUG	Cold and Flu plus Congestion	Daytime	Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	SOLUTION	ORAL	20230815		OTC MONOGRAPH DRUG	M012	WALMART INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 400; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-191_c51e8ecf-c0bd-4f67-8751-980b63cde037	79903-191	HUMAN OTC DRUG	Cold and Flu plus Congestion	Nighttime	Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCl	SOLUTION	ORAL	20230816		OTC MONOGRAPH DRUG	M012	WALMART INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	650; 20; 12.5; 10	mg/30mL; mg/30mL; mg/30mL; mg/30mL	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-192_0028be18-5163-ff51-e063-6294a90ae517	79903-192	HUMAN OTC DRUG	Equate Honey Lemon Cough Drops		Menthol	LOZENGE	ORAL	20230710		OTC MONOGRAPH FINAL	part341	WalMart	MENTHOL	7.5	mg/1			N	20241231
79903-193_0bef3e36-ead7-e4bd-e063-6394a90a1e42	79903-193	HUMAN OTC DRUG	Allergy Relief	Dye Free	Diphenhydramine HCl	CAPSULE, LIQUID FILLED	ORAL	20230313		OTC MONOGRAPH DRUG	M012	Wal-Mart Stores Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-194_01e1f418-c233-e89e-e063-6294a90abd35	79903-194	HUMAN OTC DRUG	Equate	Rub	Camphor, Eucalyptus Oil, Menthol	OINTMENT	TOPICAL	20230801		OTC MONOGRAPH FINAL	part341	Walmart Inc	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.8; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
79903-195_020942c1-2839-a1d7-e063-6394a90aa9dc	79903-195	HUMAN OTC DRUG	Equate		Oxymetazoline HCL	SPRAY	NASAL	20230804		OTC MONOGRAPH FINAL	part341	Walmart Inc	OXYMETAZOLINE HYDROCHLORIDE	.05	g/100mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
79903-197_01e1ce82-113e-14eb-e063-6394a90aea7f	79903-197	HUMAN OTC DRUG	EQUATE	PAIN RELIEVING PATCHES	LIDOCAINE 4%	PATCH	TOPICAL; TRANSDERMAL	20230801		OTC MONOGRAPH NOT FINAL	part348	WALMART, INC	LIDOCAINE	.04	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79903-198_ffbe8b3e-3695-e9be-e053-6394a90a9455	79903-198	HUMAN OTC DRUG	Equate Homeopathic Earache Drops		BELLADONNA LEAF,CALCIUM CARBONATE,CHAMOMILE,LYCOPODIUM CLAVATUM SPORE,ANEMONE PATENS WHOLE,SULFUR	LIQUID	AURICULAR (OTIC)	20230705		UNAPPROVED HOMEOPATHIC		Walmart Inc.	ANEMONE PATENS WHOLE; BELLADONNA LEAF; CALCIUM CARBONATE; CHAMOMILE; LYCOPODIUM CLAVATUM SPORE; SULFUR	30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
79903-200_44f75eb5-a0f2-4cf7-ac84-05ac96761a11	79903-200	HUMAN OTC DRUG	equate Extra Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20211220		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.	CALCIUM CARBONATE	750	mg/1			N	20241231
79903-201_4a9a732b-0a4c-499b-a0ea-18d687dbe4fa	79903-201	HUMAN OTC DRUG	equate Extra Strength	Antacid	Calcium Carbonate	TABLET, CHEWABLE	ORAL	20211220		OTC MONOGRAPH DRUG	M001	Wal-Mart Stores,Inc.,	CALCIUM CARBONATE	750	mg/1			N	20241231
79903-202_0281c9f0-b4a8-3f1f-e063-6294a90a58a5	79903-202	HUMAN OTC DRUG	All Day Moisturizing SPF 15	EQB	Octinoxate 6% Zinc Oxide 3%	LOTION	TOPICAL	20230809		OTC MONOGRAPH FINAL	part352	Walmart	OCTINOXATE; ZINC OXIDE	6; 3	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79903-203_02a79ada-dc51-ca73-e063-6394a90acb0c	79903-203	HUMAN OTC DRUG	Daily Facial Moisturizer SPF 15	EQB	Avobenzone 3% Octocrylene 10%	LOTION	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Walmart	AVOBENZONE; OCTOCRYLENE	3; 10	g/100mL; g/100mL			N	20241231
79903-204_0c6ae634-4d34-246c-e063-6394a90af1ac	79903-204	HUMAN OTC DRUG	Naproxen Sodium Diphenhydramine HCL		Naproxen Sodium Diphenhydramine HCL	TABLET	ORAL	20231214		ANDA	ANDA213663	Walmart	DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM	25; 220	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79903-205_02e22590-d1fc-31a4-e063-6294a90abd77	79903-205	HUMAN OTC DRUG	Wrinkle Repair Moisturizer SPF 30	EQB	Avobenzone 2% Homosalate 4% Octisalate 4% Octocrylene 2%	LOTION	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Walmart	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2; 4; 4; 2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
79903-206_0323fd1e-d885-6ac0-e063-6294a90a39d4	79903-206	HUMAN OTC DRUG	Advanced Firming And Anti-Wrinkle Day SPF 18	EQB	Avobenzone 2% Octisalate 5% Octocrylene 5%	CREAM	TOPICAL	20230811		OTC MONOGRAPH FINAL	M020	Walmart	AVOBENZONE; OCTISALATE	2; 5	g/100g; g/100g			N	20241231
79903-207_07ebb1fe-5b3e-f073-e063-6394a90a4c78	79903-207	HUMAN OTC DRUG	Maximum Sterngth Cleansing Pads	Equate	Salicylic Acid	LIQUID	TOPICAL	20231017		OTC MONOGRAPH DRUG	M006	Walmart	SALICYLIC ACID	2	g/1			N	20241231
79903-208_039d3187-b8d7-3613-e063-6294a90a9b15	79903-208	HUMAN OTC DRUG	Oil Free Daily Face	EQB	Salicylic Acid 2%	LIQUID	TOPICAL	20230823		OTC MONOGRAPH FINAL	M006	Walmart	SALICYLIC ACID	2	g/100mL			N	20241231
79903-209_0387628b-604d-5755-e063-6294a90a0af7	79903-209	HUMAN OTC DRUG	Eczema Reliegf Skin Protectant	EQB	Colloidal Oatmeal 2%	CREAM	TOPICAL	20230822		OTC MONOGRAPH FINAL	M016	Walmart	OATMEAL	2	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
79903-210_07ef707a-f9e7-42b0-e063-6294a90acce9	79903-210	HUMAN OTC DRUG	All Day Moisturizing SPF 15	EQB	Octinoxate 6% Zinc Oxide 3%	LOTION	TOPICAL	20230809		OTC MONOGRAPH DRUG	M006	Walmart	OCTINOXATE; ZINC OXIDE	6; 3	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79903-212_0d6e3c43-9696-7732-e063-6394a90adc1e	79903-212	HUMAN OTC DRUG	Equate Calaspray		Pramoxine HCl 1%, Zinc Acetate 0.1%	SPRAY	TOPICAL	20231226		OTC MONOGRAPH DRUG	M017	Walmart Inc	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	1; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79903-213_0d80b13c-e446-6bb5-e063-6394a90a2aca	79903-213	HUMAN OTC DRUG	Equate Cortisone		Hydrocortisone 1%	SPRAY	TOPICAL	20231227		OTC MONOGRAPH DRUG	M017	Walmart Inc	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
79903-217_03feaade-963d-d473-e063-6294a90a4f09	79903-217	HUMAN OTC DRUG	Itch Relief		Diphenhydramine HCl and Zinc Acetate	SPRAY	TOPICAL	20230828		OTC MONOGRAPH FINAL	M017	Wal-Mart Stores, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	20	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
79903-218_33d35c9f-4057-4420-b0b6-b21dd195cddc	79903-218	HUMAN OTC DRUG	Cold and Flu		Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20231215		OTC MONOGRAPH DRUG	M013	WALMART INC.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
79903-219_09967ac3-0014-c6ea-e063-6294a90a38d4	79903-219	HUMAN OTC DRUG	Equate Bismuth Stomach Relief Chew		Bismuth subsalicylate	TABLET, CHEWABLE	ORAL	20231107		OTC MONOGRAPH DRUG	M008	Walmart	BISMUTH SUBSALICYLATE	262	mg/1	Bismuth [CS], Bismuth [EPC]		N	20241231
79903-220_0997c1b7-16dc-7db7-e063-6294a90a5928	79903-220	HUMAN OTC DRUG	Equate Gentle Laxative Soft chew		Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20231107		OTC MONOGRAPH DRUG	M007	Walmart	MAGNESIUM HYDROXIDE	1200	mg/1	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
79903-221_0994d92e-c1db-e36e-e063-6294a90aacdc	79903-221	HUMAN OTC DRUG	Equate Wild Berry Antacid Chews		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20231107		OTC MONOGRAPH DRUG	M001	Walmart	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
79903-224_0c54f442-46c0-05f7-e063-6394a90a0d71	79903-224	HUMAN OTC DRUG	Equate One-Step Medicated Corn Removers		SALICYLIC ACID	PATCH	TOPICAL	20231012		OTC MONOGRAPH DRUG	M030	Walmart Inc.	SALICYLIC ACID	40	mg/100mg			N	20241231
79903-226_0c54a0a0-b5bf-eaad-e063-6394a90a15a0	79903-226	HUMAN OTC DRUG	Equate One Step Wart Remover Strips		SALICYLIC ACID	PLASTER	TOPICAL	20231012		OTC MONOGRAPH DRUG	M028	Walmart Inc.	SALICYLIC ACID	40	mg/1			N	20241231
79903-227_0a54f289-d5c2-bcda-e063-6394a90a7235	79903-227	HUMAN OTC DRUG	Alcohol Wipe		Isopropyl Alcohol	SWAB	TOPICAL	20230929		OTC MONOGRAPH DRUG	M003	Walmart Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
79903-229_fafba76b-1f68-45bf-95bc-108f4ac87286	79903-229	HUMAN OTC DRUG	equate Maximum Strength Pain Relieving 4% Lidocaine with Lavender Essential Oil	Topical analgesic	LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20231205		OTC MONOGRAPH DRUG	M017	Walmart Inc.	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79903-230_0764f80a-a50b-8821-e063-6294a90ad3dc	79903-230	HUMAN OTC DRUG	equate First Aid Antiseptic		POVIDONE-IODINE	SOLUTION	TOPICAL	20231010		OTC MONOGRAPH DRUG	M003	Walmart Inc.	POVIDONE-IODINE	1	g/100mL			N	20241231
79903-233_7c90a8f1-8f30-4d51-8a46-d6503f44509a	79903-233	HUMAN OTC DRUG	Equate Vagicaine		20% Benzocaine and 3% Resorcinol Cream	CREAM	TOPICAL	20231201		OTC MONOGRAPH DRUG	M017	Walmart Inc.	BENZOCAINE HYDROCHLORIDE; RESORCINOL	200; 30	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20251231
79903-236_d2dc1544-4dc7-4cbb-8f4a-11d01cf5dfc2	79903-236	HUMAN OTC DRUG	Cold and Flu	Daytime Nighttime	Acetaminophen, Dextromethorphan HBr, Diphenhydramine HCl, Guaifenesin, Phenylephrine HCl	KIT		20231208		OTC MONOGRAPH DRUG	M012	WALMART INC.						N	20241231
79903-237_0a3a9b5b-a7ed-c9ba-e063-6294a90a6b0d	79903-237	HUMAN OTC DRUG	equate Burn Relief		LIDOCAINE HYDROCHLORIDE	GEL	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	Walmart Inc	LIDOCAINE HYDROCHLORIDE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
79903-241_f5e9e02d-3bc3-4d24-b397-f5b491593a79	79903-241	HUMAN OTC DRUG	Equate Miconazole 3		Miconazole nitrate	KIT		20231031		ANDA	ANDA075329	WALMART INC.						N	20241231
79903-284_cdbb8af4-710c-4d58-aba2-185f0dbdeb02	79903-284	HUMAN OTC DRUG	Equate Extra Strength Therapeutic Dandruff	Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis	COAL TAR	SHAMPOO	TOPICAL	20231016		OTC MONOGRAPH DRUG	M032	Walmart Inc.	COAL TAR	10	mg/mL			N	20251231
79903-291_7efb998f-a29a-4671-96d6-aaac494fc726	79903-291	HUMAN OTC DRUG	Equate Therapeutic Dandruff	Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis	COAL TAR	SHAMPOO	TOPICAL	20231016		OTC MONOGRAPH DRUG	M032	Walmart Inc.	COAL TAR	5	mg/mL			N	20251231
79903-485_f3911c25-b63e-3b40-e053-2a95a90a6d1e	79903-485	HUMAN OTC DRUG	Liquid Bandage		Benzethonium chloride and Dyclonine hydrochloride	LIQUID	TOPICAL	20120112		OTC MONOGRAPH NOT FINAL	part333A	Wal-Mart Stores, Inc.	BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE	.06; .23	mg/29.6mL; mg/29.6mL			N	20241231
79903-609_0bafa4ac-8c2d-006b-e063-6294a90ab1fc	79903-609	HUMAN OTC DRUG	All Day Back and Muscle Pain Relief		Naproxen sodium	TABLET, COATED	ORAL	20231215		ANDA	ANDA090545	Walmart Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79903-724_afd337cc-08b9-5c0b-e053-2995a90a065b	79903-724	HUMAN OTC DRUG	Medicated Body	Powder	MENTHOL	POWDER	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part348	Walmart Stores Inc	MENTHOL	.42	g/283g			N	20241231
79903-801_085d8e68-8e70-25d5-e063-6394a90a177a	79903-801	HUMAN OTC DRUG	Petroleum Jelly		White Petrolatum	JELLY	TOPICAL	20231215		OTC MONOGRAPH DRUG	M016	WAL-MART STORES INC	PETROLATUM	1	g/g			N	20241231
79903-897_ecab59d4-1f0a-ef9e-e053-2995a90a0781	79903-897	HUMAN OTC DRUG	Walmart		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20221104		OTC MONOGRAPH FINAL	M032	Wal-Mart Stores, Inc	PYRITHIONE ZINC	10	mg/mL			N	20241231
79903-899_ecaab315-3bfb-beeb-e053-2a95a90aa411	79903-899	HUMAN OTC DRUG	Walmart		Pyrithione Zinc	LOTION/SHAMPOO	TOPICAL	20221104		OTC MONOGRAPH FINAL	M032	Wal-Mart Stores, Inc	PYRITHIONE ZINC	300	mg/100mL			N	20241231
79903-900_e7d323cb-8715-64d1-e053-2a95a90a1715	79903-900	HUMAN OTC DRUG	Equate		Pyrithione Zinc	SHAMPOO	TOPICAL	20220831		OTC MONOGRAPH FINAL	M032	Wal-Mart Stores, Inc	PYRITHIONE ZINC	300	mg/100mL			N	20241231
79903-931_00b3b488-8bb2-0fee-e063-6294a90a4d26	79903-931	HUMAN OTC DRUG	Acetaminophen and Ibuprofen (NSAID)		Acetaminophen and Ibuprofen (NSAID)	TABLET	ORAL	20230718		ANDA	ANDA216592	Wal-Mart Stores Inc.	ACETAMINOPHEN; IBUPROFEN	250; 125	mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
79906-001_0aa49205-0a9d-8ae4-e063-6394a90a5475	79906-001	HUMAN OTC DRUG	Kiss Alcohol Prep Pads		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20200730		OTC MONOGRAPH DRUG	505G(a)(3)	IVY ENTERPRISES, INC.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
79913-101_08fb2e11-6a3b-edc4-e063-6394a90a26d1	79913-101	HUMAN OTC DRUG	Alcohol sanitizer wipes		Alcohol/purified water	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	SHANDONG HENGFA HYGIENIC PRODUCTS CO., LTD.	ALCOHOL	1	mL/1			N	20241231
79913-201_08fabde3-bd57-015a-e063-6394a90a6014	79913-201	HUMAN OTC DRUG	Instant Hand Sanitizeing Wipe		ALCOHOL	CLOTH	TOPICAL	20210309		OTC MONOGRAPH DRUG	M003	SHANDONG HENGFA HYGIENIC PRODUCTS CO., LTD.	ALCOHOL	1	mL/1			N	20241231
79929-003_f8968223-652d-55a2-e053-6394a90a8fb5	79929-003	HUMAN PRESCRIPTION DRUG	Levonorgestrel and Ethinyl Estradiol		Levonorgestrel and Ethinyl Estradiol	KIT		20221231		ANDA	ANDA207033	Naari Pte Limited						N	20241231
79929-005_f4b93309-134c-b904-e053-2995a90aa4c8	79929-005	HUMAN PRESCRIPTION DRUG	Norethindrone and ethinyl estradiol and ferrous fumarate		norethindrone and ethinyl estradiol and ferrous fumarate tablet	KIT		20221231		ANDA	ANDA207066	Naari Pte Limited						N	20241231
79929-009_015d721f-c65d-1bf8-e063-6394a90abd77	79929-009	HUMAN PRESCRIPTION DRUG	Norgestimate and ethinyl estradiol		Norgestimate and ethinyl estradiol	KIT		20221231		ANDA	ANDA200383	Naari Pte Limited						N	20251231
79929-016_f703ab77-e4f3-cd5d-e053-6394a90a232f	79929-016	HUMAN OTC DRUG	Levonorgestrel		levonorgestrel	TABLET	ORAL	20230216		ANDA	ANDA207660	Naari Pte Limited	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
79929-019_f8924348-8732-9026-e053-6394a90ade31	79929-019	HUMAN PRESCRIPTION DRUG	DROSPIRENONE AND ETHINYL ESTRADIOL		DROSPIRENONE AND ETHINYL ESTRADIOL	KIT		20230405		ANDA	ANDA207245	Naari Pte. Limited						N	20241231
79929-020_f8961fa2-eb9c-a3f0-e053-6294a90a75df	79929-020	HUMAN PRESCRIPTION DRUG	desogestrel and ethinyl estradiol and ethinyl estradiol		desogestrel and ethinyl estradiol and ethinyl estradiol	KIT		20230405		ANDA	ANDA209170	Naari Pte. Limited						N	20241231
79937-000_08c16579-fb5f-5c01-e063-6294a90af226	79937-000	HUMAN OTC DRUG	Primest Hand Sanitizer Isopropyl Antiseptic Non-Sterile Topical Solution 70		ISOPROPYL ALCOHOL	GEL	TOPICAL	20200715		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
79937-001_08c155a9-0712-3c59-e063-6294a90a7340	79937-001	HUMAN OTC DRUG	Primest Hand Sanitizer Isopropyl Antiseptic Non-Sterile Topical Solution 75		ISOPROPYL ALCOHOL	GEL	TOPICAL	20200715		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ISOPROPYL ALCOHOL	.75	mL/mL			N	20241231
79937-002_08c163c7-b6a1-57f2-e063-6294a90ac409	79937-002	HUMAN OTC DRUG	Primest Hand Sanitizer Non Sterile Alcohol 75		ALCOHOL	GEL	TOPICAL	20200715		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ALCOHOL	.75	mL/mL			N	20241231
79937-003_08c13e47-679c-4607-e063-6294a90a20a5	79937-003	HUMAN OTC DRUG	Primest Hand Sanitizer Non Sterile Alcohol 70		ALCOHOL	GEL	TOPICAL	20200715		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ALCOHOL	.7	mL/mL			N	20241231
79937-004_08c13e47-67ac-4607-e063-6294a90a20a5	79937-004	HUMAN OTC DRUG	Primest ETHYL Alcohol Antiseptic 70		ALCOHOL	GEL	TOPICAL	20200715		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ALCOHOL	.7	mL/mL			N	20241231
79937-005_08c13282-54c3-52a8-e063-6394a90a5c1d	79937-005	HUMAN OTC DRUG	PRIMEST Hand Sanitizer Non-Sterile Alcohol Antiseptic Topical Solution 70		ALCOHOL	GEL	TOPICAL	20201101		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ALCOHOL	70	mL/100mL			N	20241231
79937-006_08c12b68-e08d-3c2e-e063-6294a90a9998	79937-006	HUMAN OTC DRUG	Primest Hand Sanitizer Isopropyl Antiseptic Non-Sterile Topical Solution 70		ISOPROPYL ALCOHOL	GEL	TOPICAL	20210201		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
79937-007_08c16a38-6233-e15a-e063-6394a90abb96	79937-007	HUMAN OTC DRUG	Primest Ethyl Alcohol Antiseptic 70		ALCOHOL	LIQUID	TOPICAL	20210501		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ALCOHOL	70	mL/100mL			N	20241231
79937-010_08c1251e-eed8-3c55-e063-6294a90a1c9e	79937-010	HUMAN OTC DRUG	PRIMEST HAND SANITIZER NonSterile Isopropy Antiseptic		ISOPROPYL ALCOHOL	GEL	TOPICAL	20201101		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
79937-011_08c1409b-a624-8a2d-e063-6394a90ac619	79937-011	HUMAN OTC DRUG	PURE DASH Antiseptic Hand ALMOND SCENTED		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20220215		OTC MONOGRAPH DRUG	505G(a)(3)	Prime Lab, LLC	BENZALKONIUM CHLORIDE	1.3	mg/.001L			N	20241231
79940-004_0905f9a0-41a8-88a1-e063-6294a90a5fd2	79940-004	HUMAN OTC DRUG	Colgate 5g and Toothbrush Dental Kit		SODIUM MONOFLUOROPHOSPHATE	KIT		20210119		OTC MONOGRAPH DRUG	M021	Formia Airline Supplies Limited						N	20241231
79940-006_08c16a38-6251-e15a-e063-6394a90abb96	79940-006	HUMAN OTC DRUG	Colgate 10g and Toothbrush Dental Kit		SODIUM MONOFLUOROPHOSPHATE	KIT		20210119		OTC MONOGRAPH DRUG	M021	Formia Airline Supplies Limited						N	20241231
79940-007_090604b0-2c76-8f1c-e063-6294a90a2fe7	79940-007	HUMAN OTC DRUG	Crest 24g and Toothbrush Dental kit		SODIUM FLUORIDE	KIT		20210115		OTC MONOGRAPH DRUG	M021	Formia Airline Supplies Limited						N	20241231
79950-001_acd95bc3-ade7-49a1-e053-2a95a90a622b	79950-001	HUMAN OTC DRUG	Bondi Sands Fragrance Free SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	18; 60; 30; 48	mg/g; mg/g; mg/g; mg/g			N	20241231
79950-002_acd95bc3-aded-49a1-e053-2a95a90a622b	79950-002	HUMAN OTC DRUG	Bondi Sands Toasted Coconut Lip Balm with SPF 50 Sunscreen		Avobenzone, Homosalate, Octocrylene	LIPSTICK	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 80; 40	mg/g; mg/g; mg/g			N	20241231
79950-003_acd96f6a-6c25-3166-e053-2a95a90a8134	79950-003	HUMAN OTC DRUG	Bondi Sands Fragrance Free SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	18; 90; 30; 60	mg/g; mg/g; mg/g; mg/g			N	20241231
79950-004_acd8cb97-2a72-6295-e053-2a95a90ad203	79950-004	HUMAN OTC DRUG	Bondi Sands Fragrance Free SPF 30 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-005_acda4622-332d-67bb-e053-2995a90a4262	79950-005	HUMAN OTC DRUG	Bondi Sands Fragrance Free SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-006_acda9863-ad9e-e430-e053-2995a90a69a6	79950-006	HUMAN OTC DRUG	Bondi Sands Fragrance Free Face SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-007_c898a9e3-869c-66b6-e053-2a95a90a285d	79950-007	HUMAN OTC DRUG	BONDI SANDS SPORT SPF 50 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210523		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-008_c3140f39-22b5-5b9f-e053-2a95a90a6b3e	79950-008	HUMAN OTC DRUG	BONDI SANDS SPORT SPF 30 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210523		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-010_c31445d3-a745-f7d6-e053-2a95a90a52b6	79950-010	HUMAN OTC DRUG	Bondi Sands Sport SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	AEROSOL, SPRAY	TOPICAL	20210524		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	18; 90; 30; 60	mg/g; mg/g; mg/g; mg/g			N	20241231
79950-011_c8d545e3-47a8-3ff7-e053-2a95a90a457f	79950-011	HUMAN OTC DRUG	BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210805		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-012_c8d6a5b1-4545-9eb3-e053-2a95a90a3083	79950-012	HUMAN OTC DRUG	BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 SUNSCREEN		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210805		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-013_c934db99-66c0-980c-e053-2995a90a1e56	79950-013	HUMAN OTC DRUG	BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 FACE FLUID		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210810		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 120; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79950-014_ca657520-1711-08e3-e053-2a95a90a81d0	79950-014	HUMAN OTC DRUG	BONDI SANDS SUNNY DAZE HYDRATING BROAD SPECTRUM SUNSCREEN SPF 50		ZINC OXIDE	LOTION	TOPICAL	20210825		OTC MONOGRAPH NOT FINAL	part352	BONDI SANDS (USA) INC.	ZINC OXIDE	250	mg/g			N	20241231
79950-015_e99d6b87-f0bd-100c-e053-2a95a90afdfe	79950-015	HUMAN OTC DRUG	Bondi Sands Sport SPF 50 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20221203		OTC MONOGRAPH FINAL	M020	BONDI SANDS (USA) INC.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
79952-110_42218472-2cc4-4e9c-837a-ff6598db59a9	79952-110	HUMAN PRESCRIPTION DRUG	ZYNLONTA		loncastuximab tesirine	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210430		BLA	BLA761196	ADC Therapeutics America, Inc.	LONCASTUXIMAB TESIRINE	10	mg/2mL			N	20241231
79974-202_14d50afd-9089-402f-abbb-acd0d84f0f63	79974-202	HUMAN OTC DRUG	CUREFINI		Petrolatum, Cod Liver Oil	OINTMENT	TOPICAL	20220601		OTC MONOGRAPH FINAL	part347	Miramar Cosmetic, Inc.	COD LIVER OIL; PETROLATUM	100; 300	mg/mL; mg/mL			N	20241231
79974-203_094ca71b-46af-4854-9f4c-4bdea98d6d66	79974-203	HUMAN OTC DRUG	CUREFINI		Petrolatum	CREAM	TOPICAL	20230424		OTC MONOGRAPH FINAL	part347	Miramar Cosmetics, Inc DBA Miramar Lab	PETROLATUM	300	mg/mL			N	20241231
79974-204_68b9310c-2063-4914-9275-91fc003545a4	79974-204	HUMAN OTC DRUG	elp essential DM		Dextromethorphan hydrobromide, Guaifenesin	SYRUP	ORAL	20231026		OTC MONOGRAPH DRUG	M012	Miramar Cosmetics, Inc DBA Miramar Lab	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
79974-205_eed09687-bd12-4694-b70d-e9198ca821d0	79974-205	HUMAN OTC DRUG	Veneno de Abeja	Aceite De Vibora Brand	Methyl Salicylate	OINTMENT	TOPICAL	20150501		OTC MONOGRAPH DRUG	M017	Miramar Cosmetics, Inc DBA Miramar Lab	METHYL SALICYLATE	15.75	g/150g			N	20241231
79974-206_613c1067-f5f9-4826-9f53-0c2d0b59ca85	79974-206	HUMAN OTC DRUG	El Veneno de Abeja Aceite de Vibora		Methyl Salicylate, Camphor, Menthol	OINTMENT	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	Miramar Cosmetics, Inc DBA Miramar Lab	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	3.5; 3; 10	g/100g; g/100g; g/100g			N	20241231
79974-207_9ebc6eff-cd58-4f32-b5fc-b63557fea0f1	79974-207	HUMAN OTC DRUG	El Unguento Cebo de Coyote		Methyl Salicylate, Menthol	OINTMENT	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	Miramar Cosmetics, Inc DBA Miramar Lab	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	3.5; 10	g/100g; g/100g			N	20241231
79974-208_9d61a135-a8cc-4f2e-b1ba-6ef9e2d3f5ea	79974-208	HUMAN OTC DRUG	El Balsamo de Tigre		Methyl Salicylate, Menthol	OINTMENT	TOPICAL	20240108		OTC MONOGRAPH DRUG	M017	Miramar Cosmetics, Inc DBA Miramar Lab	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	3.5; 10	g/100g; g/100g			N	20241231
79974-209_e92570a4-d837-4201-8153-1a9796126820	79974-209	HUMAN OTC DRUG	Belladona		Methyl Salicylate, Menthol	OINTMENT	TOPICAL	20240108		OTC MONOGRAPH DRUG	M017	Miramar Cosmetics, Inc DBA Miramar Lab	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	3.5; 10	g/100g; g/100g			N	20241231
79985-200_f4ae5e54-387b-4ec6-e053-2995a90a949b	79985-200	HUMAN OTC DRUG	Freshnap Plus - 80% Ethyl Alcohol Towelette		Alcohol Towelette	CLOTH	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part333E	KARI-OUT LLC	ALCOHOL	80	mL/100mL			N	20241231
79988-001_0d92351f-7554-58bd-e063-6394a90ad623	79988-001	HUMAN OTC DRUG	Medik8 Physical Sunscreen SPF 50		ZINC OXIDE	CREAM	TOPICAL	20210210		OTC MONOGRAPH DRUG	M020	Pangaea Laboratories Limited	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
79992-650_be94c234-ada4-4d85-8b4c-be4ebb4b3962	79992-650	HUMAN OTC DRUG	ANTISEPTIC HAND SANITIZER		Alcohol	GEL	TOPICAL	20200824	20240131	OTC MONOGRAPH NOT FINAL	part333A	Solvent Systems International	ALCOHOL	65	L/100L			N	
79992-700_6a6f11b2-3528-4a2d-972a-ee37498df5eb	79992-700	HUMAN OTC DRUG	ANTISEPTIC HAND SANITIZER		Alcohol	GEL	TOPICAL	20200824	20240131	OTC MONOGRAPH NOT FINAL	part333A	Solvent Systems International	ALCOHOL	70	L/100L			N	
79996-300_fae03cb4-e67e-23b6-e053-6394a90ada89	79996-300	HUMAN OTC DRUG	AQUAGEL ADVANCED FORMULA		HAND SANITIZER	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	EPOXEMEX, S.A DE C.V.	ALCOHOL	70	mL/100mL			N	20241231
79996-350_fadff0cd-144e-c2b7-e053-6394a90a9c8a	79996-350	HUMAN OTC DRUG	Hand Sanitizer Liquid Antiseptic		ALCOHOL	LIQUID	TOPICAL	20211230		OTC MONOGRAPH NOT FINAL	part333A	EPOXEMEX, S.A. DE C.V.	ALCOHOL	70	mL/100mL			N	20241231
80004-005_28af6505-4e24-4c7d-917d-e817d1608269	80004-005	HUMAN OTC DRUG	ARNICA MONTANA	30X HPUS	ARNICA MONTANA	TABLET	ORAL	20220518		UNAPPROVED HOMEOPATHIC		Grove Acquisition Subsidiary, Inc. dba VitaMedica	ARNICA MONTANA WHOLE	30	[hp_X]/1			N	20241231
80004-005_6439998c-3f61-4636-b158-4b070398e933	80004-005	HUMAN OTC DRUG	Arnica Montana	30X HPUS	Arnica Montana	TABLET	ORAL	20220314		UNAPPROVED HOMEOPATHIC		VitaMedica	ARNICA MONTANA WHOLE	30	[hp_X]/1			N	20241231
80005-119_7228c13b-f6eb-44aa-b3df-823d20289521	80005-119	HUMAN PRESCRIPTION DRUG	FAMOTIDINE		FAMOTIDINE	POWDER, FOR SUSPENSION	ORAL	20230810		ANDA	ANDA217137	Carnegie Pharmaceuticals LLC	FAMOTIDINE	40	mg/5mL	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
80005-128_98b3715d-7fcf-4802-8b34-c1296b03b5fb	80005-128	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	TABLET	ORAL	20210315		ANDA	ANDA213928	Carnegie Pharmaceuticals, LLC	AMINOCAPROIC ACID	500	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
80005-129_98b3715d-7fcf-4802-8b34-c1296b03b5fb	80005-129	HUMAN PRESCRIPTION DRUG	AMINOCAPROIC ACID		AMINOCAPROIC ACID	TABLET	ORAL	20210315		ANDA	ANDA213928	Carnegie Pharmaceuticals, LLC	AMINOCAPROIC ACID	1000	mg/1	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
80016-001_0e9991c9-a5f1-cdbd-e063-6294a90ae5bc	80016-001	HUMAN OTC DRUG	Latalia Hand Sanitizer 80 Alcohol Antiseptic		ALCOHOL	GEL	TOPICAL	20201001		OTC MONOGRAPH DRUG	M003	INTERNATIONAL CONSUMER PRODUCTS (PVT.) LTD	ALCOHOL	.8	mL/mL			N	20251231
80016-002_0e999a13-bfb0-44f0-e063-6394a90a43af	80016-002	HUMAN OTC DRUG	Latalia Sanitizing Wipe		ALCOHOL	CLOTH	TOPICAL	20201001		OTC MONOGRAPH DRUG	M003	INTERNATIONAL CONSUMER PRODUCTS (PVT.) LTD	ALCOHOL	.8	mL/mL			N	20251231
80016-003_0e99b470-86fe-4f34-e063-6394a90a3d10	80016-003	HUMAN OTC DRUG	Latalia Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20201001		OTC MONOGRAPH DRUG	M003	INTERNATIONAL CONSUMER PRODUCTS (PVT) LTD	ALCOHOL	.8	mL/mL			N	20251231
80016-004_0e99b72a-f4ff-4f9f-e063-6394a90aa2f0	80016-004	HUMAN OTC DRUG	Latalia Alcohol Antiseptic 80 Sanitizing		ALCOHOL	LIQUID	TOPICAL	20210301		OTC MONOGRAPH DRUG	M003	INTERNATIONAL CONSUMER PRODUCTS (PVT) LTD	ALCOHOL	80	mL/100mL			N	20251231
80016-005_05170bfd-9add-7b1a-e063-6394a90af385	80016-005	HUMAN OTC DRUG	Latalia Alcohol Antiseptic 80% Sanitizing		ALCOHOL	LIQUID	TOPICAL	20230915		OTC MONOGRAPH NOT FINAL	part333E	INTERNATIONAL CONSUMER PRODUCTS (PVT) LTD	ALCOHOL	80	mL/100mL			N	20241231
80042-003_0863632c-c1b9-aab8-e063-6394a90adc89	80042-003	HUMAN OTC DRUG	New Wave Cleaning Solutions Foaming Hand Sanitizer		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20210101		OTC MONOGRAPH DRUG	505G(a)(3)	NEW WAVE CLEANING SOLUTIONS,LLC	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
80045-313_09e2382c-481b-e207-e063-6394a90a3997	80045-313	HUMAN OTC DRUG	DOCTORS TOUCH Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20211110		OTC MONOGRAPH DRUG	505G(a)(3)	DOCTOR'S CHOICE MEDICAL, LLC	ALCOHOL	70	mL/100mL			N	20241231
80045-396_0976085c-9b99-3792-e063-6394a90a58c5	80045-396	HUMAN OTC DRUG	DOCTORS TOUCH Erase The Pain		MENTHOL	LIQUID	TOPICAL	20230327		OTC MONOGRAPH DRUG	M017	DOCTOR'S CHOICE MEDICAL, LLC	MENTHOL	50	mg/mL			N	20241231
80045-400_0975eb87-fab2-1621-e063-6394a90a9880	80045-400	HUMAN OTC DRUG	DOCTORS TOUCH Erase The Pain Lidocaine		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20230417		OTC MONOGRAPH DRUG	M015	DOCTOR'S CHOICE MEDICAL, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80046-001_16a48855-d158-489f-843f-1fe9bb9eb506	80046-001	HUMAN OTC DRUG	Sinus Remedy		Calc carb, Euphorbium, Hydrastis, Kali bic, Kali iod, Lycopodium, Phosphorus, Pulsatilla, Sanguinaria, Thuja occ	LIQUID	ORAL	20210309		UNAPPROVED HOMEOPATHIC		Sunset 20 LLC	EUPHORBIA RESINIFERA RESIN; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PULSATILLA VULGARIS WHOLE; SANGUINARIA CANADENSIS ROOT; THUJA OCCIDENTALIS LEAFY TWIG	6; 6; 6; 9; 10; 9; 8; 4; 9; 6	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
80056-143_1fc18c67-20db-4fe5-bc22-2772f0788d13	80056-143	HUMAN PRESCRIPTION DRUG	Reltone 200 mg		Ursodiol	CAPSULE	ORAL	20200701		ANDA	ANDA205789	Intra-Sana Laboratories	URSODIOL	200	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
80056-144_1fc18c67-20db-4fe5-bc22-2772f0788d13	80056-144	HUMAN PRESCRIPTION DRUG	Reltone 400 mg		Ursodiol	CAPSULE	ORAL	20200701		ANDA	ANDA205789	Intra-Sana Laboratories	URSODIOL	400	mg/1	Bile Acid [EPC], Bile Acids and Salts [CS]		N	20241231
80057-001_fad59b1e-9a77-1346-e053-6394a90a3af7	80057-001	HUMAN OTC DRUG	Hand Sanitizing Wipes		Ethyl Alcohol	CLOTH	TOPICAL	20200820		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Bright Commodity Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
80057-002_fad64a8d-e58a-f3d4-e053-6294a90a0175	80057-002	HUMAN OTC DRUG	First Line Alcohol Wipes		Ethyl Alcohol	CLOTH	TOPICAL	20200905		OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Bright Commodity Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
80063-000_09894522-56a1-4c5e-e063-6394a90a1b29	80063-000	HUMAN OTC DRUG	Antiseptic Instant Hand Sanitizer		ALCOHOL	SOLUTION	TOPICAL	20200817		OTC MONOGRAPH DRUG	505G(a)(3)	Laboratoires Paris Elysees	ALCOHOL	.76	mL/mL			N	20241231
80064-141_e6271611-8634-48f6-b39a-b141d665561e	80064-141	HUMAN PRESCRIPTION DRUG	Vyleesi		bremelanotide	INJECTION	SUBCUTANEOUS	20190621		NDA	NDA210557	Palatin Technologies	BREMELANOTIDE ACETATE	1.75	mg/.3mL	Melanocortin Receptor Agonist [EPC], Melanocortin Receptor Agonists [MoA]		N	20241231
80069-003_c0799a27-9c79-46d0-888f-4d5ea1d3b688	80069-003	HUMAN OTC DRUG	Zone 1		Lidocaine HCl	CREAM	TOPICAL	20041101		OTC MONOGRAPH DRUG	M015	Dermal Source, Inc.	LIDOCAINE HYDROCHLORIDE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80069-007_e995dc6d-dcab-4c2b-90c2-a826fb3e5844	80069-007	HUMAN OTC DRUG	Vasocaine		Lidocaine HCl, Epinephrine HCl	SPRAY	TOPICAL	20050601		OTC MONOGRAPH DRUG	M015	Dermal Source, Inc.	EPINEPHRINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE	.1; 50	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
80069-009_bbc239cf-a36f-4265-bbd1-1f2b1754b6b9	80069-009	HUMAN OTC DRUG	Pro Plus		Lidocaine HCl, Tetracaine HCl	CREAM	TOPICAL	20210410		OTC MONOGRAPH DRUG	M017	Dermal Source, Inc.	LIDOCAINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE	50; 10	mg/29.5735mL; mg/29.5735mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
80069-010_b1e0401b-d425-4be0-92d3-bdd31fc8eb1a	80069-010	HUMAN OTC DRUG	Super T		Lidocaine HCl, Tetracaine HCl, Benzocaine	CREAM	TOPICAL	20210815		OTC MONOGRAPH DRUG	M017	Dermal Source, Inc.	BENZOCAINE; LIDOCAINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE	120; 50; 10	mg/g; mg/g; mg/g	Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
80069-011_effc8758-819d-4c83-8931-929b203e56f9	80069-011	HUMAN OTC DRUG	SJ3		Lidocaine HCl, Tetracaine HCl, Benzocaine	SPRAY	TOPICAL	20210815		OTC MONOGRAPH DRUG	M017	Dermal Source, Inc.	BENZOCAINE; LIDOCAINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE	120; 50; 10	mg/mL; mg/mL; mg/mL	Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE], Local Anesthesia [PE], Standardized Chemical Allergen [EPC]		N	20241231
80069-012_9dfe74f4-a084-41d4-90f5-fb705439fe83	80069-012	HUMAN OTC DRUG	Zone 2		Lidocaine HCl, Epinephrine	GEL	TOPICAL	20220401		OTC MONOGRAPH DRUG	M015	Dermal Source, Inc.	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	.1; 50	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
80069-013_a507f3d6-9f6a-4db5-aded-5003e5e7a7f5	80069-013	HUMAN OTC DRUG	Blue Gel Anesthetic		Lidocaine HCl, Tetracaine HCl, Racepinephrine HCl	GEL	TOPICAL	20220607		OTC MONOGRAPH DRUG	M017	Dermal Source, Inc.	LIDOCAINE HYDROCHLORIDE; RACEPINEPHRINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE	50; .1; 10	mg/g; mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
80070-100_b349557d-e1ba-435d-b0db-1cdce853b418	80070-100	HUMAN OTC DRUG	Alavert	Allergy and Congestion D-12 hour	LORATADINE and PSEUDOEPHEDRINE SULFATE	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211215		ANDA	ANDA076050	Foundation Consumer Brands	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
80070-110_02be30ba-b056-4446-bafc-3bde0c0c04f5	80070-110	HUMAN OTC DRUG	Alavert	Allergy	LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210402		NDA	NDA021375	Foundation Consumer Brands	LORATADINE	10	mg/1			N	20241231
80070-120_bd411eb7-c97c-47b5-a370-4e7d50838be7	80070-120	HUMAN OTC DRUG	Alavert	Allergy	LORATADINE	TABLET, ORALLY DISINTEGRATING	ORAL	20210402		NDA	NDA021375	Foundation Consumer Brands	LORATADINE	10	mg/1			N	20241231
80070-220_a71bb9fc-6a9d-4a22-8ad5-097a2385077f	80070-220	HUMAN OTC DRUG	Anbesol	Maximum Strength	BENZOCAINE	GEL	TOPICAL	20210915		OTC MONOGRAPH NOT FINAL	part356	Foundation Consumer Brands	BENZOCAINE	200	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
80070-230_4d9d7dc5-dbee-437f-bd07-afcd5add7dc4	80070-230	HUMAN OTC DRUG	Anbesol	Maximum Strength	BENZOCAINE	SOLUTION	TOPICAL	20210915		OTC MONOGRAPH NOT FINAL	part356	Foundation Consumer Brands	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
80070-300_75816e1a-090e-4fba-a41c-5bd924c62546	80070-300	HUMAN OTC DRUG	Dimetapp	Cold and Allergy	BROMPHENIRAMINE MALEATE and PHENYLEPHRINE HYDROCHLORIDE	ELIXIR	ORAL	20210915		OTC MONOGRAPH FINAL	part341	Foundation Consumer Brands	BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	1; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80070-310_cca65683-af44-4aae-923f-ef3e6bef0827	80070-310	HUMAN OTC DRUG	Dimetapp	Cold and Cough	BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE	ELIXIR	ORAL	20210915		OTC MONOGRAPH FINAL	part341	Foundation Consumer Brands	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	1; 5; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80070-330_15dbed8a-0ef3-49e8-9a3c-8af837d5ec45	80070-330	HUMAN OTC DRUG	Dimetapp	Multi-Symptom Cold and Flu	acetaminophen, diphenhydramine hydrochloride, and phenylephrine hydrochloride	SOLUTION	ORAL	20210915		UNAPPROVED DRUG OTHER		Foundation Consumer Brands	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	320; 12.5; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80070-340_3e48c538-7083-49d2-8b11-eb1c0a810565	80070-340	HUMAN OTC DRUG	Dimetapp	Nighttime Cold and Congestion	DIPHENHYDRAMINE HYDROCHLORIDE and PHENYLEPHRINE HYDROCHLORIDE	SOLUTION	ORAL	20210915		OTC MONOGRAPH DRUG	M012	Foundation Consumer Brands	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80070-350_2a546aec-eda6-4959-aee6-7c8e7994ff39	80070-350	HUMAN OTC DRUG	Dimetapp Cold and Cough and Nighttime Cold and Congestion		DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, BROMPHENIRAMINE MALEATE, and DEXTROMETHORPHAN HYDROBROMIDE	KIT		20210915		OTC MONOGRAPH FINAL	part341	Foundation Consumer Brands						N	20241231
80070-400_78391470-c4bc-415a-86df-a3d55c965efb	80070-400	HUMAN OTC DRUG	Dristan	12 hr	OXYMETAZOLINE HYDROCHLORIDE	SPRAY	NASAL	20210817		OTC MONOGRAPH FINAL	part341	Foundation Consumer Brands	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
80070-500_aa5be2e6-ba6c-40db-ae32-31cce50bcb2e	80070-500	HUMAN OTC DRUG	Fibercon		CALCIUM POLYCARBOPHIL	TABLET	ORAL	20210415		OTC MONOGRAPH NOT FINAL	part334	Foundation Consumer Brands	CALCIUM POLYCARBOPHIL	625	mg/1			N	20241231
80070-600_36209716-0092-4824-9aaa-aa2c582d3b63	80070-600	HUMAN OTC DRUG	Primatene		EPHEDRINE HYDROCHLORIDE	TABLET	ORAL	20210122		OTC MONOGRAPH FINAL	part341	Foundation Consumer Brands	EPHEDRINE HYDROCHLORIDE	12.5	mg/1	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
80125-001_f48f4a03-3d7a-158e-e053-2a95a90a5188	80125-001	HUMAN OTC DRUG	CLEACE 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200813		OTC MONOGRAPH NOT FINAL	part333A	Warehouse Agency Llc	ALCOHOL	7.5	mg/mL			N	20241231
80125-002_f48fa482-28a4-307f-e053-2995a90a3bca	80125-002	HUMAN OTC DRUG	CLEACE 75% Alcohol hand sanitizer		ALCOHOL	GEL	TOPICAL	20200813		OTC MONOGRAPH NOT FINAL	part333A	Warehouse Agency Llc	ALCOHOL	75	mL/100mL			N	20241231
80136-063_017f9445-dec5-4b96-9cc9-7d3f20e22fb8	80136-063	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20210122		ANDA	ANDA076497	Northeast Pharma	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
80136-378_0a20bfde-2901-285a-e063-6394a90a02b8	80136-378	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine HCl	TABLET	ORAL	20220501		OTC MONOGRAPH DRUG	M009	NORTHEAST PHARMA	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
80136-381_bf79e556-1f18-416a-e053-2995a90ae061	80136-381	HUMAN OTC DRUG	Anti-Diarrheal		Loperamide HCl	TABLET	ORAL	20200901		ANDA	ANDA076497	Northeast Pharma	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
80136-384_fe513f68-88e7-4d43-9886-f5316c67ba1d	80136-384	HUMAN OTC DRUG	Loperamide Hydrochloride and Simethicone		Loperamide Hydrochloride and Simethicone	TABLET	ORAL	20211027		ANDA	ANDA211059	NORTHEAST PHARMA	DIMETHICONE; LOPERAMIDE HYDROCHLORIDE	125; 2	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA], Skin Barrier Activity [PE]		N	20241231
80136-555_0b61edd3-f126-d8a9-e063-6294a90a17fa	80136-555	HUMAN OTC DRUG	SENNA-PLUS		Sennosides and Docusate Sodium	TABLET	ORAL	20221201		OTC MONOGRAPH DRUG	505G(a)(3)	NORTHEAST PHARMA	DOCUSATE SODIUM; SENNOSIDES	50; 8.6	mg/1; mg/1			N	20241231
80136-683_0a33e0f6-e28a-5f8a-e063-6294a90ad2dc	80136-683	HUMAN OTC DRUG	Allergy relief		Diphenhydramine HCl	TABLET, COATED	ORAL	20231001		OTC MONOGRAPH DRUG	M012	NORTHEAST PHARMA	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80136-779_08a175ae-230a-ef8d-e063-6394a90ad234	80136-779	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine HCl	TABLET, CHEWABLE	ORAL	20221101		OTC MONOGRAPH DRUG	M009	NORTHEAST PHARMA	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
80136-785_08a1dbae-5c8e-f0b8-e063-6294a90a44be	80136-785	HUMAN OTC DRUG	Nighttime Sleep-aid		Diphenhydramine HCl	TABLET	ORAL	20210901		OTC MONOGRAPH DRUG	M010	NORTHEAST PHARMA	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80136-791_08a20812-db29-5b60-e063-6294a90a5b9e	80136-791	HUMAN OTC DRUG	GAS RELIEF		Simethicone	TABLET, CHEWABLE	ORAL	20210601		OTC MONOGRAPH DRUG	M002	NORTHEAST PHARMA	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
80136-792_138e17af-8457-45c7-ba15-ecfad75485a1	80136-792	HUMAN OTC DRUG	Gas Relief	Ultra Strength	Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210625		OTC MONOGRAPH FINAL	part332	NORTHEAST PHARMA (Heartland Pharma)	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20241231
80136-851_f1172e57-0b18-d64f-e053-2a95a90a44db	80136-851	HUMAN OTC DRUG	ANTI-DIARRHEAL		LOPERAMIDE HYDROCHLORIDE	CAPSULE, LIQUID FILLED	ORAL	20210521		NDA	NDA021855	Northeast Pharma	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
80136-852_6cdc4a40-7c0a-4c48-ba63-90ed8a9b66a7	80136-852	HUMAN OTC DRUG	Acid Reducer		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20210705		ANDA	ANDA206877	NORTHEAST PHARMA	OMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80136-855_e8ba7003-9d10-90ac-e053-2995a90aa7de	80136-855	HUMAN OTC DRUG	Caffeine		Caffeine	TABLET	ORAL	20220120		OTC MONOGRAPH FINAL	part340	Northeast Pharma	CAFFEINE	200	mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
80136-856_0647ef67-e7f9-a73e-e063-6294a90abe76	80136-856	HUMAN OTC DRUG	Cetirizine HCl		Cetirizine HCl	CAPSULE	ORAL	20230926		NDA	NDA022429	Northeast Pharma	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80136-859_b6f991e1-0121-487b-9db7-a10342c3cee8	80136-859	HUMAN OTC DRUG	Gas Relief		Simethicone	TABLET, CHEWABLE	ORAL	20230630		OTC MONOGRAPH DRUG	M002	Northeast Pharma	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
80136-904_08a2e381-22fb-ca69-e063-6294a90a2e4d	80136-904	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, FILM COATED	ORAL	20200901		OTC MONOGRAPH DRUG	M013	NORTHEAST PHARMA	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
80136-921_08f1b9a9-c748-2d9a-e063-6294a90a1c00	80136-921	HUMAN OTC DRUG	Regular Strength Enteric coated aspirin		Aspirin	TABLET, COATED	ORAL	20000701		OTC MONOGRAPH DRUG	M013	NORTHEAST PHARMA	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
80136-951_94fa59d8-82f2-4645-87bb-2eb215a02c68	80136-951	HUMAN OTC DRUG	Stool Softener		DOCUSATE SODIUM	CAPSULE	ORAL	20210628		OTC MONOGRAPH NOT FINAL	part334	NORTHEAST PHARMA (Heartland Pharma)	DOCUSATE SODIUM	100	mg/1			N	20241231
80148-001_d7c6e95f-6ec9-4316-e053-2a95a90ac39c	80148-001	HUMAN OTC DRUG	Sambrosa	night	DOXYLAMINE SUCCINATE	SYRUP	ORAL	20200110		OTC MONOGRAPH FINAL	part341	Lelypharma bv	DOXYLAMINE SUCCINATE	9.78	mg/3mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
80159-101_8ce311e4-a47c-467a-9f04-45d0fc7fe52e	80159-101	HUMAN OTC DRUG	picnic antihistamine		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20210119		ANDA	ANDA078336	30M One, Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80159-102_03bb20aa-456c-4957-a399-654901490cdd	80159-102	HUMAN OTC DRUG	Picnic Antihistamine		fexofenadine hcl	TABLET, FILM COATED	ORAL	20210119		ANDA	ANDA076447	30M One, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80159-103_c32eea8b-4e6c-46a8-988b-a4f7820e91be	80159-103	HUMAN OTC DRUG	Picnic Antihistamine		Loratadine	TABLET	ORAL	20210119		ANDA	ANDA076301	30M One, Inc.	LORATADINE	10	mg/1			N	20241231
80159-104_c3336068-55bb-48e9-abae-902bc68d847f	80159-104	HUMAN OTC DRUG	picnic antihistamine		Diphenhydramine Hydrochloride	TABLET	ORAL	20210126		OTC MONOGRAPH FINAL	part341	30M One, Inc.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80159-112_6f8209d9-f5fa-4732-a007-f2290351a7a0	80159-112	HUMAN OTC DRUG	picnic antihistamine		fexofenadine hydrochloride	TABLET, FILM COATED	ORAL	20220424		ANDA	ANDA212971	30M One, Inc.	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80159-201_02acfc8c-28f4-421c-bbd0-68bdecd85c63	80159-201	HUMAN OTC DRUG	Picnic Allergy Symptom Reliever Nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20210119		ANDA	ANDA207957	30M One, Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80159-301_1e0e25f0-9c84-489e-9cde-76cbff1c5e16	80159-301	HUMAN OTC DRUG	picnic nasal decongestant and antihistamine		loratadine, Pseudoephedrine sulfate	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220104		ANDA	ANDA076050	30M One, Inc.	LORATADINE; PSEUDOEPHEDRINE SULFATE	5; 120	mg/1; mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
80159-302_eab7b9f4-4267-42cd-92e2-75a689a9eb2e	80159-302	HUMAN OTC DRUG	Picnic Nasal Decongestant		Pseudoephedrine HCl	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20220208		ANDA	ANDA075153	30M One, Inc.	PSEUDOEPHEDRINE HYDROCHLORIDE	120	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
80176-001_09032c0b-a099-2601-e063-6294a90a2d34	80176-001	HUMAN OTC DRUG	ALLPURE HAND SANITIZER SANITIZING WIPE		Alcohol	CLOTH	TOPICAL	20200820		OTC MONOGRAPH DRUG	M003	CERCI KOZMETIK VE OTEL EKIPMANLARI PAZARLAMA IC VE DIS TICARET LIMITED SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
80176-002_089ee9d3-7986-9ff3-e063-6394a90ae14a	80176-002	HUMAN OTC DRUG	ALLPURE HAND SANITIZER		Alcohol	GEL	TOPICAL	20200820		OTC MONOGRAPH DRUG	M003	CERCI KOZMETIK VE OTEL EKIPMANLARI PAZARLAMA IC VE DIS TICARET LIMITED SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
80176-003_089efd8c-3ed1-ac12-e063-6294a90a8c05	80176-003	HUMAN OTC DRUG	C.O.BIGELOW HAND SANITIZER		Alcohol	GEL	TOPICAL	20211120		OTC MONOGRAPH DRUG	M003	CERCI KOZMETIK VE OTEL EKIPMANLARI PAZARLAMA IC VE DIS TICARET LIMITED SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
80176-004_089f1c4c-b4fb-df51-e063-6294a90ac81b	80176-004	HUMAN OTC DRUG	THE PENINSULA HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20220310		OTC MONOGRAPH DRUG	M003	CERCI KOZMETIK VE OTEL EKIPMANLARI PAZARLAMA IC VE DIS TICARET LIMITED SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
80190-003_0aa497e1-f7cc-ac87-e063-6294a90a85a5	80190-003	HUMAN OTC DRUG	Antibacterial Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200821		OTC MONOGRAPH DRUG	505G(a)(3)	CARSONS NUT-BOLT AND TOOL COMPANY INCORPORATED	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
80203-347_fc88624a-61eb-c16b-e053-6294a90a3467	80203-347	HUMAN PRESCRIPTION DRUG	Enjaymo		sutimlimab-jome	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220204		BLA	BLA761164	Bioverativ Therapeutics Inc.	SUTIMLIMAB	50	mg/mL	Classical Complement Pathway Inhibitor [EPC], Classical Complement Pathway Inhibitors [MoA]		N	20241231
80204-001_7105d4aa-ebc0-4f25-b570-4011bc42e227	80204-001	HUMAN OTC DRUG	MOSAIC Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200826	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-002_a6852096-ee08-4e2c-aad0-6915dd0704a9	80204-002	HUMAN OTC DRUG	MOSAIC Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200826	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-003_d241ef7e-5e61-431b-9b92-0dc331aad63d	80204-003	HUMAN OTC DRUG	MOSAIC Hand Sanitizer		Alcohol	GEL	TOPICAL	20200826	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-004_82b6371e-21b0-47c1-ba29-1febcce49fa9	80204-004	HUMAN OTC DRUG	MOSAIC Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200826	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-005_1c31053e-1dd8-4b34-adee-41b997898c15	80204-005	HUMAN OTC DRUG	MOSAIC Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200826	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-006_b9c42e93-2f1a-46a0-a62e-5652a3f0ca65	80204-006	HUMAN OTC DRUG	MOSAIC Hand Sanitizer		Alcohol	GEL	TOPICAL	20200826	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-007_2883c4f3-4390-4e7f-8084-87ae1f3a0255	80204-007	HUMAN OTC DRUG	Mosaic instant hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-008_7074127e-16ae-4e34-8cbb-b298aa789551	80204-008	HUMAN OTC DRUG	Mosaic instant hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-009_37ff51fd-4ecc-4a87-86a5-6f18deeed806	80204-009	HUMAN OTC DRUG	Premium Nature hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-010_c81e0fff-2db7-4fd7-b7c5-901f227ae927	80204-010	HUMAN OTC DRUG	Premium Nature hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-011_945cdcb6-9fb3-436b-bb69-74aee77f0cd4	80204-011	HUMAN OTC DRUG	Premium Nature hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-012_838cc605-0b46-4a10-8fb2-14847c7a7ec2	80204-012	HUMAN OTC DRUG	Secret Plus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-013_10af6a71-f542-48e2-9437-5225ce9010de	80204-013	HUMAN OTC DRUG	Secret Plus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-014_da9c6bd2-7d8f-47cc-971a-23264977188c	80204-014	HUMAN OTC DRUG	Secret Plus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-015_298448e4-375b-49b2-a64a-c66bd3b157b4	80204-015	HUMAN OTC DRUG	Secret Plus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-016_e9bf0ca7-4fe6-456f-9120-923763bfaffb	80204-016	HUMAN OTC DRUG	Secret Plus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-017_e5c0f424-a352-4eba-b5e6-257080bd27f0	80204-017	HUMAN OTC DRUG	Secret Plus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-018_fad6c10e-6b19-46f1-ae0c-94692ce0dde1	80204-018	HUMAN OTC DRUG	Secret Plus Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-019_0ff07543-2ead-4915-9d24-7115b3e577ce	80204-019	HUMAN OTC DRUG	Wish		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ISOPROPYL ALCOHOL	99	mL/100mL			N	
80204-020_5b3adc46-7af2-43c7-80e6-56de3f4b852d	80204-020	HUMAN OTC DRUG	Wish		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ISOPROPYL ALCOHOL	91	mL/100mL			N	
80204-021_22f101a9-00ca-4459-adee-9c6681eb96a9	80204-021	HUMAN OTC DRUG	Wish		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ISOPROPYL ALCOHOL	99	mL/100mL			N	
80204-022_456f2b36-92b9-44d6-9e15-4d93900e8b17	80204-022	HUMAN OTC DRUG	Wish hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-023_7d11f3d6-cbf7-4e14-bb70-a3b386bf8d67	80204-023	HUMAN OTC DRUG	Wish Ultra Slim hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-024_d98556e2-23b2-4886-9144-d979c0a49c9e	80204-024	HUMAN OTC DRUG	Wish Ultra Slim hand sanitizer		Alcohol	SOLUTION	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-025_ae9d72c0-4208-45d5-a250-68d7c1e3fc4a	80204-025	HUMAN OTC DRUG	Wish Ultra Slim hand sanitizer		Alcohol	SOLUTION	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-026_5c463c5b-eeaa-4ee5-8207-959b64f68bd1	80204-026	HUMAN OTC DRUG	Wish Ultra Slim hand sanitizer		Alcohol	SOLUTION	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-027_affc92ca-8b44-474f-be87-657804ab54dd	80204-027	HUMAN OTC DRUG	Watermelon hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-028_ce99ee23-e084-4ee8-bf50-64c337a2aebc	80204-028	HUMAN OTC DRUG	Strawberries hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-029_477f3b14-2819-4224-82fc-7c468d1647e8	80204-029	HUMAN OTC DRUG	Bubble Gum hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-030_a9fc8480-b8b6-4e6f-9714-a360a67734d9	80204-030	HUMAN OTC DRUG	Wish Ultra hand sanitizer dream in cherry blossoms		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-031_bc20111f-81fc-45a7-ab36-d7066410e6ac	80204-031	HUMAN OTC DRUG	Wish Ultra Hand Sanitizer Lifes a Peach Beach		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-032_a2892649-2fae-4c85-94c9-96ac1fbd4044	80204-032	HUMAN OTC DRUG	Wish Ultra Hand Sanitizer A Coconut Kinda Life		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-033_c8082169-a08c-4e38-bd02-e090977ceec8	80204-033	HUMAN OTC DRUG	Wish Ultra Hand Sanitizer Easy Peasy Lemon Squeezy		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-034_369621b9-966a-4a3d-8dbd-5d54161ab7c1	80204-034	HUMAN OTC DRUG	Wish Ultra Hand Sanitizer I Love You Cherry Much		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-035_9612a593-4cec-4e18-a491-6b2966f226bd	80204-035	HUMAN OTC DRUG	Antibacterial wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
80204-036_765337c5-a78c-4c96-b3ba-55639f25d295	80204-036	HUMAN OTC DRUG	Tizer sanitizing wet wipes		Alcohol	CLOTH	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-037_5ab6d677-47a2-4788-a0bd-2d5dc1a7a5ce	80204-037	HUMAN OTC DRUG	Wish hand sanitizing wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	1.3	mg/mL			N	
80204-038_d576a93a-ee36-47dc-9f55-090f34e719d8	80204-038	HUMAN OTC DRUG	Wish hand sanitizing wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
80204-039_57d80c9d-0494-42c5-88a8-3c89dfa9cccb	80204-039	HUMAN OTC DRUG	Wish hand sanitizing wipes		Alcohol	CLOTH	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-040_6e0a33cd-59b1-440f-b8c5-9f0d550526b9	80204-040	HUMAN OTC DRUG	KLX hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-041_4242d88a-3658-4b1b-8921-fd6ce47d8a83	80204-041	HUMAN OTC DRUG	KLX hand sanitizer		Alcohol	LIQUID	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-042_e7195794-ef24-4070-8de6-148d020b7230	80204-042	HUMAN OTC DRUG	Lovali hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-043_96c71680-e106-4535-8802-6f1671ea28d1	80204-043	HUMAN OTC DRUG	Wish advanced hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-044_9a5873e2-9007-467d-8eca-258857985fca	80204-044	HUMAN OTC DRUG	Wish advanced hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-045_02692d79-fb66-4b59-b8e0-cd794b60ba06	80204-045	HUMAN OTC DRUG	Wish advanced hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-046_ba14e7bd-f767-48ce-8ebe-0389e0a2a73e	80204-046	HUMAN OTC DRUG	Wish advanced hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-047_0014183f-a051-4a1b-a78b-2e0c2d80ead4	80204-047	HUMAN OTC DRUG	Lovali hand sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-048_2a698de9-5821-4d5a-ba0f-cee7c26950cb	80204-048	HUMAN OTC DRUG	al-SHIELDS Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-049_58fd79dc-bc0d-40e4-84ba-6aa353cfd432	80204-049	HUMAN OTC DRUG	XTREME Hand Sanitizer		Alcohol	GEL	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	70	mL/100mL			N	
80204-050_244b9b58-8c8d-43a3-b4b1-dc8c21fe56f9	80204-050	HUMAN OTC DRUG	Secrete plus wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200828	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	
80204-051_8e8bad4c-583c-4c0f-80f4-2d0fc3390d80	80204-051	HUMAN OTC DRUG	GREEN SUPPLY HAND SANITIZER		Alcohol	SPRAY	TOPICAL	20201019	20240324	OTC MONOGRAPH NOT FINAL	part333A	Zhejiang Meizhiyuan Cosmetics Co.,Ltd	ALCOHOL	75	mL/100mL			N	
80204-052_05baf420-7de4-4fa5-b4b8-fd744cf9a434	80204-052	HUMAN OTC DRUG	Advanced Instant Hand Sanitizer alcohol gel		Ethyl Alcohol	GEL	TOPICAL	20220328	20240324	OTC MONOGRAPH NOT FINAL	part333A	ZHEJIANG MEIZHIYUAN COSMETICS CO.,LTD	ALCOHOL	70	mL/100mL			N	
80216-111_1d400354-9ad8-44ff-8ba0-b0b96a8b6f4c	80216-111	HUMAN OTC DRUG	SANO TI AMO RELIEF AND REPAIR PAIN RELIEF		MENTHOL, UNSPECIFIED FORM, CAMPHOR (SYNTHETIC)	CREAM	TOPICAL	20191008		OTC MONOGRAPH NOT FINAL	part348	Sano Ti Amo, LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	3; 13.4	mg/mL; mg/mL			N	20241231
80223-002_0b4bdac1-6a5d-3912-e063-6294a90accb3	80223-002	HUMAN OTC DRUG	Paingone Freeze 5		Menthol	GEL	TOPICAL	20220601		OTC MONOGRAPH DRUG	M017	QUALITY HEALTH INNOVATIONS LIMITED	MENTHOL	5	g/100mL			N	20241231
80228-2001_09869d3a-ba81-6509-e063-6394a90aeccc	80228-2001	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	GEL	TOPICAL	20210301		OTC MONOGRAPH DRUG	M003	Universal Synergetics, Inc	ALCOHOL	.84	mL/1.2mL			N	20241231
80254-000_09c28e4c-cef4-8f33-e063-6294a90a580e	80254-000	HUMAN OTC DRUG	Skin Block Extra Strength Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200901		OTC MONOGRAPH DRUG	505G(a)(3)	Charter Oak Development Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80256-000_0c5d3da7-2abb-a2bc-e063-6294a90a7a3d	80256-000	HUMAN OTC DRUG	HEXADERMAL ANTISEPTIC HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20200731		OTC MONOGRAPH DRUG	505G(a)(3)	KUZEY SAGLIK URUNLERI VE KIMYA SANAYI ANONIM SIRKETI KAZAN SUBESI	ALCOHOL	.72	mL/mL			N	20241231
80256-001_0c5d1392-3505-098b-e063-6394a90a95d6	80256-001	HUMAN OTC DRUG	HEXADERMAL ANTISEPTIC HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20200731		OTC MONOGRAPH DRUG	505G(a)(3)	KUZEY SAGLIK URUNLERI VE KIMYA SANAYI ANONIM SIRKETI KAZAN SUBESI	ALCOHOL	.72	mL/mL			N	20241231
80262-701_b57ed090-f1c8-714f-e053-2995a90ab0dc	80262-701	HUMAN OTC DRUG	DISINFECT Wet WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201120		OTC MONOGRAPH NOT FINAL	part333A	Aarjay Products LLC	BENZALKONIUM CHLORIDE	.13	1/1001			N	20241231
80267-000_f1afa697-1104-4dd3-bb57-02f4a0442a70	80267-000	HUMAN OTC DRUG	betr allergy relief nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20210127		ANDA	ANDA207957	Live Betr LLC	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80267-001_eaf6d2fc-ebcb-4d11-8e3f-a494f0f7920b	80267-001	HUMAN OTC DRUG	betr headache pain relief		naproxen sodium	TABLET, FILM COATED	ORAL	20210209		ANDA	ANDA074661	Live Betr LLC	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80267-002_5855b61a-c880-47b0-a67e-4e6cecb47f2c	80267-002	HUMAN OTC DRUG	Betr chest congestion relief		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20210930		ANDA	ANDA213420	Live Betr LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
80267-010_638390ce-4a25-459c-a475-12e079a1d67f	80267-010	HUMAN OTC DRUG	Betr remedies chest congestion relief		Guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20230320		ANDA	ANDA213420	Live Betr LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
80267-020_e683211f-8985-4170-8be0-17c0553524be	80267-020	HUMAN OTC DRUG	betr remedies stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20230707		OTC MONOGRAPH NOT FINAL	part334	Live Betr LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
80267-100_12c2c0fa-8cdf-4a28-94ae-2e8c1ec10137	80267-100	HUMAN OTC DRUG	betr remedies allergy relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20230724		OTC MONOGRAPH FINAL	part341	Live Betr LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80267-194_31b77883-b640-45ab-a4e6-72e30e2347b4	80267-194	HUMAN OTC DRUG	betr acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20211012		ANDA	ANDA077351	Live Betr LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
80267-350_c177ec01-7a24-420c-8a04-b2a41d3cd3ea	80267-350	HUMAN OTC DRUG	betr cold and flu daytime relief		acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20211018		OTC MONOGRAPH FINAL	part341	Live Betr LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80267-409_4a017852-db01-4085-8947-d92a19ec4e5c	80267-409	HUMAN OTC DRUG	betr remedies all day allergy relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20230510		ANDA	ANDA078336	Live Betr LLC	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80267-428_16e2fa07-b6be-40d4-b926-fb0389bdf9cd	80267-428	HUMAN OTC DRUG	Betr gas relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20210930		OTC MONOGRAPH FINAL	part332	Live Betr LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
80267-431_a4e9362f-6535-430b-830d-316acca752b5	80267-431	HUMAN OTC DRUG	Betr sleep aid		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20210125		OTC MONOGRAPH FINAL	part338	Live Betr LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80267-479_a2ce83a0-750e-467d-9c6a-c841a0cd21b0	80267-479	HUMAN OTC DRUG	Betr Allergy Relief		Diphenhydramine Hydrochloride	TABLET	ORAL	20210203		OTC MONOGRAPH FINAL	part341	Live Betr LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80267-484_6d5f55e7-51ae-4c1d-839b-baa61ce769a4	80267-484	HUMAN OTC DRUG	betr pain relief		Acetaminophen	TABLET	ORAL	20210215		OTC MONOGRAPH NOT FINAL	part343	Live Betr LLC	ACETAMINOPHEN	500	mg/1			N	20241231
80267-486_345b0d2c-843f-4f89-9bfc-2b7fabd55167	80267-486	HUMAN OTC DRUG	Betr stool softener		Docusate sodium	CAPSULE, LIQUID FILLED	ORAL	20211005		OTC MONOGRAPH NOT FINAL	part334	Live Betr LLC	DOCUSATE SODIUM	100	mg/1			N	20241231
80267-501_6826fde0-f6e7-49f8-b242-5ce6bdd56bda	80267-501	HUMAN OTC DRUG	betr remedies acid reducer		Famotidine	TABLET, FILM COATED	ORAL	20230718		ANDA	ANDA077351	Live Betr LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
80267-604_fd59f89f-ba16-4879-a92b-fddc24a50292	80267-604	HUMAN OTC DRUG	betr pain relief		Ibuprofen	TABLET, FILM COATED	ORAL	20210121		ANDA	ANDA072096	Live Betr LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80267-721_aeec3496-41b8-4f25-b73d-583224039afe	80267-721	HUMAN OTC DRUG	betr cold and flu nighttime relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	TABLET, FILM COATED	ORAL	20211019		OTC MONOGRAPH FINAL	part341	Live Betr LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80267-999_0a50820f-1dfa-45b5-824f-2c28822fc6c6	80267-999	HUMAN OTC DRUG	betr remedies ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20230726		ANDA	ANDA072096	Live Betr LLC	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80272-002_3391101f-621b-4176-86ab-0908dfc9b2d7	80272-002	HUMAN OTC DRUG	Pain Relief Fever Reducer	children	Acetaminophen	SUSPENSION	ORAL	20200930		OTC MONOGRAPH DRUG	M013	Ellywell, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
80284-000_0d0058f6-9c5e-20a4-e063-6394a90a68f1	80284-000	HUMAN OTC DRUG	Exgerm Antiseptic Hand Sanitizer		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20200820		OTC MONOGRAPH DRUG	505G(a)(3)	International Biotech Factory, S.A. de C.V.	ISOPROPYL ALCOHOL	.72	mL/mL			N	20241231
80284-001_0d0b8e90-206b-1c76-e063-6394a90af668	80284-001	HUMAN OTC DRUG	Gabgerm Antiseptic Hand Sanitizer		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20210104		OTC MONOGRAPH DRUG	505G(a)(3)	International Biotech Factory, S.A. de C.V.	ISOPROPYL ALCOHOL	72	mL/100mL			N	20241231
80284-002_0d004edb-7e8f-05a6-e063-6394a90a6ca8	80284-002	HUMAN OTC DRUG	Gabgerm Antisec hand sanitizer		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20210104		OTC MONOGRAPH DRUG	505G(a)(3)	International Biotech Factory, S.A. de C.V.	ISOPROPYL ALCOHOL	72	mL/100mL			N	20241231
80294-301_f63b623e-086b-44be-e053-2995a90a97ab	80294-301	HUMAN OTC DRUG	MagiCare Premium Hand Sanitizing Wipes		ALCOHOL	CLOTH	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333E	Chaozhou Cecilia Technology Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
80295-100_031b1035-b933-ea0e-e063-6394a90a4d90	80295-100	HUMAN OTC DRUG	CANNAVERA PAIN RELIEF		CAPSAICIN	OIL	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part348	Leading Edge Pharms, Inc.	CAPSAICIN	1	mg/mL			N	20241231
80324-078_09d6b845-ce77-6bac-e063-6394a90a1369	80324-078	HUMAN OTC DRUG	STING MASTER		LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20200820		OTC MONOGRAPH DRUG	M017	Les Technologies Ptero, Inc	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80325-000_09c28c59-b8c6-195c-e063-6394a90abbac	80325-000	HUMAN OTC DRUG	Spit and Polish Mineral Face SPF 30		ZINC OXIDE	STICK	TOPICAL	20200301		OTC MONOGRAPH DRUG	M020	Naturally Uncommon, LLC	ZINC OXIDE	220	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
80325-001_09c2d4fa-e9fb-318b-e063-6394a90a6d51	80325-001	HUMAN OTC DRUG	Spit and Polish Sun Smart Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20200301		OTC MONOGRAPH DRUG	M020	Naturally Uncommon, LLC	TITANIUM DIOXIDE; ZINC OXIDE	70; 100	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
80325-002_09c2dbb9-bc6a-b54b-e063-6294a90a9c25	80325-002	HUMAN OTC DRUG	Spit and Polish Mineral Lip Balm Broad Spectrum Lip Protectant SPF 30		ZINC OXIDE	STICK	TOPICAL	20200301		OTC MONOGRAPH DRUG	M020	Naturally Uncommon, LLC	ZINC OXIDE	80	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
80325-003_e2192ce7-1fdb-80d1-e053-2a95a90a6ef8	80325-003	HUMAN OTC DRUG	OCEAN SAFE SUNSCREEN		Titanium Dioxide	CREAM	TOPICAL	20220701		OTC MONOGRAPH FINAL	part352	Naturally Uncommon, LLC	TITANIUM DIOXIDE	88	mg/88mL			N	20241231
80327-002_0b592264-9c16-0b76-e063-6394a90a38da	80327-002	HUMAN OTC DRUG	SHINGBASE Topical Analgesic		LIDOCAINE, MENTHOL	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M017	JOONEM LLC	LIDOCAINE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80327-008_0b58f836-260c-5d03-e063-6294a90a6d8b	80327-008	HUMAN OTC DRUG	Base Laboratories Base Numb Topical Anorectal Cream		LIDOCAINE	CREAM	TOPICAL	20211001		OTC MONOGRAPH DRUG	M015	Joonem LLC	LIDOCAINE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80327-009_efa7982b-6aef-274a-e053-2a95a90a7d71	80327-009	HUMAN OTC DRUG	Sterile Hypertonic Saline Solution 7 Sodium Chloride		SODIUM CHLORIDE	LIQUID	TOPICAL	20220401		UNAPPROVED DRUG OTHER		JOONEM LLC	SODIUM CHLORIDE	70	mg/mL			N	20241231
80327-010_0b590070-bf68-5cc2-e063-6294a90a8e14	80327-010	HUMAN OTC DRUG	Base Laboratories Lidocaine Anesthetic Pain Relief		LIDOCAINE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M017	Joonem LLC	LIDOCAINE	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80327-011_0b5919d0-5cfe-da71-e063-6394a90a97b3	80327-011	HUMAN OTC DRUG	Base Laboratories Corneal Flow Hypertonicity Ophthalmic Eye		SODIUM CHLORIDE	OINTMENT	TOPICAL	20230101		OTC MONOGRAPH DRUG	M018	Joonem LLC	SODIUM CHLORIDE	30	mg/g			N	20241231
80334-0630_0d8a26e5-b5da-2f9e-e063-6294a90a47ca	80334-0630	HUMAN OTC DRUG	75% Alcohol Antiseptic Wipes		Hand Sanitizer	CLOTH	TOPICAL	20200904		OTC MONOGRAPH DRUG	505G(a)(3)	Wuhan Snow Medical Disinfectant Co., Ltd	ALCOHOL	75	g/100g			N	20241231
80334-0731_0d7821d6-ce8d-0c44-e063-6394a90ae03c	80334-0731	HUMAN OTC DRUG	Wash Free Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200904		OTC MONOGRAPH DRUG	505G(a)(3)	Wuhan Snow Medical Disinfectant Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
80334-0831_0d8a0b05-dd71-82e3-e063-6394a90aa9e7	80334-0831	HUMAN OTC DRUG	ALCOHOL BASED HAND SANITIZER		Hand Sanitizer	SOLUTION	TOPICAL	20200904		OTC MONOGRAPH DRUG	505G(a)(3)	Wuhan Snow Medical Disinfectant Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
80335-103_0cfbba69-217d-2ba7-e063-6394a90a1474	80335-103	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20201221		OTC MONOGRAPH DRUG	M003	EverywhereAire LLC	ALCOHOL	70	mL/100mL			N	20241231
80335-105_0cfb904b-c76a-2beb-e063-6394a90ab233	80335-105	HUMAN OTC DRUG	PlaneAire Hands hand sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20201221		OTC MONOGRAPH DRUG	M003	EverywhereAire LLC	ALCOHOL	70	mL/100mL			N	20241231
80335-105_0cfce3e1-1c77-8b45-e063-6294a90a388d	80335-105	HUMAN OTC DRUG	PlaneAire Hands hand sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20210108		OTC MONOGRAPH DRUG	M003	EverywhereAire LLC	ALCOHOL	70	mL/100mL			N	20241231
80335-112_0cfbc234-6e0e-cb4e-e063-6294a90a3253	80335-112	HUMAN OTC DRUG	PlaneAire Hands		Ethanol Hand Sanitizer	GEL	TOPICAL	20210111		OTC MONOGRAPH DRUG	M003	EverywhereAire LLC	ALCOHOL	70	mL/100mL			N	20241231
80335-114_0d002185-d46c-d439-e063-6294a90ac30e	80335-114	HUMAN OTC DRUG	Hand Sanitizer gel		ALCOHOL	GEL	TOPICAL	20220101		OTC MONOGRAPH DRUG	M003	EverywhereAire LLC	ALCOHOL	70	mL/100mL			N	20241231
80335-115_0cf85455-341b-feb1-e063-6394a90af831	80335-115	HUMAN OTC DRUG	PlaneAire Hands hand sanitizer		Hand sanitizer ethanol-based	LOTION	TOPICAL	20221024		OTC MONOGRAPH DRUG	M003	EverywhereAire LLC	ALCOHOL	70	mL/100mL			N	20241231
80335-116_0cfbba69-2180-2ba7-e063-6394a90a1474	80335-116	HUMAN OTC DRUG	PlaneAire Hands		Hand sanitizer ethanol-based	LOTION	TOPICAL	20221024		OTC MONOGRAPH DRUG	M003	EverywhereAire LLC	ALCOHOL	70	mL/100mL			N	20241231
80335-117_0cf870f0-554c-0443-e063-6394a90a1be3	80335-117	HUMAN OTC DRUG	PlaneAire Hands		Hand sanitizer ethanol based	SPRAY	TOPICAL	20221024		OTC MONOGRAPH DRUG	M003	EverywhereAire LLc	ALCOHOL	70	mL/100mL			N	20241231
80337-301_07f85c50-d207-8903-e063-6394a90a8318	80337-301	HUMAN OTC DRUG	HAND SANITIZING WIPES		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	Jiangsu Xiaolikang Medical Technology Co., Ltd.	ISOPROPYL ALCOHOL	3.3	mL/1			N	20241231
80337-601_07f5ec88-fbe0-6801-e063-6294a90ab866	80337-601	HUMAN OTC DRUG	DISINFECT Wet WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200330		OTC MONOGRAPH DRUG	M003	Jiangsu Xiaolikang Medical Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	mg/1001			N	20241231
80337-701_07f59f9b-040d-a0c7-e063-6394a90a1fcb	80337-701	HUMAN OTC DRUG	DISINFECT Wet WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201105		OTC MONOGRAPH DRUG	M003	Jiangsu Xiaolikang Medical Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	mg/1001			N	20241231
80337-801_07e5bca3-5244-b6f3-e063-6394a90a7329	80337-801	HUMAN OTC DRUG	DISINFECTING WET WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210309		OTC MONOGRAPH DRUG	M003	Jiangsu Xiaolikang Medical Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	mg/100mg			N	20241231
80353-132_0d52d6fd-5a97-95c3-e063-6294a90ac052	80353-132	HUMAN OTC DRUG	Cell Detox		Cesium, Narcotics, and Dioxin Detox	CAPSULE	ORAL	20211108		UNAPPROVED HOMEOPATHIC		HCBIOPHARM LLC	PORTULACA OLERACEA LEAF; SAURURUS CHINENSIS WHOLE	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
80353-150_0d52ef75-61da-742a-e063-6394a90af4ba	80353-150	HUMAN OTC DRUG	HCBIOPHARM CELL DETOX ATOPY		FLUSH TOXINS THAT TRIGGER ATOPIC SKIN, IMPROVE SKIN HEALTH	CAPSULE	ORAL	20230905		UNAPPROVED HOMEOPATHIC		HCBIOPHARM	PORTULACA OLERACEA LEAF; SAURURUS CHINENSIS WHOLE	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
80353-196_0d52ef75-61db-742a-e063-6394a90af4ba	80353-196	HUMAN OTC DRUG	Immunies		Homeopathic Immunomodulator	CAPSULE	ORAL	20211020		UNAPPROVED HOMEOPATHIC		HCBIOPHARM LLC	PANAX GINSENG WHOLE	1	[hp_X]/1			N	20241231
80353-451_0d532b10-9d72-db5b-e063-6394a90ae5b0	80353-451	HUMAN OTC DRUG	Insulizen		Insulin Resistance Reducer, Insulin Receptor Restore, and Blood Sugar Level Balance	CAPSULE	ORAL	20211124		UNAPPROVED HOMEOPATHIC		HCBIOPHARM LLC	LAGERSTROEMIA SPECIOSA LEAF; MORINDA CITRIFOLIA FRUIT	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
80353-551_0d53175c-ddfd-2339-e063-6294a90a001a	80353-551	HUMAN OTC DRUG	Archibone		Rheumatoid arthritis and osteoarthritis recovery, and cartilage restore	CAPSULE	ORAL	20211119		UNAPPROVED HOMEOPATHIC		HCBIOPHARM LLC	ACHYRANTHES JAPONICA ROOT; PRUNUS PERSICA WHOLE	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
80353-601_0d52f2b5-781e-ae72-e063-6294a90ac15c	80353-601	HUMAN OTC DRUG	Nephricare		Kidney Function Repair	CAPSULE	ORAL	20211112		UNAPPROVED HOMEOPATHIC		HCBIOPHARM LLC	CORNUS OFFICINALIS FRUIT; PANAX GINSENG WHOLE	1; 1	[hp_X]/1; [hp_X]/1			N	20241231
80353-702_0d532e20-778c-dbfc-e063-6394a90abd85	80353-702	HUMAN OTC DRUG	Prostazen		Enlarged Prostate, Prostatic Utricle Function, and Prostatitis Recovery	CAPSULE	ORAL	20220112		UNAPPROVED HOMEOPATHIC		HCBIOPHARM LLC	REYNOUTRIA JAPONICA ROOT; RUBIA CORDIFOLIA ROOT; SAW PALMETTO	1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
80353-900_0bfb4b71-8393-15fa-e063-6394a90a771b	80353-900	HUMAN OTC DRUG	URICOZEN		Gout recovery, Joint pain and inflammation relief, and gout crystal dissolution	CAPSULE	ORAL	20231207		UNAPPROVED HOMEOPATHIC		HCBIOPHARM	LONICERA JAPONICA FLOWER; PORTULACA OLERACEA WHOLE; WOLFIPORIA COCOS WHOLE	1; 1; 1	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
80384-001_7a64af35-851e-45a6-a3eb-d99a9890fa77	80384-001	HUMAN OTC DRUG	SCENT FOR GOOD HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333E	SCENT FOR GOOD LLC	ALCOHOL	60	g/100mL			N	20241231
80396-079_0975bb48-249d-e8bd-e063-6394a90ae8d9	80396-079	HUMAN OTC DRUG	Defend tattoo sunscreen SPF 30		ZINC OXIDE	CREAM	TOPICAL	20200825		OTC MONOGRAPH DRUG	M020	Rabbit Mad Tattoo LLC	ZINC OXIDE	140	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
80404-501_086d83fb-1341-42f9-e063-6294a90a900e	80404-501	HUMAN OTC DRUG	Cough Drops		MENTHOL	TABLET, ORALLY DISINTEGRATING	ORAL	20230629		OTC MONOGRAPH DRUG	M012	Xinsanyang Pharmaceutical (Xiamen) Co., Ltd.	MENTHOL	5.4	mg/1			N	20241231
80404-601_ffa59aa6-bb97-d12b-e053-6294a90a375d	80404-601	HUMAN OTC DRUG	Vitamin C Drops		Vitamin C	TABLET, CHEWABLE, EXTENDED RELEASE	SUBLINGUAL	20230703		UNAPPROVED DRUG OTHER		Xinsanyang Pharmaceutical (Xiamen) Co., Ltd.	ASCORBIC ACID	2.25	mg/100mg	Ascorbic Acid [CS], Vitamin C [EPC]		N	20241231
80421-100_625ba69c-7705-4bde-988c-3db1b4d08393	80421-100	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20200701		NDA	NDA205849	Empresas De Soldaduras	OXYGEN	1	L/L			N	20241231
80425-0001_ed34b45c-7c7c-5e92-e053-2995a90a48fc	80425-0001	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim	DS	Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100913		ANDA	ANDA076899	Advanced Rx Pharmacy of Tennessee, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
80425-0002_ed34b45c-7c7d-5e92-e053-2995a90a48fc	80425-0002	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim	DS	Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Advanced Rx Pharmacy of Tennessee, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
80425-0003_f5c95456-750d-79a1-e053-2a95a90a3b6f	80425-0003	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim	DS	Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20100216		ANDA	ANDA090624	Advanced Rx Pharmacy of Tennessee, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
80425-0004_f0480feb-f085-b1be-e053-2995a90a1e3f	80425-0004	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20220914		ANDA	ANDA065253	ADVANCED RX PHARMACY OF TENNESSEE, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
80425-0005_f28e4eff-a0d5-9310-e053-2995a90af4ef	80425-0005	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	ADVANCED RX PHARMACY OF TENNESSEE, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
80425-0006_ec1ebea6-27e6-1b86-e053-2995a90a29be	80425-0006	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20060111		ANDA	ANDA065229	ADVANCED RX PHARMACY OF TENNESSEE, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
80425-0007_f821789c-2599-f8d6-e053-6394a90a799b	80425-0007	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150119		ANDA	ANDA202801	ADVANCED RX PHARMACY OF TENNESSEE, LLC	LEVOFLOXACIN	500	mg/1			N	20241231
80425-0008_ed217210-3a31-4f1b-e053-2995a90a1267	80425-0008	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20110620		ANDA	ANDA201043	Advanced Rx Pharmacy of Tennessee, LLC	LEVOFLOXACIN	500	mg/1			N	20241231
80425-0009_ed218357-185e-6b65-e053-2a95a90ac93a	80425-0009	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Advanced Rx Pharmacy of Tennessee, LLC	LEVOFLOXACIN	500	mg/1			N	20241231
80425-0010_ed22bfe5-c7b4-7a6f-e053-2a95a90a0f71	80425-0010	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Advanced Rx Pharmacy of Tennessee, LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0012_f2a3ff81-893e-5b2c-e053-2a95a90a3293	80425-0012	HUMAN PRESCRIPTION DRUG	Duloxetine HCL	DR	Duloxetine HCL	CAPSULE, DELAYED RELEASE	ORAL	20120501		ANDA	ANDA203197	Advanced Rx Pharmacy of Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0013_edadcf21-8edf-db27-e053-2995a90a44eb	80425-0013	HUMAN PRESCRIPTION DRUG	Duloxetine HCL	DR	Duloxetine HCL	CAPSULE, DELAYED RELEASE	ORAL	20190930		ANDA	ANDA090778	Advanced Rx Pharmacy of Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0014_edadc877-cd48-18be-e053-2a95a90ab3e0	80425-0014	HUMAN PRESCRIPTION DRUG	Duloxetine HCL	DR	Duloxetine HCL	CAPSULE, DELAYED RELEASE	ORAL	20221211		ANDA	ANDA090778	Advanced Rx Pharmacy of Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0015_ed0c581e-ff7e-b4f4-e053-2a95a90ab431	80425-0015	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL		Cyclobenzaprine HCL	TABLET, FILM COATED	ORAL	20180116		ANDA	ANDA078722	ADVANCED RX PHARMACY OF TENNESSEE, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0016_ed0d5afb-d442-9e27-e053-2a95a90ab6e8	80425-0016	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL		Cyclobenzaprine HCL	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Advanced Rx Pharmacy of Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0017_ed0d797a-cb73-3e7d-e053-2a95a90a83c7	80425-0017	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL		Cyclobenzaprine HCL	TABLET, FILM COATED	ORAL	20060404		ANDA	ANDA077563	Advanced Rx Pharmacy of Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0018_ec1f509c-8fc8-a271-e053-2995a90af811	80425-0018	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL		Cyclobenzaprine HCL	TABLET, FILM COATED	ORAL	20170531		ANDA	ANDA208170	Advanced Rx Pharmacy of Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0019_ec1f147c-a033-6fad-e053-2a95a90a00e2	80425-0019	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		Cyclobenzaprine Hydrochloride	TABLET, FILM COATED	ORAL	20170330		ANDA	ANDA077797	Advanced Rx Pharmacy of Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0020_f436ac9d-5db5-49a5-e053-2a95a90a7588	80425-0020	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, COATED	ORAL	20180702		ANDA	ANDA209312	ADVANCED RX PHARMACY OF TENNESSEE, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0021_ed228b03-3c58-ef01-e053-2a95a90a9900	80425-0021	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20190815		ANDA	ANDA040489	Advanced Rx Pharmacy of Tennessee, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0022_ed350506-f251-79dc-e053-2a95a90a0289	80425-0022	HUMAN PRESCRIPTION DRUG	Tizanidine HCL		Tizanidine HCL	TABLET	ORAL	20031211		ANDA	ANDA076416	ADVANCED RX PHARMACY OF TENNESSEE, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
80425-0023_ed350afb-b8e0-3201-e053-2a95a90a6f1b	80425-0023	HUMAN PRESCRIPTION DRUG	Tizanidine HCL		Tizanidine HCL	TABLET	ORAL	20020703		ANDA	ANDA076286	Advanced Rx Pharmacy of Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
80425-0024_f83456aa-7dc1-91f3-e053-6294a90a35a4	80425-0024	HUMAN PRESCRIPTION DRUG	Tizanidine HCL		Tizanidine HCL	TABLET	ORAL	20130401		ANDA	ANDA091283	Advanced Rx Pharmacy of Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
80425-0025_ed246552-3940-796a-e053-2a95a90af4ca	80425-0025	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	ADVANCED RX PHARMACY OF TENNESSEE, LLC	PREGABALIN	50	mg/1		CV	N	20241231
80425-0026_ed2487d7-8ad0-174c-e053-2a95a90a1bd3	80425-0026	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
80425-0027_ed248797-857b-41ef-e053-2995a90a4a11	80425-0027	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA210432	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
80425-0028_f88862c4-9148-a761-e053-6394a90a2256	80425-0028	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
80425-0029_f44b234a-9550-fa94-e053-2995a90a6cbd	80425-0029	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
80425-0030_ed24992a-efd0-fab4-e053-2a95a90a4d15	80425-0030	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209357	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
80425-0031_f8212367-3310-26ad-e053-6394a90a4cdb	80425-0031	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20180514		ANDA	ANDA206943	ADVANCED RX PHARMACY OF TENNESSEE, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0032_ed10069e-784f-3bbf-e053-2a95a90a7970	80425-0032	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20220403		ANDA	ANDA075350	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0033_ed10253e-2d8b-72a1-e053-2995a90acee0	80425-0033	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0035_ed11262f-bfec-4aee-e053-2995a90af901	80425-0035	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20151101		ANDA	ANDA206402	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0036_ed1146a3-3246-d7dc-e053-2995a90adfd1	80425-0036	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0037_ed0c24e8-a06d-d14c-e053-2995a90ae308	80425-0037	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	ADVANCED RX PHARMACY OF TENNESSEE, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0038_ed0c24e8-a070-d14c-e053-2995a90ae308	80425-0038	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20141210		NDA AUTHORIZED GENERIC	NDA020998	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0039_ed0d2668-6c45-9b9b-e053-2a95a90a47cc	80425-0039	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20170926		ANDA	ANDA207446	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0040_ed0d2ce7-d12d-da32-e053-2a95a90af7a7	80425-0040	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20180601		ANDA	ANDA204776	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0041_ed21864f-7e96-1977-e053-2995a90a0f22	80425-0041	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Advanced Rx Pharmacy of Tennessee, LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0042_ed219efc-84e9-5bdc-e053-2a95a90a56fc	80425-0042	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Advanced Rx Pharmacy of Tennessee, LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0043_ed21ab33-5ad2-7c8f-e053-2a95a90a38f8	80425-0043	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	Advanced Rx Pharmacy of Tennessee, LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0044_ed21df8b-b100-16b8-e053-2a95a90a6e0f	80425-0044	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20070307		ANDA	ANDA077927	Advanced Rx Pharmacy of Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0045_ed220eaa-477d-2805-e053-2995a90a73a2	80425-0045	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077921	Advanced Rx Pharmacy of Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0046_ed20b686-02f6-78da-e053-2995a90a01ba	80425-0046	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Advanced Rx Pharmacy of Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0047_ed20f09d-4c81-b4e4-e053-2a95a90a08a9	80425-0047	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20091123		ANDA	ANDA078558	Advanced Rx Pharmacy of Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0048_ed22c707-e2cb-41b6-e053-2a95a90a56f0	80425-0048	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20160706		ANDA	ANDA091416	Advanced Rx Pharmacy of Tennessee, LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0049_ed22dec5-5116-9b5d-e053-2995a90a1e9f	80425-0049	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20100218		ANDA	ANDA075927	Advanced Rx Pharmacy of Tennessee, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0050_ed22e3ae-6b76-d570-e053-2a95a90ab1d9	80425-0050	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20070701		ANDA	ANDA078250	Advanced Rx Pharmacy of Tennessee, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0051_ed22d768-46e8-7088-e053-2995a90a2314	80425-0051	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20111108		ANDA	ANDA200429	Advanced Rx Pharmacy of Tennessee, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0053_ed22b49c-e6bb-5363-e053-2995a90a3d6b	80425-0053	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET, FILM COATED	ORAL	20190306		ANDA	ANDA078671	Advanced Rx Pharmacy of Tennessee, LLC	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0054_ed22b49c-e6bc-5363-e053-2995a90a3d6b	80425-0054	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Advanced Rx Pharmacy of Tennessee, LLC	NABUMETONE	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0055_f291457a-2ace-d849-e053-2a95a90a4375	80425-0055	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	DR	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0056_edad9591-04d5-3f3c-e053-2995a90ad5ae	80425-0056	HUMAN PRESCRIPTION DRUG	Diclofenac	DR	Diclofenac	TABLET, DELAYED RELEASE	ORAL	20080819		ANDA	ANDA077863	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0057_ed356156-e7ee-8cfe-e053-2995a90a1554	80425-0057	HUMAN PRESCRIPTION DRUG	Tramadol HCL		Tramadol HCL	TABLET, COATED	ORAL	20101115		ANDA	ANDA076003	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0058_f2a36470-d7d4-a4fb-e053-2a95a90aa976	80425-0058	HUMAN PRESCRIPTION DRUG	Tramadol HCL		Tramadol HCL	TABLET	ORAL	20020622		ANDA	ANDA075964	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0059_fa16aa5b-8200-6ed2-e053-6394a90a0d05	80425-0059	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0060_ed361417-a0bc-b15e-e053-2995a90a4eac	80425-0060	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20070423		ANDA	ANDA077322	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0061_ed35f8b7-f366-9bd0-e053-2995a90a4108	80425-0061	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0062_ed0f6286-becc-28bf-e053-2a95a90a52eb	80425-0062	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	2	mg/1		CIV	N	20241231
80425-0063_ed0f6286-becd-28bf-e053-2a95a90a52eb	80425-0063	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	2	mg/1		CIV	N	20241231
80425-0064_ed0c7709-0412-7fcf-e053-2995a90a8898	80425-0064	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, COATED	ORAL	20140415		ANDA	ANDA091024	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	2	mg/1		CIV	N	20241231
80425-0065_ed0f7a79-1358-0d2a-e053-2995a90abf9f	80425-0065	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140425		ANDA	ANDA202929	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
80425-0066_ed0f8249-aba4-b67c-e053-2a95a90af7eb	80425-0066	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20160915		ANDA	ANDA208451	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
80425-0067_f2a3fcea-a9fe-5220-e053-2995a90a7e8f	80425-0067	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, COATED	ORAL	20140415		ANDA	ANDA091024	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
80425-0068_ed24547f-87ad-3b47-e053-2a95a90a40f3	80425-0068	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20220915		ANDA	ANDA080352	Advanced Rx Pharmacy of Tennessee, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0069_ed24547f-87b0-3b47-e053-2a95a90a40f3	80425-0069	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Advanced Rx Pharmacy of Tennessee, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0070_f98cdb92-b9ed-a48e-e053-6394a90ac481	80425-0070	HUMAN PRESCRIPTION DRUG	Omeprazole	DR	Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Advanced Rx Pharmacy of Tennessee, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0071_f2a3ab51-ace2-2218-e053-2a95a90ac885	80425-0071	HUMAN PRESCRIPTION DRUG	Omeprazole	DR	Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA075576	Advanced Rx Pharmacy of Tennessee, LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0072_ed23c8d1-bcbc-440d-e053-2a95a90ab9e9	80425-0072	HUMAN PRESCRIPTION DRUG	Ondansetron HCL		Ondansetron HCL	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Advanced Rx Pharmacy of Tennessee, LLC	ONDANSETRON HYDROCHLORIDE	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
80425-0073_f2a2fd19-5710-ba31-e053-2995a90a6b75	80425-0073	HUMAN PRESCRIPTION DRUG	Ondansetron	ODT	Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20100412		ANDA	ANDA090469	Advanced Rx Pharmacy of Tennessee, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
80425-0074_f2178528-100b-05fb-e053-2995a90af655	80425-0074	HUMAN PRESCRIPTION DRUG	Ondansetron HCL		Ondansetron HCL	TABLET, FILM COATED	ORAL	20200916		ANDA	ANDA078539	Advanced Rx Pharmacy of Tennessee, LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
80425-0075_f436f5b6-f2fc-ff6e-e053-2995a90a2f7d	80425-0075	HUMAN PRESCRIPTION DRUG	Ondansetron HCL		Ondansetron HCL	TABLET, FILM COATED	ORAL	20070731		ANDA	ANDA078539	Advanced Rx Pharmacy of Tennessee, LLC	ONDANSETRON HYDROCHLORIDE	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
80425-0076_ed2190aa-3346-27cb-e053-2a95a90a6733	80425-0076	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20120322		ANDA	ANDA200839	Advanced Rx Pharmacy of Tennessee, LLC	LEVOFLOXACIN	750	mg/1			N	20241231
80425-0077_ed219aea-47b7-8ed8-e053-2995a90a5c19	80425-0077	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20150109		ANDA	ANDA202801	Advanced Rx Pharmacy of Tennessee, LLC	LEVOFLOXACIN	750	mg/1			N	20241231
80425-0078_ed0d8152-5eef-9303-e053-2a95a90a9c43	80425-0078	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL		Cyclobenzaprine HCL	TABLET, FILM COATED	ORAL	20150325		ANDA	ANDA078722	Advanced Rx Pharmacy of Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	7.5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0079_ed115155-54a1-3a38-e053-2a95a90abf69	80425-0079	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20151230		ANDA	ANDA090007	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0080_ec1e207a-d3af-df8e-e053-2a95a90a77ef	80425-0080	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	19880721		ANDA	ANDA072234	Advanced Rx Pharmacy of Tennessee, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
80425-0081_ec1e763d-4b36-908f-e053-2a95a90a36df	80425-0081	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20110101		ANDA	ANDA078401	Advanced Rx Pharmacy of Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
80425-0082_ed115bee-0386-2e9f-e053-2995a90acbf2	80425-0082	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0083_ed2214c3-6edb-33fc-e053-2995a90aa901	80425-0083	HUMAN PRESCRIPTION DRUG	Meloxicam		Meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	Advanced Rx Pharmacy of Tennessee, LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0084_ed2221e9-ad06-d974-e053-2a95a90a56db	80425-0084	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20130531		ANDA	ANDA203399	Advanced Rx Pharmacy of Tennessee, LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
80425-0085_edae1cc7-acd3-6d51-e053-2995a90ae6d1	80425-0085	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium	DR	Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20160620		ANDA	ANDA205119	Advanced Rx Pharmacy of Tennessee, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0086_edadb5c7-a7b5-6d02-e053-2995a90ae132	80425-0086	HUMAN PRESCRIPTION DRUG	Duloxetine HCL	DR	Duloxetine HCL	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20131217		ANDA	ANDA090776	Advanced Rx Pharmacy of Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0087_ed3621b3-98d1-5002-e053-2995a90a639c	80425-0087	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0088_edaf13e8-06dd-3a8b-e053-2a95a90ad808	80425-0088	HUMAN PRESCRIPTION DRUG	Venlafaxine HCL	ER	Venlafaxine HCL	CAPSULE, EXTENDED RELEASE	ORAL	20110106		ANDA	ANDA090899	Advanced Rx Pharmacy of Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0089_f2a34be7-9f70-c6e0-e053-2995a90a4e36	80425-0089	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	Advanced Rx Pharmacy of Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0090_f5d99350-aa58-c5fc-e053-2a95a90ae6da	80425-0090	HUMAN PRESCRIPTION DRUG	Tizanidine HCL		Tizanidine HCL	CAPSULE	ORAL	20190320		ANDA	ANDA210267	Advanced Rx Pharmacy of Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
80425-0091_ed34b78e-f380-b0ad-e053-2995a90a2bae	80425-0091	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	19961111		ANDA	ANDA070848	Advanced Rx Pharmacy of Tennessee, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
80425-0092_f44b1583-111d-e6ad-e053-2995a90a344d	80425-0092	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078235	Advanced Rx Pharmacy of Tennessee, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0093_ec1ef3c7-f786-5f48-e053-2995a90a9b8e	80425-0093	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram	TABLET	ORAL	20071018		ANDA	ANDA078216	Advanced Rx Pharmacy of Tennessee, LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80425-0094_f2a39216-8a91-3033-e053-2995a90ab567	80425-0094	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium	DR	Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	Advanced Rx Pharmacy of Tennessee, LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0095_ec1ea90d-3dee-c012-e053-2995a90afc7f	80425-0095	HUMAN PRESCRIPTION DRUG	Ciprofloxacin HCL		Ciprofloxacin HCL	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Advanced Rx Pharmacy of Tennessee, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
80425-0096_f28de55c-9e0f-6c06-e053-2a95a90adfe6	80425-0096	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0097_ed1157da-27fe-126a-e053-2995a90af76f	80425-0097	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	600	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0098_ed0f8249-aba7-b67c-e053-2a95a90af7eb	80425-0098	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091124	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	1	mg/1		CIV	N	20241231
80425-0099_ec064c09-f952-19d9-e053-2a95a90a763d	80425-0099	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Advanced Rx Pharmacy of Tennessee, LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0100_ec063b8e-1e22-822b-e053-2995a90a1323	80425-0100	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19951225		ANDA	ANDA074112	Advanced Rx Pharmacy of Tennessee, LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0102_edad86d1-bd95-fa3f-e053-2995a90a7632	80425-0102	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20101231		ANDA	ANDA090066	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0103_ec1f55dd-3fd0-bdaf-e053-2a95a90a122f	80425-0103	HUMAN PRESCRIPTION DRUG	Clindamycin HCL		Clindamycin HCL	CAPSULE	ORAL	20010323		ANDA	ANDA065061	Advanced Rx Pharmacy of Tennessee, LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
80425-0104_f8c37dbd-3bb3-f1d8-e053-6294a90aeac0	80425-0104	HUMAN PRESCRIPTION DRUG	Nabumetone		Nabumetone	TABLET	ORAL	20190626		ANDA	ANDA078420	Advanced Rx Pharmacy of Tennessee, LLC	NABUMETONE	750	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0105_fbd0ae72-2165-539f-e053-6294a90a6f32	80425-0105	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Advanced Rx Pharmacy of Tennessee, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0106_ed243c9a-5dda-264d-e053-2a95a90ac394	80425-0106	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20010829		ANDA	ANDA040362	Advanced Rx Pharmacy of Tennessee, LLC	PREDNISONE	5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0107_ed25c725-1199-1e37-e053-2a95a90a6e65	80425-0107	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Advanced Rx Pharmacy of Tennessee, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
80425-0108_edaed0bb-6393-9f67-e053-2995a90a6993	80425-0108	HUMAN PRESCRIPTION DRUG	Tramadol HCL	ER	Tramadol HCL	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0109_f2a3e1e8-00d4-30d9-e053-2a95a90aae40	80425-0109	HUMAN PRESCRIPTION DRUG	Omeprazole	DR	Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20191025		ANDA	ANDA078490	Advanced Rx Pharmacy of Tennessee, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0110_ec0625da-878f-25f6-e053-2995a90adba1	80425-0110	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	19931001		ANDA	ANDA074342	Advanced Rx Pharmacy of Tennessee, LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0111_edadd9dc-3ec5-558b-e053-2a95a90ad242	80425-0111	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium	DR	Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20160421		ANDA	ANDA205606	Advanced Rx Pharmacy of Tennessee, LLC	ESOMEPRAZOLE MAGNESIUM DIHYDRATE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0112_ec1e4b29-196e-70e6-e053-2995a90ae022	80425-0112	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20051220		ANDA	ANDA077241	Advanced Rx Pharmacy of Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
80425-0114_ed0e78fc-7bdf-440e-e053-2a95a90a432b	80425-0114	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20160628		ANDA	ANDA207289	Advanced Rx Pharmacy of Tennessee, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
80425-0115_ed0f8922-d0c3-7878-e053-2995a90aa629	80425-0115	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20140415		ANDA	ANDA091124	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
80425-0116_ed24cd4b-acc9-2c19-e053-2995a90afb2a	80425-0116	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		NDA AUTHORIZED GENERIC	NDA021446	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
80425-0117_032503ba-b1a2-b87d-e063-6294a90a586a	80425-0117	HUMAN PRESCRIPTION DRUG	Orphenadrine Citrate	ER	Orphenadrine Citrate	TABLET, EXTENDED RELEASE	ORAL	19980619		ANDA	ANDA040284	Advanced Rx Pharmacy of Tennessee, LLC	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0118_ed245536-d6a3-60f5-e053-2995a90a2caf	80425-0118	HUMAN PRESCRIPTION DRUG	Phentermine HCL		Phentermine HCL	TABLET	ORAL	20050415		ANDA	ANDA040555	Advanced Rx Pharmacy of Tennessee, LLC	PHENTERMINE HYDROCHLORIDE	37.5	mg/1	Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]	CIV	N	20241231
80425-0119_f8205a72-46a8-68b5-e053-6294a90a4f61	80425-0119	HUMAN PRESCRIPTION DRUG	Duloxetine	DR	Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Advanced Rx Pharmacy of Tennessee, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0120_ed0e3537-7411-02f3-e053-2995a90a44a0	80425-0120	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	19861210		ANDA	ANDA071322	Advanced Rx Pharmacy of Tennessee, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0121_0567a880-529c-22e4-e063-6394a90a27f3	80425-0121	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20110119		ANDA	ANDA090836	Advanced Rx Pharmacy of Tennessee, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
80425-0122_f436bd8c-b985-8e43-e053-2a95a90a2c8d	80425-0122	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20161122		ANDA	ANDA204770	Advanced Rx Pharmacy of Tennessee, LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0123_ed24d539-a11f-6e1b-e053-2995a90a30e9	80425-0123	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
80425-0124_ed24df75-9298-c579-e053-2a95a90a0bc8	80425-0124	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
80425-0125_f2043f93-741a-6d54-e053-2a95a90abaac	80425-0125	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Advanced Rx Pharmacy of Tennessee, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0126_ed0ffe51-4a21-1707-e053-2a95a90a8136	80425-0126	HUMAN PRESCRIPTION DRUG	Etodolac	ER	Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Advanced Rx Pharmacy of Tennessee, LLC	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0127_edaefcae-1d69-424f-e053-2a95a90aa59e	80425-0127	HUMAN PRESCRIPTION DRUG	Tramadol HCL	ER	Tramadol HCL	TABLET, EXTENDED RELEASE	ORAL	20111230		ANDA	ANDA091607	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0128_ed0fe0d0-7149-2a04-e053-2995a90a799d	80425-0128	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20080131		ANDA	ANDA078787	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0129_ed24e13a-89e3-1b2e-e053-2995a90a5817	80425-0129	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA209743	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	300	mg/1		CV	N	20241231
80425-0130_f929e8f6-d0b8-b5c6-e053-6294a90ad7d2	80425-0130	HUMAN PRESCRIPTION DRUG	Ergocalciferol (Vitamin D2)		Ergocalciferol (Vitamin D2)	CAPSULE	ORAL	20181210		ANDA	ANDA204276	Advanced Rx Pharmacy of Tennessee, LLC	ERGOCALCIFEROL	1.25	mg/1	Ergocalciferols [CS], Provitamin D2 Compound [EPC]		N	20241231
80425-0131_ed2246ed-eec2-e1af-e053-2995a90ad2e9	80425-0131	HUMAN PRESCRIPTION DRUG	Metaxalone		Metaxalone	TABLET	ORAL	20170619		ANDA	ANDA203695	Advanced Rx Pharmacy of Tennessee, LLC	METAXALONE	800	mg/1	Centrally-mediated Muscle Relaxation [PE]		N	20241231
80425-0132_ed206b81-cb23-2a8f-e053-2995a90af116	80425-0132	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151230		ANDA	ANDA090796	Advanced Rx Pharmacy of Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0133_edae9324-4f19-3601-e053-2995a90a0485	80425-0133	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium	DR	Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Advanced Rx Pharmacy of Tennessee, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0134_fa67b41d-0f3c-005d-e053-6294a90ac90e	80425-0134	HUMAN PRESCRIPTION DRUG	Rabeprazole Sodium	DR	Rabeprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20180427		ANDA	ANDA208644	Advanced Rx Pharmacy of Tennessee, LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0135_ec1f3525-c1d3-6c51-e053-2995a90ab405	80425-0135	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20110603		ANDA	ANDA077147	Advanced Rx Pharmacy of Tennessee, LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0136_fc4b82fa-1862-f7fc-e053-6394a90a5773	80425-0136	HUMAN PRESCRIPTION DRUG	Tramadol HCL	ER	Tramadol HCL	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0137_ec068135-5acf-eac3-e053-2a95a90a0bd8	80425-0137	HUMAN PRESCRIPTION DRUG	Amitriptyline HCL		Amitriptyline HCL	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Advanced Rx Pharmacy of Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0138_ed228d72-2285-f42b-e053-2a95a90adc03	80425-0138	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Advanced Rx Pharmacy of Tennessee, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0139_ed21337e-dc37-0fbd-e053-2995a90a7bc4	80425-0139	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	19980617		ANDA	ANDA074754	Advanced Rx Pharmacy of Tennessee, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0140_ed0f8922-d0cc-7878-e053-2995a90aa629	80425-0140	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20180611		ANDA	ANDA208834	Advanced Rx Pharmacy of Tennessee, LLC	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0141_edaee1f2-7393-ad2d-e053-2a95a90a9e3e	80425-0141	HUMAN PRESCRIPTION DRUG	Tramadol HCL	ER	Tramadol HCL	TABLET, EXTENDED RELEASE	ORAL	20111212		ANDA	ANDA201384	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	100	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0142_f28d851a-7bb1-ebd2-e053-2995a90a20e5	80425-0142	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20170926		ANDA	ANDA207446	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0143_f2a3d32a-d8ab-f1b7-e053-2995a90a69cb	80425-0143	HUMAN PRESCRIPTION DRUG	Quetiapine		Quetiapine	TABLET, FILM COATED	ORAL	20151201		ANDA	ANDA202152	Advanced Rx Pharmacy of Tennessee, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
80425-0144_ed35200e-7bc1-ae0b-e053-2a95a90ac869	80425-0144	HUMAN PRESCRIPTION DRUG	Tizanidine HCL		Tizanidine HCL	CAPSULE	ORAL	20190329		ANDA	ANDA212196	Advanced Rx Pharmacy of Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	4	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
80425-0145_052bd05f-941b-b554-e063-6394a90aeb59	80425-0145	HUMAN PRESCRIPTION DRUG	Clindamycin HCL		Clindamycin HCL	CAPSULE	ORAL	20090826		ANDA	ANDA065442	Advanced Rx Pharmacy of Tennessee, LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
80425-0146_f7a761b9-6584-81b3-e053-6394a90a88f4	80425-0146	HUMAN PRESCRIPTION DRUG	Duloxetine HCL	DR	Duloxetine HCL	CAPSULE, DELAYED RELEASE	ORAL	20170316		ANDA	ANDA208706	Advanced Rx Pharmacy of Tennessee, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0147_ed24e13a-89e5-1b2e-e053-2995a90a5817	80425-0147	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	75	mg/1		CV	N	20241231
80425-0148_edade565-8417-3f4f-e053-2995a90ac91c	80425-0148	HUMAN PRESCRIPTION DRUG	Lansoprazole	DR	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20101015		ANDA	ANDA091269	Advanced Rx Pharmacy of Tennessee, LLC	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0149_ed11a31c-6509-35b6-e053-2995a90a768d	80425-0149	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20200101		ANDA	ANDA075477	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0150_ed202694-bf2f-be2b-e053-2995a90a7564	80425-0150	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20200907		ANDA	ANDA075360	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0151_ed0e31e3-f44e-eb81-e053-2995a90aaf61	80425-0151	HUMAN PRESCRIPTION DRUG	Diazepam		Diazepam	TABLET	ORAL	20191031		ANDA	ANDA071136	Advanced Rx Pharmacy of Tennessee, LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0152_ed2526e7-0b9b-62ad-e053-2a95a90a5aa8	80425-0152	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
80425-0153_ed362c6b-6601-0ea4-e053-2a95a90aa50b	80425-0153	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, FILM COATED	ORAL	20070504		ANDA	ANDA078413	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0154_fbd0a22f-b36a-c0a2-e053-6394a90a1e07	80425-0154	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Advanced Rx Pharmacy of Tennessee, LLC	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0155_f820467c-8793-03d3-e053-6294a90a11c9	80425-0155	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL		Cyclobenzaprine HCL	TABLET, FILM COATED	ORAL	20200706		ANDA	ANDA213324	Advanced Rx Pharmacy of Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	5	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0156_fbf9f8bb-09f4-fe00-e053-6394a90a3ec5	80425-0156	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Advanced Rx Pharmacy of Tennessee, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
80425-0157_f0d3c335-ddc7-13e4-e053-2995a90a6b87	80425-0157	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20210730		ANDA	ANDA209102	Advanced Rx Pharmacy of Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
80425-0158_ed2029cb-32af-c2f0-e053-2a95a90a8023	80425-0158	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20111006		ANDA	ANDA200651	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	800	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0159_ed357999-3616-fd99-e053-2995a90a9ac6	80425-0159	HUMAN PRESCRIPTION DRUG	Tramadol HCL		Tramadol HCL	TABLET	ORAL	20020622		ANDA	ANDA075964	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0160_f10edbb8-3965-40b0-e053-2a95a90a6bda	80425-0160	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	300	mg/1		CV	N	20241231
80425-0161_ec067f8b-2eaa-75df-e053-2a95a90aba6c	80425-0161	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20180709		ANDA	ANDA207507	Advanced Rx Pharmacy of Tennessee, LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0162_edaea35f-8895-77b2-e053-2995a90a722a	80425-0162	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium	DR	Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20140910		ANDA	ANDA202882	Advanced Rx Pharmacy of Tennessee, LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0163_ed2010f1-8929-6ab2-e053-2a95a90a6fe5	80425-0163	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20110129		ANDA	ANDA090858	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0164_ec1df227-e95e-4cc5-e053-2995a90a0987	80425-0164	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, FILM COATED	ORAL	20040609		ANDA	ANDA075593	Advanced Rx Pharmacy of Tennessee, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
80425-0165_ed3619ed-3c48-295a-e053-2995a90a9088	80425-0165	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0166_ed252a00-715a-6647-e053-2a95a90a41d1	80425-0166	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20200331		ANDA	ANDA212865	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
80425-0167_f2044f0a-983a-5289-e053-2995a90aa13d	80425-0167	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20160316		ANDA	ANDA204590	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0168_f8997043-0909-06c5-e053-6294a90ae460	80425-0168	HUMAN PRESCRIPTION DRUG	Eszopiclone		Eszopiclone	TABLET, FILM COATED	ORAL	20150131		ANDA	ANDA202929	Advanced Rx Pharmacy of Tennessee, LLC	ESZOPICLONE	1	mg/1		CIV	N	20241231
80425-0169_f44b1c9e-d917-fc92-e053-2995a90a1596	80425-0169	HUMAN PRESCRIPTION DRUG	Omeprazole	DR	Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20141031		ANDA	ANDA091672	Advanced Rx Pharmacy of Tennessee, LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0170_ed252722-08bd-61a5-e053-2a95a90a55e2	80425-0170	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
80425-0171_ed228b03-3c62-ef01-e053-2a95a90a9900	80425-0171	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET, FILM COATED	ORAL	20180115		ANDA	ANDA208507	Advanced Rx Pharmacy of Tennessee, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0172_ec064c09-f953-19d9-e053-2a95a90a763d	80425-0172	HUMAN PRESCRIPTION DRUG	Amitriptyline HCL		Amitriptyline HCL	TABLET, FILM COATED	ORAL	20141205		ANDA	ANDA202446	Advanced Rx Pharmacy of Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0173_ed20a3ab-0aab-571f-e053-2995a90afd15	80425-0173	HUMAN PRESCRIPTION DRUG	Hydroxyzine HCL		Hydroxyzine HCL	TABLET, FILM COATED	ORAL	20121022		ANDA	ANDA088619	Advanced Rx Pharmacy of Tennessee, LLC	HYDROXYZINE DIHYDROCHLORIDE	50	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
80425-0174_edae1aff-07d9-cb30-e053-2995a90a6194	80425-0174	HUMAN PRESCRIPTION DRUG	Lansoprazole	DR	Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20180604		ANDA	ANDA205868	Advanced Rx Pharmacy of Tennessee, LLC	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0175_ed22e3ae-6b79-d570-e053-2a95a90ab1d9	80425-0175	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20200301		ANDA	ANDA212517	Advanced Rx Pharmacy of Tennessee, LLC	NAPROXEN	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0176_f834b072-b902-8c0d-e053-6294a90aad7a	80425-0176	HUMAN PRESCRIPTION DRUG	TRAZODONE HCL		TRAZODONE HCL	TABLET	ORAL	20171211		ANDA	ANDA205253	Advanced Rx Pharmacy of Tennessee, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
80425-0177_f8238b00-3984-9e03-e053-6294a90a5e74	80425-0177	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	300	mg/1		CV	N	20241231
80425-0178_f8233a6a-b22b-ce03-e053-6394a90aa424	80425-0178	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20191008		ANDA	ANDA206912	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
80425-0179_edae7639-1835-c774-e053-2a95a90a43e5	80425-0179	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium	DR	Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20110119		ANDA	ANDA090970	Advanced Rx Pharmacy of Tennessee, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0180_ec1b9beb-eab8-30f1-e053-2a95a90ad6d1	80425-0180	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20170301		ANDA	ANDA204755	Advanced Rx Pharmacy of Tennessee, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
80425-0181_ed0ffc4f-b985-74a7-e053-2995a90a3d06	80425-0181	HUMAN PRESCRIPTION DRUG	Etodolac	ER	Etodolac	TABLET, EXTENDED RELEASE	ORAL	20030313		ANDA	ANDA076174	Advanced Rx Pharmacy of Tennessee, LLC	ETODOLAC	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0182_ed2029cb-32b3-c2f0-e053-2a95a90a8023	80425-0182	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20160218		ANDA	ANDA204989	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0183_edade565-8416-3f4f-e053-2995a90ac91c	80425-0183	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium	DR	Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20180531		ANDA	ANDA209735	Advanced Rx Pharmacy of Tennessee, LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0184_ed25d024-4dcc-7eb9-e053-2995a90ae5b8	80425-0184	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20160701		ANDA	ANDA202674	Advanced Rx Pharmacy of Tennessee, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
80425-0185_fbe7d4e6-436c-550f-e053-6294a90ae27f	80425-0185	HUMAN PRESCRIPTION DRUG	PREGABALIN		PREGABALIN	CAPSULE	ORAL	20190721		ANDA	ANDA207799	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	150	mg/1		CV	N	20241231
80425-0186_ed25c5e3-7cdd-0ecb-e053-2a95a90a2091	80425-0186	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET	ORAL	20130301		ANDA	ANDA201504	Advanced Rx Pharmacy of Tennessee, LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
80425-0187_f823d931-19fc-1035-e053-6394a90a6ea2	80425-0187	HUMAN PRESCRIPTION DRUG	Tizanidine HCL		Tizanidine HCL	TABLET	ORAL	20130401		ANDA	ANDA091283	Advanced Rx Pharmacy of Tennessee, LLC	TIZANIDINE HYDROCHLORIDE	2	mg/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	20241231
80425-0188_ed34b45c-7c7a-5e92-e053-2995a90a48fc	80425-0188	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20200217		ANDA	ANDA074415	Advanced Rx Pharmacy of Tennessee, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
80425-0189_f436ac9d-5dbc-49a5-e053-2a95a90a7588	80425-0189	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	DR	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	19981113		ANDA	ANDA075185	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0190_f05a520a-dce7-ee99-e053-2a95a90a4a97	80425-0190	HUMAN PRESCRIPTION DRUG	Etodolac		Etodolac	TABLET, FILM COATED	ORAL	20220614		ANDA	ANDA076004	Advanced Rx Pharmacy of Tennessee, LLC	ETODOLAC	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0191_f823bb90-ba36-f7d2-e053-6394a90a0a6e	80425-0191	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20220614		ANDA	ANDA071456	Advanced Rx Pharmacy of Tennessee, LLC	TEMAZEPAM	15	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0192_f04836dc-4196-6e07-e053-2995a90a1967	80425-0192	HUMAN PRESCRIPTION DRUG	Ciprofloxacin HCL		Ciprofloxacin HCL	TABLET, FILM COATED	ORAL	20070426		ANDA	ANDA077859	Advanced Rx Pharmacy of Tennessee, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
80425-0193_f06dfab5-5c73-ec76-e053-2995a90ae964	80425-0193	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20220620		ANDA	ANDA040362	Advanced Rx Pharmacy of Tennessee, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0194_f070af2d-ffca-a9c4-e053-2995a90a910e	80425-0194	HUMAN PRESCRIPTION DRUG	Venlafaxine HCL	ER	Venlafaxine HCL	CAPSULE, EXTENDED RELEASE	ORAL	20220614		ANDA	ANDA212277	Advanced Rx Pharmacy of Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0195_f06f8ca5-a2e0-5148-e053-2a95a90a481d	80425-0195	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20220614		ANDA	ANDA076343	Advanced Rx Pharmacy of Tennessee, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0196_f8213a77-31c8-ae4a-e053-6294a90afe8f	80425-0196	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20221026		ANDA	ANDA075477	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	300	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0197_f290ca7b-1620-31de-e053-2a95a90aa231	80425-0197	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	DR	Diclofenac Sodium	TABLET, DELAYED RELEASE	ORAL	20221027		ANDA	ANDA075185	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0198_f5d97011-7be2-3b1c-e053-2a95a90ade86	80425-0198	HUMAN PRESCRIPTION DRUG	Cefadroxil		Cefadroxil	CAPSULE	ORAL	20221102		ANDA	ANDA065352	Advanced Rx Pharmacy of Tennessee, LLC	CEFADROXIL	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
80425-0199_f820d47e-90ba-a843-e053-6294a90add6d	80425-0199	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20221028		ANDA	ANDA075477	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0200_fa19e9d3-6ab2-cbd6-e053-6294a90aae9b	80425-0200	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20221028		ANDA	ANDA077206	Advanced Rx Pharmacy of Tennessee, LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80425-0201_091c6a54-b04f-69bc-e063-6394a90ae007	80425-0201	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20221028		ANDA	ANDA207057	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0202_ed392b6a-91d2-0d86-e053-2995a90ab8c1	80425-0202	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20090327		ANDA	ANDA078462	Advanced Rx Pharmacy of Tennessee, LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0203_ed38993d-49cc-6960-e053-2995a90a020b	80425-0203	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20200630		ANDA	ANDA212650	Advanced Rx Pharmacy of Tennessee, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
80425-0204_091c6a54-b04f-69bc-e063-6394a90ae007	80425-0204	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20221028		ANDA	ANDA207057	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0205_f2a55c02-e624-7ce6-e053-2a95a90a6155	80425-0205	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Advanced Rx Pharmacy of Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
80425-0206_f059728c-2750-c2d1-e053-2a95a90af265	80425-0206	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20221027		ANDA	ANDA203154	Advanced Rx Pharmacy of Tennessee, LLC	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
80425-0207_ecac7026-f5d4-9d0b-e053-2a95a90af729	80425-0207	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide	TABLET	ORAL	20221104		ANDA	ANDA076230	Advanced Rx Pharmacy of Tennessee, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
80425-0208_f8347c51-dfb9-f125-e053-6294a90a67f7	80425-0208	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET	ORAL	20140614		ANDA	ANDA076343	Advanced Rx Pharmacy of Tennessee, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0209_f2159495-8a74-b28c-e053-2995a90afe1a	80425-0209	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20201221		ANDA	ANDA210071	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0210_f059a524-5d5c-5f0f-e053-2995a90a2c09	80425-0210	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium	ER	Diclofenac Sodium	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20221104		ANDA	ANDA075492	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0211_f5c93e42-9fb5-257c-e053-2995a90a0a8e	80425-0211	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20221104		ANDA	ANDA062676	Advanced Rx Pharmacy of Tennessee, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
80425-0212_f780c78d-6226-3a96-e053-6394a90a4616	80425-0212	HUMAN PRESCRIPTION DRUG	Amitriptyline HCL		Amitriptyline HCL	TABLET, FILM COATED	ORAL	20230322		ANDA	ANDA202446	Advanced Rx Pharmacy of Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0213_f160095a-3877-8c98-e053-2995a90ad586	80425-0213	HUMAN PRESCRIPTION DRUG	Sucralfate		Sucralfate	TABLET	ORAL	20230103		NDA AUTHORIZED GENERIC	NDA018333	Advanced Rx Pharmacy of Tennessee, LLC	SUCRALFATE	1	g/1	Aluminum Complex [EPC], Organometallic Compounds [CS]		N	20241231
80425-0214_fe800ff7-fee7-ad79-e053-6294a90a2181	80425-0214	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20230103		ANDA	ANDA090162	Advanced Rx Pharmacy of Tennessee, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0215_f1648f07-98bb-1e5f-e053-2995a90a869a	80425-0215	HUMAN PRESCRIPTION DRUG	Butalbital/Acetaminophen/Caffeine		Butalbital/Acetaminophen/Caffeine	CAPSULE	ORAL	20230103		ANDA	ANDA213321	Advanced Rx Pharmacy of Tennessee, LLC	ACETAMINOPHEN; BUTALBITAL; CAFFEINE	300; 50; 40	mg/1; mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]	CIII	N	20241231
80425-0217_f1d6f7ac-c13d-870d-e053-2a95a90ae2ad	80425-0217	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230104		ANDA	ANDA065093	Advanced Rx Pharmacy of Tennessee, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
80425-0218_f1d77282-0126-a0e7-e053-2a95a90aa035	80425-0218	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20230109		ANDA	ANDA208250	Advanced Rx Pharmacy of Tennessee, LLC	AZITHROMYCIN DIHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
80425-0219_f1d83ddb-9d56-80d5-e053-2995a90a50ba	80425-0219	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20230109		ANDA	ANDA065225	Advanced Rx Pharmacy of Tennessee, LLC	AZITHROMYCIN MONOHYDRATE	250	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
80425-0220_f1d9e305-4290-1c1b-e053-2a95a90add06	80425-0220	HUMAN PRESCRIPTION DRUG	Azithromycin Dihydrate		Azithromycin Dihydrate	TABLET, FILM COATED	ORAL	20230109		ANDA	ANDA208249	Advanced Rx Pharmacy of Tennessee, LLC	AZITHROMYCIN DIHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
80425-0221_f213c567-f2f0-5089-e053-2995a90acb82	80425-0221	HUMAN PRESCRIPTION DRUG	Silver Sulfadiazine		Silver Sulfadiazine	CREAM	TOPICAL	20230112		NDA	NDA018810	Advanced Rx Pharmacy of Tennessee, LLC	SILVER SULFADIAZINE	10	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
80425-0222_f21340f6-fb7b-b55e-e053-2a95a90a2450	80425-0222	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20230112		ANDA	ANDA078152	Advanced Rx Pharmacy of Tennessee, LLC	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
80425-0223_fb5d3ec8-87e9-881d-e053-6294a90a1cc5	80425-0223	HUMAN PRESCRIPTION DRUG	Betalido Kit		Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Povidine Iodine	KIT	INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; PERINEURAL; TOPICAL	20230510		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0224_f2148ccd-5ce1-38d8-e053-2a95a90a0cca	80425-0224	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET	ORAL	20230112		ANDA	ANDA078327	Advanced Rx Pharmacy of Tennessee, LLC	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
80425-0225_f1da11c3-c0ff-5f15-e053-2a95a90af7f9	80425-0225	HUMAN PRESCRIPTION DRUG	Ciclopirox Olamine		Ciclopirox Olamine	CREAM	TOPICAL	20230109		ANDA	ANDA090273	Advanced Rx Pharmacy of Tennessee, LLC	CICLOPIROX OLAMINE	7.7	mg/g	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
80425-0226_fb859c55-5b3b-c976-e053-6294a90a1f97	80425-0226	HUMAN PRESCRIPTION DRUG	Multi-Specialty Kit		Depo-Medrol, Lidocaine, Isopropyl Alcohol	KIT	INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE; TOPICAL	20230512		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0227_f20367e7-11e2-3a93-e053-2995a90a8f73	80425-0227	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20230111		ANDA	ANDA078152	Advanced Rx Pharmacy of Tennessee, LLC	ONDANSETRON	8	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
80425-0228_fa674ea9-57f2-e4c7-e053-6394a90ae591	80425-0228	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20230111		ANDA	ANDA090469	Advanced Rx Pharmacy of Tennessee, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
80425-0229_f2028317-2a29-fd58-e053-2995a90ac1cf	80425-0229	HUMAN PRESCRIPTION DRUG	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE		NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	OINTMENT	OPHTHALMIC	20230111		ANDA	ANDA064063	Advanced Rx Pharmacy of Tennessee, LLC	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
80425-0230_f2004485-c430-a493-e053-2a95a90a7284	80425-0230	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230111		ANDA	ANDA040189	Advanced Rx Pharmacy of Tennessee, LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0231_f2017750-8bbf-3100-e053-2995a90a92cd	80425-0231	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230111		ANDA	ANDA206751	Advanced Rx Pharmacy of Tennessee, LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0232_fb85e937-4767-6024-e053-6294a90a97bb	80425-0232	HUMAN PRESCRIPTION DRUG	DoubleDex Kit		Dexamethasone Sodium Phosphate, Povidine Iodine	KIT	INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20230512		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0233_f3d27ae6-125a-5375-e053-2995a90a572d	80425-0233	HUMAN OTC DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230206		ANDA	ANDA210986	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0234_f1daf2d7-ec7d-3839-e053-2a95a90aa689	80425-0234	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230109		ANDA	ANDA200936	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0235_f1eb7759-4860-820f-e053-2995a90aca0e	80425-0235	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230110		ANDA	ANDA206298	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0236_f1db7db2-5fd2-40c1-e053-2995a90a5986	80425-0236	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230109		ANDA	ANDA208301	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0237_f27a44dc-c421-ed92-e053-2995a90a1640	80425-0237	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230110		ANDA	ANDA206116	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0238_f1ec87b6-3898-1d10-e053-2995a90a053d	80425-0238	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230110		ANDA	ANDA203818	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0239_f201aa0f-3405-eb75-e053-2995a90adc4c	80425-0239	HUMAN PRESCRIPTION DRUG	Moxifloxacin		Moxifloxacin	SOLUTION/ DROPS	OPHTHALMIC	20230111		ANDA	ANDA090080	Advanced Rx Pharmacy of Tennessee, LLC	MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE	5	mg/mL	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
80425-0242_f2014688-1bfe-e539-e053-2995a90acee0	80425-0242	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230111		ANDA	ANDA040194	Advanced Rx Pharmacy of Tennessee, LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0243_f216c634-c7dd-7d9c-e053-2a95a90ad1fc	80425-0243	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20230110		ANDA	ANDA090796	Advanced Rx Pharmacy of Tennessee, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0244_fbbd3242-b52e-7cd0-e053-6394a90aa00d	80425-0244	HUMAN PRESCRIPTION DRUG	Lidolog Kit		lidocaine, kenalog, povidone iodine	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL	20230515		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0245_fb81c331-cfbb-f028-e053-6394a90a9e5f	80425-0245	HUMAN PRESCRIPTION DRUG	Ketorocaine LM Kit		Ketorolac Tromethamine, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine	KIT	EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRAVENOUS; TOPICAL	20230512		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0246_f2023291-2551-fb97-e053-2a95a90a6949	80425-0246	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20230111		ANDA	ANDA065085	Advanced Rx Pharmacy of Tennessee, LLC	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
80425-0247_f1eefd08-2aeb-5c49-e053-2995a90a17e1	80425-0247	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230110		ANDA	ANDA206297	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0248_f1ef59c1-1a10-fac9-e053-2995a90a4701	80425-0248	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230110		ANDA	ANDA206498	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0249_f1efbc49-cdd4-239f-e053-2a95a90a4d80	80425-0249	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230110		ANDA	ANDA205318	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0250_f1f00a9c-2920-f720-e053-2995a90a486a	80425-0250	HUMAN PRESCRIPTION DRUG	Diclona Gel		Lidocaine HCL and Diclofenac Sodium	GEL	TOPICAL	20230110		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM; LIDOCAINE	.01; .045	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Antiarrhythmic [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0251_f1f06dad-b42b-22ae-e053-2a95a90a1642	80425-0251	HUMAN PRESCRIPTION DRUG	Lidothol		Lidocaine HCL and Menthol	GEL	TOPICAL	20230110		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL	4.5; 5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0252_f1f094b1-3a35-0b7b-e053-2a95a90a7acb	80425-0252	HUMAN PRESCRIPTION DRUG	Lidothol		Lidocaine and Menthol	PATCH	TOPICAL	20230110		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE; MENTHOL	4.5; 5	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0253_facea383-548b-15d3-e053-6294a90a74e3	80425-0253	HUMAN OTC DRUG	LidoPro Patch		lidocaine, menthol, methyl salicylate	PATCH	TOPICAL	20230503		OTC MONOGRAPH NOT FINAL	part348	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	4; 5; 4	mg/100mg; mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0254_f2021959-cf81-d286-e053-2a95a90a58e4	80425-0254	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	OINTMENT	TOPICAL	20230111		ANDA	ANDA065170	Advanced Rx Pharmacy of Tennessee, LLC	MUPIROCIN	20	mg/g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
80425-0255_f201034e-540e-303d-e053-2a95a90a6504	80425-0255	HUMAN PRESCRIPTION DRUG	Methylprednisolone		Methylprednisolone	TABLET	ORAL	20230111		ANDA	ANDA204072	Advanced Rx Pharmacy of Tennessee, LLC	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0256_f4bfc4a6-06f0-1f76-e053-2995a90a2b8f	80425-0256	HUMAN OTC DRUG	New Terocin		Methyl Salicylate, Capsaicin, and Menthol	LOTION	TOPICAL	20230215		OTC MONOGRAPH NOT FINAL	part348	Advanced Rx Pharmacy of Tennessee, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.025; 10; 25	g/100mL; g/100mL; g/100mL			N	20241231
80425-0257_fb808dc5-bf65-836c-e053-6294a90a80aa	80425-0257	HUMAN OTC DRUG	VIVA Patch		Camphor, Lidocaine, and Methyl Salicylate	PATCH	TOPICAL	20230512		OTC MONOGRAPH NOT FINAL	part348	Advanced Rx Pharmacy of Tennessee, LLC	CAMPHOR (NATURAL); LIDOCAINE; METHYL SALICYLATE	2; 2.5; 4	mg/100mg; mg/100mg; mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0258_f27ca3c0-9de1-ff9c-e053-2a95a90ab894	80425-0258	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET, FILM COATED	ORAL	20230117		ANDA	ANDA078284	Advanced Rx Pharmacy of Tennessee, LLC	SUMATRIPTAN SUCCINATE	100	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
80425-0259_f4373402-d797-ad6a-e053-2995a90aec86	80425-0259	HUMAN PRESCRIPTION DRUG	Naloxone HCl		Naloxone HCl	SPRAY	NASAL	20230208		ANDA	ANDA211951	Advanced Rx Pharmacy of Tennessee, LLC	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
80425-0260_f4c00d9c-3a18-06a0-e053-2a95a90a8413	80425-0260	HUMAN PRESCRIPTION DRUG	Tobramycin and dexamethasone		Tobramycin and dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20230215		ANDA	ANDA212715	Advanced Rx Pharmacy of Tennessee, LLC	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0261_f4d6c7c8-7a78-6a46-e053-2995a90a4411	80425-0261	HUMAN PRESCRIPTION DRUG	Dexamethasone Sodium Phosphate		Dexamethasone Sodium Phosphate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230216		ANDA	ANDA207442	Advanced Rx Pharmacy of Tennessee, LLC	DEXAMETHASONE SODIUM PHOSPHATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0262_f4c077f2-260a-2235-e053-2995a90a1b57	80425-0262	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRAMUSCULAR	20230215		ANDA	ANDA209852	Advanced Rx Pharmacy of Tennessee, LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0263_f4d733c0-97c6-1966-e053-2995a90a5df4	80425-0263	HUMAN PRESCRIPTION DRUG	Fluticasone propionate		Fluticasone propionate	SPRAY, METERED	NASAL	20230216		ANDA	ANDA077570	Advanced Rx Pharmacy of Tennessee, LLC	FLUTICASONE PROPIONATE	50	ug/.1g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0264_f4d7aca4-0ace-74c2-e053-2995a90a9d94	80425-0264	HUMAN PRESCRIPTION DRUG	Epinephrine		Epinephrine	INJECTION	SUBCUTANEOUS	20230216		NDA AUTHORIZED GENERIC	NDA020800	Advanced Rx Pharmacy of Tennessee, LLC	EPINEPHRINE	.3	mg/.3mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
80425-0265_f4c23037-e416-7604-e053-2995a90a5bb6	80425-0265	HUMAN PRESCRIPTION DRUG	Promethazine Hydrochloride		Promethazine Hydrochloride	TABLET	ORAL	20230215		ANDA	ANDA040596	Advanced Rx Pharmacy of Tennessee, LLC	PROMETHAZINE HYDROCHLORIDE	25	mg/1	Phenothiazine [EPC], Phenothiazines [CS]		N	20241231
80425-0266_f44b325d-0f75-552c-e053-2995a90ac1c9	80425-0266	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20230209		ANDA	ANDA209954	Advanced Rx Pharmacy of Tennessee, LLC	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
80425-0267_f8216add-97fc-100d-e053-6294a90a9aaa	80425-0267	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		Ketorolac Tromethamine	TABLET, FILM COATED	ORAL	20230217		ANDA	ANDA215788	Advanced Rx Pharmacy of Tennessee, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0268_f4c19cf5-c8b2-5e9f-e053-2995a90aee53	80425-0268	HUMAN PRESCRIPTION DRUG	Lidocaine hydrochloride		Lidocaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL	20230215		ANDA	ANDA203082	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0269_f4c36acc-828e-323b-e053-2a95a90a4d1c	80425-0269	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20230215		ANDA	ANDA065271	Advanced Rx Pharmacy of Tennessee, LLC	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
80425-0270_f4c5779d-e4c0-4f2b-e053-2995a90a9187	80425-0270	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230215		ANDA	ANDA203834	Advanced Rx Pharmacy of Tennessee, LLC	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
80425-0271_f4e8a719-ef9d-a2ef-e053-2995a90ad788	80425-0271	HUMAN PRESCRIPTION DRUG	Indomethacin	ER	Indomethacin	CAPSULE, EXTENDED RELEASE	ORAL	20230217		ANDA	ANDA201807	Advanced Rx Pharmacy of Tennessee, LLC	INDOMETHACIN	75	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0273_f4d8c198-63e2-3109-e053-2995a90acad9	80425-0273	HUMAN PRESCRIPTION DRUG	DICLOENAC SODIUM and MISOPROSTOL	DR	DICLOENAC SODIUM and MISOPROSTOL	TABLET	ORAL	20230216		ANDA	ANDA204355	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM; MISOPROSTOL	75; 200	mg/1; ug/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
80425-0274_f44c53ec-26eb-d272-e053-2a95a90a5e59	80425-0274	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20230209		ANDA	ANDA208708	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0275_f4e98f9f-b20c-8608-e053-2a95a90aa6b0	80425-0275	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20230217		ANDA	ANDA090200	Advanced Rx Pharmacy of Tennessee, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0276_f8348370-5bfc-5adb-e053-6394a90a7ec9	80425-0276	HUMAN PRESCRIPTION DRUG	Tramadol Hydrochloride		Tramadol Hydrochloride	TABLET, COATED	ORAL	20230217		ANDA	ANDA208708	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	50	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0277_fbf9f420-797f-29e0-e053-6294a90a48f6	80425-0277	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230301		ANDA	ANDA208677	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	100	mg/1		CV	N	20241231
80425-0278_f8223c1c-42a6-2d01-e053-6294a90aa33a	80425-0278	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium	DR	Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20230228		ANDA	ANDA202882	Advanced Rx Pharmacy of Tennessee, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0279_f601c634-2272-2fcd-e053-2995a90aaaba	80425-0279	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230303		ANDA	ANDA091568	Advanced Rx Pharmacy of Tennessee, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
80425-0280_fdb737e0-edff-3708-e053-6294a90a0d98	80425-0280	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20230302		ANDA	ANDA062676	Advanced Rx Pharmacy of Tennessee, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
80425-0281_f60394f5-fd6a-929b-e053-2995a90a5793	80425-0281	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230303		ANDA	ANDA210628	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0282_f5edb048-9780-0a82-e053-2995a90af50d	80425-0282	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20201009		ANDA	ANDA212378	Advanced Rx Pharmacy of Tennessee, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
80425-0283_f665e83a-f467-8bc2-e053-2a95a90a6aae	80425-0283	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol	TABLET	ORAL	20230307		ANDA	ANDA040489	Advanced Rx Pharmacy of Tennessee, LLC	METHOCARBAMOL	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0284_f666bd1c-d75a-545b-e053-2995a90a207a	80425-0284	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230308		ANDA	ANDA074112	Advanced Rx Pharmacy of Tennessee, LLC	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0285_f98d258d-6478-253a-e053-6394a90acbb3	80425-0285	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230322		ANDA	ANDA214548	Advanced Rx Pharmacy of Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0286_f781d400-7305-5d3e-e053-6294a90ac572	80425-0286	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230322		ANDA	ANDA075477	Advanced Rx Pharmacy of Tennessee, LLC	GABAPENTIN	400	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0287_f783df41-e471-de89-e053-6394a90a12f5	80425-0287	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230322		ANDA	ANDA214548	Advanced Rx Pharmacy of Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0288_0293d3bf-b3d0-bbf3-e063-6394a90a79e5	80425-0288	HUMAN PRESCRIPTION DRUG	Topiramate		Topiramate	TABLET, FILM COATED	ORAL	20230322		ANDA	ANDA090162	Advanced Rx Pharmacy of Tennessee, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
80425-0289_f7a86237-ece5-7cc4-e053-6294a90a1308	80425-0289	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230324		ANDA	ANDA090170	Advanced Rx Pharmacy of Tennessee, LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
80425-0290_f7a9741b-2dd4-d8f3-e053-6294a90a4d73	80425-0290	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride	ER	Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230324		ANDA	ANDA214654	Advanced Rx Pharmacy of Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0291_f835e66e-f3f4-c3cf-e053-6294a90addf2	80425-0291	HUMAN PRESCRIPTION DRUG	Carisoprodol		Carisoprodol	TABLET	ORAL	20230331		ANDA	ANDA203374	Advanced Rx Pharmacy of Tennessee, LLC	CARISOPRODOL	350	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]	CIV	N	20241231
80425-0292_f8360da5-f1d4-1d89-e053-6294a90ad31c	80425-0292	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine HCL	ER	Cyclobenzaprine HCL	CAPSULE, EXTENDED RELEASE	ORAL	20230331		NDA AUTHORIZED GENERIC	NDA021777	Advanced Rx Pharmacy of Tennessee, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	15	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0293_f8375029-e568-c6a5-e053-6394a90a5b67	80425-0293	HUMAN OTC DRUG	Aspirin		Aspirin	TABLET, COATED	ORAL	20230427		OTC MONOGRAPH NOT FINAL	part343	Advanced Rx Pharmacy of Tennessee, LLC	ASPIRIN	325	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
80425-0294_f887062a-7c83-664f-e053-6294a90a2773	80425-0294	HUMAN PRESCRIPTION DRUG	Imipramine hydrochloride		Imipramine hydrochloride	TABLET, FILM COATED	ORAL	20230404		ANDA	ANDA040903	Advanced Rx Pharmacy of Tennessee, LLC	IMIPRAMINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0295_f885bb1a-0446-c452-e053-6394a90ae8aa	80425-0295	HUMAN PRESCRIPTION DRUG	Temazepam		Temazepam	CAPSULE	ORAL	20230404		ANDA	ANDA071456	Advanced Rx Pharmacy of Tennessee, LLC	TEMAZEPAM	30	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0296_f89bcae0-e715-599a-e053-6294a90a2c3a	80425-0296	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride	ER	Venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230405		ANDA	ANDA200834	Advanced Rx Pharmacy of Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0297_f8fd422f-c1e6-aa2a-e053-6294a90a99dd	80425-0297	HUMAN PRESCRIPTION DRUG	Venlafaxine hydrochloride	ER	Venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20230410		ANDA	ANDA200834	Advanced Rx Pharmacy of Tennessee, LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0298_f89ad429-0057-e4d6-e053-6294a90a7ab1	80425-0298	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20230405		ANDA	ANDA204852	Advanced Rx Pharmacy of Tennessee, LLC	TRAZODONE HYDROCHLORIDE	100	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
80425-0299_f899d6f5-37b6-2dff-e053-6394a90a314a	80425-0299	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20230405		ANDA	ANDA073556	Advanced Rx Pharmacy of Tennessee, LLC	NORTRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0300_f8af7829-8b62-6785-e053-6294a90af052	80425-0300	HUMAN PRESCRIPTION DRUG	Bupropion hydrochloride		Bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230406		ANDA	ANDA210497	Advanced Rx Pharmacy of Tennessee, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
80425-0301_fc76ab32-be5f-39c1-e053-6394a90a9ee2	80425-0301	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET	ORAL	20230407		ANDA	ANDA077903	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	10	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0302_f8fd11f5-e74d-6911-e053-6394a90ad897	80425-0302	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20230410		ANDA	ANDA204852	Advanced Rx Pharmacy of Tennessee, LLC	TRAZODONE HYDROCHLORIDE	150	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
80425-0303_f8afd9b8-0886-2f0c-e053-6294a90a9c57	80425-0303	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride		Buspirone Hydrochloride	TABLET	ORAL	20230406		ANDA	ANDA210907	Advanced Rx Pharmacy of Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	15	mg/1			N	20241231
80425-0304_f925abbe-4978-00b0-e053-6294a90a6e53	80425-0304	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil Citrate	TABLET	ORAL	20230412		ANDA	ANDA091479	Advanced Rx Pharmacy of Tennessee, LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
80425-0305_f8c383c1-d1b4-ceaa-e053-6294a90a6053	80425-0305	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20230407		ANDA	ANDA076921	Advanced Rx Pharmacy of Tennessee, LLC	MIRTAZAPINE	15	mg/1			N	20241231
80425-0306_f8b1a4a2-83fd-6b4b-e053-6394a90ac46a	80425-0306	HUMAN PRESCRIPTION DRUG	Mefenamic Acid		Mefenamic Acid	CAPSULE	ORAL	20230406		ANDA	ANDA090562	Advanced Rx Pharmacy of Tennessee, LLC	MEFENAMIC ACID	250	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0307_f8fe5af6-5427-60c0-e053-6294a90a133f	80425-0307	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230410		ANDA	ANDA211685	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	25	mg/1		CV	N	20241231
80425-0308_f8ae3db3-2647-f55b-e053-6294a90a9d18	80425-0308	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230406		ANDA	ANDA208677	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	200	mg/1		CV	N	20241231
80425-0309_f8b06b55-f6a3-2438-e053-6394a90a530a	80425-0309	HUMAN PRESCRIPTION DRUG	Citalopram Hydrobromide		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20230406		ANDA	ANDA077031	Advanced Rx Pharmacy of Tennessee, LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80425-0310_f8c44cc1-3f04-275a-e053-6294a90af4ca	80425-0310	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20230407		ANDA	ANDA077206	Advanced Rx Pharmacy of Tennessee, LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80425-0311_f8c0bae0-39dd-1a17-e053-6294a90a495d	80425-0311	HUMAN PRESCRIPTION DRUG	Duloxetine	DR	Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20230407		ANDA	ANDA208706	Advanced Rx Pharmacy of Tennessee, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
80425-0312_f8c526d6-3312-ff17-e053-6394a90a08b0	80425-0312	HUMAN PRESCRIPTION DRUG	Tramadol HCL	ER	Tramadol HCL	TABLET, EXTENDED RELEASE	ORAL	20230407		ANDA	ANDA200503	Advanced Rx Pharmacy of Tennessee, LLC	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
80425-0313_f917063a-226f-0978-e053-6294a90aeb4b	80425-0313	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine	CAPSULE	ORAL	20230411		ANDA	ANDA204597	Advanced Rx Pharmacy of Tennessee, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80425-0314_f901a1ba-1717-8795-e053-6294a90a4e77	80425-0314	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20230410		ANDA	ANDA065062	Advanced Rx Pharmacy of Tennessee, LLC	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
80425-0315_f8ff7293-89b7-b6ee-e053-6394a90a7d39	80425-0315	HUMAN PRESCRIPTION DRUG	Chlorzoxazone		Chlorzoxazone	TABLET	ORAL	20230410		ANDA	ANDA089853	Advanced Rx Pharmacy of Tennessee, LLC	CHLORZOXAZONE	500	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0316_f900bac4-02f3-6bf3-e053-6394a90a2161	80425-0316	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		Doxepin Hydrochloride	CAPSULE	ORAL	20230410		ANDA	ANDA213063	Advanced Rx Pharmacy of Tennessee, LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0317_0c080ad7-4369-4a34-e063-6294a90aa534	80425-0317	HUMAN PRESCRIPTION DRUG	Diclofenac Epolamine		Diclofenac Epolamine	SYSTEM	TOPICAL	20230411	20250131	NDA AUTHORIZED GENERIC	NDA021234	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	
80425-0318_f8c47eeb-cd61-29da-e053-6294a90a25e0	80425-0318	HUMAN PRESCRIPTION DRUG	Sumatriptan		Sumatriptan	TABLET	ORAL	20230407		ANDA	ANDA078327	Advanced Rx Pharmacy of Tennessee, LLC	SUMATRIPTAN SUCCINATE	50	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
80425-0319_f91373f2-c57c-f1f1-e053-6294a90a7bdd	80425-0319	HUMAN PRESCRIPTION DRUG	Doxycycline Monohydrate		Doxycycline Monohydrate	TABLET, FILM COATED	ORAL	20230411		ANDA	ANDA209582	Advanced Rx Pharmacy of Tennessee, LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
80425-0320_f914fec5-4ce8-794d-e053-6294a90a7cc5	80425-0320	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20230411		ANDA	ANDA078032	Advanced Rx Pharmacy of Tennessee, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80425-0321_f8fda1e6-a080-4b31-e053-6294a90a039f	80425-0321	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230410		ANDA	ANDA210071	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0322_f9392308-bdf9-4523-e053-6294a90a8acc	80425-0322	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET	ORAL	20070905		ANDA	ANDA077903	Advanced Rx Pharmacy of Tennessee, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
80425-0323_f8fdd580-09c7-9c1c-e053-6394a90a4706	80425-0323	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230410		ANDA	ANDA204590	Advanced Rx Pharmacy of Tennessee, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0324_f93cbde5-329b-f880-e053-6294a90a1af2	80425-0324	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230413		ANDA	ANDA206297	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0325_f94d388c-8472-885b-e053-6294a90ab67a	80425-0325	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20230414		ANDA	ANDA206463	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0326_f98b1e8f-9c67-3e9c-e053-6294a90ab057	80425-0326	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20230417		ANDA	ANDA202180	Advanced Rx Pharmacy of Tennessee, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
80425-0327_f98c2173-fc58-956d-e053-6294a90afec5	80425-0327	HUMAN PRESCRIPTION DRUG	Pregabalin		Pregabalin	CAPSULE	ORAL	20230417		ANDA	ANDA208677	Advanced Rx Pharmacy of Tennessee, LLC	PREGABALIN	50	mg/1		CV	N	20241231
80425-0328_fa16db27-3c8d-eb22-e053-6394a90add59	80425-0328	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230424		ANDA	ANDA088481	Advanced Rx Pharmacy of Tennessee, LLC	DEXAMETHASONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0329_fa18ed52-f037-02dd-e053-6394a90ac946	80425-0329	HUMAN PRESCRIPTION DRUG	Famotidine		Famotidine	TABLET, FILM COATED	ORAL	20230424		ANDA	ANDA215767	Advanced Rx Pharmacy of Tennessee, LLC	FAMOTIDINE	20	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
80425-0330_fa3ecbbb-86e8-6fca-e053-6394a90a56d9	80425-0330	HUMAN PRESCRIPTION DRUG	Diclona Patch		lidocaine, diclofenac	PATCH	TOPICAL	20230426		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM; LIDOCAINE HYDROCHLORIDE	.0125; .045	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Anti-Inflammatory Agents, Non-Steroidal [CS], Antiarrhythmic [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Local Anesthesia [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0331_fab87a2d-79c9-6045-e053-6394a90a2368	80425-0331	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium	DR	Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230502		ANDA	ANDA211977	Advanced Rx Pharmacy of Tennessee, LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0332_fbfab521-c538-8ca9-e053-6394a90a2120	80425-0332	HUMAN OTC DRUG	LidoPro		Capsaicin, Lidocaine, Menthol, and Methyl Salicylate	OINTMENT	TOPICAL	20230518		OTC MONOGRAPH NOT FINAL	part348	Advanced Rx Pharmacy of Tennessee, LLC	CAPSAICIN; LIDOCAINE HYDROCHLORIDE; MENTHOL; METHYL SALICYLATE	.000325; .04; .1; .275	g/g; g/g; g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0333_016775ad-3a11-16be-e063-6294a90a2eee	80425-0333	HUMAN PRESCRIPTION DRUG	Accucaine		Lidocaine Hydrochloride	INJECTION, SOLUTION	INFILTRATION	20230726		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0334_fc0f2890-6584-4052-e053-6294a90a9c59	80425-0334	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20230519		ANDA	ANDA078246	Advanced Rx Pharmacy of Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	5	mg/1			N	20241231
80425-0335_fc4a70e8-3f4a-efa9-e053-6394a90a6d64	80425-0335	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac	SOLUTION	TOPICAL	20230519		ANDA	ANDA208198	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0336_fc4a1c86-086e-27ff-e053-6394a90a1cbd	80425-0336	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230519		NDA AUTHORIZED GENERIC	NDA204623	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0337_fc4a52a5-be76-d4b8-e053-6394a90a5e70	80425-0337	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac sodium	SOLUTION	TOPICAL	20230519		ANDA	ANDA212506	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0338_fc49c595-a253-cd5e-e053-6294a90ac7c7	80425-0338	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical	GEL	TOPICAL	20230519		ANDA	ANDA212351	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0339_fc0e3e2c-1706-8de4-e053-6394a90a9ffc	80425-0339	HUMAN PRESCRIPTION DRUG	Paroxetine		Paroxetine	TABLET, FILM COATED	ORAL	20230519		ANDA	ANDA077584	Advanced Rx Pharmacy of Tennessee, LLC	PAROXETINE HYDROCHLORIDE HEMIHYDRATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80425-0340_0324f0b9-3e5a-0c3c-e063-6394a90a93d6	80425-0340	HUMAN PRESCRIPTION DRUG	ORPHENADRINE CITRATE		ORPHENADRINE CITRATE	TABLET, EXTENDED RELEASE	ORAL	20230523		ANDA	ANDA040284	Advanced Rx Pharmacy of Tennessee, LLC	ORPHENADRINE CITRATE	100	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
80425-0341_fc7357ab-adce-6e36-e053-6394a90a53f4	80425-0341	HUMAN PRESCRIPTION DRUG	Tobramycin		Tobramycin	SOLUTION	OPHTHALMIC	20230524		ANDA	ANDA064052	Advanced Rx Pharmacy of Tennessee, LLC	TOBRAMYCIN	3	mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]		N	20241231
80425-0342_fd7bb896-af73-b157-e053-6394a90ab252	80425-0342	HUMAN PRESCRIPTION DRUG	Imipramine Hydrochloride		Imipramine Hydrochloride	TABLET, FILM COATED	ORAL	20230606		ANDA	ANDA040751	Advanced Rx Pharmacy of Tennessee, LLC	IMIPRAMINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0343_fe2f6deb-f09a-e0c8-e053-6394a90a692a	80425-0343	HUMAN PRESCRIPTION DRUG	Ramelteon		Ramelteon	TABLET, FILM COATED	ORAL	20230615		ANDA	ANDA213815	Advanced Rx Pharmacy of Tennessee, LLC	RAMELTEON	8	mg/1	Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA]		N	20241231
80425-0344_fe2ebee2-3fc5-0697-e053-6294a90a1cf6	80425-0344	HUMAN PRESCRIPTION DRUG	Clotrimazole and Betamethasone Dipropionate		Clotrimazole and Betamethasone Dipropionate	CREAM	TOPICAL	20230615		ANDA	ANDA075673	Advanced Rx Pharmacy of Tennessee, LLC	BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE	.5; 10	mg/g; mg/g	Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0345_fe7d7aa8-4f30-83ae-e053-6394a90a01d6	80425-0345	HUMAN OTC DRUG	Laxacin		Docusate sodium and sennosides	TABLET	ORAL	20230619		OTC MONOGRAPH NOT FINAL	part334	Advanced Rx Pharmacy of Tennessee, LLC	DOCUSATE SODIUM; SENNOSIDES A AND B	50; 8.6	mg/1; mg/1			N	20241231
80425-0346_01cac0d7-5cdb-2fc0-e063-6394a90a45d0	80425-0346	HUMAN PRESCRIPTION DRUG	Dexamethasone		Dexamethasone	TABLET	ORAL	20230731		ANDA	ANDA201270	Advanced Rx Pharmacy of Tennessee, LLC	DEXAMETHASONE	1.5	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0347_016a466c-de62-0a68-e063-6394a90ae49a	80425-0347	HUMAN PRESCRIPTION DRUG	Betaloan SUIK		Betamethasone Sodium Phosphate and Betamethasone Acetate	INJECTION, SUSPENSION	INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR	20230726		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC	BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE	3; 3	mg/mL; mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]		N	20241231
80425-0348_01ca15d5-0f6a-9bf1-e063-6394a90ac43b	80425-0348	HUMAN PRESCRIPTION DRUG	Dyural 40 Kit		Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Sodium Chloride, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE; SUBCUTANEOUS; TOPICAL	20230731		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0349_01ca2f07-9bc2-e418-e063-6294a90ac760	80425-0349	HUMAN PRESCRIPTION DRUG	Dyural 80 Kit		Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Sodium Chloride, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE; SUBCUTANEOUS; TOPICAL	20230731		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0350_01ca467b-4b4f-eeed-e063-6294a90ac7bc	80425-0350	HUMAN PRESCRIPTION DRUG	Dyural 80-LM		Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol	KIT	EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE; SUBCUTANEOUS; TOPICAL	20230731		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0351_01cb11bb-72ff-d044-e063-6394a90a5e15	80425-0351	HUMAN OTC DRUG	Lidocaine		Lidocaine	CREAM	TOPICAL	20230731		OTC MONOGRAPH FINAL	part348	Advanced Rx Pharmacy of Tennessee, LLC	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0352_01cb2ed2-4841-e738-e063-6394a90ae39f	80425-0352	HUMAN OTC DRUG	Loratadine		loratadine	TABLET	ORAL	20230731		ANDA	ANDA214684	Advanced Rx Pharmacy of Tennessee, LLC	LORATADINE	10	mg/1			N	20241231
80425-0353_01cb6a0a-3ec6-a106-e063-6394a90aefc3	80425-0353	HUMAN PRESCRIPTION DRUG	Bupivilog Kit		marcaine, kenalog, povidone iodine	KIT	EPIDURAL; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL	20230731		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC						N	20241231
80425-0354_03112814-eefb-8ecf-e063-6394a90a5a25	80425-0354	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230816		NDA AUTHORIZED GENERIC	NDA021908	Advanced Rx Pharmacy of Tennessee, LLC	LUBIPROSTONE	8	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
80425-0355_03109e97-46a6-91f1-e063-6394a90abe7c	80425-0355	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230816		NDA AUTHORIZED GENERIC	NDA021908	Advanced Rx Pharmacy of Tennessee, LLC	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
80425-0356_07daff8e-5923-4bfe-e063-6294a90a5958	80425-0356	HUMAN OTC DRUG	Nuvira		Capsaicin 0.025%, Menthol 10%, Methyl Nicotinate 0.25%, Methyl Salicylate 10%	PATCH	TOPICAL	20231016		OTC MONOGRAPH DRUG	505G(a)(3)	Advanced Rx Pharmacy of Tennessee, LLC	CAPSAICIN; MENTHOL; METHYL NICOTINATE; METHYL SALICYLATE	.00025; .1; .0025; .1	g/g; g/g; g/g; g/g	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
80425-0357_04daeab9-a99b-c895-e063-6294a90ab1d4	80425-0357	HUMAN PRESCRIPTION DRUG	Clonazepam		Clonazepam	TABLET	ORAL	20230908		ANDA	ANDA075150	Advanced Rx Pharmacy of Tennessee, LLC	CLONAZEPAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0358_04db1907-b3a0-6774-e063-6394a90a20b4	80425-0358	HUMAN PRESCRIPTION DRUG	Clonazepam		clonazepam	TABLET	ORAL	20230908		ANDA	ANDA077147	Advanced Rx Pharmacy of Tennessee, LLC	CLONAZEPAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80425-0359_04c7c0a8-7981-9c59-e063-6294a90a67dc	80425-0359	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate	HFA	albuterol sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20230907		NDA AUTHORIZED GENERIC	NDA020983	Advanced Rx Pharmacy of Tennessee, LLC	ALBUTEROL SULFATE	90	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
80425-0361_08014998-0725-5edd-e063-6294a90af738	80425-0361	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20231018		ANDA	ANDA203818	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0362_082b5545-da03-0306-e063-6394a90a14fe	80425-0362	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20231020		ANDA	ANDA214548	Advanced Rx Pharmacy of Tennessee, LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
80425-0363_0863c813-ed4a-cf81-e063-6294a90ab427	80425-0363	HUMAN PRESCRIPTION DRUG	RABEPRAZOLE SODIUM		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20231023		ANDA	ANDA204237	Advanced Rx Pharmacy of Tennessee, LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80425-0364_08b89251-0599-926d-e063-6294a90a7a23	80425-0364	HUMAN PRESCRIPTION DRUG	diclofenac epolamine		diclofenac epolamine	SYSTEM	TOPICAL	20231127		NDA AUTHORIZED GENERIC	NDA021234	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0365_0908db70-aecb-d01a-e063-6394a90a68b5	80425-0365	HUMAN PRESCRIPTION DRUG	Hydroxyzine hydrochloride		Hydroxyzine hydrochloride	TABLET	ORAL	20231031		ANDA	ANDA204279	Advanced Rx Pharmacy of Tennessee, LLC	HYDROXYZINE DIHYDROCHLORIDE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
80425-0366_093170e9-fcd5-59f7-e063-6294a90a165a	80425-0366	HUMAN PRESCRIPTION DRUG	Tobramycin and Dexamethasone		Tobramycin and Dexamethasone	SUSPENSION/ DROPS	OPHTHALMIC	20231102		NDA AUTHORIZED GENERIC	NDA050592	Advanced Rx Pharmacy of Tennessee, LLC	DEXAMETHASONE; TOBRAMYCIN	1; 3	mg/mL; mg/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80425-0367_0a98cce4-f5ac-12a8-e063-6294a90a4e7e	80425-0367	HUMAN PRESCRIPTION DRUG	Trubrexa		lidocaine and capsaicin	PATCH	TRANSDERMAL	20231127		UNAPPROVED DRUG OTHER		Advanced Rx Pharmacy of Tennessee, LLC	CAPSAICIN; LIDOCAINE	.00025; .0475	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
80425-0368_0c55ddd8-f187-63a2-e063-6394a90a0215	80425-0368	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20231128		ANDA	ANDA206116	Advanced Rx Pharmacy of Tennessee, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
80425-0369_0b7706f0-eb84-5bce-e063-6294a90a4048	80425-0369	HUMAN OTC DRUG	Calypxo Pain Relief		Methyl Salicylate, Menthol	CREAM	TOPICAL	20231201		OTC MONOGRAPH DRUG	M017	Advanced Rx Pharmacy of Tennessee, LLC	MENTHOL; METHYL SALICYLATE	3; 10	g/100g; g/100g			N	20241231
80425-0370_0bc55439-c4b3-172e-e063-6394a90a3197	80425-0370	HUMAN PRESCRIPTION DRUG	Zonisamide		Zonisamide	CAPSULE	ORAL	20231205		ANDA	ANDA214492	Advanced Rx Pharmacy of Tennessee, LLC	ZONISAMIDE	100	mg/1	Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS]		N	20241231
80425-0371_0beda514-b750-63dc-e063-6394a90ad238	80425-0371	HUMAN PRESCRIPTION DRUG	Desonide		Desonide	CREAM	TOPICAL	20231207		ANDA	ANDA210198	Advanced Rx Pharmacy of Tennessee, LLC	DESONIDE	.5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80426-044_9ab9c030-ff6f-4136-b2e9-fe22d52667cd	80426-044	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA211444	PEL HEALTHCARE LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80426-045_9ab9c030-ff6f-4136-b2e9-fe22d52667cd	80426-045	HUMAN PRESCRIPTION DRUG	FLUOXETINE		FLUOXETINE	TABLET, FILM COATED	ORAL	20230313		ANDA	ANDA211444	PEL HEALTHCARE LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
80434-051_f9173d54-027d-468c-92f5-d3b707328d8c	80434-051	HUMAN OTC DRUG	COASTWIDE PROFESSIONAL Antibacterial Hand Sp		Chloroxylenol	LIQUID	TOPICAL	20210801		OTC MONOGRAPH NOT FINAL	part333E	Worklifebrands LLC	CHLOROXYLENOL	.3	mg/100mL			N	20241231
80434-230_7a398f50-2897-46cd-85c2-e34c2da89c40	80434-230	HUMAN OTC DRUG	Perk Hand Sanitizer		alcohol	GEL	TOPICAL	20210403		OTC MONOGRAPH NOT FINAL	part333E	Worklifebrands LLC	ALCOHOL	70	mL/100mL			N	20241231
80434-280_24939735-9769-42b3-a516-636935c53b39	80434-280	HUMAN OTC DRUG	Perk Hand Sanitizer Moisturizing Gel		ALCOHOL	GEL	TOPICAL	20210403		OTC MONOGRAPH NOT FINAL	part333E	Worklifebrands LLC	ALCOHOL	70	mL/100mL			N	20241231
80447-649_0994b9a4-bc5d-566e-e063-6294a90afc18	80447-649	HUMAN OTC DRUG	MILK OF MAGNESIA		magnesium hydroxide	SUSPENSION	ORAL	20200901		OTC MONOGRAPH DRUG	M007	Fact Products	MAGNESIUM HYDROXIDE	1200	mg/15mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
80464-1000_0d126ec0-f149-9e8b-e063-6394a90a236e	80464-1000	HUMAN OTC DRUG	Hand Sanitizer Mist Watermelon		ALCOHOL	SPRAY	TOPICAL	20200902		OTC MONOGRAPH DRUG	505G(a)(3)	Everyone Must Use, LLC	ALCOHOL	.62	g/g			N	20241231
80464-1001_0d12352b-d995-a745-e063-6394a90a477c	80464-1001	HUMAN OTC DRUG	Hand Sanitizer Mist Lemongrass		ALCOHOL	SPRAY	TOPICAL	20200902		OTC MONOGRAPH DRUG	505G(a)(3)	Everyone Must Use, LLC	ALCOHOL	.62	g/g			N	20241231
80464-1002_0d134903-6e09-f6eb-e063-6394a90a6f5f	80464-1002	HUMAN OTC DRUG	EMU Hand Sanitizer Mist Ocean Surf		ALCOHOL	SPRAY	TOPICAL	20200921		OTC MONOGRAPH DRUG	505G(a)(3)	EVERYONE MUST USE, LLC	ALCOHOL	.62	g/g			N	20241231
80464-1003_0d13915c-7bde-6c9b-e063-6294a90acd6e	80464-1003	HUMAN OTC DRUG	EMU Hand Sanitizer Mist Ocean Air		ALCOHOL	SPRAY	TOPICAL	20201123		OTC MONOGRAPH DRUG	505G(a)(3)	Everyone Must Use, LLC	ALCOHOL	.62	g/g			N	20241231
80464-1004_0d13915c-7bdf-6c9b-e063-6294a90acd6e	80464-1004	HUMAN OTC DRUG	EMU Hand Sanitizer Mist Mint		ALCOHOL	SPRAY	TOPICAL	20201125		OTC MONOGRAPH DRUG	505G(a)(3)	Everyone Must Use, LLC	ALCOHOL	.62	g/g			N	20241231
80464-1005_0d135646-75d8-f0a7-e063-6394a90a3bcd	80464-1005	HUMAN OTC DRUG	EMU Hand Sanitizer Mist Orange Blossom		ALCOHOL	SPRAY	TOPICAL	20201123		OTC MONOGRAPH DRUG	505G(a)(3)	EVERYONE MUST USE, LLC	ALCOHOL	.62	g/g			N	20241231
80464-1006_0d13aae2-ca0a-2f63-e063-6394a90a3af8	80464-1006	HUMAN OTC DRUG	Hand Sanitizer Mist Sea Salt		ALCOHOL	SPRAY	TOPICAL	20210601		OTC MONOGRAPH DRUG	505G(a)(3)	Everyone Must Use LLC	ALCOHOL	.62	g/g			N	20241231
80465-003_e2882ba8-7281-f9ed-e053-2a95a90a0269	80465-003	HUMAN OTC DRUG	MENTHOL, CAMPHOR		MENTHOL, CAMPHOR	CREAM	TOPICAL	20201104		OTC MONOGRAPH NOT FINAL	part348	EROS GLOBAL	CAMPHOR (NATURAL); MENTHOL	3; 3	g/100g; g/100g			N	20241231
80465-008_ec1a2a1f-a38e-9c59-e053-2a95a90ad268	80465-008	HUMAN OTC DRUG	NATUREANCE MIRACLE		Menthol	OIL	TOPICAL	20200919		OTC MONOGRAPH NOT FINAL	part348	EROS GLOBAL CORP	MENTHOL	8	g/100g			N	20241231
80465-100_05b859cc-c48d-ba90-e063-6294a90a87f8	80465-100	HUMAN OTC DRUG	NATUREANCE BODY BALM		CAMPHOR	LIQUID	TOPICAL	20231003		OTC MONOGRAPH DRUG	M017	EROS GLOBAL CORP	CAMPHOR (SYNTHETIC)	.9	g/100mL			N	20241231
80476-101_0e234413-208e-082a-e063-6394a90af9c2	80476-101	HUMAN OTC DRUG	PLUMSCREEN	SPF 31	ZINC OXIDE	CREAM	TOPICAL	20220621		OTC MONOGRAPH DRUG	M020	LP FOUNDERS, INC.	ZINC OXIDE	4.7	g/100mL			N	20251231
80487-311_f1789f1c-523b-0a92-e053-2a95a90ae677	80487-311	HUMAN OTC DRUG	Kindfill		Mint Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	By Humankind Inc	SODIUM FLUORIDE	.62	mg/312mg			N	20241231
80487-312_f1790611-3545-3d1e-e053-2a95a90a39e9	80487-312	HUMAN OTC DRUG	Kindfill		Cinnamon Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	By Humankind Inc	SODIUM FLUORIDE	.62	mg/312mg			N	20241231
80487-321_029560a6-5d7c-c0be-e063-6394a90a81d4	80487-321	HUMAN OTC DRUG	Kindfill		Mint Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	By Humankind Inc	SODIUM FLUORIDE	.62	mg/1			N	20241231
80487-322_029553d5-0392-9313-e063-6394a90a6d2b	80487-322	HUMAN OTC DRUG	Kindfill		Cinnamon Toothpaste Tablets	TABLET, CHEWABLE	DENTAL	20230105		OTC MONOGRAPH FINAL	part355	By Humankind Inc	SODIUM FLUORIDE	.62	mg/1			N	20241231
80489-001_0ab5222b-a8ad-c08a-e063-6394a90a5015	80489-001	HUMAN OTC DRUG	Hydrocortisone		Drs. Hydrocortisone	CREAM	TOPICAL	20210101		OTC MONOGRAPH DRUG	M016	OL PHARMA TECH,LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80489-002_06b9af3e-eab0-b447-e063-6294a90acf54	80489-002	HUMAN OTC DRUG	Clotrimazole		Drs. Clotrimazole	CREAM	TOPICAL	20210101		OTC MONOGRAPH FINAL	part333C	OL PHARMA TECH,LLC	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
80489-003_f2733fd6-4928-0f00-e053-2a95a90a0006	80489-003	HUMAN OTC DRUG	PAIN-X		MENTHOL	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part348	OL PHARMA TECH,LLC	MENTHOL, UNSPECIFIED FORM	25	mg/g			N	20241231
80489-004_06b953b5-4f96-774b-e063-6294a90a79b0	80489-004	HUMAN OTC DRUG	MUSCLE RUB		menthol	GEL	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part348	OL PHARMA TECH,LLC	MENTHOL, UNSPECIFIED FORM	25	mg/g			N	20241231
80489-005_06b9a891-604e-a6bb-e063-6394a90a218a	80489-005	HUMAN OTC DRUG	ANTI-ITCH		ZINC ACETATE , DIPHENHYDRAMINE	CREAM	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part348	OL PHARMA TECH, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	1; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80489-006_06b9a891-604b-a6bb-e063-6394a90a218a	80489-006	HUMAN OTC DRUG	Drs. Antibiotic Bacitracin		Bacitracin	OINTMENT	TOPICAL	20211001		OTC MONOGRAPH FINAL	part333B	OL PHARMA TECH, LLC	BACITRACIN ZINC	500	[USP'U]/g	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
80489-012_06b9a891-604d-a6bb-e063-6394a90a218a	80489-012	HUMAN OTC DRUG	Drs. pharmacy triple antibiotic		bacitracin zinc, polymyxin b sulfate, neomycin sulfate ointment	OINTMENT	TOPICAL	20210216		OTC MONOGRAPH FINAL	part333B	OL PHARMA TECH, LLC	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
80489-088_0df0642f-1b0a-1bd9-e063-6294a90a72df	80489-088	HUMAN OTC DRUG	Drs. Hydrocortisone Aloe Vera		Hydrocortisone	CREAM	TOPICAL	20210101		OTC MONOGRAPH DRUG	M016	OL PHARMA TECH,LLC	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
80489-103_073ad8bb-f606-e99d-e063-6294a90a6e53	80489-103	HUMAN OTC DRUG	ANTI-ITCH FEMININE CARE		HYDROCORTISONE 0.5%	CREAM	TOPICAL	20220201		OTC MONOGRAPH DRUG	M005	OL PHARMA TECH, LLC Drs PHARMACY	HYDROCORTISONE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80489-232_0def1454-0c3f-5a66-e063-6294a90ae1b7	80489-232	HUMAN OTC DRUG	Drs. pharmacy sunscreen SPF 30		sunscreen SPF 30	LOTION	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	OL PHARMA TECH LLC. (Drs. Pharmacy)	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20251231
80489-234_0def6fd8-43a7-fa6b-e063-6294a90a93ee	80489-234	HUMAN OTC DRUG	Drs. pharmacy sunscreen SPF 70		sunscreen SPF 70	CREAM	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	OL PHARMA TECH LLC. (Drs. Pharmacy)	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20251231
80489-235_0defd17e-14d7-4207-e063-6294a90a59bd	80489-235	HUMAN OTC DRUG	Drs. pharmacy sunscreen SPF 50		sunscreen SPF 50	LOTION	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	OL PHARMA TECH LLC. (Drs. Pharmacy)	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20251231
80489-300_073aae7e-403b-90f0-e063-6294a90a9ba6	80489-300	HUMAN OTC DRUG	Drs. ACNE CLEAR		SALICYLIC ACID	GEL	TOPICAL	20220201		OTC MONOGRAPH DRUG	M006	OL PHARMA TECH, LLC Drs. PHARMACY	SALICYLIC ACID	5	mg/g			N	20241231
80489-333_073af0fe-13e2-f8e8-e063-6294a90ab671	80489-333	HUMAN OTC DRUG	Drs. pharmacy Scar Cream		Allantoin	CREAM	TOPICAL	20211101		OTC MONOGRAPH DRUG	M016	OL PHARMA TECH, LLC Drs PHARMACY	ALLANTOIN	.5	g/100g			N	20241231
80489-444_073b1fd5-718d-3441-e063-6294a90a48b2	80489-444	HUMAN OTC DRUG	OLP diaper Rash cream A and D		Zinc Oxide	CREAM	TOPICAL	20220201		OTC MONOGRAPH DRUG	M016	OL PHARMA TECH, LLC Drs PHARMACY	ZINC OXIDE	10	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
80489-757_06b99a44-3d0a-d5bf-e063-6394a90a5b41	80489-757	HUMAN OTC DRUG	Drs. Pharmacy Triple Antibiotic Plus		bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine	OINTMENT	TOPICAL	20210905		OTC MONOGRAPH FINAL	part333B	OL PHARMA TECH, LLC Drs PHARMACY	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE	400; 3.5; 5000; 10	[USP'U]/1000mg; mg/1000mg; [USP'U]/1000mg; mg/1000mg	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
80489-959_06b99a44-3d09-d5bf-e063-6394a90a5b41	80489-959	HUMAN OTC DRUG	Drs. pharmacy HEMORRHOIDAL COOLING		phenylephrine HCL, witch hazel	GEL	TOPICAL	20211101		OTC MONOGRAPH FINAL	part346	OL PHARMA TECH, LLC Drs PHARMACY	PHENYLEPHRINE HYDROCHLORIDE; WITCH HAZEL	25; 500	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80491-7825_4ee2df0f-c9f4-4b59-992c-0c2b838676c7	80491-7825	HUMAN PRESCRIPTION DRUG	QUVIVIQ		Daridorexant	TABLET, FILM COATED	ORAL	20220407		NDA	NDA214985	Idorsia Pharmaceuticals Ltd	DARIDOREXANT	25	mg/1	Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA]	CIV	N	20241231
80491-7850_4ee2df0f-c9f4-4b59-992c-0c2b838676c7	80491-7850	HUMAN PRESCRIPTION DRUG	QUVIVIQ		Daridorexant	TABLET, FILM COATED	ORAL	20220407		NDA	NDA214985	Idorsia Pharmaceuticals Ltd	DARIDOREXANT	50	mg/1	Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA]	CIV	N	20241231
80499-001_08c08704-4e9c-4151-e063-6394a90abe3a	80499-001	HUMAN OTC DRUG	Hygiene Clean Clean Cotton Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-002_08bfdf87-5843-5743-e063-6294a90a807e	80499-002	HUMAN OTC DRUG	Hygiene Clean Eucalyptus Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-003_08c09710-bbda-dbd0-e063-6394a90a75bc	80499-003	HUMAN OTC DRUG	Hygiene Clean Unscented Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-004_08c09710-bbcc-dbd0-e063-6394a90a75bc	80499-004	HUMAN OTC DRUG	Hygiene Clean Balsam Fir Hand Sanitizer Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-005_08c032e7-f9c1-bafd-e063-6394a90a0bf8	80499-005	HUMAN OTC DRUG	Hygiene Clean Leather Oak Hand Sanitizer Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-006_08c09aa5-83dc-dacf-e063-6394a90a325d	80499-006	HUMAN OTC DRUG	Hygiene Clean Mahogany Teakwood Hand Sanitizer Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-007_08c01c0f-6d5f-2cb4-e063-6394a90a6f61	80499-007	HUMAN OTC DRUG	Hygiene Clean Pumpkin Spice Hand Sanitizer Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20200930		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-008_08c09aa5-8406-dacf-e063-6394a90a325d	80499-008	HUMAN OTC DRUG	Hygiene Clean Pumpkin Spice Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-009_08c019c9-2cdf-8867-e063-6294a90a5182	80499-009	HUMAN OTC DRUG	Hygiene Clean Blueberry Lemonade Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-010_08c08f83-9ca4-cad2-e063-6294a90aa787	80499-010	HUMAN OTC DRUG	Hygiene Clean Leather Oak Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-011_08c019c9-2cfb-8867-e063-6294a90a5182	80499-011	HUMAN OTC DRUG	Hygiene Clean Mahogany Teakwood Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-012_08c019c9-2ced-8867-e063-6294a90a5182	80499-012	HUMAN OTC DRUG	Hygiene Clean Bubble Gum Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-013_08c08f83-9cc0-cad2-e063-6294a90aa787	80499-013	HUMAN OTC DRUG	Hygiene Clean Eucalyptus Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-014_08bfa6cc-1df1-6d62-e063-6394a90a671e	80499-014	HUMAN OTC DRUG	Hygiene Clean Unscented Clean Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-015_08bfc58c-d4a3-ce0b-e063-6394a90aa83a	80499-015	HUMAN OTC DRUG	Hygiene Clean Balsam Fir Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20201030		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-017_08c09aa5-83f8-dacf-e063-6394a90a325d	80499-017	HUMAN OTC DRUG	Hygiene Clean Blueberry Lemonade Hand Sanitizer Car Safe Alcohol-Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210120		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-018_08c07ef8-6ce2-bd48-e063-6294a90a51b9	80499-018	HUMAN OTC DRUG	Hygiene Clean Vanilla Woods Hand Sanitizer Car Safe Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210120		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-025_08c081f1-aa62-988c-e063-6394a90ab87a	80499-025	HUMAN OTC DRUG	Hygiene Clean Spring Bloom Hand Sanitizer Bottle Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210120		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-026_08bfa6cc-1de3-6d62-e063-6394a90a671e	80499-026	HUMAN OTC DRUG	Hygiene Clean Lilac Garden Hand Sanitizer Bottle Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210120		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-027_08bfe1ce-49de-3165-e063-6394a90a0375	80499-027	HUMAN OTC DRUG	Hygiene Clean Lavender Blossom Hand Sanitizer Bottle Alcohol Free		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210120		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-030_08c03ee9-d949-4446-e063-6394a90a0ab0	80499-030	HUMAN OTC DRUG	Hygiene Clean Vanilla Sugar Hand Sanitizer on the go and car safe		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210228		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-031_08bfee10-3520-f20e-e063-6394a90a635b	80499-031	HUMAN OTC DRUG	Hygiene Clean Luxury Clean hand Sanitizer on the go and car safe		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210228		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-100_08c08f83-9cb2-cad2-e063-6294a90aa787	80499-100	HUMAN OTC DRUG	Hygiene Clean Clean Cotton Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210316		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-101_08bfe1ce-49c3-3165-e063-6394a90a0375	80499-101	HUMAN OTC DRUG	Hygiene Clean Eucalyptus Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210316		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-102_08c01c0f-6d6d-2cb4-e063-6394a90a6f61	80499-102	HUMAN OTC DRUG	Hygiene Clean Luxury Clean Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210316		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-103_08c02945-b565-8f5d-e063-6294a90a9178	80499-103	HUMAN OTC DRUG	Hygiene Clean Lavender Blossom Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210405		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-104_08bfe1ce-49b5-3165-e063-6394a90a0375	80499-104	HUMAN OTC DRUG	Hygiene Clean Lilac Garden Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210405		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80499-105_08c09710-bbe8-dbd0-e063-6394a90a75bc	80499-105	HUMAN OTC DRUG	Hygiene Clean Spring Bloom Hand Sanitizer		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210405		OTC MONOGRAPH DRUG	505G(a)(3)	USA Broom LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80513-100_fc8d239b-f9aa-9a01-e053-6394a90af67d	80513-100	HUMAN OTC DRUG	DOCUSATE SODIUM, EXTRA STRENGTH	250 MG	DOCUSATE SODIUM	CAPSULE, GELATIN COATED	ORAL	20220915		OTC MONOGRAPH NOT FINAL	part334	Advanced Rx LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
80513-101_fc8cf24e-8ca2-b3fb-e053-6294a90a7a50	80513-101	HUMAN OTC DRUG	DOCUSATE SODIUM, EXTRA STRENGTH	250 MG	DOCUSATE SODIUM	CAPSULE, GELATIN COATED	ORAL	20230525		OTC MONOGRAPH NOT FINAL	part334	Advanced Rx LLC	DOCUSATE SODIUM	250	mg/1			N	20241231
80513-301_fc8d30f3-9932-fc30-e053-6394a90a7861	80513-301	HUMAN OTC DRUG	DAYTIME COLD AND FLU RELIEF SOFTGELS	NON-DROWSY	ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE	CAPSULE, GELATIN COATED	ORAL	20230424		OTC MONOGRAPH FINAL	part341	Advanced Rx LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DIPHENHYDRAMINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
80513-302_fc8d239b-f9ab-9a01-e053-6394a90af67d	80513-302	HUMAN OTC DRUG	NIGHTTIME COLD AND FLU RELIEF SOFTGELS	MULTI-SYMPTOM	ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE	CAPSULE, GELATIN COATED	ORAL	20230424		OTC MONOGRAPH FINAL	part341	Advanced Rx LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
80514-001_0d63964f-9211-6ba7-e063-6294a90ad835	80514-001	HUMAN OTC DRUG	Alcohol Pad		isopropyl alcohol	SWAB	TOPICAL	20200903		OTC MONOGRAPH DRUG	505G(a)(3)	JIANGSU HAIDA INTERNATIONAL TRADING CO., LTD.	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
80514-002_0d63964f-9212-6ba7-e063-6294a90ad835	80514-002	HUMAN OTC DRUG	Povidone-iodine prep pad		povidone-iodine	SWAB	TOPICAL	20200904		OTC MONOGRAPH DRUG	505G(a)(3)	JIANGSU HAIDA INTERNATIONAL TRADING CO., LTD.	POVIDONE-IODINE	10	g/100g			N	20241231
80514-003_0d636430-a360-7ce8-e063-6394a90a7197	80514-003	HUMAN OTC DRUG	BZK Antiseptic Swab		Benzalkonium Chloride	SWAB	TOPICAL	20200904		OTC MONOGRAPH DRUG	505G(a)(3)	JIANGSU HAIDA INTERNATIONAL TRADING CO., LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
80514-004_ae730c97-ee2c-54be-e053-2995a90a3735	80514-004	HUMAN OTC DRUG	PRE-MOISTENED TOWELETTE		chlorhexidine gluconate	SWAB	TOPICAL	20200904		UNAPPROVED DRUG OTHER		JIANGSU HAIDA INTERNATIONAL TRADING CO., LTD.	CHLORHEXIDINE GLUCONATE	.2	g/100g	Decreased Cell Wall Integrity [PE]		N	20241231
80514-005_0d63c644-46bc-b4c0-e063-6394a90a9dd3	80514-005	HUMAN OTC DRUG	sting relief medicated pad		Benzocaine 6%, Isopropyl alcohol 60%	SWAB	TOPICAL	20200904		OTC MONOGRAPH DRUG	505G(a)(3)	JIANGSU HAIDA INTERNATIONAL TRADING CO., LTD.	BENZOCAINE; ISOPROPYL ALCOHOL	6; 60	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
80518-123_ebab8c68-b0fa-4769-9fda-2c54e23f5480	80518-123	HUMAN OTC DRUG	The Day Formula Broad Spectrum SPF 30 Sunscreen		Titanium Dioxide	CREAM	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part352	Dar Companies, LLC	TITANIUM DIOXIDE	88	mg/mL			N	20241231
80524-000_0c86bd59-1f12-763f-e063-6394a90af4f1	80524-000	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200918		OTC MONOGRAPH DRUG	505G(a)(3)	Tempo Industries, Inc.	ALCOHOL	.62	mL/mL			N	20241231
80524-001_0c868adb-99d1-5c7a-e063-6394a90a6638	80524-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200918		OTC MONOGRAPH DRUG	505G(a)(3)	Tempo Industries, Inc.	ALCOHOL	.62	mL/mL			N	20241231
80524-002_0c86cec5-0779-ade6-e063-6294a90afac0	80524-002	HUMAN OTC DRUG	Sunscreen SPF 30		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	LOTION	TOPICAL	20200918		OTC MONOGRAPH DRUG	M020	Tempo Industries, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
80534-1000_d61a5389-0a84-465d-aacb-9407049f12d6	80534-1000	HUMAN PRESCRIPTION DRUG	XENOVIEW		xenon Xe 129 hyperpolarized	GAS	RESPIRATORY (INHALATION)	20221223		NDA	NDA214375	Polarean, Inc.	XENON XE-129, HYPERPOLARIZED	75	mL/L			N	20241231
80534-6350_d61a5389-0a84-465d-aacb-9407049f12d6	80534-6350	HUMAN PRESCRIPTION DRUG	XENOVIEW		xenon Xe 129 hyperpolarized	GAS	RESPIRATORY (INHALATION)	20221223		NDA	NDA214375	Polarean, Inc.	HELIUM; NITROGEN; XENON XE-129	5651.5; 635; 63.5	L/1; L/1; L/1			N	20241231
80539-001_12d48ef6-ccf1-4bc3-8469-0061bb083f7c	80539-001	HUMAN OTC DRUG	OLOPATADINE HYDROCHLORIDE		OLOPATADINE HYDROCHLORIDE	SOLUTION	OPHTHALMIC	20200715		ANDA	ANDA209995	Allwell Health Inc	OLOPATADINE HYDROCHLORIDE	2	mg/mL	Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]		N	20241231
80539-453_b4ed7c18-fdac-4239-afb0-024b9dbc535c	80539-453	HUMAN OTC DRUG	Sinus Congestion		Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210312		OTC MONOGRAPH DRUG	M012	Allwell Health Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80539-504_841428c6-d783-4f55-bf43-9a6f00fda511	80539-504	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20210129		ANDA	ANDA204507	Allwell Health Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80539-527_eff1e459-91ba-494c-b47f-46d6e0bda819	80539-527	HUMAN OTC DRUG	head congestion and mucus		Acetaminophen, Guaifenesin, Phenylephrine HCl	TABLET, FILM COATED	ORAL	20210309		OTC MONOGRAPH DRUG	M012	Allwell Health Inc	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
80539-614_990bdcce-3988-4e40-92fe-a771af9f70b4	80539-614	HUMAN OTC DRUG	allergy relief		Diphenhydramine HCl	TABLET, FILM COATED	ORAL	20210315		OTC MONOGRAPH DRUG	M012	Allwell Health Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80539-801_6ba40d69-8a47-4e16-ba2e-63e621cc6ff0	80539-801	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET	ORAL	20210129		ANDA	ANDA211075	Allwell Health Inc	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
80551-101_06324538-8eeb-ad54-e063-6394a90a137f	80551-101	HUMAN OTC DRUG	HEMP PAIN RELIEF		Trolamine Salicylate	CREAM	TOPICAL	20210721		OTC MONOGRAPH NOT FINAL	part348	ACUTENS, INC.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
80551-102_0632749f-b219-4d27-e063-6294a90a9ed7	80551-102	HUMAN OTC DRUG	HEMP PAIN RELIEF		MENTHOL	GEL	TOPICAL	20210720		OTC MONOGRAPH NOT FINAL	part348	ACUTENS, INC.	MENTHOL	5	g/100g			N	20241231
80551-103_06324538-8ef8-ad54-e063-6394a90a137f	80551-103	HUMAN OTC DRUG	HEMP PAIN RELIEF ROLLER		MENTHOL	SOLUTION	TOPICAL	20210721		OTC MONOGRAPH NOT FINAL	part348	ACUTENS, INC.	MENTHOL	5	g/100g			N	20241231
80551-201_b4f3383c-5bdb-77b3-e053-2995a90afb55	80551-201	HUMAN OTC DRUG	Kanjo Homeopathic Pain Relief Cream		Homeopathic Pain Relief Cream	CREAM	TOPICAL	20201125		UNAPPROVED HOMEOPATHIC		ACUTENS	ARNICA MONTANA	1	[hp_X]/g			N	20241231
80551-301_0632749f-b226-4d27-e063-6294a90a9ed7	80551-301	HUMAN OTC DRUG	ECZEMA RELIEF		COLLOIDAL OATMEAL	CREAM	TOPICAL	20211003		OTC MONOGRAPH FINAL	part347	ACUTENS, INC.	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
80552-001_0b77e0f6-26ab-3ff4-e063-6394a90a8c63	80552-001	HUMAN OTC DRUG	Activa		Alcohol	CLOTH	TOPICAL	20200901		OTC MONOGRAPH DRUG	M003	Lenaco Corporation dba Blue Ribbon Supply Company	ALCOHOL	75	mL/100mL			N	20241231
80569-084_09e240de-0009-c20f-e063-6294a90a09c4	80569-084	HUMAN OTC DRUG	FLUSH Maximum Strength Antifungal formula		UNDECYLENIC ACID	LIQUID	TOPICAL	20200917		OTC MONOGRAPH DRUG	M005	Triple Point Group, LLC	UNDECYLENIC ACID	250	mg/mL			N	20241231
80573-089_0976085c-9baa-3792-e063-6394a90a58c5	80573-089	HUMAN OTC DRUG	Plius Daily SPF Moisturizer SPF 30		AVOBENZONE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20200914		OTC MONOGRAPH DRUG	M020	PLIUS, Inc	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 80	mg/mL; mg/mL; mg/mL			N	20241231
80579-000_e78c56df-0644-644c-e053-2a95a90a5388	80579-000	HUMAN OTC DRUG	DEFENSE Hand Sanitizer		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20200325	20261230	OTC MONOGRAPH NOT FINAL	part333E	Walla Walla Environmental, Inc.	ISOPROPYL ALCOHOL	.75	mL/mL			N	
80579-001_e78c6687-dec8-956b-e053-2a95a90ae94b	80579-001	HUMAN OTC DRUG	DEFENSE Hand Sanitizer		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20200325	20261230	OTC MONOGRAPH NOT FINAL	part333E	Walla Walla Environmental, Inc.	ISOPROPYL ALCOHOL	.75	mL/mL			N	
80584-081_31f906d9-b3a0-42cb-84c7-05c1c127d384	80584-081	HUMAN OTC DRUG	STIX 3 DAY YEAST INFECTION TREATMENT		Miconazole nitrate	KIT		20220420		ANDA	ANDA075329	Get Stix Inc.						N	20241231
80584-100_e75a86ed-48d3-41d1-839d-399ce11af888	80584-100	HUMAN OTC DRUG	Stix Restart		levonorgestrel	TABLET	ORAL	20220616		ANDA	ANDA202334	Get Stix Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
80584-101_0cdf198e-c115-b9fa-e063-6294a90a566a	80584-101	HUMAN OTC DRUG	Stix Restart		Levonorgestrel	TABLET	ORAL	20220913		ANDA	ANDA202380	Get Stix Inc	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
80584-113_00c8478e-9a27-4ad6-a32a-633bcafefbf7	80584-113	HUMAN OTC DRUG	Stix Maximum Strength Urinary Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20200930		UNAPPROVED DRUG OTHER		Get Stix Inc.	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
80586-202_e99b3955-6601-f942-e053-2995a90a6e14	80586-202	HUMAN OTC DRUG	Greenex Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20210413	20240308	OTC MONOGRAPH NOT FINAL	part333E	Cleanslate Group LLC	ALCOHOL	70	mL/100mL			N	
80586-523_f2793e82-67bd-ff6e-e053-2a95a90a8554	80586-523	HUMAN OTC DRUG	Cleanslate Antibacterial Foam		Chloroxylenol	LIQUID	TOPICAL	20211117	20240726	OTC MONOGRAPH NOT FINAL	part333E	Cleanslate Group LLC	CHLOROXYLENOL	.3	g/100mL			N	
80586-801_0e999251-cb52-ceec-e063-6294a90a35ad	80586-801	HUMAN OTC DRUG	Beverly Gel Hand Sanitizer		ethyl alcohol	GEL	TOPICAL	20240110		OTC MONOGRAPH DRUG	505G(a)(3)	Cleanslate Group LLC	ALCOHOL	.7	mL/mL			N	20251231
80588-010_0e7735ff-ad09-c569-e063-6294a90a29c0	80588-010	HUMAN OTC DRUG	Sanitizing Hand Mist - Unscented		Ethyl Alcohol	SPRAY	TOPICAL	20220609		OTC MONOGRAPH DRUG	M003	Alkaline Corporation	ALCOHOL	70	mL/100mL			N	20251231
80588-011_0e7735ff-ad09-c569-e063-6294a90a29c0	80588-011	HUMAN OTC DRUG	Sanitizing Hand Mist - Peppermint Eucalyptus		Ethyl Alcohol	SPRAY	TOPICAL	20220609		OTC MONOGRAPH DRUG	M003	Alkaline Corporation	ALCOHOL	70	mL/100mL			N	20251231
80588-012_0e7735ff-ad09-c569-e063-6294a90a29c0	80588-012	HUMAN OTC DRUG	Sanitizing Hand Mist - Lemongrass		Ethyl Alcohol	SPRAY	TOPICAL	20220609		OTC MONOGRAPH DRUG	M003	Alkaline Corporation	ALCOHOL	70	mL/100mL			N	20251231
80588-020_0e7735ff-ad09-c569-e063-6294a90a29c0	80588-020	HUMAN OTC DRUG	Sanitizing Hand Gel - Unscented		Ethyl Alcohol	GEL	TOPICAL	20220609		OTC MONOGRAPH DRUG	M003	Alkaline Corporation	ALCOHOL	70	mL/100mL			N	20251231
80588-021_0e7735ff-ad09-c569-e063-6294a90a29c0	80588-021	HUMAN OTC DRUG	Sanitizing Hand Gel - Peppermint Eucalyptus		Ethyl Alcohol	GEL	TOPICAL	20220609		OTC MONOGRAPH DRUG	M003	Alkaline Corporation	ALCOHOL	70	mL/100mL			N	20251231
80588-022_0e7735ff-ad09-c569-e063-6294a90a29c0	80588-022	HUMAN OTC DRUG	Sanitizing Hand Gel - Lemongrass		Ethyl Alcohol	GEL	TOPICAL	20220609		OTC MONOGRAPH DRUG	M003	Alkaline Corporation	ALCOHOL	70	mL/100mL			N	20251231
80591-001_c8369a0e-932e-8f25-e053-2995a90af213	80591-001	HUMAN OTC DRUG	ELIZABETH HEALTH STYLE CHESTRUB VAPORIZING ACTION		CAMPHOR (SYNTHETIC), LEVOMENTHOL, EUCALYPTUS	OINTMENT	TOPICAL	20200928	20240228	OTC MONOGRAPH NOT FINAL	part348	AYUSHREE PHARMACEUTICALS PRIVATE LIMITED	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; LEVOMENTHOL	5; 1.2; 2.6	g/100g; g/100g; g/100g			N	
80591-002_c836cc9a-9803-2b1f-e053-2995a90ae3a6	80591-002	HUMAN OTC DRUG	ELIZABETH HEALTH STYLE ICE COLD		CAMPHOR (SYNTHETIC), LEVOMENTHOL	GEL	TOPICAL	20200928	20240228	OTC MONOGRAPH NOT FINAL	part348	AYUSHREE PHARMACEUTICALS PRIVATE LIMITED	CAMPHOR (SYNTHETIC); LEVOMENTHOL	2.5; .5	g/100g; g/100g			N	
80603-101_08a20812-db25-5b60-e063-6294a90a5b9e	80603-101	HUMAN PRESCRIPTION DRUG	Kyzatrex		TESTOSTERONE UNDECANOATE	CAPSULE, LIQUID FILLED	ORAL	20220727		NDA	NDA213953	Marius Pharmaceuticals	TESTOSTERONE UNDECANOATE	100	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
80603-103_08a20812-db25-5b60-e063-6294a90a5b9e	80603-103	HUMAN PRESCRIPTION DRUG	Kyzatrex		TESTOSTERONE UNDECANOATE	CAPSULE, LIQUID FILLED	ORAL	20220727		NDA	NDA213953	Marius Pharmaceuticals	TESTOSTERONE UNDECANOATE	150	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
80603-105_08a20812-db25-5b60-e063-6294a90a5b9e	80603-105	HUMAN PRESCRIPTION DRUG	Kyzatrex		TESTOSTERONE UNDECANOATE	CAPSULE, LIQUID FILLED	ORAL	20220727		NDA	NDA213953	Marius Pharmaceuticals	TESTOSTERONE UNDECANOATE	200	mg/1	Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]	CIII	N	20241231
80606-001_fdb47d2c-56bd-4a7a-e053-6294a90a32e6	80606-001	HUMAN OTC DRUG	Molchem hand purifier		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20210715		OTC MONOGRAPH NOT FINAL	part333E	MOL BELTING SYSTEMS, INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
80610-130_b4c7f129-dd3a-4f31-8f40-b85a68ad0738	80610-130	HUMAN PRESCRIPTION DRUG	ZORYVE		roflumilast	CREAM	TOPICAL	20220729		NDA	NDA215985	Arcutis Biotherapeutics, Inc.	ROFLUMILAST	3	mg/g	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
80610-430_719ba7f8-cd93-4aee-b77d-10bdcabddb78	80610-430	HUMAN PRESCRIPTION DRUG	ZORYVE		roflumilast	AEROSOL, FOAM	TOPICAL	20231215		NDA	NDA217242	Arcutis Biotherapeutics, Inc.	ROFLUMILAST	3	mg/g	Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]		N	20241231
80619-015_afc83c20-7c42-24e2-e053-2995a90a2186	80619-015	HUMAN OTC DRUG	Lemon Twist HAND SANITISER		ETHYL ALCOHOL	GEL	TOPICAL	20200921		OTC MONOGRAPH NOT FINAL	part333E	Arl, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80619-115_b6933950-b0be-466b-e053-2995a90ac587	80619-115	HUMAN OTC DRUG	Lemon Twist HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20201217		OTC MONOGRAPH NOT FINAL	part333E	Arl, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80619-215_c42e5b13-c2db-25e0-e053-2995a90aa015	80619-215	HUMAN OTC DRUG	Pineapple HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20210608		OTC MONOGRAPH NOT FINAL	part333E	Arl, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80619-315_c9a920d3-f380-a897-e053-2a95a90a5733	80619-315	HUMAN OTC DRUG	Lemon Twist HAND SANITIZER		ETHYL ALCOHOL	GEL	TOPICAL	20210816		OTC MONOGRAPH NOT FINAL	part333E	Arl, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80631-100_14627b8c-23f4-4570-a21a-9ad7302013b5	80631-100	VACCINE	NOVAVAX COVID-19 Vaccine, Adjuvanted		nvx-cov2373	INJECTION, SUSPENSION	INTRAMUSCULAR	20220131		EMERGENCY USE AUTHORIZATION		Novavax, Inc.	SARS-COV-2 SPIKE GLYCOPROTEIN VACCINE ANTIGEN NVX-COV2373	5	ug/.5mL			N	20241231
80631-102_14627b8c-23f4-4570-a21a-9ad7302013b5	80631-102	VACCINE	NOVAVAX COVID-19 Vaccine, Adjuvanted		nvx-cov2373	INJECTION, SUSPENSION	INTRAMUSCULAR	20230201		EMERGENCY USE AUTHORIZATION		Novavax, Inc.	SARS-COV-2 SPIKE GLYCOPROTEIN VACCINE ANTIGEN NVX-COV2373	5	ug/.5mL			N	20241231
80631-105_14627b8c-23f4-4570-a21a-9ad7302013b5	80631-105	VACCINE	NOVAVAX COVID-19 Vaccine, Adjuvanted		nvx-cov2373	INJECTION, SUSPENSION	INTRAMUSCULAR	20231003		EMERGENCY USE AUTHORIZATION		Novavax, Inc.	SARS-COV-2 SPIKE GLYCOPROTEIN VACCINE ANTIGEN NVX-COV2373	5	ug/.5mL			N	20241231
80638-150_f1ea51cf-44d5-74dc-e053-2995a90a57da	80638-150	HUMAN OTC DRUG	Antibacterial Antiseptic Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20200918		OTC MONOGRAPH NOT FINAL	part333A	FRESH CO COSMETICS SH.P.K.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20241231
80638-151_f1ea51cf-44d7-74dc-e053-2995a90a57da	80638-151	HUMAN OTC DRUG	Frescosal Alcohol Wipes		70% Isopropyl Alcohol	CLOTH	TOPICAL	20200918		OTC MONOGRAPH NOT FINAL	part333A	FRESH CO COSMETICS SH.P.K.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
80638-260_0e848a42-3761-b856-e063-6394a90ad7ca	80638-260	HUMAN OTC DRUG	70%ALCOHOL WET WIPES		ANTIBACTERIAL ANTISEPTIC WET WIPES	CLOTH	TOPICAL	20201101		OTC MONOGRAPH DRUG	M003	FRESH CO COSMETICS SH.P.K	ISOPROPYL ALCOHOL	70	mL/100mL			N	20251231
80638-600_0e84acda-5cfa-2ab0-e063-6294a90a4fff	80638-600	HUMAN OTC DRUG	ANTIBACTERIAL ANTISEPTIC WET WIPES		ANTIBACTERIAL ANTISEPTIC WET WIPES	CLOTH	TOPICAL	20201101		OTC MONOGRAPH DRUG	M003	FRESH CO COSMETICS SH. P.K.	BENZALKONIUM CHLORIDE	.13	mg/100mL			N	20251231
80641-005_dd308c14-89ec-f1a0-e053-2995a90a4339	80641-005	HUMAN OTC DRUG	Vacation World	Classic Whip SPF 30	Homosalate, Octisalate, Octocrylene, Avobenzone	AEROSOL, FOAM	TOPICAL	20220408		OTC MONOGRAPH NOT FINAL	part352	Vacation Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	.03; .075; .05; .05	g/g; g/g; g/g; g/g			N	20241231
80641-006_f268fb1c-d7c3-f2f9-e053-2995a90a9e22	80641-006	HUMAN OTC DRUG	Vacation SPF 50 Classic		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20221101		OTC MONOGRAPH FINAL	M020	Vacation Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.8; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
80641-007_f278138d-3100-24af-e053-2a95a90a4a4a	80641-007	HUMAN OTC DRUG	Vacation SPF 50 Classic		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20221201		OTC MONOGRAPH FINAL	part352	Vacation Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 8.8; 4.9; 8.6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
80641-008_f6947fb0-21c8-71f0-e053-2995a90aadbf	80641-008	HUMAN OTC DRUG	Vacation SPF 30 Chardonnay Oil		Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20230101		OTC MONOGRAPH FINAL	M020	Vacation Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
80641-009_f69513ae-f211-075f-e053-2a95a90a9b2e	80641-009	HUMAN OTC DRUG	Vacation SPF 30 Mineral		Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH FINAL	M020	Vacation Inc.	ZINC OXIDE	15.5	g/100mL			N	20241231
80641-010_f67fbe98-93cf-2882-e053-2a95a90ab713	80641-010	HUMAN OTC DRUG	Vacation SPF 50 Super Spritz Face Mist		Avobenzone, Octisalate, Octocrylene	SPRAY	TOPICAL	20230201		OTC MONOGRAPH FINAL	M020	Vacation Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	2.9; 4.9; 9.5	g/100mL; g/100mL; g/100mL			N	20241231
80641-011_f6030311-5288-3aa3-e053-2995a90a1b87	80641-011	HUMAN OTC DRUG	Vacation SPF 30 Baby Oil		Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20230101		OTC MONOGRAPH FINAL	M020	Vacation Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.8; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
80644-0012_06e3f110-a8d1-d5cc-e063-6394a90ab33d	80644-0012	HUMAN PRESCRIPTION DRUG	Zegalogue		dasiglucagon	INJECTION, SOLUTION	SUBCUTANEOUS	20210405		NDA	NDA214231	Zealand Pharma US, Inc	DASIGLUCAGON	.6	mg/.6mL	Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]		N	20241231
80644-0013_06e3f110-a8d1-d5cc-e063-6394a90ab33d	80644-0013	HUMAN PRESCRIPTION DRUG	Zegalogue		dasiglucagon	INJECTION, SOLUTION	SUBCUTANEOUS	20210405		NDA	NDA214231	Zealand Pharma US, Inc	DASIGLUCAGON	.6	mg/.6mL	Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]		N	20241231
80650-001_0e1221bd-0cf9-82af-e063-6394a90aca35	80650-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20200923		UNAPPROVED MEDICAL GAS		Pur O2 LLC	OXYGEN	99	L/100L			N	20251231
80651-093_09762412-1b73-516e-e063-6294a90a6753	80651-093	HUMAN OTC DRUG	DiaperDerm Diaper Rash		ZINC OXIDE	CREAM	TOPICAL	20200930		OTC MONOGRAPH DRUG	M016	Diaperderm Inc	ZINC OXIDE	50	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
80652-001_af727835-97ff-5af0-e053-2a95a90a5ad7	80652-001	HUMAN OTC DRUG	Scented Hand Sanitizer - Citrus Scented		ALCOHOL	GEL	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Little Kids, Inc.	ALCOHOL	62	mL/100mL			N	20241231
80652-002_af727835-97ff-5af0-e053-2a95a90a5ad7	80652-002	HUMAN OTC DRUG	Scented Hand Sanitizer - Vanilla Scented		ALCOHOL	GEL	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Little Kids, Inc.	ALCOHOL	62	mL/100mL			N	20241231
80652-003_af727835-97ff-5af0-e053-2a95a90a5ad7	80652-003	HUMAN OTC DRUG	Scented Hand Sanitizer - Cherry Blossom Scented		ALCOHOL	GEL	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Little Kids, Inc.	ALCOHOL	62	mL/100mL			N	20241231
80652-004_af727835-97ff-5af0-e053-2a95a90a5ad7	80652-004	HUMAN OTC DRUG	Scented Hand Sanitizer - Strawberry Scented		ALCOHOL	GEL	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333A	Little Kids, Inc.	ALCOHOL	62	mL/100mL			N	20241231
80656-700_fc76ab4c-3609-39c3-e053-6394a90a6877	80656-700	HUMAN OTC DRUG	Perfecto Tricolan Healthcare Personnel Hand Wash		Tricolan Hand Wash	LIQUID	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	DPI, LLC	CHLOROXYLENOL	.6	g/100g			N	20241231
80656-800_fd2b9f33-4970-c5c0-e053-6294a90a47f5	80656-800	HUMAN OTC DRUG	PERFECTO HALT Healthcare Personnel Antiseptic Hand Rub		Halt	SOLUTION	TOPICAL	20230612		OTC MONOGRAPH NOT FINAL	part333A	Direct Packaged Ingredients (DPI), LLC	ALCOHOL	63.31	g/100g			N	20241231
80661-001_0817d7fc-2eb1-094c-e063-6394a90ad8da	80661-001	HUMAN OTC DRUG	MyHealth Alcohol Antiseptic Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200926		OTC MONOGRAPH DRUG	M003	Aeroflex Industria de Aerosol Ltda	ALCOHOL	70	mL/100mL			N	20241231
80661-002_0817d7fc-2ebe-094c-e063-6394a90ad8da	80661-002	HUMAN OTC DRUG	MyHealth Advanced Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200926		OTC MONOGRAPH DRUG	M003	Aeroflex Industria de Aerosol Ltda	ALCOHOL	70	mL/100mL			N	20241231
80661-003_0817a373-ed85-f7fb-e063-6294a90a2259	80661-003	HUMAN OTC DRUG	Bem Bio Antiperspirant sea breeze		Magnesium Hydroxide,Magnesium Carbonate Hydroxide	AEROSOL, SPRAY	TOPICAL	20220615		UNAPPROVED DRUG OTHER		Aeroflex Industria de Aerosol Ltda	MAGNESIUM CARBONATE HYDROXIDE; MAGNESIUM HYDROXIDE	10; 10	g/100g; g/100g	Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
80661-004_0817d1ef-7cdf-4128-e063-6394a90ac4ab	80661-004	HUMAN OTC DRUG	Bem Bio Antiperspirant floral		Magnesium Hydroxide,Magnesium Carbonate Hydroxide	AEROSOL, SPRAY	TOPICAL	20220615		UNAPPROVED DRUG OTHER		Aeroflex Industria de Aerosol Ltda	MAGNESIUM CARBONATE HYDROXIDE; MAGNESIUM HYDROXIDE	10; 10	g/100g; g/100g	Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
80661-005_0817caab-8c1f-f9e3-e063-6294a90a9b67	80661-005	HUMAN OTC DRUG	Bem Bio Antiperspirant original		Magnesium Hydroxide,Magnesium Carbonate Hydroxide	AEROSOL, SPRAY	TOPICAL	20220615		UNAPPROVED DRUG OTHER		Aeroflex Industria de Aerosol Ltda	MAGNESIUM CARBONATE HYDROXIDE; MAGNESIUM HYDROXIDE	10; 10	g/100g; g/100g	Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
80661-006_0817d3c9-00fe-4eec-e063-6294a90a48fc	80661-006	HUMAN OTC DRUG	Bem Bio Antiperspirant unscented		Magnesium Hydroxide,Magnesium Carbonate Hydroxide	AEROSOL, SPRAY	TOPICAL	20220615		UNAPPROVED DRUG OTHER		Aeroflex Industria de Aerosol Ltda	MAGNESIUM CARBONATE HYDROXIDE; MAGNESIUM HYDROXIDE	10; 10	g/100g; g/100g	Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
80661-007_08181605-eabe-ccbf-e063-6294a90aba2a	80661-007	HUMAN OTC DRUG	Bem Bio Antiperspirant forest trails		Magnesium Hydroxide,Magnesium Carbonate Hydroxide	AEROSOL, SPRAY	TOPICAL	20220615		UNAPPROVED DRUG OTHER		Aeroflex Industria de Aerosol Ltda	MAGNESIUM CARBONATE HYDROXIDE; MAGNESIUM HYDROXIDE	10; 10	g/100g; g/100g	Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
80661-008_f0d011ab-e6d8-6d9e-e053-2a95a90a5622	80661-008	HUMAN OTC DRUG	MyHealth Mood Care Women		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-009_f0d026ed-47ed-cbe1-e053-2a95a90af337	80661-009	HUMAN OTC DRUG	MyHealth Mood Care Men		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-010_f0d026ed-47f8-cbe1-e053-2a95a90af337	80661-010	HUMAN OTC DRUG	MyHealth Mood Care Unissex		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-011_f0d03d57-bc0c-ee5b-e053-2a95a90ab23a	80661-011	HUMAN OTC DRUG	MyHealth Mood Care Sem perfume		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-012_f0d03d57-bc17-ee5b-e053-2a95a90ab23a	80661-012	HUMAN OTC DRUG	MyHealth Mood Care Teen Boy		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-013_f0d02629-edce-cbdf-e053-2a95a90af603	80661-013	HUMAN OTC DRUG	MyHealth Mood Care Teen Girl		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-014_f0d02629-edd9-cbdf-e053-2a95a90af603	80661-014	HUMAN OTC DRUG	MyHealth Mood Care Sport Women		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-015_f0d00e68-5b60-6b66-e053-2a95a90ae231	80661-015	HUMAN OTC DRUG	MyHealth Mood Care Sport Men		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80661-016_f0d00e68-5b6b-6b66-e053-2a95a90ae231	80661-016	HUMAN OTC DRUG	MyHealth Mood Care Sport Unissex		Aluminum sesquichlorohydrate	AEROSOL, SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	part350	Aeroflex Industria de Aerosol Ltda	ALUMINUM SESQUICHLOROHYDRATE	25	g/100mL			N	20241231
80684-000_08a0077a-68a4-310c-e063-6394a90a8e27	80684-000	HUMAN OTC DRUG	P b pure Antibacterial Hand Sanitizer Cucumber Melon Scented		ALCOHOL	GEL	TOPICAL	20200924		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	.65	mL/mL			N	20241231
80684-001_089fffdd-2eed-6928-e063-6294a90af1c6	80684-001	HUMAN OTC DRUG	P b pure Antibacterial Hand Sanitizer Ocean Breeze Scented		ALCOHOL	GEL	TOPICAL	20200924		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	.65	mL/mL			N	20241231
80684-002_08a01894-2d70-5945-e063-6394a90a6404	80684-002	HUMAN OTC DRUG	P b pure Antibacterial Hand Sanitizer Sweet Pea Scented		ALCOHOL	GEL	TOPICAL	20200924		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	.65	mL/mL			N	20241231
80684-003_08a00809-1692-83f1-e063-6294a90ae667	80684-003	HUMAN OTC DRUG	Cucumber Melon Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201107		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	.7	mL/mL			N	20241231
80684-004_08a0077a-68b4-310c-e063-6394a90a8e27	80684-004	HUMAN OTC DRUG	Fresh Peach Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201107		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	.7	mL/mL			N	20241231
80684-005_08a026b8-bede-ca5b-e063-6294a90a0b4e	80684-005	HUMAN OTC DRUG	Ocean Breeze Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201107		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	.7	mL/mL			N	20241231
80684-006_08a0077a-68c4-310c-e063-6394a90a8e27	80684-006	HUMAN OTC DRUG	Sweet Pea Scented Antibacterial Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201107		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	.7	mL/mL			N	20241231
80684-007_08a01894-2d81-5945-e063-6394a90a6404	80684-007	HUMAN OTC DRUG	Theraplus Antibacterial Wipes Fresh Scent with Aloe and Vitamin E		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201110		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
80684-030_08a06323-c9d2-e2e0-e063-6294a90a860f	80684-030	HUMAN OTC DRUG	Coconut and Lime Scented Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210610		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-031_08a06887-82f2-eb1b-e063-6294a90a1e74	80684-031	HUMAN OTC DRUG	Cucumber and Melon Scented Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210610		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-032_08a06d0f-8640-ebb2-e063-6294a90ab995	80684-032	HUMAN OTC DRUG	Pomegranate and Vanilla Scented Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210610		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-033_08a0591e-6cb5-30ce-e063-6394a90a33fb	80684-033	HUMAN OTC DRUG	Lavender scented anti-bacterial hand sanitizer		ALCOHOL	GEL	TOPICAL	20210820		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-034_08a069fb-2cca-eb9f-e063-6294a90a609d	80684-034	HUMAN OTC DRUG	Aloe scented anti-bacterial hand sanitizer		ALCOHOL	GEL	TOPICAL	20210820		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-035_08a069fb-2cd8-eb9f-e063-6294a90a609d	80684-035	HUMAN OTC DRUG	Rose scented anti-bacterial hand sanitizer		ALCOHOL	GEL	TOPICAL	20210820		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-036_08a0ee56-0507-10b9-e063-6294a90a8dc5	80684-036	HUMAN OTC DRUG	Jasmine scented anti-bacterial hand sanitizer		ALCOHOL	GEL	TOPICAL	20210820		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-038_08a0f5fb-bc99-45d2-e063-6294a90a623c	80684-038	HUMAN OTC DRUG	Thera plus Anti-itch with aloe Hydrocortisone		HYDROCORTISONE	CREAM	TOPICAL	20220130		OTC MONOGRAPH DRUG	M017	Fourstar Group USA, Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
80684-039_08a0ce90-0c11-15f4-e063-6294a90a6ca7	80684-039	HUMAN OTC DRUG	Thera plus Antifungal Clotrimazole		CLOTRIMAZOLE	CREAM	TOPICAL	20220130		OTC MONOGRAPH DRUG	M005	FOURSTAR GROUP USA, INC.	CLOTRIMAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
80684-040_08a0d819-d9c5-15e9-e063-6294a90acb44	80684-040	HUMAN OTC DRUG	Thera plus Antifungal Tolnaftate		TOLNAFTATE	CREAM	TOPICAL	20220130		OTC MONOGRAPH DRUG	M005	FOURSTAR GROUP USA, INC.	TOLNAFTATE	10	mg/g			N	20241231
80684-060_08a1186c-966a-a4c0-e063-6294a90a1908	80684-060	HUMAN OTC DRUG	BERRY SCENTED CLIP ON HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20220510		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-061_08a10850-f9b8-c26c-e063-6394a90a3d15	80684-061	HUMAN OTC DRUG	CHERRY BLOSSOM SCENTED HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20220510		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-062_08a13b11-6efc-a07e-e063-6294a90a4070	80684-062	HUMAN OTC DRUG	CHAI LATTE SCENTED CLIP ON HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20220510		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-063_08a1186c-9679-a4c0-e063-6294a90a1908	80684-063	HUMAN OTC DRUG	CHAI LATTE SCENTED HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20220510		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-064_08a14085-7d0c-738a-e063-6394a90a16aa	80684-064	HUMAN OTC DRUG	PUMPKIN SPICE SCENTED CLIP ON HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20220510		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-065_08a13e35-788e-3322-e063-6294a90a47fa	80684-065	HUMAN OTC DRUG	PUMPKIN SPICE SCENTED HAND SANITIZER		ALCOHOL	GEL	TOPICAL	20220510		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-080_08a1414b-c708-47fd-e063-6394a90a5732	80684-080	HUMAN OTC DRUG	Lavender Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20221225		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-081_08a13f7d-b1d4-2e5d-e063-6294a90ae1b0	80684-081	HUMAN OTC DRUG	Aloe Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20221225		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-082_08a156da-814d-35f1-e063-6294a90a5830	80684-082	HUMAN OTC DRUG	Rose Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20221225		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-083_08a1414b-c717-47fd-e063-6394a90a5732	80684-083	HUMAN OTC DRUG	Jasmine Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20221225		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-090_08a13e35-78a3-3322-e063-6294a90a47fa	80684-090	HUMAN OTC DRUG	LAVENDER SCENTED HAND SANITIZER PEN		ALCOHOL	LIQUID	TOPICAL	20221215		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-091_08a14085-7d1a-738a-e063-6394a90a16aa	80684-091	HUMAN OTC DRUG	CITRUS SCENTED HAND SANITIZER PEN		ALCOHOL	LIQUID	TOPICAL	20221215		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc	ALCOHOL	70	mL/100mL			N	20241231
80684-092_08a14d4e-8a92-9712-e063-6394a90a0bad	80684-092	HUMAN OTC DRUG	COCONUT SCENTED HAND SANITIZER PEN		ALCOHOL	LIQUID	TOPICAL	20221215		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-095_0b61f145-2020-c878-e063-6394a90a976a	80684-095	HUMAN OTC DRUG	B-Pure Lavender Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20231125		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-096_0b61fcb7-353b-f293-e063-6294a90a40b4	80684-096	HUMAN OTC DRUG	B-Pure Citrus Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20231125		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-099_0a228cd8-1c3c-2cbc-e063-6394a90ae3d4	80684-099	HUMAN OTC DRUG	B-Pure Hydrating Hand Sanitizer Cucumber Mint Scented		ALCOHOL	LIQUID	TOPICAL	20231205		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-100_0a225714-ccb2-4676-e063-6294a90aeeb2	80684-100	HUMAN OTC DRUG	B-Pure Hydrating Hand Sanitizer Watermelon Scented		ALCOHOL	LIQUID	TOPICAL	20231205		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-102_0b5fae73-623b-d90d-e063-6294a90a66de	80684-102	HUMAN OTC DRUG	B-Pure Citrus scented Hand Sanitizing		ALCOHOL	LIQUID	TOPICAL	20231208		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-103_0aac0b96-e46a-173c-e063-6294a90a9a16	80684-103	HUMAN OTC DRUG	B-Pure Coconut Scented Hand Sanitizing		ALCOHOL	LIQUID	TOPICAL	20231208		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-104_0aac17cf-fc56-0b08-e063-6394a90a980c	80684-104	HUMAN OTC DRUG	B-Pure Lavender Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20231208		OTC MONOGRAPH DRUG	505G(a)(3)	Fourstar Group USA, Inc.	ALCOHOL	70	mL/100mL			N	20241231
80684-105_0b4cc7b6-dc91-579c-e063-6394a90a308b	80684-105	HUMAN OTC DRUG	Coconut Scented Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20231125		OTC MONOGRAPH DRUG	505G(a)(3)	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-120_029068a4-6186-1d8d-e063-6294a90abcf6	80684-120	HUMAN OTC DRUG	ALOE SCENTED HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20230815		OTC MONOGRAPH NOT FINAL	part333E	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-121_02906bf8-2934-4f03-e063-6294a90a389a	80684-121	HUMAN OTC DRUG	EUCALYPTUS SCENTED HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20230815		OTC MONOGRAPH NOT FINAL	part333E	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80684-122_02906fbd-02c6-1589-e063-6394a90adcf2	80684-122	HUMAN OTC DRUG	SHEA BUTTER SCENTED HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20230815		OTC MONOGRAPH NOT FINAL	part333E	FOURSTAR GROUP USA, INC.	ALCOHOL	70	mL/100mL			N	20241231
80689-000_089ebdf5-d354-1657-e063-6294a90a82b5	80689-000	HUMAN OTC DRUG	hand sanitizer		ALCOHOL	GEL	TOPICAL	20201015		OTC MONOGRAPH DRUG	505G(a)(3)	Hygieia	ALCOHOL	.75	mL/mL			N	20241231
80700-113_0d8333a4-0451-1a58-e063-6294a90a4add	80700-113	HUMAN PRESCRIPTION DRUG	Propofol 1%		Propofol 1%	INJECTION, EMULSION	INTRAVENOUS	20230329		UNAPPROVED DRUG OTHER		Genixus	PROPOFOL	10	mg/mL	General Anesthesia [PE], General Anesthetic [EPC]		N	20241231
80705-100_c5d28d30-f9b7-446f-a36f-e88fe98e9151	80705-100	HUMAN PRESCRIPTION DRUG	ELEPSIA XR 1000 MG		levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20210212		NDA	NDA204417	TRIPOINT THERAPEUTICS, LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
80705-101_c5d28d30-f9b7-446f-a36f-e88fe98e9151	80705-101	HUMAN PRESCRIPTION DRUG	ELEPSIA XR 1500 MG		levetiracetam	TABLET, EXTENDED RELEASE	ORAL	20210212		NDA	NDA204417	TRIPOINT THERAPEUTICS, LLC	LEVETIRACETAM	1500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
80710-213_ea4d87bf-70c3-5abf-e053-2a95a90aad11	80710-213	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	D3W Industries Inc.	ALCOHOL	70	mL/100mL			N	20241231
80711-001_f4b05624-98a4-5778-e053-2995a90a871c	80711-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210503		OTC MONOGRAPH NOT FINAL	part333A	IVM Especialidades Quimicas, S.A. de C.V.	ALCOHOL	80	mL/100mL			N	20241231
80711-002_f4b092aa-b7fa-a114-e053-2a95a90a8d0d	80711-002	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210507		OTC MONOGRAPH NOT FINAL	part333A	IVM Especialidades Quimicas, S.A. de C.V.	ALCOHOL	70	mL/100mL			N	20241231
80714-034_0d8507ac-785d-f790-e063-6294a90a2991	80714-034	HUMAN OTC DRUG	CLOROX Hand sanitizer Gel		Alcohol hand Sanitizer	GEL	TOPICAL	20201030	20250131	OTC MONOGRAPH DRUG	505G(a)(3)	New Wave Global Services Inc	ALCOHOL	.7	mL/mL			N	
80724-201_0c4b2490-fc08-1eb0-e063-6294a90a57ed	80724-201	HUMAN OTC DRUG	Triple X-Lotion		Glycolic Acid, Sulfur, Salicylic Acid	LOTION	TOPICAL	20201015		UNAPPROVED DRUG OTHER		EMS TRADE	GLYCOLIC ACID; SALICYLIC ACID; SULFUR	3; .5; 3	g/100mL; g/100mL; g/100mL			N	20241231
80725-004_090830a3-cd62-cc3f-e063-6294a90a322a	80725-004	HUMAN PRESCRIPTION DRUG	Valium		Diazepam	TABLET	ORAL	20220404		NDA	NDA013263	Waylis Therapuetics LLC	DIAZEPAM	2	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80725-005_090830a3-cd62-cc3f-e063-6294a90a322a	80725-005	HUMAN PRESCRIPTION DRUG	Valium		Diazepam	TABLET	ORAL	20220404		NDA	NDA013263	Waylis Therapuetics LLC	DIAZEPAM	5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80725-006_090830a3-cd62-cc3f-e063-6294a90a322a	80725-006	HUMAN PRESCRIPTION DRUG	Valium		Diazepam	TABLET	ORAL	20220404		NDA	NDA013263	Waylis Therapuetics LLC	DIAZEPAM	10	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
80725-010_2c91f978-7c47-4f1d-8523-417d038c5030	80725-010	HUMAN PRESCRIPTION DRUG	Lunesta		ESZOPICLONE	TABLET, COATED	ORAL	20230815		NDA	NDA021476	Waylis Therapeutics LLC	ESZOPICLONE	1	mg/1		CIV	N	20241231
80725-011_2c91f978-7c47-4f1d-8523-417d038c5030	80725-011	HUMAN PRESCRIPTION DRUG	Lunesta		ESZOPICLONE	TABLET, COATED	ORAL	20230815		NDA	NDA021476	Waylis Therapeutics LLC	ESZOPICLONE	2	mg/1		CIV	N	20241231
80725-012_2c91f978-7c47-4f1d-8523-417d038c5030	80725-012	HUMAN PRESCRIPTION DRUG	Lunesta		ESZOPICLONE	TABLET, COATED	ORAL	20230815		NDA	NDA021476	Waylis Therapeutics LLC	ESZOPICLONE	3	mg/1		CIV	N	20241231
80725-139_3dd1ad33-b8a4-4111-af4c-4113719f1ccf	80725-139	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Waylis Therapeutics LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-140_3dd1ad33-b8a4-4111-af4c-4113719f1ccf	80725-140	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Waylis Therapeutics LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-141_3dd1ad33-b8a4-4111-af4c-4113719f1ccf	80725-141	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Waylis Therapeutics LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-142_3dd1ad33-b8a4-4111-af4c-4113719f1ccf	80725-142	HUMAN PRESCRIPTION DRUG	Coreg		Carvedilol	TABLET, FILM COATED	ORAL	20230315		NDA	NDA020297	Waylis Therapeutics LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-243_a7e7efb0-65cc-403b-9de2-a2b328f6c908	80725-243	HUMAN PRESCRIPTION DRUG	Aciphex		rabeprazole sodium	TABLET, DELAYED RELEASE	ORAL	20220515		NDA	NDA020973	Waylis Therapeutics LLC	RABEPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
80725-250_218563ce-a4f4-490b-99fe-eabc713bbdba	80725-250	HUMAN PRESCRIPTION DRUG	Humatin		PAROMOMYCIN SULFATE	CAPSULE	ORAL	20210408		ANDA	ANDA065173	Waylis Therapeutics LLC	PAROMOMYCIN SULFATE	250	mg/1	Antiprotozoal [EPC]		N	20241231
80725-383_9376abd9-c71f-4036-b69f-98bf95fdeb9d	80725-383	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Waylis Therapeutics LLC	CARVEDILOL PHOSPHATE	10	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-385_9376abd9-c71f-4036-b69f-98bf95fdeb9d	80725-385	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Waylis Therapeutics LLC	CARVEDILOL PHOSPHATE	20	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-387_9376abd9-c71f-4036-b69f-98bf95fdeb9d	80725-387	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Waylis Therapeutics LLC	CARVEDILOL PHOSPHATE	40	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-388_9376abd9-c71f-4036-b69f-98bf95fdeb9d	80725-388	HUMAN PRESCRIPTION DRUG	Coreg CR		Carvedilol Phosphate	CAPSULE, EXTENDED RELEASE	ORAL	20221107		NDA	NDA022012	Waylis Therapeutics LLC	CARVEDILOL PHOSPHATE	80	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
80725-600_7c581273-b507-4c4b-bcda-fa67a21b1c56	80725-600	HUMAN PRESCRIPTION DRUG	Eulexin		Flutamide	CAPSULE	ORAL	20211112		ANDA	ANDA075298	Waylis Therapeutics LLC	FLUTAMIDE	125	mg/1	Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC]		N	20241231
80725-610_fde39257-c7bf-40e7-a480-1044b55142f5	80725-610	HUMAN PRESCRIPTION DRUG	LEUKERAN		chlorambucil	TABLET, FILM COATED	ORAL	20230515		NDA	NDA010669	Waylis Therapeutics LLC	CHLORAMBUCIL	2	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
80725-620_f7df90c1-716d-47cd-b3ce-e1c3269edbb8	80725-620	HUMAN PRESCRIPTION DRUG	MYLERAN		busulfan	TABLET, FILM COATED	ORAL	20230515		NDA	NDA009386	Waylis Therapeutics LLC	BUSULFAN	2	mg/1	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
80725-630_4f31c81f-0c6e-4c3f-9f50-44578fad9988	80725-630	HUMAN PRESCRIPTION DRUG	TABLOID		thioguanine	TABLET	ORAL	20230515		NDA	NDA012429	Waylis Therapeutics LLC	THIOGUANINE	40	mg/1	Antimetabolite [EPC]		N	20241231
80725-712_ebeee383-e0e9-4524-a0b7-81a69c1cd2c5	80725-712	HUMAN PRESCRIPTION DRUG	AVODART		dutasteride	CAPSULE, LIQUID FILLED	ORAL	20221215		NDA	NDA021319	Waylis Therapeutics LLC	DUTASTERIDE	.5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
80733-005_2cf2f216-3e2a-461f-8cfd-d1a1a859ce00	80733-005	HUMAN OTC DRUG	TC Max		calcium carbonate	POWDER, FOR SOLUTION	ORAL	20190603		OTC MONOGRAPH FINAL	part331	Romavision Investing LLC	CALCIUM CARBONATE	4	g/237mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
80733-006_ee020a7c-8a83-4f5e-bda1-439266616776	80733-006	HUMAN OTC DRUG	TC Max		calcium carbonate	POWDER, FOR SOLUTION	ORAL	20190603		OTC MONOGRAPH DRUG	M001	Romavision Investing LLC	CALCIUM CARBONATE	4	g/237mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
80733-007_2cf2f216-3e2a-461f-8cfd-d1a1a859ce00	80733-007	HUMAN OTC DRUG	TC Max		calcium carbonate	KIT	ORAL	20190718		OTC MONOGRAPH FINAL	part331	Romavision Investing LLC						N	20241231
80735-820_2b813678-540b-41e8-bed5-609cc99fd663	80735-820	HUMAN PRESCRIPTION DRUG	Zemdri (plazomicin)		Plazomicin	INJECTION	INTRAVENOUS	20180716		NDA	NDA210303	Cipla Therapeutics Inc.	PLAZOMICIN	500	mg/10mL			N	20241231
80739-812_3a7320c2-d678-4a23-b2d1-3873e2e73e30	80739-812	HUMAN PRESCRIPTION DRUG	KRAZATI		adagrasib	TABLET, COATED	ORAL	20221212		NDA	NDA216340	Mirati Therapeutics, Inc	ADAGRASIB	200	mg/1			N	20241231
80762-0020_07a420ef-6915-821b-e063-6294a90a4c3e	80762-0020	HUMAN OTC DRUG	Bye Zero		Magnesium	LIQUID	TOPICAL	20201006		UNAPPROVED DRUG OTHER		Korea Life Science	MAGNESIUM	4.95	g/500mL			N	20241231
80762-0021_07a43c87-8559-9c20-e063-6394a90a188a	80762-0021	HUMAN OTC DRUG	Bye Zero		magnesium	POWDER	TOPICAL	20201006		UNAPPROVED DRUG OTHER		Korea Life Science	MAGNESIUM	4.95	g/500g			N	20241231
80762-0023_07f2f725-7469-aad1-e063-6394a90a0321	80762-0023	HUMAN OTC DRUG	Minaral mi tea		magnesium	LIQUID	TOPICAL	20230620		UNAPPROVED DRUG OTHER		Korea Life Science	MAGNESIUM	4.95	g/500mL			N	20241231
80770-002_04de21db-3ccf-fe30-e063-6394a90aadd5	80770-002	HUMAN OTC DRUG	MENTHOL		MENTHOL	SPRAY	TOPICAL	20201019	20250327	OTC MONOGRAPH FINAL	part341	NATURAL 17	MENTHOL	2	g/100g			N	
80770-020_056b2d43-79e3-5faa-e063-6294a90a410e	80770-020	HUMAN OTC DRUG	NATURAL 17 HERBAL SPLASH		MENTHOL	SPRAY	TOPICAL	20230915		OTC MONOGRAPH NOT FINAL	part348	NATURAL 17	MENTHOL	1.7	g/100mL			N	20241231
80770-033_ed0c7709-0411-7fcf-e053-2995a90a8898	80770-033	HUMAN OTC DRUG	NATURAL 17 MUSCLE		CAMPHOR	GEL	TOPICAL	20201103		OTC MONOGRAPH NOT FINAL	part348	NATURAL 17	CAMPHOR (SYNTHETIC)	.33	g/100mL			N	20241231
80771-000_da307e45-06b6-cf3d-e053-2995a90ab8cf	80771-000	HUMAN OTC DRUG	Wild Horse 777 Moisturizing Nasal		SODIUM CHLORIDE	LIQUID	TOPICAL	20201002		UNAPPROVED DRUG OTHER		Wild Horse 777, Inc.	SODIUM CHLORIDE	6.5	mg/mL			N	20241231
80771-001_09ce2f4e-4b7a-7516-e063-6394a90aa28e	80771-001	HUMAN OTC DRUG	Wild Horse 777 Oral		PHENOL	LIQUID	TOPICAL	20201002		OTC MONOGRAPH DRUG	M022	Wild Horse 777, Inc.	PHENOL	6	mg/mL			N	20241231
80773-001_0b66957e-9fa4-e352-e063-6294a90a8109	80773-001	HUMAN OTC DRUG	SOPURE		Denatured Ethanol	LIQUID	TOPICAL	20200207		OTC MONOGRAPH DRUG	M003	EnviroServe Chemicals & Cleaners Ltd	ALCOHOL	80	mL/100mL			N	20241231
80773-003_0b669e31-2f53-ed77-e063-6294a90ad408	80773-003	HUMAN OTC DRUG	SOPURE 80% Ethanol Sanitizing wipes		Ethanol	CLOTH	TOPICAL	20230616		OTC MONOGRAPH DRUG	M003	EnviroServe Chemicals & Cleaners Ltd.	ALCOHOL	80	mL/100mL			N	20241231
80777-102_a6d5b957-5064-4d6f-a833-2dbac53b2635	80777-102	VACCINE	Spikevax		COVID-19 Vaccine, mRNA	INJECTION, SUSPENSION	INTRAMUSCULAR	20230911		BLA	BLA125752	Moderna US, Inc.	CX-038839 OMICRON (XBB.1.5)	50	ug/.5mL			N	20241231
80777-287_b0834e35-9390-40b8-b968-2211a0f3c187	80777-287	VACCINE	Moderna COVID-19 Vaccine		Moderna COVID-19 Vaccine	INJECTION, SUSPENSION	INTRAMUSCULAR	20230911		EMERGENCY USE AUTHORIZATION		Moderna US, Inc.	CX-038839 OMICRON (XBB.1.5)	25	ug/.25mL			N	20241231
80781-094_09d6fabb-0d08-222e-e063-6294a90a95b6	80781-094	HUMAN OTC DRUG	MIGGY FOUNDATION 70% Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200917		OTC MONOGRAPH DRUG	505G(a)(3)	Miguel Cabrera Foundation, Inc.	ALCOHOL	.7	mL/mL			N	20241231
80782-001_f306dd76-d266-ff95-e053-2a95a90a8a0c	80782-001	HUMAN OTC DRUG	Day in the sun kit		AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE	KIT		20210801		OTC MONOGRAPH FINAL	part352	THE WONDERFUL GROUP LLC						N	20241231
80789-117_afd0f424-6e6b-4f5f-a97d-98532adbabc6	80789-117	HUMAN PRESCRIPTION DRUG	VIGPODER		vigabatrin	POWDER, FOR SOLUTION	ORAL	20240103		ANDA	ANDA214961	Pyros Pharmaceuticals, Inc.	VIGABATRIN	50	mg/mL	Anti-epileptic Agent [EPC]		N	20251231
80792-001_06e3e1ea-f809-e7e3-e063-6394a90af52f	80792-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20201007		UNAPPROVED MEDICAL GAS		Healthmark Home Medical Equipment Inc	OXYGEN	99	L/100L			N	20241231
80801-101_fb274920-ea6b-386b-e053-6394a90a22e4	80801-101	HUMAN OTC DRUG	URBAN WASH DANDRUFF		pyrithione zinc	SHAMPOO	TOPICAL	20230501		OTC MONOGRAPH FINAL	M032	Primal Elements	PYRITHIONE ZINC	.3	g/100mL			N	20241231
80801-102_076c23d7-7f71-0415-e063-6394a90a8af0	80801-102	HUMAN OTC DRUG	BODY GUARD ANTI-PERSPIRANT DEODORANT SPORT		Aluminum Zironium Tetrachlorohydrex GLY	STICK	TOPICAL	20230101		OTC MONOGRAPH DRUG	M019	PRIMAL ELEMENTS	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	8.6	g/100g			N	20241231
80801-103_076df3bb-83e8-62be-e063-6294a90aef9d	80801-103	HUMAN OTC DRUG	DANDRUFF		pyrithione zinc	SHAMPOO	TOPICAL	20230501		OTC MONOGRAPH DRUG	M032	Primal Elements	PYRITHIONE ZINC	.3	g/100mL			N	20241231
80801-104_079433c0-8dff-946c-e063-6394a90a7898	80801-104	HUMAN OTC DRUG	PETROLEUM		PETROLATUM	JELLY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M016	PRIMAL ELEMENTS	WHITE PETROLATUM	100	g/100g			N	20241231
80801-105_0794de46-c4ba-9299-e063-6394a90aab5d	80801-105	HUMAN OTC DRUG	ARCTIC ICE		MENTHOL	GEL	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	PRIMAL ELEMENTS	MENTHOL	1.25	g/100g			N	20241231
80803-153_e003672a-9c04-402c-85c0-1ac030580cb3	80803-153	HUMAN PRESCRIPTION DRUG	FYARRO		Sirolimus	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20211206		NDA	NDA213312	Aadi Bioscience	SIROLIMUS	5	mg/mL	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]		N	20241231
80814-0001_a5fc6490-f739-41d2-a638-3aa8916d380c	80814-0001	HUMAN OTC DRUG	Transform 30		Fucus Vesiculosus, Cysteinum, Nicotinamidum, Alpha-Lipoicum Acidum, Antimonium Crudum, Chromium Sulphuricum, Gambogia, Anacardium Orientale, Graphites	LIQUID	ORAL	20210107		UNAPPROVED HOMEOPATHIC		H2 Nutrition	ALPHA LIPOIC ACID; ANTIMONY TRISULFIDE; CHROMIC SULFATE PENTADECAHYDRATE; CYSTEINE; FUCUS VESICULOSUS; GAMBOGE; GRAPHITE; NIACINAMIDE; SEMECARPUS ANACARDIUM JUICE	12; 12; 12; 6; 3; 12; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
80814-0002_74166481-6f28-40cc-a8b1-114958980bf0	80814-0002	HUMAN OTC DRUG	Ultra Slim 30		Fucus Vesiculosus, Cysteinum, Nicotinamidum, Alpha-Lipoicum Acidum, Antimonium Crudum, Chromium Sulphuricum, Gambogia, Anacardium Orientale, Graphites	LIQUID	ORAL	20210106		UNAPPROVED HOMEOPATHIC		H2 Nutrition	ALPHA LIPOIC ACID; ANTIMONY TRISULFIDE; CHROMIC SULFATE PENTADECAHYDRATE; CYSTEINE; FUCUS VESICULOSUS; GAMBOGE; GRAPHITE; NIACINAMIDE; SEMECARPUS ANACARDIUM JUICE	12; 12; 12; 6; 3; 12; 30; 6; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL			N	20241231
80818-245_09e242d5-3c75-e0b7-e063-6394a90a5dc3	80818-245	HUMAN OTC DRUG	CANAFARMA Spot On Acne Treatment Cleanser		SALICYLIC ACID	CREAM	TOPICAL	20201001		OTC MONOGRAPH DRUG	M006	Canafarma Corp.	SALICYLIC ACID	10	mg/mL			N	20241231
80818-246_09e2208a-9184-e219-e063-6394a90a7f63	80818-246	HUMAN OTC DRUG	CANAFARMA Spot On Acne Treatment		SALICYLIC ACID	CREAM	TOPICAL	20201001		OTC MONOGRAPH DRUG	M006	Canafarma Corp.	SALICYLIC ACID	20	mg/mL			N	20241231
80823-693_bd9a851c-1c0e-75cc-e053-2995a90a1838	80823-693	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20200501		OTC MONOGRAPH NOT FINAL	part333A	Kandel & Son	ALCOHOL	67	mL/100mL			N	20241231
80830-1691_5696e7b6-5fcf-42a1-9373-1883d6b43c73	80830-1691	HUMAN PRESCRIPTION DRUG	POTASSIUM PHOSPHATES		potassium phosphate, monobasic potassium phosphate, dibasic injection,	SOLUTION, CONCENTRATE	INTRAVENOUS	20231023		ANDA	ANDA216344	Puniska Healthcare Private Limited	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
80830-1692_5696e7b6-5fcf-42a1-9373-1883d6b43c73	80830-1692	HUMAN PRESCRIPTION DRUG	POTASSIUM PHOSPHATES		potassium phosphate, monobasic potassium phosphate, dibasic injection,	SOLUTION, CONCENTRATE	INTRAVENOUS	20231023		ANDA	ANDA216344	Puniska Healthcare Private Limited	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
80830-1693_5696e7b6-5fcf-42a1-9373-1883d6b43c73	80830-1693	HUMAN PRESCRIPTION DRUG	POTASSIUM PHOSPHATES		potassium phosphate, monobasic potassium phosphate, dibasic injection,	SOLUTION, CONCENTRATE	INTRAVENOUS	20231023		ANDA	ANDA216344	Puniska Healthcare Private Limited	POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC	236; 224	mg/mL; mg/mL	Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]		N	20241231
80830-2329_6630b7f1-b7bc-4d15-87b2-41fea937e84b	80830-2329	HUMAN PRESCRIPTION DRUG	TRANEXAMIC ACID IN SODIUM CHLORIDE		tranexamic acid	INJECTION, SOLUTION	INTRAVENOUS	20231023		ANDA	ANDA217155	Puniska Healthcare Private Limited	TRANEXAMIC ACID	10	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
80830-2362_448385c8-2014-4771-a67f-0f0cb081271d	80830-2362	HUMAN PRESCRIPTION DRUG	CALCIUM GLUCONATE		calcium gluconate	INJECTION, SOLUTION	INTRAVENOUS	20230908		ANDA	ANDA217174	Puniska Healthcare Private Limited	CALCIUM GLUCONATE MONOHYDRATE	20	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
80830-2363_448385c8-2014-4771-a67f-0f0cb081271d	80830-2363	HUMAN PRESCRIPTION DRUG	CALCIUM GLUCONATE		calcium gluconate	INJECTION, SOLUTION	INTRAVENOUS	20230908		ANDA	ANDA217174	Puniska Healthcare Private Limited	CALCIUM GLUCONATE MONOHYDRATE	20	mg/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
80830-2465_40c54190-5216-46f7-9df3-15bbd6906e67	80830-2465	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	INJECTION, SOLUTION	INTRAVENOUS	20230617		ANDA	ANDA217665	Puniska Healthcare Private Limited	METRONIDAZOLE	500	mg/100mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
80841-100_08e9c424-06dd-3994-e063-6394a90ad43a	80841-100	HUMAN OTC DRUG	Anna Guanche MD Miracle Cream The Pimple Cream		Sulfur	CREAM	TOPICAL	20201117		OTC MONOGRAPH DRUG	M006	Bella Cosmeceuticals, Inc.	SULFUR	100	mg/mL			N	20241231
80851-403_0d911a60-b06b-5874-e063-6394a90a56b8	80851-403	HUMAN OTC DRUG	DROXYD 3.98		Chitosan	LIQUID	TOPICAL	20231112		UNAPPROVED DRUG OTHER		Oxytical	CHITOSAN MEDIUM MOLECULAR WEIGHT (200-400 MPA.S)	99.99	mg/100mL			N	20241231
80855-201_c2135cbf-cc9c-4668-bf6b-c8204212c937	80855-201	HUMAN OTC DRUG	Minoxidil	(for Women)	Minoxidil	AEROSOL, FOAM	TOPICAL	20201223		ANDA	ANDA209074	Virtue Labs, LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
80856-001_0872bf07-a697-d653-e063-6394a90a3f2d	80856-001	HUMAN OTC DRUG	PPE COMPANY CARE Anti-Bacterial Wipes		Alcohol Wipes	CLOTH	TOPICAL	20201022		OTC MONOGRAPH DRUG	505G(a)(3)	PPE COMPANY CARE LTD	ALCOHOL	75	mL/100mL			N	20241231
80861-001_0d8084cc-c191-6108-e063-6394a90adf9a	80861-001	HUMAN OTC DRUG	Acne Clearing Sulfur Mask		SULFUR	CREAM	TOPICAL	20171201		OTC MONOGRAPH DRUG	M006	AcneFree, LLC	SULFUR	35	mg/g			N	20241231
80861-002_0d804a3e-9558-3ca8-e063-6394a90a2668	80861-002	HUMAN OTC DRUG	Terminator 10		BENZOYL PEROXIDE	CREAM	TOPICAL	20171226		OTC MONOGRAPH DRUG	M006	AcneFree, LLC	BENZOYL PEROXIDE	100	mg/mL			N	20241231
80861-003_0d802eba-7562-f2d8-e063-6394a90ad4ba	80861-003	HUMAN OTC DRUG	Oil Free Deep Cleansing Duo Cleansing Brush Oil Free Acne Cleanser		BENZOYL PEROXIDE	KIT		20170816		OTC MONOGRAPH DRUG	M006	AcneFree, LLC						N	20241231
80861-006_0d805ace-ef8b-4bf9-e063-6394a90a56b8	80861-006	HUMAN OTC DRUG	Acne Free Free 24 HR Acne Clearing System		BENZOYL PEROXIDE	KIT		20171201		OTC MONOGRAPH DRUG	M006	AcneFree, LLC						N	20241231
80861-007_0d8026ea-575e-f19d-e063-6394a90a1c42	80861-007	HUMAN OTC DRUG	Acne Free SENSITIVE SKIN 24 HR Acne Clearing System		SALICYLIC ACID, BENZOYL PEROXIDE	KIT		20171201		OTC MONOGRAPH DRUG	M006	AcneFree LLC						N	20241231
80861-010_0d8097f5-9743-123c-e063-6394a90aedd1	80861-010	HUMAN OTC DRUG	Acne Free SEVERE ACNE 24 HR Acne Clearing System		BENZOYL PEROXIDE	KIT		20171201		OTC MONOGRAPH DRUG	M006	AcneFree, LLC						N	20241231
80861-012_0d805053-05f4-f7dc-e063-6394a90a8c40	80861-012	HUMAN OTC DRUG	Acne Free BLACKHEAD REMOVING SCRUB 2 Salicylic Acid with Charcoal		SALICYLIC ACID	GEL	TOPICAL	20180731		OTC MONOGRAPH DRUG	M006	AcneFree LLC	SALICYLIC ACID	20	mg/mL			N	20241231
80861-013_0d8026ea-56ed-f19d-e063-6394a90a1c42	80861-013	HUMAN OTC DRUG	Acne Free Oil Free Acne Cleanser 2.5 Benzoyl Peroxide		BENZOYL PEROXIDE	LIQUID	TOPICAL	20171201		OTC MONOGRAPH DRUG	M006	AcneFree LLC	BENZOYL PEROXIDE	25	mg/mL			N	20241231
80861-111_f8fe4fff-e840-36b8-e053-6394a90aa932	80861-111	HUMAN OTC DRUG	Spot On Acne Patch		salicylic acid	PATCH	TOPICAL	20230424		OTC MONOGRAPH FINAL	M006	ACNEFREE, LLC	SALICYLIC ACID	1.24	g/1			N	20241231
80861-112_fe2d0e24-8c69-b2ea-e053-6294a90ad72c	80861-112	HUMAN OTC DRUG	Benzoyl Peroxide Deep Cleansing Foaming Wash		Benzoyl Peroxide	CREAM	TOPICAL	20230621		OTC MONOGRAPH FINAL	M006	AcneFree, LLC	BENZOYL PEROXIDE	.1	g/g			N	20241231
80861-113_feb82a3d-cda4-c62a-e053-6394a90ad9bb	80861-113	HUMAN OTC DRUG	Sulfur Acne Foaming Cleanser		Sulfur	CREAM	TOPICAL	20230622		OTC MONOGRAPH FINAL	M006	Acne Free, LLC	SULFUR	.001	g/g			N	20241231
80861-114_0ce4684a-4734-e669-e063-6394a90a58c1	80861-114	HUMAN OTC DRUG	Adapalene Gel		Adaplaene	GEL	TOPICAL	20231220		ANDA	ANDA091314	Acne Free LLC	ADAPALENE	.00036	g/g	Retinoid [EPC], Retinoids [CS]		N	20251231
80861-115_0dc574e0-397b-7bc8-e063-6394a90a27e2	80861-115	HUMAN OTC DRUG	Adapalene		Adaplane 0.1%	GEL	TOPICAL	20240105		ANDA	ANDA091314	Acne Free, LLC	ADAPALENE	.1	g/g	Retinoid [EPC], Retinoids [CS]		N	20251231
80873-100_3e4d9974-42f9-4ecf-bfc8-97edd048ea1e	80873-100	HUMAN OTC DRUG	SKIN REJUVENATING DAILY MOISTURIZER BROAD SPECTRUM SPF 30 SUNSCREEN		OCTINOXATE and ZINC OXIDE	CREAM	TOPICAL	20201030		OTC MONOGRAPH NOT FINAL	part352	Dermaset, Inc.	OCTINOXATE; ZINC OXIDE	75; 100	mg/g; mg/g			N	20241231
80883-097_0975eb87-fad5-1621-e063-6394a90a9880	80883-097	HUMAN OTC DRUG	SCALAR Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20201015		OTC MONOGRAPH DRUG	M015	Miracle Balance, LLC	MENTHOL	50	mg/mL			N	20241231
80884-2020_f038fd91-a1fe-05d8-e053-2995a90ac39a	80884-2020	HUMAN OTC DRUG	Lets Go Clean, LLC		ALCOHOL	LIQUID	TOPICAL	20201122		OTC MONOGRAPH NOT FINAL	part333A	Lets go clean, LLC	ALCOHOL	80	mL/100mL			N	20241231
80897-001_f1f0d8fe-4b65-0079-e053-2a95a90af579	80897-001	HUMAN OTC DRUG	Athomer Propolis		Nasal decongestant	SPRAY	NASAL	20200330		UNAPPROVED DRUG OTHER		Nobu Baby LLC	SODIUM CHLORIDE	.9	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
80897-002_f1f0dfad-8398-0bee-e053-2a95a90a3202	80897-002	HUMAN OTC DRUG	Athomer Baby		Nasal decongestant	SPRAY	NASAL	20201105		UNAPPROVED DRUG OTHER		Nobu Baby LLC	SODIUM CHLORIDE	.9	mg/100mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
80897-030_f1f0be1e-39c3-a6d4-e053-2a95a90af0b6	80897-030	HUMAN OTC DRUG	Incarvexx Essential		Sodium Chloride, Iodine	SPRAY	NASAL	20210622		UNAPPROVED DRUG OTHER		Nobu Baby LLC	IODINE; SODIUM CHLORIDE	20; 9	ug/mL; mg/mL			N	20241231
80928-201_f5e1afaa-5850-7279-e053-2995a90a5f8c	80928-201	HUMAN OTC DRUG	O2safe		CHLORITE ION	LIQUID	TOPICAL	20201031		UNAPPROVED DRUG OTHER		O2NS	CHLORITE ION	.1	g/100mL			N	20241231
80937-222_06c0b025-77ee-b446-e063-6394a90a68a1	80937-222	HUMAN OTC DRUG	Dena-Vie First Aid Antiseptic		Isopropyl alcohol	SPRAY	TOPICAL	20201110		OTC MONOGRAPH NOT FINAL	part333A	Dena Brands Usa Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
80948-002_0c6a2e89-2ce7-b52d-e063-6294a90a8659	80948-002	HUMAN OTC DRUG	PUROMA		ALCOHOL	GEL	TOPICAL	20201220		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	ALCOHOL	70	mL/100mL			N	20241231
80948-003_0c6a56f2-31ff-f4b8-e063-6394a90a788f	80948-003	HUMAN OTC DRUG	PUROMA Hand sanitizer		ALCOHOL	LIQUID	TOPICAL	20201220		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	ALCOHOL	75	mL/100mL			N	20241231
80948-004_0c6a614e-eecc-fe41-e063-6394a90a7a35	80948-004	HUMAN OTC DRUG	PUROMA Alcohol Hand Sanitizer Wipes Fragrance Free		Alcohol	CLOTH	TOPICAL	20210301		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	ALCOHOL	75	mL/100mL			N	20241231
80948-005_0c6aae41-e022-e1dc-e063-6294a90abafc	80948-005	HUMAN OTC DRUG	PUROMA Antibacterial Foaming Hand Wash FRAGRANCE FREE		Benzalkonium chloride	LIQUID	TOPICAL	20210310		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-006_0c774d61-cc66-dc9f-e063-6394a90a6258	80948-006	HUMAN OTC DRUG	PUROMA Antibacterial Hand Wash Fragrance Free		Benzalkonium chloride	LIQUID	TOPICAL	20210305		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-007_0c779a5b-075a-0e40-e063-6294a90a52c7	80948-007	HUMAN OTC DRUG	PUROMA Foaming Hand Alcohol Free Fragrance Free		Benzalkonium chloride	LIQUID	TOPICAL	20210310		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-009_0c778bde-ae9b-f219-e063-6394a90a24ed	80948-009	HUMAN OTC DRUG	PUROMA Hand Sanitizer Fragrance Free		Alcohol	LIQUID	TOPICAL	20210311		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	ALCOHOL	70	mL/100mL			N	20241231
80948-010_0c779961-2494-1090-e063-6294a90a0ff7	80948-010	HUMAN OTC DRUG	PUROMA Hand Sanitizer Fragrance Free		Alcohol	LIQUID	TOPICAL	20210312		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	ALCOHOL	75	mL/100mL			N	20241231
80948-011_0c783860-aac0-1b67-e063-6394a90ae93b	80948-011	HUMAN OTC DRUG	PUROMA Hand Sanitizer Wipe Alcohol Free		Benzalkonium chloride	CLOTH	TOPICAL	20210312		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-012_0c781d97-bc97-2ab9-e063-6394a90a9aa8	80948-012	HUMAN OTC DRUG	PUROMA Instant Foaming Hand Sanitizer without Fragrance		Alcohol	LIQUID	TOPICAL	20210310		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	ALCOHOL	75	mL/100mL			N	20241231
80948-014_0c783860-aac1-1b67-e063-6394a90ae93b	80948-014	HUMAN OTC DRUG	PUROMA Antibacterial Foaming Hand Wash With Fragrance alcohol Free citrus floral		Benzalkonium chloride	LIQUID	TOPICAL	20210423		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-015_0c781cb2-d8ce-562d-e063-6294a90af95d	80948-015	HUMAN OTC DRUG	PUROMA Antibacterial Hand Wash with Fragrance Lavender rose		Benzalkonium chloride	LIQUID	TOPICAL	20210305		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-016_0c78626d-2b61-2aaa-e063-6394a90a091e	80948-016	HUMAN OTC DRUG	PUROMA Foaming Hand Sanitizer Alcohol Free With Fragrance Floral		Benzalkonium chloride	LIQUID	TOPICAL	20210427		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-017_0d81120b-f334-bcde-e063-6294a90a70b7	80948-017	HUMAN OTC DRUG	PUROMA Hand Sanitizer Wipe Alcohol Free with Fragrance		Benzalkonium chloride	LIQUID	TOPICAL	20210305		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	BENZALKONIUM CHLORIDE	130	mg/100mL			N	20241231
80948-018_0c78d401-5e40-4dad-e063-6394a90ab5d1	80948-018	HUMAN OTC DRUG	PUROMA Instant Foaming Hand Sanitizer with Fragrance citrus floral		Alcohol	LIQUID	TOPICAL	20210427		OTC MONOGRAPH DRUG	M003	ZENITH MICRO CONTROL	ALCOHOL	75	mL/100mL			N	20241231
80949-001_74d7bc30-db15-4cfc-8918-40897d54da70	80949-001	HUMAN OTC DRUG	Advanced Formula Lip Balm SPF 25		Avobenzone, Octinoxate	CREAM	TOPICAL	20200105		OTC MONOGRAPH NOT FINAL	part352	Anthony Skin LLC	AVOBENZONE; OCTINOXATE	3; 7.5	g/100g; g/100g			N	20241231
80949-002_74853b40-a773-4488-98a9-c8029ad21134	80949-002	HUMAN OTC DRUG	Advanced Formula Lip Balm SPF 25	Blood Orange	Avobenzone, Octinoxate	CREAM	TOPICAL	20200105		OTC MONOGRAPH NOT FINAL	part352	Anthony Skin LLC	AVOBENZONE; OCTINOXATE	3; 7.5	g/100g; g/100g			N	20241231
80953-894_c737fae6-1b01-4506-a6a1-fe75697132c2	80953-894	HUMAN OTC DRUG	AQUALABS ANTISEPTIC HAND SANITIZER		Ethyl Alcohol	GEL	TOPICAL	20201126		OTC MONOGRAPH NOT FINAL	part333A	Aquatonale FZC	ALCOHOL	72	mL/100mL			N	20241231
80954-000_09c2d3bb-e838-3015-e063-6394a90aff27	80954-000	HUMAN OTC DRUG	Votivo Red Currant Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200820		OTC MONOGRAPH DRUG	505G(a)(3)	Votivo, LLC	ALCOHOL	.65	mL/mL			N	20241231
80958-001_f48f9f3a-2160-1b81-e053-2a95a90a12bd	80958-001	HUMAN OTC DRUG	Sweet skin Hand sanitizer		Benzalkonium Chloride	GEL	TOPICAL	20201020		OTC MONOGRAPH NOT FINAL	part333A	Sweet Skin Etc. Llc	BENZALKONIUM CHLORIDE	1	g/L			N	20241231
80969-006_f321a5ba-6e3d-cfbb-e053-2995a90a26e0	80969-006	HUMAN OTC DRUG	PFA STRONGHOLD SANITIZING HANDLOTION MINT		Alcohol	LOTION	TOPICAL	20211126		UNAPPROVED DRUG OTHER		STRONGHOLD TRADING LLC	ALCOHOL	62	mL/100mL			N	20241231
80969-007_f321f8f3-8625-147a-e053-2995a90a9b59	80969-007	HUMAN OTC DRUG	PFA STRONGHOLD SANITIZING HANDLOTION SHEA BUTTER		Alcohol	LOTION	TOPICAL	20211126		UNAPPROVED DRUG OTHER		STRONGHOLD TRADING LLC	ALCOHOL	62	mL/100mL			N	20241231
80969-008_f321f8f3-8623-147a-e053-2995a90a9b59	80969-008	HUMAN OTC DRUG	PFA STRONGHOLD SANITIZING HANDLOTION ROSE		Alcohol	LOTION	TOPICAL	20230126		UNAPPROVED DRUG OTHER		STRONGHOLD TRADING LLC	ALCOHOL	62	mL/100mL			N	20241231
80971-102_0152af37-33c9-8de5-e063-6294a90a9e1e	80971-102	HUMAN OTC DRUG	Protect Prevent Daily Mineral Sunscreen Broad Spectrum SPF30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Norwex Usa, Inc.	TITANIUM DIOXIDE; ZINC OXIDE	28.8; 68	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
80975-001_b9c21d5f-ef3c-1ab8-e053-2a95a90a99b9	80975-001	HUMAN OTC DRUG	Shamrock Sun SPF50	Sunscreen	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20210125		OTC MONOGRAPH FINAL	part352	Shamrock Sun, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
80976-100_0ab24e0a-9238-4e37-99b5-942b6f2fd408	80976-100	HUMAN OTC DRUG	WIPES4HEALTH		Benzalkonium Chloride	CLOTH	TOPICAL	20201104		OTC MONOGRAPH NOT FINAL	part333A	Bubble Marketing Llc	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
80976-101_755c433c-c038-4f33-a191-c8314bc554fb	80976-101	HUMAN OTC DRUG	Club Wipes USA Sanitizing Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20201203		OTC MONOGRAPH NOT FINAL	part333A	Bubble Marketing Llc	BENZALKONIUM CHLORIDE	.12	g/100mL			N	20241231
80976-102_1063929e-7aa6-4cb9-83f4-24b5999a4730	80976-102	HUMAN OTC DRUG	CLUB WIPES USA SANITIZING WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20220930		OTC MONOGRAPH DRUG	505G(a)(3)	Bubble Marketing LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
80978-111_e3f85a13-f3cd-43aa-bdf4-7d088b1ea406	80978-111	HUMAN PRESCRIPTION DRUG	NELARABINE		nelarabine injection	INJECTION	INTRAVENOUS	20230412		ANDA	ANDA214809	AqVida GmbH	NELARABINE	250	mg/50mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
80985-302_f56f16ab-cb9c-08a8-e053-2a95a90a4086	80985-302	HUMAN OTC DRUG	J farm citrus Inner Serum plus		GLYCERIN, ALLANTOIN	INJECTION	TOPICAL	20201110		OTC MONOGRAPH FINAL	part347	Eco on	ALLANTOIN; GLYCERIN	.5; 10	g/100mL; mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
80986-101_06c30174-fe07-5232-e063-6394a90a2da1	80986-101	HUMAN OTC DRUG	Topical Analgesic		Menthol	CREAM	TOPICAL	20200630		OTC MONOGRAPH NOT FINAL	part348	Youngevity International Inc.	MENTHOL	1.4	g/100g			N	20241231
81005-104_0db0e6cd-e711-d259-e063-6394a90a8775	81005-104	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20230906		ANDA	ANDA217197	Aarkish Pharmaceuticals NJ Inc.	ACETAZOLAMIDE	125	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
81005-105_0db0e6cd-e711-d259-e063-6394a90a8775	81005-105	HUMAN PRESCRIPTION DRUG	Acetazolamide		Acetazolamide	TABLET	ORAL	20230906		ANDA	ANDA217197	Aarkish Pharmaceuticals NJ Inc.	ACETAZOLAMIDE	250	mg/1	Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]		N	20241231
81005-123_0c7f12d6-6532-87b3-e063-6394a90abd35	81005-123	HUMAN PRESCRIPTION DRUG	BUTALBITAL AND ACETAMINOPHEN		butalbital and acetaminophen	TABLET	ORAL	20230821		ANDA	ANDA214955	Aarkish Pharmaceuticals NJ Inc.	ACETAMINOPHEN; BUTALBITAL	300; 50	mg/1; mg/1	Barbiturate [EPC], Barbiturates [CS]	CIII	N	20241231
81005-124_0c7f0538-050e-81f2-e063-6394a90adf57	81005-124	HUMAN PRESCRIPTION DRUG	METOLAZONE		metolazone	TABLET	ORAL	20230815		ANDA	ANDA216216	Aarkish Pharmaceuticals NJ Inc.	METOLAZONE	2.5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
81005-125_0c7f0538-050e-81f2-e063-6394a90adf57	81005-125	HUMAN PRESCRIPTION DRUG	METOLAZONE		metolazone	TABLET	ORAL	20230815		ANDA	ANDA216216	Aarkish Pharmaceuticals NJ Inc.	METOLAZONE	5	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
81005-126_0c7f0538-050e-81f2-e063-6394a90adf57	81005-126	HUMAN PRESCRIPTION DRUG	METOLAZONE		metolazone	TABLET	ORAL	20230815		ANDA	ANDA216216	Aarkish Pharmaceuticals NJ Inc.	METOLAZONE	10	mg/1	Increased Diuresis [PE], Thiazide-like Diuretic [EPC]		N	20241231
81013-101_f1f406b0-c983-63ab-e053-2a95a90ad8c3	81013-101	HUMAN OTC DRUG	Aspire Daytime Mucus and Sinus Softgel		Aspire Daytime Mucus and Sinus Softgel	CAPSULE, LIQUID FILLED	ORAL	20210317		OTC MONOGRAPH FINAL	part341	Aspire Pharmaceuticals Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 200; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81013-102_f1f406b0-c983-63ab-e053-2a95a90ad8c3	81013-102	HUMAN OTC DRUG	Aspire Night Cold and Flu Softgel		Aspire Night Cold and Flu Softgel	CAPSULE, LIQUID FILLED	ORAL	20210317		OTC MONOGRAPH FINAL	part341	Aspire Pharmaceuticals Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 6.25; 5	mg/1; mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81013-103_f1f406b0-c983-63ab-e053-2a95a90ad8c3	81013-103	HUMAN OTC DRUG	Aspire Day Congestion and Headache Softgel		Aspire Day Congestion and Headache Softgel	CAPSULE, LIQUID FILLED	ORAL	20210317		OTC MONOGRAPH FINAL	part341	Aspire Pharmaceuticals Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81013-104_f43a9389-c644-ce49-e053-2a95a90a537f	81013-104	HUMAN OTC DRUG	Aspire Congestion and Cough Relief DM Softgels		Aspire Congestion and Cough Relief DM Softgels	CAPSULE, LIQUID FILLED	ORAL	20220414		OTC MONOGRAPH FINAL	part341	Aspire Pharmaceuticals Inc	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	10; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81013-105_f43ab341-0829-b18c-e053-2995a90ac22b	81013-105	HUMAN OTC DRUG	Aspire Mucus and Pain Relief Softgels		Aspire Mucus and Pain Relief Softgels	CAPSULE, LIQUID FILLED	ORAL	20220414		OTC MONOGRAPH FINAL	part341	Aspire Pharmaceuticals Inc.	ACETAMINOPHEN; GUAIFENESIN	325; 200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
81016-0002_f3b0adf6-4937-5ee6-e053-2995a90a7b85	81016-0002	HUMAN OTC DRUG	IONIC		mineral	LIQUID	TOPICAL	20201109		UNAPPROVED DRUG OTHER		AML Bio Co., Ltd.	MINERAL OIL	100	g/100mL			N	20241231
81016-0003_f3b0b1f2-f0a3-7486-e053-2995a90ae074	81016-0003	HUMAN OTC DRUG	THE GRID		mineral	LIQUID	TOPICAL	20210411		UNAPPROVED DRUG OTHER		AML Bio Co., Ltd.	MINERAL OIL	100	g/100mL			N	20241231
81030-020_f1ee334a-b0f2-c58a-e053-2995a90a0ab5	81030-020	HUMAN OTC DRUG	Purizee Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Grupo Empresarial Jn, S.A. de C.V.	ALCOHOL	80	mL/100mL			N	20241231
81033-002_ca98e7ea-ec14-4f6b-bdca-9e03f005b507	81033-002	HUMAN OTC DRUG	Acetaminophen		Acetaminophen	SOLUTION	ORAL	20210630		OTC MONOGRAPH NOT FINAL	part343	Kesin Pharma Corporation	ACETAMINOPHEN	160	mg/5mL			N	20241231
81033-003_2434b630-ca13-42c9-8b41-37ed0868e4dd	81033-003	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	LIQUID	ORAL	20210916		OTC MONOGRAPH FINAL	part341	Kesin Pharma Corporation	DIPHENHYDRAMINE HYDROCHLORIDE	2.5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81033-025_f8673fbf-62e2-47bc-9c94-2b522bf5b60b	81033-025	HUMAN PRESCRIPTION DRUG	LIDOCAINE AND PRILOCAINE		Lidocaine and Prilocaine	CREAM	TOPICAL	20230415		ANDA	ANDA212482	Kesin Pharma Corporation	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
81033-066_ac096066-a1e5-460c-9044-5af66399e678	81033-066	HUMAN PRESCRIPTION DRUG	LIKMEZ		Metronidazole Oral	SUSPENSION	ORAL	20231013		NDA	NDA216755	Kesin Pharma Corporation	METRONIDAZOLE	100	mg/mL	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
81033-102_54c00cdd-5f4a-4e45-8fd3-18c42ad9e8ec	81033-102	HUMAN OTC DRUG	Guaifenesin		Guaifenesin	LIQUID	ORAL	20231120		OTC MONOGRAPH DRUG	M012	KESIN PHARMA CORPORATION	GUAIFENESIN	100	mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
81033-213_06a6a831-218c-4c29-a43b-2afafc16e560	81033-213	HUMAN OTC DRUG	Dextromethorphan HBr and Guaifenesin		Dextromethorphan HBr and Guaifenesin	LIQUID	ORAL	20231115		OTC MONOGRAPH DRUG	M012	KESIN PHARMA CORPORATION	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81033-220_77b74507-6eb1-4105-8f19-3c549b478395	81033-220	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20220815		ANDA	ANDA211648	Kesin Pharma Corporation	POTASSIUM CHLORIDE	1.5	g/15mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
81033-240_77b74507-6eb1-4105-8f19-3c549b478395	81033-240	HUMAN PRESCRIPTION DRUG	POTASSIUM CHLORIDE		POTASSIUM CHLORIDE	SOLUTION	ORAL	20220815		ANDA	ANDA211648	Kesin Pharma Corporation	POTASSIUM CHLORIDE	3	g/30mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
81033-512_d799ecc8-299b-4b25-9000-887721b73ae2	81033-512	HUMAN PRESCRIPTION DRUG	Chlorhexidine Gluconate, 0.12% Oral Rinse Solution		Chlorhexidine Gluconate, 0.12% Oral Rinse	SOLUTION	DENTAL	20230815		ANDA	ANDA075561	Kesin Pharma Corporation	CHLORHEXIDINE GLUCONATE	1.2	mg/mL	Decreased Cell Wall Integrity [PE]		N	20241231
81034-103_0976085c-9bba-3792-e063-6394a90a58c5	81034-103	HUMAN OTC DRUG	RadiaGuard Advanced Radiation Relief		LIDOCAINE HYDROCHLORIDE	LOTION	TOPICAL	20201001		OTC MONOGRAPH DRUG	M017	SMOOTH SIDE, INC	LIDOCAINE HYDROCHLORIDE	10	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81040-822_d32a6da7-3f7d-46bd-9184-55a80f9b4471	81040-822	HUMAN OTC DRUG	HANSAN HAND SANITIZING Gel		Isopropyl Alcohol	GEL	TOPICAL	20201201	20240930	OTC MONOGRAPH NOT FINAL	part333A	HanSan LLC	ISOPROPYL ALCOHOL	72	mL/100mL			N	
81046-0111_7f8f2bce-c1ab-4009-a939-57748bc81e68	81046-0111	HUMAN PRESCRIPTION DRUG	MYDCOMBI		Tropicamide and Phenylephrine Hydrochloride	SPRAY, METERED	OPHTHALMIC	20230509		NDA	NDA215352	Eyenovia, Inc.	PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE	.2; .08	mg/.008mL; mg/.008mL	Adrenergic alpha1-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81050-108_09e2208a-9193-e219-e063-6394a90a7f63	81050-108	HUMAN OTC DRUG	KINETIC ICE Muscle and Joint Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20201110		OTC MONOGRAPH DRUG	M017	No Reason, LLC	MENTHOL	100	mg/mL			N	20241231
81052-138_003bb9a7-50aa-5483-e063-6294a90a9620	81052-138	HUMAN PRESCRIPTION DRUG	Cytalux		Pafolacianine injection	INJECTION	INTRAVENOUS	20211129		NDA	NDA214907	On Target Laboratories, Inc.	PAFOLACIANINE SODIUM	3.2	mg/1.6mL	Fluorescence Contrast Activity [MoA], Optical Imaging Agent [EPC]		N	20241231
81072-001_d9b6a68e-1896-4967-9c36-58f228bf286a	81072-001	HUMAN OTC DRUG	Nurture ANTISEPTIC WIPES		Benzalkonium chloride	CLOTH	TOPICAL	20201113		OTC MONOGRAPH NOT FINAL	part333A	Devon Products, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
81073-000_09c2ffcf-4b01-c8a6-e063-6294a90a27ce	81073-000	HUMAN OTC DRUG	Sweet Grace Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20200820		OTC MONOGRAPH DRUG	505G(a)(3)	Bridgewater Candle Company LLC	ALCOHOL	.65	mL/mL			N	20241231
81077-010_5992e67f-12df-42a8-b427-35cc6828e373	81077-010	HUMAN OTC DRUG	SOLEP PREMIER HI GRO		Panthenol, Zinc Pyrithione, Salicylic Acid	SHAMPOO	TOPICAL	20201101		UNAPPROVED DRUG OTHER		Kobizstar Co., Ltd.	PANTHENOL; PYRITHIONE ZINC; SALICYLIC ACID	1.5; .9; .6	g/300mL; g/300mL; g/300mL			N	20241231
81077-020_af3b1396-8a36-464a-ba7c-949fe85d35b1	81077-020	HUMAN OTC DRUG	SOLEP PREMIER HI GRO TONIC		Menthol, Panthenol, Salicylic Acid	SPRAY	TOPICAL	20201101		UNAPPROVED DRUG OTHER		Kobizstar Co., Ltd.	MENTHOL; PANTHENOL; SALICYLIC ACID	.29; .22; .25	g/100mL; g/100mL; g/100mL			N	20241231
81077-030_5d6f5f27-8b9a-4a20-8cb3-a934f005a397	81077-030	HUMAN OTC DRUG	SOLEP PREMIER HI GRO AMPOULE PACK		Panthenol, Menthol, Salicylic Acid	LIQUID	TOPICAL	20201101		UNAPPROVED DRUG OTHER		Kobizstar Co., Ltd.	MENTHOL; PANTHENOL; SALICYLIC ACID	.11; .2; .1	g/40mL; g/40mL; g/40mL			N	20241231
81079-001_0ab848b7-668f-4af1-e063-6294a90a5fc4	81079-001	HUMAN OTC DRUG	Antibacterial Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20201115		OTC MONOGRAPH DRUG	505G(a)(3)	SHAOXING ELITE BIO-TECH CO.,LTD.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
81079-002_0ab86da8-eb13-46d1-e063-6294a90a4fe7	81079-002	HUMAN OTC DRUG	Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20201116		OTC MONOGRAPH DRUG	505G(a)(3)	Shaoxing Elite Bio-Tech Co.,Ltd.	ALCOHOL	.75	mL/mL			N	20241231
81085-0001_0b73e9ec-877d-4a33-9a4e-ebb16fb1e218	81085-0001	HUMAN OTC DRUG	Curaplex Alcohol Prep Pad		Isopropyl Alcohol	SWAB	TOPICAL	20170913		OTC MONOGRAPH NOT FINAL	part333A	Sarnova Inc	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
81085-0002_6d188825-eca9-4890-8281-c23ea22b3e4c	81085-0002	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	CLOTH	TOPICAL	20220405		OTC MONOGRAPH NOT FINAL	part333E	Sarnova, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
81091-000_f5648315-798d-0efe-e053-2995a90a1400	81091-000	HUMAN OTC DRUG	Kate Aspen Spread Love Not Germs Hand Sanitizer Woodland 75 Ethyl Alcohol		ALCOHOL	GEL	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part333E	Kate Aspen, Inc.	ALCOHOL	.75	mL/mL			N	20241231
81091-001_f5649216-0de0-db6e-e053-2a95a90a606b	81091-001	HUMAN OTC DRUG	Kate Aspen Spread Love Not Germs Hand Sanitizer Burgundy Blush Floral 75 Ethyl Alcohol		ALCOHOL	GEL	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part333E	Kate Aspen, Inc.	ALCOHOL	.75	mL/mL			N	20241231
81091-003_f5649a68-b616-b69a-e053-2a95a90ad575	81091-003	HUMAN OTC DRUG	Kate Aspen Spread Love Not Germs Hand Sanitizer 75 Ethyl Alcohol		ALCOHOL	GEL	TOPICAL	20201016		OTC MONOGRAPH NOT FINAL	part333E	Kate Aspen, Inc.	ALCOHOL	.75	mL/mL			N	20241231
81092-1120_2feb689e-7fb4-4865-b6e5-1b5193de2fba	81092-1120	HUMAN PRESCRIPTION DRUG	IGALMI		DEXMEDETOMIDINE	FILM	SUBLINGUAL	20220701		NDA	NDA215390	BioXcel Therapeutics, Inc.	DEXMEDETOMIDINE	120	ug/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
81092-1180_2feb689e-7fb4-4865-b6e5-1b5193de2fba	81092-1180	HUMAN PRESCRIPTION DRUG	IGALMI		DEXMEDETOMIDINE	FILM	SUBLINGUAL	20220701		NDA	NDA215390	BioXcel Therapeutics, Inc.	DEXMEDETOMIDINE	180	ug/1	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE]		N	20241231
81101-200_f8b4474f-58fa-a37d-e053-6394a90a992d	81101-200	HUMAN OTC DRUG	Sanetto		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	CERGOMEX IMPORTS LLC	ALCOHOL	70	mL/100mL			N	20241231
81104-002_0ccd7e09-a4f2-5bf9-e063-6394a90a00e8	81104-002	HUMAN OTC DRUG	NAKED SUNDAYS COLLAGEN GLOW 100% MINERAL SUNSCREEN	SPF 50	Zinc Oxide	LIQUID	TOPICAL	20231006		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	ZINC OXIDE	22.75	g/100mL			N	20241231
81104-003_0ce1338a-3745-7975-e063-6294a90a8a40	81104-003	HUMAN OTC DRUG	NAKED SUNDAYS BROAD SPECTRUM SUNSCREEN	SPF 50	Zinc Oxide	CREAM	TOPICAL	20231006		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	ZINC OXIDE	22.75	g/100g			N	20241231
81104-004_0ccf12dd-0c17-d5d0-e063-6394a90ae972	81104-004	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220701		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-102_0cce8fb0-5fca-6274-e063-6294a90a4b08	81104-102	HUMAN OTC DRUG	HYDRATING GLOW MIST	SPF 50	AVOBENZONE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20201201		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-103_0ce1e5fe-fc71-e2c9-e063-6394a90a1705	81104-103	HUMAN OTC DRUG	COLLAGEN GLOW MINERAL SUNSCREEN	SPF 50	ZINC OXIDE	LOTION	TOPICAL	20201201		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	ZINC OXIDE	22.75	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81104-110_0ccf5ed7-0390-e3d5-e063-6294a90ad9db	81104-110	HUMAN OTC DRUG	GLOW BODY MIST	SPF 50	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	4.5; 15; 7.5; 10.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-112_0cb2ba1f-dd4a-9e3c-e063-6394a90af96d	81104-112	HUMAN OTC DRUG	CLEAR GLOW RADIANT SUN SERUM	SPF50	Avobenzone 15mg/g, Homosalate 5mg/g, Octocrylene 25mg/g, (SUNSCREEN)	LOTION	TOPICAL	20220131		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 10; 5	g/100mL; g/100mL; g/100mL			N	20241231
81104-500_0ccdac1a-3506-782b-e063-6394a90a5d38	81104-500	HUMAN OTC DRUG	Naked Sundays Golden Glow Body Sunscreen SPF50 100ml		Naked Sundays Golden Glow Body Sunscreen SPF50 100ml	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-600_0ccf049c-96a3-af91-e063-6294a90a3527	81104-600	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220807		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-700_0ccef9f0-948b-d01d-e063-6394a90a3bc8	81104-700	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220807		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-800_0d48297e-476d-68f6-e063-6394a90ae900	81104-800	HUMAN OTC DRUG	Glow Go Lip Oil		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20220807		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-896_0ce26e9f-39c8-16fa-e063-6294a90ac34a	81104-896	HUMAN OTC DRUG	SPF50 SHEER GLOW BALM CHAMPAGNE 9g		ZINC OXIDE 22.75%	LIPSTICK	TOPICAL	20221222		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	ZINC OXIDE	22.75	g/100g			N	20241231
81104-897_0ce3505c-8e8b-5433-e063-6394a90ae58d	81104-897	HUMAN OTC DRUG	SPF50 SHEER GLOW BALM ESPRESSO MARTINI 9g		ZINC OXIDE 22.75%	LIPSTICK	TOPICAL	20221222		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	ZINC OXIDE	22.75	g/100g			N	20241231
81104-898_0ce302bb-0000-4273-e063-6394a90a5795	81104-898	HUMAN OTC DRUG	SPF50 SHEER GLOW BALM ROSE 9g		ZINC OXIDE 22.75%	LIPSTICK	TOPICAL	20221222		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	ZINC OXIDE	22.75	g/100g			N	20241231
81104-899_0ce361f9-99b4-b4fe-e063-6294a90ab46b	81104-899	HUMAN OTC DRUG	SPF50 SHEER GLOW BALM TRIO		ZINC OXIDE 22.75%	LIPSTICK	TOPICAL	20221226		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	ZINC OXIDE	22.75	g/100g			N	20241231
81104-900_0cb20a34-54fb-15e1-e063-6394a90a376b	81104-900	HUMAN OTC DRUG	ANTIOXIDANT BODY SUNSCREEN CREME SPF50 BROAD SPECTRUM		Avobenzone 30mg/g, Homosalate 100mg/g, Octocrylene 100mg/g, Octisalate 50mg/g,	OIL	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	NAKED SUNDAY PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81104-981_0cf46231-0d81-ea51-e063-6294a90adb85	81104-981	HUMAN OTC DRUG	NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS Sheer Tint 40mL	SPF 50	Titanium Oxide, Zinc Oxide	LIQUID	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 14.9	g/100mL; g/100mL			N	20241231
81104-982_0ce809a1-45fc-9d4d-e063-6294a90a26a2	81104-982	HUMAN OTC DRUG	NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS Blush 40mL	SPF 50	Titanium Oxide, Zinc Oxide	LIQUID	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 14.9	g/100mL; g/100mL			N	20241231
81104-983_0cce5c23-3f0f-9b8d-e063-6394a90a74b2	81104-983	HUMAN OTC DRUG	NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS PEARL 40mL with Pink Algae	SPF 50	Titanium Oxide, Zinc Oxide	LIQUID	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 14.9	g/100mL; g/100mL			N	20241231
81104-984_0ce117c5-2f3b-55bd-e063-6294a90a0afe	81104-984	HUMAN OTC DRUG	CLEAR GLOW BROAD SPECTRUM SUNCREEN	SPF 50	AVOBENZONE, Homosalate OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8	g/100g; g/100g; g/100g; g/100g			N	20241231
81104-985_0ccdc418-7682-7961-e063-6394a90aade5	81104-985	HUMAN OTC DRUG	NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS BRONZE 40mL with wild Rosella	SPF 50	Titanium Oxide, Zinc Oxide	LIQUID	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 14.9	g/100mL; g/100mL			N	20241231
81104-986_0cce2606-9229-9663-e063-6394a90a4806	81104-986	HUMAN OTC DRUG	NAKED SUNDAYS CABANA GLOW MINERAL GLOW SERUM DROPS Illuminating 40mL with Pink Algae	SPF 50	Titanium Oxide, Zinc Oxide	LIQUID	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	NAKED SUNDAYS PTY LTD	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 14.9	g/100mL; g/100mL			N	20241231
81105-001_f22821d1-a344-21a0-e053-2a95a90a483a	81105-001	HUMAN OTC DRUG	Shuddi Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333E	Multiplex Bio-tech Private Limited	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
81105-002_f22821d1-a344-21a0-e053-2a95a90a483a	81105-002	HUMAN OTC DRUG	Arabsabio Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part333E	Multiplex Bio-tech Private Limited	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
81110-049_f655c763-1003-19d3-e053-2995a90a7822	81110-049	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST0.5 SKYE)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-050_f654a6e5-87e1-36e8-e053-2995a90a4292	81110-050	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST2.5 SOMBRIO)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-051_f655c4c0-02f0-3d64-e053-2a95a90a2bb4	81110-051	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST6.5 KAI)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-052_f655b3ad-4c27-587b-e053-2a95a90adf7a	81110-052	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST9.5 BAIKAL)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-053_f655b7ae-6cf1-067f-e053-2a95a90ab4c6	81110-053	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST11.5 MORGAT)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-054_f655aa2f-17f1-51b8-e053-2a95a90ac53e	81110-054	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST12.5 RAMLA BAY)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-055_f655b311-6dbf-66e7-e053-2a95a90aba0f	81110-055	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST12.75 PAPAKOLEA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-056_f655aa72-065e-9d19-e053-2995a90a2079	81110-056	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST13.5 RIALTO)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-057_f65587f2-0d1f-288f-e053-2a95a90a3520	81110-057	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST14.5 HONOPU)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-058_f6558454-52ab-2893-e053-2a95a90a2a37	81110-058	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST16.5 JARDIN)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-059_f655802a-a3aa-ad73-e053-2a95a90a3eb1	81110-059	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST17.5 PERISSA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-060_f6556e35-2e51-1e1d-e053-2995a90a3ff2	81110-060	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST19 LOVINA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-070_f653cbb4-7afe-e55d-e053-2995a90aaec4	81110-070	HUMAN OTC DRUG	C BEYOND TRIPLE SERUM (TONE 1)		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	107	mg/mL			N	20241231
81110-071_f653d6a5-81ee-75fb-e053-2a95a90aa5e3	81110-071	HUMAN OTC DRUG	C BEYOND TRIPLE SERUM (TONE 2)		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	107	mg/mL			N	20241231
81110-072_f653e8ad-7c4c-19fd-e053-2a95a90a9c45	81110-072	HUMAN OTC DRUG	C BEYOND TRIPLE SERUM (TONE 3)		Zinc Oxide	LOTION	TOPICAL	20220316		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	107	mg/mL			N	20241231
81110-691_f654cf91-c07f-17c0-e053-2a95a90abb77	81110-691	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST6 ORA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-750_f654c81e-d0fe-f41e-e053-2a95a90aa0c8	81110-750	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST1 RENDEZVOUS)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-751_f65497d3-dc73-1bed-e053-2a95a90a9e19	81110-751	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST2 TULUM)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-752_f654cf91-c079-17c0-e053-2a95a90abb77	81110-752	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST3 BALOS)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-753_f654cf91-c07c-17c0-e053-2a95a90abb77	81110-753	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST4 FORMOSA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-754_f654d13b-e4a9-074a-e053-2995a90ad776	81110-754	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST5 BOM BOM)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-755_f654bb0d-4871-1b21-e053-2a95a90a2369	81110-755	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST7 DIAZ)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-756_f65497d3-dc74-1bed-e053-2a95a90a9e19	81110-756	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST8 SHELA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-757_f654e7eb-ffc5-73ae-e053-2a95a90a2722	81110-757	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST9 PALOMA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-758_f654f346-d4f2-1e6a-e053-2a95a90aac80	81110-758	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST10 PORTO FERRO)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-759_f654f7b0-3cf2-f75f-e053-2995a90abb85	81110-759	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST11 MATIRA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-760_f654f9eb-0fca-f761-e053-2995a90a8788	81110-760	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST12 KOKKINI)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-761_f6550dcb-09a6-8fc4-e053-2a95a90a0b2d	81110-761	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST13 KAMARI)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-762_f6551756-b265-74c6-e053-2995a90a319f	81110-762	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST14 DOMINICA)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-763_f6550d9a-cb70-9261-e053-2a95a90a8df7	81110-763	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST15 PORTO COVO)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-764_f655143d-eb58-ab5a-e053-2a95a90a11af	81110-764	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST16 PAVONES)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-765_f655d8d8-cc74-713b-e053-2995a90af916	81110-765	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST17 MIHO)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81110-766_f654a6e5-87e2-36e8-e053-2995a90a4292	81110-766	HUMAN OTC DRUG	ILIA SUPER SERUM SKIN TINT (ST18 MALI)		Zinc Oxide	LOTION	TOPICAL	20200120		OTC MONOGRAPH NOT FINAL	part352	Ilia, Inc.	ZINC OXIDE	132	mg/mL			N	20241231
81125-100_d606fa34-e154-45d3-e053-2995a90a8638	81125-100	HUMAN OTC DRUG	FastAction GermaStat		ALCOHOL	LIQUID	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Hygenall Corporation	ALCOHOL	80	mL/100mL			N	20241231
81126-020_a7fbba98-d780-47eb-8e77-fe782ddeeaf2	81126-020	HUMAN OTC DRUG	BOREL ANTISEPTIC HAND SANITIZER		Ethyl alcohol	LIQUID	TOPICAL	20201220		OTC MONOGRAPH NOT FINAL	part333A	Eti Maden Isletmeleri Genel Mudurlugu	ALCOHOL	80	g/100mL			N	20241231
81136-001_09c79224-b825-8a0d-e063-6394a90a36d8	81136-001	HUMAN OTC DRUG	SPF 30 Daily Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20210419		OTC MONOGRAPH DRUG	M020	Brand Evangelists for Beauty Ltd.	ZINC OXIDE	220	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81136-017_09c78b92-8f4d-7c88-e063-6394a90a370c	81136-017	HUMAN OTC DRUG	THE INKEY LIST SUCCINIC ACID ACNE TREATMENT		SALICYLIC ACID	CREAM	TOPICAL	20201201		OTC MONOGRAPH DRUG	M006	Brand Evangelists for Beauty Ltd	SALICYLIC ACID	10	mg/mL			N	20241231
81136-019_09c76e71-2ec7-80a7-e063-6394a90ab5b7	81136-019	HUMAN OTC DRUG	The INKEY List Salicylic Acid Cleanser		SALICYLIC ACID	GEL	TOPICAL	20210520		OTC MONOGRAPH DRUG	M006	Brand Evangelists for Beauty Ltd	SALICYLIC ACID	20	mg/mL			N	20241231
81136-020_09c76e71-2ed8-80a7-e063-6394a90ab5b7	81136-020	HUMAN OTC DRUG	The INKEY List C 50 Serum		SALICYLIC ACID	GEL	TOPICAL	20210520		OTC MONOGRAPH DRUG	M006	Brand Evangelists for Beauty Ltd	SALICYLIC ACID	20	mg/mL			N	20241231
81136-021_09c79224-b838-8a0d-e063-6394a90a36d8	81136-021	HUMAN OTC DRUG	The INKEY List Beta Hydroxy Acid Serum		SALICYLIC ACID	GEL	TOPICAL	20210520		OTC MONOGRAPH DRUG	M006	Brand Evangelists for Beauty Ltd	SALICYLIC ACID	20	mg/mL			N	20241231
81136-023_09c77795-2e82-22c2-e063-6294a90afc96	81136-023	HUMAN OTC DRUG	5 Percent Benzoyl Peroxide Cleanser		BENZOYL PEROXIDE	GEL	TOPICAL	20220824		OTC MONOGRAPH DRUG	M006	Brand Evangelists for Beauty Limited	BENZOYL PEROXIDE	50	mg/mL			N	20241231
81136-024_09c77795-2e92-22c2-e063-6294a90afc96	81136-024	HUMAN OTC DRUG	The INKEY List Acne Clearing Moisturizer		SULFUR	CREAM	TOPICAL	20230701		OTC MONOGRAPH DRUG	M006	Brand Evangelists for Beauty Limited	SULFUR	30	mg/mL			N	20241231
81140-101_55ca614b-d1c7-46f7-9d3c-cdc79ec2f908	81140-101	HUMAN PRESCRIPTION DRUG	RoxyBond		Oxycodone hydrochloride	TABLET, COATED	ORAL	20170420		NDA	NDA209777	Protega Pharmaceuticals Inc	OXYCODONE HYDROCHLORIDE	5	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
81140-102_55ca614b-d1c7-46f7-9d3c-cdc79ec2f908	81140-102	HUMAN PRESCRIPTION DRUG	RoxyBond		Oxycodone hydrochloride	TABLET, COATED	ORAL	20170420		NDA	NDA209777	Protega Pharmaceuticals Inc	OXYCODONE HYDROCHLORIDE	15	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
81140-103_55ca614b-d1c7-46f7-9d3c-cdc79ec2f908	81140-103	HUMAN PRESCRIPTION DRUG	RoxyBond		Oxycodone hydrochloride	TABLET, COATED	ORAL	20170420		NDA	NDA209777	Protega Pharmaceuticals Inc	OXYCODONE HYDROCHLORIDE	30	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
81151-102_41eeeb9d-1e56-4df4-9130-298271847c48	81151-102	HUMAN OTC DRUG	Rise Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20210301	20240630	OTC MONOGRAPH NOT FINAL	part333E	Shop Safely, LLC.	ALCOHOL	63	mL/100mL			N	
81151-103_10ad25fe-5315-4fd1-aa83-8cadc5796e5b	81151-103	HUMAN OTC DRUG	Rise Hand Sanitizer		Ethyl Alcohol	GEL	TOPICAL	20220211		OTC MONOGRAPH NOT FINAL	part333E	Shop Safely, LLC.	ALCOHOL	70	mL/100mL			N	20241231
81155-104_09e2208a-91a4-e219-e063-6394a90a7f63	81155-104	HUMAN OTC DRUG	KARMA RUB Elemental Pain Relief		LIDOCAINE HYDROCHLORIDE	LOTION	TOPICAL	20201123		OTC MONOGRAPH DRUG	M017	Elemental Bliss LLC	LIDOCAINE HYDROCHLORIDE	15	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81159-131_09e25fad-8fe9-b0f7-e063-6294a90a20e8	81159-131	HUMAN OTC DRUG	SEAWEED BATH CO. SPF 50 SPORT		OCTOCRYLENE, ZINC OXIDE, OCTISALATE	LOTION	TOPICAL	20201123		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 100; 85	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81159-132_09e2677b-0035-b1b5-e063-6294a90ab597	81159-132	HUMAN OTC DRUG	SEAWEED BATH CO SPF 40 SPORT		AVOBENZONE, OCTISALATE, OCTOCRYLENE	SPRAY	TOPICAL	20201123		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
81159-133_09e272c0-a7c7-0c1f-e063-6394a90ac62e	81159-133	HUMAN OTC DRUG	SEAWEED BATH CO. SPF-30		OCTOCRYLENE, ZINC OXIDE, OCTISALATE	CREAM	TOPICAL	20201123		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 50; 50	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81159-258_09e279a0-3ad0-daa2-e063-6294a90a623d	81159-258	HUMAN OTC DRUG	SEAWEED BATH CO Cooling Mist SPF-60 Sport		HOMOSALATE, OCTISALATE, ZINC OXIDE	LIQUID	TOPICAL	20220103		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	HOMOSALATE; OCTISALATE; ZINC OXIDE	100; 50; 50	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81159-259_09e285b2-b5f7-08b4-e063-6394a90a8964	81159-259	HUMAN OTC DRUG	SEAWEED BATH CO Everyday Mineral SPF 40		ZINC OXIDE	LOTION	TOPICAL	20220103		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81159-387_6afc9ddc-3ad6-433b-8127-a7ec86969e3f	81159-387	HUMAN OTC DRUG	Dewy Skin Face		Zinc Oxide	LOTION	TOPICAL	20230401		OTC MONOGRAPH FINAL	part352	The Seaweed Bath Co.	ZINC OXIDE	20.8	g/100mL			N	20241231
81159-388_09767258-5baf-95ce-e063-6294a90a12c3	81159-388	HUMAN OTC DRUG	SEAWEED BATH CO. Super Sheer Face Serum SPF-50		ZINC OXIDE	SOLUTION	TOPICAL	20230206		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	ZINC OXIDE	180	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81159-393_09762c8e-b9b8-ccc3-e063-6294a90aa7a3	81159-393	HUMAN OTC DRUG	SEAWEED BATH CO. Clear Moisture Mineral SPF-30		ZINC OXIDE	SOLUTION	TOPICAL	20230306		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81159-394_09764ab9-1a72-b42b-e063-6394a90a4a77	81159-394	HUMAN OTC DRUG	SEAWEED BATH CO. Sheer Mineral Sensitive SPF-50		ZINC OXIDE	SOLUTION	TOPICAL	20230306		OTC MONOGRAPH DRUG	M020	The Seaweed Bath Co.	ZINC OXIDE	170	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81173-615_a21bacdd-f8a0-4907-aa14-3be10251c234	81173-615	HUMAN OTC DRUG	TCI Antiseptic Hand Sanitizer		Isopropyl alcohol	LIQUID	TOPICAL	20201125	20240614	OTC MONOGRAPH NOT FINAL	part333A	Tetra-Chem Industries Ltd	ISOPROPYL ALCOHOL	70	L/100L			N	
81173-635_26f7cc32-a79e-4f58-855f-49bd3fb30ddc	81173-635	HUMAN OTC DRUG	Vital gel Antiseptic Hand Sanitizer		Isopropyl alcohol	GEL	TOPICAL	20201125	20240429	OTC MONOGRAPH NOT FINAL	part333A	Tetra-Chem Industries Ltd	ISOPROPYL ALCOHOL	74	L/100L			N	
81179-007_0e127c48-e134-a961-e063-6394a90a3174	81179-007	HUMAN OTC DRUG	EXPECTORANT GUAIFENESIN EXTENDED-RELEASE		GUAIFENESIN	TABLET	ORAL	20210405		ANDA	ANDA213420	YET HEALTH GROUP LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20251231
81179-010_0e128306-1359-daad-e063-6294a90a760a	81179-010	HUMAN OTC DRUG	ANTIGAS	250 MG	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20210811		OTC MONOGRAPH DRUG	M002	YET HEALTH GROUP LLC	DIMETHICONE	250	mg/1	Skin Barrier Activity [PE]		N	20251231
81179-015_0e129a45-40d9-b056-e063-6394a90adeb4	81179-015	HUMAN OTC DRUG	COUGH RELIEF	15 MG	DEXTROMETHORPHAN HBR	CAPSULE, LIQUID FILLED	ORAL	20210505		OTC MONOGRAPH DRUG	M012	YET HEALTH GROUP LLC	DEXTROMETHORPHAN HYDROBROMIDE	15	mg/1	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
81179-803_0e12b04e-2bd4-0a8b-e063-6294a90a3d47	81179-803	HUMAN OTC DRUG	DayTime NightTime Cold and Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl	KIT		20210902		OTC MONOGRAPH DRUG	M012	YET HEALTH GROUP LLC						N	20251231
81179-804_0e12a47e-7acd-fe31-e063-6294a90a4917	81179-804	HUMAN OTC DRUG	Severe DayTime NightTime Cold and Flu Relief	Max Strength	Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl, Guaifenesin	KIT	ORAL	20210902		OTC MONOGRAPH DRUG	M012	YET HEALTH GROUP LLC						N	20251231
81183-100_36db5700-ab76-4733-b948-5e98124fef86	81183-100	HUMAN OTC DRUG	THE FLOWER REMEDY Peaceful Feeling		Impatiens glandulifera, Helianthemum nummularium, Aesculus hippocastanum, Prunus cerasifera, Mimulus guttatus, Populus tremula, Aconitum Napellus	LIQUID	ORAL	20210419		UNAPPROVED HOMEOPATHIC		The Flower Remedy	ACONITUM NAPELLUS WHOLE; AESCULUS HIPPOCASTANUM FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; MIMULUS GUTTATUS FLOWERING TOP; POPULUS TREMULA FLOWERING TOP; PRUNUS CERASIFERA FLOWER	200; 5; 5; 5; 5; 5; 5	[hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
81183-101_ba4279e1-3de4-4978-8db6-f42e12661b8a	81183-101	HUMAN OTC DRUG	THE FLOWER REMEDY Peaceful Night		Prunus cerasifera, Clematis vitalba, Ulmus procera, Impatiens glandulifera, Quercus robur, Helianthemum nummularium, Aesculus hippocastanum, Ignatia Amara	LIQUID	ORAL	20210426		UNAPPROVED HOMEOPATHIC		The Flower Remedy	AESCULUS HIPPOCASTANUM FLOWER; CLEMATIS VITALBA FLOWER; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; PRUNUS CERASIFERA FLOWER; QUERCUS ROBUR FLOWER; STRYCHNOS IGNATII SEED; ULMUS MINOR FLOWERING TWIG	5; 5; 5; 5; 5; 5; 200; 5	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL			N	20241231
81183-102_78a8d075-f8eb-4cde-9242-a6510f0d1c03	81183-102	HUMAN OTC DRUG	THE FLOWER REMEDY Get Up and Go		Gentianella amarella, Ulex europaeus, Larix decidua, Quercus robur, Olea europaea, Castanea sativa, Bromus ramosus, Carbo Vegetabilis	LIQUID	ORAL	20210426		UNAPPROVED HOMEOPATHIC		The Flower Remedy	ACTIVATED CHARCOAL; BROMUS RAMOSUS FLOWER; CASTANEA SATIVA FLOWER; GENTIANELLA AMARELLA FLOWER; LARIX DECIDUA FLOWERING TOP; OLEA EUROPAEA FLOWER; QUERCUS ROBUR FLOWER; ULEX EUROPAEUS FLOWER	200; 5; 5; 5; 5; 5; 5; 5	[hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
81183-103_2ebde8f9-61a3-4346-8d5e-6237828774d9	81183-103	HUMAN OTC DRUG	THE FLOWER REMEDY Happy Heart		Gentianella amarella, Ulex europaeus, Ilex aquifolium, Lonicera caprifolium, Sinapis arvensis, Ornithogalum umbellatum, Castanea sativa, Salix vitellina, Ignatia Amara, Natrum Muriaticum	LIQUID	ORAL	20210426		UNAPPROVED HOMEOPATHIC		The Flower Remedy	CASTANEA SATIVA FLOWER; GENTIANELLA AMARELLA FLOWER; ILEX AQUIFOLIUM FLOWERING TOP; LONICERA CAPRIFOLIUM FLOWERING TOP; ORNITHOGALUM UMBELLATUM FLOWERING TOP; SALIX ALBA FLOWERING TOP; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; ULEX EUROPAEUS FLOWER	5; 5; 5; 5; 5; 5; 5; 200; 200; 5	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL			N	20241231
81186-000_0b6e43ea-38e7-10b0-e063-6394a90a5220	81186-000	HUMAN OTC DRUG	Perbelle CC SPF43 UVA UVB Broad Spectrum		TITANIUM DIOXIDE	CREAM	TOPICAL	20210120		OTC MONOGRAPH DRUG	M020	Perbelle Cosmetics Global Ltd.	TITANIUM DIOXIDE	120	mg/g			N	20241231
81200-109_09e279a0-3ae0-daa2-e063-6294a90a623d	81200-109	HUMAN OTC DRUG	STATE-48 SUNCARE MINERAL SPF-30		ZINC OXIDE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20201201		OTC MONOGRAPH DRUG	M020	State 48 Suncare LLC	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 50; 60	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81201-111_09e29758-299d-1153-e063-6394a90ab827	81201-111	HUMAN OTC DRUG	YOUTH CORRIDOR Soothe and Defend SPF-30		OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20201201		OTC MONOGRAPH DRUG	M020	Youth Corridor	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 80; 30	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81204-001_0038f516-ca67-3338-e063-6394a90a250c	81204-001	HUMAN OTC DRUG	AccuMed Antibacterial Hand Sanitizing Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20210715		OTC MONOGRAPH NOT FINAL	part333A	ACCUMED BIOTECH LLC	BENZALKONIUM CHLORIDE	1.1	mg/mL			N	20241231
81208-202_0ea177ee-ba69-636d-e063-6294a90a6ef5	81208-202	HUMAN OTC DRUG	Le Mieux Just Glow BB Cream SPF 50		Mineral Sunblock SPF 50	EMULSION	TOPICAL	20220413		OTC MONOGRAPH DRUG	M020	YB CHEMIA LLC	TITANIUM DIOXIDE; ZINC OXIDE	10.5; 15.3	g/100mL; g/100mL			N	20251231
81234-805_f3b185e6-9742-38c9-e053-2995a90a38f8	81234-805	HUMAN OTC DRUG	Lumin UV Defense Moisturizing Balm Broad Spectrum SPF 30		ZINC OXIDE	CREAM	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part352	Pangaea Holdings, Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81234-806_f8c1965c-086f-4b8b-e053-6294a90a1dbc	81234-806	HUMAN OTC DRUG	Lumin Broad Spectrum Moisturizer with SPF 30 PA UVA/UVB Protection Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Pangaea Holdings, Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81234-808_f3b1afcf-951e-b35a-e053-2a95a90aa261	81234-808	HUMAN OTC DRUG	Lumin Broad Spectrum Moisturizer with SPF 30 PA UVA/UVB Protection Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part352	Pangaea Holdings Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81235-000_f17d5321-ef51-c42d-e053-2a95a90a6cbc	81235-000	HUMAN OTC DRUG	Mova Al-kogel Hand Sanitizer 75 Alcohol		ALCOHOL	GEL	TOPICAL	20201101		OTC MONOGRAPH NOT FINAL	part333E	Mova Chemical S.A	ALCOHOL	.75	mL/mL			N	20241231
81235-001_f17d6854-cc0f-2900-e053-2a95a90a3ab0	81235-001	HUMAN OTC DRUG	Mova Liquid Hand Antibacterial		BENZALKONIUM CHLORIDE	GEL	TOPICAL	20201101		OTC MONOGRAPH NOT FINAL	part333E	Mova Chemical S.A	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
81235-002_f17d72d3-e2c0-3054-e053-2995a90ad516	81235-002	HUMAN OTC DRUG	Mova First Aid Antiseptic Denatured Alcohol 94		ALCOHOL	LIQUID	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333E	Mova Chemical S.A	ALCOHOL	.94	mL/mL			N	20241231
81235-003_f17d7cb1-b9f0-1fc2-e053-2a95a90adc00	81235-003	HUMAN OTC DRUG	Mova al-kogel hand sanitizer 75 Alcohol		ALCOHOL	LIQUID	TOPICAL	20201201		OTC MONOGRAPH NOT FINAL	part333E	Mova Chemical S.A	ALCOHOL	.75	mL/mL			N	20241231
81238-6708_5d57a131-2f7c-4803-a080-21e8774a3e30	81238-6708	HUMAN OTC DRUG	Neutral-Eyes		Purified Water 98.3%	SOLUTION	OPHTHALMIC	20210215		NDA	NDA022305	Western First Aid Safety	WATER	98.3	g/100mL			N	20241231
81244-001_087295fc-c1cc-71a0-e063-6394a90a01fe	81244-001	HUMAN OTC DRUG	SANITIZING ALCOHOL FREE WIPES		SANITIZING ALCOHOL FREE WIPES	CLOTH	TOPICAL	20201220		OTC MONOGRAPH DRUG	505G(a)(3)	Ironcompany.com, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
81252-1000_04750ce1-a27c-43df-a7bf-ece68646251e	81252-1000	HUMAN OTC DRUG	ENVIO 30 Day Daily Essentials Duo		Benzoyl Peroxide and Salicylic Acid	KIT		20211021		OTC MONOGRAPH FINAL	part333D	Smart Skin Health, LLC						N	20241231
81252-1001_32d28779-8c3d-446a-8033-d921af59a2ae	81252-1001	HUMAN OTC DRUG	ENVIO 30 Day Daily Essentials Trio		Benzoyl Peroxide and Salicylic Acid	KIT		20211021		OTC MONOGRAPH FINAL	part333D	Smart Skin Health, LLC						N	20241231
81252-1002_776db4aa-86f7-45ae-8c57-e4564180e1a2	81252-1002	HUMAN OTC DRUG	ENVIO 90 Day Daily Essentials Duo		Benzoyl Peroxide and Salicylic Acid	KIT		20211021		OTC MONOGRAPH FINAL	part333D	Smart Skin Health, LLC						N	20241231
81252-1003_0bd8c8f0-4f24-4149-8bd6-fb4755519b98	81252-1003	HUMAN OTC DRUG	ENVIO 90 Day Daily Essentials Trio		Benzoyl Peroxide and Salicylic Acid	KIT		20211021		OTC MONOGRAPH FINAL	part333D	Smart Skin Health, LLC						N	20241231
81252-2000_448dc797-ce1b-4c48-be2a-b5d7389b7492	81252-2000	HUMAN OTC DRUG	ENVIO 90 Day Daily Essentials Duo Sub Shipment		Benzoyl Peroxide and Salicylic Acid	KIT		20211021		OTC MONOGRAPH FINAL	part333D	Smart Skin Health, LLC						N	20241231
81252-2001_005b4173-6f7e-4142-a3a2-4145a1bef5c8	81252-2001	HUMAN OTC DRUG	ENVIO 90 Day Daily Essentials Trio Sub Shipment		Benzoyl Peroxide and Salicylic Acid	KIT		20211021		OTC MONOGRAPH FINAL	part333D	Smart Skin Health, LLC						N	20241231
81274-001_d650e2ad-dd1c-736a-e053-2995a90a8ce1	81274-001	HUMAN OTC DRUG	Hygiene of Sweden		Pocket Spray	AEROSOL, SPRAY	TOPICAL	20200101		OTC MONOGRAPH NOT FINAL	part333A	Hygiene of Sweden AB	BENZALKONIUM CHLORIDE	9.9	mg/100mL			N	20241231
81275-010_2b1c7567-8515-499d-b5c6-b261b6c556ac	81275-010	HUMAN OTC DRUG	Rorobell WaWa Tooth		Sodium Monofluorophosphate	PASTE, DENTIFRICE	ORAL	20201201		OTC MONOGRAPH FINAL	part355	ROROBELL	SODIUM MONOFLUOROPHOSPHATE	.72	g/100g			N	20241231
81277-801_0eaed6bb-6aa6-0dce-e063-6394a90ab6b5	81277-801	HUMAN OTC DRUG	Pert Plus 2 in 1	Anti-Dandruff	Pyrithione Zinc	SHAMPOO, SUSPENSION	TOPICAL	20221027		OTC MONOGRAPH DRUG	M032	TCP HRB Holdings	PYRITHIONE ZINC	1	g/100mL			N	20251231
81279-100_25d8122d-c1b4-4da3-98cf-0012d79e17cc	81279-100	HUMAN PRESCRIPTION DRUG	Florafol Pediatric 0.25 mg/mL Multivitamin and Fluoride Liquid Drops		VITAMIN A (as Retinyl Palmitate) VITAMIN C (as Ascorbic Acid) VITAMIN D3 (as Cholecalciferol) VITAMIN E (as d-Alpha-Tocopherol Acetate) VITAMIN B1 (as Thiamine HCl) VITAMIN B2 (as Riboflavin Phosphate Sodium) NIACIN (as Niacinamide) VITAMIN B6 (Pyridoxine HCl) Folate (as 69 mcg Quatrefolic ((6S)-5 Methyltetrahydrofolate, glucosamine salt, molar equivalent to 37.5 mcg of Folic Acid)) VITAMIN B12 (as Cyanocobalamin) FLUORIDE (as Sodium Fluoride)	SOLUTION/ DROPS	ORAL	20231220		UNAPPROVED DRUG OTHER		Pangea Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	3.35; 36; 10; 2; 117; 4; .4; .6; .25; .5; 450	mg/mL; mg/mL; ug/mL; ug/mL; ug/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; ug/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
81279-101_ba4fb008-255c-4ddf-8e9e-6e917dcf959f	81279-101	HUMAN PRESCRIPTION DRUG	Florafol FE Pediatric 0.25 mg/mL Multivitamin and Fluoride Liquid Drops		VITAMIN A (as Retinyl Palmitate) VITAMIN C (as Ascorbic Acid) VITAMIN D3 (as Cholecalciferol) VITAMIN E (as d-Alpha-Tocopherol Acetate) VITAMIN B1 (as Thiamine HCl) VITAMIN B2 (as Riboflavin Phosphate Sodium) NIACIN (as Niacinamide) VITAMIN B6 (Pyridoxine HCl) Folate (as 69 mcg Quatrefolic ((6S)-5 Methyltetrahydrofolate, glucosamine salt, molar equivalent to 37.5 mcg of Folic Acid)) VITAMIN B12 (as Cyanocobalamin) IRON (as Ferrous Sulfate) FLUORIDE (as Sodium Fluoride)	SOLUTION/ DROPS	ORAL	20231220		UNAPPROVED DRUG OTHER		Pangea Pharmaceuticals, LLC	.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; CHOLECALCIFEROL; CYANOCOBALAMIN; FERROUS SULFATE; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM FLUORIDE; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE	3.35; 36; 10; 2; 9.5; 117; 4; .4; .6; .25; .5; 450	mg/mL; mg/mL; ug/mL; ug/mL; mg/mL; ug/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; ug/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
81280-001_eac64a39-af18-4063-be30-6ead92bc4928	81280-001	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	20210301		OTC MONOGRAPH FINAL	part344	Mazza Healthcare, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
81280-002_48e3b9e9-8c1d-4b47-9e30-681c2fab38ff	81280-002	HUMAN OTC DRUG	Povidone-Iodine		Povidone-Iodine	SWAB	TOPICAL	20210301		OTC MONOGRAPH FINAL	part333C	Mazza Healthcare, LLC	POVIDONE-IODINE	.1	mg/mL			N	20241231
81280-003_63b1becd-3420-4873-b768-01c79a2f1ae6	81280-003	HUMAN OTC DRUG	Povidone-Iodine		Povidone-Iodine	SWAB	TOPICAL	20210301		OTC MONOGRAPH FINAL	part333C	Mazza Healthcare, LLC	POVIDONE-IODINE	.1	mg/mL			N	20241231
81284-151_7ca532ce-126a-4214-87ce-d876461e9e56	81284-151	HUMAN PRESCRIPTION DRUG	PIPERACILLIN AND TAZOBACTAM		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA207847	Provepharm Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81284-152_7ca532ce-126a-4214-87ce-d876461e9e56	81284-152	HUMAN PRESCRIPTION DRUG	PIPERACILLIN AND TAZOBACTAM		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA207847	Provepharm Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81284-153_7ca532ce-126a-4214-87ce-d876461e9e56	81284-153	HUMAN PRESCRIPTION DRUG	PIPERACILLIN AND TAZOBACTAM		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA207847	Provepharm Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81284-154_cc032a4f-4a9c-47f3-9580-22cf5f828927	81284-154	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230111		ANDA	ANDA207848	Provepharm Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	12; 1.5	g/60mL; g/60mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81284-155_cc032a4f-4a9c-47f3-9580-22cf5f828927	81284-155	HUMAN PRESCRIPTION DRUG	Piperacillin and Tazobactam		Piperacillin sodium and Tazobactam sodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA207848	Provepharm Inc.	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	36; 4.5	g/180mL; g/180mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81284-211_0c1ce0ec-3a14-4aa5-bb5c-429a16e6fda5	81284-211	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Provepharm Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81284-212_0c1ce0ec-3a14-4aa5-bb5c-429a16e6fda5	81284-212	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Provepharm Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81284-213_0c1ce0ec-3a14-4aa5-bb5c-429a16e6fda5	81284-213	HUMAN PRESCRIPTION DRUG	Phenylephrine hydrochloride		Phenylephrine hydrochloride	INJECTION	INTRAVENOUS	20200812		ANDA	ANDA211081	Provepharm Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81284-315_689e77d3-6ca0-4b8a-9240-a4fdf5eaa9f0	81284-315	HUMAN PRESCRIPTION DRUG	BLUDIGO		indigotindisulfonate sodium	INJECTION	INTRAVENOUS	20220906		NDA	NDA216264	Provepharm Inc.	INDIGOTINDISULFONATE SODIUM	8	mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
81284-411_d81b6a7a-03c5-421e-a754-313b8305f3d2	81284-411	HUMAN PRESCRIPTION DRUG	Dihydroergotamine Mesylate		Dihydroergotamine Mesylate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20210930		ANDA	ANDA212046	Provepharm Inc.	DIHYDROERGOTAMINE MESYLATE	1	mg/mL	Ergotamine Derivative [EPC], Ergotamines [CS]		N	20241231
81284-521_5994400d-741c-4a11-815c-07d81f2fe66a	81284-521	HUMAN PRESCRIPTION DRUG	EXTENCILLINE		benzathine benzylpenicillin	KIT		20231221		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Provepharm Inc.						N	20241231
81284-522_5994400d-741c-4a11-815c-07d81f2fe66a	81284-522	HUMAN PRESCRIPTION DRUG	EXTENCILLINE		benzathine benzylpenicillin	KIT		20231221		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Provepharm Inc.						N	20241231
81284-523_5994400d-741c-4a11-815c-07d81f2fe66a	81284-523	HUMAN PRESCRIPTION DRUG	EXTENCILLINE		benzathine benzylpenicillin	INJECTION, POWDER, FOR SUSPENSION	INTRAMUSCULAR	20231221		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Provepharm Inc.	PENICILLIN G BENZATHINE	1200000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
81284-524_5994400d-741c-4a11-815c-07d81f2fe66a	81284-524	HUMAN PRESCRIPTION DRUG	EXTENCILLINE		benzathine benzylpenicillin	INJECTION, POWDER, FOR SUSPENSION	INTRAMUSCULAR	20231221		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Provepharm Inc.	PENICILLIN G BENZATHINE	2400000	[iU]/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
81284-611_7426498f-9f93-44f8-a117-ce8ef4c7d449	81284-611	HUMAN PRESCRIPTION DRUG	tranexamic acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20210930		ANDA	ANDA212676	Provepharm Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
81284-612_7426498f-9f93-44f8-a117-ce8ef4c7d449	81284-612	HUMAN PRESCRIPTION DRUG	tranexamic acid		Tranexamic Acid	INJECTION, SOLUTION	INTRAVENOUS	20210930		ANDA	ANDA212676	Provepharm Inc.	TRANEXAMIC ACID	100	mg/mL	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
81284-831_810a40d3-9ec3-4ec0-9ca7-3b465752f96e	81284-831	HUMAN PRESCRIPTION DRUG	ANTICHOLIUM		physostigmine salicylate	INJECTION	INTRAVENOUS	20231005		UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE		Provepharm Inc.	PHYSOSTIGMINE SALICYLATE	.4	mg/mL			N	20241231
81286-101_9e07b73e-28a0-4a4b-8c57-32d9a15c8e06	81286-101	HUMAN OTC DRUG	PALMA HAND SANITIZER		Ethyl alcohol	GEL	TOPICAL	20210726		OTC MONOGRAPH NOT FINAL	part333A	UNITRADE FZE	ALCOHOL	70	mL/100mL			N	20241231
81286-102_67b0614a-0bd7-4425-836c-aa52a608c3cb	81286-102	HUMAN OTC DRUG	PALMA HYDRATING HAND SANITIZING SERUM		Ethyl alcohol	LIQUID	TOPICAL	20231011		OTC MONOGRAPH DRUG	505G(a)(3)	UNITRADE FZE	ALCOHOL	70	mL/100mL			N	20241231
81287-001_f4484f5d-cc10-35d5-e053-2a95a90a6422	81287-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20091202		UNAPPROVED MEDICAL GAS		Service Drug dba Petersen Drug	OXYGEN	99	L/100L			N	20241231
81288-018_d57d68ac-9e19-431d-a086-a055a14ca472	81288-018	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20220729		ANDA	ANDA210401	EMC PHARMA, LLC	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
81288-019_a266fef4-6cf6-4e3e-9df2-a531b7ca7102	81288-019	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20220729		ANDA	ANDA210401	EMC PHARMA, LLC	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
81288-020_9dca0e35-a3f7-499a-a256-ad4de9a78812	81288-020	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20220718		ANDA	ANDA211412	EMC PHARMA, LLC	CELECOXIB	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81288-021_9dca0e35-a3f7-499a-a256-ad4de9a78812	81288-021	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20220718		ANDA	ANDA211412	EMC PHARMA, LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81288-022_9dca0e35-a3f7-499a-a256-ad4de9a78812	81288-022	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20220718		ANDA	ANDA211412	EMC PHARMA, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81288-023_9dca0e35-a3f7-499a-a256-ad4de9a78812	81288-023	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20220718		ANDA	ANDA211412	EMC PHARMA, LLC	CELECOXIB	400	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81288-039_ed2d0aea-0a4c-41a4-b415-af5531106337	81288-039	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20220729		ANDA	ANDA212173	EMC PHARMA, LLC	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
81288-751_08f8f1f0-b056-438e-8fdc-e56127cf8e27	81288-751	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220728		ANDA	ANDA207375	EMC PHARMA, LLC	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
81288-755_08f8f1f0-b056-438e-8fdc-e56127cf8e27	81288-755	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220728		ANDA	ANDA207375	EMC PHARMA, LLC	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
81288-798_2d3a0fbd-5918-484c-8afc-680445e326bc	81288-798	HUMAN OTC DRUG	Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%		Carboxymethylcellulose Sodium	SOLUTION/ DROPS	OPHTHALMIC	20220101		OTC MONOGRAPH FINAL	part349	EMC Pharma, LLC	CARBOXYMETHYLCELLULOSE SODIUM	5	mg/mL			N	20241231
81293-000_f90ed33c-49e4-781f-e053-6294a90a7f29	81293-000	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230430		ANDA	ANDA216390	Steriscience Pte. Limited	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
81298-5010_e52ef6de-3867-4dfa-acce-7de7934661e7	81298-5010	HUMAN PRESCRIPTION DRUG	Carboprost Tromethamine		Carboprost Tromethamine	INJECTION	INTRAMUSCULAR	20221015		ANDA	ANDA214499	Long Grove Pharmaceuticals, LLC	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
81298-5781_551dbcb2-7dca-4e17-9c46-5c65cceade2d	81298-5781	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	SUSPENSION	INTRA-ARTERIAL; INTRAMUSCULAR	20220502		ANDA	ANDA213543	Long Grove Pharmaceuticals, LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
81298-5783_551dbcb2-7dca-4e17-9c46-5c65cceade2d	81298-5783	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	SUSPENSION	INTRA-ARTERIAL; INTRAMUSCULAR	20220502		ANDA	ANDA213543	Long Grove Pharmaceuticals, LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
81298-5785_551dbcb2-7dca-4e17-9c46-5c65cceade2d	81298-5785	HUMAN PRESCRIPTION DRUG	Triamcinolone Acetonide		Triamcinolone Acetonide	SUSPENSION	INTRA-ARTERIAL; INTRAMUSCULAR	20220502		ANDA	ANDA213543	Long Grove Pharmaceuticals, LLC	TRIAMCINOLONE ACETONIDE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
81298-8110_09c81542-46cc-aeaa-e063-6394a90acc34	81298-8110	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20220101		ANDA	ANDA215089	Long Grove Pharmaceuticals, LLC	CYCLOPHOSPHAMIDE	500	mg/25mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
81298-8112_09c81542-46cc-aeaa-e063-6394a90acc34	81298-8112	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20210101		ANDA	ANDA215089	Long Grove Pharmaceuticals, LLC	CYCLOPHOSPHAMIDE	1	g/50mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
81298-8114_09c81542-46cc-aeaa-e063-6394a90acc34	81298-8114	HUMAN PRESCRIPTION DRUG	Cyclophosphamide		cyclophosphamide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS; ORAL	20220101		ANDA	ANDA215089	Long Grove Pharmaceuticals, LLC	CYCLOPHOSPHAMIDE	2	g/100mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
81310-007_0d0b8a06-8586-2cfe-e063-6294a90af7a0	81310-007	HUMAN OTC DRUG	Medcosa Adult Care		ZINC OXIDE	CREAM	TOPICAL	20211203		OTC MONOGRAPH DRUG	M016	STRETTON ONLINE LTD.	ZINC OXIDE	20	g/100g			N	20241231
81310-010_0d0b9493-0c26-220a-e063-6294a90ab139	81310-010	HUMAN OTC DRUG	Adult Wash Gloves with Skin Protectant		DIMETHICONE	CLOTH	TOPICAL	20211213		OTC MONOGRAPH DRUG	M016	Stretton Online Ltd.	DIMETHICONE	3	g/100g	Skin Barrier Activity [PE]		N	20241231
81313-001_0a4a0161-4b73-c0b4-e063-6394a90a801f	81313-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20201217		NDA	NDA206023	AMERICAN MEDICAL GAS RESOURCES LLC	OXYGEN	992	mL/L			N	20241231
81319-112_09e28a29-b7c5-10d0-e063-6394a90a7861	81319-112	HUMAN OTC DRUG	LEMONBELLA Lavender Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20201220		OTC MONOGRAPH DRUG	505G(a)(3)	Lemonbella LLC	ALCOHOL	.7	mL/mL			N	20241231
81323-621_f44ad10b-565d-4832-902f-d2390ad40746	81323-621	HUMAN OTC DRUG	75% ALCOHOL HAND SANITIZER		Ethyl Alcohol	LIQUID	TOPICAL	20210113		OTC MONOGRAPH NOT FINAL	part333A	FUYUE BIO-TECHNOLOGY CO., LTD.	ALCOHOL	75	mL/100mL			N	20241231
81326-111_081421e6-eab3-828d-e063-6294a90aba34	81326-111	HUMAN OTC DRUG	The Green Scissor		Isopropyl Alcohol 99%	LIQUID	TOPICAL	20210510		UNAPPROVED DRUG OTHER		Tarr Acquisition LLC	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
81326-111_08143945-c1df-075b-e063-6394a90ad5de	81326-111	HUMAN OTC DRUG	The Green Scissor		Isopropyl Alcohol 99%	LIQUID	TOPICAL	20210510		UNAPPROVED DRUG OTHER		Tarr Acquisition LLC	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
81332-101_fe778fed-286a-72de-e053-6394a90a610e	81332-101	HUMAN OTC DRUG	75% alcohol sanitary wipes		ALCOHOL	CLOTH	TOPICAL	20201222		OTC MONOGRAPH NOT FINAL	part333A	Shandong Green Huineng Technology Co., Ltd.	ALCOHOL	3.15	mL/1			N	20241231
81332-102_fe778fed-286a-72de-e053-6394a90a610e	81332-102	HUMAN OTC DRUG	Sanitary wipes		Didecyl dimethyl ammonium chloride	CLOTH	TOPICAL	20201222		OTC MONOGRAPH NOT FINAL	part333A	Shandong Green Huineng Technology Co., Ltd.	BENZALKONIUM CHLORIDE; DIDECYLDIMONIUM CHLORIDE	.00189; .00168	mg/1; mg/1			N	20241231
81335-532_ea635da8-e3b7-10d3-e053-2995a90aca8f	81335-532	HUMAN OTC DRUG	ZCort	Ultra	Hydrocortisone Acetate 1%	CREAM	TOPICAL	20210301		OTC MONOGRAPH NOT FINAL	part348	RxDino, LLC	HYDROCORTISONE ACETATE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
81339-100_0c3cf795-e8e6-21bb-e063-6294a90aa488	81339-100	HUMAN OTC DRUG	Hand Sanitizing Wipe		Alcohol	CLOTH	TOPICAL	20201228		OTC MONOGRAPH DRUG	505G(a)(3)	NeatGoods LLC	ALCOHOL	65	mL/100mL			N	20241231
81339-101_0bc96929-553c-4b4e-e063-6394a90af4f2	81339-101	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	CLOTH	TOPICAL	20230208		OTC MONOGRAPH DRUG	505G(a)(3)	NeatGoods LLC	ALCOHOL	65	mL/100mL			N	20241231
81341-0650_04b36e59-8078-ef21-e063-6294a90a13c2	81341-0650	HUMAN OTC DRUG	Stay AgelessTinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	PURA VIDA BODY & MIND SPA, INC.	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
81341-2650_04b6992d-c7c8-56c7-e063-6394a90ae8d0	81341-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	PURA VIDA BODY & MIND SPA, INC.	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
81351-001_0846df7f-0bc2-f9c8-e063-6294a90a825a	81351-001	HUMAN OTC DRUG	Saninta Antiseptic Wipe		ALCOHOL	LIQUID	TOPICAL	20210309		OTC MONOGRAPH DRUG	505G(a)(3)	LL Pharma	ISOPROPYL ALCOHOL	.7	L/L			N	20241231
81351-002_0846de12-2d3c-1082-e063-6394a90a829a	81351-002	HUMAN OTC DRUG	Saninta Hand Sanitizing Gel		ALCOHOL	LIQUID	TOPICAL	20210315		OTC MONOGRAPH DRUG	505G(a)(3)	LL Pharma	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
81351-004_08470de3-deaa-5d02-e063-6394a90ae8bf	81351-004	HUMAN OTC DRUG	Saninta 10% Povidone-Iodine		Povidone-Iodine Solution	LIQUID	TOPICAL	20210825		OTC MONOGRAPH DRUG	505G(a)(3)	LL Pharma	POVIDONE-IODINE	100	mg/mL			N	20241231
81352-321_09769ae3-d18d-e2dd-e063-6294a90a1f64	81352-321	HUMAN OTC DRUG	SANTO REMEDIOS Piel Eterna Radiance Sunscreen Primer SPF-42		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20220321		OTC MONOGRAPH DRUG	M020	SANTO REMEDIO LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81352-421_ef6c06e5-62e2-dd42-e053-2a95a90aad16	81352-421	HUMAN OTC DRUG	Dr. Juans Santo Remedio PARA LA ACIDEZ		Aspirin, Citric Acid, Sodium Bicarbonate	TABLET, EFFERVESCENT	ORAL	20200506	20241231	OTC MONOGRAPH FINAL	part343	Santo Remedio LLC.	ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE	1000; 325; 1916	mg/1; mg/1; mg/1	Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Activity [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	
81352-521_0976c8f2-de9c-fb24-e063-6394a90a04dd	81352-521	HUMAN OTC DRUG	RADIANCE Silky Mineral Primer Sunscreen SPF-42 HONEY		TITANIUM DIOXIDE, ZINC OXIDE	SOLUTION	TOPICAL	20230306		OTC MONOGRAPH DRUG	M020	SANTO REMEDIO LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81353-026_b734f042-d5a6-3850-e053-2995a90afcb7	81353-026	HUMAN OTC DRUG	GUARDEX SANITIZING HAND		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20201226		OTC MONOGRAPH NOT FINAL	part333A	Nile Hudson LLC	BENZALKONIUM CHLORIDE	.95	g/mL			N	20241231
81353-126_b76bdbd3-c12a-42b5-e053-2995a90a6e79	81353-126	HUMAN OTC DRUG	GUARDEX SANITIZING HAND		BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20201226		OTC MONOGRAPH NOT FINAL	part333A	Nile Hudson LLC	BENZALKONIUM CHLORIDE	.95	g/mL			N	20241231
81361-002_eafd2305-1396-1f32-e053-2995a90aa0c8	81361-002	HUMAN OTC DRUG	Wet Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20221014		OTC MONOGRAPH NOT FINAL	part333A	Hangzhou ChunChi Touring Commodity CO., LTD.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
81362-302_0e127c48-e12a-a961-e063-6394a90a3174	81362-302	HUMAN OTC DRUG	EXTRA STRENGTH SIMETHICONE ANTIGAS	125 MG	SIMETHICONE	CAPSULE, GELATIN COATED	ORAL	20210405		OTC MONOGRAPH DRUG	M002	LLS HEALTH LLC	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20251231
81368-0650_fea61544-6686-ad34-e053-6294a90a48f3	81368-0650	HUMAN OTC DRUG	Broad Spectrum SPF 30 Tinted Sunscreen		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	National Hair Loss LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
81377-203_afc69817-0075-420f-8101-b3d617ab15f1	81377-203	HUMAN OTC DRUG	Emme Diane Tinted Mineral Sunscreen		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220122		OTC MONOGRAPH NOT FINAL	part352	Emme Diane, Inc	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
81377-208_df4735fb-f9dd-46e7-8c18-de078d077fce	81377-208	HUMAN OTC DRUG	Emme Diane Pure Protection Tinted Antioxidant Sunscreen		Zinc Oxide	CREAM	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part352	Emme Diane, Inc.	ZINC OXIDE	160	mg/g			N	20241231
81379-001_09cebfb6-6a27-c509-e063-6294a90a7a0b	81379-001	HUMAN OTC DRUG	Thai Duong Hand Sanitizer Antiseptic Hand Rub		ALCOHOL	GEL	TOPICAL	20210427		OTC MONOGRAPH DRUG	505G(a)(3)	SAO THAI DUONG JOINT STOCK COMPANY - BRANCH	ALCOHOL	70	mL/100mL			N	20241231
81379-002_0b4c6ff6-b57a-2387-e063-6394a90aa1b7	81379-002	HUMAN OTC DRUG	Thai Duong External Analgesic		CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE	OIL	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	BRANCH OF SAO THAI DUONG JOINT STOCK COMPANY IN HA NAM	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	110; 160; 300	mg/mL; mg/mL; mg/mL			N	20241231
81381-258_f31d542f-d388-4a59-97d6-ff0d8bf5b545	81381-258	HUMAN OTC DRUG	Shunly Natural Cover SPF50		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230814		OTC MONOGRAPH NOT FINAL	part352	Shunly Skin Care	TITANIUM DIOXIDE; ZINC OXIDE	100; 30	mg/g; mg/g			N	20241231
81385-000_08bfdf87-5851-5743-e063-6294a90a807e	81385-000	HUMAN OTC DRUG	CleanGenic Foaming Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200610		OTC MONOGRAPH DRUG	505G(a)(3)	CleanGenic, LLC	ALCOHOL	62	mL/100mL			N	20241231
81385-001_08bfe1ce-49ec-3165-e063-6394a90a0375	81385-001	HUMAN OTC DRUG	CleanGenic 1 GALLON HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20200610		OTC MONOGRAPH DRUG	505G(a)(3)	CleanGenic, LLC	ALCOHOL	62	mL/100mL			N	20241231
81385-002_08c08704-4eac-4151-e063-6394a90abe3a	81385-002	HUMAN OTC DRUG	CleanGenic Foaming Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20200610		OTC MONOGRAPH DRUG	505G(a)(3)	CleanGenic, LLC	ALCOHOL	62	mL/100mL			N	20241231
81385-003_08c00977-1db2-6d24-e063-6294a90a9cfe	81385-003	HUMAN OTC DRUG	CleanGenic 8 OZ HAND SANITIZER		ALCOHOL	LIQUID	TOPICAL	20200610		OTC MONOGRAPH DRUG	505G(a)(3)	CleanGenic, LLC	ALCOHOL	62	mL/100mL			N	20241231
81389-001_08c11030-7b99-55ae-e063-6394a90a1437	81389-001	HUMAN OTC DRUG	SafeTynadol		ACETAMINOPHEN	TABLET, COATED	ORAL	20210121		OTC MONOGRAPH DRUG	M013	Sinew Pharma Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
81391-001_0e1adb2e-a3aa-d37d-e063-6394a90ab743	81391-001	HUMAN OTC DRUG	Pube Chlorine Dioxide Disinfection		Pube Chlorine Dioxide Disinfection Tablets	TABLET	TOPICAL	20200330		UNAPPROVED DRUG OTHER		Guangdong Jiajie Technology Co., Ltd.	SODIUM CHLORITE	30	g/100g			N	20251231
81393-0650_ff376647-070e-b181-e053-6394a90ab10a	81393-0650	HUMAN OTC DRUG	EVEN DEFENSE Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part352	Premier Plastic Surgery	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
81394-2650_ff48ea77-f530-a958-e053-6394a90a17bc	81394-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part352	Rian A. Maercks, M.D., P.A.	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
81403-0001_8a8d12ac-f8b7-4501-ac6d-9d84746fcc14	81403-0001	HUMAN OTC DRUG	2 Transform		Fucus Vesiculosus, Chelidonium Majus, Kali Phosphoricum, Lycopodium Clavatum, Natrum Muriaticum, Quercus Glandium Spiritus, Quercus Robur, Nux Vomica, Phytolacca Decandra, Ornithogalum Umbellatum, Agnus Castus, Berberis Aquifolium, Berberis Vulgaris, Saccharum Officinale, Solidago Virgaurea, Calcarea Carbonica, Carbo Vegetabilis, Magnesia Phosphorica, Natrum Phosphoricum, Sinapis Arvensis, Flos, Ubidecarenonum, Graphites, Hypophysis Suis, Placenta Totalis Suis, Hypothalamus (Bovine)	LIQUID	ORAL	20210628		UNAPPROVED HOMEOPATHIC		Murphree Chiropractic	ACTIVATED CHARCOAL; BERBERIS AQUIFOLIUM ROOT BARK; BERBERIS VULGARIS ROOT BARK; BOS TAURUS HYPOTHALAMUS; CHASTE TREE FRUIT; CHELIDONIUM MAJUS WHOLE; DIBASIC POTASSIUM PHOSPHATE; FUCUS VESICULOSUS; GRAPHITE; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ORNITHOGALUM UMBELLATUM WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; QUERCUS ROBUR NUT; QUERCUS ROBUR TWIG BARK; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUCROSE; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; UBIDECARENONE	12; 8; 8; 16; 8; 6; 6; 4; 12; 6; 12; 8; 12; 6; 6; 6; 12; 6; 12; 8; 6; 8; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81404-001_e1a45730-2b01-7035-e053-2a95a90a3e33	81404-001	HUMAN OTC DRUG	Bee Clean - Beeswax Hand Sanitizer - Citrus and Peppermint		ALCOHOL	SPRAY	TOPICAL	20220615		OTC MONOGRAPH NOT FINAL	part333A	BeeCleanSpot	ALCOHOL	70	mL/100mL			N	20241231
81404-002_e1a46d37-5886-5c09-e053-2a95a90aa2fc	81404-002	HUMAN OTC DRUG	Bee Clean - Beeswax Hand Sanitizer - Lavender Oil		ALCOHOL	SPRAY	TOPICAL	20220615		OTC MONOGRAPH NOT FINAL	part333A	BeeCleanSpot	ALCOHOL	70	mL/100mL			N	20241231
81409-001_08aab616-178b-b096-e063-6394a90a2f88	81409-001	HUMAN OTC DRUG	Maui Vera Reef Friendly Mineral Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Maui Vera, Inc.	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81425-001_b1479533-89f2-4b41-92ba-a5403b65ea5d	81425-001	HUMAN OTC DRUG	LUMO Calm Stress Ease		Absinthium, Cenchris contortrix, Ignatia amara, Mygale	TABLET, CHEWABLE	ORAL	20231015		UNAPPROVED HOMEOPATHIC		Applied Bioenergetics, LLC	AGKISTRODON CONTORTRIX VENOM; AVICULARIA AVICULARIA; STRYCHNOS IGNATII SEED; WORMWOOD	30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
81425-002_01db10f1-9b0a-4822-852e-8fef0c604ab5	81425-002	HUMAN OTC DRUG	LUMO Live Vitality Boost		Arnica montana, Euphorbium officinarum, Pulsatilla, Solanum nigrum	TABLET, CHEWABLE	ORAL	20231015		UNAPPROVED HOMEOPATHIC		Applied Bioenergetics, LLC	ARNICA MONTANA; EUPHORBIA RESINIFERA RESIN; PULSATILLA PRATENSIS WHOLE; SOLANUM NIGRUM WHOLE	30; 30; 30; 9	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
81425-003_901b1683-20f4-4b8b-96a4-f892e2c6602e	81425-003	HUMAN OTC DRUG	LUMO Booz Hangover Companiion		Chininum arsenicosum, Natrum phosphoricum, Nux voomica, Vespa crabro	TABLET, CHEWABLE	ORAL	20231015		UNAPPROVED HOMEOPATHIC		Applied Bioenergetics, LLC	QUININE ARSENITE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; VESPA CRABRO	30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Allergens [CS], Antimalarial [EPC], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
81425-004_660d6951-b614-4b87-98db-9a83cb606873	81425-004	HUMAN OTC DRUG	LUMO Heal Seasonal Flu Companion		Arsenicum album, Eupatorium perfoliatum, Kali muriaticum, Sticta pulmonaria	TABLET, CHEWABLE	ORAL	20231015		UNAPPROVED HOMEOPATHIC		Applied Bioenergetics, LLC	ARSENIC TRIOXIDE; EUPATORIUM PERFOLIATUM FLOWERING TOP; LOBARIA PULMONARIA; POTASSIUM CHLORIDE	12; 30; 12; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
81426-001_07eed0e5-3578-f3b6-e063-6294a90a899a	81426-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20210111		NDA	NDA205889	ADVANCED GASES AND EQUIPMENT INC	OXYGEN	999	mL/L			N	20241231
81428-070_075cdcd7-5631-87d1-e063-6294a90a850f	81428-070	HUMAN OTC DRUG	Singular Wipes		Alcohol	CLOTH	TOPICAL	20220421		OTC MONOGRAPH DRUG	M003	SINGULAR ENTERPRISES LLC	ALCOHOL	70	mL/100mL			N	20241231
81428-071_075cdcd7-563c-87d1-e063-6294a90a850f	81428-071	HUMAN OTC DRUG	Singular Wipes fragrance free		Isopropyl Alcohol	CLOTH	TOPICAL	20220422		OTC MONOGRAPH DRUG	M003	SINGULAR ENTERPRISES LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
81428-072_075d1f8e-f135-5e2b-e063-6394a90a0a81	81428-072	HUMAN OTC DRUG	Singular Wipes lavender fragrance		Alcohol	CLOTH	TOPICAL	20220421		OTC MONOGRAPH DRUG	M003	SINGULAR ENTERPRISES LLC	ALCOHOL	70	mL/100mL			N	20241231
81428-073_075d0f21-26df-3b6d-e063-6294a90a872f	81428-073	HUMAN OTC DRUG	Travel Wipes		Isopropyl Alcohol	CLOTH	TOPICAL	20220510		OTC MONOGRAPH DRUG	M003	SINGULAR ENTERPRISES LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
81428-074_0643494a-36d7-8f3e-e063-6294a90ad8ce	81428-074	HUMAN OTC DRUG	Travel Wipes Moisturizer and fragrance		Alcohol	CLOTH	TOPICAL	20231001		OTC MONOGRAPH NOT FINAL	part333A	SINGULAR ENTERPRISES LLC	ALCOHOL	70	mL/100mL			N	20241231
81431-172_09e28a29-b7d6-10d0-e063-6394a90a7861	81431-172	HUMAN OTC DRUG	COMMON GOOD Hand Sanitizer (Grapefruit)		ALCOHOL	SPRAY	TOPICAL	20210115		OTC MONOGRAPH DRUG	505G(a)(3)	Common Good LLC	ALCOHOL	.95	mL/mL			N	20241231
81434-693_bd4a4a30-74f0-1f70-e053-2995a90ac051	81434-693	HUMAN OTC DRUG	Sani-Lotion		Sani-Lotion	LIQUID	TOPICAL	20101117		OTC MONOGRAPH NOT FINAL	part333A	Tifco Industries	ALCOHOL	67	mL/100mL			N	20241231
81438-693_bd9a0b41-4860-adfc-e053-2a95a90ae7a0	81438-693	HUMAN OTC DRUG	Instant		Instant	LIQUID	TOPICAL	20130204		OTC MONOGRAPH NOT FINAL	part333A	Detco Industries	ALCOHOL	67	mL/100mL			N	20241231
81439-110_ebce1af7-0ea3-435d-a19b-08bad9af0d77	81439-110	HUMAN OTC DRUG	Good Hygiene Therapeutic Mouth Rinse		Hydrogen Peroxide Debriding Agent	LIQUID	ORAL	20210501		OTC MONOGRAPH NOT FINAL	part356	Good Hygiene Company	HYDROGEN PEROXIDE	1.5	g/100mL			N	20241231
81439-120_ebce1af7-0ea3-435d-a19b-08bad9af0d77	81439-120	HUMAN OTC DRUG	Good Hygiene Therapeutic Mouth Rinse		Hydrogen Peroxide Debriding Agent	LIQUID	ORAL	20210501		OTC MONOGRAPH NOT FINAL	part356	Good Hygiene Company	HYDROGEN PEROXIDE	1.5	g/100mL			N	20241231
81440-102_d800c741-5e64-4cec-b32f-a235283527a5	81440-102	HUMAN OTC DRUG	BISAC-10 Bisacodyl Stimulant Laxative		Bisacodyl	SUPPOSITORY	RECTAL	20210215		OTC MONOGRAPH NOT FINAL	part334	GALEN PHARMACEUTICALS LIMITED	BISACODYL	10	mg/1	Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81441-001_fa153458-bc7f-7a69-e053-6294a90a823d	81441-001	HUMAN OTC DRUG	Prosana Skin and Body		Ethanol	GEL	TOPICAL	20210104		OTC MONOGRAPH NOT FINAL	part333A	Bodywell Natural Skin Care Inc	ALCOHOL	70	mL/100mL			N	20241231
81441-002_f27712f3-fa0b-c042-e053-2995a90a9cf2	81441-002	HUMAN OTC DRUG	Prosana Skin and Body		Ethanol	SPRAY	TOPICAL	20210104		OTC MONOGRAPH NOT FINAL	part333A	Bodywell Natural Skin Care Inc	ALCOHOL	70	mL/100mL			N	20241231
81441-006_f2771849-c893-b834-e053-2995a90a69e3	81441-006	HUMAN OTC DRUG	VivaLaCara Dermalere Advanced Skin Cream		COCONUT, German chamomile, Pot-marigold, Helianthus annuus, D-Panthenol, Plantago major, Urtica dioica, Cotinus coggygria	CREAM	TOPICAL	20210324		UNAPPROVED HOMEOPATHIC		Bodywell Natural Skin Care Inc	CALENDULA OFFICINALIS FLOWER; CHAMOMILE; COCONUT OIL; COTINUS COGGYGRIA LEAF; DEXPANTHENOL; PLANTAGO MAJOR LEAF; SUNFLOWER OIL; URTICA DIOICA LEAF	1; 1; 6; .02; .1; .02; 2; .02	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81441-007_f2778771-135a-a052-e053-2995a90a70b6	81441-007	HUMAN OTC DRUG	VivaLaCara Dermalere Advanced Burn and Scar Cream		COCONUT, chamomile, sunflower oil, Dexpanthenol, Plantago major, Urtica dioica, Cotinus coggygria,Calendula officinalis flower	CREAM	TOPICAL	20210402		UNAPPROVED HOMEOPATHIC		Bodywell Natural Skin Care Inc	CALENDULA OFFICINALIS FLOWER; CHAMOMILE; COCONUT OIL; COTINUS COGGYGRIA LEAF; DEXPANTHENOL; PLANTAGO MAJOR LEAF; SUNFLOWER OIL; URTICA DIOICA LEAF	1; 1; 6; .02; .1; .02; 2; .02	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
81441-008_f2773fc2-8ad7-2ba7-e053-2a95a90a6cfc	81441-008	HUMAN OTC DRUG	Moor Spa Hand Sanitizing		Ethanol	LIQUID	TOPICAL	20210507		OTC MONOGRAPH NOT FINAL	part333A	Bodywell Natural Skin Ca re Inc	ALCOHOL	70	mL/100mL			N	20241231
81442-693_bd997c2c-97cd-722a-e053-2995a90a3f79	81442-693	HUMAN OTC DRUG	Germ Free		Germ Free	LIQUID	TOPICAL	20101028		OTC MONOGRAPH NOT FINAL	part333A	Competitive Choice	ALCOHOL	67	mL/100mL			N	20241231
81450-001_06fdc23e-8aa0-9e4b-e063-6394a90a089c	81450-001	HUMAN OTC DRUG	ZIVA HAND SANITIZER		Alcohol	GEL	TOPICAL	20211224		OTC MONOGRAPH DRUG	M003	Ziva Wetwipes FZCo	ALCOHOL	80	mL/100mL			N	20241231
81450-002_06fdaec0-7c72-70cd-e063-6394a90a1b46	81450-002	HUMAN OTC DRUG	ZIVA ANTIBACTERIAL MULTIPURPOSE WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20211224		OTC MONOGRAPH DRUG	M003	Ziva Wetwipes FZCo	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
81450-004_06fdc83d-788e-8ff3-e063-6394a90ad4d9	81450-004	HUMAN OTC DRUG	ZIVA HAND SANITIZER		ALCOHOL	SPRAY	TOPICAL	20211224		OTC MONOGRAPH DRUG	M003	Ziva Wetwipes FZCo	ALCOHOL	80	mL/100mL			N	20241231
81450-005_06fdbe50-9363-a608-e063-6394a90a4088	81450-005	HUMAN OTC DRUG	ZIVA BABY WIPES		ZINC OXIDE	CLOTH	TOPICAL	20211224		OTC MONOGRAPH DRUG	M003	Ziva Wetwipes FZCo	ZINC OXIDE	.1	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81450-007_06fdaec0-7c71-70cd-e063-6394a90a1b46	81450-007	HUMAN OTC DRUG	ZIVA PERFUMED WIPES GARDENIA		Benzethonium Chloride	CLOTH	TOPICAL	20211224		OTC MONOGRAPH DRUG	M003	Ziva Wetwipes FZCo	BENZETHONIUM CHLORIDE	.1	g/100mL			N	20241231
81450-008_06fd8984-8a08-b19f-e063-6294a90a95d4	81450-008	HUMAN OTC DRUG	ZIVA ALCOHOL WIPES		Isopropyl Alcohol	CLOTH	TOPICAL	20211224		OTC MONOGRAPH DRUG	M003	Ziva Wetwipes FZCo	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
81457-002_e3c449cf-60b4-22f6-e053-2a95a90af0f9	81457-002	HUMAN OTC DRUG	ALEVAI  STEM CELL ANTI-DANDRUFF CONDITIONER		Pyrithione Zinc	LOTION	TOPICAL	20211116		OTC MONOGRAPH FINAL	M032	ALEVAI PRODUCTS LLC	PYRITHIONE ZINC	2.1	g/100mL			N	20241231
81457-012_f6525731-c6c3-6355-e053-2a95a90a89f4	81457-012	HUMAN OTC DRUG	ALEVAI - ANTI DANDRUFF SCALP SERUM		ZINC PYRITHIONE	CREAM	TOPICAL	20230417		OTC MONOGRAPH FINAL	M032	ALEVAI PRODUCTS LLC	PYRITHIONE ZINC	.12	g/100mL			N	20241231
81457-020_e3c4b2e7-c511-c4c8-e053-2995a90a78ae	81457-020	HUMAN OTC DRUG	ALEVAI - STEM CELL ANTI DANDRUFF		Pyrithione Zinc	SHAMPOO	TOPICAL	20211112		OTC MONOGRAPH FINAL	M032	ALEVAI PRODUCTS LLC	PYRITHIONE ZINC	2	g/100g			N	20241231
81457-123_09e2a350-7cc5-0898-e063-6394a90ad3dc	81457-123	HUMAN OTC DRUG	ALEVAI Stem Cell Anti-Dandruff Conditioner		PYRITHIONE ZINC	SOLUTION	TOPICAL	20210201		OTC MONOGRAPH DRUG	M032	Alevai Products LLC	PYRITHIONE ZINC	20	mg/mL			N	20241231
81457-124_09e285b2-b607-08b4-e063-6394a90a8964	81457-124	HUMAN OTC DRUG	ALEVAI Stem Cell Anti-Dandruff		PYRITHIONE ZINC	SOLUTION	TOPICAL	20210201		OTC MONOGRAPH DRUG	M032	Alevai Products LLC	PYRITHIONE ZINC	20	mg/mL			N	20241231
81461-001_081d677a-c4a0-6a69-e063-6294a90a0cbd	81461-001	HUMAN OTC DRUG	MARA Algae Zinc Sea Kale Sunscreen Serum SPF 30		ZINC OXIDE	OIL	TOPICAL	20210106		OTC MONOGRAPH DRUG	M020	Mara Beauty LLC	ZINC OXIDE	132.2	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81464-001_075bbd2d-9b6b-cdb6-e063-6394a90a4d28	81464-001	HUMAN OTC DRUG	SkinGuard24		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210126		OTC MONOGRAPH DRUG	M003	SG24, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
81464-002_075c142c-58bf-c3d2-e063-6294a90a53f1	81464-002	HUMAN OTC DRUG	SkinGuard24		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210202		OTC MONOGRAPH DRUG	M003	SG24, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
81469-415_1387a91f-3253-4c9c-a228-1f2974ac488e	81469-415	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20230111		ANDA	ANDA215710	First Nation Group, LLC	DOXEPIN HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
81469-416_1387a91f-3253-4c9c-a228-1f2974ac488e	81469-416	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20230111		ANDA	ANDA215710	First Nation Group, LLC	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
81469-417_1387a91f-3253-4c9c-a228-1f2974ac488e	81469-417	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20230111		ANDA	ANDA215710	First Nation Group, LLC	DOXEPIN HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
81469-418_1387a91f-3253-4c9c-a228-1f2974ac488e	81469-418	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20230111		ANDA	ANDA215710	First Nation Group, LLC	DOXEPIN HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
81469-419_1387a91f-3253-4c9c-a228-1f2974ac488e	81469-419	HUMAN PRESCRIPTION DRUG	Doxepin Hydrochloride		doxepin hydrochloride	CAPSULE	ORAL	20230111		ANDA	ANDA215710	First Nation Group, LLC	DOXEPIN HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
81469-999_065c53a2-3605-24d4-e063-6394a90a0e5d	81469-999	HUMAN OTC DRUG	Astringent Solution		Aluminum Sulfate Tetradecahydrate, Calcium Acetate Monohydrate	POWDER, FOR SOLUTION	TOPICAL	20230927		OTC MONOGRAPH NOT FINAL	part347	First Nation Group	ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE	1347; 952	mg/2299mg; mg/2299mg	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
81470-001_fa540c14-3c0e-d3a0-e053-6394a90a4e3d	81470-001	HUMAN OTC DRUG	Shield and Heal Medicated Lip Balm		Menthol	STICK	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part348	Shield and Heal Inc.	MENTHOL	10	mg/g			N	20241231
81470-002_fa53f692-e689-97ed-e053-6294a90a1763	81470-002	HUMAN OTC DRUG	Shield and Heal Lip Balm		Menthol	KIT	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part348	Shield and Heal Inc.						N	20241231
81471-693_c2898640-f18a-215c-e053-2995a90adb45	81471-693	HUMAN OTC DRUG	Antiseptic Gel Handwash		Antiseptic Gel Handwash	LIQUID	TOPICAL	20200130		OTC MONOGRAPH NOT FINAL	part333A	SafeSpace Co.	ALCOHOL	67	mL/100mL			N	20241231
81484-101_ffa6d744-b494-0e4a-e053-6394a90aa76d	81484-101	HUMAN OTC DRUG	Detox Foot Patch		PHYLLOSTACHYS EDULIS VINEGAR(Bamboo vinegar), Pyroligneous acid(wood vinegar), SCHORL TOURMALINE, Houttuynia cordata thunb	PATCH	TOPICAL	20210129		UNAPPROVED DRUG OTHER		Anhui Miao De Tang Pharmaceutical Co., Ltd.	HOUTTUYNIA CORDATA WHOLE; PHYLLOSTACHYS EDULIS VINEGAR; PYROLIGNEOUS ACID; SCHORL TOURMALINE	.7875; 2.625; 1.75; .2625	g/1; g/1; g/1; g/1			N	20241231
81484-102_0e7ffc0f-e2ba-377c-e063-6294a90a29d6	81484-102	HUMAN OTC DRUG	Knee Pain Relief Patch		camphor, menthol, methyl salicylate	PATCH	TOPICAL	20240109		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	g/1001; g/1001; g/1001			N	20251231
81484-201_0a28578b-717a-7e42-e063-6294a90aaec6	81484-201	HUMAN OTC DRUG	Pain Relief Patch		Camphor, Menthol, Methyl Salicylate	PATCH	TOPICAL	20210407		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.8; 5.2; 3.1	g/1; g/1; g/1			N	20241231
81484-301_0a284cca-a827-7498-e063-6394a90a9aa7	81484-301	HUMAN OTC DRUG	Lidocaine Patch		LIDOCAINE 4% MENTHOL 1%	PATCH	TOPICAL	20211101		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	LIDOCAINE; MENTHOL	.4; .1	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81484-401_0a283b77-4b25-370d-e063-6294a90ae4df	81484-401	HUMAN OTC DRUG	Knee Pain Relief Patch		camphor, menthol, methyl salicylate	PATCH	TOPICAL	20220523		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	.036; .171; .189	g/1; g/1; g/1			N	20241231
81484-501_0a286ab2-a4ac-8792-e063-6294a90a7812	81484-501	HUMAN OTC DRUG	Lidocaine Patch		Lidocaine HCI 4%	PATCH	TOPICAL	20230314		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	LIDOCAINE HYDROCHLORIDE	.4	g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81484-601_08099eb1-4b9a-113e-e063-6294a90aef48	81484-601	HUMAN OTC DRUG	Pain Reliveing Patch		Lidocaine 4%	PATCH	TOPICAL	20230601		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	LIDOCAINE	4	mg/1001	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81484-701_0a284cca-a828-7498-e063-6394a90a9aa7	81484-701	HUMAN OTC DRUG	Capsicum Patch		Camphor,Capsicum extract as Capsaicin, Menthol	PATCH	TOPICAL	20230621		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); CAPSAICIN; MENTHOL	9.6; .25; 7.8	g/1; g/1; g/1			N	20241231
81484-801_0a18bc96-0ff2-1ba8-e063-6294a90ad903	81484-801	HUMAN OTC DRUG	Pain Relief Patch		Camphor, Menthol, Methyl Salicylate	PATCH	TOPICAL	20230726		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	3.1; 6; 10	mg/1001; mg/1001; mg/1001			N	20241231
81484-901_0a18ac24-4dab-2479-e063-6294a90a52c5	81484-901	HUMAN OTC DRUG	Lidocaine Patch		Lidocaine 4%, Menthol 1%	PATCH	TOPICAL	20230914		OTC MONOGRAPH DRUG	M017	Anhui Miao De Tang Pharmaceutical Co., Ltd.	LIDOCAINE; MENTHOL	.04; .01	g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81486-001_b8f34e6d-6dc1-1ec9-e053-2a95a90a2d7a	81486-001	HUMAN OTC DRUG	Wotnot Naturals Natural Sunscreen SPF 30		ZINC OXIDE	LOTION	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part352	ECOdirect Pty Ltd (Trading as Wotnot Naturals)	ZINC OXIDE	250	mg/g			N	20241231
81486-002_ba48f7eb-0387-2827-e053-2a95a90a78ff	81486-002	HUMAN OTC DRUG	Wotnot Naturals Natural Sunscreen SPF 30		ZINC OXIDE	LOTION	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part352	ECOdirect Pty Ltd (Trading as Wotnot Naturals)	ZINC OXIDE	250	mg/g			N	20241231
81488-002_09069155-96aa-e4d9-e063-6294a90ab8cf	81488-002	HUMAN OTC DRUG	Mineffect skin protectant		Alumina, Calcarea Silicata, Magnesia Sulphurica, Silicea, Sulphur, Titanium Metallicum, Zincum Metallicum	SPRAY	TOPICAL	20210201		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	ALUMINUM OXIDE; CALCIUM SILICATE; MAGNESIUM SULFATE HEPTAHYDRATE; SILICON DIOXIDE; SULFUR; TITANIUM; ZINC	7; 6; 7; 4; 4; 7; 8	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81488-003_0906a66d-7248-a993-e063-6394a90a7150	81488-003	HUMAN OTC DRUG	Mineffect facial skin protectant and acne treatment solution		Alumina, Calcarea Silicata, Ferrum Metallicum, Magnesia Sulphurica, Phosphorus, Sulphur, Titanium Metallicum, Zincum Metallicum	SPRAY	TOPICAL	20210201		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	ALUMINUM OXIDE; CALCIUM SILICATE; IRON; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; SULFUR; TITANIUM; ZINC	7; 5; 7; 7; 6; 4; 7; 8	[hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL; [hp_X]/118mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81488-004_0906a804-bf9d-a63f-e063-6394a90a8e77	81488-004	HUMAN OTC DRUG	Mineffect first aid antiseptic and antibiotic solution		Silicea, Sulphur, Phosphorus, Calcarea Silicata, Natrum Nitricum, Ferrum Muriaticum, Kali Silicatum	SPRAY	TOPICAL	20210201		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM SILICATE; FERRIC CHLORIDE HEXAHYDRATE; PHOSPHORUS; POTASSIUM SILICATE; SILICON DIOXIDE; SODIUM NITRATE; SULFUR	5; 7; 6; 6; 4; 4; 4	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Iron [CS], Osmotic Activity [MoA], Osmotic Laxative [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
81488-005_09069632-9843-c1ad-e063-6294a90aa320	81488-005	HUMAN OTC DRUG	Mineffect nasal mist		Calcarea Silicata, Silicea, Sulphur, Natrum Muriaticum, Ferrum Metallicum, Ferrum Phosphoricum, Phosphorus, Ferrum Muriaticum, Titanium Metallicum,	SPRAY	NASAL	20210201		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM SILICATE; FERRIC CHLORIDE HEXAHYDRATE; FERROSOFERRIC PHOSPHATE; IRON; PHOSPHORUS; SILICON DIOXIDE; SODIUM CHLORIDE; SULFUR; TITANIUM	5; 7; 7; 7; 6; 4; 4; 4; 7	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA]		N	20241231
81488-007_0906a66d-7256-a993-e063-6394a90a7150	81488-007	HUMAN OTC DRUG	Mineffect hangover relief		Alumina Silicata, Calcarea Silicata, Silicea, Ferrum Metallicum, Ferrum Phosphoricum, Ferrum Muriaticum, Sulphur, Phosphorus	LIQUID	ORAL	20210601		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM SILICATE; FERRIC CHLORIDE HEXAHYDRATE; FERROSOFERRIC PHOSPHATE; IRON; KAOLIN; PHOSPHORUS; SILICON DIOXIDE; SULFUR	5; 7; 7; 7; 5; 6; 4; 4	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA]		N	20241231
81488-008_09069632-9851-c1ad-e063-6294a90aa320	81488-008	HUMAN OTC DRUG	Mineffect acid indigestion and heartburn relief		Alumina, Calcarea Silicata, Ferrum Metallicum, Ferrum Phosphoricum, Magnesia Muriatica, Natrum Nitricum, Phosphorus, Silicea, Zincum Metallicum	LIQUID	ORAL	20220121		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	ALUMINUM OXIDE; CALCIUM SILICATE; FERROSOFERRIC PHOSPHATE; IRON; MAGNESIUM CHLORIDE; PHOSPHORUS; SILICON DIOXIDE; SODIUM NITRATE; ZINC	5; 5; 7; 7; 4; 6; 4; 4; 8	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81488-009_0906ab71-cd97-8a1f-e063-6394a90ab610	81488-009	HUMAN OTC DRUG	Mineffect cold remedy		Calcarea Flourica, Ferrum Metallicum, Ferrum Phosphoricum, Phosphorus, Silicea, Sulphur, Zincum Metallicum	LIQUID	ORAL	20220121		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM FLUORIDE; FERROSOFERRIC PHOSPHATE; IRON; PHOSPHORUS; SILICON DIOXIDE; SULFUR; ZINC	6; 7; 7; 6; 4; 4; 8	[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL			N	20241231
81488-010_0339df62-44db-fd6e-e063-6394a90aa997	81488-010	HUMAN OTC DRUG	MEB Gluco-Vitality Patch		MEB Gluco-Vitality Patch	PATCH	TRANSDERMAL	20230801		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM FLUORIDE; IRON; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; SULFUR; VANADIUM; ZINC	6; 7; 7; 6; 4; 12; 8	[hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81488-011_0339df62-44db-fd6e-e063-6394a90aa997	81488-011	HUMAN OTC DRUG	MEB PainGuard Patch		MEB PainGuard Patch	PATCH	TRANSDERMAL	20230801		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM FLUORIDE; CALCIUM SILICATE; FERRIC CHLORIDE HEXAHYDRATE; FERROSOFERRIC PHOSPHATE; KAOLIN; MAGNESIUM CHLORIDE; MANGANESE; SODIUM NITRATE; SULFUR; VANADIUM; ZINC	6; 5; 7; 7; 5; 7; 12; 5; 4; 12; 8	[hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]; [hp_X]/12[hp_X]	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA]		N	20241231
81488-012_018125f2-ad4c-b38a-e063-6294a90a7f6e	81488-012	HUMAN OTC DRUG	MEB Puri-Mega		MEB Puri-Mega	LIQUID	ORAL	20230818		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM FLUORIDE; FERRIC CHLORIDE HEXAHYDRATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; PHOSPHORUS; SILICON DIOXIDE; SODIUM NITRATE; SULFUR; TITANIUM; ZINC	6; 7; 7; 7; 7; 6; 4; 5; 4; 7; 8	[hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Iron [CS], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81488-013_04a53245-9a12-49fa-e063-6394a90af203	81488-013	HUMAN OTC DRUG	MEB Puri-vega		MEB Puri-Vega	LIQUID	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Kadesh Incoporation Co,Ltd	CALCIUM FLUORIDE; FERROSOFERRIC PHOSPHATE; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; SILICON DIOXIDE; SODIUM NITRATE; SULFUR; ZINC	6; 7; 7; 7; 4; 5; 4; 8	[hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL; [hp_X]/300mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
81493-201_8b245746-5fe8-4008-82d5-ffa6c311fd15	81493-201	HUMAN OTC DRUG	Priia Tinted Mineral Sunscreen and Primer		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220122		OTC MONOGRAPH NOT FINAL	part352	Priia Cosmetics Inc	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
81493-203_e753539a-dcdf-447f-bba4-0e79f9214385	81493-203	HUMAN OTC DRUG	Priia Tinted Mineral Sunscreen and Primer		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20220122		OTC MONOGRAPH NOT FINAL	part352	Priia Cosmetics Inc	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
81502-001_d9194f69-0cbd-9a17-e053-2a95a90a277d	81502-001	HUMAN OTC DRUG	Dead Down Wind Unscented Soft Solid Antiperspirant and Deodorant		20% Aluminum Zirconium Tetrachlorohydrex Gly	STICK	TOPICAL	20210413		OTC MONOGRAPH FINAL	part350	Dead Down Wind, LLC	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	12.8	g/64g			N	20241231
81504-693_bd4a83d0-e665-5e7e-e053-2995a90adbb3	81504-693	HUMAN OTC DRUG	Han-San		Han-San	LIQUID	TOPICAL	20160916		OTC MONOGRAPH NOT FINAL	part333A	Pro-Line Industrial Products	ALCOHOL	67	mL/100mL			N	20241231
81507-002_0c645151-9c6d-9a6f-e063-6394a90abc30	81507-002	HUMAN OTC DRUG	Dermeleve		Aluminum Acetate	CREAM	TOPICAL	20210605		OTC MONOGRAPH DRUG	M016	Advanced Derm Solutions LLC	ALUMINUM ACETATE	.2	g/100g			N	20241231
81507-003_0c645754-26ae-f4eb-e063-6294a90a6ed2	81507-003	HUMAN OTC DRUG	Dermeleve		Aluminum Acetate	CREAM	TOPICAL	20220204		OTC MONOGRAPH DRUG	M016	Advanced Derm Solutions LLC	ALUMINUM ACETATE	.2	g/100g			N	20241231
81507-004_0c645151-9cb2-9a6f-e063-6394a90abc30	81507-004	HUMAN OTC DRUG	Dermeleve Anti Itch Scalp Serum		Aluminum Acetate	SOLUTION	TOPICAL	20230602		OTC MONOGRAPH DRUG	M016	Advanced Derm Solutions LLC	ALUMINUM ACETATE	.2	g/100mL			N	20241231
81515-500_08c196b2-7272-778c-e063-6294a90a2bd3	81515-500	HUMAN OTC DRUG	Peach and Lily Peaches Slices Acne Clarifying Cleanser		SALICYLIC ACID	GEL	TOPICAL	20210301		OTC MONOGRAPH DRUG	M006	Peach & Lily, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
81515-501_08c183af-2eb9-1e0b-e063-6294a90ab37b	81515-501	HUMAN OTC DRUG	Peach and Lily Peaches Slices Acne Exfoliating toner		SALICYLIC ACID	LIQUID	TOPICAL	20210301		OTC MONOGRAPH DRUG	M006	Peach & Lily Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
81515-502_08c1a8af-2e2d-682c-e063-6394a90a8892	81515-502	HUMAN OTC DRUG	Peach and Lily Peaches Slices Acne Oil Acne Free Moisturizer		SALICYLIC ACID	GEL	TOPICAL	20210301		OTC MONOGRAPH DRUG	M006	Peach & Lily, Inc.	SALICYLIC ACID	5	mg/mL			N	20241231
81520-100_26b97544-2b59-4dc7-9335-3c010885e5e6	81520-100	HUMAN PRESCRIPTION DRUG	VOQUEZNA		vonoprazan fumarate	TABLET	ORAL	20231110		NDA	NDA215151	Phathom Pharmaceuticals Inc.	VONOPRAZAN FUMARATE	13.36	mg/1			N	20241231
81520-200_26b97544-2b59-4dc7-9335-3c010885e5e6	81520-200	HUMAN PRESCRIPTION DRUG	VOQUEZNA		vonoprazan fumarate	TABLET	ORAL	20231110		NDA	NDA215151	Phathom Pharmaceuticals Inc.	VONOPRAZAN FUMARATE	26.72	mg/1			N	20241231
81520-250_28800cb1-5f87-4537-85fc-86ea1bac4a19	81520-250	HUMAN PRESCRIPTION DRUG	VOQUEZNA DUAL PAK		vonoprazan fumarate and amoxicillin	KIT		20231108		NDA	NDA215153	Phathom Pharmaceuticals Inc.						N	20241231
81520-255_28800cb1-5f87-4537-85fc-86ea1bac4a19	81520-255	HUMAN PRESCRIPTION DRUG	VOQUEZNA TRIPLE PAK		vonoprazan fumarate, amoxicillin and clarithromycin	KIT		20231108		NDA	NDA215152	Phathom Pharmaceuticals Inc.						N	20241231
81522-000_a0f0116d-b752-49b5-ba0e-e81d319887c3	81522-000	HUMAN OTC DRUG	caring mill all day allergy		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20210825	20240331	ANDA	ANDA078336	FSA Store Inc.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	
81522-001_13146f20-c6ee-4dc0-a3c3-3f9acfb05c70	81522-001	HUMAN OTC DRUG	caring mill lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20210830		ANDA	ANDA202319	FSA Store Inc.	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
81522-002_639f9c0f-a2a0-4547-8bca-6c7169b76d06	81522-002	HUMAN OTC DRUG	caring mill allergy relief nasal		Fluticasone propionate	SPRAY, METERED	NASAL	20210721		ANDA	ANDA207957	FSA Store Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
81522-005_8e416210-47dc-4f67-9408-62f4c00d616a	81522-005	HUMAN OTC DRUG	caring mill childrens allergy relief nasal		Fluticasone Propionate	SPRAY, METERED	NASAL	20211005		ANDA	ANDA207957	FSA Store Inc.	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
81522-006_591e2143-3e73-4504-9cab-fb66b7020c75	81522-006	HUMAN OTC DRUG	caring mill mucus er		guaifenesin	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20211102		ANDA	ANDA078912	FSA Store Inc.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
81522-045_faca91ed-e013-0961-e053-6294a90acc66	81522-045	HUMAN OTC DRUG	NAPROXEN SODIUM		NAPROXEN SODIUM	TABLET, COATED	ORAL	20230502		ANDA	ANDA079096	FSA STORE INC.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-056_f0479daa-9634-42d3-a904-5c48d334519c	81522-056	HUMAN OTC DRUG	caring mill nighttime		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate	CAPSULE, LIQUID FILLED	ORAL	20210903		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81522-068_fb34b0d3-ccc2-305e-e053-6394a90a231d	81522-068	HUMAN OTC DRUG	Tolnaftate		Antifungal Spray Liquid	AEROSOL, SPRAY	TOPICAL	20230508		OTC MONOGRAPH FINAL	part333C	FSA Store Inc.	TOLNAFTATE	10	mg/g			N	20241231
81522-069_fb3548d2-4600-1cee-e053-6294a90a6867	81522-069	HUMAN OTC DRUG	Menthol		Maximum Strength Medicated Foot Powder Talc Free	POWDER	TOPICAL	20230502		OTC MONOGRAPH NOT FINAL	part348	FSA Store Inc.	MENTHOL	10	mg/g			N	20241231
81522-073_ce6650f5-855a-4bc4-b673-a765ac61c213	81522-073	HUMAN OTC DRUG	Allergy Relief		fluticasone propionate	SPRAY, METERED	NASAL	20230323		ANDA	ANDA208024	FSA Store Inc. (Caring Mills)	FLUTICASONE PROPIONATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
81522-075_fabc40ff-3105-28b4-e053-6294a90a1ec9	81522-075	HUMAN OTC DRUG	Menthol		Maximum Strength Medicated Foot Powder Talc Free	POWDER	TOPICAL	20230502		OTC MONOGRAPH NOT FINAL	part348	FSA Store Inc.	MENTHOL	2.8	g/283g			N	20241231
81522-076_fb326743-4dbe-661e-e053-6394a90ae187	81522-076	HUMAN OTC DRUG	Wart Removers		Salicylic Acid	PATCH	TOPICAL	20230508		OTC MONOGRAPH FINAL	part358B	FSA Store Inc.	SALICYLIC ACID	.4	g/g			N	20241231
81522-077_fae3629c-2785-341d-e053-6294a90adc51	81522-077	HUMAN OTC DRUG	Maximum Strength Antifungal Liquid		Tolnaftate	LIQUID	TOPICAL	20230504		OTC MONOGRAPH FINAL	part333C	FSA Store Inc.	TOLNAFTATE	10	mg/mL			N	20241231
81522-078_fb2f4136-cf6e-f2b8-e053-6394a90a8584	81522-078	HUMAN OTC DRUG	Tolnaftate		Antifungal Spray Liquid	AEROSOL, SPRAY	TOPICAL	20230508		OTC MONOGRAPH FINAL	part333C	FSA Store Inc.	TOLNAFTATE	.15	g/150g			N	20241231
81522-081_3a7ac36f-1c51-4160-b1d8-04e499fd1bce	81522-081	HUMAN OTC DRUG	caring mill miconazole 3		Miconazole nitrate	KIT		20220106		ANDA	ANDA075329	FSA Store Inc.						N	20241231
81522-094_cfe59650-e3b4-4246-8fe8-9885c496f308	81522-094	HUMAN OTC DRUG	caring mill Sinus PE		Phenylephrine Hydrochloride	TABLET, FILM COATED	ORAL	20220112		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81522-095_faca6208-9140-d434-e053-6394a90ad95a	81522-095	HUMAN OTC DRUG	Acetaminophen PM		Acetaminophen and Diphenhydramine Hydrochloride	TABLET, COATED	ORAL	20230502		OTC MONOGRAPH FINAL	part341	FSA STORE INC.	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81522-104_faca928e-d1c7-095c-e053-6294a90a716a	81522-104	HUMAN OTC DRUG	Acetaminophen	Extra Strength	Acetaminophen	TABLET, COATED	ORAL	20230111		OTC MONOGRAPH NOT FINAL	part343	FSA Store Inc.	ACETAMINOPHEN	500	mg/1			N	20241231
81522-105_faca6663-6a67-d0e0-e053-6394a90ac2c6	81522-105	HUMAN OTC DRUG	Low dose Chewable Aspirin		ASPIRIN	TABLET, CHEWABLE	ORAL	20230502		OTC MONOGRAPH NOT FINAL	part343	FSA STORE INC.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
81522-109_f213097e-61a1-ed8d-e053-2a95a90a965a	81522-109	HUMAN OTC DRUG	Allergy Relief		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET, COATED	ORAL	20230111		OTC MONOGRAPH FINAL	part341	FSA STORE INC.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81522-112_a9314303-4e77-42f8-8937-53947d9b0504	81522-112	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	FSA Store Inc. (Caring Mills)	DOCOSANOL	100	mg/g			N	20241231
81522-119_faca7132-7c91-dfe4-e053-6294a90ac54d	81522-119	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, COATED	ORAL	20230111		ANDA	ANDA079174	FSA STORE INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-130_b816a046-fa6d-43f4-b000-271675f24512	81522-130	HUMAN OTC DRUG	caring mill childrens acetaminophen		Acetaminophen	SUSPENSION	ORAL	20210727		OTC MONOGRAPH NOT FINAL	part343	FSA Store Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
81522-141_aad803fa-9fe8-4dee-bc64-d7c4414275ce	81522-141	HUMAN OTC DRUG	caring mill famotidine		Famotidine	TABLET, FILM COATED	ORAL	20211021		ANDA	ANDA075400	FSA Store Inc.	FAMOTIDINE	10	mg/1	Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]		N	20241231
81522-185_f213039f-2da2-8ea9-e053-2995a90a9a82	81522-185	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	CAPSULE, LIQUID FILLED	ORAL	20230111		ANDA	ANDA079205	FSA STORE INC.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-194_f212fdf7-7ca0-ed89-e053-2a95a90ac688	81522-194	HUMAN OTC DRUG	Allergy Relief		Cetirizine hydrochloride	TABLET, COATED	ORAL	20230111		ANDA	ANDA209274	FSA STORE INC.	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81522-203_f212f808-9349-2b65-e053-2995a90a5775	81522-203	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230111		ANDA	ANDA213420	FSA STORE INC.	GUAIFENESIN	600	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
81522-204_faca6208-912f-d434-e053-6394a90ad95a	81522-204	HUMAN OTC DRUG	Mucus Relief		Guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20230502		ANDA	ANDA213420	FSA STORE INC.	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
81522-205_f212f808-9330-2b65-e053-2995a90a5775	81522-205	HUMAN OTC DRUG	Migraine Relief		ACETAMINOPHEN, ASPIRIN and CAFFEINE	TABLET	ORAL	20230111		ANDA	ANDA214039	FSA STORE INC.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
81522-285_1fd3d489-a719-4ddb-8ebc-8b400b54f53b	81522-285	HUMAN OTC DRUG	Childrens Acetaminophen	Dye Free Grape	Acetaminophen	SUSPENSION	ORAL	20220418		OTC MONOGRAPH NOT FINAL	part343	FSA Store Inc. (Caring Mills)	ACETAMINOPHEN	160	mg/5mL			N	20241231
81522-293_aae41060-1fd5-43ee-8392-6272b141cd3c	81522-293	HUMAN OTC DRUG	Childrens Allergy Relief	Dye Free Bubble Gum	Diphenhydramine Hydrochloride	LIQUID	ORAL	20220418		OTC MONOGRAPH FINAL	part341	FSA Store Inc. (Caring Mills)	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81522-374_994152a5-2d28-4a3f-b686-58c01fa09834	81522-374	HUMAN OTC DRUG	caring mill migraine relief		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210826		ANDA	ANDA075794	FSA Store Inc.	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
81522-393_f212641c-ab8f-62ff-e053-2a95a90a626e	81522-393	HUMAN OTC DRUG	Allergy Relief		Loratadine	TABLET	ORAL	20230111		ANDA	ANDA210722	FSA STORE INC.	LORATADINE	10	mg/1			N	20241231
81522-467_5669df0c-42bb-47f0-baf8-2c27ecc2fae2	81522-467	HUMAN OTC DRUG	caring mill aspirin		Aspirin	TABLET, CHEWABLE	ORAL	20211005		OTC MONOGRAPH NOT FINAL	part343	FSA Store Inc.	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
81522-475_403b939a-ce86-40bc-9434-d82276ef9e65	81522-475	HUMAN OTC DRUG	caring mill all day allergy		Cetirizine HCl	SOLUTION	ORAL	20210902		ANDA	ANDA204226	FSA Store Inc.	CETIRIZINE HYDROCHLORIDE	5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81522-490_dd9361bc-912b-4647-9e55-2d8a38f8a398	81522-490	HUMAN OTC DRUG	caring mill all day pain relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20210810		ANDA	ANDA074661	FSA Store Inc.	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-521_4eceaf79-3a94-441d-a557-5c04a40f5877	81522-521	HUMAN OTC DRUG	caring mill childrens ibuprofen		Ibuprofen	TABLET, CHEWABLE	ORAL	20210910		ANDA	ANDA076359	FSA Store Inc.	IBUPROFEN	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-604_f54d3f29-b25d-4e30-802a-13667fe98feb	81522-604	HUMAN OTC DRUG	caring mill ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20210727		ANDA	ANDA072096	FSA Store Inc.	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-612_ec53b677-42ac-4bad-8d56-52d2831cb4eb	81522-612	HUMAN OTC DRUG	caring mill allergy relief		Loratadine	TABLET	ORAL	20210727		ANDA	ANDA076301	FSA Store Inc.	LORATADINE	10	mg/1			N	20241231
81522-613_656f01c8-0010-416f-8df7-1bb00735b955	81522-613	HUMAN OTC DRUG	Allergy Relief		Fexofenadine HCl	TABLET, COATED	ORAL	20211008		ANDA	ANDA211075	FSA Store Inc. (Caring Mills)	FEXOFENADINE HYDROCHLORIDE	180	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81522-648_f13e19d3-9e31-4a04-9c83-0914541e8afc	81522-648	HUMAN OTC DRUG	caring mill nasal four		Phenylephrine hydrochloride	SPRAY	NASAL	20211005		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	PHENYLEPHRINE HYDROCHLORIDE	1	g/100mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81522-656_dc71f5de-dd84-4d7f-864c-77380ef57866	81522-656	HUMAN OTC DRUG	caring mill daytime cold and flu		acetaminophen, dextromethorphan Hbr, Phenylephrine HCl	SOLUTION	ORAL	20211119		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81522-700_086f55c9-08f1-4ea6-ad00-5b1765e3ca03	81522-700	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20220421		ANDA	ANDA074916	FSA Store Inc. (Caring Mills)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-725_f20184e2-1ccf-5c6b-e053-2a95a90ace4a	81522-725	HUMAN OTC DRUG	Caring Mill	Chest Rub	camphor, eucalyptus oil, menthol	OINTMENT	TOPICAL	20220128		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL, UNSPECIFIED FORM	48; 12; 26	mg/g; mg/g; mg/g			N	20241231
81522-734_901d97b4-e5ab-416b-bea2-5ad75045a57b	81522-734	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET, EXTENDED RELEASE	ORAL	20231231		ANDA	ANDA209692	FSA Store Inc. (Caring Mills)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81522-812_34efe9f6-c515-4283-8c2f-ef506bb2eed6	81522-812	HUMAN OTC DRUG	caring mill mucus dm		dextromethorphan HBr, guaifenesin	TABLET, EXTENDED RELEASE	ORAL	20211110		ANDA	ANDA207602	FSA Store Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81522-839_971f93de-0213-4831-867b-aeb0f0e3499e	81522-839	HUMAN OTC DRUG	caring mill childrens mucus relief		dextromethorphan HBr, guaifenesin, phenylephrine HCl	SOLUTION	ORAL	20211005		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	5; 100; 2.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81522-897_f2584603-36cf-4b2a-9299-7c1a07518f31	81522-897	HUMAN OTC DRUG	caring mill childrens ibuprofen		Ibuprofen	SUSPENSION	ORAL	20210914		ANDA	ANDA074937	FSA Store Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-898_42d8b4cb-6945-465e-b903-e5818d95c295	81522-898	HUMAN OTC DRUG	Daytime Cold and Flu		ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL	CAPSULE, LIQUID FILLED	ORAL	20221125		OTC MONOGRAPH FINAL	part341	FSA Store Inc. (Caring Mills)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81522-899_29753fef-4e86-4f22-b585-fbb3eacc7fa2	81522-899	HUMAN OTC DRUG	Night Time Cold and Flu Relief		Acetaminophen. Dextromethorphan HBr, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20221125		OTC MONOGRAPH FINAL	part341	FSA Store Inc. (Caring Mills)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81522-901_2497b993-1c79-4eaf-8e50-db6f9c9842d9	81522-901	HUMAN OTC DRUG	Daytime Nighttime Cold Flu Relief		Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, Phenylephrine HCL	KIT		20230131		OTC MONOGRAPH FINAL	part341	FSA Store Inc. (Caring Mills)						N	20241231
81522-915_9d0c13bc-c484-4192-aacf-2aa1c651f2cc	81522-915	HUMAN OTC DRUG	caring mill omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20210914		NDA	NDA022032	FSA Store Inc.	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
81522-916_1472e3b5-4849-4e9b-94de-199b955ac92a	81522-916	HUMAN OTC DRUG	Sleep Aid		Diphenhydramine HCL	CAPSULE	ORAL	20211008		OTC MONOGRAPH FINAL	part338	FSA Store Inc. (Caring Mills)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
81522-922_7f6cfb0e-6357-4328-8fb3-25e99a0f9e85	81522-922	HUMAN OTC DRUG	Cold Sore Treatment		Docosanol	CREAM	TOPICAL	20211008		ANDA	ANDA208754	FSA Store Inc. (Caring Mills)	DOCOSANOL	100	mg/g			N	20241231
81522-923_7a7cb11e-f748-4ece-be37-15686e9c4e1c	81522-923	HUMAN OTC DRUG	Cold Sore Fever Blister Treatment		Docosanol	CREAM	TOPICAL	20211008		ANDA	ANDA208754	FSA Store Inc. (Caring Mills)	DOCOSANOL	100	mg/g			N	20241231
81522-938_4d5620e3-33b4-411a-9b19-561762e312f5	81522-938	HUMAN OTC DRUG	Ibuprofen	Childrens	Ibuprofen	SUSPENSION	ORAL	20220415		ANDA	ANDA074916	FSA Store Inc. (Caring Mills)	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
81522-958_a5f7d6ba-0c8b-4c09-8d38-68b85ba4a511	81522-958	HUMAN OTC DRUG	Caring Mill Childrens Cough DM		dextromethorphan polistirex	SUSPENSION	ORAL	20211213		ANDA	ANDA091135	FSA Store Inc.	DEXTROMETHORPHAN HYDROBROMIDE	30	mg/5mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81522-987_0970ab90-d982-4681-9162-52c893bcf114	81522-987	HUMAN OTC DRUG	caring mill childrens cold and cough		Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl	SOLUTION	ORAL	20210902		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 10; 5	mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81522-994_af803685-2e3f-4ad8-91eb-e993a90fc3fd	81522-994	HUMAN OTC DRUG	caring mill daytime		Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl	CAPSULE, LIQUID FILLED	ORAL	20220216		OTC MONOGRAPH FINAL	part341	FSA Store Inc.	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
81526-001_0b515520-4fd5-0872-e063-6294a90a0cc5	81526-001	HUMAN OTC DRUG	TM TITUS MEDICAL ANTISEPTIC Non Sterile		POVIDONE-IODINE	SOLUTION	TOPICAL	20210204		OTC MONOGRAPH DRUG	M003	Titus Medical LLC	POVIDONE-IODINE	1	g/100mL			N	20241231
81526-002_0b515218-f4a6-0b9c-e063-6294a90a337d	81526-002	HUMAN OTC DRUG	TM Titus Medical Povidone Iodine		POVIDONE-IODINE	OINTMENT	TOPICAL	20210621		OTC MONOGRAPH DRUG	M003	Titus Medical LLC	POVIDONE-IODINE	1	g/100g			N	20241231
81533-200_0d9561e6-8902-600e-e063-6294a90a2a79	81533-200	HUMAN OTC DRUG	Capsaicin Cream		Capsaicin	CREAM	TOPICAL	20220714		OTC MONOGRAPH DRUG	M017	Noble OTC LLC	CAPSAICIN	.1	g/100g			N	20241231
81533-600_dfeb9b83-7ff4-4268-94b5-e6988a64ce06	81533-600	HUMAN OTC DRUG	NobleAid PAIN RELIEVER		Aspirin	TABLET, DELAYED RELEASE	ORAL	20211115		OTC MONOGRAPH NOT FINAL	part343	Noble Otc LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
81535-210_80cd6814-9d07-4b69-908e-bbcf5ccacf8a	81535-210	HUMAN OTC DRUG	Face and Body Mineral SPF - Tinted		Titanium Dioxide, Zinc Oxide	AEROSOL, FOAM	TOPICAL	20180424		OTC MONOGRAPH NOT FINAL	part352	Flawless Skin Care, LLC (dba Abby Skin Clinic)	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
81535-211_be28ca4c-97a8-4e3d-9c94-e2199ec95db4	81535-211	HUMAN OTC DRUG	Face and Body Mineral SPF Non-Tinted		Titanium Dioxide, Zinc Oxide	AEROSOL, FOAM	TOPICAL	20180424		OTC MONOGRAPH NOT FINAL	part352	Flawless Skin Care, LLC (dba Abby Skin Clinic)	TITANIUM DIOXIDE; ZINC OXIDE	30; 100	mg/g; mg/g			N	20241231
81537-102_06e86339-8bb1-2eac-e063-6394a90acde8	81537-102	HUMAN OTC DRUG	Nutrascreen		Replenish and Protect Day Cream	LOTION	TOPICAL	20160314		OTC MONOGRAPH DRUG	M020	Danne Montague King	ZINC OXIDE	19.8	g/100mL			N	20241231
81537-103_06c00fab-af76-d477-e063-6294a90a1083	81537-103	HUMAN OTC DRUG	Acu Moist		Hydrating Lotion with SPF 15	LOTION	TOPICAL	20131206		OTC MONOGRAPH DRUG	M020	Danne Montague King	ZINC OXIDE	8.67	g/100mL			N	20241231
81537-104_076171d0-7308-d126-e063-6394a90afafd	81537-104	HUMAN OTC DRUG	Nutrascreen Color Balanced		Zinc Oxide	LOTION	TOPICAL	20220815		OTC MONOGRAPH DRUG	M020	DMK - Danne Montague King	ZINC OXIDE	20.24	g/100mL			N	20241231
81537-105_0774809c-3169-fd07-e063-6394a90aeeac	81537-105	HUMAN OTC DRUG	Soft Touch		Sunscreen with SPF 30	LOTION	TOPICAL	20210825		OTC MONOGRAPH DRUG	M020	Danne Montague King	ZINC OXIDE	23.12	g/100mL			N	20241231
81537-106_07792518-524f-569f-e063-6294a90aaa22	81537-106	HUMAN OTC DRUG	DMK MD Satinscreen		Broad Spectrum SPF 40 Sunscreen	LOTION	TOPICAL	20220825		OTC MONOGRAPH DRUG	M020	Danne Montague King	ZINC OXIDE	24.99	g/100mL			N	20241231
81542-201_04b759b5-ac3c-f32f-e063-6294a90a41d9	81542-201	HUMAN PRESCRIPTION DRUG	UREA		UREA	LOTION	TOPICAL	20210907	20250630	UNAPPROVED DRUG OTHER		Bantry Pharma, LLC	UREA	400	mg/g			N	
81542-202_04b71a07-20e9-a089-e063-6294a90a4fe1	81542-202	HUMAN PRESCRIPTION DRUG	SULFACETAMIDE SODIUM, SULFUR		SULFACETAMIDE SODIUM, SULFUR	SOLUTION	TOPICAL	20230208	20250531	UNAPPROVED DRUG OTHER		Bantry Pharma, LLC	SULFACETAMIDE SODIUM; SULFUR	100; 50	mg/mL; mg/mL	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	
81545-101_f1f190da-554c-55cb-e053-2a95a90a2871	81545-101	HUMAN OTC DRUG	MINERAL SUNSCREEN	SPF 30	ZINC OXIDE	LOTION	TOPICAL	20210917		OTC MONOGRAPH NOT FINAL	part352	Lee Indie & Co Inc	ZINC OXIDE	20	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81545-102_eb070c0e-d7f0-f554-e053-2995a90a392b	81545-102	HUMAN OTC DRUG	DAILY SPF PRIMER	SPF 50	ZINC OXIDE	LOTION	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part352	Lee Indie & Co Inc	ZINC OXIDE	12	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81550-010_15b8cb91-db70-423a-b551-3fb294ee2aee	81550-010	HUMAN OTC DRUG	SELEX DNA		Zinc Pyrithione	SHAMPOO	TOPICAL	20210201		OTC MONOGRAPH DRUG	M032	NEXMOS Co., Ltd.	PYRITHIONE ZINC	5	g/500mL			N	20241231
81551-063_e99b4b38-5abb-3ccd-e053-2a95a90a1bc0	81551-063	HUMAN OTC DRUG	Novo ProSeries Antibacterial	Foaming	Chloroxylenol	LIQUID	TOPICAL	20210427	20240614	OTC MONOGRAPH NOT FINAL	part333E	Noble Chemical	CHLOROXYLENOL	.3	g/100mL			N	
81551-064_f2794ede-7b0b-baa4-e053-2995a90a143a	81551-064	HUMAN OTC DRUG	Novo ProSeries Foaming Sanitizing		Benzalkonium chloride	LIQUID	TOPICAL	20210427	20240217	OTC MONOGRAPH NOT FINAL	part333E	Noble Chemical	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
81551-075_f2794ede-7b0c-baa4-e053-2995a90a143a	81551-075	HUMAN OTC DRUG	Novo ProSeries Foaming Instant Hand Sanitizer		Benzalkonium Chloride	LIQUID	TOPICAL	20210427	20240705	OTC MONOGRAPH NOT FINAL	part333E	Noble Chemical	BENZALKONIUM CHLORIDE	.1	g/100mL			N	
81551-693_092d5414-61f9-61bd-e063-6394a90a0100	81551-693	HUMAN OTC DRUG	Instant Hand Sanitizer		Instant Hand Sanitizer	LIQUID	TOPICAL	20200522		OTC MONOGRAPH DRUG	505G(a)(3)	Clark Core Services, LLC	ALCOHOL	67	mL/100mL			N	20241231
81553-001_f1e96fe0-0675-26a8-e053-2a95a90ae60b	81553-001	HUMAN OTC DRUG	bourn Hair Regrowth Treatment for Men		Minoxidil 5%	SOLUTION	TOPICAL	20210204		ANDA	ANDA076239	Octri, Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81555-201_0ae24f02-32ed-5a0b-e063-6394a90ab8eb	81555-201	HUMAN OTC DRUG	FYENACEL CALMING SHOOTER CELLANDIR HAIR LOSS-Shampoo		SALICYLIC ACID	SHAMPOO	TOPICAL	20210219		UNAPPROVED DRUG OTHER		H.L.C GROUP Co., ltd	SALICYLIC ACID	2	mg/100mL			N	20241231
81555-202_0ae285fc-b1e6-74b7-e063-6394a90a3cc8	81555-202	HUMAN OTC DRUG	CELLANDIR SCALP AMPOULE		Menthol, Salicylic Acid, Allantoin	LIQUID	TOPICAL	20210506		OTC MONOGRAPH DRUG	M016	H.L.C GROUP Co., ltd	ALLANTOIN; MENTHOL, UNSPECIFIED FORM; SALICYLIC ACID	.05; .3; .25	mg/100mL; mg/100mL; mg/100mL			N	20241231
81555-203_0ae25750-b9e6-a7cc-e063-6294a90a3784	81555-203	HUMAN OTC DRUG	SeboRaserShampoo		SALICYLIC ACID	SHAMPOO	TOPICAL	20211021		UNAPPROVED DRUG OTHER		H.L.C GROUP Co., ltd	SALICYLIC ACID	.2	mg/100mL			N	20241231
81555-301_0ae28065-c851-6878-e063-6394a90abbba	81555-301	HUMAN OTC DRUG	Confiche Anti-Hair LossShampoo		Salicylic Acid	SHAMPOO	TOPICAL	20221001		UNAPPROVED DRUG OTHER		H.L.C GROUP Co., ltd	SALICYLIC ACID	2	mg/100mL			N	20241231
81565-205_f781b62a-e8a8-4994-9e8c-64d66e107c06	81565-205	HUMAN PRESCRIPTION DRUG	Fentanyl Citrate		Fentanyl Citrate	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230111		NDA	NDA019101	Phlow Corp.	FENTANYL CITRATE	50	ug/mL	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CII	N	20241231
81565-206_88c5271c-91cc-4903-92f6-6eee059a8b31	81565-206	HUMAN PRESCRIPTION DRUG	Vecuronium Bromide		Vecuronium Bromide	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20190801		ANDA	ANDA203725	Phlow Corp.	VECURONIUM BROMIDE	10	mg/1	Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]		N	20241231
81568-101_4c5f8adf-9f74-46e5-bea4-9d6ca39d2765	81568-101	HUMAN OTC DRUG	dr. brandt SUN SHIELD SPF 50		Zinc Oxide	LIQUID	TOPICAL	20210215		OTC MONOGRAPH NOT FINAL	part352	Dr. Brandt	ZINC OXIDE	17	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81574-001_f277cc95-fed9-16c3-e053-2995a90a7c6c	81574-001	HUMAN OTC DRUG	Skinlycious Glow Exfoliant		Salicylic Acid	LIQUID	TOPICAL	20210701		OTC MONOGRAPH FINAL	part333D	Skinlycious Pte Ltd	SALICYLIC ACID	2	g/100mL			N	20241231
81574-002_f2780f75-d066-1af7-e053-2995a90af23d	81574-002	HUMAN OTC DRUG	Skinlycious Multi Protection Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide , Zinc Oxide	CREAM	TOPICAL	20210701		OTC MONOGRAPH NOT FINAL	part352	Skinlycious Pte Ltd	TITANIUM DIOXIDE; ZINC OXIDE	3.3; 13.8	g/100mL; g/100mL			N	20241231
81574-003_f27be283-a074-4b3d-e053-2995a90af5a5	81574-003	HUMAN OTC DRUG	Skinlycious Clear Skin Essentials Starter kit		SALICYLIC ACID	KIT		20210701		OTC MONOGRAPH FINAL	part333D	Skinlycious Pte Ltd						N	20241231
81582-0001_fb501945-bcd1-289b-e053-6394a90ad926	81582-0001	HUMAN OTC DRUG	Etiquette Sterilization wet wipes		ALCOHOL	LIQUID	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part333A	YOOSEUNG IN NATURE Co.,Ltd	ALCOHOL	60	g/1001			N	20241231
81583-100_397d3c52-dea3-489e-a843-dc93b4185cdf	81583-100	HUMAN PRESCRIPTION DRUG	ZTALMY		ganaxolone	SUSPENSION	ORAL	20220606		NDA	NDA215904	Marinus Pharmaceuticals, Inc.	GANAXOLONE	50	mg/mL	GABA A Receptor Positive Modulators [MoA], Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]	CV	N	20241231
81584-1102_7bad4367-4449-46e9-8e5a-61296bc466fd	81584-1102	HUMAN OTC DRUG	Povidone Iodine		POVIDONE-IODINE	OINTMENT	TOPICAL	20210630		OTC MONOGRAPH DRUG	M005	Dr Radows	POVIDONE-IODINE	100	mg/g			N	20241231
81587-622_f2146723-ee50-1753-e053-2995a90ac5b9	81587-622	HUMAN OTC DRUG	NEEM HAND SANITIZER		HAND SANITIZER	SPRAY	TOPICAL	20210801		OTC MONOGRAPH NOT FINAL	part333A	Maharishi Ayur-Ved Products International Corporation	ALCOHOL	62	mL/100mL			N	20241231
81591-001_bc40ac4f-6c0f-82fd-e053-2995a90a5db3	81591-001	HUMAN OTC DRUG	Micro-Aseptic		CHLOROXYLENOL	LIQUID	TOPICAL	20210226		OTC MONOGRAPH NOT FINAL	part333A	ASEPTIC CONTROL PRODUCTS, INC.	CHLOROXYLENOL	.6	g/100mL			N	20241231
81603-625_0a530f20-70da-9350-e063-6294a90a1ce3	81603-625	HUMAN OTC DRUG	Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20220204		OTC MONOGRAPH DRUG	M003	Htl-Strefa, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
81607-005_96a1d1a1-1b78-4199-9770-08093ef03b39	81607-005	HUMAN PRESCRIPTION DRUG	ARSENIC TRIOXIDE		arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20230531		ANDA	ANDA217413	Orbicular Pharmaceutical Technologies Private Limited	ARSENIC TRIOXIDE	1	mg/mL			N	20241231
81607-006_96a1d1a1-1b78-4199-9770-08093ef03b39	81607-006	HUMAN PRESCRIPTION DRUG	ARSENIC TRIOXIDE		arsenic trioxide	INJECTION, SOLUTION	INTRAVENOUS	20230531		ANDA	ANDA217413	Orbicular Pharmaceutical Technologies Private Limited	ARSENIC TRIOXIDE	2	mg/mL			N	20241231
81609-201_0e91a2e1-6f7b-8eaf-e063-6294a90a61e2	81609-201	HUMAN OTC DRUG	Dr. Forest Hand Sanitizer		QUERCUS ACUTISSIMA WHOLE, CHAMAECYPARIS OBTUSA WHOLE, CRYPTOMERIA JAPONICA BARK	LIQUID	TOPICAL	20210219		UNAPPROVED DRUG OTHER		Forest On Co., Ltd	CHAMAECYPARIS OBTUSA WHOLE; CRYPTOMERIA JAPONICA BARK; QUERCUS ACUTISSIMA WHOLE	1; 1; 1	mg/100mL; mg/100mL; mg/100mL			N	20251231
81614-015_bbbb933e-34a9-143a-e053-2995a90a7c91	81614-015	HUMAN OTC DRUG	Antibacterial Hand Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20210217		OTC MONOGRAPH NOT FINAL	part333A	Orange (Fujian) Sanitary Products Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
81614-075_bbea063f-e211-1118-e053-2a95a90a3601	81614-075	HUMAN OTC DRUG	75% ALCOHOL WIPES		ALCOHOL	CLOTH	TOPICAL	20210217		OTC MONOGRAPH NOT FINAL	part333A	Orange (Fujian) Sanitary Products Co., Ltd.	ALCOHOL	75	mL/100mL			N	20241231
81625-548_fc711743-ad12-7879-e053-6394a90ac31a	81625-548	HUMAN OTC DRUG	Vaask Moisturizing Hand Sanitizer		Ethyl alcohol	GEL	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part333A	Vaask, LLC	ALCOHOL	.7	mL/mL			N	20241231
81628-693_bdac178f-b728-45b6-e053-2995a90a855e	81628-693	HUMAN OTC DRUG	Gel Antiseptic Handwash		Gel Antiseptic Handwash	LIQUID	TOPICAL	20121116		OTC MONOGRAPH NOT FINAL	part333A	Shop Bee's Wax LLC	ALCOHOL	67	mL/100mL			N	20241231
81630-001_ea824804-fc93-47ae-bc50-706155a8ef91	81630-001	HUMAN OTC DRUG	Wash-Free Surgical Hand Disinfectant Gel	II	Ethanol	GEL	TOPICAL	20210312		OTC MONOGRAPH NOT FINAL	part333A	Shan Dong Lircon Medical Technology Co., Ltd	ALCOHOL	64.8	mL/100mL			N	20241231
81630-003_178ff765-af2b-4025-8fca-61190f4bfec6	81630-003	HUMAN OTC DRUG	Wash-Free Surgical Hand Disinfectant Gel II		Ethanol	GEL	TOPICAL	20210331		OTC MONOGRAPH NOT FINAL	part333A	Shan Dong Lircon Medical Technology Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
81632-001_f1e95bc6-e987-ec93-e053-2a95a90a0a50	81632-001	HUMAN OTC DRUG	Mens Intelligent Hair Regrowth Treatment		Minoxidil 5%	SOLUTION	TOPICAL	20211104		ANDA	ANDA076239	Intelligent Elephant LLC.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81632-408_fc6dc3bd-fab3-7884-e053-6394a90a79f1	81632-408	HUMAN OTC DRUG	INTELLIGENT Mens Minoxidil Extra Strength 5 Minoxidil		MINOXIDIL	LIQUID	TOPICAL	20230605		ANDA	ANDA076239	INTELLIGENT ELEPHANT, LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81634-001_f90effbe-3915-8f70-e053-6294a90aedfd	81634-001	HUMAN OTC DRUG	Ollie Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210401		OTC MONOGRAPH NOT FINAL	part333A	F.P. Aromatics Singapore Pte Ltd	ALCOHOL	70	mL/100mL			N	20241231
81637-139_09e261d4-ab14-c829-e063-6294a90a8e85	81637-139	HUMAN OTC DRUG	PROJECT REEF SPF-30 Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20210308		OTC MONOGRAPH DRUG	M020	Project Reef LLC	ZINC OXIDE	140	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81637-179_0976cb4f-2ad9-fc33-e063-6394a90a11c7	81637-179	HUMAN OTC DRUG	PROJECT REEF SPF-50		ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20210405		OTC MONOGRAPH DRUG	M020	Project Reef LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 140	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81637-289_09e272c0-a7da-0c1f-e063-6394a90ac62e	81637-289	HUMAN OTC DRUG	PROJECT REEF Mineral Sunscreen SPF-30		ZINC OXIDE	LOTION	TOPICAL	20220321		OTC MONOGRAPH DRUG	M020	Project Reef LLC	ZINC OXIDE	140	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81637-299_09e285b2-b615-08b4-e063-6394a90a8964	81637-299	HUMAN OTC DRUG	PROJECT REEF Mineral Sunscreen SPF-50		ZINC OXIDE, TITANIUM DIOXIDE	LOTION	TOPICAL	20220321		OTC MONOGRAPH DRUG	M020	Project Reef LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 140	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81638-171_09e272c0-a7eb-0c1f-e063-6394a90ac62e	81638-171	HUMAN OTC DRUG	EARLY MOMMY Baby Bum Butta		ZINC OXIDE	OINTMENT	TOPICAL	20210301		OTC MONOGRAPH DRUG	M016	TEKT TONE LABS LLC	ZINC OXIDE	140	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81641-001_06c2f709-de38-61a5-e063-6394a90acb91	81641-001	HUMAN OTC DRUG	Magical Mist Hand Sanitizer		Isopropyl Alcohol	SPRAY	TOPICAL	20200330		OTC MONOGRAPH DRUG	505G(a)(3)	Just Peachy Life	ISOPROPYL ALCOHOL	95.07	mL/100mL			N	20241231
81649-030_f268083a-cd6a-5b85-e053-2a95a90aae67	81649-030	HUMAN OTC DRUG	Neurodexx		Pain Relief	LOTION	TOPICAL	20210501		OTC MONOGRAPH NOT FINAL	part348	Rely Wellness	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.015; 6; 18	g/60mL; g/60mL; g/60mL			N	20241231
81651-0001_d548284c-6aca-465f-e053-2995a90a0247	81651-0001	HUMAN OTC DRUG	COZACO MAN		Red ginseng	TABLET	ORAL	20210310		UNAPPROVED DRUG OTHER		Kone Bio Logics Co., Ltd.	PANAX GINSENG ROOT OIL	21.19	1/1			N	20241231
81651-0002_d5483787-9c25-9588-e053-2a95a90a9972	81651-0002	HUMAN OTC DRUG	COZACO WOMAN		Red ginseng	TABLET	ORAL	20210310		UNAPPROVED DRUG OTHER		Kone Bio Logics Co., Ltd.	PANAX GINSENG ROOT OIL	44.2	1/1			N	20241231
81653-001_0cd80cfa-4153-5edc-e063-6294a90a4e01	81653-001	HUMAN OTC DRUG	BUNEE Hair Growth Serum		Minoxidil	LIQUID	TOPICAL	20210305		UNAPPROVED DRUG OTHER		Guangzhou Jianyuan Biological Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-002_0cd80519-c4ce-73cb-e063-6294a90ad6f6	81653-002	HUMAN OTC DRUG	ELEVATE HAIR GROWTH SERUM		Minoxidil	LIQUID	TOPICAL	20220323		UNAPPROVED DRUG OTHER		Guangzhou Jianyuan Biological Technology.Co.,Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-003_0cd7ec70-0743-2e9e-e063-6394a90a2f55	81653-003	HUMAN OTC DRUG	HAIRFX HAIR GROWTH FOAM		Minoxidil	AEROSOL, FOAM	TOPICAL	20220323		UNAPPROVED DRUG OTHER		Guangzhou Jianyuan Biological Technology.Co.,Ltd	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-004_0cd80a91-b353-773c-e063-6294a90ab344	81653-004	HUMAN OTC DRUG	ELEVATE BEARD GROWTH SERUM		Minoxidil	LIQUID	TOPICAL	20220513		UNAPPROVED DRUG OTHER		Guangzhou Jianyuan Biological Technology.Co.,Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-008_0b313113-4571-3bcc-e063-6294a90a66da	81653-008	HUMAN OTC DRUG	Regenivade Hair Growth Foam		Regenivade Hair Growth (Serum) Foam	LIQUID	TOPICAL	20231112		ANDA	ANDA075357	Guangzhou Jianyuan Biological Technology.Co.,Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-009_0b313556-868c-ec8c-e063-6394a90ad076	81653-009	HUMAN OTC DRUG	PROFOLIX MINOXIDIL HAIR GROWTH SERUM		PROFOLIX MINOXIDIL HAIR GROWTH SERUM	LIQUID	TOPICAL	20231112		ANDA	ANDA075357	Guangzhou Jianyuan Biological Technology.Co.,Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-011_0c103fb8-e463-dead-e063-6394a90abd9a	81653-011	HUMAN OTC DRUG	FINALLY HAIR MINOXIDIL 5% HAIR GROWTH FOAM		HAIR GROWTH FOAM (SERUM)	LIQUID	TOPICAL	20231208		ANDA	ANDA075357	Guangzhou Jianyuan Biological Technology Co.,Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-012_0cd9629f-694d-1c5e-e063-6294a90ab388	81653-012	HUMAN OTC DRUG	FINALLY HAIR MINOXIDIL 5% HAIR GROWTH SERUM		MINOXIDIL 5% HAIR GROWTH SERUM	LIQUID	TOPICAL	20231218		ANDA	ANDA075357	Guangzhou Jianyuan Biological Technology Co.,Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81653-013_0d8c178e-948d-617e-e063-6394a90a4f2d	81653-013	HUMAN OTC DRUG	SOTI HAIR GROWTH SERUM		Minoxidil	LIQUID	TOPICAL	20231204		UNAPPROVED DRUG OTHER		Guangzhou Jianyuan Biological Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81665-100_0391d6a3-a297-5712-e063-6394a90a3208	81665-100	HUMAN PRESCRIPTION DRUG	LEVETIRACETAM	Extended-release	LEVETIRACETAM	TABLET, EXTENDED RELEASE	ORAL	20200611		ANDA	ANDA212688	Omnivium Pharmaceuticals LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
81665-200_ada1be4a-11f4-4850-b98c-88e6ef02cd31	81665-200	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20230616		ANDA	ANDA216364	OMNIVIUM PHARMACEUTICALS LLC.	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
81665-301_4aa46865-9d43-4f88-b5d3-81200c6ec945	81665-301	HUMAN PRESCRIPTION DRUG	cocaine hydrochloride nasal		cocaine hydrochloride nasal	SOLUTION	TOPICAL	20231015		NDA AUTHORIZED GENERIC	NDA209575	OMNIVIUM PHARMACEUTICALS LLC.	COCAINE HYDROCHLORIDE	40	mg/mL		CII	N	20241231
81670-000_089ee9d3-7994-9ff3-e063-6394a90ae14a	81670-000	HUMAN OTC DRUG	BANANA SCENT ANTI GERM		ALCOHOL	SPRAY	TOPICAL	20210324		OTC MONOGRAPH DRUG	505G(a)(3)	F21 OpCo, LLC	ALCOHOL	62	mL/100mL			N	20241231
81670-001_089f0e30-618c-0b60-e063-6294a90a5f87	81670-001	HUMAN OTC DRUG	STRAWBERRY SCENT ANTI GERM		ALCOHOL	SPRAY	TOPICAL	20210324		OTC MONOGRAPH DRUG	505G(a)(3)	F21 OpCo, LLC	ALCOHOL	62	mL/100mL			N	20241231
81670-002_089f4065-6b21-3c04-e063-6294a90a48b7	81670-002	HUMAN OTC DRUG	ALOE VERA SCENT ANTI GERM		ALCOHOL	SPRAY	TOPICAL	20211022		OTC MONOGRAPH DRUG	505G(a)(3)	F21 OpCo,LLC	ALCOHOL	62	mL/100mL			N	20241231
81670-003_089f0e30-619b-0b60-e063-6294a90a5f87	81670-003	HUMAN OTC DRUG	BERRY SCENT ANTI GERM		ALCOHOL	SPRAY	TOPICAL	20211022		OTC MONOGRAPH DRUG	505G(a)(3)	F21 OpCo,LLC	ALCOHOL	62	mL/100mL			N	20241231
81672-5051_00ef33c1-86d8-2846-e063-6394a90ad76d	81672-5051	HUMAN PRESCRIPTION DRUG	VTAMA		tapinarof	CREAM	TOPICAL	20220526		NDA	NDA215272	Dermavant Sciences, Inc.	TAPINAROF	10	mg/g	Aryl Hydrocarbon Receptor Agonist [EPC], Aryl Hydrocarbon Receptor Agonists [MoA]		N	20241231
81676-001_bc001ba9-b0c2-4843-a89e-d93f46a8b3b0	81676-001	HUMAN PRESCRIPTION DRUG	Oxygen		oxygen	GAS	RESPIRATORY (INHALATION)	20210308		NDA	NDA206023	Joerns LLC	OXYGEN	99	L/100L			N	20241231
81678-000_08aa9221-ffb1-277e-e063-6294a90aa372	81678-000	HUMAN OTC DRUG	Summer Fridays Shadedrops Broad Spectrum SPF 30 Mineral Milk Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	Summer Fridays LLC	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81679-203_633790a2-e688-4c18-a675-56d0385c3971	81679-203	HUMAN OTC DRUG	HUTTON KLEIN HK DERMATOLOGISTS SPF 40 Mineral Based Facial Sunscreen Tinted		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20170217		OTC MONOGRAPH DRUG	M020	Hutton, Kathleen MD	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
81679-212_1a51eea6-cbb2-465a-a11f-f9047a8faaed	81679-212	HUMAN OTC DRUG	Mineral Lip Sunscreen		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20170217		OTC MONOGRAPH DRUG	M020	Hutton, Kathleen MD	TITANIUM DIOXIDE; ZINC OXIDE	40; 55	mg/g; mg/g			N	20241231
81681-001_08049197-7d4f-2425-e063-6294a90aadf6	81681-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20210309		NDA	NDA205767	WEST PENN LACO, INC.	OXYGEN	998	mL/L			N	20241231
81681-002_0804987d-a026-2f75-e063-6294a90a43f3	81681-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20210309		NDA	NDA205766	WEST PENN LACO, INC.	NITROGEN	999	mL/L			N	20241231
81683-003_bd4fdff1-9175-31c2-e053-2a95a90a749f	81683-003	HUMAN OTC DRUG	RockSauce ICY COLD PAIN RELIEF		Menthol	GEL	TOPICAL	20210318		OTC MONOGRAPH NOT FINAL	part348	Implus Footcare, LLC	MENTHOL	8.3	g/88.5mL			N	20241231
81683-012_bdc7c7f3-ac99-8fe9-e053-2a95a90a2663	81683-012	HUMAN OTC DRUG	RockSauce ICY COLD PAIN RELIEF		Menthol	GEL	TOPICAL	20210318		OTC MONOGRAPH NOT FINAL	part348	Implus Footcare, LLC	MENTHOL	33.2	g/355mL			N	20241231
81683-013_bdee3366-9056-0664-e053-2995a90ac4a0	81683-013	HUMAN OTC DRUG	RockSauce FIERY HOT PAIN RELIEF		Methyl Salicylate, Menthol, Capsaicin	CREAM	TOPICAL	20210318		OTC MONOGRAPH NOT FINAL	part348	Implus Footcare, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.0018; 9.02; 18	g/88.5mL; g/88.5mL; g/88.5mL			N	20241231
81683-025_cc7cbf28-a34e-4187-e053-2a95a90a0de7	81683-025	HUMAN OTC DRUG	RockSauce FIERY HOT PAIN RELIEF		Methyl Salicylate, Menthol, Capsaicin	CREAM	TOPICAL	20210921		OTC MONOGRAPH NOT FINAL	part348	Implus Footcare, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.00005; .25; .5	g/2.45mL; g/2.45mL; g/2.45mL			N	20241231
81683-112_bdee959b-6d1e-5879-e053-2995a90a31c4	81683-112	HUMAN OTC DRUG	RockSauce FIERY HOT PAIN RELIEF		Methyl Salicylate, Menthol, Capsaicin	CREAM	TOPICAL	20210318		OTC MONOGRAPH NOT FINAL	part348	Implus Footcare, LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.00724; 36.2; 72.4	g/355mL; g/355mL; g/355mL			N	20241231
81689-020_7469ceca-8e51-450c-8981-41b12b477d8b	81689-020	HUMAN OTC DRUG	JUVEHEAL B Ampoule		Niacinamide, Adenosine	LIQUID	TOPICAL	20210301		UNAPPROVED DRUG OTHER		J MEDICAL Inter Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
81689-030_02a62a0e-564a-4a9b-953b-b3b46c06bed0	81689-030	HUMAN OTC DRUG	JUVEHEAL W Ampoule		Niacinamide	LIQUID	TOPICAL	20210301		UNAPPROVED DRUG OTHER		J MEDICAL Inter Co., Ltd.	NIACINAMIDE	2	g/100mL			N	20241231
81689-040_f9e372bb-613f-4d9d-ae4f-cbbcc61ec949	81689-040	HUMAN OTC DRUG	JUVEHEAL A Ampoule		Adenosine	LIQUID	TOPICAL	20210301		UNAPPROVED DRUG OTHER		J MEDICAL Inter Co., Ltd.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
81689-050_e511ef9b-364c-49f8-b511-3ca8523ea3bf	81689-050	HUMAN OTC DRUG	JUVEHEAL Hydro Synergy Balancing LHA Toner		NIACINAMIDE, ADENOSINE	LIQUID	TOPICAL	20220801		UNAPPROVED DRUG OTHER		J MEDICAL Inter Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
81689-060_0f69473f-5c77-4da0-b5da-6b4952beb8ec	81689-060	HUMAN OTC DRUG	JUVEHEAL Hydro Synergy Intensive Serum		NIACINAMIDE, ADENOSINE	LIQUID	TOPICAL	20220801		UNAPPROVED DRUG OTHER		J MEDICAL Inter Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
81689-070_6d8d26ac-fd07-4e8f-9aa8-8dd0ad9b97bc	81689-070	HUMAN OTC DRUG	JUVEHEAL Hydro Synergy Liposome Barrier		NIACINAMIDE, ADENOSINE	CREAM	TOPICAL	20220801		UNAPPROVED DRUG OTHER		J MEDICAL Inter Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
81700-001_0d8236b2-55e2-79de-e063-6294a90a9bb3	81700-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20100903		UNAPPROVED MEDICAL GAS		Ozark Physical Medicine Center for Operations Ozark Plaza and Medical Services DBA Ozark Home Medical Equipment	OXYGEN	99	L/100L			N	20241231
81715-0001_bf1f1a39-3124-ea7e-e053-2a95a90ad5f4	81715-0001	HUMAN OTC DRUG	Pahaba Control		niacinamide	LIQUID	TOPICAL	20210404		UNAPPROVED DRUG OTHER		JH Science Co., Ltd.	NIACINAMIDE	5	g/100mL			N	20241231
81715-0004_bf22e8e1-e93f-43be-e053-2995a90abc85	81715-0004	HUMAN OTC DRUG	Pahaba Solution		niacinamide	LIQUID	TOPICAL	20210404		UNAPPROVED DRUG OTHER		JH Science Co., Ltd.	ADENOSINE; NIACINAMIDE	.04; 5	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
81715-0005_aa0dd6b9-465a-4279-b043-b209305fe285	81715-0005	HUMAN OTC DRUG	Pahaba Solution 4.0		Niacinamide, Adenosine, Marine Collagen	LIQUID	TOPICAL	20221101		UNAPPROVED DRUG OTHER		JH Science Co., Ltd.	ADENOSINE; MARINE COLLAGEN, SOLUBLE; NIACINAMIDE	.04; 1.3; 5	g/100mL; g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
81718-001_f1e964cb-33ec-61b4-e053-2a95a90a7183	81718-001	HUMAN OTC DRUG	myhair hair regrowth treatment		Minoxidil 5%	SOLUTION	TOPICAL	20210324		ANDA	ANDA076239	APV Life Sciences, LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
81731-203_f278dd67-0c7a-39c5-e053-2995a90a9398	81731-203	HUMAN OTC DRUG	Bortek E-3 Foaming Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20210412	20240427	OTC MONOGRAPH NOT FINAL	part333E	Bortek Industries	ALCOHOL	70	mL/100mL			N	
81731-401_f278ffa7-5098-06fc-e053-2995a90a6bb9	81731-401	HUMAN OTC DRUG	Bortek E-2 Foaming Hand Wash		Benzalkonium chloride	LIQUID	TOPICAL	20210412	20240217	OTC MONOGRAPH NOT FINAL	part333E	Bortek Industries	BENZALKONIUM CHLORIDE	.13	g/100mL			N	
81731-508_e99adbfd-c374-0521-e053-2a95a90afba1	81731-508	HUMAN OTC DRUG	Bortek Antibacterial Hand Wash		Chloroxylenol	LIQUID	TOPICAL	20210412	20240720	OTC MONOGRAPH NOT FINAL	part333E	Bortek Industries	CHLOROXYLENOL	.3	g/100mL			N	
81734-001_0712020c-f4cb-cdd3-e063-6294a90a8197	81734-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20210830		NDA	NDA205767	CRYOGENIC SOLUTIONS LLC	OXYGEN	995	mL/L			N	20241231
81736-0001_0e78023c-a3f5-77c4-e063-6294a90a246f	81736-0001	HUMAN OTC DRUG	Dr.FORHAIR FOLLIGEN		PYRITHIONE ZINC, SALICYLIC ACID	SHAMPOO	TOPICAL	20210327	20240131	OTC MONOGRAPH DRUG	M032	Wyatt Co., Ltd.	PYRITHIONE ZINC; SALICYLIC ACID	2.88; 2	g/100mL; g/100mL			N	
81738-138_09e2dbc8-0d27-16eb-e063-6394a90a40d8	81738-138	HUMAN OTC DRUG	SUNNY Q Broad Spectrum SPF-30		ZINC OXIDE	LOTION	TOPICAL	20210301		OTC MONOGRAPH DRUG	M020	Sunny Q Sunscreen LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81746-183_09e29758-29ad-1153-e063-6394a90ab827	81746-183	HUMAN OTC DRUG	ZITSTICKA MEGASHADE SUNSCREEN SERUM (SPF-50)		HOMOSALATE, OCTINOXATE, OCTISALATE, ZINC OXIDE	LIQUID	TOPICAL	20210410		OTC MONOGRAPH DRUG	M020	ZITSTICKA, Inc	HOMOSALATE; OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 75; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81746-417_fe03b9f5-90b7-b07c-e053-6394a90afac9	81746-417	HUMAN OTC DRUG	Killa Extra Strength 4 pack		Salicylic Acid	PATCH	TOPICAL	20230101		OTC MONOGRAPH FINAL	M006	ZitSticka, Inc.	SALICYLIC ACID	.0125	mg/.6216mg			N	20241231
81746-420_fe3f5807-cd71-52d2-e053-6294a90a21c6	81746-420	HUMAN OTC DRUG	Killa Acne Extra Strength		Salicylic Acid	PATCH	TOPICAL	20230101		OTC MONOGRAPH FINAL	M006	Zitsticka, Inc.	SALICYLIC ACID	.0125	mg/.6216mg			N	20241231
81746-526_fc9922ba-5165-5837-e053-6294a90a3de5	81746-526	HUMAN OTC DRUG	Killa Extra Strength 2 pack		Salicylic Acid	PATCH	TOPICAL	20230526		OTC MONOGRAPH FINAL	M006	ZitSticka, Inc.	SALICYLIC ACID	.0125	mg/.6216mg			N	20241231
81746-899_0428c7f2-7bd2-23dd-e063-6394a90ad7cd	81746-899	HUMAN OTC DRUG	Killa Acne Extra Strength 2 pack		Salicylic Acid	PATCH	TOPICAL	20230526		OTC MONOGRAPH FINAL	M006	ZitSticka, Inc.	SALICYLIC ACID	.0125	mg/.6216mg			N	20241231
81749-004_fd1ce4f1-f790-4c27-ac31-b2108e8e7a80	81749-004	HUMAN PRESCRIPTION DRUG	Tarpeyo		budesonide	CAPSULE, DELAYED RELEASE	ORAL	20211215		NDA	NDA215935	Calliditas Therapeutics AB	BUDESONIDE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20251231
81750-010_f1e9261e-20e4-c1bc-e053-2a95a90ac1a6	81750-010	HUMAN OTC DRUG	Kinfield Daily Dew Sea Kelp Moisturizer Sunscreen Broad Spectrum SPF 35		Kinfield Daily Dew Sea Kelp Moisturizer Sunscreen Lotion Broad Spectrum SPF 35	LOTION	TOPICAL	20210405		OTC MONOGRAPH FINAL	part352	Kinfield, Inc.	ZINC OXIDE	20	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81750-020_f9a01a0b-0e15-1692-e053-6294a90a5c7e	81750-020	HUMAN OTC DRUG	Kinfield Relief Balm Anti-Itch Remedy		Kinfield Relief Balm Anti-Itch Remedy	LOTION	TOPICAL	20210405		OTC MONOGRAPH FINAL	part347	Kinfield, Inc.	OATMEAL	10	g/17g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
81750-030_f1e9261e-20e6-c1bc-e053-2a95a90ac1a6	81750-030	HUMAN OTC DRUG	Kinfield Sunglow Luminizing Sunscreen SPF 30		Kinfield Sunglow Luminizing Sunscreen SPF 30	LOTION	TOPICAL	20210405		OTC MONOGRAPH FINAL	part352	Kinfield, Inc.	ZINC OXIDE	20.3	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81750-100_fa53425d-2cc1-0551-e053-6394a90a7764	81750-100	HUMAN OTC DRUG	Kinfield Liplock SPF 15 Lip Balm Broad Spectrum Sunscreen		Kinfield Liplock Sunscreen	STICK	TOPICAL	20230427		OTC MONOGRAPH FINAL	part352	Kinfield, Inc.	ZINC OXIDE	10.5	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81751-001_7b4d345f-4ed6-42c9-a98b-2cfdc1c032b3	81751-001	HUMAN OTC DRUG	Saluja MD Essential Hand Sanitizer		Ethyl Alcohol	SPRAY	TOPICAL	20201001		OTC MONOGRAPH NOT FINAL	part333A	Anita Saluja, Md, LLC	ALCOHOL	70	mL/100mL			N	20241231
81752-050_9c95cbf5-c728-4f5f-86ef-e8c518a79c96	81752-050	HUMAN OTC DRUG	EVERYTOKTOK Hair Tonic		L Menthol, Salicylic Acid, Dexpanthenol	LIQUID	TOPICAL	20220901		UNAPPROVED DRUG OTHER		Dreamin	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.2; .3; .25	g/100mL; g/100mL; g/100mL			N	20241231
81755-001_c4c135ed-3b6b-69c8-e053-2a95a90aad1c	81755-001	HUMAN OTC DRUG	Shimmy Original Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20210614		OTC MONOGRAPH NOT FINAL	part333A	Shimmy Products LLC	ALCOHOL	70	mg/100mL			N	20241231
81755-002_c50b6ea2-54e1-70f3-e053-2a95a90a4ac6	81755-002	HUMAN OTC DRUG	Shimmy Rose Hibiscus Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20210614		OTC MONOGRAPH NOT FINAL	part333A	Shimmy Products LLC	ALCOHOL	70	mg/100mL			N	20241231
81755-003_c50b9543-e277-9052-e053-2a95a90a8325	81755-003	HUMAN OTC DRUG	Shimmy Meyer Lemon Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20210614		OTC MONOGRAPH NOT FINAL	part333A	Shimmy Products LLC	ALCOHOL	70	mg/100mL			N	20241231
81755-004_df27620e-7311-8082-e053-2995a90aaca6	81755-004	HUMAN OTC DRUG	Shimmy Neutral Hand Sanitizer		ALCOHOL	SPRAY	TOPICAL	20220214		OTC MONOGRAPH NOT FINAL	part333A	Shimmy Products LLC	ALCOHOL	62	mg/100mL			N	20241231
81759-002_0da6e293-9150-3146-e063-6394a90a0399	81759-002	HUMAN PRESCRIPTION DRUG	Sodium Fluoride	F 18	SODIUM FLUORIDE F-18	INJECTION	INTRAVENOUS	20221206		ANDA	ANDA204328	BAMF Health Inc.	SODIUM FLUORIDE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
81761-111_089f16c0-5013-e65c-e063-6394a90aa02b	81761-111	HUMAN OTC DRUG	QUR Lavender essential oil hand sanitizer		ALCOHOL	GEL	TOPICAL	20210224		OTC MONOGRAPH DRUG	505G(a)(3)	Qur, Inc	ALCOHOL	62	mL/100mL			N	20241231
81761-112_089ef6e3-523d-af62-e063-6294a90ae5b7	81761-112	HUMAN OTC DRUG	QUR Vanilla essential oil hand sanitizer		ALCOHOL	GEL	TOPICAL	20210224		OTC MONOGRAPH DRUG	505G(a)(3)	Qur, Inc	ALCOHOL	62	mL/100mL			N	20241231
81761-113_089f22a6-fd92-1fb6-e063-6394a90aa132	81761-113	HUMAN OTC DRUG	360 by QUR Lemon Verbena lip balm		OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	STICK	TOPICAL	20210224		OTC MONOGRAPH DRUG	M020	Qur, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	5; 50; 22; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
81761-114_089f22a6-fda1-1fb6-e063-6394a90aa132	81761-114	HUMAN OTC DRUG	360 by QUR Spanish lime lip balm		OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	STICK	TOPICAL	20210224		OTC MONOGRAPH DRUG	M020	Qur, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	5; 50; 22; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
81761-115_089f2ad0-1f4a-d83c-e063-6294a90a34a7	81761-115	HUMAN OTC DRUG	360 by QUR Vanilla lace lip balm		OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	STICK	TOPICAL	20210224		OTC MONOGRAPH DRUG	M020	Qur, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	5; 50; 22; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
81761-116_089f2ad0-1f59-d83c-e063-6294a90a34a7	81761-116	HUMAN OTC DRUG	360 by QUR Watercress mint lip balm		OCTINOXATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	STICK	TOPICAL	20210224		OTC MONOGRAPH DRUG	M020	Qur, Inc	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	5; 50; 22; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
81767-001_f2563be8-2ba3-3a87-e053-2995a90aefbb	81767-001	HUMAN OTC DRUG	Mint Foaming Hand Sanitizer 62%		Mint Foaming Hand Sanitizer 62%	LIQUID	TOPICAL	20210408		OTC MONOGRAPH NOT FINAL	part333A	Domestic Linen Supply and Laundry Company	ALCOHOL	62	mL/100mL			N	20241231
81768-0001_f1551f0f-2125-6ec0-e053-2a95a90af3ef	81768-0001	HUMAN OTC DRUG	AI kungang		Calcium Carbonate	LIQUID	TOPICAL	20210414		UNAPPROVED DRUG OTHER		TheJoenSpace Co,. LTD	CALCIUM CARBONATE	55	g/100mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
81773-012_09734a55-eff3-3b22-e063-6394a90ad2d2	81773-012	HUMAN OTC DRUG	Sterile Alcohol Prep Pads		70% isopropyl alcohol	CLOTH	TOPICAL	20230915		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Qimei Cosmetics Co., Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
81773-013_0c524d20-a3c8-3448-e063-6294a90ae7ee	81773-013	HUMAN OTC DRUG	Simplify Antibacterial Hand	Apple Blossom Scent	Chloroxylenol	SOAP	TOPICAL	20230809		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Qimei Cosmetics Co., Ltd.	CHLOROXYLENOL	.3	g/100mL			N	20241231
81773-014_0c5253d5-2149-0de5-e063-6394a90a5e66	81773-014	HUMAN OTC DRUG	Simplify Antibacterial Hand	Orange Scent	Chloroxylenol	SOAP	TOPICAL	20230809		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Qimei Cosmetics Co., Ltd.	CHLOROXYLENOL	.3	g/100mL			N	20241231
81773-015_0c52a254-27a5-6ad7-e063-6394a90a034a	81773-015	HUMAN OTC DRUG	Simplify Antibacterial Hand Wipes		Benzalkonium chloride	CLOTH	TOPICAL	20230911		OTC MONOGRAPH DRUG	505G(a)(3)	Zhejiang Qimei Cosmetics Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
81776-204_e99ad2dd-3e07-a18f-e053-2995a90a70e2	81776-204	HUMAN OTC DRUG	Medama Foam Hand Sanitizer		Ethanol	LIQUID	TOPICAL	20210413	20240731	OTC MONOGRAPH NOT FINAL	part333E	Ace Janitorial Supply co., Inc.	ALCOHOL	70	mL/100mL			N	
81777-101_06c3176d-e6fb-4231-e063-6394a90a694b	81777-101	HUMAN OTC DRUG	Xesso Rear Comfort Glide		Lidocaine	GEL	TOPICAL	20210601		OTC MONOGRAPH FINAL	M015	Premium Natural Cosmetics Inc	LIDOCAINE HYDROCHLORIDE	4.625	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81777-104_06c31263-d37a-778e-e063-6394a90aa305	81777-104	HUMAN OTC DRUG	Xesso Rear Comfort Glide		Lidocaine	GEL	RECTAL	20221110		OTC MONOGRAPH FINAL	M015	PREMIUM NATURAL COSMETICS INC	LIDOCAINE HYDROCHLORIDE	2.35	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81777-105_06c311d7-6741-f659-e063-6294a90a4b99	81777-105	HUMAN OTC DRUG	Xesso Strawberry Rear Comfort Glide 4% Lidocaine		Lidocaine	GEL	RECTAL	20221213		OTC MONOGRAPH FINAL	M015	Premium Natural Cosmetics Inc	LIDOCAINE HYDROCHLORIDE	4.625	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81780-007_50dea822-3b7c-4d26-bdf7-3f82d7413625	81780-007	HUMAN OTC DRUG	Apostrophe Screen SPF43		Sunscreen	LOTION	TOPICAL	20210409		OTC MONOGRAPH DRUG	M020	Yoderm, Inc.	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 25; 75	g/1000g; g/1000g; g/1000g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81781-101_e8cc5ec1-732d-40d4-bb5e-29a21cf19377	81781-101	HUMAN OTC DRUG	DAILY FACE SUNSCREEN	Broad Spectrum SPF 30	Zinc Oxide	CREAM	TOPICAL	20210715		OTC MONOGRAPH NOT FINAL	part352	Lilyana Naturals LLC	ZINC OXIDE	10	g/100g			N	20241231
81790-001_081d8baa-7eda-5008-e063-6294a90ad5d4	81790-001	HUMAN OTC DRUG	Relieve and Relax Pain Relieving		CAMPHOR (SYNTHETIC), MENTHOL	GEL	TOPICAL	20210601		OTC MONOGRAPH DRUG	M017	MAC Innovations, LLC	CAMPHOR (SYNTHETIC); MENTHOL	40; 100	mg/mL; mg/mL			N	20241231
81792-002_bff148a6-02ed-6e86-e053-2995a90a5c9d	81792-002	HUMAN OTC DRUG	Transcend E2 Sanitizing Foam		Benzalkonium Chloride	SOAP	TOPICAL	20210414		OTC MONOGRAPH NOT FINAL	part333A	Von Drehle Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
81792-003_bfdefc20-494f-6156-e053-2995a90a77cb	81792-003	HUMAN OTC DRUG	Harbor Mist Alco-Foam Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20210430		OTC MONOGRAPH NOT FINAL	part333E	Von Drehle Corporation	ALCOHOL	62	mL/100mL			N	20241231
81792-004_c3b710b5-cf41-0e09-e053-2a95a90a2173	81792-004	HUMAN OTC DRUG	Harbor Mist E2 Sanitizing Foam with BZK		Benzalkonium Chloride	LIQUID	TOPICAL	20210601		OTC MONOGRAPH NOT FINAL	part333A	Von Drehle Corporation	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
81793-187_09e2e2ce-d84c-0711-e063-6294a90a9213	81793-187	HUMAN OTC DRUG	ArmiCare Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210405		OTC MONOGRAPH DRUG	505G(a)(3)	Armis Biopharma, Inc	ALCOHOL	75	mL/100mL			N	20241231
81799-001_f1e21df7-59c3-2245-e053-2995a90a82cf	81799-001	HUMAN OTC DRUG	Nicotine Transdermal Patches		Aroamas Nicotine Transdermal Patches - Stop Smoking Aid	PATCH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part348	Ehy Holdings LLC	MENTHOL; NICOTINE	.3; 18	mg/100mg; mg/100mg	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
81799-002_f1e21df7-59d1-2245-e053-2995a90a82cf	81799-002	HUMAN OTC DRUG	Nicotine Transdermal Patches		Aroamas Nicotine Transdermal Patches - Stop Smoking Aid	PATCH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part348	Ehy Holdings LLC	MENTHOL; NICOTINE	.3; 6	mg/100mg; mg/100mg	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
81799-003_f1e21048-6b54-df20-e053-2a95a90ae667	81799-003	HUMAN OTC DRUG	Nicotine Transdermal Patches		Aroamas Nicotine Transdermal Patches - Stop Smoking Aid	PATCH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part348	Ehy Holdings LLC	MENTHOL; NICOTINE	.3; 12	mg/100mg; mg/100mg	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
81799-005_f209ee77-d28f-1203-e053-2a95a90adb8c	81799-005	HUMAN OTC DRUG	Herpes Relief Cream		RoyceDerm Herpes Relief Cream	CREAM	TOPICAL	20230111		UNAPPROVED DRUG OTHER		Ehy Holdings LLC	GRAPHITE	1	g/100g			N	20241231
81799-006_f20d62d3-b2d5-6915-e053-2a95a90ad194	81799-006	HUMAN OTC DRUG	Seborrheic Dermatitis and Psoriasis Cream		RoyceDerm Seborrheic Dermatitis and Psoriasis Cream	CREAM	TOPICAL	20230111		UNAPPROVED DRUG OTHER		Ehy Holdings LLC	WORMWOOD	3	mg/100mL			N	20241231
81799-007_f20cc32d-f2da-009f-e053-2995a90a2319	81799-007	HUMAN OTC DRUG	Seborrheic Dermatitis and Psoriasis		RoyceDerm Seborrheic Dermatitis and Psoriasis Shampoo	SHAMPOO	TOPICAL	20230111		UNAPPROVED DRUG OTHER		Ehy Holdings LLC	WORMWOOD	3	mg/100mL			N	20241231
81799-008_f4be3cb8-7017-1b65-e053-2995a90a3955	81799-008	HUMAN OTC DRUG	Nupharmisto Tattoo Numbing Cream		Tattoo Numbing Cream	CREAM	TOPICAL	20230215		OTC MONOGRAPH FINAL	part348	Ehy Holdings LLC	LIDOCAINE	5	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81799-009_f57d6b13-3b88-5204-e053-2a95a90acee8	81799-009	HUMAN OTC DRUG	Shingles Pain Relief Cream		RoyceDerm Shingles Pain Relief Cream	CREAM	TOPICAL	20230215		UNAPPROVED DRUG OTHER		Ehy Holdings LLC	WORMWOOD	3	g/100g			N	20241231
81799-010_f9fd2aa7-1d4f-c3fc-e053-6294a90ae72b	81799-010	HUMAN OTC DRUG	Nupharmisto Psoriasis Eczema Cream		Psoriasis Eczema Cream	CREAM	EXTRACORPOREAL	20230315		OTC MONOGRAPH FINAL	M032	Ehy Holdings LLC	DICTAMNUS DASYCARPUS WHOLE; EUPHORBIA HIRTA; MENTHA CANADENSIS TOP; MURRAYA PANICULATA FRUIT; RHINACANTHUS NASUTUS LEAF; SOPHORA FLAVESCENS WHOLE; VIOLA PHILIPPICA WHOLE	7; 2; 1.2; 2; 7; 1.8; 3	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
81803-020_e702ec8c-730c-4e54-ab83-9e2ee22cc932	81803-020	HUMAN OTC DRUG	Peraflu D		PERACETIC ACID	LIQUID	TOPICAL	20211101		UNAPPROVED DRUG OTHER		Valley Inc.	PERACETIC ACID	8	g/4000mL			N	20241231
81803-030_9c6b7c59-9754-4107-8522-7e2a84d9eb3c	81803-030	HUMAN OTC DRUG	Safe OPA		O-PHTHALALDEHYDE	LIQUID	TOPICAL	20220501		UNAPPROVED DRUG OTHER		Valley Inc.	O-PHTHALALDEHYDE	22	g/4000mL			N	20241231
81803-040_55f8fa59-a4a7-4f10-adbd-54b4ea74b207	81803-040	HUMAN OTC DRUG	Cygzyme		CITRIC ACID	LIQUID	TOPICAL	20220501		UNAPPROVED DRUG OTHER		Valley Inc.	CITRIC ACID MONOHYDRATE	160	g/4000mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
81810-301_fcf85f06-4fac-858d-e053-6294a90ad8fe	81810-301	HUMAN OTC DRUG	The Cica Serum Plus		Glycerin	LOTION	TOPICAL	20210423		UNAPPROVED DRUG OTHER		ENNA COSMETIC, Inc.	GLYCERIN	5	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
81810-302_fcf83646-5ce6-2844-e053-6294a90a8a92	81810-302	HUMAN OTC DRUG	QUEEN79 NOBLE GOLD SERUM		Glycerin	CREAM	TOPICAL	20210507		UNAPPROVED DRUG OTHER		ENNA COSMETIC, Inc.	GLYCERIN	5	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
81810-303_fcf8867b-5ef9-9a95-e053-6294a90a0789	81810-303	HUMAN OTC DRUG	QUEEN79 NOBLE GOLD EYECREAM		Glycerin	CREAM	TOPICAL	20210517		UNAPPROVED DRUG OTHER		ENNA COSMETIC, Inc.	GLYCERIN	3	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
81810-304_fcf83bd1-e1be-5eda-e053-6294a90a48e9	81810-304	HUMAN OTC DRUG	QUEEN79 NOBLE GOLD AQUACREAM		Glycerin	CREAM	TOPICAL	20210521		UNAPPROVED DRUG OTHER		ENNA COSMETIC, Inc.	GLYCERIN	5	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
81810-305_fcf85f06-4fae-858d-e053-6294a90ad8fe	81810-305	HUMAN OTC DRUG	QUEEN79 NOBLE GOLDCREAM		Glycerin	CREAM	TOPICAL	20210518		UNAPPROVED DRUG OTHER		ENNA COSMETIC, Inc.	GLYCERIN	5	mg/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
81811-100_0bb5d729-5109-e387-e063-6394a90a1fce	81811-100	HUMAN PRESCRIPTION DRUG	Ecoza		econazole nitrate	AEROSOL, FOAM	TOPICAL	20231204		NDA	NDA205175	Resilia Pharmaceuticals, Inc.	ECONAZOLE NITRATE	10	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
81825-0001_bcaaa148-5549-4a13-b358-47bd4354a316	81825-0001	HUMAN OTC DRUG	Hydrate II		Berber Aqui, Beta Vulg, Boldo, Carduus Mar, Chelidonium Maj, Hordeum Vulgare, Iris Vers, Rosmarinus, Taraxacum, Avena, Eleutherococcus Senticosus, Xanthoxylum, Equisetum Hyem, Hypericum, Ulmus Fulv, Gettysburg Aqua, Glycyrrhiza, Wildbad Aqua, Carlsbad Aqua, ATP, Hydrogen, Nat Mur, Oxygen, Silicea, Wiesbaden Aqua	LIQUID	ORAL	20220216		UNAPPROVED HOMEOPATHIC		Zorex International	ADENOSINE TRIPHOSPHATE; AVENA SATIVA FLOWERING TOP; BERBERIS AQUIFOLIUM ROOT BARK; BETA VULGARIS WHOLE; CHELIDONIUM MAJUS WHOLE; ELEUTHEROCOCCUS SENTICOSUS WHOLE; EQUISETUM HYEMALE WHOLE; GLYCYRRHIZA GLABRA; HORDEUM VULGARE WHOLE; HYDROGEN; HYPERICUM PERFORATUM WHOLE; IRIS VERSICOLOR ROOT; MILK THISTLE; OXYGEN; PEUMUS BOLDUS LEAF; SALVIA ROSMARINUS FLOWERING TOP; SILICON DIOXIDE; SODIUM CHLORIDE; TARAXACUM OFFICINALE; ULMUS RUBRA BARK; ZANTHOXYLUM AMERICANUM BARK	30; 8; 8; 8; 8; 8; 8; 12; 8; 34; 8; 8; 8; 30; 8; 8; 30; 30; 8; 8; 8	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
81825-0002_539d3aeb-4490-4871-adf9-3db0d41c56a9	81825-0002	HUMAN OTC DRUG	Mold Antigen		Alternaria Alternata, Aspergillus Fumigatus, Aspergillus Niger, Boletus Sat, Botrytis Cinerea, Cladosporium Metanigrum, Fusarium Oxysporum, Helminthosporium, Mucor Muecedo, Pullularia Pullulans, Rhizopus Nigricans, Ustilago Maydis, Arsenicum Alb, Candida Alb, Carbo An, Lachesis, Lycopodium, Merc Solub, Nitricum Ac, Phosphorus, Pulsatilla, Sepia, Silicea, Thuja Occ	LIQUID	ORAL	20211201		UNAPPROVED HOMEOPATHIC		Zorex International	ALTERNARIA ALTERNATA; ARSENIC TRIOXIDE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; BOLETUS SATANAS FRUITING BODY; BOTRYTIS CINEREA; CANDIDA ALBICANS; CARBO ANIMALIS; COCHLIOBOLUS SATIVUS; FUSARIUM OXYSPORUM; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; NITRIC ACID; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; RHIZOPUS STOLONIFER; SEPIA OFFICINALIS JUICE; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; USTILAGO MAYDIS	200; 30; 200; 200; 200; 200; 200; 30; 30; 200; 200; 30; 30; 30; 30; 30; 30; 200; 30; 30; 30; 200	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
81825-0003_70783c3e-4437-477e-8a45-0345fbcf573a	81825-0003	HUMAN OTC DRUG	E.N.V.		Belladonna, Berberis Vulg, Carduus Mar, Chelidonium Maj, Colocynthis, Dioscorea, Hydrastis, Lycopodium, Nat Sulphuricum, Nux Vom, Phos, Pulsatilla, Veratrum Alb	LIQUID	ORAL	20211208		UNAPPROVED HOMEOPATHIC		Zorex International	ATROPA BELLADONNA; BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS WHOLE; CITRULLUS COLOCYNTHIS FRUIT PULP; DIOSCOREA VILLOSA TUBER; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; VERATRUM ALBUM ROOT	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
81825-0004_32b5e01c-67ef-4251-b6a4-b7e007fafc83	81825-0004	HUMAN OTC DRUG	Candida		Baptisia Tinctoria, Echinacea Purp, Glycyrrhiza Glabra, Astragalus, Candida Alb, Borax, Calc Carb, Kreosotum, Lycopodium, Nux Vom, Phosphoricum Ac, Pulsatilla, Sepia, Thuja Occ, Nat Phos, Nitricum Ac	LIQUID	ORAL	20211222		UNAPPROVED HOMEOPATHIC		Zorex International	ASTRAGALUS NUTTALLII LEAF; BAPTISIA TINCTORIA WHOLE; CANDIDA ALBICANS; ECHINACEA PURPUREA WHOLE; GLYCYRRHIZA GLABRA; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PULSATILLA VULGARIS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG; WOOD CREOSOTE	6; 4; 200; 4; 4; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
81825-0005_0c4e3a22-7313-46b1-b838-de8ef161524c	81825-0005	HUMAN OTC DRUG	H.M.D.		Allium Sat, Avena, Berber Vulg, Lappa, Phytolacca, Solidago, Alumina, Arg Nit, Baryta Carb, Beryllium, Cadmium Met, Curprum Met, Fluoricum Acidum, Indium, Iodium, Lithium Carb, Merc Solub, Niccolum carb, Nitrogenum Oxygenatum, Plumb Met, Selenium, Strontium Carb, Titanium, Arsenicum Alb, Nat Mur, Nux Vom	LIQUID	ORAL	20211222		UNAPPROVED HOMEOPATHIC		Zorex International	ALUMINUM OXIDE; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; AVENA SATIVA FLOWERING TOP; BARIUM CARBONATE; BERBERIS VULGARIS ROOT BARK; BERYLLIUM; CADMIUM; COPPER; GARLIC; HYDROFLUORIC ACID; INDIUM; IODINE; LEAD; LITHIUM CARBONATE; MERCURIUS SOLUBILIS; NICKEL CARBONATE HYDROXIDE TETRAHYDRATE; NITROUS OXIDE; PHYTOLACCA AMERICANA ROOT; SELENIUM; SILVER NITRATE; SODIUM CHLORIDE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRONTIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; TITANIUM	12; 6; 12; 6; 12; 6; 12; 12; 12; 6; 12; 12; 12; 12; 12; 12; 12; 12; 6; 12; 12; 12; 6; 12; 12; 12	[hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Mood Stabilizer [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
81825-0006_9a35761c-cf72-4cf5-9212-1116dfd29a33	81825-0006	HUMAN OTC DRUG	PSORIASIS		Arsenicum Album, Arsenicum Iodatum, Borax, Calcarea Carbonica, Graphites, Mezereum, Proteus, Natrum Muriaticum, Phytolacca Decandra, Sepia, Silicea, Sulphur, Thyroidinum	LIQUID	ORAL	20211201		UNAPPROVED HOMEOPATHIC		Zorex International	ARSENIC TRIIODIDE; ARSENIC TRIOXIDE; DAPHNE MEZEREUM BARK; GRAPHITE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PROTEUS MORGANII; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CHLORIDE; SULFUR; THYROID, UNSPECIFIED	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
81825-0007_dda1ff79-ce5d-47c0-99e6-0b77f3defed7	81825-0007	HUMAN OTC DRUG	Allergy		Allium Cepa, Ambrosia, Arsenicum Alb, Carbo Veg, Euphrasia, Nux Vom, Phosphorus, Pulsatilla, Sulphur, Solidago	LIQUID	ORAL	20220216		UNAPPROVED HOMEOPATHIC		Zorex International	ACTIVATED CHARCOAL; AMBROSIA ARTEMISIIFOLIA WHOLE; EUPHRASIA STRICTA; ONION; PHOSPHORUS; PULSATILLA VULGARIS WHOLE; SOLIDAGO VIRGAUREA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SULFUR	30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Vegetable Proteins [CS]		N	20241231
81825-0008_e046f17a-6e28-4862-9e58-3d00fe8ba1fd	81825-0008	HUMAN OTC DRUG	VIRAL HP		Arsenic Trioxide, Atropa Belladonna, Echinacea Angustifolia, Eupatorium Perfoliatum Flowering Top, Gelsemium Sempervirens Root, Lycopodium Clavatum Spore, Phosphoric Acid, Phosphorus, Rancid Beef, Toxicodendron Pubescens Leaf	LIQUID	ORAL	20220406		UNAPPROVED HOMEOPATHIC		Zorex International	ARSENIC TRIOXIDE; ATROPA BELLADONNA; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; RANCID BEEF; TOXICODENDRON PUBESCENS LEAF	30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
81825-0009_aac5fee0-2288-48b4-8546-f05b07ff654f	81825-0009	HUMAN OTC DRUG	FLU		Aconitum Napellus, Arsenic Trioxide, Atropa Belladonna, Bryonia Alba Root, Eupatorium Perfoliatum Flowering Top, Ferrum Phosphoricum, Gelsemium Sempervirens Root	LIQUID	ORAL	20221003		UNAPPROVED HOMEOPATHIC		Zorex International	ACONITUM NAPELLUS; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; FERRUM PHOSPHORICUM; GELSEMIUM SEMPERVIRENS ROOT	30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
81825-0010_b8371d3e-0e08-478c-8713-561e4672efb6	81825-0010	HUMAN OTC DRUG	Stress		Aralia Quin, Passiflora, Scutellaria, Valeriana, Arsenicum Alb, Aur Met, Calc Carb, Coffea Cruda, Ignatia, Kali Phos, Lycopus, Phosphorus, Staphysagria	LIQUID	ORAL	20220922		UNAPPROVED HOMEOPATHIC		Zorex International	AMERICAN GINSENG; ARABICA COFFEE BEAN; ARSENIC TRIOXIDE; DELPHINIUM STAPHISAGRIA SEED; DIBASIC POTASSIUM PHOSPHATE; GOLD; LYCOPUS VIRGINICUS WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PASSIFLORA INCARNATA FLOWERING TOP; PHOSPHORUS; SCUTELLARIA LATERIFLORA WHOLE; STRYCHNOS IGNATII SEED; VALERIAN	6; 12; 12; 12; 12; 12; 12; 12; 6; 12; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC]		N	20241231
81826-001_301f4be6-4c42-4c18-b416-15f08c6db000	81826-001	HUMAN PRESCRIPTION DRUG	Sodium Chloride		SODIUM CHLORIDE	INJECTION, SOLUTION	INTRAVENOUS	20170525		ANDA	ANDA207956	CODAN US CORPORATION	SODIUM CHLORIDE	9	g/1000mL			N	20241231
81831-101_c06778b6-0edb-7d82-e053-2a95a90a2ef8	81831-101	HUMAN OTC DRUG	Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card		Natural Herbal Antibacterial Card and TCM Magic Card	POWDER	TOPICAL	20210416		UNAPPROVED DRUG OTHER		Chuanzongbao (Hangzhou) intangible cultural heritage protection Co., Ltd	ANGELICA DAHURICA ROOT; BORNEOL; MINT	.5; 1; 1	g/6.5g; g/6.5g; g/6.5g			N	20241231
81839-782_2f9d0600-c8af-4701-aadb-ee29592f7a12	81839-782	HUMAN PRESCRIPTION DRUG	Anticoagulant Sodium Citrate		Trisodium Citrate Dihydrate	SOLUTION	INTRAVENOUS	20220701		ANDA	BA125750	CSL Plasma Inc.	TRISODIUM CITRATE DIHYDRATE	40	mg/mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20251231
81840-1001_e22b8f86-7412-6e61-e053-2995a90ae0ea	81840-1001	HUMAN OTC DRUG	Hoo gargle (Mouthwash)		xylitol	LIQUID	DENTAL	20210420		UNAPPROVED DRUG OTHER		MIKO CO LTD	XYLITOL	1	g/100mL			N	20241231
81840-1003_e22c386c-0c5d-542e-e053-2a95a90a7814	81840-1003	HUMAN OTC DRUG	Hoo gargle (Rooibos Tea Flavor)(Mouthwash)		xylitol	LIQUID	DENTAL	20220624		UNAPPROVED DRUG OTHER		MIKO CO LTD	XYLITOL	1	g/100mL			N	20241231
81840-1022_e23bcbf4-b746-2b83-e053-2a95a90ad725	81840-1022	HUMAN OTC DRUG	Hoo gargle (Jasmine Flavor)(Mouthwash)		xylitol	LIQUID	DENTAL	20220624		UNAPPROVED DRUG OTHER		MIKO CO LTD	XYLITOL	1	g/100mL			N	20241231
81840-1111_0707faa4-01dd-34c0-e063-6294a90af34a	81840-1111	HUMAN OTC DRUG	Hoo gargle (Jasmine Flavor)(Mouthwash)		Sodium Flouride	LIQUID	ORAL	20210202		OTC MONOGRAPH DRUG	M021	MIKO CO LTD	SODIUM FLUORIDE	.02	g/100mL			N	20241231
81840-2222_0707e17f-bfe8-5ce2-e063-6394a90a8cc2	81840-2222	HUMAN OTC DRUG	Hoo gargle (Rooibos Tea Flavor)(Mouthwash)		Sodium Flouride	LIQUID	DENTAL	20220703		OTC MONOGRAPH DRUG	M021	MIKO CO LTD	SODIUM FLUORIDE	.02	g/100mL			N	20241231
81840-3333_0707e10b-31cd-39e3-e063-6394a90a2851	81840-3333	HUMAN OTC DRUG	Hoo gargle (apple spearmint flavor)		Sodium Flouride	LIQUID	DENTAL	20220101		OTC MONOGRAPH DRUG	M021	MIKO CO LTD	SODIUM FLUORIDE	.02	g/100mL			N	20241231
81845-2650_fea8311d-1500-831b-e053-6294a90a3721	81845-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	James Christian Cosmetics	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
81849-001_0b7a8999-645c-3b47-e063-6294a90a9dbe	81849-001	HUMAN OTC DRUG	Alcohol Pads		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20210428		OTC MONOGRAPH DRUG	505G(a)(3)	Shandong Lianfa Medical Plastic Products CO.,LTD	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
81860-113_858db7fc-517e-4cac-a579-8f851c27ee64	81860-113	HUMAN OTC DRUG	Cheeky Bonsai UTI Pain Relief		PHENAZOPYRIDINE HYDROCHLORIDE	TABLET	ORAL	20210512		UNAPPROVED DRUG OTHER		IXXA, INC	PHENAZOPYRIDINE HYDROCHLORIDE	99.5	mg/1			N	20241231
81864-101_06ff7cff-7d39-470d-ba52-1c61c74f4a05	81864-101	HUMAN PRESCRIPTION DRUG	Ojjaara		Momelotinib	TABLET	ORAL	20230915		NDA	NDA216873	GlaxoSmithKline LLC	MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE	200	mg/1			N	20241231
81864-102_06ff7cff-7d39-470d-ba52-1c61c74f4a05	81864-102	HUMAN PRESCRIPTION DRUG	Ojjaara		Momelotinib	TABLET	ORAL	20230915		NDA	NDA216873	GlaxoSmithKline LLC	MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE	150	mg/1			N	20241231
81864-103_06ff7cff-7d39-470d-ba52-1c61c74f4a05	81864-103	HUMAN PRESCRIPTION DRUG	Ojjaara		Momelotinib	TABLET	ORAL	20230915		NDA	NDA216873	GlaxoSmithKline LLC	MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE	100	mg/1			N	20241231
81873-201_0d706571-03d2-3bd1-e063-6394a90a11ae	81873-201	HUMAN OTC DRUG	YENAYA SECRET GUNG CLEANSER		Cocamidopropyl Betaine, Lactic Acid	GEL	TOPICAL	20210504		UNAPPROVED DRUG OTHER		IFACKOREA CO., LTD	COCAMIDOPROPYL BETAINE; LACTIC ACID, UNSPECIFIED FORM	8; 1	mg/100mL; mg/100mL	Acidifying Activity [MoA]		N	20241231
81873-202_0e91bb73-0024-89e0-e063-6294a90a5664	81873-202	HUMAN OTC DRUG	YENAYA SECRET GUNG CLEANSER		Cocamidopropyl Betaine, Lactic Acid	GEL	TOPICAL	20210506		UNAPPROVED DRUG OTHER		IFACKOREA CO., LTD	COCAMIDOPROPYL BETAINE; LACTIC ACID, UNSPECIFIED FORM	8; 1	mg/100mL; mg/100mL	Acidifying Activity [MoA]		N	20251231
81877-300_100cd433-e13e-4458-8c07-2f853a529723	81877-300	HUMAN PRESCRIPTION DRUG	TriaDime		Triamcinolone Acetonide Cream .1%, Dimethicone 5% Cream	KIT		20230504		UNAPPROVED DRUG OTHER		ForReal Pharmaceuticals						N	20241231
81877-514_2b6781f5-573a-41cb-a5c9-827c6af89b5b	81877-514	HUMAN OTC DRUG	Lidocaine		Lidocaine	PATCH	TOPICAL	20220627		UNAPPROVED DRUG OTHER		FORREAL PHARMACEUTICALS LLC	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81877-518_187248b7-833f-4fba-b73d-64c2c98cd4c8	81877-518	HUMAN PRESCRIPTION DRUG	Lidosol		Lidocaine	OINTMENT	TOPICAL	20230531		ANDA	ANDA205318	FORREAL PHARMACEUTICALS LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81877-519_19f97022-b79c-42b4-a264-8d6ae923a806	81877-519	HUMAN PRESCRIPTION DRUG	lidocaine		lidocaine	OINTMENT	TOPICAL	20230822		ANDA	ANDA206498	FORREAL PHARMACEUTICALS LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81877-520_314b8669-dfc8-49a2-96ad-678219786426	81877-520	HUMAN PRESCRIPTION DRUG	MOMETACURE		mometasone furoate, Dimethicone	KIT	TOPICAL	20230913		UNAPPROVED DRUG OTHER		FORREAL PHARMACEUTICALS LLC						N	20241231
81877-601_14e840e9-6339-4a26-a93f-edad992758b8	81877-601	HUMAN OTC DRUG	MCM Topical Gel Patch		L-Menthol	PATCH	TOPICAL	20230123		UNAPPROVED DRUG OTHER		FORREAL PHARMACEUTICALS LLC	CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	96; 76.8; 57.6	mg/1; mg/1; mg/1			N	20241231
81877-620_3a62c345-673f-4ec4-9992-60be21df3c05	81877-620	HUMAN OTC DRUG	Methyl Salicylate 40% Topical Oil		Methyl Salicylate	LIQUID	TOPICAL	20230303		UNAPPROVED DRUG OTHER		FORREAL PHARMACEUTICALS LLC	METHYL SALICYLATE	40	g/100mL			N	20241231
81877-630_1d5a9da2-040b-421d-ab83-b6a661eafdbc	81877-630	HUMAN PRESCRIPTION DRUG	Calsodore		calcipotriene	CREAM	TOPICAL	20230802		ANDA	ANDA205772	FORREAL PHARMACEUTICALS LLC	CALCIPOTRIENE	50	ug/g	Vitamin D Analog [EPC], Vitamin D [CS]		N	20241231
81877-640_2a9df36e-cae7-4dcb-a924-7643e58d351b	81877-640	HUMAN PRESCRIPTION DRUG	CALSODORE kit		Calcipotriene, Dimethicone	KIT	TOPICAL	20230911		UNAPPROVED DRUG OTHER		FORREAL PHARMACEUTICALS LLC						N	20241231
81877-645_13ec8fae-d0be-4cce-a4f3-6e69b1d7d862	81877-645	HUMAN PRESCRIPTION DRUG	DICLAREAL TOPICAL kit		Diclofenac Sodium, Capsaicin	KIT	TOPICAL	20231012		UNAPPROVED DRUG OTHER		FORREAL PHARMACEUTICALS LLC						N	20241231
81877-650_1f8c9d3e-68f7-4fda-810d-742e28f7dcc0	81877-650	HUMAN PRESCRIPTION DRUG	EmReal		Lidocaine and Prilocaine	CREAM	TOPICAL	20231116		ANDA	ANDA212482	Forreal Pharmaceuticals LLC	LIDOCAINE; PRILOCAINE	25; 25	mg/g; mg/g	Amide Local Anesthetic [EPC], Amide Local Anesthetic [EPC], Amides [CS], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
81877-660_1c88252b-dcb0-4374-836e-c9358d8dcd1f	81877-660	HUMAN PRESCRIPTION DRUG	LidoLite		lidocaine	OINTMENT	TOPICAL	20231117		ANDA	ANDA206498	Forreal Pharmaceuticals LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81885-0001_f4a6003e-ea9a-eb37-e053-2995a90abc6a	81885-0001	HUMAN OTC DRUG	s panax all in one liquidsoap		salt	LIQUID	TOPICAL	20210518		UNAPPROVED DRUG OTHER		S AND PANAX CO LTD	SEA SALT	2	g/100mL			N	20241231
81885-0002_f4a6003e-ea9b-eb37-e053-2995a90abc6a	81885-0002	HUMAN OTC DRUG	s panax all in one mist		Sodium benzoate	LIQUID	TOPICAL	20210518		UNAPPROVED DRUG OTHER		S AND PANAX CO LTD	SODIUM BENZOATE	.5	g/100mL	Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	20241231
81890-002_070bbc81-b388-527e-e063-6394a90a775d	81890-002	HUMAN OTC DRUG	VANIBISS BUTT AND THIGHS		SALICYLIC ACID	CREAM	TOPICAL	20231102		OTC MONOGRAPH DRUG	M006	Vanibiss Inc	SALICYLIC ACID	2	g/100mL			N	20241231
81890-192_09e2e5e3-aaf0-d4b0-e063-6294a90a1f57	81890-192	HUMAN OTC DRUG	VANIBISS BUTT and THIGHS Acne Treatment Cream		SALICYLIC ACID	CREAM	TOPICAL	20210510		OTC MONOGRAPH DRUG	M006	Vanibiss Inc	SALICYLIC ACID	20	mg/mL			N	20241231
81893-111_0653c166-a966-e924-e063-6294a90a93a2	81893-111	HUMAN OTC DRUG	The Green Scissor		Isopropyl Alcohol 99%	LIQUID	TOPICAL	20210510		UNAPPROVED DRUG OTHER		The Green Scissor Inc	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
81893-111_0653d1f7-9041-6e66-e063-6394a90a09e0	81893-111	HUMAN OTC DRUG	The Green Scissor		Isopropyl Alcohol 99%	LIQUID	TOPICAL	20210510		UNAPPROVED DRUG OTHER		The Green Scissor Inc	ISOPROPYL ALCOHOL	99	mL/100mL			N	20241231
81899-005_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-005	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	5 Fairfax	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-010_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-010	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	10 Larchmont	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-013_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-013	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	13 La Cienega	Zinc Oxide	LOTION	TOPICAL	20230124		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-015_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-015	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	15 Melrose	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-018_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-018	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	18 Montana	Zinc Oxide	LOTION	TOPICAL	20230124		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-020_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-020	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	20 Mulholland	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-025_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-025	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	25 Ocean Park	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-030_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-030	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	30 PCH	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-035_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-035	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	35 Point Dume	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-038_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-038	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	38 Pomona	Zinc Oxide	LOTION	TOPICAL	20230124		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-040_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-040	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	40 Runyon	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-045_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-045	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	45 Silver Lake	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-050_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-050	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	50 Sunset	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-055_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-055	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	55 Temescal	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-060_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-060	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	60 Third St	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-065_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-065	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	65 Topanga	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81899-070_b2394e8b-7845-4a2c-a166-b4bed4cfc163	81899-070	HUMAN OTC DRUG	SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen	70 Venice	Zinc Oxide	LOTION	TOPICAL	20210815		OTC MONOGRAPH FINAL	part352	Tower 28	ZINC OXIDE	126	mg/mL			N	20241231
81900-013_05418455-0146-71ff-e063-6294a90a0c94	81900-013	HUMAN OTC DRUG	NasoClenz		Benzalkonium Chloride 0.13%	GEL	TOPICAL	20211101		OTC MONOGRAPH NOT FINAL	part333E	Silicon Valley Innovations, Inc.	BENZALKONIUM CHLORIDE	1.19	mg/mL			N	20241231
81900-014_05418455-0146-71ff-e063-6294a90a0c94	81900-014	HUMAN OTC DRUG	NasoClenz		Benzalkonium Chloride 0.13%	GEL	TOPICAL	20230925		OTC MONOGRAPH NOT FINAL	part333E	Silicon Valley Innovations, Inc.	BENZALKONIUM CHLORIDE	1.19	mg/mL			N	20241231
81902-101_08321e0d-e6c9-ee04-e063-6294a90a9503	81902-101	HUMAN OTC DRUG	Zylotrol Maximum Pain Patch		Lidocaine 4%, Menthol 1%	PATCH	TOPICAL	20210730		OTC MONOGRAPH DRUG	505G(a)(3)	Whitestone Products LLC	LIDOCAINE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81902-104_08157e80-effb-147b-e063-6394a90aca36	81902-104	HUMAN OTC DRUG	ZYLOTROL MAXIMUM PAIN		lidocaine 4%, menthol 1%	PATCH	TOPICAL	20221223		OTC MONOGRAPH DRUG	505G(a)(3)	Whitestone Products LLC	LIDOCAINE; MENTHOL	.12; .03	g/3g; g/3g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81902-201_07cf1076-0948-5b74-e063-6294a90a2396	81902-201	HUMAN OTC DRUG	Zylotrol		Lidocaine HCl 4%, Menthol 1%	GEL	TOPICAL	20220104		OTC MONOGRAPH DRUG	M017	Whitestone Products LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81902-230_07cf15a8-e485-3949-e063-6394a90a97a0	81902-230	HUMAN OTC DRUG	ZYLOTROL PAIN RELIEVING		Lidocaine HCl, Menthol	CREAM	TOPICAL	20221229		OTC MONOGRAPH DRUG	M017	Whitestone Products LLC	LIDOCAINE HYDROCHLORIDE; MENTHOL, UNSPECIFIED FORM	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81907-101_eb6a1376-bf85-5aaa-e053-2995a90a18a4	81907-101	HUMAN OTC DRUG	NasalGuard Antiseptic Topical Cool Menthol		Benzalkonium Chloride	GEL	TOPICAL	20221024		OTC MONOGRAPH NOT FINAL	part333E	TRUTEK CORP.	BENZALKONIUM CHLORIDE	1.3	mg/1000mg			N	20241231
81907-102_ebdfb265-611a-c47b-e053-2a95a90a6fcd	81907-102	HUMAN OTC DRUG	Unscented NasalGuard Antiseptic Topical		Benzalkonium Chloride	GEL	TOPICAL	20220214		OTC MONOGRAPH NOT FINAL	part333E	TRUTEK CORP.	BENZALKONIUM CHLORIDE	1.3	mg/1000mg			N	20241231
81923-197_09e2a350-7cd3-0898-e063-6394a90ad3dc	81923-197	HUMAN OTC DRUG	INTIMALE Maximum Strength Delay		LIDOCAINE HYDROCHLORIDE	SOLUTION	TOPICAL	20210525		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81923-198_09e2a350-7ce1-0898-e063-6394a90ad3dc	81923-198	HUMAN OTC DRUG	POWERECT Max Power Male Delay		LIDOCAINE HYDROCHLORIDE	SOLUTION	TOPICAL	20210525		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81923-199_09e2e5e3-aaff-d4b0-e063-6294a90a1f57	81923-199	HUMAN OTC DRUG	SKINS DELAY Maximum Strength Lidocaine		LIDOCAINE HYDROCHLORIDE	SOLUTION	TOPICAL	20210525		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81923-364_0976c569-770c-ecde-e063-6394a90a76b1	81923-364	HUMAN OTC DRUG	SKINS DELAY Climax Control Lidocaine		LIDOCAINE HYDROCHLORIDE	SOLUTION	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81923-365_0976dfc5-c34c-11fe-e063-6294a90aa2bb	81923-365	HUMAN OTC DRUG	SKINS DELAY Climax Control Benzocaine Gel		BENZOCAINE	GEL	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
81923-366_0976dfc5-c35a-11fe-e063-6294a90aa2bb	81923-366	HUMAN OTC DRUG	POWERECT Lidocaine Male Delay		LIDOCAINE HYDROCHLORIDE	SOLUTION	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81923-367_0976edf3-b970-fff9-e063-6294a90a2c4e	81923-367	HUMAN OTC DRUG	POWERECT Benzocaine Male Delay Gel		BENZOCAINE	GEL	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
81923-368_0976eff9-48ab-1669-e063-6394a90a8240	81923-368	HUMAN OTC DRUG	INTIMALE LIDOCAINE DELAY		LIDOCAINE HYDROCHLORIDE	SOLUTION	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	LIDOCAINE HYDROCHLORIDE	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
81923-369_0976eff9-48b9-1669-e063-6394a90a8240	81923-369	HUMAN OTC DRUG	INTIMALE Benzocaine Delay Gel		BENZOCAINE	GEL	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	SKINS SEXUAL HEALTH LIMITED	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
81926-001_01a3bd34-494e-ecc8-e063-6394a90a8e29	81926-001	HUMAN OTC DRUG	Dr. Piercing Aftercare		Benzalkonium Chloride	SWAB	TOPICAL	20210101		OTC MONOGRAPH NOT FINAL	part333A	Broadway Products LLC	BENZALKONIUM CHLORIDE	1.1	mg/mL			N	20241231
81926-101_019153d9-74c2-658f-e063-6294a90aa2bf	81926-101	HUMAN OTC DRUG	DR. PIERCING AFTERCARE MEDICATION		BENZALKONIUM CHLORIDE	SPRAY	TOPICAL	20220804		OTC MONOGRAPH NOT FINAL	part333A	Broadway Products LLC	BENZALKONIUM CHLORIDE	.11	g/100mL			N	20241231
81927-111_8f294d33-293a-4696-808f-2dbdf94d729d	81927-111	HUMAN PRESCRIPTION DRUG	nelarabine		nelarabine	INJECTION	INTRAVENOUS	20230315		ANDA	ANDA214809	Shorla Oncology Inc.	NELARABINE	5	mg/mL	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
81927-204_a52b047b-bb14-428f-9175-5d55e5a019d0	81927-204	HUMAN PRESCRIPTION DRUG	JYLAMVO		Methotrexate	SOLUTION	ORAL	20231215		NDA	NDA212479	SHORLA ONCOLOGY INC.	METHOTREXATE	2	mg/mL	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]		N	20241231
81929-001_09ce5c6f-239e-7dca-e063-6394a90aa47c	81929-001	HUMAN OTC DRUG	Derman Antifungal Powder Tolnaftate		TOLNAFTATE	AEROSOL, POWDER	TOPICAL	20220501		OTC MONOGRAPH DRUG	M005	Taisho Pharmaceutical California Inc.	TOLNAFTATE	10	mg/g			N	20241231
81929-002_09ce5c6f-23ad-7dca-e063-6394a90aa47c	81929-002	HUMAN OTC DRUG	Vitacilina Bebe Diaper Rash		ZINC OXIDE	OINTMENT	TOPICAL	20220701		OTC MONOGRAPH DRUG	M016	Taisho Pharmaceutical California Inc.	ZINC OXIDE	400	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
81929-003_09ce4763-a8f8-7cff-e063-6294a90a851c	81929-003	HUMAN OTC DRUG	Vitacilina First Aid Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	OINTMENT	TOPICAL	20220701		OTC MONOGRAPH DRUG	M004	Taisho Pharmaceutical California Inc.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	U/g; mg/g; U/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
81929-004_09ce6831-6c39-8029-e063-6394a90a2feb	81929-004	HUMAN OTC DRUG	Derman antifungal cream		TOLNAFTATE	CREAM	TOPICAL	20220701		OTC MONOGRAPH DRUG	M005	Taisho Pharmaceutical California Inc.	TOLNAFTATE	10	mg/g			N	20241231
81931-0650_fea896ce-a72d-70f1-e053-6294a90aa7cb	81931-0650	HUMAN OTC DRUG	Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	New Beginnings Tattoo Removal	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
81938-939_f2001755-4604-11ab-e053-2a95a90afa31	81938-939	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	LaCore Nutraceuticals, Inc.	ALCOHOL	80	mL/100mL			N	20241231
81942-125_d183d20e-3915-4108-9568-de8059d227be	81942-125	HUMAN PRESCRIPTION DRUG	XDEMVY		Lotilaner ophthalmic solution	SOLUTION/ DROPS	OPHTHALMIC	20230814		NDA	NDA217603	Tarsus Pharmaceuticals, Inc.	LOTILANER	2.5	mg/mL			N	20241231
81943-202_090c1d7f-2885-23a3-e063-6394a90a8eff	81943-202	HUMAN OTC DRUG	X-TERIL		ALCOHOL	GEL	TOPICAL	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	ALCOHOL	70	mL/100mL			N	20241231
81943-202_090c1d7f-2886-23a3-e063-6394a90a8eff	81943-202	HUMAN OTC DRUG	X-TERIL		ALCOHOL	GEL	TOPICAL	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	ALCOHOL	70	mL/100mL			N	20241231
81943-202_090c1d7f-2887-23a3-e063-6394a90a8eff	81943-202	HUMAN OTC DRUG	X-TERIL		ALCOHOL	GEL	TOPICAL	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	ALCOHOL	70	mL/100mL			N	20241231
81943-502_090c1d7f-2888-23a3-e063-6394a90a8eff	81943-502	HUMAN OTC DRUG	QUABIC-300		Hemodialysis Grade Sodium Bicarbonate Solution	SOLUTION, CONCENTRATE	HEMODIALYSIS	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	SODIUM BICARBONATE	8.4	g/100mL	Alkalinizing Activity [MoA]		N	20241231
81943-503_090bda94-9272-99f0-e063-6294a90a396c	81943-503	HUMAN OTC DRUG	QUABIC-100		Hemodialysis Grade Sodium Bicarbonate Solution	SOLUTION, CONCENTRATE	HEMODIALYSIS	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	SODIUM BICARBONATE	8.4	g/100mL	Alkalinizing Activity [MoA]		N	20241231
81943-601_0404b5ce-f8a3-74ad-e063-6294a90a0337	81943-601	HUMAN OTC DRUG	DRY-CID		Dry Concentrate for Hemodialysis	POWDER, FOR SOLUTION	HEMODIALYSIS	20230330		OTC MONOGRAPH NOT FINAL	part356	AQUA MEDICA, S.A. DE C.V.	POTASSIUM CHLORATE	.51	kg/100kg			N	20241231
81943-602_090c195f-d12f-24e5-e063-6394a90a05b7	81943-602	HUMAN OTC DRUG	AQUACID-220		Acid Concentrate for Hemodialysis	SOLUTION, CONCENTRATE	HEMODIALYSIS	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	POTASSIUM CHLORATE	.671	g/100mL			N	20241231
81943-603_090c02e7-5f97-0e72-e063-6394a90a026a	81943-603	HUMAN OTC DRUG	AQUACID-200		Acid Concentrate for Hemodialysis	SOLUTION, CONCENTRATE	HEMODIALYSIS	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	POTASSIUM CHLORATE	.671	g/100mL			N	20241231
81943-604_090c13a7-e58e-ae0d-e063-6294a90a720d	81943-604	HUMAN OTC DRUG	AQUACID-120		Acid Concentrate for Hemodialysis	SOLUTION, CONCENTRATE	HEMODIALYSIS	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	POTASSIUM CHLORATE	.671	g/100mL			N	20241231
81943-605_090c0f11-97ae-bb1b-e063-6294a90a07ee	81943-605	HUMAN OTC DRUG	AQUACID-100		Acid Concentrate for Hemodialysis	SOLUTION, CONCENTRATE	HEMODIALYSIS	20200330		UNAPPROVED DRUG OTHER		AQUA MEDICA, S.A. DE C.V.	POTASSIUM CHLORATE	.671	g/100mL			N	20241231
81943-701_040713e7-67ce-8eb0-e063-6394a90aa2a9	81943-701	HUMAN OTC DRUG	CITRACID-50		Desinfectant Solution for Hemodialysis Machine	SOLUTION, CONCENTRATE	HEMODIALYSIS	20230330		OTC MONOGRAPH NOT FINAL	part356	AQUA MEDICA, S.A. DE C.V.	CITRIC ACID MONOHYDRATE	.5	g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
81943-801_040775ab-41be-cd36-e063-6394a90a08aa	81943-801	HUMAN OTC DRUG	AQUACETIC-30		Cleaning Solution for Hemodialysis Machines	SOLUTION, CONCENTRATE	HEMODIALYSIS	20230330		OTC MONOGRAPH NOT FINAL	part356	AQUA MEDICA, S.A. DE C.V.	CITRIC ACID MONOHYDRATE	.3	g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
81944-0002_fb489d85-907a-6e96-e053-6394a90a8b42	81944-0002	HUMAN OTC DRUG	O2 Patch		KO2, Ca(OH)2	POWDER	RESPIRATORY (INHALATION)	20210612		UNAPPROVED DRUG OTHER		DIGENT BIO Co., Ltd.	CALCIUM HYDROXIDE	.5	g/100g			N	20241231
81948-6250_a6a7fcf7-b9dc-4dac-b127-418588586a8a	81948-6250	HUMAN PRESCRIPTION DRUG	Cefaclor		cefaclor	SUSPENSION	ORAL	20221101		ANDA	ANDA065412	Azorian Pharma, LLC	CEFACLOR	250	mg/5mL	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
81952-111_0640c98a-d8e1-1977-e063-6394a90a7d78	81952-111	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	Hepalink USA Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
81952-112_0640c98a-d8e1-1977-e063-6394a90a7d78	81952-112	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202957	Hepalink USA Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
81952-113_0640c98a-d8e1-1977-e063-6394a90a7d78	81952-113	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA203198	Hepalink USA Inc.	HEPARIN SODIUM	10000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
81952-114_0640c98a-d8e1-1977-e063-6394a90a7d78	81952-114	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202733	Hepalink USA Inc.	HEPARIN SODIUM	5000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
81952-115_0640c98a-d8e1-1977-e063-6394a90a7d78	81952-115	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA202732	Hepalink USA Inc.	HEPARIN SODIUM	1000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
81952-116_0640c98a-d8e1-1977-e063-6394a90a7d78	81952-116	HUMAN PRESCRIPTION DRUG	Heparin Sodium		Heparin Sodium	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20140612		ANDA	ANDA203198	Hepalink USA Inc.	HEPARIN SODIUM	20000	[USP'U]/mL	Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]		N	20241231
81952-123_f9fd7c4a-4024-46d1-e053-6394a90a439d	81952-123	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	Hepalink USA Inc.	ENOXAPARIN SODIUM	30	mg/.3mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
81952-124_f9fd7c4a-4024-46d1-e053-6394a90a439d	81952-124	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	Hepalink USA Inc.	ENOXAPARIN SODIUM	40	mg/.4mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
81952-126_f9fd7c4a-4024-46d1-e053-6394a90a439d	81952-126	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	Hepalink USA Inc.	ENOXAPARIN SODIUM	60	mg/.6mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
81952-128_f9fd7c4a-4024-46d1-e053-6394a90a439d	81952-128	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	Hepalink USA Inc.	ENOXAPARIN SODIUM	80	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
81952-130_f9fd7c4a-4024-46d1-e053-6394a90a439d	81952-130	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	Hepalink USA Inc.	ENOXAPARIN SODIUM	100	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
81952-132_f9fd7c4a-4024-46d1-e053-6394a90a439d	81952-132	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	Hepalink USA Inc.	ENOXAPARIN SODIUM	120	mg/.8mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
81952-135_f9fd7c4a-4024-46d1-e053-6394a90a439d	81952-135	HUMAN PRESCRIPTION DRUG	Enoxaparin Sodium		Enoxaparin Sodium	INJECTION, SOLUTION	SUBCUTANEOUS	20230315		ANDA	ANDA205660	Hepalink USA Inc.	ENOXAPARIN SODIUM	150	mg/mL	Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]		N	20241231
81952-911_38730e0b-146d-4b8f-b69e-797da8f231d9	81952-911	HUMAN PRESCRIPTION DRUG	FOSAPREPITANT		FOSAPREPITANT	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230714		ANDA	ANDA212143	Hepalink USA Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
81953-100_0dc0df69-741c-db51-e063-6394a90a3263	81953-100	HUMAN OTC DRUG	SCANTILY PAD		Acne Treatment	LIQUID	TOPICAL	20210601		OTC MONOGRAPH DRUG	M006	Dermala Inc	SALICYLIC ACID	.01	mg/mg			N	20241231
81962-000_f6c2ed1b-42e5-576d-e053-6394a90a537e	81962-000	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION	INTRAVENOUS	20230531		ANDA	ANDA216154	BROOKS STERISCIENCE LIMITED	MEROPENEM	500	mg/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
81962-001_f6c2ed1b-42e5-576d-e053-6394a90a537e	81962-001	HUMAN PRESCRIPTION DRUG	Meropenem		Meropenem	INJECTION	INTRAVENOUS	20230531		ANDA	ANDA216154	BROOKS STERISCIENCE LIMITED	MEROPENEM	1	g/20mL	Carbapenems [CS], Penem Antibacterial [EPC]		N	20241231
81963-101_0d3808a3-511e-756d-e063-6294a90a02d0	81963-101	HUMAN OTC DRUG	Avenova Lubricant Eye Drops High Performance		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20210928		OTC MONOGRAPH DRUG	M018	NovaBay Pharmaceuticals, Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
81964-003_15337b6c-0275-4f78-b7b8-e7f44db2a9d7	81964-003	HUMAN PRESCRIPTION DRUG	AUGMENTIN ES-600		amoxicillin and clavulanate potassium	FOR SUSPENSION	ORAL	20220715		NDA	NDA050755	USAntibiotics, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81964-203_542fee34-529c-4aa0-8bc6-cb1b70324014	81964-203	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		amoxicillin and clavulanate potassium	FOR SUSPENSION	ORAL	20220919		NDA AUTHORIZED GENERIC	NDA050755	USAntibiotics, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81964-204_d92713aa-67c3-477d-9fb8-ef54a948fd9a	81964-204	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	FOR SUSPENSION	ORAL	20221205		NDA AUTHORIZED GENERIC	NDA050575	USAntibiotics, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	250; 62.5	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81964-205_75084685-263a-4008-970f-b856aa75238a	81964-205	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		Amoxicillin	CAPSULE	ORAL	20220915		ANDA	ANDA062216	USAntibiotics, LLC	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
81964-212_d92713aa-67c3-477d-9fb8-ef54a948fd9a	81964-212	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		Amoxicillin and Clavulanate Potassium	FOR SUSPENSION	ORAL	20221205		NDA AUTHORIZED GENERIC	NDA050575	USAntibiotics, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	125; 31.25	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81964-221_d92713aa-67c3-477d-9fb8-ef54a948fd9a	81964-221	HUMAN PRESCRIPTION DRUG	AMOXICILLIN AND CLAVULANATE POTASSIUM		amoxicillin and clavulanate potassium	TABLET, COATED	ORAL	20221121		NDA AUTHORIZED GENERIC	NDA050720	USAntibiotics, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
81964-225_75084685-263a-4008-970f-b856aa75238a	81964-225	HUMAN PRESCRIPTION DRUG	AMOXICILLIN		Amoxicillin	CAPSULE	ORAL	20220915		ANDA	ANDA062216	USAntibiotics, LLC	AMOXICILLIN	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
81968-045_ed41b2a2-19c2-4357-8818-712d09c8ba79	81968-045	HUMAN PRESCRIPTION DRUG	AUVELITY		dextromethorphan hydrobromide, bupropion hydrochloride	TABLET, MULTILAYER, EXTENDED RELEASE	ORAL	20220818		NDA	NDA215430	Axsome Therapeutics, Inc.	BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE	105; 45	mg/1; mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
81968-350_675fa3ba-cafd-496b-8820-ab42b4e95df8	81968-350	HUMAN PRESCRIPTION DRUG	SUNOSI		solriamfetol	TABLET, FILM COATED	ORAL	20190618		NDA	NDA211230	Axsome Therapeutics, Inc.	SOLRIAMFETOL	75	mg/1		CIV	N	20241231
81968-351_675fa3ba-cafd-496b-8820-ab42b4e95df8	81968-351	HUMAN PRESCRIPTION DRUG	SUNOSI		solriamfetol	TABLET, FILM COATED	ORAL	20190618		NDA	NDA211230	Axsome Therapeutics, Inc.	SOLRIAMFETOL	150	mg/1		CIV	N	20241231
81984-099_60c0bc37-83b2-3280-e053-2a91aa0ae7c9	81984-099	HUMAN OTC DRUG	4OZ MEDICATED CHEST RUB		menthol, camphor, eucalyptus oil	OINTMENT	TOPICAL	20171201		OTC MONOGRAPH NOT FINAL	part348	Pride Products Corporation	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	4.7; 1; 1	g/100g; g/100g; g/100g			N	20241231
81985-186_09e2e2ce-d85c-0711-e063-6294a90a9213	81985-186	HUMAN OTC DRUG	M3 NATURALS Eczema Cream		OATMEAL	CREAM	TOPICAL	20210419		OTC MONOGRAPH DRUG	M016	M3 Naturals LLC	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
81986-001_82333885-28e4-4f1a-809b-c6c9e625d424	81986-001	HUMAN PRESCRIPTION DRUG	Fludeoxyglucose F 18		Fludeoxyglucose F 18	INJECTION, SOLUTION	INTRAVENOUS	20210601		ANDA	ANDA203664	Pharmalogic Puerto Rico, Inc.	FLUDEOXYGLUCOSE F-18	200	mCi/mL	Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]		N	20241231
81987-001_0878f27e-5369-c93f-e063-6394a90a1086	81987-001	HUMAN OTC DRUG	ALCOHOL WET WIPES		Alcohol wet Wipes	CLOTH	TOPICAL	20210601		OTC MONOGRAPH DRUG	505G(a)(3)	CB Shelton Enterprises Llc.	ALCOHOL	75	mL/100mL			N	20241231
81990-001_0dc6d95e-3419-ec48-e063-6394a90af849	81990-001	HUMAN OTC DRUG	Hops ANTIBACTERIAL WET WIPES		Benzalkonium chloride 0.10%	CLOTH	TOPICAL	20210701		OTC MONOGRAPH DRUG	505G(a)(3)	Sapro Temizlik Urunleri Sanayi ve Ticaret Anonim Sirketi	BENZALKONIUM CHLORIDE	.1	U/100U			N	20241231
81991-001_f5d244f5-d4c1-edd1-e053-2a95a90a92be	81991-001	HUMAN OTC DRUG	Isopropanol Wipes		Isopropanol Wipes	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	Hangzhou Jiexiang Technology Co., Ltd.	ISOPROPYL ALCOHOL	70	g/1001			N	20241231
81995-056_09ce75b1-647c-98bf-e063-6294a90acb4a	81995-056	HUMAN OTC DRUG	First honey Burn Salve		ALLANTOIN	CREAM	TOPICAL	20220510		OTC MONOGRAPH DRUG	M016	First Honey, LLC	ALLANTOIN	5	mg/mL			N	20241231
81996-244_0894ba40-2d73-f381-e063-6394a90a2b21	81996-244	HUMAN OTC DRUG	NUTURNA Arthritis Intensive Concentrate for Pain Relief and Recovery		MENTHOL	CREAM	TOPICAL	20201122		OTC MONOGRAPH DRUG	M017	Nuturna International LLC	MENTHOL	3.7	g/100g			N	20251231
82000-0650_ff35288c-2270-29ba-e053-6294a90ada83	82000-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part352	Skin & Laser Surgery Ctr of PA.	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
82001-001_0bb0a2d7-3395-f107-e063-6294a90a825e	82001-001	HUMAN OTC DRUG	Eye Wash		WATER	LIQUID	TOPICAL	20210707	20261128	OTC MONOGRAPH DRUG	505G(a)(3)	Jiangxi Zhenmei Biological Technology Co.,Ltd	WATER	991	mg/mL			N	
82009-001_d0513f11-a7bd-87b3-cd04-ace3f7a69579	82009-001	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20211123		ANDA	ANDA090548	Quallent	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-002_d0513f11-a7bd-87b3-cd04-ace3f7a69579	82009-002	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20211123		ANDA	ANDA090548	Quallent	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-003_d0513f11-a7bd-87b3-cd04-ace3f7a69579	82009-003	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20211123		ANDA	ANDA090548	Quallent	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-004_d0513f11-a7bd-87b3-cd04-ace3f7a69579	82009-004	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20211123		ANDA	ANDA090548	Quallent	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-006_14710852-7997-c674-fec5-ef015302e666	82009-006	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20211203		ANDA	ANDA076341	Quallent	PRAVASTATIN SODIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-007_14710852-7997-c674-fec5-ef015302e666	82009-007	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20211203		ANDA	ANDA076341	Quallent	PRAVASTATIN SODIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-008_14710852-7997-c674-fec5-ef015302e666	82009-008	HUMAN PRESCRIPTION DRUG	PRAVASTATIN SODIUM		PRAVASTATIN SODIUM	TABLET	ORAL	20211203		ANDA	ANDA076341	Quallent	PRAVASTATIN SODIUM	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-009_e0f31e06-f756-b74c-e053-2995a90a1c12	82009-009	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20220607		ANDA	ANDA202843	Quallent Pharmaceuticals Health LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
82009-010_e8b18fdc-61a8-72f0-e053-2a95a90a4d67	82009-010	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220606		ANDA	ANDA202882	Quallent Pharmaceuticals Health LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82009-011_e8b18fdc-61a8-72f0-e053-2a95a90a4d67	82009-011	HUMAN PRESCRIPTION DRUG	PANTOPRAZOLE SODIUM		PANTOPRAZOLE	TABLET, DELAYED RELEASE	ORAL	20220606		ANDA	ANDA202882	Quallent Pharmaceuticals Health LLC	PANTOPRAZOLE SODIUM	40	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82009-012_00579b50-3f9a-9f59-e063-6394a90af798	82009-012	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20220526		ANDA	ANDA200895	Quallent Pharmaceuticals Health LLC	SIMVASTATIN	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-013_00579b50-3f9a-9f59-e063-6394a90af798	82009-013	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20220526		ANDA	ANDA200895	Quallent Pharmaceuticals Health LLC	SIMVASTATIN	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-014_00579b50-3f9a-9f59-e063-6394a90af798	82009-014	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20220526		ANDA	ANDA200895	Quallent Pharmaceuticals Health LLC	SIMVASTATIN	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-015_00579b50-3f9a-9f59-e063-6394a90af798	82009-015	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20220526		ANDA	ANDA200895	Quallent Pharmaceuticals Health LLC	SIMVASTATIN	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-016_00579b50-3f9a-9f59-e063-6394a90af798	82009-016	HUMAN PRESCRIPTION DRUG	Simvastatin		Simvastatin	TABLET, FILM COATED	ORAL	20220526		ANDA	ANDA200895	Quallent Pharmaceuticals Health LLC	SIMVASTATIN	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-017_e9fb4684-5494-4b46-bb3d-6bd23a08d9d8	82009-017	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220309		ANDA	ANDA208898	QUALLENT	ROSUVASTATIN CALCIUM	5	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-018_e9fb4684-5494-4b46-bb3d-6bd23a08d9d8	82009-018	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220309		ANDA	ANDA208898	QUALLENT	ROSUVASTATIN CALCIUM	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-019_e9fb4684-5494-4b46-bb3d-6bd23a08d9d8	82009-019	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220309		ANDA	ANDA208898	QUALLENT	ROSUVASTATIN CALCIUM	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-020_e9fb4684-5494-4b46-bb3d-6bd23a08d9d8	82009-020	HUMAN PRESCRIPTION DRUG	Rosuvastatin Calcium		Rosuvastatin Calcium	TABLET, FILM COATED	ORAL	20220309		ANDA	ANDA208898	QUALLENT	ROSUVASTATIN CALCIUM	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82009-021_599b792d-2fa0-0fda-239d-ad545fc452c0	82009-021	HUMAN PRESCRIPTION DRUG	Clopidogrel bisulfate		Clopidogrel bisulfate	TABLET, FILM COATED	ORAL	20221115		ANDA	ANDA076273	Quallent Pharmaceuticals Health LLC	CLOPIDOGREL BISULFATE	75	mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]		N	20241231
82009-022_61f30995-d9eb-8da3-661c-cd5cbf334f91	82009-022	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20221115		ANDA	ANDA075576	Quallent Pharmaceuticals Health LLC	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82009-023_21cc1966-28ae-35ad-95fd-2784dc4182f6	82009-023	HUMAN PRESCRIPTION DRUG	Omeprazole		Omeprazole	CAPSULE, DELAYED RELEASE	ORAL	20221115		ANDA	ANDA078490	Quallent Pharmaceuticals Health LLC	OMEPRAZOLE	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82009-024_e36b9853-298c-4018-92a6-56031268ed9c	82009-024	HUMAN PRESCRIPTION DRUG	ezetimibe		ezetimibe	TABLET	ORAL	20220820		ANDA	ANDA204331	Quallent Pharmaceuticals Health LLC	EZETIMIBE	10	mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]		N	20241231
82009-025_82b44507-051f-4892-a0b7-ed3955c2f72f	82009-025	HUMAN PRESCRIPTION DRUG	Tamsulosin Hydrochloride		Tamsulosin Hydrochloride	CAPSULE	ORAL	20220820		ANDA	ANDA078225	Quallent Pharmaceuticals Health LLC	TAMSULOSIN HYDROCHLORIDE	.4	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
82009-026_7bd158b9-a62d-4b69-95ba-d026595836ac	82009-026	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20221201		ANDA	ANDA077073	Quallent Pharmaceuticals Health LLC	AMLODIPINE BESYLATE	2.5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
82009-027_7bd158b9-a62d-4b69-95ba-d026595836ac	82009-027	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20221201		ANDA	ANDA077073	Quallent Pharmaceuticals Health LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
82009-028_7bd158b9-a62d-4b69-95ba-d026595836ac	82009-028	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20221201		ANDA	ANDA077073	Quallent Pharmaceuticals Health LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
82009-029_c6042c04-f7be-4ee0-b09a-171ea47adf51	82009-029	HUMAN PRESCRIPTION DRUG	Duloxetine		DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Quallent Pharmaceuticals Health, LLC	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82009-030_c6042c04-f7be-4ee0-b09a-171ea47adf51	82009-030	HUMAN PRESCRIPTION DRUG	Duloxetine		DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Quallent Pharmaceuticals Health, LLC	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82009-031_c6042c04-f7be-4ee0-b09a-171ea47adf51	82009-031	HUMAN PRESCRIPTION DRUG	Duloxetine		DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20180521		ANDA	ANDA203088	Quallent Pharmaceuticals Health, LLC	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82009-032_c6042c04-f7be-4ee0-b09a-171ea47adf51	82009-032	HUMAN PRESCRIPTION DRUG	Duloxetine		DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20140611		ANDA	ANDA203088	Quallent Pharmaceuticals Health, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82009-033_6f3a1a71-26be-439b-9960-95734f768c7c	82009-033	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20221201		ANDA	ANDA213486	Quallent Pharmaceuticals Health LLC	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82009-034_6f3a1a71-26be-439b-9960-95734f768c7c	82009-034	HUMAN PRESCRIPTION DRUG	ESOMEPRAZOLE MAGNESIUM		ESOMEPRAZOLE MAGNESIUM	CAPSULE, DELAYED RELEASE	ORAL	20221201		ANDA	ANDA213486	Quallent Pharmaceuticals Health LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82009-035_a92b4700-c7be-4b31-a3bd-136779914152	82009-035	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20230301		ANDA	ANDA090939	Quallent Pharmaceuticals Health LLC	ESCITALOPRAM OXALATE	5	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-036_a92b4700-c7be-4b31-a3bd-136779914152	82009-036	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20230301		ANDA	ANDA090939	Quallent Pharmaceuticals Health LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-037_a92b4700-c7be-4b31-a3bd-136779914152	82009-037	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20230301		ANDA	ANDA090939	Quallent Pharmaceuticals Health LLC	ESCITALOPRAM OXALATE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-039_ec1531f7-4c0d-61f4-e053-2995a90a5247	82009-039	HUMAN PRESCRIPTION DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20221014		ANDA	ANDA203083	Quallent Pharmaceuticals Health LLC	LANSOPRAZOLE	30	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82009-040_ec1531f7-4c54-61f4-e053-2995a90a5247	82009-040	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20221014		ANDA	ANDA203047	Quallent Pharmaceuticals Health LLC	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
82009-041_ec1531f7-4c54-61f4-e053-2995a90a5247	82009-041	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET, FILM COATED	ORAL	20221014		ANDA	ANDA203047	Quallent Pharmaceuticals Health LLC	VALACYCLOVIR HYDROCHLORIDE	1	g/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
82009-042_4b6c3bfa-4344-4173-820e-e6ac6b25bd6f	82009-042	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220920		ANDA	ANDA078243	Quallent Pharmaceuticals Health LLC	LOSARTAN POTASSIUM	25	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
82009-043_4b6c3bfa-4344-4173-820e-e6ac6b25bd6f	82009-043	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220920		ANDA	ANDA078243	Quallent Pharmaceuticals Health LLC	LOSARTAN POTASSIUM	50	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
82009-044_4b6c3bfa-4344-4173-820e-e6ac6b25bd6f	82009-044	HUMAN PRESCRIPTION DRUG	Losartan Potassium		Losartan Potassium	TABLET, FILM COATED	ORAL	20220920		ANDA	ANDA078243	Quallent Pharmaceuticals Health LLC	LOSARTAN POTASSIUM	100	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
82009-045_6b8f8a91-9504-46e2-a789-562771803a4e	82009-045	HUMAN PRESCRIPTION DRUG	Hydroxychloroquine sulfate		Hydroxychloroquine sulfate	TABLET, FILM COATED	ORAL	20220930		ANDA	ANDA040657	Quallent Pharmaceuticals Health LLC	HYDROXYCHLOROQUINE SULFATE	200	mg/1	Antimalarial [EPC], Antirheumatic Agent [EPC]		N	20241231
82009-046_0171a6ea-0b23-1679-e063-6394a90aa099	82009-046	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Tablet	TABLET	ORAL	20220201		ANDA	ANDA090564	Quallent Pharmaceuticals Health LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
82009-047_0171a6ea-0b23-1679-e063-6394a90aa099	82009-047	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride Tablet	TABLET	ORAL	20230201		ANDA	ANDA090564	Quallent Pharmaceuticals Health LLC	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
82009-049_8e47f2bc-3bc6-4c48-a535-6db3c05b942c	82009-049	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20230928		ANDA	ANDA077397	Quallent Pharmaceuticals Health LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-050_8e47f2bc-3bc6-4c48-a535-6db3c05b942c	82009-050	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20230928		ANDA	ANDA077397	Quallent Pharmaceuticals Health LLC	SERTRALINE HYDROCHLORIDE	100	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-051_d4972b84-9442-42dc-b5c7-3dae4833203a	82009-051	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230707		ANDA	ANDA090693	Quallent Pharmaceuticals Health LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
82009-052_d4972b84-9442-42dc-b5c7-3dae4833203a	82009-052	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride		Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20230707		ANDA	ANDA090693	Quallent Pharmaceuticals Health LLC	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
82009-054_f57d840d-c172-ec41-f01a-3b559509f721	82009-054	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20230720		ANDA	ANDA090509	Quallent Pharmaceuticals Health LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
82009-056_6d7f4b15-6d28-4e79-8fc9-5d48fb809498	82009-056	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20221121		ANDA	ANDA200834	QUALLENT PHARMACEUTICALS HEALTH LLC	VENLAFAXINE HYDROCHLORIDE	37.5	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82009-057_6d7f4b15-6d28-4e79-8fc9-5d48fb809498	82009-057	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20221121		ANDA	ANDA200834	QUALLENT PHARMACEUTICALS HEALTH LLC	VENLAFAXINE HYDROCHLORIDE	75	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82009-058_6d7f4b15-6d28-4e79-8fc9-5d48fb809498	82009-058	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20221121		ANDA	ANDA200834	QUALLENT PHARMACEUTICALS HEALTH LLC	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82009-060_215a5000-9f89-47d9-b2d5-94e13f5e1767	82009-060	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET, COATED	ORAL	20221118		ANDA	ANDA205118	QUALLENT PHARMACEUTICALS HEALTH LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
82009-061_5efc695c-d9fd-4892-a63f-a35cceb8d3c7	82009-061	HUMAN PRESCRIPTION DRUG	Finasteride		Finasteride	TABLET, FILM COATED	ORAL	20221121		ANDA	ANDA078341	QUALLENT PHARMACEUTICALS HEALTH LLC	FINASTERIDE	5	mg/1	5-alpha Reductase Inhibitor [EPC], 5-alpha Reductase Inhibitors [MoA]		N	20241231
82009-062_d2b42923-6e5f-47a1-9b31-4d019142a102	82009-062	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230707		ANDA	ANDA077321	Quallent Pharmaceuticals Health LLC	LISINOPRIL	2.5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
82009-063_d2b42923-6e5f-47a1-9b31-4d019142a102	82009-063	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230707		ANDA	ANDA077321	Quallent Pharmaceuticals Health LLC	LISINOPRIL	5	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
82009-064_d2b42923-6e5f-47a1-9b31-4d019142a102	82009-064	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230707		ANDA	ANDA077321	Quallent Pharmaceuticals Health LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
82009-065_d2b42923-6e5f-47a1-9b31-4d019142a102	82009-065	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230707		ANDA	ANDA077321	Quallent Pharmaceuticals Health LLC	LISINOPRIL	20	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
82009-066_d2b42923-6e5f-47a1-9b31-4d019142a102	82009-066	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230707		ANDA	ANDA077321	Quallent Pharmaceuticals Health LLC	LISINOPRIL	40	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
82009-068_cc196603-bf08-49e9-aebb-dbb03aa3fca6	82009-068	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20230928		ANDA	ANDA207446	Quallent Pharmaceuticals Health LLC	CELECOXIB	100	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82009-069_cc196603-bf08-49e9-aebb-dbb03aa3fca6	82009-069	HUMAN PRESCRIPTION DRUG	CELECOXIB		CELECOXIB	CAPSULE	ORAL	20230928		ANDA	ANDA207446	Quallent Pharmaceuticals Health LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82009-071_0b1dfe79-6d0f-4652-8043-605ab799ff35	82009-071	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA200651	QUALLENT PHARMACEUTICALS HEALTH LLC	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-072_0b1dfe79-6d0f-4652-8043-605ab799ff35	82009-072	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA200651	QUALLENT PHARMACEUTICALS HEALTH LLC	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-073_98f930d5-f7c2-4870-92b4-0ad37ce45797	82009-073	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA204798	QUALLENT PHARMACEUTICALS HEALTH LLC	OLMESARTAN MEDOXOMIL	5	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
82009-074_98f930d5-f7c2-4870-92b4-0ad37ce45797	82009-074	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA204798	QUALLENT PHARMACEUTICALS HEALTH LLC	OLMESARTAN MEDOXOMIL	20	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
82009-075_98f930d5-f7c2-4870-92b4-0ad37ce45797	82009-075	HUMAN PRESCRIPTION DRUG	Olmesartan Medoxomil		Olmesartan Medoxomil	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA204798	QUALLENT PHARMACEUTICALS HEALTH LLC	OLMESARTAN MEDOXOMIL	40	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
82009-077_dc14daa3-cae9-4751-9034-b0e9c18054b4	82009-077	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230719		ANDA	ANDA209654	Quallent Pharmaceuticals Health LLC	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82009-079_dc14daa3-cae9-4751-9034-b0e9c18054b4	82009-079	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230719		ANDA	ANDA209654	Quallent Pharmaceuticals Health LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82009-080_84cb16c8-30ab-49f2-a6df-ec3c97bf6284	82009-080	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20230719		ANDA	ANDA210392	Quallent Pharmaceuticals Health LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82009-086_92ab5711-1241-43d8-9e2c-47c973ca0cc1	82009-086	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA212773	QUALLENT PHARMACEUTICALS HEALTH LLC	IMATINIB MESYLATE	100	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
82009-087_92ab5711-1241-43d8-9e2c-47c973ca0cc1	82009-087	HUMAN PRESCRIPTION DRUG	Imatinib Mesylate		Imatinib Mesylate	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA212773	QUALLENT PHARMACEUTICALS HEALTH LLC	IMATINIB MESYLATE	400	mg/1	Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]		N	20241231
82009-088_3a0890cc-f7e0-4bfd-b530-c5a72100bf84	82009-088	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230719		ANDA	ANDA206174	Quallent Pharmaceuticals Health LLC	ARIPIPRAZOLE	2	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-089_3a0890cc-f7e0-4bfd-b530-c5a72100bf84	82009-089	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230719		ANDA	ANDA206174	Quallent Pharmaceuticals Health LLC	ARIPIPRAZOLE	5	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-090_3a0890cc-f7e0-4bfd-b530-c5a72100bf84	82009-090	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230719		ANDA	ANDA206174	Quallent Pharmaceuticals Health LLC	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-091_3a0890cc-f7e0-4bfd-b530-c5a72100bf84	82009-091	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20230719		ANDA	ANDA206174	Quallent Pharmaceuticals Health LLC	ARIPIPRAZOLE	15	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-093_41b67fd2-3d9a-49d6-88b8-285044b98dc1	82009-093	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA206401	Quallent Pharmaceuticals Health LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82009-094_e4b79eee-491e-49c1-b2ed-f848fc530704	82009-094	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET	ORAL	20230719		ANDA	ANDA210394	Quallent Pharmaceuticals Health LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
82009-095_3b8dc425-7585-4e4a-a61c-b96e8d8f9708	82009-095	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20230714		ANDA	ANDA201109	Quallent Pharmaceuticals Health LLC	QUETIAPINE FUMARATE	25	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-096_3b8dc425-7585-4e4a-a61c-b96e8d8f9708	82009-096	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20230714		ANDA	ANDA201109	Quallent Pharmaceuticals Health LLC	QUETIAPINE FUMARATE	50	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-097_3b8dc425-7585-4e4a-a61c-b96e8d8f9708	82009-097	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20230714		ANDA	ANDA201109	Quallent Pharmaceuticals Health LLC	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-098_3b8dc425-7585-4e4a-a61c-b96e8d8f9708	82009-098	HUMAN PRESCRIPTION DRUG	Quetiapine fumarate		quetiapine fumarate	TABLET	ORAL	20230714		ANDA	ANDA201109	Quallent Pharmaceuticals Health LLC	QUETIAPINE FUMARATE	200	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82009-100_54957a13-ec3e-449a-b7a7-7c40dd23fa0b	82009-100	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20230901		ANDA	ANDA078619	QUALLENT PHARMACEUTICALS HEALTH LLC	FLUOXETINE HYDROCHLORIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-101_54957a13-ec3e-449a-b7a7-7c40dd23fa0b	82009-101	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20230901		ANDA	ANDA078619	QUALLENT PHARMACEUTICALS HEALTH LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-102_54957a13-ec3e-449a-b7a7-7c40dd23fa0b	82009-102	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20230901		ANDA	ANDA078619	QUALLENT PHARMACEUTICALS HEALTH LLC	FLUOXETINE HYDROCHLORIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-103_0331400c-b163-4856-bfb0-965470247cb3	82009-103	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20230801		ANDA	ANDA200268	QUALLENT PHARMACEUTICALS HEALTH LLC	PIOGLITAZONE HYDROCHLORIDE	15	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
82009-104_0331400c-b163-4856-bfb0-965470247cb3	82009-104	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20230801		ANDA	ANDA200268	QUALLENT PHARMACEUTICALS HEALTH LLC	PIOGLITAZONE HYDROCHLORIDE	30	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
82009-105_0331400c-b163-4856-bfb0-965470247cb3	82009-105	HUMAN PRESCRIPTION DRUG	PIOGLITAZONE HYDROCHLORIDE		pioglitazone hydrochloride	TABLET	ORAL	20230801		ANDA	ANDA200268	QUALLENT PHARMACEUTICALS HEALTH LLC	PIOGLITAZONE HYDROCHLORIDE	45	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]		N	20241231
82009-106_3067efd5-1026-485b-8e96-a7c36c5808b8	82009-106	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA077031	QUALLENT PHARMACEUTICALS HEALTH LLC	CITALOPRAM HYDROBROMIDE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-107_3067efd5-1026-485b-8e96-a7c36c5808b8	82009-107	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA077031	QUALLENT PHARMACEUTICALS HEALTH LLC	CITALOPRAM HYDROBROMIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-108_3067efd5-1026-485b-8e96-a7c36c5808b8	82009-108	HUMAN PRESCRIPTION DRUG	Citalopram		Citalopram Hydrobromide	TABLET, FILM COATED	ORAL	20230801		ANDA	ANDA077031	QUALLENT PHARMACEUTICALS HEALTH LLC	CITALOPRAM HYDROBROMIDE	40	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82009-109_904c1fe5-6b1e-419e-ae7c-0bfeff8aa4d3	82009-109	HUMAN PRESCRIPTION DRUG	Emtricitabine and Tenofovir Disoproxil Fumarate		Emtricitabine and Tenofovir Disoproxil Fumarate	TABLET, FILM COATED	ORAL	20230901		ANDA	ANDA090513	QUALLENT PHARMACEUTICALS HEALTH LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
82009-112_e41f1ddf-8358-cc54-baca-9ff0f9dc7930	82009-112	HUMAN PRESCRIPTION DRUG	Capecitabine		Capecitabine	TABLET	ORAL	20230721		ANDA	ANDA204345	Quallent Pharmaceuticals Health LLC	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
82009-113_3825e0c0-e602-e693-cbee-8e130e62e332	82009-113	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230720		ANDA	ANDA090617	Quallent Pharmaceuticals Health LLC	METOPROLOL SUCCINATE	25	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82009-114_3825e0c0-e602-e693-cbee-8e130e62e332	82009-114	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230720		ANDA	ANDA090617	Quallent Pharmaceuticals Health LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82009-115_8b8e2bf6-e8dc-d0cb-41ed-c0cb93c2e742	82009-115	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230720		ANDA	ANDA078889	Quallent Pharmaceuticals Health LLC	METOPROLOL SUCCINATE	100	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82009-116_8b8e2bf6-e8dc-d0cb-41ed-c0cb93c2e742	82009-116	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230720		ANDA	ANDA078889	Quallent Pharmaceuticals Health LLC	METOPROLOL SUCCINATE	200	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82009-117_ff196435-14d6-8b9d-e053-6294a90a4ee8	82009-117	HUMAN PRESCRIPTION DRUG	Metformin ER 500 mg		Metformin ER 500 mg	TABLET	ORAL	20230725		ANDA	ANDA209313	Quallent Pharmaceuticals Health LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
82009-118_ff196435-14d6-8b9d-e053-6294a90a4ee8	82009-118	HUMAN PRESCRIPTION DRUG	Metformin ER 750 mg		Metformin ER 750 mg	TABLET	ORAL	20230725		ANDA	ANDA209313	Quallent Pharmaceuticals Health LLC	METFORMIN HYDROCHLORIDE	750	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
82009-119_00c293f4-fb97-586d-e063-6294a90a7ab8	82009-119	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20230719		ANDA	ANDA203034	Quallent Pharmaceuticals Health LLC	DONEPEZIL HYDROCHLORIDE	5	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
82009-120_00c293f4-fb97-586d-e063-6294a90a7ab8	82009-120	HUMAN PRESCRIPTION DRUG	Donepezil		Donepezil hydrochloride	TABLET	ORAL	20230719		ANDA	ANDA203034	Quallent Pharmaceuticals Health LLC	DONEPEZIL HYDROCHLORIDE	10	mg/1	Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]		N	20241231
82009-121_00844287-6fae-0ab5-e063-6294a90a9014	82009-121	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA090515	Quallent Pharmaceuticals Health LLC	LEVETIRACETAM	250	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-122_00844287-6fae-0ab5-e063-6294a90a9014	82009-122	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20220719		ANDA	ANDA090515	Quallent Pharmaceuticals Health LLC	LEVETIRACETAM	500	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-123_00844287-6fae-0ab5-e063-6294a90a9014	82009-123	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA090515	Quallent Pharmaceuticals Health LLC	LEVETIRACETAM	750	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-124_00844287-6fae-0ab5-e063-6294a90a9014	82009-124	HUMAN PRESCRIPTION DRUG	Levetiracetam		Levetiracetam	TABLET, FILM COATED	ORAL	20230719		ANDA	ANDA090515	Quallent Pharmaceuticals Health LLC	LEVETIRACETAM	1000	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-125_4dd2a87e-6ec3-4ff4-8ba0-e2e5f852c6bf	82009-125	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20230803		ANDA	ANDA077614	Quallent Pharmaceuticals Health LLC	CARVEDILOL	3.125	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
82009-126_4dd2a87e-6ec3-4ff4-8ba0-e2e5f852c6bf	82009-126	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20230803		ANDA	ANDA077614	Quallent Pharmaceuticals Health LLC	CARVEDILOL	6.25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
82009-127_4dd2a87e-6ec3-4ff4-8ba0-e2e5f852c6bf	82009-127	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20230803		ANDA	ANDA077614	Quallent Pharmaceuticals Health LLC	CARVEDILOL	12.5	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
82009-128_4dd2a87e-6ec3-4ff4-8ba0-e2e5f852c6bf	82009-128	HUMAN PRESCRIPTION DRUG	Carvedilol		Carvedilol	TABLET, FILM COATED	ORAL	20230803		ANDA	ANDA077614	Quallent Pharmaceuticals Health LLC	CARVEDILOL	25	mg/1	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
82009-129_03e00c77-cef1-4b64-be56-9c383dc425ae	82009-129	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20230803		ANDA	ANDA077921	Quallent Pharmaceuticals Health LLC	MELOXICAM	7.5	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82009-130_03e00c77-cef1-4b64-be56-9c383dc425ae	82009-130	HUMAN PRESCRIPTION DRUG	meloxicam		meloxicam	TABLET	ORAL	20230803		ANDA	ANDA077921	Quallent Pharmaceuticals Health LLC	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82009-131_cf0abcdf-ed52-4665-a579-aba7d63f339d	82009-131	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230803		ANDA	ANDA077633	Quallent Pharmaceuticals Health LLC	LAMOTRIGINE	25	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
82009-132_cf0abcdf-ed52-4665-a579-aba7d63f339d	82009-132	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230803		ANDA	ANDA077633	Quallent Pharmaceuticals Health LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
82009-133_cf0abcdf-ed52-4665-a579-aba7d63f339d	82009-133	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230803		ANDA	ANDA077633	Quallent Pharmaceuticals Health LLC	LAMOTRIGINE	150	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
82009-134_cf0abcdf-ed52-4665-a579-aba7d63f339d	82009-134	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230803		ANDA	ANDA077633	Quallent Pharmaceuticals Health LLC	LAMOTRIGINE	200	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
82009-135_f79d45f8-ef87-493f-8301-b3674fab3afd	82009-135	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20230724		ANDA	ANDA078235	Quallent Pharmaceuticals Health LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-136_f79d45f8-ef87-493f-8301-b3674fab3afd	82009-136	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20230724		ANDA	ANDA078235	Quallent Pharmaceuticals Health LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82009-137_f79d45f8-ef87-493f-8301-b3674fab3afd	82009-137	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20230724		ANDA	ANDA078235	Quallent Pharmaceuticals Health LLC	TOPIRAMATE	100	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82012-027_dd924d44-b14d-440c-9670-8faa42422ba1	82012-027	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20200307		ANDA	ANDA202111	Senores Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	150	mg/1	Antiarrhythmic [EPC]		N	20241231
82012-028_dd924d44-b14d-440c-9670-8faa42422ba1	82012-028	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Senores Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	200	mg/1	Antiarrhythmic [EPC]		N	20241231
82012-029_dd924d44-b14d-440c-9670-8faa42422ba1	82012-029	HUMAN PRESCRIPTION DRUG	MEXILETINE HYDROCHLORIDE		mexiletine hydrochloride	CAPSULE	ORAL	20211129		ANDA	ANDA214089	Senores Pharmaceuticals, Inc.	MEXILETINE HYDROCHLORIDE	250	mg/1	Antiarrhythmic [EPC]		N	20241231
82026-609_ca03d733-b54b-4689-e053-2995a90aa8e1	82026-609	HUMAN OTC DRUG	PlusCBD Pain Cream (Muscle) 4oz		Camphor, Menthol	CREAM	TOPICAL	20210823		OTC MONOGRAPH NOT FINAL	part348	CV Sciences, Inc.	CAMPHOR (NATURAL); MENTHOL	5; 4	g/100g; g/100g			N	20241231
82026-610_d6ee84dd-083b-9f1b-e053-2a95a90aa9b5	82026-610	HUMAN OTC DRUG	PlusCBD Pain Cream (Arthritis) 2oz		Camphor, Menthol	CREAM	TOPICAL	20210823		OTC MONOGRAPH NOT FINAL	part348	CV Sciences, Inc.	CAMPHOR (NATURAL); MENTHOL	10; 5	g/100g; g/100g			N	20241231
82026-611_d6eea70a-07b3-70da-e053-2a95a90a0bf1	82026-611	HUMAN OTC DRUG	PlusCBD Pain Cream (Penetrating) 2oz		Camphor, Menthol	CREAM	TOPICAL	20210823		OTC MONOGRAPH NOT FINAL	part348	CV Sciences, Inc.	CAMPHOR (NATURAL); MENTHOL	11; 10	g/100g; g/100g			N	20241231
82026-612_c9fe0d78-6410-975d-e053-2995a90a2452	82026-612	HUMAN OTC DRUG	PlusCBD Sport Recovery Stick 1oz		Camphor, Menthol	CREAM	TOPICAL	20210823		OTC MONOGRAPH NOT FINAL	part348	CV Sciences, Inc.	CAMPHOR (NATURAL); MENTHOL	10; 15	g/100g; g/100g			N	20241231
82026-614_ca3a33ea-ce55-c209-e053-2995a90abe20	82026-614	HUMAN OTC DRUG	ProCBD Pain Cream (Muscle) 4oz		Camphor, Menthol	CREAM	TOPICAL	20210823		OTC MONOGRAPH NOT FINAL	part348	CV Sciences, Inc.	CAMPHOR (NATURAL); MENTHOL	5; 4	g/100g; g/100g			N	20241231
82026-615_d6ee700c-9fb3-3198-e053-2a95a90a3c21	82026-615	HUMAN OTC DRUG	ProCBD Pain Cream (Arthritis) 2oz		Camphor, Menthol	CREAM	TOPICAL	20210823		OTC MONOGRAPH NOT FINAL	part348	CV Sciences, Inc.	CAMPHOR (NATURAL); MENTHOL	10; 5	g/100g; g/100g			N	20241231
82026-616_d6ee6e26-0f86-a0f0-e053-2a95a90af54b	82026-616	HUMAN OTC DRUG	ProCBD Pain Cream (Penetrating) 2oz		Camphor, Menthol	CREAM	TOPICAL	20210823		OTC MONOGRAPH NOT FINAL	part348	CV Sciences, Inc.	CAMPHOR (NATURAL); MENTHOL	11; 10	g/100g; g/100g			N	20241231
82030-010_c5fc1ecd-ea39-8b7a-e053-2a95a90aad0d	82030-010	HUMAN OTC DRUG	Soft Services CLEARING Mist Breakout Tonic		Acne Treatment	LIQUID	TOPICAL	20210630		OTC MONOGRAPH FINAL	part333D	A TO Z INTERNATIONAL CORPORATION	SALICYLIC ACID	1	g/100g			N	20241231
82033-017_0863632c-c1c6-aab8-e063-6394a90adc89	82033-017	HUMAN OTC DRUG	Laundry Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20210708		OTC MONOGRAPH DRUG	505G(a)(3)	Sheralven Enterprise Ltd.	ALCOHOL	75	mL/100mL			N	20241231
82034-888_f296147a-cf71-475b-ab32-d0c6465dc6b8	82034-888	HUMAN OTC DRUG	Adapalene		Adapalene	GEL	TOPICAL	20211112	20241231	ANDA	ANDA091314	Stryke Club, Inc.	ADAPALENE	1	mg/g	Retinoid [EPC], Retinoids [CS]		N	
82036-4274_06d1650d-74cf-d159-e063-6394a90a2a12	82036-4274	HUMAN PRESCRIPTION DRUG	Fosfomycin Tromethamine		Fosfomycin Tromethamine	POWDER	ORAL	20210825		NDA AUTHORIZED GENERIC	NDA050717	Zambon USA, Ltd	FOSFOMYCIN TROMETHAMINE	3	g/1			N	20241231
82041-693_deac4e46-21ae-23c2-e053-2a95a90a0e27	82041-693	HUMAN OTC DRUG	San-A-Gel		San-A-Gel	LIQUID	TOPICAL	20171025		OTC MONOGRAPH NOT FINAL	part333A	Misco Industrial, LLC	ALCOHOL	67	mL/100mL			N	20241231
82043-001_0d1b8cb7-f894-514f-e063-6294a90ae4b3	82043-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20210623		UNAPPROVED MEDICAL GAS		At Home Health Equipment	OXYGEN	99	L/100L			N	20241231
82046-692_0d120008-eec4-6e06-e063-6294a90a35b9	82046-692	HUMAN OTC DRUG	La Roche Posay Anthelios Sunscreen SPF 60 Ultra light		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	SPRAY	TOPICAL	20140101		OTC MONOGRAPH DRUG	M020	L'Oreal USA, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	27; 96; 29; 54; 35	mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
82049-201_0cfcb22f-00af-53b9-e063-6294a90a6946	82049-201	HUMAN OTC DRUG	Hepad S5		rhynchophylline, magnolol	CAPSULE	TOPICAL	20210625		UNAPPROVED DRUG OTHER		YOUNGJIN Korean Medicine Clinic	MAGNOLOL; RHYNCHOPHYLLINE	30; 40	g/100g; g/100g			N	20241231
82052-157_f1d7d0a1-b98f-40c5-e053-2a95a90a3147	82052-157	HUMAN OTC DRUG	Annmarie SPF 20 Sunscreen		Zinc Oxide 15%	LOTION	TOPICAL	20210920		OTC MONOGRAPH NOT FINAL	part352	Annmarie Gianni Skin Care LLC	ZINC OXIDE	15	g/100mL			N	20241231
82061-006_f79dbac0-cec1-46bc-e053-6294a90a2b13	82061-006	HUMAN OTC DRUG	Alcohol wet wipes		Alcohol wet wipes	DRESSING	TOPICAL	20230324		OTC MONOGRAPH NOT FINAL	part333A	Shandong Aishule Hygiene Products Co., Ltd	ALCOHOL	75	mL/100mL			N	20241231
82061-007_f7ca1799-eee5-66f0-e053-6294a90a273f	82061-007	HUMAN OTC DRUG	Sterilized wet wipes		Sterilized wet wipes	PATCH	TOPICAL	20230326		OTC MONOGRAPH NOT FINAL	part333A	Shandong Aishule Hygiene Products Co., Ltd	BENZETHONIUM CHLORIDE	.0018	g/g			N	20241231
82069-101_097163fc-0d30-7871-e063-6394a90a18ea	82069-101	HUMAN OTC DRUG	TINTED MINERAL SUNSCREEN	SPF-30	TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20210713		OTC MONOGRAPH DRUG	M020	Buttah Enterprises, LLC.	TITANIUM DIOXIDE; ZINC OXIDE	2.5; 6	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82076-301_0e20a506-e85d-79ab-e063-6294a90a38fc	82076-301	HUMAN OTC DRUG	Puro Azul Awapuhi AntiBac		PCMX	SOAP	TOPICAL	20210813		OTC MONOGRAPH DRUG	505G(a)(3)	National Paper Company, Inc.	CHLOROXYLENOL	1	g/L			N	20251231
82077-701_09d27f23-ff54-66b6-e063-6394a90a7aeb	82077-701	HUMAN OTC DRUG	RoyaLab Germ Away Antibacterial		PMCX, Handwashing and Hand Soap	SOAP	TOPICAL	20210630		OTC MONOGRAPH DRUG	505G(a)(3)	Royal Papers, Inc.	CHLOROXYLENOL	1	g/L			N	20241231
82078-301_0e215787-2502-cc30-e063-6294a90af884	82078-301	HUMAN OTC DRUG	Antibacterial White Pearl		PCMX	SOAP	TOPICAL	20210813		OTC MONOGRAPH DRUG	505G(a)(3)	Morrisette Paper Company, Inc.	CHLOROXYLENOL	1	g/L			N	20251231
82081-0001_c70cec0a-24ee-cd7b-e053-2a95a90a57b4	82081-0001	HUMAN OTC DRUG	NWK A-FV		Cochlearia Armoracia(Horseradish) Root Extract	LIQUID	TOPICAL	20210714		UNAPPROVED DRUG OTHER		Nae Woi Korea Ltd	HORSERADISH	10	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
82081-0002_d2c91d4a-1a9a-23b2-e053-2a95a90a44fb	82081-0002	HUMAN OTC DRUG	NWK A-FV		Cinnamon oil	LIQUID	TOPICAL	20210714		UNAPPROVED DRUG OTHER		Nae Woi Korea Ltd	CINNAMON OIL	10	g/100mL			N	20241231
82081-0003_fc8edcc9-6afa-18cb-e053-6394a90a4d78	82081-0003	HUMAN OTC DRUG	NWK A-FV		Cinnamon oil	LIQUID	TOPICAL	20230526		UNAPPROVED DRUG OTHER		Nae Woi Korea Ltd	CINNAMON OIL	100	g/100mL			N	20241231
82083-0001_c7707a44-2309-5602-e053-2a95a90a6de3	82083-0001	HUMAN OTC DRUG	DERLADIE WITCH HAZEL PERFECT VITAMIN GELCREAM		niacinamide, adenosine	CREAM	TOPICAL	20210719		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0002_c7709df7-6ea5-6c59-e053-2995a90a032c	82083-0002	HUMAN OTC DRUG	DERLADIE WITCH HAZEL PERFECT VITAMIN SERUM		niacinamide, adenosine	LIQUID	TOPICAL	20210719		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0003_cf131624-b222-55c0-e053-2995a90a31f3	82083-0003	HUMAN OTC DRUG	DERMAHAN THE WHITENING MOISTURIZING MASK		niacinamide, adenosine	LIQUID	TOPICAL	20211024		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	NIACINAMIDE	2	g/100g			N	20241231
82083-0004_cf13a88b-db9c-2759-e053-2a95a90ac173	82083-0004	HUMAN OTC DRUG	DERMAHAN WHITENING PERFECTCREAM		niacinamide, adenosine	CREAM	TOPICAL	20211024		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0005_cf13e702-92a9-3044-e053-2a95a90a5170	82083-0005	HUMAN OTC DRUG	PETIT COCHON TONE UP PRE SHOWER		niacinamide, adenosine	LIQUID	TOPICAL	20211024		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0006_d4408b15-f13c-1448-e053-2995a90afeda	82083-0006	HUMAN OTC DRUG	LAONMEDI PREMIUM ROSE MASK		niacinamide, adenosine	LIQUID	TOPICAL	20211227		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0007_d44150dd-149c-f251-e053-2a95a90a8ada	82083-0007	HUMAN OTC DRUG	YOMA AMPOULE PLUS ALOE MASK PACK		adenosine	LIQUID	TOPICAL	20211227		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE	.04	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0008_d441c521-e630-6ac7-e053-2a95a90a27d0	82083-0008	HUMAN OTC DRUG	YOMA AMPOULE PLUS SNAIL MASK PACK		adenosine	LIQUID	TOPICAL	20211227		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE	.04	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0009_d441c736-a213-6d7f-e053-2a95a90a7647	82083-0009	HUMAN OTC DRUG	YOMA AMPOULE PLUS GINSENG MASK PACK		adenosine	LIQUID	TOPICAL	20211227		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE	.04	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0010_d441f9f9-889e-3f0b-e053-2a95a90a8d2c	82083-0010	HUMAN OTC DRUG	YOMA AMPOULE PLUS WHITE PEAL MASK PACK		niacinamide, adenosine	LIQUID	TOPICAL	20211227		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100g; g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0011_d44213dc-2e77-cde1-e053-2995a90a110a	82083-0011	HUMAN OTC DRUG	YOMA AMPOULE PLUS COLLAGEN MASK PACK		adenosine	LIQUID	TOPICAL	20211227		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE	.04	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0012_e900ae94-1167-0d31-e053-2a95a90a2e64	82083-0012	HUMAN OTC DRUG	Tenue 24k gold ampoule		adenosine	LIQUID	TOPICAL	20220919		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0013_ebf95552-db2f-bd6f-e053-2a95a90a8857	82083-0013	HUMAN OTC DRUG	Tenue Whitenning Tone upCream		adenosine, niacinamide	CREAM	TOPICAL	20221027		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0014_f644c802-85aa-73d4-e053-2a95a90ac4e6	82083-0014	HUMAN OTC DRUG	DERMAHAN V10 WHITENING TONE UpCREAM		adenosine, niacinamide	CREAM	TOPICAL	20230307		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0016_f992b41b-850a-37e1-e053-6294a90adb4b	82083-0016	HUMAN OTC DRUG	DERMAHAN UV SUN		Adenosine, Niacinamide	CREAM	TOPICAL	20230401		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0017_fa607ef0-e3fe-2288-e053-6394a90a4b10	82083-0017	HUMAN OTC DRUG	DERLADIE MICELLAR CLEANSING WATER WITCH HAZEL		Witch Hazel	LIQUID	TOPICAL	20230401		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ALLANTOIN; WITCH HAZEL	.1; 1.984	g/100mL; g/100mL			N	20241231
82083-0018_fc7eaa91-3479-d03e-e053-6394a90a2248	82083-0018	HUMAN OTC DRUG	ReOrganic Womans Inner Care Essence Gel		Adenosine	GEL	TOPICAL	20230501		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0019_fdab3553-fb9b-47ec-e053-6394a90aacf8	82083-0019	HUMAN OTC DRUG	HA Plus 100DT Cream Toning Light		Niacinamide, Adenosine	CREAM	TOPICAL	20230601		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 5	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0020_ff2718f7-827c-8d90-e053-6394a90ab31f	82083-0020	HUMAN OTC DRUG	Dr. sunmi care Duel Hyaluronic Acid Essence		Niacinamide, Adenosine	LIQUID	TOPICAL	20230601		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 5	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0021_ffb3a515-8a08-e27e-e053-6294a90ad7f8	82083-0021	HUMAN OTC DRUG	Reorganic Feminine wash		Adenosine	GEL	VAGINAL	20230701		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	LACTOBACILLUS CRISPATUS	.1	g/100mL			N	20241231
82083-0022_0030108d-9c2e-d304-e063-6394a90a5ce5	82083-0022	HUMAN OTC DRUG	PETITCOCHON TONE UP BODY SUN		Adenosine, Niacinamide	CREAM	TOPICAL	20230701		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0023_0185e220-a4a8-57b8-e063-6394a90a21aa	82083-0023	HUMAN OTC DRUG	DERLADIE HerbalExtract BodySolution MIST		Niacinamide	LIQUID	VAGINAL	20230701		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	NIACINAMIDE	3	g/100mL			N	20241231
82083-0024_05229446-657c-1d8e-e063-6394a90aea9d	82083-0024	HUMAN OTC DRUG	ReOrganic Eyelash Growth Boosting Serum		Panthenol	LIQUID	TOPICAL	20230901		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	PANTHENOL	.501	g/100mL			N	20241231
82083-0025_05ece83b-0a10-dbcf-e063-6394a90aed1c	82083-0025	HUMAN OTC DRUG	Reoganic EX Whitening Pore Care Deodorant		Arbutin, Niacinamide, Adenosine	LIQUID	TOPICAL	20230901		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; ARBUTIN; NIACINAMIDE	.04; 5; 5	g/100mL; g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0026_05ee1e3d-09ae-42b6-e063-6294a90a1e7f	82083-0026	HUMAN OTC DRUG	Reoganic Body Firming StretchCream		Niacinamide, Adenosine	CREAM	TOPICAL	20230901		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82083-0027_0be4881b-9f86-764a-e063-6394a90a77bf	82083-0027	HUMAN OTC DRUG	Derladie Vegan Pink Clay Mask Deep Pore Tightening		Kaolin	CREAM	TOPICAL	20231201		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	KAOLIN	25	g/100g			N	20241231
82083-0028_0be5f801-9960-dbac-e063-6394a90a86a1	82083-0028	HUMAN OTC DRUG	DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE		Niacinamide	LIQUID	TOPICAL	20231201		UNAPPROVED DRUG OTHER		LAON COMMERCE co ltd	NIACINAMIDE	20	g/100mL			N	20241231
82084-0011_f399685c-ad12-2344-e053-2995a90afe02	82084-0011	HUMAN OTC DRUG	AGELESS SOLAR DEFENSE (SPF 30)		OCTINOXATE, OCTISALATE, OXYBENZONE, AVOBENZONE	CREAM	TOPICAL	20210715		OTC MONOGRAPH NOT FINAL	part352	Divine 369 LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE	30; 75; 50; 40	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82086-001_147469bd-eecd-4de2-bb21-c0adae376f9e	82086-001	HUMAN OTC DRUG	Maui Island Secret Browning Creme Broad Spectrum SPF 5 Sunscreen		Zinc Oxide	CREAM	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part352	Formula 7venz L.L.C.	ZINC OXIDE	7	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82086-002_cc00fc1a-8e0a-4a9e-8d03-005ab129dd0f	82086-002	HUMAN OTC DRUG	Red Gecko Broad Spectrum SPF 30 Sunscreen		Zinc oxide	LOTION	TOPICAL	20200702		OTC MONOGRAPH NOT FINAL	part352	Formula 7venz L.L.C.	ZINC OXIDE	18	g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82088-131_f6546ed6-4ac3-44da-e053-2995a90a8401	82088-131	HUMAN OTC DRUG	ODACITE		Zinc Oxide	LOTION	TOPICAL	20220418		OTC MONOGRAPH NOT FINAL	part352	Odacite Skincare	ZINC OXIDE	132	mg/mL			N	20241231
82088-167_fa3e667d-20c5-9ee9-e053-6294a90aeb35	82088-167	HUMAN OTC DRUG	Odacite Flex Perfecting		Zinc Oxide	LOTION	TOPICAL	20230424		OTC MONOGRAPH NOT FINAL	part352	Odacite Beauty	ZINC OXIDE	132	mg/mL			N	20241231
82089-101_091041c3-9f97-437f-b893-07053b30214e	82089-101	HUMAN PRESCRIPTION DRUG	Catapres-TTS-1		clonidine transdermal system	PATCH	TRANSDERMAL	20220301	20261030	NDA	NDA018891	Technomed Inc.	CLONIDINE	.1	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	
82089-102_091041c3-9f97-437f-b893-07053b30214e	82089-102	HUMAN PRESCRIPTION DRUG	Catapres-TTS-2		clonidine transdermal system	PATCH	TRANSDERMAL	20220301	20261030	NDA	NDA018891	Technomed Inc.	CLONIDINE	.2	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	
82089-103_091041c3-9f97-437f-b893-07053b30214e	82089-103	HUMAN PRESCRIPTION DRUG	Catapres-TTS-3		clonidine transdermal system	PATCH	TRANSDERMAL	20220301	20261030	NDA	NDA018891	Technomed Inc.	CLONIDINE	.3	mg/d	Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]		N	
82091-112_f21449ec-2e8e-54ca-e053-2a95a90a9454	82091-112	HUMAN OTC DRUG	KAYLAAN		Zero Waste Refill For Toothpaste	TABLET, CHEWABLE	DENTAL	20210816		OTC MONOGRAPH FINAL	part355	Kaylaan LLC	SODIUM FLUORIDE	.37	mg/440mg			N	20241231
82091-113_f1ed1ec4-fd79-a448-e053-2995a90ab6fa	82091-113	HUMAN OTC DRUG	KAYLAAN		Zero Waste Refill For Toothpaste	TABLET, CHEWABLE	DENTAL	20210901		OTC MONOGRAPH FINAL	part355	Kaylaan LLC	SODIUM FLUORIDE	.37	mg/440mg			N	20241231
82091-114_f214592f-ec1d-740b-e053-2995a90a2aa8	82091-114	HUMAN OTC DRUG	KAYLAAN		Zero Waste Refill For Toothpaste	TABLET, CHEWABLE	DENTAL	20210913		OTC MONOGRAPH FINAL	part355	Kaylaan LLC	SODIUM FLUORIDE	.37	mg/440mg			N	20241231
82091-115_f2145922-8ef6-5f25-e053-2995a90afd61	82091-115	HUMAN OTC DRUG	KAYLAAN		Zero Waste Refill For Toothpaste	TABLET, CHEWABLE	DENTAL	20210913		OTC MONOGRAPH FINAL	part355	Kaylaan LLC	SODIUM FLUORIDE	.37	mg/440mg			N	20241231
82091-116_f214592f-ec1e-740b-e053-2995a90a2aa8	82091-116	HUMAN OTC DRUG	KAYLAAN		Zero Waste Refill For Toothpaste	TABLET, CHEWABLE	DENTAL	20210913		OTC MONOGRAPH FINAL	part355	Kaylaan LLC	SODIUM FLUORIDE	.37	mg/440mg			N	20241231
82092-001_f26b449a-8c15-44a1-e053-2a95a90a54ae	82092-001	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part333A	Rebel Rebel Personal Care Corp.	ALCOHOL	65	mL/100mL			N	20241231
82092-002_f26b449a-8c15-44a1-e053-2a95a90a54ae	82092-002	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part333A	Rebel Rebel Personal Care Corp.	ALCOHOL	65	mL/100mL			N	20241231
82092-003_f26b449a-8c15-44a1-e053-2a95a90a54ae	82092-003	HUMAN OTC DRUG	Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20210201		OTC MONOGRAPH NOT FINAL	part333A	Rebel Rebel Personal Care Corp.	ALCOHOL	65	mL/100mL			N	20241231
82094-401_724902b4-4d93-478d-bae3-bc29d97700b1	82094-401	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210420		ANDA	ANDA212396	Tianjin Kingyork Pharmaceuticals Co., Ltd	METHYLPREDNISOLONE SODIUM SUCCINATE	40	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82094-402_724902b4-4d93-478d-bae3-bc29d97700b1	82094-402	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210420		ANDA	ANDA212396	Tianjin Kingyork Pharmaceuticals Co., Ltd	METHYLPREDNISOLONE SODIUM SUCCINATE	125	mg/2mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82094-403_724902b4-4d93-478d-bae3-bc29d97700b1	82094-403	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210420		ANDA	ANDA212396	Tianjin Kingyork Pharmaceuticals Co., Ltd	METHYLPREDNISOLONE SODIUM SUCCINATE	500	mg/8mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82094-404_724902b4-4d93-478d-bae3-bc29d97700b1	82094-404	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210420		ANDA	ANDA212396	Tianjin Kingyork Pharmaceuticals Co., Ltd	METHYLPREDNISOLONE SODIUM SUCCINATE	1	g/16mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82094-405_724902b4-4d93-478d-bae3-bc29d97700b1	82094-405	HUMAN PRESCRIPTION DRUG	Methylprednisolone Sodium Succinate		Methylprednisolone	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20210420		ANDA	ANDA212396	Tianjin Kingyork Pharmaceuticals Co., Ltd	METHYLPREDNISOLONE SODIUM SUCCINATE	2	g/30.6mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82095-701_ab968b29-12ff-4222-8a75-e5dadd8946a3	82095-701	HUMAN OTC DRUG	iVizia Lubricant Eye for Severe Night Dry Eyes		Povidone	SOLUTION, GEL FORMING / DROPS	OPHTHALMIC	20211105		OTC MONOGRAPH FINAL	M018	Laboratoires Thea	POVIDONE	2.5	mg/.5g			N	20241231
82098-008_451b35bf-a29b-423a-bcd3-789ef31142e0	82098-008	HUMAN PRESCRIPTION DRUG	RayaSore Kit		Silver sulfadiazine	KIT	TOPICAL	20220823		UNAPPROVED DRUG OTHER		Raya Pharmaceuticals LLC						N	20241231
82098-009_0dfae59f-c3a1-eb47-e063-6394a90a394a	82098-009	HUMAN PRESCRIPTION DRUG	RayaSal		Salicylic Acid 5.9%	CREAM	TOPICAL	20221017		UNAPPROVED DRUG OTHER		Raya Pharmaceuticals LLC	SALICYLIC ACID	59	mg/g			N	20251231
82098-617_08b47e2f-3919-c3ff-e063-6294a90a537b	82098-617	HUMAN OTC DRUG	POVIDONE-IODINE PAD- povidone-iodine swab		Povidone Iodine 10% w/w (equivalent to iodine 1%)	SWAB	TOPICAL	20220403		OTC MONOGRAPH DRUG	M003	Raya Pharmaceuticals LLC	POVIDONE-IODINE	10	g/100g			N	20241231
82098-814_08b3fb58-1f79-d17b-e063-6294a90a5850	82098-814	HUMAN OTC DRUG	Alcohol Prep Pads		70%Isopropyl Alcohol	SWAB	TOPICAL	20220312		OTC MONOGRAPH DRUG	M003	Raya Pharmaceuticals LLC	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
82109-100_eb459863-f4b4-19da-e053-2995a90a506b	82109-100	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 10N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-101_eb459863-f4b4-19da-e053-2995a90a506b	82109-101	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 12C		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-102_eb459863-f4b4-19da-e053-2995a90a506b	82109-102	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 14W		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-103_eb459863-f4b4-19da-e053-2995a90a506b	82109-103	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 16C		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-104_eb459863-f4b4-19da-e053-2995a90a506b	82109-104	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 20W		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-105_eb459863-f4b4-19da-e053-2995a90a506b	82109-105	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 22W		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-106_eb459863-f4b4-19da-e053-2995a90a506b	82109-106	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 24N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-107_eb459863-f4b4-19da-e053-2995a90a506b	82109-107	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 26W		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-108_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-108	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 28C		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-109_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-109	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 30N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-110_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-110	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 32N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-111_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-111	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 34W		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-112_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-112	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 36C		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-113_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-113	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 38N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-114_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-114	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 40N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-115_eb45bb04-5f83-70f1-e053-2995a90a3077	82109-115	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 42N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-116_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-116	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 44N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-117_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-117	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 46C		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-118_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-118	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 48W		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-119_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-119	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 50N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-120_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-120	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 52W		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-121_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-121	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 54N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-122_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-122	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 56N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82109-123_eb45e1a0-8696-ce65-e053-2a95a90a05cb	82109-123	HUMAN OTC DRUG	Positive Light Tinted Moisturizer Broad Spectrum SPF 20 Sunscreen 58N		Homosalate, Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20220330		OTC MONOGRAPH NOT FINAL	part352	Rare Beauty, LLC	HOMOSALATE; TITANIUM DIOXIDE; ZINC OXIDE	90; 18; 9	mg/mL; mg/mL; mg/mL			N	20241231
82110-001_f564a53f-cefa-7160-e053-2995a90a116e	82110-001	HUMAN OTC DRUG	Foaming Hand		BENZALKONIUM CHLORIDE	LIQUID	TOPICAL	20210627		OTC MONOGRAPH NOT FINAL	part333E	SHIBY INC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
82111-517_326d1b45-cb0b-4dfe-a4ea-27c7b1e73d7f	82111-517	HUMAN PRESCRIPTION DRUG	DARTISLA ODT		Glycopyrrolate Orally Disintegrating Tablets	TABLET, ORALLY DISINTEGRATING	ORAL	20231011		NDA	NDA215019	Edenbridge Pharmaceuticals LLC.	GLYCOPYRROLATE	.85	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
82111-955_6b9cf32c-6d60-4853-bbfd-2304ffc2c129	82111-955	HUMAN PRESCRIPTION DRUG	Hemady		dexamethasone	TABLET	ORAL	20191003		NDA	NDA211379	Edenbridge Pharmaceuticals LLC.	DEXAMETHASONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82114-001_068ad85b-45bd-4b0d-8b9b-959209dc5b23	82114-001	HUMAN OTC DRUG	Shine On Living 30A Broad Spectrum SPF 30 Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210131		OTC MONOGRAPH NOT FINAL	part352	Shine On Living, LLC	ZINC OXIDE	18	g/100mL			N	20241231
82120-125_e790e881-a4ea-43df-b997-f10fc06933be	82120-125	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN AND EZETIMIBE		rosuvastatin and ezetimibe	TABLET	ORAL	20210815		NDA AUTHORIZED GENERIC	NDA213072	SCOV3 LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 5.2	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82120-126_e790e881-a4ea-43df-b997-f10fc06933be	82120-126	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN AND EZETIMIBE		rosuvastatin and ezetimibe	TABLET	ORAL	20210815		NDA AUTHORIZED GENERIC	NDA213072	SCOV3 LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 10.4	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82120-127_e790e881-a4ea-43df-b997-f10fc06933be	82120-127	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN AND EZETIMIBE		rosuvastatin and ezetimibe	TABLET	ORAL	20210815		NDA AUTHORIZED GENERIC	NDA213072	SCOV3 LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 20.8	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82120-128_e790e881-a4ea-43df-b997-f10fc06933be	82120-128	HUMAN PRESCRIPTION DRUG	ROSUVASTATIN AND EZETIMIBE		rosuvastatin and ezetimibe	TABLET	ORAL	20210815		NDA AUTHORIZED GENERIC	NDA213072	SCOV3 LLC	EZETIMIBE; ROSUVASTATIN CALCIUM	10; 41.7	mg/1; mg/1	Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82123-004_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-004	HUMAN OTC DRUG	AfterSun		Non Nano Zinc Oxide	CREAM	TOPICAL	20210628		OTC MONOGRAPH DRUG	M020	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	ZINC OXIDE	1.6	mg/80mL			N	20241231
82123-005_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-005	HUMAN OTC DRUG	Diaper Rash Cream		Non Nano Zinc Oxide	CREAM	TOPICAL	20210628		OTC MONOGRAPH DRUG	M016	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	ZINC OXIDE	11	mg/50mg			N	20241231
82123-007_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-007	HUMAN OTC DRUG	S.O.S Cream Intensive Moisturizing Skin Protectant		Non Nano Zinc Oxide	CREAM	TOPICAL	20211111		OTC MONOGRAPH DRUG	M016	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	ZINC OXIDE	.6	mg/15mL			N	20241231
82123-008_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-008	HUMAN OTC DRUG	Acne Control Serum		Salicylic Acid	LIQUID	TOPICAL	20230929		OTC MONOGRAPH DRUG	M006	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	SALICYLIC ACID	.15	mg/30mL			N	20241231
82123-009_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-009	HUMAN OTC DRUG	PROPOLIS NASAL		NASAL	LIQUID	NASAL	20231002		OTC MONOGRAPH DRUG	M012	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	OXYMETAZOLINE HYDROCHLORIDE	.015	mg/30mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
82123-010_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-010	HUMAN OTC DRUG	PROPOLIS NASAL PLUS		PLUS NASAL	LIQUID	NASAL	20231003		OTC MONOGRAPH DRUG	M012	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	OXYMETAZOLINE HYDROCHLORIDE	.015	mg/30mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20241231
82123-011_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-011	HUMAN OTC DRUG	Sunscreen SPF50		Non Nano Zinc Oxide	CREAM	TOPICAL	20210628		OTC MONOGRAPH DRUG	M020	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	ZINC OXIDE	12	mg/80mL			N	20241231
82123-012_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-012	HUMAN OTC DRUG	Sunscreen for kids SPF50		Non Nano Zinc Oxide	CREAM	TOPICAL	20210628		OTC MONOGRAPH DRUG	M020	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	ZINC OXIDE	17.6	mg/80mg			N	20241231
82123-013_fdb90776-0b20-ffd1-e053-6394a90ae54b	82123-013	HUMAN OTC DRUG	Sunscreen for Face SPF50		Non Nano Zinc Oxide	CREAM	TOPICAL	20210628		OTC MONOGRAPH DRUG	M020	SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI	ZINC OXIDE	6	mg/40mL			N	20241231
82125-2650_fbbf6628-1fa0-e1d6-e053-6394a90a5dcd	82125-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	LYNNETTE ALLEN ADULT CARE NP, P.C.	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
82127-000_0dacb8db-f4d4-ad53-e063-6294a90acca2	82127-000	HUMAN OTC DRUG	Cherry Blossom Scented Antiseptic Hand Sanitizer 80 Ethyl Alcohol		ALCOHOL	LIQUID	TOPICAL	20210801	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	80	mL/100mL			N	
82127-001_0daa3ebd-3919-4d0c-e063-6294a90a706d	82127-001	HUMAN OTC DRUG	Jasmine Scented Antiseptic Hand Sanitizer 80 Ethyl Alcohol		ALCOHOL	LIQUID	TOPICAL	20210801	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	80	mL/100mL			N	
82127-002_0daa8612-d9dd-87f2-e063-6294a90a65af	82127-002	HUMAN OTC DRUG	Lemon Scented Antiseptic Hand Sanitizer 80 Ethyl Alcohol		ALCOHOL	LIQUID	TOPICAL	20210801	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	80	mL/100mL			N	
82127-003_0daa8612-d9df-87f2-e063-6294a90a65af	82127-003	HUMAN OTC DRUG	Lime Scented Antiseptic Hand Sanitizer 80 Ethyl Alcohol		ALCOHOL	LIQUID	TOPICAL	20210801	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	80	mL/100mL			N	
82127-004_0daab837-6092-b472-e063-6394a90a360f	82127-004	HUMAN OTC DRUG	Mandarin Orange Scented Antiseptic Hand Sanitizer 80 Ethyl Alcohol		ALCOHOL	LIQUID	TOPICAL	20210801	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	80	mL/100mL			N	
82127-005_0daad8a9-e59b-841e-e063-6294a90ac43d	82127-005	HUMAN OTC DRUG	Olive Blossom Scented Antiseptic Hand Sanitizer 80 Ethyl Alcohol		ALCOHOL	LIQUID	TOPICAL	20210801	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	80	mL/100mL			N	
82127-006_0daaed20-1e97-b0e4-e063-6294a90a0f19	82127-006	HUMAN OTC DRUG	Koku All Natural Hand Body 80 Percent Vegan Ethyl Alcohol Lemon		ALCOHOL	LIQUID	TOPICAL	20220915	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	.8	mL/mL			N	
82127-007_0daad4cd-1078-bcca-e063-6394a90ab8cf	82127-007	HUMAN OTC DRUG	Koku All Natural Hand Body 80 Percent Vegan Ethyl Alcohol Lime		ALCOHOL	LIQUID	TOPICAL	20220915	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	.8	mL/mL			N	
82127-008_0daad8a9-e59e-841e-e063-6294a90ac43d	82127-008	HUMAN OTC DRUG	Koku All Natural Hand Body 80 Percent Vegan Ethyl Alcohol Mandarin Orange		ALCOHOL	LIQUID	TOPICAL	20220915	20250731	OTC MONOGRAPH DRUG	505G(a)(3)	H&Y Products LLC dba Kolonya Carre	ALCOHOL	.8	mL/mL			N	
82131-252_0878d5b0-672b-da39-e063-6394a90a0068	82131-252	HUMAN OTC DRUG	Homworks Alcohol Wipes Multipurpose		Ethyl Alcohol	SWAB	TOPICAL	20220101		OTC MONOGRAPH DRUG	M003	Acadian Crossing Consumer Products, LLC.	ALCOHOL	75	mL/75mL			N	20241231
82137-016_0a02a181-987b-bdf0-e063-6394a90ab096	82137-016	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20221101		ANDA	ANDA216848	Lepu Pharmaceutical Technology Co., Ltd.	ATORVASTATIN CALCIUM TRIHYDRATE	10	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82137-017_0a02a181-987b-bdf0-e063-6394a90ab096	82137-017	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20221101		ANDA	ANDA216848	Lepu Pharmaceutical Technology Co., Ltd.	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82137-018_0a02a181-987b-bdf0-e063-6394a90ab096	82137-018	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20221101		ANDA	ANDA216848	Lepu Pharmaceutical Technology Co., Ltd.	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82137-019_0a02a181-987b-bdf0-e063-6394a90ab096	82137-019	HUMAN PRESCRIPTION DRUG	atorvastatin calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20221101		ANDA	ANDA216848	Lepu Pharmaceutical Technology Co., Ltd.	ATORVASTATIN CALCIUM TRIHYDRATE	80	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82140-432_f89a8129-e68a-7a0e-e053-6294a90acd83	82140-432	HUMAN OTC DRUG	STAYKLEAR		ALCOHOL	LIQUID	TOPICAL	20210816		OTC MONOGRAPH NOT FINAL	part333E	eHealth Nexus LLC	ALCOHOL	.6	kg/kg			N	20241231
82141-2327_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2327	HUMAN OTC DRUG	toty Ilumina CC Cream 1N		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2328_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2328	HUMAN OTC DRUG	toty Ilumina CC Cream 1W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2329_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2329	HUMAN OTC DRUG	toty Ilumina CC Cream 1C		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2330_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2330	HUMAN OTC DRUG	toty Ilumina CC Cream 2N		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2331_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2331	HUMAN OTC DRUG	toty Ilumina CC Cream 2W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2332_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2332	HUMAN OTC DRUG	toty Ilumina CC Cream 2C		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2333_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2333	HUMAN OTC DRUG	toty Ilumina CC Cream 3N		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2334_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2334	HUMAN OTC DRUG	toty Ilumina CC Cream 3W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2335_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2335	HUMAN OTC DRUG	toty Ilumina CC Cream 3C		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2336_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2336	HUMAN OTC DRUG	toty Ilumina CC Cream 4N		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2337_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2337	HUMAN OTC DRUG	toty Ilumina CC Cream 4W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2338_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2338	HUMAN OTC DRUG	toty Ilumina CC Cream 4C		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2339_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2339	HUMAN OTC DRUG	toty Ilumina CC Cream 5W		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2340_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2340	HUMAN OTC DRUG	toty Ilumina CC Cream 5W1		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2341_e4efe14e-7d47-78c0-e053-2995a90a2364	82141-2341	HUMAN OTC DRUG	toty Ilumina CC Cream 5W2		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH FINAL	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	9; 6.3	g/100g; g/100g			N	20241231
82141-2357_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2357	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 1N		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2358_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2358	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 1W		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2359_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2359	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 1C		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2360_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2360	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 2N		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2361_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2361	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 2W		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2362_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2362	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 2C		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2363_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2363	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 3N		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2364_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2364	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 3W		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2365_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2365	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 3C		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2366_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2366	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 4N		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2367_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2367	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 4W		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2368_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2368	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 4C		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2369_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2369	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 5W		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2370_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2370	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 5W1		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-2371_0ccb9b36-b06f-aea7-e063-6294a90ad058	82141-2371	HUMAN OTC DRUG	toty Ilumina CC Creamy Compact Refill 5W2		Titanium Dioxide	CREAM	TOPICAL	20230531		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE	10.4	g/100g			N	20241231
82141-3161_0d09a4a2-bfd9-09fb-e063-6294a90aa6f4	82141-3161	HUMAN OTC DRUG	toty Solaria Mineral		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230601		OTC MONOGRAPH DRUG	M020	Chipican LLC	TITANIUM DIOXIDE; ZINC OXIDE	7; 6	g/100g; g/100g			N	20241231
82145-0001_c8b14b2a-5ce1-3a33-e053-2a95a90a679f	82145-0001	HUMAN OTC DRUG	AMULDY S		glycerin	LIQUID	TOPICAL	20210804		OTC MONOGRAPH NOT FINAL	part347	Aloe Vera Korea Co.,Ltd.	GLYCERIN	8	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82145-0002_c8b1bcaf-178a-3d0b-e053-2995a90a6ae1	82145-0002	HUMAN OTC DRUG	SPORTS gel		menthol	LIQUID	TOPICAL	20210804		UNAPPROVED DRUG OTHER		Aloe Vera Korea Co.,Ltd.	MENTHOL	2.5	g/100mL			N	20241231
82145-0003_c8b1a2f4-4540-aab4-e053-2995a90ab0d7	82145-0003	HUMAN OTC DRUG	NO itching		glycerin	LIQUID	TOPICAL	20210804		OTC MONOGRAPH NOT FINAL	part347	Aloe Vera Korea Co.,Ltd.	GLYCERIN	8	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82145-0004_c8b1c5d6-9c94-c48e-e053-2995a90aec59	82145-0004	HUMAN OTC DRUG	BUX GUARD		citronella oil	LIQUID	TOPICAL	20210804		UNAPPROVED DRUG OTHER		Aloe Vera Korea Co.,Ltd.	LAVENDER OIL	10	g/100mL			N	20241231
82145-0005_db520fa4-221d-4cd7-e053-2a95a90ac829	82145-0005	HUMAN OTC DRUG	Miracle FootCream Lavender		urea, glycerin, aloe, disodium edta	CREAM	TOPICAL	20190822		UNAPPROVED DRUG OTHER		Aloe Vera Korea Co.,Ltd.	ALOE VERA LEAF; EDETATE DISODIUM; GLYCERIN; UREA	.5; .05; 8; 4	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Lead Chelating Activity [MoA], Lead Chelator [EPC], Non-Standardized Chemical Allergen [EPC]		N	20241231
82145-0006_db521042-42ce-da21-e053-2995a90ae5a4	82145-0006	HUMAN OTC DRUG	Miracle FootCream Lemon		urea, glycerin, aloe, disodium edta	CREAM	TOPICAL	20220329		UNAPPROVED DRUG OTHER		Aloe Vera Korea Co.,Ltd.	ALOE VERA LEAF; EDETATE DISODIUM; GLYCERIN; UREA	.5; .05; 8; 4	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Lead Chelating Activity [MoA], Lead Chelator [EPC], Non-Standardized Chemical Allergen [EPC]		N	20241231
82149-001_18656ae0-bd97-4a3a-8025-b23c16533352	82149-001	HUMAN OTC DRUG	FLUORIDE		Sodium Fluoride	TABLET	DENTAL	20210830		OTC MONOGRAPH FINAL	part355	Mintly Inc.	SODIUM FLUORIDE	.6552	mg/1			N	20241231
82153-001_08c183af-2ec5-1e0b-e063-6294a90ab37b	82153-001	HUMAN OTC DRUG	Live Tinted Hueguard 3-in1 Mineral Sunscreen Moisturizer Primer Broad Spectrum SPF 30		ZINC OXIDE	CREAM	TOPICAL	20210701		OTC MONOGRAPH DRUG	M020	Live Tinted, Inc.	ZINC OXIDE	182.3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82153-271_08c16579-fb9a-5c01-e063-6294a90af226	82153-271	HUMAN OTC DRUG	LIVE TINTED Hueguard 3-in-1 Mineral Sunscreen Moisturizer Primer Broad Spectrum SPF 30		ZINC OXIDE	CREAM	TOPICAL	20230308		OTC MONOGRAPH DRUG	M020	Live Tinted, Inc.	ZINC OXIDE	182.3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82153-276_08c19c7c-b484-761c-e063-6294a90a0279	82153-276	HUMAN OTC DRUG	LIVE TINTED Hueguard Invisible Sunscreen Stick Broad Spectrum SPF 50 Water Resistant 80 Mins		HOMOSALATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE	STICK	TOPICAL	20230524		OTC MONOGRAPH DRUG	M020	Live Tinted, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
82153-280_08c1b333-9b78-90d9-e063-6394a90a52fd	82153-280	HUMAN OTC DRUG	LIVE TINTED Glow-up Hyperpigmentation Essentials		ZINC OXIDE	KIT		20230606		OTC MONOGRAPH DRUG	M020	Live Tinted, Inc.						N	20241231
82153-282_08c1a8af-2e1f-682c-e063-6394a90a8892	82153-282	HUMAN OTC DRUG	LIVE TINTED Hueguard 3-in-1 Mineral Sunscreen Moisturizer Primer Broad Spectrum SPF 30		ZINC OXIDE	CREAM	TOPICAL	20230606		OTC MONOGRAPH DRUG	M020	Live Tinted, Inc.	ZINC OXIDE	182.3	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82154-0449_0c57f759-de3c-b601-e063-6294a90a2099	82154-0449	HUMAN PRESCRIPTION DRUG	Pegasys		peginterferon alfa-2a	INJECTION, SOLUTION	SUBCUTANEOUS	20021016		BLA	BLA103964	zr pharma& GmbH	PEGINTERFERON ALFA-2A	180	ug/mL	Interferon alpha [EPC], Interferon-alpha [CS]		N	20251231
82154-0451_0c57f759-de3c-b601-e063-6294a90a2099	82154-0451	HUMAN PRESCRIPTION DRUG	Pegasys		peginterferon alfa-2a	INJECTION, SOLUTION	SUBCUTANEOUS	20110329		BLA	BLA103964	zr pharma& GmbH	PEGINTERFERON ALFA-2A	180	ug/.5mL	Interferon alpha [EPC], Interferon-alpha [CS]		N	20251231
82154-0783_0bd95919-d536-a6cb-e063-6394a90a5158	82154-0783	HUMAN PRESCRIPTION DRUG	Rubraca		rucaparib	TABLET, FILM COATED	ORAL	20161219		NDA	NDA209115	pharmaand GmbH	RUCAPARIB CAMSYLATE	200	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
82154-0784_0bd95919-d536-a6cb-e063-6394a90a5158	82154-0784	HUMAN PRESCRIPTION DRUG	Rubraca		rucaparib	TABLET, FILM COATED	ORAL	20170501		NDA	NDA209115	pharmaand GmbH	RUCAPARIB CAMSYLATE	250	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
82154-0785_0bd95919-d536-a6cb-e063-6394a90a5158	82154-0785	HUMAN PRESCRIPTION DRUG	Rubraca		rucaparib	TABLET, FILM COATED	ORAL	20161219		NDA	NDA209115	pharmaand GmbH	RUCAPARIB CAMSYLATE	300	mg/1	Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]		N	20241231
82157-001_f19f452b-80af-ae59-e053-2a95a90aa46d	82157-001	HUMAN OTC DRUG	Nioxin Hair Regrowth Treatment	for Men	Minoxidil	SOLUTION	TOPICAL	20211001		ANDA	ANDA075598	Wella Operations US LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82157-002_f19f4304-bf3a-da04-e053-2a95a90a4044	82157-002	HUMAN OTC DRUG	Nioxin Hair Regrowth Treatment	For Women	Minoxidil	SOLUTION	TOPICAL	20211001		ANDA	ANDA075357	Wella Operations US LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82157-003_eee1f553-e6cf-963e-e053-2a95a90a8037	82157-003	HUMAN OTC DRUG	Nioxin Scalp Recovery Medicating Cleanser		Pyrithione zinc	SHAMPOO	TOPICAL	20221201		OTC MONOGRAPH FINAL	M032	Wella Operations US LLC	PYRITHIONE ZINC	1	g/100mL			N	20241231
82157-004_eee1f553-e6c0-963e-e053-2a95a90a8037	82157-004	HUMAN OTC DRUG	Nioxin Scalp Recovery Moisturizing Conditioner		Pyrithione Zinc	LOTION	TOPICAL	20221201		OTC MONOGRAPH FINAL	M032	Wella Operations US LLC	PYRITHIONE ZINC	.5	g/100mL			N	20241231
82157-005_eee20915-edb0-13a6-e053-2995a90aebd9	82157-005	HUMAN OTC DRUG	Nioxin Scalp Recovery Soothing Serum		Pyrithione zinc	LOTION	TOPICAL	20221201		OTC MONOGRAPH FINAL	M032	Wella Operations US LLC	PYRITHIONE ZINC	.1	g/100mL			N	20241231
82157-006_eee204b3-e5ac-c065-e053-2995a90a1fad	82157-006	HUMAN OTC DRUG	Nioxin Scalp Recovery Anti-Dandruff System		Pyrithione zinc	KIT		20221201		OTC MONOGRAPH FINAL	M032	Wella Operations US LLC						N	20241231
82157-100_eee1c392-6dc4-523c-e053-2a95a90a2f55	82157-100	HUMAN OTC DRUG	Nioxin Hair Regrowth Kit	for Men	Minoxidil	KIT		20211001		ANDA	ANDA075598	Wella Operations US LLC						N	20241231
82157-200_e00584ce-7518-6083-e053-2a95a90a35b1	82157-200	HUMAN OTC DRUG	Nioxin Hair Regrowth Kit	For Women	Minoxidil	KIT	TOPICAL	20211001		ANDA	ANDA075357	Wella Operations US LLC						N	20241231
82158-003_08aadf7f-d901-96f8-e063-6294a90ae623	82158-003	HUMAN OTC DRUG	Antibacterial Hand Sanitizing 3 Wipes and 2 non-medical masks		ALCOHOL	KIT		20210625		OTC MONOGRAPH DRUG	505G(a)(3)	Convenience Kits International Ltd						N	20241231
82160-124_0d6bf85c-3bbc-4b8d-e063-6294a90a728e	82160-124	HUMAN PRESCRIPTION DRUG	Tacrus		Tacrolimus	OINTMENT	TOPICAL	20141211		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	TACROLIMUS	30	mg/30g	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
82160-125_0d6dea2d-dc2e-5a71-e063-6394a90a4a26	82160-125	HUMAN PRESCRIPTION DRUG	Florexa		Eflornithine Hydrochloride	CREAM	TOPICAL	20120209		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	EFLORNITHINE HYDROCHLORIDE	4170	mg/30g	Antiprotozoal [EPC], Decarboxylase Inhibitor [EPC], Decarboxylase Inhibitors [MoA]		N	20241231
82160-126_0d6bef61-c1ba-1b9c-e063-6294a90a8bda	82160-126	HUMAN PRESCRIPTION DRUG	Spotex		Erythromycin	GEL	TOPICAL	20130910		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	ERYTHROMYCIN	1200	mg/30g	Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]		N	20241231
82160-127_0d6d72e1-ce60-2564-e063-6394a90af4fe	82160-127	HUMAN PRESCRIPTION DRUG	Aquax-H		Hydrocortisone Butyrate	CREAM	TOPICAL	20150316		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. ltd	HYDROCORTISONE BUTYRATE	30	mg/30g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82160-238_e1de47ff-90a8-0b0d-e053-2a95a90a67c1	82160-238	HUMAN OTC DRUG	Cornex		Lactic Acid, Salicylic Acid	GEL	TOPICAL	20100325		OTC MONOGRAPH FINAL	M030	Pella Pharmaceuticals Co. Ltd	LACTIC ACID; SALICYLIC ACID	2505; 2505	mg/15g; mg/15g	Acidifying Activity [MoA]		N	20241231
82160-306_d3815c45-be4e-a0cd-e053-2995a90abb31	82160-306	HUMAN OTC DRUG	Mostal		Pyrus Malus (Apple) Fruit Extract	SOLUTION	TOPICAL	20110120		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	APPLE	500	mg/50mL	Allergens [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
82160-351_d393e6b1-6c7a-065f-e053-2a95a90a0029	82160-351	HUMAN OTC DRUG	Delice		Dimethicone	SOLUTION	TOPICAL	20110919		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	DIMETHICONE; DIMETHICONE 100	21; 25	g/50mL; g/50mL	Skin Barrier Activity [PE]		N	20241231
82160-634_d381636a-80d9-15e2-e053-2a95a90ab261	82160-634	HUMAN OTC DRUG	Mostal Lashes and Brows Enhancing Serum		Pyrus Malus (Apple) Fruit Extract, Acetyl Tetrapeptide-3, Biotinoyl Tripeptide-1	GEL	TOPICAL	20200930		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	ACETYL TETRAPEPTIDE-3; APPLE; BIOTINOYL TRIPEPTIDE-1	1; 100; .066	mg/10mL; mg/10mL; mg/10mL	Allergens [CS], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
82160-641_fe26caf9-8287-cf5d-e053-6394a90a9acc	82160-641	HUMAN OTC DRUG	Derma Glide		Glycerin	GEL	RECTAL; TOPICAL; VAGINAL	20220531		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	GLYCERIN	50	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82160-696_fea2b4d1-c525-60ee-e053-6294a90ae6fe	82160-696	HUMAN OTC DRUG	Derma Wound-Eaz		Cetrimide	CREAM	TOPICAL	20221031		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	CETRIMIDE	5	mg/g			N	20241231
82160-719_fe941e08-2ad3-33e8-e053-6394a90ab7ab	82160-719	HUMAN OTC DRUG	Derma Pella Luminous Cream		Titanium Dioxide, Niacinamide, Adenosine	CREAM	TOPICAL	20230605		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	ADENOSINE; NIACINAMIDE; TITANIUM DIOXIDE	.4; 20; 28	mg/g; mg/g; mg/g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82160-726_fe95fdbf-73e0-a587-e053-6394a90a53a0	82160-726	HUMAN OTC DRUG	Derma Pella Sunscreen Advance Cream-Gel		Octocrylene, Avobenzone, Ethylhexyl Salicylate, Phenylbenzimidazole Sulfonic Acid, Polysilicone-15, Titanium Dioxide	CREAM	TOPICAL	20221226		OTC MONOGRAPH FINAL	M020	Pella Pharmaceuticals Co. Ltd	AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE; POLYSILICONE-15; TITANIUM DIOXIDE	50; 20; 50; 100; 20; 16	mg/g; mg/g; mg/g; mg/g; mg/g; mg/g			N	20241231
82160-757_fe76096f-3854-05b8-e053-6294a90a5d60	82160-757	HUMAN OTC DRUG	Derma Pella Facial Cleanser for Normal Skin		Niacinamide	SOLUTION	TOPICAL	20230516		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	NIACINAMIDE	10	mg/mL			N	20241231
82160-764_fe667ac6-4606-0670-e053-6294a90aa1b8	82160-764	HUMAN OTC DRUG	Derma Pella Acne Wash for Oily Skin		Salicylic Acid	SOLUTION	TOPICAL	20230516		OTC MONOGRAPH FINAL	M006	Pella Pharmaceuticals Co. Ltd	SALICYLIC ACID	5	mg/mL			N	20241231
82160-771_fe7cfebb-bd82-5210-e053-6394a90a24b3	82160-771	HUMAN OTC DRUG	Derma Pella Cleanser for Sensitive and Dry Skin		Niacinamide	SOLUTION	TOPICAL	20230516		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	NIACINAMIDE	5	mg/mL			N	20241231
82160-795_fea499ac-c9ba-4474-e053-6394a90aea03	82160-795	HUMAN OTC DRUG	Derma Pella Acne Care		Salicylic Acid	GEL	TOPICAL	20230330		OTC MONOGRAPH FINAL	M006	Pella Pharmaceuticals Co. Ltd	SALICYLIC ACID	18	mg/g			N	20241231
82160-818_feb200b9-00ef-2e29-e053-6394a90a1848	82160-818	HUMAN OTC DRUG	Derma Pella Intimate Brightening		Alpha Arbutin	CREAM	TOPICAL	20230509		UNAPPROVED DRUG OTHER		Pella Pharmaceuticals Co. Ltd	ALPHA-ARBUTIN	10	mg/g			N	20241231
82165-100_f6016fc7-5c00-0a67-e053-2995a90a0ce1	82165-100	HUMAN OTC DRUG	Topical Analgesic		Methyl Salicylate	OINTMENT	TOPICAL	20210515		OTC MONOGRAPH NOT FINAL	part348	Dermaline USA Corp	METHYL SALICYLATE	15	mg/100g			N	20241231
82165-101_f4aab735-de95-2ade-e053-2a95a90aea0a	82165-101	HUMAN OTC DRUG	Topical Analgesic		Dermaline Arnica 3 in 1	OINTMENT	TOPICAL	20210515		OTC MONOGRAPH NOT FINAL	part348	Dermaline USA Corp	METHYL SALICYLATE	15	mg/100g			N	20241231
82165-102_f601320e-064f-9b34-e053-2a95a90ac61b	82165-102	HUMAN OTC DRUG	Topical Analgesic		Dermaline Arnica Salve Black	OINTMENT	TOPICAL	20210530		OTC MONOGRAPH NOT FINAL	part348	Dermaline USA Corp	METHYL SALICYLATE	5	mg/100g			N	20241231
82165-103_f49c1fe8-7774-58c3-e053-2a95a90a00f9	82165-103	HUMAN OTC DRUG	Topical Analgesic		Dermaline Camphor	OINTMENT	TOPICAL	20190512		OTC MONOGRAPH NOT FINAL	part348	Dermaline USA Corp	CAMPHOR (SYNTHETIC)	10	g/100g			N	20241231
82165-104_f4aab3cb-e7eb-1f9f-e053-2a95a90ae583	82165-104	HUMAN OTC DRUG	Topical Analgesic		Dermaline Arnica Menthol Gel	GEL	TOPICAL	20210510		OTC MONOGRAPH NOT FINAL	part348	Dermaline USA Corp	MENTHOL	1	g/100g			N	20241231
82167-000_0a2c3f15-32a3-ac35-e063-6294a90a1213	82167-000	HUMAN OTC DRUG	Tinfu Isopropyl Alcohol Prep Pads		Isopropyl Alcohol	CLOTH	TOPICAL	20210825		OTC MONOGRAPH DRUG	M003	Shandong T&F Medical Technology Co., Ltd	ISOPROPYL ALCOHOL	.7	mL/mL			N	20241231
82174-201_fc7e32d3-1f20-bf96-e053-6394a90a728d	82174-201	HUMAN OTC DRUG	HELLO SPORT HAND SANITIZER	70 PERCENT	ETHYL ALCOHOL	SPRAY	TOPICAL	20230524		OTC MONOGRAPH NOT FINAL	part333A	MELLENUSA STUDIO, LLC	ALCOHOL	70	mL/100mL			N	20241231
82175-404_f279ad80-1742-6497-e053-2995a90a796c	82175-404	HUMAN OTC DRUG	Professional Choice Gold Hand Cleaner		Chloroxylenol	LIQUID	TOPICAL	20211110	20240729	OTC MONOGRAPH NOT FINAL	part333E	Sheppard Enterprises, Inc.	CHLOROXYLENOL	.3	g/100mL			N	
82177-203_09e2dbc8-0d37-16eb-e063-6394a90a40d8	82177-203	HUMAN OTC DRUG	GET MR. Butter Body SPF-30		TITANIUM DIOXIDE, ZINC OXIDE	LIQUID	TOPICAL	20210810		OTC MONOGRAPH DRUG	M020	Biomin LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82177-204_09e3018f-8531-2069-e063-6394a90ad672	82177-204	HUMAN OTC DRUG	GET MR. The Active Mineral Body SPF-30		TITANIUM DIOXIDE, ZINC OXIDE	LIQUID	TOPICAL	20210810		OTC MONOGRAPH DRUG	M020	Biomin LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82179-001_09a996e1-cfb7-fc86-e063-6294a90ab24c	82179-001	HUMAN OTC DRUG	KOSHER MEDS		Ibuprofen	SUSPENSION	ORAL	20210817		ANDA	ANDA210602	Mollec Inc	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82179-002_f30918da-8bb9-58e4-e053-2995a90af9c4	82179-002	HUMAN OTC DRUG	KOSHER MEDS Childrens Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20230118		OTC MONOGRAPH NOT FINAL	part343	Mollec Inc	ACETAMINOPHEN	160	mg/5mL			N	20241231
82179-003_f3091029-d99d-2069-e053-2995a90ab48d	82179-003	HUMAN OTC DRUG	KOSHER MEDS Childrens Allergy Relief		Diphenhydramine	LIQUID	ORAL	20230118		OTC MONOGRAPH FINAL	part341	Mollec Inc	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82182-321_4c90a66d-535b-445e-85be-ba5ff4b71351	82182-321	HUMAN PRESCRIPTION DRUG	Brimonidine tartrate		brimonidine tartrate	SOLUTION/ DROPS	OPHTHALMIC	20240102		NDA AUTHORIZED GENERIC	NDA021770	Pacific Pharma, Inc.	BRIMONIDINE TARTRATE	1	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
82182-455_31018ddc-ab7a-4ff5-8ccc-43e9c3fbd470	82182-455	HUMAN PRESCRIPTION DRUG	BRIMONIDINE TARTRATE and TIMOLOL MALEATE		BRIMONIDINE TARTRATE, TIMOLOL MALEATE	SOLUTION/ DROPS	TOPICAL	20221021		NDA AUTHORIZED GENERIC	NDA021398	Pacific Pharma, Inc.	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2; 5	mg/mL; mg/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC]		N	20241231
82182-773_4c90a66d-535b-445e-85be-ba5ff4b71351	82182-773	HUMAN PRESCRIPTION DRUG	Brimonidine tartrate		brimonidine tartrate	SOLUTION/ DROPS	OPHTHALMIC	20220228		NDA AUTHORIZED GENERIC	NDA021262	Pacific Pharma, Inc.	BRIMONIDINE TARTRATE	1.5	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
82184-1001_dac29445-e3b7-95ff-e053-2a95a90a43de	82184-1001	HUMAN OTC DRUG	KINLO ALWAYS GOLDEN BODY		Zinc Oxide	LOTION	TOPICAL	20220228		OTC MONOGRAPH NOT FINAL	part352	A-Frame SunCo Inc	ZINC OXIDE	10	g/100g			N	20241231
82184-1173_d9b57ac4-d91d-4912-e053-2995a90a9989	82184-1173	HUMAN OTC DRUG	KINLO Golden Rays Sunscreen (Medium Tinted)		Zinc Oxide	LOTION	TOPICAL	20220308		OTC MONOGRAPH NOT FINAL	part352	A-Frame SunCo Inc	ZINC OXIDE	132	mg/mL			N	20241231
82184-1337_f654357b-5c04-2e9a-e053-2a95a90ad436	82184-1337	HUMAN OTC DRUG	Always Golden Daily Moisturizer (Tinted)		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20220308		OTC MONOGRAPH NOT FINAL	part352	A-Frame SunCo Inc	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
82184-1350_f6543cc2-45f9-69d5-e053-2a95a90a4a93	82184-1350	HUMAN OTC DRUG	Golden Ray Sunscreen (Deep Tinted)		Zinc Oxide	LOTION	TOPICAL	20220308		OTC MONOGRAPH NOT FINAL	part352	A-Frame SunCo Inc	ZINC OXIDE	132	mg/mL			N	20241231
82184-1351_f654357b-5c05-2e9a-e053-2a95a90ad436	82184-1351	HUMAN OTC DRUG	Golden Rays Sunscreen (Light Tinted)		Zinc Oxide	LOTION	TOPICAL	20220308		OTC MONOGRAPH NOT FINAL	part352	A-Frame SunCo Inc	ZINC OXIDE	132	mg/mL			N	20241231
82184-4480_cb18e595-9870-6769-e053-2a95a90acfd3	82184-4480	HUMAN OTC DRUG	KINLO Golden Rays Sunscreen		Zinc Oxide	LOTION	TOPICAL	20210826		OTC MONOGRAPH NOT FINAL	part352	A-Frame SunCo Inc	ZINC OXIDE	132	mg/mL			N	20241231
82186-162_d025b22f-33d6-76e0-e053-2a95a90a8bf8	82186-162	HUMAN OTC DRUG	Zaxs Aches and Pain		Capsicum, Methyl salicylate, Menthol	CREAM	TOPICAL	20211122		OTC MONOGRAPH NOT FINAL	part348	Zax Healthcare Inc.	CAPSICUM; MENTHOL; METHYL SALICYLATE	1.3; 50; 105	mg/g; mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
82188-222_09e2e5e3-ab0d-d4b0-e063-6294a90a1f57	82188-222	HUMAN OTC DRUG	I KNOW Very Necessary Broad Spectrum SPF-40 Moisturizing Cream		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20210901		OTC MONOGRAPH DRUG	M020	Thirty7 LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
82191-001_0a5dc368-f034-8eee-e063-6394a90a45fe	82191-001	HUMAN OTC DRUG	Steady Freddy		Lidocaine	SPRAY	TOPICAL	20210830		OTC MONOGRAPH DRUG	M017	Medical Symbiosis Pty Ltd	LIDOCAINE	96	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82194-510_1aa57daf-c1a3-4b98-b5b9-32f0da1c2f6c	82194-510	HUMAN PRESCRIPTION DRUG	VYJUVEK		VYJUVEK	KIT		20230519		BLA	BLA125774	Krystal Biotech, Inc.						N	20241231
82198-0001_0aa3499b-1310-d2ca-e063-6294a90a7acd	82198-0001	HUMAN OTC DRUG	Max Revive Plaster		Menthol, Methyl Salicylate	PATCH	TOPICAL	20211011		OTC MONOGRAPH DRUG	505G(a)(3)	Big 5 Nutrition LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.04; .01	g/g; g/g			N	20241231
82198-0002_0aa34a75-7a11-a1f9-e063-6394a90ac052	82198-0002	HUMAN OTC DRUG	Max Revive Plaster		menthol, methyl salicylate	PATCH	TOPICAL	20211011		OTC MONOGRAPH DRUG	505G(a)(3)	Big 5 Nutrition LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.04; .01	g/g; g/g			N	20241231
82198-0005_0aa34a75-7a27-a1f9-e063-6394a90ac052	82198-0005	HUMAN OTC DRUG	Zhong Hua Feng Shi Die Da Gao External Analgesic Plaster		menthol, methyl salicylate	PATCH	TOPICAL	20211011		OTC MONOGRAPH DRUG	505G(a)(3)	Big 5 Nutrition LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.04; .01	g/g; g/g			N	20241231
82198-0006_0aa36675-89d8-92da-e063-6394a90a63ad	82198-0006	HUMAN OTC DRUG	Dit Da Shui		Menthol and Methyl Salicylate	LIQUID	TOPICAL	20221001		OTC MONOGRAPH DRUG	M017	Big 5 Nutrition LLC	MENTHOL; METHYL SALICYLATE	100; 50	mg/mL; mg/mL			N	20241231
82198-0007_0aa37145-cd8b-beb7-e063-6394a90afa97	82198-0007	HUMAN OTC DRUG	Herbal Balm		Methyl Salicylate, Menthol and	CREAM	TOPICAL	20221001		OTC MONOGRAPH DRUG	M017	Big 5 Nutrition LLC	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	31; 156; 207	mg/g; mg/g; mg/g			N	20241231
82198-0008_0aa37a7b-851a-d9d5-e063-6294a90a23be	82198-0008	HUMAN OTC DRUG	UtaSpray		Menthol and Methyl Salicylate	LIQUID	TOPICAL	20221001		OTC MONOGRAPH DRUG	M017	Big 5 Nutrition LLC	MENTHOL; METHYL SALICYLATE	100; 50	mg/mL; mg/mL			N	20241231
82198-0009_0aa37a7b-8526-d9d5-e063-6294a90a23be	82198-0009	HUMAN OTC DRUG	Top Medicated Oil		CAMPHOR, MENTHOL, METHYL SALICYLATE	OIL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M017	Big 5 Nutrition LLC	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	10; 16; 40	mg/mL; mg/mL; mg/mL			N	20241231
82198-0010_0aa441d8-a293-a678-e063-6294a90a698e	82198-0010	HUMAN OTC DRUG	BT Pain Relief Balm		Methyl Salicylate, Menthol, Camphor	OINTMENT	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	Big 5 Nutrition LLC	CAMPHOR, (-)-; MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	31.1; 155.5; 207.3	mg/g; mg/g; mg/g			N	20241231
82198-0011_0ab7cd72-6a18-d846-e063-6294a90aa6ff	82198-0011	HUMAN OTC DRUG	BT Pain Relief		MENTHOL, METHYL SALICYLATE	PATCH	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	Big 5 Nutrition LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.06; .1	g/g; g/g			N	20241231
82198-0012_0aa61368-2851-7dba-e063-6394a90af0ee	82198-0012	HUMAN OTC DRUG	BT Pain Relief		MENTHOL, METHYL SALICYLATE	SPRAY	TOPICAL	20240101		OTC MONOGRAPH DRUG	M017	Big 5 Nutrition LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	100; 50	mg/mL; mg/mL			N	20241231
82198-0015_0b32bdc5-c8ed-e6cb-e063-6394a90aa155	82198-0015	HUMAN OTC DRUG	SC HERBAL		methyl salicylate, menthol, camphor	PATCH	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	Big 5 Nutrition LLC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.031; .06; .1	g/g; g/g; g/g			N	20241231
82198-0016_0b32b98c-2483-8d0c-e063-6294a90a90b1	82198-0016	HUMAN OTC DRUG	Herbal Utaplas External Analgesic Plaster		menthol, methyl salicylate	PATCH	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	Big 5 Nutrition LLC	MENTHOL, UNSPECIFIED FORM; METHYL SALICYLATE	.06; .1	g/g; g/g			N	20241231
82213-001_09c2d90b-b48e-31ff-e063-6394a90a7c20	82213-001	HUMAN OTC DRUG	Mjalli Hand Sanitizer 2.0		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20210531		OTC MONOGRAPH DRUG	505G(a)(3)	Noor Brands Company, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
82213-002_094013f2-0451-3ef7-e063-6394a90a2607	82213-002	HUMAN OTC DRUG	SynaGel		Diclofinac Sodium	GEL	TOPICAL	20231102		UNAPPROVED DRUG OTHER		Noor Brands Company, LLC	DICLOFENAC SODIUM	1	g/100mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82214-001_0a4c1fcc-ab7a-88ef-e063-6394a90a40b4	82214-001	HUMAN OTC DRUG	Moon Platinum Advanced Whitening Anticavity		Sodium Fluoride	PASTE	TOPICAL	20220125		OTC MONOGRAPH DRUG	M022	Moon Oral Care LLC	SODIUM FLUORIDE	.24	g/100g			N	20241231
82214-002_0bdcad3e-b8ea-bd91-e063-6394a90a666a	82214-002	HUMAN OTC DRUG	Moon Whitening Anticavity		Sodium Fluoride	PASTE	TOPICAL	20190701		OTC MONOGRAPH DRUG	M022	Moon Oral Care, LLC	SODIUM FLUORIDE	.23	g/100g			N	20241231
82214-003_0c55f7b3-fea2-58f3-e063-6394a90a3bde	82214-003	HUMAN OTC DRUG	Moon Charcoal Whitening Anticavity		Sodium Fluoride	PASTE	TOPICAL	20210101		OTC MONOGRAPH DRUG	M022	Moon Oral Care, LLC	SODIUM FLUORIDE	.24	g/100g			N	20241231
82214-004_0c556a29-a698-3a66-e063-6394a90abfee	82214-004	HUMAN OTC DRUG	Moon Whitening Gel Anticavity		Sodium Fluoride	GEL, DENTIFRICE	TOPICAL	20220301		OTC MONOGRAPH DRUG	M022	Moon Oral Care, LLC	SODIUM FLUORIDE	.24	g/100g			N	20241231
82215-0001_f94bd3f3-07f3-1a4f-e053-6294a90a528a	82215-0001	HUMAN OTC DRUG	Marlowe	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230414		OTC MONOGRAPH FINAL	M020	Marlowe Holdings, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.94; 99.8; 49.9; 49.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82217-710_cd45b228-bab0-40e6-aa9b-8cff545340ea	82217-710	HUMAN OTC DRUG	GMHS, LLC Hand Sanitizer		Isopropyl alcohol	SPRAY	TOPICAL	20230216		OTC MONOGRAPH NOT FINAL	part333A	Global Medical and Health Services, LLC	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
82217-720_16981546-e4c0-48a1-b524-690211995ca5	82217-720	HUMAN OTC DRUG	GMHS, LLC Hand Sanitizer		Isopropyl alcohol	GEL	TOPICAL	20230302		OTC MONOGRAPH NOT FINAL	part333A	Global Medical and Health Services, LLC	ISOPROPYL ALCOHOL	75	mL/100mL			N	20241231
82219-411_1d417bc0-4ff2-42b2-a5ba-9af2b2129a06	82219-411	HUMAN OTC DRUG	Mega Patch		Capsaicin, Lidocaine, Menthol, Methyl Salicylate	PATCH	TOPICAL	20230821		UNAPPROVED DRUG OTHER		GREENHILL TRADING, INC.	CAPSAICIN; LIDOCAINE; MENTHOL; METHYL SALICYLATE	.0375; 4; 5; 20	g/1; g/1; g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82221-102_07021188-b4b1-a428-e063-6294a90a7112	82221-102	HUMAN OTC DRUG	BodyVita Shower Filter		Vitamin C (Ascorbic Acid), Green Plum Blossom Extract, Shea butter Extract	JELLY	TOPICAL	20211006		UNAPPROVED DRUG OTHER		Goodwell Corporation Co., Ltd.	ASCORBIC ACID; PRUNUS MUME FLOWER OIL; SHEANUT OIL	.61; .005; .005	g/100g; g/100g; g/100g	Ascorbic Acid [CS], Vitamin C [EPC]		N	20241231
82229-001_0a546bd3-cf4b-6626-e063-6394a90a8b98	82229-001	HUMAN OTC DRUG	Reset U		HOVENIA DULCIS THUNB.	LIQUID	TOPICAL	20210916		UNAPPROVED DRUG OTHER		DOCTOR CARE	HOVENIA DULCIS WHOLE	19	g/100mL			N	20241231
82237-0001_0c6dda11-f0e0-42b9-e063-6294a90af8e5	82237-0001	HUMAN OTC DRUG	TANIA PURECREAM		Niacinamide	CREAM	TOPICAL	20210911		UNAPPROVED DRUG OTHER		NFC LIFE SCIENCE CO.,LTD	NIACINAMIDE	2	g/100mL			N	20241231
82237-0002_0c6de33c-681f-40b2-e063-6394a90a58b0	82237-0002	HUMAN OTC DRUG	TANIA PURE ESSENCE		Niacinamide	LIQUID	TOPICAL	20210911		UNAPPROVED DRUG OTHER		NFC LIFE SCIENCE CO.,LTD	NIACINAMIDE	2	g/100mL			N	20241231
82237-0003_0c6dd62b-ff76-37f7-e063-6394a90aec9c	82237-0003	HUMAN OTC DRUG	CURICIN PFcream		Dendropanax morbiferus extract	CREAM	TOPICAL	20210911		UNAPPROVED DRUG OTHER		NFC LIFE SCIENCE CO.,LTD	DENDROPANAX DENTIGER ROOT WITH STEM	15	g/100mL			N	20241231
82237-0004_0c6e057a-678e-5bd4-e063-6294a90a96e0	82237-0004	HUMAN OTC DRUG	AZALEA PFCREAM		Dendropanax morbiferus extract	CREAM	TOPICAL	20211224		UNAPPROVED DRUG OTHER		NFC LIFE SCIENCE CO.,LTD	RHODODENDRON INDICUM FLOWER	5	g/100mL			N	20241231
82238-018_924b2761-10ea-4588-8d6c-3cb2f345a63b	82238-018	HUMAN PRESCRIPTION DRUG	FOSAPREPITANT DIMEGLUMINE		FOSAPREPITANT DIMEGLUMINE	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20210112		ANDA	ANDA210625	EUGIA Pharma Specialities Limited	FOSAPREPITANT DIMEGLUMINE	150	mg/5mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
82240-223_09e2e5e3-ab1e-d4b0-e063-6294a90a1f57	82240-223	HUMAN OTC DRUG	DERMAKA Broad Spectrum SPF-42 Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210921		OTC MONOGRAPH DRUG	M020	DERMAKA SKIN PRODUCTS	TITANIUM DIOXIDE; ZINC OXIDE	60; 77	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82240-424_09e30a62-356e-3cff-e063-6394a90a270f	82240-424	HUMAN OTC DRUG	DERMAKA Broad Spectrum SPF-42 Sunscreen Untinted		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20231002		OTC MONOGRAPH DRUG	M020	DERMAKA SKIN PRODUCTS	TITANIUM DIOXIDE; ZINC OXIDE	60; 110	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82243-1001_043c336f-60e6-dc23-e063-6294a90a4b13	82243-1001	HUMAN PRESCRIPTION DRUG	FOCINVEZ		FOSAPREPITANT	INJECTION	INTRAVENOUS	20230830		NDA	NDA216686	Spes Pharmaceuticals Inc.	FOSAPREPITANT DIMEGLUMINE	150	mg/50mL	Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]		N	20241231
82247-225_09e2e2ce-d869-0711-e063-6294a90a9213	82247-225	HUMAN OTC DRUG	BRICKELL Daily Defense Face Moisturizer SPF-20		OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20210921		OTC MONOGRAPH DRUG	M020	BRICKELL BRANDS LLC	OCTISALATE; ZINC OXIDE	50; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82247-234_09e2e2ce-d877-0711-e063-6294a90a9213	82247-234	HUMAN OTC DRUG	BRICKELL Element Defense Moisturizer SPF-45		OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20210921		OTC MONOGRAPH DRUG	M020	BRICKELL BRANDS LLC	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 100; 50	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82247-278_09e30a62-357f-3cff-e063-6394a90a270f	82247-278	HUMAN OTC DRUG	TIGER BABY Baby Sunscreen SPF-50		ZINC OXIDE	CREAM	TOPICAL	20220221		OTC MONOGRAPH DRUG	M020	BRICKELL BRANDS LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82247-384_09e3156c-9351-43f6-e063-6394a90ad71e	82247-384	HUMAN OTC DRUG	EIGHT SAINTS Chase The Sun SPF-30		OCTOCRYLENE, OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20220214		OTC MONOGRAPH DRUG	M020	BRICKELL BRANDS LLC	OCTISALATE; OCTOCRYLENE; ZINC OXIDE	50; 50; 40	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82247-421_09e30a62-358f-3cff-e063-6394a90a270f	82247-421	HUMAN OTC DRUG	Brickell Mens Products Daily Defense Face Moisturizer SPF-20		OCTISALATE, ZINC OXIDE	CREAM	TOPICAL	20230911		OTC MONOGRAPH DRUG	M020	BRICKELL BRANDS LLC	OCTISALATE; ZINC OXIDE	50; 40	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82249-010_e53ac743-7511-43a5-b28d-68c6feb7abc8	82249-010	HUMAN PRESCRIPTION DRUG	Abiraterone		Abiraterone acetate	TABLET	ORAL; ORAL	20181123		ANDA	ANDA208339	CivicaScript, LLC	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
82260-001_e294ce2b-6bb5-4f84-8a6d-ce2402ed926d	82260-001	HUMAN PRESCRIPTION DRUG	Atropine Sulfate		Atropine Sulfate	SOLUTION	OPHTHALMIC	20230421		NDA	NDA213581	Bausch & Lomb Americas Inc.	ATROPINE SULFATE	10	mg/mL	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
82260-045_8e444e2c-a2c1-42f5-9a3a-87bd9d738ba2	82260-045	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION/ DROPS	OPHTHALMIC	20220623		NDA AUTHORIZED GENERIC	NDA021516	Bausch & Lomb Americas Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82260-102_278d0147-c5b0-4d85-80f5-500ec567feed	82260-102	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		phenylephrine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20230331		NDA AUTHORIZED GENERIC	NDA203510	Bausch & Lomb Americas Inc.	PHENYLEPHRINE HYDROCHLORIDE	25	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82260-103_278d0147-c5b0-4d85-80f5-500ec567feed	82260-103	HUMAN PRESCRIPTION DRUG	Phenylephrine Hydrochloride		phenylephrine hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20230331		NDA AUTHORIZED GENERIC	NDA203510	Bausch & Lomb Americas Inc.	PHENYLEPHRINE HYDROCHLORIDE	25	mg/mL	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82260-299_324b2258-9755-44eb-8137-f1693a67b70d	82260-299	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		loteprednol etabonate	SUSPENSION/ DROPS	OPHTHALMIC	20230407		NDA AUTHORIZED GENERIC	NDA020583	Bausch & Lomb Americas Inc.	LOTEPREDNOL ETABONATE	5	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82260-496_63a7516f-eb4b-42e3-b3ea-725c3a3098a4	82260-496	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20220217		NDA AUTHORIZED GENERIC	NDA019463	Bausch & Lomb Americas Inc.	TIMOLOL MALEATE	6.8	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82260-508_caee0e93-a905-4661-baab-a225c881d1a1	82260-508	HUMAN PRESCRIPTION DRUG	Loteprednol Etabonate		loteprednol etabonate	GEL	OPHTHALMIC	20230630		NDA AUTHORIZED GENERIC	NDA202872	Bausch & Lomb Americas Inc.	LOTEPREDNOL ETABONATE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82260-630_10087ae6-04b2-4f64-b5e7-54ff878fe756	82260-630	HUMAN PRESCRIPTION DRUG	Bepotastine Besilate		bepotastine besilate	SOLUTION/ DROPS	OPHTHALMIC	20210528		NDA AUTHORIZED GENERIC	NDA022288	Bausch & Lomb Americas Inc.	BEPOTASTINE BESYLATE	15	mg/mL	Histamine-1 Receptor Antagonist [EPC]		N	20241231
82260-734_f70ca102-e4d9-3e2f-e053-6394a90acbd9	82260-734	HUMAN PRESCRIPTION DRUG	Fluorescein Sodium and Benoxinate Hydrochloride		Fluorescein Sodium and Benoxinate Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20200320		NDA AUTHORIZED GENERIC	NDA211039	Bausch & Lomb Americas Inc.	BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM	4.4; 2.6	mg/mL; mg/mL	Diagnostic Dye [EPC], Dyes [MoA]		N	20241231
82260-812_5ddb199c-0d86-457d-b8bb-42877c15d7aa	82260-812	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20220726		NDA AUTHORIZED GENERIC	NDA018086	Bausch & Lomb Americas Inc.	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82260-813_5ddb199c-0d86-457d-b8bb-42877c15d7aa	82260-813	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20220726		NDA AUTHORIZED GENERIC	NDA018086	Bausch & Lomb Americas Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82260-818_7ce68ada-5473-41f6-b9d0-426db96d5dbb	82260-818	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20180214		NDA AUTHORIZED GENERIC	NDA020330	Bausch & Lomb Americas Inc.	TIMOLOL MALEATE	2.5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82260-819_7ce68ada-5473-41f6-b9d0-426db96d5dbb	82260-819	HUMAN PRESCRIPTION DRUG	Timolol Maleate		Timolol Maleate	SOLUTION	OPHTHALMIC	20180214		NDA AUTHORIZED GENERIC	NDA020330	Bausch & Lomb Americas Inc.	TIMOLOL MALEATE	5	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82260-920_b681ef9c-e19f-426f-8c85-db0075ea34f3	82260-920	HUMAN PRESCRIPTION DRUG	Tetracaine Hydrochloride		Tetracaine Hydrochloride	SOLUTION/ DROPS	OPHTHALMIC	20220921		NDA	NDA210821	Bausch & Lomb Americas Inc.	TETRACAINE HYDROCHLORIDE	5	mg/mL	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
82262-224_09e31e63-2198-2c4d-e063-6294a90a3d86	82262-224	HUMAN OTC DRUG	GASPARI Ageless Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20210920		OTC MONOGRAPH DRUG	M017	GASPARI ANTI-AGING LLC	MENTHOL	20	mg/mL			N	20241231
82266-237_09e3219d-1fc8-1c81-e063-6294a90a09ed	82266-237	HUMAN OTC DRUG	WARTRIN Wart Remover		SALICYLIC ACID	CREAM	TOPICAL	20211001		OTC MONOGRAPH DRUG	M028	BALBOA COMPANIES LLC	SALICYLIC ACID	50	mg/mL			N	20241231
82266-238_0976f648-dbe4-1b13-e063-6394a90ad2dc	82266-238	HUMAN OTC DRUG	WARTOVIR Wart Remover		SALICYLIC ACID	CREAM	TOPICAL	20211001		OTC MONOGRAPH DRUG	M028	BALBOA COMPANIES LLC	SALICYLIC ACID	50	mg/mL			N	20241231
82269-607_669593ec-e5b3-42a8-97ac-e4b8a75f56aa	82269-607	HUMAN OTC DRUG	Hair Regrowth Treatment	Extra Strength for Men	Minoxidil	SOLUTION	TOPICAL	20211015		ANDA	ANDA075518	Seiseidou America, Inc.	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82275-001_f6f20d9a-72d7-5588-e053-6294a90a24eb	82275-001	HUMAN OTC DRUG	Isopropyl Alcohol		Alcohol Prep Pads	SWAB	TOPICAL	20210921		OTC MONOGRAPH NOT FINAL	part333A	Shenzhen Intra Industry Co., Ltd	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
82280-425_0bba8c3a-f3bb-62f2-e063-6394a90a541e	82280-425	HUMAN OTC DRUG	THERAPLEX Eczema Therapy		OATMEAL	CREAM	TOPICAL	20231219		OTC MONOGRAPH DRUG	M016	THERAPLEX, LLC	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
82280-816_09e3256c-3b25-0427-e063-6294a90a8569	82280-816	HUMAN OTC DRUG	THERAPLEX Eczema Therapy		OATMEAL	CREAM	TOPICAL	20220110		OTC MONOGRAPH DRUG	M016	THERAPLEX, LLC	OATMEAL	10	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
82281-239_09e32958-ac5a-2307-e063-6294a90a1ec6	82281-239	HUMAN OTC DRUG	STRYX Daily Moisturizer SPF-30		OCTISALATE, ENSULIZOLE	CREAM	TOPICAL	20211010		OTC MONOGRAPH DRUG	M020	STRYX MEN, INC.	ENSULIZOLE; OCTISALATE	40; 50	mg/mL; mg/mL			N	20241231
82283-001_0b512a58-f509-dfbf-e063-6294a90a8cea	82283-001	HUMAN OTC DRUG	Skin Cleansing Wipe		ISOPROPYL ALCOHOL	SOLUTION	TOPICAL	20210930		OTC MONOGRAPH DRUG	M005	RFX+CARE Manufacturing Co., Ltd.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
82293-001_080def7e-d896-1b25-e063-6394a90ac1e3	82293-001	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		abiraterone acetate	TABLET, FILM COATED	ORAL	20220105		ANDA	ANDA215947	Novugen Pharma (USA) LLC	ABIRATERONE ACETATE	250	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
82293-002_080def7e-d896-1b25-e063-6394a90ac1e3	82293-002	HUMAN PRESCRIPTION DRUG	Abiraterone Acetate		abiraterone acetate	TABLET, FILM COATED	ORAL	20220105		ANDA	ANDA215947	Novugen Pharma (USA) LLC	ABIRATERONE ACETATE	500	mg/1	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]		N	20241231
82293-003_08212b35-9d8c-dc89-e063-6294a90af5f2	82293-003	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20231018		ANDA	ANDA211973	Novugen Pharma (USA) LLC	MIDODRINE HYDROCHLORIDE	2.5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
82293-004_08212b35-9d8c-dc89-e063-6294a90af5f2	82293-004	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20231018		ANDA	ANDA211973	Novugen Pharma (USA) LLC	MIDODRINE HYDROCHLORIDE	5	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
82293-005_08212b35-9d8c-dc89-e063-6294a90af5f2	82293-005	HUMAN PRESCRIPTION DRUG	Midodrine Hydrochloride		Midodrine Hydrochloride	TABLET	ORAL	20231018		ANDA	ANDA211973	Novugen Pharma (USA) LLC	MIDODRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
82301-001_f382d908-3daf-66ac-e053-2a95a90a8aa0	82301-001	HUMAN OTC DRUG	Photocil		Dimethicone	CREAM	TOPICAL	20211005		OTC MONOGRAPH FINAL	M016	Jupiter Wellness, Inc.	DIMETHICONE	.6	g/60g	Skin Barrier Activity [PE]		N	20241231
82301-004_f382ed0e-6140-1293-e053-2a95a90aad95	82301-004	HUMAN OTC DRUG	Photocil		Dimethicone	CREAM	TOPICAL	20211130		OTC MONOGRAPH FINAL	M016	Jupiter Wellness, Inc.	DIMETHICONE	.6	g/60g	Skin Barrier Activity [PE]		N	20241231
82305-003_0b39b74a-a84e-2067-e063-6394a90a9495	82305-003	HUMAN OTC DRUG	Regener-Eyes	PRO	Regener-Eyes	SOLUTION/ DROPS	OPHTHALMIC	20220824		OTC MONOGRAPH DRUG	M018	Regenerative Processing Plant, LLC	GLYCERIN	15	mg/3mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82305-006_0b38bd65-2993-55d7-e063-6294a90a5cf2	82305-006	HUMAN OTC DRUG	Regener-Eyes	LITE	Glycerin	SOLUTION/ DROPS	OPHTHALMIC	20220824		OTC MONOGRAPH DRUG	M018	Regenerative Processing Plant, LLC	GLYCERIN	12	mg/3mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82309-024_091fc02c-5c36-d72a-e063-6294a90aa920	82309-024	HUMAN OTC DRUG	Face Saver Gel		Antiperspirant	GEL	TOPICAL	20211201		OTC MONOGRAPH DRUG	M019	Tripak Pharmaceuticals	ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY	16	g/100g			N	20241231
82309-032_0cca5b7e-5e79-65f8-e063-6294a90a13e7	82309-032	HUMAN OTC DRUG	Willow Wart		Salix alba, Thuja occidentalis	CREAM	TOPICAL	20190601		UNAPPROVED HOMEOPATHIC		Tripak Pharmaceuticals	SALIX ALBA BARK; THUJA OCCIDENTALIS LEAF	.5; .2	g/10g; g/10g			N	20241231
82309-033_0cca45e4-0549-5fbb-e063-6294a90a8098	82309-033	HUMAN OTC DRUG	Natural Pain Relief Foot Cream		camphor	CREAM	TOPICAL	20190601		OTC MONOGRAPH DRUG	M017	Tripak Pharmaceuticals	CAMPHOR (NATURAL)	1.5	g/50g			N	20241231
82311-0101_070eab9b-bf50-b7d4-e063-6394a90a7ace	82311-0101	HUMAN OTC DRUG	biom Sanitizing Alcohol Wipes - Eucalyptus Chill		ALCOHOL	SWAB	TOPICAL	20220225		UNAPPROVED DRUG OTHER		Biom Innovations Inc	ALCOHOL	184.1	mL/263mL			N	20241231
82311-0101_07d485a9-7728-b0ac-e063-6394a90a95e0	82311-0101	HUMAN OTC DRUG	biom Sanitizing Alcohol Wipes - Eucalyptus Chill		ALCOHOL	SWAB	TOPICAL	20211004		UNAPPROVED DRUG OTHER		Biom Innovations Inc	ALCOHOL	184.1	mL/263mL			N	20241231
82311-0102_07867d3d-b2ff-0e1d-e063-6294a90aec16	82311-0102	HUMAN OTC DRUG	biom Sanitizing Alcohol Wipes - Bergamot Bloom		ALCOHOL	SWAB	TOPICAL	20211004		UNAPPROVED DRUG OTHER		Biom Innovations Inc	ALCOHOL	184.1	mL/263mL			N	20241231
82311-0102_07d7ce40-20d4-4765-e063-6294a90a726e	82311-0102	HUMAN OTC DRUG	biom Sanitizing Alcohol Wipes - Bergamot Bloom		ALCOHOL	SWAB	TOPICAL	20230115		UNAPPROVED DRUG OTHER		Biom Innovations Inc	ALCOHOL	184.1	mL/263mL			N	20241231
82311-0118_07fca72a-f2bb-0737-e063-6294a90afdd6	82311-0118	HUMAN OTC DRUG	biom Sanitizing Alcohol Wipes - Tea Tree Bliss		ALCOHOL	SWAB	TOPICAL	20231018		UNAPPROVED DRUG OTHER		Biom Innovations Inc	ALCOHOL	184.1	mL/263mL			N	20241231
82311-0118_07fe173b-5ce3-7af6-e063-6294a90a4dd9	82311-0118	HUMAN OTC DRUG	biom Sanitizing Alcohol Wipes - Tea Tree Bliss		ALCOHOL	SWAB	TOPICAL	20231018		UNAPPROVED DRUG OTHER		Biom Innovations Inc	ALCOHOL	42.854	mL/61.22mL			N	20241231
82312-001_088f5106-92aa-2c97-e063-6394a90ab1f9	82312-001	HUMAN OTC DRUG	ArthroNEO		CAMPHOR	SPRAY	TOPICAL	20211027		OTC MONOGRAPH DRUG	M017	Likasso LTD	CAMPHOR (NATURAL)	.5	g/100g			N	20241231
82312-002_088f3be4-ce2d-67af-e063-6294a90a18d0	82312-002	HUMAN OTC DRUG	SustaFix		CAMPHOR	CREAM	TOPICAL	20211027		OTC MONOGRAPH DRUG	M017	Likasso, LTD	CAMPHOR (NATURAL)	1	g/100g			N	20241231
82317-001_e07b6268-6401-6849-e053-2a95a90a8b3e	82317-001	HUMAN OTC DRUG	Serum X		Lidocaine hydrochloride	GEL	TOPICAL	20220421		OTC MONOGRAPH NOT FINAL	part348	AO Biologix, LLC	LIDOCAINE HYDROCHLORIDE	.5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82319-240_09e32c60-2b41-0226-e063-6294a90a6a2f	82319-240	HUMAN OTC DRUG	ZENSEZONE Arthmed Temporary Pain Relief Cream		CAPSAICIN, MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20211020		OTC MONOGRAPH DRUG	M017	ZENSEZONE LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.25; 100; 150	mg/mL; mg/mL; mg/mL			N	20241231
82325-4482_015475df-27f1-4371-e063-6294a90adddb	82325-4482	HUMAN OTC DRUG	Ourself Mineral Sunscreen		Zinc Oxide	LOTION	TOPICAL	20211022		OTC MONOGRAPH NOT FINAL	part352	GLO PHARMA	ZINC OXIDE	12	mg/mL			N	20241231
82329-247_09e3018f-8541-2069-e063-6394a90ad672	82329-247	HUMAN OTC DRUG	WILMA SCHUMANN Moisture Protektiv Day Cream SPF-20		OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE	CREAM	TOPICAL	20211101		OTC MONOGRAPH DRUG	M020	SKINMETICS INC	OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE	60; 30; 30	mg/mL; mg/mL; mg/mL			N	20241231
82330-100_0b8a5664-9eee-99c2-e063-6394a90a880f	82330-100	HUMAN OTC DRUG	DR JOE LAB PMS Menstrual Pain Relief Cream	DR JOE LAB	Menstrual Pain Relief Cream	CREAM	TOPICAL	20220401		OTC MONOGRAPH DRUG	M014	DESPINA PHARMA, INC.	MENTHOL, (+)-; METHYL SALICYLATE	1.4; 10	g/100g; g/100g			N	20241231
82330-401_0b8a1cca-4839-abcd-e063-6294a90a9ded	82330-401	HUMAN OTC DRUG	Dr Joe lab ARTHRITIS EXTRA STRENGTH		TROLAMINE SALICYLATE	GEL	TOPICAL	20220601		OTC MONOGRAPH DRUG	M014	DESPINA PHARMA INC	TROLAMINE SALICYLATE	10	g/100mL			N	20241231
82330-501_0b8a1832-35f0-8988-e063-6394a90ad8d2	82330-501	HUMAN OTC DRUG	Dr Joe lab ARTHRITIS EXTRA STRENGTH		Trolamine salicylate	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M014	DESPINA PHARMA INC.	TROLAMINE SALICYLATE	10	g/100g			N	20241231
82332-102_0d78aae8-38f5-432c-e063-6394a90a461b	82332-102	HUMAN OTC DRUG	BDFERM BIOSPRAY		Calcium Oxide	SPRAY	ORAL	20211018		UNAPPROVED DRUG OTHER		BDFERM CO.,ltd	LIME (CALCIUM OXIDE)	.295	g/100mL			N	20241231
82341-302_0cea0329-77bc-303c-e063-6294a90a8d28	82341-302	HUMAN OTC DRUG	Onsaemiro Damda		Anotec 0307, Cypress Water, Houttuynia Cordata Eextract, Glycerin	LIQUID	TOPICAL	20211028		UNAPPROVED DRUG OTHER		WEMON	ALCOHOL; CHAMAECYPARIS OBTUSA WHOLE; EUCALYPTUS OIL; GLYCERIN; HOUTTUYNIA CORDATA FLOWERING TOP; OLIVE OIL; SORBITOL; WHITE PINE OIL	30; 25; .3; .1; 5; .3; .3; .3	mL/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Lipid Emulsion [EPC], Lipids [CS], Non-Standardized Chemical Allergen [EPC]		N	20241231
82345-854_09738b82-8e23-7e4c-e063-6294a90a4dd0	82345-854	HUMAN OTC DRUG	Cramergesic		MENTHOL, METHYL SALICYLATE	OINTMENT	TOPICAL	20220401		OTC MONOGRAPH DRUG	M017	The Hygenic Company, LLC	MENTHOL; METHYL SALICYLATE	19; 137	mg/g; mg/g			N	20241231
82345-855_0884b4eb-7fd2-b2c7-e063-6294a90aa02e	82345-855	HUMAN OTC DRUG	Red hot		CAPSAICIN	OINTMENT	TOPICAL	20220401		OTC MONOGRAPH DRUG	M017	The Hygenic Company, LLC	CAPSAICIN	.5	mg/g			N	20241231
82345-856_097358e0-ead1-c991-e063-6294a90acb81	82345-856	HUMAN OTC DRUG	Atomic Balm		METHYL SALICYLATE, CAPSAICIN	OINTMENT	TOPICAL	20220401		OTC MONOGRAPH DRUG	M017	The Hygenic Company, LLC	CAPSAICIN; METHYL SALICYLATE	.25; 125	mg/g; mg/g			N	20241231
82345-858_097353b6-422b-cea1-e063-6294a90aea19	82345-858	HUMAN OTC DRUG	Iso-Quin hand sanitizer		ALCOHOL	LIQUID	TOPICAL	20220401		OTC MONOGRAPH DRUG	505G(a)(3)	The Hygenic Company, LLC.	ALCOHOL	65	mL/100mL			N	20241231
82345-860_0973a822-e675-feb3-e063-6294a90ab132	82345-860	HUMAN OTC DRUG	Skin-lube		PETROLATUM, DIMETHICONE	OINTMENT	TOPICAL	20220401		OTC MONOGRAPH DRUG	M016	The Hygenic Company, LLC.	DIMETHICONE; PETROLATUM	15; 850	mg/g; mg/g	Skin Barrier Activity [PE]		N	20241231
82347-0005_0b272993-c511-9f29-e063-6394a90aad20	82347-0005	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	13	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0010_0b272993-c511-9f29-e063-6394a90aad20	82347-0010	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	25	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0015_0b272993-c511-9f29-e063-6394a90aad20	82347-0015	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	50	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0020_0b272993-c511-9f29-e063-6394a90aad20	82347-0020	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0025_0b272993-c511-9f29-e063-6394a90aad20	82347-0025	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	88	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0030_0b272993-c511-9f29-e063-6394a90aad20	82347-0030	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	100	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0035_0b272993-c511-9f29-e063-6394a90aad20	82347-0035	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	112	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0040_0b272993-c511-9f29-e063-6394a90aad20	82347-0040	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	125	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0045_0b272993-c511-9f29-e063-6394a90aad20	82347-0045	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	137	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0050_0b272993-c511-9f29-e063-6394a90aad20	82347-0050	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	150	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0055_0b272993-c511-9f29-e063-6394a90aad20	82347-0055	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	175	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0060_0b272993-c511-9f29-e063-6394a90aad20	82347-0060	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		levothyroxine sodium	CAPSULE	ORAL	20230301		NDA AUTHORIZED GENERIC	NDA021924	YARAL Pharma Inc.	LEVOTHYROXINE SODIUM	200	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82347-0405_0b7076b4-79ec-e5fa-e063-6394a90ad12d	82347-0405	HUMAN PRESCRIPTION DRUG	Diclofenac Epolamine		Diclofenac Epolamine	SYSTEM	TOPICAL	20221118		NDA AUTHORIZED GENERIC	NDA021234	YARAL Pharma Inc.	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82347-0505_fc483fca-a407-5866-e053-6294a90afabd	82347-0505	HUMAN PRESCRIPTION DRUG	Lidocaine 5%		Lidocaine 5%	PATCH	TOPICAL	20230615		ANDA	ANDA209190	YARAL Pharma Inc.	LIDOCAINE	700	mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82349-120_f1e51714-95cf-562e-e053-2995a90ac56e	82349-120	HUMAN OTC DRUG	Canagyn		Homeopathic Antifungal	SUPPOSITORY	VAGINAL	20220201		UNAPPROVED HOMEOPATHIC		Palcare Enterprises Inc	BORIC ACID	.3	mg/1			N	20241231
82350-001_8358ca15-7e80-4166-a0ea-2c802ff172a8	82350-001	HUMAN OTC DRUG	Skinuva Bruise		Arnica Montana, Bromelain, Grape Seed Extract, Vitamin C, Rutin, Zinc Oxide, Cellulose	CAPSULE	ORAL	20230410		UNAPPROVED HOMEOPATHIC		MD Medical Designs, Inc.	ARNICA MONTANA	30	[hp_X]/1			N	20241231
82355-550_eea08dac-4409-88ea-e053-2995a90ae4e8	82355-550	HUMAN OTC DRUG	Benzalkonium Chloride		Sanitizing Hand Wipes	CLOTH	TOPICAL	20211221		OTC MONOGRAPH NOT FINAL	part333A	ALO NEW YORK LLC	BENZALKONIUM CHLORIDE	.0013	mg/100mg			N	20241231
82355-551_eea0d965-93d1-bb5e-e053-2995a90a3cfc	82355-551	HUMAN OTC DRUG	Benzalkonium Chloride		Sanitizing Hand Wipes	CLOTH	TOPICAL	20211221		OTC MONOGRAPH NOT FINAL	part333A	ALO NEW YORK LLC	BENZALKONIUM CHLORIDE	.0013	mg/100mg			N	20241231
82355-552_0e1f57d6-525c-b484-e063-6294a90a8e06	82355-552	HUMAN OTC DRUG	Benzalkonium Chloride		Sanitizing Hand Wipes	CLOTH	TOPICAL	20240104		OTC MONOGRAPH DRUG	M004	ALO NEW YORK LLC	BENZALKONIUM CHLORIDE	.0013	mg/100mg			N	20251231
82362-0650_ff47bdbb-6800-0d6a-e053-6294a90af1c9	82362-0650	HUMAN OTC DRUG	For the Win Tinted Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part352	Glo Skin Care MD	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
82362-2650_f45d597b-1b3b-43de-e053-2995a90a8883	82362-2650	HUMAN OTC DRUG	FOR THE WIN Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Glo Skin Care MD	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
82372-002_077be812-df9a-7d5d-e063-6294a90ac560	82372-002	HUMAN OTC DRUG	2% Minoxidil Hair regrowth serum		Hair loss prodcut	SPRAY	TOPICAL	20230301		ANDA	ANDA075357	good manager holdings inc.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82372-003_f5e65b42-4bf3-d52e-e053-2a95a90a2789	82372-003	HUMAN OTC DRUG	5% Minoxidil Hair growth foam		Hair loss product	AEROSOL, FOAM	TOPICAL	20230302		UNAPPROVED DRUG OTHER		good manager holdings inc.	MINOXIDIL	5	mg/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82372-005_077c9e4e-9a7b-a79c-e063-6294a90aa777	82372-005	HUMAN OTC DRUG	5% Minoxidil Hair growth Serum		Hair loss product	SPRAY	TOPICAL	20230302		ANDA	ANDA075357	good manager holdings inc	MINOXIDIL	5	mg/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82372-006_016e9d99-5418-b42f-e063-6394a90acc8d	82372-006	HUMAN OTC DRUG	Molluscum Contagiosum Treatment		Molluscum Contagiosum Treatment Pen	LIQUID	TOPICAL	20230726		UNAPPROVED DRUG OTHER		Good Manager Holdings Inc	SALICYLIC ACID	10	mg/100mL			N	20241231
82372-007_047e5246-d207-356a-e063-6394a90a5070	82372-007	HUMAN OTC DRUG	YOUCOPIA TATTOO NUMBING		Tattoo Numbing Cream	CREAM	TOPICAL	20230904		OTC MONOGRAPH FINAL	M016	Good Manager Holdings Inc	LIDOCAINE	5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82372-008_0820c319-0cc7-f575-e063-6294a90a70b2	82372-008	HUMAN OTC DRUG	LILIVERA 5% MINOXIDIL HAIR SERUM		5% MINOXIDIL HAIR SERUM	LIQUID	TOPICAL	20231020		ANDA	ANDA075357	Good Manager Holdings Inc	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82373-248_09e31e63-21a8-2c4d-e063-6294a90a3d86	82373-248	HUMAN OTC DRUG	TRENDY JOHN SPF-32 Sheer Mineral Sunscreen		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20211115		OTC MONOGRAPH DRUG	M020	TRENDY JOHN LLC	TITANIUM DIOXIDE; ZINC OXIDE	24; 58.2	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82377-201_f3891d5d-9163-961d-e053-2995a90a15b9	82377-201	HUMAN OTC DRUG	Disinfectant		HOCL	LIQUID	TOPICAL	20211104		UNAPPROVED DRUG OTHER		Jinhua Shuxin Pharmaceutical Biotechnology Co., Ltd.	HYPOCHLOROUS ACID	.01	g/100mL			N	20241231
82377-301_f38e249d-e695-d86e-e053-2995a90a4b6a	82377-301	HUMAN OTC DRUG	Disinfection-Tablets		HOCL	SOLUTION	TOPICAL	20211104		UNAPPROVED DRUG OTHER		Jinhua Shuxin Pharmaceutical Biotechnology Co., Ltd.	HYPOCHLOROUS ACID	.8	mg/mg			N	20241231
82380-103_0c498f35-7617-32fe-e063-6294a90a266c	82380-103	HUMAN OTC DRUG	Medimom Lava Pink Cleansing Wipes		Noni extract, Houttuynia Cordata Extract	LIQUID	TOPICAL	20220106		UNAPPROVED DRUG OTHER		Medimom Inc.	HOUTTUYNIA CORDATA FLOWERING TOP; MORINDA CITRIFOLIA LEAF	.1; .1	g/100g; g/100g			N	20241231
82380-202_0c49be2b-2d39-e698-e063-6394a90ac994	82380-202	HUMAN OTC DRUG	Medimom AntibacterialSpray		Noni extract, Houttuynia Cordata Extract	SPRAY	ORAL; TOPICAL	20220923		UNAPPROVED DRUG OTHER		Medimom Inc.	HOUTTUYNIA CORDATA FLOWERING TOP; MORINDA CITRIFOLIA LEAF	.1; .1	g/100mL; g/100mL			N	20241231
82381-2174_1f24ba51-dc76-411c-8aac-e419d3299192	82381-2174	HUMAN PRESCRIPTION DRUG	BRENZAVVY		Bexagliflozin	TABLET	ORAL	20230713		NDA	NDA214373	TheracosBio, LLC	BEXAGLIFLOZIN	20	mg/1	Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]		N	20241231
82385-102_06f55b56-be3a-5845-e063-6294a90a8371	82385-102	HUMAN OTC DRUG	AN12 ANUS PREMIUM CLEANSER		Glycerin, Allantoin	GEL	TOPICAL	20211119		UNAPPROVED DRUG OTHER		BESTVALUE Co., Ltd	ALLANTOIN; GLYCERIN	.1; 3	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82385-103_06f55ad6-2f5b-2edf-e063-6394a90a6b9b	82385-103	HUMAN OTC DRUG	AN12 Secret Therapy Feminine Cleanser		Glycerin	LIQUID	TOPICAL	20211201		UNAPPROVED DRUG OTHER		BESTVALUE Co., Ltd	GLYCERIN	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82385-104_06f51f5b-84f0-462a-e063-6294a90ab36d	82385-104	HUMAN OTC DRUG	AN12 Skin Therapy Vita-B Aloe Soothing Gel		Glycerin	GEL	TOPICAL	20211206		UNAPPROVED DRUG OTHER		BESTVALUE Co., Ltd	GLYCERIN	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82392-100_896116dd-ec4f-4a75-84cb-b4e41405ac9a	82392-100	HUMAN OTC DRUG	RID Lice Killing		Piperonyl butoxide and Pyrethrum extract	SHAMPOO	TOPICAL	20210105		OTC MONOGRAPH DRUG	M031	Oystershell Consumer Health Inc	PIPERONYL BUTOXIDE; PYRETHRUM EXTRACT	40; .033	mg/mL; mg/mL			N	20241231
82392-101_2dc25751-15e3-4c94-a335-ab341dbf7f1b	82392-101	HUMAN OTC DRUG	RID Lice Treatment Complete Kit		Piperonyl Butoxide, Pyrethrum Extract	KIT		20210105		OTC MONOGRAPH DRUG	M031	Oystershell Consumer Health Inc						N	20241231
82401-001_0d822af5-f39f-e5dc-e063-6394a90ad068	82401-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20030501		UNAPPROVED MEDICAL GAS		Cornerstone Medical Services - Midwest, LLC	OXYGEN	99	L/100L			N	20241231
82404-101_0bcbd210-a4cd-206a-e063-6394a90a6e6f	82404-101	HUMAN OTC DRUG	LUXURY SUN RITUAL	PORE SMOOTHING SPF 30 SUNSCREEN	ZINC OXIDE	LOTION	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	JANE STREET LLC	ZINC OXIDE	10	g/100mL			N	20241231
82406-0001_bc8eff08-27bc-4f20-94f8-8bd8c214b8bc	82406-0001	HUMAN OTC DRUG	Rhus Tox 6x/12x		Rhus Toxicodendron	LIQUID	ORAL	20220217		UNAPPROVED HOMEOPATHIC		MedCara Pharmaceuticals, LLC	TOXICODENDRON PUBESCENS LEAF	12	[hp_X]/mL			N	20241231
82415-0650_fea64a0d-c07d-ff30-e053-6294a90a28d9	82415-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	Suzanne's Skin2soul LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
82417-1062_f65485e5-ee13-1d2d-e053-2a95a90aac18	82417-1062	HUMAN OTC DRUG	Daybird Tinted Skincare (SHADE 1)		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Resette, Inc	ZINC OXIDE	132	mg/mL			N	20241231
82417-1063_f6548278-9550-2b5c-e053-2a95a90a72cc	82417-1063	HUMAN OTC DRUG	Daybird Tinted Skincare (SHADE 2)		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Resette, Inc	ZINC OXIDE	132	mg/mL			N	20241231
82417-1064_f6546da4-001a-ce8a-e053-2a95a90a6b55	82417-1064	HUMAN OTC DRUG	Daybird Tinted Skincare (SHADE 3)		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Resette, Inc	ZINC OXIDE	132	mg/mL			N	20241231
82417-1065_f6547b14-287d-27d5-e053-2995a90aaa29	82417-1065	HUMAN OTC DRUG	Daybird Tinted Skincare (SHADE 4)		Zinc Oxide	LOTION	TOPICAL	20220412		OTC MONOGRAPH NOT FINAL	part352	Resette, Inc	ZINC OXIDE	132	mg/mL			N	20241231
82418-2650_04b64a64-8fc7-720a-e063-6294a90ab0ae	82418-2650	HUMAN OTC DRUG	Love your Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	LOVE Medical Spa - NW 23rd	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
82426-150_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-150	HUMAN OTC DRUG	HAPEE EXPLOSIVE MENTHOL RED 150		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH FINAL	part355	LAMOIYAN CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.15	g/100g			N	20241231
82426-151_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-151	HUMAN OTC DRUG	HAPEE FRESH AND COOL WHITE 150		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH FINAL	part355	LAMOIYAN CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.15	g/100g			N	20241231
82426-152_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-152	HUMAN OTC DRUG	HAPEE FRESH AND COOL WHITE 100		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH FINAL	part355	LAMOIYAN CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.15	g/100g			N	20241231
82426-153_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-153	HUMAN OTC DRUG	HAPEE GUMTECT GUM CARE		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH FINAL	part355	LAMOIYAN CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.15	g/100g			N	20241231
82426-154_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-154	HUMAN OTC DRUG	HAPEE GUMTECT SENSITIVE 100		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH NOT FINAL	part356	LAMOIYAN CORPORATION	POTASSIUM NITRATE; SODIUM FLUORIDE	5; .331	g/100g; g/100g			N	20241231
82426-155_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-155	HUMAN OTC DRUG	HAPEE FRESH GREEN OUTBURST 100		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH FINAL	part355	LAMOIYAN CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.15	g/100g			N	20241231
82426-156_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-156	HUMAN OTC DRUG	HAPEE FRESH GREEN OUTBURST 150		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH FINAL	part355	LAMOIYAN CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.15	g/100g			N	20241231
82426-157_00ed80df-b761-4bb2-80b2-f11af7d9dfd3	82426-157	HUMAN OTC DRUG	HAPEE OUTRAGEOUS BLUE CHILL 150		SODIUM MONOFLUOROPHOSPHATE	GEL, DENTIFRICE	DENTAL	20220520		OTC MONOGRAPH FINAL	part355	LAMOIYAN CORPORATION	SODIUM MONOFLUOROPHOSPHATE	.15	g/100g			N	20241231
82428-010_7df4be28-7bf0-4527-a66a-2a27d0104e57	82428-010	HUMAN OTC DRUG	Dermall Matrix Quick Vitalizing		Adenosine	PATCH	TOPICAL	20211201		UNAPPROVED DRUG OTHER		Dermall Matrix Co., Ltd.	ADENOSINE	.04	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82428-030_26c1f4fc-6618-4e22-9158-8c624e342596	82428-030	HUMAN OTC DRUG	Dermall Matrix Facial Dermal care Mask		Adenosine	PATCH	TOPICAL	20221001		UNAPPROVED DRUG OTHER		DERMALL MATRIX CO., LTD.	ADENOSINE	.014	g/35g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82429-012_ea57283f-ac8b-3aef-e053-2a95a90a47ca	82429-012	HUMAN PRESCRIPTION DRUG	Adapalene and Benzoyl Peroxide 0.1%/2.5% Gel Pad		Adapalene and Benzoyl Peroxide	GEL	TOPICAL	20221010		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
82429-107_0839eb1f-14f7-5ffb-e063-6394a90a2991	82429-107	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10% and Sulfur 5% Cleanser		sulfacetamide sodium and sulfur	RINSE	TOPICAL	20221010		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM; SULFUR	10; 5	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-108_083989f7-cffb-9ac2-e063-6394a90a2708	82429-108	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 10% and Sulfur 2% Cleanser		Sodium Sulfacetamide, Sulfur	LIQUID	TOPICAL	20231030		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM; SULFUR	10; 2	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-109_0836a1d0-c352-6c32-e063-6294a90add2f	82429-109	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser		Sodium Sulfacetamide, Sulfur	RINSE	TOPICAL	20221010		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM; SULFUR	98; 48	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-118_f5c63850-5e8e-8488-e053-2a95a90a83ef	82429-118	HUMAN PRESCRIPTION DRUG	SKYNPLEX		HYDROCORTISONE ACETATE, IODOQUINOL	CREAM	TOPICAL	20230224		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	HYDROCORTISONE ACETATE; IODOQUINOL	19; 10	mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82429-119_f620dd08-f5a7-6cca-e053-2a95a90a61fb	82429-119	HUMAN PRESCRIPTION DRUG	IODOQUINOL HYDROCORTISONE ACETATE ALOE POLYSACCHARIDES		IODOQUINOL, HYDROCORTISONE ACETATE, and ALOE VERA LEAF	GEL	TOPICAL	20230224		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	ALOE VERA LEAF; HYDROCORTISONE ACETATE; IODOQUINOL	10; 20; 10	mg/g; mg/g; mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82429-126_08368bc6-272c-a9f2-e063-6394a90a3ab9	82429-126	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 8% and Sulfur 4% Cleanser		SULFACETAMIDE SODIUM, SULFUR	LIQUID	TOPICAL	20230405		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM; SULFUR	80; 40	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-127_0836adc6-8d09-1d7e-e063-6394a90a6448	82429-127	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide Wash 10%		SODIUM SULFACETAMIDE	LIQUID	TOPICAL	20230405		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-127_0836cbcd-349b-c16b-e063-6294a90a3bd6	82429-127	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide Wash 10%		SODIUM SULFACETAMIDE	LIQUID	TOPICAL	20231020		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM	100	mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-128_083965a5-b0ab-f648-e063-6294a90a8a30	82429-128	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9% and Sulfur 4% Cleanser		Sodium Sulfacetamide, Sulfur	LIQUID	TOPICAL	20231030		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM; SULFUR	90; 4	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-200_ee253d94-4b61-6e9f-e053-2995a90a4726	82429-200	HUMAN OTC DRUG	5% Minoxidil Topical Solution		Minoxidil	SOLUTION	TOPICAL	20221010		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82429-202_083b2ced-4454-fe40-e063-6394a90a911b	82429-202	HUMAN OTC DRUG	Povidone-Iodine 10% Solution		Povidone Iodine 10% Liquid	LIQUID	TOPICAL	20221010		OTC MONOGRAPH DRUG	M003	Gabar Health Sciences Corp.	POVIDONE-IODINE	10	mg/mL			N	20241231
82429-203_083b24e0-f62e-3472-e063-6394a90af9c2	82429-203	HUMAN OTC DRUG	NUMB		Lidocaine 5%	CREAM	TOPICAL	20221010		OTC MONOGRAPH DRUG	M015	Gabar Health Sciences Corp.	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82429-261_0846946b-a04e-826c-e063-6294a90a0a0f	82429-261	HUMAN OTC DRUG	Gainextra Hair Regrowth Treatment for Men 5%		Minoxidil 5%	SPRAY	TOPICAL	20231023		ANDA	ANDA076239	Gabar Health Sciences Corp.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82429-301_08367dde-b657-c569-e063-6294a90a7b97	82429-301	HUMAN PRESCRIPTION DRUG	Sodium Sulfacetamide 9% and Sulfur 4.5% Wash		Sulfacetamide Sodium and Sulfur	RINSE	TOPICAL	20221010		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	SULFACETAMIDE SODIUM; SULFUR	10; 5	mg/g; mg/g	Sulfonamide Antibacterial [EPC], Sulfonamides [CS]		N	20241231
82429-308_083abb11-fe7d-9051-e063-6394a90aaa9f	82429-308	HUMAN PRESCRIPTION DRUG	UREA 40%		UREA	CREAM	TOPICAL	20220801		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	UREA	40	g/100g			N	20241231
82429-309_083a759c-6bad-4b56-e063-6294a90a69c5	82429-309	HUMAN PRESCRIPTION DRUG	Hydroquinone 4%		Hydroquinone	CREAM	TOPICAL	20231023		UNAPPROVED DRUG OTHER		Gabar Health Sciences Corp.	HYDROQUINONE	40	mg/g	Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]		N	20241231
82429-310_0b6cfcd2-8764-9abb-e063-6394a90aa228	82429-310	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	CREAM	TOPICAL	20210902		ANDA	ANDA213076	Gabar Health Sciences Corp.	MUPIROCIN CALCIUM	2	g/100g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
82429-311_0b6cfcd2-8742-9abb-e063-6394a90aa228	82429-311	HUMAN PRESCRIPTION DRUG	Mupirocin		Mupirocin	CREAM	TOPICAL	20210902		ANDA	ANDA213076	Gabar Health Sciences Corp.	MUPIROCIN CALCIUM	2	g/100g	RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]		N	20241231
82429-312_0c3a7efa-e36d-7115-e063-6394a90a9d5f	82429-312	HUMAN PRESCRIPTION DRUG	Adapalene Gel USP, 0.3%		Adapalene Gel USP, 0.3% with swab applicator	GEL	TOPICAL	20230505		ANDA	ANDA200298	Gabar Health Sciences Corp.	ADAPALENE	3	mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
82429-313_0bee3ad3-98a2-a732-e063-6394a90a616c	82429-313	HUMAN PRESCRIPTION DRUG	Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%		Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%	GEL	TOPICAL	20230814		ANDA	ANDA206164	GABAR HEALTH SCIENCES CORP	ADAPALENE; BENZOYL PEROXIDE	1; 25	mg/g; mg/g	Retinoid [EPC], Retinoids [CS]		N	20241231
82429-314_0b36729f-6473-9eae-e063-6294a90a8d3c	82429-314	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical Gel, 1%,	GEL	TOPICAL	20200130		ANDA	ANDA210986	Gabar Health Sciences Corp	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82431-101_0b3ae643-cf2b-c609-e063-6394a90a88e8	82431-101	HUMAN OTC DRUG	Wonderbelly Maximum Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230102		OTC MONOGRAPH DRUG	M001	Ginger Health Company	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82431-102_0b392a16-a82f-0ca4-e063-6394a90ab730	82431-102	HUMAN OTC DRUG	Wonderbelly Maximum Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220601		OTC MONOGRAPH DRUG	M001	Ginger Health Company	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82431-103_0b3beab8-73f1-b7fd-e063-6394a90aafc7	82431-103	HUMAN OTC DRUG	Wonderbelly Maximum Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220601		OTC MONOGRAPH DRUG	M001	Ginger Health Company	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82431-104_0b3beab8-73e5-b7fd-e063-6394a90aafc7	82431-104	HUMAN OTC DRUG	Wonderbelly Maximum Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20220601		OTC MONOGRAPH DRUG	M001	Ginger Health Company	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82431-105_0b39b74a-a84d-2067-e063-6394a90a9495	82431-105	HUMAN OTC DRUG	Wonderbelly Maximum Strength Antacid		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230630		OTC MONOGRAPH DRUG	M001	Ginger Health Company	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82432-101_52b8bd13-33cb-4def-a172-8853a39fe4c4	82432-101	HUMAN PRESCRIPTION DRUG	nalmefene hydrochloride		nalmefene hydrochloride injection	SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20231115		ANDA	ANDA216007	Chengdu Shuode Pharmaceutical Co., Ltd	NALMEFENE HYDROCHLORIDE	.1	mg/mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
82432-102_52b8bd13-33cb-4def-a172-8853a39fe4c4	82432-102	HUMAN PRESCRIPTION DRUG	nalmefene hydrochloride		nalmefene hydrochloride injection	SOLUTION	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS	20231115		ANDA	ANDA216007	Chengdu Shuode Pharmaceutical Co., Ltd	NALMEFENE HYDROCHLORIDE	2	mg/2mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20251231
82442-001_eb4c2c4e-54ba-edb5-e053-2a95a90ac736	82442-001	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	PASTILLE	ORAL	20221018		OTC MONOGRAPH FINAL	part341	Target Corporation Inc.	MENTHOL	5.8	mg/1			N	20241231
82442-001_ebf6bcbb-c262-8194-e053-2995a90a8f31	82442-001	HUMAN OTC DRUG	Menthol Cough Drops		Menthol	PASTILLE	ORAL	20221018		OTC MONOGRAPH FINAL	part341	Target Corporation Inc.	MENTHOL	5.8	mg/1			N	20241231
82442-101_55023546-2509-4655-87ac-cbaf31e6a8fb	82442-101	HUMAN OTC DRUG	up and up ultra strength antacid 1000		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230407		OTC MONOGRAPH FINAL	part331	Target Corporation	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
82442-102_0dae2813-5867-4960-bc76-91f90877189b	82442-102	HUMAN OTC DRUG	up and up extra strength antacid 750		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20230407		OTC MONOGRAPH FINAL	part331	Target Corporation	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
82442-103_95f50a18-cb48-492b-a073-670891460f6b	82442-103	HUMAN OTC DRUG	up and up nicotine		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230629		ANDA	ANDA206393	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82442-123_f49b99b0-9022-4d56-866e-e26cb88c498b	82442-123	HUMAN OTC DRUG	up and up nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230728		ANDA	ANDA206393	Target Corporation	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82442-213_dc67bb11-e77f-4dc3-e053-2a95a90af4e4	82442-213	HUMAN OTC DRUG	Up and Up Pain		Camphor, Menthol, and Methyl Salicylate	PATCH	TOPICAL	20220111		OTC MONOGRAPH NOT FINAL	part348	Target Corporation	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	12; 57; 63	mg/1; mg/1; mg/1			N	20241231
82442-250_f604c684-8550-b7fe-e053-2a95a90a1a2c	82442-250	HUMAN OTC DRUG	Benzalkonium Chloride		Antibacterial Hand Wipes	CLOTH	TOPICAL	20230303		OTC MONOGRAPH NOT FINAL	part333A	Target Corporation	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
82442-800_483e0b57-8d14-48ca-9cc9-06f0cba9d81f	82442-800	HUMAN OTC DRUG	up and up nicotine		nicotine polacrilex	GUM, CHEWING	ORAL	20230615		ANDA	ANDA206394	Target Corporation	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82442-999_9bc2843b-ece4-44b2-b8f6-8d920a46bfe7	82442-999	HUMAN OTC DRUG	up and up allergy		mometasone furoate monohydrate	SPRAY	NASAL	20230316		NDA	NDA215712	Target Corporation	MOMETASONE FUROATE MONOHYDRATE	50	ug/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82447-101_23005932-8d17-47ed-92ba-fc1202cea414	82447-101	HUMAN OTC DRUG	Hand Wipes		benzalkonium chloride	SWAB	TOPICAL	20211213		OTC MONOGRAPH NOT FINAL	part333A	Meizhou Jubona Technology Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
82447-102_117fdefe-af83-4209-a13d-4090f13703bc	82447-102	HUMAN OTC DRUG	Alcohol Wipes		Alcohol	SWAB	TOPICAL	20211213		OTC MONOGRAPH NOT FINAL	part333A	Meizhou Jubona Technology Co., Ltd.	ALCOHOL	75	g/100g			N	20241231
82447-103_c9a45325-51f7-47c7-bafc-73e5a153994d	82447-103	HUMAN OTC DRUG	Hand Sanitizer		alcohol	LIQUID	TOPICAL	20211213		OTC MONOGRAPH NOT FINAL	part333E	Meizhou Jubona Technology Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
82448-050_b3bd60da-6ceb-415a-b001-b659a0913723	82448-050	HUMAN PRESCRIPTION DRUG	OGSIVEO		nirogacestat	TABLET, FILM COATED	ORAL	20231127		NDA	NDA217677	SpringWorks Therapeutics, Inc.	NIROGACESTAT	50	mg/1			N	20241231
82449-000_ff42fd9a-0c66-09d5-e053-6394a90a4f1a	82449-000	HUMAN PRESCRIPTION DRUG	Sodium Bicarbonate		SODIUM BICARBONATE	INJECTION, SOLUTION	INTRAVENOUS	20230731		ANDA	ANDA217594	Steriscience Specialties Private Limited	SODIUM BICARBONATE	84	mg/mL	Alkalinizing Activity [MoA]		N	20241231
82449-200_ffbc2301-05e0-5f75-e053-6394a90ab415	82449-200	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230930		ANDA	ANDA078244	Steriscience Specialties Private Limited	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
82449-201_ffbca7dc-f518-29a8-e053-6294a90af2b2	82449-201	HUMAN PRESCRIPTION DRUG	ondansetron hydrochloride		ondansetron hydrochloride	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230930		ANDA	ANDA078257	Steriscience Specialties Private Limited	ONDANSETRON HYDROCHLORIDE	2	mg/mL	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
82449-203_0c63b5cb-696a-9c6c-e063-6394a90a8fd9	82449-203	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230731		ANDA	ANDA090315	Steriscience Specialties Private Limited	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82449-204_0c63b5cb-696a-9c6c-e063-6394a90a8fd9	82449-204	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230731		ANDA	ANDA090315	Steriscience Specialties Private Limited	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82449-205_0c63b5cb-696a-9c6c-e063-6394a90a8fd9	82449-205	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230731		ANDA	ANDA090315	Steriscience Specialties Private Limited	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82449-206_0c63b5cb-696a-9c6c-e063-6394a90a8fd9	82449-206	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230731		ANDA	ANDA090315	Steriscience Specialties Private Limited	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82449-207_0c638f3c-bdd6-8385-e063-6394a90a53ef	82449-207	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230731		ANDA	ANDA090316	Steriscience Specialties Private Limited	MIDAZOLAM HYDROCHLORIDE	1	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82449-208_0c638f3c-bdd6-8385-e063-6394a90a53ef	82449-208	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230731		ANDA	ANDA090316	Steriscience Specialties Private Limited	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82449-209_0c638f3c-bdd6-8385-e063-6394a90a53ef	82449-209	HUMAN PRESCRIPTION DRUG	Midazolam		midazolam hydrochloride	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230731		ANDA	ANDA090316	Steriscience Specialties Private Limited	MIDAZOLAM HYDROCHLORIDE	5	mg/mL	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82449-215_ffbbb04d-cdf7-ff52-e053-6394a90ad3d4	82449-215	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230930		ANDA	ANDA078299	Steriscience Specialties Private Limited	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82449-216_ffbbb04d-cdf7-ff52-e053-6394a90ad3d4	82449-216	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230930		ANDA	ANDA078299	Steriscience Specialties Private Limited	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82449-217_ffbbb04d-cdf7-ff52-e053-6394a90ad3d4	82449-217	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION	INTRAMUSCULAR	20230930		ANDA	ANDA078299	Steriscience Specialties Private Limited	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82449-218_ffbbce4c-38d4-b02f-e053-6394a90aa562	82449-218	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230930		ANDA	ANDA201155	Steriscience Specialties Private Limited	KETOROLAC TROMETHAMINE	15	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82449-219_ffbbce4c-38d4-b02f-e053-6394a90aa562	82449-219	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION	INTRAMUSCULAR; INTRAVENOUS	20230930		ANDA	ANDA201155	Steriscience Specialties Private Limited	KETOROLAC TROMETHAMINE	30	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82449-220_ffbbce4c-38d4-b02f-e053-6394a90aa562	82449-220	HUMAN PRESCRIPTION DRUG	KETOROLAC TROMETHAMINE		KETOROLAC TROMETHAMINE	INJECTION	INTRAMUSCULAR	20230930		ANDA	ANDA201155	Steriscience Specialties Private Limited	KETOROLAC TROMETHAMINE	60	mg/2mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82449-223_fd5b79e0-ca88-d729-e053-6294a90a200b	82449-223	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20230609		ANDA	ANDA091487	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-224_fd5b79e0-ca88-d729-e053-6294a90a200b	82449-224	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20230609		ANDA	ANDA091487	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-225_fd5b79e0-ca88-d729-e053-6294a90a200b	82449-225	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL	20230609		ANDA	ANDA091487	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-226_fd5b79e0-ca88-d729-e053-6294a90a200b	82449-226	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL	20230609		ANDA	ANDA091487	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-227_fd5b79e0-ca88-d729-e053-6294a90a200b	82449-227	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20230609		ANDA	ANDA091487	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-228_fd5b79e0-ca88-d729-e053-6294a90a200b	82449-228	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		Bupivacaine Hydrochloride	INJECTION, SOLUTION	EPIDURAL; RETROBULBAR	20230609		ANDA	ANDA091487	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	7.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-229_fd5b557d-781c-4c95-e053-6394a90a8c6e	82449-229	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		bupivacaine hydrochloride	INJECTION, SOLUTION	INFILTRATION	20230609		ANDA	ANDA091503	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	2.5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-230_fd5b557d-781c-4c95-e053-6394a90a8c6e	82449-230	HUMAN PRESCRIPTION DRUG	Bupivacaine Hydrochloride		bupivacaine hydrochloride	INJECTION, SOLUTION	INFILTRATION	20230609		ANDA	ANDA091503	Steriscience Specialties Private Limited	BUPIVACAINE HYDROCHLORIDE	5	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]		N	20241231
82449-500_ffbc18e0-b4f9-ea17-e053-6294a90ab00a	82449-500	HUMAN PRESCRIPTION DRUG	piperacillin and tazobactam		piperacillin and tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160630		ANDA	ANDA065458	Steriscience Specialties Private Limited	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	2; .25	g/10mL; g/10mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82449-501_ffbc18e0-b4f9-ea17-e053-6294a90ab00a	82449-501	HUMAN PRESCRIPTION DRUG	piperacillin and tazobactam		piperacillin and tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20150814		ANDA	ANDA065458	Steriscience Specialties Private Limited	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	3; .375	g/15mL; g/15mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82449-502_ffbc18e0-b4f9-ea17-e053-6294a90ab00a	82449-502	HUMAN PRESCRIPTION DRUG	piperacillin and tazobactam		piperacillin and tazobactam	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20160630		ANDA	ANDA065458	Steriscience Specialties Private Limited	PIPERACILLIN SODIUM; TAZOBACTAM SODIUM	4; .5	g/20mL; g/20mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82449-503_07e8b20a-f473-78ed-e063-6394a90a3340	82449-503	HUMAN PRESCRIPTION DRUG	NAFCILLIN SODIUM		NAFCILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231017		ANDA	ANDA200002	Steriscience Specialties Private Limited	NAFCILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82449-504_07e8b20a-f473-78ed-e063-6394a90a3340	82449-504	HUMAN PRESCRIPTION DRUG	NAFCILLIN SODIUM		NAFCILLIN SODIUM	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20231017		ANDA	ANDA200002	Steriscience Specialties Private Limited	NAFCILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82449-511_fb85df45-6918-776e-e053-6294a90a2aaf	82449-511	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230512		ANDA	ANDA201025	Steriscience Specialties Private Limited	AMPICILLIN SODIUM	1	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82449-512_fb85df45-6918-776e-e053-6294a90a2aaf	82449-512	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAVENOUS	20230512		ANDA	ANDA201025	Steriscience Specialties Private Limited	AMPICILLIN SODIUM	2	g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82449-513_f9364723-42be-c3f6-e053-6394a90a2c8b	82449-513	HUMAN PRESCRIPTION DRUG	ampicillin sodium and sulbactam sodium		ampicillin sodium and sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230414		ANDA	ANDA201024	Steriscience Specialties Private Limited	AMPICILLIN SODIUM; SULBACTAM SODIUM	1; .5	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82449-514_f9364723-42be-c3f6-e053-6394a90a2c8b	82449-514	HUMAN PRESCRIPTION DRUG	ampicillin sodium and sulbactam sodium		ampicillin sodium and sulbactam sodium	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230414		ANDA	ANDA201024	Steriscience Specialties Private Limited	AMPICILLIN SODIUM; SULBACTAM SODIUM	2; 1	g/1; g/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82449-902_fb85df45-6918-776e-e053-6294a90a2aaf	82449-902	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230512		ANDA	ANDA201025	Steriscience Specialties Private Limited	AMPICILLIN SODIUM	250	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82449-903_fb85df45-6918-776e-e053-6294a90a2aaf	82449-903	HUMAN PRESCRIPTION DRUG	Ampicillin		Ampicillin	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230512		ANDA	ANDA201025	Steriscience Specialties Private Limited	AMPICILLIN SODIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82454-0015_d44ece12-6365-fef4-e053-2a95a90a0dec	82454-0015	STANDARDIZED ALLERGENIC	Oralair	300 IR	ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	TABLET, ORALLY DISINTEGRATING	SUBLINGUAL	20140430		BLA	BLA125471	CENEXI HSC	ANTHOXANTHUM ODORATUM POLLEN; DACTYLIS GLOMERATA POLLEN; LOLIUM PERENNE POLLEN; PHLEUM PRATENSE POLLEN; POA PRATENSIS POLLEN	300; 300; 300; 300; 300	[IR]/1; [IR]/1; [IR]/1; [IR]/1; [IR]/1	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC], Standardized Pollen Allergenic Extract [EPC]		N	20241231
82454-0020_d44ece12-6365-fef4-e053-2a95a90a0dec	82454-0020	STANDARDIZED ALLERGENIC	Oralair		ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHELUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	KIT		20140430		BLA	BLA125471	CENEXI HSC						N	20241231
82454-0025_d44ece12-6365-fef4-e053-2a95a90a0dec	82454-0025	STANDARDIZED ALLERGENIC	Oralair		ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHELUM PRATENSE POLLEN, and POA PRATENSIS POLLEN	KIT		20140430		BLA	BLA125471	CENEXI HSC						N	20241231
82457-003_07dcd278-e933-afed-e063-6294a90a148b	82457-003	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20211217		NDA	NDA205850	Toll Company	NITROGEN	999	mL/L			N	20241231
82457-004_07dcb683-a5eb-b016-e063-6394a90a746d	82457-004	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20211217		NDA	NDA205849	Toll Company	OXYGEN	995	mL/L			N	20241231
82459-249_09e3156c-9361-43f6-e063-6394a90ad71e	82459-249	HUMAN OTC DRUG	LUCKY 13s ALL NATURAL TATTOO SUNSCREEN SPF-30		ZINC OXIDE	CREAM	TOPICAL	20211213		OTC MONOGRAPH DRUG	M020	SALES BRAIN HOLDINGS LLC	ZINC OXIDE	140	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82460-262_09e2e2ce-d887-0711-e063-6294a90a9213	82460-262	HUMAN OTC DRUG	SIMPLY VITAL HEMORRHOID and ANORECTAL RELIEF		LIDOCAINE	CREAM	TOPICAL	20220109		OTC MONOGRAPH DRUG	M015	ALPHA PLANTS INC	LIDOCAINE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82460-272_09e31e63-21b9-2c4d-e063-6294a90a3d86	82460-272	HUMAN OTC DRUG	SIMPLY VITAL Acne Face Cream		SALICYLIC ACID	CREAM	TOPICAL	20220201		OTC MONOGRAPH DRUG	M006	ALPHA PLANTS INC	SALICYLIC ACID	20	mg/mL			N	20241231
82460-343_e43915d7-f9e9-52d5-e053-2a95a90a08ae	82460-343	HUMAN OTC DRUG	SIMPLY VITAL Skin Tag Remover		THUJA OCCIDENTALIS LEAFY TWIG	SOLUTION	TOPICAL	20220901		UNAPPROVED HOMEOPATHIC		ALPHA PLANTS INC	THUJA OCCIDENTALIS LEAFY TWIG	6	[hp_X]/mL			N	20241231
82460-344_09e32c60-2b51-0226-e063-6294a90a6a2f	82460-344	HUMAN OTC DRUG	SIMPLY VITAL Antifungal Cream		CLOTRIMAZOLE	CREAM	TOPICAL	20220725		OTC MONOGRAPH DRUG	M005	ALPHA PLANTS INC	CLOTRIMAZOLE	10	mg/mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
82460-345_09e31e63-21c8-2c4d-e063-6294a90a3d86	82460-345	HUMAN OTC DRUG	SIMPLY VITAL PAIN RELIEF HEMP		MENTHOL	CREAM	TOPICAL	20220801		OTC MONOGRAPH DRUG	M017	ALPHA PLANTS INC	MENTHOL	80	mg/mL			N	20241231
82463-018_d7c5edc3-5eff-a4c9-e053-2a95a90a4f8e	82463-018	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220211		OTC MONOGRAPH NOT FINAL	part333A	Goose Creek Candles, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-019_d9a4482b-d0b4-e55e-e053-2995a90a7d3b	82463-019	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-024_d9a40ac3-46ab-c328-e053-2a95a90a41ad	82463-024	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-027_d9a3ed17-48e3-725d-e053-2995a90a8ac7	82463-027	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-028_d9a3bdac-ac29-69be-e053-2995a90a375c	82463-028	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-029_d9a39aa1-d568-64a2-e053-2995a90a481b	82463-029	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-034_d9a2e0b9-5ce1-76ac-e053-2995a90a151d	82463-034	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-036_d9a3893b-60f6-8ead-e053-2995a90a4cba	82463-036	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-037_d9a371f1-10ce-3f22-e053-2995a90a5f1e	82463-037	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-038_d9a322d5-8f41-c87c-e053-2995a90af8dd	82463-038	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220307		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.4	mL/100mL			N	20241231
82463-069_e6102086-0462-55b2-e053-2a95a90abee3	82463-069	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220812		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-071_e6108358-305e-59cd-e053-2995a90a92d8	82463-071	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220812		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-072_e610b370-9c28-4e67-e053-2995a90a87fd	82463-072	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220812		OTC MONOGRAPH NOT FINAL	part333A	Oxygen Development LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-073_e65e107f-d298-305d-e053-2a95a90a81be	82463-073	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-074_e65e1dbc-9ec2-5a54-e053-2a95a90a3392	82463-074	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-075_e65eb4cd-cbc2-6083-e053-2995a90a618b	82463-075	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-076_e6601782-7a4f-2cfa-e053-2a95a90a1e0d	82463-076	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-077_e660b9cd-390f-a538-e053-2a95a90a8a78	82463-077	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-078_e660ac15-f0cf-077c-e053-2995a90aa867	82463-078	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82463-079_e66119c9-aab4-f25b-e053-2a95a90a2c4f	82463-079	HUMAN OTC DRUG	Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20220816		OTC MONOGRAPH NOT FINAL	part333A	GOOSE CREEK CANDLES, LLC	ALCOHOL	73.409	mL/100mL			N	20241231
82465-101_db000f96-dc47-4d4d-e053-2995a90a0c21	82465-101	HUMAN OTC DRUG	ESSENTIAL DAILY SUNSCREEN		Zinc Oxide	LOTION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	ANTEDOTUM INC.	ZINC OXIDE	10	g/100mL			N	20241231
82488-693_d5782235-e2c1-7b26-e053-2a95a90ab5de	82488-693	HUMAN OTC DRUG	SaniTex 60		SaniTex 60	LIQUID	TOPICAL	20200408		OTC MONOGRAPH NOT FINAL	part333A	Solutex, Inc.	ALCOHOL	67	mL/100mL			N	20241231
82492-010_16526848-8834-40f4-bc50-339caf936202	82492-010	HUMAN OTC DRUG	BonGin Revitalizing GIN Water		Niacinamide, Adenosine	LIQUID	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Cosmo Nature	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82492-020_f1f1f53e-8ff4-40c8-82f4-9a65d824e302	82492-020	HUMAN OTC DRUG	BonGin Rebalancing GIN		Niacinamide, Adenosine	EMULSION	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Cosmo Nature	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82492-030_07b80ad7-11d5-44c4-a6fb-71b7dda97ccd	82492-030	HUMAN OTC DRUG	BonGin Rebalancing GIN		Niacinamide, Adenosine	CREAM	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Cosmo Nature	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82492-040_586575c8-ea6f-459a-9d62-4d14c1462bf9	82492-040	HUMAN OTC DRUG	BonGin BonCell Rejuvenating Mask Pack		Niacinamide, Adenosine	PATCH	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Cosmo Nature	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82492-050_484a819c-b92c-4715-b374-7053e96fbf8d	82492-050	HUMAN OTC DRUG	BonGin BonCell ECM Boost 195 HA		Niacinamide, Adenosine	LIQUID	TOPICAL	20220201		UNAPPROVED DRUG OTHER		Cosmo Nature	ADENOSINE; NIACINAMIDE	1.2; 3	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82494-000_08c1251e-eec7-3c55-e063-6294a90a1c9e	82494-000	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 00 AMANDE		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-001_08c1251e-eeb6-3c55-e063-6294a90a1c9e	82494-001	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 10 COQUILLAGE		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-002_08c11d0d-601e-5641-e063-6394a90a1134	82494-002	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 20 SABLE		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-003_08c13e47-678b-4607-e063-6294a90a20a5	82494-003	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 30 FICELLE		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-004_08c12b68-e05c-3c2e-e063-6294a90a9998	82494-004	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 40 CHANVRE		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-005_08c12b68-e07c-3c2e-e063-6294a90a9998	82494-005	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 50 PALOMINO		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-006_08c1157e-e2e2-2809-e063-6394a90acf48	82494-006	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 60 SIENNE		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-007_08c1409b-a613-8a2d-e063-6394a90ac619	82494-007	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 70 SANTAL		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	124	mg/mL			N	20241231
82494-008_08c11d0d-602f-5641-e063-6394a90a1134	82494-008	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 80 BARENIA		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	73	mg/mL			N	20241231
82494-009_08c115b6-8e97-149b-e063-6294a90a51fb	82494-009	HUMAN OTC DRUG	Hermes Plein Air Natural Enhancing Complexion Balm SPF 30 Sunscreen 90 ALEZAN		TITANIUM DIOXIDE	CREAM	TOPICAL	20220115		OTC MONOGRAPH DRUG	M020	COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	73	mg/mL			N	20241231
82494-010_08c12b68-e04b-3c2e-e063-6294a90a9998	82494-010	HUMAN OTC DRUG	Hermes Plein Air-Baume de Teint Perfecteur Naturel-Enhancing Complexion Balm 85 TAMARIN		TITANIUM DIOXIDE	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M020	S.A. COMPTOIR NOUVEAU DE LA PARFUMERIE	TITANIUM DIOXIDE	73	mg/mL			N	20241231
82495-101_d4dc10ff-6ae6-45d3-e053-2995a90aae89	82495-101	HUMAN OTC DRUG	BRIGHTER DAY BROAD SPECTRUM	SPF 30 SUNSCREEN	ZINC OXIDE	LOTION	TOPICAL	20211220		OTC MONOGRAPH NOT FINAL	part352	SQN Lab	ZINC OXIDE	10	g/100mL			N	20241231
82498-149_e1c35778-377e-44e8-9681-9dee84b04723	82498-149	HUMAN OTC DRUG	Wax B Gone Ear Wax Removal Drops		Carbamide Peroxide - 6.5%	SOLUTION/ DROPS	TOPICAL	20220330		OTC MONOGRAPH DRUG	M014	SIGMAR, LLC	CARBAMIDE PEROXIDE	65	mg/mL			N	20251231
82499-267_09e3474c-5785-44f0-e063-6294a90a8568	82499-267	HUMAN OTC DRUG	HAIRCARE Physicians Recommended		SALICYLIC ACID	SHAMPOO	TOPICAL	20220115		OTC MONOGRAPH DRUG	M032	LAWRENCE E SAMUELS MD INC	SALICYLIC ACID	30	mg/mL			N	20241231
82501-0067_e8e2d079-e0e5-42b3-a45a-495407c0d5be	82501-0067	HUMAN OTC DRUG	goodnow triple antibiotic		bacitracin zinc, neomycin, polymyxin B	OINTMENT	TOPICAL	20230412		OTC MONOGRAPH FINAL	part333B	Gobrands, Inc	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
82501-0224_5aa00883-3105-4840-b8df-f51ba730398a	82501-0224	HUMAN OTC DRUG	goodnow diarrhea relief		Loperamide HCl	TABLET, FILM COATED	ORAL	20230412		ANDA	ANDA075232	Gobrands, Inc	LOPERAMIDE HYDROCHLORIDE	2	mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]		N	20241231
82501-0915_fa4938ea-ffb5-466e-8fce-4fdfdc97989e	82501-0915	HUMAN OTC DRUG	good now omeprazole		Omeprazole	TABLET, DELAYED RELEASE	ORAL	20230721		NDA	NDA022032	Gobrands, Inc	OMEPRAZOLE	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
82501-1574_0c046516-3ae9-25e6-e063-6394a90a2ea9	82501-1574	HUMAN OTC DRUG	Allergy Relief		Cetirizine Hydrochloride	TABLET, FILM COATED	ORAL	20220527		ANDA	ANDA077829	Gobrands, Inc	CETIRIZINE HYDROCHLORIDE	10	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82501-1575_0c045fe8-f6bd-1f65-e063-6394a90ad727	82501-1575	HUMAN OTC DRUG	Extra Strength Pain Relief		Acetaminophen	TABLET, COATED	ORAL	20220511		OTC MONOGRAPH DRUG	M013	Gobrands, Inc	ACETAMINOPHEN	500	mg/1			N	20241231
82501-1576_0c047e21-c3c8-1a6a-e063-6294a90a39c6	82501-1576	HUMAN OTC DRUG	Pain Relief		Naproxen Sodium	TABLET, FILM COATED	ORAL	20220530		ANDA	ANDA091353	Gobrands, Inc	NAPROXEN SODIUM	220	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82501-1577_0c047e21-c3db-1a6a-e063-6294a90a39c6	82501-1577	HUMAN OTC DRUG	Sinus Congestion Relief		Phenylephrine Hydrochloride	TABLET, COATED	ORAL	20220530		OTC MONOGRAPH DRUG	M012	Gobrands, Inc	PHENYLEPHRINE HYDROCHLORIDE	10	mg/1	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82501-1578_0c04ef09-109f-4c9f-e063-6394a90a3bbf	82501-1578	HUMAN OTC DRUG	Diphenhydramine Hydrochloride		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220516		OTC MONOGRAPH DRUG	M010	Gobrands, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82501-1579_0c052697-8b00-596c-e063-6394a90a94a9	82501-1579	HUMAN OTC DRUG	Cold and Flu Non Drowsy Day Relief and Night Relief		acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride	KIT		20220908		OTC MONOGRAPH DRUG	M012	Gobrands, Inc						N	20241231
82501-1580_0c05574c-f99c-5d92-e063-6394a90a9d00	82501-1580	HUMAN OTC DRUG	Loratadine		Loratadine	TABLET	ORAL	20220516		ANDA	ANDA214684	Gobrands, Inc	LORATADINE	10	mg/1			N	20241231
82501-1581_0c044daa-1302-19b6-e063-6394a90a65b6	82501-1581	HUMAN OTC DRUG	Allergy Relief		Diphenhydramine Hydrochloride	TABLET, FILM COATED	ORAL	20220525		OTC MONOGRAPH DRUG	M017	Gobrands, Inc	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82501-1582_0c055eef-1457-67a0-e063-6394a90aa2e7	82501-1582	HUMAN OTC DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20220705		ANDA	ANDA079129	Gobrands, Inc	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82501-1585_0829357f-0ea8-6ba2-e063-6394a90afb09	82501-1585	HUMAN OTC DRUG	Good Now Extra Strength Gas Relief		Simethicone 125mg	CAPSULE, LIQUID FILLED	ORAL	20231020		OTC MONOGRAPH DRUG	M002	Gobrands, Inc	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
82501-1586_0c055a0d-1034-e7d5-e063-6294a90a17e2	82501-1586	HUMAN OTC DRUG	Antacid Calcium Carbonate		Calcium Carbonate	TABLET, CHEWABLE	ORAL	20231107		OTC MONOGRAPH DRUG	M001	Gobrands, Inc	CALCIUM CARBONATE	1000	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82501-1587_0c0560be-fb10-509d-e063-6394a90ab6f7	82501-1587	HUMAN OTC DRUG	EXTRA STRENGTH PAIN RELIEVER PM		ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20231019		OTC MONOGRAPH DRUG	M013	Gobrands, Inc	ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE	500; 25	mg/1; mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82501-3141_33f81df6-a097-4429-a414-1c5f138fb412	82501-3141	HUMAN OTC DRUG	Sleep Aid	NightTime	Diphenhydramine HCL	LIQUID	ORAL	20220415		OTC MONOGRAPH FINAL	part338	Gobrands, Inc. (Goodnow)	DIPHENHYDRAMINE HYDROCHLORIDE	50	mg/30mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82501-3431_bab1aee9-8c18-4a7f-93c5-fadf9317b64c	82501-3431	HUMAN OTC DRUG	Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20220429		OTC MONOGRAPH FINAL	part341	Gobrands, Inc. (Goodnow)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
82501-4661_d167d706-2681-45f1-9089-4a55c9a1d359	82501-4661	HUMAN OTC DRUG	Cold and Flu Relief		Acetaminophen, Dextromethorphan Hydrobromide,Phenylephrine Hydrochloride	LIQUID	ORAL	20220429		OTC MONOGRAPH FINAL	part341	Gobrands, Inc. (Goodnow)	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/15mL; mg/15mL; mg/15mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82501-4672_10d1e5cb-b3f2-4967-a61d-b34764d82f09	82501-4672	HUMAN OTC DRUG	Daytime Nighttime Cold and Flu		Acetaminophen, Dextromethorphan Hydrobromide,Phenylephrine Hydrochloride DoxylamineSucinate	KIT		20220429		OTC MONOGRAPH FINAL	part341	Gobrands, Inc. (Goodnow)						N	20241231
82501-7240_01ad5d52-eb40-40a8-8c4e-8e36209911dd	82501-7240	HUMAN OTC DRUG	Stomach Relief	Regular Strength	Bismuth subsalicylate	LIQUID	ORAL	20220415		OTC MONOGRAPH FINAL	part335	Gobrands, Inc. (Goodnow)	BISMUTH SUBSALICYLATE	525	mg/30mL	Bismuth [CS], Bismuth [EPC]		N	20241231
82501-7340_4343f016-7501-4b76-90cd-2792f4cf8427	82501-7340	HUMAN OTC DRUG	Mucus Relief DM		Guaifenesin, Dextromethorphan HBr	TABLET	ORAL	20220422		ANDA	ANDA209692	Gobrands, Inc. (Goodnow)	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60; 1200	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
82509-001_6e693a24-c1c3-4d99-a423-7c11cec028fe	82509-001	HUMAN OTC DRUG	encer		Cadmium sulphuratum, Carbo animalis, Phosphoricum acidum, Radium bromatum, X-ray	TABLET, ORALLY DISINTEGRATING	ORAL	20230522		UNAPPROVED HOMEOPATHIC		B'OKCARES LTD	ALCOHOL, X-RAY EXPOSED (1000 RAD); CADMIUM SULFIDE; CARBO ANIMALIS; PHOSPHORIC ACID; RADIUM BROMIDE	6; 30; 30; 30; 30	[hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1			N	20241231
82510-000_0d0d5824-168d-a063-e063-6294a90aa025	82510-000	HUMAN OTC DRUG	Wander PACK UP and GLOW		TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20220401		OTC MONOGRAPH DRUG	M020	Wander Beauty Inc.	TITANIUM DIOXIDE; ZINC OXIDE	20; 10	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82511-001_08ed8ab8-92e0-ff1e-e063-6294a90add12	82511-001	HUMAN PRESCRIPTION DRUG	Capecitabine		capecitabine	TABLET, FILM COATED	ORAL	20220216		ANDA	ANDA217237	Teyro Labs Private Limited	CAPECITABINE	150	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
82511-002_08ed8ab8-92e0-ff1e-e063-6294a90add12	82511-002	HUMAN PRESCRIPTION DRUG	Capecitabine		capecitabine	TABLET, FILM COATED	ORAL	20220216		ANDA	ANDA217237	Teyro Labs Private Limited	CAPECITABINE	500	mg/1	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]		N	20241231
82511-003_03ba3378-341e-39f5-e063-6394a90a8860	82511-003	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20070118		ANDA	ANDA077861	Teyro Labs Private Limited	CARBOPLATIN	50	mg/5mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
82511-004_03ba3378-341e-39f5-e063-6394a90a8860	82511-004	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20070118		ANDA	ANDA077861	Teyro Labs Private Limited	CARBOPLATIN	150	mg/15mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
82511-005_03ba3378-341e-39f5-e063-6394a90a8860	82511-005	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20070118		ANDA	ANDA077861	Teyro Labs Private Limited	CARBOPLATIN	450	mg/45mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
82511-006_03ba3378-341e-39f5-e063-6394a90a8860	82511-006	HUMAN PRESCRIPTION DRUG	CARBOPLATIN		CARBOPLATIN	INJECTION, SOLUTION	INTRAVENOUS	20230824		ANDA	ANDA077861	Teyro Labs Private Limited	CARBOPLATIN	600	mg/60mL	Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]		N	20241231
82512-100_925b2267-8537-462c-b520-73cee87d308c	82512-100	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	SPRAY	TOPICAL	20220204		OTC MONOGRAPH DRUG	M003	Gold Bond, Inc.	ALCOHOL	62	mL/100mL			N	20241231
82516-101_e92146a2-3dc2-f4a5-e053-2995a90a6a19	82516-101	HUMAN OTC DRUG	sunscreen		Skin Barrier Sun Shield SPF 30	CREAM	TOPICAL	20220411		OTC MONOGRAPH FINAL	part352	True Botanicals, Inc.	ZINC OXIDE	19	g/100g			N	20241231
82516-202_e19520f4-2815-d2d9-e053-2995a90ae7f4	82516-202	HUMAN OTC DRUG	Sunscreen		Everyday Skin Tint SPF 30	LOTION	TOPICAL	20220616		OTC MONOGRAPH FINAL	part352	True Botanicals	ZINC OXIDE	18	g/100g			N	20241231
82517-001_62dcb5b2-9da8-4086-b078-6b6d6360f437	82517-001	HUMAN OTC DRUG	Hunter Beach 4%		Lidocaine	LOTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part348	HUNTERS BEACH LIFE	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82517-002_938c639e-087a-4c76-97af-fc659fbabbec	82517-002	HUMAN OTC DRUG	Hunter Beach 4%		Lidocaine	GEL	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part348	HUNTERS BEACH LIFE	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82518-103_d788a7fe-b0fb-bb22-e053-2a95a90a92a0	82518-103	HUMAN OTC DRUG	DEAR BRIGHTLY NEVERSKIP	SPF 30	ZINC OXIDE	LOTION	TOPICAL	20211220		OTC MONOGRAPH NOT FINAL	part352	DEARBRIGHTLY INC	ZINC OXIDE	10	g/100mL			N	20241231
82520-263_09e3474c-5795-44f0-e063-6294a90a8568	82520-263	HUMAN OTC DRUG	HAWAIIAN SOL Natural Sunscreen SPF-30		ZINC OXIDE	SOLUTION	TOPICAL	20220124		OTC MONOGRAPH DRUG	M020	Caribbean Sol International, LLC	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82520-264_09e31e63-21d9-2c4d-e063-6294a90a3d86	82520-264	HUMAN OTC DRUG	CARIBBEAN SOL Natural Sunscreen SPF-30		ZINC OXIDE	SOLUTION	TOPICAL	20220124		OTC MONOGRAPH DRUG	M020	Caribbean Sol International, LLC	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82526-268_09e30a62-359f-3cff-e063-6394a90a270f	82526-268	HUMAN OTC DRUG	YAYA Organics SPF-50 Baby Kids Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220202		OTC MONOGRAPH DRUG	M020	YAYA ORGANICS L.L.C.	ZINC OXIDE	175	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82526-269_09e3474c-57a5-44f0-e063-6294a90a8568	82526-269	HUMAN OTC DRUG	YAYA Organics SPF-50 Sports Cream		ZINC OXIDE	CREAM	TOPICAL	20220202		OTC MONOGRAPH DRUG	M020	YAYA ORGANICS L.L.C.	ZINC OXIDE	175	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82536-002_f82d36be-ad33-ae98-e053-6294a90a6334	82536-002	HUMAN OTC DRUG	Tiger Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20230330		OTC MONOGRAPH NOT FINAL	part333A	WHITEHALL PRODUCTS LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
82539-211_9065df22-c3c9-469a-91ec-5c31a5d990e0	82539-211	HUMAN OTC DRUG	Nozin Nasal Sanitizer (Antiseptic)		Alcohol	LIQUID	NASAL	20060101		OTC MONOGRAPH DRUG	part333A	Global Life Technologies Corp.	ALCOHOL	62	mL/100mL			N	20251231
82543-327_09e32c60-2b61-0226-e063-6294a90a6a2f	82543-327	HUMAN OTC DRUG	PRFC HEMP Topical Analgesic		MENTHOL	CREAM	TOPICAL	20220207		OTC MONOGRAPH DRUG	M017	DOBEST INC	MENTHOL	80	mg/mL			N	20241231
82548-4530_081d934f-bbd7-0cea-e063-6394a90aac69	82548-4530	HUMAN OTC DRUG	Tulip Dew Sunscreen		ZINC OXIDE	LOTION	TOPICAL	20220501		OTC MONOGRAPH DRUG	M020	Bloomeffects, Inc.	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82551-119_0a36c562-2c8b-8eef-e063-6394a90a5f92	82551-119	HUMAN OTC DRUG	COOLING		MENTHOL	GEL	TOPICAL	20231115		OTC MONOGRAPH DRUG	M017	FULL EIGHT LLC	MENTHOL	1.2	g/100mL			N	20241231
82552-354_09e35e72-c02c-4d9a-e063-6294a90acdd1	82552-354	HUMAN OTC DRUG	JOYSPRING Kids Mineral Sunscreen SPF-30		ZINC OXIDE	CREAM	TOPICAL	20220214		OTC MONOGRAPH DRUG	M020	JOYSPRING HOLDINGS LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82552-356_0976f84b-5b3d-23b9-e063-6294a90adc57	82552-356	HUMAN OTC DRUG	JOY SPRING Kids Mineral Sunscreen SPF-30		ZINC OXIDE	LOTION	TOPICAL	20220321		OTC MONOGRAPH DRUG	M020	JOYSPRING HOLDINGS LLC	ZINC OXIDE	200	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82556-2009_f2f77015-be34-8349-e053-2a95a90ab8d9	82556-2009	HUMAN OTC DRUG	C9 Cream		menthol cream	CREAM	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part348	OceanSide Health Products Ltd	MENTHOL, UNSPECIFIED FORM	55	mg/mL			N	20241231
82557-100_0b8a5a10-a02c-99c9-e063-6394a90a7076	82557-100	HUMAN OTC DRUG	DR JOE LAB PMS Menstrual Pain Relief Cream	DR JOE LAB	Menstrual Pain Relief Cream	CREAM	TOPICAL	20220401		OTC MONOGRAPH DRUG	M014	DR JOE LAB Inc.	MENTHOL, (+)-; METHYL SALICYLATE	1.4; 10	g/100g; g/100g			N	20241231
82557-300_0b8a1e5b-a313-8c0c-e063-6394a90a5efb	82557-300	HUMAN OTC DRUG	DR JOE LAB VITAMIN C SERUM		VITAMIN C SERUM	LIQUID	TOPICAL	20220601		OTC MONOGRAPH DRUG	M014	DR JOE LAB	GLYCERIN	20	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82557-401_0b8a1832-35ef-8988-e063-6394a90ad8d2	82557-401	HUMAN OTC DRUG	Dr Joe lab ARTHRITIS EXTRA STRENGTH		TROLAMINE SALICYLATE	GEL	TOPICAL	20220601		OTC MONOGRAPH DRUG	M014	DR JOE LAB	TROLAMINE SALICYLATE	10	g/100mL			N	20241231
82557-501_0b8a19cb-9afb-888b-e063-6394a90a60ec	82557-501	HUMAN OTC DRUG	Dr Joe lab ARTHRITIS EXTRA STRENGTH		Trolamine salicylate	CREAM	TOPICAL	20220601		OTC MONOGRAPH DRUG	M014	DR JOE LAB	TROLAMINE SALICYLATE	10	g/100g			N	20241231
82557-600_0b8a1cca-483a-abcd-e063-6294a90a9ded	82557-600	HUMAN OTC DRUG	DR JOE LAB CLARIFYING TONER		CLARIFYING TONER SALICYLIC ACID 1%	LIQUID	TOPICAL	20220701		OTC MONOGRAPH DRUG	M014	DR JOE LAB	SALICYLIC ACID	1	g/100mL			N	20241231
82560-273_09e3474c-57b6-44f0-e063-6294a90a8568	82560-273	HUMAN OTC DRUG	AMP RELIEF Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20220215		OTC MONOGRAPH DRUG	M017	COASTAL FORMULAS LLC	MENTHOL	80	mg/mL			N	20241231
82560-283_09e32c60-2b72-0226-e063-6294a90a6a2f	82560-283	HUMAN OTC DRUG	AMP RELIEF Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20220325		OTC MONOGRAPH DRUG	M017	COASTAL FORMULAS LLC	MENTHOL	80	mg/mL			N	20241231
82561-001_dd1c02b3-16ef-7474-e053-2995a90a7984	82561-001	HUMAN OTC DRUG	Simple Truth Organic Hand Sanitizer Lavender		Alcohol	SPRAY	TOPICAL	20220420		OTC MONOGRAPH NOT FINAL	part333E	Vital Innovations Inc.	ALCOHOL	62	mL/100mL			N	20241231
82564-000_0b592264-9c23-0b76-e063-6394a90a38da	82564-000	HUMAN OTC DRUG	CAO Cosmetic Lip Sunscreen SPF 30		AVOBENZONE, OCTOCRYLENE	OINTMENT	TOPICAL	20221001		OTC MONOGRAPH DRUG	M020	S & J INTERNATIONAL ENTERPRISES PUBLIC COMPANY LIMITED	AVOBENZONE; OCTOCRYLENE	28; 50	mg/g; mg/g			N	20241231
82575-032_0a275b15-29c7-521b-e063-6394a90aa742	82575-032	HUMAN OTC DRUG	Curology the sunscreen broad spectrum SPF 30		ZINC OXIDE	CREAM	TOPICAL	20220716		OTC MONOGRAPH DRUG	M020	Curology Inc.	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82575-034_0a275b15-29d7-521b-e063-6394a90aa742	82575-034	HUMAN OTC DRUG	Curology The Lip Balm Broad Spectrum SPF 30 Sunscreen		ZINC OXIDE	STICK	TOPICAL	20220716		OTC MONOGRAPH DRUG	M020	Curology Inc.	ZINC OXIDE	94	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82575-035_0a275f91-c955-6113-e063-6394a90a5acc	82575-035	HUMAN OTC DRUG	Curology Everyday Sunscreen Broad Spectrum SPF 30 No-clog UV defense		ZINC OXIDE	CREAM	TOPICAL	20221201		OTC MONOGRAPH DRUG	M020	Curology	ZINC OXIDE	94	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82575-100_bb5d1f07-5e72-47c9-8177-af941a026e30	82575-100	HUMAN OTC DRUG	Acne Body Wash		Salicylic Acid	SOAP	TOPICAL	20221205		OTC MONOGRAPH FINAL	part333D	Curology	SALICYLIC ACID	20	mg/mL			N	20241231
82575-200_bb5d1f07-5e72-47c9-8177-af941a026e30	82575-200	HUMAN OTC DRUG	Acne Body Wash		Salicylic Acid	SOAP	TOPICAL	20221205		OTC MONOGRAPH FINAL	part333D	Curology	SALICYLIC ACID	20	mg/mL			N	20241231
82575-300_fda2afaf-3d15-92b3-e053-6394a90a7493	82575-300	HUMAN OTC DRUG	Silkscreen Sheer Tint Mineral Sunscreen Broad Spectrum SPF 50 - Light/Medium Shade		Sheer Tint Mineral Sunscreen Broad Spectrum 50 - Light/Medium Shade	LOTION	TOPICAL	20230715		OTC MONOGRAPH FINAL	M020	Curology	TITANIUM DIOXIDE; ZINC OXIDE	2.37; 13.35	g/100g; g/100g			N	20241231
82575-301_fda2afaf-3d15-92b3-e053-6394a90a7493	82575-301	HUMAN OTC DRUG	Silkscreen Sheer Tint Mineral Sunscreen Broad Spectrum SPF 50 - Medium/Deep Shade		Sheer Tint Mineral Sunscreen Broad Spectrum 50 - Medium/Deep Shade	LOTION	TOPICAL	20230715		OTC MONOGRAPH FINAL	M020	Curology	TITANIUM DIOXIDE; ZINC OXIDE	2.37; 13.35	g/100g; g/100g			N	20241231
82575-302_04b2ba38-0f82-be51-e063-6294a90af821	82575-302	HUMAN OTC DRUG	Curology Barrier Balm		Skin Barrier Balm	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH FINAL	M016	Curology	DIMETHICONE 20; PETROLATUM	13; 41.9	g/100g; g/100g			N	20241231
82584-001_049ec4eb-aa64-7d84-e063-6294a90af57b	82584-001	HUMAN PRESCRIPTION DRUG	BETIMOL		timolol	SOLUTION/ DROPS	OPHTHALMIC	20221201		NDA	NDA020439	Thea Pharma Inc.	TIMOLOL	2.56	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82584-002_049ec4eb-aa64-7d84-e063-6294a90af57b	82584-002	HUMAN PRESCRIPTION DRUG	BETIMOL		timolol	SOLUTION/ DROPS	OPHTHALMIC	20221115		NDA	NDA020439	Thea Pharma Inc.	TIMOLOL	5.12	mg/mL	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82584-003_089f9101-116a-2132-e063-6294a90a64a3	82584-003	HUMAN PRESCRIPTION DRUG	IYUZEH		Latanoprost Ophthalmic Solution 0.005%	SOLUTION/ DROPS	OPHTHALMIC	20230714		NDA	NDA216472	Thea Pharma Inc.	LATANOPROST	50	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
82584-307_f1a04b58-01cc-298b-e053-2a95a90a947f	82584-307	HUMAN PRESCRIPTION DRUG	AZASITE		azithromycin monohydrate	SOLUTION/ DROPS	OPHTHALMIC	20221101		NDA	NDA050810	Thea Pharma Inc.	AZITHROMYCIN MONOHYDRATE	10	mg/mL	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
82584-604_0e768c1f-3ca0-c128-e063-6294a90a4463	82584-604	HUMAN PRESCRIPTION DRUG	COSOPT PF		dorzolamide hydrochloride and timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20221210		NDA	NDA202667	Thea Pharma Inc.	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20251231
82584-605_049eac88-a497-82d9-e063-6294a90a2af9	82584-605	HUMAN PRESCRIPTION DRUG	COSOPT		dorzolamide hydrochloride and timolol maleate	SOLUTION/ DROPS	OPHTHALMIC	20221110		NDA	NDA020869	Thea Pharma Inc.	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE	20; 5	mg/mL; mg/mL	Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82584-609_0e768ed0-43ca-a4d8-e063-6294a90ac36e	82584-609	HUMAN PRESCRIPTION DRUG	ZIOPTAN		Tafluprost	SOLUTION/ DROPS	OPHTHALMIC	20221028		NDA	NDA202514	Thea Pharma Inc.	TAFLUPROST	.015	mg/mL	Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]		N	20251231
82584-792_049edf75-a3eb-a9fe-e063-6294a90a73b4	82584-792	HUMAN PRESCRIPTION DRUG	AKTEN		LIDOCAINE HYDROCHLORIDE ANHYDROUS	GEL	OPHTHALMIC	20221201		NDA	NDA022221	Thea Pharma Inc.	LIDOCAINE HYDROCHLORIDE ANHYDROUS	35	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82588-000_0d6d62ce-eec2-7863-e063-6294a90aa9cf	82588-000	HUMAN OTC DRUG	Seavenger ocean kiss sunscreen SPF 30		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220401		OTC MONOGRAPH DRUG	M017	SHOP 709 Corp	TITANIUM DIOXIDE; ZINC OXIDE	85; 10	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82588-001_0d6d5a93-c97f-3c03-e063-6394a90a9f4b	82588-001	HUMAN OTC DRUG	Seavenger ocean kiss sunscreen SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220401		OTC MONOGRAPH DRUG	M020	SHOP 709 Corp	TITANIUM DIOXIDE; ZINC OXIDE	119; 10	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82589-000_0d6bb92a-8442-9847-e063-6394a90ac78f	82589-000	HUMAN OTC DRUG	IST Sunscreen SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20220401		OTC MONOGRAPH DRUG	M020	IST DIVING SYSTEM, INC	TITANIUM DIOXIDE; ZINC OXIDE	85; 10	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82590-030_92497e06-806b-42c6-9d22-7c4afd422c50	82590-030	HUMAN OTC DRUG	Satya ORGANIC FRAGRANCE-FREE ECZEMA RELIEF		Colloidal Oatmeal	OINTMENT	TOPICAL	20220817		OTC MONOGRAPH FINAL	part347	Satya Organic Inc.	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
82590-030_b9a60e34-a82e-4c24-ab36-298d92e9ce6f	82590-030	HUMAN OTC DRUG	Satya ORGANIC FRAGRANCE-FREE ECZEMA RELIEF		Colloidal Oatmeal	OINTMENT	TOPICAL	20220301		OTC MONOGRAPH FINAL	part347	Satya Organic Inc.	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
82594-001_872cf41e-7bf8-4d28-878e-32059e796199	82594-001	HUMAN OTC DRUG	Scalp Revival		Salicylic Acid 3%	SHAMPOO	TOPICAL	20220228		OTC MONOGRAPH DRUG	M032	Beccair, LLC	SALICYLIC ACID	3	g/100mL			N	20241231
82600-220_0d6a3eef-54b6-2315-e063-6294a90a6ffe	82600-220	HUMAN OTC DRUG	Camphor		CAMPHOR	GEL	TOPICAL	20220314		OTC MONOGRAPH DRUG	M017	8E6 YOUR PAIN	CAMPHOR (NATURAL)	3.1	mg/g			N	20251231
82600-222_0d6ac3da-ec15-9679-e063-6294a90a4443	82600-222	HUMAN OTC DRUG	Camphor		CAMPHOR	CLOTH	TOPICAL	20220302		OTC MONOGRAPH DRUG	M017	8E6 YOUR PAIN	CAMPHOR (NATURAL)	3.1	mg/g			N	20251231
82604-600_ffe62883-85a4-6e94-e053-6294a90ac61f	82604-600	HUMAN PRESCRIPTION DRUG	Omidria		phenylephrine and ketorolac	INJECTION, SOLUTION, CONCENTRATE	INTRAOCULAR	20230701		NDA	NDA205388	Rayner Surgical Inc.	KETOROLAC; PHENYLEPHRINE	2.88; 10.16	mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82605-001_07105e71-b822-b295-e063-6394a90a0129	82605-001	HUMAN PRESCRIPTION DRUG	Carbon Dioxide		Carbon Dioxide	GAS	RESPIRATORY (INHALATION)	20220322		NDA	NDA206025	AIRGAS THERAPEUTICS LLC	CARBON DIOXIDE	1	g/g	Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
82605-006_0d08535a-992e-1ca6-e063-6394a90a1ed2	82605-006	HUMAN PRESCRIPTION DRUG	Ulspira		Ulspira	GAS	RESPIRATORY (INHALATION)	20230804		ANDA	ANDA203144	Airgas Therapeutics, LLC	NITRIC OXIDE	.8	mL/100L	Vasodilation [PE], Vasodilator [EPC]		N	20241231
82606-002_0bee8ef4-cf6b-a934-e063-6294a90a73d9	82606-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20220415		NDA	NDA205766	AMERICAN GASES CORPORATION	NITROGEN	990	mL/L			N	20241231
82617-101_0555ca8d-7b15-e4ad-e063-6394a90a6ba2	82617-101	HUMAN OTC DRUG	THE SOLUTION		LIDOCAINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE	SPRAY	TOPICAL	20220401		OTC MONOGRAPH DRUG	M015	SCALP TECH INC	EPINEPHRINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE	.01; 5	g/100mL; g/100mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
82618-320_0a279ab0-63f1-7c18-e063-6394a90aad39	82618-320	HUMAN OTC DRUG	Gin Amber Beauty Mineral Sunscreen Broad Spectrum SPF 25 BB Cream		ZINC OXIDE	CREAM	TOPICAL	20221101		OTC MONOGRAPH DRUG	M020	Gin Amber Beauty LLC	ZINC OXIDE	220	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82619-101_e1f9aae1-cd76-4449-a092-0202d95fced1	82619-101	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20230907		ANDA	ANDA217732	Creekwood Pharmaceuticals LLC	FENOFIBRATE	40	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
82619-102_e1f9aae1-cd76-4449-a092-0202d95fced1	82619-102	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20230907		ANDA	ANDA217732	Creekwood Pharmaceuticals LLC	FENOFIBRATE	120	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
82619-111_f2e8f52a-5931-461f-8fe1-d319a62cddf6	82619-111	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202047	Creekwood Pharmaceuticals LLC	RIZATRIPTAN BENZOATE	5	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
82619-112_f2e8f52a-5931-461f-8fe1-d319a62cddf6	82619-112	HUMAN PRESCRIPTION DRUG	Rizatriptan Benzoate		Rizatriptan Benzoate	TABLET	ORAL	20121231		ANDA	ANDA202047	Creekwood Pharmaceuticals LLC	RIZATRIPTAN BENZOATE	10	mg/1	Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]		N	20241231
82620-001_0c57e1df-2807-4aa6-e063-6294a90a6883	82620-001	HUMAN OTC DRUG	HemRid Anorectal Cream		lidocaine	CREAM	TOPICAL	20220404		OTC MONOGRAPH DRUG	M015	KKA & Associates LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82622-0001_dca7b2f5-6dcb-a7cb-e053-2a95a90adafd	82622-0001	HUMAN OTC DRUG	MEDISPRAY		Calcined Weathered Sedimentary Coral Powder	LIQUID	TOPICAL	20200909		UNAPPROVED DRUG OTHER		MEDIPLUS	OYSTER SHELL CALCIUM CARBONATE, CRUDE	10	g/100mL			N	20241231
82625-8801_47bc4f0f-13e6-4c5b-97f2-d6dab432a660	82625-8801	HUMAN PRESCRIPTION DRUG	MOVANTIK		naloxegol oxalate	TABLET, FILM COATED	ORAL	20230328		NDA	NDA204760	Valinor Pharma, LLC	NALOXEGOL OXALATE	12.5	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
82625-8802_47bc4f0f-13e6-4c5b-97f2-d6dab432a660	82625-8802	HUMAN PRESCRIPTION DRUG	MOVANTIK		naloxegol oxalate	TABLET, FILM COATED	ORAL	20230328		NDA	NDA204760	Valinor Pharma, LLC	NALOXEGOL OXALATE	25	mg/1	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
82626-101_db9f8cc5-b339-3b45-e053-2a95a90a1e23	82626-101	HUMAN OTC DRUG	KELSEN - SPF 30	DAILY SUNSCREEN	ZINC OXIDE	LOTION	TOPICAL	20220401		OTC MONOGRAPH NOT FINAL	part352	KELSEN PRODUCTS INC	ZINC OXIDE	10	g/100mL			N	20241231
82626-102_ef1cfeb7-4b98-beaf-e053-2995a90a3d79	82626-102	HUMAN OTC DRUG	KELSEN - UNDER THE SUN BROAD SPECTRUM	SPF 50 MINERAL SUNSCREEN	ZINC OXIDE	PASTE	TOPICAL	20221205		OTC MONOGRAPH NOT FINAL	part352	KELSEN PRODUCTS INC	ZINC OXIDE	30	g/100g			N	20241231
82630-001_e11f08b2-f8ea-40e4-b865-9fa3a31399b4	82630-001	HUMAN OTC DRUG	Will Relieve		Lidocaine	LOTION	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part348	Will Perform, PBC	LIDOCAINE	3.4	g/85g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82630-002_b665f3a8-af0f-490c-b929-21cf48ab00a0	82630-002	HUMAN OTC DRUG	Will Relieve Roll-On		Lidocaine Hydrochloride	GEL	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part348	Will Perform, PBC	LIDOCAINE HYDROCHLORIDE	3.2	g/88mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82630-003_20a8be4b-7234-42e5-9732-01111a985536	82630-003	HUMAN OTC DRUG	Will Relieve		Lidocaine	AEROSOL, SPRAY	TOPICAL	20220801		OTC MONOGRAPH DRUG	M017	Will Perform, PBC	LIDOCAINE	4.52	g/113g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82630-004_931a47cd-8e6a-4391-bce9-b9497999b899	82630-004	HUMAN OTC DRUG	Will Cool Roll-On		CAMPHOR (SYNTHETIC) and MENTHOL, UNSPECIFIED FORM	GEL	TOPICAL	20220801		OTC MONOGRAPH DRUG	M017	Will Perform, PBC	CAMPHOR (SYNTHETIC); MENTHOL, UNSPECIFIED FORM	3.3; 5	g/88mL; g/88mL			N	20241231
82635-403_f6541d38-3523-9c03-e053-2995a90a8c34	82635-403	HUMAN OTC DRUG	Melan RX		Zinc Oxide	LOTION	TOPICAL	20220323		OTC MONOGRAPH NOT FINAL	part352	Melan RX	ZINC OXIDE	132	mg/mL			N	20241231
82637-9363_08158b7c-7bcf-b9d4-e063-6294a90ad86e	82637-9363	HUMAN OTC DRUG	Anti-Itch Soothing Wipes 1 Pramoxine Hydrochloride		PRAMOXINE HYDROCHLORIDE	CLOTH	TOPICAL	20220301		OTC MONOGRAPH DRUG	M017	The Honey Pot Company LLC	PRAMOXINE HYDROCHLORIDE	10	mg/mL			N	20241231
82637-9370_08157e80-efcb-147b-e063-6394a90aca36	82637-9370	HUMAN OTC DRUG	Anti Itch Soothing 1 Pramoxine Hydrochloride		PRAMOXINE HYDROCHLORIDE	SPRAY	TOPICAL	20220301		OTC MONOGRAPH DRUG	M017	The Honey Pot Company LLC	PRAMOXINE HYDROCHLORIDE	10	mg/mL			N	20241231
82637-9455_08157e2c-2c75-1487-e063-6394a90a1092	82637-9455	HUMAN OTC DRUG	Anti-Itch Vulva Cream 1 Hydrocortisone Acetate		HYDROCORTISONE ACETATE	CREAM	TOPICAL	20220301		OTC MONOGRAPH DRUG	M017	The Honey Pot Company LLC	HYDROCORTISONE ACETATE	10	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82638-112_0780a258-655b-3c85-e063-6294a90a202a	82638-112	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20231006		ANDA	ANDA214443	Harman Finochem Limited	ALLOPURINOL	100	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
82638-113_0780a258-655b-3c85-e063-6294a90a202a	82638-113	HUMAN PRESCRIPTION DRUG	Allopurinol		Allopurinol	TABLET	ORAL	20231006		ANDA	ANDA214443	Harman Finochem Limited	ALLOPURINOL	300	mg/1	Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]		N	20241231
82643-002_f9de1807-95b0-4740-e053-6394a90a2482	82643-002	HUMAN OTC DRUG	ClorRelief		Chlorpheniramine Maleate	AEROSOL, SPRAY	ORAL	20230421		OTC MONOGRAPH FINAL	part341	FERRER MEDICAL INNOVATIONS LLC	CHLORPHENIRAMINE MALEATE	5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82643-011_fa1c1c15-c9a3-9d7f-e053-6294a90a9e32	82643-011	HUMAN OTC DRUG	ClorRelief KIDs		Chlorpheniramine Maleate	AEROSOL, SPRAY	ORAL	20230421		OTC MONOGRAPH FINAL	part341	FERRER MEDICAL INNOVATIONS LLC	CHLORPHENIRAMINE MALEATE	5	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82645-207_0d99d51f-ba65-9536-e063-6394a90aecd3	82645-207	HUMAN OTC DRUG	Freskaro Decolorized Iodine		Alcohol	LIQUID	TOPICAL	20230516		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	ALCOHOL	.48	mL/mL			N	20241231
82645-310_0d1c551e-97f1-67fe-e063-6394a90a2b10	82645-310	HUMAN OTC DRUG	Magnesium Citrate		Freskaro Magnesium Citrate Oral Solution - Lemon	LIQUID	ORAL	20221227		OTC MONOGRAPH DRUG	M007	Pharma Nobis, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
82645-311_0d1c5d55-b64c-8097-e063-6394a90a25ca	82645-311	HUMAN OTC DRUG	Magnesium Citrate		Freskaro Magnesium Citrate Oral Solution - Grape	LIQUID	ORAL	20221227		OTC MONOGRAPH DRUG	M007	Pharma Nobis, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
82645-312_0d1c551e-97f4-67fe-e063-6394a90a2b10	82645-312	HUMAN OTC DRUG	Magnesium Citrate		Freskaro Magnesium Citrate Oral Solution - Cherry	LIQUID	ORAL	20221227		OTC MONOGRAPH DRUG	M007	Pharma Nobis, LLC	MAGNESIUM CITRATE	1.745	g/29.6mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
82645-418_0d99b79b-1d28-e1bc-e063-6294a90a5c9b	82645-418	HUMAN OTC DRUG	Calamine		Calamine and Zinc Oxide	LOTION	TOPICAL	20230516		OTC MONOGRAPH DRUG	M016	Pharma Nobis, LLC	FERRIC OXIDE RED; ZINC OXIDE	80; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82645-515_0d99cc17-4c17-6458-e063-6394a90a02c1	82645-515	HUMAN OTC DRUG	Freskaro Castor Oil		Castor Oil	LIQUID	ORAL	20230516		OTC MONOGRAPH DRUG	M007	Pharma Nobis, LLC	CASTOR OIL	1	mg/mL			N	20241231
82645-900_0d1cd55e-cd93-6e7e-e063-6294a90ae7a5	82645-900	HUMAN OTC DRUG	Calamine		Calamine 8% and Zinc Oxide 8%	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Pharma Nobis, LLC	ZINC OXIDE	160	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82645-901_0d1cd578-e127-6e8e-e063-6294a90a5060	82645-901	HUMAN OTC DRUG	Itch Relief Gel		Itch Relief Gel	GEL	TOPICAL	20181220		OTC MONOGRAPH DRUG	M017	Pharma Nobis, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	2	mg/100mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82645-902_0d1cd55e-cd94-6e7e-e063-6294a90ae7a5	82645-902	HUMAN OTC DRUG	Antiseptic Instant Pain Relief		Camphor 10.8% and Phenol 4.7%	LIQUID	TOPICAL	20171109		OTC MONOGRAPH DRUG	M017	Pharma Nobis, LLC	CAMPHOR (NATURAL); PHENOL	108; 47	mg/mL; mg/mL			N	20241231
82645-903_0d1cdfd7-c2cd-9fd5-e063-6394a90a8eda	82645-903	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M017	Pharma Nobis, LLC	WITCH HAZEL	855	mg/mL			N	20241231
82645-904_0d1ce47a-8aa6-6673-e063-6294a90a9456	82645-904	HUMAN OTC DRUG	Sodium Bicarbonate		Sodium Bicarbonate	POWDER	ORAL	20171027		OTC MONOGRAPH DRUG	M001	Pharma Nobis, LLC	SODIUM BICARBONATE	1000	mg/g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
82645-906_0d1cde4b-4304-9c0b-e063-6394a90ac843	82645-906	HUMAN OTC DRUG	Mineral Oil Heavy		Mineral Oil	LIQUID	ORAL	20181218		OTC MONOGRAPH DRUG	M007	Pharma Nobis, LLC	MINERAL OIL	1000	mg/mL			N	20241231
82645-907_0d1cde4b-4305-9c0b-e063-6394a90ac843	82645-907	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	POVIDONE-IODINE	100	mg/mL			N	20241231
82645-908_0d1cec8f-8e2f-7e85-e063-6294a90addbf	82645-908	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine Gargle 0.5%	LIQUID	ORAL	20200610		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	POVIDONE-IODINE	5	mg/mL			N	20241231
82645-909_0d1ce3b4-41f8-98a4-e063-6394a90a7eaf	82645-909	HUMAN OTC DRUG	Decolorized Iodine		Ethyl Alcohol	LIQUID	TOPICAL	20220623		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	ALCOHOL	.45	mL/mL			N	20241231
82645-910_0d1cdfd7-c2cf-9fd5-e063-6394a90a8eda	82645-910	HUMAN OTC DRUG	Earwax Removal Drops		Carbamide Peroxide 6.5%	LIQUID	AURICULAR (OTIC)	20190604		OTC MONOGRAPH DRUG	M014	Pharma Nobis, LLC	CARBAMIDE PEROXIDE	.065	mg/mL			N	20241231
82645-911_0c828ba2-6479-25ab-e063-6294a90af579	82645-911	HUMAN OTC DRUG	Iodine Tincture Mild		Iodine and Sodium Iodide and Alcohol	LIQUID	TOPICAL	19790101		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	ALCOHOL; IODINE; SODIUM IODIDE	470; 20; 20.4	mg/mL; mg/mL; mg/mL			N	20241231
82645-912_0d1cf782-d2a5-7dee-e063-6294a90a3604	82645-912	HUMAN OTC DRUG	Merthiolate		Benzalkonium Chloride	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
82645-913_0d1ce3b4-41fa-98a4-e063-6394a90a7eaf	82645-913	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol 70 Percent		Isopropyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
82645-914_0d1cfe14-52e7-8975-e063-6294a90afbb7	82645-914	HUMAN OTC DRUG	Isopropyl Alcohol 91 Percent		isopropyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	ISOPROPYL ALCOHOL	910	mg/mL			N	20241231
82645-915_0d6ccefd-6382-35fb-e063-6294a90adf31	82645-915	HUMAN OTC DRUG	Isopropyl Alcohol 70 Percent With Wintergreen Oil		isopropyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	ISOPROPYL ALCOHOL	700	mg/mL			N	20241231
82645-916_0d6cb70d-47af-08a3-e063-6294a90a3961	82645-916	HUMAN OTC DRUG	Humco Hydrogen Peroxide		Hydrogen Peroxide 3%	LIQUID	TOPICAL	19980325		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	HYDROGEN PEROXIDE	30	mg/mL			N	20241231
82645-917_0d6cd501-d9a1-0357-e063-6394a90a45d3	82645-917	HUMAN OTC DRUG	Gentian Violet 1%		Gentian Violet 1%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	GENTIAN VIOLET	10	mg/mL			N	20241231
82645-918_0d6cb70d-47b0-08a3-e063-6294a90a3961	82645-918	HUMAN OTC DRUG	Chigg Away		Benzocaine	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Pharma Nobis, LLC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
82645-919_0d6cb70d-47b1-08a3-e063-6294a90a3961	82645-919	HUMAN OTC DRUG	Humco Castor Oil		Castor Oil	LIQUID	ORAL	20080101		OTC MONOGRAPH DRUG	M007	Pharma Nobis, LLC	CASTOR OIL	1	mg/mL			N	20241231
82645-920_0d6ccb8f-d9be-28e6-e063-6294a90a8a87	82645-920	HUMAN OTC DRUG	Camphor Spirit		Camphor 10%	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M017	Pharma Nobis, LLC	CAMPHOR (NATURAL)	100	mg/mL			N	20241231
82645-921_0d6ccb8f-d9bf-28e6-e063-6294a90a8a87	82645-921	HUMAN OTC DRUG	Calamine Phenolated Topical Suspension		Calamine and Zinc Oxide and Phenol	LOTION	TOPICAL	20080101		OTC MONOGRAPH DRUG	M016	Pharma Nobis, LLC	PHENOL; ZINC OXIDE	10; 160	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82645-922_0d6ccb8f-d9c0-28e6-e063-6294a90a8a87	82645-922	HUMAN OTC DRUG	Humco Calagesic		Calamine and Pramoxine Hydrochloride	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Pharma Nobis, LLC	PRAMOXINE HYDROCHLORIDE; ZINC OXIDE	10; 80	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82645-923_0d6cc629-bac0-1229-e063-6294a90a2610	82645-923	HUMAN OTC DRUG	Calaclear		Pramoxine Hydrochloride and Zinc Acetate	LOTION	TOPICAL	19980325		OTC MONOGRAPH DRUG	M016	Pharma Nobis, LLC	PRAMOXINE HYDROCHLORIDE; ZINC ACETATE	10; 1	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82645-924_0d6cc91d-1d9b-25ae-e063-6394a90aa6a0	82645-924	HUMAN OTC DRUG	Benzoin Tincture		Benzoin Resin	LIQUID	TOPICAL	20080101		OTC MONOGRAPH DRUG	M022	Pharma Nobis, LLC	BENZOIN RESIN	1000	mg/mL			N	20241231
82645-925_0d6cc629-bac1-1229-e063-6294a90a2610	82645-925	HUMAN OTC DRUG	Ear Drops for Swimmers		Isopropyl Alcohol	LIQUID	AURICULAR (OTIC)	20080101		OTC MONOGRAPH DRUG	M014	Pharma Nobis, LLC	ISOPROPYL ALCOHOL	950	mg/mL			N	20241231
82645-926_0d6cc629-bac2-1229-e063-6294a90a2610	82645-926	HUMAN OTC DRUG	Ethyl Rubbing Alcohol 70 Percent		ethyl alcohol	LIQUID	TOPICAL	20160101		OTC MONOGRAPH DRUG	M003	Pharma Nobis, LLC	ALCOHOL	700	mg/mL			N	20241231
82649-012_98ee3e19-eefd-46b2-8c69-bf0324e0dcee	82649-012	HUMAN OTC DRUG	Arthritis Pain Reliever		Diclofenac sodium	GEL	TOPICAL	20220815		ANDA	ANDA208077	LifeMD	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82649-199_8c7f6be7-3f21-4e3d-ad51-61b8699d7dd6	82649-199	HUMAN OTC DRUG	Ibuprofen		IBUPROFEN	CAPSULE, LIQUID FILLED	ORAL	20220826		ANDA	ANDA078682	LifeMD	IBUPROFEN	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82649-732_142919a4-6352-4abd-9eb7-886e676ec0d1	82649-732	HUMAN OTC DRUG	Mucus Relief	Maximum Strength	Guaifenesin	TABLET	ORAL	20220815		ANDA	ANDA207342	LifeMD	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
82649-897_8bdf9fce-01e2-4b79-a1ff-6ccb4cf0f200	82649-897	HUMAN OTC DRUG	Gas Relief	Extra Strength	SIMETHICONE	CAPSULE, LIQUID FILLED	ORAL	20220826		OTC MONOGRAPH FINAL	part347	LifeMD	DIMETHICONE	125	mg/1	Skin Barrier Activity [PE]		N	20241231
82649-927_1b1fc9b4-d5af-4c6c-81b3-cf1c1d5c24ef	82649-927	HUMAN OTC DRUG	Nicotine Polacrilex		Nicotine Polacrilex	GUM, CHEWING	ORAL	20220815		ANDA	ANDA078699	LifeMD	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82652-021_7e3354b4-6202-423f-bb85-88c0ac01958d	82652-021	HUMAN OTC DRUG	Diphen		Benzocaine, Benzalkonium chloride, Lidocaine hydrochloride, Hydrocortisone, Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, Calcium Carbonate, Ibuprofen, Loratadine, Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride, Potassium Chloride, Magnesium Oxide, Meclizine Hydrochloride, and Bismuth Subsalicylate	KIT		20220510		ANDA	ANDA076134	Remedy Pack LLC						N	20241231
82654-000_09ce5c6f-23ba-7dca-e063-6394a90aa47c	82654-000	HUMAN OTC DRUG	Quick Screen Sunscreen SPF 50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230615		OTC MONOGRAPH DRUG	M020	The Quick Flick PTY LTD	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82656-010_f12b1d51-cd18-4d72-a981-7bb806fa774b	82656-010	HUMAN OTC DRUG	Dr.LORD Green Propol Tooth		Silicon Dioxide, Aminocaproic Acid, Aluminum Chlorohydroxy Allantoinate	PASTE, DENTIFRICE	ORAL	20220301		UNAPPROVED DRUG OTHER		Red 99	ALCLOXA; AMINOCAPROIC ACID; SILICON DIOXIDE	.1; .1; 17	g/100g; g/100g; g/100g	Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]		N	20241231
82656-020_17f91172-51da-45e4-8022-3d3637f654b3	82656-020	HUMAN OTC DRUG	Dr.LORD Propol Whitening Tooth		Hydrogen Peroxide, Colloidal Silicon Dioxide, Tocopherol Acetate	PASTE, DENTIFRICE	ORAL	20220301		UNAPPROVED DRUG OTHER		Red 99	.ALPHA.-TOCOPHEROL ACETATE; HYDROGEN PEROXIDE; SILICON DIOXIDE	.2; 2.14; 7	g/100g; g/100g; g/100g			N	20241231
82657-001_0d0633dd-065b-9df6-e063-6294a90ad35f	82657-001	HUMAN OTC DRUG	Cay Skin Isle Lip Balm SPF 30		Avobenzone, Homosalate, Octisalate	CREAM	TOPICAL	20220329		OTC MONOGRAPH DRUG	M020	Cay Skin, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	30; 100; 50	mg/g; mg/g; mg/g			N	20241231
82657-002_d91bba06-fd9c-3eb5-e053-2995a90a6124	82657-002	HUMAN OTC DRUG	Cay Skin Isle Glow Face SPF 45		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20220329		OTC MONOGRAPH NOT FINAL	part352	Cay Skin, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
82657-003_db5f6bad-65ad-2b05-e053-2a95a90a8569	82657-003	HUMAN OTC DRUG	Cay Skin Isle Glow Body SPF 45		Avobenzone, Octisalate, Octocrylene	LOTION	TOPICAL	20220329		OTC MONOGRAPH NOT FINAL	part352	Cay Skin, Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
82657-004_d929a719-5377-0c59-e053-2995a90aeec6	82657-004	HUMAN OTC DRUG	Cay Skin Universal Mineral Body SPF 55		Zinc Oxide	LOTION	TOPICAL	20220301		OTC MONOGRAPH NOT FINAL	part352	Cay Skin, Inc.	ZINC OXIDE	100	mg/mL			N	20241231
82657-005_db5fc83c-ed39-8dd7-e053-2a95a90a3ae2	82657-005	HUMAN OTC DRUG	Cay Skin Universal Mineral Face SPF 55		Zinc Oxide	LOTION	TOPICAL	20220301		OTC MONOGRAPH NOT FINAL	part352	Cay Skin, Inc.	ZINC OXIDE	120	mg/mL			N	20241231
82657-006_d91b2097-9272-21d0-e053-2a95a90ac39f	82657-006	HUMAN OTC DRUG	Cay Skin Isle Body Oil SPF 30		Avobenzone, Homosalate, Octisalate, Octocrylene	OIL	TOPICAL	20220329		OTC MONOGRAPH NOT FINAL	part352	Cay Skin, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82659-1000_0c40be0f-4d69-8a2e-e063-6394a90a2e8a	82659-1000	HUMAN OTC DRUG	Men Delay Wipe		Benzocaine 3.5%	CLOTH	TOPICAL	20220420		OTC MONOGRAPH DRUG	M017	Limitless Male Medical Clinic	BENZOCAINE	3.5	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
82662-010_fa61d727-e53d-4430-9d1e-4ff727f62ec8	82662-010	HUMAN OTC DRUG	TOOSTY GOLDEN DOOKKEOBI TOOTH		Silicon Dioxide, Sodium Monofluorophosphate	PASTE, DENTIFRICE	ORAL	20220301		UNAPPROVED DRUG OTHER		Headquarter Co., Ltd	SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE	17; .76	g/100g; g/100g			N	20241231
82662-020_c3bc04a8-1b36-464f-8fa3-c7717b96b936	82662-020	HUMAN OTC DRUG	Toosty Rucola Toothpaste		Silicon Dioxide, Sodium Monofluorophosphate, Sodium Pyrophosphate, Tocopherol Acetate	PASTE, DENTIFRICE	ORAL	20230701		UNAPPROVED DRUG OTHER		Headquarter Co., Ltd	.ALPHA.-TOCOPHEROL ACETATE; SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE; SODIUM PYROPHOSPHATE	.2; 17; .76; .5	g/100g; g/100g; g/100g; g/100g			N	20241231
82662-030_09a4f54d-bc4a-471d-ae39-b71056dfaaa2	82662-030	HUMAN OTC DRUG	Toosty Custard Pudding Toothpaste		Silicon Dioxide, Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20230701		UNAPPROVED DRUG OTHER		Headquarter Co., Ltd	SILICON DIOXIDE; SODIUM FLUORIDE	19; .32	g/100g; g/100g			N	20241231
82662-040_6e1bad30-5b46-47ab-a8a1-0d9f13463bce	82662-040	HUMAN OTC DRUG	Toosty Lemon Sorbet Toothpaste		Colloidal Silicon Dioxide, Hydrogen Peroxide Solution, Tocopherol Acetate	PASTE, DENTIFRICE	ORAL	20230701		UNAPPROVED DRUG OTHER		Headquarter Co., Ltd	.ALPHA.-TOCOPHEROL ACETATE; HYDROGEN PEROXIDE; SILICON DIOXIDE	.2; 2.4; 7	g/100g; g/100g; g/100g			N	20241231
82662-050_d1b592e5-3ded-41b3-91eb-2a7f553f3c10	82662-050	HUMAN OTC DRUG	Toosty Mint Chocolate Toothpaste		Precipitated Calcium Carbonate, Dicalcium Phosphate Dihydrate, Aluminium Chlorohydroxy Allantoinate, Sodium Monofluorophosphate	PASTE, DENTIFRICE	ORAL	20230701		UNAPPROVED DRUG OTHER		Headquarter Co., Ltd	ALCLOXA; CALCIUM CARBONATE; DIBASIC CALCIUM PHOSPHATE DIHYDRATE; SODIUM MONOFLUOROPHOSPHATE	.05; 40; .5; .72	g/100g; g/100g; g/100g; g/100g	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82666-001_07eecc9b-2680-c6c3-e063-6394a90a2e89	82666-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20220630		NDA	NDA217500	ABSOLUTE AIR LLC	OXYGEN	995	mL/L			N	20241231
82666-002_07eebb05-cf19-81c2-e063-6294a90a6905	82666-002	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20220630		NDA	NDA217499	ABSOLUTE AIR LLC	NITROGEN	999	mL/L			N	20241231
82667-013_049e9cc9-0664-53bc-e063-6294a90a2c4f	82667-013	HUMAN OTC DRUG	FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS		povidone, polyvinyl alcohol solution	SOLUTION/ DROPS	OPHTHALMIC	20230915		OTC MONOGRAPH FINAL	part349	Harrow Eye, LLC	POLYVINYL ALCOHOL, UNSPECIFIED; POVIDONE	27; 20	g/1000mL; g/1000mL			N	20241231
82667-100_0c6d14e8-f4ef-d92d-e063-6294a90a6d68	82667-100	HUMAN PRESCRIPTION DRUG	Maxitrol		neomycin sulfate, polymyxin b sulfate and dexamethasone	SUSPENSION	OPHTHALMIC	19641115		NDA	NDA050023	Harrow Eye, LLC	DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	1; 3.5; 10000	mg/mL; mg/mL; [USP'U]/mL	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
82667-200_00f18845-ccdf-8678-e063-6294a90a3374	82667-200	HUMAN PRESCRIPTION DRUG	IOPIDINE 1%		apraclonidine hydrochloride ophthalmic solution	SOLUTION/ DROPS	OPHTHALMIC	20230801		NDA	NDA019779	Harrow Eye, LLC	APRACLONIDINE HYDROCHLORIDE	10	mg/mL	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]		N	20241231
82667-300_f53b7b04-53bc-6730-e053-2995a90aaee0	82667-300	HUMAN PRESCRIPTION DRUG	IHEEZO		chloroprocaine hydrochloride ophthalmic gel	GEL	OPHTHALMIC	20220927		NDA	NDA216227	Harrow Eye, LLC	CHLOROPROCAINE HYDROCHLORIDE	24	mg/800mg	Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE]		N	20241231
82667-900_0a612c10-7125-d2aa-e063-6294a90ac954	82667-900	HUMAN PRESCRIPTION DRUG	VEVYE		cyclosporine ophthalmic solution	SOLUTION/ DROPS	OPHTHALMIC	20230530		NDA	NDA217469	Harrow Eye, LLC	CYCLOSPORINE	1	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
82670-0625_ff342e34-6783-c50b-e053-6394a90a5622	82670-0625	HUMAN OTC DRUG	defense Broad Spectrum SPF30 Tinted Sunscreen		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20220201		OTC MONOGRAPH NOT FINAL	part352	Emerald Aesthetics LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
82670-0650_f80f4455-e838-8523-e053-6394a90aa486	82670-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part352	Emerald Aesthetics LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
82670-2650_f80fc7c7-2ee9-688f-e053-6394a90ae7ab	82670-2650	HUMAN OTC DRUG	Defense Broad Spectrum SPF 25 Sunscreen		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part352	Emerald Aesthetics LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
82673-096_e4fc08bf-ed68-4fd0-ba32-71d0b9edaf9c	82673-096	HUMAN OTC DRUG	Infants Pain and Fever		Acetaminophen	SUSPENSION	ORAL	20220429		OTC MONOGRAPH DRUG	M013	KinderFarms, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
82673-097_60f16d27-36ea-4174-a999-2fd3e94b3f78	82673-097	HUMAN OTC DRUG	Pain and Fever	Childrens	Acetaminophen	SUSPENSION	ORAL	20220527		OTC MONOGRAPH NOT FINAL	part343	KinderFarms, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
82673-102_a51418bd-4e04-48fa-8aa0-9e20bcef21e2	82673-102	HUMAN OTC DRUG	Mucus Relief Cough and Congestion	Childrens	Dextromethorphan HBr, Guaifensin	LIQUID	ORAL	20220429		OTC MONOGRAPH FINAL	part341	KinderFarms, LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	5; 100	mg/5mL; mg/5mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
82673-103_b67ba049-5871-4e42-8ff0-9b6160baf770	82673-103	HUMAN OTC DRUG	Childrens Nighttime Cold and Cough		Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20220429		OTC MONOGRAPH FINAL	part341	KinderFarms, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82673-109_66f75c03-1322-4efa-8fc9-81ca72781271	82673-109	HUMAN OTC DRUG	Childrens Allergy		Diphenhydramine Hydrochloride	LIQUID	ORAL	20220902		OTC MONOGRAPH FINAL	part341	KinderFarms, LLC	DIPHENHYDRAMINE HYDROCHLORIDE	12.5	mg/5mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82673-190_1441e4cc-d3cc-4202-8ecb-8c1025d0f24c	82673-190	HUMAN OTC DRUG	Nighttime Cold and Cough		Diphenhydramine HCl, Phenylephrine HCl	LIQUID	ORAL	20231231		OTC MONOGRAPH DRUG	M012	KinderFarms, LLC	DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE	6.25; 2.5	mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82675-279_09e35e72-c03d-4d9a-e063-6294a90acdd1	82675-279	HUMAN OTC DRUG	TANCEUTICALS SPF DROPS Broad Spectrum SPF-30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	SOLUTION	TOPICAL	20220228		OTC MONOGRAPH DRUG	M020	TANCEUTICALS, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82682-001_5a6e1b89-a4a1-45e0-b505-1f081ff1d5dc	82682-001	HUMAN PRESCRIPTION DRUG	KOURZEQ		Triamcinolone Acetonide	PASTE	TOPICAL	20230915		ANDA	ANDA040771	MidAmerica Pharmaceuticals	TRIAMCINOLONE ACETONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82685-201_e813063f-dcaf-4992-9e45-e47df74757d4	82685-201	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220901		ANDA	ANDA076268	Oliva Therapeutics, LLC	DIGOXIN	125	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
82685-202_e813063f-dcaf-4992-9e45-e47df74757d4	82685-202	HUMAN PRESCRIPTION DRUG	Digoxin		Digoxin	TABLET	ORAL	20220901		ANDA	ANDA076268	Oliva Therapeutics, LLC	DIGOXIN	250	ug/1	Cardiac Glycoside [EPC], Cardiac Glycosides [CS]		N	20241231
82688-001_dcf383ba-94ca-155d-e053-2995a90a5a75	82688-001	HUMAN OTC DRUG	Antiflu Des	Cough and Flu	Acetaminophen Phenylephrine HCl Chlorpheniramine Maleate	CAPSULE	ORAL	20220415		OTC MONOGRAPH FINAL	part341	Productos Farmaceuticos, S.A. de C.V.	ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE	325; 4; 10	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82691-035_0989568f-a2af-c4b7-e063-6294a90a2cfb	82691-035	HUMAN OTC DRUG	Sensitif Renewal Cream Daily Protection SPF 30 Broad Spectrum UVA UVB Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20171201		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 10; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82691-140_09891759-b1b0-6a81-e063-6394a90a2f89	82691-140	HUMAN OTC DRUG	Acne Reparatif		SALICYLIC ACID	GEL	TOPICAL	20171201		OTC MONOGRAPH DRUG	M006	RV Skincare LLC	SALICYLIC ACID	5	mg/mL			N	20241231
82691-141_0989568f-a2c2-c4b7-e063-6294a90a2cfb	82691-141	HUMAN OTC DRUG	Fermitif Neck Renewal Cream Broad Spectrum SPF 15 Sunscreen US		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20171201		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	20; 60; 27; 20	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82691-142_09898669-2882-e17b-e063-6294a90a45c7	82691-142	HUMAN OTC DRUG	Intensite Creme Lustre Day SPF 30 US		AVOBENZONE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20171201		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 80	mg/mL; mg/mL; mg/mL			N	20241231
82691-143_0989568f-a2d3-c4b7-e063-6294a90a2cfb	82691-143	HUMAN OTC DRUG	Moisturizing Renewal Cream Broad Spectrum SPF 30 US		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20220101		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82691-144_0989936c-236c-dc63-e063-6294a90a885f	82691-144	HUMAN OTC DRUG	Sensitif Eye US SPF 30 Broad Spectrum UVA UVB Sunscreen PA		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20210109		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	TITANIUM DIOXIDE; ZINC OXIDE	34; 49	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82691-145_09898669-2893-e17b-e063-6294a90a45c7	82691-145	HUMAN OTC DRUG	Soleil Superieur Body SPF 50 US		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20200401		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82691-146_09899a6b-0e1a-ace4-e063-6394a90a6548	82691-146	HUMAN OTC DRUG	Soleil Superieur Broad Spectrum SPF 50 Sunscreen US		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20171201		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 26	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82691-147_0b37d675-8f0a-b440-e063-6294a90a708e	82691-147	HUMAN OTC DRUG	Perfectif Even Skin Tone Cream Broad Spectrum SPF 30 Sunscreen		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE	CREAM	TOPICAL	20171201		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE	30; 100; 50; 10; 50	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82691-148_09899c87-15ba-9b6a-e063-6394a90a6be5	82691-148	HUMAN OTC DRUG	Fermitif Hand Renewal Cream Broad Spectrum SPF 15 Sunscreen		AVOBENZONE, OCTINOXATE, OCTISALATE	CREAM	TOPICAL	20171201		OTC MONOGRAPH DRUG	M020	RV Skincare LLC	AVOBENZONE; OCTINOXATE; OCTISALATE	30; 75; 20	mg/g; mg/g; mg/g			N	20241231
82699-001_f30620dc-4547-c0f8-e053-2a95a90ae861	82699-001	HUMAN OTC DRUG	Right Guard Sport Antiperspirant Fresh		Right Guard Sport Antiperspirant Fresh	AEROSOL, SPRAY	TOPICAL	20221212		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
82699-002_f30620dc-4547-c0f8-e053-2a95a90ae861	82699-002	HUMAN OTC DRUG	Right Guard Sport Antiperspirant Powder Dry		Right Guard Sport Antiperspirant Powder Dry	AEROSOL, SPRAY	TOPICAL	20221212		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
82699-003_f30620dc-4547-c0f8-e053-2a95a90ae861	82699-003	HUMAN OTC DRUG	Right Guard Sport Antiperspirant Unscented		Right Guard Sport Antiperspirant Unscented	AEROSOL, SPRAY	TOPICAL	20230116		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
82699-004_05567059-9158-d509-e063-6394a90a72e5	82699-004	HUMAN OTC DRUG	Dry Idea Antiperspirant and Deodorant Fragrance Free		Dry Idea Antiperspirant and Deodorant Fragrance Free	AEROSOL, SPRAY	TOPICAL	20231101		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
82699-005_05a985e7-cb98-7ff4-e063-6294a90a4308	82699-005	HUMAN OTC DRUG	Right Guard X Antiperspirant and Deodorant DrySpray Fragrance Free		Right Guard X Antiperspirant and Deodorant DrySpray Fragrance Free	AEROSOL, SPRAY	TOPICAL	20231101		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
82699-006_05aa1a1a-9e52-2781-e063-6394a90aef6b	82699-006	HUMAN OTC DRUG	Right Guard X Antiperspirant and Deodorant DrySpray Fresh Blast		Right Guard X Antiperspirant and Deodorant DrySpray Fresh Blast	AEROSOL, SPRAY	TOPICAL	20231101		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM CHLOROHYDRATE	20	g/100g			N	20241231
82699-101_fb381288-e91c-4d2a-e053-6294a90a0cd8	82699-101	HUMAN OTC DRUG	Dry Idea Advanced Dry Antiperspirant and Deodorant Clear Gel Unscented		Dry Idea Advanced Dry Antiperspirant and Deodorant Clear Gel Unscented	GEL	TOPICAL	20230417		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-102_fb455461-db4d-fcb9-e053-6294a90a1c60	82699-102	HUMAN OTC DRUG	Dry Idea Advanced Dry Antiperspirant and Deodorant Clear Gel Powder Fresh		Dry Idea Advanced Dry Antiperspirant and Deodorant Clear Gel Powder Fresh	GEL	TOPICAL; TRANSMUCOSAL	20230508		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-103_0cdff8a8-db85-4bc6-e063-6394a90a3824	82699-103	HUMAN OTC DRUG	Right Guard Xtreme Defense Antiperspirant Deodorant Gel Fresh Blast		Right Guard Xtreme Defense Antiperspirant Deodorant Gel Fresh Blast	GEL	TOPICAL	20230320		OTC MONOGRAPH DRUG	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-104_0cdf92c0-1808-79cd-e063-6294a90a4698	82699-104	HUMAN OTC DRUG	Right Guard Xtreme Defense Antiperspirant Deodorant Gel Arctic Refresh		Right Guard Xtreme Defense Antiperspirant Deodorant Gel Arctic Refresh	GEL	TOPICAL	20230313		OTC MONOGRAPH DRUG	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-105_fb45dd76-ea18-ca2e-e053-6394a90a0b10	82699-105	HUMAN OTC DRUG	Right Guard Xtreme Defense Antiperspirant Deodorant Gel Ocean Rush		Right Guard Xtreme Defense Antiperspirant Deodorant Gel Ocean Rush	GEL	TOPICAL	20230522		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-106_066de7bb-d744-d802-e063-6394a90aaa82	82699-106	HUMAN OTC DRUG	Right Guard Sport Antiperspirant Deodorant Gel Fresh		Right Guard Sport Antiperspirant Deodorant Gel Fresh	GEL	TOPICAL	20230327		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-110_066d83da-0cf3-581c-e063-6394a90a5bfa	82699-110	HUMAN OTC DRUG	Right Guard Xtreme Defense Antiperspirant Deodorant Gel Forest Spring		Right Guard Xtreme Defense Antiperspirant Deodorant Gel Forest Spring	GEL	TOPICAL	20230626		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-201_0ce0336e-5dfe-5d1b-e063-6394a90a8af4	82699-201	HUMAN OTC DRUG	Dry Idea Advanced Dry Antiperspirant Roll-On, Powder Fresh		Dry Idea Advanced Dry Antiperspirant Roll-On, Powder Fresh	LIQUID	TOPICAL	20230331		OTC MONOGRAPH DRUG	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	16.3	g/16.3g			N	20241231
82699-202_066d83da-0cf7-581c-e063-6394a90a5bfa	82699-202	HUMAN OTC DRUG	Dry Idea Advanced Dry Roll-On Antiperspirant and Deodorant Unscented		Dry Idea Advanced Dry Roll-On Antiperspirant and Deodorant Unscented	LIQUID	TOPICAL	20230703		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	16.3	g/96mL			N	20241231
82699-204_f7927bc1-bc2a-54b9-e053-6294a90a25b7	82699-204	HUMAN OTC DRUG	Dry Idea Advanced Dry Roll-On Antiperspirant and Deodorant Unscented		Dry Idea Advanced Dry Roll-On Antiperspirant and Deodorant Unscented	LIQUID	TOPICAL	20230329		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY	16.3	g/96mL			N	20241231
82699-301_066d33e8-562e-7786-e063-6394a90adc20	82699-301	HUMAN OTC DRUG	Right Guard Sport Antiperspirant Deodorant Invisible Solid Fresh		Right Guard Sport Antiperspirant Deodorant Invisible Solid Fresh	STICK	TOPICAL	20230227		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	14	g/100g			N	20241231
82699-303_0ce03cc2-84fa-d990-e063-6294a90a3df7	82699-303	HUMAN OTC DRUG	Right Guard Xtreme Defense Antiperspirant Deodorant Invisible Solid Fresh Blast		Right Guard Xtreme Defense Antiperspirant Deodorant Invisible Solid Fresh Blast	STICK	TOPICAL	20230327		OTC MONOGRAPH DRUG	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	16.4	g/100g			N	20241231
82699-304_066cde3d-85b7-75ad-e063-6394a90ac800	82699-304	HUMAN OTC DRUG	Right Guard Xtreme Defense Antiperspirant Deodorant Invisible Solid Arctic Refresh		Right Guard Xtreme Defense Antiperspirant Deodorant Invisible Solid Arctic Refresh	STICK	TOPICAL	20230515		OTC MONOGRAPH FINAL	M019	Thriving Brands LLC	ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY	16.4	g/100g			N	20241231
82704-0630_f27885a0-95c5-0c66-e053-2995a90a653c	82704-0630	HUMAN OTC DRUG	Smooth Even Glow Tinted Mineral Sunscreen Broad Spectrum SPF30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	sknvcare, llc	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
82704-2650_f69297e2-fe90-5f53-e053-2995a90a7c25	82704-2650	HUMAN OTC DRUG	STAY HOT BURN NOT Broad Spectrum SPF 25 Sunscreen		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part352	SKNVCARE,LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
82705-002_2c937c38-5141-42d4-9fe7-29a19b3e8d0e	82705-002	HUMAN PRESCRIPTION DRUG	EPKINLY		epcoritamab-bysp	INJECTION, SOLUTION, CONCENTRATE	SUBCUTANEOUS	20230519		BLA	BLA761324	Genmab US, Inc.	EPCORITAMAB	4	mg/.8mL			N	20241231
82705-010_2c937c38-5141-42d4-9fe7-29a19b3e8d0e	82705-010	HUMAN PRESCRIPTION DRUG	EPKINLY		epcoritamab-bysp	INJECTION, SOLUTION	SUBCUTANEOUS	20230519		BLA	BLA761324	Genmab US, Inc.	EPCORITAMAB	48	mg/.8mL			N	20241231
82706-001_05d2ce2c-2589-8c1a-e063-6394a90afa04	82706-001	HUMAN OTC DRUG	AXIM DayTime		Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220509		OTC MONOGRAPH FINAL	part341	VIVUNT PHARMA LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	325; 10; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82706-002_05d300d0-6caa-47e4-e063-6394a90a6c14	82706-002	HUMAN OTC DRUG	Axim Night Time		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	CAPSULE, LIQUID FILLED	ORAL	20220509		OTC MONOGRAPH FINAL	part341	VIVUNT PHARMA LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	325; 15; 6.25	mg/1; mg/1; mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
82706-003_f435d670-87fe-f226-e053-2a95a90ac0ee	82706-003	HUMAN OTC DRUG	AXIM DayTime - Night Time 48 Softgels		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride	KIT		20220509		OTC MONOGRAPH FINAL	part341	VIVUNT PHARMA LLC						N	20241231
82706-004_f435d670-87fe-f226-e053-2a95a90ac0ee	82706-004	HUMAN OTC DRUG	AXIM DayTime - Night Time 72 Softgels		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride	KIT		20220509		OTC MONOGRAPH FINAL	part341	VIVUNT PHARMA LLC						N	20241231
82706-005_05d300d0-6cac-47e4-e063-6394a90a6c14	82706-005	HUMAN OTC DRUG	Axim Allergy		Diphenhydramine Hydrochloride	CAPSULE, LIQUID FILLED	ORAL	20220509		OTC MONOGRAPH FINAL	part341	VIVUNT LLC	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82706-006_05d329c8-d2a4-da24-e063-6294a90a91d5	82706-006	HUMAN OTC DRUG	AXIM Sinus Severe Mucus		Acetaminophen, Guaifenesin, Phenylephine HCl	CAPSULE, LIQUID FILLED	ORAL	20220509		OTC MONOGRAPH FINAL	part341	VIVUNT PHARMA LLC	ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	325; 200; 5	mg/1; mg/1; mg/1	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
82706-007_05d33daa-8558-5c5a-e063-6394a90a533b	82706-007	HUMAN OTC DRUG	NOTTS - Extra Strength 500 mg		Acetaminophen	TABLET	ORAL	20220817		OTC MONOGRAPH NOT FINAL	part343	VIVUNT PHARMA LLC	ACETAMINOPHEN	500	mg/1			N	20241231
82706-008_08676d23-82b5-be00-e063-6294a90a8771	82706-008	HUMAN OTC DRUG	NOTTS - Muscle Aches and Pain		Acetaminophen	TABLET	ORAL	20220817		OTC MONOGRAPH DRUG	M013	VIVUNT PHARMA LLC	ACETAMINOPHEN	650	mg/1			N	20241231
82706-010_0aeeedc8-dcb9-087d-e063-6394a90ad1f5	82706-010	HUMAN OTC DRUG	NOTTS - Tension Headache		Acetaminophen, Caffeine	TABLET	ORAL	20231030		OTC MONOGRAPH DRUG	M013	VIVUNT PHARMA LLC	ACETAMINOPHEN; CAFFEINE	500; 65	mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
82706-011_0e742e10-daeb-6443-e063-6294a90ab5af	82706-011	HUMAN OTC DRUG	AXIM DayTime - Liquid		Acetaminophen, Dextromethorphan Hydrobromide	LIQUID	ORAL	20240105		OTC MONOGRAPH DRUG	M012	VIVUNT PHARMA LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE	650; 20	mg/30mL; mg/30mL	Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
82706-012_0e741260-f76c-41bf-e063-6294a90a6154	82706-012	HUMAN OTC DRUG	AXIM Night Time - Liquid		Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate	LIQUID	ORAL	20240105		OTC MONOGRAPH DRUG	M012	VIVUNT PHARMA LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE	650; 30; 12.5	mg/30mL; mg/30mL; mg/30mL	Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
82706-013_0e740063-80d6-c48b-e063-6394a90a3b30	82706-013	HUMAN OTC DRUG	AXIM DM Max		Dextromethorphan Hydrobromide, Guaifenesin	LIQUID	ORAL	20240105		OTC MONOGRAPH DRUG	M012	VIVUNT PHARMA LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	20; 400	mg/20mL; mg/20mL	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20251231
82707-101_064645f9-7b66-26bf-e063-6294a90af3ea	82707-101	HUMAN OTC DRUG	MAX PAIN RELIEF		CAMPHOR, MENTHOL	CREAM	TOPICAL	20220510		OTC MONOGRAPH NOT FINAL	part348	PROVEDA	CAMPHOR OIL; MENTHOL	3.1; 3.1	g/100mL; g/100mL			N	20241231
82714-001_f2270f97-e3ba-564e-e053-2995a90a39f2	82714-001	HUMAN OTC DRUG	BlueStop Max		External Analgesic	GEL	TOPICAL	20230110		OTC MONOGRAPH NOT FINAL	part348	Clavel Corporation	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82714-002_f2277e27-868c-57ef-e053-2a95a90abf28	82714-002	HUMAN OTC DRUG	BlueStop Max		External Analgesic	CREAM	TOPICAL	20230110		OTC MONOGRAPH NOT FINAL	part348	Clavel Corporation	LIDOCAINE HYDROCHLORIDE; MENTHOL, (+)-	40; 10	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82715-101_1b3f38c0-5909-4e8f-acbd-78e71bc69e03	82715-101	HUMAN OTC DRUG	GR BB SPF 25		Octinoxate, Oxybenzone, Titanium Dioxide	CREAM	TOPICAL	20220606		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE	2.5; .25; 4.95	g/100mL; g/100mL; g/100mL			N	20241231
82715-102_eee10c52-7efa-45ef-9f4d-fb1dc592f040	82715-102	HUMAN OTC DRUG	GR CC Broad Spectrum SPF 30		Octinoxate, Oxybenzone	CREAM	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	OCTINOXATE; OXYBENZONE	6; 2	g/100mL; g/100mL			N	20241231
82715-103_8de5b7e1-7b89-4e58-9c87-a2715d5d6984	82715-103	HUMAN OTC DRUG	GR NUDE LOOK SPF 25		Avobenzone, Octinoxate	CREAM	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	.25; 2.5	g/100mL; g/100mL			N	20241231
82715-104_ea2163ef-e487-4aa3-81be-58df90466f17	82715-104	HUMAN OTC DRUG	GR SATIN SMOOTHING Fluid Foundation SPF 15		Octinoxate, Oxybenzone	LIQUID	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	OCTINOXATE; OXYBENZONE	1; .1	g/100mL; g/100mL			N	20241231
82715-105_40f81747-2727-40c8-b079-c05706395614	82715-105	HUMAN OTC DRUG	GR HD FOUNDATION HIGH DEFINITION SPF 15		Avobenzone, Octinoxate	LOTION	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	.1; 1	g/100mL; g/100mL			N	20241231
82715-106_850bb768-5899-4762-897c-a1a618eb9bbf	82715-106	HUMAN OTC DRUG	GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15		Octinoxate	LOTION	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	OCTINOXATE	1	g/100mL			N	20241231
82715-107_1a24486e-18b5-406e-b03f-45454de044f1	82715-107	HUMAN OTC DRUG	GR LONGSTAY Matte Face Powder SPF 15		Octinoxate	POWDER	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	OCTINOXATE	1.995	g/100g			N	20241231
82715-108_808395f7-3fd5-4fdf-97b6-48c4380c6f25	82715-108	HUMAN OTC DRUG	GOLDEN ROSE GLOW KISS TINTED LIP BALM CHOCO CAKE		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-109_bfe4d6a3-0660-4337-a3cc-a8f2fa22f723	82715-109	HUMAN OTC DRUG	GOLDEN ROSE GLOW KISS TINTED LIP BALM VANILLA LATTE		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-110_6a8f1959-1306-4243-915b-4f65ae231af3	82715-110	HUMAN OTC DRUG	GOLDEN ROSE GLOW KISS TINTED LIP BALM STRAWBERRY		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-111_6aea14a4-ef75-41c8-b5a7-6cb39c1cb97d	82715-111	HUMAN OTC DRUG	GOLDEN ROSE GLOW KISS TINTED LIP BALM BERRY PINK		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-112_0fb77b09-9450-4730-8d71-5e292821a6a8	82715-112	HUMAN OTC DRUG	GOLDEN ROSE GLOW KISS TINTED LIP BALM PEACH SHAKE		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-113_d3be5261-7e88-4ac4-9894-77d3667b09c6	82715-113	HUMAN OTC DRUG	GOLDEN ROSE glow kiss TINTED LIP BALM CHERRY JUICE		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20220722		OTC MONOGRAPH FINAL	part352	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-114_2cb7d61b-eade-4c1e-a8da-03390d44dfb3	82715-114	HUMAN OTC DRUG	GR LIP BUTTER RASPBERRY SPF 15		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20231025		OTC MONOGRAPH DRUG	M020	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-115_e737fe46-2e86-47bb-9d9c-0f9bb040eee9	82715-115	HUMAN OTC DRUG	GR LIP BUTTER STRAWBERRY SPF 15		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20231025		OTC MONOGRAPH DRUG	M020	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-116_c2dfc54a-75fb-48c5-8786-02aca6ceed83	82715-116	HUMAN OTC DRUG	GR LIP BUTTER PEACH SPF 15		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20231025		OTC MONOGRAPH DRUG	M020	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-117_6b53e3c7-944c-49e7-a35d-d7c68ca5cade	82715-117	HUMAN OTC DRUG	GR LIP BUTTER ICE MINT SPF 15		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20231025		OTC MONOGRAPH DRUG	M020	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-118_c5be2b40-3e2e-4d31-88ce-7dcdd47d4d02	82715-118	HUMAN OTC DRUG	GR LIP BUTTER BLUEBERRY SPF 15		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20231025		OTC MONOGRAPH DRUG	M020	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82715-119_417ac9d8-0696-4777-bfb8-6044a81ef963	82715-119	HUMAN OTC DRUG	GR LIP BUTTER COOKIE SPF 15		Avobenzone, Octinoxate	LIPSTICK	TOPICAL	20231025		OTC MONOGRAPH DRUG	M020	ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	AVOBENZONE; OCTINOXATE	2.7; 6	g/100g; g/100g			N	20241231
82716-000_0899d0d4-0261-c060-e063-6294a90a2feb	82716-000	HUMAN OTC DRUG	NSI Sanitizing Wipes		ALCOHOL	PATCH	TOPICAL	20220528		OTC MONOGRAPH DRUG	505G(a)(3)	NORTHERN SAFETY CO., INC.	ALCOHOL	75	mL/g			N	20241231
82718-1110_de4b93cc-1f65-1a4a-e053-2995a90a48a5	82718-1110	HUMAN OTC DRUG	Blockaid		Lidocaine, Tetracaine	CREAM	TOPICAL	20220506		UNAPPROVED DRUG OTHER		SofTap Inc	LIDOCAINE; TETRACAINE	.03; .02	g/10g; g/10g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Ester Local Anesthetic [EPC], Esters [CS], Local Anesthesia [PE], Local Anesthesia [PE]		N	20241231
82718-2210_de4a096f-33d4-35f1-e053-2a95a90a8ee7	82718-2210	HUMAN OTC DRUG	Minnerva II		Lidocaine, Epinephrine	GEL	TOPICAL	20220511		UNAPPROVED DRUG OTHER		SofTap Inc	EPINEPHRINE HYDROCHLORIDE; LIDOCAINE	.004; .3	g/10g; g/10g	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
82721-001_f49e718b-ef8a-b648-e053-2a95a90a96c8	82721-001	HUMAN OTC DRUG	Pain Be Gone		Menthol	CREAM	TOPICAL	20230727		OTC MONOGRAPH DRUG	M014	Back to Earth Inc.	MENTHOL	9.6	mg/mL			N	20241231
82723-002_f66f6b73-311a-593d-e053-2995a90a7003	82723-002	HUMAN OTC DRUG	BadaBOOM Sunscreen		Sunscreen	CREAM	TOPICAL	20220507		OTC MONOGRAPH NOT FINAL	part352	Aopline Health Industry Technology (Guangzhou) Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	23.9; 24.1	g/100g; g/100g			N	20241231
82723-003_f750ee2d-12f0-e7d7-e053-6294a90ae901	82723-003	HUMAN OTC DRUG	ROE wellness spf 50 mineral powder		spf 50 mineral powder	POWDER	TOPICAL	20220507		OTC MONOGRAPH NOT FINAL	part352	Aopline Health Industry Technology (Guangzhou) Co., Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	23.9; 24.1	g/100g; g/100g			N	20241231
82723-004_0b702c2f-52f0-ad75-e063-6294a90a6b1e	82723-004	HUMAN OTC DRUG	SEXY MIX Tattoo Mineral Sunscreen Stick Broad Spectrum SPF 50		Zinc Oxide	STICK	TOPICAL	20231101		OTC MONOGRAPH DRUG	M020	Aopline Health Industry Technology (Guangzhou) Co., Ltd.	ZINC OXIDE	21.6	g/100g			N	20241231
82723-005_0bd4968f-5e4b-1e28-e063-6394a90a4fbb	82723-005	HUMAN OTC DRUG	SEXY MIX Tattoo Ultra Sunscreen Broad Spectrum SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M020	Aopline Health Industry Technology (Guangzhou) Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 5; 5; 10	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
82724-008_f1fea52b-005b-ab09-e053-2a95a90a299a	82724-008	HUMAN OTC DRUG	Polyvinyl Alcohol Eye Drops 1,4 % w/v		Polyvinyl Alcohol Eye Drops 1,4 % w/v	FOR SOLUTION	TOPICAL	20220920		OTC MONOGRAPH FINAL	part349	COVALENT MEDICAL	POLYVINYL ALCOHOL, UNSPECIFIED	5	mg/mL			N	20241231
82725-2002_0c050cbf-7109-4d2d-e063-6394a90abc65	82725-2002	HUMAN OTC DRUG	Sanitizer Hand Wipes		Alcohol	CLOTH	TOPICAL	20220511		OTC MONOGRAPH DRUG	505G(a)(3)	CABINET HEALTH, INC	ALCOHOL	1	g/g			N	20241231
82728-001_0cf48d47-5f3b-bfd6-e063-6394a90ac5cb	82728-001	HUMAN OTC DRUG	ManaMed Lidocaine 4% Pain Relieving Gel Patch		Lidocaine	PATCH	TOPICAL	20220622		OTC MONOGRAPH DRUG	M017	Manamed, Inc.	LIDOCAINE	4	g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82729-005_0506a90d-6d9a-e6d9-e063-6294a90a6e25	82729-005	HUMAN OTC DRUG	Aboniki Balm - Ultra Strength Topical Pain Relief Balm - White		Camphor, Eucalyptus, Menthol, Methyl Salicylate	OINTMENT	TOPICAL	20231002		OTC MONOGRAPH DRUG	M017	J C UDEOZOR & SONS GLOBAL INDUSTRIES LTD	CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE	40; 160; 490	mg/g; mg/g; mg/g			N	20241231
82730-100_dec189a2-5f94-7c3e-e053-2a95a90af988	82730-100	HUMAN OTC DRUG	Good Molecules Acne Foaming Cleanser		Salicylic Acid	GEL	TOPICAL	20220511		OTC MONOGRAPH FINAL	part333D	Good Molecules	SALICYLIC ACID	2	g/100mL			N	20241231
82733-294_09e32c60-2b83-0226-e063-6294a90a6a2f	82733-294	HUMAN OTC DRUG	SIMPLI DAY All In One SmartCream SPF 42		ZINC OXIDE, OCTISALATE, OCTOCRYLENE, ENSULIZOLE	CREAM	TOPICAL	20220520		OTC MONOGRAPH DRUG	M020	SIMPLI SKIN MD LLC	ENSULIZOLE; OCTISALATE; OCTOCRYLENE; ZINC OXIDE	40; 50; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82734-0001_f7b9f15a-d9a4-4ab8-a993-41c7565344cf	82734-0001	HUMAN OTC DRUG	Bruise	RX	Erigeron Canadensis, Hamamelis Virginiana, Phosphorus, Sulphuricum Acidum, Arnica Montana, Ledum Palustre, Bellis Perennis	LIQUID	ORAL	20220810		UNAPPROVED HOMEOPATHIC		Remedies Cure, LLC	ARNICA MONTANA WHOLE; BELLIS PERENNIS WHOLE; ERIGERON CANADENSIS WHOLE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; PHOSPHORUS; RHODODENDRON TOMENTOSUM LEAFY TWIG; SULFURIC ACID	12; 30; 30; 6; 6; 12; 9	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL			N	20241231
82735-200_dfdd038b-04ae-2431-e053-2995a90a77c5	82735-200	HUMAN OTC DRUG	One and Done		SPF 40	CREAM	TOPICAL	20220530		OTC MONOGRAPH FINAL	part352	Thirteen Lune Inc.	TITANIUM DIOXIDE; ZINC OXIDE	2; 1	g/100mL; g/100mL			N	20241231
82737-073_f7cdc584-ebf1-a68e-e053-6294a90a9ea9	82737-073	HUMAN PRESCRIPTION DRUG	Aphexda		Motixafortide	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	SUBCUTANEOUS	20230908		NDA	NDA217159	BioLineRx USA Inc	MOTIXAFORTIDE ACETATE	62	mg/1.7mL			N	20241231
82739-001_02660c3e-1a63-e31e-e063-6294a90aec59	82739-001	HUMAN OTC DRUG	Treatonic Nail Fungus Treatment		Nail Fungus Treatment	OINTMENT	EXTRACORPOREAL	20220519		UNAPPROVED DRUG OTHER		Shenzhen Situya Trading Co., Ltd.	MICONAZOLE NITRATE	2	mg/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
82739-002_027657e8-337b-85a6-e063-6294a90a365f	82739-002	HUMAN OTC DRUG	Treatonic Wart Remover		Wart Remover	OINTMENT	EXTRACORPOREAL	20221206		UNAPPROVED DRUG OTHER		Shenzhen Situya Trading Co., Ltd.	SALICYLIC ACID	17	mg/100mL			N	20241231
82739-006_f8b742c2-2aa1-a1ab-e053-6294a90a3707	82739-006	HUMAN OTC DRUG	Hermon Molluscum Contagiosum Treatment Oil		Molluscum Contagiosum Treatment	OIL	CUTANEOUS; EXTRACORPOREAL	20230405		UNAPPROVED DRUG OTHER		Shenzhen Situya Trading Co., Ltd.	CAMPHOR (SYNTHETIC); ECHINACEA ANGUSTIFOLIA; FUCUS VESICULOSUS; MENTHOL; SILVER CATION; TEA TREE OIL; THUJA OCCIDENTALIS BARK	.5; 10; 5; .5; 10; .5; 5	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82739-007_f8b742c2-2aa1-a1ab-e053-6294a90a3707	82739-007	HUMAN OTC DRUG	Hermon Molluscum Contagiosum Treatment Oil		Tea Tree Oil Body Wash	OIL	CUTANEOUS	20230405		UNAPPROVED DRUG OTHER		Shenzhen Situya Trading Co., Ltd.	COCAMIDOPROPYL BETAINE; COCO MONOETHANOLAMIDE	.5; .5	g/100mL; g/100mL			N	20241231
82739-009_fafdcaaa-dad3-0c60-e053-6294a90af79e	82739-009	HUMAN OTC DRUG	HealthyDerm Molluscum Contagiosum Treatment Oil		Molluscum Contagiosum Treatment	OIL	TOPICAL	20230420		OTC MONOGRAPH FINAL	M028	Shenzhen Situya Trading Co., Ltd.	SALICYLIC ACID	1	mg/100mL			N	20241231
82739-010_fc90ec3b-c594-d201-e053-6294a90a0655	82739-010	HUMAN OTC DRUG	VigorWell Hair Oil		Hair Oil	OIL	TOPICAL	20230525		OTC MONOGRAPH FINAL	M032	Shenzhen Situya Trading Co., Ltd.	BIOTIN; CAFFEINE; CASTOR OIL; COCONUT OIL; GINGER; MILLET; OLIVE OIL; ROSEMARY OIL; TYPHA ORIENTALIS WHOLE; WHEAT	2; 1; 1; 1; 2; .5; 1; 1; .5; .5	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Lipid Emulsion [EPC], Lipids [CS], Methylxanthine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Xanthines [CS]		N	20241231
82739-011_fc94abd8-0a45-6546-e053-6394a90a8a0d	82739-011	HUMAN OTC DRUG	VigorWell Neuropathy Cream		Nerve and Neuropathy Cream	CREAM	TOPICAL	20230525		OTC MONOGRAPH FINAL	M016	Shenzhen Situya Trading Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL; THYMOL	.5; .5; .5	mg/100mL; mg/100mL; mg/100mL			N	20241231
82739-012_fd970a09-1755-61cc-e053-6294a90a5d18	82739-012	HUMAN OTC DRUG	Hermon Varicose Veins Cream		Varicose Veins Cream	CREAM	TOPICAL	20230607		OTC MONOGRAPH NOT FINAL	part348	Shenzhen Situya Trading Co., Ltd.	AESCULUS CHINENSIS WHOLE; ARTEMISIA ARGYI LEAF; CUPRESSUS SEMPERVIRENS LEAF OIL; HAMAMELIS VIRGINIANA TOP; MENTHOL	.105; 1; .5; .175; 2	g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
82739-013_ffb412b1-d2ab-97fa-e053-6394a90a7ac0	82739-013	HUMAN OTC DRUG	Treatonic Tattoo Numbing Cream		Tattoo Numbing Cream	CREAM	TOPICAL	20230704		OTC MONOGRAPH FINAL	M016	Shenzhen Situya Trading Co., Ltd.	LIDOCAINE	5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82739-014_ffb5226b-b42e-bf4f-e053-6294a90a4b68	82739-014	HUMAN OTC DRUG	AOBBIY Tattoo Numbing Cream		Tattoo Numbing Cream	CREAM	TOPICAL	20230704		OTC MONOGRAPH FINAL	M016	Shenzhen Situya Trading Co., Ltd.	LIDOCAINE	5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82739-015_00a946be-4dcb-da16-e063-6394a90a7ea2	82739-015	HUMAN OTC DRUG	Treatonic Tattoo Numbing Cream		Tattoo Numbing Cream	CREAM	TOPICAL	20230704		OTC MONOGRAPH FINAL	M016	Shenzhen Situya Trading Co., Ltd.	LIDOCAINE	5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82739-016_057479e9-79ff-436e-e063-6294a90aa0d0	82739-016	HUMAN OTC DRUG	AOBBIY Tattoo Numbing Cream		Tattoo Numbing Cream	CREAM	TOPICAL	20230915		OTC MONOGRAPH NOT FINAL	part348	Shenzhen Situya Trading Co., Ltd.	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82739-017_099cf7f6-d34b-d8a1-e063-6294a90a5b6f	82739-017	HUMAN OTC DRUG	Vigorwell Medinail Toenail Fungus Treatment Spray.		Toenail Spray	LIQUID	TOPICAL	20231107		OTC MONOGRAPH DRUG	M005	Shenzhen Situya Trading Co., Ltd.	ANHYDROVITAMIN A; CHLORHEXIDINE ACETATE; PROQUAZONE; PYRIDOXINE	2; .2; 2; 2	g/100mL; g/100mL; g/100mL; g/100mL	Analogs/Derivatives [Chemical/Ingredient], Decreased Cell Wall Integrity [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
82740-001_0ce36844-9311-c01f-e063-6294a90abed6	82740-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20220511		UNAPPROVED MEDICAL GAS		San Marcos Hays County Emergency Medical Services Inc	OXYGEN	99	L/100L			N	20241231
82745-502_e19e0778-d2ec-510a-e053-2a95a90adbc1	82745-502	HUMAN OTC DRUG	Unicorn		Alcohol	GEL	TOPICAL	20220701		OTC MONOGRAPH NOT FINAL	part333E	GLIMMER WISH LLC	ALCOHOL	62	mL/100mL			N	20241231
82745-503_dfcbdb19-e6d1-2b51-e053-2a95a90a4c8d	82745-503	HUMAN OTC DRUG	Mermaid		Alcohol	GEL	TOPICAL	20220601		OTC MONOGRAPH NOT FINAL	part333E	GLIMMER WISH LLC	ALCOHOL	62	mL/100mL			N	20241231
82746-203_d4f56c56-3cef-4a4c-887d-defb30a66268	82746-203	HUMAN OTC DRUG	Clove Hill tinted mineral sunscreen spf 40		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20221018		OTC MONOGRAPH DRUG	M020	Clove Hill LLC	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
82746-212_6fe3b087-69e2-42a3-8e9f-2e05a7fca6e7	82746-212	HUMAN OTC DRUG	tinted mineral lip sunscreen		Titanium Dioxide, Zinc Oxide	STICK	TOPICAL	20221116		OTC MONOGRAPH DRUG	M020	Clove Hill LLC	TITANIUM DIOXIDE; ZINC OXIDE	40; 55	mg/g; mg/g			N	20241231
82749-001_08b6f9a7-d2f9-4dd3-e063-6394a90a8da9	82749-001	HUMAN OTC DRUG	Hydrogen Peroxide 3%		Hydrogen Peroxide 3%	SOLUTION	TOPICAL	20220624		OTC MONOGRAPH DRUG	M003	Epic Medical Supply Corp.	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
82749-002_08b7077b-7d65-65f0-e063-6294a90a05e3	82749-002	HUMAN OTC DRUG	Isopropyl Rubbing Alcohol		Isopropyl Alcohol	SOLUTION	TOPICAL	20221209		OTC MONOGRAPH DRUG	M003	Epic Medical Supply Corp.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
82749-004_08b6f9a7-d308-4dd3-e063-6394a90a8da9	82749-004	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	LIQUID	TOPICAL	20230313		OTC MONOGRAPH DRUG	M003	Epic Medical Supply Corp.	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
82749-008_08b71dd7-b5d2-cb3c-e063-6294a90ab928	82749-008	HUMAN OTC DRUG	Witch Hazel		Witch Hazel	LIQUID	TOPICAL	20120315		OTC MONOGRAPH DRUG	505G(a)(3)	Epic Medical Supply Corp.	WITCH HAZEL	86	mg/100mL			N	20241231
82749-100_fbd2a10d-e1d4-01ab-e053-6294a90a063c	82749-100	HUMAN OTC DRUG	EPIC Burn Cream		Lidocaine	CREAM	TOPICAL	20230516		OTC MONOGRAPH NOT FINAL	part348	Epic Medical Supply Corp	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	.13; .5	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82749-302_fbbe80b3-8777-894a-e053-6394a90a820a	82749-302	HUMAN OTC DRUG	EPIC	First Aid	Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate	OINTMENT	TOPICAL	20210515		OTC MONOGRAPH FINAL	part333B	Epic Medical Supply Corp	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	[USP'U]/g; mg/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
82752-013_0c7c99b9-8cd2-29e5-e063-6294a90a48c8	82752-013	HUMAN OTC DRUG	TaeTu Aftercare		Benzalkonium Chloride	SOLUTION	TOPICAL	20220501		OTC MONOGRAPH DRUG	M003	Taetu LLC	BENZALKONIUM CHLORIDE	.13	g/mL			N	20241231
82753-001_ef65d1ad-1804-ecac-e053-2995a90aa89f	82753-001	HUMAN OTC DRUG	SUPERSMOOTH ACNE CLEAR 5 MIN MASK		SALICYLIC ACID	CREAM	TOPICAL	20220525		OTC MONOGRAPH FINAL	M006	GLAMGLOW LLC	SALICYLIC ACID	10	mg/mL			N	20241231
82761-001_06e8bd89-6594-d974-e063-6294a90a66d9	82761-001	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 0N1 Petal		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-002_06e8bd89-6594-d974-e063-6294a90a66d9	82761-002	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 0W1 Pearl		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-003_06e8bd89-6594-d974-e063-6294a90a66d9	82761-003	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 1C0 Cameo		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-004_06e8bd89-6594-d974-e063-6294a90a66d9	82761-004	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 1W1 Porcelain		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20211201		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-005_06e8bd89-6594-d974-e063-6294a90a66d9	82761-005	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 2N1 Nude		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-006_06e8bd89-6594-d974-e063-6294a90a66d9	82761-006	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 2W1 Natural		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-007_06e8bd89-6594-d974-e063-6294a90a66d9	82761-007	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 3N1 Sand		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-008_06e8bd89-6594-d974-e063-6294a90a66d9	82761-008	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 3W1 Bisque		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-009_06e8bd89-6594-d974-e063-6294a90a66d9	82761-009	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 4C1 Almond		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-010_06e8bd89-6594-d974-e063-6294a90a66d9	82761-010	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 4W1 Tawny		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-011_06e8bd89-6594-d974-e063-6294a90a66d9	82761-011	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 5N1 Walnut		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-012_06e8bd89-6594-d974-e063-6294a90a66d9	82761-012	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 5W1 Tan		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-013_06e8bd89-6594-d974-e063-6294a90a66d9	82761-013	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 6N1 Mocha		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-014_06e8bd89-6594-d974-e063-6294a90a66d9	82761-014	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Light Revealer Natural Skin Illuminator Broad Spectrum SPF 25 Sunscreen 6C1 Cacao		avobenzone, homosalate, octisalate, and octocrylene	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.53; 2.55; 2.55; 1.53	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-015_06e87f73-19cf-99ce-e063-6294a90a8756	82761-015	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	0N1 Petal	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-016_06e87f73-19cf-99ce-e063-6294a90a8756	82761-016	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	0W1 Pearl	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-017_06e87f73-19cf-99ce-e063-6294a90a8756	82761-017	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	1C0 Cameo	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-018_06e87f73-19cf-99ce-e063-6294a90a8756	82761-018	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	1N2 Vanille	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-019_06e87f73-19cf-99ce-e063-6294a90a8756	82761-019	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	1W1 Porcelain	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-020_06e87f73-19cf-99ce-e063-6294a90a8756	82761-020	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	2C1 Blush	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-021_06e87f73-19cf-99ce-e063-6294a90a8756	82761-021	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	2N1 Nude	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-022_06e87f73-19cf-99ce-e063-6294a90a8756	82761-022	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	2W1 Natural	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-023_06e87f73-19cf-99ce-e063-6294a90a8756	82761-023	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	3C1 Fawn	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-024_06e87f73-19cf-99ce-e063-6294a90a8756	82761-024	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	3N1 Sand	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-025_06e87f73-19cf-99ce-e063-6294a90a8756	82761-025	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	3W1 Bisque	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-026_06e87f73-19cf-99ce-e063-6294a90a8756	82761-026	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	4C1 Almond	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-027_06e87f73-19cf-99ce-e063-6294a90a8756	82761-027	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	4N1 Wheat	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-028_06e87f73-19cf-99ce-e063-6294a90a8756	82761-028	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	4W1 Tawny	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-029_06e87f73-19cf-99ce-e063-6294a90a8756	82761-029	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	5C1 Nutmeg	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-030_06e87f73-19cf-99ce-e063-6294a90a8756	82761-030	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	5N1 Walnut	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-031_06e87f73-19cf-99ce-e063-6294a90a8756	82761-031	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	5W1 Tan	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-032_06e87f73-19cf-99ce-e063-6294a90a8756	82761-032	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	6C1 Cacao	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-033_06e87f73-19cf-99ce-e063-6294a90a8756	82761-033	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	6N1 Mocha	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-034_06e87f73-19cf-99ce-e063-6294a90a8756	82761-034	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Oil Free Natural Skin Perfector Broad Spectrum SPF 20 Sunscreen	6W1 Ganache	OCTINOXATE and OCTISALATE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	OCTINOXATE; OCTISALATE	2.827; 1.542	g/50mL; g/50mL			N	20241231
82761-035_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-035	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	0N1 Petal	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-036_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-036	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	1N2 Vanille	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-037_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-037	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	2N1 Nude	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-038_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-038	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	3N1 Sand	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-039_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-039	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	4W1 Tawny	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-040_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-040	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	5W1 Tan	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-041_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-041	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	6N1 Mocha	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-042_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-042	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	0W1 Pearl	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-043_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-043	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	1W1 Porcelain	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-044_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-044	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	2W1 Natural	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-045_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-045	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	4C1 Almond	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-046_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-046	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	5C1 Nutmeg	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-047_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-047	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	6C1 Cacao	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-048_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-048	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	3W1 Bisque	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-049_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-049	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	1C0 Cameo	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-050_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-050	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	2C1 Blush	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-051_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-051	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	3C1 Fawn	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-052_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-052	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	4N1 Wheat	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-053_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-053	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	5N1 Walnut	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-054_06e8c4f2-b478-be34-e063-6394a90a57e7	82761-054	HUMAN OTC DRUG	Laura Mercier Tinted Moisturizer Natural Skin Perfector Broad Spectrum SPF 30 Sunscreen	6W1 Ganache	AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.25; 3.745; 1; .5	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-055_06e8a505-7e9c-882c-e063-6394a90aae31	82761-055	HUMAN OTC DRUG	Laura Mercier Pure Canvas Primer Protecting Broad Spectrum SPF 30 Sunscreen		OCTINOXATE, OCTOCRYLENE, AVOBENZONE, and OXYBENZONE	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE	1.515; 3.681; 1.515; 1.01	g/50mL; g/50mL; g/50mL; g/50mL			N	20241231
82761-056_06e8d217-ed11-bfba-e063-6394a90a4eb6	82761-056	HUMAN OTC DRUG	Laura Mercier Flawless Skin Repair	Day Creme Broad Spectrum SPF 15 Sunscreen	Avobenzone, Octinoxate, and Oxybenzone	CREAM	TOPICAL	20220831		OTC MONOGRAPH DRUG	M020	Laura Mercier US Buyer LLC	AVOBENZONE; OCTINOXATE; OXYBENZONE	8; 35; 5	mg/g; mg/g; mg/g			N	20241231
82763-1020_f65442f9-6f93-3425-e053-2a95a90a589a	82763-1020	HUMAN OTC DRUG	VERIBELLA PROTECT DAILY DROPS		Zinc Oxide	LOTION	TOPICAL	20220522		OTC MONOGRAPH NOT FINAL	part352	Veribella	ZINC OXIDE	132	mg/mL			N	20241231
82766-1095_f654546d-e217-581d-e053-2995a90a5baa	82766-1095	HUMAN OTC DRUG	Daily Uniform		Zinc Oxide	LOTION	TOPICAL	20210515		OTC MONOGRAPH NOT FINAL	part352	Daily Uniform, LLC	ZINC OXIDE	132	mg/mL			N	20241231
82767-002_08025e53-5dc0-37f7-e063-6394a90a50c9	82767-002	HUMAN OTC DRUG	BUTT AND THIGHS	ACNE TREATMENT	SALICYLIC ACID	CREAM	TOPICAL	20220922		OTC MONOGRAPH DRUG	M006	Teamtrade Inc.	SALICYLIC ACID	2	g/100mL			N	20241231
82776-000_0c5d1392-3513-098b-e063-6394a90a95d6	82776-000	HUMAN OTC DRUG	TETRACYTE TOPICAL tetracycline hydrochloride		TETRACYCLINE HYDROCHLORIDE	OINTMENT	TOPICAL	20220601		OTC MONOGRAPH DRUG	M004	THE WOUND DOCS, LLC	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
82776-001_0c5d6ddd-ba13-92f5-e063-6294a90a81e7	82776-001	HUMAN OTC DRUG	TETRACYTE TOPICAL - tetracycline hydrochloride		TETRACYCLINE HYDROCHLORIDE	SPRAY	TOPICAL	20220601		OTC MONOGRAPH DRUG	M004	THE WOUND DOCS, LLC	TETRACYCLINE HYDROCHLORIDE	30	mg/mL	Tetracycline-class Antimicrobial [EPC], Tetracyclines [CS]		N	20241231
82777-000_f2682ffa-4ee2-d366-e053-2a95a90a01b6	82777-000	HUMAN OTC DRUG	Campo pharma 70 isopropyl alcohol		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333E	Latin Shots, Inc	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
82777-001_f268454a-cffb-0724-e053-2995a90ae8bf	82777-001	HUMAN OTC DRUG	Campo pharma Muscle hot		CAPSAICIN	CREAM	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part348	Latin Shots, Inc	CAPSAICIN	.5	mg/g			N	20241231
82778-342_c5f221e7-417e-4cfd-acf4-349c259388e0	82778-342	HUMAN OTC DRUG	PINXAV DAIPER RASH		Zinc Oxide	OINTMENT	TOPICAL	20040330		OTC MONOGRAPH FINAL	part347	Emjay Laboratories Inc.	ZINC OXIDE	300	mg/g			N	20241231
82791-332_fc705e79-abca-5b32-e053-6294a90a573c	82791-332	HUMAN OTC DRUG	Julie		Levonorgestrel	TABLET	ORAL	20221227		ANDA	ANDA202380	Julie Products, Inc	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
82791-532_948ae936-bb6a-4ada-96bd-c7c001daf10f	82791-532	HUMAN OTC DRUG	Julie		Levonorgestrel	TABLET	ORAL	20221028		ANDA	ANDA206867	Julie Products Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
82791-538_95a0b354-f911-4081-95fe-1ad316b13de6	82791-538	HUMAN OTC DRUG	Julie		Levonorgestrel	TABLET	ORAL	20220715		ANDA	ANDA206867	Julie Products Inc.	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]		N	20241231
82796-100_0dc078be-59db-3338-e063-6294a90ae1ab	82796-100	HUMAN OTC DRUG	Minoxidil	(for Men)	Minoxidil	AEROSOL, FOAM	TOPICAL	20230101		ANDA	ANDA209074	RESTORATION HOLDINGS, LLC	MINOXIDIL	50	mg/g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82797-111_0e7e29a7-23b7-4d62-e063-6294a90af807	82797-111	HUMAN OTC DRUG	Arnica		Arnica Montana	OINTMENT	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals(Private) Limited	ARNICA MONTANA FLOWER	2	g/20g			N	20251231
82797-112_0e7e0a06-6fb4-34a7-e063-6294a90a1681	82797-112	HUMAN OTC DRUG	Masood Arnica		Arnica Montana	OINTMENT	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARNICA MONTANA FLOWER	2	g/20g			N	20251231
82797-120_0e7dd377-dad5-16ee-e063-6294a90a8064	82797-120	HUMAN OTC DRUG	Masood Arnica Hair Oil		Arnica Montana	OIL	TOPICAL	20221201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARNICA MONTANA FLOWER	12	g/120mL			N	20251231
82797-123_0e7db5ba-bbec-313a-e063-6394a90aad47	82797-123	HUMAN OTC DRUG	Masood Ivypan Cough Syrup		Hedera Helix	SYRUP	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	HEDERA HELIX LEAF	9.6	mg/120mL			N	20251231
82797-222_0e7e0ecb-e4ad-278a-e063-6294a90a46d3	82797-222	HUMAN OTC DRUG	Masood Arnica Montana 30 C		Arnica Montana	LIQUID	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARNICA MONTANA FLOWER	30	[hp_C]/30mL			N	20251231
82797-321_0e7dde08-86e1-06a8-e063-6294a90af62a	82797-321	HUMAN OTC DRUG	Masood Biogen 21 Oracure		Calcarea Phosphoricum	TABLET	ORAL	20221201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	FERROSOFERRIC PHOSPHATE; TRIBASIC CALCIUM PHOSPHATE	48; 48	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20251231
82797-333_f2254b7e-611e-0dd2-e053-2a95a90aedf8	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceutical Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82797-333_f26142dc-c3cb-ea95-e053-2995a90abab5	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceutical Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82797-333_f271e23b-811c-e231-e053-2995a90ad816	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82797-333_f275c75f-f097-257a-e053-2a95a90ae7d2	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82797-333_f2b1e132-360a-f325-e053-2995a90aef40	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82797-333_f2b210c5-6e83-2051-e053-2a95a90aa9f1	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82797-333_f2e83031-7c38-784a-e053-2a95a90aa644	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82797-333_f2e88f65-2271-5861-e053-2a95a90a28e8	82797-333	HUMAN OTC DRUG	Masood Abrotanum		Abrotanum	PELLET	ORAL	20230201		UNAPPROVED HOMEOPATHIC		Dr. Masood Homeopathic Pharmaceuticals Private Limited	ARTEMISIA ABROTANUM FLOWERING TOP	1	g/30g			N	20241231
82798-295_0976fa2b-1b10-140f-e063-6394a90a72a5	82798-295	HUMAN OTC DRUG	RAPID PAIN-RELIEF TOPICAL		LIDOCAINE HYDROCHLORIDE, MENTHOL	CREAM	TOPICAL	20220701		OTC MONOGRAPH DRUG	M017	NORDIC HEALTHY LIVING INC.	LIDOCAINE HYDROCHLORIDE; MENTHOL	40; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82800-008_05de2a4c-65db-f02a-e063-6394a90ae73c	82800-008	HUMAN OTC DRUG	Prequel		Multi Purpose Skin Protectant	OINTMENT	TOPICAL	20230713		OTC MONOGRAPH FINAL	M016	The Center Brands, LLC	PETROLATUM	45	g/100g			N	20241231
82800-009_0b26450d-311f-fef1-e063-6394a90a7f6f	82800-009	HUMAN OTC DRUG	Prequel Barrier Cream		Skin Protectant Cream	CREAM	TOPICAL	20230823		OTC MONOGRAPH DRUG	M006	The Center Brands, LLC	OATMEAL	1	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
82800-010_05e5bf17-62d6-1eca-e063-6294a90a38b5	82800-010	HUMAN OTC DRUG	Prequel Sun Barrier Mineral Sunscreen Broad Spectrum SPF 50		Mineral Sunscreen	CREAM	TOPICAL	20230921		OTC MONOGRAPH FINAL	part352	The Center Brands, LLC	ZINC OXIDE	18	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82800-050_08f19f3e-eda6-bdd2-e063-6394a90ac626	82800-050	HUMAN OTC DRUG	Prequel Skin Utility Gel Multi-Purpose Skin Protectant		Skin Protectant Gel	GEL	TOPICAL	20231030		OTC MONOGRAPH DRUG	M016	The Center Brands, LLC	GLYCERIN	20	mg/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82800-060_08f24588-4d88-70b0-e063-6294a90ab195	82800-060	HUMAN OTC DRUG	Prequel Skin Utility Balm Multi-Purpose Skin Protectant		Skin Protectant Balm	OINTMENT	TOPICAL	20231030		OTC MONOGRAPH DRUG	M016	The Center Brands, LLC	DIMETHICONE	5.25	mg/g	Skin Barrier Activity [PE]		N	20241231
82803-001_ebf2f7f8-1a14-1986-e053-2995a90a3982	82803-001	HUMAN OTC DRUG	Skin Proud Serious Shade Sunscreen SPF 50		Avobenzone, Homosalate, Octisalate, Octocrylene	EMULSION	TOPICAL	20230227		OTC MONOGRAPH FINAL	M020	Lottie London Limited	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 150; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82804-001_34c547c4-4c29-45a9-97c7-a828bf2ecde0	82804-001	HUMAN PRESCRIPTION DRUG	Lubiprostone		Lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230101		NDA AUTHORIZED GENERIC	NDA021908	Proficient Rx LP	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
82804-002_ed491286-f756-42f7-9a35-ea0380d1ff58	82804-002	HUMAN OTC DRUG	good sense migraine formula		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20020417		ANDA	ANDA075794	Proficient Rx LP	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
82804-003_62dd3c7a-4150-44a2-b05b-bc31308f2200	82804-003	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20000726		ANDA	ANDA040400	Proficient Rx LP	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 10	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
82804-004_7c546a97-624f-4429-8a1f-674e90d59cfc	82804-004	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
82804-005_2ff9056b-ed65-4a2b-abb1-793b1fe9bf4c	82804-005	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230620		ANDA	ANDA210401	Proficient Rx LP	ACYCLOVIR	400	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20251231
82804-006_dcd80515-07e5-476c-b923-22bb48af61f3	82804-006	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20230214		ANDA	ANDA209553	Proficient Rx LP	VALACYCLOVIR HYDROCHLORIDE	1000	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
82804-007_177fd649-4339-4bfd-bd12-7e8de302412b	82804-007	HUMAN PRESCRIPTION DRUG	methylprednisolone		methylprednisolone	TABLET	ORAL	20180501		ANDA	ANDA206751	Proficient Rx LP	METHYLPREDNISOLONE	4	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82804-008_af8b30a0-7a56-4557-8404-cc8059fcd6bc	82804-008	HUMAN OTC DRUG	Acetaminophen, Aspirin, Caffeine		Acetaminophen, Aspirin, Caffeine	TABLET, FILM COATED	ORAL	20210603		OTC MONOGRAPH DRUG	M013	Proficient Rx LP	ACETAMINOPHEN; ASPIRIN; CAFFEINE	250; 250; 65	mg/1; mg/1; mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]		N	20241231
82804-009_dcd80515-07e5-476c-b923-22bb48af61f3	82804-009	HUMAN PRESCRIPTION DRUG	Valacyclovir		Valacyclovir	TABLET	ORAL	20230214		ANDA	ANDA209553	Proficient Rx LP	VALACYCLOVIR HYDROCHLORIDE	500	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
82804-010_94586867-c75b-4d60-be1d-03a9e4b7cd10	82804-010	HUMAN PRESCRIPTION DRUG	Diclofenac Potassium		diclofenac potassium	TABLET, COATED	ORAL	20201219		ANDA	ANDA075229	Proficient Rx LP	DICLOFENAC POTASSIUM	50	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82804-011_7cfbb3d0-f19f-4977-ad0f-77676a8c6f83	82804-011	HUMAN PRESCRIPTION DRUG	Doxepin hydrochloride		Doxepin hydrochloride	CAPSULE	ORAL	20191220		ANDA	ANDA212624	Proficient Rx LP	DOXEPIN HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
82804-012_640290e0-0203-43c8-b024-9eaeae591e37	82804-012	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	TABLET	ORAL	20230620		ANDA	ANDA210401	Proficient Rx LP	ACYCLOVIR	800	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
82804-013_80f4a4ef-8190-458d-af2e-5daaf32abc01	82804-013	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	(XL)	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20160829		ANDA	ANDA206556	Proficient Rx LP	BUPROPION HYDROCHLORIDE	300	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
82804-014_502653e6-1971-4abf-9b21-ba0a9957672b	82804-014	HUMAN PRESCRIPTION DRUG	Metoprolol Succinate		Metoprolol Succinate	TABLET, EXTENDED RELEASE	ORAL	20220427		ANDA	ANDA207206	Proficient Rx LP	METOPROLOL TARTRATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82804-015_9c96b488-19bd-431e-af9a-b313ffd9eaae	82804-015	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET	ORAL	20160411		ANDA	ANDA205101	Proficient Rx LP	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82804-016_a8bbb1f8-0b2f-4e92-bd48-dfea9a0ef67e	82804-016	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20230508		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	200	mg/1			N	20241231
82804-017_e05caabb-b95c-4e54-890e-bbc371a20fc3	82804-017	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	POWDER, FOR SUSPENSION	ORAL	20111220		ANDA	ANDA201091	Proficient Rx LP	AMOXICILLIN; CLAVULANATE POTASSIUM	600; 42.9	mg/5mL; mg/5mL	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82804-018_8e81aaa7-7c40-4b05-b19a-cc70edd1d9f9	82804-018	HUMAN PRESCRIPTION DRUG	Oseltamivir Phosphate		Oseltamivir Phosphate	CAPSULE	ORAL	20180223		ANDA	ANDA209438	Proficient Rx LP	OSELTAMIVIR PHOSPHATE	30	mg/1	Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]		N	20241231
82804-019_6bb0edc7-643b-4b20-aa48-ee3b22bce575	82804-019	HUMAN PRESCRIPTION DRUG	Triamcinolone acetonide		Triamcinolone acetonide	OINTMENT	TOPICAL	20181123		ANDA	ANDA209828	Proficient Rx LP	TRIAMCINOLONE ACETONIDE	5	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82804-020_2b387188-c2c1-4865-984c-341a358d1c6c	82804-020	HUMAN PRESCRIPTION DRUG	Quetiapine Fumarate		Quetiapine Fumarate	TABLET, FILM COATED	ORAL	20120327		ANDA	ANDA091388	Proficient Rx LP	QUETIAPINE FUMARATE	100	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82804-021_b8a9cbee-c526-4d1e-ad2f-cf7fbb784936	82804-021	HUMAN PRESCRIPTION DRUG	prazosin hydrochloride		prazosin hydrochloride	CAPSULE	ORAL	20230103		ANDA	ANDA215697	Proficient Rx LP	PRAZOSIN HYDROCHLORIDE	2	mg/1	Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]		N	20241231
82804-022_39efe933-bfed-4a6a-b270-0883871c5186	82804-022	HUMAN PRESCRIPTION DRUG	lamotrigine		lamotrigine extended-release	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20211209		ANDA	ANDA213949	Proficient Rx LP	LAMOTRIGINE	50	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
82804-023_fbd81df7-8482-493e-bfc5-a3352f466b9e	82804-023	HUMAN PRESCRIPTION DRUG	Aripiprazole		Aripiprazole	TABLET	ORAL	20151008		ANDA	ANDA203908	Proficient Rx LP	ARIPIPRAZOLE	10	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82804-024_f5e7503a-b28f-4cd0-a4ee-47bdca88d54b	82804-024	HUMAN PRESCRIPTION DRUG	Duloxetine	Delayed-Release	DULOXETINE HYDROCHLORIDE	CAPSULE, DELAYED RELEASE PELLETS	ORAL	20180521		ANDA	ANDA203088	Proficient Rx LP	DULOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82804-025_b9b1d6ee-da42-4ef2-ab93-cd36d7f34150	82804-025	HUMAN PRESCRIPTION DRUG	Sildenafil Citrate		Sildenafil	TABLET, FILM COATED	ORAL	20181012		ANDA	ANDA206401	Proficient Rx LP	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82804-026_ba7a8604-93bb-4b82-b160-328ed17f89f9	82804-026	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		Atorvastatin Calcium	TABLET, FILM COATED	ORAL	20181223		ANDA	ANDA209288	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82804-027_60c90b4b-174f-4fd2-b65f-fc166c16bdc1	82804-027	HUMAN PRESCRIPTION DRUG	Alprazolam		alprazolam	TABLET	ORAL	19811016		NDA AUTHORIZED GENERIC	NDA018276	Proficient Rx LP	ALPRAZOLAM	.25	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82804-028_b83c4c4b-2885-43e7-b1c9-0b3bbf75528d	82804-028	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20180111		ANDA	ANDA209582	Proficient Rx LP	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
82804-029_3cc9741f-0574-485f-bbf5-027cb236736c	82804-029	HUMAN PRESCRIPTION DRUG	MELOXICAM		meloxicam	TABLET	ORAL	20060719		ANDA	ANDA077929	Proficient Rx LP	MELOXICAM	15	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82804-030_fc4fccd8-19d2-4704-afa9-9ce0ab1d2b5f	82804-030	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20081007		ANDA	ANDA077731	Proficient Rx LP	FLUCONAZOLE	200	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
82804-031_9dd2f58b-d143-4d0c-a298-6d9390e6187a	82804-031	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide		Hydrochlorothiazide	TABLET	ORAL	20080815		ANDA	ANDA040907	Proficient Rx LP	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
82804-032_20d1c12a-bf4b-4467-93a0-ee8b892abea9	82804-032	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20090810		ANDA	ANDA065461	Proficient Rx LP	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
82804-033_ce06afcb-4e6c-4b78-8bad-9909c8fffa52	82804-033	HUMAN PRESCRIPTION DRUG	Mycophenolate mofetil		Mycophenolate mofetil	TABLET, FILM COATED	ORAL	20221015		ANDA	ANDA090456	Proficient Rx LP	MYCOPHENOLATE MOFETIL	500	mg/1	Antimetabolite Immunosuppressant [EPC]		N	20241231
82804-034_5c5f8dc7-3941-42be-8e7f-3c5027ac570e	82804-034	HUMAN PRESCRIPTION DRUG	lurasidone hydrochloride		lurasidone hydrochloride	TABLET, FILM COATED	ORAL	20230220		ANDA	ANDA212091	Proficient Rx LP	LURASIDONE HYDROCHLORIDE	20	mg/1	Atypical Antipsychotic [EPC]		N	20241231
82804-035_68e6ef8c-4104-4636-9719-6aa386c892d9	82804-035	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20150731		ANDA	ANDA203346	Proficient Rx LP	ALPRAZOLAM	.5	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
82804-036_07b1ee8b-d920-49dd-9fad-cb0fe8a35e0d	82804-036	HUMAN PRESCRIPTION DRUG	Albuterol Sulfate		Albuterol Sulfate	AEROSOL, METERED	RESPIRATORY (INHALATION)	20210315		NDA AUTHORIZED GENERIC	NDA020503	Proficient Rx LP	ALBUTEROL SULFATE	108	ug/1	Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]		N	20241231
82804-037_85410e16-d164-4666-9539-778e2b4dd138	82804-037	HUMAN PRESCRIPTION DRUG	Misoprostol		Misoprostol	TABLET	ORAL	20220411		ANDA	ANDA076095	Proficient Rx LP	MISOPROSTOL	200	ug/1	Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS]		N	20241231
82804-038_5c558ab8-b4b3-4973-b016-ed5cfcb4d88b	82804-038	HUMAN PRESCRIPTION DRUG	Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	CAPSULE, EXTENDED RELEASE	ORAL	20111123		ANDA	ANDA200834	Proficient Rx LP	VENLAFAXINE HYDROCHLORIDE	150	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
82804-039_75b1ae3f-e926-4555-a0e9-50323fc66cb2	82804-039	HUMAN PRESCRIPTION DRUG	BUSPIRONE HYDROCHLORIDE		BUSPIRONE HYDROCHLORIDE	TABLET	ORAL	20200221		ANDA	ANDA078246	Proficient Rx LP	BUSPIRONE HYDROCHLORIDE	7.5	mg/1			N	20241231
82804-040_7dfb450b-4d39-40e7-b115-9a96023052a0	82804-040	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA211298	Proficient Rx LP	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82804-041_a930511d-110e-4d2e-a4ca-df712f968b2d	82804-041	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA211298	Proficient Rx LP	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82804-042_78b6659c-3a46-4998-9151-1a53afd83375	82804-042	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET, FILM COATED	ORAL	20201102		ANDA	ANDA211298	Proficient Rx LP	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82804-043_a5e523b3-475e-4d28-a89c-c4325c59c939	82804-043	HUMAN OTC DRUG	Simethicone 80 mg		Simethicone	TABLET, CHEWABLE	ORAL	20180424		OTC MONOGRAPH DRUG	M002	Proficient Rx LP	DIMETHICONE	80	mg/1	Skin Barrier Activity [PE]		N	20241231
82804-044_8ab4f222-018f-40fc-a6aa-39dab563a8a0	82804-044	HUMAN PRESCRIPTION DRUG	Solifenacin Succinate		Solifenacin Succinate	TABLET, FILM COATED	ORAL	20200323		ANDA	ANDA211701	Proficient Rx LP	SOLIFENACIN SUCCINATE	5	mg/1	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]		N	20241231
82804-045_8566c432-741f-4af7-91d7-1b7668ce5e95	82804-045	HUMAN PRESCRIPTION DRUG	Nystatin		Nystatin	CREAM	TOPICAL	20190724		ANDA	ANDA212557	Proficient Rx LP	NYSTATIN	100000	U/g	Polyene Antifungal [EPC], Polyenes [CS]		N	20241231
82804-046_716dccec-7480-44dd-91b9-249ae2c25088	82804-046	HUMAN PRESCRIPTION DRUG	doxycycline		doxycycline	CAPSULE	ORAL	20211119		ANDA	ANDA209402	Proficient Rx LP	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
82804-047_140a40f8-26ec-46ac-a04b-998ea96e8f93	82804-047	HUMAN PRESCRIPTION DRUG	Phenazopyridine Hydrochloride		Phenazopyridine Hydrochloride	TABLET	ORAL	20231019		UNAPPROVED DRUG OTHER		Proficient Rx LP	PHENAZOPYRIDINE HYDROCHLORIDE	100	mg/1			N	20241231
82804-048_6dc9d113-1156-43ec-a7eb-253c2ff6bcfa	82804-048	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20210526		ANDA	ANDA214548	Proficient Rx LP	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
82804-049_38e80423-0194-4064-9447-abfd29fce1da	82804-049	HUMAN PRESCRIPTION DRUG	Pregabalin		PREGABALIN	CAPSULE	ORAL	20190719		ANDA	ANDA208677	Proficient Rx LP	PREGABALIN	25	mg/1		CV	N	20241231
82804-051_3fa7b9c3-f500-49d5-b0c5-27ff01779713	82804-051	HUMAN PRESCRIPTION DRUG	Loxapine		Loxapine	CAPSULE	ORAL	20110926		ANDA	ANDA090695	Proficient Rx LP	LOXAPINE SUCCINATE	5	mg/1			N	20241231
82804-052_f19bf286-f4dd-4491-90c3-9f8713071903	82804-052	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	GEL	TOPICAL	20160913		ANDA	ANDA208301	Proficient Rx LP	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82804-053_89df6a0f-6602-4c22-a052-b565ea8368a7	82804-053	HUMAN PRESCRIPTION DRUG	Levothyroxine sodium		Levothyroxine Sodium	TABLET	ORAL	20201125		ANDA	ANDA212399	Proficient Rx LP	LEVOTHYROXINE SODIUM	75	ug/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82804-054_f3af6315-08b5-4ff9-80ae-2984f0598611	82804-054	HUMAN PRESCRIPTION DRUG	Atorvastatin Calcium		atorvastatin calcium	TABLET, FILM COATED	ORAL	20230301		ANDA	ANDA216436	Proficient Rx LP	ATORVASTATIN CALCIUM TRIHYDRATE	20	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20241231
82804-055_c38e051f-5765-4066-9953-2d0832481b1e	82804-055	HUMAN PRESCRIPTION DRUG	MOXIFLOXACIN		MOXIFLOXACIN	SOLUTION/ DROPS	OPHTHALMIC	20171004		ANDA	ANDA206242	Proficient Rx LP	MOXIFLOXACIN HYDROCHLORIDE	5	mg/mL	Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]		N	20251231
82806-001_0d004edb-7ea4-05a6-e063-6394a90a6ca8	82806-001	HUMAN OTC DRUG	Black Rose		LANOLIN	OINTMENT	TOPICAL	20220901		OTC MONOGRAPH DRUG	M016	MAKRA KOZMETIKA D.O.O.	LANOLIN	249.1	mg/g			N	20241231
82806-002_0d0064ea-665b-26f8-e063-6394a90a1615	82806-002	HUMAN OTC DRUG	Sun Protection		LANOLIN, AVOBENZONE, OCTINOXATE	OINTMENT	TOPICAL	20220901		OTC MONOGRAPH DRUG	M016	MAKRA KOZMETIKA D.O.O.	AVOBENZONE; LANOLIN; OCTINOXATE	25; 249.1; 70	mg/g; mg/g; mg/g			N	20241231
82806-003_0d006218-649c-0b73-e063-6394a90a1075	82806-003	HUMAN OTC DRUG	MAKRA TATTOO SUNSCREEN and SKIN PROTECTANT Broad Spectrum SPF 30		AVOBENZONE, LANOLIN, OCTINOXATE	OINTMENT	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	MAKRA KOZMETIKA D.O.O.	AVOBENZONE; LANOLIN; OCTINOXATE	25; 249.1; 70	mg/g; mg/g; mg/g			N	20241231
82810-111_0a075ab9-bc5e-dc0c-e063-6394a90aafde	82810-111	HUMAN OTC DRUG	Aldamed		PainElimin with collagen cooling	GEL	TOPICAL	20220808		OTC MONOGRAPH DRUG	M017	Green Idea s.r.o.	CAMPHOR (SYNTHETIC); MENTHOL	3; 3	mg/100mL; mg/100mL			N	20241231
82810-112_0a1d86e3-00b2-e93c-e063-6394a90ade3f	82810-112	HUMAN OTC DRUG	Aldamed		PainElimin Extra Strong Cooling	GEL	TOPICAL	20220906		OTC MONOGRAPH DRUG	M017	Green Idea s.r.o.	CAMPHOR (SYNTHETIC); MENTHOL	3; 2	mg/100mL; mg/100mL			N	20241231
82810-113_0a1d5aeb-3c62-6485-e063-6294a90a8654	82810-113	HUMAN OTC DRUG	Aldamed		PainElimin with Hemp Cooling	GEL	TOPICAL	20220906		OTC MONOGRAPH DRUG	M017	Green Idea s.r.o.	CAMPHOR (SYNTHETIC); MENTHOL	3; 2	mg/100mL; mg/100mL			N	20241231
82810-114_0a45e70e-ab0f-ca6a-e063-6394a90a068e	82810-114	HUMAN OTC DRUG	Aldamed		Sundermia Sun-Exposure Skin Relief Gel	GEL	TOPICAL	20220906		OTC MONOGRAPH DRUG	M017	Green Idea s.r.o.	MENTHOL	3	mg/100mL			N	20241231
82810-115_0a1d926c-e9b9-faa0-e063-6394a90ab810	82810-115	HUMAN OTC DRUG	Aldamed		Vaporizing Chest Rub Cough Suppressant	CREAM	TOPICAL	20230321		OTC MONOGRAPH DRUG	M012	Green Idea s.r.o.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	3; 1; 2	mg/100mL; mg/100mL; mg/100mL			N	20241231
82811-111_0a07af2c-bd7d-5faa-e063-6394a90a9ceb	82811-111	HUMAN OTC DRUG	Aldamed		PainElimin with collagen cooling	GEL	TOPICAL	20220808		OTC MONOGRAPH DRUG	M017	Herbamedicus, s.r.o.	CAMPHOR (SYNTHETIC); MENTHOL	3; 3	mg/100mL; mg/100mL			N	20241231
82811-112_0a08628f-1f73-0f1d-e063-6294a90ab050	82811-112	HUMAN OTC DRUG	Aldamed		PainElimin Extra Strong Cooling	GEL	TOPICAL	20220906		OTC MONOGRAPH DRUG	M017	Herbamedicus, s.r.o.	CAMPHOR (SYNTHETIC); MENTHOL	3; 2	mg/100mL; mg/100mL			N	20241231
82811-113_0a07af2c-bd6e-5faa-e063-6394a90a9ceb	82811-113	HUMAN OTC DRUG	Aldamed		PainElimin with Hemp Cooling	GEL	TOPICAL	20220906		OTC MONOGRAPH DRUG	M017	Herbamedicus, s.r.o.	CAMPHOR (SYNTHETIC); MENTHOL	3; 2	mg/100mL; mg/100mL			N	20241231
82811-114_0a07a426-394e-8e6e-e063-6294a90ae94d	82811-114	HUMAN OTC DRUG	Aldamed		Sundermia Sun-Exposure Skin Relief Gel	GEL	TOPICAL	20220906		OTC MONOGRAPH DRUG	M017	Herbamedicus, s.r.o.	MENTHOL	3	mg/100mL			N	20241231
82811-115_0a1dafd7-7126-90ea-e063-6294a90adb40	82811-115	HUMAN OTC DRUG	Aldamed		Vaporizing Chest Rub Cough Suppressant	CREAM	TOPICAL	20230321		OTC MONOGRAPH DRUG	M012	Herbamedicus, s.r.o.	CAMPHOR (SYNTHETIC); EUCALYPTUS OIL; MENTHOL	3; 1; 2	mg/100mL; mg/100mL; mg/100mL			N	20241231
82812-336_09d3ce09-6271-76d1-e063-6294a90af271	82812-336	HUMAN OTC DRUG	MIAMI BEACH BUM Save Face SPF-30 Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220705		OTC MONOGRAPH DRUG	M020	MIAMI BEACH BUM	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82812-337_09e31e63-21e9-2c4d-e063-6294a90a3d86	82812-337	HUMAN OTC DRUG	MIAMI BEACH BUM Blocked SPF-30 Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220705		OTC MONOGRAPH DRUG	M020	MIAMI BEACH BUM	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82813-2650_ff488f16-b30e-117c-e053-6394a90a6ec1	82813-2650	HUMAN OTC DRUG	Sheer Radiance Daily Moisturizer Mineral Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part352	Key Wellness, PLLC.	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
82818-301_f777e6ed-4281-3eea-e053-6294a90af190	82818-301	HUMAN OTC DRUG	Kskinny PCL Slim Body Ampoule		Phosphatidylcholine	SOLUTION/ DROPS	TOPICAL	20220707		UNAPPROVED DRUG OTHER		KSKINNY Co., Ltd	PHOSPHATIDYLCHOLINE:CERAMIDE CHOLINEPHOSPHOTRANSFERASE 1	3.21	g/100mL			N	20241231
82822-001_e34f6b5e-a25d-ae2d-e053-2a95a90a6611	82822-001	HUMAN OTC DRUG	LE K - ESSENTIAL-DM	ALOE VERA	BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20220722		OTC MONOGRAPH NOT FINAL	part333A	HCD ANTI AGING LABORATORIES LLC	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
82822-010_e4685baf-e0f1-eb37-e053-2a95a90a6dea	82822-010	HUMAN OTC DRUG	LE K - CBD PURE CALM	LAVENDER	BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20220722		OTC MONOGRAPH NOT FINAL	part333A	HCD ANTI AGING LABORATORIES LLC	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
82822-100_e580dcaa-2761-47c6-e053-2a95a90a06d7	82822-100	HUMAN OTC DRUG	LE K - IMMUNI-T	LEMON LIME	BENZALKONIUM CHLORIDE	LOTION	TOPICAL	20220722		OTC MONOGRAPH NOT FINAL	part333A	HCD ANTI AGING LABORATORIES LLC	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
82825-001_e2aeebcb-c8a8-660e-e053-2995a90ab603	82825-001	HUMAN OTC DRUG	ALCOGel Hand Sanitizer		alcohol	GEL	TOPICAL	20220630		OTC MONOGRAPH NOT FINAL	part333A	Erie Cotton Products Inc.	ALCOHOL	70	mL/100mL			N	20241231
82829-002_3e31fcc8-05c6-4c34-a0c6-4273f892b71e	82829-002	HUMAN PRESCRIPTION DRUG	IZERVAY		avacincaptad pegol	INJECTION	INTRAVITREAL	20230819		NDA	NDA217225	IVERIC bio, Inc.	AVACINCAPTAD PEGOL SODIUM	20	mg/mL	Complement Inhibitor [EPC], Complement Inhibitors [MoA]		N	20241231
82864-001_f31c77ce-9290-2d59-e053-2995a90a8ae1	82864-001	HUMAN OTC DRUG	Revitalize Energizing Eye Drops		Naphazoline Hydrochloride ,Propylene Glycol	LIQUID	OPHTHALMIC	20230201		OTC MONOGRAPH FINAL	part349	Revitalize Energy Inc.	NAPHAZOLINE HYDROCHLORIDE; PROPYLENE GLYCOL	.03; 1	g/100mL; g/100mL			N	20241231
82865-002_0aaa1c43-52bb-f6b0-e063-6394a90a1362	82865-002	HUMAN OTC DRUG	PAIN RELIEVING		LIDOCAINE	PATCH	TOPICAL	20220501	20260214	OTC MONOGRAPH DRUG	M017	UNIAID Health Management (Suzhou) Co.,Ltd	LIDOCAINE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
82866-000_089fc3c4-f7b4-ba8f-e063-6294a90a950d	82866-000	HUMAN OTC DRUG	PRIDEFUL SPF 15 LIP BALM-cherry vanilla		HOMOSALATE, OCTISALATE, OCTOCRYLENE, AVOBENZONE	STICK	TOPICAL	20220728		OTC MONOGRAPH DRUG	M020	PRIDEFUL LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
82866-001_089fca84-104b-dabe-e063-6294a90adfca	82866-001	HUMAN OTC DRUG	PRIDEFUL SPF 15 LIP BALM-citrus		HOMOSALATE, OCTISALATE, OCTOCRYLENE, AVOBENZONE	STICK	TOPICAL	20220728		OTC MONOGRAPH DRUG	M020	PRIDEFUL LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
82866-002_089fcdb1-9803-b024-e063-6394a90a26d5	82866-002	HUMAN OTC DRUG	PRIDEFUL SPF 15 LIP BALM-coconut		HOMOSALATE, OCTISALATE, OCTOCRYLENE, AVOBENZONE	STICK	TOPICAL	20220728		OTC MONOGRAPH DRUG	M020	PRIDEFUL LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
82866-003_089fcdb1-9812-b024-e063-6394a90a26d5	82866-003	HUMAN OTC DRUG	PRIDEFUL SPF 15 LIP BALM-melon		HOMOSALATE, OCTISALATE, OCTOCRYLENE, AVOBENZONE	STICK	TOPICAL	20220728		OTC MONOGRAPH DRUG	M020	PRIDEFUL LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
82866-004_089fcdb1-9821-b024-e063-6394a90a26d5	82866-004	HUMAN OTC DRUG	PRIDEFUL SPF 15 LIP BALM-orange mango		HOMOSALATE, OCTISALATE, OCTOCRYLENE, AVOBENZONE	STICK	TOPICAL	20220728		OTC MONOGRAPH DRUG	M020	PRIDEFUL LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
82866-005_089fcbdc-abce-8534-e063-6394a90a2923	82866-005	HUMAN OTC DRUG	PRIDEFUL SPF 15 LIP BALM-passion fruit		HOMOSALATE, OCTISALATE, OCTOCRYLENE, AVOBENZONE	STICK	TOPICAL	20220728		OTC MONOGRAPH DRUG	M020	PRIDEFUL LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	20; 100; 50; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
82867-001_ff06d68f-d660-d097-e053-6294a90a7e5f	82867-001	HUMAN PRESCRIPTION DRUG	LODOCO		Colchicine Tablets 0.5 mg	TABLET	ORAL	20230616		NDA	NDA215727	AGEPHA Pharma USA, LLC	COLCHICINE	.5	mg/1	Alkaloid [EPC], Alkaloids [CS], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Interactions [MoA]		N	20241231
82868-001_ffc38ad5-d417-4e68-e053-6294a90aa840	82868-001	HUMAN PRESCRIPTION DRUG	Levothyroxine Sodium		Levothyroxine Sodium	TABLET	ORAL	20230710		ANDA	ANDA209713	Northwind Pharmaceuticals, LLC	LEVOTHYROXINE SODIUM	.2	mg/1	Thyroxine [CS], l-Thyroxine [EPC]		N	20241231
82868-003_03afa75a-5ae5-3921-e063-6294a90aa77a	82868-003	HUMAN PRESCRIPTION DRUG	Propranolol Hydrochloride		Propranolol Hydrochloride	TABLET	ORAL	20230815		ANDA	ANDA071972	Northwind Pharmaceuticals, LLC	PROPRANOLOL HYDROCHLORIDE	20	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
82868-004_03b0aee4-804b-de63-e063-6394a90a6635	82868-004	HUMAN PRESCRIPTION DRUG	Folic Acid		Folic Acid	TABLET	ORAL	20230815		ANDA	ANDA040625	Northwind Pharmaceuticals, LLC	FOLIC ACID	1	mg/1			N	20241231
82868-005_03fd8413-df57-50ab-e063-6394a90a6950	82868-005	HUMAN PRESCRIPTION DRUG	Lamotrigine		Lamotrigine	TABLET	ORAL	20230815		ANDA	ANDA077633	Northwind Pharmaceuticals, LLC	LAMOTRIGINE	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]		N	20241231
82868-006_03b1099f-9fc4-dc67-e063-6394a90a311a	82868-006	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20230818		ANDA	ANDA216211	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
82868-009_03fe0ff5-a384-22c3-e063-6394a90aa8d1	82868-009	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230821		ANDA	ANDA077321	Northwind Pharmaceuticals, LLC	LISINOPRIL	30	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
82868-010_04b31e5a-35c5-8b68-e063-6294a90a7961	82868-010	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20230831		ANDA	ANDA203311	Northwind Pharmaceuticals, LLC	VALSARTAN	80	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20241231
82868-011_04b39bf1-dcd1-18b8-e063-6394a90a0229	82868-011	HUMAN PRESCRIPTION DRUG	Valsartan		Valsartan	TABLET, FILM COATED	ORAL	20230905		ANDA	ANDA205536	Northwind Pharmaceuticals, LLC	VALSARTAN	160	mg/1	Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]		N	20251231
82868-012_04b41542-243e-b7ed-e063-6294a90a71c3	82868-012	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20230830		ANDA	ANDA077066	Northwind Pharmaceuticals, LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
82868-012_0631dc59-463d-8f2d-e063-6294a90a1a7b	82868-012	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20230920		ANDA	ANDA077066	Northwind Pharmaceuticals, LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
82868-013_0a72bc4f-ee0c-f927-e063-6394a90a437d	82868-013	HUMAN PRESCRIPTION DRUG	Baclofen		Baclofen	TABLET	ORAL	20230927		ANDA	ANDA072234	Northwind Pharmaceuticals, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20251231
82868-014_0c580ed0-af2e-3a91-e063-6394a90a86fe	82868-014	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20230928		ANDA	ANDA206560	Northwind Pharmaceuticals, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20251231
82868-015_075fc256-266b-f8fd-e063-6294a90a05dd	82868-015	HUMAN PRESCRIPTION DRUG	nitrofurantoin macrocrystals		nitrofurantoin macrocrystals	CAPSULE	ORAL	20231006		ANDA	ANDA217272	Northwind Pharmaceuticals, LLC	NITROFURANTOIN	100	mg/1	Nitrofuran Antibacterial [EPC], Nitrofurans [CS]		N	20241231
82868-016_075ff876-2661-4489-e063-6294a90ab13a	82868-016	HUMAN PRESCRIPTION DRUG	HYDROCHLOROTHIAZIDE		hydrochlorothiazide	TABLET	ORAL	20231006		ANDA	ANDA085182	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE	50	mg/1	Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
82868-017_076017ce-8ab2-1336-e063-6394a90a76b5	82868-017	HUMAN PRESCRIPTION DRUG	Minocycline hydrochloride		Minocycline hydrochloride	CAPSULE	ORAL	20231004		ANDA	ANDA063009	Northwind Pharmaceuticals, LLC	MINOCYCLINE HYDROCHLORIDE	100	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
82868-018_08659f5f-269b-6db2-e063-6294a90af818	82868-018	HUMAN PRESCRIPTION DRUG	Fenofibrate		Fenofibrate	TABLET	ORAL	20231017		ANDA	ANDA090856	Northwind Pharmaceuticals, LLC	FENOFIBRATE	145	mg/1	Peroxisome Proliferator Receptor alpha Agonist [EPC]		N	20241231
82868-019_0865fba8-cb19-d3ab-e063-6394a90ab222	82868-019	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	SR	bupropion hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20231019		ANDA	ANDA205794	Northwind Pharmaceuticals, LLC	BUPROPION HYDROCHLORIDE	150	mg/1	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]		N	20241231
82868-020_0a1ea9fd-9c78-4889-e063-6394a90afbba	82868-020	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20231019		ANDA	ANDA215788	Northwind Pharmaceuticals, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
82868-021_08676fab-a5b6-94a8-e063-6294a90aa861	82868-021	HUMAN PRESCRIPTION DRUG	Nitrofurantoin	(monohydrate/macrocrystals)	Nitrofurantoin monohydrate/macrocrystals	CAPSULE	ORAL	20231023		ANDA	ANDA207372	Northwind Pharmaceuticals, LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
82868-022_08f38d50-490b-56d9-e063-6294a90a4dea	82868-022	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	CAPSULE	ORAL	20231024		ANDA	ANDA208358	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	25; 37.5	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
82868-023_09a50ecc-3465-1b41-e063-6394a90a55c2	82868-023	HUMAN PRESCRIPTION DRUG	Nortriptyline Hydrochloride		Nortriptyline Hydrochloride	CAPSULE	ORAL	20231031		ANDA	ANDA075520	Northwind Pharmaceuticals, LLC	NORTRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
82868-024_09a5bddd-4b5f-696b-e063-6394a90a2d19	82868-024	HUMAN PRESCRIPTION DRUG	Diltiazem Hydrochloride		Diltiazem Hydrochloride	TABLET	ORAL	20231103		ANDA	ANDA216521	Northwind Pharmaceuticals, LLC	DILTIAZEM HYDROCHLORIDE	60	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
82868-025_0a1e3e61-5dfe-25ab-e063-6394a90a8cd7	82868-025	HUMAN PRESCRIPTION DRUG	Glipizide		Glipizide	TABLET, EXTENDED RELEASE	ORAL	20231108		ANDA	ANDA206928	Northwind Pharmaceuticals, LLC	GLIPIZIDE	5	mg/1	Sulfonylurea Compounds [CS], Sulfonylurea [EPC]		N	20241231
82868-026_0a1e4275-7fb6-f08c-e063-6294a90a212b	82868-026	HUMAN PRESCRIPTION DRUG	Estradiol		Estradiol	TABLET	ORAL	20231109		ANDA	ANDA217334	Northwind Pharmaceuticals, LLC	ESTRADIOL	2	mg/1	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20251231
82868-027_0a730e0f-d703-dbf1-e063-6294a90a57f8	82868-027	HUMAN PRESCRIPTION DRUG	Potassium Chloride		potassium chloride	TABLET, EXTENDED RELEASE	ORAL	20231114		ANDA	ANDA074726	Northwind Pharmaceuticals, LLC	POTASSIUM CHLORIDE	750	mg/1	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20251231
82868-028_0afd069b-74c1-2dd1-e063-6394a90ac524	82868-028	HUMAN PRESCRIPTION DRUG	Tadalafil		Tadalafil	TABLET	ORAL	20231116		ANDA	ANDA206286	Northwind Pharmaceuticals, LLC	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20251231
82868-029_0c581608-8ef9-5c72-e063-6294a90a72e9	82868-029	HUMAN PRESCRIPTION DRUG	ATORVASTATIN CALCIUM		ATORVASTATIN CALCIUM	TABLET, FILM COATED	ORAL	20231130		ANDA	ANDA090548	Northwind Pharmaceuticals, LLC	ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE	40	mg/1	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]		N	20251231
82868-030_0de69ab0-7808-a735-e063-6394a90a132a	82868-030	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen Sodium	TABLET	ORAL	20231212		ANDA	ANDA074140	Northwind Pharmaceuticals, LLC	NAPROXEN SODIUM	375	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
82868-031_0de69ab0-7809-a735-e063-6394a90a132a	82868-031	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20231212		ANDA	ANDA203245	Northwind Pharmaceuticals, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20251231
82868-032_0de7211d-b8cd-214d-e063-6294a90aec41	82868-032	HUMAN PRESCRIPTION DRUG	Triamterene and Hydrochlorothiazide		Triamterene and Hydrochlorothiazide	TABLET	ORAL	20231226		ANDA	ANDA216211	Northwind Pharmaceuticals, LLC	HYDROCHLOROTHIAZIDE; TRIAMTERENE	50; 75	mg/1; mg/1	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]		N	20251231
82868-033_0de6ad92-ad22-8116-e063-6294a90ac1a3	82868-033	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20231214		ANDA	ANDA077253	Northwind Pharmaceuticals, LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20251231
82868-034_0de7be17-d503-03b4-e063-6394a90abf69	82868-034	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20231220		ANDA	ANDA210071	Northwind Pharmaceuticals, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
82869-001_088b81e4-76c3-6680-e063-6294a90acb73	82869-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20220713		UNAPPROVED MEDICAL GAS		Comanche County Hospital Authority DBA Lawton Medi-Equip	OXYGEN	99	L/100L			N	20241231
82870-001_e4ce6c19-e6dc-278b-e053-2a95a90a3537	82870-001	HUMAN OTC DRUG	Wonderscreen Broad Spectrum SPF 30		Zinc Oxide	CREAM	TOPICAL	20220225		OTC MONOGRAPH FINAL	M020	Dime Beauty Co, LLC	ZINC OXIDE	19	g/100g			N	20241231
82870-002_e4ce6afd-8c90-cbc9-e053-2995a90aaa71	82870-002	HUMAN OTC DRUG	Creamy Foam Cleanser		Salicylic Acid	CREAM	TOPICAL	20220711		OTC MONOGRAPH FINAL	M006	Dime Beauty Co, LLC	SALICYLIC ACID	.5	g/100mL			N	20241231
82870-003_e5c35684-e8b6-70fd-e053-2a95a90aedae	82870-003	HUMAN OTC DRUG	Acne Toner Serum		Salicylic Acid	CREAM	TOPICAL	20220812		OTC MONOGRAPH FINAL	M006	Dime Beauty Co, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
82870-005_f2a59fa4-f19d-a15f-e053-2a95a90a6ace	82870-005	HUMAN OTC DRUG	Wonderscreen Tinted Broad Spectrum SPF 30		Zinc Oxide	CREAM	TOPICAL	20230202		OTC MONOGRAPH FINAL	M020	Dime Beauty Co, LLC	ZINC OXIDE	19	g/100g			N	20241231
82870-006_f7fd3f24-7c28-b45b-e053-6394a90a50ae	82870-006	HUMAN OTC DRUG	Acne Spot Treatment		Salicylic Acid	CREAM	TOPICAL	20230327		OTC MONOGRAPH FINAL	M006	Dime Beauty Co, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
82870-007_07104cbf-0447-a053-e063-6394a90ab41f	82870-007	HUMAN OTC DRUG	Wonderscreen Broad Spectrum SPF 30 Shade 1		Zinc Oxide	CREAM	TOPICAL	20231006		OTC MONOGRAPH DRUG	M020	Dime Beauty Co, LLC	ZINC OXIDE	19	g/100g			N	20241231
82870-008_082da06e-990c-1cae-e063-6294a90a9e75	82870-008	HUMAN OTC DRUG	Wonderscreen Tinted Broad Spectrum SPF 30 Shade 3		Zinc Oxide	CREAM	TOPICAL	20231009		OTC MONOGRAPH DRUG	M020	Dime Beauty Co, LLC	ZINC OXIDE	19	g/100g			N	20241231
82871-301_0d8ccd5a-6a26-9524-e063-6394a90a2021	82871-301	HUMAN OTC DRUG	Stomasin		Gypsum fibrosum extract, Forsythia viridissima fruit extract, Arctium lappa fruit extract, Platycodon grandiflorus root extract, Saposhnikovia divaricata root extract, Glycyrrhiza uralensis root extract, Ostericum koreanum extract, Schizonepeta tenuifolia extract	CAPSULE, COATED	ORAL	20220713		UNAPPROVED HOMEOPATHIC		MedicareBio.Co.Ltd	ARCTIUM LAPPA FRUIT; CALCIUM SULFATE, UNSPECIFIED FORM; FORSYTHIA VIRIDISSIMA FRUIT; GLYCYRRHIZA URALENSIS ROOT; NEPETA TENUIFOLIA FLOWERING TOP; OSTERICUM GROSSESERRATUM ROOT; PLATYCODON GRANDIFLORUM ROOT; SAPOSHNIKOVIA DIVARICATA ROOT	500; 1665; 835; 250; 250; 250; 500; 500	mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
82875-001_0d3842c0-149c-b681-e063-6394a90a52ed	82875-001	HUMAN OTC DRUG	CorneaCare Recover for dry eyes		Glycerin, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20230101		OTC MONOGRAPH DRUG	M018	CorneaCare Inc.	GLYCERIN; POVIDONE	.63; .25	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
82876-010_01e2ae1a-c96a-6dd2-e063-6394a90a9d9e	82876-010	HUMAN OTC DRUG	Cannarelief 1000mg		Menthol	SALVE	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part348	Carolina Cannabis Creations LLC	MENTHOL	7.9	g/71.9g			N	20241231
82876-011_01f8155d-7221-70ae-e063-6394a90aeec5	82876-011	HUMAN OTC DRUG	Cannarelief 2000mg		Menthol	SALVE	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part348	Carolina Cannabis Creations LLC	MENTHOL	7.9	g/71.9g			N	20241231
82876-221_01f8795b-9f96-c793-e063-6394a90a8330	82876-221	HUMAN OTC DRUG	Healing Hand Cream 2000mg		Menthol	SALVE	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part348	Carolina Cannabis Creations LLC	MENTHOL	1.4	g/111.45g			N	20241231
82876-438_04b54195-468d-33ab-e063-6294a90acd13	82876-438	HUMAN OTC DRUG	Allantoin		Medicinal Massage Oil	OIL	TOPICAL	20220906		OTC MONOGRAPH FINAL	M016	Carolina Cannabis Creations L.L.C	ALLANTOIN	1	g/108.48g			N	20241231
82876-830_04a6e079-d599-17a8-e063-6394a90a7465	82876-830	HUMAN OTC DRUG	Uplift Chewable		Caffeine	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part340	Carolina Cannabis Creations LLC	CAFFEINE	1	g/108.27g	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
82876-831_04a72aec-0e61-5d16-e063-6294a90a3c49	82876-831	HUMAN OTC DRUG	Uplift Chewable		Caffeine	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part340	Carolina Cannabis Creations LLC	CAFFEINE	1	g/108.27g	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
82876-832_04a75f75-ccac-608e-e063-6294a90adc84	82876-832	HUMAN OTC DRUG	Uplift Chewable		Caffeine	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part340	Carolina Cannabis Creations LLC	CAFFEINE	1	g/108.27g	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
82876-833_04a71ddc-403a-4f5d-e063-6394a90acfa1	82876-833	HUMAN OTC DRUG	Uplift Chewable		Caffeine	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part340	Carolina Cannabis Creations LLC	CAFFEINE	1	g/108.27g	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
82876-840_04a79a9d-78bd-dbea-e063-6294a90ad5f1	82876-840	HUMAN OTC DRUG	Soothe Chewable		Citric Acid	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part331	Carolina Cannabis Creations LLC	CITRIC ACID MONOHYDRATE	1.5	g/108.27g	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
82876-841_04a77d35-25c9-6092-e063-6294a90ae4c4	82876-841	HUMAN OTC DRUG	Soothe Chewable		Citric Acid	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part331	Carolina Cannabis Creations LLC	CITRIC ACID MONOHYDRATE	1.5	g/108.27g	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
82876-842_04a78a65-73ab-d98e-e063-6294a90a714c	82876-842	HUMAN OTC DRUG	Soothe Chewable		Citric Acid	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part331	Carolina Cannabis Creations LLC	CITRIC ACID MONOHYDRATE	1.5	g/108.27g	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
82876-843_04a7721c-f33f-7573-e063-6394a90ae0c9	82876-843	HUMAN OTC DRUG	Soothe Chewable		Citric Acid	CHEWABLE GEL	ORAL	20230801		OTC MONOGRAPH FINAL	part331	Carolina Cannabis Creations LLC	CITRIC ACID MONOHYDRATE	1.5	g/108.27g	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
82879-0001_e3a60e33-2a18-2307-e053-2a95a90a7996	82879-0001	HUMAN OTC DRUG	INTOMEDI Amplance Hydro		adenosine	LIQUID	TOPICAL	20220713		UNAPPROVED DRUG OTHER		Janytree Inc.	ADENOSINE	.1	g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82879-0002_e3a633e8-0210-2c1f-e053-2995a90a6fc5	82879-0002	HUMAN OTC DRUG	INTOMEDI Amplance HydroCream		adenosine	CREAM	TOPICAL	20220713		UNAPPROVED DRUG OTHER		Janytree Inc.	ADENOSINE	.1	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82879-0003_e3a67a76-3f1a-3e13-e053-2995a90a4bbe	82879-0003	HUMAN OTC DRUG	INTOMEDI FIRST AMPOULE EGF		adenosine	LIQUID	TOPICAL	20220713		UNAPPROVED DRUG OTHER		Janytree Inc.	ADENOSINE	.04	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82879-0004_e3a7311c-632a-7a7d-e053-2995a90a7da1	82879-0004	HUMAN OTC DRUG	INTOMEDI FIRST AMPOULE CYSTEINE		niacinamide	LIQUID	TOPICAL	20220713		UNAPPROVED DRUG OTHER		Janytree Inc.	NIACINAMIDE	2	g/100mL			N	20241231
82879-0005_e3a752d8-e306-276b-e053-2a95a90a2479	82879-0005	HUMAN OTC DRUG	INTOMEDI FIRST AMPOULE PLACENTA		adenosine	LIQUID	TOPICAL	20220713		UNAPPROVED DRUG OTHER		Janytree Inc.	ADENOSINE	.1	g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
82879-0006_e3a7d79b-d06b-9547-e053-2995a90a2712	82879-0006	HUMAN OTC DRUG	INTOMEDI FIRST AMPOULE PEPTIDE		Sodium Hyaluronate	LIQUID	TOPICAL	20220713		UNAPPROVED DRUG OTHER		Janytree Inc.	HYALURONATE SODIUM	.5	g/100mL			N	20241231
82879-0007_e3a82785-3035-6712-e053-2a95a90a07e1	82879-0007	HUMAN OTC DRUG	INTOMEDI HR PEPTIDE		Niacinamide	LIQUID	TOPICAL	20220713		UNAPPROVED DRUG OTHER		Janytree Inc.	NIACINAMIDE	.3	g/100mL			N	20241231
82892-302_fa10a8a7-82c4-8353-e053-6394a90a87b7	82892-302	HUMAN OTC DRUG	LACTO REMEDY ladys cleansing wipes		Lactobacillus Ferment Lysate	SWAB	TOPICAL	20220726		UNAPPROVED DRUG OTHER		Body and Co Corp.	LIMOSILACTOBACILLUS FERMENTUM	.01	g/100g			N	20241231
82892-303_fa10d2e1-77f0-d62d-e053-6394a90a692a	82892-303	HUMAN OTC DRUG	LACTO REMEDY Ladys foaming wash		Lactobacillus Ferment Lysate	LIQUID	TOPICAL	20220726		UNAPPROVED DRUG OTHER		Body and Co Corp.	LIMOSILACTOBACILLUS FERMENTUM	.0176	g/100g			N	20241231
82892-304_fa10e0cb-1f81-4e46-e053-6294a90a9a3b	82892-304	HUMAN OTC DRUG	LACTO REMEDY Ladys inner care gel		Lactobacillus Ferment Lysate	SOLUTION, GEL FORMING / DROPS	TOPICAL	20220725		UNAPPROVED DRUG OTHER		Body and Co Corp.	LIMOSILACTOBACILLUS FERMENTUM	.025	g/100g			N	20241231
82895-715_0c419012-62b2-e052-e063-6394a90ab7ad	82895-715	HUMAN OTC DRUG	Westlake Itch Relief		Diphenhydramine HCl, Zinc Acetate	SPRAY	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	Westlake HB Pharma LLC	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
82895-716_0c53d505-4d34-bb34-e063-6394a90abc7b	82895-716	HUMAN OTC DRUG	Westlake Anti-itch		HYDROCORTISONE	CREAM	TOPICAL	20230303		OTC MONOGRAPH DRUG	M017	Westlake Pharma LLC	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82895-717_0c586a14-1a29-9f42-e063-6294a90a16c1	82895-717	HUMAN OTC DRUG	Westlake Lidocaine		Lidocaine HCL	CREAM	TOPICAL	20231001		OTC MONOGRAPH DRUG	M017	Westlake Pharma LLC	LIDOCAINE HYDROCHLORIDE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82895-857_0d6ce7d1-99b1-25b0-e063-6394a90a79f5	82895-857	HUMAN OTC DRUG	Chigg Away		Benzocaine	LOTION	TOPICAL	20220623		OTC MONOGRAPH DRUG	M017	Westlake HB Pharma LLC	BENZOCAINE	50	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
82897-293_09e37389-88c4-6f4c-e063-6394a90a9861	82897-293	HUMAN OTC DRUG	GRANULOTION Hemorrhoidal		MENTHOL, ZINC OXIDE	LOTION	TOPICAL	20220520		OTC MONOGRAPH DRUG	M015	GL Health, Inc.	MENTHOL; ZINC OXIDE	1.1; 51	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82897-379_0976dfc5-c368-11fe-e063-6294a90aa2bb	82897-379	HUMAN OTC DRUG	GL HEALTH Barrier Skin Protectant		ZINC OXIDE	CREAM	TOPICAL	20221216		OTC MONOGRAPH DRUG	M016	GL HEALTH, INC.	ZINC OXIDE	205	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82898-001_f90ec2a3-f2fa-d269-e053-6294a90af71d	82898-001	HUMAN OTC DRUG	EnaSkin Dark Spot Corrector		niacinamide, 3-o-ethyl ascorbic acid, alpha-arbutin, panthenol	LIQUID	TOPICAL	20230410		UNAPPROVED DRUG OTHER		EnaSkin LLC	3-O-ETHYL ASCORBIC ACID; ALPHA-ARBUTIN; NIACINAMIDE; PANTHENOL	2; 1; 3; .5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82899-0650_026b9b39-ff40-d80f-e063-6394a90ac5b0	82899-0650	HUMAN OTC DRUG	Stay AgelessTinted Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part352	Spectrum Aesthetics Laser Training LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
8290-3268_6fc8e4b2-96b3-4f04-8fa8-8ae4ae1cf82f	8290-3268	HUMAN OTC DRUG	Isopropyl Alcohol		Isopropyl Alcohol	SWAB	TOPICAL	19931001		OTC MONOGRAPH DRUG	505G(a)(3)	Becton Dickinson and Company	ISOPROPYL ALCOHOL	.75	g/1			N	20241231
82901-002_0a476db2-d62a-7fa5-e063-6294a90a6482	82901-002	HUMAN OTC DRUG	PentaCleanse Alcohol Wipes		Alcohol	CLOTH	TOPICAL	20220914		OTC MONOGRAPH DRUG	505G(a)(3)	Prestige Care Pharmacy Inc	ALCOHOL	75	mL/100mL			N	20241231
82904-301_0688a09e-f918-28f7-e063-6294a90a33c9	82904-301	HUMAN OTC DRUG	I DEW CARE FIX MY ZIT ACNE GELTREATMENT		SALICYLIC ACID	GEL	TOPICAL	20220808		OTC MONOGRAPH FINAL	M006	Memebox Corporation	SALICYLIC ACID	.55	g/100mL			N	20241231
82904-301_fe38d247-9f00-3801-e053-6394a90aaeb2	82904-301	HUMAN OTC DRUG	I DEW CARE FIX MY ZIT ACNE GELTREATMENT		SALICYLIC ACID	GEL	TOPICAL	20220808		OTC MONOGRAPH FINAL	M006	Memebox Corporation	SALICYLIC ACID	.55	g/100mL			N	20241231
82904-303_069a06f1-e325-77cd-e063-6394a90aee9a	82904-303	HUMAN OTC DRUG	I DEW CARE CLEAN ZIT AWAY ACNE FOAMING CLEANSER		Salicylic Acid	LIQUID	TOPICAL	20220927		OTC MONOGRAPH FINAL	M006	Memebox Corporation	SALICYLIC ACID	1.5	g/100mL			N	20241231
82904-303_fe38d235-1473-8dd7-e053-6394a90a0161	82904-303	HUMAN OTC DRUG	I DEW CARE CLEAN ZIT AWAY ACNE FOAMING CLEANSER		Salicylic Acid	LIQUID	TOPICAL	20220927		OTC MONOGRAPH FINAL	M006	Memebox Corporation	SALICYLIC ACID	1.5	g/100mL			N	20241231
82904-304_069a419c-f61a-e604-e063-6394a90a7f8b	82904-304	HUMAN OTC DRUG	I DEW CARE TEA TREE O STARTERKIT		Salicylic Acid	KIT		20220927		OTC MONOGRAPH FINAL	M006	Memebox Corporation						N	20241231
82904-304_fe38fb5e-e1f2-b20e-e053-6394a90a3241	82904-304	HUMAN OTC DRUG	I DEW CARE TEA TREE O STARTERKIT		Salicylic Acid	KIT		20220927		OTC MONOGRAPH FINAL	M006	Memebox Corporation						N	20241231
82906-506_3b3b24e6-8c4f-4fff-9178-aee598b413f4	82906-506	HUMAN PRESCRIPTION DRUG	Reveos Select CPD/AS-5 Red Cell Preservative For Collection Of Blood		Dextrose Monohydrate, Trisodium Citrate Dihydrate, Anhydrous Citric Acid, and Sodium Phosphate, Monobasic, Unspecified Form	SOLUTION	INTRAVENOUS	20230816		NDA	BN880217	Terumo BCT Vietnam CO., Ltd.	ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM; TRISODIUM CITRATE DIHYDRATE	.229; 1.624; .176; 1.841	g/70mL; g/70mL; g/70mL; g/70mL	Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]		N	20241231
82908-357_09e37389-88cf-6f4c-e063-6394a90a9861	82908-357	HUMAN OTC DRUG	AMINO ACTIVE Topical Analgesic Cream		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20220808		OTC MONOGRAPH DRUG	M017	VIREO SYSTEMS, INC.	HISTAMINE DIHYDROCHLORIDE	.25	mg/mL			N	20241231
82908-358_09e37389-88df-6f4c-e063-6394a90a9861	82908-358	HUMAN OTC DRUG	CLARIFAST One Step Acne Treatment		SALICYLIC ACID	CREAM	TOPICAL	20220808		OTC MONOGRAPH DRUG	M006	VIREO SYSTEMS, INC.	SALICYLIC ACID	5	mg/mL			N	20241231
82912-322_09e35e72-c04e-4d9a-e063-6294a90acdd1	82912-322	HUMAN OTC DRUG	PROTEKT SPF-50 Sheer Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220701		OTC MONOGRAPH DRUG	M020	Protekt Products, Inc.	ZINC OXIDE	180	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82912-323_09e35e72-c05e-4d9a-e063-6294a90acdd1	82912-323	HUMAN OTC DRUG	PROTEKT SPF-50 Sheer Mineral Sunscreen		ZINC OXIDE	CREAM	TOPICAL	20220701		OTC MONOGRAPH DRUG	M020	Protekt Products, Inc.	ZINC OXIDE	180	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
82913-001_00c7c8e2-ece9-cbaf-e063-6394a90a2459	82913-001	HUMAN OTC DRUG	AutoBrush Bubblegum		Sodium Fluoride	LIQUID	ORAL	20220801		OTC MONOGRAPH FINAL	part355	Lander Enterprises, LLC	SODIUM FLUORIDE	.24	g/100mL			N	20241231
82913-002_00c79b30-0929-5b40-e063-6394a90a0bb1	82913-002	HUMAN OTC DRUG	AutoBrush strawberry		Sodium Fluoride	LIQUID	ORAL	20220801		OTC MONOGRAPH FINAL	part355	Lander Enterprises, LLC	SODIUM FLUORIDE	.24	g/100mL			N	20241231
82913-003_00c7ebb1-861d-4973-e063-6294a90a3d22	82913-003	HUMAN OTC DRUG	AutoBrush Watermelon		Sodium Fluoride	LIQUID	ORAL	20221201		OTC MONOGRAPH FINAL	part355	Lander Enterprises, LLC	SODIUM FLUORIDE	.24	g/100mL			N	20241231
82913-004_00c78586-02df-4426-e063-6394a90a61a6	82913-004	HUMAN OTC DRUG	AutoBrush Mint		Sodium Fluoride	LIQUID	ORAL	20221201		OTC MONOGRAPH FINAL	part355	Lander Enterprises, LLC	SODIUM FLUORIDE	.24	g/100mL			N	20241231
82916-030_27a2ae92-023b-49f4-8f57-1efdb9f02ae1	82916-030	HUMAN OTC DRUG	CH6 Scalp Ssag Serum Red Edition		L Menthol, Salicylic Acid, Dexpanthenol	LIQUID	TOPICAL	20220801		UNAPPROVED DRUG OTHER		Rea Company	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.2; .3; .25	g/100mL; g/100mL; g/100mL			N	20241231
82916-120_ed2a3f21-b746-4064-bed4-6685437c74c9	82916-120	HUMAN OTC DRUG	CH6 GREENOL HERB HAIR CONTROL NON WASH TREATMENT		LEVOMENTHOL, SALICYLIC ACID, DEXPANTHENOL	LIQUID	TOPICAL	20221001		UNAPPROVED DRUG OTHER		Rea Company	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.2; .3; .25	g/100mL; g/100mL; g/100mL			N	20241231
82916-130_1c4b938e-6f0e-4a76-9e68-f5e4c0f6f39a	82916-130	HUMAN OTC DRUG	CH6 SCALP SSAG		LEVOMENTHOL, SALICYLIC ACID, NIACINAMIDE	SHAMPOO	TOPICAL	20221001		UNAPPROVED DRUG OTHER		Rea Company	LEVOMENTHOL; NIACINAMIDE; SALICYLIC ACID	.3; .1; .2	g/100mL; g/100mL; g/100mL			N	20241231
82916-140_a70779a5-db15-457e-af02-4e5e933f23d0	82916-140	HUMAN OTC DRUG	CH6 SCALP SSAG SERUM		LEVOMENTHOL, SALICYLIC ACID, Dexpanthenol	LIQUID	TOPICAL	20221001		UNAPPROVED DRUG OTHER		Rea Company	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.2; .3; .25	g/100mL; g/100mL; g/100mL			N	20241231
82918-001_7a9af416-2a5d-494a-9bb4-5df28273b374	82918-001	HUMAN OTC DRUG	Anti-Gas Strip		SIMETHICONE	STRIP	ORAL	20230720		OTC MONOGRAPH FINAL	part332	Calmour	DIMETHICONE	62.5	mg/1	Skin Barrier Activity [PE]		N	20241231
82931-001_19e7a666-f960-4453-8744-08f37e08320c	82931-001	HUMAN OTC DRUG	SAND AND SKY TINTED GLOW PRIMER SPF30		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230101		OTC MONOGRAPH FINAL	part352	Supernova USA Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 4; 2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82931-002_1fc1b603-bc69-4f0a-997e-bd2afeef265c	82931-002	HUMAN OTC DRUG	COCO AND EVE DAILY RADIANCE PRIMER SPF 50		COCO AND EVE DAILY RADIANCE PRIMER SPF 50	LOTION	TOPICAL	20230401		OTC MONOGRAPH FINAL	part352	Supernova USA Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 8; 5; 6	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82931-003_2ff24811-2e53-4bed-a115-a60461d10781	82931-003	HUMAN OTC DRUG	COCO EVE BODY SUNSCREEN SPF50 plus		COCO EVE BODY SUNSCREEN SPF50 plus	LOTION	TOPICAL	20230104		OTC MONOGRAPH FINAL	part352	Supernova USA Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82931-004_16e5b75e-6282-4df4-8f63-4a60bea58b85	82931-004	HUMAN OTC DRUG	Sand Sky Australian Sunshield Body Sunscreen SPF50 plus		Sand Sky Australian Sunshield Body Sunscreen spf50 plus	LOTION	TOPICAL	20230104		OTC MONOGRAPH FINAL	part352	Supernova USA Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82931-005_10d78a03-f625-4b75-a1a4-ec05f712703e	82931-005	HUMAN OTC DRUG	coco and eve tan boosting anti-aging body oil spf 30		coco and eve tan boosting anti-aging body oil spf 30	LOTION	TOPICAL	20240101		OTC MONOGRAPH FINAL	part352	Supernova USA Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82931-008_1e1cf1f2-9958-438c-8b88-2a9f0265af11	82931-008	HUMAN OTC DRUG	coco and eve tan boosting anti-aging body oil spf 30		coco and eve tan boosting anti-aging body oil spf 30	LOTION	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Supernova USA Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82931-011_17138fe0-3273-4832-9e0d-d7d1a32c2e9a	82931-011	HUMAN OTC DRUG	coco and eve tan boosting anti-aging body oil spf 20		coco and eve tan boosting anti-aging body oil spf 20	LOTION	TOPICAL	20240101		OTC MONOGRAPH DRUG	M020	Supernova USA Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20251231
82937-003_05f42449-bc8d-397a-e063-6294a90a1f47	82937-003	HUMAN OTC DRUG	CARIBBEAN BEAUTY - SCALP TREATMENT MASK		SALICYLIC ACID	CREAM	TOPICAL	20220829		OTC MONOGRAPH DRUG	M032	ZM Group of companies	SALICYLIC ACID	7.0753	g/237mL			N	20241231
82939-000_0c06e3d2-4481-f4b5-e063-6394a90a0608	82939-000	HUMAN OTC DRUG	ORCA Complete Menthol Pain Reliever		MENTHOL	LIQUID	ORAL	20220915		OTC MONOGRAPH DRUG	M022	ORCA Products, LLC	MENTHOL, UNSPECIFIED FORM	20	mg/mL			N	20241231
82939-001_09ce4763-a8e6-7cff-e063-6294a90a851c	82939-001	HUMAN OTC DRUG	ORCA Pain Reliever Putty with Menthol		MENTHOL	PASTE	ORAL	20220915		OTC MONOGRAPH DRUG	M022	ORCA Products, LLC	MENTHOL, UNSPECIFIED FORM	8.4	mg/.525g			N	20241231
82942-1003_fb407714-dde8-d3d2-e053-6294a90a6197	82942-1003	HUMAN OTC DRUG	Hydrocortisone		HYDROCORTISONE	CREAM	TOPICAL	20230508		OTC MONOGRAPH NOT FINAL	part348	J&A Digital Inc.	HYDROCORTISONE	10	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82943-100_481dc90c-9ba2-4063-93a9-4729f034add4	82943-100	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		Cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20240101		NDA	NDA217651	Nevakar Injectables Inc.	CYCLOPHOSPHAMIDE	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
82943-101_481dc90c-9ba2-4063-93a9-4729f034add4	82943-101	HUMAN PRESCRIPTION DRUG	CYCLOPHOSPHAMIDE		Cyclophosphamide	INJECTION, SOLUTION	INTRAVENOUS	20240101		NDA	NDA217651	Nevakar Injectables Inc.	CYCLOPHOSPHAMIDE	200	mg/mL	Alkylating Activity [MoA], Alkylating Drug [EPC]		N	20241231
82944-100_13866e55-3eb0-483e-afc5-a72a0b1c1ae7	82944-100	HUMAN OTC DRUG	LIDOCORE		Lidocaine 4%	PATCH	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part348	Ion Pharma, LLC	LIDOCAINE	4	g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82944-101_1f75c20e-eaf6-4146-80b4-17502a2ea892	82944-101	HUMAN OTC DRUG	Methyl Salicylate 10%		Methyl Salicylate	PATCH	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part348	ION PHARMA, LLC	METHYL SALICYLATE	10	g/1			N	20241231
82944-102_184abc40-746d-43c2-aff7-3065907a8952	82944-102	HUMAN OTC DRUG	LIDOSYNC		Lidocaine 4%, Menthol 1%, Methyl Salicylate 2%	PATCH	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part348	Ion Pharma, LLC	LIDOCAINE; MENTHOL; METHYL SALICYLATE	4; 1; 2	g/1; g/1; g/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82951-002_08f094ec-21ea-877e-e063-6294a90a496c	82951-002	HUMAN PRESCRIPTION DRUG	Acyclovir		Acyclovir	CAPSULE	ORAL	20231002		ANDA	ANDA212173	The Davinci Company	ACYCLOVIR	200	mg/1	DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]		N	20241231
82952-0001_e7b49095-e4d0-072f-e053-2995a90a3fdc	82952-0001	HUMAN OTC DRUG	Morning Sickness and Nausea Pellets		Chamomilla, Hydrastis canadensis, Iris versicolor, Bismuthum metallicum, Bryonia, Cimicifuga racemosa, Gossypium herbaceum, Ipecacuanha, Kreosotum, Lycopodium clavatum, Magnesia carbonica, Nux vomica, Pulsatilla, Sepia, Symphoricarpus racemosus, Tabacum, Zingiber officinale.	PELLET	ORAL	20220908		UNAPPROVED HOMEOPATHIC		Legendairy Milk	ANEMONE PULSATILLA; BISMUTH; BLACK COHOSH; BRYONIA ALBA ROOT; GINGER; GOLDENSEAL; GOSSYPIUM HERBACEUM ROOT BARK; IPECAC; IRIS VERSICOLOR ROOT; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CARBONATE; MATRICARIA CHAMOMILLA; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; SYMPHORICARPOS ALBUS FRUIT; TOBACCO LEAF; WOOD CREOSOTE	15; 15; 15; 15; 15; 6; 15; 15; 6; 15; 15; 6; 15; 15; 15; 15; 15	[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
82953-001_e79eda0c-c293-d877-e053-2995a90a4d77	82953-001	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Cosmuses Cosmetics (Ningbo) Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
82953-002_03f8ce73-d78d-174d-e063-6294a90a6fa1	82953-002	HUMAN OTC DRUG	SUNSCREEN	01	Avobenzone,Homosalate,Octocrylene,Octisalate	CREAM	TOPICAL	20220926		OTC MONOGRAPH NOT FINAL	part352	Cosmuses Cosmetics (Ningbo) Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
82953-003_eafa3c60-a7d8-8ec8-e053-2995a90a5863	82953-003	HUMAN OTC DRUG	sunscreen	01	avobenzone, homosalate, octocrylene, octisalate	SPRAY	TOPICAL	20220930		OTC MONOGRAPH NOT FINAL	part352	Cosmuses Cosmetics (Ningbo) Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82953-004_e9f2a1f1-ceb7-2f20-e053-2a95a90a18db	82953-004	HUMAN OTC DRUG	antiseptic towelette	01	Benzalkonium Chloride	CLOTH	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part333A	Cosmuses Cosmetics (Ningbo) Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/1001			N	20241231
82953-005_e9f90310-1974-ffb2-e053-2995a90abe98	82953-005	HUMAN OTC DRUG	broad spectrum natural scent lip balm	01	avobenzone, octinoxate, octisalate	LIPSTICK	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part352	Cosmuses Cosmetics (Ningbo) Co., Ltd.	AVOBENZONE; OCTINOXATE; OCTISALATE	1; 2; 1	g/100g; g/100g; g/100g			N	20241231
82953-006_eaf9f8fd-7764-1c72-e053-2995a90a415c	82953-006	HUMAN OTC DRUG	Sunscreen stick		avobenzone, homosalate, octisalate, octocrylene	STICK	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part352	Cosmuses Cosmetics (Ningbo) Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	1.5; 4; 2; 4	g/100g; g/100g; g/100g; g/100g			N	20241231
82953-007_0c367f27-7fa4-6d0f-e063-6294a90a1a17	82953-007	HUMAN OTC DRUG	antiseptic hand sanitizer	01	alcohol	LIQUID	TOPICAL	20221001		OTC MONOGRAPH DRUG	M003	Cosmuses Cosmetics (Ningbo) Co., Ltd.	ALCOHOL	62	mL/100mL			N	20241231
82953-008_03f89070-a388-453c-e063-6294a90a11e2	82953-008	HUMAN OTC DRUG	Antibacterial Hand Sanitizer		Alcohol	SOLUTION	TOPICAL	20200529		OTC MONOGRAPH NOT FINAL	part333A	Cosmuses Cosmetics (Ningbo) Co., Ltd	ALCOHOL	62	mL/100mL			N	20241231
82953-009_03f88721-92a4-1453-e063-6294a90a1591	82953-009	HUMAN OTC DRUG	SPF15 lip balm	01	octocrylene, octisalate	LIPSTICK	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part352	Cosmuses Cosmetics (Ningbo) Co., Ltd.	OCTISALATE; OCTOCRYLENE	2; 2	g/100g; g/100g			N	20241231
82953-010_f8f29aec-9360-e828-e053-6394a90a570a	82953-010	HUMAN OTC DRUG	Sun ,Bug Handsfree	01	Avobenzone,Homosalate,Octocrylene,Octisalate	CREAM	TOPICAL	20220926		OTC MONOGRAPH NOT FINAL	part352	Cosmuses Cosmetics (Ningbo) Co., Ltd.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82953-011_006e4103-36dd-7405-e063-6394a90aa09e	82953-011	HUMAN OTC DRUG	insect bite relief	01	menthol	SPRAY	TOPICAL	20220930		OTC MONOGRAPH FINAL	M016	Cosmuses Cosmetics (Ningbo) Co., Ltd.	MENTHOL	1	g/100mL			N	20241231
82953-012_03a6805e-6597-ef81-e063-6294a90ad65b	82953-012	HUMAN OTC DRUG	alcohol pad	01	alcohol	CLOTH	TOPICAL	20230824		OTC MONOGRAPH NOT FINAL	part333A	Cosmuses Cosmetics (Ningbo) Co., Ltd.	ALCOHOL	.7	mL/1			N	20241231
82953-013_0e1b75c1-96b6-e939-e063-6394a90abffc	82953-013	HUMAN OTC DRUG	triple antibiotic	01	Bacitracin Zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20240104		OTC MONOGRAPH DRUG	M004	Cosmuses Cosmetics (Ningbo) Co., Ltd.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	U/g; mg/g; U/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20251231
82956-0001_f309e158-96c8-241e-e053-2995a90a7bf5	82956-0001	HUMAN OTC DRUG	Herbitual	Skin Protectant Cream	Dimethicone	CREAM	TOPICAL	20230124		OTC MONOGRAPH FINAL	M016	Prime Matter Labs West	DIMETHICONE 100	9.98	mg/mL			N	20241231
82956-0002_f94ebc68-e803-273f-e053-6294a90ac174	82956-0002	HUMAN OTC DRUG	Marlowe	SPF 50	Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20230414		OTC MONOGRAPH FINAL	M020	Prime Matter Labs West	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	29.94; 99.8; 49.9; 49.9	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82957-101_f5cbed63-58e3-4d24-e053-2995a90a30a0	82957-101	HUMAN OTC DRUG	LaboFlex Acne Spot Care		Salicylic Acid 0.5%	PATCH	TOPICAL	20230207		OTC MONOGRAPH FINAL	M006	WOOSHIN LABOTTACH CO., LTD.	SALICYLIC ACID	5	g/100g			N	20241231
82957-103_f6d59e7e-3fbc-d9f8-e053-6394a90a7095	82957-103	HUMAN OTC DRUG	LaboFlex Cool and Hot Menthol 1.25 percent Capsaicin 0.025 percent		Menthol, Capsaicin	PATCH	TOPICAL	20230220		OTC MONOGRAPH NOT FINAL	part348	WOOSHIN LABOTTACH CO., LTD.	CAPSAICIN; MENTHOL	1.75; 87.5	mg/1; mg/1			N	20241231
82964-850_0e1172b3-bec8-f719-e063-6294a90a7174	82964-850	HUMAN OTC DRUG	YOUNG CLARITI MINERAL BRIGHTENING SHEER TINT BROAD SPECTRUM SPF 20- PORCELAIN		YOUNG CLARITI MINERAL BRIGHTENING SHEER TINT - PORCELAIN	CREAM	TOPICAL	20230228		OTC MONOGRAPH DRUG	M020	BioYouth Inc.	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
82964-851_0e1172b3-bec4-f719-e063-6294a90a7174	82964-851	HUMAN OTC DRUG	YOUNG CLARITI MINERAL BRIGHTENING SHEER TINT BROADSPECTRUM SPF 20		BRIGHTENING SHEER TINT	CREAM	TOPICAL	20230228		OTC MONOGRAPH DRUG	M020	BioYouth Inc.	TITANIUM DIOXIDE; ZINC OXIDE	5; 5	g/30mL; g/30mL			N	20251231
82966-001_52194405-c68d-4597-bb3c-78e53eadda3a	82966-001	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX MINI	LOZENGE	ORAL	20230106		ANDA	ANDA215357	BLIP PRODUCTS, INC.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82966-002_cf7fbe21-9a76-4832-88a4-2ef371510784	82966-002	HUMAN OTC DRUG	NICOTINE		NICOTINE POLACRILEX MINI	LOZENGE	ORAL	20230106		ANDA	ANDA215357	BLIP PRODUCTS, INC.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82966-012_2f829466-f2fb-43f1-9e82-0d33b50b913a	82966-012	HUMAN OTC DRUG	BLIP		Nicotine polacrilex	GUM, CHEWING	ORAL	20230314		ANDA	ANDA206394	Blip Products, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82966-269_ad5fc90e-d3b4-4701-bfd8-1cda9087d09a	82966-269	HUMAN OTC DRUG	BLIP		Nicotine Polacrilex	GUM, CHEWING	ORAL	20230314		ANDA	ANDA206394	Blip Products, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82966-971_451863c3-4c17-448e-9225-a5492344af15	82966-971	HUMAN OTC DRUG	blip		nicotine polacrilex	GUM, CHEWING	ORAL	20230314		ANDA	ANDA206393	Blip Products, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
82967-0001_e8118233-8f4f-d447-e053-2a95a90a6ad7	82967-0001	HUMAN OTC DRUG	ACTS38 BoswelliaGel		Boswellia Serrata Extract,, Acetyl Glucosamine , Centella Asiatica Extract, Sodium Hyaluronate	GEL	TOPICAL	20220907		UNAPPROVED DRUG OTHER		A-Lot Biologics Inc	CENTELLA ASIATICA; HYALURONATE SODIUM; INDIAN FRANKINCENSE; N-ACETYLGLUCOSAMINE	.01; .01; 1.2; .1	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82967-0002_eba83e5c-bb7e-92c1-e053-2995a90a7eb3	82967-0002	HUMAN OTC DRUG	ACTS38 BoswelliaGel (100ml)		Boswellia Serrata Extract,, Acetyl Glucosamine , Centella Asiatica Extract, Sodium Hyaluronate	GEL	TOPICAL	20221023		UNAPPROVED DRUG OTHER		A-Lot Biologics Inc	CENTELLA ASIATICA; HYALURONATE SODIUM; INDIAN FRANKINCENSE; N-ACETYLGLUCOSAMINE	.01; .01; 1.2; .1	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
82973-000_0b6e5a3a-42f4-1257-e063-6394a90a972e	82973-000	HUMAN OTC DRUG	Vitastem Ultra Topical Antibiotic		BACITRACIN ZINC	SPRAY	TOPICAL	20220901		OTC MONOGRAPH DRUG	M004	Native First Health, LLC	BACITRACIN ZINC	500	U/mL	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
82973-001_0b6e5d2a-8b3b-2742-e063-6394a90a44fd	82973-001	HUMAN OTC DRUG	Vitastem Ultra Topical Antibiotic		BACITRACIN ZINC	OINTMENT	TOPICAL	20220901		OTC MONOGRAPH DRUG	M004	Native First Health, LLC	BACITRACIN ZINC	500	U/mL	Decreased Cell Wall Synthesis & Repair [PE]		N	20241231
82975-101_e8bb47dd-7d81-1647-e053-2995a90ac881	82975-101	HUMAN OTC DRUG	Hydrating Body Sunscreen		Homosalate, Octocrylene, Octisalate, Avobenzone	LOTION	TOPICAL	20221231		OTC MONOGRAPH FINAL	M020	frank body	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 80	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
82975-102_e9bd6632-57d3-6bdf-e053-2a95a90a172e	82975-102	HUMAN OTC DRUG	The Better Oil		Homosalate, Octocrylene, Avobenzone	OIL	TOPICAL	20221231		OTC MONOGRAPH FINAL	M020	frank body	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	30; 100; 80	mg/mL; mg/mL; mg/mL			N	20241231
82976-100_fc0f7f01-2ca4-9b72-e053-6394a90aa39a	82976-100	HUMAN OTC DRUG	Fluoride Bits		Sodium Monofluorophosphate 0.76%	TABLET	DENTAL	20221206		OTC MONOGRAPH FINAL	part355	The Kind Lab, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/1001			N	20241231
82976-101_fb711520-65dd-35d7-e053-6294a90a0ef8	82976-101	HUMAN OTC DRUG	Fluoride Bits		Sodium Monofluorophosphate 0.76%	TABLET	DENTAL	20230519		OTC MONOGRAPH FINAL	part355	The Kind Lab, Inc.	SODIUM MONOFLUOROPHOSPHATE	.76	g/1001			N	20241231
82982-012_f1ed7654-9576-1d03-e053-2a95a90a8432	82982-012	HUMAN PRESCRIPTION DRUG	Penicillin V Potassium		Penicillin V Potassium	TABLET, FILM COATED	ORAL	20221219		ANDA	ANDA065435	Pharmasource Meds LLC	PENICILLIN V POTASSIUM	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82982-013_f3bca91e-f59c-f31a-e053-2a95a90a7934	82982-013	HUMAN PRESCRIPTION DRUG	Naproxen		Naproxen	TABLET	ORAL	20230202		ANDA	ANDA212517	Pharmasource Meds, LLC	NAPROXEN	500	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82982-017_f2047f00-c3fd-3e18-e053-2a95a90af35f	82982-017	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20230116		ANDA	ANDA077066	Pharmasource Meds, LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
82982-018_f9059d8f-c823-b908-e053-6294a90a6d96	82982-018	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		amoxicillin and clavulanate potassium	TABLET, FILM COATED	ORAL	20230320		ANDA	ANDA065093	Pharmasource Meds, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82982-019_f573e586-dd7c-59c9-e053-2a95a90a9536	82982-019	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230320		ANDA	ANDA091568	Pharmasource Meds, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82982-020_f5c6c095-3b69-17f3-e053-2a95a90ad160	82982-020	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20230303		ANDA	ANDA203245	Pharmasource Meds, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
82982-021_f5c6c095-3b67-17f3-e053-2a95a90ad160	82982-021	HUMAN PRESCRIPTION DRUG	Azithromycin		Azithromycin	TABLET, FILM COATED	ORAL	20230404		ANDA	ANDA065223	Pharmasource Meds, LLC	AZITHROMYCIN MONOHYDRATE	500	mg/1	Macrolide Antimicrobial [EPC], Macrolides [CS]		N	20241231
82982-022_f4e99b4f-2cf5-ba35-e053-2a95a90ada5f	82982-022	HUMAN PRESCRIPTION DRUG	Amoxicillin		Amoxicillin	CAPSULE	ORAL	20230217		ANDA	ANDA065271	Pharmasource Meds, LLC	AMOXICILLIN	500	mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS]		N	20241231
82982-023_efe6b6f2-c90f-f440-e053-2a95a90a90fc	82982-023	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20230109		ANDA	ANDA202765	Pharmasource Meds, LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
82982-024_f1a0ea2c-078c-4e8a-e053-2a95a90a2f32	82982-024	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20230109		ANDA	ANDA090836	Pharmasource Meds, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
82982-025_f2b7743f-de14-aece-e053-2a95a90a9906	82982-025	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin	TABLET, COATED	ORAL	20230206		ANDA	ANDA208921	Pharmasource Meds, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
82982-027_f5633f2e-54d9-390c-e053-2995a90a37e2	82982-027	HUMAN PRESCRIPTION DRUG	Cyclobenzaprine Hydrochloride		cyclobenzaprine hydrochloride	TABLET, FILM COATED	ORAL	20230308		ANDA	ANDA077797	Pharmasource Meds, LLC	CYCLOBENZAPRINE HYDROCHLORIDE	10	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
82982-028_f4ea8099-20b6-3e2e-e053-2995a90a8758	82982-028	HUMAN PRESCRIPTION DRUG	Clindamycin hydrochloride		Clindamycin hydrochloride	CAPSULE	ORAL	20230217		ANDA	ANDA065061	Pharmasource Meds, LLC	CLINDAMYCIN HYDROCHLORIDE	300	mg/1	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]		N	20241231
82982-029_f57c58cf-886c-786e-e053-2a95a90adf90	82982-029	HUMAN PRESCRIPTION DRUG	Dicyclomine		Dicyclomine hydrochloride	TABLET	ORAL	20230314		ANDA	ANDA040161	Pharmasource Meds, LLC	DICYCLOMINE HYDROCHLORIDE	20	mg/1	Anticholinergic [EPC], Cholinergic Antagonists [MoA]		N	20241231
82982-030_f57c66d1-a082-0baa-e053-2a95a90ae409	82982-030	HUMAN PRESCRIPTION DRUG	Escitalopram		Escitalopram	TABLET, FILM COATED	ORAL	20230404		ANDA	ANDA202389	Pharmasource Meds, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82982-031_f5c6b875-e74f-c193-e053-2995a90afa61	82982-031	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20230228		ANDA	ANDA206948	Pharmasource Meds, LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
82982-032_f563aa1a-1e20-49d4-e053-2a95a90a3264	82982-032	HUMAN PRESCRIPTION DRUG	hydroxyzine pamoate		hydroxyzine pamoate	CAPSULE	ORAL	20230227		ANDA	ANDA087479	Pharmasource Meds, LLC	HYDROXYZINE PAMOATE	25	mg/1	Antihistamine [EPC], Histamine Receptor Antagonists [MoA]		N	20241231
82982-033_f563c40e-1e5a-3a37-e053-2995a90a2c06	82982-033	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET	ORAL	20230308		ANDA	ANDA078558	Pharmasource Meds, LLC	IBUPROFEN	800	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
82982-034_f57a8a4b-788e-0e5c-e053-2a95a90ae35b	82982-034	HUMAN PRESCRIPTION DRUG	Levofloxacin		Levofloxacin	TABLET, FILM COATED	ORAL	20230329		ANDA	ANDA202801	Pharmasource Meds, LLC	LEVOFLOXACIN	500	mg/1			N	20241231
82982-036_f956fc32-0e88-39bf-e053-6394a90a1574	82982-036	HUMAN OTC DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET, CHEWABLE	ORAL	20230414		OTC MONOGRAPH FINAL	M009	Pharmasource Meds, LLC	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
82982-037_f83a5873-529b-5b4c-e053-6294a90aa783	82982-037	HUMAN PRESCRIPTION DRUG	Metformin		Metformin ER 500 mg	TABLET	ORAL	20230331		ANDA	ANDA209313	Pharmasource Meds, LLC	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
82982-038_f43a9389-c62c-ce49-e053-2a95a90a537f	82982-038	HUMAN PRESCRIPTION DRUG	Methocarbamol		Methocarbamol Tablets	TABLET, COATED	ORAL	20230208		ANDA	ANDA209312	Pharmasource Meds, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
82982-039_f578b693-d578-6564-e053-2a95a90ad68d	82982-039	HUMAN PRESCRIPTION DRUG	metronidazole		metronidazole	TABLET	ORAL	20230315		ANDA	ANDA206560	Pharmasource Meds, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
82982-040_f5759a3b-8544-4472-e053-2995a90a24f5	82982-040	HUMAN PRESCRIPTION DRUG	Montelukast		Montelukast	TABLET, FILM COATED	ORAL	20230329		ANDA	ANDA202843	Pharmasource Meds, LLC	MONTELUKAST SODIUM	10	mg/1	Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]		N	20241231
82982-041_f53fae3f-20a1-6041-e053-2a95a90a61a7	82982-041	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230221		ANDA	ANDA040362	Pharmasource Meds, LLC	PREDNISONE	10	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82982-042_f6f60241-ad92-373c-e053-6294a90a3a73	82982-042	HUMAN PRESCRIPTION DRUG	Prednisone		Prednisone	TABLET	ORAL	20230315		ANDA	ANDA040362	Pharmasource Meds, LLC	PREDNISONE	20	mg/1	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
82982-043_f56790e4-809a-540d-e053-2a95a90ab294	82982-043	HUMAN PRESCRIPTION DRUG	Sertraline Hydrochloride		Sertraline Hydrochloride	TABLET, FILM COATED	ORAL	20230404		ANDA	ANDA077206	Pharmasource Meds, LLC	SERTRALINE HYDROCHLORIDE	50	mg/1	Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82982-044_f5649da0-6559-2534-e053-2a95a90a0cb9	82982-044	HUMAN PRESCRIPTION DRUG	Sulfamethoxazole and Trimethoprim		Sulfamethoxazole and Trimethoprim	TABLET	ORAL	20230228		ANDA	ANDA090624	Pharmasource Meds, LLC	SULFAMETHOXAZOLE; TRIMETHOPRIM	800; 160	mg/1; mg/1	Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]		N	20241231
82982-046_f566a056-e9d0-b1f4-e053-2995a90a2742	82982-046	HUMAN PRESCRIPTION DRUG	Terbinafine		Terbinafine Hydrochloride	TABLET	ORAL	20230315		ANDA	ANDA078297	Pharmasource Meds, LLC	TERBINAFINE HYDROCHLORIDE	250	mg/1	Allylamine Antifungal [EPC], Allylamine [CS]		N	20241231
82982-047_f56633a5-f58f-a3d9-e053-2995a90a10a3	82982-047	HUMAN PRESCRIPTION DRUG	Trazodone Hydrochloride		Trazodone Hydrochloride	TABLET	ORAL	20230314		ANDA	ANDA071523	Pharmasource Meds, LLC	TRAZODONE HYDROCHLORIDE	50	mg/1	Serotonin Reuptake Inhibitor [EPC]		N	20241231
82982-048_f19d070a-239d-1cb2-e053-2a95a90a59ba	82982-048	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20230113		ANDA	ANDA062505	Pharmasource Meds, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
82982-049_f5651ec3-5594-08c8-e053-2a95a90a1d9a	82982-049	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230314		ANDA	ANDA206943	Pharmasource Meds, LLC	GABAPENTIN	100	mg/1	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82982-050_f2b7cc11-0ad7-81c6-e053-2a95a90a698a	82982-050	HUMAN PRESCRIPTION DRUG	Ciprofloxacin		Ciprofloxacin Hydrochloride	TABLET, FILM COATED	ORAL	20230123		ANDA	ANDA077859	Pharmasource Meds, LLC	CIPROFLOXACIN HYDROCHLORIDE	500	mg/1	Quinolone Antimicrobial [EPC], Quinolones [CS]		N	20241231
82982-052_f4484f5d-cc09-35d5-e053-2a95a90a6422	82982-052	HUMAN PRESCRIPTION DRUG	Nitrofurantoin (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20230207		ANDA	ANDA077066	Pharmasource Meds, LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
82982-053_f904773f-0d7c-6456-e053-6394a90aa0bb	82982-053	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET	ORAL	20230410		ANDA	ANDA207773	Pharmasource Meds, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
82982-054_f53eefb6-34c2-13cb-e053-2a95a90a4bf2	82982-054	HUMAN PRESCRIPTION DRUG	ELIQUIS		APIXABAN	TABLET, FILM COATED	ORAL	20230221		NDA	NDA202155	Pharmasource Meds, LLC	APIXABAN	5	mg/1	Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]		N	20241231
82982-055_f5667400-84d4-7f8c-e053-2995a90ab81a	82982-055	HUMAN PRESCRIPTION DRUG	ISENTRESS		RALTEGRAVIR	TABLET, FILM COATED	ORAL	20230303		NDA	NDA022145	Pharmasource Meds, LLC	RALTEGRAVIR POTASSIUM	400	mg/1	HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]		N	20241231
82982-056_f57924bb-94f7-fe82-e053-2a95a90af55a	82982-056	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20230303		ANDA	ANDA203442	Pharmasource Meds, LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
82982-058_f57a8a4b-788b-0e5c-e053-2a95a90ae35b	82982-058	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20230404		ANDA	ANDA077253	Pharmasource Meds, LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
82982-059_f579ea8e-eff0-5a24-e053-2995a90aaf99	82982-059	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20230328		ANDA	ANDA090469	Pharmasource Meds, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
82982-060_f6594451-6322-1466-e053-2a95a90a5bd5	82982-060	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	TABLET, FILM COATED	ORAL	20230307		ANDA	ANDA062269	Pharmasource Meds, LLC	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
82982-061_f8218ba4-d0d3-8526-e053-6294a90ae6d7	82982-061	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20230330		ANDA	ANDA078152	Pharmasource Meds, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
82982-063_f904d269-2709-d62f-e053-6394a90a8322	82982-063	HUMAN PRESCRIPTION DRUG	Sildenafil		Sildenafil	TABLET, FILM COATED	ORAL	20230410		ANDA	ANDA202659	Pharmasource Meds, LLC	SILDENAFIL CITRATE	100	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
82982-064_fa46d4d0-2b48-d562-e053-6394a90a3bcd	82982-064	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20230501		ANDA	ANDA081297	Pharmasource Meds, LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
82982-065_faa4abcc-506e-d8dc-e053-6294a90aadcf	82982-065	HUMAN PRESCRIPTION DRUG	escitalopram oxalate		escitalopram oxalate	TABLET	ORAL	20230501		ANDA	ANDA090939	Pharmasource Meds, LLC	ESCITALOPRAM OXALATE	10	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20241231
82982-066_fab2ad51-5330-1d4e-e053-6294a90aef5a	82982-066	HUMAN PRESCRIPTION DRUG	Lisinopril		Lisinopril	TABLET	ORAL	20230502		ANDA	ANDA077321	Pharmasource Meds, LLC	LISINOPRIL	10	mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]		N	20241231
82982-067_fab269ea-950e-3702-e053-6394a90ada0d	82982-067	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230502		ANDA	ANDA078787	Pharmasource Meds, LLC	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
82982-068_fe304bc1-e749-d206-e053-6294a90a0930	82982-068	HUMAN PRESCRIPTION DRUG	Emtricitabine and tenofovir disoproxil fumarate		Emtricitabine and tenofovir disoproxil fumarate	TABLET, FILM COATED	ORAL	20230613		ANDA	ANDA212689	Pharmasource Meds, LLC	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	200; 300	mg/1; mg/1	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]		N	20241231
82982-069_fc8ddda4-0427-6df9-e053-6394a90aae1a	82982-069	HUMAN PRESCRIPTION DRUG	Amoxicillin and Clavulanate Potassium		Amoxicillin and Clavulanate Potassium	TABLET, FILM COATED	ORAL	20230526		ANDA	ANDA065063	Pharmasource Meds, LLC	AMOXICILLIN; CLAVULANATE POTASSIUM	875; 125	mg/1; mg/1	Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]		N	20241231
82982-070_fe0ccb26-4c05-b83a-e053-6294a90a2c0b	82982-070	HUMAN PRESCRIPTION DRUG	Fluconazole		Fluconazole	TABLET	ORAL	20230613		ANDA	ANDA077731	Pharmasource Meds, LLC	FLUCONAZOLE	150	mg/1	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]		N	20241231
82982-071_05422865-666c-9a97-e063-6294a90aedd5	82982-071	HUMAN PRESCRIPTION DRUG	Cefdinir		Cefdinir	CAPSULE	ORAL	20230925		ANDA	ANDA210220	Pharmasource Meds, LLC	CEFDINIR	300	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
82982-072_0949690c-28cf-8241-e063-6394a90a1363	82982-072	HUMAN PRESCRIPTION DRUG	Metronidazole		Metronidazole	TABLET	ORAL	20231103		ANDA	ANDA203974	Pharmasource Meds, LLC	METRONIDAZOLE	500	mg/1	Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]		N	20241231
82982-073_09493e24-ab0d-26fd-e063-6294a90a491d	82982-073	HUMAN PRESCRIPTION DRUG	Cephalexin		Cephalexin	CAPSULE	ORAL	20231103		ANDA	ANDA065253	Pharmasource Meds, LLC	CEPHALEXIN	500	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
82983-400_ca08d4aa-3de2-4a9d-9554-6288e5d36f29	82983-400	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20230131		ANDA	ANDA206651	Ajenat Pharmaceuticals LLC	TACROLIMUS	.5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
82983-401_ca08d4aa-3de2-4a9d-9554-6288e5d36f29	82983-401	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20230131		ANDA	ANDA206651	Ajenat Pharmaceuticals LLC	TACROLIMUS	1	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
82983-402_ca08d4aa-3de2-4a9d-9554-6288e5d36f29	82983-402	HUMAN PRESCRIPTION DRUG	Tacrolimus		Tacrolimus	CAPSULE	ORAL	20230131		ANDA	ANDA206651	Ajenat Pharmaceuticals LLC	TACROLIMUS	5	mg/1	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]		N	20241231
82983-403_5cd4ffde-a37f-4d05-976f-1842d267f755	82983-403	HUMAN PRESCRIPTION DRUG	Potassium Chloride for Oral Solution		Potassium Chloride for Oral Solution	POWDER, FOR SOLUTION	ORAL	20230301		ANDA	ANDA212183	Ajenat Pharmaceuticals LLC	POTASSIUM CHLORIDE	1.5	g/1.58g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]		N	20241231
82984-0001_0776f9c5-d6a8-fbb5-e063-6394a90a5e71	82984-0001	HUMAN OTC DRUG	Neuromuscular Cream		Lidocaine 4%	CREAM	TOPICAL	20231012		OTC MONOGRAPH DRUG	M017	BioClinical Science, LLC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82985-002_f70af0f1-ac2a-72cc-e053-6394a90a2e85	82985-002	HUMAN OTC DRUG	Caring Hands		Benzalkonium Chloride	LIQUID	TOPICAL	20220910		OTC MONOGRAPH NOT FINAL	part333A	AXM Premium Cleaning Services, L.P.	BENZALKONIUM CHLORIDE	.125	g/100mL			N	20241231
82986-361_0976dfc5-c376-11fe-e063-6294a90aa2bb	82986-361	HUMAN OTC DRUG	ARTHRO LIFE Instant Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20220919		OTC MONOGRAPH DRUG	M017	BIOBEST SERVICES LLC	MENTHOL	15	mg/mL			N	20241231
82987-101_098d5c92-f124-a868-e063-6394a90ad164	82987-101	HUMAN OTC DRUG	THAPPINK HAIR GROWTH SERUM		Minoxidil	LIQUID	TOPICAL	20220906		ANDA	ANDA076239	Shenzhen Tianzhu Fragrance Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82987-201_09b310d0-9431-3f97-e063-6294a90ae2b4	82987-201	HUMAN OTC DRUG	SALUBRITO HAIR GROWTH TREATMENT		Minoxidil 5%	LIQUID	TOPICAL	20231109		ANDA	ANDA076239	Shenzhen Tianzhu Fragrance Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82987-301_0cc4e5cc-1321-3513-e063-6394a90ab7d8	82987-301	HUMAN OTC DRUG	Glemme Beard Growth Oil		Minoxidil 5%	LIQUID	TOPICAL	20231218		ANDA	ANDA076239	Shenzhen Tianzhu Fragrance Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
82992-001_0a976b19-ccb8-39a5-e063-6294a90a8ebb	82992-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20220920		UNAPPROVED MEDICAL GAS		ProHealth Home Medical Supplies	OXYGEN	99	L/100L			N	20241231
82994-0001_e93ae609-f672-78fd-e053-2995a90a95bd	82994-0001	HUMAN OTC DRUG	Beol Cho Long		menthol, garlic oil	LIQUID	TOPICAL	20220922		UNAPPROVED DRUG OTHER		sunkyung trading	GARLIC OIL; MENTHOL	7.5; 1.2	g/100mL; g/100mL			N	20241231
82994-0002_f8b55170-7a77-8a53-e053-6294a90a260c	82994-0002	HUMAN OTC DRUG	ATO Tell		menthol, garlic oil	LIQUID	TOPICAL	20230407		UNAPPROVED DRUG OTHER		sunkyung trading	GARLIC OIL; MENTHOL	7.5; 1.2	g/100mL; g/100mL			N	20241231
82996-000_0b5a1c6a-5ae1-b21e-e063-6394a90a3320	82996-000	HUMAN OTC DRUG	Isopropyl Alcohol Cleansing Pad		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20221101		OTC MONOGRAPH DRUG	505G(a)(3)	Hubei Changjian Medical Products Co., Ltd.	ISOPROPYL ALCOHOL	700	mg/g			N	20241231
82996-001_0b5a2098-7131-b80a-e063-6394a90af008	82996-001	HUMAN OTC DRUG	First Aid Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	GEL	TOPICAL	20221101		OTC MONOGRAPH DRUG	M004	Hubei Changjian Medical Products Co., Ltd.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 35; 5000	[iU]/g; mg/g; [iU]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
82996-002_0b5a1a85-c8b3-b698-e063-6394a90abb01	82996-002	HUMAN OTC DRUG	First Aid Antiseptic Pain Relieving		BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE	CREAM	TOPICAL	20221101		OTC MONOGRAPH DRUG	M003	Hubei Changjian Medical Products Co., Ltd.	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
82996-003_0b5a22aa-173b-7615-e063-6294a90a46e6	82996-003	HUMAN OTC DRUG	Insect Sting Relief Pad		BENZOCAINE, ALCOHOL	CLOTH	TOPICAL	20221101		OTC MONOGRAPH DRUG	M017	Hubei Changjian Medical Products Co., Ltd.	ALCOHOL; BENZOCAINE	600; 60	mg/g; mg/g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
82996-004_0b5a14e3-4d7b-6a1a-e063-6294a90a59c5	82996-004	HUMAN OTC DRUG	Antiseptic Towelette		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221101		OTC MONOGRAPH DRUG	M003	Hubei Changjian Medical Products Co., Ltd.	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
82996-005_0b5a18c0-b6f3-7233-e063-6294a90aa8f1	82996-005	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20221101		OTC MONOGRAPH DRUG	505G(a)(3)	Hubei Changjian Medical Products Co., Ltd.	ALCOHOL	620	mg/g			N	20241231
82996-006_0b5a14e3-4d87-6a1a-e063-6294a90a59c5	82996-006	HUMAN OTC DRUG	Antiseptic Povidone-lodine Prep Pad		POVIDONE-IODINE	CLOTH	TOPICAL	20221101		OTC MONOGRAPH DRUG	M003	Hubei Changjian Medical Products Co., Ltd.	POVIDONE-IODINE	10	mg/g			N	20241231
82996-007_0cf40104-a9cd-9e76-e063-6394a90a0259	82996-007	HUMAN OTC DRUG	Eye Wash		WATER	LIQUID	TOPICAL	20230920		OTC MONOGRAPH DRUG	M018	Hubei Changjian Medical Products Co., Ltd.	WATER	991	mg/mL			N	20241231
83000-110_6f5a9f7b-d8e7-44ff-99a6-6c8796728f42	83000-110	HUMAN PRESCRIPTION DRUG	GOHIBIC		vilobelimab	INJECTION	INTRAVENOUS	20230404		EMERGENCY USE AUTHORIZATION		InflaRx GmbH	VILOBELIMAB	10	mg/mL			N	20241231
83002-002_febd8ce9-c578-6a58-e053-6394a90a411f	83002-002	HUMAN OTC DRUG	Freegells Cough Drops Menthol Cherry 80ct		MENTHOL	LOZENGE	ORAL	20230621		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	5.8	mg/1			N	20241231
83002-003_ff371cbc-3091-891a-e053-6294a90a0f72	83002-003	HUMAN OTC DRUG	Freegells Cough Drops Menthol Cherry 30ct		MENTHOL	LOZENGE	ORAL	20230705		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	5.8	mg/1			N	20241231
83002-004_fff5822a-7d04-5a43-e053-6294a90ab63c	83002-004	HUMAN OTC DRUG	Freegells Cough Drops Menthol 80ct		MENTHOL	LOZENGE	ORAL	20230705		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	5.4	mg/1			N	20241231
83002-005_fff58c05-8001-f202-e053-6294a90acf24	83002-005	HUMAN OTC DRUG	Freegells Cough Drops Menthol 30ct		MENTHOL	LOZENGE	ORAL	20230705		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	5.4	mg/1			N	20241231
83002-006_fff5822a-7d0e-5a43-e053-6294a90ab63c	83002-006	HUMAN OTC DRUG	Freegells Cough Drops Menthol Honey Lemon 30ct		MENTHOL	LOZENGE	ORAL	20230705		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	7.5	mg/1			N	20241231
83002-007_004c0936-afd4-103f-e063-6394a90af217	83002-007	HUMAN OTC DRUG	Freegells Cough Drops Menthol Honey Lemon 200ct		MENTHOL	LOZENGE	ORAL	20230705		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	7.5	mg/1			N	20241231
83002-008_004bbcd7-9abe-5809-e063-6294a90a2526	83002-008	HUMAN OTC DRUG	Freegells Cough Drops Menthol Cherry 200ct		MENTHOL	LOZENGE	ORAL	20230705		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	5.8	mg/1			N	20241231
83002-009_004bbcd7-9ac9-5809-e063-6294a90a2526	83002-009	HUMAN OTC DRUG	Freegells Cough Drops Menthol Honey Lemon 80ct		MENTHOL	LOZENGE	ORAL	20230705		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	7.5	mg/1			N	20241231
83002-010_00b08b8a-44c7-0238-e063-6394a90a5047	83002-010	HUMAN OTC DRUG	Cough Drops Freegells Strawberry 30ct		MENTHOL	LOZENGE	ORAL	20230714		OTC MONOGRAPH FINAL	part341	R.L. ALBERT & SON, INC	MENTHOL	2.7	mg/1			N	20241231
83004-001_f70b4446-2813-47c9-e053-6294a90aaa5d	83004-001	HUMAN OTC DRUG	Rida Hair Research Institute		Salicylic acid	LIQUID	TOPICAL	20230308		UNAPPROVED DRUG OTHER		Rida LLC	SALICYLIC ACID	3	g/100mL			N	20241231
83004-002_f98a72c5-e0fd-9cff-e053-6294a90acbcf	83004-002	HUMAN OTC DRUG	Hair Growth		saw palmetto, black pepper, reynoutria japonica root, equisetum arvense top, marine collagen, soluble	CAPSULE	ORAL	20230415		UNAPPROVED DRUG OTHER		Rida LLC	BLACK PEPPER; EQUISETUM ARVENSE TOP; MARINE COLLAGEN, SOLUBLE; REYNOUTRIA JAPONICA ROOT; SAW PALMETTO	3; 2; 4; 5; 3	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
83004-003_f98a87cb-d66f-c6a2-e053-6294a90a48e7	83004-003	HUMAN OTC DRUG	Migraine Relief		turmeric, curcuma aromatica root, indian frankincense, ginger, feverfew	POWDER	ORAL	20230415		UNAPPROVED DRUG OTHER		Rida LLC	CURCUMA AROMATICA ROOT; FEVERFEW; GINGER; INDIAN FRANKINCENSE; TURMERIC	4; 3; 5; 4; 2	[hp_X]/6g; [hp_X]/6g; [hp_X]/6g; [hp_X]/6g; [hp_X]/6g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83004-004_08a48df8-e809-3477-e063-6394a90a2bc3	83004-004	HUMAN OTC DRUG	Terramed Just Think Comfort Yeast relief		Olive Extract,Hydrastis,Borax,Calendula Officinalis	GEL	TOPICAL	20231111		UNAPPROVED HOMEOPATHIC		Rida LLC	CALENDULA OFFICINALIS FLOWERING TOP; GOLDENSEAL; OLEUROPEIN; SODIUM BORATE	1; 5; 3; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
83004-005_08a46139-bc77-0acc-e063-6394a90ae6d0	83004-005	HUMAN OTC DRUG	Terramed Just Think Comfort gyno care		Olive Extract,Hydrastis,Borax,Calendula Officinalis	GEL	TOPICAL	20231111		UNAPPROVED HOMEOPATHIC		Rida LLC	CALENDULA OFFICINALIS FLOWERING TOP; GOLDENSEAL; OLEUROPEIN; SODIUM BORATE	1; 5; 3; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL			N	20241231
83004-006_08a496a0-1200-10e2-e063-6294a90a6ea3	83004-006	HUMAN OTC DRUG	Terramed Just Think Comfort Hydro		Olive Extract,Calendula Officinalis	GEL	TOPICAL	20231111		UNAPPROVED HOMEOPATHIC		Rida LLC	CALENDULA OFFICINALIS FLOWERING TOP; OLEUROPEIN	3; 3	[hp_X]/100mL; [hp_X]/100mL			N	20241231
83004-007_08a49a67-ba73-9743-e063-6394a90a4f07	83004-007	HUMAN OTC DRUG	Terramed Just Think Comfort leg cramp		Aconitum Napellus,Arnica Montana,Magnesium Phosphorica,Rhus Toxicodendron,Viscum Album	LIQUID	TOPICAL	20231111		UNAPPROVED HOMEOPATHIC		Rida LLC	ACONITUM NAPELLUS WHOLE; ARNICA MONTANA WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; TOXICODENDRON PUBESCENS LEAF; VISCUM ALBUM WHOLE	3; 3; 10; 6; 3	[hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83004-008_0aeab588-99e2-87d2-e063-6394a90aa922	83004-008	HUMAN OTC DRUG	Remixdil Extra Strength hair regrowth treatment for Men		Minoxidil 5%	SOLUTION	TOPICAL	20231122		ANDA	ANDA076239	Rida LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83004-009_0aeadd60-705c-8228-e063-6294a90ad140	83004-009	HUMAN OTC DRUG	REMIXDIL HAIR REGROWTH TREATMENT FOR WOMEN		Minoxidil 2%	SOLUTION	TOPICAL	20231122		ANDA	ANDA078176	Rida LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83005-0001_098b088a-8f37-9eae-e063-6394a90a42a1	83005-0001	HUMAN OTC DRUG	Sqween 100% Mineral Sunscreen Broad Spectrum SPF 30 Water Resistant		zinc oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH DRUG	M020	SQWEEN LLC	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83008-001_395c7b94-82a7-4c7b-8216-b536bae55881	83008-001	HUMAN PRESCRIPTION DRUG	Lubiprostone		lubiprostone	CAPSULE, GELATIN COATED	ORAL	20230314		NDA AUTHORIZED GENERIC	NDA021908	Quality Care Products, LLC	LUBIPROSTONE	24	ug/1	Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]		N	20241231
83008-002_0730c242-fcc4-4bba-9c77-4d9e55730d47	83008-002	HUMAN PRESCRIPTION DRUG	HYDROCODONE BITARTRATE AND ACETAMINOPHEN		HYDROCODONE BITARTRATE AND ACETAMINOPHEN	TABLET	ORAL	20230125		ANDA	ANDA040405	Quality Care Products, LLC	ACETAMINOPHEN; HYDROCODONE BITARTRATE	325; 7.5	mg/1; mg/1	Opioid Agonist [EPC], Opioid Agonists [MoA]	CII	N	20241231
83008-003_927d4347-be9b-45a4-bcdb-8affe34f1fd6	83008-003	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230217		ANDA	ANDA214548	Quality Care Products, LLC	AMITRIPTYLINE HYDROCHLORIDE	10	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
83008-004_927d4347-be9b-45a4-bcdb-8affe34f1fd6	83008-004	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230217		ANDA	ANDA214548	Quality Care Products, LLC	AMITRIPTYLINE HYDROCHLORIDE	25	mg/1	Tricyclic Antidepressant [EPC]		N	20251231
83008-005_e3c8d70a-3617-4524-87e5-c194f0546c0e	83008-005	HUMAN PRESCRIPTION DRUG	Ketorolac Tromethamine		ketorolac tromethamine	TABLET, FILM COATED	ORAL	20230214		ANDA	ANDA215788	Quality Care Products, LLC	KETOROLAC TROMETHAMINE	10	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-006_8c2e23fe-88c1-4079-85d4-63448c0b3a9e	83008-006	HUMAN PRESCRIPTION DRUG	Mirtazapine		Mirtazapine	TABLET, FILM COATED	ORAL	20230411		ANDA	ANDA076921	Quality Care Products, LLC	MIRTAZAPINE	15	mg/1			N	20241231
83008-007_a7ff7310-8d57-46c6-909f-5ebc433c2e83	83008-007	HUMAN PRESCRIPTION DRUG	NALOXONE HYDROCHLORIDE		naloxone hydrochloride	SPRAY	NASAL	20230216		ANDA	ANDA211951	Quality Care Products, LLC	NALOXONE HYDROCHLORIDE	4	mg/.1mL	Opioid Antagonist [EPC], Opioid Antagonists [MoA]		N	20241231
83008-008_312ec45b-3910-4411-9945-6d12aae2f53e	83008-008	HUMAN PRESCRIPTION DRUG	Methocarbamol		methocarbamol	TABLET	ORAL	20230214		ANDA	ANDA040489	Quality Care Products, LLC	METHOCARBAMOL	750	mg/1	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]		N	20241231
83008-009_39f4023a-d6dd-498f-b749-a5be08087b2b	83008-009	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20230303		ANDA	ANDA200503	Quality Care Products, LLC	TRAMADOL HYDROCHLORIDE	200	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
83008-010_4584e58a-eeee-4a10-b75b-b31494c5f38e	83008-010	HUMAN PRESCRIPTION DRUG	Alprazolam		Alprazolam	TABLET	ORAL	20230307		ANDA	ANDA074342	Quality Care Products, LLC	ALPRAZOLAM	1	mg/1	Benzodiazepine [EPC], Benzodiazepines [CS]	CIV	N	20241231
83008-011_224ec91c-9064-4886-be09-e3c23473e9e2	83008-011	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20230324		ANDA	ANDA090162	Quality Care Products, LLC	TOPIRAMATE	50	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
83008-012_224ec91c-9064-4886-be09-e3c23473e9e2	83008-012	HUMAN PRESCRIPTION DRUG	topiramate		topiramate	TABLET, FILM COATED	ORAL	20230323		ANDA	ANDA090162	Quality Care Products, LLC	TOPIRAMATE	25	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
83008-013_51f4efeb-6b04-46b4-ad86-cec4a7a38f5f	83008-013	HUMAN PRESCRIPTION DRUG	Celecoxib		Celecoxib	CAPSULE	ORAL	20230425		ANDA	ANDA205129	Quality Care Products, LLC	CELECOXIB	200	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-014_8e40533c-012d-4bb7-b731-98146ed81b24	83008-014	HUMAN PRESCRIPTION DRUG	Zolpidem Tartrate		Zolpidem Tartrate	TABLET, COATED	ORAL	20230504		ANDA	ANDA077322	Quality Care Products, LLC	ZOLPIDEM TARTRATE	5	mg/1	Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]	CIV	N	20241231
83008-015_509eed64-67b8-4486-8f2c-3c04bc8f47c8	83008-015	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20230308		ANDA	ANDA214374	Quality Care Products, LLC	BACLOFEN	10	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
83008-016_cff36173-3fd2-4039-96f4-a924c0bbf534	83008-016	HUMAN PRESCRIPTION DRUG	Esomeprazole Magnesium		Esomeprazole Magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230316		ANDA	ANDA211977	Quality Care Products, LLC	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
83008-017_6a625f3d-eee5-4e28-89e0-bb4e38d0b578	83008-017	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20230330		ANDA	ANDA203818	Quality Care Products, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-018_4a84e8fc-5a34-44e5-9bd8-0890a1e7ee07	83008-018	HUMAN PRESCRIPTION DRUG	BACLOFEN		BACLOFEN	TABLET	ORAL	20230425		ANDA	ANDA214374	Quality Care Products, LLC	BACLOFEN	20	mg/1	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]		N	20241231
83008-019_0a185502-0aeb-4f2e-bb4e-a2433e572d0e	83008-019	HUMAN PRESCRIPTION DRUG	Diclofenac sodium		Diclofenac sodium	SOLUTION	TOPICAL	20230502		ANDA	ANDA212506	Quality Care Products, LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-020_6201ff59-4677-4a3a-84b0-16b8a147ff35	83008-020	HUMAN PRESCRIPTION DRUG	Probenecid		Probenecid	TABLET, FILM COATED	ORAL	20230524		ANDA	ANDA080966	Quality Care Products, LLC	PROBENECID	500	mg/1			N	20241231
83008-021_04d350f2-158d-469a-8e8c-b6f7d604f679	83008-021	HUMAN PRESCRIPTION DRUG	TRAMADOL HYDROCHLORIDE		TRAMADOL HYDROCHLORIDE	TABLET, EXTENDED RELEASE	ORAL	20140819		ANDA	ANDA200503	Quality Care Products, LLC	TRAMADOL HYDROCHLORIDE	300	mg/1	Full Opioid Agonists [MoA], Opioid Agonist [EPC]	CIV	N	20241231
83008-022_8e1c665f-520e-47fc-9c9c-c483f8e6f61b	83008-022	HUMAN PRESCRIPTION DRUG	Meclizine Hydrochloride		Meclizine Hydrochloride	TABLET	ORAL	20230505	20241031	ANDA	ANDA084657	Quality Care Products, LLC	MECLIZINE HYDROCHLORIDE	12.5	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	
83008-023_0c8357fd-6723-4b23-9ec2-8625cefda426	83008-023	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20230510		ANDA	ANDA040597	Quality Care Products, LLC	BENZONATATE	100	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
83008-024_947610c7-adfb-4e1a-bea2-51cd02085cbe	83008-024	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20230526		ANDA	ANDA211697	Quality Care Products, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83008-025_317a65b7-63ae-407d-82ee-bd76f52ae32d	83008-025	HUMAN PRESCRIPTION DRUG	Lidocaine		Lidocaine	OINTMENT	TOPICAL	20231026		ANDA	ANDA206297	Quality Care Products, LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83008-026_ab0d906b-1557-4549-9d2c-262720350792	83008-026	HUMAN PRESCRIPTION DRUG	Ondansetron		Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20230512		ANDA	ANDA078152	Quality Care Products, LLC	ONDANSETRON	4	mg/1	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]		N	20241231
83008-027_acd33f6e-e43b-4e55-9237-498bed214325	83008-027	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20230517		ANDA	ANDA214548	Quality Care Products, LLC	AMITRIPTYLINE HYDROCHLORIDE	50	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
83008-028_097841d4-c795-4c75-ae0e-9596825860fa	83008-028	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium Topical	GEL	TOPICAL	20230615		ANDA	ANDA212351	Quality Care Products, LLC	DICLOFENAC SODIUM	30	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-029_482cff39-0e8e-4987-b42e-0f26e5da5798	83008-029	HUMAN PRESCRIPTION DRUG	busPIRone HCl		buspirone hydrochloride	TABLET	ORAL	20230620		ANDA	ANDA075521	Quality Care Products, LLC	BUSPIRONE HYDROCHLORIDE	10	mg/1			N	20241231
83008-030_985ae56c-fb3b-40c3-ad0b-0fcc38d324c6	83008-030	HUMAN PRESCRIPTION DRUG	Metoprolol succinate		Metoprolol succinate	TABLET, EXTENDED RELEASE	ORAL	20230607		ANDA	ANDA213854	Quality Care Products, LLC	METOPROLOL SUCCINATE	50	mg/1	Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]		N	20241231
83008-031_6bd358e4-fd13-4140-8378-c0b567307a71	83008-031	HUMAN PRESCRIPTION DRUG	Doxycycline		Doxycycline	TABLET, FILM COATED	ORAL	20230616		ANDA	ANDA209582	Quality Care Products, LLC	DOXYCYCLINE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
83008-032_b8f16d66-6cb6-442a-af75-409cd7fa3930	83008-032	HUMAN PRESCRIPTION DRUG	NITROFURANTOIN (monohydrate/macrocrystals)		Nitrofurantoin (monohydrate/macrocrystals)	CAPSULE	ORAL	20230628		ANDA	ANDA211013	Quality Care Products, LLC	NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE	25; 75	mg/1; mg/1	Nitrofuran Antibacterial [EPC], Nitrofuran Antibacterial [EPC], Nitrofurans [CS], Nitrofurans [CS]		N	20241231
83008-033_39c89cc0-1372-4f89-ad08-d2c920ac0a8b	83008-033	HUMAN PRESCRIPTION DRUG	DICLOFENAC SODIUM		diclofenac sodium	SOLUTION	TOPICAL	20230705		NDA AUTHORIZED GENERIC	NDA204623	Quality Care Products, LLC	DICLOFENAC SODIUM	20	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-034_3a34f7ac-1545-444d-9223-657959a92f34	83008-034	HUMAN PRESCRIPTION DRUG	Pantoprazole Sodium		Pantoprazole Sodium	TABLET, DELAYED RELEASE	ORAL	20230718		ANDA	ANDA202038	Quality Care Products, LLC	PANTOPRAZOLE SODIUM	20	mg/1	Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
83008-035_80853e7f-5cb0-4417-86ab-89fe8a465f30	83008-035	HUMAN PRESCRIPTION DRUG	Amlodipine Besylate		Amlodipine Besylate	TABLET	ORAL	20230720		ANDA	ANDA203245	Quality Care Products, LLC	AMLODIPINE BESYLATE	5	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
83008-036_91f4cb17-362c-4961-be6f-2ba453ec4d79	83008-036	HUMAN PRESCRIPTION DRUG	diclofenac epolamine		diclofenac epolamine	SYSTEM	TOPICAL	20230815		NDA AUTHORIZED GENERIC	NDA021234	Quality Care Products, LLC	DICLOFENAC EPOLAMINE	.013	g/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-037_88780d50-4e26-47ed-927b-64dbb3551c98	83008-037	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	GEL	TOPICAL	20230804		ANDA	ANDA209903	Quality Care Products, LLC	DICLOFENAC SODIUM	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83008-038_3a9543f1-5534-45e1-bf58-c5372104ddfd	83008-038	HUMAN PRESCRIPTION DRUG	SILDENAFIL CITRATE		SILDENAFIL CITRATE	TABLET	ORAL	20230803		ANDA	ANDA091479	Quality Care Products, LLC	SILDENAFIL CITRATE	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]		N	20241231
83008-039_5784dcb8-803d-407e-bb50-815888015019	83008-039	HUMAN PRESCRIPTION DRUG	AMLODIPINE BESYLATE		AMLODIPINE BESYLATE	TABLET	ORAL	20230818		ANDA	ANDA077073	Quality Care Products, LLC	AMLODIPINE BESYLATE	10	mg/1	Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]		N	20241231
83008-040_c6863077-f18d-4d80-a95c-dda47b70ebd9	83008-040	HUMAN PRESCRIPTION DRUG	Duloxetine		Duloxetine	CAPSULE, DELAYED RELEASE	ORAL	20230911		ANDA	ANDA090694	Quality Care Products, LLC	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]		N	20241231
83008-041_ed8aafb8-4707-4be9-a9bc-20a9cb8be50e	83008-041	HUMAN PRESCRIPTION DRUG	Benzonatate		Benzonatate	CAPSULE	ORAL	20231010		ANDA	ANDA040597	Quality Care Products, LLC	BENZONATATE	200	mg/1	Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]		N	20241231
83008-042_8ab2a797-a2e6-49bf-82d0-da7b3509e33a	83008-042	HUMAN PRESCRIPTION DRUG	Lisinopril and Hydrochlorothiazide		Lisinopril and Hydrochlorothiazide Tablets	TABLET	ORAL	20150312		ANDA	ANDA076230	Quality Care Products, LLC	HYDROCHLOROTHIAZIDE; LISINOPRIL	12.5; 10	mg/1; mg/1	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]		N	20241231
83008-043_e5ce6269-273f-4672-adef-5204764e353e	83008-043	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20231101		ANDA	ANDA214548	Quality Care Products, LLC	AMITRIPTYLINE HYDROCHLORIDE	75	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
83008-045_e5ce6269-273f-4672-adef-5204764e353e	83008-045	HUMAN PRESCRIPTION DRUG	Amitriptyline Hydrochloride		Amitriptyline Hydrochloride	TABLET, FILM COATED	ORAL	20231109		ANDA	ANDA214548	Quality Care Products, LLC	AMITRIPTYLINE HYDROCHLORIDE	100	mg/1	Tricyclic Antidepressant [EPC]		N	20241231
83008-047_08dc7445-f9fa-4923-8b86-ea126a67e7e0	83008-047	HUMAN PRESCRIPTION DRUG	Fluoxetine		Fluoxetine Hydrochloride	CAPSULE	ORAL	20231211		ANDA	ANDA204597	Quality Care Products, LLC	FLUOXETINE HYDROCHLORIDE	20	mg/1	Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]		N	20251231
83008-048_868e2bcb-9841-4171-bf31-613acb40fe00	83008-048	HUMAN PRESCRIPTION DRUG	Diclofenac Sodium		Diclofenac Sodium	SOLUTION	TOPICAL	20240103		ANDA	ANDA206116	Quality Care Products, LLC	DICLOFENAC SODIUM	16.05	mg/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20251231
83008-049_b741b2b3-4529-47ca-8b3a-28108f2547c2	83008-049	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20231221		ANDA	ANDA204989	Quality Care Products, LLC	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20251231
83009-169_07731045-0d2c-76b7-e063-6294a90af921	83009-169	HUMAN OTC DRUG	Capsadyn		Capsaicin	CREAM	TOPICAL	20231013		OTC MONOGRAPH DRUG	M017	Chorda Pharma, Inc	CAPSAICIN	.25	g/100g			N	20241231
83010-010_0b6e5660-7915-223f-e063-6394a90abee3	83010-010	HUMAN OTC DRUG	B-Lucid Targeted Body Acne Gel		SALICYLIC ACID	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M006	Maelys Cosmetics, LTD	SALICYLIC ACID	20	mg/mL			N	20241231
83010-011_0b6e4faa-7128-2433-e063-6294a90aa55c	83010-011	HUMAN OTC DRUG	Get-Gone - Acne Body Cleanser		SALICYLIC ACID	GEL	TOPICAL	20230101		OTC MONOGRAPH DRUG	M006	Maelys Cosmetics, LTD	SALICYLIC ACID	20	mg/mL			N	20241231
83010-012_0b6e45f6-9f17-121a-e063-6394a90a36d0	83010-012	HUMAN OTC DRUG	Get-Back - Targeted Body Acne		SALICYLIC ACID	SPRAY	TOPICAL	20230101		OTC MONOGRAPH DRUG	M006	Maelys Cosmetics, LTD	SALICYLIC ACID	20	mg/mL			N	20241231
83011-001_e9ebcd18-e22a-78b0-e053-2995a90acd1f	83011-001	HUMAN OTC DRUG	Proflexa		Camphor	CREAM	TOPICAL	20220930		OTC MONOGRAPH NOT FINAL	part348	Sinoveda Canada Inc	CAMPHOR (NATURAL)	3.3	g/100g			N	20241231
83013-304_20e71a36-babb-434e-abf4-608c1a5fcc76	83013-304	HUMAN OTC DRUG	hismile SMOOTH MINT FLAVOR anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20221209		OTC MONOGRAPH FINAL	part355	HISMILE PTY LTD	SODIUM FLUORIDE	2.4	mg/g			N	20241231
83013-306_50ef297e-1ebd-44df-9bf5-d764e2051163	83013-306	HUMAN OTC DRUG	hismile RED VELVET FLAVOR anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230113		OTC MONOGRAPH FINAL	part355	HISMILE PTY LTD	SODIUM FLUORIDE	2.4	mg/g			N	20241231
83013-307_7978ce6f-9be9-46d8-ae9b-5401881ddccc	83013-307	HUMAN OTC DRUG	hismile GRAPE BUBBLEGUM FLAVOR anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230614		OTC MONOGRAPH FINAL	part355	HISMILE PTY LTD	SODIUM FLUORIDE	2.4	mg/g			N	20241231
83013-308_9d96b1dc-860e-4d08-afe5-26c695efdcc7	83013-308	HUMAN OTC DRUG	hismile STRAWBERRY FLAVOR anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230614		OTC MONOGRAPH FINAL	part355	HISMILE PTY LTD	SODIUM FLUORIDE	2.4	mg/g			N	20241231
83013-309_2820fa38-8eff-4902-808f-dcdfbfff6c1a	83013-309	HUMAN OTC DRUG	hismile BANANA FLAVOR anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230614		OTC MONOGRAPH FINAL	part355	HISMILE PTY LTD	SODIUM FLUORIDE	2.4	mg/g			N	20241231
83013-310_56d852ce-5a86-40a5-8f1d-c5f3f0f13265	83013-310	HUMAN OTC DRUG	hismile VANILLA FLAVOR anticavity		Sodium Fluoride	PASTE, DENTIFRICE	DENTAL	20230614		OTC MONOGRAPH FINAL	part355	HISMILE PTY LTD	SODIUM FLUORIDE	2.4	mg/g			N	20241231
83014-0001_0ec293a4-4002-426a-9459-1acced827c4f	83014-0001	HUMAN OTC DRUG	Weight Loss Support Plus Female Balance		Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin (Derived From Egg), Capsicum Annuum, Caulophyllum Thalictroides, Cimicifuga Racemosa, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum (NSPC), Phytolacca Decandra, Rubus Idaeus, Thyroidinum (Bovine), Pituitarum Posterium Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus, Hepar Sulphuris Calcareum, Oxytocin, Progesterone	SPRAY	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Carolinas Weight Loss Institute	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BLACK COHOSH; BOS TAURUS PITUITARY GLAND, POSTERIOR; CALCIUM SULFIDE; CAPSICUM; CAULOPHYLLUM THALICTROIDES ROOT; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; OXYTOCIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; PROGESTERONE; RUBUS IDAEUS LEAF; SILVER; SKIM MILK; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	3; 9; 6; 8; 12; 6; 6; 3; 12; 2; 3; 6; 30; 9; 12; 6; 6; 30; 6; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Uterine Smooth Muscle Contraction or Tone [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Oxytocic [EPC], Oxytocin [CS], Plant Proteins [CS], Progesterone [CS], Progesterone [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83014-0002_f67a3c43-4b82-4cd8-8098-78e6846cab67	83014-0002	HUMAN OTC DRUG	Weight Loss Support Plus Adrenal		Glycyrrhiza Glabra, Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin (Derived From Egg), Aralia Quinquefolia, Capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum (NSPC), Phytolacca Decandra, Thyroidinum (Bovine), Glandula Suprarenalis (Bovine), Pituitarum Posterium (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus, Adrenocorticotrophin	SPRAY	ORAL	20230321		UNAPPROVED HOMEOPATHIC		Carolinas Weight Loss Institute	AMERICAN GINSENG; AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS ADRENAL GLAND; BOS TAURUS PITUITARY GLAND, POSTERIOR; CAPSICUM; CORTICOTROPIN; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; GLYCYRRHIZA GLABRA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SILVER; SKIM MILK; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	3; 3; 9; 6; 8; 6; 15; 3; 12; 2; 3; 6; 1; 9; 12; 6; 6; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83014-0003_dfe0363b-3ebf-4e23-b260-b59f0e0c3126	83014-0003	HUMAN OTC DRUG	Weight Loss Support Plus Male Balance		Agnus Castus, Foeniculum Vulgare, Ammonium Bromatum, Caladium Seguinum, Fucus Vesiculosus, Lecithin (Derived From Egg), Capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum (NSPC), Phytolacca Decandra, Thyroidinum (Bovine), Pituitarum Posterium (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Selenium Metallicum, Adrenalinum, Phosphorus, Orchitinum (Bovine), Onosmodium Virginianum	SPRAY	ORAL	20230310	20280614	UNAPPROVED HOMEOPATHIC		Carolinas Weight Loss Institute	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS TESTICLE; CAPSICUM; CHASTE TREE FRUIT; DIEFFENBACHIA SEGUINE WHOLE; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; ONOSMODIUM VIRGINIANUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SELENIUM; SILVER; SKIM MILK; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	3; 9; 8; 16; 6; 2; 3; 3; 12; 2; 3; 6; 30; 9; 12; 6; 6; 9; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	
83014-0004_f3615271-c476-4c03-9e41-26e22c8f3a8d	83014-0004	HUMAN OTC DRUG	Weight Loss Support Plus		Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin (Derived From Egg), capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum (NSPC), Phytolacca Decandra, Pituitarum Posterium (Bovine), Thyroidinum (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus	SPRAY	ORAL	20230216		UNAPPROVED HOMEOPATHIC		Carolinas Weight Loss Institute	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; CAPSICUM; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SILVER; SKIM MILK; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	3; 9; 8; 6; 3; 12; 2; 3; 6; 9; 12; 6; 6; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83014-0005_be59aebe-65e5-4be6-9610-b0e30a5cf839	83014-0005	HUMAN OTC DRUG	Weight Loss Support Plus Immune Support		Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin (Derived From Egg), Petroselinum Sativum, Capsicum Annuum, Galium Aparine, Hydrastis Canadensis, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum (NSPC), Phytolacca Decandra, Thyroidinum (Bovine), Thymus (Bovine Thymus Gland), Pituitarum Posterium (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus	SPRAY	ORAL	20230217		UNAPPROVED HOMEOPATHIC		Carolinas Weight Loss Institute	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS THYMUS; CAPSICUM; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; GOLDENSEAL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PETROSELINUM CRISPUM WHOLE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SILVER; SKIM MILK; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	3; 9; 8; 6; 6; 3; 12; 2; 3; 6; 6; 9; 3; 12; 6; 6; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83014-0006_b840b2b5-07c2-4e02-b090-f8ec69cc61e8	83014-0006	HUMAN OTC DRUG	Weight Loss Support Plus Thyroid		Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin, Rutinic Acid, Iodium, Capsicum Annuum, Galium aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum, Phytolacca Decandra, Spongia Tosta, Thyroidinum (Bovine), Pituitarum Posterium (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus, Lapis Albus	SPRAY	ORAL	20230822		UNAPPROVED HOMEOPATHIC		Carolinas Weight Loss Institute	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; CALCIUM HEXAFLUOROSILICATE; CAPRIC ACID; CAPSICUM; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; IODINE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SILVER; SKIM MILK; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA HYPOTHALAMUS; THYROID, BOVINE	3; 9; 8; 15; 3; 6; 3; 12; 2; 3; 6; 4; 9; 12; 6; 6; 9; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83014-0007_8fa8e390-fe92-407c-a78e-ad98ee6ce27e	83014-0007	HUMAN OTC DRUG	Weight Loss Support Plus Male Balance		Agnus Castus, Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin (Derived From Egg), Capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum, Phytolacca Decandra, Thyroidinum (Bovine), Pituitarum Posterium (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Selenium Metallicum, Adrenalinum, Phosphorus, Orchitinum (Bovine), Caladium Seguinum, Onosmodium Virginianum	SPRAY	ORAL	20231030		UNAPPROVED HOMEOPATHIC		Carolinas Weight Loss Institute	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS TESTICLE; CAPSICUM; CHASTE TREE FRUIT; DIEFFENBACHIA SEGUINE WHOLE; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; ONOSMODIUM VIRGINIANUM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SELENIUM; SILVER; SKIM MILK; SUS SCROFA HYPOTHALAMUS; THYROID, BOVINE	3; 9; 8; 16; 6; 2; 18; 3; 12; 2; 3; 6; 30; 9; 12; 6; 6; 9; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83016-171_fe0478d8-2f07-cd56-e053-6294a90a58e5	83016-171	HUMAN OTC DRUG	Pain Relief Gel-Patch		Lidocaine, Menthol	PATCH	TOPICAL	20230615		OTC MONOGRAPH NOT FINAL	part348	R & Y Group, LLC	LIDOCAINE; MENTHOL	.48; .12	g/12g; g/12g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83016-331_08fe8fdc-425a-f841-e063-6394a90a0908	83016-331	HUMAN OTC DRUG	PAIN RELIEF Gel-Roll On		Menthol	GEL	TOPICAL	20231027		OTC MONOGRAPH DRUG	M017	R & Y Group, LLC	MENTHOL	.04	g/mL			N	20241231
83018-0001_09b3e2a3-7a15-469c-bcf7-c0c3530b585c	83018-0001	HUMAN OTC DRUG	CellTropin		Arginine, Ginkgo Biloba, Hypophysis Suis, Silicea, astragalus Excapus	LIQUID	ORAL	20230213		UNAPPROVED HOMEOPATHIC		Micro Balance Health Products LLC	ARGININE; ASTRAGALUS EXSCAPUS WHOLE; GINKGO; SILICON DIOXIDE; SUS SCROFA PITUITARY GLAND	3; 12; 6; 9; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83018-0002_6d346b99-0998-42ce-b151-c47ccb674757	83018-0002	HUMAN OTC DRUG	Sinus Defense		Lac Vaccinum, Silicea, Aspergillus Niger, Babesia Microti, Borrelia Burgdorferi, Candida Albicans, Candida Parapsilosis, Chlamydia Trachomatis, Colibacillinum Cum Natrum Muriaticum, Cytomegalovirus Nosode, Ehrlichia Nosode, Herpes Simplex I and II Nosode, Human Papilloma Nosode, Klebsiella Pneumoniae, Mucor Racemosus, Mycobacterium Paratuberculosis, Pneumoccoccinum, Staphylococcus Aureus, Streptococcus Viridans, Epstein-Barr Virus Nosode, Herpes Zoster Nosode	SPRAY	ORAL	20230308		UNAPPROVED HOMEOPATHIC		Micro Balance Health Products LLC	ASPERGILLUS NIGER VAR. NIGER; BABESIA MICROTI; BORRELIA BURGDORFERI; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CHLAMYDIA TRACHOMATIS; COW MILK; EHRLICHIA CANIS; ESCHERICHIA COLI; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN PAPILLOMAVIRUS; KLEBSIELLA PNEUMONIAE; MUCOR RACEMOSUS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; SILICON DIOXIDE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	16; 16; 16; 16; 16; 16; 6; 16; 16; 16; 16; 15; 15; 16; 16; 16; 16; 16; 9; 16; 16; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
83018-0003_f529aef5-ed58-7b26-e053-2995a90a5430	83018-0003	HUMAN OTC DRUG	CitriDrops		Ascorbicum Acidum, Citrus Limonun, Pulsatilla, Sinapis Nigra, Luffa Operculata, Berberis Vulgaris, Euphorbium Officinarum, Guaiacum, Hepar Sulphuris Calcareum, Mercurius Sulphuratu Ruber	SPRAY	NASAL	20230221		UNAPPROVED HOMEOPATHIC		Micro Balance Health Products	ASCORBIC ACID; BERBERIS VULGARIS ROOT BARK; BLACK MUSTARD SEED; CALCIUM SULFIDE; EUPHORBIA RESINIFERA RESIN; GUAIAC; LEMON JUICE; LUFFA OPERCULATA WHOLE; MERCURIC SULFIDE; PULSATILLA PRATENSIS	3; 6; 4; 12; 6; 8; 4; 4; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ascorbic Acid [CS], Vitamin C [EPC]		N	20241231
83018-0004_08ea860f-0184-8ce8-e063-6394a90a582b	83018-0004	HUMAN OTC DRUG	Ahh Sleep		Coffea cruda	SPRAY	ORAL	20231030		UNAPPROVED HOMEOPATHIC		Micro Balance Health Products	ARABICA COFFEE BEAN; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; HYDROCHLORIC ACID; HYOSCYAMUS NIGER; POTASSIUM PHOSPHATE, UNSPECIFIED FORM; STRYCHNOS IGNATII SEED; SULFUR; ZINC	200; 4; 12; 30; 12; 12; 6; 12	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
83020-301_0d8e4892-7752-40ca-e063-6394a90a6bda	83020-301	HUMAN OTC DRUG	Calming Days Vegan Sunscreen		Diethylamino Hydroxybenzoyl Hexyl Benzoate, Octyl Triazone (ethylhexyl triazone), Bisoctrizole, Diethylhexyl Butamido Triazone	GEL	TOPICAL	20221018		UNAPPROVED DRUG OTHER		Merci Co.	BISOCTRIZOLE; DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE; ETHYLHEXYL TRIAZONE; ISCOTRIZINOL	2; 3; 2.4; 1.2	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83021-033_0452aac5-a078-8ea7-e063-6394a90a7c02	83021-033	HUMAN OTC DRUG	Anubis Barcelona New Even		Lactic Acid, Citric Acid, Glycolic Acid	LOTION	TOPICAL	20221013	20270113	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	.ALPHA.-HEXYLCINNAMALDEHYDE; ALLANTOIN; BENZOIC ACID; DEHYDROACETIC ACID; DIETHYLENE GLYCOL MONOETHYL ETHER; FD&C BLUE NO. 1; FRAGRANCE 13576; GLYCOLIC ACID; LACTIC ACID; LIMONENE, (+)-; LINALOOL, (+/-)-; PHENOXYETHANOL; POLYOXYL 40 HYDROGENATED CASTOR OIL; PROPYLENE GLYCOL; TROLAMINE; WATER	.0150375; .75; .625; .25; .75; .0005; .075; 1.220625; 2.348125; .022755; .0041025; 2.5; 1.25; 10.5; .5; 228.15635	g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; mL/250mL	Acidifying Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]		N	
83021-064_0414db8c-fb90-8076-e063-6394a90a2d3d	83021-064	HUMAN OTC DRUG	Anubis Barcelona Vital Line		Hydrolyzed Collagen	CREAM	TOPICAL	20230223	20261020	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	.BETA.-SITOSTEROL; AMILOXATE; AVOBENZONE; CETEARYL ETHYLHEXANOATE; CETYL PEG/PPG-10/1 DIMETHICONE (HLB 4); ETHYLHEXYLGLYCERIN; FRAGRANCE 13576; GLYCERIN; HEXYL LAURATE; HYDROGENATED CASTOR OIL; HYDROLYSED MARINE COLLAGEN (ENZYMATIC; 2000 MW); LINOLEIC ACID; LINOLENIC ACID; MALVA SYLVESTRIS FLOWERING TOP; MEDIUM-CHAIN TRIGLYCERIDES; PAPAVER RHOEAS FLOWER; PHENOXYETHANOL; POLYGLYCERYL-4 ISOSTEARATE; SHEA BUTTER; SQUALANE; TOCOPHEROL; WATER; WHITE WAX	.01; 4; 2; 4; 3; .2; .8; 7; 2.7; 4; .2; .16; .04; .06; 34; .04; 1.8; 3; 4; .01; .08; 125.88; 1	g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	
83021-187_045289e2-7a72-8d91-e063-6394a90ab123	83021-187	HUMAN OTC DRUG	Anubis Barcelona Vital Line		Hydrolyzed Elastin, Hydrolysed Collagen, Cocoglycerides	CREAM	TOPICAL	20221025	20261020	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	.ALPHA.-HEXYLCINNAMALDEHYDE; .BETA.-CITRONELLOL, (R)-; AVOBENZONE; BENZOIC ACID; BUTYLATED HYDROXYTOLUENE; CENTAUREA CYANUS FLOWER; CETOSTEARYL ALCOHOL; CETYL ALCOHOL; COCO-GLYCERIDES; DEHYDROACETIC ACID; FRAGRANCE 13576; GLYCERIN; HYDROLYSED MARINE COLLAGEN (ENZYMATIC; 2000 MW); HYDROLYZED BOVINE ELASTIN (BASE; 1000 MW); ISOMETHYL-.ALPHA.-IONONE; LIMONENE, (+)-; MEDIUM-CHAIN TRIGLYCERIDES; OCTINOXATE; PHENOXYETHANOL; POTASSIUM PHOSPHATE, UNSPECIFIED FORM; VIOLA ODORATA; WATER	.16; .0056; 2; .24; .005; .05; 12.58; 4; 8; .14; .98; 6.94; .6; .03; .0054; .038; 12; 5; 1.62; .006; .05; 140	g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; mL/200mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Chemical Allergen [EPC]		N	
83021-300_0452aac5-a076-8ea7-e063-6394a90a7c02	83021-300	HUMAN OTC DRUG	Anubis Barcelona Regul Oil		Propylene Glycol, Glyceryl Stearate Se, Humulus Lupulus (Hops) Cone Extract	CREAM	TOPICAL	20221020	20280203	OTC MONOGRAPH FINAL	M006	ANUBIS COSMETICS SL	ALCOHOL; ARCTIUM LAPPA ROOT; C13-14 ISOPARAFFIN; CETEARYL ETHYLHEXANOATE; CETOSTEARYL ALCOHOL; ETHYLHEXYLGLYCERIN; FD&C YELLOW NO. 5; FRAGRANCE 13576; GLYCERIN; GLYCERYL STEARATE SE; HOPS; IMIDUREA; LAURETH-7; LIMONENE, (+)-; METHYLCHLOROISOTHIAZOLINONE; METHYLISOTHIAZOLINONE; METHYLPARABEN; MINERAL OIL; NIACINAMIDE; PANTHENOL; PEG/PPG-20/6 DIMETHICONE; PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE); PHENOXYETHANOL; POLYACRYLAMIDE (CROSSLINKED; 0.01-0.2 MOLE PERCENT BISACRYLAMIDE); PROPYLENE GLYCOL; PROPYLPARABEN; RIBOFLAVIN; TIOXOLONE; TRIISOPROPANOLAMINE; WATER; YEAST, UNSPECIFIED	.08; .012; .48; 4; 26; .0028; .00004; .6; .048; 7; .0012; .6; .12; .08398; .045; .15; .48; 6; .023; .1; 1.372; .0012; .0252; .8; 10.148; .24; .00012; .3; .004; 123.55598; .023	mL/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; mL/200mL; g/200mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Fungal Proteins [CS], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-305_04529ef6-e35a-95c2-e063-6394a90ae70d	83021-305	HUMAN OTC DRUG	Anubis Barcelona Spa Line		ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID	CREAM	TOPICAL	20221014	20271013	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	.BETA.-CITRONELLOL, (R)-; ALCOHOL; BUTYLATED HYDROXYTOLUENE; C12-20 ACID PEG-8 ESTER; CETEARYL ETHYLHEXANOATE; ETHYLHEXYLGLYCERIN; FRAGRANCE 13576; GLYCERIN; GLYCERYL MONOSTEARATE; GRAPE SEED OIL; HYDROXYACETOPHENONE; ISOMETHYL-.ALPHA.-IONONE; LINALOOL, (+/-)-; PALMITIC ACID; PERLITE; PHENOXYETHANOL; PROPYLENE GLYCOL; STARCH, RICE; STEARIC ACID; TITANIUM DIOXIDE; TROLAMINE; WATER	.012; 4.752; .25; 1; .75; .05; .15; .0115; 3.5; .25; .25; .00639; .0114; 1; 4; .45; 1.5; 5.5; 1; .25; .25; 25.04945	g/50mL; mL/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	
83021-400_049fe4c2-996a-198f-e063-6294a90a40b9	83021-400	HUMAN OTC DRUG	AnubisMed		Sodium Bicarbonate, Aloe Barbadensis Leaf Juice, Imidazolidinyl Urea	LIQUID	TOPICAL	20221026	20270510	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	ALOE VERA LEAF; IMIDUREA; WATER	.15; .25; 45.8293	g/50mL; g/50mL; mL/50mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	
83021-401_049fdc9c-b52f-63c1-e063-6394a90aaa6a	83021-401	HUMAN OTC DRUG	AnubisMed		Glycolic Acid, Citric Acid, Lactic Acid, Kojic Acid	LIQUID	TOPICAL	20221104	20270701	OTC MONOGRAPH FINAL	M006	ANUBIS COSMETICS SL	ALCOHOL; AMMONIA; ASCORBYL GLUCOSIDE; ETHYLHEXYLGLYCERIN; GLYCOLIC ACID; HEXYLRESORCINOL; HYDROXYETHYL CELLULOSE, UNSPECIFIED; ISOPROPYL ALCOHOL; KOJIC ACID; LACTIC ACID; PHENOXYETHANOL; PROPYLENE GLYCOL; SALICYLIC ACID; WATER	6.3; 2.75; .25; .025; 17; 1; .34875; .75; 2.5; 5; .225; .5; 1; 7.333	mL/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL	Acidifying Activity [MoA]		N	
83021-402_049fca13-6921-d895-e063-6294a90a42da	83021-402	HUMAN OTC DRUG	AnubisMed		Azelaic Acid, Salicylic Acid	LIQUID	TOPICAL	20221026	20270908	OTC MONOGRAPH FINAL	M006	ANUBIS COSMETICS SL	ALCOHOL; AZELAIC ACID; ISOPROPYL ALCOHOL; POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL; SALICYLIC ACID; WATER	22.68; 7; 2.7; 4.9965; 10; 1; 1.62	mL/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL	Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]		N	
83021-495_045289e2-7a73-8d91-e063-6394a90ab123	83021-495	HUMAN OTC DRUG	Anubis Barcelona		Proteoglycan, Glycerin, Butylene Glycol	CONCENTRATE	TOPICAL	20221025	20270902	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	BENZOIC ACID; BUTYLENE GLYCOL; DEHYDROACETIC ACID; EDETIC ACID; FRAGRANCE 13576; GLYCERIN; PHENOXYETHANOL; POLYSORBATE 20; PROPANEDIOL; PROTEOGLYCAN 4; WATER; XANTHAN GUM	.024; .46; .014; .0002; .03; 2; .162; .2; .4; .002; 16.4578; .08	g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; mL/20mL; g/20mL	Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Lead Chelating Activity [MoA], Lead Chelator [EPC], Nitrogen Binding Agent [EPC], Non-Standardized Chemical Allergen [EPC]		N	
83021-501_04529ef6-e35b-95c2-e063-6394a90ae70d	83021-501	HUMAN OTC DRUG	Anubis Barcelona		Ferulic Acid, Vitamin C, DMAE	CONCENTRATE	TOPICAL	20221013	20280124	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	ALCOHOL; FERULIC ACID; FRAGRANCE 13576; GLYCERIN; LECITHIN, SOYBEAN; MALONDIALDEHYDE; PEG-8 CAPRYLIC/CAPRIC GLYCERIDES; POLYOXYL 35 CASTOR OIL; WATER	.96; .1; .02; .02; .12; 2; 2; .18; 14.26	mL/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; mL/20mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	
83021-546_04522475-b450-eb2f-e063-6294a90afc2b	83021-546	HUMAN OTC DRUG	Anubis Barcelona		DMAE	CONCENTRATE	TOPICAL	20230113	20270805	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	ASCORBYL GLUCOSIDE; BENZOIC ACID; DEHYDROACETIC ACID; DICAPRYLYL ETHER; FRAGRANCE 13576; GLYCERIN; HYDROLYZED BOVINE ELASTIN (BASE; 1000 MW); HYDROXYCITRONELLAL; HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (100000 MPA.S AT 1.5%); LECITHIN, SOYBEAN; LIMONENE, (+)-; PHENOXYETHANOL; POLYSORBATE 60; PROPANEDIOL; SORBITAN ISOSTEARATE; TOCOPHEROL; WATER; XANTHAN GUM	.15; .036; .021; .9; .027; .555; .0012; .0006; .405; .45; .0009; .243; .024; 1.08; .024; .0003; 25.5564; .09	g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; g/30mL; mL/30mL; g/30mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Nitrogen Binding Agent [EPC], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-551_049fca13-6920-d895-e063-6294a90a42da	83021-551	HUMAN OTC DRUG	AnubisMed		SPF 50 Broad Spectrum Protection Fluid Emulsion	CREAM	TOPICAL	20221015	20270429	OTC MONOGRAPH FINAL	M020	ANUBIS COSMETICS SL	.ALPHA.-TOCOPHEROL; ANHYDROUS CITRIC ACID; ASCORBIC ACID; ASCORBYL PALMITATE; AVOBENZONE; BEMOTRIZINOL; BUTYLATED HYDROXYTOLUENE; BUTYLENE GLYCOL; C20-22 ALCOHOLS; CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED); CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; CHLORPHENESIN; DIMETHICONE; FRAGRANCE 13576; GLYCERIN; LINOLEIC ACID; LINOLENIC ACID; OCTINOXATE; OCTISALATE; OCTOCRYLENE; PHENOXYETHANOL; POLY(METHYL METHACRYLATE; 450000 MW); POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL; SILICON DIOXIDE; TITANIUM DIOXIDE; TROMETHAMINE; WATER	.006; .00025; .00025; .00125; 1.8; 1.45; .0018; 2.5; .3375; .075; .025; .1; 1.25; .3; .005; .49725; .00275; 3.5982; 1.8; 1.8; .35; 2.1; .14225; 2.5; .575; .425; .22; 27.55	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL	Acidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Skin Barrier Activity [PE], Vitamin C [EPC]		N	
83021-553_045252bb-c4ae-54e9-e063-6394a90aba06	83021-553	HUMAN OTC DRUG	Anubis Barcelona		DMAE, ZIRHAFIRM	CREAM	TOPICAL	20230113	20280306	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	.BETA.-CITRONELLOL, (R)-; ALOE VERA LEAF; BAICALIN; BENZYL ALCOHOL; CETOSTEARYL ALCOHOL; DECYL OLEATE; DICAPRYLYL ETHER; EUGENOL; FRAGRANCE 13576; GLYCERIN; GLYCERYL MONOSTEARATE; HYDROXYCITRONELLAL; JUJUBE SEED; LECITHIN, SOYBEAN; LEUZEA CARTHAMOIDES ROOT; LIMONENE, (+)-; LINALOOL, (+/-)-; PROPANEDIOL; SALICYLIC ACID; SHEA BUTTER; SORBIC ACID; TOCOPHEROL; WATER; XANTHAN GUM	.0006; 5.988; .012; .456; 1.2; 3.9; 1.5; .0006; .114; 3.036; 2.4; .0024; .048; .036; .012; .006; .0006; 2.496; .09; 2.1; .024; .0018; 33.2616; .18	g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; mL/60mL; g/60mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Pediculicide [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-617_045252bb-c4b5-54e9-e063-6394a90aba06	83021-617	HUMAN OTC DRUG	Anubis Barcelona		Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin	CONCENTRATE	TOPICAL	20221021	20270920	OTC MONOGRAPH FINAL	M006	ANUBIS COSMETICS SL	ALCOHOL; ALLANTOIN; ARCTIUM LAPPA ROOT; ASCORBYL PALMITATE; BUTYLPARABEN; CITRAL; ETHYLPARABEN; FARNESOL; FD&C YELLOW NO. 5; FRAGRANCE 13576; HYDROXYETHYL CELLULOSE, UNSPECIFIED; ISOPROPYL ALCOHOL; LEVOMENOL; LIMONENE, (+)-; METHYLPARABEN; NIACINAMIDE; PANTHENOL; PHENOXYETHANOL; POLYOXYL 40 HYDROGENATED CASTOR OIL; POWDERED CELLULOSE; PROPYLENE GLYCOL; PROPYLPARABEN; RIBOFLAVIN; TIOXOLONE; TOCOPHEROL; WATER; YEAST, UNSPECIFIED	1.756; .0125; .000035; .00005; .00000025; .000097; .00000015; .0005; .00001; .01; .017; .0006; .0045; .002095; .00500065; .0001; .0025; .000003; .02; .0003; .0069; .0000001; .000003; .01; .000001; 3.12515585; .01725	mL/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; g/5mL; mL/5mL; g/5mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-624_0452a0dd-b516-29ea-e063-6294a90aecca	83021-624	HUMAN OTC DRUG	Anubis Barcelona Regul OIl		Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Arctium Majus Root Extract	CONCENTRATE	TOPICAL	20221021	20270707	OTC MONOGRAPH FINAL	M006	ANUBIS COSMETICS SL	ALCOHOL; ALLANTOIN; ARCTIUM LAPPA ROOT; ASCORBYL PALMITATE; BUTYLPARABEN; CITRAL; ETHYLPARABEN; FARNESOL; FD&C YELLOW NO. 5; FRAGRANCE 13576; HYDROXYETHYL CELLULOSE, UNSPECIFIED; ISOPROPYL ALCOHOL; LEVOMENOL; LIMONENE, (+)-; METHYLPARABEN; NIACINAMIDE; PANTHENOL; PHENOXYETHANOL; POLYOXYL 40 HYDROGENATED CASTOR OIL; POWDERED CELLULOSE; PROPYLENE GLYCOL; PROPYLPARABEN; RIBOFLAVIN; TIOXOLONE; TOCOPHEROL; WATER; YEAST, UNSPECIFIED	3.512; .025; .00007; .0001; .0000005; .000194; .0000003; .001; .00002; .02; .034; .0012; .009; .00419; .0100013; .0002; .005; .000006; .04; .0006; .0138; .0000002; .000006; .02; .000002; 6.2503117; .0345	mL/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; g/10mL; mL/10mL; g/10mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-686_0452914b-b325-8a71-e063-6394a90a92de	83021-686	HUMAN OTC DRUG	Anubis Barcelona Protective Line		Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene	CREAM	TOPICAL	20221102	20280309	OTC MONOGRAPH FINAL	M020	ANUBIS COSMETICS SL	ASCORBIC ACID; ASCORBYL PALMITATE; AVOBENZONE; BEMOTRIZINOL; BUTYLATED HYDROXYTOLUENE; BUTYLENE GLYCOL; C20-22 ALCOHOLS; CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED); CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; CHLORPHENESIN; DIMETHICONE; FRAGRANCE 13576; GLYCERIN; LINOLEIC ACID; LINOLENIC ACID; OCTINOXATE; OCTISALATE; OCTOCRYLENE; PHENOXYETHANOL; POLY(METHYL METHACRYLATE; 450000 MW); POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL; SILICON DIOXIDE; TITANIUM DIOXIDE; TOCOPHEROL; TROMETHAMINE; WATER	.00025; .00125; 1.8; 1.45; .0018; 2.5; .3375; .075; .025; .1; 1.25; .3; .005; .49725; .00275; 3.5982; 1.8; 1.8; .35; 2.1; .14225; 2.5; .575; .425; .006; .22; 27.55	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL	Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Skin Barrier Activity [PE], Vitamin C [EPC]		N	
83021-692_0452aac5-a077-8ea7-e063-6394a90a7c02	83021-692	HUMAN OTC DRUG	Anubis Barcelona Total Hydrating		Betaine, Glycerin, Polysorbate 20	LOTION	TOPICAL	20221013	20270912	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	BENZOIC ACID; BETAINE; ETHYLHEXYLGLYCERIN; FD&C BLUE NO. 1; FRAGRANCE 13576; GLYCERIN; IMIDUREA; PHENOXYETHANOL; POLYSORBATE 20; WATER	1.75; 5; .125; .00025; .125; 5; .75; 2.25; 2.75; 232.139	g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; mL/250mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Methylating Activity [MoA], Methylating Agent [EPC], Nitrogen Binding Agent [EPC], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-740_04528cb8-0159-86e0-e063-6394a90a5904	83021-740	HUMAN OTC DRUG	Anubis Barcelona Regul Oil		Propylene Glycol, Panthenol, Thiamine HCL	LOTION	TOPICAL	20221021	20270922	OTC MONOGRAPH FINAL	M006	ANUBIS COSMETICS SL	ALCOHOL; ALLANTOIN; ARCTIUM LAPPA ROOT; CITRAL; FD&C YELLOW NO. 5; FRAGRANCE 13576; GLYCERIN; LIMONENE, (+)-; METHYLPARABEN; NIACINAMIDE; PANTHENOL; POLYOXYL 40 HYDROGENATED CASTOR OIL; PROPYLENE GLYCOL; RIBOFLAVIN; TIOXOLONE; WATER; YEAST, UNSPECIFIED	52.5; .25; .0225; .00485; .0015; .5; .45; .10475; .5; .025; .05; 2; 13; .0025; .25; 179.89815; .14375	mL/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; g/250mL; mL/250mL; g/250mL	Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Chemical Allergen [EPC]		N	
83021-742_04529ef6-e358-95c2-e063-6394a90ae70d	83021-742	HUMAN OTC DRUG	Anubis Barcelona Regul Oil		Cetearyl Ethylhexanoate, Propylene Glycol, Glyceryl Stearate Se	CREAM	TOPICAL	20221019	20270220	OTC MONOGRAPH FINAL	M006	ANUBIS COSMETICS SL	.ALPHA.-HEXYLCINNAMALDEHYDE; ALCOHOL; ALLANTOIN; ARCTIUM LAPPA ROOT; BENZYL BENZOATE; BUTYLATED HYDROXYTOLUENE; C12-20 ACID PEG-8 ESTER; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; CETEARYL ETHYLHEXANOATE; CETYL ALCOHOL; CITRAL; COUMARIN; FD&C YELLOW NO. 5; FRAGRANCE 13576; GERANIOL; GLYCERIN; GLYCERYL STEARATE SE; GREEN TEA LEAF; HYDROXYETHYL CELLULOSE, UNSPECIFIED; IMIDUREA; ISOPROPYL ALCOHOL; LIMONENE, (+)-; LINALOOL, (+/-)-; METHYLPARABEN; NIACINAMIDE; OCTINOXATE; OXYBENZONE; PANTHENOL; PHENOXYETHANOL; POLYOXYL 40 HYDROGENATED CASTOR OIL; POWDERED CELLULOSE; PROPYLENE GLYCOL; PROPYLPARABEN; RIBOFLAVIN; TEA TREE OIL; TIOXOLONE; WATER; YEAST, UNSPECIFIED	.00574; 3.5436; .2; .003512; .004; .104; 4; .8; 10; .015; .01032; .003924; .01044; .5; .003398; .08784; 6; .00679; .12863; .4; .002132; .061818; .026404; .6; .02; 3.996; 1.6; .04; 1.3; 1.8; .001066; 6.469044; .28; .00012; .1; .3; 155.839258; .1	g/200mL; mL/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; g/200mL; mL/200mL; g/200mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-750_049f9ce0-73cc-2865-e063-6394a90a505a	83021-750	HUMAN OTC DRUG	ANUBISMED		HA HYALURONIC	CREAM	TOPICAL	20221017	20280116	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	1,2-HEXANEDIOL; ALLANTOIN; ALOE VERA LEAF; BUTYLATED HYDROXYTOLUENE; C12-20 ACID PEG-8 ESTER; CAPRYLYL GLYCOL; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; CETEARYL ETHYLHEXANOATE; CETYL ALCOHOL; DECYL OLEATE; DIMETHICONE; FRAGRANCE 13576; GLYCERIN; GLYCERYL MONOSTEARATE; GLYCERYL STEARATE SE; IMIDUREA; MEDIUM-CHAIN TRIGLYCERIDES; OCTINOXATE; OXYBENZONE; PROPYLENE GLYCOL; TOCOPHEROL; TROLAMINE; TROPOLONE; WATER	.198; .05; 2.5; .0535; 2.25; .198; .25; 1.75; .0038; 1.9996; .25; .225; .4975; .875; 1.5; .15; 1.5; 3.4965; 2; 1.996; .0004; .3; .004; 27.4065	g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Skin Barrier Activity [PE], Standardized Chemical Allergen [EPC]		N	
83021-774_049fc41b-5140-1a0c-e063-6394a90ac8d7	83021-774	HUMAN OTC DRUG	AnubisMed		Aloe Barbadensis Leaf Extract, Propylene Glycol, Cetearyl Ethylhexanoate	CREAM	TOPICAL	20221014	20260203	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	1,2-HEXANEDIOL; ALLANTOIN; ALOE VERA LEAF; ARGAN OIL; BUTYLATED HYDROXYTOLUENE; BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES; C12-20 ACID PEG-8 ESTER; CAPRYLYL GLYCOL; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; DECYL OLEATE; FRAGRANCE 13576; GLYCERIN; GRAPE SEED OIL; HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER; IMIDUREA; MEDIUM-CHAIN TRIGLYCERIDES; PROPYLENE GLYCOL; SILICON DIOXIDE; TOCOPHEROL; TROLAMINE; TROPOLONE; WATER	.06; .015; .6; .075; .015; .15; .15; .0588; .12; .2999994; .0375; .15; .15; .1176; .045; .375; .6; .0024; .0000006; .12; .0012; 11.358	g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; mL/15mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	
83021-839_04529ef6-e359-95c2-e063-6394a90ae70d	83021-839	HUMAN OTC DRUG	Anubis Barcelona		Propanediol, Glycerin, Magnesium Ascorbyl Phosphate	CONCENTRATE	TOPICAL	20221018	20270113	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	BENZOIC ACID; BENZYL ALCOHOL; DEHYDROACETIC ACID; EDETIC ACID; FRAGRANCE 13576; GLYCERIN; HYDROXYCITRONELLAL; ISOMETHYL-.ALPHA.-IONONE; PEG-8 CAPRYLIC/CAPRIC GLYCERIDES; PHENOXYETHANOL; PROPANEDIOL; SORBIC ACID; WATER	.0009; .01215; .00135; .000009; .00285; .01035; .00006; .00003; .15; .0003; .15; .0006; 1.16659425	g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; mL/1.5mL	Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Lead Chelating Activity [MoA], Lead Chelator [EPC], Nitrogen Binding Agent [EPC], Non-Standardized Chemical Allergen [EPC], Pediculicide [EPC], Standardized Chemical Allergen [EPC]		N	
83021-877_04522475-b44b-eb2f-e063-6294a90afc2b	83021-877	HUMAN OTC DRUG	Anubis Barcelona		Glycerin, Sorbitol, Aloe Barbadensis Leaf Juice	CONCENTRATE	TOPICAL	20221019	20270114	OTC MONOGRAPH FINAL	M016	ANUBIS COSMETICS SL	1,2-HEXANEDIOL; ALOE VERA LEAF; ETHYLHEXYLGLYCERIN; FD&C BLUE NO. 1; GLYCERIN; HYALURONATE SODIUM; LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE; PHENOXYETHANOL; SACCHAROMYCES LYSATE; SORBITOL; WATER	.0165; .008955; .0015; .000009; .16875; .0075; .000015; .0141; .00075; .0525; 1.219341	g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; g/1.5mL; mL/1.5mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	
83027-0001_06a829c0-79d5-4e2a-8b51-db7a856d0244	83027-0001	HUMAN OTC DRUG	Dizzy Formula		Arnica Montana, Hydrocotyle Asiatica, Ambra Grisea, Argentum Nitricum, Cocculus Indicus, Conium Maculatum, Lac Caninum, Theridion	SPRAY	ORAL	20230220		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMBERGRIS; ANAMIRTA COCCULUS SEED; ARNICA MONTANA WHOLE; CANIS LUPUS FAMILIARIS MILK; CENTELLA ASIATICA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; SILVER NITRATE; THERIDION CURASSAVICUM	12; 12; 3; 12; 3; 12; 12; 18	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0002_6cdb2a5e-7603-46c7-ac19-5cf1fd922fac	83027-0002	HUMAN OTC DRUG	EPI Formula		Belladonna, Hyoscyamus Niger, Asterias Rubens, Calcarea Carbonica, Cicuta Virosa, Oenanthe Crocata, Cuprum Metallicum	SPRAY	ORAL	20230324		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ASTERIAS RUBENS; ATROPA BELLADONNA; CICUTA VIROSA ROOT; COPPER; HYOSCYAMUS NIGER; OENANTHE CROCATA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE	8; 4; 10; 12; 4; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
83027-0003_82e0471a-9a29-4671-9443-0be16eb840a0	83027-0003	HUMAN OTC DRUG	Sciatic Formula		Kali Iodatum, Ruta Graveolens, Ammonium Muriaticum, Belladonna, Gnaphalium Polycephalum, Colocynthis, Aconitum Napellus, Nux Vomica, Arsenicum Album	SPRAY	ORAL	20230222		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; AMMONIUM CHLORIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CITRULLUS COLOCYNTHIS FRUIT PULP; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED	8; 4; 12; 6; 7; 3; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
83027-0004_aac01ec8-8bfb-47c0-ad09-49c9186856ca	83027-0004	HUMAN OTC DRUG	Circulation		Niacin, Nicotinamidum, Arnica Montana, Camphora, Nux Vomica, Veratrum Album, Adrenalinum, Aesculus Hippocastanum, Aurum Metallicum, Gelsemium Sempervirens, Heloderma (Horridus), Rhus Tox, Tabacum	SPRAY	ORAL	20230413		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARNICA MONTANA WHOLE; CAMPHOR (NATURAL); EPINEPHRINE; GELSEMIUM SEMPERVIRENS ROOT; GOLD; HELODERMA HORRIDUM VENOM; HORSE CHESTNUT; NIACIN; NIACINAMIDE; STRYCHNOS NUX-VOMICA SEED; TOBACCO LEAF; TOXICODENDRON PUBESCENS LEAF; VERATRUM ALBUM ROOT	6; 8; 12; 12; 12; 12; 12; 6; 6; 8; 12; 12; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Nicotinic Acid [EPC], Nicotinic Acids [CS], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83027-0005_0099e296-8ba9-4efd-bb32-1f5a8eb58b9d	83027-0005	HUMAN OTC DRUG	Femmepap		Thuja Occidentalis, Nitricum Acidum, Causticum, Sabina, X-Ray, Antimonium Sulphuratum, Human Papilloma Nosode, Adenoviren Nosode	SPRAY	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); ANTIMONY PENTASULFIDE; CAUSTICUM; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN PAPILLOMAVIRUS; JUNIPERUS SABINA LEAFY TWIG; NITRIC ACID; THUJA OCCIDENTALIS LEAFY TWIG	15; 18; 6; 20; 20; 6; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	20241231
83027-0006_9c06873f-c7b6-41fd-b50e-4430141d124f	83027-0006	HUMAN OTC DRUG	Tinnitus Formula		Cimicifuga Racemosa, Ginkgo Biloba, Cinchona Officinalis, Hydrastis Canadensis, Lycopodium Clavatum, Sulphur, Cerebellum (Suis), Ear (Suis) Digitalis Purpurea, Kali Carbonicum	SPRAY	ORAL	20230410		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BLACK COHOSH; CINCHONA OFFICINALIS BARK; DIGITALIS; GINKGO; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; POTASSIUM CARBONATE; SULFUR; SUS SCROFA CEREBRUM; SUS SCROFA EAR	2; 3; 12; 2; 6; 6; 30; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0007_d3a698b6-65f7-4b0b-9cee-26e750269303	83027-0007	HUMAN OTC DRUG	Cold Sore Formula		Dulcamara, Glycyrrhiza Glabra, Ranunculus Bulbosus, Rhus Tox, Natrum Muriaticum, Fagopyrum Esculentum, Natrum Muriaticum, Aconitum Napellus, Cytomegalovirus Nosode, Herpes Simplex I and II Nosode, Sepia, Epstein Barr Virus Nosode, Herpes Zoster Nosode, Adenoviren Nosode	SPRAY	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; FAGOPYRUM ESCULENTUM WHOLE; GLYCYRRHIZA GLABRA; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; RANUNCULUS BULBOSUS WHOLE; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SODIUM HYPOCHLORITE; SOLANUM DULCAMARA TOP; TOXICODENDRON PUBESCENS LEAF	15; 8; 3; 20; 18; 18; 18; 15; 15; 3; 30; 6; 12; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	20241231
83027-0008_56dc449f-fa58-40e5-a01f-fefc123b1926	83027-0008	HUMAN OTC DRUG	Myco Immuno Nosode		Du Huo (Angelica Pubescens), Angelica Archangelica, Kali Muriaticum, Radix Sileris (Saposhnikovia Divaricata), Yucca Filamentosa, Achyranthes Bidentata, Angelica Sinensis, Ligusticum Porteri, Panax Ginseng, Rhus Tox, Hydrastis Canadensis, Uncaria Tomentosa, Cartilago Suis, Hordeum Vulgare, Oxalicum Acidum, Arnica Montana, Latrodectus Mactans, Magnesia Phosphorica, Manganum Metallicum, Borrelia Burgdorferi, Babesia Microti	SPRAY	ORAL	20230317		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACHYRANTHES BIDENTATA ROOT; ANGELICA ARCHANGELICA ROOT; ANGELICA PUBESCENS ROOT; ANGELICA SINENSIS ROOT; ARNICA MONTANA WHOLE; ASIAN GINSENG; BABESIA MICROTI; BARLEY; BORRELIA BURGDORFERI; GOLDENSEAL; LATRODECTUS MACTANS; LIGUSTICUM PORTERI ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID DIHYDRATE; POTASSIUM CHLORIDE; SAPOSHNIKOVIA DIVARICATA ROOT; SUS SCROFA CARTILAGE; TOXICODENDRON PUBESCENS LEAF; UNCARIA TOMENTOSA ROOT; YUCCA FILAMENTOSA WHOLE	4; 3; 2; 4; 8; 4; 16; 8; 15; 6; 10; 4; 12; 12; 8; 3; 3; 6; 5; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83027-0009_7f08dd14-771e-44be-b900-5d40c3a12626	83027-0009	HUMAN OTC DRUG	Anxiety		Borax, Natrum Muriaticum, Causticum, Elettaria Cardamomum, Plumbum Metallicum, Sepia, Lilium Tigrinum, Oxytropis Lambertii	SPRAY	ORAL	20230403		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CARDAMOM; CAUSTICUM; LEAD; LILIUM LANCIFOLIUM WHOLE FLOWERING; OXYTROPIS LAMBERTII TOP; SEPIA OFFICINALIS JUICE; SODIUM BORATE; SODIUM CHLORIDE	6; 6; 12; 30; 16; 12; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0010_f41587af-c104-4800-9902-1bc299fb38bc	83027-0010	HUMAN OTC DRUG	Aging Eye Formula		Cineraria Maritima, Eye (Suis), Calcarea Fluorica, Causticum, Germanium Metallicum, Phosphorus, Silicea, Zincum Metallicum, Natrum Muriaticum	SPRAY	ORAL	20230214		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CALCIUM FLUORIDE; CAUSTICUM; GERMANIUM; JACOBAEA MARITIMA WHOLE; PHOSPHORUS; SILICON DIOXIDE; SODIUM CHLORIDE; SUS SCROFA EYE; ZINC	12; 12; 12; 6; 12; 12; 30; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0011_73920b86-8119-4825-b3c5-e55974fefd65	83027-0011	HUMAN OTC DRUG	Lymph Formula		Astragalus Membranaceus, Angelica Sinensis, Myrrha, Aconitum Napellus, Ephedra Vulgaris	SPRAY	ORAL	20230214		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; ANGELICA SINENSIS ROOT; ASTRAGALUS MONGHOLICUS ROOT; EPHEDRA DISTACHYA FLOWERING TWIG; MYRRH	8; 4; 3; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0012_a8bc2a1e-e1bf-4c1e-953d-cd3882792fe3	83027-0012	HUMAN OTC DRUG	Purge Formula		Chuan Lian Zi (Melia Toosendan Fructus), Cucurbita Pepo, Semen, Fei Zi (Torreya Grandis Semen), Lei Wan (Omphalia Lapidescens), Shi Jun Zi (Quisqualis Indicus Fructus)	SPRAY	ORAL	20230413		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	HONEY MUSHROOM; MELIA AZEDARACH FRUIT; PUMPKIN SEED; QUISQUALIS INDICA FRUIT; TORREYA GRANDIS SEED	3; 3; 3; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0013_53dde9e7-3e52-482b-9dc3-e4e43266e4fd	83027-0013	HUMAN OTC DRUG	Neuro Calming Formula		Avena Sativa, Humulus Lupulus, Passiflora Incarnata, Valeriana Officinalis, Ignatia Amara, Scutellaria Lateriflora, Zincum Metallicum	SPRAY	ORAL	20230221		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AVENA SATIVA FLOWERING TOP; HOPS; PASSIFLORA INCARNATA FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; STRYCHNOS IGNATII SEED; VALERIAN; ZINC	2; 2; 2; 6; 6; 2; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83027-0014_1e8c9461-f47e-4b2d-8bfa-c6a33190ff38	83027-0014	HUMAN OTC DRUG	Adrenal Liquescence		Glycyrrhiza Glabra, Rosa Canina, Aralia Quinquefolia (American Ginseng), Glandula Suprarenalis (Bovine), Adrenalinum, Ephedra Vulgaris, Natrum Muriaticum, Zincum Metallicum, Adrenocorticotrophin	LIQUID	ORAL	20230221		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMERICAN GINSENG; BOS TAURUS ADRENAL GLAND; CORTICOTROPIN; EPHEDRA DISTACHYA FLOWERING TWIG; EPINEPHRINE; GLYCYRRHIZA GLABRA; ROSA CANINA FRUIT; SODIUM CHLORIDE; ZINC	3; 6; 15; 12; 12; 2; 3; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83027-0015_31719e0e-bceb-4cdf-b201-aa9ec60928fa	83027-0015	HUMAN OTC DRUG	Kidney Liquescence		Juniperus Communis, Uva-Ursi, Equisetum Hyemale, Taraxacum Officinale, Urinary Bladder (Suis), Eupatorium Purpureum, Kidney (suis), Nitricum Acidum, Cantharis, Hepar Sulphuris Calcareum	LIQUID	ORAL	20230329		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARCTOSTAPHYLOS UVA-URSI LEAF; CALCIUM SULFIDE; EQUISETUM HYEMALE WHOLE; EUTROCHIUM PURPUREUM ROOT; JUNIPER BERRY; LYTTA VESICATORIA; NITRIC ACID; PORK KIDNEY; SUS SCROFA URINARY BLADDER; TARAXACUM OFFICINALE	2; 12; 3; 6; 2; 12; 8; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83027-0016_a7c7181e-3f29-49fd-865a-6559f189903f	83027-0016	HUMAN OTC DRUG	Liver Liquescence		Carduus Marianus, Chelidonium Majus, Lappa Major, Uva Ursi, Raphanus Sativus, Taraxacum Officinale, Lycopodium Clavatum, Hydrastis Canadensis, Gallbladder (Bovine), Hepar Suis, Beta Vulgaris, Phosphorus	LIQUID	ORAL	20230403	20280418	UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARCTIUM LAPPA ROOT; ARCTOSTAPHYLOS UVA-URSI LEAF; BETA VULGARIS WHOLE; BOS TAURUS GALLBLADDER; CHELIDONIUM MAJUS WHOLE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHOSPHORUS; PORK LIVER; RADISH; TARAXACUM OFFICINALE	2; 2; 12; 6; 2; 5; 4; 2; 12; 6; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	
83027-0017_56371dff-5a05-4dfc-8e42-9a3084dd5c71	83027-0017	HUMAN OTC DRUG	Brain Liquescence		Ginkgo Biloba, Colchicum Autumnale, Convallaria Majalis, Nux Moschata, Cerebrum (Suis), Agaricus Muscarius, Scutellaria Lateriflora, Anacardium Orientale, Riboflavinum, Ambra Grisea, Baryta Carbonica, Glycerinum	LIQUID	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMANITA MUSCARIA FRUITING BODY; AMBERGRIS; BARIUM CARBONATE; COLCHICUM AUTUMNALE BULB; CONVALLARIA MAJALIS; GINKGO; GLYCERIN; NUTMEG; RIBOFLAVIN; SCUTELLARIA LATERIFLORA WHOLE; SEMECARPUS ANACARDIUM JUICE; SUS SCROFA CEREBRUM	7; 9; 10; 4; 4; 3; 16; 4; 8; 7; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
83027-0018_d2f6dc06-25e5-4f93-af41-f99c423c0ccf	83027-0018	HUMAN OTC DRUG	Female Liquescence		Dioscorea Villosa, Glycyrrhiza Glabra, Hamamelis Virginiana, Rubus Idaeus, Viburnum Opulus, Caulophyllum Thalictroides, Oophorinum (Suis), Uterus (Suis), Human Growth Hormone (HGH), Ignatia Amara	LIQUID	ORAL	20230222		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CAULOPHYLLUM THALICTROIDES ROOT; DIOSCOREA VILLOSA TUBER; GLYCYRRHIZA GLABRA; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; RUBUS IDAEUS LEAF; SOMATROPIN; STRYCHNOS IGNATII SEED; SUS SCROFA OVARY; SUS SCROFA UTERUS; VIBURNUM OPULUS BARK	3; 2; 2; 2; 2; 12; 12; 6; 6; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Human Growth Hormone [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Recombinant Human Growth Hormone [EPC]		N	20241231
83027-0019_1fd66515-fc10-4ce3-9d27-0d71b49f2b82	83027-0019	HUMAN OTC DRUG	Heart Liquescence		Ginkgo Biloba, Leonurus Cardiaca, Cactus Grandiflorus (N), Heart (Bovine), Taurine, Ubidecarenonum (CoQ 10), aurum Muriaticum Natronatum, Magnesia Phosphorica	LIQUID	ORAL	20230314		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BEEF HEART; GINKGO; LEONURUS CARDIACA WHOLE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; SELENICEREUS GRANDIFLORUS STEM; SODIUM TETRACHLOROAURATE; TAURINE; UBIDECARENONE	6; 3; 3; 10; 4; 10; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83027-0020_0835d6a7-9650-4a22-b46f-8bdb0e6f49ed	83027-0020	HUMAN OTC DRUG	Spleen Thymus Liquescence		Cinchona Officinalis, Quercus Glandium Spiritus, Ceanothus Americanus, Spleen (Bovine), Thymus (Bovine), Chininum Arsenicosum, Natrum Muriaticum, Helianthus Annuus	LIQUID	ORAL	20230324		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS SPLEEN; BOS TAURUS THYMUS; CEANOTHUS AMERICANUS LEAF; CINCHONA OFFICINALIS BARK; HELIANTHUS ANNUUS FLOWERING TOP; QUERCUS ROBUR NUT; QUININE ARSENITE; SODIUM CHLORIDE	6; 6; 6; 4; 16; 4; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Antimalarial [EPC]		N	20241231
83027-0021_1fcec285-3108-4a1b-b30d-36549f97a847	83027-0021	HUMAN OTC DRUG	Prostate Liquescence		Sabal Serrulata, Taraxacum Officinale, Phytolacca Decandra, Thuja Occidentalis, Estradiol, Progesterone, Conium Maculatum Asterias Rubens, Euphorbium Officinarum, Triticum Repens, Calcarea Fluorica, Arsenicum Album	LIQUID	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARSENIC TRIOXIDE; ASTERIAS RUBENS; CALCIUM FLUORIDE; CONIUM MACULATUM FLOWERING TOP; ELYMUS REPENS ROOT; ESTRADIOL; EUPHORBIA RESINIFERA RESIN; PHYTOLACCA AMERICANA ROOT; PROGESTERONE; SAW PALMETTO; TARAXACUM OFFICINALE; THUJA OCCIDENTALIS LEAFY TWIG	12; 8; 12; 7; 10; 4; 8; 4; 4; 3; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone [CS], Progesterone [EPC]		N	20241231
83027-0022_59857a8f-c5a9-4c50-9fab-a9b643958df6	83027-0022	HUMAN OTC DRUG	Fatigue Formula		Medulla Ossis Suis, Spleen (Bovine), Thymus (Bovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans, Toxoplasma Gondii, Epstein-Bar Virus Nosode	SPRAY	ORAL	20230313	20280802	UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS SPLEEN; BOS TAURUS THYMUS; HUMAN BREAST TUMOR CELL; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); STREPTOCOCCUS VIRIDANS GROUP; SUS SCROFA BONE MARROW; TOXOPLASMA GONDII	6; 6; 16; 16; 16; 16; 16; 16; 16; 16; 6; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	
83027-0023_b4b273a8-70fd-49a6-8444-6935e565eb6b	83027-0023	HUMAN OTC DRUG	DNA Pancreas Formula		Lycopodium Clavatum, Pancreatinum, DNA, Insulinum, Phosphoricum Acidum, Uranium Nitricum, Radium Bromatum	SPRAY	ORAL	20230223		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	HERRING SPERM DNA; INSULIN HUMAN; LYCOPODIUM CLAVATUM SPORE; PANCRELIPASE; PHOSPHORIC ACID; RADIUM BROMIDE; URANYL NITRATE HEXAHYDRATE	12; 12; 6; 9; 30; 60; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Insulin [CS], Insulin [EPC]		N	20241231
83027-0024_64077b86-0bfb-47c0-ac23-71eab065aa7c	83027-0024	HUMAN OTC DRUG	Defense		Petroselinum Sativum, Natrum Muriaticum, Hepar Suis, Medulla Ossis Suis, Spleen (Bovine), Thymus (Bovine) Saccharinum	SPRAY	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS SPLEEN; BOS TAURUS THYMUS; PETROSELINUM CRISPUM WHOLE; PORK LIVER; SACCHARIN; SODIUM CHLORIDE; SUS SCROFA BONE MARROW	6; 6; 3; 6; 50; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0025_473464a4-7433-4bf4-aded-10ba9d820f19	83027-0025	HUMAN OTC DRUG	Homeostop		Apis Mellifica, Belladonna, Bryonia (Alba), Arsenicum Album, Ferrum Phosphoricum, Hepar Sulphuris Calcareum, Lachesis Mutus, Mercurius Solubilis	SPRAY	ORAL	20230220		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	APIS MELLIFERA; ARSENIC TRIOXIDE; ATROPA BELLADONNA; BRYONIA ALBA ROOT; CALCIUM SULFIDE; FERROSOFERRIC PHOSPHATE; LACHESIS MUTA VENOM; MERCURIUS SOLUBILIS	6; 8; 6; 6; 12; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
83027-0026_01589ee6-d8df-4b45-8b57-e04baf7f667c	83027-0026	HUMAN OTC DRUG	Pancreas Liquescence		Cinnamomum, Gymnema Sylvestre, Phosphoricum Acidum, Syzygium Jambolanum, Trigonella Foenum-Graceum, Argentum Nitricum, Chionanthus Virginica, Hepar Suis, Pancreas Suis, Rhus Aromatica, Sulphur, Lycopodium Clavatum, Chromium Picolinate, Chromium Metallicum, Phosphorus, Vanadium Metallicum, Zincum Metallicum, Murex Purpurea, DNA, Insulinum (Human), Uranium Nitricum	LIQUID	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CHIONANTHUS VIRGINICUS ROOT BARK; CHROMIUM; CHROMIUM PICOLINATE; CINNAMON; FENUGREEK SEED; GYMNEMA SYLVESTRE LEAF; HERRING SPERM DNA; HEXAPLEX TRUNCULUS HYPOBRANCHIAL GLAND JUICE; INSULIN HUMAN; LYCOPODIUM CLAVATUM SPORE; PHOSPHORIC ACID; PHOSPHORUS; PORK LIVER; RHUS AROMATICA ROOT BARK; SILVER NITRATE; SULFUR; SUS SCROFA PANCREAS; SYZYGIUM CUMINI SEED; URANYL NITRATE HEXAHYDRATE; VANADIUM; ZINC	6; 12; 10; 3; 3; 3; 30; 20; 30; 8; 3; 12; 6; 8; 6; 8; 6; 3; 30; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Insulin [CS], Insulin [EPC], Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC]		N	20241231
83027-0027_de50a39b-9b8d-4632-96d9-ee5d657f0755	83027-0027	HUMAN OTC DRUG	XS H2O Liquescence		Valeriana Officinalis, Citricum Acidum, Potassium Bitartrate, Allium Sativum, Arteria Suis, Cerebrum Suis, Kidney (Suis) Rauwolfia Serpentina, Adrenocorticotrophin	LIQUID	ORAL	20230412		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ANHYDROUS CITRIC ACID; CORTICOTROPIN; GARLIC; PORK KIDNEY; POTASSIUM BITARTRATE; RAUWOLFIA SERPENTINA; SUS SCROFA ARTERY; SUS SCROFA CEREBRUM; VALERIAN	3; 15; 6; 6; 3; 10; 6; 6; 2	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]		N	20241231
83027-0028_8adc1a09-d2d7-4e7d-b3d3-6e73eeb8305e	83027-0028	HUMAN OTC DRUG	Weight Off		Foeniculum Vulgare, Fucus Vesiculosus, Lecithin, Ammonium Carbonicum, Caulophyllum Thalictroides, Galium Aparine, Lac Defloratum (NSPC), Manganum Aceticum, Phytolacca Decandra, Rubus Idaeus, Thyroidinum (Bovine), Ammonium Bromatum, Antimonium Crudum, Calcarea Carbonica, Calcarea Arsenicica, Human Growth Hormone (HGH), Phosphorus	SPRAY	ORAL	20230331		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMMONIUM BROMIDE; AMMONIUM CARBONATE; ANTIMONY TRISULFIDE; CALCIUM ARSENATE; CAULOPHYLLUM THALICTROIDES ROOT; EGG PHOSPHOLIPIDS; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; MANGANESE ACETATE TETRAHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; RUBUS IDAEUS LEAF; SKIM MILK; SOMATROPIN; THYROID, BOVINE	8; 6; 9; 12; 6; 4; 2; 3; 6; 6; 9; 12; 6; 6; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Human Growth Hormone [CS], Magnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC], Recombinant Human Growth Hormone [EPC]		N	20241231
83027-0029_aa7471dc-7a30-4e16-8138-e447f368a0f5	83027-0029	HUMAN OTC DRUG	Assist		Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin (Derived From Egg), Capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum (NSPC), Phytolacca Decandra, Thyroidinum (Bovine), Pituitarum Posterium (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus	SPRAY	ORAL	20230329		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; CAPSICUM; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; SILVER; SKIM MILK; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	3; 9; 8; 6; 4; 12; 2; 3; 6; 9; 12; 6; 6; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83027-0030_23e08e6e-31ae-4a4b-a8fc-900962bb0b54	83027-0030	HUMAN OTC DRUG	Cats Claw		Uncaria Tomentosa	SPRAY	ORAL	20230221		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	UNCARIA TOMENTOSA WHOLE	2	[hp_X]/mL			N	20241231
83027-0031_cef9f242-7a0a-422f-b5bb-07de71828ea9	83027-0031	HUMAN OTC DRUG	Pituitary Liquescence		Caulophyllum Thalictroides, Hypophysis Suis, Hypothalamus Suis, Pineal Gland (Suis), Cimicifuga Racemosa, Natrum Muriaticum, Cinchona Officinalis, Adrenocorticotrophin	LIQUID	ORAL	20230221		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BLACK COHOSH; CAULOPHYLLUM THALICTROIDES ROOT; CINCHONA OFFICINALIS BARK; CORTICOTROPIN; SODIUM CHLORIDE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND	6; 6; 30; 15; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
83027-0032_125143db-6c38-46c2-a732-680ec9690aea	83027-0032	HUMAN OTC DRUG	Neuro T Support Liquescence		Alfalfa, Banana, Valeriana Officinalis, Cholinum, Gaba (Gamma Aminobutyric Acid), Inositol, Oleander, Hypophysis Suis, Hypothalamus Suis, Pineal Gland (Suis), Scutellaria Lateriflora, Acetylcholine Chloride, Norepinephrine (Bitartrate), Cadmium Metallicum, Dopamine (Hydrochloride), Serotonin (Hydrochloride), Adrenalinum	LIQUID	ORAL	20230425		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	.GAMMA.-AMINOBUTYRIC ACID; ACETYLCHOLINE CHLORIDE; BANANA; CADMIUM; CHOLINE HYDROXIDE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; INOSITOL; MEDICAGO SATIVA WHOLE; NERIUM OLEANDER LEAF; NOREPINEPHRINE BITARTRATE; SCUTELLARIA LATERIFLORA WHOLE; SEROTONIN HYDROCHLORIDE; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; VALERIAN	4; 6; 3; 12; 4; 12; 12; 4; 3; 5; 6; 6; 12; 6; 6; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Dietary Proteins [CS], Fruit Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83027-0033_22bcdca0-90e7-4a0f-846d-eec0ff826d7d	83027-0033	HUMAN OTC DRUG	Cellular Liquescence		Sabal Serrulata, Arnica Montana, Cholinum, Thuja Occidentalis, Thymolum, Thymus Serpyllum, Arsenicum Iodatum, Asterias Rubens, Bufo Rana, Carcinosin, Arsenicum Bromatum, Shark Cartilage, Hoang Nan	LIQUID	ORAL	20230417		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARNICA MONTANA WHOLE; ARSENIC TRIBROMIDE; ARSENIC TRIIODIDE; ASTERIAS RUBENS; BUFO BUFO CUTANEOUS GLAND; CHOLINE HYDROXIDE; HUMAN BREAST TUMOR CELL; SAW PALMETTO; SHARK CARTILAGE; STRYCHNOS WALLICHIANA BARK; THUJA OCCIDENTALIS LEAFY TWIG; THYMOL; THYMUS SERPYLLUM WHOLE	3; 20; 6; 12; 12; 4; 16; 3; 8; 9; 4; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0034_f1f1df80-77b6-4828-b8a5-aa32a653a979	83027-0034	HUMAN OTC DRUG	Thyroid Liquescence		Fucus Vesiculosus, Iodium, Spongia Tosta, Parathyroid (Bovine), Rutinic Acid, Thyroidinum (Bovine), Lapis Albus, Bromium	LIQUID	ORAL	20230329		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS PARATHYROID GLAND; BROMINE; CALCIUM HEXAFLUOROSILICATE; CAPRIC ACID; FUCUS VESICULOSUS; IODINE; SPONGIA OFFICINALIS SKELETON, ROASTED; THYROID, BOVINE	12; 30; 15; 12; 4; 6; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0035_161804eb-ab3b-48b9-b13f-6f1b66ecb74e	83027-0035	HUMAN OTC DRUG	Vitamin C Liquescence		Citrus Vulgaris, Citrus Limonum, Malpighia Spp, Petroselinum Sativum, Rosa Canina, Agaricus Muscarius, Ascorbicum Acidum, Capsicum Annuum, Medulla Ossis Suis, Solanum Tuberosum	LIQUID	ORAL	20230328		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACEROLA; AMANITA MUSCARIA FRUITING BODY; ASCORBIC ACID; CAPSICUM; CITRUS AURANTIUM FRUIT RIND; LEMON JUICE; PETROSELINUM CRISPUM WHOLE; ROSA CANINA FRUIT; SOLANUM TUBEROSUM WHOLE; SUS SCROFA BONE MARROW	3; 6; 6; 6; 2; 3; 3; 3; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; meq/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS], Vitamin C [EPC]		N	20241231
83027-0036_81407128-3772-4f5a-b94e-d9cfe54e3ff1	83027-0036	HUMAN OTC DRUG	Ligatend Liquescence		Hypericum Perforatum, Ruta Graveolens, Arnica Montana, Bryonia (Alba), Chondroitin Sulfate, Collagen, Eupatorium Perfoliatum, Medulla Ossis Suis, Rhus Tox, Manganum Metallicum, Magnesium Metallicum	LIQUID	ORAL	20230421		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARNICA MONTANA WHOLE; BRYONIA ALBA ROOT; CHONDROITIN SULFATE (BOVINE); EUPATORIUM PERFOLIATUM FLOWERING TOP; HYDROLYSED BOVINE COLLAGEN (ENZYMATIC; 3500 MW); HYPERICUM PERFORATUM WHOLE; MAGNESIUM; MANGANESE; RUTA GRAVEOLENS FLOWERING TOP; SUS SCROFA BONE MARROW; TOXICODENDRON PUBESCENS LEAF	6; 6; 6; 6; 6; 3; 15; 12; 3; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0037_0089f702-702b-4519-9173-29fbe7ee9953	83027-0037	HUMAN OTC DRUG	Degex Liquescence		Thuja Occidentalis, Ubidecarenonum, Conium Maculatum, Asterias Rubens, Germanium Metallicum, Lachesis Mutus, Bufo Rana, Carcinosin, Phosphorus	LIQUID	ORAL	20230327		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ASTERIAS RUBENS; BUFO BUFO CUTANEOUS GLAND; CONIUM MACULATUM FLOWERING TOP; GERMANIUM; HUMAN BREAST TUMOR CELL; LACHESIS MUTA VENOM; PHOSPHORUS; THUJA OCCIDENTALIS LEAFY TWIG; UBIDECARENONE	12; 12; 9; 12; 16; 12; 30; 6; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0038_217d644d-2521-4a3c-af22-6dc3e060aaab	83027-0038	HUMAN OTC DRUG	Virility Liquescence		Avena Sativa, Damiana, Berberis Vulgaris, Epimedium Grandiflorum, Glycerinum, Sabal Serrulata, Iodium, Lecithin, Ferrum Muriaticum, Natrum Muriaticum, Agnus Castus, Bufo Rana, Cinchona Officinalis, Human Growth Hormone (HGH), Orchitinum (Bovine), Phosphoricum Acidum, Phosphorus, Selenium Metallicum, Zincum Valerianicum, Oophorinum (Suis), Sepia	LIQUID	ORAL	20230329		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AVENA SATIVA FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; BOS TAURUS TESTICLE; BUFO BUFO CUTANEOUS GLAND; CHASTE TREE FRUIT; CINCHONA OFFICINALIS BARK; EGG PHOSPHOLIPIDS; EPIMEDIUM GRANDIFLORUM TOP; FERRIC CHLORIDE HEXAHYDRATE; GLYCERIN; IODINE; PHOSPHORIC ACID; PHOSPHORUS; SAW PALMETTO; SELENIUM; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; SOMATROPIN; SUS SCROFA OVARY; TURNERA DIFFUSA LEAFY TWIG; ZINC VALERATE DIHYDRATE	2; 3; 12; 12; 8; 12; 4; 3; 4; 3; 4; 12; 12; 3; 12; 30; 4; 12; 16; 2; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Human Growth Hormone [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Iron [CS], Non-Standardized Chemical Allergen [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Recombinant Human Growth Hormone [EPC]		N	20241231
83027-0039_1c3c696a-50bc-411b-aa02-6fc2894fe37b	83027-0039	HUMAN OTC DRUG	Poison Ivy and Oak Formula		Glandula Suprarenalis (Bovine), Hepar Suis, Rhus Tox, Urtica Dioica, Rhus Aromatica, Rhus Glabra, Histaminum Hydrochloricum, Rhus Diversiloba, Adrenocorticotrophin	SPRAY	ORAL	20230329		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS ADRENAL GLAND; CORTICOTROPIN; HISTAMINE DIHYDROCHLORIDE; PORK LIVER; RHUS AROMATICA ROOT BARK; RHUS GLABRA TOP; TOXICODENDRON DIVERSILOBUM LEAF; TOXICODENDRON PUBESCENS LEAF; URTICA DIOICA WHOLE	6; 15; 12; 6; 8; 8; 16; 6; 6	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]		N	20241231
83027-0040_aa2c761c-97b8-4645-a7cc-10c2d869b6c7	83027-0040	HUMAN OTC DRUG	Grass Mix		Glandula Suprarenalis (Bovine), Hepar Suis (Liver), Histaminum Hydrochloricum, Bahia Grass, Bermuda Grass, Johnson Grass, Kentucky Bluegrass, Orchard Grass, Rye Grass, Timothy Grass, Vernal Grass, Adrenocorticotrophin	SPRAY	ORAL	20230322		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ANTHOXANTHUM ODORATUM POLLEN; BOS TAURUS ADRENAL GLAND; CORTICOTROPIN; CYNODON DACTYLON WHOLE; DACTYLIS GLOMERATA TOP; HISTAMINE DIHYDROCHLORIDE; LOLIUM PERENNE TOP; PASPALUM NOTATUM POLLEN; PHLEUM PRATENSE TOP; POA PRATENSIS TOP; PORK LIVER; SORGHUM HALEPENSE POLLEN	16; 6; 15; 16; 16; 12; 16; 16; 16; 16; 6; 16	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Standardized Pollen Allergenic Extract [EPC]		N	20241231
83027-0041_415c073d-a527-4b8f-bbe0-9124d92e2d6a	83027-0041	HUMAN OTC DRUG	Tree Mix		Glandula Suprarenalis (Bovine), Hepar Suis, Histaminum Hydrochloricum, Alder, American Elm, Ash, Beech, Cedar, Elder, Hazel, Hickory, Maple, Oak, Plane (Sycamore), Poplar, Silver Birch, Willow, Adrenocorticotrophin	SPRAY	ORAL	20230323		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACER SACCHARUM POLLEN; ALNUS RUBRA POLLEN; BETULA PENDULA POLLEN; BOS TAURUS ADRENAL GLAND; CARYA GLABRA POLLEN; CORTICOTROPIN; CORYLUS AVELLANA POLLEN; FAGUS SYLVATICA POLLEN; FRAXINUS EXCELSIOR POLLEN; HISTAMINE DIHYDROCHLORIDE; JUNIPERUS VIRGINIANA POLLEN; PLATANUS X ACERIFOLIA POLLEN; POPULUS ALBA POLLEN; PORK LIVER; QUERCUS ROBUR POLLEN; SALIX X FRAGILIS POLLEN; SAMBUCUS CANADENSIS FLOWER; ULMUS GLABRA POLLEN	16; 16; 16; 6; 16; 15; 16; 16; 16; 12; 16; 16; 16; 6; 16; 16; 16; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS]		N	20241231
83027-0042_0f627e53-afe6-4272-babc-de2eb495e490	83027-0042	HUMAN OTC DRUG	Animal Mix		Glandula Suprarenalis (Bovine), Hepar Suis, Histaminum Hydrochloricum, Adrenocorticotrophin, Canary Feathers, Cat Hair Mix, Chicken Feathers, Cow Hair, Dog Hair, Guinea Pig Hair, Horse Dander, Pig Hair, Rat Hair, Duck Feathers, Goose Feathers, Rabbit Fur	SPRAY	ORAL	20230220		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ANAS PLATYRHYNCHOS FEATHER; ANSER ANSER FEATHER; BOS TAURUS ADRENAL GLAND; BOS TAURUS HAIR; CANIS LUPUS FAMILIARIS HAIR; CAVIA PORCELLUS HAIR; CORTICOTROPIN; EQUUS CABALLUS DANDER; FELIS CATUS HAIR; GALLUS GALLUS FEATHER; HISTAMINE DIHYDROCHLORIDE; ORYCTOLAGUS CUNICULUS HAIR; PORK LIVER; RATTUS NORVEGICUS HAIR; SERINUS CANARIA FEATHER; SUS SCROFA HAIR	18; 18; 6; 15; 15; 15; 15; 15; 15; 15; 12; 40; 6; 15; 15; 15	[hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Dander [CS], Dander [CS], Feathers [CS], Feathers [CS], Feathers [CS], Feathers [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Dander Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Non-Standardized Feather Allergenic Extract [EPC], Salivary Proteins and Peptides [CS], Salivary Proteins and Peptides [CS], Standardized Animal Hair Allergenic Extract [EPC]		N	20241231
83027-0043_500181d4-47d4-414c-acea-c64f8de0f4cf	83027-0043	HUMAN OTC DRUG	Household Dust and Mold Mix		Glandula Suprarenalis (Bovine), Hepar Suis, Histaminum Hydrochloricum, Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Dust, Mucor Racemosus, Torula Cerevisiae, House Dust Mite, Rhizopus Nigricans	SPRAY	ORAL	20230321	20280502	UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; BOS TAURUS ADRENAL GLAND; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CORTICOTROPIN; DERMATOPHAGOIDES PTERONYSSINUS; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; MUCOR RACEMOSUS; PORK LIVER; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE	16; 16; 6; 16; 16; 15; 12; 12; 16; 16; 6; 15; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	
83027-0044_a3dc4577-9fe1-4e2a-a578-8c7ab9051295	83027-0044	HUMAN OTC DRUG	Addex		Lappa Major, Plantago Major, Taraxacum Officinale, Glyphosate	SPRAY	ORAL	20230224		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARCTIUM LAPPA ROOT; GLYPHOSATE; PLANTAGO MAJOR WHOLE; TARAXACUM OFFICINALE	3; 12; 3; 3	[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0045_611be7cb-61b8-42ca-86fc-57161ac8e054	83027-0045	HUMAN OTC DRUG	Radialgin		Citrus Limonum, Fucus Vesiculosus, Hydrangea Arborescens, Sodium Alginate, Natrum Muriaticum, Phosphorus, Agate, Radium Bromatum, X Ray	SPRAY	ORAL	20230412		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALCOHOL, X-RAY EXPOSED (1000 RAD); FUCUS VESICULOSUS; HYDRANGEA ARBORESCENS ROOT; LEMON JUICE; PHOSPHORUS; RADIUM BROMIDE; SILICON DIOXIDE; SODIUM ALGINATE; SODIUM CHLORIDE	30; 3; 4; 2; 12; 30; 30; 16; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0046_3a1b9bf5-dda3-45d7-954f-02d9b9adb161	83027-0046	HUMAN OTC DRUG	Amebex		Absinthium, Allium Sativum, Baptisia Tinctoria, Cinchona Officinalis, Ammonium Phosphoricum, Entamoeba Histolytica	SPRAY	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMMONIUM PHOSPHATE, DIBASIC; BAPTISIA TINCTORIA ROOT; CINCHONA OFFICINALIS BARK; ENTAMOEBA HISTOLYTICA; GARLIC; WORMWOOD	6; 6; 6; 30; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83027-0047_f5307c70-b68b-4d37-aabe-0139c0b587df	83027-0047	HUMAN OTC DRUG	Bactex		Aloe, Hydrastis Canadensis, Allium Sativum, Anthracinum, Bacillus Tetani (Clostridium Tetani), Brucella Abortus, Colibacillinum Cum Natrum Muriaticum, Klebsiella Pneumoniae, Mycoplasma Pneumoniae, Pneumococcinum, Proteus (Vulgaris) Pseudomonas Aeruginosa, Staphylococcus Aureus, Streptococcus Viridans, Staphysagria, Eucalyptol, Pyrogenium, Lac Caninum, Lac Vaccinum, Pertussinum, Bacillus Cereus, Clostridium Perfringens, Coxiella Burnetii (Q Fever), Rickettsia Nosode, Serratia Marcescens	SPRAY	ORAL	20230915		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALOE; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BACILLUS CEREUS; BRUCELLA ABORTUS; CANIS LUPUS FAMILIARIS MILK; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM TETANI; COW MILK; COXIELLA BURNETII; DELPHINIUM STAPHISAGRIA SEED; ESCHERICHIA COLI; EUCALYPTOL; GARLIC; GOLDENSEAL; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; KLEBSIELLA PNEUMONIAE; MYCOPLASMA PNEUMONIAE; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RANCID BEEF; RICKETTSIA PROWAZEKII; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	6; 16; 18; 16; 30; 18; 16; 30; 18; 16; 16; 20; 12; 6; 30; 16; 16; 16; 16; 20; 18; 18; 16; 16; 16	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83027-0048_4b74a618-fab0-4779-8531-4abe1f2d20ea	83027-0048	HUMAN OTC DRUG	Industriox		Berberis Vulgaris, Taraxacum Officinale, Ammonium Carbonicum, Camphora, Spinacia, Sulphuricum Acidum, Nux Vomica, Acetone, Benzinum, Butyl Methacrylate, Calcarea Carbonica, Lachesis Mutus, Methyl Ethyl Ketone, Naphthalinum, Plumbum Metallicum, Trichloroethylene, Forlmalinum, MTBE (Tert-Butyl Methyl Ether), Petroleum, Carboneum Chloratum	SPRAY	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACETONE; AMMONIUM CARBONATE; BENZENE; BERBERIS VULGARIS ROOT BARK; CAMPHOR (NATURAL); CARBON TETRACHLORIDE; FORMALDEHYDE SOLUTION; KEROSENE; LACHESIS MUTA VENOM; LEAD; METHYL ETHYL KETONE; N-BUTYL METHACRYLATE; NAPHTHALENE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SPINACIA OLERACEA ROOT; STRYCHNOS NUX-VOMICA SEED; SULFURIC ACID; TARAXACUM OFFICINALE; TERT-BUTYL METHYL ETHER; TRICHLOROETHYLENE	12; 6; 12; 3; 6; 20; 12; 16; 12; 12; 12; 12; 12; 12; 6; 8; 6; 3; 16; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]		N	20241231
83027-0049_b1a704f8-1417-46e9-8293-4a00ab5c6510	83027-0049	HUMAN OTC DRUG	Vermex		Juglans Nigra, Berberis Vulgaris, Abrotanum (Artemisia Abrotanum), Sabadilla, Spigelia Anthelmia, Teucrium Marum, Filix Mas, Cuprum Metallicum, Chelone Glabra	SPRAY	ORAL	20230724		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARTEMISIA ABROTANUM FLOWERING TOP; BERBERIS VULGARIS ROOT BARK; BLACK WALNUT HUSK; CHELONE GLABRA WHOLE; COPPER; DRYOPTERIS FILIX-MAS ROOT; SCHOENOCAULON OFFICINALE SEED; SPIGELIA ANTHELMIA WHOLE; TEUCRIUM MARUM WHOLE	4; 3; 2; 16; 12; 7; 4; 4; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Inhibit Ovum Fertilization [PE]		N	20241231
83027-0050_258b7839-fcd2-44f5-b2dc-b732edce65cd	83027-0050	HUMAN OTC DRUG	Virex		Asclepias Tuberosa, Echinacea Purpurea, Trifolium Pratense, Natrum Muriaticum, Phytolacca Decandra, Euphrasia Officinalis, Lac Vaccinum (NSPC), Thuja Occidentalis, Calcarea Arsenicica, Camphora, Influenzinum, Cytomegalovirus Nosode, Morbillinum, Variolinum, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B5 Nosode, Coxsackie A5 Nosode, Adenoviren Nosode, Epstein Barr Virus Nosode, Coxsackie B4 Nosode	SPRAY	ORAL	20230413		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ASCLEPIAS TUBEROSA ROOT; CALCIUM ARSENATE; CAMPHOR (NATURAL); COW MILK; ECHINACEA PURPUREA WHOLE; EUPHRASIA STRICTA; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN COXSACKIEVIRUS A; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B5; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); MEASLES VIRUS; PHYTOLACCA AMERICANA ROOT; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; TRIFOLIUM PRATENSE FLOWER; VARIOLA VIRUS	3; 12; 12; 6; 3; 6; 15; 9; 9; 9; 18; 9; 9; 9; 15; 15; 12; 12; 12; 12; 16; 4; 4; 6; 3; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	20241231
83027-0051_c0aeb193-e5ae-411a-9272-2da3f7a0fab5	83027-0051	HUMAN OTC DRUG	Chem Trail Detox		Lappa Major, Taraxacum Officinale, Trifolium Pratense, Formalinum, Picricum Acidum, Anthracinum, Brucella Abortus, Klebsiella Pneumoniae, Mycoplasma Pneumoniae, Variolinum, Dibromoethane	SPRAY	ORAL	20230918		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARCTIUM LAPPA ROOT; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; BRUCELLA ABORTUS; ETHYLENE DIBROMIDE; FORMALDEHYDE SOLUTION; KLEBSIELLA PNEUMONIAE; MYCOPLASMA PNEUMONIAE; PICRIC ACID; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; VACCINIA VIRUS	3; 16; 16; 30; 6; 16; 16; 10; 3; 3; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0052_4bd5faa5-bac4-4b93-b8bf-295e2ba3e2a9	83027-0052	HUMAN OTC DRUG	Blood Liquescence		Allium Cepa, Hyssopus Officinalis, Avena Sativa, Paloondo, Urtica Dioica, Trifolium Pratense, Zingiber Officinale, Capsicum Annuum, Hepar Suis, Hypophysis Suis, Juglans Regia, Medulla Ossis Suis, Remex Crispus, Spleen (Bovine), Camphora, Magnesia Phosphorica, Ferrum Phosphoricum, Pyrogenium	LIQUID	ORAL	20230413		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AVENA SATIVA FLOWERING TOP; BOS TAURUS SPLEEN; CAMPHOR (NATURAL); CAPSICUM; FERROSOFERRIC PHOSPHATE; GINGER; HYSSOPUS OFFICINALIS FLOWERING TOP; JUGLANS REGIA LEAF; LARREA TRIDENTATA LEAF; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; ONION; PORK LIVER; RANCID BEEF; RUMEX CRISPUS ROOT; SUS SCROFA BONE MARROW; SUS SCROFA PITUITARY GLAND; TRIFOLIUM PRATENSE FLOWER; URTICA DIOICA WHOLE	2; 6; 8; 6; 12; 3; 1; 6; 2; 10; 1; 6; 20; 6; 6; 6; 3; 2	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS], Vegetable Proteins [CS]		N	20241231
83027-0053_b8ad4a3d-b9ff-4b7a-87ee-5057abb71fa7	83027-0053	HUMAN OTC DRUG	Bone Liquescence		Taraxacum Officinale, Trifolium Pratense, Calcarea Muriatica, Equisetum Arvense, Juglans Nigra, Sesame Oil, Calcarea Sulphurica, Hepar Suis, Kidney (Suis), Medulla Ossis Suis, Menadione, Thyroidinum (Bovine), Vitamin A, Vitamin D3, Calcarea Phosphorica, Calcarea Carbonica, Calcarea Fluorica, Manganum Metallicum, Niccolum Metallicum, Magnesium Metallicum	LIQUID	ORAL	20230517	20280525	UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BLACK WALNUT HUSK; CALCIUM CHLORIDE; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CHOLECALCIFEROL; EQUISETUM ARVENSE TOP; MAGNESIUM; MANGANESE; MENADIONE; NICKEL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PORK KIDNEY; PORK LIVER; SESAME OIL; SUS SCROFA BONE MARROW; TARAXACUM OFFICINALE; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE; TRIFOLIUM PRATENSE FLOWER; VITAMIN A	4; 4; 12; 5; 6; 4; 15; 12; 6; 12; 9; 6; 6; 4; 6; 3; 6; 9; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC], Vitamin A [CS], Vitamin A [EPC], Vitamin D [CS], Vitamin D [EPC]		N	
83027-0054_ddaeb838-0dc9-4c7f-a1dd-cdb80f90e112	83027-0054	HUMAN OTC DRUG	Skin Liquescence		Angelica Archangelica, Berberis Aquifolium, Berberis Vulgaris, Equisetum Arvense, Geranium Maculatum, Myrrha, Iris Versicolor, Thuja Occidentalis, Nux Vomica, Hypericum Perforatum, Human Growth Hormone (HGH), Mercurius Solubilis, Petroleum, Graphites	LIQUID	ORAL	20230417		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ANGELICA ARCHANGELICA ROOT; BERBERIS AQUIFOLIUM ROOT BARK; BERBERIS VULGARIS ROOT BARK; EQUISETUM ARVENSE TOP; GERANIUM MACULATUM ROOT; GRAPHITE; HYPERICUM PERFORATUM WHOLE; IRIS VERSICOLOR ROOT; KEROSENE; MERCURIUS SOLUBILIS; MYRRH; SOMATROPIN; STRYCHNOS NUX-VOMICA SEED; THUJA OCCIDENTALIS LEAFY TWIG	3; 3; 3; 3; 3; 16; 10; 4; 12; 12; 3; 12; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Human Growth Hormone [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Recombinant Human Growth Hormone [EPC], Seed Storage Proteins [CS]		N	20241231
83027-0055_f501c751-d677-49d3-af43-f84b7efbc05c	83027-0055	HUMAN OTC DRUG	Spleen Liquescence		Quercus Robur, Ceanothus Americanus, Spleen (Bovine), Natrum Muriaticum, Helianthus Annuus	LIQUID	ORAL	20230330		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS SPLEEN; CEANOTHUS AMERICANUS LEAF; HELIANTHUS ANNUUS FLOWERING TOP; QUERCUS ROBUR TWIG BARK; SODIUM CHLORIDE	6; 6; 16; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL			N	20241231
83027-0056_28c1916b-0fd5-4b1e-b1a4-78786891190b	83027-0056	HUMAN OTC DRUG	Boost Liquescence		Echinacea Angustifolia, Populus Candicans, Hydrastis Canadensis, Kali Bichromicum, Hepar Sulphuris Calcareum, Mercurius Solubilis.	LIQUID	ORAL	20230417		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA WHOLE; GOLDENSEAL; MERCURIUS SOLUBILIS; POPULUS BALSAMIFERA LEAF BUD; POTASSIUM DICHROMATE	12; 1; 6; 12; 2; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0057_3b41912c-775a-488e-9f59-9ef9ee35ff12	83027-0057	HUMAN OTC DRUG	Pineal Liquescence		Valeriana Officinalis, Hydrocotyle Asiatica, Melatonin, Stellaria Media, Cerebrum Suis, Hypothalamus Suis, Pineal Gland (Suis), Scutellaria Lateriflora, Calcarea Carbonica, Zincum Metallicum, Dopamine (Hydrochloride), Serotonin (Hydrochloride), Magnesium Metallicum	LIQUID	ORAL	20230413		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CENTELLA ASIATICA WHOLE; DOPAMINE HYDROCHLORIDE; MAGNESIUM; MELATONIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SCUTELLARIA LATERIFLORA WHOLE; SEROTONIN HYDROCHLORIDE; STELLARIA MEDIA; SUS SCROFA CEREBRUM; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; VALERIAN; ZINC	3; 12; 15; 3; 9; 6; 12; 3; 6; 6; 6; 2; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Catecholamine [EPC], Catecholamines [CS]		N	20241231
83027-0058_0cea6aa3-68a2-4125-8ffe-4760b974d0e8	83027-0058	HUMAN OTC DRUG	Pollen and Dander Liquescence		Allium Cepa, Euphrasia Officinalis, Echinacea (Angustifolia), Sabadilla, Ambrosia Artemisiaefolia, Apis Mellifica, Galium Aparine, Glandula Suprarenalis (Bovine), Hepar Suis, Hydrastis Canadensis, Adrenalinum, Ephedra Vulgaris, Histaminum Hydrochloricum	LIQUID	ORAL	20230724		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMBROSIA ARTEMISIIFOLIA WHOLE; APIS MELLIFERA; BOS TAURUS ADRENAL GLAND; ECHINACEA ANGUSTIFOLIA WHOLE; EPHEDRA DISTACHYA FLOWERING TWIG; EPINEPHRINE; EUPHRASIA STRICTA; GALIUM APARINE WHOLE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; ONION; PORK LIVER; SCHOENOCAULON OFFICINALE SEED	6; 6; 6; 2; 12; 12; 1; 6; 6; 12; 1; 6; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83027-0059_e5f62cb6-003b-4996-9d3a-d40a6339bbd0	83027-0059	HUMAN OTC DRUG	Hypothalamus, Adrenal, Pituitary Sarcode		Berberis Vulgaris, Glandula Suprarenalis (Bovine), Hypophysis Suis, Hypothalamus Suis, Pineal Gland (Suis), Cinchona Officinalis, Phosphorus	SPRAY	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BERBERIS VULGARIS ROOT BARK; BOS TAURUS ADRENAL GLAND; CINCHONA OFFICINALIS BARK; PHOSPHORUS; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND	3; 6; 8; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0060_da92f483-65e5-4e76-93c5-cb1b043922c5	83027-0060	HUMAN OTC DRUG	Liver, Gallbladder Sarcode		Gallbladder (Bovine), Hepar Suis	SPRAY	ORAL	20230418		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS GALLBLADDER; PORK LIVER	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
83027-0061_efb6c8df-52c5-435f-991e-aa06e6b0ce82	83027-0061	HUMAN OTC DRUG	Mycocan Combo		Candida Albicans	SPRAY	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CANDIDA ALBICANS	12	[hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
83027-0062_41e59553-c28e-4153-a0b3-2929ab10ab1d	83027-0062	HUMAN OTC DRUG	Muscle, Ligament, Cartilage Sarcode		Cartilago Suis, Ligament (Suis), Beef	SPRAY	ORAL	20230420		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BEEF; SUS SCROFA CARTILAGE; SUS SCROFA LIGAMENT	12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
83027-0063_a8f19274-8fc0-4e32-aa6b-fbf17c5d3686	83027-0063	HUMAN OTC DRUG	Pancreas Sarcode		Chamomilla, Glycyrrhiza Glabra, Syzygium Jambolanum, Vaccinium Myrtillus, Aceticum Acidum, Condurango, Phaseolus, Sarsaparilla (Smilax Regelii), Pancreas Suis, Uricum Acidum	SPRAY	ORAL	20230925		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACETIC ACID; BILBERRY; GLYCYRRHIZA GLABRA; KIDNEY BEAN; MATRICARIA CHAMOMILLA WHOLE; RUEHSSIA CUNDURANGO BARK; SMILAX ORNATA ROOT; SUS SCROFA PANCREAS; SYZYGIUM CUMINI SEED; URIC ACID	4; 3; 3; 4; 3; 4; 4; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
83027-0064_ba94d755-c60d-4bb2-b962-6819a4a4adb8	83027-0064	HUMAN OTC DRUG	Pineal, Pituitary, Hypothalamus Sarcode		Hypophysis Suis, Hypothalamus Suis, Pineal Gland (Suis)	SPRAY	ORAL	20230418		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0065_721a4889-d5a7-4266-b11c-48039570711c	83027-0065	HUMAN OTC DRUG	Small and Large Intestine Sarcode		Colon (Suis), Intestine (Suis)	SPRAY	ORAL	20230418		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	PORK INTESTINE; SUS SCROFA COLON	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
83027-0066_8b73abbf-461d-421c-ad5a-a1b3ec871540	83027-0066	HUMAN OTC DRUG	Thyroid Sarcode		Calcarea Iodata, Fucus Vesiculosus, Glandula Suprarenalis (Bovine), Hypophysis Suis, Kali Iodatum, Spleen (Bovine), Spongia Tosta, Thymus (Bovine), Thyroidinum (Bovine), Calcarea Carbonica, Hepar Sulphuris Calcareum, Lapis Albus	SPRAY	ORAL	20230424		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS ADRENAL GLAND; BOS TAURUS SPLEEN; BOS TAURUS THYMUS; CALCIUM HEXAFLUOROSILICATE; CALCIUM IODIDE; CALCIUM SULFIDE; FUCUS VESICULOSUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM IODIDE; SPONGIA OFFICINALIS SKELETON, ROASTED; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	6; 6; 6; 15; 4; 12; 6; 9; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]		N	20241231
83027-0067_5eb17fba-83f8-4c52-b08f-226d8af8a207	83027-0067	HUMAN OTC DRUG	Thyroid, Thymus, Parathyroid Sarcode		Thymus (Bovine), Thyroidinum (Bovine), Parathyroid Gland (Bovine)	SPRAY	ORAL	20230418		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS PARATHYROID GLAND; BOS TAURUS THYMUS; THYROID, BOVINE	12; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0068_fb36c9b5-9d59-4117-8fef-e1d8888199ae	83027-0068	HUMAN OTC DRUG	Myco Sode		Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Mucor Racemosus, Candida Krusei, Rhizopus Nigricans, Candida Tropicalis	SPRAY	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS WHOLE; MUCOR RACEMOSUS; RHIZOPUS STOLONIFER	16; 16; 16; 16; 32; 16; 16; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]		N	20241231
83027-0069_f3ea3575-3fcb-4b63-9c20-67abe0f03f17	83027-0069	HUMAN OTC DRUG	Bacti Sode		Bacillus Tetani, Chlamydia Trachomatis, Colibacillinum Cum Natrum Muriaticum, Klebsiella Pneumoniae, Mycobacterium Paratuberculosis, Mycoplasma Pneumoniae, Pneumococcinum, Salmonella Typhi Nosode, Staphylococcus Aureus, Streptococcus Viridans, Pyrogenium, Pertussinum, Streptococcus Agalactiae, Streptococcus Dysgalactiae, Streptococcus Mutans, Bacillus Cereus	SPRAY	ORAL	20230503		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BACILLUS CEREUS; CHLAMYDIA TRACHOMATIS; CLOSTRIDIUM TETANI; ESCHERICHIA COLI; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; KLEBSIELLA PNEUMONIAE; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; MYCOPLASMA PNEUMONIAE; RANCID BEEF; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP	18; 16; 16; 16; 30; 16; 16; 16; 20; 16; 16; 15; 15; 15; 16; 16	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0070_e8b10acd-4b26-4652-8170-ae4355878e73	83027-0070	HUMAN OTC DRUG	Viri Sode		Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode	SPRAY	ORAL	20230530		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); RUBELLA VIRUS	30; 30; 30; 16; 16; 15; 15; 16; 16; 16; 16; 16; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0071_ebf0e33d-b1fa-457e-9ea5-6c843003bd9f	83027-0071	HUMAN OTC DRUG	Vax Sode		Thuja Occidentalis, Calcarea Carbonica, Silicea, Salmonella Typhi Nosode, Serum Anguillae, Bacillus Tetani(Clostridium Tetani), Malandrinum, Morbillinum, Parotidinum, Rubella Nosode, Yersinia Enterocolitica, Salmonella Enteriditis	SPRAY	ORAL	20230911		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ANGUILLA ROSTRATA BLOOD SERUM; CLOSTRIDIUM TETANI; MEASLES VIRUS; MUMPS VIRUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; RUBELLA VIRUS; SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; SILICON DIOXIDE; THUJA OCCIDENTALIS LEAFY TWIG; VACCINIA VIRUS; YERSINIA ENTEROCOLITICA	18; 30; 30; 30; 9; 30; 18; 18; 9; 6; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0072_86223b7e-e9e6-4b59-9419-372103dc7278	83027-0072	HUMAN OTC DRUG	Bowel Sode		Ascaris Lumbricoides, Borrelia Burgdorferi, Botulinum, Colibacillinum Cum Natrum Muriaticum, Enterobius Vermicularis, Giardia Lamblia, Helicobacter Pylori, Proteus (Vulgaris), Trichinella Spiralis, Enterococcus Faecalis, Taenia Saginatta, Taenia Solium, Adenoviren Nosode, Campylobacter Jejuni, Clostridium Perfringens, Dysentery Bacillus, Clostridium Difficile, Entamoeba Histolytica	SPRAY	ORAL	20230915		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ASCARIS LUMBRICOIDES; BORRELIA BURGDORFERI; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; ENTAMOEBA HISTOLYTICA; ENTEROBIUS VERMICULARIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GIARDIA LAMBLIA; HELICOBACTER PYLORI; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; PROTEUS VULGARIS; SHIGELLA DYSENTERIAE; TAENIA SAGINATA; TAENIA SOLIUM; TRICHINELLA SPIRALIS	16; 16; 12; 16; 32; 18; 32; 16; 20; 16; 16; 16; 12; 16; 18; 8; 8; 16	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL	Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]		N	20241231
83027-0073_28ef8ea9-9588-4eca-8585-647c9a5dbf3c	83027-0073	HUMAN OTC DRUG	Progesterone Combo		Progesterone	SPRAY	ORAL	20230427		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	PROGESTERONE	5	[hp_X]/mL	Progesterone [CS], Progesterone [EPC]		N	20241231
83027-0074_0b244b94-4f89-45a1-b906-8bae6e50f842	83027-0074	HUMAN OTC DRUG	Digestive Enzyme Liquescence		Chamomilla, Cinnamomum, Coriandrum Sativum, Illicium Anisatum, Rheum (Palmatum), Syzygium Jambolanum, Zingiber Officinale, Angelica Archangelica, Cardamomum (Elettaria Cardamomum), Myrrha, Aloe, Crocus Sativus, Gallbladder (Bovine), Pancreas Suis, Stomach (Suis), Papain, Camphora, Valeriana Officinalis, Bromelain	LIQUID	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALOE; ANGELICA ARCHANGELICA ROOT; BOS TAURUS GALLBLADDER; BROMELAINS; CAMPHOR (NATURAL); CINNAMON; CORIANDER; ELETTARIA CARDAMOMUM WHOLE; GINGER; MATRICARIA CHAMOMILLA WHOLE; MYRRH; PAPAIN; RHEUM PALMATUM ROOT; SAFFRON; STAR ANISE; SUS SCROFA PANCREAS; SUS SCROFA STOMACH; SYZYGIUM CUMINI SEED; VALERIAN	6; 4; 6; 8; 8; 3; 3; 4; 3; 3; 5; 7; 3; 6; 3; 6; 6; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83027-0075_5cc95de9-855d-4857-add9-93a37fbcfd0c	83027-0075	HUMAN OTC DRUG	Estrogen	4X	Estradiol	SPRAY	ORAL	20230725		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ESTRADIOL	4	[hp_X]/mL	Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]		N	20241231
83027-0076_eb1e7c74-4398-46f7-aa34-baa743e12d38	83027-0076	HUMAN OTC DRUG	Adrenal Sarcode		Carduus Marianus, Berberis Vulgaris, Chelidonium Majus, Echinacea Purpurea, Zingiber Officinale, Bryonia (Alba), Glandula Suprarenalis (Bovine), Spleen (Suis), Atropinum Sulphuricum, Magnesia Phosphorica, Lycopodium Clavatum	SPRAY	ORAL	20230804		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ATROPINE SULFATE; BERBERIS VULGARIS ROOT BARK; BOS TAURUS ADRENAL GLAND; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS WHOLE; ECHINACEA PURPUREA WHOLE; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MILK THISTLE; SUS SCROFA SPLEEN	10; 3; 6; 6; 3; 3; 3; 12; 10; 2; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83027-0077_475b1d14-8d8c-42f2-8149-9090ff84ece9	83027-0077	HUMAN OTC DRUG	Bladder Sarcode		Urinary Bladder (Suis)	SPRAY	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	SUS SCROFA URINARY BLADDER	6	[hp_X]/mL			N	20241231
83027-0078_2f086ecb-4d75-482d-9d75-0f3b3c6aa7ab	83027-0078	HUMAN OTC DRUG	Ear Eye Sinuses Sarcode		Ear (Suis), Eye (Suis), Mucosa Nasalis Suis	SPRAY	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	SUS SCROFA EAR; SUS SCROFA EYE; SUS SCROFA NASAL MUCOSA	6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0079_3f03a411-e4eb-4d8c-ae6c-67ff0cf809eb	83027-0079	HUMAN OTC DRUG	Nerve Sarcode		Cerebellum (Suis), Thalamus Opticus (Suis)	SPRAY	ORAL	20230627		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	SUS SCROFA CEREBELLUM; SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS	6; 12	[hp_X]/mL; [hp_X]/mL			N	20241231
83027-0080_c0696e65-396f-4729-bf1a-eb9873a0b662	83027-0080	HUMAN OTC DRUG	Myocard Sarcode		Leonurus Cardiaca, Valeriana Officinalis, Cactus Grandiflorus, Convallaria Majalis, Spigelia Anthelmia, Heart (Bovine), Veratrum Album, arteria Suis, Aurum Muriaticum Natronatum, Digitalis Purpurea, Kali Carbonicum	SPRAY	ORAL	20230927		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BEEF HEART; CONVALLARIA MAJALIS; DIGITALIS; LEONURUS CARDIACA WHOLE; POTASSIUM CARBONATE; SELENICEREUS GRANDIFLORUS STEM; SODIUM TETRACHLOROAURATE; SPIGELIA ANTHELMIA WHOLE; SUS SCROFA ARTERY; VALERIAN; VERATRUM ALBUM ROOT	6; 4; 12; 3; 30; 4; 12; 4; 12; 3; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0081_cd31bfc0-b91e-4536-82dd-24262d1225e7	83027-0081	HUMAN OTC DRUG	Parathyroid Sarcode		Parathyroid Gland (Bovine)	SPRAY	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS PARATHYROID GLAND	12	[hp_X]/mL			N	20241231
83027-0082_b938e358-69bc-46f6-b096-428f792687e1	83027-0082	HUMAN OTC DRUG	Spinal Sarcode		Cartilago Suis, Cerebellum (Suis), Discus Intervertebralis (Suis), Medulla Ossis Suis	SPRAY	ORAL	20230627		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	SUS SCROFA BONE MARROW; SUS SCROFA CARTILAGE; SUS SCROFA CEREBELLUM; SUS SCROFA INTERVERTEBRAL DISC	6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0083_f638d0cb-016f-4e25-8ab8-67205da952e2	83027-0083	HUMAN OTC DRUG	Attention Formula		Clematis Vitalba, Flos, Convallaria Majalis, Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos, Cerebellum (Suis), Belladonna, Phosphorus, Sepia, Kidney (Bovine), Lycopodium Clavatum	SPRAY	ORAL	20230724		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ATROPA BELLADONNA; BEEF KIDNEY; CLEMATIS VITALBA FLOWER; CONVALLARIA MAJALIS; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; LYCOPODIUM CLAVATUM SPORE; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PHOSPHORUS; PRUNUS CERASIFERA FLOWER; SEPIA OFFICINALIS JUICE; SUS SCROFA CEREBELLUM	12; 30; 6; 6; 6; 6; 30; 6; 12; 6; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0084_6cb92469-3c55-47e3-9c13-f4b373e2883c	83027-0084	HUMAN OTC DRUG	A L O Formula		Cholinum, L-arginine, L-Carnitine, L-Ornithine, Pantothenic Acid	SPRAY	ORAL	20230707		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARGININE; CHOLINE HYDROXIDE; LEVOCARNITINE; ORNITHINE; PANTOTHENIC ACID	6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Carnitine Analog [EPC], Carnitine [CS]		N	20241231
83027-0085_e9df8e1e-cf24-4499-8a03-cc206872e6ae	83027-0085	HUMAN OTC DRUG	Anti Stress Formula		Apis Mellifica, Citrus Vulgaris, Clematis Vitalba, Flos, Glandula Suprarenalis (Bovine), Helianthemum Nummularium, Flos, Impatiens Glandulifera, Flos, Kali Phosphoricum, Ornithogalum Umbellatum, Flos, Prunus Cerasifera, Flos, Scutellaria Lateriflora, Viburnum Opulus, Cortisone Aceticum, Aconitum Napellus, Adrenalinum, Dopamine (Hydrochloride)	SPRAY	ORAL	20230725		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; APIS MELLIFERA; BOS TAURUS ADRENAL GLAND; CITRUS AURANTIUM FRUIT RIND; CLEMATIS VITALBA FLOWER; CORTISONE ACETATE; DIBASIC POTASSIUM PHOSPHATE; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; HELIANTHEMUM NUMMULARIUM FLOWER; IMPATIENS GLANDULIFERA FLOWER; ORNITHOGALUM UMBELLATUM FLOWERING TOP; PRUNUS CERASIFERA FLOWER; SCUTELLARIA LATERIFLORA WHOLE; VIBURNUM OPULUS BARK	12; 6; 6; 6; 6; 6; 6; 16; 12; 6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Bee Venoms [CS], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83027-0086_300f91b2-127b-40d4-8bf5-d2fd358a5a51	83027-0086	HUMAN OTC DRUG	Introvert Formula		Passiflora Incarnata, Pulsatilla (Pratensis), Ignatia Amara, Natrum Muriaticum, Duodenum (Suis), Petroleum, Sulphur	SPRAY	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	KEROSENE; PASSIFLORA INCARNATA FLOWERING TOP; PULSATILLA PRATENSIS WHOLE; SODIUM CHLORIDE; STRYCHNOS IGNATII SEED; SULFUR; SUS SCROFA DUODENUM	60; 3; 4; 12; 6; 60; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0087_1328f257-44b2-4be8-b0e4-6dbad85d7361	83027-0087	HUMAN OTC DRUG	Facial Pain Formula		Salix Nigra, Belladonna, Cerebellum (Suis), Aconitum Napellus	SPRAY	ORAL	20230706		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; ATROPA BELLADONNA; SALIX NIGRA BARK; SUS SCROFA CEREBELLUM	8; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0088_37bb07da-a667-4df0-b4da-bf1e4b5c698d	83027-0088	HUMAN OTC DRUG	Occulopress		Coleus Forskohlii, Euphrasia Officinalis, Vaccinium Myrtillus, Spigelia Anthelmia, Aconitum Napellus, Belladonna, Hydrastis Canadensis, Eye (Suis), Bryonia (Alba), Gelsemium Sempervirens, Phosphorus	SPRAY	ORAL	20230803		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; ATROPA BELLADONNA; BILBERRY; BRYONIA ALBA ROOT; COLEUS BARBATUS ROOT; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; PHOSPHORUS; SPIGELIA ANTHELMIA WHOLE; SUS SCROFA EYE	6; 6; 3; 12; 3; 3; 12; 6; 12; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; ng/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0089_e628f00a-afe7-4e81-9a54-32a3014a6b9c	83027-0089	HUMAN OTC DRUG	Cardiovascular Formula		Cactus Grandiflorus, Spigelia Anthelmia, Kalmia Latifolia, Arsenicum Album, Strophanthus Hispidus, Scilla Maritima, Digitalis Purpurea, Phosphorus, Kali Carbonicum	SPRAY	ORAL	20230922		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARSENIC TRIOXIDE; DIGITALIS; DRIMIA MARITIMA BULB; KALMIA LATIFOLIA LEAF; PHOSPHORUS; POTASSIUM CARBONATE; SELENICEREUS GRANDIFLORUS STEM; SPIGELIA ANTHELMIA WHOLE; STROPHANTHUS HISPIDUS SEED	8; 12; 9; 7; 12; 30; 4; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0090_47b95d16-55f7-49cc-834e-d1bd9051c315	83027-0090	HUMAN OTC DRUG	Flu Formula		Apis Mellifica, Aconitum Napellus, Allium Cepa, Bryonia (Alba), Eupatorium Perfoliatum, Euphrasia Officinalis, Ipecacuanha, Belladonna, Echinacea Purpurea, Asclepias Vincetoxicum, Gelsemium Sempervirens, Phosphorus, Influenzinum	SPRAY	ORAL	20230627		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; APIS MELLIFERA; ATROPA BELLADONNA; BRYONIA ALBA ROOT; ECHINACEA PURPUREA WHOLE; EUPATORIUM PERFOLIATUM FLOWERING TOP; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); IPECAC; ONION; PHOSPHORUS; VINCETOXICUM HIRUNDINARIA ROOT	6; 6; 6; 6; 6; 6; 6; 12; 12; 12; 12; 12; 6; 6; 12; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Standardized Insect Venom Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
83027-0091_cb61d393-7887-47a6-a278-60f43cc118d7	83027-0091	HUMAN OTC DRUG	Metex		Plantago Major, Lycopodium Clavatum, Arsenicum Album, Cadmium Metallicum, Chromium (Metallicum), Cuprum Metallicum, Mercurius Vivus, Niccolum Metallicum, Plumbum Metallicum, Zincum Metallicum	SPRAY	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARSENIC TRIOXIDE; CADMIUM; CHROMIUM; COPPER; LEAD; LYCOPODIUM CLAVATUM SPORE; MERCURY; NICKEL; PLANTAGO MAJOR WHOLE; ZINC	30; 30; 30; 30; 30; 6; 30; 30; 3; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]		N	20241231
83027-0092_9b5cf627-6fce-485d-8a4c-dd1d6f32fe0f	83027-0092	HUMAN OTC DRUG	Mytox		Borax, Colchicum Autumnale, Drosera (Rotundifolia), Arsenicum Album, Ubidecarenonum, Agaricus Muscarius, Bufo Rana	SPRAY	ORAL	20230802		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMANITA MUSCARIA FRUITING BODY; ARSENIC TRIOXIDE; BUFO BUFO CUTANEOUS GLAND; COLCHICUM AUTUMNALE BULB; DROSERA ROTUNDIFOLIA WHOLE; SODIUM BORATE; UBIDECARENONE	12; 8; 12; 4; 6; 4; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0093_72cca1c2-129f-4ad7-acfb-783e3e8d09b9	83027-0093	HUMAN OTC DRUG	Tap Water Detox		Acetone, Aluminium Metallicum, Antimonium Crudum, Arsenicum Metallicum, Baryta Muriatica, Cadmium Metallicum, Carbolicum Acidum, Chlorinum, chromium (Metallicum), Cuprum Metallicum, Ferrum Metallicum, Germanium Metallicum, Natrum Fluoratum, Plumbum Metallicum, Radium Bromatum, Vanadium Metallicum, Glyphosate Herbicide	SPRAY	ORAL	20230711		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACETONE; ALUMINUM; ANTIMONY TRISULFIDE; ARSENIC; BARIUM CHLORIDE DIHYDRATE; CADMIUM; CHLORINE; CHROMIUM; COPPER; GERMANIUM; GLYPHOSATE; IRON; LEAD; PHENOL; RADIUM BROMIDE; SODIUM FLUORIDE; VANADIUM	30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
83027-0094_939dec30-d2c2-49fe-92e7-46a21b3cdcc8	83027-0094	HUMAN OTC DRUG	Lung Liquescence		Eucalyptus Globulus, Lung (Bovine), Sanguinaria Canadensis, Adrenalinum, Belladonna	LIQUID	ORAL	20230801		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ATROPA BELLADONNA; BEEF LUNG; EPINEPHRINE; EUCALYPTUS GLOBULUS LEAF; SANGUINARIA CANADENSIS ROOT	12; 6; 12; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83027-0095_80eed639-4867-48e0-9848-f3b41e280cad	83027-0095	HUMAN OTC DRUG	Methylation Assist Liquescence		Inositol, Methylcobalamin (Vitamin B12), Nadidum (NADH), Niacin (Nicotinic Acid) , Nicotinamidum (Niacinamide), L-Methionine, Pyridoxinum Hydrochloricum (Vitamin B6), SAMe (S-Adenosyl Methionine), Zincum Gluconicum, Magnesium Gluconicum Dihydricum, Riboflavinum (Vitamin B2), Ubidecarenonum CoQ10), Dopamine, Serotonin, Egg White	LIQUID	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ADEMETIONINE; DOPAMINE HYDROCHLORIDE; EGG WHITE; INOSITOL; MAGNESIUM GLUCONATE; METHIONINE; METHYLCOBALAMIN; NADIDE; NIACIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SEROTONIN HYDROCHLORIDE; UBIDECARENONE; ZINC GLUCONATE	6; 12; 15; 6; 8; 6; 6; 6; 6; 6; 6; 8; 12; 8; 6	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Egg Proteins, Dietary [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC]		N	20241231
83027-0096_ef2b4f53-55db-4fd5-b745-4a4c3d597e21	83027-0096	HUMAN OTC DRUG	Gallbladder Sarcode		Carduus Marianus, Chelidonium Majus, Belladonna, Leptandra Virginica, Gallbladder (Bovine), Hepar (Bovine), Colocynthis, Cholesterinum	SPRAY	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ATROPA BELLADONNA; BEEF LIVER; BOS TAURUS GALLBLADDER; CHELIDONIUM MAJUS WHOLE; CHOLESTEROL; CITRULLUS COLOCYNTHIS FRUIT PULP; MILK THISTLE; VERONICASTRUM VIRGINICUM ROOT	4; 6; 6; 3; 8; 7; 3; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
83027-0097_d0cd198a-136e-49a8-b628-36870779209d	83027-0097	HUMAN OTC DRUG	Heart Lung Sarcode		Heart (Bovine), Lung (Bovine)	SPRAY	ORAL	20230811		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BEEF HEART; BEEF LUNG	6; 6	[hp_X]/mL; [hp_X]/mL			N	20241231
83027-0098_4923458e-1ec0-4a9b-819d-7379214d1e9c	83027-0098	HUMAN OTC DRUG	Hepaticol Sarcode		Carduus Marianus, Zingiber Officinale, Berberis Vulgaris, Chelidonium Majus, Magnesia Muriatica, Leptandra Virginica, Natrum Muriaticum, Bryonia (Alba), Hepar (Bovine), Natrum Sulphuricum, Atropinum Sulphuricum, Lycopodium Clavatum	SPRAY	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ATROPINE SULFATE; BEEF LIVER; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CHELIDONIUM MAJUS WHOLE; GINGER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM CHLORIDE; MILK THISTLE; SODIUM CHLORIDE; SODIUM SULFATE; VERONICASTRUM VIRGINICUM ROOT	10; 6; 4; 6; 4; 3; 12; 4; 3; 5; 6; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Anticholinergic [EPC], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Dietary Proteins [CS], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83027-0099_92cb708d-5148-45d9-9b01-3f3d19953be3	83027-0099	HUMAN OTC DRUG	Pneumo Sarcode		Teucrium Scorodonia, Arsenicum Iodatum, Lung (Bovine), Calcarea Phosphorica, Stannum Metallicum, Carbo Vegetabilis, Phellandrium Aquaticum, Silicea, Sulphur	SPRAY	ORAL	20230814		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACTIVATED CHARCOAL; ARSENIC TRIIODIDE; BEEF LUNG; OENANTHE AQUATICA FRUIT; SILICON DIOXIDE; SULFUR; TEUCRIUM SCORODONIA FLOWERING TOP; TIN; TRIBASIC CALCIUM PHOSPHATE	12; 6; 6; 12; 12; 12; 4; 10; 10	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
83027-0100_8e2f0d3a-f70e-4b37-9cb9-4008b92d880d	83027-0100	HUMAN OTC DRUG	Renal Sarcode		Rubia Tinctorum, Urtica Dioica, Sarsaparilla (smilax Regelii), Berberis Vulgaris, Coccus Cacti, Benzoicum Acidum, Kidney (Bovine), Lithium Carbonicum, Lycopodium Clavatum, Petroselinum Sativum, Taraxacum Officinale, Colocynthis, Atropinum Sulphuricum, Calcarea Carbonica, Hydrangea Arborescens	SPRAY	ORAL	20230811		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ATROPINE SULFATE; BEEF KIDNEY; BENZOIC ACID; BERBERIS VULGARIS ROOT BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; HYDRANGEA ARBORESCENS ROOT; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PETROSELINUM CRISPUM WHOLE; PROTORTONIA CACTI; RUBIA TINCTORUM ROOT; SMILAX ORNATA ROOT; TARAXACUM OFFICINALE; URTICA DIOICA WHOLE	10; 6; 6; 5; 7; 12; 6; 6; 12; 6; 5; 3; 4; 6; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ammonium Ion Binding Activity [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Mood Stabilizer [EPC], Nitrogen Binding Agent [EPC]		N	20241231
83027-0101_bda8e64a-6e70-411e-a2cb-905f2b2504e6	83027-0101	HUMAN OTC DRUG	Liver Liquescence		Carduus Marianus, Chelidonium Majus, Lappa Major, Uva Ursi, Raphanus Sativus, Taraxacum Officinale, Lycopodium Clavatum, Hydrastis Canadensis, Gallbladder (Bovine), Hepar (Bovine), Beta Vulgaris, Phosphorus	LIQUID	ORAL	20230911		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARCTIUM LAPPA ROOT; ARCTOSTAPHYLOS UVA-URSI LEAF; BETA VULGARIS WHOLE; BOS TAURUS GALLBLADDER; CHELIDONIUM MAJUS WHOLE; GOLDENSEAL; HEPARIN, BOVINE; LYCOPODIUM CLAVATUM SPORE; MILK THISTLE; PHOSPHORUS; RADISH; TARAXACUM OFFICINALE	2; 2; 12; 6; 2; 5; 6; 4; 2; 12; 3; 3	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Vegetable Proteins [CS]		N	20241231
83027-0102_1a3a8aaf-710c-4882-b894-8f6e895db7bd	83027-0102	HUMAN OTC DRUG	Renal Health Formula		Sarsaparilla (Smilax Regelii), Berberis Vulgaris, Leonurus Cardiaca, Lycopodium Clavatum, Nitricum Acidum, Digitalis Purpurea, Oxalicum Acidum, Uricum Acidum	SPRAY	ORAL	20230823		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BERBERIS VULGARIS ROOT BARK; DIGITALIS; LEONURUS CARDIACA WHOLE; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; OXALIC ACID DIHYDRATE; SMILAX ORNATA ROOT; URIC ACID	6; 12; 6; 6; 6; 30; 4; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0103_ea5be260-d197-423c-9e0c-7f118e419b38	83027-0103	HUMAN OTC DRUG	Pain Formula		Salix Alba, Ascorbicum Acidum, Vitamin A, Vitamin E, Acetylsalicylicum Acidum	SPRAY	ORAL	20231120		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	.ALPHA.-TOCOPHEROL; ASCORBIC ACID; ASPIRIN; SALIX ALBA BARK; VITAMIN A	6; 6; 6; 4; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Ascorbic Acid [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Vitamin A [CS], Vitamin A [EPC], Vitamin C [EPC]		N	20241231
83027-0104_6d5f8f14-75b3-4156-a20a-eb612c33e029	83027-0104	HUMAN OTC DRUG	Polyhesion Formula		Sanguinaria Canadensis, Nitricum Acidum, Teucrium Marum, Thuja Occidentalis, Sanguinarinum Nitricum, Calcarea Carbonica, Phosphorus	SPRAY	ORAL	20230912		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	NITRIC ACID; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SANGUINARIA CANADENSIS ROOT; SANGUINARINE NITRATE; TEUCRIUM MARUM WHOLE; THUJA OCCIDENTALIS LEAFY TWIG	6; 30; 30; 3; 15; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0105_3dbc6757-7f6e-48a5-9a07-147e7c115696	83027-0105	HUMAN OTC DRUG	Sinus Relief Formula		Pulsatilla (Pratensis), Sinapis Nigra, Luffa Operculata, Euphorbium Officinarum, Guaiacum, Mercurius Sulphuratus Ruber	SPRAY	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BLACK MUSTARD SEED; EUPHORBIA RESINIFERA RESIN; GUAIACUM OFFICINALE RESIN; LUFFA OPERCULATA FRUIT; MERCURIC SULFIDE; PULSATILLA PRATENSIS WHOLE	4; 8; 12; 5; 12; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0106_70c1a075-b19d-4896-b019-754d83210cf2	83027-0106	HUMAN OTC DRUG	Stomach Enzyme Formula		Betainum Muriaticum, Muriaticum Acidum, Natrum Phosphoricum, Pancreas Suis, Stomach (Suis) Symphytum Officinale, Pepsinum	SPRAY	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BETAINE HYDROCHLORIDE; COMFREY ROOT; HYDROCHLORIC ACID; PEPSIN; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SUS SCROFA PANCREAS; SUS SCROFA STOMACH	6; 6; 6; 12; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Methylating Activity [MoA], Methylating Agent [EPC]		N	20241231
83027-0107_732e38b5-3ce3-4554-9ea8-4741889ae869	83027-0107	HUMAN OTC DRUG	Kidney Formula		Hai-Chin-Sha (Lygodium Japonicum), Astragalus Membranaceous, Chin-Chien-Tsao (Lysimachia Christinae), Lobelia Inflata, Lycopodium Clavatum	SPRAY	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ASTRAGALUS MONGHOLICUS ROOT; LOBELIA INFLATA WHOLE; LYCOPODIUM CLAVATUM SPORE; LYGODIUM JAPONICUM SPORE; LYSIMACHIA CHRISTINAE WHOLE	4; 6; 6; 3; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0108_25eb87ec-c9c8-417d-824a-d5af6320c73e	83027-0108	HUMAN OTC DRUG	Hyten Formula		Allium Sativum, Kidney (Bovine), Leonurus Cardiaca, Viscum Album, Aurum Metallicum, Digitalis Purpurea, Glonoinum, Lycopodium Clavatum, Rauwolfia Serpentina, Sulphur, Plumbum Aceticum, Baryta Muriatica	SPRAY	ORAL	20230928		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BARIUM CHLORIDE DIHYDRATE; BEEF KIDNEY; DIGITALIS; GARLIC; GOLD; LEAD ACETATE ANHYDROUS; LEONURUS CARDIACA WHOLE; LYCOPODIUM CLAVATUM SPORE; NITROGLYCERIN; RAUWOLFIA SERPENTINA; SULFUR; VISCUM ALBUM FRUITING TOP	30; 6; 12; 6; 12; 12; 6; 12; 12; 12; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Nitrate Vasodilator [EPC], Nitrates [CS], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS], Standardized Chemical Allergen [EPC], Vasodilation [PE]		N	20241231
83027-0109_0094d78a-2f44-4b06-8bb8-bd756b921f74	83027-0109	HUMAN OTC DRUG	Mood Balancer		Lithium Carbonicum, Cerebellum (Suis), Cerebrum Suis, Hypothalamus Suis, Pineal Gland (suis), Aurum Metallicum, Natrum Sulphuricum, Sepia, Serotonin (Hydrochloride)	SPRAY	ORAL	20231005		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	GOLD; LITHIUM CARBONATE; SEPIA OFFICINALIS JUICE; SEROTONIN HYDROCHLORIDE; SODIUM SULFATE; SUS SCROFA CEREBELLUM; SUS SCROFA CEREBRUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PINEAL GLAND	12; 6; 12; 12; 12; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Mood Stabilizer [EPC], Standardized Chemical Allergen [EPC]		N	20241231
83027-0110_6ebd89f5-aab0-4532-a592-afd65aa80089	83027-0110	HUMAN OTC DRUG	Diarrhea Formula		Cinchona Officinalis, Rheum (Palmatum), Podophyllum Peltatum, Ipecacuanha, Aloe, Colocynthis, Arsenicum Album, Terebinthina, Veratrum Album, Antimonium Crudum, Mercurius Corrosivus	SPRAY	ORAL	20231005		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALOE; ANTIMONY TRISULFIDE; ARSENIC TRIOXIDE; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; IPECAC; MERCURIC CHLORIDE; PODOPHYLLUM; RHEUM PALMATUM ROOT; TURPENTINE OIL; VERATRUM ALBUM ROOT	6; 9; 8; 3; 7; 6; 12; 5; 4; 8; 8	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0111_72677556-e646-41cd-b53a-10043664b87c	83027-0111	HUMAN OTC DRUG	Digestive Enzyme Formula		Gallbladder (Bovine), Hepar (Bovine), Intestine (Suis), Pancreas Suis, Rectal Mucosa (Suis), Stomach (Suis)	SPRAY	ORAL	20231005		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS GALLBLADDER; HEPARIN, BOVINE; PORK INTESTINE; SUS SCROFA PANCREAS; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH	6; 6; 6; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0112_ffecf46b-62f2-4fe0-b89a-9d74087ea1ba	83027-0112	HUMAN OTC DRUG	Uric Acid Balancer		Dulcamara, Ledum Palustre, Arnica Montana, Benzoicum Acidum, Bryonia (Alba), Colchicum Autumnale, Lithium Carbonicum, Natrum Phosphoricum, Urtica Urens, Formica Rufa, Lycopodium Clavatum	SPRAY	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARNICA MONTANA WHOLE; BENZOIC ACID; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; FORMICA RUFA; LITHIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SOLANUM DULCAMARA TOP; URTICA URENS WHOLE	6; 6; 6; 6; 12; 6; 12; 4; 6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Ammonium Ion Binding Activity [MoA], Mood Stabilizer [EPC], Nitrogen Binding Agent [EPC]		N	20241231
83027-0113_5340ad50-4a85-46b9-a74c-eec9690d160c	83027-0113	HUMAN OTC DRUG	Injury Formula		Echinacea Purpurea, Arnica Montana, Calendula Officinalis, Medulla Ossis Suis, Symphytum Officinale, Rhus Tox	SPRAY	ORAL	20231004		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARNICA MONTANA WHOLE; CALENDULA OFFICINALIS FLOWERING TOP; COMFREY ROOT; ECHINACEA PURPUREA WHOLE; SUS SCROFA BONE MARROW; TOXICODENDRON PUBESCENS LEAF	3; 3; 6; 3; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0114_a75ae51c-a7cb-4914-b27e-475b65f9af05	83027-0114	HUMAN OTC DRUG	Shallow Breathing Formula		Aralia Quinquefolia, Aconitum Napellus, Antimonium Tartaricum, Ipecacuanha, Blatta Orientalis, Arsenicum Album, Cuprum Metallicum	SPRAY	ORAL	20231013		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM NAPELLUS WHOLE; AMERICAN GINSENG; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BLATTA ORIENTALIS; COPPER; IPECAC	6; 3; 6; 12; 10; 12; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC]		N	20241231
83027-0115_b4fb928b-53fd-4e0b-817d-495f3da96496	83027-0115	HUMAN OTC DRUG	Prostate Formula		Sabal Serrulata, Chimaphila Umbellata, Prostate (Suis), Zincum Metallicum, Pulsatilla (Pratensis)	SPRAY	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	CHIMAPHILA UMBELLATA WHOLE; PULSATILLA PRATENSIS WHOLE; SAW PALMETTO; SUS SCROFA PROSTATE; ZINC	6; 12; 4; 6; 9	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL			N	20241231
83027-0116_600cfb8b-93f0-4a23-bad0-7a7be18aa746	83027-0116	HUMAN OTC DRUG	Metab		Calcarea Sulphurica, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Cerebellum (Suis), Gallbladder (Bovine), Heart (Bovine), Hepar (Bovine), Hypothalamus Suis, Intestine (Suis), Kidney (Bovine), Lung (Bovine), Medulla Ossis Suis, Pancreas Suis, Pineal Gland (Suis), Rectal Mucosa (Suis), Spleen (Bovine), Stomach (Suis), Thymus (Ovine), Thyroidinum (Bovine), Urinary Bladder (Suis), Pituitarum Posterium (Bovine), Acetyl Coenzyme A,	SPRAY	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACETYL COENZYME A; ACONITIC ACID; ALANINE; ANHYDROUS CITRIC ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; BEEF HEART; BEEF KIDNEY; BEEF LIVER; BEEF LUNG; BOS TAURUS GALLBLADDER; BOS TAURUS PARATHYROID GLAND; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS SPLEEN; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CYSTEINE; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; FUMARIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HERRING SPERM DNA; HISTIDINE; ISOLEUCINE; LAMB; LEUCINE; LYSINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MALIC ACID; METHIONINE; OXOGLURIC ACID; PHENYLALANINE; PORK INTESTINE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; PROLINE; SACCHAROMYCES CEREVISIAE RNA; SERINE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SUCCINIC ACID; SUS SCROFA BONE MARROW; SUS SCROFA CEREBELLUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA PINEAL GLAND; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; THREONINE; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE; TYROSINE; VALINE	12; 16; 12; 12; 12; 12; 12; 6; 6; 6; 6; 6; 12; 8; 6; 12; 6; 12; 6; 12; 12; 12; 12; 12; 30; 12; 12; 6; 12; 12; 12; 12; 12; 12; 12; 6; 6; 6; 12; 30; 12; 12; 6; 6; 6; 12; 6; 6; 6; 6; 6; 6; 6; 6; 12; 6; 12; 12; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83027-0117_0626ed57-c6fc-49dc-a8fa-e94033c0a914	83027-0117	HUMAN OTC DRUG	Bio Detox Formula		Eucalyptus Globulus, Aloe, Hydrastis Canadensis, Allium Sativum, Alternaria Tenuis Nees, Aspergillus Niger, Bacillus Tetani, Pneumococcinum, Staphylococcus Aureus, Streptococcus Viridans, Staphysagria, Eucalyptol, Pyrogenium, Lac Caninum, Lac Vaccinum, Pestinum	SPRAY	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALOE; ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; CANIS LUPUS FAMILIARIS MILK; CLOSTRIDIUM TETANI; COW MILK; DELPHINIUM STAPHISAGRIA SEED; EUCALYPTOL; EUCALYPTUS GLOBULUS LEAF; GARLIC; GOLDENSEAL; RANCID BEEF; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS VIRIDANS GROUP; YERSINIA PESTIS	4; 16; 16; 30; 16; 30; 16; 20; 3; 6; 6; 20; 16; 16; 16; 18	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83027-0118_481322c6-54e2-4302-b6b6-f9fc98d80358	83027-0118	HUMAN OTC DRUG	Cellular Oxygenator		Cactus Grandiflorus, Ascorbicum Acidum, Nicotinamidum, Pyridoxinum Hydrochloricum, Thiaminum Hydrochloricum, Magnesium Gluconicum Dihydricum, Riboflavinum, Magnesia Phosphorica, Adenosinum Triphosphoricum Dinatrum, Alpha-Lipoicum Acidum, Anthrachinonum, Coenzyme A, Nadidum, Naja Tripudians, Ubidecarenonum (CoQ10)	SPRAY	ORAL	20231121		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ADENOSINE TRIPHOSPHATE DISODIUM; ALPHA LIPOIC ACID; ANTHRAQUINONE; ASCORBIC ACID; COENZYME A; MAGNESIUM GLUCONATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NADIDE; NAJA NAJA VENOM; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENICEREUS GRANDIFLORUS STEM; THIAMINE HYDROCHLORIDE; UBIDECARENONE	12; 12; 12; 6; 12; 8; 10; 12; 12; 6; 6; 8; 4; 6; 12	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]		N	20241231
83027-0119_c6726814-8af9-4195-bf0b-961091f95e25	83027-0119	HUMAN OTC DRUG	Thymus Sarcode		Echinacea Purpurea, Myristica Sebifera, Belladonna, Calcarea Sulphurica, Thymus (Ovine), Arsenicum Album, Silicea, Sulphur Iodatum, Calcarea Fluorica, Hepar Sulphuris Calcareum, Lachesis Mutus	SPRAY	ORAL	20231101		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ARSENIC TRIOXIDE; ATROPA BELLADONNA; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CALCIUM SULFIDE; ECHINACEA PURPUREA WHOLE; LACHESIS MUTA VENOM; LAMB; SILICON DIOXIDE; SULFUR IODIDE; VIROLA SEBIFERA RESIN	8; 6; 12; 6; 121; 3; 12; 6; 9; 10; 4	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
83027-0120_21c70f99-2a67-415b-baea-9d46016850fa	83027-0120	HUMAN OTC DRUG	Enviro Detox Formula		Lappa Major, Taraxacum Officinale, Trifolium Pratense, Spinacia, Petroleum, Plumbum Metallicum, Sulphuricum acidum, Ammonium Phosphoricum, Arsenicum Album, chromium (Metallicum), Cuprum Metallicum, Dibromoethane, Kreosotum, Mercurius Vivus, MTBE (Tert-Butyl Methyl Ether), Nitricum Acidum, Radium Bromatum	SPRAY	ORAL	20231006		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMMONIUM PHOSPHATE, DIBASIC; ARCTIUM LAPPA ROOT; ARSENIC TRIOXIDE; CHROMIUM; COPPER; ETHYLENE DIBROMIDE; KEROSENE; LEAD; MERCURY; NITRIC ACID; RADIUM BROMIDE; SPINACIA OLERACEA ROOT; SULFURIC ACID; TARAXACUM OFFICINALE; TERT-BUTYL METHYL ETHER; TRIFOLIUM PRATENSE FLOWER; WOOD CREOSOTE	30; 3; 30; 30; 30; 30; 12; 12; 30; 30; 30; 6; 12; 3; 30; 3; 30	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Chemical Allergen [EPC]		N	20241231
83027-0121_ad73cbe5-4242-4cf0-866d-1914f4d3efa8	83027-0121	HUMAN OTC DRUG	Food Poisoning Detox		Echinacea Purpurea, Glycyrrhiza Glabra, Hydrastis Canadensis, Podophyllum Peltatum, Aconitum Napellus, Colocynthis, Arsenicum Album, Colibacillinum Cum Natrum Muriaticum, Salmonella Typhi Nosode, Staphylococcus Aureus, Streptococcus Viridans, Mercurius Corrosivus, Mercurius Solubilis, Aconitum Lycoctonum, Campylobacter Jejuni, Clostridium Perfringens, Listeria Monocytogenes	SPRAY	ORAL	20231101		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ACONITUM LYCOCTONUM WHOLE; ACONITUM NAPELLUS WHOLE; ARSENIC TRIOXIDE; CAMPYLOBACTER JEJUNI; CITRULLUS COLOCYNTHIS FRUIT PULP; CLOSTRIDIUM PERFRINGENS; ECHINACEA PURPUREA WHOLE; ESCHERICHIA COLI; GLYCYRRHIZA GLABRA; GOLDENSEAL; LISTERIA MONOCYTOGENES; MERCURIC CHLORIDE; MERCURIUS SOLUBILIS; PODOPHYLLUM; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS VIRIDANS GROUP	8; 8; 8; 18; 8; 18; 3; 18; 3; 6; 18; 30; 30; 6; 18; 18; 18	[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83027-0122_37909445-becc-47ba-9ed4-008f7027b8f0	83027-0122	HUMAN OTC DRUG	B Complex Liquescence		Cholinum (Choline), Inositol (Vitamin B8), Folic Acid (Vitamin B9), Pantothenic Acid (Calcium Pantothenate, Vitamin B5), Thiaminum Hydrochloricum (Vitamin B1), Heart (Bovine), Hepar (Bovine), Methylcobalamin (Vitamin B12), Nicotinamidum (Vitamin B3), PABA (Para Aminobenzoic Acid Vitamin B10), Pyridoxinum Hydrochloricum (Vitamin B6), Biotin (Vitamin B7), Hordeum Vulgare, Riboflavinum (Vitamin B2), Torula Cerevisiae	LIQUID	ORAL	20231009		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	AMINOBENZOIC ACID; BEEF HEART; BEEF LIVER; BIOTIN; CALCIUM PANTOTHENATE; CHOLINE HYDROXIDE; FOLIC ACID; HORDEUM VULGARE TOP; INOSITOL; METHYLCOBALAMIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SACCHAROMYCES CEREVISIAE; THIAMINE HYDROCHLORIDE	6; 6; 6; 8; 5; 4; 5; 8; 4; 6; 6; 6; 8; 16; 5	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Allergens [CS], Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Vitamin B 6 [Chemical/Ingredient], Vitamin B Complex Member [EPC], Vitamin B Complex [CS], Vitamin B6 Analog [EPC]		N	20241231
83027-0123_de80a35f-cfe2-4e8b-824d-451a5eeb0c86	83027-0123	HUMAN OTC DRUG	Household Dust and Mold Mix		Glandula Suprarenalis (Bovine), Hepar (Bovine), Histaminum Hydrochloricum, Alternaria Tenuis Nees, Aspergillus Niger, Candida Albicans, Candida Parapsilosis, Dust, Mucor Racemosus, Torula Cerevisiae, House Dust Mite, Adrenocorticotrophin, Rhizopus Nigricans	SPRAY	ORAL	20230824		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	ALTERNARIA ALTERNATA; ASPERGILLUS NIGER VAR. NIGER; BEEF LIVER; BOS TAURUS ADRENAL GLAND; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CORTICOTROPIN; DERMATOPHAGOIDES PTERONYSSINUS; HISTAMINE DIHYDROCHLORIDE; HOUSE DUST; MUCOR RACEMOSUS; RHIZOPUS STOLONIFER; SACCHAROMYCES CEREVISIAE	16; 16; 6; 6; 16; 16; 15; 12; 12; 16; 16; 15; 16	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL	Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Antigens, Dermatophagoides [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], House Dust [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized House Dust Allergenic Extract [EPC], Standardized Insect Allergenic Extract [EPC]		N	20241231
83027-0124_32e0ef29-9584-498c-b09d-418280128a78	83027-0124	HUMAN OTC DRUG	Bone Liquescence		Taraxacum Officinale, Trifolium Pratense, Calcarea Muriatica, Equisetum Arvense, Juglans Nigra, Sesame Oil, Calcarea Sulphurica, Hepar (Bovine), Kidney (Bovine), Medulla Ossis Suis, Menadione, Thyroidinum (Bovine), Vitamin A, Vitamin D3, Calcarea Phosphorica, Calcarea Carbonica, Calcarea Fluorica, Manganum Metallicum, Niccolum Metallicum, Magnesium Metallicum	LIQUID	ORAL	20231117		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BEEF KIDNEY; BLACK WALNUT HUSK; CALCIUM CHLORIDE; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CHOLECALCIFEROL; EQUISETUM ARVENSE TOP; HEPARIN, BOVINE; MAGNESIUM; MANGANESE; MENADIONE; NICKEL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SESAME OIL; SUS SCROFA BONE MARROW; TARAXACUM OFFICINALE; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE; TRIFOLIUM PRATENSE FLOWER; VITAMIN A	6; 4; 4; 12; 5; 6; 4; 6; 15; 12; 6; 12; 9; 4; 6; 3; 6; 9; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC], Vitamin A [CS], Vitamin A [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
83027-0125_f6c3daa3-4663-48ff-a588-28991b3ead7d	83027-0125	HUMAN OTC DRUG	Fatigue Formula		Medulla Ossis Suis, Spleen (Bovine), Thymus (Ovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans, Toxoplasma Gondii, Epstein-Bar Virus Nosode	SPRAY	ORAL	20231110		UNAPPROVED HOMEOPATHIC		Nutritional Specialties, Inc.	BOS TAURUS SPLEEN; HUMAN BREAST TUMOR CELL; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); LAMB; STREPTOCOCCUS VIRIDANS GROUP; SUS SCROFA BONE MARROW; TOXOPLASMA GONDII	6; 16; 16; 16; 16; 16; 16; 16; 6; 16; 6; 16	[hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
83033-0010_09f73bec-516e-90f0-e063-6394a90aecab	83033-0010	HUMAN OTC DRUG	ANTIBACTERIAL DREAMY FLORALS		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0020_09f73bec-516e-90f0-e063-6394a90aecab	83033-0020	HUMAN OTC DRUG	ANTIBACTERIAL BOLD CITRUS		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0030_09f73bec-516e-90f0-e063-6394a90aecab	83033-0030	HUMAN OTC DRUG	ANTIBACTERIAL DELIGHTFUL SWEETNESS		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0040_09f73bec-516e-90f0-e063-6394a90aecab	83033-0040	HUMAN OTC DRUG	ANTIBACTERIAL FRUITY ZEST		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0050_09f73bec-516e-90f0-e063-6394a90aecab	83033-0050	HUMAN OTC DRUG	ANTIBACTERIAL COOLING BREEZE		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0060_09f73bec-516e-90f0-e063-6394a90aecab	83033-0060	HUMAN OTC DRUG	ANTIBACTERIAL DREAMY FLORALS		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0070_09f73bec-516e-90f0-e063-6394a90aecab	83033-0070	HUMAN OTC DRUG	ANTIBACTERIAL BOLD CITRUS		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0080_09f73bec-516e-90f0-e063-6394a90aecab	83033-0080	HUMAN OTC DRUG	ANTIBACTERIAL DELIGHTFUL SWEETNESS		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0090_09f73bec-516e-90f0-e063-6394a90aecab	83033-0090	HUMAN OTC DRUG	ANTIBACTERIAL FRUITY ZEST		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-0100_09f73bec-516e-90f0-e063-6394a90aecab	83033-0100	HUMAN OTC DRUG	ANTIBACTERIAL COOLING BREEZE		GLYCERIN	SOAP	TRANSDERMAL	20221111		OTC MONOGRAPH DRUG	M016	Quimicas Handal de Centroamerica SA de CV	GLYCERIN	1	g/g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83033-1594_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1594	HUMAN OTC DRUG	RAYO ACTIVE ICE		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1595_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1595	HUMAN OTC DRUG	RAYO ACTIVE HEAT		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Quimicas Handal de Centroamerica SA de CV	MENTHOL; METHYL SALICYLATE	1; 1	g/g; g/g			N	20241231
83033-1598_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1598	HUMAN OTC DRUG	RAYO ACTIVE ICE		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1599_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1599	HUMAN OTC DRUG	RAYO ACTIVE HEAT		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Quimicas Handal de Centroamerica SA de CV	MENTHOL; METHYL SALICYLATE	1; 1	g/g; g/g			N	20241231
83033-1600_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1600	HUMAN OTC DRUG	RAYO ACTIVE ICE		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1601_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1601	HUMAN OTC DRUG	RAYO ACTIVE HEAT		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Quimicas Handal de Centroamerica SA de CV	MENTHOL; METHYL SALICYLATE	1; 1	g/g; g/g			N	20241231
83033-1602_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1602	HUMAN OTC DRUG	RAYO POWER ICE HEAT DUAL ACTION		MENTHOL	GEL	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Quimicas Handal de Centroamerica SA de CV	MENTHOL	1	g/g			N	20241231
83033-1605_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1605	HUMAN OTC DRUG	RAYO BREATH MENTHOL		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1606_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1606	HUMAN OTC DRUG	RAYO BREATH CHAMOMILE		MENTHOL, CAMPHOR	OINTMENT	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1609_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1609	HUMAN OTC DRUG	RAYO ACTIVE ICE SACHET		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1610_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1610	HUMAN OTC DRUG	RAYO ACTIVE HEAT		MENTHOL, METHYL SALICYLATE	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Quimicas Handal de Centroamerica SA de CV	MENTHOL; METHYL SALICYLATE	1; 1	g/g; g/g			N	20241231
83033-1611_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1611	HUMAN OTC DRUG	RAYO BREATH MENTHOL		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1612_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1612	HUMAN OTC DRUG	RAYO BREATH CHAMOMILE		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83033-1620_09e4a36b-020b-c5b1-e063-6394a90a3e31	83033-1620	HUMAN OTC DRUG	RAYO BREATH CHAMOMILE		MENTHOL, CAMPHOR	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M012	Quimicas Handal de Centroamerica SA de CV	CAMPHOR (SYNTHETIC); MENTHOL	1; 1	g/g; g/g			N	20241231
83035-1061_fc74288c-93d3-6ae3-e053-6394a90a8312	83035-1061	HUMAN OTC DRUG	Votriza-AL		Clotrimazole 1%	LOTION	TOPICAL	20230520		OTC MONOGRAPH FINAL	part333C	Singular Dreamer, Ltd dba True Marker	CLOTRIMAZOLE	1	g/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
83035-1062_f8ffe76d-f801-24eb-e053-6394a90a9b0e	83035-1062	HUMAN OTC DRUG	TM-Clotrimazole		Clotrimazole 1%	CREAM	TOPICAL	20230403		OTC MONOGRAPH FINAL	part333C	Singular Dreamer, Ltd dba True Marker	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
83035-1260_02a7c7a7-9adc-0575-e063-6294a90aadb1	83035-1260	HUMAN OTC DRUG	TM -Tolnaftate		Tolnaftate 1%	LIQUID	TOPICAL	20230328		OTC MONOGRAPH FINAL	part333C	Singular Dreamer, Ltd dba True Marker	TOLNAFTATE	1	g/100mL			N	20241231
83035-1262_fea3f313-ad83-0e09-e053-6394a90a6029	83035-1262	HUMAN OTC DRUG	TM-Tolnaftate LR		Tolnaftate	LIQUID	TOPICAL	20230601		OTC MONOGRAPH FINAL	part333C	Singular Dreamer Ltd.dba True Marker	TOLNAFTATE	1	g/100mL			N	20241231
83035-5002_01f4dd9b-0994-2d9c-e063-6394a90a5509	83035-5002	HUMAN OTC DRUG	Lintera Wash		BENZOYL PEROXIDE	LIQUID	TOPICAL	20230801		OTC MONOGRAPH FINAL	part333D	Singular Dreamer dba True Marker	BENZOYL PEROXIDE	10	g/100mL			N	20241231
83035-6202_04135c5f-ca90-dd24-e063-6294a90aa9cd	83035-6202	HUMAN OTC DRUG	Sentriva-ES		Calcium Carbonate,Magnesium Hydroxide	TABLET, CHEWABLE	ORAL	20230601		OTC MONOGRAPH FINAL	part331	Singular Dreamer, LTD dba True Marker	CALCIUM CARBONATE; MAGNESIUM HYDROXIDE	975; 232	mg/1; mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83035-8030_0de8ecc7-052c-5e06-e063-6394a90ac8be	83035-8030	HUMAN OTC DRUG	Ventiva Tears Lubricant Eye Drops		CARBOXYMETHYLCELLULOSE SODIUM	LIQUID	OPHTHALMIC	20240101		OTC MONOGRAPH DRUG	M018	Singular Dreamer Ltd.dba True Marker	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	.5	g/100mL			N	20251231
83035-8031_0de94b4f-7287-bd2b-e063-6394a90a2c08	83035-8031	HUMAN OTC DRUG	Ventiva Tears Plus Lubricant Eye Drops		CARBOXYMETHYLCELLULOSE SODIUM	LIQUID	OPHTHALMIC	20240101		OTC MONOGRAPH DRUG	M018	Singular Dreamer Ltd.dba True Marker	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED	.6	g/100mL			N	20251231
83035-8121_0d1e49be-ba64-49cd-e063-6294a90ad5a7	83035-8121	HUMAN OTC DRUG	Ventiva Lubricant Eye Drops		Propylene Glycol	LIQUID	OPHTHALMIC	20231010		OTC MONOGRAPH DRUG	M018	Singular Dreamer dba True Marker	PROPYLENE GLYCOL	.7	g/100mL			N	20251231
83035-8124_0b3740eb-90c6-335a-e063-6294a90a93df	83035-8124	HUMAN OTC DRUG	Sentia Lubricant Eye Drops		Propylene Glycol	LIQUID	OPHTHALMIC	20231127		OTC MONOGRAPH DRUG	M018	Singular Dreamer dba True Marker	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
83037-001_05e427ce-8645-343a-e063-6394a90a9089	83037-001	HUMAN OTC DRUG	DZUL ANTI-DANDRUFF		Zinc Pyrithione	SHAMPOO	TOPICAL	20230922		OTC MONOGRAPH FINAL	M032	Caball Sales, Inc.	PYRITHIONE ZINC	1	g/100mL			N	20241231
83037-002_05f2912a-642a-365a-e063-6394a90a2d4a	83037-002	HUMAN OTC DRUG	DZUL ANTI-DANDRUFF CONDITIONER		Pyrithione Zinc	CREAM	TOPICAL	20230922		OTC MONOGRAPH FINAL	M032	Caball Sales, Inc.	PYRITHIONE ZINC	2	g/100mL			N	20241231
83037-041_0634096d-328c-db03-e063-6394a90a63cd	83037-041	HUMAN OTC DRUG	DZUL - LIDO CREME		LIDOCAINE HCL, MENTHOL	LOTION	TOPICAL	20221017		OTC MONOGRAPH DRUG	M017	Caball Sales, Inc.	LIDOCAINE HYDROCHLORIDE; MENTHOL	4; 1	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83037-423_06bfe007-b26c-085c-e063-6394a90a3e39	83037-423	HUMAN OTC DRUG	DZUL - LIDO CREME	MAXIMUM STRENGTH	LIDOCAINE, MENTHOL	LOTION	TOPICAL	20221017	20250428	OTC MONOGRAPH DRUG	M017	Caball Sales, Inc.	LIDOCAINE; MENTHOL	4; 2.3	g/100g; g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	
83038-693_eac24f52-e339-25db-e053-2995a90a42c8	83038-693	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	LIQUID	TOPICAL	20200310		OTC MONOGRAPH NOT FINAL	part333A	Fehr Bros. Industries Inc	ALCOHOL	67	mL/100mL			N	20241231
83040-001_2e5eb337-081a-405b-8b3b-b30b36c35c30	83040-001	HUMAN OTC DRUG	Pursuit Body Surf Daily SPF 40 Body Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	LOTION	TOPICAL	20221129		OTC MONOGRAPH NOT FINAL	part352	Pursuit Beauty Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100g; g/100g; g/100g; g/100g			N	20241231
83040-002_97d91723-88c5-47f4-a362-1842e608e266	83040-002	HUMAN OTC DRUG	Pursuit Hit the Lip SPF 15 Lip Balm		Avobenzone, Homosalate, Octisalate	LIPSTICK	TOPICAL	20221103		OTC MONOGRAPH NOT FINAL	part352	Pursuit Beauty Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE	3; 8; 5	g/100g; g/100g; g/100g			N	20241231
83040-003_3731c523-85e7-4aac-97ce-fc8da1269c6a	83040-003	HUMAN OTC DRUG	Pursuit Hang 40 SPF 40 Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	GEL	TOPICAL	20221130		OTC MONOGRAPH NOT FINAL	part352	Pursuit Beauty Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 15; 5; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83042-701_09d2be72-23a4-e5c8-e063-6294a90a4306	83042-701	HUMAN OTC DRUG	PowerClean Technologies CleanCare		PCMX	SOAP	TOPICAL	20221027		OTC MONOGRAPH DRUG	505G(a)(3)	PowerClean Technologies	CHLOROXYLENOL	1	g/L			N	20241231
83046-100_0bdb8e62-2098-4e49-e063-6394a90a8c37	83046-100	HUMAN OTC DRUG	Resurfacing acne swipes		Salicylic Acid	SWAB	TOPICAL	20221222		OTC MONOGRAPH DRUG	M006	Oars And Alps LLC	SALICYLIC ACID	.005	mg/mL			N	20241231
83046-101_0bdd9cc4-4574-0741-e063-6394a90a2286	83046-101	HUMAN OTC DRUG	Hand Sanitizing Wipe		Alcohol	CLOTH	TOPICAL	20221219		OTC MONOGRAPH DRUG	505G(a)(3)	Oars And Alps LLC	ALCOHOL	65	mL/100mL			N	20241231
83046-360_f3975f04-3a53-9147-e053-2a95a90a44d3	83046-360	HUMAN OTC DRUG	Oars and Alps SPF 50 Hydrating Antioxidant SunscreenSpray		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20210101		OTC MONOGRAPH FINAL	M020	Oars and Alps LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83046-369_f3971b85-a13f-4195-e053-2995a90a73cb	83046-369	HUMAN OTC DRUG	Oars and Alps SPF 50 100% Mineral Antioxidant Sunscreen		Titanium Dioxide, Zinc Oxide	SPRAY	TOPICAL	20221201		OTC MONOGRAPH FINAL	M020	Oars and Alps LLC	TITANIUM DIOXIDE; ZINC OXIDE	3.4; 15.7	g/100mL; g/100mL			N	20241231
83046-370_f39673a7-0b63-bdf7-e053-2995a90aa2b7	83046-370	HUMAN OTC DRUG	Oars and Alps SPF 70 Hydrating Antioxidant Sunscreen		Avobenzone, Homosalate, Octisalate, Octocrylene	SPRAY	TOPICAL	20230101		OTC MONOGRAPH FINAL	M020	Oars and Alps LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	2.9; 9.8; 4.9; 9.5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83046-371_f395bc39-daa6-53b8-e053-2995a90a5f48	83046-371	HUMAN OTC DRUG	Oars and Alps SPF 50 Mineral		Zinc Oxide	LOTION	TOPICAL	20221201		OTC MONOGRAPH FINAL	M020	Oars and Alps LLC	ZINC OXIDE	19.6	g/100mL			N	20241231
83048-001_075c2446-5018-0f37-e063-6294a90a89b0	83048-001	HUMAN OTC DRUG	RR Roll-On for Pain		Lidocaine HCL	GEL	TOPICAL	20221103		OTC MONOGRAPH DRUG	M003	Revolutionary Relief dba Medical XLabs	LIDOCAINE HYDROCHLORIDE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83049-489_a0526808-00a6-42a5-aeb8-42db54626a28	83049-489	HUMAN OTC DRUG	FLO PMS Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET	ORAL	20221205		OTC MONOGRAPH DRUG	M013	O Positiv, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
83054-1502_0152828d-efa2-01f4-e063-6294a90aa608	83054-1502	HUMAN OTC DRUG	Inde Wild		Zinc Oxide	LOTION	TOPICAL	20220915		OTC MONOGRAPH NOT FINAL	part352	Inde Wild	ZINC OXIDE	132	mg/mL			N	20241231
83056-001_fd61d862-7e3a-cfab-e053-6394a90a75cc	83056-001	HUMAN OTC DRUG	KASEHA Pain Relieving Gel		camphor, capsaicin, menthol, methyl salicylate	GEL	TOPICAL	20230407		OTC MONOGRAPH NOT FINAL	part348	Denali Natural Products	CAMPHOR (NATURAL); CAPSAICIN; MENTHOL; METHYL SALICYLATE	3.2; .15; 1.25; 10	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83056-002_fbc27909-8df5-5d99-e053-6294a90a373e	83056-002	HUMAN OTC DRUG	KASEHA Pain Relieving Gel		camphor, capsaicin, menthol, methyl salicylate	GEL	TOPICAL	20230407		OTC MONOGRAPH NOT FINAL	part348	Denali Natural Products	CAMPHOR (NATURAL); CAPSAICIN; MENTHOL; METHYL SALICYLATE	3.5; .18; 1.25; 12	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83057-0001_06c1066e-9103-09c9-e063-6294a90abf9d	83057-0001	HUMAN OTC DRUG	Novalgina	Children Cough and Cold	Acetaminofen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20221101		OTC MONOGRAPH FINAL	part341	HBC Pharma, LLC	ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	250; 13.33; 200; 5	mg/10mL; mg/10mL; mg/10mL; mg/10mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
83057-0002_06c0fe9a-92ba-1679-e063-6394a90a4bf8	83057-0002	HUMAN OTC DRUG	Novalgina Pediatrico Cough and Cold	Pediatrico	Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl	LIQUID	ORAL	20230201		OTC MONOGRAPH FINAL	part341	HBC Pharma LLC	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE	7.5; 88; 2.5	mg/mL; mg/mL; mg/mL	Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
83057-0003_06c113f5-63bb-f431-e063-6294a90a7d4f	83057-0003	HUMAN OTC DRUG	Novalgina Acetaminophen Pain and Fever for Childrens		Acetaminophen 160mg	SUSPENSION	ORAL	20230608		OTC MONOGRAPH NOT FINAL	part343	HBC Pharma, LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
83059-0007_0bf59ea9-df41-d9da-e063-6394a90acbf4	83059-0007	HUMAN OTC DRUG	Motion Sickness Relief		Meclizine HCl	TABLET, FILM COATED	ORAL	20231206		OTC MONOGRAPH DRUG	M002	Shield Pharmaceuticals Corp	MECLIZINE HYDROCHLORIDE	25	mg/1	Antiemetic [EPC], Emesis Suppression [PE]		N	20241231
83060-013_eb79e11a-6c2a-556b-e053-2a95a90a728a	83060-013	HUMAN OTC DRUG	Jelly Smack		Benzalkonium Chloride	SOLUTION	TOPICAL	20220101		OTC MONOGRAPH NOT FINAL	part333E	VULCAN MICROBIAL CORPORATION	BENZALKONIUM CHLORIDE	.13	g/mL			N	20241231
83061-001_08aee630-21f6-6ba1-e063-6294a90ae9eb	83061-001	HUMAN OTC DRUG	CLEANZ ECO BAMBOO WIPES		Wipes	CLOTH	TOPICAL	20221015		OTC MONOGRAPH DRUG	505G(a)(3)	McF Holdings LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
83062-030_08272b36-9e91-1228-e063-6294a90a90eb	83062-030	HUMAN OTC DRUG	DuoCare Clinical Oral Rinse		cetylpyridinium chloride mouthwash	MOUTHWASH	DENTAL	20231006		OTC MONOGRAPH DRUG	M022	IIMED MEDICAL MEXICANA S DE RL DE CV	CETYLPYRIDINIUM CHLORIDE	1	mg/mL			N	20241231
83062-032_07c2aaf3-57a2-1679-e063-6294a90a3a61	83062-032	HUMAN OTC DRUG	62% Ethyl Alcohol Nasal Swab		Ethyl Alcohol Nasal Swab	SWAB	TOPICAL	20231015		OTC MONOGRAPH DRUG	M003	IIMED MEDICAL MEXICANA S DE RL DE CV	DEHYDRATED ALCOHOL	62	mL/100mL			N	20241231
83062-083_0715c095-f8b2-f6f8-e063-6294a90a2672	83062-083	HUMAN OTC DRUG	Sparklefresh Fluoride		Sodium monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20231006		OTC MONOGRAPH DRUG	M022	IIMED MEDICAL MEXICANA S DE RL DE CV	SODIUM MONOFLUOROPHOSPHATE	1	mg/g			N	20241231
83062-086_0714d475-68d1-9eb7-e063-6294a90a1c12	83062-086	HUMAN OTC DRUG	Medline Peroxi Fresh Mouthwash		Hydrogen peroxide mouthwash	MOUTHWASH	DENTAL	20231006		OTC MONOGRAPH DRUG	M022	IIMED MEDICAL MEXICANA S DE RL DE CV	HYDROGEN PEROXIDE	15	mg/mL			N	20241231
83062-410_06ffc47c-5591-1ca9-e063-6394a90abda5	83062-410	HUMAN OTC DRUG	Dentek Instant Pain Relief	Maximum Strength	Benzocaine	LIQUID	DENTAL	20221010		OTC MONOGRAPH DRUG	M022	IIMED MEDICAL MEXICANA S. DE R.L. DE C.V	BENZOCAINE	200	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83067-363_09770368-70f8-2f7c-e063-6294a90a81ff	83067-363	HUMAN OTC DRUG	DIRT Pain Relieving Gel		MENTHOL	GEL	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	PURIVITAE, LLC	MENTHOL	40	mg/mL			N	20241231
83067-463_097705c5-f169-19a5-e063-6294a90acfaf	83067-463	HUMAN OTC DRUG	DIRT Pain Relieving Gel		MENTHOL	GEL	TOPICAL	20231003		OTC MONOGRAPH DRUG	M017	PURIVITAE, LLC	MENTHOL	40	mg/mL			N	20241231
83069-010_399fb656-09ec-4193-ad3d-2440dca0b253	83069-010	HUMAN OTC DRUG	Kopher Calming Ocean Sun		Ethylhexyl Methoxycinnamate, Zinc Oxide, Ethylhexyl Salicylate, Titanium Dioxide	CREAM	TOPICAL	20221001		OTC MONOGRAPH NOT FINAL	part352	Best Innovation	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	7.5; 3; 1.6; 4	g/100mL; g/100mL; g/100mL; g/100mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83071-010_fc23644d-c3a7-4d8f-a395-89dd4d313399	83071-010	HUMAN OTC DRUG	Dr.Jucre Rebirth White Booster		Niacinamide	LIQUID	TOPICAL	20221001		UNAPPROVED DRUG OTHER		NATURECELL CO., LTD.	NIACINAMIDE	2	g/100mL			N	20241231
83071-020_ff0ae282-1f6c-441a-a7dd-863b46931dc2	83071-020	HUMAN OTC DRUG	Dr.Jucre Rebirth Activating Toner		Betaine	LIQUID	TOPICAL	20221001		UNAPPROVED DRUG OTHER		NATURECELL CO., LTD.	BETAINE	.001	g/100mL	Methylating Activity [MoA], Methylating Agent [EPC]		N	20241231
83071-030_590e648c-c739-4991-88a8-30154849bfb9	83071-030	HUMAN OTC DRUG	Dr.Jucre Rebirth White		Niacinamide	EMULSION	TOPICAL	20221001		UNAPPROVED DRUG OTHER		NATURECELL CO., LTD.	NIACINAMIDE	2	g/100mL			N	20241231
83071-040_267cfff9-7793-46d8-9c8c-cac1a42d66a5	83071-040	HUMAN OTC DRUG	Dr.Jucre Rebirth White Eye		Niacinamide	CREAM	TOPICAL	20221001		UNAPPROVED DRUG OTHER		NATURECELL CO., LTD.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
83071-050_fbbba033-9699-4a98-a429-5e77b9c00c9a	83071-050	HUMAN OTC DRUG	Dr.Jucre Rebirth White		Niacinamide, Adenosine	CREAM	TOPICAL	20221001		UNAPPROVED DRUG OTHER		NATURECELL CO., LTD.	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
83071-060_f667986b-9023-46e3-9f1f-6abb3162b5a1	83071-060	HUMAN OTC DRUG	Dr.Jucre Rebirth White Sun Protection		OCTINOXATE, HOMOSALATE, OCTISALATE, AVOBENZONE, ENSULIZOLE, OCTOCRYLENE, BEMOTRIZINOL, NIACINAMIDE, ADENOSINE	CREAM	TOPICAL	20221001		UNAPPROVED DRUG OTHER		NATURECELL CO., LTD.	ADENOSINE; AVOBENZONE; BEMOTRIZINOL; ENSULIZOLE; HOMOSALATE; NIACINAMIDE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	.04; 4; 1.5; 3.5; 6; 2; 7.3; 4.5; 2	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
83071-070_4a721851-a5ae-4fa0-9a32-e46efb61c3c1	83071-070	HUMAN OTC DRUG	Dr.Jucre Rebirth White BB		Titanium Dioxide, Octinoxate, Zinc Oxide, Niacinamide, Adenosine	CREAM	TOPICAL	20221001		UNAPPROVED DRUG OTHER		NATURECELL CO., LTD.	ADENOSINE; NIACINAMIDE; OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE	.04; 2; 5; 12.11; 2.93	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83072-374_0976fa2b-1b24-140f-e063-6394a90a72a5	83072-374	HUMAN OTC DRUG	PURE PERSONAL All Natural Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20221024		OTC MONOGRAPH DRUG	M017	PURE PERSONAL CARE, LLC	MENTHOL	75	mg/mL			N	20241231
83073-0001_19a4a4f9-4f64-40d7-9724-cfe39e64b925	83073-0001	HUMAN OTC DRUG	Metabolic Correction Blend		Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin (Derived From Egg), Capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum (NSPC), Phytolacca Decandra, Progesterone, Thyroidinum (Bovine), Pituitarum Posterium (Bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Ferrum Metallicum, Graphites, Adrenalinum, Phosphorus	SPRAY	ORAL	20230321		UNAPPROVED HOMEOPATHIC		IHA Distribution, LLC	AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; CAPSICUM; EGG PHOSPHOLIPIDS; EPINEPHRINE; FOENICULUM VULGARE FRUIT; FUCUS VESICULOSUS; GALIUM APARINE WHOLE; GRAPHITE; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; PHYTOLACCA AMERICANA ROOT; POTASSIUM DICHROMATE; PROGESTERONE; SILVER; SKIM MILK; SUS SCROFA PITUITARY GLAND; THYROID, BOVINE	3; 9; 8; 6; 3; 12; 2; 3; 6; 9; 9; 9; 12; 6; 6; 6; 9; 6; 6; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Progesterone [CS], Progesterone [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83078-701_215cd2e5-9ef8-419e-a975-5c6fa6c6e32f	83078-701	HUMAN PRESCRIPTION DRUG	TachoSil		THROMBIN HUMAN and FIBRINOGEN	PATCH	TOPICAL	20230401		BLA	BLA125351	Corza Medical GmbH	FIBRINOGEN HUMAN; HUMAN THROMBIN	5.5; 2	mg/1; [USP'U]/1	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
83078-702_215cd2e5-9ef8-419e-a975-5c6fa6c6e32f	83078-702	HUMAN PRESCRIPTION DRUG	TachoSil		THROMBIN HUMAN and FIBRINOGEN	PATCH	TOPICAL	20230401		BLA	BLA125351	Corza Medical GmbH	FIBRINOGEN HUMAN; HUMAN THROMBIN	5.5; 2	mg/1; [USP'U]/1	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
83078-704_215cd2e5-9ef8-419e-a975-5c6fa6c6e32f	83078-704	HUMAN PRESCRIPTION DRUG	TachoSil		THROMBIN HUMAN and FIBRINOGEN	PATCH	TOPICAL	20230401		BLA	BLA125351	Corza Medical GmbH	FIBRINOGEN HUMAN; HUMAN THROMBIN	5.5; 2	mg/1; [USP'U]/1	Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE]		N	20241231
83080-121_f5b2d9f2-ff2a-2da1-e053-2995a90a68f3	83080-121	HUMAN OTC DRUG	Anti-Dandruff		Zinc Pyrithione	SHAMPOO	TOPICAL	20230301		OTC MONOGRAPH FINAL	M032	MEERAY COSMETICS CO., LTD.	PYRITHIONE ZINC	10	mg/100mL			N	20241231
83081-2045_0bd90c39-aa47-2790-e063-6294a90a33b6	83081-2045	HUMAN OTC DRUG	Sand Cloud Mineral Sunscreen		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	Sand Cloud Holdings, LLC	TITANIUM DIOXIDE; ZINC OXIDE	54; 108	mg/mL; mg/mL			N	20241231
83081-2056_0bd8abb2-4b13-db01-e063-6294a90a1e50	83081-2056	HUMAN OTC DRUG	Sand Cloud Mineral Sunscreen For Face		Titanium Dioxide and Zinc Oxide	LOTION	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	Sand Cloud Holdings, LLC	TITANIUM DIOXIDE; ZINC OXIDE	10; 83.4	mg/g; mg/g			N	20241231
83083-001_fd134f21-9214-33f8-e053-6294a90acc75	83083-001	HUMAN OTC DRUG	Activated Mineral Sunscreen		Activated Mineral Sunscreen	CREAM	TOPICAL	20230601		OTC MONOGRAPH NOT FINAL	part352	Reve Skincare LLC	ZINC OXIDE	142.8	mg/mL			N	20241231
83086-001_09735b2f-2b02-ca91-e063-6294a90a210a	83086-001	HUMAN OTC DRUG	NATRULAB ANTISEPTIC SANITIZING WIPES		ANTISEPTIC SANITIZING WIPES	CLOTH	TOPICAL	20230120		OTC MONOGRAPH DRUG	505G(a)(3)	Natrulab Innovations Inc	BENZALKONIUM CHLORIDE	.26	g/100g			N	20241231
83088-8120_08a2d847-ea3b-4fac-e063-6394a90a193c	83088-8120	HUMAN OTC DRUG	histamine dihydrochloride		histamine dihydrochloride	CREAM	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	USA Hemp Store LLC	HISTAMINE DIHYDROCHLORIDE	.00025	g/mL			N	20241231
83088-8120_0b767f10-5f3d-d650-e063-6294a90aaa19	83088-8120	HUMAN OTC DRUG	histamine dihydrochloride		histamine dihydrochloride	CREAM	TOPICAL	20230201		OTC MONOGRAPH DRUG	M017	USA Hemp Store LLC	HISTAMINE DIHYDROCHLORIDE	.00025	g/mL			N	20241231
83088-8120_0b768ab0-5fc8-f20b-e063-6294a90a3bbe	83088-8120	HUMAN OTC DRUG	histamine dihydrochloride		histamine dihydrochloride	CREAM	TOPICAL	20230201		OTC MONOGRAPH DRUG	M017	USA Hemp Store LLC	HISTAMINE DIHYDROCHLORIDE	.00025	g/mL			N	20241231
83088-8120_0b768ab0-5fca-f20b-e063-6294a90a3bbe	83088-8120	HUMAN OTC DRUG	histamine dihydrochloride		histamine dihydrochloride	CREAM	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	USA Hemp Store LLC	HISTAMINE DIHYDROCHLORIDE	.00025	g/mL			N	20241231
83088-8120_0b776c22-1535-ac7b-e063-6294a90a7f4a	83088-8120	HUMAN OTC DRUG	histamine dihydrochloride		histamine dihydrochloride	CREAM	TOPICAL	20221003		OTC MONOGRAPH DRUG	M017	USA Hemp Store LLC	HISTAMINE DIHYDROCHLORIDE	.00025	g/mL			N	20241231
83090-001_0d18f291-3a92-421e-8841-6be743b1f154	83090-001	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20221115		ANDA	ANDA214267	Sintetica US LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83090-002_0d18f291-3a92-421e-8841-6be743b1f154	83090-002	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20221115		ANDA	ANDA214267	Sintetica US LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83090-003_0d18f291-3a92-421e-8841-6be743b1f154	83090-003	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20221115		ANDA	ANDA214267	Sintetica US LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	10	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83090-004_0d18f291-3a92-421e-8841-6be743b1f154	83090-004	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20221115		ANDA	ANDA214267	Sintetica US LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83090-005_0d18f291-3a92-421e-8841-6be743b1f154	83090-005	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20221115		ANDA	ANDA214267	Sintetica US LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83090-006_0d18f291-3a92-421e-8841-6be743b1f154	83090-006	HUMAN PRESCRIPTION DRUG	NA		LIDOCAINE HYDROCHLORIDE	INJECTION, SOLUTION	INFILTRATION	20221115		ANDA	ANDA214267	Sintetica US LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83090-007_eff2e41b-a181-2c76-e053-2995a90aa8b0	83090-007	HUMAN PRESCRIPTION DRUG	NA		Lidocaine Hydrochloride	INJECTION, SOLUTION	RETROBULBAR	20221115		ANDA	ANDA214269	Sintetica US LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	40	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83090-008_074a288f-8a8f-7c41-e063-6294a90a68dc	83090-008	HUMAN PRESCRIPTION DRUG	Bortezomib		Bortezomib	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20230715		ANDA	ANDA209622	Sintetica US LLC	BORTEZOMIB	3.5	mg/3.5mL	Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]		N	20241231
83090-011_ec2f5ec8-e443-46a1-b6e9-85210d9b53e3	83090-011	HUMAN PRESCRIPTION DRUG	daptomycin		daptomycin	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	INTRAVENOUS	20231105		ANDA	ANDA215890	Sintetica US LLC	DAPTOMYCIN	500	mg/20mL	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]		N	20241231
83092-104_ec9a9517-2800-35cf-e053-2995a90ae8a9	83092-104	HUMAN OTC DRUG	ECZEMA RELIEF SOOTHING WASH	2% COLLOIDAL OATMEAL	COLLOIDAL OATMEAL	GEL	TOPICAL	20220928		OTC MONOGRAPH FINAL	M016	Three Dog Beauty LLC	OATMEAL	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83092-105_ec9a6190-9bbe-96b4-e053-2995a90a8179	83092-105	HUMAN OTC DRUG	ECZEMA RELIEF SOOTHING	2% COLLOIDAL OATMEAL	COLLOIDAL OATMEAL	CREAM	TOPICAL	20220928		OTC MONOGRAPH FINAL	M016	Three Dog Beauty LLC	OATMEAL	2	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83095-203_3b0137af-8511-4087-9dd5-e5c63cf8fa06	83095-203	HUMAN OTC DRUG	BHSkin Sheer Tinted Zinc and Titanium SPF 40		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Don Mehrabi, M.D. A Professional Medical Corporation	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
83099-000_089fd7d6-e589-daec-e063-6294a90ab9b6	83099-000	HUMAN OTC DRUG	Evercare Antifungal Treatment Super Absorbent Powder		MICONAZOLE NITRATE	POWDER	TOPICAL	20221128		OTC MONOGRAPH DRUG	M005	PANEFFORT, LLC	MICONAZOLE NITRATE	20	mg/g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
83100-1720_f9014410-ea1d-0ce3-e053-6394a90a66d2	83100-1720	HUMAN OTC DRUG	pavise Dynamic Age Defense		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	B.A.I BIOSCIENCES, INC	ZINC OXIDE	174	mg/mL			N	20241231
83100-1761_f4ebbc29-0d7d-1a7b-e053-2a95a90aa4d8	83100-1761	HUMAN OTC DRUG	pavise Lip Defense tinted hydrating oil (hue 604)		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	B.A.I. Biosciences INC.	ZINC OXIDE	100	mg/mL			N	20241231
83100-1762_f4eb6b84-780c-cc4f-e053-2995a90ae9bb	83100-1762	HUMAN OTC DRUG	pavise Lip Defense tinted hydrating oil (hue 616)		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	B.A.I. Biosciences INC.	ZINC OXIDE	100	mg/mL			N	20241231
83100-1763_f4ebd850-11a9-0d43-e053-2a95a90a2d34	83100-1763	HUMAN OTC DRUG	pavise Lip Defense tinted hydrating oil (hue 774)		Zinc Oxide	LOTION	TOPICAL	20230217		OTC MONOGRAPH NOT FINAL	part352	B.A.I. Biosciences INC.	ZINC OXIDE	100	mg/mL			N	20241231
83101-004_bdd0f399-1c92-4424-ac0a-e0c599a95297	83101-004	HUMAN OTC DRUG	Sacheu Spot Eraser		Benzoyl Peroxide	LOTION	TOPICAL	20221130		OTC MONOGRAPH FINAL	part333D	Sacheu Beauty Inc.	BENZOYL PEROXIDE	2.5	g/100mL			N	20241231
83102-1060_f5d9ec67-6772-653d-e053-2995a90a75c3	83102-1060	HUMAN OTC DRUG	Umcka ColdCare	Day Plus Night	Umcka ColdCare Day Plus Night	KIT		20230301		UNAPPROVED HOMEOPATHIC		ProSolutions Inc.						N	20241231
83102-1166_f5751a54-dca1-0aa4-e053-2995a90a2eb3	83102-1166	HUMAN OTC DRUG	Umcka FastActives Cherry		Pelargonium sidoides	POWDER	ORAL	20230224		UNAPPROVED HOMEOPATHIC		ProSolutions Inc.	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/700mg			N	20241231
83102-5146_f5776f96-13fc-0570-e053-2a95a90aa12c	83102-5146	HUMAN OTC DRUG	Umcka Coldcare Lemon		Pelargonium Sidoides	POWDER	ORAL	20230224		UNAPPROVED HOMEOPATHIC		ProSolutions, Inc.	PELARGONIUM SIDOIDES ROOT	1	[hp_X]/5g			N	20241231
83102-9349_eedab4b9-509c-3fe5-e053-2995a90a2027	83102-9349	HUMAN OTC DRUG	Umcka Fastactv Berry		Pelargonuim sidoides, Aconitum Napellus, Eucalyptus Globulus, Bryonia, Eupatorium Perfoliatum, Gelsemium Sempervirens, Phosphorus, Alpha CF	POWDER	ORAL	20221206		UNAPPROVED HOMEOPATHIC		ProSolutions Inc	ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUCALYPTUS GLOBULUS LEAF; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; PELARGONIUM SIDOIDES ROOT; PHOSPHORUS	4; 4; 2; 6; 4; 3; 1; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
83103-1513_0162c8a1-e723-1e63-e063-6394a90a81c9	83103-1513	HUMAN OTC DRUG	Ciele Blush and Protect		Zinc Oxide	LOTION	TOPICAL	20230623		OTC MONOGRAPH NOT FINAL	part352	Ciele	ZINC OXIDE	73.6	mg/mL			N	20241231
83103-1819_0162c889-d5a2-461c-e063-6394a90ae851	83103-1819	HUMAN OTC DRUG	Ciele Tint and Protect		Zinc Oxide	LOTION	TOPICAL	20230602		OTC MONOGRAPH NOT FINAL	part352	Ciele	ZINC OXIDE	132	mg/mL			N	20241231
83103-1910_03095ee6-1725-2351-e063-6394a90a78f3	83103-1910	HUMAN OTC DRUG	Ciele Filter and Protect		Titanium dioxide, Zinc Oxide	POWDER	TOPICAL	20230725		OTC MONOGRAPH NOT FINAL	part352	Ciele	TITANIUM DIOXIDE; ZINC OXIDE	.125; .225	g/g; g/g			N	20241231
83105-2001_0cbd6441-ac25-0030-e063-6294a90a9f9c	83105-2001	HUMAN OTC DRUG	Omega-Boost Sheer Mineral Sunscreen		Mineral Sunscreen	LOTION	TOPICAL	20231101		OTC MONOGRAPH DRUG	M020	Trilogy Natural Products Limited	ZINC OXIDE	229.25	mg/mL			N	20241231
83106-371_0976e636-18ed-0818-e063-6294a90adeb8	83106-371	HUMAN OTC DRUG	UFORIC Wart Remover		SALICYLIC ACID	SOLUTION	TOPICAL	20221121		OTC MONOGRAPH DRUG	M028	UFORIC HEALTH LLC	SALICYLIC ACID	50	mg/mL			N	20241231
83107-005_a6a7702f-36c9-45db-b640-453dc324baee	83107-005	HUMAN PRESCRIPTION DRUG	BETAPACE		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Legacy Pharma USA, Inc.	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
83107-006_a6a7702f-36c9-45db-b640-453dc324baee	83107-006	HUMAN PRESCRIPTION DRUG	BETAPACE		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Legacy Pharma USA, Inc.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
83107-007_a6a7702f-36c9-45db-b640-453dc324baee	83107-007	HUMAN PRESCRIPTION DRUG	BETAPACE		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Legacy Pharma USA, Inc.	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
83107-008_a6a7702f-36c9-45db-b640-453dc324baee	83107-008	HUMAN PRESCRIPTION DRUG	BETAPACE AF		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Legacy Pharma USA, Inc.	SOTALOL HYDROCHLORIDE	80	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
83107-009_a6a7702f-36c9-45db-b640-453dc324baee	83107-009	HUMAN PRESCRIPTION DRUG	BETAPACE AF		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Legacy Pharma USA, Inc.	SOTALOL HYDROCHLORIDE	120	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
83107-010_a6a7702f-36c9-45db-b640-453dc324baee	83107-010	HUMAN PRESCRIPTION DRUG	BETAPACE AF		sotalol hydrochloride	TABLET	ORAL	20160901		NDA	NDA019865	Legacy Pharma USA, Inc.	SOTALOL HYDROCHLORIDE	160	mg/1	Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]		N	20241231
83108-000_0b57eb9f-301f-283f-e063-6394a90a2f97	83108-000	HUMAN OTC DRUG	The Enriched Creme Broad Spectrum SPF 15		ZINC OXIDE	EMULSION	TOPICAL	20221125		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-001_080f2a90-8b80-27cb-e063-6294a90a1319	83108-001	HUMAN OTC DRUG	The Tinted Serum Broad Spectrum SPF 50		ZINC OXIDE	EMULSION	TOPICAL	20221125		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	240	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-002_0b5802a9-dd10-3433-e063-6394a90abed3	83108-002	HUMAN OTC DRUG	The Enriched Eye Creme Broad Spectrum SPF15		ZINC OXIDE	EMULSION	TOPICAL	20221208		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-010_0b58121c-9861-7daf-e063-6294a90a0395	83108-010	HUMAN OTC DRUG	Beautiful Skin Superfluid Broad Spectrum SPF30 M1		ZINC OXIDE	EMULSION	TOPICAL	20230129		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	169	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-020_0b580e23-67cd-7c82-e063-6294a90ad95a	83108-020	HUMAN OTC DRUG	Beautiful Skin Superfluid Broad Spectrum SPF30 M2		ZINC OXIDE	EMULSION	TOPICAL	20230129		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	169	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-030_0b580a20-eff9-78c3-e063-6294a90a3c4f	83108-030	HUMAN OTC DRUG	Beautiful Skin Superfluid Broad Spectrum SPF30 M3		ZINC OXIDE	EMULSION	TOPICAL	20230129		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	168	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-040_0b581013-1cd9-8568-e063-6294a90a1424	83108-040	HUMAN OTC DRUG	Beautiful Skin Superfluid Broad Spectrum SPF30 M4		ZINC OXIDE	EMULSION	TOPICAL	20230129		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	159	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-050_0b58081a-3762-7c15-e063-6294a90a2487	83108-050	HUMAN OTC DRUG	Beautiful Skin Superfluid Broad Spectrum SPF30 M5		ZINC OXIDE	EMULSION	TOPICAL	20230129		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	144	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-060_0b580c43-c45b-3d74-e063-6394a90af477	83108-060	HUMAN OTC DRUG	Beautiful Skin Superfluid Broad Spectrum SPF30 M6		ZINC OXIDE	EMULSION	TOPICAL	20230129		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd	ZINC OXIDE	141	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83108-100_07f9cf41-5247-5240-e063-6394a90aaebe	83108-100	HUMAN OTC DRUG	Luminosity Activation Day Edition		ZINC OXIDE	KIT		20231115		OTC MONOGRAPH DRUG	M020	Rationale Group Pty Ltd						N	20241231
83109-0002_09b1b234-0d95-49a0-e063-6294a90a75f0	83109-0002	HUMAN OTC DRUG	QWG-1000		ginsenoside	LIQUID	TOPICAL	20221120		UNAPPROVED DRUG OTHER		Institute of Quantum Bioscience	GINSENOSIDES	.04	g/100mL			N	20241231
83111-001_f1eeb782-a976-1ca9-e053-2a95a90ad3ce	83111-001	HUMAN OTC DRUG	Kuribl Active Cooling Roll-on		Camphor, Menthol	LIQUID	TOPICAL	20230131		OTC MONOGRAPH NOT FINAL	part348	Radiance Beauty & Wellness Inc. dba Saavy Naturals	CAMPHOR (NATURAL); MENTHOL	2; 8	g/100mL; g/100mL			N	20241231
83111-002_f346fa35-1df8-4927-e053-2a95a90a43ed	83111-002	HUMAN OTC DRUG	Kuribl Active Dry		Camphor, Menthol	CREAM	TOPICAL	20230127		OTC MONOGRAPH NOT FINAL	part348	Radiance Beauty & Wellness Inc. dba Saavy Naturals	CAMPHOR (NATURAL); MENTHOL	2; 8	g/100mL; g/100mL			N	20241231
83111-003_f565e89b-c369-0b0a-e053-2995a90a67df	83111-003	HUMAN OTC DRUG	Kuribl Active Muscle		Camphor, Menthol	CREAM	TOPICAL	20230223		OTC MONOGRAPH NOT FINAL	part348	Radiance Beauty & Wellness Inc. dba Saavy Naturals	CAMPHOR (NATURAL); MENTHOL	2; 8	g/100mL; g/100mL			N	20241231
83111-004_f5b7c4a4-bca2-9611-e053-2a95a90a7fb8	83111-004	HUMAN OTC DRUG	Kuribl Active Pain		Camphor, Menthol	STICK	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part348	Radiance Beauty & Wellness Inc. dba Saavy Naturals	CAMPHOR (NATURAL); MENTHOL	2; 6	g/100g; g/100g			N	20241231
83111-005_f5b7dfc4-ed87-6d9e-e053-2995a90a1788	83111-005	HUMAN OTC DRUG	Kuribl Active Pain		Camphor, Menthol	STICK	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part348	Radiance Beauty & Wellness Inc. dba Saavy Naturals	CAMPHOR (NATURAL); MENTHOL	2; 6	g/100g; g/100g			N	20241231
83112-071_f437618b-43f9-673d-e053-2a95a90ad7ad	83112-071	HUMAN PRESCRIPTION DRUG	Isoniazid 300 mg		Isoniazid	TABLET	ORAL	20230201		ANDA	ANDA080936	Health Department, Oklahoma State	ISONIAZID	300	mg/1	Antimycobacterial [EPC]		N	20241231
83112-584_f0fdb14b-e4fc-707e-e053-2a95a90a9049	83112-584	HUMAN PRESCRIPTION DRUG	Cefixime 400 mg UD		Cefixime	CAPSULE	ORAL	20230101		ANDA	ANDA210574	Health Department, Oklahoma State	CEFIXIME	400	mg/1	Cephalosporin Antibacterial [EPC], Cephalosporins [CS]		N	20241231
83112-985_f437d2a5-75dc-078d-e053-2995a90aab42	83112-985	HUMAN PRESCRIPTION DRUG	Doxycycline Hyclate		Doxycycline Hyclate	CAPSULE	ORAL	20230201		ANDA	ANDA062500	Health Department, Oklahoma State	DOXYCYCLINE HYCLATE	100	mg/1	Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
83117-003_f8aaf064-0ab1-206c-e053-6294a90a77c7	83117-003	HUMAN OTC DRUG	Biogram Anti Hair Loss Ampoule		Stem Cell Germinal Fluid	POWDER, FOR SOLUTION	TOPICAL	20221120		UNAPPROVED DRUG OTHER		Beijing Xinghui Regeneration Technology Co., LTD.	ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STEM CELLS (MSCS) EXOSOMES	15	mg/3mL			N	20241231
83117-005_f8ab1161-ee22-e62a-e053-6394a90a35cb	83117-005	HUMAN OTC DRUG	Hairstem Cell Exosomes		Stem Cell Germinal Fluid	POWDER, FOR SOLUTION	TOPICAL	20221223		UNAPPROVED DRUG OTHER		Beijing Xinghui Regeneration Technology Co., LTD.	ALLOGENEIC HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS	15	mg/3mL			N	20241231
83117-006_00f73071-8930-7a73-e063-6294a90a981c	83117-006	HUMAN OTC DRUG	XINGHUI Cell Exosome		STEM CELL EXOSOME WOUND HEALING FLUID	POWDER, FOR SOLUTION	TOPICAL	20230703		UNAPPROVED DRUG OTHER		Beijing Xinghui Regeneration Technology Co., LTD.	ALLOGENIC ADIPOSE DERIVED MESENCHYMAL STEM CELLS (MSCS) EXOSOMES	15	mg/3mL			N	20241231
83118-010_08f90edd-ef6e-1d69-e063-6394a90ad85b	83118-010	HUMAN OTC DRUG	Non-proprietary name		Alcohol Prep Pad	SWAB	TOPICAL	20221201		OTC MONOGRAPH DRUG	M003	Guangzhou Four E's Scientific Co., Ltd.	ISOPROPYL ALCOHOL	.8	g/1			N	20241231
83118-015_08f90315-88fc-4662-e063-6394a90aab31	83118-015	HUMAN OTC DRUG	Non-proprietary name		Alcohol Prep Pad	SWAB	TOPICAL	20221201		OTC MONOGRAPH DRUG	M003	Guangzhou Four E's Scientific Co., Ltd.	ISOPROPYL ALCOHOL	1.59	g/1			N	20241231
83119-126_09dfe59d-b0b3-4c16-96cc-1c7f840441fa	83119-126	HUMAN OTC DRUG	MeO UV Clear Sunscreen		Titanium Dioxide	LOTION	TOPICAL	20221128		OTC MONOGRAPH DRUG	M020.10	Sage Pharmaceuticals Inc	TITANIUM DIOXIDE	11.3	g/100mL			N	20241231
83119-243_49182a1f-67d4-4293-8101-4493b6d4b8c7	83119-243	HUMAN OTC DRUG	UNID Physical Sun		Titanium Dioxide	LOTION	TOPICAL	20221128		OTC MONOGRAPH DRUG	M020.10	Sage Pharmaceuticals Inc	TITANIUM DIOXIDE	11.3	g/100mL			N	20241231
83120-378_0976eff9-48c6-1669-e063-6394a90a8240	83120-378	HUMAN OTC DRUG	SECONDARY NUMB Lidocaine Phenylephrine Gel		LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE	GEL	TOPICAL	20221010		OTC MONOGRAPH DRUG	M015	LALANI Rx Consulting, Inc.	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	50; 2.5	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
83123-0012_f2650b0c-19ef-6f2e-e053-2995a90aaddb	83123-0012	HUMAN OTC DRUG	HYDROGEN PEROXIDE		HYDROGEN PEROXIDE	LIQUID	TOPICAL	20230116		OTC MONOGRAPH NOT FINAL	part356	BROSANT GROUP LLC	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
83123-0019_f27d1790-fbc9-5964-e053-2995a90a9898	83123-0019	HUMAN OTC DRUG	ISOPROPYL ALCOHOL		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20230117		OTC MONOGRAPH NOT FINAL	part333E	BROSANT GROUP LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83124-002_fbe62904-3d22-3197-e053-6394a90a9540	83124-002	HUMAN OTC DRUG	TXL Active Wart Remover Pads		Wart Remover Pads	PATCH	TOPICAL	20230516		OTC MONOGRAPH FINAL	M028	Kairos Trading Inc	SALICYLIC ACID	40	mg/100g			N	20241231
83124-003_fbe6de4f-a0df-7a51-e053-6394a90a22fc	83124-003	HUMAN OTC DRUG	TXL Active Wart Remover Pads		Wart Remover Pads	PATCH	TOPICAL	20230516		OTC MONOGRAPH FINAL	M028	Kairos Trading Inc	SALICYLIC ACID	40	g/1001			N	20241231
83127-101_0bcb2b81-a1e3-dd30-e063-6394a90ab829	83127-101	HUMAN OTC DRUG	ARAMORE MULTI-DEFENSE SUNSCREEN - AM	BROAD SPECTRUM SPF 30	ZINC OXIDE	LOTION	TOPICAL	20221209		OTC MONOGRAPH DRUG	M020	New Frontier Bio, Inc	ZINC OXIDE	20	g/100mL			N	20241231
83133-010_f2e4e473-2d5d-417b-a0ed-f35cddb3c32e	83133-010	HUMAN OTC DRUG	HL Joint100 for Joint and Cartilage		PUNICA GRANATUM FRUIT, EUCOMMIA ULMOIDES BARK, ACHYRANTHES JAPONICA ROOT	TABLET	ORAL	20221101		UNAPPROVED DRUG OTHER		HLSCIENCE CO.,LTD	ACHYRANTHES JAPONICA ROOT; EUCOMMIA ULMOIDES BARK; POMEGRANATE	50; 200; 250	mg/1; mg/1; mg/1			N	20241231
83135-001_f2f3e25c-e005-cc20-e053-2a95a90a7569	83135-001	HUMAN OTC DRUG	Intelliwrist Personal Hand Sanitizer		Topical Antiseptic	LIQUID	TOPICAL	20221130		OTC MONOGRAPH NOT FINAL	part333A	Intelwrist, LLC	ALCOHOL	28	mL/40mL			N	20241231
83136-101_fcc19814-4c1a-a757-e053-6294a90a02d7	83136-101	HUMAN OTC DRUG	Diclofenac Sodium Gel		Diclofenac Sodium Gel	GEL	TOPICAL	20230528		ANDA	ANDA211253	Galloping LLC	DICLOFENAC	10	mg/g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83139-175_f61d3ae0-11ec-2a82-e053-2995a90a95da	83139-175	HUMAN OTC DRUG	GUAIFENESIN - ODAAT	1200 MG	GUAIFENESIN	TABLET	ORAL	20230304		ANDA	ANDA213420	LODAAT LLC	GUAIFENESIN	1200	mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]		N	20241231
83139-372_5b92f4e4-ab6b-4195-9a80-69d36ae40f0f	83139-372	HUMAN OTC DRUG	Aspirin	Enteric Coated	Aspirin 81 mg	TABLET	ORAL	20230131		OTC MONOGRAPH DRUG	M013	Lodaat LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
83140-373_0976e636-18dc-0818-e063-6294a90adeb8	83140-373	HUMAN OTC DRUG	MIAMI MD SUN SHIELD Broad Spectrum SPF 40		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20221205		OTC MONOGRAPH DRUG	M020	BRAND BOLT LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 60	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83142-005_08aad0f9-dd98-dfeb-e063-6294a90a7432	83142-005	HUMAN OTC DRUG	Dirteeze Rough and smooth heavy duty antiseptic hand sanitizer wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20221130		OTC MONOGRAPH DRUG	505G(a)(3)	Yourlink Ltd	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
83146-003_07131644-0196-8510-e063-6294a90acd0f	83146-003	HUMAN PRESCRIPTION DRUG	Keylosa		Multivitamin	CAPSULE, COATED	ORAL	20231006		UNAPPROVED DRUG OTHER		Novian Pharmaceuticals	.ALPHA.-TOCOPHEROL; ASCORBIC ACID; CALCIUM CARBONATE; CHOLECALCIFEROL; CHROMIUM; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; MAGNESIUM OXIDE; MANGANESE SULFATE; MOLYBDENUM; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; VITAMIN A; ZINC OXIDE	30; 120; 200; 20; 35; 8; 27; 1000; 200; 23; 45; 20; 20; 3.4; 55; 3; 1500; 25	mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1	Allergens [CS], Analogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]		N	20241231
83148-012_0aab5067-a87e-857f-e063-6394a90a1f8c	83148-012	HUMAN PRESCRIPTION DRUG	Hydrocortisone Butyrate		Hydrocortisone Butyrate	LOTION	TOPICAL	20231106		ANDA	ANDA209556	The J. Molner Company LLC	HYDROCORTISONE BUTYRATE	1	mg/mL	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
83149-000_089fd765-c6ae-07e7-e063-6294a90a519e	83149-000	HUMAN OTC DRUG	Wellcare Sunstick Lip Balm		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20221215		OTC MONOGRAPH DRUG	M020	BAMKO, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	5; 50; 22; 30	mg/g; mg/g; mg/g; mg/g			N	20241231
83149-001_089fd765-c6ae-07e7-e063-6294a90a519e	83149-001	HUMAN OTC DRUG	Wellcare Sunstick Sunscreen Stick		AVOBENZONE, OCTINOXATE, OCTOCRYLENE, OCTISALATE	STICK	TOPICAL	20221215		OTC MONOGRAPH DRUG	M020	BAMKO, LLC	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	25; 75; 50; 100	mg/g; mg/g; mg/g; mg/g			N	20241231
83153-301_fe2709ae-4e92-a705-e053-6394a90a786f	83153-301	HUMAN OTC DRUG	DR.K CELL REPAIR GENIC AMPOULE		Prunus Yedoensis Sprout Cell Extract, Acetyl Hexapeptide-8, Tetrapeptide-51, Palmitoyl Pentapeptide-4, Nonapeptide-1	SOLUTION	TOPICAL	20230615		UNAPPROVED DRUG OTHER		Noblesse Korea Co., Ltd.	ACETYL HEXAPEPTIDE-8; ALANINE; NONAPEPTIDE-1; PALMITOYL PENTAPEPTIDE-4; PRUNUS X YEDOENSIS FLOWER	80.5; 50; 10; 30; 100	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Amino Acid [EPC], Amino Acids [CS]		N	20241231
83154-001_f16d7bda-2ed1-159e-e053-2995a90a8b61	83154-001	HUMAN OTC DRUG	ELROEL Pang Pang Big Sun Cushion S7		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate, Bemotrizinol	CREAM	TOPICAL	20230104		OTC MONOGRAPH NOT FINAL	part352	MONOGLOT HOLDINGS Inc.	BEMOTRIZINOL; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	2.5; 7; 3; 1.52; 9.7	g/100g; g/100g; g/100g; g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83154-002_f16d82ce-2341-5870-e053-2a95a90ad276	83154-002	HUMAN OTC DRUG	ELROEL Pang Pang Mini Sun Cushion S7		Zinc Oxide, Titanium Dioxide, Octinoxate, Octisalate, Bemotrizinol	CREAM	TOPICAL	20230104		OTC MONOGRAPH NOT FINAL	part352	MONOGLOT HOLDINGS Inc.	BEMOTRIZINOL; OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	2.5; 7; 3; 1.52; 9.7	g/100g; g/100g; g/100g; g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83158-387_0976edf3-b97e-fff9-e063-6294a90a2c4e	83158-387	HUMAN OTC DRUG	BRONSON SOOTHE Pain Relief		CAPSAICIN	CREAM	TOPICAL	20221226		OTC MONOGRAPH DRUG	M017	BRONSON NUTRITIONALS, LLC	CAPSAICIN	.25	mg/mL			N	20241231
83163-386_0976ef49-eccc-1b67-e063-6294a90a4ec6	83163-386	HUMAN OTC DRUG	WAXUP Numbing		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M015	CONSTRUSOLUTION, LLC	LIDOCAINE HYDROCHLORIDE	50	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83164-000_f2f3ca46-f096-a87a-e053-2995a90ab2be	83164-000	HUMAN OTC DRUG	DORMMY-LON		DIPHENHYDRAMINE HYDROCHLORIDE	TABLET	ORAL	20230104		OTC MONOGRAPH FINAL	M010	Haendel Farma, S.A. de C.V.	DIPHENHYDRAMINE HYDROCHLORIDE	25	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
83165-000_09ce7e86-3b8f-8e30-e063-6394a90a2d55	83165-000	HUMAN OTC DRUG	Antiseptic Hand Sanitizer		ALCOHOL	LIQUID	TOPICAL	20230107		OTC MONOGRAPH DRUG	505G(a)(3)	Hubei Fanjian Medical Product Co.,Ltd	ALCOHOL	62	mL/100mL			N	20241231
83165-001_09ce88fa-a043-9708-e063-6394a90a5d44	83165-001	HUMAN OTC DRUG	Alcohol Cleansing Wipe		ALCOHOL	CLOTH	TOPICAL	20230114		OTC MONOGRAPH DRUG	505G(a)(3)	Hubei Fanjian Medical Product Co.,Ltd	ALCOHOL	.7	mL/mL			N	20241231
83165-002_09ce7749-d5d6-8dc4-e063-6394a90a5296	83165-002	HUMAN OTC DRUG	Antiseptic Wipe		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20230114		OTC MONOGRAPH DRUG	505G(a)(3)	Hubei Fanjian Medical Product Co.,Ltd	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
83165-003_09ce9190-e6f8-81b9-e063-6394a90a4f2d	83165-003	HUMAN OTC DRUG	Insect Sting Relief		BENZOCAINE, ALCOHOL	CLOTH	TOPICAL	20230114		OTC MONOGRAPH DRUG	M017	Hubei Fanjian Medical Product Co.,Ltd	ALCOHOL; BENZOCAINE	600; 60	mg/mL; mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83165-004_09ce75b1-648c-98bf-e063-6294a90acb4a	83165-004	HUMAN OTC DRUG	First Aid Antiseptic Pain Relieving Cream		BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20230101		OTC MONOGRAPH DRUG	505G(a)(3)	Hubei Fanjian Medical Product Co.,Ltd	BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE	1.3; 5	mg/g; mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83165-005_09ce7749-d5e6-8dc4-e063-6394a90a5296	83165-005	HUMAN OTC DRUG	First Aid Antibiotic		BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	LIQUID	TOPICAL	20230101		OTC MONOGRAPH DRUG	M004	Hubei Fanjian Medical Product Co.,Ltd	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; 3.5; 5000	U/g; mg/g; U/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
83170-101_0dd94e3b-8a97-d0cf-e063-6394a90aef16	83170-101	HUMAN OTC DRUG	Alcohol Pad		Alcohol	CLOTH	TOPICAL	20221220		OTC MONOGRAPH DRUG	M003	Hua Jing Medical Supplies INC.	ALCOHOL	75	mL/100mL			N	20241231
83171-001_0b6e48cf-97f0-106d-e063-6394a90aa91d	83171-001	HUMAN OTC DRUG	Clear as Day SPF46		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	GEL	TOPICAL	20220602		OTC MONOGRAPH DRUG	M020	Starface World, Inc.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83171-002_0b6e4bad-985c-1109-e063-6394a90a1331	83171-002	HUMAN OTC DRUG	Super-Sulfur Magic Mask		SULFUR	PASTE	TOPICAL	20220727		OTC MONOGRAPH DRUG	M006	Starface World, Inc.	SULFUR	100	mg/mL			N	20241231
83173-111_f59d7dfb-6e74-4687-e053-2a95a90aac4a	83173-111	HUMAN OTC DRUG	MGC Health		Cough Drops Cherry	TABLET, CHEWABLE, EXTENDED RELEASE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	5.8	mg/2850mg			N	20241231
83173-112_fc867c5c-80bb-e97b-e053-6394a90ae434	83173-112	HUMAN OTC DRUG	MGC Health		Cough Drops Menthol	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	5.4	mg/1			N	20241231
83173-113_fc8655fa-437d-a00e-e053-6394a90a5efb	83173-113	HUMAN OTC DRUG	MGC Health		Cough Drops Menthol Sugar-Free	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	5.4	mg/1			N	20241231
83173-114_fc86b98e-d554-4769-e053-6394a90afc6e	83173-114	HUMAN OTC DRUG	MGC Health		Cough Drops Honey	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	7.5	mg/1			N	20241231
83173-115_fc866102-a930-8fc0-e053-6294a90a8ba6	83173-115	HUMAN OTC DRUG	MGC Health		Cough Drops Honey Sugar-Free	LOZENGE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	7.6	mg/1			N	20241231
83173-116_f59d88a4-c41c-0829-e053-2a95a90ae1ec	83173-116	HUMAN OTC DRUG	MGC Health		Cough Drops Assorted Citrus Vitamin C	TABLET, CHEWABLE, EXTENDED RELEASE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	2.7	mg/2850mg			N	20241231
83173-117_f59d88a4-c41d-0829-e053-2a95a90ae1ec	83173-117	HUMAN OTC DRUG	MGC Health		Cough Drops Assorted Citrus Vitamin C Sugar-Free	TABLET, CHEWABLE, EXTENDED RELEASE	ORAL	20230212		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	2.7	mg/2850mg			N	20241231
83173-126_ff99c57a-e06b-69d3-e053-6394a90a6775	83173-126	HUMAN OTC DRUG	MGC Health		Cough Drops Assorted Citrus Vitamin C	LOZENGE	ORAL	20230701		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	2.7	mg/1			N	20241231
83173-127_043aea38-b0ee-e395-e063-6394a90a7599	83173-127	HUMAN OTC DRUG	MGC Health		Cough Drops Black Cherry Sugar Free	LOZENGE	ORAL	20230901		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	5.8	mg/1			N	20241231
83173-128_0439a5bb-f27b-988e-e063-6394a90a3eff	83173-128	HUMAN OTC DRUG	MGC Health		Cough Drops Vanilla Honey	LOZENGE	ORAL	20230901		OTC MONOGRAPH FINAL	part341	Medical Group Care LLC	MENTHOL	2.5	mg/1			N	20241231
83173-129_043a110b-ea70-37f4-e063-6394a90af086	83173-129	HUMAN OTC DRUG	MGC Health		Cough Drops Creamy Strawberry	LOZENGE	ORAL	20230901		OTC MONOGRAPH NOT FINAL	part356	Medical Group Care LLC	MENTHOL; PECTIN	2.5; 7	mg/1; mg/1			N	20241231
83174-613_fe55a768-b96d-48fb-a61e-47418827a137	83174-613	HUMAN OTC DRUG	Easyfast		Acetaminophen	CAPSULE	ORAL	20230401		OTC MONOGRAPH NOT FINAL	part343	Easyfast Supplements LLC	ACETAMINOPHEN	500	mg/1			N	20241231
83175-232_7d3bce6f-606f-4028-bae4-59c98d452cd7	83175-232	HUMAN OTC DRUG	DR. BARBARA STURM MOLECULAR COSMETICS SPF 50 sunscreen		Homosalate, Octinoxate, Octisalate, Avobenzone	LIQUID	TOPICAL	20230102		OTC MONOGRAPH FINAL	part352	Barbara Sturm Molecular Cosmetics GmbH	AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTISALATE	3; 10; 7.5; 5	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83176-002_f2d63739-eb8b-12ab-e053-2a95a90adb97	83176-002	HUMAN OTC DRUG	OHEAL ARTHRITIS PAIN RELIEF cream		ARTHRITIS PAIN RELIEF cream	CREAM	TOPICAL	20230122		OTC MONOGRAPH NOT FINAL	part348	Dr.luke Healthcare LLC	MENTHOL	3	mg/100mL			N	20241231
83176-003_f2d7294b-a299-b012-e053-2995a90a343b	83176-003	HUMAN OTC DRUG	DR.Luke SCIATICA AND NEUROPATHY PAIN RELIEF Cream		SCIATICA AND NEUROPATHY PAIN RELIEF Cream	CREAM	TOPICAL	20230122		OTC MONOGRAPH NOT FINAL	part348	Dr.luke Healthcare LLC	MENTHOL	3	mg/100mL			N	20241231
83176-004_f684c4e3-f61a-b5f1-e053-2a95a90a1e9e	83176-004	HUMAN OTC DRUG	OHEAL SHINGLES PAIN RELIEF Cream		SHINGLES PAIN RELIEF Cream	CREAM	TOPICAL	20230310		OTC MONOGRAPH NOT FINAL	part348	Dr.luke Healthcare LLC	MENTHOL	3	mg/100mL			N	20241231
83176-005_f802c75b-eaa6-4808-e053-6294a90ae3bb	83176-005	HUMAN OTC DRUG	Pureskin Liquid Wart Corn Removal Mask		Liquid Wart Corn Removal Mask	PASTE	TOPICAL	20230328		OTC MONOGRAPH FINAL	M028	Dr.luke Healthcare LLC	SALICYLIC ACID	1	g/100g			N	20241231
83176-006_f8cc5335-fe25-7e63-e053-6294a90ad42a	83176-006	HUMAN OTC DRUG	Dr. Luke Fungal Nail Renewal		Fungal Nail Renewal	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	M005	Dr.luke Healthcare LLC	TOLNAFTATE	1	mg/100mL			N	20241231
83176-008_f99dd6bb-ff19-a50d-e053-6294a90ae53c	83176-008	HUMAN OTC DRUG	Dr. Luke Molluscum Wart Remover		Molluscum Wart Remover	LIQUID	TOPICAL	20230417		OTC MONOGRAPH FINAL	M028	Dr.luke Healthcare LLC	CHLORHEXIDINE; SALICYLIC ACID	1; 1	mg/100mL; mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
83176-009_fd0a1f0f-06ab-8cd7-e053-6394a90ab7b6	83176-009	HUMAN OTC DRUG	Oheal Ringworm Cream		Ringworm Cream	CREAM	TOPICAL	20230531		OTC MONOGRAPH FINAL	M005	Dr.luke Healthcare LLC	CLOTRIMAZOLE	1	g/100g	Azole Antifungal [EPC], Azoles [CS]		N	20241231
83176-011_ff140a57-8ea7-d7a4-e053-6394a90a3c5e	83176-011	HUMAN OTC DRUG	Oheal Manuka Honey Eczema Cream		Manuka Honey Eczema Cream	CREAM	TOPICAL	20230610		OTC MONOGRAPH FINAL	M005	Dr.luke Healthcare LLC	CLOTRIMAZOLE	1	g/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
83176-012_ff52921a-8dbb-0613-e053-6294a90ae7fd	83176-012	HUMAN OTC DRUG	Oheal Tattoo Numbing Cream		Tattoo Numbing Cream	CREAM	TOPICAL	20230629		OTC MONOGRAPH FINAL	M016	Dr.luke Healthcare LLC	LIDOCAINE	4	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83176-013_028bfd58-f398-55b3-e063-6294a90abfef	83176-013	HUMAN OTC DRUG	DR. LUKE WART REMOVER		WART REMOVER	LIQUID	TOPICAL	20230809		OTC MONOGRAPH FINAL	M005	Dr.luke Healthcare LLC	CHLORHEXIDINE ACETATE; SALICYLIC ACID	1; 1	mg/100mL; mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
83178-101_0befdbae-25f8-261d-e063-6394a90aacd4	83178-101	HUMAN OTC DRUG	Buddle Diaper Rash Rescue Healing		White petrolatum, zinc oxide	PASTE	TOPICAL	20231201		OTC MONOGRAPH DRUG	M016	The Goodsprout Company LLC	WHITE PETROLATUM; ZINC OXIDE	50.7; 40	g/100g; g/100g			N	20241231
83178-102_0befd4fd-6807-1928-e063-6394a90a129b	83178-102	HUMAN OTC DRUG	Buddle Bottom Buddy Diaper Cream		Zinc oxide	CREAM	TOPICAL	20231207		OTC MONOGRAPH DRUG	M016	The Goodsprout Company LLC	ZINC OXIDE	20	g/100g			N	20241231
83179-001_f4969ceb-6bdc-e619-e053-2995a90a6d3c	83179-001	HUMAN OTC DRUG	Jinglinzi ethanol disinfectant		Ethanol	LIQUID	TOPICAL	20230214		OTC MONOGRAPH NOT FINAL	part333A	Shaoyang Jinglinzi Biotechnology Co., Ltd	ALCOHOL; HYDROGEN PEROXIDE	70; 400	mL/100mL; mg/100mL			N	20241231
83179-002_f4a47167-c30d-eb81-e053-2995a90a5dd4	83179-002	HUMAN OTC DRUG	Jinlingzi disinfectant		quatenary ammonium salt	LIQUID	TOPICAL	20230214		UNAPPROVED DRUG OTHER		Shaoyang Jinglinzi Biotechnology Co., Ltd	BENZALKONIUM CHLORIDE	.25	g/100mL			N	20241231
83181-2650_f32e83ac-23d8-a9fd-e053-2995a90af931	83181-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	DERM ASSO. MID OHIO	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83182-2650_f32e9965-9ca3-0df9-e053-2995a90a7ee7	83182-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	THE SKIN CLINIC L L C	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83183-0650_fa6baf95-6226-9c59-e053-6294a90aaa36	83183-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	ADAM S. NALLY, DO, P.C	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83183-2650_f32e0a47-2374-1d3b-e053-2995a90a5ae7	83183-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20220801		OTC MONOGRAPH NOT FINAL	part352	ADAM S. NALLY, DO, P.C.	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83186-001_f6c3eb88-48e2-0713-e053-6294a90a312a	83186-001	HUMAN OTC DRUG	Air Purifying Agent		Air Purifying Agent	GEL	TOPICAL	20201130		UNAPPROVED HOMEOPATHIC		Jiangsu Shenying Information Technology Co. Ltd.	WORMWOOD OIL	100	g/250mL			N	20241231
83187-144_d7477910-b44a-4e9d-afb5-230fd47a5fe7	83187-144	HUMAN OTC DRUG	Beach BB Scalp and Hair Protect Mist SPf30		Avobenzone, Homosalate, Octisalate, and Octocrylene	SPRAY	CUTANEOUS	20230501		OTC MONOGRAPH NOT FINAL	part352	Demert Brands, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 4	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83188-405_0b62d440-4402-3e5c-e063-6394a90abddb	83188-405	HUMAN OTC DRUG	Foamy Blue		Benzalkonium Chloride	SOLUTION	TOPICAL	20230210		OTC MONOGRAPH DRUG	505G(a)(3)	Pro Chem Solutions, Inc.	BENZALKONIUM CHLORIDE	1	mg/mL			N	20241231
83191-001_f71ec778-e308-7fd9-e053-6394a90af31d	83191-001	HUMAN OTC DRUG	Level Select Menthol Camphor Muscle Rub		10% Menthol, 5% Camphor Muscle Rub Lotion	LOTION	TOPICAL	20230213		OTC MONOGRAPH NOT FINAL	part348	Kandenwood LLC	CAMPHOR (SYNTHETIC); MENTHOL	5; 10	g/100g; g/100g			N	20241231
83191-004_f7a76b91-fc13-3866-e053-6294a90ad409	83191-004	HUMAN OTC DRUG	Level Select Menthol Camphor Patch		10% Menthol, 5% Camphor Patch	PATCH	TOPICAL	20230119		OTC MONOGRAPH NOT FINAL	part348	Kadenwood LLC	CAMPHOR (SYNTHETIC); MENTHOL	5; 10	mg/100mg; mg/100mg			N	20241231
83193-010_3be63bff-52a9-44a4-a808-9cdab0302d74	83193-010	HUMAN OTC DRUG	QFORET BORN TO GROW		Menthol, Salicylic Acid, Panthenol	SHAMPOO	TOPICAL	20221201		UNAPPROVED DRUG OTHER		QGENETICS CO.,LTD.	MENTHOL; PANTHENOL; SALICYLIC ACID	1.5; .95; 1.25	g/500mL; g/500mL; g/500mL			N	20241231
83193-020_9dbc8c59-fcf1-4129-80be-d6acf7955d0d	83193-020	HUMAN OTC DRUG	QFORET BORN TO GROW TREATMENT		Menthol, Salicylic Acid, Panthenol	LIQUID	TOPICAL	20221201		UNAPPROVED DRUG OTHER		QGENETICS CO.,LTD.	MENTHOL; PANTHENOL; SALICYLIC ACID	.75; .47; .62	g/250mL; g/250mL; g/250mL			N	20241231
83193-030_755a2dcf-33aa-457f-bad7-72e5b4242708	83193-030	HUMAN OTC DRUG	QFORET SHARON TOOTHPASTE		Sodium Monofluorophosphate, Silica, Alcloxa	PASTE, DENTIFRICE	ORAL	20230501		UNAPPROVED DRUG OTHER		QGENETICS CO.,LTD.	ALCLOXA; SILICON DIOXIDE; SODIUM MONOFLUOROPHOSPHATE	.11; 15; .758	g/100g; g/100g; g/100g			N	20241231
83194-0650_f32d54a6-c3ae-6490-e053-2995a90a768a	83194-0650	HUMAN OTC DRUG	Ti Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	THE SKIN APOTHECARY LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83195-2650_f32d66b0-e3b8-8fef-e053-2995a90ad28c	83195-2650	HUMAN OTC DRUG	Protect Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	MARTIN GREGORY DDS LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83196-676_dbdcf089-c36b-4b90-9bbb-e3b07851fc6b	83196-676	HUMAN OTC DRUG	Shaant Pore Purifying Face Scrub		SALICYLIC ACID	CREAM	TOPICAL	20230714		OTC MONOGRAPH FINAL	part333D	Codex Labs Corporation	SALICYLIC ACID	2	g/100g			N	20241231
83196-690_52a1af4b-53b3-47f0-8617-496e5cfa1aa2	83196-690	HUMAN OTC DRUG	Shaant Spot Hero Drying Acne Treatment		Sulfur	GEL	TOPICAL	20230515		OTC MONOGRAPH FINAL	part333D	Codex Labs Corporation	SULFUR	50	mg/mL			N	20241231
83196-785_77863e51-c6e4-41db-b1b2-c71013719d10	83196-785	HUMAN OTC DRUG	Shaant Hydrating Body Scrub		Salicylic Acid	CREAM	TOPICAL	20230714		OTC MONOGRAPH FINAL	part333D	Codex Labs Corporation	SALICYLIC ACID	2	g/100g			N	20241231
83199-100_6bbf20b1-68a4-4846-9604-3216dbf036c0	83199-100	HUMAN OTC DRUG	Everest		Stannous Fluoride	RINSE	DENTAL	20200724		OTC MONOGRAPH FINAL	part355	Alpine Dental, Inc.	STANNOUS FLUORIDE	.63	mg/100mL			N	20241231
83199-101_09de2b97-8ec4-4cec-bc14-7f62e9767637	83199-101	HUMAN OTC DRUG	Everest		Stannous Fluoride	RINSE	DENTAL	20220819		OTC MONOGRAPH FINAL	part355	Alpine Dental, Inc.	STANNOUS FLUORIDE	.63	mg/100mL			N	20241231
83199-102_ad1826fa-f665-473c-aaca-79cf9921914f	83199-102	HUMAN OTC DRUG	Evernamel		Stannous Fluoride	PASTE, DENTIFRICE	DENTAL	20230123		OTC MONOGRAPH NOT FINAL	part356	Alpine Dental, Inc.	STANNOUS FLUORIDE	.454	mg/100g			N	20241231
83200-0650_f31d5e85-7364-3523-e053-2995a90a7897	83200-0650	HUMAN OTC DRUG	Antioxidant Tinted Mineral Sunscreen Broad Spectrum SPF30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Skinhealth Studios LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83201-002_0d385aa4-0521-b4c5-e063-6294a90a65f8	83201-002	HUMAN OTC DRUG	Eye Love Heyedrate Long Lasting Hydration		Glycerin, Povidone	SOLUTION/ DROPS	OPHTHALMIC	20230208		OTC MONOGRAPH DRUG	M018	Physician Recommended Neutraceuticals, L.P.	GLYCERIN; POVIDONE	.63; .25	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83202-1405_f5007862-99e0-d666-e053-2995a90ade0f	83202-1405	HUMAN OTC DRUG	IBSIBD NO 180 Start (Helps improve intestinal healthy and immunity, Lettuce and Soybean fermented powder)		Nitric Oxide, Vitamin D3, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	500	mg/500mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-1469_f6196a87-0798-b6cd-e053-2995a90a5483	83202-1469	HUMAN OTC DRUG	NO MORE DRIP FOR NOSE COMFORT (Relieves nasal congestion, sinus congestion, rehydrate nasal passages, allergy relief, concentrated lettuce fermentation)		Ntric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	10	mg/20mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-1583_f5178bda-69c2-6773-e053-2a95a90a30f9	83202-1583	HUMAN OTC DRUG	Dr. GNO Deep Moisturizing Essence (Brightening, Wrinckle care, and Moisturizing effect, Acne Treatment, Fermented Cabbage Extract, Mesoporous Silica Nanoparticle, Zinc, Gold)		Nitric Oxide, Niacinamide, Adenosine, Zinc	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	40	mg/50mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-1766_f515d306-37aa-669b-e053-2a95a90a8134	83202-1766	HUMAN OTC DRUG	Top NO Doctors (Helps improve matabolic disorder, Bean sprout powder)		Nitric Oxide, Zinc, Glutathione	TABLET	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/500mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-1857_f516c9d4-ae4b-4cae-e053-2a95a90aaf33	83202-1857	HUMAN OTC DRUG	Dr. GNO Refreshing Mist (For skin care, and dry skin, safe to use it in the eye, Acne treatment, Fermented Sunflower seed Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	50	mg/100mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-2139_f6197c69-28b7-150e-e053-2995a90a7645	83202-2139	HUMAN OTC DRUG	Dr. GNO CLEANSER (Helps cleanse sensitive skin, clears skin troubles, especially acne, fermented cabbage extract, mesoporous silica nanoparticle, zinc)		Nitric Oxide, Zinc	SOAP	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	50	mg/100mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-2149_f619415c-3051-8d76-e053-2a95a90a57a6	83202-2149	HUMAN OTC DRUG	Dr. GNO All Care 500 (Brightening, Wrinckle care, and Moisturizing effect, Pain relief, Acne Treatment, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	400	mg/500mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-2278_f501d8c1-349b-10a0-e053-2995a90a05e5	83202-2278	HUMAN OTC DRUG	NO more Eye Pain (Relieves dryness of the eye, Protects against irritaion of the eye) redness of the eye, Concentrated Cabbage fermentation solubles)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	5	mg/10mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-2288_f515efa4-34ba-6414-e053-2995a90a79ce	83202-2288	HUMAN OTC DRUG	NO Care (Helps improve matabolic disorder, Lettuce fermented powder)		Nitric Oxide, Zinc, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/400mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-2349_f619a63e-b011-0d1d-e053-2a95a90a4f8a	83202-2349	HUMAN OTC DRUG	Dr. GNO Deep Moisturizing Mist (Brightening, Wrinckle care, and Moisturizing effect, Acne Treatment, Fermented Cabbage Extract, Mesoporous Silica Nanoparticle, Zinc, Gold)		Nitric Oxide, Niacinamide, Adenosine, Zinc	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	12	mg/120mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-2922_f516dad6-4676-1807-e053-2995a90a16b6	83202-2922	HUMAN OTC DRUG	Dr. GNO Essence (Brightening, Wrinckle care, and Moisturizing effect, Acne treatment, Fermented Lettuce Extract)		Nitric Oxide, Niacinamide, Adenosine	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	10	mg/50mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-2952_f5172c98-9831-2254-e053-2995a90ab319	83202-2952	HUMAN OTC DRUG	Dr. GNO Recovery Oil (Brightening, Wrinckle care, and Moisturizing effect, Acne Treatment, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	8	mg/10mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-3285_f500e0bf-85c0-b8ad-e053-2995a90af8df	83202-3285	HUMAN OTC DRUG	Bio NO Pharm V (Helps improve metabolic disorder and immunity, Lettuce fermented powder)		Nitric Oxide, Vitamin D3, Zinc	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/350mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-3585_f619b829-1c72-72db-e053-2a95a90afa79	83202-3585	HUMAN OTC DRUG	Dr. GNO Deep Moisturizing Cream (Brightening, Wrinckle care, and Moisturizing effect, Acne Treatment, Fermented Cabbage Extract, Mesoporous Silica Nanoparticle, Zinc, Gold)		Nitric Oxide, Niacinamide, Adenosine, Zinc	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	30	mg/50mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-3751_f5160d3d-4cbe-36af-e053-2995a90a6d7c	83202-3751	HUMAN OTC DRUG	OIC Premium NO 365 (Helps improve matabolic disorder, Bean sprout powder)		Nitric Oxide, Zinc, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/400mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-5147_f51751ff-fab0-aaf1-e053-2995a90a5a8e	83202-5147	HUMAN OTC DRUG	Dr. GNO All Care 200 (Brightening, Wrinckle care, and Moisturizing effect, Pain relief, Acne Treatment, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/200mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-5578_f501a52b-dfe6-7eec-e053-2a95a90aeb06	83202-5578	HUMAN OTC DRUG	Hexalong NO (Helps hematopoiesis and immunity, Hexalong fermented powder)		Nitric Oxide, Zinc, Vitamin D3	TABLET	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/500mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-5785_f5013dd0-b13f-bd06-e053-2995a90ad6a5	83202-5785	HUMAN OTC DRUG	Bio NO more Menopause (Helps improve menopouse and Immunity, Soybean fermented powder)		Nitric Oxide, Sophoricoside, Zinc	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/480mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-5813_f517ccea-7966-9866-e053-2995a90a40a7	83202-5813	HUMAN OTC DRUG	Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)		Nitric Oxide, Vitamin D3, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	400	mg/500mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6255_f5017a0c-5267-228f-e053-2a95a90a85c1	83202-6255	HUMAN OTC DRUG	NO Happy Dream (Helps improve sleep, lettuce and chamomile fermented powder)		Nitric Oxide, Vitamin D3, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/420mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6447_f7768469-bf4f-7fe0-e053-6294a90aee1c	83202-6447	HUMAN OTC DRUG	Bio NO more Yeast infection (Helps improve vaginal yeast infection, fermented Cabbage powder)		Nitric Oxide, Vitamin D3, Glutathione	TABLET	TOPICAL	20230321	20240320	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/900mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6487_f51734d7-16df-27f6-e053-2995a90a3dcb	83202-6487	HUMAN OTC DRUG	Dr. GNO All-Care 50 (Brightening, Wrinckle care, and Moisturizing effect, Pain relief, Acne Treatment, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	40	mg/50mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6518_f517b631-6fce-f23a-e053-2a95a90abe9b	83202-6518	HUMAN OTC DRUG	Dr. NO II (Wound recovery, Burn wound recovery, Acne Treatmentm Fermented Lettuce Extract Concentrate)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	8	mg/10mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6645_f516d73a-c3c1-3bd7-e053-2a95a90afc2d	83202-6645	HUMAN OTC DRUG	Dr. GNO Cooling Gel (Provides sense of cooling and pain relief, Acne Treatment, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	10	mg/100mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6658_f516e416-4468-8f21-e053-2a95a90afd88	83202-6658	HUMAN OTC DRUG	Dr. GNO Premium Soothing Gel (Brightening, Wrinckle care, and Moisturizing effect, Acne treatment, Fermented Lettuce Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/500mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6712_f619ccac-212c-2fba-e053-2a95a90ae653	83202-6712	HUMAN OTC DRUG	Dr. GNO All-in-One Cleanser (Prevents hairloss, Fermented lettuce, garlic, bean, cabbage, cricket Greentea leaf, Mulberry branch, leaf, and roots extract Mesoporous Silica Nanoparticle, Zinc)	Nitric Oxide, Dexpanthenol, Niacinamide, Salicylic acid, Zinc	Nitric Oxide, Dexpanthenol, Niacinamide, Salicylic acid, Zinc	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/300mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6841_f517a5b3-ce90-380c-e053-2995a90a47fb	83202-6841	HUMAN OTC DRUG	Dr. NO I (Wound recovery, Burn wound recovery, Acne Treatment, Fermented Lettuce Extract Concentrate)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	20	mg/30mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6923_f61a0c5f-f536-580c-e053-2995a90ae88a	83202-6923	HUMAN OTC DRUG	Bio NO more Joint Pain (Helps improve osteoarthritis and immunity, Soybean fermented powder and Oplopanax elatus nakai extract powder)		Nitric Oxide, Zinc, N-Acetylglucosamine	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/800mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-6931_f51767d1-96d4-fd0e-e053-2995a90a2fb0	83202-6931	HUMAN OTC DRUG	Dr. GNO Concentrated Ampoule (Wound recovery, Burn wound recovery, Acne Treatment, Fermented Lettuce Extract Concentrate)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	12	mg/14mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-7413_f619fda8-c40a-1ce8-e053-2995a90ae1a8	83202-7413	HUMAN OTC DRUG	Renair Renaissance In Hair (Prevents hairloss, fermented lettuce, garlic, bean, cabbage, cricket greentea leaf,mulberry branch, leaf, and roots extract)		Nitric Oxide, Dexpanthenol, Niacinamide, Salicylic acid, Zinc	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/500mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-7712_f517088b-3ea8-a069-e053-2995a90a0f7d	83202-7712	HUMAN OTC DRUG	Dr. GNO Warming Gel (Provides sense of heating and pain relieft, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	15	mg/150mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-7715_f517174e-4123-0d2d-e053-2a95a90a8c04	83202-7715	HUMAN OTC DRUG	Dr. GNO Recovery Oil (Brightening, Wrinckle care, and Moisturizing effect, Acne Treatment, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	30	mg/40mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-8251_f517430f-3a24-b1f2-e053-2a95a90a3f11	83202-8251	HUMAN OTC DRUG	Dr. GNO All-Care 100 (Brightening, Wrinckle care, and Moisturizing effect, Pain relief, Acne Treatment, Fermented Cabbage Extract)		Nitric Oxide	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	10	mg/100mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-8841_f50224e8-3124-34b7-e053-2995a90a79f7	83202-8841	HUMAN OTC DRUG	Dr. NOtatione Pet care (Helps improve metabolic disorder, Cabbage fermented powder)		Nitric Oxide, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/250mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-9325_f515b5c6-dec6-6bc0-e053-2a95a90a46ab	83202-9325	HUMAN OTC DRUG	Top NO Care Ultra (Helps improve matabolic disorder, Lettuce fermented powder)		Nitric Oxide, Zinc, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/400mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-9575_f619d473-bfef-660b-e053-2995a90aab07	83202-9575	HUMAN OTC DRUG	NO DENTAL CARE (Improves gum disease, gum health, breath)		Nitric Oxide, Tri-Calcium Phosphate, Dental type Silica, Tocopheryl Acetate	LIQUID	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/150mg	Vasodilation [PE], Vasodilator [EPC]		N	
83202-9723_f619f146-fb5e-133c-e053-2995a90a2658	83202-9723	HUMAN OTC DRUG	Bio NO V Plus (Helps improve matabolic disorder, Bean sprout powder)		Nitric Oxide, Zinc, Glutathione	CAPSULE	TOPICAL	20230214	20240213	UNAPPROVED DRUG OTHER		HumanEnos LLC	NITRIC OXIDE	100	mg/400mg	Vasodilation [PE], Vasodilator [EPC]		N	
83204-375_0976e636-18cd-0818-e063-6294a90adeb8	83204-375	HUMAN OTC DRUG	FISICO Arthrozene Pain Cream		MENTHOL	CREAM	TOPICAL	20221114		OTC MONOGRAPH DRUG	M017	FISICO INC.	MENTHOL	50	mg/g			N	20241231
83206-0100_f481b976-9959-e351-e053-2995a90a796a	83206-0100	HUMAN OTC DRUG	Saranghae Lets Get Physical Sheer UV Defense Sunscreen Broad Spectrum SPF 50		Zinc Oxide	LOTION	TOPICAL	20230212		OTC MONOGRAPH FINAL	part352	TOOCOO MEDIA INC.	ZINC OXIDE	12	g/100g			N	20241231
83220-001_d8093b20-8080-40e1-82ad-97bd0359f7a1	83220-001	HUMAN PRESCRIPTION DRUG	Deluxe Dental Emergency Kit		Epinephrine, Albuterol Sulfate, Nitroglycerin, Diphenhydramine Hydrochloride, Aspirin	KIT		20230130		UNAPPROVED DRUG OTHER		Best Dental Kit LLC						N	20241231
83220-002_b1c486d2-693c-499b-a49f-7fc3890cf9db	83220-002	HUMAN PRESCRIPTION DRUG	Basic Dental Emergency Kit		Epinephrine, Albuterol Sulfate, Nitroglycerin, Diphenhydramine Hydrochloride, Aspirin	KIT		20230130		UNAPPROVED DRUG OTHER		Best Dental Kit LLC						N	20241231
83224-372_0976e636-18bd-0818-e063-6294a90adeb8	83224-372	HUMAN OTC DRUG	PARACTIN QuantumActiv Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20221017		OTC MONOGRAPH DRUG	M017	NHR SCIENCE CORP	MENTHOL	15	mg/mL			N	20241231
83225-100_021bd888-1023-4f68-9549-d8479aa0d970	83225-100	HUMAN OTC DRUG	Seven Aroma Dr		Alcohol	LIQUID	TOPICAL	20230102		OTC MONOGRAPH NOT FINAL	part333A	Happy Seven Co., Ltd.	ALCOHOL	70	mL/100mL			N	20241231
83233-0650_f45e5f4e-3321-1ec0-e053-2a95a90a8cf7	83233-0650	HUMAN OTC DRUG	Tinted Sunscreen AM -Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	All About Eyes, LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83235-0001_f3a0b650-693b-6699-e053-2995a90a2035	83235-0001	HUMAN OTC DRUG	Solcure Thera roll		menthol	LIQUID	TOPICAL	20230201		UNAPPROVED DRUG OTHER		Erae Natural Life	MENTHOL	1	g/100mL			N	20241231
83235-0002_f3a14330-c441-138c-e053-2995a90ae041	83235-0002	HUMAN OTC DRUG	Solcure Thera Roll Hot Pro		menthol	LIQUID	TOPICAL	20230201		UNAPPROVED DRUG OTHER		Erae Natural Life	MENTHOL	1	g/100mL			N	20241231
83235-0003_f3a970f2-0bcb-7afa-e053-2995a90acb2e	83235-0003	HUMAN OTC DRUG	Solcure Water Balm		illite	STICK	TOPICAL	20230201		UNAPPROVED DRUG OTHER		Erae Natural Life	LEDIKITE	.01	g/100g			N	20241231
83235-0004_f3a9e6be-ea25-8d43-e053-2995a90ac56b	83235-0004	HUMAN OTC DRUG	SolcureCream		menthol	CREAM	TOPICAL	20230201		UNAPPROVED DRUG OTHER		Erae Natural Life	CHAMAECYPARIS OBTUSA WOOD OIL	.5	g/100mL			N	20241231
83235-0005_f3b4a81b-3659-3d09-e053-2995a90a9c61	83235-0005	HUMAN OTC DRUG	Solcure 2 be1 Magic Pack		adenosine, niacinamide	LIQUID	TOPICAL	20230201		UNAPPROVED DRUG OTHER		Erae Natural Life	ADENOSINE; NIACINAMIDE	.08; 4	g/100g; g/100g	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
83239-2650_f45e4f1d-f65f-d87e-e053-2a95a90a7fbb	83239-2650	HUMAN OTC DRUG	SPF BFF Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	BERBURY AESTHETICS LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83240-001_99e82a7e-09c8-0a52-e053-2995a90ab7dd	83240-001	HUMAN OTC DRUG	Thieves Cough Drop		Menthol	LOZENGE	ORAL	20191217		OTC MONOGRAPH FINAL	part341	Young Living	MENTHOL	8	mg/1			N	20241231
83241-1039_00d8355c-0c19-4606-e063-6294a90afae9	83241-1039	HUMAN OTC DRUG	Balmere Mineral Sunscreen Moisturizer Primer		Zinc Oxide	LOTION	TOPICAL	20230520		OTC MONOGRAPH NOT FINAL	part352	Balmere	ZINC OXIDE	132	mg/mL			N	20241231
83242-2650_f45df86d-9e40-be4e-e053-2995a90ace8a	83242-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizing Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Oceanside Aesthetics and	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83243-001_f4a89e39-3185-9382-e053-2995a90a7d92	83243-001	HUMAN OTC DRUG	AZZURX		MELISSA OFFICINALIS LEAF,THUJA OCCIDENTALIS LEAF,GERANIUM MACULATUM,CALENDULA OFFICINALlS	LIQUID	TOPICAL	20230213		UNAPPROVED HOMEOPATHIC		Outbreaks, Inc.	CALENDULA OFFICINALIS FLOWER; GERANIUM MACULATUM ROOT; MELISSA OFFICINALIS LEAF; THUJA OCCIDENTALIS LEAF	3; 3; 3; 3	[hp_X]/.5mL; [hp_X]/.5mL; [hp_X]/.5mL; [hp_X]/.5mL			N	20241231
83243-002_04ca536e-38ec-e254-e063-6294a90a172d	83243-002	HUMAN OTC DRUG	GENTANX		melissa officinalis leaf, thuja occidentalis leaf, geranium maculatum, calendula officinalis	LIQUID	TOPICAL	20230907		UNAPPROVED HOMEOPATHIC		Outbreaks, Inc.	CALENDULA OFFICINALIS FLOWER; GERANIUM MACULATUM ROOT; MELISSA OFFICINALIS LEAF; THUJA OCCIDENTALIS LEAF	3; 3; 3; 3	[hp_X]/.5mL; [hp_X]/.5mL; [hp_X]/.5mL; [hp_X]/.5mL			N	20241231
83244-001_f5c63850-5e9a-8488-e053-2a95a90a83ef	83244-001	HUMAN OTC DRUG	Childs Farm Eczema Moisturizing Cream		Colloidal Oatmeal	CREAM	TOPICAL	20230401		OTC MONOGRAPH FINAL	M016	Childs Farm, Inc.	OATMEAL	15	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83249-001_f45b59b6-4992-155e-e053-2995a90a471c	83249-001	HUMAN OTC DRUG	RMS SUPERNATURAL RADIANCE SERUM SPF 30 SUNSCREEN LIGHT AURA		ZINC OXIDE	EMULSION	TOPICAL	20230615		OTC MONOGRAPH FINAL	M020	Rms organics LLC	ZINC OXIDE	200	mg/mL			N	20241231
83249-002_f45b59b6-4992-155e-e053-2995a90a471c	83249-002	HUMAN OTC DRUG	RMS SUPERNATURAL RADIANCE SERUM SPF 30 SUNSCREEN MEDIUM AURA		ZINC OXIDE	EMULSION	TOPICAL	20230615		OTC MONOGRAPH FINAL	M020	Rms organics LLC	ZINC OXIDE	200	mg/mL			N	20241231
83249-003_f45b59b6-4992-155e-e053-2995a90a471c	83249-003	HUMAN OTC DRUG	RMS SUPERNATURAL RADIANCE SERUM SPF 30 SUNSCREEN RICH AURA		ZINC OXIDE	EMULSION	TOPICAL	20230615		OTC MONOGRAPH FINAL	M020	Rms organics LLC	ZINC OXIDE	200	mg/mL			N	20241231
83252-001_f2e83031-7c36-784a-e053-2a95a90aa644	83252-001	HUMAN OTC DRUG	SParms Organic Sensitive Skin Facial Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230124		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-002_f3fd7667-9bc7-7761-e053-2a95a90a225a	83252-002	HUMAN OTC DRUG	SParms Organic Sports Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230125		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-003_f3fd06e3-1e52-6a8d-e053-2995a90afe32	83252-003	HUMAN OTC DRUG	SParms Organic Kids Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230206		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-004_f556e1fa-d732-392f-e053-2995a90aa0e1	83252-004	HUMAN OTC DRUG	Fitcover Hydrating Tinted Sunscreen SPF50		Zinc Oxide	CREAM	TOPICAL	20230224		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-005_f5d2036b-7ab5-d04e-e053-2995a90a780d	83252-005	HUMAN OTC DRUG	Wear Me Tinted Hydrating Facial Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-006_f5a52cb5-4bd5-d646-e053-2a95a90a146c	83252-006	HUMAN OTC DRUG	Wear Me Tinted Hydrating Facial Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-007_f5a6cd2e-9d28-4d04-e053-2a95a90af908	83252-007	HUMAN OTC DRUG	Wear Me Tinted Sunscreen for Acne Prone Skin		Zinc Oxide	CREAM	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-009_f5a77dbc-a6ed-17a4-e053-2995a90a12f3	83252-009	HUMAN OTC DRUG	Gday Organic Body Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-010_f5a852f9-1cd3-5128-e053-2995a90a1808	83252-010	HUMAN OTC DRUG	Gday Organic Anti-Mosquito Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230227		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83252-030_f6c1b1ba-50f8-a256-e053-6394a90ac1d3	83252-030	HUMAN OTC DRUG	SunKids Anti-Mozzie Sunscreen		Zinc Oxide	CREAM	TOPICAL	20230313		OTC MONOGRAPH NOT FINAL	part352	Veganic SKN Limited	ZINC OXIDE	25	kg/100kg			N	20241231
83253-262_ac551ff5-e56c-496d-96ec-c4ea0d11698b	83253-262	HUMAN OTC DRUG	Nicotine Mini		nicotine polacrilex	LOZENGE	ORAL	20230430		ANDA	ANDA207868	HC Jones, Inc.	NICOTINE	2	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
83253-264_edff1a78-b654-4032-a3e9-85e69a278630	83253-264	HUMAN OTC DRUG	Mini Nicotine		Nicotine Polacrilex	LOZENGE	ORAL	20230430		ANDA	ANDA207868	HC Jones, Inc.	NICOTINE	4	mg/1	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]		N	20241231
83254-001_fbfb0179-91a3-c830-e053-6294a90abfdb	83254-001	HUMAN OTC DRUG	Povidone Iodine		Povinanz Ointment 10%	OINTMENT	TOPICAL	20230504		OTC MONOGRAPH FINAL	M005	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	10	g/100g			N	20241231
83254-005_0077ade4-c56b-a58f-e063-6394a90a8f3e	83254-005	HUMAN OTC DRUG	Hand Sanitizer		Hand Sanitizer	GEL	TOPICAL	20200824		OTC MONOGRAPH NOT FINAL	part333A	1201258 Ontario Inc.	ALCOHOL	66.5	mL/100mL			N	20241231
83254-008_faf75adb-ed4d-f79d-e053-6294a90a7e71	83254-008	HUMAN OTC DRUG	Aloe Vera Calamine		Nanz Aloe Vera Calamine Lotion	LOTION	TOPICAL	20230505		OTC MONOGRAPH FINAL	M016	1201258 Ontario Inc O/A Nanz Pharma	FERRIC OXIDE RED; ZINC OXIDE	8; 8	g/100mL; g/100mL			N	20241231
83254-010_fbfb282f-194d-1b18-e053-6294a90a1d2d	83254-010	HUMAN OTC DRUG	Nanz Povidone Iodine 10% Solution		Povidone Iodine 10% Solution	LIQUID	TOPICAL	20230208		OTC MONOGRAPH FINAL	M005	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	10	g/100mL			N	20241231
83254-015_fbfb427f-ae44-6b49-e053-6294a90ace59	83254-015	HUMAN OTC DRUG	Calananz		Calamine Lotion 15%	LOTION	TOPICAL	20230207		OTC MONOGRAPH FINAL	M016	1201258 Ontario Inc. O/A Nanz Pharma	FERRIC OXIDE RED; ZINC OXIDE	15; 5	g/100mL; g/100mL			N	20241231
83254-019_fbfb2e64-3d6c-40e3-e053-6294a90a9fd1	83254-019	HUMAN OTC DRUG	Nanz Pure		Calamine Lotion	LIQUID	TOPICAL	20230215		OTC MONOGRAPH FINAL	M016	1201258 Ontario Inc.O/A Nanz Pharma	FERRIC OXIDE RED; ZINC OXIDE	19; 19	g/100mL; g/100mL			N	20241231
83254-050_fbfb0719-54fc-50b5-e053-6394a90a7130	83254-050	HUMAN OTC DRUG	Nanz Povidone Iodine 5% Solution		Povidone Iodine 5% Solution	LIQUID	TOPICAL	20230208		OTC MONOGRAPH FINAL	M005	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	5	g/100mL			N	20241231
83254-076_fbfb2125-9110-8d05-e053-6394a90a8b61	83254-076	HUMAN OTC DRUG	Calamine		Nanz Relieve Calamine Lotion	LOTION	TOPICAL	20230505		OTC MONOGRAPH FINAL	M016	1201258 Ontario Inc. O/A Nanz Pharma	FERRIC OXIDE RED; ZINC OXIDE	7.6; 7.6	g/100mL; g/100mL			N	20241231
83254-100_fda33030-2621-11d1-e053-6394a90ae99a	83254-100	HUMAN OTC DRUG	Povidone Iodine		Povinanz 10% Antiseptic Solution	SOLUTION	TOPICAL	20230608		OTC MONOGRAPH NOT FINAL	part333E	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	10	g/100mL			N	20241231
83254-105_fd9f4d82-1f82-b1f6-e053-6394a90a33d8	83254-105	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine Antiseptic 5% Solution	SOLUTION	TOPICAL	20230607		OTC MONOGRAPH NOT FINAL	part356	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	5	g/100mL			N	20241231
83254-500_fbfaf868-091e-2d7a-e053-6394a90aade8	83254-500	HUMAN OTC DRUG	Povidone Iodine		Povinanz Ointment	OINTMENT	TOPICAL	20230504		OTC MONOGRAPH FINAL	M005	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	5	g/100g			N	20241231
83254-705_fbfb2125-910f-8d05-e053-6394a90a8b61	83254-705	HUMAN OTC DRUG	Povidone Iodine		Povidone Iodine 7.5 Solution	SOLUTION	TOPICAL	20230504		OTC MONOGRAPH FINAL	M005	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	7.5	g/100mL			N	20241231
83254-750_fbfb2125-910e-8d05-e053-6394a90a8b61	83254-750	HUMAN OTC DRUG	Nanz Povidone		Povinanz 7.5%	OINTMENT	TOPICAL	20230504		OTC MONOGRAPH FINAL	M005	1201258 Ontario Inc. O/A Nanz Pharma	POVIDONE-IODINE	7.5	g/100g			N	20241231
83257-001_acd49d86-cf8e-35d1-6e34-923cead9ecb4	83257-001	HUMAN PRESCRIPTION DRUG	OGIVRI		trastuzumab	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231001		BLA	BLA761074	Biocon Biologics Inc.	TRASTUZUMAB	150	mg/7.4mL	HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]		N	20241231
83257-004_acd49d86-cf8e-35d1-6e34-923cead9ecb4	83257-004	HUMAN PRESCRIPTION DRUG	OGIVRI		trastuzumab	KIT		20231001		BLA	BLA761074	Biocon Biologics Inc.						N	20241231
83257-005_b48cb2c8-6d4f-311a-7019-7ff34c79d42a	83257-005	HUMAN PRESCRIPTION DRUG	Fulphila		pegfilgrastim	INJECTION	SUBCUTANEOUS	20230728		BLA	BLA761075	Biocon Biologics Inc.	PEGFILGRASTIM	6	mg/.6mL	Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]		N	20241231
83257-011_f92f9876-08db-3bad-7322-5e8548965211	83257-011	HUMAN PRESCRIPTION DRUG	SEMGLEE		insulin glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		BLA	BLA761201	Biocon Biologics Inc.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
83257-012_f92f9876-08db-3bad-7322-5e8548965211	83257-012	HUMAN PRESCRIPTION DRUG	SEMGLEE		insulin glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		BLA	BLA761201	Biocon Biologics Inc.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
83257-014_bd2e1126-9310-e454-56a4-5d714bb906a7	83257-014	HUMAN PRESCRIPTION DRUG	Insulin Glargine		insulin Glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		BLA	BLA761201	Biocon Biologics Inc.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
83257-015_bd2e1126-9310-e454-56a4-5d714bb906a7	83257-015	HUMAN PRESCRIPTION DRUG	Insulin Glargine		insulin Glargine-yfgn	INJECTION, SOLUTION	SUBCUTANEOUS	20230728		BLA	BLA761201	Biocon Biologics Inc.	INSULIN GLARGINE	100	[iU]/mL	Insulin Analog [EPC], Insulin [CS]		N	20241231
83257-016_b88c5ba5-8f29-b6f1-c761-a1258f0e1ec1	83257-016	HUMAN PRESCRIPTION DRUG	HULIO		adalimumab	KIT		20231230		BLA	BLA761154	Biocon Biologics Inc						N	20241231
83257-017_b88c5ba5-8f29-b6f1-c761-a1258f0e1ec1	83257-017	HUMAN PRESCRIPTION DRUG	HULIO		adalimumab	KIT		20231230		BLA	BLA761154	Biocon Biologics Inc						N	20241231
83257-019_b88c5ba5-8f29-b6f1-c761-a1258f0e1ec1	83257-019	HUMAN PRESCRIPTION DRUG	HULIO		adalimumab	KIT		20231230		BLA	BLA761154	Biocon Biologics Inc						N	20241231
83259-693_f41cf3f4-6c6d-7354-e053-2a95a90affcc	83259-693	HUMAN OTC DRUG	Guard 2U Hand Sanitizer		Guard 2U Hand Sanitizer	LIQUID	TOPICAL	20200307		OTC MONOGRAPH NOT FINAL	part333A	American Industries, Inc.	ALCOHOL	67	mL/100mL			N	20241231
83260-100_0bc92b6a-a460-38b2-e063-6394a90a7b62	83260-100	HUMAN OTC DRUG	Daily Broad Spectrum Serum Solardrops		Zinc Oxide	LOTION	TOPICAL	20231205		OTC MONOGRAPH DRUG	M020	Motley Brands LLC	ZINC OXIDE	245	mg/g			N	20241231
83262-001_f604d30c-b17d-ec01-e053-2a95a90aa304	83262-001	HUMAN OTC DRUG	Magsoothium Body		Menthol, Capsaicin	CREAM	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part348	Ubu/Elements, Inc.	CAPSAICIN; MENTHOL	.032; 2	g/100mL; g/100mL			N	20241231
83262-002_f7fb6aec-aada-90d3-e053-6294a90a12d6	83262-002	HUMAN OTC DRUG	Magsoothium Body Cooling Formula		Menthol	CREAM	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part348	Ubu/Elements, Inc.	MENTHOL	5	g/100mL			N	20241231
83262-003_f9b87fbe-b88a-67a1-e053-6394a90acbcd	83262-003	HUMAN OTC DRUG	Magsoothium CBD Body Lavender		Menthol	CREAM	TOPICAL	20230421		OTC MONOGRAPH NOT FINAL	part348	Ubu/Elements, Inc.	MENTHOL	5	g/100mL			N	20241231
83262-004_00b2ef34-42d8-523c-e063-6294a90a753d	83262-004	HUMAN OTC DRUG	Magsoothium CBD Body		Menthol	SPRAY	TOPICAL	20230717		OTC MONOGRAPH NOT FINAL	part348	Ubu/Elements, Inc.	MENTHOL	118	g/100mL			N	20241231
83265-001_f5c83321-7832-9686-e053-2995a90a538e	83265-001	HUMAN OTC DRUG	Baby Donna SHeer SPF Sunscreen Stick		Zinc Oxide	STICK	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part352	BabyDonna LLC	ZINC OXIDE	19	g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83268-2650_f45e5a3b-dd2a-1cf3-e053-2995a90af361	83268-2650	HUMAN OTC DRUG	Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	Beso Management, LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83269-0650_f7e769a3-f2f1-1ed7-e053-6294a90a91c6	83269-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part352	Moss Dermatology, LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83270-000_f90ea51b-7872-75f3-e053-6394a90af2c7	83270-000	HUMAN PRESCRIPTION DRUG	mycophenolate mofetil		mycophenolate mofetil	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230430		ANDA	ANDA216390	STELIS BIOPHARMA LIMITED	MYCOPHENOLATE MOFETIL	500	mg/20mL	Antimetabolite Immunosuppressant [EPC]		N	20241231
83270-001_fa2285f3-8b37-4b74-e053-6294a90adfce	83270-001	HUMAN PRESCRIPTION DRUG	Acetylcysteine		Acetylcysteine	INJECTION, SOLUTION	INTRAVENOUS	20230426		ANDA	ANDA217182	STELIS BIOPHARMA LIMITED	ACETYLCYSTEINE	200	mg/mL	Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Decreased Respiratory Secretion Viscosity [PE], Increased Glutathione Concentration [PE], Mucolytic [EPC], Reduction Activity [MoA]		N	20241231
83270-002_01d627d1-3c91-36c6-e063-6294a90a6bdb	83270-002	HUMAN PRESCRIPTION DRUG	Carboprost Tromethamine		Carboprost Tromethamine	INJECTION, SOLUTION	INTRAMUSCULAR	20231101		ANDA	ANDA216897	STELIS BIOPHARMA LIMITED	CARBOPROST TROMETHAMINE	250	ug/mL	Prostaglandin Analog [EPC], Prostaglandins [CS]		N	20241231
83274-2650_f7fbe2e3-f7ec-f905-e053-6294a90a6724	83274-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230101		OTC MONOGRAPH NOT FINAL	part352	TOXFAIRY, LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83276-390_0976e2fc-b22e-e037-e063-6294a90a586a	83276-390	HUMAN OTC DRUG	BB OSKIN Broad Spectrum SPF-30		TITANIUM DIOXIDE, OCTOCRYLENE, ZINC OXIDE	CREAM	TOPICAL	20230227		OTC MONOGRAPH DRUG	M020	O'Skin Studio NY	OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	50; 70; 60	mg/mL; mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83278-001_f6cbe742-c5de-1a6f-e053-6394a90a983b	83278-001	HUMAN OTC DRUG	ArtemiC Rescue		Oral Spray	SPRAY, SUSPENSION	ORAL	20230220		UNAPPROVED DRUG OTHER		AMC Pharma LLC	ARTEMISININ; ASCORBIC ACID; BOSWELLIA SACRA BARK; CURCUMIN	.6; 6; 1.5; 2	g/100g; g/100g; g/100g; g/100g	Ascorbic Acid [CS], Vitamin C [EPC]		N	20241231
83279-401_55c09269-9a10-4c04-bb82-5ca72c22500e	83279-401	HUMAN OTC DRUG	BioFilm Blast MD		Hydrogen Peroxide	SPRAY	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part333A	Synergy Wound Technology, Inc	HYDROGEN PEROXIDE	1	mL/100mL			N	20241231
83280-0650_fea5cbca-619c-c454-e053-6394a90a0a32	83280-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	SERRAO, E JOHN MD FACOG	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83282-139_01546da4-81c1-ec29-e063-6394a90a0304	83282-139	HUMAN OTC DRUG	SOL Science The Fifty		Zinc Oxide	LOTION	TOPICAL	20230725		OTC MONOGRAPH NOT FINAL	part352	Beauty Pie	ZINC OXIDE	132	mg/mL			N	20241231
83282-851_0e0f43f5-9b1d-9af8-e063-6294a90a00ad	83282-851	HUMAN OTC DRUG	TRACELESS MINERAL BROAD SPECTRUM SPF SUNSCREEN AND PRIMER		TRACELESS MINERAL BROAD SPECTRUM SPF SUNSCREEN AND PRIMER	CREAM	TOPICAL	20230612		OTC MONOGRAPH DRUG	M020	BEAUTY PIE U.S.A. INC.	ZINC OXIDE	12.4	g/100g			N	20251231
83286-001_6083d3e4-40b1-49e4-978a-b039e4925f8a	83286-001	HUMAN OTC DRUG	DAYDREAM Broad Spectrum Sunscreen SPF 40		Zinc Oxide	CREAM	TOPICAL	20230221		OTC MONOGRAPH FINAL	part352	Drmtlgy, LLC	ZINC OXIDE	17	g/100mL			N	20241231
83288-2650_ff350acd-8e47-98b8-e053-6294a90ae411	83288-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230201		OTC MONOGRAPH NOT FINAL	part352	NU-SKIN LASER SOLUTIONS, LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83290-001_f541aa10-93a3-9482-e053-2a95a90a4485	83290-001	HUMAN OTC DRUG	ISOPROPYL ALCOHOL		200 WET WIPES	CLOTH	TOPICAL	20230222		OTC MONOGRAPH NOT FINAL	part333A	Amtime, Inc.	ISOPROPYL ALCOHOL	2.97	g/1			N	20241231
83294-101_0d825267-d5d6-8e03-e063-6294a90a1487	83294-101	HUMAN OTC DRUG	SPF 30 Sunscreen		Zinc Oxide, Titanium Dioxide	LOTION	TOPICAL	20220822		OTC MONOGRAPH DRUG	M020	CLEURE	TITANIUM DIOXIDE; ZINC OXIDE	4.51; 9	g/100mL; g/100mL			N	20241231
83295-3313_09410717-fd73-9a07-e063-6394a90a738d	83295-3313	HUMAN OTC DRUG	Nuvira		Capsaicin 0.025%, Menthol 10%, Methyl Nicotinate 0.25%, Methyl Salicylate 10%	PATCH	TOPICAL	20230629		OTC MONOGRAPH DRUG	M017	Strand Health Group	CAPSAICIN; MENTHOL; METHYL NICOTINATE; METHYL SALICYLATE	.00025; .1; .0025; .1	g/g; g/g; g/g; g/g	Nicotinic Acid [EPC], Nicotinic Acids [CS]		N	20241231
83295-4000_0b4c0be1-1d96-7f38-e063-6294a90ad8b1	83295-4000	HUMAN PRESCRIPTION DRUG	Trubrexa		lidocaine and capsaicin	PATCH	TRANSDERMAL	20231003		UNAPPROVED DRUG OTHER		Strand Health Group	CAPSAICIN; LIDOCAINE	.00025; .0475	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83299-001_faa303ee-60bb-726f-e053-6394a90a49c0	83299-001	HUMAN OTC DRUG	WART REMOVER		WART REMOVER	LIQUID	TOPICAL	20230215		OTC MONOGRAPH FINAL	M028	Consilii LLC	METHYL SALICYLATE	12	mg/100mL			N	20241231
83299-002_f8a800dc-0830-43a5-e053-6294a90a6548	83299-002	HUMAN OTC DRUG	Wart Remover Ointment.		You Yuping antibacterial ointment	OINTMENT	TOPICAL	20230405		OTC MONOGRAPH FINAL	M028	Consilii LLC	CHLORHEXIDINE; SALICYLIC ACID	1; 1	g/100g; g/100g	Decreased Cell Wall Integrity [PE]		N	20241231
83299-003_f8bac722-88e5-7431-e053-6294a90ac130	83299-003	HUMAN OTC DRUG	Milia Remover Serum		Milia Remover	LIQUID	TOPICAL	20230405		OTC MONOGRAPH FINAL	M006	Consilii LLC	AMMONIUM CATION; AMYLOPECTIN (4,5-DIHYDROXY-1,3-DIMETHYLIMIDAZOLIDIN-2-ONE CROSS LINKED)	.8; 1	mg/100mL; mg/100mL			N	20241231
83299-004_fb0760c7-24b7-376a-e053-6394a90ac7d8	83299-004	HUMAN OTC DRUG	Meoly Liquid Wart Corn Remover		Liquid Wart Corn Remover	LIQUID	TOPICAL	20230505		OTC MONOGRAPH FINAL	M028	Consilii LLC	SALICYLIC ACID	7	mg/100mL			N	20241231
83299-007_fe0611db-7ae0-9678-e053-6294a90a1153	83299-007	HUMAN OTC DRUG	WART REMOVER		WART REMOVER	LIQUID	TOPICAL	20230613		OTC MONOGRAPH FINAL	M028	Consilii LLC	METHYL SALICYLATE	12	g/100mL			N	20241231
83299-008_fe3c319c-e74f-3de3-e053-6394a90a7f19	83299-008	HUMAN OTC DRUG	CORN CALLUS REMOVER		CORN CALLUS REMOVER	LIQUID	TOPICAL	20230615		OTC MONOGRAPH FINAL	M005	Consilii LLC	MATRINE; SALICYLIC ACID	2; 20	g/100mL; g/100mL			N	20241231
83299-009_ff501036-6ff3-0073-e053-6394a90a411f	83299-009	HUMAN OTC DRUG	Genital Wart Remover Ointment.		Genital Wart Remover Cream	CREAM	TOPICAL	20230629		OTC MONOGRAPH FINAL	M016	Consilii LLC	CHLOROACETIC ACID; SALICYLIC ACID	1; 1	g/100g; g/100g			N	20241231
83299-010_005992e9-db96-b3aa-e063-6294a90a52a8	83299-010	HUMAN OTC DRUG	WART REMOVER		WART REMOVER	LIQUID	TOPICAL	20230712		OTC MONOGRAPH FINAL	M028	Consilii LLC	SALICYLIC ACID	12	mg/100mL			N	20241231
83299-011_020f8bd6-21ad-0732-e063-6394a90a125e	83299-011	HUMAN OTC DRUG	KRONA WART REMOVER		WART REMOVER	LIQUID	TOPICAL	20230602		OTC MONOGRAPH FINAL	M028	Consilii LLC	METHYL SALICYLATE	7	g/100mL			N	20241231
83299-013_031c0a5d-139f-0623-e063-6394a90a5537	83299-013	HUMAN OTC DRUG	MEOLY Milia Remover Serum		Milia Remover Serum	LIQUID	TOPICAL	20230814		OTC MONOGRAPH FINAL	M005	Consilii LLC	DIDECYLDIMONIUM	.025	g/100g			N	20241231
83299-014_071b9257-9e7e-e71c-e063-6294a90ae837	83299-014	HUMAN OTC DRUG	5% Minoxidil Spray.		5% Minoxidil Spray	SPRAY	TOPICAL	20231007		ANDA	ANDA075357	Consilii LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83299-015_07415d92-031e-73d9-e063-6394a90afdb1	83299-015	HUMAN OTC DRUG	5% Minoxidil Foam		5% Minoxidil Foam	SPRAY, SUSPENSION	TOPICAL	20231008		ANDA	ANDA075357	Consilii LLC	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83299-016_07430632-6140-01fa-e063-6294a90a25c8	83299-016	HUMAN OTC DRUG	5% Minoxidil Foam		5% Minoxidil Foam	SPRAY, SUSPENSION	TOPICAL	20231008		ANDA	ANDA075357	Consilii LLC	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83299-017_0744812f-73e5-14b9-e063-6394a90ada09	83299-017	HUMAN OTC DRUG	5% Minoxidil hair growth oil		5% Minoxidil hair growth oil	LIQUID	TOPICAL	20231008		ANDA	ANDA075357	Consilii LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83299-018_090e409a-4265-dfc6-e063-6294a90aea91	83299-018	HUMAN OTC DRUG	5% Minoxidil Serum		5% Minoxidil Serum	LIQUID	TOPICAL	20231031		ANDA	ANDA075357	Consilii LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83299-020_0aa11281-0f48-1dfb-e063-6394a90a2d2a	83299-020	HUMAN OTC DRUG	5% Minoxidil Spray.		5% Minoxidil Spray	LIQUID	TOPICAL	20231101		ANDA	ANDA075357	Consilii LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83301-0001_fb825b9b-851e-c4fe-e053-6294a90a99bf	83301-0001	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20230501		ANDA	ANDA207057	Mullan Pharmaceutical Inc.	GABAPENTIN	600	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
83301-0002_fb825b9b-851e-c4fe-e053-6294a90a99bf	83301-0002	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	TABLET, COATED	ORAL	20230501		ANDA	ANDA207057	Mullan Pharmaceutical Inc.	GABAPENTIN	800	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
83301-0003_fb8242bd-32e6-55bc-e053-6294a90ab660	83301-0003	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230501		ANDA	ANDA075477	Mullan Pharmaceutical Inc.	GABAPENTIN	100	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
83301-0004_fb8242bd-32e6-55bc-e053-6294a90ab660	83301-0004	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230501		ANDA	ANDA075477	Mullan Pharmaceutical Inc.	GABAPENTIN	300	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
83301-0005_fb8242bd-32e6-55bc-e053-6294a90ab660	83301-0005	HUMAN PRESCRIPTION DRUG	Gabapentin		Gabapentin	CAPSULE	ORAL	20230501		ANDA	ANDA075477	Mullan Pharmaceutical Inc.	GABAPENTIN	400	mg/1	Decreased Central Nervous System Disorganized Electrical Activity [PE]		N	20241231
83301-0006_fb826815-09dc-b982-e053-6294a90ab381	83301-0006	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230501		ANDA	ANDA212949	Mullan Pharmaceutical Inc.	ESOMEPRAZOLE MAGNESIUM	20	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
83301-0007_fb826815-09dc-b982-e053-6294a90ab381	83301-0007	HUMAN PRESCRIPTION DRUG	Esomeprazole magnesium		Esomeprazole magnesium	CAPSULE, DELAYED RELEASE	ORAL	20230501		ANDA	ANDA212949	Mullan Pharmaceutical Inc.	ESOMEPRAZOLE MAGNESIUM	40	mg/1	Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
83301-0008_0c562e1f-4e20-eb70-e063-6294a90a7455	83301-0008	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20231020		ANDA	ANDA205096	Mullan Pharmaceutical Inc.	METFORMIN HYDROCHLORIDE	500	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
83301-0009_0c562e1f-4e20-eb70-e063-6294a90a7455	83301-0009	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20231020		ANDA	ANDA205096	Mullan Pharmaceutical Inc.	METFORMIN HYDROCHLORIDE	850	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
83301-0010_0c562e1f-4e20-eb70-e063-6294a90a7455	83301-0010	HUMAN PRESCRIPTION DRUG	Metformin Hydrochloride		Metformin Hydrochloride	TABLET, COATED	ORAL	20231020		ANDA	ANDA205096	Mullan Pharmaceutical Inc.	METFORMIN HYDROCHLORIDE	1000	mg/1	Biguanide [EPC], Biguanides [CS]		N	20241231
83301-0016_0c7fd25e-6ad0-1a54-e063-6294a90af27d	83301-0016	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20230918		ANDA	ANDA216373	Mullan Pharmaceutical Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
83301-0017_0c7fd25e-6ad0-1a54-e063-6294a90af27d	83301-0017	HUMAN PRESCRIPTION DRUG	Milrinone Lactate		Milrinone Lactate	INJECTION, SOLUTION	INTRAVENOUS	20230918		ANDA	ANDA216373	Mullan Pharmaceutical Inc.	MILRINONE LACTATE	1	mg/mL	Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]		N	20241231
83306-414_feac58ea-9bdf-243f-e053-6394a90a2831	83306-414	HUMAN OTC DRUG	Carpe SPF 30 Face Primer		Titanium Dioxide, Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH FINAL	M020	Clutch, Inc. DBA Carpe	TITANIUM DIOXIDE; ZINC OXIDE	5.3; 2.4	g/100g; g/100g			N	20241231
83311-335_0976dfc5-c33b-11fe-e063-6294a90aa2bb	83311-335	HUMAN OTC DRUG	SIMPLE PROMISE Simple H Hemorrhoid Relief Cream		PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE	CREAM	TOPICAL	20230306		OTC MONOGRAPH DRUG	M015	SIMPLE PROMISE PTE LTD	PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE	2.5; 10	mg/g; mg/g	Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
83312-001_f6353130-207b-5db6-e053-2a95a90a34c4	83312-001	HUMAN OTC DRUG	MUSK KETONE, SAFFRON, SALVIA MILTIORRHIZA, FRANKINCENSE, LICORICE, TURMERIC		Xinxueqing Tongmai Shuqi Kang	PASTE	TOPICAL	20230306		UNAPPROVED HOMEOPATHIC		Nanjing Yiming Biotechnology Co., Ltd.	FRANKINCENSE; LICORICE; MUSK KETONE; SAFFRON; SALVIA MILTIORRHIZA WHOLE; TURMERIC	8; 12; 3; 10; 25; 12	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
83314-111_f6e380e4-5100-ad5a-e053-6294a90a4190	83314-111	HUMAN OTC DRUG	Averex		Childrens Acetaminophen Oral Suspension	SUSPENSION	ORAL	20230314		OTC MONOGRAPH NOT FINAL	part343	A-Z Pharma Group LLC	ACETAMINOPHEN	160	mg/5mL			N	20241231
83315-100_b7057362-4cf9-4969-90e7-d8ed5a880359	83315-100	HUMAN PRESCRIPTION DRUG	UDSx Medicated System		Furosemide, Benzalkonium Chloride	KIT		20230307		ANDA	ANDA076796	Wellbeing Medical Supply						N	20241231
83315-200_6e03ccbe-a29b-4a4e-b18f-1aca115ad656	83315-200	HUMAN PRESCRIPTION DRUG	UDSxMP Medicated System		Furosemide, Benzalkonium Chloride	KIT		20230307		ANDA	ANDA076796	Wellbeing Medical Supply						N	20241231
83316-001_cfd3ea82-7dbf-4378-b79c-be9d2d4e034f	83316-001	HUMAN OTC DRUG	Crystal Clear Acne Treatment Pads		Salicylic acid	PATCH	TOPICAL	20230216		OTC MONOGRAPH FINAL	M006	Skin Pharm, LLC	SALICYLIC ACID	2	g/100mL			N	20241231
83318-265_f793cdb3-9fc7-79e1-e053-6394a90ae08b	83318-265	HUMAN OTC DRUG	PLUS BRASEPT		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20230323		OTC MONOGRAPH NOT FINAL	part333E	NEWDROP NORTH AMERICA LLC	BENZALKONIUM CHLORIDE	25	mg/mL			N	20241231
83318-544_f7927c08-95e8-df20-e053-6394a90a7c4f	83318-544	HUMAN OTC DRUG	PLUS BRASEPT THD		CHLOROXYLENOL	SOAP	TOPICAL	20230324		OTC MONOGRAPH NOT FINAL	part333E	NEWDROP NORTH AMERICA LLC	CHLOROXYLENOL	3	mg/mL			N	20241231
83318-605_f7a8dad4-b29d-429f-e053-6394a90a21db	83318-605	HUMAN OTC DRUG	Plus Brasept Alcocol Gel		ALCOHOL	GEL	TOPICAL	20230324		OTC MONOGRAPH NOT FINAL	part333E	NEWDROP NORTH AMERICA LLC	ALCOHOL	.7	mL/mL			N	20241231
83324-001_b9e5cd11-1284-5f7b-733f-1836dde2a9db	83324-001	HUMAN OTC DRUG	Lansoprazole		Lansoprazole	CAPSULE, DELAYED RELEASE	ORAL	20220412		ANDA	ANDA202194	Chain Drug Marketing Association	LANSOPRAZOLE	15	mg/1	Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]		N	20241231
83324-004_749ef202-8126-4e52-9cf2-6a8fc7c661d7	83324-004	HUMAN OTC DRUG	Senna		Sennosides	TABLET	ORAL	20230531		OTC MONOGRAPH NOT FINAL	part334	QUALITY CHOICE (Chain Drug Marketing Association)	SENNOSIDES	8.6	mg/1			N	20241231
83324-005_c9ae72d8-d205-4736-9bc4-2325cd77d36b	83324-005	HUMAN OTC DRUG	Concentrated ibuprofen infants		Ibuprofen	SUSPENSION/ DROPS	ORAL	20231103		ANDA	ANDA210755	Chain Drug Marketing Association Inc.	IBUPROFEN	50	mg/1.25mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83324-009_fc49fe88-56a3-6dcf-e053-6294a90adb84	83324-009	HUMAN OTC DRUG	Allergy Relief		Fexofenadine Hydrochloride	TABLET	ORAL	20230522		ANDA	ANDA211075	Chain Drug Marketing Association, Inc.	FEXOFENADINE HYDROCHLORIDE	60	mg/1	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
83324-012_ba0baba6-a7f9-4e4c-88f7-c7fbecc61f25	83324-012	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20231025		ANDA	ANDA210149	Chain Drug Marketing Association Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83324-013_c7e59784-a338-4922-a806-98c7505957cd	83324-013	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20231110		ANDA	ANDA210149	Chain Drug Marketing Association Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83324-014_e210c707-2bae-44a5-93dc-459dd24fd960	83324-014	HUMAN OTC DRUG	Childrens Ibuprofen		Ibuprofen	SUSPENSION/ DROPS	ORAL	20231120		ANDA	ANDA210149	Chain Drug Marketing Association Inc.	IBUPROFEN	100	mg/5mL	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83324-017_8242ccf7-5290-4f93-8f37-1cf0bb0eff7b	83324-017	HUMAN OTC DRUG	Menstrual Complete		Acetaminophen, Caffeine, Pyrilamine maleate	TABLET, FILM COATED	ORAL	20231102		OTC MONOGRAPH DRUG	M013	Chain Drug Marketing Association, Inc.	ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE	500; 60; 15	mg/1; mg/1; mg/1	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]		N	20241231
83324-028_0c59876a-50c4-b56c-e063-6394a90a94a8	83324-028	HUMAN OTC DRUG	Quality Choice Lubricant Eye Drops Restorative Performance		Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20231212		OTC MONOGRAPH DRUG	M018	Chain Drug Marketing Assoc., Inc.	PROPYLENE GLYCOL	.6	g/100mL			N	20241231
83324-029_0cd1b36a-a07b-a1db-e063-6294a90a5994	83324-029	HUMAN OTC DRUG	Quality Choice Lubricant Eye Drops High Performance		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20231218		OTC MONOGRAPH DRUG	M018	Chain Drug Marketing Assoc., Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
83324-030_0cd91c45-88a3-f88c-e063-6294a90ad127	83324-030	HUMAN OTC DRUG	Quality Choice Lubricant Eye Drops Long Lasting		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20231219		OTC MONOGRAPH DRUG	M018	Chain Drug Marketing Assoc., Inc.	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
83325-001_f90fd439-6f07-0f9c-e053-6394a90a992e	83325-001	HUMAN OTC DRUG	2% Salicylic Acid BODY WASH FOR ACNE PRONE SKIN		Glycerin, Sodium PCA, Salicylic acid, Kaolin clay, Vitamin B5, Vitamin E, Rosa Canina Fruit Oil	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	M016	Volans Epic LLC	.ALPHA.-TOCOPHEROL; GLYCERIN; KAOLIN; PANTOTHENIC ACID; ROSA CANINA FRUIT OIL; SALICYLIC ACID; SODIUM PYRROLIDONE CARBOXYLATE	5; 50; 20; 10; 1; 20; 20	mg/472mL; mg/472mL; mg/472mL; mg/472mL; mg/472mL; mg/472mL; mg/472mL	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83325-002_f90fdebb-af22-3132-e053-6294a90a1742	83325-002	HUMAN OTC DRUG	3% OAT BODY WASH FOR SENSITIVE SKIN		Glycerin, Oatmeal Extract, Sodium PCA, Vitamin B5, Hyaluronic Acid, Ceramide NG, Rosa Canina (Rosehip) Seed oil	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	M016	Volans Epic LLC	CERAMIDE NG; GLYCERIN; HYALURONIC ACID; OATMEAL; PANTOTHENIC ACID; ROSA CANINA SEED OIL; SODIUM PYRROLIDONE CARBOXYLATE	1; 50; 5; 30; 10; 1; 20	mg/472mL; mg/472mL; mg/472mL; mg/472mL; mg/472mL; mg/472mL; mg/472mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Glycerol [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83325-003_f90fd439-6efa-0f9c-e053-6394a90a992e	83325-003	HUMAN OTC DRUG	2% Salicylic Acid FACIAL CLEANSER		Glycerin, Kaolin clay, Salicylic acid, Zinc PCA, azelaic acid	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	M016	Volans Epic LLC	AZELAIC ACID; GLYCERIN; KAOLIN; SALICYLIC ACID; ZINC PIDOLATE	10; 50; 20; 20; 10	mg/236mL; mg/236mL; mg/236mL; mg/236mL; mg/236mL	Allergens [CS], Cell-mediated Immunity [PE], Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83325-005_f90ff171-ed43-2a55-e053-6394a90a0801	83325-005	HUMAN OTC DRUG	5% Oat Facial Cleanser		Glycerin, Oatmeal Extract,Ceramide NG	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	M016	Volans Epic LLC	CERAMIDE NG; GLYCERIN; OATMEAL	1; 50; 50	mg/236mL; mg/236mL; mg/236mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Glycerol [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83325-006_08381c17-1951-7795-e063-6394a90adc81	83325-006	HUMAN OTC DRUG	TINTED MOISTURIZER		aloe vera extract, niacinamide,vitamin e, sodium hyaluronate acetate	CREAM	TOPICAL	20231018		UNAPPROVED DRUG OTHER		Volans Epic LLC	.ALPHA.-TOCOPHEROL ACETATE; ALOE VERA LEAF; HYALURONATE SODIUM; NIACINAMIDE	.0482; 1.205; .241; .482	g/48.2g; g/48.2g; g/48.2g; g/48.2g			N	20241231
83326-001_faa78cd9-fbb7-4c9a-a7fa-68a5a1bca20c	83326-001	HUMAN OTC DRUG	Zealios Sun Barrier SPF 45		ZINC OXIDE, OCTINOXATE, and OCTISALATE	CREAM	TOPICAL	20120708		OTC MONOGRAPH DRUG	M020	Personal Best Products Inc. dba Zealios	OCTINOXATE; OCTISALATE; ZINC OXIDE	75; 30; 80	mg/mL; mg/mL; mg/mL			N	20241231
83326-002_8eff949d-4027-4c4f-bbb6-4eaa5de64ad5	83326-002	HUMAN OTC DRUG	Zealios SPF LipGuard		OCTISALATE and AVOBENZONE	GEL	TOPICAL	20210621		OTC MONOGRAPH DRUG	M020	Personal Best Products Inc. dba Zealios	AVOBENZONE; OCTISALATE	30; 50	mg/mL; mg/mL			N	20241231
83332-301_f44fdfeb-4359-5884-e053-2a95a90ae231	83332-301	HUMAN OTC DRUG	Furryden Dental Easy Orange		hydrolyzed salmon protein, OMEGA-3	GUM, CHEWING	ORAL	20230217		UNAPPROVED DRUG OTHER		Welpenschutz Inc.	OMEGA-3 FATTY ACIDS; SALMON, UNSPECIFIED	.06; 6	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fatty Acids, Omega-3 [CS], Fish Proteins, Dietary [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Omega-3 Fatty Acid [EPC]		N	20241231
83332-401_f44ffb76-0b66-34aa-e053-2995a90a499c	83332-401	HUMAN OTC DRUG	Furryden Dental Easy Green		Hydrolyzed Chicken Protein, Lutein	GUM, CHEWING	ORAL	20230217		UNAPPROVED DRUG OTHER		Welpenschutz Inc.	CHICKEN; LUTEIN	6; .01	g/100mL; g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
83332-501_f44fed36-13d0-117a-e053-2995a90a4ea2	83332-501	HUMAN OTC DRUG	Furryden Dental Easy Blue		Hydrolyzed Duck protein	GUM, CHEWING	ORAL	20230217		UNAPPROVED DRUG OTHER		Welpenschutz Inc.	DUCK	6	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Poultry Proteins [EXT]		N	20241231
83335-001_06be0304-15d2-e134-e063-6294a90a4f6e	83335-001	HUMAN OTC DRUG	Magnesium Oxide		Magnesium Oxide	TABLET	ORAL	20230316		OTC MONOGRAPH FINAL	part331	Wittman Pharma, Inc.	MAGNESIUM OXIDE	241.3	mg/1000mg	Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83335-002_06be1d04-c8a0-4bc5-e063-6394a90a8008	83335-002	HUMAN OTC DRUG	Sodium Chloride		Normal Salt Tablets	TABLET	ORAL	20230809		OTC MONOGRAPH FINAL	part349	Wittman Pharma, Inc.	SODIUM CHLORIDE	1	g/g			N	20241231
83335-004_0b62981b-5919-26d1-e063-6394a90a15f8	83335-004	HUMAN OTC DRUG	CuraNEX DM		Dextromethorphan Hydrobromide 20 mg Guaifenesin 400 mg	TABLET	ORAL	20231101		OTC MONOGRAPH DRUG	M012	Wittman Pharma, Inc.	DEXTROMETHORPHAN; GUAIFENESIN	20; 400	mg/1; mg/1	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]		N	20241231
83335-104_0ce0f4af-da23-7a3d-e063-6394a90a2321	83335-104	HUMAN OTC DRUG	CuraNOL		Acetaminophen	SUSPENSION	ORAL	20231201		OTC MONOGRAPH DRUG	M013	Wittman Pharma, Inc.	ACETAMINOPHEN	160	mg/5mL			N	20241231
83336-0391_fb833d26-1a7e-cfcc-e053-6394a90af9c7	83336-0391	HUMAN OTC DRUG	YAY NOVELTY ALL-IN-ONE		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20230424		OTC MONOGRAPH FINAL	part352	YAY Novelty	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
83338-0087_fbcf615c-e66f-6633-e053-6394a90a817d	83338-0087	HUMAN OTC DRUG	Covey Sun and Done Daily Moisturizing		Zinc Oxide	LOTION	TOPICAL	20230616		OTC MONOGRAPH NOT FINAL	part352	Covey Skin	ZINC OXIDE	132	mg/mL			N	20241231
83339-002_fd21e3ba-e154-d426-e053-6294a90afeba	83339-002	HUMAN PRESCRIPTION DRUG	VEVYE		cyclosporine ophthalmic solution	SOLUTION/ DROPS	OPHTHALMIC	20230530		NDA	NDA217469	Novaliq GmbH	CYCLOSPORINE	1	mg/mL	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
83342-136_342c1e98-1921-4bcc-ad98-5b7b4bd96148	83342-136	HUMAN OTC DRUG	Kerastase Paris K Symbiose Scalp Renewal Micro Exfoliating Scrub Antidandruff Treatment		Salicylic Acid	SHAMPOO	TOPICAL	20230502		OTC MONOGRAPH DRUG	M032	PRODUCTOS CAPILARES LOREAL SA	SALICYLIC ACID	19	mg/mL			N	20241231
83345-103_f821789c-2598-f8d6-e053-6394a90a799b	83345-103	HUMAN OTC DRUG	GREEN LEAF CBD JOINT AND MUSCLE PAIN RELIEF		MENTHOL, CAMPHOR	CREAM	TOPICAL	20230417		OTC MONOGRAPH NOT FINAL	part348	SURF LINE, INC	CAMPHOR (NATURAL); MENTHOL, UNSPECIFIED FORM	3; 10	g/100g; g/100g			N	20241231
83345-602_f8744925-580f-d893-e053-6294a90a76e5	83345-602	HUMAN OTC DRUG	GREEN LEAF CBD ULTRA RELIEF		MENTHOL, CAMPHOR	GEL	TOPICAL	20230417		OTC MONOGRAPH NOT FINAL	part348	SURF LINE, INC	CAMPHOR (SYNTHETIC); MENTHOL	2; 6	g/100g; g/100g			N	20241231
83347-1844_0a7adae9-2f84-f74f-e063-6294a90a4533	83347-1844	HUMAN OTC DRUG	Rash Buster		Zinc Oxide paste	PASTE	TOPICAL	20230501		OTC MONOGRAPH DRUG	M016	Jeshurun Pharmaceutical LLC	LANOLIN; WHITE PETROLATUM; ZINC OXIDE	10.857; 139.629; 42.42	g/210g; g/210g; g/210g			N	20241231
83348-001_fab60b65-ed0f-76a4-e053-6394a90a887c	83348-001	HUMAN OTC DRUG	Anesthetic Lozenges Raspberry flavour		Benzocaine, Menthol	LOZENGE	ORAL	20230415		OTC MONOGRAPH NOT FINAL	part356	PRASON FOODS	BENZOCAINE; MENTHOL	15; 2.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83348-002_fab61465-dfeb-0498-e053-6294a90a9aec	83348-002	HUMAN OTC DRUG	Anesthetic Lozenges Honey Lime Flavors		Benzocaine,Menthol	LOZENGE	ORAL	20230415		OTC MONOGRAPH NOT FINAL	part356	PRASON FOODS	BENZOCAINE; MENTHOL	15; 2.6	mg/1; mg/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83360-001_f89da869-8ec3-03da-e053-6294a90aeb90	83360-001	HUMAN OTC DRUG	Balancing Act		Salicylic acid	LIQUID	TOPICAL	20230406		OTC MONOGRAPH FINAL	part333D	Parea, Inc.	SALICYLIC ACID	.5	g/100mL			N	20241231
83363-003_0c86cec5-076b-ade6-e063-6294a90afac0	83363-003	HUMAN OTC DRUG	DermaGreen Skin Care		ALLANTOIN, LIDOCAINE	CREAM	TOPICAL	20231121		OTC MONOGRAPH DRUG	M017	Healthy Gourmet Plus, Inc	ALLANTOIN; LIDOCAINE	10; 10	mg/mL; mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83364-001_fb6cf72b-f2f2-3e8b-e053-6294a90a2231	83364-001	HUMAN OTC DRUG	Ariella Nail Repair Pen		POLIGLUSAM, SALICYLIC ACID	LIQUID	TOPICAL	20230512		UNAPPROVED DRUG OTHER		YITONGBADA (SHENZHEN) INTERNATIONAL TRADE CO., LTD	POLIGLUSAM; SALICYLIC ACID	2; 3	g/100mL; g/100mL			N	20241231
83364-002_fb6d0158-4db1-5e3c-e053-6394a90a691f	83364-002	HUMAN OTC DRUG	Ariella Hemorrhoid Gel		PHELLODENDRON CHINENSE WHOLE,SENEGALIA CATECHU WOOD,SOPHORA FLAVESCENS ROOT	GEL	TOPICAL	20230517		UNAPPROVED DRUG OTHER		YITONGBADA (SHENZHEN) INTERNATIONAL TRADE CO., LTD	PHELLODENDRON CHINENSE WHOLE; SENEGALIA CATECHU WOOD; SOPHORA FLAVESCENS ROOT	6; 2; 12	g/100g; g/100g; g/100g			N	20241231
83365-002_f9a7f08e-9e00-b9d2-e053-6394a90a8582	83365-002	HUMAN OTC DRUG	LIDOCAINE		LIDOCAINE spray	SPRAY	TOPICAL	20230325		OTC MONOGRAPH NOT FINAL	part348	Sichuan Gumo Brand Management Co.,Ltd	LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE	5; .25	g/100g; g/100g	Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC]		N	20241231
83365-003_f9d4e0f6-59a5-ce0f-e053-6294a90a6be5	83365-003	HUMAN OTC DRUG	LIDOCAINE		LIDOCAINE	CREAM	TOPICAL	20230421		OTC MONOGRAPH FINAL	M015	Sichuan Gumo Brand Management Co.,Ltd	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83366-001_f6fb8608-ae4e-7a21-e053-6294a90aa104	83366-001	HUMAN OTC DRUG	External delayed product for men		EPIMEDIUM BREVICORNUM, PILOSE ANTLER, EUGENIA CARYOPHYLLUS, CISTANCHE DESERTICOLA, ZANTHOXYLUM BUNGEANUM, MORINDA OFFICINALIS, CNIDIUM MONNIERI	LIQUID	TOPICAL	20230328		UNAPPROVED HOMEOPATHIC		Taizhou Guan Lan Import and Export Co., Ltd	CERVUS ELAPHUS HORN; CISTANCHE DESERTICOLA WHOLE; CLOVE; CNIDIUM MONNIERI FRUIT; EPIMEDIUM BREVICORNU WHOLE; GYNOCHTHODES OFFICINALIS ROOT; ZANTHOXYLUM BUNGEANUM FRUIT	7; 6; 6; 10; 5; 10; 8	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83367-100_f93eb3c0-5c31-d5e6-e053-6294a90a2118	83367-100	HUMAN OTC DRUG	Hoo Gargle Apple Spearmint Flavor		Sodium fluoride	LIQUID	ORAL	20230401		OTC MONOGRAPH FINAL	M022	Nuriearth Global Co., Ltd.	SODIUM FLUORIDE	.2	mg/mL			N	20241231
83367-101_f9298f43-04e0-430c-e053-6294a90a9cb7	83367-101	HUMAN OTC DRUG	Hoo Gargle Jasmine Mint Flavor		Sodium fluoride	LIQUID	ORAL	20230401		OTC MONOGRAPH FINAL	M022	Nuriearth Global Co., Ltd	SODIUM FLUORIDE	.2	mg/mL			N	20241231
83367-102_f92c5561-2a65-e7c0-e053-6294a90ada87	83367-102	HUMAN OTC DRUG	Hoo Gargle Rooibos Tea Flavor		Sodium fluoride	LIQUID	ORAL	20230401		OTC MONOGRAPH FINAL	M022	Nuriearth Global Co., Ltd	SODIUM FLUORIDE	.2	mg/mL			N	20241231
83369-001_f9b83a8d-d275-d9e4-e053-6394a90ac708	83369-001	HUMAN OTC DRUG	spf 50 mineral powder sunscreen		titanium dioxide, zinc oxide	POWDER	TOPICAL	20230413		OTC MONOGRAPH FINAL	M020	Smalls Brand LLC DBA Roe Wellness	TITANIUM DIOXIDE; ZINC OXIDE	23.9; 24.1	g/100g; g/100g			N	20241231
83371-111_fcfec7bb-31b7-25b0-e053-6294a90a9545	83371-111	HUMAN OTC DRUG	ZeroPain 5		Topical Anesthetic Cream	CREAM	TOPICAL	20230531		OTC MONOGRAPH FINAL	M015	Blackbull Store LLC	LIDOCAINE HYDROCHLORIDE	5	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83371-112_0011c61b-e3ce-d909-e063-6394a90a6ac2	83371-112	HUMAN OTC DRUG	Numbed As FXXK		Topical Anesthetic Cream	CREAM	TOPICAL	20230810		OTC MONOGRAPH NOT FINAL	part348	Blackbull Store LLC	LIDOCAINE	4	mg/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83380-001_f82cc145-47e6-d701-e053-6394a90aca88	83380-001	HUMAN OTC DRUG	Tiger Wipes		Benzalkonium Chloride	CLOTH	TOPICAL	20230330		OTC MONOGRAPH NOT FINAL	part333A	Quanzhou Jiechen Daily Necessities Co., Ltd.	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
83383-398_f87e82e8-7e9c-c215-e053-6394a90a2871	83383-398	HUMAN OTC DRUG	PACINOS 5 Minoxidil Topical Solution		MINOXIDIL	LIQUID	TOPICAL	20230410		ANDA	ANDA076239	PACINOS SIGNATURE INC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83384-2650_ff34c7cf-49a5-95dc-e053-6294a90a0920	83384-2650	HUMAN OTC DRUG	Escape the Sun Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part352	Escape Aesthetics	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83386-101_06d42f39-2489-7b3d-e063-6294a90ab05c	83386-101	HUMAN OTC DRUG	BOGEY BLOCKER	SPF 30	HOMOSALATE, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE	LOTION	TOPICAL	20230410		OTC MONOGRAPH FINAL	M020	Bogey Blocker LLC	HOMOSALATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; ZINC OXIDE	5; 3; 5; 1; 2	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83387-399_09769ae3-d1b1-e2dd-e063-6294a90a1f64	83387-399	HUMAN OTC DRUG	Mineral Sunscreen SPF-30		TITANIUM DIOXIDE, ZINC OXIDE	LIQUID	TOPICAL	20230417		OTC MONOGRAPH DRUG	M020	NEWCO LLC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83388-001_f901ed9b-a961-16b2-e053-6394a90af098	83388-001	HUMAN OTC DRUG	HAND SANITIZER		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230410		OTC MONOGRAPH NOT FINAL	part333A	QBLUE TECHNOLOGIES, INC.	BENZALKONIUM CHLORIDE	.9	mg/mL			N	20241231
83388-002_f9039552-11da-a4a3-e053-6294a90a9049	83388-002	HUMAN OTC DRUG	HAND SANITIZER		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20230410		OTC MONOGRAPH NOT FINAL	part333A	QBLUE TECHNOLOGIES, INC.	BENZALKONIUM CHLORIDE	.9	mg/mL			N	20241231
83388-003_f90335c1-7fd9-bd3d-e053-6394a90ac9b8	83388-003	HUMAN OTC DRUG	ANTIBACTERIAL SANITIZING AND MOISTURIZING HAND		BENZALKONIUM CHLORIDE	CREAM	TOPICAL	20230410		OTC MONOGRAPH NOT FINAL	part333A	QBLUE TECHNOLOGIES, INC.	BENZALKONIUM CHLORIDE	.9	mg/mL			N	20241231
83389-111_00b3b7f5-3e19-836e-e063-6394a90ac915	83389-111	HUMAN OTC DRUG	Pro Numb		Tattoo Numbing Spray	SPRAY	TOPICAL	20230412		UNAPPROVED DRUG OTHER		Pro Numb Tattoo Numbing Spray LLC	EPINEPHRINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE	.1; 5	mg/100mL; mg/100mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83391-001_00a6eb5e-22a9-fdd4-e063-6394a90a956f	83391-001	HUMAN OTC DRUG	AUVON LIDOCAINE MENTHOL Pain Relief		lidocaine and menthol	PATCH	TOPICAL	20230412		OTC MONOGRAPH NOT FINAL	part348	SHENZHEN YUWEN E-COMMERCE CO., LTD.	LIDOCAINE; MENTHOL	370; 100	mg/1; mg/1	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83391-002_ffc13112-3f8c-f071-e053-6394a90a7673	83391-002	HUMAN OTC DRUG	AUVON Pain Relief		menthol	PATCH	TOPICAL	20230705		OTC MONOGRAPH NOT FINAL	part348	SHENZHEN YUWEN E-COMMERCE CO., LTD.	MENTHOL	470	mg/1			N	20241231
83395-050_fe7e3cb3-7f9c-515c-e053-6394a90a5d5a	83395-050	HUMAN OTC DRUG	Vaihea Protect Clean SPF Drops		Zinc Oxide	LOTION	TOPICAL	20230831		OTC MONOGRAPH NOT FINAL	part352	Vaihea Skincare LLC	ZINC OXIDE	132	mg/mL			N	20241231
83403-001_f9a65f7e-2852-deff-e053-6394a90a8eb7	83403-001	HUMAN OTC DRUG	iUNIK Centella Calming Daily Sunscreen		Diethylamino Hydroxybenzoyl Hexyl Benzoate, Ethylhexyl Triazone, Methylene Bis-Benzotriazolyl Tetramethylbutylphenol	CREAM	TOPICAL	20230418		UNAPPROVED DRUG OTHER		IUNIK Co., Ltd.	BISOCTRIZOLE; DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE; ETHYLHEXYL TRIAZONE	2; 5; 4	g/100mL; g/100mL; g/100mL			N	20241231
83404-301_f942fa8e-3c4e-e857-e053-6394a90a4a65	83404-301	HUMAN OTC DRUG	K-Power Patch		achyranthes bidentata extract, achyranthes bidentata extract,	PATCH	TOPICAL	20230530		UNAPPROVED DRUG OTHER		BCT	ACHYRANTHES BIDENTATA WHOLE; CAPSAICIN; EUCOMMIA ULMOIDES WHOLE; HARPAGOPHYTUM PROCUMBENS WHOLE; LITHOSPERMUM ERYTHRORHIZON WHOLE; XANTHIUM STRUMARIUM LEAF	3; .4; 2; 1; 3; 2	g/100mm; g/100mm; g/100mm; g/100mm; g/100mm; g/100mm			N	20241231
83406-121_fa9ee809-8320-6cbf-e053-6394a90a2aa6	83406-121	HUMAN OTC DRUG	Unpaste		Zero waste fluoride cinnamon tooth tabs	TABLET, CHEWABLE	DENTAL	20230501		OTC MONOGRAPH FINAL	part355	PTG Lohnabfuellung GmbH	SODIUM FLUORIDE	.62	mg/1			N	20241231
83406-122_fa9e93dc-7249-49ba-e053-6394a90a7d4e	83406-122	HUMAN OTC DRUG	Unpaste		Zero waste fluoride mint tooth tabs	TABLET, CHEWABLE	DENTAL	20230501		OTC MONOGRAPH FINAL	part355	PTG Lohnabfuellung GmbH	SODIUM FLUORIDE	.62	mg/1			N	20241231
83407-001_fc632cb9-a4cd-07a9-e053-6394a90a63b9	83407-001	HUMAN OTC DRUG	Sun-Light Sunscreen	Broad Spectrum SPF 45	octyl salicylate, octocrylene, avobenzone	LOTION	TOPICAL	20230905		OTC MONOGRAPH FINAL	M020	Indeed Laboratories Inc.	AVOBENZONE; OCTISALATE; OCTOCRYLENE	3; 5; 9	mg/mL; mg/mL; mg/mL			N	20241231
83422-000_0ce36844-9314-c01f-e063-6294a90abed6	83422-000	HUMAN OTC DRUG	Bella V Antacid Extra Strength Berries Flavor		CALCIUM CARBONATE	TABLET	ORAL	20240101		OTC MONOGRAPH DRUG	M001	Biovantek	CALCIUM CARBONATE	750	mg/1	Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]		N	20241231
83429-010_fb43a1ba-f10e-652a-e053-6294a90ad4dc	83429-010	HUMAN OTC DRUG	INNBEAUTY PROJECT Acne Serum		Acne Treatment	LIQUID	TOPICAL	20230509		OTC MONOGRAPH FINAL	part333D	Inn Beauty Lab Inc.	SALICYLIC ACID	1.5	g/100g			N	20241231
83432-402_0976c8f2-debf-fb24-e063-6394a90a04dd	83432-402	HUMAN OTC DRUG	Doctors Diaper Rash Cream		ZINC OXIDE	CREAM	TOPICAL	20230508		OTC MONOGRAPH DRUG	M016	DOCTOR'S DIAPER RASH CREAM, INC	ZINC OXIDE	140	mg/g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83434-2650_fea919c2-d7d8-e5fa-e053-6294a90aea0c	83434-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	NUDERMA MEDSPA AND WELLNESS CENTER LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83435-0650_fa6b66a9-f8aa-0eba-e053-6294a90a72ce	83435-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	Dermio Dermatology LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83436-001_fadbf554-7f1c-d18d-e053-6394a90aed89	83436-001	HUMAN OTC DRUG	Wart Remover set		Wart Remover set	OIL	TOPICAL	20230504		OTC MONOGRAPH FINAL	part358H	RD2 GROUP, LLC	SALICYLIC ACID	2	mg/100mL			N	20241231
83438-2650_fbbee10d-78c3-e8fd-e053-6294a90aaa84	83438-2650	HUMAN OTC DRUG	Timeless Shield Moisturizing Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	Dr. Faina Aesthetics and Medi Spa LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83440-2650_ff33feb8-0211-2465-e053-6294a90aed48	83440-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	Plaza Health and Wellness Center	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83445-010_62463456-a6c9-4c83-8bbf-d2c7f1aaa944	83445-010	HUMAN OTC DRUG	GIFTEAST BAJA SALT GARGLE ORIGIN		Sodium Fluoride, Sodium Chloride	MOUTHWASH	ORAL	20230501		UNAPPROVED DRUG OTHER		FOODPORT	SODIUM CHLORIDE; SODIUM FLUORIDE	2; .05	g/100mL; g/100mL			N	20241231
83445-020_cc3ee472-e78e-467e-91b2-4952371bca15	83445-020	HUMAN OTC DRUG	GIFTEAST BAJA SALT TOOTHPASTE ORIGIN		Sodium Chloride, Hydrated Silica, Sodium Fluoride, Tocopheryl Acetate	PASTE, DENTIFRICE	ORAL	20230501		UNAPPROVED DRUG OTHER		FOODPORT	.ALPHA.-TOCOPHEROL ACETATE; HYDRATED SILICA; SODIUM CHLORIDE; SODIUM FLUORIDE	.2; 13; 5; .22	g/100g; g/100g; g/100g; g/100g			N	20241231
83446-001_f7928fef-dc77-289f-e053-6394a90aee2b	83446-001	HUMAN OTC DRUG	ALCOHOL PREP PADS MEDIUM STERILE		isopropyl alcohol cloth	CLOTH	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part333A	JINHUA JINGDI MEDICAL SUPPLIES CO., LTD	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83446-002_fafd197e-d037-5ce5-e053-6294a90a6da9	83446-002	HUMAN OTC DRUG	ALCOHOL PREP PADS LARGE STERILE		isopropyl alcohol cloth	CLOTH	TOPICAL	20230301		OTC MONOGRAPH NOT FINAL	part333A	JINHUA JINGDI MEDICAL SUPPLIES CO.,LTD	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83447-001_fae8ecaf-7a9d-902b-e053-6394a90a5f31	83447-001	HUMAN OTC DRUG	sunscreen powder		sunscreen powder	POWDER	CUTANEOUS	20230505		OTC MONOGRAPH NOT FINAL	part352	Guangzhou Fantesy Biotechnology Co.,Ltd	ZINC OXIDE	25	g/100g			N	20241231
83447-002_062be336-2af5-10e2-e063-6294a90a480a	83447-002	HUMAN OTC DRUG	EVERYRAY SUNCARE SUNSHINE SERUM		EVERYRAY SUNCARE SUNSHINE SERUM	LIQUID	CUTANEOUS	20230925		OTC MONOGRAPH NOT FINAL	part352	Guangzhou Fantesy Biotechnology Co.,Ltd	ZINC OXIDE	12	g/100mL			N	20241231
83447-003_0808b0cd-2cfc-8554-e063-6294a90ad6c4	83447-003	HUMAN OTC DRUG	ORLASKIN HYDRATING SUNSCREEN		ORLASKIN HYDRATING SUNSCREEN	SPRAY	CUTANEOUS	20231019		UNAPPROVED DRUG OTHER		Guangzhou Fantesy Biotechnology Co.,Ltd	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	3; 10; 5; 8	g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83448-025_f662930a-cc91-43f6-9888-7323d13ba841	83448-025	HUMAN OTC DRUG	goPure Sunscreen		Zinc oxide	LOTION	TOPICAL	20230828		OTC MONOGRAPH FINAL	part352	Natural Lifestyle Brands, LLC dba GoPure beauty	ZINC OXIDE	25	g/100mL			N	20241231
83453-405_0976c8f2-deae-fb24-e063-6394a90a04dd	83453-405	HUMAN OTC DRUG	CALIFORNIA MANGO SPF-30 SUNSCREEN		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LIQUID	TOPICAL	20230522		OTC MONOGRAPH DRUG	M020	CALMANGO, INC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 50	mg/mL; mg/mL; mg/mL			N	20241231
83453-406_09769ae3-d1a0-e2dd-e063-6294a90a1f64	83453-406	HUMAN OTC DRUG	CALIFORNIA MANGO SPF-50 SUNSCREEN		AVOBENZONE, OCTISALATE, OCTOCRYLENE	LIQUID	TOPICAL	20230522		OTC MONOGRAPH DRUG	M020	CALMANGO, INC	AVOBENZONE; OCTISALATE; OCTOCRYLENE	30; 50; 100	mg/mL; mg/mL; mg/mL			N	20241231
83454-404_fb6963da-f4ba-c8b4-e053-6394a90ae202	83454-404	HUMAN OTC DRUG	Hair Labs Mens Extra Strength 5 Minoxidil		MINOXIDIL	LIQUID	TOPICAL	20230515		ANDA	ANDA076239	HAIR RESTORATION LABS, LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83455-112_d3362d26-2a63-45be-b5b8-42e75f1869d7	83455-112	HUMAN OTC DRUG	Docosanol		Docosanol	CREAM	TOPICAL	20231231		ANDA	ANDA212385	United Natural Foods, Inc. dba UNFI	DOCOSANOL	100	mg/g			N	20241231
83455-152_ef62f56e-b2e9-484e-9fe3-f1cd502a30d3	83455-152	HUMAN OTC DRUG	Gas Relief		Simethicone	CAPSULE, LIQUID FILLED	ORAL	20231231		OTC MONOGRAPH DRUG	M002	United Natural Foods, Inc. dba UNFI	DIMETHICONE	180	mg/1	Skin Barrier Activity [PE]		N	20251231
83455-200_fb7e30c0-cfff-d5ae-e053-6294a90a963d	83455-200	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc.	MENTHOL	7.6	mg/1			N	20241231
83455-201_f9f0cfc0-15c0-e327-e053-6394a90a5ce5	83455-201	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc.	MENTHOL	5.8	mg/1			N	20241231
83455-202_f9f0e8e2-c4f9-a4d9-e053-6294a90a63f3	83455-202	HUMAN OTC DRUG	Cough Drops		Cherry	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc.	MENTHOL	5.8	mg/1			N	20241231
83455-203_fb7ee4de-a364-2b56-e053-6394a90a19b4	83455-203	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc.	MENTHOL	7.5	mg/1			N	20241231
83455-204_fb7ef898-de4a-b242-e053-6394a90a7989	83455-204	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc.	MENTHOL	5.8	mg/1			N	20241231
83455-205_fb7f9b67-ff0c-3af4-e053-6294a90ac539	83455-205	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc.	MENTHOL	5.8	mg/1			N	20241231
83455-206_fb7f5ae0-fa8c-a21a-e053-6294a90a9866	83455-206	HUMAN OTC DRUG	Cough Drops		Menthol	PASTILLE	ORAL	20230512		OTC MONOGRAPH FINAL	part341	United Natural Foods, Inc.	MENTHOL	5.4	mg/1			N	20241231
83455-300_3fa9cc84-97c5-4621-8dae-3949108aeda5	83455-300	HUMAN OTC DRUG	Equaline Regular Strength Chocolated Stimulant Laxative		Sennosides	TABLET, CHEWABLE	ORAL	20240101		OTC MONOGRAPH DRUG	M007	United Natural Foods, Inc. dba UNFI	SENNOSIDES	15	mg/1			N	20241231
83456-000_08c0d21a-b12f-45d4-e063-6394a90a6c48	83456-000	HUMAN OTC DRUG	Ursa Major Force Field SPF 30		ZINC OXIDE	CREAM	TOPICAL	20230501		OTC MONOGRAPH DRUG	M020	Ursa Major Natural Care, LLC	ZINC OXIDE	149.5	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83457-100_0a7e0261-756d-4427-b50c-7555556a2634	83457-100	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230921		BLA	BLA761071	Cordavis Limited	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
83457-101_0a7e0261-756d-4427-b50c-7555556a2634	83457-101	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230921		BLA	BLA761071	Cordavis Limited	ADALIMUMAB	40	mg/.4mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
83457-102_0a7e0261-756d-4427-b50c-7555556a2634	83457-102	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230921		BLA	BLA761071	Cordavis Limited	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
83457-103_0a7e0261-756d-4427-b50c-7555556a2634	83457-103	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20230921		BLA	BLA761071	Cordavis Limited	ADALIMUMAB	40	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
83457-107_0a7e0261-756d-4427-b50c-7555556a2634	83457-107	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20231215		BLA	BLA761071	Cordavis Limited	ADALIMUMAB	80	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
83457-108_0a7e0261-756d-4427-b50c-7555556a2634	83457-108	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20231215		BLA	BLA761071	Cordavis Limited	ADALIMUMAB	20	mg/.2mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
83457-112_0a7e0261-756d-4427-b50c-7555556a2634	83457-112	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	KIT		20231215		BLA	BLA761071	Cordavis Limited						N	20241231
83457-113_0a7e0261-756d-4427-b50c-7555556a2634	83457-113	HUMAN PRESCRIPTION DRUG	HYRIMOZ		adalimumab-adaz	INJECTION, SOLUTION	SUBCUTANEOUS	20231215		BLA	BLA761071	Cordavis Limited	ADALIMUMAB	80	mg/.8mL	Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]		N	20241231
83458-003_fc99b62a-64e1-81f7-e053-6394a90aa9bf	83458-003	HUMAN OTC DRUG	ELITEHEALTH		Nicotinamide Mononucleotide	CAPSULE	ORAL	20230320		UNAPPROVED DRUG OTHER		MOHAMMEDJALI Co., Ltd	NICOTINAMIDE MONONUCLEOTIDE	500	mg/1			N	20241231
83459-001_fc999a87-d8d4-bf9c-e053-6294a90a1f32	83459-001	HUMAN OTC DRUG	Ascuoli		Resveratrol,NICOTINAMIDE MONONUCLEOTIDE,Piper nigrum extract	CAPSULE	ORAL	20230320		UNAPPROVED DRUG OTHER		HEALGROW INC	NICOTINAMIDE MONONUCLEOTIDE; RESVERATROL; WHITE PEPPER	500; 600; 50	mg/1; mg/1; mg/1			N	20241231
83459-002_fc99b62a-64d6-81f7-e053-6394a90aa9bf	83459-002	HUMAN OTC DRUG	Ascuoli		Resveratrol,NICOTINAMIDE MONONUCLEOTIDE,Piper nigrum extract	LOZENGE	ORAL	20230320		UNAPPROVED DRUG OTHER		HEALGROW INC	NICOTINAMIDE MONONUCLEOTIDE; RESVERATROL; WHITE PEPPER	500; 400; 50	mg/1; mg/1; mg/1			N	20241231
83459-003_089f5a6f-d8d0-c144-e063-6294a90a1d13	83459-003	HUMAN OTC DRUG	Herodianow		Nicotinamide Mononucleotide,Resveratrol,Black Pepper Extract	LOZENGE	ORAL	20230930		UNAPPROVED DRUG OTHER		HEALGROW INC	NICOTINAMIDE MONONUCLEOTIDE; RESVERATROL; WHITE PEPPER	500; 400; 50	mg/1; mg/1; mg/1			N	20241231
83462-001_03339501-199f-81bc-e063-6294a90aac3e	83462-001	HUMAN OTC DRUG	BEAUELI		Lidocaine	CREAM	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part348	EUbizrival LLC	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83462-002_04b6fb32-4f58-b262-e063-6394a90a5855	83462-002	HUMAN OTC DRUG	Tobcharm		Undecylenic Acid	LIQUID	TOPICAL	20230905		OTC MONOGRAPH FINAL	part333C	EUbizrival LLC	UNDECYLENIC ACID	10	g/100mL			N	20241231
83462-003_092dab03-f891-80f8-e063-6394a90a57a9	83462-003	HUMAN OTC DRUG	Beaueli 5% Minoxidil hair growth oil		5% Minoxidil hair growth oil	LIQUID	TOPICAL	20231101		ANDA	ANDA075357	Eubizrival Llc	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-004_092efccd-df38-e306-e063-6294a90a8495	83462-004	HUMAN OTC DRUG	Beaueli 5% Minoxidil hair growth oil		5% Minoxidil hair growth oil	LIQUID	TOPICAL	20231102		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-005_092f27ab-b520-f7a4-e063-6294a90a56fc	83462-005	HUMAN OTC DRUG	5% Minoxidil hair growth oil		5% Minoxidil Spray	LIQUID	TOPICAL	20231102		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-006_092f7745-1604-2ef0-e063-6394a90ad962	83462-006	HUMAN OTC DRUG	Beaueli 5% Minoxidil hair growth oil		5% Minoxidil hair growth oil	LIQUID	TOPICAL	20231102		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-007_092fd0e0-860b-62a2-e063-6294a90aeb0e	83462-007	HUMAN OTC DRUG	2% Minoxidil hair growth oil		2% Minoxidil hair growth oil	LIQUID	TOPICAL	20231102		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-008_0936740d-cb79-729f-e063-6394a90a20ea	83462-008	HUMAN OTC DRUG	5% Minoxidil hair growth oil		5% Minoxidil hair growth kit	LIQUID	TOPICAL	20231102		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-009_0936b2ec-68a8-b8c1-e063-6394a90a0e17	83462-009	HUMAN OTC DRUG	OLISMO 5% Minoxidil Hair Growth Serum		OLISMO 5% Minoxidil Hair Growth Serum	LIQUID	TOPICAL	20231102		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-010_09370b17-eb6f-bfe1-e063-6394a90a4c69	83462-010	HUMAN OTC DRUG	SUNHEAL 5% Minoxidil Hair Growth Kit		SUNHEAL 5% Minoxidil Hair Growth Kit	LIQUID	TOPICAL	20231102		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-011_094b9bf3-a940-5e2a-e063-6394a90a74dd	83462-011	HUMAN OTC DRUG	OLISMO 5% Minoxidil Hair Growth Kit		OLISMO 5% Minoxidil Hair Growth Kit	LIQUID	TOPICAL	20231103		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-012_094bd248-4853-7264-e063-6394a90aa192	83462-012	HUMAN OTC DRUG	SUNHEAL 5% Minoxidil Hair Growth Foam		SUNHEAL 5% Minoxidil Hair Growth Foam	CREAM	TOPICAL	20231103		ANDA	ANDA075357	Eubizrival LLC	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83462-016_0cf31b40-816d-d055-e063-6294a90af5d0	83462-016	HUMAN OTC DRUG	Tobcharm		UNDECYLENIC ACID	LIQUID	TOPICAL	20231214		OTC MONOGRAPH DRUG	M005	Eubizrival LLC	UNDECYLENIC ACID	24.8	g/100mL			N	20241231
83463-0002_fc52ae90-738a-2c41-e053-6294a90ac1b6	83463-0002	HUMAN OTC DRUG	GROWTH SUPPORTPATCH, HAUTUKI		Cholecalciferol (vitamin D3)	PATCH	TOPICAL	20230501		UNAPPROVED DRUG OTHER		CUSTICS	CHOLECALCIFEROL	.2	mg/100g	Vitamin D [CS], Vitamin D [EPC]		N	20241231
83465-101_0827d95f-d137-2d96-e063-6394a90ae347	83465-101	HUMAN OTC DRUG	Nasal Decolonization Swab		PVP-I Solution	LIQUID	TOPICAL	20231031		OTC MONOGRAPH DRUG	M003	I2 Strategic Solutions	POVIDONE-IODINE	.114	mg/1.5mg			N	20241231
83466-010_8e05541f-ad3e-4d77-acc7-babbac907551	83466-010	HUMAN OTC DRUG	Delixir G Toothpaste		Sodium Fluoride	PASTE, DENTIFRICE	ORAL	20230501		UNAPPROVED DRUG OTHER		Froncare, Inc.	SODIUM FLUORIDE	.11	g/100g			N	20241231
83469-0650_fea8376b-3865-acdd-e053-6294a90ad22f	83469-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	JSGB MANAGEMENT LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83469-2650_fea8244b-411c-614f-e053-6394a90a04ff	83469-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	JSGB MANAGEMENT LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83472-311_0e196b09-7bb0-5d0e-e063-6394a90a70c7	83472-311	HUMAN OTC DRUG	MONPURIEL Daily all in one ample		L-Menthol, Dexpanthenol, Salicylic Acid	LIQUID	TOPICAL	20230501		UNAPPROVED DRUG OTHER		Y2K Co., Ltd.	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.22; .33; .25	g/100mL; g/100mL; g/100mL			N	20251231
83472-411_0e196b09-7bb3-5d0e-e063-6394a90a70c7	83472-411	HUMAN OTC DRUG	MONPURIEL Hair loss care-shampoo		L-Menthol, Dexpanthenol, Salicylic Acid	SHAMPOO	TOPICAL	20230501		UNAPPROVED DRUG OTHER		Y2K Co., Ltd.	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.22; .33; .25	g/100mL; g/100mL; g/100mL			N	20251231
83472-412_0e197723-ee92-5ef8-e063-6394a90a0c21	83472-412	HUMAN OTC DRUG	MONPURIEL Hair Loss Care-shampoo		L-Menthol, Dexpanthenol, Salicylic Acid	SHAMPOO	TOPICAL	20230501		UNAPPROVED DRUG OTHER		Y2K Co., Ltd.	DEXPANTHENOL; LEVOMENTHOL; SALICYLIC ACID	.22; .33; .25	g/100mL; g/100mL; g/100mL			N	20251231
83472-511_0e1972eb-957f-18fb-e063-6294a90a4541	83472-511	HUMAN OTC DRUG	Scalp deep cleansing-shampoo		Dexpanthenol, Niacinamide, Salicylic Acid	SHAMPOO	TOPICAL	20230501		UNAPPROVED DRUG OTHER		Y2K Co., Ltd.	DEXPANTHENOL; NIACINAMIDE; SALICYLIC ACID	.2; .1; .2	g/100mL; g/100mL; g/100mL			N	20251231
83472-521_0e19f336-9c9a-7e63-e063-6394a90a58bf	83472-521	HUMAN OTC DRUG	MONPURIEL Scalp deep cleansing-shampoo		Dexpanthenol, Niacinamide, Salicylic Acid	SHAMPOO	TOPICAL	20230501		UNAPPROVED DRUG OTHER		Y2K Co., Ltd.	DEXPANTHENOL; NIACINAMIDE; SALICYLIC ACID	.2; .1; .2	g/100mL; g/100mL; g/100mL			N	20251231
83472-522_0e19f336-9c99-7e63-e063-6394a90a58bf	83472-522	HUMAN OTC DRUG	MONPURIEL Scalp deep cleansing-shampoo		Dexpanthenol, Niacinamide, Salicylic Acid	SHAMPOO	TOPICAL	20230501		UNAPPROVED DRUG OTHER		Y2K Co., Ltd.	DEXPANTHENOL; NIACINAMIDE; SALICYLIC ACID	.2; .1; .2	g/100mL; g/100mL; g/100mL			N	20251231
83478-000_0989111d-fee1-5abb-e063-6394a90a94c2	83478-000	HUMAN OTC DRUG	SETT Mineral Sunscreen SPF 50		ZINC OXIDE, TITANIUM DIOXIDE	CREAM	TOPICAL	20230801		OTC MONOGRAPH DRUG	M020	Sett Surf, Ltd.	TITANIUM DIOXIDE; ZINC OXIDE	45; 125	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83490-302_fc6a8835-6814-c90e-e053-6394a90a0aed	83490-302	HUMAN OTC DRUG	LACTO REMEDY ladys cleansing wipes		Lactobacillus Ferment Lysate	SWAB	TOPICAL	20220726		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	.01	g/100g			N	20241231
83490-303_fc6a4a20-4516-c829-e053-6394a90a8870	83490-303	HUMAN OTC DRUG	LACTO REMEDY Ladys foaming wash		Lactobacillus Ferment Lysate	LIQUID	TOPICAL	20220726		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	.0176	g/100g			N	20241231
83490-304_fc6a45bf-4feb-7cac-e053-6294a90a2d60	83490-304	HUMAN OTC DRUG	LACTO REMEDY Ladys inner care gel		Lactobacillus Ferment Lysate	SOLUTION, GEL FORMING / DROPS	TOPICAL	20220725		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	.025	g/100g			N	20241231
83490-312_fc903604-e03b-e521-e053-6294a90aca41	83490-312	HUMAN OTC DRUG	LACTOMEDI ladys cleansing wipes		Lactobacillus Ferment Lysate	SWAB	TOPICAL	20220726		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	.01	g/100g			N	20241231
83490-313_fc9047e8-141d-4994-e053-6294a90ad770	83490-313	HUMAN OTC DRUG	LACTOMEDI Ladys foaming wash		Lactobacillus Ferment Lysate	LIQUID	TOPICAL	20220726		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	.0176	g/100g			N	20241231
83490-314_fc903604-e03d-e521-e053-6294a90aca41	83490-314	HUMAN OTC DRUG	LACTOMEDI Ladys inner care gel		Lactobacillus Ferment Lysate	SOLUTION, GEL FORMING / DROPS	TOPICAL	20220725		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	.025	g/100g			N	20241231
83490-315_fd0e0a18-24f9-863e-e053-6294a90ac1d5	83490-315	HUMAN OTC DRUG	purified water		HYALURONIC ACID	INJECTION, SOLUTION	VAGINAL	20230601		UNAPPROVED DRUG OTHER		2359 US INC	WATER	99.99	g/100mL			N	20241231
83490-316_fd0e3c98-9bae-85b9-e053-6294a90a7cc1	83490-316	HUMAN OTC DRUG	Dimethicone		Cyclomethicone	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		2359 US INC	DIMETHICONE	48	g/100g	Skin Barrier Activity [PE]		N	20241231
83490-317_04a82b8f-0f21-8ef6-e063-6394a90a555e	83490-317	HUMAN OTC DRUG	LACTOMEDI Ferminine Soothing Cream		Lactobacillus Ferment Lysate, Allantoin, Panthenol	CREAM	VAGINAL	20230822		OTC MONOGRAPH FINAL	M016	2359 US INC	ALLANTOIN; LIMOSILACTOBACILLUS FERMENTUM; PANTHENOL	1; 1; 1	g/100mL; g/100mL; g/100mL			N	20241231
83490-318_0171c71c-4f03-4917-e063-6394a90a6d6e	83490-318	HUMAN OTC DRUG	LACTOMEDI Ferminine Probiotics Powder Mist		Lactobacillus Ferment Lysate	SPRAY	VAGINAL	20230824		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	12	g/100g			N	20241231
83490-501_f6710434-c224-2b68-e053-2a95a90a06b5	83490-501	HUMAN OTC DRUG	LACTOMEDI Pleasure gel		Lactobacillus Ferment Lysate	GEL	VAGINAL	20230524		UNAPPROVED DRUG OTHER		2359 US INC	LIMOSILACTOBACILLUS FERMENTUM	.1	g/100mL			N	20241231
83490-601_f673e59f-7c54-3e2c-e053-2995a90ac7b5	83490-601	HUMAN OTC DRUG	Celladix Sebum Rebalancing Rx 131 Ampoule		Niacinamide, Adenosine	SOLUTION/ DROPS	TOPICAL	20230524		UNAPPROVED DRUG OTHER		2359 US INC	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
83490-602_f6741846-7f62-3608-e053-2995a90adcc1	83490-602	HUMAN OTC DRUG	Celladix Skin Barrier Recovery 131 Cream		Niacinamide, Adenosine	CREAM	TOPICAL	20230524		UNAPPROVED DRUG OTHER		2359 US INC	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
83490-603_f6741dd0-0c4c-a06b-e053-2995a90ace85	83490-603	HUMAN OTC DRUG	Celladix Skin Balancing pH 5.5 Toner Mist		Niacinamide, Adenosine	SPRAY	TOPICAL	20230524		UNAPPROVED DRUG OTHER		2359 US INC	ADENOSINE; NIACINAMIDE	.04; 2	g/100mL; g/100mL	Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]		N	20241231
83490-604_f6741dd0-0c4e-a06b-e053-2995a90ace85	83490-604	HUMAN OTC DRUG	Celladix Acne Control Gel Cleanser		Salicylic Acid	GEL	TOPICAL	20230524		UNAPPROVED DRUG OTHER		2359 US INC	SALICYLIC ACID	.5	g/100mL			N	20241231
83490-605_0171c4a5-da54-1f0b-e063-6394a90ad3b2	83490-605	HUMAN OTC DRUG	Celladix C.E.F ADVANCED BRIGHTENING AMPOULE		Ascorbic Acid	LIQUID	TOPICAL	20230724		UNAPPROVED DRUG OTHER		2359 US INC	ASCORBIC ACID	15	g/100mL	Ascorbic Acid [CS], Vitamin C [EPC]		N	20241231
83490-901_fa11836a-5aed-c4ec-e053-6394a90ac468	83490-901	HUMAN OTC DRUG	Lactomedi Self-care Trial Kit		Lactobacillus Ferment Lysate	KIT	TOPICAL	20230401		UNAPPROVED DRUG OTHER		2359 US INC						N	20241231
83493-150_0c5b3b82-94c8-169a-e063-6394a90aa73e	83493-150	HUMAN OTC DRUG	Beet the sun lightweight sunscreen broad spectrum spf 40 pa		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230301		OTC MONOGRAPH DRUG	M020	Krave Beauty, LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 30	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83494-001_fc951d1d-dcd5-b55a-e053-6294a90a420e	83494-001	HUMAN OTC DRUG	Ixeris Denticulata		CREPIDIASTRUM SONCHIFOLIUM WHOLE	POWDER	ORAL	20230526		UNAPPROVED HOMEOPATHIC		Oriental Yutai Health Management LLC	CREPIDIASTRUM SONCHIFOLIUM WHOLE	80	g/100g			N	20241231
83494-002_fd0ecee5-0655-7857-e053-6394a90aa16c	83494-002	HUMAN OTC DRUG	FU LING CAKE		FU LING, WURFBAINIA VILLOSA FRUIT	OINTMENT	ORAL	20230601		UNAPPROVED HOMEOPATHIC		Oriental Yutai Health Management LLC	FU LING; WURFBAINIA VILLOSA FRUIT	9; 9	g/100g; g/100g			N	20241231
83494-003_fd20ad7b-b4d9-dd79-e053-6294a90ac404	83494-003	HUMAN OTC DRUG	broad bean and ginseng cake		ASIAN GINSENG	OINTMENT, AUGMENTED	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Oriental Yutai Health Management LLC	ASIAN GINSENG	9	g/100g			N	20241231
83494-004_fd21b49e-de9a-3103-e053-6294a90ad584	83494-004	HUMAN OTC DRUG	DIOSCOREA VILLOSA CAKE		ASIAN GINSENG, DIOSCOREA VILLOSA TUBER	OINTMENT, AUGMENTED	ORAL	20230602		UNAPPROVED HOMEOPATHIC		Oriental Yutai Health Management LLC	ASIAN GINSENG; DIOSCOREA VILLOSA TUBER	3; 6	g/100g; g/100g			N	20241231
83495-101_1140b7a9-dbbc-44dc-8473-b1d084449a02	83495-101	HUMAN OTC DRUG	Glowell SPF 30 Tinted Mineral Sunscreen	Light	zinc oxide and titanium dioxide	CREAM	TOPICAL	20230705		OTC MONOGRAPH FINAL	part352	GLOWELL, LLC.	TITANIUM DIOXIDE; ZINC OXIDE	.005; .142	g/mL; g/mL			N	20241231
83495-102_1140b7a9-dbbc-44dc-8473-b1d084449a02	83495-102	HUMAN OTC DRUG	Glowell SPF 30 Tinted Mineral Sunscreen	Medium	zinc oxide and titanium dioxide	CREAM	TOPICAL	20230705		OTC MONOGRAPH FINAL	part352	GLOWELL, LLC.	TITANIUM DIOXIDE; ZINC OXIDE	.005; .142	g/mL; g/mL			N	20241231
83495-103_1140b7a9-dbbc-44dc-8473-b1d084449a02	83495-103	HUMAN OTC DRUG	Glowell SPF 30 Tinted Mineral Sunscreen	Tan	zinc oxide and titanium dioxide	CREAM	TOPICAL	20230705		OTC MONOGRAPH FINAL	part352	GLOWELL, LLC.	TITANIUM DIOXIDE; ZINC OXIDE	.005; .142	g/mL; g/mL			N	20241231
83495-104_1140b7a9-dbbc-44dc-8473-b1d084449a02	83495-104	HUMAN OTC DRUG	Glowell SPF 30 Tinted Mineral Sunscreen	Deep	zinc oxide and titanium dioxide	CREAM	TOPICAL	20230705		OTC MONOGRAPH FINAL	part352	GLOWELL, LLC.	TITANIUM DIOXIDE; ZINC OXIDE	.005; .142	g/mL; g/mL			N	20241231
83497-001_01777c19-d136-ca09-e063-6294a90ab8d2	83497-001	HUMAN OTC DRUG	Eyelash Growth Serum		panthenol ,myristoyl pentapeptide-4	LIQUID	TOPICAL	20230714		UNAPPROVED DRUG OTHER		Guangzhou Homar Bio Technology Co. Ltd	MYRISTOYL PENTAPEPTIDE-4; PANTHENOL	.01; .1	g/100mL; g/100mL			N	20241231
83499-001_ffe99e41-8117-bcf6-e053-6294a90a7c45	83499-001	HUMAN OTC DRUG	Hammertech	Vitamin A and D	White Petrolatum	OINTMENT	TOPICAL	20230701		OTC MONOGRAPH FINAL	part347	HAMMER TECH LLC	PETROLATUM	76	g/100g			N	20241231
83500-001_fca370da-e6c7-d0f4-e053-6394a90adddd	83500-001	HUMAN OTC DRUG	Vaginne Intimate Hygiene Wash		Patent Vaginne, Patent Barrief, Sodium Hyaluronate	GEL	TOPICAL	20220614		UNAPPROVED DRUG OTHER		WOYA BIO-TECHNOLOGY CO.,LTD.	HYALURONATE SODIUM; LACTIC ACID; SORBITAN MONOLAURATE	.5; 30; 10	g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA]		N	20241231
83502-001_fcb9fe65-837d-011b-e053-6294a90a4605	83502-001	HUMAN OTC DRUG	Sipa Foam hand sanitizer with Moisturizers		Instant hand sanitizer	LIQUID	TOPICAL	20230527		OTC MONOGRAPH NOT FINAL	part333A	Tourel (Changsha)Hotel Supplies Co.,Ltd	BENZALKONIUM CHLORIDE	.15	g/100mL			N	20241231
83502-002_fcbad83b-b8ab-a780-e053-6294a90a58ab	83502-002	HUMAN OTC DRUG	Sipa hand sanitizer with Moisturizers		Instant hand sanitizer	LIQUID	TOPICAL	20230527		OTC MONOGRAPH NOT FINAL	part333A	Tourel (Changsha)Hotel Supplies Co.,Ltd	ALCOHOL	75	mL/100mL			N	20241231
83502-003_fcbc3c5d-c232-9024-e053-6294a90a9c59	83502-003	HUMAN OTC DRUG	Sipa hand sanitizer S.pray with Moisturizers		Instant hand sanitizer	LIQUID	TOPICAL	20230527		OTC MONOGRAPH NOT FINAL	part333E	Tourel (Changsha)Hotel Supplies Co.,Ltd	BENZALKONIUM CHLORIDE	.1	g/100mL			N	20241231
83504-150_0cb38471-474b-4eb2-89d3-b0b45d131658	83504-150	HUMAN PRESCRIPTION DRUG	EXXUA		gepirone	TABLET, DELAYED RELEASE	ORAL	20240101		NDA	NDA021164	Fabre Kramer Pharmaceuticals, Inc.	GEPIRONE HYDROCHLORIDE	18.2	mg/1			N	20241231
83504-151_0cb38471-474b-4eb2-89d3-b0b45d131658	83504-151	HUMAN PRESCRIPTION DRUG	EXXUA		gepirone	TABLET, DELAYED RELEASE	ORAL	20240101		NDA	NDA021164	Fabre Kramer Pharmaceuticals, Inc.	GEPIRONE HYDROCHLORIDE	36.3	mg/1			N	20241231
83504-152_0cb38471-474b-4eb2-89d3-b0b45d131658	83504-152	HUMAN PRESCRIPTION DRUG	EXXUA		gepirone	TABLET, DELAYED RELEASE	ORAL	20240101		NDA	NDA021164	Fabre Kramer Pharmaceuticals, Inc.	GEPIRONE HYDROCHLORIDE	54.5	mg/1			N	20241231
83504-153_0cb38471-474b-4eb2-89d3-b0b45d131658	83504-153	HUMAN PRESCRIPTION DRUG	EXXUA		gepirone	TABLET, DELAYED RELEASE	ORAL	20240101		NDA	NDA021164	Fabre Kramer Pharmaceuticals, Inc.	GEPIRONE HYDROCHLORIDE	72.6	mg/1			N	20241231
83506-001_7d1685e8-48f4-40a1-87f0-c44f4c369f0f	83506-001	HUMAN OTC DRUG	HCS Hydrogen Peroxide 3%		Hydrogen Peroxide	LIQUID	TOPICAL	20230814		OTC MONOGRAPH NOT FINAL	part333A	Concordance Healthcare Solutions, LLC.	HYDROGEN PEROXIDE	3	mL/100mL			N	20241231
83506-004_61d0e086-b513-4ff1-a47e-0ba0b70844b7	83506-004	HUMAN OTC DRUG	HCS Roll-on Antiperspirant		Aluminum Chlorohydrate	LIQUID	TOPICAL	20230606		OTC MONOGRAPH FINAL	part350	Concordance Healthcare Solutions, LLC.	ALUMINUM CHLOROHYDRATE	45	mg/mL			N	20241231
83506-009_d3f55740-df7d-47de-b245-dec43aba89b5	83506-009	HUMAN OTC DRUG	HCS Alcohol Prep Pad Large		Isopropyl alcohol	SWAB	TOPICAL	20230606		OTC MONOGRAPH NOT FINAL	part333A	Concordance Healthcare Solutions, LLC.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83506-018_d3f55740-df7d-47de-b245-dec43aba89b5	83506-018	HUMAN OTC DRUG	HCS Alcohol Prep Pad Medium		Isopropyl alcohol	SWAB	TOPICAL	20230606		OTC MONOGRAPH NOT FINAL	part333A	Concordance Healthcare Solutions, LLC.	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83506-810_2b4f4da8-8316-467b-add7-29b7ebcdeb3d	83506-810	HUMAN OTC DRUG	Isopropyl alcohol		Isopropyl alcohol	LIQUID	TOPICAL	20230623		OTC MONOGRAPH DRUG	M003	Concordance Healthcare Solutions, LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83508-301_0d8d44bf-ccbc-f7f5-e063-6394a90a52ec	83508-301	HUMAN OTC DRUG	O2hundred		oxygen	GAS	TOPICAL	20230605		UNAPPROVED DRUG OTHER		Tov Innovation Co.Ltd	OXYGEN	99.9	mg/100mg			N	20241231
83510-400_fe2bf35b-d120-8a08-e053-6294a90aebb6	83510-400	HUMAN OTC DRUG	Ware Sonny Universal		Titanium dioxide, Zinc Oxide	LOTION	TOPICAL	20230508		OTC MONOGRAPH FINAL	part352	Ware Cosmetics	TITANIUM DIOXIDE; ZINC OXIDE	19.4; 9.7	mg/mL; mg/mL			N	20241231
83514-0020_45b71c39-69fe-4418-a8b7-acfe26ac21d8	83514-0020	HUMAN OTC DRUG	Zinc oxide		Zinc oxide	OINTMENT	TOPICAL	20230606		OTC MONOGRAPH FINAL	part347	AB Brands, LLC	ZINC OXIDE	400	mg/g			N	20241231
83521-111_0019528c-2f66-ef52-e063-6394a90a37bb	83521-111	HUMAN OTC DRUG	Dexbrompheniramine-DM-Phenylephrine 2-15-7.5		Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride	LIQUID	ORAL	20230701		OTC MONOGRAPH FINAL	part341	AddGen Pharmaceuticals, Inc.	DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE	2; 15; 7.5	mg/5mL; mg/5mL; mg/5mL	Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]		N	20241231
83522-001_043cadde-b9e2-7c77-e063-6394a90abee6	83522-001	HUMAN OTC DRUG	Medix Nasal Decongestant Oxymetazoline Hydrochloride		OXYMETAZOLINE HYDROCHLORIDE	LIQUID	TOPICAL	20230910		OTC MONOGRAPH DRUG	M012	Medic -33, Inc.	OXYMETAZOLINE HYDROCHLORIDE	.5	mg/mL	Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]		N	20251231
83524-407_0976cebf-697b-e194-e063-6394a90a8fd9	83524-407	HUMAN OTC DRUG	DERMOIA Manuka Honey Eczema Cream		OATMEAL	CREAM	TOPICAL	20230605		OTC MONOGRAPH DRUG	M016	TREASUREWISE LLC	OATMEAL	10	mg/mL	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83525-001_fdadeb0b-63d4-0510-e053-6394a90a2732	83525-001	HUMAN OTC DRUG	toothpastetablets		toothpaste tablets	TABLET	PERIODONTAL	20230609		OTC MONOGRAPH NOT FINAL	part356	HONG KONG DAILYGREEN TRADE CO., LIMITED	SODIUM MONOFLUOROPHOSPHATE	.877	g/1001			N	20241231
83527-1001_fe43061a-be2e-e873-e053-6294a90adbe3	83527-1001	HUMAN OTC DRUG	TATOO CARE		LIDOCAINE	CREAM	TOPICAL	20230619		OTC MONOGRAPH FINAL	M015	INDUSTRIAS QUIMICAS INDEPENDENCIA SA	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83531-497_0976cb4f-2ac9-fc33-e063-6394a90a11c7	83531-497	HUMAN OTC DRUG	KOVR All-Natural SPF-30 Moisturizing Sunscreen for Men		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230619		OTC MONOGRAPH DRUG	M020	ACTIVE LIFE INC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83531-499_09e37389-88ed-6f4c-e063-6394a90a9861	83531-499	HUMAN OTC DRUG	KOVR All-Natural SPF-30 Moisturizing Sunscreen for Women		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230619		OTC MONOGRAPH DRUG	M020	ACTIVE LIFE INC	TITANIUM DIOXIDE; ZINC OXIDE	60; 60	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83532-001_fe72826b-6c85-7a43-e053-6294a90a9d03	83532-001	HUMAN OTC DRUG	GANODERMA LUCIDUM SPORES POLYSACCHARIDES		GANODERMA LUCIDUM SPORES POLYSACCHARIDES	CAPSULE	ORAL	20230617		UNAPPROVED DRUG OTHER		Bestway Biomedical Technology (Shanghai) Co., Ltd.	AMINO ACIDS; BARLEY MALT	2; 1	g/9.91; g/9.91	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83533-2650_fea68cb5-c5fb-addc-e053-6294a90a05a0	83533-2650	HUMAN OTC DRUG	Sun Hat and This Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	BON BARE LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83534-0650_fe9345dc-7bda-96bc-e053-6394a90a2d7b	83534-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	BEAUTY SENSE MEDSPA INC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83535-001_fe776871-0550-4266-e053-6294a90a0857	83535-001	HUMAN OTC DRUG	BIOPURE 50CT ANTI BACTERIAL HAND WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20230618		OTC MONOGRAPH NOT FINAL	part333A	QUANZHOU YUELIANGYUAN BIOTECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
83535-002_ff53aa26-5f37-76b7-e053-6294a90ab04d	83535-002	HUMAN OTC DRUG	BIOPURE 40CT ANTI BACTERIAL HAND WIPES(FRESH SCENT)		Benzalkonium Chloride	CLOTH	TOPICAL	20230630		OTC MONOGRAPH NOT FINAL	part333A	QUANZHOU YUELIANGYUAN BIOTECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
83535-003_ff53d3ab-39b7-8f54-e053-6294a90ac6ab	83535-003	HUMAN OTC DRUG	BIOPURE 40CT ANTI BACTERIAL HAND WIPES(HONEY WILDFLOWER SCENT)		Benzalkonium Chloride	CLOTH	TOPICAL	20230630		OTC MONOGRAPH NOT FINAL	part333A	QUANZHOU YUELIANGYUAN BIOTECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
83535-004_ff549f53-4fab-ba06-e053-6394a90a376b	83535-004	HUMAN OTC DRUG	BIOPURE 16CT ANTI BACTERIAL INDIVIDUALLY WRAPPED HAND WIPES (FRESH SCENT)		Benzalkonium Chloride	CLOTH	TOPICAL	20230630		OTC MONOGRAPH NOT FINAL	part333A	QUANZHOU YUELIANGYUAN BIOTECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
83535-007_0c4d853f-058e-d280-e063-6294a90a3a0a	83535-007	HUMAN OTC DRUG	BIOPURE 1600CT ANTIBACTERIAL HAND WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20231207		OTC MONOGRAPH DRUG	M003	QUANZHOU YUELIANGYUAN BIOTECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
83535-008_0c4d9ec4-25d8-94d8-e063-6394a90add64	83535-008	HUMAN OTC DRUG	BIOPURE 1400CT ANTIBACTERIAL HAND WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20231207		OTC MONOGRAPH DRUG	M003	QUANZHOU YUELIANGYUAN BIOTECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.12	g/100g			N	20241231
83535-009_0cffd254-947d-e497-e063-6394a90a53c9	83535-009	HUMAN OTC DRUG	BIOPURE 40CT ANTI BACTERIAL HAND WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20231221		OTC MONOGRAPH DRUG	M003	QUANZHOU YUELIANGYUAN BIOTECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.13	g/100g			N	20241231
83538-101_02707552-03da-3ad2-e063-6294a90a3472	83538-101	HUMAN OTC DRUG	MED O-3 BIO-		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part348	Biological M.D. Solutions LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.03; 1; 10	g/100mL; g/100mL; g/100mL			N	20241231
83538-102_055513db-1547-cadf-e063-6394a90abc5d	83538-102	HUMAN OTC DRUG	OPRAVA		METHYL SALICYLATE, MENTHOL, CAPSAICIN	CREAM	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part348	Biological M.D. Solutions LLC	CAPSAICIN; MENTHOL; METHYL SALICYLATE	.03; 1; 10	g/100mL; g/100mL; g/100mL			N	20241231
83542-409_0976c569-76fc-ecde-e063-6394a90a76b1	83542-409	HUMAN OTC DRUG	JESS BEAUTY Sun Drops Sunscreen Oil SPF-50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	JESS BEAUTY PRODUCTS LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83542-410_09764ab9-1a62-b42b-e063-6394a90a4a77	83542-410	HUMAN OTC DRUG	JESS BEAUTY Let It Sun Sunscreen SPF-50		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	LOTION	TOPICAL	20230630		OTC MONOGRAPH DRUG	M020	JESS BEAUTY PRODUCTS LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83542-429_07e56d87-5c87-dacb-e063-6394a90a4f29	83542-429	HUMAN OTC DRUG	JESS BEAUTY Sun Drops Protection SPF 30		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	OIL	TOPICAL	20231101		OTC MONOGRAPH DRUG	M020	JESS BEAUTY PRODUCTS LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83544-0650_fea8be9d-acd3-4712-e053-6394a90abd10	83544-0650	HUMAN OTC DRUG	iAM Flawless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	Iam Center For Integrative Aesthetic Medicine LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83545-0650_fea820a7-b9a6-391d-e053-6394a90ae59e	83545-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	PATIENT PREFERRED DERMATOLOGY MEDICAL GROUP, INC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83545-2650_fea8311d-14fd-831b-e053-6294a90a3721	83545-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	PATIENT PREFERRED DERMATOLOGY MEDICAL GROUP, INC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83546-2650_fecdd779-556b-291a-e053-6294a90ad968	83546-2650	HUMAN OTC DRUG	Daily Moisturizer Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	N4 MEDSPA + SALON LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83548-0650_fecd72cb-e01b-2739-e053-6294a90abad9	83548-0650	HUMAN OTC DRUG	Protect Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230501		OTC MONOGRAPH NOT FINAL	part352	NEW SEASON DERMATOLOGY, PLLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83549-000_08853630-67a7-fee9-e063-6394a90a4c1e	83549-000	HUMAN OTC DRUG	Cryo10 Topical Analgesic		MENTHOL	GEL	TOPICAL	20230526		OTC MONOGRAPH DRUG	M017	Element 26 LLC	MENTHOL	100	mg/mL			N	20241231
83550-0650_fecdd779-556c-291a-e053-6294a90ad968	83550-0650	HUMAN OTC DRUG	Stay Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	McDevitt Wellness, LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83551-2650_fecd72cb-e01d-2739-e053-6294a90abad9	83551-2650	HUMAN OTC DRUG	The Pearl Sun Defender Sunscreen Broad Spectrum SPF 25		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230401		OTC MONOGRAPH NOT FINAL	part352	CARL B. PEARL, M.D., P.C	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83552-101_002997d0-3177-3918-e063-6294a90a4408	83552-101	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230710		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-102_002da62b-aec8-8e2a-e063-6294a90a5efc	83552-102	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230710		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-103_002db658-6b03-ea49-e063-6294a90ae3e7	83552-103	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230710		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-104_002e56c5-4f1a-ffb2-e063-6294a90a0c43	83552-104	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230710		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-105_002db658-6b20-ea49-e063-6294a90ae3e7	83552-105	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230710		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-106_003799f9-5088-876f-e063-6294a90a3fc7	83552-106	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230711		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-107_0037842e-2fcd-e9c3-e063-6294a90aec5e	83552-107	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230711		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-108_003799f9-50ac-876f-e063-6294a90a3fc7	83552-108	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20230711		OTC MONOGRAPH NOT FINAL	part348	Americanna Wellness, Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-109_0d132102-12b4-d941-e063-6394a90a160c	83552-109	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-110_0d1304e5-1c5f-13b6-e063-6294a90a0ce9	83552-110	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-111_0d12c6f1-1847-e856-e063-6294a90ad1b8	83552-111	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-112_0d12c6f1-1846-e856-e063-6294a90ad1b8	83552-112	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-113_0d128a54-0f10-c59f-e063-6294a90ac949	83552-113	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-114_0d12a4f5-e78a-cfa1-e063-6294a90aa6e6	83552-114	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-115_0d12829b-83ba-baa7-e063-6394a90a98cf	83552-115	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-116_0d1262db-4ec7-b1a8-e063-6294a90a2e2d	83552-116	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-117_0d11ab8e-d3eb-c7ef-e063-6294a90ae0a3	83552-117	HUMAN OTC DRUG	Dragon Pain Relieving Balm		Camphor, Menthol	SALVE	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-118_0d1188ed-1791-3782-e063-6394a90a4d16	83552-118	HUMAN OTC DRUG	Dragon Pain Relieving		Camphor, Menthol	LOTION	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	3.1; 5.3	g/100g; g/100g			N	20241231
83552-119_0d1104d8-1127-8ec2-e063-6294a90a4e11	83552-119	HUMAN OTC DRUG	Dragon Pain Relieving		Camphor, Menthol	LOTION	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83552-120_0d1059cc-1b0c-4e7b-e063-6294a90a56ea	83552-120	HUMAN OTC DRUG	Dragon Pain Relieving		Camphor, Menthol	LOTION	TOPICAL	20231221		OTC MONOGRAPH DRUG	M017	AMERICANNA WELLNESS, INC.	CAMPHOR (SYNTHETIC); MENTHOL	10; 11	g/100g; g/100g			N	20241231
83553-001_098692be-efb6-5175-e063-6394a90a1ac2	83553-001	HUMAN OTC DRUG	Brazzers Anal Desensitizing		LIDOCAINE	CREAM	TOPICAL	20230706		OTC MONOGRAPH DRUG	M015	Metro Media Ent	LIDOCAINE	20	mg/mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83558-017_a0802a46-35cf-422a-905b-5878bd623964	83558-017	HUMAN OTC DRUG	Day and Night Cold Symptom Relief		Day and Night Cold Symptom Relief	KIT		20230731		OTC MONOGRAPH DRUG	M013	Intrivo Diagnostics Inc.						N	20241231
83558-020_6c999083-433a-481f-9ae4-cd0ca9e12e86	83558-020	HUMAN OTC DRUG	Day and Night Multi Symptom Cold and Flu Relief		Day and Night Multi Symptom Cold and Flu Relief	KIT		20231028		OTC MONOGRAPH DRUG	M012	Intrivo Diagnostics Inc.						N	20241231
83559-001_ff3d50a2-7843-a64e-e053-6294a90a6ead	83559-001	HUMAN OTC DRUG	Enokon Pain relief patch-acupoint pressure stimulation		Pain relief patch-acupoint pressure stimulation	PATCH	TOPICAL	20230106		OTC MONOGRAPH FINAL	M016	Henan Enokon Medical Instrument Co Ltd.	BORNEOL	1	g/1001			N	20241231
83559-002_ff416fb0-3c91-4bc9-e053-6394a90a5447	83559-002	HUMAN OTC DRUG	Enokon Pain relief patch		Pain relief patch	PATCH	TOPICAL	20230628		OTC MONOGRAPH FINAL	M016	Henan Enokon Medical Instrument Co Ltd.	BORNEOL	1	g/1001			N	20241231
83562-0625_026bb485-a48d-bc30-e063-6394a90a9d74	83562-0625	HUMAN OTC DRUG	Ageless Tinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230701		OTC MONOGRAPH NOT FINAL	part352	Renew Esthetics and Med Spa	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83563-001_081cec7e-d354-637c-e063-6294a90a0f08	83563-001	HUMAN OTC DRUG	Hair Growth Serum		Hair Growth Serum	SPRAY	TOPICAL	20230624		ANDA	ANDA075357	Fujian Oumao Electronic Commerce Co. , Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83563-001_08fa59a7-eb44-c510-e063-6394a90ad7c8	83563-001	HUMAN OTC DRUG	Hair Growth Serum		Hair Growth Serum	SPRAY	TOPICAL	20231031		ANDA	ANDA075357	Fujian Oumao Electronic Commerce Co. , Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83565-001_fff56b94-b74f-039a-e053-6294a90a3918	83565-001	HUMAN OTC DRUG	Pureskin Seborrheic Dermatitis Eczema Cream		Seborrheic Dermatitis Eczema Cream	CREAM	TOPICAL	20230707		OTC MONOGRAPH FINAL	M005	Stellans Inc.	KETOCONAZOLE	.5	g/100mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
83565-002_006a523a-00ca-d74b-e063-6394a90a4768	83565-002	HUMAN OTC DRUG	Pureskin Molluscum Treatment		Molluscum Treatment	LIQUID	TOPICAL	20230713		OTC MONOGRAPH FINAL	M028	Stellans Inc.	THUJA OCCIDENTALIS LEAF	5	[hp_X]/100mL			N	20241231
83565-003_04349547-aeee-3f60-e063-6294a90a8b3e	83565-003	HUMAN OTC DRUG	PURESKIN FUNGAL NAIL RENEWAL		FUNGAL NAIL RENEWAL	LIQUID	TOPICAL	20230830		OTC MONOGRAPH FINAL	M005	Stellans Inc.	UNDECYLENIC ACID	10	g/100mL			N	20241231
83565-005_07e49cde-5bba-6cd3-e063-6394a90a2483	83565-005	HUMAN OTC DRUG	Pureskin Tinea Treatment		Pureskin Tinea Treatment	CREAM	TOPICAL	20231004		OTC MONOGRAPH DRUG	M005	Stellans Inc.	THUJA OCCIDENTALIS LEAF	6	g/100mL			N	20241231
83565-006_09235f26-2261-6ca2-e063-6394a90ad8f1	83565-006	HUMAN OTC DRUG	Inkcouture Tattoo Numbing .Spray		Tattoo Numbing Spray	LIQUID	TOPICAL	20231101		OTC MONOGRAPH DRUG	M017	Stellans Inc.	UNDECYLENIC ACID	10	g/100mL			N	20241231
83565-007_0af4a607-206e-de30-e063-6394a90acd99	83565-007	HUMAN OTC DRUG	LE PHOQUA Hair Regrowth Serum BIOTIN 5% MINOXIDIL		Hair Regrowth Serum	LIQUID	TOPICAL	20231124		ANDA	ANDA075357	Stellans Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83566-101_0a90b0ba-db7e-b171-e063-6294a90a21a3	83566-101	HUMAN OTC DRUG	GZE Tinted Sunscreen		Zinc Oxide 3%	CREAM	TOPICAL	20230707		OTC MONOGRAPH DRUG	M020	Guangdong Aimu Biological Technology Co., Ltd	ZINC OXIDE	3	mg/100mL			N	20241231
83566-201_0a91ce99-6b71-bc62-e063-6394a90a2bba	83566-201	HUMAN OTC DRUG	Mouth Rinse		MENTHOLUM 0.02% MENTHONE GLYCERIN ACETAL 0.005%	LIQUID	ORAL	20231121		OTC MONOGRAPH DRUG	M021	Guangdong Aimu Biological Technology Co., Ltd	MENTHOL; MENTHONE 1,2-GLYCEROL KETAL, (+/-)-	.02; .005	g/100mL; g/100mL			N	20241231
83566-301_0c5ed735-0c6a-b355-e063-6294a90a42ec	83566-301	HUMAN OTC DRUG	Black Castor oil		Castor oil 100%	OIL	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangdong Aimu Biological Technology Co., Ltd	CASTOR OIL	100	g/100mL			N	20241231
83566-401_0e7f464b-99fa-d598-e063-6394a90afa51	83566-401	HUMAN OTC DRUG	Lexi White Beauty 5% Minoxidil Serum		Minoxidil	LIQUID	TOPICAL	20240108		ANDA	ANDA209074	Guangdong Aimu Biological Technology Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
83567-7003_0167c34f-4a92-d0f9-e063-6294a90a96d3	83567-7003	HUMAN OTC DRUG	Empowered Choice		Levonorgestrel 1.5 mg	TABLET	ORAL	20230825		ANDA	ANDA202635	Versea Diagnostics	LEVONORGESTREL	1.5	mg/1	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]		N	20241231
83568-0001_0202272f-5b0b-2d10-e063-6394a90a2f6b	83568-0001	HUMAN OTC DRUG	CareLiving Alcohol Prep Pads		Isopropyl Alcohol	SWAB	TOPICAL	20220901		OTC MONOGRAPH NOT FINAL	part333A	CARE LIVING DIAGNOSTICS INC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83568-4643_019efef6-b8c1-59ec-e063-6294a90a3468	83568-4643	HUMAN OTC DRUG	Pro Comfort 8 Hours Patch		Lidocaine Patch 4%	PATCH	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part348	CARE LIVING DIAGNOSTICS INC	LIDOCAINE	4	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83570-443_0dba3e8a-1315-7ab3-e063-6394a90a8a6a	83570-443	HUMAN OTC DRUG	OWELL NATURALS Deep Penetrating Pain Relief		MENTHOL	OINTMENT	TOPICAL	20240108		OTC MONOGRAPH DRUG	M017	OWELL NATURALS BRAND, LLC	MENTHOL	76.6	mg/mL			N	20251231
83571-001_00192bf2-1280-2656-e063-6294a90a4237	83571-001	HUMAN OTC DRUG	Immune Essence to Prolong Life		Immune Essence Capsule to Prolong Life	CAPSULE	ORAL	20230710		UNAPPROVED DRUG OTHER		Japan Chuangyan Biopharmaceutical Co., Ltd	BARLEY MALT; DIMETHICONE	2; 1	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Skin Barrier Activity [PE]		N	20241231
83572-999_b444c82c-6d45-4e5c-856a-8676a321d59e	83572-999	HUMAN OTC DRUG	Hair Illusion 5% Minoxidil Foam		Minoxidil	AEROSOL, FOAM	TOPICAL	20231024		UNAPPROVED DRUG OTHER		Hair Illusion	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83573-100_09ca2d4b-e0c3-9961-e063-6394a90aa82e	83573-100	HUMAN OTC DRUG	ERBORIAN CC RED CORRECT		ERBORIAN CC RED CORRECT SPF 25- octinoxate, octisalate, titanium dioxide, zinc oxide cream	CREAM	TOPICAL	20231113		OTC MONOGRAPH DRUG	M020	Kolmask Co., Ld.	OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE	60; 20; 23.4; 38.4	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83574-413_09766af0-0cc8-7466-e063-6294a90abbed	83574-413	HUMAN OTC DRUG	K19 RELIEF		MENTHOL	LIQUID	TOPICAL	20230710		OTC MONOGRAPH DRUG	M017	K19 LLC	MENTHOL	12.5	mg/mL			N	20241231
83575-001_0040bfe1-1a0d-efbb-e063-6294a90a908c	83575-001	HUMAN OTC DRUG	Quick-Acting Wart Removal		Quick-Acting Wart Removal	LIQUID	CUTANEOUS	20230712		OTC MONOGRAPH FINAL	M016	Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd.	BIFIDOBACTERIUM LONGUM; GLYCYRRHIZINATE DIPOTASSIUM; SALICYLIC ACID; SALIX ALBA BARK	1; .2; 20; 2	mg/100mL; mg/100mL; mg/100mL; mg/100mL			N	20241231
83575-002_08e60814-4ee4-ee06-e063-6294a90a0e11	83575-002	HUMAN OTC DRUG	Wart Removal		Wart Removal	LIQUID	CUTANEOUS	20231030		OTC MONOGRAPH DRUG	M016	Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd.	LACTIC ACID, DL-; SALICYLIC ACID	17; 1	mg/100mL; mg/100mL			N	20241231
83575-003_08e692a5-b544-72ab-e063-6294a90a30d6	83575-003	HUMAN OTC DRUG	Wart Removal		Wart Removal	OINTMENT	CUTANEOUS	20231030		OTC MONOGRAPH DRUG	M016	Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd.	CHLORHEXIDINE ACETATE; SALICYLIC ACID	.3; 15	g/100g; g/100g	Decreased Cell Wall Integrity [PE]		N	20241231
83578-205_fbf73cad-4473-41b8-a028-5bb79ddb65ef	83578-205	HUMAN OTC DRUG	Safeguard SPF 40		Zinc Oxide	CREAM	TOPICAL	20230630		OTC MONOGRAPH NOT FINAL	part352	Skinsalvation Skincare, Inc.	ZINC OXIDE	200	mg/g			N	20241231
83582-001_017262ec-1b2a-b6d5-e063-6394a90aded7	83582-001	HUMAN OTC DRUG	Rhinitis Yituling		PORIA,GLYCYRRHIZA URALENSIS,MANDARIN PEEL, ATRACTYLODES MACROCEPHALA,DIOSCOREA OPPOSITA,JUJUBE,HONEY,MENTHAE,XANTHIUM,MAGNOLIA CITRIODORA FLOWER BUD	GEL	NASAL	20230727		UNAPPROVED DRUG OTHER		Sanfutang Traditional Chinese Medicine Investment (Yunnan) Co., Ltd	ATRACTYLODES MACROCEPHALA WHOLE; CHINESE YAM; FU LING; GLYCYRRHIZA URALENSIS; HONEY; JUJUBE FRUIT; MAGNOLIA DENUDATA FLOWER BUD; MENTHA ARVENSIS LEAF; TANGERINE PEEL; XANTHIUM SIBIRICUM FRUIT	7; 12; 18; 9; 3; 2; 3; 6; 7; 5	g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g			N	20241231
83584-002_03658d11-dfb6-2944-e063-6294a90a8b8e	83584-002	HUMAN OTC DRUG	Hand sanitizer		Alcohol	GEL	TOPICAL	20230806		OTC MONOGRAPH NOT FINAL	part333E	PurCel Labs LLC	ALCOHOL	70	mL/100mL			N	20241231
83584-004_03658d11-dfb6-2944-e063-6294a90a8b8e	83584-004	HUMAN OTC DRUG	Hand sanitizer		Alcohol	GEL	TOPICAL	20230806		OTC MONOGRAPH NOT FINAL	part333E	PurCel Labs LLC	ALCOHOL	70	mL/100mL			N	20241231
83584-016_013d22cd-1088-8cf9-e063-6294a90ab860	83584-016	HUMAN OTC DRUG	Hand sanitizer		Alcohol gel	GEL	TOPICAL	20230725		OTC MONOGRAPH NOT FINAL	part333E	PurCel Labs LLC	ALCOHOL	70	mL/100mL			N	20241231
83584-116_03658d11-dfb6-2944-e063-6294a90a8b8e	83584-116	HUMAN OTC DRUG	Hand sanitizer		Alcohol	GEL	TOPICAL	20230806		OTC MONOGRAPH NOT FINAL	part333E	PurCel Labs LLC	ALCOHOL	70	mL/100mL			N	20241231
83584-200_01dcfd14-7a20-98fa-e063-6294a90a0336	83584-200	HUMAN OTC DRUG	STERILE ALCOHOL PREP PADS		ISOPROPYL ALCOHOL	CLOTH	TOPICAL	20230810		OTC MONOGRAPH NOT FINAL	part333A	PurCel Labs LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83590-002_03a6805e-6599-ef81-e063-6294a90ad65b	83590-002	HUMAN OTC DRUG	Gunk Getter Sanitizing		Benzalkonium Chloride	SPRAY	TOPICAL	20230720		OTC MONOGRAPH NOT FINAL	part333A	PeerBasics LLC	BENZALKONIUM CHLORIDE; LAURAMIDOPROPYLAMINE OXIDE	.5; 1.5	mg/100mL; mg/100mL			N	20241231
83591-416_097667a6-8c92-70ba-e063-6294a90a7af0	83591-416	HUMAN OTC DRUG	EMU THERAPY Cool Menthol Therapy Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20230808		OTC MONOGRAPH DRUG	M017	ACA MANAGEMENT LLC	MENTHOL	27.5	mg/mL			N	20241231
83591-417_09760958-f963-2465-e063-6294a90a0278	83591-417	HUMAN OTC DRUG	EMU THERAPY Red Hot Pepper Pain Relief Cream		MENTHOL, CAPSAICIN	CREAM	TOPICAL	20230808		OTC MONOGRAPH DRUG	M017	ACA MANAGEMENT LLC	CAPSAICIN; MENTHOL	.25; 15	mg/mL; mg/mL			N	20241231
83591-418_09760958-f954-2465-e063-6294a90a0278	83591-418	HUMAN OTC DRUG	BLUE SPRING Foot and Leg Comfort		MENTHOL	CREAM	TOPICAL	20230808		OTC MONOGRAPH DRUG	M017	ACA MANAGEMENT LLC	MENTHOL	27.5	mg/mL			N	20241231
83592-125_0784ac7f-0a77-7c10-e063-6394a90add39	83592-125	HUMAN PRESCRIPTION DRUG	SALYNTRA		SALICYLIC ACID	GEL	TOPICAL	20240101		UNAPPROVED DRUG OTHER		True Marker Pharmaceuticals, Inc.	SALICYLIC ACID	6	g/100g			N	20241231
83592-480_099292d4-85b8-a87b-e063-6294a90a905e	83592-480	HUMAN OTC DRUG	Tolnafi-AL		Tolnaftate	LIQUID	TOPICAL	20230801		OTC MONOGRAPH DRUG	M005	True Marker Pharmaceuticals, Inc.	TOLNAFTATE	1	g/100mL			N	20241231
83592-580_08a39c49-13d3-ecd0-e063-6294a90ab504	83592-580	HUMAN OTC DRUG	Miconi-AL		Miconazole Nitrate	LIQUID	TOPICAL	20231017		OTC MONOGRAPH DRUG	M005	True Marker Pharmaceuticals, Inc.	MICONAZOLE NITRATE	2	g/100mL	Azole Antifungal [EPC], Azoles [CS]		N	20241231
83596-001_0a3c025d-6a5d-b491-e063-6294a90a0373	83596-001	HUMAN OTC DRUG	Adellina TATTOO NUMBING		Lidocaine	CREAM	TOPICAL	20230728		OTC MONOGRAPH DRUG	M017	Aramode	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83596-002_0a91508b-8153-1de6-e063-6394a90ae9d1	83596-002	HUMAN OTC DRUG	Jardient 5% Minoxidil Hair Growth Serum		5% Minoxidil Hair Growth Serum	LIQUID	TOPICAL	20231119		ANDA	ANDA075357	Aramode	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83600-001_0cccea81-ebf2-8bc8-e063-6294a90a18f8	83600-001	HUMAN OTC DRUG	Medzah Ditek Alcohol Prep Pads		Isopropyl Alcohol	CLOTH	TOPICAL	20230828		OTC MONOGRAPH DRUG	M003	Medzah Industries	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83601-0001_01d169fa-9b2d-4e1a-e063-6294a90a0413	83601-0001	HUMAN OTC DRUG	SM SWABALPHA		Isopropyl Alcohol	LIQUID	TOPICAL	20230801		UNAPPROVED DRUG OTHER		BORAMI PHARM	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83602-132_0ae7af3a-7dfd-9736-e063-6394a90abe3c	83602-132	HUMAN OTC DRUG	Menthol Pain Relief Gel-Patch		Menthol	PATCH	TOPICAL	20231128		OTC MONOGRAPH DRUG	M017	Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.	MENTHOL	.05	g/g			N	20241231
83602-157_0897cc86-c776-8821-e063-6394a90a6fcf	83602-157	HUMAN OTC DRUG	Lidocaine Pain Relief Gel-Patch		Lidocaine	PATCH	TOPICAL	20231027		OTC MONOGRAPH DRUG	M017	Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.	LIDOCAINE	.04	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83602-158_01ff3442-5a4f-4013-e063-6294a90a809e	83602-158	HUMAN OTC DRUG	LIDOCAINE PAIN RELIEF Gel-Patch		Lidocaine	PATCH	TOPICAL	20230808		OTC MONOGRAPH NOT FINAL	part348	Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.	LIDOCAINE	.04	g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83602-172_0ae6cfd1-bbeb-3fe6-e063-6294a90a541f	83602-172	HUMAN OTC DRUG	Pain Relief Gel-Patch		Lidocaine and Menthol	PATCH	TOPICAL	20231128		OTC MONOGRAPH DRUG	M017	Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.	LIDOCAINE; MENTHOL	.04; .01	g/g; g/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83602-323_0bbbe69f-8bd4-d8bc-e063-6394a90a700a	83602-323	HUMAN OTC DRUG	Menthol Pain Relief Gel-Tube		Menthol	GEL	TOPICAL	20231206		OTC MONOGRAPH DRUG	M017	Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.	MENTHOL	.04	g/mL			N	20241231
83602-333_0bd62de8-ce8c-c110-e063-6294a90a98cb	83602-333	HUMAN OTC DRUG	Menthol Pain Relief Gel-Roll On		Menthol	GEL	TOPICAL	20231208		OTC MONOGRAPH DRUG	M017	Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.	MENTHOL	.04	g/mL			N	20241231
83603-001_024c9aea-bd5e-8557-e063-6294a90a50e9	83603-001	HUMAN OTC DRUG	JUANCHI Tattoo Numbing		Lidocaine	CREAM	TOPICAL	20230807		OTC MONOGRAPH FINAL	M017	Shenzhen Langmi Technology Co., Ltd.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83603-001_024d0265-0e43-2e4a-e063-6294a90aee3a	83603-001	HUMAN OTC DRUG	JUANCHI Tattoo Numbing		Lidocaine	CREAM	TOPICAL	20230807		OTC MONOGRAPH FINAL	M017	Shenzhen Langmi Technology Co., Ltd.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83603-001_024d10a9-e92b-96ba-e063-6294a90a550f	83603-001	HUMAN OTC DRUG	JUANCHI Tattoo Numbing		Lidocaine	CREAM	TOPICAL	20230807		OTC MONOGRAPH FINAL	M017	Shenzhen Langmi Technology Co., Ltd.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83603-002_024d711e-59a9-0b0e-e063-6294a90a08b6	83603-002	HUMAN OTC DRUG	KAISASA Tattoo Numbing		Lidocaine	CREAM	TOPICAL	20230807		OTC MONOGRAPH FINAL	M017	Shenzhen Langmi Technology Co., Ltd.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83603-002_024d79ae-b2fd-29e7-e063-6294a90ad00b	83603-002	HUMAN OTC DRUG	KAISASA Tattoo Numbing		Lidocaine	CREAM	TOPICAL	20230807		OTC MONOGRAPH FINAL	M017	Shenzhen Langmi Technology Co., Ltd.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83603-002_024d8330-92d4-28eb-e063-6294a90a58d7	83603-002	HUMAN OTC DRUG	KAISASA Tattoo Numbing		Lidocaine	CREAM	TOPICAL	20230807		OTC MONOGRAPH FINAL	M017	Shenzhen Langmi Technology Co., Ltd.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83604-101_0369d659-590d-4bd9-e063-6394a90ac54c	83604-101	HUMAN OTC DRUG	Hair Strengthens Oil		Hair Strengthens Oil	OIL	TOPICAL	20230726		OTC MONOGRAPH NOT FINAL	part334	Shenzhen Xiyue Electronic Commerce Co., Ltd.	AMENTOFLAVONE; ASIAN GINSENG; BIOTIN; GINGER; GLYCERIN; PINUS PALUSTRIS LEAF	.5; 2; 5; 2; .05; .4	mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL	Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83605-001_0322ab8b-719d-c9c9-e063-6394a90a80cf	83605-001	HUMAN OTC DRUG	LION POSE GHOST-BUSTER BROAD SPECTRUM SPF 42 SUNSCREEN		ZINC OXIDE	LOTION	TOPICAL	20230816		OTC MONOGRAPH FINAL	M020	Lion Pose Inc.	ZINC OXIDE	150	mg/mL			N	20241231
83607-001_021a19b2-b1b3-ea8b-e063-6394a90a9a44	83607-001	HUMAN OTC DRUG	AsCurin Fast Action		ASPIRIN	POWDER	ORAL	20231023		OTC MONOGRAPH DRUG	M013	HealthDoc LLC	ASPIRIN	81	mg/2g	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
83607-002_0a0aae7a-7db5-3f96-e063-6294a90a6f81	83607-002	HUMAN OTC DRUG	Ascurin		ASPIRIN	CAPSULE	ORAL	20231210		OTC MONOGRAPH DRUG	M013	Healthdoc LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
83608-100_0261ec88-8fe5-d5f8-e063-6294a90ab3d4	83608-100	HUMAN OTC DRUG	Stallion		Delay Creme	CREAM	TOPICAL	20230807		OTC MONOGRAPH NOT FINAL	part348	Novelties by Nasswalk, Inc.	BENZOCAINE	5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83608-102_02eff27b-60b8-ef9a-e063-6294a90a9f0c	83608-102	HUMAN OTC DRUG	STA-HARD		Desensitizing Lubricant	CREAM	TOPICAL	20230807		OTC MONOGRAPH NOT FINAL	part348	Novelties by Nasswalk, Inc.	BENZOCAINE	5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83608-104_03a44623-5a11-1412-e063-6294a90a5682	83608-104	HUMAN OTC DRUG	Instant Erection		Ultimate Erection Enhancer	CREAM	TOPICAL	20230807		OTC MONOGRAPH NOT FINAL	part348	Novelties by Nasswalk, Inc.	BENZOCAINE	5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83608-106_03a4a829-192e-ccfa-e063-6294a90afdcd	83608-106	HUMAN OTC DRUG	ANAL-ESE		Desensitizer	CREAM	TOPICAL	20230807		OTC MONOGRAPH NOT FINAL	part348	Novelties by Nasswalk, Inc.	BENZOCAINE	7.5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83608-107_03b89070-4441-45fc-e063-6394a90a720a	83608-107	HUMAN OTC DRUG	ANAL-ESE		Desensitizer	CREAM	TOPICAL	20230807		OTC MONOGRAPH NOT FINAL	part348	Novelties by Nasswalk, Inc.	BENZOCAINE	7.5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83608-108_03b9556b-bd1e-2869-e063-6294a90a50d6	83608-108	HUMAN OTC DRUG	Anal Blu		Desensitizer	CREAM	TOPICAL	20230807		OTC MONOGRAPH NOT FINAL	part348	Novelties by Nasswalk, Inc.	BENZOCAINE	7.5	g/100mL	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83612-0282_09b89b27-455e-ec19-e063-6294a90a4488	83612-0282	HUMAN OTC DRUG	Organys Derma Made		Zinc Oxide	LOTION	TOPICAL	20230724		OTC MONOGRAPH DRUG	M020	Organys Beauty	ZINC OXIDE	132	mg/mL			N	20241231
83612-0330_09bb4b77-5f8d-9bf0-e063-6394a90a582f	83612-0330	HUMAN OTC DRUG	Organys Derma Made		Zinc Oxide	LOTION	TOPICAL	20210429		OTC MONOGRAPH DRUG	M020	Organys Beauty	ZINC OXIDE	132	mg/mL			N	20241231
83612-0403_0b37d675-8f1a-b440-e063-6294a90a708e	83612-0403	HUMAN OTC DRUG	Organys Derma Made		Zinc Oxide	LOTION	TOPICAL	20220607		OTC MONOGRAPH DRUG	M020	Organys Beauty	ZINC OXIDE	132	mg/mL			N	20241231
83612-1039_0b3a3867-12db-348d-e063-6394a90a6adb	83612-1039	HUMAN OTC DRUG	Organys Derma Made Sheer		Zinc Oxide	LOTION	TOPICAL	20210804		OTC MONOGRAPH DRUG	M020	Organys Beauty	ZINC OXIDE	132	mg/mL			N	20241231
83612-1391_0b3aa22b-eb8d-ec1d-e063-6394a90a098e	83612-1391	HUMAN OTC DRUG	Organys Open Formula Sheer		Zinc Oxide	LOTION	TOPICAL	20210804		OTC MONOGRAPH DRUG	M020	Organys Beauty	ZINC OXIDE	132	mg/mL			N	20241231
83613-411_09765451-b4c7-6a8d-e063-6294a90aa698	83613-411	HUMAN OTC DRUG	ROPANA Pain Relief Cream		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20230821		OTC MONOGRAPH DRUG	M017	FUSION PAIN SOLUTIONS LLC	HISTAMINE DIHYDROCHLORIDE	.4	mg/mL			N	20241231
83614-001_027588d2-f20b-8ce8-e063-6294a90a0aa8	83614-001	HUMAN OTC DRUG	Immune Essence to Prolong Life		Immune Essence Capsule to Prolong Life	CAPSULE	ORAL	20230809		UNAPPROVED DRUG OTHER		Shanghai Lingziyuan Biotechnology Co. , Ltd.	BARLEY MALT; DIMETHICONE	2; 1	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Skin Barrier Activity [PE]		N	20241231
83615-0001_2f35d4cd-6db7-4d56-986d-7bbb86940987	83615-0001	HUMAN PRESCRIPTION DRUG	Ibuprofen		Ibuprofen	TABLET, FILM COATED	ORAL	20151221		ANDA	ANDA091625	Bryant Ranch Prepack	IBUPROFEN	600	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]		N	20241231
83617-001_09898669-28b4-e17b-e063-6294a90a45c7	83617-001	HUMAN OTC DRUG	Cleared For Take Off Hand Sanitizer		ALCOHOL	GEL	TOPICAL	20221111		OTC MONOGRAPH DRUG	505G(a)(3)	Careeon LLC	ALCOHOL	70	mL/100mL			N	20241231
83619-001_02881c00-8a86-22eb-e063-6294a90a7fdc	83619-001	HUMAN OTC DRUG	WART REMOVER		WART REMOVER	LIQUID	TOPICAL	20230810		UNAPPROVED DRUG OTHER		Shenzhen Derbit Technology Co., Ltd.	ACETIC ACID; AMINO ACIDS, HAIR KERATIN; DICTAMNUS DASYCARPUS ROOT BARK; IMPATIENS BALSAMINA FLOWER; PANAX NOTOGINSENG ROOT; REHMANNIA GLUTINOSA ROOT; SALIX ALBA BARK; SOPHORA FLAVESCENS ROOT	1; .5; 2; 3; 2; 3; 2; 3	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL			N	20241231
83619-002_0e1a315b-0c4b-9405-e063-6294a90a32fe	83619-002	HUMAN OTC DRUG	Anti-Dandruff		Anti-Dandruff Shampoo	SHAMPOO	TOPICAL	20240104		UNAPPROVED DRUG OTHER		Shenzhen Derbit Technology Co., Ltd.	AMMONIUM LAURYL SULFATE; PYRITHIONE ZINC	3.22; .384	g/100mL; g/100mL			N	20251231
83621-2650_04b5f721-10ed-97e9-e063-6394a90a90dc	83621-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	IRIS MIGRAINE AND WELLNESS CENTER LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83623-161_b09dd3f4-dd1d-4ece-ab0c-54ee2845b861	83623-161	HUMAN OTC DRUG	JOINT-RITIS PAIN RELIEVING ROLL-ON		Menthol	OINTMENT	TOPICAL	20230901		OTC MONOGRAPH FINAL	M017	Lifeline Naturals of America, Inc.	MENTHOL, UNSPECIFIED FORM	16	g/100mL			N	20241231
83625-101_03daacb3-750f-6176-e063-6394a90a2d4b	83625-101	HUMAN OTC DRUG	PELLE WELLNESS SPF 50 FACE AND BODY BROAD SPECTRUM MINERAL SUNSCREEN		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230826		OTC MONOGRAPH FINAL	M020	Pelle Wellness LLC	TITANIUM DIOXIDE; ZINC OXIDE	3; 7	g/100mL; g/100mL			N	20241231
83625-102_03dd6f8e-5070-dffd-e063-6294a90a81cc	83625-102	HUMAN OTC DRUG	PELLE WELLNESS SPF 30 FACE AND BODY BROAD SPECTRUM MINERAL SUNSCREEN		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20230826		OTC MONOGRAPH FINAL	M020	Pelle Wellness LLC	TITANIUM DIOXIDE; ZINC OXIDE	2.5; 6	g/100mL; g/100mL			N	20241231
83627-901_03ef74bc-31e5-57fe-e063-6294a90a31f3	83627-901	HUMAN OTC DRUG	Blue Scorpion Pain and Inflammation Relief		HETEROCTENUS PRINCEPS VENOM, APIS MELLIFICA, RHUS TOXICODENDRON	LIQUID	ORAL	20230827		UNAPPROVED HOMEOPATHIC		Blue Scorpion Inc.	APIS MELLIFERA; RHOPALURUS PRINCEPS VENOM; TOXICODENDRON PUBESCENS LEAF	6; 3; 6	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL	Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]		N	20241231
83628-208_1db4701d-ce8c-478a-8c6a-f3f9894044cb	83628-208	HUMAN OTC DRUG	Skin Apeel Ageless Defense SPF 40 Broad Spectrum		Zinc Oxide	CREAM	TOPICAL	20190917		OTC MONOGRAPH NOT FINAL	part352	Skin Apeel, Inc.	ZINC OXIDE	160	mg/g			N	20241231
83629-015_a22353fd-e6e4-4a43-8f63-5f90c0ed5893	83629-015	HUMAN OTC DRUG	NEXXGEN 70% RUBBING ALCOHOL		Isopropyl alcohol	LIQUID	TOPICAL	20230801		OTC MONOGRAPH DRUG	M003	A & A Nexxgen LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20251231
83629-016_66959b9a-9324-498e-a72f-8e4bd47cf54b	83629-016	HUMAN OTC DRUG	NEXXGEN 91% RUBBING ALCOHOL		Isopropyl alcohol	LIQUID	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part333A	A & A Nexxgen LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
83629-017_0401b3f8-f743-4b66-94c5-93e6894da6c7	83629-017	HUMAN OTC DRUG	NEXXGEN 70% RUBBING ALCOHOL with Wintergreen		Isopropyl alcohol	LIQUID	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part333A	A & A Nexxgen LLC	ISOPROPYL ALCOHOL	70	mL/100mL			N	20241231
83629-018_a290167a-1df0-4ccd-b9f4-3b8e60c6bc46	83629-018	HUMAN OTC DRUG	NEXXGEN 91% RUBBING ALCOHOL with Wintergreen		Isopropyl alcohol	LIQUID	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part333A	A & A Nexxgen LLC	ISOPROPYL ALCOHOL	91	mL/100mL			N	20241231
83629-019_d805daac-0006-4d1e-ae9d-8e98cd41257d	83629-019	HUMAN OTC DRUG	NEXXGEN 50% RUBBING ALCOHOL		Isopropyl alcohol	LIQUID	TOPICAL	20240103		OTC MONOGRAPH DRUG	M003	A & A Nexxgen LLC	ISOPROPYL ALCOHOL	50	mL/100mL			N	20251231
83630-010_ace8f64c-7c32-426a-964e-d9556b93f8db	83630-010	HUMAN OTC DRUG	BREXTEM S		Niacinamide	LIQUID	TOPICAL	20230801		UNAPPROVED DRUG OTHER		Brexogen Inc.	NIACINAMIDE	2	g/100mL			N	20241231
83630-020_af4cbf3a-d9b9-4499-823e-f9df9998e983	83630-020	HUMAN OTC DRUG	BREXTEM H		Panthenol	LIQUID	TOPICAL	20230801		UNAPPROVED DRUG OTHER		Brexogen Inc.	PANTHENOL	.19	g/100mL			N	20241231
83632-001_03018008-c390-845e-e063-6394a90a23b7	83632-001	HUMAN OTC DRUG	motion sickness		motion sickness patch	PATCH	TOPICAL	20230816		UNAPPROVED DRUG OTHER		Zhengzhou Zhuoqing Trading Co., Ltd.	MENTHOL	2	g/1001			N	20241231
83632-002_0831954e-61c7-a468-e063-6294a90a32f4	83632-002	HUMAN OTC DRUG	HEMORRHOID		HEMORRHOID	CREAM	TOPICAL	20231021		UNAPPROVED DRUG OTHER		Zhengzhou Zhuoqing Trading Co., Ltd.	PETROLATUM; ZINC OXIDE	77.99; 7.6	g/100g; g/100g			N	20241231
83633-2063_0436f4bb-6632-379e-e063-6394a90a5ec9	83633-2063	HUMAN OTC DRUG	Agent Natuer holi (sun) dewy tinted skin drops		Zinc Oxide	LOTION	TOPICAL	20230908		OTC MONOGRAPH NOT FINAL	part352	Agent Natuer	ZINC OXIDE	132	mg/mL			N	20241231
83634-202_47da36c6-67e2-44c7-93d8-4f236abb73e7	83634-202	HUMAN PRESCRIPTION DRUG	Melphalan Hydrochloride		melphalan hydrochloride	KIT	INTRAVENOUS	20231218		ANDA	ANDA211463	Avenacy Inc.						N	20241231
83634-400_f893cc33-8b26-4b98-848d-61daf2e93a2c	83634-400	HUMAN PRESCRIPTION DRUG	Bivalirudin		bivalirudin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20231218		ANDA	ANDA210031	Avenacy, Inc.	BIVALIRUDIN	250	mg/1	Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]		N	20241231
83635-301_0137f663-fccf-9d31-e063-6394a90a4897	83635-301	HUMAN OTC DRUG	PENGSPRAY		Cypress oil, Eucalyptus oil, Coral calcium	SPRAY	TOPICAL	20230816		UNAPPROVED DRUG OTHER		CA GLOBAL	CUPRESSUS SEMPERVIRENS LEAF OIL; EUCALYPTUS OIL; OYSTER SHELL CALCIUM CARBONATE, CRUDE	.5; .1; .0053	g/100mL; g/100mL; g/100mL			N	20241231
83636-201_0c84b2ba-8593-8902-e063-6394a90ada9d	83636-201	HUMAN OTC DRUG	The Zoeun Skin Total Care Cream		Sturgeon	CREAM	TOPICAL	20230719		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd.	STURGEON, UNSPECIFIED	98.7	g/100mL			N	20241231
83636-501_04335576-6102-69e5-e063-6394a90a5a52	83636-501	HUMAN OTC DRUG	The Zoeun Skin Total Care-Shampoo		Sturgeon extract	SHAMPOO	TOPICAL	20230831		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd.	STURGEON, UNSPECIFIED	57.9	g/100mL			N	20241231
83636-601_04466c3e-d67e-f7f8-e063-6394a90ae562	83636-601	HUMAN OTC DRUG	The Zoeun Skin Total Cleanser		Sturgeon extract	SOLUTION	TOPICAL	20230912		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd.	STURGEON, UNSPECIFIED	40.45	g/100mL			N	20241231
83636-602_0523b245-36a1-97c7-e063-6294a90a53e1	83636-602	HUMAN OTC DRUG	The Zoeun Skin Total Conditioner		Sturgeon extract	SPRAY	TOPICAL	20230912		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd	STURGEON, UNSPECIFIED	98.4	g/100mL			N	20241231
83636-604_0c84d2a6-599c-3b44-e063-6294a90ace69	83636-604	HUMAN OTC DRUG	The Zoeun Skin Night Mask		Sturgeon extract	LIQUID	TOPICAL	20231006		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd.	STURGEON, UNSPECIFIED	89.34	g/100mL			N	20241231
83636-605_0cfda5f5-3807-23d1-e063-6394a90a00c4	83636-605	HUMAN OTC DRUG	The Zoeun Skin Y-zone Feminine Moisturizer		Sturgeon extract	CREAM	TOPICAL	20231006		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd.	STURGEON, UNSPECIFIED	95.79	g/100mL			N	20241231
83636-606_0cc38dc7-8da0-bedb-e063-6394a90a3d8a	83636-606	HUMAN OTC DRUG	The Zoeun Skin Sturgeon Body Wash		Sturgeon extract	SOLUTION	TOPICAL	20240101		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd.	STURGEON, UNSPECIFIED	40.45	g/100mL			N	20251231
83636-701_0cfd8f6d-6d4e-02b1-e063-6394a90a40eb	83636-701	HUMAN OTC DRUG	The Zoeun Skin Nourishing Cream		Sturgeon extract	CREAM	TOPICAL	20230905		UNAPPROVED DRUG OTHER		Sturgeonbio Co.,Ltd	STURGEON, UNSPECIFIED	81.7	g/100mL			N	20241231
83638-001_0428977f-753e-a324-e063-6394a90ab29f	83638-001	HUMAN OTC DRUG	MedBox Hand Sanitizer		Alcohol	LIQUID	TOPICAL	20230904		OTC MONOGRAPH NOT FINAL	part333A	Harpers Pharmacy, Inc.	ALCOHOL	75	mL/100mL			N	20241231
83640-172_03b9d38e-5ffe-ae35-e063-6294a90ad494	83640-172	HUMAN OTC DRUG	Me-Ga Care	TM	Ethyl alcohol	LIQUID	TOPICAL	20230315		OTC MONOGRAPH NOT FINAL	part333A	Babikian Healthcare Products CJSC	ALCOHOL	72	mL/100mL			N	20241231
83641-001_056c4c48-8327-2219-e063-6294a90a391b	83641-001	HUMAN OTC DRUG	Anatra		Anas Barbariae	TABLET	ORAL	20230901		UNAPPROVED DRUG OTHER		Anatra LLC	CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE	200	[hp_C]/1			N	20241231
83645-551_0e77e515-b084-13af-e063-6394a90ad9dd	83645-551	HUMAN OTC DRUG	sterile		POVIDONE-IODINE	SOLUTION	TOPICAL	20230927		OTC MONOGRAPH DRUG	M003	Asia Dynamics Inc., d/b/a ADI Medical	POVIDONE-IODINE	10	g/100g			N	20251231
83645-552_066fa82e-2f2f-27f0-e063-6394a90a4e31	83645-552	HUMAN OTC DRUG	sterile		POVIDONE-IODINE	SOLUTION	TOPICAL	20230927		OTC MONOGRAPH NOT FINAL	part333E	Asia Dynamics Inc., d/b/a ADI Medical	POVIDONE-IODINE	10	g/100g			N	20241231
83646-420_09e3474c-57c6-44f0-e063-6294a90a8568	83646-420	HUMAN OTC DRUG	LIDOSOLVE PAIN RELIEF		LIDOCAINE HYDROCHLORIDE	LIQUID	TOPICAL	20230522		OTC MONOGRAPH DRUG	M017	HENNIKA HEALTH, LLC	LIDOCAINE HYDROCHLORIDE	40	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83648-001_03a2a76d-ef96-980d-e063-6394a90af9cc	83648-001	HUMAN OTC DRUG	SANNUO WART REMOVER		Salicylic Acid	LIQUID	TOPICAL	20230824		OTC MONOGRAPH FINAL	part358B	Shenzhen Baixingchen Technology Co., Ltd.	SALICYLIC ACID	3.4	g/20mL			N	20241231
83648-002_08c6d31f-f686-63e9-e063-6394a90a04b4	83648-002	HUMAN OTC DRUG	5% minoxidil hair regrowth treatment		SANNUO 5% minoxidil hair regrowth treatment	SPRAY	TOPICAL	20231028		ANDA	ANDA075357	Shenzhen Baixingchen Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83649-330_c7c0666e-57ea-45e4-b3b4-e3950a173011	83649-330	HUMAN PRESCRIPTION DRUG	Daraprim		pyrimethamine	TABLET	ORAL	19530123		NDA	NDA008578	TILDE Sciences LLC	PYRIMETHAMINE	25	mg/1	Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA]		N	20241231
83650-101_05ede7f5-7ab1-5348-e063-6394a90a72e9	83650-101	HUMAN OTC DRUG	Oral Gel	Oral Pain Relief	Benzocaine Benzalkonium Chloride	GEL	TOPICAL	20230922		OTC MONOGRAPH NOT FINAL	part356	Savvy Care and Cosmetics	BENZALKONIUM CHLORIDE; BENZOCAINE	.1; 20	g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83650-102_05ee71cf-92e3-c3f2-e063-6294a90a1039	83650-102	HUMAN OTC DRUG	Savvy	Itch Stopping	Diphenhydramine hydrochloride Zinc acetate	CREAM	TOPICAL	20230922		OTC MONOGRAPH NOT FINAL	part348	Savvy Care and Cosmetics	DIPHENHYDRAMINE HYDROCHLORIDE; ZINC ACETATE	2; .1	g/100g; g/100g	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
83651-203_6eb5a087-7a91-4ad1-9a2f-26e278aaef17	83651-203	HUMAN OTC DRUG	Sara Elizabeth sheer tinted sunscreen spf40		Titanium Dioxide, Zinc Oxide	CREAM	TOPICAL	20170317		OTC MONOGRAPH NOT FINAL	part352	Sara Elizabeth Skincare	TITANIUM DIOXIDE; ZINC OXIDE	80; 38	mg/g; mg/g			N	20241231
83655-101_0d86b8fd-498c-5818-e063-6294a90a36fe	83655-101	HUMAN OTC DRUG	LABOFLEX Arnipatch Muscle and Joint Patch		Arnica Montana	PATCH	TOPICAL	20230907		UNAPPROVED HOMEOPATHIC		Laboflex, Inc.	ARNICA MONTANA	1	[hp_X]/g			N	20241231
83655-102_04d8ff7c-240d-c626-e063-6294a90a77c5	83655-102	HUMAN OTC DRUG	LABOFLEX Arnipatch Muscle and Joint Patch		Arnica Montana	PATCH	TOPICAL	20230907		UNAPPROVED HOMEOPATHIC		Laboflex, Inc.	ARNICA MONTANA	1	[hp_X]/g			N	20241231
83655-103_04d8f77e-f3fd-db90-e063-6294a90ae9bf	83655-103	HUMAN OTC DRUG	LABOFLEX Cool and Hot Menthol 1.25 percent Capsaicin 0.025 percent		Menthol, Capsaicin	PATCH	TOPICAL	20230828		OTC MONOGRAPH NOT FINAL	part348	Laboflex, Inc.	CAPSAICIN; MENTHOL	1.75; 87.5	mg/1; mg/1			N	20241231
83655-105_06987b20-53e6-e0d7-e063-6294a90a7c46	83655-105	HUMAN OTC DRUG	LABOFLEX Acne Spot Care		Salicylic Acid 0.5%	PATCH	TOPICAL	20230927		OTC MONOGRAPH FINAL	M006	Laboflex, Inc.	SALICYLIC ACID	5	g/100g			N	20241231
83657-610_04c86019-b54c-5bae-e063-6394a90a929f	83657-610	HUMAN OTC DRUG	Sheer Protection SPF 30		Zinc Oxide	CREAM	TOPICAL	20120101		OTC MONOGRAPH FINAL	M020	Skin Script, LLC	ZINC OXIDE	.0135	g/g			N	20241231
83658-009_0aa0788a-fbf5-c975-e063-6394a90a8e0a	83658-009	HUMAN OTC DRUG	Dona		Menthol Eucalyptus	PATCH	TOPICAL	20231120		UNAPPROVED DRUG OTHER		Sj Incorporation Ltd	EUCALYPTUS OIL; MENTHOL	5; 10	mg/100mg; mg/100mg			N	20241231
83658-011_0a9fe520-83b2-3452-e063-6294a90a15ab	83658-011	HUMAN OTC DRUG	Loxyine		Lidocaine	PATCH	PERCUTANEOUS; TOPICAL; TRANSDERMAL	20231120		UNAPPROVED DRUG OTHER		Sj Incorporation Ltd	LIDOCAINE	4	mg/100mg	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83660-001_0444ce63-47de-8f99-e063-6394a90a7b4d	83660-001	HUMAN OTC DRUG	nasal wash saline		Sodium chloride	LIQUID	NASAL	20230728		UNAPPROVED DRUG OTHER		Shenzhen Jun&Liang Media Tech Limited	SODIUM CHLORIDE	245	mg/9.5mL			N	20241231
83663-002_040bfcf7-f512-2fa1-e063-6394a90a5ef9	83663-002	HUMAN OTC DRUG	REUS NR		REUS NR	CAPSULE	ORAL	20230720		UNAPPROVED DRUG OTHER		REUS POLSKA SP Z O O	NICOTINAMIDE MONONUCLEOTIDE	600	mg/1			N	20241231
83663-003_0562df7b-0bad-a879-e063-6394a90a4087	83663-003	HUMAN OTC DRUG	REUS NR		REUS NR	CAPSULE	ORAL	20230720		UNAPPROVED DRUG OTHER		REUS POLSKA SP Z O O	NICOTINAMIDE MONONUCLEOTIDE	600	mg/1			N	20241231
83665-001_05d3c01a-8f93-460b-e063-6294a90ace4f	83665-001	HUMAN OTC DRUG	Balance		Adrenalinum, Adrenocorticotrophin (30X, 100X), Agrimonia eup flos, Anacardium, Antimon crud, Calc carb, Castanea sativa flos, Cortisone aceticum, Fucus, Hypothalamus, Kali bic, Oleander, Pituitarum popsterium, Sabadilla, Staphysag, Thyroidinum	SPRAY	ORAL	20230919		UNAPPROVED HOMEOPATHIC		EATactics, LLC	AGRIMONIA EUPATORIA FLOWER; ANTIMONY TRISULFIDE; BOS TAURUS HYPOTHALAMUS; CASTANEA SATIVA FLOWER; CORTICOTROPIN; CORTISONE ACETATE; DELPHINIUM STAPHISAGRIA SEED; EPINEPHRINE; FUCUS VESICULOSUS; NERIUM OLEANDER LEAF; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; SCHOENOCAULON OFFICINALE SEED; SEMECARPUS ANACARDIUM JUICE; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIED	10; 10; 10; 10; 30; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10	[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Catecholamine [EPC], Catecholamines [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]		N	20241231
83666-001_0cd7501c-b75e-e0b7-e063-6294a90a75e4	83666-001	HUMAN OTC DRUG	ANTISEPTIC SANITIZING WIPES		Benzalkonium Chloride 0.13%	CLOTH	TOPICAL	20230907		OTC MONOGRAPH DRUG	M003	ZHEJIANG WIPEX NEW MATERIAL TECHNOLOGY CO.,LTD	BENZALKONIUM CHLORIDE	.013	g/g			N	20241231
83668-010_eeb41f63-3412-43ad-8cc4-fb05d4b043a1	83668-010	HUMAN OTC DRUG	UNKNOT ROOT		Salicylic Acid	SHAMPOO	TOPICAL	20230801		OTC MONOGRAPH FINAL	part358H	Unknot Co.,Ltd.	SALICYLIC ACID	.2	g/100mL			N	20241231
83669-2650_04cad7af-ae04-d00c-e063-6294a90a290f	83669-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230801		OTC MONOGRAPH NOT FINAL	part352	Boxbar Beauty LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83670-200_08905ec2-307e-4ad2-e063-6294a90a8a53	83670-200	HUMAN OTC DRUG	Cough and Cold Therapy		Camphor, Menthol, Eucalyptus Oil	OINTMENT	TOPICAL	20230914		OTC MONOGRAPH DRUG	M012	Everlaan Organics Inc	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	5; 1.3; 2.8	g/100g; g/100g; g/100g			N	20241231
83670-201_088df369-114d-db4f-e063-6394a90acfac	83670-201	HUMAN OTC DRUG	Cough and Cold Therapy For Kids		Camphor, Menthol, Eucalyptus Oil	OINTMENT	TOPICAL	20230914		OTC MONOGRAPH DRUG	M012	Everlaan Organics Inc	CAMPHOR (NATURAL); EUCALYPTUS OIL; MENTHOL	4.7; 1.2; 2.6	g/100g; g/100g; g/100g			N	20241231
83670-202_08904b77-d6dc-8b82-e063-6394a90ace4f	83670-202	HUMAN OTC DRUG	Joint Therapy		Camphor	SALVE	TOPICAL	20230914		OTC MONOGRAPH DRUG	M017	Everlaan Organics Inc	CAMPHOR (NATURAL)	4	g/100g			N	20241231
83670-203_0890a683-9a67-fdbd-e063-6294a90ae526	83670-203	HUMAN OTC DRUG	Muscle Therapy		Methyl Salicylate, Camphor	SALVE	TOPICAL	20230914		OTC MONOGRAPH DRUG	M017	Everlaan Organics Inc	CAMPHOR (NATURAL); METHYL SALICYLATE	4; 10	g/100g; g/100g			N	20241231
83672-001_05568511-22a6-bc23-e063-6394a90a9c60	83672-001	HUMAN OTC DRUG	ETT HOJAKDO		Sodium Monofluorophosphate	PASTE, DENTIFRICE	DENTAL	20230914		OTC MONOGRAPH FINAL	part355	LIFE STEALER Co., Ltd.	SODIUM MONOFLUOROPHOSPHATE	.758	g/100g			N	20241231
83674-001_04e3e713-4d0b-fffd-e063-6394a90a4f95	83674-001	HUMAN OTC DRUG	MAGNESIUM HYDROXIDE		MAGNESIUM HYDROXIDE	LIQUID	ORAL	20230909		UNAPPROVED DRUG OTHER		Shandong Zhouyu Fire Technology Co.,Ltd	CALCIUM CHLORIDE; MAGNESIUM HYDROXIDE	.001; 14	g/100g; g/100g	Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]		N	20241231
83675-001_05386230-9cf7-bedd-e063-6294a90ada71	83675-001	HUMAN OTC DRUG	Varicose Veins Patch		Varicose Veins Patch	PATCH	TOPICAL	20230912		OTC MONOGRAPH FINAL	M016	Guangzhou Hanhai Trading Co., Ltd	BORNEOL	12	g/1001			N	20241231
83675-002_053aa1dc-fba9-2ac9-e063-6294a90aa64d	83675-002	HUMAN OTC DRUG	Varicose Veins Patch		Varicose Veins Patch	PATCH	TOPICAL	20230912		OTC MONOGRAPH FINAL	M016	Guangzhou Hanhai Trading Co., Ltd	BORNEOL	12	g/1001			N	20241231
83675-003_053af311-c07b-f10f-e063-6294a90a8158	83675-003	HUMAN OTC DRUG	Arm Slimming Patch		Arm Slimming Patch	PATCH	TOPICAL	20230912		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	ASTRAGALUS PROPINQUUS ROOT	13	g/1001			N	20241231
83675-004_05c30472-66f4-933d-e063-6394a90a7ff3	83675-004	HUMAN OTC DRUG	Herbal Digestive Patch		Herbal Digestive Patch	PATCH	TOPICAL	20230919		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	PADANG CASSIA	16	g/1001			N	20241231
83675-005_05c51725-5fe3-e091-e063-6294a90a1f82	83675-005	HUMAN OTC DRUG	Digestive Patch		Digestive Patch	PATCH	TOPICAL	20230919		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	CINNAMON	26	g/1001	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]		N	20241231
83675-006_05c56472-34fd-57c9-e063-6394a90a7d58	83675-006	HUMAN OTC DRUG	Tendon Sheath Patch		Tendon Sheath Patch	PATCH	TOPICAL	20230919		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	BORNEOL	15	g/1001			N	20241231
83675-007_05c5d862-d45d-a166-e063-6394a90ac87a	83675-007	HUMAN OTC DRUG	Quit Smoking Patch		Quit Smoking Patch	PATCH	TOPICAL	20230919		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	LICORICE	14	g/1001			N	20241231
83675-008_05c60118-e286-6666-e063-6394a90acec9	83675-008	HUMAN OTC DRUG	Neck Hump Removal Patch		Neck Hump Removal Patch	PATCH	TOPICAL	20230919		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	IVERMECTIN	14	g/1001	Antiparasitic [EPC], Pediculicide [EPC]		N	20241231
83675-009_05c66103-fc9c-904c-e063-6294a90aca2a	83675-009	HUMAN OTC DRUG	Diabetic Patch		Diabetic Patch	PATCH	TOPICAL	20230919		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	ASTRAGALUS PROPINQUUS ROOT	13	g/1001			N	20241231
83675-010_05c6a652-5e3d-6920-e063-6294a90adecf	83675-010	HUMAN OTC DRUG	Menthol Patch		Menthol Patch	PATCH	TOPICAL	20230919		OTC MONOGRAPH NOT FINAL	part348	Guangzhou Hanhai Trading Co., Ltd	MENTHOL	19	g/1001			N	20241231
83675-011_05c761fd-0514-17cf-e063-6294a90ab025	83675-011	HUMAN OTC DRUG	Throat Calm Patch		Throat Calm Patch	PATCH	TOPICAL	20230919		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	GINGER	14	g/1001	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-012_05c7a818-0c97-1494-e063-6294a90a2756	83675-012	HUMAN OTC DRUG	Tiger Pain Relief Patch		Tiger Pain Relief Patch	PATCH	TOPICAL	20230919		OTC MONOGRAPH NOT FINAL	part348	Guangzhou Hanhai Trading Co., Ltd	MENTHOL	19	g/1001			N	20241231
83675-013_0653d068-98cf-eae1-e063-6294a90a9209	83675-013	HUMAN OTC DRUG	iBeaLee Hair Cream		Hair Cream	CREAM	TOPICAL	20230926		OTC MONOGRAPH NOT FINAL	part334	Guangzhou Hanhai Trading Co., Ltd	CASTOR OIL	2	g/100g			N	20241231
83675-014_06543998-cc0e-2a74-e063-6294a90acd6a	83675-014	HUMAN OTC DRUG	iBeaLee WART REMOVER		WART REMOVER	PATCH	TOPICAL	20230926		OTC MONOGRAPH FINAL	part358B	Guangzhou Hanhai Trading Co., Ltd	SALICYLIC ACID	40	g/1001			N	20241231
83675-015_071c5449-2097-b0c4-e063-6294a90a1fc7	83675-015	HUMAN OTC DRUG	Shaping Patch Set		Shaping Patch Set	PATCH	TOPICAL	20231006		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	ALOE VERA LEAF	29	g/1001			N	20241231
83675-016_071c8881-34f3-704f-e063-6394a90aba6e	83675-016	HUMAN OTC DRUG	Capsicum Plaster-HOT		Capsicum Plaster-HOT	PATCH	TOPICAL	20231006		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	CAPSICUM	12	g/1001	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Vegetable Proteins [CS]		N	20241231
83675-017_071db38c-3137-fb5e-e063-6394a90abf5d	83675-017	HUMAN OTC DRUG	Breast Enhancement Cream		Breast Enhancement Cream	CREAM	TOPICAL	20231006		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	GLYCERIN	18	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83675-018_071e23c6-0be1-9512-e063-6294a90a80d7	83675-018	HUMAN OTC DRUG	Scar Diminishing Cream		Scar Diminishing Cream	CREAM	TOPICAL	20231006		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	CAMPHOR (NATURAL)	13	g/100g			N	20241231
83675-019_072ca179-daff-8602-e063-6294a90a975c	83675-019	HUMAN OTC DRUG	Bunion Pain Relief Cream		Bunion Pain Relief Cream	CREAM	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	GINGER	12	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-020_072cbadd-1772-1f85-e063-6394a90a0f7c	83675-020	HUMAN OTC DRUG	Hot Sweat Cream		Hot Sweat Cream	CREAM	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	PROPYLENE GLYCOL	19	g/100g			N	20241231
83675-021_072cfa31-906f-d1a1-e063-6294a90a19d3	83675-021	HUMAN OTC DRUG	Ginger slimming Tear and pull membrane		Ginger slimming Tear and pull membrane	CREAM	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	GINGER	18	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-022_072d0283-4105-103b-e063-6294a90a2209	83675-022	HUMAN OTC DRUG	Fat Burning Body Slimming Cream		Fat Burning Body Slimming Cream	CREAM	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	GINGER	26	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-023_072d9800-63b9-9a86-e063-6294a90acaa9	83675-023	HUMAN OTC DRUG	Perfect Body Curves Cream		Perfect Body Curves Cream	CREAM	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	GINGER	25	g/100g	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-024_072dc302-1579-c97c-e063-6294a90aa5cf	83675-024	HUMAN OTC DRUG	Pure Green Coffee Bean Extract diet patch		Pure Green Coffee Bean Extract diet patch	PATCH	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	COFFEE BEAN	25	g/1001	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-025_072de6ab-2df3-5c45-e063-6294a90ad93e	83675-025	HUMAN OTC DRUG	Lymphatic Drainage Detox Slimming Patch		Lymphatic Drainage Detox Slimming Patch	PATCH	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	GINGER	27	g/1001	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-026_072dfaf5-5d2b-e4b1-e063-6394a90a4c61	83675-026	HUMAN OTC DRUG	Slimming Patch		Slimming Patch	PATCH	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	HAWTHORN LEAF WITH FLOWER	23	g/1001			N	20241231
83675-027_072de6ab-2dfb-5c45-e063-6294a90ad93e	83675-027	HUMAN OTC DRUG	Wonderposted Quick Slimming Patch		Wonderposted Quick Slimming Patch	PATCH	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	ARTEMISIA VULGARIS WHOLE	29	g/1001			N	20241231
83675-028_072f00ee-fd4c-8b82-e063-6294a90a12aa	83675-028	HUMAN OTC DRUG	Slimming Patch		Slimming Patch	PATCH	TOPICAL	20231007		UNAPPROVED DRUG OTHER		Guangzhou Hanhai Trading Co., Ltd	COFFEE BEAN	23	g/1001	Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83675-029_0a000d77-7dea-6078-e063-6394a90a8a01	83675-029	HUMAN OTC DRUG	iBeaLee Nali liquid		iBeaLee Nali liquid	LIQUID	TOPICAL	20231112		OTC MONOGRAPH DRUG	M005	Guangzhou Hanhai Trading Co., Ltd	TOLNAFTATE	1	g/100mL			N	20241231
83675-030_0a00b26f-de9a-a250-e063-6294a90a504f	83675-030	HUMAN OTC DRUG	iBeaLee NAIL PATCHES		iBealee Nail Patches	PATCH	TOPICAL	20231112		OTC MONOGRAPH DRUG	M005	Guangzhou Hanhai Trading Co., Ltd	TOLNAFTATE	1	g/1001			N	20241231
83675-031_0c292d3c-5335-cf55-e063-6294a90afc6b	83675-031	HUMAN OTC DRUG	JoyPretty VITAMIN C BRIGHTENING EYE SERUM		VITAMIN C BRIGHTENING EYE SERUM	CREAM	TOPICAL	20231209		OTC MONOGRAPH DRUG	M016	Guangzhou Hanhai Trading Co., Ltd	ASCORBIC ACID; BUTYLENE GLYCOL; DENDROBIUM MONILIFORME WHOLE; GLYCERIN; HYALURONATE SODIUM; HYDROGENATED STARCH HYDROLYSATE; LEONURUS SIBIRICUS LEAF; MALTOOLIGOSYL GLUCOSIDE; PROPYLENE GLYCOL; RICE BRAN; SIZOFIRAN; VINCETOXICUM ATRATUM STEM	1.5; 2.68; 1.92; 2.5; .1; 3.15; 2; 3.2; 5; 2; 3.2; 1.56	g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL	Allergens [CS], Ascorbic Acid [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Vitamin C [EPC]		N	20241231
83675-032_0c29b233-33a5-2355-e063-6294a90aa2d0	83675-032	HUMAN OTC DRUG	AUQUEST INSTANT WRINKLE REMOVER		INSTANT WRINKLE REMOVER	CREAM	TOPICAL	20231209		OTC MONOGRAPH DRUG	M016	Guangzhou Hanhai Trading Co., Ltd	BOMBYX MORI FIBER; HOUTTUYNINE; HYDROGENATED JOJOBA OIL; PEPTIDE-T	3; 2.5; 5; 81.7	mg/100g; mg/100g; mg/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Silk [CS]		N	20241231
83676-435_0a063d7f-23a2-c949-e063-6294a90a5b57	83676-435	HUMAN OTC DRUG	PURE EASE Joint Muscle lnstant Pain Relief		CAPSAICIN, MENTHOL	CREAM	TOPICAL	20231127		OTC MONOGRAPH DRUG	M017	SERENU, INC.	CAPSAICIN; MENTHOL	.25; 80	mg/mL; mg/mL			N	20241231
83676-436_0a0641ca-08cd-ad95-e063-6394a90af331	83676-436	HUMAN OTC DRUG	PURE EASE Neur Cream Instant Deep Pain Relief		CAPSAICIN, MENTHOL	CREAM	TOPICAL	20231127		OTC MONOGRAPH DRUG	M017	SERENU, INC.	CAPSAICIN; MENTHOL	.25; 80	mg/mL; mg/mL			N	20241231
83677-610_0cf8c1ee-3391-42f9-e063-6394a90aa733	83677-610	HUMAN OTC DRUG	Hale and Hush Broad Spectrum SPF 30	SPF 30	Zinc Oxide	CREAM	TOPICAL	20180402		OTC MONOGRAPH DRUG	M020	Eclectic Solutions LLC	ZINC OXIDE	13.5	g/100g			N	20241231
83690-422_09e38c78-e36f-7257-e063-6394a90a9ffc	83690-422	HUMAN OTC DRUG	NERVE ACTIVE Pain Relief Cream		MENTHOL	CREAM	TOPICAL	20230918		OTC MONOGRAPH DRUG	M017	TOP DOG DIRECT, LLC	MENTHOL	30	mg/mL			N	20241231
83691-000_0a98e57c-f850-f8a4-e063-6294a90a063d	83691-000	HUMAN OTC DRUG	Antifungal Treatment Liquid 25 undeclylenic Acid		UNDECYLENIC ACID	LIQUID	TOPICAL	20230201		OTC MONOGRAPH DRUG	M005	Sansar, LLC	UNDECYLENIC ACID	250	mg/mL			N	20241231
83695-001_066d840b-d707-559d-e063-6394a90a55b3	83695-001	HUMAN OTC DRUG	SPF 30 Moisturizer with Aloe Vera		Homosalate,Octocrylene,Avobenzone	CREAM	TOPICAL	20231002		OTC MONOGRAPH FINAL	part352	Audrey Morris Cosmetics International, LLC	AVOBENZONE; HOMOSALATE; OCTOCRYLENE	2; 7; 5	g/100mL; g/100mL; g/100mL			N	20241231
83696-601_0d854a8a-52b2-be2b-e063-6394a90affb1	83696-601	HUMAN OTC DRUG	Medterra Pain Relief Menthol Roll-On		Menthol	CREAM	TOPICAL	20220101		OTC MONOGRAPH DRUG	M017	Respect Manufacturing Corporation	MENTHOL, UNSPECIFIED FORM	2.36	g/59.1g			N	20241231
83696-602_06c4640a-ee43-5d1a-e063-6394a90ad254	83696-602	HUMAN OTC DRUG	Medterra Pain Relief 500mg Hemp Menthol Cream		Menthol	CREAM	TOPICAL	20200301		OTC MONOGRAPH DRUG	M017	Respect Manufacturing Corporation	MENTHOL, UNSPECIFIED FORM	2.012	g/50.3g			N	20241231
83696-603_06e944e8-71f7-9fe9-e063-6294a90a8c37	83696-603	HUMAN OTC DRUG	Medterra Pain Relief 1000mg Hemp Menthol Cream		Menthol	CREAM	TOPICAL	20200101		OTC MONOGRAPH DRUG	M017	Respect Manufacturing Corporation	MENTHOL, UNSPECIFIED FORM	2.012	g/50.3g			N	20241231
83702-001_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-001	HUMAN OTC DRUG	Rotosxika shoulder pain plaster		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-002_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-002	HUMAN OTC DRUG	Xinhuazhx shoulder pain plaster		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-003_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-003	HUMAN OTC DRUG	Rotosxika knee plaster		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-004_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-004	HUMAN OTC DRUG	Xinhuazhx knee plaster		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-005_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-005	HUMAN OTC DRUG	Rotosxika wormwood cervical patch		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-006_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-006	HUMAN OTC DRUG	Xinhuazhx wormwood cervical patch		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-007_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-007	HUMAN OTC DRUG	Rotosxika Lumbat Vertebra Plaster		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-008_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-008	HUMAN OTC DRUG	Xinhuazhx Lumbat Vertebra Plaster		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-009_05ea9eea-3d6b-3778-e063-6294a90ad8ac	83702-009	HUMAN OTC DRUG	Rotosxika Herbal pain patch		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83702-010_071cc0fa-f9dc-77ba-e063-6394a90a11d8	83702-010	HUMAN OTC DRUG	Rotosxika Foot Detox Pads		Bamboo vinegar, tourmaline, Pyroligneous Acid, Houttuynia cordata	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	BAMBUSA BAMBOS SAP; HOUTTUYNIA CORDATA WHOLE; PYROLIGNEOUS ACID; SCHORL TOURMALINE	5; 2; 5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
83702-011_071cc0fa-f9dc-77ba-e063-6394a90a11d8	83702-011	HUMAN OTC DRUG	Xinhuazhx Foot Detox Pads		Bamboo vinegar, tourmaline, Pyroligneous Acid, Houttuynia cordata	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	BAMBUSA BAMBOS SAP; HOUTTUYNIA CORDATA WHOLE; PYROLIGNEOUS ACID; SCHORL TOURMALINE	5; 2; 5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
83702-012_07e7b8d1-4609-4926-e063-6394a90aa72c	83702-012	HUMAN OTC DRUG	Rotosxika SLIMMING patch		Topical Starch	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	STARCH, CORN	31.75	g/100g			N	20241231
83702-013_07e73716-3090-8f0f-e063-6394a90a532e	83702-013	HUMAN OTC DRUG	Xinhuazhx SLIMMING patch		Topical Starch	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	STARCH, CORN	31.75	g/100g			N	20241231
83702-014_07f6285e-9c15-a345-e063-6394a90a07c3	83702-014	HUMAN OTC DRUG	Rotosxika Lymphatic Detox Patch		Aconitum, arsenic iodide, honeysuckle	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	ACONITUM CHASMANTHUM WHOLE; ARSENIC TRIIODIDE; LONICERA CAPRIFOLIUM FLOWER	4; 3; 3	g/100g; g/100g; g/100g			N	20241231
83702-015_08096e9d-a5a8-446d-e063-6294a90a8047	83702-015	HUMAN OTC DRUG	Xinhuazhx Lymphatic Detox Patch		Aconitum, arsenic iodide, honeysuckle	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	ACONITUM CHASMANTHUM WHOLE; ARSENIC TRIIODIDE; LONICERA CAPRIFOLIUM FLOWER	4; 3; 3	g/100g; g/100g; g/100g			N	20241231
83702-016_0873e52c-3e77-e9bb-e063-6394a90a7c79	83702-016	HUMAN OTC DRUG	Rotosxika Varicoce Veins Plaster		Aesculus chinensis, Arnica	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	AESCULUS CHINENSIS WHOLE; ARNICA CORDIFOLIA WHOLE	4; 3	g/100g; g/100g			N	20241231
83702-017_089aacf8-6e8f-0485-e063-6394a90a01f6	83702-017	HUMAN OTC DRUG	Xinhuazhx Varicoce Veins Plaster		Aesculus chinensis, Arnica	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	AESCULUS CHINENSIS WHOLE; ARNICA CORDIFOLIA WHOLE	4; 3	g/100g; g/100g			N	20241231
83702-018_08106f34-d0bd-a18d-e063-6394a90a08b9	83702-018	HUMAN OTC DRUG	Rotosxika Tinnitus Relief Patch		Menthol	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	MENTHOL	5	g/100g			N	20241231
83702-019_07fbeef7-4198-65ee-e063-6394a90a5882	83702-019	HUMAN OTC DRUG	Rotosxika Prostate Patch		adrenal gland, Chelidonium majus, Menthol	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CHELIDONIUM MAJUS; HUMAN ADRENAL GLAND; MENTHOL, UNSPECIFIED FORM	1; 1; 5	g/100g; g/100g; g/100g			N	20241231
83702-020_0810ac48-9752-ba93-e063-6294a90a8b45	83702-020	HUMAN OTC DRUG	Rotosxika Sleep Aid Patch		Docylamine succinate, Diphenhydramine hydrochloride, chamomile, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (NATURAL); CHAMOMILE; DIPHENHYDRAMINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE	3; 3; 3; 5	g/100g; g/100g; g/100g; g/100g	Antihistamine [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
83702-021_081e80fb-d3cf-cf4b-e063-6394a90a6249	83702-021	HUMAN OTC DRUG	Rotosxika Ventilation Health patch		Doxylamine succinate, Diphenhydramine hydrochloride, Camphor, chamomile	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Puning Xinhua Trade Co., Ltd.	CAMPHOR (NATURAL); CHAMOMILE; DIPHENHYDRAMINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE	3; 3; 3; 5	g/100g; g/100g; g/100g; g/100g	Antihistamine [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
83705-0650_065d250e-56e4-4be0-e063-6294a90a930f	83705-0650	HUMAN OTC DRUG	Stay AgelessTinted Mineral Sunscreen Broad Spectrum SPF 30		Titanium Dioxide and Zinc Oxide	CREAM	TOPICAL	20230901		OTC MONOGRAPH NOT FINAL	part352	ETHEREAL AESTHETICS LLC	TITANIUM DIOXIDE; ZINC OXIDE	7.75; 10	g/100mL; g/100mL			N	20241231
83705-2650_065d1b2c-b059-a9eb-e063-6394a90ac06a	83705-2650	HUMAN OTC DRUG	Stay Ageless Daily Moisturizer Sunscreen		Octinoxate and Zinc Oxide	LOTION	TOPICAL	20230901		OTC MONOGRAPH NOT FINAL	part352	ETHEREAL AESTHETICS LLC	OCTINOXATE; ZINC OXIDE	7; 6	g/100mL; g/100mL			N	20241231
83706-001_0cfcc9b3-6ea0-9eb3-e063-6394a90a3ca9	83706-001	HUMAN OTC DRUG	ATOZCUP TATTOO NUMBING		Lidocaine	CREAM	TOPICAL	20230922		OTC MONOGRAPH DRUG	M017	Dongguan City Bobiter Electronic Technology Co., Ltd	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83706-001_0cfcd116-09a1-a5ce-e063-6394a90a98a8	83706-001	HUMAN OTC DRUG	ATOZCUP TATTOO NUMBING		Lidocaine	CREAM	TOPICAL	20230922		OTC MONOGRAPH DRUG	M017	Dongguan City Bobiter Electronic Technology Co., Ltd	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83706-001_0cfcf0c9-34e5-a3ae-e063-6394a90a0669	83706-001	HUMAN OTC DRUG	ATOZCUP TATTOO NUMBING		Lidocaine	CREAM	TOPICAL	20230922		OTC MONOGRAPH DRUG	M017	Dongguan City Bobiter Electronic Technology Co., Ltd	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83707-426_08883535-87c8-c510-e063-6294a90a33ac	83707-426	HUMAN OTC DRUG	AAVRANI DRY SCALP RESCUE SERUM		SALICYLIC ACID	LIQUID	TOPICAL	20231002		OTC MONOGRAPH DRUG	M029	AAVRANI, INC.	SALICYLIC ACID	18	mg/mL			N	20241231
83713-001_07836a4a-4760-c62c-e063-6294a90ab380	83713-001	HUMAN OTC DRUG	Knee Pain Relief Patch		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83713-002_07831e0d-c839-7153-e063-6394a90a8b7a	83713-002	HUMAN OTC DRUG	Lumbar Pain Relief Patch		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83713-003_07835a4e-6a3a-afe0-e063-6294a90a476e	83713-003	HUMAN OTC DRUG	Lumbar Vertebra Plaster		Menthol, Camphor	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	CAMPHOR (SYNTHETIC); MENTHOL	.5; 2.5	g/100g; g/100g			N	20241231
83713-004_0667192c-cf46-236e-e063-6294a90a57e8	83713-004	HUMAN OTC DRUG	Foot Detox Pads		Bamboo vinegar, tourmaline, Pyroligneous Acid, Houttuynia cordata	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	BAMBUSA BAMBOS SAP; HOUTTUYNIA CORDATA WHOLE; PYROLIGNEOUS ACID; SCHORL TOURMALINE	5; 2; 5; 3	g/100g; g/100g; g/100g; g/100g			N	20241231
83713-005_0783e95c-bd8e-49de-e063-6394a90afe29	83713-005	HUMAN OTC DRUG	Slimming Patch		Topical Starch	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	STARCH, CORN	31.75	g/100g			N	20241231
83713-005_0796ec1f-7944-60f3-e063-6294a90afc41	83713-005	HUMAN OTC DRUG	Slimming Patch		Topical Starch	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	STARCH, CORN	31.75	g/100g			N	20241231
83713-005_07e6bbc1-e70a-499f-e063-6294a90ae6d6	83713-005	HUMAN OTC DRUG	Slimming Patch		Topical Starch	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	STARCH, CORN	31.75	g/100g			N	20241231
83713-006_075a1e20-737d-253d-e063-6294a90a7471	83713-006	HUMAN OTC DRUG	Tinnitus Patch		Menthol	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	MENTHOL	5	g/100g			N	20241231
83713-006_07e67720-4735-c363-e063-6394a90ae9a2	83713-006	HUMAN OTC DRUG	Tinnitus Patch		Menthol	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	MENTHOL	5	g/100g			N	20241231
83713-007_075a8e3b-60d8-a1e2-e063-6294a90a1dde	83713-007	HUMAN OTC DRUG	Lymphatic Detox Patch		Aconitum, arsenic iodide, honeysuckle	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	ACONITUM CHASMANTHUM WHOLE; ARSENIC TRIIODIDE; LONICERA CAPRIFOLIUM FLOWER	4; 3; 3	g/100g; g/100g; g/100g			N	20241231
83713-007_07e67720-4744-c363-e063-6394a90ae9a2	83713-007	HUMAN OTC DRUG	Lymphatic Detox Patch		Aconitum, arsenic iodide, honeysuckle	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	ACONITUM CHASMANTHUM WHOLE; ARSENIC TRIIODIDE; LONICERA CAPRIFOLIUM FLOWER	4; 3; 3	g/100g; g/100g; g/100g			N	20241231
83713-007_07e6bbc1-e71a-499f-e063-6294a90ae6d6	83713-007	HUMAN OTC DRUG	Lymphatic Detox Patch		Aconitum, arsenic iodide, honeysuckle	PATCH	TOPICAL	20230601		UNAPPROVED DRUG OTHER		Guangzhou Hongboyuan Trading Co., Ltd.	ACONITUM CHASMANTHUM WHOLE; ARSENIC TRIIODIDE; LONICERA CAPRIFOLIUM FLOWER	4; 3; 3	g/100g; g/100g; g/100g			N	20241231
83717-002_0a518fbe-7dec-d815-e063-6294a90ac79c	83717-002	HUMAN OTC DRUG	Wart removal		Wart removal liquid	LIQUID	TOPICAL	20231007		OTC MONOGRAPH DRUG	M028	Wenchang Panzhijie Trading Co., Ltd.	CHLORHEXIDINE ACETATE; SALICYLIC ACID	.3; .3	mg/100mL; mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
83717-003_0b33b346-12ee-554c-e063-6294a90a9c48	83717-003	HUMAN OTC DRUG	wart removal pen		wart removal pen	LIQUID	CUTANEOUS	20231007		OTC MONOGRAPH DRUG	M028	Wenchang Panzhijie Trading Co., Ltd.	CHLORHEXIDINE ACETATE; SALICYLIC ACID	.2; .5	mg/100mL; mg/100mL	Decreased Cell Wall Integrity [PE]		N	20241231
83719-427_06e10b84-2976-febb-e063-6394a90a8ec8	83719-427	HUMAN OTC DRUG	MENS RAPID REINVENT 5 Minoxidil Solution		MINOXIDIL	LIQUID	TOPICAL	20231016		ANDA	ANDA076239	THE SELF AND BODY LOVE COMPANY LLC	MINOXIDIL	50	mg/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83722-000_086196b3-2126-70bb-e063-6394a90aa0b8	83722-000	HUMAN OTC DRUG	ClearChoice Sport Shield		ZINC OXIDE	LOTION	TOPICAL	20231016		OTC MONOGRAPH DRUG	M020	Dermastart Inc.	ZINC OXIDE	120	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83724-001_06fd4e9f-bc67-0d5f-e063-6294a90ad352	83724-001	HUMAN OTC DRUG	ChopSaver SPF 15 Lip Care		AVOBENZONE,OCTINOXATE,OCTISALATE,OCTOCRYLENE	LIPSTICK	TOPICAL	20231015		OTC MONOGRAPH DRUG	M020	Good For The Goose Products, LLC dba ChopSaver	AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE	2; 6.5; 5; 1.5	g/100g; g/100g; g/100g; g/100g			N	20241231
83727-294_071038d9-8174-6953-e063-6394a90a8a84	83727-294	HUMAN OTC DRUG	Skin Laundry. Clean Slate Exfoliating 2 Salicylic Acid Treatment Gel Cleanser Cleanse Exfoliate		SALICYLIC ACID	GEL	TOPICAL	20231014		OTC MONOGRAPH DRUG	M006	Skin Laundry Holdings, Inc.	SALICYLIC ACID	20	mg/mL			N	20241231
83727-295_07104ea7-3ee4-8e8a-e063-6394a90a6900	83727-295	HUMAN OTC DRUG	Skin Laundry Sun Defense Mineral SPF 30 Sunscreen Broad Spectrum SPF 30 UVA UVB		ZINC OXIDE	CREAM	TOPICAL	20231014		OTC MONOGRAPH DRUG	M020	Skin Laundry Holdings, Inc.	ZINC OXIDE	182	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83729-100_70bc3ece-c3b1-4418-a5a2-9e92bc69c669	83729-100	HUMAN PRESCRIPTION DRUG	Super Vanilla Prescription		Anticavity Toothpaste	PASTE, DENTIFRICE	DENTAL	20231013		UNAPPROVED DRUG OTHER		SuperMouth, LLC.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
83729-101_573c1b72-2b9f-4046-bdae-c873d00267a3	83729-101	HUMAN PRESCRIPTION DRUG	Super Strawberry Prescription		Anticavity Toothpaste	PASTE, DENTIFRICE	DENTAL	20231013		UNAPPROVED DRUG OTHER		SuperMouth, LLC.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
83729-102_e2919e6d-cf21-40fd-80ba-0208c500aed5	83729-102	HUMAN PRESCRIPTION DRUG	Super Mint Prescription		Anticavity Toothpaste	PASTE, DENTIFRICE	DENTAL	20231013		UNAPPROVED DRUG OTHER		SuperMouth, LLC.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
83729-103_5069d331-5e49-4496-af99-98b42269fc0f	83729-103	HUMAN PRESCRIPTION DRUG	Super Chocolate Prescription		Anticavity Toothpaste	PASTE, DENTIFRICE	DENTAL	20231013		UNAPPROVED DRUG OTHER		SuperMouth, LLC.	SODIUM FLUORIDE	1.1	g/100g			N	20241231
83732-0110_06f91e45-38a1-235c-e063-6294a90afbe6	83732-0110	HUMAN OTC DRUG	NGA ALCOHOL WIPES SANDSTONE		Ethanol	SWAB	TOPICAL	20231005		UNAPPROVED DRUG OTHER		NEVER GO ALONE	ALCOHOL	17.55	g/27g			N	20241231
83733-037_0428288d-4048-e853-e063-6294a90adb0c	83733-037	HUMAN OTC DRUG	UNITED Asutra TC Kit Colgate		SODIUM MONOFLUOROPHOSPHATE	KIT		20230807		OTC MONOGRAPH DRUG	M021	Procurall Solutions						N	20241231
83735-001_07edd9bd-1159-44fa-e063-6394a90a2097	83735-001	HUMAN OTC DRUG	P.CALM Water Barrier Suncream		ETHYLHEXYL TRIAZONE,TEREPHTHALYLIDENE DICAMPHOR SULFONIC ACID, POLYSILICONE-15, DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE, BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE	CREAM	TOPICAL	20231017		UNAPPROVED DRUG OTHER		LIFE WITH CORPORATION Inc.	BEMOTRIZINOL; DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE; ECAMSULE; ETHYLHEXYL TRIAZONE; POLYSILICONE-15	5; 10; 26.4; 27; 10	mg/mL; mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83737-001_0a38e951-4cfa-71bf-e063-6294a90a995f	83737-001	HUMAN OTC DRUG	Archies Dry Eye Relief		Polyethylene glycol 400, Propylene glycol	SOLUTION/ DROPS	OPHTHALMIC	20231016		OTC MONOGRAPH DRUG	M018	Archie's Remedies	POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL	.4; .3	g/100mL; g/100mL			N	20241231
83739-001_07a411a9-b2ca-66e4-e063-6394a90a3e17	83739-001	HUMAN OTC DRUG	Joint health		Joint health capsules	CAPSULE	ORAL	20231014		UNAPPROVED DRUG OTHER		XIAN CHIANG COMPANY LIMITED	AMINO ACIDS; BARLEY MALT	2; 1	g/1001; g/1001	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83739-002_07a59edb-318d-388a-e063-6294a90a986f	83739-002	HUMAN OTC DRUG	Anti aging		Anti aging powder	POWDER	ORAL	20231014		UNAPPROVED DRUG OTHER		XIAN CHIANG COMPANY LIMITED	AMINO ACIDS; BARLEY MALT	2; 1	g/1001; g/1001	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83739-003_07a81afd-b870-87af-e063-6294a90a65f9	83739-003	HUMAN OTC DRUG	Nerve Mushroom gummies		Nerve Mushroom gummies	CHEWABLE GEL	ORAL	20231014		UNAPPROVED DRUG OTHER		XIAN CHIANG COMPANY LIMITED	AMINO ACIDS; BARLEY MALT	2; 1	g/1001; g/1001	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83739-004_07a88f30-6a67-40d5-e063-6394a90a19a3	83739-004	HUMAN OTC DRUG	Sleep gummies		Sleep gummies	CHEWABLE GEL	ORAL	20231014		UNAPPROVED DRUG OTHER		XIAN CHIANG COMPANY LIMITED	AMINO ACIDS; BARLEY MALT	2; 1	g/1001; g/1001	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83739-005_07a932fb-38ee-4b35-e063-6394a90ad61f	83739-005	HUMAN OTC DRUG	sugar management gummies		sugar management gummies	CHEWABLE GEL	ORAL	20231014		UNAPPROVED DRUG OTHER		XIAN CHIANG COMPANY LIMITED	AMINO ACIDS; BARLEY MALT	2; 1	g/1001; g/1001	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83739-006_07a9966c-dd8c-fad0-e063-6394a90a6d2f	83739-006	HUMAN OTC DRUG	Eye health		Eye health capsule	CAPSULE	ORAL	20231014		UNAPPROVED DRUG OTHER		XIAN CHIANG COMPANY LIMITED	AMINO ACIDS; BARLEY MALT	2; 1	g/1001; g/1001	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83739-007_07a9c66d-ae9c-0d23-e063-6294a90a43a6	83739-007	HUMAN OTC DRUG	weight loss gummies		weight loss gummies	CHEWABLE GEL	ORAL	20231014		UNAPPROVED DRUG OTHER		XIAN CHIANG COMPANY LIMITED	AMINO ACIDS; BARLEY MALT	2; 1	g/1001; g/1001	Allergens [CS], Amino Acid Hypertonic Solution [EPC], Amino Acids [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]		N	20241231
83740-101_09c712f0-9414-428b-e063-6394a90ad096	83740-101	HUMAN OTC DRUG	Cleanote Saline Nasal Sprays		Sodium Chloride 0.9%	AEROSOL, SPRAY	INTRASINAL	20231023		OTC MONOGRAPH DRUG	M012	Cloudgoose Biology Science & Technology Co., Ltd.	SODIUM CHLORIDE	9	mg/100mL			N	20241231
83744-001_08006b60-966c-155b-e063-6294a90a206a	83744-001	HUMAN OTC DRUG	Empower		White Petrolatum, Zinc Oxide	SPRAY	TOPICAL	20231018		OTC MONOGRAPH DRUG	M016	Bemis Manufacturing Company Inc	WHITE PETROLATUM; ZINC OXIDE	30; 10	g/100g; g/100g			N	20241231
83746-001_05a6f3ad-c96b-4345-e063-6294a90a8b7a	83746-001	HUMAN PRESCRIPTION DRUG	Nitrogen		Nitrogen	GAS	RESPIRATORY (INHALATION)	20231016		NDA	NDA205766	Gas and Supply Carolinas, LLC	NITROGEN	995	mL/L			N	20241231
83746-002_05a73ef4-f9bb-f4fc-e063-6294a90a8321	83746-002	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20231016		NDA	NDA205767	Gas and Supply Carolinas, LLC	OXYGEN	995	mL/L			N	20241231
83748-001_07654845-3109-8811-e063-6294a90a80f0	83748-001	HUMAN OTC DRUG	Sunscreen		Sunscreen, zinc oxide	LOTION	TOPICAL	20231213		OTC MONOGRAPH DRUG	M020	NATURAL AND ORGANIC FORMULATIONS (PTY) LTD	ZINC OXIDE	20	mg/100mL			N	20241231
83766-101_0972b579-61d5-d1ff-e063-6394a90ac8af	83766-101	HUMAN OTC DRUG	Dizop Minoxidil Topical Gel		Minoxidil 5%	GEL	TOPICAL	20231026		ANDA	ANDA209074	Shenzhen Joyuflsh Technology Co.,Ltd.	MINOXIDIL	5	mg/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83767-101_098723f8-9176-a36b-e063-6394a90ac5a6	83767-101	HUMAN OTC DRUG	Ruigoo Minoxidil Topical Gel		MINOXIDIL 5%	GEL	EXTRACORPOREAL	20231026		ANDA	ANDA209074	Guangzhou Ruijiu Electronic Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83770-001_08ffb0af-a630-57fe-e063-6294a90a067e	83770-001	HUMAN OTC DRUG	Nincrane 5% Minoxidil for Men		5% Minoxidil for Men	LIQUID	TOPICAL	20231030		ANDA	ANDA075357	Clearchic, Inc.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83771-001_08aee3eb-5140-9899-e063-6294a90a106c	83771-001	HUMAN OTC DRUG	RoyceDerm Seborrheic Dermatitis Psoriasis		Dermatitis cream	CREAM	TOPICAL	20231026		OTC MONOGRAPH DRUG	M005	Inner Mongolia Green source pharmaceutical Products Co., LTD	KETOCONAZOLE; MICONAZOLE	.5; .15	g/100mL; g/100mL	Azole Antifungal [EPC], Azole Antifungal [EPC], Azoles [CS], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20241231
83778-001_09008c6f-faa1-ccd4-e063-6294a90ad315	83778-001	HUMAN OTC DRUG	V34 Colour Corrector		V34 Colour Corrector	CREAM	TOPICAL	20231030		UNAPPROVED DRUG OTHER		Nanchang Dental Bright Technology Co.,Ltd.	SODIUM PYROPHOSPHATE	.5	g/100mL			N	20241231
83778-002_0973b73d-5dea-0986-e063-6294a90a5917	83778-002	HUMAN OTC DRUG	Teeth Whitening Kit		Teeth Whitening Kit	CREAM	TOPICAL	20231105		UNAPPROVED DRUG OTHER		Nanchang Dental Bright Technology Co.,Ltd.	PHTHALIMIDOPEROXYCAPROIC ACID; POTASSIUM CITRATE; TRIBASIC CALCIUM PHOSPHATE	12; 3; 1	g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
83778-003_097478f1-9b48-b749-e063-6394a90a9977	83778-003	HUMAN OTC DRUG	Teeth Whitening Strips		Teeth Whitening Strips	PATCH	TOPICAL	20231105		UNAPPROVED DRUG OTHER		Nanchang Dental Bright Technology Co.,Ltd.	PHTHALIMIDOPEROXYCAPROIC ACID	12	g/1001			N	20241231
83778-005_0b45d2e0-f874-1f31-e063-6294a90aa24f	83778-005	HUMAN OTC DRUG	Glorysmile Toothpaste.		Glorysmile Toothpaste.	CREAM	TOPICAL	20231119		UNAPPROVED DRUG OTHER		Nanchang Dental Bright Technology Co.,Ltd.	SODIUM FLUORIDE; SODIUM GLUCONATE	.1; .1	g/100g; g/100g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
83778-006_0d018b4b-16ba-8ea3-e063-6294a90a18ba	83778-006	HUMAN OTC DRUG	Neateeth Teeth Whitening Strips		Neateeth Teeth Whitening Strips	PATCH	TOPICAL	20231220		UNAPPROVED DRUG OTHER		Nanchang Dental Bright Technology Co.,Ltd.	PHTHALIMIDOPEROXYCAPROIC ACID	12	g/1001			N	20241231
83779-001_08e69fef-6d12-8533-e063-6394a90ac4a7	83779-001	HUMAN OTC DRUG	Advanced Caresour Wipes		75% ALCOHOL WIPES	CLOTH	TOPICAL	20231029		OTC MONOGRAPH DRUG	505G(a)(3)	Caresour LLC	ALCOHOL	75	mL/100mL			N	20241231
83779-002_09b41281-23a9-adad-e063-6294a90a5f44	83779-002	HUMAN OTC DRUG	Caresour		75% ALCOHOL WIPES	CLOTH	TOPICAL	20231029		OTC MONOGRAPH DRUG	505G(a)(3)	Caresour LLC	ALCOHOL	75	mL/100mL			N	20241231
83781-001_09769ae3-d19e-e2dd-e063-6294a90a1f64	83781-001	HUMAN OTC DRUG	MQUPIN Corn Removal Pads		Corn Removal Pads	PATCH	TOPICAL	20231105		OTC MONOGRAPH DRUG	M030	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	SALICYLIC ACID	40	g/1001			N	20241231
83781-002_09772e4b-8194-3771-e063-6394a90a9516	83781-002	HUMAN OTC DRUG	Mqupin Knee Patch		Knee Patch	PATCH	TOPICAL	20231105		OTC MONOGRAPH DRUG	M017	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	BORNEOL; CAMPHOR (SYNTHETIC)	1.2; 1.5	g/1001; g/1001			N	20241231
83781-003_09777a9d-2dd2-4f87-e063-6294a90ac139	83781-003	HUMAN OTC DRUG	MYMULIKE Corn Removal Pads		Corn Removal Pads	PATCH	TOPICAL	20231105		OTC MONOGRAPH DRUG	M030	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	SALICYLIC ACID	40	g/1001			N	20241231
83781-004_09af4166-1e93-4169-e063-6294a90a7bbd	83781-004	HUMAN OTC DRUG	Mqupin Knee Patch Pain Relife		Knee Patch Pain Relife	PATCH	TOPICAL	20231105		OTC MONOGRAPH DRUG	M017	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	BORNEOL; MENTHOL	1.5; 1	g/1001; g/1001			N	20241231
83781-005_09789de2-4e82-a6ed-e063-6394a90af5e0	83781-005	HUMAN OTC DRUG	Mqupin Liquid Wart Corn Remover		Liquid Wart Corn Remover	LIQUID	TOPICAL	20231105		OTC MONOGRAPH DRUG	M030	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	SALICYLIC ACID	20	g/100mL			N	20241231
83781-006_0978ff22-c358-e266-e063-6394a90a98a4	83781-006	HUMAN OTC DRUG	MQ Pain Relieving Patch		Pain Relieving Patch	PATCH	TOPICAL	20231105		OTC MONOGRAPH DRUG	M017	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	.ALPHA.-TOCOPHEROL ACETATE; CAMPHOR (SYNTHETIC); LEVOMENTHOL; METHYL SALICYLATE	2; 1.2; 5.7; 6.3	g/1001; g/1001; g/1001; g/1001			N	20241231
83781-007_0e031aa5-edf5-8c9d-e063-6394a90afee3	83781-007	HUMAN OTC DRUG	Sumifun Knee Relieve Patch		Knee Relieve Patch	PATCH	TOPICAL	20240102		OTC MONOGRAPH DRUG	M017	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	BORNEOL; CAMPHOR (SYNTHETIC); MENTHOL	1.2; 1.5; 1	g/1001; g/1001; g/1001			N	20251231
83781-008_0e7e7a45-0a9d-7430-e063-6294a90a894f	83781-008	HUMAN OTC DRUG	Sumifun Knee Relieving Patch		Knee Relieving Patch	PATCH	TOPICAL	20240102		OTC MONOGRAPH DRUG	M017	Zhengzhou Miaoqi Pharmaceutical Technology Co., Ltd	BORNEOL; CAMPHOR (SYNTHETIC); MENTHOL	1.2; 1.5; 1	g/1001; g/1001; g/1001			N	20251231
83782-101_0911fc43-a9d6-4202-e063-6394a90a6a14	83782-101	HUMAN OTC DRUG	Varicose Veins Cream		MENTHOL	CREAM	TOPICAL	20231101		OTC MONOGRAPH DRUG	M016	Meizhuangzhiku Guangzhou Technology Co.,Ltd	AESCULUS CHINENSIS WHOLE; AMMOPIPTANTHUS MONGOLICUS STEM; MENTHOL	.1; .1; .2	g/100g; g/100g; g/100g			N	20241231
83788-101_0d6236d4-f868-e3e7-e063-6394a90ab57a	83788-101	HUMAN OTC DRUG	Castor oil		Castor oil 100%	LIQUID	TOPICAL	20231108		OTC MONOGRAPH DRUG	M016	Xiamen Panmai Technology Co., Ltd	CASTOR OIL	1000	mg/mL			N	20241231
83788-201_0b5c3815-75d5-2ea0-e063-6294a90a307d	83788-201	HUMAN OTC DRUG	Minoxidil Hair Growth Sprays		Minoxidil 5%	LIQUID	TOPICAL	20231108		OTC MONOGRAPH DRUG	M032	Xiamen Panmai Technology Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83789-434_09b53878-59e1-2326-e063-6294a90aa3a4	83789-434	HUMAN OTC DRUG	BELASOL Sun Cream Non-Tinted Moisturizing SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	CREAM	TOPICAL	20231120		OTC MONOGRAPH DRUG	M020	EK Clothing LLC dba Belasol	TITANIUM DIOXIDE; ZINC OXIDE	20; 170	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83800-430_09b887be-a12e-7faf-e063-6394a90a4a30	83800-430	HUMAN OTC DRUG	DR REAL NUMB Topical Anorectal		LIDOCAINE	CREAM	TOPICAL	20231103		OTC MONOGRAPH DRUG	M015	FUZZYLULU LLC	LIDOCAINE	50	mg/g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83802-001_0a5a4a8d-f942-3ca0-e063-6394a90a222a	83802-001	HUMAN OTC DRUG	Sunscreen Color Broad spectrum SPF 50		TITANIUM DIOXIDE, ZINC OXIDE	GEL	TOPICAL	20231201		OTC MONOGRAPH DRUG	M020	CryoGen, LLC	TITANIUM DIOXIDE; ZINC OXIDE	100; 50	mg/mL; mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
83804-101_0c3a278e-9417-5ada-e063-6394a90aee90	83804-101	HUMAN OTC DRUG	Hair Serum		Minoxidil 5%	OIL	TOPICAL	20231110		ANDA	ANDA075357	Shenzhen Shandian Jingling Technology Co., Ltd.	MINOXIDIL	.05	g/mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83804-102_0c5fd8dc-2ef9-1e3c-e063-6394a90a9506	83804-102	HUMAN OTC DRUG	sefudun 5% Minoxidil Hair Growth serum		5% Minoxidil Hair Growth serum	LIQUID	TOPICAL	20231212		ANDA	ANDA075357	Shenzhen Shandian Jingling Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83804-103_0c601675-149b-39ec-e063-6394a90ac744	83804-103	HUMAN OTC DRUG	VIOFAIRY 5% Minoxidil Hair Growth serum		5% Minoxidil Hair Growth serum	LIQUID	TOPICAL	20231212		ANDA	ANDA075357	Shenzhen Shandian Jingling Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83806-001_0a8cd5a7-77d3-84e3-e063-6394a90a7eda	83806-001	HUMAN OTC DRUG	LINGRUI Bone Strength Musk Pain Relief Cream		Bone Strength Musk Pain Relief Cream	PATCH	TOPICAL	20231119		OTC MONOGRAPH DRUG	M017	Dengfeng City Jucai Trading Co., LTD	MENTHOL	4	g/1001			N	20241231
83807-001_0a28ec41-462a-c927-e063-6394a90a95c4	83807-001	HUMAN OTC DRUG	EVERLIT CARE Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20231114		OTC MONOGRAPH DRUG	M005	EVERLIT GLOBAL INC.	ALCOHOL	75	mL/100mL			N	20241231
83807-002_0a292232-ca12-12be-e063-6394a90a9857	83807-002	HUMAN OTC DRUG	EVERLIT CARE Triple Antibiotic		Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate	OINTMENT	TOPICAL	20231114		OTC MONOGRAPH DRUG	M004	EVERLIT GLOBAL INC.	BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE	400; .0035; 5000	[USP'U]/g; g/g; [USP'U]/g	Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]		N	20241231
83807-016_0d504fae-c313-914d-e063-6394a90abed8	83807-016	HUMAN OTC DRUG	EVERLIT SURVIVAL ALCOHOL PAD		Alcohol Prep Pad	CLOTH	TOPICAL	20231226		OTC MONOGRAPH DRUG	M003	EVERLIT GLOBAL INC.	ISOPROPYL ALCOHOL	.34	g/1			N	20241231
83807-017_0d4ee161-7bf4-8ae7-e063-6294a90ab3b3	83807-017	HUMAN OTC DRUG	Everlit Survival Sting Relief Pad		Sting Relief	CLOTH	TOPICAL	20231226		OTC MONOGRAPH DRUG	M003	EVERLIT GLOBAL INC.	BENZOCAINE; ISOPROPYL ALCOHOL	.34; 8	g/1; g/1	Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]		N	20241231
83807-018_0d4d8991-d2c7-4bdd-e063-6294a90ae913	83807-018	HUMAN OTC DRUG	EVERLIT SURVIVAL IODINE PREP PADS		POVIDONE-IODINE PREP PADS	CLOTH	TOPICAL	20231226		OTC MONOGRAPH DRUG	M003	EVERLIT GLOBAL INC.	POVIDONE-IODINE	.54	g/1			N	20241231
83807-019_0d4e542a-c909-ea38-e063-6394a90a8bba	83807-019	HUMAN OTC DRUG	Everlit Survival Antiseptic Wipe		Antiseptic Wipe	CLOTH	TOPICAL	20231226		OTC MONOGRAPH DRUG	M003	EVERLIT GLOBAL INC.	BENZALKONIUM CHLORIDE	1.22	g/1			N	20241231
83808-001_0ade6feb-accb-cbcf-e063-6394a90a0598	83808-001	HUMAN OTC DRUG	Baoveri Hair growth serum		5% minoxidil hair growth serum	LIQUID	TOPICAL	20231123		ANDA	ANDA075357	Shenzhen Pengyun Zhichuang Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83809-001_0a4079cc-ca7e-427c-e063-6394a90a3f05	83809-001	HUMAN OTC DRUG	Retinol Serum		Retinol Serum	LIQUID	TOPICAL	20231115		OTC MONOGRAPH DRUG	M016	Shenzhen Yikai Electronic Technology Co., Ltd.	RETINOL	.1	g/100mL			N	20241231
83809-002_0aa59400-feb8-abb2-e063-6394a90a7df7	83809-002	HUMAN OTC DRUG	iBeaLee Wart Remover		iBeaLee Wart Remover	LIQUID	TOPICAL	20231120		OTC MONOGRAPH DRUG	M005	Shenzhen Yikai Electronic Technology Co., Ltd.	SALICYLIC ACID	12	g/100mL			N	20241231
83809-003_0aa6206e-ea1a-3a7e-e063-6294a90aaa38	83809-003	HUMAN OTC DRUG	AlJIEYO WART REMOVER		AlJIEYO WART REMOVER	PATCH	TOPICAL	20231120		OTC MONOGRAPH DRUG	M005	Shenzhen Yikai Electronic Technology Co., Ltd.	SALICYLIC ACID	12	g/1001			N	20241231
83809-004_0aded82e-3693-fddd-e063-6394a90a2eed	83809-004	HUMAN OTC DRUG	SUAI WART REMOVER		SUAI WART REMOVER	PATCH	TOPICAL	20231123		OTC MONOGRAPH DRUG	M028	Shenzhen Yikai Electronic Technology Co., Ltd.	SALICYLIC ACID	12	g/1001			N	20241231
83809-005_0af300f2-3a1f-a82d-e063-6394a90ac118	83809-005	HUMAN OTC DRUG	AIJIEYO Wart Remover		AIJIEYO Wart Remover	LIQUID	TOPICAL	20231124		OTC MONOGRAPH DRUG	M028	Shenzhen Yikai Electronic Technology Co., Ltd.	SALICYLIC ACID	12	g/100mL			N	20241231
83809-010_0bfd1ae2-db0a-9408-e063-6394a90ad758	83809-010	HUMAN OTC DRUG	Hair Cream		Hair Cream	CREAM	TOPICAL	20231129		OTC MONOGRAPH DRUG	M032	Shenzhen Yikai Electronic Technology Co., Ltd.	BIOTIN	.1	g/100g			N	20241231
83809-011_0c4aae47-1e90-56ac-e063-6394a90aa182	83809-011	HUMAN OTC DRUG	AIJIEYO 5% MinoxidiL Hair Growth Solution		AIJIEYO 5% MinoxidiL Hair Growth Solution	LIQUID	TOPICAL	20231204		OTC MONOGRAPH DRUG	M032	Shenzhen Yikai Electronic Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83809-012_0c4b6748-de76-9f7f-e063-6394a90a146c	83809-012	HUMAN OTC DRUG	iBeaLee 5% MinoxidiL Hair Growth Solution		iBeaLee 5% MinoxidiL Hair Growth Solution	LIQUID	TOPICAL	20231204		OTC MONOGRAPH DRUG	M032	Shenzhen Yikai Electronic Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83809-013_0c4b6055-e227-528f-e063-6294a90a8d3f	83809-013	HUMAN OTC DRUG	SUAI 5% MinoxidiL Hair Growth Solution		SUAI 5% MinoxidiL Hair Growth Solution	LIQUID	TOPICAL	20231204		OTC MONOGRAPH DRUG	M032	Shenzhen Yikai Electronic Technology Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83809-014_0c4c69d2-12a7-e805-e063-6394a90aae48	83809-014	HUMAN OTC DRUG	SUAl Wart Remover Liquid		SUAl Wart Remover Liquid	LIQUID	TOPICAL	20231211		OTC MONOGRAPH DRUG	M028	Shenzhen Yikai Electronic Technology Co., Ltd.	SALICYLIC ACID	12	g/100mL			N	20241231
83809-015_0d78aae8-38f7-432c-e063-6394a90a461b	83809-015	HUMAN OTC DRUG	AlJIEYO Fungal Nail Treatment Liquid		AlJIEYO Fungal Nail Treatment Liquid	LIQUID	TOPICAL	20231226		OTC MONOGRAPH DRUG	M005	Shenzhen Yikai Electronic Technology Co., Ltd.	UNDECYLENIC ACID	10	g/100mL			N	20241231
83809-016_0d78fe3f-516c-6ef6-e063-6394a90a723e	83809-016	HUMAN OTC DRUG	iBeaLee Dark Spot Corrector Cream		iBeaLee Dark Spot Corrector Cream	CREAM	TOPICAL	20231226		OTC MONOGRAPH DRUG	M016	Shenzhen Yikai Electronic Technology Co., Ltd.	NIACINAMIDE	5	g/100g			N	20241231
83809-017_0d79829a-30f7-c30c-e063-6294a90a7077	83809-017	HUMAN OTC DRUG	SUAI Fungus Nail Treatment Liquid		SUAI Fungus Nail Treatment Liquid	LIQUID	TOPICAL	20231226		OTC MONOGRAPH DRUG	M005	Shenzhen Yikai Electronic Technology Co., Ltd.	TOLNAFTATE	1	g/100mL			N	20241231
83809-018_0e7fdebd-8aba-024a-e063-6394a90afec3	83809-018	HUMAN OTC DRUG	FUNGAL NAIL PATCHES		Fungal Nail Patches	PATCH	TOPICAL	20240108		OTC MONOGRAPH DRUG	M005	Shenzhen Yikai Electronic Technology Co., Ltd.	TOLNAFTATE	1	g/1001			N	20251231
83811-0001_0a8abb63-d312-2f26-e063-6294a90a7896	83811-0001	HUMAN OTC DRUG	HYDROGEMToothpaste		calcium hydrogen phosphate hydrate	PASTE, DENTIFRICE	DENTAL	20231120		UNAPPROVED DRUG OTHER		H2 biohealthcare Co.,Ltd	CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	2.14	g/100g			N	20241231
83811-0002_0a8c98c5-7bb0-96c0-e063-6294a90aa4fa	83811-0002	HUMAN OTC DRUG	HYDROGEM AeaSoap		aloe vera extract	SOAP	TOPICAL	20231120		UNAPPROVED DRUG OTHER		H2 biohealthcare Co.,Ltd	ALOE VERA LEAF	5	g/100g			N	20241231
83812-001_0a8d5d7a-156c-ef9e-e063-6294a90a395f	83812-001	HUMAN OTC DRUG	Teeth Whitening Kit		Teeth Whitening Kit	LIQUID	TOPICAL	20231121		UNAPPROVED DRUG OTHER		LLRN PERSONAL CARE(SHENZHEN)CO., LTD	PHTHALIMIDOPEROXYCAPROIC ACID; POTASSIUM CITRATE; TRIBASIC CALCIUM PHOSPHATE	12; 3; 1	g/100mL; g/100mL; g/100mL	Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]		N	20241231
83812-002_0add86fa-f77c-3c67-e063-6394a90ac9f4	83812-002	HUMAN OTC DRUG	V34 Colour Corrector		V34 Colour Corrector	CREAM	TOPICAL	20231123		UNAPPROVED DRUG OTHER		LLRN PERSONAL CARE(SHENZHEN)CO., LTD	SODIUM PYROPHOSPHATE	.5	g/100mL			N	20241231
83812-003_0addc66f-2dfd-66ed-e063-6394a90a3513	83812-003	HUMAN OTC DRUG	GlorySmile toothpaste.		GlorySmile toothpaste	CREAM	TOPICAL	20231123		UNAPPROVED DRUG OTHER		LLRN PERSONAL CARE(SHENZHEN)CO., LTD	SODIUM FLUORIDE; SODIUM GLUCONATE	.1; .1	g/100g; g/100g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
83812-004_0ade20e9-ae3c-4303-e063-6294a90a637a	83812-004	HUMAN OTC DRUG	Teeth Whitening Strips		Teeth Whitening Strips	PATCH	TOPICAL	20231123		UNAPPROVED DRUG OTHER		LLRN PERSONAL CARE(SHENZHEN)CO., LTD	PHTHALIMIDOPEROXYCAPROIC ACID	12	g/1001			N	20241231
83812-005_0af2587d-07ca-285a-e063-6394a90a2ebf	83812-005	HUMAN OTC DRUG	V34 Toothpaste. Tablets.		V34 Toothpaste Tablets	TABLET	TOPICAL	20231124		UNAPPROVED DRUG OTHER		LLRN PERSONAL CARE(SHENZHEN)CO., LTD	HYDRATED SILICA; PHTHALIMIDOPEROXYCAPROIC ACID; SODIUM BICARBONATE	5; 6; 7	g/1001; g/1001; g/1001	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
83813-001_0adde55f-f93a-71c5-e063-6394a90aa1bf	83813-001	HUMAN OTC DRUG	Aspirin 81 mg		Aspirin Enteric Coated Tablets 81 mg	TABLET, DELAYED RELEASE	ORAL	20210503		OTC MONOGRAPH DRUG	M013	NewVue LLC	ASPIRIN	81	mg/1	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]		N	20241231
83814-001_0b567ef2-a783-3daa-e063-6294a90a064e	83814-001	HUMAN OTC DRUG	Zoviro		Benzalkonium Chloride	SWAB	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	Zoviro, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20251231
83814-003_0b41ff48-a0db-2bc6-e063-6294a90a7e98	83814-003	HUMAN OTC DRUG	Zoviro		Benzalkonium Chloride	SWAB	TOPICAL	20240101		OTC MONOGRAPH DRUG	505G(a)(3)	Zoviro, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20251231
83814-004_0e2b4917-0423-b320-e063-6394a90a731b	83814-004	HUMAN OTC DRUG	Zoviro		Benzalkonium Chloride	SWAB	TOPICAL	20240104		OTC MONOGRAPH DRUG	505G(a)(3)	Zoviro, LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20251231
83814-005_0e85fb58-7ccb-8ae3-e063-6294a90a2553	83814-005	HUMAN OTC DRUG	Zoviro		ALCOHOL	LIQUID	TOPICAL	20240109		OTC MONOGRAPH DRUG	505G(a)(3)	Zoviro, LLC	ALCOHOL	70	mL/100mL			N	20251231
83818-001_0a8c7bdb-19f5-54c9-e063-6394a90ac5f5	83818-001	HUMAN OTC DRUG	Milia Remover Treatment		Milia Remover	LIQUID	TOPICAL	20231119		OTC MONOGRAPH DRUG	M005	Shenzhen Xinxin Yunhai Technology Co., Ltd.	DIDECYLDIMONIUM CHLORIDE; NIACINAMIDE; SALICYLIC ACID	.025; .5; .15	g/100mL; g/100mL; g/100mL			N	20241231
83819-001_43f7ca2a-a024-420d-b4b4-8d7629036769	83819-001	HUMAN OTC DRUG	dermveda ACNE TREATMENT SERUM		Salicylic acid	LIQUID	TOPICAL	20240101		OTC MONOGRAPH DRUG	M006	Celcius Corp.	SALICYLIC ACID	.5	g/100mL			N	20241231
83819-003_4e1d5cab-8a0c-4224-8b5d-80cae557bb6a	83819-003	HUMAN OTC DRUG	dermveda JOCK ITCH		Olive extract, Sulfur	SPRAY	TOPICAL	20231222		UNAPPROVED HOMEOPATHIC		Celcius Corp.	OLEA EUROPAEA LEAF; SULFUR	8; 6	[hp_X]/118mL; [hp_X]/118mL			N	20251231
83819-012_3c2c8b89-d303-411b-b737-67f80c7b520d	83819-012	HUMAN OTC DRUG	dermveda SCABIES ITCH RELIEF SERUM		Olive extract, Sulfur	SOLUTION	TOPICAL	20231227		UNAPPROVED HOMEOPATHIC		Celcius Corp.	OLEA EUROPAEA LEAF; SULFUR	6; 6	[hp_X]/118mL; [hp_X]/118mL			N	20251231
83819-030_39baebd0-f633-4cdf-b673-124bee2f47cf	83819-030	HUMAN OTC DRUG	dermveda Complete Lice Treatment NATURAL SERUM		Eucalyptus Globulus	LIQUID	TOPICAL	20231220		UNAPPROVED HOMEOPATHIC		Celcius Corp.	EUCALYPTUS GLOBULUS LEAF	6	[hp_X]/118mL			N	20251231
83819-102_77e23ff6-c27a-42e3-a5f7-c0c220267756	83819-102	HUMAN OTC DRUG	dermveda BORIC ACID BV, YEAST INFECTION		Boricum Acidum, Chamomilla	SPRAY	TOPICAL	20231227		UNAPPROVED HOMEOPATHIC		Celcius Corp.	BORIC ACID; CHAMOMILE	6; 8	[hp_X]/118mL; [hp_X]/118mL			N	20251231
83819-120_970f5cfd-3e2b-4a3f-bf31-461da6624c0b	83819-120	HUMAN OTC DRUG	dermveda NAIL FUNGUS SERUM		Olive extract, Sulfur	SOLUTION	TOPICAL	20231225		UNAPPROVED HOMEOPATHIC		Celcius Corp.	OLEA EUROPAEA LEAF; SULFUR	8; 6	[hp_X]/118mL; [hp_X]/118mL			N	20251231
83820-001_0a9aac4c-a28c-98bb-e063-6294a90a236c	83820-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20231127		UNAPPROVED MEDICAL GAS		Life DME, LLC	OXYGEN	99	L/100L			N	20241231
83822-001_0d2512e3-7b30-4fa6-e063-6394a90a9f52	83822-001	HUMAN OTC DRUG	Knee Patch		Knee Patch	PATCH	TOPICAL	20231222		OTC MONOGRAPH DRUG	M017	Fuzhou Ayimong Trading Co., Ltd.	MENTHOL	40	g/1001			N	20241231
83823-001_063a1e99-dda7-9cb9-e063-6294a90aa1b3	83823-001	HUMAN OTC DRUG	NOxyDERM		Benzalkonium Chloride	LIQUID	TOPICAL	20240105		OTC MONOGRAPH DRUG	M003	NOxy Health Products	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
83830-101_0e80dd17-7c44-45fd-e063-6294a90ae1a5	83830-101	HUMAN OTC DRUG	Elevate 5% Minoxidil Liquid		DS-0075 Elevate 5% Minoxidil Liquid	LIQUID	TOPICAL	20231221		ANDA	ANDA209074	Foshan Yilai Cosmetics Co., Ltd.	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
83830-102_0d65e58a-be77-76f6-e063-6394a90ade66	83830-102	HUMAN OTC DRUG	Elevate 5% Minoxidil Foam		Elevate 5% Minoxidil Foam	LIQUID	TOPICAL	20231222		UNAPPROVED DRUG OTHER		Foshan Yilai Cosmetics Co., Ltd.	MINOXIDIL	5	g/100g	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83830-103_0d6192c9-a51a-f6c2-e063-6294a90ab9bc	83830-103	HUMAN OTC DRUG	Elevate 5% Minoxidil Hair Liquid		Elevate 5% Minoxidil Hair Liquid	LIQUID	TOPICAL	20231226		UNAPPROVED DRUG OTHER		Foshan Yilai Cosmetics Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83830-104_0d7521df-ecd0-0eb0-e063-6294a90ab5c0	83830-104	HUMAN OTC DRUG	Elevate 2% Minoxidil Hair Liquid		Elevate 2% Minoxidil Hair Liquid	LIQUID	TOPICAL	20231227		UNAPPROVED DRUG OTHER		Foshan Yilai Cosmetics Co., Ltd.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83830-105_0d79ae91-6d6f-fda8-e063-6294a90a91dd	83830-105	HUMAN OTC DRUG	Elevate 2% Minoxidil Liquid		Elevate 2% Minoxidil Liquid	LIQUID	TOPICAL	20231227		UNAPPROVED DRUG OTHER		Foshan Yilai Cosmetics Co., Ltd.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83830-106_0d7ad1db-127d-0172-e063-6394a90a4ec6	83830-106	HUMAN OTC DRUG	Elevate 2% Minoxidil Foam		Elevate 2% Minoxidil Foam	LIQUID	TOPICAL	20231227		UNAPPROVED DRUG OTHER		Foshan Yilai Cosmetics Co., Ltd.	MINOXIDIL	2	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83830-107_0e6d01c9-59bf-bcf3-e063-6294a90a58c9	83830-107	HUMAN OTC DRUG	Elevate Anti Dandruff		Elevate Anti Dandruff Shampoo	SHAMPOO	TOPICAL	20240105		OTC MONOGRAPH DRUG	M032	Foshan Yilai Cosmetics Co., Ltd.	KETOCONAZOLE	1	g/100mL	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]		N	20251231
83833-101_0b75e83e-8c7c-6247-e063-6294a90ac413	83833-101	HUMAN OTC DRUG	WelAhead by Welmate Lidocaine 5% Roll-on		Lidocaine 5%	SOLUTION	TOPICAL	20231201		OTC MONOGRAPH DRUG	M017	OTC PHARM LLC	LIDOCAINE HYDROCHLORIDE ANHYDROUS	5	g/100mL	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83835-211_0d92faf1-8974-8151-e063-6294a90a238c	83835-211	HUMAN OTC DRUG	FOLLIXIL Hair and Beard Growth-Lotion		5% Minoxidil	LIQUID	TOPICAL	20231207		UNAPPROVED DRUG OTHER		Matykos Beauty LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83835-221_0d62b11b-b9b3-eb1d-e063-6294a90ab368	83835-221	HUMAN OTC DRUG	FOLLIXIL Hair and Beard Growth-Foam		5% Minoxidil	LIQUID	TOPICAL	20231207		UNAPPROVED DRUG OTHER		Matykos Beauty LLC	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83838-153_0b645092-ebc3-e4bb-e063-6294a90ad4cf	83838-153	HUMAN OTC DRUG	Bloop Fissure Healing Anorectal Topical		Lidocaine	CREAM	TOPICAL	20231114		OTC MONOGRAPH DRUG	M015	Three Nations Corp	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83838-155_0b6419e3-f1c8-bdfe-e063-6294a90a5d92	83838-155	HUMAN OTC DRUG	Bloop Hemorrhoid Relief Topical		Glycerin, Petrolatum, Phenylephrine HCl, Pramoxine HCl	CREAM	TOPICAL	20231114		OTC MONOGRAPH DRUG	M015	Three Nations Corp	GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE, (+/-)-; PRAMOXINE HYDROCHLORIDE	14.4; 15; .25; 1	g/100g; g/100g; g/100g; g/100g	Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]		N	20241231
83838-415_0b64677e-d4be-0929-e063-6294a90af137	83838-415	HUMAN OTC DRUG	Bloop Itch Soothing Topical		Hydrocortisone	CREAM	TOPICAL	20231114		OTC MONOGRAPH DRUG	M017	Three Nations Corp	HYDROCORTISONE	1	g/100g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
83852-438_0be65353-4d1c-86cb-e063-6294a90aac66	83852-438	HUMAN OTC DRUG	ALLIES OF SKIN The One SPF-50 Invisible Sunscreen		AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE	GEL	TOPICAL	20231211		OTC MONOGRAPH DRUG	M020	ALLIES GROUP PTE. LTD.	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 70; 50; 100	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83857-0001_0bf2f33a-af99-30a8-e063-6294a90a9349	83857-0001	HUMAN OTC DRUG	HANHOO BlemishPatch		mineral oil	PATCH	TOPICAL	20231207		UNAPPROVED DRUG OTHER		New Bio Pharmaceutical Co., Ltd.	MINERAL OIL	4.25	g/100g			N	20241231
83861-001_0c389ae5-8708-7ded-e063-6394a90a3945	83861-001	HUMAN OTC DRUG	Tooth		Toothpaste Tablets	TABLET	PERIODONTAL	20231211		UNAPPROVED DRUG OTHER		Henan Dailygreen Biotechnology Co. LTD	SODIUM MONOFLUOROPHOSPHATE	.877	g/1001			N	20241231
83867-0002_0c72fc83-fb12-329e-e063-6394a90a4aca	83867-0002	HUMAN OTC DRUG	AnYi Beauty Skin Tag Patches Mole Wart Remover		Salicylic acid	PATCH	TOPICAL	20231209		OTC MONOGRAPH DRUG	M028	Guangzhou Zhicunxiu Cosmetics Co., Ltd	SALICYLIC ACID	20	mg/1			N	20241231
83867-0003_0c53e464-b591-ae4d-e063-6394a90a9fa5	83867-0003	HUMAN OTC DRUG	AnYi Beauty Master Patch		SALICYLIC ACID	PATCH	TOPICAL	20231211		OTC MONOGRAPH DRUG	M006	Guangzhou Zhicunxiu Cosmetics Co., Ltd	SALICYLIC ACID	5	mg/1			N	20241231
83867-0004_0c53c982-3f22-a2d5-e063-6394a90acd55	83867-0004	HUMAN OTC DRUG	NowNoon Fast Effective Peptides Cream		Dimethicone	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0005_0c53fe8c-e4c9-ab3a-e063-6394a90a3424	83867-0005	HUMAN OTC DRUG	NowNoon Fast Effective Peptides Cream		Dimethicone	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0006_0c540422-1576-9217-e063-6294a90ad06a	83867-0006	HUMAN OTC DRUG	NowNoon Fast Effective Neck Cream		Dimethicone	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0007_0c540172-3b7b-c99e-e063-6394a90abe5e	83867-0007	HUMAN OTC DRUG	NowNoon Fast Effective Day Night Face Lift Cream		Dimethicone	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0008_0c540422-1571-9217-e063-6294a90ad06a	83867-0008	HUMAN OTC DRUG	NowNoon Fast Effective Eye Cream		Dimethicone	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0009_0c53f393-942d-bf86-e063-6394a90a6fdf	83867-0009	HUMAN OTC DRUG	NowNoon Fast Effective Collagen Cream		Dimethicone	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0010_0c540172-3b7c-c99e-e063-6394a90abe5e	83867-0010	HUMAN OTC DRUG	NowNoon Fast Effective Retinol Cream		Dimethicone	CREAM	TOPICAL	20231211		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0011_0c540422-157a-9217-e063-6294a90ad06a	83867-0011	HUMAN OTC DRUG	NowNoon Fast Effective RADIANCE Cream		Niacinamide	CREAM	TOPICAL	20231208		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	NIACINAMIDE	30	mg/g			N	20241231
83867-0025_0d24e99d-5ef7-2bac-e063-6294a90ab238	83867-0025	HUMAN OTC DRUG	NowNoon Bum Bum Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/g	Skin Barrier Activity [PE]		N	20241231
83867-0044_0c88e8b2-858f-2f55-e063-6394a90a8272	83867-0044	HUMAN OTC DRUG	AnYi Beauty Retinol Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0045_0c891cab-ba9d-27a1-e063-6294a90a12dc	83867-0045	HUMAN OTC DRUG	AnYi Beauty Bum Bum Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0046_0c891c45-97aa-2629-e063-6294a90ac71d	83867-0046	HUMAN OTC DRUG	AnYi Beauty Face Lift Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0047_0c893020-17db-5416-e063-6394a90a638a	83867-0047	HUMAN OTC DRUG	AnYi Beauty Neck Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0049_0c89270a-134e-4c2f-e063-6394a90a09f3	83867-0049	HUMAN OTC DRUG	VOVA Neck Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0050_0c891cab-ba9e-27a1-e063-6294a90a12dc	83867-0050	HUMAN OTC DRUG	CHANCHI Neck Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0051_0c892ff5-8ef6-1996-e063-6294a90a6d5b	83867-0051	HUMAN OTC DRUG	VOVA WATERMELON NIACINAMIDE Cream		Niacinamide	CREAM	TOPICAL	20231208		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	NIACINAMIDE	30	mg/mL			N	20241231
83867-0052_0c891c45-97ac-2629-e063-6294a90ac71d	83867-0052	HUMAN OTC DRUG	VOVA Eye Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0053_0c892ff5-8ef8-1996-e063-6294a90a6d5b	83867-0053	HUMAN OTC DRUG	AnYi Beauty Eye Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0054_0c892f95-15da-52ab-e063-6394a90a1b33	83867-0054	HUMAN OTC DRUG	CHICHAN Eye Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83867-0056_0c893020-17de-5416-e063-6394a90a638a	83867-0056	HUMAN OTC DRUG	VOVA NIACINAMIDE Cream		Niacinamide	CREAM	TOPICAL	20231208		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	NIACINAMIDE	30	mg/mL			N	20241231
83867-0057_0c89616c-841c-600f-e063-6394a90a2317	83867-0057	HUMAN OTC DRUG	AnYi Beauty NIACINAMIDE Cream		Niacinamide	CREAM	TOPICAL	20231208		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	NIACINAMIDE	30	mg/mL			N	20241231
83867-0058_0c897f74-326d-5403-e063-6294a90ad46c	83867-0058	HUMAN OTC DRUG	CHANCHI NIACINAMIDE Cream		Niacinamide	CREAM	TOPICAL	20231208		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	NIACINAMIDE	30	mg/mL			N	20241231
83867-0060_0c896adc-3641-6099-e063-6394a90a5758	83867-0060	HUMAN OTC DRUG	AnYi Beauty Vitamin C Cream		Niacinamide	CREAM	TOPICAL	20231208		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	NIACINAMIDE	30	mg/mL			N	20241231
83867-0061_0c897ee8-d079-558b-e063-6294a90ad835	83867-0061	HUMAN OTC DRUG	CHANCHI Vitamin C Cream		Niacinamide	CREAM	TOPICAL	20231208		UNAPPROVED DRUG OTHER		Guangzhou Zhicunxiu Cosmetics Co., Ltd	NIACINAMIDE	30	mg/mL			N	20241231
83867-0063_0c897f74-3274-5403-e063-6294a90ad46c	83867-0063	HUMAN OTC DRUG	AnYi Beauty Stretch Marks Cream		Dimethicone	CREAM	TOPICAL	20231213		OTC MONOGRAPH DRUG	M016	Guangzhou Zhicunxiu Cosmetics Co., Ltd	DIMETHICONE	30	mg/mL	Skin Barrier Activity [PE]		N	20241231
83870-001_0d1791f4-d2ec-0af1-e063-6294a90a167e	83870-001	HUMAN OTC DRUG	ASDTOTIO 5% minoxidil		Minoxidil	LIQUID	TOPICAL	20220323		UNAPPROVED DRUG OTHER		Guangzhou Colif Cosmetics Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83871-001_0cd8045e-6563-2ca7-e063-6394a90a54d7	83871-001	HUMAN OTC DRUG	SUNHEAL Tattoo Numbing Cream		SUNHEAL Tattoo Numbing Cream	CREAM	TOPICAL	20231218		OTC MONOGRAPH DRUG	M017	IBP CORP CO. LTD.	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83872-001_0cc05610-8b30-5f29-e063-6394a90a193b	83872-001	HUMAN OTC DRUG	Hair essential oil		Essential oil	LIQUID	TOPICAL	20231217		UNAPPROVED DRUG OTHER		Shenzhen Xiaomai Manufacturing Co., Ltd.	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83873-001_0c717667-4423-9c35-e063-6394a90aee8d	83873-001	HUMAN OTC DRUG	RxClothing Medicine Infused Socks		Capsaicin	CLOTH	TOPICAL	20231213		OTC MONOGRAPH DRUG	M017	Textile-Based Delivery, Inc.	CAPSAICIN	.11	g/100g			N	20241231
83873-002_0c70e77e-18e7-70da-e063-6394a90a6c0b	83873-002	HUMAN OTC DRUG	RxClothing Medicine Infused Socks		Capsaicin	CLOTH	TOPICAL	20231213		OTC MONOGRAPH DRUG	M017	Textile-Based Delivery, Inc.	CAPSAICIN	.11	g/100g			N	20241231
83873-003_0c7119bf-9894-7ecd-e063-6394a90a7193	83873-003	HUMAN OTC DRUG	RxClothing Pain Relief Socks		Capsaicin	CLOTH	TOPICAL	20231213		OTC MONOGRAPH DRUG	M017	Textile-Based Delivery, Inc.	CAPSAICIN	.17	g/100g			N	20241231
83873-004_0c7119bf-9896-7ecd-e063-6394a90a7193	83873-004	HUMAN OTC DRUG	RxClothing Pain Relief Socks		Capsaicin	CLOTH	TOPICAL	20231213		OTC MONOGRAPH DRUG	M017	Textile-Based Delivery, Inc.	CAPSAICIN	.17	g/100g			N	20241231
83879-001_0d11e07b-c138-6efc-e063-6394a90a6bba	83879-001	HUMAN OTC DRUG	Premixed saline packets		Sodium chloride, Sodium bicarbonate	GRANULE, FOR SOLUTION	NASAL	20231222		UNAPPROVED DRUG OTHER		Shenzhen Kerui lntl Trading Co., Ltd	SODIUM BICARBONATE; SODIUM CHLORIDE	700; 2300	mg/3000mg; mg/3000mg	Alkalinizing Activity [MoA]		N	20241231
83880-440_0c85c4b2-7252-1c81-e063-6394a90aa1f0	83880-440	HUMAN OTC DRUG	CHEVOURI Brightening Serum Broad Spectrum SPF-40		AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	CREAM	TOPICAL	20231226		OTC MONOGRAPH DRUG	M020	CHE'VOURI LLC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 90; 50; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83885-001_0cebd559-b9fa-8e56-e063-6394a90a1ecc	83885-001	HUMAN OTC DRUG	FATAZEN SWEAT ENHANCE HOT		FATAZEN SWEAT ENHANCE HOT	CREAM	TOPICAL	20231220		UNAPPROVED DRUG OTHER		Guangzhou Guocui Biological Technology Co., Ltd	CAPSAICIN; LAUROCAPRAM; VANILLYL BUTYL ETHER	.008; .8; .8	g/100g; g/100g; g/100g			N	20241231
83887-001_0d27b90a-bd72-c1f5-e063-6394a90a22a0	83887-001	HUMAN OTC DRUG	Pressy Tattoo Numbing Cream		Numbing Cream	CREAM	TOPICAL	20231222		OTC MONOGRAPH DRUG	M017	Changsha Beiliang E-commerce Co., Ltd	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83887-002_0d281d68-021f-675d-e063-6294a90a07dd	83887-002	HUMAN OTC DRUG	Ophyte Tattoo Numbing Cream		Numbing Cream	CREAM	TOPICAL	20231222		OTC MONOGRAPH DRUG	M017	Changsha Beiliang E-commerce Co., Ltd	LIDOCAINE	5	g/100g	Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]		N	20241231
83887-003_0e6b7931-6ca0-9057-e063-6294a90ad725	83887-003	HUMAN OTC DRUG	RACORMY 5% Minoxidil Hair Growth Serum		5% Minoxidil Hair Growth Serum	LIQUID	TOPICAL	20240107		OTC MONOGRAPH DRUG	M032	Changsha Beiliang E-commerce Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
83889-101_0d14dbe6-35a7-5849-e063-6394a90a49b8	83889-101	HUMAN OTC DRUG	5% Minoxidil		Minoxidil	OIL	TOPICAL	20231222		ANDA	ANDA075357	Shenzhen Lancity Information Technology Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83910-001_0d8934f2-29ae-1a31-e063-6394a90a6348	83910-001	HUMAN OTC DRUG	GIOTTO Minoxidil Hair Growth Serum		Hair Growth Serum	LIQUID	TOPICAL	20231227		ANDA	ANDA075357	Xiamen Beishan Ecommerce Co.,LTD	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
83910-002_0e071e03-d44e-5bc7-e063-6394a90a9804	83910-002	HUMAN OTC DRUG	GIOTTO Minoxidil Hair Growth Spray.		Hair Growth Spray	SPRAY	TOPICAL	20240102		ANDA	ANDA075357	Xiamen Beishan Ecommerce Co.,LTD	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
83912-001_0d27b90a-bd6f-c1f5-e063-6394a90a22a0	83912-001	HUMAN OTC DRUG	Fidyn 5% Minoxidil HAIR GROWTH SERUM For Men		5% Minoxidil HAIR GROWTH SERUM For Men	LIQUID	TOPICAL	20231222		ANDA	ANDA075357	Fidyn 5% Minoxidil HAIR GROWTH SERUM For Men	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20241231
83913-001_0d6d4200-583c-3fda-e063-6394a90aac3f	83913-001	HUMAN OTC DRUG	IMPACTFUL CLEANING DISINFECTING WIPES		Wipes	CLOTH	TOPICAL	20231225		OTC MONOGRAPH DRUG	505G(a)(3)	IMPACTFUL BRANDS LLC	BENZALKONIUM CHLORIDE	.13	g/100g			N	20251231
83918-001_0d9b03a5-1bcc-f586-e063-6394a90a1bab	83918-001	HUMAN OTC DRUG	solful face sunlotion		Homosalate, Avobenzone, Otisalate, Octocrylene	LOTION	TOPICAL	20231227		OTC MONOGRAPH DRUG	M020	KARA BEAUTY INC	AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE	30; 100; 40; 50	mg/mL; mg/mL; mg/mL; mg/mL			N	20241231
83919-600_4a8ce714-37de-42ab-8b9d-4972168ca5ba	83919-600	HUMAN OTC DRUG	Antimicrobial Hand SP		Chloroxylenol	LIQUID	TOPICAL	20220426		OTC MONOGRAPH DRUG	505G(a)(3)	Envoy Solutions, LLC	CHLOROXYLENOL	.3	mg/100mL			N	20241231
83930-010_4f29ee91-d321-49d0-8fb5-2c08e3943789	83930-010	HUMAN OTC DRUG	Medi wiper Hand Sanitizing Wipes		Benzalkonium Chloride	LIQUID	TOPICAL	20231201		OTC MONOGRAPH DRUG	M003	TIMK, INC.	BENZALKONIUM CHLORIDE	.1	g/100g			N	20251231
83933-0001_0e0348ea-d272-59fd-e063-6294a90a0030	83933-0001	HUMAN OTC DRUG	1912 Herb Co Vital Air Herb		Honeysuckle, Bellflower, Ginseng	POWDER	ORAL	20240103		UNAPPROVED DRUG OTHER		Agricultural Corporation YUBIMUHUAN CO Ltd	LONICERA CAPRIFOLIUM FLOWER; PANAX GINSENG ROOT OIL; PLATYCODON GRANDIFLORUS WHOLE	20; 5; 15	g/100g; g/100g; g/100g			N	20251231
83933-0002_0e03da21-01e9-954d-e063-6294a90a0ce4	83933-0002	HUMAN OTC DRUG	1912 Herb Co Easy Stomach Herb		Malt, Hawthorn	POWDER	ORAL	20240103		UNAPPROVED DRUG OTHER		Agricultural Corporation YUBIMUHUAN CO Ltd	HAWTHORN LEAF WITH FLOWER	20	g/100g			N	20251231
83981-001_0dfe5f6a-6967-68e6-e063-6294a90ae25b	83981-001	HUMAN PRESCRIPTION DRUG	Oxygen		Oxygen	GAS	RESPIRATORY (INHALATION)	20231228		UNAPPROVED MEDICAL GAS		Classic Home Care Services, Inc.	OXYGEN	99	L/100L			N	20251231
83984-441_0e6c8b79-89f9-2d24-e063-6394a90a5206	83984-441	HUMAN OTC DRUG	2nd CHANCE MOBILITY Pain Relief		HISTAMINE DIHYDROCHLORIDE	CREAM	TOPICAL	20231227		OTC MONOGRAPH DRUG	M017	ALPHA NUTRITION, LLC	HISTAMINE DIHYDROCHLORIDE	.5	mg/g			N	20251231
83988-001_0ea6cbb4-10cb-fecf-e063-6394a90a513b	83988-001	HUMAN OTC DRUG	Chrmplx Hair Regrowth Treatment		Minoxidil 5%	LIQUID	TOPICAL	20240111		ANDA	ANDA209074	Jinan Guyun Technology Co., Ltd	MINOXIDIL	5	g/100mL	Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]		N	20251231
84006-101_0c3e209e-0b5d-7794-e063-6294a90a8377	84006-101	HUMAN OTC DRUG	Anesthall Pain Relieving Cream		Methyl Salicylate, Menthol	CREAM	TOPICAL	20231211		UNAPPROVED DRUG OTHER		Advanced Pharmaceutics Inc	MENTHOL; METHYL SALICYLATE	4.6; 6.1	g/100g; g/100g			N	20251231
86050-4700_cba4b70e-f00d-486d-94d4-5194bd2408d7	86050-4700	HUMAN OTC DRUG	Last Call Final Step Sanitizer		Isopropyl Alcohol 70%	SOLUTION	TOPICAL	20230816		OTC MONOGRAPH DRUG	505G(a)(3)	Blendpack, Inc.	ISOPROPYL ALCOHOL	700	g/L			N	20241231
86089-400_97245535-f475-4170-b03a-4f03b7690fa1	86089-400	HUMAN OTC DRUG	BAC-D	Hand and Wound Sanitizer	Benzalkonium Chloride	SPRAY	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part333A	AEC CONSUMER PRODUCTS	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
86089-500_9f3122d5-9c8f-4780-b74f-76f7e8324611	86089-500	HUMAN OTC DRUG	BAC-D	Foaming Hand and Wound Sanitizer	Benzalkonium Chloride	LIQUID	TOPICAL	20140101		OTC MONOGRAPH NOT FINAL	part333A	AEC Consumer Products, LLC	BENZALKONIUM CHLORIDE	.13	g/100mL			N	20241231
86089-900_3ec75db5-fdbf-42e3-9ff0-62e2d6fa0615	86089-900	HUMAN OTC DRUG	BAC-D Hand Sanitizer		Alcohol	SPRAY	TOPICAL	20200601		OTC MONOGRAPH NOT FINAL	part333A	AEC CONSUMER PRODUCTS	ALCOHOL	80	mL/100mL			N	20241231
86815-002_d64741db-01c4-3382-e053-2a95a90a4648	86815-002	HUMAN OTC DRUG	Deep Fresh Antibacterial Hand Sanitizer Gel		ALCOHOL	GEL	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	AKSAN KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	ALCOHOL	70	mL/100mL			N	20241231
86815-003_dc20b4de-504c-8727-e053-2995a90a5209	86815-003	HUMAN OTC DRUG	DEEP FRESH ANTIBACTERIAL WET WIPES		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	AKSAN KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.23	g/100g			N	20241231
86815-005_d6474506-cb78-3dd7-e053-2a95a90a7d0b	86815-005	HUMAN OTC DRUG	DEEPFRESH ANTIBACTERIALSOAP		BENZALKONIUM CHLORIDE	SOAP	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	AKSAN KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.23	g/100mL			N	20241231
86815-006_fb5e5c40-5834-eed8-e053-6294a90a0ebd	86815-006	HUMAN OTC DRUG	Deep Fresh Antiviral Alcohol Wipes		ALCOHOL	CLOTH	TOPICAL	20200330		OTC MONOGRAPH NOT FINAL	part333A	AKSAN KOZMETIK SANAYI VE TICARET ANONIM SIRKETI	ALCOHOL	75	mL/100mL			N	20241231
86937-002_ad5587c1-eedc-6a43-e053-2995a90ad1bb	86937-002	HUMAN OTC DRUG	Medifresh Hand Skin Antiseptic Disinfectant Wet Wipes		ALCOHOL-BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part333A	KARDESLER UCAN YAGLAR SANAYI ANONIM SIRKETI	ALCOHOL; BENZALKONIUM CHLORIDE	80; .1	g/100g; g/100g			N	20241231
86937-005_a67e780c-3176-4180-aec8-ccf0c5a46ae5	86937-005	HUMAN OTC DRUG	FRESH N SOFT ANTIBACTERIAL WET WIPES		Benzalkonium Chloride	CLOTH	TOPICAL	20201223		OTC MONOGRAPH NOT FINAL	part333A	KARDESLER UCAN YAGLAR SANAYI ANONIM SIRKETI	BENZALKONIUM CHLORIDE	.1	g/100g			N	20241231
86937-008_d177f614-57ea-447d-88e4-755c018ec6c5	86937-008	HUMAN OTC DRUG	medifresh Antiseptic Hand and Skin Disinfectant Wet Wipes		Ethyl Alcohol	CLOTH	TOPICAL	20220622		OTC MONOGRAPH NOT FINAL	part333A	KARDESLER UCAN YAGLAR SANAYI ANONIM SIRKETI	ALCOHOL	80	g/100g			N	20241231
89156-000_004a6db7-65ec-45e9-a5b7-9e3840f7e4cc	89156-000	HUMAN OTC DRUG	Global EASY PREP alcohol prep pads		ISOPROPYL ALCOHOL	LIQUID	TOPICAL	20160803		OTC MONOGRAPH NOT FINAL	part333A	Global Diabetic Distributors	ISOPROPYL ALCOHOL	70	g/100g			N	20241231
90020-000_09c2d3bb-e846-3015-e063-6394a90aff27	90020-000	HUMAN OTC DRUG	Novalent Shield Advanced Antiseptic Hand Sanitizer		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	IndusCo, Ltd. (dba) Novalent Biotech	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
90020-001_09c2d4fa-ea0a-318b-e063-6394a90a6d51	90020-001	HUMAN OTC DRUG	Novalent Shield Antiseptic Hand Sanitizer		BENZALKONIUM CHLORIDE	SOLUTION	TOPICAL	20200801		OTC MONOGRAPH DRUG	505G(a)(3)	IndusCo, Ltd. (dba) Novalent Biotech	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
90078-521_ad3d4f7d-459e-330e-e053-2995a90a9d0a	90078-521	HUMAN OTC DRUG	AK47 MENTHOL WARMING		MENTHOL WARMING	CREAM	TOPICAL	20200720		OTC MONOGRAPH NOT FINAL	part348	Crosstown Concepts Corporation	MENTHOL	5.6	g/112g			N	20241231
90082-074_f60495b2-22de-4d29-e053-2995a90a7076	90082-074	HUMAN OTC DRUG	HP2514-001.20		Isopropyl Alcohol	GEL	TOPICAL	20200925	20241231	OTC MONOGRAPH NOT FINAL	part333A	Sani Clean Plus	ISOPROPYL ALCOHOL	75	mL/100mL			N	
90082-081_f6049740-5068-6326-e053-2995a90ad324	90082-081	HUMAN OTC DRUG	HP2511-003.20		Isopropyl Alcohol	GEL	TOPICAL	20200902	20241231	OTC MONOGRAPH NOT FINAL	part333A	First Galaxy Enterprises Inc	ISOPROPYL ALCOHOL	75	mL/100mL			N	
90082-082_f604f079-dbd2-714c-e053-2a95a90aef6f	90082-082	HUMAN OTC DRUG	HP2511-001.20		Isopropyl Alcohol	GEL	TOPICAL	20200902	20241231	OTC MONOGRAPH NOT FINAL	part333A	First Galaxy Enterprises Inc	ISOPROPYL ALCOHOL	75	mL/100mL			N	
90086-002_0c5d53d4-6dfd-0d14-e063-6394a90ad59d	90086-002	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer One		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-003_0c5d06ec-059b-f60c-e063-6394a90a79b9	90086-003	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Two		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-004_0c5d598a-daa6-d236-e063-6294a90abf85	90086-004	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Three		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-005_0c5d3da7-2acd-a2bc-e063-6294a90a7a3d	90086-005	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Four		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-006_0c5d3da7-2add-a2bc-e063-6294a90a7a3d	90086-006	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Five		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-007_0c5d06ec-05ad-f60c-e063-6394a90a79b9	90086-007	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Six		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-008_0c5d3da7-2aed-a2bc-e063-6294a90a7a3d	90086-008	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Seven		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-009_0c5d598a-dab6-d236-e063-6294a90abf85	90086-009	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Eight		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-010_0c5d598a-dac6-d236-e063-6294a90abf85	90086-010	HUMAN OTC DRUG	Saie Slip Cover Broad Spectrum SPF 35 Sunscreen Tinted Moisturizer Nine		ZINC OXIDE	CREAM	TOPICAL	20200907		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-011_0c5d6ddd-b9fe-92f5-e063-6294a90a81e7	90086-011	HUMAN OTC DRUG	Saie Sunvisor Broad Spectrum SPF 35 Sheer Moisturizer		ZINC OXIDE	LOTION	TOPICAL	20200101		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90086-012_0c5d598a-dad6-d236-e063-6294a90abf85	90086-012	HUMAN OTC DRUG	Slip Tint Broad Spectrum SPF 35 Tinted Moisturizer		ZINC OXIDE	CREAM	TOPICAL	20210914		OTC MONOGRAPH DRUG	M020	Clean Beauty For All, Inc	ZINC OXIDE	150	mg/mL	Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE]		N	20241231
90089-153_fcbdd85d-2e4e-48e6-9bb3-29ae98f61a3d	90089-153	HUMAN OTC DRUG	Dandruff		Pyrithione Zinc	SHAMPOO	TOPICAL	20200803		OTC MONOGRAPH FINAL	part358H	TKC Holdings, Inc	PYRITHIONE ZINC	1	mg/mL			N	20241231
90092-001_c8bde9a5-6d15-4e47-8474-cceebb97d760	90092-001	HUMAN OTC DRUG	Everclear	Alcohol Hand Sanitizing and Surface Wipes	Isopropyl Alcohol	CLOTH	TOPICAL	20200801	20240117	OTC MONOGRAPH NOT FINAL	part333A	Everclear Chemical Solutions, Inc.	ISOPROPYL ALCOHOL	70	mL/100mL			N	
90100-201_0c047e21-c3c9-1a6a-e063-6294a90a39c6	90100-201	HUMAN OTC DRUG	HERSTAT		Moisturizing Lip Protectant	LIQUID	TOPICAL	20200814		OTC MONOGRAPH DRUG	M016	Herstat (USA) Inc.	PETROLATUM	89.5	g/100g			N	20241231
90100-202_0c0473a0-dd7b-0d79-e063-6294a90a84df	90100-202	HUMAN OTC DRUG	HERSTAT		Moisturizing Lip Care Stick	LIPSTICK	TOPICAL	20201130		OTC MONOGRAPH DRUG	M016	Herstat (USA) Inc.	PETROLATUM	47.95	g/100g			N	20241231
90100-221_0c047e21-c3d9-1a6a-e063-6294a90a39c6	90100-221	HUMAN OTC DRUG	HERSTAT PLUS Cold Sore Treatment		Camphor, Menthol	OINTMENT	TOPICAL	20220622		OTC MONOGRAPH DRUG	M017	Herstat (USA) Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3; .1	g/100g; g/100g			N	20241231
90100-222_0c049cac-82ec-3788-e063-6394a90a1625	90100-222	HUMAN OTC DRUG	HERSTAT GST Genital Sore Treatment		Camphor, Menthol	OINTMENT	TOPICAL	20220916		OTC MONOGRAPH DRUG	M017	Herstat (USA) Inc.	CAMPHOR (SYNTHETIC); MENTHOL	3; .1	g/100g; g/100g			N	20241231
90106-001_ac558a95-79b2-8fb1-e053-2995a90a9fa6	90106-001	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200807		OTC MONOGRAPH NOT FINAL	part333E	Sarina Accessories, LLC	ALCOHOL	62	mL/100mL			N	20241231
90106-002_ac57aad9-6f49-45b6-e053-2a95a90ad83e	90106-002	HUMAN OTC DRUG	Hand Sanitizer		ETHYL ALCOHOL	GEL	TOPICAL	20200807		OTC MONOGRAPH NOT FINAL	part333E	Sarina Accessories, LLC	ALCOHOL	62	mL/100mL			N	20241231
90106-003_adaa3f3c-b3cb-aa87-e053-2995a90ad2f0	90106-003	HUMAN OTC DRUG	SARINA	ANTISEPTIC	Chlorhexidine Digluconate	LIQUID	ORAL	20200825		OTC MONOGRAPH NOT FINAL	part356	Sarina Accessories, LLC	CETYLPYRIDINIUM CHLORIDE	1	mg/100mL			N	20241231
90107-1103_f2a34cdd-8f64-58af-e053-2a95a90a87d6	90107-1103	HUMAN OTC DRUG	After Bite Advanced		SODIUM BICARBONATE	LIQUID	TOPICAL	20210101		OTC MONOGRAPH FINAL	part347	Adventure Ready Brands	SODIUM BICARBONATE	50	mg/mL	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20241231
90107-1280_0df87e23-0bcb-494c-e063-6294a90a786f	90107-1280	HUMAN OTC DRUG	After Bite Kids		SODIUM BICARBONATE	CREAM	TOPICAL	20200901		OTC MONOGRAPH DRUG	M016	Adventure Ready Brands	SODIUM BICARBONATE	1	g/20g	Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]		N	20251231
90107-2410_f2a1fed2-d2db-5aa9-e053-2a95a90af718	90107-2410	HUMAN OTC DRUG	The Itch Eraser		DIPHENHYDRAMINE HYDROCHLORIDE	SPRAY	TOPICAL	20200901		OTC MONOGRAPH NOT FINAL	part348	Adventure Ready Brands	DIPHENHYDRAMINE HYDROCHLORIDE	20	mg/mL	Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]		N	20241231
90119-001_08aae52c-2d0c-377b-e063-6294a90a0635	90119-001	HUMAN OTC DRUG	Rough and Smooth Heavy Duty Antiseptic Hand Sanitizer		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20200830		OTC MONOGRAPH DRUG	505G(a)(3)	Orbizorb LLC	BENZALKONIUM CHLORIDE	1.3	mg/g			N	20241231
90119-002_08aad8d0-da11-e9b2-e063-6394a90a962e	90119-002	HUMAN OTC DRUG	Rayon Bamboo Heavy Duty Antiseptic Hand Sanitizer Wipes		BENZALKONIUM CHLORIDE	CLOTH	TOPICAL	20210105		OTC MONOGRAPH DRUG	505G(a)(3)	Orbizorb LLC	BENZALKONIUM CHLORIDE	1.3	mg/mL			N	20241231
98132-000_06e761d0-9eeb-3e5a-e063-6394a90ab72c	98132-000	HUMAN OTC DRUG	bareMinerals Complexion Rescue Defense Radiant Protective Veil Broad Spectrum SPF 30	Soft Radiance	TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20180601		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	32.8; 124.8	mg/mL; mg/mL			N	20241231
98132-001_06e6eed4-610b-69dd-e063-6294a90ae369	98132-001	HUMAN OTC DRUG	BAREMINERALS SPF 20 CORRECTING CONCEALER	Dark 2	TITANIUM DIOXIDE	CREAM	TOPICAL	20210426		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.1	g/2g			N	20241231
98132-002_06e6eed4-610b-69dd-e063-6294a90ae369	98132-002	HUMAN OTC DRUG	BAREMINERALS SPF 20 CORRECTING CONCEALER	Deep 2	TITANIUM DIOXIDE	CREAM	TOPICAL	20210426		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.1	g/2g			N	20241231
98132-003_06e76ca9-ea3e-5e57-e063-6294a90a89e9	98132-003	HUMAN OTC DRUG	bareMinerals Prime Time BB Primer-Cream Broad Spectrum SPF 30	Medium	TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20210730		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	781; 1861	mg/31mL; mg/31mL			N	20241231
98132-004_06e76ca9-ea3e-5e57-e063-6294a90a89e9	98132-004	HUMAN OTC DRUG	bareMinerals Prime Time BB Primer-Cream Broad Spectrum SPF 30	Light	TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20210730		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	780; 1860	mg/30mL; mg/30mL			N	20241231
98132-005_06e82259-5f4b-e44a-e063-6394a90a45ce	98132-005	HUMAN OTC DRUG	bareMinerals Multi-Tasking SPF 20 Concealer	Bisque	Titanium Dioxide	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	488	mg/2g			N	20241231
98132-006_06e82259-5f4b-e44a-e063-6394a90a45ce	98132-006	HUMAN OTC DRUG	bareMinerals Multi-Tasking SPF 20 Concealer	Summer Bisque	Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	500; 400	mg/2g; mg/2g			N	20241231
98132-007_06e82259-5f4b-e44a-e063-6394a90a45ce	98132-007	HUMAN OTC DRUG	bareMinerals Multi-Tasking SPF 20 Concealer	Honey Bisque	Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	400; 400	mg/2g; mg/2g			N	20241231
98132-008_06e82259-5f4b-e44a-e063-6394a90a45ce	98132-008	HUMAN OTC DRUG	bareMinerals Multi-Tasking SPF 20 Concealer	Deep Bisque	Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	320; 200	mg/2g; mg/2g			N	20241231
98132-009_06e77370-10c9-6354-e063-6294a90ad20f	98132-009	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Fairly Light 03	TITANIUM DIOXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	2000	mg/8g			N	20241231
98132-010_06e77d10-8fe4-736f-e063-6294a90a2c29	98132-010	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Light 08	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	1440; 1760	mg/8g; mg/8g			N	20241231
98132-011_06e77d10-8fe8-736f-e063-6294a90a2c29	98132-011	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Medium Tan 18	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	688; 2000	mg/8g; mg/8g			N	20241231
98132-012_06e7762a-930c-3f6e-e063-6394a90a2bf9	98132-012	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Tan 19	Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	720; 1760	mg/8g; mg/8g			N	20241231
98132-013_06e79929-8b06-7799-e063-6394a90a7416	98132-013	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Deep 28	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	777; 1600	mg/8g; mg/8g			N	20241231
98132-014_06e79289-06bc-8a1c-e063-6294a90a0747	98132-014	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Deepest Deep 30	ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	ZINC OXIDE	1440	mg/8g			N	20241231
98132-015_06e81c98-d6dc-d54a-e063-6394a90a04e0	98132-015	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Medium Dark 23	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	560; 1600	mg/8g; mg/8g			N	20241231
98132-016_06e81c98-d6dc-d54a-e063-6394a90a04e0	98132-016	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Warm Tan 22	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	560; 1600	mg/8g; mg/8g			N	20241231
98132-017_06e79289-06bb-8a1c-e063-6294a90a0747	98132-017	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Fair 04	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	2000; 1376	mg/8g; mg/8g			N	20241231
98132-018_06e79a65-1451-804e-e063-6394a90a2f3d	98132-018	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Fairly Medium 05	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	2000; 744	mg/8g; mg/8g			N	20241231
98132-019_06e78a6b-7745-6c50-e063-6394a90a0206	98132-019	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Tan 20	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	936; 1600	mg/8g; mg/8g			N	20241231
98132-020_06e81c98-d6dc-d54a-e063-6394a90a04e0	98132-020	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Dark 25	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	560; 1600	mg/8g; mg/8g			N	20241231
98132-021_06e81c98-d6dc-d54a-e063-6394a90a04e0	98132-021	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Warm Dark 26	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	560; 1600	mg/8g; mg/8g			N	20241231
98132-022_06e81c98-d6dc-d54a-e063-6394a90a04e0	98132-022	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Warm Deep 27	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	560; 1600	mg/8g; mg/8g			N	20241231
98132-023_06e77370-10c9-6354-e063-6294a90ad20f	98132-023	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Medium 10	TITANIUM DIOXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	2000	mg/8g			N	20241231
98132-024_06e768c5-8c28-3e1d-e063-6394a90a5cc5	98132-024	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Medium Beige 12	TITANIUM DIOXIDE and ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	1008; 1744	mg/8g; mg/8g			N	20241231
98132-025_06e77370-10c9-6354-e063-6294a90ad20f	98132-025	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Medium 14	TITANIUM DIOXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	2000	mg/8g			N	20241231
98132-026_06e78bae-6d9f-667f-e063-6394a90a8322	98132-026	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Neutral Dark 24	ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	ZINC OXIDE	1600	mg/8g			N	20241231
98132-027_06e78bae-6d9f-667f-e063-6394a90a8322	98132-027	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Neutral Deep 29	ZINC OXIDE	POWDER	TOPICAL	20210801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	ZINC OXIDE	1600	mg/8g			N	20241231
98132-028_06e61042-133e-6f8a-e063-6294a90a0be5	98132-028	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	FAIR 01	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-029_06e61042-133e-6f8a-e063-6294a90a0be5	98132-029	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	FAIR IVORY 02	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-030_06e61042-133e-6f8a-e063-6294a90a0be5	98132-030	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	FAIRLY LIGHT 03	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-031_06e61042-133e-6f8a-e063-6294a90a0be5	98132-031	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN FAIR 04	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-032_06e61042-133e-6f8a-e063-6294a90a0be5	98132-032	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	FAIRLY MEDIUM 05	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-033_06e61042-133e-6f8a-e063-6294a90a0be5	98132-033	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	NEUTRAL IVORY 06	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-034_06e61042-133e-6f8a-e063-6294a90a0be5	98132-034	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN IVORY 07	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-035_06e61042-133e-6f8a-e063-6294a90a0be5	98132-035	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	LIGHT 08	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-036_06e61042-133e-6f8a-e063-6294a90a0be5	98132-036	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	LIGHT BEIGE 09	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-037_06e61042-133e-6f8a-e063-6294a90a0be5	98132-037	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	MEDIUM 10	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-038_06e61042-133e-6f8a-e063-6294a90a0be5	98132-038	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	SOFT MEDIUM 11	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-039_06e61042-133e-6f8a-e063-6294a90a0be5	98132-039	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	MEDIUM BEIGE 12	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-040_06e61042-133e-6f8a-e063-6294a90a0be5	98132-040	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN BEIGE 13	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-041_06e61042-133e-6f8a-e063-6294a90a0be5	98132-041	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN MEDIUM 14	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-042_06e61042-133e-6f8a-e063-6294a90a0be5	98132-042	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	NEUTRAL MEDIUM 15	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-043_06e61042-133e-6f8a-e063-6294a90a0be5	98132-043	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN NUDE 16	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-044_06e61042-133e-6f8a-e063-6294a90a0be5	98132-044	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	TAN NUDE 17	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-045_06e61042-133e-6f8a-e063-6294a90a0be5	98132-045	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	MEDIUM TAN 18	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-046_06e61042-133e-6f8a-e063-6294a90a0be5	98132-046	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	TAN 19	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-047_06e61042-133e-6f8a-e063-6294a90a0be5	98132-047	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN TAN 20	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-048_06e61042-133e-6f8a-e063-6294a90a0be5	98132-048	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	NEUTRAL TAN 21	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-049_06e61042-133e-6f8a-e063-6294a90a0be5	98132-049	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	WARM TAN 22	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-050_06e61042-133e-6f8a-e063-6294a90a0be5	98132-050	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	MEDIUM DARK 23	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-051_06e61042-133e-6f8a-e063-6294a90a0be5	98132-051	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	NEUTRAL DARK 24	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-052_06e61042-133e-6f8a-e063-6294a90a0be5	98132-052	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN DARK 25	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-053_06e61042-133e-6f8a-e063-6294a90a0be5	98132-053	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	WARM DARK 26	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-054_06e61042-133e-6f8a-e063-6294a90a0be5	98132-054	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	WARM DEEP 27	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-055_06e61042-133e-6f8a-e063-6294a90a0be5	98132-055	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	GOLDEN DEEP 28	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-056_06e61042-133e-6f8a-e063-6294a90a0be5	98132-056	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	NEUTRAL DEEP 29	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-057_06e61042-133e-6f8a-e063-6294a90a0be5	98132-057	HUMAN OTC DRUG	bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen	DEEPEST DEEP 30	Titanium Dioxide	LIQUID	TOPICAL	20221223		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	.747	mg/mL			N	20241231
98132-159_06e82259-5f4c-e44a-e063-6394a90a45ce	98132-159	HUMAN OTC DRUG	BareMinerals	Mineral Veil	Titanium Dioxide and Zinc Oxide	POWDER	TOPICAL	20090730		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	25; 10	g/100g; g/100g			N	20241231
98132-201_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-201	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Fair 01	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-204_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-204	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Aspen 04	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-205_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-205	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Sateen 05	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-206_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-206	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Cashmere 06	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-207_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-207	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Warm Light 07	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-208_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-208	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Golden Ivory 08	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-209_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-209	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Light Natural 09	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-210_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-210	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Cool Beige 10	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-211_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-211	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Natural 11	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-212_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-212	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Warm Natural 12	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-213_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-213	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Golden Nude 13	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-214_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-214	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Silk 14	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-215_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-215	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Sandalwood 15	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-216_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-216	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Sandstone 16	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-218_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-218	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Pecan 18	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-219_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-219	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Toffee 19	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-221_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-221	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Sable 21	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-226_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-226	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Chai 26	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-229_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-229	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Truffle 29	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-230_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-230	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Cocoa 30	Titanium Dioxide	LIQUID	TOPICAL	20170801		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-231_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-231	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Fair 1C	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-232_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-232	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Fair Ivory 1N	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-233_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-233	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Fairly Light 1 NW	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-234_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-234	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Fairly Medium 1.5C	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-235_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-235	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Neutral Ivory 2N	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-236_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-236	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Light 2W	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-237_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-237	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Medium 3C	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-238_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-238	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Soft Medium 2CN	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-239_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-239	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Medium Beige 2.5N	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-240_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-240	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Golden Beige 2.5NW	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-241_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-241	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Neutral Medium 3N	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-242_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-242	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Golden Nude 3.5NW	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-243_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-243	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Tan Nude 3.5W	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-244_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-244	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Medium Tan 3.5CN	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-245_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-245	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Neutral Tan 4N	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-246_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-246	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Warm Tan 4.5CN	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-247_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-247	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Medium Dark 5CN	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-248_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-248	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Warm Deep 5.5N	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-249_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-249	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Neutral Deep 5.5NW	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-250_f06fbeeb-d455-6447-e053-2995a90a4a89	98132-250	HUMAN OTC DRUG	bareMinerals Blemish Rescue Skin-Clearing Loose Foundation	Deepest Deep 6C	SALICYLIC ACID	POWDER	TOPICAL	20191201		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	30	mg/6g			N	20241231
98132-252_06e77370-10c3-6354-e063-6294a90ad20f	98132-252	HUMAN OTC DRUG	bareMinerals Skinlongevity Vital Power Moisturizer Broad Spectrum SPF 30		TITANIUM DIOXIDE and ZINC OXIDE	CREAM	TOPICAL	20190101		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE; ZINC OXIDE	1870; 7128	mg/50mL; mg/50mL			N	20241231
98132-274_06e703b4-f438-c097-e063-6294a90a4821	98132-274	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Cashew 3.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-275_06e703b4-f438-c097-e063-6294a90a4821	98132-275	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Cinnamon 10.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-276_06e703b4-f438-c097-e063-6294a90a4821	98132-276	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Cedar 11	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-277_06e703b4-f438-c097-e063-6294a90a4821	98132-277	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Mahogany 11.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-278_06e703b4-f438-c097-e063-6294a90a4821	98132-278	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Bamboo 5.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-279_06e703b4-f438-c097-e063-6294a90a4821	98132-279	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Birch 1.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-280_06e703b4-f438-c097-e063-6294a90a4821	98132-280	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Desert 6.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-281_06e703b4-f438-c097-e063-6294a90a4821	98132-281	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Dune 7.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-282_06e703b4-f438-c097-e063-6294a90a4821	98132-282	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Wheat 4.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-283_06e703b4-f438-c097-e063-6294a90a4821	98132-283	HUMAN OTC DRUG	bareMinerals Complexion Rescue Tinted Hydrating Broad Spectrum SPF 30	Terra 8.5	Titanium Dioxide	GEL	TOPICAL	20191201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-284_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-284	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Deep Mahogany	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-285_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-285	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Fair Opal	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-286_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-286	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Fair Vanilla	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-287_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-287	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Fair Birch	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-288_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-288	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Light Cashew	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-289_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-289	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Light Bamboo	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-290_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-290	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Medium Wheat	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-291_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-291	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Medium Suede	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-292_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-292	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Medium Natural Pecan	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-293_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-293	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Medium Deep Tan Amber	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-294_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-294	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Medium Deep Desert	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-295_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-295	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Medium Deep Spice	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-296_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-296	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Deep Chestnut	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-297_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-297	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Deep Sienna	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-298_06e6f3fd-5abd-915a-e063-6394a90a95f4	98132-298	HUMAN OTC DRUG	bareMinerals Complexion Rescue Brightening Concealer SPF 25	Deep Cinnamon	Titanium Dioxide	LIQUID	TOPICAL	20221202		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	.065	g/10mL			N	20241231
98132-306_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-306	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Porcelain 0.5	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-307_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-307	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Ivory 02	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-308_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-308	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Shell 7.5	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-309_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-309	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Flax 9.5	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-310_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-310	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Linen 10.5	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-311_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-311	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Butterscotch 15.5	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-312_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-312	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Fawn 17	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-313_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-313	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Oak 20	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-314_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-314	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Almond 22	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-315_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-315	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Walnut 23	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-316_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-316	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Latte 24	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-317_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-317	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Maple 24.5	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-318_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-318	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Cinnamon 25	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-319_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-319	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Espresso 27	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-320_0c6aa8f4-c51c-10bf-e063-6394a90a59e5	98132-320	HUMAN OTC DRUG	bareMinerals BAREPRO Performance Wear Liquid Foundation Broad Spectrum SPF 20	Mocha 31	Titanium Dioxide	LIQUID	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	33.2	mg/mL			N	20241231
98132-751_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-751	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Opal 01	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-752_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-752	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Vanilla 02	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-753_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-753	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Buttercream 03	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-754_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-754	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Suede 04	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-755_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-755	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Natural 05	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-756_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-756	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Ginger 06	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-757_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-757	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Tan 07	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-758_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-758	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Spice 08	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-759_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-759	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Chestnut 09	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-760_06e6f3fd-5aba-915a-e063-6394a90a95f4	98132-760	HUMAN OTC DRUG	bareMinerals Complexion Rescue Broad Spectrum SPF 30	Sienna 10	Titanium Dioxide	LIQUID	TOPICAL	20150101		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE	62	mg/mL			N	20241231
98132-770_f05d88fc-f91e-3fa3-e053-2a95a90ace9b	98132-770	HUMAN OTC DRUG	bareMinerals Blemish Remedy Acne Treatment Gelee Cleanser		SALICYLIC ACID	EMULSION	TOPICAL	20160130		OTC MONOGRAPH FINAL	part333D	Orveon Global US LLC	SALICYLIC ACID	10	mg/g			N	20241231
98132-871_06e6ebb0-493c-a18f-e063-6394a90acaa1	98132-871	HUMAN OTC DRUG	Fair Foundation SPF 15		Zinc Oxide, Titanium Dioxide	POWDER	TOPICAL	20221003		OTC MONOGRAPH DRUG	M020	Orveon Global US, LLC	TITANIUM DIOXIDE; ZINC OXIDE	25; 19	g/100g; g/100g			N	20241231
98132-894_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-894	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Fair Ivory	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-895_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-895	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Beige	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-896_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-896	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Ivory	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-897_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-897	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Golden Nude	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-898_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-898	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Light Beige	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-899_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-899	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Neutral Ivory	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-900_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-900	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Neutral Medium	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-901_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-901	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Neutral Tan	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-905_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-905	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Soft Medium	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
98132-906_06e761d0-9ee5-3e5a-e063-6394a90ab72c	98132-906	HUMAN OTC DRUG	bareMinerals Original Foundation Broad Spectrum SPF 15	Tan Nude	Titanium Dioxide	POWDER	TOPICAL	20170201		OTC MONOGRAPH DRUG	M020	Orveon Global US LLC	TITANIUM DIOXIDE	25	g/100g			N	20241231
99207-010_d2c79614-6d4f-441f-a3a2-71c885a4ce39	99207-010	HUMAN PRESCRIPTION DRUG	Loprox		ciclopirox	SHAMPOO	TOPICAL	20030320		NDA	NDA021159	Bausch Health US, LLC	CICLOPIROX	10	mg/.96mL	Decreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]		N	20241231
99207-260_06f8e9e9-eba2-176e-e063-6394a90ab88e	99207-260	HUMAN PRESCRIPTION DRUG	Aldara		imiquimod	CREAM	TOPICAL	19970227		NDA	NDA020723	Bausch Health US LLC	IMIQUIMOD	50	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20241231
99207-270_0e7a6f8f-fba5-afe1-e063-6294a90ae551	99207-270	HUMAN PRESCRIPTION DRUG	Zyclara		imiquimod	CREAM	TOPICAL	20111128		NDA	NDA022483	Bausch Health US, LLC	IMIQUIMOD	37.5	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20251231
99207-271_0e7a6f8f-fba5-afe1-e063-6294a90ae551	99207-271	HUMAN PRESCRIPTION DRUG	Zyclara		imiquimod	CREAM	TOPICAL	20120101		NDA	NDA022483	Bausch Health US, LLC	IMIQUIMOD	37.5	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20251231
99207-276_0e7a6f8f-fba5-afe1-e063-6294a90ae551	99207-276	HUMAN PRESCRIPTION DRUG	Zyclara		imiquimod	CREAM	TOPICAL	20120229		NDA	NDA022483	Bausch Health US, LLC	IMIQUIMOD	2.5	mg/g	Increased Cytokine Activity [PE], Increased Cytokine Production [PE], Interferon Inducers [MoA]		N	20251231
99207-300_4b7e1338-0ec2-4a3f-acbd-8605c74d5d40	99207-300	HUMAN PRESCRIPTION DRUG	ZIANA		clindamycin phosphate and tretinoin	GEL	TOPICAL	20061201		NDA	NDA050802	Bausch Health US, LLC	CLINDAMYCIN PHOSPHATE; TRETINOIN	12; .25	mg/g; mg/g	Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Retinoid [EPC], Retinoids [CS]		N	20241231
99207-463_56aa28d4-9493-4cfb-ac2e-794105f6be64	99207-463	HUMAN PRESCRIPTION DRUG	Solodyn		minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090723		NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	65	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
99207-464_56aa28d4-9493-4cfb-ac2e-794105f6be64	99207-464	HUMAN PRESCRIPTION DRUG	Solodyn		minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20090723		NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	115	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
99207-465_56aa28d4-9493-4cfb-ac2e-794105f6be64	99207-465	HUMAN PRESCRIPTION DRUG	Solodyn		minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100927		NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	55	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
99207-466_56aa28d4-9493-4cfb-ac2e-794105f6be64	99207-466	HUMAN PRESCRIPTION DRUG	Solodyn		minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100927		NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	80	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
99207-467_56aa28d4-9493-4cfb-ac2e-794105f6be64	99207-467	HUMAN PRESCRIPTION DRUG	Solodyn		minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100927		NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]		N	20241231
99207-525_3c0a3f60-6794-4630-bbd7-a1b7aeba5c14	99207-525	HUMAN PRESCRIPTION DRUG	Vanos		fluocinonide	CREAM	TOPICAL	20060313		NDA	NDA021758	Bausch Health US, LLC	FLUOCINONIDE	1	mg/g	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]		N	20241231
99207-850_e52ec481-1114-4f09-9be0-311e5eb52fa1	99207-850	HUMAN PRESCRIPTION DRUG	Luzu		LULICONAZOLE	CREAM	TOPICAL	20131114		NDA	NDA204153	Bausch Health US, LLC	LULICONAZOLE	10	mg/g	Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA]		N	20241231
99528-606_f1e9f234-cca3-876f-e053-2995a90a5d40	99528-606	HUMAN OTC DRUG	Valerin		Valerian Root, Passiflora, Magnesium Carbonate	TABLET	ORAL	19860612		UNAPPROVED HOMEOPATHIC		Wonder Laboratories	MAGNESIUM CARBONATE; PASSIFLORA INCARNATA FLOWER; VALERIAN	1; 3; 6	[hp_X]/1; [hp_X]/1; [hp_X]/1			N	20241231
